<SEC-DOCUMENT>0001599298-26-000015.txt : 20260223
<SEC-HEADER>0001599298-26-000015.hdr.sgml : 20260223
<ACCEPTANCE-DATETIME>20260223161000
ACCESSION NUMBER:		0001599298-26-000015
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		116
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260223
DATE AS OF CHANGE:		20260223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Summit Therapeutics Inc.
		CENTRAL INDEX KEY:			0001599298
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				371979717
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36866
		FILM NUMBER:		26665225

	BUSINESS ADDRESS:	
		STREET 1:		601 BRICKELL KEY DRIVE
		STREET 2:		SUITE 1000
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33131
		BUSINESS PHONE:		305-203-2034

	MAIL ADDRESS:	
		STREET 1:		601 BRICKELL KEY DRIVE
		STREET 2:		SUITE 1000
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33131

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Summit Therapeutics plc
		DATE OF NAME CHANGE:	20150219

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Summit Corp plc
		DATE OF NAME CHANGE:	20140205
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>smmt-20251231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:5ba7c3ca-9242-422c-a50f-4bf839baf136,g:2c7db6f2-9106-44bc-b090-f2695a3e242b,d:defbe961c00a4bd4a140a4270c7a5ec4-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:smmt="http://www.summitplc.com/20251231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>smmt-20251231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-32">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-33">0001599298</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-34">2025</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-35">FY</ix:nonNumeric><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" scale="0" id="f-466">1</ix:nonFraction><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" scale="0" id="f-467">1</ix:nonFraction><ix:nonNumeric contextRef="c-115" name="smmt:NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering" id="f-775">P5D</ix:nonNumeric><ix:nonNumeric contextRef="c-177" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-888">P3Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="smmt-20251231.xsd"/></ix:references><ix:resources><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>smmt:segment</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:unit id="promissory_note"><xbrli:measure>smmt:promissory_note</xbrli:measure></xbrli:unit><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="contract"><xbrli:measure>smmt:contract</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AtMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AtMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AtMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AtMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AtMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AtMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AtMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AkesoLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AkesoLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AkesoLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:DistributionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">smmt:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">smmt:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">smmt:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">smmt:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">smmt:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-06</xbrli:startDate><xbrli:endDate>2023-03-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">smmt:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:KY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:KY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:KY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignTaxJurisdictionOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignTaxJurisdictionOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignTaxJurisdictionOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">smmt:NewJerseyAndCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">smmt:NewJerseyAndCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-08-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:NotePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:DugganFebruaryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:ZanganehNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:DugganSeptemberNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:DugganFebruaryNoteAndZanganehNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-06</xbrli:startDate><xbrli:endDate>2022-12-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:RevisedDugganFebruaryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-19</xbrli:startDate><xbrli:endDate>2023-01-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-19</xbrli:startDate><xbrli:endDate>2023-01-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:ZanganehNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-15</xbrli:startDate><xbrli:endDate>2023-02-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:RevisedDugganFebruaryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-15</xbrli:startDate><xbrli:endDate>2023-02-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:NotePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-06</xbrli:startDate><xbrli:endDate>2022-12-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="smmt:VariableRatePeriodAxis">smmt:VariableRatePeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:NotePurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-06</xbrli:startDate><xbrli:endDate>2022-12-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="smmt:VariableRatePeriodAxis">smmt:VariableRatePeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:NotePurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-06</xbrli:startDate><xbrli:endDate>2022-12-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:RevisedDugganFebruaryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-17</xbrli:startDate><xbrli:endDate>2024-02-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:RevisedDugganFebruaryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:ZanganehNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:RevisedDugganSeptemberNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-16</xbrli:startDate><xbrli:endDate>2024-09-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:PromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:PromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:PromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:RevisedDugganSeptemberNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-06</xbrli:startDate><xbrli:endDate>2022-12-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-06</xbrli:startDate><xbrli:endDate>2022-12-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-19</xbrli:startDate><xbrli:endDate>2023-01-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:S3RegistrationStatementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:S3RegistrationStatementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:S3RegistrationStatementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefOperatingOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-13</xbrli:startDate><xbrli:endDate>2023-10-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefOperatingOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefOperatingOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-13</xbrli:startDate><xbrli:endDate>2023-10-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-03</xbrli:startDate><xbrli:endDate>2024-06-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-11</xbrli:startDate><xbrli:endDate>2024-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-11</xbrli:startDate><xbrli:endDate>2024-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-11</xbrli:startDate><xbrli:endDate>2024-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-21</xbrli:startDate><xbrli:endDate>2025-10-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-10-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-21</xbrli:startDate><xbrli:endDate>2025-10-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-21</xbrli:startDate><xbrli:endDate>2025-10-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-21</xbrli:startDate><xbrli:endDate>2025-10-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-05-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:OriginalDistributionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-13</xbrli:startDate><xbrli:endDate>2024-05-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:DistributionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-11</xbrli:startDate><xbrli:endDate>2025-08-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:DistributionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-13</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:DistributionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2020StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2020StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-21</xbrli:startDate><xbrli:endDate>2020-09-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2020StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2020StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2020IncrementalPoolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2020IncrementalPoolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2024InducementPoolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2024InducementPoolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2024InducementPoolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-19</xbrli:startDate><xbrli:endDate>2020-08-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-19</xbrli:startDate><xbrli:endDate>2020-08-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionTimeBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionTimeBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionTimeBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionTimeBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionTimeBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionTimeBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionPerformanceBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionPerformanceBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionPerformanceBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionPerformanceBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionPerformanceBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionTimeBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionPerformanceAndMarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionPerformanceAndMarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionPerformanceAndMarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementFirstAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementFirstAndThirdAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementFirstAndThirdAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementFirstAndThirdAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementSecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementSecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementSecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementSecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:GeniusSubleaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:InvestmentsResearchSubleaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:GeniusSubleaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:InvestmentsResearchSubleaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementThirdAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementThirdAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2024-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:AkesoSupplyAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:AkesoSupplyAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:AkesoSupplyAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:AkesoSupplyAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:AkesoSupplyAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:CoChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:CoChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:CoChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:CoChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-08</xbrli:startDate><xbrli:endDate>2025-04-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:ConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:WilsonSonsiniGoodrichRosatiP.C.WSGRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-129 f-130 f-131" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"/><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-183 f-184 f-185 f-186 f-187 f-200 f-201 f-202 f-203 f-216 f-217 f-218 f-219 f-220 f-242 f-243 f-244 f-245" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"/><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-339 f-340 f-341 f-345 f-346 f-347 f-351 f-352 f-353" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"/></ix:resources></ix:header></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_1"></div><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:700;line-height:120%">_____________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:700;line-height:120%">_____________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(Mark One)</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric>&#160;&#160;&#160;&#160;ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">December 31</ix:nonNumeric>, 2025</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">or</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">For the transition period from                      to                     </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Commission file number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-36866</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.637%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">Summit Therapeutics Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.637%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"><tr><td style="width:1.0%"/><td style="width:20.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.298%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.972%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">37-1979717</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(State or Other Jurisdiction of Incorporation or Organization)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">601 Brickell Key Drive, Suite 1000</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">Miami</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-12">FL</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">33131</ix:nonNumeric></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">305</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">203-2034</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.625%"><tr><td style="width:1.0%"/><td style="width:34.039%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.489%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">SMMT</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    <ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-19">Yes</ix:nonNumeric> &#9746;   No  &#9744;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.   Yes  &#9744;    <ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-20">No</ix:nonNumeric>  &#9746;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-21">Yes</ix:nonNumeric> &#9746;    No &#9744;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-22">Yes</ix:nonNumeric>  &#9746;    No  &#9744;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:18.658%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:51.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.675%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.728%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-23">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-24">&#9744;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-25">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  <ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="f-26">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%"></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-27"></ix:nonNumeric>Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive o&#64259;cers during the relevant recovery period pursuant to &#167;240.10D-1(b). </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes     No  <ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-28">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of the voting common stock held by non-affiliates based on the closing stock price on June 30, 2025, was $<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-5" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="6" id="f-29">2,483.8</ix:nonFraction> million. For purposes of this computation only, all executive officers and directors have been deemed affiliates.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">The number of outstanding shares of the registrant&#8217;s common stock, par value $0.01 per share, as of February&#160;17, 2026 was <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-30">775,372,700</ix:nonFraction>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Documents Incorporated by Reference</span></div><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-31" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">Portions of the registrant&#8217;s definitive proxy statement relating to the registrant&#8217;s 2026 annual meeting of stockholders to be filed hereafter are incorporated by reference into Part III of this Annual Report on Form 10-K. The registrant&#8217;s definitive proxy statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:3pt"><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_7"></div><div style="text-align:right"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:12.264%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:80.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibd616e29c28a438eae0fdb36a9f9a331_34624">Cautionary Note Regarding Forward-Looking Statements</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ibd616e29c28a438eae0fdb36a9f9a331_34625">Summary of Risk Factors</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_10">PART I</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_16">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_16">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_19">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_19">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 1C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_22">Cybersecurity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_22">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_25">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_25">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_28">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_28">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_31">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_31">68</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_34">PART II</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_37">Market for Registrant</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_37">s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_37">69</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_40">[Reserved]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_40">70</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic81c3275ebf442faa7530f3ad20bea42_145527">Management</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic81c3275ebf442faa7530f3ad20bea42_145527">&#8217;</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic81c3275ebf442faa7530f3ad20bea42_145527">s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_43">70</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_46">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_46">82</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_49">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_49">82</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_52">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_52">82</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_55">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_55">83</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_58">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_58">83</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_61">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_61">83</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_64">PART III</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_67">Directors, Executive Officers, and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_67">84</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_70">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_70">84</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_73">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_73">84</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_76">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_76">84</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_79">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_79">84</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_82">PART IV</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_85">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_85">85</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;16</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_91">Report Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_91">89</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_94">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idefbe961c00a4bd4a140a4270c7a5ec4_94">90</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span id="ibd616e29c28a438eae0fdb36a9f9a331_12209"></span><span id="ibd616e29c28a438eae0fdb36a9f9a331_34624"></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), regarding the future financial performance, business prospects and growth of Summit Therapeutics Inc., that involve substantial risks and uncertainties. All statements contained in this Annual Report on Form 10-K, other than statements of historical fact, including statements regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects, plans and objectives of management, are forward-looking statements. The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;target,&#8221; &#8220;potential,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;continue,&#8221; and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements in this Annual Report on Form 10-K include, among other things, statements about:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to develop a successful product candidate under the License Agreement (as defined in Part I, Item I Business, Company Overview);</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to raise sufficient additional funds to make payments under the License Agreement, and fund ongoing operations and capital needs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of and the ability to effectively execute clinical development of ivonescimab;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing, costs, conduct and outcomes of clinical trials for any product candidates, including ivonescimab;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our plans with respect to possible future collaborations and partnering arrangements;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential benefits of possible future acquisitions or investments in other businesses, products or technologies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our plans to pursue research and development of other future product candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our estimates regarding the potential market opportunity and patient population for commercializing our product candidates, if approved for commercial use;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our sales, marketing and distribution capabilities and strategy;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to establish and maintain arrangements with third parties, such as contract research organizations, contract manufacturing organizations, suppliers and distributors;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and protecting our intellectual property rights and defending against any intellectual property-related claims;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our estimates regarding expenses, future revenues, capital requirements and needs for additional financing;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of government laws and regulations in the United States and in foreign countries;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and likelihood of regulatory filings and approvals for our product candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether regulatory authorities determine that additional trials or data are necessary in order to accept a new drug application for review and approval;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our competitive position;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our planned use of our existing cash, cash equivalents and marketable securities; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract and retain key scientific or management personnel;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of public health epidemics, such as the coronavirus pandemic (&#8220;COVID-19&#8221;), natural disasters or geopolitical instability, the response to such events and the potential effects of such events on our business, financial results, supply chain and market; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic conditions, including economic slowdowns or other adverse economic conditions, such as periods of increased or prolonged inflation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. We have included important factors in the cautionary statements included in this Annual Report on Form 10-K, particularly in the &#8220;Risk Factors&#8221; in Part 1, Item 1A of this Annual Report on Form 10-K, that we believe could cause actual results or events to differ materially from the forward-looking statements that we make. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">You should read this Annual Report on Form 10-K and the documents that we have filed as exhibits to this Annual Report on Form 10-K completely and with the understanding that our actual future results may be materially different from what we expect. We do not assume any obligation to update any forward-looking statements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span id="ibd616e29c28a438eae0fdb36a9f9a331_12211"></span><span id="ibd616e29c28a438eae0fdb36a9f9a331_34625"></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">SUMMARY OF RISK FACTORS</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Below is a summary of the principal factors that make an investment in Summit speculative or risky. The following summary does not contain all of the information that may be important to you, and you should read the below summary in conjunction with the more detailed discussion of risks set forth under the heading &#8220;Risk Factors&#8221; in Part I, Item IA of this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Financial Position and Need for Additional Capital</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">We are a development-stage company and have incurred significant losses since our inception. We anticipate that we will continue to incur significant losses for at least the next several years and may never generate profits from operations or maintain profitability.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">We have not yet demonstrated an ability to successfully complete development of any product candidates, and a Biologics License Application (&#8220;BLA&#8221;) that has been accepted for filing, such as the BLA relating to the HARMONi study, may not ultimately lead to regulatory approval and commercialization of ivonescimab.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">We will need substantial additional capital to fund our operations. Raising additional capital may cause dilution to our investors or restrict our operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">We depend heavily on the success of ivonescimab. If we are unable to successfully develop and commercialize ivonescimab, or experience significant delays in doing so, we may extend the period in which we will incur significant financial losses as an organization.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Worldwide economic, social and geopolitical instability could adversely affect our business and ability to raise capital in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Development and Commercialization of our Product Candidates</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">We can provide no assurance that our clinical product candidates, including our lead product candidate, ivonescimab, will obtain regulatory approval or that the results of clinical studies will be favorable.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Clinical development involves a lengthy and expensive process with an uncertain outcome, and results of earlier studies and trials conducted by us or Akeso (as defined in Part I, Item I Business, Company Overview), as well as any interim results thereof, may not be predictive of future trial results and may negatively impact the size and scope of our ongoing or future Phase III clinical trials. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Regulatory requirements and timelines may affect the scope and timeline of our trials and the potential market for our product candidates.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">If we experience unforeseen events, including unfavorable results, in connection with our clinical trials, potential marketing approval or commercialization of our product candidates could be delayed or prevented.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Serious adverse events may limit our development of a product candidate.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Even if a product candidate receives marketing approval, it may fail to achieve commercial success.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">We may expend our limited resources to pursue a particular product candidate and fail to capitalize on product candidates that may be more profitable or for which there is a greater likelihood of success.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Others may discover, develop or commercialize products before us or more successfully than we do.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Dependencies on Third Parties</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">We depend on our relationship with, and the intellectual property licensed from Akeso.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">We may be reliant on Akeso for knowledge transfer relating to any improvements in manufacturing of ivonescimab. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">We depend on collaborations with third parties for the development and commercialization of some of our product candidates.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">We rely on the use of third parties, including Akeso, to manufacture our product candidate.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">We rely on third parties to conduct our clinical trials and those third parties may not perform satisfactorily.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Legal, Tax, Regulatory and Compliance Risks</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Any approved product candidate may become subject to unfavorable pricing regulations, third-party reimbursement practices or other healthcare reform initiatives.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Our business is subject to the risks associated with doing business in China, including impacts from tariffs, data security laws and regulations, and restrictions on data transfer. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Product liability lawsuits against us could materially harm our business.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">If we fail to comply with applicable laws and regulations, we could face material adverse consequences.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Changes to tax laws or the interpretation thereof could increase our future tax liabilities and adversely affect our business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ii</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Our future tax liabilities may be greater than expected if our net operating loss carryforwards and other tax attributes are limited, we do not generate expected deductions, or tax authorities challenge our tax positions. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">If we are unsuccessful or delayed in obtaining required regulatory approvals, we may not be able to commercialize our product candidates, and our ability to generate revenue will be materially impaired.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Our ability to obtain and maintain conditional marketing authorizations in the EU and other countries in our Licensed Territory (as defined in Part I, Item I Business, Akeso Collaboration and License Agreement) may be more limited in number as well as scope of the relevant authorizations and subject to several conditions and obligations that could prevent us from continuing to market our products.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">The terms of any received marketing approvals, including post-marketing requirements, and  regulations may limit how we manufacture, market and price our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Intellectual Property, Cybersecurity and Data Privacy</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Insufficient patent protection could materially negatively impact our competitive position.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Any litigation relating to our intellectual property may have a material adverse effect on our business.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">We may be subject to claims by third parties asserting misappropriation of their intellectual property.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">If we are unable to protect the confidentiality of our trade secrets, our business could be harmed.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Any interruption, malfunction, or lapse related to information technology, including any cybersecurity incidents, could harm our business.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Failure to comply with data privacy and security obligations could harm our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Operations</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">We depend on our ability to retain our Co-Chief Executive Officers, Chief Operating Officer and other key executives and personnel.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">We or the third parties we rely on may be adversely affected by social unrest, terrorism or natural disasters.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Widespread health concerns or pandemics or epidemics could harm our business.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Any non-compliance with regulations or other misconduct by employees could harm our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Owning Our Common Stock</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Our principal stockholder and Co-Chief Executive Officer maintains the ability to control or significantly influence all matters submitted to stockholders for approval.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">We are a &#8220;controlled company&#8221; under the listing requirements of the Nasdaq Stock Market, which could adversely affect our stockholders.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">The price of our shares of common stock have been, and may continue to be, volatile.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Substantial future sales of our shares of common stock in the public market, or the perception that these sales could occur, could cause the price of the shares to decline significantly, even if our business is doing well.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Any failure to maintain an effective system of internal control over financial reporting could decrease confidence in our financial and other public reporting, which would harm our business.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers and employees is limited by our Certificate of Incorporation.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">Because we do not anticipate paying any cash dividends on our shares of common stock in the foreseeable future, capital appreciation, if any, will be the sole source of gain for our stockholders.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;padding-left:14.5pt">We are exposed to risks related to currency exchange rates.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">iii</span></div></div></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:24pt;text-align:center"><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_13"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:156%">PART I</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Business </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Summit Therapeutics Inc. (&#8220;we&#8221;, &#8220;Summit&#8221; or the &#8220;Company&#8221;) is a biopharmaceutical company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The Company&#8217;s pipeline of product candidates is designed with the goal to become the patient-friendly, new-era standard-of-care medicines, in the therapeutic area of oncology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s current lead development candidate is ivonescimab, a novel, potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF (as defined in Part I, Item I Business, Company Overview, Ivonescimab) compound into a single molecule. On December 5, 2022, the Company entered into the License Agreement with Akeso, Inc. and its affiliates (collectively, &#8220;Akeso&#8221;) pursuant to which the Company has in-licensed intellectual property rights related to ivonescimab (as amended, the &#8220;License Agreement&#8221;). Through the License Agreement, the Company obtained the rights to develop and commercialize ivonescimab in the United States, Canada, Europe, and Japan. The License Agreement and transaction closed in January 2023 following customary waiting periods. On June 3, 2024, the Company entered into the Second Amendment with Akeso to expand its territories covered under the License Agreement to also include Latin America, including Mexico and all countries in Central America and South America, the Middle East and Africa. The Company&#8217;s operations are focused on the development of ivonescimab and other future activities, as the Company determines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company is developing ivonescimab in non-small cell lung cancer (&#8220;NSCLC&#8221;) and colorectal cancer (&#8220;CRC&#8221;), specifically conducting Phase III clinical trials in the following proposed indications:</span></div><div><span><br/></span></div><div style="padding-left:31.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(a)  ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (&#8220;EGFR&#8221;)-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a third-generation EGFR tyrosine kinase inhibitor (&#8220;TKI&#8221;) (&#8220;HARMONi&#8221;); </span></div><div><span><br/></span></div><div style="padding-left:31.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(b)  ivonescimab combined with chemotherapy in patients with first-line metastatic NSCLC (including separate statistical analyses planned for patients with squamous NSCLC and non-squamous NSCLC) (&#8220;HARMONi-3&#8221;); </span></div><div><span><br/></span></div><div style="padding-left:31.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(c)  ivonescimab monotherapy in patients with first-line metastatic NSCLC whose tumors have high PD-L1 expression (&#8220;HARMONi-7&#8221;); and</span></div><div style="padding-left:31.5pt"><span><br/></span></div><div style="padding-left:31.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(d)  ivonescimab combined with chemotherapy in patients with first-line unresectable metastatic CRC (&#8220;HARMONi-GI3&#8221;).</span></div><div style="padding-left:31.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In October 2024, the Company completed enrollment in its HARMONi clinical trial. In May 2025, we announced topline results from our multiregional, double-blinded, placebo-controlled, Phase III study HARMONi. At the prespecified primary data analysis, ivonescimab in combination with chemotherapy demonstrated a statistically significant improvement in progression free survival (&#8220;PFS&#8221;), the magnitude of which we believe to be clinically meaningful, with a hazard ratio of 0.52 (95% CI: 0.41 &#8211; 0.66; p&lt;0.00001) compared to placebo in combination with chemotherapy; median PFS was 6.8 months for those patients receiving ivonescimab plus chemotherapy compared to 4.4 months for those receiving chemotherapy. PFS was assessed by blinded independent central radiology committee (&#8220;BICR&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We believe the PFS hazard ratio that was observed in both Asian and Western sub-populations to be clinically meaningful. The primary analysis demonstrated the consistency of the magnitude of the PFS benefit between patients randomized in Asian and Western territories, as well as the consistency in a single-region study (HARMONi-A) with this multiregional study.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In a longer-term follow-up of PFS, which included all Western patients and at least six months of follow-up time for all patients, ivonescimab plus chemotherapy demonstrated a consistent improvement in PFS with an observed HR of 0.57 (95% CI: 0.46 &#8211; 0.71). With the longer-term follow-up analysis, consistency of the magnitude of PFS benefit was demonstrated between patients randomized in Asia and Western patients when measured by hazard ratio. This longer-term follow-up analysis of PFS was performed at the time of the primary overall survival (&#8220;OS&#8221;) analysis.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Ivonescimab in combination with chemotherapy showed a positive trend in OS in the primary analysis without achieving a statistically significant benefit with a hazard ratio of 0.79 (95% CI: 0.62 &#8211; 1.01; p=0.057). This trend provides further support for its use in 2L+ EGFRm NSCLC, a setting where high unmet need continues to exist with limited approved options in the United States and other western territories. Currently, there are no FDA-approved regimens that have demonstrated a statistically significant OS benefit in this patient setting. Both Asian and North American patients demonstrated a positive trend in OS. The results of the primary analysis in this multiregional study were consistent with that of the single-region randomized Phase III HARMONi-A study, which demonstrated a statistically significant OS benefit with a hazard ratio of 0.74 in the primary OS analysis in a similar patient population.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In September 2025, an additional ad hoc OS analysis was performed for the HARMONi study whereby the Western patients were followed for a longer period of time (Asian patients were locked at the time of the primary analysis). In this analysis that included longer-term follow-up of Western patients (median follow-up time of Western patients of 13.7 months), a hazard ratio consistent with the primary analysis was observed with an improved nominal p-value (HR=0.78; 95% CI: 0.62 &#8211; 0.98; nominal p=0.0332). Median OS for this analysis remained the same in both arms as was observed in the primary analysis. Median OS in Western patients receiving ivonescimab was 17.0 months compared to 14.0 months for those receiving placebo (HR=0.84); median OS in North American patients, specifically, had not yet been reached in the ivonescimab arm compared to 14.0 months in the placebo arm (HR=0.70). The hazard ratios for Western patients in totality, as well as patients from the North American and European regions individually, improved from the primary OS analysis to the analysis with longer-term follow-up of Western patients. Consistent benefit was observed across pre-defined subgroups.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The dual primary endpoints were allocated separate alpha levels and tested individually. The alpha was recycled from the PFS to the OS analysis upon the successful achievement of the PFS endpoint.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Based on the results of the HARMONi clinical trial, we submitted a BLA in the fourth quarter of 2025 to seek approval for ivonescimab plus chemotherapy for this proposed indication. The positive results of the multiregional Phase III study are detailed further under &#8220;Product Pipeline&#8221; below. As previously disclosed, the FDA noted that a statistically significant overall survival benefit is necessary to support marketing authorization in this setting.  After careful consideration of the safety and efficacy profile of the current FDA-approved options for patients in this setting, the positive results of the Phase III multiregional study, including regional consistency, as well as discussions with key opinion leaders and those physicians who have administered ivonescimab to patients in a clinical study setting, we believe that the safety and efficacy data generated in the HARMONi study demonstrates that the ivonescimab regimen offers a potential treatment option for patients impacted by EGFR-mutant NSCLC in this setting with a favorable benefit-risk profile despite the lack of a statistically significant overall survival benefit. Summit announced in January 2026 that the FDA accepted for filing the BLA, seeking approval for ivonescimab in combination with chemotherapy for this proposed indication. The FDA noted it intends to perform a complete review of the accepted and filed BLA, including planned mid-cycle and wrap-up meetings, and, subject to major deficiencies not being identified during the FDA&#8217;s review, proposed labeling, prior to the Prescription Drug User Fee Act goal action date of November 14, 2026.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Akeso Collaboration and License Agreement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the License Agreement with Akeso, the Company received the rights to develop and commercialize ivonescimab in the United States, Canada, Europe, Japan, Latin America, Middle East and Africa regions (collectively, the &#8220;Licensed Territory&#8221;). Akeso retained development and commercialization rights for the rest of the world excluding the Licensed Territory. In exchange for these rights, Summit made an upfront payment during the first quarter of 2023 comprised of $474.9 million cash and the issuance of 10 million shares of Company common stock in lieu of $25.1 million cash pursuant to a share transfer agreement. Furthermore, on June 3, 2024, the Company entered into an amendment to the License Agreement with Akeso to expand its territories covered under the License Agreement to also include the Latin America, Middle East and Africa regions for which Summit paid an upfront payment of $15.0 million cash in the third quarter of 2024. In addition, the Company may also pay Akeso (a) milestone payments tied to achievement of regulatory approval of ivonescimab with various regulatory authorities in the Licensed Territory, (b) milestone payments tied to achievement of annual revenue from ivonescimab in the Licensed Territory and (c) royalty payments equal to low-double-digit percentage of annual revenues from ivonescimab in the Licensed Territory. In connection with the License Agreement, the Company agreed to purchase a certain portion of drug substance and/or drug product for clinical and commercial supply and to enter into a supply agreement with Akeso.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the terms of the License Agreement, Summit has final decision-making authority with respect to all of its commercialization activities including, but not limited to, commercial strategy, pricing and reimbursement in the Licensed Territory.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Summit has not assumed any liabilities (including contingent liabilities), nor acquired any physical assets or trade names, or hired or acquired any employees from Akeso in connection with the License Agreement.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Ivonescimab</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Ivonescimab is a novel potential first-in-class PD-1 / VEGF-A bispecific antibody, believed to be the most advanced in clinical development in the Licensed Territory. Engineered with Akeso&#8217;s unique Tetrabody technology, ivonescimab, as a single molecule, blocks programmed cell death protein 1 (&#8220;PD-1&#8221;) from binding to PD-L1 and PD-L2, and blocks the protein vascular endothelial growth factor-A (&#8220;VEGF&#8221;) from binding to VEGF receptors. Ivonescimab is designed to potentially allow cooperative binding of the intended targets, such that the binding of VEGF increases the binding affinity of PD-1. In view of the co-expression of VEGF and PD-1 in the tumor micro-environment (&#8220;TME&#8221;), ivonescimab may block these two pathways more effectively and enhance the antitumor activity, as compared to combination therapy through what is believed to be a unique cooperative binding mechanism.</span></div><div><span><br/></span></div><div><img src="smmt-20251231_g1.jpg" alt="smmt-20240630_g1.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:507px" id="i-1"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">This could differentiate ivonescimab as there is potentially higher expression (presence) of both PD-1 and VEGF in tumor tissue and the TME as compared to normal tissue in the body. As shown in Akeso&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">in-vitro</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> studies, ivonescimab&#8217;s tetravalent structure (four binding sites) enables higher avidity (accumulated strength of multiple binding interactions) in the TME with over 10-fold increased binding affinity to PD-1 in the presence of VEGF. This tetravalent structure, the intentional novel design of the molecule, and bringing these two targets into a single bispecific antibody with cooperative binding qualities has the potential to direct ivonescimab to the tumor tissue versus healthy tissue. The intent of this design is to improve upon previously established efficacy thresholds, in addition to side effects and safety profiles associated with these targets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Ivonescimab is currently being developed by both Akeso and the Company in multiple Phase III clinical trials. Over 4,000 patients have been treated with ivonescimab in clinical studies globally, and over 60,000 patients when considering those treated in a commercial setting in China as noted by Akeso.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:103%">Product Pipeline</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summit Sponsored Ivonescimab Trials</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Ivonescimab is currently being investigated in global Phase III clinical trials. Phase I and II trials were completed by or are ongoing with our partner Akeso. This pipeline reflects Phase III clinical trials that have been or are planned to be initiated by Summit in its Licensed Territory.</span></div><div><span><br/></span></div><div><img src="smmt-20251231_g2.jpg" alt="Picture1.jpg" style="height:150px;margin-bottom:5pt;vertical-align:text-bottom;width:684px" id="i-2"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">HARMONi</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">HARMONi study (NCT05184712) is a Phase III, multi-regional, potentially registration-enabling clinical trial, which enrolled patients in North America, Europe, and China. Patients enrolled in China were also enrolled as a part of the HARMONi-A study. We completed enrollment of patients in North America and Europe in October 2024. The two primary endpoints for this study are PFS and OS, and the study compares ivonescimab plus platinum-based doublet chemotherapy versus placebo plus platinum-based doublet chemotherapy in patients with advanced or metastatic EGFR-mutated NSCLC whose tumors have progressed following treatment with a third generation EGFR-TKI. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In May 2025, we announced topline results from our multiregional, double-blinded, placebo-controlled, Phase III study HARMONi. At the prespecified primary data analysis, ivonescimab in combination with chemotherapy demonstrated a statistically significant improvement in PFS, the magnitude of which we believe to be clinically meaningful, with a hazard ratio of 0.52 (95% CI: 0.41 &#8211; 0.66; p&lt;0.00001)  compared to placebo in combination with chemotherapy; median PFS was 6.8 months for those patients receiving ivonescimab plus chemotherapy compared to 4.4 months for those receiving chemotherapy. PFS was assessed by BICR.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We believe the PFS hazard ratio that was observed in both Asian and Western sub-populations to be clinically meaningful. The primary analysis demonstrated the consistency of the magnitude of the PFS benefit between patients randomized in Asia and Western territories, as well as the consistency in a single-region study (HARMONi-A) with this multiregional study.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In a longer-term follow-up of PFS, which included all Western patients and at least six months of follow-up time for all patients, ivonescimab plus chemotherapy demonstrated a consistent improvement in PFS with an observed HR of 0.57 (95% CI: 0.46 &#8211; 0.71). With the longer-term follow-up analysis, consistency of the magnitude of PFS benefit was demonstrated between patients randomized in Asia and Western patients when measured by hazard ratio. This longer-term follow-up analysis of PFS was performed at the time of the primary OS analysis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Ivonescimab in combination with chemotherapy showed a positive trend in OS in the primary analysis without achieving a statistically significant benefit with a hazard ratio of 0.79 (95% CI: 0.62 &#8211; 1.01; p=0.057). This trend provides further support for its use in 2L+ EGFRm NSCLC, a setting where high unmet need continues to exist with limited approved options in the United States and other western territories. Currently, there are no FDA-approved regimens that have demonstrated a statistically significant overall survival benefit in this patient setting. Both Asian and North American patients demonstrated a positive trend in overall survival. The results of the primary analysis in this multiregional study were consistent with that of the single-region randomized Phase III HARMONi-A study, which demonstrated a statistically significant OS benefit hazard ratio of 0.74 in the primary OS analysis in a similar patient population.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In September 2025, an additional ad hoc OS analysis was performed for the HARMONi study whereby the Western patients were followed for a longer period of time (Asian patients were locked at the time of the primary analysis). In this analysis that included longer-term follow-up of Western patients (median follow-up time of Western patients of 13.7 months), a hazard ratio consistent with the primary analysis was observed with an improved nominal p-value (HR=0.78; 95% CI: 0.62 &#8211; 0.98; nominal p=0.0332). Median OS for this analysis remained the same in both arms as was observed in the primary analysis. Median OS in Western patients receiving ivonescimab was 17.0 months compared to 14.0 months for those receiving placebo (HR=0.84); median OS in North American patients, specifically, had not yet been reached in the ivonescimab arm compared to 14.0 months </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">in the placebo arm (HR=0.70). The hazard ratios for Western patients in totality, as well as patients from the North American and European regions individually, improved from the primary OS analysis to the analysis with longer-term follow-up of Western patients. Consistent benefit was observed across pre-defined subgroups.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:119%">The dual primary endpoints were allocated separate alpha levels and tested individually. The alpha was recycled from the PFS to the OS analysis upon the successful achievement of the PFS endpoint.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The safety profile of ivonescimab in combination with chemotherapy was acceptable and manageable in the context of the observed clinical benefit with comparable rates of discontinuation and death between both arms. There were 16 patients (7.3%) who discontinued ivonescimab due to treatment-related adverse events (&#8220;TRAEs&#8221;) compared to 11 patients (5.0%) who discontinued placebo due to TRAEs. There were four patients (1.8%) in the ivonescimab plus chemotherapy arm and five patients (2.3%) in the chemotherapy alone arm who died as a result of TRAEs. In the ivonescimab plus chemotherapy arm, 50.0% of patients experienced Grade 3 or higher TRAEs compared to 42.2% in the chemotherapy arm. Of note, 0.9% of patients in the ivonescimab plus chemotherapy arm experienced Grade 3 or higher treatment-related hemorrhagic (bleeding) events. Based on the results of the HARMONi clinical trial, Summit submitted a BLA in the fourth quarter of 2025 in order to seek approval for ivonescimab plus chemotherapy in this setting.  Summit announced in January 2026 that the FDA accepted for filing the BLA, seeking approval for ivonescimab in combination with chemotherapy for this proposed indication. The FDA noted it intends to perform a complete review of the accepted and filed BLA, including planned mid-cycle and wrap-up meetings, and, subject to major deficiencies not being identified during the FDA&#8217;s review, proposed labeling, prior to the Prescription Drug User Fee Act goal action date of November 14, 2026.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">HARMONi-3 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">HARMONi-3 study (NCT05899608) is a Phase III, multi-regional, potentially registration-enabling clinical trial for which we initiated sites in North America, China and Europe. The two primary endpoints for this study are PFS and OS, and the study compares ivonescimab plus platinum-based doublet chemotherapy versus pembrolizumab plus platinum-based doublet chemotherapy in first-line patients with metastatic squamous NSCLC and non-squamous NSCLC. Enrollment is ongoing in all regions for patients with squamous and non-squamous tumors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In October 2025, the Company announced a protocol amendment to separate the statistical analysis of the primary endpoints by histology. Therefore, there will be separate analyses conducted to evaluate ivonescimab plus chemotherapy compared to pembrolizumab plus chemotherapy in patients with squamous NSCLC and in patients with non-squamous NSCLC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In order to sufficiently power for both primary endpoints (PFS and OS) in both cohorts of this study, Summit plans to enroll approximately 600 patients with squamous NSCLC and 1,000 patients with non-squamous NSCLC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As a result of having two separate intention-to-treat analyses within the HARMONi-3 study, the analyses for squamous tumors and non-squamous tumors may be conducted at separate times, as each analysis will be conducted upon the prespecified numbers of events being reached in the separate cohorts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Screening for patient enrollment has been completed for the planned patient count for the squamous cohort of HARMONi-3 in the first quarter of 2026. For the squamous cohort, we amended the study&#8217;s statistical analysis plan and expect to conduct an interim analysis for PFS in the second quarter of 2026. We anticipate that OS will be immature at the time of the interim PFS analysis. The Company expects to reach the prespecified number of events for the final PFS analysis for this cohort, if required, in the second half of 2026. An interim analysis for OS may be conducted at a similar time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Enrollment in the non-squamous cohort of HARMONi-3 is expected to complete in the second half of 2026. The Company expects to perform the final PFS analysis for this cohort in the first half of 2027. The Company will determine if an interim PFS analysis will be conducted for the study in the second half of 2026. Interim analyses for OS are planned to be conducted, based upon reaching prespecified numbers of events.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">HARMONi-7</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Based on the results of HARMONi-2, the Company is enrolling in the HARMONi-7 study (NCT06767514). HARMONi-7 is a multi-regional, potentially registration-enabling Phase III clinical trial that will compare ivonescimab monotherapy to pembrolizumab monotherapy in patients with metastatic squamous and non-squamous NSCLC whose tumors have high PD-L1 expression. The sample size for this study is currently planned to have an estimated 780 patients with two primary endpoints, PFS and OS.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:119%">HARMONi-GI3</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In the fourth quarter of 2025, the Company activated trial sites and began enrolling patients in HARMONi-GI3, a Phase III, multi-regional, clinical trial evaluating ivonescimab plus chemotherapy compared to bevacizumab plus chemotherapy as first line therapy in patients with unresectable metastatic CRC. The primary endpoint for this study is PFS and Summit plans to enroll approximately 600 patients.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Non-Sponsored Phase III Clinical Studies (Summit&#8217;s License Territories)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In the first quarter of 2026, the Company announced that GORTEC, a cooperative group dedicated to Head and Neck Oncology, will begin to activate clinical trial sites in the Phase III clinical study, ILLUMINE (NCT07264075), which will evaluate ivonescimab monotherapy and ivonescimab in combination with ligufalimab, Akeso&#8217;s proprietary anti-CD47 monoclonal antibody, against monotherapy pembrolizumab in a three-arm study. The study is intended to be conducted in multiple countries in Europe and in China; Summit will consider the expansion of this study into the United States. The primary endpoint for the study is OS. The study, currently planned to enroll 780 patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma (HNSCC), is expected to begin enrollment in the second quarter of 2026.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Data supporting this study was previously presented at ESMO 2024, whereby ivonescimab in combination with ligufalimab demonstrated an objective response rate of 60% in 20 patients with a median PFS of 7.1 months after a median follow-up time of 4.1 months; OS was not mature at the time of this analysis. At the time of data cut-off for this presentation, no patients receiving ivonescimab plus ligufalimab permanently discontinued drug treatment due to treatment-related adverse events.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Potential Future Clinical Development and Additional Current Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Summit is conducting its current clinical trials and plans to design and conduct additional clinical trial activities for ivonescimab within its Licensed Territory to support and submit relevant regulatory filings. We intend to explore further clinical development of ivonescimab in solid tumor settings outside of metastatic NSCLC and metastatic CRC, our current areas of focus in our Phase III clinical trials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In the fourth quarter of 2023, we began collaborating with multiple institutions globally and opened our investigator- sponsored trials program across several disease areas. We continued to expand this program in 2024 and 2025 in order to discover additional opportunities for ivonescimab, including in several tumors outside of our current development plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We plan to review the data generated from these clinical trials as well as Akeso-sponsored clinical trials as a part of our consideration for advancing our clinical development pipeline for ivonescimab in the Licensed Territory.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Additional Ivonescimab Development: Akeso-Sponsored Trials</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Akeso is currently developing ivonescimab in NSCLC and other solid tumor settings. Ivonescimab was approved by the National Medical Products Administration (&#8220;NMPA&#8221;) in May 2024 in China in combination with chemotherapy for patients with EGFR-mutated NSCLC whose tumors have progressed following an EGFR-TKI based on the results of the HARMONi-A clinical trial. Subsequently, ivonescimab was approved by the NMPA in April 2025 as monotherapy based on the results of the HARMONi-2 study in first-line, PD-L1 positive NSCLC. Also in October 2025, Akeso announced the positive data for the HARMONi-6 study in first-line squamous NSCLC for ivonescimab in combination with chemotherapy. Further details related to these three trials, in addition to other Phase II clinical data, are described further below. Akeso is currently conducting Phase III clinical trials in combination with chemotherapy in first-line biliary tract cancer (&#8220;HARMONi-GI1&#8221;), in first-line advanced PD-L1 low or negative triple-negative breast cancer (&#8220;TNBC&#8221;) (&#8220;HARMONi-BC1&#8221;), in first-line advanced microsatellite stable CRC (&#8220;HARMONi-GI6&#8221;) and in NSCLC for patients whose tumors have progressed following PD-(L)1 inhibitor based therapy (&#8220;HARMONi-8A&#8221;), as well as in combination with ligufalimab, a proprietary Akeso-owned investigational CD-47 monoclonal antibody, in first-line recurrent / metastatic PD-L1 positive head-and-neck cancer (&#8220;HARMONi-HN1&#8221;) and in combination with ligufalimab plus chemotherapy in first-line advanced pancreatic cancer (&#8220;HARMONi-GI2&#8221;). In addition, Akeso is conducting a Phase 3 study with ivonescimab after consolidation chemotherapy and radiotherapy in the limited stage small cell lung cancer (&#8220;SCLC&#8221;) setting (HARMONi-9).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">HARMONi-A</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Based on data published by Akeso at the American Society of Clinical Oncology (&#8220;ASCO 2024&#8221;) and in a publication in the </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Journal of the American Medical Association (JAMA)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> in the HARMONi-A study, in a single-region (China), randomized, double-blinded Phase III study in patients with NSCLC who have progressed following an EGFR-TKI, ivonescimab achieved its primary endpoint of PFS when combined with doublet chemotherapy (pemetrexed and carboplatin). Patients experienced a 54% reduction in disease progression or death as compared to placebo plus doublet-chemotherapy (HR: 0.46, 95% CI: 0.34 - 0.62; p&lt;0.001). In a pre-specified subgroup analysis of patients who received a previous third-generation TKI, a hazard ratio of 0.48 was observed. At the primary OS analysis of HARMONi-A, ivonescimab achieved a hazard ratio of 0.74 (95% CI: 0.58, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">0.95, p=0.019), demonstrating a statistically significant and clinically meaningful OS benefit, which was presented in November 2025 at the 2025 Annual Meeting for the Society for Immunotherapy for Cancer (SITC 2025). Ivonescimab demonstrated an acceptable and manageable safety profile, which was consistent with previous studies. There were nine patients (5.6%) who discontinued ivonescimab plus chemotherapy due to TRAEs compared to four patients (2.5%) who discontinued chemotherapy plus placebo due to TRAEs. No TRAEs resulted in the death of a patient in either arm in this Phase III study. Full results were published in JAMA (Fang et al. 2024).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">HARMONi-2</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">After announcing positive qualitative results on May 30, 2024 for the HARMONi-2 trial, also referred to as AK112-303, a randomized, single-region (China) Phase III study sponsored by Akeso, quantitative data was presented on September 8, 2024 from the primary analysis as part of the Presidential Symposium at the International Association for the Study of Lung Cancer&#8217;s (&#8220;IASLC&#8221;) 2024 World Conference on Lung Cancer (&#8220;WCLC 2024&#8221;). The HARMONi-2 presentation evaluated monotherapy ivonescimab compared to monotherapy pembrolizumab in patients with locally advanced or metastatic NSCLC whose tumors have positive PD-L1 expression. HARMONi-2 is a single region, multi-center, double-blinded Phase III study conducted in China sponsored by Akeso, with all relevant data exclusively generated, managed, and analyzed by Akeso.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In the HARMONi-2 primary analysis, ivonescimab monotherapy demonstrated a statistically significant improvement in the trial&#8217;s primary endpoint, PFS by Independent Radiologic Review Committee (&#8220;IRRC&#8221;), when compared to monotherapy pembrolizumab, achieving a hazard ratio of 0.51 (95% CI: 0.38, 0.69; p&lt;0.0001). A clinically meaningful benefit was demonstrated across clinical subgroups, including patients with tumors with high PD-L1 expression. OS data was not yet mature at the time of the data cutoff of the primary PFS analysis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Ivonescimab demonstrated an acceptable and manageable safety profile, which was consistent with previous studies. There were three patients (1.5%) who discontinued ivonescimab due to TRAEs compared to six patients (3.0%) who discontinued pembrolizumab due to TRAEs. There was one patient in the ivonescimab arm and two patients in the pembrolizumab arm who died as a result of TRAEs in this Phase III study. Full results were published in Lancet (Xiong et al. 2025).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On April 25, 2025, Akeso announced that ivonescimab was approved in China by the NMPA for a second indication based on the results of the HARMONi-2 trial. As a part of the review of the supplemental marketing application submitted by Akeso seeking a label expansion of ivonescimab in China, the NMPA requested that Akeso perform an interim analysis of OS. Akeso announced that the results of this interim OS analysis included a clinically meaningful hazard ratio of 0.777. The analysis was conducted at 39% data maturity, with a nominal alpha level of 0.0001 that had not reached statistical significance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">HARMONi-6</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">After announcing positive qualitative results for the HARMONi-6 trial, on April 23, 2025, detailed clinical trial results of the study were presented as part of the Presidential Symposium at the European Society for Medical Oncology&#8217;s 2025 Congress (&#8220;ESMO 2025&#8221;). The HARMONi-6 study evaluated ivonescimab in combination with platinum-based chemotherapy compared to tislelizumab (a PD-1 inhibitor) in combination with platinum-based chemotherapy in patients with previously untreated advanced NSCLC irrespective of PD-L1 expression. HARMONi-6, also referred to as AK112-306, is a single region, multi-center, double-blinded Phase III study conducted in China sponsored by Akeso, with all relevant data exclusively generated, managed, and analyzed by Akeso. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In the HARMONi-6 planned PFS interim analysis, ivonescimab in combination with chemotherapy demonstrated a statistically significant improvement in the primary endpoint, PFS, by IRRC, when compared to tislelizumab in combination with chemotherapy, achieving a hazard ratio of 0.60 (95% CI: 0.46, 0.78; p&lt;0.0001). A clinically meaningful benefit was demonstrated across clinical subgroups, including those with either PD-L1 negative or positive expression, as well as high-risk patients. OS data was not yet mature at the time of the data cutoff and is planned to be evaluated in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Ivonescimab demonstrated an acceptable and manageable safety profile in the HARMONi-6 study, which was consistent with previous Phase III studies conducted studying ivonescimab. Nine patients (3.4%) discontinued ivonescimab plus chemotherapy due to TRAEs compared to 11 patients (4.2%) receiving tislelizumab plus chemotherapy due to TRAEs. There were eight patients in the ivonescimab plus chemotherapy arm and 10 patients in the tislelizumab plus chemotherapy arm who died as a result of TRAEs in this Phase III study. Results were published in Lancet (Chen et al. 2025)</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Additional Phase II Data Sets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition to the HARMONi-2 data announced at WCLC 2024, Akeso also announced Phase II trial results from AK112-205, for patients with Stage II or III resectable NSCLC. Further, the Company announced data for ivonescimab was presented as a part of the 2024 European Society for Medical Oncology Annual Congress (&#8220;ESMO 2024&#8221;) featuring updated Phase II ivonescimab data in advanced TNBC, for which subsequent updates to the data have been presented thereafter, recurrent / </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">metastatic head and neck squamous cell carcinoma, and metastatic microsatellite-stable CRC. At ASCO 2024, Akeso presented ivonescimab Phase II data in biliary-tract cancer. Earlier, at the 2024 European Lung Cancer Conference, Akeso announced updated data from AK112-201 (Cohort 1), a Phase II study for patients with first-line advanced NSCLC. Each trial from which the data was generated was a multi-center Phase II study conducted in China sponsored by Akeso, with data generated and analyzed by Akeso.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The markets for oncology pharmaceuticals, in which we compete, are characterized by significant scientific innovation, regulatory oversight and intense competition. The key competitive factors affecting the success of our product candidates are likely to be their efficacy, safety, convenience, price and availability of coverage and reimbursement from government and other third-party payors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Many of our competitors may have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals, and marketing approved products than we do. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient, or are less expensive than any products that we may develop. Our competitors also may obtain marketing approvals for their products more rapidly than we obtain approval for ours giving them significant first movers advantage. Our commercial opportunity could also be reduced or eliminated if the results of our clinical trials, both safety and efficacy, combined with other factors, do not lead to significant adoption of our product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Competition for ivonescimab </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is developing ivonescimab in NSCLC and CRC, specifically conducting Phase III clinical trials in the following proposed indications:</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(a)  ivonescimab combined with chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a third-generation EGFR-TKI (&#8220;HARMONi&#8221;);</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(b)  ivonescimab combined with chemotherapy in patients with first-line metastatic NSCLC (including separate statistical analyses planned for patients with squamous NSCLC and non-squamous NSCLC) (&#8220;HARMONi-3&#8221;);</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(c)  ivonescimab monotherapy in patients with first-line metastatic NSCLC whose tumors have high PD-L1 expression (&#8220;HARMONi-7&#8221;); and</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(d)  ivonescimab combined with chemotherapy in patients with first-line unresectable metastatic CRC (&#8220;HARMONi-GI3&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Ivonescimab is also being investigated in multiple Phase II and Phase III clinical trials in China. We plan to review the data generated from these clinical trials as well as other data generated in studies with ivonescimab as a part of our consideration for advancing our clinical development pipeline for ivonescimab in the Licensed Territory.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">There are no known PD-1-based bispecific antibodies currently approved by the FDA, the European Medicines Agency (&#8220;EMA&#8221;), or Japan&#8217;s Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;). There are currently no known approved PD-1 / VEGF bispecific antibodies that are further advanced in clinical trial development or approved in the territories in which we have licensed ivonescimab. However, there are several PD-(L)1/VEGF(R2) bispecific antibodies in development around the world, including multiple that are currently in development or with planned development globally. These include, but are not limited to pumitamig (BNT327), which is owned by BioNTech SE and being developed in a collaboration with Bristol Myers Squibb Co. since June 2025, which has begun conducting Phase III clinical studies globally, PF&#8217;4404 (SSGJ-707 / PF-08634404), which was licensed globally, ex-China by Pfizer Inc. in July 2025, LM-299, which was licensed globally by Merck &amp; Co., Inc. in November 2024, and RC148, which was licensed outside of Greater China by AbbVie Inc. in January 2026.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our current clinical development plan in the Licensed Territory has focused primarily on NSCLC. Several pharmaceutical and biotechnology companies have established themselves in the market for the treatment of NSCLC, and several additional companies are developing products for the treatment of NSCLC. Currently, the most commonly used treatments for first-line NSCLC without genomic alterations are several immuno-oncology drugs and chemotherapies, administered either individually as monotherapy, in combination with each other, or in combination with other approved therapeutics. In addition to various chemotherapies, several immunotherapies have been approved by the FDA for these treatments, including, but not limited to pembrolizumab, atezolizumab, nivolumab, durvalumab, cemiplimab and ipilimumab. There are anti-angiogenic therapies which are approved for the treatment of certain lung cancers, including bevacizumab in front-line non-squamous NSCLC, as well as ramucirumab for patients who have progressed after platinum-based chemotherapy. The proposed indications for ivonescimab in the HARMONi-3 and HARMONi-7 clinical trial settings in first-line NSCLC may face competition from clinical candidates such as novel immunotherapy targets including various clinical candidates targeting T-cell immunoreceptors with Ig and ITIM domains (TIGIT) and lymphocyte activation gene 3 (LAG-3) each of which have various developers for different candidates as either monoclonal antibodies or multispecific antibodies, a bispecific antibody, volrustomig (AstraZeneca), rilvegostomig (AstraZeneca) and antibody drug conjugates (ADCs) with novel targets such as datopotamab deruxetecan (AstraZeneca and Daiichi Sankyo), sacituzumab tirumotecan (Merck), and sigvotatug vedotin (Pfizer), each having announced, are currently enrolling in, or having completed enrollment in Phase III clinical trials. Phase III clinical trials with pumitamig and PF&#8217;4404 are being conducted or intentions to conduct have been announced by their respective sponsors in first-line NSCLC in combination with chemotherapy, similar to the setting in which HARMONi-3 is currently being conducted.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For those patients with advanced NSCLC with EGFR mutations, there are several targeted therapies that have also been approved in the front-line setting, including, but not limited to, osimertinib (AstraZeneca) with or without chemotherapy and amivantamab and lazertinib (both from Johnson &amp; Johnson). The proposed indication for ivonescimab in the HARMONi clinical trial setting, post third-generation EGFR-TKIs such as osimertinib or lazertinib, may face competition from amivantamab plus chemotherapy and  datopotamab deruxetecan (AstraZeneca and Daiichi Sankyo), which are fully approved post TKI and have an accelerated approval post TKI and post chemotherapy, respectively. In addition, investigational agents such as sacituzumab tirumotecan (Merck), izalontamab brengitecan (BMS), telisotuzumab adizutecan (AbbVie) and savolitinib (AstraZeneca) are currently being investigated in the post-TKI setting in those patients with advanced EGFR mutation positive NSCLC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Beyond NSCLC, we are currently conducting the Phase III study for patients with first line metastatic unresectable CRC, HARMONi-GI3. For those patients with metastatic unresectable CRC whose tumors are not designated as mismatch repair deficient or have a specific treatable driver mutation (e.g., BRAF) in the first-line setting, there are limited treatment options beyond the currently approved regimens of bevacizumab plus chemotherapy, as well as cetuximab plus chemotherapy for a subset of these patients.  Intentions to conduct Phase III clinical trials with pumitamig and PF&#8217;4404 have been announced by their respective sponsors in first-line metastatic unresectable CRC, similar to the setting in which HARMONi-GI3 is currently being conducted. In addition, novel agents such as amivantamab plus chemotherapy are currently being investigated in a subset of this setting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Should ivonescimab ultimately receive marketing authorization in certain jurisdictions within the Licensed Territory, the marketing authorization holder for some of the approved agents may lose exclusive rights to these agents, increasing competition from biosimilar agents or generic compounds.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As we intend to explore further clinical development of ivonescimab in solid tumor settings outside of metastatic NSCLC and metastatic CRC, our current area of focus in our Phase III clinical trials, we will encounter significant competition in the development of ivonescimab in each of these potential settings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Manufacturing</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We do not own or operate, and currently have no plans to own manufacturing facilities for the production of clinical or commercial quantities of ivonescimab. We currently rely, and expect to continue to rely, on third parties for the manufacture of our product candidates and any products that we may develop.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ivonescimab</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the License Agreement, we agreed to purchase a certain portion of drug substance and/or drug product for clinical and commercial use and to enter into a supply agreement with Akeso. Until such time that we are able to establish second source suppliers or are able to manufacture the drug substance independently, Akeso shall be solely responsible for the manufacture of the drug substance for use in the Licensed Territory. We continue to make progress in transferring relevant </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">know-how to third parties to establish additional supply sources. We are using a different third-party supplier for clinical packaging, labeling and distribution of the clinical drug product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have obtained and maintain proprietary protection for our product candidates, technology and know-how. We strive to protect the proprietary technology by, among other methods, seeking and maintaining patents, where available, that are intended to cover our product candidates, compositions and formulations, their methods of use and processes for their manufacture and any other inventions that are commercially important to the development of our business. We also rely on trade secrets, know-how, continuing technological innovation and in-licensing opportunities to develop and maintain our proprietary and competitive position.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Ivonescimab Program</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> Following the completion of the License Agreement with Akeso, we have in-licensed the rights to various Akeso patents and patent applications covering ivonescimab and related compositions of matter and methods of manufacture/use in the Licensed Territory and have rights to control prosecution of such in-licensed intellectual property in the Licensed Territory in collaboration with Akeso. We continue to develop, identify, and strive to protect other technologies that are commercially relevant to our ivonescimab position. Our current ivonescimab patents cover regions including the United States, Europe and Japan and include compositions of matter and methods of preparation / use. Our current ivonescimab patents expire from 2039 &#8211; 2040. The protection afforded by any particular patent depends upon many factors, including the type of patent, scope of coverage encompassed by the granted claims, availability of extensions of patent term, availability of legal remedies in the particular territory in which the patent is granted, and success of any challenges to the patent, if asserted. Changes in either patent laws or in the interpretation of patent laws in the United States and other countries could diminish our ability to protect our inventions and to enforce our intellectual property rights. Accordingly, we cannot predict with certainty the enforceability of any granted patent claims or of any claims that may be granted from our patent applications.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Secrets</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> In addition to patents, we rely on trade secrets and know-how to develop and maintain our competitive position. Trade secrets and know-how can be difficult to protect; however, we take reasonable steps to protect our proprietary technology and processes, in part, by confidentiality agreements and invention assignment agreements with our employees, consultants, scientific advisors, contractors, manufacturers, and commercial partners. These agreements are designed to protect our proprietary information and, in the case of the invention assignment agreements, to grant us ownership of technologies that are developed through a relationship with a third party. We also seek to preserve the integrity and confidentiality of our data, trade secrets and know-how by maintaining physical security of our premises and physical and electronic security of our information technology systems.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trademarks</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> We are in the process of selecting a name for ivonescimab, which we will pursue protection for as a trademark in the Licensed Territory. In connection with the development of our product pipeline, we will seek protection for marks we currently use and future marks when appropriate.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to obtain, maintain or protect the intellectual property rights necessary to conduct our business, and we may be subject to claims, whether or not meritorious, that we infringe or otherwise violate the intellectual property rights of third parties or that our patent claims are not valid. For more information, please see the section on &#8220;Risk Factors &#8211; Risks Related to Intellectual Property&#8221;.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for serious diseases, we are subject to extensive and ongoing regulation by government authorities, including regulation by the FDA under the Federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;) and its implementing regulations, as well as by other regulatory bodies in the United States, Europe and other countries in which we operate. Government authorities in the United States, at the federal, state and local level, and in other countries and jurisdictions, including the European Union, extensively regulate, among other things, the research, development, testing, manufacture, quality control, approval, packaging, storage, record keeping, labeling, pricing, reimbursement, advertising, promotion, distribution, marketing, post-approval monitoring and reporting, import and export and patenting of pharmaceutical products. The processes for obtaining regulatory approvals in the United States and in foreign countries and jurisdictions, along with compliance with applicable statutes and regulations and other regulatory authorities, require the expenditure of substantial time and financial resources.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Review and Approval of Drugs and Biological Products in the United States</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In the United States, the FDA regulates drugs under the FDCA and implementing regulations. An entity that takes responsibility for the initiation and management of a clinical development program for such products, and for their regulatory approval, is </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">typically referred to as a &#8220;sponsor&#8221; or &#8220;applicant.&#8221; Biological products used for the prevention, treatment or cure of a disease or condition of a human being are subject to regulation under the FDCA, except that the section of the FDCA that governs the approval of new drug applications (&#8220;NDAs&#8221;) does not apply to the approval of biological products. Biological products are approved for marketing under provisions of the Public Health Service Act (the &#8220;PHSA&#8221;), via a BLA. However, the application process and requirements for approval of BLAs are very similar to those for NDAs, and biologics are associated with similar approval risks and costs as drugs. The failure of a sponsor to comply with the FDCA and applicable U.S. requirements at any time during the product development process, approval process or after approval may subject an applicant or sponsor to a variety of administrative or judicial sanctions, including imposition of a clinical hold or other delays in the conduct of a study, refusal by the FDA to approve pending applications, withdrawal of an approval, issuance of warning letters and other types of letters, product recalls, product seizures, total or partial suspension of production, importation or distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement of profits, or civil or criminal investigations and penalties brought by the FDA and the Department of Justice (&#8220;DOJ&#8221;), or other federal and state governmental entities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">An applicant seeking approval to market and distribute a new drug or biological product in the United States must typically undertake the following:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">completion of nonclinical laboratory tests, animal studies and formulation studies in compliance with the FDA&#8217;s good laboratory practice (&#8220;GLP&#8221;) regulations;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">submission to the FDA of an Investigational New Drug (&#8220;IND&#8221;) Application, which must take effect before human clinical trials may begin;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approval by an independent institutional review board (&#8220;IRB&#8221;) of each clinical study at each research site before a clinical trial may be initiated at the site;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">performance of adequate and well-controlled human clinical trials in accordance with current good clinical practice (&#8220;GCP&#8221;) standards, to establish the safety and efficacy of the proposed drug product for each indication;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">preparation and submission to the FDA of an NDA or BLA;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a determination by the FDA within 60 days of its receipt of an NDA or BLA to file the submission for review;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">review of the product candidate by an FDA advisory committee, where appropriate or if applicable;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">satisfactory completion of one or more FDA inspections of the manufacturing facility or facilities at which the product, or components thereof, are produced to assess compliance with current Good Manufacturing Practices (&#8220;cGMP&#8221;), requirements and to ensure that the facilities, methods and controls are adequate to preserve the product&#8217;s identity, strength, quality and purity;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">satisfactory completion of FDA audits of clinical trial sites to ensure compliance with GCPs and the integrity of the clinical data submitted in support of the NDA/BLA;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">payment of user fees and securing FDA approval of the NDA/BLA for the marketing of the drug product; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compliance with any post-approval requirements, including Risk Evaluation and Mitigation Strategies (&#8220;REMS&#8221;), where applicable, and any post-approval studies required by the FDA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nonclinical Studies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Before an applicant begins testing a compound with potential therapeutic value in humans, the product candidate must undergo rigorous preclinical testing. Preclinical studies include laboratory evaluation of the purity and stability of the API and the formulated drug product, as well as </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">and animal studies to assess the safety and activity of the drug for initial testing in humans and to establish a rationale for therapeutic use. The conduct of preclinical studies is subject to federal regulations and requirements, including GLP regulations and the United States Department of Agriculture's Animal Welfare Act, if applicable. Some long-term preclinical testing, such as animal tests of reproductive adverse events and carcinogenicity, may continue after the IND is submitted.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Companies usually must complete some long-term preclinical testing, such as animal tests of reproductive adverse events and carcinogenicity, and must also develop additional information about the synthesis and physical characteristics of the investigational product. Prior to submission of an NDA or BLA, a manufacturer must finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the candidate product and, among other things, the manufacturer must develop methods for testing the identity, strength, quality and purity of the final product. Additionally, appropriate packaging must be selected and tested. Stability studies must be conducted to demonstrate that the candidate product does not undergo unacceptable deterioration over its shelf-life.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The IND and IRB Processes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">An IND is an exemption from the FDCA that allows an unapproved drug to be shipped in interstate commerce for use in a clinical investigation and serves as a request for FDA authorization to administer an investigational drug to humans. Such authorization must be secured prior to interstate shipment and administration of any new drug that is not the subject of an approved NDA/BLA. In support of a request for an IND, a sponsor must submit a protocol for each clinical trial and any subsequent protocol amendments must be submitted to the FDA as part of the IND. In addition, the results of the preclinical tests, together with manufacturing information, analytical data, any available clinical data or literature and plans for clinical trials, among other things, are submitted to the FDA as part of an IND. The FDA requires a 30-day waiting period after the submission of each new IND before clinical trials may begin. This waiting period is designed to allow the FDA to review the IND to determine whether human research subjects will be exposed to unreasonable health risks. At any time during this 30-day period, the FDA may raise concerns or questions about the conduct of the trials as outlined in the IND and impose a clinical hold. In this case, the IND sponsor and the FDA must resolve any outstanding concerns before clinical trials can begin.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Following commencement of a clinical trial under an IND, the FDA may also place a clinical hold or partial clinical hold on that trial. Clinical holds are imposed by the FDA when there is concern for patient safety and may be a result of new data, findings, or developments in clinical, nonclinical, and/or chemistry, manufacturing, and controls (&#8220;CMC&#8221;). A clinical hold is an order issued by the FDA to the sponsor to delay a proposed clinical investigation or to suspend an ongoing investigation, and FDA must provide a basis for its imposition within 30 days after imposition of a clinical hold. A partial clinical hold is a delay or suspension of fewer than all of the clinical investigations, or certain parts of a clinical investigation, subject to the IND.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Following issuance of a clinical hold or partial clinical hold, an investigation, or the parts of the investigation subject to the partial clinical hold, may only resume after the FDA has notified the sponsor that the investigation may proceed. The FDA will base that determination on information provided by the sponsor correcting the deficiencies previously cited or otherwise satisfying the FDA that the investigation can proceed.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A sponsor may choose, but is not required, to conduct a foreign clinical study under an IND. When a foreign clinical study is conducted under an IND, all FDA IND requirements must be met unless waived. When the foreign clinical study is not conducted under an IND, the sponsor must ensure that the study complies with certain regulatory requirements of the FDA in order to use the study as support for an IND or application for marketing approval. Specifically, such studies must be conducted in accordance with GCP, including review,  approval, and continuing review by an independent ethics committee, or IEC, and freely given informed consent from subjects. The GCP requirements encompass both ethical and data integrity standards for clinical studies. The FDA&#8217;s requirements are intended to help ensure the protection of human subjects enrolled in non-IND foreign clinical studies, as well as the quality and integrity of the resulting data. They further help ensure that non-IND foreign studies are conducted in a manner comparable to that required for IND studies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the foregoing IND requirements, an IRB/Ethics Committee (&#8220;EC&#8221;) representing each institution participating in any clinical trial for which data is intended to be submitted to FDA must review and approve the plan for any clinical trial before it commences at that institution, and the IRB must conduct continuing review and reapprove the study at least annually. The IRB/EC must review and approve, among other things, the study protocol and informed consent information to be provided to study subjects. An IRB/EC must operate in compliance with FDA/HA (&#8220;Health Authority&#8221;) regulations. An IRB/EC can suspend or terminate approval of a clinical trial at its institution, or an institution it represents, if the clinical trial is not being conducted in accordance with the IRB&#8217;s/EC&#8217;s requirements or if the product candidate has been associated with unexpected serious harm to patients.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, some trials are overseen by an independent group of qualified experts with relevant expertise known as a data safety monitoring board or data safety monitoring committee (&#8220;DSMB</span><span style="color:#008080;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">). A DSMB is organized by the trial sponsor but should be independent of the sponsor. The DSMB recommends to the sponsor whether to continue, modify, or stop a trial or trials based on its periodic review of accumulating data from one or more clinical trials. Suspension or termination of a clinical trial or a clinical development program during any phase of clinical trials can occur if it is determined by the FDA, an IRB/EC, the sponsor, or the clinical investigator that the participants or patients are being exposed to an unacceptable health risk. Other reasons for suspension or termination may be made by us based on evolving business objectives and/or competitive climate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Information about certain clinical trials must be submitted within specific timeframes for public dissemination on its ClinicalTrials.gov website. The failure to submit such clinical trial information to clinicaltrials.gov, as required, is a prohibited act under the FDCA with violations subject to potential civil monetary penalties.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expanded Access to an Investigational Drug for Treatment Use</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Expanded access, sometimes called &#8220;compassionate use,&#8221; is the use of investigational new drug products outside of clinical trials to treat patients with serious or immediately life-threatening diseases or conditions when there are no comparable or satisfactory alternative treatment options. The rules and regulations related to expanded access are intended to improve access to investigational drugs for patients who may benefit from investigational therapies. FDA regulations allow access to investigational drugs under a protocol submitted to an IND for: individual patients (single-patient IND applications for treatment in emergency settings and non-emergency settings); intermediate-size patient populations; and larger populations for use of the drug.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">When considering an IND application for expanded access to an investigational product with the purpose of treating a patient or a group of patients, the sponsor and treating physicians or investigators will determine suitability when all of the following criteria apply: patient(s) have a serious or immediately life-threatening disease or condition, and there is no comparable or satisfactory alternative therapy to diagnose, monitor, or treat the disease or condition; the potential patient benefit justifies the potential risks of the treatment and the potential risks are not unreasonable in the context or condition to be treated; and the expanded use of the investigational drug for the requested treatment will not interfere with initiation, conduct, or completion of clinical investigations that could support marketing approval of the product or otherwise compromise the potential development of the product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Sponsors of one or more investigational drugs for the treatment of a serious disease(s) or condition(s) must make publicly available their policy for evaluating and responding to requests for expanded access for individual patients.  Sponsors are required to make expanded access policy publicly available upon the earlier of the first initiation of a Phase II or Phase III study with respect to such investigational drug; or 15 days after the drug or biologic receives designation as a breakthrough therapy, fast track product, or regenerative medicine advanced therapy. Sponsors are not required to provide access to investigational products via expanded access, but the manufacturer must develop an internal policy and respond to patient requests according to that policy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Right to Try Act, among other things, provides a federal framework for certain patients to access certain investigational new drug products that have completed a Phase 1 clinical trial and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek access to an investigational drug product without enrolling in clinical trials and without obtaining FDA permission under the FDA expanded access program. There is no obligation for a drug manufacturer to make its drug products available to eligible patients as a result of the Right to Try Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Human Clinical Trials in Support of an NDA/BLA</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials involve the administration of the investigational product to human subjects under the supervision of qualified investigators in accordance with GCP requirements, which include, among other things, the requirement that all research subjects provide their freely given informed consent in accordance with FDA regulations and applicable local laws before their participation in any clinical trial. Clinical trials are conducted under written study protocols detailing, among other things, the inclusion and exclusion criteria, the objectives of the study, the parameters to be used in monitoring the study and the safety and effectiveness criteria to be evaluated.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Human clinical trials are typically conducted in three sequential phases, which may overlap or be combined:</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Phase 1</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The investigational drug is initially introduced into healthy human subjects or, in certain indications such as cancer, patients with the target disease or condition, and tested for safety, dosage tolerance, absorption, metabolism, distribution, excretion and, if possible, to gain an early indication of its effectiveness and to determine optimal dosage.</span></div><div style="text-align:justify;text-indent:32.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Phase 2</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The investigational drug is administered to a limited patient population to identify possible adverse effects and safety risks, to preliminarily evaluate the efficacy of the product for specific targeted diseases and to determine dosage tolerance and optimal dosage.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Phase 3</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The investigational drug is administered to an expanded patient population, generally at geographically dispersed clinical trial sites, in well-controlled clinical trials to generate sufficient data to statistically evaluate the efficacy and safety of the product for approval, to establish the overall risk-benefit profile of the product, and to provide adequate information for the labeling of the product. These clinical trials are commonly referred to as &#8220;pivotal&#8221; studies, which denotes a study that is intended to generate data that will be relied upon by the FDA or another relevant regulatory agency as the primary basis for approval of a product candidate.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Progress reports of the clinical trials must be submitted at least annually to the FDA, and more frequently in some circumstances, such as if serious adverse events occur. In addition, IND safety reports must be submitted to the FDA for any of the following: serious and unexpected suspected adverse reactions; findings from other studies or animal or </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> testing that suggest a significant risk in humans exposed to the drug; and any clinically important increase in the case of a serious suspected adverse reaction over that listed in the protocol or investigator brochure. Phase 1, Phase 2 and Phase 3 clinical trials may not be completed successfully within any specified period, or at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the Pediatric Research Equity Act (&#8220;PREA&#8221;) of 2003, an application or supplement to an NDA or BLA for a new active ingredient, new indication, new dosage form, new dosing regimen, or new route of administration must contain a pediatric assessment unless the applicant has obtained a waiver or deferral. The pediatric assessment includes data to assess the safety and effectiveness of the drug product for the claimed indications in all relevant pediatric subpopulations, and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective or reasons why dosing in pediatric patients is not recommended. Sponsors of drug product applications subject to PREA must also submit pediatric study plans during the development program. Those plans must contain an outline of the proposed pediatric study or studies the applicant plans to conduct, any deferral or waiver requests and other information required or applicable by regulation. The applicant, the FDA, and the FDA&#8217;s internal review committee must then review the information submitted, consult with each other, and agree upon a final plan. The FDA or the applicant may request an amendment to the pediatric plan at any time.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A sponsor must submit an initial pediatric study plan, if required under PREA, no later than either 60 calendar days after the date of the end-of-phase II meeting or such other time as agreed upon between FDA and the sponsor. The FDA may, on its own initiative or at the request of the applicant, grant deferrals for submission of some or all pediatric data until after approval of the product for use in adults, or full or partial waivers from the pediatric data requirements.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Any company that submits an NDA/BLA for certain cancer indications must submit pediatric assessments with the NDA/BLA if the drug is intended for the treatment of an adult cancer and is directed at a molecular target that the FDA determines to be substantially relevant to the growth or progression of a pediatric cancer. The investigation must be designed to yield clinically meaningful pediatric study data regarding the dosing, safety and preliminary efficacy to inform pediatric labeling for the product.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Submission of an NDA/BLA to the FDA</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Assuming successful completion of required clinical investigations and other requirements, the results of the preclinical studies and clinical trials, together with detailed information relating to the product&#8217;s chemistry, manufacture, controls and proposed labeling, among other things, are submitted to the FDA as part of an NDA or BLA requesting approval to market the drug product for one or more indications. Under federal law, the submission of most NDAs and BLAs is subject, under the Prescription Drug User Fee Reauthorization Act of 2022 (&#8220;PDUFA VII&#8221;), to an application user fee, which for federal fiscal year 2026 is $4,682,000 for an application requiring clinical data. The applicant for an approved NDA/BLA is also subject to an annual program fee, which for the fiscal year 2026 is $442,213. Certain exceptions and waivers are available for some of these fees, such as an exception from the application fee for products with orphan designation and a waiver for the first application for certain small businesses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Following submission of an application, the FDA conducts a filing review of an NDA or BLA within 60 calendar days of its receipt and strives to inform the sponsor by the 74th day after the FDA&#8217;s receipt of the submission whether the application is sufficiently complete to permit substantive review. The FDA may refuse to file any NDA or BLA that it deems incomplete or not properly reviewable at the time of submission and may request additional information rather than file an NDA or BLA. In this event, the application must be resubmitted with the additional information. The resubmitted application is also subject to review before the FDA files it. Once the submission is filed, the FDA begins an in-depth substantive review.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has agreed to certain performance goals in the review process of NDAs and BLAs. Under the agency's PDUFA VII commitments, 90% of applications seeking approval of new molecular entities (&#8220;NMEs&#8221;) are meant to be reviewed within ten months from the date on which FDA files the NDA or BLA, and 90% of applications for NMEs that have been designated for &#8220;priority review&#8221; are meant to be reviewed within six months of the filing date. The review process may be extended by the FDA for three additional months to consider new information or clarification provided by the applicant to address an outstanding deficiency identified by the FDA following the original submission. The FDA does not always meet its PDUFA goal dates for standard and priority applications.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Before approving an NDA or BLA, the FDA typically will inspect the facility or facilities where the product is or will be manufactured. These pre-approval inspections cover all or selected facilities associated with an NDA/BLA submission, including drug component manufacturing (such as API), finished drug product manufacturing, and control testing laboratories. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to ensure consistent production of the product within required specifications. Additionally, before approving an NDA or BLA, the FDA will typically inspect one or more clinical sites to ensure compliance with GCP. </span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a condition of approval, the FDA may require an applicant to develop a REMS. REMS use risk minimization strategies beyond the professional labeling to ensure that the benefits of the product outweigh the potential risks. To determine whether a REMS is needed, the FDA will consider the size of the population likely to use the product, seriousness of the disease, expected benefit of the product, expected duration of treatment, seriousness of known or potential adverse events, and whether the product is a new molecular entity. REMS can include medication guides, physician communication plans for healthcare professionals, and elements to ensure safe use (&#8220;ETASU&#8221;). ETASU may include, but are not limited to, special training or certification for prescribing or dispensing, dispensing only under certain circumstances, special monitoring, and the use of patient registries. The FDA may require a REMS before approval or post-approval if it becomes aware of a serious risk associated with use of the product. The requirement for a REMS can materially affect the potential market and profitability of a product.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may refer an application for a drug to an advisory committee or explain why such referral was not made. Typically, an advisory committee is a panel of independent experts, including clinicians and other scientific experts, that reviews, evaluates and provides a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fast Track, Breakthrough Therapy and Priority Review</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The FDA is authorized to designate certain products for expedited review if they are intended to address an unmet medical need in the treatment of a serious or life-threatening disease or condition. These programs are referred to as fast-track designation, breakthrough therapy designation and priority review designation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, the FDA may grant fast track designation to a product if it is intended, whether alone or in combination with one or more other products, for the treatment of a serious or life-threatening disease or condition, and it demonstrates the potential to address unmet medical needs for such a disease or condition. For fast track products, sponsors may have greater interactions with the FDA, and the FDA may initiate review of sections of a fast track product&#8217;s application before the NDA or BLA is complete. This rolling review may be available if the FDA determines, after preliminary evaluation of clinical data submitted by the sponsor, that a fast-track product may be effective. The sponsor must also provide, and the FDA must approve, a schedule for the submission of the remaining information and the sponsor must pay applicable user fees. However, the FDA&#8217;s goal for reviewing a fast track application does not begin until the last section of the NDA or BLA is submitted. In addition, the fast track designation may be withdrawn by the FDA if the FDA believes that the designation is no longer supported by data emerging from the clinical development program.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Second, a product may be designated as a breakthrough therapy if it is intended, either alone or in combination with one or more other products, to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates that the product may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. The FDA may take certain actions with respect to breakthrough therapies, including holding meetings with the sponsor throughout the development process; providing timely advice to the product sponsor regarding development and approval; involving more senior staff in the review process; assigning a cross-disciplinary project lead for the review team; and taking other steps to design the clinical trials in an efficient manner.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Third, the FDA may designate a product for priority review if it is a product that treats a serious condition and, if approved, would provide a significant improvement in safety or effectiveness. The FDA determines, on a case-by-case basis, whether the proposed product represents a significant improvement when compared with other available therapies. Significant improvement may be illustrated by evidence of increased effectiveness in the treatment of a condition, elimination or substantial reduction of a treatment-limiting product reaction, documented enhancement of patient compliance that may lead to improvement in serious outcomes, and evidence of safety and effectiveness in a new subpopulation. A priority review designation is intended to direct overall attention and resources to the evaluation of such applications, and to shorten the FDA&#8217;s goal for taking action on a marketing application from ten months to six months following the FDA&#8217;s filing of the application.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accelerated Approval Pathway</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may grant accelerated approval to a drug for a serious or life-threatening condition that provides meaningful therapeutic advantage to patients over existing treatments based upon a determination that the drug has an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit. The FDA may also grant accelerated approval for such a drug when the product has an effect on an intermediate clinical endpoint that can be measured earlier than an effect on irreversible morbidity or mortality (&#8220;IMM&#8221;), and that is reasonably likely to predict an effect on IMM or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. Drugs granted accelerated approval must meet the same statutory standards for safety and effectiveness as those granted traditional approval.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of accelerated approval, a surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign, or other measure that is thought to predict clinical benefit, but is not itself a measure of clinical benefit. Surrogate endpoints can often be measured more easily or more rapidly than clinical endpoints. An intermediate clinical endpoint is a measurement of a therapeutic effect that is considered reasonably likely to predict the clinical benefit of a drug, such as an effect on IMM. The FDA has limited experience with accelerated approvals based on intermediate clinical endpoints, but has indicated that such endpoints generally may support accelerated approval where the therapeutic effect measured by the endpoint is not itself a clinical benefit and basis for traditional approval, if there is a basis for concluding that the therapeutic effect is reasonably likely to predict the ultimate clinical benefit of a drug.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accelerated approval pathway is most often used in settings in which the course of a disease is long and an extended period of time is required to measure the intended clinical benefit of a drug, even if the effect on the surrogate or intermediate clinical endpoint occurs rapidly. For example, accelerated approval has been used extensively in the development and approval of drugs for treatment of a variety of cancers in which the goal of therapy is generally to improve survival or decrease morbidity and the duration of the typical disease course requires lengthy and sometimes large clinical trials to demonstrate a clinical or survival benefit.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accelerated approval pathway is usually contingent on a sponsor&#8217;s agreement to conduct, in a diligent manner, additional post-approval confirmatory studies to verify and describe the drug&#8217;s clinical benefit. As a result, a product candidate approved on this basis is subject to rigorous post-marketing compliance requirements, including the completion of Phase IV or post-approval clinical trials to confirm the effect on the clinical endpoint. Failure to conduct required post-approval studies, or confirm a clinical benefit during post-marketing studies, would allow the FDA to withdraw the drug from the market on an expedited basis. All promotional materials for product candidates approved under accelerated regulations are subject to prior review by the FDA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Food and Drug Omnibus Reform Act of 2022 modified certain statutory provisions governing accelerated approval of drug and biologic products. Specifically, the new legislation authorized the FDA to: require a sponsor to have its confirmatory clinical trial well underway before accelerated approval is awarded, require a sponsor of a product granted accelerated approval to submit progress reports on its post-approval studies to FDA every six months; and use expedited procedures to withdraw accelerated approval of an NDA or BLA if a confirmatory trial fails to verify the product&#8217;s clinical benefit or the sponsor fails to conduct the required confirmatory trial with due diligence. In March 2023, the FDA issued draft guidance outlining its current thinking and approach to accelerated approval for oncology therapeutics. Noting that the accelerated approval pathway is commonly used for approval of oncology drugs due to the serious and life-threatening nature of cancer, FDA&#8217;s guidance outlined considerations for designing, conducting, and analyzing data for trials intended to support accelerated approvals of oncology products. FDA recommended a randomized controlled trial as the preferred approach to assessing the safety and efficacy as it provides a more robust efficacy and safety assessment and allows for direct comparisons to a concurrent control. This is a departure from the previously common use of single-arm trials to support accelerated approval of oncology products. While this draft guidance is not legally binding, sponsors seeking consideration of a product for accelerated approval typically adhere to the FDA&#8217;s guidance to enhance the likelihood of their products qualifying for accelerated approval.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The FDA&#8217;s Decision on an NDA or BLA</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On the basis of the FDA&#8217;s evaluation of the NDA or BLA and accompanying information, including the results of the inspection of the manufacturing facilities, the FDA will issue an approval letter or a complete response letter. An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications. A complete response letter generally outlines the deficiencies in the submission and may require substantial additional testing or information in order for the FDA to reconsider the application. If and when those deficiencies have been addressed to the FDA&#8217;s satisfaction in a resubmission of the NDA or BLA, the FDA will issue an approval letter. The FDA has committed to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">reviewing such resubmissions in two or six months depending on the type of information included. Even with submission of this additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA approves a product, it may limit the approved indications for use for the product, require that contraindications, warnings or precautions be included in the product labeling, require that post-approval studies, including Phase IV clinical trials, be conducted to further assess the drug&#8217;s safety after approval, require testing and surveillance programs to monitor the product after commercialization, or impose other conditions, including distribution restrictions or other risk management mechanisms, including REMS, which can materially affect the potential market and profitability of the product. The FDA may prevent or limit further marketing of a product based on the results of post-market studies or surveillance programs.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-Approval Requirements</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Drugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to record keeping, periodic reporting, product sampling and distribution, advertising and promotion and reporting of adverse experiences related to the use of the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. There also are continuing, annual program fee requirements for any marketed product.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may impose a number of post-approval requirements as a condition of approval of an NDA. For example, the FDA may require post-marketing testing, including post-marketing clinical trials, and surveillance to further assess and monitor the product&#8217;s safety and effectiveness after commercialization.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, drug manufacturers and other entities involved in the manufacture and distribution of approved drugs are required to register their establishments with the FDA and some state agencies and submit to FDA an annual listing of products manufactured for commercial distribution at each facility. Drug manufacturers are subject to periodic announced or unannounced inspections by the FDA and these state agencies for compliance with cGMP and other regulatory requirements. Changes to the manufacturing process for a drug product are strictly regulated and often require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP and impose reporting and documentation requirements upon the sponsor and any third-party manufacturers that the sponsor may decide to use. Accordingly, manufacturers must continue to expend time, money and effort in the area of production, quality control and pharmacovigilance to maintain cGMP compliance.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Once an approval is granted, the FDA may withdraw marketing approval for a drug product if compliance with regulatory requirements and standards is not maintained or if unanticipated adverse events or other safety concerns occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of distribution or other restrictions under a REMS program. Other potential consequences include, among other things:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on the marketing or manufacturing of the product, suspension of the approval, complete withdrawal of the product from the market or product recalls;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fines, warning letters or imposition of clinical holds on post-approval clinical trials;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal of the FDA to approve pending NDAs or supplements to approved NDAs, or suspension or revocation of product license approvals;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product seizure or detention, or refusal to permit the import or export of products; or</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injunctions or the imposition of civil or criminal penalties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The FDA strictly regulates the marketing, labeling, advertising and promotion of prescription drug products placed on the market. Regulation includes, among other things, standards and regulations for direct-to-consumer advertising, communications regarding unapproved uses, industry-sponsored scientific and educational activities, and promotional activities involving the Internet and social media. Promotional claims about a drug&#8217;s safety or effectiveness are prohibited before the drug is approved. After approval, a drug product may not be promoted for uses that are not approved by the FDA, as reflected in the product&#8217;s approved prescribing information. In the United States, health care professionals are generally permitted to prescribe drugs for such uses not described in the drug&#8217;s labeling, known as off-label uses, because the FDA does not regulate the practice of medicine. However, FDA regulations impose rigorous restrictions on manufacturers&#8217; communications, prohibiting manufacturers and their representatives from promoting a drug product for off-label uses or uses that are otherwise inconsistent </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">with the product&#8217;s labeling. It may be permissible, under very specific, narrow conditions, for a manufacturer to engage in non-promotional, non-misleading communication regarding uses of a product that are inconsistent with a product&#8217;s labeling, such as distributing certain scientific information or publications such as medical journal articles.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If a company is alleged to have promoted a product for off-label uses, it may become subject to investigations, adverse public relations and administrative and judicial enforcement by the FDA, the DOJ, or the Office of the Inspector General of the Department of Health and Human Services, as well as state authorities. In addition, an action may be brought on behalf of the government by a </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">qui tam </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">relator under the Federal False Claims Act asserting that a manufacturer&#8217;s communications regarding an off-label use of its product caused submission of false claims for payment by a government health care program. These actions could subject a company to a range of penalties that could have a significant commercial impact, including civil and criminal fines and agreements that materially restrict the manner in which a company promotes or distributes drug products. These actions have resulted in the imposition of large civil and criminal fines and penalties against, and substantial settlements by, companies for alleged improper promotion. As a result of these actions, companies have entered into consent decrees, non-prosecution agreements, deferred prosecution agreements or corporate integrity agreements under which specified promotional conduct is changed or curtailed, and substantial compliance obligations are imposed on manufacturers.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the distribution of prescription pharmaceutical products is subject to the Prescription Drug Marketing Act (&#8220;PDMA&#8221;), and its implementing regulations, as well as the Drug Supply Chain Security Act (&#8220;DSCSA&#8221;), which regulate the distribution and tracing of prescription drug samples at the federal level, and set minimum standards for the regulation of distributors by the states. The PDMA, its implementing regulations and state laws limit the distribution of prescription pharmaceutical product samples, and the DSCSA imposes requirements to ensure accountability in distribution and to identify and remove counterfeit and other illegitimate products from the market.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marketing Exclusivity and Biosimilars</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Biologics Price Competition and Innovation Act of 2009 created an abbreviated approval pathway for biological products shown to be biosimilar to an FDA-licensed reference biological product. Biosimilarity, which requires that the biological product be highly similar to the reference product notwithstanding minor differences in clinically inactive components and that there be no clinically meaningful differences between the biological product and the reference product in terms of safety, purity and potency, can be shown through analytical studies, toxicity studies, and a clinical trial or trials. A biosimilar may be approved as interchangeable with its reference biological product. Interchangeability requires that a biological product both be biosimilar to the reference product and that the product can be expected to produce the same clinical results as the reference product in any given patient and, for products administered multiple times to an individual, that the product and the reference product may be alternated or switched after one has been previously administered without increasing safety risks or risks of diminished efficacy relative to exclusive use of the reference biological product without such alternation or switch. Under most state laws, interchangeable products may be used in place of the reference biological product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A reference biological product is granted 12 years of data exclusivity from the time of first licensure of the product during which the FDA will not approve a biosimilar referencing the reference biological product, and the FDA will not accept an application for a biosimilar or interchangeable product based on the reference biological product until four years after the date of first licensure of the reference product. &#8220;First licensure&#8221; typically means the initial date the particular product at issue was licensed in the United States. Date of first licensure does not include the date of licensure of (and a new period of exclusivity is not available for) a biological product if the licensure is for a supplement for the biological product or for a subsequent application by the same sponsor or manufacturer of the biological product (or licensor, predecessor in interest, or other related entity) for a change that results in a new indication, route of administration, dosing schedule, dosage form, delivery system, delivery device or strength, or for a modification to the structure of the biological product that does not result in a change in safety, purity or potency.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pediatric Exclusivity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pediatric exclusivity is an extension of existing non-patent marketing exclusivity available to biological product manufacturers in the United States who have met criteria qualifying their products for pediatric exclusivity and, if granted, provides for the attachment of an additional six months of marketing protection to the term of any existing regulatory exclusivity for each of the manufacturers products with the same active moiety, including the non-patent and orphan exclusivity. This six-month exclusivity may be granted if an NDA/BLA sponsor submits pediatric data or fairly responds to a written request from the FDA for such data. The data do not need to show the product to be effective in the pediatric population studied; rather, if the clinical trial is deemed to fairly respond to the FDA&#8217;s request, the studies were completed using appropriate formulations and within the requested time frame, and the studies were conducted in accordance with commonly accepted scientific principles, the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">additional protection may be granted. Upon any exclusivity determination by the FDA within the statutory time limits, whatever statutory or regulatory periods of exclusivity cover the product are extended by six months.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patent Term Restoration and Extension</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The term of a U.S. patent that covers a drug, biological product or medical device approved pursuant to a premarket approval may also be eligible for patent term extension when FDA approval is granted, provided that certain statutory and regulatory requirements are met. The length of the patent term extension is related to the length of time the drug is under development and regulatory review while the patent is in force, reduced by any time during which the applicant failed to exercise due diligence. The Hatch-Waxman Act permits a patent term extension of up to five years beyond the expiration date set for the patent. Patent extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval, only one patent applicable to each regulatory review period may be granted an extension, and only those claims reading on the approved drug may be extended. Similar provisions are available in Europe and certain other foreign jurisdictions to extend the term of a patent that covers an approved drug, provided that statutory and regulatory requirements are met. The U.S. Patent and Trademark Office (&#8220;USPTO&#8221;) reviews and approves the application for any patent term extension or restoration in consultation with the FDA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Orphan-Drug Designation and Exclusivity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the Orphan Drug Act, FDA may grant orphan drug designation to a drug or biologic product intended to treat a rare disease or condition. A rare disease or condition is defined as one that either affects fewer than 200,000 individuals in the United States or for which a manufacturer has no reasonable expectation that the cost of developing and making the product available in the United States for the disease or condition will be recovered from sales of the product. A manufacturer may request an orphan drug designation for either a previously unapproved product or a new use of an FDA-approved product. Orphan drug designation must be requested before submission of an NDA or BLA. Orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process, though companies developing orphan products may be eligible for certain financial incentives such as tax credits for qualified clinical testing or waiver of certain application fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If a product that has orphan drug designation subsequently receives the first FDA approval for the rare disease or condition for which it has such designation, the product is entitled to orphan drug exclusivity. This is a seven-year period of marketing exclusivity during which FDA may not approve any other applications to market the same active ingredient or active moiety for the same indication, except in limited circumstances. Such limited circumstances may include a subsequent product&#8217;s showing of clinical superiority over the product with orphan drug exclusivity or drug shortage. Competitors, however, may receive approval of different active ingredients or active moieties for the same indication or obtain approval for the same therapeutic agent or active moiety for a different indication.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulation Outside the United States</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In order to market any product outside of the United States, a company must also comply with numerous and varying regulatory requirements of other countries and jurisdictions regarding quality, safety and efficacy and governing, among other things, clinical trials, marketing authorization, promotion, commercial sales and distribution of drug products. Whether or not it obtains FDA approval for a product, the company would need to obtain the necessary approvals by the comparable foreign regulatory authorities before it can commence clinical trials or marketing of the product in those countries or jurisdictions. The approval process ultimately varies between countries and jurisdictions and can involve additional product testing and additional administrative review periods. The time required to obtain approval in other countries and jurisdictions might differ from and be longer than that required to obtain FDA approval. Regulatory approval in one country or jurisdiction does not ensure regulatory approval in another, but a failure or delay in obtaining regulatory approval in one country or jurisdiction may negatively impact the regulatory process in others.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulation and Marketing Authorization in the European Union (</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">E.U.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">)</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clinical Trial Approval</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Clinical Trials (EU) No Regulation 536/2014 (&#8220;CTR&#8221;), Commission Implementing Regulation (EU) 2017/556 on the detailed arrangements for the GCP,  Commission Delegated Regulation (EU) 2017/1569 and Commission Directive (EU) 2017/1572 on Good Manufacturing Practice (&#8220;GMP&#8221;) and Commission Guidelines such as Volume 10 of &#8220;The rules governing medicinal products in the European Union&#8221; govern the system for the approval of clinical trials in the E.U. Under this system, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">an applicant planning to conduct a clinical trial on an investigational medicinal product in the EU or European Economic Area (EEA&#8221;) must apply for authorization of this trial through the EU central single entry point: the Clinical Trials Information System (&#8220;CTIS&#8221;). The applicant submits its application dossier via CTIS, consisting of (among other documents) the cover letter, the EU application form, the study protocol and the Investigational Medicinal Product Dossier. The applicant shall submit this dossier to the intended Member States concerned through CTIS and shall propose one of the Member States concerned as the Reporting Member State (&#8220;RMS&#8221;).  The RMS validates the application and reviews whether the application dossier is complete. After this, the RMS will draw up an assessment report (Part I of the approval process). For Part II of the approval process, all Concerned Member States shall assess, for their own territory, the application dossier of the applicant. Each Concerned Member State shall notify the applicant through the EU CTIS portal as to whether the clinical trial is authorized, whether it is authorized subject to conditions, or whether authorization is refused.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2022, the CTR became applicable. From this date, a three-year transition period started, to ensure that ongoing clinical trials could align with the rules as laid down in the CTR. From 31 January 2025 onwards, all clinical trials in the EU/EEA must be conducted in accordance with the CTR. This means that the Clinical Trials Directive 2001/20/EC (and any national legislation implementing the Directive) is now fully replaced by the CTR. The CTR is directly applicable in all the E.U. Member States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The CTR simplifies and streamlines the approval of clinical trials in the E.U. The main characteristics of the Regulation include: a streamlined application procedure via a single entry point, the CTIS; a single set of documents to be prepared and submitted for the application as well as simplified reporting procedures for clinical trial sponsors; and a harmonized procedure for the assessment of applications for clinical trials, which is divided in two parts as described above. Part I is assessed by the appointed RMS, whose assessment report is submitted for review by the sponsor and all other competent authorities of all E.U. Member States in which an application for authorization of a clinical trial has been submitted. Part II is assessed separately by each Concerned Member State. Strict deadlines have been established for the assessment of clinical trial applications. The role of the relevant ethics committees in the assessment procedure will continue to be governed by the national law of the Concerned Member State. However, overall related timelines will be defined by the Clinical Trials Regulation.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As in the United States, similar requirements for posting clinical trial information are present in the E.U. and in other countries.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marketing Authorization</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To obtain a marketing authorization for a product under E.U. regulatory systems, an applicant must submit a marketing authorization application (&#8220;MAA&#8221;) either under a centralized procedure administered by the EMA, or one of the procedures administered by competent authorities in the E.U. Member States (decentralized procedure, national procedure or mutual recognition procedure). A marketing authorization may be granted only to an applicant established in the E.U. Prior to obtaining a marketing authorization in the E.U., applicants have to demonstrate compliance with all measures included in an EMA-approved Paediatric Investigation Plan (&#8220;PIP&#8221;), covering all subsets of the pediatric population, unless the EMA has granted (1) a product-specific waiver, (2) a class waiver or (3) a deferral for one or more of the measures included in the PIP. These requirements are discussed in more detail below.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The centralized procedure provides for the grant of a single marketing authorization by the European Commission that is valid across the European Economic Area (i.e., the E.U. as well as Iceland, Liechtenstein and Norway). Pursuant to Regulation (EC) No 726/2004, the centralized procedure is compulsory for specific products, including for medicines produced by certain biotechnological processes, products designated as orphan medicinal products and products with a new active substance indicated for the treatment of certain diseases, including products for the treatment of cancer. For products with a &#8220;new active substance&#8221; indicated for the treatment of other diseases and products that are highly innovative or for which a centralized process is in the interest of patients, the centralized procedure may be optional. The centralized procedure may at the request of the applicant also be used in certain other cases. We anticipate that the centralized procedure will be mandatory for the product candidates we are developing.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the centralized procedure, the Committee for Medicinal Products for Human Use (&#8220;CHMP&#8221;) &#8211; EMA&#8217;s committee responsible for human medicines &#8211; is also responsible for several post-authorization and maintenance activities, such as the assessment of modifications or extensions to an existing marketing authorization. Under the centralized procedure in the E.U., the maximum timeframe for the evaluation of an MAA is 210 days after submission of a valid application, excluding clock stops, when additional information or written or oral explanation is to be provided by the applicant in response to questions of the CHMP. Overall, the assessment of a new medicine usually lasts around a year. Accelerated evaluation might be granted by the CHMP in exceptional cases when a medicinal product is of major interest from the point of view of public health and in particular from the viewpoint of therapeutic innovation. If the CHMP accepts such request, the time limit of 210 days will be </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">reduced to 150 days, but the CHMP can revert to the standard time limit for the centralized procedure if it determines that it is no longer appropriate to conduct an accelerated assessment. At the end of this period, the CHMP provides a scientific opinion on whether or not a marketing authorization should be granted in relation to a medicinal product. Within 15 calendar days of receipt of a final opinion from the CHMP, the European Commission must prepare a draft decision concerning an application for marketing authorization. This draft decision must take the opinion and any relevant provisions of E.U. law into account. Before arriving at a final decision on an application for centralized authorization of a medicinal product, the European Commission must consult the Standing Committee on Medicinal Products for Human Use. The Standing Committee is composed of representatives of the E.U. Member States and chaired by a non- voting European Commission representative. The European Parliament also has a related &#8220;droit de regard.&#8221; The European Parliament&#8217;s role is to ensure that the European Commission has not exceeded its powers in deciding to grant or refuse to grant a marketing authorization.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The European Commission may grant a so-called &#8220;marketing authorization under exceptional circumstances&#8221; on the basis of article 14(8) of Regulation (EC) No 726/2004.  Such authorization is intended for products for which the applicant can demonstrate that it is unable to provide comprehensive data on the efficacy and safety under normal conditions of use, for objective, verifiable reasons, for instance because the indications for which the product in question is intended are encountered so rarely that the applicant cannot reasonably be expected to provide comprehensive evidence, or in the present state of scientific knowledge, comprehensive information cannot be provided, or it would be contrary to generally accepted principles of medical ethics to collect such information. The Rapporteur, Co-Rapporteur and the other CHMP members will assess the justification/data submitted for exceptional circumstances as part of the overall assessment of the benefit/risk of the application. Consequently, marketing authorization under exceptional circumstances may be granted subject to certain specific obligations, which may include the following:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the applicant must complete an identified program of studies within a time period specified by the competent authority, the results of which form the basis of a reassessment of the benefit/risk profile;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the medicinal product in question may be supplied on medical prescription only and may in certain cases be administered only under strict medical supervision, possibly in a hospital and in the case of a radiopharmaceutical, by an authorized person; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the package leaflet and any medical information must draw the attention of the medical practitioner to the fact that the particulars available concerning the medicinal product in question are as yet inadequate in certain specified respects.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A marketing authorization under exceptional circumstances is subject to annual review to reassess the risk-benefit balance in an annual reassessment procedure. Continuation of the authorization is linked to the annual reassessment and a negative assessment could potentially result in the marketing authorization being suspended or revoked. The renewal of a marketing authorization of a medicinal product under exceptional circumstances, however, follows the same rules as a &#8220;normal&#8221; marketing authorization. Thus, a marketing authorization under exceptional circumstances is granted for an initial five years, after which the authorization will become valid indefinitely, unless the EMA decides that safety grounds merit one additional five-year renewal.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The European Commission may also grant a so-called &#8220;conditional marketing authorization&#8221; on the basis of article 14a of Regulation (EC) No 726/2004, prior to the applicant obtaining the comprehensive clinical data required for an application for a full marketing authorization, in order to meet unmet medical needs of patients and in the interest of public health. Such conditional marketing authorizations may be granted for product candidates (including medicines designated as orphan medicinal products) if: (i) the risk-benefit balance of the product candidate is positive, (ii) it is likely that the applicant will be in a position to provide the required comprehensive clinical trial data, (iii) the product fulfills an unmet medical need and (iv) the benefit to public health of the immediate availability on the market of the medicinal product concerned outweighs the risk inherent in the fact that additional data are still required. A conditional marketing authorization may contain specific obligations to be fulfilled by the marketing authorization holder, including obligations with respect to the completion of ongoing or new studies, and with respect to the collection of pharmacovigilance data. Conditional marketing authorizations are valid for one year, and may be renewed annually, if the risk-benefit balance remains positive, and after an assessment of the need for additional or modified conditions and/or specific obligations. The timelines for the centralized procedure described above also apply with respect to the review by the CHMP of applications for a conditional marketing authorization. Applicants for a potential conditional marketing authorization are strongly encouraged to engage in early dialogue with EMA and other stakeholders (e.g. health technology assessment bodies) and discuss their development plan. EMA also encourages applicants to request accelerated assessment for products deemed suitable for a conditional marketing authorization.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The E.U. medicines framework preserves the competence of the E.U. Member States to adopt national legislation prohibiting or restricting the sale, supply or use of any medicinal product containing, consisting of or derived from a specific type of human or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">animal cell, such as embryonic stem cells. While the products we have in development do not make use of embryonic stem cells, it is possible that the national laws in certain E.U. Member States may prohibit or restrict us from commercializing our products, even if they have been granted an E.U. marketing authorization.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Unlike the centralized authorization procedure, the decentralized marketing authorization procedure requires a separate application to, and leads to separate approval by, the competent authorities of each E.U. Member State in which the product is to be marketed (these are known as the &#8220;Concerned&#8221; Member States). This application is identical to the application that would be submitted to the EMA for authorization through the centralized procedure. The referenced E.U. Member State prepares a draft assessment and drafts of the related materials within 120 days after receipt of a valid application. The resulting assessment report is submitted to the concerned E.U. Member States who, within 90 days of receipt, must decide whether to approve the assessment report and related materials. If a concerned E.U. Member State cannot approve the assessment report and related materials due to concerns relating to a potential serious risk to public health, disputed elements may be referred to the European Commission, whose decision is binding on all E.U. Member States.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The mutual recognition procedure similarly is based on the acceptance by the competent authorities of the E.U. Member States of the marketing authorization of a medicinal product by the competent authorities of other E.U. Member States. The holder of a national marketing authorization may submit an application to the competent authority of an E.U. Member State requesting that this authority recognize the marketing authorization delivered by the competent authority of another E.U. Member State.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For certain applications, such as applications for products designated as orphan medicinal products or products falling under the compulsory scope of the centralized procedure, the mutual recognition procedure and the decentralized procedure cannot be used.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Data Protection in the E.U.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the E.U., innovative medicinal products approved on the basis of a complete independent data package qualify for eight years of data exclusivity after grant of the marketing authorization and an additional two years of market exclusivity pursuant to Directive 2001/83/EC. Regulation (EC) No 726/2004 repeats this entitlement for medicinal products authorized in accordance to the centralized authorization procedure. Data exclusivity prevents applicants for authorization of generics of these innovative products, from referencing the innovator&#8217;s data to assess a generic (or abridged) application for a period of eight years. During an additional two-year period of market exclusivity, a generic MAA can be submitted and authorized, and the innovator&#8217;s data may be referenced, but no generic medicinal product can be placed on the E.U. market until the expiration of the market exclusivity. The overall ten-year period will be extended to a maximum of 11 years if, during the first eight years of those ten years, the marketing authorization holder obtains an authorization for one or more new therapeutic indications which, during the scientific evaluation prior to their authorization, are held to bring a significant clinical benefit in comparison with existing therapies. Even if a compound is considered to be a new chemical entity so that the innovator gains the prescribed period of data exclusivity, another company nevertheless could also market another version of the product if such company obtained marketing authorization based on an MAA with a complete independent data package of pharmaceutical tests, preclinical tests and clinical trials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In April 2023, the European Commission published a proposal to reform the current pharmaceutical framework, including revision of the regulatory data protection system. In the latest version of the proposal, published on 11 December 2025, the regulatory data protection will consist of 8 years of data exclusivity, same as under the current legal framework, and one additional year of market exclusivity. This means a total of 8+1 years of protection, instead of the current 8+2 years. Under the reformed legislation, there will be a possibility to obtain one additional year of exclusivity (8+1+1) under certain circumstances and another year (8+1+1 or 8+1+1+1) for a new indication of significant clinical benefit, with a capped overall regulatory protection of 11 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The final text of the reform proposal is expected to be endorsed and published in the first half of 2026 and, after a transition period, the new legislation is expected to start to apply from mid-2028.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Orphan Drug Designation and Exclusivity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Regulation (EC) No. 141/2000, as implemented by Regulation (EC) No. 847/2000 provides that a medicine can be designated as an orphan medicinal product by the European Commission if its sponsor can establish: that the product is intended for the diagnosis, prevention or treatment of (1) a life-threatening or chronically debilitating condition affecting not more than five in ten thousand persons in the E.U. when the application is made, or (2) a life-threatening, seriously debilitating or serious and chronic condition in the E.U. and that without incentives it is unlikely that the marketing of the drug in the EU would generate sufficient return to justify the necessary investment. For either of these conditions, the sponsor must demonstrate that there </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">exists no satisfactory method of diagnosis, prevention or treatment of the condition in question that has been authorized in the E.U. or, if such method exists, the medicinal product will be of significant benefit to those affected by that condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Once authorized, orphan medicinal products are entitled to 10 years of market exclusivity in all E.U. Member States and in addition a range of other benefits during the development and regulatory review process including scientific assistance for study protocols, authorization through the centralized marketing authorization procedure covering all Member States and a reduction or elimination of registration and marketing authorization fees. However, marketing authorization may be granted to a similar medicinal product with the same orphan indication during the 10-year period with the consent of the marketing authorization holder for the original orphan medicinal product, or if the manufacturer of the original orphan medicinal product is unable to supply the medicine in sufficient quantities. Marketing authorization may also be granted to a similar medicinal product with the same orphan indication if this product is shown to be safer, more effective or otherwise clinically superior to the original orphan medicinal product. The period of market exclusivity may, in addition, be reduced to six years if it can be demonstrated on the basis of available evidence that the original orphan medicinal product (a) no longer satisfies the original designation criteria; or (b) is sufficiently profitable not to justify maintenance of market exclusivity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The proposal to reform the current pharmaceutical framework as mentioned above also intends to revise the orphan drug designation and exclusivity regime. In the latest version of the proposal, orphan market exclusivity will be reduced from the current 10 years to 9 years. Extension by another 2 years will be possible for so-called &#8220;breakthrough orphan medicinal products&#8221;. Although the final text has not yet been published, previous drafts also included the concept of &#8220;global orphan marketing authorization&#8221;, which would no longer grant additional separate orphan market exclusivity for second or further orphan therapeutic indications. Also, previous drafts allowed generics, biosimilars or other second applicants to apply for marketing authorization two years before expiry of orphan market exclusivity thus effectively reducing the innovator&#8217;s market exclusivity compared to the current legal framework. Again, final text of the reform proposal is expected to be endorsed and published in Q1 or Q2 of 2026 and, after a transition period, the new legislation is expected to start to apply from mid-2028.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Periods of Authorization and Renewals</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A marketing authorization has an initial validity for five years in principle. The marketing authorization may be renewed after five years on the basis of a re-evaluation of the risk-benefit balance by the EMA or by the competent authority of the E.U. Member State. To this end, the marketing authorization holder must provide the EMA or the competent authority with a consolidated version of the file in respect of quality, safety and efficacy, including all variations introduced since the marketing authorization was granted, at least six months before the marketing authorization ceases to be valid. The European Commission or the competent authorities of the E.U. Member States decide on justified grounds relating to pharmacovigilance, whether to proceed with one further five-year period of marketing authorization. Once subsequently definitively renewed, the marketing authorization shall be valid for an unlimited period. Any authorization which is not followed by the actual placing of the medicinal product on the E.U. market (in the case of the centralized procedure) or on the market of the authorizing E.U. Member State within three years after authorization ceases to be valid (the so-called sunset clause).</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span id="i89f8815532d548b79644312fc22001d1_129919"></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pediatric Studies</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Prior to obtaining a marketing authorization in the E.U., applicants have to demonstrate compliance with all measures included in an EMA-approved Paediatric Investigation Plan, covering all subsets of the pediatric population, unless the EMA has granted a product-specific waiver, a class waiver, or a deferral for one or more of the measures included in the PIP. The respective requirements for all marketing authorization procedures are set forth in Regulation (EC) No 1901/2006, which is referred to as the Paediatric Regulation. This requirement also applies when a company wants to add a new indication, pharmaceutical form or route of administration for a medicine that is already authorized. The Paediatric Committee of the EMA (&#8220;PDCO&#8221;) may grant deferrals for some medicines, allowing a company to delay development of the medicine in children until there is enough information to demonstrate its effectiveness and safety in adults. The PDCO may also grant waivers when development of a medicine in children is not needed or is not appropriate, such as for diseases that only affect the elderly population.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Before an MAA can be filed, or an existing marketing authorization can be amended, the EMA determines that companies actually comply with the agreed studies and measures listed in each relevant PIP.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Requirements after a Marketing Authorization has been Obtained</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In case an authorization for a medicinal product in the E.U. is obtained, the holder of the marketing authorization is required to comply with a range of requirements applicable to the manufacturing, marketing, promotion and sale of medicinal products. These include:</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Compliance with the E.U.&#8217;s stringent pharmacovigilance or safety reporting rules. These rules can impose post-authorization studies and additional monitoring obligations;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The manufacturing of authorized medicinal products, for which a separate manufacturer&#8217;s license is mandatory, must also be conducted in strict compliance with the applicable E.U. laws, regulations and guidance, including Directive 2001/83/EC, Directive 2017/1572/EC, Regulation (EC) No 726/2004 and the European Commission Guidelines for GMP. These requirements include compliance with E.U. cGMP standards when manufacturing medicinal products and active pharmaceutical ingredients, including the manufacture of active pharmaceutical ingredients outside of the E.U. with the intention to import the active pharmaceutical ingredients into the E.U.;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The marketing and promotion of authorized medicines, including industry-sponsored continuing medical education and advertising directed toward the prescribers of medicines and/or the general public, are strictly regulated in the E.U. notably under Directive 2001/83EC, Regulation (EC) 726/2004 and E.U. Member State laws. Direct-to- consumer advertising of prescription medicines is prohibited across the E.U.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patent Term Extension</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In order to compensate the patentee for delays in obtaining a marketing authorization for a patented product, a supplementary protection certificate (&#8220;SPC&#8221;)  in E.U. Member State or Patent Term Extension (&#8220;PTE&#8221;) in U.S. may be granted extending the exclusivity period for that specific product by up to five years. PTE applications must be filed with the USPTO within 60 days of regulatory approval.  Applications for SPCs must be made to the relevant patent office in each E.U. Member State  and the granted certificates are valid only in the Member State of grant. An application has to be made by the patent owner within six months of the first marketing authorization being granted in the E.U. (assuming the patent in question has not expired, lapsed or been revoked) or within six months of the grant of the patent (if the marketing authorization is granted first). In the context of SPCs, the term &#8220;product&#8221; means the active ingredient or combination of active ingredients for a medicinal product and the term &#8220;patent&#8221; means a patent protecting such a product or a new manufacturing process or application for it. The duration of an SPC is calculated as the difference between the patent&#8217;s filing date and the date of the first marketing authorization, minus five years, subject to a maximum term of five years.</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A six month pediatric extension of an SPC may be obtained where the patentee has carried out an agreed Pediatric Investigation Plan, the authorized product information includes information on the results of the studies and the product is authorized in all E.U. Member States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Regulatory Framework in the United Kingdom (&#8220;UK&#8221;)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The United Kingdom&#8217;s withdrawal from the E.U. took place on January 31, 2020 (&#8220;Brexit&#8221;). The EU and the UK have two separate markets governed by two distinct regulatory and legal regimes, although the UK&#8217;s GMP and GCP frameworks remain largely based on the EU frameworks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2023, the UK government and the European Commission announced a political agreement in principle to replace the &#8220;Northern Ireland Protocol&#8221; which was put in place shortly after Brexit with a new set of arrangements, known as the &#8220;Windsor Framework&#8221;. The Windsor Framework was approved by the EU-UK Joint Committee on March 24, 2023, and each of the UK government and the E.U. have enacted legislative measures to bring it into law. The Windsor Framework fundamentally changed the post-Brexit system under the Northern Ireland Protocol, including with respect to the regulation of medicinal products in the UK. From January 1, 2025, the UK&#8217;s Medicines and Healthcare products Regulatory Agency (the &#8220;MHRA&#8221;) became responsible for approving all medicinal products destined for the UK market (i.e., Great Britian and Northern Ireland) via a single UK-wide marketing authorization, enabling products to be sold in a single pack and under a single authorization throughout the UK. New medicinal products assessed by the MHRA are designated as one of two categories. &#8220;Category 1&#8221; medicinal products are those which fall within the mandatory or optional scope of the EU&#8217;s centralized procedure and are assessed on the basis of UK legislation. &#8220;Category 2&#8221; medicinal products are those which do not fall within Category 1 and are authorized in accordance with UK and EU law.  Under the MHRA&#8217;s international recognition framework (in place since January 1, 2024), the MHRA will have regard to decisions on the approval of MAs made by the EMA and certain other regulators when determining an application for a new UK MA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Human Medicines Regulations 2012 (SI 2012/1916) (as amended) (&#8220;HMR&#8221;) is the primary legal instrument for the regulation of medicines in the UK. The HMR has incorporated into the domestic law the body of EU law instruments governing medicinal products that pre-existed prior to the UK&#8217;s withdrawal from the EU.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">EU laws which have been transposed into UK law through secondary legislation continue to be applicable as &#8220;retained EU law.&#8221; New EU legislation, such as the (EU) Clinical Trials Regulation, is not applicable in Great Britain but does apply in Northern Ireland as a result of the Windsor Framework. The UK&#8217;s Medicines for Human Use (Clinical Trials) Regulations 2004 implement the requirements of the previous EU clinical trials regime under Directive 2001/20/EC, but will be modernized by the Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024, which were passed into law on April 10, 2025 and come into effect of April 28, 2026.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare Law and Regulation</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Health Care Providers and third-party payors play a primary role in the recommendation and prescription of drug products that are granted marketing approval. Arrangements between drug product manufacturers and providers, consultants, third-party payors and customers are subject to broadly applicable fraud and abuse, anti-kickback, false claims laws, patient privacy laws and regulations, and other healthcare laws and regulations that may constrain business and/or financial arrangements. Restrictions under applicable federal and state healthcare laws and regulations, include the following:</span></div><div style="text-indent:32.5pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Anti-Kickback Statute, which prohibits, among other things, persons and entities from knowingly and willfully soliciting, offering, paying, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made, in whole or in part, under a federal healthcare program such as Medicare and Medicaid;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal civil and criminal false claims laws, including the civil False Claims Act, and civil monetary penalties laws, which prohibit individuals or entities from, among other things, knowingly presenting, or causing to be presented, to the federal government, claims for payment that are false, fictitious or fraudulent or knowingly making, using or causing to be made or used a false record or statement to avoid, decrease or conceal an obligation to pay money to the federal government;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), which created additional federal criminal laws that prohibit, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or making false statements relating to health care matters;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act (&#8220;HITECH&#8221;), and their respective implementing regulations, including the Final Omnibus Rule published in January 2013, impose obligations on covered entities and their business associates, as defined by HIPAA, including mandatory contractual terms, and requirements for safeguarding the privacy, security and transmission of individually identifiable protected health information;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign Corrupt Practices Act (&#8220;FCPA&#8221;), which prohibits companies and their intermediaries from making, or offering or promising to make improper payments to non-U.S. officials for the purpose of obtaining or retaining business or otherwise seeking favorable treatment;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal false statements statute, which prohibits knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement in connection with the delivery of or payment for healthcare benefits, items or services;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal transparency requirements known as the federal Physician Payments Sunshine Act, under the Patient Protection and Affordable Care Act, as amended by the Health Care Education Reconciliation Act, or the Affordable Care Act (&#8220;ACA&#8221;), which requires certain manufacturers of drugs, devices, biologics and medical supplies to report annually to the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), within the United States Department of Health and Human Services, information related to payments and other transfers of value made by that entity to physicians and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">analogous state and foreign laws and regulations, such as state anti-kickback and false claims laws, which may apply to healthcare items or services that are reimbursed by non-government third-party payors, including private insurers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Some state and local laws impose regulations restricting the activities of pharmaceutical manufacturers that sell products in the state. Some of these laws require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and/or the relevant compliance guidance promulgated by the local, state or federal government. Manufacturers are required by the laws of some states to make certain disclosures or certifications related to their compliance activities to state agencies or on the manufacturer&#8217;s website. Others may impose restrictions on, or registration requirements for, a manufacturer&#8217;s sales representatives. Some state laws require manufacturers to report information related to payments to physicians and other healthcare providers, marketing expenditures, or price information for certain drug products. State and foreign laws also govern the privacy and security of health information in some circumstances, many of which differ from each </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">other in significant ways and often are broader than and/or not preempted by HIPAA, thus complicating compliance efforts. Manufacturers are expected to expend substantial resources to implement compliance controls to prevent and detect noncompliance with these requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmaceutical Coverage and Reimbursement </span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the United States and markets in many other countries, patients who are prescribed treatments for their conditions and providers performing the prescribed services generally rely on third-party payors to reimburse all or part of the associated healthcare costs. Significant uncertainty exists as to the coverage and reimbursement status of products approved by the FDA and other government authorities. Thus, even if a product candidate is approved, sales of the product will depend, in part, on the extent to which third-party payors, including government health programs in the United States such as Medicare and Medicaid, commercial health insurers and managed care organizations, provide coverage and establish adequate reimbursement levels for, the product. The process for determining whether a payor will provide coverage for a product may be separate from the process for setting the price or reimbursement rate that the payor will pay for the product once coverage is approved. Third-party payors are increasingly challenging the prices charged, examining the medical necessity and reviewing the cost-effectiveness of medical products and services and imposing controls to manage costs. Third-party payors may limit coverage to specific products on an approved list, also known as a formulary, which might not include all of the approved products for a particular indication. Other times, they will attempt to dictate the utilization of products to treat a disease via clinical guidelines or pathways. </span></div><div style="text-indent:32.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In order to secure coverage and reimbursement for any product that might be approved for sale, a company may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of the product, in addition to the costs required to obtain FDA or other comparable marketing approvals. Nonetheless, product candidates may not be considered medically necessary or cost effective resulting in payers deciding to limit reimbursement of a product. A decision by a third-party payor not to cover a product could reduce physician utilization once the product is approved and have a material adverse effect on sales, results of operations and financial condition. Additionally, a payor&#8217;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be approved. Further, one payor&#8217;s determination to provide coverage for a product does not ensure that other payors will also provide coverage and reimbursement for the product, and the level of coverage and reimbursement can differ significantly from payor to payor.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pricing Decisions for Approved Products</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the E.U., pricing and reimbursement schemes vary widely from country to country. Some countries provide that products may be marketed only after a reimbursement price has been agreed. Some countries may require the completion of additional studies that compare the cost-effectiveness of a particular product candidate to currently available therapies or so- called health technology assessments in order to obtain reimbursement or pricing approval. For example, the E.U. provides options for its Member States to restrict the range of products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. Member States may approve a specific price for a product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the product on the market. Other Member States allow companies to fix their own prices for products, but monitor and control prescription volumes and issue guidance to physicians to limit prescriptions. Recently, many countries in the E.U. have increased the amount of discounts (or rebates) required on pharmaceuticals and these efforts could continue as countries attempt to manage health care expenditures, especially in light of the severe fiscal and debt crises experienced by many countries in the E.U. The downward pressure on health care costs in general, particularly prescription products, has become intense. As a result, increasingly high barriers are being erected to the entry of new products. Political, economic and regulatory developments may further complicate pricing negotiations, and pricing negotiations may continue after reimbursement has been obtained. Reference pricing used by various Member States, and parallel trade, i.e., arbitrage between low-priced and high-priced Member States, can further reduce prices. There can be no assurance that any country that has price controls or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any products, if approved in those countries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmaceutical Price Reforms</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The prices of pharmaceutical and biopharmaceutical products have been a focal point of federal, state, and foreign governments&#8217; efforts to contain health care costs. Most significantly, interest in the adoption and implementation of cost-containment programs, including price controls, mandated price negotiations, tenders based on perceived therapeutic equivalence, restrictions on reimbursement, and requirements for substitution of generic products, have increased. Adoption of such price controls and cost-containment measures&#8212;including adoption of more restrictive policies in jurisdictions with existing controls and measures&#8212;could further limit the revenue a company might generate from the sale of an approved product, particularly if such measures result in more restrictive coverage or lower reimbursement from third party payors. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Prescription pharmaceutical pricing has been the subject of considerable discussion and activity in the United States on both the federal and state levels and from both political parties. A number of foreign, federal, and state laws impose limitations on the pricing of pharmaceutical and biopharmaceutical products. These laws may also impose controls that limit coverage and reimbursement for drugs and other medical products. Recent approaches to contain pharmaceutical costs have varied and include&#8212;among other strategies&#8212;increasing transparency in pharmaceutical pricing, reviewing the relationship between pricing and manufacturer patient programs, and directly addressing the costs of pharmaceuticals in the Medicare and Medicaid programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Most significantly, on the federal level, the Inflation Reduction Act (the &#8220;IRA&#8221;) was signed into law on August 16, 2022.  The IRA contained substantial pharmaceutical pricing updates to the Medicare programs. The extent and scope of impacts the IRA may have will continue to evolve as the current administration advances implementation of the IRA&#8217;s pharmaceutical pricing provisions. Several changes included in the IRA may impact pricing, disrupt current pharmaceutical supply chain operations, and alter stakeholder behavior in a manner that ultimately reshapes the industry and impacts areas beyond the Medicare program. For example, each year, CMS will engage with selected high-spend Medicare Part D and Part B single-source drug and biologic products as part of the &#8220;Medicare Drug Price Negotiations Program.&#8221; These negotiations compel manufacturers of these products to negotiate substantial discounts to the Medicare program or face substantial penalties.  The pricing reached during these negotiations will likely have significant impacts on selected and related products, such as on pricing, prescribing, and formulary management, within Medicare and secondarily in other coverage markets. The &#8220;Medicare Drug Inflation Rebate Program,&#8221; which penalizes manufacturers for increasing prices of Medicare Part B and Medicare Part D drugs faster than the rate of inflation may also further impact industry pricing considerations for future products. Changes stemming from the Part D benefit redesign may similarly impact downstream stakeholder behavior and formulary management practices that may influence pricing and the demand for certain drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on October 20, 2020, HHS and the FDA published a final rule allowing states and other entities to develop a Section 804 Importation Program to import certain prescription drugs from Canada into the U.S. That regulation was challenged in a lawsuit by the Pharmaceutical Research and Manufacturers of America (&#8220;PhRMA&#8221;), but the case was dismissed by a federal district court in February 2023 after the court found that PhRMA did not have standing to sue HHS. Nine states (Colorado, Florida, Maine, New Hampshire, New Mexico, North Dakota, Texas, Vermont and Wisconsin) have passed laws allowing for the importation of drugs from Canada. Certain of these states have submitted Section 804 Importation Program proposals and are awaiting FDA approval. On January 5, 2024, the FDA approved Florida&#8217;s plan for Canadian drug importation. This plan was granted extensions until May 6, 2026. It is unclear how this program will be implemented, if at all, including which drugs will be chosen, and whether it will be subject to legal challenges in the United States or Canada.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Recent litigation, enforcement activity, and state and federal legislative interest and efforts have resulted in changes within the landscape of the 340B Drug Pricing Program (the &#8220;340B Program&#8221;). Established by Section 340B of the PHSA and overseen by the Health Resources and Services Administration (&#8220;HRSA&#8221;), the 340B Program requires manufacturers to sell outpatient prescription drugs to certain statutorily-defined safety net &#8220;covered entities&#8221; at significantly discounted prices. In recent years, there has been increased third-party utilization of the 340B Program as a result of expanded interpretations of the statute by covered entities, which has had implications for manufacturers of covered outpatient drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Potential statutory or regulatory updates at the federal level, in addition to 340B-related litigation, could significantly reshape the 340B Program and its resulting impact on future sales, as approved. Notably, the landscape of contract pharmacy involvement in the dispensing of 340B drugs sold to covered entities particularly on the state-level&#8212;has continued to evolve through enforcement activity, litigation, and state-level legislation. The changes stemming from continued litigation and state activity, as well as the growing number of contract pharmacies, or any related federal legislative activity may continue to impact the volume of drugs purchased at 340B prices and the 340B Program&#8217;s impact on our product candidates, if approved.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In May 2025, the current administration published an executive order regarding most favored nation (&#8220;MFN&#8221;) drug pricing, which is sometimes referred to as international reference pricing. This executive order directs the Secretary of Health and Human Services to communicate MFN price targets to pharmaceutical manufacturers, and if significant progress towards MFN pricing is not delivered, to propose a rule making plan to impose MFN pricing. HHS is currently developing a proposed rule to establish a demonstration model under the auspices of CMS&#8217;s Center for Medicare and Medicaid Innovation that will require MFN pricing, but the proposed rule has not yet been published, so it is not yet known which drugs will be covered, how long the model will be in effect, or how pricing will be determined. If that rule or other MFN pricing rules are finalized, they are likely to establish reference price controls on U.S. drug prices, using prices in comparator countries as the benchmark for allowable U.S. reimbursement.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">More broadly, individual states are increasingly active in passing legislation and implementing regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, provisions designed to encourage importation from other countries and bulk purchasing of drug products by state agencies. A number of states, for example, require drug manufacturers and other entities in the drug supply chain, including health carriers, pharmacy benefit managers, wholesale distributors, to disclose information about pricing of pharmaceuticals. Several states have also authorized the use of prescription drug affordability boards to impose price constraints on certain high-cost prescription drugs. In addition, regional healthcare organizations and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription pharmaceutical and other healthcare programs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The evolving nature of these federal and state measures could reduce ultimate demand for products, once approved, or put pressure on our product pricing. Additional state and federal healthcare reform measures may be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could also impact third party payor behavior and result in reduced demand or additional pricing pressures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">General Data Protection Regulation and other Privacy Laws</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to or affected by numerous data privacy and security obligations, that apply in Europe and other countries, including the European Economic Area&#8217;s (EEA&#8217;s) General Data Protection Regulation (&#8220;GDPR&#8221;). Following the withdrawal of the United Kingdom from the EU, the U.K. Data Protection Act 2018 was enacted and includes parallel obligations to those set forth by GDPR.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The GDPR</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">is wide-ranging in scope and imposes numerous strict requirements on companies that process personal data, including heightened requirements on companies that process health and other sensitive data, such as requiring in many situations that a company obtain consent of individuals before processing their personal data. Other examples of obligations imposed by the GDPR include providing information to individuals regarding data processing activities, implementing safeguards to protect the security and confidentiality of personal data, appointing a data protection officer, taking certain measures when engaging third-party processors, and providing notification of data breaches. The GDPR also permits data protection authorities to impose large penalties for violations of the GDPR, including potential fines of up to &#8364;20 million or 4% of annual global revenues, whichever is greater.  In addition, the GDPR confers a private right of action on data subjects and consumer associations to lodge complaints with supervisory authorities, seek judicial remedies, and obtain compensation for damages resulting from violations of the GDPR. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The GDPR also imposes strict rules on the transfer of personal data to countries outside the EEA, including the U.S. The transfer of personal data from the EEA to the U.S. is generally restricted unless a company participates in the EU-U.S. Data Privacy Framework or have otherwise implemented specific safeguards to protect the data. Some privacy advocacy groups are interested in challenging these mechanisms, so the uncertainty surrounding what will constitute a legal cross-border transfer of data in the future may impact our business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with the GDPR is a rigorous and time-intensive process that may increase the cost of doing business. Moreover, failure to comply may lead to significant penalties or reputational harm. Beyond the GDPR, there are privacy and data security laws in a growing number of countries around the world. While many loosely follow the GDPR as a model, other laws contain different or conflicting provisions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Summit employees are the cornerstone of our strategy. We believe our ability to hire, retain and develop top talent is key in achieving our long-term strategic goals. We are committed to fostering an inclusive work environment where employees are empowered to contribute to Summit&#8217;s mission while simultaneously enhancing their professional development. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our workforce consists of world-class leaders and experienced professionals to include, scientists, researchers, regulatory experts, clinical development specialists and business administrators working together to resolve serious, unmet medical needs for the betterment of overall human health and making a significant difference in the quality and potential duration of life for oncology patients. We are committed to employing the best talent regardless of the employee&#8217;s gender, age, ethnicity,  sexual orientation, or any other characteristic protected by applicable law.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of December 31, 2025, we had 265 total employees. Of our total workforce, approximately 71% work in research and development, and 29% work in finance, legal, information technology, general management and other administrative functions. Approximately 91% of our workforce is in the United States and approximately 9% is outside of the United States. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation and Benefits </span></div><div style="text-indent:31.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To address a competitive and dynamic labor market and attract and retain talent, Summit provides a comprehensive total rewards package which includes market competitive salaries, stock options, an annual performance discretionary bonus, employer contributions to pension/401(k) plans, an employee stock purchase plan, paid vacations, holidays and a hybrid work schedule.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Summit visits its compensation practices and reviews its benefit programs annually, adjusting as needed to ensure that its total reward offerings continue to address the needs of its employees and compensation packages assist Summit in hiring and retaining top-talent to meet business goals and objectives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Culture and Engagement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Summit&#8217;s culture continues to be at the center of its success. Summit&#8217;s core values are a huge part of Summit&#8217;s culture, and include:</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Integrity &#8211; to uphold the highest standards; Passion for Excellence &#8211; a learning mindset embracing change to drive success; Purposeful Urgency</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; unwavering commitment to fulfill our mission to patients pursuing audacious goals; Accountability &#8211; assuming responsibility for our actions and outcomes;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration &#8211; the power of teamwork; and Our Commitment to People</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; prioritizing patients and the health and safety of every Summit colleague actively providing impactful growth opportunities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As Summit continues to grow, maintaining and emphasizing Summit&#8217;s core values will be essential in maintaining its culture.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Belief in Summit&#8217;s mission and commitment to help patients is not only a core value but continues to be at the forefront of employee engagement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2025, Summit employees participated in the Great Place to Work Survey and has been able to maintain its  Great Place To Work&#174; certification for a second year in a row, with 81% of employees believing in the statement that Summit is a great place to work. We believe these results continue to show employees to be engaged, enthusiastic and strongly aligned with the Company&#8217;s mission.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Learning and Development</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to investing in learning and development for our employees and provide ongoing education through the employee&#8217;s life-cycle led by &#8220;Summit University&#8221;. The employee education process begins during orientation where all new employees receive a comprehensive overview of the Company, partnership, and the molecule&#8217;s mechanism of action. This educational program also includes oncology training, anatomy, physiology, disease state awareness, testing, and symptoms along with the patient journey as it pertains to the Summit clinical trials. This strategy helps to ensure scientists as well as administrators start their employment with a strong foundation of shared knowledge to power the Company and its culture.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Workplace Health and Safety</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to the health and safety of all of our employees. We accomplish this through goals of compliance with applicable workplace safety laws and regulations, continuous risk assessment and expeditious action. We had no reportable health and safety issues in 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Our Corporate Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Summit Therapeutics Inc. was incorporated in Delaware on July 17, 2020. Our principal executive office is located at 601 Brickell Key Drive, Suite 1000, Miami, Florida 33131 and our phone number is (305) 203-2034. Our website is https://www.smmttx.com. The information contained on, or that can be accessed through, our website is not incorporated by reference into this Annual Report on Form 10-K or in any other report or document we file with the SEC, and any reference to our website address is intended to be an inactive textual reference only.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We own or have rights to trademarks, service marks, and trade names that we use in connection with the operation of our business, including our corporate name, logos and website names. Other trademarks, service marks, and trade names appearing in this Annual Report on Form 10-K are the property of their respective owners. Solely for convenience, some of the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">trademarks, service marks, and trade names referred to in this Annual Report on Form 10-K are listed without the &#174; and &#8482; symbols.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a website with the address https://www.smmttx.com/. We are not including the information contained on our website as part of, or incorporating it by reference into, this Annual Report on Form 10-K. Through our website, we make available free of charge our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K,  amendments to these reports in a timely manner after we provide them to the SEC, and other material information from time to time in our press releases, annual meetings of stockholders, publicly accessible conferences and investor presentations.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.  Risk Factors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This section describes certain risks we face in our business. Additional risks we do not yet know of or that we currently believe are immaterial may also impair our business. If any of the events or circumstances described in this section actually occurs, our business, financial condition or operating results could suffer, and the market price of our common stock could decline. In assessing these risks, investors should also refer to the other information contained or incorporated by reference in this Annual Report on Form 10-K and our other filings with the SEC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Financial Position and Need for Additional Capital</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a development-stage company and have incurred significant losses since our inception. We expect to incur losses for at least the next several years and may never generate or maintain profits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are a development-stage company and we cannot ensure profitability. Since inception, we have incurred significant operating losses. During the year ended December 31, 2025, we incurred a net loss of $1,079.6 million, and cash flows used in operating activities was $322.9&#160;million. As of December 31, 2025 we had an accumulated deficit of $2,294.2 million, cash and cash equivalents of $225.3&#160;million, short-term investments in U.S. treasury securities of $488.2 million, and current and long-term research and development tax credits receivable of $0.9&#160;million. These losses could continue for the next several years as we invest in clinical development of ivonescimab. We expect to continue to generate operating losses for the foreseeable future. Until we can generate substantial revenue and achieve profitability, we will need to raise additional capital to fund ongoing operations and capital needs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To become and remain profitable, we must succeed in developing and eventually either commercializing or partnering with other organizations to commercialize products that generate significant revenue. This will require us to be successful in a range of challenging activities, including but not limited to completing preclinical testing and clinical trials of our product candidates, discovering additional product candidates, obtaining regulatory approval for these product candidates, and manufacturing, marketing, and selling any products for which we may obtain regulatory approval. We are in the preliminary stages of many of these activities. We may never succeed in these activities and, even if we do, may never generate revenue that is significant enough to achieve profitability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Because of the numerous risks and uncertainties associated with pharmaceutical products and biological development, we are unable to accurately predict the timing or amount of increased expenses or when, or if, we will be able to achieve profitability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Even if we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to become and remain profitable would depress our value and could impair our ability to raise capital, expand our business, maintain our research and development efforts, diversify our product offerings or even continue our operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have not yet demonstrated an ability to successfully complete development of any product candidates, which may make it difficult for you to evaluate our success and future viability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have not yet demonstrated an ability to successfully complete development of any product candidates, obtain marketing approvals, manufacture a commercial scale product, or arrange for a third party to do so on our behalf, or conduct sales and marketing activities or otherwise obtain a partner to do so, as is necessary for successful product commercialization. Consequently, any predictions you make about our future success or viability may not be as accurate as they could be if we had a longer operating history.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In January 2026, the FDA accepted for filing our BLA seeking approval of ivonescimab in combination with chemotherapy in patients with EGFR-mutated locally advanced or metastatic non-squamous NSCLC post-TKI therapy and provided a PDUFA target action date of November 14, 2026. The delay or denial of regulatory approval, inability to maintain regulatory approval, inability to complete post-marketing requirements, or the requirement to resubmit any marketing application with additional data or information could mean that we otherwise negatively would delay commercialization of ivonescimab and adversely impact our ability to generate revenue, our business and our operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Assuming we obtain marketing approval for any of our product candidates, we will need to transition from a company with a research and development focus to a company capable of supporting commercial activities or seek an appropriate partner or partners to maximize the commercial opportunity of our products with a deal structure that maximizes our opportunities for profitability. We may encounter unforeseen expenses, difficulties, complications, and delays, and may not be successful in such a transition.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will need substantial additional capital to fund our operations and to make payments under the License Agreement, and if we fail to obtain necessary financing, we could be forced to delay, reduce or eliminate the development and commercialization of our product candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Conducting preclinical testing and clinical trials is a time-consuming, expensive, and uncertain process that takes years to complete, and we may never generate the necessary data or results required to obtain marketing approval or achieve product sales. In addition, our product candidates, if approved, may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of products that may not be  commercially available for several years, if at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We expect our research and development expenses to increase substantially in connection with our ongoing activities, particularly in connection with the License Agreement. In addition, if we obtain marketing approval for our potential future product candidates where we retain commercial rights or any other product candidates we develop, we expect to incur significant commercialization expenses related to product sales, marketing, distribution and manufacturing. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, we will need to continue to rely on additional financing in connection with our continuing operations. Additional financing may not be available to us on acceptable terms, or at all. If we are unable to raise capital when needed or on attractive terms, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to generate operating losses for the foreseeable future. Our primary future capital requirements will be related to our obligations under the License Agreement and funding research and development efforts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The License Agreement, as amended, calls for initial consideration payments of $515 million (of which $500 million was paid in 2023 and $15 million was paid in 2024), as well as total contingent payments by the Company of up to $4.56 billion, as Akeso will be eligible to receive regulatory milestones of up to $1.05 billion, some of which will be due before the Company anticipates generating revenue and commercial milestones of up to $3.51 billion. We will need additional capital to fund our operations and payments under the License Agreement, which we may do via issuances of equity or debt or through global or regional partnerships in the Licensed Territory.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Raising additional capital may cause dilution to our investors, restrict our operations or require us to relinquish rights to our product candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Until such time, if ever, as we can generate substantial product revenues, we expect to finance our cash needs through a combination of equity offerings, collaborations, strategic alliances, grants and clinical trial support from government entities, philanthropic, non-government and not-for-profit organizations and patient advocacy groups, debt financings, and marketing, distribution or licensing arrangements. We do not have any committed external source of funds. We will need to seek additional funding in the future to fund operations. Additional capital, when needed, may not be available to us on acceptable terms, or at all. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our existing stockholders may be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our existing stockholders. Additional debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends or other distributions. If we raise additional funds through collaborations, strategic alliances or marketing, distribution, or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or to grant licenses on terms that may not be favorable to us. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to raise additional funds through equity or debt financings, or other arrangements when needed based on our liquidity needs, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Worldwide economic, social and geopolitical instability could adversely affect our operations, revenue, financial condition, results of operations or ability to raise capital.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Generally, worldwide economic conditions remain uncertain, particularly due to the effects of the conflict between Russia and Ukraine, the conflicts in the Middle East, including those in Gaza, Lebanon and Yemen, the escalating tensions in Venezuela and Greenland, and disruptions in the banking system and financial markets, including those in Japan, increased inflation and rising interest rates. The general economic and capital market conditions, both in the U.S. and worldwide, have been volatile in the past and at times have adversely affected the Company&#8217;s access to capital and increased the cost of capital. The ongoing </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">geopolitical conflicts in various parts of the world, including but not limited to Russia, Ukraine, the Middle East, Venezuela and Greenland, are difficult to predict and could adversely affect our business in the Licensed Territory as well as our ability to enroll patients and supply ivonescimab to various clinical sites in the world, resulting in adverse effects on our business and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The capital and credit markets may not be available to support future capital raising activity on favorable terms. If economic conditions decline, the Company&#8217;s future cost of equity or debt capital and access to the capital markets could be adversely affected.  In addition, adverse economic conditions, such as recent supply chain disruptions and labor shortages and persistent inflation, may negatively impact our business. These economic conditions make it more difficult for us to accurately forecast and plan our future business activities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We depend heavily on the success of ivonescimab. If we are unable to successfully develop or commercialize ivonescimab, or experience significant delays in doing so, we may continue to incur significant financial losses.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have and plan to continue investing a significant portion of our efforts and financial resources in the development of ivonescimab, which is still in clinical development. Our ability to generate product revenues, which may not occur for several years, if ever, will depend heavily on the successful development and commercialization of ivonescimab. The success of this product candidate depends on a number of factors, including, but not limited to, the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to use preclinical data and data of patients from Akeso&#8217;s clinical trials in China supporting registration studies and regulatory approval;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successful completion of global clinical development;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">receipt of clinical trial approvals and future marketing approvals from applicable regulatory authorities in all the countries where we intend to conduct clinical trials or seek marketing approval; the costs of post-marketing studies, if any, that could be required by regulatory authorities in jurisdictions where approval is obtained;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing supply chain and commercial manufacturing arrangements with third-party manufacturers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtaining and maintaining patent and trade secret protection and regulatory exclusivity;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enforcing our rights in our intellectual property portfolio;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing sales, marketing and distribution capabilities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">launching commercial sales of ivonescimab if and when approved, whether alone or in collaboration with others;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acceptance of ivonescimab, if and when approved, by patients, the medical community and third-party payors;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtaining timely and adequate pricing and reimbursement from payors;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ensuring no disruption in supply or lack of sufficient quantities of ivonescimab;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">effectively competing with other therapies; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintaining an acceptable safety profile of ivonescimab during development and following approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Risks and uncertainties related to these factors could cause us to experience significant delays or an inability to successfully commercialize ivonescimab, which would materially harm our business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Development and Commercialization of our Product Candidates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical development is a lengthy process with an uncertain outcome, and results of earlier studies and trials, conducted by us or Akeso, as well any interim results thereof, may not be predictive of future trial results and may negatively impact the size and scope of our ongoing or future Phase III clinical trials. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Clinical development can take several years to complete and is an expensive process with inherent uncertainty in outcomes. Failure can occur at any time during the clinical development process. The results of preclinical studies and early clinical trials of ivonescimab, conducted by us or Akeso, may not be predictive of the results of our later-stage clinical trials. Similarly, initial or interim results of a clinical trial may not be predictive of the final results and results for one indication, in one cohort, or in one of the primary endpoints or secondary endpoints, may not be predictive of the success in additional indications, with different cohorts or in additional primary or secondary endpoints. Drug candidates in later stages of clinical trials may fail to show the desired safety and efficacy traits despite having progressed through preclinical studies and initial clinical trials. Several factors can lead to significant variability in safety and/or efficacy results between different trials of the same drug candidate, including changes in trial procedures set forth in protocols, differences in the size, type and geographic location of the patient populations, including genetic differences, patient adherence to the dosing regimen, and other trial protocol elements and the rate of dropout among clinical trial participants. In the case of any trials we conduct, results may differ from earlier trials due to the larger number of clinical trial sites and additional countries involved in such later trials. Results may differ materially in clinical trials held across multiple cohorts or subgroups, which could lead to unfavorable regulatory or health authority decisions. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If ongoing Phase II or Phase III clinical trials conducted by Summit or Akeso involving ivonescimab, or future clinical trial results, are unfavorable, the size and scope, including the number of patients, primary and secondary endpoints, and population of patients, of ongoing and future clinical trials could be impacted. Further, we may incur additional product development costs, experience delays or become unable to obtain regulatory approval of ivonescimab for the whole clinical trial or the approved label may be restricted to one cohort or subgroup, thereby adversely affecting our business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we experience delays or difficulties in the enrollment of patients in our clinical trials, our receipt of necessary marketing approvals could be delayed or prevented.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to initiate or continue clinical trials for our product candidates for several factors including inability to get required regulatory approvals to initiate clinical trials in all the planned countries, as well as inability to locate and enroll a sufficient number of eligible patients to participate in these clinical trials. For our clinical trials of ivonescimab, we need to identify potential patients, potentially test them for specific diagnoses and enroll them. In addition, our competitors in NSCLC have ongoing clinical trials for product candidates that could be competitive with our product candidates, and patients who would otherwise be eligible for our clinical trials may instead enroll in clinical trials of our competitors&#8217; product candidates or choose not to enroll in any clinical trials for various reasons, including due to fears of contagious diseases, illnesses or side effects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Patient enrollment is affected by several factors, including, but not limited to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">severity of the disease under investigation;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">eligibility criteria for the clinical trial in question;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">perceived risks and benefits of the product candidate under study;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition for patients, time and resources at clinical trials sites from other investigational therapies in clinical trials that target the same patient population;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the standard of care, including new clinical trial data;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approval of other therapies to treat the indication that is being investigated in the clinical trial;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">efforts to facilitate timely enrollment in clinical trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">patient referral practices of physicians;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to monitor patients adequately during and after treatment; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">proximity and availability of clinical trial sites for prospective patients.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Enrollment delays in our clinical trials may result in increased development costs for our product candidates, which would cause the value of our company to decline and limit our ability to obtain additional financing. Our inability to enroll a sufficient number of patients in our planned clinical trials of ivonescimab or any other planned clinical trials would result in significant delays, may generate a limited data set from which no meaningful conclusions could be made, or may require us to abandon one or more clinical trials altogether.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If clinical trials of our product candidates fail to demonstrate safety and efficacy to the satisfaction of regulatory authorities, or do not otherwise produce favorable results, we may incur additional costs or experience delays, or ultimately be unable to, develop and commercialize any product candidate. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Prior to obtaining marketing approval from regulatory authorities (including the FDA, EMA, PMDA or any other regulatory authority in the Licensed Territory) for the sale of ivonescimab, or any other product candidate, we must complete preclinical development and then conduct extensive clinical trials to demonstrate the safety and efficacy of our product candidates in humans. Clinical testing is expensive, difficult to design and implement, can take many years to complete and is inherently uncertain as to outcome. A failure of one or more clinical trials can occur at any stage of testing. The outcome of preclinical testing and early clinical trials may not be predictive of the success of later clinical trials, and interim results of a clinical trial do not necessarily predict final results. In particular, due to the small number of patients in our early clinical trials, results from such trials may not be predictive of the outcome of later clinical trials. The design of a clinical trial can determine whether its results will support approval of a product, and flaws in the design of a clinical trial may not become apparent until the clinical trial is well advanced or completed. We have limited experience in designing clinical trials and may be unable to design and execute a clinical trial to support marketing approval. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval of their products. For instance, although we believe that the safety and efficacy data generated in the HARMONi study demonstrates that the ivonescimab regimen offers a potential treatment option for patients impacted by EGFR-mutant NSCLC in this setting with a favorable benefit-risk profile, FDA has noted that a statistically significant OS benefit is necessary to support marketing authorization in </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">this setting. If the FDA does not agree with our analysis of the HARMONi data, they may delay or deny regulatory approval in this proposed indication, require us to resubmit the marketing application with additional data or information, or take other actions that could delay commercialization of ivonescimab and adversely impact our ability to generate revenue, our business and our operations. We cannot predict the results of our ongoing or future clinical trials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory authorities have substantial discretion in the approval process. They may refuse to accept any application or may decide that our data are insufficient for approval and require additional clinical trials or other studies. In our public communications, we may designate certain of our clinical trials as &#8220;pivotal&#8221; if we believe that these clinical trials, if successful, will support BLA submissions; however, there can be no assurance that any clinical trial that we designate as &#8220;pivotal&#8221; will be viewed as sufficient by the FDA, the EMA and other comparable regulatory authorities in other jurisdictions to support regulatory approval. If we are required to conduct additional clinical trials or other testing of any of our product candidates beyond those that are contemplated, we may incur significant additional costs and regulatory approval may be delayed or prevented.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There can be no guarantee that the FDA or other regulatory authorities will interpret the results or reach the same conclusions from the data as we do, or fully agree that our development plans are sufficient for submission or approval of a BLA. In the event that the FDA requires us to conduct clinical trials with more patients than planned, to conduct clinical trials with designs or endpoints other than we currently anticipate, we may not have the funding to enlarge or conduct such trials and we may not be able to raise sufficient funding to do so, which could delay or prevent commercialization of our product candidates. In addition, the FDA or other regulatory authorities may change their views on aspects of the clinical programs, including clinical trial designs, or the ability of the trials as designed to support approval of a product. If we are unable to effectively and efficiently resolve and comply with the inquiries and requests of the FDA and other comparable international regulatory authorities, the approval of our product candidates may be delayed, which could delay or prevent commercialization of our product candidates.</span></div><div><span><br/></span></div><div><span id="i833d9a3311bb416a8658b1f40154b324_183414"></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory requirements and timelines may affect the scope and timeline of our trials and the potential market for our product candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As we expand into additional countries and sites for our current and additional clinical trials, we are required to obtain the regulatory approval of the applicable clinical trial applications with the respective regulatory authorities and approvals from central or local institutional review boards. We may decide to modify our plans to enter certain regions or countries based on the timelines and requirements for the respective regulatory regions. If the process to obtain regulatory approvals in a given region or country places onerous requirements on the Company or if the Company cannot reasonably obtain such approvals without material delays to its plans, we may choose not to enter certain regions or countries for our clinical trials, which may delay the development of our product in those countries and impact the scope of our dataset and market for our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we experience any number of possible unforeseen events in connection with our clinical trials, potential marketing approval or commercialization of our product candidates could be delayed or prevented.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may experience numerous unforeseen events during, or as a result of, clinical trials that could delay or prevent our ability to complete the clinical trials and receive marketing approval for or commercialize our product candidates, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clinical trials of our product candidates may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical trials or abandon product development programs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in clinical trials that include multiple endpoints, unfavorable results in any individual endpoint may limit any regulatory approval or commercialization of the applicable product candidate; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of patients required for clinical trials of our product candidates may be larger, and the diversity of the patient population required for our clinical trials may be higher, than we anticipate or participants may drop out of these clinical trials at a higher rate than we anticipate for various reasons, including due to contagious diseases or illnesses;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to combine data from different regions and countries may be limited due to lack of consistency in data in these regions and countries, potentially delaying or preventing marketing approval for our product in some or all of the Licensed Territory;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in our multi-regional trials, we may experience delays in enrollment across one or more countries and/or regions that could lead to variability in data or the trial missing the required endpoints resulting in lack of approval from regulatory authorities in some or all of the Licensed Territory;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be unable to enroll a sufficient number of patients in our clinical trials to ensure adequate statistical power to detect any statistically significant treatment effects;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we or our third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulators, institutional review boards or independent ethics committees may not authorize us or our investigators to commence a clinical trial or conduct a clinical trial at a prospective trial site;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may have delays in reaching or fail to reach agreement on acceptable clinical trial contracts or clinical trial protocols with multiple prospective trial sites;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may have to suspend or terminate clinical trials of our product candidates for various reasons, including a finding that the participants are being exposed to unacceptable health risks;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulators, institutional review boards or independent ethics committees may require that we or our investigators materially modify the terms of our clinical research in order to meet additional requirements for receiving marketing approval, including by requiring that we enlarge our trials, broaden the scope of our research, or perform studies in addition to those we currently anticipate, which may delay our ability to obtain marketing approval or impose additional costs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulators, institutional review boards or independent ethics committees may require that we or our investigators suspend or terminate clinical research for various reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable health risks;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the supply or quality of our product candidates, comparator drugs or other materials necessary to conduct clinical trials of our product candidates in adolescent patients may be insufficient or inadequate, which may occur if, for example, enrollment for our clinical trial programs are delayed and the clinical supply of ivonescimab or related comparator drug manufactured for such trials was not utilized prior to its expiration and needed to be replaced, or if there were disruptions in our supply chain due to weather conditions, natural disasters or contagious diseases or illnesses, or pandemics or epidemics; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our product candidates may have undesirable side effects or other unexpected characteristics, causing us or our investigators, regulators, institutional review boards or independent ethics committees to suspend or terminate the clinical trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">preclinical tests or clinical trials not beginning as planned, needing to be restructured or not being completed on schedule, or at all; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">data privacy or other laws being implemented that restrict transfer of patient data from one country to another.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If serious adverse or inappropriate side effects are identified during the development of any product candidate, we may need to abandon or limit our development of that product candidate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">All of our product candidates are in clinical or early-stage development and their risk of failure is high. It is impossible to predict when or if any of our product candidates will prove effective or safe in humans or will receive marketing approval. If our product candidates are associated with undesirable side effects or have characteristics that are unexpected, we may need to abandon their development or limit development to certain uses or subpopulations in which the undesirable side effects or other characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Many compounds that initially showed promise in clinical or earlier stage testing have later been found to cause side effects or other safety issues that prevented further development of the compound. If we elect or are forced to suspend or terminate any clinical trial of our product candidates, the commercial prospects of such product candidate will be harmed and our ability to generate product revenues from such product candidate will be delayed or eliminated. Any of these occurrences could materially harm our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have conducted, and may in the future conduct, clinical trials for current or future product candidates outside the United States, and the FDA and comparable foreign regulatory authorities may not accept data from such trials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have conducted, and may in the future conduct, clinical trials for current or future product candidates outside the United States, and the FDA and comparable foreign regulatory authorities may not accept data from such trials. We are currently conducting clinical trials in China, and we expect to continue to conduct trials internationally in the future. The acceptance of data from clinical trials conducted outside the United States by the FDA or other regulatory authorities may be subject to certain conditions or may not be accepted at all. In cases where data from foreign clinical trials are intended to serve as the sole basis for regulatory approval in the United States, the FDA will generally not approve the application unless (i) the data are applicable to the U.S. population and U.S. medical practice and (ii) the trials were performed by clinical investigators of recognized competence and pursuant to GCP regulations, and the data may be considered valid without the need for an on-site inspection by the FDA or, if the FDA considers such an inspection to be necessary, the FDA is able to validate the data through an on-site inspection or other appropriate means. In addition, even where the foreign study data are not intended to serve as the sole basis for approval, the FDA will not accept the data as support for an application for marketing approval unless the study is well-designed and well-conducted in accordance with GCPs and the FDA is able to validate the data from the study through an </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">onsite inspection if deemed necessary. Additionally, the FDA&#8217;s clinical trial requirements, including sufficient size of patient populations and statistical powering, must be met. Many foreign regulatory authorities have similar approval requirements. In addition, such foreign trials are subject to the applicable local laws of the foreign jurisdictions where the trials are conducted. Conducting clinical trials outside the United States also exposes us to additional risks, including risks associated with foreign exchange fluctuations, compliance with foreign manufacturing, customs, shipment and storage requirements, and cultural differences in medical practice and clinical research, and diminished protection of intellectual property in some countries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that the FDA or any comparable foreign regulatory authority will accept data from trials conducted outside of the United States or the applicable jurisdiction. For example, for FDA acceptance, we will have to demonstrate that the foreign data are applicable to the U.S. population and U.S. medical practice. If the FDA or other regulatory authorities do not accept such data, it would result in the need for additional trials, which could be costly and time-consuming, and which may result in current or future product candidates that we may develop being delayed or not receiving approval for commercialization in the applicable jurisdiction.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if a product candidate receives marketing approval, it may fail to achieve the degree of market acceptance by physicians, patients, third-party payors and others in the medical community necessary for commercial success.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If ivonescimab or any of our other product candidates receive marketing approval, such products may nonetheless fail to gain sufficient market acceptance by physicians, patients, third-party payors and others in the medical community. If these products do not achieve an adequate level of acceptance, it could make it more difficult to enter into third-party partnership arrangements, and we may not generate significant product revenues or revenue from collaboration agreements or any income from operations. The degree of market acceptance of our product candidates, if approved for commercial sale, will depend on a number of factors, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the efficacy and potential advantages compared to alternative treatments or competitive products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prevalence and severity of any side effects;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to offer our product candidates for sale at competitive prices;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">convenience and ease of administration compared to alternative treatments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the strength of marketing and distribution support;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability of third-party coverage and adequate reimbursement;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of any such marketing approval in relation to other product approvals;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">support from patient advocacy groups; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any restrictions on concomitant use of other medications.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The ability to negotiate, secure and maintain third-party coverage and reimbursement may be affected by political, economic and regulatory developments in the United States, the E.U., Japan and other jurisdictions in the Licensed Territory.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Governments continue to impose cost containment measures, and third-party payors are increasingly challenging prices charged for medicines and examining their cost effectiveness, in addition to their safety and efficacy. These and other similar developments could significantly limit the degree of payor acceptance of ivonescimab or any of our other product candidates that receive marketing approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to establish sales and marketing capabilities or enter into agreements with third parties to market and sell our product candidates, we may not be successful in commercializing a product candidate if and when such product candidates are approved.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">With our BLA submission in Q4, 2025  and the FDA&#8217;s acceptance for filing the BLA in January 2026, we are in the process of building our Sales, Marketing and Market Access organization. We have already  hired our senior commercial leadership team with extensive experience in the sale and marketing of pharmaceutical products. In addition, we are in the process to build infrastructure of supporting  operations to ensure a successful commercial launch. To achieve commercial success for any approved product, we must either develop a sales and marketing organization and/or outsource these functions  to third parties . If ivonescimab receives marketing approval, we may seek commercialization partners in some parts of the Licensed Territory. There are risks involved with establishing our own sales and marketing capabilities as well as entering into arrangements with third parties to perform these services. If the commercial launch of a product candidate for which we recruit a sales force and establish marketing capabilities is delayed or does not occur for any reason, we would have incurred these commercialization expenses. This may be costly, and our investment would be lost if we cannot retain or reposition our sales and marketing personnel. </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Factors that may inhibit our efforts to commercialize our products on our own include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to recruit, train and retain adequate numbers of effective sales and marketing personnel in a timely fashion;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to build a marketing operations infrastructure with the development of advance analytics allowing for different channels to be utilized for promotions beyond the sales organization</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability of sales personnel to obtain access to or persuade adequate numbers of physicians to prescribe any future products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Lack of appropriate guidelines, pathways, and formulary placement for reimbursement;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Lack of key opinion development for the support of the product data;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the lack of complementary products to be offered by sales personnel, which may put us at a competitive disadvantage relative to companies with more extensive product lines; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unforeseen costs and expenses associated with creating an independent sales and marketing organization.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Evolving competition with new products or existing products with new data or combinations which may confer efficacy or safety advantages. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we enter into arrangements with third parties to perform sales and marketing services, our product revenues or the profitability of these product revenues to us are likely to be lower than if we were to market and sell any products that we develop ourselves. In addition, we may not be successful in entering into arrangements with third parties to sell and market our product candidates or may be unable to do so on terms that are acceptable to us. We likely will have little control over such third parties, and any of them may fail to devote the necessary resources and attention to sell and market our products effectively. If we do not establish sales and marketing capabilities successfully, either on our own or in collaboration with third parties, we will not be successful in commercializing our product candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Biologics, such as ivonescimab, carry unique risks and uncertainties that could negatively impact our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The successful development, manufacturing and sale of biologics is a long, expensive and uncertain process. There are unique risks and uncertainties with biologics. For example, access to and supply of necessary biological materials, such as cell lines, may be limited and governmental regulations restrict access to and regulate the transport and use of such materials. In addition, the development, manufacturing and sale of biologics is subject to regulations that are often more complex and extensive than the regulations applicable to other pharmaceutical products. Manufacturing biologics, especially in large quantities, is often complex and may require the use of innovative technologies. Such manufacturing also requires facilities specifically designed and validated for this purpose and sophisticated quality assurance and quality control procedures. Biologics are also frequently costly to manufacture. Failure to successfully develop, manufacture and sell ivonescimab could adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may expend our limited resources to pursue a particular product candidate and fail to capitalize on product candidates that may be more profitable or for which there is a greater likelihood of success.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding our large investment to date and anticipated future expenditures in proprietary technologies, we have not yet developed, and may never successfully develop, any marketed drugs. As a result of pursuing the development of product candidates using our proprietary technologies, we may fail to develop product candidates or address indications based on other scientific approaches that may offer greater commercial potential or for which there is a greater likelihood of success. Research programs to identify new product candidates require substantial technical, financial and human resources. These research programs may initially show promise in identifying potential product candidates, yet fail to yield product candidates for clinical development.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may relinquish valuable rights to that product candidate through collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We face substantial competition, which may result in others discovering, developing or commercializing products before us or more successfully than we do.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The development and commercialization of new drug products is highly competitive. We face competition with respect to our current product candidate and any products we may seek to develop or commercialize whether ourselves or through third-party partners, in the future from major pharmaceutical companies, specialty pharmaceutical companies and biotechnology companies worldwide.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Several pharmaceutical and biotechnology companies have established themselves in the market for the treatment of NSCLC, and several additional companies are developing products for the treatment of NSCLC. Currently, the most commonly used treatments for first-line NSCLC without genomic alterations are several immuno-oncology drugs and chemotherapies, administered either individually as monotherapy, in combination with each other, or in combination with other approved therapeutics. In addition to various chemotherapies, several immunotherapies have been approved by the FDA for these treatments, including, but not limited to pembrolizumab, atezolizumab, nivolumab, durvalumab, cemiplimab and ipilimumab. There are anti-angiogenic therapies which are approved for the treatment of certain lung cancers, including bevacizumab in front-line non-squamous NSCLC as well as ramucirumab for patients who have progressed after platinum-based chemotherapy. The proposed indications for ivonescimab in the HARMONi-3 and HARMONi-7 clinical trial settings in first-line NSCLC may face competition from clinical candidates such as novel immunotherapy targets including various clinical candidates targeting T-cell immunoreceptors with Ig and ITIM domains (TIGIT) and lymphocyte activation gene 3 (LAG-3) each of which have various developers for different candidates as either monoclonal antibodies or multispecific antibodies, a bispecific antibody, volrustomig (AstraZeneca), and antibody drug conjugates (ADCs) with novel targets such as datopotamab deruxetecan (AstraZeneca and Daiichi Sankyo), sacituzumab tirumotecan (Merck), and sigvotatug vedotin (Pfizer), each having announced, are currently enrolling in, or having completed enrollment in Phase III clinical trials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For those patients having EGFR mutations, there are several targeted therapies that have also been approved in the front-line setting, including, but not limited to, osimertinib (AstraZeneca) with or without chemotherapy and amivantamab and lazertinib (both from Johnson &amp; Johnson). The proposed indication for ivonescimab in the HARMONi clinical trial setting, post third-generation EGFR-TKIs such as osimertinib or lazertinib, may face competition from amivantamab plus chemotherapy, as well as clinical candidates such as datopotamab deruxetecan (AstraZeneca and Daiichi Sankyo) and patritumab deruxtecan (Merck and Daiichi Sankyo).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There are several PD-(L)1/VEGF(R2) bispecific antibodies in development or with planned development globally. These include, but are not limited to pumitamig (BNT327), which is owned by BioNTech SE and being developed in a collaboration with Bristol Myers Squibb Co. since June 2025, which has begun conducting Phase III clinical studies globally, PF-08634404 (PF&#8217;4404 / SSGJ-707), which was licensed globally, ex-China by Pfizer Inc. in July 2025, LM-299, which was licensed globally by Merck &amp; Co., Inc. in November 2024, and RC148, which was licensed outside of Greater China by AbbVie Inc. in January 2026.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Potential competitors also include academic institutions, government agencies and other public and private research organizations that conduct research, seek patent protection and establish collaborative arrangements for research, development, manufacturing and commercialization. Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are more effective, safer, have fewer or less severe side effects, are approved for broader indications or patient populations, or are more convenient or less expensive than any products that we develop and commercialize. Our competitors may also obtain marketing approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe that many competitors are attempting to develop therapeutics for the target indications of our product candidates, including academic institutions, government agencies, public and private research organizations, large pharmaceutical companies and smaller more focused companies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Multiple in-class and related competitors for our product candidate are and can be developed, our competitive position could be compromised because it may be more difficult for us to obtain marketing approval for that product candidate and market acceptance of that product candidate due to a similar competitor. In addition, any product that competes with another approved product typically must demonstrate compelling advantages in efficacy, convenience, tolerability or safety, or some combination of these factors, to gain regulatory approvals, overcome price competition and be commercially successful.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Many of our competitors may have significantly greater financial and operational resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining approvals from regulatory authorities and marketing approved products than we do. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller and other early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties compete with us in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to or necessary for our programs.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If we fail to plan, execute and manage our growth effectively, our ability to develop and commercialize products could suffer. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We expect that if our clinical product candidates continue to progress in development, and we continue to build our clinical operations and invest in our commercial operations, we will require significant additional investment in personnel, infrastructure and resources. Our ability to achieve our research, development and commercialization objectives depends on our ability to respond timely and effectively to these demands and expand our internal organization, systems and controls to accommodate additional anticipated growth. The expansion of our operations may lead to significant costs and may divert our management and business resources. Failure to effectively manage our growth may impact our ability to successfully develop and commercialize our product candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Dependencies on Third Parties</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on our relationship with, and the comprehensiveness of the intellectual property licensed from, Akeso, and termination of the License Agreement, or issues related to intellectual property could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We depend on the know-how and other intellectual property licensed from Akeso through the License Agreement for the development and, if approved, commercialization of the bispecific antibody, ivonescimab. If the License Agreement is terminated, or found to be unenforceable, it could result in the loss of significant rights and could harm our ability to commercialize ivonescimab.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The License Agreement imposes certain obligations on us, including obligations to use diligent efforts to meet development thresholds, funding requirements, payment obligations, and commercialization. If we are unable to meet our obligations, some or all of our rights under the License Agreement may be restricted or terminated.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our primary product candidate, ivonescimab, is subject to the License Agreement from Akeso, which is revocable in certain circumstances, including in the event we do not achieve certain payment deadlines. Without the rights to the patents under the License Agreement, we will not be able to continue to develop ivonescimab.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The License Agreement may be terminated by Akeso in the event of a material breach by Summit or if we default in the performance of any of our material obligations under the License Agreement, and such default continues for 90 days, or with respect to any breach of any undisputed payment obligations, for 60 days, or with respect to any breach of a supply requirement, for 30 days after written notice thereof. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the ability of Summit to realize the full potential of the License Agreement may be severely limited by factors involving intellectual property rights, including:  </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether and to what extent our technology and processes infringe on intellectual property rights of other third parties that are not subject to the License Agreement;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether third parties are entitled to compensation or equitable relief, such as an injunction, for our use of intellectual property without their authorization;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our right to sublicense patent and other intellectual property rights to third parties under collaborative development relationships;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our compliance with our obligations with respect to the use of the licensed technology in relation to our development and commercialization of product candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ownership of specific intellectual property; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact on payments and costs associated with commercialization if there is blocking intellectual property or the costs associated with prosecution, maintenance and enforcement of intellectual property under the License Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These issues, if they arise, could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, increase what we believe to be our financial or other obligations under the relevant agreement, or increase our costs to develop, manufacture and commercialize products under the License Agreement.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be reliant on Akeso for knowledge transfer relating to any improvements in manufacturing of ivonescimab. The loss of any of the knowledge transferred relating to ivonescimab from Akeso may cause us to incur additional transition costs or result in delays in the manufacturing and delivery of ivonescimab.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into the License Agreement pursuant to which we agreed to purchase a certain portion of drug substance and/or drug product for clinical and commercial supply, and the termination or Akeso&#8217;s breach of these agreements could have a material adverse effect on our business. Akeso&#8217;s drug substance and drug product may not comply with regulatory authority quality requirements or have sufficient stability for commercialization which may require additional investment and delay our development, approval and commercialization plans. Further, failure of Akeso to adequately transfer knowledge to Summit relating to any improvements in producing ivonescimab could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturing of biological compounds is inherently complex and establishing new manufacturing relationships with a third-party manufacturer may take longer, resulting in higher costs and potential inventory issues. Manufacturing processes may use materials which Summit may not be able to secure, requiring Summit to develop alternative processes and delay manufacturing. The product may not comply with regulatory authority quality requirements or have sufficient stability for commercialization, which may require additional manufacturing development and delays. As Summit is relying initially on supply from Akeso, any delays in obtaining import or export licenses may delay development.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on collaborations with third parties for the development and commercialization of some of our product candidates. If those collaborations are not successful, we may not be able to capitalize on the market potential of these product candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may enter into third-party collaborations for the development and commercialization of ivonescimab. Additionally, we may seek third-party collaborators for development and commercialization of any other product candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our likely future collaborators for any marketing, distribution, development, licensing or broader collaboration arrangements include large and mid-size pharmaceutical companies, regional and national pharmaceutical companies and biotechnology companies. Under our license and commercialization agreements we have, and under any such arrangements we enter into with any third parties in the future, we will likely have, limited control over the amount and timing of resources that our collaborators dedicate to the development or commercialization of our product candidates. Our ability to generate revenues from these arrangements will depend on our collaborators&#8217; abilities and efforts to successfully perform the functions assigned to them in these arrangements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our current collaborations pose, and any future collaborations likely will pose, numerous risks to us, including without limitation the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators have significant discretion in determining the efforts and resources that they will apply to these collaborations and may not perform their obligations as expected;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may de-emphasize or not pursue development and commercialization of our product candidates or may elect not to continue or renew development or commercialization programs based on clinical trial results, changes in the collaborators&#8217; strategic focus, including as a result of a sale or disposition of a business unit or development function, or available funding, or external factors such as an acquisition that diverts resources or creates competing priorities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may delay clinical trials, provide insufficient funding for a clinical trial program, stop a clinical trial or abandon a product candidate, repeat or conduct new or unsuccessful clinical trials or require a new formulation of a product candidate for clinical testing;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our products or product candidates if the collaborators believe that competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than ours;a collaborator with marketing and distribution rights to multiple products may not commit sufficient resources to the marketing and distribution of our product relative to other products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may not properly maintain or defend our intellectual property rights or may use our proprietary information in such a way as to invite litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential litigation;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may infringe the intellectual property rights of third parties, which may expose us to litigation and potential liability;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disputes may arise between the collaborator and Summit as to the ownership of intellectual property arising during the collaboration;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may grant exclusive rights to our collaborators, which would prevent us from collaborating with others;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disputes may arise between the collaborators and us that result in the delay or termination of the research, development or commercialization of our products or product candidates or that result in costly litigation or arbitration that diverts management attention and resources; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable product candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration agreements may not lead to development or commercialization of product candidates in the most efficient manner or at all. If a collaborator of ours were to be involved in a business combination, the continued pursuit and emphasis on our product development or commercialization program could be delayed, diminished or terminated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on the use of third parties, including Akeso, to manufacture our product candidate, which may increase the risk that we will not have sufficient quantities of our product candidates or products or such quantities at an acceptable time and cost, which could delay, prevent or impair our development or commercialization efforts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We do not own or operate manufacturing facilities for the production of clinical or commercial supplies of our product candidates. We have limited personnel with experience in drug manufacturing and lack the resources and the capabilities to manufacture any of our product candidates on a clinical or commercial scale. We currently rely on third parties for supply of the active pharmaceutical ingredients ("API"), drug substance and drug product in our product candidates. Our strategy is to outsource all manufacturing of our product candidates and products to third parties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have supply agreements with Akeso for supply of ivonescimab for use in clinical trials as well as for commercial supply. We have agreements with third-party manufacturers for development, validation and manufacturing of ivonescimab to secure the long-term clinical or commercial supply of our product candidates. We are in the process of setting up agreements with third party manufacturers for the long-term clinical and commercial supply of ivonescimab.  We may be unable to conclude agreements for commercial supply with third-party manufacturers, or may be unable to do so on acceptable terms. The third-party manufacturers may not successfully carry out their contractual duties or obligations, the occurrence of which could substantially increase our costs and limit our supply of such product candidates. The demand for third-party manufacturers&#8217; services is very high, and such manufacturers could be subject to market transactions including mergers, acquisitions and other market consolidation transactions that limit their ability to provide products and services to us thereby increasing the time and cost it could take us to manufacture our product. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are able to establish and maintain arrangements with third-party manufacturers, reliance on third-party manufacturers, including Akeso, entails additional risks, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reliance on the third party for regulatory compliance and quality assurance;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possible breach of the manufacturing agreement by the third party;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possible diversion of manufacturing capacity to other customers by the third party;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possible misappropriation of our proprietary information, including our trade secrets and know-how; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possible termination or non-renewal of the agreement by the third party at a time that is costly or inconvenient for us.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The manufacturing process for a product candidate is subject to FDA and other foreign regulatory authority review. We, and our suppliers and manufacturers, must meet applicable manufacturing requirements and undergo rigorous facility and process validation tests required by regulatory authorities in order to comply with regulatory requirements, such as cGMP. Securing regulatory approval also requires the submission of information about the product manufacturing process to, and inspection of manufacturing facilities by, the FDA and other foreign regulatory authorities. If our contract manufacturers are unable to maintain a compliance status acceptable to the FDA and other foreign regulatory authorities, our product candidates may not be approved. If our contract manufacturers cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements of the FDA or comparable foreign regulatory authorities, we may not be able to rely on their manufacturing facilities for the manufacture of components of any product candidates. Moreover, although we do not control the manufacturing process at our contract manufacturers and are completely dependent on them for compliance with current regulatory requirements, we are nonetheless responsible for ensuring that any product candidates are manufactured in accordance with applicable laws and regulatory requirements. In the event that any of our manufacturers fails to comply with such requirements or to perform its obligations in relation to quality, timing or otherwise, or if our supply of components or other materials becomes limited or interrupted for other reasons, we may be forced to enter into an agreement with another third party, which we may not be able to do on reasonable terms, if at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Third-party manufacturers, including Akeso, may not be able to comply with cGMP, regulations or similar regulatory requirements outside the United States. Our failure, or the failure of our third-party manufacturers, including Akeso, to comply with applicable regulations could result in sanctions being imposed on us, including fines, injunctions, civil penalties, delays, </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">suspension or withdrawal of approvals, license revocation, seizures or recalls of product candidates or products, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect supplies of our product candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our product candidates and any products that we may develop may compete with other product candidates and products for access to manufacturing facilities. There are a limited number of manufacturers that operate under cGMP regulations and that might be capable of manufacturing for us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in order to conduct late-stage clinical trials of our product candidates, we will need to have them manufactured in large quantities. Our third-party manufacturers, including Akeso, may be unable to successfully increase the manufacturing capacity for any of our product candidates in a timely or cost-effective manner, or at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, if our third-party manufacturers, including Akeso, are unable to successfully scale up the manufacture of our product candidates in sufficient quality and quantity, the development, testing and clinical trials of that product candidate may be delayed or infeasible, and regulatory approval or commercial launch of that product candidate may be delayed or not obtained, which could significantly harm our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If the third parties, including Akeso, that we engage to manufacture product for our preclinical tests and clinical trials should cease to continue to do so for any reason, including due to the coronavirus or another outbreak, we likely would experience delays in advancing these clinical trials while we identify and qualify replacement suppliers, and we may be unable to obtain replacement supplies on terms that are favorable to us. In addition, if we are not able to obtain adequate supplies of our product candidates or the drug substances used to manufacture them, it will be more difficult for us to develop our product candidates and compete effectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Large pharmaceutical companies with greater resources, either through acquisitions, market consolidation or otherwise, may be able to obtain privileged access to manufacturing capacity and supply of material needed for the manufacture of ivonescimab or other similar competing drugs.  If our competitors are able to use their resources to secure preferential access to the supply capacity of third party manufacturers, or if third party manufacturers elect to terminate their contracts with us in favor of exclusive contracts with other larger pharmaceutical companies, our ability to obtain a supply of ivonescimab or any other future product candidates may be impacted resulting in significant delays and higher costs for development and commercialization of our products. We may not be able to complete our clinical trials or market our products at scale without stable partnerships with third party manufacturers who produce ivonescimab or other drug compounds necessary for our product candidates. Shifting manufacturing relationship to another third-party manufacturer takes significant time and resources, and could delay development and commercialization of our product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties to conduct our clinical trials and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such clinical trials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We do not independently conduct clinical trials for our product candidates. We rely on third parties, such as contract research organizations, clinical data management organizations, medical institutions and clinical investigators, to perform this function. Any of these third parties may terminate their engagements with us at any time. If we need to enter into alternative arrangements, it would delay our product development activities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our reliance on these third parties for clinical development activities reduces our control over these activities but does not relieve us of our responsibilities. For example, we remain responsible for ensuring that each of our clinical trials is conducted in accordance with the general investigational plan and protocols for the clinical trial. Moreover, the FDA requires us to comply with standards, commonly referred to as GCP, for conducting, recording and reporting the results of clinical trials to ensure that data and reported results are credible and accurate and that the rights, integrity of data and confidentiality of clinical trial participants are protected. The EMA and PDMA impose similar requirements on us for products that are the subject of clinical trials in the E.U., including the U.K., and Japan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, third parties that we rely on for our clinical development activities may also have relationships with other entities, some of which may be our competitors. If these third parties do not successfully carry out their contractual duties, meet expected deadlines or conduct our clinical trials in accordance with regulatory requirements or our stated protocols, we will not be able to obtain, or may be delayed in obtaining, marketing approvals for our product candidates and will not be able to, or may be delayed in our efforts to, successfully commercialize our product candidates. Our product development costs will increase if we experience delays in testing or obtaining marketing approvals.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We also rely on other third parties to store and distribute drug supplies for our clinical trials. Any performance failure on the part of our distributors could delay clinical development or marketing approval of our product candidates or commercialization of our products, producing additional losses and depriving us of potential product revenue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not able to establish additional collaborations, we may have to alter our development and commercialization plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our product development programs and the potential commercialization of our product candidates will require substantial additional cash to fund expenses. For some of our product candidates, we may decide to collaborate further with pharmaceutical and biotechnology companies for the development and potential commercialization of those product candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We face significant competition in seeking appropriate collaborators. Whether we reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator&#8217;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#8217;s evaluation of a number of factors. Those factors may include the design or results of clinical trials, the likelihood of approval by regulatory authorities, the potential market for the subject product candidate, the costs and complexities of manufacturing and delivering such product candidate to patients, the potential of competing products, the existence of uncertainty with respect to our ownership of technology, which can exist if there is a challenge to such ownership without regard to the merits of the challenge; and industry and market conditions generally. The collaborator may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on and whether such a collaboration could be more attractive than the one with us for our product candidate. We may also be restricted under future license agreements from entering into agreements on certain terms with potential collaborators. Collaborations are complex and time-consuming to negotiate and document. In addition, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future collaborators and changes to the strategies of the combined company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of a product candidate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of any sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to further develop our product candidates or bring them to market and generate product revenue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Legal, Tax, Regulatory, and Compliance Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if we are able to commercialize a product candidate, it may become subject to unfavorable pricing regulations, third-party reimbursement practices or healthcare reform initiatives, which could harm our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The regulations that govern marketing approvals, pricing, coverage and reimbursement for new drug products vary widely from country to country. Current and future legislation may significantly change the approval requirements in ways that could involve additional costs and cause delays in obtaining approvals. Some countries require approval of the sale price of a drug before it can be marketed. In many countries, the pricing review period begins after marketing or product licensing approval is granted. In some foreign markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted. As a result, we might obtain marketing approval for a product in a particular country, but then be subject to price regulations that delay our commercial launch of the product, possibly for lengthy time periods, and negatively impact the revenues we are able to generate from the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if our product candidates obtain marketing approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to commercialize ivonescimab or any other product candidate successfully also will depend in part on the extent to which coverage and adequate reimbursement for these products and related treatments will be available from government health administration authorities, private health insurers and other organizations. Significant uncertainty exists as to the coverage and reimbursement status of any of our products for which we obtain regulatory approval. Government authorities and other third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish reimbursement levels. In the United States, although private third-party payors tend to follow Medicare practices, no uniform or consistent policy of coverage and reimbursement for drug products exists among third-party payors. Therefore, coverage and reimbursement for drug products can differ significantly from payor to payor as well as from state to state. Consequently, the coverage determination process is often a time-consuming and costly process that must be played out across many jurisdictions and different entities and that will require us to provide scientific, clinical and health economics support for </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">the use of our products compared to current alternatives and do so to each payor separately, with no assurance that coverage and adequate reimbursement will be obtained and in what time frame.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We cannot be sure that coverage and reimbursement will be available for ivonescimab or any other product that we commercialize and, if coverage and reimbursement are available, the level of reimbursement. Reimbursement may impact the demand for, or the price of, any product candidate for which we obtain marketing approval. In addition, third-party payors are likely to impose strict requirements for reimbursement of a higher priced drug. If reimbursement is not available or is available only to limited levels, we may not be able to successfully commercialize any product candidate for which we obtain marketing approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There may be significant delays in obtaining coverage and reimbursement for newly approved drugs, and coverage may be more limited than the purposes for which the drug is approved by the applicable regulatory authority. Moreover, eligibility for coverage and reimbursement does not imply that any drug will be paid for in all cases or at a rate that covers our costs, including, but not limited to, research, development, intellectual property, manufacture, sale and distribution expenses. Interim reimbursement levels for new drugs, if applicable, may also not be sufficient to cover our costs and may not be made permanent. Reimbursement rates may vary according to the use of the drug and the clinical setting in which it is used, may be based on reimbursement levels already set for lower cost drugs, and may be incorporated into existing payments for other services. Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States.  Our inability to promptly obtain and maintain coverage and adequate reimbursement rates from both government-funded and private payors for any approved products that we develop could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize products and our overall financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, third-party payors, whether domestic or foreign, governmental or commercial, are developing increasingly sophisticated methods of controlling healthcare costs. In both the United States and certain foreign jurisdictions, there have been a number of legislative and regulatory changes to healthcare systems that could impact our ability to sell our product candidates, if approved, profitably. There have been, and likely will continue to be, legislative and regulatory proposals at the federal and state levels directed at broadening the availability of, and containing or lowering the cost of, healthcare. The implementation of cost containment measures that third-party payors and healthcare providers are instituting and any other healthcare reforms may prevent us from being able to generate, or may reduce, our revenues from the sale of our product candidates, if approved, and our product candidates may not be profitable. Such reforms could have an adverse effect on anticipated revenue from product candidates for which we may obtain regulatory approval and may affect our overall financial condition and ability to develop product candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governments outside the United States tend to impose strict price controls, which may adversely affect our revenues, if any.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In some countries, particularly the E.U. Member States, the pricing of prescription pharmaceuticals is subject to governmental control. In these countries, pricing negotiations with governmental authorities can take considerable time after the receipt of marketing approval for a product. In addition, there can be considerable pressure by governments and other stakeholders on prices and reimbursement levels, including as part of cost containment measures. Political, economic and regulatory developments may further complicate pricing negotiations, and pricing negotiations may continue after reimbursement has been obtained. Reference pricing used by various E.U. Member States and parallel distribution, or arbitrage between low-priced and high-priced E.U. Member States, can further reduce prices. In some countries, we may be required to conduct a clinical trial or other studies that compare the cost-effectiveness of our product candidate to other available therapies in order to obtain or maintain reimbursement or pricing approval. Publication of discounts by third-party payors or authorities may lead to further pressure on prices or reimbursement levels within the country of publication and other countries. If reimbursement of our products is unavailable or limited in scope or amount, or if pricing is set at unsatisfactory levels, our business could be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is subject to the risks associated with doing business in China. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our reliance on Akeso, located in China, our results of operations, financial condition, and prospects are subject to a significant degree to economic, political, and legal developments in China including government control over capital investments or changes in tax regulations that are applicable to us. China&#8217;s economy differs from the economies of most developed countries in many respects, including with respect to the amount of government involvement, level of development, growth rate and control of foreign exchange, and allocation of resources. Since we rely on an entity located in China, our business is subject to the risks associated with doing business in China, including:</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse political and economic conditions, particularly those potentially negatively affecting the trade relationship between the United States and China;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trade protection measures, such as tariff increases, and import and export licensing and control requirements;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potentially negative consequences from changes in tax laws;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties associated with the Chinese legal system, including increased costs and uncertainties associated with enforcing contractual obligations in China;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">historically lower protection of intellectual property rights;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requirements relating to China&#8217;s data security rules and regulations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requirements relating to China personal information protection laws; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes and volatility in currency exchange rates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unexpected or unfavorable changes in regulatory requirements; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in U.S. law regarding data security and providing sensitive personal data to China; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in managing foreign relationships and operations generally.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the possibility of product supply disruption and increased costs in the event of changes in the policies of the U.S. or Chinese governments, political unrest or unstable economic conditions in China. New legislation, regulations or court decisions may impede, delay, limit, or increase the cost of manufacturing our therapeutic candidates. Such events could result in our clinical or commercial supply of drug being interrupted or limited, which could harm our business.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S.-China trade relations may adversely impact our supply chain operations and business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. and Chinese governments have taken certain actions that change trade policies, including tariffs and threats of additional tariffs that affect certain products which are manufactured in China and mutual exchange of certain types of data. Due to our collaboration with Akeso, we are reliant on collaborating with a company with significant operations in China. </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We do not know whether and to what extent the Trump administration will in the future implement or alter any tariffs, laws or regulations that may increase the cost or feasibility of importing and exporting products, components and information from China to the United States and vice versa. Further, the effect of any such new tariffs or actions on our industry or customers, and whether they may be subject to any exceptions, is unknown and difficult to predict. As additional tariffs, legislation or regulations are implemented, or if existing trade agreements are renegotiated, or if China or other affected countries take retaliatory trade actions, such changes could have a material adverse effect on our clinical development plans, business, financial condition, results of operations or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain Chinese biotechnology companies may become subject to trade restrictions, sanctions, other regulatory requirements, or proposed legislation by the U.S. government, which could restrict or even prohibit our ability to work with such entities, thereby potentially disrupting the supply of material to us. For example, the BIOSECURE Act, which was recently signed into law in December 2025, prohibits U.S. federal agencies from entering into or renewing any contract with any entity that uses biotechnology equipment or services produced or provided by a &#8220;biotechnology company of concern&#8221; to perform that contract as well as authorizes the U.S. government to name additional Chinese &#8220;biotechnology companies of concern.&#8221; While prior versions of the BIOSECURE Act explicitly named &#8220;biotechnology companies of concern,&#8221; the revised version defines a &#8220;biotechnology company of concern&#8221; as an entity that is identified on the annual 1260H List of Chinese military companies (the &#8220;1260H List&#8221;) issued by the U.S. Department of Defense, any entity designated by the U.S. Government as such, and certain affiliates of the foregoing. If this law, or similar laws that may be enacted, impact Chinese biotechnology manufacturing companies that are or may become contractors or subcontractors of ours or provide biotechnology equipment or services in the manufacture of our products or products candidates, we may be restricted in our ability to work with such Chinese biotechnology manufacturing companies to the extent we would contract with, or otherwise receive funding from, the U.S. government, or work with sites or institutions that may receive funding from the U.S. government. As a result, we may need to seek alternative contract manufacturer relationships. While we believe we will be able to identify and contract with such alternative contract manufacturers, we cannot predict the terms of any such alternative arrangement nor what actions may ultimately be taken with respect to trade relations between the United States and China or other countries, what products and services may be subject to such actions or what actions may be taken by China or the other countries in retaliation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product liability lawsuits against us could cause us to incur substantial liabilities and to limit commercialization of any products that we may develop.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We face an inherent risk of product liability exposure related to the testing of our product candidates in human clinical trials and will face an even greater risk if we commercially sell any products that we may develop. If we cannot successfully defend ourselves against claims that our product candidates or products caused injuries, we will incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in:</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduced resources of our management to pursue our business strategy;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreased demand for any product candidates or products that we may develop;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injury to our reputation and significant negative media attention;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">withdrawal of clinical trial participants;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant costs to defend the related litigation;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">substantial monetary awards to clinical trial participants or patients;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of revenue;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased insurance costs; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability to commercialize any products that we may develop.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The insurance policies covering our clinical trials are subject to a per claim deductible. The amount of insurance that we currently hold may not be adequate to cover all liabilities that we may incur. We will need to increase our insurance coverage when and if we begin commercializing ivonescimab or any other product candidate that receives marketing approval. Insurance coverage is increasingly expensive. We may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our operations currently, and may in the future, involve the use of hazardous and flammable materials, including chemicals and medical and biological materials, and produce hazardous waste products. Even if we contract with third parties for the disposal of these materials and wastes, we cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials or disposal of hazardous wastes, we could be held liable for any resulting damages, and any liability could exceed our resources.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Although we maintain workers&#8217; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our research, development or production efforts. Failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent and potential future changes to U.S. and non-U.S. tax laws or the interpretation thereof or the imposition of new or increased taxes or fees could increase our future tax liabilities and adversely affect our operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">Changes to tax laws in the US, UK, and other countries, as well as new or increased taxes or fees, could raise our future tax liabilities and negatively impact our operating results and cash flows. Recent US tax reforms, such as the IRA and the One Big Beautiful Bill Act (&#8220;OBBBA&#8221;), have introduced significant changes to corporate taxation, including new rules for interest deductions, research and development expenses, and stock repurchases. The OBBBA, signed into law on July 4, 2025, has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. In the UK, updates to the research and development tax regime may reduce the cash benefits we receive, especially for spending outside the UK, and further changes are expected as the government considers merging existing research and development schemes. The interpretation and implementation of these laws may change, and any new legislation or guidance could affect our tax rates, increase compliance costs, and have an adverse effect on our financial position.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future tax liabilities may be greater than expected if our net operating loss carryforwards and other tax attributes are limited or tax authorities challenge our tax positions. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to utilize net operating loss (NOL) carryovers and other tax attributes to offset potential future taxable income and related income taxes that would otherwise be due is dependent upon our generation of future taxable income, which cannot be ensured. In addition, our ability to use NOL carryforwards and other tax attributes  may be subject to significant limitations under Sections 382 and 383 of the Code. Under those sections of the Code, if a corporation undergoes an &#8220;ownership change&#8221; (as defined in Section 382 of the Code), the corporation&#8217;s ability to use its pre-change NOL carryforwards and other tax attributes may be substantially limited. An ownership change generally occurs if one or more stockholders (or groups of stockholders) who are each deemed to own at least 5% of such corporation&#8217;s stock change their ownership by more than 50 percentage points over their lowest  ownership percentage within a rolling three-year period. In the event that we were to </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">undergo an ownership change, utilization of our NOL carryforwards and other tax attributes would be subject to an annual limitation under Section 382 of the Code and Section 383 of the Code (as applicable), determined by multiplying the value of our stock at the time of the ownership change by the applicable long-term tax-exempt rate in effect during the month in which the ownership change occurs, subject to certain adjustments, which could result in a portion of our tax attributes expiring prior to their utilization. Any unused annual limitation may be carried over to later years. Any limitation on our ability to utilize our NOL carryforwards or other tax attributes against income or gain we generate in the future could increase our future tax liabilities and adversely affect our operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, we are subject to various complex and evolving U.S. federal, state, local and non-U.S. tax laws. U.S. federal,</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">state, local and non-U.S. tax laws, policies, statutes, rules, regulations or ordinances could be interpreted, changed, modified or applied adversely to us, in each case, possibly with retroactive effect. Any significant variance in our interpretation of current tax laws, including as result of the release of final Treasury Regulations or other interpretive guidance implementing, or a successful challenge of one or more of our tax positions by the IRS or other state, local or non-U.S. tax authorities could increase our future tax liabilities and adversely affect our operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and regulations affecting government contracts make it more costly and difficult for us to successfully conduct our business. Failure to comply with these laws and regulations could result in significant civil and criminal penalties and adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We must comply during the term of such government contracts and upon expiration/termination of such contracts, as to continuing obligations, with numerous laws and regulations. These laws, regulations and obligations include, for example, the Federal Acquisition Regulation, compliance regulations, business ethics and public integrity obligations, export and import laws and regulations, etc. Additionally, government agencies routinely audit and investigate government contractors for compliance with the applicable laws and standards. If an audit uncovers improper or illegal activities, we may be subject to civil and criminal penalties including fines, debarment and exclusion from government funding and administrative sanctions, such as long-term monitoring arrangements and exclusion from regulatory approvals. In addition, we could suffer serious reputational harm if allegations of impropriety were made against us, which could jeopardize our other research programs, deter research institutions from engaging with us, and cause our stock price to decrease.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The marketing approval process is expensive, time-consuming and uncertain, and may prevent us from obtaining approvals for the commercialization of some or all of our product candidates. If we are unsuccessful or delayed in obtaining required regulatory approvals, we will not be able to commercialize our product candidates, and our ability to generate revenue will be materially impaired.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our product candidates, including ivonescimab, and the activities associated with their development and commercialization, including their design, testing, manufacture, safety, efficacy, recordkeeping, labeling, storage, approval, advertising, promotion, sale and distribution, are subject to comprehensive regulation by the FDA and by comparable authorities in other countries. Failure to obtain marketing approval for a product candidate will prevent us or our collaborators from commercializing the product candidate. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have only limited experience in filing and supporting the applications necessary to obtain marketing approvals for product candidates and expect to rely on third-party contract research organizations to assist us in this process. Securing marketing approval requires the submission of extensive preclinical and clinical data and supporting information to regulatory authorities for each therapeutic indication to establish the product candidate&#8217;s safety and efficacy. Securing marketing approval also requires the submission of information about the product manufacturing process to, and inspection of manufacturing facilities by, the regulatory authorities. Regulatory authorities may determine that ivonescimab or any of our other product candidates are not effective or only moderately effective, or have undesirable or unintended side effects, toxicities, safety profiles or other characteristics that preclude us from obtaining marketing approval or that prevent or limit commercial use.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The process of obtaining marketing approvals is expensive, may take many years, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity and novelty of the product candidates involved. Changes in marketing approval policies during the development period, changes in or the enactment of additional statutes or regulations, or changes in regulatory review for each submitted product application, may cause delays in the approval or rejection of an application. Regulatory authorities have substantial discretion in the approval process and may refuse to accept any application or may decide that our data are insufficient for approval and require additional preclinical, clinical or other studies. In addition, varying interpretations of the data obtained from preclinical and clinical testing could delay, limit or prevent marketing approval of a product candidate. Any marketing approval we ultimately obtain may be limited or subject to restrictions or post-approval commitments that render the approved product not commercially viable. If we experience delays in </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">obtaining approval or if we fail to obtain approval of our product candidates, the commercial prospects for our product candidates may be harmed and our ability to generate revenues will be materially impaired.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We also are required to register ongoing clinical trials and post the results of completed clinical trials on a U.S. government-sponsored database, www.ClinicalTrials.gov, within certain timeframes. Failure to comply would violate federal requirements and could result in fines and/or civil and criminal sanctions, which would delay the regulatory approval process and result in adverse publicity. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure to obtain marketing approval in a jurisdiction would prevent our product candidates from being marketed in such jurisdiction, and any approval we are granted for our product candidates in one jurisdiction would not ensure approval of our product candidates in any other jurisdictions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In order to market and sell ivonescimab and our other product candidates in foreign jurisdictions, we must obtain separate marketing approvals and comply with numerous and varying regulatory requirements in those jurisdictions. The approval procedure varies among countries and can involve additional testing. The time required to obtain approval may differ from that required to obtain FDA or EMA/EC approval. The regulatory approval process outside the United States and Europe generally includes all of the risks associated with obtaining FDA and EMA/EC approval. In addition, some countries outside the United States and Europe require approval of the sales price of a drug before it can be marketed. In many countries, separate procedures must be followed to obtain reimbursement. We may not obtain marketing, pricing or reimbursement approvals outside the United States and Europe on a timely basis, if at all. Approval by the FDA or the EMA/EC does not ensure approval by regulatory authorities in other countries or jurisdictions, and approval by one regulatory authority outside the United States and Europe does not ensure approval by regulatory authorities in other countries or jurisdictions or by the FDA or the EMA/EC. We may not be able to file for marketing approvals and may not receive necessary approvals to commercialize our products in any market. Marketing approvals in countries outside the United States and Europe do not ensure pricing approvals in those countries or in any other countries, and marketing approvals and pricing approvals do not ensure that reimbursement will be obtained.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to obtain and maintain conditional marketing authorizations in the E.U. is limited to specific circumstances and subject to several conditions and obligations. A failure to renew any conditional approval that we obtain prior to full approval for the applicable indication would prevent us from continuing to market our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Conditional marketing authorizations based on incomplete clinical data may be granted for a limited number of listed medicinal products for human use, including products designated as orphan medicinal products under E.U. law, if (1) the risk-benefit balance of the product is positive, (2) it is likely that the applicant will be in a position to provide the required comprehensive clinical trial data, (3) unmet medical needs will be fulfilled and (4) the benefit to public health of the immediate availability on the market of the medicinal product outweighs the risk inherent in the fact that additional data are still required. Specific obligations, including with respect to the completion of ongoing or new studies, and with respect to the collection of pharmacovigilance data, may be specified in the conditional marketing authorization. Conditional marketing authorizations are valid for one year and may be renewed annually, if the risk-benefit balance remains positive, and after an assessment of the need for additional or modified conditions. Even if we, or a third-party collaborator, obtain conditional approval for ivonescimab, or any other product candidate, we or they may not be able to renew such conditional approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if we obtain marketing approvals for our product candidates, the terms of approvals and ongoing regulation of our products may limit how we manufacture and market our products and compliance with such requirements may involve substantial resources, which could materially impair our ability to generate revenue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Even if marketing approval of a product candidate is granted, an approved product and its manufacturer and marketer are subject to ongoing review and extensive regulation, including the potential requirement to implement a risk evaluation and mitigation strategy or to conduct costly post-marketing studies or clinical trials and surveillance to monitor the safety or efficacy of the product. We and our collaborators must also comply with requirements concerning advertising and promotion for any of our product candidates for which we obtain marketing approval. Promotional communications with respect to prescription drugs are subject to a variety of legal and regulatory restrictions and must be consistent with the information in the product&#8217;s approved labeling. Thus, neither we nor our collaborators will be able to promote any products we develop for indications or uses for which they are not approved. In addition, manufacturers of approved products and those manufacturers&#8217; facilities are required to ensure that quality control and manufacturing procedures conform to cGMP, which include requirements relating to quality control and quality assurance as well as the corresponding maintenance of records and documentation and reporting requirements. We and our contract manufacturers could be subject to periodic unannounced inspections by the FDA to monitor and ensure compliance with cGMP.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, assuming we receive marketing approval for one or more of our product candidates, we and our contract manufacturers will continue to expend time, money and effort in all areas of regulatory compliance, including manufacturing, production, product surveillance and quality control. If we are not able to comply with post-approval regulatory requirements, we could have the marketing approvals for our products withdrawn by regulatory authorities and our ability to market any future products could be limited, which could adversely affect our ability to achieve or sustain profitability. Thus, the cost of compliance with post-approval regulations may have a negative effect on our operating results and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any product candidate for which we obtain marketing approval will be subject to strict enforcement of post-marketing requirements and we could be subject to substantial penalties, including withdrawal of our product from the market, if we fail to comply with all regulatory requirements or if we experience unanticipated problems with our products, when and if any of them are approved.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Any product candidate for which we obtain marketing approval, along with the manufacturing processes, post-approval clinical data, labeling, advertising and promotional activities for such product, will be subject to continual requirements of and review by the FDA and other regulatory authorities. These requirements include, but are not limited to, restrictions governing promotion of an approved product, submissions of safety and other post-marketing information and reports, registration and listing requirements, cGMP requirements relating to manufacturing, quality control, quality assurance and corresponding maintenance of records and documents, and requirements regarding the distribution of samples to physicians and recordkeeping.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The FDA and other federal and state agencies, including the DOJ, closely regulate compliance with all requirements governing prescription drug products, including requirements pertaining to marketing and promotion of drugs in accordance with the provisions of the approved labeling and manufacturing of products in accordance with cGMP requirements. The FDA and DOJ impose stringent restrictions on manufacturers&#8217; communications regarding off-label use, and if we market our products for  unapproved indications, we may be subject to enforcement action for off-label marketing. Violations of such requirements may lead to investigations alleging violations of the Food, Drug and Cosmetic Act and other statutes, including the False Claims Act and other federal and state health care fraud and abuse laws as well as state consumer protection laws. Our failure to comply with all regulatory requirements, and later discovery of previously unknown adverse events or other problems with our products, manufacturers or manufacturing processes, may yield various results, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation involving patients taking our products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on such products, manufacturers or manufacturing processes;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on the labeling or marketing of a product;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on product distribution or use;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">holds on clinical trials; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requirements to conduct post-marketing studies or clinical trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">warning or untitled letters;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">withdrawal of the products from the market;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal to approve pending applications or supplements to approved applications that we submit;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">recall of products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fines, restitution or disgorgement of profits or revenues;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspension or revocation of marketing approvals;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">damage to relationships with any potential collaborators;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unfavorable press coverage and damage to our reputation;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal to permit the import or export of our products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product seizure; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injunctions or the imposition of civil or criminal penalties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Non-compliance by us or any future collaborator with regulatory requirements regarding safety monitoring or pharmacovigilance, and with requirements related to the development of products for the pediatric population, can also result in significant financial penalties. Similarly, failure to comply with regulatory requirements regarding the protection of personal information can also lead to significant penalties and sanctions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Non-compliance with E.U. requirements regarding safety monitoring or pharmacovigilance, and with requirements related to the development of products for the pediatric population, can also result in significant financial penalties. Similarly, failure to comply with the E.U.&#8217;s requirements regarding the protection of personal information can also lead to significant penalties and sanctions.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our relationships with customers, healthcare providers and professionals and third-party payors will be subject to applicable anti-kickback, fraud and abuse and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, contractual damages, reputational harm and diminished profits and future earnings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare providers, physicians and third-party payors play a primary role in the recommendation and prescription of any product candidates, including ivonescimab, for which we obtain marketing approval. Our future arrangements with customers, healthcare providers and professionals and third-party payors may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations that may constrain the business or financial arrangements and relationships through which we market, sell and distribute our products for which we obtain marketing approval. Restrictions under applicable federal and state healthcare laws and regulations, include, and are not limited to, the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal healthcare anti-kickback statute prohibits, among other things, persons from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made under federally funded healthcare programs such as Medicare and Medicaid. This statute has been broadly interpreted to apply to manufacturer arrangements with prescribers, purchasers and formulary managers, among others. Several other countries, including the U.K., have enacted similar anti-kickback, fraud and abuse, and healthcare laws and regulations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal False Claims Act imposes civil penalties, including civil whistleblower or qui tam actions, against individuals or entities for knowingly presenting, or causing to be presented, claims for payment of government funds that are false or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government. The government and qui tam relators have brought False Claims Act actions against pharmaceutical companies on the theory that their practices have caused false claims to be submitted to the government. There is also a separate false claims provision imposing criminal penalties.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, as amended by the HITECH, imposes criminal and civil liability for executing a scheme to defraud any healthcare benefit program and also imposes obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health information.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA also imposes criminal liability for knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement in connection with the delivery of or payment for healthcare benefits, items or services.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal Physician Sunshine Act requirements under the ACA require manufacturers of drugs, devices, biologics and medical supplies to report to the Department of Health and Human Services information related to payments and other transfers of value made to or at the request of covered recipients, such as physicians and teaching hospitals, and physician ownership and investment interests in such manufacturers. Payments made to physicians and research institutions for clinical trials are included within the ambit of this law. Failure to submit timely, accurate and required information for all payments, transfers of value and ownership or investment interests may result in civil monetary penalties.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Analogous state laws and regulations, such as state anti-kickback and false claims laws, may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental third-party payors, including private insurers, and some state laws require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government in addition to requiring drug manufacturers to report information related to payments to physicians and other health care providers or marketing expenditures. Additionally, some state and local laws require the registration of pharmaceutical sales representatives in the jurisdiction.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, exclusion from government funded healthcare programs, such as Medicare and Medicaid, and the curtailment or restructuring of our operations. Exclusion, suspension and debarment from government funded healthcare programs would significantly impact our ability to commercialize, sell or distribute any drug. If any of the physicians or other providers or entities with whom we expect to do business are found to be not in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inadequate funding for or other disruptions to government agencies could hinder or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business.</span></div><div style="text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The ability of reviewing regulatory agencies, including the FDA, to review and approve new products can be affected by a variety of factors, including government budget and funding levels, the ability to hire and retain key leadership and other personnel and the acceptance of user fees payments, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. If funding is inadequate, a prolonged government shutdown occurs, the FDA is required to furlough review staff or necessary employees, or if the agency operations are otherwise disrupted, it could significantly affect the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our ability to successfully develop and commercialize ivonescimab or any other product candidate in our pipeline. Further, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current and future legislation may increase the difficulty and cost to obtain marketing approval of and commercialize our product candidates and could affect the prices we may obtain.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the United States and some foreign jurisdictions, there have been and continue to be a number of legislative and regulatory changes and proposed changes regarding the healthcare system that could, among other things, prevent or delay marketing approval of our product candidates, restrict or regulate post-approval activities and affect our ability, or the ability of any future collaborators, to profitably sell any products for which we, or they, obtain marketing approval. We expect that current laws, as well as other healthcare reform measures that may be adopted in the future, may result in more limits on reimbursement and  additional downward pressure on the price that we, or any future collaborators, may receive for any approved products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We expect that recently enacted healthcare reforms, as well as other healthcare reform measures that may be adopted in the future, may result in additional reductions in Medicare and other healthcare funding, more rigorous coverage criteria, new payment methodologies and additional downward pressure on the price that we receive for any approved product as well as impact reimbursement to stakeholders that administer any approved product we might bring to market. Any reductions in reimbursement may negatively impact physicians, hospitals and other provider's ability to purchase and appropriately prescribe our products. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The costs of prescription pharmaceuticals have also been the subject of considerable discussion in the United States. To date, there have been several U.S. congressional inquiries and proposed and enacted state and federal legislation designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing and manufacturer patient programs, reduce the costs of drugs under Medicare and reform government program reimbursement methodologies for drug products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the ACA substantially changed the way healthcare is financed by both governmental and private insurers, and significantly impacts the pharmaceutical industry. The ACA was intended to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against healthcare fraud and abuse, add new transparency requirements for healthcare and health insurance industries, impose new taxes and fees on pharmaceutical and medical device manufacturers, and impose additional health policy reforms. Since its passage, there have been significant ongoing efforts to modify or eliminate the ACA and potential future legislative, judicial or regulatory actions related to the ACA, and any effects on us, are uncertain.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other legislative changes have been proposed and adopted since passage of the ACA. These have, among other things, reduced Medicare payments to several types of providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers. For example, several healthcare reform initiatives culminated in the enactment of the IRA, which includes several provisions to lower prescription drug costs for Medicare patients and reduce drug spending by the federal government. Among other things, the IRA requires HHS to directly negotiate the selling price of a statutorily specified number of drugs and biologics each year that the U.S. Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) reimburses under Medicare Part B and Part D. Negotiations will occur for high expenditure single-source biological products that have been on the market for 11 years (seven years for single-source drugs). Revised prices will take effect two years after these negotiations occur. For 2026, the first year in which negotiated prices become effective, CMS selected 10 high-cost Medicare Part D products in 2023, negotiations began in 2024, and the negotiated  price for each product has been announced. In addition, CMS has selected and announced the negotiated  price for 15 additional Medicare Part D drugs which will become effective in 2027. For 2028, an additional 15 drugs, which may be covered under either Medicare Part B or Part D, the negotiated price will be effective, and for 2029 and subsequent years, 20 </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Part B or D drug negotiated prices will be effective. The negotiated prices have represented, and will continue to represent, a significant discount from average prices to wholesalers and direct purchasers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">The IRA also imposes rebates on Medicare Part B and Part D drugs whose prices have increased at a rate greater than the rate of inflation, and in 2024, CMS finalized regulations for the Medicare Part B and Part D inflation rebates. The IRA permits the Secretary of HHS to implement many of these provisions through guidance, as opposed to regulation, for the initial years. Manufacturers that fail to comply with the IRA may be subject to various penalties, including civil monetary penalties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">The current administration is pursuing policies to reduce regulations and expenditures across government including at HHS, which include the FDA and CMS, and related agencies. For example, on May 12, 2025, President Trump issued an Executive Order that, among other things, required HHS, within 30 days, to establish and communicate to drug manufacturers MFN price targets designed to bring drug prices for American patients in line with those in comparably developed nations.  If significant progress towards MFN pricing is not achieved, the Executive Order requires HHS to propose a rulemaking to implement MFN pricing.  Recently, on December 23, 2025, CMS issued proposed regulations to establish, under the Center for Medicare and Medicaid Innovation, two mandatory MFN demonstration models under Medicare Parts B and D, respectively. If these rules or other MFN pricing rules are finalized, they are likely to reduce prices of at least some drugs in the United States, if they are also sold in comparator countries.  Even if we do not market drugs in such countries, we will be indirectly affected if our drugs competed with drugs whose prices were reduced as a result of MFN pricing initiatives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">At the state level, individual states are increasingly aggressive in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. In addition, regional health care authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other healthcare programs. These measures could reduce the ultimate demand for our products, once approved, or put pressure on our product pricing. We expect that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for our product candidates or additional pricing pressures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Legislative and regulatory proposals have also been made to expand post-approval requirements and restrict sales and promotional activities for pharmaceutical products. We cannot be sure whether additional legislative changes will be enacted, or whether the FDA regulations, guidance or interpretations will be changed, or what the impact of such changes on the marketing approvals of our product candidates, if any, may be. In addition, increased scrutiny by the U.S. Congress of the FDA&#8217;s approval process may significantly delay or prevent marketing approval, as well as subject us and any future collaborators to more stringent product labeling and post-marketing testing and other requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the E.U., similar political, economic and regulatory developments may affect our ability to profitably commercialize our products. In addition to continuing pressure on prices and cost containment measures, legislative developments at the E.U. or Member State level may result in significant additional requirements or obstacles that may increase our operating costs. An example of reform measures is the forthcoming EU pharmaceutical legislation revision, which intends to change &#8211; among other things &#8211; the regulatory data protection regime and the orphan designation regime. The final text of the reform proposal is expected to be endorsed and published in the first half of 2026 and, after a transition period, the new legislation is expected to start to apply from mid-2028.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to anti-corruption laws, as well as export control laws, customs laws, sanctions laws and other laws governing our operations. If we fail to comply with these laws, we could be subject to civil or criminal penalties, other remedial measures and legal expenses, which could adversely affect our business, results of operations and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are subject to anti-corruption laws, including the FCPA, the U.K. Bribery Act 2010 (the &#8220;Bribery Act&#8221;), and other anti-corruption laws that apply in countries where we do business and may do business in the future. The FCPA, Bribery Act and these other laws generally prohibit us, our officers, and our employees and intermediaries from bribing, being bribed or making other prohibited payments to government officials or other persons to obtain or retain business or gain some other business advantage. We may in the future operate in jurisdictions that pose a high risk of potential FCPA or Bribery Act violations, and we may participate in collaborations and relationships with third parties whose actions could potentially subject us to liability under the FCPA, Bribery Act or local anti-corruption laws. In addition, we cannot predict the nature, scope or effect of future regulatory requirements to which our international operations might be subject or the manner in which existing laws might be administered or interpreted.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to other laws and regulations governing our international operations, including regulations administered by the governments of the U.S. and the U.K., and authorities in the E.U., including applicable export control regulations, economic sanctions on countries and persons, customs requirements and currency exchange regulations (collectively, the &#8220;Trade Control laws&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There is no assurance that we will be completely effective in ensuring our compliance with all applicable anti-corruption laws, including the FCPA, the Bribery Act or other legal requirements, including Trade Control laws. If we are not in compliance with the FCPA, the Bribery Act and other anti-corruption laws or Trade Control laws, we may be subject to criminal and civil penalties, disgorgement and other sanctions and remedial measures, and legal expenses, which could have an adverse impact on our business, financial condition, results of operations and liquidity. Likewise, any investigation of any potential violations of the FCPA, the Bribery Act, other anti-corruption laws or Trade Control laws by U.S., U.K. or other authorities could also have an adverse impact on our reputation, our business, results of operations and financial condition.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental, social and governance (</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESG</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">) matters may impact our business and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Governmental authorities, non-governmental organizations, customers, investors, external stakeholders and employees are increasingly aware of ESG concerns, such as climate change, water use, recyclability or recoverability of packaging, and plastic waste. The ESG landscape is uncertain and constantly evolving due to changes in executive action, legislation, regulations and court orders. ESG concerns may lead to new requirements that could result in increased costs associated with developing, manufacturing and distributing our products. Our ability to compete could also be affected by changing customer preferences and requirements or by failure to meet such customer expectations or demand. We risk negative stockholder reaction, including from proxy advisory services, as well as damage to our brand and reputation, if we do not act responsibly, or if we are perceived to not be acting responsibly in key ESG areas. If we do not meet the ESG expectations of government agencies, our investors, customers and other stakeholders, we could experience reduced demand for our products, loss of customers, and other negative impacts on our business and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reputation or relationships with its stakeholders and other third parties could also be adversely impacted as a result of, among other things, (i) stakeholder or third-party perceptions of certain statements, if any, made by the Company, its employees, agents, any industry trade associations, or other third parties; or (ii) public pressure from investors or policy groups to change the Company's policies. Such statements or initiatives with respect to ESG matters are increasingly subject to heightened scrutiny from the public and governmental authorities, as well as other parties. Certain regulators, such as the SEC and various state agencies, as well as nongovernmental organizations and other private actors have filed lawsuits under various securities and consumer protection laws alleging that certain ESG statements, goals or standards were misleading, false or otherwise deceptive. Additionally, certain employment practices and social initiatives are the subject of scrutiny by both those calling for the continued advancement of such policies, as well as those who believe they should be curbed, including government actors, and the complex regulatory and legal frameworks applicable to such initiatives continue to evolve. We cannot be certain of the impact of such regulatory, legal and other developments on our business. More recent political developments could mean that we could face criticism from certain &#8220;anti-ESG&#8221; parties, including various governmental agencies, if we were to make environmental or social commitments or pursue certain environmental or social initiatives that are alleged to be inherently political or polarizing in nature and could subject the Company to pressure in the media or through other means, which could adversely affect our reputation, business, financial performance, market access and growth. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to Our Intellectual Property, Cybersecurity and Data Privacy</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to obtain and maintain patent protection for our technology and product candidates, our competitors could develop and commercialize technology and drug products similar or identical to ours, and our ability to successfully commercialize our technology and drug product candidates may be impaired.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in large part on our ability to obtain and maintain patent protection in the United States and other countries for our proprietary technology and products. We seek to protect our proprietary position by filing patent applications in strategic jurisdictions, including the United States, Europe and other key markets. However, this process is inherently costly, time-consuming, and uncertain. We may not successfully identify patentable aspects of our research in a timely manner, potentially missing opportunities to secure meaningful protection. Additionally, challenges such as high costs, delays in prosecution, and changes in the law could compromise our ability to file and prosecute all necessary or desirable applications. These factors may limit the scope of protection we achieve, increasing our vulnerability to competition and undermining the commercial potential of our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, if we license technology or product candidates from third parties in the future, we may have limited control over the preparation, filing, prosecution, or enforcement of the associated patents, leaving us vulnerable to decisions that may not align </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">with our goals or interests. For example, under the License Agreement, patent prosecution and enforcement in the Licensed Territory are subject to consultation and cooperation with Akeso. Actions or statements during patent prosecution outside of the Licensed Territory could significantly influence the prosecution of any patent application within the Licensed Territory. Additionally, Akeso owned patents and patent applications, which are non-exclusively licensed to Summit under the License Agreement, are under the control of Akeso. Akeso&#8217;s prosecution, enforcement, and licensing strategies with regard to their owned patents and patent applications may conflict with our objectives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions, and is currently the focus of extensive litigation. This unpredictability makes the issuance, scope, validity, enforceability and commercial value of our patent rights highly uncertain. While we strive to secure patents that protect our technology and products, our pending and future patent applications may not yield issued patents that provide meaningful protection. Even when patents are granted, they may fail to effectively prevent competitors from developing and commercializing similar or identical technologies and products. Furthermore, ongoing changes in patent laws or their interpretation due to changing administrations, specifically in the United States and internationally, may diminish the value of our patents, restrict the scope of our patent protection, or complicate our enforcement efforts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The laws of foreign countries may offer less robust protection for patent rights compared to those in the United States, potentially exposing us to heightened competition. For example, European patent law imposes stricter limitations on the patentability of methods of treatment for the human body when compared with U.S. law, which may leave aspects of our technology and products vulnerable in certain markets. Additionally, differences in national patent laws and enforcement mechanisms may make it more difficult to obtain and maintain comprehensive protection across all major markets. This patchwork of international protection may hinder our ability to prevent the entry of third parties into the market.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Assuming the other requirements for patentability are met, under current U.S. law, the first to file a patent application is generally entitled to the patent. This framework, implemented after March 16, 2013, replaced the previous &#8220;first to invent&#8221; system which granted rights to the original inventor regardless of the filing date. Unfortunately, publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing, or in some cases not at all. This lack of clarity makes it difficult to ascertain whether we were the first to make the inventions claimed in our U.S. patents or pending U.S. patent applications. We face similar uncertainties when seeking patent protection outside of the United States, where filing dates are critical to determining patent rights.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, we may be subject to third-party pre-issuance submissions of prior art to the USPTO or become involved in opposition, derivation, reexamination, reissue, inter parties review, post grant review, interference proceedings or other patent office proceedings, court litigation or International Trade Commission proceedings, in the United States or elsewhere, challenging our patent rights or the patent rights of others. Adverse determinations in any of these proceedings could severely restrict or invalidate our patents, reducing their enforceability and allowing third parties to commercialize similar or identical technologies without compensation to us.  Furthermore, when third-party patents are involved, such disputes may result in our inability to manufacture, market, or commercialize our products without infringing on third-party rights. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened or narrowed by operation of any of the foregoing, such an event could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Third parties may have filed patent applications or received patents and may obtain additional patents and proprietary rights that block or compete with our patents. Resolving intellectual property disputes, such as infringement claims, can be costly and time consuming.  Such disputes may force us to design around third-party patents, incurring additional expenses, or seek licenses on terms that may not be commercially reasonable, favorable, or even obtainable.  A successful claim of patent or other intellectual property infringement could result in substantial damages, disrupt our operations, or lead to an injunction preventing the manufacture, sale, or use of the affected product. We may choose not to file patents for certain intellectual property to maintain trade secrets or know-how, leaving a risk that third parties may subsequently patent those innovations. Even if our patent applications issue as patents, they may not issue in a form that would provide us with adequate protection against competition. Our competitors may circumvent our owned or licensed patents by developing similar, improved or alternative technologies or products in a non-infringing manner, eroding our competitive advantage.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, other companies may attempt to circumvent any regulatory data protection or market exclusivity, such as orphan drug exclusivity in the United States, which we obtain under applicable legislation, which may require us to allocate significant resources to preventing such circumvention. These efforts can divert attention and financial resources away from other critical business activities, potentially slowing our overall progress. Legal and regulatory developments in the E.U. and elsewhere may also result in clinical trial data submitted as part of a marketing authorization application becoming publicly available. Such </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">developments could enable other companies to use our clinical trial data to assist in their own product development and to obtain marketing authorizations in the E.U. and in other jurisdictions. Loss of market exclusivity, particularly through the entry of generic or biosimilar competitors, could significantly reduce our revenue and market share. Such developments may also require us to allocate significant resources to prevent other companies from circumventing or violating our intellectual property rights. Despite our best efforts, our attempts to prevent third parties from circumventing our intellectual property and other rights may ultimately be unsuccessful. Additionally, any failure to take the required actions, such as paying necessary maintenance fees or addressing administrative formalities, could jeopardize the longevity and enforceability of our patents, further exposing us to risks of market erosion and reduced exclusivity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our owned and licensed patents may be challenged in the courts or patent offices in the United States and abroad. Such challenges may result in loss of exclusivity or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection of our technology and products. Future changes in U.S. statutory or case law beyond our control could affect some or all of the foregoing possibilities. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. This could be the case even after giving effect to patent term extensions and data exclusivity provisions preventing third parties from relying on clinical trial data filed by us for regulatory approval in support of their own applications for such approval. As a result, our patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become involved in lawsuits or other enforcement proceedings to protect or enforce our patents or other intellectual property, which could be expensive, time-consuming and potentially unsuccessful.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Competitors may infringe our patents, trademarks, copyrights or other intellectual property rights. To counter infringement or unauthorized use, we may be required to initiate legal claims or enforcement actions, which can be expensive and time-consuming. Such actions are not always successful. Any claims we assert against perceived infringers may prompt these parties to assert counterclaims against us, alleging that we infringe their intellectual property or that our patent and other intellectual property rights are invalid or unenforceable, including counterclaims based on antitrust or other legal theories. In a patent infringement proceeding, a court or administrative body may decide that a patent of ours is invalid or unenforceable, in whole or in part, or may construe the patent&#8217;s claims narrowly. Such rulings could allow the other party to continue using the disputed technology at issue on the grounds that our patents do not cover the competitor's activities or products. Antitrust considerations may also hinder our ability to settle such matters on favorable terms, as certain types of settlement agreements, particularly in the pharmaceutical sector, are subject to heightened scrutiny by antitrust authorities. In the E.U., for instance, antitrust regulators closely monitor settlement agreements for compliance with competition laws, adding another layer of complexity and potential risk to these proceedings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third parties may initiate legal proceedings alleging that we are infringing their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success depends upon our ability and the ability of our collaborators to develop, manufacture, market and sell our product candidates and use our proprietary technologies, including our in-licensed drug candidate ivonescimab, without infringing the intellectual property and other proprietary rights of third parties. There is considerable intellectual property litigation in the biotechnology and pharmaceutical industries, and we may become party to, or threatened with, future adversarial proceedings or litigation regarding intellectual property rights with respect to our products and technology, including interference, derivation, inter parties review, reexamination, reissue or post-grant review proceedings before the USPTO or similar proceedings in other jurisdictions. The risks of being involved in such disputes may increase as our product candidates approach commercialization, and as we gain greater visibility as a publicly traded company in the United States. Third parties may assert infringement claims against us based on their existing or future intellectual property rights, potentially restricting our freedom to operate or delaying our progress. Moreover, they may seek injunctive relief to bar us from practicing our technologies altogether while litigation against us is pending, potentially causing significant disruptions to our operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we are found to infringe third party&#8217;s intellectual property rights, or if we choose to settle a dispute to avoid prolonged litigation, we may be required to obtain a license to enable us to continue developing and marketing our products and technology. However, obtaining such licenses may be challenging or unattainable on commercially reasonable terms. Even if we were able to obtain a license, it could be non-exclusive, which would enable our competitors access to the same technologies and we may be required to pay substantial upfront or ongoing royalties. Absent a license, we could be forced, including by court order, to cease commercializing the infringing technology or product entirely. In addition, we could be found liable for monetary damages, including treble damages and attorneys&#8217; fees, particularly if we are found to have willfully </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">infringed a patent or other intellectual property right. A finding of infringement could prevent us from commercializing our product candidates or force us to cease some of our business operations, which could materially harm our business. Claims that we have misappropriated the confidential information or trade secrets of third parties, or claims that we derived our inventions from another, could have a similar negative impact on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims by third parties asserting that we or our employees have misappropriated their intellectual property, or claiming ownership of what we regard as our own intellectual property.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Many of our employees were previously employed at universities, research institutions or other biotechnology or pharmaceutical companies, including competitors or potential competitors. Although we take measures to ensure that our employees do not use the proprietary or otherwise confidential information or know-how from former employers, we may be subject to claims that we or our employees have, without authorization, misappropriated intellectual property, trade secrets or other proprietary or confidential information. Litigation may be necessary to defend against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, while we typically require our employees and contractors who may be involved in the development of intellectual property to execute agreements assigning such intellectual property to us and agreeing to cooperate and assist us with securing and defending our intellectual property, certain risks may arise. We may be unsuccessful in executing such an agreement from all relevant parties who develop intellectual property for us, and certain agreements may not be enforceable under applicable laws or may be subject to challenges from third parties. Furthermore, assignment agreements may not be self-executing or may be breached, and we may be forced to bring claims against third parties, or defend claims third parties may bring against us, to determine the ownership of what we regard as our intellectual property.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we fail in prosecuting or defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in prosecuting or defending against such claims, litigation could result in substantial costs and be a distraction to management.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual property litigation could cause us to spend substantial resources and could distract our personnel from their normal responsibilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are successful in defending against intellectual property claims, litigation or related legal proceedings can still impose significant financial and operational burdens. These disputes often require us to allocate substantial resources, including legal fees and other expenses, which can strain our finances and reduce funds available for critical business functions like development, sales, and marketing. Moreover, these proceedings can pull key technical and management personnel away from their normal responsibilities, disrupting our operations and slowing our progress.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, public announcements of the outcomes of hearings, motions or other interim proceedings or developments could have far reaching consequences. If securities analysts or investors interpret these developments negatively, it could have a substantial adverse effect on the price of our shares of common stock. Beyond the reputational impact, such litigation or proceedings could severely impact our business by diverting critical resources away from development, sales, marketing, and distribution efforts. Our ability to manage these legal challenges effectively may be constrained by limited financial and operational resources, especially when compared to competitors with deeper financial reserves who may weather such disputes more effectively. As a result, the cumulative costs, management distraction, and lingering uncertainties stemming from patent litigation or similar proceedings could substantially impair our ability to compete and succeed in the marketplace.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to seeking patents for some of our technology and products, we also rely on trade secrets, including unpatented know-how, technology and other proprietary and confidential information, to maintain our competitive position. To safeguard these trade secrets, we employ non-disclosure and confidentiality agreements with parties who have access to them, such as our employees, corporate collaborators, outside scientific collaborators, contract manufacturers, consultants, advisors and other third parties. However, despite these reasonable measures, we cannot guarantee that we have executed these agreements with each party that may have or have had access to our trade secrets or that the agreements we have executed will provide adequate protection. Even with these protections, any party with whom we have executed such an agreement may breach their obligations and disclose our proprietary or confidential information, including our trade secrets unlawfully. We may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. Additionally, if any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no legal recourse to prevent them from using this information to compete with us. If any of our trade secrets, particularly unpatented know-how, were to be obtained or independently developed by a competitor, our competitive position would be harmed.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We operate in the biotechnology sector and rely heavily on information technology. Any interruption, malfunction, or lapse related to that technology, including any cybersecurity incidents, could harm our ability to operate our business effectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We rely on both internal information technology systems and those of third parties to process and store sensitive data, including confidential research, business plans, financial information, intellectual property and personal data that may be subject to legal protection, and ensure the continuity of the Company's operations. As of the date of this Annual Report on Form 10-K, though the Company and our service providers have experienced certain cybersecurity incidents, we are not aware of any previous cybersecurity incidents that have materially affected or are reasonably likely to materially affect the Company. Any such cybersecurity incidents could result in a material compromise of our systems or the systems of our third-party vendors, and the information stored there could be accessed, publicly disclosed, lost, stolen, corrupted or rendered, permanently or temporarily, inaccessible. Furthermore, the Company or its service providers may not promptly discover a system intrusion. Cybersecurity incidents could have a material impact on our business, operations or financial results. Any access, disclosure or other loss of information, including Company data being compromised within the systems of our third-party providers, could result in legal claims or proceedings, liability under laws that protect the privacy of personal information or personal health information, disrupt our operations and damage our reputation, which could adversely affect our business. We also may need to make a material ransom payment to unencrypt, re-access, or preserve the confidentiality of our data or systems. We could be required to spend significant financial and other resources to respond to and remedy the damage caused by such an incident, including the costs to recover data or to repair or replace networks and information technology systems, increased cybersecurity protection costs and increased insurance premiums. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our information technology systems or data, or those of third parties upon whom we rely or interact, are or were compromised, we could experience material adverse consequences resulting from such compromise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we and the third parties we rely on collect, receive, store, use, transfer, make accessible,  dispose of, transmit, disclose or otherwise process proprietary, confidential and sensitive information, personal information, personal health information, participant-study-health-related data, proprietary information, intellectual property, and trade secrets (collectively, the &#8220;sensitive data&#8221;). In addition, we rely on service providers to establish and maintain appropriate information technology and data security protections to operate critical business systems (such as cloud-based infrastructure and systems, personnel email, as well as data storage and management systems). However, except for contractual protections, which may prove ineffective, we have limited ability to control the safeguards implemented and actions taken by such third parties. These service providers may not maintain adequate information security measures. We may share or receive sensitive data with or from third parties whose information security measures may not be adequate. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The risk of cybersecurity incidents may be heightened as a result of our some of our employees utilizing a remote working environment, which may be less secure and more susceptible to cybersecurity incidents. Additionally, the prevalent use of mobile devices that access our sensitive data increases the risk of data breaches. Advances in computer capabilities, discoveries in the field of artificial intelligence, cryptography, inadequate facility security or other developments may result in a compromise or breach of the technology we use to safeguard sensitive information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our information technology systems, including in our remote work environment, and those of parties upon which we rely, are vulnerable to evolving threats. These threats are prevalent, continue to increase and come from a variety of sources such as hackers; external or internal bad actors; personnel (such as through theft, error and misuse); sophisticated nation-states and nation-state-supported actors; and others. These threats include, but are not limited to, outages, social-engineering attacks, malicious code or intrusions, malware, denial-of-service attacks, personnel misconduct or errors, ransomware attacks, supply-chain attacks, software bugs, computer viruses, server malfunctions, software and hardware failures, misdirected wire transfers, theft or loss of data and other information technology assets, adware, natural disasters, terrorism, war, as well as telecommunication and electrical failures. In particular, ransomware attacks are becoming increasingly prevalent and severe and can lead to significant disruptions to operations, loss of data and income, reputational harm and diversion of funds. If we were to experience such an attack, ransom payments might alleviate some of the negative impacts of a ransomware attack but we might be unwilling or unable to make such payments due to, for example, applicable laws or regulations prohibiting such payments. Any of these threats may result in unauthorized, unlawful or accidental loss, corruption, access, modification, destruction, alteration, acquisition or disclosure of sensitive data (including without limitation clinical trial data). The costs to us to attempt to protect against such cybersecurity incidents and breaches are significant and could potentially require us to modify our business (including without limitation non-clinical and clinical trial activities). While we have implemented security measures designed to protect our information technology systems and to identify and remediate potential vulnerabilities, such measures may not be successful. We may not be able to detect vulnerabilities in our information technology systems because such threats and techniques used by threat actors change frequently, are sophisticated in nature and may not be detected until after a security incident has occurred. In addition, we may not have adequate insurance coverage to remediate or provide compensation for any losses associated with such events.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we or our third-party partners upon whom we rely experience or are perceived to have experienced a breach, we may experience adverse consequences. These consequences may include: government enforcement actions (for example, investigations, fines, penalties, audits and inspections), interruptions in our operations (including disruptions to our clinical trials), interruptions or restrictions on processing sensitive data (which could result in delays in obtaining, or our inability to obtain, regulatory approvals and significantly increase our costs to recover or reproduce the sensitive data), reputational harm, litigation (including class-action claims), indemnification obligations, monetary fund diversions, financial loss and other harms. In addition, such a breach may require notification of the breach to relevant stakeholders, certain state agencies or the media. Such disclosures are costly and the disclosure or the failure to comply with such requirements could lead to adverse consequences.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Many of our contracts with relevant stakeholders include obligations relating to safeguarding sensitive data and a breach or other cybersecurity incident could lead to claims against us by such stakeholders. There can be no assurance that the limitations of liability or other protections in our contracts would be enforceable or adequate or would otherwise protect us from liabilities, damages or claims relating to our data privacy and security obligations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, failure to maintain effective internal accounting controls related to data security breaches and cybersecurity in general could impact our ability to produce timely and accurate financial statements and could subject us to regulatory and private party scrutiny.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to stringent and changing obligations related to data privacy and security. Our actual or perceived failure to comply with such obligations could lead to material adverse consequences.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we process personal data and other sensitive data (including proprietary and confidential business information, trade secrets, intellectual property, clinical trial data, and other sensitive third-party data). We are subject to or affected by numerous data privacy and security obligations such as various federal, state, local and foreign laws, regulations, and guidance; industry standards; external and internal privacy and security notices and policies; contracts; and other obligations governing the processing of personal data by us and on our behalf. These obligations may change, are subject to differing interpretations and may be inconsistent across jurisdictions. The global data protection landscape is rapidly evolving and implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future. This evolution may create uncertainty in our business, affect us or our collaborators&#8217;, service providers&#8217; and others&#8217; ability to operate in certain jurisdictions or to collect, store, transfer (including across jurisdictional borders), use, share, and otherwise process personal data, necessitate the acceptance of more onerous obligations in our contracts, result in liability or impose additional costs on us. The cost of compliance with these obligations is high and is likely to increase in the future. These obligations may necessitate changes to our information technologies, systems and practices and to those of any service providers that process personal data on our behalf. In addition, these obligations may require us to change our business plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">An increasing number of laws, regulations and industry standards apply to data privacy and security. For example, the E.U.&#8217;s GDPR, imposes strict requirements on the processing of personal data. Under the E.U. GDPR, government regulators may impose temporary or definitive bans on personal data processing as well as fines of up to 20 million Euros or 4% of the annual global revenues of the noncompliant company, whichever is greater. Additionally, the Personal Information Protection Law (&#8220;PIPL&#8221;) of the People&#8217;s Republic of China may apply to certain personal data processed by us, our collaborators or others on our behalf. Similar to the E.U. GDPR, PIPL imposes strict requirements on the processing of personal data and allows for statutory fines and penalties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain jurisdictions, including the U.K., E.U., and China have enacted data localization laws and cross-border personal data transfer laws which make it more difficult to transfer information across jurisdictions (such as transferring or receiving personal data that originates in the U.K. or in other foreign jurisdictions). Existing mechanisms that facilitate cross-border personal data transfers may change or be invalidated. The processing of sensitive personal data, such as physical health conditions, is a topic of active interest among regulators. As we expand into countries and jurisdictions outside the U.S., we will be subject to additional laws and regulations that may affect how we conduct business in relation to the personal data or personal health information we or our third-party partners process. For example, in relation to cross-border personal data laws, if we cannot maintain a valid compliance mechanism for cross-border personal data transfers, we may face increased exposure to regulatory actions, fines and injunctions against the transferring of personal data from the U.K., Europe, China and elsewhere. We may have to increase our personal data processing capabilities and infrastructure in foreign jurisdictions at significant expense.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Likewise, we expect that there will continue to be new laws, regulations and industry standards relating to data privacy and security in the U.S. For example, the California Consumer Privacy Act, as amended by the California Privacy Rights Act (the &#8220;CCPA&#8221;), imposes obligations on business to which it applies. These obligations include, but are not limited to, providing </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">specific disclosures in privacy notices and affording California residents certain rights related to their personal data. The CCPA allows for statutory fines for noncompliance (up to $7,500 per violation). While the CCPA contains limited exceptions for clinical trial data, the CCPA&#8217;s implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future. In addition, the CCPA establishes a new California Privacy Protection Agency to implement and enforce the CCPA which could increase the risk of an enforcement action. Other states (such as Colorado, Virginia, Delaware, Texas and others) have also enacted data privacy laws. If we become subject to new data privacy laws, the risk of enforcement actions or class-action litigation brought against us could increase because we may become subject to additional obligations and the number of individuals or entities that can initiate actions against us may increase (including individuals, via a private right of action, and state agencies).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Further, there are regulations related to data privacy and security that are specific to our industry. For example, the U.S. Department of Health and Human Services has issued rules governing the use, disclosure, and security of protected health information, and the FDA has issued further guidance concerning cybersecurity for medical devices. HIPAA, as amended by HITECH, and their respective implementing regulations impose significant obligations on covered entities and business associates to safeguard the privacy, security, and integrity of individually identifiable health information, also known as protected health information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 8, 2025, the U.S. Department of Justice implemented a final rule carrying out Executive Order 14117, &#8220;Preventing Access to U.S. Sensitive Personal Data and Government-Related Data by Countries of Concern or Covered Persons (the &#8220;Rule&#8221;), which places restrictions on certain bulk data transactions involving "Countries of Concern" (China, Hong Kong, Iran, Cuba, Russia, North Korea, and Venezuela) and covered individuals (i.e., individuals and entities located in or controlled by individuals or entities located in those jurisdictions). The Rule's restrictions could significantly impact some of our business activities, such as clinical related vendor engagements and collaborations and partnerships. If there is no lawful manner, including applicable exemptions under the Rule, for us to transfer sensitive personal information of U.S. persons to persons or entities located in Countries of Concern, we may face significant business disruptions, including needing to change our operations by re-locating portions of our business, personnel and/or data processing activities to other jurisdictions (such as the United States) and having to engage with vendors and partners located outside Countries of Concern. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Although we endeavor to comply with all applicable data privacy and security obligations, we may at times fail to do so or may be perceived to have failed to do so. Moreover, despite our efforts, we may not be successful in achieving compliance if our personnel or third parties we rely on fail to comply with such obligations, which could negatively impact our business operations and compliance posture. For example, any failure by a service provider to comply with applicable data privacy and security obligations could result in adverse effects, including inability to operate our business and proceedings against us by governmental entities or others. If we fail, or are perceived to have failed, to address or comply with data privacy and security obligations, we could face significant consequences. These consequences may include, but are not limited to, government enforcement actions (e.g., investigations, fines, penalties, audits, inspections and similar activities); litigation (including class-related claims); additional reporting requirements and oversight; bans on processing personal data; orders to destroy or not use personal data; individual, media or agency notifications, including without limitation notice to the Department of Health and Human Services; and imprisonment of company officials. Any of these events could have a material adverse effect on our reputation, business or financial condition, including but not limited to: interruptions or stoppages in our business operations (including, as relevant, our clinical trials); inability to process personal data or to operate in certain jurisdictions; limited ability to develop or commercialize our products; expenditure of time and resources to comply as well as to defend any claim or inquiry; adverse publicity; or revision or restructuring of our operations. Moreover, trial participants or research subjects as well as the providers who share their information with us, may contractually limit our ability to use and disclose the information, and we may face significant liability for failing to abide by such limitations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our future success depends on our ability to retain our Co-Chief Executive Officers, Chief Operating Officer and other key executives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are highly dependent on the principal members of our executive and scientific teams, including Mr. Robert W. Duggan and Dr. Mahkam Zanganeh, our Co-Chief Executive Officers, and Mr. Manmeet Soni, our Chief Operating Officer and Chief Financial Officer, all of whom are at-will employees. They may terminate their employment with us at any time. Mr. Duggan and Dr. Zanganeh have also been married since December 18, 2024. We do not maintain &#8220;key person&#8221; insurance on any of our executive officers. The unplanned loss of the services of any of these persons could materially impact the achievement of our research, development and commercialization objectives.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We or the third parties we rely on may be adversely affected by social unrest or terrorism.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Social instability, disruption, or widespread destruction in areas where we operate or in significant markets could have a negative impact on our business. Events, including war, terrorism, riot, civil insurrection or social unrest, regardless of cause, could result in material adverse effects on our ability to operate, the ability of our suppliers to operate, and macroeconomic conditions. Such negative impacts may adversely affect the Company&#8217;s business, results of operations and financial</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We or the third parties we rely on may be adversely affected by natural disasters and our business continuity and disaster recovery plans may not adequately protect us from a serious disaster.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The changing nature, frequency, and severity of natural disasters and extreme weather events such as tornadoes, hurricanes flooding, extreme heat, and wildfires pose a risk to Company facilities, assets, and programs, as well as those of third parties on whom we rely. Natural disasters could severely disrupt our operations and have a material adverse effect on our business, results of operations, financial condition and prospects. If a natural disaster, power outage, or other event occurred that prevented us, or a third party on whom we rely, from using offices or other facilities, or if a disaster damaged infrastructure critical to such offices or facilities, or if a disaster otherwise disrupted operations, it may be difficult or, in certain cases, impossible, for us to continue our business for extended periods period of time. In addition to operational impacts, natural disasters could significantly affect clinical trial participants, institutions, doctors, and supporting staff. For participants, a disruption in trial operations could delay access to investigational therapies, compromise ongoing treatment regimens, or create uncertainty about trial continuity. Institutions and medical personnel and staff could face logistical challenges, including damage to clinical trial sites, limited availability of resources, and interrupted communication channels. Key staff may be unable to perform their duties due to displacement, injury, or other disaster-related issues, leading to trial delays and operational challenges. Such disruptions may result in increased costs, delays in regulatory submissions, and reputational harm. Our existing disaster recovery and business continuity plans may not fully mitigate these risks, and unanticipated gaps in communication during emergencies may hinder our decision making and response efforts. We may incur substantial expenses to address and recover from such disruptions, which could further strain our financial and operational resources.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Widespread health concerns, pandemics or epidemics, and other outbreaks of illness may negatively affect the Company&#8217;s ability to maintain operations and execute its business plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Widespread health concerns, pandemics, epidemics and other outbreaks of illness can have evolving and uncertain impacts on our business. As a result of any widespread health concern, pandemic, or other outbreaks of illness, including the COVID-19 pandemic, the Company has in the past and may experience disruptions that severely impact our business, commercialization, third party vendor operations, including foreign and domestic supply chains, or delays in clinical trial activities, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays or difficulties in initiating clinical trial sites;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruption to and delays in preclinical research and analysis activities due to an extended temporary closure of contract lab facilities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruptions in supply, logistics or other activities related to the procurement of materials, which could have a negative impact on the Company&#8217;s ability to conduct preclinical studies, initiate or complete clinical trials or commercialize product candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of healthcare resources away from conducting clinical trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interruption of key preclinical studies and clinical trial activities, due to limitations on travel imposed or recommended by federal, state, provincial or municipal governments, employers and others;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limitations in resources that would otherwise be focused on the conduct of the Company&#8217;s business or current or planned preclinical studies or clinical trials, including due to sickness, restrictions on travel, prolonged stay-at-home or shelter-in-place orders and other pandemic related concerns;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">slowed enrollment in and delayed execution of clinical trials due to hospital closures to clinical trials or patient hesitation to enroll in clinical trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impact of infection of patients on the outcomes of clinical trials; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in regulations as part of a response to the future pandemic or epidemic may require the Company to change the ways in which the preclinical studies and clinical trials are conducted and incur unexpected costs, or requires the Company to discontinue our preclinical research or clinical trials altogether.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our employees may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements, which could cause significant liability for us and harm our reputation.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may be exposed to the risk of employee fraud or other misconduct, including intentional failures to (i) comply with FDA or Office of Inspector General regulations or similar regulations of comparable non-U.S. regulatory authorities, (ii) provide </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">accurate information to the FDA or comparable non-U.S. regulatory authorities, (iii) comply with manufacturing standards we have established, comply with federal and state healthcare fraud and abuse laws and regulations and similar laws and regulations established and enforced by comparable non-U.S. regulatory authorities, (iv) report financial information or data accurately or (v) disclose unauthorized activities to us. Employee misconduct could also involve the improper use of information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to our reputation, or a request for the reimbursement of expenses that were not incurred. It is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws, standards or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business and results of operations, including the imposition of significant fines and other sanctions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Key personnel have been, and may continue to be, difficult to attract and retain.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to maintain and grow our business is directly related to the service of our employees in each area of our business, as we consider talent to be a key asset. Our performance is directly tied to our ability to hire, train, motivate and retain qualified personnel, including highly skilled technical, operational and program managerial, clinical, medical, analytical and legal or financial personnel. There is significant competition for personnel in the clinical sciences marketplace, particularly in certain geographies where we are located, including but not limited to the United States, where we plan to expand our physical presence, as well as Europe. Also, employees in our industry are increasingly able to work remotely, which could increase employee mobility and turnover, making it more difficult for us to attract and retain employees. In addition, many of our clinical development, operational and program management positions require deep technical expertise, and it can be particularly challenging to identify and attract candidates and retain employees possessing such expertise. We have experienced, and may continue to experience, attrition across the company. If we are unable to hire sufficient numbers of qualified employees or retain and motivate existing employees, our business and operating results would be harmed. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research and development, and commercialization strategy. Our consultants and advisors may be employed by employers other than us and may have commitments under consulting or advisory contracts with other entities that may limit their availability to us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Owning Our Common Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our principal stockholder and Co-Chief Executive Officer maintains the ability to control or significantly influence all matters submitted to stockholders for approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, Mr. Duggan beneficially owned, in the aggregate, shares of common stock representing over 70% of our outstanding capital stock. Mr. Duggan is able to control or significantly influence all matters submitted to our stockholders for approval, as well as our management and affairs. For example, Mr. Duggan is able to control or influence the election of directors and approval of any merger, consolidation or sale of all or substantially all of our assets. This concentration of voting power could delay or prevent an acquisition of our company on terms that other stockholders may desire. As a member of the board of directors, Mr. Duggan will adhere to the corporate governance standards adopted by the company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As a &#8220;controlled company&#8221; under the listing requirements of the Nasdaq Stock Market, we have an exemption from certain corporate governance requirements, which could adversely affect our stockholders by denying them certain rights and protections.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Duggan owns more than a majority of the voting power of our outstanding shares of common stock. Under the Nasdaq Stock Market listing requirements, a company of which more than 50% of the voting power is held by an individual, group, or another company is a &#8220;controlled company&#8221;. We have in the past, and we expect in the future, to rely on the &#8220;controlled company&#8221; exemptions under the Nasdaq Stock Market listing requirements. For example, in the past, a majority of the members of our board of directors were not independent directors, and our compensation and nominating and corporate governance committees did not consist entirely of independent directors. Accordingly, during the period we remain a controlled company and during any transition period following a time when we are no longer a controlled company, you may not have the same protections afforded to stockholders of companies that are subject to all of the corporate governance requirements of the Nasdaq Stock Market.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The price of our shares of common stock have in the past, and may continue to be volatile and fluctuate substantially, which could result in substantial losses for our stockholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The market prices of our shares of common stock on the Nasdaq Global Market have in the past and may continue to be volatile and fluctuate substantially. The stock market in general and the market for smaller pharmaceutical and biotechnology companies in particular have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. As a result of this volatility, stockholders may not be able to sell their shares of common stock at or above the price at which they were purchased.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The market price for our shares of common stock may be influenced by many factors, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the success of competitive products or technologies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">results of clinical trials of ivonescimab and any other product candidate that we develop;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">results of clinical trials of product candidates of our competitors;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the acquisition activity and licensing and collaboration efforts of our competitors and large biopharmaceutical companies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes or developments in laws or regulations applicable to ivonescimab and any other product candidates that we develop;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our entry into, and the success of, any collaboration agreements with third parties;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments or disputes concerning patent applications, issued patents or other proprietary rights;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the recruitment or departure of key personnel;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level of expenses related to any of our product candidates or clinical development programs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the results of our efforts to discover, develop, acquire or in-license additional product candidates, products or technologies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated changes in estimates as to financial results, development timelines or recommendations by securities analysts;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">variations in our financial results or those of companies that are perceived to be similar to us;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the structure of healthcare payment systems;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market conditions in the biotechnology and pharmaceutical sectors;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory or legal developments in the United States and other countries;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the societal and economic impact of public health epidemics and pandemics, and government efforts to slow their spread;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic, industry and market conditions;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the trading volume of the shares on the Nasdaq Global Market; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the other factors described in this &#8220;Risk Factors&#8221; section.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the stock market historically has experienced significant price and volume fluctuations. These fluctuations are often unrelated to the operating performance of particular companies. These broad market fluctuations may cause declines in the trading price and market value of our common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Substantial future sales of our shares of common stock in the public market, or the perception that these sales could occur, could cause the price of the shares to decline significantly, even if our business is doing well.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Sales of a substantial number of our shares of common stock in the public market could occur at any time. These sales, or the perception in the market that these sales could occur, could cause the market price of the shares to decline. Following the domestication, all of our outstanding shares of common stock were freely tradeable in the public market without restriction, unless held by our affiliates. Our principal stockholder and Co-Chief Executive Officer, Mr. Duggan, holds a substantial number of shares. Mr. Duggan&#8217;s shares have been registered for resale pursuant to an effective registration statement on Form S-3. If he sells, or indicates an intention to sell, substantial amounts of shares in the public market, the trading price of our shares could decline.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, stockholders could lose confidence in our financial and other public reporting, which would harm our business and the trading price of our shares of common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section 404 of the Sarbanes-Oxley Act, or Section 404, or any subsequent </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">testing by our independent registered public accounting firm, as and when required, may reveal deficiencies in our internal controls over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further attention or improvement. Inferior internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our shares of common stock.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are required to disclose changes made in our internal controls and procedures on a quarterly basis, and our management is required to assess the effectiveness of these controls annually. Now that we have transitioned from a </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">non-accelerated filer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and  &#8220;smaller reporting company&#8221; to a &#8220;large accelerated filer,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> our independent registered public accounting firm is required to attest to the effectiveness of our internal control over financial reporting pursuant to Section 404. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 404(a) of the Sarbanes-Oxley Act, we are required to furnish a report by our management on our internal controls over financial reporting. In order to comply with Section 404(a) of the Sarbanes-Oxley Act, we expect to incur additional expenses and devote increased management effort including documenting and evaluating our internal controls over financial reporting. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that we will not be able to conclude that our internal control over financial reporting is effective as required by Section 404. This could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our restated certificate of incorporation designates the Court of Chancery of the State of Delaware and the federal district courts of the U.S. as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers and employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our restated certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, if the Court of Chancery of the State of Delaware does not have jurisdiction, the federal district court for the District of Delaware) will be the sole and exclusive forum for the following types of actions or proceedings under Delaware statutory or common law:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any derivative action or proceeding brought on our behalf;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers, employees or stockholders to our company or our stockholders;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law (&#8220;DGCL&#8221;) or as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a claim arising pursuant to any provision of our certificate of incorporation or bylaws (in each case, as they may be amended from time to time) or governed by the internal affairs doctrine.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These choice of forum provisions will not apply to suits brought to enforce a duty or liability created by the Exchange Act. Furthermore, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our restated certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the U.S. shall, to the fullest extent permitted by law, be the sole and exclusive forum for the resolution of any claims arising under the Securities Act. While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions. In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our restated certificate of incorporation. This may require significant additional costs associated with resolving such action in other jurisdictions and there can be no assurance that the provisions will be enforced by a court in those other jurisdictions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These exclusive forum provisions may limit the ability of our stockholders to bring a claim in a judicial forum that such stockholders find favorable for disputes with us or our directors, officers or employees, which may discourage such lawsuits against us and our directors, officers and employees. If a court were to find the either exclusive forum provision contained in our restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur further significant additional costs associated with resolving such action in other jurisdictions, all of which could materially adversely affect our business, financial condition and operating results.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because we do not anticipate paying any cash dividends on our shares of common stock in the foreseeable future, capital appreciation, if any, will be the sole source of gain for our stockholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid cash dividends on our shares of common stock. We currently intend to retain all of our future earnings to fund the development and expansion of our business. Any determination to pay dividends in the future will be at the discretion of our board of directors. As a result, capital appreciation of our shares of common stock, if any, will be the sole source of gain for our stockholders for the foreseeable future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If equity research analysts stop publishing research or reports about our business or if they issue unfavorable commentary or downgrade our shares of common stock, the price of the shares could decline.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our shares of common stock relies in part on the research and reports that equity research analysts publish about us and our business. We do not control these analysts. The price of our shares of common stock could decline if one or more equity research analysts downgrades such securities or if analysts issue other unfavorable commentary about us or our business. In addition, if one or more of these analysts cease coverage of our company or fail to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause the trading prices and trading volumes of our shares of common stock to decline.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are exposed to risks related to currency exchange rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We conduct a portion of our operations in the U.K and rely on third parties across the globe.  Exchange rate fluctuations between local currencies and the U.S. dollar create risk in several ways, including the following: weakening of the U.S. dollar may increase the U.S. dollar cost of overseas research and development expenses and the cost of sourced product components outside the United Kingdom; strengthening of the U.S. dollar may decrease the value of our revenues denominated in other currencies; the exchange rates on non-dollar transactions and cash deposits can distort our financial results; and commercial pricing and profit margins are affected by currency fluctuations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have broad discretion in the use of our cash and cash equivalents and may not use them effectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our management has broad discretion in the use of our cash and cash equivalents and could spend our cash in ways that do not improve our results of operations or enhance the value of our shares of common stock. If our management team were to fail to apply these funds effectively, such failure could result in financial losses that could have a material adverse effect on our business, cause the market price of our shares of common stock to decline and delay the development of our product candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may complete a future acquisition that may not achieve intended results or could increase the number of our outstanding shares or amount of outstanding debt or result in a change of control. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the License Agreement and the transactions contemplated thereby, we may pursue business development opportunities to expand or enhance our pipeline of drug candidates, including without limitation, through potential acquisitions of and/or collaborations with other entities. Any such transaction could happen at any time, could be material to our business and could take any number of forms, including, for example, an acquisition, merger or a collaboration with other entities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Evaluating potential transactions and integrating completed ones may divert the attention of our management from ordinary operating matters. The success of these potential transactions will depend, in part, on our ability to realize the anticipated growth opportunities through the successful integration of the businesses we acquire with our existing business, as well as the success of the underlying business or intellectual property that we acquire or otherwise obtain rights to. Even if we are successful in integrating the acquired businesses, these integrations may not result in the realization of the full benefit of any anticipated growth opportunities or these benefits may not be realized within the expected time frames. In addition, acquired businesses may have unanticipated liabilities or contingencies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we complete an acquisition, investment or other strategic transaction, we may require additional financing that could result in an increase in the number of our outstanding shares or the aggregate amount of our debt.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1B. Unresolved Staff Comments </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_22"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1C. <span id="i656f527524a349fbb9ab8ebc3481cb16_5178"></span>Cybersecurity</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="f-37" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="f-36" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented a risk-based approach to identify and assess the cybersecurity threats that could affect our business and information systems. We use recognized commercially reasonable measures, tools and methodologies designed to manage cybersecurity risk that are tested on a regular cadence. We also monitor and evaluate our cybersecurity posture on an ongoing basis through regular vulnerability scans, penetration tests and third-party reviews. We rely on third-party service providers to provide the systems required to effectively run our clinical trials and endeavor to require third-party service providers that have access to personal, confidential or proprietary information to implement and maintain cybersecurity practices. Specific controls that are used in appropriate portions of our environment include endpoint threat detection and response, identity and access management, privileged access management, logging and monitoring involving the use of security information and event management, multi-factor authentication, firewalls and intrusion detection and prevention, and vulnerability and patch management. Our cybersecurity risk management processes are <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true" id="f-38">integrated</ix:nonNumeric> into our enterprise risk management program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To manage our material risks from cybersecurity threats and to protect against, detect, and prepare to respond to cybersecurity incidents, we endeavor to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Monitor emerging data protection laws and implement changes to our processes to comply;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conduct annual cybersecurity management and incident training for employees that process sensitive data;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conduct onboarding and cybersecurity training for all employees on an ongoing basis;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conduct regular phishing email simulations for all employees; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Carry cybersecurity risk insurance meant to provide protection against the potential losses arising from a cybersecurity incident.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true" id="f-39">engage several third-party consultants</ix:nonNumeric> in connection with our risk assessment and risk management, and <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true" id="f-40">we have established separate processes and procedures to oversee and identify cybersecurity risks associated with third parties</ix:nonNumeric>. All third parties involved in our cybersecurity risk assessments and risk management are required to provide reports designed to allow us to monitor and assess such third parties&#8217; security controls.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our incident response plan coordinates the activities that we and our third-party cybersecurity provider take to respond and recover from cybersecurity incidents, which include processes to triage, assess severity, investigate, escalate, contain, and remediate an incident, as well as to comply with legal obligations and attempt to mitigate brand and reputational damage. We have business continuity plans that we periodically review and update in line with our evolving applications architecture.</span></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="f-41" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" id="f-44" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-43" continuedAt="f-43-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="f-42" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our cybersecurity leadership team is responsible for assessing and managing cybersecurity risks and is made up of experienced professionals with an extensive background in information security, risk management, and incident response. This team is led by our <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true" id="f-45">Head of Information Technology</ix:nonNumeric>. The Head of Information Technology is a senior technology strategist and thought leader with over two decades of experience in the bio pharma, life sciences, and high-tech sectors.</span></div></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="f-46" escape="true">Our Board of Directors provides oversight to our cybersecurity efforts to ensure effective governance in assessing and managing risks associated with cybersecurity threats.</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-48" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="f-47" escape="true">Our <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true" id="f-49">Head of Information Technology</ix:nonNumeric> provides periodic updates to senior management and quarterly updates to the Board of Directors regarding our cybersecurity program, including information about cyber risk management governance, <ix:continuation id="f-43-1">status updates on various projects intended to enhance the overall cybersecurity posture of the Company, and information about the prevention, detection, mitigation and remediation of any cybersecurity incidents, as appropriate.</ix:continuation></ix:nonNumeric></ix:nonNumeric></span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false" id="f-50" continuedAt="f-50-1">As of the date of this Annual Report on Form 10-K, we are not aware of any previous cybersecurity incidents that have materially affected or are reasonably likely to materially affect the Company. However, we acknowledge that cybersecurity threats are continually evolving, and the possibility of future cybersecurity incidents remains. Despite the implementation of our cybersecurity processes, our security measures cannot guarantee that a significant cyberattack will not occur. While we devote resources to security measures designed to protect our systems and information, these measures cannot provide absolute security. No security measure is infallible. A successful attack on our information technology systems or on the systems of our third-party vendors could have material consequences on our business. We describe whether and how risks from cybersecurity threats have or are reasonably likely to affect our financial position, results of operations and cash flows, under the heading </ix:nonNumeric></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-50-1">&#8220;Risks Related to Our Intellectual Property, Cybersecurity and Data Privacy&#8221; included as part of Part 1, Item 1A, Risk Factors of this Annual Report on Form 10-K, which disclosures are incorporated by reference herein.</ix:continuation></span></div><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_25"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Properties</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information concerning Summit&#8217;s principal leased facilities as of December 31, 2025:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We maintain the following leased properties: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.298%"><tr><td style="width:1.0%"/><td style="width:18.744%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.815%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.279%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.195%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.314%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Type/Uses</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Size</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Lease&#160;Expiration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Headquarters</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Miami, Florida</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,425 square feet</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">April 2029</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Executive office</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Palo Alto, CA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">36,406 square feet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">October 2033</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Executive office</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Princeton, NJ</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,857 square feet</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">August 2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Executive office</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Oxfordshire,&#160;United&#160;Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,781 square feet</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;2027</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Executive office</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Menlo Park, California</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,523 square feet</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">May 2026</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe our facilities are suitable and adequate to meet our needs.</span></div><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_28"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. Legal Proceedings </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may become involved in legal proceedings arising in the ordinary course of our business.  Except as described below, we are not aware of any legal proceedings arising outside the ordinary course of business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Litigation Relating to the December 2022 Notes Entered into in Connection with the License Agreement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 17, 2025, Rainaldi Revocable Trust, a purported stockholder of the Company, filed a derivative lawsuit in the Delaware Court of Chancery against certain of the Company&#8217;s current and former directors and the Company, solely as a nominal defendant, concerning the December 2022 Notes entered into by the Company, Mr. Duggan and Dr. Zanganeh in connection with the License Agreement. The suit asserts claims for breach of fiduciary duty and unjust enrichment and seeks, among other things, unspecified damages, rescission of the shares that Mr. Duggan and Dr. Zanganeh received as part of prepaid interest payments under the December 2022 Notes, as well as attorneys&#8217; fees and costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the December 2022 Notes, the Company obtained $520 million in bridge financing through three unsecured promissory notes: (1) a $400 million note issued to Mr. Duggan due on February 15, 2023; (2) a $20 million note issued to Dr. Zanganeh due on February 15, 2023; and (3) a $100 million note issued to Mr. Duggan due on September 15, 2023 (the &#8220;$100 Million Note&#8221;). The notes had an interest rate of 7.5% through February 15, 2023, with prepaid interest through that date paid in shares valued at $0.7913 per share. For periods after February 15, 2023, interest would accrue at the U.S. prime interest rate plus 50 basis points for three months, and thereafter at the U.S. prime rate plus 300 basis points. The notes contained no warrant coverage and no security interests. The Company announced the 2023 Rights Offering on December 6, 2022, which ran from February 7 through March 1, 2023. The 2023 Rights Offering was fully subscribed, with stockholders purchasing 476,190,471 shares of the Company&#8217;s common stock at $1.05 per share, raising $500 million in gross proceeds. Mr. Duggan and Dr. Zanganeh fully subscribed to their basic subscription rights, with Mr. Duggan participating by purchasing 376,489,880 shares for approximately $395.31 million. Following the Company&#8217;s fully subscribed $500 million 2023 Rights Offering, Dr. Zanganeh&#8217;s $20 million note was repaid on February 15, 2023, and Mr. Duggan's $400 million note was repaid. In the interest of minimizing stockholders dilution, the $100 Million Note was extended, and eventually the $75.5 million repayment was funded through the proceeds of the September 2024 Private Placement in which Mr. Duggan purchased 3,325,991 shares for an aggregate purchase price of $75.5 million as a participant in the September 2024 Private Placement at a purchase price of $22.70 per share, and the remaining $24.5 million was repaid in full on October 1, 2024, along with $7.3 million in accrued interest. Defendants&#8217; motion to dismiss the complaint was filed on May 16, 2025 (the &#8220;Motion to Dismiss&#8221;). Plaintiff filed a motion to certify certain constitutional questions to the Delaware Supreme Court on May 29, 2025 (the &#8220;Motion to Certify&#8221;). Defendants agreed to a stipulation staying briefing on the Motion to Certify and the Motion to Dismiss pending the Delaware Supreme Court&#8217;s decision in another case involving substantially the same constitutional questions. On June 18, 2025, the Court granted such stipulation.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">European Patent Opposition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 18, 2025, an unknown third party filed a notice of opposition against the Company&#8217;s in-licensed EP3882275B1 patent (the &#8220;&#8217;275 patent&#8221;) in the European Opposition Division of the European Patent Office (&#8220;EPO&#8221;). The &#8217;275 patent covers Ivonescimab. The notice primarily asserts that the &#8217;275 patent lacks inventive step. The Company contests these assertions and worked with its collaboration partner, Akeso, to timely file a response before the European Opposition Division of the EPO on January 2, 2026.</span></div><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_31"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:24pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div style="margin-top:24pt;text-align:center"><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_37"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Market Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock has been publicly traded on the Nasdaq Global Market under the symbol &#8220;SMMT&#8221; since September 21, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following performance graph shall not be deemed &#8220;soliciting material&#8221; or to be &#8220;filed&#8221; with the SEC for purposes of the Exchange Act or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated by reference into any filing of Summit Therapeutics Inc. under the Securities Act or the Exchange Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following graph illustrates a comparison for the five years ended December 31, 2025 of the cumulative total return for our common stock, the Nasdaq Biotechnology Index and the Nasdaq Composite Index each of which assumes an initial investment of $100. Such returns are based on historical results and are not intended to suggest future performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The comparison shown in the graph below are based upon historical data. We caution that the stock price performance shown in the graph below is not necessarily indicative of, nor is it intended to forecast, the potential future performance of our common stock.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="smmt-20251231_g3.jpg" alt="Performance Graph.jpg" style="height:283px;margin-bottom:5pt;vertical-align:text-bottom;width:576px" id="i-3"/></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Holders of Record</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;17, 2026, there were approximately 123 holders of record of our common stock, which number does not include stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust by other entities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid cash dividends on our common stock or ordinary shares. We currently intend to retain all available funds and any future earnings to fund the development and expansion of our business and we do not anticipate paying any cash dividends in the foreseeable future. Any future determination to declare and pay dividends will be made at the discretion of our Board of Directors and will depend on then-existing conditions, including our results of operations, financial </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">condition, contractual restrictions, capital requirements, business prospects, and other factors our Board of Directors may deem relevant.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sales of Unregistered Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">There were no unregistered sales of equity securities sold during the period covered by this Annual Report on Form 10-K that were not previously included in a Quarterly Report on Form 10-Q or in a Current Report on Form 8-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><br/>Not applicable.</span></div><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_40"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. [RESERVED]</span></div><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_43"></div><div><span id="ic81c3275ebf442faa7530f3ad20bea42_145527"></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">The following discussion and analysis of our financial condition and results of operations is for the year ended December 31, 2025 compared with the year ended December 31, 2024. This comparison should be read in conjunction with our consolidated financial statements and related notes appearing elsewhere in this Annual Report on Form 10-K. This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under &#8220;Risk Factors&#8221; included in Part I, Item 1A or in other parts of this Annual Report on Form 10-K. For a discussion and analysis of our financial condition and results of operations for the year ended December 31, 2024 compared to December 31, 2023, see Part II, Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in the 2024 Annual Report on Form 10-K, filed with the Securities and Exchange Commission on February&#160;24, 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, or MD&amp;A, describes principal factors affecting the results of our operations, financial condition and liquidity, as well as our critical accounting policies and estimates that require significant judgment and thus have the most significant potential impact on our Consolidated Financial Statements. This section provides an analysis of our financial results for the year ended December 31, 2025 compared to the same period in the prior year. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Summit Therapeutics Inc. (&#8220;we&#8221;, &#8220;Summit&#8221; or the &#8220;Company&#8221;) is a biopharmaceutical company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The Company&#8217;s pipeline of product candidates is designed with the goal to become the patient-friendly, new-era standard-of-care medicines, in the therapeutic area of oncology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s current lead development candidate is ivonescimab, a novel, potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF  compound into a single molecule. On December 5, 2022, the Company entered into the License Agreement with Akeso pursuant to which the Company has in-licensed intellectual property rights related to ivonescimab (as amended, the &#8220;License Agreement&#8221;). Through the License Agreement, the Company obtained the rights to develop and commercialize ivonescimab in the United States, Canada, Europe, and Japan. The License Agreement and transaction closed in January 2023 following customary waiting periods. On June 3, 2024, the Company entered into the Second Amendment with Akeso to expand its territories covered under the License Agreement to also include Latin America, including Mexico and all countries in Central America and South America, the Middle East and Africa. The Company&#8217;s operations are focused on the development of ivonescimab and other future activities, as the Company determines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company is developing ivonescimab in NSCLC and CRC, specifically conducting Phase III clinical trials in the following proposed indications:</span></div><div><span><br/></span></div><div style="padding-left:31.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(a)  ivonescimab combined with chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a third-generation EGFR TKI (&#8220;HARMONi&#8221;); </span></div><div><span><br/></span></div><div style="padding-left:31.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(b)  ivonescimab combined with chemotherapy in patients with first-line metastatic NSCLC (including separate statistical analyses planned for patients with squamous NSCLC and non-squamous NSCLC) (&#8220;HARMONi-3&#8221;); </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="padding-left:31.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(c)  ivonescimab monotherapy in patients with first-line metastatic NSCLC whose tumors have high PD-L1 expression (&#8220;HARMONi-7&#8221;); and</span></div><div style="padding-left:31.5pt"><span><br/></span></div><div style="padding-left:31.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(d)  ivonescimab combined with chemotherapy in patients with first-line unresectable metastatic CRC (&#8220;HARMONi-GI3&#8221;).</span></div><div style="padding-left:31.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In October 2024, the Company completed enrollment in its HARMONi clinical trial. In May 2025, we announced topline results from our multiregional, double-blinded, placebo-controlled, Phase III study HARMONi. At the prespecified primary data analysis, ivonescimab in combination with chemotherapy demonstrated a statistically significant improvement in PFS, the magnitude of which we believe to be clinically meaningful, with a hazard ratio of 0.52 (95% CI: 0.41 &#8211; 0.66; p&lt;0.00001) compared to placebo in combination with chemotherapy; median PFS was 6.8 months for those patients receiving ivonescimab plus chemotherapy compared to 4.4 months for those receiving chemotherapy. PFS was assessed by BICR.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We believe the PFS hazard ratio that was observed in both Asian and Western sub-populations to be clinically meaningful. The primary analysis demonstrated the consistency of the magnitude of the PFS benefit between patients randomized in Asian and Western territories, as well as the consistency in a single-region study (HARMONi-A) with this multiregional study.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In a longer-term follow-up of PFS, which included all Western patients and at least six months of follow-up time for all patients, ivonescimab plus chemotherapy demonstrated a consistent hazard ratio in PFS as the primary PFS analysis observed HR = 0.57; 95% CI: 0.46 &#8211; 0.71). With the longer-term follow-up analysis, consistency of the magnitude of PFS benefit was demonstrated between patients randomized in Asia and Western patients when measured by hazard ratio. This longer-term follow-up analysis of PFS was performed at the time of the primary OS analysis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Ivonescimab in combination with chemotherapy showed a positive trend in OS in the primary analysis without achieving a statistically significant benefit with a hazard ratio of 0.79 (95% CI: 0.62 &#8211; 1.01; p=0.057). This trend provides further support for its use in EGFRm NSCLC post-TKI therapy, a setting where high unmet need continues to exist with limited approved options in the United States and other western territories. Currently there are no FDA-approved regimens that have demonstrated a statistically significant OS benefit in this patient setting. Both Asian and North American patients demonstrated a positive trend in OS. The results of the primary analysis in this multiregional study were consistent with that of the single-region randomized Phase III HARMONi-A study, which demonstrated a statistically significant OS benefit with a hazard ratio of 0.74 in the primary OS analysis in a similar patient population.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In September 2025, an additional ad hoc OS analysis was performed for the HARMONi study, whereby the Western patients were followed for a longer period of time (Asian patients were locked at the time of the primary analysis). In this analysis that included longer-term follow-up of Western patients (median follow-up time of Western patients of 13.7 months), a hazard ratio consistent with the primary analysis was observed with an improved nominal p-value (HR=0.78; 95% CI: 0.62 &#8211; 0.98; nominal p=0.0332). Median OS for this analysis remained the same in both arms as was observed in the primary analysis. Median OS in Western patients receiving ivonescimab was 17.0 months compared to 14.0 months for those receiving placebo (HR=0.84); median OS in North American patients, specifically, had not yet been reached in the ivonescimab arm compared to 14.0 months in the placebo arm (HR=0.70). The hazard ratios for Western patients in totality, as well as patients from the North American and European regions individually, improved from the primary OS analysis to the analysis with longer-term follow-up of Western patients. Consistent benefit was observed across pre-defined subgroups.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The dual primary endpoints were allocated separate alpha levels and tested individually. The alpha was recycled from the PFS to the OS analysis upon the successful achievement of the PFS endpoint.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Based on the results of the HARMONi clinical trial, we submitted a BLA in the fourth quarter of 2025 in order to seek approval for ivonescimab plus chemotherapy for this proposed indication. The positive results of the multiregional Phase III study are detailed further under &#8220;Product Pipeline&#8221; below. As previously disclosed, the FDA noted that a statistically significant OS benefit is necessary to support marketing authorization in this setting. After careful consideration of the safety and efficacy profile of the current FDA-approved options for patients in this setting, the positive results of the Phase III multiregional study, including regional consistency, as well as discussions with key opinion leaders and those physicians who have administered ivonescimab to patients in a clinical study setting, we believe that the safety and efficacy data generated in the HARMONi study demonstrates that the ivonescimab regimen offers a potential treatment option for patients impacted by EGFR-mutant NSCLC in this setting with a favorable benefit-risk profile despite the lack of a statistically significant OS benefit. Summit announced in January 2026 that the FDA accepted for filing the BLA seeking approval for ivonescimab in combination with chemotherapy for this proposed indication. The FDA noted it intends to perform a complete review of the accepted and filed BLA, including planned mid-cycle and wrap-up meetings, and, subject to major deficiencies not being identified during the FDA&#8217;s review, proposed labeling, prior to the Prescription Drug User Fee Act goal action date of November 14, 2026.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Key Components of our Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Research and Development Expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consist of all costs associated with our research and development activities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These include:&#160;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs incurred in conducting our preclinical studies and clinical trials through contract research and development organizations, including, but not limited to, preclinical toxicology, pharmacology, formulation and manufacturing work, as well as regulatory, operational, drug supply and treatment costs related to conducting the study; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laboratory and vendor expenses incurred in relation to our preclinical, non-clinical and clinical studies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs incurred in supply chain development and scale up activities to support product registration; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">employee related expenses, which include salary, benefits and stock-based compensation, for our research and development staff; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs incurred in development and conduct of training and education related our development candidates; and  </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">facilities, depreciation and other expenses, which include direct and allocated expenses for rent and maintenance of facilities, insurance and other supplies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We utilize our employee and infrastructure resources across multiple research projects. We track expenses related to our clinical programs and certain preclinical programs on a per project basis. We expect our research and development expenses to continue to be significant as we initiate our planned clinical trials of ivonescimab, and continue our activities to initiate preclinical programs for future product candidates. The timing and amount of these expenses will depend upon the outcome of our clinical trials and the associated costs. The timing and amount of these expenses will also depend on the costs associated with potential future clinical trials of our product candidates and the related expansion of our research and development organization, regulatory requirements, advancement of our preclinical programs and product candidate manufacturing costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of salaries and benefits related to our executive, finance, business development, human resources, legal and other support functions. Other general and administrative expenses include stock-based compensation expenses, market research costs, facility-related costs, consulting costs and expenses associated with the requirements of being a publicly traded company in the United States, including insurance, legal, audit and taxation services fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that our general and administrative expenses will continue to increase in the future as we increase our headcount to support our planned clinical trials of ivonescimab, continued research and development and potential commercialization of our product candidates. We also anticipate continued accounting, audit, regulatory, compliance, insurance and investor and public relations expenses associated with being a publicly traded company in the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net primarily consists of foreign currency net gains and losses and investment income related to investments in money market funds and U.S. treasury securities. All highly liquid investments with a maturity date of 90 days or less at the date of purchase are considered to be cash equivalents and the related investment income is recognized in net loss. The appropriate classification of investments in securities is determined by the Company at the time of purchase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense consists of cash and imputed interest expense incurred related to our promissory notes to related parties. Imputed interest is calculated as the difference between the expected interest payable and the deemed market rate of interest and is recorded as a debt discount at inception of the note payable with a credit to additional paid-in capital for notes payable to related parties. The debt discount is amortized to interest expense using an effective interest rate method.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As a U.S. tax resident trading entity, we are subject to U.S. corporate taxation. Our U.K. resident trading subsidiaries are individually subject to U.K. corporate taxation. Due to the nature of our business, we have generated losses since inception. We </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">have recorded a full valuation allowance against the deferred tax assets with respect to these tax losses in excess of our deferred tax liabilities in each jurisdiction because we do not consider it more likely than not that there will be suitable taxable profits in the foreseeable future based on the evidence available against which to offset these losses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion and analysis of our financial condition and results of operations for the year ended December 31, 2024 compared to December 31, 2023, please refer to Item 7 of Part II, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in our Annual Report on Form 10-K for the year ended December 31, 2024, which was filed with the SEC on February&#160;24, 2025, and is available on the SEC&#8217;s website at www.sec.gov and our Investor Relations website at www.smmttx.com/investor-information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reported in millions within this Annual Report on Form 10-K are computed based on the amounts in thousands, and therefore, the sum of components may not equal the total amount reported in millions due to rounding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Year Ended December 31, 2025 to the Year Ended December 31, 2024</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">537.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">150.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">386.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(15.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">556.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">60.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">496.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,094.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">226.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">868.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,079.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">221.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">858.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes our research and development expenses by category for the year ended December 31, 2025 and 2024, respectively.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Oncology clinical trial related costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">266.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">165.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(15.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Compensation related costs, excluding stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">218.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">202.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">537.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">165.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">371.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The entry into the License Agreement represents a significant change in our strategy from anti-infectives to the therapeutic area of oncology. We invested our resources in the clinical development of ivonescimab in the periods presented.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Oncology clinical trial related costs represent our investment in the clinical development of ivonescimab, known as SMT112 in the Licensed Territory.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Research and development expenses increased by $371.9 million during the year ended December 31, 2025, compared to the same period in the prior year. This increase was in part due to the increase in stock-based compensation expense of $202.6 million for the year ended December 31, 2025, as a result of the modification to our performance-based stock option awards during the second quarter of 2025. In addition, our continued investment in oncology expenses for ivonescimab, known as SMT112 in our Licensed Territory, resulted in an increase of $165.5 million for the year ended December 31, 2025, primarily due to adding new clinical trials and expanding current clinical trials from last year. We expect oncology-related research and development costs to continue to increase as we progress with the development of ivonescimab.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In June 2024, we entered into a second amendment (the &#8220;Second Amendment&#8221;) to the License Agreement with Akeso to expand the Licensed Territory to include Latin America, Middle East and Africa regions. Considered an extension of the original License Agreement, we agreed to make an upfront payment to Akeso in the amount of $15.0 million for these expanded territories which we paid in the third quarter of 2024. This was recorded in our consolidated statement of operations and comprehensive loss as acquired in process research and development expenses for the year ended December 31, 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes our general and administrative expenses by category for the year ended December 31, 2025 and 2024, respectively. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Compensation related costs, excluding stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">513.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">478.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Legal fees and professional services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">556.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">60.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">496.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased by $496.5 million for the year ended December 31, 2025, compared to the same period in the prior year. The increase was primarily due to the increase in stock-based compensation expense of $478.8 million for the year ended December 31, 2025, as a result of the modification to our performance-based stock option awards during the second quarter of 2025. In addition, compensation related costs, excluding stock-based compensation, increased by $8.2 million, for the year ended December 31, 2025, compared to the same period in the prior year, as the Company is focused on building its executive management team and legal fees and professional services increased by $6.4 million for the year ended December 31, 2025, compared to the same period in the prior year to continue supporting the development of ivonescimab. We expect general and administrative expenses to continue to increase as we scale our infrastructure and management to support development of ivonescimab.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes our other income, net by category for the year ended December 31, 2025 and 2024, respectively.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency loss</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Other income, net increased by $1.4 million for the year ended December 31, 2025, compared to the same period in the prior year, primarily due to an increase of $2.0 million in interest income due to the higher cash equivalents and short-term investments balance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense decreased for the year ending December 31, 2025 compared to the same period in the prior year, due to the repayment in full of the promissory note in October 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Liquidity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">To date, we have financed our operations primarily through issuances of our common stock, including our most recent private placements issued in October 2025 and September 2024 for gross proceeds of $500.0 million and $235.0 million, respectively, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">and the raise of $150.7 million gross proceeds from our ATM Agreement since inception, issuance of debt, and receipt of payments to us under license and collaboration arrangements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have devoted substantially all of our efforts to research and development, including clinical trials. We have not completed the development of any drugs. We expect to continue to incur significant expenses and increasing operating losses for at least the next few years. The net losses we incur may fluctuate significantly from quarter to quarter and year to year, due to the nature and timing of our research and development activities. We expect that our research and development and general and administrative expenses will continue to be significant in connection with our ongoing research and development efforts. In addition, if we obtain marketing approval for any of our product candidates in the United States or other jurisdictions where we retain commercial rights, and if we choose to retain those rights, we would expect to incur significant sales, marketing, distribution and outsourced manufacturing expenses, as well as ongoing research and development expenses. In addition, our expenses will increase if and as we:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">invest in clinical development of ivonescimab in our Licensed Territory;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conduct research and continue development of additional product candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain and augment our intellectual property portfolio and opportunistically acquire complimentary intellectual property;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek further regulatory advancement for ivonescimab;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">invest in our manufacturing capabilities for ivonescimab and any other products for which we may obtain regulatory approval;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek marketing approvals for any product candidates that successfully complete clinical development;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ultimately establish a sales, marketing and distribution infrastructure in jurisdictions where we have retained commercialization rights and scale up external manufacturing capabilities to commercialize any product candidates for which we receive marketing approval;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">perform our obligations under our collaboration agreements;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pursue business development opportunities, including investing in other businesses, products and technologies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">experience any delays or encounter any issues with any of the above, including but not limited to failed studies, complex results, safety issues or other regulatory challenges;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">hire additional clinical, regulatory, scientific and administrative personnel;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expand our physical presence;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">add operational, financial and management information systems and personnel, including personnel to support our product development and planned future commercialization efforts; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">borrow capital to fund our resources and have to pay interest expenses on such borrowings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2025, we incurred a net loss of $1,079.6&#160;million, and cash flows used in operating activities was $322.9&#160;million. As of December 31, 2025 we had an accumulated deficit of $2,294.2&#160;million, cash and cash equivalents and short-term investments of $713.4&#160;million. We expect to continue to generate operating losses for the foreseeable future. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December 31, 2025, the Company raised gross proceeds of $500,037 from a private placement and $106,498 from the Company&#8217;s at-the-market sales agreement. With these recent financings, the Company has evaluated and concluded that its cash, cash equivalents and short-term investments provide sufficient cash to fund its operating cash needs for at least the next 12 months from the date of issuance of these consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, we may raise additional equity or debt capital through both registered offerings off of a shelf registration, including ATM offerings, and private offerings of securities. On February 20, 2024, we filed a shelf registration statement on Form S-3 with the SEC, which the SEC declared effective on February 27, 2024.  Through our shelf registration statement we may, from time to time, sell up to an aggregate of $450.0 million of our common stock, preferred stock, debt securities, depository shares, warrants, subscription rights, purchase contracts, or units. Of the $450.0 million of liquidity available to us under this shelf registration statement, on May 13, 2024, we had established an ATM offering program with J.P. Morgan Securities LLC, as sales agent, in the amount of up to $90.0 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On August 11, 2025, we entered into an amendment (the &#8220;Amendment&#8221;) to the distribution agreement, which amended that certain distribution agreement, dated May 13, 2024, by and between us and sales agent (the &#8220;Original Distribution Agreement&#8221; and, as amended by the Amendment, the &#8220;Distribution Agreement&#8221;). Pursuant to the Amendment, the Original Distribution Agreement was amended to, among other things, increase the aggregate offering price of shares of the Company&#8217;s common stock, par value $0.01 per share, from time to time, through the sales agent, by up to an additional $360.0&#160;million. The remaining gross proceeds available under the Distribution Agreement as of December 31, 2025 was approximately $299.3&#160;million.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the payments already made to Akeso, under the License Agreement and Second Amendment, there are additional potential milestone payments of $4.56 billion, as Akeso will be eligible to receive regulatory milestones of up to $1.05 billion and commercial milestones of up to $3.51 billion. In addition, Akeso will be eligible to receive low double-digit royalties on net sales. Until we can generate substantial revenue and achieve profitability, we will need to raise additional capital to fund ongoing operations and capital needs, including the payment of the milestone payments referenced above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have based the foregoing estimate on assumptions that may prove to be wrong, and we could use our capital resources sooner than we currently expect. This estimate assumes, among other things, that we do not obtain any additional funding through grants and clinical trial support or through new collaboration arrangements. Our future capital requirements will depend on many factors, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs, timing and outcome of clinical trials required for clinical development of ivonescimab;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number and development requirements of other future product candidates that we pursue;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs, timing and outcome of regulatory review of ivonescimab and/or our other product candidates we develop;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and timing of commercialization activities, including product sales, marketing, distribution and manufacturing, for any of our product candidates that receive marketing approval;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we become liable for milestone payments under the License Agreement and Second Amendment for ivonescimab;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">subject to receipt of marketing approval, revenue received from commercial sales of any product candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and protecting our intellectual property rights and defending against any intellectual property-related claims;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to establish and maintain collaborations, licensing or other arrangements and the financial terms of such arrangements;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we acquire or invest in other businesses, products and technologies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the rate of the expansion of our physical presence; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we change our physical presence.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Until such time, if ever, as we can generate substantial product revenues, we expect to finance our cash needs through a combination of some, or all, of the following: equity and debt offerings, collaborations, strategic alliances, grants and clinical trial support from government entities, philanthropic, non-government and not-for-profit organizations, and marketing, distribution or licensing arrangements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We will need to seek additional funding in the future to fund operations. Additional capital, when needed, may not be available to us on acceptable terms, or at all. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our existing stockholders may be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our existing stockholders. Additional debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends or other distributions. If we raise additional funds through collaborations, strategic alliances or marketing, distribution, or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or to grant licenses on terms that may not be favorable to us. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to raise additional funds through equity or debt financings or other arrangements when needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves, which could materially adversely affect our business, operating results and financial condition and our ability to continue operations. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flows for the years ended December 31, 2025 and 2024.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:66.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(322.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(142.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(174.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(205.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">617.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">381.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities for the year ended December 31, 2025 was $322.9&#160;million and primarily consisted of net loss of $1,079.6&#160;million and a $31.4&#160;million net change in operating assets and liabilities, partially offset by non-cash charges of $725.2&#160;million. The non-cash charges primarily consisted of $732.4&#160;million of stock-based compensation driven by the modification to outstanding performance-based stock option awards which removed the performance-based vesting criteria, partially offset by $7.0&#160;million relating to amortization of the discount on short-term investments in U.S. Treasury securities. The net change in working capital is primarily due to a $15.3 million increase in accounts payable, a $12.9 million increase in accrued liabilities and other current liabilities, a $4.9 million decrease in prepaid expenses and other current assets, a $2.9 million increase in accrued compensation, partially offset by a $4.9 million increase in other assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities for the year ended December 31, 2024 was $142.1 million and primarily resulted from a net loss of $221.3 million, which included an adjustment of $15.0 million in cash payments related to investing activities for the purchase of in-process research and development from Akeso under the terms of the License Agreement and the associated direct transaction costs, non-cash charges of $48.7 million and a net change in operating assets and liabilities of $15.5 million. Non-cash charges primarily include $51.0 million of stock-based compensation, partially offset by $2.6 million related to the amortization of discount on short-term investments. The net change in operating assets and liabilities is primarily due to an $11.9 million increase in accrued liabilities and other current liabilities, a $6.6 million increase in accrued compensation, a $2.5 million decrease in other assets, and a $2.0 million increase in accounts payable, partially offset by a $7.4 million increase in prepaid expenses and other current assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities for the years ended December 31, 2025 was $174.3&#160;million and primarily consisted of net purchases of short-term investments of $173.7&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities for the years ended December 31, 2024 was $205.3 million and was primarily due to $190.2 million of net purchases of short-term investments and $15.0 million of cash payments made to Akeso pursuant to the License Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the year ended December 31, 2025 was $617.5&#160;million and primarily consisted of proceeds from a private placement of $500.0 million, $104.5 million net proceeds from our current Distribution Agreement, $7.3 million of proceeds received related to the exercise of warrants and proceeds received of $5.7 million related to employee stock awards and purchase plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the year ended December 31, 2024 was $381.2 million and was primarily due to $434.9 million of proceeds from various private placements, $43.0 million net proceeds from our current ATM Agreement, and proceeds received of $2.7 million related to employee stock awards, partially offset by a $100.0 million early principal payment on promissory notes payable to a related party.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fixed asset purchase commitments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2025 and 2024, we had no capital commitments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lease commitments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our lease contractual obligations as of December 31, 2025:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:36.624%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.880%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Payment due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Less than 1 year</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Between 1 and 3 years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Between 3 and 5 years</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">More than 5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">  For additional information, please see Note 11 to our consolidated financial statements contained in this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt commitments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On December 6, 2022, we entered into a Note Purchase Agreement (the &#8220;Note Purchase Agreement&#8221;), with Mr. Duggan and Dr. Zanganeh, pursuant to which we agreed to sell to each of Mr. Duggan and Dr. Zanganeh unsecured promissory notes in the aggregate amount of $520 million. Pursuant to the Note Purchase Agreement, we issued to Mr. Duggan and Dr. Zanganeh unsecured promissory notes in the amount of $400 million (the &#8220;Duggan February Note&#8221;) and $20 million (the &#8220;Zanganeh Note&#8221;), respectively, which matured and became due on February 15, 2023 and an unsecured promissory note to Mr. Duggan in the amount of $100 million (the &#8220;Duggan September Note&#8221; and together with the Duggan February Note and the Zanganeh Note, the &#8220;December 2022 Notes&#8221;), which was originally due on September 15, 2023. The maturity dates of the December 2022 Notes could have been extended one or more times at our election, but in no event to a date later than September 6, 2024. In addition, if we consummated a public offering, then upon the later to occur of (i) five business days after we receive the net cash proceeds therefrom or (ii) May 15, 2023, the Duggan February Note and the Zanganeh Note were to be prepaid by an amount equal to the lesser of (a) 100% of the amount of the net proceeds of such offering and (b) the outstanding principal amount on such Notes. On January 19, 2023, we provided notice to extend the term of the Duggan February Note and Duggan September Note to a maturity date of September 6, 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, on January 19, 2023, we and Mr. Duggan rectified the Duggan February Note and Duggan September Note in order to correctly reflect the parties&#8217; intent that we may only prepay (i) the Duggan February Note following the completion of a public rights offering to be conducted by us in the approximate amount of $500 million, or a similar capital raise, in an amount equal to the lesser of (x) the net proceeds of the 2023 Rights Offering or such capital raise or (y) the full amount outstanding of the Duggan February Note, and (ii) the Duggan September Note following the completion of a capital raising transaction subsequent to the 2023 Rights Offering (as defined in Note 17 Stockholders&#8217; Equity to the consolidated financial statements included under Item 15 Exhibits, Financial Statement Schedules) in an amount equal to the lesser of (A) the net proceeds of such capital raise or (B) the full amount outstanding of the Duggan September Note. Following the issuance of the two new Promissory Notes (the &#8220;Duggan Promissory Notes&#8221;), the Duggan February Note and Duggan September Note were marked as &#8220;cancelled&#8221; on their face and replaced in their entirety by the Duggan Promissory Notes (together with the Zanganeh Note, the &#8220;Notes&#8221;). The Notes accrued interest at an initial rate of 7.5%. All interest on the Notes was paid on the date of signing for the period through February 15, 2023. Such prepaid interest was paid in a number of shares of our common stock, par value $0.01 (&#8220;Common Stock&#8221;) equal to the dollar amount of such prepaid interest, divided by $0.7913 (the consolidated closing bid price immediately preceding the time we entered into the Note Purchase Agreement, plus $.01), which was 9,720,291 shares. For all applicable periods following February 15, 2023, interest accrued on the outstanding principal balance of the Notes at the US prime interest rate, as reported in the </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> plus 50 basis points, as adjusted monthly, for three months immediately following February 15, 2023, and thereafter at the US prime rate plus 300 basis points, as adjusted monthly. Accrued interest was paid in cash, quarterly in arrears, on each of March 31, June 30, September 30 and December 31.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 15, 2023, the $20 million Zanganeh Note matured and we repaid the outstanding principal balance. In connection with the closing of the 2023 Rights Offering, the $400 million Duggan Promissory Note matured and became due, and we satisfied all principal and accrued interest thereunder using a combination of a portion of the cash proceeds from the 2023 Rights Offering and the extinguishment of a portion of the amount due equal to the subscription price of shares subscribed by Mr. Duggan in the 2023 Rights Offering. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 17, 2024 the Duggan February Note was amended to extend the maturity date from September 6, 2024 to April 1, 2025. For all applicable periods commencing  February 17, 2024, interest accrued on the outstanding principal balance at the greater of 12% or the US prime interest rate, as reported in the </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">plus 350 basis points, as adjusted monthly, compounded quarterly. Interest was paid upon maturity of the loan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;1, 2024, the Company repaid the Duggan September Note in full, resulting in principal payments in the aggregate amount of $100.0 million and accrued cash interest of $7.3 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other commitments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We enter into contracts in the normal course of business with various third parties for clinical trials, preclinical research studies and testing, manufacturing and other services and products for operating purposes. Most contracts provide for termination upon notice, and therefore are cancellable contracts. As of December 31, 2025, total unconditional purchase obligations, excluding lease commitments, are estimated to be approximately $18.0 million.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have certain commitments under our agreements with Akeso. The License Agreement with Akeso also contains certain manufacturing and purchase commitments. As of December 31, 2025, we are unable to estimate the amount, timing or likelihood of achieving the milestones, making future product sales or assessing estimated forecasts for manufacturing and supplied materials which these contingent payment obligations relate to. For additional information about the License Agreement with Akeso, refer to Note 4, &#8220;Akeso License and Collaboration Agreement&#8221; to the Consolidated Financial Statements included under Item 15, &#8220;Exhibits, Financial Statement Schedules.&#8221;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Litigation Relating to the December 2022 Notes Entered into in Connection with the License Agreement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 17, 2025, Rainaldi Revocable Trust, a purported stockholder of the Company, filed a derivative lawsuit in the Delaware Court of Chancery against certain of the Company&#8217;s current and former directors and the Company, solely as a nominal defendant, concerning the December 2022 Notes entered into by the Company, Mr. Duggan and Dr. Zanganeh in connection with the License Agreement. The suit asserts claims for breach of fiduciary duty and unjust enrichment and seeks, among other things, unspecified damages, rescission of the shares that Mr. Duggan and Dr. Zanganeh received as part of prepaid interest payments under the December 2022 Notes, as well as attorneys&#8217; fees and costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to the December 2022 Notes, the Company obtained $520 million in bridge financing through three unsecured promissory notes: (1) a $400 million note issued to Mr. Duggan due on February 15, 2023; (2) a $20 million note issued to Dr. Zanganeh due on February 15, 2023; and (3) a $100 million note issued to Mr. Duggan due on September 15, 2023 (the &#8220;$100 Million Note&#8221;). The notes had an interest rate of 7.5% through February 15, 2023, with prepaid interest through that date paid in shares valued at $0.7913 per share. For periods after February 15, 2023, interest would accrue at the U.S. prime interest rate plus 50 basis points for three months, and thereafter at the U.S. prime rate plus 300 basis points. The notes contained no warrant coverage and no security interests. The Company announced the 2023 Rights Offering on December 6, 2022, which ran from February 7 through March 1, 2023. The 2023 Rights Offering was fully subscribed, with stockholders purchasing 476,190,471 shares of the Company&#8217;s common stock at $1.05 per share, raising $500 million in gross proceeds. Mr. Duggan and Dr. Zanganeh fully subscribed to their basic subscription rights, with Mr. Duggan participating by purchasing 376,489,880 shares for approximately $395.31 million. Following the Company&#8217;s fully subscribed $500 million 2023 Rights Offering, Dr. Zanganeh&#8217;s $20 million note was repaid on February 15, 2023, and Mr. Duggan's $400 million note was repaid. In the interest of minimizing stockholders dilution, the $100 Million Note was extended, and eventually the $75.5 million repayment was funded through the proceeds of the September 2024 Private Placement in which Mr. Duggan purchased 3,325,991 shares for an aggregate purchase price of $75.5 million as a participant in the September 2024 Private Placement at a purchase price of $22.70 per share, and the remaining $24.5 million was repaid in full on October 1, 2024, along with $7.3 million in accrued interest. Defendants&#8217; motion to dismiss the complaint was filed on May 16, 2025 (the &#8220;Motion to Dismiss&#8221;). Plaintiff filed a motion to certify certain constitutional questions to the Delaware Supreme Court on May 29, 2025 (the &#8220;Motion to Certify&#8221;). Defendants agreed to a stipulation staying briefing on the Motion to Certify and the Motion to Dismiss pending the Delaware Supreme Court&#8217;s decision in another case involving substantially the same constitutional questions. On June 18, 2025, the Court granted such stipulation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">European Patent Opposition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On June 18, 2025, an unknown third party filed a notice of opposition against the Company&#8217;s in-licensed EP3882275B1 patent (the &#8220;&#8217;275 patent&#8221;) in the European Opposition Division of the European Patent Office (&#8220;EPO&#8221;). The &#8217;275 patent covers Ivonescimab. The notice primarily asserts that the 275 patent lacks inventive step. The Company contests these assertions and worked with its collaboration partner, Akeso, to timely file a response before the European Opposition Division of the EPO on January 2, 2026.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Significant Judgments and Estimates </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our management&#8217;s discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with United States generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, and expenses and the disclosure of contingent assets and liabilities in our financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related to accrued research and development expenses, stock-based compensation and income taxes. We base our estimates on historical experience, known trends and events, and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe the following critical accounting policies affect the most significant judgments, assumptions and estimates we use in preparing the consolidated financial statements:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquired In-Process Research and Development</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company may enter into agreements with collaboration partners for the development and commercialization of its products. These arrangements may include payments contingent on the occurrence of certain events such as development, regulatory or sales-based milestones. The Company considers the unique nature, terms and facts and circumstances of each transaction. The Company considers whether or not the assets acquired have a future alternative use. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The fair value associated with acquired in-process research and development which does not have an alternative future use is expensed and is recorded as research and development expense. Any development or commercial milestone payments are recognized when the achievement of the associated milestone becomes probable and will either be expensed or capitalized depending upon whether or not regulatory approval has been obtained.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred to discover, research and develop product candidates, including personnel expenses, stock-based compensation expense, allocated facility-related and depreciation expenses, third-party license fees and external costs of outside vendors engaged to conduct preclinical and clinical development activities and clinical trials as well as to manufacture clinical trial materials. Non- refundable prepayments for goods or services that will be used or rendered for future research and development activities are recorded as prepaid expenses. Such amounts are recognized as an expense as the goods are delivered or the related services are performed, or until it is no longer expected that the goods will be delivered, or the services rendered. The significant estimates in our accrued research and development expenses include the costs incurred for services performed by our vendors in connection with research and development activities for which we have not yet been invoiced. Milestone and other payments made to third-parties with respect to in-process research and development, in accordance with the Company&#8217;s license, acquisition and other similar agreements are expensed when determined to be probable and estimable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has entered into various research and development contracts with other companies. These agreements are generally cancellable, and related payments are recorded as research and development expenses as incurred. The Company records accruals for estimated ongoing research and development costs or prepaid expenses where the payments made exceed the estimated costs. These amounts are determined based on the estimated costs to complete each study or activity, the estimation of the current stage of completion and the invoices received, as well as predetermined milestones which are not reflective of the current stage of development for prepaid expenses. Actual results could differ from the Company&#8217;s estimates. In all cases, the full cost of each study or activity is expensed by the time the final report or where applicable, product, has been received. The Company&#8217;s historical estimates have not been materially different from the actual costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all stock option and restricted stock unit awards based on the estimated fair value of the award on the grant date. The Company uses the Black-Scholes option pricing model to estimate the fair value of stock option awards. Additionally, the Company uses a Monte Carlo simulation model to calculate the estimated fair value on the date of grant related to awards with market-based service conditions. The fair value is recognized as expense, over the requisite service period, which is generally the vesting period of the respective award, on a straight-line basis for each separately vesting portion of the award when the only condition to vesting is continued service. If vesting is subject to a market or performance condition, recognition is based on the derived service period of the award. Expense for awards with performance conditions is estimated and adjusted on a quarterly basis based upon the assessment of the probability that the performance condition will be met. Use of the Black-Scholes option-pricing model requires management to apply judgment under subjective assumptions. These assumptions include:</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected term&#8212;The expected term of stock options represents the weighted-average period the stock options are expected to be outstanding. The Company uses the simplified method for estimating the expected term as provided by the Securities and Exchange Commission. The simplified method calculates the expected term as the average of the time-to-vesting and the contractual life of the options.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected volatility&#8212;The expected volatility is calculated based on historical volatility of the Company&#8217;s share price.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk-free interest rate&#8212;The risk-free rate assumption is based on the U.S. Treasury instruments, the terms of which were consistent with the expected term of the Company&#8217;s stock options.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected dividend&#8212;The expected dividend assumption is based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not intend to pay dividends. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a Monte Carlo simulation model to estimate the fair value of Performance and Market-based Stock Options at the date of grant. Key assumptions used in the model include the risk-free interest rate, which reflects the US Treasury Constant Maturity Yield with a term commensurate with the contractual term of the award, and stock price volatility, which is derived based on the historical volatility of the Company&#8217;s stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates expected forfeitures at the time of grant instead of accounting for forfeitures as they occur. Stock option  awards have been granted at fair value to non-employees, in connection with research and consulting services provided to the Company, to non-employees in connection with corporate activities, and to employees, in connection with Stock Purchase and Restriction Agreements. Equity awards generally vest over terms of 3 or 4 years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies stock-based compensation expense in the consolidated statements of operations and comprehensive loss in the same manner in which the award recipient&#8217;s payroll costs are classified.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is determined using the asset and liability approach. Tax laws may require items to be included in tax filings at different times than the items are reflected in the financial statements. A current asset or liability is recognized for the estimated taxes receivable or payable for the current year. Deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. Deferred taxes are initially recognized at enacted tax rates in force at the time of initial recognition and are subsequently adjusted for any enacted changes in tax rates and tax laws. Subsequent changes to deferred taxes originally recognized in equity are recognized in income. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. The Company has recorded a full valuation allowance against the deferred tax assets in excess of its deferred tax liabilities, as the deferred tax liability represents future reversals of existing taxable temporary differences. The Company records interest and penalties related to income tax matters as part of income tax expense.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for uncertain tax positions taken in its tax filings by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities having full knowledge of the facts and applicable tax rules. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed as the amount of benefit to recognize in the consolidated financial statements. The amount of benefits that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate, as well as the related net interest and penalties. At December 31, 2025, 2024, and 2023 the Company had unrecognized tax positions of $3.9 million, $2.1 million, and $1.1 million, respectively. Due to the Company&#8217;s full valuation allowance, the unrecognized tax benefits are not expected to materially impact the Company&#8217;s effective tax rate when recognized or significantly increase or decrease in the next 12 months. In addition, the Company&#8217;s policy is to recognize interest and penalties related to uncertain tax positions as part of its income tax provision. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of recent accounting pronouncements, please see Note 2 to our consolidated financial statements contained in this Annual Report on Form 10-K. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_46"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;7A. Quantitative and Qualitative Disclosures About Market Risk </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our primary exposures to market risk are liquidity risk and foreign currency risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have funded our operations since inception primarily through the issuance of equity and debt securities. We have also received funding from our license and collaboration arrangements. Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through a combination of public or private equity or debt financings or other sources. Adequate additional financing may not be available to us on acceptable terms, or at all. Our inability to raise capital as and when needed would have a negative impact on our financial condition and our ability to pursue our business strategy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Rate Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency exchange rate risk refers to the risk that the value of a financial commitment or recognized asset or liability will fluctuate due to changes in foreign currency rates. Our net loss and financial position, as expressed in U.S. dollars, are exposed to movements in foreign exchange rates against the pound sterling and the euro. The main trading currencies are the pound sterling, the U.S. dollar, Japanese Yen, and the euro. We are exposed to foreign currency exchange rate risk as a result of entering into operating transactions denominated in currencies other than the functional currency of our subsidiaries, particularly in relation to our monetary assets and liabilities relating to intercompany transactions, supplier liabilities and the translation of foreign cash balances. Operating transaction foreign currency gains and losses are included in the determination of net loss in our statements of operations and comprehensive loss. We monitor our exposure to foreign currency exchange rate risk. Exposures are generally managed through natural hedging via the currency denomination of cash balances and any impact currently is not material to us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We hold our cash, cash equivalents and short-term investments for working capital purposes. Some of the securities we invest in are subject to market risk. This means that a change in prevailing interest rates may cause the principal amount of such investments to fluctuate. To minimize this risk, we maintain our portfolio of cash, cash equivalents and short-term investments which are invested in a variety of short term securities, including money market funds, certificates of deposit and U.S. treasury securities. Due to the short-term nature of these instruments, we believe that we do not have any material exposure to changes in the fair value of our investment portfolio as a result of changes in interest rates. Declines in interest rates, however, would reduce future interest income. The effect of a hypothetical 10% increase or decrease in overall interest rates would not have had a material impact on our operating results or the total fair value of our portfolio.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:107%">Credit Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We consider all of our material counterparties to be creditworthy. We consider the credit risk for each of our counterparties to be low and do not have a significant concentration of credit risk at any of our counterparties. We have $0.9&#160;million of research and development tax credits outstanding at December 31, 2025. Given that these receivables relate to U.K. research and development tax credit cash rebate regimes and given our history of collection, it is highly unlikely that these amounts will not be collected.</span></div><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_49"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;8. Financial Statements and Supplementary Data</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements required to be filed pursuant to this Item 8 are included in this Annual Report on Form 10-K. An index of those financial statements is found in Item 15, &#8220;Exhibits, Financial Statement Schedules.&#8221; </span></div><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_52"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_55"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9A. Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have performed an evaluation of the effectiveness of our disclosure controls and procedures under the supervision and the participation of the company&#8217;s management, including our Co-Chief Executive Officers (our Principal Executive Officers) and our Chief Operating Officer and Chief Financial Officer (our Principal Financial Officer). The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based upon our evaluation of our disclosure controls and procedures as o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">f </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">December 31, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> our Co-Chief Executive Officer and Executive Chairman and our Co-Chief Executive Officer, President and Director (our Principal Executive Officers), and our Chief Operating Officer, Chief Financial Officer and Director (our Principal Financial Officer) concluded that, as of such date, our disclosure controls and procedures were effective at a reasonable level of assurance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is a process designed, under the supervision of the Co-Chief Executive Officers (our Principal Executive Officers), and our Chief Operating Officer and Chief Financial Officer (our Principal Financial Officer), to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external reporting purposes in accordance with generally accepted accounting principles.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of the effectiveness of internal control to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our management has assessed the effectiveness of internal control over financial reporting as of December 31, 2025, based on the &#8220;Internal Control&#8212;Integrated Framework&#8221; issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in 2013. Based on this assessment, management concluded that, as of December 31, 2025, our internal control over financial reporting is effective based on the COSO internal control criteria. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The effectiveness of the Company&#8217;s internal control over financial reporting as of December 31, 2025 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in its report included in Item 15, &#8220;Exhibits, Financial Statement Schedules&#8221; of this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Rules 13a&#8209;15(f) and 15d&#8209;15(f) under the Exchange Act) during the quarter ended </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_58"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B. Other Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Rule 10b5-1 Trading Plans.</span></div><div><span><br/></span></div><div><span style="color:#2c2c2c;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-4" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-51"><ix:nonNumeric contextRef="c-4" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-52"><ix:nonNumeric contextRef="c-4" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-53"><ix:nonNumeric contextRef="c-4" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-54">None.</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_61"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_64"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:1pt;font-weight:700;line-height:120%">s</span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_67"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 10. Directors, Executive Officers and Corporate Governance</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The information required in response to this item will be set forth in our definitive proxy statement for the 2026 annual meeting of stockholders and is incorporated herein by reference.</span></div><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_70"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;11. Executive Compensation</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The information required in response to this item will be set forth in our definitive proxy statement for the 2026 annual meeting of stockholders and is incorporated herein by reference.</span></div><div style="text-align:center"><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_73"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The information required in response to this item will be set forth in our definitive proxy statement for the 2026 annual meeting of stockholders and is incorporated herein by reference.</span></div><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_76"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 13. Certain Relationships and Related Party Transactions</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The information required in response to this item will be set forth in our definitive proxy statement for the 2026 annual meeting of stockholders and is incorporated herein by reference.</span></div><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_79"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;14. Principal Accounting Fees and Services </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The information required in response to this item will be set forth in our definitive proxy statement for the 2026 annual meeting of stockholders and is incorporated herein by reference.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:6pt"><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_82"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_85"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;15. Exhibits, Financial Statement Schedules </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.982%"><tr><td style="width:1.0%"/><td style="width:25.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.160%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Financial Statements</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As part of this Annual Report on Form 10-K, the consolidated financial statements are listed in the accompanying index to financial statements on page </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i41c8a90424914cbe810928f0de0d7cad_0-0-1-1-327646">92</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.409%"><tr><td style="width:1.0%"/><td style="width:19.744%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.744%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:57.212%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Financial Statement Schedules</span></div></td></tr></table></div><div style="text-indent:32.05pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">All financial statement schedules have been omitted because they are not applicable, not required, or the information required is shown in the consolidated financial statements or the notes thereto.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span><br/></span></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.982%"><tr><td style="width:1.0%"/><td style="width:25.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.160%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(3)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Exhibits</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">The exhibits filed as part of this Annual Report on Form 10-K are listed below.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.814%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit&#160;No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119312520248702/d76627dex31.htm">Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K (File No. 001-36866), filed with the Securities and Exchange Commission on September 18, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119312520248702/d76627dex32.htm">Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K (File No. 001-36866), filed with the Securities and Exchange Commission on September 18, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929822000086/summittherapeuticsinc-de.htm">Amendment to Restated Certificate of Incorporation of Summit Therapeutics Inc., as filed with the Delaware Secretary of State on July 27, 2022 (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K (File No. 001-36866), filed with the Securities and Exchange Commission on July 29, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929823000012/exhibit51summittherapeut.htm">Amendment No. 2 to Restated Certificate of Incorporation of Summit Therapeutics Inc., dated January 19, 2023 (incorporated by reference to Exhibit 5.1 to the Company's Current Report on Form 8-K (File No. 001-36866), filed with the Securities and Exchange Commission on January 20, 2023</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119312519005734/d683406dex21.htm">Registration Rights Agreement, dated January 9, 2019, by and among Summit Therapeutics plc and Robert W. Duggan (incorporated by reference to Exhibit 2.1 to the Company&#8217;s Report on Form 6-K (File No. 001-36866), filed with the Securities and Exchange Commission on January 10, 2019)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119312520248702/d76627dex42.htm">Form of Consultant Warrant (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K (File No. 001-36866), filed with the Securities and Exchange Commission on September 18, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119312520248702/d76627dex41.htm">Form of Investor Warrant (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K (File No. 001-36866), filed with the Securities and Exchange Commission on September 18, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119312520248702/d76627d8k12b.htm">Description of Securities Registered Under Section 12 of the Exchange Act (incorporated by reference to the description of securities contained in the Company&#8217;s Current Report on Form 8-K12B (File No. 001-36866), filed with the Securities and Exchange Commission on September 18, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000092189520002819/ex103to8k12566007_11052020.htm">Registration Rights Agreement, dated November 6, 2020, by and among Summit Therapeutics Inc., Polar Capital Funds plc - Biotechnology Fund and the Mahkam Zanganeh Revocable Trust (incorporated by reference to Exhibit 10.3 to the Company</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000092189520002819/ex103to8k12566007_11052020.htm">s Current Report on Form 8-K (File No. 001-36866), filed with the Securities and Exchange Commission on November 6, 2020)</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929820000005/sum-ex43_20191231x20f.htm">2005 Enterprise Management Incentive Scheme </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929820000005/sum-ex43_20191231x20f.htm">(incorporated by reference to Exhibit 4.3 to the Company&#8217;s Transition Report on 20-F (File No. 333-36866), as amended, filed with the Securities and Exchange Commission on April 30, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119312516587491/d185299dex422.htm">2016 Long Term Incentive Plan (incorporated by reference to Exhibit 4.22 to the Company&#8217;s Annual Report on Form 20-F (File No. 001-36866), filed with the Securities and Exchange Commission on May 12, 2016)</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119312517104086/d365559dex425.htm">Lease, dated February 17, 2017, by and among MEPC Milton Park No. 1 Limited, MEPC Milton Park No. 2 Limited and Summit Therapeutics plc (incorporated by reference to Exhibit 4.25 to the Company&#8217;s Annual Report on Form 20-F (File No. 001-36866), filed with the Securities and Exchange Commission on March 30, 2017)</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000162828018004229/sum-ex431_20180131x20f.htm">Lease, dated December 22, 2017, by and between Merrifield Centre Ltd and Discuva Limited (incorporated by reference to Exhibit 4.31 to the Company&#8217;s Annual Report on Form 20-F (File No. 001-36866), filed with the Securities and Exchange Commission on April 13, 2018)</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.5#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000162828018004229/sum-ex433_20180131x20f.htm">Form of Non-Executive Director Restricted Stock Unit (RSU) Agreement (incorporated by reference to Exhibit 4.33 to the Company&#8217;s Annual Report on Form 20-F (File No. 001-36866), filed with the Securities and Exchange Commission on April 13, 2018)</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119380520001233/ex101to8k12566001_10052020.htm">Securities Purchase Agreement, dated October 2, 2020, by and between Summit Therapeutics Inc. and Robert W. Duggan (incorporated by reference to Exhibit 10.1 to the Company</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8217;</span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119380520001233/ex101to8k12566001_10052020.htm">s Current Report on Form 8-K (File No. 001-36866) filed with the Securities and Exchange Commission on October 5, 2020)</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.7#*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit107-formofindemni.htm">Form of Indemnification Agreement between Summit Therapeutics Inc. and each of its Executive Officers and Directors</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.8#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119312520248702/d76627dex102.htm">2020 Stock Incentive Plan (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K (File No. 001-36866), filed with the Securities and Exchange Commission on September 18, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.9#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929820000039/smmt-20200929.htm#i5f970bbb3fbc499788e0a3a1c28008bd_2807">Form of Option Award under 2020 Stock Incentive Plan (incorporated by reference to Exhibit 10.28 to the Company</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929820000039/smmt-20200929.htm#i5f970bbb3fbc499788e0a3a1c28008bd_2807">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929820000039/smmt-20200929.htm#i5f970bbb3fbc499788e0a3a1c28008bd_2807">s Current Report on Form 8-K (File No. 001-36866), filed with the Securities and Exchange Commission on September 29, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.10#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929820000039/smmt-20200929.htm#i5f970bbb3fbc499788e0a3a1c28008bd_2812">Form of Restricted Stock Unit Agreement under 2020 Stock Incentive Plan (incorporated by reference to Exhibit 10.29 to the Company</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929820000039/smmt-20200929.htm#i5f970bbb3fbc499788e0a3a1c28008bd_2812">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929820000039/smmt-20200929.htm#i5f970bbb3fbc499788e0a3a1c28008bd_2812">s Current Report on Form 8-K (File No. 001-36866), filed with the Securities and Exchange Commission on September 29, 2020)</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.814%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit&#160;No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.11#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119312520248702/d76627dex103.htm">2020 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K (File No. 001-36866), filed with the Securities and Exchange Commission on September 18, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001599298/000159929821000011/sum-ex1036_20201231x10k.htm">Sublease Agreement, dated March 26, 2021, by and between Maky Zanganeh &amp; Associates Inc. and Summit Therapeutics Sub Inc. (incorporated by reference to Exhibit 10.36 to the Company</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001599298/000159929821000011/sum-ex1036_20201231x10k.htm">s Annual Report on Form 10-K (File No. 001-36866), filed with the Securities and Exchange Commission on March 31, 2021)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001599298/000159929822000022/summit-notepurchaseagreeme.htm">Note Purchase Agreement, dated March 10, 2022, by and between Summit Therapeutics Inc. and Robert W. Duggan (incorporated by reference to Exhibit 10.1 to the Company</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">&#8217;</span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001599298/000159929822000022/summit-notepurchaseagreeme.htm">s Current Report on Form 8-K (File. No. 001-36866), filed with the Securities and Exchange Commission on March 11, 2022)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001599298/000159929822000022/summit-promissorynote4867x.htm">Promissory Note, dated March 10, 2022, in the name of Robert W. Duggan (incorporated by reference to Exhibit 10.2 to the Company</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">&#8217;</span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001599298/000159929822000022/summit-promissorynote4867x.htm">s Current Report on Form 8-K (File. No. 001-36866), filed with the Securities and Exchange Commission on March 11, 2022)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929822000136/notepurchaseagreementpre.htm">Note Purchase Agreement, dated December 6, 2022, by and among Summit Therapeutics Inc., Robert W. Duggan, and Dr. Mahkam Zanganeh (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 001-36866), filed with the Securities and Exchange Commission on December 6, 2022)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.16&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000138713122012619/ex-10_1.htm">Collaboration and License Agreement, dated December 5, 2022, by and between Akeso, Inc. and its affiliates and Summit Therapeutics Sub Inc. (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Form S-3 (File No. 333-268932) filed with the Securities and Exchange Commission on December 21, 2022)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929823000012/exhibit101amendment1toak.htm">Amendment No. 1 to Collaboration and License Agreement Amendment, dated January 16, 2023, by and among Summit Therapeutics Inc. and Akeso, Inc. (incorporated by reference to Exhibit 10.1 of Form 8-K filed by the Company on January 20, 2023, File No. 001-36866)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929823000012/redactedakeso-summitcomm.htm">Common Stock Issuance Agreement, dated January 17, 2023, by and among Summit Therapeutics Inc. and Akeso, Inc. (incorporated by reference to Exhibit 10.2 of Form 8-K filed by the Company on January 20, 2023, File No. 001-36866)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929823000012/exhibit103promissorynote.htm">Promissory Notes, dated January 19, 2023, by and among Summit Therapeutics Inc. and Robert W. Duggan (incorporated by reference to Exhibit 10.3 of Form 8-K filed by the Company on January 20, 2023, File No. 001-36866)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.20#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929823000034/amendedandrestated2020st.htm">Amended and Restated 2020 Stock Incentive Plan, dated July 27, 2022 (incorporated by reference to Exhibit 10.45 to the Company's Annual Report on Form 10-K (File No. 001-36866), filed with the Securities and Exchange Commission on March 9, 2023)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.21&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929823000034/amd1tosublease.htm">First Amendment to Sublease Agreement, dated July 25, 2022, by and among Summit Therapeutics Inc. and Maky Zanganeh and Associates, Inc. (incorporated by reference to Exhibit 10.45 to the Company's Annual Report on Form 10-K (File No. 001-36866), filed with the Securities and Exchange Commission on March 9, 2023)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.22&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929823000034/amd2tosublease.htm">Second Amendment to Sublease Agreement, dated July 29, 2022, by and among Summit Therapeutics Inc. and Maky Zanganeh and Associates, Inc. (incorporated by reference to Exhibit 10.45 to the Company's Annual Report on Form 10-K (File No. 001-36866), filed with the Securities and Exchange Commission on March 9, 2023)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.23#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929824000085/sum-ex101xamendedemploymen.htm">A</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929824000085/sum-ex101xamendedemploymen.htm">mended Employment Agreement, dated October 31, 2023 by and between Summit Therapeutics Inc. and Mahkam Zanganeh. (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q (File No. 001-36866), filed with the Securities and Exchange Commission on May 1, 2024)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.24#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929823000098/sum-ex101xmsoniemploymenta.htm">Employment Agreement, dated October 13, 2023, by and between Summit Therapeutics Inc. and Manmeet Soni (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q (File No. 001-36866), filed with the Securities and Exchange Commission on November 7, 2023)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929823000098/sum-ex102xsharepurchaseagr.htm">Securities Purchase Agreement, dated October 13, 2023, by and between Summit Therapeutics Inc. and Manmeet Soni (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q (File No. 001-36866), filed with the Securities and Exchange Commission on November 7, 2023)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.26</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929824000031/exhibit1051loanagreement.htm">Amended and Restated Promissory Note, dated February 17, 2024, by and between Summit Therapeutics Inc. and Robert W. Duggan (incorporated by reference to Exhibit 10.51 to the Company's Annual Report on Form 10-K (File No. 001-36866), filed with the Securities and Exchange Commission on February 20, 2024).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929824000085/sum-ex102leasexsummitthera.htm">Lease Agreement, dated January 8, 2024 by and between Brickell Key Center, LLC and Summit Therapeutics, Inc (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q (File No. 001-36866), filed with the Securities and Exchange Commission on May 1, 2024) </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.28</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929824000089/summitatm-distributionag.htm">Distribution Agreement, dated May 13, 2024, by and between Summit Therapeutics Inc. and J.P. Morgan Securities LLC (incorporated by reference to Exhibit 1.1 to the Company&#8217;s Current Report on Form 8-K (File No. 001-36866), filed with the Securities and Exchange Commission on May 13, 2024)</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.814%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit&#160;No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.29+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119312524152309/d768276dex101.htm">Securities Purchase Agreement, dated June 3, 2024, by and among the Company and the Investors named therein (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 001-36866), filed with the Securities and Exchange Commission on June 3, 2024)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.30+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119312524152309/d768276dex102.htm">Registration Rights Agreement, dated June 3, 2024, by and among the Company and the Investors named therein (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K (File No. 001-36866), filed with the Securities and Exchange Commission on June 3, 2024)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.31&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929824000117/summit-akesoxamendment2t.htm">Amendment No. 2 to Collaboration and License Agreement Amendment, dated June 3, 2024, by and among Summit Therapeutics Sub, Inc. and Akeso, Inc. and its affiliates (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Quarterly Report on Form 10-Q (File No. 001-36866), filed with the Securities and Exchange Commission on August 6, 2024.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.32&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929824000117/a2024-06x24subleasexdugg.htm">Sublease, dated June 27, 2024, by and between Summit Therapeutics Inc. and Duggan Investments Research LLC (incorporated by reference to Exhibit 10.5 of the Company&#8217;s Quarterly Report on Form 10-Q (File No. 001-36866), filed with the Securities and Exchange Commission on August 6, 2024)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.33&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929824000117/a2024-06x24subleasexgeni.htm">Sublease, dated June 27, 2024, by and between Summit Therapeutics Inc. and Genius 24C Inc. (incorporated by reference to Exhibit 10.6 of the Company&#8217;s Quarterly Report on 10-Q (File No. 001-36866), filed with the Securities and Exchange Commission on August 6, 2024)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.34&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929824000117/amd3tosublease-for10xqwi.htm">Third Amendment to Sublease, dated August 2, 2024, by and between Summit Therapeutics Sub, Inc. and Zanganeh &amp; Associates Inc. (incorporated by reference to Exhibit 10.7 of the Company&#8217;s Quarterly Report on 10-Q (File No. 001-36866), filed with the Securities and Exchange Commission on August 6, 2024)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.35+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119312524217618/d799002dex101.htm">Securities Purchase Agreement, dated September 11, 2024, by and among Summit Therapeutics Inc. and the Investors named therein (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed (File No. 001-36866), filed with the Securities and Exchange Commission on September 12, 2024)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.36+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119312524217618/d799002dex102.htm">Registration Rights Agreement, dated September 11, 2024, by and among Summit Therapeutics Inc. and the Investors named therein (incorporated by reference to Exhibit 10.2 of the Company&#8217;s Current Report on Form 8-K filed (File No. 001-36866), filed with the Securities and Exchange Commission on September 12, 2024)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.37&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929825000126/paloaltosub-sublease.htm">Sub-Sublease Agreement, dated June 2, 2025, by and between Summit Therapeutics Inc. and Ascendis Pharma, Inc. (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Quarterly Report on Form 10-Q filed (File No. 001-36866), filed with the Securities and Exchange Commission on August 11, 2025)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119312525178022/d56029dex12.htm">Amendment to Distribution Agreement, dated August 11, 2025, by and between Summit Therapeutics Inc. and J.P. Morgan Securities LLC (incorporated by reference to Exhibit 1.2 of the Company&#8217;s Current Report on Form 8-K filed (File No. 001-36866), filed with the Securities and Exchange Commission on August 11, 2025)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.39+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119312525245790/d274712dex101.htm">Form of Securities Purchase Agreement by and between Summit Therapeutics Inc. and certain Investors (incorporated by reference to Exhibit 1.1 of the Company&#8217;s Current Report on Form 8-K filed (File No. 001-36866), filed with the Securities and Exchange Commission on October 22, 2025)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.40+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000119312525245790/d274712dex102.htm">Form of Registration Rights Agreement and between Summit Therapeutics Inc. and certain Investors (incorporated by reference to Exhibit 1.2 of the Company&#8217;s Current Report on Form 8-K filed (File No. 001-36866), filed with the Securities and Exchange Commission on October 22, 2025)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14.1*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="ethicsemployeepolicybook.htm">Code of Business Conduct and Ethics of Summit Therapeutics Inc</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-55">19.1</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929825000048/sum-ex191_20241231xinsid.htm">Insider Trading Policy</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21.1*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sum-ex211_20251231xxsubsid.htm">List of Significant Subsidiaries</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23.1*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sum-ex231_20251231xxuscons.htm">Consent of PricewaterhouseCoopers LLP, an independent registered public accounting firm</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sum-ex311_20251231xduggan.htm">Certification of Chief Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to &#167;302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sum-ex312_20251231xzanganeh.htm">Certification of Co-Chief Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to &#167;302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31.3*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sum-ex313_20251231x10ksoni.htm">Certification of Chief Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to &#167;302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sum-ex321_20251231xx404906.htm">Certification pursuant to 18 U.S.C. &#167;1350, as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">97.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1599298/000159929824000031/ex971summitclawbackpolicy.htm">Summit Therapeutics, Inc. Incentive-based Compensation Clawback Policy (incorporated by reference to Exhibit 97.1 to the Company's Annual Report on Form 10-K (File No. 001-36866), filed with the Securities and Exchange Commission on February 20, 2024)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.814%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit&#160;No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">**</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Portions of this exhibit have been omitted in compliance with Regulation S-K Item 601(b)(10)(iv) because the Registrant has determined that the information is not material and is the type that the Registrant treats as private or confidential. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Company agrees to furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon its request. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">The schedules and exhibits have been omitted. A copy of any omitted schedule or exhibit will be furnished to the SEC upon request. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Indicates management contract or compensatory plan or arrangement.</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_91"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 16. Report Summary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_94"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">SIGNATURES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:right;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.497%"><tr><td style="width:1.0%"/><td style="width:18.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.793%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">SUMMIT THERAPEUTICS INC.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Robert W. Duggan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name:<br/>Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Robert W. Duggan</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer and Executive Chairman (Principal Executive Officer)</span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mahkam Zanganeh</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name:<br/>Title:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Mahkam Zanganeh</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer, President and Director</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Manmeet S. Soni</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name:<br/>Title:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Manmeet S. Soni</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Officer, Chief Financial Officer and Director (Principal Financial Officer)</span></div></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date: February&#160;23, 2026</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:23.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:55.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.493%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Title</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Robert W. Duggan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer and Executive Chairman (</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Executive Officer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Robert W. Duggan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mahkam Zanganeh</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer, President and Director</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Executive Officer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Mahkam Zanganeh</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Manmeet S. Soni</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Officer, Chief Financial Officer and Director</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Manmeet S. Soni</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Bhaskar Anand</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Head of Finance and Chief Accounting Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Bhaskar Anand</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Robert F. Booth</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Robert F. Booth</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Alessandra Cesano</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Alessandra Cesano</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kenneth Clark</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Kenneth Clark</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jeff Huber</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Jeff Huber</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mostafa Ronaghi</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mostafa Ronaghi</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Yu Xia</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Yu Xia</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:90.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span id="i41c8a90424914cbe810928f0de0d7cad_0-0-1-1-327646"></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">SUMMIT THERAPEUTICS INC.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_103">Report of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> (PCAOB ID: <ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-56">238</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_103">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_109">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_109">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_112">Consolidated Statements of Operations and Comprehensive Loss</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_112">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_115">Consolidated Statements of Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_115">97</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_118">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_118">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_121">Notes to </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_121">Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idefbe961c00a4bd4a140a4270c7a5ec4_121">99</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">To the</span><span style="color:#ff0000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Board of Directors and Stockholders of Summit Therapeutics Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of Summit Therapeutics Inc. and its subsidiaries (the "Company") as of December 31, 2025 and 2024, and the related consolidated statements of operations and comprehensive loss, of stockholders&#8217; equity and of cash flows for each of the three years in the period ended December 31, 2025, including the related notes (collectively referred to as the "consolidated financial statements"). We also have audited the Company's internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2025 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis for Opinions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management&#8217;s Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company&#8217;s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Emphasis of Matter</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As discussed in Note 1 to the consolidated financial statements, the Company has incurred net losses from operations and cash outflows from operating activities. Management&#8217;s evaluation of the events and conditions and management&#8217;s plans to mitigate these matters are also described in Note 1.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Critical Audit Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">External Research and Development Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s research and development expense for the year ended December 31, 2025 was $537.7 million, of which a portion relates to external research and development costs. As described in Note 2 to the consolidated financial statements, research and development costs are expensed as incurred.  Research and development expenses consist of costs incurred to discover, research and develop product candidates, including third-party license fees and external costs of outside vendors engaged to conduct preclinical and clinical development activities and clinical trials as well as to manufacture clinical trial materials. Management has entered into various research and development contracts with other companies. These agreements are generally cancellable, and related payments are recorded as research and development expenses as incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">The principal consideration for our determination that performing procedures relating to external research and development costs is a critical audit matter is a high degree of auditor effort in performing procedures related to the Company&#8217;s external research and development costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls related to the research and development costs process. These procedures also included, among others, testing external research and development costs on a sample basis by (i) evaluating costs incurred to underlying agreements with outside vendors, invoices received, and underlying payments made for costs incurred on the contract; and (ii) evaluating the classification as research and development costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">/s/ <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-57">PricewaterhouseCoopers LLP</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-58">San Jose, California</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">February&#160;23, 2026</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have served as the Company&#8217;s auditor since 2021. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_109"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.447%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-59">225,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-60">104,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="f-61">316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="f-62">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-63">488,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-64">307,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-65">6,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-66">11,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-67">720,301</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-68">423,750</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-69">1,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-70">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-71">20,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-72">7,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-73">2,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-74">1,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-75">7,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-76">2,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-77">751,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-78">435,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-79">20,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-80">4,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-81">32,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-82">19,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-83">14,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-84">11,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-85">3,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-86">3,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-87">2,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-88">1,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-89">72,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-90">41,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-91">17,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-92">3,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-93">1,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-94">1,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-95">92,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-96">46,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 16)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-97"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-6" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-98"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-99"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-100">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-101"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-102">20,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-103"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-104"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-105"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-106">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at December 31, 2025 and 2024, respectively</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-108">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-109"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-110">0.01</ix:nonFraction></ix:nonFraction> par value: <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-111"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-112">1,000,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-113"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-114">775,371,200</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-115"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-116">737,626,004</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2025 and 2024, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="f-117">7,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="f-118">7,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-119">2,947,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-120">1,598,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-121">2,540</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-122">2,285</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-123">2,294,159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-124">1,214,573</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-125">658,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-126">388,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders' equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-127">751,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-128">435,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_112"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations and Comprehensive Loss </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.500%"><tr><td style="width:1.0%"/><td style="width:54.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.369%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.369%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.369%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.005%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="f-129">537,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="f-130">150,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="f-131">59,471</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="smmt:AcquiredInProcessResearchAndDevelopmentExpense" format="ixt:fixed-zero" scale="3" id="f-132">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="smmt:AcquiredInProcessResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-133">15,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="smmt:AcquiredInProcessResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-134">520,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-135">556,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-136">60,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-137">29,264</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-138">1,094,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-139">225,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-140">609,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-141">14,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-142">13,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-143">11,183</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:fixed-zero" scale="3" id="f-144">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-145">8,686</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-146">16,461</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-147">1,079,586</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-148">221,315</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-149">614,928</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-150"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-151">1.44</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-152"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-153">0.31</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-154"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-155">0.99</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-156"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-157">747,702,265</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-158"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-159">718,541,896</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-160"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-161">619,646,180</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign currency translation adjustments </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="f-162">327</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="f-163">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="f-164">172</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of unrealized loss on short-term investments to other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax" format="ixt:fixed-zero" scale="3" id="f-165">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax" scale="3" id="f-166">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax" format="ixt:fixed-zero" scale="3" id="f-167">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of cumulative currency translation gain to other income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" format="ixt:fixed-zero" scale="3" id="f-168">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" format="ixt:fixed-zero" scale="3" id="f-169">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="3" id="f-170">419</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain on short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="3" id="f-171">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="3" id="f-172">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="3" id="f-173">36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-174">1,079,841</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-175">221,152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-176">615,483</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">(1)</span><ix:footnote id="fn-1" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.92pt">Refer to Note 15 &#8211; Related Party Transactions for expenses incurred.</span></ix:footnote></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_115"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Stockholders&#8217; Equity </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share data)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.926%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.952%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.497%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.529%"/><td style="width:0.1%"/></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-177">211,091,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-178">2,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-179">504,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-180">1,893</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-181">378,330</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-182">126,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2023 Rights Offering of common stock, net of offering costs of $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-183">619</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-184">476,190,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-185">4,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-186">494,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-187">499,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock purchase plans and exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-188">596,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-189">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-190">922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-191">929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock in lieu of cash for Akeso upfront payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="smmt:StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest" format="ixt:num-dot-decimal" scale="0" id="f-192">10,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="smmt:StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest" scale="3" id="f-193">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="smmt:StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest" format="ixt:num-dot-decimal" scale="3" id="f-194">45,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="smmt:StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest" format="ixt:num-dot-decimal" scale="3" id="f-195">45,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Private placement of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-196">2,976,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-197">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-198">4,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-199">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of warrants </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="smmt:StockIssuedDuringPeriodSharesWarrantsExercised" format="ixt:num-dot-decimal" scale="0" id="f-200">805,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="smmt:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="f-201">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="smmt:StockIssuedDuringPeriodValueWarrantsExercised" format="ixt:num-dot-decimal" scale="3" id="f-202">1,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="smmt:StockIssuedDuringPeriodValueWarrantsExercised" format="ixt:num-dot-decimal" scale="3" id="f-203">1,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-204">14,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-205">14,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-206">555</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-207">555</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-208">614,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-209">614,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-24" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-210">701,660,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-211">7,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-212">1,066,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-213">2,448</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-214">993,258</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-215">77,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Private placement of common stock, net of offering costs of $<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-216">140</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-30" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-217">32,574,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-218">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-219">434,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-220">434,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under stock purchase plans and exercise of stock options and warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-32" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-221">1,584,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-222">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-223">3,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-224">3,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from at-the-market offering, net of commissions and offering costs of $<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-225">1,190</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-35" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-226">1,807,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-227">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-228">43,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-229">43,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-230">50,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-231">50,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-232">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-233">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-234">221,315</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-235">221,315</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-236">737,626,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-237">7,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-238">1,598,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-239">2,285</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-240">1,214,573</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-241">388,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Private placement of common stock </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-43" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-242">26,682,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-243">267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-244">499,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-245">500,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under stock purchase plans and exercise of stock options and warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-46" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-246">5,723,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-247">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-248">12,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-249">12,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from at-the-market offering, net of commissions and offering costs of $<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-250">1,969</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-49" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-251">5,339,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-252">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-253">104,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-254">104,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-255">732,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-256">732,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-257">255</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-258">255</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-259">1,079,586</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-260">1,079,586</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-53" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-261">775,371,200</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-262">7,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-263">2,947,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-264">2,540</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-265">2,294,159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-266">658,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">(2)</span><ix:footnote id="fn-2" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.92pt">Refer to Note 13 &#8211; Stockholders&#8217; Equity for related party transactions.</span></ix:footnote></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%"> Summit Therapeutics Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.820%"><tr><td style="width:1.0%"/><td style="width:61.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.022%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash flows used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-267">1,079,586</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-268">221,315</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-269">614,928</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="smmt:InterestExpenseIncomeNoncash" format="ixt:fixed-zero" scale="3" id="f-270">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="smmt:InterestExpenseIncomeNoncash" format="ixt:fixed-zero" scale="3" id="f-271">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="smmt:InterestExpenseIncomeNoncash" format="ixt:num-dot-decimal" scale="3" id="f-272">6,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Amortization of discount on short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="f-273">7,006</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="f-274">2,576</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="f-275">1,924</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Unrealized foreign exchange loss (gain)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="f-276">320</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="f-277">229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="f-278">812</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Reclassification of currency translation gain   </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome" format="ixt:fixed-zero" scale="3" id="f-279">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome" format="ixt:fixed-zero" scale="3" id="f-280">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome" scale="3" id="f-281">419</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Impairment of fixed assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:fixed-zero" scale="3" id="f-282">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:fixed-zero" scale="3" id="f-283">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:TangibleAssetImpairmentCharges" scale="3" id="f-284">474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-285">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-286">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-287">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-288">732,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-289">50,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-290">14,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Loss on disposal of assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets1" format="ixt:fixed-zero" scale="3" id="f-291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets1" format="ixt:fixed-zero" scale="3" id="f-292">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="f-293">109</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Acquired in-process research and development expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="smmt:AcquiredInProcessResearchAndDevelopmentExpense" format="ixt:fixed-zero" scale="3" id="f-294">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="smmt:AcquiredInProcessResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-295">15,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="smmt:AcquiredInProcessResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-296">520,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-297">4,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-298">7,370</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-299">3,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="f-300">4,875</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="f-301">2,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="f-302">3,421</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-303">15,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-304">2,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-305">2,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Accrued liabilities and other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-306">12,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-307">11,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-308">2,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Accrued compensation </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-309">2,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-310">6,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="f-311">235</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="f-312">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="f-313">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:fixed-zero" scale="3" id="f-314">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets and lease liabilities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="smmt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet" scale="3" id="f-315">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="smmt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet" scale="3" id="f-316">167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="smmt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet" scale="3" id="f-317">359</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-318">322,930</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-319">142,106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-320">76,760</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash flows used in investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Maturities and sales of short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-321">311,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-322">489,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-323">208,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Purchase of short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-324">484,993</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-325">680,032</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-326">321,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-327">657</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-328">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-329">128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Proceeds from sale of property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-330">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-331">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="f-332">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Payments to Akeso for upfront milestone payments and associated direct transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="smmt:PaymentsForCollaborativeArrangement" format="ixt:fixed-zero" scale="3" id="f-333">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="smmt:PaymentsForCollaborativeArrangement" format="ixt:num-dot-decimal" scale="3" id="f-334">15,007</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="smmt:PaymentsForCollaborativeArrangement" format="ixt:num-dot-decimal" scale="3" id="f-335">475,015</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-336">174,310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-337">205,341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-338">587,774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash flows provided by financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Proceeds from the issuance of common stock via private placements, net of offering costs </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.52pt;font-weight:400;line-height:100%;position:relative;top:-2.97pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:num-dot-decimal" scale="3" id="f-339">500,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:num-dot-decimal" scale="3" id="f-340">434,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:num-dot-decimal" scale="3" id="f-341">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Proceeds from the issuance of common stock under at-the-market offering, net of commissions and offering costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-342">104,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-343">43,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-344">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Proceeds from exercise of warrants </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.52pt;font-weight:400;line-height:100%;position:relative;top:-2.97pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="f-345">7,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" scale="3" id="f-346">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="f-347">1,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Proceeds received related to employee stock purchase plan and exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="f-348">5,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="f-349">2,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="f-350">929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Proceeds from the issuance of common stock for rights offering </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.52pt;font-weight:400;line-height:100%;position:relative;top:-2.97pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-352">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-353">104,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Transaction costs from the issuance of common stock for rights offering</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-354">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-355">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-356">619</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Re-payment of related party promissory notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfRelatedPartyDebt" format="ixt:fixed-zero" scale="3" id="f-357">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RepaymentsOfRelatedPartyDebt" format="ixt:num-dot-decimal" scale="3" id="f-358">100,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:RepaymentsOfRelatedPartyDebt" format="ixt:num-dot-decimal" scale="3" id="f-359">24,686</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-360">617,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-361">381,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-362">86,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Effect of exchange rates on cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="f-363">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="f-364">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="f-365">839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-366">120,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-367">33,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-368">577,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-369">105,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-370">71,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-371">648,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-372">225,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-373">105,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-374">71,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:700;line-height:100%">Supplemental Disclosure of Cash Flow Information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash paid for interest on related party promissory note</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:fixed-zero" scale="3" id="f-375">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-376">8,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-377">10,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:fixed-zero" scale="3" id="f-378">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:fixed-zero" scale="3" id="f-379">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="f-380">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:700;line-height:100%">Supplemental Disclosure of Non-Cash Investing and Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-381">17,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-382">4,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-383">4,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Unpaid amounts related to purchase of property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="f-384">291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:fixed-zero" scale="3" id="f-385">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:fixed-zero" scale="3" id="f-386">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Consideration for the issuance of common stock for rights offering used to satisfy a portion of a related party promissory note (Note 12)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:StockIssued1" format="ixt:fixed-zero" scale="3" id="f-387">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockIssued1" format="ixt:fixed-zero" scale="3" id="f-388">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockIssued1" format="ixt:num-dot-decimal" scale="3" id="f-389">395,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">Issuance of common stock pursuant to the Akeso License Agreement (Note 4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:StockIssued1" format="ixt:fixed-zero" scale="3" id="f-390">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:StockIssued1" format="ixt:fixed-zero" scale="3" id="f-391">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:StockIssued1" format="ixt:num-dot-decimal" scale="3" id="f-392">45,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:footnote id="fn-3" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:120%">Refer to Note 13 &#8211; Stockholders&#8217; Equity for related party transactions.</span></ix:footnote></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div style="height:37.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_121"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_124"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-393" continuedAt="f-393-1" escape="true">Organization</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-393-1" continuedAt="f-393-2"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Summit Therapeutics Inc. (&#8220;we&#8221;, &#8220;Summit&#8221; or the &#8220;Company&#8221;) is a biopharmaceutical company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The Company&#8217;s pipeline of product candidates is designed with the goal to become the patient-friendly, new-era standard-of-care medicines, in the therapeutic area of oncology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s current lead development candidate is ivonescimab, a novel, potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. On December 5, 2022, the Company entered into the License Agreement with Akeso, Inc. and its affiliates (collectively, &#8220;Akeso&#8221;) pursuant to which the Company has in-licensed intellectual property rights related to ivonescimab (as amended, the &#8220;License Agreement&#8221;), as further described in Note 4. Through the License Agreement, the Company obtained the rights to develop and commercialize ivonescimab in the United States, Canada, Europe, and Japan. The License Agreement and transaction closed in January 2023 following customary waiting periods. On June 3, 2024, the Company entered into an amendment to the License Agreement (the  &#8220;Second Amendment&#8221;) with Akeso to expand its territories covered under the License Agreement to also include Latin America, including Mexico and all countries in Central America and South America, the Middle East and Africa (collectively, and as expanded, the &#8220;Licensed Territory&#8220;) . The Company&#8217;s operations are focused on the development of ivonescimab and other future activities, as the Company determines.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-394" continuedAt="f-394-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Basis of Presentation </span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-394-1">The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Any reference in these notes to applicable guidance is meant to refer to authoritative U.S. GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and as amended by Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</ix:continuation> <ix:nonNumeric contextRef="c-1" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="f-395" escape="true">Certain reclassifications have been made to the prior years&#8217; financial statements to conform to current year presentation.</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-396" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of income and expenses during the reporting period. On an on-going basis, management evaluates its estimates and judgments, including those related to accrued research and development expenses, stock-based compensation, and income taxes. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2025, the Company incurred a net loss of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-397">1,079,586</ix:nonFraction> and cash used in operating activities was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-398">322,930</ix:nonFraction>. As of December 31, 2025, the Company had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-399">2,294,159</ix:nonFraction>, and cash and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-400">225,266</ix:nonFraction> and short-term investments of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-401">488,182</ix:nonFraction>. The Company expects to continue to generate operating losses for the foreseeable future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December 31, 2025, the Company raised gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-402">500,037</ix:nonFraction> from a private placement and $<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-403">106,498</ix:nonFraction> from the Company&#8217;s at-the-market sales agreement, both described further in Note 13. With these recent financings, the Company has evaluated and concluded that its cash, cash equivalents and short-term investments provide sufficient cash to fund its operating cash needs for at least the next 12 months from the date of issuance of these consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Until the Company can generate substantial revenue and achieve profitability, the Company will need to raise additional capital to fund its ongoing operations and capital needs. The Company continues to evaluate options to further finance its operating </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><ix:continuation id="f-393-2"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">cash needs for its product candidates through a combination of some, or all, of the following: equity and debt offerings, collaborations, strategic alliances, grants and clinical trial support from government entities, philanthropic, non-government and not-for-profit organizations, and marketing, distribution or licensing arrangements. There is no assurance, however, that additional financing will be available when needed or that management of the Company will be able to obtain financing on terms acceptable to the Company. If the Company is unable to obtain funding when required in the future, the Company could be required to delay, reduce, or eliminate research and development programs, product portfolio expansion, or future commercialization efforts, which could adversely affect its business prospects.</span></div></ix:continuation><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_136"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-404" continuedAt="f-404-1" escape="true">Summary of Significant Accounting Policies and Recent Accounting Pronouncements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-404-1" continuedAt="f-404-2"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The significant accounting policies adopted by the Company in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-405" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. GAAP and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. The consolidated financial statements reflect the accounts of Summit Therapeutics Inc. and its wholly owned subsidiaries. Intercompany balances and transactions are eliminated in consolidation.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-406" continuedAt="f-406-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div></ix:nonNumeric><div><span><br/></span></div><div><ix:continuation id="f-406-1" continuedAt="f-406-2"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company&#8217;s subsidiaries with functional currencies other than the U.S. dollar are translated into U.S. dollars using period-end exchange rates for assets and liabilities, historical exchange rates for stockholders&#8217; equity and weighted average exchange rates for operating results. Translation gains and losses are included in accumulated other comprehensive (loss) income in stockholders&#8217; equity. Foreign currency transaction gains and losses are included in other income</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-406-2">, net in the consolidated statements of operations and comprehensive loss.</ix:continuation> The Company recorded realized and unrealized foreign currency transaction (loss) gain of ($<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="f-407">610</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="f-408">97</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="f-409">613</ix:nonFraction> for the years ended December 31, 2025, 2024 and 2023, respectively, which is included in other income, net in the consolidated statements of operations and comprehensive loss.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-410" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the diluted net loss by the weighted-average number of common shares outstanding for the period, including potentially dilutive common shares. The dilutive effect of share options and warrants are determined under the treasury stock method using the average market price for the period.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the assumed proceeds under the treasury stock method include the average unrecognized compensation expense of stock options and warrants that are in-the-money.</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="f-411" continuedAt="f-411-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the consideration transferred over the fair value of net assets acquired. Goodwill is assigned to reporting units at the time of acquisition or when there is a change in the reporting structure and bases that allocation on which reporting units will benefit from the acquired assets and liabilities. Reporting units are defined as operating segments or one level below an operating segment, referred to as a component. Typically acquisitions related to a single reporting unit do not require the allocation of goodwill to multiple reporting units. If the net assets obtained in an acquisition are assigned to multiple reporting units, the goodwill is distributed to the respective reporting units as part of the purchase price allocation process.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill for impairment on an annual basis as of December 31 or more frequently when events and circumstances occur indicating that the recorded goodwill may be impaired. The Company regularly monitors current business conditions and other factors including, but not limited to, adverse industry or economic trends and lower projections of </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><ix:continuation id="f-404-2" continuedAt="f-404-3"><ix:continuation id="f-411-1"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">profitability that may impact future operating results. The process of evaluating the potential impairment of goodwill requires significant judgment. In performing the Company&#8217;s annual goodwill impairment test, the Company is permitted to first assess qualitative factors to determine whether it is more likely than not that the fair value of the Company&#8217;s reporting unit is less than its carrying amount, including goodwill. In performing the qualitative assessment, the Company considers certain events and circumstances specific to the reporting unit and to the entity as a whole, such as macroeconomic conditions, industry and market considerations, overall financial performance and cost factors when evaluating whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. The Company is also permitted to bypass the qualitative assessment and proceed directly to the quantitative test. If the Company chooses to undertake the qualitative assessment and concludes that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, the Company would then proceed to the quantitative impairment test. In the quantitative assessment, the Company compares the fair value of the reporting unit to its carrying amount, which includes goodwill. If the fair value exceeds the carrying value, no impairment loss exists. If the fair value is less than the carrying amount, a goodwill impairment loss is measured and recorded.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-412" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for real estate. The Company does not have any finance leases. A contract is or contains a lease when the lessee has the right to control the use of an identified asset. The Company determines if an arrangement is a lease at inception of the contract, which is the date on which the terms of the contract are agreed to and the agreement creates enforceable rights and obligations. The lease term used to calculate the lease liability include options to extend or terminate the lease when it is reasonably certain that the option will be exercised.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">At the lease commencement date, the Company measures and recognizes a lease liability and a right-of-use asset in the financial statements. Lease liabilities are recognized based on the present value of the future lease payments over the lease term at commencement date. The right-of use asset is measured by taking the present value of future lease payments, plus any incremental direct costs incurred, less any lease incentives received. As most of the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">s leases do not provide an implicit rate, the Company uses an estimated incremental borrowing rate based on the lease term and the economic environment of the lease at the lease commencement date, which is then utilized to determine the present value of future lease payments. Lease expense for minimum lease payments are recognized on a straight-line basis over the lease term, with variable lease payments recognized in the periods in which they are incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has existing lease agreements with lease and non-lease components, has elected to account for the lease and non-lease components as a single lease component, and has allocated all of the contract consideration to the lease component only. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Leases with an initial lease term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for its short-term leases on a straight-line basis over the lease term.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="smmt:InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock" id="f-413" continuedAt="f-413-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Acquired In-Process Research and Development</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company may enter into agreements with collaboration partners for the development and commercialization of its products. These arrangements may include payments contingent on the occurrence of certain events such as development, regulatory or sales-based milestones. The Company considers the unique nature, terms and facts and circumstances of each transaction. The Company considers whether or not the assets acquired have an alternative future use. </span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-413-1">The fair value associated with acquired in-process research and development which does not have an alternative future use is expensed and is recorded as research and development expense. Any development or commercial milestone payments are recognized when the achievement of the associated milestone becomes probable and will either be expensed or capitalized depending upon whether or not regulatory approval has been obtained.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="f-414" continuedAt="f-414-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred to discover, research and develop product candidates, including personnel expenses, stock-based compensation expense, allocated facility-related and depreciation expenses, third-party license fees and external costs of outside vendors engaged to conduct preclinical and clinical development activities and clinical trials as well as to manufacture clinical trial materials. Non-</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><ix:continuation id="f-404-3" continuedAt="f-404-4"><ix:continuation id="f-414-1"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">refundable prepayments for goods or services that will be used or rendered for future research and development activities are recorded as prepaid expenses. Such amounts are recognized as an expense as the goods are delivered or the related services are performed, or until it is no longer expected that the goods will be delivered, or the services rendered. Milestone and other payments made to third-parties with respect to in-process research and development, in accordance with the Company&#8217;s license, acquisition and other similar agreements are expensed when determined to be probable and estimable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has entered into various research and development contracts with other companies. These agreements are generally cancellable, and related payments are recorded as research and development expenses as incurred. The Company records accruals for estimated ongoing research and development costs or prepaid expenses where the payments made exceed the estimated costs. These amounts are determined based on the estimated costs to complete each study or activity, the estimation of the current stage of completion and the invoices received, as well as predetermined milestones which are not reflective of the current stage of development for prepaid expenses. Actual results could differ from the Company&#8217;s estimates. In all cases, the full cost of each study or activity is expensed by the time the final report or where applicable, product, has been received. The Company&#8217;s historical estimates have not been materially different from the actual costs.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-415" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all stock option awards based on the estimated fair value of the award on the grant date. The Company uses the Black-Scholes option pricing model to estimate the fair value of stock option awards. Additionally, the Company uses a Monte Carlo simulation model to calculate the estimated fair value on the date of grant related to awards with market-based service conditions. The fair value is recognized as expense, over the requisite service period, which is generally the vesting period of the respective award, on a straight-line basis for each separately vesting portion of the award when the only condition to vesting is continued service. If vesting is subject to a market or performance condition, recognition is based on the derived service period of the award. Expense for awards with performance conditions is estimated and adjusted on a quarterly basis based upon the assessment of the probability that the performance condition will be met. Use of the Black-Scholes option-pricing model requires management to apply judgment under subjective assumptions. These assumptions include:</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected term&#8212;The expected term of stock options represents the weighted-average period the stock options are expected to be outstanding. The Company uses the simplified method for estimating the expected term as provided by the SEC. The simplified method calculates the expected term as the average of the time-to-vesting and the contractual life of the options.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected volatility&#8212;The expected volatility is calculated based on historical volatility of the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">s share price.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk-free interest rate&#8212;The risk-free rate assumption is based on the U.S. Treasury instruments, the terms of which were consistent with the expected term of the Company&#8217;s stock options.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected dividend&#8212;The expected dividend assumption is based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not intend to pay dividends. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company uses a Monte Carlo simulation model to estimate the fair value of Performance and Market-based Stock Options at the date of grant which utilizes multiple input variables to estimate the probability that the market condition will be achieved. Key assumptions used in the model include the risk-free interest rate, which reflects the US Treasury Constant Maturity Yield with a term commensurate with the contractual term of the award, and stock price volatility, which is derived based on the historical volatility of the Company&#8217;s stock. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates expected forfeitures at the time of grant instead of accounting for forfeitures as they occur. Stock option awards have been granted at fair value to non-employees in connection with research and consulting services provided to the Company. Equity awards generally vest over terms of <ix:nonNumeric contextRef="c-64" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="f-416">3</ix:nonNumeric> or <ix:nonNumeric contextRef="c-65" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="f-417">4</ix:nonNumeric> years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies stock-based compensation expense in the consolidated statements of operations and comprehensive loss in the same manner in which the award recipient&#8217;s payroll costs are classified.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-418" continuedAt="f-418-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is determined using the asset and liability approach. Tax laws may require items to be included in tax filings at different times than the items are reflected in the financial statements. A current asset or liability is recognized </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><ix:continuation id="f-404-4" continuedAt="f-404-5"><ix:continuation id="f-418-1"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">for the estimated taxes receivable or payable for the current year. Deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. Deferred taxes are initially recognized at enacted tax rates in force at the time of initial recognition and are subsequently adjusted for any enacted changes in tax rates and tax laws. Subsequent changes to deferred taxes originally recognized in equity are recognized in income. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. The Company has recorded a full valuation allowance against the deferred tax assets in excess of its deferred tax liabilities, as the deferred tax liabilities represent future reversals of existing taxable temporary differences. The Company records interest and penalties related to income tax matters as part of income tax expense.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-419" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash and short-term investments. The Company&#8217;s cash is comprised of short-term cash deposits at a variety of financial institutions which the Company believes are of high credit ratings in amounts that may exceed federally insured limits. The Company has not experienced any losses on such accounts. Cash balances maintained during the year have been principally held with U.S.-based and U.K.-based banks. The Company does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies, and expects to continue to rely, on a number of vendors to conduct its clinical trials and preclinical studies, manufacture drug product and supply clinical trial and preclinical study materials for its development programs. These programs could be adversely affected by a significant interruption in these services or the availability of materials.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="f-420" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the provisions of fair value accounting, a fair value measurement assumes that the transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability and defines fair value based on the exit price model.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The fair value measurement guidance establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance describes three levels of inputs that may be used to measure fair value:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level 1</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Quoted prices in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level 2</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 2 assets and liabilities include debt securities with quoted prices that are traded less frequently than exchange-traded instruments or securities or derivative contracts that are valued using a pricing model with inputs that are observable in the market or can be derived principally from or corroborated by observable market data.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level 3</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the Company categorizes such assets and liabilities based on the lowest level input that is significant to the fair value measurement in its entirety. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><div><span><br/></span></div><ix:continuation id="f-404-5" continuedAt="f-404-6"><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" id="f-421" continuedAt="f-421-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-421-1">The Company considers only those investments that are highly liquid, readily convertible to cash and that mature within 90 days or less from date of purchase to be cash equivalents.</ix:continuation> As of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025, cash equivalents were comprised of money market funds and U.S. treasury securities. As of </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">December 31,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> cash equivalents were comprised of money market funds.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="f-422" continuedAt="f-422-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-422-1">Restricted cash represents amounts which are legally restricted to withdrawal or usage and is presented in the consolidated balance sheet as restricted cash.</ix:continuation> As of December 31, 2025 the Company has $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="f-423">316</ix:nonFraction> of restricted cash associated with an irrevocable letter of credit required by the landlord to enter into the lease for Company&#8217;s corporate office.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="f-425" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="f-424" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s total cash, cash equivalents and restricted cash balances were as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.794%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-426">225,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-427">104,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-428">71,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="f-429">316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="f-430">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:fixed-zero" scale="3" id="f-431">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-432">225,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-433">105,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-434">71,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentPolicyTextBlock" id="f-435" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Short-term Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consist of marketable securities with original maturities greater than ninety days from the date of acquisition. The Company classifies marketable securities with original maturities of greater than 90 days and less than one year as short-term, based on the liquid nature of the marketable securities and because such marketable securities represent the investment of cash that is available for current operations. The Company considers its investment portfolio of marketable securities as available-for-sale. Accordingly, these investments are recorded at fair value, which is based on quoted market prices or other observable inputs. Unrealized gains and losses are recorded as a component of other comprehensive income (loss). Realized gains and losses are determined on a specific identification basis and are included in other income, net. Amortization and accretion of discounts and premiums are also recorded in other income, net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">When the fair value is below the amortized cost of the asset, an estimate of expected credit losses is made. This estimate is limited to the amount by which fair value is less than amortized cost. The credit-related impairment amount is recognized in the consolidated statements of operations and comprehensive loss and the remaining impairment amount and unrealized gains are reported as a component of accumulated other comprehensive income (loss) in stockholders&#8217; equity. Credit losses are recognized through the use of an allowance for credit losses account and subsequent improvements in expected credit losses are recognized as a reversal of the allowance account. If the Company has the intent to sell the security or it is more likely than not that the Company will be required to sell the security prior to recovery of its amortized cost basis the allowance for credit loss is written off and the excess of the amortized cost basis of the asset over its fair value is recorded in the consolidated statements of operations and comprehensive loss.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_139"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-436" continuedAt="f-436-1" escape="true"><ix:continuation id="f-404-6" continuedAt="f-404-7"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update &#8220;ASU&#8221; 2023-09, &#8220;Improvements to Income Tax Disclosures&#8221;, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024 and allows for adoption on a prospective basis, with a retrospective option. Early adoption is permitted. The Company adopted ASU 2023-09 for the year ended December 31, 2025 using a retrospective approach. The adoption of ASU-2023-09 did not have a material impact on the Company&#8217;s consolidated financial statements and related disclosures.</span></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><ix:continuation id="f-436-1"><ix:continuation id="f-404-7"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, &#8220;Disaggregation of Income Statement Expenses&#8221;, which requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures. The guidance is to be applied prospectively, with the option for retrospective application and is effective for public business entities for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this standard on the Company&#8217;s consolidated financial statements and related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2025, the FASB issued ASU 2025-11, &#8220;Narrow-Scope Improvements&#8221;, which is intended to improve the navigability of the guidance in ASC 270 and clarify when the guidance is applicable. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this standard on the Company&#8217;s consolidated financial statements and related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other recent authoritative guidance issued by the FASB (including technical corrections to the FASB ASC), the American Institute of Certified Public Accountants, and the SEC did not or are not expected to have a material impact on the Company&#8217;s consolidated financial statements and related disclosures.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_145"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-437" continuedAt="f-437-1" escape="true">Segment Reporting </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-437-1"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s chief operating decision makers (the &#8220;CODM function</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">), which are the Company</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">s Co-Chief Executive Officers, Mr. Duggan and Dr. Zanganeh, and Chief Operating Officer and Chief Financial Officer, Mr. Soni, utilize consolidated net loss that is reported on the consolidated statement of operations and comprehensive loss to make decisions about allocating resources and assessing performance for the entire Company. The CODM function approves of key operating and strategic decisions, including key decisions in clinical development and clinical operating activities, entering into significant contracts, such as revenue contracts and collaboration agreements and approves the Company</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">s consolidated operating budget. The CODM function views the Company's operations and manages its business on a consolidated basis and as a single reportable operating segment. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-438" continuedAt="f-438-1" escape="true">The CODM function is regularly provided with the following significant segment expenses: </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-438-1"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Oncology clinical trial related costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="f-439">266,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="f-440">100,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="f-441">35,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="smmt:AcquiredInProcessResearchAndDevelopmentExpense" format="ixt:fixed-zero" scale="3" id="f-442">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="smmt:AcquiredInProcessResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-443">15,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="smmt:AcquiredInProcessResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-444">520,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Compensation related costs, excluding stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="smmt:LaborAndRelatedExpensesExcludingStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-445">75,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="smmt:LaborAndRelatedExpensesExcludingStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-446">48,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="smmt:LaborAndRelatedExpensesExcludingStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-447">31,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-448">732,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-449">50,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-450">14,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-451">19,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-452">10,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-453">8,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total segment expenses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-454">1,094,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-455">225,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-456">609,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-457">14,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-458">13,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-459">11,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:fixed-zero" scale="3" id="f-460">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-461">8,686</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-462">16,461</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-463">1,079,586</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-464">221,315</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-465">614,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">  Other expenses include general and administrative expenses excluding compensation and stock-based compensation.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of December 31, 2025 and 2024, substantially all of our long-lived assets are located in the United States.</span></div></ix:continuation><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_142"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> 4.  <ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="f-468" continuedAt="f-468-1" escape="true">Akeso License and Collaboration Agreement</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-468-1" continuedAt="f-468-2"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On December 5, 2022, the Company entered into the License Agreement with Akeso pursuant to which the Company is in-licensing its breakthrough bispecific antibody, ivonescimab. The License Agreement and transaction closed in January 2023 following customary waiting periods.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><ix:continuation id="f-468-2"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Ivonescimab, known as AK112 in China and Australia, and also as SMT112 in the United States, Canada, Europe, and Japan, is a novel, potential first-in-class bispecific antibody intending to combine the effect of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF into a single molecule. Ivonescimab was engineered to bring two well established oncology targeted mechanisms together. Ivonescimab is currently in clinical development and, pursuant to the terms of the License Agreement, Summit will design and conduct the clinical trial activities to support regulatory filings in the Licensed Territory that Summit will submit. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the License Agreement, Summit will have final decision making authority with respect to clinical development strategy and execution in the Licensed Territory. For co-joined studies in which both Summit and Akeso participate, mutual agreement is required for material decisions; Summit retains the exclusive decision making with respect to participating in, and continuing its participation in, co-joined studies. Pursuant to the terms of the License Agreement, Summit will have final decision-making authority with respect to commercial strategy, pricing and reimbursement and other commercialization matters in the Licensed Territory. In connection with the License Agreement, the Company agreed to purchase a certain portion of drug substance and/or drug product for clinical and commercial supply and to enter into a supply agreement with Akeso. Summit is not assuming any liabilities (including contingent liabilities), acquiring any physical assets or trade names, or hiring or acquiring any employees from Akeso in connection with the License Agreement. Through the License Agreement, the Company obtained the rights to develop and commercialize ivonescimab in the United States, Canada, Europe, and Japan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In exchange for the rights obtained, the Company made an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="smmt:CollaborativeArrangementRightsAndObligationsUpfrontPayment" format="ixt:num-dot-decimal" scale="3" id="f-469">500,000</ix:nonFraction> to Akeso, of which $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="smmt:CashPaymentForCollaborativeArrangementUpfrontPayment" format="ixt:num-dot-decimal" scale="3" id="f-470">274,900</ix:nonFraction> was paid in cash and, pursuant to the License Agreement and Issuance Agreement, Akeso elected to receive <ix:nonFraction unitRef="shares" contextRef="c-70" decimals="INF" name="smmt:CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash" format="ixt:num-dot-decimal" scale="0" id="f-471">10,000,000</ix:nonFraction> shares of the Company&#8217;s common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-71" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-472">0.01</ix:nonFraction> per share (&#8220;common stock&#8221;) in lieu of $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="smmt:CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares" format="ixt:num-dot-decimal" scale="3" id="f-473">25,100</ix:nonFraction> in cash. The remaining $<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="smmt:CashPaymentForCollaborativeArrangementUpfrontPayment" format="ixt:num-dot-decimal" scale="3" id="f-474">200,000</ix:nonFraction> amount of the upfront payment was paid on March 6, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Effective June 3, 2024, the Company and Akeso entered into the Second Amendment to the License Agreement to expand the Company&#8217;s territories covered under the License Agreement to include the Latin America, Middle East and Africa regions. Pursuant to the Second Amendment, the Company paid an upfront payment to Akeso of $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="smmt:PaymentsForCollaborativeArrangement" format="ixt:num-dot-decimal" scale="3" id="f-475">15,000</ix:nonFraction> in the third quarter of 2024. Akeso will also be eligible to receive up to an additional $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="smmt:CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments" format="ixt:num-dot-decimal" scale="3" id="f-476">55,000</ix:nonFraction> upon the achievement of certain commercial milestones. Except as specifically modified by the Second Amendment, the terms and conditions of the License Agreement remain in full force and effect.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has accounted for the License Agreement and Second Amendment to acquire the rights to develop and commercialize ivonescimab as the acquisition of an asset. All of the consideration relates to ivonescimab and technological feasibility of the asset has not yet been established since ivonescimab is in clinical development. As such, the Company has expensed the consideration as acquired in-process research and development upon closing of the transaction in the consolidated statement of operations and comprehensive loss. Acquired in-process research and development expense for the year ended December 31, 2025 was <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="smmt:AcquiredInProcessResearchAndDevelopmentExpense" format="ixt:fixed-zero" scale="0" id="f-477">nil</ix:nonFraction>. Acquired in-process research and development expense for the year ended December 31, 2024,  was $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="smmt:AcquiredInProcessResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-478">15,007</ix:nonFraction> which is comprised of the upfront payment and immaterial transaction costs. For the year ended December 31, 2023, acquired in-process research and development expense totaled $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="smmt:AcquiredInProcessResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-479">520,915</ix:nonFraction> pursuant to the License Agreement, which was comprised of the $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="smmt:CashPaymentForCollaborativeArrangementUpfrontPayment" format="ixt:num-dot-decimal" scale="3" id="f-480">474,900</ix:nonFraction> paid in cash, the fair value of the <ix:nonFraction unitRef="shares" contextRef="c-76" decimals="INF" name="smmt:CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash" format="ixt:num-dot-decimal" scale="0" id="f-481">10,000,000</ix:nonFraction> shares of common stock on the date of closing the transaction of $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="smmt:StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement" format="ixt:num-dot-decimal" scale="3" id="f-482">45,900</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="smmt:CollaborativeArrangementRightsAndObligationsDirectTransactionCosts" scale="3" id="f-483">115</ix:nonFraction> of direct transactions costs incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the payments already made to Akeso, under the License Agreement and Second Amendment, there are additional potential milestone payments of up to $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="smmt:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments" format="ixt:num-dot-decimal" scale="3" id="f-484">4,555,000</ix:nonFraction>, as Akeso will be eligible to receive regulatory milestones of up to $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="smmt:CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments" format="ixt:num-dot-decimal" scale="3" id="f-485">1,050,000</ix:nonFraction> and commercial milestones of up to $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="smmt:CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments" format="ixt:num-dot-decimal" scale="3" id="f-486">3,505,000</ix:nonFraction>. In addition, Akeso will be eligible to receive low double-digit royalties on net sales.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_160"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="c-1" name="us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock" id="f-487" continuedAt="f-487-1" escape="true">Other Income, Net</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="f-488" escape="true"><ix:continuation id="f-487-1"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of other income, net:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency (loss) gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="f-489">610</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="f-490">97</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="f-491">613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investment income </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-492">15,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InvestmentIncomeNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-493">13,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:InvestmentIncomeNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-494">10,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of cumulative currency translation gain </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome" format="ixt:fixed-zero" scale="3" id="f-495">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome" format="ixt:fixed-zero" scale="3" id="f-496">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome" scale="3" id="f-497">419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-498">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="f-499">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-500">252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-501">14,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-502">13,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-503">11,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"> Investment income relates to the Company&#8217;s money market funds and short-term investments in U.S. treasury securities. Refer to Note 9 for details. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"> The reclassification of cumulative currency translation gain related to the reclassification of cumulative foreign currency translation gains from accumulated other comprehensive loss due to the dissolution of certain dormant entities.</span></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_163"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-504" continuedAt="f-504-1" escape="true">Income Tax&#160;</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-504-1" continuedAt="f-504-2"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is primarily subject to corporation taxes in the U.S. and the U.K. The calculation of the Company&#8217;s tax provision involves the application of both U.S. and U.K. tax law and requires judgment and estimates. The Company has also assessed the applicability of the OECD/G20 Inclusive Framework on Base Erosion and Profit Shifting (BEPS) Pillar 2 rules, which establish a global minimum tax rate. Based on the Company&#8217;s current financial position and revenue it does not meet the thresholds for Pillar 2 to apply. Therefore, the provisions and requirements under Pillar 2 do not impact our financial statements for the reporting period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is determined using the asset and liability approach. Tax laws may require items to be included in tax filings at different times than the items are reflected in the financial statements. A current asset or liability is recognized for the estimated taxes receivable or payable for the current year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. Deferred taxes are initially recognized at enacted tax rates in force at the time of initial recognition and are subsequently adjusted for any enacted changes in tax rates and tax laws. Subsequent changes to deferred taxes originally recognized in equity are recognized in income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. The Company has recorded a full valuation allowance against the deferred tax assets in excess of its deferred tax liabilities, as the deferred tax liabilities represent future reversals of existing taxable temporary differences. The Company records interest and penalties related to income tax matters as part of income tax expense.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Uncertain Tax Positions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for uncertain tax positions taken in its tax filings by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities having full knowledge of the facts and applicable tax rules. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed as the amount of benefit to recognize in the consolidated financial statements. The amount of benefits that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate, as well as the related net interest and penalties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Due to the Company&#8217;s full valuation allowance, the unrecognized tax benefits are not expected to materially impact the Company&#8217;s effective tax rate when recognized or significantly increase or decrease in the next 12 months. In addition, the </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><ix:continuation id="f-504-2" continuedAt="f-504-3"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Company&#8217;s policy is to recognize interest and penalties related to uncertain tax positions as part of its income tax provision. However, for the years ended December 31, 2025 and 2024, the Company had <ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="0" id="f-505"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="0" id="f-506">no</ix:nonFraction></ix:nonFraction> interest or penalties related to unrecognized tax benefits because any potential disallowance would not result in current tax but only result in a reduction to the Company&#8217;s net operating loss carryforwards.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Loss Before Income Taxes</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="f-507" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company&#8217;s loss before income taxes are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.378%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="f-508">326,729</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="f-509">199,040</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="f-510">499,810</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="f-511">752,857</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="f-512">22,275</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="f-513">115,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-514">1,079,586</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-515">221,315</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-516">614,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-517"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-518"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-519"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-520"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-521"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-522"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-523"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-524"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-525"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-526"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-527"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-528">not</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> recognized a current or deferred provision for federal, state or non-United States income taxes in either of the years ending December 31, 2025 or December 31, 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes are recognized for temporary differences between the basis of assets and liabilities for financial statement and income tax purposes. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-529" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The major components of deferred tax assets and liabilities are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforward</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-530">73,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-531">59,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credit carryforward</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="3" id="f-532">16,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="3" id="f-533">7,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-534">32,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-535">14,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 Research and Development Capitalization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="smmt:DeferredTaxAssetsCapitalizedResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="f-536">11,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="smmt:DeferredTaxAssetsCapitalizedResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="f-537">14,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="f-538">711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="f-539">475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-540">133,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-541">95,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="f-542">417</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="f-543">337</ix:nonFraction>)  </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="f-544">417</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="f-545">337</ix:nonFraction>)</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets before valuation allowance </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="smmt:DeferredTaxAssetsLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-546">133,161</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="smmt:DeferredTaxAssetsLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-547">95,588</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-548">133,161</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-549">95,588</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="f-550">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="f-551">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2025 and 2024, the Company recorded a deferred tax asset of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-552">133,578</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-553">95,925</ix:nonFraction>, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated the positive and negative evidence bearing upon its ability to realize its deferred tax assets, which are comprised primarily of net operating loss carryforwards, research and development credits, stock-based compensation expense, and research and development costs capitalized for tax purposes. Management has considered the Company&#8217;s history of cumulative net losses in each taxing jurisdiction, estimated future taxable income, as well as prudent and feasible tax planning strategies, and has concluded that it is more likely than not that the Company will not realize the tax benefits in each </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><ix:continuation id="f-504-3" continuedAt="f-504-4"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">jurisdiction. Accordingly, a full valuation allowance has been established against these net deferred tax assets as of December 31, 2025 and 2024, respectively. The Company reevaluates the positive and negative evidence at each reporting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the valuation allowance during the years ended December 31, 2025, 2024 and 2023 primarily related to net operating loss carryforwards and capitalized research and development expenses.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SummaryOfValuationAllowanceTextBlock" id="f-554" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The change in the valuation allowance was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance as of beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-555">95,588</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-556">84,751</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-557">64,016</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increases recorded to income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="3" id="f-558">37,573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="3" id="f-559">10,837</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="3" id="f-560">20,735</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance as of end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-561">133,161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-562">95,588</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-563">84,751</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Net Operating Loss and Tax Credit Carryforwards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024, the Company had U.S. Federal gross operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-564">93,210</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-565">44,270</ix:nonFraction>, respectively, which may be available to offset future income tax liabilities. The 2017 Tax Cuts and Jobs Act (&#8220;TCJA&#8221;) will generally allow losses incurred after 2017 to be carried over indefinitely but generally limits the net operating loss deduction to the lesser of the net operating loss carryover or 80% of a corporation&#8217;s taxable income (subject to Section 382 of the Internal Revenue Code of 1986, as amended). In addition, the Company has approximately $<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-566">21,335</ix:nonFraction> in U.S. State gross loss carryforwards which expire through various dates through 2044.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, the Company had an estimated U.S. federal and state research and development tax credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="3" id="f-567">15,565</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="3" id="f-568">5,002</ix:nonFraction>, respectively, which may be available to offset future tax liabilities, and each begin to expire in 2041 and 2037, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024, the Company had U.K. gross operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-569">211,096</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-570">198,653</ix:nonFraction> respectively, which may be available to offset future income tax liabilities. To the extent that U.K. taxable profits exceed &#163;5,000 in each year, the loss available to utilize against profits in excess of &#163;5,000 will be restricted to 50%. The U.K. loss carryforwards do not lapse and therefore, the full amount will be relieved over time provided there are sufficient profits against which the losses can be utilized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Utilization of the U.S. net operating loss carryforwards and research and development tax credit carryforwards may be subject to a substantial annual limitation under Section 382 of the Internal Revenue Code of 1986 due to ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50% over a three-year period. The Company has not completed a study to assess whether a change of ownership has occurred, or whether there have been multiple ownership changes since its formation. Any limitation may result in the loss of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">U.K. tax losses are subject to additional restrictions where there is a change in ownership in the business and certain other conditions are met. An ownership change of a U.K. tax resident company would occur where (directly or indirectly) a single person acquires more than half of the ordinary share capital of a company, or two or more persons each acquire a holding of at least 5% of the ordinary share capital of a company and these holdings together amount to more than half the ordinary share capital of a company. Where a change in ownership has occurred, and within three years prior to that change in ownership and five years afterwards, there is a major change in the nature and conduct of trade of that company or the trade of that business becomes small or negligible, any losses carried forward will be extinguished from the point of the change in ownership. In addition, losses accrued subsequent to April 1, 2017 will be extinguished on a change of ownership when there is a major change in the nature or conduct of a company&#8217;s business, or where there is a major change in the scale of that business, or a company ceases to carry on a particular trade or business. The Company has not completed a study to assess whether a change of ownership has occurred since its formation, or whether there has been a major change in the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">s business that would </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><ix:continuation id="f-504-4" continuedAt="f-504-5"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">restrict the U.K. tax losses. Any limitation may result in the loss of a portion of the net operating loss carryforwards before utilization.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Deemed U.S. Income Inclusions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The  TCJA created a requirement that US corporations include in income earnings of certain controlled foreign corporations under the global intangible low taxed income (&#8220;GILTI&#8221;) regime. Pursuant to the FASB Staff Q&amp;A, Topic 740 No.5. Accounting for Global Intangible Low-taxed Income, the Company is allowed to make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or to provide for the tax expense related to GILTI in the year the tax is incurred as period expense only. The Company has elected to account for GILTI in the year the tax is incurred and include the current tax impact of GILTI in the effective tax rate. Given the Company&#8217;s loss position in the U.S. and the valuation allowance recorded against its U.S. net deferred tax assets, these provisions have not had a material impact on the Company&#8217;s consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Annual Effective Tax Rate Reconciliation</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-571" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the Company&#8217;s effective tax rate to the U.S. federal statutory rate is as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Tax at federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-572">226,702</ix:nonFraction>)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-573">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-574">46,476</ix:nonFraction>)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-575">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-576">129,048</ix:nonFraction>)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-577">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">State income tax, net of federal tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:fixed-zero" scale="3" id="f-578">&#8212;</ix:nonFraction></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" format="ixt:fixed-zero" scale="-2" id="f-579">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="f-580">17</ix:nonFraction>)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" format="ixt:fixed-zero" scale="-2" id="f-581">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:fixed-zero" scale="3" id="f-582">&#8212;</ix:nonFraction></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" format="ixt:fixed-zero" scale="-2" id="f-583">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="f-584">6,828</ix:nonFraction>)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="f-585">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="f-586">4,782</ix:nonFraction>)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="f-587">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="f-588">2,275</ix:nonFraction>)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="f-589">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Nontaxable or nondeductible Items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-590">134,033</ix:nonFraction></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-591">12.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="3" id="f-592">130</ix:nonFraction>)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-593">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-594">2,978</ix:nonFraction></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-595">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="f-596">299</ix:nonFraction></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" format="ixt:fixed-zero" scale="-2" id="f-597">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="f-598">77</ix:nonFraction></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" format="ixt:fixed-zero" scale="-2" id="f-599">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="f-600">521</ix:nonFraction></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-601">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Foreign Tax Effects</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Cayman Islands Statutory income tax rate differential</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="f-602">67,969</ix:nonFraction></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-82" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-603">6.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="f-604">41,570</ix:nonFraction></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-83" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-605">18.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="f-606">104,282</ix:nonFraction></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-84" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-607">17.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Other foreign jurisdictions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="f-608">644</ix:nonFraction></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-85" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-609">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="f-610">229</ix:nonFraction></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-86" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-611">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="f-612">678</ix:nonFraction></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-87" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-613">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Changes in unrecognized tax benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxContingencies" format="ixt:num-dot-decimal" scale="3" id="f-614">1,357</ix:nonFraction></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="f-615">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="3" id="f-616">956</ix:nonFraction></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="f-617">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="3" id="f-618">800</ix:nonFraction></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="f-619">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-620">29,228</ix:nonFraction></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-621">2.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-622">8,573</ix:nonFraction></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-623">4.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-624">22,064</ix:nonFraction></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-625">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-626">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:fixed-zero" scale="-2" id="f-627">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-628">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:fixed-zero" scale="-2" id="f-629">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-630">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:fixed-zero" scale="-2" id="f-631">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Unrecognized Tax Benefit Reconciliation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company records unrecognized tax benefits in accordance with ASC 740-10, Income Taxes. ASC 740-10 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of uncertain tax positions taken or expected to be taken in the Company&#8217;s income tax return and also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. As of December 31, 2025, 2024, and 2023, the Company had total unrecognized tax benefits of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-632">3,903</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-633">2,122</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-634">1,064</ix:nonFraction>, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="f-635" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of unrecognized tax benefits from continuing operations is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits, beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-636">2,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-637">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:fixed-zero" scale="3" id="f-638">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="f-639">592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="f-640">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="f-641">610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-642">1,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="f-643">936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="f-644">454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits, end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-645">3,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-646">2,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-647">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><ix:continuation id="f-504-5"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Audit Examinations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">In the U.S., the Company files a Federal consolidated income tax return and income tax returns in various states. In the U.S., the filings for tax years from 2020 remain subject to examination by the U.S. Internal Revenue Service and state tax authorities. The Company is not currently under examination by the Internal Revenue Service or any other jurisdiction for years 2020 through present. To the extent the Company has tax attribute carryforwards, the tax years in which the attribute was generated may be adjusted upon examination by the Internal Revenue Service or state tax authorities to the extent utilized in a future period. In the U.K., tax returns for the year ended December 31, 2023 remains subject to examination by HMRC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Legislative Impacts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">On July 4, 2025, H.R. 1, a U.S. budget reconciliation bill, was signed into law. The Company has assessed the provisions of the new legislation and has integrated the resulting impacts into its effective income tax rate. Management has concluded that the bill does not have an impact on the Company's consolidated financial statements for the current period.</span></div></ix:continuation><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_166"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-648" continuedAt="f-648-1" escape="true">Net Loss per Share </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-648-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-649" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per share: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-650">1,079,586</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-651">221,315</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-652">614,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average number of shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-653"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-654">747,702,265</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-655"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-656">718,541,896</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-657"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-658">619,646,180</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic net loss per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-659">1.44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-660">0.31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-661">0.99</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net loss per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-662">1.44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-663">0.31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-664">0.99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the diluted net loss by the weighted-average number of common shares outstanding for the period, including potentially dilutive common shares. Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods, as the inclusion of all potential common share equivalents outstanding would have been antidilutive.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Because the 2023 Rights Offering (see Note 13) exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-88" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-665">1.05</ix:nonFraction> per share was less than the closing price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-89" decimals="2" name="us-gaap:SharePrice" scale="0" id="f-666">1.82</ix:nonFraction> per share on March 1, 2023, the expiration, the Company has retroactively adjusted earnings per share and the weighted average number of shares outstanding for the bonus element for the year ended December 31, 2023.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-667" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities were excluded from the computation of the diluted net loss per share of common stock for the periods presented because their effect would have been anti-dilutive:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-90" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-668">115,614,728</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-91" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-669">68,920,334</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-92" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-670">54,209,289</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-93" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-671">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-94" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-672">4,629,988</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-95" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-673">5,015,642</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares expected to be purchased under employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-96" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-674">65,905</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-97" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-675">86,550</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-98" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-676">155,163</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-677">115,680,633</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-678">73,636,872</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-679">59,380,094</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Stock options that are outstanding and contain improbable vesting criteria are excluded from the presentation of common stock equivalents outstanding in the table above.</span></div></ix:continuation><div style="margin-top:1pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_169"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="f-680" continuedAt="f-680-1" escape="true">Goodwill</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-680-1"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the Company expanded its activities in the field of infectious diseases with the acquisition of Discuva Limited, a privately held United Kingdom-based company. Through this acquisition, the Company obtained a bacterial genetics platform and a suite of software-based technologies, which facilitates the discovery and development of new mechanism antibiotics. This resulted in the recognition of goodwill of &#163;<ix:nonFraction unitRef="gbp" contextRef="c-99" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="f-681">1.5</ix:nonFraction>&#160;million, which is translated into U.S. dollars at each reporting period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024, goodwill was $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-682">2,001</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-683">1,864</ix:nonFraction>, respectively. Changes year over year are the result of changes in foreign currency. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill for impairment on an annual basis as of December 31 or more frequently when events and circumstances occur indicating that recorded goodwill may be impaired. As of December 31, 2025, the Company performed its annual impairment assessment of goodwill and determined that it is more likely than not that the fair value of the reporting unit exceeds its carrying amount. The Company has recorded <ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="3" id="f-684">no</ix:nonFraction> goodwill impairment charges to date.</span></div></ix:continuation><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_172"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="c-1" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="f-685" continuedAt="f-685-1" escape="true">Fair Value Measurements and Short-Term Investments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-685-1" continuedAt="f-685-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="f-686" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables sets forth the Company&#8217;s fair value hierarchy for its assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2025 and 2024:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.138%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hierarchy Level</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Credit (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets included within cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-687">163,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-688">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-689">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-690">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-691">163,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government treasury bills</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-692">45,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-693">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-694">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-695">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-696">45,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets included within short-term investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of deposit</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-697">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-698">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-699">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-700">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-701">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government treasury bills</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-702">463,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-703">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-704">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-705">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-706">463,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-707">696,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-708">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-709">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-710">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-711">697,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.284%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hierarchy Level</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Credit (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets included within cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-712">88,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-713">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-714">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-715">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-716">88,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets included within short-term investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government treasury bills</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-717">307,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-718">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-719">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-720">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-721">307,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-722">395,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-723">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-724">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-725">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-726">396,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The tables above do not include cash at December 31, 2025 and 2024 of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="3" id="f-727">16,366</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="3" id="f-728">16,263</ix:nonFraction>, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that the carrying amounts of prepaid expenses, other current assets, accounts payable, and accrued expenses approximates their fair values due to the short-term nature of those instruments. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><div><span><br/></span></div><ix:continuation id="f-685-2"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Realized gain (loss) on short-term investments for the years ended December 31, 2025 and 2024 were immaterial, respectively.</span></div></ix:continuation><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_181"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" id="f-729" continuedAt="f-729-1" escape="true">Research and Development Prepaid Expenses and Accrued Liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-729-1"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Included within prepaid expenses and other current assets at December 31, 2025 and 2024 is $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="smmt:ResearchAndDevelopmentPrepaidExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-730">3,996</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="smmt:ResearchAndDevelopmentPrepaidExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-731">8,338</ix:nonFraction>, respectively, of prepayments relating to research and development expenditures. Included within accrued liabilities at December 31, 2025 and 2024 is $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="smmt:AccruedResearchAndDevelopmentCurrent" format="ixt:num-dot-decimal" scale="3" id="f-732">31,498</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="smmt:AccruedResearchAndDevelopmentCurrent" format="ixt:num-dot-decimal" scale="3" id="f-733">17,441</ix:nonFraction>, respectively, relating to research and development expenditures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These amounts are determined based on the estimated costs to complete each study or activity related to the ongoing clinical trials for ivonescimab, the estimation of the current stage of completion and the invoices received, as well as predetermined milestones which are not reflective of the current stage of development for prepaid expenses. However, accrued liabilities increase as the activities progress. The key sensitivity is the estimated current stage of completion of each study or activity, which is based on information received from the supplier and the Company&#8217;s operational knowledge of the work completed under those contracts.</span></div></ix:continuation><div style="margin-bottom:6pt"><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_187"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-734" continuedAt="f-734-1" escape="true">Leases</ix:nonNumeric></span><ix:continuation id="f-734-1" continuedAt="f-734-2"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:continuation></div><div><span><br/></span></div><ix:continuation id="f-734-2" continuedAt="f-734-3"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for real estate. The Company does not have any finance leases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company leases its offices and facilities in Miami, FL, Palo Alto, CA, Princeton, NJ, Oxford, U.K., and Menlo Park, CA under non-cancellable operating lease agreements. The lease agreements for the Company&#8217;s offices and facilities in Miami, FL, Palo Alto, CA, Princeton, NJ and Oxford, U.K., expire in April 2029, October 2033, August 2028, and February 2027, respectively. The remaining lease agreement for the Company&#8217;s office and facility in Menlo Park, CA expires in May 2026. Under the terms of the lease agreements, the Company is responsible for certain repair and maintenance, utilities, licensing and permit fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2025, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-735">17,056</ix:nonFraction> of operating right-of-use assets and operating lease liabilities related to new leases for office space for its Palo Alto, CA and Princeton, NJ locations. Total future lease payments as of December 31, 2025 are approximately $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-736">23,117</ix:nonFraction> on an undiscounted basis. The Palo Alto lease commenced on December&#160;1, 2025 and has a term of approximately <ix:nonNumeric contextRef="c-108" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-737">8</ix:nonNumeric> years. The Princeton, NJ lease commenced on August&#160;18, 2025 and has a term of <ix:nonNumeric contextRef="c-109" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-738">3</ix:nonNumeric> years. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-739">4,216</ix:nonFraction> of right-of-use assets during the year ended December 31, 2024 related to its Miami, Florida headquarters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the right-of-use assets as of December 31, 2025 and 2024 is $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-740">20,616</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-741">7,144</ix:nonFraction>, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-742" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The elements of lease expense were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Fixed lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-743">3,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-744">3,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-745">2,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Variable lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="f-746">225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="f-747">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="f-748">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-749">4,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-750">3,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-751">2,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average discount rate and the weighted average remaining lease term were <ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-752">7.6</ix:nonFraction>% and <ix:nonNumeric contextRef="c-5" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-753">6.7</ix:nonNumeric> years, respectively, as of December 31, 2025. The weighted average discount rate and the weighted average remaining lease term were <ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-754">6.9</ix:nonFraction>% and <ix:nonNumeric contextRef="c-6" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-755">2.8</ix:nonNumeric> years, respectively, as of December 31, 2024. The Company made cash payments related to lease liabilities of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-756">3,741</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-757">2,568</ix:nonFraction> for the years ended December 31, 2025 and 2024, respectively.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-758" escape="true"><ix:continuation id="f-734-3"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Future lease payments under non-cancelable leases as of December 31, 2025 are detailed as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-759">3,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-760">4,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-761">4,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-762">3,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="f-763">3,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-764">9,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-765">27,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-766">6,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-767">20,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Operating lease liabilities, current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-768">3,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-769">17,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_190"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-770" continuedAt="f-770-1" escape="true">Promissory Note Payable to Related Parties</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-770-1" continuedAt="f-770-2"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">December 2022 Promissory Notes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On December 6, 2022, the Company entered into a Note Purchase Agreement (the &#8220;Note Purchase Agreement&#8221;), with Mr. Duggan and Dr. Zanganeh, pursuant to which the Company agreed to sell to each of Mr. Duggan and Dr. Zanganeh unsecured promissory notes in the aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-771">520,000</ix:nonFraction>. Pursuant to the Note Purchase Agreement, the Company issued to Mr. Duggan and Dr. Zanganeh unsecured promissory notes in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-772">400,000</ix:nonFraction> (the &#8220;Duggan February Note&#8221;) and $<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-773">20,000</ix:nonFraction> (the &#8220;Zanganeh Note&#8221;), respectively, which matured and became due on February 15, 2023 and an unsecured promissory note to Mr. Duggan in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-774">100,000</ix:nonFraction> (the &#8220;Duggan September Note&#8221; and together with the Duggan February Note and the Zanganeh Note, the &#8220;December 2022 Notes&#8221;), which was originally due on September 15, 2023. The maturity dates of the December 2022 Notes could have been extended one or more times at the Company&#8217;s election, but in no event to a date later than September 6, 2024. In addition, if the Company consummated a public offering, then upon the later to occur of (i) <span style="-sec-ix-hidden:f-775">five</span> business days after the Company receives the net cash proceeds therefrom or (ii) May 15, 2023, the Duggan February Note and the Zanganeh Note were to be prepaid by an amount equal to the lesser of (a) <ix:nonFraction unitRef="number" contextRef="c-115" decimals="2" name="smmt:NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering" scale="-2" id="f-776">100</ix:nonFraction>% of the amount of the net proceeds of such offering and (b) the outstanding principal amount on such Notes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On January 19, 2023, the Company provided notice to extend the term of the Duggan February Note and Duggan September Note to a maturity date of September 6, 2024. Furthermore, on January 19, 2023, the Company and Mr. Duggan rectified the Duggan February Note and Duggan September Note in order to correctly reflect the parties&#8217; intent that the Company may only prepay (i) the Duggan February Note following the completion of a public rights offering to be conducted by Summit in the approximate amount of $<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="smmt:NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold" format="ixt:num-dot-decimal" scale="3" id="f-777">500,000</ix:nonFraction>, or a similar capital raise, in an amount equal to the lesser of (x) the net proceeds of the rights offering or such capital raise or (y) the full amount outstanding of the Duggan February Note, and (ii) Duggan September Note following the completion of a capital raising transaction subsequent to the rights offering in an amount equal to the lesser of (A) the net proceeds of such capital raise or (B) the full amount outstanding of the Duggan September Note. Following the issuance of the <ix:nonFraction unitRef="promissory_note" contextRef="c-117" decimals="INF" name="smmt:NotesPayableRelatedPartiesNewIssuances" format="ixt-sec:numwordsen" scale="0" id="f-778">two</ix:nonFraction> new Promissory Notes (the &#8220;Revised Duggan February Note&#8221; and the &#8220;Revised Duggan September Note&#8221;, respectively), the Duggan February Note and Duggan September Note were marked as &#8220;cancelled&#8221; on their face and replaced in their entirety by the Revised Duggan February Note and the Revised Duggan September Note (together with the Zanganeh Note, the &#8220;Notes&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 15, 2023, the $<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:RepaymentsOfRelatedPartyDebt" format="ixt:num-dot-decimal" scale="3" id="f-779">20,000</ix:nonFraction> Zanganeh Note matured and the Company repaid the outstanding principal balance. In connection with the closing of the rights offering in 2023 (the &#8220;2023 Rights Offering&#8221;), the $<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:RepaymentsOfRelatedPartyDebt" format="ixt:num-dot-decimal" scale="3" id="f-780">400,000</ix:nonFraction> Revised Duggan February Note matured and became due, and the Company repaid all principal and accrued interest thereunder using a combination of a portion of the cash proceeds from the 2023 Rights Offering and the extinguishment of a portion of the amount due equal to the subscription price of shares subscribed by Mr. Duggan in the 2023 Rights Offering.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><ix:continuation id="f-770-2" continuedAt="f-770-3"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Notes accrued interest at an initial rate of <ix:nonFraction unitRef="number" contextRef="c-120" decimals="3" name="us-gaap:RelatedPartyTransactionRate" scale="-2" id="f-781">7.5</ix:nonFraction>%. All interest on the Notes was paid on the date of signing for the period through February 15, 2023. Such prepaid interest was paid in a number of shares of the Company&#8217;s common stock equal to the dollar amount of such prepaid interest, divided by $<ix:nonFraction unitRef="usdPerShare" contextRef="c-120" decimals="4" name="smmt:NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator" scale="0" id="f-782">0.7913</ix:nonFraction> (the consolidated closing bid price immediately preceding the time the Company entered into the Note Purchase Agreement, plus $<ix:nonFraction unitRef="usdPerShare" contextRef="c-120" decimals="2" name="smmt:NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice" scale="0" id="f-783">0.01</ix:nonFraction>), which was <ix:nonFraction unitRef="shares" contextRef="c-120" decimals="INF" name="smmt:StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest" format="ixt:num-dot-decimal" scale="0" id="f-784">9,720,291</ix:nonFraction> shares. For all applicable periods following February 15, 2023, interest accrued on the outstanding principal balance of the Notes at the U.S. prime interest rate, as reported in the </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> plus <ix:nonFraction unitRef="number" contextRef="c-121" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="f-785">50</ix:nonFraction> basis points, as adjusted monthly, for three months immediately following February 15, 2023, and thereafter at the U.S. prime rate plus <ix:nonFraction unitRef="number" contextRef="c-122" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="f-786">300</ix:nonFraction> basis points, as adjusted monthly. Accrued interest was paid in cash, quarterly in arrears, on each of March 31, June 30, September 30 and December 31. Debt issuance costs associated with the Notes were $<ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" scale="3" id="f-787">44</ix:nonFraction> and were capitalized as part of the carrying value of the promissory notes payable to related parties. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 17, 2024, the Revised Duggan February Note was amended to extend the maturity date from September 6, 2024 to April 1, 2025. For all applicable periods commencing February 17, 2024, interest accrued on the outstanding principal balance at the greater of <ix:nonFraction unitRef="number" contextRef="c-123" decimals="2" name="us-gaap:RelatedPartyTransactionRate" scale="-2" id="f-788">12</ix:nonFraction>% or the U.S. prime interest rate, as reported in the </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> plus <ix:nonFraction unitRef="number" contextRef="c-123" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="f-789">350</ix:nonFraction> basis points, as adjusted monthly, and compounded quarterly. Interest was paid upon maturity of the loan. The debt discount was amortized to interest expense using an effective interest rate method. The effective interest rate of the Revised Duggan February Note and Zanganeh Note was <ix:nonFraction unitRef="number" contextRef="c-124" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-790"><ix:nonFraction unitRef="number" contextRef="c-125" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-791">8.9</ix:nonFraction></ix:nonFraction>% and the effective interest rate of the Revised Duggan September Note was <ix:nonFraction unitRef="number" contextRef="c-126" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-792">11.3</ix:nonFraction>%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September 16, 2024, the Company used some of the proceeds raised from the September 2024 Private Placement (see Note 13 for further details) to repay $<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:RepaymentsOfRelatedPartyDebt" format="ixt:num-dot-decimal" scale="3" id="f-793">75,500</ix:nonFraction> in principal on the Revised Duggan September Note. On October 1, 2024, the Company repaid the remaining outstanding balance of the Revised Duggan September Note in full, resulting in principal payments of $<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:RepaymentsOfRelatedPartyDebt" format="ixt:num-dot-decimal" scale="3" id="f-794">24,500</ix:nonFraction> and accrued cash interest of $<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-795">7,305</ix:nonFraction>.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of December 31, 2025 and 2024, the Company had <ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:NotesPayable" format="ixt:fixed-zero" scale="0" id="f-796"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:NotesPayable" format="ixt:fixed-zero" scale="0" id="f-797">no</ix:nonFraction></ix:nonFraction> debt. During the year ended December 31, 2025, the Company incurred <ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:fixed-zero" scale="0" id="f-798">no</ix:nonFraction> interest expense. During the year ended December 31, 2024, the Company incurred interest expense of $<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="f-799">8,686</ix:nonFraction> related to the Revised Duggan September Note.</span></div></ix:continuation><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_193"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-800" continuedAt="f-800-1" escape="true">Stockholders' Equity </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-800-1" continuedAt="f-800-2"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and December 31, 2024, the Company had <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-801"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-802">20,000,000</ix:nonFraction></ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-803"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-804">0.01</ix:nonFraction></ix:nonFraction> authorized and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-805"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-806"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-807"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-808">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and December 31, 2024, the Company had authorized <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-809"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-810">1,000,000,000</ix:nonFraction></ix:nonFraction> shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-811"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-812">0.01</ix:nonFraction></ix:nonFraction> (the &#8220;Common Stock&#8221;). As of December 31, 2025 and December 31, 2024, the Company had <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-813"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-814">775,371,200</ix:nonFraction></ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-815"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-816">737,626,004</ix:nonFraction></ix:nonFraction> shares of Common Stock issued and outstanding, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On December 6, 2022, the Company announced the 2023 Rights Offering for its existing shareholders to participate in the purchase of additional shares of its Common Stock for $<ix:nonFraction unitRef="usdPerShare" contextRef="c-133" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-817">1.05</ix:nonFraction> per share. The 2023 Rights Offering commenced on February 7, 2023 and the associated subscription rights expired on March 1, 2023. Aggregate gross proceeds from the 2023 Rights Offering were $<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-818">500,000</ix:nonFraction> from the sale of <ix:nonFraction unitRef="shares" contextRef="c-134" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-819">476,190,471</ix:nonFraction> shares of the Company&#8217;s Common Stock and issuance costs were $<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-820">619</ix:nonFraction>. Mr. Duggan and Dr. Zanganeh fully subscribed to their respective basic subscription rights at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-133" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-821">1.05</ix:nonFraction> per share. To satisfy the $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:StockIssued1" format="ixt:num-dot-decimal" scale="3" id="f-822">395,314</ix:nonFraction> subscription price for the shares subscribed by Mr. Duggan in the 2023 Rights Offering, Mr. Duggan agreed with the Company to extinguish a portion of the amount due and payable to him by the Company at the closing of the 2023 Rights Offering pursuant to the $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-823">400,000</ix:nonFraction> Duggan Promissory Note in an amount equal to the subscription price (see also Note 12).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;19, 2023, the Company filed Amendment No. 2 to the Restated Certificate of Incorporation (the &#8220;Amendment No. 2&#8221;) with the Secretary of State of the State of Delaware to increase the number of authorized shares of its Common Stock by <ix:nonFraction unitRef="shares" contextRef="c-136" decimals="INF" name="smmt:CommonStockSharesAuthorizedIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="f-824">650,000,000</ix:nonFraction> (from <ix:nonFraction unitRef="shares" contextRef="c-137" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-825">350,000,000</ix:nonFraction> to <ix:nonFraction unitRef="shares" contextRef="c-138" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-826">1,000,000,000</ix:nonFraction>), which became effective on such date. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><div><span><br/></span></div><ix:continuation id="f-800-2" continuedAt="f-800-3"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 17, 2023, the Company filed a registration statement on Form S-3 to register for resale the following shares of the Company&#8217;s Common Stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-139" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-827">0.01</ix:nonFraction> par value: (i) <ix:nonFraction unitRef="shares" contextRef="c-140" decimals="INF" name="smmt:SaleOfStockNumberOfSharesRegisteredForResale" format="ixt:num-dot-decimal" scale="0" id="f-828">10,000,000</ix:nonFraction> shares of Common Stock issued on January 17, 2023 in connection with the License Agreement (as defined in Note 4) with Akeso pursuant to which the Company issued Akeso such shares; and (ii) the <ix:nonFraction unitRef="shares" contextRef="c-141" decimals="INF" name="smmt:SaleOfStockNumberOfSharesRegisteredForResale" format="ixt:num-dot-decimal" scale="0" id="f-829">9,346,434</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-142" decimals="INF" name="smmt:SaleOfStockNumberOfSharesRegisteredForResale" format="ixt:num-dot-decimal" scale="0" id="f-830">373,857</ix:nonFraction> shares of Common Stock issued in December 2022 to Mr. Duggan and Dr. Zanganeh, respectively, as payment of prepaid interest in connection with the Note Purchase Agreement dated December 6, 2022 between Mr. Duggan, Dr. Zanganeh and the Company. On April 27, 2023, the SEC issued the Company a Notice of Effectiveness for the registration statement on Form S-3.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Soni entered into a share purchase agreement with the Company to purchase $<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:num-dot-decimal" scale="3" id="f-831">5,000</ix:nonFraction> of its Common Stock via a private placement. The transaction was effective October 13, 2023 with a closing price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-144" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-832">1.68</ix:nonFraction>, resulting in the purchase of <ix:nonFraction unitRef="shares" contextRef="c-145" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-833">2,976,190</ix:nonFraction> shares of the Company&#8217;s Common Stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">June 2024 PIPE (Private Investment in Public Equity)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On June 3, 2024, the Company entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with 667, L.P. and Baker Brothers Life Sciences, L.P., affiliates of Baker Bros. Advisors, L.P., for the sale by the Company in a private placement (the &#8220;June 2024 Private Placement&#8221;) of <ix:nonFraction unitRef="shares" contextRef="c-146" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-834">22,222,222</ix:nonFraction> shares (the &#8220;Shares&#8221;) of Common Stock, at a purchase price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-147" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-835">9.00</ix:nonFraction> per share, for an aggregate purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="f-836">200,000</ix:nonFraction>. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The closing of the June 2024 Private Placement was June&#160;6, 2024. The Purchase Agreement contained customary representations, warranties and covenants by the Company, customary indemnification obligations of the Company, including for liabilities under the Securities Act of 1933, other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Purchase Agreement were made only for purposes of the Purchase Agreement and as of specific dates, were solely for the benefit of the parties to such agreements and were subject to limitations agreed upon by the contracting parties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;3, 2024, in connection with the Purchase Agreement, the Company entered into a Registration Rights Agreement with certain investors (the &#8220;Registration Rights Agreement&#8221;). The Registration Rights Agreement provides, among other things, that the Company will as soon as reasonably practicable, file with the SEC a registration statement registering the resale of the shares. The Company agreed to use its reasonable best efforts to have such registration statement declared effective as soon as practicable after the filing thereof. The Company filed the registration statement on August 6, 2024, which was automatically effective upon filing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">September 2024 PIPE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;11, 2024, the Company entered into securities purchase agreements (the &#8220;September 2024 Purchase Agreements&#8221;) with multiple  biotech institutional investors and individual accredited investors, for the sale by the Company in a private placement (the &#8220;September 2024 Private Placement&#8221;) for an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-148" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-837">10,352,418</ix:nonFraction> shares of the Company&#8217;s Common Stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-149" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-838">0.01</ix:nonFraction> per share of Common Stock, at purchase price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-149" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-839">22.70</ix:nonFraction> per share, which was the closing price of the Common Stock on September&#160;11, 2024, for aggregate gross proceeds to the Company of approximately $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-840">235,000</ix:nonFraction>, with offering costs of $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-841">140</ix:nonFraction>.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company's Section 16 officers participated in the capital raise. A total of $<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="f-842">79,000</ix:nonFraction> was raised by the Company's Co-Chief Executive Officer (&#8220;CEO&#8221;), Executive Chairman and majority stockholder, its CEO and the President and member of the Company's Board of Directors (the &#8220;Board&#8221;), its Chief Operating Officer (&#8220;COO&#8221;), Chief Financial Officer (&#8220;CFO&#8221;), and member of the Board, its Chief Accounting Officer (&#8220;CAO&#8221;), and a member of the Board, who invested via a controlled entity. The remaining $<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="f-843">156,000</ix:nonFraction> was raised with multiple leading biotech institutional investors. Refer to Note 15 Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">for further details regarding related parties' participation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The closing of the September 2024 Private Placement was September 13, 2024. The September 2024 Purchase Agreements contain customary representations, warranties and covenants by the Company, customary indemnification obligations of the Company, including for liabilities under the Securities Act, as amended (the &#8220;Securities Act&#8221;), other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the September 2024 Purchase </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><ix:continuation id="f-800-3" continuedAt="f-800-4"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Agreements were made only for purposes of the September 2024 Purchase Agreements and as of specific dates, were solely for the benefit of the parties to such agreements and were subject to limitations agreed upon by the contracting parties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;11, 2024, in connection with the September 2024 Purchase Agreements, the Company entered into Registration Rights Agreements with certain investors (the &#8220;September 2024 Registration Rights Agreements&#8221;). The September 2024 Registration Rights Agreements provide, among other things, that the Company will as soon as reasonably practicable file with the SEC a registration statement registering the resale of the shares. The Company filed the registration statement on September 19, 2024, which was automatically effective upon filing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">October 2025 PIPE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On October&#160;21, 2025, the Company entered into securities purchase agreements (the &#8220;October 2025 Purchase Agreements&#8221;)  with multiple  biotech institutional investors and individual accredited investors, for the sale by the Company in a private placement for an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-152" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-844">26,682,846</ix:nonFraction> shares of the Company&#8217;s Common Stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-153" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-845">0.01</ix:nonFraction> per share of Common Stock, at purchase price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-153" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-846">18.74</ix:nonFraction> per Share, which was the closing price of the Common Stock on October&#160;21, 2025, for aggregate gross proceeds to the Company of approximately $<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-847">500,037</ix:nonFraction>, with immaterial offering costs. The private placement transaction was completed in October 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company's Section 16 officers participated in the capital raise. The Company's Co-CEO, Executive Chairman and majority stockholder, its Co-CEO and the President and member of the Board, its COO, CFO, and member of the Board, its CAO, and certain non-executive employees and other related persons purchased an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-154" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-848">14,514,402</ix:nonFraction> shares of Common Stock for gross proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-849">272,000</ix:nonFraction>. Additionally, Akeso purchased <ix:nonFraction unitRef="shares" contextRef="c-155" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-850">533,617</ix:nonFraction> shares of Common Stock for gross proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-851">10,000</ix:nonFraction>. The remaining $<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="f-852">218,037</ix:nonFraction> was raised with multiple leading biotech institutional investors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The October 2025 Purchase Agreements contain customary representations, warranties and covenants by the Company, customary indemnification obligations of the Company, including for liabilities under the Securities Act, as amended (the &#8220;Securities Act&#8221;), other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the October 2025 Purchase Agreements were made only for purposes of the October 2025 Purchase Agreements and as of specific dates, were solely for the benefit of the parties to such agreements and were subject to limitations agreed upon by the contracting parties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;21, 2025, in connection with the October 2025 Purchase Agreements, the Company entered into Registration Rights Agreements with the Investors (the &#8220;October 2025 Registration Rights Agreements&#8221;). The October 2025 Registration Rights Agreements provide, among other things, that the Company will as soon as reasonably practicable, and in any event by no later than December 19, 2025, file with the SEC a registration statement registering the resale of the shares. The Company filed the registration statement on October 29, 2025, which was automatically effective upon filing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-the-Market Offering (ATM Offering)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On May 13, 2024, the Company entered into an at-the-market  (&#8220;ATM&#8221;) sales agreement (the &#8220;Original Distribution Agreement&#8221;) pursuant to which the Company may, subject to the terms and conditions set forth in the agreement offer and sell, from time to time, through or to the agents, acting as agents or principal, shares of the Company's Common Stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-157" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-853">0.01</ix:nonFraction>, having an aggregate offering price of up to $<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="smmt:SaleOfStockAggregateOfferingPrice" format="ixt:num-dot-decimal" scale="3" id="f-854">90,000</ix:nonFraction>. On August 11, 2025, the Company entered into an amendment to the Original Distribution Agreement (as amended, the &#8220;Distribution Agreement&#8221;), which among other things, increased the aggregate offering price of Common Stock that the Company may offer and sell from time to time through the sales agent under the Distribution Agreement by an additional $<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="smmt:SaleOfStockAggregateOfferingPrice" format="ixt:num-dot-decimal" scale="3" id="f-855">360,000</ix:nonFraction>.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From the date of the Original Distribution Agreement through December 31, 2025, the Company sold <ix:nonFraction unitRef="shares" contextRef="c-160" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-856">7,146,432</ix:nonFraction> shares of Common Stock under the ATM at a weighted-average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-161" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-857">21.09</ix:nonFraction> per share, for gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-858">150,721</ix:nonFraction>, with commissions and fees of approximately $<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-859">3,160</ix:nonFraction>. The remaining gross proceeds available under the Distribution Agreement as of December 31, 2025 was approximately $<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="smmt:SaleOfStockAmountRemainingUnderTheOffering" format="ixt:num-dot-decimal" scale="3" id="f-860">299,279</ix:nonFraction>. The Company plans to use the net proceeds from this offering for working capital and general corporate purposes.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><div><span><br/></span></div><ix:continuation id="f-800-4"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, the Company had <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:fixed-zero" scale="0" id="f-861">no</ix:nonFraction> outstanding warrants. As of December 31, 2024, the Company had outstanding and exercisable warrants of <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-862">4,629,988</ix:nonFraction> with a weighted average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="smmt:ClassOfWarrantOrRightWeightedAverageExercisePrice" scale="0" id="f-863">1.58</ix:nonFraction>. During the year ended December 31, 2025, <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="smmt:ClassOfWarrantOrRightExercisesInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-864">4,629,988</ix:nonFraction> warrants were exercised with a weighted average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="smmt:ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" scale="0" id="f-865">1.58</ix:nonFraction>.</span></div></ix:continuation><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_196"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-866" continuedAt="f-866-1" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-866-1" continuedAt="f-866-2"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">2016 Long Term Incentive Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Upon the effectiveness of the 2020 Stock Incentive Plan (the &#8220;2020 Plan&#8221;), no additional grants will be made under the 2016 Long Term Incentive Plan, (the &#8220;2016 Plan&#8221;) and any outstanding awards continue with their original terms. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">2020 Stock Award Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, the Company&#8217;s Board of Directors approved the 2020 Stock Incentive Plan, which became effective on September 21, 2020. The 2020 plan provides for the grant of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units and other stock-based awards. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A total of <ix:nonFraction unitRef="shares" contextRef="c-162" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-867">8,000,000</ix:nonFraction> shares of Common Stock were initially reserved for issuance under the 2020 Plan. Additionally, up to <ix:nonFraction unitRef="shares" contextRef="c-162" decimals="INF" name="smmt:CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration" format="ixt:num-dot-decimal" scale="0" id="f-868">5,000,000</ix:nonFraction> shares of Common Stock, including RSUs can be added to the 2020 Plan for future issuance from options that expire, lapse or are terminated from the 2016 Plan or any other predecessor plans. The number of shares of Common Stock that may be issued under the 2020 Plan will automatically increase on each January 1, beginning in 2021 and continuing for each fiscal year until, and including, the fiscal year ending December 31, 2030, equal to the lesser of (i) <ix:nonFraction unitRef="shares" contextRef="c-162" decimals="INF" name="smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan" format="ixt:num-dot-decimal" scale="0" id="f-869">6,400,000</ix:nonFraction> shares of Common Stock, (ii) <ix:nonFraction unitRef="number" contextRef="c-163" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" scale="-2" id="f-870">4</ix:nonFraction>% of the common shares outstanding on the final day of the immediately preceding calendar year and (iii) an amount as determined by the Company&#8217;s Board of Directors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, there are <ix:nonFraction unitRef="shares" contextRef="c-164" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-871">2,643,200</ix:nonFraction> shares available to be issued under the 2020 Plan. The Company currently grants stock options to employees and directors under the 2020 Stock Incentive Plan (the &#8220;2020 Plan&#8221;) and formerly, the Company granted stock options under the 2016 Long Term Incentive Plan (the &#8220;2016 Plan&#8221;). The 2020 Plan is administered by the Compensation Committee of the Company's Board of Directors. The 2020 Plan is intended to attract and retain employees and directors and provide an incentive for these individuals to assist the Company to achieve long-range performance goals and to enable these individuals to participate in the long-term growth of the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Based on the provisions of the 2020 Plan, the number of shares of common stock available for issuance under the 2020 Plan increased by <ix:nonFraction unitRef="shares" contextRef="c-165" decimals="INF" name="smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" format="ixt:num-dot-decimal" scale="0" id="f-872">6,400,000</ix:nonFraction> shares on January 1, 2025. On September 18, 2025, the Board approved an increase of <ix:nonFraction unitRef="shares" contextRef="c-166" decimals="INF" name="smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" format="ixt:num-dot-decimal" scale="0" id="f-873">8,000,000</ix:nonFraction> shares of common stock available for issuance under the 2020 Plan (the &#8220;Incremental Pool&#8221;), subject to the approval of the holders of a majority of the shares voting at the Company&#8217;s stockholder meeting. As of December 31, 2025, there are <ix:nonFraction unitRef="shares" contextRef="c-167" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-874">3,082,075</ix:nonFraction> shares available to be issued under the Incremental Pool. The Company&#8217;s consolidated financial statements have treated the grant date of such stock options as the date Board approval was obtained.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On May 3, 2024, the Board adopted the 2024 Inducement Pool (the &#8220;Inducement Pool&#8221;), which mirrors the terms of the 2020 Plan, with a total of <ix:nonFraction unitRef="shares" contextRef="c-168" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-875">2,000,000</ix:nonFraction> shares of Common Stock reserved for issuance under the Inducement Pool. Effective January 22, 2025, the number of shares of common stock available under the Inducement Pool increased by <ix:nonFraction unitRef="shares" contextRef="c-169" decimals="INF" name="smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" format="ixt:num-dot-decimal" scale="0" id="f-876">2,000,000</ix:nonFraction> shares. The Inducement Pool provides for the grant of non-qualified stock options and was approved by the Compensation Committee of the Board without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Inducement Pool is administered by the Compensation Committee of the Board. In accordance with Rule 5635(c)(4) of the Nasdaq Listing Rules, non-qualified stock options under the Inducement Pool may only be made to an employee who has not previously been an employee of the Company or member of the Board (or any parent or subsidiary of the Company), if he or she is granted such non-qualified stock options in connection with his or her commencement of employment with the Company or a subsidiary and such grant is an inducement material to his or her entering into employment with the Company or such subsidiary. As of December 31, 2025, there were <ix:nonFraction unitRef="shares" contextRef="c-170" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-877">1,936,452</ix:nonFraction> shares available for grant under the Inducement Pool.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><ix:continuation id="f-866-2" continuedAt="f-866-3"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">2020 Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Employee Stock Purchase Plan (the &#8220;2020 ESPP&#8221;) was adopted by the Board of Directors and approved by the Company&#8217;s shareholders on July 17, 2020 and approved by the predecessor company shareholders on August 19, 2020 and is qualified under Section 423 of the Internal Revenue Code. The 2020 ESPP initially authorized the issuance of up to <ix:nonFraction unitRef="shares" contextRef="c-171" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-878">1,000,000</ix:nonFraction> shares of Common Stock to participating employees. The number of common shares that may be issued under the 2020 ESPP automatically increases on each fiscal year commencing January 1, 2021 and continuing for each fiscal year until, and including the fiscal year commencing on, January 1, 2030 equal to the lesser of (i) <ix:nonFraction unitRef="shares" contextRef="c-171" decimals="INF" name="smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan" format="ixt:num-dot-decimal" scale="0" id="f-879">1,600,000</ix:nonFraction> shares of Common Stock, (ii) <ix:nonFraction unitRef="number" contextRef="c-172" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" scale="-2" id="f-880">1</ix:nonFraction>% of the common shares outstanding on such date and (iii) an amount as determined by the Company&#8217;s Board of Directors. As of December 31, 2025, there were <ix:nonFraction unitRef="shares" contextRef="c-173" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-881">1,743,682</ix:nonFraction> shares available to be issued under the 2020 ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 ESPP is comprised of purchase periods of <ix:nonNumeric contextRef="c-172" name="smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" format="ixt-sec:durwordsen" id="f-882">six months</ix:nonNumeric> in duration and commence immediately preceding the end of the previous offering period, unless otherwise determined by the Board of Directors or Compensation Committee. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2020 ESPP, eligible employees can purchase shares of Common Stock through payroll deductions of up to <ix:nonFraction unitRef="number" contextRef="c-171" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="f-883">15</ix:nonFraction>% of their compensation received during the plan period or such shorter period during which deductions from payroll are made, up to a defined maximum amount. The option price is determined based on the lesser of the closing price of Common Stock on (i) the first business day of the plan period or (ii) the exercise date, or shall be based solely on the closing price of the Common Stock on the exercise date; provided that such option price shall be at least <ix:nonFraction unitRef="number" contextRef="c-174" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="f-884">85</ix:nonFraction>% of the applicable closing price. In the absence of a determination by the Board of Directors or the Compensation Committee, the option price is <ix:nonFraction unitRef="number" contextRef="c-172" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="f-885">85</ix:nonFraction>% of the lesser of the closing price of the Common Stock on (i) the first business day of the plan period or (ii) the exercise date. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The closing price is the (a) the closing price (for the primary trading session) on the Nasdaq Global Select Market or (b) the average of the closing bid and asked prices in the over-the-counter-market, whichever is applicable, as published in the </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> or another source selected by the Board or the Committee. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended December 31, 2025 and 2024, <ix:nonFraction unitRef="shares" contextRef="c-175" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-886">139,459</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-176" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-887">353,578</ix:nonFraction> shares, respectively, were issued under the 2020 ESPP Plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair value of stock options granted to employees and directors using the Black-Scholes valuation model. Stock options granted under the 2016 and 2020 Plans generally vest over <span style="-sec-ix-hidden:f-888">three</span> or <ix:nonNumeric contextRef="c-178" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-889">four years</ix:nonNumeric> and expire after <ix:nonNumeric contextRef="c-179" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-890">ten years</ix:nonNumeric>. This valuation methodology utilizes several key assumptions as highlighted below.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-891" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used in the Company&#8217;s valuation are summarized as follows, presented on a weighted average basis:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-179" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-892">3.8</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-179" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-893">3.9</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-180" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-894">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-181" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-895">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-177" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-896">2.5</ix:nonNumeric> - <ix:nonNumeric contextRef="c-178" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-897">6.2</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-180" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-898">6.2</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-181" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-899">4.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="f-900">124.9</ix:nonFraction>% -<ix:nonFraction unitRef="number" contextRef="c-178" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="f-901">142.5</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-180" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="f-902">107.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-181" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="f-903">98.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected annual dividends per share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-179" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-904">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-180" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-905">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-181" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-906">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><ix:continuation id="f-866-3" continuedAt="f-866-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-907" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%">The following table summarizes the Company&#8217;s stock option activity for the year ended December 31, 2025:&#160;&#160;&#160;&#160;&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of share options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate intrinsic value </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2024*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-182" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-908">108,136,310</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-182" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-909">2.34</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-183" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-910">8.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-911">1,677,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-179" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-912">13,297,732</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-179" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-913">19.20</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-179" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-914">1,015,750</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-179" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-915">10.12</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-179" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-916">953,564</ix:nonFraction>)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-179" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-917">3.99</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-184" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-918">119,464,728</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-184" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-919">4.14</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-179" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-920">7.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-921">1,618,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-184" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-922">110,536,687</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-184" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="f-923">3.86</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-179" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-924">7.7</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-925">1,527,454</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-184" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-926">64,834,314</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-184" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-927">2.32</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-179" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-928">7.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="f-929">983,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">* The stock option activity in the table above includes performance-based options outstanding as of December 31, 2024 of <ix:nonFraction unitRef="shares" contextRef="c-185" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-930">48,220,320</ix:nonFraction> of which <ix:nonFraction unitRef="shares" contextRef="c-185" decimals="INF" name="smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber" format="ixt:num-dot-decimal" scale="0" id="f-931">39,013,976</ix:nonFraction> options were unvested and converted to time-based vesting. During the three months ended March 31, 2025, the company granted <ix:nonFraction unitRef="shares" contextRef="c-186" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-932">5,475,000</ix:nonFraction> performance-based options which were modified to time-based vesting during the three months ended June 30, 2025.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2025, the Compensation Committee of the Board of Directors approved a modification to the Company's outstanding unvested performance-based stock option awards for certain employees and executives that will require only the service-based vesting requirements to continue to be satisfied in order to become fully vested, subject to employee consent. The Company accounted for this change as a Type III modification (improbable-to-probable) in accordance with the requirements of Accounting Standards Codification Topic 718 (ASC 718). As a result, <ix:nonFraction unitRef="shares" contextRef="c-187" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" format="ixt:num-dot-decimal" scale="0" id="f-933">44,488,976</ix:nonFraction> options were valued on the modification date. The Company is recognizing the newly assessed measurement date fair value of the awards as compensation expense over the remaining vesting period. During the year ended December 31, 2025, the Company recognized expense of $<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-934">650,959</ix:nonFraction> associated with the modification. As of December 31, 2025, the unrecognized compensation cost associated with the modification was $<ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="smmt:ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount" format="ixt:num-dot-decimal" scale="3" id="f-935">214,295</ix:nonFraction> and is expected to be expensed over a weighted-average recognition period of approximately <ix:nonNumeric contextRef="c-188" name="smmt:ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod" format="ixt-sec:duryear" id="f-936">1.6</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of stock options granted during the years ended December 31, 2025, 2024 and 2023 was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-937">17.10</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-938">3.40</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-939">1.41</ix:nonFraction>, per share, respectively. The aggregate intrinsic value of stock options exercised during the years ended December 31, 2025, 2024 and 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-940">15,212</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="3" id="f-941">863</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="3" id="f-942">474</ix:nonFraction>, respectively. The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options and the fair value of the Company&#8217;s common stock for those stock options that had exercise prices lower than the fair value of the Company&#8217;s common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, there was $<ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="3" id="f-943">345,387</ix:nonFraction> total unrecognized compensation cost related to unvested stock option grants. The unvested amount is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="c-179" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-944">1.8</ix:nonNumeric> years. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-945" continuedAt="f-945-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Stock&#8209;based compensation expense related to stock options is recorded within the consolidated statements of operations and comprehensive loss as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:83%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-946">218,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-947">16,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-948">4,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-949">513,856</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-950">34,974</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-951">9,700</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%">Total stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-952">732,420</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-953">50,981</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-954">14,108</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-945-1"><ix:continuation id="f-866-4"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock-based compensation expense associated with each of our stock-based compensation arrangements:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:83%">Time-based stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-955">731,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-956">39,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-957">12,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Performance and market-based stock options </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="f-958">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-959">11,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-960">1,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-961">1,062</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-962">599</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-963">184</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%">Total stock-based compensation</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-964">732,420</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-965">50,981</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-966">14,108</ix:nonFraction></span></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_202"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:continuation id="f-770-3" continuedAt="f-770-4">Related Party Transactions</ix:continuation></span></div><div><span><br/></span></div><ix:continuation id="f-770-4" continuedAt="f-770-5"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">July 25, 2022 First Amendment to Sublease Agreement with Maky Zanganeh and Associates, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On July 25, 2022 the Company entered into a first amendment, dated July 19, 2022, to its existing sublease agreement with Maky Zanganeh and Associates, Inc. (&#8220;MZA&#8221;), an entity owned by Maky Zanganeh, consisting of <ix:nonFraction unitRef="sqft" contextRef="c-201" decimals="0" name="smmt:AreaOfPremisesSubleased" format="ixt:num-dot-decimal" scale="0" id="f-967">4,500</ix:nonFraction> square feet of office space at 2882 Sand Hill Road, Menlo Park, California. The existing sublease term, which was set to expire on September 30, 2022, was extended for a period of <ix:nonNumeric contextRef="c-201" name="smmt:RelatedPartyTransactionSubleaseExtensionTerm" format="ixt-sec:durwordsen" id="f-968">thirty-nine months</ix:nonNumeric> from October 1, 2022 through December 31, 2025. The rent payable under the terms of the sublease is equivalent to the proportionate share of the net payable by MZA to the third-party landlord, based on the square footage of office space sublet by the Company, and no mark-up has been applied. The agreement was further amended to include additional space, as noted below under the August 2, 2024 Third Amendment to Sublease Agreement with Maky Zanganeh and Associates, Inc. During the years ended December 31, 2025, 2024 and 2023, payments of $<ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="smmt:RelatedPartyTransactionPaymentsToRelatedParty" scale="3" id="f-969">834</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="smmt:RelatedPartyTransactionPaymentsToRelatedParty" scale="3" id="f-970">795</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" name="smmt:RelatedPartyTransactionPaymentsToRelatedParty" scale="3" id="f-971">762</ix:nonFraction>, respectively, were made pursuant to the first and third amendments to the Sublease Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">July 29, 2022 Second Amendment to Sublease Agreement with Maky Zanganeh and Associates, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On July 29, 2022, the Company entered into a second amendment to its existing sublease agreement with MZA, described above. The second amendment was effective as of August 1, 2022 and expires on December 31, 2025. The second amendment includes an additional <ix:nonFraction unitRef="sqft" contextRef="c-205" decimals="0" name="smmt:AreaOfPremisesSubleased" format="ixt:num-dot-decimal" scale="0" id="f-972">1,277</ix:nonFraction> square feet of office space at 2882 Sand Hill Road, Menlo Park, California. The rent payable under the terms of the sublease is equivalent to the proportionate share of the net payable by MZA to the third-party landlord, based on the square footage of office space sublet by the Company, and no mark-up has been applied. During the years ended December 31, 2025, 2024 and 2023, payments of $<ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="smmt:RelatedPartyTransactionPaymentsToRelatedParty" scale="3" id="f-973">232</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="smmt:RelatedPartyTransactionPaymentsToRelatedParty" scale="3" id="f-974">224</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="smmt:RelatedPartyTransactionPaymentsToRelatedParty" scale="3" id="f-975">218</ix:nonFraction>, respectively, were made pursuant to the second amendment to the Sublease Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">April 1, 2024 Miami Sublease Agreements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2024, the Company entered into <ix:nonFraction unitRef="contract" contextRef="c-209" decimals="INF" name="smmt:LessorOperatingLeaseNumberOfContracts" format="ixt-sec:numwordsen" scale="0" id="f-976">two</ix:nonFraction> sublease agreements of its Miami headquarters location, <ix:nonFraction unitRef="contract" contextRef="c-210" decimals="INF" name="smmt:LessorOperatingLeaseNumberOfContracts" format="ixt-sec:numwordsen" scale="0" id="f-977">one</ix:nonFraction> with Genius 24C Inc. (&#8220;Genius&#8221;), an affiliate of the Company&#8217;s Co-CEO, Robert W. Duggan (the &#8220;Genius Sublease Agreement&#8221;) and <ix:nonFraction unitRef="contract" contextRef="c-211" decimals="INF" name="smmt:LessorOperatingLeaseNumberOfContracts" format="ixt-sec:numwordsen" scale="0" id="f-978">one</ix:nonFraction> with Duggan Investments Research LLC (&#8220;Investments Research&#8221;), also an affiliate of the Company's Co-CEO, Robert W. Duggan (the &#8220;Investments Research Sublease Agreement&#8221;). Pursuant to the Genius Sublease Agreement, Genius sublet from the Company <ix:nonFraction unitRef="sqft" contextRef="c-212" decimals="0" name="smmt:LessorOperatingLeaseAreaOfPremisesLeased" scale="0" id="f-979">848</ix:nonFraction> square feet of office space in the Miami HQ for a <ix:nonNumeric contextRef="c-212" name="us-gaap:LessorOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="f-980">sixty-two month</ix:nonNumeric> term for total rental payments of approximately $<ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" scale="3" id="f-981">446</ix:nonFraction>. Pursuant to the Investments Research Sublease Agreement, Investments Research sublet from the Company <ix:nonFraction unitRef="sqft" contextRef="c-213" decimals="0" name="smmt:LessorOperatingLeaseAreaOfPremisesLeased" scale="0" id="f-982">848</ix:nonFraction> square feet of office space in the Miami HQ for a <ix:nonNumeric contextRef="c-213" name="us-gaap:LessorOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="f-983">sixty-two month</ix:nonNumeric> term for total rental payments of approximately $<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" scale="3" id="f-984">446</ix:nonFraction>. During the years ended December 31, 2025 and 2024, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="f-985">186</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="f-986">156</ix:nonFraction>, respectively, of sublease income recorded net of operating lease expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">August 2, 2024 Third Amendment to Sublease Agreement with Maky Zanganeh and Associates, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2024, the Company entered into a third amendment to its existing sublease agreement with MZA. The third amendment was effective August 1, 2024 and included an additional space of <ix:nonFraction unitRef="sqft" contextRef="c-216" decimals="0" name="smmt:AreaOfPremisesSubleased" scale="0" id="f-987">145</ix:nonFraction> square feet of office space located at 2882 </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><ix:continuation id="f-770-5" continuedAt="f-770-6"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Sand Hill Road, Menlo Park, California. The Company continues to be obligated to pay its proportionate share of the net payable by MZA to the third-party landlord, which is revised to <ix:nonFraction unitRef="number" contextRef="c-217" decimals="3" name="smmt:LesseeOperatingLeaseProportionOfAmountPayablePercentage" scale="-2" id="f-988">93.6</ix:nonFraction>% as of the effective date, based on the square footage of office space sublet by the landlord.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Promissory Note Payable to Related Parties</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 12 for disclosure of the promissory note payable to related parties issued December 6, 2022 and fully repaid as of October 1, 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Akeso Agreements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the License Agreement, the Board appointed Dr. Yu (Michelle) Xia to serve as a member of the Board pursuant to the terms of the License Agreement. Dr. Xia is the founder of Akeso, and has been the chairwoman, president and CEO of Akeso since its inception in 2012. Furthermore, in connection with the License Agreement, the Company also entered into a Supply Agreement with Akeso, pursuant to which Summit agreed to purchase a certain portion of drug substance for clinical and commercial supply (the &#8220;Supply Agreement&#8221;). Refer to Note 4 for details on the License Agreement and Second Amendment. In addition to the License and Second Amendment and supply agreements, the Company also entered into various clinical services agreements with Akeso. During the years ended December 31, 2025, 2024 and 2023, the Company incurred research and development expenses of $<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="f-989">46,133</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="f-990">24,635</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="f-991">6,207</ix:nonFraction>, respectively, under these agreements with Akeso. As of December 31, 2025 and 2024 the Company included in accrued expenses, related to Akeso, $<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-992">1,215</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-993">3,956</ix:nonFraction>, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">2023 Rights Offering</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Refer to Note 13 for a discussion on the 2023 Rights Offering.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Private Placements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">October 2023 PIPE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 13 for a discussion on the participation by related parties in October 2023 PIPE.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">September 2024 PIPE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 13 for a discussion on the participation by related parties in September 2024 PIPE.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">October 2025 PIPE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 13 for a discussion on the participation by related parties in October 2025 PIPE.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Warrants Exercise</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2025, Mr. Duggan, the Company&#8217;s Co-Chief Executive Officer, exercised <ix:nonFraction unitRef="shares" contextRef="c-223" decimals="INF" name="smmt:ClassOfWarrantOrRightExercisesInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-994">2,936,221</ix:nonFraction> of the <ix:nonFraction unitRef="shares" contextRef="c-224" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-995">3,985,055</ix:nonFraction> warrants which he received in connection with a private placement completed by the Company with Mr. Duggan and other investors on December 24, 2019, resulting in the purchase of <ix:nonFraction unitRef="shares" contextRef="c-223" decimals="INF" name="smmt:ClassOfWarrantOrRightExercisesInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-996">2,936,221</ix:nonFraction> shares of common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-225" decimals="2" name="smmt:ClassOfWarrantOrRightWeightedAverageExercisePrice" scale="0" id="f-997">1.58</ix:nonFraction>.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On April 8, 2025, Mr. Duggan completed the exercise of the remaining warrants received in the December 24, 2019 private placement, resulting in the purchase of <ix:nonFraction unitRef="shares" contextRef="c-226" decimals="INF" name="smmt:ClassOfWarrantOrRightExercisesInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-998">1,048,834</ix:nonFraction> shares of common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-226" decimals="2" name="smmt:ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" scale="0" id="f-999">1.58</ix:nonFraction>.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In October 2024, the Shaun Zanganeh Irrevocable Trust exercised a warrant to purchase <ix:nonFraction unitRef="shares" contextRef="c-227" decimals="INF" name="smmt:ClassOfWarrantOrRightExercisesInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1000">315,681</ix:nonFraction> shares of Common Stock.  Refer to Note 13 for the warrants exercise activity for the year ended December 31, 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Professional Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December 31, 2025, the Company engaged the law firm Wilson Sonsini Goodrich &amp; Rosati P.C. (&#8220;WSGR&#8221;), where Mr. Kenneth A. Clark, a member of the Board, is a partner. Payments to be made by the Company to WSGR </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summit Therapeutics Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><ix:continuation id="f-770-6"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">were approved by the Audit Committee in accordance with its Related Party Transaction Policy. For the year ended December 31, 2025, the Company incurred expenses for legal services rendered by WSGR totaling approximately $<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" name="us-gaap:LegalFees" scale="6" id="f-1001">1.4</ix:nonFraction> million included in general and administrative expenses.</span></div></ix:continuation><div><span><br/></span></div><div id="idefbe961c00a4bd4a140a4270c7a5ec4_199"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-1002" continuedAt="f-1002-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1002-1"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Fixed asset purchase commitments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2025 and 2024, the Company had <ix:nonFraction unitRef="usd" contextRef="c-5" decimals="INF" name="us-gaap:PurchaseObligation" format="ixt:fixed-zero" scale="0" id="f-1003"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="INF" name="us-gaap:PurchaseObligation" format="ixt:fixed-zero" scale="0" id="f-1004">no</ix:nonFraction></ix:nonFraction> capital commitments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Lease commitments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">11 for a discussion of the Company&#8217;s lease commitments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Other commitments</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company enters into contracts in the normal course of business with various third parties for clinical trials, preclinical research studies and testing, manufacturing and other services and products for operating purposes. Most contracts provide for termination upon notice, and therefore are cancellable contracts. The majority of these commitments are due within <ix:nonNumeric contextRef="c-5" name="smmt:OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid" format="ixt-sec:durwordsen" id="f-1005">one year</ix:nonNumeric>. As of December 31, 2025, total unconditional purchase obligations, excluding leases commitments, are estimated to be approximately $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="3" id="f-1006">17,976</ix:nonFraction>.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has certain commitments under its agreements with Akeso. The License Agreement also contains certain manufacturing and purchase commitments. As of December 31, 2025, the Company is unable to estimate the amount, timing or likelihood of achieving the milestones, making future product sales or assessing estimated forecasts for manufacturing and supplied materials which these contingent payment obligations relate to. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation Relating to the December 2022 Notes Entered into in Connection with the License Agreement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">On March 17, 2025, Rainaldi Revocable Trust, a purported stockholder of the Company, filed a derivative lawsuit in the Delaware Court of Chancery against certain of the Company&#8217;s current and former directors and the Company, solely as a nominal defendant, concerning the December 2022 Notes entered into by the Company, Mr. Duggan and Dr. Zanganeh in connection with the License Agreement. The suit asserts claims for breach of fiduciary duty and unjust enrichment and seeks, among other things, unspecified damages, rescission of the shares that Mr. Duggan and Dr. Zanganeh received as part of prepaid interest payments under the December 2022 Notes, as well as attorneys&#8217; fees and costs. Defendants&#8217; Motion to Dismiss the complaint was filed on May 16, 2025. Plaintiff filed the Motion to Certify certain constitutional questions to the Delaware Supreme Court on May 29, 2025. Defendants agreed to a stipulation staying briefing on the Motion to Certify and the Motion to Dismiss pending the Delaware Supreme Court&#8217;s decision in another case involving substantially the same constitutional questions. On June 18, 2025, the Court granted such stipulation. Defendants believe that Plaintiff's allegations are without merit and plan to vigorously defend against its claims</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>2
<FILENAME>exhibit107-formofindemni.htm
<DESCRIPTION>EX-10.7
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit107-formofindemni</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- exhibit107-formofindemni001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit107-formofindemni001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Exhibit 10.7        INDEMNIFICATION AGREEMENT  This Agreement is made as of the [_____] day of [_______] 202[_], by and between  Summit Therapeutics Inc., a Delaware corporation (the &#8220;Corporation&#8221;), and [______________]  (the &#8220;Indemnitee&#8221;), a director or officer of the Corporation.  WHEREAS, it is essential to the Corporation to retain and attract as directors and officers  the most capable persons available, and  WHEREAS, the substantial increase in corporate litigation subjects directors and officers  to expensive litigation risks at the same time that the availability of directors&#8217; and officers&#8217;  liability insurance has been severely limited, and  WHEREAS, it is now and has always been the express policy of the Corporation to  indemnify its directors and officers, and  WHEREAS, the Indemnitee does not regard the protection available under the  Corporation&#8217;s Certificate of Incorporation and insurance as adequate in the present  circumstances, and may not be willing to serve or continue to serve as a director or officer  without adequate protection, and  WHEREAS, the Corporation desires the Indemnitee to serve, or continue to serve, as a  director or officer of the Corporation.  NOW THEREFORE, the Corporation and the Indemnitee do hereby agree as follows:  1. Agreement to Serve.  The Indemnitee agrees to serve or continue to serve as a  director or officer of the Corporation for so long as the Indemnitee is duly elected or appointed  or until such time as the Indemnitee tenders a resignation in writing.  2. Definitions.  As used in this Agreement:  (a) The term &#8220;Proceeding&#8221; shall include any threatened, pending or completed  action, suit, arbitration, alternative dispute resolution proceeding, administrative hearing or other  proceeding, whether brought by or in the right of the Corporation or otherwise and whether of a  civil, criminal, administrative or investigative nature, and any appeal therefrom.  (b) The term &#8220;Corporate Status&#8221; shall mean the status of a person who is or  was, or has agreed to become, a director or officer of the Corporation, or is or was serving, or has  agreed to serve, at the request of the Corporation, as a director, officer, fiduciary, partner, trustee,  member, employee or agent of, or in a similar capacity with, another corporation, partnership,  joint venture, trust, limited liability company or other enterprise.  (c) The term &#8220;Expenses&#8221; shall include, without limitation, attorneys&#8217; fees,  retainers, court costs, transcript costs, fees and expenses of experts, travel expenses, duplicating  costs, printing and binding costs, telephone charges, postage, delivery service fees and other  disbursements or expenses of the types customarily incurred in connection with investigations,  judicial or administrative proceedings or appeals, but shall not include the amount of judgments,  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit107-formofindemni002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit107-formofindemni002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    fines or penalties against Indemnitee or amounts paid in settlement in connection with such  matters.  (d) References to &#8220;other enterprise&#8221; shall include employee benefit plans;  references to &#8220;fines&#8221; shall include any excise tax assessed with respect to any employee benefit  plan; references to &#8220;serving at the request of the Corporation&#8221; shall include any service as a  director, officer, employee or agent of the Corporation which imposes duties on, or involves  services by, such director, officer, employee, or agent with respect to an employee benefit plan,  its participants, or beneficiaries; and a person who acted in good faith and in a manner such  person reasonably believed to be in the interests of the participants and beneficiaries of an  employee benefit plan shall be deemed to have acted in a manner &#8220;not opposed to the best  interests of the Corporation&#8221; as referred to in this Agreement.  3. Indemnity of Indemnitee.  Subject to Sections 6, 7 and 9, the Corporation shall  indemnify the Indemnitee in connection with any Proceeding as to which the Indemnitee is, was  or is threatened to be made a party (or is otherwise involved) by reason of the Indemnitee&#8217;s  Corporate Status, to the fullest extent permitted by law (as such may be amended from time to  time).  In furtherance of the foregoing and without limiting the generality thereof:  (a) Indemnification in Third-Party Proceedings.  The Corporation shall  indemnify the Indemnitee in accordance with the provisions of this Section 3(a) if the Indemnitee  was or is a party to or threatened to be made a party to or otherwise involved in any Proceeding  (other than a Proceeding by or in the right of the Corporation to procure a judgment in its favor  or a Proceeding referred to in Section 6 below) by reason of the Indemnitee&#8217;s Corporate Status or  by reason of any action alleged to have been taken or omitted in connection therewith, against all  Expenses, judgments, fines, penalties and amounts paid in settlement actually and reasonably  incurred by or on behalf of the Indemnitee in connection with such Proceeding, if the Indemnitee  acted in good faith and in a manner which the Indemnitee reasonably believed to be in, or not  opposed to, the best interests of the Corporation and, with respect to any criminal Proceeding,  had no reasonable cause to believe that his or her conduct was unlawful.    (b) Indemnification in Proceedings by or in the Right of the Corporation.  The  Corporation shall indemnify the Indemnitee in accordance with the provisions of this Section  3(b) if the Indemnitee was or is a party to or threatened to be made a party to or otherwise  involved in any Proceeding by or in the right of the Corporation to procure a judgment in its  favor by reason of the Indemnitee&#8217;s Corporate Status or by reason of any action alleged to have  been taken or omitted in connection therewith, against all Expenses and, to the extent permitted  by law, amounts paid in settlement actually and reasonably incurred by or on behalf of the  Indemnitee in connection with such Proceeding, if the Indemnitee acted in good faith and in a  manner which the Indemnitee reasonably believed to be in, or not opposed to, the best interests  of the Corporation, except that, if applicable law so provides, no indemnification shall be made  under this Section 3(b) in respect of any claim, issue, or matter as to which the Indemnitee shall  have been adjudged to be liable to the Corporation, unless, and only to the extent, that the Court  of Chancery of Delaware or the court in which such action or suit was brought shall determine  upon application that, despite the adjudication of such liability but in view of all the  circumstances of the case, the Indemnitee is fairly and reasonably entitled to indemnity for such  Expenses as the Court of Chancery or such other court shall deem proper.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit107-formofindemni003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit107-formofindemni003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    4. Indemnification of Expenses of Successful Party.  Notwithstanding any other  provision of this Agreement, to the extent that the Indemnitee has been successful, on the merits  or otherwise, in defense of any Proceeding or in defense of any claim, issue or matter therein  (other than a Proceeding referred to in Section 6), the Indemnitee shall be indemnified against all  Expenses actually and reasonably incurred by or on behalf of the Indemnitee in connection  therewith.  Without limiting the foregoing, if any Proceeding or any claim, issue or matter  therein is disposed of, on the merits or otherwise (including a disposition without prejudice),  without (i) the disposition being adverse to the Indemnitee, (ii) an adjudication that the  Indemnitee was liable to the Corporation, (iii) a plea of guilty or nolo contendere by the  Indemnitee, (iv) an adjudication that the Indemnitee did not act in good faith and in a manner the  Indemnitee reasonably believed to be in or not opposed to the best interests of the Corporation,  and (v) with respect to any criminal proceeding, an adjudication that the Indemnitee had  reasonable cause to believe his or her conduct was unlawful, the Indemnitee shall be considered  for the purposes hereof to have been wholly successful with respect thereto.  5. Indemnification for Expenses of a Witness.  To the extent that the Indemnitee is,  by reason of the Indemnitee&#8217;s Corporate Status, a witness in any Proceeding to which the  Indemnitee is not a party, the Indemnitee shall be indemnified against all Expenses actually and  reasonably incurred by or on behalf of the Indemnitee in connection therewith.  6. Exceptions to Right of Indemnification.  Notwithstanding anything to the contrary  in this Agreement, except as set forth in Section 10, the Corporation shall not indemnify the  Indemnitee in connection with a Proceeding (or part thereof) initiated by the Indemnitee unless  the initiation thereof was approved by the Board of Directors of the Corporation.   Notwithstanding anything to the contrary in this Agreement, the Corporation shall not indemnify  the Indemnitee to the extent the Indemnitee is reimbursed from the proceeds of insurance, and in  the event the Corporation makes any indemnification payments to the Indemnitee and the  Indemnitee is subsequently reimbursed from the proceeds of insurance, the Indemnitee shall  promptly refund such indemnification payments to the Corporation to the extent of such  insurance reimbursement.  7. Notification and Defense of Claim.  As a condition precedent to the Indemnitee&#8217;s  right to be indemnified, the Indemnitee must notify the Corporation in writing as soon as  practicable of any Proceeding for which indemnity will or could be sought.  With respect to any  Proceeding of which the Corporation is so notified, the Corporation will be entitled to participate  therein at its own expense and/or to assume the defense thereof at its own expense, with legal  counsel of the Corporation&#8217;s choosing upon written consent by the Indemnitee, which consent  shall not be unreasonably withheld.  After notice from the Corporation to the Indemnitee of its  election so to assume such defense, the Corporation shall not be liable to the Indemnitee for any  legal or other expenses subsequently incurred by the Indemnitee in connection with such  Proceeding, other than as provided below in this Section 7.  The Indemnitee shall have the right  to employ his or her own counsel in connection with such Proceeding, but the fees and expenses  of such counsel incurred after notice from the Corporation of its assumption of the defense  thereof shall be at the expense of the Indemnitee unless (i) the employment of counsel by the  Indemnitee has been authorized by the Corporation, (ii) counsel to the Indemnitee shall have  reasonably concluded that there may be a conflict of interest or position on any significant issue  between the Corporation and the Indemnitee in the conduct of the defense of such Proceeding or  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit107-formofindemni004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit107-formofindemni004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    (iii) the Corporation shall not in fact have employed counsel to assume the defense of such  Proceeding, in each of which cases the fees and expenses of counsel for the Indemnitee shall be  at the expense of the Corporation, except as otherwise expressly provided by this Agreement,  and provided that Indemnitee&#8217;s counsel shall cooperate reasonably with the Corporation&#8217;s  counsel to minimize the cost of defending claims against the Corporation and the Indemnitee.   The Corporation shall not be entitled, without the consent of the Indemnitee, to assume the  defense of any claim brought by or in the right of the Corporation or as to which counsel for the  Indemnitee shall have reasonably made the conclusion provided for in clause (ii) above.  The  Corporation shall not be required to indemnify the Indemnitee under this Agreement for any  amounts paid in settlement of any Proceeding effected without its written consent.  The  Corporation shall not settle any Proceeding in any manner that would impose any penalty or  limitation on the Indemnitee without the Indemnitee&#8217;s written consent.  Neither the Corporation  nor the Indemnitee will unreasonably withhold or delay their consent to any proposed settlement.  8. Advancement of Expenses.  In the event that the Corporation does not assume the  defense pursuant to Section 7 of any Proceeding of which the Corporation receives notice under  this Agreement, any Expenses actually and reasonably incurred by or on behalf of the  Indemnitee in defending such Proceeding shall be paid by the Corporation in advance of the final  disposition of such Proceeding; provided, however, that the payment of such Expenses incurred  by or on behalf of the Indemnitee in advance of the final disposition of such Proceeding shall be  made only upon receipt of an undertaking by or on behalf of the Indemnitee to repay all amounts  so advanced in the event that it shall ultimately be determined that the Indemnitee is not entitled  to be indemnified by the Corporation as authorized in this Agreement.  Such undertaking shall be  accepted without reference to the financial ability of the Indemnitee to make repayment.  Any  advances and undertakings to repay pursuant to this Section 8 shall be unsecured and interest- free.  9. Procedures.    (a) In order to obtain indemnification or advancement of Expenses pursuant to  this Agreement, the Indemnitee shall submit to the Corporation a written request, including in  such request such documentation and information as is reasonably available to the Indemnitee  and is reasonably necessary to determine whether and to what extent the Indemnitee is entitled to  indemnification or advancement of Expenses.  Any such indemnification or advancement of  Expenses shall be made promptly, and in any event within (i) in the case of indemnification  under Sections 4 or 5or advancement of Expenses, 30 days after receipt by the Corporation of the  written request of the Indemnitee, or (ii) in the case of all other indemnification, 60 days after  receipt by the Corporation of the written request of the Indemnitee, unless with respect to  requests under this clause (ii) the Corporation determines, by clear and convincing evidence,  within the 60-day period that the Indemnitee did not meet the applicable standard of conduct.   Such determination, and any determination that advanced Expenses must be repaid to the  Corporation, shall be made in each instance (a) by a majority vote of the directors of the  Corporation consisting of persons who are not at that time parties to the Proceeding  (&#8220;disinterested directors&#8221;), whether or not a quorum, (b) by a committee of disinterested directors  designated by a majority vote of disinterested directors, whether or not a quorum, (c) if there are  no disinterested directors, or if the disinterested directors so direct, by independent legal counsel  (who may, to the extent permitted by applicable law, be regular legal counsel to the Corporation)  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit107-formofindemni005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit107-formofindemni005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    in a written opinion, or (d) by the stockholders of the Corporation.  The termination of any  Proceeding by judgment, order, settlement, conviction or upon a plea of nolo contendere or its  equivalent, shall not, of itself, create a presumption that the Indemnitee did not act in good faith  and in a manner that the Indemnitee reasonably believed to be in, or not opposed to, the best  interests of the Corporation, and, with respect to any criminal Proceeding, had reasonable cause  to believe that his or her conduct was unlawful.  (b) The Indemnitee shall cooperate with the person, persons or entity making  such determination with respect to the Indemnitee&#8217;s entitlement to indemnification, including  providing to such person, persons or entity upon reasonable advance request any documentation  or information which is not privileged or otherwise protected from disclosure and which is  reasonably available to the Indemnitee and reasonably necessary to such determination.  Any  Expenses actually and reasonably incurred by the Indemnitee in so cooperating shall be borne by  the Corporation (irrespective of the determination as to the Indemnitee&#8217;s entitlement to  indemnification) and the Corporation hereby indemnifies the Indemnitee therefrom.  10. Remedies.  The right to indemnification or advancement of Expenses as provided  by this Agreement shall be enforceable by the Indemnitee as provided in Section 25 if the  Corporation denies such request, in whole or in part, or if no disposition thereof is made within  the applicable period referred to in Section 9.  Unless otherwise required by law, the burden of  proving that indemnification or advancement of Expenses is not appropriate shall be on the  Corporation.  Neither the failure of the Corporation to have made a determination prior to the  commencement of such action that indemnification is proper in the circumstances because the  Indemnitee has met the applicable standard of conduct, nor an actual determination by the  Corporation that the Indemnitee has not met such applicable standard of conduct, shall be a  defense to the action or create a presumption that the Indemnitee has not met the applicable  standard of conduct.  The Indemnitee&#8217;s Expenses actually and reasonably incurred in connection  with successfully establishing the Indemnitee&#8217;s right to indemnification, in whole or in part, in  any such Proceeding shall also be indemnified by the Corporation.  11. Partial Indemnification.  If the Indemnitee is entitled under any provision of this  Agreement to indemnification by the Corporation for some or a portion of the Expenses,  judgments, fines, penalties or amounts paid in settlement actually and reasonably incurred by or  on behalf of the Indemnitee in connection with any Proceeding but not, however, for the total  amount thereof, the Corporation shall nevertheless indemnify the Indemnitee for the portion of  such Expenses, judgments, fines, penalties or amounts paid in settlement to which the  Indemnitee is entitled.  12. Subrogation.  In the event of any payment under this Agreement, the Corporation  shall be subrogated to the extent of such payment to all of the rights of recovery of the  Indemnitee, who shall execute all papers required and take all action necessary to secure such  rights, including execution of such documents as are necessary to enable the Corporation to bring  suit to enforce such rights.  13. Term of Agreement.  This Agreement shall continue until and terminate upon the  later of (a) six years after the date that the Indemnitee shall have ceased to serve as a director or  officer of the Corporation or, at the request of the Corporation, as a director, officer, partner,  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit107-formofindemni006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit107-formofindemni006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    trustee, member, employee or agent of another corporation, partnership, joint venture, trust,  limited liability company or other enterprise or (b) the final termination of all Proceedings  pending on the date set forth in clause (a) in respect of which the Indemnitee is granted rights of  indemnification or advancement of Expenses hereunder and of any proceeding commenced by  the Indemnitee pursuant to Section 10 of this Agreement relating thereto.  14. Indemnification Hereunder Not Exclusive.  The indemnification and advancement  of Expenses provided by this Agreement shall not be deemed exclusive of any other rights to  which the Indemnitee may be entitled under the Certification of Incorporation, the By-Laws, any  other agreement, any vote of stockholders or disinterested directors, the General Corporation  Law of Delaware, any other law (common or statutory), or otherwise, both as to action in the  Indemnitee&#8217;s official capacity and as to action in another capacity while holding office for the  Corporation.  Nothing contained in this Agreement shall be deemed to prohibit the Corporation  from purchasing and maintaining insurance, at its expense, to protect itself or the Indemnitee  against any expense, liability or loss incurred by it or the Indemnitee in any such capacity, or  arising out of the Indemnitee&#8217;s status as such, whether or not the Indemnitee would be  indemnified against such expense, liability or loss under this Agreement; provided that the  Corporation shall not be liable under this Agreement to make any payment of amounts otherwise  indemnifiable hereunder if and to the extent that the Indemnitee has otherwise actually received  such payment under any insurance policy, contract, agreement or otherwise.  15. No Special Rights.  Nothing herein shall confer upon the Indemnitee any right to  continue to serve as an officer or director of the Corporation for any period of time or at any  particular rate of compensation.  16. Savings Clause.  If this Agreement or any portion thereof shall be invalidated on  any ground by any court of competent jurisdiction, then the Corporation shall nevertheless  indemnify the Indemnitee as to Expenses, judgments, fines, penalties and amounts paid in  settlement with respect to any Proceeding to the full extent permitted by any applicable portion  of this Agreement that shall not have been invalidated and to the fullest extent permitted by  applicable law.  17. Counterparts.  This Agreement may be executed in any number of counterparts,  each of which shall constitute the original.  18. Successors and Assigns.  This Agreement shall be binding upon the Corporation  and its successors and assigns and shall inure to the benefit of the estate, heirs, executors,  administrators and personal representatives of the Indemnitee.  19. Headings.  The headings of the paragraphs of this Agreement are inserted for  convenience only and shall not be deemed to constitute part of this Agreement or to affect the  construction thereof.  20. Modification and Waiver.  This Agreement may be amended from time to time to  reflect changes in Delaware law or for other reasons.  No supplement, modification or  amendment of this Agreement shall be binding unless executed in writing by both of the parties  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit107-formofindemni007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit107-formofindemni007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    hereto.  No waiver of any of the provisions of this Agreement shall be deemed or shall constitute  a waiver of any other provision hereof nor shall any such waiver constitute a continuing waiver.  21. Notices.  All notices, requests, demands and other communications hereunder  shall be in writing and shall be deemed to have been given (i) when delivered by hand, (ii) if  mailed by certified or registered mail with postage prepaid, on the third day after the date on  which it is so mailed, or (iii) when emailed:  (a) if to the Indemnitee, to the address set forth below    (b) if to the Corporation, to:  Summit Therapeutics Inc.  601 Brickell Key Drive  Suite 1000  Miami, FL 33131  Attention: Legal Department  Email: Legalnotices@smmttx.com     or to such other address as may have been furnished to the Indemnitee by the Corporation or to  the Corporation by the Indemnitee, as the case may be.  22. Applicable Law.  This Agreement shall be governed by, and construed and  enforced in accordance with, the laws of the State of Delaware.  The Indemnitee may elect to  have the right to indemnification or reimbursement or advancement of Expenses interpreted on  the basis of the applicable law in effect at the time of the occurrence of the event or events giving  rise to the applicable Proceeding, to the extent permitted by law, or on the basis of the applicable  law in effect at the time such indemnification or reimbursement or advancement of Expenses is  sought.  Such election shall be made, by a notice in writing to the Corporation, at the time  indemnification or reimbursement or advancement of Expenses is sought; provided, however,  that if no such notice is given, and if the General Corporation Law of Delaware is amended, or  other Delaware law is enacted, to permit further indemnification of the directors and officers,  then the Indemnitee shall be indemnified to the fullest extent permitted under the General  Corporation Law, as so amended, or by such other Delaware law, as so enacted.    23. Enforcement.  The Corporation expressly confirms and agrees that it has entered  into this Agreement in order to induce the Indemnitee to continue to serve as an officer or  director of the Corporation, and acknowledges that the Indemnitee is relying upon this  Agreement in continuing in such capacity.  24. Entire Agreement.  This Agreement sets forth the entire agreement of the parties  hereto in respect of the subject matter contained herein and supercedes all prior agreements,  whether oral or written, by any officer, employee or representative of any party hereto in respect  of the subject matter contained herein; and any prior agreement of the parties hereto in respect of  the subject matter contained herein is hereby terminated and cancelled.  For avoidance of doubt,  the parties confirm that the foregoing does not apply to or limit the Indemnitee&#8217;s rights under  Delaware law or the Corporation&#8217;s Certificate of Incorporation or By-Laws.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit107-formofindemni008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit107-formofindemni008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    25. Consent to Suit.  In the case of any dispute under or in connection with this  Agreement, the Indemnitee may only bring suit against the Corporation in the Court of Chancery  of the State of Delaware.  The Indemnitee hereby consents to the exclusive jurisdiction and  venue of the courts of the State of Delaware, and the Indemnitee hereby waives any claim the  Indemnitee may have at any time as to forum non conveniens with respect to such venue.  The  Corporation shall have the right to institute any legal action arising out of or relating to this  Agreement in any court of competent jurisdiction.  Any judgment entered against either of the  parties in any proceeding hereunder may be entered and enforced by any court of competent  jurisdiction.    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit107-formofindemni009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit107-formofindemni009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as  of the day and year first above written.  SUMMIT THERAPEUTICS INC.  By:       Name:       Title:       INDEMNITEE  By:       Name:       Address:                   Email:   _______________________                                      [Signature Page to Summit Therapeutics Inc. Indemnification Agreement]  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-14.1
<SEQUENCE>3
<FILENAME>ethicsemployeepolicybook.htm
<DESCRIPTION>EX-14.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ethicsemployeepolicybook</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ethicsemployeepolicybook001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ethicsemployeepolicybook001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">www.smmttx.com Summit Code of Business  Conduct and Ethics </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ethicsemployeepolicybook002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ethicsemployeepolicybook002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">TABLE OF   CONTENTS www.smmttx.com Overview  &#8226; Our Individual Responsibility &#8226; Non-Retaliation &#8226; Conflicts of Interest &#8226; Insider Training &#8226; Compliance With Anti-Bribery/ Anti-Corruption Laws and Other International Laws &#8226; Compliance With Antitrust Laws &#8226; Confidentiality &#8226; Compliance With Data Privacy Laws &#8226; Honest and Ethical Conduct and Fair Dealing &#8226; Protection and Proper Use of Corporate Assets &#8226; Intellectual Property Ownership &#8226; Gifts and Gratuities &#8226; Employee Privacy &#8226; Accuracy of Books and Records and Public Reports &#8226; Dealings with Independent Auditors &#8226; Ensure Human Subject Protection in Clinical Trials &#8226; Social Media Activities &#8226; Compliance with Environmental Laws &#8226; Waivers of this Code of Business Conduct and Ethics &#8226; Reporting and Compliance Procedures &#8226; Dissemination and Amendment 2 Overview Compliance with Company Policies  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ethicsemployeepolicybook003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ethicsemployeepolicybook003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Summit Code of Business Conduct and Ethics Code of Business Conduct and Ethics COMPLIANCE WITH COMPANY POLICIESOVERVIEW &#8220; Summit Mission Statement: &#8220;&#8230;We accomplish this by building a team of  world class professional scientists and business administrators that apply  their experience and knowledge to this mission. SUMMIT THERAPEUTICS INC. CODE OF BUSINESS CONDUCT AND ETHICS It is the Company&#8217;s policy to promote high standards of integrity by conducting our affairs in an honest and  ethical manner. The integrity and reputation of the Company depends on the honesty, fairness and integrity  brought by all Summit Personnel. Unyielding personal integrity is the foundation of corporate integrity. Obeying the law is the foundation of our Code. Our success depends upon Summit Personnel operating within  legal guidelines and cooperating with local, national, and international authorities. All Summit Personnel are  expected to understand the legal and regulatory requirements applicable to their business units and areas of  responsibility. While you are not expected to memorize every detail of applicable laws, rules, and regulations, it  is expected that you will be able to determine when it is appropriate to seek guidance. If you have a question  about compliance with local, national, or international laws, you should seek an answer from your manager, the  legal department or compliance office. Summit Therapeutics Inc., and its affiliates and  subsidiaries (the &#8220;Company&#8221; or &#8220;Summit&#8221;) is committed  to creating an environment where we are able to do our  best work while maintaining the highest standards of  business conduct and ethics. This Code of Business  Conduct and Ethics (the &#8220;Code&#8221;) sets forth legal and  ethical standards of conduct for employees, officers, and  directors of Summit Therapeutics Inc. (the &#8220;Summit  Personnel&#8221;). This Code is intended to deter wrongdoing and to  promote the conduct of Company business in  accordance with high standards of integrity and in  compliance with all applicable laws and regulations.  Except as otherwise required by applicable local law, this  Code applies to the Company, its subsidiaries and other  business entities controlled by the Company worldwide. If you have any questions regarding this Code or its application to you in any situation,  you should contact your manager, the Legal Department, or the Compliance Office. &#8220; Our Individual Responsibility Overview  3 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ethicsemployeepolicybook004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ethicsemployeepolicybook004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Summit Code of Business Conduct and Ethics Code of Business Conduct and Ethics COMPLIANCE WITH COMPANY POLICIES Employees, officers, and directors shall not  discharge, demote, suspend, threaten, harass or  in any other manner discriminate or retaliate  against an employee because he or she reports  any such violation. However, if the report was  made with knowledge that it was false, the  Company may take appropriate disciplinary  action up to and including termination.  This Code should not be construed to prohibit  you from engaging in concerted activity  protected by the rules and regulations of the  National Labor Relations Board or from  testifying, participating, or otherwise assisting in  any state or federal administrative, judicial, or  legislative proceeding or investigation. Disregard of the law, rules, regulations, and policies will not be tolerated. Violation of laws, rules, and regulations  of any country may subject an individual, as well as the Company, to civil and/or criminal penalties. Failure to  comply in all respects with the Company&#8217;s policies, including the Code, may have disciplinary consequences, up  to and including termination. You should be aware that conduct and records, including emails, are subject to  internal and external audits and to discovery by third parties in the event of a government investigation or civil  litigation. It is in everyone&#8217;s best interests to know and comply with our legal obligations. While it is the Company&#8217;s desire to address matters internally, nothing in this Code prohibits you from reporting  any illegal activity, including any violation of the securities laws, antitrust laws, environmental laws or any other  federal, state, or foreign law, rule, or regulation, to the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) or  any other applicable regulatory agency or governmental entity (each, a &#8220;Government Body&#8221;). For the avoidance of doubt, nothing in this Code is to be interpreted or applied in any way that prohibits,  restricts or interferes with an employee&#8217;s (a) exercise of rights provided under, or participation in,  &#8220;whistleblower&#8221; programs of the SEC or any other Government Body, (b) good faith reporting of possible  violations of applicable law to any Government Body, including cooperating with a Government Body in any  governmental investigation regarding possible violations of applicable law, or (c) right to engage in other legally  protected communications. Non-Retaliation 4 Our Individual Responsibility (continued) </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ethicsemployeepolicybook005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ethicsemployeepolicybook005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Summit Code of Business Conduct and Ethics Code of Business Conduct and Ethics COMPLIANCE WITH COMPANY POLICIES COMPLIANCE WITH COMPANY POLICIES Summit Personnel must refrain from engaging in any activity or having a personal interest that presents a  &#8220;conflict of interest&#8221; and should seek to avoid even the appearance of a conflict of interest. A conflict of  interest occurs when your personal interest interferes with the business interests of the Company. A conflict of  interest can arise whenever you, as a Summit Personnel, or a member of your immediate family, take action or  have an interest that prevents you from performing your Company duties and responsibilities honestly,  objectively and effectively. An immediate family member includes all family members of Summit Personnel who share the same address  as, or are financially dependent on, the Summit Personnel and any other person who shares the same address  as such Summit Personnel (other than (x) an employee or tenant of such Summit Personnel (y) another  unrelated person whom the Chief Executive Officer or Chief Financial Officer determines should not be  covered by this policy.  For example: &#8226; No Summit Personnel (or their immediate family) shall perform services as an employee, officer, director, consultant, advisor or in any other capacity for a direct competitor of the Company, as determined by the Board of Directors of the Company (the &#8220;Board&#8221;), other than services performed at the request of the Company; &#8226; No Summit Personnel (or their immediate family) shall have a financial interest in a direct competitor of the Company, as determined by the Board, other than a financial interest representing less than three percent (3%) of the outstanding shares of a publicly held company; and &#8226; No Summit Personnel (or their immediate family) shall use his or her position with the Company to influence a transaction with a supplier or customer in which such person has any personal interest, other than a financial interest representing less than three percent (3%) of the outstanding shares of a publicly held company. Conflicts of Interest 5 Every employee, officer and director is expected to comply with all Company policies  and rules. You are expected to familiarize yourself with such policies. </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ethicsemployeepolicybook006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ethicsemployeepolicybook006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Summit Code of Business Conduct and Ethics Code of Business Conduct and Ethics COMPLIANCE WITH COMPANY POLICIES It is your responsibility to disclose any material transaction or relationship that reasonably could be expected  to give rise to a conflict of interest to the principal financial officer or, if you are an executive officer or director,  to the Board, who shall be responsible for determining whether such transaction or relationship constitutes a  conflict of interest. There are strict laws that prohibit the use of material non-public information when transacting in our or another  company&#8217;s publicly traded securities. All Summit Personnel shall comply with the Company&#8217;s Insider Trading  Policy. See POL-CORP-004: Insider Trading Policy Summit Personnel are expected to comply with the applicable laws in all countries to which they travel, in  which they operate and where the Company is located, or otherwise does business, including laws prohibiting  bribery, corruption or the conduct of business with specified individuals, companies or countries. The fact that,  in some countries, certain laws are not enforced or that violation of those laws is not subject to public criticism  is not an excuse for noncompliance. We expect Summit Personnel to comply with U.S. laws, rules, and  regulations governing the conduct of business by its citizens and corporations outside the U.S. These U.S.  laws, rules, and regulations, which extend to all our activities outside the U.S., include: &#8226; The Foreign Corrupt Practices Act, which prohibits directly or indirectly giving anything of value to a government official to obtain or retain business or favorable treatment and requires the maintenance of accurate books of account, with all company transactions being properly recorded; &#8226; U.S. embargoes, which generally prohibit U.S. companies, their subsidiaries, and their employees from doing business with, or traveling to, countries subject to sanctions imposed by the U.S. government (including, Iran, North Korea, Sudan, and Syria), as well as doing business with specific companies and individuals identified on lists published by the U.S. Treasury Department; &#8226; U.S. export controls, which restrict exports from the U.S. and re-exports from other countries of goods, software, and technology to many countries, and prohibit transfers of U.S.-origin items to denied persons and entities; and &#8226; Antiboycott regulations, which prohibit U.S. companies from taking any action that has the effect of furthering or supporting a restrictive trade practice or boycott imposed by a foreign country against a country friendly to the U.S. or against any U.S. person. If you have a question as to whether an activity is restricted or prohibited, please ask before taking any action,  including giving any verbal assurances that might be regulated by international laws. COMPLIANCE WITH COMPANY POLICIES continued Insider Trading Compliance With Anti-Bribery/Anti-Corruption Laws and Other International Laws 6 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ethicsemployeepolicybook007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ethicsemployeepolicybook007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Summit Code of Business Conduct and Ethics Code of Business Conduct and Ethics COMPLIANCE WITH COMPANY POLICIES Antitrust laws are designed to protect the competitive process. These laws generally prohibit: &#8226; Formal or informal agreements with competitors that harm competition or customers, including price fixing and allocations of customers, territories, or contracts; &#8226; Formal or informal agreements that establish or fix the price at which a customer may resell a product; and &#8226; The acquisition or maintenance of a monopoly or attempted monopoly through anti- competitive conduct. Certain kinds of information, such as our strategies and identification of local business partnerships,  should not be exchanged with competitors, regardless of how innocent or casual the exchange may be  and regardless of the setting, whether business or social. Confidential information is one of the Company&#8217;s most important assets. Summit may sometimes share  confidential information with Summit Personnel, and we expect you to keep that information confidential, and  not disclose or use it except as needed to perform your work here, as you agreed in your confidentiality  agreement with the Company. Confidential information includes all non-public information that, if disclosed,  might be of use to competitors, harmful to the Company or its customers, or is information that provides  economic advantage to the Company because the information is not generally known.  Confidential  information also includes: (1) personally identifiable information obtained within the scope of employment; (2)  Company inventions; (3) written material provided, and information discussed at all meetings of the Board or  any committee thereof; and (4) all information that is learned about the Company&#8217;s suppliers and customers  that is not in the public domain.  The obligation to preserve confidential information continues even after  employment or agency with the Company ends.  Unless you are instructed otherwise, you should assume that  everything (financials, strategy and plans, scientific and technical data, details and results of our studies and  clinical trials, information about our drug candidates, personnel information, legal disputes, etc.) is  confidential. If you have any questions about whether information may be considered confidential, you should  consult the VP of Legal. In addition, because we interact with other companies and organizations, there may be times when you learn  confidential information about other companies before that information has been made available to the  public. You must treat this information in the same manner as you are required to treat our confidential and  proprietary information. There may even be times when you must treat as confidential the fact that we have an  interest in, or are involved with, another company. All Summit Personnel have a duty to refrain from disclosing to any person confidential or proprietary  information about us or any other company learned in the course of employment here, until that information is  disclosed to the public through approved channels (usually through a press release, an SEC filing, or a formal  communication from a member of senior management). This policy requires you to refrain from discussing  confidential or proprietary information with outsiders and even with other Summit Personnel unless those  fellow Company Personnel have a legitimate need to know the information in order to perform their job  duties. Unauthorized use or distribution of this information could also be illegal and result in civil liability  and/or criminal penalties. COMPLIANCE WITH COMPANY POLICIES continued Compliance With Antitrust Laws Confidentiality 7 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ethicsemployeepolicybook008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ethicsemployeepolicybook008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Summit Code of Business Conduct and Ethics Code of Business Conduct and Ethics COMPLIANCE WITH COMPANY POLICIES You should also take care not to inadvertently disclose confidential information. Materials that contain  confidential information, such as memos, notebooks, computer disks, memory sticks, laptop computers,  tablets, and mobile devices, should be stored securely. Unauthorized posting or discussion of any information concerning our business, information or prospects on  the internet is prohibited. All Company emails, voicemails, and other communications are presumed  confidential and should not be forwarded or otherwise disseminated outside of the Company, except when  required for legitimate business purposes. Be cautious when discussing sensitive information in public places  like elevators, airports, restaurants and &#8220;quasi- public&#8221; areas within the Company, such as cafeterias. Please take special care when talking to your friends, family, or others about the Company or our industry.  Summit is committed to complying with all applicable state, federal and international privacy and data  protection laws including, but not limited to, the General Data Protection Regulation (&#8220;GDPR&#8221;) the Health  Insurance Portability and Accountability Act and its implementing regulations (&#8220;HIPAA&#8221;), and state laws (e.g.,  California Consumer Privacy Act (CCPA) in the United States) by; &#8226; Following industry best practices in relation to data protection; &#8226; Respecting the rights of an identified or identifiable natural person (&#8220;Data Subjects&#8221;); &#8226; Providing transparency as to how Summit collects, processes and maintains information relating to a Data Subject (&#8220;Personal Data&#8221;); &#8226; Safeguarding Personal Data and Summit&#8217;s systems that are used for the processing of Personal Data; &#8226; Working with third parties acting as Data Controllers or Data Processors (as defined by the GDPR) to ensure that their security and processes meet our requirements; and &#8226; Protecting Summit&#8217;s organization, Summit Personnel, and the Personal Data that Summit maintains against the risk of data breaches. See POL-CORP-006: Privacy Policy for more details. COMPLIANCE WITH COMPANY POLICIES continued Summit Personnel should endeavor to deal honestly,  ethically, and fairly with the Company&#8217;s suppliers,  customers, competitors, and employees. Statements  regarding the Company&#8217;s therapies and services must be  true and accurate, and not misleading, deceptive or  fraudulent. You must not take unfair advantage of anyone  through manipulation, concealment, abuse of privileged  information, misrepresentation of material facts or any  other unfair-dealing practice. Compliance With Data Privacy Laws Honest and Ethical Conduct and Fair Dealing  8 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ethicsemployeepolicybook009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ethicsemployeepolicybook009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Summit Code of Business Conduct and Ethics Code of Business Conduct and Ethics COMPLIANCE WITH COMPANY POLICIES Summit Personnel should seek to protect the Company&#8217;s assets, including Proprietary Information. Theft,  carelessness, and waste have a direct impact on the Company&#8217;s financial performance. Employees, officers, and  directors must use the Company&#8217;s assets and services solely for legitimate business purposes of the Company  and not for any personal benefit or the personal benefit of anyone else. The use of any Company funds or assets  for any unlawful or improper purpose is prohibited. Summit Personnel must advance the Company&#8217;s legitimate interests when the opportunity to do so arises. You  must not take for yourself personal opportunities that are discovered through your position with the Company or  the use of property or information of the Company. The Company, to the fullest extent allowed by law, owns all right, title and interest, including intellectual property  rights relating to any and all inventions, discoveries, developments, improvements, innovations, works of  authorship, designs, know-how, ideas, formulas, processes, techniques, data and information employees  conceive, develop, reduce to practice, or create, which are (i) conceived, developed, reduced to practice, or  created by the employees (a) within the scope of their employment or (b) with the aid, assistance, or use of any of  the Company&#8217;s property, equipment, facilities, supplies, resources, or intellectual property; (ii) the result of any  work, services, or duties performed by employees for the Company; (iii) related to the industry or trade of the  Company; or (iv) related to the current or demonstrably anticipated business, research, or development of the  Company (&#8220;Company Inventions&#8221;). The Company may require an employee to execute an intellectual property assignment to confirm the  Company&#8217;s ownership of Company Inventions; however, the failure of the Company to request or obtain such an  agreement shall not reduce or otherwise limit the rights the Company has or may have pursuant to this Code. There are certain times when the exchange of gifts may be appropriate in the course of conducting business. It is  important to remember, however, that we must never exchange gifts if such exchange could compromise or be  reasonably perceived as compromising our business judgment. As a general rule, exchanging gifts or customary  business entertainment with business partners is appropriate so long as the gift or entertainment is modest in  value and not given frequently. Stricter and more specific rules apply when we do business with healthcare  professionals and state, local, and federal government personnel and contractors acting on their behalf. See  Summit Policy POL-COMP-003: Gifts, Meals and Business Courtesies COMPLIANCE WITH COMPANY POLICIES continued Protection and Proper Use of Corporate Assets Intellectual Property Ownership Gifts and Gratuities 9 Remember: Summit&#8217;s interactions with HCPs are intended to inform HCPs about  Summit&#8217;s products, provide relevant scientific and educational information to support  patient care and the practice of medicine. Summit only provides meals to HCPs when  the meal is incidental to the legitimate business or educational purpose of the  discussion. Similarly, Summit only provides educational items for the purpose of  aiding HCP or patient education. </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ethicsemployeepolicybook010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ethicsemployeepolicybook010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Summit Code of Business Conduct and Ethics Code of Business Conduct and Ethics COMPLIANCE WITH COMPANY POLICIES Personal information about Summit Personnel is treated with the strictest confidentiality and will be shared on  a need-to-know basis internally and externally with relevant authorities as required by law. Personal  information includes information which identifies an individual, or from which an individual&#8217;s identity can be  ascertained, and includes sensitive information. Sensitive information includes information about an  individual&#8217;s racial or ethnic origin, political opinions, philosophical or religious beliefs or affiliations,  membership of a political, trade or professional association, sexual preferences or practices, criminal record,  government assigned information (e.g., U.S. Social Security number) or health information. Summit Personnel who are responsible for maintaining personal information must ensure that the information  is not disclosed inappropriately or misused. However, except as provided by applicable law, employees shall have a very limited expectation of privacy  with respect to their use of Company-provided information systems (e.g., work computers, mobile phones and  email). To the extent allowed by applicable law, the Company may monitor and inspect its information systems  for purposes of assuring system security and/or compliance with Company policies. For such purposes the  Company may, with or without notice, audit or monitor computerized information, messages, email, or  Internet transactions electronically, in accordance with applicable laws. The Company may also, in accordance  with applicable laws, inspect the content of files, email or other messages in the course of an investigation  triggered by indications of impropriety or as necessary to locate information that is no more available by other  less intrusive means. COMPLIANCE WITH COMPANY POLICIES continued Summit Personnel must honestly and accurately report all  Company business transactions. You are responsible for the  accuracy of your records and reports. Accurate information is  essential to the Company&#8217;s ability to meet legal and regulatory  obligations. All Company books, records and accounts shall be maintained  in accordance with all applicable regulations and standards and  accurately reflect the true nature of the transactions they record.  The financial statements of the Company shall conform to  generally accepted accounting rules and the Company&#8217;s  accounting policies. No undisclosed or unrecorded account or  fund shall be established for any purpose. No false or  misleading entries shall be made in the Company&#8217;s books or  records for any reason, and no disbursement of corporate funds  or other corporate property shall be made without adequate  supporting documentation. It is the policy of the Company to  provide full, fair, accurate, timely and understandable  disclosure in reports and documents filed with, or submitted to,  the SEC and in other public communications. Employee Privacy Accuracy of Books and Records and Public Reports 10 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ethicsemployeepolicybook011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ethicsemployeepolicybook011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Summit Code of Business Conduct and Ethics Code of Business Conduct and Ethics COMPLIANCE WITH COMPANY POLICIES No employee, officer or director shall, directly or indirectly, make or cause to be made a materially false or  misleading statement to an accountant in connection with (or omit to state, or cause another person to omit to  state, any material fact necessary in order to make statements made, in light of the circumstances under which  such statements were made, not misleading to, an accountant in connection with) any audit, review or  examination of the Company&#8217;s financial statements or the preparation or filing of any document or report with  the SEC. No employee, officer or director shall, directly or indirectly, take any action to coerce, manipulate,  mislead, or fraudulently influence any independent public or certified public accountant engaged in the  performance of an audit or review of the Company&#8217;s financial statements. Clinical trials determine the safety and efficacy of our products in people who volunteer to participate in our  studies. It is, therefore, crucial that we conduct these trials with the utmost regard for the health and safety of  participants while furthering the interests of science and society. Summit is committed to ensuring the safety of  patients and volunteers who take part in our clinical trials, and to upholding the highest ethical, scientific and  clinical standards in all our research initiatives worldwide. In addition, in all research endeavors sponsored by  the Company, personnel and those working on behalf of the Company are strictly prohibited from  inappropriately influencing the results and conclusion published from such research. Information about specific Summit-sponsored patient trials is available on http://www.ClinicalTrials.gov, a  publicly available study registry and results database maintained by the U.S. National Institutes of Health. COMPLIANCE WITH COMPANY POLICIES continued Dealings with Independent Auditors Ensure Human Subject Protection in Clinical Trials 11 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ethicsemployeepolicybook012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ethicsemployeepolicybook012.jpg" title="slide12" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Summit Code of Business Conduct and Ethics Code of Business Conduct and Ethics COMPLIANCE WITH COMPANY POLICIES The Company&#8217;s relations with patients, Health Care Professionals, and business partners depend on appropriate  channels for full discussion and providing accurate information. Using Company computers or equipment is  strongly discouraged when engaging in social media activities unless you are an authorized based upon your  job responsibilities. You are not allowed to discuss any Company products or investigational compounds in any  social media forum or otherwise disclose confidential or non-public information. You should direct all medial  inquires to Investor Relations. You may only speak on behalf of the Company if you are authorized to do so. See  Summit&#8217;s Social Media Policy.  See Summit Policy POL-CORP-006: Social Media Policy Federal law imposes criminal liability on any person or company that contaminates the environment with any  hazardous substance that could cause injury to the community or environment. Violation of environmental laws  can involve monetary fines and imprisonment. It is expected that all Summit Personnel will comply with all  applicable environmental laws. While some of the policies contained in this Code must be strictly adhered to and no exceptions can be allowed,  in other cases exceptions may be appropriate.  Any waiver of this Code must be initially discussed with the  Summit Personnel&#8217;s immediate manager. If the manager agrees that a waiver should be considered, then a  waiver request must be submitted to the Legal Department for review and approval. The Legal Department may  consult with individuals from Compliance, Finance or Human Resources in determining whether to grant a  waiver. Any executive officer or director who seeks a waiver of this Code should contact the Chair of the Audit  Committee. Any waiver of this Code for executive officers or directors or any change to this Code that applies to  executive officers or directors must be approved by the Board of Directors of the Company and will be disclosed  as required by law or stock exchange regulation. COMPLIANCE WITH COMPANY POLICIES continued Social Media Activities Compliance with Environmental Laws Waivers of this Code of Business Conduct and Ethics 12 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ethicsemployeepolicybook013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ethicsemployeepolicybook013.jpg" title="slide13" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Summit Code of Business Conduct and Ethics Code of Business Conduct and Ethics COMPLIANCE WITH COMPANY POLICIES All Summit Personnel are expected and encouraged to ask questions and raise concerns. Reporting concerns  and raising questions allows our Company to quickly remedy any potential misconduct, sometimes even  before it takes place. You have several options if you need to ask a question or make a report. Speaking with  your manager is always a good place to start. If for some reason, you are not comfortable speaking with or  making a report to your manager, you have other options.  Compliance: You can contact the Compliance Office directly to report a concern or ask a question by: Email: compliance@smmttx.com; or Mail: Summit Compliance; 601 Brickell Key Drive, Suite 1000, Miami, FL 33131 The Audit Committee of The Board of Directors: You can raise concerns regarding questionable accounting and/or auditing matters to the Audit Committee  by using the following webtool: https://www.whistleblowerservices.com/smmt or calling: This Code shall be distributed to each new employee, officer, and director of the Company upon  commencement of employment or other relationship with the Company and shall also be distributed annually  to each employee, officer and director of the Company, and each employee and officer shall certify via  MasterControl or other designated certification process that he or she has received, read and understood the  Code and has complied with its terms. The Company reserves the right to amend, alter or terminate this Code at any time for any reason. This Code  shall be reviewed and approved annually, or as otherwise needed, by the Board.  The most current version of  this Code can be found on the corporate governance page of the Company&#8217;s Intranet and on the &#8220;Corporate  Governance&#8221; section of the Company&#8217;s Investor webpage of the Company&#8217;s website. This document is not an employment contract between the Company and any of its employees, officers, or  directors. This document states a policy of Summit and is not intended to be regarded as the rendering of  legal advice. COMPLIANCE WITH COMPANY POLICIES continued 1-855-853-8089 HOTLINE  Reporting and Compliance Procedures Dissemination and Amendment 13 You may speak with other members of management, the Compliance Office, the Legal  Department, or Human Resources. Here is a list of additional compliance resources: </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ethicsemployeepolicybook014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ethicsemployeepolicybook014.jpg" title="slide14" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Summit Therapeutics and the Summit Therapeutics logo are trademarks of Summit Therapeutics Inc.  Copyright 2025, Summit Therapeutics Inc. All Rights Reserved Contact Information Email: compliance@smmttx.com Whistleblower line: 1-855-853-8089 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>sum-ex211_20251231xxsubsid.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i87c7089e2eac4a2aa8278b07b6ba093a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1 </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SUBSIDIARIES OF THE REGISTRANT </font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.608%"><tr><td style="width:1.0%"></td><td style="width:66.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.192%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Name of Subsidiary</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction&#160;of&#160;incorporation <br>or organization</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Summit Therapeutics Sub Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Delaware, USA</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Summit International Holdings Limited (Cayman Islands)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cayman Islands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Summit Therapeutics Global LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Delaware, USA</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Summit (Oxford) Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Summit Therapeutics Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Discuva Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">England and Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Summit Therapeutics Swiss STS GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Summit Therapeutics Ireland Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>sum-ex231_20251231xxuscons.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i551f099575e74c8d88626e92ec57be9e_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-291151, 333-277169, 333-281273, 333-282230, 333-270656, 333-251958) and Form S-8 (No. 333-287402, 333-279024, 333-264163, 333-249313, 333-238582) of Summit Therapeutics Inc. of our report dated February&#160;23, 2026 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; PricewaterhouseCoopers LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">San Jose, California</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;23, 2026</font></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>sum-ex311_20251231xduggan.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i466b2bcc7c3c43e8aa27cb85e8094923_1"></div><div style="min-height:45.36pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:133%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:133%">CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">I, Robert W. Duggan, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K of Summit Therapeutics Inc. (the &#34;registrant&#34;)&#59;  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">c.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">d.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45.36pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">Date&#58; February&#160;23, 2026                                                                            </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.071%"><tr><td style="width:1.0%"></td><td style="width:41.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.290%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Robert W. Duggan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Robert W. Duggan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer and Executive Chairman<br>(Principal Executive Officer)</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>sum-ex312_20251231xzanganeh.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i20b9bc8587ab44c495c4e5e4689776e2_1"></div><div style="min-height:45.36pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:133%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:133%">CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">I, Dr. Mahkam Zanganeh, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K of Summit Therapeutics Inc. (the &#34;registrant&#34;)&#59;  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">c.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">d.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45.36pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">Date&#58; February&#160;23, 2026                                                                            </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.168%"><tr><td style="width:1.0%"></td><td style="width:39.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.360%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mahkam Zanganeh</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Mahkam Zanganeh</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer, President and Director<br>(Principal Executive Officer)</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.3
<SEQUENCE>8
<FILENAME>sum-ex313_20251231x10ksoni.htm
<DESCRIPTION>EX-31.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i56114420af9b415285763bb582986ef3_1"></div><div style="min-height:45.36pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:133%">Exhibit 31.3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:133%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">I, Manmeet S. Soni, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K of Summit Therapeutics Inc. (the &#34;registrant&#34;)&#59;  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">c.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%">d.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45.36pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">Date&#58; February&#160;23, 2026                                                                             </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.436%"><tr><td style="width:1.0%"></td><td style="width:39.890%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.004%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Manmeet S. Soni</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Manmeet S. Soni</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Officer, Chief Financial Officer and Director<br>(Principal Financial Officer)</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>9
<FILENAME>sum-ex321_20251231xx404906.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i195031f848ba4828b8f3ff941b2397b0_1"></div><div style="min-height:45.36pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:133%">Exhibit 32.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:133%">CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER(S) AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="text-indent:24pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">In connection with the Annual Report on Form 10-K of Summit Therapeutics Inc. (the &#8220;Company&#8221;) for the year ended December 31, 2025, as filed with the U.S. Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned officers of the Company does hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his or her knowledge&#58; </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.923%"><tr><td style="width:1.0%"></td><td style="width:42.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.682%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">Dated&#58; February&#160;23, 2026</font></div></td><td colspan="6" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Robert W. Duggan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Robert W. Duggan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer and Executive Chairman<br>(Principal Executive Officer) </font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.923%"><tr><td style="width:1.0%"></td><td style="width:42.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.682%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">Dated&#58; February&#160;23, 2026</font></div></td><td colspan="6" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mahkam Zanganeh</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Mahkam Zanganeh</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Co-Chief Executive Officer, President and Director<br>(Principal Executive Officer)</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.923%"><tr><td style="width:1.0%"></td><td style="width:41.798%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.975%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">Dated&#58; February&#160;23, 2026</font></div></td><td colspan="6" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Manmeet S. Soni</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Manmeet S. Soni</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Officer, Chief Financial Officer and Director<br>(Principal Financial Officer)</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>smmt-20251231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:5ba7c3ca-9242-422c-a50f-4bf839baf136,g:2c7db6f2-9106-44bc-b090-f2695a3e242b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:smmt="http://www.summitplc.com/20251231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.summitplc.com/20251231">
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af-sub/2025" schemaLocation="https://xbrl.sec.gov/cyd/2025/cyd-af-sub-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="smmt-20251231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="smmt-20251231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="smmt-20251231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="smmt-20251231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.summitplc.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.summitplc.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.summitplc.com/role/ConsolidatedBalanceSheets">
        <link:definition>9952151 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.summitplc.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperationsandComprehensiveLoss" roleURI="http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss">
        <link:definition>9952153 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>9952154 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityParenthetical" roleURI="http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical">
        <link:definition>9952155 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>9952156 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Organization" roleURI="http://www.summitplc.com/role/Organization">
        <link:definition>9952157 - Disclosure - Organization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements" roleURI="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements">
        <link:definition>9952158 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.summitplc.com/role/SegmentReporting">
        <link:definition>9952159 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AkesoLicenseandCollaborationAgreement" roleURI="http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreement">
        <link:definition>9952160 - Disclosure - Akeso License and Collaboration Agreement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeNet" roleURI="http://www.summitplc.com/role/OtherIncomeNet">
        <link:definition>9952161 - Disclosure - Other Income, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTax" roleURI="http://www.summitplc.com/role/IncomeTax">
        <link:definition>9952162 - Disclosure - Income Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossperShare" roleURI="http://www.summitplc.com/role/NetLossperShare">
        <link:definition>9952163 - Disclosure - Net Loss per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://www.summitplc.com/role/Goodwill">
        <link:definition>9952164 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsandShortTermInvestments" roleURI="http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestments">
        <link:definition>9952165 - Disclosure - Fair Value Measurements and Short-Term Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchandDevelopmentPrepaidExpensesandAccruedLiabilities" roleURI="http://www.summitplc.com/role/ResearchandDevelopmentPrepaidExpensesandAccruedLiabilities">
        <link:definition>9952166 - Disclosure - Research and Development Prepaid Expenses and Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.summitplc.com/role/Leases">
        <link:definition>9952167 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PromissoryNotePayabletoRelatedParties" roleURI="http://www.summitplc.com/role/PromissoryNotePayabletoRelatedParties">
        <link:definition>9952168 - Disclosure - Promissory Note Payable to Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.summitplc.com/role/StockholdersEquity">
        <link:definition>9952169 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.summitplc.com/role/StockBasedCompensation">
        <link:definition>9952170 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.summitplc.com/role/RelatedPartyTransactions">
        <link:definition>9952171 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.summitplc.com/role/CommitmentsandContingencies">
        <link:definition>9952172 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies" roleURI="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies">
        <link:definition>9955511 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTables" roleURI="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTables">
        <link:definition>9955512 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.summitplc.com/role/SegmentReportingTables">
        <link:definition>9955513 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeNetTables" roleURI="http://www.summitplc.com/role/OtherIncomeNetTables">
        <link:definition>9955514 - Disclosure - Other Income, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxTables" roleURI="http://www.summitplc.com/role/IncomeTaxTables">
        <link:definition>9955515 - Disclosure - Income Tax (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossperShareTables" roleURI="http://www.summitplc.com/role/NetLossperShareTables">
        <link:definition>9955516 - Disclosure - Net Loss per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsandShortTermInvestmentsTables" roleURI="http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsTables">
        <link:definition>9955517 - Disclosure - Fair Value Measurements and Short-Term Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.summitplc.com/role/LeasesTables">
        <link:definition>9955518 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.summitplc.com/role/StockBasedCompensationTables">
        <link:definition>9955519 - Disclosure - Stock Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationDetails" roleURI="http://www.summitplc.com/role/OrganizationDetails">
        <link:definition>9955520 - Disclosure - Organization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails" roleURI="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails">
        <link:definition>9955521 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTotalCashCashEquivalentsandRestrictedCashBalancesDetails" roleURI="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTotalCashCashEquivalentsandRestrictedCashBalancesDetails">
        <link:definition>9955522 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements - Total Cash, Cash Equivalents and Restricted Cash Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSignificantExpenseoftheCODMFunctionDetails" roleURI="http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails">
        <link:definition>9955523 - Disclosure - Segment Reporting - Significant Expense of the CODM Function (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNarrativeDetails" roleURI="http://www.summitplc.com/role/SegmentReportingNarrativeDetails">
        <link:definition>9955524 - Disclosure - Segment Reporting - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AkesoLicenseandCollaborationAgreementDetails" roleURI="http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails">
        <link:definition>9955525 - Disclosure - Akeso License and Collaboration Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeNetDetails" roleURI="http://www.summitplc.com/role/OtherIncomeNetDetails">
        <link:definition>9955526 - Disclosure - Other Income, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxNarrativeDetails" roleURI="http://www.summitplc.com/role/IncomeTaxNarrativeDetails">
        <link:definition>9955527 - Disclosure - Income Tax - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxComponentsofLossBeforeIncomeTaxesDetails" roleURI="http://www.summitplc.com/role/IncomeTaxComponentsofLossBeforeIncomeTaxesDetails">
        <link:definition>9955528 - Disclosure - Income Tax - Components of Loss Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9955529 - Disclosure - Income Tax - Major Components of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxValuationAllowanceDetails" roleURI="http://www.summitplc.com/role/IncomeTaxValuationAllowanceDetails">
        <link:definition>9955530 - Disclosure - Income Tax - Valuation Allowance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails" roleURI="http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails">
        <link:definition>9955531 - Disclosure - Income Tax - Reconciliation of the Effective Income Tax Rate to Statutory Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxReconciliationofUnrecognizedTaxBenefitsDetails" roleURI="http://www.summitplc.com/role/IncomeTaxReconciliationofUnrecognizedTaxBenefitsDetails">
        <link:definition>9955532 - Disclosure - Income Tax - Reconciliation of Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossperShareComputationofNetLossperShareDetails" roleURI="http://www.summitplc.com/role/NetLossperShareComputationofNetLossperShareDetails">
        <link:definition>9955533 - Disclosure - Net Loss per Share - Computation of Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossperShareNarrativeDetails" roleURI="http://www.summitplc.com/role/NetLossperShareNarrativeDetails">
        <link:definition>9955534 - Disclosure - Net Loss per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails" roleURI="http://www.summitplc.com/role/NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails">
        <link:definition>9955535 - Disclosure - Net Loss per Share - Securities Excluded from the Computation of Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillDetails" roleURI="http://www.summitplc.com/role/GoodwillDetails">
        <link:definition>9955536 - Disclosure - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>9955537 - Disclosure - Fair Value Measurements and Short-Term Investments - Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsandShortTermInvestmentsNarrativeDetails" roleURI="http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsNarrativeDetails">
        <link:definition>9955538 - Disclosure - Fair Value Measurements and Short-Term Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchandDevelopmentPrepaidExpensesandAccruedLiabilitiesDetails" roleURI="http://www.summitplc.com/role/ResearchandDevelopmentPrepaidExpensesandAccruedLiabilitiesDetails">
        <link:definition>9955539 - Disclosure - Research and Development Prepaid Expenses and Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.summitplc.com/role/LeasesNarrativeDetails">
        <link:definition>9955540 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostDetails" roleURI="http://www.summitplc.com/role/LeasesLeaseCostDetails">
        <link:definition>9955541 - Disclosure - Leases - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFutureLeasePaymentsDetails" roleURI="http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails">
        <link:definition>9955542 - Disclosure - Leases - Future Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFutureLeasePaymentsDetails_1" roleURI="http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails_1">
        <link:definition>9955542 - Disclosure - Leases - Future Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PromissoryNotePayabletoRelatedPartiesDetails" roleURI="http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails">
        <link:definition>9955543 - Disclosure - Promissory Note Payable to Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityPreferredStockandCommonStockDetails" roleURI="http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails">
        <link:definition>9955544 - Disclosure - Stockholders' Equity - Preferred Stock and Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityPrivateInvestmentinPublicEquityDetails" roleURI="http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails">
        <link:definition>9955545 - Disclosure - Stockholders' Equity - Private Investment in Public Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityAttheMarketOfferingandWarrantsDetails" roleURI="http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails">
        <link:definition>9955546 - Disclosure - Stockholders' Equity - At-the-Market Offering and Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails">
        <link:definition>9955547 - Disclosure - Stock Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails" roleURI="http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails">
        <link:definition>9955548 - Disclosure - Stock Based Compensation - Weighted-Average Assumptions used for Stock Option Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockOptionActivityDetails" roleURI="http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails">
        <link:definition>9955549 - Disclosure - Stock Based Compensation - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails" roleURI="http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails">
        <link:definition>9955550 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://www.summitplc.com/role/RelatedPartyTransactionsDetails">
        <link:definition>9955551 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.summitplc.com/role/CommitmentsandContingenciesDetails">
        <link:definition>9955552 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="smmt_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="smmt_AcquiredInProcessResearchAndDevelopmentExpense" abstract="false" name="AcquiredInProcessResearchAndDevelopmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_EarningsPerShareBasicAndDilutedEPSAbstract" abstract="true" name="EarningsPerShareBasicAndDilutedEPSAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="smmt_RightsOfferingMember" abstract="true" name="RightsOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_AtMarketOfferingMember" abstract="true" name="AtMarketOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest" abstract="false" name="StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest" abstract="false" name="StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_StockIssuedDuringPeriodSharesWarrantsExercised" abstract="false" name="StockIssuedDuringPeriodSharesWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="smmt_StockIssuedDuringPeriodValueWarrantsExercised" abstract="false" name="StockIssuedDuringPeriodValueWarrantsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_AkesoLicenseAgreementMember" abstract="true" name="AkesoLicenseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_InterestExpenseIncomeNoncash" abstract="false" name="InterestExpenseIncomeNoncash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome" abstract="false" name="CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet" abstract="false" name="IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_PaymentsForCollaborativeArrangement" abstract="false" name="PaymentsForCollaborativeArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock" abstract="false" name="InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="smmt_DistributionAgreementMember" abstract="true" name="DistributionAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_SignificantAccountingPoliciesTable" abstract="true" name="SignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="smmt_SignificantAccountingPoliciesLineItems" abstract="true" name="SignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="smmt_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation" abstract="false" name="LaborAndRelatedExpensesExcludingStockBasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember" abstract="true" name="CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember" abstract="true" name="CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment" abstract="false" name="CollaborativeArrangementRightsAndObligationsUpfrontPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_CashPaymentForCollaborativeArrangementUpfrontPayment" abstract="false" name="CashPaymentForCollaborativeArrangementUpfrontPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash" abstract="false" name="CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares" abstract="false" name="CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments" abstract="false" name="CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement" abstract="false" name="StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts" abstract="false" name="CollaborativeArrangementRightsAndObligationsDirectTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments" abstract="false" name="CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments" abstract="false" name="CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments" abstract="false" name="CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment" abstract="false" name="DeferredTaxAssetsCapitalizedResearchAndDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_DeferredTaxAssetsLiabilities" abstract="false" name="DeferredTaxAssetsLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_DeferredTaxAssetsValuationAllowanceRollForward" abstract="true" name="DeferredTaxAssetsValuationAllowanceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract" abstract="true" name="EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract" abstract="true" name="EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="smmt_ResearchAndDevelopmentPrepaidExpensesCurrent" abstract="false" name="ResearchAndDevelopmentPrepaidExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_AccruedResearchAndDevelopmentCurrent" abstract="false" name="AccruedResearchAndDevelopmentCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_NewJerseyAndCaliforniaMember" abstract="true" name="NewJerseyAndCaliforniaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_NotePurchaseAgreementMember" abstract="true" name="NotePurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_DugganFebruaryNoteAndZanganehNoteMember" abstract="true" name="DugganFebruaryNoteAndZanganehNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_DugganFebruaryNoteMember" abstract="true" name="DugganFebruaryNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_ZanganehNoteMember" abstract="true" name="ZanganehNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_DugganSeptemberNoteMember" abstract="true" name="DugganSeptemberNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember" abstract="true" name="RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_RevisedDugganFebruaryNoteMember" abstract="true" name="RevisedDugganFebruaryNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_RevisedDugganSeptemberNoteMember" abstract="true" name="RevisedDugganSeptemberNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_PromissoryNotesMember" abstract="true" name="PromissoryNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember" abstract="true" name="ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_ChiefExecutiveOfficerAndPresidentMember" abstract="true" name="ChiefExecutiveOfficerAndPresidentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_VariableRatePeriodAxis" abstract="true" name="VariableRatePeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="smmt_VariableRatePeriodDomain" abstract="true" name="VariableRatePeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_VariableRatePeriodOneMember" abstract="true" name="VariableRatePeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_VariableRatePeriodTwoMember" abstract="true" name="VariableRatePeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering" abstract="false" name="NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering" abstract="false" name="NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold" abstract="false" name="NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_NotesPayableRelatedPartiesNewIssuances" abstract="false" name="NotesPayableRelatedPartiesNewIssuances" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator" abstract="false" name="NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice" abstract="false" name="NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest" abstract="false" name="StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="smmt_S3RegistrationStatementMember" abstract="true" name="S3RegistrationStatementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_CommonStockSharesAuthorizedIncreaseDecrease" abstract="false" name="CommonStockSharesAuthorizedIncreaseDecrease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="smmt_SaleOfStockNumberOfSharesRegisteredForResale" abstract="false" name="SaleOfStockNumberOfSharesRegisteredForResale" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="smmt_OriginalDistributionAgreementMember" abstract="true" name="OriginalDistributionAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_SaleOfStockAggregateOfferingPrice" abstract="false" name="SaleOfStockAggregateOfferingPrice" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_SaleOfStockAmountRemainingUnderTheOffering" abstract="false" name="SaleOfStockAmountRemainingUnderTheOffering" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice" abstract="false" name="ClassOfWarrantOrRightWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="smmt_ClassOfWarrantOrRightExercisesInPeriod" abstract="false" name="ClassOfWarrantOrRightExercisesInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" abstract="false" name="ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="smmt_A2020StockIncentivePlanMember" abstract="true" name="A2020StockIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_A2020IncrementalPoolMember" abstract="true" name="A2020IncrementalPoolMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_A2024InducementPoolMember" abstract="true" name="A2024InducementPoolMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_EmployeeStockOptionPerformanceBasedMember" abstract="true" name="EmployeeStockOptionPerformanceBasedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_EmployeeStockOptionTimeBasedMember" abstract="true" name="EmployeeStockOptionTimeBasedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration" abstract="false" name="CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount" abstract="false" name="ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod" abstract="false" name="ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="smmt_EmployeeStockOptionPerformanceAndMarketBasedMember" abstract="true" name="EmployeeStockOptionPerformanceAndMarketBasedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_SubleaseAgreementFirstAndThirdAmendmentMember" abstract="true" name="SubleaseAgreementFirstAndThirdAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_SubleaseAgreementFirstAmendmentMember" abstract="true" name="SubleaseAgreementFirstAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_SubleaseAgreementThirdAmendmentMember" abstract="true" name="SubleaseAgreementThirdAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_SubleaseAgreementSecondAmendmentMember" abstract="true" name="SubleaseAgreementSecondAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_GeniusSubleaseAgreementMember" abstract="true" name="GeniusSubleaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_InvestmentsResearchSubleaseAgreementMember" abstract="true" name="InvestmentsResearchSubleaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember" abstract="true" name="GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_AkesoSupplyAgreementMember" abstract="true" name="AkesoSupplyAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_ConsultingAgreementMember" abstract="true" name="ConsultingAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_CoChiefExecutiveOfficerMember" abstract="true" name="CoChiefExecutiveOfficerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember" abstract="true" name="WilsonSonsiniGoodrichRosatiP.C.WSGRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="smmt_AreaOfPremisesSubleased" abstract="false" name="AreaOfPremisesSubleased" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:areaItemType"/>
  <xs:element id="smmt_RelatedPartyTransactionSubleaseExtensionTerm" abstract="false" name="RelatedPartyTransactionSubleaseExtensionTerm" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="smmt_RelatedPartyTransactionPaymentsToRelatedParty" abstract="false" name="RelatedPartyTransactionPaymentsToRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="smmt_LessorOperatingLeaseNumberOfContracts" abstract="false" name="LessorOperatingLeaseNumberOfContracts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="smmt_LessorOperatingLeaseAreaOfPremisesLeased" abstract="false" name="LessorOperatingLeaseAreaOfPremisesLeased" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:areaItemType"/>
  <xs:element id="smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage" abstract="false" name="LesseeOperatingLeaseProportionOfAmountPayablePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid" abstract="false" name="OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>smmt-20251231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:5ba7c3ca-9242-422c-a50f-4bf839baf136,g:2c7db6f2-9106-44bc-b090-f2695a3e242b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.summitplc.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="smmt-20251231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.summitplc.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c3b5e300-bec0-4976-803c-6177a4021768" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_304e93dc-003b-49c5-b149-25148de400d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c3b5e300-bec0-4976-803c-6177a4021768" xlink:to="loc_us-gaap_AccountsPayableCurrent_304e93dc-003b-49c5-b149-25148de400d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_80b269d1-c8f2-49f4-899f-7287af7c5d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c3b5e300-bec0-4976-803c-6177a4021768" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_80b269d1-c8f2-49f4-899f-7287af7c5d8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ba8cdb91-27c5-4f25-9bfd-163ed27943b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c3b5e300-bec0-4976-803c-6177a4021768" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ba8cdb91-27c5-4f25-9bfd-163ed27943b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5ec0083b-b1ff-4620-910d-b64fabbb3419" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c3b5e300-bec0-4976-803c-6177a4021768" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5ec0083b-b1ff-4620-910d-b64fabbb3419" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_62253b5d-c665-49a2-9637-7ed478d12eda" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c3b5e300-bec0-4976-803c-6177a4021768" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_62253b5d-c665-49a2-9637-7ed478d12eda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3f57dbbb-d572-4b21-9eed-841d22d75ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_fe76e6c7-390f-430d-a8c9-5e74f63d3a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3f57dbbb-d572-4b21-9eed-841d22d75ec3" xlink:to="loc_us-gaap_LiabilitiesCurrent_fe76e6c7-390f-430d-a8c9-5e74f63d3a8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f2b15d38-6c62-4431-91d5-1accd005c8ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3f57dbbb-d572-4b21-9eed-841d22d75ec3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f2b15d38-6c62-4431-91d5-1accd005c8ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_98d1727d-b61f-4b07-8590-e7cebefcda17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3f57dbbb-d572-4b21-9eed-841d22d75ec3" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_98d1727d-b61f-4b07-8590-e7cebefcda17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4ea43733-9be0-4cd4-8fb7-7e728ebebada" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_09da670b-d909-4e51-943e-fd56088920a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4ea43733-9be0-4cd4-8fb7-7e728ebebada" xlink:to="loc_us-gaap_Liabilities_09da670b-d909-4e51-943e-fd56088920a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_711ed767-2cc0-4223-978b-330f080db18c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4ea43733-9be0-4cd4-8fb7-7e728ebebada" xlink:to="loc_us-gaap_CommitmentsAndContingencies_711ed767-2cc0-4223-978b-330f080db18c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bdbc8ba3-b54f-45db-9c21-1bf76459047f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4ea43733-9be0-4cd4-8fb7-7e728ebebada" xlink:to="loc_us-gaap_StockholdersEquity_bdbc8ba3-b54f-45db-9c21-1bf76459047f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a1cb17ac-c11c-4569-a096-200990ba10c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_76b3ce92-b7eb-4500-9965-b54d108e1e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a1cb17ac-c11c-4569-a096-200990ba10c3" xlink:to="loc_us-gaap_CommonStockValue_76b3ce92-b7eb-4500-9965-b54d108e1e4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_e79d7b74-d020-4dcd-a5cb-8101607ae111" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a1cb17ac-c11c-4569-a096-200990ba10c3" xlink:to="loc_us-gaap_AdditionalPaidInCapital_e79d7b74-d020-4dcd-a5cb-8101607ae111" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b5fcbc06-3db8-40c2-8c98-a2d59c1679cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a1cb17ac-c11c-4569-a096-200990ba10c3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b5fcbc06-3db8-40c2-8c98-a2d59c1679cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f06db127-521a-47c5-99f3-424120170325" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a1cb17ac-c11c-4569-a096-200990ba10c3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f06db127-521a-47c5-99f3-424120170325" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_87cf5400-8cb3-48b9-8e93-e4e9553aaba1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a1cb17ac-c11c-4569-a096-200990ba10c3" xlink:to="loc_us-gaap_PreferredStockValue_87cf5400-8cb3-48b9-8e93-e4e9553aaba1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_eccd1add-df4c-4a9f-ace7-f25dbc94b833" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1f6b9964-5746-4c75-92a0-7573da575581" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_eccd1add-df4c-4a9f-ace7-f25dbc94b833" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1f6b9964-5746-4c75-92a0-7573da575581" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_79c74d23-5f85-465c-ab1a-20d5075cb23a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_eccd1add-df4c-4a9f-ace7-f25dbc94b833" xlink:to="loc_us-gaap_RestrictedCashCurrent_79c74d23-5f85-465c-ab1a-20d5075cb23a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_f8568b83-54ac-43ab-9357-f8fd4a702675" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_eccd1add-df4c-4a9f-ace7-f25dbc94b833" xlink:to="loc_us-gaap_ShortTermInvestments_f8568b83-54ac-43ab-9357-f8fd4a702675" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1558bc20-4cf5-4a23-88e6-93942a6273c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_eccd1add-df4c-4a9f-ace7-f25dbc94b833" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1558bc20-4cf5-4a23-88e6-93942a6273c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_90dc8905-72f5-4af6-8181-69e9750d1d49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a2f18e08-a5f7-4630-a0ed-e0dd14667b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_90dc8905-72f5-4af6-8181-69e9750d1d49" xlink:to="loc_us-gaap_AssetsCurrent_a2f18e08-a5f7-4630-a0ed-e0dd14667b3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5d09adf8-09f5-4d3e-b540-820d51cd895e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_90dc8905-72f5-4af6-8181-69e9750d1d49" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5d09adf8-09f5-4d3e-b540-820d51cd895e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c1f5a1d6-ca5a-40bf-ba70-c280c3dd0888" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_90dc8905-72f5-4af6-8181-69e9750d1d49" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c1f5a1d6-ca5a-40bf-ba70-c280c3dd0888" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f043a44d-b086-468c-8cbe-1c1472ba9f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_90dc8905-72f5-4af6-8181-69e9750d1d49" xlink:to="loc_us-gaap_Goodwill_f043a44d-b086-468c-8cbe-1c1472ba9f5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3b71e222-ae9f-45fb-b655-65e2e1a8821a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_90dc8905-72f5-4af6-8181-69e9750d1d49" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3b71e222-ae9f-45fb-b655-65e2e1a8821a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="smmt-20251231.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_39e9130a-fdca-4abb-8f66-191f98f5ac5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c0675cd9-ccaa-42af-947c-140de1cc7bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_39e9130a-fdca-4abb-8f66-191f98f5ac5e" xlink:to="loc_us-gaap_NetIncomeLoss_c0675cd9-ccaa-42af-947c-140de1cc7bd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_c3d498b4-0b65-43c3-8f1f-fb1f38b545a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_39e9130a-fdca-4abb-8f66-191f98f5ac5e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_c3d498b4-0b65-43c3-8f1f-fb1f38b545a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_e4d5c43f-2133-457e-8d95-d7d883f73743" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_39e9130a-fdca-4abb-8f66-191f98f5ac5e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_e4d5c43f-2133-457e-8d95-d7d883f73743" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax_476add6a-df0f-4e0b-9c33-f8570bc5b356" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_39e9130a-fdca-4abb-8f66-191f98f5ac5e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax_476add6a-df0f-4e0b-9c33-f8570bc5b356" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_06de3dc1-ad9f-4a8d-a1be-e8b7a82e0bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_39e9130a-fdca-4abb-8f66-191f98f5ac5e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_06de3dc1-ad9f-4a8d-a1be-e8b7a82e0bc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d658a765-5692-46f6-a1e0-b3872da171cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_66b58881-4d72-4fdd-8940-d4c0f67b06cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d658a765-5692-46f6-a1e0-b3872da171cb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_66b58881-4d72-4fdd-8940-d4c0f67b06cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_55258a35-b0ae-4380-b1d0-ed87597d558f" xlink:href="smmt-20251231.xsd#smmt_AcquiredInProcessResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d658a765-5692-46f6-a1e0-b3872da171cb" xlink:to="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_55258a35-b0ae-4380-b1d0-ed87597d558f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_decd3113-fb20-4742-9200-07f6573dc5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d658a765-5692-46f6-a1e0-b3872da171cb" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_decd3113-fb20-4742-9200-07f6573dc5fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9b2b0f27-3dec-46d2-8fb8-2fc9182877df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_02f1e450-49ad-40f9-aae0-d88756f25276" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_9b2b0f27-3dec-46d2-8fb8-2fc9182877df" xlink:to="loc_us-gaap_OperatingExpenses_02f1e450-49ad-40f9-aae0-d88756f25276" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_e7f2efa0-79a0-42c6-997c-4c02a716f0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_9b2b0f27-3dec-46d2-8fb8-2fc9182877df" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_e7f2efa0-79a0-42c6-997c-4c02a716f0b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_9597ce7e-d353-4c2f-8413-e1b3dda526ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_9b2b0f27-3dec-46d2-8fb8-2fc9182877df" xlink:to="loc_us-gaap_InterestExpenseNonoperating_9597ce7e-d353-4c2f-8413-e1b3dda526ba" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="smmt-20251231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd67adbf-bf92-49ab-baaf-9b7337628fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_d7db611c-77c8-4dc8-ad9f-faba53a79545" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd67adbf-bf92-49ab-baaf-9b7337628fc4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_d7db611c-77c8-4dc8-ad9f-faba53a79545" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f9feec65-2b95-48fb-b96a-84c46841a8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd67adbf-bf92-49ab-baaf-9b7337628fc4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f9feec65-2b95-48fb-b96a-84c46841a8f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_3fa5c8fe-80f2-4bcb-b62f-6673266088d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd67adbf-bf92-49ab-baaf-9b7337628fc4" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_3fa5c8fe-80f2-4bcb-b62f-6673266088d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_6c32b8a5-6a36-4fd5-9f45-66f2bc249a47" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd67adbf-bf92-49ab-baaf-9b7337628fc4" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_6c32b8a5-6a36-4fd5-9f45-66f2bc249a47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_8a5485f0-e7d4-4f2b-9843-4d6eea346262" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd67adbf-bf92-49ab-baaf-9b7337628fc4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_8a5485f0-e7d4-4f2b-9843-4d6eea346262" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_5b108201-7d0b-408e-b6d2-0348b267da77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd67adbf-bf92-49ab-baaf-9b7337628fc4" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_5b108201-7d0b-408e-b6d2-0348b267da77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a7bf1b19-4119-4cb6-88d7-2ae34ebabb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b44d980-d1b9-41b6-9158-9cf3e47d3e93" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a7bf1b19-4119-4cb6-88d7-2ae34ebabb6f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b44d980-d1b9-41b6-9158-9cf3e47d3e93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60d27ae5-f3c6-4790-b808-3553053cdfe6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a7bf1b19-4119-4cb6-88d7-2ae34ebabb6f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60d27ae5-f3c6-4790-b808-3553053cdfe6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_40bb992d-606d-4be6-a69a-c0cd5e7101f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a7bf1b19-4119-4cb6-88d7-2ae34ebabb6f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_40bb992d-606d-4be6-a69a-c0cd5e7101f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_b4afc0e9-b6dd-4fd0-bb48-d615071ac8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a7bf1b19-4119-4cb6-88d7-2ae34ebabb6f" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_b4afc0e9-b6dd-4fd0-bb48-d615071ac8f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1f19210-65d1-491b-a84d-88ecb88e20e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d3b9208b-d93b-49ce-a5ec-020b66aabeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1f19210-65d1-491b-a84d-88ecb88e20e0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d3b9208b-d93b-49ce-a5ec-020b66aabeb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_712df4c6-61c3-4b48-b80b-360f7c927305" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1f19210-65d1-491b-a84d-88ecb88e20e0" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_712df4c6-61c3-4b48-b80b-360f7c927305" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_74962c9f-d7e1-4605-a589-8f24e3d1ae4a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1f19210-65d1-491b-a84d-88ecb88e20e0" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_74962c9f-d7e1-4605-a589-8f24e3d1ae4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_6caa04ec-d033-4c58-97e1-90c835f37030" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1f19210-65d1-491b-a84d-88ecb88e20e0" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_6caa04ec-d033-4c58-97e1-90c835f37030" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_PaymentsForCollaborativeArrangement_f4534fcc-cc0e-4f09-a993-d04dd39bcc3c" xlink:href="smmt-20251231.xsd#smmt_PaymentsForCollaborativeArrangement"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1f19210-65d1-491b-a84d-88ecb88e20e0" xlink:to="loc_smmt_PaymentsForCollaborativeArrangement_f4534fcc-cc0e-4f09-a993-d04dd39bcc3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_05e16342-1a63-4d1b-8eed-15f3b6948b67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:to="loc_us-gaap_NetIncomeLoss_05e16342-1a63-4d1b-8eed-15f3b6948b67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_InterestExpenseIncomeNoncash_73a42ddd-35b8-4242-af7f-1fd9c793ec2a" xlink:href="smmt-20251231.xsd#smmt_InterestExpenseIncomeNoncash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:to="loc_smmt_InterestExpenseIncomeNoncash_73a42ddd-35b8-4242-af7f-1fd9c793ec2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_be80de3f-7249-4839-b20c-91c6b015682b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_be80de3f-7249-4839-b20c-91c6b015682b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_94e7399b-c6cc-477a-9607-3e6cb46705c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_94e7399b-c6cc-477a-9607-3e6cb46705c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome_cc15c5c8-ae73-4b78-8f80-9b8be13269d7" xlink:href="smmt-20251231.xsd#smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:to="loc_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome_cc15c5c8-ae73-4b78-8f80-9b8be13269d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_14fb667a-7185-4dce-89e9-03f4e0b8300a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_14fb667a-7185-4dce-89e9-03f4e0b8300a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_022a5367-5b11-492c-9c83-b469c93431a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:to="loc_us-gaap_Depreciation_022a5367-5b11-492c-9c83-b469c93431a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9da7e78a-4a76-47d3-9e2a-c7e7eae23d45" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:to="loc_us-gaap_ShareBasedCompensation_9da7e78a-4a76-47d3-9e2a-c7e7eae23d45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_fdf9020d-c36a-4ba5-a624-1d365510d0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_fdf9020d-c36a-4ba5-a624-1d365510d0dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_77e1a8eb-b362-4632-8200-70be435203ba" xlink:href="smmt-20251231.xsd#smmt_AcquiredInProcessResearchAndDevelopmentExpense"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:to="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_77e1a8eb-b362-4632-8200-70be435203ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_99db6cc1-37ac-4940-9898-e3e36916c2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_99db6cc1-37ac-4940-9898-e3e36916c2dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_a8005367-c436-43af-8efd-0e340f18ec58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_a8005367-c436-43af-8efd-0e340f18ec58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_602032b8-29a0-4798-a548-9e85e50ec285" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_602032b8-29a0-4798-a548-9e85e50ec285" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_8ea301ab-ea65-4d0d-ae0f-7d3d1bc02266" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_8ea301ab-ea65-4d0d-ae0f-7d3d1bc02266" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_e0d9d470-26eb-4640-b591-f5a6a734c479" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_e0d9d470-26eb-4640-b591-f5a6a734c479" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_44b26bc6-a7a2-40c5-bae9-e8c0a5436830" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_44b26bc6-a7a2-40c5-bae9-e8c0a5436830" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet_7de74cb9-9c76-4939-b424-6546b2786d93" xlink:href="smmt-20251231.xsd#smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42bfcd51-78f4-4f5c-b560-1e7336ddbb96" xlink:to="loc_smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet_7de74cb9-9c76-4939-b424-6546b2786d93" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTotalCashCashEquivalentsandRestrictedCashBalancesDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTotalCashCashEquivalentsandRestrictedCashBalancesDetails"/>
  <link:calculationLink xlink:role="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTotalCashCashEquivalentsandRestrictedCashBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ec7e83ae-2898-4404-81bd-4c41fc5d77b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cbfecd04-3e75-457f-ad37-4a26ae8ebefe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ec7e83ae-2898-4404-81bd-4c41fc5d77b9" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cbfecd04-3e75-457f-ad37-4a26ae8ebefe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_4cc3bbc8-bc3b-40d1-9d8b-3aa2133d9167" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ec7e83ae-2898-4404-81bd-4c41fc5d77b9" xlink:to="loc_us-gaap_RestrictedCashCurrent_4cc3bbc8-bc3b-40d1-9d8b-3aa2133d9167" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#SegmentReportingSignificantExpenseoftheCODMFunctionDetails"/>
  <link:calculationLink xlink:role="http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_8ff97a6b-62de-4ed7-be4e-19426696380f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_e23ae5c7-6727-4a02-af99-86d4f079238a" xlink:href="smmt-20251231.xsd#smmt_AcquiredInProcessResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8ff97a6b-62de-4ed7-be4e-19426696380f" xlink:to="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_e23ae5c7-6727-4a02-af99-86d4f079238a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_a694dc0a-3583-4967-861f-f7ffa46bf8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8ff97a6b-62de-4ed7-be4e-19426696380f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_a694dc0a-3583-4967-861f-f7ffa46bf8bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation_51e0ba79-6d5d-44b6-8dfa-8390e5af3261" xlink:href="smmt-20251231.xsd#smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8ff97a6b-62de-4ed7-be4e-19426696380f" xlink:to="loc_smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation_51e0ba79-6d5d-44b6-8dfa-8390e5af3261" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_3f8af868-509f-4030-b801-3edb643cc512" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8ff97a6b-62de-4ed7-be4e-19426696380f" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_3f8af868-509f-4030-b801-3edb643cc512" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_454e7b5a-5689-4f2c-a4a9-26e8d85e823a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8ff97a6b-62de-4ed7-be4e-19426696380f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_454e7b5a-5689-4f2c-a4a9-26e8d85e823a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#AkesoLicenseandCollaborationAgreementDetails"/>
  <link:calculationLink xlink:role="http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments_91e2d327-7021-433c-b1b2-17af089881a8" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments_8b0abfda-a070-42cd-9bb8-1b59e517dde8" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments_91e2d327-7021-433c-b1b2-17af089881a8" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments_8b0abfda-a070-42cd-9bb8-1b59e517dde8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments_84b4a8c8-d1cd-49ff-8682-863206d13dbb" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments_91e2d327-7021-433c-b1b2-17af089881a8" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments_84b4a8c8-d1cd-49ff-8682-863206d13dbb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/OtherIncomeNetDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#OtherIncomeNetDetails"/>
  <link:calculationLink xlink:role="http://www.summitplc.com/role/OtherIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1aebaf72-c44d-4526-9381-3c306b157870" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_7f5d181d-f97a-4db7-8dc7-9850985ead09" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_1aebaf72-c44d-4526-9381-3c306b157870" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_7f5d181d-f97a-4db7-8dc7-9850985ead09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_96bf4ec6-e92d-40fb-9b4d-c00175bbe8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_1aebaf72-c44d-4526-9381-3c306b157870" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_96bf4ec6-e92d-40fb-9b4d-c00175bbe8d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome_f2e7fb8e-d671-4d43-a4b5-b2074daf6d75" xlink:href="smmt-20251231.xsd#smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_1aebaf72-c44d-4526-9381-3c306b157870" xlink:to="loc_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome_f2e7fb8e-d671-4d43-a4b5-b2074daf6d75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b780dc43-6cf4-46c7-9e39-b1f7f47ab79d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_1aebaf72-c44d-4526-9381-3c306b157870" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b780dc43-6cf4-46c7-9e39-b1f7f47ab79d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/IncomeTaxComponentsofLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#IncomeTaxComponentsofLossBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.summitplc.com/role/IncomeTaxComponentsofLossBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_99c3064e-ebc4-46f0-b228-5b330f988285" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_493bfff5-1c5e-44df-845b-7dfc862f8aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_99c3064e-ebc4-46f0-b228-5b330f988285" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_493bfff5-1c5e-44df-845b-7dfc862f8aa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_ccc149ca-5b0f-4d3d-ba94-c323436651d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_99c3064e-ebc4-46f0-b228-5b330f988285" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_ccc149ca-5b0f-4d3d-ba94-c323436651d8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_8d3e8679-4b09-41f3-976f-0cad1c1e4f63" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_dce0893c-6aad-479b-a18e-36232fd77f59" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8d3e8679-4b09-41f3-976f-0cad1c1e4f63" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_dce0893c-6aad-479b-a18e-36232fd77f59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_de48fe03-7d10-4fec-8815-37ad7ff8fe02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8d3e8679-4b09-41f3-976f-0cad1c1e4f63" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_de48fe03-7d10-4fec-8815-37ad7ff8fe02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d30eaace-ee76-403d-9e4c-cde81ac8acae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8d3e8679-4b09-41f3-976f-0cad1c1e4f63" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d30eaace-ee76-403d-9e4c-cde81ac8acae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment_632a2c3e-cae1-46eb-98e9-50a283f2f667" xlink:href="smmt-20251231.xsd#smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8d3e8679-4b09-41f3-976f-0cad1c1e4f63" xlink:to="loc_smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment_632a2c3e-cae1-46eb-98e9-50a283f2f667" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_319eb900-5a9c-490f-ad74-d2a6a176d1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8d3e8679-4b09-41f3-976f-0cad1c1e4f63" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_319eb900-5a9c-490f-ad74-d2a6a176d1e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DeferredTaxAssetsLiabilities_09622a3a-e7ae-4d4b-b263-cd22bd65bc70" xlink:href="smmt-20251231.xsd#smmt_DeferredTaxAssetsLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_b9995483-3728-4e50-8f5c-f7f1521ad035" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_smmt_DeferredTaxAssetsLiabilities_09622a3a-e7ae-4d4b-b263-cd22bd65bc70" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_b9995483-3728-4e50-8f5c-f7f1521ad035" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_562b7460-d3a9-4a99-8f66-b5ffa26fe83a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_smmt_DeferredTaxAssetsLiabilities_09622a3a-e7ae-4d4b-b263-cd22bd65bc70" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_562b7460-d3a9-4a99-8f66-b5ffa26fe83a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_2db6ade5-2ca8-451f-bc3a-07f2ed7f3d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DeferredTaxAssetsLiabilities_9ac4ef38-a6b7-418e-a5f2-c7335924caf8" xlink:href="smmt-20251231.xsd#smmt_DeferredTaxAssetsLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_2db6ade5-2ca8-451f-bc3a-07f2ed7f3d7e" xlink:to="loc_smmt_DeferredTaxAssetsLiabilities_9ac4ef38-a6b7-418e-a5f2-c7335924caf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0fe97035-c1e7-4de2-b7f1-9451211dda6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_2db6ade5-2ca8-451f-bc3a-07f2ed7f3d7e" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0fe97035-c1e7-4de2-b7f1-9451211dda6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_c4ab20b1-d0ef-4a5e-a3db-89d5f61810a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_635ce881-889c-4ac6-87cb-139d9eb516df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_c4ab20b1-d0ef-4a5e-a3db-89d5f61810a7" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_635ce881-889c-4ac6-87cb-139d9eb516df" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"/>
  <link:calculationLink xlink:role="http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019bfb9c-aac0-7587-a21a-22685a832f15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019bfb9c-aac0-76b2-be1e-e99e983c87da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019bfb9c-aac0-7587-a21a-22685a832f15" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019bfb9c-aac0-76b2-be1e-e99e983c87da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_019bfb9c-aac0-7e30-b642-9fffb33ea49a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019bfb9c-aac0-7587-a21a-22685a832f15" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_019bfb9c-aac0-7e30-b642-9fffb33ea49a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_019bfb9c-aac0-7ace-a499-db517bc3db15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019bfb9c-aac0-7587-a21a-22685a832f15" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_019bfb9c-aac0-7ace-a499-db517bc3db15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_019bfb9c-aac0-728f-bb7e-26c88ae58bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019bfb9c-aac0-7587-a21a-22685a832f15" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_019bfb9c-aac0-728f-bb7e-26c88ae58bf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_019bfb9c-aac0-7609-8622-36c64b5f1656" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019bfb9c-aac0-7587-a21a-22685a832f15" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_019bfb9c-aac0-7609-8622-36c64b5f1656" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_019bfb9c-aac0-7448-a60f-a217cf5f09cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019bfb9c-aac0-7587-a21a-22685a832f15" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_019bfb9c-aac0-7448-a60f-a217cf5f09cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_019bfb9c-aac0-76c3-bf4c-581714f807d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019bfb9c-aac0-7587-a21a-22685a832f15" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_019bfb9c-aac0-76c3-bf4c-581714f807d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019bfb9c-aac0-7a3d-8c2f-5f8a5c39a7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019bfb9c-aac0-7587-a21a-22685a832f15" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019bfb9c-aac0-7a3d-8c2f-5f8a5c39a7ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c2f6b-e70f-7cfe-95d1-8a3bfec517f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_019c2f6b-e70f-7a46-8242-bc72120eb825" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c2f6b-e70f-7cfe-95d1-8a3bfec517f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_019c2f6b-e70f-7a46-8242-bc72120eb825" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_019c2f6b-e70f-735b-9c7c-180af7887f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c2f6b-e70f-7cfe-95d1-8a3bfec517f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_019c2f6b-e70f-735b-9c7c-180af7887f3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_019c2f6b-e70f-7f91-9692-171c91484ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c2f6b-e70f-7cfe-95d1-8a3bfec517f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_019c2f6b-e70f-7f91-9692-171c91484ab3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_019c2f6b-e70f-779e-a9b3-1dfedb6e333c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c2f6b-e70f-7cfe-95d1-8a3bfec517f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_019c2f6b-e70f-779e-a9b3-1dfedb6e333c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_019c2f6b-e70f-7cff-9f2d-d4bbbee62a88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c2f6b-e70f-7cfe-95d1-8a3bfec517f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_019c2f6b-e70f-7cff-9f2d-d4bbbee62a88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_019c2f6b-e70f-7bef-b4dd-bb7c0bcb273d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c2f6b-e70f-7cfe-95d1-8a3bfec517f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_019c2f6b-e70f-7bef-b4dd-bb7c0bcb273d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_019c2f6b-e70f-78b9-bf20-72ef71927867" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c2f6b-e70f-7cfe-95d1-8a3bfec517f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_019c2f6b-e70f-78b9-bf20-72ef71927867" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_019c2f6b-e70f-72b1-b4cb-2892b73f66c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c2f6b-e70f-7cfe-95d1-8a3bfec517f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_019c2f6b-e70f-72b1-b4cb-2892b73f66c6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.summitplc.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_26754cb7-5921-497d-9a6e-17516d9e8f81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_f622cb46-59d9-4149-9c31-b85ea7e2af85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_26754cb7-5921-497d-9a6e-17516d9e8f81" xlink:to="loc_us-gaap_OperatingLeaseCost_f622cb46-59d9-4149-9c31-b85ea7e2af85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_8f283d45-5812-48d6-8f4b-b876a5085c53" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_26754cb7-5921-497d-9a6e-17516d9e8f81" xlink:to="loc_us-gaap_VariableLeaseCost_8f283d45-5812-48d6-8f4b-b876a5085c53" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#LeasesFutureLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5173e356-d769-4dbd-954b-26db5e9866ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e2412676-5d59-4fcd-9705-980f195c44e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5173e356-d769-4dbd-954b-26db5e9866ab" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e2412676-5d59-4fcd-9705-980f195c44e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8c51cc18-daba-4b6c-ab90-442037c36459" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5173e356-d769-4dbd-954b-26db5e9866ab" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8c51cc18-daba-4b6c-ab90-442037c36459" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_aa669c70-0d49-44e3-bf0e-1326cc6c8540" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5173e356-d769-4dbd-954b-26db5e9866ab" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_aa669c70-0d49-44e3-bf0e-1326cc6c8540" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_62be16a4-c53c-4a66-ba86-a6d31dd7915b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5173e356-d769-4dbd-954b-26db5e9866ab" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_62be16a4-c53c-4a66-ba86-a6d31dd7915b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_babafd2b-479e-4b4d-9442-2945dfb70ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5173e356-d769-4dbd-954b-26db5e9866ab" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_babafd2b-479e-4b4d-9442-2945dfb70ef5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_10c791ef-bb90-43ca-9232-9d848fc9b110" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5173e356-d769-4dbd-954b-26db5e9866ab" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_10c791ef-bb90-43ca-9232-9d848fc9b110" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c74fc561-fd29-426c-98f1-94e66fa02dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_debade53-c2b6-493a-b1ac-854710d2f699" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_c74fc561-fd29-426c-98f1-94e66fa02dfd" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_debade53-c2b6-493a-b1ac-854710d2f699" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_485a8a84-08fd-425e-87b3-03a49bc38bff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_c74fc561-fd29-426c-98f1-94e66fa02dfd" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_485a8a84-08fd-425e-87b3-03a49bc38bff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails_1" xlink:type="simple" xlink:href="smmt-20251231.xsd#LeasesFutureLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_57d77319-513a-4c12-9c2a-ec0b59392094" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_98a80b8f-fc83-4195-af83-b9224474387c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_57d77319-513a-4c12-9c2a-ec0b59392094" xlink:to="loc_us-gaap_OperatingLeaseLiability_98a80b8f-fc83-4195-af83-b9224474387c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_89c5b833-e6df-4973-9526-ff795b4cb37d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_57d77319-513a-4c12-9c2a-ec0b59392094" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_89c5b833-e6df-4973-9526-ff795b4cb37d" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>smmt-20251231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:5ba7c3ca-9242-422c-a50f-4bf839baf136,g:2c7db6f2-9106-44bc-b090-f2695a3e242b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="smmt-20251231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e2ce2d05-7aa9-4d98-8854-f486122141a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_52783512-863f-4584-b5e7-a9ff5280d107" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e2ce2d05-7aa9-4d98-8854-f486122141a0" xlink:to="loc_us-gaap_StatementTable_52783512-863f-4584-b5e7-a9ff5280d107" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_abf0b7dd-85b6-4247-a53e-008fde67fe92" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_52783512-863f-4584-b5e7-a9ff5280d107" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_abf0b7dd-85b6-4247-a53e-008fde67fe92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_abf0b7dd-85b6-4247-a53e-008fde67fe92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_abf0b7dd-85b6-4247-a53e-008fde67fe92" xlink:to="loc_us-gaap_EquityComponentDomain_abf0b7dd-85b6-4247-a53e-008fde67fe92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e68728e8-580b-42ce-8d50-11b9f4afc6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_abf0b7dd-85b6-4247-a53e-008fde67fe92" xlink:to="loc_us-gaap_EquityComponentDomain_e68728e8-580b-42ce-8d50-11b9f4afc6f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3347367a-86fd-4bd6-ae6c-49835697e75c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e68728e8-580b-42ce-8d50-11b9f4afc6f3" xlink:to="loc_us-gaap_CommonStockMember_3347367a-86fd-4bd6-ae6c-49835697e75c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_87f0c241-7c3d-434b-9ade-a533f0878986" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e68728e8-580b-42ce-8d50-11b9f4afc6f3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_87f0c241-7c3d-434b-9ade-a533f0878986" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4ed17614-4cb7-46e2-baef-f4214b783fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e68728e8-580b-42ce-8d50-11b9f4afc6f3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4ed17614-4cb7-46e2-baef-f4214b783fe7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d0746096-d651-4cf1-b5c6-9cba593a866e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e68728e8-580b-42ce-8d50-11b9f4afc6f3" xlink:to="loc_us-gaap_RetainedEarningsMember_d0746096-d651-4cf1-b5c6-9cba593a866e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_534ad496-5aa5-4eff-83c2-1b8f05d876d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_52783512-863f-4584-b5e7-a9ff5280d107" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_534ad496-5aa5-4eff-83c2-1b8f05d876d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_534ad496-5aa5-4eff-83c2-1b8f05d876d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_534ad496-5aa5-4eff-83c2-1b8f05d876d4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_534ad496-5aa5-4eff-83c2-1b8f05d876d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_19c846bf-d079-4e91-9dc4-0798bff15569" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_534ad496-5aa5-4eff-83c2-1b8f05d876d4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_19c846bf-d079-4e91-9dc4-0798bff15569" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RightsOfferingMember_160c9bf1-76af-4c4a-a552-01ece1e93a76" xlink:href="smmt-20251231.xsd#smmt_RightsOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_19c846bf-d079-4e91-9dc4-0798bff15569" xlink:to="loc_smmt_RightsOfferingMember_160c9bf1-76af-4c4a-a552-01ece1e93a76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_615e5406-2d0f-4771-84d2-ffb221092bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_19c846bf-d079-4e91-9dc4-0798bff15569" xlink:to="loc_us-gaap_PrivatePlacementMember_615e5406-2d0f-4771-84d2-ffb221092bf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AtMarketOfferingMember_75311df6-04ed-4cc4-a6ad-3e73aef864f3" xlink:href="smmt-20251231.xsd#smmt_AtMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_19c846bf-d079-4e91-9dc4-0798bff15569" xlink:to="loc_smmt_AtMarketOfferingMember_75311df6-04ed-4cc4-a6ad-3e73aef864f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2ce2d05-7aa9-4d98-8854-f486122141a0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c061c032-6fbb-44ce-9f8d-fd67ab079e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c061c032-6fbb-44ce-9f8d-fd67ab079e8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_acc52331-8ac5-4cd5-9d29-66d4fb811174" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_StockholdersEquity_acc52331-8ac5-4cd5-9d29-66d4fb811174" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_33e66292-1def-4cda-bdec-9d6e26ff6323" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_33e66292-1def-4cda-bdec-9d6e26ff6323" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_38e291a6-cc01-4f0b-a8a4-84e3cb4b6711" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_38e291a6-cc01-4f0b-a8a4-84e3cb4b6711" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_6d1cf29e-80e4-4bbd-87aa-a524037af590" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_6d1cf29e-80e4-4bbd-87aa-a524037af590" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ed3fab30-6220-4366-9d8e-77a27bad8216" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ed3fab30-6220-4366-9d8e-77a27bad8216" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest_18a71ad7-172a-4e68-b3e2-1abfae051f38" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest_18a71ad7-172a-4e68-b3e2-1abfae051f38" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest_b9b1adde-fcaf-41aa-a2a0-bf5f9ab1b48e" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest_b9b1adde-fcaf-41aa-a2a0-bf5f9ab1b48e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodSharesWarrantsExercised_5613ef86-57fd-485f-9775-c172c86e3456" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_smmt_StockIssuedDuringPeriodSharesWarrantsExercised_5613ef86-57fd-485f-9775-c172c86e3456" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodValueWarrantsExercised_42bd0cf8-cb5c-4d1c-871b-bdb8121db1e9" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_smmt_StockIssuedDuringPeriodValueWarrantsExercised_42bd0cf8-cb5c-4d1c-871b-bdb8121db1e9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3967508f-86c8-40da-856a-393544c4776b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3967508f-86c8-40da-856a-393544c4776b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c4bd8769-c3fb-497f-b526-ef322b12b400" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c4bd8769-c3fb-497f-b526-ef322b12b400" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_21fa807c-48db-43a6-839b-688a3704897b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_NetIncomeLoss_21fa807c-48db-43a6-839b-688a3704897b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ef96a68e-5480-4f67-9e5c-0d72513bf1b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_16626d01-c2c3-45f7-9cde-1037a5c6b1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="smmt-20251231.xsd#ConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6d56a42c-669d-4c22-9b3d-4577e51d89ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ce8aca5b-c4e3-47aa-ba03-0243d916bed5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6d56a42c-669d-4c22-9b3d-4577e51d89ba" xlink:to="loc_us-gaap_StatementTable_ce8aca5b-c4e3-47aa-ba03-0243d916bed5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_10573c67-49e5-4552-84fa-df12d1c66caa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ce8aca5b-c4e3-47aa-ba03-0243d916bed5" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_10573c67-49e5-4552-84fa-df12d1c66caa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_10573c67-49e5-4552-84fa-df12d1c66caa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_10573c67-49e5-4552-84fa-df12d1c66caa" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_10573c67-49e5-4552-84fa-df12d1c66caa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7e7f800e-9e1d-4d8d-a40f-2716f2d735fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_10573c67-49e5-4552-84fa-df12d1c66caa" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7e7f800e-9e1d-4d8d-a40f-2716f2d735fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RightsOfferingMember_c9a5831a-77d7-4af7-ad20-02efe3389570" xlink:href="smmt-20251231.xsd#smmt_RightsOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7e7f800e-9e1d-4d8d-a40f-2716f2d735fc" xlink:to="loc_smmt_RightsOfferingMember_c9a5831a-77d7-4af7-ad20-02efe3389570" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_af383a67-095e-42fc-86d2-b70a1e56707c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7e7f800e-9e1d-4d8d-a40f-2716f2d735fc" xlink:to="loc_us-gaap_PrivatePlacementMember_af383a67-095e-42fc-86d2-b70a1e56707c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AtMarketOfferingMember_f959af7a-5c47-43a2-a9fd-c18a73bb8b61" xlink:href="smmt-20251231.xsd#smmt_AtMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7e7f800e-9e1d-4d8d-a40f-2716f2d735fc" xlink:to="loc_smmt_AtMarketOfferingMember_f959af7a-5c47-43a2-a9fd-c18a73bb8b61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_80b9d18c-9d91-4ee4-b6ea-b5c1de86749c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6d56a42c-669d-4c22-9b3d-4577e51d89ba" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_80b9d18c-9d91-4ee4-b6ea-b5c1de86749c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="smmt-20251231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_69c34961-d783-4ae7-ab47-ed2c40dac651" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_StatementTable_69c34961-d783-4ae7-ab47-ed2c40dac651" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_d2d949b4-c666-44d3-a7ed-38f86c3d0ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_69c34961-d783-4ae7-ab47-ed2c40dac651" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_d2d949b4-c666-44d3-a7ed-38f86c3d0ea2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d2d949b4-c666-44d3-a7ed-38f86c3d0ea2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_d2d949b4-c666-44d3-a7ed-38f86c3d0ea2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d2d949b4-c666-44d3-a7ed-38f86c3d0ea2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cf96cbcb-1c30-46df-99cf-08ac24d2eaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_d2d949b4-c666-44d3-a7ed-38f86c3d0ea2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cf96cbcb-1c30-46df-99cf-08ac24d2eaf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AtMarketOfferingMember_f6ca83ad-ed6d-47c3-9848-6fecc2e58c68" xlink:href="smmt-20251231.xsd#smmt_AtMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cf96cbcb-1c30-46df-99cf-08ac24d2eaf7" xlink:to="loc_smmt_AtMarketOfferingMember_f6ca83ad-ed6d-47c3-9848-6fecc2e58c68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RightsOfferingMember_a25017f9-3f50-4d33-a4d0-7d9388678d95" xlink:href="smmt-20251231.xsd#smmt_RightsOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cf96cbcb-1c30-46df-99cf-08ac24d2eaf7" xlink:to="loc_smmt_RightsOfferingMember_a25017f9-3f50-4d33-a4d0-7d9388678d95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AkesoLicenseAgreementMember_c9ea5904-4fb4-487b-b18a-4f44700b6908" xlink:href="smmt-20251231.xsd#smmt_AkesoLicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cf96cbcb-1c30-46df-99cf-08ac24d2eaf7" xlink:to="loc_smmt_AkesoLicenseAgreementMember_c9ea5904-4fb4-487b-b18a-4f44700b6908" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_633d7c58-120b-4bd6-9935-542378a5035f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_633d7c58-120b-4bd6-9935-542378a5035f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cb46b84a-b646-4a00-9c8d-34c961c2a87e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_633d7c58-120b-4bd6-9935-542378a5035f" xlink:to="loc_us-gaap_NetIncomeLoss_cb46b84a-b646-4a00-9c8d-34c961c2a87e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_633d7c58-120b-4bd6-9935-542378a5035f" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_InterestExpenseIncomeNoncash_963b7bbf-33b5-4d3b-b150-31c572120910" xlink:href="smmt-20251231.xsd#smmt_InterestExpenseIncomeNoncash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_smmt_InterestExpenseIncomeNoncash_963b7bbf-33b5-4d3b-b150-31c572120910" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_90e49aab-ecde-4e7f-85e5-dac21f58ff6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_90e49aab-ecde-4e7f-85e5-dac21f58ff6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_80b48d7e-3871-4bdf-a894-a6aaa3ffa9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_80b48d7e-3871-4bdf-a894-a6aaa3ffa9d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome_77a2e2c0-3fdb-455d-a5bd-392f6a6b4b34" xlink:href="smmt-20251231.xsd#smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome_77a2e2c0-3fdb-455d-a5bd-392f6a6b4b34" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_90cee13e-5a9d-4307-bf2b-3b8e8f4a2e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_90cee13e-5a9d-4307-bf2b-3b8e8f4a2e4d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_b9fbfc54-44c6-4d15-ae7c-66636054d38b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_us-gaap_Depreciation_b9fbfc54-44c6-4d15-ae7c-66636054d38b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2fb51ef9-11fd-43ca-b213-2881d07e8da5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_us-gaap_ShareBasedCompensation_2fb51ef9-11fd-43ca-b213-2881d07e8da5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_41c3a842-54f3-4481-be67-ec4c54b4d180" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_41c3a842-54f3-4481-be67-ec4c54b4d180" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_7defc85f-b3bb-4dcb-b1bb-cf82cb169f88" xlink:href="smmt-20251231.xsd#smmt_AcquiredInProcessResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_7defc85f-b3bb-4dcb-b1bb-cf82cb169f88" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f4e65df7-c298-4211-aa69-9aa7056904e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f4e65df7-c298-4211-aa69-9aa7056904e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e496b1c6-8159-49e2-95d8-8128dcdae02c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e496b1c6-8159-49e2-95d8-8128dcdae02c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3e786722-a27d-42cf-b4c1-daac6f9047f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3e786722-a27d-42cf-b4c1-daac6f9047f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_136f938c-beeb-48ee-bdf5-3da4a12ccab9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_136f938c-beeb-48ee-bdf5-3da4a12ccab9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_aa41e21a-a211-4614-8e1f-96d6097cb6e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_aa41e21a-a211-4614-8e1f-96d6097cb6e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_bfa45abd-e24a-4d49-bbbd-a5c505a5eaae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_bfa45abd-e24a-4d49-bbbd-a5c505a5eaae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet_4fa01063-083f-44a5-8718-5051d4e80d5f" xlink:href="smmt-20251231.xsd#smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:to="loc_smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet_4fa01063-083f-44a5-8718-5051d4e80d5f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c6766698-435b-41f4-b981-5f6112098f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_633d7c58-120b-4bd6-9935-542378a5035f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c6766698-435b-41f4-b981-5f6112098f6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5031ce16-6f9a-4ff0-9076-e36b62ac7bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5031ce16-6f9a-4ff0-9076-e36b62ac7bdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_4f459730-9604-4696-85f6-f68480305c87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5031ce16-6f9a-4ff0-9076-e36b62ac7bdf" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_4f459730-9604-4696-85f6-f68480305c87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_430a10bf-7ab1-45ac-bf35-e3afbe41df8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5031ce16-6f9a-4ff0-9076-e36b62ac7bdf" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_430a10bf-7ab1-45ac-bf35-e3afbe41df8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c9741f4a-4d5c-4081-8acf-73c3cee56884" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5031ce16-6f9a-4ff0-9076-e36b62ac7bdf" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c9741f4a-4d5c-4081-8acf-73c3cee56884" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_27aa455e-31c1-4c4e-9e5b-0b8b04688b98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5031ce16-6f9a-4ff0-9076-e36b62ac7bdf" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_27aa455e-31c1-4c4e-9e5b-0b8b04688b98" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_PaymentsForCollaborativeArrangement_f2cd5bbf-4f94-4fdb-9c5d-252d4f53a7a0" xlink:href="smmt-20251231.xsd#smmt_PaymentsForCollaborativeArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5031ce16-6f9a-4ff0-9076-e36b62ac7bdf" xlink:to="loc_smmt_PaymentsForCollaborativeArrangement_f2cd5bbf-4f94-4fdb-9c5d-252d4f53a7a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5aa9d016-6613-440a-b460-df3a391d9b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5031ce16-6f9a-4ff0-9076-e36b62ac7bdf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5aa9d016-6613-440a-b460-df3a391d9b6c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_09ade157-8ee4-437b-b77e-99c758a2381c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_09ade157-8ee4-437b-b77e-99c758a2381c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f53cf7d9-8cc7-4072-af56-6da308c7a60d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f53cf7d9-8cc7-4072-af56-6da308c7a60d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_60e0b3a9-0f02-4ee1-88a5-08db65958510" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_60e0b3a9-0f02-4ee1-88a5-08db65958510" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3e4e2a58-cc59-451f-a073-2ff060e070df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3e4e2a58-cc59-451f-a073-2ff060e070df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_62e534b3-0e14-476b-828d-8be711a9fe12" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_62e534b3-0e14-476b-828d-8be711a9fe12" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_520e86a1-5f0e-42d0-837a-dfe8a2bdec6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_520e86a1-5f0e-42d0-837a-dfe8a2bdec6f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f4d1ab72-fcdf-4697-9cd8-909372e25e28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f4d1ab72-fcdf-4697-9cd8-909372e25e28" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1c20c0cf-db80-4a01-8ffb-fad05c1bec76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1c20c0cf-db80-4a01-8ffb-fad05c1bec76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_786f6c1d-39e2-470a-8d47-43b653e85fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_786f6c1d-39e2-470a-8d47-43b653e85fc7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_120c7f60-1fc0-41b4-b19e-89f98c99b0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_120c7f60-1fc0-41b4-b19e-89f98c99b0ee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e78382d0-fdff-4180-b0c1-43a553126046" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_a3e29343-7d67-4f0f-8649-9e037bddf624" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_a3e29343-7d67-4f0f-8649-9e037bddf624" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_2bb09eed-d9cf-478d-8676-fb7e942f624d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a3e29343-7d67-4f0f-8649-9e037bddf624" xlink:to="loc_us-gaap_InterestPaidNet_2bb09eed-d9cf-478d-8676-fb7e942f624d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_c510e61c-6c11-4454-9f50-24f2e4af9ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a3e29343-7d67-4f0f-8649-9e037bddf624" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_c510e61c-6c11-4454-9f50-24f2e4af9ac3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_a93efb9d-5426-4c71-b094-7ecdad954a49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_a93efb9d-5426-4c71-b094-7ecdad954a49" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_dccb3632-fba5-426b-99c8-2aa751d498e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_a93efb9d-5426-4c71-b094-7ecdad954a49" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_dccb3632-fba5-426b-99c8-2aa751d498e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d470c2ec-b4c0-4aed-87d4-3eef39d67aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_a93efb9d-5426-4c71-b094-7ecdad954a49" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d470c2ec-b4c0-4aed-87d4-3eef39d67aa1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_2fb2b505-6349-4034-b954-c30f6eb3489e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_a93efb9d-5426-4c71-b094-7ecdad954a49" xlink:to="loc_us-gaap_StockIssued1_2fb2b505-6349-4034-b954-c30f6eb3489e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/OrganizationDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#OrganizationDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/OrganizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_019c40ea-1035-7af2-8339-4f1eee3d0466" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_019c40ea-1035-7765-bcec-8ff30032aebf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_019c40ea-1035-7af2-8339-4f1eee3d0466" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_019c40ea-1035-7765-bcec-8ff30032aebf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019c40ea-1035-770c-84c8-8bbbb65cfba9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019c40ea-1035-7765-bcec-8ff30032aebf" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019c40ea-1035-770c-84c8-8bbbb65cfba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c40ea-1035-770c-84c8-8bbbb65cfba9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019c40ea-1035-770c-84c8-8bbbb65cfba9" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c40ea-1035-770c-84c8-8bbbb65cfba9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c40ea-1035-72cd-b0d3-6a9678110a86" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019c40ea-1035-770c-84c8-8bbbb65cfba9" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c40ea-1035-72cd-b0d3-6a9678110a86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_019c40ea-1035-705a-81df-a537a1faed8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c40ea-1035-72cd-b0d3-6a9678110a86" xlink:to="loc_us-gaap_PrivatePlacementMember_019c40ea-1035-705a-81df-a537a1faed8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DistributionAgreementMember_019c4431-b20b-7ad3-a06e-dde4f7d48249" xlink:href="smmt-20251231.xsd#smmt_DistributionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c40ea-1035-72cd-b0d3-6a9678110a86" xlink:to="loc_smmt_DistributionAgreementMember_019c4431-b20b-7ad3-a06e-dde4f7d48249" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9266348f-91e3-480c-adb1-1053d3c95515" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019c40ea-1035-7af2-8339-4f1eee3d0466" xlink:to="loc_us-gaap_NetIncomeLoss_9266348f-91e3-480c-adb1-1053d3c95515" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a67d78e9-fde2-4c04-a38e-28a74ab1ec39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019c40ea-1035-7af2-8339-4f1eee3d0466" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a67d78e9-fde2-4c04-a38e-28a74ab1ec39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_971904fa-02d7-4cbd-b752-73e1d436b6a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019c40ea-1035-7af2-8339-4f1eee3d0466" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_971904fa-02d7-4cbd-b752-73e1d436b6a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_125488e5-1ea2-4f79-973e-df222c20f4da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019c40ea-1035-7af2-8339-4f1eee3d0466" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_125488e5-1ea2-4f79-973e-df222c20f4da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_307fa111-e3ca-4ae1-9ccc-f3e5327a6141" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019c40ea-1035-7af2-8339-4f1eee3d0466" xlink:to="loc_us-gaap_ShortTermInvestments_307fa111-e3ca-4ae1-9ccc-f3e5327a6141" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019c40ea-1035-7ef4-aef4-61e26b66ccaf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019c40ea-1035-7af2-8339-4f1eee3d0466" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019c40ea-1035-7ef4-aef4-61e26b66ccaf" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SignificantAccountingPoliciesLineItems_f3a08cd3-f551-42fc-b11e-6a101381405f" xlink:href="smmt-20251231.xsd#smmt_SignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SignificantAccountingPoliciesTable_2450cbd5-9c17-446a-9ff5-34b87bd78c2c" xlink:href="smmt-20251231.xsd#smmt_SignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_smmt_SignificantAccountingPoliciesLineItems_f3a08cd3-f551-42fc-b11e-6a101381405f" xlink:to="loc_smmt_SignificantAccountingPoliciesTable_2450cbd5-9c17-446a-9ff5-34b87bd78c2c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e66b1d4a-d40c-41d7-a101-ae75fcdc9a85" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_smmt_SignificantAccountingPoliciesTable_2450cbd5-9c17-446a-9ff5-34b87bd78c2c" xlink:to="loc_srt_RangeAxis_e66b1d4a-d40c-41d7-a101-ae75fcdc9a85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e66b1d4a-d40c-41d7-a101-ae75fcdc9a85_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e66b1d4a-d40c-41d7-a101-ae75fcdc9a85" xlink:to="loc_srt_RangeMember_e66b1d4a-d40c-41d7-a101-ae75fcdc9a85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3b0ad7ed-df54-4b28-aa01-9f629921a273" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e66b1d4a-d40c-41d7-a101-ae75fcdc9a85" xlink:to="loc_srt_RangeMember_3b0ad7ed-df54-4b28-aa01-9f629921a273" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d6f1829c-20f4-4401-96c5-9cfe7cfaa8db" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3b0ad7ed-df54-4b28-aa01-9f629921a273" xlink:to="loc_srt_MinimumMember_d6f1829c-20f4-4401-96c5-9cfe7cfaa8db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_40b5f83a-b472-4c9d-b7c6-be9fd949fcb1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3b0ad7ed-df54-4b28-aa01-9f629921a273" xlink:to="loc_srt_MaximumMember_40b5f83a-b472-4c9d-b7c6-be9fd949fcb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_d1e4f593-97fb-432c-b296-24497a173585" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_SignificantAccountingPoliciesLineItems_f3a08cd3-f551-42fc-b11e-6a101381405f" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_d1e4f593-97fb-432c-b296-24497a173585" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_87b36c66-62bb-4d25-a9dd-825a530cd3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_SignificantAccountingPoliciesLineItems_f3a08cd3-f551-42fc-b11e-6a101381405f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_87b36c66-62bb-4d25-a9dd-825a530cd3f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_a2e33995-12e0-47db-b3f2-122fc93bd1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_SignificantAccountingPoliciesLineItems_f3a08cd3-f551-42fc-b11e-6a101381405f" xlink:to="loc_us-gaap_RestrictedCashCurrent_a2e33995-12e0-47db-b3f2-122fc93bd1a5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#SegmentReportingSignificantExpenseoftheCODMFunctionDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_684bf59c-4605-44a7-b252-408d7be32fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_684bf59c-4605-44a7-b252-408d7be32fdf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6869e405-a8fb-4aa6-848f-d118405e5b11" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_684bf59c-4605-44a7-b252-408d7be32fdf" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6869e405-a8fb-4aa6-848f-d118405e5b11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6869e405-a8fb-4aa6-848f-d118405e5b11_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6869e405-a8fb-4aa6-848f-d118405e5b11" xlink:to="loc_us-gaap_SegmentDomain_6869e405-a8fb-4aa6-848f-d118405e5b11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_944509a3-4556-433e-bccd-b45589907fff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6869e405-a8fb-4aa6-848f-d118405e5b11" xlink:to="loc_us-gaap_SegmentDomain_944509a3-4556-433e-bccd-b45589907fff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ReportableSegmentMember_fde5533c-4125-43b9-b1cc-318cae771dd4" xlink:href="smmt-20251231.xsd#smmt_ReportableSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_944509a3-4556-433e-bccd-b45589907fff" xlink:to="loc_smmt_ReportableSegmentMember_fde5533c-4125-43b9-b1cc-318cae771dd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_9ac196ee-bb3f-48d4-82a7-9649b968b2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_9ac196ee-bb3f-48d4-82a7-9649b968b2f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_8d78d064-69ce-4562-8a84-db225e1889b3" xlink:href="smmt-20251231.xsd#smmt_AcquiredInProcessResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_8d78d064-69ce-4562-8a84-db225e1889b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation_73a7eb7f-0d94-4123-9b34-f505927a1655" xlink:href="smmt-20251231.xsd#smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation_73a7eb7f-0d94-4123-9b34-f505927a1655" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_d5166ed4-e802-4448-a8b0-b80b923a17df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_d5166ed4-e802-4448-a8b0-b80b923a17df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_2450acec-00bd-46ac-aee0-482b7bfe78ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_2450acec-00bd-46ac-aee0-482b7bfe78ee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_c2f63699-fb7c-4952-9a2b-d9e98ab3d062" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_us-gaap_OperatingExpenses_c2f63699-fb7c-4952-9a2b-d9e98ab3d062" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_728e58d3-3c9c-4273-a775-428d94b309fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_728e58d3-3c9c-4273-a775-428d94b309fd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_7cbd804f-7239-4943-8bd7-2342f73e4aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_us-gaap_InterestExpenseNonoperating_7cbd804f-7239-4943-8bd7-2342f73e4aa0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4936bc25-10d8-4a74-ba24-e50c039c5970" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_us-gaap_NetIncomeLoss_4936bc25-10d8-4a74-ba24-e50c039c5970" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#AkesoLicenseandCollaborationAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_ecf0ab5f-d6ed-469f-a761-117c7741986a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_ecf0ab5f-d6ed-469f-a761-117c7741986a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_e768c6da-a04b-4500-b0a1-acf0a37e90f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_ecf0ab5f-d6ed-469f-a761-117c7741986a" xlink:to="loc_us-gaap_TypeOfArrangementAxis_e768c6da-a04b-4500-b0a1-acf0a37e90f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e768c6da-a04b-4500-b0a1-acf0a37e90f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e768c6da-a04b-4500-b0a1-acf0a37e90f9" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e768c6da-a04b-4500-b0a1-acf0a37e90f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_016f955c-1620-4f38-9b7e-d92cd9597fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e768c6da-a04b-4500-b0a1-acf0a37e90f9" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_016f955c-1620-4f38-9b7e-d92cd9597fd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_2544faba-8072-4276-bfae-3e6d4fc158e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_016f955c-1620-4f38-9b7e-d92cd9597fd8" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_2544faba-8072-4276-bfae-3e6d4fc158e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember_d86a09e5-0e16-4d73-a15f-f40eafe0d85b" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_2544faba-8072-4276-bfae-3e6d4fc158e1" xlink:to="loc_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember_d86a09e5-0e16-4d73-a15f-f40eafe0d85b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember_582752f3-6de7-4246-8d45-4d28d8d905b5" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_2544faba-8072-4276-bfae-3e6d4fc158e1" xlink:to="loc_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember_582752f3-6de7-4246-8d45-4d28d8d905b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment_a9cbeda1-ddb0-445a-af26-0502c4d5f75d" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment_a9cbeda1-ddb0-445a-af26-0502c4d5f75d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CashPaymentForCollaborativeArrangementUpfrontPayment_03cbf150-20d3-4c66-be56-7e624f661b21" xlink:href="smmt-20251231.xsd#smmt_CashPaymentForCollaborativeArrangementUpfrontPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CashPaymentForCollaborativeArrangementUpfrontPayment_03cbf150-20d3-4c66-be56-7e624f661b21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash_22512b5e-413b-4f55-9875-4ff1c244e9f8" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash_22512b5e-413b-4f55-9875-4ff1c244e9f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a2e3bf92-d6e7-4407-aa65-ee2a53f04e23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a2e3bf92-d6e7-4407-aa65-ee2a53f04e23" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares_76e17882-836b-47b3-a9e0-ce3643743434" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares_76e17882-836b-47b3-a9e0-ce3643743434" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_PaymentsForCollaborativeArrangement_da4a7405-acb6-4ac2-a77d-0e0f064d0af6" xlink:href="smmt-20251231.xsd#smmt_PaymentsForCollaborativeArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_PaymentsForCollaborativeArrangement_da4a7405-acb6-4ac2-a77d-0e0f064d0af6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments_307775ff-e7bb-4992-85f0-003c582b019f" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments_307775ff-e7bb-4992-85f0-003c582b019f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_2c9c36e4-d23f-4fd6-b1ba-4be39d8c8c05" xlink:href="smmt-20251231.xsd#smmt_AcquiredInProcessResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_2c9c36e4-d23f-4fd6-b1ba-4be39d8c8c05" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement_4b46e32b-1a8e-4fcb-b182-2b32b7218e93" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement_4b46e32b-1a8e-4fcb-b182-2b32b7218e93" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts_d5944610-8d24-4d0f-b571-ebbceb07a6d4" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts_d5944610-8d24-4d0f-b571-ebbceb07a6d4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments_e2dafca7-a0d0-4936-b04b-bc5586c4253c" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments_e2dafca7-a0d0-4936-b04b-bc5586c4253c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments_f5f2ebf6-35e0-47bd-a126-15edc8879c12" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments_f5f2ebf6-35e0-47bd-a126-15edc8879c12" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments_f20c2605-3e89-46ae-9380-d6e77acd72b2" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments_f20c2605-3e89-46ae-9380-d6e77acd72b2" xlink:type="arc" order="12"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/IncomeTaxNarrativeDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#IncomeTaxNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/IncomeTaxNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_4e3873f6-9b6b-44c6-9f1f-49b12cf2fe55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_4e3873f6-9b6b-44c6-9f1f-49b12cf2fe55" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_019be574-82a1-7943-b9d6-ed23ea45ca4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_4e3873f6-9b6b-44c6-9f1f-49b12cf2fe55" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_019be574-82a1-7943-b9d6-ed23ea45ca4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_019be574-82a1-7943-b9d6-ed23ea45ca4d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_019be574-82a1-7943-b9d6-ed23ea45ca4d" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_019be574-82a1-7943-b9d6-ed23ea45ca4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_019be574-82a1-7ac4-b481-4257f506d10c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_019be574-82a1-7943-b9d6-ed23ea45ca4d" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_019be574-82a1-7ac4-b481-4257f506d10c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_019be574-82a1-7224-b6e2-acec6365e640" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_019be574-82a1-7ac4-b481-4257f506d10c" xlink:to="loc_us-gaap_DomesticCountryMember_019be574-82a1-7224-b6e2-acec6365e640" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_019be574-82a1-7893-8f89-fb68460295c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_019be574-82a1-7ac4-b481-4257f506d10c" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_019be574-82a1-7893-8f89-fb68460295c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_019be574-82a1-7dbe-8c74-8b8f41f21f58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_019be574-82a1-7ac4-b481-4257f506d10c" xlink:to="loc_us-gaap_ForeignCountryMember_019be574-82a1-7dbe-8c74-8b8f41f21f58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_019be574-14a6-7854-90b9-3e6f90ad1af0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_019be574-14a6-7854-90b9-3e6f90ad1af0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_019be574-34e0-7c81-84ee-79f155e60a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_019be574-34e0-7c81-84ee-79f155e60a6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_019be574-34e0-72a2-add5-c7b0e2c6e0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_019be574-34e0-72a2-add5-c7b0e2c6e0a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_019be574-34e0-7ea8-ae0f-9ffcbb7e6686" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_019be574-34e0-7ea8-ae0f-9ffcbb7e6686" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_019be574-34e0-7c6d-a54a-c5991d326a46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_019be574-34e0-7c6d-a54a-c5991d326a46" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_019be574-34e0-796f-988b-6aeedac3274d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_019be574-34e0-796f-988b-6aeedac3274d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_019be574-34e0-7830-8eb8-61479e8a571b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_019be574-34e0-7830-8eb8-61479e8a571b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_019be574-58eb-77f9-a2ec-5c7e780e20db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_019be574-58eb-77f9-a2ec-5c7e780e20db" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_019be574-82a1-76d7-860c-79d50ba0d171" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_OperatingLossCarryforwards_019be574-82a1-76d7-860c-79d50ba0d171" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_019be574-82a1-7e06-98c4-2ca330664c38" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_019be574-82a1-7e06-98c4-2ca330664c38" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_019be574-af74-7ff7-bd99-c76f1c56b9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_019be574-af74-7ff7-bd99-c76f1c56b9ba" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_019bfb90-d414-774d-a5f6-95b97a5bb036" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTable_019bfb90-d414-71fa-9dd4-7956d042ad3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_019bfb90-d414-774d-a5f6-95b97a5bb036" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTable_019bfb90-d414-71fa-9dd4-7956d042ad3c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_019bfb90-d414-7f06-afef-1d095264d6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTable_019bfb90-d414-71fa-9dd4-7956d042ad3c" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_019bfb90-d414-7f06-afef-1d095264d6fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_019bfb90-d414-7f06-afef-1d095264d6fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_019bfb90-d414-7f06-afef-1d095264d6fb" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_019bfb90-d414-7f06-afef-1d095264d6fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_019bfb90-d414-7309-8e2d-2f2b79edb500" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_019bfb90-d414-7f06-afef-1d095264d6fb" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_019bfb90-d414-7309-8e2d-2f2b79edb500" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_KY_019bfb91-aaa1-7f97-b1eb-36b21ff5a403" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_KY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_019bfb90-d414-7309-8e2d-2f2b79edb500" xlink:to="loc_country_KY_019bfb91-aaa1-7f97-b1eb-36b21ff5a403" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignTaxJurisdictionOtherMember_019bfb92-7adf-7ded-bb89-337a7f67e8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignTaxJurisdictionOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_019bfb90-d414-7309-8e2d-2f2b79edb500" xlink:to="loc_us-gaap_ForeignTaxJurisdictionOtherMember_019bfb92-7adf-7ded-bb89-337a7f67e8e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_019bfb90-d414-774d-a5f6-95b97a5bb036" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019bfb95-f3c8-721e-b7ec-364a64ab899e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019bfb95-f3c8-721e-b7ec-364a64ab899e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_019bfb96-6569-79cd-93f9-c4041c6cb9c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_019bfb96-6569-79cd-93f9-c4041c6cb9c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_019bfb96-cabf-7308-b073-ca4417b65e29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_019bfb96-cabf-7308-b073-ca4417b65e29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_019bfb97-8778-7112-8085-247eb17a583c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_019bfb97-8778-7112-8085-247eb17a583c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_019bfb97-fb7f-7c6f-ad28-bf9ef8af01ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_019bfb97-8778-7112-8085-247eb17a583c" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_019bfb97-fb7f-7c6f-ad28-bf9ef8af01ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_019bfb98-6e3d-7df8-8b0d-45c375b785dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_019bfb97-8778-7112-8085-247eb17a583c" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_019bfb98-6e3d-7df8-8b0d-45c375b785dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract_019bfb98-ecee-7ee3-a4f2-008539baa361" xlink:href="smmt-20251231.xsd#smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:to="loc_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract_019bfb98-ecee-7ee3-a4f2-008539baa361" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_019bfb9a-610e-735b-8ac1-ce0fe3f0f6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract_019bfb98-ecee-7ee3-a4f2-008539baa361" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_019bfb9a-610e-735b-8ac1-ce0fe3f0f6b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_019bfb9b-8338-73f7-a4de-4c848cb102ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_019bfb9b-8338-73f7-a4de-4c848cb102ed" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019bfb9c-19f4-7217-b308-8476545497e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019bfb9c-19f4-7217-b308-8476545497e6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019bfb9c-6744-72b0-bb82-9d0e18d46114" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019bfb9c-6744-72b0-bb82-9d0e18d46114" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_019bfb90-d414-774d-a5f6-95b97a5bb036" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1c355700-baff-4851-8843-61a4ea0cd2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1c355700-baff-4851-8843-61a4ea0cd2e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_019bfb84-c7ce-72c8-aa8f-209d0f1bbaad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_019bfb84-c7ce-72c8-aa8f-209d0f1bbaad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_7ca12646-82b9-4ec4-9ff3-11f11c0892d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_7ca12646-82b9-4ec4-9ff3-11f11c0892d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract_019bfb87-2cef-77a8-bb02-cc011f576e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract_019bfb87-2cef-77a8-bb02-cc011f576e5d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_171ce48e-8b67-44c7-997f-5281f18c6b81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract_019bfb87-2cef-77a8-bb02-cc011f576e5d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_171ce48e-8b67-44c7-997f-5281f18c6b81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_ade76101-6dbd-476a-ae99-bd6a59f33d08" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract_019bfb87-2cef-77a8-bb02-cc011f576e5d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_ade76101-6dbd-476a-ae99-bd6a59f33d08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract_019bfb89-9b6c-7b32-9fa3-1845a25e6892" xlink:href="smmt-20251231.xsd#smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:to="loc_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract_019bfb89-9b6c-7b32-9fa3-1845a25e6892" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_f72636ba-9ec4-4a8d-857c-ea5872cfb571" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract_019bfb89-9b6c-7b32-9fa3-1845a25e6892" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_f72636ba-9ec4-4a8d-857c-ea5872cfb571" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_019bfb93-4364-7cbf-b7fa-0873c41fa2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_019bfb93-4364-7cbf-b7fa-0873c41fa2e9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_6b1df81e-7c9d-4ae5-b1d4-8182604200e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_6b1df81e-7c9d-4ae5-b1d4-8182604200e1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c2f6b-3c16-7a33-a57f-8f125d45f58e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c2f6b-3c16-7a33-a57f-8f125d45f58e" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/NetLossperShareNarrativeDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#NetLossperShareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/NetLossperShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_65a40557-c49a-465e-8150-1412e0e9f9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_f636dd5a-4013-4ba3-814e-ef10838eb326" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_65a40557-c49a-465e-8150-1412e0e9f9c6" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_f636dd5a-4013-4ba3-814e-ef10838eb326" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_c2d474a9-1b18-4bd6-a40a-9cb9e5984bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_f636dd5a-4013-4ba3-814e-ef10838eb326" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_c2d474a9-1b18-4bd6-a40a-9cb9e5984bf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c2d474a9-1b18-4bd6-a40a-9cb9e5984bf0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_c2d474a9-1b18-4bd6-a40a-9cb9e5984bf0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c2d474a9-1b18-4bd6-a40a-9cb9e5984bf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_36297f1c-cde8-49a6-9486-452245133499" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_c2d474a9-1b18-4bd6-a40a-9cb9e5984bf0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_36297f1c-cde8-49a6-9486-452245133499" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RightsOfferingMember_5327e07f-999e-4f1a-80f1-57b6d44c6659" xlink:href="smmt-20251231.xsd#smmt_RightsOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_36297f1c-cde8-49a6-9486-452245133499" xlink:to="loc_smmt_RightsOfferingMember_5327e07f-999e-4f1a-80f1-57b6d44c6659" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_15ee8fb5-bb2d-475f-96be-4d7081430c00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_65a40557-c49a-465e-8150-1412e0e9f9c6" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_15ee8fb5-bb2d-475f-96be-4d7081430c00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_7dab02e5-aaba-42ee-bf5f-e98af5c86b44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_65a40557-c49a-465e-8150-1412e0e9f9c6" xlink:to="loc_us-gaap_SharePrice_7dab02e5-aaba-42ee-bf5f-e98af5c86b44" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_617d5b2d-be07-42a4-bf27-6c594a756814" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ee1d04f6-7637-4b01-9b22-b0fa4afe06d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_617d5b2d-be07-42a4-bf27-6c594a756814" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ee1d04f6-7637-4b01-9b22-b0fa4afe06d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c3b5d058-6615-4b23-b76f-7ede5a7972ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ee1d04f6-7637-4b01-9b22-b0fa4afe06d8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c3b5d058-6615-4b23-b76f-7ede5a7972ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c3b5d058-6615-4b23-b76f-7ede5a7972ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c3b5d058-6615-4b23-b76f-7ede5a7972ab" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c3b5d058-6615-4b23-b76f-7ede5a7972ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11aa9624-2823-4565-92d9-a39951325bca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c3b5d058-6615-4b23-b76f-7ede5a7972ab" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11aa9624-2823-4565-92d9-a39951325bca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_12e1f863-bc73-40d5-8df7-6aaccd4fa817" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11aa9624-2823-4565-92d9-a39951325bca" xlink:to="loc_us-gaap_EmployeeStockOptionMember_12e1f863-bc73-40d5-8df7-6aaccd4fa817" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_f48df752-aec0-4073-ad65-b544e1f992da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11aa9624-2823-4565-92d9-a39951325bca" xlink:to="loc_us-gaap_WarrantMember_f48df752-aec0-4073-ad65-b544e1f992da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_ce02af01-9eb0-47e8-9fbe-caec97b3e546" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11aa9624-2823-4565-92d9-a39951325bca" xlink:to="loc_us-gaap_EmployeeStockMember_ce02af01-9eb0-47e8-9fbe-caec97b3e546" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b59d97b5-2bff-4c36-847c-c46ea7d1ca02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_617d5b2d-be07-42a4-bf27-6c594a756814" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b59d97b5-2bff-4c36-847c-c46ea7d1ca02" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ef144252-5045-405e-be39-f2133aa3fa74" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e868fc74-7bb7-4045-8572-69f3434d33b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ef144252-5045-405e-be39-f2133aa3fa74" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e868fc74-7bb7-4045-8572-69f3434d33b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b2d338bc-b00a-4b9a-ae04-d420c7d54791" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e868fc74-7bb7-4045-8572-69f3434d33b6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b2d338bc-b00a-4b9a-ae04-d420c7d54791" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b2d338bc-b00a-4b9a-ae04-d420c7d54791_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b2d338bc-b00a-4b9a-ae04-d420c7d54791" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b2d338bc-b00a-4b9a-ae04-d420c7d54791_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ecc88577-b258-4a95-ae45-eabe01904c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b2d338bc-b00a-4b9a-ae04-d420c7d54791" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ecc88577-b258-4a95-ae45-eabe01904c9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_749781db-c536-4f8e-9109-a6b61c1ed061" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ecc88577-b258-4a95-ae45-eabe01904c9c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_749781db-c536-4f8e-9109-a6b61c1ed061" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_e090ed70-906c-4627-bd22-23bc2e7f97bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ecc88577-b258-4a95-ae45-eabe01904c9c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_e090ed70-906c-4627-bd22-23bc2e7f97bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_c91e58f4-4ded-497b-9d63-b7e654536b35" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e868fc74-7bb7-4045-8572-69f3434d33b6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_c91e58f4-4ded-497b-9d63-b7e654536b35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c91e58f4-4ded-497b-9d63-b7e654536b35_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_c91e58f4-4ded-497b-9d63-b7e654536b35" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c91e58f4-4ded-497b-9d63-b7e654536b35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d348bf55-6faa-42a7-b774-69aa0cfce1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_c91e58f4-4ded-497b-9d63-b7e654536b35" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d348bf55-6faa-42a7-b774-69aa0cfce1eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_95697a3d-fd54-4370-bd6e-a6786f20722b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d348bf55-6faa-42a7-b774-69aa0cfce1eb" xlink:to="loc_us-gaap_MoneyMarketFundsMember_95697a3d-fd54-4370-bd6e-a6786f20722b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_019be57b-9d6d-749b-b955-f2d1107693cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d348bf55-6faa-42a7-b774-69aa0cfce1eb" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_019be57b-9d6d-749b-b955-f2d1107693cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e07b2ea3-13e0-4135-ab9b-3b0b05c30818" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e868fc74-7bb7-4045-8572-69f3434d33b6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e07b2ea3-13e0-4135-ab9b-3b0b05c30818" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e07b2ea3-13e0-4135-ab9b-3b0b05c30818_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e07b2ea3-13e0-4135-ab9b-3b0b05c30818" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e07b2ea3-13e0-4135-ab9b-3b0b05c30818_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e9959b3-0764-4598-96d0-8a9d07cd339a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e07b2ea3-13e0-4135-ab9b-3b0b05c30818" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e9959b3-0764-4598-96d0-8a9d07cd339a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_019be579-d2de-752a-8717-b9bd302fa5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e9959b3-0764-4598-96d0-8a9d07cd339a" xlink:to="loc_us-gaap_CertificatesOfDepositMember_019be579-d2de-752a-8717-b9bd302fa5c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_f3b0e239-6cf8-4c34-a845-b53fbd85c12a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e9959b3-0764-4598-96d0-8a9d07cd339a" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_f3b0e239-6cf8-4c34-a845-b53fbd85c12a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_3c98168d-0a35-4cd9-acf2-192499569d72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ef144252-5045-405e-be39-f2133aa3fa74" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_3c98168d-0a35-4cd9-acf2-192499569d72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9a9f36f9-deec-4c83-bb10-ac83a1fa72a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ef144252-5045-405e-be39-f2133aa3fa74" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9a9f36f9-deec-4c83-bb10-ac83a1fa72a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_aad0033a-f0b5-46e0-9be0-70d586d9b3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ef144252-5045-405e-be39-f2133aa3fa74" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_aad0033a-f0b5-46e0-9be0-70d586d9b3e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_6a25c757-18b3-4fab-b318-e5319c7287d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ef144252-5045-405e-be39-f2133aa3fa74" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_6a25c757-18b3-4fab-b318-e5319c7287d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_1334f2b7-e78f-4026-939b-34adf6e8fa93" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ef144252-5045-405e-be39-f2133aa3fa74" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_1334f2b7-e78f-4026-939b-34adf6e8fa93" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_fe3661d4-81c4-4273-b1e7-faa7f03c03aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_fe3661d4-81c4-4273-b1e7-faa7f03c03aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_019be586-3864-7c84-aecc-57e7c036ad8a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_fe3661d4-81c4-4273-b1e7-faa7f03c03aa" xlink:to="loc_srt_StatementGeographicalAxis_019be586-3864-7c84-aecc-57e7c036ad8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019be586-3864-7c84-aecc-57e7c036ad8a_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_019be586-3864-7c84-aecc-57e7c036ad8a" xlink:to="loc_srt_SegmentGeographicalDomain_019be586-3864-7c84-aecc-57e7c036ad8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019be586-3864-7913-9ade-57fc7a426c4d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_019be586-3864-7c84-aecc-57e7c036ad8a" xlink:to="loc_srt_SegmentGeographicalDomain_019be586-3864-7913-9ade-57fc7a426c4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NewJerseyAndCaliforniaMember_019be586-3864-7d6a-8794-ac41719f6050" xlink:href="smmt-20251231.xsd#smmt_NewJerseyAndCaliforniaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_019be586-3864-7913-9ade-57fc7a426c4d" xlink:to="loc_smmt_NewJerseyAndCaliforniaMember_019be586-3864-7d6a-8794-ac41719f6050" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_019be586-3864-7697-a444-d44525c14554" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_NewJerseyAndCaliforniaMember_019be586-3864-7d6a-8794-ac41719f6050" xlink:to="loc_stpr_CA_019be586-3864-7697-a444-d44525c14554" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_019be586-3864-714f-8a8f-381be56d08b9" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_NJ"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_NewJerseyAndCaliforniaMember_019be586-3864-7d6a-8794-ac41719f6050" xlink:to="loc_stpr_NJ_019be586-3864-714f-8a8f-381be56d08b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_019be586-3864-7575-91d3-e8adff615670" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_019be586-3864-7913-9ade-57fc7a426c4d" xlink:to="loc_stpr_FL_019be586-3864-7575-91d3-e8adff615670" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_019be586-3864-721f-ad88-441086c3cadf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_019be586-3864-721f-ad88-441086c3cadf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019be586-3864-7a75-a886-6b2a18c55d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019be586-3864-7a75-a886-6b2a18c55d7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_019be586-3864-7cb4-86c2-c2b5cd97d6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_019be586-3864-7cb4-86c2-c2b5cd97d6e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019be586-3864-70a1-a6cc-8b8207f212ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019be586-3864-70a1-a6cc-8b8207f212ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_019be586-5645-731d-a512-44387ac583c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_019be586-5645-731d-a512-44387ac583c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_019be586-5645-7cf0-bfe4-a610b8b539e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_019be586-5645-7cf0-bfe4-a610b8b539e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_019be586-5645-7f44-9be8-64b3d5ce7577" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:to="loc_us-gaap_OperatingLeasePayments_019be586-5645-7f44-9be8-64b3d5ce7577" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#PromissoryNotePayabletoRelatedPartiesDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_37c54476-77f0-4755-b0b2-446efb7766ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_37c54476-77f0-4755-b0b2-446efb7766ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_a889fa34-9254-48c1-975c-8f4c496078ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_37c54476-77f0-4755-b0b2-446efb7766ee" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_a889fa34-9254-48c1-975c-8f4c496078ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_a889fa34-9254-48c1-975c-8f4c496078ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_a889fa34-9254-48c1-975c-8f4c496078ef" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_a889fa34-9254-48c1-975c-8f4c496078ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_7089aabf-eaf5-4029-b745-1ee03fde2327" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_a889fa34-9254-48c1-975c-8f4c496078ef" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_7089aabf-eaf5-4029-b745-1ee03fde2327" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotePurchaseAgreementMember_5cf743fd-4b5e-4187-9771-093279755bfe" xlink:href="smmt-20251231.xsd#smmt_NotePurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_7089aabf-eaf5-4029-b745-1ee03fde2327" xlink:to="loc_smmt_NotePurchaseAgreementMember_5cf743fd-4b5e-4187-9771-093279755bfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DugganFebruaryNoteAndZanganehNoteMember_019b0200-eadc-7629-8596-3587c024e6c5" xlink:href="smmt-20251231.xsd#smmt_DugganFebruaryNoteAndZanganehNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_NotePurchaseAgreementMember_5cf743fd-4b5e-4187-9771-093279755bfe" xlink:to="loc_smmt_DugganFebruaryNoteAndZanganehNoteMember_019b0200-eadc-7629-8596-3587c024e6c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DugganFebruaryNoteMember_7472985d-a37a-4949-a540-dfdb08ef762b" xlink:href="smmt-20251231.xsd#smmt_DugganFebruaryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_DugganFebruaryNoteAndZanganehNoteMember_019b0200-eadc-7629-8596-3587c024e6c5" xlink:to="loc_smmt_DugganFebruaryNoteMember_7472985d-a37a-4949-a540-dfdb08ef762b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ZanganehNoteMember_ba603965-f0ff-4aba-956d-361847354f72" xlink:href="smmt-20251231.xsd#smmt_ZanganehNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_DugganFebruaryNoteAndZanganehNoteMember_019b0200-eadc-7629-8596-3587c024e6c5" xlink:to="loc_smmt_ZanganehNoteMember_ba603965-f0ff-4aba-956d-361847354f72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DugganSeptemberNoteMember_7b491740-53c5-4ebc-9be1-0aa385a93fa7" xlink:href="smmt-20251231.xsd#smmt_DugganSeptemberNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_7089aabf-eaf5-4029-b745-1ee03fde2327" xlink:to="loc_smmt_DugganSeptemberNoteMember_7b491740-53c5-4ebc-9be1-0aa385a93fa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember_019bfb62-6e57-7171-b7a4-7759362dc7da" xlink:href="smmt-20251231.xsd#smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_7089aabf-eaf5-4029-b745-1ee03fde2327" xlink:to="loc_smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember_019bfb62-6e57-7171-b7a4-7759362dc7da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RevisedDugganFebruaryNoteMember_6a87f212-51d3-4cae-97ee-aa392d2ce571" xlink:href="smmt-20251231.xsd#smmt_RevisedDugganFebruaryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember_019bfb62-6e57-7171-b7a4-7759362dc7da" xlink:to="loc_smmt_RevisedDugganFebruaryNoteMember_6a87f212-51d3-4cae-97ee-aa392d2ce571" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RevisedDugganSeptemberNoteMember_019b0910-8978-7b0b-bacb-0b952ace8595" xlink:href="smmt-20251231.xsd#smmt_RevisedDugganSeptemberNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember_019bfb62-6e57-7171-b7a4-7759362dc7da" xlink:to="loc_smmt_RevisedDugganSeptemberNoteMember_019b0910-8978-7b0b-bacb-0b952ace8595" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_PromissoryNotesMember_dfb1b860-8aa7-4c31-bbdb-54a9a5caf036" xlink:href="smmt-20251231.xsd#smmt_PromissoryNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_7089aabf-eaf5-4029-b745-1ee03fde2327" xlink:to="loc_smmt_PromissoryNotesMember_dfb1b860-8aa7-4c31-bbdb-54a9a5caf036" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_96ea8ee0-2c40-4a12-ab7d-3df4ccee756e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_37c54476-77f0-4755-b0b2-446efb7766ee" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_96ea8ee0-2c40-4a12-ab7d-3df4ccee756e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_96ea8ee0-2c40-4a12-ab7d-3df4ccee756e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_96ea8ee0-2c40-4a12-ab7d-3df4ccee756e" xlink:to="loc_us-gaap_RelatedPartyDomain_96ea8ee0-2c40-4a12-ab7d-3df4ccee756e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0bd645e5-d700-4948-bb87-fdcaefe8c2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_96ea8ee0-2c40-4a12-ab7d-3df4ccee756e" xlink:to="loc_us-gaap_RelatedPartyDomain_0bd645e5-d700-4948-bb87-fdcaefe8c2e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember_7245b37a-765b-4baf-8fb2-cf6b756b9f15" xlink:href="smmt-20251231.xsd#smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_0bd645e5-d700-4948-bb87-fdcaefe8c2e1" xlink:to="loc_smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember_7245b37a-765b-4baf-8fb2-cf6b756b9f15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_b95a5527-5d76-40ba-97f2-a6dcf84ac9c4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember_7245b37a-765b-4baf-8fb2-cf6b756b9f15" xlink:to="loc_srt_ChiefExecutiveOfficerMember_b95a5527-5d76-40ba-97f2-a6dcf84ac9c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ChiefExecutiveOfficerAndPresidentMember_db60d0ff-8e5e-4e07-9af7-80241979af31" xlink:href="smmt-20251231.xsd#smmt_ChiefExecutiveOfficerAndPresidentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember_7245b37a-765b-4baf-8fb2-cf6b756b9f15" xlink:to="loc_smmt_ChiefExecutiveOfficerAndPresidentMember_db60d0ff-8e5e-4e07-9af7-80241979af31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_75dc1889-f18c-41e0-afec-59b90bc74811" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_0bd645e5-d700-4948-bb87-fdcaefe8c2e1" xlink:to="loc_us-gaap_RelatedPartyMember_75dc1889-f18c-41e0-afec-59b90bc74811" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_VariableRatePeriodAxis_c1671e70-973d-4278-86e4-1f0977fdece8" xlink:href="smmt-20251231.xsd#smmt_VariableRatePeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_37c54476-77f0-4755-b0b2-446efb7766ee" xlink:to="loc_smmt_VariableRatePeriodAxis_c1671e70-973d-4278-86e4-1f0977fdece8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_VariableRatePeriodDomain_c1671e70-973d-4278-86e4-1f0977fdece8_default" xlink:href="smmt-20251231.xsd#smmt_VariableRatePeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_smmt_VariableRatePeriodAxis_c1671e70-973d-4278-86e4-1f0977fdece8" xlink:to="loc_smmt_VariableRatePeriodDomain_c1671e70-973d-4278-86e4-1f0977fdece8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_VariableRatePeriodDomain_162fc59b-7d75-46f7-bd79-04f7c280e815" xlink:href="smmt-20251231.xsd#smmt_VariableRatePeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_smmt_VariableRatePeriodAxis_c1671e70-973d-4278-86e4-1f0977fdece8" xlink:to="loc_smmt_VariableRatePeriodDomain_162fc59b-7d75-46f7-bd79-04f7c280e815" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_VariableRatePeriodOneMember_601578ca-99d8-4836-a215-c8ee3f106f1c" xlink:href="smmt-20251231.xsd#smmt_VariableRatePeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_VariableRatePeriodDomain_162fc59b-7d75-46f7-bd79-04f7c280e815" xlink:to="loc_smmt_VariableRatePeriodOneMember_601578ca-99d8-4836-a215-c8ee3f106f1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_VariableRatePeriodTwoMember_d69a8406-d148-42dc-aa2e-f5914b90d790" xlink:href="smmt-20251231.xsd#smmt_VariableRatePeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_VariableRatePeriodDomain_162fc59b-7d75-46f7-bd79-04f7c280e815" xlink:to="loc_smmt_VariableRatePeriodTwoMember_d69a8406-d148-42dc-aa2e-f5914b90d790" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_019b0204-60e7-7a29-8106-ce7ca8c27a72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_us-gaap_NotesPayable_019b0204-60e7-7a29-8106-ce7ca8c27a72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering_019b0204-60e7-767c-a363-4f9144df305e" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering_019b0204-60e7-767c-a363-4f9144df305e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering_019b0204-60e7-74cb-aeb2-b2a69620d19b" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering_019b0204-60e7-74cb-aeb2-b2a69620d19b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold_019b0204-a123-756e-a7ec-eff2b3ad6f43" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold_019b0204-a123-756e-a7ec-eff2b3ad6f43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartiesNewIssuances_019b0204-a123-74ef-9ccd-45363c60a763" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartiesNewIssuances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_smmt_NotesPayableRelatedPartiesNewIssuances_019b0204-a123-74ef-9ccd-45363c60a763" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_019b0204-bfaa-72d7-a656-b5ea2e1972e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_019b0204-bfaa-72d7-a656-b5ea2e1972e9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_019b0205-1b56-72c0-8c2c-e50ca6dae0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_019b0205-1b56-72c0-8c2c-e50ca6dae0fb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator_019b0205-1b56-7e37-bda2-0175c10e1a61" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator_019b0205-1b56-7e37-bda2-0175c10e1a61" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice_019b0205-1b56-7b89-ba44-bd1e37ddbdb5" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice_019b0205-1b56-7b89-ba44-bd1e37ddbdb5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest_019b0205-1b56-7a2c-acd6-68038411c114" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest_019b0205-1b56-7a2c-acd6-68038411c114" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019b0205-1b56-7211-852b-50debebf4ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019b0205-1b56-7211-852b-50debebf4ceb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_019b0205-1b56-70fb-9c0a-aa842a438af3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_019b0205-1b56-70fb-9c0a-aa842a438af3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_019b0205-40a5-77a4-b269-0d3083ee49bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_019b0205-40a5-77a4-b269-0d3083ee49bf" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_019b0205-6abd-768d-aaf3-d3faa28f4426" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_us-gaap_InterestPaidNet_019b0205-6abd-768d-aaf3-d3faa28f4426" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_019b0205-6abd-7a65-9249-dc1ec33d0fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_us-gaap_InterestExpenseDebt_019b0205-6abd-7a65-9249-dc1ec33d0fc5" xlink:type="arc" order="14"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#StockholdersEquityPreferredStockandCommonStockDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_0b53d6bd-b6d4-4429-9219-1e00af98bdba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_0b53d6bd-b6d4-4429-9219-1e00af98bdba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6fc2bfeb-b4c3-4955-8415-91fddd7aa842" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_0b53d6bd-b6d4-4429-9219-1e00af98bdba" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6fc2bfeb-b4c3-4955-8415-91fddd7aa842" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6fc2bfeb-b4c3-4955-8415-91fddd7aa842_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6fc2bfeb-b4c3-4955-8415-91fddd7aa842" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6fc2bfeb-b4c3-4955-8415-91fddd7aa842_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2e12ec36-77a3-40f9-87ff-207b2ae0d054" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6fc2bfeb-b4c3-4955-8415-91fddd7aa842" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2e12ec36-77a3-40f9-87ff-207b2ae0d054" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RightsOfferingMember_ac0d93bd-9f5a-4a8b-bcbb-57bffee794f7" xlink:href="smmt-20251231.xsd#smmt_RightsOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2e12ec36-77a3-40f9-87ff-207b2ae0d054" xlink:to="loc_smmt_RightsOfferingMember_ac0d93bd-9f5a-4a8b-bcbb-57bffee794f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_S3RegistrationStatementMember_69e8763e-98a0-49b0-8502-15133e80e6b2" xlink:href="smmt-20251231.xsd#smmt_S3RegistrationStatementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2e12ec36-77a3-40f9-87ff-207b2ae0d054" xlink:to="loc_smmt_S3RegistrationStatementMember_69e8763e-98a0-49b0-8502-15133e80e6b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_d2c81441-71e5-4d03-b72a-05b53dbce339" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2e12ec36-77a3-40f9-87ff-207b2ae0d054" xlink:to="loc_us-gaap_PrivatePlacementMember_d2c81441-71e5-4d03-b72a-05b53dbce339" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9988b586-a13c-4a7d-9fe1-d5c953a9f2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_0b53d6bd-b6d4-4429-9219-1e00af98bdba" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9988b586-a13c-4a7d-9fe1-d5c953a9f2c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9988b586-a13c-4a7d-9fe1-d5c953a9f2c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9988b586-a13c-4a7d-9fe1-d5c953a9f2c4" xlink:to="loc_us-gaap_RelatedPartyDomain_9988b586-a13c-4a7d-9fe1-d5c953a9f2c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_709470d4-bd12-4e1b-aa51-10831d40c717" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9988b586-a13c-4a7d-9fe1-d5c953a9f2c4" xlink:to="loc_us-gaap_RelatedPartyDomain_709470d4-bd12-4e1b-aa51-10831d40c717" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_b568ca08-751b-4b75-a469-2b71bd8c5905" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_709470d4-bd12-4e1b-aa51-10831d40c717" xlink:to="loc_srt_ChiefExecutiveOfficerMember_b568ca08-751b-4b75-a469-2b71bd8c5905" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_b469824c-40d0-4c25-bf0a-be362957b3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_709470d4-bd12-4e1b-aa51-10831d40c717" xlink:to="loc_us-gaap_RelatedPartyMember_b469824c-40d0-4c25-bf0a-be362957b3ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ChiefExecutiveOfficerAndPresidentMember_3f133c29-ba36-4f50-aa22-e85c46e25b3a" xlink:href="smmt-20251231.xsd#smmt_ChiefExecutiveOfficerAndPresidentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_709470d4-bd12-4e1b-aa51-10831d40c717" xlink:to="loc_smmt_ChiefExecutiveOfficerAndPresidentMember_3f133c29-ba36-4f50-aa22-e85c46e25b3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefOperatingOfficerMember_1d249b06-f9e9-48c8-92d2-b2b86f047ace" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefOperatingOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_709470d4-bd12-4e1b-aa51-10831d40c717" xlink:to="loc_srt_ChiefOperatingOfficerMember_1d249b06-f9e9-48c8-92d2-b2b86f047ace" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_a9771baf-8cf9-4a84-85fd-73e035ae9acf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_0b53d6bd-b6d4-4429-9219-1e00af98bdba" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_a9771baf-8cf9-4a84-85fd-73e035ae9acf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_a9771baf-8cf9-4a84-85fd-73e035ae9acf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_a9771baf-8cf9-4a84-85fd-73e035ae9acf" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_a9771baf-8cf9-4a84-85fd-73e035ae9acf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_a12a05f5-be3d-4440-a58a-e403423e310b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_a9771baf-8cf9-4a84-85fd-73e035ae9acf" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_a12a05f5-be3d-4440-a58a-e403423e310b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DugganFebruaryNoteMember_6b211f2c-f0a3-46ae-ab39-b915ffa6b9b8" xlink:href="smmt-20251231.xsd#smmt_DugganFebruaryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_a12a05f5-be3d-4440-a58a-e403423e310b" xlink:to="loc_smmt_DugganFebruaryNoteMember_6b211f2c-f0a3-46ae-ab39-b915ffa6b9b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_0bff06d9-b581-4028-a0da-1e21537a2f72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_0bff06d9-b581-4028-a0da-1e21537a2f72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e2cee6b0-5743-4780-a440-73cbc2814a94" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e2cee6b0-5743-4780-a440-73cbc2814a94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_9d233a71-e3cf-49c9-8a28-cb6b29b7f411" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_9d233a71-e3cf-49c9-8a28-cb6b29b7f411" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_f27c23f7-dc60-4390-b2a2-c024f6150b82" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_PreferredStockSharesIssued_f27c23f7-dc60-4390-b2a2-c024f6150b82" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_75ce9a9a-fa60-4e67-afaa-d472aab52f20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_75ce9a9a-fa60-4e67-afaa-d472aab52f20" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_84085f0f-8925-4044-8dea-9faa4f43e6db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_84085f0f-8925-4044-8dea-9faa4f43e6db" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_1221ecbc-7de0-4493-a090-aa3f425f93a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_CommonStockSharesIssued_1221ecbc-7de0-4493-a090-aa3f425f93a1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2a4ec6df-49c6-4b75-930a-78952d5f0cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2a4ec6df-49c6-4b75-930a-78952d5f0cf3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_4a178df3-b965-44b2-affc-c13f2d1aa464" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_4a178df3-b965-44b2-affc-c13f2d1aa464" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6adacd27-41bb-432a-80dc-6136fd810215" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6adacd27-41bb-432a-80dc-6136fd810215" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8317ce3b-b87d-4498-8166-79e9d3d26693" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8317ce3b-b87d-4498-8166-79e9d3d26693" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_9adf96cb-2f80-431c-8754-1231e0b28d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_9adf96cb-2f80-431c-8754-1231e0b28d7e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_1d7eb4e6-5490-4b94-92aa-ec4058d50015" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_StockIssued1_1d7eb4e6-5490-4b94-92aa-ec4058d50015" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_7784f0e2-d134-45f9-9553-26c78489bebf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_NotesPayable_7784f0e2-d134-45f9-9553-26c78489bebf" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CommonStockSharesAuthorizedIncreaseDecrease_69e21d79-0c7d-41cf-b587-715f34a6c481" xlink:href="smmt-20251231.xsd#smmt_CommonStockSharesAuthorizedIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_smmt_CommonStockSharesAuthorizedIncreaseDecrease_69e21d79-0c7d-41cf-b587-715f34a6c481" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SaleOfStockNumberOfSharesRegisteredForResale_7cf853a2-75e6-4208-a601-1c2744578881" xlink:href="smmt-20251231.xsd#smmt_SaleOfStockNumberOfSharesRegisteredForResale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_smmt_SaleOfStockNumberOfSharesRegisteredForResale_7cf853a2-75e6-4208-a601-1c2744578881" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_b98fb172-0a61-4a8f-982b-90c6a7baebfe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_b98fb172-0a61-4a8f-982b-90c6a7baebfe" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#StockholdersEquityPrivateInvestmentinPublicEquityDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_a725b59f-05d0-4b0d-9c58-050c8f1c2d25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_6f35d5d3-f673-423f-9021-3ab40b2c5fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_a725b59f-05d0-4b0d-9c58-050c8f1c2d25" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_6f35d5d3-f673-423f-9021-3ab40b2c5fb5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_32762fdd-7790-44d1-86f8-986b651cf895" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_6f35d5d3-f673-423f-9021-3ab40b2c5fb5" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_32762fdd-7790-44d1-86f8-986b651cf895" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_32762fdd-7790-44d1-86f8-986b651cf895_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_32762fdd-7790-44d1-86f8-986b651cf895" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_32762fdd-7790-44d1-86f8-986b651cf895_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_68a385a7-4de1-453b-94d6-ca13d492afc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_32762fdd-7790-44d1-86f8-986b651cf895" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_68a385a7-4de1-453b-94d6-ca13d492afc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_068deba9-6c8e-4dc8-8679-13ffd6bbba3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_68a385a7-4de1-453b-94d6-ca13d492afc2" xlink:to="loc_us-gaap_PrivatePlacementMember_068deba9-6c8e-4dc8-8679-13ffd6bbba3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0bc62d62-10a7-4111-82fc-de259698dac7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_6f35d5d3-f673-423f-9021-3ab40b2c5fb5" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0bc62d62-10a7-4111-82fc-de259698dac7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0bc62d62-10a7-4111-82fc-de259698dac7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0bc62d62-10a7-4111-82fc-de259698dac7" xlink:to="loc_us-gaap_RelatedPartyDomain_0bc62d62-10a7-4111-82fc-de259698dac7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_502525e6-d5b4-4af4-8c38-8b2a3da717c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0bc62d62-10a7-4111-82fc-de259698dac7" xlink:to="loc_us-gaap_RelatedPartyDomain_502525e6-d5b4-4af4-8c38-8b2a3da717c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_c0392f18-63c2-427d-a74a-72053ccaaec1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_502525e6-d5b4-4af4-8c38-8b2a3da717c5" xlink:to="loc_srt_AffiliatedEntityMember_c0392f18-63c2-427d-a74a-72053ccaaec1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrelatedPartyMember_365a720c-6c0c-4a97-8a71-cd683a76a855" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonrelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_502525e6-d5b4-4af4-8c38-8b2a3da717c5" xlink:to="loc_us-gaap_NonrelatedPartyMember_365a720c-6c0c-4a97-8a71-cd683a76a855" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_019b03cb-b5ba-7474-93fc-555eea38dbad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_502525e6-d5b4-4af4-8c38-8b2a3da717c5" xlink:to="loc_us-gaap_RelatedPartyMember_019b03cb-b5ba-7474-93fc-555eea38dbad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_fc0ac8c4-108a-4885-a281-b925fc32e4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_a725b59f-05d0-4b0d-9c58-050c8f1c2d25" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_fc0ac8c4-108a-4885-a281-b925fc32e4dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_2a8cace6-f8fb-49c8-a134-4b4c75dea1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_a725b59f-05d0-4b0d-9c58-050c8f1c2d25" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_2a8cace6-f8fb-49c8-a134-4b4c75dea1ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_be3d5b2a-f646-4ba8-b0ae-7b8af51faef1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_a725b59f-05d0-4b0d-9c58-050c8f1c2d25" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_be3d5b2a-f646-4ba8-b0ae-7b8af51faef1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_19b00f00-8b11-48eb-83ec-ecb3e66a25b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_a725b59f-05d0-4b0d-9c58-050c8f1c2d25" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_19b00f00-8b11-48eb-83ec-ecb3e66a25b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_35e31634-582d-409b-80a9-c7821d61708c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_a725b59f-05d0-4b0d-9c58-050c8f1c2d25" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_35e31634-582d-409b-80a9-c7821d61708c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_6c3e2e6b-375b-4760-9ab1-f00a25d5c829" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_a725b59f-05d0-4b0d-9c58-050c8f1c2d25" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_6c3e2e6b-375b-4760-9ab1-f00a25d5c829" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#StockholdersEquityAttheMarketOfferingandWarrantsDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_33017be8-4736-4303-890d-98c06815189a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_33017be8-4736-4303-890d-98c06815189a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6208f531-0a0c-4e32-879b-dd26b6373bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_33017be8-4736-4303-890d-98c06815189a" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6208f531-0a0c-4e32-879b-dd26b6373bf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6208f531-0a0c-4e32-879b-dd26b6373bf4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6208f531-0a0c-4e32-879b-dd26b6373bf4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6208f531-0a0c-4e32-879b-dd26b6373bf4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6a513fa5-5f2f-40dd-a4ab-462afa29b1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6208f531-0a0c-4e32-879b-dd26b6373bf4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6a513fa5-5f2f-40dd-a4ab-462afa29b1bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_OriginalDistributionAgreementMember_7d53bcb5-60ac-4a56-b069-539e9de61d53" xlink:href="smmt-20251231.xsd#smmt_OriginalDistributionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6a513fa5-5f2f-40dd-a4ab-462afa29b1bf" xlink:to="loc_smmt_OriginalDistributionAgreementMember_7d53bcb5-60ac-4a56-b069-539e9de61d53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DistributionAgreementMember_4e02de20-5593-4700-af5e-78a70e9ac74c" xlink:href="smmt-20251231.xsd#smmt_DistributionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6a513fa5-5f2f-40dd-a4ab-462afa29b1bf" xlink:to="loc_smmt_DistributionAgreementMember_4e02de20-5593-4700-af5e-78a70e9ac74c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_9f7922b7-7dae-41a4-84b3-165df25e443e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_9f7922b7-7dae-41a4-84b3-165df25e443e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SaleOfStockAggregateOfferingPrice_464ff90e-253f-47d5-8c6b-fbe43f660053" xlink:href="smmt-20251231.xsd#smmt_SaleOfStockAggregateOfferingPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_smmt_SaleOfStockAggregateOfferingPrice_464ff90e-253f-47d5-8c6b-fbe43f660053" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e3ad922d-7387-40bc-a606-487f4297c68c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e3ad922d-7387-40bc-a606-487f4297c68c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_8d873908-7a33-4df1-b893-4f8aea9f0458" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_8d873908-7a33-4df1-b893-4f8aea9f0458" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8030d4ff-6c84-4867-bdae-4858da612abd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8030d4ff-6c84-4867-bdae-4858da612abd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_b24fd2e3-d227-45b1-85de-188758bddbff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_b24fd2e3-d227-45b1-85de-188758bddbff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SaleOfStockAmountRemainingUnderTheOffering_19085925-274a-4c96-9d37-388edab5c9fc" xlink:href="smmt-20251231.xsd#smmt_SaleOfStockAmountRemainingUnderTheOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_smmt_SaleOfStockAmountRemainingUnderTheOffering_19085925-274a-4c96-9d37-388edab5c9fc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e58e5375-23ab-470b-bce6-7b551624c4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e58e5375-23ab-470b-bce6-7b551624c4b8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice_47961178-b1af-45f0-a165-c544e93540de" xlink:href="smmt-20251231.xsd#smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice_47961178-b1af-45f0-a165-c544e93540de" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ClassOfWarrantOrRightExercisesInPeriod_019b01e1-26e6-71cc-958a-c4cafdd07eaf" xlink:href="smmt-20251231.xsd#smmt_ClassOfWarrantOrRightExercisesInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_smmt_ClassOfWarrantOrRightExercisesInPeriod_019b01e1-26e6-71cc-958a-c4cafdd07eaf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_019b01e2-2ad7-7255-8b6d-20ae1184e4b0" xlink:href="smmt-20251231.xsd#smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_019b01e2-2ad7-7255-8b6d-20ae1184e4b0" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019b01d6-d31d-75ae-813e-740a18dadc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019b01d6-d31d-75ae-813e-740a18dadc6f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019be58f-5426-789f-9ca2-271d41b35655" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019b01d6-d31d-75ae-813e-740a18dadc6f" xlink:to="loc_us-gaap_PlanNameAxis_019be58f-5426-789f-9ca2-271d41b35655" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019be58f-5426-789f-9ca2-271d41b35655_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_019be58f-5426-789f-9ca2-271d41b35655" xlink:to="loc_us-gaap_PlanNameDomain_019be58f-5426-789f-9ca2-271d41b35655_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019be58f-5426-75bd-808c-00f8b4a5c406" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_019be58f-5426-789f-9ca2-271d41b35655" xlink:to="loc_us-gaap_PlanNameDomain_019be58f-5426-75bd-808c-00f8b4a5c406" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_A2020StockIncentivePlanMember_019be58f-5426-71c3-b342-d245b009878e" xlink:href="smmt-20251231.xsd#smmt_A2020StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019be58f-5426-75bd-808c-00f8b4a5c406" xlink:to="loc_smmt_A2020StockIncentivePlanMember_019be58f-5426-71c3-b342-d245b009878e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_A2020IncrementalPoolMember_019be58f-84dd-7f3e-9aa5-a0e01e721e4b" xlink:href="smmt-20251231.xsd#smmt_A2020IncrementalPoolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019be58f-5426-75bd-808c-00f8b4a5c406" xlink:to="loc_smmt_A2020IncrementalPoolMember_019be58f-84dd-7f3e-9aa5-a0e01e721e4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_A2024InducementPoolMember_019be58f-84dd-7969-b8b4-c482fcd175ab" xlink:href="smmt-20251231.xsd#smmt_A2024InducementPoolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019be58f-5426-75bd-808c-00f8b4a5c406" xlink:to="loc_smmt_A2024InducementPoolMember_019be58f-84dd-7969-b8b4-c482fcd175ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019be58f-a8d5-7852-9a6a-3fc8553798db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019b01d6-d31d-75ae-813e-740a18dadc6f" xlink:to="loc_us-gaap_AwardTypeAxis_019be58f-a8d5-7852-9a6a-3fc8553798db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019be58f-a8d5-7852-9a6a-3fc8553798db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019be58f-a8d5-7852-9a6a-3fc8553798db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019be58f-a8d5-7852-9a6a-3fc8553798db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019be58f-a8d5-79fb-be32-e6880cff8eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019be58f-a8d5-7852-9a6a-3fc8553798db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019be58f-a8d5-79fb-be32-e6880cff8eeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_019be58f-a8d5-776e-a80d-81c01b029b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019be58f-a8d5-79fb-be32-e6880cff8eeb" xlink:to="loc_us-gaap_EmployeeStockMember_019be58f-a8d5-776e-a80d-81c01b029b4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EmployeeStockOptionPerformanceBasedMember_019be590-19af-7bc1-8ad5-b68ab3cc5228" xlink:href="smmt-20251231.xsd#smmt_EmployeeStockOptionPerformanceBasedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019be58f-a8d5-79fb-be32-e6880cff8eeb" xlink:to="loc_smmt_EmployeeStockOptionPerformanceBasedMember_019be590-19af-7bc1-8ad5-b68ab3cc5228" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EmployeeStockOptionTimeBasedMember_019c443b-94c1-791d-8161-97a5e96a59d3" xlink:href="smmt-20251231.xsd#smmt_EmployeeStockOptionTimeBasedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019be58f-a8d5-79fb-be32-e6880cff8eeb" xlink:to="loc_smmt_EmployeeStockOptionTimeBasedMember_019c443b-94c1-791d-8161-97a5e96a59d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019be58f-e2c8-7fc5-ba84-fd84fa962000" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019b01d6-d31d-75ae-813e-740a18dadc6f" xlink:to="loc_srt_RangeAxis_019be58f-e2c8-7fc5-ba84-fd84fa962000" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019be58f-e2c8-7fc5-ba84-fd84fa962000_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019be58f-e2c8-7fc5-ba84-fd84fa962000" xlink:to="loc_srt_RangeMember_019be58f-e2c8-7fc5-ba84-fd84fa962000_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019be58f-e2c8-7107-90da-8ae6420302c6" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019be58f-e2c8-7fc5-ba84-fd84fa962000" xlink:to="loc_srt_RangeMember_019be58f-e2c8-7107-90da-8ae6420302c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019be58f-e2c8-702a-a4b0-bad35f0b4464" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019be58f-e2c8-7107-90da-8ae6420302c6" xlink:to="loc_srt_MinimumMember_019be58f-e2c8-702a-a4b0-bad35f0b4464" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019be58f-e2c8-7629-a8aa-eb50fc0d3657" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019be58f-e2c8-7107-90da-8ae6420302c6" xlink:to="loc_srt_MaximumMember_019be58f-e2c8-7629-a8aa-eb50fc0d3657" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019be58f-5426-777f-9a92-e08917f4ceef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019be58f-5426-777f-9a92-e08917f4ceef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration_019be58f-5426-72c3-8cbc-74191faac15b" xlink:href="smmt-20251231.xsd#smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration_019be58f-5426-72c3-8cbc-74191faac15b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan_019be58f-5426-738a-840b-c7073e46464e" xlink:href="smmt-20251231.xsd#smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan_019be58f-5426-738a-840b-c7073e46464e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_019be58f-5426-7c59-ad82-674ee417a3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_019be58f-5426-7c59-ad82-674ee417a3b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019be58f-5426-7c99-9839-e52f2f2f5732" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019be58f-5426-7c99-9839-e52f2f2f5732" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan_019be58f-84dd-79d9-97e4-0eca03578083" xlink:href="smmt-20251231.xsd#smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan_019be58f-84dd-79d9-97e4-0eca03578083" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod_019be58f-a8d5-7be1-a98f-99436f004cd2" xlink:href="smmt-20251231.xsd#smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod_019be58f-a8d5-7be1-a98f-99436f004cd2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_019be58f-e2c8-762f-b378-2820a42b1f48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_019be58f-e2c8-762f-b378-2820a42b1f48" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_019be58f-e2c8-7bf9-b1fd-955eda3800ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_019be58f-e2c8-7bf9-b1fd-955eda3800ac" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_019be58f-e2c8-7326-a3f6-40a67a64dc70" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_019be58f-e2c8-7326-a3f6-40a67a64dc70" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019be58f-e2c8-7665-8cc5-14e43ddd26dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019be58f-e2c8-7665-8cc5-14e43ddd26dd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019be58f-e2c8-70ac-902e-7f7538fd83e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019be58f-e2c8-70ac-902e-7f7538fd83e8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_019be590-19af-7584-b31f-f1c02e24f4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_019be590-19af-7584-b31f-f1c02e24f4fb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_019be590-19af-7cb4-a756-731e829ed1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_019be590-19af-7cb4-a756-731e829ed1e1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount_019be590-19af-7338-a76f-3bbe61b81540" xlink:href="smmt-20251231.xsd#smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount_019be590-19af-7338-a76f-3bbe61b81540" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod_019be590-19af-78ac-b7b4-b4692975f2b8" xlink:href="smmt-20251231.xsd#smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod_019be590-19af-78ac-b7b4-b4692975f2b8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019c4436-d1b6-7440-bae6-a961a23259ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019c4436-d1b6-7440-bae6-a961a23259ff" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_019c40f1-9c4b-778e-99bb-9140cd46ec10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_019c40f1-9c4b-778e-99bb-9140cd46ec10" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019be590-19af-7f0a-a882-5586266a46c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019be590-19af-7f0a-a882-5586266a46c5" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019be590-19af-7c42-bbde-d74a2ce5c570" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019be590-19af-7c42-bbde-d74a2ce5c570" xlink:type="arc" order="19"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c69d60e4-c5b3-4558-903c-f48a6c5a47f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb394730-451d-471c-ba78-f68f88a1a911" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c69d60e4-c5b3-4558-903c-f48a6c5a47f3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb394730-451d-471c-ba78-f68f88a1a911" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2b7e9db6-5617-4ecb-8a40-f7ac2f93041c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb394730-451d-471c-ba78-f68f88a1a911" xlink:to="loc_us-gaap_AwardTypeAxis_2b7e9db6-5617-4ecb-8a40-f7ac2f93041c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2b7e9db6-5617-4ecb-8a40-f7ac2f93041c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2b7e9db6-5617-4ecb-8a40-f7ac2f93041c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2b7e9db6-5617-4ecb-8a40-f7ac2f93041c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5eac9bba-a8b4-4348-9f8f-f58ddd9a7af2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2b7e9db6-5617-4ecb-8a40-f7ac2f93041c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5eac9bba-a8b4-4348-9f8f-f58ddd9a7af2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019c4d59-46a1-79fe-9152-46276064e731" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5eac9bba-a8b4-4348-9f8f-f58ddd9a7af2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019c4d59-46a1-79fe-9152-46276064e731" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EmployeeStockOptionTimeBasedMember_019c443d-e576-75eb-a4f2-39a7a1b2e993" xlink:href="smmt-20251231.xsd#smmt_EmployeeStockOptionTimeBasedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeStockOptionMember_019c4d59-46a1-79fe-9152-46276064e731" xlink:to="loc_smmt_EmployeeStockOptionTimeBasedMember_019c443d-e576-75eb-a4f2-39a7a1b2e993" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019c26f1-e0d9-756f-a08b-3ced21c680ec" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb394730-451d-471c-ba78-f68f88a1a911" xlink:to="loc_srt_RangeAxis_019c26f1-e0d9-756f-a08b-3ced21c680ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019c26f1-e0d9-756f-a08b-3ced21c680ec_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019c26f1-e0d9-756f-a08b-3ced21c680ec" xlink:to="loc_srt_RangeMember_019c26f1-e0d9-756f-a08b-3ced21c680ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019c26f1-e0d9-7f31-ac1f-85041d5fd626" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019c26f1-e0d9-756f-a08b-3ced21c680ec" xlink:to="loc_srt_RangeMember_019c26f1-e0d9-7f31-ac1f-85041d5fd626" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019c26f1-e0d9-712e-97dc-5d03c8883943" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019c26f1-e0d9-7f31-ac1f-85041d5fd626" xlink:to="loc_srt_MinimumMember_019c26f1-e0d9-712e-97dc-5d03c8883943" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019c26f1-e0d9-7db9-b661-17a79a5ebefb" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019c26f1-e0d9-7f31-ac1f-85041d5fd626" xlink:to="loc_srt_MaximumMember_019c26f1-e0d9-7db9-b661-17a79a5ebefb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_019c2f6e-6749-79d1-a59b-83cc5464937a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c69d60e4-c5b3-4558-903c-f48a6c5a47f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_019c2f6e-6749-79d1-a59b-83cc5464937a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_019c2f6f-45cd-7625-9fde-58f49783459e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c69d60e4-c5b3-4558-903c-f48a6c5a47f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_019c2f6f-45cd-7625-9fde-58f49783459e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_30524fac-9357-4e80-bd68-c9fc912d7ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c69d60e4-c5b3-4558-903c-f48a6c5a47f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_30524fac-9357-4e80-bd68-c9fc912d7ffe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4bb48605-def3-4a27-a959-a347a94c8ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c69d60e4-c5b3-4558-903c-f48a6c5a47f3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4bb48605-def3-4a27-a959-a347a94c8ae6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_6988c591-6aff-41bd-bd8f-95bef4613427" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c69d60e4-c5b3-4558-903c-f48a6c5a47f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_6988c591-6aff-41bd-bd8f-95bef4613427" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_d2e74903-c84e-4810-baa6-5f0fb850309a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c69d60e4-c5b3-4558-903c-f48a6c5a47f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_d2e74903-c84e-4810-baa6-5f0fb850309a" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#StockBasedCompensationStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_692025e2-9fe0-46cd-965f-fbf513681e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3403429d-31b7-483d-9177-4d46b883ab73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_692025e2-9fe0-46cd-965f-fbf513681e5d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3403429d-31b7-483d-9177-4d46b883ab73" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0bca7ada-7f7a-4dea-b526-7f1f28e348ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3403429d-31b7-483d-9177-4d46b883ab73" xlink:to="loc_us-gaap_AwardTypeAxis_0bca7ada-7f7a-4dea-b526-7f1f28e348ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0bca7ada-7f7a-4dea-b526-7f1f28e348ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0bca7ada-7f7a-4dea-b526-7f1f28e348ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0bca7ada-7f7a-4dea-b526-7f1f28e348ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d7073ab-2e60-49b0-916f-ea218da001b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0bca7ada-7f7a-4dea-b526-7f1f28e348ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d7073ab-2e60-49b0-916f-ea218da001b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EmployeeStockOptionTimeBasedMember_019c443a-be06-79f9-be7a-5ea19a35db73" xlink:href="smmt-20251231.xsd#smmt_EmployeeStockOptionTimeBasedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d7073ab-2e60-49b0-916f-ea218da001b7" xlink:to="loc_smmt_EmployeeStockOptionTimeBasedMember_019c443a-be06-79f9-be7a-5ea19a35db73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EmployeeStockOptionPerformanceBasedMember_315f5f7d-3736-4a26-98b7-761b907cdf27" xlink:href="smmt-20251231.xsd#smmt_EmployeeStockOptionPerformanceBasedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d7073ab-2e60-49b0-916f-ea218da001b7" xlink:to="loc_smmt_EmployeeStockOptionPerformanceBasedMember_315f5f7d-3736-4a26-98b7-761b907cdf27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58e1a6d9-1ee2-4b41-9e17-8415faf21b13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_692025e2-9fe0-46cd-965f-fbf513681e5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58e1a6d9-1ee2-4b41-9e17-8415faf21b13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a2614cb9-c785-485f-b286-dae0d971dccb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58e1a6d9-1ee2-4b41-9e17-8415faf21b13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a2614cb9-c785-485f-b286-dae0d971dccb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4f32ae48-72dc-43aa-bef2-404a1fca5798" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58e1a6d9-1ee2-4b41-9e17-8415faf21b13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4f32ae48-72dc-43aa-bef2-404a1fca5798" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_9aa013d3-523d-4052-b688-8bab3ef05d43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58e1a6d9-1ee2-4b41-9e17-8415faf21b13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_9aa013d3-523d-4052-b688-8bab3ef05d43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5acd9bee-be9d-40f6-bb83-b4a41cc53c80" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58e1a6d9-1ee2-4b41-9e17-8415faf21b13" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5acd9bee-be9d-40f6-bb83-b4a41cc53c80" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_695b8f26-af34-41f6-8a67-4636b11c8565" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5506c0c9-e3e2-4935-b886-08cb6ec3a4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_692025e2-9fe0-46cd-965f-fbf513681e5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5506c0c9-e3e2-4935-b886-08cb6ec3a4ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e1a39eff-1544-44e2-8898-3e8ae922031f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5506c0c9-e3e2-4935-b886-08cb6ec3a4ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e1a39eff-1544-44e2-8898-3e8ae922031f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fd595489-ca4c-4a21-8245-6bb08e460f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5506c0c9-e3e2-4935-b886-08cb6ec3a4ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fd595489-ca4c-4a21-8245-6bb08e460f8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_897c7dcc-0716-4cc2-9a23-7bbcba311261" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5506c0c9-e3e2-4935-b886-08cb6ec3a4ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_897c7dcc-0716-4cc2-9a23-7bbcba311261" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_10810c41-0dd3-40fc-b8af-96f81c905b51" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5506c0c9-e3e2-4935-b886-08cb6ec3a4ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_10810c41-0dd3-40fc-b8af-96f81c905b51" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_44f9a2c6-774d-4c84-8faa-476808f4610e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_692025e2-9fe0-46cd-965f-fbf513681e5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_41183b6f-e684-4238-a412-7f03d06f778c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_41183b6f-e684-4238-a412-7f03d06f778c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d64fe22e-54ca-4f8e-b4eb-21aae4130815" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d64fe22e-54ca-4f8e-b4eb-21aae4130815" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_959091c3-4407-4768-b3bc-2e6680f3e7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_959091c3-4407-4768-b3bc-2e6680f3e7e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_cdd562cc-ebac-4b71-a7e0-bac07a8c73a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_cdd562cc-ebac-4b71-a7e0-bac07a8c73a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ee002dc1-ff33-49f9-a653-b240c2d9084b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ee002dc1-ff33-49f9-a653-b240c2d9084b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_189ddf82-28a5-4246-8eb8-e86c217ee82a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_189ddf82-28a5-4246-8eb8-e86c217ee82a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_bde53f66-de50-4f33-bf10-d873ce149f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_bde53f66-de50-4f33-bf10-d873ce149f1f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ce82ab63-12e0-42b6-becf-5e63045115a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ce82ab63-12e0-42b6-becf-5e63045115a8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_6b59f6eb-1451-42e0-8961-b45cf383d629" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_6b59f6eb-1451-42e0-8961-b45cf383d629" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_86568391-efac-4db7-8a70-05ea941d0667" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_86568391-efac-4db7-8a70-05ea941d0667" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber_aecde3ab-a10b-46f2-b0b1-d3550150da5c" xlink:href="smmt-20251231.xsd#smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_692025e2-9fe0-46cd-965f-fbf513681e5d" xlink:to="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber_aecde3ab-a10b-46f2-b0b1-d3550150da5c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3022b26e-42b4-4df0-bcb6-845bef5584c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_44b10dec-2458-44ae-988c-7c5ac813719c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3022b26e-42b4-4df0-bcb6-845bef5584c9" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_44b10dec-2458-44ae-988c-7c5ac813719c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_76ffedd0-80dd-4b83-b1c3-ab65f40689a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_44b10dec-2458-44ae-988c-7c5ac813719c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_76ffedd0-80dd-4b83-b1c3-ab65f40689a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_76ffedd0-80dd-4b83-b1c3-ab65f40689a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_76ffedd0-80dd-4b83-b1c3-ab65f40689a7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_76ffedd0-80dd-4b83-b1c3-ab65f40689a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_727ae78a-c2fc-4a39-8313-3a6340c9f191" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_76ffedd0-80dd-4b83-b1c3-ab65f40689a7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_727ae78a-c2fc-4a39-8313-3a6340c9f191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_44fc8018-d3bc-46ef-9d32-ed23f2643bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_727ae78a-c2fc-4a39-8313-3a6340c9f191" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_44fc8018-d3bc-46ef-9d32-ed23f2643bcd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_a153fab1-6d0a-4f10-820a-2656937a3a98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_727ae78a-c2fc-4a39-8313-3a6340c9f191" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_a153fab1-6d0a-4f10-820a-2656937a3a98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0bc0dd6a-befd-4159-b33e-48ba5465d155" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_44b10dec-2458-44ae-988c-7c5ac813719c" xlink:to="loc_us-gaap_AwardTypeAxis_0bc0dd6a-befd-4159-b33e-48ba5465d155" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0bc0dd6a-befd-4159-b33e-48ba5465d155_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0bc0dd6a-befd-4159-b33e-48ba5465d155" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0bc0dd6a-befd-4159-b33e-48ba5465d155_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ce81d84-faea-4b3a-9b27-9a5047126b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0bc0dd6a-befd-4159-b33e-48ba5465d155" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ce81d84-faea-4b3a-9b27-9a5047126b3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EmployeeStockOptionTimeBasedMember_a29de4ff-9cbc-4d86-b5e7-d06ee18f8aa5" xlink:href="smmt-20251231.xsd#smmt_EmployeeStockOptionTimeBasedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ce81d84-faea-4b3a-9b27-9a5047126b3b" xlink:to="loc_smmt_EmployeeStockOptionTimeBasedMember_a29de4ff-9cbc-4d86-b5e7-d06ee18f8aa5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EmployeeStockOptionPerformanceAndMarketBasedMember_6caef275-5e84-4679-b98f-8769279c7a45" xlink:href="smmt-20251231.xsd#smmt_EmployeeStockOptionPerformanceAndMarketBasedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ce81d84-faea-4b3a-9b27-9a5047126b3b" xlink:to="loc_smmt_EmployeeStockOptionPerformanceAndMarketBasedMember_6caef275-5e84-4679-b98f-8769279c7a45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_2d9f173d-a50f-4a08-b89a-97707e8c16d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ce81d84-faea-4b3a-9b27-9a5047126b3b" xlink:to="loc_us-gaap_EmployeeStockMember_2d9f173d-a50f-4a08-b89a-97707e8c16d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4ff3d8c5-6295-424b-87cc-78a53ca19aae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3022b26e-42b4-4df0-bcb6-845bef5584c9" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4ff3d8c5-6295-424b-87cc-78a53ca19aae" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#RelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.summitplc.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_718fa32e-1fcd-4ec5-abb4-7837778f19ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_718fa32e-1fcd-4ec5-abb4-7837778f19ec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_019be593-181e-7ec9-9be8-126035cf636d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_718fa32e-1fcd-4ec5-abb4-7837778f19ec" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_019be593-181e-7ec9-9be8-126035cf636d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_019be593-181e-7ec9-9be8-126035cf636d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_019be593-181e-7ec9-9be8-126035cf636d" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_019be593-181e-7ec9-9be8-126035cf636d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_019be593-181e-7c1a-8d65-efa62ae588c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_019be593-181e-7ec9-9be8-126035cf636d" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_019be593-181e-7c1a-8d65-efa62ae588c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SubleaseAgreementFirstAndThirdAmendmentMember_019be593-181e-7047-9bd4-b16d8eeee655" xlink:href="smmt-20251231.xsd#smmt_SubleaseAgreementFirstAndThirdAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019be593-181e-7c1a-8d65-efa62ae588c5" xlink:to="loc_smmt_SubleaseAgreementFirstAndThirdAmendmentMember_019be593-181e-7047-9bd4-b16d8eeee655" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SubleaseAgreementFirstAmendmentMember_019be593-181e-7d64-a29a-6eb4a553600f" xlink:href="smmt-20251231.xsd#smmt_SubleaseAgreementFirstAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_SubleaseAgreementFirstAndThirdAmendmentMember_019be593-181e-7047-9bd4-b16d8eeee655" xlink:to="loc_smmt_SubleaseAgreementFirstAmendmentMember_019be593-181e-7d64-a29a-6eb4a553600f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SubleaseAgreementThirdAmendmentMember_019be593-74d9-7989-b2f0-a4e8ab87c298" xlink:href="smmt-20251231.xsd#smmt_SubleaseAgreementThirdAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_SubleaseAgreementFirstAndThirdAmendmentMember_019be593-181e-7047-9bd4-b16d8eeee655" xlink:to="loc_smmt_SubleaseAgreementThirdAmendmentMember_019be593-74d9-7989-b2f0-a4e8ab87c298" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SubleaseAgreementSecondAmendmentMember_019be593-4644-7a4d-a9f5-b7163e4d389b" xlink:href="smmt-20251231.xsd#smmt_SubleaseAgreementSecondAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019be593-181e-7c1a-8d65-efa62ae588c5" xlink:to="loc_smmt_SubleaseAgreementSecondAmendmentMember_019be593-4644-7a4d-a9f5-b7163e4d389b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_GeniusSubleaseAgreementMember_019be593-74d9-7c3c-9668-bb0f7a198e22" xlink:href="smmt-20251231.xsd#smmt_GeniusSubleaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019be593-181e-7c1a-8d65-efa62ae588c5" xlink:to="loc_smmt_GeniusSubleaseAgreementMember_019be593-74d9-7c3c-9668-bb0f7a198e22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_InvestmentsResearchSubleaseAgreementMember_019be593-74d9-726d-85c6-61d61284072f" xlink:href="smmt-20251231.xsd#smmt_InvestmentsResearchSubleaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_GeniusSubleaseAgreementMember_019be593-74d9-7c3c-9668-bb0f7a198e22" xlink:to="loc_smmt_InvestmentsResearchSubleaseAgreementMember_019be593-74d9-726d-85c6-61d61284072f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember_019be593-74d9-7a33-a22b-9004929bd041" xlink:href="smmt-20251231.xsd#smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_smmt_GeniusSubleaseAgreementMember_019be593-74d9-7c3c-9668-bb0f7a198e22" xlink:to="loc_smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember_019be593-74d9-7a33-a22b-9004929bd041" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AkesoSupplyAgreementMember_019be593-96b3-7d56-a5ce-514ce1b71e93" xlink:href="smmt-20251231.xsd#smmt_AkesoSupplyAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019be593-181e-7c1a-8d65-efa62ae588c5" xlink:to="loc_smmt_AkesoSupplyAgreementMember_019be593-96b3-7d56-a5ce-514ce1b71e93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ConsultingAgreementMember_019be593-c37c-7fbc-92a4-4ba5479c3e6e" xlink:href="smmt-20251231.xsd#smmt_ConsultingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019be593-181e-7c1a-8d65-efa62ae588c5" xlink:to="loc_smmt_ConsultingAgreementMember_019be593-c37c-7fbc-92a4-4ba5479c3e6e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019be593-181e-75e3-909b-ec9ba9f01dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_718fa32e-1fcd-4ec5-abb4-7837778f19ec" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019be593-181e-75e3-909b-ec9ba9f01dd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_019be593-181e-75e3-909b-ec9ba9f01dd4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019be593-181e-75e3-909b-ec9ba9f01dd4" xlink:to="loc_us-gaap_RelatedPartyDomain_019be593-181e-75e3-909b-ec9ba9f01dd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_019be593-181e-7936-b724-d0622ff8639b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019be593-181e-75e3-909b-ec9ba9f01dd4" xlink:to="loc_us-gaap_RelatedPartyDomain_019be593-181e-7936-b724-d0622ff8639b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_019be593-96b3-72a5-a80f-0a8b07771ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_019be593-181e-7936-b724-d0622ff8639b" xlink:to="loc_us-gaap_RelatedPartyMember_019be593-96b3-72a5-a80f-0a8b07771ab9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_019be593-181e-7508-9dc2-c2d11820a243" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyMember_019be593-96b3-72a5-a80f-0a8b07771ab9" xlink:to="loc_srt_AffiliatedEntityMember_019be593-181e-7508-9dc2-c2d11820a243" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CoChiefExecutiveOfficerMember_019be593-c37c-7493-bcd0-6d84e09dc8ab" xlink:href="smmt-20251231.xsd#smmt_CoChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyMember_019be593-96b3-72a5-a80f-0a8b07771ab9" xlink:to="loc_smmt_CoChiefExecutiveOfficerMember_019be593-c37c-7493-bcd0-6d84e09dc8ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember_019be593-c37c-7835-92d3-bf896c627cfa" xlink:href="smmt-20251231.xsd#smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyMember_019be593-96b3-72a5-a80f-0a8b07771ab9" xlink:to="loc_smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember_019be593-c37c-7835-92d3-bf896c627cfa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019be593-c37c-7f71-a4b8-c754579b413f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_718fa32e-1fcd-4ec5-abb4-7837778f19ec" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019be593-c37c-7f71-a4b8-c754579b413f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019be593-c37c-7f71-a4b8-c754579b413f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019be593-c37c-7f71-a4b8-c754579b413f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019be593-c37c-7f71-a4b8-c754579b413f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019be593-c37c-7958-87bf-3457a79ab942" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019be593-c37c-7f71-a4b8-c754579b413f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019be593-c37c-7958-87bf-3457a79ab942" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_019be593-c37c-717d-be5e-41c0874d5cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019be593-c37c-7958-87bf-3457a79ab942" xlink:to="loc_us-gaap_PrivatePlacementMember_019be593-c37c-717d-be5e-41c0874d5cf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AreaOfPremisesSubleased_019be593-181e-7615-b8ae-2fe42faa7a15" xlink:href="smmt-20251231.xsd#smmt_AreaOfPremisesSubleased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_AreaOfPremisesSubleased_019be593-181e-7615-b8ae-2fe42faa7a15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RelatedPartyTransactionSubleaseExtensionTerm_019be593-181e-7466-ad1a-7d27e583fc6e" xlink:href="smmt-20251231.xsd#smmt_RelatedPartyTransactionSubleaseExtensionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_RelatedPartyTransactionSubleaseExtensionTerm_019be593-181e-7466-ad1a-7d27e583fc6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RelatedPartyTransactionPaymentsToRelatedParty_019be593-181e-7ed0-9b2e-9607ab4efc9d" xlink:href="smmt-20251231.xsd#smmt_RelatedPartyTransactionPaymentsToRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_RelatedPartyTransactionPaymentsToRelatedParty_019be593-181e-7ed0-9b2e-9607ab4efc9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_LessorOperatingLeaseNumberOfContracts_019be593-74d9-7563-b2f5-b7cf6fcc8944" xlink:href="smmt-20251231.xsd#smmt_LessorOperatingLeaseNumberOfContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_LessorOperatingLeaseNumberOfContracts_019be593-74d9-7563-b2f5-b7cf6fcc8944" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_LessorOperatingLeaseAreaOfPremisesLeased_019be593-74d9-7b42-b275-c7c9690cd16e" xlink:href="smmt-20251231.xsd#smmt_LessorOperatingLeaseAreaOfPremisesLeased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_LessorOperatingLeaseAreaOfPremisesLeased_019be593-74d9-7b42-b275-c7c9690cd16e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseTermOfContract_019be593-74d9-74dc-b556-3f4acb4989f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LessorOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_us-gaap_LessorOperatingLeaseTermOfContract_019be593-74d9-74dc-b556-3f4acb4989f7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_019be593-74d9-762d-8246-d9b54f00d198" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_019be593-74d9-762d-8246-d9b54f00d198" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_019be593-74d9-7848-9682-195a8a9d29c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubleaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_us-gaap_SubleaseIncome_019be593-74d9-7848-9682-195a8a9d29c0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage_019be593-74d9-7078-8286-98cd8cd2dd75" xlink:href="smmt-20251231.xsd#smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage_019be593-74d9-7078-8286-98cd8cd2dd75" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_019c52c2-5833-773c-ba60-4f595974228d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_019c52c2-5833-773c-ba60-4f595974228d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019be593-96b3-77e8-a10a-0592ac1d4cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019be593-96b3-77e8-a10a-0592ac1d4cc3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ClassOfWarrantOrRightExercisesInPeriod_019be593-c37c-7ca4-a3f7-42337093f7e3" xlink:href="smmt-20251231.xsd#smmt_ClassOfWarrantOrRightExercisesInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_ClassOfWarrantOrRightExercisesInPeriod_019be593-c37c-7ca4-a3f7-42337093f7e3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019be593-c37c-7af5-bd47-a33459ab5d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019be593-c37c-7af5-bd47-a33459ab5d8d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice_019be593-c37c-7f65-a46a-80516e68df8b" xlink:href="smmt-20251231.xsd#smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice_019be593-c37c-7f65-a46a-80516e68df8b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_019be593-c37c-75fb-93f8-b903fd4257b7" xlink:href="smmt-20251231.xsd#smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_019be593-c37c-75fb-93f8-b903fd4257b7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_019be593-c37c-797c-a153-e35305f98e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LegalFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_us-gaap_LegalFees_019be593-c37c-797c-a153-e35305f98e7d" xlink:type="arc" order="15"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>smmt-20251231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:5ba7c3ca-9242-422c-a50f-4bf839baf136,g:2c7db6f2-9106-44bc-b090-f2695a3e242b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_1bef041c-542b-4949-8574-f57865d99abf_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies and Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefOperatingOfficerMember_42208138-053e-43ca-b5ec-72384b5da5a7_terseLabel_en-US" xlink:label="lab_srt_ChiefOperatingOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Chief Operations Officer</link:label>
    <link:label id="lab_srt_ChiefOperatingOfficerMember_label_en-US" xlink:label="lab_srt_ChiefOperatingOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Chief Operating Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefOperatingOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefOperatingOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefOperatingOfficerMember" xlink:to="lab_srt_ChiefOperatingOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_5443e1fb-abe4-40e3-94a4-684261e383fb_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_d665af9f-e5d4-45b3-b7ea-3372ddd7e0f6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_37b36b99-1e68-40f8-8a15-d11519bf89d2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_92a698ff-682f-450d-8f18-b518334988a6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_AkesoSupplyAgreementMember_24d61280-c583-455a-8bb7-505392a2d340_terseLabel_en-US" xlink:label="lab_smmt_AkesoSupplyAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Akeso Supply Agreement</link:label>
    <link:label id="lab_smmt_AkesoSupplyAgreementMember_label_en-US" xlink:label="lab_smmt_AkesoSupplyAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Akeso Supply Agreement [Member]</link:label>
    <link:label id="lab_smmt_AkesoSupplyAgreementMember_documentation_en-US" xlink:label="lab_smmt_AkesoSupplyAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Akeso Supply Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AkesoSupplyAgreementMember" xlink:href="smmt-20251231.xsd#smmt_AkesoSupplyAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_AkesoSupplyAgreementMember" xlink:to="lab_smmt_AkesoSupplyAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_eb294ceb-7162-42ca-9fd6-90242dbb1352_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_3b9858be-02db-4b1e-b718-1257a3b07487_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_d06b9f32-a379-4c2b-92f1-287d0472ee7c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_ff2952ab-b8b2-4d79-8cb3-78b9991a96f8_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_PromissoryNotesMember_e82138c9-c036-4999-9ed7-6c1e3571383d_terseLabel_en-US" xlink:label="lab_smmt_PromissoryNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Promissory Notes</link:label>
    <link:label id="lab_smmt_PromissoryNotesMember_label_en-US" xlink:label="lab_smmt_PromissoryNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Promissory Notes [Member]</link:label>
    <link:label id="lab_smmt_PromissoryNotesMember_documentation_en-US" xlink:label="lab_smmt_PromissoryNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Promissory Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_PromissoryNotesMember" xlink:href="smmt-20251231.xsd#smmt_PromissoryNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_PromissoryNotesMember" xlink:to="lab_smmt_PromissoryNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_904788e0-36a6-4f7a-a877-56eeb85ceedd_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increases related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4179d01f-2f8b-471b-a642-3788898f81c9_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_eaeb3aba-9fd2-4c15-b109-753a26d080c2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of short-term investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_33725c48-79dc-48ed-8c90-1a6bc129e3fe_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_df492420-1eb7-4b43-8d59-1b83ef2c1cdf_terseLabel_en-US" xlink:label="lab_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_label_en-US" xlink:label="lab_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period</link:label>
    <link:label id="lab_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_documentation_en-US" xlink:label="lab_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:href="smmt-20251231.xsd#smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:to="lab_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_019bfb97-004c-77e0-827a-b9c6a370fb10_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8087302b-136c-4cb9-9afb-10eeaf33f0a6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unrealized (Loss)</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_673a6bb9-d134-4960-b518-8be21e1be28b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_9eaa28c9-2cde-4098-be27-5cd2d8d6a281_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_4737222b-7b81-4c16-be18-a6ee439edec2_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic net loss per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_42f3e23c-8f09-472c-a98b-10d7878b9ea9_verboseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Promissory Note Payable to Related Parties</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_d3ab77c2-ba73-416a-a22f-260c3cf732bf_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9b0a18ae-1a82-4b06-962d-36c569db882f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares initially reserve for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice_ec29177e-1c82-4eb7-94d7-466f5b3ec7f6_terseLabel_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid interest, conversion amount base (in dollars per share)</link:label>
    <link:label id="lab_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice_label_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Related Party, Prepaid Interest, Equity Interests Issuable Calculation, Denominator, Base Amount Added To Closing Bid Price</link:label>
    <link:label id="lab_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice_documentation_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes Payable, Related Party, Prepaid Interest, Equity Interests Issuable Calculation, Denominator, Base Amount Added To Closing Bid Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice" xlink:to="lab_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_e35647bf-da6d-4446-adb6-76c47caa25f3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_36e8a17d-61b7-4d35-aab3-c3d2d89696df_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_019bfb93-4364-7dc2-8b76-0047fb908ef7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_55da0d97-fb6d-4572-bc96-5cb24ae4b93f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_c57fec41-0b32-47fb-8235-448e13501cd0_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_EarningsPerShareBasicAndDilutedEPSAbstract_67d09045-d3d0-4a30-bbc1-ad5dd525d283_terseLabel_en-US" xlink:label="lab_smmt_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share:</link:label>
    <link:label id="lab_smmt_EarningsPerShareBasicAndDilutedEPSAbstract_label_en-US" xlink:label="lab_smmt_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic and Diluted EPS [Abstract]</link:label>
    <link:label id="lab_smmt_EarningsPerShareBasicAndDilutedEPSAbstract_documentation_en-US" xlink:label="lab_smmt_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic and Diluted EPS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:href="smmt-20251231.xsd#smmt_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:to="lab_smmt_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_48c82465-dfb3-4811-a70c-6af2e145f260_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of significant expenses of the CODM function</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_5cb7f1de-7bf9-44e7-a728-690014e7a9a9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage_8c2f94a2-809b-44ee-ac1d-6c5440b94b76_terseLabel_en-US" xlink:label="lab_smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proportionate share of net payable</link:label>
    <link:label id="lab_smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage_label_en-US" xlink:label="lab_smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Proportion Of Amount Payable, Percentage</link:label>
    <link:label id="lab_smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage_documentation_en-US" xlink:label="lab_smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Proportion Of Amount Payable, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage" xlink:href="smmt-20251231.xsd#smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage" xlink:to="lab_smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_3948a4af-1293-440c-b6fa-44342b944761_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Affiliated entity</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_b1c57a99-cf0d-485c-be04-7a0ef8bf6985_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_f75d5d2a-1b66-4ac4-b7bb-bf5c0fa51911_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_90390a2e-c737-4585-837a-0d8e635e7799_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_7f29f400-5c55-4134-b4eb-f2a82a7a5019_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Options to purchase common stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_c4a8e2cb-6967-43b4-aa49-20ce65690f94_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock_05006181-ad79-47e3-9d26-b02d9cdc789d_terseLabel_en-US" xlink:label="lab_smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired In-Process Research and Development</link:label>
    <link:label id="lab_smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock_label_en-US" xlink:label="lab_smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Process Research And Development, Through A Collaboration [Policy Text Block]</link:label>
    <link:label id="lab_smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock_documentation_en-US" xlink:label="lab_smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">In Process Research And Development, Through A Collaboration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock" xlink:href="smmt-20251231.xsd#smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock" xlink:to="lab_smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_cb4cd189-f304-4d34-b75f-344e32d3e413_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_DugganFebruaryNoteAndZanganehNoteMember_51ec125e-a3e8-4aff-b3a5-13f3ee89c9a7_terseLabel_en-US" xlink:label="lab_smmt_DugganFebruaryNoteAndZanganehNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Duggan February Note and Zanganeh Note</link:label>
    <link:label id="lab_smmt_DugganFebruaryNoteAndZanganehNoteMember_label_en-US" xlink:label="lab_smmt_DugganFebruaryNoteAndZanganehNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Duggan February Note And Zanganeh Note [Member]</link:label>
    <link:label id="lab_smmt_DugganFebruaryNoteAndZanganehNoteMember_documentation_en-US" xlink:label="lab_smmt_DugganFebruaryNoteAndZanganehNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Duggan February Note And Zanganeh Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DugganFebruaryNoteAndZanganehNoteMember" xlink:href="smmt-20251231.xsd#smmt_DugganFebruaryNoteAndZanganehNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_DugganFebruaryNoteAndZanganehNoteMember" xlink:to="lab_smmt_DugganFebruaryNoteAndZanganehNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-7e50-a732-43d40a2c8fdc_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_191b4820-fd2b-4649-8d95-1479b0431d0d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_a2a31402-d13a-498e-a3d4-d5da900c1f23_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_12c9ec03-066f-4fa1-af4c-e802db517640_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_d3657b24-7a50-4d26-9a4d-b7f0fb45fce8_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_a3bc59d4-a3e7-4d0b-b8d5-bbef1279ec84_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_855662cc-6ae8-416b-8b60-015f12281363_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_93e06ce7-0db2-4564-bd7d-cd722a2e132d_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Prepaid Expenses and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research, Development, and Computer Software Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6af7cf56-732d-42f5-aaa9-68264510ab3c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rights Offering of common stock, net of offering costs / Private placement of common stock, net of offering costs / Proceeds from at-the-market offering, net of commissions and offering costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_4545e1b5-395b-46ef-8c08-f6967fa7cf6f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_a83feba8-f397-42a5-88a3-0d5b38104e0e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_68fd4fec-a722-42a6-8c43-4ef1522a8ebe_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_219ba288-6b2c-4f18-85da-80aba553c073_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1968f2a1-39e0-432b-9581-5e63f8992b5c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a0fab29d-b430-46d5-92b2-30acb1afa9ea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of share options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_80ace9c3-ca15-48c1-899d-c73524b98d27_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration of Credit Risk and Other Risks and Uncertainties</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c6a21b12-4a52-433c-939e-9b29a7a6ea9f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_52544d79-beee-4428-bedc-2f27c267d7ee_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember_db07f015-c4b5-4643-af23-6f4869ca8ecd_terseLabel_en-US" xlink:label="lab_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative arrangement, transaction with party to collaborative arrangement, upfront payment one</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember_label_en-US" xlink:label="lab_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Transaction With Party To Collaborative Arrangement, Upfront Payment One [Member]</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember_documentation_en-US" xlink:label="lab_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Transaction With Party To Collaborative Arrangement, Upfront Payment One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember" xlink:to="lab_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_23cf4a7d-c327-4d9b-92cc-ddbd43aba319_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_25714235-4144-4b9e-ba5b-71c88e60e504_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_4e728a8c-9039-4d09-a14c-93355cfa7248_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9f37a0c2-3351-4636-bb72-7ee4d0eba437_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_6a1e6513-405f-4361-9b17-cc9a3295fb65_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of future lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0de8cd6-3db7-45e0-ad1c-bcd52c13119e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_9a20dfdb-3fef-4026-94b8-300c55b3b8f9_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_6b4dad29-4c62-4574-9a58-3c5e3a723eab_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total sublease rental payments to be received</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation_ffe51916-7f81-44bb-a908-069c0069b6c0_terseLabel_en-US" xlink:label="lab_smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation related costs, excluding stock-based compensation</link:label>
    <link:label id="lab_smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation_label_en-US" xlink:label="lab_smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Labor And Related Expenses, Excluding Stock-Based Compensation</link:label>
    <link:label id="lab_smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation_documentation_en-US" xlink:label="lab_smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Labor And Related Expenses, Excluding Stock-Based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation" xlink:href="smmt-20251231.xsd#smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation" xlink:to="lab_smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_SubleaseAgreementSecondAmendmentMember_a949bb03-bd86-4270-845f-8fd0839f770d_terseLabel_en-US" xlink:label="lab_smmt_SubleaseAgreementSecondAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Second amendment to sublease</link:label>
    <link:label id="lab_smmt_SubleaseAgreementSecondAmendmentMember_label_en-US" xlink:label="lab_smmt_SubleaseAgreementSecondAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sublease Agreement, Second Amendment [Member]</link:label>
    <link:label id="lab_smmt_SubleaseAgreementSecondAmendmentMember_documentation_en-US" xlink:label="lab_smmt_SubleaseAgreementSecondAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sublease Agreement, Second Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SubleaseAgreementSecondAmendmentMember" xlink:href="smmt-20251231.xsd#smmt_SubleaseAgreementSecondAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_SubleaseAgreementSecondAmendmentMember" xlink:to="lab_smmt_SubleaseAgreementSecondAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_53727954-5223-4b63-a23d-9330eeeffa51_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d648f6c5-7a19-4329-a95a-d6ba6e0529fa_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss before income tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_fccdeaa5-bd9f-471b-bd81-d98f7bacdd33_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_e0caa0a0-776c-42f2-9032-8514598bb2a3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_fdd10a17-c7f0-41e2-b7cb-2cc0372d19e4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_ac02d1cc-c786-49c4-8b75-1e2f10851eac_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_SubleaseAgreementFirstAmendmentMember_f3020329-a919-4806-b777-e3ebd6828b4b_terseLabel_en-US" xlink:label="lab_smmt_SubleaseAgreementFirstAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">First amendment to sublease</link:label>
    <link:label id="lab_smmt_SubleaseAgreementFirstAmendmentMember_label_en-US" xlink:label="lab_smmt_SubleaseAgreementFirstAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sublease Agreement, First Amendment [Member]</link:label>
    <link:label id="lab_smmt_SubleaseAgreementFirstAmendmentMember_documentation_en-US" xlink:label="lab_smmt_SubleaseAgreementFirstAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sublease Agreement, First Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SubleaseAgreementFirstAmendmentMember" xlink:href="smmt-20251231.xsd#smmt_SubleaseAgreementFirstAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_SubleaseAgreementFirstAmendmentMember" xlink:to="lab_smmt_SubleaseAgreementFirstAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e7769409-4109-4fcf-a771-291162383b04_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_6f70bc45-eb45-4fa0-867a-5bd92173de2e_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_b90e9e15-d5ce-4b30-9905-cebdcea474b6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice_abd0471a-8b4c-4987-b829-70635c459916_terseLabel_en-US" xlink:label="lab_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice_label_en-US" xlink:label="lab_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Weighted Average Exercise Price</link:label>
    <link:label id="lab_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice" xlink:href="smmt-20251231.xsd#smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice" xlink:to="lab_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_0d65f955-43e6-486b-a207-d4d782fb73f8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_76cd472d-5d0d-4d2b-857c-3707a48fc72d_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNonoperating_c8449aeb-71c1-4685-96ad-4213a3d6b400_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNonoperating_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNonoperating" xlink:to="lab_us-gaap_InvestmentIncomeNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments_cf6fd021-01bc-40c1-be5e-3653403228b5_totalLabel_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Collaborative arrangement, additional potential milestone payments</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments_label_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights And Obligations, Maximum Aggregate Milestone Payments</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments_documentation_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights And Obligations, Maximum Aggregate Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments" xlink:to="lab_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_CommonStockSharesAuthorizedIncreaseDecrease_03c28258-7634-4e3e-a929-2559ddd14643_terseLabel_en-US" xlink:label="lab_smmt_CommonStockSharesAuthorizedIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_smmt_CommonStockSharesAuthorizedIncreaseDecrease_label_en-US" xlink:label="lab_smmt_CommonStockSharesAuthorizedIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized, Increase (Decrease)</link:label>
    <link:label id="lab_smmt_CommonStockSharesAuthorizedIncreaseDecrease_documentation_en-US" xlink:label="lab_smmt_CommonStockSharesAuthorizedIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CommonStockSharesAuthorizedIncreaseDecrease" xlink:href="smmt-20251231.xsd#smmt_CommonStockSharesAuthorizedIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_CommonStockSharesAuthorizedIncreaseDecrease" xlink:to="lab_smmt_CommonStockSharesAuthorizedIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_bcc2432c-4042-4de2-a96a-39a252c3bc87_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of components of loss before income taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_InterestExpenseIncomeNoncash_58d8f8b3-895b-4f19-8692-97f2da1e06d1_terseLabel_en-US" xlink:label="lab_smmt_InterestExpenseIncomeNoncash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_smmt_InterestExpenseIncomeNoncash_label_en-US" xlink:label="lab_smmt_InterestExpenseIncomeNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense (Income), Noncash</link:label>
    <link:label id="lab_smmt_InterestExpenseIncomeNoncash_documentation_en-US" xlink:label="lab_smmt_InterestExpenseIncomeNoncash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Expense (Income), Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_InterestExpenseIncomeNoncash" xlink:href="smmt-20251231.xsd#smmt_InterestExpenseIncomeNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_InterestExpenseIncomeNoncash" xlink:to="lab_smmt_InterestExpenseIncomeNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_73b31222-dc54-43f3-a4d2-c4a531c94bbb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_a2ad7b16-1541-4cae-9281-f86e652e7774_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_b5f32e0f-246d-4ae7-941a-f57f5de76188_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_bd61e832-6a04-4ea0-9d57-2dcd876c7d51_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Less: Operating lease liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract_019bfb87-2cef-7d5d-a0a6-9ccd9406cdd5_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nontaxable or nondeductible Items</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_15af99d5-70e6-4328-9cae-2144aa7a1c76_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_RelatedPartyTransactionSubleaseExtensionTerm_a1412343-4d8b-4965-99fa-9f7391976250_terseLabel_en-US" xlink:label="lab_smmt_RelatedPartyTransactionSubleaseExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sublease extension term (in months)</link:label>
    <link:label id="lab_smmt_RelatedPartyTransactionSubleaseExtensionTerm_label_en-US" xlink:label="lab_smmt_RelatedPartyTransactionSubleaseExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Sublease Extension Term</link:label>
    <link:label id="lab_smmt_RelatedPartyTransactionSubleaseExtensionTerm_documentation_en-US" xlink:label="lab_smmt_RelatedPartyTransactionSubleaseExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Sublease Extension Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RelatedPartyTransactionSubleaseExtensionTerm" xlink:href="smmt-20251231.xsd#smmt_RelatedPartyTransactionSubleaseExtensionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_RelatedPartyTransactionSubleaseExtensionTerm" xlink:to="lab_smmt_RelatedPartyTransactionSubleaseExtensionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_SaleOfStockNumberOfSharesRegisteredForResale_035a338c-9a26-4b7b-a634-faf632408e8d_terseLabel_en-US" xlink:label="lab_smmt_SaleOfStockNumberOfSharesRegisteredForResale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares registered for resale (in shares)</link:label>
    <link:label id="lab_smmt_SaleOfStockNumberOfSharesRegisteredForResale_label_en-US" xlink:label="lab_smmt_SaleOfStockNumberOfSharesRegisteredForResale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Number Of Shares Registered For Resale</link:label>
    <link:label id="lab_smmt_SaleOfStockNumberOfSharesRegisteredForResale_documentation_en-US" xlink:label="lab_smmt_SaleOfStockNumberOfSharesRegisteredForResale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Number Of Shares Registered For Resale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SaleOfStockNumberOfSharesRegisteredForResale" xlink:href="smmt-20251231.xsd#smmt_SaleOfStockNumberOfSharesRegisteredForResale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_SaleOfStockNumberOfSharesRegisteredForResale" xlink:to="lab_smmt_SaleOfStockNumberOfSharesRegisteredForResale" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_a35615e0-24cb-4ce1-ad4f-506599c2e33c_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember_0ec52ba6-e635-4d9a-bf30-7d49aced5119_terseLabel_en-US" xlink:label="lab_smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Wilson Sonsini Goodrich &amp; Rosati P.C. (&#8220;WSGR&#8221;)</link:label>
    <link:label id="lab_smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember_label_en-US" xlink:label="lab_smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Wilson Sonsini Goodrich &amp; Rosati P.C. (&#8220;WSGR&#8221;) [Member]</link:label>
    <link:label id="lab_smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember_documentation_en-US" xlink:label="lab_smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Wilson Sonsini Goodrich &amp; Rosati P.C. (&#8220;WSGR&#8221;)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember" xlink:href="smmt-20251231.xsd#smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember" xlink:to="lab_smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_3dd654ff-3626-419c-a8d6-f78bef3cea0c_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_821f9148-b99d-4c3c-be4d-5bc082f2e73a_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_439ea64c-dcbd-4ae2-a961-8f1e7e5c4c4f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_41b6a63c-b476-47a1-8905-a3e623617935_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_87099a55-e8d6-4f9b-b07d-8a737ba636fe_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_05328a6d-c2f8-4223-a5b4-026b8b6a8dfe_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_33b87afd-f331-4179-94fd-4b507aa211fd_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_947e20c5-675d-4da2-a04d-3dc98d8fb2ff_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_e4ced91b-c6c7-4e34-ab0a-1dfa596fa7fb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_ca9d3818-2bc9-4ec2-803e-18a916c54d13_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_c682c31a-dced-4356-9a78-1a5ca865f66f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturities and sales of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale, Maturity and Collection of Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2eb91969-b03c-475f-80d1-8300786d1be2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock under employee stock purchase plans and exercise of stock options and warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_81a54d1d-25e3-4308-b134-e47a7ce67e17_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6250c7b1-03fa-4294-971e-bdb29a895de2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows used in operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_019bfb82-5f02-7e85-b652-7d18716f350c_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_cbd7edbe-f997-44b8-9c63-478e6ba0f1ba_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other expenses</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Other Segment Item, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:to="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_255077ef-9454-4233-bd7c-6e680031b9a3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold_4b1cc0f5-bebd-46a4-b0e0-31a77513039f_terseLabel_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes payable, maturity triggering event, public offering proceeds threshold</link:label>
    <link:label id="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold_label_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Related Parties, Potential Prepayment, Triggering Event, Public Offering Net Proceeds Threshold</link:label>
    <link:label id="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold_documentation_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes Payable, Related Parties, Potential Prepayment, Triggering Event, Public Offering Net Proceeds Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold" xlink:to="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment_07a90ea2-dd09-41d1-bf00-ad84097f5c0f_terseLabel_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative arrangement, upfront payment</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment_label_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights And Obligations, Upfront Payment</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment_documentation_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights And Obligations, Upfront Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment" xlink:to="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_d6f14796-1b7c-45ca-9b4f-822154b01303_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3583c921-4683-4be0-bdb6-335e238c03bd_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_56a8ef2c-e917-41d1-b62d-82582fe4de04_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Oncology clinical trial related costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_5654031a-3407-4228-bd02-7fddb45d5fc4_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_f861bba5-2e44-47a8-be61-b7ebb22b1537_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_eb1609cc-a267-462f-8917-62c7ba68408f_verboseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Leased assets obtained in exchange for operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_cf31ea99-49f5-44c4-8825-7fa8ff5b0847_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_be2069b7-cbf4-4abb-8538-30bbeda103ea_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b5c9c144-ef60-4c55-895a-96901fc661f9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_75d7bc05-71bc-4d2e-b531-f6da63ae67d3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_c2482a35-3d8e-475f-9ff1-f2a49a26e31f_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_019bfb96-6569-7cfb-ae76-e5f66b197c37_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State income tax, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyMember_4fc7c234-dae8-4918-b200-c22282407d3e_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyMember_label_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyMember" xlink:to="lab_us-gaap_RelatedPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9b1ab2b1-5af2-4dd5-93b5-efce1ebd3f1f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_8b2d6fe6-5948-4c6d-a4a4-f4bd33d112d3_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_65e75810-72bd-4401-97b5-9df98ed70862_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_abf36094-033b-4c43-89bc-565a62a10898_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_04db6721-c8d2-45b2-a5a8-33c78a5b5084_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Chief Executive Officer</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_AuditInformationAbstract_label_en-US" xlink:label="lab_smmt_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_smmt_AuditInformationAbstract_documentation_en-US" xlink:label="lab_smmt_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AuditInformationAbstract" xlink:href="smmt-20251231.xsd#smmt_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_AuditInformationAbstract" xlink:to="lab_smmt_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalFees_32f86e82-9c82-453a-ac77-f32dc82875b5_terseLabel_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal fees</link:label>
    <link:label id="lab_us-gaap_LegalFees_label_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LegalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalFees" xlink:to="lab_us-gaap_LegalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_ReportableSegmentMember_ea8217f2-4152-47ef-856c-65cf22c3c772_terseLabel_en-US" xlink:label="lab_smmt_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:label id="lab_smmt_ReportableSegmentMember_label_en-US" xlink:label="lab_smmt_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reportable Segment [Member]</link:label>
    <link:label id="lab_smmt_ReportableSegmentMember_documentation_en-US" xlink:label="lab_smmt_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ReportableSegmentMember" xlink:href="smmt-20251231.xsd#smmt_ReportableSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_ReportableSegmentMember" xlink:to="lab_smmt_ReportableSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_1af0ed84-054f-43a1-a08a-9270b56fbd49_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unrealized foreign exchange loss (gain)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrealized Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c853365b-554f-434b-86ed-5fc1476812aa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_de71bf2c-e3e4-477b-a4da-e7052144581e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net increases recorded to income tax provision</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ab73cf0b-3ad3-45ec-9e9b-985478a8af4c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan_144f6e6e-710a-479e-bcd1-a598b90fd5fc_terseLabel_en-US" xlink:label="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential number of additional shares that can be added to the plan for future issuance (in shares)</link:label>
    <link:label id="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan_label_en-US" xlink:label="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Potential Number of Additional Shares Allowable Under The Plan</link:label>
    <link:label id="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan_documentation_en-US" xlink:label="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Potential Number of Additional Shares Allowable Under The Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan" xlink:href="smmt-20251231.xsd#smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan" xlink:to="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019bfb9c-19f4-77b0-847a-309c3cfa7fc8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_f2990fc0-6d08-43b3-b7cb-ef6844e20e2c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nature of Operation, Product Information, Concentration of Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Operation, Product Information, Concentration of Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_8fd0a52b-b7fe-41ef-a116-3152e944bc09_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_167fa83d-7b67-4bc6-b377-fe358a1259cb_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_6ed75c94-45b6-4e16-afed-2239f0cff2c4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_76506e6a-6bbf-4fa8-ab9f-53f7cb0c1dbb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_2da70faa-e914-46ad-b29c-edd6bdead4cd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ea145bb4-a288-4465-af6c-a533f10b7042_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4ec50457-ae84-49cb-83c5-6570532ce532_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9559d28c-45ab-4fd1-b96c-1be1ebf7cb1b_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_706b8c54-5505-4fda-9b1c-1842ee0ee68a_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ba41b12c-8a7c-4483-a583-022087dc1a2a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate margin</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_d3a8a2e6-f109-4c85-85dc-277446767e9f_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares_c95b10d6-8449-4781-b92b-8301a1814703_terseLabel_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative arrangement, upfront payment, paid in shares</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares_label_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights And Obligations, Upfront Payment, Paid In Shares</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares_documentation_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights And Obligations, Upfront Payment, Paid In Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares" xlink:to="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_b91fde77-a848-4ef9-be36-882aeb8bd155_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_0e96f762-a8ca-4a73-a672-b2187d29d18f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_SignificantAccountingPoliciesTable_68e9646e-8e7a-49fd-b1a2-66a9ad32c11f_terseLabel_en-US" xlink:label="lab_smmt_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_smmt_SignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_smmt_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_smmt_SignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_smmt_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SignificantAccountingPoliciesTable" xlink:href="smmt-20251231.xsd#smmt_SignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_SignificantAccountingPoliciesTable" xlink:to="lab_smmt_SignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_7cb031de-6589-42bf-8b06-31d53d31085f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod_b39ddaf8-d81a-4cc1-9771-010de4770121_terseLabel_en-US" xlink:label="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consecutive offering period (in months)</link:label>
    <link:label id="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod_label_en-US" xlink:label="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Consecutive Offering Period</link:label>
    <link:label id="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod_documentation_en-US" xlink:label="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Consecutive Offering Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" xlink:href="smmt-20251231.xsd#smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" xlink:to="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_53764435-935d-4781-9ac1-b9bf8b29b37d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recognition of goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_a044b09c-9171-494c-aa9c-e8de1bc463b7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from the issuance of common stock via private placements, net of offering costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Private Placement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_86e3a4e4-0b87-43b4-aa23-102e1c3ecfb2_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_19691e93-9958-4015-8632-c4c83d3af4b9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual term, vested and expected to vest (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_292474d8-1ede-43c4-88c8-d6edff715669_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_019bfb98-6e3d-7dcc-952c-bad7141be119_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d5ed216-c7b7-4003-a574-e071fea232fd_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows used in investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_586c070d-93d9-420c-a88b-6a92ee645b0a_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_5513eec7-0f90-4bef-86b3-46de71709eee_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbc9b8b2-9fbf-442e-9680-557a5e072e9f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_a0636c92-d1c4-466f-a63f-d05fbdb12b29_negatedLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_6fa345eb-c1f1-40eb-9c10-5044a480c6b8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTable_019bfb90-d414-75bf-b6df-e726d7c81907_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTable_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest_392a17e4-8ec5-4570-af75-a02262b1e905_terseLabel_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock in lieu of cash for Akeso upfront payment</link:label>
    <link:label id="lab_smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest_label_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Issued For Related Party Interest</link:label>
    <link:label id="lab_smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest_documentation_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Issued For Related Party Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest" xlink:to="lab_smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_c7b4256c-dda1-40fd-b56e-89908a84ac62_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_398f12db-b1a3-4f8c-bfe6-2af8698e85e1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of weighted-average assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_8a29db2a-381c-4fe1-8aa5-b846eff579f2_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_019bfb90-d414-7b73-a169-7faf814eed73_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_AcquiredInProcessResearchAndDevelopmentExpense_87f485dd-b203-4d80-be8a-fd65e08bdcbb_terseLabel_en-US" xlink:label="lab_smmt_AcquiredInProcessResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired in-process research and development</link:label>
    <link:label id="lab_smmt_AcquiredInProcessResearchAndDevelopmentExpense_2725e4b2-db1d-4f66-a274-bcb229868600_verboseLabel_en-US" xlink:label="lab_smmt_AcquiredInProcessResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Acquired in-process research and development expense</link:label>
    <link:label id="lab_smmt_AcquiredInProcessResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_smmt_AcquiredInProcessResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired-In-Process Research And Development Expense</link:label>
    <link:label id="lab_smmt_AcquiredInProcessResearchAndDevelopmentExpense_documentation_en-US" xlink:label="lab_smmt_AcquiredInProcessResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Acquired-In-Process Research And Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense" xlink:href="smmt-20251231.xsd#smmt_AcquiredInProcessResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense" xlink:to="lab_smmt_AcquiredInProcessResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_6b309c14-7598-4008-a0ea-c0e08f617bd3_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_b1895db6-35e6-46a2-ba00-d30945de8bfd_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of lease expense</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator_89fecdfb-de83-4b17-991d-17c77add973b_terseLabel_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid interest, conversion amount (in dollars per share)</link:label>
    <link:label id="lab_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator_label_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Related Party, Prepaid Interest, Equity Interests Issuable Calculation, Denominator</link:label>
    <link:label id="lab_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator_documentation_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes Payable, Related Party, Prepaid Interest, Equity Interests Issuable Calculation, Denominator</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator" xlink:to="lab_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_6c98f88d-3cab-47ab-b3aa-9c5c7287c4a0_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_fbc743e7-cab9-428a-a4f9-cc7cc668c566_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, vested and expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_fb235813-fb7a-4ca2-a7cf-72eecdd40dd6_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_793126ae-74c4-45c2-b743-081954a4d2be_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of fixed assets</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_69360389-d2c1-4c95-8941-e38b419eb1b5_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred provision for federal income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_a1ae7a97-327c-4d56-811a-f46b8231bd9c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_6ba41e2b-0618-4d03-8cbe-bfffbe6a3088_terseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_909b2e76-d6ad-42fb-bcea-29a1425f03b6_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_e5705061-0edc-4d84-9342-7c21ae9e53d3_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_EmployeeStockOptionTimeBasedMember_261e6a4f-cc95-445e-9735-bdb245b692e0_terseLabel_en-US" xlink:label="lab_smmt_EmployeeStockOptionTimeBasedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Time-based stock options</link:label>
    <link:label id="lab_smmt_EmployeeStockOptionTimeBasedMember_label_en-US" xlink:label="lab_smmt_EmployeeStockOptionTimeBasedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Option, Time-Based [Member]</link:label>
    <link:label id="lab_smmt_EmployeeStockOptionTimeBasedMember_documentation_en-US" xlink:label="lab_smmt_EmployeeStockOptionTimeBasedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Stock Option, Time-Based</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EmployeeStockOptionTimeBasedMember" xlink:href="smmt-20251231.xsd#smmt_EmployeeStockOptionTimeBasedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_EmployeeStockOptionTimeBasedMember" xlink:to="lab_smmt_EmployeeStockOptionTimeBasedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_e6927c9d-f844-4cc1-9cde-b3409c16cbba_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_RevisedDugganSeptemberNoteMember_27bd1752-512c-4e71-9f73-aa2c6aa428ba_terseLabel_en-US" xlink:label="lab_smmt_RevisedDugganSeptemberNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revised Duggan September Note</link:label>
    <link:label id="lab_smmt_RevisedDugganSeptemberNoteMember_label_en-US" xlink:label="lab_smmt_RevisedDugganSeptemberNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revised Duggan September Note [Member]</link:label>
    <link:label id="lab_smmt_RevisedDugganSeptemberNoteMember_documentation_en-US" xlink:label="lab_smmt_RevisedDugganSeptemberNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revised Duggan September Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RevisedDugganSeptemberNoteMember" xlink:href="smmt-20251231.xsd#smmt_RevisedDugganSeptemberNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_RevisedDugganSeptemberNoteMember" xlink:to="lab_smmt_RevisedDugganSeptemberNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash_d1aa24f8-850c-47d1-b996-e912b04d00ff_terseLabel_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative arrangement, common stock issued in lieu of cash upfront payment (in shares)</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash_label_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights And Obligations, Upfront Payment, Shares Of Common Stock Issued In Lieu Of Cash</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash_documentation_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights And Obligations, Upfront Payment, Shares Of Common Stock Issued In Lieu Of Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash" xlink:to="lab_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8088c661-707f-442b-ab9d-68a16e1a5531_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_4c778b86-ed23-4007-8644-504da324c7ee_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental Disclosure of Cash Flow Information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_47153230-d723-4067-b4d9-d2e51a9201aa_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative goodwill impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3f04a3e-071f-4dc2-bcb0-65673232bcdf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_ea1eeca9-f690-413e-8b25-76738401dca7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of restricted cash balances</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_cf23237a-39a9-4a09-8e08-ac21a5df0485_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_68ef719d-a619-4c8a-8780-c187dc0097c1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_PaymentsForCollaborativeArrangement_fffd6b58-c7ef-4fe6-8b25-6815897348cb_negatedTerseLabel_en-US" xlink:label="lab_smmt_PaymentsForCollaborativeArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments to Akeso for upfront milestone payments and associated direct transaction costs</link:label>
    <link:label id="lab_smmt_PaymentsForCollaborativeArrangement_05a67f64-67bc-449d-a14e-2d8a1c85574d_terseLabel_en-US" xlink:label="lab_smmt_PaymentsForCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments to Akeso for upfront milestone payments</link:label>
    <link:label id="lab_smmt_PaymentsForCollaborativeArrangement_label_en-US" xlink:label="lab_smmt_PaymentsForCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments For Collaborative Arrangement</link:label>
    <link:label id="lab_smmt_PaymentsForCollaborativeArrangement_documentation_en-US" xlink:label="lab_smmt_PaymentsForCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments For Collaborative Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_PaymentsForCollaborativeArrangement" xlink:href="smmt-20251231.xsd#smmt_PaymentsForCollaborativeArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_PaymentsForCollaborativeArrangement" xlink:to="lab_smmt_PaymentsForCollaborativeArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b0698f4b-deb2-41c3-980a-073bba7b1d8d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_635b862a-1eef-4070-8756-f6b3a12a8123_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_47cbe7fa-e5ef-487a-8bf0-92111bb8bd41_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7c47-bd57-32797dab9229_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_b911f6c0-2bef-4736-a114-6d9820e6e803_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_0f90477a-95f8-4582-acba-0795ca84904d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_87f99afd-7fef-4636-a835-1fcba3444156_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_b937df81-95c4-4d68-a9a4-856b000d79b1_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_3f00d989-5828-4aaf-8936-cdc2c7ff13b3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet_d9dd1c1d-30a1-45df-9987-a49855da190f_terseLabel_en-US" xlink:label="lab_smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets and lease liabilities, net</link:label>
    <link:label id="lab_smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet_label_en-US" xlink:label="lab_smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Operating Lease Right-Of-Use-Asset And Operating Lease Liability, Net</link:label>
    <link:label id="lab_smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet_documentation_en-US" xlink:label="lab_smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Operating Lease Right-Of-Use-Asset And Operating Lease Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet" xlink:href="smmt-20251231.xsd#smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet" xlink:to="lab_smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_StockIssuedDuringPeriodValueWarrantsExercised_b59fa57d-7ee4-4d5e-8290-2b4f40655ae4_terseLabel_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodValueWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of warrants</link:label>
    <link:label id="lab_smmt_StockIssuedDuringPeriodValueWarrantsExercised_label_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodValueWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Warrants Exercised</link:label>
    <link:label id="lab_smmt_StockIssuedDuringPeriodValueWarrantsExercised_documentation_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodValueWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodValueWarrantsExercised" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_StockIssuedDuringPeriodValueWarrantsExercised" xlink:to="lab_smmt_StockIssuedDuringPeriodValueWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_d7b7b04a-ced5-420e-92f5-d71dafee3b71_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for interest on related party promissory note</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_276e36bb-2018-4e16-ac6f-dca1bd1ee287_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_651c9190-1b46-467d-8dab-2e8272dffbae_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_c16691fb-f552-4c3a-8604-d577b47108a7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c94d1854-838d-4df3-9764-29a1c590893e_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_34a07136-4817-4396-aafb-0964f0f3e505_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_a4ee358b-c406-403e-beec-eca06be0cbe3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fixed lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest_72923355-3621-4649-810f-f2e971af0652_terseLabel_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock in lieu of cash for Akeso upfront payment (in shares)</link:label>
    <link:label id="lab_smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest_label_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Issued For Related Party Interest</link:label>
    <link:label id="lab_smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest_documentation_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Issued For Related Party Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest" xlink:to="lab_smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_RevisedDugganFebruaryNoteMember_97c6d5c5-21fa-4c82-81b6-aca2f51c9702_terseLabel_en-US" xlink:label="lab_smmt_RevisedDugganFebruaryNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revised Duggan February Note</link:label>
    <link:label id="lab_smmt_RevisedDugganFebruaryNoteMember_label_en-US" xlink:label="lab_smmt_RevisedDugganFebruaryNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revised Duggan February Note [Member]</link:label>
    <link:label id="lab_smmt_RevisedDugganFebruaryNoteMember_documentation_en-US" xlink:label="lab_smmt_RevisedDugganFebruaryNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revised Duggan February Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RevisedDugganFebruaryNoteMember" xlink:href="smmt-20251231.xsd#smmt_RevisedDugganFebruaryNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_RevisedDugganFebruaryNoteMember" xlink:to="lab_smmt_RevisedDugganFebruaryNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_ffa72d5a-2d04-4f8e-9385-43fa860844ee_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement_a8819993-e317-4282-8e56-ae4e0d22378a_terseLabel_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock in lieu of cash for Akeso upfront payment</link:label>
    <link:label id="lab_smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement_label_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, In Lieu Of Cash For Collaborative Arrangement</link:label>
    <link:label id="lab_smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement_documentation_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, In Lieu Of Cash For Collaborative Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement" xlink:to="lab_smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_eba3be35-690b-4825-889e-e58038968ca7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation expense, period of recognition (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_StockIssuedDuringPeriodSharesWarrantsExercised_65eeb99c-a646-4d7d-a266-5159ead7fd33_terseLabel_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of warrants (in shares)</link:label>
    <link:label id="lab_smmt_StockIssuedDuringPeriodSharesWarrantsExercised_label_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Warrants Exercised</link:label>
    <link:label id="lab_smmt_StockIssuedDuringPeriodSharesWarrantsExercised_documentation_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:to="lab_smmt_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f5f0d5c7-9a9f-4abd-b33b-85e24e41237a_negatedNetLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_6c456583-5de9-44d9-bc46-665b6a56f638_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_08560c89-a581-4e47-a9cd-42ec1d971acb_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance as of beginning of year</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_b2945076-c02d-4df4-ad92-b5b2ba45744c_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance as of end of year</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_2ac2e238-ce22-420b-a614-e1254c4e7317_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts_3849b84d-d645-4fd3-ab13-8131b52b2418_terseLabel_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative arrangement, direct transaction costs</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts_label_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights And Obligations, Direct Transaction Costs</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts_documentation_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights And Obligations, Direct Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts" xlink:to="lab_smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_525c97dd-31ba-4321-85cc-23e7dbdb89d0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value, exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_019bfb97-fb7f-7da5-8bc0-1029eb64e2e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_RightsOfferingMember_6513d071-6e8e-40b2-9ed2-023e87ed93b6_terseLabel_en-US" xlink:label="lab_smmt_RightsOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rights Offering</link:label>
    <link:label id="lab_smmt_RightsOfferingMember_label_en-US" xlink:label="lab_smmt_RightsOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rights Offering [Member]</link:label>
    <link:label id="lab_smmt_RightsOfferingMember_documentation_en-US" xlink:label="lab_smmt_RightsOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Rights Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RightsOfferingMember" xlink:href="smmt-20251231.xsd#smmt_RightsOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_RightsOfferingMember" xlink:to="lab_smmt_RightsOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligation_1a8480c9-829e-440f-9c37-48bb72735afb_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital commitments</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation" xlink:to="lab_us-gaap_PurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_9f06843b-6e76-4f1d-a0d3-e350d84ee935_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_InvestmentsResearchSubleaseAgreementMember_bafac377-8bb4-488f-b436-2a32c34e28c2_terseLabel_en-US" xlink:label="lab_smmt_InvestmentsResearchSubleaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments Research Sublease Agreement</link:label>
    <link:label id="lab_smmt_InvestmentsResearchSubleaseAgreementMember_label_en-US" xlink:label="lab_smmt_InvestmentsResearchSubleaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments Research Sublease Agreement [Member]</link:label>
    <link:label id="lab_smmt_InvestmentsResearchSubleaseAgreementMember_documentation_en-US" xlink:label="lab_smmt_InvestmentsResearchSubleaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investments Research Sublease Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_InvestmentsResearchSubleaseAgreementMember" xlink:href="smmt-20251231.xsd#smmt_InvestmentsResearchSubleaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_InvestmentsResearchSubleaseAgreementMember" xlink:to="lab_smmt_InvestmentsResearchSubleaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d007aa82-e117-44f2-97f8-c708617fc153_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_da4b0cc2-f4cd-409d-aa78-f662ecae631d_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. Government treasury bills</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_eb6b012f-b1ff-4a0a-b9ae-4b59321da02c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_a846f45f-88c7-4fa0-a4ff-98b8de0f29e4_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current provision for federal income taxes</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_732cbae1-0fa2-424e-b76c-a4f3c5933bff_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_DeferredTaxAssetsValuationAllowanceRollForward_bd5ae06d-6c13-49fd-85c1-5d7b54dea4d6_terseLabel_en-US" xlink:label="lab_smmt_DeferredTaxAssetsValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance [Roll Forward]</link:label>
    <link:label id="lab_smmt_DeferredTaxAssetsValuationAllowanceRollForward_label_en-US" xlink:label="lab_smmt_DeferredTaxAssetsValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance [Roll Forward]</link:label>
    <link:label id="lab_smmt_DeferredTaxAssetsValuationAllowanceRollForward_documentation_en-US" xlink:label="lab_smmt_DeferredTaxAssetsValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DeferredTaxAssetsValuationAllowanceRollForward" xlink:href="smmt-20251231.xsd#smmt_DeferredTaxAssetsValuationAllowanceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_DeferredTaxAssetsValuationAllowanceRollForward" xlink:to="lab_smmt_DeferredTaxAssetsValuationAllowanceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount_d120d245-859d-47b5-9311-d1f226d86cd1_terseLabel_en-US" xlink:label="lab_smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost not yet recognized due to accelerated vesting, amount</link:label>
    <link:label id="lab_smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount_label_en-US" xlink:label="lab_smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Cost Not Yet Recogned Due To Accelerated Vesting, Amount</link:label>
    <link:label id="lab_smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount_documentation_en-US" xlink:label="lab_smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Cost Not Yet Recogned Due To Accelerated Vesting, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount" xlink:href="smmt-20251231.xsd#smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount" xlink:to="lab_smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_A2020IncrementalPoolMember_019b01d7-4072-779e-aa71-49b755056486_terseLabel_en-US" xlink:label="lab_smmt_A2020IncrementalPoolMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020 Incremental Pool</link:label>
    <link:label id="lab_smmt_A2020IncrementalPoolMember_label_en-US" xlink:label="lab_smmt_A2020IncrementalPoolMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2020 Incremental Pool [Member]</link:label>
    <link:label id="lab_smmt_A2020IncrementalPoolMember_documentation_en-US" xlink:label="lab_smmt_A2020IncrementalPoolMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2020 Incremental Pool</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_A2020IncrementalPoolMember" xlink:href="smmt-20251231.xsd#smmt_A2020IncrementalPoolMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_A2020IncrementalPoolMember" xlink:to="lab_smmt_A2020IncrementalPoolMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ce32c5d6-8da4-4386-8bfb-53c63a73b529_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember_301f643f-0057-478c-b92a-bbbc688c8ab9_terseLabel_en-US" xlink:label="lab_smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Chief Executive Officer and Chief Executive Officer and President</link:label>
    <link:label id="lab_smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember_label_en-US" xlink:label="lab_smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Chief Executive Officer And Chief Executive Officer And President [Member]</link:label>
    <link:label id="lab_smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember_documentation_en-US" xlink:label="lab_smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Chief Executive Officer And Chief Executive Officer And President</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember" xlink:href="smmt-20251231.xsd#smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember" xlink:to="lab_smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_c81ce231-a30c-496e-bff8-1cc37cba2e3c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_f216ac3b-36d9-4b8d-859f-2929a60440ec_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_SignificantAccountingPoliciesLineItems_dfaff1ed-1fde-4f96-b205-46da7d9508b0_terseLabel_en-US" xlink:label="lab_smmt_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_smmt_SignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_smmt_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_smmt_SignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_smmt_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SignificantAccountingPoliciesLineItems" xlink:href="smmt-20251231.xsd#smmt_SignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_SignificantAccountingPoliciesLineItems" xlink:to="lab_smmt_SignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_f0bcaa80-b5d0-40f5-9c5d-4deacb5e73e7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_a0209bdb-46ec-4cb7-9c53-b8a8e5d6b2e6_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_917938a8-5ea4-4383-864e-db37491233f0_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock aggregate price</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration_4cc7a5b9-84d9-4f62-ae00-fedeac6832af_terseLabel_en-US" xlink:label="lab_smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares that can be added to the plan upon option expiration (in shares)</link:label>
    <link:label id="lab_smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration_label_en-US" xlink:label="lab_smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Additional Capital Shares Allowable For Future Issuance Upon Option Expiration</link:label>
    <link:label id="lab_smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration_documentation_en-US" xlink:label="lab_smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Additional Capital Shares Allowable For Future Issuance Upon Option Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration" xlink:href="smmt-20251231.xsd#smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration" xlink:to="lab_smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_A2024InducementPoolMember_b902b53e-48c2-42c8-90f3-9705d3c3e673_terseLabel_en-US" xlink:label="lab_smmt_A2024InducementPoolMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 Inducement Pool</link:label>
    <link:label id="lab_smmt_A2024InducementPoolMember_label_en-US" xlink:label="lab_smmt_A2024InducementPoolMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2024 Inducement Pool [Member]</link:label>
    <link:label id="lab_smmt_A2024InducementPoolMember_documentation_en-US" xlink:label="lab_smmt_A2024InducementPoolMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2024 Inducement Pool</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_A2024InducementPoolMember" xlink:href="smmt-20251231.xsd#smmt_A2024InducementPoolMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_A2024InducementPoolMember" xlink:to="lab_smmt_A2024InducementPoolMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_DugganFebruaryNoteMember_e78aaaed-cf53-478b-990b-5b172e5e90f2_terseLabel_en-US" xlink:label="lab_smmt_DugganFebruaryNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Duggan February Note</link:label>
    <link:label id="lab_smmt_DugganFebruaryNoteMember_label_en-US" xlink:label="lab_smmt_DugganFebruaryNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Duggan February Note [Member]</link:label>
    <link:label id="lab_smmt_DugganFebruaryNoteMember_documentation_en-US" xlink:label="lab_smmt_DugganFebruaryNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Duggan February Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DugganFebruaryNoteMember" xlink:href="smmt-20251231.xsd#smmt_DugganFebruaryNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_DugganFebruaryNoteMember" xlink:to="lab_smmt_DugganFebruaryNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_019bfb9a-610e-7570-bf82-e1128a645ce2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Tax Effects</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7ceec74b-ffe0-4099-882e-bbe40215fba9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_f9f5ff0a-590a-49f2-b923-58f07be35918_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements and Short-Term Investments</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_019bfb97-8778-7017-a94d-c41e39c83606_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nontaxable or nondeductible Items</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_042ba4c3-6b77-44fb-8ce2-53d8f00e8a36_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_56b5fc9b-53cf-4428-ad45-c134cb78d2c0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_fc0b3e88-59e2-4d77-9d64-8276bf3778da_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d0032a3b-47fd-4c8d-bde7-218bada4be1b_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_DeferredTaxAssetsLiabilities_0e7c9da4-d367-4b85-8f72-459903cd8b87_totalLabel_en-US" xlink:label="lab_smmt_DeferredTaxAssetsLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax assets before valuation allowance</link:label>
    <link:label id="lab_smmt_DeferredTaxAssetsLiabilities_label_en-US" xlink:label="lab_smmt_DeferredTaxAssetsLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets (Liabilities)</link:label>
    <link:label id="lab_smmt_DeferredTaxAssetsLiabilities_documentation_en-US" xlink:label="lab_smmt_DeferredTaxAssetsLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets (Liabilities)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DeferredTaxAssetsLiabilities" xlink:href="smmt-20251231.xsd#smmt_DeferredTaxAssetsLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_DeferredTaxAssetsLiabilities" xlink:to="lab_smmt_DeferredTaxAssetsLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_eaea4540-081f-4b60-a3ae-c1074475c259_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_ca9c5928-7a9f-4e6f-b255-91d3e12667b5_verboseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2970bef1-d4cd-4f73-836e-a7db1e1ed179_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax at federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_419b67f1-4b65-4fce-b3d5-ee39555dbc51_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_eb15ac69-97d8-4fed-bf24-567c1f119e63_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonrelatedPartyMember_bfea979b-d256-4663-af27-bedc2277b5f8_terseLabel_en-US" xlink:label="lab_us-gaap_NonrelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonrelated Party</link:label>
    <link:label id="lab_us-gaap_NonrelatedPartyMember_label_en-US" xlink:label="lab_us-gaap_NonrelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonrelated Party [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonrelatedPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonrelatedPartyMember" xlink:to="lab_us-gaap_NonrelatedPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_69aa635c-3d78-4714-a173-68ce4af76492_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_9b2d2624-a7ec-4164-a333-24d874a16dfc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract_019bfb98-ecee-70ac-b7e9-5ab4a232cb84_terseLabel_en-US" xlink:label="lab_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Tax Effects</link:label>
    <link:label id="lab_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract_label_en-US" xlink:label="lab_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Tax Effects, Amount [Abstract]</link:label>
    <link:label id="lab_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract_documentation_en-US" xlink:label="lab_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Tax Effects, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract" xlink:href="smmt-20251231.xsd#smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract" xlink:to="lab_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4c1afe1f-65ed-4365-8ca6-46c52e13cbe0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_d1fe22f1-5a32-4169-ad92-6d0832609116_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_07e88c2a-4d90-4c6e-83e3-a766214a53ba_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_a3d6392d-c205-4c1e-93da-5c94448e79e2_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_ResearchAndDevelopmentPrepaidExpensesCurrent_63f7a27c-e35e-43b6-8e04-a8537be263fb_terseLabel_en-US" xlink:label="lab_smmt_ResearchAndDevelopmentPrepaidExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_smmt_ResearchAndDevelopmentPrepaidExpensesCurrent_label_en-US" xlink:label="lab_smmt_ResearchAndDevelopmentPrepaidExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Prepaid Expenses, Current</link:label>
    <link:label id="lab_smmt_ResearchAndDevelopmentPrepaidExpensesCurrent_documentation_en-US" xlink:label="lab_smmt_ResearchAndDevelopmentPrepaidExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development Prepaid Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ResearchAndDevelopmentPrepaidExpensesCurrent" xlink:href="smmt-20251231.xsd#smmt_ResearchAndDevelopmentPrepaidExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_ResearchAndDevelopmentPrepaidExpensesCurrent" xlink:to="lab_smmt_ResearchAndDevelopmentPrepaidExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssued1_7f88a901-4e11-45af-82c4-366d4d505dc0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock</link:label>
    <link:label id="lab_us-gaap_StockIssued1_label_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_cc6f8e92-2205-44f1-a804-b910d3f6efe3_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax_aee125ca-cb32-45b9-872d-556e85ead6d1_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of unrealized loss on short-term investments to other income, net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI for Write-down of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_30433ec9-83aa-4aaa-b9a2-a9fadec8f4d5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_38fa29ff-8740-4ed5-996a-39c108b7bad9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of other income, net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_b0482322-52a9-4fbb-a924-90321f2b092c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_VariableRatePeriodAxis_1de68ff1-4003-4b60-b430-9fc00a24cb13_terseLabel_en-US" xlink:label="lab_smmt_VariableRatePeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate Period [Axis]</link:label>
    <link:label id="lab_smmt_VariableRatePeriodAxis_label_en-US" xlink:label="lab_smmt_VariableRatePeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate Period [Axis]</link:label>
    <link:label id="lab_smmt_VariableRatePeriodAxis_documentation_en-US" xlink:label="lab_smmt_VariableRatePeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variable Rate Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_VariableRatePeriodAxis" xlink:href="smmt-20251231.xsd#smmt_VariableRatePeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_VariableRatePeriodAxis" xlink:to="lab_smmt_VariableRatePeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_019bfb9b-8338-72a9-adde-14496589cc00_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_1ea6ecec-61ef-46ca-a760-01bb99fc5e94_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_0396f569-6411-48bc-b70e-cd93ddb17236_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c7aeb318-dd23-48d5-9883-a6de01d8a62c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to additional paid in capital, stock issued, issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f8365bba-7af4-47a0-b601-64fc74eb6064_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_c2c6867c-026f-4aa3-a155-9804b6799bcd_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_307b7183-a413-47d1-a0b5-5df4362383a0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amortization of discount on short-term investments</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c6d20b93-95f1-4853-8371-2e9b65e2db58_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual term, options outstanding (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod_80e75ff3-7d63-4caa-9db5-bf9ce4c6c5ba_terseLabel_en-US" xlink:label="lab_smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average recognition period (in years)</link:label>
    <link:label id="lab_smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod_label_en-US" xlink:label="lab_smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Weighted Average Recognition Period</link:label>
    <link:label id="lab_smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod_documentation_en-US" xlink:label="lab_smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Weighted Average Recognition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod" xlink:href="smmt-20251231.xsd#smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod" xlink:to="lab_smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a0026431-e1b1-41df-b2d8-bda750c4b938_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_ChiefExecutiveOfficerAndPresidentMember_3c0bcc2a-92b9-4fcc-bfc4-0fa3fb6eb275_terseLabel_en-US" xlink:label="lab_smmt_ChiefExecutiveOfficerAndPresidentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Chief Executive Officer and President</link:label>
    <link:label id="lab_smmt_ChiefExecutiveOfficerAndPresidentMember_label_en-US" xlink:label="lab_smmt_ChiefExecutiveOfficerAndPresidentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Chief Executive Officer And President [Member]</link:label>
    <link:label id="lab_smmt_ChiefExecutiveOfficerAndPresidentMember_documentation_en-US" xlink:label="lab_smmt_ChiefExecutiveOfficerAndPresidentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Chief Executive Officer And President</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ChiefExecutiveOfficerAndPresidentMember" xlink:href="smmt-20251231.xsd#smmt_ChiefExecutiveOfficerAndPresidentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_ChiefExecutiveOfficerAndPresidentMember" xlink:to="lab_smmt_ChiefExecutiveOfficerAndPresidentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_246cc671-0cf4-48b2-9c26-77230287a508_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_454707a9-6198-404f-93dc-477e24df5c52_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock under stock purchase plans and exercise of stock options and warrants</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1d5204df-8d0a-495a-bd31-36c571717e31_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value, options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_299f84fb-a86e-4944-9b23-19c797dc57eb_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred provision for non-United States income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_d4fab762-2f35-4f24-9a5f-53ef23bda1c2_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Incurred interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_2bb16d2d-d30b-4c20-b0df-e6592dde880c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_GeniusSubleaseAgreementMember_033a732b-52b6-4577-8c25-baa942a61bad_terseLabel_en-US" xlink:label="lab_smmt_GeniusSubleaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Genius Sublease Agreement</link:label>
    <link:label id="lab_smmt_GeniusSubleaseAgreementMember_label_en-US" xlink:label="lab_smmt_GeniusSubleaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Genius Sublease Agreement [Member]</link:label>
    <link:label id="lab_smmt_GeniusSubleaseAgreementMember_documentation_en-US" xlink:label="lab_smmt_GeniusSubleaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Genius Sublease Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_GeniusSubleaseAgreementMember" xlink:href="smmt-20251231.xsd#smmt_GeniusSubleaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_GeniusSubleaseAgreementMember" xlink:to="lab_smmt_GeniusSubleaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3eaf40b3-64bb-4090-a957-da4baf6a0429_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized Gain</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21a2abaf-df44-41ce-b051-f68094252516_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_420e473b-8e88-429b-821b-794a45bdbc8d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_fa555d97-2b25-4ae7-944b-aab42bd4f7b7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected annual dividends per share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_019be579-d2de-796d-aaee-0980fa9b5d4a_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Certificate of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_071f5f0a-ff40-4b50-b13a-9620967b84bf_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_817fed1b-cf5f-414d-989d-35853b234417_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Tax Effects</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_eb829ad3-b240-4175-b1b0-b09451991209_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitment_89d2c6e7-a9b6-4097-9b4a-b68dbb17b79f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contractual commitments</link:label>
    <link:label id="lab_us-gaap_OtherCommitment_label_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitment" xlink:to="lab_us-gaap_OtherCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_a05bd78a-6a55-408b-8e01-a9312c836491_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares expected to be purchased under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_f0204a87-57e5-4444-9dd9-1713f3cc9582_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_4ad799a6-5837-401c-a5eb-76b58ec0d693_netLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_3a5aa3f8-ef66-4c28-a9b0-e90d29127b06_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_18baa5c0-8b16-4a44-aeb8-006480ba76a7_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_LessorOperatingLeaseAreaOfPremisesLeased_b76ef9c6-5893-48d7-931d-f8dbb6bfe85e_terseLabel_en-US" xlink:label="lab_smmt_LessorOperatingLeaseAreaOfPremisesLeased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Area of premises subleased to other party (in square feet)</link:label>
    <link:label id="lab_smmt_LessorOperatingLeaseAreaOfPremisesLeased_label_en-US" xlink:label="lab_smmt_LessorOperatingLeaseAreaOfPremisesLeased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Area Of Premises Leased</link:label>
    <link:label id="lab_smmt_LessorOperatingLeaseAreaOfPremisesLeased_documentation_en-US" xlink:label="lab_smmt_LessorOperatingLeaseAreaOfPremisesLeased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Area Of Premises Leased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_LessorOperatingLeaseAreaOfPremisesLeased" xlink:href="smmt-20251231.xsd#smmt_LessorOperatingLeaseAreaOfPremisesLeased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_LessorOperatingLeaseAreaOfPremisesLeased" xlink:to="lab_smmt_LessorOperatingLeaseAreaOfPremisesLeased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5f4d150a-ca1a-41cd-9ea4-1980f988d36e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f0da4afa-f2ad-4a9a-a45d-18ed527f5a9c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_99b01527-1144-4a5e-a306-89895245e940_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value, vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_51ae4f1c-d3a9-4a26-a3e4-1373353fe17f_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_6e54f365-171a-48f5-a7e8-30ad596ba0e4_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_640e7997-b67d-42d1-b48b-4a43a9428731_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.K.</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Tax Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_9cd04b19-9b35-400f-ad22-3aef4c9e447e_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_a55cd5f2-b584-440f-ac4c-1f77ae5b0906_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_c2a0d801-fb37-4506-acb7-65e9cb48990f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_5f35366c-861a-4da4-bf05-614dfcf7d1ae_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_AkesoLicenseAgreementMember_fc3c2e53-a65c-4c85-816a-73e3bdb4364e_terseLabel_en-US" xlink:label="lab_smmt_AkesoLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Akeso License Agreement</link:label>
    <link:label id="lab_smmt_AkesoLicenseAgreementMember_label_en-US" xlink:label="lab_smmt_AkesoLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Akeso License Agreement [Member]</link:label>
    <link:label id="lab_smmt_AkesoLicenseAgreementMember_documentation_en-US" xlink:label="lab_smmt_AkesoLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Akeso License Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AkesoLicenseAgreementMember" xlink:href="smmt-20251231.xsd#smmt_AkesoLicenseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_AkesoLicenseAgreementMember" xlink:to="lab_smmt_AkesoLicenseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c9848e76-af62-49ec-b35b-066aee04c2f7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_03e0bfa8-fd26-4fff-af43-38f80b0b80ea_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_SaleOfStockAggregateOfferingPrice_7eaa39e7-1878-4bfd-b15f-676216ddb92f_terseLabel_en-US" xlink:label="lab_smmt_SaleOfStockAggregateOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, aggregate offering price</link:label>
    <link:label id="lab_smmt_SaleOfStockAggregateOfferingPrice_label_en-US" xlink:label="lab_smmt_SaleOfStockAggregateOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Offering Price</link:label>
    <link:label id="lab_smmt_SaleOfStockAggregateOfferingPrice_documentation_en-US" xlink:label="lab_smmt_SaleOfStockAggregateOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Offering Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SaleOfStockAggregateOfferingPrice" xlink:href="smmt-20251231.xsd#smmt_SaleOfStockAggregateOfferingPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_SaleOfStockAggregateOfferingPrice" xlink:to="lab_smmt_SaleOfStockAggregateOfferingPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_fbff8bca-3e84-4986-b8c7-55e9f02b15e7_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_a3248d6f-0f9c-43a7-a1ce-33c9e096ce1a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_DistributionAgreementMember_a0c05100-8d45-4457-b764-52bf932f7def_terseLabel_en-US" xlink:label="lab_smmt_DistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distribution Agreement</link:label>
    <link:label id="lab_smmt_DistributionAgreementMember_label_en-US" xlink:label="lab_smmt_DistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Distribution Agreement [Member]</link:label>
    <link:label id="lab_smmt_DistributionAgreementMember_documentation_en-US" xlink:label="lab_smmt_DistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Distribution Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DistributionAgreementMember" xlink:href="smmt-20251231.xsd#smmt_DistributionAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_DistributionAgreementMember" xlink:to="lab_smmt_DistributionAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember_7f5f438d-8853-4c3d-aa69-32f9cf5e135b_terseLabel_en-US" xlink:label="lab_smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revised Duggan February Note And Revised Duggan September Note</link:label>
    <link:label id="lab_smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember_label_en-US" xlink:label="lab_smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revised Duggan February Note And Revised Duggan September Note [Member]</link:label>
    <link:label id="lab_smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember_documentation_en-US" xlink:label="lab_smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revised Duggan February Note And Revised Duggan September Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember" xlink:href="smmt-20251231.xsd#smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember" xlink:to="lab_smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_4b2d9169-e7c9-43dd-9a77-3a17b42ee3ff_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, $0.01 par value, 20,000,000 shares authorized; none issued and outstanding at December 31, 2025 and 2024, respectively</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_8751a6a3-7208-4b7f-9989-660873b3fee3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_54791fe3-bc37-46bd-bd9e-3942625b099c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash payments related to lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0e0dd13f-ceac-4ebc-ba3d-89dae26983d7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of major components of deferred tax assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering_10305d67-2f33-49a8-baf5-99223da1dcc0_terseLabel_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period from public offering (in business days)</link:label>
    <link:label id="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering_label_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Related Parties, Potential Prepayment, Period Post Receipt Of Cash Proceeds From Public Offering</link:label>
    <link:label id="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering_documentation_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes Payable, Related Parties, Potential Prepayment, Period Post Receipt Of Cash Proceeds From Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering" xlink:to="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_15622690-60e8-4b1e-9181-170a077a4e4a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.01 par value: 1,000,000,000 shares authorized; 775,371,200 and 737,626,004 shares issued and outstanding at December 31, 2025 and 2024, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_ClassOfWarrantOrRightExercisesInPeriod_46a35a08-a2e6-4e7d-bcf4-b9ad9c458a0f_terseLabel_en-US" xlink:label="lab_smmt_ClassOfWarrantOrRightExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_smmt_ClassOfWarrantOrRightExercisesInPeriod_label_en-US" xlink:label="lab_smmt_ClassOfWarrantOrRightExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Exercises In Period</link:label>
    <link:label id="lab_smmt_ClassOfWarrantOrRightExercisesInPeriod_documentation_en-US" xlink:label="lab_smmt_ClassOfWarrantOrRightExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Exercises In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ClassOfWarrantOrRightExercisesInPeriod" xlink:href="smmt-20251231.xsd#smmt_ClassOfWarrantOrRightExercisesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_ClassOfWarrantOrRightExercisesInPeriod" xlink:to="lab_smmt_ClassOfWarrantOrRightExercisesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_71fc4486-db70-4c55-bee1-69d5480247f3_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current provision for non-United States income taxes</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_80c1484e-129d-4699-9f2f-e5f06ae13f80_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9395f4d7-715c-40e0-ba51-a1a6fe603d3a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_623654d4-e712-4877-9808-35945c24560a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6ffd775b-2f51-4bb2-bd52-d71ecdfe4b17_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted weighted average number of shares of common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_77c1860f-4e72-4f6e-a95a-079760a8a2e6_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (Note 16)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_3b6d9118-7a8b-4a41-959a-0fe4b47950aa_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_07264b83-7713-4e49-b386-db6c82be43ea_negatedNetLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xml:lang="en-US">Transaction costs from the issuance of common stock for rights offering</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_6468222f-9450-4654-8a07-498f88a9b3e1_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_b05645ed-7ee4-44d9-89bc-7f20123a7c00_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_22684b50-0159-491a-824e-741c1040bb86_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current provision for state income taxes</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_b669dc4a-9fac-40bc-816f-03b87057a099_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_EmployeeStockOptionPerformanceBasedMember_0eb073ca-3bb4-493d-9034-59941e091698_terseLabel_en-US" xlink:label="lab_smmt_EmployeeStockOptionPerformanceBasedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option, Performance Based</link:label>
    <link:label id="lab_smmt_EmployeeStockOptionPerformanceBasedMember_label_en-US" xlink:label="lab_smmt_EmployeeStockOptionPerformanceBasedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Option, Performance Based [Member]</link:label>
    <link:label id="lab_smmt_EmployeeStockOptionPerformanceBasedMember_documentation_en-US" xlink:label="lab_smmt_EmployeeStockOptionPerformanceBasedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Stock Option, Performance Based</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EmployeeStockOptionPerformanceBasedMember" xlink:href="smmt-20251231.xsd#smmt_EmployeeStockOptionPerformanceBasedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_EmployeeStockOptionPerformanceBasedMember" xlink:to="lab_smmt_EmployeeStockOptionPerformanceBasedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_AtMarketOfferingMember_fba3d478-9509-4695-92f5-af7847324246_terseLabel_en-US" xlink:label="lab_smmt_AtMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At Market Offering</link:label>
    <link:label id="lab_smmt_AtMarketOfferingMember_label_en-US" xlink:label="lab_smmt_AtMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At Market Offering [Member]</link:label>
    <link:label id="lab_smmt_AtMarketOfferingMember_documentation_en-US" xlink:label="lab_smmt_AtMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At Market Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AtMarketOfferingMember" xlink:href="smmt-20251231.xsd#smmt_AtMarketOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_AtMarketOfferingMember" xlink:to="lab_smmt_AtMarketOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_d858f1b6-3153-411b-9f4f-5202bd5349ad_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Deferred tax, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_85190a50-f99a-4e7b-9b21-d91f5354e54d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_0b52609e-872d-4239-9fd3-1db9025113ea_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_05421a51-a21b-4e6c-a408-dead25f8c957_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_1036738c-8660-4c80-8e7a-35f2e276529e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_ec48173e-6244-4409-b0dc-6c489c82ae1a_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Reclassification of cumulative currency translation gain to other income, net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_defa3dfa-399b-4f3d-8bfe-fcc976ff16b1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual term, exercisable (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_a15a6132-81e9-4450-8db4-e107e5744e89_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of reconciliation of unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_d4e12ef0-7b76-4b01-ad3d-6e4a23c44f66_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Income, Net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income and Expense [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:to="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_8a845557-8da9-42a1-bc49-db207eb16e26_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_8ce02629-b3b7-41f0-98ae-13f0de304768_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_8cb5d916-a43f-4bc9-afe6-d2039cc82c37_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA_603aa603-684b-4cbd-8d41-265c47185024_terseLabel_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CALIFORNIA</link:label>
    <link:label id="lab_stpr_CA_label_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CALIFORNIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA" xlink:to="lab_stpr_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering_3cce77b2-b8de-4e62-92ca-267ea1491a9b_terseLabel_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Public offering proceeds threshold percentage</link:label>
    <link:label id="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering_label_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Related Parties, Potential Prepayment, Maximum Amount, Percentage Of Net Proceeds From Public Offering</link:label>
    <link:label id="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering_documentation_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes Payable, Related Parties, Potential Prepayment, Maximum Amount, Percentage Of Net Proceeds From Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering" xlink:to="lab_smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_5a51a944-6212-451d-8602-15ab6ae65d21_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeaseTermOfContract_8688a603-a429-4dbd-bde9-71e07027a4f0_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sublease term to other party (in months)</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LessorOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LessorOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayable_0d8de872-5660-435d-b066-1f1e5ce9b4cd_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Promissory note</link:label>
    <link:label id="lab_us-gaap_NotesPayable_label_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayable" xlink:to="lab_us-gaap_NotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_EmployeeStockOptionPerformanceAndMarketBasedMember_57ad2fd5-8d10-404a-bdda-26e83c869478_terseLabel_en-US" xlink:label="lab_smmt_EmployeeStockOptionPerformanceAndMarketBasedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance and market-based stock options</link:label>
    <link:label id="lab_smmt_EmployeeStockOptionPerformanceAndMarketBasedMember_label_en-US" xlink:label="lab_smmt_EmployeeStockOptionPerformanceAndMarketBasedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Option, Performance And Market-Based [Member]</link:label>
    <link:label id="lab_smmt_EmployeeStockOptionPerformanceAndMarketBasedMember_documentation_en-US" xlink:label="lab_smmt_EmployeeStockOptionPerformanceAndMarketBasedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Stock Option, Performance And Market-Based</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EmployeeStockOptionPerformanceAndMarketBasedMember" xlink:href="smmt-20251231.xsd#smmt_EmployeeStockOptionPerformanceAndMarketBasedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_EmployeeStockOptionPerformanceAndMarketBasedMember" xlink:to="lab_smmt_EmployeeStockOptionPerformanceAndMarketBasedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_063fea3f-1f8f-41bf-8fef-8dd1d858e6cc_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable lease costs</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_3baadbd0-0811-4347-a490-b19993e27cb1_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative arrangement, transaction with party to collaborative arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_78ef6611-e42e-4c86-b8f7-5ede46aefc68_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_712e8689-5370-4f43-a527-9e725e86f3a2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of share options, vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber_f337040c-91b7-426b-a245-186f446e29e2_terseLabel_en-US" xlink:label="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares unvested and converted (in shares)</link:label>
    <link:label id="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber_label_en-US" xlink:label="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding And Converted, Number</link:label>
    <link:label id="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber_documentation_en-US" xlink:label="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding And Converted, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber" xlink:href="smmt-20251231.xsd#smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber" xlink:to="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_df54ff6b-0c85-4366-b0ca-30da0c68d6cf_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration period (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_0acbbf9d-9e40-4a32-9622-1aa41c0dab1b_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_cd8dc044-48e4-48d7-80d7-db10176846da_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember_e1f20cc5-0fdf-41e9-a17f-265f3df7abbd_terseLabel_en-US" xlink:label="lab_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative arrangement, transaction with party to collaborative arrangement, upfront payment two</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember_label_en-US" xlink:label="lab_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement, Upfront Payment Two [Member]</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember_documentation_en-US" xlink:label="lab_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement, Upfront Payment Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember" xlink:to="lab_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_a6424f69-0df6-4f22-adf9-93be163809d8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds received related to employee stock purchase plan and exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_c536b116-2b17-4887-80cc-cc4cfb107720_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum percentage of outstanding shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_ac75d475-f916-48e1-8975-f09955ee705b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase price of common stock as a percentage of closing price</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_24f28f78-c8fa-40ff-a4ee-2b6f783f02fa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value of stock options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_d053ef94-aadb-4470-be45-788d4c4637ab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accelerated charges</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Accelerated Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivatePlacementMember_821c48c9-fc50-428f-93ee-1d3d07d9f2b9_verboseLabel_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Private Placement</link:label>
    <link:label id="lab_us-gaap_PrivatePlacementMember_ad947ad8-132c-4bc9-b9ea-90bb1c3f33b6_terseLabel_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Private placement</link:label>
    <link:label id="lab_us-gaap_PrivatePlacementMember_label_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Private Placement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember" xlink:to="lab_us-gaap_PrivatePlacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_dfe3e3ac-0b49-4e62-baff-f01048c19d59_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net other comprehensive (loss) gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_4cddf7fa-1e45-47d1-a9d4-a915969e1822_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_c8763363-7169-4331-8591-20621fef38f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock option activity, additional disclosures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_cd14289f-92cd-4c2c-9ed3-49c9b176cd2b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development credit carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_2ccf8cbb-aa71-4ee2-b43e-8f4de5f1d340_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_22ba9024-6fc7-4195-8baa-4fc8ff7bbc06_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_3edada76-f52a-46e6-a9aa-1b1722772b9a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain on short-term investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_2fc7f04d-3661-4d08-bab3-ad438708b8d3_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_019c2f6e-6749-7a9a-8051-54bab94ff529_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk- free interest rate, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_e9d6312b-f468-4287-b4b4-a8f812677e1a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_deb04d9d-e8ab-4d7e-9c31-0d18a2353859_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on disposal of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_fa244524-b35e-407b-8e97-861bf64445f6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_36319b29-c8e4-4e80-bae6-eacfc69a858b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency (loss) gain</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments_43526d3d-d80a-44d1-a6bc-1df2043e3222_terseLabel_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative arrangement, potential commercial milestone payments</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments_label_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights And Obligations, Potential Commercial Milestone Payments</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments_documentation_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights And Obligations, Potential Commercial Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments" xlink:to="lab_smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_79367d18-3004-4661-ba3d-faa686dae68b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities and other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_AreaOfPremisesSubleased_08a5e14f-c0e4-47d6-bec6-aba139684dd5_terseLabel_en-US" xlink:label="lab_smmt_AreaOfPremisesSubleased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Area of premises subleased (in square feet)</link:label>
    <link:label id="lab_smmt_AreaOfPremisesSubleased_label_en-US" xlink:label="lab_smmt_AreaOfPremisesSubleased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Area Of Premises Subleased</link:label>
    <link:label id="lab_smmt_AreaOfPremisesSubleased_documentation_en-US" xlink:label="lab_smmt_AreaOfPremisesSubleased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Area Of Premises Subleased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AreaOfPremisesSubleased" xlink:href="smmt-20251231.xsd#smmt_AreaOfPremisesSubleased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_AreaOfPremisesSubleased" xlink:to="lab_smmt_AreaOfPremisesSubleased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_be374388-6a3b-4e5b-b06d-41ebc786eb5b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments_0b4889a2-cd54-4b03-8d9b-0ac038c1b941_terseLabel_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional potential commercial milestone payments</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments_label_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights And Obligations, Additional Potential Commercial Milestone Payments</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments_documentation_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights And Obligations, Additional Potential Commercial Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments" xlink:to="lab_smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_1b37726a-1d97-44f8-b985-4a9bf9a3910d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_1e2369a1-b533-4589-b538-bba17f7a55ed_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted net loss per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionRate_fd4ba280-336a-4bf6-b0a0-64a7452f975b_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionRate_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionRate" xlink:to="lab_us-gaap_RelatedPartyTransactionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_ZanganehNoteMember_d56073b1-7f0c-4175-90cc-295659373cd7_terseLabel_en-US" xlink:label="lab_smmt_ZanganehNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Zanganeh Note</link:label>
    <link:label id="lab_smmt_ZanganehNoteMember_label_en-US" xlink:label="lab_smmt_ZanganehNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Zanganeh Note [Member]</link:label>
    <link:label id="lab_smmt_ZanganehNoteMember_documentation_en-US" xlink:label="lab_smmt_ZanganehNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Zanganeh Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ZanganehNoteMember" xlink:href="smmt-20251231.xsd#smmt_ZanganehNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_ZanganehNoteMember" xlink:to="lab_smmt_ZanganehNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b52aa56c-5a8f-4489-b24c-149bb6f07618_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_8199e38c-bf59-4dec-a6f1-2930128b5e90_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_f36959b9-a2f6-4ce4-9988-3aeaf0205200_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_VariableRatePeriodOneMember_993629ed-99c2-495b-ac87-d7a53569e14c_terseLabel_en-US" xlink:label="lab_smmt_VariableRatePeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable rate, three months immediately following February 15, 2023</link:label>
    <link:label id="lab_smmt_VariableRatePeriodOneMember_label_en-US" xlink:label="lab_smmt_VariableRatePeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate, Period One [Member]</link:label>
    <link:label id="lab_smmt_VariableRatePeriodOneMember_documentation_en-US" xlink:label="lab_smmt_VariableRatePeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variable Rate, Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_VariableRatePeriodOneMember" xlink:href="smmt-20251231.xsd#smmt_VariableRatePeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_VariableRatePeriodOneMember" xlink:to="lab_smmt_VariableRatePeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_005c1b6b-8d96-47dc-a5b3-38fae050a9e9_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_country_KY_019bfb91-aaa1-7b91-9af9-0d1790233c52_terseLabel_en-US" xlink:label="lab_country_KY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CAYMAN ISLANDS</link:label>
    <link:label id="lab_country_KY_label_en-US" xlink:label="lab_country_KY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CAYMAN ISLANDS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_KY" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_KY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_KY" xlink:to="lab_country_KY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_6277744f-cc45-41be-a9ae-3249b481bbe9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2030</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_60f7035d-3e2a-4a78-aec4-827e3be721b8_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_bb07c242-c5df-44d3-815d-b35630b211e8_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_03bd3b70-0497-4c84-b92d-d86cab0a61e4_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_6092ffb8-60fa-4269-9dfa-0a1b25f6ee6c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of potentially dilutive securities excluded from the computation of loss per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_0b56a356-21fe-4bb8-a8b5-94cfd43f1b09_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credit carryforward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_LessorOperatingLeaseNumberOfContracts_a72e58ed-9238-4476-a6d8-43faf55a253b_terseLabel_en-US" xlink:label="lab_smmt_LessorOperatingLeaseNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of sublease contracts to other party</link:label>
    <link:label id="lab_smmt_LessorOperatingLeaseNumberOfContracts_label_en-US" xlink:label="lab_smmt_LessorOperatingLeaseNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Number Of Contracts</link:label>
    <link:label id="lab_smmt_LessorOperatingLeaseNumberOfContracts_documentation_en-US" xlink:label="lab_smmt_LessorOperatingLeaseNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Number Of Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_LessorOperatingLeaseNumberOfContracts" xlink:href="smmt-20251231.xsd#smmt_LessorOperatingLeaseNumberOfContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_LessorOperatingLeaseNumberOfContracts" xlink:to="lab_smmt_LessorOperatingLeaseNumberOfContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_1b616f75-f4f4-4f70-8c48-e0dc64bfc785_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Tax Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ed5aa952-78ea-4956-9636-6619a79b873a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome_3cfb5955-0cd7-4c43-9eca-d0b0a42bbe2e_negatedTerseLabel_en-US" xlink:label="lab_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of currency translation gain</link:label>
    <link:label id="lab_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome_e67128e6-79c6-4748-af3e-9d6733abdc7d_terseLabel_en-US" xlink:label="lab_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of cumulative currency translation gain</link:label>
    <link:label id="lab_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome_label_en-US" xlink:label="lab_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Currency Translation Gains (Losses), Realized upon Sale or Liquidation, Reclassified From Other Comprehensive Income</link:label>
    <link:label id="lab_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome_documentation_en-US" xlink:label="lab_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cumulative Currency Translation Gains (Losses), Realized upon Sale or Liquidation, Reclassified From Other Comprehensive Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome" xlink:href="smmt-20251231.xsd#smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome" xlink:to="lab_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_9813f123-8db9-4904-9af5-761e6479137d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_69d3c83e-792b-4374-b113-863f0d94376d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_VariableRatePeriodTwoMember_f7a0f80d-88b8-4ca6-98c0-6093b21ebd3d_terseLabel_en-US" xlink:label="lab_smmt_VariableRatePeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable rate, thereafter</link:label>
    <link:label id="lab_smmt_VariableRatePeriodTwoMember_label_en-US" xlink:label="lab_smmt_VariableRatePeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate, Period Two [Member]</link:label>
    <link:label id="lab_smmt_VariableRatePeriodTwoMember_documentation_en-US" xlink:label="lab_smmt_VariableRatePeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variable Rate, Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_VariableRatePeriodTwoMember" xlink:href="smmt-20251231.xsd#smmt_VariableRatePeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_VariableRatePeriodTwoMember" xlink:to="lab_smmt_VariableRatePeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_OriginalDistributionAgreementMember_88e6d041-d3b8-4388-8709-e58c9315fb44_terseLabel_en-US" xlink:label="lab_smmt_OriginalDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Original Distribution Agreement</link:label>
    <link:label id="lab_smmt_OriginalDistributionAgreementMember_label_en-US" xlink:label="lab_smmt_OriginalDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Original Distribution Agreement [Member]</link:label>
    <link:label id="lab_smmt_OriginalDistributionAgreementMember_documentation_en-US" xlink:label="lab_smmt_OriginalDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Original Distribution Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_OriginalDistributionAgreementMember" xlink:href="smmt-20251231.xsd#smmt_OriginalDistributionAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_OriginalDistributionAgreementMember" xlink:to="lab_smmt_OriginalDistributionAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_80fc868b-f3ac-4d81-b8dd-d1995744634e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_ad8b9119-ed75-46a5-a255-14b891168b84_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_6e2019a8-423c-4c4f-bbc1-f8095c86eda1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_1f025c94-f4fc-4add-8ba1-7cbb06f2e519_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_f2312e75-349e-48a6-aada-c8f8de7211ee_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e3d87119-c2a6-4ab3-aad2-8184b7115f48_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5a6b0397-7ce2-4bdb-a732-528cfe044e19_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_CashPaymentForCollaborativeArrangementUpfrontPayment_b0e4f5f4-c2cb-49f6-b99d-6ce542d65e0d_terseLabel_en-US" xlink:label="lab_smmt_CashPaymentForCollaborativeArrangementUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash payment for collaborative arrangement, upfront payment</link:label>
    <link:label id="lab_smmt_CashPaymentForCollaborativeArrangementUpfrontPayment_label_en-US" xlink:label="lab_smmt_CashPaymentForCollaborativeArrangementUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash payment For Collaborative Arrangement, Upfront Payment</link:label>
    <link:label id="lab_smmt_CashPaymentForCollaborativeArrangementUpfrontPayment_documentation_en-US" xlink:label="lab_smmt_CashPaymentForCollaborativeArrangementUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash payment For Collaborative Arrangement, Upfront Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CashPaymentForCollaborativeArrangementUpfrontPayment" xlink:href="smmt-20251231.xsd#smmt_CashPaymentForCollaborativeArrangementUpfrontPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_CashPaymentForCollaborativeArrangementUpfrontPayment" xlink:to="lab_smmt_CashPaymentForCollaborativeArrangementUpfrontPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_NotePurchaseAgreementMember_d0c83083-349c-461c-8cb3-9a384a0980a4_terseLabel_en-US" xlink:label="lab_smmt_NotePurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Note Purchase Agreement</link:label>
    <link:label id="lab_smmt_NotePurchaseAgreementMember_label_en-US" xlink:label="lab_smmt_NotePurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note Purchase Agreement [Member]</link:label>
    <link:label id="lab_smmt_NotePurchaseAgreementMember_documentation_en-US" xlink:label="lab_smmt_NotePurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Note Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotePurchaseAgreementMember" xlink:href="smmt-20251231.xsd#smmt_NotePurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_NotePurchaseAgreementMember" xlink:to="lab_smmt_NotePurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_98cda94d-0020-4055-bef3-d554ee506b76_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_e21b2ab8-fc1e-448b-9582-21be44ec16b5_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred provision for state income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_b1d9f07f-0eb1-4665-ae0e-900912244bb0_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_0910f18a-9082-40ba-8b22-5888cbed9049_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_743eaa65-4437-454f-8e4b-eed0cd07d211_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_a95ab7e7-b06a-41f7-a3c6-8801e2e2df45_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_c885b04b-6d89-4f11-8956-b164b11d392d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiary or Equity Method Investee [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary or Equity Method Investee [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_fecf8cfc-2191-4ce7-af9b-e2b7d9b9566c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_a852b613-2303-420f-8601-2a85e29ff415_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accelerated vesting, number (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_019c40ea-1035-7f65-9f8d-5c18db6cd68a_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_a780f9df-912b-4710-afee-96d5752ecbf2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of reconciliation of the effective income tax rate to the statutory rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_DugganSeptemberNoteMember_c63331a2-fc34-4462-8a08-6b1e4b2826d8_terseLabel_en-US" xlink:label="lab_smmt_DugganSeptemberNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Duggan September Note</link:label>
    <link:label id="lab_smmt_DugganSeptemberNoteMember_label_en-US" xlink:label="lab_smmt_DugganSeptemberNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Duggan September Note [Member]</link:label>
    <link:label id="lab_smmt_DugganSeptemberNoteMember_documentation_en-US" xlink:label="lab_smmt_DugganSeptemberNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Duggan September Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DugganSeptemberNoteMember" xlink:href="smmt-20251231.xsd#smmt_DugganSeptemberNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_DugganSeptemberNoteMember" xlink:to="lab_smmt_DugganSeptemberNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_886ad1ea-c293-4adf-8922-72f14c9270b1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity award, vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_7e92f751-835e-400b-918d-7f5c56cd8014_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_63badf6e-bd37-4d70-80a5-00d0a5cecba5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_8ee88c5f-91d7-4924-ba0b-b9f2fcc4ddb3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_313f2520-9ba5-46ab-b0fe-958f76640303_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_651f66c5-64aa-432c-97b9-0099b80e037f_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_e16210e4-acfb-47ad-926a-7cf5758dc723_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_08ba0608-f2c4-432e-9f43-3c4f869558e3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease term (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_FL_c1e6b1a4-d48f-4e74-ba67-767d800123b2_terseLabel_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FLORIDA</link:label>
    <link:label id="lab_stpr_FL_label_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">FLORIDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_FL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_FL" xlink:to="lab_stpr_FL" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_f861d1a7-fce5-4068-a6ba-d158ba5895ab_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_3ca2ef86-cc94-48b2-b8f4-3dfc02fb9cec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019bfb95-f3c8-7f60-8a31-df92c8ca886e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax at federal statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_345d587f-e0ed-446f-a8c6-85bc2a5a6933_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_20dcd6ef-5a86-435e-af1c-893f039c35dc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_SubleaseAgreementFirstAndThirdAmendmentMember_1e145bb7-4fa9-4b75-a203-1027c4c251e7_terseLabel_en-US" xlink:label="lab_smmt_SubleaseAgreementFirstAndThirdAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sublease Agreement, First and Third Amendment</link:label>
    <link:label id="lab_smmt_SubleaseAgreementFirstAndThirdAmendmentMember_label_en-US" xlink:label="lab_smmt_SubleaseAgreementFirstAndThirdAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sublease Agreement, First and Third Amendment [Member]</link:label>
    <link:label id="lab_smmt_SubleaseAgreementFirstAndThirdAmendmentMember_documentation_en-US" xlink:label="lab_smmt_SubleaseAgreementFirstAndThirdAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sublease Agreement, First and Third Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SubleaseAgreementFirstAndThirdAmendmentMember" xlink:href="smmt-20251231.xsd#smmt_SubleaseAgreementFirstAndThirdAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_SubleaseAgreementFirstAndThirdAmendmentMember" xlink:to="lab_smmt_SubleaseAgreementFirstAndThirdAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_019bfb90-0063-7589-86ac-711d43f91f25_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_970b969a-0676-472e-b8cc-b8c45543674b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State income tax, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment_b08495d5-2279-48a8-9228-0745edc19432_terseLabel_en-US" xlink:label="lab_smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Section 174 Research and Development Capitalization</link:label>
    <link:label id="lab_smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment_label_en-US" xlink:label="lab_smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Capitalized Research And Development</link:label>
    <link:label id="lab_smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment_documentation_en-US" xlink:label="lab_smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Capitalized Research And Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:href="smmt-20251231.xsd#smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:to="lab_smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_71541225-a452-4b57-81ac-48ae62a4bd4c_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4bc3c238-34de-4adf-8911-62a1267ec4ac_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_9a0b937f-232a-4b7d-bed0-4442a7860ff2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_A2020StockIncentivePlanMember_8cb5a9e6-cdf3-4a32-be34-0bef4355a0be_terseLabel_en-US" xlink:label="lab_smmt_A2020StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020 Plan</link:label>
    <link:label id="lab_smmt_A2020StockIncentivePlanMember_label_en-US" xlink:label="lab_smmt_A2020StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2020 Stock Incentive Plan [Member]</link:label>
    <link:label id="lab_smmt_A2020StockIncentivePlanMember_documentation_en-US" xlink:label="lab_smmt_A2020StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2020 Stock Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_A2020StockIncentivePlanMember" xlink:href="smmt-20251231.xsd#smmt_A2020StockIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_A2020StockIncentivePlanMember" xlink:to="lab_smmt_A2020StockIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_24bf783e-91f7-4444-a6e7-2ec1c9aed6b4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_ee7ceff1-53b8-48cd-9500-231842fce2a9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_8a010a78-7aa2-45ec-8799-75b542a54707_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_077fd939-0506-4500-b178-1ddb8f251b4b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum common stock purchase allowable as a percentage of compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_fd5d9563-de6c-472e-80d0-166479700334_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rates on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef5a43ac-8b93-4267-af8a-8ef6c7a6a938_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_81b80f0b-d0f6-4dde-b5fb-afdb1f39e1fd_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Akeso License and Collaboration Agreement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_41df6fdd-036b-421e-8533-eace2489a8c3_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows provided by financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_73b89a29-aa0d-4f7b-9919-be1b5ab6b951_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average grant date fair value of stock options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignTaxJurisdictionOtherMember_019bfb92-7adf-7875-81bc-771276d97383_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignTaxJurisdictionOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other foreign jurisdictions</link:label>
    <link:label id="lab_us-gaap_ForeignTaxJurisdictionOtherMember_label_en-US" xlink:label="lab_us-gaap_ForeignTaxJurisdictionOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Tax Jurisdiction, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignTaxJurisdictionOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignTaxJurisdictionOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignTaxJurisdictionOtherMember" xlink:to="lab_us-gaap_ForeignTaxJurisdictionOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfRelatedPartyDebt_a83d6f7d-f187-40fd-8869-115cb8a5760f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Re-payment of related party promissory notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfRelatedPartyDebt_6e856435-d5b0-4fb7-b414-c16c7e4f42c6_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayment of related party notes payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfRelatedPartyDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Related Party Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_9733d7cf-09c7-48b8-9c5e-c508651d3a49_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_edab1b74-1bb1-488a-bca6-b7f29da9e106_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_b97d5f32-96df-4dca-8dbc-eaa068c9eaee_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits, beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_453dabb3-3451-48c3-9aa7-60220c4b3555_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits, end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a1e806fc-e6af-447c-aab5-8614084699e8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potentially dilutive securities excluded from the computation of diluted loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_9d853a33-1e5f-4e08-96a3-987defddebb9_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_9af7ffab-6e38-4b41-b604-c85758251b1e_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan_019b01d7-4072-7934-9050-3a8fa78273ac_terseLabel_en-US" xlink:label="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of additional shares allowable (in shares)</link:label>
    <link:label id="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan_label_en-US" xlink:label="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Allowable Under The Plan</link:label>
    <link:label id="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan_documentation_en-US" xlink:label="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Allowable Under The Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" xlink:href="smmt-20251231.xsd#smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" xlink:to="lab_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_SaleOfStockAmountRemainingUnderTheOffering_cdb25e29-a022-4b7d-a998-70e2d9d63057_terseLabel_en-US" xlink:label="lab_smmt_SaleOfStockAmountRemainingUnderTheOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining availability under the offering</link:label>
    <link:label id="lab_smmt_SaleOfStockAmountRemainingUnderTheOffering_label_en-US" xlink:label="lab_smmt_SaleOfStockAmountRemainingUnderTheOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Amount Remaining Under The Offering</link:label>
    <link:label id="lab_smmt_SaleOfStockAmountRemainingUnderTheOffering_documentation_en-US" xlink:label="lab_smmt_SaleOfStockAmountRemainingUnderTheOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Amount Remaining Under The Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SaleOfStockAmountRemainingUnderTheOffering" xlink:href="smmt-20251231.xsd#smmt_SaleOfStockAmountRemainingUnderTheOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_SaleOfStockAmountRemainingUnderTheOffering" xlink:to="lab_smmt_SaleOfStockAmountRemainingUnderTheOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_d5932513-e5c4-4a78-a3c4-9177cddb8cc1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_15690d85-8791-4cfd-9acd-027f172b18ab_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_578d70ea-cde1-4ee2-80a3-1e38123da031_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid_15691dcb-94cf-45f9-b656-c3617a0205b3_terseLabel_en-US" xlink:label="lab_smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period for which the majority of contractual commitments are to be paid (in years)</link:label>
    <link:label id="lab_smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid_label_en-US" xlink:label="lab_smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitment, Period for Which the Majority of Commitments are To Be Paid</link:label>
    <link:label id="lab_smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid_documentation_en-US" xlink:label="lab_smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Commitment, Period for Which the Majority of Commitments are To Be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid" xlink:href="smmt-20251231.xsd#smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid" xlink:to="lab_smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5b6a52e9-e4cd-4036-beef-50c27b23f8a9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9d767bb9-18e8-45d9-aafe-33023b8643cf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of stock option activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_93c393ff-4588-4a44-b912-e766f79f43e9_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability for interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_02b59d39-4691-49ce-9968-882aada04c3d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of assets and liabilities measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9ca2ed29-0e70-453e-b1ef-e8b43ec588ab_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_83ef5083-c7d4-4834-9dc5-61aa3c6de469_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic weighted average number of shares of common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dcb04038-adef-48e9-93a0-e13e13d9e79d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NJ_e0807dfa-faa7-429e-bd9d-84cb945957c3_terseLabel_en-US" xlink:label="lab_stpr_NJ" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NEW JERSEY</link:label>
    <link:label id="lab_stpr_NJ_label_en-US" xlink:label="lab_stpr_NJ" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEW JERSEY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_NJ"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NJ" xlink:to="lab_stpr_NJ" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0289db29-a11a-4f33-abb9-add7c89e8486_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of net loss per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a04c7930-c219-4ddf-8f21-57aca581635b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of share options, exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_e036e3e4-3336-4711-aac3-de86b8735c93_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_S3RegistrationStatementMember_0ce8bb83-1ef2-44da-84a5-986e36fa71ec_terseLabel_en-US" xlink:label="lab_smmt_S3RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">S-3 Registration Statement</link:label>
    <link:label id="lab_smmt_S3RegistrationStatementMember_label_en-US" xlink:label="lab_smmt_S3RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">S-3 Registration Statement [Member]</link:label>
    <link:label id="lab_smmt_S3RegistrationStatementMember_documentation_en-US" xlink:label="lab_smmt_S3RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">S-3 Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_S3RegistrationStatementMember" xlink:href="smmt-20251231.xsd#smmt_S3RegistrationStatementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_S3RegistrationStatementMember" xlink:to="lab_smmt_S3RegistrationStatementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3bbb2fc4-d3d7-490f-9687-189099ee8035_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_96a709f9-ce2c-4e3f-932e-c8ff2c02995d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental Disclosure of Non-Cash Investing and Financing Activities:</link:label>
    <link:label id="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_36e263be-eef4-4628-96f3-efd42d18195d_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_AccruedResearchAndDevelopmentCurrent_a207a194-e77e-4310-b3ea-fe35fd389bfe_terseLabel_en-US" xlink:label="lab_smmt_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued research and development expenditure</link:label>
    <link:label id="lab_smmt_AccruedResearchAndDevelopmentCurrent_label_en-US" xlink:label="lab_smmt_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Research And Development, Current</link:label>
    <link:label id="lab_smmt_AccruedResearchAndDevelopmentCurrent_documentation_en-US" xlink:label="lab_smmt_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Research And Development, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AccruedResearchAndDevelopmentCurrent" xlink:href="smmt-20251231.xsd#smmt_AccruedResearchAndDevelopmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_AccruedResearchAndDevelopmentCurrent" xlink:to="lab_smmt_AccruedResearchAndDevelopmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2c42e7c1-df87-41f7-96a9-947bed61f4b6_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5898360c-db79-42f0-b0bc-0954a4f21663_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_RelatedPartyTransactionPaymentsToRelatedParty_a85b848d-86ab-42d4-8fe1-3755701b0777_terseLabel_en-US" xlink:label="lab_smmt_RelatedPartyTransactionPaymentsToRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments to related party</link:label>
    <link:label id="lab_smmt_RelatedPartyTransactionPaymentsToRelatedParty_label_en-US" xlink:label="lab_smmt_RelatedPartyTransactionPaymentsToRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Payments To Related Party</link:label>
    <link:label id="lab_smmt_RelatedPartyTransactionPaymentsToRelatedParty_documentation_en-US" xlink:label="lab_smmt_RelatedPartyTransactionPaymentsToRelatedParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Payments To Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RelatedPartyTransactionPaymentsToRelatedParty" xlink:href="smmt-20251231.xsd#smmt_RelatedPartyTransactionPaymentsToRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_RelatedPartyTransactionPaymentsToRelatedParty" xlink:to="lab_smmt_RelatedPartyTransactionPaymentsToRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35634d47-49ae-4bf5-95b1-01b60f3172ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_aed14df1-258a-4a0c-b58f-ad649113a6ad_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember_f2ca56a8-307e-49d2-ace0-4a86cf00f951_terseLabel_en-US" xlink:label="lab_smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Genius Sublease Agreement And Investments Research Sublease Agreement</link:label>
    <link:label id="lab_smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember_label_en-US" xlink:label="lab_smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Genius Sublease Agreement And Investments Research Sublease Agreement [Member]</link:label>
    <link:label id="lab_smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember_documentation_en-US" xlink:label="lab_smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Genius Sublease Agreement And</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember" xlink:href="smmt-20251231.xsd#smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember" xlink:to="lab_smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_92608ab3-95cf-47fe-b20a-83eb404c03f2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_ConsultingAgreementMember_d74d9787-3eaa-4a39-93b6-ef1e6afb6f79_terseLabel_en-US" xlink:label="lab_smmt_ConsultingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consulting Agreement</link:label>
    <link:label id="lab_smmt_ConsultingAgreementMember_label_en-US" xlink:label="lab_smmt_ConsultingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consulting Agreement [Member]</link:label>
    <link:label id="lab_smmt_ConsultingAgreementMember_documentation_en-US" xlink:label="lab_smmt_ConsultingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consulting Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ConsultingAgreementMember" xlink:href="smmt-20251231.xsd#smmt_ConsultingAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_ConsultingAgreementMember" xlink:to="lab_smmt_ConsultingAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_NotesPayableRelatedPartiesNewIssuances_d8206507-365f-4b08-b339-f0506085a22d_terseLabel_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartiesNewIssuances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New note issuances</link:label>
    <link:label id="lab_smmt_NotesPayableRelatedPartiesNewIssuances_label_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartiesNewIssuances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Related Parties, New Issuances</link:label>
    <link:label id="lab_smmt_NotesPayableRelatedPartiesNewIssuances_documentation_en-US" xlink:label="lab_smmt_NotesPayableRelatedPartiesNewIssuances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes Payable, Related Parties, New Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartiesNewIssuances" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartiesNewIssuances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_NotesPayableRelatedPartiesNewIssuances" xlink:to="lab_smmt_NotesPayableRelatedPartiesNewIssuances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_03507372-3229-48b7-bb8a-f4ad8ceda4e4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b57bb74f-7dc3-4fa9-adaa-1a108f776d71_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_d6af2f5c-3b22-431c-ad26-77e7717bee2d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_bda26112-f724-4fdf-af00-6feb7101cf21_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_3f2a3516-485b-4062-a7ff-a72f530c9743_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_9a37192f-7a80-47c7-97ad-cbf7447c3d0c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_056458ca-b6c6-4e3f-b11b-1062d582f05c_negatedNetLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments_b207af10-5c50-497f-acbc-5813d39880e4_terseLabel_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative arrangement, potential regulatory milestone payments</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments_label_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights And Obligations, Potential Regulatory Milestone Payments</link:label>
    <link:label id="lab_smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments_documentation_en-US" xlink:label="lab_smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights And Obligations, Potential Regulatory Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments" xlink:to="lab_smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_8bd6699f-cfac-4873-aaa7-28a6d50e476e_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_e2c6d270-2d2c-4a73-91c1-3baa613bbe8a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_2d315a3c-d6da-4c9e-ae1a-510999b04346_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Credit (Loss)</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_CoChiefExecutiveOfficerMember_d83fe98b-08f1-4443-b2db-79fdfb6ee0c7_terseLabel_en-US" xlink:label="lab_smmt_CoChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Co-Chief Executive Officer</link:label>
    <link:label id="lab_smmt_CoChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_smmt_CoChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Co-Chief Executive Officer [Member]</link:label>
    <link:label id="lab_smmt_CoChiefExecutiveOfficerMember_documentation_en-US" xlink:label="lab_smmt_CoChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Co-Chief Executive Officer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CoChiefExecutiveOfficerMember" xlink:href="smmt-20251231.xsd#smmt_CoChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_CoChiefExecutiveOfficerMember" xlink:to="lab_smmt_CoChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_80929e4b-00d1-4d71-9bd0-d031d04dc49c_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_7d8f8c2d-3432-4257-a62f-3a70823f2ed0_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_0cad817a-b3d5-42e9-af88-56550a8d0586_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_2efdc41c-660b-45b5-8cb5-9fa61da0ee52_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unpaid amounts related to purchase of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_ec438c37-63b3-420d-ab69-dac7a0343de7_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increases related to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_01345d89-ae5e-4a3f-b8a9-5c31bc574bf8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest_b406e73c-3a5c-4c26-b7b6-093e59062c77_terseLabel_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued for prepaid interest (in shares)</link:label>
    <link:label id="lab_smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest_label_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Related Party Prepaid Interest</link:label>
    <link:label id="lab_smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest_documentation_en-US" xlink:label="lab_smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Related Party Prepaid Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest" xlink:to="lab_smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_VariableRatePeriodDomain_57c9c2fe-e143-4fd1-bd32-e30fb35252a4_terseLabel_en-US" xlink:label="lab_smmt_VariableRatePeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate Period [Domain]</link:label>
    <link:label id="lab_smmt_VariableRatePeriodDomain_label_en-US" xlink:label="lab_smmt_VariableRatePeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate Period [Domain]</link:label>
    <link:label id="lab_smmt_VariableRatePeriodDomain_documentation_en-US" xlink:label="lab_smmt_VariableRatePeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variable Rate Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_VariableRatePeriodDomain" xlink:href="smmt-20251231.xsd#smmt_VariableRatePeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_VariableRatePeriodDomain" xlink:to="lab_smmt_VariableRatePeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_5cf02532-7ece-4519-91cc-854abf29522c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_NewJerseyAndCaliforniaMember_019b03c4-2f9e-7732-9b13-4bcf34580712_terseLabel_en-US" xlink:label="lab_smmt_NewJerseyAndCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Jersey And California</link:label>
    <link:label id="lab_smmt_NewJerseyAndCaliforniaMember_label_en-US" xlink:label="lab_smmt_NewJerseyAndCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Jersey And California [Member]</link:label>
    <link:label id="lab_smmt_NewJerseyAndCaliforniaMember_documentation_en-US" xlink:label="lab_smmt_NewJerseyAndCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">New Jersey And California</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NewJerseyAndCaliforniaMember" xlink:href="smmt-20251231.xsd#smmt_NewJerseyAndCaliforniaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_NewJerseyAndCaliforniaMember" xlink:to="lab_smmt_NewJerseyAndCaliforniaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_0d89fd04-5df9-4c7a-a8e7-951683824349_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rights Offering of common stock, net of offering costs / Private placement of common stock, net of offering costs / Proceeds from at-the-market offering, net of commissions and offering costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_87661c46-ceff-4afd-b75c-991193e94bcf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_db2fb1e7-c869-43c2-baae-0f7b40b742f0_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_03f66582-242b-4cd6-85c5-3d81001e45d4_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_019c2f6f-45cd-7cee-b554-4ebf9db16118_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk- free interest rate, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_a1ae0c15-46d5-41ca-83fd-2778ebadb9cb_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_SubleaseAgreementThirdAmendmentMember_3571937f-79ac-46d8-8b78-0104060c24c6_terseLabel_en-US" xlink:label="lab_smmt_SubleaseAgreementThirdAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sublease Agreement, Third Amendment</link:label>
    <link:label id="lab_smmt_SubleaseAgreementThirdAmendmentMember_label_en-US" xlink:label="lab_smmt_SubleaseAgreementThirdAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sublease Agreement, Third Amendment [Member]</link:label>
    <link:label id="lab_smmt_SubleaseAgreementThirdAmendmentMember_documentation_en-US" xlink:label="lab_smmt_SubleaseAgreementThirdAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sublease Agreement, Third Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SubleaseAgreementThirdAmendmentMember" xlink:href="smmt-20251231.xsd#smmt_SubleaseAgreementThirdAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_SubleaseAgreementThirdAmendmentMember" xlink:to="lab_smmt_SubleaseAgreementThirdAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_66a8be9f-8f0b-4c93-9367-aa7856065e7e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract_019bfb8d-30bb-7936-bef7-931dd911ddb8_terseLabel_en-US" xlink:label="lab_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Tax Effects</link:label>
    <link:label id="lab_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract_label_en-US" xlink:label="lab_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Tax Effects, Percent [Abstract]</link:label>
    <link:label id="lab_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract_documentation_en-US" xlink:label="lab_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Tax Effects, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract" xlink:href="smmt-20251231.xsd#smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract" xlink:to="lab_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_72ab3461-1c74-442e-9920-860afb3b6bac_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_99e97224-ce3d-4a18-973e-9ffda8279b0b_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>smmt-20251231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:5ba7c3ca-9242-422c-a50f-4bf839baf136,g:2c7db6f2-9106-44bc-b090-f2695a3e242b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.summitplc.com/role/Cover" xlink:type="simple" xlink:href="smmt-20251231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_013a31f9-1971-47ec-abc6-4559acbb806c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_DocumentType_013a31f9-1971-47ec-abc6-4559acbb806c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_e576cfc1-51a0-4a35-a19d-1be86a89a393" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_DocumentAnnualReport_e576cfc1-51a0-4a35-a19d-1be86a89a393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b682200c-27a4-4dc4-b10a-c1513ab1732b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_DocumentPeriodEndDate_b682200c-27a4-4dc4-b10a-c1513ab1732b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_4d9c8f37-d26c-4adc-81b6-7447ffaa10d6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_CurrentFiscalYearEndDate_4d9c8f37-d26c-4adc-81b6-7447ffaa10d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a2bfd27b-26bb-4869-82fb-8df683cf6b6e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_DocumentTransitionReport_a2bfd27b-26bb-4869-82fb-8df683cf6b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_45b91b8e-e03f-49f9-a83c-9b31570c0883" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityFileNumber_45b91b8e-e03f-49f9-a83c-9b31570c0883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a320c4de-c95a-4341-822e-feb77bf8b357" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityRegistrantName_a320c4de-c95a-4341-822e-feb77bf8b357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_33b34b71-21b8-473e-bbc2-a2f3307e01a4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityIncorporationStateCountryCode_33b34b71-21b8-473e-bbc2-a2f3307e01a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_978efab9-b5bd-4c16-8093-19cb0807d8b7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityTaxIdentificationNumber_978efab9-b5bd-4c16-8093-19cb0807d8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b2da4e56-442a-451b-a8e8-a5d106cf6792" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityAddressAddressLine1_b2da4e56-442a-451b-a8e8-a5d106cf6792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_d384798f-8ad9-422d-9565-1d8d6ddc9b40" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityAddressCityOrTown_d384798f-8ad9-422d-9565-1d8d6ddc9b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7680a173-b8fa-469b-87f7-81a9adc1ba62" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityAddressStateOrProvince_7680a173-b8fa-469b-87f7-81a9adc1ba62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_ebc6593b-4232-4841-91ac-9c55ece73cc4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityAddressPostalZipCode_ebc6593b-4232-4841-91ac-9c55ece73cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c641eb16-26c3-4c05-9ab0-31e84a8c1c33" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_CityAreaCode_c641eb16-26c3-4c05-9ab0-31e84a8c1c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_c840d173-ca4d-4a78-a35f-c305a0586697" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_LocalPhoneNumber_c840d173-ca4d-4a78-a35f-c305a0586697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_092f03d7-fb49-4c29-8819-fb4262a578fc" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_Security12bTitle_092f03d7-fb49-4c29-8819-fb4262a578fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_fa67c66e-ca06-4c05-915e-5e446d5e437b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_TradingSymbol_fa67c66e-ca06-4c05-915e-5e446d5e437b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_525f3459-2c46-41e0-b049-afba45b211e0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_SecurityExchangeName_525f3459-2c46-41e0-b049-afba45b211e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_f36bb81b-9f6e-4fc5-b44d-3fe96f1bb447" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_f36bb81b-9f6e-4fc5-b44d-3fe96f1bb447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_7d4d2435-8f10-4723-867f-ae2af0d6244e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityVoluntaryFilers_7d4d2435-8f10-4723-867f-ae2af0d6244e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_4053b951-732d-46a7-98b2-ea64b6f60b64" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityCurrentReportingStatus_4053b951-732d-46a7-98b2-ea64b6f60b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ab8d247c-a102-4eb4-a1dd-c30b3fd2901b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityInteractiveDataCurrent_ab8d247c-a102-4eb4-a1dd-c30b3fd2901b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_6d31f9a0-24b9-48a1-a540-a18184b6d9f5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityFilerCategory_6d31f9a0-24b9-48a1-a540-a18184b6d9f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_f25bd274-b895-4900-9598-adc538ce2945" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntitySmallBusiness_f25bd274-b895-4900-9598-adc538ce2945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_60e81a08-3715-4321-a6a6-692abd85ebf6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityEmergingGrowthCompany_60e81a08-3715-4321-a6a6-692abd85ebf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_6790f31b-2659-4117-b177-bf658fad9775" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_IcfrAuditorAttestationFlag_6790f31b-2659-4117-b177-bf658fad9775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_8ca9a3ec-7993-4899-b108-739a8c239321" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_8ca9a3ec-7993-4899-b108-739a8c239321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_ea885b9e-8045-4d3d-a287-319a0fc57488" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityShellCompany_ea885b9e-8045-4d3d-a287-319a0fc57488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_0eaec161-4bcf-4807-8666-9f2affa2c454" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityPublicFloat_0eaec161-4bcf-4807-8666-9f2affa2c454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_c0d189ab-6df4-4aba-8b65-ece20029b62f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_c0d189ab-6df4-4aba-8b65-ece20029b62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_b721ecab-f155-4ef1-88b2-b90684d1b305" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_b721ecab-f155-4ef1-88b2-b90684d1b305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_cf1e20b9-9cf7-4729-8ad9-1a827bd72a67" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_AmendmentFlag_cf1e20b9-9cf7-4729-8ad9-1a827bd72a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_30ea5fc7-228e-4adc-946f-6b963eb14cf1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_EntityCentralIndexKey_30ea5fc7-228e-4adc-946f-6b963eb14cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_40212e38-14a7-4a57-a86b-4b9fab630ece" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_DocumentFiscalYearFocus_40212e38-14a7-4a57-a86b-4b9fab630ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_554240b9-4d8e-44a7-b5bf-c00632f20fac" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_32e0560e-c3f1-4aa5-a1f8-eb26aa3b3afe" xlink:to="loc_dei_DocumentFiscalPeriodFocus_554240b9-4d8e-44a7-b5bf-c00632f20fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/AuditInformation" xlink:type="simple" xlink:href="smmt-20251231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AuditInformationAbstract_c4e0df0e-02d2-4477-b36b-d1307df26bb6" xlink:href="smmt-20251231.xsd#smmt_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_2d718b57-b628-455f-bbff-b181e63f62e8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_AuditInformationAbstract_c4e0df0e-02d2-4477-b36b-d1307df26bb6" xlink:to="loc_dei_AuditorFirmId_2d718b57-b628-455f-bbff-b181e63f62e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_c2479337-8ec5-494e-b350-fb8fd41e7fc7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_AuditInformationAbstract_c4e0df0e-02d2-4477-b36b-d1307df26bb6" xlink:to="loc_dei_AuditorName_c2479337-8ec5-494e-b350-fb8fd41e7fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_f81b028d-ba5a-43fc-a1ac-4dd144431a04" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_AuditInformationAbstract_c4e0df0e-02d2-4477-b36b-d1307df26bb6" xlink:to="loc_dei_AuditorLocation_f81b028d-ba5a-43fc-a1ac-4dd144431a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="smmt-20251231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3c14ad84-5830-4e27-b1ab-cf9294ad8422" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_6b6fb38e-0247-4009-9196-3de9926e5f91" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3c14ad84-5830-4e27-b1ab-cf9294ad8422" xlink:to="loc_us-gaap_AssetsAbstract_6b6fb38e-0247-4009-9196-3de9926e5f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_6b94c475-9bc2-4f39-a4dd-9d8191cfcbef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6b6fb38e-0247-4009-9196-3de9926e5f91" xlink:to="loc_us-gaap_AssetsCurrentAbstract_6b94c475-9bc2-4f39-a4dd-9d8191cfcbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4a62f501-0a51-43f9-8700-f6275fe87250" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6b94c475-9bc2-4f39-a4dd-9d8191cfcbef" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4a62f501-0a51-43f9-8700-f6275fe87250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_32cc34ff-e1fd-4951-995d-ff765ddf4ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6b94c475-9bc2-4f39-a4dd-9d8191cfcbef" xlink:to="loc_us-gaap_RestrictedCashCurrent_32cc34ff-e1fd-4951-995d-ff765ddf4ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_f90e8ae6-fd0f-402e-86db-c99064b725bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6b94c475-9bc2-4f39-a4dd-9d8191cfcbef" xlink:to="loc_us-gaap_ShortTermInvestments_f90e8ae6-fd0f-402e-86db-c99064b725bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2f5b0603-8a15-4612-9efe-e36d03db4475" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6b94c475-9bc2-4f39-a4dd-9d8191cfcbef" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2f5b0603-8a15-4612-9efe-e36d03db4475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_02201122-7cf1-442e-8be6-ad78b37ed0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6b94c475-9bc2-4f39-a4dd-9d8191cfcbef" xlink:to="loc_us-gaap_AssetsCurrent_02201122-7cf1-442e-8be6-ad78b37ed0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_4c0712ec-dbdf-4309-8677-d99c09d849a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6b6fb38e-0247-4009-9196-3de9926e5f91" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_4c0712ec-dbdf-4309-8677-d99c09d849a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ea113137-9109-4323-999a-830604b7d106" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_4c0712ec-dbdf-4309-8677-d99c09d849a6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ea113137-9109-4323-999a-830604b7d106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_fb722dcc-8f47-4bd3-9089-30134f91dc75" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_4c0712ec-dbdf-4309-8677-d99c09d849a6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_fb722dcc-8f47-4bd3-9089-30134f91dc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_54f80455-eba6-4044-a00e-db8ffe8b1b25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_4c0712ec-dbdf-4309-8677-d99c09d849a6" xlink:to="loc_us-gaap_Goodwill_54f80455-eba6-4044-a00e-db8ffe8b1b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_aeb3e2c0-62f3-441b-9da5-4b235d7ed437" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_4c0712ec-dbdf-4309-8677-d99c09d849a6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_aeb3e2c0-62f3-441b-9da5-4b235d7ed437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_97336506-72bb-49b6-b02f-bbd0d6c0d757" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6b6fb38e-0247-4009-9196-3de9926e5f91" xlink:to="loc_us-gaap_Assets_97336506-72bb-49b6-b02f-bbd0d6c0d757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eee431cb-b3b5-43e7-806a-e167055d3442" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3c14ad84-5830-4e27-b1ab-cf9294ad8422" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eee431cb-b3b5-43e7-806a-e167055d3442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_a4d4b888-f16c-4744-ad5c-511f951470a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eee431cb-b3b5-43e7-806a-e167055d3442" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_a4d4b888-f16c-4744-ad5c-511f951470a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_c89bee78-0e5b-4151-8fb6-2445bbd2ccb4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a4d4b888-f16c-4744-ad5c-511f951470a4" xlink:to="loc_us-gaap_AccountsPayableCurrent_c89bee78-0e5b-4151-8fb6-2445bbd2ccb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a86703a7-033d-4e33-9959-803691cf5669" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a4d4b888-f16c-4744-ad5c-511f951470a4" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a86703a7-033d-4e33-9959-803691cf5669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e3199ccc-7a17-4722-ac02-cc127df25523" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a4d4b888-f16c-4744-ad5c-511f951470a4" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e3199ccc-7a17-4722-ac02-cc127df25523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f6e7c832-7fd0-4d39-9a1e-954a5425944f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a4d4b888-f16c-4744-ad5c-511f951470a4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f6e7c832-7fd0-4d39-9a1e-954a5425944f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_2178e2a9-a9b6-4a5b-98a1-f7c9b8dc8daf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a4d4b888-f16c-4744-ad5c-511f951470a4" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_2178e2a9-a9b6-4a5b-98a1-f7c9b8dc8daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_22eb4b18-a213-43c6-9048-95efed7b3a13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a4d4b888-f16c-4744-ad5c-511f951470a4" xlink:to="loc_us-gaap_LiabilitiesCurrent_22eb4b18-a213-43c6-9048-95efed7b3a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_cb36bc5b-2d5c-4a81-b990-47c112d8531e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eee431cb-b3b5-43e7-806a-e167055d3442" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_cb36bc5b-2d5c-4a81-b990-47c112d8531e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_967a9e9b-2d42-4f73-b8e9-fc317f2dc978" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_cb36bc5b-2d5c-4a81-b990-47c112d8531e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_967a9e9b-2d42-4f73-b8e9-fc317f2dc978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f2bafe99-2120-4635-afd0-99654c2faf4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_cb36bc5b-2d5c-4a81-b990-47c112d8531e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f2bafe99-2120-4635-afd0-99654c2faf4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_14d28938-0f87-4487-8fa4-af771c67150a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eee431cb-b3b5-43e7-806a-e167055d3442" xlink:to="loc_us-gaap_Liabilities_14d28938-0f87-4487-8fa4-af771c67150a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_da4638be-8b5f-4692-8a3b-7e5beccebf1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eee431cb-b3b5-43e7-806a-e167055d3442" xlink:to="loc_us-gaap_CommitmentsAndContingencies_da4638be-8b5f-4692-8a3b-7e5beccebf1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_82519253-a6e9-4750-8e55-016393ef8389" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eee431cb-b3b5-43e7-806a-e167055d3442" xlink:to="loc_us-gaap_StockholdersEquityAbstract_82519253-a6e9-4750-8e55-016393ef8389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_0f2f8acf-043a-4551-bd2d-46fe9480bac1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_82519253-a6e9-4750-8e55-016393ef8389" xlink:to="loc_us-gaap_PreferredStockValue_0f2f8acf-043a-4551-bd2d-46fe9480bac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7a358003-620e-470a-a5d1-7ecb63646b77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_82519253-a6e9-4750-8e55-016393ef8389" xlink:to="loc_us-gaap_CommonStockValue_7a358003-620e-470a-a5d1-7ecb63646b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_930308db-5f9a-4ca9-abcc-738cd1c82690" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_82519253-a6e9-4750-8e55-016393ef8389" xlink:to="loc_us-gaap_AdditionalPaidInCapital_930308db-5f9a-4ca9-abcc-738cd1c82690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c4444197-0087-436e-af2e-d466bde2c500" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_82519253-a6e9-4750-8e55-016393ef8389" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c4444197-0087-436e-af2e-d466bde2c500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8750a794-4ee9-47da-8f80-bef302483228" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_82519253-a6e9-4750-8e55-016393ef8389" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8750a794-4ee9-47da-8f80-bef302483228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_41600b3f-ffcf-4a67-b2ee-a78ac15685b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_82519253-a6e9-4750-8e55-016393ef8389" xlink:to="loc_us-gaap_StockholdersEquity_41600b3f-ffcf-4a67-b2ee-a78ac15685b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_496a28af-3be6-41f9-8c89-7c21ccfc8a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eee431cb-b3b5-43e7-806a-e167055d3442" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_496a28af-3be6-41f9-8c89-7c21ccfc8a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="smmt-20251231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0e98b9d3-152c-43fb-b6c9-9110a4372595" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_88ee9e89-92b8-4de9-93b7-8936f8842fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0e98b9d3-152c-43fb-b6c9-9110a4372595" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_88ee9e89-92b8-4de9-93b7-8936f8842fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_f97920ba-4fcf-4add-b1ab-a68529b1ae44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0e98b9d3-152c-43fb-b6c9-9110a4372595" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_f97920ba-4fcf-4add-b1ab-a68529b1ae44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_1dda399e-4b49-42b0-8352-71d97426f80c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0e98b9d3-152c-43fb-b6c9-9110a4372595" xlink:to="loc_us-gaap_PreferredStockSharesIssued_1dda399e-4b49-42b0-8352-71d97426f80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_79a02227-a107-4b86-83df-31da08cd88c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0e98b9d3-152c-43fb-b6c9-9110a4372595" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_79a02227-a107-4b86-83df-31da08cd88c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_21a2f412-120e-44e0-81c9-4cc6ed67d21a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0e98b9d3-152c-43fb-b6c9-9110a4372595" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_21a2f412-120e-44e0-81c9-4cc6ed67d21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_803e3b4e-336b-4402-9a35-9bc990fb9f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0e98b9d3-152c-43fb-b6c9-9110a4372595" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_803e3b4e-336b-4402-9a35-9bc990fb9f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4fd21567-ea5b-46b7-9b53-d1474bd0cfe4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0e98b9d3-152c-43fb-b6c9-9110a4372595" xlink:to="loc_us-gaap_CommonStockSharesIssued_4fd21567-ea5b-46b7-9b53-d1474bd0cfe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9b45cd97-b5ed-4d7a-a575-36eed679aacf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0e98b9d3-152c-43fb-b6c9-9110a4372595" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_9b45cd97-b5ed-4d7a-a575-36eed679aacf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="smmt-20251231.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_47216879-53ab-4e8e-a4ce-2dd2f1ff54a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_c7c2281d-659c-43ab-9234-e9a6d8f11af1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_47216879-53ab-4e8e-a4ce-2dd2f1ff54a2" xlink:to="loc_us-gaap_OperatingExpensesAbstract_c7c2281d-659c-43ab-9234-e9a6d8f11af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_835ea005-9077-4377-a1c3-4161760a848f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c7c2281d-659c-43ab-9234-e9a6d8f11af1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_835ea005-9077-4377-a1c3-4161760a848f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_14ea6d71-03cd-4bc0-9814-68574edaa99c" xlink:href="smmt-20251231.xsd#smmt_AcquiredInProcessResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c7c2281d-659c-43ab-9234-e9a6d8f11af1" xlink:to="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_14ea6d71-03cd-4bc0-9814-68574edaa99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_4e65d237-c9e2-4a1f-8102-f9cbca5276af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c7c2281d-659c-43ab-9234-e9a6d8f11af1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_4e65d237-c9e2-4a1f-8102-f9cbca5276af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_ffbf04b2-ce8e-4dfe-a3f1-82aef67cc513" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c7c2281d-659c-43ab-9234-e9a6d8f11af1" xlink:to="loc_us-gaap_OperatingExpenses_ffbf04b2-ce8e-4dfe-a3f1-82aef67cc513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b4a79fe6-070d-4782-9cb9-7368f7e34d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_47216879-53ab-4e8e-a4ce-2dd2f1ff54a2" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_b4a79fe6-070d-4782-9cb9-7368f7e34d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_34c74078-c712-4ef4-a9df-dd712b87cd99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_47216879-53ab-4e8e-a4ce-2dd2f1ff54a2" xlink:to="loc_us-gaap_InterestExpenseNonoperating_34c74078-c712-4ef4-a9df-dd712b87cd99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_56d77fff-e663-434e-b79f-65d71a974cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_47216879-53ab-4e8e-a4ce-2dd2f1ff54a2" xlink:to="loc_us-gaap_NetIncomeLoss_56d77fff-e663-434e-b79f-65d71a974cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EarningsPerShareBasicAndDilutedEPSAbstract_8460453c-b00d-416c-8889-f45c84e60079" xlink:href="smmt-20251231.xsd#smmt_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_47216879-53ab-4e8e-a4ce-2dd2f1ff54a2" xlink:to="loc_smmt_EarningsPerShareBasicAndDilutedEPSAbstract_8460453c-b00d-416c-8889-f45c84e60079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1f886a58-1aa3-4b7c-9748-0a097d0b2d40" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_EarningsPerShareBasicAndDilutedEPSAbstract_8460453c-b00d-416c-8889-f45c84e60079" xlink:to="loc_us-gaap_EarningsPerShareBasic_1f886a58-1aa3-4b7c-9748-0a097d0b2d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9a41997b-c0f1-40b7-91a6-3b0b57a2affb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_EarningsPerShareBasicAndDilutedEPSAbstract_8460453c-b00d-416c-8889-f45c84e60079" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9a41997b-c0f1-40b7-91a6-3b0b57a2affb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_02736266-d2e0-403b-a835-d8138ec401db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_47216879-53ab-4e8e-a4ce-2dd2f1ff54a2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_02736266-d2e0-403b-a835-d8138ec401db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_947e9446-f6c8-443f-a476-261b7c7198f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_02736266-d2e0-403b-a835-d8138ec401db" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_947e9446-f6c8-443f-a476-261b7c7198f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e0c9c538-ca23-48b0-beb9-5d1a24869eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_02736266-d2e0-403b-a835-d8138ec401db" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e0c9c538-ca23-48b0-beb9-5d1a24869eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_143df4cb-c821-4427-a266-af966e9ed03d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_47216879-53ab-4e8e-a4ce-2dd2f1ff54a2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_143df4cb-c821-4427-a266-af966e9ed03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_355f74ea-37ea-4b45-a0f3-5eceee548d74" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_143df4cb-c821-4427-a266-af966e9ed03d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_355f74ea-37ea-4b45-a0f3-5eceee548d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax_80f8e16d-ffbc-426f-b40c-dd9ebccff140" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_143df4cb-c821-4427-a266-af966e9ed03d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax_80f8e16d-ffbc-426f-b40c-dd9ebccff140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_abbc1fcb-3f19-4da7-8059-f0f649413828" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_143df4cb-c821-4427-a266-af966e9ed03d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_abbc1fcb-3f19-4da7-8059-f0f649413828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_a67b4956-82e4-4343-af3b-cf8443c9388f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_143df4cb-c821-4427-a266-af966e9ed03d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_a67b4956-82e4-4343-af3b-cf8443c9388f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_437e25c3-29ca-4bd5-b7e1-8ca3ec431bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_47216879-53ab-4e8e-a4ce-2dd2f1ff54a2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_437e25c3-29ca-4bd5-b7e1-8ca3ec431bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="smmt-20251231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_97d570c2-9da0-4c70-9c10-547b0ef2d454" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_52783512-863f-4584-b5e7-a9ff5280d107" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_97d570c2-9da0-4c70-9c10-547b0ef2d454" xlink:to="loc_us-gaap_StatementTable_52783512-863f-4584-b5e7-a9ff5280d107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_abf0b7dd-85b6-4247-a53e-008fde67fe92" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_52783512-863f-4584-b5e7-a9ff5280d107" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_abf0b7dd-85b6-4247-a53e-008fde67fe92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e68728e8-580b-42ce-8d50-11b9f4afc6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_abf0b7dd-85b6-4247-a53e-008fde67fe92" xlink:to="loc_us-gaap_EquityComponentDomain_e68728e8-580b-42ce-8d50-11b9f4afc6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3347367a-86fd-4bd6-ae6c-49835697e75c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e68728e8-580b-42ce-8d50-11b9f4afc6f3" xlink:to="loc_us-gaap_CommonStockMember_3347367a-86fd-4bd6-ae6c-49835697e75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_87f0c241-7c3d-434b-9ade-a533f0878986" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e68728e8-580b-42ce-8d50-11b9f4afc6f3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_87f0c241-7c3d-434b-9ade-a533f0878986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4ed17614-4cb7-46e2-baef-f4214b783fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e68728e8-580b-42ce-8d50-11b9f4afc6f3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4ed17614-4cb7-46e2-baef-f4214b783fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d0746096-d651-4cf1-b5c6-9cba593a866e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e68728e8-580b-42ce-8d50-11b9f4afc6f3" xlink:to="loc_us-gaap_RetainedEarningsMember_d0746096-d651-4cf1-b5c6-9cba593a866e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_534ad496-5aa5-4eff-83c2-1b8f05d876d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_52783512-863f-4584-b5e7-a9ff5280d107" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_534ad496-5aa5-4eff-83c2-1b8f05d876d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_19c846bf-d079-4e91-9dc4-0798bff15569" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_534ad496-5aa5-4eff-83c2-1b8f05d876d4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_19c846bf-d079-4e91-9dc4-0798bff15569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RightsOfferingMember_160c9bf1-76af-4c4a-a552-01ece1e93a76" xlink:href="smmt-20251231.xsd#smmt_RightsOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_19c846bf-d079-4e91-9dc4-0798bff15569" xlink:to="loc_smmt_RightsOfferingMember_160c9bf1-76af-4c4a-a552-01ece1e93a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_615e5406-2d0f-4771-84d2-ffb221092bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_19c846bf-d079-4e91-9dc4-0798bff15569" xlink:to="loc_us-gaap_PrivatePlacementMember_615e5406-2d0f-4771-84d2-ffb221092bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AtMarketOfferingMember_75311df6-04ed-4cc4-a6ad-3e73aef864f3" xlink:href="smmt-20251231.xsd#smmt_AtMarketOfferingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_19c846bf-d079-4e91-9dc4-0798bff15569" xlink:to="loc_smmt_AtMarketOfferingMember_75311df6-04ed-4cc4-a6ad-3e73aef864f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e2ce2d05-7aa9-4d98-8854-f486122141a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_52783512-863f-4584-b5e7-a9ff5280d107" xlink:to="loc_us-gaap_StatementLineItems_e2ce2d05-7aa9-4d98-8854-f486122141a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2ce2d05-7aa9-4d98-8854-f486122141a0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c061c032-6fbb-44ce-9f8d-fd67ab079e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c061c032-6fbb-44ce-9f8d-fd67ab079e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_acc52331-8ac5-4cd5-9d29-66d4fb811174" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_StockholdersEquity_acc52331-8ac5-4cd5-9d29-66d4fb811174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_33e66292-1def-4cda-bdec-9d6e26ff6323" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_33e66292-1def-4cda-bdec-9d6e26ff6323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_38e291a6-cc01-4f0b-a8a4-84e3cb4b6711" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_38e291a6-cc01-4f0b-a8a4-84e3cb4b6711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_6d1cf29e-80e4-4bbd-87aa-a524037af590" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_6d1cf29e-80e4-4bbd-87aa-a524037af590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ed3fab30-6220-4366-9d8e-77a27bad8216" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ed3fab30-6220-4366-9d8e-77a27bad8216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest_18a71ad7-172a-4e68-b3e2-1abfae051f38" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest_18a71ad7-172a-4e68-b3e2-1abfae051f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest_b9b1adde-fcaf-41aa-a2a0-bf5f9ab1b48e" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest_b9b1adde-fcaf-41aa-a2a0-bf5f9ab1b48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodSharesWarrantsExercised_5613ef86-57fd-485f-9775-c172c86e3456" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_smmt_StockIssuedDuringPeriodSharesWarrantsExercised_5613ef86-57fd-485f-9775-c172c86e3456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodValueWarrantsExercised_42bd0cf8-cb5c-4d1c-871b-bdb8121db1e9" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_smmt_StockIssuedDuringPeriodValueWarrantsExercised_42bd0cf8-cb5c-4d1c-871b-bdb8121db1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3967508f-86c8-40da-856a-393544c4776b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3967508f-86c8-40da-856a-393544c4776b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c4bd8769-c3fb-497f-b526-ef322b12b400" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c4bd8769-c3fb-497f-b526-ef322b12b400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_21fa807c-48db-43a6-839b-688a3704897b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_NetIncomeLoss_21fa807c-48db-43a6-839b-688a3704897b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ef96a68e-5480-4f67-9e5c-0d72513bf1b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ef96a68e-5480-4f67-9e5c-0d72513bf1b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_16626d01-c2c3-45f7-9cde-1037a5c6b1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ef94017-ab79-4c6a-a6f1-4bc154d329af" xlink:to="loc_us-gaap_StockholdersEquity_16626d01-c2c3-45f7-9cde-1037a5c6b1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="smmt-20251231.xsd#ConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_6f2ba574-4f62-4c81-b710-e0a48cb31e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ce8aca5b-c4e3-47aa-ba03-0243d916bed5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_6f2ba574-4f62-4c81-b710-e0a48cb31e1b" xlink:to="loc_us-gaap_StatementTable_ce8aca5b-c4e3-47aa-ba03-0243d916bed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_10573c67-49e5-4552-84fa-df12d1c66caa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ce8aca5b-c4e3-47aa-ba03-0243d916bed5" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_10573c67-49e5-4552-84fa-df12d1c66caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7e7f800e-9e1d-4d8d-a40f-2716f2d735fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_10573c67-49e5-4552-84fa-df12d1c66caa" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7e7f800e-9e1d-4d8d-a40f-2716f2d735fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RightsOfferingMember_c9a5831a-77d7-4af7-ad20-02efe3389570" xlink:href="smmt-20251231.xsd#smmt_RightsOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7e7f800e-9e1d-4d8d-a40f-2716f2d735fc" xlink:to="loc_smmt_RightsOfferingMember_c9a5831a-77d7-4af7-ad20-02efe3389570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_af383a67-095e-42fc-86d2-b70a1e56707c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7e7f800e-9e1d-4d8d-a40f-2716f2d735fc" xlink:to="loc_us-gaap_PrivatePlacementMember_af383a67-095e-42fc-86d2-b70a1e56707c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AtMarketOfferingMember_f959af7a-5c47-43a2-a9fd-c18a73bb8b61" xlink:href="smmt-20251231.xsd#smmt_AtMarketOfferingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7e7f800e-9e1d-4d8d-a40f-2716f2d735fc" xlink:to="loc_smmt_AtMarketOfferingMember_f959af7a-5c47-43a2-a9fd-c18a73bb8b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6d56a42c-669d-4c22-9b3d-4577e51d89ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ce8aca5b-c4e3-47aa-ba03-0243d916bed5" xlink:to="loc_us-gaap_StatementLineItems_6d56a42c-669d-4c22-9b3d-4577e51d89ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_80b9d18c-9d91-4ee4-b6ea-b5c1de86749c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6d56a42c-669d-4c22-9b3d-4577e51d89ba" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_80b9d18c-9d91-4ee4-b6ea-b5c1de86749c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="smmt-20251231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_4cb47f0a-bd7d-49a0-b211-cedac9fa358a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_69c34961-d783-4ae7-ab47-ed2c40dac651" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4cb47f0a-bd7d-49a0-b211-cedac9fa358a" xlink:to="loc_us-gaap_StatementTable_69c34961-d783-4ae7-ab47-ed2c40dac651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_d2d949b4-c666-44d3-a7ed-38f86c3d0ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_69c34961-d783-4ae7-ab47-ed2c40dac651" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_d2d949b4-c666-44d3-a7ed-38f86c3d0ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cf96cbcb-1c30-46df-99cf-08ac24d2eaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_d2d949b4-c666-44d3-a7ed-38f86c3d0ea2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cf96cbcb-1c30-46df-99cf-08ac24d2eaf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AtMarketOfferingMember_f6ca83ad-ed6d-47c3-9848-6fecc2e58c68" xlink:href="smmt-20251231.xsd#smmt_AtMarketOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cf96cbcb-1c30-46df-99cf-08ac24d2eaf7" xlink:to="loc_smmt_AtMarketOfferingMember_f6ca83ad-ed6d-47c3-9848-6fecc2e58c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RightsOfferingMember_a25017f9-3f50-4d33-a4d0-7d9388678d95" xlink:href="smmt-20251231.xsd#smmt_RightsOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cf96cbcb-1c30-46df-99cf-08ac24d2eaf7" xlink:to="loc_smmt_RightsOfferingMember_a25017f9-3f50-4d33-a4d0-7d9388678d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AkesoLicenseAgreementMember_c9ea5904-4fb4-487b-b18a-4f44700b6908" xlink:href="smmt-20251231.xsd#smmt_AkesoLicenseAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cf96cbcb-1c30-46df-99cf-08ac24d2eaf7" xlink:to="loc_smmt_AkesoLicenseAgreementMember_c9ea5904-4fb4-487b-b18a-4f44700b6908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_69c34961-d783-4ae7-ab47-ed2c40dac651" xlink:to="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_633d7c58-120b-4bd6-9935-542378a5035f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_633d7c58-120b-4bd6-9935-542378a5035f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cb46b84a-b646-4a00-9c8d-34c961c2a87e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_633d7c58-120b-4bd6-9935-542378a5035f" xlink:to="loc_us-gaap_NetIncomeLoss_cb46b84a-b646-4a00-9c8d-34c961c2a87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_633d7c58-120b-4bd6-9935-542378a5035f" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_InterestExpenseIncomeNoncash_963b7bbf-33b5-4d3b-b150-31c572120910" xlink:href="smmt-20251231.xsd#smmt_InterestExpenseIncomeNoncash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_smmt_InterestExpenseIncomeNoncash_963b7bbf-33b5-4d3b-b150-31c572120910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_90e49aab-ecde-4e7f-85e5-dac21f58ff6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_90e49aab-ecde-4e7f-85e5-dac21f58ff6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_80b48d7e-3871-4bdf-a894-a6aaa3ffa9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_80b48d7e-3871-4bdf-a894-a6aaa3ffa9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome_77a2e2c0-3fdb-455d-a5bd-392f6a6b4b34" xlink:href="smmt-20251231.xsd#smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome_77a2e2c0-3fdb-455d-a5bd-392f6a6b4b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_90cee13e-5a9d-4307-bf2b-3b8e8f4a2e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_90cee13e-5a9d-4307-bf2b-3b8e8f4a2e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_b9fbfc54-44c6-4d15-ae7c-66636054d38b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_us-gaap_Depreciation_b9fbfc54-44c6-4d15-ae7c-66636054d38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2fb51ef9-11fd-43ca-b213-2881d07e8da5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_us-gaap_ShareBasedCompensation_2fb51ef9-11fd-43ca-b213-2881d07e8da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_41c3a842-54f3-4481-be67-ec4c54b4d180" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_41c3a842-54f3-4481-be67-ec4c54b4d180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_7defc85f-b3bb-4dcb-b1bb-cf82cb169f88" xlink:href="smmt-20251231.xsd#smmt_AcquiredInProcessResearchAndDevelopmentExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_7defc85f-b3bb-4dcb-b1bb-cf82cb169f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79148334-cc78-4744-b3f8-f6a434363058" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f4e65df7-c298-4211-aa69-9aa7056904e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f4e65df7-c298-4211-aa69-9aa7056904e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e496b1c6-8159-49e2-95d8-8128dcdae02c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e496b1c6-8159-49e2-95d8-8128dcdae02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3e786722-a27d-42cf-b4c1-daac6f9047f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3e786722-a27d-42cf-b4c1-daac6f9047f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_136f938c-beeb-48ee-bdf5-3da4a12ccab9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_136f938c-beeb-48ee-bdf5-3da4a12ccab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_aa41e21a-a211-4614-8e1f-96d6097cb6e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_aa41e21a-a211-4614-8e1f-96d6097cb6e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_bfa45abd-e24a-4d49-bbbd-a5c505a5eaae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_bfa45abd-e24a-4d49-bbbd-a5c505a5eaae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet_4fa01063-083f-44a5-8718-5051d4e80d5f" xlink:href="smmt-20251231.xsd#smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_97904b2a-9103-4047-a7b4-623532d7bc31" xlink:to="loc_smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet_4fa01063-083f-44a5-8718-5051d4e80d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c6766698-435b-41f4-b981-5f6112098f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_633d7c58-120b-4bd6-9935-542378a5035f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c6766698-435b-41f4-b981-5f6112098f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5031ce16-6f9a-4ff0-9076-e36b62ac7bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5031ce16-6f9a-4ff0-9076-e36b62ac7bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_4f459730-9604-4696-85f6-f68480305c87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5031ce16-6f9a-4ff0-9076-e36b62ac7bdf" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_4f459730-9604-4696-85f6-f68480305c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_430a10bf-7ab1-45ac-bf35-e3afbe41df8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5031ce16-6f9a-4ff0-9076-e36b62ac7bdf" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_430a10bf-7ab1-45ac-bf35-e3afbe41df8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c9741f4a-4d5c-4081-8acf-73c3cee56884" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5031ce16-6f9a-4ff0-9076-e36b62ac7bdf" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c9741f4a-4d5c-4081-8acf-73c3cee56884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_27aa455e-31c1-4c4e-9e5b-0b8b04688b98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5031ce16-6f9a-4ff0-9076-e36b62ac7bdf" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_27aa455e-31c1-4c4e-9e5b-0b8b04688b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_PaymentsForCollaborativeArrangement_f2cd5bbf-4f94-4fdb-9c5d-252d4f53a7a0" xlink:href="smmt-20251231.xsd#smmt_PaymentsForCollaborativeArrangement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5031ce16-6f9a-4ff0-9076-e36b62ac7bdf" xlink:to="loc_smmt_PaymentsForCollaborativeArrangement_f2cd5bbf-4f94-4fdb-9c5d-252d4f53a7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5aa9d016-6613-440a-b460-df3a391d9b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5031ce16-6f9a-4ff0-9076-e36b62ac7bdf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5aa9d016-6613-440a-b460-df3a391d9b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_09ade157-8ee4-437b-b77e-99c758a2381c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_09ade157-8ee4-437b-b77e-99c758a2381c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f53cf7d9-8cc7-4072-af56-6da308c7a60d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f53cf7d9-8cc7-4072-af56-6da308c7a60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_60e0b3a9-0f02-4ee1-88a5-08db65958510" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_60e0b3a9-0f02-4ee1-88a5-08db65958510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3e4e2a58-cc59-451f-a073-2ff060e070df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3e4e2a58-cc59-451f-a073-2ff060e070df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_62e534b3-0e14-476b-828d-8be711a9fe12" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_62e534b3-0e14-476b-828d-8be711a9fe12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_520e86a1-5f0e-42d0-837a-dfe8a2bdec6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_520e86a1-5f0e-42d0-837a-dfe8a2bdec6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f4d1ab72-fcdf-4697-9cd8-909372e25e28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2765ae-ec77-4a88-b43d-6dda93260a4a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f4d1ab72-fcdf-4697-9cd8-909372e25e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1c20c0cf-db80-4a01-8ffb-fad05c1bec76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1c20c0cf-db80-4a01-8ffb-fad05c1bec76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_786f6c1d-39e2-470a-8d47-43b653e85fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_786f6c1d-39e2-470a-8d47-43b653e85fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_120c7f60-1fc0-41b4-b19e-89f98c99b0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_120c7f60-1fc0-41b4-b19e-89f98c99b0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e78382d0-fdff-4180-b0c1-43a553126046" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e78382d0-fdff-4180-b0c1-43a553126046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_a3e29343-7d67-4f0f-8649-9e037bddf624" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_a3e29343-7d67-4f0f-8649-9e037bddf624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_2bb09eed-d9cf-478d-8676-fb7e942f624d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a3e29343-7d67-4f0f-8649-9e037bddf624" xlink:to="loc_us-gaap_InterestPaidNet_2bb09eed-d9cf-478d-8676-fb7e942f624d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_c510e61c-6c11-4454-9f50-24f2e4af9ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a3e29343-7d67-4f0f-8649-9e037bddf624" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_c510e61c-6c11-4454-9f50-24f2e4af9ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_a93efb9d-5426-4c71-b094-7ecdad954a49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9cfe8d19-20a2-4d5d-8636-0f222f1a18d8" xlink:to="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_a93efb9d-5426-4c71-b094-7ecdad954a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_dccb3632-fba5-426b-99c8-2aa751d498e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_a93efb9d-5426-4c71-b094-7ecdad954a49" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_dccb3632-fba5-426b-99c8-2aa751d498e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d470c2ec-b4c0-4aed-87d4-3eef39d67aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_a93efb9d-5426-4c71-b094-7ecdad954a49" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d470c2ec-b4c0-4aed-87d4-3eef39d67aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_2fb2b505-6349-4034-b954-c30f6eb3489e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_a93efb9d-5426-4c71-b094-7ecdad954a49" xlink:to="loc_us-gaap_StockIssued1_2fb2b505-6349-4034-b954-c30f6eb3489e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/Organization" xlink:type="simple" xlink:href="smmt-20251231.xsd#Organization"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/Organization" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8bdf2f0a-a209-4387-9f10-ed530b51f4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3aae1384-d067-4d1b-b193-252ba02cbdb7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8bdf2f0a-a209-4387-9f10-ed530b51f4a4" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3aae1384-d067-4d1b-b193-252ba02cbdb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements" xlink:type="simple" xlink:href="smmt-20251231.xsd#SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f69ac0e4-f2bc-48ad-ba8e-5699629e0082" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_019b018e-7803-7bc9-bcca-15087b90adac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f69ac0e4-f2bc-48ad-ba8e-5699629e0082" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_019b018e-7803-7bc9-bcca-15087b90adac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/SegmentReporting" xlink:type="simple" xlink:href="smmt-20251231.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_774bba89-0e25-4ab8-b41b-a7eb27e7465e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_9e88f94a-b9b8-4f31-9be0-b9df8290d127" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_774bba89-0e25-4ab8-b41b-a7eb27e7465e" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_9e88f94a-b9b8-4f31-9be0-b9df8290d127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreement" xlink:type="simple" xlink:href="smmt-20251231.xsd#AkesoLicenseandCollaborationAgreement"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_30fc2ed7-2e5d-46de-8da7-00d85c58c237" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_e78542e8-d97d-4fc2-9023-bd420b415746" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_30fc2ed7-2e5d-46de-8da7-00d85c58c237" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_e78542e8-d97d-4fc2-9023-bd420b415746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/OtherIncomeNet" xlink:type="simple" xlink:href="smmt-20251231.xsd#OtherIncomeNet"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/OtherIncomeNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_9dbae209-3b0e-40e8-8e5c-2411181242ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_c90bab9a-7283-42cd-a5f8-a81188c12f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_9dbae209-3b0e-40e8-8e5c-2411181242ae" xlink:to="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_c90bab9a-7283-42cd-a5f8-a81188c12f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/IncomeTax" xlink:type="simple" xlink:href="smmt-20251231.xsd#IncomeTax"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/IncomeTax" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8a196546-bf98-48b5-9fae-fbe396ad8fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_c20d197b-b0c2-47f6-ad99-f9c532d69647" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8a196546-bf98-48b5-9fae-fbe396ad8fe8" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_c20d197b-b0c2-47f6-ad99-f9c532d69647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/NetLossperShare" xlink:type="simple" xlink:href="smmt-20251231.xsd#NetLossperShare"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/NetLossperShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3a17b07d-23e9-463c-baa8-825eb59c0f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_e748a1e9-22fa-48fc-9b8f-3c0714dbcfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3a17b07d-23e9-463c-baa8-825eb59c0f0b" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_e748a1e9-22fa-48fc-9b8f-3c0714dbcfbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/Goodwill" xlink:type="simple" xlink:href="smmt-20251231.xsd#Goodwill"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/Goodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e2c1261e-34f3-46a7-9464-45301890f1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_bdbf8d0c-6e0e-449a-acfa-e62d257fa265" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e2c1261e-34f3-46a7-9464-45301890f1fc" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_bdbf8d0c-6e0e-449a-acfa-e62d257fa265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestments" xlink:type="simple" xlink:href="smmt-20251231.xsd#FairValueMeasurementsandShortTermInvestments"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bda49b2c-d387-47bc-99bb-acb0a2a11cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_e7b54bfe-5053-4337-88a8-3e57178fd958" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bda49b2c-d387-47bc-99bb-acb0a2a11cd7" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_e7b54bfe-5053-4337-88a8-3e57178fd958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/ResearchandDevelopmentPrepaidExpensesandAccruedLiabilities" xlink:type="simple" xlink:href="smmt-20251231.xsd#ResearchandDevelopmentPrepaidExpensesandAccruedLiabilities"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/ResearchandDevelopmentPrepaidExpensesandAccruedLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_87a610ed-0e32-4869-bb87-d1cba626f18e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_5c3d72da-1638-438b-b20b-4c88833e6f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_87a610ed-0e32-4869-bb87-d1cba626f18e" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_5c3d72da-1638-438b-b20b-4c88833e6f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/Leases" xlink:type="simple" xlink:href="smmt-20251231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3bbc7673-4457-46ca-843b-764ab040e910" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_25deacd4-fd68-40a6-861f-06017f9b1087" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3bbc7673-4457-46ca-843b-764ab040e910" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_25deacd4-fd68-40a6-861f-06017f9b1087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/PromissoryNotePayabletoRelatedParties" xlink:type="simple" xlink:href="smmt-20251231.xsd#PromissoryNotePayabletoRelatedParties"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/PromissoryNotePayabletoRelatedParties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_a5e042be-98a5-428c-8426-6340ba46dba5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_bd712055-814b-4656-9e23-5e77c526cbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_a5e042be-98a5-428c-8426-6340ba46dba5" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_bd712055-814b-4656-9e23-5e77c526cbd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/StockholdersEquity" xlink:type="simple" xlink:href="smmt-20251231.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_020a84ef-5d20-4efb-890f-550b8c69cb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ca7ec6fe-fe0c-4b28-affa-3a90a84210fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_020a84ef-5d20-4efb-890f-550b8c69cb4d" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ca7ec6fe-fe0c-4b28-affa-3a90a84210fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="smmt-20251231.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7af071ad-f59d-4091-b409-e3ffa9884ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_59c71984-c928-43e8-b490-91b2b32a9efa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7af071ad-f59d-4091-b409-e3ffa9884ac2" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_59c71984-c928-43e8-b490-91b2b32a9efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="smmt-20251231.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_76c2a4d6-78e8-4748-8b57-76c4ec316a66" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_6fbb0433-0e81-4004-84b8-6dec718283c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_76c2a4d6-78e8-4748-8b57-76c4ec316a66" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_6fbb0433-0e81-4004-84b8-6dec718283c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="smmt-20251231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_eac4e2c5-6b19-4da3-9b3c-d680aea37517" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d93623c9-6414-4c90-ad99-5d27f4126909" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_eac4e2c5-6b19-4da3-9b3c-d680aea37517" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d93623c9-6414-4c90-ad99-5d27f4126909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="smmt-20251231.xsd#SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d86d3664-394b-424d-ac0d-c01c797e07fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d86d3664-394b-424d-ac0d-c01c797e07fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_019b0191-6c87-77eb-8a93-9111beebe5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_019b0191-6c87-77eb-8a93-9111beebe5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_d4f0a61b-b97c-4e08-befc-ae48100537e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_us-gaap_UseOfEstimates_d4f0a61b-b97c-4e08-befc-ae48100537e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_e4ae48f7-7f49-49bb-b554-b0536dcfa3b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_e4ae48f7-7f49-49bb-b554-b0536dcfa3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0587268d-4331-4949-9609-54893ef2b928" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0587268d-4331-4949-9609-54893ef2b928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_f28816c9-f672-450e-a47a-48876ba69f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_f28816c9-f672-450e-a47a-48876ba69f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_30074146-ba89-4e92-8b2b-3a0286c98a21" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_30074146-ba89-4e92-8b2b-3a0286c98a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_5ba2a78c-3c48-4586-a15b-1e40e19b5ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_5ba2a78c-3c48-4586-a15b-1e40e19b5ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock_5973e42e-761e-4701-bdfe-7e4666ba8acc" xlink:href="smmt-20251231.xsd#smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock_5973e42e-761e-4701-bdfe-7e4666ba8acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_440009c7-0a97-4aed-a827-de1d222103d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_440009c7-0a97-4aed-a827-de1d222103d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7609dc99-43dd-4943-b73d-4feded1554b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7609dc99-43dd-4943-b73d-4feded1554b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_5c5c6d52-d266-47e1-aec1-e7dcd9981b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_5c5c6d52-d266-47e1-aec1-e7dcd9981b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_96ed91b8-21d2-41d9-a791-90b840d3c363" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_96ed91b8-21d2-41d9-a791-90b840d3c363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_ee7e90fd-e844-4638-9c06-e78da6d8b18f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_ee7e90fd-e844-4638-9c06-e78da6d8b18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_18d90db2-d220-40a4-895d-3b2e9b03a090" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_18d90db2-d220-40a4-895d-3b2e9b03a090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_fa933913-68c8-4441-8728-a27748ff5280" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_fa933913-68c8-4441-8728-a27748ff5280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_30f58f48-cf40-4dae-8984-0b8f6afa6279" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_30f58f48-cf40-4dae-8984-0b8f6afa6279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_cae0a9db-1ee8-4b90-ae43-a64ddcb2226d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0873faa7-c73d-4854-89c5-5a7c90967b96" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_cae0a9db-1ee8-4b90-ae43-a64ddcb2226d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTables" xlink:type="simple" xlink:href="smmt-20251231.xsd#SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTables"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7c8f4214-9f74-4213-928d-741d7c1dd485" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_42f2ce26-cd26-4ee8-8b83-fa7f555905c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7c8f4214-9f74-4213-928d-741d7c1dd485" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_42f2ce26-cd26-4ee8-8b83-fa7f555905c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_4beb1acf-3da9-4f42-8fc9-dbe43bf73fad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7c8f4214-9f74-4213-928d-741d7c1dd485" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_4beb1acf-3da9-4f42-8fc9-dbe43bf73fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="smmt-20251231.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f1618c53-0c22-490f-b86b-4610dfc84de5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019b0217-a9a0-7e7a-9165-462f6c0f7d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f1618c53-0c22-490f-b86b-4610dfc84de5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019b0217-a9a0-7e7a-9165-462f6c0f7d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/OtherIncomeNetTables" xlink:type="simple" xlink:href="smmt-20251231.xsd#OtherIncomeNetTables"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/OtherIncomeNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_52ecc148-cb7b-43ed-aee1-63bb1b0d53c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_687f8c81-4cbe-42be-848b-817f73288cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_52ecc148-cb7b-43ed-aee1-63bb1b0d53c0" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_687f8c81-4cbe-42be-848b-817f73288cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/IncomeTaxTables" xlink:type="simple" xlink:href="smmt-20251231.xsd#IncomeTaxTables"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/IncomeTaxTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_dd6a7831-e569-4bc0-9054-d798a5992295" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_f9b60c74-ad12-4b6a-b3dd-96aae21df3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dd6a7831-e569-4bc0-9054-d798a5992295" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_f9b60c74-ad12-4b6a-b3dd-96aae21df3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_5ca64ebb-2ec9-4372-8fb5-8ddf94624555" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dd6a7831-e569-4bc0-9054-d798a5992295" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_5ca64ebb-2ec9-4372-8fb5-8ddf94624555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_ec2a75c8-59d0-4d35-b589-744419b7925a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dd6a7831-e569-4bc0-9054-d798a5992295" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_ec2a75c8-59d0-4d35-b589-744419b7925a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_a8fbebf3-39d4-4cbd-b505-9e24a5202dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dd6a7831-e569-4bc0-9054-d798a5992295" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_a8fbebf3-39d4-4cbd-b505-9e24a5202dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_2928b4ad-6f29-4ecb-a86d-d83d20b31e58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dd6a7831-e569-4bc0-9054-d798a5992295" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_2928b4ad-6f29-4ecb-a86d-d83d20b31e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/NetLossperShareTables" xlink:type="simple" xlink:href="smmt-20251231.xsd#NetLossperShareTables"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/NetLossperShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_868c2505-7ccb-4b81-885b-8f947a817106" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b40716de-a718-4268-bfb0-21a69105ecfe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_868c2505-7ccb-4b81-885b-8f947a817106" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b40716de-a718-4268-bfb0-21a69105ecfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_bb77afc2-c6e5-4dc9-b42e-993450a28df3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_868c2505-7ccb-4b81-885b-8f947a817106" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_bb77afc2-c6e5-4dc9-b42e-993450a28df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsTables" xlink:type="simple" xlink:href="smmt-20251231.xsd#FairValueMeasurementsandShortTermInvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f016a316-a7ee-4178-b036-c8e02ba28669" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_10db73f8-5c94-4c42-b923-5db21ce39dff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f016a316-a7ee-4178-b036-c8e02ba28669" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_10db73f8-5c94-4c42-b923-5db21ce39dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/LeasesTables" xlink:type="simple" xlink:href="smmt-20251231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f0119061-eb4d-4286-a03d-d28901c6435e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_103bf7e3-ac1e-4d47-9a7d-16cebb31a465" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f0119061-eb4d-4286-a03d-d28901c6435e" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_103bf7e3-ac1e-4d47-9a7d-16cebb31a465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_51fbeedd-89c5-41a3-bcb1-dfe4b137620c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f0119061-eb4d-4286-a03d-d28901c6435e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_51fbeedd-89c5-41a3-bcb1-dfe4b137620c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="smmt-20251231.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_53935be5-3e94-43ea-b674-6b23635535e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_00d6f97e-583e-44b1-8584-70b0dce95d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_53935be5-3e94-43ea-b674-6b23635535e0" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_00d6f97e-583e-44b1-8584-70b0dce95d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_59a6d0f6-cd89-4cba-82e2-f296255089ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_53935be5-3e94-43ea-b674-6b23635535e0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_59a6d0f6-cd89-4cba-82e2-f296255089ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_e8d52658-4728-47a2-9347-32486e29a5de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_53935be5-3e94-43ea-b674-6b23635535e0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_e8d52658-4728-47a2-9347-32486e29a5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/OrganizationDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#OrganizationDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/OrganizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0a561826-a3c7-4b17-bf2b-69552219f443" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_019c40ea-1035-7765-bcec-8ff30032aebf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0a561826-a3c7-4b17-bf2b-69552219f443" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_019c40ea-1035-7765-bcec-8ff30032aebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019c40ea-1035-770c-84c8-8bbbb65cfba9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019c40ea-1035-7765-bcec-8ff30032aebf" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019c40ea-1035-770c-84c8-8bbbb65cfba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c40ea-1035-72cd-b0d3-6a9678110a86" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019c40ea-1035-770c-84c8-8bbbb65cfba9" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c40ea-1035-72cd-b0d3-6a9678110a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_019c40ea-1035-705a-81df-a537a1faed8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c40ea-1035-72cd-b0d3-6a9678110a86" xlink:to="loc_us-gaap_PrivatePlacementMember_019c40ea-1035-705a-81df-a537a1faed8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DistributionAgreementMember_019c4431-b20b-7ad3-a06e-dde4f7d48249" xlink:href="smmt-20251231.xsd#smmt_DistributionAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c40ea-1035-72cd-b0d3-6a9678110a86" xlink:to="loc_smmt_DistributionAgreementMember_019c4431-b20b-7ad3-a06e-dde4f7d48249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_019c40ea-1035-7af2-8339-4f1eee3d0466" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019c40ea-1035-7765-bcec-8ff30032aebf" xlink:to="loc_us-gaap_ProductInformationLineItems_019c40ea-1035-7af2-8339-4f1eee3d0466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9266348f-91e3-480c-adb1-1053d3c95515" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019c40ea-1035-7af2-8339-4f1eee3d0466" xlink:to="loc_us-gaap_NetIncomeLoss_9266348f-91e3-480c-adb1-1053d3c95515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a67d78e9-fde2-4c04-a38e-28a74ab1ec39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019c40ea-1035-7af2-8339-4f1eee3d0466" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a67d78e9-fde2-4c04-a38e-28a74ab1ec39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_971904fa-02d7-4cbd-b752-73e1d436b6a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019c40ea-1035-7af2-8339-4f1eee3d0466" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_971904fa-02d7-4cbd-b752-73e1d436b6a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_125488e5-1ea2-4f79-973e-df222c20f4da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019c40ea-1035-7af2-8339-4f1eee3d0466" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_125488e5-1ea2-4f79-973e-df222c20f4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_307fa111-e3ca-4ae1-9ccc-f3e5327a6141" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019c40ea-1035-7af2-8339-4f1eee3d0466" xlink:to="loc_us-gaap_ShortTermInvestments_307fa111-e3ca-4ae1-9ccc-f3e5327a6141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019c40ea-1035-7ef4-aef4-61e26b66ccaf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019c40ea-1035-7af2-8339-4f1eee3d0466" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019c40ea-1035-7ef4-aef4-61e26b66ccaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7ca8b1f5-8889-48ee-8b1d-c3f5e6627671" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SignificantAccountingPoliciesTable_2450cbd5-9c17-446a-9ff5-34b87bd78c2c" xlink:href="smmt-20251231.xsd#smmt_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7ca8b1f5-8889-48ee-8b1d-c3f5e6627671" xlink:to="loc_smmt_SignificantAccountingPoliciesTable_2450cbd5-9c17-446a-9ff5-34b87bd78c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e66b1d4a-d40c-41d7-a101-ae75fcdc9a85" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_SignificantAccountingPoliciesTable_2450cbd5-9c17-446a-9ff5-34b87bd78c2c" xlink:to="loc_srt_RangeAxis_e66b1d4a-d40c-41d7-a101-ae75fcdc9a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3b0ad7ed-df54-4b28-aa01-9f629921a273" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e66b1d4a-d40c-41d7-a101-ae75fcdc9a85" xlink:to="loc_srt_RangeMember_3b0ad7ed-df54-4b28-aa01-9f629921a273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d6f1829c-20f4-4401-96c5-9cfe7cfaa8db" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3b0ad7ed-df54-4b28-aa01-9f629921a273" xlink:to="loc_srt_MinimumMember_d6f1829c-20f4-4401-96c5-9cfe7cfaa8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_40b5f83a-b472-4c9d-b7c6-be9fd949fcb1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3b0ad7ed-df54-4b28-aa01-9f629921a273" xlink:to="loc_srt_MaximumMember_40b5f83a-b472-4c9d-b7c6-be9fd949fcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SignificantAccountingPoliciesLineItems_f3a08cd3-f551-42fc-b11e-6a101381405f" xlink:href="smmt-20251231.xsd#smmt_SignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_SignificantAccountingPoliciesTable_2450cbd5-9c17-446a-9ff5-34b87bd78c2c" xlink:to="loc_smmt_SignificantAccountingPoliciesLineItems_f3a08cd3-f551-42fc-b11e-6a101381405f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_d1e4f593-97fb-432c-b296-24497a173585" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_SignificantAccountingPoliciesLineItems_f3a08cd3-f551-42fc-b11e-6a101381405f" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_d1e4f593-97fb-432c-b296-24497a173585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_87b36c66-62bb-4d25-a9dd-825a530cd3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_SignificantAccountingPoliciesLineItems_f3a08cd3-f551-42fc-b11e-6a101381405f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_87b36c66-62bb-4d25-a9dd-825a530cd3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_a2e33995-12e0-47db-b3f2-122fc93bd1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_SignificantAccountingPoliciesLineItems_f3a08cd3-f551-42fc-b11e-6a101381405f" xlink:to="loc_us-gaap_RestrictedCashCurrent_a2e33995-12e0-47db-b3f2-122fc93bd1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTotalCashCashEquivalentsandRestrictedCashBalancesDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTotalCashCashEquivalentsandRestrictedCashBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTotalCashCashEquivalentsandRestrictedCashBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2b1dc93e-c5d2-492c-8a28-c364a3f9ff1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_71e026a2-62f5-4a22-837f-7171f1bc6ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2b1dc93e-c5d2-492c-8a28-c364a3f9ff1c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_71e026a2-62f5-4a22-837f-7171f1bc6ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_25519d96-c809-4f5e-8846-2fc7f51cca26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2b1dc93e-c5d2-492c-8a28-c364a3f9ff1c" xlink:to="loc_us-gaap_RestrictedCashCurrent_25519d96-c809-4f5e-8846-2fc7f51cca26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cdd11c6a-ec22-447d-aa7a-a7d8528c6a99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2b1dc93e-c5d2-492c-8a28-c364a3f9ff1c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cdd11c6a-ec22-447d-aa7a-a7d8528c6a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#SegmentReportingSignificantExpenseoftheCODMFunctionDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_df7c7ee8-b586-47bb-be65-59b2d1aa817e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_684bf59c-4605-44a7-b252-408d7be32fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_df7c7ee8-b586-47bb-be65-59b2d1aa817e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_684bf59c-4605-44a7-b252-408d7be32fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6869e405-a8fb-4aa6-848f-d118405e5b11" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_684bf59c-4605-44a7-b252-408d7be32fdf" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6869e405-a8fb-4aa6-848f-d118405e5b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_944509a3-4556-433e-bccd-b45589907fff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6869e405-a8fb-4aa6-848f-d118405e5b11" xlink:to="loc_us-gaap_SegmentDomain_944509a3-4556-433e-bccd-b45589907fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ReportableSegmentMember_fde5533c-4125-43b9-b1cc-318cae771dd4" xlink:href="smmt-20251231.xsd#smmt_ReportableSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_944509a3-4556-433e-bccd-b45589907fff" xlink:to="loc_smmt_ReportableSegmentMember_fde5533c-4125-43b9-b1cc-318cae771dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_684bf59c-4605-44a7-b252-408d7be32fdf" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_9ac196ee-bb3f-48d4-82a7-9649b968b2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_9ac196ee-bb3f-48d4-82a7-9649b968b2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_8d78d064-69ce-4562-8a84-db225e1889b3" xlink:href="smmt-20251231.xsd#smmt_AcquiredInProcessResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_8d78d064-69ce-4562-8a84-db225e1889b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation_73a7eb7f-0d94-4123-9b34-f505927a1655" xlink:href="smmt-20251231.xsd#smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation_73a7eb7f-0d94-4123-9b34-f505927a1655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_d5166ed4-e802-4448-a8b0-b80b923a17df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_d5166ed4-e802-4448-a8b0-b80b923a17df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_2450acec-00bd-46ac-aee0-482b7bfe78ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_2450acec-00bd-46ac-aee0-482b7bfe78ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_c2f63699-fb7c-4952-9a2b-d9e98ab3d062" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_us-gaap_OperatingExpenses_c2f63699-fb7c-4952-9a2b-d9e98ab3d062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_728e58d3-3c9c-4273-a775-428d94b309fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_728e58d3-3c9c-4273-a775-428d94b309fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_7cbd804f-7239-4943-8bd7-2342f73e4aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_us-gaap_InterestExpenseNonoperating_7cbd804f-7239-4943-8bd7-2342f73e4aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4936bc25-10d8-4a74-ba24-e50c039c5970" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60bc7542-519c-409c-9dbf-55fdd120d46f" xlink:to="loc_us-gaap_NetIncomeLoss_4936bc25-10d8-4a74-ba24-e50c039c5970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#SegmentReportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_dc6eb393-7db1-456b-9fe2-0e90b35d991e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_594c4a0f-1a63-4377-8a2a-0b666ba14f77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_dc6eb393-7db1-456b-9fe2-0e90b35d991e" xlink:to="loc_us-gaap_NumberOfReportableSegments_594c4a0f-1a63-4377-8a2a-0b666ba14f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_1f1cacab-3b9b-4bc8-a04a-6a4ee679b972" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_dc6eb393-7db1-456b-9fe2-0e90b35d991e" xlink:to="loc_us-gaap_NumberOfOperatingSegments_1f1cacab-3b9b-4bc8-a04a-6a4ee679b972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#AkesoLicenseandCollaborationAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e33c45e5-0a12-4d4a-ac69-ee7295ae956e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_ecf0ab5f-d6ed-469f-a761-117c7741986a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e33c45e5-0a12-4d4a-ac69-ee7295ae956e" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_ecf0ab5f-d6ed-469f-a761-117c7741986a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_e768c6da-a04b-4500-b0a1-acf0a37e90f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_ecf0ab5f-d6ed-469f-a761-117c7741986a" xlink:to="loc_us-gaap_TypeOfArrangementAxis_e768c6da-a04b-4500-b0a1-acf0a37e90f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_016f955c-1620-4f38-9b7e-d92cd9597fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e768c6da-a04b-4500-b0a1-acf0a37e90f9" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_016f955c-1620-4f38-9b7e-d92cd9597fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_2544faba-8072-4276-bfae-3e6d4fc158e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_016f955c-1620-4f38-9b7e-d92cd9597fd8" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_2544faba-8072-4276-bfae-3e6d4fc158e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember_d86a09e5-0e16-4d73-a15f-f40eafe0d85b" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_2544faba-8072-4276-bfae-3e6d4fc158e1" xlink:to="loc_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember_d86a09e5-0e16-4d73-a15f-f40eafe0d85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember_582752f3-6de7-4246-8d45-4d28d8d905b5" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_2544faba-8072-4276-bfae-3e6d4fc158e1" xlink:to="loc_smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember_582752f3-6de7-4246-8d45-4d28d8d905b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_ecf0ab5f-d6ed-469f-a761-117c7741986a" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment_a9cbeda1-ddb0-445a-af26-0502c4d5f75d" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment_a9cbeda1-ddb0-445a-af26-0502c4d5f75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CashPaymentForCollaborativeArrangementUpfrontPayment_03cbf150-20d3-4c66-be56-7e624f661b21" xlink:href="smmt-20251231.xsd#smmt_CashPaymentForCollaborativeArrangementUpfrontPayment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CashPaymentForCollaborativeArrangementUpfrontPayment_03cbf150-20d3-4c66-be56-7e624f661b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash_22512b5e-413b-4f55-9875-4ff1c244e9f8" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash_22512b5e-413b-4f55-9875-4ff1c244e9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a2e3bf92-d6e7-4407-aa65-ee2a53f04e23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a2e3bf92-d6e7-4407-aa65-ee2a53f04e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares_76e17882-836b-47b3-a9e0-ce3643743434" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares_76e17882-836b-47b3-a9e0-ce3643743434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_PaymentsForCollaborativeArrangement_da4a7405-acb6-4ac2-a77d-0e0f064d0af6" xlink:href="smmt-20251231.xsd#smmt_PaymentsForCollaborativeArrangement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_PaymentsForCollaborativeArrangement_da4a7405-acb6-4ac2-a77d-0e0f064d0af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments_307775ff-e7bb-4992-85f0-003c582b019f" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments_307775ff-e7bb-4992-85f0-003c582b019f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_2c9c36e4-d23f-4fd6-b1ba-4be39d8c8c05" xlink:href="smmt-20251231.xsd#smmt_AcquiredInProcessResearchAndDevelopmentExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_AcquiredInProcessResearchAndDevelopmentExpense_2c9c36e4-d23f-4fd6-b1ba-4be39d8c8c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement_4b46e32b-1a8e-4fcb-b182-2b32b7218e93" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement_4b46e32b-1a8e-4fcb-b182-2b32b7218e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts_d5944610-8d24-4d0f-b571-ebbceb07a6d4" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts_d5944610-8d24-4d0f-b571-ebbceb07a6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments_e2dafca7-a0d0-4936-b04b-bc5586c4253c" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments_e2dafca7-a0d0-4936-b04b-bc5586c4253c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments_f5f2ebf6-35e0-47bd-a126-15edc8879c12" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments_f5f2ebf6-35e0-47bd-a126-15edc8879c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments_f20c2605-3e89-46ae-9380-d6e77acd72b2" xlink:href="smmt-20251231.xsd#smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_397e80a8-eedf-4814-b5f4-fafbe6b5c289" xlink:to="loc_smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments_f20c2605-3e89-46ae-9380-d6e77acd72b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/OtherIncomeNetDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#OtherIncomeNetDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/OtherIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_2c70efb3-49c8-43b4-8f8b-256f5c1c877d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_e348e3df-7e46-4405-90a0-644a9e576d62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_2c70efb3-49c8-43b4-8f8b-256f5c1c877d" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_e348e3df-7e46-4405-90a0-644a9e576d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_7d184223-b6dc-4005-8719-40d352d8b633" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_2c70efb3-49c8-43b4-8f8b-256f5c1c877d" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_7d184223-b6dc-4005-8719-40d352d8b633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome_29d768ca-ba49-4247-af26-b005efee7390" xlink:href="smmt-20251231.xsd#smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_2c70efb3-49c8-43b4-8f8b-256f5c1c877d" xlink:to="loc_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome_29d768ca-ba49-4247-af26-b005efee7390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_79657f32-8be4-45d3-9a42-60add067e99d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_2c70efb3-49c8-43b4-8f8b-256f5c1c877d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_79657f32-8be4-45d3-9a42-60add067e99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_07577662-6138-4001-a1cb-f22e9a1481e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_2c70efb3-49c8-43b4-8f8b-256f5c1c877d" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_07577662-6138-4001-a1cb-f22e9a1481e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/IncomeTaxNarrativeDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#IncomeTaxNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/IncomeTaxNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ab33a493-cd60-4e68-beee-c7a8f849ab8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_4e3873f6-9b6b-44c6-9f1f-49b12cf2fe55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ab33a493-cd60-4e68-beee-c7a8f849ab8c" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_4e3873f6-9b6b-44c6-9f1f-49b12cf2fe55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_019be574-82a1-7943-b9d6-ed23ea45ca4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_4e3873f6-9b6b-44c6-9f1f-49b12cf2fe55" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_019be574-82a1-7943-b9d6-ed23ea45ca4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_019be574-82a1-7ac4-b481-4257f506d10c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_019be574-82a1-7943-b9d6-ed23ea45ca4d" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_019be574-82a1-7ac4-b481-4257f506d10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_019be574-82a1-7224-b6e2-acec6365e640" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_019be574-82a1-7ac4-b481-4257f506d10c" xlink:to="loc_us-gaap_DomesticCountryMember_019be574-82a1-7224-b6e2-acec6365e640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_019be574-82a1-7893-8f89-fb68460295c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_019be574-82a1-7ac4-b481-4257f506d10c" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_019be574-82a1-7893-8f89-fb68460295c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_019be574-82a1-7dbe-8c74-8b8f41f21f58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_019be574-82a1-7ac4-b481-4257f506d10c" xlink:to="loc_us-gaap_ForeignCountryMember_019be574-82a1-7dbe-8c74-8b8f41f21f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_4e3873f6-9b6b-44c6-9f1f-49b12cf2fe55" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_019be574-14a6-7854-90b9-3e6f90ad1af0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_019be574-14a6-7854-90b9-3e6f90ad1af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_019be574-34e0-7c81-84ee-79f155e60a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_019be574-34e0-7c81-84ee-79f155e60a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_019be574-34e0-72a2-add5-c7b0e2c6e0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_019be574-34e0-72a2-add5-c7b0e2c6e0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_019be574-34e0-7ea8-ae0f-9ffcbb7e6686" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_019be574-34e0-7ea8-ae0f-9ffcbb7e6686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_019be574-34e0-7c6d-a54a-c5991d326a46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_019be574-34e0-7c6d-a54a-c5991d326a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_019be574-34e0-796f-988b-6aeedac3274d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_019be574-34e0-796f-988b-6aeedac3274d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_019be574-34e0-7830-8eb8-61479e8a571b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_019be574-34e0-7830-8eb8-61479e8a571b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_019be574-58eb-77f9-a2ec-5c7e780e20db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_019be574-58eb-77f9-a2ec-5c7e780e20db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_019be574-82a1-76d7-860c-79d50ba0d171" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_OperatingLossCarryforwards_019be574-82a1-76d7-860c-79d50ba0d171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_019be574-82a1-7e06-98c4-2ca330664c38" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_019be574-82a1-7e06-98c4-2ca330664c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_019be574-af74-7ff7-bd99-c76f1c56b9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_019be574-14a6-7659-a940-c67bd08b688f" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_019be574-af74-7ff7-bd99-c76f1c56b9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/IncomeTaxComponentsofLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#IncomeTaxComponentsofLossBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/IncomeTaxComponentsofLossBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a7d61324-5260-4725-ab01-2e0989009f00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_9a4fe4af-166e-491b-b904-11d4ebc56a07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a7d61324-5260-4725-ab01-2e0989009f00" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_9a4fe4af-166e-491b-b904-11d4ebc56a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_75dcb292-082f-42f7-af99-a0b88bdc188e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a7d61324-5260-4725-ab01-2e0989009f00" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_75dcb292-082f-42f7-af99-a0b88bdc188e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_109536e9-6c30-41a3-9787-db5ab0f73d79" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a7d61324-5260-4725-ab01-2e0989009f00" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_109536e9-6c30-41a3-9787-db5ab0f73d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ecbd420d-cc78-430c-b46e-aa66aa744074" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_c372c35b-58dc-4c03-ae24-22e90a9cb86c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ecbd420d-cc78-430c-b46e-aa66aa744074" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_c372c35b-58dc-4c03-ae24-22e90a9cb86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_fc1f6dd9-a04a-4a0b-a0a3-b04efce0e446" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_c372c35b-58dc-4c03-ae24-22e90a9cb86c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_fc1f6dd9-a04a-4a0b-a0a3-b04efce0e446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_644878cb-61a0-43cc-ac8b-e527ce0d632d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_c372c35b-58dc-4c03-ae24-22e90a9cb86c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_644878cb-61a0-43cc-ac8b-e527ce0d632d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_097a633c-acd8-4407-b547-45fa0f348fde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_c372c35b-58dc-4c03-ae24-22e90a9cb86c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_097a633c-acd8-4407-b547-45fa0f348fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment_57242752-0614-4f83-8446-a381401a6100" xlink:href="smmt-20251231.xsd#smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_c372c35b-58dc-4c03-ae24-22e90a9cb86c" xlink:to="loc_smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment_57242752-0614-4f83-8446-a381401a6100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_f3b45eb7-493b-4d6e-b28b-3ed3edda98fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_c372c35b-58dc-4c03-ae24-22e90a9cb86c" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_f3b45eb7-493b-4d6e-b28b-3ed3edda98fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_d84a60fb-cd51-4ffe-87ba-b23615cc38b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_c372c35b-58dc-4c03-ae24-22e90a9cb86c" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_d84a60fb-cd51-4ffe-87ba-b23615cc38b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_5f76f6d7-93bb-4def-9772-696516d561ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ecbd420d-cc78-430c-b46e-aa66aa744074" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_5f76f6d7-93bb-4def-9772-696516d561ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_8680c4af-09d5-4e39-8129-d2b5eb983a33" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_5f76f6d7-93bb-4def-9772-696516d561ef" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_8680c4af-09d5-4e39-8129-d2b5eb983a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_08df2676-7100-4117-8482-5730aefc25e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_5f76f6d7-93bb-4def-9772-696516d561ef" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_08df2676-7100-4117-8482-5730aefc25e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DeferredTaxAssetsLiabilities_2e5dea99-f093-4bb1-a3ce-53cedff0a335" xlink:href="smmt-20251231.xsd#smmt_DeferredTaxAssetsLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ecbd420d-cc78-430c-b46e-aa66aa744074" xlink:to="loc_smmt_DeferredTaxAssetsLiabilities_2e5dea99-f093-4bb1-a3ce-53cedff0a335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_cdeca3d9-faa0-4c60-8531-a3b181de21a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ecbd420d-cc78-430c-b46e-aa66aa744074" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_cdeca3d9-faa0-4c60-8531-a3b181de21a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_83471ef1-5471-4bbe-868b-7950942979de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ecbd420d-cc78-430c-b46e-aa66aa744074" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_83471ef1-5471-4bbe-868b-7950942979de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/IncomeTaxValuationAllowanceDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#IncomeTaxValuationAllowanceDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/IncomeTaxValuationAllowanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6995ab39-2f1d-4667-a5ca-205c4011d1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DeferredTaxAssetsValuationAllowanceRollForward_78d54314-63ba-4275-a9d5-de554a4da1e6" xlink:href="smmt-20251231.xsd#smmt_DeferredTaxAssetsValuationAllowanceRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6995ab39-2f1d-4667-a5ca-205c4011d1e4" xlink:to="loc_smmt_DeferredTaxAssetsValuationAllowanceRollForward_78d54314-63ba-4275-a9d5-de554a4da1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_b19a14f1-df76-41d8-82fe-2b13ef737c42" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_DeferredTaxAssetsValuationAllowanceRollForward_78d54314-63ba-4275-a9d5-de554a4da1e6" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_b19a14f1-df76-41d8-82fe-2b13ef737c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_10108cf9-cf05-4818-b714-593a866e9cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_DeferredTaxAssetsValuationAllowanceRollForward_78d54314-63ba-4275-a9d5-de554a4da1e6" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_10108cf9-cf05-4818-b714-593a866e9cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_dc3f6aa8-e208-46b7-9ebb-8067ebb26dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_DeferredTaxAssetsValuationAllowanceRollForward_78d54314-63ba-4275-a9d5-de554a4da1e6" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_dc3f6aa8-e208-46b7-9ebb-8067ebb26dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_becbfa1e-7ef5-40af-bd9e-7fcb835e8f34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTable_019bfb90-d414-71fa-9dd4-7956d042ad3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_becbfa1e-7ef5-40af-bd9e-7fcb835e8f34" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTable_019bfb90-d414-71fa-9dd4-7956d042ad3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_019bfb90-d414-7f06-afef-1d095264d6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTable_019bfb90-d414-71fa-9dd4-7956d042ad3c" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_019bfb90-d414-7f06-afef-1d095264d6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_019bfb90-d414-7309-8e2d-2f2b79edb500" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_019bfb90-d414-7f06-afef-1d095264d6fb" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_019bfb90-d414-7309-8e2d-2f2b79edb500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_KY_019bfb91-aaa1-7f97-b1eb-36b21ff5a403" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_KY"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_019bfb90-d414-7309-8e2d-2f2b79edb500" xlink:to="loc_country_KY_019bfb91-aaa1-7f97-b1eb-36b21ff5a403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignTaxJurisdictionOtherMember_019bfb92-7adf-7ded-bb89-337a7f67e8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignTaxJurisdictionOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_019bfb90-d414-7309-8e2d-2f2b79edb500" xlink:to="loc_us-gaap_ForeignTaxJurisdictionOtherMember_019bfb92-7adf-7ded-bb89-337a7f67e8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_019bfb90-d414-774d-a5f6-95b97a5bb036" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTable_019bfb90-d414-71fa-9dd4-7956d042ad3c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_019bfb90-d414-774d-a5f6-95b97a5bb036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_019bfb90-d414-774d-a5f6-95b97a5bb036" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019bfb95-f3c8-721e-b7ec-364a64ab899e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019bfb95-f3c8-721e-b7ec-364a64ab899e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_019bfb96-6569-79cd-93f9-c4041c6cb9c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_019bfb96-6569-79cd-93f9-c4041c6cb9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_019bfb96-cabf-7308-b073-ca4417b65e29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_019bfb96-cabf-7308-b073-ca4417b65e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_019bfb97-8778-7112-8085-247eb17a583c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_019bfb97-8778-7112-8085-247eb17a583c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_019bfb97-fb7f-7c6f-ad28-bf9ef8af01ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_019bfb97-8778-7112-8085-247eb17a583c" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_019bfb97-fb7f-7c6f-ad28-bf9ef8af01ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_019bfb98-6e3d-7df8-8b0d-45c375b785dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_019bfb97-8778-7112-8085-247eb17a583c" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_019bfb98-6e3d-7df8-8b0d-45c375b785dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract_019bfb98-ecee-7ee3-a4f2-008539baa361" xlink:href="smmt-20251231.xsd#smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:to="loc_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract_019bfb98-ecee-7ee3-a4f2-008539baa361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_019bfb9a-610e-735b-8ac1-ce0fe3f0f6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract_019bfb98-ecee-7ee3-a4f2-008539baa361" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_019bfb9a-610e-735b-8ac1-ce0fe3f0f6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_019bfb9b-8338-73f7-a4de-4c848cb102ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_019bfb9b-8338-73f7-a4de-4c848cb102ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019bfb9c-19f4-7217-b308-8476545497e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019bfb9c-19f4-7217-b308-8476545497e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019bfb9c-6744-72b0-bb82-9d0e18d46114" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019bfb95-8c5b-7109-acd0-fb7195711019" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019bfb9c-6744-72b0-bb82-9d0e18d46114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_019bfb90-d414-774d-a5f6-95b97a5bb036" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1c355700-baff-4851-8843-61a4ea0cd2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1c355700-baff-4851-8843-61a4ea0cd2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_019bfb84-c7ce-72c8-aa8f-209d0f1bbaad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_019bfb84-c7ce-72c8-aa8f-209d0f1bbaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_7ca12646-82b9-4ec4-9ff3-11f11c0892d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_7ca12646-82b9-4ec4-9ff3-11f11c0892d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract_019bfb87-2cef-77a8-bb02-cc011f576e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract_019bfb87-2cef-77a8-bb02-cc011f576e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_171ce48e-8b67-44c7-997f-5281f18c6b81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract_019bfb87-2cef-77a8-bb02-cc011f576e5d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_171ce48e-8b67-44c7-997f-5281f18c6b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_ade76101-6dbd-476a-ae99-bd6a59f33d08" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract_019bfb87-2cef-77a8-bb02-cc011f576e5d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_ade76101-6dbd-476a-ae99-bd6a59f33d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract_019bfb89-9b6c-7b32-9fa3-1845a25e6892" xlink:href="smmt-20251231.xsd#smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:to="loc_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract_019bfb89-9b6c-7b32-9fa3-1845a25e6892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_f72636ba-9ec4-4a8d-857c-ea5872cfb571" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract_019bfb89-9b6c-7b32-9fa3-1845a25e6892" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_f72636ba-9ec4-4a8d-857c-ea5872cfb571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_019bfb93-4364-7cbf-b7fa-0873c41fa2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_019bfb93-4364-7cbf-b7fa-0873c41fa2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_6b1df81e-7c9d-4ae5-b1d4-8182604200e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_6b1df81e-7c9d-4ae5-b1d4-8182604200e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c2f6b-3c16-7a33-a57f-8f125d45f58e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019bfb87-b15b-73c8-8f00-2db171b9f928" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c2f6b-3c16-7a33-a57f-8f125d45f58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/IncomeTaxReconciliationofUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#IncomeTaxReconciliationofUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/IncomeTaxReconciliationofUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4790957f-082a-4e6a-b13c-eb211e56cd5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_e2a2cda9-3e0d-4de9-8f2b-41bef451ca33" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4790957f-082a-4e6a-b13c-eb211e56cd5f" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_e2a2cda9-3e0d-4de9-8f2b-41bef451ca33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_bb453142-07df-468e-9528-d5bd44f8ab9a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_e2a2cda9-3e0d-4de9-8f2b-41bef451ca33" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_bb453142-07df-468e-9528-d5bd44f8ab9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c49c7033-2ecd-49b9-b711-44ebc5570aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_e2a2cda9-3e0d-4de9-8f2b-41bef451ca33" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c49c7033-2ecd-49b9-b711-44ebc5570aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5fd76358-e7bd-4c53-8489-2d5f822964c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_e2a2cda9-3e0d-4de9-8f2b-41bef451ca33" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5fd76358-e7bd-4c53-8489-2d5f822964c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_3d02d1e2-413d-466c-8f0f-fe9c5c1e7fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_e2a2cda9-3e0d-4de9-8f2b-41bef451ca33" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_3d02d1e2-413d-466c-8f0f-fe9c5c1e7fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/NetLossperShareComputationofNetLossperShareDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#NetLossperShareComputationofNetLossperShareDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/NetLossperShareComputationofNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4a104b8c-2cff-4838-b06d-de65ac6a7f09" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_06239292-938b-4951-9ff3-42a9549b87ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4a104b8c-2cff-4838-b06d-de65ac6a7f09" xlink:to="loc_us-gaap_NetIncomeLoss_06239292-938b-4951-9ff3-42a9549b87ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_20c992c9-249e-4b17-9529-cda36536c708" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4a104b8c-2cff-4838-b06d-de65ac6a7f09" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_20c992c9-249e-4b17-9529-cda36536c708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2116a892-185c-43fa-a3bb-3ff5a22d45a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4a104b8c-2cff-4838-b06d-de65ac6a7f09" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2116a892-185c-43fa-a3bb-3ff5a22d45a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_385ed6ba-1fd6-40af-85dc-7b72fc7b6a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4a104b8c-2cff-4838-b06d-de65ac6a7f09" xlink:to="loc_us-gaap_EarningsPerShareBasic_385ed6ba-1fd6-40af-85dc-7b72fc7b6a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_117d11ce-217e-4376-9a23-7e5b8b018013" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4a104b8c-2cff-4838-b06d-de65ac6a7f09" xlink:to="loc_us-gaap_EarningsPerShareDiluted_117d11ce-217e-4376-9a23-7e5b8b018013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/NetLossperShareNarrativeDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#NetLossperShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/NetLossperShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9177c888-1189-4099-bff7-5c906eb578b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_f636dd5a-4013-4ba3-814e-ef10838eb326" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9177c888-1189-4099-bff7-5c906eb578b1" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_f636dd5a-4013-4ba3-814e-ef10838eb326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_c2d474a9-1b18-4bd6-a40a-9cb9e5984bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_f636dd5a-4013-4ba3-814e-ef10838eb326" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_c2d474a9-1b18-4bd6-a40a-9cb9e5984bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_36297f1c-cde8-49a6-9486-452245133499" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_c2d474a9-1b18-4bd6-a40a-9cb9e5984bf0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_36297f1c-cde8-49a6-9486-452245133499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RightsOfferingMember_5327e07f-999e-4f1a-80f1-57b6d44c6659" xlink:href="smmt-20251231.xsd#smmt_RightsOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_36297f1c-cde8-49a6-9486-452245133499" xlink:to="loc_smmt_RightsOfferingMember_5327e07f-999e-4f1a-80f1-57b6d44c6659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_65a40557-c49a-465e-8150-1412e0e9f9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_f636dd5a-4013-4ba3-814e-ef10838eb326" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_65a40557-c49a-465e-8150-1412e0e9f9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_15ee8fb5-bb2d-475f-96be-4d7081430c00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_65a40557-c49a-465e-8150-1412e0e9f9c6" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_15ee8fb5-bb2d-475f-96be-4d7081430c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_7dab02e5-aaba-42ee-bf5f-e98af5c86b44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_65a40557-c49a-465e-8150-1412e0e9f9c6" xlink:to="loc_us-gaap_SharePrice_7dab02e5-aaba-42ee-bf5f-e98af5c86b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a5312d05-cfad-474e-b8b4-65c2eb5ffeaa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ee1d04f6-7637-4b01-9b22-b0fa4afe06d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a5312d05-cfad-474e-b8b4-65c2eb5ffeaa" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ee1d04f6-7637-4b01-9b22-b0fa4afe06d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c3b5d058-6615-4b23-b76f-7ede5a7972ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ee1d04f6-7637-4b01-9b22-b0fa4afe06d8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c3b5d058-6615-4b23-b76f-7ede5a7972ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11aa9624-2823-4565-92d9-a39951325bca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c3b5d058-6615-4b23-b76f-7ede5a7972ab" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11aa9624-2823-4565-92d9-a39951325bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_12e1f863-bc73-40d5-8df7-6aaccd4fa817" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11aa9624-2823-4565-92d9-a39951325bca" xlink:to="loc_us-gaap_EmployeeStockOptionMember_12e1f863-bc73-40d5-8df7-6aaccd4fa817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_f48df752-aec0-4073-ad65-b544e1f992da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11aa9624-2823-4565-92d9-a39951325bca" xlink:to="loc_us-gaap_WarrantMember_f48df752-aec0-4073-ad65-b544e1f992da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_ce02af01-9eb0-47e8-9fbe-caec97b3e546" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_11aa9624-2823-4565-92d9-a39951325bca" xlink:to="loc_us-gaap_EmployeeStockMember_ce02af01-9eb0-47e8-9fbe-caec97b3e546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_617d5b2d-be07-42a4-bf27-6c594a756814" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ee1d04f6-7637-4b01-9b22-b0fa4afe06d8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_617d5b2d-be07-42a4-bf27-6c594a756814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b59d97b5-2bff-4c36-847c-c46ea7d1ca02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_617d5b2d-be07-42a4-bf27-6c594a756814" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b59d97b5-2bff-4c36-847c-c46ea7d1ca02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/GoodwillDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#GoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/GoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4961e9a2-7e6b-445c-8429-47401b62487d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_781d74ee-6686-43d7-b61b-d25d94e5e8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4961e9a2-7e6b-445c-8429-47401b62487d" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_781d74ee-6686-43d7-b61b-d25d94e5e8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c9ec1390-6f14-46c5-9c59-f2dd6f37b5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4961e9a2-7e6b-445c-8429-47401b62487d" xlink:to="loc_us-gaap_Goodwill_c9ec1390-6f14-46c5-9c59-f2dd6f37b5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_4413287d-5d62-468d-87a8-f062be36ee3b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4961e9a2-7e6b-445c-8429-47401b62487d" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_4413287d-5d62-468d-87a8-f062be36ee3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ee90b2f8-4350-4ca6-b4ed-c3113f6009e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e868fc74-7bb7-4045-8572-69f3434d33b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ee90b2f8-4350-4ca6-b4ed-c3113f6009e1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e868fc74-7bb7-4045-8572-69f3434d33b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b2d338bc-b00a-4b9a-ae04-d420c7d54791" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e868fc74-7bb7-4045-8572-69f3434d33b6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b2d338bc-b00a-4b9a-ae04-d420c7d54791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ecc88577-b258-4a95-ae45-eabe01904c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b2d338bc-b00a-4b9a-ae04-d420c7d54791" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ecc88577-b258-4a95-ae45-eabe01904c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_749781db-c536-4f8e-9109-a6b61c1ed061" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ecc88577-b258-4a95-ae45-eabe01904c9c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_749781db-c536-4f8e-9109-a6b61c1ed061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_e090ed70-906c-4627-bd22-23bc2e7f97bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ecc88577-b258-4a95-ae45-eabe01904c9c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_e090ed70-906c-4627-bd22-23bc2e7f97bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_c91e58f4-4ded-497b-9d63-b7e654536b35" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e868fc74-7bb7-4045-8572-69f3434d33b6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_c91e58f4-4ded-497b-9d63-b7e654536b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d348bf55-6faa-42a7-b774-69aa0cfce1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_c91e58f4-4ded-497b-9d63-b7e654536b35" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d348bf55-6faa-42a7-b774-69aa0cfce1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_95697a3d-fd54-4370-bd6e-a6786f20722b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d348bf55-6faa-42a7-b774-69aa0cfce1eb" xlink:to="loc_us-gaap_MoneyMarketFundsMember_95697a3d-fd54-4370-bd6e-a6786f20722b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_019be57b-9d6d-749b-b955-f2d1107693cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d348bf55-6faa-42a7-b774-69aa0cfce1eb" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_019be57b-9d6d-749b-b955-f2d1107693cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e07b2ea3-13e0-4135-ab9b-3b0b05c30818" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e868fc74-7bb7-4045-8572-69f3434d33b6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e07b2ea3-13e0-4135-ab9b-3b0b05c30818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e9959b3-0764-4598-96d0-8a9d07cd339a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e07b2ea3-13e0-4135-ab9b-3b0b05c30818" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e9959b3-0764-4598-96d0-8a9d07cd339a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_019be579-d2de-752a-8717-b9bd302fa5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e9959b3-0764-4598-96d0-8a9d07cd339a" xlink:to="loc_us-gaap_CertificatesOfDepositMember_019be579-d2de-752a-8717-b9bd302fa5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_f3b0e239-6cf8-4c34-a845-b53fbd85c12a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e9959b3-0764-4598-96d0-8a9d07cd339a" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_f3b0e239-6cf8-4c34-a845-b53fbd85c12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ef144252-5045-405e-be39-f2133aa3fa74" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e868fc74-7bb7-4045-8572-69f3434d33b6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ef144252-5045-405e-be39-f2133aa3fa74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_3c98168d-0a35-4cd9-acf2-192499569d72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ef144252-5045-405e-be39-f2133aa3fa74" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_3c98168d-0a35-4cd9-acf2-192499569d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9a9f36f9-deec-4c83-bb10-ac83a1fa72a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ef144252-5045-405e-be39-f2133aa3fa74" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9a9f36f9-deec-4c83-bb10-ac83a1fa72a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_aad0033a-f0b5-46e0-9be0-70d586d9b3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ef144252-5045-405e-be39-f2133aa3fa74" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_aad0033a-f0b5-46e0-9be0-70d586d9b3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_6a25c757-18b3-4fab-b318-e5319c7287d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ef144252-5045-405e-be39-f2133aa3fa74" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_6a25c757-18b3-4fab-b318-e5319c7287d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_1334f2b7-e78f-4026-939b-34adf6e8fa93" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ef144252-5045-405e-be39-f2133aa3fa74" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_1334f2b7-e78f-4026-939b-34adf6e8fa93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsNarrativeDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#FairValueMeasurementsandShortTermInvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_92fd47ef-cf38-49fe-9c2d-0a345a1b61b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_4317b3bc-6e9c-441f-beef-34720987478c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_92fd47ef-cf38-49fe-9c2d-0a345a1b61b0" xlink:to="loc_us-gaap_Cash_4317b3bc-6e9c-441f-beef-34720987478c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/ResearchandDevelopmentPrepaidExpensesandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#ResearchandDevelopmentPrepaidExpensesandAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/ResearchandDevelopmentPrepaidExpensesandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_58b499a1-f1c2-44bc-b63a-4addf6fa6c82" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ResearchAndDevelopmentPrepaidExpensesCurrent_14f13f7c-5bdf-4b6a-8bf6-74b40be586d7" xlink:href="smmt-20251231.xsd#smmt_ResearchAndDevelopmentPrepaidExpensesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_58b499a1-f1c2-44bc-b63a-4addf6fa6c82" xlink:to="loc_smmt_ResearchAndDevelopmentPrepaidExpensesCurrent_14f13f7c-5bdf-4b6a-8bf6-74b40be586d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AccruedResearchAndDevelopmentCurrent_c8faec5c-4f17-4ba4-a776-3307c92095e0" xlink:href="smmt-20251231.xsd#smmt_AccruedResearchAndDevelopmentCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_58b499a1-f1c2-44bc-b63a-4addf6fa6c82" xlink:to="loc_smmt_AccruedResearchAndDevelopmentCurrent_c8faec5c-4f17-4ba4-a776-3307c92095e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_eeffd3e0-ac11-4ea7-990d-29b1ecce1b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_fe3661d4-81c4-4273-b1e7-faa7f03c03aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eeffd3e0-ac11-4ea7-990d-29b1ecce1b2d" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_fe3661d4-81c4-4273-b1e7-faa7f03c03aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_019be586-3864-7c84-aecc-57e7c036ad8a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_fe3661d4-81c4-4273-b1e7-faa7f03c03aa" xlink:to="loc_srt_StatementGeographicalAxis_019be586-3864-7c84-aecc-57e7c036ad8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019be586-3864-7913-9ade-57fc7a426c4d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_019be586-3864-7c84-aecc-57e7c036ad8a" xlink:to="loc_srt_SegmentGeographicalDomain_019be586-3864-7913-9ade-57fc7a426c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NewJerseyAndCaliforniaMember_019be586-3864-7d6a-8794-ac41719f6050" xlink:href="smmt-20251231.xsd#smmt_NewJerseyAndCaliforniaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_019be586-3864-7913-9ade-57fc7a426c4d" xlink:to="loc_smmt_NewJerseyAndCaliforniaMember_019be586-3864-7d6a-8794-ac41719f6050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_019be586-3864-7697-a444-d44525c14554" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_NewJerseyAndCaliforniaMember_019be586-3864-7d6a-8794-ac41719f6050" xlink:to="loc_stpr_CA_019be586-3864-7697-a444-d44525c14554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_019be586-3864-714f-8a8f-381be56d08b9" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_NJ"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_NewJerseyAndCaliforniaMember_019be586-3864-7d6a-8794-ac41719f6050" xlink:to="loc_stpr_NJ_019be586-3864-714f-8a8f-381be56d08b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_019be586-3864-7575-91d3-e8adff615670" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_FL"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_019be586-3864-7913-9ade-57fc7a426c4d" xlink:to="loc_stpr_FL_019be586-3864-7575-91d3-e8adff615670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_fe3661d4-81c4-4273-b1e7-faa7f03c03aa" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_019be586-3864-721f-ad88-441086c3cadf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_019be586-3864-721f-ad88-441086c3cadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019be586-3864-7a75-a886-6b2a18c55d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019be586-3864-7a75-a886-6b2a18c55d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_019be586-3864-7cb4-86c2-c2b5cd97d6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_019be586-3864-7cb4-86c2-c2b5cd97d6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019be586-3864-70a1-a6cc-8b8207f212ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019be586-3864-70a1-a6cc-8b8207f212ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_019be586-5645-731d-a512-44387ac583c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_019be586-5645-731d-a512-44387ac583c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_019be586-5645-7cf0-bfe4-a610b8b539e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_019be586-5645-7cf0-bfe4-a610b8b539e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_019be586-5645-7f44-9be8-64b3d5ce7577" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019be586-3864-7fe3-8255-05025dc9edce" xlink:to="loc_us-gaap_OperatingLeasePayments_019be586-5645-7f44-9be8-64b3d5ce7577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#LeasesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_127d3fef-6e5c-4c5e-ad78-e055b8f470bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_897f1cce-df74-4dc0-9c39-6538ed0dd47a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_127d3fef-6e5c-4c5e-ad78-e055b8f470bb" xlink:to="loc_us-gaap_LeaseCostAbstract_897f1cce-df74-4dc0-9c39-6538ed0dd47a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_14f33882-11b8-4781-acfd-7702906caa92" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_897f1cce-df74-4dc0-9c39-6538ed0dd47a" xlink:to="loc_us-gaap_OperatingLeaseCost_14f33882-11b8-4781-acfd-7702906caa92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_531e17a3-b2fd-4227-a15b-ddedf164c9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_897f1cce-df74-4dc0-9c39-6538ed0dd47a" xlink:to="loc_us-gaap_VariableLeaseCost_531e17a3-b2fd-4227-a15b-ddedf164c9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_daf31161-966f-47b9-a409-1e3805fb180c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_897f1cce-df74-4dc0-9c39-6538ed0dd47a" xlink:to="loc_us-gaap_LeaseCost_daf31161-966f-47b9-a409-1e3805fb180c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#LeasesFutureLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_54d0eed5-b2f9-4168-9517-c513df54873e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ed7941c4-a64e-47d5-8e78-be740f4937f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_54d0eed5-b2f9-4168-9517-c513df54873e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ed7941c4-a64e-47d5-8e78-be740f4937f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3dd2e6ba-5a03-4533-97ff-82650164db47" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_54d0eed5-b2f9-4168-9517-c513df54873e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3dd2e6ba-5a03-4533-97ff-82650164db47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_33c14289-44bb-4ab4-87f8-48990f824a55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_54d0eed5-b2f9-4168-9517-c513df54873e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_33c14289-44bb-4ab4-87f8-48990f824a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_45a68afe-d4a8-4ba3-a380-576ee2c6bd96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_54d0eed5-b2f9-4168-9517-c513df54873e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_45a68afe-d4a8-4ba3-a380-576ee2c6bd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_29287b6b-338e-4e4c-b54c-c94532602168" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_54d0eed5-b2f9-4168-9517-c513df54873e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_29287b6b-338e-4e4c-b54c-c94532602168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d1dc908e-9a37-418b-a23d-e7f2535bce53" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_54d0eed5-b2f9-4168-9517-c513df54873e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d1dc908e-9a37-418b-a23d-e7f2535bce53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7999c0a0-d342-4f91-bcc7-979fb1128773" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_54d0eed5-b2f9-4168-9517-c513df54873e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7999c0a0-d342-4f91-bcc7-979fb1128773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_afdc18fa-4eb9-4173-abc5-49d4645d2930" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_54d0eed5-b2f9-4168-9517-c513df54873e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_afdc18fa-4eb9-4173-abc5-49d4645d2930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_153d7d07-5ece-4d06-91fa-4a98e43af16a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_54d0eed5-b2f9-4168-9517-c513df54873e" xlink:to="loc_us-gaap_OperatingLeaseLiability_153d7d07-5ece-4d06-91fa-4a98e43af16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_67699061-9033-41c2-849f-3158660c9588" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_54d0eed5-b2f9-4168-9517-c513df54873e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_67699061-9033-41c2-849f-3158660c9588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2ce9523e-b244-4a4d-97e4-eec52c6b83df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_54d0eed5-b2f9-4168-9517-c513df54873e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2ce9523e-b244-4a4d-97e4-eec52c6b83df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#PromissoryNotePayabletoRelatedPartiesDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_a698a2cd-bf2b-4dc8-bc87-57842314bd0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_37c54476-77f0-4755-b0b2-446efb7766ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_a698a2cd-bf2b-4dc8-bc87-57842314bd0b" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_37c54476-77f0-4755-b0b2-446efb7766ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_a889fa34-9254-48c1-975c-8f4c496078ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_37c54476-77f0-4755-b0b2-446efb7766ee" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_a889fa34-9254-48c1-975c-8f4c496078ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_7089aabf-eaf5-4029-b745-1ee03fde2327" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_a889fa34-9254-48c1-975c-8f4c496078ef" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_7089aabf-eaf5-4029-b745-1ee03fde2327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotePurchaseAgreementMember_5cf743fd-4b5e-4187-9771-093279755bfe" xlink:href="smmt-20251231.xsd#smmt_NotePurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_7089aabf-eaf5-4029-b745-1ee03fde2327" xlink:to="loc_smmt_NotePurchaseAgreementMember_5cf743fd-4b5e-4187-9771-093279755bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DugganFebruaryNoteAndZanganehNoteMember_019b0200-eadc-7629-8596-3587c024e6c5" xlink:href="smmt-20251231.xsd#smmt_DugganFebruaryNoteAndZanganehNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_NotePurchaseAgreementMember_5cf743fd-4b5e-4187-9771-093279755bfe" xlink:to="loc_smmt_DugganFebruaryNoteAndZanganehNoteMember_019b0200-eadc-7629-8596-3587c024e6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DugganFebruaryNoteMember_7472985d-a37a-4949-a540-dfdb08ef762b" xlink:href="smmt-20251231.xsd#smmt_DugganFebruaryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_DugganFebruaryNoteAndZanganehNoteMember_019b0200-eadc-7629-8596-3587c024e6c5" xlink:to="loc_smmt_DugganFebruaryNoteMember_7472985d-a37a-4949-a540-dfdb08ef762b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ZanganehNoteMember_ba603965-f0ff-4aba-956d-361847354f72" xlink:href="smmt-20251231.xsd#smmt_ZanganehNoteMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_DugganFebruaryNoteAndZanganehNoteMember_019b0200-eadc-7629-8596-3587c024e6c5" xlink:to="loc_smmt_ZanganehNoteMember_ba603965-f0ff-4aba-956d-361847354f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DugganSeptemberNoteMember_7b491740-53c5-4ebc-9be1-0aa385a93fa7" xlink:href="smmt-20251231.xsd#smmt_DugganSeptemberNoteMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_7089aabf-eaf5-4029-b745-1ee03fde2327" xlink:to="loc_smmt_DugganSeptemberNoteMember_7b491740-53c5-4ebc-9be1-0aa385a93fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember_019bfb62-6e57-7171-b7a4-7759362dc7da" xlink:href="smmt-20251231.xsd#smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_7089aabf-eaf5-4029-b745-1ee03fde2327" xlink:to="loc_smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember_019bfb62-6e57-7171-b7a4-7759362dc7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RevisedDugganFebruaryNoteMember_6a87f212-51d3-4cae-97ee-aa392d2ce571" xlink:href="smmt-20251231.xsd#smmt_RevisedDugganFebruaryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember_019bfb62-6e57-7171-b7a4-7759362dc7da" xlink:to="loc_smmt_RevisedDugganFebruaryNoteMember_6a87f212-51d3-4cae-97ee-aa392d2ce571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RevisedDugganSeptemberNoteMember_019b0910-8978-7b0b-bacb-0b952ace8595" xlink:href="smmt-20251231.xsd#smmt_RevisedDugganSeptemberNoteMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember_019bfb62-6e57-7171-b7a4-7759362dc7da" xlink:to="loc_smmt_RevisedDugganSeptemberNoteMember_019b0910-8978-7b0b-bacb-0b952ace8595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_PromissoryNotesMember_dfb1b860-8aa7-4c31-bbdb-54a9a5caf036" xlink:href="smmt-20251231.xsd#smmt_PromissoryNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_7089aabf-eaf5-4029-b745-1ee03fde2327" xlink:to="loc_smmt_PromissoryNotesMember_dfb1b860-8aa7-4c31-bbdb-54a9a5caf036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_96ea8ee0-2c40-4a12-ab7d-3df4ccee756e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_37c54476-77f0-4755-b0b2-446efb7766ee" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_96ea8ee0-2c40-4a12-ab7d-3df4ccee756e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0bd645e5-d700-4948-bb87-fdcaefe8c2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_96ea8ee0-2c40-4a12-ab7d-3df4ccee756e" xlink:to="loc_us-gaap_RelatedPartyDomain_0bd645e5-d700-4948-bb87-fdcaefe8c2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember_7245b37a-765b-4baf-8fb2-cf6b756b9f15" xlink:href="smmt-20251231.xsd#smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_0bd645e5-d700-4948-bb87-fdcaefe8c2e1" xlink:to="loc_smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember_7245b37a-765b-4baf-8fb2-cf6b756b9f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_b95a5527-5d76-40ba-97f2-a6dcf84ac9c4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember_7245b37a-765b-4baf-8fb2-cf6b756b9f15" xlink:to="loc_srt_ChiefExecutiveOfficerMember_b95a5527-5d76-40ba-97f2-a6dcf84ac9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ChiefExecutiveOfficerAndPresidentMember_db60d0ff-8e5e-4e07-9af7-80241979af31" xlink:href="smmt-20251231.xsd#smmt_ChiefExecutiveOfficerAndPresidentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember_7245b37a-765b-4baf-8fb2-cf6b756b9f15" xlink:to="loc_smmt_ChiefExecutiveOfficerAndPresidentMember_db60d0ff-8e5e-4e07-9af7-80241979af31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_75dc1889-f18c-41e0-afec-59b90bc74811" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_0bd645e5-d700-4948-bb87-fdcaefe8c2e1" xlink:to="loc_us-gaap_RelatedPartyMember_75dc1889-f18c-41e0-afec-59b90bc74811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_VariableRatePeriodAxis_c1671e70-973d-4278-86e4-1f0977fdece8" xlink:href="smmt-20251231.xsd#smmt_VariableRatePeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_37c54476-77f0-4755-b0b2-446efb7766ee" xlink:to="loc_smmt_VariableRatePeriodAxis_c1671e70-973d-4278-86e4-1f0977fdece8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_VariableRatePeriodDomain_162fc59b-7d75-46f7-bd79-04f7c280e815" xlink:href="smmt-20251231.xsd#smmt_VariableRatePeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_VariableRatePeriodAxis_c1671e70-973d-4278-86e4-1f0977fdece8" xlink:to="loc_smmt_VariableRatePeriodDomain_162fc59b-7d75-46f7-bd79-04f7c280e815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_VariableRatePeriodOneMember_601578ca-99d8-4836-a215-c8ee3f106f1c" xlink:href="smmt-20251231.xsd#smmt_VariableRatePeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_VariableRatePeriodDomain_162fc59b-7d75-46f7-bd79-04f7c280e815" xlink:to="loc_smmt_VariableRatePeriodOneMember_601578ca-99d8-4836-a215-c8ee3f106f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_VariableRatePeriodTwoMember_d69a8406-d148-42dc-aa2e-f5914b90d790" xlink:href="smmt-20251231.xsd#smmt_VariableRatePeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_VariableRatePeriodDomain_162fc59b-7d75-46f7-bd79-04f7c280e815" xlink:to="loc_smmt_VariableRatePeriodTwoMember_d69a8406-d148-42dc-aa2e-f5914b90d790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_37c54476-77f0-4755-b0b2-446efb7766ee" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_019b0204-60e7-7a29-8106-ce7ca8c27a72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_us-gaap_NotesPayable_019b0204-60e7-7a29-8106-ce7ca8c27a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering_019b0204-60e7-767c-a363-4f9144df305e" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering_019b0204-60e7-767c-a363-4f9144df305e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering_019b0204-60e7-74cb-aeb2-b2a69620d19b" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering_019b0204-60e7-74cb-aeb2-b2a69620d19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold_019b0204-a123-756e-a7ec-eff2b3ad6f43" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold_019b0204-a123-756e-a7ec-eff2b3ad6f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartiesNewIssuances_019b0204-a123-74ef-9ccd-45363c60a763" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartiesNewIssuances"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_smmt_NotesPayableRelatedPartiesNewIssuances_019b0204-a123-74ef-9ccd-45363c60a763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_019b0204-bfaa-72d7-a656-b5ea2e1972e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_019b0204-bfaa-72d7-a656-b5ea2e1972e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_019b0205-1b56-72c0-8c2c-e50ca6dae0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_019b0205-1b56-72c0-8c2c-e50ca6dae0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator_019b0205-1b56-7e37-bda2-0175c10e1a61" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator_019b0205-1b56-7e37-bda2-0175c10e1a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice_019b0205-1b56-7b89-ba44-bd1e37ddbdb5" xlink:href="smmt-20251231.xsd#smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice_019b0205-1b56-7b89-ba44-bd1e37ddbdb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest_019b0205-1b56-7a2c-acd6-68038411c114" xlink:href="smmt-20251231.xsd#smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest_019b0205-1b56-7a2c-acd6-68038411c114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019b0205-1b56-7211-852b-50debebf4ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019b0205-1b56-7211-852b-50debebf4ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_019b0205-1b56-70fb-9c0a-aa842a438af3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_019b0205-1b56-70fb-9c0a-aa842a438af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_019b0205-40a5-77a4-b269-0d3083ee49bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_019b0205-40a5-77a4-b269-0d3083ee49bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_019b0205-6abd-768d-aaf3-d3faa28f4426" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_us-gaap_InterestPaidNet_019b0205-6abd-768d-aaf3-d3faa28f4426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_019b0205-6abd-7a65-9249-dc1ec33d0fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b0204-60e7-7ef0-8b3e-3accc3c3174e" xlink:to="loc_us-gaap_InterestExpenseDebt_019b0205-6abd-7a65-9249-dc1ec33d0fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#StockholdersEquityPreferredStockandCommonStockDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_360af166-1c79-413a-8b67-97f090e49ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_0b53d6bd-b6d4-4429-9219-1e00af98bdba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_360af166-1c79-413a-8b67-97f090e49ec5" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_0b53d6bd-b6d4-4429-9219-1e00af98bdba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6fc2bfeb-b4c3-4955-8415-91fddd7aa842" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_0b53d6bd-b6d4-4429-9219-1e00af98bdba" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6fc2bfeb-b4c3-4955-8415-91fddd7aa842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2e12ec36-77a3-40f9-87ff-207b2ae0d054" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6fc2bfeb-b4c3-4955-8415-91fddd7aa842" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2e12ec36-77a3-40f9-87ff-207b2ae0d054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RightsOfferingMember_ac0d93bd-9f5a-4a8b-bcbb-57bffee794f7" xlink:href="smmt-20251231.xsd#smmt_RightsOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2e12ec36-77a3-40f9-87ff-207b2ae0d054" xlink:to="loc_smmt_RightsOfferingMember_ac0d93bd-9f5a-4a8b-bcbb-57bffee794f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_S3RegistrationStatementMember_69e8763e-98a0-49b0-8502-15133e80e6b2" xlink:href="smmt-20251231.xsd#smmt_S3RegistrationStatementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2e12ec36-77a3-40f9-87ff-207b2ae0d054" xlink:to="loc_smmt_S3RegistrationStatementMember_69e8763e-98a0-49b0-8502-15133e80e6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_d2c81441-71e5-4d03-b72a-05b53dbce339" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2e12ec36-77a3-40f9-87ff-207b2ae0d054" xlink:to="loc_us-gaap_PrivatePlacementMember_d2c81441-71e5-4d03-b72a-05b53dbce339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9988b586-a13c-4a7d-9fe1-d5c953a9f2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_0b53d6bd-b6d4-4429-9219-1e00af98bdba" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9988b586-a13c-4a7d-9fe1-d5c953a9f2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_709470d4-bd12-4e1b-aa51-10831d40c717" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9988b586-a13c-4a7d-9fe1-d5c953a9f2c4" xlink:to="loc_us-gaap_RelatedPartyDomain_709470d4-bd12-4e1b-aa51-10831d40c717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_b568ca08-751b-4b75-a469-2b71bd8c5905" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_709470d4-bd12-4e1b-aa51-10831d40c717" xlink:to="loc_srt_ChiefExecutiveOfficerMember_b568ca08-751b-4b75-a469-2b71bd8c5905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_b469824c-40d0-4c25-bf0a-be362957b3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_709470d4-bd12-4e1b-aa51-10831d40c717" xlink:to="loc_us-gaap_RelatedPartyMember_b469824c-40d0-4c25-bf0a-be362957b3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ChiefExecutiveOfficerAndPresidentMember_3f133c29-ba36-4f50-aa22-e85c46e25b3a" xlink:href="smmt-20251231.xsd#smmt_ChiefExecutiveOfficerAndPresidentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_709470d4-bd12-4e1b-aa51-10831d40c717" xlink:to="loc_smmt_ChiefExecutiveOfficerAndPresidentMember_3f133c29-ba36-4f50-aa22-e85c46e25b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefOperatingOfficerMember_1d249b06-f9e9-48c8-92d2-b2b86f047ace" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefOperatingOfficerMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_709470d4-bd12-4e1b-aa51-10831d40c717" xlink:to="loc_srt_ChiefOperatingOfficerMember_1d249b06-f9e9-48c8-92d2-b2b86f047ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_a9771baf-8cf9-4a84-85fd-73e035ae9acf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_0b53d6bd-b6d4-4429-9219-1e00af98bdba" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_a9771baf-8cf9-4a84-85fd-73e035ae9acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_a12a05f5-be3d-4440-a58a-e403423e310b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_a9771baf-8cf9-4a84-85fd-73e035ae9acf" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_a12a05f5-be3d-4440-a58a-e403423e310b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DugganFebruaryNoteMember_6b211f2c-f0a3-46ae-ab39-b915ffa6b9b8" xlink:href="smmt-20251231.xsd#smmt_DugganFebruaryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_a12a05f5-be3d-4440-a58a-e403423e310b" xlink:to="loc_smmt_DugganFebruaryNoteMember_6b211f2c-f0a3-46ae-ab39-b915ffa6b9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_0b53d6bd-b6d4-4429-9219-1e00af98bdba" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_0bff06d9-b581-4028-a0da-1e21537a2f72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_0bff06d9-b581-4028-a0da-1e21537a2f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e2cee6b0-5743-4780-a440-73cbc2814a94" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e2cee6b0-5743-4780-a440-73cbc2814a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_9d233a71-e3cf-49c9-8a28-cb6b29b7f411" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_9d233a71-e3cf-49c9-8a28-cb6b29b7f411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_f27c23f7-dc60-4390-b2a2-c024f6150b82" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_PreferredStockSharesIssued_f27c23f7-dc60-4390-b2a2-c024f6150b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_75ce9a9a-fa60-4e67-afaa-d472aab52f20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_75ce9a9a-fa60-4e67-afaa-d472aab52f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_84085f0f-8925-4044-8dea-9faa4f43e6db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_84085f0f-8925-4044-8dea-9faa4f43e6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_1221ecbc-7de0-4493-a090-aa3f425f93a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_CommonStockSharesIssued_1221ecbc-7de0-4493-a090-aa3f425f93a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2a4ec6df-49c6-4b75-930a-78952d5f0cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2a4ec6df-49c6-4b75-930a-78952d5f0cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_4a178df3-b965-44b2-affc-c13f2d1aa464" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_4a178df3-b965-44b2-affc-c13f2d1aa464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6adacd27-41bb-432a-80dc-6136fd810215" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6adacd27-41bb-432a-80dc-6136fd810215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8317ce3b-b87d-4498-8166-79e9d3d26693" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8317ce3b-b87d-4498-8166-79e9d3d26693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_9adf96cb-2f80-431c-8754-1231e0b28d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_9adf96cb-2f80-431c-8754-1231e0b28d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_1d7eb4e6-5490-4b94-92aa-ec4058d50015" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_StockIssued1_1d7eb4e6-5490-4b94-92aa-ec4058d50015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_7784f0e2-d134-45f9-9553-26c78489bebf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayable"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_NotesPayable_7784f0e2-d134-45f9-9553-26c78489bebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CommonStockSharesAuthorizedIncreaseDecrease_69e21d79-0c7d-41cf-b587-715f34a6c481" xlink:href="smmt-20251231.xsd#smmt_CommonStockSharesAuthorizedIncreaseDecrease"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_smmt_CommonStockSharesAuthorizedIncreaseDecrease_69e21d79-0c7d-41cf-b587-715f34a6c481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SaleOfStockNumberOfSharesRegisteredForResale_7cf853a2-75e6-4208-a601-1c2744578881" xlink:href="smmt-20251231.xsd#smmt_SaleOfStockNumberOfSharesRegisteredForResale"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_smmt_SaleOfStockNumberOfSharesRegisteredForResale_7cf853a2-75e6-4208-a601-1c2744578881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_b98fb172-0a61-4a8f-982b-90c6a7baebfe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cda0ef38-f73d-4f1f-8bab-4bf696ee90a4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_b98fb172-0a61-4a8f-982b-90c6a7baebfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#StockholdersEquityPrivateInvestmentinPublicEquityDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b01c3e4e-198e-4174-8991-347e15babf38" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_6f35d5d3-f673-423f-9021-3ab40b2c5fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b01c3e4e-198e-4174-8991-347e15babf38" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_6f35d5d3-f673-423f-9021-3ab40b2c5fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_32762fdd-7790-44d1-86f8-986b651cf895" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_6f35d5d3-f673-423f-9021-3ab40b2c5fb5" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_32762fdd-7790-44d1-86f8-986b651cf895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_68a385a7-4de1-453b-94d6-ca13d492afc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_32762fdd-7790-44d1-86f8-986b651cf895" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_68a385a7-4de1-453b-94d6-ca13d492afc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_068deba9-6c8e-4dc8-8679-13ffd6bbba3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_68a385a7-4de1-453b-94d6-ca13d492afc2" xlink:to="loc_us-gaap_PrivatePlacementMember_068deba9-6c8e-4dc8-8679-13ffd6bbba3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0bc62d62-10a7-4111-82fc-de259698dac7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_6f35d5d3-f673-423f-9021-3ab40b2c5fb5" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0bc62d62-10a7-4111-82fc-de259698dac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_502525e6-d5b4-4af4-8c38-8b2a3da717c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0bc62d62-10a7-4111-82fc-de259698dac7" xlink:to="loc_us-gaap_RelatedPartyDomain_502525e6-d5b4-4af4-8c38-8b2a3da717c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_c0392f18-63c2-427d-a74a-72053ccaaec1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_502525e6-d5b4-4af4-8c38-8b2a3da717c5" xlink:to="loc_srt_AffiliatedEntityMember_c0392f18-63c2-427d-a74a-72053ccaaec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrelatedPartyMember_365a720c-6c0c-4a97-8a71-cd683a76a855" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonrelatedPartyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_502525e6-d5b4-4af4-8c38-8b2a3da717c5" xlink:to="loc_us-gaap_NonrelatedPartyMember_365a720c-6c0c-4a97-8a71-cd683a76a855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_019b03cb-b5ba-7474-93fc-555eea38dbad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_502525e6-d5b4-4af4-8c38-8b2a3da717c5" xlink:to="loc_us-gaap_RelatedPartyMember_019b03cb-b5ba-7474-93fc-555eea38dbad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_a725b59f-05d0-4b0d-9c58-050c8f1c2d25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_6f35d5d3-f673-423f-9021-3ab40b2c5fb5" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_a725b59f-05d0-4b0d-9c58-050c8f1c2d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_fc0ac8c4-108a-4885-a281-b925fc32e4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_a725b59f-05d0-4b0d-9c58-050c8f1c2d25" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_fc0ac8c4-108a-4885-a281-b925fc32e4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_2a8cace6-f8fb-49c8-a134-4b4c75dea1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_a725b59f-05d0-4b0d-9c58-050c8f1c2d25" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_2a8cace6-f8fb-49c8-a134-4b4c75dea1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_be3d5b2a-f646-4ba8-b0ae-7b8af51faef1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_a725b59f-05d0-4b0d-9c58-050c8f1c2d25" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_be3d5b2a-f646-4ba8-b0ae-7b8af51faef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_19b00f00-8b11-48eb-83ec-ecb3e66a25b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_a725b59f-05d0-4b0d-9c58-050c8f1c2d25" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_19b00f00-8b11-48eb-83ec-ecb3e66a25b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_35e31634-582d-409b-80a9-c7821d61708c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_a725b59f-05d0-4b0d-9c58-050c8f1c2d25" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_35e31634-582d-409b-80a9-c7821d61708c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_6c3e2e6b-375b-4760-9ab1-f00a25d5c829" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_a725b59f-05d0-4b0d-9c58-050c8f1c2d25" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_6c3e2e6b-375b-4760-9ab1-f00a25d5c829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#StockholdersEquityAttheMarketOfferingandWarrantsDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_826ac476-5186-4928-8c5e-0b2e1ed7f13f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_33017be8-4736-4303-890d-98c06815189a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_826ac476-5186-4928-8c5e-0b2e1ed7f13f" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_33017be8-4736-4303-890d-98c06815189a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6208f531-0a0c-4e32-879b-dd26b6373bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_33017be8-4736-4303-890d-98c06815189a" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6208f531-0a0c-4e32-879b-dd26b6373bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6a513fa5-5f2f-40dd-a4ab-462afa29b1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6208f531-0a0c-4e32-879b-dd26b6373bf4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6a513fa5-5f2f-40dd-a4ab-462afa29b1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_OriginalDistributionAgreementMember_7d53bcb5-60ac-4a56-b069-539e9de61d53" xlink:href="smmt-20251231.xsd#smmt_OriginalDistributionAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6a513fa5-5f2f-40dd-a4ab-462afa29b1bf" xlink:to="loc_smmt_OriginalDistributionAgreementMember_7d53bcb5-60ac-4a56-b069-539e9de61d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_DistributionAgreementMember_4e02de20-5593-4700-af5e-78a70e9ac74c" xlink:href="smmt-20251231.xsd#smmt_DistributionAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6a513fa5-5f2f-40dd-a4ab-462afa29b1bf" xlink:to="loc_smmt_DistributionAgreementMember_4e02de20-5593-4700-af5e-78a70e9ac74c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_33017be8-4736-4303-890d-98c06815189a" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_9f7922b7-7dae-41a4-84b3-165df25e443e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_9f7922b7-7dae-41a4-84b3-165df25e443e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SaleOfStockAggregateOfferingPrice_464ff90e-253f-47d5-8c6b-fbe43f660053" xlink:href="smmt-20251231.xsd#smmt_SaleOfStockAggregateOfferingPrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_smmt_SaleOfStockAggregateOfferingPrice_464ff90e-253f-47d5-8c6b-fbe43f660053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e3ad922d-7387-40bc-a606-487f4297c68c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e3ad922d-7387-40bc-a606-487f4297c68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_8d873908-7a33-4df1-b893-4f8aea9f0458" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_8d873908-7a33-4df1-b893-4f8aea9f0458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8030d4ff-6c84-4867-bdae-4858da612abd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8030d4ff-6c84-4867-bdae-4858da612abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_b24fd2e3-d227-45b1-85de-188758bddbff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_b24fd2e3-d227-45b1-85de-188758bddbff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SaleOfStockAmountRemainingUnderTheOffering_19085925-274a-4c96-9d37-388edab5c9fc" xlink:href="smmt-20251231.xsd#smmt_SaleOfStockAmountRemainingUnderTheOffering"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_smmt_SaleOfStockAmountRemainingUnderTheOffering_19085925-274a-4c96-9d37-388edab5c9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e58e5375-23ab-470b-bce6-7b551624c4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e58e5375-23ab-470b-bce6-7b551624c4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice_47961178-b1af-45f0-a165-c544e93540de" xlink:href="smmt-20251231.xsd#smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice_47961178-b1af-45f0-a165-c544e93540de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ClassOfWarrantOrRightExercisesInPeriod_019b01e1-26e6-71cc-958a-c4cafdd07eaf" xlink:href="smmt-20251231.xsd#smmt_ClassOfWarrantOrRightExercisesInPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_smmt_ClassOfWarrantOrRightExercisesInPeriod_019b01e1-26e6-71cc-958a-c4cafdd07eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_019b01e2-2ad7-7255-8b6d-20ae1184e4b0" xlink:href="smmt-20251231.xsd#smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_d62ffc07-9c65-4f60-bb2b-2e4539800ae9" xlink:to="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_019b01e2-2ad7-7255-8b6d-20ae1184e4b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0adb60ae-eeb1-4794-bc3b-1c14a33d1516" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019b01d6-d31d-75ae-813e-740a18dadc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0adb60ae-eeb1-4794-bc3b-1c14a33d1516" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019b01d6-d31d-75ae-813e-740a18dadc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019be58f-5426-789f-9ca2-271d41b35655" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019b01d6-d31d-75ae-813e-740a18dadc6f" xlink:to="loc_us-gaap_PlanNameAxis_019be58f-5426-789f-9ca2-271d41b35655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019be58f-5426-75bd-808c-00f8b4a5c406" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_019be58f-5426-789f-9ca2-271d41b35655" xlink:to="loc_us-gaap_PlanNameDomain_019be58f-5426-75bd-808c-00f8b4a5c406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_A2020StockIncentivePlanMember_019be58f-5426-71c3-b342-d245b009878e" xlink:href="smmt-20251231.xsd#smmt_A2020StockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019be58f-5426-75bd-808c-00f8b4a5c406" xlink:to="loc_smmt_A2020StockIncentivePlanMember_019be58f-5426-71c3-b342-d245b009878e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_A2020IncrementalPoolMember_019be58f-84dd-7f3e-9aa5-a0e01e721e4b" xlink:href="smmt-20251231.xsd#smmt_A2020IncrementalPoolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019be58f-5426-75bd-808c-00f8b4a5c406" xlink:to="loc_smmt_A2020IncrementalPoolMember_019be58f-84dd-7f3e-9aa5-a0e01e721e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_A2024InducementPoolMember_019be58f-84dd-7969-b8b4-c482fcd175ab" xlink:href="smmt-20251231.xsd#smmt_A2024InducementPoolMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019be58f-5426-75bd-808c-00f8b4a5c406" xlink:to="loc_smmt_A2024InducementPoolMember_019be58f-84dd-7969-b8b4-c482fcd175ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019be58f-a8d5-7852-9a6a-3fc8553798db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019b01d6-d31d-75ae-813e-740a18dadc6f" xlink:to="loc_us-gaap_AwardTypeAxis_019be58f-a8d5-7852-9a6a-3fc8553798db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019be58f-a8d5-79fb-be32-e6880cff8eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019be58f-a8d5-7852-9a6a-3fc8553798db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019be58f-a8d5-79fb-be32-e6880cff8eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_019be58f-a8d5-776e-a80d-81c01b029b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019be58f-a8d5-79fb-be32-e6880cff8eeb" xlink:to="loc_us-gaap_EmployeeStockMember_019be58f-a8d5-776e-a80d-81c01b029b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EmployeeStockOptionPerformanceBasedMember_019be590-19af-7bc1-8ad5-b68ab3cc5228" xlink:href="smmt-20251231.xsd#smmt_EmployeeStockOptionPerformanceBasedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019be58f-a8d5-79fb-be32-e6880cff8eeb" xlink:to="loc_smmt_EmployeeStockOptionPerformanceBasedMember_019be590-19af-7bc1-8ad5-b68ab3cc5228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EmployeeStockOptionTimeBasedMember_019c443b-94c1-791d-8161-97a5e96a59d3" xlink:href="smmt-20251231.xsd#smmt_EmployeeStockOptionTimeBasedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019be58f-a8d5-79fb-be32-e6880cff8eeb" xlink:to="loc_smmt_EmployeeStockOptionTimeBasedMember_019c443b-94c1-791d-8161-97a5e96a59d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019be58f-e2c8-7fc5-ba84-fd84fa962000" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019b01d6-d31d-75ae-813e-740a18dadc6f" xlink:to="loc_srt_RangeAxis_019be58f-e2c8-7fc5-ba84-fd84fa962000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019be58f-e2c8-7107-90da-8ae6420302c6" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019be58f-e2c8-7fc5-ba84-fd84fa962000" xlink:to="loc_srt_RangeMember_019be58f-e2c8-7107-90da-8ae6420302c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019be58f-e2c8-702a-a4b0-bad35f0b4464" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019be58f-e2c8-7107-90da-8ae6420302c6" xlink:to="loc_srt_MinimumMember_019be58f-e2c8-702a-a4b0-bad35f0b4464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019be58f-e2c8-7629-a8aa-eb50fc0d3657" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019be58f-e2c8-7107-90da-8ae6420302c6" xlink:to="loc_srt_MaximumMember_019be58f-e2c8-7629-a8aa-eb50fc0d3657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019b01d6-d31d-75ae-813e-740a18dadc6f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019be58f-5426-777f-9a92-e08917f4ceef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019be58f-5426-777f-9a92-e08917f4ceef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration_019be58f-5426-72c3-8cbc-74191faac15b" xlink:href="smmt-20251231.xsd#smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration_019be58f-5426-72c3-8cbc-74191faac15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan_019be58f-5426-738a-840b-c7073e46464e" xlink:href="smmt-20251231.xsd#smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan_019be58f-5426-738a-840b-c7073e46464e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_019be58f-5426-7c59-ad82-674ee417a3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_019be58f-5426-7c59-ad82-674ee417a3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019be58f-5426-7c99-9839-e52f2f2f5732" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019be58f-5426-7c99-9839-e52f2f2f5732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan_019be58f-84dd-79d9-97e4-0eca03578083" xlink:href="smmt-20251231.xsd#smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan_019be58f-84dd-79d9-97e4-0eca03578083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod_019be58f-a8d5-7be1-a98f-99436f004cd2" xlink:href="smmt-20251231.xsd#smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod_019be58f-a8d5-7be1-a98f-99436f004cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_019be58f-e2c8-762f-b378-2820a42b1f48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_019be58f-e2c8-762f-b378-2820a42b1f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_019be58f-e2c8-7bf9-b1fd-955eda3800ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_019be58f-e2c8-7bf9-b1fd-955eda3800ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_019be58f-e2c8-7326-a3f6-40a67a64dc70" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_019be58f-e2c8-7326-a3f6-40a67a64dc70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019be58f-e2c8-7665-8cc5-14e43ddd26dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019be58f-e2c8-7665-8cc5-14e43ddd26dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019be58f-e2c8-70ac-902e-7f7538fd83e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019be58f-e2c8-70ac-902e-7f7538fd83e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_019be590-19af-7584-b31f-f1c02e24f4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_019be590-19af-7584-b31f-f1c02e24f4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_019be590-19af-7cb4-a756-731e829ed1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_019be590-19af-7cb4-a756-731e829ed1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount_019be590-19af-7338-a76f-3bbe61b81540" xlink:href="smmt-20251231.xsd#smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount_019be590-19af-7338-a76f-3bbe61b81540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod_019be590-19af-78ac-b7b4-b4692975f2b8" xlink:href="smmt-20251231.xsd#smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod_019be590-19af-78ac-b7b4-b4692975f2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019c4436-d1b6-7440-bae6-a961a23259ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019c4436-d1b6-7440-bae6-a961a23259ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_019c40f1-9c4b-778e-99bb-9140cd46ec10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_019c40f1-9c4b-778e-99bb-9140cd46ec10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019be590-19af-7f0a-a882-5586266a46c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019be590-19af-7f0a-a882-5586266a46c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019be590-19af-7c42-bbde-d74a2ce5c570" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019be58f-5426-7f15-86b3-8e1b2228963f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019be590-19af-7c42-bbde-d74a2ce5c570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d6127b55-f9c5-492d-bf89-b225fb6e39b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb394730-451d-471c-ba78-f68f88a1a911" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d6127b55-f9c5-492d-bf89-b225fb6e39b1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb394730-451d-471c-ba78-f68f88a1a911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2b7e9db6-5617-4ecb-8a40-f7ac2f93041c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb394730-451d-471c-ba78-f68f88a1a911" xlink:to="loc_us-gaap_AwardTypeAxis_2b7e9db6-5617-4ecb-8a40-f7ac2f93041c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5eac9bba-a8b4-4348-9f8f-f58ddd9a7af2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2b7e9db6-5617-4ecb-8a40-f7ac2f93041c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5eac9bba-a8b4-4348-9f8f-f58ddd9a7af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019c4d59-46a1-79fe-9152-46276064e731" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5eac9bba-a8b4-4348-9f8f-f58ddd9a7af2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019c4d59-46a1-79fe-9152-46276064e731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EmployeeStockOptionTimeBasedMember_019c443d-e576-75eb-a4f2-39a7a1b2e993" xlink:href="smmt-20251231.xsd#smmt_EmployeeStockOptionTimeBasedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOptionMember_019c4d59-46a1-79fe-9152-46276064e731" xlink:to="loc_smmt_EmployeeStockOptionTimeBasedMember_019c443d-e576-75eb-a4f2-39a7a1b2e993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019c26f1-e0d9-756f-a08b-3ced21c680ec" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb394730-451d-471c-ba78-f68f88a1a911" xlink:to="loc_srt_RangeAxis_019c26f1-e0d9-756f-a08b-3ced21c680ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019c26f1-e0d9-7f31-ac1f-85041d5fd626" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019c26f1-e0d9-756f-a08b-3ced21c680ec" xlink:to="loc_srt_RangeMember_019c26f1-e0d9-7f31-ac1f-85041d5fd626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019c26f1-e0d9-712e-97dc-5d03c8883943" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019c26f1-e0d9-7f31-ac1f-85041d5fd626" xlink:to="loc_srt_MinimumMember_019c26f1-e0d9-712e-97dc-5d03c8883943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019c26f1-e0d9-7db9-b661-17a79a5ebefb" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019c26f1-e0d9-7f31-ac1f-85041d5fd626" xlink:to="loc_srt_MaximumMember_019c26f1-e0d9-7db9-b661-17a79a5ebefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c69d60e4-c5b3-4558-903c-f48a6c5a47f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb394730-451d-471c-ba78-f68f88a1a911" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c69d60e4-c5b3-4558-903c-f48a6c5a47f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_019c2f6e-6749-79d1-a59b-83cc5464937a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c69d60e4-c5b3-4558-903c-f48a6c5a47f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_019c2f6e-6749-79d1-a59b-83cc5464937a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_019c2f6f-45cd-7625-9fde-58f49783459e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c69d60e4-c5b3-4558-903c-f48a6c5a47f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_019c2f6f-45cd-7625-9fde-58f49783459e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_30524fac-9357-4e80-bd68-c9fc912d7ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c69d60e4-c5b3-4558-903c-f48a6c5a47f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_30524fac-9357-4e80-bd68-c9fc912d7ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4bb48605-def3-4a27-a959-a347a94c8ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c69d60e4-c5b3-4558-903c-f48a6c5a47f3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4bb48605-def3-4a27-a959-a347a94c8ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_6988c591-6aff-41bd-bd8f-95bef4613427" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c69d60e4-c5b3-4558-903c-f48a6c5a47f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_6988c591-6aff-41bd-bd8f-95bef4613427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_d2e74903-c84e-4810-baa6-5f0fb850309a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c69d60e4-c5b3-4558-903c-f48a6c5a47f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_d2e74903-c84e-4810-baa6-5f0fb850309a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#StockBasedCompensationStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b8b39ca4-6228-4393-b06b-8d17bd43d921" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3403429d-31b7-483d-9177-4d46b883ab73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b8b39ca4-6228-4393-b06b-8d17bd43d921" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3403429d-31b7-483d-9177-4d46b883ab73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0bca7ada-7f7a-4dea-b526-7f1f28e348ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3403429d-31b7-483d-9177-4d46b883ab73" xlink:to="loc_us-gaap_AwardTypeAxis_0bca7ada-7f7a-4dea-b526-7f1f28e348ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d7073ab-2e60-49b0-916f-ea218da001b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0bca7ada-7f7a-4dea-b526-7f1f28e348ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d7073ab-2e60-49b0-916f-ea218da001b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EmployeeStockOptionTimeBasedMember_019c443a-be06-79f9-be7a-5ea19a35db73" xlink:href="smmt-20251231.xsd#smmt_EmployeeStockOptionTimeBasedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d7073ab-2e60-49b0-916f-ea218da001b7" xlink:to="loc_smmt_EmployeeStockOptionTimeBasedMember_019c443a-be06-79f9-be7a-5ea19a35db73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EmployeeStockOptionPerformanceBasedMember_315f5f7d-3736-4a26-98b7-761b907cdf27" xlink:href="smmt-20251231.xsd#smmt_EmployeeStockOptionPerformanceBasedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d7073ab-2e60-49b0-916f-ea218da001b7" xlink:to="loc_smmt_EmployeeStockOptionPerformanceBasedMember_315f5f7d-3736-4a26-98b7-761b907cdf27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_692025e2-9fe0-46cd-965f-fbf513681e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3403429d-31b7-483d-9177-4d46b883ab73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_692025e2-9fe0-46cd-965f-fbf513681e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58e1a6d9-1ee2-4b41-9e17-8415faf21b13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_692025e2-9fe0-46cd-965f-fbf513681e5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58e1a6d9-1ee2-4b41-9e17-8415faf21b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a2614cb9-c785-485f-b286-dae0d971dccb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58e1a6d9-1ee2-4b41-9e17-8415faf21b13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a2614cb9-c785-485f-b286-dae0d971dccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4f32ae48-72dc-43aa-bef2-404a1fca5798" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58e1a6d9-1ee2-4b41-9e17-8415faf21b13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4f32ae48-72dc-43aa-bef2-404a1fca5798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_9aa013d3-523d-4052-b688-8bab3ef05d43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58e1a6d9-1ee2-4b41-9e17-8415faf21b13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_9aa013d3-523d-4052-b688-8bab3ef05d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5acd9bee-be9d-40f6-bb83-b4a41cc53c80" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58e1a6d9-1ee2-4b41-9e17-8415faf21b13" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5acd9bee-be9d-40f6-bb83-b4a41cc53c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_695b8f26-af34-41f6-8a67-4636b11c8565" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58e1a6d9-1ee2-4b41-9e17-8415faf21b13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_695b8f26-af34-41f6-8a67-4636b11c8565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5506c0c9-e3e2-4935-b886-08cb6ec3a4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_692025e2-9fe0-46cd-965f-fbf513681e5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5506c0c9-e3e2-4935-b886-08cb6ec3a4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e1a39eff-1544-44e2-8898-3e8ae922031f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5506c0c9-e3e2-4935-b886-08cb6ec3a4ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e1a39eff-1544-44e2-8898-3e8ae922031f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fd595489-ca4c-4a21-8245-6bb08e460f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5506c0c9-e3e2-4935-b886-08cb6ec3a4ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fd595489-ca4c-4a21-8245-6bb08e460f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_897c7dcc-0716-4cc2-9a23-7bbcba311261" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5506c0c9-e3e2-4935-b886-08cb6ec3a4ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_897c7dcc-0716-4cc2-9a23-7bbcba311261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_10810c41-0dd3-40fc-b8af-96f81c905b51" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5506c0c9-e3e2-4935-b886-08cb6ec3a4ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_10810c41-0dd3-40fc-b8af-96f81c905b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_44f9a2c6-774d-4c84-8faa-476808f4610e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5506c0c9-e3e2-4935-b886-08cb6ec3a4ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_44f9a2c6-774d-4c84-8faa-476808f4610e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_692025e2-9fe0-46cd-965f-fbf513681e5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_41183b6f-e684-4238-a412-7f03d06f778c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_41183b6f-e684-4238-a412-7f03d06f778c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d64fe22e-54ca-4f8e-b4eb-21aae4130815" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d64fe22e-54ca-4f8e-b4eb-21aae4130815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_959091c3-4407-4768-b3bc-2e6680f3e7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_959091c3-4407-4768-b3bc-2e6680f3e7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_cdd562cc-ebac-4b71-a7e0-bac07a8c73a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_cdd562cc-ebac-4b71-a7e0-bac07a8c73a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ee002dc1-ff33-49f9-a653-b240c2d9084b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ee002dc1-ff33-49f9-a653-b240c2d9084b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_189ddf82-28a5-4246-8eb8-e86c217ee82a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_189ddf82-28a5-4246-8eb8-e86c217ee82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_bde53f66-de50-4f33-bf10-d873ce149f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_bde53f66-de50-4f33-bf10-d873ce149f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ce82ab63-12e0-42b6-becf-5e63045115a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ce82ab63-12e0-42b6-becf-5e63045115a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_6b59f6eb-1451-42e0-8961-b45cf383d629" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_6b59f6eb-1451-42e0-8961-b45cf383d629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_86568391-efac-4db7-8a70-05ea941d0667" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_21ad73ce-f823-47dd-a56e-92815e7ee1c6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_86568391-efac-4db7-8a70-05ea941d0667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber_aecde3ab-a10b-46f2-b0b1-d3550150da5c" xlink:href="smmt-20251231.xsd#smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_692025e2-9fe0-46cd-965f-fbf513681e5d" xlink:to="loc_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber_aecde3ab-a10b-46f2-b0b1-d3550150da5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40e26e35-756b-4ba3-b01a-f4180931e92e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_44b10dec-2458-44ae-988c-7c5ac813719c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40e26e35-756b-4ba3-b01a-f4180931e92e" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_44b10dec-2458-44ae-988c-7c5ac813719c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_76ffedd0-80dd-4b83-b1c3-ab65f40689a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_44b10dec-2458-44ae-988c-7c5ac813719c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_76ffedd0-80dd-4b83-b1c3-ab65f40689a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_727ae78a-c2fc-4a39-8313-3a6340c9f191" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_76ffedd0-80dd-4b83-b1c3-ab65f40689a7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_727ae78a-c2fc-4a39-8313-3a6340c9f191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_44fc8018-d3bc-46ef-9d32-ed23f2643bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_727ae78a-c2fc-4a39-8313-3a6340c9f191" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_44fc8018-d3bc-46ef-9d32-ed23f2643bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_a153fab1-6d0a-4f10-820a-2656937a3a98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_727ae78a-c2fc-4a39-8313-3a6340c9f191" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_a153fab1-6d0a-4f10-820a-2656937a3a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0bc0dd6a-befd-4159-b33e-48ba5465d155" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_44b10dec-2458-44ae-988c-7c5ac813719c" xlink:to="loc_us-gaap_AwardTypeAxis_0bc0dd6a-befd-4159-b33e-48ba5465d155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ce81d84-faea-4b3a-9b27-9a5047126b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0bc0dd6a-befd-4159-b33e-48ba5465d155" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ce81d84-faea-4b3a-9b27-9a5047126b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EmployeeStockOptionTimeBasedMember_a29de4ff-9cbc-4d86-b5e7-d06ee18f8aa5" xlink:href="smmt-20251231.xsd#smmt_EmployeeStockOptionTimeBasedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ce81d84-faea-4b3a-9b27-9a5047126b3b" xlink:to="loc_smmt_EmployeeStockOptionTimeBasedMember_a29de4ff-9cbc-4d86-b5e7-d06ee18f8aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_EmployeeStockOptionPerformanceAndMarketBasedMember_6caef275-5e84-4679-b98f-8769279c7a45" xlink:href="smmt-20251231.xsd#smmt_EmployeeStockOptionPerformanceAndMarketBasedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ce81d84-faea-4b3a-9b27-9a5047126b3b" xlink:to="loc_smmt_EmployeeStockOptionPerformanceAndMarketBasedMember_6caef275-5e84-4679-b98f-8769279c7a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_2d9f173d-a50f-4a08-b89a-97707e8c16d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ce81d84-faea-4b3a-9b27-9a5047126b3b" xlink:to="loc_us-gaap_EmployeeStockMember_2d9f173d-a50f-4a08-b89a-97707e8c16d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3022b26e-42b4-4df0-bcb6-845bef5584c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_44b10dec-2458-44ae-988c-7c5ac813719c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3022b26e-42b4-4df0-bcb6-845bef5584c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4ff3d8c5-6295-424b-87cc-78a53ca19aae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3022b26e-42b4-4df0-bcb6-845bef5584c9" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4ff3d8c5-6295-424b-87cc-78a53ca19aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_94cd2e3c-08c7-4998-a81b-3410b0f5d2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_718fa32e-1fcd-4ec5-abb4-7837778f19ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_94cd2e3c-08c7-4998-a81b-3410b0f5d2d1" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_718fa32e-1fcd-4ec5-abb4-7837778f19ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_019be593-181e-7ec9-9be8-126035cf636d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_718fa32e-1fcd-4ec5-abb4-7837778f19ec" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_019be593-181e-7ec9-9be8-126035cf636d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_019be593-181e-7c1a-8d65-efa62ae588c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_019be593-181e-7ec9-9be8-126035cf636d" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_019be593-181e-7c1a-8d65-efa62ae588c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SubleaseAgreementFirstAndThirdAmendmentMember_019be593-181e-7047-9bd4-b16d8eeee655" xlink:href="smmt-20251231.xsd#smmt_SubleaseAgreementFirstAndThirdAmendmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019be593-181e-7c1a-8d65-efa62ae588c5" xlink:to="loc_smmt_SubleaseAgreementFirstAndThirdAmendmentMember_019be593-181e-7047-9bd4-b16d8eeee655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SubleaseAgreementFirstAmendmentMember_019be593-181e-7d64-a29a-6eb4a553600f" xlink:href="smmt-20251231.xsd#smmt_SubleaseAgreementFirstAmendmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_SubleaseAgreementFirstAndThirdAmendmentMember_019be593-181e-7047-9bd4-b16d8eeee655" xlink:to="loc_smmt_SubleaseAgreementFirstAmendmentMember_019be593-181e-7d64-a29a-6eb4a553600f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SubleaseAgreementThirdAmendmentMember_019be593-74d9-7989-b2f0-a4e8ab87c298" xlink:href="smmt-20251231.xsd#smmt_SubleaseAgreementThirdAmendmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_SubleaseAgreementFirstAndThirdAmendmentMember_019be593-181e-7047-9bd4-b16d8eeee655" xlink:to="loc_smmt_SubleaseAgreementThirdAmendmentMember_019be593-74d9-7989-b2f0-a4e8ab87c298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_SubleaseAgreementSecondAmendmentMember_019be593-4644-7a4d-a9f5-b7163e4d389b" xlink:href="smmt-20251231.xsd#smmt_SubleaseAgreementSecondAmendmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019be593-181e-7c1a-8d65-efa62ae588c5" xlink:to="loc_smmt_SubleaseAgreementSecondAmendmentMember_019be593-4644-7a4d-a9f5-b7163e4d389b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_GeniusSubleaseAgreementMember_019be593-74d9-7c3c-9668-bb0f7a198e22" xlink:href="smmt-20251231.xsd#smmt_GeniusSubleaseAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019be593-181e-7c1a-8d65-efa62ae588c5" xlink:to="loc_smmt_GeniusSubleaseAgreementMember_019be593-74d9-7c3c-9668-bb0f7a198e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_InvestmentsResearchSubleaseAgreementMember_019be593-74d9-726d-85c6-61d61284072f" xlink:href="smmt-20251231.xsd#smmt_InvestmentsResearchSubleaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_GeniusSubleaseAgreementMember_019be593-74d9-7c3c-9668-bb0f7a198e22" xlink:to="loc_smmt_InvestmentsResearchSubleaseAgreementMember_019be593-74d9-726d-85c6-61d61284072f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember_019be593-74d9-7a33-a22b-9004929bd041" xlink:href="smmt-20251231.xsd#smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_smmt_GeniusSubleaseAgreementMember_019be593-74d9-7c3c-9668-bb0f7a198e22" xlink:to="loc_smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember_019be593-74d9-7a33-a22b-9004929bd041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AkesoSupplyAgreementMember_019be593-96b3-7d56-a5ce-514ce1b71e93" xlink:href="smmt-20251231.xsd#smmt_AkesoSupplyAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019be593-181e-7c1a-8d65-efa62ae588c5" xlink:to="loc_smmt_AkesoSupplyAgreementMember_019be593-96b3-7d56-a5ce-514ce1b71e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ConsultingAgreementMember_019be593-c37c-7fbc-92a4-4ba5479c3e6e" xlink:href="smmt-20251231.xsd#smmt_ConsultingAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019be593-181e-7c1a-8d65-efa62ae588c5" xlink:to="loc_smmt_ConsultingAgreementMember_019be593-c37c-7fbc-92a4-4ba5479c3e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019be593-181e-75e3-909b-ec9ba9f01dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_718fa32e-1fcd-4ec5-abb4-7837778f19ec" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019be593-181e-75e3-909b-ec9ba9f01dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_019be593-181e-7936-b724-d0622ff8639b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019be593-181e-75e3-909b-ec9ba9f01dd4" xlink:to="loc_us-gaap_RelatedPartyDomain_019be593-181e-7936-b724-d0622ff8639b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_019be593-96b3-72a5-a80f-0a8b07771ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_019be593-181e-7936-b724-d0622ff8639b" xlink:to="loc_us-gaap_RelatedPartyMember_019be593-96b3-72a5-a80f-0a8b07771ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_019be593-181e-7508-9dc2-c2d11820a243" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyMember_019be593-96b3-72a5-a80f-0a8b07771ab9" xlink:to="loc_srt_AffiliatedEntityMember_019be593-181e-7508-9dc2-c2d11820a243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_CoChiefExecutiveOfficerMember_019be593-c37c-7493-bcd0-6d84e09dc8ab" xlink:href="smmt-20251231.xsd#smmt_CoChiefExecutiveOfficerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyMember_019be593-96b3-72a5-a80f-0a8b07771ab9" xlink:to="loc_smmt_CoChiefExecutiveOfficerMember_019be593-c37c-7493-bcd0-6d84e09dc8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember_019be593-c37c-7835-92d3-bf896c627cfa" xlink:href="smmt-20251231.xsd#smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyMember_019be593-96b3-72a5-a80f-0a8b07771ab9" xlink:to="loc_smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember_019be593-c37c-7835-92d3-bf896c627cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019be593-c37c-7f71-a4b8-c754579b413f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_718fa32e-1fcd-4ec5-abb4-7837778f19ec" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019be593-c37c-7f71-a4b8-c754579b413f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019be593-c37c-7958-87bf-3457a79ab942" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019be593-c37c-7f71-a4b8-c754579b413f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019be593-c37c-7958-87bf-3457a79ab942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_019be593-c37c-717d-be5e-41c0874d5cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019be593-c37c-7958-87bf-3457a79ab942" xlink:to="loc_us-gaap_PrivatePlacementMember_019be593-c37c-717d-be5e-41c0874d5cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_718fa32e-1fcd-4ec5-abb4-7837778f19ec" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_AreaOfPremisesSubleased_019be593-181e-7615-b8ae-2fe42faa7a15" xlink:href="smmt-20251231.xsd#smmt_AreaOfPremisesSubleased"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_AreaOfPremisesSubleased_019be593-181e-7615-b8ae-2fe42faa7a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RelatedPartyTransactionSubleaseExtensionTerm_019be593-181e-7466-ad1a-7d27e583fc6e" xlink:href="smmt-20251231.xsd#smmt_RelatedPartyTransactionSubleaseExtensionTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_RelatedPartyTransactionSubleaseExtensionTerm_019be593-181e-7466-ad1a-7d27e583fc6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_RelatedPartyTransactionPaymentsToRelatedParty_019be593-181e-7ed0-9b2e-9607ab4efc9d" xlink:href="smmt-20251231.xsd#smmt_RelatedPartyTransactionPaymentsToRelatedParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_RelatedPartyTransactionPaymentsToRelatedParty_019be593-181e-7ed0-9b2e-9607ab4efc9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_LessorOperatingLeaseNumberOfContracts_019be593-74d9-7563-b2f5-b7cf6fcc8944" xlink:href="smmt-20251231.xsd#smmt_LessorOperatingLeaseNumberOfContracts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_LessorOperatingLeaseNumberOfContracts_019be593-74d9-7563-b2f5-b7cf6fcc8944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_LessorOperatingLeaseAreaOfPremisesLeased_019be593-74d9-7b42-b275-c7c9690cd16e" xlink:href="smmt-20251231.xsd#smmt_LessorOperatingLeaseAreaOfPremisesLeased"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_LessorOperatingLeaseAreaOfPremisesLeased_019be593-74d9-7b42-b275-c7c9690cd16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseTermOfContract_019be593-74d9-74dc-b556-3f4acb4989f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LessorOperatingLeaseTermOfContract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_us-gaap_LessorOperatingLeaseTermOfContract_019be593-74d9-74dc-b556-3f4acb4989f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_019be593-74d9-762d-8246-d9b54f00d198" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_019be593-74d9-762d-8246-d9b54f00d198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_019be593-74d9-7848-9682-195a8a9d29c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_us-gaap_SubleaseIncome_019be593-74d9-7848-9682-195a8a9d29c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage_019be593-74d9-7078-8286-98cd8cd2dd75" xlink:href="smmt-20251231.xsd#smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage_019be593-74d9-7078-8286-98cd8cd2dd75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_019c52c2-5833-773c-ba60-4f595974228d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_019c52c2-5833-773c-ba60-4f595974228d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019be593-96b3-77e8-a10a-0592ac1d4cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019be593-96b3-77e8-a10a-0592ac1d4cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ClassOfWarrantOrRightExercisesInPeriod_019be593-c37c-7ca4-a3f7-42337093f7e3" xlink:href="smmt-20251231.xsd#smmt_ClassOfWarrantOrRightExercisesInPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_ClassOfWarrantOrRightExercisesInPeriod_019be593-c37c-7ca4-a3f7-42337093f7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019be593-c37c-7af5-bd47-a33459ab5d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019be593-c37c-7af5-bd47-a33459ab5d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice_019be593-c37c-7f65-a46a-80516e68df8b" xlink:href="smmt-20251231.xsd#smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice_019be593-c37c-7f65-a46a-80516e68df8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_019be593-c37c-75fb-93f8-b903fd4257b7" xlink:href="smmt-20251231.xsd#smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_019be593-c37c-75fb-93f8-b903fd4257b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_019be593-c37c-797c-a153-e35305f98e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LegalFees"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019be593-181e-75cf-9015-bb1073e95718" xlink:to="loc_us-gaap_LegalFees_019be593-c37c-797c-a153-e35305f98e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.summitplc.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="smmt-20251231.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.summitplc.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019c2fbf-07ae-7551-bad8-683676f9140e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_019c40f4-fc65-7dd4-80fe-e22691e9e858" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PurchaseObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019c2fbf-07ae-7551-bad8-683676f9140e" xlink:to="loc_us-gaap_PurchaseObligation_019c40f4-fc65-7dd4-80fe-e22691e9e858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid_019c40f4-fc65-7a01-bf53-164b44443fbe" xlink:href="smmt-20251231.xsd#smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019c2fbf-07ae-7551-bad8-683676f9140e" xlink:to="loc_smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid_019c40f4-fc65-7a01-bf53-164b44443fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_019c40f4-fc65-7798-a6c2-0559b805a286" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019c2fbf-07ae-7551-bad8-683676f9140e" xlink:to="loc_us-gaap_OtherCommitment_019c40f4-fc65-7798-a6c2-0559b805a286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ethicsemployeepolicybook001.jpg
<TEXT>
begin 644 ethicsemployeepolicybook001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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MMI7'8B*TPK5C;32O%-,EHJL.*B/%6F6H76J3,FBJQIA'-2,*95$B"G"@#BE
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M#3:7^$_6@8H-/!J+-.4T 3BE%1@T\&D $4PBI*0B@9&10*=BC%,0HIU-%.%
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MB2$FD5?89S_4USGQ@7=J.E?]<I/YBN:BN2MRKS.O$/VF&4GY%WX.+MT[5/\
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M@<5985 XYIDE60<9JLPJY(.*K,M,FQ#3E:D(I.E,1;C:IU-4T/I5A&I%%D'
M%/!J$-G%2 U(Q3332TTF@!CCBH&%3MR*A:F(B(P:3%.-)3$(*>*9WIPH ?WI
MQ^Z/QIHI_P# /QI ,--IQ%)0,A8<TVI'%1FJ) 4ZFBG#I2 *,4ZB@!!3Q]P_
M6F@4[^ _6@!I'%,(J2F&@&(#3U-,[4JF@"<&I%-0*:D!YH'<EIII10:!B4O6
MD-+0 N/D/UIA%2?\LS]:8:!#34$@J8FHY.E BE+527O5R7K5.;O5$,H35GR]
MZOS'K6?*>331G(J/U^E"GFD<X-,#<U1B]S3MVQ"#_M?TK5M7Z5BPG_1@<_\
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MLILO-1E?>K#+43+3$(IP:F5O<57[TY6H NJ3@5(#556X%2HU)@BQ^(I#]13
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MZY<*D$;1HV!&P.WI6IJMZD5U&IL[=R84.6!STZ=:QM;;&NW?^_\ T%6];/\
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M$D:KCCU^M>V:;J4>HZ6MS!(&1\$$?2MKWU.6SB[,L@T[--$K>OZ4X2GU'Y4
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M[4Y+?P#VJBO%63_Q[0_5OZ4#)A<-_=C_ .^!_A3O/?\ NQ?]\#_"JZFG9I6
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MB0LG2.7LWL??^==H#GI70K-71QM..C)Q,_J/^^5_PI?-?U7_ +Y'^%0@T[-
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MYZ-."BK".:C+8I6-0,2S8%9MFR0N-Q]J=PHXI"0/E6F2-M3%*]AB22[8"?\
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MVGYF/ %="; 3@R2D)"O5C_2LR^02#RH$\N ?PCJWUK1+JR9.^B-[3/&<=F1
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M2B.1%>733-C&V,?=0=!5/@FI7 SUJ/%;(BUA-BGL*:8U'84[I1UJD9L8J9/
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M***"*!##3G'^C+_OG^0I*>W_ !ZK_OG^0H%8ILM1,*L,*B851!5D7BGZ:O\
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ML1_IT?X_R-,-2V(_TV/\?Y&A[ MT>% 4X"@"G 5Z%S@ "G 4H%/ HN-(0"E
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MM0CEM;>\1PV277C.>M=U)!)$VY 6'H*JWQO)H&CCMRK'N6_^M35C.:;'Z7J
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M)7G^=5YK>(C_ %KY_P!S_P"O6O/?W"L"J6O0=;2+_P")J+^U)^\=I_X"1?\
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M@%(8]:=3<$=0>>E+0,,TTFE(I-I- FQA/%,.XU-LIP2D20!*DV]/I4FRGE"
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MJR \I_B*HQJK*QW'H*ZG2-7CU&/ ^2=1\R9_457U31V*R7%DH!'+1#C/N/\
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M#\J5AJ_<ZJU>*4;5N%//.%;W]JT L2I_K5P!Z&LCP1/Y^AWDLG+[1U[#!_\
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MIWMYDNHXW\K'+PVEE$ZNFM1*RG(98900?^^:Z[2[^RO%\IM2@,X'.V-P&QZ
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ML@^$+_!R"[\X_P!D41V7HR9[OU0R> 3>!+B,]W_]F%9$MP]A\.Y-Q^[( /\
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MC_Z$*??Y!V,R9!_PE\+?Y^X:KP+GQE,<]C@?\!%7I!_Q5D8QS_\ 8FH((_\
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M:L8P-4FD0ED.X9]#D<&M=E9G,U=W18ML>?<8[QI_Z#6=8Q[[N)F.%5ES[G/
M_.M"Q&Z23'),:?U']*IQ';=6T*\A9%W8[MD9_P /_P!=0MK(MKWKLKQ;[JT
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M>!L&UUY/4_I5CRKC> L8C7T7C\SU/XUDKK4>M6$MTYF5Q,JOO _ND CGH?\
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M?E0JA/WTK;F/2KLUL6PW3'%5WLVVE\!CV!K:>J)6]A@G7/SG!/0>U.+*KX)
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MU,JB6PXTW+4CDG.:KW09Y8QS]Q?Y5*R&IUAWS)Q_ O\ *N=S;-E32+VGQ>7
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MU8D*BMH:G/4T949B/2L:_A\J4D'Y7YK:<!B:J7T'FVYV_?7D5HXW1BI69BX
M)YR?:GY#?-'N4=#GGZU']TCCK4F1MJ#7<T;[37M_!HNQ/#)%->)MV$Y&$?((
M['VK$N_"&HKI+:T+BV%L(/.V[VW[<=,8QG\:T+B1E\*S(#\AO8SM]]CUO2W4
M%S\,YQ!*DABL=D@4\HP'(([5O2BI7OV.2O.4+6ZLY3PUH>IZW:R3VD]NB1R>
M61*[ DX![ ^M:6A?;K_5;C38)HUFMPQ9G8A3M8*<<>IK0^&!SHMY_P!?0_\
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M_P"*JS.I?Y<51>S9NQK2*;,I6(Y-1CS_ ,>%K_X__P#%5!)J$./^0?:?D_\
M\52R6H0_,<55E48XK6S1E:Y%<:I$N0--LS^#_P#Q58%]J<;/SI5B?KYG_P 7
M6K<1X'2LB:T>7+@?*M%VAJ"ZF[X=OK>.^M7?3K.)5E1F=5?*C/7[QZ5ZG=:]
MITFFR&.82>:CJBLC88^GZUY-IT.%7/6NF*XTZS'O)_,4E5:31E.E&33+0NX^
MGV*V_P#'O_BJ7[5%_P ^=O\ F_\ \55)#@T,>]8W9TI(LM>(#Q96_P#X_P#_
M !50R7\8ZV5M_P"/_P#Q50%N*KS-FJ38I)$SZA%_SX6O_C__ ,559]0BSQI]
MI_X__P#%56<\U&2*T1C)(F?4(P/^0=:?D_\ \56?=:A#@YTRS/X/_P#%5-(1
MMK*O&PC'%.[)L@TV^ADU#_D%6(QW ?/_ *%7?Z?<(=/+?8K< 2J-HW8Z'GK7
MG>@Q>9?,:]%LH]NF,,?\M%_D:AR9I&"+JW*+C_0[?_Q[_&GB_2-MPM80?^!?
MXU5J*4@#FL[LULC9^U6[_O%M("2.O.?YU!+=)_SZP?\ CW^-8D5\892#]QCS
M[>]6GFR,]C6T-3"=D3R7<>?^/2#_ ,>_QJ!KN//_ !Z6_P#X]_C5624U69SF
MM48-HT#>1_\ /G;_ /CW^-1?;H\X^Q6^/^!?XU09ZA9S6B1DVC2:^CQ_QY6_
M_CW^-9UWJ$9.W[#;'Z[_ /XJD+$K525552[G '4FJV)W+8N(CI#M]AML?:%&
MWY\?=;G[W6JZW4?_ $#[3\G_ /BJC@NEETJ12FU?M2!23_LMUIZQ'-'/V(]F
MT]29;B(\'3[7GV?_ .*J&6"),R1:;:$=QA^/I\U6(X3GI5Z.+CIBHD[HU@K&
M!)=Q"/(TVS/X/_\ %4EE>1F<.NG6BL#P0'X_\>K4OM-61&>( /W'K6=86Y5B
M&4@@\YKGFY(ZH*,CIK.6WNL>98VR2]FPV#^M:T 6(@-90K_WU_C6/:1=.*W;
M1MJ['&Y/U%8N1TQA8NQ2IC_CWB_7_&K2.AQ^XCY^O^-55A&-T9W+W]14\9YP
M:F[1IRIG2_;;8Q$AQ@\?=/6L)Y,\^5#_ -\4\'_1/^VG]*B>KG-LF$$B-I>/
M]1#_ -\57>7/_+"#_OBIRN::8AUJ+LTLBJSY!_T>W_[]U )F0_+! OTCJ^T6
M14#QD'I34F*R96>]?:5-O;G(Q_JZJM-_TZVW_?NK,D?-5G7%6I,AP1*US$(U
M'E6O Z;*IS3@@D6UJ0!G_5TR1,U0N(^O&#6BJ,R=-&;)='K]BLN?^F-:EE/G
M22WV6U'[T# BP.AK-E4GMS4L;R+ICJKD#S5X_ TX2LQ3A=6-6&<DC_1;4?\
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MDJ;R\4A2@1785&W%6&7'-5V% R)L&@ #M2E<4U<DXIV)N7)A_P 2ZU_WI/\
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MJ):D!J64/%+FFBB@8\4\5&#4BFDQ#J<.M(#2CK2*'CK3J8#3LTAV%I124 T
M24A-)G%,+<T) V/S4BU!NJ5&H8)DM%-S03Q4ED-P^%->=^,+[RHI,'MBNZOY
M=D3'VKR/QI=[G" \DYKJH1U/,QD^AS%S(6N 3W1#_P".BE0U!.V)E_ZYI_Z"
M*?&:[&<"6AH0'.*WM,_U@^M<];DYK?TXX<5RUMCMH'=:9PJUL)6)IC_*M;2'
MBO/9ZD=B84X-4>:=FI+)0:1N13,TN:8QA)%.E.<?[HICT.>1_NBD,:I[4_%0
MYPU2@Y%(I#7%1G@U*QJ,TAD;"JTHJTW2JTM(+E*;I5&1N:N3=ZI2#-4B60,U
M0.:D?BH2:9#(V&:DNQF?_@*_^@BF'K4\ZYF_X"O_ *"*:V)ZE=5IVVI .*7&
M*+C&;::14E,8T"(B.:8PXZ5*:C85:)(6&:C?@5/MXJ&3IBJ)*S#)XIO(-3A:
M8RT"999LV-O_ +S_ -*J3'BII"4M+?\ WG_]EJK*V10T)/0@1/,E ]ZZ73X0
MD8XK&L8=TF<=ZZ2V3""L)&D2RB\58'%,1:EQ4&@PCFG#BG8I!3*0X"GP-B85
M'FF[MK U0S9)&VLK4T!AC^K?TK0B<20@BJ>HG]PG_ OZ4#.2N&VR@5,J@*,5
M5O#F?BKL0S&*<61*)7E7BL^=>:U)Q@5GRUK$EF;(G6H1!DU;=<M4J182MXG/
M)&.\/SFE$9%7VC^;.*8R5%Q$$0VOFNKL+KS[#8W57 'N,&N:"XJ];L8[4D$\
M2#^1J)+F1<78[*SMQL\P^E6)B,56T2\BN+?RG(WCIGO5JY08^4UAMH=,7?4S
M9C520X%2W&\$\52=ZI#9%.>*JA<MBI97R:?;VS2$]1^%;15S&I*Q3QNGP&.>
MQ]#4P24G:ZX8?K6O;Z0 P<]:TC8H4Y4<=*V5,XW/F1S<:L 3C %(]G/=N"1M
M0=!71&Q4D$@<=L5,L 48P*IPON0I6,6'2-MFRD\>8#^AJ0:5'6YY8$!X'WA_
M(U&5'I35.(O:-&0VDQ$=,4U=+5#P>/2M<BDQ1[*(>UD9ATY",4]+!%'%7\"G
M)M# D<4>SB'M9&=]CVG*L0:D2(]&./<5HF%6&8SD5"5P<$8H]F@]HV5FM9%&
M0=P[5"3-$?NDU>Y7[IQFIPF5!8#-+V:'[5HHK='[-\R_Q]Q[4])%;H&JYY2^
M21@?>_I3!&!V%'LD'MY(:I#K@YQ[BF/;J>G'TJ8#%**ET(LN.)DBFT$JCCFJ
M[[U^\I'O6I3& YSC%9/#=C6.,[F.TOO49?-:SVT<G\(-5GT^)CR&_ XJ/J\C
M3ZW$S&-0N*U)-,A8?*S+^.:K-IA!XER/I2]C-"^L09EL12A2]LW;YQ_(U?.G
M;?XQ^5'V1EA(!7[P_K6L*,NIE4Q$;:&:(E7D\FDQGI5TVCD]5_6E%FW]X5U0
M@HG!4J2F]2LB5.BU.EH>[#\JF2V4=6/Y59"(5'-3H*E6",=L_6G^2"V00!06
MA@IPJ585'<GZU*JJO0"D.Y"JMC..**L]1CUJL?E)%2QIBU>1MT"GW/\ 2J(J
MQ"W[L ]R:!DV:6FBEH$.!JWIO_'_ !?C_(U4JWIO_'_%^/\ (TI;,J'Q(PE-
M2@U IJ53Q3.@G4U,IJNIJ934LI$ZFIDZU74U*K<U+*)P:>M0J:E!J6-$P-2
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M:C!IW% 7'@T]6J(&G T 3 T\&H0U/4TFAHF!IP-1@T[(J;%#LTN>*832YXH
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M[@* _M0!,*/K46XFCK0,D+#!I@HI12&+3J;3A0 8J[I7_(2B_'^1JG5S2O\
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M"B934@-0@T\&D!,*,4T&G@T":$^M&10:8300R4&I ]5@U/#YH$6 U.S4"FI
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M6.J2,W.Y&J>U2JE/5<5(H&:H@14J95QUIH(IP-)C0\4ZF!Q2[N:0Q<T4E.%
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MRJY9R02WD;- 8Y@2.#P>#2;=BHI<R/(@:>#40-/!KO,R4&G@U$#3Q28R8&G
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M+%.!I9(I(6VR*5--!KWXRC-<T7=$,>#3J8#3@:8#\TN:92@T@) :<#3 :44
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M -EIX^!^L]]4L!^#_P"%3]:H_P Q7U6KV/+Z4$CH2/QKU#_A1^L]M4L?R?\
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ML$1?]3C^5;MK\$]"CP;F_OYCW"E4!_0_SKTW%+6,L56?4U6%I+H<7;?"KPA
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MEYR@Q(H]U[_A7JT<9">DM&>;5PDX:QU1P-%*00<$8([&DKK.0**** "BBB@
MHHHH **** "BBB@ HHHH **** "K5MJ5[:']S<.H]"<C\C56BHG3A47+-70T
MVMCH[7Q9,I NH5<?WDX/Y5L6WB#3KC \[RV/:08KA**\JOD>$JZQ7*_+_(TC
M5DCTY'1P&5@P]0<TM>:PW,]NVZ&5T/\ LMBM2V\37\)Q(RS+Z,,?RKQZW#M:
M.M*2?X&JKKJ=HR*W50:C-M&>F1]*Q(/%EL^!/!)&>Y7#"M.#6=/N3B.Y3=Z-
MD']:X70S#"]))?>BU*,B0VI'W6!^M,,+C^'/TJX"&&001ZBEK2GG6*IZ2L_D
M/D10VD=0:,5?(!ZBF&-#U45W4\_C]N'W$N!4Q15DP*>F::;?T/YUVPSC"2WE
M;U0N1D(I:?Y#CT-(8W'5:ZX8S#S^&:^\FS&TM&#W%%;J2>S *6@44P%I:04M
M !3J;2B@!U%%%(!:44E+0 M**2EH&.%**2E%(!12BD%.% QPI:04H-(!PIPI
MHI10 ZEI!1FD,<*6FBG4 %+244K@+132R]V%-,L8_B%9RK4X_%)?>,?2BH3<
M1^IIIN5[ UA+'X:.\T*S+-+53[4>RBFFY<],"N>>;X6.SO\ (?*R[3JSC/*?
MXS32[GJQ_.N:>>4E\,6Q\II;E'4BFFXB'5Q6;U[T5S3SRH_ABD/E+YO(ATR?
MH*8;X?PQ_F:ITA95&6( ]S7-+-<5/X7;T0[%DWDAZ8%,-Q*>KG\.*SY=4L8/
M]9=1 ^F[/\JI2^)=-CZ2/)_N)_C27]H5]N9_>2Y16[-DNS=6)^II*YR7Q="/
M]5:R-_O$"J4WBN\;/E111_7FM89-CJFKC;U9+JQ.PH) ZD"N!EUW4I>MTRCT
M4 ?RJG)<SRG,DTC?5B:[*?#E5_'-(AUUT1Z#-J%G!_K;F)3Z%A5&7Q)IL?W9
M7D/^PG^-</17=3X<H+XY-_@2Z[Z'5S>+HAD0VKM[NV*H2^*K]_N+%&/9<UAT
M5WT\GP=/:%_74AU9/J7Y=:U&;[UW(!_LG;_*J;S2RG,DCN?]IB:917;"A2I_
M!%+Y$-MA1116H@HHHH **** "BM#3M"U75W"Z?I]Q<'U1,C\^E=?IWP@\3WN
MUKA;:R0]?-DW-^2Y_G6<JT(?$S2-*<OA1P%%>V:;\$;"+#ZEJ<TY[I"@1?S.
M3_*NPT[X>^%M,P8=(@=Q_%/F0_\ CV:YIXZFMM3HC@JCWT/FVRTR^U&01V5G
M/</Z11EOY5U>G_"KQ7?%2UDEJI[W$@&/P&3^E?145O# @2&)(U' "* !^52"
MN>6/F_A1T1P,%\3/'=-^!QW!]3U?CO';1_\ LS?X5UEA\*?"EC@O8O=./XIY
M2?T&!^E=O17-+$59;R.B.'IQV10LM%TS35 LM.M;;'_/*)5/Y@5=Q[4ZBL6[
M[FMDA,4M%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC6]BAZAVWN/P7C]:SG6IPW9I&C.6R//*.M>Y:;\$](AVMJ&H75TPZK&!&O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DQ2T4 )BC;2T4 07%G
M;72[;BWBF7TD0-_.L>Y\$>&+O)FT.R)/4K$%/YC%;]%-2:V9+BGNCB+KX3^$
MKG)6QDA)[Q3,/YYK&N/@CHCY^SZE?Q^F_8X_D*]0HK18BJMI$.A3>\3QN;X&
M'_EAKH^CV_\ @U9TWP1UE#^YU.RD'^T'4_R->Z8HQ6BQE9=3-X2D^A\^R_!O
MQ0GW#92?28C^8JG+\*/&$><:;&X]5N8_ZFOH_%)BK^O5?(AX*F?,DWP[\60_
M>T6X/^X5;^1JJ_@KQ/'][0KX?]L2:^I:7%4L?4[(EX&'<^4F\+:^GWM%U ?]
MN[?X5&?#FN#KH^H?^ S_ .%?6-%/^T)]A?4(]SY*.AZN#_R"[W_P'?\ PH_L
M/5_^@7>_^ [_ .%?6M%/^T)?RA]07\Q\EC0M7)P-*OB?^O=_\*>/#FN'IHVH
M?^ S_P"%?6.*,4?VA+I$%@(]6?**^%M??IHNH'_MW;_"IT\%^)G^[H5_ST_<
MD5]3TF*7]H3[#^HP[GS%'\/?%DIPNB7(_P!X!?YFKD7PL\82C_D%!?\ >N(Q
M_P"S5](XHQ4O'U.R&L#3[L^>8_@_XK?&Z*TC_P!Z<'^0-78O@KX@?'F7EA'_
M ,#8_P#LM>\XI<5+QU4I8*D>)P_ V^/^OUJW3_<A9OYD5H0_ VU'^OUN8_[D
M '\R:];Q2U#Q=9]2UA:2Z'FMO\%/#T9!FO-0F]MZJ#^2Y_6M:#X5>$8,9TYI
M<?\ /29S_6NTHJ'7J/>3+5&FMD<_!X&\+VV/+T*QR.[Q!C^9S6I;Z586@Q;V
M5M#_ -<XE7^0JY14.4GNRU%+9#=HI<4M%24&*3%+10 F*6BB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ***Q/$WBK2_"E@+K493N?(BA09>0^P_J>
M*<8N3LA2DHJ[-NBO"]2^-NL32L-.T^TMHNQEW2/^>0/TJO:?&GQ'#(#<V]A<
M1]U\MD/X$'^E=7U*K:YS?7*5['OE%<=X.^(NE^+G^RK&]IJ 7<;>0Y# =2K=
M_P!#78US3A*#M)'1"<9J\6%%%%24%%%% !1110 4444 %%%% !1110 4444
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M8-9UC4?$VLO>WCM-<S-M1%!(49X11Z>U>L_''4'CTS2M.5L+/*\SCUV  ?\
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M_2O=/#GB*P\3Z1'J-@Y*-\KHWWHV[J?>LZV'G2U>QI2Q$*NBW,[XB2M#\/\
M660X)@V_@S ']#7BOPKMX[CXA:=YJAA&)) #_>"'!_ \_A1XH\8>*+R;4]-N
MKZ9]/,SH8S"H&T/P,[<]AWKFM(U/4-'U%+S2YFBNT!"NJ!B 1@\$'M7HT:$H
MT91OJS@K5XRJQE;1'UM17E?PK\3^(==U>_AUF[EFBC@#('B5,-N [ 5ZI7EU
M:;IRY6>E3J*I'F05Y!\=?]1H?^]/_)*]?KR#XZ_ZC0_]Z?\ DE:X3^-'^NAG
MB_X+_KJ8?PH\)Z-XG75CJUJ9_L_D^7B5DQNWY^Z1G[HKT*?X1^$)8RJ64\)/
M\<=PY(_[Z)%><_"WQAI'A0:J-4DE3[3Y7E^7&6SMWYZ?[PKOKCXR>%HHBT9O
M9F'1$AQG\2171B%7]J^2]CGH.A[-<]KGCWC;PP?"7B.33EF,T+()87888H<C
MGW!!'X5[;\*M3GU/P):_:&+O;.UN&/4JO*_D"!^%>,ZU?ZK\1?%K3VEB[RR
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M4=&&0P/4&ODS5+;^S-<O;6-B/LMR\:MGGY6(!_2OK>OE'Q1_R-NL_P#7]/\
M^C&I9>]9(>/6D6?5-K(9K2&5OO/&K'\17RSXN_Y'37?^PA/_ .C&KZCL/^0=
M:_\ 7)/Y"OESQ=_R.FN_]A"?_P!&-2P'QR'CO@B?1?@K1+;0?"EA;01JKO"L
MLS@<N[ $D_G@>P%>??''3K=8]+U)(U6X9GA=@.77 (S].?SKU;2O^0/8_P#7
MO'_Z"*\T^.7_ "!=*_Z^'_\ 0:QP\F\0F:XB*5!HY_X+Z';:AKE[J5S&LAL4
M3RE89 =R?F^H"G\Z]JU73;?5]*N=/ND#PSQE&!&<9Z'Z@\UY5\"?NZ]]8/\
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MK6[>]UJQTN!P[6*.TQ4YP[X^7Z@*/SK#!.7M;+8VQBC[*[.A^!W_ "+VI_\
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M%9_]<I?_ $ U[#\2O^2>:Q_US7_T-:\>^$G_ "4*S_ZY2_\ H!I8?_=I_/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,C9DN9<[![LY_P#KFO?_  9X,M_">AR632FYFN/FN6;[C'&,!?3'XGOZ#IP
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ1I-A'?7VH006TJAHW9O]8",_*!R>/2L:T^)?A"]N!!'K$:.3@&:-XU/_ F
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M * *U*J:59MI^D65D[AVMX(XBPZ$JH&?TJW7F2=VSTHJR05\R_$C_DH6L?\
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH) !).
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ethicsemployeepolicybook002.jpg
<TEXT>
begin 644 ethicsemployeepolicybook002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M^F>U.*-G@#ZBD*N>,*P]Z! <'N W<>M,Q_=DPW<&D*[< IQZCJ*"1P&0^QH
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M Q>F?H*/W/934FV(?=>FE1D@2#% "!8R<8(%*5MAW;CTIOEC<!OS2^3R<,*
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M92,CGV[T%L [DR.X%-7&"4<X]#U%,!?E)."/=301M7E<KZCM0<DCS%#>C"C
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M'LWK2LJL-X7:>^* %+R1GGYE]:7<DJ[E ##KFDB!;Y0W!]:>L>U_G0$].*0
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MDL>C@_C2&-QU;%  0XZ &FEL<-&?RIWER]=V*DW$##NI]J ( P7H#3LQ/U#
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MEVRAQ]TU&$OI=[$C(.&4"KL3<N3$K*V>1FH\#.4/X4^7<)7P<C-1\-TX-)#
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MBQ@>]4UO95'WN*JR3>;,[JH4,Q( J_H:0W&K0Q7)'E$\YK:W+$ROS2&"^E+
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M#3 <6R.#3"6_N$T?.#]PC\* 9B>.* &Y(_Y9FE#.#D#\Z?F0_>(HPK#EC^%
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M)->737%S-( =A)(08Z_K4IUE8KU[W2]+S;V\7EJ^P##<\_K3/MVB:?JUU/#
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M:3S&7C=QZ4X2L".0?J*/,#$Y !]:!"";C#8^OI2;P3D8SW'K2DG!P 0>],W
M$?+SV]Z8!DJ#\H*'MZ4TL%ZK\I[TOF <JOU%*)%'.W<I[>E #,A>0N5HRA^9
M%.?3-.#1C+!3MI-D3?,A(]LT )YJGY74_P!11OV_,!GWI<*W4<TTJT1Y0XI@
M.^T(WWXP3ZTUF!Y5!BD)1OX,&D+,@^Z/K0 X38X\L4IE0]81]<4T2DC!4?E1
ML=N5(H$/R^/EC4TS=*IZ!::=PZMBC>/XLM3 =Y\F>7'Y4>8K?>W?A3-T1Z*0
M?>@[L87;18+CMH)^4'\32%6'5A^%1'=WSFD&[MFBPKCV8#J"?K3/,;MQ3AO'
M4#\:7"G[V!]*8#/,;NQ_&DWJ?O+3]D1_C/XT%=O*C(H 8$5OND_2@Q/W7 H+
MG/&!0)&SUS1J 8 _CY]J=YB8^9-WO2?(_7@TTH5]Q0 \C(S&!]*C+MWX-(,@
M\'%/WAN&'/K0(02%N'Y%(4(&X$D?RH9".^1ZBD#E3_2@ 5MIZY]C2E<C<OXB
ME(##<GXBF*Q4TP%1\<'D4K*!ZX]J&4,N]?Q%)&P'!Y!H F7+KC/S"IH@S AA
MD'VZ5&@V.,_G7=>#$TJ;[0E[$K.Z84D]#656?)&YI3AS.QPY558JRX!XJ/RU
M!9 >#TS6WJVGQ+>3)!("RN?E;TK&FBD3DH05ZD4XRNA2C9D&"JD$'*FG _-G
MUYIV_D$C(;K0$!^[V/2K(+,AR@8'J!41(<<\,.E2+S ,]N*A(I(H85*G!ZYR
M:%^4D>G(IX(<;6//K49!7GNO%,D=(.1*.AZU):C%T/[N,_I3$Y)C)PI&14D(
M*02D_>!P*0R&8XG+CN<BIEB60B<\1CD_6FQQ_: %_,^E.DD C\E?N+U]Z !Y
MO,F5B<#^$>E7PWGQECRX&"!644Q&1GIT-6K2XV2H>QX-*2[%)DV P"G@]![U
M(5/V,J!@J>GK231[6*@$\Y %:MGI,EWI,\S2I&(SD%CSVK-RL4E<YL\/E#AA
MU%3+ UST4JWJ>!3Y###)M5"TOJ3P:A>XDE^5VV$=-HXK3<C8D$45L3YK;C_=
M7I^=!N<KBW41_ADU"'Q\D@R#WI'B*_,GS+ZCM3L%Q1+(I.YB?8ULZ/!I\D4M
MQ<@NPX6%<Y/Y5C(RNRJW'.-WI76VSV5C/'::;!]IO'3:).J[CW_E6=5V6A=-
M7>I>5=0O&6.!4L[&5-NX@!@HZ^_K557TJ*)=Y>^N#+DD9)51CCC\:EFM;BXM
MTN=5OA;;9!"J(0!C(S_.FC4;&TN+A-,L3*SH(8I0"P+'O^M<QTNQ8^T:U>2F
M6UB2VAO6$:$@ X'].:N)H]LUQ>3W%RUVMI'PBDG#8/ Q^%5A8:M>.POIA9P6
M$><K@<]?Z58M=0L/#VEQ^7)]HDO'S,6.3MZ?XUG)O:)4?,K17%E%I,%A:V9D
MNI)=[(5.3TXS6=JOBG5AJA8?Z.T2;!& .*N:AXKBL]=%U:62>6L6V,D=^>:Y
M>2674]0+.,S3-P1ZUK3IMZR1E4GI:).L[-92RRON:1L;CU-5<MZ BMG7?#][
MHUE;?:!A&!SQWXK"5BN._%;0:DKQ,IIQ>I,' [5J))&RP,3C>"I_S^-9'#<J
M>?2KF2=/0@<H].2N-,;(GE.48XP<4Y6(Z,#]:?<G<Z2@9$@_6HBG!(/%(#7T
MPP1!)+D P%QN'K6UXB\2V]W<PQ6" 6\8.X;<9KEI3LLH5'5B3C\J2&*6X.Q(
MG;_='(K%PBWS,U4VE9&LLD; 21 ^^WJ/PH-JEV"\)4/Z9QFLM9&M7)4G(X.:
MMP7*RS)*A\N9#G;GAJ;78$T]S<A\*ZM;6$EV8025X3/-4+.":&0-,NQ&&"O?
M%=L?'>GK88DC83@8V8[UP=Q%=RL]PTW[ECNW'C'M6%.<Y7YD;5(QC9Q9=N)Y
M;8&))4C3LS')(JEY*3MNDE=_<\"D2>":W"*/-FC'#,>M9TUR\I^=B!V"C&*V
MC%F,IFB9M.M3_JC,_IGBJ[ZK.01"5A4_PJ!5#((QNICAD/\ 6K4$0YLL?;IM
MV6E?/L>:G35[F-0"X=?<#/YUG%@Z_P"U3%.?E-5RI[H7,S<O5MM3L1=JWE2@
M@2*?IUK*^RS1+N7#@G[R\YJSIN5F,4GS1N,$8I]U9R:?= *[!0,IGH:E-+0=
MFU<S)"J,P(VR&JK CKU]:NR7@=V%Q"K<\L.#3!%#*-L4P'^RU:IVW,VDRJ&!
M*^8I(!ZUT-[J=C)9VMM;Q[@% ?CIQ3-2DM5\/P016^9@1N915'P]/:PZM;O>
MA3 IYSVJ6^97+2Y78O:3;V=M/)<2KNC"G"D<@_2HTN=,>SO"8@)68E>/>NR_
MM'PR)KJY0)@H1C=P:Y6&?29K:[$2*LY)VJ3U&>U8QGS/8TE#EZD'VC3[K2[>
M)5_TB,Y)(ZC/-.%[I@U>W=8?W0&&XZ'%,D:S&GV_DQ$7(;YQW'/.:M7(L1=V
MUVL(\H >:!V.*J_0DV/#][IUU>7EO+&&1@?*R.5XJP-!&KZ:8K0+OBE/SM_O
M9Q6%I>L6%KK%RZQC8R';^57-"\9Q:9:W<;Q;CYA<#\:QG":UB:PE%Z2(-362
M#5H+?[*5$6%8XX;BH+B<1W$D8A+1E2 BKT)IVJZ^M\PO"A5R00O;%99U@RZM
M%)'$Q4KAEQQTK:*E97,Y-="6.YE^RF""RSM;.YNW?FI[K4+Z)(98508&"W&"
M:JKJ2H]S!!"S/*#GKQQ4*7,L5@8IH"VTY..W.:KE\B+EU(KVZD?:RQO(/F#=
M,5-:V4T,$RA6,47S%R._7BJ<=]=RR1RNFV(KM0@=^U=%!J[1Z?\ 9+BU(N)%
M*C X.>E3.Z1<+-ZG-W*3E%O3>'#G8&[K4 L8X[OR9KAF249SNX)J:ZT^Y>![
M:.3(7+L@Z@UF&QE>S%P9SE#@C/2M(V,G<OFRLIK652Y,L/(!/45;MK[1K&P4
MM;CSVZ9ZBL^*QB@N8)VF)A8 N<_I4L]K9/<S*SJ-R_NSGBAH:;Z$3WEG;S31
M+!NBD&5^7G/M2)?2740MQ;?,G0X[4%[=M-201_Z1 W(]12?;C]I6XM8",KAL
M D9JB?42;_7/]:93Y?\ 7/\ 6F8H0@HHHI@!I*** #K0"5HHH$.'/*G\*!U)
M7K_=J,]:=N#?>X/8B@!1TR!]5H.-N?X?Y4'K@]?6C)SZ-_.@8OX\^OK2?0'Z
M>E'K@?44=AW]#0 H[],FF_R]?2EX(([>E)DY!% "<Y]&]>QI!W*]>X-*<8]C
MT]J3.3C^,=/>@0G &Y>G<4;<_,O!]* 2<D<,.HI#\PRO#=Z8!\K#T:DRR'&3
M2_*_7AJ3)'#=* %R6^ZV#Z4BRO&W6D(XW*<BD#DKA@"M,"SYBO\ > !/>F-Q
M_#D4Q/0'(I0Q4\&D,7>.F.:7S%8?,N1W]J;N5A\PH*=<'/K0( (V)QD,.WK1
MM7[R@D=UJ,CD#/\ NF@$YRO##J*8"G:OS*,CN#287&]!SZ9I=YP64 CN#2?(
M1N1<'OS0 ;HW[8:D\UHSC'%*563[IPWTI,,/E."*!#C(6&5 'L::+B13@J"/
M2F&-AR <>M&X$?./Q%,!YD$AS]TTUCCJOXBFE"1E>12!B./TH =YP[J#2YC;
M^';3<HW'0TC(RC../:BPKBD$=%XIOF$= !2 D<C-+O\ [R@TP%$[^U!ESU&/
MI280^U(T9'N* %^4]'/XTUD/7@TW!'&#2X8= : &]*4$CN14HWD<@8I#'&>K
M[: &;@?O+^-+L5ON'\*4H%' +#US3=^.@Q0 FQLX*FG!77N*3SF_B.1045QE
M3^% #BL;'EP#3754/.3[BF$8/2E#D<'D4 .60+T7(I3AAE%'TINP$$H?PI@R
M.1Q0(>LVT_=%/,GF#[@#4SB3L ],P0?0BF X2;3G:*<Q0_,!@>U-($G/\7>F
MJQ5SQQWH LQLC?)NQGD&M*VN7LXX2KC<S@GZ5C;?F4CH34\[[V"KUC&*AJY4
M78UM6<SS&0#Y\9^HK)%Q)&^-V4/K5LS/) K*?F09'\JK3+'+&) N,\GV-**L
M.6HW=%(61TP>N12B+=\T3@G&,&H2AP'!R!Q1T)([<BJL3<N(#L*R J?7UJ%U
MPV.OTI\%PZMC.X'UJ9I(9/DE7'N#2V8RB1VZ>E/'[P<]2,&IGM3U1PP]*B*.
MA.1CN*=Q6(R#@'^)35N=2+:$@<MR<=Z(X?-FC9>CD UHS6_V5F=QSC;&O]:E
MR+478S&Q;*$7_6.,GVJMC!#=NAJR+69V;S/E&<[C2'R(3QF1CWZ8JDR6AD,;
MRYC"DGL:<(4B4^<_S _=':FRW$A88.U?04T@.21W'- &Q#<^?;'RD =1R>Y%
M1":3RY%WMM8<BJ5C+Y4ZG/RM\IK1$>6D(&1@UFU8M.YG288A'X/\+5$R<[7X
M;L:?,.QY!Z&FJ^[,;]NAK1;$,;N_A?\ .E#/$WRD%?TIQ7Y<-^!I@)3Y",KZ
M4"-;1H+*XN'ENSM2)"Q0G[QQVJ?1HM02ZGN]/A^0-M!89QGBHY+*T@T*.0$O
M=S-E0/X%X_\ KUK:!'=WMI_9[2^3%%F5F49)P._Y5A-Z-F\%JD6QI-G!<3_;
M[PSF.+?Y9/1R#_\ 6IT.I?N;:STFPW2VV969NF<Y_I4<_P#9EI;VLMW(9)I)
MLMM/.T$?_7I'UJ]F-Y-IUF%@F A63T'3^M8:LUNDPETW4KRSCN[N^,8O)=IC
M]1Q_C5EYM T?7L,?-C@AX!.06Y_^M4]EX;N!>)#J]_NAABWA1QCKG^5945SH
MEEH]_P B6ZD<H@8\@8Z_K0M1VMJ8TMVFIW$JLBHQ),6/3TJG'(UK<K( 5DC8
M$?6J^6C<'H1R*N2D3PBX SMXD6NI)+3H<U[^IMZCXCN_$=NMO=LH=.5QT8UA
M&(@D#J.HJ'!!W*>0>W:K>1=QF1.)TX8#O245#;8)2<M7N0;&!Z5KZ/97&J[K
M*$9=F&..GO63EA@2 J3ZUI:)?W.G7CS6[@2A>#2FVX^Z5"REJ=58^$"^K'2[
MF8#RQOW =JW8? -C:WK2W,Q:U X!XKA+'7KIM5-U+,=[\$BM*_\ $5Y=JMM)
M,Q"G'!ZUR3A6ON=4)T[;&S;+H%GK=S]H"B&)1Y89N.__ -:L_1?$&G:9?7\S
MVX(D_P!3SVY_^M7.7LLUQ=E%0,%&*81!$A^T'<P_A2K5%6U>YFZFNB)3!=ZE
M<3W,$!9"Q9@HX7-7+/PU?7<#W*KB).6(ZUJ:7XML]-T*6TAML2L.#FJNF>++
MVSTIM-BA5VD/^LSTIMU/LH$H?:9)!K5I:Z.;9[8,SGY96^\*R&,\)\QI@Z'H
M>WXU:DT:_O;5[R*'_1XN-Q[U-I?AV_N-)EU%0HMP,F-OXA0G"*W!J3>Q0C$;
M2B6W(67'*'HWTJ&\B6*7)R$?D9'0UOV/@XZCH[:G%.8TQN5".1^.:N:)X;36
MO#SS7<^"A^1@.F/6AU8+J"IR.*95 SO&* Z#@M2W-K):R,#AT!(W#O55AQD#
MY:W5I;&#TW)V,:MR3[$4J+#(<ACGN#54,,8/(_E1DH1^AJK"O8[GPBFFF]/V
MSLF1N/':K/B-++46D6T(+0#*X[BN*M[MHT=E)W8P:DL[YA=!PQ4XP1GJ*YY4
M7S\QNJJY>4S)'^=E8=#3 H# C[H//KBM/48(FE$RC"L>:LZQ-IRZ5:Q6H'G8
M&XCZ5LIW,7'J&K:G9C3[6.R^^H&_\N]5]'NK"2_5KZ$*H!R0<9K'RK]@'QCZ
MUI:);VS7Q^V@",*<$^M-Q48@I-R-FT;27O;PB1?+8$(I-4TBL+;3[DRC;-N^
M0Y[9HM8=+>:\\QA@9V5+8O9MI4X;:\BD[5;ZUE:VQIN=+X9TRPUBQAC? EQE
MV'4UTUSX5TZ"WW[-B*,MGH17*Z'JUA8645RKHDP^5QFNCU#Q-;W5DD2.KQL!
MY@!Y KCJ*ISZ'73=/EU.#N8;&U\1R*(QY!0E3VZ5GVALQ#>@QY61B$/>NCDM
MK>]U4" !XMORCTXJ+^PWL6EEFB_=MG:1V-=*FDK,YW"[NC!,L$FC&T2,^;&W
M!/IG-1R7L!CMQ#'M\G'F,>]7EN["Q@FBD.7Y_'-9MYJ%O_9XB* 2!L@#N,UL
MM7L9.UA&UF"+4A+!;_*1@D]33+?4G\VX5H"T<F3COTI9=1MY#;2I$O[O[YI'
MUN)=1$\=O^[VX(]:=O(F^NY/9RS7EL;9(MT*'<2.J<YK3G75)+6.Z$6(8\ /
MCT.*IZ=K/V)IRMKN:?.$!KO--UO3KKP7/&\1WHC!X^^<UA5G*-FD;TXJ5TV>
M;7,>J0Z@CLX1Y^AQP::EA/<7$EHS['QDX'#5=U*[O[JW2>.-3#$<*>XYJE*U
M_&([F5\/+A4..E;Q;:,&DF$FER?8I(Q(V8SSZ&IK2QMA';F1_E+#=D]#4"07
M2WHMYYB5E&2?6D32TE>9%E.Y.54T^FK!;Z([.UD\.V]PUI(BNTZ;<@]">*ET
MI-+T^VN+6[@)?S-R''..*XN(1)##?1'_ $F&0;@>^"*TM;\19NX+@D$F/! K
M"5-MV3-HU$M6C'E_US_6FTZ4_OG^M-S72CG$-)110 4444" TF:4TV@ HHHI
M@*&P,'D4O\//(_E3,T;L'^E%@'^F3SV84O?CJ>M(.>5_$4=O8?I2&'&/;M1C
MUH[Y_3UH_P _2@!#R??^8I#]W_9[>U*1Z_C[&CZ=?YT"&GG@\,.AH^\>.''7
MWH.",?P]CZ&D/(VG[PZ'UI@!P_'1J"?X7'XTA^;Y6X8=Z,_PO^=,!IW)R.GK
M2_*_)X;UHY3W%(5#<KU]* $PR\]#ZU*KAU^8?B*B#XX(R*7 SE#^% $I0]1R
M*CZ=.#VIV2.A(H+*>'&?>D ;^.1D']#1M5CUVN._K1L[J<^H]13".<'C^Z:8
M 48?..3W [TW_:7CU%+DD[ESO'4>M+YASN4#/<4 -(#\@X:D#9X;@^HIQV2?
M,!M;VHVJXQD!NU,0W+H?O&E\P/['^=&UXQ@KE?3-(4)&5S]*  LRG.!2B1&^
M\@^M,#%>",_6@J&^X1]#0 YE'8 BFJRKV(^E-&5X!Q[4NX-]X8HL XR(>"GX
MTF$/3!I"@/W3GVIA!'52*8AQ./X */,('R@4@=AWX]*"R'JN/I0 OVB3H0,4
M&0,,$E?I2;0?NL/QIA4@]#0 _P LD<-FH]N.HIPSVSFG M_$-PH 8K,.AIQ9
M6^\,'U%.\D-R"%II14^\<_2@!"IZC!%,[^]/#JO*@_C3O,5NJA3V- #021AA
MQ086QE>10V\<[N*:'8'.:! %8'(X/O4GE^8,Y :F$+)T)#4Q@0><Y]* '^40
M<9 IVPNN&(SZTP$,-K?@::05/4_6F XQNAZ<BE:-G7(&#WI%;>-K$Y[&D#.A
MY."* );7B0Y'R@=_6HFR)"WJ:L;RMJ7 !+FHP4D&PC&.AI#)XFVHI'3.#30?
M*E9&_P!6YX]J+==XDA#]1D9]:)E9HT+#GIGW%(9&RM#,RCH>12@AP">&'%.#
M&XBV8_>Q<CW%1=>>Q_G3$2*"CC/K3W&22!3(VY ;E:ED7C(.14C(T8#Y>WK4
M\=S)$<$AE'KZ56/?%/5@Z[#U/2G81U_A%-)N=2_TW$/E@L/0\58\1R6KW+R:
M;Y;CID]?PKDK&39/DG'RD'\J89F;<NXA@<@@US^S?/S7-_:6ARC;PS%MTF[(
MZYJLPWJ2.U6([R0YCD^<?[0I%:!W*$&,GTK=:;F+(,^9 <=5H5\%&[="*D%N
MZ2'8P=>F*CDC9,@C [4[B',NTDCIG(K;LW\U%EZ?*5/UQ6*A!.T]"*U-)4O,
M8"?O E?RJ);%PW*=R@Y.,C/Y&JV,\$\]C6A<1&-F[\X-0+;/<'$0)]^@IQ>@
MFB!2=VT_>_G5RULC=2(C'RE8XW-0$@@^_B28=L<"HWFDG(W,0PX %)NZ&E8Z
M6>?2]%M;J"W0R7)38),=R/\ Z]<_8M<&Y$,,S)]H8+(<]CQ6GJ4UE_9MK;0J
M'DQNDDQSGT_2H=$T@:AJ:QM*(X5^9VS@@"LTU&+N6[RDK&XIT/0]1EY\XQP<
M<9^<Y_\ K5&EYJM_#::59VIMPTGF!^@//7]*9NT>RTN= !<73S84%<G:,=S^
M-74U;4=2U%I].MC$EI;%2K84C@FL/,V\AL^F/?6=]>:C?$-;C8&4_>./_P!5
M9^LQZ-;>';6"T$<EV_S/(!R*630KIM)ANKF^*K=3?ZHN<8XR35;Q9;:9I]Y!
M;Z:P<"/]X1ZU<$G)*Y,WHS! /3[PJ:!S!+O W1GAE]JK$'&4/'I4EL9))DBC
M)RY"@?6NINZ.9;ED6RI?11L^(9#]_P!J[+5%T#3]7TQ8&4K'S*R '/(Z_K4-
MQX6CLKRQL;VX3]_SG/W.F:E-AH&F^+E@ED7[.B9.X;ANS7)*:D[G5&#BBEXI
MG@UR^%U8($MXAAB1BL6RMW6X78ZNIX8#K71RW6EW/BJ+;MBTU^,8PK'/<5=\
M3Q:387-F^FQ0BY8\K$.,<41GRVC8<J=[RN<QHNAS:M>-#'*L(7D,_&:T+>6V
MTW6H)I$6Y.<,!TXK*>>9-5E G8%2<;3@4[3B)TD#$!X_FS5RBW=O8S326@[5
MM7.HZC+)&GDQL?NKQ69@CD&FE>Y/6G+QSNX]*TC%):$.3;U!6*]#5VSVJLDY
MRNT8&.YJGM1C\K<U9GQ%;1P9^8_,V*):A'0VT\8W<6@?V8L07/'F9[55@\47
M\.EG3@W[@C&0>0*QQ@@!L^W%+Y#]55B/I4*E!="G4F:46M7T-C]C@NG6W)SM
MR>*=!?3R0F*.Y:%B<D!CM;ZUFI:7!SM0_B:D-A.V"%"G_>Q0XQZ!S2+<_G0*
M)U4%6^_'VS58HLN9+<_,/O1M_2M31;:>YG&GW4T:12#[Q;[M1:AH[:?=-&;B
M-]IXD3FDI6=AVNKF,V&SE,$=5I% (QG@UK,EG.%$TVR4_P#+0#K5N#1K1Y4"
MRM(6/7M5NHEN)0?0PC"\<:\'YCP?:M/3='ENMTJ(=BKD\5VFL6>DZ7H4$/DJ
MTIQR!DCBH[K5])LM,M8;=@&D"AP!T&.<US.NVO=1M[)1>K,S5/[-&D0V\&PR
MJH#X'-<=+&L$C($+@]!C@UTOB&[T^SFA;3DC;</WA K'EN)94( 4/C<C #D>
ME:TKI&=2QF%)6XBCVGTQ6CHE@EU/(M]D*%.-U9;7ESO.Z0^F*E660KNED8CL
M >:V:;5C%-)W9K6>BV;+=M,RA03Y9)Z4Z#3[-M(D8RQK,#\K9Y/-5K"QCO+*
M>>2X(V X7<:9;Z9;MI$MV)OG7("Y([XK/5[LT^1:FT^QBT=)&G02D_,13WM=
M-MXK5X[C!<@-BJB:;"=&64S;I'/3/0Y]*DETFVM(+9S+OD8C*YR.:-.X_1'8
M^'UM(YW\AP6(ZUM7DB):R^:0$*D-DUQ0CBM&1HIMJ,1N*GH:2^NG>Z$4UVSP
MMCY23TQ7-*G>5SHC42C8RT32_M=V).4;.QC4<*Z?-IEPC'#)G:Q'(&:D2RM#
MJ,VTAK<#E3_"<4EI'I[2W$.X8P0,]#73Z'.RK-/ISZ8D49"NI].O-/EN+2:2
MU,(4-'@MQZ5 D5C%9W$4P E4G:2/RIWG62:(,*!.3@''/6K(+4NI1KJ\=U$1
MA1M(]>,58BU:>"ZD\N,;;@$%>_(Q61<WEF\%L8X_WB8W87WJ2YU*(7]O-%$?
ME !&*3@F-2L202WK)/:^7E"23S]VH9)M0GM2OE9BB/?J*GFU(VUV'BB;,HY&
M*I0WMXLDT2(VZ3/R_A3BA-DDMO=3P17+DKC@>U#Z7=)=0R/*Q$N 74]*AADU
M&6WE@0G8IR03R*?&NHS6HD\]ML9QC=TJM43H;>B:0DVI.ESA@!D>]:.M:)IM
MO:B0(%.?XJQ8)KR":WN%GW(" W/;-6-:N/M5_')<3G[.5QM[9K"2ES;FT7'E
MV,F;_7/]:CJ2;_7/]:CK=&(4444""DHS030 &DHHI@%)FBDS0 &BDI:  9!R
M*>&R?>HZ7..AYH ?[_IZ4=_?^=(&R1T#>OK2C&>GX4@#G%'\J._U_6CT]>U
M#3[_ (CUH/3_ &>WM1U_STHQS_,>M,!,=F/_  *DZ_*_X&EXQ@\K_*DZ?*W3
ML:8"9*\-R/6D92/F4\49V_*W3UH(*<CE: #(8?-P?6FE2I_J*7"MR.#2!BO&
M/PH$/20'Y'_ TXIZ<XJ/:&'RG!]*<K$>Q% P/R].#V-&_(^897^5*6# AA^(
MH*<9!R.XH 0[6X!PXZ>]-*L?F09/<4$$?+G!ZB@$_>4X8=10 W&>5X;N*3A^
M.C4_>#R ">]!$<G3*MZ>M,0W>1PQ/UH)D7Y@W'K2[=^,D$],TTI)&?N__7H
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MCKT-3JQ8/&>2.1FJBDQR#([U8=O*N4D!R&_PH8#48+(LJ':>C#UIT\>/WBC
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MC*QNWU-1W:;XXYQR",&JP##!Q5):$MFC:R023@+;\#DY[4LVHK).[^0@'0'
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MI8XB73!.144MZW]H1W"1;01C!H%Y:G3D7(\S.,#O3;V\MS#"%3]Y&035)=+
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M9^8BW4&LU;=M-R)AE/NA,9Q_]>H+AC-.[P-F)$^[W6D[2V!>Z9\9EG:2*96
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MG/2BH[*]@IJ[U9S-Y>?:--:$6Y5E."<<=:K->3&P17B(*$8.*V;K5+"+39(
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MEOM[,L87Y"/6J#;DZDX[4J2L/E(ROO2:!$DX"SN""8RQVM[5$5*GV[&I1+M
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MT0ES*XY1Y78OJ1-(DB_*Y&?K3;Q#YT-PH^8'D57MP<%03N3YEK3C_P!+MR%
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MH: $.4;U7TH*Y&Y>G\J!\OR-T]:3E#FF(4-GAA364CWI2 P)7KZ4@8J?;N*
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M#-A9>Y%#.)+5&SRIP3Z579<?.G/K0E8&RW #%,H?E6Z,.U:VFR+:7HD."N[
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M>S?O$+K#W!'2K6E06DNI0QRH5@W?-GO]:TER\G*B8\W-=FM9>)+&PUFXNK.
M21R\,%!S^%0Z3XKO4UJZ,5KYK7'W5VG(//\ C5JY71M(\5PSJT0A*_,H((!S
M2?\ "0:-;>*S=6ZJR[<,RXP3GM6%DUI&^AM=KJ9NCW7B5=:O(K&)A/*29%9>
M!SUJUH6EZP^M75JMX\5P03, >O-30>,=GB:::&V/S?*JX.6&:HQZ_K"^)Y;J
MUMMMQ-\ODE3G&?3K3:D[V2V%>/<T=!T:^F\07=@)C;,@S*Z'EN:T])\ S-J4
MQOIY#&O"D-@M6!9W>O\ _"5']WY5[+]X;2.,UZ'I&K3I,-/O\"^7_P ?'J*Y
MZTIQV-J,8/1G.6'@BSB\0W$-^=T&"8@6QGFHM$TS2[3QM=VCLC6\:G8&/&<^
MM:FOI-JWB"WT^.9H& +%E.":R[?PXMEXA-I-=-(9>59CAJ%)M>\]T-Q2?NK8
M?;CP_I_C:?>8C&02&8_*IS55K_0[3QT;U1$;4@C<.1NSUJ&\\,6=MXSALIKA
MC;2Y8[V&>W^-.U30-)L?&=E:*^;67)92P..G^-6N5[M[&;YNB6X7&NZ1#XV7
M4X8D:U"E3M7C/'/Z5%JGBBRN/%EMJ%M;EEBR& 7[V:N:OIFA6GBNT6*5!;M_
MK(E8$9J7Q'_8UGK5DUNUNL6?WRJ0>,4+ETLGL#YM;M;E77?$UO<ZE:7_ )1B
M\DY52N&/M70*)?%L%M?*GV=86#H&7!8_C6'XGOM&N;^Q>SBBF*,"^T\!<=ZT
M-9\=Z?I\%O'I8BE)(#JI^X._2IE!M+D6I<9)-N3'ZSXAMH\VNI6A:>,YC&TX
M)'<5S^K^)-1U/38EELVM[9""79#SCIUK1USQ)IVK6EJUI$DTH<-)ZH.]0^)?
M$>E7NC)I\(59!M/ X&*<(VM>(IRO>S,Z\U_5[_1(H&L62V. 9MIP0.E20^(M
M8_L98!9YL@=GG!#]WD5H7&NP3^#UM8(5>3:L9VCT[_I56W\5VT'AQ=)^QD2@
M;-Q4X^M:=+*/4C9W;$@UWQ!;Z#-;6EN9+49VS[<X4G_Z]4-(UC7X-(N8;2!I
M4Y)?;]W)YK3T[Q3##H\VE"WWO@@,!QSS571?$KZ+IMQ97%D79BVUPI[GO^=%
MK)^[U%>]O>)O#S:I!I4LT"EY92S,".^:R;'5-8M]7N7LX3-,0?-3;G%;?A[5
M[BTBN#);EHGRRX!XK,TGQ%'I>IWD]Q &:X)(51DCFJ5[RT$VM-2II5_JL>MS
M7@A9Y9,AXB.>F*D2?4=8U:?SR\+@8\H#&!BF:=XGCAU^XOI8,QR<; .5XJ:+
M7H?^$D?4I$\N)A@(.O3%6T[WMT)35K7ZE>WL]U[+97$7ENAR' P34;Z41J@@
M\QE0\X/4U8N]?AG\2P7D<1\E.#[\=ZM7>J1:GKUM-;P$)"?F)&-W%%Y(+195
MAL)CJPM!&X3 (.*OW?AEA()6.]!SSU%;:ZE:-?)$-JLP^]WSZ5?E:)8RTDBJ
M#QR1S6$JDKW-E3C9G$)I<YN]L$3&-AR>U;4MW#I^G_9W@W'&W8%ZYK=BM\0!
MXP=K<\"L/Q&F+<,A"R<?4BA5.>5@<.17.>U.[MXEA,03<#DHG.!Z4MS<_:;5
M3#L5N#C':MVV\,:?/;QW +++D$C<.:[/3/#6F1H)$@C?(P2>:<Z\8(F%&4F>
M57]YBP1U@5F7[QQ5&?5$N+1%";0.Y'2O1/&&G6%@A$<<8=U)V _TK@KR>U33
MRJP+NQ]WWK>E-3C>QE4ARNURO/>7<ULH"+M'.['!HEN+Y[ %T.W. 0M*VJP?
MV>(UB7=C&/2G_P!KR#3UC$ +9ZXXQ6GR,]+[E*8_OG^M,I\W^N?ZTRM$2!HI
M#10(*2E-)0 4444 %%%%,044&DH #2444 %%%% !24M)0 444E "FDHHH$%%
M%)3 **** "I%;(P>H_6HZ <&D,DY')_'Z4T@#AON-T/I3@=PR/PI"1@@\@_H
M: &C^XW7L:3.T[7Y%.QGY&ZCO2#YOE;J.E,0A!0@C\#2G#CIAJ0';E6^[364
MK@@Y'KZ4 !RI]#ZT[*N/F&/>@,&&&_[ZIK*5^GK0 C(4QZ>M..3AUZCK35<K
MTY%/4J3D''KF@!Q;>,XSZTF%E&%;#>]-93$P(^[2,!]X?=H 7#1GD?+Z4UAQ
MN7E:>'+KQPP_6D$F"<KQWI -5@!AN132N.1R*D,:L-R-QZ&FJ'7H 1Z4P$60
MKQR12DG&8SQW!H*?*63..XQS3%)!R#0 JRN.0:EWB3K@'UJ/"R'CAO3UH'7!
MXH MQ6LLHS@!1_%3S;2(F]661.^*Z+PY;V5UJEG;W[ 6N,\]">*Z#QE9:/I]
MS;-81(9FR'1,8QQUKFE6M-1L=$:5X.1YH5:0YC7/M2E6 Q(%2I;NX?[1($(5
M 3C%5"X<_-G/K70KV.=DOGP+P4WGUI'G/4+@>U0^6V]5R,DXSVK0OM+;263S
MI4?>,X2@"BI#-\NXM4WDPG'F/M;N!3#*'7$0"#T]:@((.".::%<GD8K\L> /
M6HQO'WAN!IJO@8;D4NTXRAR/2BP T?&5/'I4:DJV1Q[5(LK+SU]J=OCE^^"I
M]J8#?E?IPU,(VGD$&I#%CH<^E&6 PXR/7TH 0,'X/#=B*4.R'!'-,:/ R#D>
MU*'PN&7(H D*+,/D.&]*=&Q>,PN/F7I4!4@;E.14L<X.!(.>S"D"'1*0KJ.1
MBF*V"63Z%:N"$K*LZ8,;\$"JLD>R1MG!!Z&DGJ-@%R?,3GU%:,1Q;+",?/\
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M:RRIQGT[&I(2!TZTJ,D@DA8<MT/O0+<B6?<A61=X'>I%A64J]O)C_9-5B"K
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M,#I=#U$Z9="\E^>,KMV@Y.?\FI]2\26^IWPE:%HEB& [8R37(BY/VI-I8+G
M&:2YD\YV)<D9Y%9>R3ES&GM6E8W+?4+VPD:6SOI(P_)P3BL^Y,]U(TDLHFD;
MDOGD_G5&":6+Y5<E3P015N*!IVY4Q_\ 313@4U%1U%S7T-'_ (1*X&D)J+RQ
MB,G&T<L*HM-# GE0(=W>0]:TX6U&.(0PW >#N&?/Z5T>D>']+U>!WNS'#,HX
M*G&:RE4<7[QI&"DO=/.I4<MN9BQ/4TZY+)*"#G(K6O[*UM[EXEE9<'@-T-5+
MRU5RAC(;"^M;QE?8Q<;&?N5QSP:L.3]AC.#PW-5V#1\>5CZBIH9F-M*O7!!
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MZD7%1:,F;_7/]:93YO\ 7/\ 6F5V(Y0HHHH$%)2TE !24II*8!1110 4444
M%%)FB@!:2BDS0(6DHHH ****8"&DI310 E+110 E%%% !1110 49P>.M%(:
M)0<CZ]/8TAR>1]\?>'K3%;%/YSD=1^M(:&GH'7\100'&X=>XHSCYEZ'J*0C8
M<KRIIB#=O&&//8TT@J<=/0BG, PW+^-"L"NU_P #0 95QAN#ZTQE*'GCWIQ4
M@Y_*@.>XR* &ABO?-.!4\_=-!3C*'(IF* )'C)&]1SW IJE2-I_ TB2%#D'C
MTJ1]CC=C'TH B(*G@G-2!R_&<-2A21M.".QJ)E*M@\>] "[L-RO/K3PT<G!X
M;L:9D.,-P13""#R.: )#'@XS^=*N>C89?7TIJL"-K<^](RE>QV]C0 IA8<@
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M. R"-1\Y^7O3+.*UF,QF"[EXY..*;I@M8[B?S,;%/RD]*;2!-EA;][5F>-"
M>2%]:@@U5_.9P55SU!'%.TZZMX[J7$@VD\!N:HW+6\]Q(=NPYZKWHC&^@FW:
MX3?ZY_K3*?-_KG^M1FK1(M%)29IB%HI** "BBB@ HHHH **#24 %%%)0 M)1
M10(****8!29H-% !249HH **** "BBB@ HH-)0 4444 %.4DC'\0Z4VDR0<Y
MYH DSCG'RGK2?<;!Y5N]+G.#_#W%-_V&Z=C0 <QMQR*"H8;E_&@<'8U(<QMF
M@ #8&#TH9<+N'(I6 <;AU[BFJ65N/QH 0$@@CK3B5;[W!H*AQE>/:F=#CO0
MK(0.>GJ*%;:<=<T*Q7Z>E+\KG^Z: $9=G*]*D67<-DG/H:: 5X/*GTICKCH>
M* '$(#Z4H7=P2#[TP,"-K?A2%=O'ZT .:-DZJ<=C2*Y7@Y(-*LI48)XI2S 9
M&"M #2H/*$'U%,]QQ4GF '.P4[=%)U&TT ,WAAA_SIK(1SU'8TXJ@..12H-I
M^5N/>F(B!YR.M2!P_#<&G^4'Y! -1M&R'#+0 ,A7Z4T$CH>?:E#%:7Y)/8T
M ESPWYTXY]F'M4;(5[<>M(&*]#^5%@'[D)Z%33N#U(84W<&^\/QH\O(RIS0
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MF0.>Y]*J]B;=R&V802()#ER>%]#4$TLAF.[J#5C[-$DR2"4NK'/ Z4S9%(Q
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M/I3@G%$S:DQ^GN;22.Z,6XYX!KI]:UZRDOK"ZM(@TD?W_P!*YFY=+MN-\1'
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MRQ2JQ&>U=+KMI-;S;]/GC"2##+WS7)WKWB2?.K8Q@E35PDY=2)14':Q-9Z9
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MIWPU\2ZOXCM=0?5I(G:%T$?EQ[>"#G^5,^)WBK5O"]KIKZ4\2O<2NK^9'NX
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M2V/.>X5[#IOPKT&\TNSNI+G4 \T"2,%E3&2H)Q\M>.YKZ:T+_D7M-_Z]8O\
MT 5PX^I.G&/*[';@J<9M\RN<C_PJ+P]_S\ZE_P!_4_\ B*/^%1>'O^?G4?\
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MY.-X"[L\AEI[21QJJ@98\,WI3EE6 [8<%B.0:;&8IR%=-C@Y)[4,8X*L<BQ
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M_P!&+1C/]XC\OS#"?P'\SY^A/[E?I4E10_ZE?I4E>NMCRGN%?36A?\B]IO\
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M\35<R1/R8\?2E\N-ONO@^].W<+ERVN 9LJD8P,\BH7GD<LWJ?X:=#;2""1U
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M% !111F@ I*** /6?@[_ ,>6J_\ 72/^356^-W_'IH?_ %WD_P#015GX._\
M'EJO_72/^356^-W_ !Z:'_UWD_\ 017C3_WS^NQZT/\ =?Z[GEZ@G  R3VKZ
M)\(:(- \-6EFRXF*^9-_OMR?RX'X5Y#\.M$_MGQ3"\BYM[,>?)GH2/NC\\?@
M#7LWB;68_#_AN_U1\?Z/$2@/\3GA1^)(K3,*EVJ2(P-.R=1D^H:-I>JM&VH:
M?:W;19\LSQ*^W/7&1QT%5O\ A%?#_P#T!-._\!D_PKYJAO-3N 9I=3O"[DL3
MY[=?SJ3S;_\ Z"5Y_P!_V_QJ8X*K;214L93OK$^H;2RM=/@\BSMHK>+).R)
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M?;B21]H^IJV\HG $Q&!P#Z5# C^7(X;J,#FHA'B%@QY%2]2EH2M#&ERG/?\
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M1RV.AK13OL0XV*I2X,N\)CVJU!8&>5!(RQY.":@-U(XRAQZKWI8DW(TS$Y'
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M:3R:SRCS+MCQ'%VSQ47*V.M.G:;;Z"E_;S&20L%8-Z=ZT+BVTJV2RN+=@J2
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MUYY16?U&CV-/KM7N:/B?Q+<^+M>BU*>R2U,=N(-BN6!PS'.<#^]77V_Q@O\
M3[*VM(M$AE6&)8PQG(SM &>GM7G]%:/"TW%0:T1"Q-12<EU/0_\ A=FI_P#0
MOP?^!!_^)H_X79J?_0OP?^!!_P#B:\\HK/ZC1[%_7:O<]#_X79J?_0OP?^!!
M_P#B:X;7M;G\2^))]7GM5MFE1%\M6W ;0!U_"JM)6E/"TZ<N:)%3$U*D>604
M445TG.%3V&I7VDWBWFG74EM<+P'0]1Z$="/8U7-)2:4E9C3:=T>D:9\9M0MU
M6/5=*CN<<>=;OY9_%3D'\"*V#\;=$5?FTK5 WH%CQ^>ZO'Z<,,NQ@,]C7'+
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M2$7[H'\1JUID;)=(96 !/S#.:RDWN:*VQ6LO#U]:V[:C',-\1^10U5+FPO\
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ME1YXK6YTO#THUN23T,<_"SQ0.EM ?^VZTG_"K/%/_/K!_P!_UKM?^%U>&/\
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M)+./TCO%4=NBO_0_A6F%J.A5=*9EB8*M356!F?"'_D;+G_KR?_T-*[+XN_\
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M_P#KU3^5?-X?CGD5](>#L?\ "&Z1CI]E3^51F7P+U*R_XWZ'AGQ%&?B=K/\
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M0UWC_EW 7MBKMV)*,Q_?/]:CS3YL^<_UJ.M49L7-&:2EH ***0F@!:*;FC-
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M^O6FQ:G=/.KQ3[3G&W&*RPQ7IQ3T93(I.0<]:IP1/.V:4^J7KR%6N71@> >
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M#N;.E:?)YPE.UXU'(4]:ZP^#M1DLA>1V\ MV&[:P^8#\JY[PX@GO%MBQ7S2
M&![]?Z5[!=3W=CHBV\/ERR;-H)8=/QKS\35E&243NH4XRC=GC][90:=AUX1N
MN1SFL&XD>:3:BD*>@']:ZO6E>XG"S*C!?OMTJCJ(T@VT,5BX27'SM71">FIS
MSCV,-&6!=IYE[>U02;F8OU;N*F-I\Y"SH3]:<;5R<AEW#K@]:VNC&S*W#H!G
MYAT-,((.#P:LFW4G(D56]#1Y2OPTRAJJX6&1S<@/S@\&GW2*9=P. PS[4TVX
M7K*OUJ=HP84)F7C@TF,J@.IXP11@-V*FIOL\;?<N%!/;FE\C;P9UHN%BLR.#
MTR/6K:G[); _QFIK2W#R_P"N4HHRV:2XEADDY=<#@<4FQI&?YA/W@#4R3+C:
MREE]Z>8X2>)4H$0'_+9:8A?L@E^>!@?]D]:G@LW>WDB(&X#<H-,CA7<#]HP?
M45U7AN+3;B_C6^N$49Y;IGZUE4FXHNG!29AC3V&P[-VP< #@FJ\D:V_4@N>I
M%=EXJ^RVL@ATX?N\??CYS7"R"(GH[$>II4Y<ZN54BH.Q%)-(X(0[%/4 \FH3
M$5/S':?>K"/&C!A$O![FKVH:G!?NA%NL>!@[5 K6[1G9,R?+4>I^@IZHQ'RQ
M$_459;/_ "S=6]@*C:6X'!R@]:;8DA%MY6ZE8Q]:<80IQO4^^:@)W'DL]+@D
M<G'L*-0NB4HH^](/H* (5/4U'M_#VIZ1;VY&T#J30!-#Y!;>T9\M>I:MR76K
M,Z<D"VFU<XW[1\M<\TJR,(E^6/NV.M6XXKD!K52DB,.&.,5$HW+C*Q.+A$N]
MD4^R-AUZ"G0&[>22!+H+'ZDX!J X^S>4+=9)(NI&*;+*+DPND+H!PP'2E;H.
MYJV,LY1H$<2,A^9F/3Z5IKK=U)IDR1,WEQD+P>O6N;DEMX9E2)W6-OOM5FV5
M1&\27)5&/WCTK*<$]RXR:T1LV4K7DL.(@,D!F['ZUT&N:7IFGZ6)X-LK @LJ
M#.WU-<9;W9CBDMK>X"A.K$XW?2I;#4+MU9?.#+@KM8YS42IR;NF7&:2LR"66
MQ:Z6X^SL$ R6<=?:JES=0-?JREXXGZX&#5W4O-GL4\M$!0Y=1BLV[DF:*"9K
M=%52.0!S6T49,3%M_:)4W$GE$=<FKU@;2"]$<TSF%L\U1N787,$IM JG QC@
MU+=.$U*%FM2%QPN.]-ZB3L;ELVEK*ZQPN&&5+%>OH:07%FL5P@A:'=&4+D8R
MW^11:W=Y/,76R18B-N"!D8__ %4YH;FZ>6&YB3RF.]5R,@_Y-8^IK>Z.<M;.
M&996>=05)QGO4MM9126[R&=0RYP*?'%%;7-S#) 7*DX*\@5-IL44JM$+=FD9
ML+QTK9RLKF26MB% 8M.<_P!]L9]:@MA^\,C?<C&XUT6MZ#=:;86XFCP"-W'O
M6%<0R0V:HJ-NE.3BE":EJARBUH5TE+"><DDG@#ZU$JK;*))<,YZ+Z5;EC:PL
MHU,9,TG.<=*S9TF1]TJD%N>:TBB),;)*TDF]CSV]JLW9S:1$=JI$^M6Y.;,?
M3^M5LR=T16\H1BC?<<8(J:V9K>^3'3=^!%4OIU%7;8^<A)^]&"1[T,$QVHMF
MZ9QRK]/:J08@Y!P:G5C/"R$_,.15;!!P>M"V![Z$XG63Y94W?[0ZT]1A",^9
M&?S%5:569#\I(]Z8BU=0,D4; $H1P<55]JW)]72?3(+>2!5"\%@!S67-:\>9
M V^,]<=14Q;V94DNA6[8[4^.5XFRIIG>BJ(V+4W^O?ZU'4DW^O?ZU'4H84E+
M13 2EI** %HI**8"TE%% !1110 44E&: %HI,T9H 6BDI* %HI** %I*** "
MBBB@ HHHH ***2@!:*04M !112=Z %HI,TM !1110 E+124 +1244 %)113
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M;_S\8>RAV,O^P;3^]+_WT/\ "C^P;3^]+_WT/\*U**/[4QO_ #\8>RAV,O\
ML&T_O2_]]#_"C^P;3^]+_P!]#_"M2BC^U,;_ ,_&'LH=C+_L&T_O2_\ ?0_P
MH_L&T_O2_P#?0_PK4HH_M3&_\_&'LH=C+_L&T_O2_P#?0_PH_L&S_O2_]]#_
M  K4HH_M3&_\_&'LH=C+_L&T_O2_]]#_  H_L&T_O2_]]#_"M2BC^U,;_P _
M&'LH=C+_ +!M/[TO_?0_PH_L&T_O2_\ ?0_PK4HH_M3&_P#/QA[*'8R_[!L_
M[TO_ 'T/\*/[!M/[TO\ WT/\*U**/[4QO_/QA[*'8R_[!M/[TO\ WT/\*/[!
MM/[TO_?0_P *U**/[4QO_/QA[*'8R_[!M/[TO_?0_P */[!M/[TO_?0_PK4H
MH_M3&_\ /QA[*'8R_P"P+/\ O2_]]#_"C^P+/^]+_P!]#_"M2BC^U,;_ ,_&
M'LH=C+_L"S_O2_\ ?0_PH_L"S_O2_P#?0_PK4HH_M7&_\_&'LH=C+_L"S_O2
M_P#?0_PH_L"S_O2_]]#_  K4HH_M7&_\_&'LH=C+_L"S_O2_]]#_  H_L"S_
M +TO_?0_PK4HH_M7&_\ /QA[*'8R_P"P+/\ O2_]]#_"C^P+/^]+_P!]#_"M
M2BC^U<;_ ,_&'LH=C+_L"S_O2_\ ?0_PH_L"S_O2_P#?0_PK4HH_M7&_\_&'
MLH=C+_L"S_O2_P#?0_PH_L"S_O2_]]#_  K4HH_M7&_\_&'LH=C+_L"S_O2_
M]]#_  H_L"S_ +TO_?0_PK4HH_M7&_\ /QA[*'8R_P"P+/\ O2_]]#_"C^P+
M/^]+_P!]#_"M2BC^U<;_ ,_&'LH=C+_L"S_O2_\ ?0_PH_L"S_O2_P#?0_PK
M4HH_M7&_\_&'LH=C+_L"S_O2_P#?0_PH_L"S_O2_]]#_  K4HH_M7&_\_&'L
MH=C+_L"S_O2_]]#_  H_L"S_ +TO_?0_PK4HH_M7&_\ /QA[*'8R_P"P+/\
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M #\8>RAV,P:':*A4&7!_VA_A3?[ L_[TO_?0_P *U:*/[4QO_/QA[*'8RO[
ML_[TO_?0_P */[ L\_>E_P"^A_A6K11_:N-_Y^,/90[%O^RM1_Y\+K_ORW^%
M']E:C_SX77_?EO\ "O:J*ZO[+C_,=OU==SQ7^RM1_P"?"Z_[\M_A1_96H_\
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M4?V5J/\ SX77_?EO\*]JHH_LN/\ ,'U==SQ7^RM1_P"?"Z_[\M_A1_96H_\
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M4?V5J/\ SX77_?EO\*]JHH_LN/\ ,'U==SQ7^RM1_P"?"Z_[\M_A1_96H_\
M/A=?]^6_PKVJBC^RX_S!]77<\5_LK4?^?"Z_[\M_A1_96H_\^%U_WY;_  KV
MJBC^RX_S!]77<\5_LK4?^?"Z_P"_+?X4?V5J/_/A=?\ ?EO\*]JHH_LN/\P?
M5UW/%?[*U'_GPNO^_+?X4?V5J/\ SX77_?EO\*]JHH_LN/\ ,'U==SQ7^RM1
M_P"?"Z_[\M_A1_96H_\ /A=?]^6_PKVJBC^RX_S!]77<\5_LK4?^?"Z_[\M_
MA1_96H_\^%U_WY;_  KVJBC^RX_S!]77<\5_LK4?^?"Z_P"_+?X4?V5J/_/A
M=?\ ?EO\*]JHH_LN/\P?5UW/%?[*U'_GPNO^_+?X4?V5J/\ SX77_?EO\*]J
MHH_LN/\ ,'U==SQ7^RM1_P"?"Z_[\M_A1_96H_\ /A=?]^6_PKVJBC^RX_S!
M]77<\5_LK4?^?"Z_[\M_A1_96H_\^%U_WY;_  KVJBC^RX_S!]77<\5_LK4?
M^?"Z_P"_+?X4?V5J/_/A=?\ ?EO\*]JHH_LN/\P?5UW/%?[*U'_GPNO^_+?X
M4?V5J/\ SX77_?EO\*]JHH_LN/\ ,'U==SQ7^RM1_P"?"Z_[\M_A1_96H_\
M/A=?]^6_PKVJBC^RX_S!]77<\5_LK4?^?"Z_[\M_A1_96H_\^%U_WY;_  KV
MJBC^RX_S!]77<\5_LK4?^?"Z_P"_+?X4?V5J/_/A=?\ ?EO\*]JHH_LN/\P?
M5UW/%?[*U'_GPNO^_+?X4?V5J/\ SX77_?EO\*]JHH_LN/\ ,'U==SQ7^RM1
M_P"?"Z_[\M_A1_96H_\ /A=?]^6_PKVJBC^RX_S!]77<\5_LK4?^?"Z_[\M_
MA1_96H_\^%U_WY;_  KVJBC^RX_S!]77<\5_LK4?^?"Z_P"_+?X4?V5J/_/A
M=?\ ?EO\*]JHH_LN/\P?5UW/%?[*U'_GPNO^_+?X4?V5J/\ SX77_?EO\*]J
MHH_LN/\ ,'U==SQ7^RM1_P"?"Z_[\M_A1_96H_\ /A=?]^6_PKVJBC^RX_S!
M]77<\5_LK4?^?"Z_[\M_A1_96H_\^%U_WY;_  KVJBC^RX_S!]77<\5_LK4?
M^?"Z_P"_+?X4?V5J/_/A=?\ ?EO\*]JHH_LN/\P?5UW/%?[*U'_GPNO^_+?X
M4?V5J/\ SX77_?EO\*]JHH_LN/\ ,'U==SQ7^RM1_P"?"Z_[\M_A1_96H_\
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M4?V5J/\ SX77_?EO\*]JHH_LN/\ ,'U==SQ7^RM1_P"?"Z_[\M_A1_96H_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\:PJZX2<HIM6.2<5&32=T@HHHJB HHHH **** "BBB@ HHHH **** "BBB@
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M(DF&8#Y9%_Q]16-7T_>V%IJ5LUM>V\<\+=4D7(^OUKDKCX6>&II"R1W4 /\
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M  J?P[_STOO^_J__ !--YAA7NOP$LMQ:V?XGB5%>V_\ "I_#O_/2^_[^K_\
M$T?\*G\._P#/2^_[^K_\35?VI0\_N(_LK$>7WGB5%>V_\*G\._\ /2^_[^K_
M /$T?\*G\._\]+[_ +^K_P#$T?VI0\_N#^RL1Y?>>)45[;_PJ?P[_P ]+[_O
MZO\ \31_PJ?P[_STOO\ OZO_ ,31_:E#S^X/[*Q'E]YXE17MO_"I_#O_ #TO
MO^_J_P#Q-'_"I_#O_/2^_P"_J_\ Q-']J4//[@_LK$>7WGB5%>V_\*G\._\
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M_:E#S^X/[*Q'E]YXE17MO_"I_#O_ #TOO^_J_P#Q-'_"I_#O_/2^_P"_J_\
MQ-']J4//[@_LK$>7WGB5%>V_\*G\._\ /2^_[^K_ /$T?\*G\._\]+[_ +^K
M_P#$T?VI0\_N#^RL1Y?>>)45[;_PJ?P[_P ]+[_OZO\ \31_PJ?P[_STOO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>_<FIE.#C9+I^-_\BHPFI7;Z_A;_ #-:BBBN<W"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\^&*1D27;MW@'&<9/6JA5A/X7TN1.C.'Q+K8G_L+5]F_^RK[9C.[[.^,?E5
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MH?\ OV*GHHNPY40?8K7_ )]H?^_8H^Q6O_/M#_W[%3T478<J(/L5K_S[0_\
M?L4?8K7_ )]H?^_8J>BB[#E1!]BM?^?:'_OV*/L5K_S[0_\ ?L5/11=ARH@^
MQ6O_ #[0_P#?L4?8K7_GVA_[]BIZ*+L.5$'V*U_Y]H?^_8H^Q6O_ #[0_P#?
ML5/11=ARH@^Q6O\ S[0_]^Q1]BM?^?:'_OV*GHHNPY40?8K7_GVA_P"_8H^Q
M6O\ S[0_]^Q4]%%V'*B#[%:_\^T/_?L4?8K7_GVA_P"_8J>BB[#E1!]BM?\
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M$'V*U_Y]H?\ OV*/L5K_ ,^T/_?L5/11=ARH@^Q6O_/M#_W[%'V*U_Y]H?\
MOV*GHHNPY40?8K7_ )]H?^_8H^Q6O_/M#_W[%3T478<J(/L5K_S[0_\ ?L4?
M8K7_ )]H?^_8J>BB[#E1!]BM?^?:'_OV*/L5K_S[0_\ ?L5/11=ARH@^Q6O_
M #[0_P#?L4?8K7_GVA_[]BIZ*+L.5$'V*U_Y]H?^_8H^Q6O_ #[0_P#?L5/1
M1=ARH@^Q6O\ S[0_]^Q1]BM?^?:'_OV*GHHNPY40?8K7_GVA_P"_8H^Q6O\
MS[0_]^Q4]%%V'*B#[%:_\^T/_?L4?8K7_GVA_P"_8J>BB[#E1!]BM?\ GVA_
M[]BC[%:_\^T/_?L5/11=ARH@^Q6O_/M#_P!^Q1]BM?\ GVA_[]BIZ*+L.5$'
MV*U_Y]H?^_8H^Q6O_/M#_P!^Q4]%%V'*B#[%:_\ /M#_ -^Q1]BM?^?:'_OV
M*GHHNPY40?8K7_GVA_[]BC[%:_\ /M#_ -^Q4]%%V'*B#[%:_P#/M#_W[%*+
M2V4Y6WB!'<(*FHHNPL@HHHI#"BBB@ HHHH **** "BBN2\?0>*KC2[9?"TA2
M839F"NJL5QQ@MQC/6JA'FE:]B9RY5>USK:*K:>+I=-M5OF1KP0H)V3[I? W$
M>V<U9J64C+U[Q!IWAO3C?:E-Y<6=JJHRSMZ*.YK!M?B"DMW;17?A[6[*&Z<1
MPSS6ORDGIG'(S^-9GCLQP^/?!]QJ&!IJRR L_P!Q9>-I/ISM_(UZ%)-%"%,L
MJ('8*I9@,D] />M^6,8IM7N8\TI2:3M8?17G.G1:EXTU37IYO$&H::EA>/:6
MUO9R",)M_C<?Q9_H:R9?%.NZEX*\/3QW[6]]+K*V3W,0P)5^8!B.A'3(Z'%"
MH-NUQ.NEK8]<KA)/B%<FRUC5+?0S)I.G,T:W+7(4S2*RK@+@D#YLYYZ56M+?
M4=/\=W7AEM>U.XM+W3#<+--*&EA??MRC8XZ'C'?VKD]/TYX?A3XEO#?W<BF:
M2'R'<&/(D3Y\8^\?6M*=&/VM=OQ(J59=--_P/5HO$<;ZEIE@;&[\R_MOM E2
M/=%&,9VLWK^'<>M;5<%#J%Y%XS\)V$=S*MI-I;/)"&^5R$X)%4O#%OJOC6VN
M-<N/$>I6,@NVCAM;1PL<2J1\K*1\QQZ_K6;I*U]E_P .6JKO;=_\,>@QZC9S
M7\]A'<1M=P*K2P@_,@/0D>]6:\PT71)Q\5M="ZQJ!>WCAFRT@_?9 (1^.5'0
M 8XIOA^[U*P\16$/B:^U^UU*XF=1O=7L;D\X5<<+V_\ K4W071]+@JSZKJ>H
MT5R?Q UB^TG1K./3YQ;37U[':&Y(SY*MG+?7BL>[BU'PGXFT2RBU[4;^VU9W
MMYHKR42.AP/WB''&,YJ(TG)7O_2*E5Y7:W],WK/Q1=:GXMNM)L=+,EE8OY=W
M>M,%V/M) 5,9;D8ZUH:GXAM=*UG2M,GCF:;4F=860 JI4 G=DY[]LUQ7P]TB
M2#Q5XDE.J7\HM;UHF220%9R0?F?CEORK0\8_\E \$?\ 7:X_]!2M'3C[3E6U
MOTN0JDO9\S[_ *V.[JM=ZC9V#6ZW=Q'"UQ*(80YQO<]%'O7FJ1ZQKEUXQ<^(
MM2M8M,N)#:QV\NT @$@,>NW@<#'4UGZR;OQ#HG@74[K4KN.>ZO(;=Q$P55;<
MP\T#'#^_3VH6'UU?]6N#KZ:+^KV/8Z*\OUS4=2'BM/#:W&OS6=C9([-IK*+F
M=SCYW<D<<XX[U7O]8\2V/PVUB2Z?4+:>VNT6SN;C"3M"77&XJ>2.03[TEAV[
M:[_J-UTKZ;?H>L45YGXEN-8\.66E:>NJZG>7&KW1:XGBVF5 %7,<(. F2>/2
MIM F\2Q:GJ%I:PZU]BDL7>VDUK:SQ7(^Z-P)RI]_3\U[#W>:X_;>]RV/1JK6
M.HV>IP--97$<\2N4+1G(##J*\W\./=MJD6DZUJOB6PU>ZMY%*3RJT,K8Y:%L
M$*5Y(Q[<^MOX3::\.EW=Z=0NY%-S-#]G=P8LAA\^,?>XZ^]$J*C%ML4:SE))
M(]&HHHK W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***A
MO)S:V5Q<!=QBC9]N<9P,T 345Y_I/C'Q?K>F0ZC8>$K>6UFSL<Z@JYP2#P1G
MJ#7>QLY@1Y5$;E077.0IQR,U<Z;AHR(34]4/HI-ZX!W#!Z<]:6H+"BF[@5+*
M01[5SW@77KOQ)X5M]3O5B6>1W4B)2%P&('!)]*KE=G(GF5U$Z.BD5E894@CV
M-+4E!12,RJ,L0!ZDTM !12*RM]T@XXX-<_XR\22^%]&BO8+1;J22X2 1M)L'
MS \YP?2JC%R=D3*2BKLZ&BN-MO&.JVNNV.E^(= _L_[>Q2WGBN5F4L.Q ''4
M?G76W$CQ6\C11B24*2D>[;O;' SVS3E!QW",U+8EHJAHMU?WNDP7&IV/V&[<
M'S+?S ^SD@<CU&#^-7ZEJSL-.ZN%%(&5L[6!QP<'I064$ D GH">M(8M%%%
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M&X1;NUJ9VFZ)9:5=W]S:JZR7TWG3EFR"WMZ4E_H=CJ6J:=J-RCFXT]F: AL
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M!_\ 7K'OF)Y)D;EOU./PK(U?0M4\0>*M.CNK*VM]"TN83QN) SSL%&T;1]T
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MK"\0^(CH5WH\ M1-_:-ZEKG?M\O=_%T.?IQ6[3<6DGW$I)MKL%%%%(84444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"9)@.QW# S[?E79LRHI9B H&23T K.T37],\16;W>E7(N(4D,;-M*X88.,$
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M<:H#D* *RJ3@U:*Z_P"1K3A).\GT_P QU%%%8&P4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44UPQC8(0'P=I(X!K
MC? >G>+[&74CXGO//1W'D R!SGG)&.BGCC]!5*-XMWV)<K22MN=I45S.MK:S
M7# E8D9R!U( S4M4]6_Y U]_U[R?^@FDMQO8X^V^)L=Q8I?KX9UPV# G[3'
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MVHW(MHRF,*QQR<]N:YGP^EWHGQ)O-!_M.^O;&33A=J+R8R,C[PO!_.G^/_\
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M8****DH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR7UQ>E.DUP06QV''I6A12E.4M&QJ$8ZI'$?\*XBBN[N>S\1ZY9BZG>>2.VN
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M&SNXK^QM[R DPSQK*A(QE6&1^AKP[1(?"$LNKGQ!I=_=W?\ :4P1[=)2H3C
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MRJO_ ,(#?6OA[0+"":*>XM-62_O)&.T'DEMO'T'OBO1**KV\A>QB<T-"O/\
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M4HII]@HHHK(U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO<SBYC?RTQD@9SUKL:*7M7S1:6P_9>ZTWN<5I>KWSZI;H? 4MBK.%-SNC_=
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MKGTS^->GT5G"?*FFKW-)PYFFG:QYY:^#-7U.U\1:EK,D,&KZO;&WCAC;*6Z
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M3X@CE?2[V.Y$1 D"@AESTR" 1T-.5.<;W6PHU(RM9[FG1114%A1110 4444
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MI2::;:^L+]$\P6]]!Y3NG]Y>3D5P6@SV\'PNM7NM0U"R0ZJ5$EB<.26.%/\
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M#[*!CR?+&SKG[O3K3_LT'GK/Y$?G*NQ9-@W!?0'TJ77O?3O^*7^12H6MKV_
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MZ 5S/A#P>FE:$EIK%I8W-S'<22H^P2;0QR,%AD&K5:-GOT]>IFZ+NMNOIT.
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M4:$6D^_]=O\ ,T=:2;7;^N_^1W]QXFT2TT>+5IM2@6QF_P!7-G(<^@ Y)X/
M&>*+'Q/HNI:;<:C::A'+:VP+3N 08P!D[E(R. >U>;ZP->GL_"/B"^AGL5MX
MY%N#:V@D-J3PK^400 0!VX^N*M:?:"^TSQ=J\%]J-_)<:<\!DGL1;K.0AP5
MQN(Z=.]'L(\M[_U>P>VES6M_5CLH_'GA:6[2V36K;S73S!DD+C&?O$8!QVSF
MK.D^*-%\0FXCTC4HIY81\P"D%??! R/<5Y_J>CA_A[X)@%@2POK;SD$7(#!B
M^X8X!/7-=#):/%\8DGB@987T4J[JF%+>8>">F< ?D*4J4+:>?X#C5G?7R_$O
M:%X@M[3PO;7VL^(+:]$UPT*7BQ>6C,2<+C';!YP*TM'\5:'K]Q-;Z7J,5S-"
M,NB@@XZ9&0,CW'%>6Q:=<2_"CP_:RV<K'^VE,D31G.W<^<CTYKL;^UDA^+>G
M7%O:G9_94BEE7"D@MA2>GI53I0N^^OX"A5E9=M/Q-@>.O#!U,:<-8MS<E_+
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MY\;2N.YYZ5)<K+I%]X+U[4;.XGTVVTM(92L1<V\I0?.5Z]P/P]<4_8PO9?\
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M7)_#J^@N?"-G:I%+%<6<2PW"RPE"' ]QS765C52C-I&U-MP384445!84444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !5._U:PTQ-UY=1PYY )Y/T'4UROB?QJ+1WL=+(:8<//U"'T'
MJ:S-'\&WVM/]OU>>6-)#NPW,CCUYZ"NN&&2CSU79?B<4\6W+V=%<S_!&M=?$
M6QC<K:6<T_H6(0'^9I(?%^M7!W0^')G0^A;^>VNCT_0M,TP#[)9QHP_C(RWY
MGFM&DZE!:1A?U94:6(>LYV]$<_:^(;]R!=>'[Z$'N@WX_E6Y#*L\8=5=0>SH
M5(_ U)16$Y1>RL=$(RCN[A1114%A1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R7C?Q
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M%B2?I7DFNZW\4]/TE?%KS6=OIQ*R&P1%9H8V(QORN3U&<'//;MI>//'.H?\
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M6."XMO/\M8KF DB4*2%V,,AL9P,9.>.HH \O\7?\E'^'7_7*W_\ 0Q6K\?\
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MDWG<RDA?1>3@Y)IZZ;=2QSW2:?>)<1F%HUN[L.TH20.5&"0O3 )/4]A74T4
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M*[?<KV;LEV/.PWA_;XL'B3[)_:'VN8 7.WS3#M'E>7GG&,8V]ZDTK3?M^O\
MAN'7+<3S1Z"9'CG&[YP\8^8'J0">O?WKT"2UMY9DED@B>5/NNR E?H>U/V)Y
M@DVKO VAL<X],U3K::"5'N>42Z/I]OX!\17<5I&MS:ZC,MO+C+0JD_R!#_"!
MSP/4^M>LCI49@A,;1F)-C$EEVC!)ZY%25%2IS[E0I\@5'.LKP.L$BQRD?*[)
MN /TR,_G4E%9FAE?9=<_Z"UG_P" )_\ CE'V77/^@M9_^ )_^.5JT57,R>5&
M5]EUS_H+6?\ X G_ ..4?9=<_P"@M9_^ )_^.5JT4<S#E1E?9=<_Z"UG_P"
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M=<_Z"UG_ . )_P#CE:M%',PY497V77/^@M9_^ )_^.4?9=<_Z"UG_P" )_\
MCE:M%',PY497V77/^@M9_P#@"?\ XY1]EUS_ *"UG_X G_XY6K11S,.5&5]E
MUS_H+6?_ ( G_P".4?9=<_Z"UG_X G_XY6K11S,.5&5]EUS_ *"UG_X G_XY
M1]EUS_H+6?\ X G_ ..5JT4<S#E1E?9=<_Z"UG_X G_XY1]EUS_H+6?_ ( G
M_P".5JT4<S#E1E?9=<_Z"UG_ . )_P#CE'V77/\ H+6?_@"?_CE:M%',PY49
M7V77/^@M9_\ @"?_ (Y1]EUS_H+6?_@"?_CE:M%',PY497V77/\ H+6?_@"?
M_CE'V77/^@M9_P#@"?\ XY6K11S,.5&5]EUS_H+6?_@"?_CE'V77/^@M9_\
M@"?_ (Y6K11S,.5&5]EUS_H+6?\ X G_ ..4?9=<_P"@M9_^ )_^.5JT4<S#
ME1E?9=<_Z"UG_P" )_\ CE'V77/^@M9_^ )_^.5JT4<S#E1E?9=<_P"@M9_^
M )_^.4?9=<_Z"UG_ . )_P#CE:M%',PY497V77/^@M9_^ )_^.4?9=<_Z"UG
M_P" )_\ CE:M%',PY497V77/^@M9_P#@"?\ XY1]EUS_ *"UG_X G_XY6K11
MS,.5&5]EUS_H+6?_ ( G_P".4?9=<_Z"UG_X G_XY6K11S,.5&5]EUS_ *"U
MG_X G_XY1]EUS_H+6?\ X G_ ..5JT4<S#E1E?9=<_Z"UG_X G_XY1]EUS_H
M+6?_ ( G_P".5JT4<S#E1E?9=<_Z"UG_ . )_P#CE'V77/\ H+6?_@"?_CE:
MM%',PY497V77/^@M9_\ @"?_ (Y1]EUS_H+6?_@"?_CE:M%',PY497V77/\
MH+6?_@"?_CE'V77/^@M9_P#@"?\ XY6K11S,.5&5]EUS_H+6?_@"?_CE'V77
M/^@M9_\ @"?_ (Y6K11S,.5&5]EUS_H+6?\ X G_ ..4?9=<_P"@M9_^ )_^
M.5JT4<S#E1E?9=<_Z"UG_P" )_\ CE7[5+B. +=3)-+DY=(]@/X9/\ZFHI-M
MC2L%%%%(84444 8>L:Q'%=#35NEM79=TMPYQL4]E]6/Y#KZ Z=@MJEA ED5-
MLJ!8RIR,#CK5FB@ HHHH *BN;:&\MI+>XC$D4B[64]Q4M%"=@:N>,^+/!USH
M<KSPJTU@QRL@'*>S?XUQLD>:^EG19$*.H96&"K#((KC-:^&^G7\C36$ALI#U
M0+N0GZ=OP_*O5P^/5N6K]YYE7!-/FI?<>*-#[4L<;(X9"58'((X(KM[SX=:]
M;.?+MDN$'\44@_D<&J8\$^( ?^07-^G^-=ZKTFM)(YG&JM'%F_X)\<WRWEOI
M>J.;B&5A'',Q^=">F3W%>JUY=X6\ ZA'J<%[J2"WB@<2!"06<@Y XZ"O4:\;
M&>R]I^[^9Z6$=1P_>!1117(=04444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'E?\ PO'2O^@1>_\
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H4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ethicsemployeepolicybook003.jpg
<TEXT>
begin 644 ethicsemployeepolicybook003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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MT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+E6BNQF\-^'/^$AET"+5=0BOEN#:I)-:H86D#;0"5?(!/?%<G<V\EI=36TH
MDB<QN >A!P:49J6PY0<=R*BBBJ("BK-Y#:0^1]DNFN-\*O+F(IY<AZIUYQZ]
MZK4)W&PHHHH$%%%% !16CHNCS:W?&".2.&*.-IIYY#\D,:]6/^>216FMMX/>
M86W]H:LA)VB\:!/+SZF,'=M_'/M4N:3L6H-JYS=%/F18IY(TE65%8A9%! <
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M@)9W37,6Q27:(QX8@%EP3V.1GO5:FG<'H%%%% @HHHH **** "BBB@ HHHH
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M43T6W_!.I\1:W=Z)XBN]&L;:WBTZSE\A;5[=&651QN<D98MUSG//&*H>/O\
MD=M1_=F+_5_NSU7]VO'X5 GB[5%BB#?999X5"174MLCS(!TPY&>.Q/([5F:E
MJ-UJVH2WUY)YEQ+C>V,9P /Y 4X0::;70)S331U0OK.R^'^B_:])M]0WW=UM
M\Z21-F!'G&QAG/OZ4WPEK"-X]T@Z?I]OI\<L\<,L<1:0."V<YD+$'IT(Z5CV
M'BC4-/TZ.P2.RFMXW9T6YM(YMI;&<%@<9P/RJ.Y\17UQ>6EVB6EM/:/YD3VE
MK'#AL@@G:!GH.M3[-V:[WZ_H/VBNGVMT_4Z+0-9N9KOQ)?7:0W$D6E.J*T*A
M.)H\94  X)SSU[U2FOIM=\$W]SJ'ERW-C=P"&81JK!)!)N4D 9'R@CTK*G\1
M7T\]W*%MH6NX/L\P@MTC#*6#'@#KD#GK5.+4+B'3KBP1P+>X=))%VC)*;MO/
M_ C35/KZ"=3IZG;R65H/%-W<-:0S&QT.&[BMV0;'D$$?++W W%B.^*YI_$UW
M?O#'JJ0W=NLZ2,OD(KA0>55@!@$<8Z55_M_4QJT.II<F.\A1(TD10,*JA ,=
M"-HP<]>]6+CQ3J$J(L*6=GME68FTM4B+.IRI) ['MT]J%3:WU!S3VT-[7;B7
M5])U"XT[4;*]T^)EE-LUH(9[-"P VC&,<A3M8_2N'K9OO$^H7UI-;,EI EP0
M;AK:V2)IL'(W%1SSSCIFL:KIQ<59DU)*3N@HHHJS,**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC#9/ /6O.JJA3E&3OTT7H36J1E%6ZZL****Z3F"BBB@ HHHH **** "BBB@
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MD%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 44=*Y'7O$IW-:Z?(1@X>9?Y*?ZT
M==17->'_ !$+H+:7K@3]$<]'^OO72T %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8VS.(8C'$ %49/++Z U>^Q_&'_G]B_.W_P#B:YF^UN7P]\8M2U*"R:]DBGE
M@5B"V5QU /3.>E=3_P +BU3_ *%"?_O\W_QNMI0FE'D@FK+L8QG%M\\FM?,Z
MR_O-=TGX97%W?3A=:@M69Y0%.'SP< ;>F.U>?>'M3^)_B?3GOM-U6-X$D,1+
MK"IW  ]-ON*] \4WKZC\*[V^DA,#W&GK*T1.2A8 [>W3->7^!/B1;>$-!ET^
M;39KEGN&FWI(% RJC'(_V:SHQ;IR<8INYI5DE.*<FE8W[/Q_XJ\+>((-,\96
MZ/!,1^^"J&52<;@4^5@.XQFO8*\&O'UGXN>([.2'3&M-,M_W;2DEE1<Y8EL
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M%2".A!%-8B*E!]E9DN@W&2[NZ//_ (-:3(;'4/$5UEKB^E*([=2H.6/XL?\
MQVL;X5?\E*U[_KE-_P"CEKU_3--M=(TV#3[*/R[:!=J+G.!]:R]&\&Z-H.K7
M.IV$$B75RK+(S2E@0S!CP?<"AUT^>_78:H-<ENFYYQKG_)?[#_?A_P#0*?\
M%JSN-"\3Z3XJL %DW!'../,3E<_5<CZ+7HMQX/T>Z\2Q^()8)#J,94JXD('
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MCK]31"HHTY0>[L$Z;E4C)=+GE%MJ5GI'QTOKR_N$M[9)I@TC]!E"!^M>G_\
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M:0Y=T*%+67-LSY1U34K]].M-#OU96TN695#_ 'DW%<H?H5/YU[MX[\-S>)/
M,45JF^[ME2XA0=7PN"H^H)_$"KVL?#KPUKNIRZA>V;FYEQO:.5D#8&,X'>NH
MCC6*)(T&%10H^@K6KB5+E<%9HRI89QYE-W3/(_AG\0M/L=(30=;G%I);,5AF
MEX4J3G:Q_A()/7C%=IK7Q%\-:/8O.-3M[R7'R06L@D9SZ<<#ZFEU_P"'OASQ
M%.UQ=V9BNF^]/;ML9OKV)]R*RK'X/>%;.<2R)>78!R$GF&W_ ,= S4REAYOG
M=UY%1C7@N56?F:;_ !#T&/PM#X@DDG6UF?RD0Q'S"_=0.AQ@\YQQUK=T?5[/
M7=*@U*PD,EM,"5)&",'!!'J"#536/"VCZYI$>EWEHHM(B#$D7R>60,#;CIP2
M*NZ5I5GHNF0Z?80B*VA&$7)/4Y))/4DDFL)>SY?=O>_X&T?:<VMK?J7****S
M- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)X*.D2?$;=X0DD@T=;0_:H993^\?G&U6.XX^7GM@^O.[\./^0YXR_P"PL_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45'Y\).!*G_?0J3-
M !111F@ HHR/6C(]: "BDR/6ER/6@ HHR/6DR/6@!:*3(]:,CU% "T4F1ZBC
M(]10 M%)D>HHR!W% "T4WS$SC>N?K3LT %%%% !1110 4444 %%)D#J12&2,
M=74?C0 ZBH_/B/\ RU3_ +Z%+YT7_/1/^^A0 ^BF>;'_ ,]$_.CS8_\ GHGY
MT /HI@EC/21?SI=Z?WU_.@!U%-WI_>7\Z-Z_WA^= #J*;O7^\/SI=Z_WA^=
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M]OZ-_P!!>P_\"4_QH]G/L'M(=T:-%9W]OZ-_T%[#_P "4_QH_M_1O^@O8?\
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M?9I_^>,G_?)H^S3_ //&3_ODU*PE-75]'?\ $J6,J.SMJK=^GD>D_P!N:/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% '(8RZCW%=,L> .:YD\$'WKH
MTF!51W(I$Q)R,K51HY Y(S5LG"\U )D)QN%)E$D6?+&>M4;L?O5-:"'*U%(J
MEN1FAK08Z+H*G%1K@8J04T(6FFG4TTP*5Y*(DR<]:HF\0GK5S4$+Q\#-9#1L
M.JG\JRDW<:-F-@0OO5D(,5G1G$2-Z8J?[6@R"PS57 M*@S231Y0@5%;SB7D&
MII' 4FFA&6%=9U!Z9K7C^Z*SC(#*OUK1C^Z*: ?1113 **** "BBB@ HHHH
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M;&,=1[UI:AXNN9]>U*QMM2ATV'3Y%AW/I\MRTTFQ6).T@*HW 8ZGD\<9W?\
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M)RR*BC W'&2<DX'I0!RUMXUU,1V-_)=P77VB6(3:;#ITRF)'8#*2G[Q7.22
M" <8XKK=&U6XO[_7X)A&$L+X6\.T8)7R(GY]3ES^&*K6'AB[L3:P+XAU!].M
M64Q6Q"!L+]U&D W,H].IQR3SE;GPL\FIWUU::O=V4.H[3>01*A#L%";E8C*$
MJ "1Z C!YH Y5+_7]=G\"ZE'J5K:R7]M)*R?9&=5<P%F/^L&1Z#MUR:V;GQ3
M>62:^([>WDN8=5@TZS7!17>6.'!D/H&D)..P JZ/!L<.DZ'9V6I7-K-HR[+:
MY549BNPH0RL"#D'\Q4\_A*QNK?6(9Y9V74[E+IF5@K0R(D:JR$="#$K#W]J
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MP_POTR;3%NXI<%3@@CO5GQ;>P@LBHK8XP1FLOP5?W5MXQ-E-+FUN;7S(U/\
M>&,UH>*K-U\]H!^]<X4D9Q7!4OR'I4[>T,_P\]UI<;3R(B+*<\KVK+UB87\D
MRQ[#&23R.3713Q&T\/P+JR&:11@O&<?I7*O<::RL+:VN"Y!&2W0U$HM:7.BF
M^9\U@T:.P=RDT"B5.M<-\1EC37HQ&,+Y0Z5VNA6$BO+)<ON?/!]J\_\ '=TE
MQXCD5#E8E"56&UJ&6+?[LTOAKKPT7Q393.^V)G\M_HW'\\5]7(P= PZ$9KX?
M@=D<,IP0<BOKCX?^(%\0^$[2YS^]50D@SR& KT$>9+N=6*9-]RGBF2_=ID$
M%#?</TH%))Q&WTIB/)-:;/B.3_?KT;0VSI\9]J\WU,[_ !!,?]HUZ'H+9TU/
MI7-2^)G15^%&B>M%*%)Z U6O[^TTR/S+R=8@>@/)/X=:ZCE2N2N!@YK@+Z-I
MO$BR%?D1QFM/6/%B"/;9LX4@$R #//3K7EGB3Q-=W$RV_G["O41G<3]?_P!=
M<U6HGHCJHT9;L]F/B"S2*(QRQE2=I+OLQ^=8U_XU6VN]GE1/$#U64,??H:\
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M))P* .SHKR\6][KFJ>(IK[3[.ZDM+V2%)+C5Y+9[2%0/+**L9"97#[\Y.?;
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MKQ)<^!TUMY_])TFZFNX0[1BX(^S[=X!'7.['X=,BO2(8HX(8X8E"QQJ%51V
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M"VDOH%*Q7+1*9$!SP&QD=3^9J:[BEFLYXH)_(F>-E2;;N\MB.&QWQUQ65?\
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M- Q(##(P0<$$'D$'@@\BL6[\96=GXPBT"2*?<]NTIE6"5L/N0*O"D$$/DMG
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M %!6@!H/-*W2F8PW6GG[M &?,!YF:O0_=%4)\^9[5>@^Z*0D34444QA1110
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ML<FS&Y#N52K $'H01GGC%<QJFOZGXE^%NNZG-ID%EI\VDW!CS<%Y68*1]W:
M%X.#G/3@9KI;/1M4NM>M]7UNXM"]G$\=K;6BML4O@,[,W).!@#  !/7-0+X4
MF7X;2^%OM4?G/8R6OG[3M!8$9Q^- %S1]=;6+UDL+42:7 NQK]GPLDHX*QC'
MS <Y;(&>!GG&[6!IWA^;1=8>73KA$TNX!:XLF4X27_GI$?X=W\2]">1@YSOT
M <AJ'C=['0M2NQIC37]GJ#6*V22\RL#N!!QWB._I[>]3ZCX@COA<V%G&)8)-
M&>^>X#<*KC$8QCG< YZ_P^]./A0GQW_;_P!I'V7R0QM=O6Y"F,2Y_P"N9*XJ
M#P_X,?1-,UBT:\$S7FZ&W;;CR;<*5BC]]NYOSH SO#OB'5=/\-^%Y+S2H(]+
MNXK6T21;DF9"ZA4=DVXP3C@,2-P]P(_%=Q:R^'_'D4%C'!-!Y:SS*<FX)AC8
M,>., A>_2N@F\-RR>&M#TH7"!].ELY&?:</Y#*2 .V=OZU6U/PE-?VGBF%;J
M-#K31LA*G]UMB1.?7[F?QH EUCQ3):ZV='T]+%KF.%9YY+Z[\B.-6)"J,*Q9
MCM)QC '4\@5>\.:\GB#3Y9Q&L4]O.]M/&D@D59%Q]UQ]Y2""#@<'H*SM8\+S
M3:\VLZ?'ILTTT"P7%OJ$.]&"DE65ARK#<0>"",=,5L:)I\VFZ:(;AK4SL[._
MV6W$,8)/ "C/08&2<G% $FKWYTO1;_4!'YIM;>2?R]V-VU2V,]LXKF'\7ZW%
M'I4\F@0^5J[+%9HMX=Z2,I=?-^3"KM#$E2Q&,8-=/K-BVJ:'J&GHX1KJVD@#
MD9"EE*Y_6L^YT"2>/PZHG0?V5<+,_'^L A>/ ].7S^% #=)UR^NK[4],U"PA
MAU&QCCE @G+QS)(&VD,R@@Y1@01QBJ&G^,)Y/$-II%^FE>9>!Q&+#4//>)D4
ML5D4JN. >1W&.]6=4\+2:G=Z_)]M,"ZKIL=BK(/FB*F7+>_^M''L:IV/A?4U
MU71+NX.DVL&ENY6VL("JR;HF3.3TQN&!]>3Q@ BA\2Q:5X=BN=-T-,W&M36"
MVT4H7=(9Y$+YQ_$RY/ID^E:-OKNLG5+K1[K3;%-26U%U;>7=L894W;6#,8]R
MD''\)SD5#%X2FCTVSM3=1DV^M2:F6VGE6FDDV_7#@9]JUFTEV\61ZSYJ^6EB
MUKY>.<F16SG_ (#0!S_A+6?$%QX!M]1O;>RFN#"K1227I42 DAFD)C^3'7C=
MFI;+Q9'JD.MV%[#IUS)9V?GN+*[\^&:-@XVD[05/R$$$="#WJL/!>J?\(O::
M+)=:?-'IUU'-:B2%BDZ(6.R9<^XZ=U!]JN6OA?4&OM4O;RXLD>^TX62P6L15
M(<%R.3RWW^O'TH CA\1W$*^'=+T?1H2=0TPW,2O<%(K94$?RDA22H#X&!U &
M.<B/4/$*7?A/7!K.CP23:;<+;W=GYN^*0GRV5E8J#@AU;D9R,5IZ?X<ELM1T
M2Z:X1AIVE/8,H4_.S&$[AZ#]T?SJMJ'A*:]M?$L*W4:G5[F*9"5/[L)'$F#Z
MY\LG\: )[[7]4_X2B?0=+TR":6*SBNS<7%P8XP'=UVD!6.?DX^IZ8Y@7QFSZ
M!;7:Z<QU.XO7TY+$2C'VA&96&_'W!L9MV.@Z9XK6ATAXO%=[K!E4I<64%L(\
M<@QO*Q.??S!^5<[J6A6^E:-OO-9@L+A=:EO[.\D7]W'+*[E4<$C(*NRGD=>"
M.* -!/$&LVFOZ7I.JZ3;)]O,FRYM;HR1KL0L00R*<\?3'.>,5T]< )=1OO'_
M (?6YU2QNWMEN)I+?3T(2)#&4#N2S')9@ .._7J._H X]=2\1'XDS:>L%F=.
M6RCDVF[8$*97!D"^7]_ QMSC@?-6)H6OZMHOA34=0CTF";2["_OGG=[DK*Z"
MYD9VC7:0=H)ZL,D'IP3UUSI%^OBZ'6K.>V\I[5;6YBF1L[%<N&0@]?F8<^U5
M1X6F_P"$&U;P_P#:4\V^%[MEVG"^>\C#(]MX_*@!=7\5-;:PFDZ>MBUS]G6Y
MEEOKKR(HT8D*. 2S':W ' &2>F;OAS7TU^RGD\M(KBUG:VN(XY1*@< '*N -
MRD,I!P.O(!K-U3PK-)J\>K6":=-<&V2UG@OX=\<BH2596'*L-S#H00?8&MG0
M]/FTW3_*N3:&=W9W^R6XAC&>@ [X&!D\G% !XB_Y%G5?^O.;_P! -<OH/B'5
M;#1/#37VE01:9>I;VL<BW):9&9 $9TVXP2 ,!B1D>^.PU.T-_I5Y9JP1IX'B
M#$< LI&?UK)N/#LL^A:)IXN$#:=/:RL^TX<0D9 ],XH HMX@L=(E\2W,>E@3
MP7\-N1"PWWLTD47E]<8.9%7Z#-/G\1:]I=WID6J:+:B._NTMA+:7C2"$L"?G
M#(OIP1P?;C,&M>'[2"P\0W>I:FME!>7L%[%= ?\ 'K)&L2HQSP</&#Z8/XUF
M:E/J>H:SX9MKC6=,NW&H).+?3HR-Z(C%I7)=L*., <98<GB@"?3KW6X?$OC!
M-(TRVNA'?QR.US<F(.?LL/R)A6^;CJ< 9'7G&C<>.('TW1)K"&%KG6(/M$"7
M<XACBC"J69VP>A91@ DD^F2-C2=(?3M2UJZ:57&HW:W"J!C8!#''@^O*$_C7
M/+X&E@T7P]'#+93:AHUN;<?:H-\,Z,%#*1U'*J01TQT.30!(/'7D:9K,EU:V
M[WNE)'(Z6EUYD,B2$A7#[05 (;=D?+M)Y&*BUG7O$)\#ZW?6]OI@DAM'EAN[
M34#)&5V,2RGR\[U(& 1@Y'(K4LM&U:UTZ],<NDVE].5,0MK+]S&!_"W(9\\Y
M/&,\#USK;P7/+#X@^UM863:O9?9&ATZ(K&IPX,K9QN<[\=!PH'- '2:)-J$^
ME0R:G#;Q7#*#B"9I5(P,$DJO/MC\:A\2:T/#^ARZCY*R['CC >3RT4NX0,[8
M.U1NR3@X -3Z/#J%OID4.IO;/<1@+NME8*0  #AN<T[58;Z>P=-.G@BN<@@W
M$1DC89Y5@"#@CC/;- '(^)-=\1Q>!-3O[>WT^*:)<I=6U^71DQ]]#Y>=P/&"
M .^:W+_5=9L-,@FGM=(@G9F$SSZBR01#MAC&"Q/I@8YYK'C\#SRZ1XBMII+*
MRDUB-4$-C$1#"R@C?@XW,21N.!D ?6K-_P"']9O=1TS5YCI,]]:PRPO!-&Y@
M&]E(=.I5P%QTY!(XH C_ .$\SX2EUF.Q2YF@OTL9(+:Y#H[M*B9CDP PPX(R
M!Z'%:-EKNI)X@BTG6;"VMGN;:2YMI;:Y,JD(5#HV47!&]3GH>>F*SX?!MX-%
MNK*>_A>>XU>+4C(D110%DB<H%R<?ZL@<GJ,YK;O-':Z\2Z;JOF*([2WN(6C(
MY;S3'@_AY9_.@#G;KQ%K.K^%KW5;'1H'T>6VE,):Z(N98]I'F!-FWD<A2V2/
M0\5:L]3O-,\$^'WM4TX(UC#YDU_>>1''^[7'1223SZ=*BB\->(;'0I/#MAJ=
MDFF")H+>Y>)C<11$$!,9VD@' ;V'!I9?"5]#+H=S:OI]U-IVGBR,5]&QCSA?
MWB8^ZWRXZ<@]10 G_">%_#4.IV^GI=7#:BNG-!!<AD:0OLRDF,,IR""0.#SC
M%7KG7M7MYK'2QIUG+K=VDDQB2Z;R(84(!=G*;CRRC 7DGT&:IVO@Z[BTY+>>
M_ADF_MI-4=TB**0&#% N3CH0.3QCK6IK.C7L^K6>LZ3<0PZA;1/ R7"EHYHG
M*DJV.5(*J01GOP<T 8-MJ5_!X[U2YU/3O*FM-#5REM)YJS 22-E"0#D],$ Y
M]1@G8\,Z_?ZZB7,MMIWV*:$2I-97WG[&./W;@JN#@]1D<'IQF*ST+6QKE[K%
M[J=L+FXL1:PI!"2EN0S,",G+]<G.,^U,TGPU?P^)EUJ_&EP3);O XTZ%D-R6
M*G=(3Z;>!SC<>: .KKF!X@UC4KF].AZ5:W%I93/;M+=79B,\B<.L8"-P#E<L
M1D@]N:Z>N6CT37=(N+Y-#N]/^QWEP]R%O(W+6\CG+[=IPZELM@XP2>: ,37]
M;OM;A\(:AI5E;/!-J8(2[N&C=9ECF!C8*C  %6^8$\KT[UZ&NXHN\ -CD Y
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MH [RBN#NKK4M.\12SZS>:O:6S7R+:W%N(Y+(PL558Y%P64DG!9AU.0V*[R@
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M "BBB@"*<9C-8Z_>%;$WW#60OWA31$B"^.V-?K4Z8:U'TJC?R94GT.*O0?\
M'HI/]VM;62,;WDS(\LR7X<]%K!\?R[X-,MT)\Q[C=Q[ UT^W:K'N:YNX0:IX
MNM8V7*6T98_4_P#ZJLE:'2:- Z6,;RC#%12W+%S\W<XJ[O7RR%Z+Q6;<L2P
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M:G:Q:2NF07,<DDB*A=Y)1D.>N0J]\<5T(N[8VGVL7$1MMF_SMXV;?7=TQ[T
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MH+:[>TF=<)/&JL8SZ@,"#6$- UG4+NR;7=6M+BULIEN$AM+-H3+(OW6<M(W
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M00, C:N !@  8Q7144 9&FZ1?6MY]IO]<N[]A&8TC9$BC )!+%4 W-QU/3G
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MRL-H<GU"EP!_M&@"[!<P7(D,$\<OEN8W\MPVUAU4XZ$>E2U!;6=K9"46MM%
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M_?\ V1:]9IHH****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9)H[1.<#.!7-O=G2_B2//?%$!'A2=A_#,@S^=>;S[2XV# P/S[U['X\L#8^
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M>49DE1@K )C@ Y&2>W2MF@#B],\)ZC9O9V\T6@-;VK+F[2Q_TB95Z @_*K'
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M+L.YK6$0@P-AQ]:20.71&,FD7$:AHKLL_P#=:IL.P\J\1HI!T?'6M-[F-/\
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MW6;SW47DW%K</"98Q;Q C*GY@&#=>ASC%;L7AK2H+"RLHK79;V<XN85#MGS
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MF<*O.6A1D1%8LYZ=O6JA;<X5%SDX%+(=PR3S6QX1T\7_ (@@#KF*']Z_X?\
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MCY@2#T7"G&,YXXT3<V=OKGAW4O$4D8TTZ.@MKBZQY,=T<%RS'A69<8)]& H
M[P7]FUE]M%W ;3;N\\2#9CUW=,4EKJ%E?6IN;2\M[BW&<RQ2JZ#'7D'%<-K$
M^@2OH>H6Z6S^&([^9[R2&+_1_.*?)*^!AD#9^;E<D'/%'B*XT'4M+,^CBVN]
M/34+9M9>QCWK+ ,\,5&'"G:6 SA0<T =Q9:GI^I!S87UM=!#AS!*K[3[X/%"
MZE8O<I;+>VQN'W%(A*NYMI(; SDX((/IBN-:[T?5/&F@2^&);2XE@,OVZ>Q*
MM&ML8V 21EXR7\LJIYX)]:BT'2G'@WQ-<:5 B:Q<7FJ"&; #^9YTJIANW04
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M[HMGJTCE;B!M*DDU 7);_6+B;<[;OF5PN,8/3B@#VFF2S101-+-(D<:C+.[
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M?&#Y@'*#'!#8YP.M/\576FZ5K&MW,=WI5Y<S>4UQHNI6Q\VX*HH46[=3D 8
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M%?B(^*);."[N)E-K+?;0LMKY:A4C+<'#>9E1SDYQR*N?#<6PT+4!90R0VO\
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M*AW+.Q. S8 QR<\UTE%9.IZU/I]QY,&B:GJ&$\QWM5C"J,GC+NNX\=%R?S%
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MN4=AU- '1!0"2  3U/K2$+D%L9Z FG5S/C'[_AW_ +#4'\GH Z:BL'5O$_\
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M:C;2>(SYWV^UNO[-6=[>>1?)CCWGD@,1OR#DC/'>JB^.;3[-'J$FEZG%H\A
M34WC00E2<!RN[S AR/F*@8.>G- '4T5@ZAXIBL];?1K?3K^^U!;9+KRK94 ,
M;,RYW.RJ,%.A(ZC&><1_\)C8R:597MO:WD\UY<-:Q6:(JS><F[>C!F"J5V/D
MDXXZGB@#HJ*IZ9?G4;3SVL[JS<,4:&Z0*ZD?0D$>A!(/K5R@ HHHH **** "
MBBB@ HHHH X&YTQ)%(*BEL=-1>-O2MIX<]J6"+:W2L;#N5)-.1UP5%<KK?@J
MUOI!*T*[AWQ7H(0&FO"&'2JL";1YU8^"[:!@RQ $=\5T]II?D* !6T+< ]*E
M6,#M18')LJV\)2KR=*0*!3P*=A#QTI1244P'44E+F@!:*2BF M+244 +BC%%
M** #:*-@I:6@!FSVI#'4E% $)C'I33"/2K%)B@"J;=3_  BH6L(FY* _A5_%
M)MH%8R9='MI?O1(?J*SY_"FFS9WV<+?5!73;:0K2'8XD^ ]&6<3+80!UZ$(*
MQ]4^&NE7\K2RP N>]>EE!4;Q ]JI2DE9,EQ3U/&)_A+ID1+HC%^P+<"N:U+X
M4W$LC.MR_L.PKZ$>W![55DLU/84^>6UPLD?-%Q\,=1B)V2!L5%!X:\1Z45,#
MDA#E5)X!KZ0ETV-OX15&;1XV_A%*]]RE.VJ/F/4]%UJYN&N+F EF[#H*RWTN
M\C^] P_"OJ"?P]"XQL6LN?PI ^?W:_E0M!N2;NSYL:VF7K&P_"F%&'52*^@Y
M_!5N^?W:_E6;/X#LRP+1%AGD#C-,6A0\,_"33M4\*V=UJ4MU%>W"^;F)P JG
M[HP0>W/XT^;X&0E_W.N2*G^W;AC_ .A"O18]<ABB56LYDVC 5 " *L_V[8^2
M)"9,_P!S8<U6AE[YX9JOP_TK3UN+>'6WGO(B!EHA'$I[@G))/TJI/H.L_9;9
M+*2*:*) ,0OR#W.#BNCU#PT^HW,@NC)Y$DOF,4X/?K6[;^&+:&!?L[$X'4'F
ML:ESI@DD<AIFA7-XXCGU9XVX#)''M;/U-;426/AX3Q0S37#28\R29@Q..WTK
M6DL9XG'S$X&/F']:IR:##,#YD;+GNK$BLK,TNCD=0M=%U"1F-MY+GG?$<'\>
MU8LOA]0V;>X#CT88->@'P=8MD[Y?H'Q_2JMQX7MH%)BBG)]1)5)M$M)G"IIM
MW$^""![]*K7,:AV7(R#U%=3/;75L_P BS8_VP#6=-:FXR6LH7;U!VFK):.;N
MH^5D'.X<GWIL$<LA^0M@=>:TI;;&Z(PR1[O[W(!JO:7;6!D1XMV>N16BU,]A
MI1AP6)J,H,]*62\\QB=F*B-QZ"E8=R01D]J7RAW-0&=C3?,8T"+/EQCO1MB]
MZK@L>U'S?W:+!<L8B_NT8C[9'TJO\W]VER?[M%@+23,I^63/^]0\D\N$XP3C
MY:J$@'!R#3XFD,BB,%F)X"CG-.P'UO\ "FR&G>%?LH&/+90?KM&:[JN%^%/V
M@^$E-UGS]R[\]<[17=4@"BBB@#DX;?6?#NJZLUEI7]IV>HW/VN,QW"1O%(45
M65PY&5^0$$9/)&.*'M=:TSQ!+KD&FQWOV^SAAO+6&X4/#)'N(*,^T,IWD'.#
MP#WQ6A?^,- TR_EL;O44CN8L>9'L9BN1D9P#V-:6GZC::K9I=V4PE@<D*X!&
M<'!ZT <==>&M7U'2M;NIX(8]0U6\M)1:K*&6**%X\ MT+;58G''( SC-=!=Z
M;<S>--*U-%4VUO974,C9Y#.T)7CZ(U;=% 'G?B;3K_3_  [XFGVQ*]YK=G<6
MI<[E(WVJ L!_M(>*UKVWUSQ'=:;;7>DKIUK:7D5W/.URDGF&,[E6,+S@L!DM
MMX!XYKI-0T^UU2T-K>1>9"723;N(^9&#J<CT90?PJU0!Q-[X;U*?1_$MLD:&
M2_U:*Z@&\<QKY&2?0_NVX]J36-&U.Y\27LUQI;ZM:31QBR!OO*AMB%PPD3(S
MEN=P#'''&*[>B@#B=%\-:C8VW@N.>./=I,,J76''RDQ%!CUYJ;5?"MUJ]UXJ
MC9UAAU2SMH;>7.</'YAR1Z LOU&:["B@#GK:ZUW4@+#4="6TBDC9+FY6\1EY
M4C]T!ECD_P!X+@>O2N5L/!US!IUKHEWX=-T(0D,EXVK2"WDB7 W>7OW!BH^Y
MMV@]\5Z710 5D>*-*DUKPU?6,#!;EH]]NQZ+,A#QG\&535O5-2MM'TV:_O&9
M;>$ N57)Y('3\:N4 >;W_@W6[G0;!H?*CU:[DG352).%ANCF4*>Y3"!?9:ZH
MZ1,GC2PU"&-%L;?3)K7@@;6:2$J /3"-^5;U% ' QZ!K3>"9?#TE@BR6][%)
M%-YZE)T%V)20.JX4=#WKH]1TVYN?%FB:A&JFWM([E926P07"!<#O]TUMU'//
M%;6\D\\BQPQ*7=W. J@9))],4 25RWBO3=0O=1TV6.UGO],B647-C!=>0SN=
MNQR2RAU&&&TG^('G%=+!/%=6\=Q!(LD,J!XW0Y#*1D$'T(J2@#SRT\)ZI%X?
MU.T%E!;/<:[;7\4$<VY4A1K<M\Q[@1O]2..HKJ-.TVYMO%FN:A(JBWNX[98B
M&R24#ALCM]X5MT4 %<3K.C:E<^);R>XTN35K.6.-;)3?>5#;$ AO,3(SD\[@
M&..,<5VU% 'F<5CJ_A\^!+&.V@GOK6"YCEA,FT. BY"MR >XSQV.,Y&Z;/4]
M3UF77-1L?[/AM-.GMK>W:59)',A5F9BI*@#RU  )ZD\5TL^GVMQ?VM[+%NN+
M3?Y+[B-N\8;CH<@=ZL21K+$\;C*."K#U!H \YT9_$FI?#/3=&BTB'-YI44"W
MYN%\E(WB W%/O[@I^Z!@D=<5T=OH-Q:>)$GB&ZSBT9;%'9AN+J^>1].]:VD'
M38K(:?I<D30:?BT\M)-_E%%&$)R3D#'7FK] '"V/A[6-&TSPG>V]K'<WVDZ;
M]ANK/S0I=66/<48_+N#1CK@$$\BK6M1^(=:TJ!O[,EMHX[U7FL8K\)-<VX4@
MJ74A5.X@X#8(7!(SBNPJIJ>I6VD6+7EVS+"KQQDJN3EW"+Q]6% '%6/A>_3_
M (2EXM*BL(M3TQ+>U@\\.V\"8'><D _.O0D8/7K4MY9>)M6\)CPO<Z1# T]L
MMK<Z@+A&A6/ #,J??+8SA2  ?XB!7;75Q'9VDUU,2(H8VD<@9. ,G^5)9W45
M]907<!)AGC65"1@E6&1^AH YC4O"TVJZEXDCD;RK/4](AL8Y0<L&4S[CCV\Q
M?K6;IWANXDN;"&]\-%&MY4DGN9-7DDA)0Y#1IN))W $!E&/>N_HH *Q/$>FW
M.I-HYME5OLNI17$N6QA%#9/OU%;=% 'F^N>&-8U+^W[>?2VU"XO#*+*]EOL0
M01,N%7R\Y#+ST7#'DGGC0\1^%=2U*/1A9B-2UN-.U,%\?Z*Y0R8]2-A _P!\
MUW%% ''6?AF]@\>R7K"/^Q8S)>6RAN5N9$6-^.P 5S]9356VT754\16MS::,
M=(87;2WLT%_NMKF,[L@19Y=B0<E%(.3D]^HB\0:9)'*[721+%>&Q)E.S,V0-
MHSU))&/6M.@ KF?%NGZC?2::UM!/=V,4KF\LH+GR'F!7"G=E00#R5) .>^,5
MTU4[W4K;3Y;**X9@UY.+>'"YR^UFY].$- '"#PCJ;>'?%MK%IT%HVJ;#:6RS
MA]H"*I#,>^1D]N>">M=9K.FW-YKWAV[A53%8W4LLQ+8(5H)$&/7YF%;=4],U
M.VU>Q6\M&9H2\D8++@Y1RC<?530!S>EV^O\ ANVGTBTTF.]@^T32VEW]I5$5
M9)&?$H/S94L1E0V0!TK5\'Z==Z1X1TVPOU1;N"+;*$((W9)XQ6W5.XU*VMM2
ML["1F%Q>"0Q +D'8 6R>W44 7*XV#PG=7/PO/AJY9;>Z>%UW Y57WEESCJ,X
MSCWKLJ* .%TS0)9=4L6NO#+VWV:02R3SZM).@=0=IB7<<\XY<+@9J?2X=>\.
M6%QIEG9V5W9I-,]M?/=;%C5G9R)5QG*DD?+G..W-=G7)Z[X;\+6%G?ZOJ%G(
MEL 9[N.&>58I3W+1*P1R>^0<]Z ,70K#4G\%^"-5L;874^GQB62VWB,RQR1,
MI*D\ C<" < CO5X:/KFH3>+KJZLH[8ZKIL5M9P^<K,"JS##D< Y<'C(YZG%=
MLJI%$%10J(,!5&  .P%5M+U&WUC2K34K1F:VNHEFB+#!*L,C([4 <CJ6B:H;
MK2_/T^?4].AT]8&LX+P0B.<=78%E#@C ZG&#@<U!;>%]7M/!J6B6EO\ ;+?6
M1J*6L<WR,@N?-V*Y_P!G@$XZ<XKT"B@#E9]$N]7UNZNKN VMM>Z+]BD'F*SQ
MNSL2..N W7I6=<6/B:_\)'PI-I4,1DMA93:D+A3#Y6W:SJGW]Q7.%( !/7 K
MNZ* ,&TTF>W\9W>H[1]D?3+:UC8MEBR22DC'T=>:Q6T"\BT:ZM[G0X=4276+
MF[\G[0(Y%1Y&9'C;@!^1_$N 3S76)J5M)K$^EJS?:H8([AQMXV.SJO/U1JEN
MKVUL1";JXBA$TJPQ^8P&^1N%4>I/I0!SFA0>(-*TE8WM'N#+J'[N"ZO=\EI:
M' .Z0YWLN"<9/! SQ75444 %%%% !1110 4444 %%%% &3Y="QX-3 "EQ46&
M, IV*7%+BF(9MHQ3L44 )BE I:* "BBB@!:*2EH 6EIM+0 M%)2TP"E%)2B@
M!U%(*6@!:*2B@!:2BB@ HHI*  T44E  :8:=330!&PJ-@#4C5&: (645$T8J
M=JC-!)7:(5 T ]*N&F&@10:U4]JA:S4]JTB*:0* ,A]/0_PU$VF)_=%;>T4W
M8/2@#".E)_=IHTI5.0,'VK?\L>E'E#TH#4P'TYFX//U%1G23V4"NC\D>E'DC
MTHL%V<R=))Z@5$^D^@KJC /2FFW'I19#NSC)=&5@<Q@_A6;<>&X9,_N5KT%K
M4'M4+V:GM2L/G9YI-X;V@@1!E]&&:R;SP=#<9D$ 5^XKUI[)?2J[:>N?NB@K
MG/%I?! &?DJE+X);G"FO;GTQ#_"*@?2D/\(HNQW1X7)X-F'0'\JKGPE<J,X/
MY5[J^CH?X!^51-HD9&-@_*CF#W3Q*/PM<;3P?RIK>&KD=C^5>V#1$'\ _*F-
MH2'^ ?E3YAZ'A[>'[H?PG\JB?1KJ)6<H<+[5[@V@1G_EF/RJM/X;C=0OEC!Z
M\4<PK(\-73+ESDQG\JZ/P=IC+XFL6D4#:Q."/8UZ4OA:,#_5C\J?!X=^SW,<
MT:X*,#P*+BLCT[P*"-,N0?\ GM_[**ZJN=\(($L)\#K+G]!714Q!1110!P=I
M=:U;^._%8TO2[2\0RVI=I[TP%3Y"\ "-L_I6MK>NZIH>CVNM7EK;16L#?\3.
MW20RM'&3@/&^%W;3@D;>03CD#*W'A>]_MO4-3T[Q!=6!OC&TL26\4BY1 @(+
MJ3T%3MX<DN_[/&K:I/J"6<IGV/&B++)_ 7"@ [.H'K@G.!0!F-XFU9?#=GJ'
MV>V%WK%VD.G0MG;%')RC2D'YB%!8A<?W1ZU/J6IZSX5T/4=4U2[M-1AAB!B6
M*W:!O-+!0I^9AM)(YZCGK4P\&60TF?2TN;F.U^U"ZLQ&0&LG!W#RCCH&R0""
M.2.G%2CPW/>6EY:ZWJ]QJ4%S#Y)B\I(54==PVC._ISGC' % &'I_BN_76-.@
MFU"WU..\E\J9+?3Y8#;,5)#!F)#)D;3G!Y!]JM:?>>*=<;4Y+>\TZQAM+^>V
MMP]JTIF".0"_SC:.W'/4\=*U;#1-1MKR"6\\0WM[#;@B.%HXXP^1C,A4 N0/
MH,\XS7.^'=%U&;^W9;+6[O3Q-J]WYD8B20?ZP@,F\':<?4<=,T 5=0U76=?B
M\(WUK=V^GO)JDEM- T#2A9XX[A7.0Z[DRAP,#L<\8KT":5K73I)9IX5>*(L\
MT@V1@@<L>>%[]>G>L6?PA:C1=,T^PNI[-M,G%Q;3C$C>9A@Q;<"&W>8^?<YK
M3U+2H=7T*YTF^=Y(KF P2NN%8@C!(QP#W]* .3TCQ9>2>(M,LI-1AU*WU'S%
M\R+39K=(V5"X*.Q*NI"D8SGH<U+H/B/4K[7([:_U"RM;AY)5DTF>T>*557.T
MQR%L2<!22!@@DC&*TH/"UR=5TW4-1UNYO9=.9S OE)&F&C9#N"CD_,#GVX R
M<D?A:X>_LI;_ %R[OK:QG-Q;PRQQA@^UE!9P 6P&..G;.: +/B35[K3(K"VL
M(XFO]1NEM8#-DQQG:SL[ 8) 5&. 1DX&15 W^NZ7K5GI5_>VETNIQRI:W26I
MC,,R(6PZ;R&4@$\$'C'?-;&MZ+!K=G'#+++!+#*L]O<0D!X9%Z,,@CN00000
M2*IV/AV5-6BU35-4FU&ZMT:.WW1K''"&QN(51RQ  R2>.F,F@#A'&KCX3>()
MKR]ANU%S=+'&L!C;>MXX.6+MP2.!C@8&3BNPCO\ 7=,\1Z59ZI<V5U!J8E3$
M%NT9@D1-_!+'<I 8<@'(!]J4^#$;2]4THZG<'3[Z5YEA*)F!GD\QMK8R06)Z
M],UL7NDQ7VJ:9?O(ZOI\DDB*,88NA0Y_!LT <*WCR^N[6[U.SOK2)(GD%OIS
MV$TC3JC$?-*#A6;'& 0N1G/-;<^M:WJ?B.UTS2GMK*WGTM+]YKF R21DN1MV
M[@,GCKTP>N:L_P#")W%N9[?3=>O;'3IY&E:VB1"8RQRXC<C* DD]\9.,5JKI
M$2^(#K E<R_9!:;#TVARV?7/- '+ZAXLUBWT_5+.U@MI=>AU/[':1,I"2(RB
M5&(SG_5;LX/535A_%LNH&6734A>RCT,ZC*9%+'?(#Y2'GT23(^G2M9O#%FWC
M%/$ADE^T+;>1Y.1Y9.3B3']X*S+]#5?2_!MCI.GZS:033%-4DD9F;!,2L" B
M_P"RN3@>] &/J'B;4H+;1W:YM]*LKG3TN'OI+)YXO-('[L[6 C7!SECST!XJ
M;6/%MQ;7.E:;'?64$]U9_:Y[Y('N(@HP (E4\[B3@DX '?-:TOAZ]CM[.+3=
M=NK-;>U2V*>5'*CA1@-M8<-[CCU!J$>#8+6STM-*OKBQNM,@-O#<J%<O&<;E
MD4C# E0>V".,4 +X3UZXU<ZA;7+),UG(JI=QV[PI.C+D':W(8$$$9(X![X$5
MSJ.N7?C6ZT6PGM+:SM[."Z>>2 R.2[R*4 W <A.O;!X.>-K2M/GL()!=:C<7
M\\K[WEFV@#@#:JJ %7CI]22<TD.DQ0^(+O5Q(YEN;:*W9#C:!&SL"/<^8?R%
M '&3^-;R\N]2:SU*SLH[.XEMX;>:PEF,[1DJQ=U("@L"!@$@<G/2M*'Q'JFO
MW>G6.E+'ILDVG1ZC=274)D:$.2JQJF5^;*MDGH!TYXNR^%[B*YNVTK7+O3K>
M]D,L\$<<;@.WWFC+ E">IZC/. :GO_#9GN[6_L=1N++4+>#[/]HP)?-BX.V0
M-][D9SP02>>30!CMX@UZP'BN&^^Q22Z1IR75K+%&RB8E93EE+'',8& >QYYX
MU=2UNZM+/P_+&L1;4+R&";<IP%=&8[>>#D"LC1=%QXK\5V5_<3WR7EC:+/+-
M@>9N$ZD * %&,# _4DDVXO!<Q;2A>Z]>W<.E3)+:QM&B_=!4;R!\YP<9X[\9
MYH J7_BC4;/0/$E]:V]JUS8:JMK"A4JL@)A'S'/7]X>?IQQ3]:U_5/#Z:=I]
MYJ%FU_J,LA^U"S?RK>)%!;$:L6<Y( R1UR>G.I/X3MI]/U2S:XF":A?+>NP
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M]L7.//A:)%^7UVE"".W'K5SQ;KC6.@:S%IEPC:Q;6+W"1)\SQKTW[?;J/7%
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MA0!M<(R#E6QE@>C<YXK1\?1R#0K6]6)YH=/U"VO;B-%W%HHW!8@=\#YL?[-
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MR\7?_?2__$T<K#0Y];@>M7K8EDW'H>E:H\(V*G_7W/\ WTO^%75T.U50 TH
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M#C:2.O2J6G7<OA:_UJ"^TO49S=W\EY!<6=J\XF5P,*2H.UEQM^; P!S7:44
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MBN<ROU<?*N3P=Y'Y8KTBJ&C:3#HFE1:?;O(\4;.P:3&?F<L>GNQH XI+;6M
MTSPYI%W<:G'I\&G".YGTJV,\AG7: APK,J8W8('..2*K6^C:A-X3N+>;3[TM
M+XD@N/+N1ND:'SXF+MCC[H)/I@^E>FT4 <]>V<[^/](O$@<VZ:==Q2RA?E!9
MX"JD^^UL#V-<YH&GW!\6#P_(A.F^&Y7N;=LY#></W"_]LU:8?@AKT&5&DA=%
MD:)F4@.H&5/J,@C(]Q6?HNBQ:-#<8N)[JYN9C-<7-P5\R5\ 9.T   *
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7A]%']JO^7\?^ 'UCR/</M,'_/:/_OH4?:8/^>T?_?0KP^BC^U7_ "_C_P
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M1_\ ?0H^TP?\]H_^^A7A]%']JO\ E_'_ ( ?6/(]P^TP?\]H_P#OH4?:8/\
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MA]%']JO^7\?^ 'UCR/</M,'_ #VC_P"^A1]I@_Y[1_\ ?0KP^BC^U7_+^/\
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M<.CLKCHRG!I99I9WWRR/(WJ[$FD\3>GRVUM;I_E?\1<^ECK_ !3(X\5:4 Q
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M1Q1.TDB>9G&<DX]:QJ<'9590Q ;J >M-KFG)2UZ]3-NX4445(@HHHH ****
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M_P#A7NI?\_=I^;?X4?\ "O=2_P"?NT_-O\*/J=?^4/93['(45U__  KW4O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHIKND4;22,%102S,<  =S0 ZBO*?$GQ6E$[V
MV@QIY:G!NI5R6_W5]/<_E7(OX]\4.Q8ZQ,"?[JJ!^0%>C3RRM-7=EZGFU<UH
M0ERJ[]#Z$HKYY_X3KQ/_ -!BX_)?\*/^$Z\3_P#08N/R7_"M/[)J_P R_$S_
M +8H_P K_ ^AJ*^>?^$Z\3_]!BX_)?\ "C_A.O$__08N/R7_  H_LFK_ #+\
M0_MBC_*_P/H:BOGG_A.O$_\ T&+C\E_PH_X3KQ/_ -!BX_)?\*/[)J_S+\0_
MMBC_ "O\#Z&HKYY_X3KQ/_T&+C\E_P */^$Z\3_]!BX_)?\ "C^R:O\ ,OQ#
M^V*/\K_ ^AJ*^>?^$Z\3_P#08N/R7_"C_A.O$_\ T&+C\E_PH_LFK_,OQ#^V
M*/\ *_P/H:BOGG_A.O$__08N/R7_  H_X3KQ/_T&+C\E_P */[)J_P R_$/[
M8H_RO\#Z&HKYY_X3KQ/_ -!BX_)?\*/^$Z\3_P#08N/R7_"C^R:O\R_$/[8H
M_P K_ ^AJ*^>?^$Z\3_]!BX_)?\ "C_A.O$__08N/R7_  H_LFK_ #+\0_MB
MC_*_P/H:BOGG_A.O$_\ T&+C\E_PH_X3KQ/_ -!BX_)?\*/[)J_S+\0_MBC_
M "O\#Z&HKYY_X3KQ/_T&+C\E_P */^$Z\3_]!BX_)?\ "C^R:O\ ,OQ#^V*/
M\K_ ^AJ*^>?^$Z\3_P#08N/R7_"C_A.O$_\ T&+C\E_PH_LFK_,OQ#^V*/\
M*_P/H:BOGG_A.O$__08N/R7_  H_X3KQ/_T&+C\E_P */[)J_P R_$/[8H_R
MO\#Z&HKYY_X3KQ/_ -!BX_)?\*/^$Z\3_P#08N/R7_"C^R:O\R_$/[8H_P K
M_ ^AJ*^>?^$Z\3_]!BX_)?\ "C_A.O$__08N/R7_  H_LFK_ #+\0_MBC_*_
MP/H:BOGG_A.O$_\ T&+C\E_PH_X3KQ/_ -!BX_)?\*/[)J_S+\0_MBC_ "O\
M#Z&HKYY_X3KQ/_T&+C\E_P */^$Z\3_]!BX_)?\ "C^R:O\ ,OQ#^V*/\K_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %8_B?0(?$FAS6$I".?GBDQ]QQT/]#[$UL454).$E
M*.Z)G!3BXRV9\RZKI-[HM\]G?P-%,OKT8>H/<52KZ<U#3+'58/(O[2&XC["1
M0<?3T_"N>?X:^%78M_9S+GLL\F/YU[E/-H6_>)W\CPJN3SYOW<E;S/!*U;+Q
M-K>G6XM[35+J*$=$60X'T';\*]D_X5GX5_Y\)/\ P(?_ !H_X5GX5_Y\)/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1133(BR+&SJ';
M)52>3CK@4 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MIJR(SLBNI=,;E!Y7/3-.H **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBF^8@E$1=?,*E@F>2!U./3D?G0 ZBBB@ HILDB1(7D=40=68X IU !1110
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MIX'0=?JNEW%YX@T&^B*>38RS/+N.#AHF08]>2* -6XGCM;:6XE.(XD+N<9P
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M3Y;21C!5B.<$%AD#C.<<55GM/$FL:[H5W=6-G8V>GW332QBY\V20F&1 00H
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M(TC<L,EF(Y&T\#D_@:P=6\1S:3H6IW6AV-Y-(FL""=Y9E<(YEC5MH=N%8-@
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MT\X2(*<^G(K M/"^K:;I6@3VWV:34]):<- \A6.:.4G<H?!VM]T@XQD8[YH
MW=-\0_:M1ETR]T^?3]0CA\]8965Q+'G!9&4D'!P"#@C(XY%95CX^CO=/T[53
MHU_#I%\\4:7DAC&QI"%7<F[=MW$+NQUYZ<U:LM-U74/$BZWJMO!9BWM)+6UM
M8YO-;]XRL[NV /X%  SW.:J+X8OQ\--*\/YA^VVJ60D.X[,Q21LV#CT0XXH
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M65\EQ.!=&9Y,*P^7Y0 !GOR?;N =A1110 4444 %%%% !1110 4444 %%%%
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MC[1(1L).8QCG*XY)I+6WFUZ#P%%K9FF$T5RTRRD@W"!,IY@[Y 4D'KWKOIM
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MPPQ&=9S$AF52BR%1N"G!(!]#@?D*C:RM621&MH2LKB213&,.PQACZG@<^PH
MXRVT?18OBQJ4LEG:)<FPMKB)F4!C(99PSK[GY<GZ58\86;7WBGPG;K=W%J6N
M+G][;L%=<0,>"01^E=5-86=Q<PW,]I!+<0<Q2O&&:/\ W2>1^%2/!%)+'*\2
M-)$28W902A(P<'MQQ0!R&NZ-)X>\)Z_J&DS7ESK$MJ0;N>4R3;5SPO'&T%B
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M(;ZYMY["S\365AI6GRW.J0^1-Y[/?/FX575CCC*[LH20!D=J[O1O^1]\4?\
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MJTT?2["YEN;/3;.WN)?]9+# J,_U(&34UW9VM_;M;WEM#<P-@F.:,.I_ \4
M<5;>'=(U?Q[KZWUG#=VT-I9)%!(-T2@K)R%Z9P  >W..IK"DGO&\&^&[222.
M33FU.YM+DWEPT<;I'),D,<C@$[254<\$A0>M>J16T$+L\4,<;,JJQ1 "0O0'
MV':FFRM&M'M3:PFV?.Z$QC8V3DY'0Y))/UH Y#PI8/I_B:^B@_L>SM?LJ&73
M=-N&=4D+';)M**$R-P..N!2^(]$TN]^(/AJ:YL+>621;G>SH"6V(I7/T/2NK
ML=-L-+@,&GV5M:0DY,=O$L:Y]< "IVAB>6.5XD:2/.QRH)7/7![9H \^TRP\
M/ZM%KEYXH%M)J=O>W"3O=/A[2)7/E>62<QKY>U@RXR23G-,TN^NS%X!O-5FD
M#2&XC,TYVE\QMY1;/\3*H//4UW-WHNE7]U'<WFF65S<1?ZN6:!7=/H2,BI[R
MQM-0MFMKVU@N;=OO131AU/U!XH \^U6^ANW^)1MIQ(L.D1H61L@,(9L@'V_F
M/:IY]$L=#D\(ZA80B*_FO8H+FZ!_>7*/"Y82-U?) //0@8Q7;Q:9800/!#8V
MT<+QB)HTB4*R#.%( P1R>/<U,]O#((P\,;")@T8*@["!@$>AP30!P>FV6A:K
M?^(+GQ*+:74;6^E0F[<!K6W'^J,>3\BE,-N7&23SQ67I%U9M\/M!T[[+'J2:
MCJ5U' ;^9HXFQ+,X:4X.[(7[I!R:]'N]'TN_N8KF\TVSN)XO]7+- KLGT)&1
M3I]+T^YLC97%A:RVC$L8)(59"2<D[2,=23]: /+UL;:;0_'^E/!ISVUG:":&
MVLP3!#,89,E >ARHSCOGOFMV&WTZSN/ R:4D$=O)=2.XM\;68V<A).._2NVM
MK"SLTV6MI! FT)MBC"C:,X' Z#)X]S3+;2]/LTC2UL+6!8W,B"*%5"L1@L,#
M@D$C- '"Z78>'M5M=:O?%'V9]4@O;A;F2ZDVO9QJY\L1DG,:^7L8%<9SGDU6
MMH)]=@\ Q:T9I?.2X:9925,Z"/*>8.^0%)!Z]^]>@76BZ5?74=U>:997%Q']
MR::!7=?H2,BK;0Q/+'*\2-)'G8Y4$KG@X/:@#E?#%I!I7BOQ'I=C$MO81K:S
MQ6T8Q'&SJX;:O10=@.!WJOJ=O8:I\03I_B!8I;%=/22PM;C!AEDWN)6VGAG4
M"/@YP&R.M=DL,23/,L2++( '<* 6 Z9/?&3^=07VFV.J0>1J%E;7<.<^7<1+
M(N?7!!H \QU:TL;CPAX]L[9$N=$L(FDL,G>D$X@)D6,GH%)' X!9@/2O2+*R
MATS15MM,M8H52,F*)!M7<>?U)JPMC:)9?8DM8%M-A3R!&!'M/4;>F/:K   P
M.!0!Y[X3L/#%SX>TO6-1>W?6G:,W-Y/+LN!=DC=&6R&'SY79TQQC%-TRP\/Z
MM%K=YXH%M)J<%[<).]T^'M(E<^5Y9)S&OE[6!7&22<YKMCHNE'4AJ)TRS-\.
MESY"^;_WUC/ZT7>BZ5?W4=S>:997-Q%_JY9H%=T^A(R* //K>";7K/P%#K33
MRB<W!E$I*M/&(F*>9Z[E"$@]><]:NW>F>'V^)4>E7\<"VB:+"MK8286!\2R\
M;/NL0.@/N<<<=^\,4DL<CQ(TD>2C%02N1@X/;BL*Y\.1W_BJZO[ZWM+K3YM/
MBMO)F0/EUDD8DJ1C&''ZT <?<3RZ;IGC.W\.S2+I5J+?RFMB6%LS?\?(B/.-
MJ8; ^ZQ.,5=U*PT#2&T&Z\+K;1:C<7T"1&T<%KN$L/-\P@YD41[F+-G! .<U
MWMM:V]E;);VMO%! @PL42!54>P' JO9Z+I6GW,EQ9:996T\O^LEA@5&?ZD#)
MH Y7P[I5A-X@\3ZO=V_VBYM-586Y<;_) @B)\L'H3N.2.3Q7,)+ 6\-:_96.
MD:<^HZE;F-H9VEO)8Y'PRR/@9X8[@<@' SD"O7(X8H3(8HD0R-O<JH&YL 9/
MJ< <^U4X=#TBWGDG@TJQBFE8/)(ENBL[ Y!) R2" <^M '$V&E:?I_BCQE-I
MEA:)J\"H]BH0!]S6V?E'H6SG\:QM,L&ET;1]2M6T"UU":: C5&OY#=32EAO1
M\QY8M\RE"<#/;%>K-86;WR7S6D#7:+L2<Q@R*OH&Z@<FH8]&TN+46U&/3;-+
MYOO7*P*)#]6QF@#(\?,5\)2E20?M=GR/^OF*LT:'IVM_$/Q NJ6R7D$5G9[(
M)QNC!;S<MM/&[@8/4<XZUVDT,5Q'Y<T22)D':Z@C(.0<'T(!_"A88DF>98D6
M60 .X4!F S@$]\9/YT >42:?I][X0\./J<,5PMKKS60EN?F*P+<2HJECVPJC
MGT%7]2LQ>^-)M-DL-&NM/M[" Z;:ZA.R0^7\P=XT",K$$*">J@+CK7H4FGV4
MMF]G)9V[VKDEX6B4HQ)R<KC!R>?K45UHVEWUI%:W>FV=Q;0@"*&6!71,# P"
M,#CTH \]??;^&-)M]0U&WDT"76'CN9;2Y>2.*WP^R)I2 =@E"H3TQ@9Q5U;;
MP]8_$7P];Z"UO"QBN6FMK-AY(&P;6*K\H8\\]2/7 KL-4M+[^RT@T9;!&0@>
M1=1GRI(\$%/E^[VYP>G0UCZ3X?OO[;M=1OK/3-.ALHY%M[+3F+J7DP&=F*)V
M7  7N<F@#'\.Z/9?\([KNKO");_[5J:1SR?,T2>=*-J$_=7C.!W)JBND:-=7
M7@&XU.SM)//TQEEDG4?.5@C*@D]<<D?C7IB6T$<31)#&L;EBR*H 8L<L2/<D
MD^N:BN-,L+NUCMKFQMIK>/!CBDB5D3' P",#% ' ZI)/IMSJG@V"1T?6[A9-
M/<'E(IB?M./39MD;VWK7?6T]C%-_9EO/")K:)";=7!>-.BDCJ!Q^E9-MI.H7
M7BLZSJB6J):0O;V$4,C2$!V!>1B57#$*@VC..>3FMM;>!;E[A88Q.ZA&E"C<
MRC. 3U(&3^= $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% %#4M<TG1E1M4U.SL@_W3<SK'N^FXC-6;2\MK^V2YL[B&X@
M?E987#JWT(XKE/ 5K!J&DMXCNXTFU349I6EF<9:-1(RK$N?NJH &/7)[T/;0
MZ%\1M.33D6&'6;>X-W;QC"&2+85EP. V&*D]\C/2@#J;*^MM1LTN[.998),[
M77H<$@_J#5BO.O"%YXFA\%6T]AIEE);0>:5AFG99K@"1B2I *KGMG.>^,UI7
MWCVU9-)33I[")]2M/MJS:E.(8XHN,9[LQ)QM'H23QR =G37=8T9W8*BC+,QP
M /4UQ4/CTMIUW<-'93G3KR&&^EM+CS8A!)C]\C#TSRIZ;6Z\&K^NZ\%DURQ^
MPPW=I8:2]U="4Y5V8-MB(Q@@JC$^Q'K0!TZL&4,I!!&01WI:Y.77]034-'T?
M2=.M=UYIS70:1RL=NJ&,8P!DCYP !CMT%-7QC<V^D7S7E@C:M::@NFBV@D^2
M>9]AC*L1\JD2*3D<8/7'(!UU%<I-K?B'2]1TFVU.PL)(M0NA;F>TE?$)V,V"
MK#G[O!^N0.,ZOB:6^@\-:A-IQB6Y2!V5I&*A0%.2"!G/I[T 7KF^MK.2V2XF
M6-KF7R80?XWVEL#\%)_"K%>:WMYK;^'?!-U<PV]S?OJ,!B"3-APUK)AI&(R#
MDDG / XS710>)KK3[O5;3Q!#;QM860U#S[1F9'A^<'AN0P*'USD4 =14=Q/%
M:VTMQ.X2*)"[L>BJ!DG\JX2W^(3#[#=7<VAFUNYHXC;6U^)+F#S&"J6'1L$C
M<!TY.3BNK\2_\BKK'_7E-_Z : -"">.YMXYX7#Q2J'1AW4C(-25R#:Q<:1X5
MT)HKK1[2-[.,//J=R8U!"+@*O\1.3W&,=\TFG^-FO=.TF]^SP&&YU)].N9(9
MMZ(XW*CHV/F5F50.GWQ0!V%%<:OCR,2>(VFM=EOI<3S6TF[/VI4+(^/0B1"O
MXKZUU=D\\MC;R74:Q7#1*TL:G(5R.0#[&@"6.2.5-\;JZY(RIR,@X/ZTZN$C
M\5)IOA;3KBSL=/TZ*[U"XMB\K>7;6^V27+N0.K%/;+-UKK-'NKN\TV.>\6U$
MK$X:TF\R-USPRG ZCG';U- %^J]E?6VHVB75I,LL#DA77H<$@_J#7+6-YX@?
MXCZM:.UH=/BM;9Q'YK_(C/. RC&-YVC=VX'-87AW7=:T7P'%J?V"T;2;6:42
MJTK>>\?GL&=1C:,9.%/4#J,T >G45R.M>,/LFORZ/:76DVTMO$DL\VIW7E+\
MV=J(O5C@9)Z#(ZYK4\,>((_$>E-=*L2R0SO;S"&42Q[T."4<?>4C!!]#0!:O
MM;T_3KVUL[F<K<W1Q#$D;.S<@9(4'"Y(^8X SUK0KAI)]3M_BG<32K8K9Q:2
M&=R[[A")6).,8W9'3IBIO^$HU_\ L#_A)O[)M/[(\K[5]F\YOM7V?&[?TV[M
MOS;/PW9H [.BL>SUP7OB2?38D4P)I\%ZDP/+>8\BXQZ8C!_&L>Z\97<.C27D
M&G)/.-9;2XX?-V[_ -\8@V<<9X/M0!V%17-S#9VDUU<2"."%&DD<]%4#)/Y"
ML"SUW4;;79=*UR&SC)LVO8I[5V*[$8*ZL&&<C<ISW![8K#U?6?$.K> M3U6+
M2[1=-N]/E>* S-]I\EHSASQMS@AMGIQG- '>Q2I/"DL;!HW4,K#N#R#3ZY2[
MUFXTC0=(,=WHUI%);)NFU.Y,8R%7"JO\6<GG(QCH<UBZEXIU?5_#.CZEI!M(
MF?5XK2<K<,R.RW CPC*/FC;!R?0]* /0_,C\WRMZ^9MW;,\X]<>E.KF/[5BL
MO$D_]I6=I'<V^CBZN+R($L$#ME 2,E1@FJDGB?7[70QXCNM*M%TD1BXDMUF8
MW,4!YWGC:6"_,5^HR: .RHKF+S7M6F\43:)I-I:,$L8KS[5<R,$ =Y%V[5&2
M3L&.G?T .CX<UB36])-Q/;K;W,4\MM<1*VY5DC<HVTX&02N1[&@#6J&ZNH+&
MTFN[J9(;>%"\DCG"JH&22:P[O6M3NM>N=(T2VM6>SC1[JXNW8(I?)5%51EC@
M9)R  1US7->+=:U'5? >MV_V2VM[ZQG6VOX7E9E'*,K1D#D,&4\@=2.U '>Z
M?J%MJEFEW:-(T+YVEXFC)P<=& /Z5:J"T-T;2,WJPK<X^<0DE,^Q(!KF(/$6
MOZII\NL:3IEE+IJL_D133,L]RBD@L,#:F<':#G/&2,\ '745S]EXHBU+4]%B
MM(]UIJFG2WR2L<,H4Q8&/^VO/TJEJOC";3K/Q).EBLQT>X@A1 ^#-YB1,?H?
MWA ^E '6U6OM1LM+MC<ZA>6]I #@RSR!%'XDXJ/2VU-[9FU6.UCG+Y5+9V95
M7 X)(&3G/( %<WI%K#K?C;7[_4(UFDTRX2RLHI!D0+Y22,Z@]&8O][KA0* .
MET[5M-U> SZ9?VM[$#@O;S+( ?3()JY6+JG]D>'8-0\2RV<:316Q\Z6) ))$
M7D+[G/3/K6;/K^OZ1;V^HZUIUC'I\DD<<R6\[-+:[V"J6R ' + -C&.HSB@#
MK*KVM];7HF^S2K)Y,K0R8_A=>H_"L-]:U?4=8O[+0[6R,.G.L4]Q>2, \I4/
ML0*.RLN6/<]#BN>TCQ(= \-ZQJ%[:I#=S:[- EO+.%02NP'S2'@(.3NQT'3/
M% 'HM%<CHWC W6OPZ1=W6D74ES$\L,NF77F@%,;D=3R.#D'H<'IWZZ@"M?:A
M9:9;&YO[R"T@!P99Y BC\3Q4>G:OINL0F;3-0M;V)3@O;3+( ?<@FN;TFVAU
MOQQKU]J$:S/I<\=G912#(@4Q)(SJ#T9B_P![KA0*/%UK!I5_H^OV4:PZA_:%
MO:2M&,&XAE<(R-C[V,[AGH5X[T =C16+IVN/>QZV[0*O]G7<ENN&SO"HK9/I
M]['X5D'Q;J=S;>%QI^G6[W.N6;7!\V4K' 0B.<D DCYR/4G'3.0 =C14*/-'
M9*]PJO.L>9%A!P6QR%SSUZ9KF?"GB>^\1&.=O[):VDBWR16UTS3VC<8CD4CK
MU!Z8(Z&@#K**Y4>+93\/H/$OV1/-D2-C!O.!ND"=?QS5BZUK5+O7KK2=$MK0
MM9(C75Q=NP56<$JBJHR3@9)R ,CK0!T5%<S<Z[K'VRQT>VL+0:Q-;M<W'F3L
MT%O&&"YR%!<DG@8'0Y/',.K>*;W0;&SBU.'38=2O+AH(2UV4M]H7<9&9@"H
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MFEE+#<P-(AC1BR%=K*01N;V(/;%5;3P9+;Z/!8RZF9Y(]7&J/.T6"Y\WS"N
M>,],_I76T4 9-SHBW/B2'59)08TL9K-H"OWA(Z-G.?\ 8QC'>L%_"6NCPY-X
M;@UZWCTHV[6T,IM";E(MNU4+;]IP,#=MSCT/-=I10!RT_AB_AU:QU/3;RS%Q
M!8+8L+NV,B[0<[TPRE3GJ,\C'I42^#;E/#1TY=5#WJZE_:4=U)!D&3SO-PR
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M'LW;<[Y%3.<'INS^% ',R^"-6?P^?#JZU;QZ3'*'A(M29M@DWK&S;\$ C&0
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M&>Y)  J6@#ATM]6?XA^(9=*OK>%DMK-7AN83)&X(DP?E92",=<XY.1T(N_\
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M6);))]!@503PCK4MKHUE>ZW;/::3<031>5:%7G$1X$A+D=/0#GGVKI=#U/\
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M;4P0V, 66=5E1F:4AV&U54L<*HR!]#ZE4,5G:P2O+#;0QR2??=$ +?4CK4U
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M(/%367AC2+![B2"V<RW,7DSRRSR222ISPS,Q)Z]2<]J &^$?^1+T+_L'6_\
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MY^E=--X7T>?2K336M"MK9L'MA%,\;0D C*NI##@D<'H<5:31M/3[;_HJ,+X
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MSMDG>P54!YZ?*JCCTH S/%5]%::5'$[WXENYTMX$T\JLTKG+;59N%R%;)R,
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M\L3V]Q)!)LSG:6C925SV)Q0!R[1>*[KPY8I<17K-!>2K<0PW<<-U<6XW"/\
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M!)XXZFN4T.9[OQK?W,>H2ZE#)I&S[6+811NPD/RJ0!NP&Z\]2,]:Z7P,CQ>
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M$TZW4)A@+++()!MC*_>#'MC!SGI5;[7(^KVT<5Y9&UEMGE\K.9I""N'3G!0
M\\=2O-<)+JL&E^'?%^C7"3?VI+<7SP6JQ,7F67<R,N!RN&Y/08.<8K7TV*0>
M*?#+F-PJ^'YE8E3@'=;\'WX/Y4 =+;:YI-[>?8[34[.XN?*\[RHIU=MF0-V
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M.@I)N^;YI JOGU$+!\^U 'I--$B-(T8=3(H!90>0#T)'X'\J\W^VW4'PUNM
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M=F( !/ ').#QP:JP>,+61K9)K2YMI9+[^SYXY-N;:8IN4-@D$,-N",@[E]:
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M^F._M5K4+87FFW5JTGEB:%XRY&=N01G]:Q]4\3W&D-//<Z'>#3+=@LM[YD>
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MW#.%+;&VL=K%02 >.",YXI-,\3R:K=(;;1KQM.DFD@2]#QE=R%E)9-VY5RI
M./3(&: .AHHK*U/4[^SG6*RT2YO_ )-[2)+'&HY^Z"S EN.F,>] &K17-3^-
M+*/3=&O;>SO+D:M)Y-O%&BAP^QFVL"0!]P@G.!ZXYJ:R\4PO_:D>IVLNF3Z9
M$L]RDS*X$3!B)%9201\C#U!4T ;LDB1(7D=40=68X IU>=>,/$5U?>";J270
M;^UL[GRO)N)#&3S(I4NBL63/N.,\XKT6@ HKE=.\<07VD3:T^FW=KI$43/\
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M$VF:7=VEX(W\^^NY\*=P*2S.Z@_\!89%<_\ #_394GO[J:436]B[Z3IK\_\
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MIZV5Q:3RF/(&"'C;!Y!W<$<@]1BNZHH P?"^CG2K6Y=],L=/EN)=QAM&+X4
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MZ5IW?AVZUK4[R>_2.WM[[13I\J1R[V1V9B<' R &ZUU5% '$7FE^)]7\._\
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MEE96 "[L.C;6P ,KCH,]*NQZ.(IM->._OQ'8QM&(C.66?( S+G)8C&0<]2:
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M (L#-$[J8VZD I@[LYSGCI6@OA"S.E:O9W-U=W,VKQ-#>7DK+YKJ5*@#"A5
M!. %P,GCDUH7NC6]\=-,KRC^S[A;B+:1RP1D ;CIASTQVH T:*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ R,XSS6-I^K3W7B76M.D6,06*VYC8
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MY:JY8?)'@@D;#EN,<#-9>CW+W7A/P/))-YVW79(T?)(*)]I50"><!0 ,\\4
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M;Y58%@8T X [N"#GCM6=8QG7M*^'4>I22SI,DOGAF/[X+ W#]R#@9!Z]^IH
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M*YWPSK5OIW@][[4[I]HU&\C4D-([G[5*JHH&2QZ   UM:9XAL-4EGAB,\%Q
MH>2"Z@>&14.<-AP,KP>1QQ0!HQV\,5NMO'#&D"KM$:J H7TQTQ5:PT?3-+,A
MT_3K2T,ARYMX%CW?7 &:Q9?B!X?@M7O99[I+!02MZUG*(),?W7VX;/;'7MFM
M/4]?M-*F2&6&^GE9-^RULY)L+TR=BD#^9H GET;2[B]^VS:;9R7>W9Y[P*7V
MXQC<1G&.U27&G6-W'%'<V5O,D)#1+)$K!".A4$<$>U<[K.J17T_@^[T^Z+VM
MWJ@P\9($B?9IS@CZ@<'N/:NAU'4;32;"6^OIU@MH@"[M[G   Y))(  Y)- %
MJJ-MHVEV=Y)>6NFV<%U)]^:*!5=_JP&37+:EXEM]0\1>%K6W-];2OJ+LT-S;
MR6[21_9IN<,!N .W/H<9QQ6U>^+](L+JX@D:ZD^RG%S+!:R2QV_&?G=5(7@Y
M/H.3B@"^-%TH:C_:(TRS%]_S\^0OF_\ ?6,U;$,0G:<1()F4(T@4;BHR0"?0
M9/YFLK4/%.D:9<6MO/<.\]W$TUM'!$\K3*"N=@4'/W@?ID] 34FF^(=.U2.Z
M:!Y4DM/^/B">%XI8N,C*, <$ X/0]J +OV.U-LUL;:'R')+1;!M.3DY'3DDF
ML:3PW%>>)]1OM0MK2[L+JSMH%AF02?/&\K$E2,8Q(,?C4UAXITW4;Z.S1;R"
M:92\ NK22 3*.I0NHS@'..N.<57/C326EN8K87UV]K))%.;:QFE$3H2I5BJG
MG(Z>F#T(- &TMA9I9"R2T@6T VB 1@(!Z;>E2>1#YS3>4GFLH1GVC<5&2 3Z
M<GCW-<MI'CW3KKPE8ZYJ8FL5G6(/YEM*J>8ZY 0E?G'H1D5:'CC1S*UOLU#[
M:N#]B^P3"<J?XQ'MSMX^]TSQUXH U+31-)L&+6>EV5NQ?S"8;=$.[!&[@=<$
MC/N:M+;0+')&L$824EI%"##D]21WSWK.7Q+I#:"NM_; +!N Y1@V[=MV;,;M
MV[Y=N,YXQ1IOB*PU2XEMHQ<P74:>:T%U;O#(4SC< P&1GC(Z'K0!<N=-L;VS
M%G=65M/:@ ""6)60 =/E(Q0FFV$>G_8$LK9;+;M^SB)1'CTVXQBL6T\=Z#??
M8WMY[AK:\98X+HVLJP,[=$\PKM#9XQGKQUXIMEXOBN_&%_H1L[Q1;I%LE^QS
M %F,@;<VW:%^088G#9."<4 ;MCIUCID'D:?9V]I#G/EV\2QKGUP !4L]O#=0
MF&XACFB;!*2*&4X.1P?<"J>JZU8Z+#$]Y(X:9_+ABBC:225L9PJ*"2< G@<5
M#8>(]-U&.[,3S1RVB[KB"X@>*6,8)!*, <$ X(X..* -)[>%YXYWAC::($1R
M%060'K@]LX'Y4""%9))%B0/+CS&"C+X&!D]^*S=%\1Z?X@0RZ:;B6WV*ZW#6
M[I&X/]UF #$=\=*9J/B?3M-OC9.+JXNE0220V=K).T:'HS; =N<'&>3CC- %
MZWTO3[-(TM;&U@6-RZ"*%5"L1@D8'!()&:L"&)9FF$:"5U"LX4;F S@$^@R?
MS-9-UXITJUALW$DT[WL?FV\-M;O++(G&6V*,@#(R3@#.*$\5:.^BW>K?:62U
MLR1<^9$ZO"1C(="-P/(X(Z'- &L\,4DD<CQ(SQDF-F4$H2,'![<$BJESHNE7
MMW'=W6F6<]S']R:6!6=?HQ&162?'6AB18V>[5Y%W6RM9R@W0R!^Y&W]YU'W<
M\'/3FK47BO29=&OM4,TL5O8;A=K+"Z20%0&(9"-V<$'IR#Q0!IW=E:ZA;-;7
MMM#<P-]Z*:,.I^H/%0'1=*.F_P!FG3+(V/\ S[&!?*_[YQC]*SX/&.CSW4$(
MDN42Y<1V]S+:R)!,QZ!)"NTY[<\]LUE2WIM]5\;R3ZC/9V]M;02>>B[S;CR6
M+.JD$$\9QCF@#J8M,T^"W>WBL;:.!X_*:-(E"LG/RD8P1R>/<U%'I4,>N2ZK
MN8S/;);*IQMC169CCZEAG_=%07VNVNEK;QRI?74LD>]1;6<DS%1C+'8N!U]O
M:HY_%FB6VD6>J27N+.\D$4$@C8EG(8[=H&0WRL,$9R,=>* ->6&*=0LT:2*&
M# .H(!!R#SW! -#0Q-,DS1H94!57*C<H.,@'L#@?D*S=+\0V&K37-O#Y\-Q;
M!6E@NH'A=5;.UL.!E3@\CT-5K/QAI-_<PQ6S7;Q3OY<-U]DE$$K>BR;=IZ'!
MS@]B: +\6AZ1!<2W$6EV4<TK!Y)$MT#.P(8$G&200#]14[V%G)>QWLEI UW&
MI5)VC!=0>H#8R!R?SK'E\9Z+%<2(TMP8(I?)DNUMI#;H^<%3*%VC!X)S@'@D
M5N3SQ6MO)<3R)%#$I=Y'.%50,DD]A0!%+IUC/8BQFLK>2S"A?L[Q*8\#H-I&
M,46VG6-E9_8[6SMX+7!'DQ1*J<]?E Q659^,=(O;FW@5KN$71VVTMS:2PQSG
M&<([* 21R!W[9KF/[=LIO'&MW5U;ZO*VFPPK9JMC<LL1(?>=JKCDD<D<@<<"
M@#T VUNT4<1@B,<14QJ4&$*]"!VQVJO-HVEW%\+Z;3;.2["[1</ IDQTQN(S
MBN*\$W5FWA_PW=?;M0M[W464W/GPN?MTWD-(PS(OW?O,&7 .W -=+>>+])L[
MNXMF:ZF-L<7,EM:2S1P'&<.RJ0#@Y(Z@=<4 :S6D. 8XTBD2(Q1R*@W1J<<#
MT' XZ<"HM)TV#1](M--MMWDVL2Q*6ZD 8R?<]3[FJ6H>)].T^[^R-]JN;D1B
M5XK.UDG:-#T9@@.T'!QGDX.,UHV-]:ZE8PWME,LUM,NZ.1>A'^>U $=_I&FZ
MJ$&HZ=:7@C.4%Q"LFT^VX'%3FV@9(D:",I$0T:E!A".A'IBI:* "H#9VI1D-
MM"5:02LOEC!<$$,??(!S[5/10 QH8FF29HD,J JCE1N4'&0#VS@?D*ABT^R@
MGGGAL[>.:X_UTB1*&D_WB!D_C5FB@"E8Z/IFEM(VGZ=:6C2G,AMX%C+_ %P!
MFK"VMNMLUNL$0@8,&B"#:=V<Y'3G)S]:EHH B:W@=(T:&-EB(:,%00A'0CTQ
M5:71=*GOC>RZ99R79789W@4R%<8QNQG&.*O44 5KC3K&Z$(N+.WF$#!H?,B5
MO+(Z%<C@_2I!:VXCEC$$024DR*$&')ZDCOFI:* *=AI.FZ4KKIVGVEFKG+BW
MA6,,??:!FIOLEM]F>V^SQ>1)NWQ;!M;<26R.AR2<^N:FHH IWFD:9J+0M>Z=
M:7+0G,1G@5S'_NY''X5,+.U"HHMH0L<AE0;!A7.<L/0G<>?<^M344 ,EBCGB
M>*6-9(W4JZ.,A@>"".XJK>:1IFH^5]NTZTNO).8O/@5]G^[D<?A5VB@" V=J
MUM);-;0F"0L7B,8VMN.3D=#DDDTY[:"1XG>"-FA.8F* E#C'R^G''%2T4 4K
MG1],O;N*[NM.LY[F+_5S2P*SI]&(R*2UTN&UU6_U$.[SWOEAMV,(J+A5'MDL
M?JQJ]10!B>)['5=5TQ]+TXVT4-XC0W5Q+(P>&-L E%"D,Q!8<E<'!YK5AM((
M+*.SCB06\<8B6/&5" 8 QZ8J:B@"G8:1IFE!QIVG6EGYAR_V>!8]Q]]H&:;+
MHNE3WK7LNF6<ETR%&G>!2Y4C!!;&<8XQ5ZB@!%4*H50 H& !VJG#H^F6]^]_
M!IUG%>29WW"0*LC9]6 R:NT4 0BUMQ!) +>(12EC)'L&U]WWLCOG)SZYJ*\T
MO3]1MEMKZQMKJ!<$13PJZC'3@C%6Z* (H;6WM[9;:""**!5VK$B!5 ] !QBJ
MUGHNE:?C[%IEG;88N/)@5,,1@G@=<$C-7J* (1:VXADA%O$(I2QD38-KEN6)
M'?.>?6J]GHNE:<%%EIEG;!6+KY$"IAB,$C ZX)&:O44 ,EBCGB>*6-9(W&UD
M<9##T(J"PTS3]+A:'3[&VM(F.XI;Q+&I/K@ 5:HH I6FC:7I]Q+<66FV=M/+
M_K)(8%1G^I R:)]&TNYODOI]-LY;R/&RXD@5I%QTPQ&15VB@!GDQ>?Y_EIYV
MW9YFT;MN<XSZ9[4V"V@M4*6\,<*%BQ6- H)/)/'<U+10!2FT?3+F^2^GTZTE
MO$&%N'@5I%'H&(R*G2UMXVB9+>)3"GEQ%4 V+Q\H]!P.!Z"IJ* &)#%'))(D
M:*\I!D95 +D# )/?@ ?A5>_TO3]4C2/4+"UNT0[E6XA60*?4 @X-6Z* *XL;
M01^6+6 )O$FT1C&X8PV/48&#["I6AB:9)FB0RHI57*C<H.,@'L#@?D*?10!2
ML]'TS3YY9[+3K.VFE_UDD,"HS_4@9-6%M;=/.VP1+YYW2X0#S#C&6]>..:EH
MH C2W@CMA;)#&L"KL$04!0N,8QTQCM5>PTG3=+5UT[3[2S$ARXMX5CW'WP!F
MKE% #(88K>%(8(TBB0;51%"JH] !TH>&*22.1XT9XR2C%02I(P<'MQQ3Z* &
M1PQ0[_*C1-[%VVJ!N8]2?4^]5%T72DU$ZBFF6:WQZW(@42'_ (%C-7J* &+#
M$LSS+&@E<!6<*-S 9P">^,G\S4?V.U^S&V^S0_9R<F+8-O7/3IUYJ>B@!LA<
M1.8E5I IVAC@$]LG!Q^58>@:3>6U]J6KZJ+<:C?L@*6[ETAB081 Q +<EF)P
M.6Z<5O44 4;K1=*O;N.[N],LY[F/[DTL"NZ_1B,BIKVQL]1MFMKZU@NH&.3%
M/&'4_@>*L44 54TS3X[=[>.QMDA= C1K$H5E'0$8P0/2K5%% #%AB69YEB02
MN '<*-S 9P">^,G\ZC^QVOV;[-]FA^SYSY6P;>N>G3KS4]% %.YTG3;VZANK
MO3[2>XA_U4LL*L\??Y21D?A4R6=LGD[+>%?)SY6$ \O/!V^GX5-10!$;: O*
MYAC+RJ%D;:,NHS@'U')_,U6L]&TK3L?8=,L[7#%QY$"IAB,$\#KCBKU% '&W
MVC^);M[B-K7P\TTH>--6VN)HHVR/]5M.6 /_ #T _E710Z+8)H=OH\MM%<V4
M$*0K%<('!50 ,@C!Z5H44 58M-L(+(64-E;1V@Z0)$HC'.?N@8ZU'>:7#>ZE
MI][*[YL7>2*,8VEV4IN/N%+ ?[QJ]10 54@TK3K50MO86L*B7S@(X54"3&-W
M ^]CC/6K=% #/)B\\S^6GG%=GF;1NVYSC/IGM56#1M+MKZ2^@TVSBO),[[B.
M!5D;/7+ 9-7:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \WE
M\-ZH?#6F2""[$^GZS=WCV]O*$E>)Y9P"A/&[;(& )&1D=35NUT#^VCJK"+7(
M'FTV6PBN]3F&?WO4+'UX*J<G'M7>TV2-9HGB<91U*L,XR#0!YIXHU'5$^&-_
MI=QX;G@GAL1#-([QFV4* -R,&);I\HVYSC.*VM=&IMXD=;B+6I=*-LGV5-*<
M)NERV\2,"&!QLQR%Z]ZO1^";%?)BFO\ 5+JR@=7CLKBZ+Q J<KGC<P! P&)'
M KI: //M(T/5+?0?!T$]G(DUEJTTURA?>8T*W(#%CU&77GOD5T/B_3KN^TZS
MFLH1<36%]#>?9MP7S@AY4$\ X.1GC(%=!10!Q=[<W^O>(O#<L&@WL%K9WKRW
M%Q=HL;)F"50 N22,L,GI]W&><9*:1?://JMI-;^(K@W%Y/<6[:?.HAF65B^&
MR1L8;MIW<<9&>E>E44 >?2HWAWQ9X9M[32YKF*UT2>(Q1N))8D#P#*DXWD<
M]R,X]*LR0Z[J.HZWX@TRPDL;C^ROL>GQW857FE!9P[+D[0"0 &]3G KJY-+M
MY-;@U9B_VF&WDME /R[79&.1ZY1?UJ[0!YU8:?>W/B?PY>I::^T=K+*;N?5)
M_NEH)%&(]VWJ<$J .0!G)QT?A73KBQT_58[B PO/J=Y,N?XE>5BK?B,5T5%
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M^E>:2RR3RM+*[/(QRS,<DFN+%8Y4GR0U9G4K<NB.TNOB)*6(L[% O9IF))_
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MN:7?MI>HQ7B1)*T1)"OTZ8KYE6<O>9P;O4]%T3P?8:=$DEU&ES=8RS.,JI]
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M10 4444 %%%% !1110!P?Q&)WZ<O;$A_]!KAJ]"^(=LSV-G<@<1R,A_X$/\
M[&O/:^=QZ:Q$OE^1Q5OC84445QF1ZCX+U634=&,4S%IK9MA8]2O8G]1^%8_Q
M&)WZ<O;$A_\ 0:D^'4;"'4)3]UF11]1NS_,5)\0[9GL;.Y XCD9#_P " _\
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M%5+J_6UN[.W:"XD-TY17BB++'A2<N?X1QCZT37ZP:E:V1@N':X5V$J1$QIM
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M$))-C(J(& )'SDDXQP!DYXM:!!-_:>OWL\3QFXO@D>]2,QQQH@(SV+!SGWH
MW:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOY)N&2UM--,LJE\(6DDPI;MD")L?4UN.Z1(SR,J(HR68X % #J*** "BBB@
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MPS/!)Y8?8H)4@D%8U.#QSFNAL='L=.M);:VA*I,2969V9Y"1@EG)+$X[DYH
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M.PM(;>9;J7YHD"XA$$FY>.Q)3\<4NAVEOJ^KZQJ=_%'<7,-Z]I"LJAA!&@
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MJ5H(V!R"L9;:,'D#&!VQ3[OPOIEY=33N+J,W!S.D%W+$DW&/F56 / QGOWH
MLZ%)83Z%93Z7"L-C/$)H8U38%5_FZ#IUK(EG.L:K<RZ?HEA<FS8VKWE])M^8
M<LJ (Q(!/).WGUQ720PQ6\$<$,:QQ1J$1%& J@8  ]*RI?#&ERW<]P8YU^T-
MOGBCN9$BE;&,M&&VG( SQSWS0!R-E-*?!,$<4B6UMJ>M-;[K5B%BA:=@1&>,
M!MI /&-_%:OC/2-'LO!-W'!:6UI(D?EV;1($99F^5 I'/).#Z@G/>NA_L/3#
MHW]D&T0V&W;Y))(QG/7.<YYSVJDOA'2"8S<+=79B=)(C=WDLOEE6#+MW,<<@
M?7H<B@#.U?2[:^\1>&]&==]I:0S7+QGHRHJQ*&]0?,/'?!'2F_V+I]U\0Y0+
M6(06VGQ/+"J@1O(TCB,LO0E0KXSTS["NH^PVW]H_;_+_ -*\KR?,W'[F<XQT
MZT16-M!>W%Y''BXN0@E?<3N"@A>.@QD]/6@#G-,:WTW7O%=S#&D5I (3(B#"
M^8L1=VQZE63/TK)-@TW@WPAHTS,LE]<P2SA20>%:X?GM\RXS[UV3:-8/:ZA;
M-!^ZU$LUT-[9D+*$/.<CY0!QCI4KZ=:/<6D[0CS+0,(#D@)N&#QT/''- &!J
M.GV=IXI\,I8VL-O(LDY8PH%_<B%@5X[;FC/U I+.V;5M1\7,D[0&9DT^.9?O
M)MA!W#Z-*WY5T3V-M)J$-\\>;F&-XHWW'Y5<J6&.G)1>>O%5I-!TV6QN;-[;
M,%S,9Y1O;)D+;MP;.0<@$8(Q@8Q0!A:1!!8ZGI^D:EH=C;W<4#O9W5J T;A0
M%?&0&0X<<'(YZFD\+6FG6UIJ^M"SMHPU_<NDBQ*"L<9\K@XX&(R?Q/K6YI^@
M6.G71NH_M$UR4\L375S),ZIG.T%R<#(&<=<#-,@\-Z9;PWT$<<PM[T.)H3<R
M&/Y\E]J[L)DL3\N.M '/^'H+'PWX'L]7N[3S;V>))9&"AI7DF88C!/3YI-O4
M#DGUJKJ]G<6T6C6W]CZ1IPDU*W6#[/*6F0APS$?(HSL5L\G@GDUVMWI=E?:8
MVG7,"O:,H3R\D8 QC!'((P"".1BJ<'AG3(;F"Y9+BXN+=]\4US<R2LAP5X+,
M<##'CH>#U - &7!IMA?>/]4FDLK9Q:V<$>6B4YD=G=CTZX"<TOABSM=6CO-:
MOX8[B]FNYX?WJAC!''(R+&N?NC"@GU))-;7]BV0UEM619DNV4*Y2=U23 (&Y
M =K$ G!(_D*K7/A;3+B[FN1]KMWG.Z=;6[EA64],LJ, 3[]30!S,DRZ?X>\:
MKIH"V,<CPV:)PBRM$JN$]!YC=!QG=6S<>$+5/"K:18+#%,4C#32)GS]K*Q60
MCDAMN#[&M<Z+IQTN/31:(ME&R,D*95048.O3_: /OWS3M2TFTU:*..Z1\Q/Y
MD4D4K1O&V,95E((X)'6@#*T22W;6;BVN-%M]/U:V@3<T&UT>%R<%7 !QE#P0
M",4WQY#%<^$[FVDBCD>Y>.VBW*"0TKK'D9Z'#GFM73=&L]*,S6ZRM-,099IY
MFED?'3+,2<#)P.@S4FI:9:ZO9-:7D;/$65_E=D964AE8,I!!! .0: .=\2Z7
M9R?V'HEO EO!=ZBLDJ0*$RL2-(>GNB#/7FI;ZPM+3Q?X<2QM8;>15N"WDH$S
M"(P"IQVW-&?PK;CTFTCELY2LDDMFCI#)+,[L V-V22=Q.!R<FI6L;9]1COVC
MS=1Q-"C[CPC%2PQTY*KSUXH YHW']KRW6IV6B:8]NI>%K[4)=K2+&Q5L (WR
M ANI'KBL2&TAO? /A>VN+>%S>WT7E INV1&4S;5SR!Y:;?H*Z[_A%-(\V5O*
MG$4KF1[<7,@A9B<D^7NV\GGIC//6IKGP]IMUIEII[PR);V>PVWE3/&\15=JE
M74AAP2.O0T 7X+:"UB$5O#'#&.0D:A0/P%<R9SK%W=7UAHFFRQ1,]LU]?R;2
M_EL0P4!&.T,&&21TZ8YKJ8HUBB2-2Q5%"@LQ8X'J3R3[FL@^%M*-Q-+Y4X2:
M0RRVXN9!"[DY),>[:<GD\8)Y- '(*T;_  JLK::5;>+5+U(4,9PL<4MUD!<]
MA&<#VQ6YXKTC2+'P9?F.SABDAA9K9XT D$__ "S*MUWE]O.<DGWIVJZ-;27G
MAK0X[/=I=N9'>)@60(D)C56)_P"N@Z]<5HVWA?3+>ZBN"+JX> [H5NKN698C
MZJKL0#[]1ZT 9.K6UOJ_BSP_I>IE7,-I/>2PD_+*_P B $=Q\SG'?'IFI=9L
M[2T\1^'6T^"*&_>Y9&\E I:W$;%PV.J@[.O0[:&T>'6O%VK37L,HCMH;:"VE
M1FC96&]V9'4@@_O ,@]B*V-.T*QTR>2XA662YD7:]Q<3/-(5_N[F)('L,"@#
M!6P&O2^-$/*W.-.0GT6 ']'E;\JCL[P^+[;1K,\VJ6T-[J7^T^ 4A/U8%F'H
MH'\5;-[=6?ANVD6TLYYKJ[EDEC@A1W,TS')RW(49(Y)  ]A3_#.AQ^']%CM!
ML,[L9KAT& \K<L1[#H/0 4 ;%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN=BE8]D8'&<* #TZECWKL** .?@T.\M_"=]9+/$VK7L4KRW!R$,\@//3.T<
M<=%%)>Z%<PQZ//I+PBZTJ,Q1QSY$<L94*RD@$K]U2#@XQT-=#10!EV#:W-=&
M74([*UMPA @@D:9F;(^8N57 '/ !Z]:SK2PUW1'N;33H;"ZL99Y)X6GN'B>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX:FZE6,4805Y)'H=%%%?4'>%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%!.!D]*165U#(P93T(.0: %H
MHHH **** "BBB@ HHHH **** "BBB@ HHHZT %%%% !1110 4444 %%'6B@
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MTO"1;37(CVR,%+;2%8E&*@D!@.F.O%0Z[X8;7;V[\V98[6YTN6Q8CEU9V!#
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M+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\
M@/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB
M_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\
M$UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO
M_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q
M-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?
M^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &
M+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\
M@/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB
M_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\
M$UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO
M_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q
M-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?
M^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &
M+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\
M@/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB
M_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\
M$UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO
M_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q
M-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?
M^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &
M+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\
M@/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB
M_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\
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M^@]I?_@9'_C1R2[!SQ[FM163_P )5X=_Z#VE_P#@9'_C1_PE7AW_ *#VE_\
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M^@]I?_@9'_C1R2[!SQ[FM163_P )5X=_Z#VE_P#@9'_C1_PE7AW_ *#VE_\
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M^@]I?_@9'_C1R2[!SQ[FM163_P )5X=_Z#VE_P#@9'_C1_PE7AW_ *#VE_\
M@9'_ (T<DNP<\>YK45D_\)5X=_Z#VE_^!D?^-'_"5>'?^@]I?_@9'_C1R2[!
MSQ[GRC1117T1\^%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
#!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ethicsemployeepolicybook004.jpg
<TEXT>
begin 644 ethicsemployeepolicybook004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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MT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+E6BNQF\-^'/^$AET"+5=0BOEN#:I)-:H86D#;0"5?(!/?%<G<V\EI=36TH
MDB<QN >A!P:49J6PY0<=R*BBBJ("BK-Y#:0^1]DNFN-\*O+F(IY<AZIUYQZ]
MZK4)W&PHHHH$%%%% !16CHNCS:W?&".2.&*.-IIYY#\D,:]6/^>216FMMX/>
M86W]H:LA)VB\:!/+SZF,'=M_'/M4N:3L6H-JYS=%/F18IY(TE65%8A9%! <
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M@)9W37,6Q27:(QX8@%EP3V.1GO5:FG<'H%%%% @HHHH **** "BBB@ HHHH
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M43T6W_!.I\1:W=Z)XBN]&L;:WBTZSE\A;5[=&651QN<D98MUSG//&*H>/O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMW^DK+9FYL(!/-B4[0I&< [>N"*]"@\.1#XV/J8V_83:_P!I*_\ #DC9G/\
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MM?$^AP:E:D#>,21YYC<=5/\ GI7E8ZDU+G74]3!5$X\CZ''?$+X9IK[2:KI
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **^N?[*T[_GPM?^_*_P"%']E:=_SX6O\ WY7_  KSO[07
M\IZ'U!_S'R-17US_ &5IW_/A:_\ ?E?\*/[*T[_GPM?^_*_X4?V@OY0^H/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!EZ]!>W%BR6DRQK@F0GJ1CH*\]@@EN)5BA
M1GD;HHZFO4;E2]K*JC+%" /PKD_#6DWUIJWFW%LT:"-AN..O% '-"*1;D1,"
MD@;;@\$'->E:9%>06:QWLJRRJ<!E[CW]ZY74]'U";7Y9X[5VB,JD,,8(XKMJ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%[H]V,E)*2V84444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4L1)Q/K<!&4<-%2"BBBN0ZPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M52;P;XHFFDE?1KG<[%CA1U)SZU]"T4O[5J7YN57*_LFG;EYG8^=_^$(\3?\
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M $!KG\A_C1_PA'B;_H#7/Y#_ !KZ(HH_M:K_ "H/['I?S/\  ^=_^$(\3?\
M0&N?R'^-'_"$>)O^@-<_D/\ &OHBBC^UJO\ *@_L>E_,_P #YW_X0CQ-_P!
M:Y_(?XT?\(1XF_Z US^0_P :^B**/[6J_P J#^QZ7\S_  /GE/!GBF,DII-V
MI(*DKQD'J.M-_P"$(\3?] :Y_(?XU]$44?VM5_E0?V/2_F9\\IX&\3NP4:/<
M G^]@#\R:['PS\*I5N$NM?= BG(M8VSN_P!YNF/8?G7JM%9U,SK3C967H:TL
MJH0ES.[]1%541410JJ,  8 %+117G'I!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!A^,KVYTWP3KE]9RF*YM
M[&:6*0 $JP0D'GWK/;0=?M[);K2_%-]-=A X@U&.&2&4XSM.U%9<],@\>]7_
M !K:7%_X'UVTM8FFN)[":..-!DLQ0@ 50/B75)K);;2?#.IM>E J/>QK!!&<
M8W.Q;) ]%!)H FTWQ%%K=KX=OUO)+$WS2 V1C#^<ZH^^,MCY=I5CGC.WWJY#
MXKT>XU(6,<\QD:5H%D^S2"%Y%SN02[=A88/ /8CM6):^&KC1I/!EG%ON4L)Y
MWNK@+@;GAEW,?0%W_6JEHE_9:];Q:+::W9H]\S7EE=1J]F(F9B\B2<[22=P"
MMU."M '46?BC2=0U*2PLYY9YXI)(I2EO(4B="0RN^W:IRIP">>V<BHK7QCHE
MY=0P0W,I$[^7!.UM(L$S?W4E*[&/!Q@\]LUFZ3H=U)X4\1Z<R-:3ZA>:ALD8
M8.))'"/^1!^E85CI<]W9Z;I%];^*/-A> 30-Y:VT)C92&$FT!E!4$!3D\<"@
M#L[_ ,4Z5IU\UE++/)<1J'E2VM99S$IZ%_+4[,^^*5/%.C3:0=5@NS/9B4PA
MX(GD+N&VE5502W([ YK&LGOO#6LZTDNCWM]#J%X;N"YLU5]V45?+<%@5*E>"
M>,$<CFL+3)M87PKOLX+FUB?7[P:@NG(LLT47FRY$8P<_/M!(!.,D"@#M[;Q/
MI5SI]]>K/)'%8*7NTG@DCDA 7=EHV4-TY''/:F1>+-%FT^YU 73+8V^TM<R0
MND;YX&QB ).>/ESR0.]<?#I6H36WC=HK/5&COM)2*S:^8M+.P2<$8/*\L/E.
M#R.!FM[7-*NW\-Z&UI:&9]+N+:Y>S7 ,BHN"JYP-PSN /=10!6O?$UMJ/BCP
MO:V<]Y [WLIE@G@EMVDC^S3$':ZJ67<!SR <=ZZS4-0M-*L9;V^N$@MHAEI'
M/ R< >Y)P !R37)W=W<Z[XJ\,SVVB7\=K9W4TD]U=0&(Q[K>10H5OF()(R<8
MSMZ]M/Q?87=W9Z==6=N;I]/OXKQ[92 TRJ&!"YXW#=N )ZJ* +-CXITJ_GDM
MXGN8[A(C-Y%Q:2PR,@ZLJ.H+#_=!ZBL'P/?VVLZIK6HL]_)>"\FA4SQSQQI
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M;R32%&+ ,%122/E.<=.^,BI+;Q%I-UI,VJ1WL:V=ON$\DH,9A*]0ZL 5(]"
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M+#.]PBP"#(NBF0WS$97:03D8S[BN6CO[PZ%9N;N?>?%<D);S#DQ_:W79_NX
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M@\=^M9>D75YX:T*;0KC0+^]NXY)O*:"'?#=AW9@QDSM3.[YMV,'/6F1:3?\
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M;H6S99?M7FB0G."6$OSCD=ZPO"VNQ67@#1[S4IKF:6=-@*QR3RR-EC@!06/
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M0B%E=L$@F7+*[$$@# //RG\>.O%&G^)=+U+[6(II(GM%#SQW4#V[QH<D,5D
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MME+=>;NY!1XUVX]]^<^U &I17"VGC;6)O#UGXCFT:VATF5XTE7[23.JLX3S
M-NT@$YQG)'/!XJU:W_B%_B1J%BR69T^.SMY GVE\JC23#>%V8WG: 1G' Y-
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MNW!.. >-PZ\U:&O:Y?ZWJ^FZ7I=ILTV9(C<W=PRK(6B23 "J3GY^>P&.N<
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MK_$^V^QW*O;V\"7.IQH0RF6-F%N"1T;+2-C_ *9K72:QXBM=(G@M/)N;R_N
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MZ#;WUKH-E%J=PUQ?B(&XD/>0\MCV!) ]@*XN75=7N/#5F8=2E@N9_$DMD9P
M66+[3*F ",<* !GT%>BUF+X>TM+>*W6VQ%%>&^1?,;B8N7+=?[S$XZ<]* ,?
M35NM)\;MI']H7=W97&G&Z"W<GF-'(L@4[6ZX(8<=B.,5:\57J0Q65DLNI_:;
MN8B*#32BRS!5)8;GP$4<$G*GISSBM<Z=:G5%U,Q?Z6L!MQ)N/$98,1C..H'/
M6H-6T2QUI8/M:RB2W?S(9H)GBDC8C!VLI!&0<$=#0!Y[J-]?2^!O'FFWOVL+
M908A2]E229%>(-M9T)#<Y(R2<'FNM@_Y*A?_ /8%MO\ T=/5J/PAHD=AJ%D+
M1FAU%=MYOGD9IN,99BV[.#USFM)=.M5U234Q%B[D@6W:3<>8U9F QG'5FYZ\
MT <_XJ>_EUWP[IUGJ$]E%>3S+</#C<R+$S8!(.#D=>V?6LG4;K4'\3R:#$FN
MSV6GV4,F;"XB669W+C=))(ZL0-F!MZG.>U=M<:=:W5[:7DT6Z>S9F@;<1L+*
M5/ .#P2.:JZIX>T_5[B*YG6>*ZB4HEQ:W#P2!3U7<A!*^QXH Y7'BVX\/11R
M0:CB#4661%G@CO+BTVDKAE;8'#$ X()"'H345SJMP_A[3H=,UK4()VUN.RFD
MOXU\^#.28FXPQP5P3G.1R:ZA_">CMIT%BD$L4=O(9HI(;B1)5D.=S>8&W$G)
MR23G/.:R->\)6ITO3--L[%I[8ZM%<78DD:1G'.]W9B68].<YZ>E #YTNO#?B
M31(H=4O;RVU.=[:>WNY/-((B>02(<97!3!'3#=!BN=M]2\0ZWIEUJUO!XA%\
MTLPM/L\MLMK%L=E5&1I 6'R_,6&<YQCBNYT_PQIFFWWVZ-;F>Z"&-);NZDN&
MC0]50NQV@X&<=>]077@S1+NYGFDAN%2Y??<6\5U*D,[=R\:L%8GOD<]\T 9<
M<NH^(O$L^FWEW=:9%96-O/);6DH1Y)9=^XEQSM79M !Y.<YXJGK.@2CQ;X6A
MEUO59&(NE\WS55@ F1T4#." 3CG%=3J?AS3=5GAN9DFANH4,<=Q:W#P2!#U7
M<A!*^QXJ*;PGH\]A:69AG1+-VD@DBNI4E1FSN/F*P<[LG.3SGF@#G=1GU'3=
M?N+O6+G6+>R^UQ_9;NS='M4B.T;)8_O DY!8J>N0P[=+XI%^/#&H2:7(T=]#
M$9H=O5F3YMOT;&W\:BF\'Z-<7SW4D5P?,F$\D NI1!)(""&:(-L)R >G)&36
M[0!Y\OB^:;Q)!K4=WCPP1'9."!M\V2+SA+GVS'']6-2Z?J&K21>#WN[N97U>
MYN9ITSC$;P2RQQ^VT;!]5K?'@SP^/#,GAP:<@TF1BS6X=N27WYW9W?>]^,8Z
M5I3:99W%S97$D(,MB[/;D$@(2A0\#@_*Q'- 'F,FE_9/ OQ"F^WWLVUKZ+9-
M+N4_NU.XC'WO>NED@U#0=7\.2G6+R[_M"Y-I>13N#&V89'#(N/DPT8QCL><]
M:VIO">CSR:FTD$VW4XVCNXA<R".0, &.P-M#$*!N !]ZT+K3;2\DLY)XM[6<
MWGP'<1L?:R9X//RLPY]: .;^)EK]I\!ZD?M$\/EH&Q$^W?R!AO4<U2UK2)O^
M$N\*V$>J7JJ(;XR7!D!F9?W1VAL<<X&<9QTP>:[._L+75+">QO85FMKA#'+&
MV<,IZ].152VT"PM9+*55GDFLED2"6>YDE=1(1NRS,2V=HZYQCC% ''WFMZIX
M<TCQ9!#=3WKZ;+;K9RW!#R()@@^8G ;:6)&X].":LZ:->M=;TXP6GB%K:20I
M?'5)[9T*;20Z[)"58,%X48()XZ5U;:-ISR:@[VJ2'45"W0?++* NT @\8QQQ
M5/3_  II6FWD5U"MU++ "L'VF[EF$ (P0@=B%XXR.<<=* ,[XAX30+2:<9L(
M=2M);T=O($JEB?\ 9!P3[ UU7F)Y?F;UV8W;L\8]<TDL4<T3Q2HLD;J59&&0
MP/4$=Q7-CP#H03R +[[#_P ^'V^;[-CT\O=MV_[/3VH AE>X\0^+K_33J5S:
M6%A;02*EG)Y;W#2[SO+CG: N !U.<YXK%U#5]9M=!UW3X-4D>ZT[5K*UM]09
M5+%)9(#M< 88J)"I]1C/-=AJ'AK3-2E@G>.:WN((_*CFLYWMW5/[FY""5]CQ
M2Q^&=(BTD:6EIBT$R7!7S&+-*KB0.S9W,VY0223G'.: .<ETV_B\96NB)K^J
M&PNK&6[GW3 REXW1<*^,H#YN2!C[HQC)S1NM4U:V\)ZI;QZM(MS8Z]#80WTP
M!81--#]_H&PLA4GN!7>MI]J^J1:DT6;N*%X$DW'A&*LPQG')1>>O%<[XJ\-Q
M7.@W%K96/G&]U2UNKJ,G<),31>82"<8V)R.G% $6HQ7GAC4=&N(-7O[M+R^2
MSN+>[D$@D#@_.O V,I&<+@8SQ6'XFUJ[2RUK6]'EUZ7^SVDVW'G0I9H\7#)Y
M9(+KN4@G:3UP:[.Q\*:587\=ZB7,T\(*P&ZNY9Q ",'8'8A>.,CG''2J]UX'
MT&]-XMQ;SM;WC.\]J+N40.[?>?RPVT,>N0.O/7F@"E?)?:IX^;3/[4N[73ET
MI+AXK9]C-(974'=C(&!SC&<#MD'-CU75K+P[-?O?37"Z%J\L5RSXW7%HK;6+
MX'+*C!L\9\OWKMUTVT34SJ*Q?Z68!;F3<?\ 5ABP&,XZD\]:R=6@&CZ/?1Z3
MHTM]/?R2,858%&E<<LY=AA"<9Q^5 $.G,?$.MZO-.PFTFUEBMK:$\HTL1\QY
M?<ARJCWC-9/B.74M/UB^O]1N-9@TF,(]M=Z:Z-';*%&\S1'YFYR2=K#;CIBN
MG\,Z)%X<\-Z?I$1W"VA",_\ ??JS?BQ)_&J]_P"$-'U*[GN+F*X_TC!N8H[J
M5(I\  >9&K!6X '(Y P<T :>H2LFDW4T3X98'9&'KM)!K@XXM4A^'$/BD^);
MR34HM-6]W,Z_9WQ'NV&/&"#T)^]DYS7>:C$TNEW<4:Y=H755'<E2 *Y;P_X%
MTR/PYH\5_:W*O%;0--9-=2>1YP5<EHMVPG<"3Q@GGKS0 13W?BCQ)<V4M[=Z
M=:6=G;S?9[:3RY)7E#$LS8SM7;M &.<Y[5D:O>W;>%_$FE7=T]X-,U*TABNG
M W.C/!(%;  ++NP3WXSSFNUU3P[IVK7,=U.L\5W&AC6XM;AX)-A.2I9""5SV
M.12)X9TB/1FTE;3%DT@E=/,8L[A@^YGSN9MP!))R<<T <[K'B+4-)G\9W$3^
M:-.LK>6VC?E(V97RQ]L@$^PK;TO09[*>"Z?7]3NY-I\\32*T4Y(ZA=N$YY&W
M'IS6@-)L1=7MR;=6DOD6.YWDL)%4$ %3QC#'MSGFJ&G>$]*TNZAGMEN_W (@
MBEO)9(X<C!V(S%5X..G X&* ..C\0:Q<^'/"%JK:A-+JB2O=369C$[B,9VJT
MC*H)SDGKA3CU&G:#Q5]EUNTLH=0@0V@?3Y=5EA>6.8[@R[D9\KC:06Z'/45T
M4GA?1Y-&MM)-J5M+4AK?9*ZO"PSAE<'<#R>0>]-A\*:1#97EJT$LZWH N9+F
M>2624#[N78EN.V",=L4 9OA6ZVZG=6$\NMPW8A24V6J.DF!D@R)(N0P)P" V
M!@<#-=97,W7@ZV72M1@T^>Y2\OH!;/=W5S)/(D1/*JSL2."V,=\$UTD<:11)
M&B[40!5 [ 4 >=_VIK%WX6T$Q:G-!<W>O36LLZ@%O*$MPN!D8X51C(Z@=:T#
M>7GAK6]7M$N[O4+:+2#J,45U)YCK(K,"H;KAL+P<X(XZUT4?A[2XK:TMTML1
M6ETUW"OF-\LK%F+=>>7;@\<_2K7]G6AU0ZD8O]+,'V<R;C_J]V[&.G7OC- &
M!X>TJ\N;'3-8G\0ZA/<SQI<3!77R) RYV"/& O/!'S<=:PM-O;BRT*P^SS-$
M)O%5S#+C^)&NILJ?KQ746O@[1K*ZBFMXKE(X9/-BMOM<OV>-_58MVP=>!C [
M58E\-:3-I,VEO:G[)+.UPRB1@PE:0R%U;.Y3O)(((QVH S-1UBYL_&<\".TL
M,.B27?V8'[SB0 'ZD BN<U;3[V]^%5_KD_B*[:[N](DN)07'V8J\1)C6/& ,
M' /WLX.3TKM--\,Z7I=^U_!%,]Z\1A>YGN))9'3(."78YY QZ=NM4I? /AZ>
M":VDM9VLI@VZR^URBW!;.2L8;:IYR, 8/(P>: &VE[<CQCIUB)F^RMHK3&+L
M7$D8#?7!(_&N6LI]8A^'FE>*IM=OIM0S;N\;./)DC:54*%,8/RM][KGG..*]
M$32[--0BOUAQ<Q6YMD?<>(R0=N,XZJ.>O%0#P]I8T&+1!;?\2Z((J0^8W 1@
MR_-G/! [T 8F+KQ#XMUBQEU.\L[73!"D4%I)Y32,Z;S(S 9(YV@=/E.<U-X,
MN+V5M?M[W4FU V>J-;QS, "$$41"G  R"QSC'.>!TJOXCM(I=;$]SX9U&["P
MA(K[2[ORI3R28W"O&VW/(Y8<GI5OP5HLNC:;>M+9I9->WCW*VB,&\A2JHJDC
M@MA 203R3R>M &;+I1D^+ F_M"_7_B6";8LV%XF V8Q]T^E8MK8WT?A7Q5K%
MOK-[;3V>H:G/:QPL!$I2:1L.N/GR0<Y[=,=:] O="L+_ %.UU&9)EN[8;8Y8
M9WB)7(;:VTC>N0#M;(I5T/3DTR]TY;?%K>M,UQ'O;YS*29.<Y&2QZ=,\8H Y
M'5M9U+4O$5IIL5OJIM?[,COI$TN2*.21W9EP7=U(5=O1>26&??=\)2:P;2\A
MU6"[1(K@K:/>-$9GA*J1O\MB,ABPSU( )YJW?^&],U%+42QS126B[()[>=X9
M8UP 5#J0<' R"<'%6=+TJST>T-M91%$9S(Y=V=W<]69F)+$^I- '/Z6R1?$[
M7X[K N9[.U>T+=6@7>&"_1R2?]X5NZUJ7]E:-?7B*LDT%M+/'"3S(44M@#\O
MSINKZ#IVN)$+Z M) Q:&:*1HY8CZHZD,OX'FH--\+Z;IEX;Q1<W5X4,?VB]N
M7G=4/55+D[0>X&,]Z .6OUU+2?!'_"5IX@O+C4(K9+QT=P;:?(!,8CQ@ YVJ
M1\W3D]]1OM7B'Q=J=A)J%Y96>FQ0%(;63RWE>0%B[,.<#&T <9#9S5V'P3H4
M$T3);SF"&02Q6C74K6\;@Y!6(ML&#R!C [8JWJ?AO3M5NX[R9;B&[1/+%Q:W
M,D$A3.=I9&!*YYP>G:@#AEU#4/#FD^-)K>[:]O5UB"W2XV(6&^*VC#$<*64-
MWP"1S@9K7TH:[:Z_IXAM-?-E*72^.JW%O(H&PE779(6#;@!@#;ACP,"N@L_"
MVBV%A>V,%A&+6^8O<Q.S.)6*A23N)Y(49]3R>233=.\+:9IEXEW$+J6>)2D+
M75W+/Y*GJ$#L=OIQSCB@#:KBUM=0UOQ;XCM9-:O[6TM/(%O':N$*NT0)8G&2
M,]NG)SGC'0^'],DTC2([:>837+.\T\HSAI'<NV,]LM@>P%68-.M;:]N[R*+;
M/=E#.^XG?M7:O&<#CTH \^LKO6!X0T'Q7/K-W+?75Q:"X@R!;O'-*L941XP,
M!\YZY'7M6CXAO);W4M2339?$$LM@@21K*:&&WMI-F_G>5WG#*2#N !'2NG7P
M]I:Z+:Z0+;%C:M$T,7F-\IC8.G.<G#*#R><<U7N_">D7M_/>313A[G'VF..Y
MD2*XP,#S$5@K< #D<C@Y% &%I_B*[A;P[K&I7.W3M8TM/.!X2&Y$?FAAZ!E\
MP?\  %K<\)2WUUX?BO\ 4'D,]\[W2QO_ ,L8W.8X_P $V@^^:R/$FA+J.F:=
MX/M-)F_LM6@\VY9@8X8(SDH&+;BY"!>AX?)/6NR    & .@% ' Z=HUQJGB#
MQBRZO?62+J*B);1PFV3[+#EVX^;^'@\<'CFECUZ76?#/AGS7U634]0LA=/;:
M4R1-( J[V9V("*&8=&&20.:[2UTZULI[R:WBV27DOG3G<3O?8J9Y/'RHHX]*
MS)/"&CM9Z=;1PSVZZ='Y-K);W4D4D:8 *[U8,0<#()/04 <K;:QK47AC4KUI
MKO?H.K?O(IG1Y9+551I$<ID,0LC$$<Y1<\YJWJ_B6_BA\3ZYI\OFV6EVJVUL
M@P8Y)R [R'U"AD'7'#5U6F:#IFD6US;V5J(XKF0RS*SL_F.5"DG<3DD*,^IR
M3R2:--T#2](T5='LK-$T\*R^0Q+A@Q);)8DG.3UH Y.P'B"UU339+>U\12+)
M,$OFU*>V:)XR#EU5)"48'! 08QD8K?\ &.IW>E^'S)92+#//<P6JW#*&$'FR
MK&9"#P<!L\\9Q3K#PCI&G7<%Q#'<NUMG[,D]W++'!D8^1'8A>"1P.!P.*UKV
MRMM1LIK.\@2>VF4I)&XR&!H XCQ!HTFEWOAMUUJ^N(VU>%7BO91)O;:V&4X!
M4]>!QC/'%6);G7;^'Q=;Z;<.US;ZE%% H=598O*@>1$9AA6(9\$]"U:T/@O1
M8KFVN'CN[F:UD$EN]U>S3&$CIMWL<#^?&<X%6[CPYI5U#?12VQ(OIUN)RLKJ
MQD55574@Y4@(N-N.E '(2:_-I?A[5TM+K5(M0BFMHS#JX61K,32",2!AD.OW
MF^\PRI'%=$=&GT>SN[N/6]4N&6UDW)<RK(K/C(<?+\I&#PN!STJU:^%])M;6
M]MS ]RM\H6Z:\F>=YE ("LSDG !.!T&3ZU'9^$]*L9&=/MDN8F@47-[-,(XV
MZJH=CMS@=.>* .:@NM3U:Y\&6C:S<6L=]HLEQ=F(@/.P$!X)'!^=CD<XW8QU
M%F62ZTO5-9T%KZXO;-]'>\B-RV^2!LLA4MU*MU&<GY6Y])]2\*6]UXET"$6D
M@TRPTZX@CDCE9&@;= (]K@A@=JMR#G@YZUMV'AO3-.@NXXHI7:\&VYFGG>66
M48( +L2V "<#.!GB@#GM#O;F*7P-9QS,MO/HLCRQCHS(EOM)^FYOSK&$VL#X
M?7OBE]=OC?6<ES+#&' AV13. C+CYLA<$GD9XQBO0(=$T^WET^2*WVOIT#6U
MJ=['RXV"@CKSPB\G)XIA\/:6=!FT0VW_ !+IA()(?,;D.Q9OFSGDL>_>@#"U
M^Z-]K9T^S.O7%Q;P*\L&F3101Q;R=K.[E<L<'"Y(P.E8]MJVLZUI'@Q/[3FM
M9=0N)X;N:()OD2..7T!4,=@Y'0G([5V%_P"&-,U&_-[*MS'<-&(I&M[J2'S4
M&2%<(PW 9/7U-/M?#FDV4>GQVUH(DTZ222U57;$3.&#8&>1AVX/ SQT% &%<
MZH_@_6+A-0O+B?2Y=.:XMVG?>ZRP#]XF>I+*58>ZM6]X<BU"+P]9?VK*TFH.
MGF7!;^%V.XJ/9<[1["L?Q)ITOB36M*TR33)?L-E=I>SWDNT(VQ3M1.<DEF /
M&,!O45UE '%:);7WBFTN=7GUS4+28W<\4$%JZJELL<C( RD$.QVY.[/7C%26
MD5WXGU?6S<:M?6<.GW?V."WLY1$1A$8R.<98L7X!^7 ''6M.[\':->7<]P\5
MS']I;=<107<L44Y]716"L?7(Y[YJ2_\ "NEZC>M>.MS!<2($EDL[N6W,JCH'
M\MANQVSR* .3?6=:O=!TJ!-3:*Z_M]],EO8D4&>)#*I<#&W)"CMC<.F.*TD7
M5=-\0:IHNGZG/<&;23=6C7S^9Y,^YD'S$9*D[3@YQ@XZUT2Z!I:6EA:1V:1V
M]A*LMM&A*B-P" >#S]X]<YS3[K1-.OKF:XN;999)K4VDFYCAHB<E<9QU[]:
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MW+ )P!@;PC -QQD\XXZ5F>'?"]NW@UM%U.Q\J%;ZZDCB5BAC7[3(\3(5(*D
MJ00010!)J6LW-EXPNX8W:6&WT-[O[*#]YQ)@'ZD BN;T^\\37&E:?J]K;>(+
MC4)_)G<RS6HLY48@LH02_*NTG:0-W SGFNWTWPSI>E7[7]O%,]Z\7E/<SW$D
MLCID'!+$YZ#'IVJM#X+T2"YCEC@G$44HFCM3=2FWC<'(98MVP8/(XP#R* ,R
M.UOM<\7>(K2;6;^VLK1H%MXK201E6:($DMC)YZ#IR<@\8H6>MZKK&D>$["2_
M>VFU/SA=WD*A7<0@_*N1A6?&<@< -C';N+?3K6UO;N\ABVSW95IWW$[RJ[5X
M)P.!VJC)X7T>71X=*:T(M('\R$+*ZO$^2=RN#N4Y)Y![T 8?B-M0\+:$$L+_
M %*[>^O8+:-I6CEDMPYPQ1GP"3T&\D D?2DT?^W;?7HHH;36ETZ6"03G5YX)
M?+D&"C(4D9N>01TY&,5N1>%=)2PN[*6&6ZBN\?:#=W$DSR8^[\SDD8[8QCJ.
M:+#POIFGSO.JW-Q,\1A\R\NI+AEC/5 9&. <#..N!G- '.^&9[ZRU>RM-=N-
M9AU2>)PZW#QRVEW(!EC$5SLP 2%^4XZ@XKNZP+3PEINERBYL%G-S!$R6@N;J
M6:.WR,8168A1T' Z<=*OZ'IG]C:%9:=YIE:WA5'E;K(V/F8_4Y/XT 9FB:C/
M-=>*1<W!9+/42D6X_P"KC^SQ-CZ99C^-<Y9ZAJNJ:7X!B.LSVSZE9L]W*FWS
M)B(5; R" Q.><<<XYKJ[WPGI%_J$U[/#.)+A56X2.YDCCN HP/,16"OQQR#Q
MP>*R=5\)6LVH^%["&Q<Z3IZ31_+(P, $8$9#YW Y'!!S[T 36376B^-8-&&H
M7-[97EE+<A+I_,DMWC=%SNZE6#]#G!7BNKK+TKP]I^CSS7%NLTEU, LEQ<SO
M-*RCHNYR2 ,]!Q6I0 4444 %%%% !1110 4444 %%%% !1110 4444 9^MZS
M9Z!H]SJ=]*J0P1L^"X4N0"=JY(!8XP!26NO:5=Z1_:D>H6OV(*"\QF79&< X
M9LX!&1WJOXMMFO/!^M0)#YTKV,ZQH%R2QC8# ]<UR5Q>:7<6_A/5/W<^@VC.
M+PI'N2&?RE$;R*!P%.X9(^4L"<8H [RPU.PU6W\_3KZVO(0<>9;RK(N?3*DB
MK$DB11M)(ZHB@EF8X 'J37&Z5<6>K?$%M2T(I+8+I[17MU /W4\N]3$ PX=E
M DR1G 8#O6QXPO9-/\+7MS%9PW1&Q6CGC,D85G56=U'+*H)8@=EH OZ?K&EZ
MNLC:;J5G>B,X<VTZR;3[[2<5&NOZ,]Y%9IJU@UU,-T4(N4+N/55SD_A7%Z#=
M"[^(MG/!JL&IQ-I5PCW-I:B.'(DA(0,"0Q&2<9.,^]48-+AM_@E"T5H%N59+
MD,$^<2B<$-GKD?RXZ4 >C:AJ^F:0B/J6HVEDKG"-<S+&&/H-Q&:S?#NJ3ZEJ
M7B!9+A9H+:_6*V*@8$9MX7X(Z\NQSSUK'EO=.T7Q]JMYX@DBMTN;>!=/NKD8
MC$8!WQJQX5MYR1U((ZXJ3P +0W'B>33[5[:SDU;?"CQF/(,$.6"G&%)R1[$4
M =-?SW$,]BL$UI&LEQLE%P2&==K'$>.KY //8&H[K7]&LI%CN]6L()&<QJLM
MRBDN,94 GKR./>LOQ6K-J7A4JI(76 3@=!]GGK+TC2;2>+QN]Q9I(]S?S1N7
M3)=!"F!SVR3^)- '87NH66F6QN;^\M[6 '!EGD"*/Q)Q6+JVN9E\.2Z5?0RV
MM]J0@DDA99%DC\F5L \]U7D>E<MI\\5B_@[5O$&1IZZ$B1W$ZDQP71"$LY/"
MEER Q]",\UJ:A<Z7J$_ANYT5(VMFU[=)+#"521OL\N7!P PZ#<,@XZ\4 =FE
MS!(LK)-&PB8K(0X.PCD@^A%0W&J:?:6 O[F^MH;,@,+B295C(/0[B<<UQ$6M
M66BCQ;IM[(8]0FO)I[:UVDR7*/$FTQC^+D$<="#G%5K-X-.C\$:CK2[=)@T5
M8UED7,=M<E(L,_9<J' 8].1QF@#I+;7FO_%ES!87]M<:>-)2YA9&5X_,,DBE
MMPZC"@=>U:L&JP6^DVMQJFH:?')) )7ECF"PMP"S(6/*<CGT(KC]/GTR^\<:
M]>:1#F"71TWW$:$1SOOD^93T;C W#KCVJ'2K".Z'PS%S;^8(-*9]KKD*X@BQ
MD>H/ZCVH ] LM0LM2M5NK"[@NK=L@2P2!T./<'%5;?Q%HEU+)%;ZQI\TD;!'
M6.Y1BK$[0" >"20/J:XO5M.O)?\ A/;/2X)-TRVT@AA^4RYC'FA?]IE7'UQ4
M/B75?#6HZ7HL.F6NZ:WU2Q\I4M6C-F/M$8(?(&SCY=IZDCCC@ ]*DD2&)Y97
M5(T4LSL<!0.I)["L?0?%.D^(DN#87<+O!-+&T8E5FPCE=^ 3\IQD'N"*V2 R
ME6 ((P0>]>6O$9_!7BK1M.4+JR:A<R2VR1'S#;FZWD!1@L&C)P ><X% 'HMC
MK>E:I++%I^IV5W)%_K$MYUD*?4 G%!UO21<"W.IV0G*NPC-PN["$ASC.<*0<
M^F#FN'TI[75_$>BM:^(;"ZDL2[K%I^E-$8X]A4QR-O(C4Y'RL <@<<5/HVGP
MP>!_%4R6P6XN+O5&=MGS-^]E ]^@% '7)K^C23S0)JU@TT*>9+&+E"T:?WF&
M>![FEAU:SU+39[K2=0L;I45@LR3"2)6 _B*GIZ^U<5=:'8CP_P" 8!8Q[([V
MW+#9ZP.S;O7+ $YZGK5^\MQ!XK\5"&+8D^A0N^U<!Y ;A<_7 4?E0!TJ:K;6
MNFVT^IZA812-;B6219@L38"[F4L?N98<^X]:GM]3L+NP^WVU[;36>"WVB.56
MCP.IW XKA[&PCN=5^'IN+?>+?1IW&]<A'V6X&??DTR^G?1F\:O;V$$L!OK1C
M'-"7A3?'$))60?>"\L<==OXT =G;^(=%N[2:[MM8T^:V@XEFCN49(_\ >(.!
M^-9VG^*K;Q!H=GJ.C7E@IEEA$L=U*"8U=L%"%/$A&0H/>N=T":._^(<<B:E;
MZK;OI$JO<6]J(X&*RQ84$$AB,GC)QN]ZH:7);2?#OP[90!?MEGJ>G1WD03#Q
M.+A<AQU!X- 'HVH:UI6DF,:EJ=G9&3A/M,ZQ[OIN(S5B2\M8H4FDN84BD(".
MS@*V1D8/?BN+@O\ 2M"\5^(9?$DD-O/=RHUI<W0PDML(E C1CQD.),J.<MG'
M-8XTS[1X6TRWFLY%TR?Q*LMI:RQD;+4R,5!4]%/)VGHK >U 'HVGZMINK([Z
M;J%I>)&VUVMIED"GT.TG!JY7+&%+;XF++'$(TDT9_-*+@,4F7;G'4@,V/K6]
MIFI6NKZ;!J%D[26TZ[XV9&0D?1@"/QH RWUF[L/%Z:9J"Q"QOX\Z?.JD'S5&
M7B<YZD?,IXR P[4NA:S<:S/J%^/*318W\JSD(^:;9D22YSC9GA?7:3T(JE\2
M;5;KP!JF8V:2)%EB*Y#(X8892.0?I1XST[9X1AM+2T9]/MY[;[3:0(27M4==
MZ!1U&T?='4 CO0!NZ?K>DZL\B:=J=E>-']\6]PLA7Z[2<58%W;M%+*MQ$8XB
MPD<.,(5^\">V._I7$W>H:3KOB/PZ?#4D-Q=6ER7GGM5^6"V\M@R.1P,DH AY
MR,XXJA)K-GI6@^,-(NG*ZI)<WKP684F699061D7^)2&Y(X&#G&* /24=)(UD
MC961@"K*<@@]P:IS:SI5MJ$>GSZE9Q7LF-EL\ZK(V>F%)R:9X?!'AO2P1@BS
MBX/^X*X37;VSTG6M5-E=6EY<W-W%)/HE_9DRW$@"*# W!(PJD'#*"#R* .CB
M\36]EXEUVWU?5;6UM+=[=;87,B1 %H]S $XSD_6NBGO;2ULS>7%U##:JH8S2
M2!4 /?<>,5S.D:=;2^/?%5U-:H[LMK$'=,_)Y7(&>Q/7Z#TKF-.1+/1?!UWJ
M<3'1;&2Z27>A9('W%8'<=E4!E!/ +#I0!Z39:II^IVINK"^MKJW!(,L$RNHQ
MUY!Q4GVRU%M'<_:8?(EV^7+O&U]Q 7!Z')(QZY%<;9R6NM>-+V^T I+8-I;P
M7=S",0SSEQY8#='95WY(S@,!6$-<LIOA_P"&=%B=GU*VN-,ANK54/F6S1S1!
MS(/X1E<9/7(Q0!W.EZA=7'BO7[*67=;V@MO)3:!MW(2W/4Y([U1\0^*[-=+;
M^Q=8LI;R.]M(I4@FCE9%>XC1P5YQD,1^-8^MVE_=2>/8;".5IY;>U"+'PTB^
M6=RJ?4KD#W-5O$FJ^%M3T32K72(XI[BWU"R,,5O"0UF!/'G>,9C&.,'')% '
MIE<IHOBJT2.^76]8LX)1JEU;VZW$R1$HDA50 <9P./6NKKS?P_JOAG26\1QZ
MPL-K<7&JW9<W47_'TGF-@)D?..VT9YSQSR >A7-Y;65J]U=7,,%N@RTLKA44
M>I)X%,L=0LM3MA<Z?>6]W 3@2V\JR*3]0<5Y>]EJ=CX>\(3WC?8K"TFN7?[9
M:M.MJK$_9C(FX$;4.W)/RDC/K73>#TBNM=U75;?6+?4%FBBBE>SLC# [J6(8
M-N8.V#@D'IM!H ZZYN8+.W>XNIXX($&7DE<*JCU)/ JM;:WI5Y9->VNIV4]J
MK!#/%.K(&)  + XSDC\ZR?&VHOIVCV[B*U,<MW''+<7<)EBM5Y/FLH(S@@ <
M@ D$GBN5TZQ3Q'K/BFR&H+>V]_I,$8O(K<11O)NF 9,<-MROS GICM0!Z4;B
M 7*VQFC$[(76(L-Q4$ D#KC)'/O5>XU;3;2UEN;C4+6&WB<QR2R3*JHPZJ23
M@'VKS"'4;VXM4^(5W:7"SZ=)#:R0;#N, 0I<8'_765C[B):U97G\.>'/#=M>
M&QM)+J62YO=2OH/,2UG<&1NX 9F=E#$@  ]>E '=PZII]S8B^@O[66S/2X29
M6C/./O XZ\4R/6=+EM;BZCU*S>WMF*3RK.I2)AC(8YPI&1P?6O+YD-YX6\<H
MLKW4$]U;,DJ0>2LV5B#.JCL<?>'7&:Z7QQ8M:QZ!);""UTJSNRUQFT,T4/[L
MB-VC4KE5;OT4D'M0!U]AJ5AJMO\ :-.O;:\ASM\RWE61<^F02*I^(?$>G^&=
M.%YJ$R(K2)&J%U5G+,%XR1G&[)] #6!X36*]\2ZAJMOK5MJ(:VCAE:RL3# [
M!B5._>RNX&1QT##-7?B%"LG@VZ<P^9Y,L$IPFXJBS(S''LH)/L* $NO$]O#X
MIL,ZK:+HLNF7%P\IE3RBZRPJK;_;>PZXYKH(=1L;BP%_!>V\MF5+?:$E5H\#
MJ=P.,5R;1Z=J_P 0= O;9(;FTCTN[DMY$7*!O-A7([9P6_6LZXN'T6S\8^18
MP20?VQ#\L\)>&)9(K??*R#EE4EG('<'IUH [6W\0:->6DUW;:O83VT'^MFCN
M49(_]Y@<#\:A\.^)-.\3Z7'?:?.CAE!>(2*SQ9S@, 3@\&N2\/3)??$(R)J,
M&JV\FD.KW-O:B.!F66/"@@D.0&/<XW5J_#>>T_X1&ULHBBWMFOE7<6W:\;[F
MX8>O!H ZB\OK33K9KF^NH+:!?O2SR!%'U)XJ.#5-/N; W\%_:RV0!)N(YE:,
M =3N!Q7,^)GM[+Q?HFIZNN='@@G42NN8[>Y)38[]A\H<!CP">V:HZ[<Z/J-M
MI^HV$*76B0ZL)=4:WMR4EQ$0LAP/WBJYC)(R/E_V30!V>GZOINKQO)INH6EZ
MB'#-;3+(%/H2I.*B_M_1OM<-I_:UA]IF_P!5#]I3?)SCY5SD\@]*YF&\T_6O
M'VEWOAYXKB.WMIDU"[MAF-D(7RXRPX9MPR!R0 >F:PUTN&'X*:@\=H!=%I[C
M=L^?S5G8JWKD8&/8"@#T?4-6TW28EEU+4+6RC<[5>YF6,$^@+$5D:/KGVG5_
M$9N+V$Z?:3PB"0LH1$:"-S\W<%F)R3WK,N[NPT;X@WM_X@>."":SACT^[N!B
M),%_-C#'A6)*G'<8]*Y\V\-]X>^(7]BV$JPS3))#$L10RXAC9F12.C$$CUS[
MT >I//#%)%')*B22DK&K, 7(&2 ._ )_"JESKFD65['976J64%W)C9!+<(KM
MGIA2<FN3N_$.FZ]XO\)?V5<"\C2YG>66($I%FVD 5CV8\_*>>*K:-J&@:19:
MIIWB40)JDU[.]S%<P[WO%:1C&47!,B["@ 4'&,8XH ZBR\6Z/?Z_>:-!>VYN
M[;:-OG(?,)!)"@')*[3GCBMJ21(8FDE=4C0%F9C@ >I-<?ILEC9?$C6;>98X
M;B\AMGM%9-IE"H^\KQVQS6KXQOI-.\+7EQ':0W1&Q62>,R1JK.JL[J.6502Q
M [+0!H:?K&F:NLC:;J-I>K&<.;:=9 I]#M)Q4::_HTEY%9IJU@UU,NZ*%;E"
M[CU5<Y(^E<7H%T+OXC6L\.JP:G$VDSHUS:6PCA)$L)"!@2&(R3C)QGWJC;Z7
M#;_!*T:*T"7*M#<A@GSB7SU.[/7/]..E 'HVH:OIFD(CZEJ-I9+(<(;F=8PQ
M]!N(S6;X<U2?4K_Q LDZS06VH"*V*@8$9@B? (Z\NQSSUK'DO=.T3Q[JUWXA
MDBMUN8(%T^ZN1B/RPIWQJQX#;\DKU.X=<5)\/Q:&3Q,]A:O;6<FK%X4>,QY!
M@A^8*>BDY(]B* .LN;VULE#75S# IS@RR!0< D]?0 GZ"JTVO:/;Z?%J$^K6
M,5E-_J[E[A%C?Z,3@UB>++**_P#$7A&*X@$T(U&1V5ERN5MI2I/_  ("L?Q&
M9M-\>)J%SJ-EIMB=/6*TN;RS,T4<F]C(N[>HC8@IU^\!CM0!WJ7EM)9B[2XA
M:V*[Q,K@H5]=W3'O4&GZQI>K)(^FZE9WBQG#M;3K(%/OM)Q7G;Z>%\*+<I,^
MI:1)KB7EY'#8O#&8!@/LC)8M'O D.,@_,:U/$5]I'B'P[JL?ALQ7UXL$8G:Q
MCRSVXD4O$' QN*!P$SGGI0!UUEKFD:E<26]AJMC=3Q_?C@N$=E^H!R*>VKZ8
MEY'9MJ-H+F1S&D)F7>S 9*A<Y) Y(KBM2U'1-;N?#]MX9,$U_;7\,B_98]IM
M(%/[T/@#8"F5VG&20,5H>&-.5;WQ;=10HE]+JDBI.Z\X$4>WGT!)/XF@#1\0
M>)=/L]-U6"UU:R75K>SFEC@$Z&565"0=A.>V>E6(M>L++1].N-7U.TM7N84(
M:YF2+>Q4$XR1Z]J\_P#MWAV'X5SZ%>6X.LQV#K<:>8B;DW04[I,8R?GRWF=,
M<YK2U22RL'TJ]?6+73;_ /LE(=FI6ADMIX^NP'*X?/4*V<$9!XH ]%5E=0RD
M,I&00<@BJVI2S0:9=36\EM%-'$S))=$B)2!D%R.0OK[5E^']8MY=+T6UEM!I
M]Y=6/GI8)&0(D0*&'3Y0-Z@ XZXI?&RL_@/Q"J@ECIMP  ,DGRVH OSZM8Z?
M;K)J.H6=N1&'=I)E1<=-PW'ID]:GM[VUN[-;NVN89K9EW+-'(&0CU##C%<G'
M8Q7'Q"T>:> 2>1H;F-F7(1S)&,CWP2/Q-8MW8R_V'XEMXK662PB\1QRW%K"A
M)DML0/*JJ.H.6) Z_,.] '7:AXDL+CPYK-SHNK6=S<6EI+(&MIDE\M@A() )
M[CO6AI5ZMQI]AYTZ-=S6J3%<@,PP-S8],D>W(KF=3U?PWJ^A:RNCR6MU=QZ3
M<*'MHMQC39]PL!\N3CY"0>.G%5_MMOH>N^&M2U.5;6Q?19+7[1+\L:2DPL%9
MNBY"MC/7% '<+<0.90DT;&%MLN&!V' .&]#@@\]B*YK5O%-I,^EKHFKV=P7U
M2&WN1;RI+A&W94XSC./K7+S&76-"\83VMM<RVLNN02RPK&P>XM5CMO,VKU(9
M%; [@X[U<US5/#FL:CX8&CB&[N(-3AQ):Q\6Z8.5<@?+GCY3SD9QQ0!VT%ZZ
M3:@U[=6 MX)E6,QOAHU*J<2Y. V3Q[%:?::QI>H7,UM9:E9W,\'^MBAG5VC[
M?, <C\:X#7[=YM#^(D9C<B6_A P#DCR+8<?K70:K8P6?B_PD;2V2%4:X@_=)
MM C\DD+QVRJ\>HH W9M;TFVU!-/GU2RBO9,;+=[A%D;/3"DY-6X)XKF!)X)4
MEB<;DDC8,K#U!'6O/M%N]'TW2-0T?7[-WU>:YG:Y@:V9WO2TC%60X^<%2H&#
M\N,<8K?^'>/^%=^'\ @?88\ G..* -K4-6TW2(EDU+4+2RC<[5:YF6,,?0%B
M*D?4+*.WCN'N[=8)?]7(T@"OP6X.<'@$_0&N"UR2?3/']W?7VJ6.FVTUG%'9
MW-]9F:/ +>9&'WJ$;)!(_B!'I55='MY-$\.0F3[=93^(S<*ILV@C52DIPL;$
MX3<"1V(;TH [H^)] %B+XZYI@M"_EB?[7'Y>_P#N[LXS[5<FU"RMK'[=/>6\
M5IM#>>\JK'@]#N)QBN:L],M?^%H:O<&TCS_95KABG&6DF#?B0B ^P%<_;7SZ
M/X*TJ#R[2WMO[7NH3=WL!DBL8UFFV-MR,?=55)( R/I0!W<FK07FA7-_H^H:
M=,$B<QW#3![=6 ZNRG[H[\]*I+J5Y_PFUIIS3(;9]*>X=$ VF02(NX'KC#'O
MWKB [7.D_$9XKK[;%-I2NEQ';^4DS&&92R <-]T#<.NVNAN(D?Q5 +A)C;GP
MW,DGE*2V"\>0N.=V,X YH ZBQUG2]3EEBL-2L[N2'B1()UD*?4 \5>KSSPEJ
M$":Y8Z=9W>G:Q:PV+HEY#:^5<62+LQ'*1Q\W'&%.5Z>G=:??VVJZ?!?V<ADM
MKA!)$^TKN4]#@@&@"/4-9TO2%1M2U*SLA(<(;F=8]Q]MQ&:DEU"R@ACFFO+>
M.*0$H[R@*P"EB02>?E!/T!-<AXBU@6_BPV=Q>:?I$2V:M'>7-KYLET69@T<9
M) ^7 )7DG<.*PM(L%O?#_@6WO+9GCCUJZ+1RQ;=H076T%?X<87CMP* /1)M?
MT:WT^+4)M7L([*;_ %5P]R@C?_=8G!_"KL$\5S D\$J2Q.-R21L&5AZ@CK7G
M_B S:9X]-_=:C9:;9-8)%9W-Y9F6)&#N9$#;U$;'*'G[P'^S6[X&M4M]'N98
M;S[5!<WDD\96T:VC4' (C0D_*6#,#G!W'% &YJ&JZ=I,2RZE?VMG&QVJ]S,L
M8)] 6(YJ5;NV<PA;B)C.I:(!P?,48)*^HY'3UKD_&$EC::SI]_)K,&EWT4$L
M<4E];>;;2(Q4LK$E0&RJXPP.,\&LN+5(K;_A#=<O[.'2K!([J&4HA2&$N!L/
M(&Q6V$C./O &@#J/%NK2:?X1UZZL+E$OK*REE4KM8Q.$+*2ISZ9Y'-7;77-*
MN;O[!'JEE)?JN7MDG0R#CG*@Y'Y5Y_J5VFJZ5\2KFT21X);%5ADV$"8"W8;E
M]1G.#WZCBK&LWV@ZCX:L]&T")%UF.6 V=HD9$]I(KJ2[C&4  ;<QX(SUSR =
MY;3W#ZI?1236C01B/RDB)\U,@Y\P=!GMCMFFV>MZ3J-U+;66J65S<1?ZR*&X
M1V3Z@'(KBM;MK^\N/']OIF\WDEG:JBI]YOD;*CIR1D#GO5?36M-5U708;77[
M"22RF$D=M8Z0T4D"A"&20^8?*4@[2& YQ0!WMWKFDV%Y'9WFJ65O=28\N&:X
M1'?/HI.35*T\6Z/>>(;O1(KVW-W;!./.3]XS;LJHSDE=AR,<9%<QI.H:#H\.
MLV'B80)J5Q?7#SI<P[VO8V<F(QC!,B^7L4*N<8QBM'3Y+"Q^).JQ3I'!+>VM
MHUF&CVF7;YN_;QU'&>] '0Z[K=GX>T:ZU2^D5(;>-GVE@ID(4G:N2 6..!1#
MKVDS:5_:BZE:"R &Z<SIL0^A;. >?6JGC.U:\\$:[!'"9I7T^<1H%W$L8V P
M/7-<O<7^DRW?A?5W:*;P_;1S)+(J9BM[HK'L>08XP!(N3]TMSB@#N['4;'5+
M87.GWEO=P$X$MO*LBY],@XJS7&:'-:ZEX]O=3T3:^EM8+%<W$(Q%<7 ?*[3T
M<JFX%AG[P&>*[.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **S/$<]
MO:^&=5N;LW MH;2624VS[)=BH2=AR,-@<<CFJ-WXGBL+^STBVT^^OKVXM/M$
M*1[>4! )9W8 =1R?7N30!T-%<5K?C:XC\(W.IZ9IEW]KM[H6MQ#((LVSAU#!
M\O@Y##!4G[P/2M>Y\2M!]DMQH]\^J72O(NGJT7F(BG!=VW[%7D?Q<Y ZYP ;
MU%<W-XTL;70[_4KRUN[=M.E2&[M613+$S%0. 2&!#@@@G(Z<\477B[[!;V4E
M[HNI02WUT;6VM\1O([;"ZD@/A0=I')X/7 YH Z2BL72_$(U"XOK.?3[JRO[)
M%DDMI=C,R-G:RE&(8':PZ]0145IXE>74[6QOM&OM.:\#?97N#&PD*KN*G8[%
M6V@G![ ^E &\KJ^=K!L$@X.<'TI:YGP3_P >>L?]AJ]_]'-6GJFIW=C+'%::
M->:@[J6)@:-%0#U+LO)[ 9H TZ*YN?QII\&B:=J@MKR5+^Y^R1PQQ@RK-\X*
M,">"&0KUQGVYJQI_B6.YO+RSO[*XTRZM(5N'CN60@PG(WAD8@@%2#SQB@#;=
MUC0N[!5 R23@"EKSCQIXJ;4/ASK4Z:)J4>G7-C((+UU3:P9?E8H&WJIXP2O?
MG KT>@ HKF9_&21B[N+;2-0N]-LW=+B^A$>Q2AP^U2P=PI!!*@]#C.*M77BS
M2[&[$5Y(T$#VAO(;I\>5,@&6"D')8#!QCH<C/. #5O;>2ZLIH(KF6UDD0JL\
M0!:,^HW C/U%8'_".ZQ?W%F-<UJWN[2TF2X2&VLC 99$.4,C%VR <'"A>0/I
M5+4/%^IQ:KX>2U\/ZB8-061WB;R%D8",L%PT@VL, G....O%:EUXG9;^XL]/
MT>^U*2TQ]J:W,:K$Q 8)EW7<^"#@9ZCUH WZ*YNY\:V$=MI$UK;7E\VK;A:1
MP(-S,HR5;<1M(YSGI@YQ1/XL>+4X])CT2_GU1K-+QK:-HL(C,RD,Y<+D%<=>
M<C&>< '24C,%4LQ 4#))/ %8UKXCCO\ 03J=GI][/(LK0/9JJB9)5?8RME@H
MP0<G.,<YK)UC7?[2\*^*+&XL;BPOK73)7D@G*-E'C?:ZLC$$$JPZY!!H [ $
M$ @Y!Z$452T?_D"6'_7M'_Z"*S-5\4/I#7$UQHFH?V;;']_?#R]BKQEPN_>5
M&>2!V/7% '045075H'UZ31PDGVB.U2Z+X&S:S,H'7.<H>WI5"7Q;I\.FWEZ\
M=QBWO6L!$J!I)I@VT*@!YR3QG'OB@#=+JI4,P!8X4$]3[4M<)J6KW%YXN\(V
M]YI%YITWVZ:1!.8W5U^RS X9&8 C(X.#SQFC5O$LFD:%J5WHUGJ%U(NKB"9I
MI$<1L98U8*'<84AL*!T)Y '- '=T5SMQXIEBN8K.+0=1GOVM_M,MJKPAH8]Q
M4$DR;220<!2>G.*W;>87-M%.(Y(Q(@?9*NUER,X(['VH EHKG]5\3R:0US-<
M:)J!TZUYGOE\O8JXR6"E][*,\D#L<9Q3M1\3I9:VFC6VFWE]?O;"Z1(-@79N
M*DEF8 8([^HQF@#>I&=5*AF +'"@GJ?:N?3QAIYT!]5EAN8BEP;1K0H#/]H#
M;/*"@D%B<8P<8.<XK%U75[B\\4>$K:\TB]TZ;^T9)$$YC=746LP/S(S $9'!
MQUXSS0!W=%9?B+4+C2O#]]>VEK)<SPPLRI&4R" ?F.Y@,#J><^F:RK+Q<Z^&
M]-O=0TR]2^O?+C@M4$;273E Q9 KD!<;CEBN #G% '4T5BZ;XA%YJ;:7>:?=
M:=?B+SDAN"C"6,$ LC(Q!P2 1P1D<<U;UC5[71-.>]N]Y0,J(D:[GD=B%5%'
M=B2 * +S.JE0S %C@9/4TM<'K.L7%YK_ (4MKS1[W3I3JAD3SS&ZNHMY@?FC
M9@",C@X]LX.-2/Q!I^F6VK7$<>H7#KJOV3R7D#L\[! %CW-A4^8<$@#F@#J*
M*PV\31VFD75_JFGWNG_9W$9AE57:1FP%$>PD/N+ #!Z\'%-B\2M%#<SZMI%]
MI-M! UPT]R8V38O4$QLV&]CU[9H WJ*YJ/Q?M>U>_P!%U'3[.[D6*&ZN!'MW
M,<('57+)N) &X=2 <&KB>); V6L74HD@32))$NEE !&Q0^X8/(*D$>N: -FB
MN?E\4YEM[:RTB^N[Z6V2ZDM4\M&MT;IYC,P4$D$  D_*>PS44_C?3[?2;>_:
MUO6::]^P&U6,&:.?YOD89QG*XR"1R#G'- '2T5CZ?K_VO4QIEWI]S87QMOM0
MBF9&#)O*'#(Q!(PI/IO6K.D:O!K5K+=6R2"%)Y(%=P )-C%2RX)^7(.#[4 7
M@ZERH8%EQD9Y&:6N'35)K'XB^(8;73+J_N)+6S81P;%"J/-R69V"CKP,Y/IP
M<:T?C*P:TCGDM[N!OMR6%S%*BAK65L;?,YQM)*X920=Z]J .BHJ@NKP/K[Z.
MB2-/';"YD< ;$5F*J"<YR=K$#'136-XJ\0ZCHNHZ)!9:7<W4=W>"*5HS%AAY
M<C;%WNI#94'/3 /.>* .G#J7*!@67!(SR,TM<)#J]Q:?$#7%M]'O;RYFL+*0
MP1-&IC \[.YF8+G) P"<\XX!-:K:_IFJV_AV_4WZ+>7QAA1&,9658Y=RS 'D
M#RW!'/S ?6@#IJ1F"J68@*!DDG@"L&S\4IJ.L75A::;>.EE<-;W=TVQ(HF"[
MNI;+9R.@.,\XK!\0^+1J'@G6;JWT;46TJ:QG6+4-J;'!1@'";M^P_P![;TYZ
M<T =Z"" 0<@]"**I:/\ \@2P_P"O:/\ ]!%8P\7FYO+^UTW0]2OWL)S!<-'Y
M2*& !^4NXW'!Z#\<9&0#IJ*QH_$45YH<&IZ997=^)G\M8(E5)%8$A@^\@+M*
MD')ZCO51O&5K;:/JU]?65W:2:2 ;NU<(SJ" 05*L58$'KGL>] '245Q6L^,-
M6M8=-FM?#FHI'<W\4(,A@S)&W8*9 59NV<8QSBM6'4[-?$%TUR+VUN8]+BN;
MA)Y088HRTG8,5#@JV2., <F@#H**YJ#QBDAM)[C2-0M-.O)$CM[V81A&+G";
ME#%T#$@ L!U&<9J6'Q0;G4I8+71[^>TBNC:27D8C*+(#@_+NW[0>"VW].: .
M@HJO?ND>G73RF01K$Y8QMAL8.<'L?2N=C\4V>GV'AZUM;/4KR34[/S+./*O(
MRHB']X[-@-AP22<<'G.,@'545E:)KD>LB[C:UGL[NSE\FXMI]NY&*A@<J2""
MK @@UE^)/$>I:3XBT2QL])NKN&[DD$AB,(\S$3MM7>ZX8%0QS@8Z$GB@#J Z
MLS*&!9>H!Y%+7!VFL7%EXW\41VNCWM_,?LLCQP&-?+7R1U9V )/. ">AK=;Q
M=8-H^G:A:0W-V^I<6EK$@$LC8)((8@+M .XD@#'7I0!OT5DZ3KJZC=W%C/97
M%A?VZK));7!4DHV0KJRDAE)4CKP1R!4FL:U#H\< :&:YN;F3RK>V@ ,DKX)(
M&2   "220 !0!I45S,GC*"TM-1DU#3+ZTN=/A6XGMF".QA)QYBE6*LHPV><C
M!XZ9U;G6K6VU/3[##R2WRR.ACP51$4%G8YX7E1QGEA0!HT5RR^-H&MTU Z5?
MKHLCA5U,B/RR"<!]N[>$)(^;;T.>G-6+OQ5Y>M7FD6.D7]_>VD:2RK#Y:H%<
M'!W.P&>",=?PR: .AHKBM5\;7'V'0+[1M,N[FWU&[6)^(E8??#1$.XP^5^GR
MGFNQ@D:6".1XGA=U#-&Y!9"1T."1D=."10!)44]Q!:Q^9<31PIG&Z1@HS]37
M./XU0P3WUMHVI76DV[,LE_"(]A"DAF5"P=U!!Y"\X.,UDZW?)J?C_P -1?V-
M-J.GM:7$\,@,+12;O(Q* S@X0,0<C/S?*#S0!WU%17,WV:UEG$4DOEH6\N(9
M=L#H!W-9%AXB>YU5--OM*O--N9HFF@%PT;"55*AL%&8!AN7(/KQF@#2&GVPU
M0ZEL)NC"(-Q)X0,6P!VR3S]!Z5:JEJVJ6NBZ9-J%XS+!$!D*I9F)("JH'4DD
M #U-8S>,&MKJPM]2T+4[%K^X6"W:3RG4LV3ABCG:<#.#^&<' !TU%<_<^*#_
M &A=6FFZ/?:HUFP6YDMS&J1L0&V NZ[FP0<#ID9.:DLO%FG7\^EQP"8KJ22M
M!(R;0'C^_&P)R''S<8_@;TH W**P;CQ;I]NNHL8KEQ97*68\M QGG8*1'&,\
MGY@#G !SSP</T_Q";G4QIM]IEWIMX\1FACN&C82HI 8JR,PR"RY!P>1U% &W
M17)6OCVVNO#EQXA&DZC'I$-J;C[1((P7QU55WYR.>3@'!P3QF[:>*EGU2SL[
MG2KZR2_#&SGG";9BJ[B"%8LAV@L P' /0C% '045R4GCZU2&^NUTG46T_3[F
M2VO;O:@2$HY5FQNW,HQN)4' /KD"Y8^*ENM3M+*YTJ^L1?(SV<MQLVS!1N(P
MK$JVWYL,!P#W&* &7.C>)':Y@M_$T:6<[,09; -<0JQ^ZCAU7C/!9"1QUK:T
MW3[?2=+M=.M%*V]K$L,8)R0JC R>YXK$N/&*(;N:UTC4+S3[)WCN+R 1[%*<
M/M4L&?:00=H/((&2*EO?%MO!J-II]E976HW5Y:_:X!;;-K1Y R69@ .1U]1W
MXH Z"BN)UOQM<1^$KC4],TR[^UP70M;B&019MG#J&#Y?!R&&"I/W@>E==97$
MMU:1S36DUI(V<P3%"Z<XY*,R^_!/6@"Q17+-XCTO1;#Q#J;_ -H/#9:@(KD.
MWF$.RQ#]V">$PZG QSNX];5IXG,NJ1Z==Z1?6,\\+S6HG,9$X3&X#:YVL-P.
M&QU]C0!OT5@KXLL'\.6.M1QW#QWLD<,, 4>;YCN$V$9P"ISGGC:?2F7/BHK=
MW<5AHVH:E%9-LN9K;RPJ.!DJH9@78 \A0?3KQ0!N7,"75K-;R;O+E0HVTX."
M,'![46UM%9VL-K;H$AA18XT'15 P!^0K"F\70226D>DV-UJSW-H+U1;-&H$)
M. Q,C+R3T'7CG%4;[Q7J4/BC1K*VT+4)+6\M9IG4B%'8CRB.&D!7;O(8'')&
M,T =A17,QZ_I>F0:[>,U\PM]1\B1)&,C/,R1[4A7)X.]0!QR3]:</%QAU#3[
M'4M$U&PFU";R;<R>4Z$[68Y9'(7 7H>>>,X. #I**Y_5O$\FCM<S3Z)J+:=:
M\SWR^7L5<9+!2^]E /) ['&<54/B74AX^.C+I%T]E]D602JT..9-OF\R9V8[
M8W<=* .KHKE[3Q#IFFZ#)=QC4)E?49[6*&1O-FFG$SJ43)Z95L9( 4<XP:N6
M'B/S]433-0TR[TR\EC:6!+@HRS*N-VUD9AD9&0<'OR* -RBN0'Q MFL'U-=(
MU+^RH9FAN+TK&%B*N48[=^YE!')4''X''7T 8VC:-<6&H:GJ-[>1W-U?NF[R
M83$B(B[54 LQ)Y))SWZ"MFN7?QHABN+RTT;4KS2[=W62^A$>T[20Y12P=U!!
MY YP<9J?4/%UK:7.FVUI:76HS:G;O<68M0FV15V$Y9F 48<')XP#WP" =#13
M(G9X4>2,Q,5!9&()4XZ$CCBN?L_%IU%HY[+1-2N-,DE\M+]!'L;G&\(6WE,_
MQ;>G/3F@#HZ*Y>RU_3K*YFB5;]EN=8DLGDG?>L<^T$ 9;*H< *!W/09I?$>O
MZ=%9:Y97*W_EV%DMQ=2V;[&4-NPJMN!#X4GZ$<\T =-O7?LW#=C.W/./6EKF
M(QCXGS#TT6/K_P!=GKIZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#*
M\3Z?/JOA/6=.M@IN+NQF@BW' W,A49/89-58-(NH_%EIJ3!/L\6E&T8[N=YD
M1NGIA36KJ>H0:3I5YJ5UN^SVD#SR[1D[54L<#UP*1-2LY+V.R6X3[5)!]H6$
MGYC'D#=CTR0* .6OO#&I7&A^*;6(0^??ZB+NU#/@,%6' 8XXR8R*CUKP]>ZK
MJ=AKTNCQSS+;/;7.GM>%&5=^Y6208!(YR#@$-UXY["]O[33H5FO+B."-I$B5
MG. 68A5'U)(%6* .&?PI<S>%=1MX-*M-/N[RY@D$27#2DI'(A^=SU; ;@<=!
MSUK?UK2[B_U?P_<PA#'8WKSS;C@[3!*@QZG+BMJB@#EM4T/5;G6-=N["X2UD
MO-'CM+6?=S',K3')] /,7FL?3?"UXOB'0=030;;3EL9)#=2O=^?/-NA=,[NI
M&XCJ<G/08Y[F[O[2P$)N[B.$32K!'O.-\C'"J/<U8H Q?#6F7&EV^H)<A09]
M1N;E-IS\CR%E_'!K(\0Z+?WGB1;N33$UC33:K%%:R7?E)!*&8L[*>&# J,\D
M;>!S78T4 <+I?A/4K/0/#]C)';+)8:Q+>2K$V$$;/.1M_"1>*U=2\.RZIX@O
MY92%L;S1VT]F4_,&9V)X^C5TM5K&_M=2MOM-G,)8=[Q[@"/F1BK#GT92/PH
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MSZ/XDM46+S-0U:.[@R_!C7R,Y]#^[;CZ5M:EIEQ=>)]#U",+Y%F+CS<GGYT
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MVGK<7E]!8M<"*4HA5-B_<4[G.X@CY0.,YKMH[9Q8"VGN))W\O8\S!0SG&"2
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<*5LY6BN"05\ME )!S[$'/3!S0!<HK$G\6:-!!9R_:)I3>PB>WBM[:665XR
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MKRP"W#QC@^3(H#!N0.2NWC@BKFGP:W=:OX3OM5M66YBL;M;ME4 (S>5M#8)
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MM2"6VIQSSSW5L8O( 5AQNY;KU&1COTKL9KRWM[BWMY9D2:Y8K"A/+D*6('X
MG\*GH XS3KBX\,:EK5O=:5J%R+R^>\M[BTMS*LH<+A6(^XRXV_-@8 YK+L-&
MU!_"VBPSZ2]O+'XC>[DM@,B&/[3*X/'&T J0?I7H](K*PRI!'3(- '%^*M-O
M$\4:?K4;ZG]D2TDM93IJJ\L19E8-L*L64[<':,\+VS5:+2;>71=7O+C3O$-V
M+NX@8^<42Y;RBNV9%7:5*GG!^8[!QVKOJ* //HQ?7NDZG#J-KKFHZ5'-;O9R
MR0B"]5@=S.  C$(0A!QN/(^:MOPC-JDKZ@MW)?S:>CH+*;48!#<-Q\X90%R
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MX,CN;7YK.6\FG"?,MMYBN53/^SOV#Z5NZ-82P>+?$]U);E([I[;RY"O$@6$
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MQ7:UE:1H,&DS7-R;FYO+VYVB:[NG#2,JYVK\H"JHR>  .36K0 4444 %%%%
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M0C2/RY2A9W"G'3. #Z9[UFF1=+US65TCQ+I-JDDWGWMIJ$98V\A1<NIWK\K
M X/&<X/45GZ)X=NM:\$V$J7$<LD>KW&HPF^BW1W:-++M,BC&-RN'!'0[3B@"
M>_\ % USP?XRL)&L)+BRTJ5VEL+KSX75XI,8. 0P*,"I]CWKN--_Y!=I_P!<
M4_\ 017+MX1U&ZC\1O>7MJ)=8TQ;%4@A*QV^!*!C)RP_> ]N<]. .LM83;VD
M,).3&BIGUP,4 <GXE\97/AN6ZGN$T=;.V&_RI-1V74R8R2D97&>N%SSCJ,UH
MW^NWKZU_8^BV<%Q<I;K<W$MS,8XH48D(.%)9FVMQQ@#.:P[WP/J<UCK^FVUY
MIT=MJSSR-=O;EKD>9GY"<X(&< ]EXQWK9O-#U*#61K&C75LES););74%TC&.
M94)*,"IRK#<WJ"#[9H R=6U7Q9'KOAN&.QL(&N)9TE@:^?;(RQN<$B(_+@!@
M<9SP0.M6+KQ!%H]SXDO8M(BWV,UJ;Z:-\-+&44M(>.=BD\=PO:K=_HFMW::1
M>_;[$ZKI]Q)+DV["%U=&0K@-N& PP<\XZ<U<M-!$>I:Y<73QS0ZIY>Z+;P L
M0C8'US@T ,U'6T_M9])2U2YB&GR7=TS/\JI]U%Q@YWX?\%/6N975]:\_P6NB
M6%A;Z?>6)D2T:Z=%QY*ML.(S@+D8(Z^@K:\.>$YM%TF_M[F_^V75THA%PR8*
MPHGEQ*?7 R2>Y9CWIC>%]0MM/\,BPO+87FBP"#,\;&.4&(1MP""#P"* )G\7
M+;:1KUU=VGEW.D2O$UNKY,O ,14X_C#+CC@DCG%=%;M*]M$T\:QS,@,B*VX*
MV.0#WY[UQ&J6$&K_ !+L(K2X5XHH!<:K$F"K&%\VX;T;>SG'HGM746MS?S^(
M=0BDB\O3K>*)(F9"#+*=S.0>Z@%!QWW>E %;Q1<6MM::>UU8Q7BOJ5K$BR'_
M %;M*JK(.#RI.:I2>(-:NM>U;2M)TJUD.FF/=/=731K)OC#A0%0G/)]AQUS@
M:FO:0^L6]G$DJQFWOK>Z)(SD1R!R/QQBC3M(>QUO6=0:5774)(G5 ,%-D83G
MUSC- &2OC)[[3=$?2]/\W4-7C9XK>>78D*H!YC.P!X4D#@')(JKXCFU272M/
M75;2W@E37+$*UO,9$D7SD.1E01Z8([=:EM_!]YI^F:*;&_A75-*$JI))$6BF
MCD.71@"".BD$'@KWZ5<NM%UC5K*!-3O+(2Q:A;W:+;Q,%5(G5BN2<L3@\X&,
M]* -#3M7-_K&L6!A"#3IHXP^[/F;XEDSC'&-V/PK&A\93WFC:++9:<DFI:OO
M\BW>;;'&J9+N[[2=H&.@R20/>K$VB:S:Z]J-]I%[9QPZD(S.+F)G:*1%V;TP
M0#E0O!QR.O.*IVO@V[T[0]"BLM0C&IZ,'6*>6,M',KY#JZ@@X(P<@\$ ^U $
M5M/JDGQ.T^/5+*&"1-'NBLEO*9(Y 9K?ID @C'(([CDYX99>)A8>&?#ATC0H
M5&IW3VL5HDVQ(3B5MV=O3*9/'0D\D8.I8Z)K#>*H==U6_M6\NREM5M;:-@B;
MWC;=N8Y)_=\].W'!)BL/"4MG8>&[<W:,=(NI+AR$/[P,DJX'I_K1^5 #X/%,
MUG+K$&OVT-K+I=HM\\EM*9$D@._D94$$&-@1]/6J6H>*?$>EZ"VN77A^V^R;
M5?R$O"9X@Q !<;-O?G!./>M+5/#]M<ZAK-_J$H.GWFDK931@'<JJ969L_23]
M*XS7KF^O/!B:?%XJTS48KDQ06GV2'_2;LEE 5CO(''+$+T!^[S0!ZK7&ZSXS
MN-#OV%XFCK;+.L7D#4?]+9&8*'$>W'?.W.<=\\5V5< W@75/['NM&BO-.CM)
M;AK@W0MB;F7,OF8<YQG/!;G('04 ;5UK^K2^)KW0]*TVVDDM;:&X:YN;ADC
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M(GCQ]?G!S[55CT/7=)EO8=#OK!;*[GDN%6[A9GMGD.Y]NU@&4L2P!QC)Y(H
MI3:O!KNK>"-2MU=(Y[FY.R089&%O*&4^X((/TJ37/&=QH%Y(UXFCK:QRJGD_
MVC_I;H6 WK'MQGG.W/0=>U7+3PBE@/#D=O<EH](DED=I!EIVDC=6;C@$LY:L
M:;P+JC:1J&CPWFG1VMU/).;O[,3<R;I#)M<YP>3C=W Q@=0 7XM1\0GXE75A
MY5F=.2QADV&Z?*J991O"^7C>=N"N<<#GTCT_Q'#:Z!81Z3H\27=_?7-O;622
M;(]R2R;Y&;'"_(6. 3DX&:UY]'OE\7IK5G<6XBDM4M;F&:-BVU'9PR$'K\[#
MD>E9T?@^YMM)T];6_CCU/3KRXNK>=HBT;"5Y"T;KD$@K)C(.<@$>E %ZPUR_
M37(]&UJRM[>YGA>>VFMIC)'*$(#K\RJ58;E..00>O:L6U\;ZM-X?M/$<VBV\
M.DRNB2C[43.JLX3>%V8*@G.,Y(YXZ5LV.BZE/KT6LZW<VSS6T+P6MO:(PCC#
ME2[$L<LQVJ.P SUSFJP\)2CX?0^&OM:>;&D:^?L.#MD#]/PQ0!U1.!DUQ\?B
MK6KS27UZPT6WFT<*TD:M=%;F>(9^=5V;1D#(4MR,<C-=@0",'I7&Q>&=?L='
M;P_I^JV<>D[6BAGD@8W$$)S\@YVL0#@,<=L@XY *E_?ZAJ'CWPM>:?!8S6,]
MC<36\DEPZLT;" LQ&PX(!&!GG)R172>++F_L_"NIW.FB+[3%;2.&DD*; %)+
M A3R.H'ZBHX_#D=MJNASVKB.UTJSEM$B(R2K",+S["/]:T]2LEU+2KRP=RBW
M,#PE@,E0RD9_6@#@]2OM::P\$W5S96\U^^HKY<<5RQ60-:2@,[%!MY))P#@#
MC/2M^#Q3-92ZQ!X@MH;633+1;YI+:4R)) =_(RH(8&-ACZ>M);>'M3>W\/KJ
M%W:-)I%SYFZ"-E$B"!X@,$G#9?/IVJS?^&(M3U;5)[N3=::AI::=)$HPP :4
MEL_23]* ,BW\<SK+837\&EI:7LT<*I;Z@);B!I" F]=H!Y(!VD[<]QS77WMS
M]BL+BZ,;R^1$TGEQC+-@$X ]3BN9TWPWJUM/9QW,FBM;VS M/%88GG Z Y.U
M#T)(STXQ747*2R6LJ03>3,R$)+MW;&QP<=\'M0!S.B^++B]TR75KV/3!I:6K
M733V-[YYAP-Q1QM'.,\CT(P*I0^/9E6RO;R#3(["[ECC$<.H"2Y@\Q@J,Z;<
M'DC< 3MSWP:FA\'7-]JLUYK/]FJ);*:RF&GP-$;I9,9:0DGH <#G!8\T[3?"
M^JV;V=M++HS6MJRYN$L/](F5>@.3M4GC+#/L!V +;:]J^H:C?P:%IMI/!82^
M1--=W+1"24*&*(%1N@(!8]^,'%7K/69;CQ#-I,UIY+Q6$%VQ\S=AI&D4IP,<
M>7U[YK/.B:UIFHZA/H5Y8BVOY?M$D-Y$[>3*5 9E*D9!P"5/?//-.N=$UF+6
MXM7TZ]LGNGLDL[M;F%@C[6++(H4Y!RS_ "\Y!ZC% %:[\9S0:--?1:89Y4U@
MZ6D"S8+GSO*#9(XR<''ZU+/=W2:WHD6H:5I[ZO+'=M!+',S+!M5> Q0'YL@$
MX[=#4%KX-NH=&BLI]12>9=9&J/-Y>W?^^\TKC/&>16W?:0]WXBTG4Q*JK8I.
MK(1R_F!0,'MC;0!Q=MK.IR>!O$5WXBTZQO[.WN+M?)-RSE]D[+Y9!C "C& >
MN .!70ZQXJ>TULZ-8#3Q<10K-/+?W7D1H&)"J, EF.TGL ,<\@55F\(ZC)H>
MO:+]NM?L6H2SS0/Y3>9&TLA<AN<$ DXQCM5O5O#-Q+KSZSIHT]YIX5@N(+^
MNCA"2K*PY5AN(/4$8Z8S0!1?Q\&T>WN(X+..YDU!M/E:>[Q;02*I;<90O*D
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M&RUG2XR+D?:251&0LLL3!/FSV!"\@@].7ZW=:S'XD\)N^GVCZB[7:B*.Y8Q
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M **%QCIG)'?KCGI*RM"TA](BOD>59/M-]/=# QM$C;@/PK5H **** "BBB@
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MK0N(3.(#(@G*>9Y18;]N<9QZ9XS7/>*@)-5\*PR?ZA]6!?T++!,Z#_OI5/U
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MDJ>>#@$XZ\4ZQU73M3A>:PO[6[B0X=X)E=5/H2#Q0!G7WA+2K^]FNV%W!+<
M"X^R7<L GP,#>$8!CCC/7'&:UK2TM["TAM+2%(;>% D<:#"JHZ "JT>N:1+<
M_9H]4LGG\OS?*6X0MLQG=C.<8YSTQ4EAJFGZK$TNG7]K>1HVUFMYED"GT)!/
M- $!T*Q_MS^V%6:.\9 DACG=4E ! WH#M8@,<$@X_ 4T>'M,&@P:(+<_V? (
MUCB\QN C!EYSG@J.]31:SI<^H/I\.I6<EZF=]NDZF1<=<J#D4EYK>DZ>V+W5
M+*V(?R\37")\V =O)ZX(./0B@"MJ7AK3M3O1>R?:K>ZV"-IK2ZD@=T'(5BA&
MX#)QGIGC%:%A86NF6,5E9PB&WB&$0$G'?J>2<\DGDUFZMXJTC1=0TZSO;R&.
M2^<JA:5%" (S;VR1A3L(!]2!5NZUS2+&6&*[U2RMY)@#$DMPB&0'IM!//X4
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MDQ0=?>K'CU+B/5?#]Z]Q;V^F6\DQGFNK4SPQ2E0(W=0RX ^<!B< L/K7<44
M>6W,4=UX:\<:C:ZM:ZBMQI3QR?8+%H8'D6.3YE8NP=\$ E3V7-;VJ:;;:?)X
M*-G;)$8+]8@R+@B-K>7<"?0D#/J:[3I10!YQ&UA:Q^/M.*PQ:@[7$T4.P!VA
M-K& R^JY!''>I)FL+#5_!5[J*PQ6YTR:%II4&WS"L!12?4[6QGT->AT4 >;:
ME:RPZU=>"D1_L6M7:WJ,!\J6Y):Z3/;++C_MX'I72>/5V^"[R0+^[MI(+B0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3:Q =5?Y@K#! /3..<4GB;4SIMC"4U."PDFF"*SVS7#OP25CC4Y9N/0X&>*
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MW;;R2!T^8'/M7)V_CK4Y-/MM8%R)C,8Y&TF+2Y_EB8CA9L<N%.<XVDC&!UH
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MA;4[9=932B6^U/;M<@8XV*P4\^N6%7*X6\_M6]\>:4VGS6]O)+HDAFGDC+[
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M?+U!*\YY&16GK/B2^T_6;?0'U)()DM!=7-\FGR3%]SLJJD:Y"_=8DDGH,=>
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MZ*DWVF[\Q5;<%;[3+D ]QFK^OZE/I]WH4<*QD7FHK;R;UR0IBD;CT.5'/UH
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M%<9I5SXKUZUO;N'4;"R6&^NK>VC-J9/-6.9T!D.X8^[C YXSGG  .SHKAO\
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M/4-E16E10!SUCX8E@U2TOK_6;S47LD=+43I&NS< "S%5!9L#&3[\9YKH:**
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M.JAG ]SSWS3)/"\L5]=SZ9K5[IT-[(9;B"%(V4N1@NA=24)QSCC/.,\UT5%
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M:UA"@HR*L3! 02V\'))/I@>@W6BZ5>V<-G=Z99SVL&WRH98%9(\# VJ1@8'
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MMFP#,TD.!@;LY!.P_*.:[6Y\/:+>:BFH7.D6,UZF"MQ);HT@QT^8C/':EO\
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M\&I3P1VT<]M&%C4C;P\9/XYK9U"^OWO=*\-Z1J3&:>V:YN-3D5)'6!2J[E
M0N[, #C  )P:QM--MIE]K<>I^%;^[EFU2>:.9-.$JM&Q&TAJU=0AO(=2TKQ3
MI.F3R)%:O:76GE!'-Y#$,"BD@;E*_=SR"<<XH T;3P_J&GW]O/!XCU"> $_:
M+>]"3+*,'[I 4HV<=#CVK?KG[;Q/)J%[;VUCH>J;6;]_-=VS6R0KW.7 +GL
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M@#[Q 8$@=\XS0!>7Q1:V?CC4OM$]XT$NF6<UO;1V\TC\M/N81*I9>-NXX&.
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MT#0+[59D:1+6%I-B]7(Z*/J<#\:Q;?P]K-Y:+=:OXEU"WOY!N,=BT<<$!/\
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M:]N;:YL_/M!@$/#(!(ISP,%6'/'%:-Y/<>)M<T-;72[^UCT^[^UW%S=VYAV
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MFB(*DJ2 00< @CN.3F@#I;>XAN[6*YMY%DAF021NO1E(R"/PJ6N,T_5;O2_
MGAM[<Z9'&VG0>9/J-YY")B-< ?*=Q//IC%9^J>+=5U/PI8ZCHT=FC_VK#:7#
M+>$H6%RB81E0[XWR<G@A3T)XH ]"W+NVY&[&<9YQ2US*ZC%;^*0-1L+6&^CT
MAIYKN*0OLC$G,8)4$K_%V^E4SXLUI-#'B.31(%T7R_M!07)-TL&,^84V[<[?
MFV;LX[YXH [*BN9O/$6HR>)!HND6%O<,UBEZ+J><I&JL[+@@*23\HQ]3TQS3
MF\<2Q:!!=R6=O;WC:BVFS"XN=MO!*I8%FDV_<.WC@9+*.* .RHJAH]U>WEB)
M;Z"WBEW$ VT_FQR+V96P#@^A%5-<UN?3[NQTZPM%NM2OB_DI))Y<:(@!=W8
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MN8 ^]02H965L#*LK @X!Z@CBK&LWMS8:<T]JEHSA@"UW<>3$B]V9L'IZ8YH
MT**XRV\=>9H?B*Z,=C<W.BVYG;[#=^;#,-C.N'QE3\I!!'&.^:M0^)-6BOM)
M_M+2K>WL=5D\J!H[@O+"Y1G42+M Y"GH3@\<]: .IHKEG\7M%X;U"_DLA_:%
MG=-9&R$GWYRX6-0V.C[HVSCHWM74+NVC< &QSCIF@"O>ZC8Z;#YU_>6]K$3C
M?/*J+GZDTZTO+6_MQ<6=S#<0MTDA<.I_$<5R7A:QMM<OM5U_4X8[J\%_<6D
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M-TZ>>.<-='S9$BD97>,;,<!<X)&2"/0D [BBD1@Z*ZG*L,@US?B/Q!>Z-/\
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M30!3O])>\U[2-1$JJM@9BR$<OO3;P>V*S[WPC'J3>(DNI_W.KB';L7YHC&@
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M.+9PDEP\C.,[L9"KL[8R6YK+U/6-7TS0?%]A%J,D]QI/DM:7L@'F 2 -L?
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M9D$:#<\CD;0">,,,D]\5U=AX<TW3HKM(HY9'O!MN)YYGEEE&" "[$G !.!G
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M)[294NI7LF#6OVB\EE$& 1A S' P<?EZ"@#D[S6_$#6$F@V%V[:[97MT\DC
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MN8XSE4>0YV ^BKM7_@-=%0 4444 %%%% !1110 4444 %%%% !1110 4444
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M$C:\T4BW5BT>;JXNCGYU&-S%FP5<< $<C' !Z1>:II^G*S7U]:VJJN]C/,J
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!F^(=*.N>'-2TD3"$WMM) )"N[9N4C..,]:T(TV1JO4@ 9IU% !1B
MBB@ HQ110 4444 &,]:*** #I1110 8Q1BBB@ HHHH **** "BBB@ HZT44
M&**** "C'.:** "BBB@ Z4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %8.I^+=.TF^>TN$N#(H!)1 1R,^M;U<[JW@^TU?4'O)KB=
M'< %4QC@8[BL:_M>7]UN3/FM[I7_ .$_TC_GE=_]^U_^*H_X3_2/^>5W_P!^
MU_\ BJA_X5YI_P#S^77_ ([_ (4?\*\T_P#Y_+K_ ,=_PKCOCNR,OWI-_P )
M_I'_ #RN_P#OVO\ \51_PG^D?\\KO_OVO_Q50_\ "O-/_P"?RZ_\=_PH_P"%
M>:?_ ,_EU_X[_A1?'=D'[TF_X3_2/^>5W_W[7_XJC_A/](_YY7?_ '[7_P"*
MJ'_A7FG_ //Y=?\ CO\ A1_PKS3_ /G\NO\ QW_"B^.[(/WI-_PG^D?\\KO_
M +]K_P#%4?\ "?Z1_P \KO\ []K_ /%5#_PKS3_^?RZ_\=_PH_X5YI__ #^7
M7_CO^%%\=V0?O2;_ (3_ $C_ )Y7?_?M?_BJ/^$_TC_GE=_]^U_^*J'_ (5Y
MI_\ S^77_CO^%'_"O-/_ .?RZ_\ '?\ "B^.[(/WI-_PG^D?\\KO_OVO_P 5
M1_PG^D?\\KO_ +]K_P#%5#_PKS3_ /G\NO\ QW_"C_A7FG_\_EU_X[_A1?'=
MD'[TF_X3_2/^>5W_ -^U_P#BJ/\ A/\ 2/\ GE=_]^U_^*J'_A7FG_\ /Y=?
M^._X4?\ "O-/_P"?RZ_\=_PHOCNR#]Z3?\)_I'_/*[_[]K_\51_PG^D?\\KO
M_OVO_P 54/\ PKS3_P#G\NO_ !W_  H_X5YI_P#S^77_ ([_ (47QW9!^])O
M^$_TC_GE=_\ ?M?_ (JC_A/](_YY7?\ W[7_ .*J'_A7FG_\_EU_X[_A1_PK
MS3_^?RZ_\=_PHOCNR#]Z3?\ "?Z1_P \KO\ []K_ /%4?\)_I'_/*[_[]K_\
M54/_  KS3_\ G\NO_'?\*/\ A7FG_P#/Y=?^._X47QW9!^])O^$_TC_GE=_]
M^U_^*H_X3_2/^>5W_P!^U_\ BJA_X5YI_P#S^77_ ([_ (4?\*\T_P#Y_+K_
M ,=_PHOCNR#]Z3?\)_I'_/*[_P"_:_\ Q5'_  G^D?\ /*[_ ._:_P#Q50_\
M*\T__G\NO_'?\*/^%>:?_P _EU_X[_A1?'=D'[TF_P"$_P!(_P">5W_W[7_X
MJC_A/](_YY7?_?M?_BJA_P"%>:?_ ,_EU_X[_A1_PKS3_P#G\NO_ !W_  HO
MCNR#]Z3?\)_I'_/*[_[]K_\ %4?\)_I'_/*[_P"_:_\ Q50_\*\T_P#Y_+K_
M ,=_PH_X5YI__/Y=?^._X47QW9!^])O^$_TC_GE=_P#?M?\ XJC_ (3_ $C_
M )Y7?_?M?_BJA_X5YI__ #^77_CO^%'_  KS3_\ G\NO_'?\*+X[L@_>DW_"
M?Z1_SRN_^_:__%4?\)_I'_/*[_[]K_\ %5#_ ,*\T_\ Y_+K_P =_P */^%>
M:?\ \_EU_P"._P"%%\=V0?O2;_A/](_YY7?_ '[7_P"*H_X3_2/^>5W_ -^U
M_P#BJA_X5YI__/Y=?^._X4?\*\T__G\NO_'?\*+X[L@_>DW_  G^D?\ /*[_
M ._:_P#Q5'_"?Z1_SRN_^_:__%5#_P *\T__ )_+K_QW_"C_ (5YI_\ S^77
M_CO^%%\=V0?O2;_A/](_YY7?_?M?_BJ/^$_TC_GE=_\ ?M?_ (JH?^%>:?\
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M (4?\*\T_P#Y_+K_ ,=_PHOCNR#]Z3?\)_I'_/*[_P"_:_\ Q5'_  G^D?\
M/*[_ ._:_P#Q50_\*\T__G\NO_'?\*/^%>:?_P _EU_X[_A1?'=D'[TF_P"$
M_P!(_P">5W_W[7_XJC_A/](_YY7?_?M?_BJA_P"%>:?_ ,_EU_X[_A1_PKS3
M_P#G\NO_ !W_  HOCNR#]Z3?\)_I'_/*[_[]K_\ %4?\)_I'_/*[_P"_:_\
MQ50_\*\T_P#Y_+K_ ,=_PH_X5YI__/Y=?^._X47QW9!^])O^$_TC_GE=_P#?
MM?\ XJC_ (3_ $C_ )Y7?_?M?_BJA_X5YI__ #^77_CO^%'_  KS3_\ G\NO
M_'?\*+X[L@_>DW_"?Z1_SRN_^_:__%4?\)_I'_/*[_[]K_\ %5#_ ,*\T_\
MY_+K_P =_P */^%>:?\ \_EU_P"._P"%%\=V0?O2;_A/](_YY7?_ '[7_P"*
MH_X3_2/^>5W_ -^U_P#BJA_X5YI__/Y=?^._X4?\*\T__G\NO_'?\*+X[L@_
M>DW_  G^D?\ /*[_ ._:_P#Q5'_"?Z1_SRN_^_:__%5#_P *\T__ )_+K_QW
M_"C_ (5YI_\ S^77_CO^%%\=V0?O2;_A/](_YY7?_?M?_BJ/^$_TC_GE=_\
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M<<^PK;KMH^TY/WFYK'FM[P4445J4%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQS2E<^8Q^II\HKFK1114C"BBB@ HHHH **** "BBB@ HHHH **** $HI:2@
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M &XI<4N**8A,4N*4"C%(!NT5$U3$4PCFF!&!3P*,4AR*  C!II/%+G--ZTP
M<FG[13=N*1B10 I45&>*=N)IK T"(V-19R:E9?6D6,4 ,Q1MJ791MI@0D5:L
M7PQ0]#4944L(VS*:&!?W#>5-5T'SR1-WZ5-*IW!A363?MD7[R]?>I0$0C"*V
M!PHXJA./)A:3&9'^5:U2N>/6J$JB74$3^%!G%4F)HIQ6 A7<XRQ&2:I7EO\
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M?A2_D'!9-@_$XKK3]VYS6UL>/*YD!D;[SL6/XFNDTR3"+7. 8"KZ "MBPDP
M*YT]3=HZF*3*TDIRM5()>!4KR96FV)(H3_>HCZBB8\T1UB]S3H:N@6OVK7H
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MK!"(;9!A1U[5EVL0 "*,+Z"MZTBVKTK6UA-W.DHHHKF+"BBB@ HHHH ****
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M<"IE/&<4@-ZBBBN8T"BBB@ HHHH *XWXB>*9/#VD)!9OMOKO*HPZQJ.K?7D
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M96E4H>]TT$I*7%%<!Z TTF*=13$-I,4XTE "4A%.I*8#**4TTT"%II%-).:
M33 7;32*?36YH$(!2XH'%.'2@8PBFE<5-CF@K0! 1@4SO4K"F;:8A-N132N:
MD%)0!"5Q14I&:-M,"+)I<4XKS2D4 *M..,4RDR: $<U2O+9+J%HW .1WJXU1
M&F@/%O%_A.;2K@WMF&$0.X[>J'U%=I\._B =6*:/J\BB]48AF/\ RV ['_:_
MG75WMG%>P-'(H.1CFO%O%/AZ;0=1%U:[DCW[D9>J,.:OXD9_"_(^AB*C9<CW
MKBOA[XX_X2.W-A?E5U*%<[N@F7^]]?45W)7-9-6-%J56&5]ZISPAD/K6A*A^
M\.H[57D!*Y%4F)G+7<8$GHPZ56F@WQ[^_I6AJL>UP?R-,B426X;'..10]0,$
M@1D@#%-8?+[UH7=N5!8=^E4,$MR.E8-69HG<YOQ3X9A\06)(0+>Q F*3U_V3
M[5Y"]NT$K12H4D0E64C!!':OH!V"#)/-<GXL\+0ZO83W]O%Y=_&A8%1_K<=B
M.Y]#6D)=&2T>4X'I377BJQN) >F*43.XYK2Y)+;P^?<QQ#J[ 5[MX;A2PTM,
M8&!@5XGH(SJ:R'HO2O2#K#QVZ1(> *AS2*4;GI^D7"W5G<Q@Y*$-^!__ %5E
M7T6R5CZUE> =1:XUB:!V_P!9 <#U((KH[VV!E8,>E4GS+0EJS,6/AJT+1@LG
M)X-49087*D8Q3XI.:R99J7%T%7"]:I1QM,^YZF15DPQI[KM7:HZUG8HSI)BE
M]!(.(TD'3O7$>/[DW'BZ49^6.)$'Y9_K7<:G%Y(1APOKZ5Y[XR'_ !4KL>KQ
M(W_CM5%Z6$UK<S(:NQ=152'D5<CJ66B]$W%6 :J)VJRIR*EC'TX-M4GTJ/-6
M;.+[1>V\'_/25$_,@41W$]CU/2H/LNC6<!'S)"H/UQS4S=:F88&/2H'.*[D<
MC(9*J3RK#&SN<*HR34\D@ .:YS6+M9YA9(V3C>^/3M3$4+=GN]2FOG&&<!4'
M]U1V_K6LH^6J=J@48Q5S.!2;*L(20*CDZ4YVJO(_>LVRTB&4X%49'SUJS,U4
MVYK"3-$AF,FI ,"D45%-)+),EI:KON'Z #.!ZFH++FBPF^\0PJ!F.W!D;_>[
M?Y]Z[IU.*H>']$32;/!PT[\NU2ZCJUI8*0\@:4=(UY/_ -:M8JQ#=RMJ5RMN
MFS/)Q_.N6NW:0'<<?_KJOJNO/+<$1QY9C@ ]>M7--TV6\*O=$\\D"NF+25D1
MZD5I"UQ-LA7/)RU=-:V'V>,?+EO4U>LK&*",+#&J^IQS6@EN3UX%-NR SEE9
M!@QBI5GSSL'X5J):IC!4$5&EO;-)L9<$\ ^M9.Z*5B*VU$0OANA]\UH7.V>U
M$J$''(Q5.XT@,N$.<]B<4RS6>R22&0[HR/E[XH;[A;L0S;HG66,X8>G>K]O<
MQWD6UP!)CD54=0ZE3WJLA:"8,"1S@XX%8Q=G8IJZN7I[+&2O3WJKL9>Q_&M6
M.02(#4<BKUQS6CCU)3*4;E#]?UJTET<?3K43,H[4SS !T%)7&7_M0:,YZXK.
M==^2.M-:7 Y--1F)SC ]Z+-BV%CC\P!B1CL*F*#MQ]%H&0..!2C![Y]ZVBDB
M6[C-ISCD_4T\#/8?Y^M*#D_X<T\#GM^=4(:J<YJ55-.48QG]:E7I_D"D *A]
MA4ZQ<<TB#/';VJ90!U-)L#4HHHKG- HHHH **** "O-_BQH$MW9V^LVZ%FM@
M8YP!SL)R#] <_G7I%(RJZ%'4,K#!!&016U"LZ-1370QQ%%5J;IOJ?+-%>OZ_
M\)[6\F>XT>Y6T9CDP2 F//L1R![<US1^$WB(' EL#[B5O_B:^BAC\/-7YK>I
M\U4R_$0=N6_H<;87(LM1M;HIO$$J2;<XSM(./TK3U?Q%+?\ BN37;5&M93(D
MB+NW%2J@=<#/2M[_ (5/XB_OV/\ W]/_ ,31_P *G\1?W['_ +^G_P")IO$8
M9RYG)7V!8;%*/*HNU[E?Q/X\DU^32YX+0V=Q8.90XDW L=IR!@8Y6I_^$VT8
MZ@-:;PZ#K0YW_:#Y6_&-^WU]OUSS2_\ "I_$7]^Q_P"_I_\ B:/^%3^(O[]C
M_P!_3_\ $UBI8-145+1>;ZFKCC7)R<7=^2Z&1;>*I$TW7K>YA,T^KLK-*&P$
M())XQSUJ"37P_@Z#01;D-%=FY\[?UX(QC'OUS6]_PJ?Q%_?L?^_I_P#B:/\
MA4_B+^_8_P#?T_\ Q-:>VPE[\RWO^A'L<7:W*]K;>=SE]&U0Z7K5GJ#JTPMI
M1)LW8SCMGM6OI_C%[#Q;>ZPMKOMKUG\ZU9^&5N<9QV/MZ^M:/_"I_$7]^Q_[
M^G_XFC_A4_B+^_8_]_3_ /$T3K82=^:2U5A0H8N%N6+T=S/T_P 46$%I>:5>
M:4UQH\TYGBA\[$D#>S8YXX[?J:HZCJ^GG4+*?1]+6Q2T(8;Y3(TK!L@L?\_R
MQO?\*G\1?W['_OZ?_B:/^%3^(O[]C_W]/_Q-)5L*G=2_$;HXMQY7#\%^8C>.
MK*+Q/'KMIH[1SR(R7BM<$B0$*!M./E(Q^.:JMXJTFVT;5-,TS1I($OU4--)<
M;WR#GGCI_P#7JW_PJ?Q%_?L?^_I_^)H_X5/XB_OV/_?T_P#Q-0I8-6][MU?3
M;[BW'&N_N[WZ+KO]YFR^+%D/AK_0R/[&()_>?ZW#*?3C[OOUJU;>-8!J&N-=
MZ<\ECJY!DC2;:Z8SC#8YZU8_X5/XB_OV/_?T_P#Q-'_"I_$7]^Q_[^G_ .)J
MG/!M6YE]_G?\Q*GC$[\K^[RM^1FZKXHL[KP[!HVGZ6;.&WNO/1C-O)X(YR.N
M3G]*N7OC2PN_$&GZZ-)>._A=6N")\K( N  ,<5-_PJ?Q%_?L?^_I_P#B:/\
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MCJW0:K;729W2@JQ^AR/YTK:CZ%>WPZ"K(3:*I6IQ@5HA@0!292'QG IY/%,
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MU6+]VS)(55F$15BIWD#"<J1EL=*AUBRD/BKPM+;VS&&WDN%=T0[8T,) !(Z
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MB:!%+,K%0WS #@89>3QSUKB]+TV]7PGH,7]DSVCQ^(I)VM?+.8(C<3,,X_A
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MX+IX;K38K:.>.W>1/,65R0Q4$)PX.6P.O- '4 4A'-+GF@TQ#=M* *4]*04
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MW*K7E]#8B#SA)^_F6!/+B9_F;IG .![G@4 <W/X3NI;'4(!<0AKG6X=24G.
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MVTI;;:  0QZD?Y_S^E=5[[G(U81)"2,#GUSS^?:I "W4C'Z?_7J$!E.".GX
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MI;*]L;R*(3&"[10S1DXW*59E(R,=<CC(YK-LO'VFWUO87D=GJ*:=?.D<-])
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M(XW.!)PQ5DX.2"<;3Z5J7.K6MKJ=CI[EVGO!(T849"J@!9F/8<J/JPH NA5
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MCT JO:6P!) Y+$D_Y_S^M6XT_=[AZ<U-91?)G')/^?\ /_UJK#K4SQ#T0D4
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MP<N/JC/&?]]?2N] "@   #@ 5GV^AV-MJ\^JJLSWLR[#)+,\FQ,Y*H&)"*2
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MJEF("@9)/:F!YQJVFSZ9X:@FM]+%I?7.N6<HANKY[EG82(JF1V+8.% ^4L
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M<&SDLVC\@1Q;&9&X7).?E.<DYS["L^;P1=R:%-X?3Q%=1Z,\+01PB%3*D9&
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MUT]=,>^BD (8F)OWJGG!X:,CCUZUE:=XOU6YTS38+FTMH==FU,6-U;@,4B4
MRLP&<_ZG!&3U85M>)?"]KXF_L_[1-)%]CN1-\G_+5/XHV_V6XS]*0>%K5?&;
M^)/.D\UK?R?(XV!^ 9/][:H7Z"@#GO$GC.ZT6;4+B'5-+GCL3E]/CM99)"H
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MWH]N;:&9X1(KH556W+D<G8IR",?C40\&*VG:I:SZG//)J-Y%>2S.BY#IY?
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MVVI&^%FFD?),WX2YKHV@G'_+,U6EMYR> 13]I+N+V<3F9?A3%N^6>7'^\/\
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MPHUQ$C)'*1\RJV"P!]#M7\A7*VGC>QUS2-::UODTZ6R\\"XDB:18T0X\T@@
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M2YM,M].MX[*<,)H50;9-PPV[^]D=<U5O/%V@V$KQ7.H(DJ*&>,(S.JD!MQ4
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M*8V*8Q(Z4#)H 0FHV:I"*85H B'-#LD8W.RJ/4G%3*H(KA_%<,LMP2TC[ <
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M@T[%(:8"4&C-% @!I:;TIH;F@"0TQJ?UJ-J &B@4F<4*<FF(=BEXI<<4W-(
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ML 'J0NI#J;VGV281+")!<G;Y;$DC8.<[AC/3&#UJS7)7\]V_C'5[6&_-JO\
M8*/&[M^[AD,DP\S!XXP,GT%5/"R-I6N0Z;?VM_:ZA/9LX8ZBUW;W6PH'<;CN
M5P6'55X;OC@ [2>:*V@DGGD6.*-2[NQP%4#))/I7,P^*-8U&W%]I7AB:XT]A
MNBDGND@DF7LR1D'@]MQ7-6/'EE<ZAX%UFULXVDGDMFVQKUD Y*CW(!'XUJZ5
MJ=CJVDV]_I\R26DL89&4\ >A]".A';% $MC=?;K&"Z\B>W\U _DSIMD3/9AV
M-6*XR^N8/$?BZPTTZ@YT=[![J,6EP4%W() A&]""0@YV@]6YZ5EW^I7WAR'Q
M?9:5=3SV^GV,-Q \SM,UG(^\.NYLDA559 "3C/H10!V7B+5GT32/MJ1+*WVB
MWAVL<#$DR1D_AOS^%:M><>+-!TW3/#EE<V^J7IDEO[(;YKUYA>9GC/(9B">-
MP*@8QQQD5)?G4-:\::S9RV-S>6]@(5MX(M3:T"JZ!C(0I!8EBR@DX&SC!S0!
MZ'16'X1.H?\ ".PKJ<RS3I)(BR"82EHPY";G'!8+@$^H-4/%NGWU]?V!MT-Y
M;11RF?3H[]K624G;MD#*1NV\C!('S@YR!0!K:AJ[V6NZ/IRQ*RW[3!G)Y38F
M[CUS6K7FTJVVOW'@E(+G4H[9I+M)#-,1<?(C*R-(#G.Y2"0>0.O.:6_O+SPU
M:^,;33;J<0V<-K-;F:1IC:B7<LC N2<*%+X/ Y[4 >D45PNKZ?#X9CTG4-)O
M[Y[N:_M[=EFO9)A>I(X5]P9B,A2SA@!C;Z<5IZ)?,NK>+Q=7+>7:WRL!(_$4
M?V:%N,]%SN/US0!I:CJ[V6N:/IZQ*RZ@\J,Y."FR,OQZYQBM6O-]"N)KNU^&
MMQ<3233202L\DC%F8FV/))Y)JYH=C#KVD7FN:IJ=[#J"W-PKNEX\:V(CD90@
M0$*-JJ"=P.[.3D&@#I_#6K/KOAO3]5DB6)[J%93&IR%SVS6K7,_#O'_"N]!P
MVX?8T^;&,\=:K:];/J/CS1=/>\NHK)["[EGA@G:,3;7@"ABI!XW=OIT)! .O
MHKS:YO[W0]#\56-I>SI#9:G;V\-Q+(9'M8)E@+G<V20GF.1G./H*TM3L(O#%
M_H4^DW=[YUW?QVLT$UY).+F-@=[$.Q^90-^X8Z'L: .PM[VVNY;F."99'MI/
M*F _@?:&P?P93^-4?$NK/H/AK4-5CB65[6%I1&QP&QVS7.^"]%L[/Q!XGEA:
M[+PZEY2B2\ED&TV\)Y#,0QR3R<GMG K0^(N/^%=Z]EMH^QOEL9Q[T =/17!Z
M[8PZ!I-GKFEZG>S:@US;JKO>/*M\))%4J4)*G*L2-H&W&1@"J;C4=>\0Z^+B
MQN[D65U]G@2'56M!;IL5@P52,LV2VXY]!TH ](HK)\,/?OX9L&U.:*:\\H"2
M6)PZR<\-N'!R,$XXR361K"G5?'-IHEY<SPZ<+!KI889FB^TRAPI!92"0HP=H
M/\0)SB@#K:*XC5+1;74]"\.Q:C>QZ7>3W!F8W;F1F10R0"7.X Y8XSG"8SBI
M+9#HOC.71["YN)+&;2Y+J2"6=I?LTBNJJ59B2H<,W&<?)D=Z .SHKRVQM9K+
MX?>&O$G]I:A+JS-8&2:6[D99$EDC1D9"=I&USVSD9SG)K0\0QS:?JVIZUJ'V
MRZTR&2-TN-/U%HY-/557<K0Y"L,Y8]20V,<"@#NX[VVEO9[..96N(%1Y8QU4
M-G:3]=I_*IZXC2-%LU^)NOW :[\R.WM)E!O)BN7,V<KNP1Z C [ 5A6<$]M\
M&)=?;4-0FU6;2@[W4EU(2J\'Y1G"X Z@9/))Y- 'JE%<SKU^8_%?A&VBNBHN
M;J<M&CX$J+;2'D=P#M/UQ7(PC5M=M=6U&:VNC=Q7=S%'<IJYMULA&[*H$8^4
M8 #'<#NSD\$4 >J5DV>K/<^)-4THQ*J644$BR \MYF_((]MGZUS@6ZUSQ+I^
MDZY<O'&FCQW;P6EPT:7-P6*R'<A!94PN!G'S@GM4GA6U@LO'/BFUM[V6YCBB
MLAB64R-#Q*=A8Y)QG/))P<=J .LO;RWTZRGO+N58K:!#)+(W15'))J;.1D5R
MOQ*M(KOX>:YYIE'DV<LJ^7*R?,$.,[2-PYZ'(/I5.]L8E\0Z+X<^U7D&E36T
M]RP^V2E[F52@$9D+;\ ,S;0><>@- ';TTUR>B[M,\::AHEI<SSZ<EE%<^7-,
MTIMI&=EVAF)(# ;MI/&#C@U9\>W$MKX$UF>"Y>VE2V)69"0R=.01S3 Z*D-<
M-KEE#H&FV.LZ7J5[+?O=6Z*TEX\JWPDD564H25.58D;0-N., 5/IEDU_XR\2
MW5S<WDRV-["+2V^TNL<;?9HF)V@@')/0Y'7CDY8CLNE9+ZLZ^*X='\I=DEB]
MUYF>05=%QC_@6?PKC;2VBOOAZWBFZUB]BU=K5[M[M;MU6WE ),8CSLVJ1M*D
M<XYYYJPUJ_B#QAH;ZB9[<R:"TUQ!#(T1+%XLH2I#8!/3/89H [6_NI+.T,T5
MI-=.&5?*AV[B"P!/S$# SD\]!5*UU9[GQ)J>E&(*EG!;RB0'EO,,F1CVV#\Z
MXZ>YNK'PKX@M(KRY*Z?KD%M;R-,S2+$SV[[-Y.2/WC#D].*N?V9::K\2=:@N
M[N<*+"T?[+%.T7F?-*-Q*D$@9QC./FY[4 =A?W4EI9O/%:37;J5 AAV[FR0.
M-Q XSGKT%*+RW:_DL5E4W,<:RM'W",2 ?Q*M^5<!>7MW9:%XHL;:^N9;;3K^
MVBM;AIF:1 S1,\6_.6VEB.23AL'I6E;Z-9_\+4U"?==>8NG6TX'VR7&XRS9^
M7=@KP/EQM'8<TQ':4444 (132*>*0B@! *4T=J:33 4&G5%GFEW4"%:F4\\T
MTT !I-PIK&HR":8$IP:3:*8 :=NQ0 UNM*.128W4F"*8#P*0KFG+TI> :0$#
M)BFL:L/C%5V'-,!@)S3NU)BC/% "$5(856V8N 2P_(5);P%_G8?*.GO4=XS[
M6Q]!4M]"X+6YPNO^$[*[BDFM)I()_0L2I_"L3X?+>Z/XR-G>QD"YA>-''*L1
MAOY*:Z;4[F2%QW]<55TJ;S]>M6'429Q^!KEJ1CS:'>K\EF=I>)\A.<<5C7+;
M4P.*VKH@KBN>O9&\T#'%<U4TH[%:55+!R1G%8UX<3[B!@5K3R[%Z#CO6)=.9
M)2.HQS7+(Z5L10N7E]O3%:2#(&*I0QJ.>E7H\A-H'6DE<&[%_3;(WUV(R<(
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M=\R_VO; Q+N;+8##(7Y3_'R0/ESR0.] &O:VMO96L=M:P1P01*%CBC4*JCT
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M&@!IIHZTI/- ZTQ!FD)IU-(H 8W- IV*2F A-,8TYB*93 <C8IV<U%CFI$%
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MT5@X 89!!R*Z"WO()U!2134-#+/F2CHN?I3A<2C^ TH(QQS3A4-(=Q/,=_O
MBC.:>!2[0>HJ7%#N0L.*C!()JRT7]TY]J@=2#R*EQ:'<Z:BBBL2PHHHH ***
M* "LGQ+I#:WH%U91.([D@26TO_/.9"&C;\& K6JCJUE<ZA8-;6NHS6#N<--"
MBL^W!! W @'GKVQ0!PEK;:AXU\)>(M;BA:WOM6M/L=I$[8*1QJ05SVW2&7GT
MVFK>LZA%XCT.ST72M*OX+_S[=E26RDB6P\N16+%RH4;0I VDY[9!KM=.L+?2
M]-MM/M$\NWMHEBC7T51@59H XU+\:!XQUY[RTOF2_$$MJUO:R3"4K'L9,J"
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M?DSP2>E>AUSD/A>XEO+2;5M<O-2CLY!+!#)''&OF#[KOL4%B,\=!GG&<5T=
M!7.^+[>:XAT<00R2E-7M9'V*6VJ'Y8XZ >M=%10!R_A_3S'K7B^::U9?M5^N
MUWCQYL8MH@,9ZC.\?7-6/ L,]MX#T&"YBDBGCL8D>.52K*0H&"#R#7044 %5
M-4MYKO2+VVMI?*GF@>..3/W&*D _@:MU';W$-W;QW%M-'-!*H>.2-@RNIZ$$
M<$4 <GX9UJTMM)TG0WTG4+>^@CC@DMOL+[(648+>9C85R,[@W.?7BLO2KV/1
M/!\_AS4=(O[C4U$T;P1V<DB7K.S'>) -F'SDEB,9.<8KT2B@#AM+T2\L]>\'
M1WT33RZ?HD\,MQM+*LW^CK][U(#X[D9JIJVC7]W;^,X;>RDD674K2Y2#;M%T
MB1V[2*I/!W!&7W/!KT2B@#E+W58?$^D:CI>DPW\-[-831I-/920+ [+@ LZC
M!R1P,]*YRQMSJ%KI&DSWOB,2V\T#&R_LR*);5HB&!,OE!=H*XRK'<#QG->G5
M%+<00/$DLT<;S/LB5V +M@G"^IP"<#L#0!S_ (6LGMM4\43R6S1/<:J65V0C
MS$$$0!!/49W?CFN3^Q7UY\/3H\-M?1WVFZ@)[F#[,09(Q<L^(RZ[)#M&X 9!
MP >M>HTE '":3&NK^);*[&IZ]>26<4I$ESIZ6T4>\!2C$QHS'H<#."O..*H6
M-W'IOP]D\,7FBW\VJQ6DEO):K9R.ERY!S(),;"K$[MQ/?UXKTFBF!E^&XI(?
M"VD12HT<B64*NCC!4A "".QK2Q3J#0!GZS->V^AW\^G0+<7T=O(UO"W1Y I*
MK^)Q7!VCW>H>)O"]R+S6M06&XE-TUQIXMX;<FVE &/+5ASQU8#C)R1GTJB@1
MPNAZA%X:L[[2M4T^_>]:]N)=T-E),+T22,RL&4%<[652&(QCG J_8R-9>/\
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MP&FDIQ%-Q0!&1S2X.*?MH/% AG(I<4$TFZF &FDT[K32,4 1OUIF:D/-&RF
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M2R7,4#LNYPFW"D[LD'..N,<UQNI:MJLVA^"M0O=.WWCZG"4CBF#&<M:RX8G
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M<#"AN8Q_".?H?RI+'[+#+.]P'\W.U ZD!?7I4RIILM5&D?7M%%%>0=H4444
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MVJO8W,K0(243SU)V\@-^[#<<9]1P0#T*L^#5HKC7+W2EC<36D,,SN<;2)"X
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M\X2(8MN[>&&,>N?2FP7$-U$);>:.6,\;HV##\Q0!)2&FR2)%&TDCJB*,EF.
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M?8+F:7[%' T!.3*1D#:/:H+FW:!,Q*\1 &#C(_,4_-$^3/L2BBBO'.\****
M"BBB@ KD_B3:6USX%U"2YMHIO("R*9(PWE@.NYAGI\N<GTS764$ @@C(/44
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M=FW['Y:[?+W\;=V_=C^+.>U=XL$*EML2 LVXX4<GU^M)-;07&WSX(Y=ARN]
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M_.>$J=K&7=M#$<[=A'.,]ZMZ+?F&7P=8?9X&%QHSR&9ES(FQ8!A3V!W\_04
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M6;.560,%3' Z,<GIZK&^O-\3YX?MUF+,:=#(83#(?D,L@P/GQOX/S8QC''%
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MD<XI_F&FXPM-!.:HDL*V1FJ3C]XU60<+55S\YJ9[#B1.V*+8;IA3'^]4EO\
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M-([LO_CY%99\(7US9PZ7J.OR7>CQ%,P&W599E4@JDDH/S#@9PJDXY/)KK**
M.?O/#UVNL7&J:-J@L)[I%6ZCEMQ-'*5&%?&Y2& XR#@@#(XIMQX;O&FL[^UU
MF2/5K> V\EU+ KK<(3NP\8VC@\C:01SUR:Z*B@#!F\.27^B2V.IZI<7-R\RW
M"72(L9@D4@H8U ( 4J#@YSSDG-3:=IFK0WGGZGK?VQ%C,:P16JPH<X^9N6);
MCL0.3Q6Q10!R'_"&WT.E3:):>()8-%=&C2 6ZF:)&S\BRY^Z,X'R[@.-W>M2
MV\.1VUYHEP+EF.E64EFHV_ZP,(QN/I_JA^=;=% '.-X2B;P3=>&OM;^7.LRF
M?8,CS'9^F>V['X5F^(Y],TSQ,+PZ^V@WTULJ233P@VUR@9MH);"[U).,,#AN
MXKM:" >HS0!QO@.!VN->U(7%Q=6U]>(T%U<+M:<+$BLX&  FX,%P,8''K6E=
M>'KR/5[K4M&U46$MX%^U1RVXGCD91M#@;E*MM &<X( XXKH** .;3P?;QZ7;
M6@NYGECU%-2GN) "\\JN')., 9P!QT  [5TE%% '.6_A**WT_2+07;L--OWO
ME;8/G+&7Y3SP/WIY]JT1I"CQ*^L^<=[6:VOE8XP'+9S_ ,"Q6E10!S^@>%+;
M0-1U&[BN))?M38BC<#%O'O9S&OMOD<_B!V%5[;PMJ.GPBPT[Q!+;:2K[HX!;
M*TL2DY\M)2>%[#*D@<9KJ** .=UWP]J.L"\MDUOR=/O8O*FMI+1)2H(P?+;(
MVDC^\&YY%2-X=>'7K34[&_: 16J6<T+Q"02Q*Q9<'(*MR>>>O2MVDH XS5M%
MTS1/#5O'>7]W;_9]1DNX-0@AW-;2R22/N8 $!,.R$L,$'G&:S]+?^VO'6E7E
MMKIUN.Q@G,]Q BK;P[PJJHV\%VY)Y) 7MW]#I.@P!BF(XP^!KG^R/[%&N.ND
MI,)HH5ME$G$GF!7?/S#/H 3W)YSLOHDR^*#K5K?F(301P7-NT0<2*A<J0V05
M/SMGKFMDTE ',KX.CAT73K.WOY8;S39GFM;Q4!*LQ;<"IX*D,01_(U9T[0+B
M/5_[6U74?M]ZD)@AV0B&*%&(+;5R3EBJY))Z#&*W:*8'.CPG$/!5OX;^UOY<
M*Q*)]@R=CA^F>^W%:\5M=)JEQ<O?O):R1HL=J8U B89RP;J<Y'!Z8JW10 4E
M+2&@09HI :6@!10:*0G% !2&C--)I@+330#FEZ4 )BBC-!XH *0XQ2$TQFXI
M@*Q%,J,L<T]33L*XC]*B!YJ9^E0;>:$!(!3&IXX%-84Q#.*CFE6%-QY] .]/
M_BQ575>7$<8R10V4E=E!WFNIOFPJYZ9S6_;1BVM .YZUEZ; #-F0Y([=A6E<
M2<$#MQ293*=W-61/)DGVYJY<28)ST%94S$<==W6LIRL7%$?4Y]:L(HQ44:\>
MU3$[5R*Q6K-F17,VQ,"O/?B3JWV3PZ;9)-LUT^S /.T<G_#\:[BY?N3@=:^?
MO$VL2:QKES<.VZ)6*1#L%!X_QK>,=#.4K(Z'PU-$MAL+@'%,DC!NFVD$GTKC
MHKR6'B-RM6(=4N(I0^[-9^Q:=T/VR:L>@:=IA9U=ATK;\G8O%<?I'C%$*QS#
M&?6NXL;NTU"(%'&3[UTQ2L<LGJ>Q6!_XE]L/2)?Y"IGZ52TF43:5;.IS^[ /
MU Q5MCQ4FA6D.":HW'*5=FJC.1L]ZE@BE+_6EBX'XTV0YX_&EC[US2W.B.P^
M5P$8'TKF-6@\[,K'\:W[W)B(!P3QFN<UF9541H<BNO#KW6V<U5ZI(Y^22%6(
M,G(]!1&5;[OS"JI8K(>.]686;&3A5H86+*K)GA0N:?Y+=WI-[D?*R#%(#(><
M CVIHDD$8V$?K5NUT]X;:/ ^5AE<52,AC RO![BNHT*6*_TQH#@O">/H>G]:
MM1N9MV,P6IQDU!>W#6=N7BCW'MFFZM?SVE[Y#H53/!QUHGF^TZ>=OIVK2%'J
MR'4['GFM6^L:]<;2P6,GI4>G>#K_ $ZZCO8Y\-&<X]?:ND@22&4EN?K5IKD^
M45+=>U;**1FS0@D2:W4Y&[&"/0UE7495\8ZTVWD,+DJQ(/:M%2MU&S$89.<&
MIG&Z*C*QG.F% ]*JM'@Y//H*NNI.5ZGO5=QC%821LF0;"Q]!_.G;0HQ^II^,
M\#@=Z, L">@J"B$QY3D53DB8DC&*U53>#GK44D2XYR:TBR6C'D7:M=UX%UA9
M,:9<-B0<PD]QW%<?- 6Z\#M4,,DEO.KHQ1U(*L#@@^M:)DGT%;@X /(]ZMD
M)D<5SWA378]<TM9FP)XL),O^UZCV-6-:U22*!HK?@G@MZ?2LY+4T0Z[NWG<V
M\'T9A_*K5G:+!& !S4.E(@LHFVC+#.16B/:HY1W H&7&*HLFUR*O;JKRKELT
MF@(QZ4; *7::4(:0#2.*I2Y#FM#RS5:XA)J9*Z*3*'WC4J-M(IWE8/-(1VI1
M0V:ULVZ+\*S[I,3M[U>M1MA%5;L8DS6DMB5N8-X-I(JC$IW5I72&23 I8K/
MR14(;*[1+)'M<9%4T#64P#?<)X-;8M6]*22Q$L91UR#^E4I"+%FR2Q@@BKRV
M^1G%<['YVF2@/DPD\-Z?6NKAN(Y=/\V,AB$S^-5<31F7E[!8X#O\YZ*.M4DU
MN660)$NW/<FL*XT^Z>=YQ-YK,<G<>:?9L\,X\U2O!ZBDVRK(]7HHHK$84444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MKCJ*B4;:EJ5RTPPN:B+YJ1VXQ42QGK63*0X#-/"T 8I<TAABHY$!J0FF,W%
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MXU+[G8R3D'"]:6-21ER2:B &[-3CBL36Y(!@4O%,W4N<T6&/X-&<4S-+GBD
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ML7^Z/RIU% #=B_W1^5&Q?[H_*G44 -V+_='Y4;%_NC\J=10 FQ?[H_*C:O\
M='Y4M% ";5_NC\J-J_W1^5+10 FU?[H_*C:OH/RI:* $VK_='Y4;5_NC\J6B
M@!-B_P!T?E1L7^Z/RI:* &[%_NC\J-B_W1^5.HH 3:O]T?E2X'I110 8'I1@
M>E%% !@>E&!Z444 &!Z48HHH ,48%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !103@9/2D5E=0R,&4]"#D&@!:*** "BBB@ HHHH
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M^\Q)(D6T1+GA?WBY'J6XK.USPOJFHD)!9Z4LX@2*#5%FDAN;4@<GY5/F ')
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M_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P"
M\O\ \31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_
M ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 3
M6U10!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\
M_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T
M?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X
M#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O
M_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P"
M\O\ \31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_
M ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 3
M6U10!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\
M_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T
M?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X
M#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O
M_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P"
M\O\ \31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_
M ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 3
M6U10!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\
M_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T
M?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X
M#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O
M_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P"
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M^@]I?_@9'_C1R2[!SQ[FM163_P )5X=_Z#VE_P#@9'_C1_PE7AW_ *#VE_\
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M^@]I?_@9'_C1R2[!SQ[FM163_P )5X=_Z#VE_P#@9'_C1_PE7AW_ *#VE_\
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A%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ethicsemployeepolicybook005.jpg
<TEXT>
begin 644 ethicsemployeepolicybook005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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MT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+E6BNQF\-^'/^$AET"+5=0BOEN#:I)-:H86D#;0"5?(!/?%<G<V\EI=36TH
MDB<QN >A!P:49J6PY0<=R*BBBJ("BK-Y#:0^1]DNFN-\*O+F(IY<AZIUYQZ]
MZK4)W&PHHHH$%%%% !16CHNCS:W?&".2.&*.-IIYY#\D,:]6/^>216FMMX/>
M86W]H:LA)VB\:!/+SZF,'=M_'/M4N:3L6H-JYS=%/F18IY(TE65%8A9%! <
M]1GG!]Z95$!1110 45KVNG02^%-1U%MWVBWNH(DP>-KB0G(_X"*R*2=[C:L%
M%%36=I-?WL%G;KNGGD6*-2<99C@#)]S3 AHI\T3P3/#(,.C%6&>A'!IE @HH
MHH ***U_%&G0:3XBNK*UW>3&$V[CD\HI/ZDTKZV';2YD45TEMH^BP^'+/5-4
MN[]&NII8D2UA1P-FW).YA_>%4I-/L=0U*SL= :\GFN'\O;=HD?S$X &&(_/%
M)33*<&9%%;&C:9!>V^M-<!M]G8M/'M./G$B+SZC#&L>FG=V):LKA15F^AM(+
M@)9W37,6Q27:(QX8@%EP3V.1GO5:FG<'H%%%% @HHHH **** "BBB@ HHHH
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M43T6W_!.I\1:W=Z)XBN]&L;:WBTZSE\A;5[=&651QN<D98MUSG//&*H>/O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMW^DK+9FYL(!/-B4[0I&< [>N"*]"@\.1#XV/J8V_83:_P!I*_\ #DC9G/\
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MM?$^AP:E:D#>,21YYC<=5/\ GI7E8ZDU+G74]3!5$X\CZ''?$+X9IK[2:KI
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **^N?[*T[_GPM?^_*_P"%']E:=_SX6O\ WY7_  KSO[07
M\IZ'U!_S'R-17US_ &5IW_/A:_\ ?E?\*/[*T[_GPM?^_*_X4?V@OY0^H/\
MF/D:BOKG^RM._P"?"U_[\K_A1_96G?\ /A:_]^5_PH_M!?RA]0?\Q\C45]<_
MV5IW_/A:_P#?E?\ "C^RM._Y\+7_ +\K_A1_:"_E#Z@_YCY&HKZY_LK3O^?"
MU_[\K_A1_96G?\^%K_WY7_"C^T%_*'U!_P Q\C45]<_V5IW_ #X6O_?E?\*/
M[*T[_GPM?^_*_P"%']H+^4/J#_F/D:BOKG^RM._Y\+7_ +\K_A1_96G?\^%K
M_P!^5_PH_M!?RA]0?\Q\C45]<_V5IW_/A:_]^5_PH_LK3O\ GPM?^_*_X4?V
M@OY0^H/^8^1J*^N?[*T[_GPM?^_*_P"%']E:=_SX6O\ WY7_  H_M!?RA]0?
M\Q\C45]<_P!E:=_SX6O_ 'Y7_"C^RM._Y\+7_ORO^%']H+^4/J#_ )CY&HKZ
MY_LK3O\ GPM?^_*_X4?V5IW_ #X6O_?E?\*/[07\H?4'_,?(U%?7/]E:=_SX
M6O\ WY7_  H_LK3O^?"U_P"_*_X4?V@OY0^H/^8^1J*^N?[*T[_GPM?^_*_X
M4?V5IW_/A:_]^5_PH_M!?RA]0?\ ,?(U%?7/]E:=_P ^%K_WY7_"C^RM._Y\
M+7_ORO\ A1_:"_E#Z@_YCY&HKZY_LK3O^?"U_P"_*_X4?V5IW_/A:_\ ?E?\
M*/[07\H?4'_,?(U%?7/]E:=_SX6O_?E?\*/[*T[_ )\+7_ORO^%']H+^4/J#
M_F/D:BOKG^RM._Y\+7_ORO\ A1_96G?\^%K_ -^5_P */[07\H?4'_,?(U%?
M7/\ 96G?\^%K_P!^5_PH_LK3O^?"U_[\K_A1_:"_E#Z@_P"8^1J*^N?[*T[_
M )\+7_ORO^%']E:=_P ^%K_WY7_"C^T%_*'U!_S'R-17US_96G?\^%K_ -^5
M_P */[*T[_GPM?\ ORO^%']H+^4/J#_F/D:BOKG^RM._Y\+7_ORO^%']E:=_
MSX6O_?E?\*/[07\H?4'_ #'R-17US_96G?\ /A:_]^5_PH_LK3O^?"U_[\K_
M (4?V@OY0^H/^8^1J*^N?[*T[_GPM?\ ORO^%']E:=_SX6O_ 'Y7_"C^T%_*
M'U!_S'R-17US_96G?\^%K_WY7_"C^RM._P"?"U_[\K_A1_:"_E#Z@_YCY&HK
MZY_LK3O^?"U_[\K_ (4?V5IW_/A:_P#?E?\ "C^T%_*'U!_S'R-17US_ &5I
MW_/A:_\ ?E?\*/[*T[_GPM?^_*_X4?V@OY0^H/\ F/D:BOKG^RM._P"?"U_[
M\K_A1_96G?\ /A:_]^5_PH_M!?RA]0?\Q\C45]<_V5IW_/A:_P#?E?\ "C^R
MM._Y\+7_ +\K_A1_:"_E#Z@_YCY&HKZY_LK3O^?"U_[\K_A1_96G?\^%K_WY
M7_"C^T%_*'U!_P Q\C45]<_V5IW_ #X6O_?E?\*/[*T[_GPM?^_*_P"%']H+
M^4/J#_F/D:BOKG^RM._Y\+7_ +\K_A1_96G?\^%K_P!^5_PH_M!?RA]0?\Q\
MC45]<_V5IW_/A:_]^5_PH_LK3O\ GPM?^_*_X4?V@OY0^H/^8^1J*^N?[*T[
M_GPM?^_*_P"%']E:=_SX6O\ WY7_  H_M!?RA]0?\Q\C45]<_P!E:=_SX6O_
M 'Y7_"C^RM._Y\+7_ORO^%']H+^4/J#_ )CY&HKZY_LK3O\ GPM?^_*_X4?V
M5IW_ #X6O_?E?\*/[07\H?4'_,?(U%?7/]E:=_SX6O\ WY7_  H_LK3O^?"U
M_P"_*_X4?V@OY0^H/^8^1J*^N?[*T[_GPM?^_*_X4?V5IW_/A:_]^5_PH_M!
M?RA]0?\ ,?(U%?7/]E:=_P ^%K_WY7_"C^RM._Y\+7_ORO\ A1_:"_E#Z@_Y
MCY&HKZY_LK3O^?"U_P"_*_X4?V5IW_/A:_\ ?E?\*/[07\H?4'_,?(U%?7/]
ME:=_SX6O_?E?\*/[*T[_ )\+7_ORO^%']H+^4/J#_F/D:BOKG^RM._Y\+7_O
MRO\ A1_96G?\^%K_ -^5_P */[07\H?4'_,?(U%?7/\ 96G?\^%K_P!^5_PH
M_LK3O^?"U_[\K_A1_:"_E#Z@_P"8^1J*^N?[*T[_ )\+7_ORO^%']E:=_P ^
M%K_WY7_"C^T%_*'U!_S'R-17US_96G?\^%K_ -^5_P */[*T[_GPM?\ ORO^
M%']H+^4/J#_F/D:BOKG^RM._Y\+7_ORO^%']E:=_SX6O_?E?\*/[07\H?4'_
M #'R-17US_96G?\ /A:_]^5_PH_LK3O^?"U_[\K_ (4?V@OY0^H/^8^1J*^N
M?[*T[_GPM?\ ORO^%']E:=_SX6O_ 'Y7_"C^T%_*'U!_S'R-17US_96G?\^%
MK_WY7_"C^RM._P"?"U_[\K_A1_:"_E#Z@_YCY&HKZY_LK3O^?"U_[\K_ (4?
MV5IW_/A:_P#?E?\ "C^T%_*'U!_S'R-17US_ &5IW_/A:_\ ?E?\*/[*T[_G
MPM?^_*_X4?V@OY0^H/\ F/D:BOKG^RM._P"?"U_[\K_A1_96G?\ /A:_]^5_
MPH_M!?RA]0?\Q\C45]<_V5IW_/A:_P#?E?\ "C^RM._Y\+7_ +\K_A1_:"_E
M#Z@_YCY&HKZY_LK3O^?"U_[\K_A1_96G?\^%K_WY7_"C^T%_*'U!_P Q\C45
M]<_V5IW_ #X6O_?E?\*/[*T[_GPM?^_*_P"%']H+^4/J#_F/D:BOKG^RM._Y
M\+7_ +\K_A1_96G?\^%K_P!^5_PH_M!?RA]0?\Q\C45]<_V5IW_/A:_]^5_P
MH_LK3O\ GPM?^_*_X4?V@OY0^H/^8^1J*^N?[*T[_GPM?^_*_P"%']E:=_SX
M6O\ WY7_  H_M!?RA]0?\Q\C45]<_P!E:=_SX6O_ 'Y7_"C^RM._Y\+7_ORO
M^%']H+^4/J#_ )CY&HKZY_LK3O\ GPM?^_*_X4?V5IW_ #X6O_?E?\*/[07\
MH?4'_,?(U%?7/]E:=_SX6O\ WY7_  H_LK3O^?"U_P"_*_X4?V@OY0^H/^8^
M1J*^N?[*T[_GPM?^_*_X4?V5IW_/A:_]^5_PH_M!?RA]0?\ ,?(U%?7/]E:=
M_P ^%K_WY7_"C^RM._Y\+7_ORO\ A1_:"_E#Z@_YCY&HKZY_LK3O^?"U_P"_
M*_X4?V5IW_/A:_\ ?E?\*/[07\H?4'_,?(U%?7/]E:=_SX6O_?E?\*/[*T[_
M )\+7_ORO^%']H+^4/J#_F/D:BOKG^RM._Y\+7_ORO\ A1_96G?\^%K_ -^5
M_P */[07\H?4'_,?(U%?7/\ 96G?\^%K_P!^5_PH_LK3O^?"U_[\K_A1_:"_
ME#Z@_P"8MT445YAZ04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11TKD=>\2G<U
MKI\A&#AYE_DI_K0!UU%<UX?\1"Z"VEZX$_1'/1_K[UTM !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDLRG Y/(I?5Y\MQ^WA>QZ11116)L%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% &7KT%[<6+):3+&N"9">I&.@KSV""6XE6*%&>1NB
MCJ:]1N5+VLJJ,L4( _"N3\-:3?6FK>;<6S1H(V&XXZ\4 <T(I%N1$P*2!MN#
MP0<UZ5ID5Y!9K'>RK+*IP&7N/?WKE=3T?4)M?EGCM7:(RJ0PQ@CBNVH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7EO#_CS7_#<K$*<F/=W\MN#^*MG\*Q4T@^/+SQIKN"XA0_8SZE3E<>^R/'_
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M2>N*O11)#$D42A(T4*JCH .@I]%%W:P65[F9/X=T>YU:/59]/@>_C*E)ROS
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MQ*A#;A0$P#G&!3+?1=-M-);2H+.*.P961H%'RD-G</QR:OT5/,^X^5=CF_\
MA7_A/_H!6G_?)_QJQ8>#_#VF7L=Y9:3;07,>=DB+RN00?T)K<HJG4F^K)5."
MZ&%K'@SP[KTWG:EI4,LQZRKE'/U*D$_C4NB^%=#\/%FTO38;=V&#)RSD>FYB
M3CVK8HI<\K<M]!\D;\UM0HHHJ2@HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **YG_A.]%_O7'_?O_P"O1_PG
M>B_WKC_OW_\ 7KG^M4?YD1[2/<Z:BN9_X3O1?[UQ_P!^_P#Z]'_"=Z+_ 'KC
M_OW_ /7H^M4?YD'M(]SIJ*YG_A.]%_O7'_?O_P"O1_PG>B_WKC_OW_\ 7H^M
M4?YD'M(]SIJ*YG_A.]%_O7'_ '[_ /KT?\)WHO\ >N/^_?\ ]>CZU1_F0>TC
MW.FHKF?^$[T7^]<?]^__ *]'_"=Z+_>N/^_?_P!>CZU1_F0>TCW.FHKF?^$[
MT7^]<?\ ?O\ ^O1_PG>B_P!ZX_[]_P#UZ/K5'^9![2/<Z:BN9_X3O1?[UQ_W
M[_\ KT?\)WHO]ZX_[]__ %Z/K5'^9![2/<Z:BN9_X3O1?[UQ_P!^_P#Z]'_"
M=Z+_ 'KC_OW_ /7H^M4?YD'M(]SIJ*YG_A.]%_O7'_?O_P"O1_PG>B_WKC_O
MW_\ 7H^M4?YD'M(]SIJ*YG_A.]%_O7'_ '[_ /KT?\)WHO\ >N/^_?\ ]>CZ
MU1_F0>TCW.FHKF?^$[T7^]<?]^__ *]'_"=Z+_>N/^_?_P!>CZU1_F0>TCW.
MFHKF?^$[T7^]<?\ ?O\ ^O1_PG>B_P!ZX_[]_P#UZ/K5'^9![2/<Z:BN9_X3
MO1?[UQ_W[_\ KT?\)WHO]ZX_[]__ %Z/K5'^9![2/<Z:BN9_X3O1?[UQ_P!^
M_P#Z]'_"=Z+_ 'KC_OW_ /7H^M4?YD'M(]SIJ*YG_A.]%_O7'_?O_P"O1_PG
M>B_WKC_OW_\ 7H^M4?YD'M(]SIJ*YG_A.]%_O7'_ '[_ /KT?\)WHO\ >N/^
M_?\ ]>CZU1_F0>TCW.FHKF?^$[T7^]<?]^__ *]'_"=Z+_>N/^_?_P!>CZU1
M_F0>TCW.FHKF?^$[T7^]<?\ ?O\ ^O1_PG>B_P!ZX_[]_P#UZ/K5'^9![2/<
MZ:BN9_X3O1?[UQ_W[_\ KT?\)WHO]ZX_[]__ %Z/K5'^9![2/<Z:BN9_X3O1
M?[UQ_P!^_P#Z]'_"=Z+_ 'KC_OW_ /7H^M4?YD'M(]SIJ*YG_A.]%_O7'_?O
M_P"O1_PG>B_WKC_OW_\ 7H^M4?YD'M(]SIJ*YG_A.]%_O7'_ '[_ /KT?\)W
MHO\ >N/^_?\ ]>CZU1_F0>TCW.FHKF?^$[T7^]<?]^__ *]'_"=Z+_>N/^_?
M_P!>CZU1_F0>TCW.FHKF?^$[T7^]<?\ ?O\ ^O1_PG>B_P!ZX_[]_P#UZ/K5
M'^9![2/<Z:BN9_X3O1?[UQ_W[_\ KT?\)WHO]ZX_[]__ %Z/K5'^9![2/<Z:
MBN9_X3O1?[UQ_P!^_P#Z]'_"=Z+_ 'KC_OW_ /7H^M4?YD'M(]SIJ*YG_A.]
M%_O7'_?O_P"O1_PG>B_WKC_OW_\ 7H^M4?YD'M(]SIJ*YG_A.]%_O7'_ '[_
M /KT?\)WHO\ >N/^_?\ ]>CZU1_F0>TCW.FHKF?^$[T7^]<?]^__ *]'_"=Z
M+_>N/^_?_P!>CZU1_F0>TCW.FHKF?^$[T7^]<?\ ?O\ ^O1_PG>B_P!ZX_[]
M_P#UZ/K5'^9![2/<Z:BN9_X3O1?[UQ_W[_\ KT?\)WHO]ZX_[]__ %Z/K5'^
M9![2/<Z:BN9_X3O1?[UQ_P!^_P#Z]'_"=Z+_ 'KC_OW_ /7H^M4?YD'M(]SI
MJ*YG_A.]%_O7'_?O_P"O1_PG>B_WKC_OW_\ 7H^M4?YD'M(]SIJ*YG_A.]%_
MO7'_ '[_ /KT?\)WHO\ >N/^_?\ ]>CZU1_F0>TCW.FHKF?^$[T7^]<?]^__
M *]'_"=Z+_>N/^_?_P!>CZU1_F0>TCW.FHKF?^$[T7^]<?\ ?O\ ^O1_PG>B
M_P!ZX_[]_P#UZ/K5'^9![2/<Z:BN9_X3O1?[UQ_W[_\ KT?\)WHO]ZX_[]__
M %Z/K5'^9![2/<Z:BN9_X3O1?[UQ_P!^_P#Z]'_"=Z+_ 'KC_OW_ /7H^M4?
MYD'M(]SIJ*YG_A.]%_O7'_?O_P"O1_PG>B_WKC_OW_\ 7H^M4?YD'M(]SIJ*
MYG_A.]%_O7'_ '[_ /KT?\)WHO\ >N/^_?\ ]>CZU1_F0>TCW.FHKF?^$[T7
M^]<?]^__ *]'_"=Z+_>N/^_?_P!>CZU1_F0>TCW.FHKF?^$[T7^]<?\ ?O\
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M<?\ ?O\ ^O1_PG>B_P!ZX_[]_P#UZ/K5'^9![2/<Z:BN9_X3O1?[UQ_W[_\
MKT?\)WHO]ZX_[]__ %Z/K5'^9![2/<Z:BN9_X3O1?[UQ_P!^_P#Z]'_"=Z+_
M 'KC_OW_ /7H^M4?YD'M(]SIJ*YG_A.]%_O7'_?O_P"O1_PG>B_WKC_OW_\
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MKC_OW_\ 7H^M4?YD'M(]SIJ*YG_A.]%_O7'_ '[_ /KT?\)WHO\ >N/^_?\
M]>CZU1_F0>TCW.FHKF?^$[T7^]<?]^__ *]'_"=Z+_>N/^_?_P!>CZU1_F0>
MTCW.FHKF?^$[T7^]<?\ ?O\ ^O1_PG>B_P!ZX_[]_P#UZ/K5'^9![2/<Z:BN
M9_X3O1?[UQ_W[_\ KT?\)WHO]ZX_[]__ %Z/K5'^9![2/<Z:BN9_X3O1?[UQ
M_P!^_P#Z]'_"=Z+_ 'KC_OW_ /7H^M4?YD'M(]SIJ*YG_A.]%_O7'_?O_P"O
M1_PG>B_WKC_OW_\ 7H^M4?YD'M(]SIJ*YG_A.]%_O7'_ '[_ /KT?\)WHO\
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MFW+SVS6I<_;W\):>C06_V5IR(F0?O&;+<']?TK!KK)]Y\#Z*(F"R?:VVDD
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M^L6%L ]R[(RQ[@"1D>OTK2$*;LDKKWK#27YEBPTR>Z\%7=E$8S(M\0SE\(
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M98H9=SI]1572]"O-5226'RXX(^'FF;:@/IFND\.Z1>:!>W&I:DR0VD<3 L)
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M<G/XXKE=8M[:TU>Z@M'WP(^$;.?PS['BN>M14:<9)$2BE%,HT445RF84444
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MFG@THZ'(IV%<RKQR6(K,D-7+ALR-]:I2]:I#*LM5'JU)55ZM 0-4+5,U0M5
M1$5&PJ8BHF%,"(]:814C4S'- #H8][XQ7164?E*HQ658JO4]:VHSP*QF]36*
MT-ZTD&P8]*P]3A$&HOSA7^8"K]M*0*I>(VVM;R?[)%2MQ/<P[O\ UM0 $T^1
MP[YH!%;)Z$"IO7H:W+.Y:2U.WAT[^]8Z,#Q6A9QD.&C/-3+4 O(Q/']H5 I'
MWP#5)?O5MR1K+ VT#=CG'>L4 AR/0TXF4U8Z32/]36M:_P"M;Z"LG2/]56K;
M<3-]*B6XT7J0\CCM2XI,"H+ >E+^=)WR.E'?(%  ?TI:2EH ;2T8I: *6I?\
M@^X'_3-OY5P8ZUWVH\Z?<?\ 7-OY5P0ZTTRHDBU+&^QPP[&HA3LT[CL)=GS9
M"YZDYJH4JTW--"9-4F2XDENE;6E#%]$/?^E9D*UKZ6O^GQ'Z_P JEL+'2#O2
MBDQBEJ1"4TX_6G\4T\CFD!'(.]1YXXI[D5%G.:&"%/7.:"0HR3@5'/,D";W/
M3M6!=ZCYLG3(]#T'X4O0N,;[FT]_;(P!D&<]N:1K^')*,K?0UA+?.!@( /RI
MC7&]\MC-3[QKRP-N?5!$0 FXGT-3QWD3QJ=V#Z>E8 EB.-Q;-(S9'S$,/;BE
M=B<%T.E$BMRIIXY%<W%.T?W3^M:%O>\X9A5*1#@:E)35<,."*<#5$#P>*0BD
MHS2+3%I*7-)0*X4TTIIM-";#-**;0*!7'L<"O._B/J ATPIGDD<5Z!*WRUXW
M\3[H!Q&#SG=421K!]3RJYD,D[,>IJN>:DD;YC20(9) N.IK1.QF]06%G'2I$
MMV3D@UV6DZ-'Y(>5 3UJ'68H8!L" 'UJ\/7ISGR+<SKPJ0AS6.4(Q24ZX(5B
M 1^%5_,YKIE)(B*NKDK'BF \TC/V%2P6KRX.*Q=1%\I)$1UK>TJ?81S5*/36
M$62#2VJE),>AI0?-(<U[IW5G=?+P:CU"Z^0\UF6;-ZTS478)71[)'-?0YS5)
MLW!QTK)=LM5^_P"23663EC7)-VD=,/A-*Q.Y\5V'AN3RM1AD'4'-<;I?^NZ=
MJZ[1FVW49_VL5C.;.FDD>VP2B>%)!_$H-3H.E<_8:BMK;IYBLRX[5MZ??6MZ
M/W4@WCJA/(JHS4D9\CC(L@9IXZ5(%Q43<,:LN]QZ]*:QP:;O-,+9H(;L4=2E
MPT:Y[$UC.=X935W5W/VA#_=6LV1]LP]^16;W-.=N*1%T8H>AZ4L7REA2RKD9
M7ZBFH<DGVK,0C\YJ*.=HW"'E3QBIR,U7E3C-)E(M2R(UNP!YZ8K)G.U'D;KV
MJY,1M##J15291(,'.*PJ:LUIJR.1U$$/D'H3G/TKG7T^*XN4$C,,#/'?GI77
MZC  S!AU/6N=EC,<L1(Z,5-1"1M**>YJVS""X!(PK-MK?1AMZ9KG;UE%N!P"
MQ! !].]:6F7J7,80M^\4<CU'K4V>YLNQHD#J#6=+:M)?B4N2%'"YJQ=W(M49
MO*9U7[V#SBJ$.LV;S?ZY4QR5<[3^M.*8[G7>'8P))#_LU%);L+ME#%E+DAC]
M:KZ9JMFK21K<)O;@*IR2/6I;W5X--MVGG5@HP$!^\[>F*W6R1A*ZDY%'Q=JP
MTG13:0G_ $F[!08/*KW/]/QJCH5K)9:7;O*?FGZ+_=4=!^9)_&N6-Q)K6O&Y
MNAEF< *#PH[ 5Z"\.8XU_P">9 P.W2M)NRY3GI^]+F9K:;(53/;%:,=X)/D&
M-PZBLVV&VRW'H1FK-A&L2M*1\[]Z(-[$5$M6::N59<=0*MJ=XS6>K8^8U:@E
M!.,'I70CE9.:3O2FD-4(;)(D2,[L%5>2?2LK^W(MP+ )%OVEF/(Z]O\ />L[
MQ1KD=EF!2H:,!W++NP3]T 9'(Y/MQ7F3^(Y4-UF.-WG.3N'"'.?E]!TXJ&]=
M"U'2[/5M8URVL8X+A9D=]_$0ZN#P<>GK6)<>);C4681W"VD*#) /S9]_:O,C
M?N9O,9RS8P23UI#?3!]Y<DY_*KBKB;2.PEU&19FD:Z#-VE8YSQT[^U5I]=NI
M-NZX;@YS&1D\?6N8>Z#'*@Y(Y-"RD\[C]:WC!&<JAOQZJ3)\TUR%/W@6SG\*
MW],\1W-KQ;NLT0ZJ3@C\#7#K-D88*0>XJS;2*K@M&6]@>*IP31*G<]ETW6(-
M150/DE(SL/\ 2M'%>4Z9=-NW1,43/W6/3]/\*[K0]::\Q!<;?,Q\I!Z_6N>2
MLS6QNTZFTX4A!2BDI<4 %+244 +2I]\4@SGCK3AG> >U SH^_MZTF1]*=]>M
M)QVJ0&G'.>M(20I)QR*4XS@_G3=ORXZ"F(P93EB:J2&K,V5=@>QJJ]6BBM)5
M=ZL/5=ZI 5VJ)JE:HFJ@(S4;5*:C89H A/6FXJ0H?2F=Z8$T#E6ZUM6SY4#-
M8L$9=@!6U;Q% ,UC,TB7XR>U5/$#%I(H3R57)_&KUI'YDZJ>AJAK2%-4D!;<
M" 0?:HB-[F.L1IWEGTJXB"I!&*KF#E* C(J[92M%* WW33Q$OI3EB&>*.8.4
MOKN$W' ZBLV\C$=ZX'0G-;2IF%3W%9>J#_3E8#J@JH,PJ&KI'^K-:MM_KV^E
M96DXV5JVW%Q^%*0D7NU)VI:#GM4%@.E&**!0 >U&*.]!H 3M11FE'6@"IJ'_
M !X7'_7-OY5P0ZUWNH?\>,__ %S;^5<&.M!<1XI:!TH-,H0TY1DTVI$ZT 68
MAS6KIHQ>Q?7^E9L(K4TX?Z;']:D3V.A-%+2&@S#''6H]V!\V!3W("Y-9\]SU
M []Z 'RS8.!C%1JW<GCK58LS'FH-1F-O9@?Q.<8]J-QHS]1OC<3$(?E' JD@
M.<FEV^E/4&J+$QF@+2XZTHZ4AC=I%+@X[U)CBI N13"Q7#,H('(/KS33+(O*
M@#\*N!!4BQ*3@@5.@796MM1N(9 6R1W%=)!,)X@Z]ZR4L(W;H*MVT<EK)MY,
M;=/:CT(9H]:*4=**!7"DIU)0(::0TZFF@!*2BD-,!DS?(:\$^)%T)-7F7/0X
MKW2_D$5K(Y.,+FOF[Q9<M=:G-*<X+G'YU#W1I'9LYICDU9T]6:Y79US58\U=
MT]C#.CXXS3E>V@H[ZG?Z69S !(!TK.UVW:695 R<5K:;<126Y^8;L=,TUY80
M69RN<UQTHRIIUK:G7./M&J:.'N-&N,GY#]36/+&T,I1NH-=]?7]NJ$9!KA[N
M02W;L.A-:4,14JM\ZL17PZI)!;1^9*H/3-=KI^DJT"N5KD;(?OT^M>DZ9@VB
MYKI1S(BDL42S/R\YKD"0MVX]&KOKS;]D;'85QDFGR[WG) 7K6E+<FIL7;2<
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M8%.J!+A&&<XJ02IZT6 DI1UJ(S(HR3BA;B-CP118"RQ[4TG''K2D=J0]J:)
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MI(I-P!J&27%0M,:!%HR>]1O(35;S:3S,T 2LY/>D_6F9%2)28T4M10-:3?\
M7-OY5Y^(USTKT/4L?8I_^N;?RK@40Y%.+T)DM25( 5Q3C:J1TJ>)>.M6 @J>
M=H+&8;.@6NT5J^736CPM"JBY2K#&:W-)7%W']:SHE%:VF ?:T]JMRN.*.C[4
M&DS2,V*@L1L8KF]8DW7! R2.,"NA9SZ5SYG\RY=1'N.>]*]C2"*ME:Y,DD@*
MA!GD55ED;DDY)/>M=S((2KA8PQQUK-E@59"N?H:%*[U+M8I!6D; &35F/3I&
M4,_"T^.(*_7BM&.2-0 3P*<IM;"45U*T$:0KL13CUJ[!&<[C^50^;%'N8'Y1
MS5J)MZA@>#4IL)(<.*?QMIN0*"PIDA@8JG.?FJTS8!.:I2'>U Q4;&*T+.<9
M*'D$=*Q_FW8%:%M@)E,L^.?:D,1'/GD'UK>B7]TOTKG[7,UT#COR*Z55PH%$
M2)$,G! IE.<Y<TTU9 4TTXU!/<1P(6=@![T 5;^Y2UB>1V 4#.37A/C3Q#+J
MEXXW8B4D(!73^./%CSS/9V[8C'!(/6O,+H23N232UW-$K(H7*1A(W23<S [E
MQT.:@8?*,#GO6U<:,T5M%-NSN&<=ZMZ5X=:ZDWS+\@Z#UJZG[N'/+8F"YI<J
M.;12O)%3.^6K9U[2A:S#R>@'*@=*PN<UC":FN9&DX.#LS9A;.C.GK6.\3(H<
MJ0I. :T8Y,6)3VK*DE=CM)X!X%$5:Y<[-(LV[0?/YN>AVX]:/W8AW>9\^<;<
M?UJH"0*4$CK6B.=G1>%I-NM1$$>O)KWC3Y!);J01TKYWT02/J4?ED @YR3BO
M9]'U15M$C9L,O!YK:'O1L82]V1UCL/+(S7&ZN56]+>HK5GU:-(68MG%<EJ&I
M1S7)(;M@YJXKEU9$Y7V(;^X.TA3S7'ZM=SAF'/)K8N;DB7@\$T2V2S ,X!SS
MQS2E6Z((PZLXJ2&=\.5X(SQ4:-L;D&O0K+2K20['4<T:GX),L1DMGSQP&KFL
MSI4D<=:7!60%1S6R@GF(?!QBH;;3'M)_*N(RKC]:W8)8XUVD=*YZDK';1BV9
MPM]PVL.33!H\B07"[4D$J?(.00P8<_\ ?.[\ZV'6"4;E(!I%)CQ@YQTS^5<W
MM9)G;[&,D9^GZ"+9/,E('<CU]JLOJMXEN+&*15B+MO( ^921_08_&HK[4A#$
M8B'9R>S8 'UI]O KVS$AFE(SE>@'I3YW\3#V<?A70TY-/2\G2XY)V_*H&>21
M7IM@\G]A6J $RF,+CN,<5YQI$V?W<N H&<$9X]*]0TI/+TNWXY*9]^>:UPK;
M=CEQR2L5+V/R4P<;C@G':JZR%:NZF 67WQ_6J# *I%=#T9RQ>@CD*V/X#T]J
MA: GE& ]B*4MD@>]/&<TMRMB VK.RAF!). *M/";>4QYR!TI'C8LKJ>14\TG
MGQ*Y&'7AJ+6"]R(&I%ZTQ1[4]*:)8\J&&".*B:'&-IX]#4X&:L+#@<T^6XN:
MQ049/3'M2-$P<$#/K6F(!OW8YQ2F("CEN'-9E!8B%'%17%LRKNVG&<C^H_$5
MK)"%YITB!D((R*.1-6#G:=SGC"'BSU.<G^=7+B &TD; PJ9_*D$)1BO4=OI_
M]:J]W=^?9+91G;+*2K'T4=36-E%.YK=R:L5-+@$\%TPY(^8']1_GWJXMN94Y
MZ^M7=-L]D;L%VB1,8],5*$"@C%-0M%!*IS29#';!%'&:LQI$RA2,>],C!W<&
MI<HW7@^HK6+L92'K;)DKC!]:M)$=@!-1Q?,H[D=ZM#[HK1&3&*N*"/:G&DIW
M%8K7N193,HR0I-<)*H*[E7;N8_I7H3+N4C&<\5Q5PH6<C'  _7FN;$=#LPCU
M:.?:R7>QQG)R:=!;Q1G+(K =R.16E- S$F-@OUJ&#YF*M]X>G>N6]COW&O;I
M+PH&#[4^VT^*-Q\@S5E8\'BIT4Y%-:DMV-"TA5$&U>!5I_F4\;L<@54@<CC%
M6V)$&5^\:TB<TRW9'KP<;<U'! \\GFQX ;[U.L"/,P.@]:TQCL *V2YMS#GY
M+V)[=0L>!VJ<5STM[);>(HT!_=R( 1^=="I! (Z5LMC![C@*<*:*>*8A0*>!
M313A0 N*4#FBC(!H <>*@D< '/04^5PBX[FL^[F 3;FFB2G(_P S-W-5BW<T
M\GK4+,*V1D(<FD'/!II)!S0IS3$2+P,'I2-%W3\J%;!Q4Z#./>I;L6E<KXSQ
MT-,)()S5YK4N,KUK.E<*Q!ZC@U49)DRC8AFE0,!WIKR!4W>E4KAP;DXJS%&+
MB(IN_>#H/6HE&[N;QE:-BE/*TA);J:I2G!&WKWJQ=[HFV'[W7%4]VULGO2&G
M<E8,[(W:HF;YR1TI\DH2'*_Q'%5P<BI-$3HY!R*NV]P@!W+UK/6K"=*3+1H1
M-"W5A^-:-M>6L.0H#OCCT%81/RTVRE5+I1(<1E@"?2DHW%)Z$^IHTT[R.2V3
MR15W18T$3>8!(YZ;AQ@?Y%:&I6EM#I[,GS.X R3UZ=*SK">"WP9)5#;LJ@.3
MZ,"/RJUL<[-@RF$;7VLA!#!@,8]*Q=0L8X-MQ;N&@<X SDJ?0U#J%U)-(06^
M4'[HX%%FYDM+J#&1L+*/=>?Y9JXZ$25RUHY_TM:Z*-@NHP_4_P JYC2&_P!*
M3ZUT9.-0A^O]*4R(F\9<+BHMY/>H\DBG 5C<V$;FF%:FP*0KF@"#92;#4^VG
M!* *N&S4B&I"E 2DQE'4>;*?'_/-OY5PHW UW]^O^A3_ /7-OY5PK+@U+V$R
M:,X'6IA)BJF_%*KY-9-,1?1\TLAPN:BA/(IUR^V,UES.X#(IANQ6WIC SJ:Y
M2.7$E=-H[;I4KK:!'29S2,>*!0W2F45IW*Q.1V%<V+B4S?*>:WKY]MM)["N=
MAW"3Y1N).*$:(T9Y 8=\@^Z,UBM=%WP>#GBK>I713]RN"%ZD>M8^XLW2G"&E
MQRD:L4P92">?6DWMT#52C(W;=P#$=^E:%I9RM*O*[0,YHDE$:=RY]A#0#YCN
M/J:FME>)"CCIT-5KF^=7$2+E_4#@4RVF;<S.3NSWK-7MJ4T:BG(S32,FFQL"
M:=(.,BBY!!</LCR*KQL)&/(%6&P5Q4+0*QST/M3&2I!&6RSU=C:*"/;&/F/<
MUFB GC<:LPQ*ASG- %ZQM\S;JV,?+5:S4;,@59;A::,V5#]XTAXI^.:SM4OU
MLXL9&]ONBG>RN+<AU/5H[)2!R^.E<#KVOW$D9\XE=QX3VJSJ<GFS[Y;@_05R
M.MS)+<(H8C(P"U<ZJJ<K(UC&VIDQP1ZB\TLARP8\5B719',6>%.!6E#>KIS3
M(1O)/)%9,C&ZN&?&"QX%>O:FZ,;;G$IU%6E?8N:<S23#S#N^M=S:6Z91<'D9
M-<EIMJ8W 85UD5U]F=&=25Q@GTKEQK7U5\NYV85/VZYC8%E:,I4VL9W#!+#.
M:\L\4:.-,UF2.)<1, ZCT![5Z=_;MFL R26Z8 KC]<U#^T+H2HB H,*Q&37A
M8*=3G=]CT\1"+@<JMM*\:*J')]>*B73T^8R3J"#@@ FM2[:[O&W,))F4=0,X
M]*JFW #,\Z#!Q@9/->IS:'"UJ0_9+/[,S$2&0 X^8 9_*L^2V*B,^8IWC=CN
M*T&:V^SN=[F0#@< 57AA0LK,^ >O&:J%S&IY%G3[4QR*Q90<9^]7565[*B?N
M\$=ZP4L(^B3J2.S BFL9K,;=W##J.AK6G5MH<U2GS:LZ&\U*7R=K2 9["LW[
M26?EN/7%9MO/B9=P!&#GC-:QDMMG*+T],4JM9W"%.Q#)(&7KGO5S3[M2I1JR
MYY8N!&"#WYS4ME:74K;XU^7U-):ZE6Z&^,,V4.#6SI^IM&PCD;<#QS6#;V5X
M#R /QJ^NGW#8/ (JB3HKC2K;4EWA1FN5UC2YM,DR5)C/1JZ'39I[8XD(XKH)
M+>#4[0QR*"&&"#6=2DI+3<Z*-9P>IY&96#\Y J5[D^4 'R.W-7/$6BRZ1=="
M8'/RM_2L&9FC3<O7%<3AK9GJ1JZ71,Q#@EN2>M$<9)PKK@^IK-\RZ+ E<CMQ
MQ5[3-5O;*\\DV]K*7/RM+%DJ/;FJ4")5?([KP?9-J$Z02^650[GVGDJ/\XKU
M,    8 &!7*>"-.FM[*:\N-OF3N=N% PN<X'MGM[5U@6NJC!1C<X,14<I6[&
M?>C?+TX6LZ2.1ONBM:>)O/&<;3R*KLC, !T-.2)B[&<+.X<\,BCOW-6([!E'
MSRL3^ JTTL-I"7D<*@[GN?\ &LF?4I[AOW1,,?\ X\?KZ5$G&.YK&,Y[%XV_
MEC()Q[FIK:V#1'G=D]ZPY)I0,M(YQ_M&I]"N7L-*EW2/<1Q NN\_,%'49[XJ
M8U(MV*G1DE<V?L@'>H9(6C/J*M6=_;:A")+>0..X[K]14LL888K6UUH8:IV9
M2B^^,U< YJN8RA!J0."<DT!<G]*<%S488<5(&S3$QVSWIKQG'6I!229(X_,T
MTA%'8J.">2 :QH+(W5W]I&0&/X!<\?F<G\JVKA"MI*5/SE2,UEW&J1:98Y*X
M0+DGZ <?S_*LJB5_>-:?-;W=S5CFV@Q# .:8W.[%927#O=))$<PNI;KTK2CD
M5E]Z%+F*<.0<@QR*F 5Q@C!J($ U)P3[U2,V/0/$V1R.]7E(9<BJ8)QS5F,X
MCR>]:6,V/---&X&@FG80E<EKC)83RM)\JXW*V.HKJR^#BN?\76,=]I!9M^(S
MEC&,D#_"LZL;Q-:$N61Q#ZNSNVR[+#H>F!^%)'J4: 8;<>YS7/7EM9/.\45[
M+$P&_#+_ /JS5*^:UM4C$4\TLN. JC!_7BN1*+/1YII:H]"BO5>)6R.?2I8[
M\,WW?I7#Z7?7P>.*YCVQ-W')%=&"4C!ZY[UG)\KLBTN97.GMY=P'(S5Q[A !
M'O )KF+2YP&+-@+SSVJQ!OO;H! 4C4Y:0GG&.@K2,DS"<;'7V!# N, 5HHXZ
MDUS?F_9XOD8@#M5/7M?&F:4TPDR[#"C/>ME-)'/R.3--W2Z\1J5((C'-='!,
M _ED]>E>2>#)+FY$]]-(Q,C8'/:NKGNY8;A")&'0\&NJ,/=..I47,['=@BG;
MAZBN<M]8BFN# 2R2!5;D\$'_ /4:O!MPR&S^-*Q2DF:IF1!\Q%-^U1^M9G)Z
MTN*+!<U!=1$?>Q4;72EPJ'/O5((<9/ I\>T2K@$^YH"Y-/.%R['Z5GL_F')I
MMQ*99,#I33\J8K1(RDQA[U"Q -.+U&S59(UCFF@TN<FD9@.@H&2[>Y.*LQGY
M<CG%41EAR:>I\IA@\'K1RH?-8U(I]QQ6=JT:Q$SHN<_>'K5C:V-Z=!3BPG38
M^.>.:R<7%W1JI<R.1=]TQ8>M7+*3%TM-U&R:TN2N/E/0TRU4M.N*M,;6A8UN
M*-98U15!<%D/<D=1_G^M87WOQK:\06TCO;N#@ 8&3CGM67)@P+*%VYSN'HW^
M>?QI2%3[,K28X'I2+2,VXFECYJ#9$RFIE;BH0*F12:3+1+_#5%CA6;WK26,[
M/6L^2,[7&#DMBB.XI[%O3W:9=\\C$1(2N3T_R34<,,C7L953M/R@X]35]+1[
M+3$5P/,D.6XY ["H-Y3#CJIS6IS,TAH9>8">7:,\A15S2;."#4KVWP"H.U=W
M7&33M1U&"%?,1A(Q. %/>LVRU*27Q(K;54/(=P'.:6HAE@&BOPA&,-C]:Z-Q
M_I\'^\*R[F!HM5Y4@"8@''&&&X?J36I)_P ?<!_VQ1(A*QK@<4X"A>E. K V
M"C%+BEP* & 8IPI<48H 0XI>*:13<XH KZCQ93G_ *9M_*O/GEYKN]2?_0KC
M_KFW\J\^=@<?2A+0EDN[(S3D.32/'M0%3FB,<U,D(O0G%)=D^5Q2QC I+GF,
M"N6WO#2,Q =]=1HA_>I]:YR),M^-='HPQ/']:['L".I0#&>]!ZT(#BGXXI%F
M/JY MRH."Q_2L>RW1N2 .F,FM/5G7S0,@_6J2@LACA&YC]X@8 J;]#:,3.GC
M$DGE0C=SU%5956 [%.Z3H?05IWL\=G;^5 !YK??D'\A6,C;F /YUM!Z&<EJ*
ML9/UKH=(MY4MS(^<'H#5;3K&,N'8YK99BBX0  "LZD[Z%15C-O\ =!$7C4#G
M)..:S ;J:(/"=S9YSZ5K3B>0XVAE;@YJ2PL6MY&)(VD8 %)2LAC8'/E+N^]C
MFIP2<9/%0>7M=\'/-21'L:SN .N#D=*0<U,1N[4BQ<Y I\P# M/5<5((7/13
M5F"RD<C=P*:=Q,OV _<<U.]$<8C0*.@HD.!6AF5IF6*-G8X"C)-><SZF^J:T
M[Y/E*<+]*ZCQA?BST65 VUYCY:_U_2N(T@*JNQ;)KFQ4^6#+IJ[-&:.%W;,:
MG/J*\W\172+K+H%^2,C@5Z&9?E8UY1JLGG:C</ZN:XLNO*HVS6L^6.A%.4+F
M4$,2?NXJ"%RDJLO!!S498]*1#\P!]:]Q:(Y'JSNM+M!-$DA')&<U?NX72W/E
MCI2Z'(@TZ(95B!C-:3?.,8'->?6Q<;\AWTL/)^\<JMK=:CF&'@;N3TJ\OAL6
M\>-JR-ZO5R!Q8W3!L*&Y%6YK[/" ,*\ZOB*BE:&QW4:,>7WM6<#KTLUJHA V
M(,X4 84^WITKG LLR.P)(')KMO$EJUZ#(J8VC)P,XKCS;M#P77:QZ*V?S%>E
MAY\]-,XJZY*C2*BHP;D5:"((=PD&[/*X-3W%K'#&CK*')[;<5'+ 4W#.< 'C
MWKJNC@E>^HU-X#%77 _VNOTI7\XY#!F"=<<@4+;2D$A#37216._<,]<TNH7'
MQ.4E4D?@1FM)IX]@S&OOVK/@Q)+^\9NG7&:OSQH(P1@X'<8K.>^H(IRR1LRE
M%QZ\YKK]'GA^R)G'2N*? <8&/QJ>.]EB 56(&.F:VBA/<]$6ZAW$9'%2_;8E
MP-PYKS\:C)M^\<DCO[5=CNG>,'<3_D57*2V=9/J<*CJ,],5MZ5?952#GVKS5
MQ*W/S5JZ)K?V.X6.X)"$XS2V ]%UBPAU?2WB=1EEX/H:\AGM7MYI(91\R$J0
M:]IL)(KJU5HV!5AU%<%XTTEX+Y;J-?W<G#?6L:\;JZ.O#5+/E9R%G((IPLHW
M1D]^WXUTUII-M<7<<R'>[855 K+M=(DGPQ7 ]Z[KPAH\$.H),[8\OD ^M8*#
M>IUNJHIG=6%O]GL882,%$ (]^]6U'--7&,@\4NX UVK0\QN[N<[?:L8/$BP9
MS"0%;V/K6K(H$09<$'H17#ZM>1)K.XN-PEW,<^]=)HEX;RPDB+;C%(=I]5S7
M-"HV[,[JM%*"DBAJ+_:+_P H_P"K@ /U8_\ UOYU%N5>M:4MD&EN2GWMV[]!
M6/-\C%6&#64[MZFE)JUD-O)-L1 [TNGL%@*MRKC:P]0>M9MS<B:78C91?YU/
M:W21@*3Q6-_>.BWNB7%I=::YN;"1]@[I]Y1[^HJU;>,[B-42[A6;/\:'!_+I
M5B&\B49W<56O;"QO2)%80R^JC@_45M&=C"<%+XD;2^(],FB!-TL1/&)?E_4\
M5:CE250\;JZGHRG(->6:SI>IQDL8P\"'(>/D8]3W%8?VZ]L&7[+=S0G.?D<@
M?E5^VU,WAE;1GNR/S5R)AC->%6^JZNMS\VJ76#DL!(?K_6N@L+R^N+@,U_.R
M9 VF5JKVZ%]3E:]SUGS%!PS ?4U1O=7L[5&'F"20$#8AR03Z^E<4R>9>0.78
M[9,<DU;O0GVZ9<??C!/U!-1+$.VB+C@U?WF-GUF^GU:))"J6\D3*L8_AD7GG
M\,4[[?!?:<R31_,A;( R.#BLV[F\NY0XP1=#'T*G-5M*E+W5_"3\I((_%<9_
M,5Q>VEK=G=]7A961M^&IY6-W;RCB%AMX[&MG:R.60_45FZ$5-@)MOS.Q#'UQ
MQ6H>I(KOH_ CS<2_WKL*+I@, <^]/2XD0[NM1E0X]&]:1?D^\#6R.?1FC#/Y
MW X([5<)XQGI56U4;0XQSZ5:-:(R8E(:.]%,0E(RJZE& *L,$'O44EU#&<%M
MS#LO-<UK_BQ+*%XH"5;'S2#G;183DD<WXP\,6D5P'7:8@,D[N4R<\^U85C86
M,4@*F-R.0%(.?>MFVU"UO;&6"5C*TR'>[');O_2N2T!HK>[FC _C(!/UK@KT
M^5NQZF%Q'M(I-'0RQ87*XR>E176J"UM_WA/7'--OK^.TC^<C>%R%S7,M=2ZW
M*55@JH1ENF>M8P@WJ]C>K44=%N='I]U<ZC/Y<;'R\CMQBNPBO(;&WCA5@74
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M!5^)V;&:+"98%6$'%0!,X .*F1@6V]Q5QW)9*:@<@!B3T&:F/2J=ZQ2UE/\
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M5D%^UNPRX8^U/D4=1TK*661,+NXSG%7XKHO%L..::9+1(K[0?7M3WG;9UJ(
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MPK+DGUKK?#>F8C3492=SIB)/[H/>KHP<YJQEB*BA3=S>W'L*<I]5I1@=.*<
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MYXY"CUXKE=/\R6..$VH !^]CFNML_/FN(<0;$4$ 8]JFS[%W7<3=[TF<D"F
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MKJN<:30EHH\@@?WJTK1=Y"]P*QX9BDFS^%C^5:UFI,FX'M2&^Y>,9!Z=*>K
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MF$SBCF#DMJ12'()%0;S068YI2PP<TQ6+%M-L93GO71QME%85R*,"U=%8SAX
MN>E3,<3IK63?&#5FLK3Y>-N:U <BH*'BI$/-1 XIP-(9<C-3CI5.-JM(<BH9
M:'4UQE<4ZD-(9S[2&VO&@8\9R/I5+Q!8B\MPJD!B<J3TS[U>\11%(X[I>J'!
M^AJK:W*75L(Y,9/2NB.JN82WL>8W%O+;WK031E9 VT@UI66CRW>H+ 5V@#<Q
M/\*^_P#A7:W>GI,RNT:-.F,%AUQTK.N)_P"SI6MXXU\R7#2.S8R?\!G%-OL)
M$6HQ0HD<:J B+M ]JN>'RBQ3E% 8;>?SKG=2DNGDBW%4$H)!+#'!]:TM!BD2
M"[^8A]R \_6D]@6XOB6ZS:[&<?>Z9]C5.PNXQHC1-OWJKLVT=N<?7M5?Q3$Y
MDM8@I9W+-@<YZ 5#';7,%FX:-E++SGC@=::V$[W-72]9GCMTMHXX\ =3GO70
M >9I_(_A!XKF] T^2ZCD=-HVMCDXKJ8HC%8[),9V8X-*=N@1OU+GA\_Z 5_N
MN16O6%X?;$4R_P"W_2MO-<KW9T1V'YH)I**0Q*,TM% #332<4[-,+<T -+4!
MJ7=[49&.@H&-+4TFE)]J8S<T@$8U6N&PIJ5FXK/OYMEO(?:@:.8NI#-=R/GO
M41JQ' GWG+<^E2>3;=_-/X@?TKJCHC%[E D4TFM PVG=9O\ OH?X4GE68_@F
M_P"^Q_A57)L4!.R=*8]P><FM+R;(_P#+*4_]M!_A2/#I\419K-GQZS&CFMT#
MEOI<QUDDF)$:.Y]$4D_I3 V5S6O/K5FVD3VEDOD2LA4 >OUZUBZ5#)=+(L\Z
M#:V,HA)S^.*<*C>K0YTTMF.,E5)IP@.3BM=M-M<'==2G_=B']352?1M/=<O=
M76/0(H_K5\Z,^1G+W]Y\AP:R=.4S7A?WKH-3T_2[>!G:6[/I]W_"D\/Z?ILO
MSEKDGV91_2I<E<T4;(TK26./;O3<![XILMPK3?+$",]"3BM>33]/@@WXN"/1
MG _]EJI';V,TZK''*#D=9 ?Z4FQI61T>GW#BW5%CCC4= B_XU/<.28DSRS5'
M D2J $(_X%22D&_B4'[JY(SZU$MA+<J7\92[9V&"J$CZX-+8IL05;U902/5@
M!4=NN%K$UOH7E?$+D=<8%6K!RDBMW%8DMQNN,*>$X_&M2S?.*EZLJUD=6IR1
M7G?Q%T,"5-3B7Y9/DEQ_>['_ #Z5Z! VZ-3[56UNQ&I:+=6NW+,F5_WAR/Y5
M$X\T1TI\LDSYUN(2AQ58KCFM[4;79)TZ5DR1GH!4TI71K6A9E4K3"AQG'%63
M$P/(I1 #&Q+88$8'K72CD95"$FIHQ@BI!& >:FBC"G<PZ<XK6*N9R8PJ9')?
MN:O1P1^2\:].HID4#R-PI)/2K<%L^\!E.374HI1N8<UY6.;U% BL:Q-^#7;Z
MCH[S1L0O8UR%]82VHW,!C.*X92YG='?[/E17+TF<U&"0/K3DY-*Y%B500V:V
M],E\V1(CG-8ZKD5N^&HU?4</Z<5<'9G/7^!LZVUMU2/8F23U-0:QI1-EYL6>
M" :Z.TL5"$GGTJU>6J_8&0X))%;<^IS4J=]3REK:1&;/:J;%\UV5W9+Y\H&!
MQ7/W5LL:$^E;)71KJC(=FZ$_E0"?4TDC?O* >:\NM&TCU:$KQ1.A.:NP,<BL
M]#5RW;YA7.T=<6=#8R8*Y]:Z[3Y 0*XNTZBNGTZ3 %9-69L]8G2S()K-T/.1
M7A6KVBV=U<HV"QE**,XVXP<G\\?G7N]N=\)'M7C'CFU^R^)97 XD -==,\VL
MM#GOL\WE^;Y+B,8^?:<?G4EODL">U=#>:G!_9,H6[#-<( (XT [\Y]!_GMFL
M.!=O)ZGIBMXZG-/0L!5+8(PN.<=ZMV\4<2[Y%RH!.,=^U11#)!QG%:^KV4FG
M1VT,[*2\0?"9XY(Q^E-BC=:F?:8%RY487L/09K;MY<-&#W;'X5S]K)^^?'IF
MK?VKRV# X*]*YZL;L[L-/EB=#>0B6W,@!)#<?2MKPP8"'@9L29W#/<5SMC?B
M7RHC@$G)K5M(]ETQZ+G'%8)V5F=<X*;NCNE@P*1X@,9KD[?7[RQE9 WFQ _<
MDY_(]:V;?Q-I]XRQR,;>4]%D/!^A_P <5:.5Q:=BX8R6IK1X/2K*X)!!R#S2
MLHJB;F=,F!D@8JOM%:,L6:QM3ENK=UCM;;S692Q8M@)Z9]<^WI29:+2CFK#*
M/).37*C7-4BN1;R:;O<\AHVX-0W^OZG"C!K,JN.JMFBVH.]C?< $]*U?#MJL
M<4[@8#S%O_'5']*\\T7Q+$VK0QZO#(+63Y222NTGH>*]<MK6"UB"P A#R!N)
M'ZU<:;3N92JJUA&C1WZ#<.3CO4<[$#:.O:K*QHC,0.6ZDFD,49;)0&K<60II
M,P[W47'B32]&B4"+!FD;OPIP/SYK>;'<#\J8UK;&X%R88_/ P)-HW >F:AN)
M, X-7LC+=W&2BU.1)#$W^\HJC)%HN3YEI9_C&M1W-BUW&P%PT;$8#  X_.L4
M^#F<DOK-X<_[*?\ Q-1SLOE74UC#X<'_ "XV.?\ KBO^%3P1Z"3\EE9CZ1+_
M (5SY\%#MJ]Y_P!\I_\ $U)%X.\LY&K77XJG^%"DP<8G61WEG$NR/RT4=E
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ML)IVHMGUA5?YFO9<^E*N2:.=B]E%N[/*;?P+J,Z,\L$EJH7<6F=#^BDFN3<
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M=FOH#GS;A3W((KHA7(^'9R=1D5CP5Z?C76URRTD;P^$=13<T9I%#J,TF:-U
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M6GR##&:/_>3_  S7$T5I];J]7<UCB:D3MFU>PF'R7:?\"X_G4+/'*?DD5_\
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M)!R@K2-:I#X69RI0ENCYZD\)ZQ9G_0]1) _A+,GZ<BJ[OXHL?]9 9E'H@?\
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M:?[S 56?5].C^]>0_P# 6S_*O/**Z(\/TU\4W]W_  XO;/L=U)XDTQ.D[/\
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M\=5>UC58*FM[GB,'P^=L>;>,?9(_ZDUJ6_P]LQC>+B7_ 'FP/T%>RQZ);I_
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 48HHH 3:/2D**>U.H
MH C,*'^$4TVT1_A%344 5C8PG^ 5&VF0-_ /RJ[10!FMH]NW\ _*HFT*W/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&(]ETOJG]QWWA>>2:W\:F61G,EE*[;CG+?-S]:;+8W.K?"G3C8J)OL$\TER
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ^XR?^$7\/\ _0#TW_P%3_"C_A%_#_\ T ]-_P# 5/\ "M:BCVL_YF'LJ?\
M*ON,G_A%_#__ $ ]-_\  5/\*/\ A%_#_P#T ]-_\!4_PK6HH]K/^9A[*G_*
MON,G_A%_#_\ T ]-_P# 5/\ "C_A%_#_ /T ]-_\!4_PK6HH]K/^9A[*G_*O
MN,H>&- 4Y&B:<"/^G5/\*THH8K>,1PQI'&.BHH 'X"GT4G.4MV5&$8[*P444
M5)04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+0(M?M/[<EOYT%Q#9):1_8V4\B+.-W3C?NSGGIQ0!ZG31+&93$'7S H8IGD
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M; ?NC?R16Q<WMK9A#=7,, <[5\V0+N/H,]:I7/B#3K37+?2)IU6ZGA>9<LH
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M75SM$MQ=2F1V"YVKGH ,G@ =3ZU-JVDVNM6!M+L/LWK(CQN4>-U(*LK#D$$
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M&!83;B#CJ>_K784A*J>2 6X^M+0 4444 %%%% !1110 4444 %%%% !1110
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M*IVL#@[L!@06V[01UKG]/T":XOM/2]\-ZC$UO,DTT]UKLLT"NG*M&OFL7.X
M@.J\=:=/I.J_\)"L^FZ-=:9<M?K+<7D-^IM)X=XWEXMV2[)D?ZL$,<[N] '7
M:KJMOH]JES=!_):>.$LHSL,CA%)]!EADU#'X@L)/$TOA]7;[=%;BY8;?EVY
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M:[-N'S@@@]CGM5O1[SQ3K%C9:PLNEV]I>*LJ63P.SI"W()E#X+X(.-N.V>]
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M]2U-969[Y8E9".%\L$#'US6</"4 \'V_AW[5)Y4+Q,)MHW'9*)!Q[E<5T5%
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M2TZWN9$4JKNGS!3U7/7'MTHO/#VCZA9V]I=:;;206W^H3RP!%QCY,?=XXXH
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MP_2&/_A)8X+Q[R)-9D19G?>QQ%$,%NY'W<GDXYYK?U/P_I&LR1R:CI]O<R1
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M45M-]IM89Q')'YJ*^R5=KKD9PP[$=Q4M !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&*]?PH U:*** "BBB@ HHHH **RM=U9]'AL9$B63[3?06I!.-HD<*3^&:U:
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MRH DHHHH **** "BBB@ HHK*\2:L^A>'[O4XXEE: *0C' .6 Z_C0!JT444
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M^U.9)\+_ *QBH4D^O"@?A5'3?#&B:1=&YT_38+>;:4#(OW%/)5?[HX' P.*
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M6_D6D*0Q;F?8@P-S,68_B23^-5=4T+2]:\K^T;**=HL^6YR&3/7##D9[\\T
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M1]&F>;3]/A@E==AD );;_=R<D#VZ4 0>*[Z&RT0K,EW(US-';11VDWE2.[L
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M65DMR%*%]T;#RW9<[@P( !R>X%0G1"^A:3Y<&I7"3^(8[V5;VW5'4;B2Y1
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M"9-JC;O"[0[ 9.!EE[GJ*XSQ1=^']2-W;ZEH6I#5K?<EI)%8R&9S_"T,T8(
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MB5DES@1D'!# \@C(X-<OI6AWMEJW@B*_B:>73M(N(IIPI98Y<0+C=ZD!@/4
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M5-Q#GG &#D\].,\"IH/%RPVVLMK-G]@GTA%DN$CE\Y61E)5D;"ELX(P0#D4
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MC;YS@X&).H!Z8P<T =-16/H6MR:JU];7=G]CO["80W$(E\Q>5#JRM@94JP[
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M=3L#>QAIQ&D0&S(=MI('SCD \XXYX .IHKBQXVU.2PU"\B\-NT>E.\>H*UV
MRLG+"+Y?WF%PV3LSD#KD#0O?%,JZK8:=I>FF^FO[-KR)VF\J-4!49<X) ^<=
M 3G QW !TE%<4/&^I/I^H7T7AQS#I3R1Z@&NP&5DY<1#;^\ 7!R2N<XZY T;
MG4+63Q+I[6EB+F^FTN>XMIFF*+L#190C!'S%U.<<8]Z .DHZ5RW@35M8UC05
MN-6MXU;S)0DRS!C)B5UP5"C&  /?K6IXG_Y%/6?^O&?_ - - &H&5ONL#]#2
MUY-IFF6%UIGA\^&_#-S8:LC6LDFHK8FU18P5,I9R!Y@9=PQSDL#[UV<_B>]F
MO;V+1])2]AL9#%/++=B$O( "R1@J=Q&0"25&>,\&@#IJ*Y6?QH)1H8TG3I+Y
M]9@DFMPT@B"; A(D)!V_>.>O(Q@YI3XIU&35KG3[318KB:Q6+[9&+Y5D#.@8
M^4I7YP WWB4!(([4 =317/7/B&]EU>[TW1=*2^DL@OVJ6:Y\B-&8;@@.UBS;
M2"> !D<\U6G\;PQ:!'J*Z;<O/]O73Y;+*B2.<OMVYZ'DC!S@@@YH ZJBL'3=
M>O)M=?1]4TQ+*Z-O]JA,5QYR21A@K<[5(8%ER,=^":Q[/QY=W.BV6O2:"T.C
M7#QQO,UT#+'O<)N\O;R@8CG<#CG% ';5%+<P6[1+--'&TS^7$'8 NV"=HSU.
M 3@>AK#OO$5T-8GTS2=.BO)[5%:Y>>Z$$<9895 =K%F(YQC !&3S61J.L1:X
MOA*\BC>%AKIBEADQNBD2&X5U..#@@\CKUH [BD+J'"%AO()"YY('7^8_.EKD
M;&66?Q!XHUM+<W4]ABPLX-VTD)$LK 'L6=\9_P!A?2@#KJ175UW(P89(R#GD
M<&L(>*;::ST&XLXFN#K+H(4#8*(4+NQ_W0#D>N!5;05_L[Q;X@TA.+=Q#J,*
M=D,V]9 /8O$6^KF@#IZ*:[%8V94+D D*,9/MSQ7-6GBFZ_MRSTS5--@M'O2Z
MP>3>K.RNJERLBA1M.U6Y!8<8S0!T]%<=)XUOVMM6O;7P^TUEI5Q-#=2-=!'8
M1$[C$NT[N!G!*^@)K2OO$C"\L[#2++^T+VZM_M05Y?)CCAX =WP2,DX  ).#
MZ4 ;]127,$,L,4LT:23,5B1F ,A +$*.YP">.P-<?J_BS4E\->(1;Z?]DUO3
M+9I)8FG#*BF-F29&VX<?*< @<J0<53U;4]4-SX+O+G3 UZU[($@BG#>9NM9
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M$,R.V.,\A3CBNNHH R)=)F?QA:ZP'3R(;":U*<[BSR1L#Z8PA_,5D)X4NU\
M6'A\SP?:;::VD:3)V$1W"2G'&>0I XZUUU% &1/I,TOBZPU<.@AM[*XMF0YW
M%I'B8$=L?NS^8K"B\*:I9>&_#5M:RV<E_HLXEVRLRQ2_NY(R-P4D<29!P>E=
MI10 V/?Y:^8%$F!N"G(SWQ63+I$S^,K761)'Y$-A-:E.=Q9Y(V!],80_F*V*
M* ,;Q3H">)-#>P9HE=9(YXC+&)$WHP8!E/WE.,$>A-9FA>')K/5H[R?0?#6G
M+%&RJ=/AW2NQXW!RB;!C(QALYZUUE% '/Z1HVH:1X/\ [,AFM#?)YI1Y$9XB
M6D9@"."1AL'^M84'@2:[75TNH-/TB"_M!!]FTIV=#*&W"<@J@W XP /7)-=;
M#JT4VO7>D+&XFM;>*X9SC:1(S@ >X\L_F*T* .2NM(\2:[#;:?K+:9%8QS13
M7$MI)(TESY;!U4(R@1@LH)^9N./>M;3-)FL==UR_D=&CU":*2-5SE0L2H<_B
MIK7HH Y'2?"=YI\7A=9)X&.D^?YVTGY]ZL!MX]^^*FU'PC_:USXD6ZF5;75[
M2"W38,M&8]_S$'@\LI'TYKJ** .+TGPI<V^I6<MQH/A2V6V;<]S9VN992!P5
M!1?*.<'[S=,>];N@Z3-I1U3SI$?[7?RW2;,\*V, Y[\5-K&LV^C:%?ZM(#-#
M91/)(L1!8[1R![UH Y /K0!C>+=.N-5\+WUM: &["K-;@]#+&PD0?BR@52NK
M6ZUHZ-XGT4QQ7D4# 6]Z&19(I0I9&(!*,"BG.#@@C!S73T4 <YI^BZC<:S<Z
MSK+VT=R]I]C@M[1F=(8RVYB78*68G'\( "BL^Q\,:PGAW0=*NY+$?V/<VQ22
M)W/FQ0KC)!4;6/''(]ZZ?5-5LM&L7O=0N%@@4@;B"223@* .6)/0#DUDP^,;
M-KJWANM/U6P6Y<1PS7=FR1NYZ+GG:3VW8H EO= -_P"(VO9F0V<FF2V,D>3N
M.]U.?3& :YW3? T]BMG9/HGA62"V9 =1:T!GE12.L>P .0.6WGGG':NOTS5H
MM4EU".*-T-C=-:ONQ\S!5;(]L.*GEOX(;^VLG+^?<*[1@1L5PN,Y8# ZCJ1G
MM0!1TW29K+7]:U!W1H[]X6C5<Y79&%.?Q%:]%9%_KC6VMVND6MC+=W4T9GDV
MNJ+#$&"EV+'GD\ 9)P: *D.CZE:^)M6NHC:/I^IJC.6=EEB=8]F ,$,#A3G(
MQSP:K?\ "+W?_" Z1H'GP_:+(66^3)V-Y$D;-CC/(0XX[BNKKFW\:V(N[JWA
MT_5[HVLS02O;6$DB!UZC<!CO0!EZAX1U"?6M7N$M='NUU''EWEZ&::S78$V(
MFTAE!!8#<O+'.:T--\-75E/X6DDFA/\ 9&F26<P4GYW981E>.G[L]<=1716E
MR+NTBN%BEB$BA@DR%'7V*GD&IJ ,C3-)FLM>UN_DD1H[^6)XU7.5"1*AS^(J
M7Q!I?]M^'-2TO=M-W;20JW]TLI /X'!K2HH Y,P7WC'PYID5P/LEI.,:M X9
M96*\-"./NEP03GE1Q][(0Q:EX2\)ZC;1L;U(?W6D*NYI</A8XWX_A8@;L_=&
M3TYZVF^8GF&/>N\#<5SSCUQ0!1T+3%T7P_IVEJVX6=M'!N_O;5 S^.*R/%'A
M^ZU74M+OH+:POX[,2AK'4'98G+[<2 A6^9=I RIX8]*WK&_@U*V^T6Q<Q[WC
M^>-D.58J>& /4'GO5F@#AH?!>H#P]K5@\MA'+J&I17J+ A2*)5\G*8QV\H@'
MOP>,D#HM0TF:[\1Z/J22((K$3B13G<V]0!C\JUZ* "N$N_!,D&K:C<V>C>'=
M2COYC<;]3BQ) [ ;L$(V]<C(&5QDC-=#J7BBQTZ__L](KN^OP@=K:RA,KHIZ
M%ST4'MN(SVJ32/$5CK$\UK$)[>]@ :6TNHC%*BGHVT]5]QD>] %.+P[+#J?A
M^XC-I'%IMM/%*D$7E*S2!.409"C*DXSW[U8T_1I[34?$-P\D974[A98@,Y4"
M"./YOQ0GCL15:3Q?!$-9N7LIQIFDB03WFY</(@!9$3.X]<9.!D$5>TW66NYD
MM;RQGL;UXC.('^?$8(&2ZY3.3]W.: ./?3-6T;4? FF6<]JU[8Z7<0R"3=Y4
MVQ(%(R!E02,@X.,#@]*W[71-4N]7N=8U=K2*Y-FUE;6UJ[2)$C$,S,[*I8DJ
MO\( "]\UT#VMO)=17+PQM/"K+'(5^9 V-P![9P,_05-0!QUMX7U32;70+G3I
MK234=-TU=/N(IV98KA $SA@"5(9,@[3P2"*T-)T:].KWNLZTUJ;NY@2U2WMR
M6BAA4LV-S %R2Q).!V&*Z&J][8VFI6<EI?6T5S;2 !XI4#*V#GD'KR!0!Q7@
M'1EEL=2N)Y?M-FS/IE@Q_P"?*)W5>?<LPSW"J:BT[P'-816NG'1/"LUO;LJ_
MVC+:!IY(U/1H]F-Y P6W]><=J[Z""&U@C@MXDBAC4*D<:A54#H !T%24 <3J
MG@UCXAOM4M=(T+5!?[&ECU1,-%(JA-R.$?*D*N5P.03GFNFT33_[+TBWM&BL
MXW0$NME!Y,6XG)VIV'/X]:T*KWU_:Z98S7M]/';VT*[I)9#@** ,_P 1Z--K
M%G;&UG2"]LKE+NV>1=R;UR,,!SM*LRG'/.>U48M*UK5-<T_4-;%A;PZ<SR06
M]G*\OF2LA3>S,JX 5FPH!Y.<\4#QO8)Y<MQI^KVMG(P5;RXL72+DX!/\2@Y'
M+ #FM:TU:*\U?4=.2-UDL3&'8XPV]=PQ0!!X;TF;1M+EM9Y$=WO+FX!3.-LL
MSR <]P& /O6O5:YOX+2>UAF+A[J0Q1;8V8%MI;D@848!Y.!5F@#B3X-O;KPY
MJ/A^\>R-HUW)=V<X!D;>TYG DC("D G! )W#/2K&A^&I[35H;N?0?#&GK K8
M?3X-TKL1C(8HGEC&>/FSG&:U]9UQM,NK*RM[&6^OKPN8H8W5 %0 LQ9B  ,@
M>N2*UZ .2/A6[/P\U3P[Y\'VF[6\"29.P>=)(RYXSP'&>*9JOAF^G\2G5(K/
M2=2C>UCMTCU)F'V5E+$M& C [MPR/E/RCFK]WXPL;75;O3DLM4NI[0JLQM;)
MY54LH8#*C'0BK]MK=M<M91F*[@EO%D:*.>V=& 3&[=D?+U&,XSVH P--\(7E
MEI'ANSDN;=WTK4I;N5D4J'1A. %&.#^]7CH,'FM9]%ED\4WFIM*@@N--CLPH
MSN#*\C$^F,./RK;HH Q/">GZEI'AZTTO4?LC&RACMHI+=V/F(BA0S!@-I..@
MS]:E\1:,VN:2;:.?[/<QRQW%O,5W".6-PZ$CN,CD>A-:U% '+-I6O:UJ&G/K
M8TZVM+"<7(CLY7E:>500N2RKL4$YQ\Q) YK2T729M-O=;GED1EO[_P"U1A<Y
M5?)B3!]\QG\Q6O5:POX-2M!<VQ<Q%F0%XV0Y5BIX8 ]0?K0!+.LS6\JV[HDQ
M0B-W7<JMC@D9&1GMD5Q^E^%+U=>_M"[L])TU3;20W"Z6[_Z8SXPS@JH&,''W
MCSU]>GUC4HM&T2^U29'>*SMWN'1,;F"*6(&>_%6XG$L22 $!E##/O0!PJ^%_
M$TFAZ/H<T^F+::5<VCB='<O<QP2*0"A4!#M7/!;)'8&M5M*UO2=9U*\T0:?<
MV^HR+/+!>2O$8I0BH65E5MP(5?E('(Z\ULZMK%CHEE]KOY_*C+!$ 4LTCGHJ
MJ 2S'T S65%XSL1<0Q7UEJ6F+.X2*6^M3'&['HN[D*3V#8S0!-:Z1?#Q+!J]
MW-;NPTW[+*(E909-X8E0<X7CN<U-H>DS:7-J[RR(XO;][I-F?E4HBX/O\II-
M8UQM,O+&QM[&6]O;S>T<,;J@"(!O9F8@ #<H]<D56_X2N'[5J1-E<C3]/?R9
MKT#>#+\N46-<N<;QSC'!H V;Y+N2PG2QFCANV0B*25-ZJW8E<C(_&N:?2O$.
MMZEI3ZU%IEI;:=<"Z_T.9Y7GD"LJXW(NQ?F)/WB>E=;10!QEQX>\00QZ[IVG
M2Z?]AU6669;B9W$MN9% <! I#\Y(.X8SR#CF_IGAVYLM4T6[DEA9+#2&L) I
M.6<F(Y''3]V??D5TE% '.0>'KF+2O$=J98B^J3SRQ$9P@DC"C=QZCM2Z=X?N
M;/6=*O7EB*6>D&P<+G+.6B.1QT_=G\Q7150O]6BT^_TRSDC=GU"=H(RN,*5C
M>3)]L(1^- &5%X=N8]%\261EB\S5)[F2)N<()$"C=QVQSBGVF@7%OK6C7K2Q
M&.QTN2RD49RSLT)!''3]V?S%=#33(@D$9=0Y!(7/) ZG'XC\Z ,+PMI6HZ)9
M2Z==FU>UCFD>VEB=M[J\C/\ .I&%(W <$Y]JTM7LWU#1;^RC95DN+>2)6;H"
MRD G\ZNT4 4])M'L-'L;.1E9[>WCB8KT)50#C\JY"Z\$20:KJ-Q9Z+X=U**_
MG:XWZG%B6!V W#(1O,7(R!E<9(S7=T4 <]%X=DAU70+F,VB1:;:SPR)!%Y2L
MT@CY1!D*,H>,]^]9GBKPSJNOSSQ+:Z*RN +747WI=6/')7"G<0<D89!S@CUZ
MN"_@N+VZLXR_G6NSS08V &X9&&(PW'H3CO5F@#F&TG6])UG4+W1?L-U#J+)+
M/!>RO$8Y50)O5E1L@JJY4@<CKS5=/"%VNEP))=PR7SZQ'JMY)M*HS!P2J#DX
M"J%&?3)KKZ* ,B729G\86NL"1/(AL)K4ISN+/)&P/IC"'\Q60OA.\'PXM?#?
MGP?:H4A4R9.P[)%8]L]!Z5UU% '%ZOX.:3Q%=ZO;:3H>J?;4030ZHF#&Z#:&
M1PC\%0 5QVSGFK:^&)UL_#\2+IUN^GZA]LG2T@\F(@QRKA%&>?WB\GK@GVK9
MO=6BL=3TRQDC=I-0E>*-EQA2L;.<_@I%:% !7-Z2DFF>,=;LWC?[/J!348)-
MIV[@BQ2KGL041L?[?L:Z2HYX(;JWEM[B))894*21N,JRD8(([@B@#B?".EC_
M (2S6[F.42:;IT\EMIZ@<1M*5EN /8/A1Z8(K6T".6\\1Z]K3QND4CQV-MO4
M@LD.[<V#V,DD@'J%![U=%QI^@W6DZ):V2P179D2!($5(X]BESP/7GIWK7H H
MZU8RZGH=_807+VLUS;O$DZ=8RRD!A],UR>F^$+^'5="NFT[0M-ATR1V=+#<S
M3[H73=N**1RP.TYSDG=D<]7HFK1:[HEGJL$;QQ740E1'QN /KBK] '-V_AVY
MA\.Z]IS2Q&749[R2-AG"B8L5SQVSS4#>']4T^[T[4M*>TEO(-/2PN;>Y=DCF
M1>5*NJDJ0V[^$Y#=JZNB@#DU\+WU_:^()M5N+=-0UBS^Q[;?+1V\05PH!."Q
MS(S$X&<XP,5)#HNKW$OAR?4/L,<NE3NTBV\CNKJ8'B!&5'.6SCL.YKIO,3S/
M+WKOQNVYYQZXIU ',ZEX4&KZCKS74JBSU738;+"??0J926]/^6BX^AK/TKPE
M<VU_9-<:%X4A6V<.]Y;6F992.A5-@$1S@YW-C'%=-8:M%J&H:I9QQNKZ?.L$
MC-C#%HTDR/;#@?4&M"@#(T'29M*_M/SG1_M=_+=)LSPKXP#GOQ6O110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7*V6LWLN@>)KJ6X!EL;J\
MC@;:HV+&,J.G./>NJKG;SP7IM[<7SM/?1V]^=UW:17!6&9L!2Q7KD@#." <<
M@T 9!U#6M2OO"EE#JCVL>H:3+<WDD<2%V91!@KN4A3ESVQ@GC."*][KFM:7X
M:\6PK?FXO='G1+6[FC3<RND;@.  I(WD9 &1CO776^@V5M<Z=/&K^9I]JUI!
MEND;;,Y]3^[7GZU%=>&=.O(M5CE60KJCH]SA\9*JJC'IP@H P->O=6\/P:9I
MZZG?WEWJEVRR726T;O"BQEV$484#G;QNW8!).<5#!?:LT&MV4XU6XTTZ9)+%
M<ZE:K%(D@!!3*JH8$$$<9&#R>*Z[5M'M-:M%@NQ(/+D$L4L3E)(G'1E8<@\G
M\"0>#56T\-VUM%>++=WUY)>1>3++=3EFV8(V@#"K]X] .O- '.+J&SP[X:T^
M#4-3AN9--CE-OIENDDKH$0;BSJ5103WQDGKQ61J=UJ>N^"$:ZU&\MY[/78;1
MCY4(>4"[B"-(-K .N0?EP"1R".*[6?PG92?87M[F]LYK*V%K'-;3;6:(8^1L
M@@C@'ID'IBD7P?I*:%<Z.BSBUN)_M+-YS&02[@P<.>=VY0V?6@##UC5=1@\0
MP^'DO=7:*"Q6ZGNK.TCDN)F=V50?DV*!L.<+SD=.<L'B#7X=#^S2K/%=SZK'
MI]I?7ML$8Q. ?-:,8!8?,O0 D XYQ7177A>UNA:R&\OXKVV0QI?13XF9"<E6
M.,,,@'!!QCC%/_X1?37T272IQ/<0ROYKR33LTIDR"'WYR&! ((QC QB@#G=5
MTS4-/\3^$O.UJXU"W;4GRMVD8D5_LT^"I15&W&<@@]L8KNZYZ'P?9)J5EJ-S
M>:A>W=DY>WDNKC=Y>492   ,$-SQDX&3Q70T <@O]L:QXNURQ&N366GV0@\M
M+6.+S=SQY.6=6^7\,D]P!@YEUXKU?3M&U"R>3[3J-MJT>EI>1P!BRR*CB3RQ
M@%PKXP, L!V.*O1>&WO?&GB&^>74+!G%LL-S;2&/S%$?S#D%6 /L<'IC)K:3
MPKI":%+HY@=[:5S+*SRL97ESN\POG=OR =V<C QTH Q=#OM83Q#!:DZU=Z=/
M$_G2ZG9I$8)!@J59%4$-\PP0<'&#5/1)O%5_\/8]=35)KS5KNS1H[=8HDC3+
M#+*"HS)MR?F.W)Z 5U.F^'H=.O#=O?:A>W'EF)'N[@OL0D$@ 8'.!SC/'6EC
M\.V,/AN'0HC<1V<,:QQM',R2+M(*D.,'((!H Y0^)KC3-"U9X-2O;J^B:WCC
MMM7M!#+;-+((P[;54/'DYR/[I&[TT+\ZOX8GTNZDURYU.&ZO8;.Y@N8HE'[U
MMH>/8JE<$@X.1C/?FM.#PEIJQ7R7K7&HM?1+!<27LF]FC7.$&  H!9CP <G/
M6DM/"5G;WMM=3WFH7[6IW6R7EP9%A.,;@.[8)&YLD9ZT 8\/]O:U>^)O+U^>
MRBT^],%FD$,1Y$,;_/N4[ER_08/7GICH_#6IR:UX7TG5)E5);RTBG=5Z!F0$
MX]LFI[32K6R>_:$,#?3FXFRV<N45./3A%IVF:=;Z1I5IIMJ&%O:PK#$&.2%4
M8&3WX% &9X@U&ZTK4M$N%FVV$MW]ENT*C'[Q2(VSU&'"C_@=<E'XRUG^R]7=
MY4^T:@B7&@_NQPDTIAC&,?-@^6YS_P ]/05WFM:/9Z_I%QI=^K-;3@!MC;6&
M"""#V((!JM<^&-*NKS1[F2W(DTC(M K8"@@#!'<#:I'N : .=.G7]Y\1]3@A
MU>XLXTTFS\Z6!(_-D;S)]O+*R@?>)P/3H,YBM_$.LW6F:5I8O$CU&ZU2ZTZ7
M4/*7A;<RY=5^[O81C Q@$DXXQ79Q:9;1:O<ZH@;[3<0QP2$GC:A<KQ]9&JA+
MX4TN;39+%DE"->27RR+*5DBG=V<NC#E3EC^!QTH H03ZCH?BS3])N-3GU*SU
M&"9D:Y1!+"\>TGE%4%2&[C(('/-<U;ZEXH_X032?$AU]GOKJ2"$V[V\?V?;+
M((@Q 4-N&X-G<!D8QBNWTSPY:Z=?/?O<7=[?-'Y0N+R7>R)G.U0  H) )P.<
M#.<4)X9TY- M-%"R?8[1XGB&_P"8&-PZY/?YE% &=I\FHZ7XSCT>XU6XU&UN
MK"2Z5KE(P\<D<B*0"BJ-I$@X(XQ[UT\BL\3HLC1LRD!UQE3ZC((S]155],MI
M-8AU5@WVJ&![=#GC8[*QX]<HM7* /)FL;FV^&OCF675;NZ3S-1C\J5(@NX.V
M7^5 =QQSSCG@"NI9M9T36] -SK,U['J<[6MS!)%&L:-Y+R!H]JA@ 8R,$MD'
MUYK1D\'Z;+%JT!DNQ:ZJ)/M%N)CY89_OLH_A)_J:T[S3+:^N+">8,7L9_/AP
MV,/L9.?7Y7:@#@!X@UK5QJ-[;7&MV[Q7,\-G!::>DEO^[=D'F$J68L5YP1C.
M!R,UZ!I=S<7FDV=S=VS6US- DDL#=8W*@E?P.163=>#[&XN;F6*[U"TBNV+W
M5O:W)CCF8\$D#E2>Y4C/>M^-%BC6-!A5 4#T H Y3Q%L/CSPD+K'V3-T8]WW
M?M.Q?+S[[?-Q^-=:<=ZI:KI%CK=@UEJ$ EA)##DJRL.0RL.58'H0<UDQ>#K;
MSX7O=4U748H'62*"\N=T:LIRI( &\@\C<3SS0!SVG6&JW-SXPGL];GT]8=3D
M:%((HV#2"&,YDWJ<CH,#'?GD8U=/\0WNH7G@^0LL<6JZ9+=7$2J""X2%A@GD
M8WM^==#:Z1:V8OQ"''VZ9IYLMG+,JJ<>G"BH+3P[I]D=),*R#^RK9K6VR^<(
M553GU.$6@#@K;Q+X@U716URS?6_MDFZ6UL8M/1K0J"=L;-MWDD#!8,,$\# Q
M6S%9W<WQ3CN3J=[$&TE9C;%(L*/-_P!4?DSC//7.>^.*UW\&:<9)1'=:A!9S
M2&66QANF2!F)RW Y )Y(! .3QS6M_9EM_;/]JX;[5]G^S9SQLW;NGKF@"Y7G
M_AU/$;7GB(Z7<:4EM_;-QQ=02.^["YY5P,?A7H%<VW@RT%W=W%OJ>KVINIFG
MECM[PHA=NI _ 4 4?%VOZEX2M++699([J$)Y%U81J%\R0KD21$Y;@@Y!)&S)
MZKS6U76=8T[3- LC?RW-[JLCM->V-LLI1 AD(A7&#V + _*"3DUTL'AZTBO;
M6\EDN+J>U@:"%[F7S-H8Y9N?XCP">N!CUJO_ ,(AI0T>+3$%Q'!;SF>U9)BK
MVK$G'EL.5 R0!TP<=.* .>3Q'J^B6.NW,T&J7EC9Z>UW;S:E;+#)YBYS&2H
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MA65I>@Q:9<R737M]>7+H(_-NYR^U<YP ,*.>^,GN:U: "BBB@ HHHH ****
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M',P.YN<#]VO;CFMA+GRK".XO7@A;RU,I$G[M6(YPQQD9Z&N,U3_D.^-\]?[
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *BDMH)I$DEAC=XSE&9
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2O$5SI\.H.'N84@1R6QC*LWW?RI1E3<VVK+I_6HY1J**2>O7^M#+B\:ZU/\
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MNW!C@D.([=1GA1^/)[X%:E<TFKZ'1%.VH4445)04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)E\UCRC$E3V(R>W/.!+%XBDC\$^'[^*ZT72#>VL3D7",47,8;9%&K*6Z]-W
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M&T^A4D#@$<8UK?0%@UBSU#[06:VT]K$)MP&!9&W=>/N=/>@"E\._^2<^'?\
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MYD9W<."2B@, #\I^8]..#VA;PAJ%U8Q:3J.OM=:-&5!A^RA9ID4@JDDN[!'
MSA5)]>36W9Z0MIKFIZF)BS7RP@Q[<!/+!'7OG- '(R^+O$2:!J7B'[-IWV#3
M;JXB>VVN9;B.*9D+*^["' Z%6R0>F>-BWU77;+Q!IMAK"V$D6I)+Y?V1'5H)
M$4-M8LQW@C/S +R.G-22>$HY/".I:!]L8)?27$AFV<IYTK2$8SSC=C\*TK[2
M%O=8TO4#,4.GM(P0+G?O0IU[8SF@#2KC+OQ1J*>*;C3%N=)L1%-''!;:@KH]
MZK*I+1R9VCDE0 K'*G.,UV=<QKGAC4-<%U9SZV/[*NF4R6[VBM(@&,K'("-O
M3J58C/!H SM4\;%?$%_IEKJNBZ:M@521]1W.TTA4/A5#KM4!A\V3SGCBB/QG
MJ6IV7AYM*M;07&JRSP2&9F:.)H@VY@1C<N4)'3((Z9S6O<^'[^+5KO4-%U9+
M%KW:;J*:V\]&=5"AU&Y2K;0 >2#@<5/_ & SW6BW,^H37$VF&0F255W3ET*D
MG& .N>!0!5MM?N+'5-1L-=>V7[)9)?)<0HR+)& 1*<%CC:R],]&6JVG:W=W6
MI>&_[0T^UBN=0L;FY8[#O@ ,15 2>,JXW>I6KOB;PI;^)FLFEN)(/L[D2[ #
MY\#8+PM_LMM7/TJ]<Z0MSX@T_5C*5:S@GA$>WAO,*<Y[8\O]: ,72-6\1Z_:
M0:S9+ID.FW#[H;:=)#*\.[&\R X5B.0NP]@369=^/'EU+4HK/5M!L8["=[<0
MZ@S&2X=.&Y##RUSD X;IG%;%CX9U/242RTS7OL^DI)OCMVM%>6)=VXQI(3C;
MU RI('&:>_AS4K6\O9-%UH6-O>RF::&2T$VR1OO/&=PVDXR00PSDXYH Q[OQ
MS<30:1<6\UCI%I?V0N?M6IQN\?F9 \G<K*%(]2>>P-=K922S6-O+.(1,\:L_
MD.73)'.UB!D>AQ65?Z1J\JPK8Z[Y:" 02I>6BW"RX_CX*$.>_)7_ &:NZ)I4
M.AZ)9:7 [O%:PK$K/C+8'4XX_*@"+Q!J+Z9I37,=YI]H=ZKYU^Q$:Y/H""Q]
M%R,^M<W8>,[V;3_$(2.WU2[TN!)XFLXI(UN X; V,68$%#G!.1C'I70>(-#?
M6!82V]V+6[L+D7-O(\7FINVLA#)D9&'/0@@X(-4[3PS?07.K7LFN2F_U&"&(
MS10*HA,9?!13N&/GZ'/0\\\ "^%M:N=8^T-)JFCZA"@7#V >-XV.<H\;,Q';
M!)!]JZ.L#2O#]U:ZY-K.I:A%=WKVXME,%KY"A V[D;F+-GOG [ 9K>(# @]#
MQ0!PD_C6YL]7@1M2T6\@EODLWM;-)&DBWR! 3+N*D@D$KM'?GUT6U;Q%J/B+
M6=,TL:;;Q:<8ML]U&\GFEXPVW:K+CG/S9Z$<'FJT'@:\BTNPTAM<SIFG7$,U
MM$EH%<B*1759&W$/TQD!>>3FNBL=(6RUC5=0$Q<Z@\;E"N-FQ G7OG&: &^&
M]7.O>';'4VA\EYX\O&#D(P)# 'N,@U'XHUZ/PUH,VHNJ.P=(HU=]BEW8*NYO
MX5R<D]@#4V@:0NA:);Z:DQF6'=ARN"<L6Z?C3]:TF#6]+EL9WDC#%726(X>)
MU8,CJ?4, ?PH Y?2/&4DWB"QTR?5-&U,7P<*VFAE:!U4MA@7;<I ;YN.0..:
MJ+XO\3#PJOB8V>FM:+-Y1L@'$L@\WR@PDW87G!VE3QWYP.IT[3=:AO5GU+75
MNXXT*K#!:"%6)Q\S_,Q)X[;1R>*J#PE&/!R^'OMC;%D$GG;.>)O-QC/X4 )9
MZIK5IXFMM(UDV,RWMM+/!+:1O'L:,H&1@S-N&) 0W'0\5G:7K/B_6/#ZZS;P
M:3$N'*6<BR%YPK$?ZP-B/../E;U/H.DNM(6Y\0:=JQF*M90SQ"/;P_F;.<]L
M>7^M<7X/T76+OP3:Q6OB!K6RN?-WH;8/+&#(P(CDW +_ ,"5L9X[  &@FKVV
MK>*?"FL1;DMKG1[RX&[JJDVYP?<4L?B#Q-<^'?\ A)[>WT[^SVA^UQZ>ZOY[
MP8W ^;NVARO.W81SC/>MJ'PS:6U]I$UL?+M],LI;**WVY!1_+ZGV$8^N:RQX
M-OX]*;0H-?>/0BIB$'V8&=(3_P LEFW8"XX!VE@._>@"[:>)EFUKR)Q''87.
MG)J%E.<@N@_U@;/==R'CLWM6)/X\N8].T;SGT[3KK5UEN8Y;TD106ZD;"PR"
MSE73Y01R6Z8H\:6>G:M/HOAFPG5+]9PCQ0.-\%F8V67</X59/E&?XBN.E='J
M^@M>SV5[I]W]@O[$,D$HB#H8VQNC9,C*G:IX((*C!H YV#XA1V^DZY<74MC?
M/I:Q.L]B^V&?S250<EMAW#!Y.!@]\4[3?&TIUK3K.YU70]12_D,6W3=P>W?:
M6!.6;>ORXW87!(XYXW&\/3ZAH]]8:WJ<EZ;S&6BB$*PXQM\L<D$$!LDMR/PI
M^GZ7K<-Y#)J'B 74$((6**S6$RDC&9#ELXZ_*%&: -NLW7]7CT'0KS5)(FE%
MNFX1J<%V)PJ@]LD@9]Z303J;Z>\NJDBXEGE=8B%'E1%SY:<=2%VY/7)-3ZMI
MEMK6E76FWBL;>YC*/M."/<'L0>0?44 <_<ZMXCT)+6^UD:9-8S3Q03QVD;J]
ML9&"*VYF(D 9@#\J\'/M63:Q^(3XM\7>3=:6#Y=OG?;2'C8VWI)UQG/OZ=*V
M_P#A&-2O7M(M:UW[=8VLJ3+"EH(FF=#E#*VXAL$ X4*"0/I6E!HJP:KJU^)R
M3J*1*4V_<V*5Z]\YH Y#PI>7=GX6\ P7D-C<"\6..%Q"0T,8M&<$$D_/\N"1
M@$$\5LVVK>(M<:\N]&&F0V-O<26\*W:2,]RT;%&.Y6 C7<& ^5CQG':K5KX5
MCMK'PQ:B[9AH6W8VS_78@:'GGCAL]^E1?\(SJ5E/=KHNN"QL[N9IWADM!,T3
MN<N8F+ +DY.&##)/':@#+U'QN_\ ;E_I]OJNB:8+!ECD.HEG::0J&(4!EVJ
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M8/% %.#PCX?M;Y+R'2K=)D<R)@':CG^)5^ZI]P :TX[.WBO9KQ(56XG1$DD
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M.<9S6F+.W%\U\(5%TT0A:7'S% 20OTRQ/XU4TSQ!I.LR2Q:=?17$D(!=%.&
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MK>EV^EKJDNH6RV+@%+CS 4?/3:1USVQUJ.V\1:1>:==7\&H0M;6@8W#DX\D
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M\7UK.)+5@Q$F" 0"0>OT-<A=^.[+6/"GBEM*NA'>V%K=F(H^6(2/B4<<<D4
M=+#X9T6V29(=.@1)IDN'11\ID5MZMCH"&YX[U-+HNG3:M%JLEI&;^)=B3]&V
M\\'U')Z],FJ6D^)]'U"2"QAU.":],6=@;ER!\V#T8COC.*DN/%6A6FH&PGU2
MW2Y#B-E+<(QZ*QZ*3D<$@\B@!K>$/#[7YO3I5N9C)YQX.PR==^S[N[/.<9S6
MF+.W%\U\(5^U-$(3+CDH"2%^F23^-5-1\0Z3I,WDW]_#!,5#B-CEV!) PHY/
MW3T]#5FPO[35+**\L;B.XMI1E)8VRI[']>* +-9NJ>']*UEXI+^R2:6($)+D
MJZ@]0&4@X/IG%,U/Q)HVC7"P:CJ,%O*R[]KM]U<XW-_=7.>3@<5)J.OZ5I*0
MO?7T,7G_ .J&=S2#J2H&21[B@!RZ)IB:0-*2Q@2PQC[.J83KGH/?GZU?K..O
M:2NF1:F=2M18RD*EQY@V$DXQNZ=0?RHT[7M+U9PEC>QS.8_-"C()3<5W 'MD
M$9H DU/2-/UFW2WU&UCN(T<2('ZJPX!!'(/)Z>IJ6WL+6UGFG@@2.68*)& Y
M;:,+GZ#BJ%QJD4M]:16FJVL>V]-M/$R;S*XC9C$IR-K 8;OP#1?^*="TN\-I
M>ZI;0SJ 71F_U8/0N>B@^IQ0!-+H.E3:5_9<MA ]CN+"$K\H;<6R/0Y).1WI
M=+T33=%25=/M$@,I#2.,L[D=-S')./<U'J7B/1](>..^U"&%Y%WHF=S%?[V!
MD[??I3KO7])L;""^N-0@6VN,>1(K;A+D9&S&=W'/':@#2K%U'PEH6J7C7EUI
MZ&Y<!7FB=HG<#H&*$%A]<UHV-_::G9QW=C<QW%O)G;)&V0<'!_$'BJ-]XHT/
M3;B2WN]2@CGC(#Q9+.. WW1SC# Y]Q0!*?#VCG1QI']FVO\ 9Z]+<1@(#G.0
M.QSSGKGFETS0=+T<3?8+..%IL>:^2SOCIN8DDX[9-2#5]-;2?[5%_;'3]GF?
M:O-'E[?7=TJ'3?$&DZOYHL+Z*9H0&D09#*#T)4X.#@\]* )ETC3UL+6Q6TB%
MK:&-H(L?+&8R"F/H0,?2IC9VYOA>^2OVH1&$2XY"$@E?ID UR?B7Q[I%KX4U
M6[TO5K:2[BLV>W9/G7S"A*<XQGH<5>TW6-$T;P]:W$NN/<07#$1SW4[2R3/T
M8*#R>0> ,"@"AX8\":7;>'-)CU;2+<ZA!;QB=2=RF10.6 .UB,#D@]!70:EX
M<TC5[F.XO[&.:9$\L/DJ2F<[201E?8Y%/AU_2;C29=5BU"W>PA#&6</\L>W[
MV[T([@]*@_X2K0?)DF.JVPACE\EI6?"!\$XW'@\*>GH: +,6BZ9#!;P164*1
M6T[7$**N!'(2Q+ =C\[?F:==01P23:E!8_:+X0>6H4A7=0<A,D@#D]ZSO^$T
M\.?9S-_:T&T/Y97G?NQG[F-W3GITK0;6--32!JS7]N-/*"07)D'EE3T.[I0!
MF>%M'GL%U+4;V"*#4=5NFN9HT(81@ +&A(ZD*!D^I:M#0=)70]%MM/$OG-&"
MTDQ7;YDC$L[XYQEB3CWI=+US3-9$O]GWD<[1$"1!D,F>F5/(SVXYKFO%OC32
MD\+ZVFF:U"-0BM9O):)_^6BJ3A6Z%A@\ YX- '67^GVFJ64EG?6\=Q;2##QR
M#(.#D?B" <U3LO#6C:>[/;:?"KO&T3NP+LZ-C(8MDL#M'7TK47E ?:LB#Q5H
M5SJ(L(=4MWN6<QJH;AF'50W0D8/ .>#0 [3/#&BZ/<FXT_3XH)=AC5AD[%Z[
M5R?E' X&!P*UJYS3?&FDZGXDO=$AG3[1;LJH=V?-)4LV!CC;@UT= !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &;X
MBL[K4?#.JV5E)Y=U<6DL4+YQM=D(!SVY-<)XAU.TU'X=/H=IH.HM?)!'&+#[
M#(/LS(5YW;=N%QP03GMFO3:CEN(8#&)IHXS(XC3>P&]CT49ZG@\>U '":U#=
MZ9XYN]3FU#4+*SN[.&*&YM+);D*4+EHV^1RF=P8= >>X%02Z>UIX0@O(8]4N
M(SKL.HS"XM0LP03*7<1(,@<%\8W<DD5Z-10!YYJC7$/C!M=^WZG9:=>Z?#'!
M<P:?YQ0JSED=6C9H\[E(X&<$'D"HGT7S?#MF4BU&[CN_$4%Y*+VU6-MOF+N;
MRU VH=N[D \DD<UZ110!S6L637'CSPS<FW:2.VAO"9-A*QL5C R>Q(W8_&J^
MDZ9LU;QJ\EF56[ND"EH\"9/LL0X_O#<7'US76T4 <#H=G>K'\/#-;3JUOICK
M<;XR#$WD1C#^AR".:B3295^%/BNV%A(+JY?59!%Y1WR,9)?+(&,DD!,>O&*]
M#HH \]U>"^L/%L&K3WVH6=I-ID5LMQ;6:W'E2*S,RN"C%=VY3G !*X/05 ^D
M2_\ "/#4+>+5+^$ZY'J5U!<VRQ23HH"EDB4#C(60*0"2IXR:])HH X6_U*VU
M[QAX5GT_3KR9+6ZF:6]>SDB6%6MY!L)=0>3M]@0 >2*V?'D$MSX"UV""!YY9
M+*14BC4EG.WH .2:Z&B@#@=<OH-=T.UT'2],O8=1$]N4B>S>-;'RW5BY<C:
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M82RPJS2+'((F4Y"@XX!(#9'2O5** ./\+0)=:_?:LM]JMXQMX[<SW=FMO'(
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MT8#!XY'(%>H44 >?6EA)KEYJ=W9ZMJUS=G2I;.*ZN;);:(-)RH!V(S,I&>A
MR><FJ&M:A;7/PLN/#T&@Z@VHQZ>(/[/%C)^Y=5'S;MNT@$;@03NXQDFO4**
M&C(BX&6"\#IS7E,EWJVL6>C-=3ZO)J*:I9RWFG1Z<(K>T G0OEC'N('/(<Y'
M/W<UZQ10!RNG2FR^(&MPW$%ROV]+=[:00.T;A(V#9<#:I!'0D=1ZUU5%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% &?KES=V>B7=Q8P":YCC+(AD"?CD@].O3G%<'>:SJMUX1\':EJ%@TEV^H6;
MJL4JLUR6A;YN@"9)Z=!7H]U +FTFMRVT2QLF?3(Q7)V?AS63H?A[3[TV"/H]
MU V^&5V$L4<93."HVL<].1[T :%EXED_M"]L=9L5TZ>UMA>;EG\Z-X<D%@V
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM*JHH55"J!@ #  ID4\,S2+%+'(8GV2!&!V-@'!]#@@X]Q4E !1110 4444
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M <'T."#CW% $E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH U;KQ!':V&DW9@=AJ,\,*J&^X9!D$^N*RKCQE=";6!9Z%-<PZ/*4NI3.J9
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MME4$[@R22L2>,8Q(._8UL4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD]M,NZ.1#PPJS7G6EZK<:=X3T[2=.Q;ZE-J\FFSS38D6&8M)++(N  P.&*C
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M.7=^NL:UH]]>O??87A:&YD15D9)$SM;8 I((/( X(K,\4V%Y<^.?#1@UBZM
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ML/D375S(&D,>#A5P JCDG  Y.36Q'-%+$)8Y$>,_Q*P(_.A9HFE,2RH9 ,E
MPR!ZXH SFT"R:QTJT/F>5ICQR6_S<YC4JN?7@U7UO1XG@U?48DE>]GTQ[0*O
M(90'90!ZY<U=L]8L[Z_OK*"3,UE(L<H/3+(KC'KPPJM=:M,OB>QT:UC1M\+W
M5V[Y_=Q#Y5 _VF<_DK4 8>C>";:3P[I=M>W6IFT6WA:33)9OW.\*"58$;L!O
MX"VWMC'%;%[X8M[O5)M0BOK^REN(UCN5M9@BSJN=N[()! )&5*GWK.UW6/$V
MCVFHZP;/3/[,L=\AMV=S/+"G+,''RJQ )"X/89J>_P!;U6?5Y=/T6&Q!MK..
M[F>^9EWB0N%50O3_ %;98YQD<&@"Y9^%M-L(-(@@658])=WM5W]"RLI!]1AS
M^E37%O9Z5>WVO.ER\LL$4,JPQM*2J,Y7:B@L3F1LXS^E9VE>*'UZZTI=/MPL
M4UFE]>F3DPI(O[N,8_C)R?\ =4^HJZ^K36_BR+2KB-!;W=JTMK*N<F1#^\1O
MP92/HWI0!E>"]'ETW2]2U 69M[O4[J:Z2VF)!B0L3&A_N]=Q'8NU;NA65SIV
MA65I>7+W-W'$HGF=BQ>3JQR><9)QZ#%7V8*I9B H&22>!3$GBDB\V.5&C_OJ
MP(_.@#"NO"%G=7E[,+R_@AOSNO+6&8+%.VT*2>-PRH .TC..:<_A2%;>RAL]
M4U2Q%I:I:*;>X WQJ,#<&!7/^T #[U'X.U&_UK2CJ]Y=QO'=,S0VT<846ZAF
M &[.6) &2>_2K4WB"VFL];^Q2 W&F!T<,.-XB$@QZC#+^M %_3=/MM)TVWT^
MSC\NVMXQ'&I)) 'J3R3[UD2^$+1KNYEM[_4;.&[<R7-K;3[(Y6/WFZ94GN4*
MYZ]:OZ%J/]HZ+IT\TL9NI[2*>1%(!!902<=ADU>DGBB*"25$+G"AF W'T'K0
M!B#P?I<>A6.DP_:(8[!M]I-%)MEA;GE6'LQ&",$'!!JQ9>'X+6&\2XN[V_>\
M3RYI+N7<63!&T!0%4?,>@'6M>HVGA258FE19'^ZA8 GZ"@#"3P?9#1H-->[O
MY5M9!):7#S_OK8JNU=C #@#(YSD$YSFI[?PU!':7\-S?7]Z]]$89IKF;+;,$
M84 !5^\>B]^<ULY&0,C)Z"J>K:K::+I5WJ5XY%O:Q-+)MY; &3@>N* (KC0[
M.YTVRL)/,\FSD@EBPW.8F#)D]^5&:E.EVYUI=6^?[2MN;8<_+L+!NGKD"K#7
M,"P^<TT:Q_WV8 ?G56\UBSL;ZPLYY,2WSLD/IE49SGT&%- %5_#&GO:3VQ\[
MRY[]=0?Y^?-619!CCIN0<5<M=+M[/4;^^BW^=?,CS9.1E4"#'IP!5EYX8W1'
MEC5G.$#, 6^GK3GD2,$NZJ "22<8'K0!AGPCIO\ 8UGIL;7,0LG,EK<1R[9H
M6.<D-[[B""""#@@U/:>';6"VO8;NXN]2^VIY=PU[)OWI@C;M "J,$] .M:J2
M)*@>-U=&&0RG(-8GB#6GL(;%K*6%VEU*WM91PV%=PK#V.* *<G@2QN+>*UNM
M2U:YM('22"":YRL11@R\XRV,8^<M_6NIJI!-=-=WBW$,,=O&RB"19=S."H)+
M# VX.1U.1S5A9HGD>-)$9T^\H8$K]1VH Y6W^'VFVNF)I4&H:JFE!=LED+G]
MW*.X)QN /<*0#D\<FH?&&G0^('TWPU%I]P8UN8YIIUA9(88%!W /C:2RYCV@
MDX<Y&*[!IHDE6)I461_NJ6 +?04X$,,@@CU% "@ # X%9'_".VHUFZU..XNH
MWNT"W$*2#RI2%V!B".H7 X(Z"M031-*T2R(9%&60,,@>XK%\.:R^HVUV;R6)
M94U*[M8E&%+)'*R+QW. ,T 3'PY8'0+#1CYOV2Q-N8OF^;]RRLF3WY09J*^\
M,6]UJ,M_;7]_IUQ.JK<-9RA1, ,#<&!&0.-PP<=^!6Q+/% F^:5(USC<[ #/
MXT\LHQDCGISUH ALK.*PLH;2#?Y4*!%\QR[8'JQ))/N:Q+GP?;SZK>ZA%JFJ
MVDEZRO.EK<A$8J@0'ID<*.];OVF#R//\Z/R1_P M-XV^G6GB1#'Y@=2F,[@>
M,>N: ,<^$](.A+HZV[I;))YR,LK>:LN[=Y@DSNW[N=V<T:?X:M[+45U&XO;W
M4;Q(S'%+>2!O*4XR%"A5&<#)QDXZUKQRQS1B2)U=#T93D'\:26>*! TTJ1J3
MC+L ,_C0!S2^ M-%M'9F]U%K""99K>S,X\J!E<.NWC) (X#$@=NU;EKI=O9Z
MC?WT6_SKYD:;)R,HH48].!5'Q9J\VB>&KJ^MC%]H&Q(?-Y4,[J@)&>0-V<>U
M:.GQ7$-C&EU>?;)AG=/Y83=SQP.!QQ^% &,_@RQ,EPL-[J-O97+M)/8PS[87
M9CEN,;E!))(5@#D\<U):Z#+I]SH5I93R1Z3I=L\?EF4[I6VJD88#A@%WGGOM
MXK;2>&5W2.5'=.&56!*_7TIY('4@=N: *^H6%KJFGSV-["LUM.A22-NX/\OK
M61:^$[:&]MKFZU#4M1-HVZVCO)PZ0MC&X  ;F ) +;B,UNQS13%A'*CE#A@K
M [3Z&G;EP3N&!U.>E &.?#5I_:E_?)<7<?V]-MS L@\J1M@3?C'#;0!P<<#B
MI'\/V4FD:?IC>;]GL'@>'YN<PE2F3W^Z,U!<ZM-#XRL=-W1BSFT^XN9"1SN1
MXE!SZ8=JNZI?&WT&^OK5T=HK:26-@=RDJI(^O(H HWOA:WN=0GOK:_U#3IKD
M 7/V.8*)L# + @X;'&X8. .>!5J/0;**YTR=/-W:;$\,&Z0M\KA0=Q.2Q^4<
MDU'I=_?WEMI,SPP-#<V0FGE\S:RR%5("ICD'+<YXP*TS/$)A"94$I&0FX;B/
M7% $E<]!X.T^"S:R6XO&L_M4=W% \H*PNDOF@)QD*6Z@D\<<5-H&JSZC<:S'
M<E,6FI/;0X&/D$:-SZG+&MK(W;<C.,XH I7&DVMUJMMJ,H8S6\$L"#/RE)"A
M;([_ '%_6L6'P)I\4=E U]J4UI831S6=M)."EN8V!4# !(&,?,6P.F*N2:Q+
M#XS.FR/$ED--^TEFX(?S-O7TQ6VK*ZAE(*D9!!X(H IVFEV]E?ZA>1;_ #;^
M1)9MQR,JBH,>G"BC2=+M]%TJWTVTW^1;IL3><G'N:LQ3Q3J6AE20 X)1@<'T
MXK(\*:K/J_A2RU*]:,32HS2%1M488C\.!0!6N_!=A=R7X-YJ$5IJ#,]U9Q3!
M8I6( )/&X9P,@$ ]P<FMZUMDL[."UBSY<,:QKN.3@# S^59,FL2GQAING021
M/9W-A<W#,O)+(\*K@^F':MLD*I9B !R2>U &/-X8T^?3-3T]_.\C49VN)\/S
MN.W.#C@?**N)I=O'K4VK#?\ :9K=+9N?EV(S,./7+M5J*6.>,212)(AZ,AR#
M^-)%/#/N\J5)-IPVQ@<'T- &+/X1T^:S,"2W4+B^?4(YXI )(IG+$LI((Q\S
M#!!&#26_A&PA.IO)<7EQ/J=L+:ZFFE!9U&\ C  4X<C@ =.*VVGA5U1I4#.2
M%4L,DCKBE2:*21XTE1G3[RA@2OU':@"A/H=G<6>G6K^9Y=A+%+#AN=T8PN?6
MJ5WX4MI[^YO+74-1TZ2ZP;E;*8(LQ QN((.&P -RX/ YXK;>XABV^9-&FYMH
MW,!D^GUISND:%Y&5449+,< 4 9,OAG39WO#.DLJWE@FGS))(6W0KOP,GG/[Q
MLG.:JVWA"UAOK"]N-1U*]GT]BUJUS,"(P49",!0#D-U.3P.:WUEC>(2)(K1D
M9# Y!_&A9HGD>-)$9T^\H8$K]?2@"KIVEV^EK<K;[\7%Q)<ON.?G<Y./:F2:
M-:RZI/J+;_/GM!:/AN/+#,W ]<L:O[UV;]PVXSG/% 92Q4$$CJ,]* ,IO#MB
MVA:?HY\W[+8&W,/S?-^X963)[\H,^M+_ &#;CQ ^L1SW,4TL:QSPHX\J8*&"
MEE(ZC<>A':M&6>*!0TTJ1J3@%V &?QIY8#&2!GI[T <[;>#;.T>*.#4-32PA
MD$D6GK<XA0@Y &!NV@_P[MO;&.*UK;2[>UU.^U"/?Y][Y?FY/'R# P.W!JU%
M-%.F^*1)%SC*,",UB^*]9?2/"^KWME+";VSM7F5&PV"!QD>E $4W@VS>:X\B
M_P!2M+6ZD,EQ9VUQLBD9CECTW+N/)VLN<GUJ;4_#$.ISRR?VGJEJDT0AGAM[
MC"2* 1C# [3@D97:?>ML<@&EH QI/#-D=0T^]MI;FTDLH1;H+>3"O"""(V!!
MRORCT/7FKFK:7;ZSIDUA=;_(EV[MAP>&##GZ@5=HH S]7T:UUJWCBN3*CPR"
M6">%RDD+@$;E8=#@D>A!(.16)J_A]K3PEXB$5UJ.I7UWITT8:XDWNV(V"JJ*
M HY)Z+DD]ZZNB@#D[#P7:-I]A%=7>I26<*1N--FFS"K* 0",;B 1PI8@8''%
M;]OI=O;:I>ZC'O\ /O%C67)XP@(7 [?>-7:* .=G\'6<L]RT%_J5G;W;F2XM
M;6XV12,WWCTW+N[["N>3U-6-2\-QZA<>='JFIV1:(0R+:W&%=!G (8, >3\R
MX/O6U10!@W'A/3VCL192W.G2V, MK>>SD"NL0 ^0[@0R\#[P/(S4G_",63:4
MMA+-=SJ+J.[:6:8O(\B.K@DGME1P !CIBMJB@"E-I=O/K%IJC[_M%K%+#'@_
M+MD*%LC_ ( OZUEKX.T];"\L/M%X;*YF$_V<R@I$WF>:=G&0"W)!)]L5T-%
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MX'*!P'2T4;T/J"&PP_"O4[BV@NX3#<PQS1'JDB!@?P-.2&*,$)&B@@ A5 R
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MWEC,TVEOFWF9EX(&!M8 #(YZ@Y.:J2IH\WCW6%\3BS8K##_9JW^TQ^3M_>%
MW&[?NW8YQM[5VMO;06D(AMH8X8AT2- H'X"DN;.UO$"75M#.@.0LJ!@#Z\T
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M64'HR9Y*^]&KZU9Z+#$]TTC/-)Y4,,,9DDE?!.U5')X!/H ,FKT:[(D4
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MUN89(Q#,KNS@R%F!0C=AN#TR,YQ3M&\,7FCZAX3B8">+3-+N;:>=2-JR,8<
M \X.U\>PH Z/1]:M-;MYI+83(\$IAGAGC*21. #M93[$'T((K(^(-TMEX2:Y
M>4Q)'>V;.X)&%^TQYZ>V:M:+I]S:^(_$EU-%L@O+F%X&R#O"P1H3[<J1SZ4>
M,-.N=4T 6MK#YTGVRTD*9 ^1+B-F//HJD_A0!+IWB:SU'4CI_D7EK=&(S1QW
M=NT1EC! ++GK@D9'49&14?\ PEEB+Z.VEMM0@CEG^SQW,]HZ1/)G 7)&1D\
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M_,6]?W?ISNK=55484 #T I: .?O-!OX]8N-3T74XK*6[5%NHKBU,\<A485P
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M\\9S0!E)JO\ 8T/BC3;B\U&ZL;*6WAM9(Y=]RKS@#R1(QY(9EP6.0'&3Q3M
M>^T[QU#ICPW5K;7.FRW#6USJ;WC;TDC4/EB2AP[ X)!Q[5U,?AS1XM&DTA-.
M@%A+DR0E<AR3DL3U+9P<GG(I-/\ #>D:7=+=6EF%N51H_/=V>0JVW(+,22/E
M7@GC'% 'G]K%>0?#6S\4/J^IRZM&T<HD>\D,;)YP7RVCSM8%>"2,YYS6_J^N
M77A;5]96622X2]M1=:9'(Q;_ $@;8FA7/0%FB('^TU=/_8NF_P!D#2?LD?V
M  0<[< Y'Z\UCZEIEWKOBO3#=:<(M-TF9KI)Y'1C/+LVH% )( W,3NQRJ\&@
M#8T:TET[2+*QN;N2ZNHH5$LTKEGE8 ;FR>>I_#(J_51]-LI-4BU-[=#>Q1-#
M',?O*C$$C\P*MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%!.!
MD]*165U#(P93T(.0: %HHHH **** "BBB@ HHHH **** "BBB@ HHHZT %%%
M% !1110 4444 %%'6B@ HHHZT %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %9/B==2?PSJ*Z07%^8&\GRR ^>^TG@-C.,
M]\5K56U!;UK"8:<\"7FW]TUPI:/=_M $''T_7I0!S'A@>&6U%GTFXO(;^.$^
M?974\RRD''S212G)(/&['<\\UL1^)+.30=+U<1S?9]1-N(5*C<OG%0NX9QQN
M&<$_C6?#INM:IXAT[4M6M+"RCTY9=BVUPT[S,Z[3DE$VH!DXY)..F*SH?#GB
M)=(T71&.FI9:3<6S?:!,[/<10NN!LV (VU0?O-R,=#D &C<^-[:W;4G&EZC+
M::7*T=]=(J!(=H#%N6#, I#':"0/RJYI_B07FHP6<^F7MBUS$TUJ]P$Q,JXS
MPK$J<,#A@#CZ$"I<^&[N;PYXITY98!+JYN3 Q)VKYD01=W'J.<9K1N]+FN-<
MTB^5XQ'9+,) 2<G>H QQ[4 8T7Q M9;"UU$:/JHT^Z<0PW'EI\\IR%0+OW<L
M-H;&W/?'-6KCQ'#/I6N17]GJ.G36-D;B>,.@E\IE?#QNC$9^1P.005^AJ.#P
MU=Q>%=$THRP>=87%O+(P)VL(Y QQQG.!QP*DUKP[=:E/K[Q2PJ-1T8:?%O)^
M60&;EN/N_O5Z9/!XH 8?$-_%XPM-'BTF[ELI+/S?/W1<_,@WY,@.T!B",9)Z
M U8\47=T#I>E65PUM-JEW]G:X3&Z*-8WD<KGC<0FT'MNSVI;C3-1A\1:;J-I
M';31QVC6EPLLS1E59T;>N%;=C:>#CJ.:M:_H[ZO:0&WN!;7UI.MS:3E=P20
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M4$#)Q] .*V* "LN[\0Z78W3VUQ<.DJ8W 0NW49Z@$5J44 8O_"6Z+_S]2?\
M@/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB
M_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\
M$UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO
M_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q
M-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?
M^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &
M+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\
M@/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB
M_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\
M$UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO
M_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q
M-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?
M^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &
M+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\
M@/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB
M_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\
M$UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO
M_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q
M-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?
M^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &
M+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\
M@/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB
M_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\
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M^@]I?_@9'_C1R2[!SQ[FM163_P )5X=_Z#VE_P#@9'_C1_PE7AW_ *#VE_\
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M^@]I?_@9'_C1R2[!SQ[FM163_P )5X=_Z#VE_P#@9'_C1_PE7AW_ *#VE_\
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5%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ethicsemployeepolicybook006.jpg
<TEXT>
begin 644 ethicsemployeepolicybook006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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MT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+E6BNQF\-^'/^$AET"+5=0BOEN#:I)-:H86D#;0"5?(!/?%<G<V\EI=36TH
MDB<QN >A!P:49J6PY0<=R*BBBJ("BK-Y#:0^1]DNFN-\*O+F(IY<AZIUYQZ]
MZK4)W&PHHHH$%%%% !16CHNCS:W?&".2.&*.-IIYY#\D,:]6/^>216FMMX/>
M86W]H:LA)VB\:!/+SZF,'=M_'/M4N:3L6H-JYS=%/F18IY(TE65%8A9%! <
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M@)9W37,6Q27:(QX8@%EP3V.1GO5:FG<'H%%%% @HHHH **** "BBB@ HHHH
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M43T6W_!.I\1:W=Z)XBN]&L;:WBTZSE\A;5[=&651QN<D98MUSG//&*H>/O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMW^DK+9FYL(!/-B4[0I&< [>N"*]"@\.1#XV/J8V_83:_P!I*_\ #DC9G/\
MO9:LSX?:FVL^*O%VI,3_ *1;2.N>R[OE'X# J98B37-'LOO94:$4[2[O[D<Q
MH_POU[6]*MM1M9K 0W"[D$DQ#=<<C;[5-??"7Q%I]C<7<TVG^7;Q-*X6<YPH
MR<#;UXK \&?\CMH?_7]#_P"ABM/XH?\ )1]7_P!Z+_T4E:-U/:<M_/;_ ()"
M5/V?-;RW,K6/#%_H>EZ7J%VT)AU*+S8!&Q) PI^88XX84:'X8O\ 7[+4KNS:
M$1Z=%YTWF,02N&/'!R?E->H>(- T[7/ _@\7^OVNDB&Q789U!\S,<><?,.F!
M^=.\+>']-T/PQXL-AXAM=6,U@V\0*!Y>$DQGYCUR?RK/ZS[E^M^WF:?5_?MT
M_P" >)UT7AKP3K?BK>^GP*MNAP]Q,VV,'TSU)^@-<[7K'Q&N9="\#^&]#T]C
M%:7$!>8H<>80%//U+$G\*WJSDFHQW9A3@FG*6R,'4/A5KMI8RW=K<6&HI$"9
M%M)BS+CKP0,_SK&\->"M:\5%VT^!5MT.'N)FVQ@^F>I/T!K$ANKBV25()Y8E
MF39($<@.OH<=17J/Q N9="^'WAG1M/8Q6MU!YDY0X\PA5)!]B7)/X5$I5(M1
MO=LN,:<KRM9(Q;OX2Z]%:O/97.GZCY?WH[68EQ^! 'ZYKEM$T"^UW7(]'M@D
M=VY<8G)4*5!)!XR#P:E\*ZO>:+XDL;JSD=6\Y5=%/$BD@%2.X->LW-C!9_'_
M $]X%"FYM&FD _O>7(I/X[0:F=2=.Z;OHVOD5&G"I9K35)_,\H\3>%M2\)W\
M5IJ0B+RQ^8C1,64C)'4@<\5?\,_#[6_%>GR7NG_9D@20Q9F<KD@ G& ?45V?
MC4'Q5X(GOU&^^T/4IK>7'),9? _39^1KJO###P_?Z!X1C($L>GR7=X!_ST8C
M _,O^0J)8B:IZ?%_D7'#P=37X?\ ,\;\.^"M4\3W-[!8/;*UF1YIFD*CDD<<
M'^Z:TM2^%GB;3K&2\$5M=Q1@L_V6;>P Z\$#/X5TGPQ@^U/XTM_,2/S82F]S
MA5SY@R?85/X5LM+^',M[JNH>)["[WP&-+.SEWF0Y!!QZ\8Z=SS3G7FI-+I;2
MVXH48.*;ZWUOL>=>&?"FI>++V6UTT1!HH_,=Y6*J!G &0#R?Z&LFYMI;.[FM
M9T*30N8W4]F!P17J=C=3^ _AW::A;Q$:IK-VEQM ^["IW ?0C'_?PUD?%?28
MH]8M/$%FO^AZO"LN<='P,_F"I^N:TA6;J6>SV^1G*BE3NM^OS,BY^'VN6WA:
M/Q"5@DLGB2;$;DNJ-CDC';//-9OAOPW?>*=3;3]/:$3",RDRL5& 0.P/J*]@
M'B:/P]X<\$QWH5M,OK/[/=JPR I1,,?IGGV)JAX0\+OX5^+5S:IEK*:RDEM9
M.NY"R\9]1T_(]ZR6(ERROOK;Y&KP\>:-MM+GF\?@W4Y_#=SKMN]M-;6KE)XX
MW)DC(.#E<=.AZ]*J^'/#6H^*=2-CIR(9%0R.\APJ*.Y./7 K<\&^*AX9\4W"
MW7SZ7>.T-W&1D;22 V/;)_ FNI\5_8?AMH%UH^C2,U_K#M(\Q^]%;Y("@_3(
M!_WCZ5I*I-2Y.KV_KR,XTX-<_1;_ ->9Y<U@XU7^SXYH99/.\D21L2C'.,@X
MZ9[UVS?!WQ*IV^=II?L@N#D_^.UQFC?\AW3_ /KYC_\ 0A7KOCSP9'K'C ZC
M+XDTS34$<8*S3;95QW R/PYHK5)1DHWM\KA2IJ47*U_F>2:MHFHZ'J;:=J%J
M\-T,83KN!Z%2.H/M75V7PGU^>S2YO9[#35D^ZEW,58_@ <?3K7;0:EI'BKXM
MZ6MK*+N'3+-L3L.)9!T(]<9SGUKR[QMJ]YK'BW49;N1SY5P\42$\1HK$  =N
MG/O2C4J3:BM':['*G3@G)ZZV1)XE\#:WX619KZ%)+5SA;F!M\9/H>A'XBJJ^
M&+]_"C^(PT/V%)?)(W'?NR!TQTY]:[WX8W,NM>%O$6@7[&6Q2WWQ;^?*)#=/
M3D CT(-4X/\ D@5S_P!A ?\ H2T>VFGRO=-+[P]E%KF6UF_N//+"REU+4;6Q
M@*B:YF2%-QP-S$ 9]LFK>M:#>Z%KDNCW(22[C* B$E@Q8 @#C)ZBI?"7_(Y:
M'_V$(/\ T8M>L6EC!>_M ZD\ZAC;6R31@_WO+C4'\-Q-74JN$O*UR*=)3CYW
ML<7:?"77Y;1+B]N-/TWS/NQW<Q#'\ "!],YK,U#X?:[IFN6.E7,<(>^?9;S+
M)F)S]<9'XBJ/BW5[S6O$U_=7DCLPF=$0GB-02 H';%7?!-U<7/CG0%GGEE6&
M=4C#N2$7)X&>@H_>J/,VMNP?NW+E2([7P1JMWXKN/#D;6WVZ $N2YV< '@X]
MQVK>_P"%.>)?^?C3/_ AO_B:Z;0_^2^ZM_US?_T!*YZ_\!Z%+J-S(WCK28V>
M5F*-C*DD\'YZR]M)M*]M$]KFJHQLW:^KZV.7TCP;K&N:W=:78Q1O):NR3RLV
M(TP2,D_4''&:T]9^'&J:1I$VIK?Z9>VT'^N-M<9*=NX&?IU]JO\ P_U[1].M
MM<\/ZO=-;6^HKY:7D8X'#+R><9!R.W7-5O$'P[O=(T:75=+U.WU72.#));MR
M .A*@D'&>Q.*MU)*IRMV^6Y"IQ<.9*_SV.'HHHKI.8**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /2_@M
MJRVGB>YTZ1L+>P?(#W=.1^A;\J]YKY#L+Z?3=0M[ZV?9/!()$/N#FOJ3PSXA
MM?$^AP:E:D#>,21YYC<=5/\ GI7E8ZDU+G74]3!5$X\CZ''?$+X9IK[2:KI
M2+4L9DBZ+<?CV;W[]_6O"[RSN=/NI+6\@D@GC.'CD7!!KZ]K&U_PMH_B6W\K
M4[-)& PDR\2)]&Z_ATJ</C'37++5%5\(IOFCHSYBTV2 "[@N)O)6XA\L2%2P
M4AU;D#G^''XU83485U#392SF.WB6-^/=LX_.N]\0_!?4+0--H=TM['U\B;"2
M#Z'H?TKS2]L;K3KI[6]MY()T.&CD7!%>E"=.KK%GGSA.GI)&Y+K-O+;FXCE@
MAG^S"W,7V7<_^KV'#=-I'?J,]#UJ!=1L[C5KN>=P#)"J6\TT7F+$PVC)7G(V
M@CH<9Z5A457(B.=G7RWUA?:5/ ;THJ6\,+2K"$4L)9&^XO\ #@CH,]\=JJ0:
MI90P_P!G"5'B$(07,T&Y2V\O]WKMY^N1G':N;HH]FA^T9T-QJ%K?6\MA+>)'
M&K1M%.+<JGRAP5VC)_C.#[<XJ.^O;"\2\BCG>-"+=XFDC.7,<10J<9P23]..
MM85%/D0N=F]=WECJBF&2Y-J(Y/,1VC+!\HBD$#D$;..QR>E-BNK$:=+#-<_:
M(T6188I;?$BDYVE7!.!G!()QUX/6L.BCD5K!SO<GF^S;(_(\W?CY]Y&,^U04
M451 4444 %%%% !5G3[Z?3-1MKZV;;/;R+(A/3(.>?:JU%#5]!IV/5=6?P;\
M0VBU.761H6K% MPDZ;D; QG)(!],YZ8R*PM8M_"OABVLY-"UB?4==@N%F%Q&
M,0@ @X(Z=NQ/4Y-</16,:/+IS.W8UE6OK97[GJNJ3>#OB*(=1N-7&A:P$"3K
M,FY'Q[D@'V.0<=11::MX6^'.G7;:+J/]LZ[<1^6LZIB.,?RQGG ))P.E>544
MOJZMRW?+V*]N[\UE?N=UX6URPM/ _BNTO;Q4O+U!Y*-DF0X.?YUM^%/B!9Z5
M\.KJUN)E&K60D2Q!4EB'Z$'V).?8"O*J*<J$97OU=R8UY1M;HK'=Z+K>G6_P
MGU_2Y[M%O[FY5XH3G<X_=\_H?RHU+6]-F^#ND:/'=HVH0WC220 '*KF7GT_B
M'YUPE%/V*O?SN+VKM;RL%>O:V_@[Q7H^A1W?BA+*6QM%C9%A+<E5SGZ;:\AH
MIU*?.T[VL*%3E35KW/4?"%QX8\(>.S)#X@2ZL'T]@;EHRH$A<?)CZ+FJ_ACQ
M)IGA+P?JVH6EW#)K]Y-MAA*DE$#8!/&.[-^5>;45#H)[N][?@6J[6R[_ (GH
M^E_&'Q"NJVIU&6W>R\U1.%A .S/.#ZXK7TG6O#.C_%C4-5@U6 :;>6C/Y@#8
M65F4LO3N03^->0T4/#0=[:7T!8B:M?6QT?A3Q/+X7\5)J,9+6[.4G0?QQD\_
MB.H]Q76_%'Q#H>HV.B1:!>Q2"T=R%B!7RAA=O4>WZ5Y?15.C%S4^J)562@X=
M&>JWFJ^%?B/I]I)K&I#1=<MX_+:5TS'(/T&,Y.,@C)ZUA:WHG@K1-!FCAUR7
M5M8<@PM;*%C3_>ZC'XYZ8QS7#T4HT>712=NPY5N;5I7[GKVMOX.\5Z/H27?B
MA+*6QM%C9%A+<E5SGZ;:X;Q-HOA[2[:!]&\0?VG([D2)Y138,=:YJBB%%PVD
M[?()U5/>*N;/A/5QH7BO3=19ML<,P\P_[!^5OT)KJOBIXFT[6KVPL]'G26QM
MT>5FC!"F5VRW7Z9_X$:\\HJG2BYJ?5$JHU!PZ,]<@\>Z:OPI:W:Y0:ZMH;$)
M@[RF=H.?93GZBN>^&>MZ;HMQK+:C=I;B>S,<98'YFSTXKA**CZO'EE'N7[>7
M,I=C6\+W4%CXKTFZN9!'!#=Q/(YZ*H8$FK_Q U&TU7QQJ5[8SK/;2F/9(N<-
MB-0>ON#7-45KR+GY_D9\[Y.4[OQQK>FZGX1\(VEG=I-/9VFRX10<QMLC&#^(
M/Y4> -;TW2M!\507UVD$MW9^7 K _O&VR# Q]1^=<)14>Q7)R?UO<KVKY^?^
MMK!7IFF>(O#WBSPG:^'?%%R]C=V0"VE\%R, 8 /IQ@'/!P#G->9T552FI_(F
M%1P/0YO#7@31;"YFOO$[:K,T9$$5B@4ANQ/+#\R!]:L:1XD\/^)_"5OX:\4S
MO93V>!9WP&0 !@ ^G''/! '(->:45#HW7O2=^Y:K6>B5CU'2]'\#>$KU-7O?
M$T>KR6Y\R"VMHARXZ$X)_4@50T+QG%J'Q7B\0ZM*MI;8D4;LD1IY;*HX_P Y
M->>T4>P3OS.[:L'MFK<JLEJ>F>"O%NFZ7XVUU+^XC&DZC)*V]U)7(<E3C'0@
MG\Q2^&O&-C-\5M0U[4KI;>TECD2)W!P%!4(./85YE12>'B[ONK#5>2LNSN>A
M>"M>TO38/%ZWEXD)O;=EMPP/[PXDX''N/SKC-$M[.ZUNSAU"X6WLFE'GRMGA
M!R>G<CC\:H45HJ:3;3W(=1M)/H>J>)OBUJ-MKDMOX<FMAID*JD3&'.[ Y(ST
M&>/PJ.Y\96?C+X?:A9^(+R"'5[>7SK0["HDP. ,=S\R_B*\OHK-8:FDK+5=2
MWB)MN^SZ'=^,];TW4?!?A2RM+M);FSM]MQ&H.8SL08/X@UUOP]^(.D+HL-KX
M@NHX+S3P8K>>0$EXF[9 [8 ^@6O%Z*)8>,H<C".(E&?.B6Z97NYG4Y5I&(/J
M,UVWQ3UO3=<URPGTR[2YBCLUC=D!X;<QQS]17"45HX)R4NQFIM1<>Y;TN5(-
M7LI9&"QI.C,Q[ ,"372_$W5K'6O&,EYIURMQ;F&-1(H.,@<]:X^BFX)R4@4V
MHN)J>'=<N/#FO6NJVP#/ W*$X#J1AE_$$UWVK:;X'\:7C:Q:^(TT:YG^>XM[
MF,??[D9(&3WP2#7EM%3.ES/F3LRH5.5<K5T>FW_B+P]X/\*W>@^%[E[^^OAM
MNKXKA0,8./P) QTR3G-.\-7OAR^^&4GA_5M;33Y7NC*?D+$ $$<>^*\PHJ/J
MZM:^M[W*]N[WMI:UCO#IGA70-8T34-.\3"_,>I0-,AA*B.,-DO\ A@?G4NN>
M,HM/^+,_B+295N[7]VIVY E3RU5AS]#^(KSZBJ]BKWD[Z6%[5VM%6UN>HZIH
MW@;Q;?2:O9>)X](DN#YD]M<Q#ASUQDC]"16>C>#=!\8: VD:A/.MM,#>W<G^
MK/N!C.?IQC'4YKSZBDJ+M9R=ANLKWY5<]2TGQ+H\'QDU'6);^-=/E1PDY!P<
MJH],]C52Z\,>!;J[FN#XW"F61GQ]F/&3FO.**7L+.\9-:6^X/;75I)/6YV6C
MZ)X/O+C5+&^\02VTJ2E;*Z,7[IT'\1]SZ$CZFM]K[P_X)\%:QI5CKB:Q?ZHO
MEXA7$<8(*D]2.A/?)XXXKRZBG*CS/63L*-7E6BU"BBBMC$**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MNA\(^+K_ ,(ZI]IM3YD$F!/;L?ED7^A'8USU%*45)6949.+NCZI\-^*]*\4V
M0N-.N 7 _>0/Q)&?<?UZ5MU\@VUU<65PEQ:SR03(<K)&Q5A]"*[W2OC'XCL4
M6.[6VOT QNE3:_YK_A7F5<!).\&>C3QT6K31] UB>)?"NF>*=/:VOX%,@'[J
M=1AXSZ@^GMTKS=?CLP4;_#H)]1>8_P#9*S=:^-.J7]G);Z=I\5@9%*F4RF5P
M/]G@ '\#64,)74KI6-)XJBXV;N>9S1&">2)B"48J2.AP<4RCJ<FBO9/("BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **^N?[*T[_GPM?^_*_P"%']E:=_SX6O\ WY7_  KSO[07
M\IZ'U!_S'R-17US_ &5IW_/A:_\ ?E?\*/[*T[_GPM?^_*_X4?V@OY0^H/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!EZ]!>W%BR6DRQK@F0GJ1CH*\]@@EN)5BA
M1GD;HHZFO4;E2]K*JC+%" /PKD_#6DWUIJWFW%LT:"-AN..O% '-"*1;D1,"
MD@;;@\$'->E:9%>06:QWLJRRJ<!E[CW]ZY74]'U";7Y9X[5VB,JD,,8(XKMJ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ]HMKJEKN$-PFX*W53T(/T((_"HKJ=DY--=T70Y+M133[,T****Y3I"BBB@
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M_CW ^]C'7CZUZI14JLU*4N]_Q*=%-178RO$T4D_A75X88VDEDLIE1$&2Q*$
M =S7*?"#3[W3?"-S#?6D]K*;UV"3QE&(V(,X/;@_E7H%%2JC4'#N-T[S4^QY
M;\9M*U'4[?1Q86%S=F-Y=X@B9]N0F,X''2O4(QB) >N!3J*)5'*$8=@C32FY
M=SRO4M*U%_CG9:@EA=-9*%W7 A8QC]V1][&.M>J4445*CG;R5@A3Y+^;N>??
M$CP)<>(O(U;2&":K:C 7=M\U0<C![,#T^M8EM\3_ !1I4 L]8\*7$]V@V^:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3'X7/AQ87_LT@@IYAW<MO^]UZUMT4.I)N]QJ$4K6,'5O!^CZSI]C9W44@6Q
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M2.5V6<A9(-B!MK*,C/.#SQ5N+5H3;+/=QRV(:Y-LBW0"EVW[%Q@GACC'KD4
M:%%%% !14,-W;W,UQ%#,CR6[B.95.2C%0P!]\,#^-34 %%%4-;U$Z1H&HZF(
MA*;.UEN!&6QOV*6QGMG% %^BJ-OJ+3W%M%]CN LUMYYG !B4\?(3G.[G(XZ
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MN[YY$\4/ K)=R)A/MS*!\K#H  IZKCC%>BPZ/I]N+ 0VJ(-/C,5KC/[I2H7
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MB53(25(("G!P=_3.*H:$MWI.M:<FMMJAO+N22-+Z._,]G>L59@#&3^[^520
MH VXW'OU>F>&M(TB=[BSLPL[IY9EDD:5]G]T,Y)"^PXJ.P\)Z%IEZEW9Z>D4
ML>[RL,Q6+=UV(3M3.3]T#K0!P%E-K^M>'9=<CM]4759#*\5R-56.W@96("&$
MN%V+C:P923@Y.:]4@:1K>-IE"2E074'(#8Y%9%QX0T"ZOGNYM-C:21Q)(NYA
M'(X_B:,':QXZD$UMT >6:EJ<YLU\2Z7'JJ0-?Q".\NM4(25&G5"HM\E=A!(
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MM57+;]RX^Z=W/&,4 <CJ)OKKQ=<:(MMJEU8:?90-##;ZF;=Y"Y8&1W+J[_=
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M5L6WVJJNT1':4^4#@?*Q'XT <_HD;Z5XTU/1HKJZFL?L-O=QI<W#S-$[/*C
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M:2LE_+*L/B0V'VK=@W,*M(J[B.#D@*>Q*UO27TC?$5[ 7+F)=&,K0!_E#&7
M;'K@$9K6GT+2[C1QI$EA!_9ZJ%6W5=JJ <C&.A! ((Z&H].\.:3I4[7%G9K'
M.R&-YF=G=U)!PS,26Z#J>U '"Z#)->:!X!T-KN>TL;O2C-,UO*8GF:../;$'
M7!4'>S'!!(3ZUKZ;I\6F?%$VT%]<3Q_V,S"&XF:9X<S+_$Q+$'' ).,'MQ71
MS>'-'N-(M]*EL(FLK8*((^1Y6T84JP.5('<'-&F^'-(TBY-S8V217#(4:8LS
M.X)!^9B26Z#DYZ"@#&^(V/\ A%8\W7V7_B8V7^D<?NO])C^;GCCKS4&I69\,
MZMH<^G7]_(][?+:7%O<WDDZSHRL2P#D[67;NRN!@$'BNJU#3K/5;7[+?VT=Q
M 75S'(,J2K!ER.^" :HZ?X6T72[P7=I8JEPJE$=W9S&IZJFXG8/9<4 <1%)J
M^O-K%X]MJYGAO;BW@DM=46WCM1&Q5?W>\ G #$N#G/IBO0M'DO9=$L9-1$8O
MFMT-P(R"OF;1NP1QC.:I7_A+0M3O)+N[T]))90!-AV59@.!YB@@/QQ\P-;*(
ML:*B*%11A548 'H* /,(I-8UY=7OGMM6-Q%>7$$$MMJBP1V@C<JO[O> 3@!C
MO!SGTQ5OQ)K6N:%9:/J<,OFZQ<V1CO-.4M+%PFY[A57/^K;KC[P(7KMKJ[[P
MEH6I7DEW=Z<DDLN/.PS*LV.GF*" _''S UH1Z;90W[7L=NBW+1+!YF.1&I)"
MCT&3T% '&:BA#>#=/M_$5X;6\DD$EVMP=]V#"S?>_P!H],=/X<8&+/[WPWXN
MM]/TZXO+NVN]/N+B2SN+EYS$\93:RLY+ -N*XSC(&.]3ZIX1M)[[P_:V^FQ-
MI-K/<23Q$C;&'C;! )_OD8QTZ\5MZ7H&EZ,\LEC:B.6; DE=VDD<#H"[$L0.
MPSB@#SK3G\0W_ANRUVUAU)]5N%CN!=R:J@MG+$$QF'?M"<E<;=P^M=-';GQ)
MXMUVUU"]O8H--:&*WM;6ZDM^'C#F5C&06)8E1DX&P\9S6L/!^@"^^V#38O-\
MWSMNYO+\S.=_EYV;L\YQG/-3:GX;TC6+A+B]M-UPB;!-'(T;[>NTLA!*^QXH
M Y:;P_;?\+(T=7O]3F;^R;A_,-_*I8I);@?=8#!'4  ,>2":SHI-7UYM8O'M
MM7,\-[<6\$EKJBV\=J(V*K^[W@$X 8EP<Y],5W4OAK1IH[&-M/B5;#BU$>4\
MH<9 VD<' R.AQS45_P"$M"U.\DN[O3TDEE $V'95F X'F*" _''S T 8"OJ.
MMZ[I.CZS=2VJC2%O+B*RN&B^T3E@K .A!V+UPIYWC.:E\,VB6'Q!\26L=]-=
M)'9V6!/(9'AR9SL+'ENN<L2<,.:Z/4M!TO5H8(KRS1Q;G,+(3&T7&/D92"O'
M'!HTS0-+T:2633[*.W>9565UR6<*6(W$\DY9N3SS0!HT444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !3)IH[>"2>9UCBC4N[L<!5 R2:?10!S_AWQ
MCI/B2WN9+6Z@#6\LJNGF@D(CLHD/HK ;A[&K6G>)M#U:Z-MI^JVES/M+!(Y
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MJ1MR=O?/-6/#FJ7MUX<T6XGU*!);B\FCD^T+EIU#2X1.1AL*#WX4\5;,,O\
MPLI)_*?R?[(9/,VG;N\X'&?7':N<TRSNDT'P8C6TP:+6YGD4QG**5NL$^@Y'
M/N* .PU#Q/H>E78M;_5;2WGP&,<DH!4'H6_NCW.*I6WC71;KQ3<Z"EY;_:(D
MC*D2@^8[%P4 ]5V<_P"\*Q]+U&T\-S:[9ZU:W(NKK4)[A66T>87D3G,84JI#
M$+A-O4;?2KUO<)9?$6Z::"XBBU#3;2.V;R'*ED>8LI(&%(#KP<=: .EO;ZTT
MVTDN[ZYBMK>,9>65PJC\35*V\3:)>6=Q=V^J6KP6PS.PD'[K_>'4?C67XNBD
MCU#0-3DMI;G3["[:2ZCBC,C)F-E278.6VL>P)&<]JKVMQ'KOCVSU32HIA:6M
MC-#=7;PM&LQ=D*1C< 6V[6;(X&<=Z %^'NIIKFCR:JVK27MW<.QGB\T%+?YV
MVJJCA?EQ[G%;::BEM<:M)>ZG9_9;5T^4#:UL"@)$A)Y)SD<#@BJ/@.&6W\$Z
M;%-&\<BJ^4=2I'SMV-<WXBL;F;2_B,B6TSFX$0B"H29/]&C!V^O((XH [*T\
M2Z)?7<MK:ZI:33Q*7=$D!.T<$CU [D=*I^'_ !EI'B.>]@L[N!I;:5TV+*&+
MHN/W@_V3FH=;LO+\0^$#:VQ$5M=RH3&G$<9MI1@XZ+D*/KBN?GMKN\T+QMX?
MM8YX]4N+FXGA0Q,JRQ,$QM<C:=PRO7U]#0!V5AXFT/5;LVMAJMI<3@$A(Y02
MP'4K_> ]1FGIX@TB34UTU-1MGO69E$"R OE<[L@=,8/7T-<98^5K&IZ+"-5U
M29[.=9UM_P"R1;_9MJD%9&VC8""5P#SGC(YK6\.Z;.EAXJ6",VMW=ZE=&.9E
M*DD@!&SW [4 ;,7B?0YM3_LZ/5K1[S>8Q$)1DN.JCU8>G6G77B31;+45T^ZU
M2UANV*CRGD (+?=!]">P/6O.M/M3<>'M,\.W6HZK#<Q&"-]/BTI0T$B,IW^9
MMQM!&[S-W(YY)Q6GKETVE:OJC:1)>-?7%Q'))I-SI[2PWC[47=&X'R\*!NW$
M KD@4 =)8^--'O\ Q->:%%=P?:;?8%Q*"96(;<H'JNWGZT_Q#XOTOPU=:?;W
M]Q%&]Y.(\/(%\M-K'><]LKCZD53LYQ8_$75X[B.=/M]O:FV<0LR/L$FX;@,
MC(ZD=13_ !HQ@_L&]:*5[>SU5)IVBC9RB>7(NXA03C++^= &I?>)-%TV*WDO
M-3MH5N%WP[G&9%Z[@.I'/6KUK=V]]:QW5I/%/;RC<DL3AE8>H(X-<?%J%MHG
MC#5M3U..X6VU*&W:RO!;NZB-4P8C@$H=V6P<9W>H-7_!5O+'!J]V;:6UM+[4
M9+FTMY4*,L95 6*GE=S*[X.#\WO0!+;^--'N/%5UX?6[@%S J8_>CYW8N&0#
M^\NSG_>%9_A/Q?I\VC6-OJ>LVYU.:21-DD@#$^8P53Z$@# ZFIXYQ8?$J^^T
M1SJE_86L=O((69'9'GW#< 0" ZGG'6N?72I(O@I>VT=E(MRWG2^4(SO,GGLP
M;'7/ (^@H [O4]=TK1?+_M*_@MC+GRUD?#-CK@=2!W]*MVMU;WMK'<VL\<\$
MJ[DEC8,K#U!'6N#UA;K2O'=]J-SJ-U86MW:0QV]S%9"X4;"VZ,G:2AR0PZ!L
M^HKH/!EDEGH;M')>.ES<RW ^UP"!AN;)P@QM4G+ $ _-R!0!:O?%.A:;+)%>
M:M:0RQOL>-I!N4X#'(ZCAE/XCUJU+K&FP6,5]+J%LEG-CRYS*OEOD9&&S@\"
MN-TG6M,T;Q=XODO;>:)Y+^,"[2W>19 +:']WE0<$9S@]=W&><44TB>;P]8K+
MITL=I<^)EO(;.2(@PVYD+#<G\()RQ!Z;L&@#M;76(-3U&RDL-4LY;*:"5A"%
M)DE*LJ[U;/W5)P>#]X4B^+/#SW<-JNLV33S,%C03 [F/0?4]AU-5;V&5OB+H
M\XB<Q)IEXK2!3M!,EO@$^IP?R-<NNE21?!.YM8[*1;EO,E\H1G>9//+!L=<\
M CZ"@#N]3UW2M%\O^TK^"V,N?+61\,^.N!U.*B34H[S4-->RU2QDL[F&5Q&O
MSM<8VX9&#8PN>>#U'2L*:ZBT#QWJ6HZM%,+:]M8([2\6%I%C";M\1*@["20W
MH<^HJ3>M]XN\-7UG:3Q6AM+[[]NT6W<T.,J0-N[!(S@F@#3?QAX;CE2-];L0
MSD ?OA@9.!D]!D^M7-3UO3-&2-M1OH+;S21&)&P7QUVCJ<>U<!X5US1K+P"=
M.N=+NFFF-P#:)9O)]L+.PRI (;/3D\=\ 596?6-"L/#>DZE>RV$<>F!;C4(;
M3[0YG7:/*#%6"\<Y(.[''2@#?\0ZT'T/3;_2;Y'AN-2LXQ- P971IT5AGW!(
M-7O%.M1Z!X9U#47GBADB@D,)E. T@4E5]\D=*X>RM+QO"FUH+UG/BF&8?:(-
MDC1FYC;>RJH R,L>!CG..:[GQ7&\W@[6XHD9Y'T^=551DL3&V !W- &3X8NU
MDM=(:W\1)?)=1R23BX?S)9I J9\L@@*%.<@ _>[5J-XL\/)<QVS:S9":1_+5
M?.'WMQ7!]#N!&#W%9/V>?_A(?!S^3)LBL+A9&VG"$I%@'TZ'\JQAI3K\'/$4
M"V3BZG.I2^6(SO=_.EV-CJ3@)CZ"@#MM3\0:1HKHFI:C;VSR LJ2/\Q ZG'7
M'OTJ2?6M+MK."\GU&UCM9^8IFE4(_P I;ALX/RJ3]!7+ZUJU[!XB^RW%]=:7
M9"SC>&>UL//DN9"6W(&*.!MPOR[<G=FL?2],GE\,^"8+JRN"8-<EDDCFB^:,
M+]I*E@!@8.WIQTQVH [_ $S6M,UJ.1]-O8;D1-MD\MLE#UP1U%06WBC0KS4/
ML%OJ]G+=%BHC24$LPZ@>I'<#D5@:QIM]=^)O$4>GAX9KSP\L,4X!5?.WS!?F
M]1N'N!5GP_KND&RTK2(]/NK>ZA18_L;63C[,RK@DG;M '(W9P<\$YH T[?6;
M:RT3[=JNKV#Q^=(GVF/]W&2'8! "3EAC:1GD@U2U[Q!;W/@+7=4T34(Y'MK*
M<I-"P)CD6,D9]".#@USMM=:EI'A#2XU62SADU2[%U=FT,SVJ&:9E8)CC<=HW
M$$ -GO50PW5UI'Q"=&U&]6ZTQ?L\]S;"-K@^3*ORJJ+GD #C)P.H(H ].MF+
MVD+,<L44D^IQ6:WBK04U+^SFU>S%WYGE&,RC(?\ N9Z;O;K5Z-)&TM8T;RY3
M"%5B/NG;UKSN"[M(/AJ?"D^E7;:R+(VCV/V5R9;@C!D#XV[2_P _F9P,YSF@
M#5\1>(K'_A-]/T.XU[[!;QV\L]PL,XC=I0T0C1CU *NQQWQ570O$":O)J^I0
M>)H!.FH&VCBE??!'!YRHF$!'S.!@,3U>M6VL[R#QKH7VG?*T.A3Q33@$J9/,
MM^_J<,?P-8T]G='P?JD0MIC(WB=957RSDI]OC;<!Z8&<^G- '::GXATC17CC
MU+4;>VDD!9$D<!B!U..N/?I1=^(-'L;*"\N=2M8[:XQY$GF B7C/RX^]QSQ7
M.QWL'ASQEKUUJ\4Z)?F%[2[6!Y%,:QA3%E0=I#AFP>N_(SS6=JQEA\3Z?KD<
MUYIFERZ8((9%T_S#;OO+,KH5)CW KS@?<P>U ':KKFE/IL>HKJ-J;*1@B7'F
MC86)P!GIG/'UJ73M3LM6M!=:?<QW-N25$D9RI(ZX/>O/9](6[\/22)]NOH=0
M\064THN;,0AU$L2NXC !"$+DD@9P3T.3Z;0!D7OBG0=-O39WNKV<%P,;DDE
M*9Z;O[N>V<58U'6]+TE4;4+^WM0ZET\V0+N (!(]>64<>HKC]'U*R\.Z5J.D
MZU8W3W[W=S)(BV;R_;Q)(S*RD*0V5*K@GC&#@"H]&T.\M+_P'#J5NSS6&G78
M<GYQ Y$052W3(7*^^#0!W\$T=S!'/"X>*10Z,.X(R#5*^O#:ZG9AK^U@MS',
M\L,J_/*% .5.1@+U/!ZCI4T6I6\VJW.FQEC<6T<<LOR_*H<MM&?7Y2<?3UK'
MU:&5_'/AN58G:..*\#N%)"Y6/&3VSB@#/\%:S;^(-2UB^766NI4NYH8[5)@8
MHX%?:C!!W(7.X^IKK8;RVN99XH9XY)+=_+F56R8VP&P1V."#^-87@Z&6"SU4
M2QO&6U>\=0ZD94S,01[$=ZQ?&!OM%UDW&EJWF>((1IF5'^KN>?*E/L$,F3_L
M+0!U-QXCT6UL(;Z?4[5+6=BL,AD&)".H7^]T/2I8M<TJ?2GU2+4+9[! 2]PL
M@*+CKD]L=\URTEK:^$_%5A<SVTO]CPZ2MA:S)$T@MG5R6W!02N]=GS8Q\F">
ME9U[I]UKNE^.KS2[.9;74K1([6-XS&US,B-OD"L ?FRB@D#.WTQ0!Z'-=6]O
M+!%-,D<EPYCA5FP9&"EB!ZG"D_0&DO;VUTZTDN[VYBM[>,9>65PJK]2:XR]U
MR'7_ !)X3;3K:\DBAO9);B1[9T6 FVF4*VX#!R?PQSU&=KQA?7NGZ-'+9)]Z
MYB2>;[.9S;Q$_-($'WB,#Z9SVH OV&O:5JEO//8W\$\<'^N*O_J^,_,.HXYY
MIMIXBT:^^T?9=3M9EMD$DSI*"L:D9R6Z#BN+TP3W7B'7;E+G4=0@ET58TN[F
MU6(2.&D^5 J+N W=2#U/-37FBW;_  ?T>QL;:1'@@LI9[:.(%W5"CR+L/#-P
M3M/4\'K0!UVF>(='UJ1X]-U*VNI$7<R1N"=O9L>GOTJSJ&HV6E6ANK^ZAMH
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M)) P#ST'2L;3-1M?#-]KUOK4%RMS=W\MS'*MK)*+J)@-@4JIR57";>HQTP:
M+'CCQ)::?;Z5:#68[$:A=QK)-'*%<6^&+,I[ X W>]9]AKMGJ7C"[T^W\2GR
M]-LXA:1_:-RS2;9#(\O>3 5<C([^M1V>EW]IX:\)036DL3)K7GBWQDVT+&9D
M1L=-JLJ^W2M<6\__  DOB]_)DV2V%LL;;3AR$FR!ZGD?G0!L#6K/3]!L[[5=
M4LPDD4?^DJ=D<S,N<H"3UZ@9/%21>(-'FTJ35(]3M#8Q$B2?S0$0CJ&/8\C@
M\UQEDCZ0/!FK:E:W#6%MHHMG*PLYM)V6+#LH!(R%9<XX[XS4WB:8:U9Z9JNE
M)=I96>IB:ZD2Q)=QY3*)5C9<R!69><'H2/NB@#K;+Q!I&I6MQ<V>HV\T-N,S
M,KC]T,9^8=1QSS3]/UO3-6EGBT^^@NG@V^;Y+A@N<XR1QV-<3% -3?6]2AU'
M4-1D&D2VOF-8""*3=E@H.T%V&#T! WGN:[#PQ:K9>%-(MDA\D1V<2^7MQM.P
M9R/7- #]3\0:1HK1IJ6H6]L\@)1)'^9@.I ZX'K4CZSID>GQ:@^H6HLIL>7<
M&5?+;/3#9Q7-+>0>'?&FN7FKQ3I%?K ;2[6!Y%V(@4Q94':0^YL'&=_&>:Q#
MI,UUHH9].F2QO?%$-W!:21$%("Z9+)_"&97<@]-W- 'HFGZC9ZK9K=V%PEQ;
ML2%D0Y!P<'%4[CQ/H=KJ!T^?5;2.\!"F)I0"I/0'T)[ ]:UJ\_T.^L]%T"[T
M'5]/NI=2::X\Z 6CR?;B[L0ZL!M8,".2?EZ'&* -/PIJE[>^&O"4]SJ4'FWE
MH'G29<RW+>5GY#D8(/)X/'I6W%X@TBXU$:=#J-M+>$N/(20,P*$AL@=,%6'/
MH:XSP]9W,>G_  X#VLR&"V<2JR$>5_HQ&&].>.:T-#TFY/A7Q1!:QFUOKV_U
M$QR,I4EF=PCY],;<'TH W[?Q/H5WJ/\ 9]OJUI+=[BHB64$LPZ@>I'<#D4[4
MO$FBZ/.L&HZI:VTK+O"22 $+_>([#W/%>?Z?"+[3-'T2;4=5CFMY;?\ T!-)
M5&M7C8')?: %!'W@>1TSFMVQU"V\-:[XA&M0W"2WUW]H@N5MGE6XA\M55 54
M\J0PVGUR.M &F/'&AMXH70Q?6QE>%9$D$RD,[-@(!W)X/XU=N?%6@V>H&PN-
M7LXKH,%:-I0"K'H#V!/H:Q?M,5IX\L+I[6Y@M;S24MX/]&?"OYN1&P ^0@,.
MN!P?2LG2[ZST?P;<>'=6TV[FU3$T<UJMH[F^=V8[U8#:P?(.XGC/.,4 =OJ6
MNZ5HY U'4+>U)7>%ED +#(&0.IY(''K5Y'62-70Y5@"#ZBN'T71[NU\2^&%U
M*,S7-CX?>*2<C<%FW0J?F]2-WN1FNNM]2M[K4;VQB+&:SV";Y> 77<!GN<8/
MXB@"Y1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%1SO)';R/%%
MYLBJ2D>[;N..!D],^M $E%<1H'C"^7PU?ZKK]F\<-O=7$:21NCM(1<-&D2JN
M/F'RH#W//>M2/Q+>6][9P:SHLFGQ7L@A@F$Z2J)""0CX^Z3@XQD9XSTH VM0
MM#?V$UJMU<6K2# GMV"R(<YR"01^8K"709_[1T^?7?$#7HMYMUI T,<"M-M.
M&..78#<0!@=3CCC2\27MYIWAV_N["#SKF*%V4;@NW )W<\''7'>N,U/6=1GT
M3P7J5]ILINVU2$K%%(C-.6M9<,,8"Y+=^E 'H]%<_9^)_P#2-1M=8LSIMQ86
MXNY,RB5&@.[YPP Z%&!! Q[YJO%XMN56SN[[0[BSTR\DCCBN7F4NAD($9DC'
MW Q('4X)&<=@#J**I:SQH>H?]>TG_H)KR2S&B6_A7P[-IFE7FF:NPL\ZJUK)
M;PJ?DWM)*0%=6&X8YW%A]: /:**PK[Q#.FKR:5I6F-J%W!&LMP3,(HX0V=H+
M'.6."0 .@R<<4MEXB;4=*NY[;3;EK^TF-O/8,R+(DO'&XG;C#!MV>5/'/% &
MY17/Z?XEDN+V\L+[3_LE[;6XN0B3K*DD9)&0PQ@@C!! ZCK5.R\;"X\-_P#"
M0W6E7%KICP1R6Y9U:6=G("HJ#U8@ D\Y'2@#J)9XH-GFRI'O8(N]@-S'H!ZG
MVJ2N!\0ZIJ<\_AZ'4=$EL1)K%NT<BSK,H()^5\?=;\QP>>F>^H **S9=8C@\
M0P:1+&R&>UDN(YB1M;8RAE^H#J?IGTK%LO'EE?\ AUM6@M)\_;([2.V8@.[2
M,@C(]F617^AH ZA)XI9)8XY4=XF"R*K E"0" 1V."#]#4E<%8ZIJ-GXN\8Q:
M=HTE^R7D$LA\Y8E ^RP@*I/WF.#QP/4C(K9;QA;SV.D2Z7:37UUJT/GVUN"(
MR$ !9I&/"A=P!ZG)  - '245C:3KS7VH7&F7UB]AJ4$:RF%G$BR1L2 Z,.HR
M"#D @]N12Z[KITB2QMX;7[5=WTQA@C,HC7(4L2S'IP.P)/I0!J23Q0F,2RHA
MD;8@9@-S8S@>IX/'M4E<-XKU.Z^Q>&KRXTFYBN5UM%^QAT9F;RY5&&!Q@G!!
M...3BMW2]?GN]4NM+O\ 37LK^"%;A4$RRK+&Q(!5ACD%2""!V]: -RH/MMH$
M+FZAVB7R2WF# DSC;_O9.,=<UA0>)[I-5L;/5-'>Q6_<QV[_ &E)&#A&?:ZK
M]TE5;H6&1C-<M+_R+]Y_V.,?_I;'0!Z:3@9-,AFBN(4F@D26*10R.C!E8'H0
M1U%$W^ID_P!T_P J\\\(^)+[3OASHMV= N9-,M=/B\ZX$JB3:J#<ZQ=648/<
M$@9 /&0#T:BL&\\2'[;;V.D61U*ZFMQ=<2B...$G"LSG/WB#@ $G!Z8JWHFL
MIK%O<$V\EK=6LQM[FWD(+1R  XR.""&4@CJ"/I0!IT5S^J^))[/7H]$L=*EO
MKV2U-RN)5C15#;3N8].<= <YZ=2&S^([R6_N[;2-&DU 63".YE\]8E$FT-Y:
M9^\P!&>@Y SG. #HJ*YB3QE'<)I*Z39->3ZG#)/%'+*( JQ[0X8G/S L!M /
M0]AFGWWBJ>RDTBV.B7CWVIK*4MMZ QL@!(=L[0.<YST'J0* .DHKG[3Q0%N[
MNSUFS.F75M;&\.Z421O .&=7']TXR" 1D>M4_P#A,KF&QBU:\T&YMM%EVG[4
MTR&2-&("R/$.57D$X)(!Y YH ZRBN=O/$MRGB"YT33M(EO+N"WCN&<S+'&%<
ML,%CG!RG P<^V*A/C2*31=-O+:QE:ZU"Z:SCM99%CV3)OWJ[G(&#&XXSGC .
M: .HJ-)XI9)(XY4=XF"R*K E"0#@CL<$'\:YW4-266STJ35])N;>9M4BACB%
MP/EDR=K[D/S)['KW%96FZCJ%MXO\70:=I#WK_;89'=IEAC4?980!N.<L<'@#
MZD9&0#MY9XH IFE2,.P1=[ ;F/  SW/I4E</K6LPZYHVCW,44L$D>O6L$\$H
M >&190&4X)'X@X((/>M>X\1W<FHWEIH^CR:B+)@ES+YZQ*'*AMB9^\P!!/0#
M(YZX .AJK-J5C;WL%E->V\=W."88'E4/)CKM4G)Z'I3-)U2WUK2K?4;3?Y,Z
M[@'&&4]"I'8@@@^XKCM+U.6V\<>*[[4M.6WMK:&%I;IIE;R8TC9AP.<').!T
MS0!UFFZ0NFWVJW*S%SJ%T+EE*XV$1)'@>O\ J\_C6E7*_P#"7W5O;0:CJ&@W
M-GI,[(!<O,C/$'("M)&.5!)&<$D9Y YQ9/B6XF\376B66DRSM:-$;BX:54C1
M)!D$9Y)Z_*!VZCC(!T-1RSQ0!3-*D8=@BEV RQ. !GN3VJMJ^JVVB:5<:C>%
M_)@4$A%W,Q) 55'<DD #U-<;XEU;4YTT.+4-"ELDFUBS,<@G24*1*#M?;]TX
M],CC&>F0#OZ*Y^Y\17<FHW=GH^CR:C]B8)<R^>L2JY4-Y:D_>;:03T R.:Q[
M_P 8:C<7WAF71+!Y[+47D#J\B1L[+%(3&0<[2K)DGVQ0!TV@Z0NA:+!IJ3&9
M82V'(P3N8MT_&M*N>G\1WDFH7-EI.CO?R6>T73FX6)$=E#"-2?O-M()Z 9'-
M5Y_&T'V+1Y['3[J[DU61X88!M1TD0,65\G P58$YXP>M '4T5S$WBB_76%T:
M'0GFU+[%'>2(+E1%&K,ZD%R.H*\8'.?8FJ2^/G?2VU@:%=+I4$GE7<\DJ!XF
M#;7PG.Y4;()R.AP#0!VE%<]+J%E:>)M686TIN[;2XKB23S3M>/=+M4+G (*-
MSCN/2J=GXTFN(M)O9]$N+;2]4>.."Y>52P:0?)N0<A6/ .<\C(&: .MHKE+C
M7]/T3_A+-1%I.7TYXWN_WI;S3Y*,"H)PN%(&!C)%6;;Q-<G6+&QU#1YK%-0#
M_9)6E5RS*N\HZC[C;03U(X/- '145S2^*;N[EN9=+T.>]T^VE>%[E9D1I&0X
M?RD/WP"",DKD@XS6GH&L1^(-!L]6AB>*.ZC\Q4?JHSWH TJ*YN\\7P6=AK4[
MV<S3Z7<K;?9E(+SNX0Q[?][S% _'TJU;>);6]O-(M[2-I1J5HUZK@C$<0"8+
M?4NH_/TH UH9XKF!)H)4EB<;D>-@RL/4$=:DKS;P5XGN--\ ^'9;C1YETKRH
M+5KPRKN5F(0-Y?79N(&<Y[XQ75WGB&Z_M6XTW2=*?4)K15-RYG6%(RPRJ G.
M6(YQC !&2,T ;U1K/$\[PK*AEC 9T##<H.<$CMG!_(UQ6J^,-1EC\/W&C:?(
MT5WJ!MKB.61$<.JRAX6!S@AD^\#_  ]>:;'J6HV_Q"UI+/2&NKJ73K)W0SK&
MD6#-D%SGG)P,#G!Z4 =W17-KXQMY=!LM0ALKB2ZO9VM8;$;1(9U+!T)S@!=C
MDMG&%SZ4J>*)(&OK?4],>SO;6S:]6)9A(DT2]2KC'(. 00,;AUS0!T=%8_A[
M6;G7;-;Y],DL[2:-)+9I95+RJPSDJ/N]L9.>>@Z5!JGB*XM=;&D:?IAOKP6P
MNG4W"Q 1EBHV[OO-E3QP!QDC(H WZ*RH=;636[;2VM98IIK$WA\PC* ,JE"
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M#F&\-W^OWUY>>($M[9)=.ETZ&VM93+L24@R.SE5RQVK@ 8&.^:@NM%\3ZKH
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MHH QXM*GC\97>L%X_L\UA#;*H)W!DDE8DC&,8<=_6LB3PK?/\/\ 5= $MO\
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ME*[@DL;JZ$CN-RC(],UG7%AKOB+3;W2=;M-/L[*YM9())+6Y>9V9A@,H**%
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M:>4SDKSE;\3R:N;TXRM"-_P/J.BOEOS9/^>C_P#?1H\V3_GH_P#WT:T_L?\
MO_A_P3+^V?[GX_\  /J2BOEOS9/^>C_]]&CS9/\ GH__ 'T:/['_ +_X?\$/
M[9_N?C_P#ZDHKY;\V3_GH_\ WT:/-D_YZ/\ ]]&C^Q_[_P"'_!#^V?[GX_\
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M)VM\KH?O1MW4UIUY4HN+<9;GKQDI)2CLPHHHJ2@HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[B_OT^XUAEM6$>6,U]VOWGS/17TQ_8>D_P#0+LO_  '3_"C^P])_Z!=E_P"
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M=U.YM+2PC#3Q1GRX_L;*;9<8*ME?W?I@XSTH BTWQ=9^(]"L]1TC4M.A:2:
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MYF<=\T >F?:8/M1M?.C^T!/,,6X;]N<;L=<9XS4+ZII\<;R/?6RHDOD.S2J
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MZ\L_#S)),PW 3;HE8Y]?O<^YKH_%=W<V'A?4+FTM$NYDCXA>,R*02 Q*CE@
M22!UQB@"?3=?T?66D73-4L[QH\%Q;S*Y4'H3@]/>H_\ A)]!^V0V@UK3S<S'
M$40N4+.<XP!GDY!'X5Q^DW+WOC_2+F+59=4B6QN8Y+A+,0PH28B$! Y/!."3
MC ]:K#3!%\$]2CCLRMRYN9]HC.\R"=BK>N1A<?04 =_J>MZ5HR(VIZC:V8D)
M">?*J;L=<9/-4-<\7Z/H6B1ZM-?6TEO,RB$K.@$V6 )0DX; .3CL#63)>6N@
M^/-4O];S%#=VT"65X\99%50V^+<!\IW'=CC=D=<5BW-I+)X,\3WEM93QZ=<Z
ME'=V<!A8-Y2M"9) F,@,R2/C&<'..: .AN_%5G%XGTN4:Q:#1)].NIFF$R&)
MW26%5._IQN8<'J:Z.SU.QU"Q%]9WEO<6A!(GBD#)QUY''%<Q(+36/'_A[48(
MQ/;1Z;>O#-L.%?S(5R,C@XW?K6+K.EWT^G^-[6P@DV-JMM.84BW>;'Y5NTP5
M>-V0'R/XCD=Z .ZTW7]'UB22/3-4L[QXQEUMYU<J/7 /3WI8-=TFYOEL;?4[
M.:Z96<0QS*SX4X)P#V((^H-<AI+PZSXHTFXCUUKZ2Q61L0:8851&3:4D<_=Y
M((7KE1QQ6M\/[)+/PU(WD>5+-?WDDA*X9C]HD )_X"%Q[8H ZFBBB@ HHHH
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M2 0>';FXE:$22A;B)5C/]S<6^9OH,>]5Y/&%FVDZ9>6=M<W4^IG;:6B +(S
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M+Y[(JYYQQO&?I4:^)GN/$EWHMGI5S.]E)$MU/N1(XU=0P;).6."> ,\'IQD
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ME?+V++CYA\^2HQCJ>E:B>-,VT.I2:/>1:).ZK'?NR?=8@+(8\[@A)'.,X()
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M&)_Z3/7H5K_QYP_]<U_E0!+17-R>*IIKJ[32]$O-1M[*4PSSQ/&@+K]Y8PS
MN5Z'H,\ DU)<^)93J<^GZ7I%SJ,]JJFZ*R)&D18;@FYCR^,' Z C)&: .@HK
MF)_&]C%HUKJ*6EY*9[W[ ;54 FCGR1L8$X!RN.N.0<XYIB^+[QM2DTD>'+S^
MUHXQ.;?SH]GDDX#^9G'4$8ZY![<T =517,2^-[./0=/U5;*]D^V7?V(6R(#*
MDP+J4(SC(9".N.^<<U9M/$<K:O!IFIZ5<:=<72LUJSR)(DNT99=RDX8#G![
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M-.L@F1@Z8Z!D;*OC_P"L:KP^([>TTC0K;3;&[O+F^LTEM;7S 76((I+R.YX
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M[O\ #_(7]L5OY5^/^9]!?\+ \+?]!>/_ +]O_P#$T?\ "P/"W_07C_[]O_\
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MS/\ #_(7]KU_Y5^/^9]!?\+ \+?]!>/_ +]O_P#$T?\ "P/"W_07C_[]O_\
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MDN+:>TG:"YADAE7[T<BE6'?D&C^R:.W,_P /\@_M>O:_*OQ_S/??^%@>%O\
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M[_#_ "#^V*W\J_'_ #/H+_A8'A;_ *"\?_?M_P#XFC_A8'A;_H+Q_P#?M_\
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M\!--;:O+-I0U)HHK=H@NX8)#YZ\^GO71^-=*T2YUVUEU;6C9O+:QI'''"7(
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M3?'@U:SU'2_$TD:6ES 1')%!]R3/!POY_A6+K6KV5WX.T'3H)2US9F7SEVD
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ML8^D?\AJP_Z^(_\ T(5N_$?_ )'S4O\ MG_Z+6N>TZ9+?4[2:0XCCF1V.,X
M8$UW.OR>"=?UJXU.77;R)YMN42U8@84+Z>U:U&X5E*S:L]E?JC*E%3H.%TG=
M;NW1F#HNBZ'?6L37NLSQW,K$>3!:-)Y7. 6/^%6_^$&==3UO37O1]KT^W^T0
MJL>1<+C/KP>5]>M:UKXDTA/#VG6UKK=UI)M%(N+>WMB7NF_O!Q@ G'?U]JK7
MGBZQ7XFQZY:RL]@P2.4E",H5VMP>>.OX5CSUW*7+?K^#TZ=?F;^SPZC'FMT_
M%:]>C]#,'@R0^"#XB^T_O/O_ &;9SY>_;NSG\>G2K=MX"\^\TNU;4"DUU9&]
MG3RLF%., #.6)STXZ5?_ .$NT<>*A "__"._V?\ 8,;#G9C.<=<[N,UFW.NV
M.K>.;G49M3N].ME4QVD]NA)0 87(Z[3R2/?%"GB'>^F[V^Y>J!PPRM;79;_>
M_1F-KFGZ39+$=-U&:X=B5DAGMS&\>.Y[<U%HMCIU[/(-2U$V<2+N4)"9'D.<
M;5 [UT/C+7K#4]*T^SCOCJE] S&6_-OY.5/1<'D]OR]ZB\&:UIVF66IV]Q=M
MIU[<*H@OU@\TQ@=1@<C/^>@K53J>PO9W_'?T_2YBX4_;VNK?AMMO^MB#6O"D
M-A!IU[8WDD]C?2>4&EA,;QMGH5/X_E6NWP_TJ/77T-_$/_$R==T$8MSC[N?F
M.< ]>/3ZXIFO^)--O-"TJRCU2ZO[BUO?-EGN(RI=>>1GMSP,YIEQXETN3XJ)
MKJS-_9X929/+.>(MO3&>M8J6(<=VK*73>VW0W<</&6R=W'KM=:]3,T?PFMU#
MJ-[JMZ+&PT^3RI9 F]FDSC:H_+\Q6_/96-G\+-3.G7_VVVEO(V5S&493\H*L
M/7_&J5AKVC7EIKFBZI/+;V=[>-=6]TD9;8V>Z]<8 _7I3;S4O#UCX'O=#TV]
MFNKB2X24RO"4$A!&<#L !WYZT3=64TI7W732VG7_ ((H*E"#<;;/6^M]>G_
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MT>[[C5/#\W*K>K?=^JV78\UHI2022!@>E)7HGF!1110 4444 %%%% !1110
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MZ.HH_M>I_*@_L>G_ #,^<?\ A$O$7_0$O_\ OPW^%'_")>(O^@)?_P#?AO\
M"OHZBC^UZG\J#^QZ?\S/G'_A$O$7_0$O_P#OPW^%'_")>(O^@)?_ /?AO\*^
MCJ*/[7J?RH/['I_S,^<?^$2\1?\ 0$O_ /OPW^%'_")>(O\ H"7_ /WX;_"O
MHZBC^UZG\J#^QZ?\S/G'_A$O$7_0$O\ _OPW^%'_  B7B+_H"7__ 'X;_"OH
MZBC^UZG\J#^QZ?\ ,SYQ_P"$2\1?] 2__P"_#?X4?\(EXB_Z E__ -^&_P *
M^CJ*/[7J?RH/['I_S,^<?^$2\1?] 2__ ._#?X4?\(EXB_Z E_\ ]^&_PKZ.
MHH_M>I_*@_L>G_,SYQ_X1+Q%_P! 2_\ ^_#?X4?\(EXB_P"@)?\ _?AO\*^C
MJ*/[7J?RH/['I_S,^<?^$2\1?] 2_P#^_#?X4?\ ")>(O^@)?_\ ?AO\*^CJ
M*/[7J?RH/['I_P S/G'_ (1+Q%_T!+__ +\-_A1_PB7B+_H"7_\ WX;_  KZ
M.HH_M>I_*@_L>G_,SYQ_X1+Q%_T!+_\ [\-_A1_PB7B+_H"7_P#WX;_"OHZB
MC^UZG\J#^QZ?\S/G'_A$O$7_ $!+_P#[\-_A1_PB7B+_ * E_P#]^&_PKZ.H
MH_M>I_*@_L>G_,SYQ'A/Q$#G^Q+_ /[\-_A6SK</C/7XX(KK1;F."#)CA@M"
MB GJ<>M>ZT5+S23:DX*Z*6512<5-V9\X_P#")>(O^@)?_P#?AO\ "C_A$O$7
M_0$O_P#OPW^%?1U%5_:]3^5$_P!CT_YF?./_  B7B+_H"7__ 'X;_"C_ (1+
MQ%_T!+__ +\-_A7T=11_:]3^5!_8]/\ F9\X_P#")>(O^@)?_P#?AO\ "C_A
M$O$7_0$O_P#OPW^%?1U%']KU/Y4']CT_YF?./_")>(O^@)?_ /?AO\*/^$2\
M1?\ 0$O_ /OPW^%?1U%']KU/Y4']CT_YF?./_")>(O\ H"7_ /WX;_"C_A$O
M$7_0$O\ _OPW^%?1U%']KU/Y4']CT_YF?./_  B7B+_H"7__ 'X;_"C_ (1+
MQ%_T!+__ +\-_A7T=11_:]3^5!_8]/\ F9\X_P#")>(O^@)?_P#?AO\ "K6F
MZ%XHTO4;>^M]$O?.@<.F^W8C/O7T)10\VFU9Q0UE$$[J3/GB^\/>)M0O[B]F
MT2]\VXD:5]MNP&6.3C\Z@_X1+Q%_T!+_ /[\-_A7T=10LVFE910/**;=W)GS
MC_PB7B+_ * E_P#]^&_PH_X1+Q%_T!+_ /[\-_A7T=11_:]3^5"_L>G_ #,^
M<?\ A$O$7_0$O_\ OPW^%'_")>(O^@)?_P#?AO\ "OHZBC^UZG\J#^QZ?\S/
MG'_A$O$7_0$O_P#OPW^%'_")>(O^@)?_ /?AO\*^CJ*/[7J?RH/['I_S,^<?
M^$2\1?\ 0$O_ /OPW^%'_")>(O\ H"7_ /WX;_"OHZBC^UZG\J#^QZ?\S/G'
M_A$O$7_0$O\ _OPW^%'_  B7B+_H"7__ 'X;_"OHZBC^UZG\J#^QZ?\ ,SYQ
M_P"$2\1?] 2__P"_#?X4?\(EXB_Z E__ -^&_P *^CJ*/[7J?RH/['I_S,^<
M?^$2\1?] 2__ ._#?X4?\(EXB_Z E_\ ]^&_PKZ.HH_M>I_*@_L>G_,SYQ_X
M1+Q%_P! 2_\ ^_#?X4?\(EXB_P"@)?\ _?AO\*^CJ*/[7J?RH/['I_S,^<?^
M$2\1?] 2_P#^_#?X4?\ ")>(O^@)?_\ ?AO\*^CJ*/[7J?RH/['I_P S/G'_
M (1+Q%_T!+__ +\-_A1_PB7B+_H"7_\ WX;_  KZ.HH_M>I_*@_L>G_,SYQ_
MX1+Q%_T!+_\ [\-_A1_PB7B+_H"7_P#WX;_"OHZBC^UZG\J#^QZ?\S/G'_A$
MO$7_ $!+_P#[\-_A1_PB7B+_ * E_P#]^&_PKZ.HH_M>I_*@_L>G_,SYQ_X1
M+Q%_T!+_ /[\-_A1_P (EXB_Z E__P!^&_PKZ.HH_M>I_*@_L>G_ #,^<?\
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M_0$O_P#OPW^%'_")>(O^@)?_ /?AO\*^CJ*/[7J?RH/['I_S,^<?^$2\1?\
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MT2_U$1^:;2VDG\O.-VU2V,]LXKGH_%.LVD.G7FL:-:1:??20Q">TOFE:)I2
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M\-5#$*=&?(SP?W$5)X<L- U+17U?Q T#:REU)]LN;B?9+:RB0@1JV08U "@
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M&&6<2SH7MVEMI(TN HR3&[*%? YX/3GIS0!J?8;0($^RP;1+YP'EC DSG?\
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MJ;=V=M?VSVUY;PW$#_>BF0.K?4'@U0B\2:1-HTVKB^1;* D322 H8F!P596
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MIVJW4EI"UQ#=QIYC6]U;R02;,XW!7 )7/&1F@#2$$(N&N!$@F90ADVC<5!)
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MTJ\:^00:K(D=DY5OWK.,J,8R,^^,'@\T ::6\,7F^7#&GFMODVJ!O; &3ZG
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M/+:IODC.Z; V]2#STS@@?44K[1=2U32/$-\VFRPG5=0LI(K)\%_*B>(,[@'
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MSP>>WOFM7P[K']O:#:ZEY!@:4,)(BV[8ZL589[X93S26.D&SU_5=3,P87PA
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M%JT<MUL8,H<ER%&0"VT<XXQFMBTT@VWB34]6,P87L-O$(]N-GE^9SGOG?^E
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MAW8Z+C(') /'(-SQ'X8U3Q!]HLY;ZP;3IG5D:6SS<6V,9\MPP&<C(8C()[T
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M".W6X!B$J!B[>8!S&%4MD#)! QDT[6[[4;3PSJ4GB#2=,NX8_**)'(S1S9D
MPRLO!4X/?/'2K-SX9N[C2[#_ (F4::O87!N8;M+4+'O(92IC!'R%6*XW9Q@Y
MSS27VAZUK6BWUCJNHV0-QY8B%M;,%CVN&))9B6)QCL!B@#/4ZLWQ9E!AL3;_
M -EH"3(^[RO-;G&W&[/;.,=Z@M?&-K8>%/#8LK/3["75(2T$$TXAM[=% +$M
MCH-R@ #)+=N374KI!'BI]:\X;6LEM/*V\Y#EMV?QQBL./P3+;:'H,%M>P_VC
MHT1BBFFM]\4JL '5DSG!PIR#D%1]" ,M?'UO%:ZP;]K2:;3($N"^FS^='.CD
MA0OHVY=I4^H.<&J/BRY\2-X?MSJ6FV*037]EN%M<,[VY^TQ$;LJ PXP2,8)'
M!'(W1X:N-1T?4K'6KFV9;Y!&$L;<0K !T*DDLS9P<DXX& .<T[_PYXDUBS@L
MM1URR\B"X@F+V]FRO<>7(KX?+D#.WHO?!Z#! -SQ+<16GA;5[F>VCNHH;*:1
M[>7[LH"$E3['&*R9]>U"/5=+T72=-MBUUIYN@\LA2.!5*+C &2/F  &/PK;U
MO3CJ^@ZCIHD$1O+62W$A&=N]2N<=\9JI!H30Z_9:G]H!%MIS61CV?>)9&W9S
M_L=/>@#,3QC-!H=_/>V"G4[._&G?98),K-.Q3R]K$#"L)$/(XYZXK/UZ;7_[
M1\-1ZK9V0B?5XF$MG,S"-@DGRL&49Z\,/3H.*UKCP>+JVUF)KUHY+[44U"WF
MC3YK>1$B"'!X;#19[9!Q4<^@:_JE[I<^J:M9"/3[M;@0VEJR"8A6&6+.2.O
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MI.ICVYW^8%'7MC;^M85OX2U/387T[3+_ $^+33(S1/-8^9<0*S$E%.[:V,D
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MUC_XF!3(4]R"<^N3757<5QHFK>&;*'4;Z=+O491<-<S%VD'V:5L'L!N4' P
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MNREF3: H^7(^8\'G%9$%I/8^,'T-=4U&6RO=,DN#YUP7DBD21%RCGD9#].G
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MN]ES%;6WV,.P"QNR/G&00"<=<'G% '8T5R?A6Y$>IW>GSMK<%V(4E-GJ<RS
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MZ=]N<=LU0UB_F@\8>&[..X9([DW)EB!_U@6/(R/8D5S_ (6T)M3L-6F.N:A
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MBECGB26&19(W 970Y# ]"".HISNL:,[L%51DL3@ >M &+I_A+1]+NX;BUAN
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M+B547/IDGK6/I&MG5/%VJ0V][%<Z;'8VLT!B963<[3!B&'7.Q>_:@#HZ***
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MR*Y1L '@9[5M+>V.O>.]'O=!83I:PSB_NX5(C,;* D1;HQWX8+SC:>F>>V)
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M^MXH;FV>;RG5HRVUT8@@@AR"#CH"/2@!9M5BFU/1I)M/U.&_EBNC#:M*$ *
M;E<!]C$\;3DCG.1FL2W\3W.H^$->N=>TS4(+6UFN4:6WGC1]J3%0BE'W!@
M3P#@\FMW^SM5OM;T'5+V&V@:T2Y$\44I<+O"A "0,G YX'-8\_AS6I/#/B30
M1;VVR\FN9[6Y\_[_ )LI<*R[?EQN(SD]* -GQ%XHE\.0S7$NAWMQ9Q!?](BE
MAPQ. %56<,6R0 ,<GI4EUXD>.Z@L;32;N[U%[=;F6V5HT^SHW \QF;:"2&
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M7?F*T8(+")-H.6QCYL8SWKIIGU8W\\4$-JMI]ES#/([%O/R?E9 /N8P<@YH
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M8R,P1%!X ^1B20>P%5_"L=_%XO\ %":C+#-,/LH$L2; Z[&P2N3@^O/;/?%
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MJ D C) 4'J,X[9J_%J^HZ)KE]8:K>#4+>/36U&.581&Z[&PZ$#@CH0>O7.:
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M!TYZT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?F&XA2H^H)[U=L+;7+KQ7XP73-1M[&-+V$JSV_FF23[+%P<D84 #IR<]1CD
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MI$'9&()1U";&7A>,=0#G-6]'T&/2KBZO);N>^U"[VB:ZGVABJYVJ H"JHR>
M.Y)R:UJ* ,K6]#76!9R+=36EW93>?;W$(4E&VLAR&!!!5F!!'>H]'\/)I.HW
MVHO?W5Y=WR1+/).5P?+W8VA0 O#XP/0=\D[-% !1110 4444 %%%% !1110
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MPQ0 S3K.SL+)+?3XXX[9<[5C.0,G)_6N-L-/TK7M:\1-XC6.>[M+PQQQ7$A
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M!(SCIDFND2RM(S;E+:%3;H8X-L8'E+@#:OH, <#T%/2WACFEF2&-99<>8ZJ
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MG SCM73VEAIFN^*/$0\0K'/<V=PJ6UO._P L-MY:%9$&>"S%\N.<C&>*ZA=
MT9-3.IKI-B+\G)NA;IYN?7=C-.U#0])U:2*34M+LKQXO]6UQ LA3Z$@XH \Y
ML[J&+P9]I@OY9[*'Q3&?M4DI;]R+I1DL>JX[GJ.:ZJ>^BE^*FGVD<X9X]'N7
MDC5LXS+!M)'X&KVA:$;*PU2TOHH)8;N_N)Q%C<ICD;(!!&.G45?L=$TK2P@T
M_3+.TV!@OD0*F V-V,#OM7/K@>E 'G5I;_VGX:\!6MQ--Y<^H3+-LD*F11%<
M$J2#G!Q@^U7-:T]F\96F@Q:;ILVE0Z<)+.QO+IH(7D\QA(0JHP=E&S@]-V1U
MX[]+"SC2!$M(%6W8M"%C $1(()7C@X8CCU/K3-0TK3]7MQ!J5C;7D(.X1W$2
MR*#ZX(ZT >?II=S<>'WT]]3T?RAJ_P#HMB;]Y874)\UHSE58_-N8+@XP!@@8
MKI?!<UM]CU"R@T_[!)97ABGMX[@S0JY1&_=-V7##Y<+@YX%;$FC:7+I@TV33
M;-[ # M6@4Q ?[N,5-96%GIMJMK86L%K;K]V*",(H^@'% '':UHVDS_%#1YK
MNUA+S:?=.6<XW.CV^W\0,U0L_#>FZK'XRNKV)IIUU&X$+ER# 1$A#1X/RMGG
M<.>!Z5WU[IMAJ/E?;K*VNO)??'Y\2OL;U&1P?>I4M;>-952")1,Q>4*@&]B,
M$MZD@=Z /,[FZU#6F\'V]Y%:7EM>:0+AH;VZ:"*YN=L9.[:C;R 20I&.2>U=
M-X+M;BSEU>!I;!;1)U$5G9W;7 M&V#>F65=H/RL%QQDUOW.DZ;>:>MA=:?:S
MV2@*MO)"K1J!P %(P,=JDLK&TTZU6UL;6&UMT^[%!&$4?0#B@#E_$]A%J?C7
MPU9W1=K5X;QI80Q"R@"+"L!U&<''M63I_A72KR]\5V=Q"TEM8W AL8C(VVT#
M6\<I,7/R'=(3D>@'05Z$UO"\\<[PQM-&"(Y"H+(#C.#VS@9^E(EM!&\SI#&K
M3'=*54 R' 7+>IP .>P% 'GD5[_PD&C>$]/NM.MM3O[K2$OG;4+EHX/N1AF*
M@'S&RW0CCDY&>:=E=2MX)DB6=&CMO$]O;Q>1*SHL?VJ+Y58\E1N('MQTKT2[
MT'1[^T@M;S2K&XM[< 0Q2VZ,D0 P-H(P...*F73;%(?)6RMA%YBR;!$NW>N-
MK8QU&U<'M@>E '(PZ%8:[XZ\3+JD1NX(EM1'!*Q,:$QG+!>F[@<]1CC&37/F
MPL]4\->"I]507,BZJ;-IIV)9HU\]5#'O]U>>YKU1+>&.:29(8UEEQYCJH#/C
M@9/?%5YM)TZXL#83:?:R69.3;O"IC)SG[I&.O/UH X&^M)=2\:ZCITNG:7>V
MEG;0?8+:_O7B18BOS2(@C8,=P*ENHV@<=V26EQ<Z!X6LKK48[B&377C62RO'
ME!@V3XB,N%+8 V$^@KO;W0='U*"&"^TJQNH8!B*.:W1UC'3"@CC\*L_8K79
MGV:'9;D-"OEC$1 (!7TX)''8T <6GV+PCXFUU+2!X=+CT5;^2TM\@;U:0,R#
M/RL54#C&<"LBQB.F^)?"EQ;V6FZ:=1F<,EK>O/+/$8)&_>DJ ^&"'=SSC!.:
M]--M 9VG,,9F9/+,FT;BN<[<]<9)X]ZI6?A[1=.??9:186S[_,W0VR(=V"-W
M ZX8C/N?6@#AH= L=3TGQ??7JR374-_>?9I6D;=;;1D&/GY3GG(Y/T JR)$U
M[5_#5IK\F^QN='%RD,C;8[JZ^3<&'1B%.0I]2<<<=XMI;)'+&MO$J3,S2J$
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MN.>02 1CO5;6+J\\4:9:Z/;Z%J%E<-<V\D\MS$$CM!'(KDJ^<.?EPNS/7L*
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M=@ *J267+#/S'M0!9\1^,+"]TNS2PN;R&2?4;(0R26TT"SH;F/<$9E <%<Y
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M''M5ZB@ HHHH 1AN4@,5R,9'45F:-H<.C"Y=;BYN[FZD$D]S<L&DD( 4 [0
M  ,   ?F:U** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M ,.^\-"ZOY;RWUC5;"2< 3+:SKL? P#M=6"G  RN#6AI>EVFC:='8V2%(8\G
MYF+,S$DLS$\DDDDD]S5RB@"C9Z5!9:EJ-_$TAEOW1Y0Q&T%$"#;QZ >M7J**
M "HKFW2[M)K:0D)*C1L5ZX(P<5+10!6TZRBTS3+2PA+M%:PI"A<Y8JH &??
MJS110 4V5#)$Z!VC+*0'7&5]QGC-.HH S=&T6#189Q'-/<SW,IFN+FX8-)*^
M N3@ <      "M*BB@ HHHH **** "BBB@ HHHH *BBMH()9I8H422=@\K*H
M!=@ H)/<X 'T J6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\B0S-Z)*RA'/I@G/:I-2\5:3I-S)!=RW :)0TSQ6DLJ0J><NZJ548YY(XYK
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M*L6!*D':,@A>V:EN=%GNO"FOSVMKK$EU?S08_M#8)9EC9,,$4#;QD?,,X44
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M[S?+R!@@_6I#KVLZ9=V(UW3;.&UO9UMUEM+EI#!*_P!Q7#(N03\NX=R.,<T
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M[HN,>K,>]59O"=]:ZC?S:4=)>"^F,[+?VAD:"1@-Q4@C<"1G:<<D\X.!V%%
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MBK-U?5UTDZ>&A,GVR\2U&&QM+ G=[]* ':-!J%KID4&I2VTL\8";[=&52H
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MULMDGDD]!Q4K:'KFJW5A_;E]8M:64Z7(CLX75IY$Y0L68[0#AMHSR!S7444
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MA1Z*+5&TU+<6P@DRX\L#:%.>3P.]5=.\+:9IEXEW%]KFFB4I"UU=RS^2IZA
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MHLS[B=P3.WCH,;CTH X]=;D_L'4A>7NH":36Y[*U%DJF=\2';&FX8'RJ>3C
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M;<W/@/5U6 S.L!=5";CP020/IF@!M_XF@B\0:(T.J6O]D7$%V\\PD0QDQ^6
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MG4R+CKE0<BD?6=+BU!=/DU*S2];[MLTZB0_1<YKE_#NI>$'L-(TVT6S34(5
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M=R@VGE1CD ] 0*34+RPTK7KM;.ZT_49;C5(Y)M'O;4BZ\TL@WPMU(& P)4C
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M74&2)NI5<;@2I&!PP%:5HVG6?BOQ?9NL$-[<;);:,J%>2/[*H9D]1E6!QWH
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MM/?SV,<F;FW1'F3:?D#YVY/3)VGC/\Q0!:HHHH **** "BBB@ HHHH ****
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MT[3\22S7XD:,Q@%51%!+L<_=Y4<9Y85=E=HX7=8WE95)$:8W,1V&2!D^Y H
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M7.,COQ51O$NEZUH^GZBAU**"354M8Q&3$YE64H XSG82.0><=1VH ZK ':C
MSG'-<W<^+U35-1TVRT;4]0N=.*"Y%NL8"AD5P07==V0V,#G(/'0G:TS4;;5]
M+M=1LWWVUS$LL;$8)4C/([&@"U@&BLC7KBUMWTH7,EXAEU"..+[-)MW.0V _
M(RG!R.>W%9.B^*[V\UW7;6_TJZM+.QF4">4PA85\E'/F%9"2222" 1@C..<
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M)P<#BLKPE?+J'BKQ5.()[=O-ME>&==KHPA (."1^()!Z@D4 =A1110 4444
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M?7UKIMG)>7MQ';VT0R\LC;549QR?J: ,)K'5=0USP_JEW:0VQM1<^?$DWF;
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ME,A)ZE7(&3C(&:L:]X9F;Q1+K46FMJ<-S;1PRP)>-;R1LA8JRG(5@0^""<C
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M[8<G\!68?"LL%U='3=;O;"TNY6FGMHEC8!VY=D9E)3<>3C/))&#0!'\.]_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MLKJ\6-)5"))&0@P/E8=?<$=>XH7P?:#1I+![JXDDFO8[ZXNG*F2:5)$?)P,
M?NU7    P* ,W28M9/Q*UX/JENUJD%J[0_93DHQGVJ#OX(QRV#GT%=!XG&?"
M>L@=?L,__HMJ8="9/$SZU;W\T)FBCBN;<(K),$+%#DC*D;VZ'GBM9T62-HW4
M,C AE(R"#VH PK!A_P *^MFR,?V4AS_VR%.\$C'@+PZ#U_LRV_\ 12UF#P1<
MKIQT6/Q'?)H17RQ:"-/,$7_/(2XW;<<>N.,UT)TTI=Z?);7<UO:V<;1_9(PO
MER@@!=V1GY<<8(H Y2)]2\!Z;=17>G)J.@12S7#7=N_[^&-W9V,D3##A=QRR
MG) ^[7<1R)+&LD;!D<!E8="#7+7?A"]O;>XT^?Q+J#Z3<,WFVSHAD*,<M'YN
M-VTY(]<<9K=CT]XM46Z2\F6V6V$"V0"^4"&SOZ9W8XZXQ0!#XCUC^P/#]WJ8
MA\YX5 CBSC>[$*H)[ L1S6?YVO:+:7&J:QJ-C=6=O;23W$,%HT;(57=A&+G(
MX(Y'Y=*V=3TVUUC3+G3KV/?;7"%'4'!P>X/8CJ#69::!>HWEZCKUUJ-F(VB^
MSRPQJ)%88_>%5RQQ]/?- &-<ZOXGTWPW_P )/=SZ?);QPBZN--C@8%(<9(67
M=RX7G)7!(Q@=:MRZCKVI^*]2TG3;JSM+6TM;><3R6YE<M)O^7&X#'R9S^'?(
M/^$*=[*/2KG7+VXT2/:!9.J99%.1&\F-S)P!CJ0,$FMRVTF*VUR_U59',MY%
M#$Z'&U1'OQCZ[S^5 '&P>)O$K>%[;Q3.]@EL)DCFT](6)*>:(F82%N&SE@,8
MQ@')YK8EOO$&H>+-3TFPN+.SL[2&"3[1) 99"S[\J%W ?PYR?I@YR+7_  B=
MK_PB7_"/?:)O(W;O-XW?ZWS/IUXK(72KR[^(6OW%GJ5Q82K:V:AEC5XY 1+D
M%6&"1Q@C!&?>@"S#XDO(M,UN#4KO3[/4-*F6%[QT;R'#JK(^S=G)#8V[OO#@
M\U'X?\2WEUKMSI<]S]M06?VN*X;3Y;0@AMI7:_##D$$>X-7&\%VS:1-:M?73
M7LUVE\^H-M,IN$*E6QC;@;5 7&,#'O4]AX:DM]:?5[S5+B]O'M6M3N140(6#
M#:JCCD'U)S[# !SMCXC\3?\ "*:+XHO9K V]VUJL]E%;L"$F=4WK(6^]EPV,
M8QQ[UIZCXK?1Y_%4\UO')%I5O!)&J##2,ZMPQ^N!TXR:T/\ A%;8>$;'P[]H
MF^SV8M@DO&YO)='7/;DH,_6I9O#5C=7&LO=;IHM6BCAGB;@!54KP1R#\W6@#
MFK'Q9J":IIL<U_;ZDEY,(9X;?3IH3;E@<,KL3N4' .[!P<\8Q5BQ\1ZE-XE-
MG>ZA9V,ANY(4TVYM'1I8E)"M',6P[$ -P".2,<9K9L-!U"VNK=[KQ%?WEO;9
M\N%TC3?P0/,90"^ ?89Y.34$OA6>ZO8#>:Y>7-C!=K>1VLB1Y#JVY09 -Q4-
MT'7@#)% &_<K,]M*MM*D4Y4B.1TWA6[$KD9^F17F>@ZAK^B^!].:VN+&YEO-
M7>TB62W9%C#3RAF8ASNYYXQ@#'/6O4:Y^+PG:PZ5I]@+B8I97QOD8XRS>8SX
M/MER/PH JW%]KB:G8^';>]M6OY+>2[N;][8A4C#A5"1!N6);'+8 4GG.*J7O
MB35]&M/$=G>M:SW^FZ8VHVMS'$425,. '3<<$,G.#@@CI6[J^@C4;RUU"VO9
MK#4;562.XB56RC8W(ZL"&4D ^H(R"*I_\(?%-I^L17U_<7=YJUL;6XNW5598
M]K *B@84#<QQW)))- &7<ZIXLM;K18VN--9M98Q!/L[8LV$9DR#O_>856&#M
MR<'@<5KZ!J.HOJ^K:/J<L-Q-8^3)'<Q1>7YD<@8@%<G!!1AP>1BKUSHL-U=Z
M1<-*X;3)6DC QAR8FCY_!R?PI]MI,5MK=_JBR.9;V.&-T.,*(]V,?7>?RH P
M?B.-0_X14O8WD=MMN;</NB+ELSQ@8(88P>O7(XXZT_6M4OM,2QLYM?LX;R1'
M:3RM-DFEEP1@I$KDA1GD\]NF:V]<TB+7='GTZ:62)9=K"2/&Y&5@RL,@CAE!
MYK,E\,WC7\&I0Z[<1:BMM]EGG\B-A-'N+#Y2,*02<$?B#0!S&I>)3?\ @[2=
M6U!=IM-=2.=HX'7<(IF4L(S\ZY"YVGD9Q6O=Z_JW_"":SXDDBLUA-H]Q86I'
MF8C"Y!E8'#%NN%X XR>M7[;P;:VVF6]B+RYD6#4O[1$DA!=Y-Y<ACCD$DTDO
M@RT;3=9TR"ZG@T[5(V4VJX*0,V=S1Y'RYSDKTSR,9- $>H:EK=QXO30]-FM;
M: Z>+N2XEA,C*WF%<*NX YXZ],'KFJ*>*]571A;M':R:R=7;2$EVLL+.,MYI
M7.0-@)VYZC&>]=,ND1+X@.L>8_F_9!:;.-NT.6S]<FL+6M#TS3]%OGNSJ#QS
MZB+[SK.,M+:RDC$BA03A<9/!X)R"* '/>^(])\1:'87EW97UGJ$TD<DRVYAD
M0K"[@ ;B""5Z]L$<YR.LZ5YS8(-:\9Z'=6NL7^LKIYFEGN981%#"K1,@4;45
M2[%@>Y 4]._HDL:S1/$XRCJ58>H- ' KXQNXM4L&35;;4K6ZO4M72VTV98D#
MMM!6XR4)!QG)YYQBM%;_ ,2ZMKWB"QT^[L+.#39XXX7DMFE:4M"DFUOF& "Q
MY')R.F.5@\#M':Z993:Y>36.ES0RV<'EQKM\H@J'(&7P!CMUSR<$;UAI,5AJ
M.J7B2.SZA.DTBMC"E8TCP/P0'\: ,#2/%=W?R>&[JXABBLM:LS@ ',5T!OVY
MSRK*'QW^3WK5\-:I<ZU8W.H2B,6LEU(MEM&"T*G:&/KN*LP]B*YGQ'I=M8^$
M-.\&V$\\FIEH%L753YD6V09F) P H#$^HX[UW-C9P:=86]E;($@MXEBC4=E4
M8 _(4 8WB?57TY;2*+5K:PDG9L![1[F60 =(XU.3C/)P<5B6OC/4)M .R**7
M5&U7^RH))8)((V8@,)'C;YU 0DE>Y'!YKH=6T"2^U2UU2SU"6QOK>)X/,6-9
M%>-RI*E6'JJD$8_&J4?@FS72KRREOKR62YO1?B[+*)8IP%PZD# Y7.,8Y(QC
MB@"AXHMO$UOX,U\S:U92HNGS.)$LF1QB-MRC$F!D=&Z@^M6;>^U/3Y?"UG>3
MVMVU]*Z/*MN8RJ"W=P!EFYRO)[@]*OIX>NKFSOK75]:N;^&[MFMFC\J.)55@
M02 H^]@]<X]J+;PV\;:0]WJ<]W+I<KO$[QHNX-$T>U@H'0,3GUH SK*_\1^(
MH+K4M+O+"SM$GEAM8)[9I3-Y;E"TC!QM!93@ <#!YZ57_P"$LU35HO"YTF.W
MMFUA9O/-PID\@QKEL8(W8(8#IG@UI/X4N(9;M-+UV\TZSNY6EEMXHXVV.YRY
MC9@2F22>XR21BK</ABQM9=%-KNABTB-XX(E.00RA3DGDGC.?6@"'P_J.HR:K
MJVD:G+#<3V#1,EQ#&8Q)'(I(RN3A@58<'!XZ51^(XU#_ (11GL;R.VVW%N'W
M1%RV9XP,$,,8/7KD<<=:WK728K76M0U-9',EZL2NAQA?+# 8^NZC7-(BUW1Y
M].FEDB67:1)'C<C*P96&01P5!YH Y348=;_X3S0X(;VT-ZVE7@FNS;$*J^;
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M"_DJ8DC3#(5.54<GD'/MP!DY1/"L[WUG)?:Y>7MK97'VFW@E2,$/@@;G !8
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M7B\VWDB$JCJ49U <<_PDU%'XS\/RW*0)?DAY/)2<PR"!WSC:LQ7RR<\8#=:
M-:]L+34K1[2^M8;JVDQOBF0.K8Y&0>.M);Z=96C*UM:00LL*P*8XPI$:YVH,
M?PC)P.@R:5+^VDU&:P64&ZAB262/!RJ.6"GTY*-^54I_$NC6UB]]/?QQVJ7+
M6K2N"%656*E3QV((STXH N'3K$VT]L;.W,%PS--$8AMD+<L6&,$GOGK4&FZ%
MI.C)(FF:;:6@E_UGD1*F_P!,XZU5M?%>CWBW1BGFWVJ"26)[65)0AZ,$90S
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MH._6@"U;:+I=EITFG6VG6L-E(&$END*A'###;EQ@Y'7/6KJJJ($10JJ,  8
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MKO/JUU&$BBSY2/<2LLC D83&#GW%=;110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*7DDD;"JHY))["O-[>#4]0U#PU/(GB&XN;>]6:_>^B\J*$^4ZG:H !Y; *Y
M'4\\]?XSTRZU?PO<VMG&LLX>*986; F\N17,9)X^8*5YXYH ;#XUT&>:"+[5
M-$]RZQVXN+26+SBQ &S>HW#)'(R.:U[>_M;JZN[:"4/-:2+'.N"-C%0X'O\
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M$M?+D(X<JC!L?3BJ7B:?4DUVUC9]6BT9K=B7TN#S)&GW<*Y"LRKMZ$8&<Y-
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M65S<HHM;MKBVFBD@;_EEL9HW /\ >P2/7'>NHU'4K/2;)[R_N$@MTP"[>I.
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M,4VXM@L_W4!S\VX@]>O&=+1M"OM*UKPO#,&F2PT&6TGN!ROF;K? S[[&Q]*
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MFU2X.FZSXAT@:QBQDD"7DNI>7;AXFVLJP!L.FY2OS+D\X/0UUD7_ "5"Z_[
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M?OX UKQ(^M:G_:%C-?S6I%TXCC6&:0*C(#M<'9CY@>#@8P* /4:*X^X,NO\
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MSZ5*;&V;44U Q W21-"LO.0C$,1^:@_A5BB@#/\ [#TT:,ND?9$^P* %@R<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+_H--_X#Q?\ Q-+_ ,+/\9?]!IO_  'B_P#B:Y*DQ1R1[!SR[G7?\+/\9?\
M0:;_ ,!XO_B:7_A9_C'_ *#3?]^(O_B:Y'%+@DC /-')'L'/+N=;_P +/\8_
M]!IO^_$7_P 31_PL_P 9?]!IO_ >+_XFN1((.",&EHY(]@YY=SK?^%G>,O\
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MDCV%[27<ZH_$;Q6/^8LW_?B/_P")IH^(WBW_ *"S?]^(_P#XFLW0=&EU>\"
M 1KR[-P,>U>@:;X(@2/>LB;B<G(K.;A'H:04Y=3DT^(GBUGQ_:S'G&/(C_\
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M*ANO$FH)<#RKH[.XV+_A5&_OXXV*Q@?-VK&:4D[J22'=FW<^*=6B7*W9&?\
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M /!H$QM%+10 4F*6B@+!11C-+B@+"4HZTN**!A1BBEI )BEQ3MK \J1]110
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M6*Y2*:4NY IJRL.*G6(1J2PYJ/REE^;.*0['REBBBBO2//"E%)2XH 6BBB@
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M5?+XS\PR,U4K?U2 V^BPIT/F8//7BL"KIRYE<52/*[!1115F8444E "T4E%
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M*HY-<.)QJ@K0W/=R_)Y5'SUM(G:^"='357>]E0BSA?"Y'^L;T%>G1Q 1EG
M485,<**RO"NFR:+H,-M=QJL^XE8Q_#]:U99DC!>1@(DZDG'-<\+VNPQ37M7&
M&RVL*S>6F\X#'G_=%>%>(;[[=J]P\?\ JC(QQZFO0=?\;6MI!-'#^_ED4KE3
MPH^M>5[C(Y<]SFN:O)-61[&5T*E.\Y*URQ OS UT.G'_ (FMA_N5@VXK>L5Q
M=:8_J64_A58-_O#3.U_LR]2K<C;K\O/2:K^O&$746]26,0 ([<FJ%_\ +XBF
M]/.']*M^)!_I5J1WB_J:]A;H^,?PLR]N#P<CTJ[:Z5-=1B11A?I5%8V(SVK6
MANI_LHV?*$X# X-:._0R1T.AZ>8HE:7'3#[AU'TKB_$^BMI=^TD*DVLS$Q^W
MM6O9ZE>"95,VX*PR3U(J/Q9K<$L26<.'*G<6[#V%3!/F+;5CES)':0\?/<-U
M/9![>]46<L<G.32NQ9LFF5T6L0A:,]J!3B..* .JTF8SZ7&3U7Y36=K,KNXB
MC4D+UP*M>% US*;->2SKC^M>M6>E:?;7)$=O$0I&/ESS[UX%"DJ6+E-KT/2G
M+GHJ*/!H[*[=@%MI3GT0ULVV@:K/C;838]6&!7T";--\?EQH/4!167=P,)W!
MZ#M7J?6GV.3V"[GG^B6=WIVFR6]S&%W/NP#FKURYW)SU05;U(,LS-&"01R.X
M/M5&0&6-' 8;5P017.WS2N;-)1L1%B>]&XTT4H4DU1F.!)I[<(<^HIT4)8]*
MDN(2D#-BE+8J.YER^&8KG5YKFY<F-V#!%[\=S72:?9P6:;+:%(A_L+R?QJ9(
M=ZI(?NE15E1Y:#:,D\"LDHQV.J=:K45I/0Y_7?%$^FRO96L16; S(W;/I7&3
M7,UQ<L\LADD;[Q)R:W/&\T4%_'%UNMGS'L >E<VB"*-LGYL9)KSJTW*;3/KL
MLHTH4%**LSTGP[YJ6&ERN,+YAVGU%>@PW(D&W/ KC;.U:+PYH39Q@JOYYKHI
M(Y+=\'BN^FO=1\GB7^^D_,WX)%3DFIGNTV\G]:Y&?4G3(+=*J_VJQ_BK3EN<
M_/8ZZ;4;:*)I)9%CB499G. *XR\\?S7$SV?ARR-S(#M^T.OR#WQ3M3:PO])=
M-1E,=L&#,0>OM6-'?7=R@L_#&EF.!>#,RX%8U&T['=AJ<9+F:N_P(K_1WNO]
M*\6ZZ[ <^0C8 ]A5!?$&G1YL- T91$_R/.RY;;ZUH#PE$LHG\0ZDTT['(@0Y
M-:IMTL[4Q6%I#:18^:24?,1["LTCJG.*C9Z_@CF;O0)=35+N^U5;33%0 *SD
M\CKA:I'7-*T0>3X<TDW5T!@7=RF\Y]A5K4;C3+:"!KY@7P0JL>.#UQ6'=>+K
M.!2MG;[CVP-HIM:W(IU)./*E?\CFKVXN9EN([VY9)4DWB KU8]359L;8)8X6
M7G!D;D,:N,VH:E>SW,5IDSC#97@?2K]MX9*0J;^[VJ.?+4]*]-58\JNSS)4I
M<_*D4K+3[G5]4GM8=TK$9+0\)GU)]*WAX-U%G5#=PQ[1M^7/3\*KPZU-I$3V
MFAV6Q&/S2%"S/]34]I)XKOF.Q95]]NVN>6,=_=.J.!;7O-(U+;X?V\2 W6H/
MCN$ 6O4/ UE9Z?I,MK8OF)),\G)S[UY*WA?7[I@UQ='/H\A.*]*^'6F2Z'8W
M-K+,)69@YP.E9.M.>C%4H4Z<;J5V26U[]@\0:DF.)&!Q5RRNQ]KF^UD+W4$]
MJHW<+2^+KJ.)0QDA# &F#2KJ6Y>:6-@FW%7&QQSN;%GJ]O/>-;1]!T85T49'
ME#G/%<?:)'IMKN1,DG(/I6S!J2FU#L<420XON69RCYP#1%M5>>E9\]XBQY#
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M707M^==FMI;>(K& V U5=8L)1X=%NN"YN>?P%=--Z(YZL7%M,X0 TO/XU?\
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M;#",=3UJPS+$K-V'\ZSXV,DI=NYKLD[:&:/8/"*"+0M';C'G'K[UZ%;Q9+C
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M5,W:+9<5>21U6D>%(K,1?,V=P:67'WL=A7%>+=0D.L7*@_.7Q]!V%>MW$X1
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MQNWT-M-GST! 'K7*7:0V[D0.JANBDXS6)K'CJ/<8[-3-+TS_  BL#3[NZO\
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MG&%1,9,_,>Y[5S8]['MY!'63L,BBPPD?#2=AV6I#J4<>]$R9#D>8#TJG=7)
M,49P3U-0Q*JC.#@=/K7G'T$Y)^ZC02UG9%98G<'NHS72>'M(-O*=0OV\J.(9
M4,>IKE[:[N;9\Q2N@]C5N;4+FZ4+-,[*.Q/6K32U.>I3J3]U.R-#6]3_ +4O
MRZ$^6@VIGT]:@LD+3%.Y1@/RJI&N.:OZ6X74[8GH7P:47[Z9I5IJ.'<5V+EU
M_P @"T_WS6= <7$9_P!H5J7R;-'B3^Y.R_SK+BXF3_>'\Z]R/PGPDU:9=UL8
MU63W /Z5G[%*D,,@UI:X/^)FWNB_RK/'Z525X"4N6I<W_$F/[%M3Z2?^RU/8
MY?PQ=#ULV_F*B\0*9-"MP!_RU'_H-6=-7&@3K_TZ.*\EJTVCVZF(BL.E%Z[G
M!1HH<G/"#)/O2PL6RS#-7;6(!'W+][^53B) ,!1^5;4\*Y1N?/U:DZTN:;U*
MD:Y;[M78SM%)MQ_^JGBME@E]IF7LTV:]GJT5OIBV[QL[K(6X/!4]JOV^H-<V
M[1!55/+8XSDYKFZOZ2S?:\ _PG&:T>'A'5';3KSY?9WT,[D]>M**>YS(W ')
MZ4E=2V.9[BKUJ_K5O'+/!(X)/E"J'>M75ON6K=C'64X1E)71O1JSIQ;@[&6%
M"C@"CK2T5JHJ.R,ISE/XG<4<5K:(<3/]!_.LD5J:,<3N/]FHJ_"QTG::(=4&
MW5+@?[9JD>:T-7'_ !-)SZG-42*J&J1,]V,QVIR_*R_6C%!'3UIO82W.FB.+
MA#ZE36!?)MU"X7TD;^=;J$9A;MM7^=9.K+MU:Y _YZ$UST?B9TU_A12 IVVD
M%/ KI.438*U=&5=TJL"=WR\>]9HK3TCB1_J*SJ_"72^(S3PQ'H:4&G3KMN)5
M]&(IE7'8A[C]V*3.33:5:8F+BD-%'6F*X)]\>QKI4^:U=?4@_I7-*.:Z*W;,
M!_W5-<N(6S.K"]3#'6ACBC[CLOH::372CE8E+3<Y-&:!"G@4S=2L>*93 =FM
M+2F&YQGT/ZUEU>TMO](=?536=5>Z:T?C1'>C;?3#_:JL3S5K4N+^0^N#52JA
MLB)Z28N:,TE%42>X_P#"N_"7_0#M_P V_P :/^%=^$O^@';_ )M_C73T5Y7/
M+N>QR1[',?\ "N_"7_0#M_S;_&C_ (5WX2_Z =O^;?XUT]%'/+N')'L<Q_PK
MOPE_T [?\V_QH_X5YX2_Z =O^;?XUT]%'/+N')'L<Q_PKSPE_P! .W_-O\:/
M^%>>$O\ H!V_YM_C73T4<\NX<D>QS/\ PKSPE_T [?\ -O\ &C_A7GA+_H!V
M_P";?XUTU%'/+N')'L<_;^!O#-KO\C2($WC:V"W(_.H?^%>>$_\ H"6_YM_C
M7344<TNX<L>QS/\ PKWPG_T!+?\ -O\ &C_A7OA/_H"6_P";?XUTU%'/+N')
M'L<S_P *]\)_] 2W_-O\:/\ A7OA/_H"6_YM_C7344<\NX<D>QS/_"O?"?\
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M&,@M_C4DOA/0IU"R:;$RCH"3_C6S136FP*,4K)& G@KPW&<II, /U;_&K/\
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MTJ%3TX)_QK=HH<I/J')%=#"E\&^'IG+R:5"S'J23_C3/^$(\-?\ 0(@_-O\
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M%0_F?\:F7PKH:KM73H@,8ZG_ !K8HI.3>[&HQ6R,(^#/#I))TJ')]S_C2?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:%HVE;*C80X/FXY*XQ5>'PW=Q^$/#VD&6#S]-:R,K G:WDE"VWC/.TXR!^%
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M);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P"
M\O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B
M_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4
MG_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\
M);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P"
M\O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B
M_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4
MG_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\
M);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P"
M\O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B
M_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4
MG_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\
M);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P"
M\O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B
M_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4
MG_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\
M);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P"
M\O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B
M_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4
MG_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\
M);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P"
M\O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B
M_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4
MG_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\
M);HO_/U)_P" \O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P"
M\O\ \36U10!B_P#"6Z+_ ,_4G_@/+_\ $T?\);HO_/U)_P" \O\ \36U10!B
M_P#"6Z+_ ,_4G_@/+_\ $U=T_5;+5!(;.5I!'C=F-DQGI]X#TJ[10 4444 %
M5-3OAIVGRW.QI&7"QQKU=R<*H^I(%6ZJW]DM_:^49&C8.LB2+U5E((/OR.E
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MTO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\
M R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^
M$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP
M[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_
M ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\
M:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV
M#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*
MR?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*
MO#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>
MTO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\
M R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^
M$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP
M[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_
M ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\
M:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV
M#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*
MR?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*
MO#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>
MTO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\
M R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^
M$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP
M[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_
M ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\
M:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV
M#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*
MR?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*
MO#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>
MTO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\
M R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^
M$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP
M[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_
M ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\
M:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV
M#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*
MR?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*
MO#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>
MTO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\
M R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^
M$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP
M[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_
M ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\
M:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV
M#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*
MR?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*
MO#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>
MTO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
H@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ethicsemployeepolicybook007.jpg
<TEXT>
begin 644 ethicsemployeepolicybook007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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MT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+E6BNQF\-^'/^$AET"+5=0BOEN#:I)-:H86D#;0"5?(!/?%<G<V\EI=36TH
MDB<QN >A!P:49J6PY0<=R*BBBJ("BK-Y#:0^1]DNFN-\*O+F(IY<AZIUYQZ]
MZK4)W&PHHHH$%%%% !16CHNCS:W?&".2.&*.-IIYY#\D,:]6/^>216FMMX/>
M86W]H:LA)VB\:!/+SZF,'=M_'/M4N:3L6H-JYS=%/F18IY(TE65%8A9%! <
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M@)9W37,6Q27:(QX8@%EP3V.1GO5:FG<'H%%%% @HHHH **** "BBB@ HHHH
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M43T6W_!.I\1:W=Z)XBN]&L;:WBTZSE\A;5[=&651QN<D98MUSG//&*H>/O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMW^DK+9FYL(!/-B4[0I&< [>N"*]"@\.1#XV/J8V_83:_P!I*_\ #DC9G/\
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MM?$^AP:E:D#>,21YYC<=5/\ GI7E8ZDU+G74]3!5$X\CZ''?$+X9IK[2:KI
M2+4L9DBZ+<?CV;W[]_6O"[RSN=/NI+6\@D@GC.'CD7!!KZ]K&U_PMH_B6W\K
M4[-)& PDR\2)]&Z_ATJ</C'37++5%5\(IOFCHSYBTV2 "[@N)O)6XA\L2%2P
M4AU;D#G^''XU83485U#392SF.WB6-^/=LX_.N]\0_!?4+0--H=TM['U\B;"2
M#Z'H?TKS2]L;K3KI[6]MY()T.&CD7!%>E"=.KK%GGSA.GI)&Y+K-O+;FXCE@
MAG^S"W,7V7<_^KV'#=-I'?J,]#UJ!=1L[C5KN>=P#)"J6\TT7F+$PVC)7G(V
M@CH<9Z5A457(B.=G7RWUA?:5/ ;THJ6\,+2K"$4L)9&^XO\ #@CH,]\=JJ0:
MI90P_P!G"5'B$(07,T&Y2V\O]WKMY^N1G':N;HH]FA^T9T-QJ%K?6\MA+>)'
M&K1M%.+<JGRAP5VC)_C.#[<XJ.^O;"\2\BCG>-"+=XFDC.7,<10J<9P23]..
MM85%/D0N=F]=WECJBF&2Y-J(Y/,1VC+!\HBD$#D$;..QR>E-BNK$:=+#-<_:
M(T6188I;?$BDYVE7!.!G!()QUX/6L.BCD5K!SO<GF^S;(_(\W?CY]Y&,^U04
M451 4444 %%%% !5G3[Z?3-1MKZV;;/;R+(A/3(.>?:JU%#5]!IV/5=6?P;\
M0VBU.761H6K% MPDZ;D; QG)(!],YZ8R*PM8M_"OABVLY-"UB?4==@N%F%Q&
M,0@ @X(Z=NQ/4Y-</16,:/+IS.W8UE6OK97[GJNJ3>#OB*(=1N-7&A:P$"3K
M,FY'Q[D@'V.0<=11::MX6^'.G7;:+J/]LZ[<1^6LZIB.,?RQGG ))P.E>544
MOJZMRW?+V*]N[\UE?N=UX6URPM/ _BNTO;Q4O+U!Y*-DF0X.?YUM^%/B!9Z5
M\.KJUN)E&K60D2Q!4EB'Z$'V).?8"O*J*<J$97OU=R8UY1M;HK'=Z+K>G6_P
MGU_2Y[M%O[FY5XH3G<X_=\_H?RHU+6]-F^#ND:/'=HVH0WC220 '*KF7GT_B
M'YUPE%/V*O?SN+VKM;RL%>O:V_@[Q7H^A1W?BA+*6QM%C9%A+<E5SGZ;:\AH
MIU*?.T[VL*%3E35KW/4?"%QX8\(>.S)#X@2ZL'T]@;EHRH$A<?)CZ+FJ_ACQ
M)IGA+P?JVH6EW#)K]Y-MAA*DE$#8!/&.[-^5>;45#H)[N][?@6J[6R[_ (GH
M^E_&'Q"NJVIU&6W>R\U1.%A .S/.#ZXK7TG6O#.C_%C4-5@U6 :;>6C/Y@#8
M65F4LO3N03^->0T4/#0=[:7T!8B:M?6QT?A3Q/+X7\5)J,9+6[.4G0?QQD\_
MB.H]Q76_%'Q#H>HV.B1:!>Q2"T=R%B!7RAA=O4>WZ5Y?15.C%S4^J)562@X=
M&>JWFJ^%?B/I]I)K&I#1=<MX_+:5TS'(/T&,Y.,@C)ZUA:WHG@K1-!FCAUR7
M5M8<@PM;*%C3_>ZC'XYZ8QS7#T4HT>712=NPY5N;5I7[GKVMOX.\5Z/H27?B
MA+*6QM%C9%A+<E5SGZ;:X;Q-HOA[2[:!]&\0?VG([D2)Y138,=:YJBB%%PVD
M[?()U5/>*N;/A/5QH7BO3=19ML<,P\P_[!^5OT)KJOBIXFT[6KVPL]'G26QM
MT>5FC!"F5VRW7Z9_X$:\\HJG2BYJ?5$JHU!PZ,]<@\>Z:OPI:W:Y0:ZMH;$)
M@[RF=H.?93GZBN>^&>MZ;HMQK+:C=I;B>S,<98'YFSTXKA**CZO'EE'N7[>7
M,I=C6\+W4%CXKTFZN9!'!#=Q/(YZ*H8$FK_Q U&TU7QQJ5[8SK/;2F/9(N<-
MB-0>ON#7-45KR+GY_D9\[Y.4[OQQK>FZGX1\(VEG=I-/9VFRX10<QMLC&#^(
M/Y4> -;TW2M!\507UVD$MW9^7 K _O&VR# Q]1^=<)14>Q7)R?UO<KVKY^?^
MMK!7IFF>(O#WBSPG:^'?%%R]C=V0"VE\%R, 8 /IQ@'/!P#G->9T552FI_(F
M%1P/0YO#7@31;"YFOO$[:K,T9$$5B@4ANQ/+#\R!]:L:1XD\/^)_"5OX:\4S
MO93V>!9WP&0 !@ ^G''/! '(->:45#HW7O2=^Y:K6>B5CU'2]'\#>$KU-7O?
M$T>KR6Y\R"VMHARXZ$X)_4@50T+QG%J'Q7B\0ZM*MI;8D4;LD1IY;*HX_P Y
M->>T4>P3OS.[:L'MFK<JLEJ>F>"O%NFZ7XVUU+^XC&DZC)*V]U)7(<E3C'0@
MG\Q2^&O&-C-\5M0U[4KI;>TECD2)W!P%!4(./85YE12>'B[ONK#5>2LNSN>A
M>"M>TO38/%ZWEXD)O;=EMPP/[PXDX''N/SKC-$M[.ZUNSAU"X6WLFE'GRMGA
M!R>G<CC\:H45HJ:3;3W(=1M)/H>J>)OBUJ-MKDMOX<FMAID*JD3&'.[ Y(ST
M&>/PJ.Y\96?C+X?:A9^(+R"'5[>7SK0["HDP. ,=S\R_B*\OHK-8:FDK+5=2
MWB)MN^SZ'=^,];TW4?!?A2RM+M);FSM]MQ&H.8SL08/X@UUOP]^(.D+HL-KX
M@NHX+S3P8K>>0$EXF[9 [8 ^@6O%Z*)8>,H<C".(E&?.B6Z97NYG4Y5I&(/J
M,UVWQ3UO3=<URPGTR[2YBCLUC=D!X;<QQS]17"45HX)R4NQFIM1<>Y;TN5(-
M7LI9&"QI.C,Q[ ,"372_$W5K'6O&,EYIURMQ;F&-1(H.,@<]:X^BFX)R4@4V
MHN)J>'=<N/#FO6NJVP#/ W*$X#J1AE_$$UWVK:;X'\:7C:Q:^(TT:YG^>XM[
MF,??[D9(&3WP2#7EM%3.ES/F3LRH5.5<K5T>FW_B+P]X/\*W>@^%[E[^^OAM
MNKXKA0,8./P) QTR3G-.\-7OAR^^&4GA_5M;33Y7NC*?D+$ $$<>^*\PHJ/J
MZM:^M[W*]N[WMI:UCO#IGA70-8T34-.\3"_,>I0-,AA*B.,-DO\ A@?G4NN>
M,HM/^+,_B+295N[7]VIVY E3RU5AS]#^(KSZBJ]BKWD[Z6%[5VM%6UN>HZIH
MW@;Q;?2:O9>)X](DN#YD]M<Q#ASUQDC]"16>C>#=!\8: VD:A/.MM,#>W<G^
MK/N!C.?IQC'4YKSZBDJ+M9R=ANLKWY5<]2TGQ+H\'QDU'6);^-=/E1PDY!P<
MJH],]C52Z\,>!;J[FN#XW"F61GQ]F/&3FO.**7L+.\9-:6^X/;75I)/6YV6C
MZ)X/O+C5+&^\02VTJ2E;*Z,7[IT'\1]SZ$CZFM]K[P_X)\%:QI5CKB:Q?ZHO
MEXA7$<8(*D]2.A/?)XXXKRZBG*CS/63L*-7E6BU"BBBMC$**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MNA\(^+K_ ,(ZI]IM3YD$F!/;L?ED7^A'8USU%*45)6949.+NCZI\-^*]*\4V
M0N-.N 7 _>0/Q)&?<?UZ5MU\@VUU<65PEQ:SR03(<K)&Q5A]"*[W2OC'XCL4
M6.[6VOT QNE3:_YK_A7F5<!).\&>C3QT6K31] UB>)?"NF>*=/:VOX%,@'[J
M=1AXSZ@^GMTKS=?CLP4;_#H)]1>8_P#9*S=:^-.J7]G);Z=I\5@9%*F4RF5P
M/]G@ '\#64,)74KI6-)XJBXV;N>9S1&">2)B"48J2.AP<4RCJ<FBO9/("BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **^N?[*T[_GPM?^_*_P"%']E:=_SX6O\ WY7_  KSO[07
M\IZ'U!_S'R-17US_ &5IW_/A:_\ ?E?\*/[*T[_GPM?^_*_X4?V@OY0^H/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!EZ]!>W%BR6DRQK@F0GJ1CH*\]@@EN)5BA
M1GD;HHZFO4;E2]K*JC+%" /PKD_#6DWUIJWFW%LT:"-AN..O% '-"*1;D1,"
MD@;;@\$'->E:9%>06:QWLJRRJ<!E[CW]ZY74]'U";7Y9X[5VB,JD,,8(XKMJ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ]HMKJEKN$-PFX*W53T(/T((_"HKJ=DY--=T70Y+M133[,T****Y3I"BBB@
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M_CW ^]C'7CZUZI14JLU*4N]_Q*=%-178RO$T4D_A75X88VDEDLIE1$&2Q*$
M =S7*?"#3[W3?"-S#?6D]K*;UV"3QE&(V(,X/;@_E7H%%2JC4'#N-T[S4^QY
M;\9M*U'4[?1Q86%S=F-Y=X@B9]N0F,X''2O4(QB) >N!3J*)5'*$8=@C32FY
M=SRO4M*U%_CG9:@EA=-9*%W7 A8QC]V1][&.M>J4445*CG;R5@A3Y+^;N>??
M$CP)<>(O(U;2&":K:C 7=M\U0<C![,#T^M8EM\3_ !1I4 L]8\*7$]V@V^:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3'X7/AQ87_LT@@IYAW<MO^]UZUMT4.I)N]QJ$4K6,'5O!^CZSI]C9W44@6Q
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M!J!MSY<]S=/EG<=0..,?A]*FI*,9<D8W?R*IPE*//*5EMU.0_MO5O^@I>_\
M@0_^-']MZM_T%+W_ ,"'_P :MWT5OKVN+'X<TJ>(2*/]'#[SN_B(]!]?TZ!F
MK>%]:T.)9=1T^2&)C@/D,N?0E20*I.GHFDF^FER6JNK3;2ZZV*_]MZM_T%+W
M_P "'_QH_MO5O^@I>_\ @0_^-7K/P=X@U!(GM=,ED26/S4?<H4KV.2<?A2P^
M"O$<\,TL>DW&V%BKYP#D=< G+?AFASH+JOP!0KO9/\2A_;>K?]!2]_\  A_\
M:/[;U;_H*7O_ ($/_C3M/T+5-5BEEL;*6=8F5'V8RI8X QUJ75_#.LZ%&DFI
M6$D$;G"OD,N?3() /M3O2YN72_R%:MR\VMOF0?VWJW_04O?_  (?_&C^V]6_
MZ"E[_P"!#_XUVNM6ENGB'PJBZ2EZLFG1L]JF$\TX/4^O?GKBN530=1UK6KZ'
M2]*D7RIFW0A@1 ,G"ECQQC'OBLX5:<E=I)?+O8TJ4JD79-MWMU[7*G]MZM_T
M%+W_ ,"'_P :/[;U;_H*7O\ X$/_ (T^_P##^JZ7?PV-Y9217$Q C4D$.2<#
M!!P>?>KI\$^)!;S3G29]D)(?E<\=<#.3^&:MRHI)MK7T(4:[;23T]3/_ +;U
M;_H*7O\ X$/_ (T?VWJW_04O?_ A_P#&ETK1-2UR=H=-M)+AU&6VX 7ZD\"I
M+OPYK%CJ46G7&GS+=R_ZN,#=O^A&0:=Z2?+I<255QYE>WS(O[;U;_H*7O_@0
M_P#C1_;>K?\ 04O?_ A_\:LZIX5UO1K87-_I\D4).-X96 /H=I./QK0\ VNG
M:AXD&GZG;I-%<Q.D>[^%P,@C\ 1^-3*=)4W4232[%1A5=14Y-IOO<QO[;U;_
M *"E[_X$/_C1_;>K?]!2]_\  A_\:ZKP3X>L3J^JOKL2/::>1 X?('F,^T?R
M/YT[1?"UJOQ$U"POH@VGV EF=7S@QX^7/X,#^%9RKT8N2MLK_P!?@:1P]:2B
M[[NW]?C]QR?]MZM_T%+W_P "'_QH_MO5O^@I>_\ @0_^-;36JZEX=4V7AW;+
M<:B4ANUEXYR1$%^G'IQ5_4O!%QH&LZ1,(Y);*22#SI)-N%D9^4QWJO:TD[-)
M/7MT%[&JU>+;6G?J<M_;>K?]!2]_\"'_ ,:/[;U;_H*7O_@0_P#C75^+_"&L
M7/B+5;W3]*<V*,,&,*HP$&=J]3WZ"N%JZ4J=6*E&W^1G6C5I2<9-_P"9?_MO
M5O\ H*7O_@0_^-']MZM_T%+W_P "'_QKL_!GAK2;G11/K*#S=4E:VL2>J$*V
M7'XC'U ]:XLZ1>_VR^DI"7O%E,7ECNP/;/TJ85*4I2C;8J=.K&$97W_K\1?[
M;U;_ *"E[_X$/_C1_;>K?]!2]_\  A_\:NS^#_$%OI\M]-I<R6\6=[$C( ZG
M&<X]\8K4A\ ZA<>$4U:*&9KN20%8 5P82N0^<T.K02O==N@1I8ANR3VOU.>_
MMO5O^@I>_P#@0_\ C1_;>K?]!2]_\"'_ ,:WO[&?5K3P]:6FA/;2SAM]TLH)
MN%!&Y@#TP.?QJ/7_  /J6F:^MA9V\T\4[;;61BH,N%#-W[<_E256C?E=D]>W
M0;I5K<RNUIWZF+_;>K?]!2]_\"'_ ,:/[;U;_H*7O_@0_P#C5S_A$-?\RVC_
M +-E$ER':)"R@L%QN.,\=1U]:S[73+V]MKJXMH&DAM5#SL"/D!SR?R-:)TGJ
MK?@9M5D[._XDG]MZM_T%+W_P(?\ QH_MO5O^@I>_^!#_ .-7;+P?K^HV O;7
M3)9+=AE6RH+#U )R?P%:MI\/]1N_"AU..WG-ZTP$=O\ * T6 =W/OG\JB56A
M'=KMT+C2Q$MD^_4YW^V]6_Z"E[_X$/\ XT?VWJW_ $%+W_P(?_&JUHBR7L".
M,JTB@CU&:W_'NGVFE^+KJTLH%A@5(RJ+T&5!-6^134+;J_W$+G<'.^S2^_\
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MZ'\Q7LMG=P7]G%=VLJRP2J&1UZ$5\OUZU\(=5DEM+[2Y&)6$B:+/8-D,/ID
M_B:\G,<'!0]K!6MN>OEN-FY^RF[I['IM%%%>&>\%%%% !1110 4444 %%%%
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M5^>2<=+>GZ)'J/Q&EM=,TCR;%^=9NOMKD?W0J_H6P?SJUK&HVX\!W'B.-O\
M3=6M(;-_]\;@_P"F?^^17DS.SXW,3@8&3TH+L4"%CM'(&>*Q6"2C&+>S^_R_
M!?<;RQS<I22W6GEY_B_O.S9BOPAA9201JW!';Y#6OXGM;RXUCPQJD09].,5H
MAE#97?O)QC/7FO--[;-FX[<YQGBG>=+Y8C\U]@.0NXX!]<5;PSYN9/J_Q,UB
M5R\K71?@>J07ERWQQ:)IY#& T>S<<;?)SC'UY^M>="PEU'Q&;"V7]Y-<F-!V
M&6_D*S_,??OWMO\ [V>:0,RMN5B&]0>:JG0]GL^B7W7U)JXCVFZZM_?;0]1\
M0ZQX5T_4K+3)XM3=]%"I"UJR! PP2>3R<@9]Q4U[:P7GCGPUXFL5/V74F&_(
MY6101@^^./JIKR@DL2222>I-.$L@  D8!3D 'I62P5DK2ULU]_\ P=39X[F;
MYHJUTU\O^!H>E^'KJ>X^(GBB.:9W1H;E2K'(PK@ 8]AQ6?IEO>ZK\*YK;3]\
MUQ!J.]T5\,J;/KTK@Q(ZL6#L&/4@\FECFDBW>7(Z;A@[6(R*IX7JGVZ=B%B^
MC7?KW.\U>86_A[P+*7V*I<LV<8&],UMSV-]#\9+2\FC<6=S(QMWW95L0<XKR
M8NS*%+$@= 3TIYN)B$!ED(3A?F/R_3TI/"NUD^DEMW=_P&L6KW:ZQ>_96_$[
M[PGJ3R_%2=KVY9FDDGC0R-QG)P!Z=, ?2IM&\/:CH/A7Q6-1A$+R6P"(7!+!
M=V6P.W(YKSC)W;LG.<YI[W$\K%I)I'9A@EF))%.>&;?NNRTZ=G<4,4DO>5WK
MU[JQZGI.FW6N66DVVM:/+$D5IMM]6M+H+Y487C<,XSQ65I=G=ZA\.=3T_2W:
MZN(-2W (^"8]H (YZ'!K@1<3K"85FD$1ZH&.T_A21RR0DF.1T)&#M8C(I?59
M:Z]4UV_,KZW'3W>C3UU_(EL?^0A;?]=5_F*]&\<^"M?UGQ5<WMA9"6W=4"OY
MR+G"@'@D&O,>E2_:9_\ GM)_WT:UJ4IN:G!VM=:J^]O-=C&G5@H.$TVFT]';
M:_D^YZ'8>&UM_#NFSQZ9<ZQ-([F0"],45HX.#]T\'CD^U:.I:A'8?%N..7:;
M:_M4MIAGA@XP/U"_A7E2SRHC(LKA'^\H8X;ZTUG=FW,S%AW)YK%X1RDW*5[W
M_'Y]#98Q1BE"-K6_#Y=?,];"0V=Q#X \Q&CET^0,_P#T\,2ZD_0#]15&XO[^
M#Q[;:;H=O%=KI-E]E\EW""0!1OP3_%T'U%>9>8Y?>7;?_>SS0'</O#,'SG=G
MG-"P=M6[W7XO=C>-O9)6LU]RV1VWC'1+2R\/V-]':7.ESRSLITZ:?S HQRZY
MY'0#\17#T^6:6=]\TKR-TW.Q)_6F5TT8.$;2=SEK5(SES15@HHHK0R"BBB@
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M 6R_[\BMNBCVU3^9_>'L:?\ *ON,3_A#_#G_ $!;+_OR*/\ A#_#G_0%LO\
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MODD/E"S9[8R,8J2+1+?7?%GBQ=0FNI(H9(%MXEN'182;="74*1ANG/;''4Y
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M.U>R^Q/;Q-:E/+\@H"FS&-NWIC':IZ* ,[2] TC13(=,TVUM&DP':&(*6 Z
MGT'I6=K7A\:QXETJXN;6"YT^"VN8IXY@&!+F(K\IZ_</TXKHJ* *&GZ+I>E6
MLEM86%M;0RDF1(HP Y/&6]?QJREI;Q6:V:01+:K&(EA"#8$ P%QTQCC%344
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M1K&&3>'#) H((.01QQSSQWK0^Q6OV_[?]FB^V>5Y/G[!O\O.=N[KC/.*GHH
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M6:\R+W5[X4T6(WUU$9_$LT,DD<S*YC^T3@KN!R!@8]N,=!6S;:3:V7C2ZT2
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M$?)RF&! XQD\"@#I**X'Q3J-YHFOWUO;SR!]=LDAL06)$=T'$1*CM\LJ,?\
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MGN/#%BNK2K,+?Q#;PV_E:@\QBA:XC!C>08+,IW+D\@ <YKI&L87\:/HY,_V
M:*N(O/?J)CSG.<\=<YH ZBPOK;4[""^LY1+;3H'CD (#*>AYJQ7E&C6\5A\.
M_",4$\]I:ZK/!#J%PEPX(78Y"AL_N]SA4RN/O8KI!:0>'O'&C6.D22I#?13F
M\LS,TB!$4%9<,3M.["Y&,[N<XH [.BO-] TAKGX>S:C_ &K+!JUW#-"M_<W+
M[8@92%4<X4<*,CG)SUK8\*>5I^MWFE2Z;-IU[]G2<Q+?-<V\B;BN]"W*MG@Y
M4$X'6@#J+J^MK)[9+B41M<RB"$$'YWVEL?DI/X51L=6DN_$>KZ8T:+'8I R.
M#RWF!B<_3;6#XZTFROM3\,27*2$MJBPDK,Z?*8ICCY2.<@<]>U5[7P[8ZGX[
M\0Q7?GO;06MFB0"=U7.U_F.""Q '!)XY]: .\J"]O+?3K&XO;N016UO&TLLA
M!(5%&2>/85Y_::@UWX/T/3+J*YU.\NKNXMX5:\: 2+ \@S+(.2-JC(P<GL:R
M[NW:;PE\0-+NT1(M.MVE@M[>^DG2!S;DE0[!21GG:1@$F@#UI6#H&4Y5AD&L
MK3]6DO/$&L:<T:*EAY.QP>6WIN.?I4VBV%KIVE00V@81%0_S2M)R0.[$FN5@
MT&SUKQ[XH-^9Y(D6U584F>-03&<M\I&3TP3TYQUH [JBO.+347O_  AX>TRZ
MAN-3OKN6:.-7O6MUD$+.I,KKR1M XP<GG'%9\MU?6GA#QW9)*ML;!E$"6]X]
MPML6C1BJR,JMC.3C'!)% 'J]%<)XAT.&P_X1VPM+J]B6\UA1=3"Z<R3C[/,6
MW-G/S;>V,=L<4RR\-V,_C/6-)E>Z;2K:TMKB*S^U2!$DE,JLP^;/2)<#. 22
M.30!WU%<[X%N)[CPA:&YGDGDBDG@\V1LLRQS.BDGN<*,GO6?+:PZ_P".]3T[
M5I)6M[.U@DM+,3-&D@?=OE(4C<00%YX7'J: .RHKAI[2UNO%.F>'IKVX?1TL
M99H8S=N?M4RR!2K/G<^P'[I/?G.*RM9FETK3?'6F:;=W!L;/2UGB)F9S:SLL
MFZ-6)) PJ-C/&[MF@#TZBO/]2\/06GB#PY:Q7=^$U!I8]0/VJ3-V%B,@W<\'
M<HZ8X)'0XJO?A](T7XA:=9SSQVMI8>?:J968P,]NQ8(Q.0,KD#/!)Q0!Z117
MG>LV-EI'A.V\0:3J%S-JFZ!K>Z-T[F]=V4;&7.U@V2-H'';&*2^CO];\;:U:
M3Z>M]#9"%;:!]3>V"(R!C(%53N)8L-V>-N!CG(!WMU?6UE);1W$HC:ZE\F$$
M'YWVEL?DK'\*B>_:&XO?M-M)#:6T2R_:F92CC!+  '<-N!G([\5YW=:2;[3_
M  @VLSB[F_M=K<30WSR!H=DY0%U(W. %!;&20?4UI:I:1W5[XQT^5IFM8-(M
M6BC\YQM(6?G(.>PSZXYS0!V3:@SQV$UG;27<%VRYEC95$<94L'(8@D=!@<\U
M=KSZUMHM+T/P&EB\L:75]"TO[YVWYLY21R3QD XZ<5+I&FV7B.'6-0UNZN/M
ML%]<0MMNWB^PHCD(%VL OR!7W=]V>E '>45YG;3WWB"R\"KJ%Y<@7;7'VAHG
M,1N8UC8H6VXX8*K''J?6NA\-0#3?%?B#2+9Y180QVMQ#"\C.(FD$@<*6)(!\
ML''3)/K0!U=%<IXJ9KG7_#^DW%Q+!IMZ\WGF.0QF9T4&.(L"" <L< \[,5GM
M&NB^)M0TG2YIOL+Z/+<S6YF9Q;2A@$9222N\%^!Q\F?6@#NZ*Y?P)I<5MX7T
MS4&EGGOKRQ@DN+B>9G9R4![G  SP!4&M1KJOCJQT;4)I4TXV#W$<"2M&+F8.
M 0Q!!8*I!V_[63TH Z^BN,U"&WT;4?#%M8W<PM?[8>.17N6D"EK:;$9))(&[
M;A3T./:F7MV]UXN\3V5OJPLS%H<"B9I/EM96:?YSS@$ J?IB@#M'=8XV=SA5
M!)/H*BL[N#4+&WO;602V]Q&LL3@$!D89!Y]0:X'3]/MX9KO0M2TRXM+JXTYI
MLV^IRSP7"QLN7!)#*^YEZ@9!(R:IZ=;Q6/@+P5:P7$]I9:L;5-0G2X<'!MRP
M4-G*!G55^7'7 QF@#U&BN,2UA\/^.=)L-(DE6"]@G:\LS,TB*J %90&)VG<=
MN1UW>U<O%IKK\,K+75U&_76&N(46\^TN61'N1$5 )VXV,1C'7GKS0!ZW17&P
M6$?A_P >6-IIIG6VO=-N9)H'G=U:2)X=K_,3AL2,">_>N2L(M9U/PDFNB*"'
M5Y!YAU.?6700S;L;&CV[54'Y#'TQQUYH ]?HKB[?35U;XA:R;^6XDBLX+.2&
MV6=UB60^82V 1D_*.OO6=ID)T?6["YU%'NS>WLD<&KV>HLZSE]Y5)8B0  !C
M"[@"HZ4 >BU6-S,-32V%G(8#"9#=;EV!@0 F,[LD$G.,<5-'+'+N\N17V,5;
M:<X(Z@^]<_+-*/B5:P>8_E'1YG,>X[2PFB ./7!/YT ='17D]E8&V^%^E^)!
M>7KZQ&;>5;E[ER=IF52A7."NTE2,<]>O-=+]C@\0^.-9LM7DE>*QB@^QV@F:
M-2CKEI<*1N.[*Y/3;QC- &[/JTD7BRQT<1H8KBRGN6DSR#&\2@#V/F'\JUJX
M^*&"W\>Z##;3O/#'H]XJ223&5F EM^K$DG\:Q)-5>'X)I<R7KK<\0^89#O\
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MDA8R^2)-C>49,XV"7&PMGC&<YXH JZ#X-TFRT[29;O2+(ZI:VT*R2^4I(E5
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M>+M-N=8\(:MIMH%:YN;5XHPQP"Q&!DUM44 9-MX9T.TU#^T(-)LX[S)/G+"
MP)ZD>A/<CK6A%:V\$\\\4*)+.P:5U7!<@!02>^  /PJ:B@"D^CZ;+ITFG26%
ML]E(S,]NT0*,68LQ*],EB3]3FHK+P]HVG6L]M::9:Q0W Q.@B&)1C&&S][CC
MFM*B@#,TOP]H^BN\FFZ9:VKR *SQ1@,5'09ZX]NE:=%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7$W>GWC?\
M"?[;68_:[=5M\(?WQ^RA<+Z\\<=Z[:B@#SSQ#H6H>)-.TC1K.W>TN+2S$TM_
M*KH$S'L\@$$$[^C@'A1ZE:T%^TZC>>#+E-(N+%;6XF6XMVB(%MBWD3&<8VYP
M%;H<C'6NSHH XFRTJ=/"7B^!K*02WEWJ#JAC.9@V0I [Y&,>M1Q17NC:MHNL
MW.G7=U;?V,EE*((C)+;2 AB2@^8ANAP"04&:[JLK5M&EU"XAN;75K_3KB%2H
M:W961@<9#(ZLIZ=<9]Z ,#PU=?;?B#XCN1I\MF'LK' F79)(-TXWLO53QC!Y
MP!TJ7Q)>ZC#XA@@>?5;32&MMPFTRS,[R3[CE&(1R@VX(X&23SQBMO1M#BT@W
M,QN;B\O+M@]Q=7!7?)@8484!54#H  .3ZFM2@#S.PT>_?PQI<%QI]YO7Q,;E
MX[A-SK']H=P[X&.A!)'%=%J6FW=UXUDD@62))=#FMQ<A3M60R+M&?49) ^M=
M510!YG>7D@^%UQX8'AO4GU2+2VM#:+9.8]ZQXWK+C8PR-PP=QXP,UZ#'Y\6C
MH(8P;A+<;$?@%PO /IS5NB@#RQ#JVJMX=DN&\07-_%?V\U_#-8^1;VN.&V_N
MQN )P"&;C))K1U;3+^71_'$<=E<,]UJ,3P*L9)E416X)7U&58<>A]*]"HH Y
M"65O#_C74]2O;.\GL]0MX%AN;6V>X,1CW QLJ L 2VX'&#DUC3Z-J5]I.KZG
M%ILRQ7.LV^HQZ9( KS11>6'RIX#/L+;3[9Y)KTBB@#EKWQ+<W^DZB=!TO4&U
M"&T>2(W=B\*"3LG[P*6;O@9'')'%8=@EW>^+_#UW'-X@OH83/]IGU"S^SI$S
M1$ !?+3J>XR.@R2:]%HH \VN[>\;P9XTT0:=?&]DFOIX0+9RDR2.638^-K$A
MN@.>#Q6W=N^A>-[C6+NSN[BQN["&WCGMK=YVMV1W+*40%@&WJ<@8RO/:NNHH
M \UU/2[W5?#WC&]CTRYCAU:2#[/9O$1+($"*TA3JI;'0\X4$XKJ-9LYI/%?A
M>>&W=HK>6X$CHG$:F%@,GL"<#ZXKHJ* //=+DNK'6[*ST6+6H[9KM_M>G:A9
M?N;:,[BSQS[<=3P [@YQ@=MOQ7;W":CH6K):2WEMIUR[SP0KO<!HV02*O\14
MGH.<$XKIZ* .1M9'U[QQ9:M9V=W;V5E930RW%S;O ;AI&0J@5P&(783DC&2,
M=ZN^"+6>S\)VT%S#)#*LLY*2*58 S.1P?4$'\:Z&B@#BK"\/A?5-=BU'3M0E
M-[?-=V]Q:6<EP)U95 0E =K+MVX; P 0:DEO'TGQI)JMUIVH?9-0TNWB0P6K
MSM'+&\K&-Q&&VG$HP>G!YKL:* /.+2T?_A%C-JVFZS:3?VY=7<;V46^>T+22
M%9-H#;EVL1PK [NF.:?</K6H>$I9KF"\O%M-9M9[>1K,Q7%Q;1RQ.SF$ '<,
M. -H)"@XYKT2B@#C);LV'B__ (2*:POYM.O=.CMXY8[.1Y+9E=V(:(+O4.&4
MYV]4YQQ61JFFWVK:!XUOX=-NHXM52)+:U>(K++L4*TACZ@MP,'G"#(%>E44
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M]*NHHI!$-,O(I)U0[58O 5!/3/#$#V-</8Z3<1^%8_"VIWGBKSPGV:6SM;"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1S^9'/%S\R/M!ZJ005!''K52T\8WTL6D7UWHGV;2]5>..&;[5NE1I!\A>/:
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M5@*;9>'AIWB""\@=%LK?2TL(XR3N&U\@^F,5A^"M+ \0:S>1RB73K*>6RTP
M<1JS>9.!ZCS"$'M'B@#NJY9?%&J7R7-YH^A"]TVWD>/S6NQ'+.4)5C$FTAAD
M$#<RYQ^-=37(VNC>)-$M9],T:;3&L7ED>WGN2XDM@[%BNP B3!8X^9>, ^M
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M 4;N=J[MPQVXKHHYHI<^7(CXZ[6!Q6"NE:I>:MHFI:@;..:Q$XECMW9E;>H
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MEN)K:;+[U:9RY5UQC )(R"<\<"M>\TK41XNM=9L6M6B-M]DN8YV96";PVY"
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M.YEN4AC6>55620* SA<[03WQDX^IJ6BB@ HHHH **** "BBB@ HHHH ****
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MH[;PAI]II_V""XU!+43I-'$MVX$6UMP5><A<]1Z5OT4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/FL[.2?;+MQ6G/<P6L1EN)HX8QU>1@H_,U3U?6['1=$N-6NI0;6&,R$QD$N
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MSG@#D+GG;G;[5NQW$,T GBFC>(C(D5@5(^M-M[NWNT+VUQ%,@."T;A@#Z<4
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MX&34?AW4[C43J_VEE(M=2FMX\#&$4+C/YFM6WN[:[5FMKB*95."8W# 'TXH
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MY.3T^4\_2M%65U#*0RD9!!R"* .;F\$:9+Y\*SW\5A<.SS6$5RRP.6.6&WJ
M23E00#D\<UKOI-H^HV-]Y966RCDB@"G"JK[<C'_ %JPMY:O<M;)<PM.HRT0<
M%A]1UHENK>$@2SQ1DL% 9P/F/0?4T 35A-X1TLZ18Z<@GB6P.ZTGBE*RPGG)
M##U!((/!'45ND@ DG '>H;>[MKM"]M<13(IP6C<, ?3B@#/TSP[9:;+<SEY[
MRZN5"37%W)YCN@SA/0+R>  .356P\(V6G30&VO=26UMVW067VMO)C] !U*CL
MI) ]*VK>\MKL,;:XAF"'#>6X;:?0XHCN[::>2&*XB>6/[Z*X++]1VH YW_A
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MD82% .C%5[=\=Z]&"(-N%4;>G'2H;N"6:TGCM9_LUQ(A5)P@8HV.#@\''H:
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M'&B1@8"*H  ^E)#;PVZ;((HXESG:BA1G\* /)CHFG?\ "H[J^%L@OFO9)!=
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M<ZE>+;SR*"R$#"@$]!DG@>I]:[2QLX-.L+>RMDV06\2Q1KZ*HP!^0J8*%S@
M9.3B@#QO3+>WN=!TF!=5\/VFI^=#AA:2'4$N0P+[_GW%R<AB1C!.>*Z7SM M
MO&&OGQ:;%+B1T^POJ.WRVM?+7Y8R_'W_ #-P'.2,]J[P6\(G,XAC$Q&#)M&X
MCTS6-J%IXC_M"273[W39+5\%(+VW;,# 8RK(1N!ZX(S[T <)I][I]CX.NXH+
M*VDT^Y\0R01'5%/D6ZD[E>0'G:-H !QR5&14NG/&+[QI#!=:=<0G1D=FTVV,
M,!DQ."0-[!FP%!8'L >17>Z'H:Z3I3VD\HO)IY9)[F5T $LCL68[><#G '.
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MD;027A'DF\(0L6)XWE/NY_VL<UZ4%49PH&>3QUIKPQ2Q&*2-'C(P4901CZ4
M>9S>8]MXT;P?G^SFLX_+-E]PW7S^=Y..-VS9G;_%COFMW3G\&M%9KX<.D?VB
M()!8"$+YJG8<[L?,/?=WZ\UV"(D2!(U5$48"J, 4U+>"*5Y8X8TD?[[JH!;Z
MGO0!XWIUO%<^&M/MWU7P_9ZL98MS&TD;44N]PW;OGWE]V<G&""?X:[2RT;3M
M1^(7B:6^LX;HI#:(BSH'504;=@'CG S]!78?9X?/\_R8_.QCS-HW8],]:>%
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M4$S2#.#QG&1GW/K7+OH>FP?"_P 57:6<0N;6YOVMYBH+P^1*XB"-U4*$7 '
MKUG:-V[ W8QGO2;$VE=J[3G(QP<T <)XCO[6;Q/]BNET"S:"P6;[;K$ E,BN
MS I&I9>!MRQW?Q#BLO2-]M\/M"\1H2TFBW5P7PA7_1/.>.1=I)("H P4]/+
MKTV2"&8H98HW*'*%E!VGU'I61XDTJ_UC3SIEG<06UG=!H[QRI,GEG&X1XX!(
MW#)Z9S0!5\&QFZM+S7Y0?-UBX-PF>H@ VPC_ +X ;ZN:PG?PXGQ.UPZX;59?
MLMK]G:]QY7W7W;=WR[NGOCIQFN_BB2&)(HD"1HH55 P !T%)+;PSJRRPQR*V
M,AU!!QTH \JNEE;PGKYT3 \.'5X3%M5FB^S?N_M!0*03#OWY"G&-^.*UM @M
MIO&%A/8ZIX>+16TGFPZ-;E?-A( 7>0Q4 -@KGGKCO7H0 50H   P .U,AMX;
M<,(88XPQRVQ0,GU.* )**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *S=4U<Z:T2)IU_>R2@D):1!L 8R2S$*.O0G)[
M#BM*N1\2V6I7'B"WE:RU'4-(%L5^S:?>"W*S[OO/ETW*5P!R<$'CF@"_-XQT
MF#0[?5Y&N!;37'V7:(6,B2[BI1DZ[@RD8]?6I],\1V^HW\]A):WEC>0Q"8PW
M<84M&3C>I!((R,'G([@5RVG^&-5A\/:?:2V21RP^(/MSQB<2!(?.9\[B<M@$
M=>3Z5O:AHMQ?>+?M)4K92://9O*K#*N\B$ #KT!.?:@#%\4>,;.]\$:Y+;V>
MHFQEL9XXM0\C]R[%& (.=VTG@-MV^]=IIW_(,M/^N*?^@BN'N(?$P\ S^%H_
M#I>]33VLENOM$0MI (]@8?-O!(Z*5 !/)QS7=64;0V-O$XPZ1*K#T(% &'IO
MC;2]4TZ74XXKN'2XH#,U]/%LBX^\HYR2.>@QP1G-367BJVNKZWM9['4+%KK/
MV5KR#8LQ W$#!.&P"=K8. >.*QH?"E[<_":'PY-MMKX6RK@OP)%8. 64]"0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*]$?F;0P,;AE93T(_P#KUG54<OPLE=+3U9$LQQ<7RR>OHCUG_A<<'_0%D_\
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MBG_9V&_E_%A_:>)_F_!'K/\ PN.#_H"R?^! _P#B:/\ A<<'_0%D_P# @?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ:'U&64Y0PZYNNH4445P'H!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% '%>)/AMI>N3O=VTAL;MSEV
M1=R.?4KQS[@UR+_"#6 QV:A8E>Q8N#_Z":]CHKLIX^O37*GH<57+\/4ES..I
MXU_PJ'6O^?\ T_\ [Z?_ .)H_P"%0ZU_S_Z?_P!]/_\ $U[+16G]IXCO^!G_
M &7ANS^\\:_X5#K7_/\ Z?\ ]]/_ /$T?\*AUK_G_P!/_P"^G_\ B:]EHH_M
M/$=_P#^R\-V?WGC7_"H=:_Y_]/\ ^^G_ /B:/^%0ZU_S_P"G_P#?3_\ Q->R
MT4?VGB._X!_9>&[/[SQK_A4.M?\ /_I__?3_ /Q-'_"H=:_Y_P#3_P#OI_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_;P8ZPSQSYM8]MJ5C,A,/&>BLOSENH/;! .ZHKA9O$>J>'[3Q/!<W U*;3!
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M?0K.XOK^[<R>;?6BV<V&X\M2Y&..#^\;]*LQ379U"YCE@B2T1$,,PERSDYW
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M."ZBGFBMRER^R$;W"AI&P<("<GCV[UI2:1:R:E8WN"K6*2+#$N @+X!;&.H
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M0N515+G+$#&XXQD^O % 'F-MJ*:AX:\%V-_;:;<W-SIWV@76L'=$I1$!PO\
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MNH(5B.0#UP?P'Y4.B2(R2*KHPPRL,@CWH X'Q$FA6>@:DOAXVL"F6U.JC3&
M9+8R .V$Z'9OR1S@>PI+N'P_::[X;_X1-;".^DN0)%T[: ]IM;S#)LX*CY2"
M?XL8ZUW5K96MC%Y5I;0V\9.=D4809]<"DMM/LK)I&M;2"!I#ES%&%+'WP.:
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M5'R\GU($2GWC:N\H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHKG_$VM3:2ULL6I:/8"7=E]09F9B,8"1J5+=\G/''!S0!T%%<9;^-KB\\.6
M%Q:VL$NIWU])I\*"0B$R(7W2;L9V;8V;&,]![U:75O$%AXCTG2]3AT^>"_,O
M^E6H=-I1"VTHQ/IUR<\\#N =317&Z=XJU.72M2U[4(;.WTC3WNU98PS32B%W
M7<#D!?NXQSD]Q6?:_$)Q/I\MSJ7AZXBO9XX6LK&YWW%N9"%4YW$28)&["K@9
M/.* /0J*X*]\>E]4U&WL]5\/6*6$S6_EZE<;9;AU^]@!AY:YX!(;."<593Q?
MJ&K3>'H]%M;91J]C-=-)=$L+?88P<A2-_+D8!&3@YQ0!VE%<-'XB\57-IK$D
M-KI2OHTCQ3A_,(NG50_[OG]V"C+R=W)([9,VK>.H8/[(AMKK3[&34K3[;Y^I
MR[8XHL+@8R"[$MP 1T)SZ@'9T5P0\?R?\(YKEW%]@O[S26B&^REW07"N1M*G
M.5/W@02<$=2#6HNK:_9ZY8Z?J4>G$:E'+]G:W#_N)47=M?)^=2,_,-O3IS0!
MU-%<?X$GURXCU1M3N;:>)-1NHUV!]ZLLI& 6)P@Y ';BMC4-7ET_Q#I-E)&G
MV._$T?FG(*S*H=1Z8*B3_OF@#8J-+B&2:2%)HVEBQYB*P+)GD9';-<1:^/KF
MZT#4[M;*);Q+B)-/A).+B*=@MNY[_-DYQ_=-+XAU*]%IXTCTV*TM;JRLD=KH
M*1)(#"YSN4@[EQ\I[4 =C<:A:VEU9VT\NR:\D:*!<$[V",Y''3Y58\^E6:\[
MU*77 ?!$D@L[C47O7\LC>J;3:2C<V222 23CKC'%=+HFK:C+K6HZ-JR6INK2
M*&X2:U5E22.0N!\K$E2#&PZGM0!OU6&H6K:F^FB7_2TA6=H\'A&8J#GIU4_E
M7->.I]9MTT8Z7<P0K)J<$;[]^6);@':1E>N1WJE,=<_X6.\5G]A%TVAP&>>5
M7:)")I>%0$$Y)X^88 /6@#NZ*XF?QT]EX8%W?16D&H_VBVED23;+<3*S N7/
M(3:I;U[=:FT#QA]N\0+H\VHZ/J+36[SQ7&ER9"E"H9'4LQ!^8$'/.#P,4 =A
M6(OC'PT]\+)=>TXW)?8$%PO+?W>N,^W6J'CQW?2].T_S&CM]2U*"SN71MI\I
MB2RY[;MH7_@5;LFD:;+I7]ER6%LUALV?9C$/+V^FWI0!=HKFI=5U:^UR]TK0
MDL8(].$:W%Q=HS@R,H8(B*5Z*5)8G^(#!K/N/&>H1Z*733H#JT.JQZ7/;F4^
M7YC%<,K8SM(=6R1QGH<4 =K17'#5_%7_  D+: 4TG[2;87BWHCD\M8]Q4H8]
MV2V<<[@,9^A8_C#4QX=M[F/3H)-3_M7^RYH!(1&7$A0LK=0IP#R#@'OB@#M*
M*YD:OK6E:QIUKK26$MMJ,I@BGLU=#%+M9PK!B=P(5OF&.1TYK*UKQM<:-?SE
M[_0YHH+A8WL(7=KD(6"Y+9PK8.=I7VSWH Z_2M,MM&TNWTZT#"WMTV1ACDX]
MS5RN7NM8URY\5WNB:7%8QI;6D-R;JY#N 7:0;=BD9SLZY&,'K4%IXNNY+'1[
MRZM(8HI[^73;[:Q/DS*[1JRG^Z9$QSS\ZT =?161I>K3:EK.KP)$@LK&1+=)
M1G,DNW=)^ W(/KN]*UZ ,S5/$6C:(R)J>J6EH\@RB2RA68>H'4BK5CJ%GJ=H
MEW874-U;O]V6&0.I_$5S/P\ACNM .O3*KZGJ<LLMS,PRPQ(RB//94 "@>Q]:
MOZQ=0>&K=3I>G6YO]5O5AC0 1K),RG+R$#. J$DX).WWH Z"BN:AU?6-.UVP
MTW6ULI8]1WK;W%FKIMD12Y1E8MU4,0P/\/05CGQ;XB/AS4/$2V>G+8:?-<+)
M V\R3QPR,K,K9PAPIP"&R1VS0!UFI:Y8:5<6MO<O*9[HD0Q0P/*[ 8R=J D*
M,C)/ R*NP7$-S'YD$T<L>2NZ-@PR#@C(]""*XRY.JO\ %?3WADLOLQTN9E#H
M^_RO-@W=\;L]#TQUIUIXFE30+!=-TVT2_P!1U&YM+>!?W<*E))=TC8Y^[&6.
M.23[YH ZR;4+6WOK:REEVW%T',*8/S; "W/08R.M6:X>8ZTOC_PY'JJV<BB*
M[*7%HK(I.Q<J48D@^AR<\],<YTOQ,#VESJEMJ/A];6%G*:?-<XNYT0D9SNPC
M-@E5*GJ,D9X /2:*Y2?Q!JU]XCCTK1HK-89--COQ=72LP0,[+MV*023@=QCG
MV%8NMZ]KU_X22>V:VL[RVUB*QN]A?#.MU&@*$$'8V>0>Q(H ]!^T0BY%MYT?
MGE-XBW#=MSC..N,\9J2N=M[R9?%]M87EM9-=G3'F>ZBC(;B51L4G)"\YQZBL
M>'QM<1ZW8VT]_H=Y'=W7V5H-/=WD@8@X)<G#X( (PIY]L4 =C:ZA:WLUW#;R
M[Y+27R9Q@C8^U7QSU^5E/'K4KW$,<T<+S1K++GRT9@&?')P.^*YWPK_R&O%W
M_87'_I+!5O4[U(/%&@VIM()&N/M&V9UR\.U ?D/;/0T 7VTRV;68]5(;[5';
MM;*<\;&96/'KE146IZY8:1+;173RF:Y8K#%# \KOC&3M0$X&1D]!D5RC>*_$
M;Z%JVNQ6>G+9:7<72/"^\R7$<$C!F5@<(=J]"&R0>@J2\?5)_BAHTMO)9?97
MTRX=!)&^_P HR6^_.#C=TQV]<T =Q17&VWB#Q'JFC-X@TRTTXZ<0TMO:3%_/
MN(ESAMX.U"P&0-IZC)ITGBG4=4U+2K30(;0Q:CIAU!;B[#8B7*8RJD;B=X&,
MCZ\8(!V%%<<^N^)+K5-=M-.M]-5-)=%\RX#G[06A20J "-O+'YN>HX/-16GB
MO6I++1-;N+2R32=6FAC2W7<9X5FXC<OG:V25RH48SU.* .VHKC?$_BJZT6[N
M5BU'08_(B\U;.X=VN)N,G.TCR\] <-Z^U5KS4M=OO%_AN;3;BVBLKVPGG2&8
M.<C$).\!@"1N^4]LGUH [>*XAG:18IHY#$^R0(P.QL X/H<$<>]5M5TR/5[%
MK2:>YAC8_,;:8QLPZ$9'.#FN;;Q,+"#6WM],MS=KK*Z?!''^[^T2ND6UI&Q_
MM\GT6K0U?6])U73K;7%L)K;493;QSV:NABEVE@K*Q.X$*PW CG''- '16MM#
M96D-K;1K%!"@CCC4<*H& !^%2UP[^)O$D^GZWJ5I:::MKI-S<Q>5*7+W*Q$Y
MVD'"' QDALG/ %=E:7*7ME!=1@A)HUD4'K@C(_G0 Z*XAF:18IHY&B;9($8$
MHV <'T."#CWJ2N+O/$LFE:5XJO[33+8S:?J*0[$&TW!9(?F8]V_>8S["KT&K
M:W9^([#3M8CL'BU&.5H6M X,+H Q1MQ.X$$_,-O3IS0!TU5K74+6]FNXK>7>
M]I-Y$XP1L?:K8YZ\,IX]:YS3M9\1:];_ -J:9#ID>FM*RP0W)?S9HU8J7+KP
MF<$@;6XQFLZ'5I=$A\97\,:2.FMQ(%?.#OBMD/3V:@#O:0D*I)Z#DUE7^K2V
MGB+1]-6-&COA/O<YRNQ0PQ^=8UIK7B'6]/EU;3+;3_[-+2"WMYM_G7"*2N[>
M#M0M@D J>V2.P!T]A?6VIZ?;W]G+YMM<QK+%)@C<K#(.#STJQ7FNE>*DT'P-
MX,T]+BPM;F]TV-A/J$NR&)$C3<3R"QRR@*",\G(Q6A;^.YI-,USROL&J7FF1
MQRK+ISEX94<D D#<5*[6++DG !'6@#NJ*P?#&KW.KPSRR7^D7\"E?+N--=NO
M.5="6VD<?Q<YZ#%3>(]3ETK3TFCO=,L]T@1IM1D(11@] "-S9QQD=^>,4 7]
M0U"UTJPFOKV7RK:%=TCX)VCZ#F@:A:MJ;Z:)?]+2%9VCP>$+%0<].JG\J\_U
M?Q&^O?#OQ7%,]M+-8CRC/:[A%,"JN& ;E?O8(R>1U-='%_R5"\_[ L'_ *.E
MH Z:BL/Q5K5UH>F07%E:QW-Q->06RQ2,5!,CA.O;KUYJI!KNI:=KDNG:[]B9
M#8R7T5Q:(ZA5C90ZLK$Y(WJ00>>>!0!TD44<$210QI'&@"JB# 4#L .E/KBF
M\1>)$\._\).]E8?V8(?M;6(+_:!!C=N\S.TOMYV[<=MW>KEUKNK77B9='T:.
MR$3Z='??:[D,P4,[+C8I!.<#'(QS["@#J:*YK2_%MM_8TEUK]S9:;-!>2V,S
M/,$B:5"1\A;'! R >?RJ.[U_5+OQ'#I>A)82V\U@MZ+Z9BZ*"Y P%(WY &,$
M=SGL0#=U33DU6R:TDN+F!&/S-;2F-R/3<.<&IK.TM["R@L[6)8K>"-8XHUZ*
MH& !^%<E=^+=1TO2O$B7]K:G5-&L_MBF(MY-Q&RL48 \KRC C)QCJ<UN:OJ\
MNG7NAP1QHPU"]^S.6S\H\F23(]\Q@?C0!>L]0M;\W MI?,-M,T$O!&UP 2.?
MJ*+O4+6QDM8[F78UW-Y$(P3O?:S8XZ<*QY]*XO0?^$A>^\2+I:Z?#"NKS,)+
MQ7<RMM3@!2-H']XY^G'*W>LG7(O"5T\'V>X37VM[B#=N\N6.&X1P#W&5.#W&
M* .XBN(9S((9HY#$^R0(P.QNN#CH>1Q[U)7''Q,-/LM;F@TV W2:P+""*+]W
M]IF<1A6=L=<OR?1:V],_X2!;DKJITR2!DR'M%D1D?(^4AB=PQGYLCITYX +&
MKVNGW]B;'4RGD7++&%:386?.5"D$'=D9&.>*HV'A6QLK^*^>>^O;F %8'O;I
MYO)!&#M!. 2.,]<=Z7Q%>I9RZ*'M(+CS]2CA!F7/E$JYWKZ,,=?<UE_VWXDU
M&_UV#2[?38X]+N?)5[D.QN#Y2/M^4C:?G^]SU''% '0:KK%EHMO'->R.HED$
M4:1Q-*\CD$[51068X!/ Z U=C<2Q)(H8!@& 92IY]0>17GFIZGJ>NZCX$U73
M?L<,-X6GBCN$9F1VM9"0Q!&1M.!CO6W#K'B#6IKZ;1(]-BLK2XDMD^V!V>Y>
M,[7(*D!%W J#ACQG% '545Q;>,;^_M_#QTBQA$^K//%(MTYQ;/$#OR5^]@JP
MXZ\=,YJ=]7\23>(IM"M4TP36]A!=37<B.4WNTBE0@;.#LR/FXYSGB@#K:*X&
M/QAX@;PY_P )))8Z?%I\$OE7%KN=I6"R>7(ZOD 88,0I4Y ZC/&QXEUZXTJ\
MB@AU30[(-'O"WS.\LAR> BD$+T^;GKTXY .FJ-+B&2>2!)HVFB ,D88%D!Z9
M';.#7G]]K^MZU!X,U+2Y;:TBO[K#Q2%V!<0S$JQ4C<GRY QU -:MSXDCT>\\
M27%S80&33[6U=WMTVR7+N&"H2>VX #/3=0!T]]:"^LI+8SSP!\?O+>38ZX.>
M&'3I3=-TZUTG3H+"RC\NWA7:BY)/J22>22<DD]2:YVXUGQ#HBVE[K4.FO8S3
MQP3+:;P]J9&"*=S$B0;F4'A>N<=J#K'B+4->US3M*ATV*/3)(T6:Z#MYQ>))
M-N%(VX+'YN>HX/- '645F^'M7&O>'K#51$8?M4*R&,G.PD<C/?!SS7/Z?/K[
M_$G6+=[JT:QCM;5_*(D^5&>?!4;L!SM^8XYP/2@#J=/U"UU2RCO+.7S;>3(5
M\$9P2#P>>H-6:\P\/:SKNB^ 8=6$%B=+M99/,A;>9Y(_/8,X8':I&20I!R!U
M&>.H\2Z_<Z7>QP0ZIH=D&BWJE\SO+*<G@(I!"]/F^;KTXY .GHKSN]U[6]:7
MP7J6E2VUI%J$YWPR%V!?R)B58J1N3Y>..H!KT*/?Y:^9M+X&[;TSWQ0 V6XA
M@,8FFCC,CA$WL!N8] ,]3P>*I'7+#^VQHZO+)>[0[K' [+&""1O<#:F0#@,1
MFJOB*]2SET4/:07'GZE'"#,N?*)5SO7T88QGW-8OA9=6'C;Q4;N2R,7VB'S/
M*1PV?(3;C)Z8Z^] ':U6DU"UAU&WL'EQ=7$;R11X/S*A4,<].-Z_G6;K^LW5
MA/I^GZ=!%+J.HRM'#YS$1QJJEG=L<D #H.I(Y'6L-3K ^)&B1ZJEH^W3[TQW
M%J&57RT&048DJ1@=SG/:@#LX+B&ZB$MO-'+&20'C8,"0<'D>X(J2N"7Q7+9>
M%-+N[:VT_38KJ[GADGDC;[-:A7D^9@I'WBO<@98Y/KIR^)-0CTS2XX4TZ\U3
M4YVAMGMYB;8JH9C*3C. JYVC/) SWH Z&_U"UTNR>\O)?*@0J&?!."Q"C@<]
M2*LUP_BS^VE\&:FFKFPD DMC%+:!TW?ODR&1B<8XYW'.>@Q6I/J^L:CKM]IF
MB+91)IX1;BYO%=PTCJ'"*JE>BE26)_B'!H Z2BN+N/&=[#X?GG>T@M[^TU :
M?>,Y:2"W. ?-. &*;64]OO $C!-.NO&,FE^%AJ=U<Z/=O/=+;6MQ:W.VVD+=
M&=CG8!\Q(RWW>#SB@#LJI:OY T>[>YN9K6".)I))X6*O&JC)((YZ"N7TCQND
MNM+IUWJ>C:@LMO).MQI<A(C\O!970LQZ'(;/.T\"J>JZIXEU?P#J.KQVFGKI
M]WITLD5F2_GB%HSAB^=N[:<[=OMN[T =EHME8Z?H]M;Z<I%H%WH68DMN^8L2
M>22222><FK]4=%_Y 6G_ /7M'_Z"*O4 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5S^I:!>R^(4UO2]0@MKK[+]DD6YM3.I3<6!7#J5;)/<@\
M<<5T%% '#:AH%AH/A>--2UFYB>+4GO8=3$.6@FD9FW. "NWYV4D@+ANW%5+"
M9]9\=Z+-#X@AUL6,<\D[V4:K;P*R;5!PS9=B>A;HIP!SGT3K50SBWOX+*.RF
M\N5'D,\:#RD((X8YSDYXX[&@#/L/#=M;>';O1;E_M-M=27+2Y7;E9I'<KU[;
M\9]LU!I^BZ[:R6L-QXA6:QMB,*MD%GF4# 620L0?<JJD^HKHJR[C5S#XGL='
M\D$75I/<&7=]WRVC7&.^?,_2@#.D\.ZG:7M[+HFL0V=O?2F::&>S\_9(0 SQ
MG>N,XR0P89Y[XJ\NAD:UIFI/>R2R6-G+:GS$&Z7>8R7)& #^ZZ ?Q=L5HW=W
M;V%I+=7<R0V\2[GD<X"CU-34 8UMH MX-<C^TEO[5N'G)V8\K=$D>.O/W,]N
MM4F\*S6]OI$FFZB+?4=-M!9B>2#S(YXL*"KIN!ZH",,"#WY-:4^KF'Q18Z/Y
M((N;2>Y,N[[OEM&N,=\^9^E:E '.W7AV^U/P[>Z;J6K^?/=NKF5+8(D0!4[4
M3)./E[L3DGGM5^_T@7NLZ5J)F*'3WE8)MSOWH4ZYXQG-:=% &+HNB7.CWVH%
M;Y);"ZN)+E(#!AXY)&W-\^[!7.<#:#SU--\5^'1XGT1K 7CV<PD62*YC7<T;
M#J0/=2R_\"K<K&\0ZQ<:5'816=O'/>7]T+6!99"B*=C.68@$X"HW0<G% %.Z
M\&VD_B'1]4BF:&+38Q&;55RLP4$19/;868CZ^U6)O#45Q/X@:6X8QZS L#JJ
MX,8$;(2#WR&STK:A\WR(_/"";:-X0DKNQSC/;-/H YRV\.7G_$C>_P!3CN)=
M)G:1&BMO+$BF%X@"-YP?GSGOZ"M&'2!#XEO-8\XDW-I#;>5M^[Y;2-G.><^9
MTQV]ZTJ* ,GQ#HSZU80Q0W7V6XM[F*ZAE,?F*'1LC<N1D'H1D=>M)::-+#KQ
MU>XNUEN'L(K214BV*2CNQ<?,<9+].<8ZFM>H;N[M[&W:XNIDAA4J"[G !) '
MYD@?C0!S\G@]'T^Y@6^DCN&U)]3M[A$&8)2<C@Y##!(.>H)Z5H:78ZQ#=O<:
MIJ\-T-FQ(+:T\B,<YW'+.Q;M]X#KQ6M10!1UC2+37=+FTZ]5C#*!\R-M9&!R
MK*>S @$'U%8IT7Q4\'V*3Q3#]E(VFXCT_;=%?]_?L#?[03\*ZBB@#G;CP]?V
M^JSZCHFJ1VDMTB+=1W5N;A)"@VJXPZ$/MP"<X( XXJ*/P<B:?! U]))<_P!I
MQZG<W+H,SRJP)&!@*,*%&.@ ZUT]% &;_9 _X2<ZUYQR;,6GE;?]O=NSG\,8
MKDO$NA-8:3:6T5]*CWGB2.Y6:-0&B,DI;C.0<>_7TKOZ1E5L;E!P<C(Z&@#G
MH?#^HW.K6=]K>JPWBV+,]M!;VI@02%2N]\NQ9@K,!C &3Q67)X%OFT:XT./7
M(XM*DG:=56S_ '^3)YFUY-^&&[_9!([^O;44 9EOI M_$=_J_G%C=V\$'E;<
M;?*,ASG/.?,].WO7-Z_::9X>\#:KIU]>B22^ENI[:,8262:25I$6-<DLRNRX
MQW /%=/)JT)TO[?912ZA'O"!;0!F8[]AQD@?*<YY[&K N;66^>T$D;74*+*T
M?5D5B0K>V=K#\#0!BZ;H6H6/@Z'3K?4?LNJL!+/>^2LN9F??*VT\')+#V!]J
MZ*BB@#F#X;U+3+VZG\.ZK#:074AFEL[NU,\0D;[SIM=&7)Y(R1G)P,TLWA:Z
MO=-*7^MSS:DMTMW!=I$J+;R*,*$CY 7&0022=QYYXZ:B@#GK70+^76;75-;U
M.&\ELU<6L5M:F"-&8;6<@NY9MN1U  )XYIO_  BB_P#"%ZEX=^V'%Z+L&?R_
MN>>[O]W/.-^.O..U7_$6KG0M"N=26$3&'9^[+;<[G"]?QK4H RAHH'B*UU?S
MSF"QDL_*V_>W.C;LY_Z9XQ[UF#P:$T6UM(=0>*\L[V:]M;M8A\CR/(Q!4GYE
MVR,I&1D>AZ=110!S4'AS4Y?$-AK.JZS'<2V:2QI;V]KY,6' !."['=QU)/L!
MSF.'PQJNGQ26&E:\EII;R,Z1M9B2: ,Q8K'(6V@9)QN1L5U-% &8FD!/$TFL
M^>27LDM/*V]-KLV[/_ L8QVK+N/"'G:+J5@E^8Y+O4?[1CF\K/E2"59%!7/S
M %!GD9'I5O2-8O=7U;452V@CTVSG>U$AD)EDE3;D[<8"\D=<\>];E &#_P (
M]+<:DM_?WJRS-ITEC*(83&&WL&++\Q*],8Y^M9EKX-U%+;1[*YUN%[+2)HI+
M>*"R\HR"/@"0[R"<?W0HSS@UNZ!JYUJPFN6A$)CN[BVVAMV?*E://X[<_C5Z
MXN[>T,(N)DC,T@BCW'&]SDA1[\&@"EI>D#3+W5K@3&3^T+L7)7;CR_W4<>WK
MS_J\YXZT7ND"\UO2]2,Q0V'FXCVYW[U"]<\8Q6G10!SR^%E7PGJ^A?:SC43>
M$S>7_J_M#.W3/.W?ZC..U6ET,+KFGZG]H.;.QDL_+V??WM&=V<\8\OI[^U:-
MU=V]E$LMS,D4;.D89S@%F8*H^I) _&J+:N1XJ31?)&UK)KOS=WHX7;C\<YH
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MP@"B,A N%7=]W"C SGU)ZUM)I 7Q/-K7G$F2S2T\K;TVN[;LY_V\8QVK3HH
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M_=[RHRI)78HP0,<9KTBL2T\(:!8WL=W;:;$DL3%XAN8I$QZE$)VH>3RH%;=
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M*D,,9/0@G SQQ6^_@[P_)>M=OID1D:3SF3<WEM)G.\QYV%L\YQG-:OV*V_M
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MD'UJI8>%=$TRYBN;6Q5;B($1RN[.Z@C& S$G&">.@S0!1\"?\@*[_P"PK?\
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MKF6-=S)&X+;?[V.X]^E>?7\ L_#=O'=:=+- GBV1UM1'RT?GR,-JGJ.X'?\
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M9"D8W %MNUSD<#=CO4WP^F"^&8=-DCGBO+$O'<1RPNFTEWQ@D -QSD$]1ZT
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MPB<>DW:ZR;(6BV'V5QLN-N/,WXV[0_S^9G'?.:Z+3=/EC^(EY=W$1DD31;2
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M0KB/1WD$<ERTR[TR^S<$ZE W4Y!ZD BHS<WC?%F02Z6IABTM0LS3K\B&5B9
M.V2 ,=?E% '<45R/_":W#:8=;CT*Y?00ID^UB5?,:(?\M1%U*8YZ[L<XJW>^
M*94UV/2-,TQ]0N)+-+U9!,L<7ELQ7)8_08P#G/L30!T=%<E<>-+A7UAK70KB
MYM]'E:.[E\Y4X50Y\L'[Q"G...W/-2VOB^6:YTQKC2)K?3M5?99W32J2S%2Z
M[TZIN521R>P.* .HHKG-<\2WNB"ZNI-$=]-M%WRW'VF-79 ,LR1]6P,\$@G!
MP#QFG<>(-:7Q]:Z;;:>)M.EL7F!\Y%W_ #QCS.1D;0Q&WOG- '7T5R=OXAT[
M2].U">WLKEI'U>6T2W60N]Q<EL';N.%!P3U  !J[9^(;D:O;Z7J^EMI]Q=*S
M6KK,LT<I499=P (8#G!&" <$XH WZ*XP^/)CI=UJZ:%<'2K*:6*ZG,RAE$;E
M&=$_C48R>1W SBNR!! (.0>E "U''/%*\B1RH[1-LD"L"4; .#Z'!!_$5SW_
M  E%W;ZE9P:GHSV4%[-Y$,AN4D=7()7>B_=!QC(+<D9K*M=:CT&X\6WCPM,S
M:W#!'&&"[G>"W5<L>%&3R30!W5%<_+XEFT_29[S5M*GM9DF2"*"*19C<NY 0
M1D8SDD#D+CGMS26_B.[BU.TL=9TA]/:])6VE6=9D9PI;8Q&-K8!(X(.#S0!T
M-%8OBF>SMM'CDOH))X3>6R!(Y"AWM,BJ<@C@,02.^,55N?$]V==O]'TS19+V
MYLDCDD=IUBCVN"0-QS\W!P,=CDB@#I*P-5TV^2[EO[7Q++IT,@59(IHXY8E/
M"@INQM)X[D$]LU#_ ,)E;2Z'IM_:V=Q/<ZE(8;:R&U9#(-V]6).%"[6R<XX[
M\5F^*[W4+KP?>IJ&E-8R1W-GM(G65) ;B/[I&#QCG(';&: .GT71X-$T\6D,
MDLI:1Y99IB"\LC$LSM@ 9)/8 #H*T*SK75DNM=U#2Q$RO91PR,Y/#>9NQCZ;
M/UK+_P"$Q@.BV][%93RW%U>2V5K:(1OED21T/)P N(V8D] * .A:>))HX7E1
M99,E$+ ,V.N!WQ4E</-J%]<_$'PY#J&EO93)#=LI$HEC<%4Z,,<CN"!U&,U=
MD\93?8[C5;;19Y]$MV??>+*H=E0D.Z1]648/<$@< \9 .KHKFKGQ5,=5GLM*
MTI]1-M!'/,4N$C8J^2OEJWWS@=R!VS6RMY<MJ_V0Z?*MM]G$OVLNNW?NQY>,
MYSCG/2@"V2 ,D@#IS2US'B%?[1\4>']'?FV+2ZA.G9Q#L" ^V^1&_P" "L[X
MAZ8\T-AJ+WUSY=OJ%BL5JK;8]YN4!=L<L=IP >!R<9- ';D@$ D GI[TM<SX
M[4P>&Y-8BXN='=;^)AUPGWU^C1EU/UK7UG4TT?0K_57C:6.SMI+@HIP6"J6P
M/RH OT5RS^+KJUMX-1O]"N+72)F0?:6F4O$'("M)'U5<D=R1GD#G%N\\077]
MJW&FZ1I3:A-:*K7+M.L*1EAE4!(.6(YQC !&2,T ;U%<K-XWA%GI4UIIMU<3
MZC<26B6P*J\4T8;<KY.!@HP)SCC/-.E\4Z@+]]/M]":XO;>VCN+N%;M 4#EL
M+'D#>?E/]T=.: .HHK!O?$5P-4.EZ7I;WU['"LUP&F6)(%;.T,W/S'!P #TR
M<<9JS^-K:V\.W^J3V-RDVGW"6UW9'!DC=F0<8R&&'5@1U!]: -;5](75OL.Z
M8Q_9+R.Z&!G<4SQ^.:TJP++Q%=/K<&EZGI,EA)=0O-:MYZRAPF-RMM^ZP# X
MY'7!XJ&\\47>FWD?V_1GM["2Y6V6<W*,X+N$5C&/X2Q'()(!R0.: -Y[RUC\
M_?<PK]G7?-N<#RUQG+>@P">:F!# $$$'D$5YUX@_U7Q+_P"P4G_I/)76Z;K$
M;ZF=&DB:.6*RBN8W)XE1LJ2/]TC!_P!X>M "^(-$DU^V2R>^>WL'R+N%(P3<
M)D?)N/W0<$''4$]*UP H    X %9^A:NFNZ3'J44+103,_D[CDN@8A7^C ;A
M[$5AVGB'3M,T.:>TL;EGEU6XLX;42;WGN/.=3@L< $JS<D!0#Z4 =2\\4<L<
M3RHLDI(C1F +D#)P._'-25PMYJ-_<^./"L&HZ4]E();EU99A+&X\A@1N &&'
M'!'?@GG&C+XNN&BN[ZQT2>[TJT=TENEF56?RR0YC0_? ((ZC.#C- '4T5S=W
MXK/]K6NFZ7ITFH37=E]MA=91''Y><99CT'(Z GD<=2,G6_&.I'PC/?Z9I[PW
MMO>K:74<DB$P.)44CG(8,&X([,#Q0!W558=2L+B^FLH;VVDNX #+ DJF2,'I
MN4'(_&L-]0)\060FTF1=8;3;F6.,764"J\8*''RDL64[L<8-<QX;O$7PC#+J
MND.JRZ[A)([G#23/>N-S%<'"-C(/# 4 >FU&T\2SI TJ"9P62,L-S 8R0.X&
M1^8K%UK7=1TIIY(M$>XLX$WR3&ZCC+C&2(U/WB!Z[>>E8FL:N6\8^%+[3K26
M^-WIUXT$:$+D-]G8%B>%&.I_  D@4 =PS*B%F8*JC)). !21R1S1)+$ZR1NH
M974Y# ]"#W%<TVO27EOJVE7]@]AJ,-D\XB,@D26,@C>C#K@C!! (X]1531==
M>R\,^&=,L;%[[49]*AE$0D$:QQK&@+NQZ#) & 23VX- '945E:+K7]JF[@FM
M7M+ZSD$5Q;NP;:2H92&'#*000?J" 152;4+*U\4:H1;2F\M]+CN))/-.UX]\
MN%"YP#E&YQW'I0!T%59M2L+:]@LI[VVBNKC/DP/*JO)CKM4G)_"N<L_&LUQ#
MI-]/HD]MI>J/''!<O,I96D'R;D'(5C@ YSR,@5G:;J4]OX]\47NHZ<D%M;6\
M!ENFG5O)B1)&!QC.#R<#I0!WU%<I_P )A=06D.IW^@W%IH\Q3%RTR-)$K$!7
MDC'W5Y&<$D9Y YJTWB6XE\37.B66DRW#VGDM<3M*J1HD@SGGDG@\ =CR.,@'
M0T5Q;^/G33KO53H=S_95C<RV]U<>:NY=DA1F1.KJ,9/3OC.*T[+Q)=/K%II^
MI:/+8&^C>2U=IEDW; "R.!]UL'..1P>>* .AHKFM2\47>DSF6]T9XM-$ZPFY
M-RA?#,$#^6/X,D=\XYQ5>UUW7)/B#?Z4^G9T^*V@=3YR?(&>4>9TR=P0?+VV
M^] '6T5R&G>([&Q\.::-,T^YDEO;B:&TLO.W.S*[EV+N>%&"22> 0!V%:>G>
M()9]5?2=2TY["_\ )-Q&OFB6.:,$!BCC'()&00#R.M &Y17&67CV6[TG3]:?
M0KB#1[QXHS<O,N^,R,$!*=2FX@9SGOC%=5J.H6VE:;<ZA>2>7;6T;2ROC.%
MR?K0!9J-)XI)9(DE1I(\>8@8$ID9&1VR*YO_ (2N\M5MKG5=!N+#3KF1(UG:
M9':(N0$\U!]P$D#@M@D9Q6=;:A?VWCSQ/!IVE/>RM]E=F:411H/*Z%B#DGL
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MQ6:^HZC!\2+H6VD-<7DVAVCO$9U1(L2SY#/@]R , Y^E '=T5S2>,;=] AU
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M0DL]HNI&G6&-&8!@@)!W-M(.,8&1D\T =!17.6OC"UNFTS_19XEO+F6RD\W
M:VN$!/EN!GD[6 (.#QZBH]5\:6^EKJLGV*>>'39[:WD:(@EY)64;5'<J'0G_
M 'L4 =/17*-XLU*/54TB3PY*NI3Q&>WC%TAC:,'#,[@?*5)4$ 'EAC/.)XO&
M-O\ V#<:A<V=Q%<6UU]BDLEP\AN-P544YPVXLN#P,')QS0!TE%8-EX@NCJT&
MFZMI3:?/=([VS+.LR2;<%E) && .<8P0#@\5DQ>/99=(76O["N$T=93%-<M,
MNY,/L+A.K*#U.0>#@&@#M**Y(:[KG_"Q)M)&G;M/6SCDSYR# ,C*9>F>@QMS
MV]ZZ'3[NXNUN#<V$MF8YWB02.K>:@/$@P> ?0\T 6\C(&1D\XI-Z[]FX;\9V
MYYQ7-:6O]I>.=;OI>1IRQZ?;#LFY%FD8>YWQC_@ KG_$'AO2=+M[&QTR(S^*
MKFZ26WOV -T2) 9)9' !V!<@C[O(4#D"@#T;(R1D9':EKF-27^S?'>C7D7RK
MJ:26%PHZ.41I8V^HVR#_ (%73T %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5CS:5/)XQL]8#Q_9X+">V923O+/)$P(&,8Q&>_I6Q5#5M9L-#M
M5N+^?RU=Q'&JJ7>1ST5%4$L?8 T <]_PBE]_PK4>&_-M_MFS;OW-Y>?,W=<9
MZ>U:KZ+)+XLN=2D:,VDVFK9E,G?N#LQ[8QAO6FV/BW3[S4(K"2&_L;J<$P1W
MMH\/G8&3M)&"0.<9S[5NT <0FB>*(/#/_"+1'339K;_8TU-IG\U8,;1F'9@N
M%X^_C//M6S8: ^G^)5O863[%'I<-A&A8EP4=CD\8Q@CO6]10!S<'A^[BTWQ/
M;&2'?JMQ-+ 0QPH>)4&[C@Y4],\47'A^[ETSPU;+)"'TNX@EF))PP2-D.WCD
MY(QG%=)10!YSJ_@;4K\:_;G3]%NIM2:4PZK>,SS0(XPL80H<;>@(8 =<9X/0
MSZ1JD'B#2=4LDLYA#9-8W,<TS1X5FC;>A"MN(V'@XSGJ*Z6B@#C9/"5_]BF:
M&XMDOXM:DU6S+;C&=Q(V/P",JS XSC.1G%6XM,UG5M?T[4=8ALK.#3?,>"WM
MIVG:25T*;F8HN %9L  YSDGC%=/10!R7_"+7O_"O-7\/^;;_ &N\6^$;[F\L
M>=)(RY.,\!QGCUZUTLD$CZ>]NDIBD:(HLB]4.,9'TZTEK?VU[+=1V\A9[67R
M9@4(VO@-CD<\,.1Q5F@#SBP\#:C%_8JMI>AVLNG744UQ?1.TD]YMX8EC&"I.
M=QRS9/&<<UO/H.I01^(&AATR[_M*_6X6VO-QCDB$42,C\':24.#AATX].IHH
M X*V\%7_ /9UX(_LFER?;(+S3[*&5IH+:2+GG(7A^00H  Z<UJ'3=<UO5M,G
MUF"QLK33IC<K%;7#3M-+L95))1-JC<3CDDXZ=^II&944LQ  ZDF@#(\3:3/K
M.DQVEN\:2+=VTY,A(&V.9)&' /.%./>C3]*GM/$VLZE(\9AO5MQ&JD[AY:L#
MGC'?CDU?FO[:"_MK*20BXN5=HEV$[@F-W(&!U'6K- '%P>$]3LM(TE[6:T.J
MZ7>7%Q&KLWDRI*\F4)QE?E<<X.".A%6]3T[Q!XAT*[M+V#3K-WFMWACCN'EP
M$E5W+/L'4+P OU//'4T4 <S=:=K5CXHO-5TF&RNHK^WBBFCN9VB,3QE\,"$;
M<"'Y'!XZ\UFV?A#5K+P_I2I=VDFLZ7?W%Y&YW"&82O+N5N,KE)>H!P1W'7N*
M* .5CT[Q#J'BG2]6U&/3[2ULHYD^RP3M*Y9P &W%%';ICCU.<#!A^'S:?%)I
M]OX<\,7L)D8PZA>QYE1&8G#QA#YC+G .]<X&<5V;>(M,2WU.X><K!ILGE7$I
M0E0P )"X^\1N P._'6HM,\46&IWYL!%>6EV8S,D-Y;/"TB @%EW#D D9[C(R
M* ,3Q/X:O]59X+;2-%EC$ BLKQY'@GL3C&5*J20#R K+Z>]=+:QZI#?1PRO;
M2Z>EHJF8EO/><'!)'W=I'/KFI-.U.UU1+AK9F)MYWMY59=K(ZG!!'TP1Z@@]
MZN4 <UXA5['Q%H&M!&:&.22QN"HSL2?;M8^PDCC!]-V:N>)](GUK2HK6V>-'
M2\MK@F0D#;',DC#@'G"G'O6S2$A5)/0<T <WXX#W?A\Z+"K-/J\JV0P/NHW,
MC'T C#GZX'>I?'0Q\/O$0'_0,N/_ $6U:]CJ%KJ5C;WEK+O@N%#Q,5*EA]"
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M3S^+=+U57C$%I:W,+J2=Q:0Q%<#&,?NSGGTJUHVJ0ZWHMEJELDB07<*S(L@
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M'XT 4GNM1TSQ%H.ERZA)=QW,5V\\DD2*SE A7[J@#&X].O>LFQNO$6L^%?\
MA*(-;%L\T+75OI_V>-K<1C)5)&(WDD 9(88)X'%=+;^'X8KG3[J:\N[NYL5E
M6.6=U+,),9W8 !^Z,=*SI/ ]B\<UK'?ZE!ID[,TNG13A8&W'+ ?+O522<JK
M<GB@"A_;6JZ_K&@P:?>MIUGJ.CMJ$V(D>1.8L!2P(!_>8Y!&,\9P0U-4\1?V
M%KEI;RO>ZCIFHI:_:(X4\UX"(I&<)PAD"2' P 2HX[5U*Z/:)J]OJ2*4FM[5
M[2-%P$$;,C$8^J+BJLOAJTD341'<7EO)?W2W<DL$Q1DD5$0%2.V(UX.0><T
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MLHK=HS!!&\A=U8D$NK#;\OIGGJ,<W+?P;:6K1Q0:EJD>GQ2"2/3TN (4(.0
M0-^T'^'=M[8QQ6M;:7;VNJ7VHQ[_ #[P1B7)X^0$+@=NIH H^$=3N=8\,6EY
M>[#=$R12L@PK-'(R%@.V=N<>]9!DU_5_$WB&RM]::PM=/,(M_*MXW8LT2L0Q
M=3E<\X&#SU&*Z72=+M]&T];&UW^2KR.-YR<NY<_JQI+;2K>TU#4+V/?YM^R-
M-D\95 @QZ<"@#B;/6O$!\.Z#XHN-3#+J%Q:I/IRP((5CG=4&UL;]PW@Y+$'!
MXJ[XCUBZ&H7\>F:QJ0FLXQNM['3DEBC?;NQ*[J<Y!!VJRD ^^:WD\,:>GA^P
MT0&;[)8M T/S_-F%U=,G'/*C-5[KPA:7-[>SK?:A;PWY#7EK!*%BG;:$R?E+
M*2J@':PSCF@#FKC^T->\0>"]3CU6>R:^T^6<1Q11,(B8HV8#<I)SGOGIQBI)
M_$6I:GJVK+#>ZM8PV5RUK ECI)N5=D RTC%&SDD_*I7@#GFNDF\)V3V6D6\-
MU>6SZ3&(K6>&0"0)L"$'((.0!GCMQBB[\*P3W]S=VFI:CISW1!N5LY559B!C
M<0RG:V !N7:>!SQ0!AR:QXBU*;PK:K(=(GU*WN'OE, +QM&$Y0.#@Y)QG/#<
M@XK0CUFXLM3\06U]J:K:Z;86TBW,\:_*S+)ND8*!G)0' QZ#%;"Z'9I=Z9<K
MYH?3H7A@!D+?*P4'<3DDX4<DU#>>&=-OWU5KE)'&J0);W"[\#:F[;MQR#\YY
M^E '-Z1KNI1^)]+LY+S5;RTU!)06U&P2VVLJ[@8\*K8X(PP)Y'-:W@7_ ) =
MY_V%M0_]*I:GM?"D$.IV>I7.I:C?W=GO$#W4JG8K*5(PJJ#G/7&>!S6EI>EV
M^D6LEO;;]DD\MP=YR=TCL[?AECB@# GEUK4O&NHZ5;:N;#3[:RMYLPPQM-O=
MI1P74@ A!G(/08QS67J/B/7=-T7Q#9BZBGU/2KFU2&[:( 2I,Z8WJ. V&8'&
M.Q&*NRZ!+J'Q"U:\$^H6!73[2.&[MB%W?/-O7YE*-_"2"#CCIFM5/".FKH]Q
MIS-<R"ZG2XN+B23=+-(K*P9FQ_L*,   #  H SKV76K._P!*T"/6I)+K43-/
M+?R6\>Z&.,)E(T"A<DL,%MV!G.>*8]QKUGJUYX=353=7%QILEW87DT,8DBD1
M@I5PJA67+J0=H_B'O70:QH=KK*0&9YH+BV?S+>YMWV21-C!(/(P02"""#W%1
M:5X?M]+NY[U[FZOK^=!&]U=N&?8#D( H"JN23@ 9/7- &19>)KC7;GPY%8'R
M3<PO>:@I4$Q(@V&/GH3*<>OR-5"T\1:QJ.B^'K6*Z2&_U:YN(WO#$I\J.(R$
M[5Z%B%4#(QU)!Q73:5X;T[1M2U&_M$<3:A('EW-D+RS84=@6=VQZL34#>$=-
M.B6VF*UQ&MI,9[:>.3;+#(68[E8#_:88Q@@X(- &-]BU&R^(VA)>:HVH0_8;
MTQ/-&B2@Y@W [ JD=,84'KG/%8MOXLUW4M$_MZSEU=KF0&:WTR/2&:V=,_+&
M9-FXL1QO#  GI@5V=EX4MK76H=8FOK^]U"*)X1-<RJ?D8J2-JJ%&-O8#J<YJ
M$>#+1'>.#4=4M[!Y#*UA!<!8<D[C@XWJ"<G:K <GB@"NUYJFO>);W3K349M)
MM=/@A>0Q11M-+)*"V/WBL%4 #MDDGD8IG@R.[AUKQ8E]/'/<#48P98UVAQ]F
MAP2.QQC/;.<<5K:EX;@OM1&HP7M[I]]Y8B>>S=09$!)"LK*RG!)P<9&3@UGR
M>$CI^C:E::)=7,5SJ=Q')<7$MPQ=<[%D=6ZAMBDC_:/8= #J:\XN?%%[#/!J
M5CJNHZA9R:A% RG3DCLS'),L?R2%0Y(W<,&8$CT->CXXQVKE4\!:>MM!9F_U
M)["VF2:ULVF7RX&1PZ[<+N(!& &+ #IVH A\S7-8\6:[IT&M/I]E8K 83!!&
M\A9TR02ZD;>,],G/48JI;>)=7U71_#=K%/%:ZAJCS1SW:QAA&(=V\HIXW,5&
M,Y R>#BNNMM+M[34[[4(]_G7OE^;D\?(NT8';BLYO"&FG1K734:YC%I,T]M<
M1R;9H9&+$LK8_P!MA@@@@X(- &.EGJ-E\2=&2\U-K^'^S;TQ231HDH.^WW!M
M@52.F,*.^<UM>*]1NM+TB"XM) DCW]I"25!^22>-&'/JK$4VQ\*6UGK46L2W
MU_>ZA'"\ FN95.48J<;54*,%>P'4YS6CJFEV^KVB6USO\M)XIQL.#NC=77\,
MJ,T <Z9-<U?Q;K>G0:R^GV5DD!B,$$;R%W0D@EU(V\9Z9.>HQS@:C<:IXA\/
M>$K^74WM;AM52"4011E3(K2)Y@# X^Z3CIS7H-MI=O:ZI?:A'O\ /O?+\W)X
M^0$# [<&J47A?3X=/L+)3-Y5C=F\BR_/F;F;GCD9<T 9<$NL:]K.JVL&LS:?
M:Z7(EKNAAB:6>7RU=G?>K +\X "@="<]*SI_$FNOH$<4,]O'JD.N)I,MQY68
MY!NQOVD\?*P) /4$9KH[[PQ#=:E+J%KJ%_IMU.JI</9R*!,%X7<KJPR!QN !
MQQFG1^%M,BTVSL(DE6&TNEO%/F$N\H;=N=CDL2Q)/K0!CWQUV#Q%HN@P:],4
MN;6ZFN;N2WA,IV/%MV@)M!&\CE2,'D$X-48)O$]W9>(&'B%HY-%FD@@9;6(_
M:2L:R@S97T=5PFSH3WX[.72[>;6;756W_:;:&6"/!^7;(4+9'K^[7]:BAT2T
M@CU2-#)C4I6FGRW\3(J''H,** ,"_P#$#7FFZ(T6I7ME=7]J+HVVG68N)F4J
MISEE944%L9(YR.17.ZK>ZIKW@8O/J%Q!-9ZW#:N3;QJTP%U$$9U((5AD'"X!
M(Z8XKLY?"-KC3VM+Z^L9[&U%G'/;NNYX1CY6#*RG[H.<9!Z8I%\&Z6FA7>D*
MUUY%U<?:GD,Q,BR[E;>&/.=RAN<\T 59]7O=&UX6=S=27EO!HT][*6C17E=)
M%P?E  X)&!Q6=-=^)+7P:?%KZTLDJ6GV^33O(C%L8]N\QJVWS,[> VX\\XQQ
M746^A6\-_#?2SW%S<Q6K6ADG93O1F#'<  ,Y4>G%9:^!=/$"61OM2?248%=,
M:<&  '(7[N\H#_"6V]L8XH @N+S5]6\9-IEGJDFGZ?\ V5#>%HX8VF#O)(N
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M6R3Z1-,L211,$7?;[D!*DD,3DD\C'!%=AK5['IVC7=W+>)9I'&3]H>,N(R>
M=HY;DCCOTJG<^&K6>XTVXCN;NVN-/B,,4L$@!>,[=R-D$$'8O;/'!%7=6TNV
MUK2Y]/O Y@F R48JRD$$,".A! (^E '*:'K>HIXKM--GNM4NK2\M9I0^I626
M[J\93[FU5)4ASD,,CCFLK2_^1<\%?]A^;_VZKL++PM!:ZM!JMQJ&H7U]!&\*
M2W4BG"-C(VJJK_".0,GN3Q3X/"^GV]GIMJAF\O3[IKN'+\[VWYSQR/WC?I0
M_P 57UQIGA#6;^T<)<VUC--$Q4':RH2#@\'D5S=U+XGM;S08O[>#/K+F&=3;
M1[;8B,REH>,]$9?G+=0>V*[#5-/@U?2;S3;G=Y%W"\$FPX.U@0<'UP:CN-(M
MKFYTR>0R;].D,D&&XR8VC.?7Y6/XT <K+XCU'PY:^*X[VX;4VTBWBN;>65%1
MW$BMA7V #AD/( X/M45EK&N0:CII^T:SJ/GSK%>0W&CF"*-6X+QML!4*<'#,
MV1GO76-H-A+=ZG<31F7^TH4@N8Y#E&10P Q[AVS5.P\+1V-S;R'5M6N8;7_C
MWMY[G*1\$<X 9\ D?.6H Y9O$NK:K/J<]M>ZM:"VNIK:U@M=(,\+^6Q3,K["
M6RRGA67 XZT^2/5M5\9>%KZ6^N],GN=+N)7M/)C)MV_T?>GS*3R3SGD8XQ71
MW/A&WENKJ:VU+4K".\;?<P6DP1)6(P6Y4E20.2A4GKUJS?\ ARUO9]/N$N+N
MUGL%9(98)?FV,%#(VX'(.U>O/'6@#G-3\1ZQ#X>\2W-K/&+JRUB.TM2\8*JC
M- -I'?\ UC<]>:T89M6TCQ;IMA=ZM)J-MJ,$[$2PQH89(]IRFQ1\I#$8;)&!
MS6A-X7T^>SU"U<S>7?7BWLV'Y\Q2A&..!^[7CZU=N-+M[K5;+49-_GV8D6+!
MX^< -D=^@H Y33+CQ#KWAT^(X-;%JTR/+;6/V>,P(@)VK(Q&\M@<D,,$]..:
MSZUKMQH7AN^DN=0@L[K3$GO+S3K))Y!.RH1N0JV$P6/RJ?J*J7MO8K%J-G;Z
M3XH@FG>7&DQ))]EF=B?F\Q<QJC$Y(W@<G(ZBNELO"<D6AZ-:_P!K:A975C8Q
M6CO93 *X50#E75EZC@XS[T ;.BW0O=%L[E;V*^$D2G[3$FQ9?]H+DX^G:N=L
M9-;\3/J5Y;ZW)ID%O>36EM!#;Q2 ^4Q0M*74DY8'A2N!CG/-=+I>FVVCZ9!I
M]FK+! NU=S%B>Y))ZDDDD^]95SX2MY;RZN+34M2TX7;;[F*SF54E;&"W*DJQ
M &2A4G'K0!R6H7>H^);#P;J)U"2QFDU5K>2.WCC9!*B7"-(N]2>=AP#D8/KS
M7<Z];SS>';V*&\DMY?(;]\B*S<#GA@1STZ=^*;_PCFFI:Z3:PPF&#2IEFMHX
MS@ A&09SUX=O<GFM22-)8GCD4,C@JP/<&@#R_P"R:C%X#\#K%J32SS7=B87G
MB3$"F!N % W8&<9Y/<UT(U;4?#VL:I:7]_+JEM!I9U*)Y8XTE4H6#)\BJ"#@
M$<9'/6M&S\(V=G86%E]KO9X-/N$GM5FD#&+8I54!P,J >^3[UI/I%K)K!U-P
MS3M:FU*DY0QEMW3ZT <)9^(M?:UL-22;5[RXG>)IK#^QV2V\MR-PCDV!AM!)
M#,Q!V].>.V\2?\BMJ_\ UY3?^@&J%GX/MK)[=(M3U7[#;.'@L#<_N8]IRHR!
MO*CC"EB.!Q6W>6L=]8W%I-N\J>-HGVG!PPP<?G0!YK>'7(_ .D76JII[Z%:Q
M6ES=+:LXN#''L92-PV\$*2."0" :Z=[C5-=\3:IIUIJDFEVFF")&:WBC>6:1
MT#Y)D5@% *C &2<\\4Z'P+8K!;VUWJ.JWUE;[-EI<W.8ODQM#*H&X# X.1Q5
M[4/#4%YJ3:C;7U]IUZ\8BEFLW4>:HS@,KJRG&3@XR,]: ,2+Q'<IH6JV^I:D
MMO?6&H#3Q>6]KYK3DA'79$,Y<JX& " 03C'%5;+Q#JL#^(+.2XOI?LNE_;K:
M;4+6.&96_> @JJA67*@CY0>H.:Z!O!^F'1H].C:YB,=Q]K6Z27,_GYR92QSE
MCDYR",'&,4D'A&SCFOIY[N^N[F^M?LEQ//("S)SC "A5QN/0 >V<T 8O]IZ]
M8>%;"_FU-;C4M9>U@B5X$6"T:7JP  9L _Q,<D#&,XI-9T[5;+7?"GVG6I-1
MMVU7+"XAC1U?[/-C:8U4;<9R"">G/6NHN=!L+S04T:X1WM$C1$.\AUV8VL&&
M"&! (([BL^/P=;'4+&^O=3U._N+"7S;=KF9<)E64C:JJ#D-U(SP.: +GBC6'
MT'PU?ZG%$LLL$>8T8X4L2%7)],D9]JQ-2DUWPQ:VNJ7.N/J41N88;NVDMXT3
M$LBQYBVJ&!!8'#%L@'ZUU=Y9V^H64]G=PK-;3H8Y8V'#*1@BL2W\'VT=Q:O=
M:EJ=_#9N)+:VNYPT<;#[K<*&<CL7+8Z]: *NE3ZSJGBO6TDU5H=.TV^2**"*
M%,R P1N5=B"=N6XQ@\GG&!7652LM+M["[U"YAW^9?SB>;<<C<$5./080?K5V
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F22QPKNED1%SC+'
M I]</XIN+.\\40Z9<6>B;X+(W/VK6%WH%9BI6-#@$C;ECD8!'K0!V^1QR.>E
M-2:.1"Z2(R@X)5@1FO*+.&/5/ GAJUG<2VQ\1/"!'N13$LLX50"20NT!<$_=
MXKH3H&EIXTU#1H+.&VT[4=$/VFW@0(CD2% VT<;MK$9^GI0!W)('4XHKSS0;
MBZ\0:SI>E7Y+S>&P[WY(XDN1F*%OQ3?)_P "6NC\</>1^#-3:P,RS",;F@SY
M@CW#S"N.=VS=C'.: -U)8Y&94D1F0X8 Y(^M EC,IB$B&0#)0,,@?2N+:'PO
M;Z9)+X2725UEM/G_ +.-HR>9(=F1G'+<X^]GGWK O8_"\?@"VNM$-J?$!2,V
M<T9!O7O"1PQ^^6+9#@]LYX% 'J;RQQ*6DD5 .I8XH,L8D$9D42$9"YY(^E<8
M-%T_5_B7K!U*SANUBTRS"Q3('C!9Y\G:>,X& >H!/J:YF+1;"W^%3ZNENAU.
MVN6>&]8;IH_+N2B .>0 BA<9QCZT >LO+'$I:214 ZECB@RQB41&11(1D+GD
MCZ5QB:)INK_$K7FU*SANTBT^S"13H'0%C/D[3QG"XSU )]37-0Z-86_PK35T
MMU.J6]R'BO6^:9-ESL0!SS@( N,XQQ0!Z;)>3V]U=M<0Q)80P+(LPER[-\VX
M%,<  #!SSFJY\2::-.TR_P#-;R-2:)+?CG,@RN1VXZUSNH6-OJ/B[Q1;7-K%
M<QMHEH?*DC#@L'N2.#WR 17-#2_"LG@/P?=K8:.R+<V(O)1#&0"R .)#CC)Q
MG/MF@#UIYHHD#R2(B'^)F %/R,9SQ7F.I0PR^-'MY8] ;3DT^'^RHM1'^C^7
M\V\Q ?)G[H/<+MQQ56\BG@\&:9&M_I]SHDFL.)F!D^RQV^'VQL>IB$H S]W&
MT?=H ]5CECF3?$ZNO]Y3D55U35;72+5+B[8K&\T< P,G=(ZHOX985R7A:SC@
M\6W+VEUHD<?V,"XLM)!V%BP\N1A]T-@./4@CL!5GXDV.GW/ARWN+^UMI5M[^
MT)DGC5A'&;B(2<GHI7@^W6@#5DUB6/QE'IK/$+,Z:]TS'J&$BKU],$UMJP90
MRD%2,@@\&N$DT;1-1^(&FPK:6DVG0:-(T,"(I@SYR@':/E.,G'OSUK&ODFL?
M"?B&QL-L.G6NOK%(@+!(;5A$\B_+RL>7;..BEJ /4HY8Y03'(K@'!*G.#2B6
M,OL#J7QNVYYQZUP&@64$7B^RDL+GP];XM9#-;:0#^_BXVE@/EX;&">>2!WK+
MTK2OL'P6;4='M@NKS6/[RZ1<SF,N-P##YL! < =,#% 'J22QR,RI(C,APP4Y
M(/O0TL:R+&TB!V^ZI89/T%>;:3968US09=+NO#-J^\LHTO<9+F'8=RMCJO0Y
M;HP'.33=,B\*S^'M3N/%1LO[86>?^T)+DK]HB<.VP(3\R@+MV;>V,<T =9XC
MU*^AU+1])T^YBM9M0ED#W$D?F&-$C+<*2!DG R?>N@3[NTL&9>&/O7FL.D1Z
MC>> )_$&FVT^IRVT@NFN8%9V*P9&_(Z@\X['-=UIT&E1:AJCZ>L0NI)U-\4.
M3YFQ<;O0[=O'O0!HNZQH7=@JCDDG %(LB.@=74H>0P/!KE?&MU;^;I&FSV6G
M3F\G<I)J9_T>)D0G)'\3')PO'0G/%<4^UO!_C>R@N+0VT=Y;^6=.0Q0H6$6X
MQC)Q\P.<'&[)H ]>66-V94=69#A@#D@^]#S1JXC,B"0@E5)Y/X5QUQH^G:'X
MV\-'2K.&S-P+F"?R$"^:@CW@/C[Q#*#DY/7UK(T:+PQ+H5_<>)#:?VXMS-]N
MDF(^U1R!VV",_>'R[=FWVQUH [+PEJ=QK7A#2-3N]GVB[M(YI-@PNYE!.!3K
M35IKWQ-?Z?#$GV2PB19I3G<9W^8(.V F"?\ ?'H:I?#W'_"NO#N.G]GPXS_N
M"JNA-=1'QA%:)&VIIJ,DD:2G"LS01F/<?[N,#\#0 _4?&#V_C/3M"M+19X)9
MO(O+DM@0R-$\B(!W;;&2?0,OK6HFK3)XKET>YB14DM1<VDBYRX4A9%/NI9#Q
MV;VKSZ6W\1:*WA2UET2U>Y_M5YI)SJ.3=7#6\Q=F_=_+G+'OC 'T[+5CYGCW
MPU&G^MCANY9,=H]J+S_P)D_*@#IB0 23@"JEY=B/2KJZMW1S'"[JP.1D FL;
MQO>P6FA117-G:W4=W=16VV\?; A9LAI#@_*".G<D#O7*Z-LMM?\ $]I;RZ68
M?[(222/2X3' ),R#IN(+[=N2,<;<]* .CT[Q#?75SX2CD\K;JNFR75QA?XU2
M(C;Z#+M^E=%J$MU!I\\MC!'/=*N8XI9?+5CZ%L''Y5Q&C?\ ']\//^P)-_Z+
MMZVOB)_R3O7O^O-Z .C:5(T+2NJ #+$M@"L?Q5J\VC>&[B]M#$;@M%%"9.5#
M22*@8@$9 W9QGM6->:18:K\4G&H6L=U'%HT;+%,H=-QFD&XJ>"0,X/;)KF[_
M $NPE\!ZK:RV<$L.G^(!!:))&&$$9NHLHF>@PQ&!VXZ4 >FVGF6>GQB_ODN)
M%SON"@C#9/' X'85:W# .1@]ZX2:RT2/QU+8ZY;V4=A#81?V1;7"*+<<OYVQ
M3\N\?)[A<8X)K"OHH)O"?B6UTUV&@?VM9QV+0N0BYEA\T1$=$#YQC@'..E '
MJPFB8,1(A"D@X8<$=:3[1 (TD,T>QSA6W##'V-<3KOAS2%\0^$],BT^WBL#<
M7+O;11A4D(A)^8#[W(&<]<<U%I/A30KKQ5XIM+C2[:6TC>%8;=XP8X=\0+F-
M>B%CR2,9(H [UW2-"[LJJ.K,< 53U35K/2-)FU.ZD_T:)=[,GS9'MZUY[:ZB
MEWX/\%V%];:?=S7=N76YU8[H4,: <C^-R&X!(Z$YXK+FM;.[\ ^-X7CTZZMK
M&],EM]FM\00GR8B[1*2VT9+G(..6(X- 'K4D]U]OMHX8(I+1U<S3&7#(1C:%
M7'S9YSR,8[U.9HQ*(C(@D(R$W#)'TKCFBTV'Q=X6314LTLQ;7_EK:!1%G]UG
M&WCKFN<LX_"\GP^N+K63:_\ "0A'-Y-(0+U+SGA3]\,&P$ [8QQ0!ZJ\B1J6
M=U4 9))Q@4JLKJ&4AE(R"#D&O/X],_M?Q?X<3Q!;)/<)X?>6XAE4%#-OA!W+
MT."6X/?GM6OX*@CLI_$FGVR"*TM=69((5&%B5H87*J.PW.QP/6@#=NM6M+/4
M;*PF<B>\W^4,<?(NXY/;BJ&F:Q)<:YKUI<O$D-E=10P'[I(:%'()[G+&L'QC
MINA/XQ\-W6KV6G-%(UQ%+-=Q(5;$1*JQ8<\Y(!HT[P[I&L>,?&$FI6$%Y_I$
M$2K.@=47[-%G:#T)SR1SP/2@#N'=(T+R,J*.K,< 53U35K32-*EU*ZD_T:)0
MQ9/FR"<<>O6O/+34$NO"7@W3KVVTZZFN8'=+G5SNA0Q +R/XW(;@$CH3GBLR
M6ULKOX?^,XI(]/NK:QU O;&WM\00_NH68Q*2VT9+G(..21P: /8P0PR""/45
M6MY;M[N[2X@BC@C91!(LNXR+M!)88&W!R.ISUIFE1:9#IT::.EHEB,^6MH%$
M?4YQMXZY_&N)U&"VNI/'EO>:A'8027=HK7$HRB_N8<!QD94G"D9'!/(H ]!C
MDCE3?&ZNOJIR*Q]8U2XL=;T"TAV>5?74D4VX9.U8)'&/3E16/X,FM8]7U73X
M=/TJ">*.&66?27S;RAMX7*XPCC:<CG@KSTJYXD_Y&GPA_P!?\W_I+-0!T;2Q
MI(L;2(';[JD\GZ"B26.%=TLBHO3+' KR$P174/B!];?PZE\MW.)YM1+"YA0,
M?**'JJA-I3;_ #S6[J<D<]_I6D:E'H=Q>6VE)/+J.KIN1\_*WEQG&3E,DDC
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M-/DNEU*;<NH;2$BVKRF_@#KDCN.>@J&WOE/A+1+"[M+6ZM[W4;A+";5V/E)
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M;RXMHK>_O&M3BY:SM6E6$XSAB.IP0=HR1GI5'6?&T-E+H+6%O/?VFIS >=!
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M+;LJS[C@>6,9?)P!@<Y&,YH V_(AP!Y28#[Q\HX;U^OO3C&AD60HI=00&QR
M>HS^ _*L>Q\3V-Y=/:RQ7=C<+$9Q'>P&(O&,;F4G@@9&1G(R,@9HTGQ/9ZQ/
M''!;7\:S1>=!+/:ND<R<?,K$>XX.#STH V%C16=E10SG+$#ECC'-0V]A9V;R
M/;6D$#2'+F*,*6/OCK6*GC729'1@MY]B>40IJ!MV^S,Y.T8?T+<!OND]ZFE\
M56":W+H\45Y<WT+()D@@+"(. 0S-T"\^O8^AH U'L+.2Z6Z>T@:Y0869HP7
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MY5969N@!##\CZ&MN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4 <';Z;JNEZ9X'N/[+GN9-+LOL]W;P/'YB,T"KD;F"D!EP<'O3M1\-ZG>?\
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MIQQ7?4 <'/X_N(-#T:\-E&;F:5_[2B#'%M%"_EW#C_=8C&>U6M<\1O\ 9_$
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M/Y;2*&8G#Y","0%P?6LJZ^()DN]1-GJ?AZUBLIY(%MK^XVS7+1G#<A@(P6!
M)#9QGO757>A"Z;0S]H*_V5<"<?)GS,0O'CKQ]_/?I6>?#>J64]XNBZW'96=Y
M,\[Q2V?G-%(YRYB;> ,G+88, 2?I0!KZ;J0UKP_:ZG8@)]KMEFA$P^Z67(#
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MM;F"2#?YB([,NUMPVG+MS@]>E;5 !1110 4444 %%%% !1110 4444 %%%%
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M8 G(#DG##T%=!K$$"WUEX>M(=9OIXH'N6C75I85",V TDI?>QR" ,G'/' H
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M12,P12S'  R37ESZA< Z-K^G1:I#;7^I6R)<WNJ,WVB*:0+C[/DH 58D=",
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M:M6LNV\2:+>ZDVG6VJ6DMXI8>2DH+$K]X#U([XZ=ZU* "BBB@ HHHH ****
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M74;.W%G,(79&9!*&^8# (R."1U%<C86<DGA6R\,7VI:K#=J(X9;"'2U+I(K
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MMXZY8=<5SD_@=[74=2>V\/>']4CO;F2Y2XO_ )9('<[F#8C;>NXDC!!P<>]
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M0F4(L,/ #.[9ZG@<$D@^A-0OXRBM]&UJ[O+">WO-&B\VZLV92=NTLK*PX96
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MI(T9.0IZ]=V#TJ#_ (2^ZGMY]0T_0;F\TF!G4W*3(KRA"0S1QGE@"#C)!..
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M31;E?8XR-RL&4_@0#^%3T4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!#=VEO?VDEK=1++!*NUT;HPI+.SMM/M(K2S@C@MXEVQQ1J%51Z
M"IZ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *I7^D:=JDEO)?6<-RUL_F0^:N[8W'('KP/RJ[10
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M* ,ZUT6UM(M1CC,FV_F>>;+?Q,H4X]!@"J4OA.R:QTNWM[B[M)M,A$%K=P2
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDG>1=N&SG##((&*H>-=!U+4=0LI=+BW+>1-IFH,'"E+:1E9GYZE0K@8Y_>4
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MV61GP)&C&2"1R!D $^] &Y8^*["^O8+4PWUJ]R";9KNU>)9\#)VDCKCG!P<
MG'!IUAXIT_4]4EL+*.ZF>":2">58&\J%T)!5G/&>.![CU%<]INEO?:OIS7&C
M>((_LLOGO)J.J%XH9 I V .WF')QT P3SVK=\*Z?<Z=;:FMS#Y33ZI=7"<@[
MD>0E6X]1B@"_JVLV6BVJ3WCN/,D$44<:%Y)7/1549)/!_(GI5-?%6G+I]U>7
M:7=BEJ5$J75LZ-EN%"C'SDG@!<\\=:K^)K&].HZ-K-C:F\;39I#):JRJ[I(A
M0E"Q W#@X)&1D9JEK U3Q%I\-Q;:-<6\FG7T%W#!>.B-=;"=RX#$+P>"W<#H
M.: -;3_$]E?:@E@\%Y97<B&2**\MVB,JCJ5)X.,C(SD>E4CX^T-5DF+77V2&
M=K>XN_LS>3!('*$.^,#GOT&03C-02C4/$FOZ+.=(N].M-,G>ZDENR@=W,;QB
M- K-Q\Y))P.!C-49?#VHM\,-8TD6>;VYGO'2'<OSA[EW4YSCE2#0!T.G>*;#
M4M02Q6*\MYIHC-;_ &JV:(3H,9*9'.,C@X//2J@\=Z1)%--;PZA<P6\CQW$T
M%G(Z0E&*MN(';&>,G&#WJQJVGW-QXK\/7D4):"U-QYSY'R!H\#WY/I7-^$]9
MU*Q\.S0P^';J\)OKW[/);/&$D_TB3[Y9@4.<Y.",8(R>  ===Z]:6UG:W4,=
MS?)= -!]BA:;>I&=V1P!CN2*K/XPT>+0VU>::2&UCG%M,)(F5X9"P3:ZXR""
M1^!STKFAH>L:+I/AW39!J%UIMM:R+>1Z3-Y4AG)4KSN5O+&7'RD'[N>*AM?#
M>J_\(_?6[:=-&TWB*VO8X9KGSG\A7@)+.S') 1LC)Y! R,9 .PTWQ)9:GJ+Z
M>(;RVNUB\Y8KNW:(R1YQN7/4 D ]QD9 S52R\0:=8>&+.\DU"[OHYI&B@>2+
M=/</N;Y0BJ,G@]!T7)[FI;VPN9?'&CZ@D1-M!97<4LF1\K.T)48Z\[&_*N5_
MX1;5(_#?AR5K:Z:XTN>=I[2UN?)F9)"XRCA@-PR#C(R"1F@#K8/%>F26M_-.
MT]D;"+SKJ*[A:-XX\$AL=P=IP1GD$=:GTO7H-5FDA6TO[:5$$FV[M6BW*>A!
M(P?IG([BN;L='6>/5KQO#^I3&2S^RI%JNH;WND))9,%F"#I@DYR3P!R;'A:#
M4X-9F"0:O;:*+8 0:K,LKK-N&/+.YFVA<YR2,XQWH Z+4]4BTN!))+>ZG:1]
MB1VT#2L3@GL.!@'DX%41XMTH:)>:M+)+!!9/Y=TDT122!N.&4\CAE.>F#FJG
MBV+4Y+C3#;IJ$NF!I/ML6G2B.=C@>7\VY3MSNSM(/([9KFQX;U27PSXMMETR
MYC;4+F*2U@N;KSY&0)$#N=F;GY3D$G'09% '86'BFPO]2CL!%>6\TT;2VYN;
M9HEG1<9*$CG&0<'!P<XJ*;QCID=Q<QJE[-#;.8[B[AM7>&%A]X,X';OC('?&
M#3M8T^YN?$_AR[AB+0VDL[3/D?(&A91^9('%9&C'5_#>ER:$-!N+R2.:8VUU
M&\8@F5W9PTA+!E(W888/0D9S0!H_#^1Y?A]H$DCL[M8Q$LQR2=OK4][XKL+2
M^GM(X+Z\EML?:?L=J\HAR,@,0.N.=HR<8XYH\&6-UIG@O1K&]A\FZ@M(XY8\
M@[6 Y''%9=BVI^%[O5K?^Q+S48;N]DO+:>T:/YO,P2C[V7:0> >1C'TH U;O
MQ=HUI8Z?>&Y::#43MM#;QM(96VE@H &<G!&/6BY\4V=K]EB:VOGO+F,RI91V
MY:94!P6=1]T9XR2.>!6#IGAG4K+_ (17SX49[;4+N\NQ&P*0><DQ"C/4!I O
M'UK1O;?4M(\7SZW:Z;+J5K>6<5M+' Z":%HV<@@.R@J?,.><@CO0!>L?%>EZ
MC%J#V[7!.G@?:HS;.)(R03MV8W$X'0"GZ;XDM-1OS8^1>6EWY9F2*[MVB,B
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M;^.N.F*QM&U?7M&\':GJMO;6+:;I]]?RR12%O-GC6YE9RK X0@9 !!R5[9H
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M=(Y^B$X')9L=\TZS\>2,=5M4DTW6KNTL'OH&TF7<LP7@QLN6*MDKW.0>.F*
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M1-(NEN;&Q6*5%*1DNS")3U"!B0@X'"XK0O;*VU&T>UNX5E@<@LC=#@@C]0*
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MXE/8EPQ(XK:U>\&L7FGV$=MJ=U>&R6[EAM+]K.)%<X#.ZL&)RK  9Z'(Z5U
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MVLW>-6NQ]H.,R?O#R<<9^G%5M8T:WNOBAH\CW%\IDT^[<B*]EC */;@ !6
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M^#NJVT5BZ3M<W4JQ+$0Q873%"!UZ!<>P% '<ZGXBT?19$CU+4K:VD==ZI)(
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M=S>7"WMR)"]S:BW#LJ*I=$P#@X') R1GW*Z=98^(VO7KVYYL;.*.9DX(S,6
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MNUA:182K.9(SM!V[MR-D\'&.U1:KJ%J-1\,:W':W46FQW%SYC"SD!7?&P#%
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M?B_3[[PYH=O?ZS;R:O<VL9='D&]Y"N<?[QZXZUUEG";:R@@:1Y&CC5"[_>;
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M7@#,)52?J#@?6NEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$^?F'T96!_#UH TZ*S]#U5=<T:VU..!X8KE2\2OU*9.UO^!##?C6A0 4444
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M710!R?\ 8.K1S>)[6-;-K+5S)-%,TS"2.1H$BVE-I!&4SNW=^E6+O0+J?0]
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME#*00>01WI:X[P?]ECU_Q#!HQ3^PHVA\@0G,*3D-YRQXX _U>0. Q/?-=C0
MWS$WA-Z[B,@9Y-"RQL[(KJ77[R@\CZUYMHFD_9_AYK6KZ3:*^ON=1$%QL#2J
M1/*%5">0.!A1QGGO5/2[*T:3P_/IMUX:M9C<1M'/:,YNIUZR(_\ $Q9=V[=T
M/)Y% ':6&I7^I>+M5@6[ABT_3'CA,(C!:9FB60L7SP!O48 ['UKH1(A+ .N4
M^\,_=^M>7W>BZ5967Q/EM-,LX)(K>2.-XH%4HK6*,R@@< L22.Y.:UM5M-(\
M/^$=/MH](L)O[2GMX)GN_EC=R"PDG?!+\@]<Y+ =Z .UEF8V<LUH(YY C&-3
M)A78#@%N<#/>E@ED-I%)=*D,QC#2('W*AQR W&0#WKS/3=EM?>,[.WDTWR!H
M\<CQZ9$8X%E(F!.-Q&[ 7)&.@R,BKL>F6FJZUX'@OH5G@70YW,4@RCD"VP&7
MHP!.<'N >U 'HBLKJ&1@RGD$'(-*3@9-<IX1MXM/UGQ1IMI&L-E;W\;0P(,)
M%O@C=@H[ L2<#C)-=1+%'/"\,T:212*5='7*L#P00>HH Y_PWJ5_J]UJ5[/=
M0BSBO)[."U2+!7RI"F\OG))*DXP!R/2N@$L91G$B;5R&;<,#'6O)?[#TR+P7
M>QVUE!:F?Q3]G>2VC$3^6-1VJNY<'"C@>G:NBUK3=&L/$FA:=>VEI:^'#%.R
M0>6J6SW>4V"0?=)V^85SU(]0* .Y5T= ZLK(1D,#D4"2,LRAU+*,L,\CZUYI
M>+8POXRM] \H:.NAR-<);8\A+HK)PH' 8I@L!_LYY-.O?"^CPP>"UCLHU:[N
M4ANY ,/=(;>21EE;JX+(I(;.<4 >DI(DJ!XW5U/0J<BG5R7A^SMM*\=>(+"P
M@CMK-K2SN?L\2A8UD8S*S!1P"0BYQUQ76T -:2-'5&=0S?=!/)^E<]H&LZGJ
MF@Z;>FW@E>>YECN#YGEB.-7D4,HP=Q^51CCJ37.Z9#X;N9M?F\4BP;58[Z83
M-?%=\4 8^3Y9;E4V;2"N.<GK5/0BA\)^ S$TK1_VW+M:7.\C;=8W9YSZT >G
M^8GF>7O7?C.W/./7%#21HRJ[JI8X4$XR?:O,G73-+\0M?8T;6!/K(7S5;9J%
MM*\@7:.I=4)QM^7Y!W'6W90>&[N_\2/XL6P?4([R4-_:!7=%:_\ +(Q[ONKM
MP<K_ !9[B@#J[35+B?QAJNEOL^SVMI;31X'S;I&E#9/I^[7]:UEEC9V174NO
MWE!Y'UKSW5I+M+_QC)HC.UP-!LS;-"=SXS<<KZMCI[XJ'4X?"UMHVDW'A3["
M-7>Y@%A):%?/FRZ^8'(^9E*;R^[W)YH ]),B"01EU#D9"YY(^E5X)KIKN[2X
M@BCMXV402++N,@*@DLN!MP<CJ<]:\ZUA=,TW7=1U1QHVL#^T8C)'(VR_M9/D
M4)&W)8 X(7Y>"1DYIWB7/]E_$W!(.R+!';_1HZ /2UD1G9%=2R_> /(^M!DC
M618RZAVZ*3R?PKB[[1-.T'Q3X3DTRTBMI9KJ:VGDC4!YT-O*^)#U<[D5LG)S
MSWK)T@>%I-/U&3Q.;,:^+N87;7! ND;S&\OROXP-NS9L]L<T >F @C(.1574
M]1M](TNZU&[8K;VL332$#)VJ"3@=S@5A_#O'_"N] QNQ]BCQNZ].]+\0;&WO
M_ &NI<6L5P8[&>6(21A]D@C;:RYZ,.Q'- '1)-')")E8;"-V<]J5'21 Z,K*
M>A4Y!KSN^A\/K+X7MPFGQ^%Y3*9TA"+;/<[4,0DV_*<_.<'@L%[XK1T--/M_
MB!=V_AX0+IGV#=>QVF/(2YWCR\!?E#E-^<<X"Y[4 =K3&EC5U1G4.WW5)Y/T
MI]>2^+;BRU&V\4W?V30K2>S,D'G72&2]DD1!L:/!!CYQLP3Z]Z /6&=$4L[*
MH R23C I0ZL 0P(;H0>M<&^GVNN>.-$.IPI=H-">8QR@,COYD7+*>#C)(SWY
M[52BTMX]'\0+I4.)=!UQKK3K=. H6**1XE'8,))5P./GH ]*R,XSSZ45R?A.
M>+Q!JFI>*HFWVMP%L[!B.L,>2S#_ 'I&?\$6NLH 8TL:E0TB@L<*">I]!3F9
M44LS!5')). *\Q\/6W@NXL_$#:V-/DN4U2^\\WQ7=$GVB3&PMRJ]\K_%GN*I
M.^I7.F>#8]7-L]C)#/\ \A<L(I) P^S^;ZL8LD!NISWQ0!ZTKHR!U92I&0P/
M%(9H@')D3"??.X?+]?2O*KZU%OX+\<?9KO3/LIM@!:Z86\JWF"G>1G@%@4)
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MQY/)- &\(T$C2!%#L "V.2!T&?Q/YTZL.Q\5Z=?:E!9+'=PO<JSVLD]NT:7
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MW@$GG73PE(8RA(92YXR,9X[4EGXPTV\N;:(17L$=VVVUN+BU>.*<XR K$=2
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M%2:+4H&O)';_ )9VX48/'<LZ#G_:]*I>/I]7MM.TY]*N(8-VI6L<A??D[IT
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M)MR%< .A5@#C.<$ <<4 9]MXQ.H>$AJT-UI%I(ERUM-/=7.;=65B"R,,;P<
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MCE00&R6Z-D#L.36MXPU*ZT?PAJFH66!<00%D8KN"=MY'<*/F_"@#:50JA5
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MUO<O"'D,K@,2A!''H1GC/2KO@R>X;3K^TN+F6Y^PZC/:Q2S,6<QJWRAF/+$
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M+$X<D-TXJ]';GQ)XLUVVO[V]B@TUH8K>UM;J2WX:,.96,9!8DDJ,G V'C.:
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MDD>M)\1@#\/=;#)Y@^S\IG&[D<9KJ*S=?TA=>T*[TMYC"MRFPR!<E>0>GX4
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M:3IJ/FWFDZQ/ID*RVIT\W5K<8#$0\#.Y69A@,#AAP:]!EGBAV>;*D>]@B;V
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MJ&FQ6,MT9[[3C;/')'@[,A$5@P)QQD;>^: .LU?4X=%T:]U2X5W@LX'GD6,
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M!(_&J^K:K!H]M#/<)(RRW,-LHC )W2R*BGDCC+#/M6=9ZM<3^,7L!<1RV?\
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M95BM;I;P-YA+R2JV_<[')8EN35UM+MWUN+5B7^TQ6SVR\_+L9E8\>N4%7:*
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M%O*JI/M7:"<J64[0!E2IP!4MGX8T^QCT9(3-MTB)H;;+_P )7:=W'/ K9HH
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M=PV\JJD^T;03E2RG: ,J5. *ELO#&GV":,D/G;=(C:*V!;/RLNT[N.>*V:*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'56P?G?(QSD<C'-&X\'ZIJMKJSZK)I[7-U>07D$2AGA7RE4>6^0"P.""WOG
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MT<;,8HHH)4<(&(!8X5SG R6 P ,UOZS9R:CH>H6,3*LES;20H7Z LI S[<T
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M:XGBTS3[>*26*"5HS<2R%\!F4@[%5.@(R6YSBK<6EZ5X42[U2.YN;:Q2 M-
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M$ )3 R;6<#.1)@^F,Y!(XQS4:>&-9F&HWMS<62:C+J46HVRQ[FB0I$D?EL2
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M^@]I?_@9'_C1R2[!SQ[FM163_P )5X=_Z#VE_P#@9'_C1_PE7AW_ *#VE_\
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M^@]I?_@9'_C1R2[!SQ[FM163_P )5X=_Z#VE_P#@9'_C1_PE7AW_ *#VE_\
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M^@]I?_@9'_C1R2[!SQ[FM163_P )5X=_Z#VE_P#@9'_C1_PE7AW_ *#VE_\
M@9'_ (T<DNP<\>Y\HT445]$?/A1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
, !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>ethicsemployeepolicybook008.jpg
<TEXT>
begin 644 ethicsemployeepolicybook008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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MT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+E6BNQF\-^'/^$AET"+5=0BOEN#:I)-:H86D#;0"5?(!/?%<G<V\EI=36TH
MDB<QN >A!P:49J6PY0<=R*BBBJ("BK-Y#:0^1]DNFN-\*O+F(IY<AZIUYQZ]
MZK4)W&PHHHH$%%%% !16CHNCS:W?&".2.&*.-IIYY#\D,:]6/^>216FMMX/>
M86W]H:LA)VB\:!/+SZF,'=M_'/M4N:3L6H-JYS=%/F18IY(TE65%8A9%! <
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M@)9W37,6Q27:(QX8@%EP3V.1GO5:FG<'H%%%% @HHHH **** "BBB@ HHHH
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M43T6W_!.I\1:W=Z)XBN]&L;:WBTZSE\A;5[=&651QN<D98MUSG//&*H>/O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMW^DK+9FYL(!/-B4[0I&< [>N"*]"@\.1#XV/J8V_83:_P!I*_\ #DC9G/\
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MM?$^AP:E:D#>,21YYC<=5/\ GI7E8ZDU+G74]3!5$X\CZ''?$+X9IK[2:KI
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **^N?[*T[_GPM?^_*_P"%']E:=_SX6O\ WY7_  KSO[07
M\IZ'U!_S'R-17US_ &5IW_/A:_\ ?E?\*/[*T[_GPM?^_*_X4?V@OY0^H/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!EZ]!>W%BR6DRQK@F0GJ1CH*\]@@EN)5BA
M1GD;HHZFO4;E2]K*JC+%" /PKD_#6DWUIJWFW%LT:"-AN..O% '-"*1;D1,"
MD@;;@\$'->E:9%>06:QWLJRRJ<!E[CW]ZY74]'U";7Y9X[5VB,JD,,8(XKMJ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ]HMKJEKN$-PFX*W53T(/T((_"HKJ=DY--=T70Y+M133[,T****Y3I"BBB@
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M_CW ^]C'7CZUZI14JLU*4N]_Q*=%-178RO$T4D_A75X88VDEDLIE1$&2Q*$
M =S7*?"#3[W3?"-S#?6D]K*;UV"3QE&(V(,X/;@_E7H%%2JC4'#N-T[S4^QY
M;\9M*U'4[?1Q86%S=F-Y=X@B9]N0F,X''2O4(QB) >N!3J*)5'*$8=@C32FY
M=SRO4M*U%_CG9:@EA=-9*%W7 A8QC]V1][&.M>J4445*CG;R5@A3Y+^;N>??
M$CP)<>(O(U;2&":K:C 7=M\U0<C![,#T^M8EM\3_ !1I4 L]8\*7$]V@V^:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3'X7/AQ87_LT@@IYAW<MO^]UZUMT4.I)N]QJ$4K6,'5O!^CZSI]C9W44@6Q
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MY*D*0_7)QGFJ&G01:1K=C>WD4&H+>ZA)';ZQ9W[&21G+[4ECZ%0/EP"P&T'
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M)P"1GYB .,^IH [NHKFXBM+6:YG;9#"C2.V,X4#)/'M7GEO>+%X4BT>>WEU
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MWM;FXE::-0\JP6TLWDJ>AD**0@_WL4Z^\3Z-IZV;3WJG[;&9+40HTIG4;<[
M@)8_.O Y.?8T .?PSH,M[->2:+I[W,P(EE:V0L^1@Y..<C@U-J>B:5K*1IJF
MFVEZL9R@N(5DVGVR.*RF\>>'5A,OVV9E0$S!;29FMP"03* F8N0?OXZ&M/4-
M=TW2[6"XNKH!+@A8!$C2O,2,@(J LW'/ /% %FTL+.P5EL[2"W5\;A#&$!P
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M346U&VTBPAO6))N([=%<D]3N SSW]:O16\%NTK0PQQF5_,D**!O; &XXZG
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M<=\6%MYOVB00R>7#Y9(<.^W:I&T\$@GJ,@B@#7BMH(6F:*".-IGWRE4 ,C8
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M.>..:Y!;76M9T7Q)I,$FIW&GW&F/%:R:M;B&83LKC8#M4LN-OS,.IZFO0Z*
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MW3RR>*(9XK:[<&253(A7+$XR?KC/>O5ZH:KI,&KQ6T<[R*+>ZBNEV$#+1L&
M.1TR.: .<O)Y_$VN:&+33+^VCT^[-W<75W;M#L C=/+7=RQ8OSC(P#STK-N=
M*U"]TCQ;H*6,ZW-S>27D#R(1!.A,;!/,Z9;!4CMS7HE% '$ZM=W'BJ/3=.M-
M&U*UECOK>YGFN[<Q+:K$X<X8\.QQM&S(^8\XJ#1M9&E>(/%@DTF^FC?5!MN+
M.W,Q9A!#\C!<D8X()XY/-=[5#3M*@TVXU&:%Y&:_N?M,@<C"ML1,#CIA!^M
M&;X-T^[L=)N9+R VTEY>SWBVQ()@61RP4XXSCDX[DU+XPTNYUKPEJ.GV@4W$
MT?R(YPLA!#;">P;&W\:W** .7DU63Q#IUSI$&E:M8SW-K+$TMQ;&-+9BA ^8
MG#<GC9N_*L.]EO-2\!_\(G%X?OH-2DM%LB'@(MX" %\P2_=*KC<,$L<#C->B
M44 <YIFGSP^.M:O)87\J2QLXHIV7[Y4S;P#^*Y^HK 71+U/A(VF+8R"[\XN(
M GS?\?6_./IS7H5% '##5!I?Q'U^5]-NKB)K.S#3VL)F>,_O<*47+8//(!Z<
M]JJ76CZIJ.@^)]0ATZ6%]0O+>[MK&3"R,L/E9)&<*[^6>#_LYYKM;?2H+;6;
M[5$>0S7D<4<BDC:!'NQCC/\ &<_A5^@#C#>76M^-=!O+?2M0AL;6*Y$L]U;M
M#AW5<+M;GL><8Y&">:RYM)U*_P#"7B+P_'9W<-[_ &E/>1,R;8YT-UYRJDAR
MI++QST)YKT>B@#@],M?[4U[3)93XIE-F[3[M1BCACA?8RX)V*7)#$?(2.^:M
MZ1I1A\%ZU:WVE37 N;R_=[1<*\Z/-)C!)'52,'([5V-% '#Z)J5[I]U?3RS:
MQ)X?M;%II)-6M_+EBD4YVHQ"LXVAB2<\@?,<UV-G<?;+&WN?*DA\Z-9/+D #
M)D9P<9Y%.N;:"\MI+:YB2:"52KQN,JP/8CN*EH **** "BBB@ HHHH ****
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M)::I;*RQ7";@K8RIS@J<<9!!''I6!<^$[RWU6_NM+72)8K^3SI$U"U+F&7:
M65@>5. =IQSGGFNFT^U:RTZWMF=)'C0*SI$(PS=R%' R><"@#G-(\4ZCK5_*
MMK9:>;>.>6!XC?8N8=A90TD>S@$J.,Y 8'FL_0_$NKV6G^(M2\016WV*PNYQ
MF"X:60,I7$2J44%>< Y!R1Q5V7PQJE]KEC>7\^EL+*Y\]+R"V*7,BC.(R<X
MP0#UR!T%//A*>:+7]-NKJ%M)U622=2B%9XI'V]\[2 5)''IZ<@#I/$6MZ6MK
M=ZWI%K;Z?<2QPNUO=F22V9V"IO!0 C<0"5/&>XYJ:'7]4OO%.H:39Z; +?3I
M8EN+J:X(W*Z*^$4*<L,GJ0.!SSQ!-H.OZNEK9:WJ%@^GPS1S2FU@99+HQL&4
M-DD(-P!(&<XP,5K:;I#V.M:S?M*KKJ$L4BH!@ILB5,'U^[F@#F)/B&YLKC5[
M:#37TJ N=CZ@%NI8T)#.L>W'8D*6R1Z9Q6S<>(;R\U;^S= M+>ZDCMX[F>XN
M9C'%&LF=BC"L68A2>P [\XK*M_!=]IT+:?I[:-]@,C-%/<6/F7$*,Q.WKM?&
M2 3CC&0<<ZUYHFHVNNR:OH=Q:(]Q D%S;72-Y;A"=CJ5Y5@&(Z$$8Z8H H^#
MY[JX\1^*Y+RT^RW'VN!7B#[UR+=!E6P,J>H. >>0#Q4VH>*+Y/$ESH^GVEA)
M-;1QR&.[O?)EN-V3^Z7:00,8R3C/''6KGA[1+_2[[5KS4;^.[GU"9)3Y<6Q8
M]L:IM R>!CCG/KS5'Q1X<U3Q EU9^9I,EC<)MC:ZM2TUH2,%D(."?XATP>YH
M ?JOBR2#6Y=(T]=.$]O$DMQ+J%YY"+OSM10 2S8&3V (ZYQ447CA;K1[26SL
M1-J=U>/81VBS@H)DW%R9 #\@52VX#D8XR<4M]X3N(]7?4]-_L^XDG@CAN(M2
MA,@8H"%D5AR&P<$8(.!TQS+/X7NY-+TXQWMM#J]A<&ZAGBM0D)9@RLAC!SL*
ML5ZYX!SF@!][KNLZ-H]Y>ZKIEIF%H1&;:Z+))O<(<[D!4KG/0@^OIHWVKFSU
MW2=-$(<7_G9DW8V;%W=,<YK-O=%UK7=$U&PU:]LH3<(@M_L<3$0NIW!R6/S?
M,%XP.!UYIL6AZY>>(M*U?5KVR L%E46]I&P5]ZX+%F.<\#CMSR<\ $>G>+;R
M[M=1U2ZT^"TT;3I+J.:9IRTC^2[*610N-OR]SG.1CC)J0>.IU:QN+Z#3([*\
MFCA"0:@);B R$*A=-H!Y(!VD[<]\5L6'AF.+PUJ&B7L@F@O9;MI"@V_)/([X
M^H#XS[5GZ;X9U2UFLX9WT1K:U92UQ'88GG"] <G:A/&6&?8#L 4X-8;0;WQ9
MJ!@$MNFMP+<MNQY436]NK2=.=N02/3/I73+K#2^*'T>& .D-H+BXGW?ZLLV(
MTQCDD*YZ\8'K5+^R;+3HO$DVK7,'V#59C+()#M54\A(V4D^R$_C6;X$TW4(?
M!;7LEQG5=1C\U)[B/)"A D&Y<_W%0D>I;UH [2BH;1;A+.!;N1)+D1J)7C7:
MK/CD@<X&<\5-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 075G:
MWT0BN[:&XC#!@DT8<9'0X/>IZ** "BBB@ HHHH **** "BBB@ HHHH ****
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M2P1PN\4OG*8Y& . &!P<D8XJOX/GDO/#MM>3:PVJ2W"++))^[VQN5!9%" 8
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MYJEE;L7\O$UPB'?@';R>N"#CW%7P<C(H **** "BBB@ HHHH **** "BBB@
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MP"O_ '6.?NGG@^E5$:PM;3Q_INV&+46:YFCAV!7:$VT>&4=USGIQFO2<8HH
MX&YTRUL- \$FTM4BD@O;4*Z)A@'0A\GKSDY]>])8W^AZ-JOB*/Q/);07US>.
MZO>*/])MB!Y:QD_? 'R[1G!!XYY[^C&: /+[?2VFT/P5::A:2?9O[;EDAM[A
M3NC@\NY:%7!]%V#!Z=#70:C-:Z;X[%U<JL=E;Z#</*0F5"B6,G@=>,\5V%%
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M&UQDC<#G:, XV\GTT+&TCU#Q)X)FO(O/:+0II0T@SB3_ $<9.>_)KT#'.:*
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MBY SV/&?7 ]*Z_%% ',_#]2G@?3HR"!'YL:@_P *K*X4?0  5FW%WIND>/\
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M/_7C/_Z+:N6\CQ)K_@BWT%]-MX8[RRC@FU$7 ,8B90&98\;M^W/R] 3]X@4
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M:=,FD\Y$8@!I1P&;'&.%R,YP: /3*P]&M]'MM9U>'3X76]1XS>22.SEBR[E
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MXAE*JWN"!R<UC:AXPN[*\-U;ZM%?VZWR6[V]OI<QB5&E$9'V@94.,YY."1C
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M6%S'<P(R1QC<AX+[5&X]O3D\9YK?N)[F*[M(HK-IH96833"15$("D@D'ELG
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M'\A8Y81N5W("23@'C)QBNFHH Q-2\.FZU--4L-1N-.OQ"())(U5UFC!)"NK
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MIL !QCY4"J/915G4O#UU>,RVVO7UG!) ()842-U*@$97<IVL0>HXZ<<5O44
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MP*Z&B@#G#X5EANKIM-UN^L+2[E::>VB6-@';[S(S*2A8\G'<DC!IL7@NSMM
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M6H3S;<F4*J(!G 1%  Z\GDGUX&*6NZIJ,.L:7I&EFUCN+U9I6GNHVD5$C"Y
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MG2&-9I0!)(J@,^.F3U.,G% 'G-I:W6L^#] @:[MKJ6&ZN4^PZA<L@ODC>2,
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MKIUP593@@^6W(KC=4L=)T_P%;^(-(NGDUCRXFM+T3LTMU,2 (VY^8,<J4Q@
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MT#[5=Z5KD\-G*7L9+]@ERA9=DRN%^=E4 99<98\BNO\ "EY;7_A>PN+..>.
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MI^0QY#CIDXP>E<W>SS^)M;T-;33+^VCT^\^UW%S=VYA" 1NOEKNY8L7YVY&
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M*1LWC;NVN'&>N!6GH-FMYXDBU!CXBE-K;R(D^IQI"@WE<H%V*S?=!SC P.:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *BAMH+=I3#$D9F<R2%1C>V ,GU. !^%2T
M4 %%%% !5'1=*@T/1;/2[9Y'AM8A$C2$%B!ZX %7J* "BBB@ HHHH BCMH(I
MY9XXD6:;'F.!R^!@9/?%2T44 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 51UC2H-:T\V5P\B1^;%+F,@',<BR#J#QE1GVJ]10 4444 %%%% !
M5#5=*@U>*VCG>11;W45TNP@9:-@P!R.F1S5^B@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J']E0#
M7SK&^3[0;46NW(V[=V[/3.<GUJ_10 4444 %94FA13^((=6N+NZF-N#]FMG*
MB*!BNUG4!02Q&1EB<;CC&:U:* (OLT'VO[5Y2?:-GE^9CYMN<XSZ9YJ6BB@
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MI-*:QM[6S^V7U_.88(3+Y:Y",[%FP< *I[$].*U8R[1J9%"N0"R@Y /<9[T
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MEFMUYN>"&=EQC_@.:T: "BBHUGA>>2!)8VEC +QA@60'.,CMG!Q]* )****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MY/XB"9O#=L+=T28ZI8B-I%+*K?:8\$@$$C/;(^HKK*JZAIMKJD$<%Y'YD<<T
M<ZC<1AXV#J>/1E!H Q[30-2FURUU76]3M[J2S5Q;0VEJ8(T+C#,=SN6..!R
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M@A8="D98J,=N..V* ,^%+OQ+XAUN&75;VRMM-G2VAM[.01LQ,22&1S@DYWX
MZ87H<UGPZ_JATRSBEO#)-;>(UTR6Y50OVF,,1D@< G(!QW!Z5TVH^&-.U*^-
MZ_VJWNF01R36=U) TBCH&V$;L9.,\CM3Y/#6D2:"NB?8U2P3!2.-F4JP;<&#
M [@V[G=G.><T 9]]/<77CD:.M]/!;R:0\S"%@&5_.10P.#@XR/SJI\,K$VO@
MFPE-W=3^=%D),X*QX9ONC QFMG3?#&F:7J)U&%)Y+YHC"US<7#RR,A(."6)X
MRHQZ<XZFIM(T*QT-9DL%FCBE;=Y33NZ)R3A%8D(,D\+B@#FM%TID^)7B&?\
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M[N/PEX5NENV$][=:>DKY&90Y7>/Q&:W]+T#3](^T-;QR237.//GN)6FDEP,
M,SDD@9.!T&3Q6=!X%T&W:VQ!<O':2K-:Q2W<KQV[*01Y:EL+R.W;CIQ0!4TZ
M._U/QMKPGU6[2RTZZ@%O:PL%4DP1LV\XR5R>F<<GKQC0\27MS9WWAU+>9HUN
M=56&8#^-/)E;:?Q53^%:MMIUK:7EY=P1[9KQUDG;<3N95" X/3Y5 XHO-.M;
M^2TDN8][6DXN(3N(VOM9<\=>&;@^M '&06^JZS)XHF?7K^V%C?21626[*HCV
MQ(V6X.X9;H>,?6G6^KZAXD?PQ8F\EL$U#2/[2NI+;"O*P$8\M&(.T9D)..<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 17%M!=PM#<PQS1-U210RG\#6$_@3PQ(Y9M'
M@!/]TLH_(&NBHJXU)P^%M$3IPG\23.;_ .$!\+_] B+_ +[?_&C_ (0'PO\
M] B+_OM_\:Z2BK^L5OYG][(^KT?Y%]R.;_X0'PO_ - B+_OM_P#&C_A ?"__
M $"(O^^W_P :Z2BCZQ6_F?WL/J]'^1?<CF_^$!\+_P#0(B_[[?\ QH_X0'PO
M_P! B+_OM_\ &NDHH^L5OYG][#ZO1_D7W(YO_A ?"_\ T"(O^^W_ ,:/^$!\
M+_\ 0(B_[[?_ !KI**/K%;^9_>P^KT?Y%]R.;_X0'PO_ - B+_OM_P#&C_A
M?"__ $"(O^^W_P :Z2BCZQ6_F?WL/J]'^1?<CF_^$!\+_P#0(B_[[?\ QH_X
M0'PO_P! B+_OM_\ &NDHH^L5OYG][#ZO1_D7W(YO_A ?"_\ T"(O^^W_ ,:/
M^$!\+_\ 0(B_[[?_ !KI**/K%;^9_>P^KT?Y%]R.;_X0'PO_ - B+_OM_P#&
MC_A ?"__ $"(O^^W_P :Z2BCZQ6_F?WL/J]'^1?<CF_^$!\+_P#0(B_[[?\
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M(B_[[?\ QH_X0'PO_P! B+_OM_\ &NDHH^L5OYG][#ZO1_D7W(YO_A ?"_\
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M*G!WC%+Y!11169H%%%% !1110 4444 %%%% !1110 444A(&,D#/2@!:***
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M,D8(!92K,#@D9&<C(XK-U6X\2:SH-_%9:3<Z7.!'Y1ENHA-*-X,BJ4+!"4!
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M^8M*"6^7=M4!@,_+SBN]KF9M!N+SQ#XB>4&.SU'2X+1)58$[@9]W'7@2+^=
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MJ,_UP%/UH N:;XD@U#4WTV6RO;&\$7GI%=QJOFQYP64JQ'!(R#@C(XJ%?%<
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M8_6L2^_Y*7HG_8+O?_1EO0!TU%<"_C2ZM]6M1_:FE:A;SWR6;V]G:R_N@[[
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MNN:9HD22:E?0VPD.V,.WS.?15ZL?H*T*Y'PU%'?>+_$^I70#WUM=K8PAN3#
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M#.V1^\4@Y'0\5TM &!#XW\+SW*6\>O:>97?8JF8#<W3 SW]JWZ\=T[4-2O/
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ML3CY@ %[TL_B;5=+L_$=K?I:2:GI6G&_@FB1EBN(RK[24+$J0T9!&X]B#SP
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MFNGHH Y.Y\):EJ4=I#J?B2>X@M+F&XC5+9(S(T;JX\PC[WW<<;1SG' JY?\
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M>6_=KA6SMQD<8-3:>UU97_BK2)(H[:!-(2X%I'?R72Q.WF@G<ZJ5)"KE1D<
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M'M+:XM[?3;:.*YB\F=5C&)4^;AO7[[=?[QJW+8VLRVZR6\;K;N)(05_U; $
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MXCTMI;"WETBUTZ>V,3 81B\)C 'L(S@CI@5L6.AZ7IME+9V5A!#!-GS41/\
M69&"6/5CCCF@#@7EOKO_ (1+1UMVGL9-%6X\@7IM1<2*L8P6 RP4'.WOG)SB
MC4$UBQ\):[;_ &IK.-+ZS6T6*_-Q+:[I8@ZER,@<@@'/#8Z8%=]>:%I6H6$-
MC=V$$MK#M\J-DXCP,#;_ '<#CBD@T'2;;3?[.ATZV2S+B0PK&-I<,&#'U.0#
MD\\4 <G=>'K:#QMINE175^NGW=E<7%U;F]E83O$T84L2V?\ EJ2<$9P,YQ6?
M=ZAJ&C^%/$=I97,_EV>LQV<4TDYWV]O)Y);]XV2-OFL QSM&#VKT=K2W>\CN
MVA0W$2-&DI'S*K$%@#Z$JOY"F+I]FJW2BUAVW;%[A2@(E)4*2P[_ "@#Z"@#
MCM)T[4M-\3Z=Y%JNGVLJ2BZADU=KDSJ%R&5'&=P;;EAV8Y[5A?8I%^&>H>)6
MO[]]6M7NI[><W4F(A'.X5 N=I7"X((.<GVQZ'IGAO1=&G:;3M,MK:5EV%T3Y
M@O\ =![#V'%6/[)T\Z9)IOV.'[%(&#P;!L8,26R/<DG\: .3;1;&7XK^>XN/
M,_LQ;@8NI0-XFQT#8QT^7I[5ES37EUX8@C&H74+R^*I;=IHY2'$?VN1=H/8;
M>!Z<>E=]=Z-IM_=VMW=V4$US:MN@E= 6C.0>#]0#^ IPTG3Q$L0LX1&MP;I5
MV# E+%B_^]N).?4T <D\4OAOQ3>6NC^>\<NBS7:VLLSRJT\;J%(W$D$[\''7
M K$U6SL(_A-<^(X]=O5U*73C,=0%Z^9)F3E-N[: 6.T*!\O;!&:],DM(3=?;
M%AC^V+$T22LO(4D$KGTR ?PK@;[PK?:O;W5G)X3T6PO;U6BNM6@D5@%;AWC7
M:'W%<CG'7DGN >APDF",GD[1_*N$T2UF,'B/7#)=7NHV=_?+9123N4C"E@$5
M,X.3GJ,\@=A7>JH50HZ 8%16]I;V@D%O"D0DD:5P@QN=CEF/N30!YAIMOJ\V
MB:5K-H@6^G:"4ZE/K3,MP69=R-&1MPV2H0#@XQR*W[.SM_$?B;Q FL7%P9+"
MX6*VM4NI(5AA,:,)0$89+,6^8]-N!C%;\7A708-2_M"+2+1+H.9!((QPYZL!
MT#>XYK'U_2[F]U5I+GPEI.M0*H%M-)(J21C'*OO4\9R>"?IZ@'/V5_*GA(3Q
MZM<74,?BF.+[6\I):'[4J\MW7!QZ'\:ZFYO2?B=IUBEPV!I%S+) 'X_UL 5B
M/^^@#]:ET+PVEIX<GT[58;6X-Y-+/=0JF8<R.6V*".5 ( R.V>*O:?X=T?2I
M5FL=.MX)55E$B)\^&VY!;J<[5_[Y'I0!PFE3Q3>#?#6D"SN+RZNS<21PI>-;
M1E8W.XR.O) WK\N#D]N*S]0B:[\!>-+&])":7=XMXXK^698<Q1L4\PA2X!9N
M&&!G'85Z5<>&]&N[&"RGTVW:WMV+PILQY9.<E2.1U/3UJ2#0]*M;.>S@TZUC
MMKA=LT*Q )(-NW##H> !0!ASP#2O%OANPLY)UMF@O6:-YWDWD",C)8DG&3C/
M3-8.GV=MJ7@"3Q/J&J7D.KF"2XENUNW3[)*N<QA,[0J$;=I'..<YKN[/1-+L
M%MEM+&"$6H<0;5_U8?&['UP,_2JTWA30+C4#?S:19O<EQ(SM$/F<=&(Z%O<\
MT <PB77B'Q'X<BU26Y@2?07NKNTBE:)7EW0_*VT@X!<_ECID4R&UO9=%\1:)
M9ZBT8M-8CAM1<W;H7B*0RF#S>7 ;>Z@C) .*[PVENUZMX84-RD9B67'S!"02
MN?0E0?PJM<:)I=W!=07%A;RQ7<@EN$>,$2.  &/N J\^PH QO"$L,4VIZ:+.
M\L;JV>-YK6:[-Q&@=3M,;$GY3M/''.>!FG''_"ST\S_H#-Y.?^NPWX_\A_I6
MSIFCZ=HT+PZ=9Q6R.V]]@Y=NF2>I./6H=1T?[;JFF:C%.8+BQD;G;N$D3C#Q
MGGH<*<]BHH NQV=K%()([:%'7=AE0 C<<MS[GD^IK@O"&BZG>:-<3V_B?4;&
M)M2OL6\,-NRKBYD'!>-FYZ\GO7H=0VMG;V,)AM84AC+M(508&YF+,?J22?QH
M \OBBD@\%W,4L[W$B>+D5II H:0B_3YB% &3[ "MQ-/OK[XB^(_L>LW.G!;6
MRW^1#$Y?(EQ]]6QCGIZUUITC3C T)LH?*:X^U,FP8,N[?O\ ][< <^M3QV=O
M%=S74<*+<3A5ED ^9PN=H)]LG\Z .&\3V?\ 8OAFW\+Z/#=7EYK%PZRCS5$T
ML9.^XD+,0,E<KG@ N,=A4:ZCJ&F>-M-U"Y\/7&DZ??1+IEPTD\+IO!)MSB-B
M1R73)&/G%=XUE;-?)>M!&;J.-HDE(^94)!(!]"0/R%%Y96VH6QM[N".>$LK%
M'&1E2"#]00#^% '"-J-_J?C/4[^W\/7&K:?9Q-ID#1SPHF[.;@XD<$Y(1,@8
M^0UH> 9Y9-&ET'5+1HKS1IA$(;@J["+[T#9!()VX&0>J&NKL[*VT^V6VM((X
M(5+,$08&222?Q))_&A;*V2^DO5@C%U)&L3R@?,RJ20">X!)_,T 9_B&*TA\)
M:NDD<:6OV.<R*  ,%&+?S)I_A^5SX?TN.X<?:_L4+2(3\V=@R<?7-+K^D?V[
MI9TYYS%;RR)]H 7)EB!!:/KQNQ@GT)IUKI*6^N7^JM+YDMU'%"J[<>5&F<*/
M7+,Q_$>E %'Q=>0V^EP6TD%S/)?7*6T,5O<& NYRV#(""JX5L^HXYS7*V$M[
MIUWXMTPJEI'!I*7*6\.H270AD83 D,ZJ4)"J=HXX![UW^H:;9:M9M::A:Q7,
M#$$I(N1D<@CT(]:KVGA[2+&.6.UTZWB6:/RI=J#,B\G#'O\ >/7UH XN.P.E
M:/X2UF*]O7U&XN;2*ZFEN783K* '5E)VXYR,#C Q6AIUA!XDUO7Y-7N+IIK*
M]-O!;QW4D(MX@BE7 1ARV2VX_0=*ZU].LWM[>W>VB,-LR-"A7B,I]TCTQVJG
MJ/AK1-7NEN=0TRVN)U79YCH"2O\ =/J/8Y% &-\.#&?#$YBNC=Q_VE>[;@D$
MRC[0_P W'!SUXJ#Q5IUW=:V;E8FU*SALP'L8-1:VF@?<Q\U0" Q(X&XC&S@\
MFNML[&UT^ PV=O'!$79RD:A1N8Y8X'J235/4_#>C:S,DVHZ;;7,J+L#NGS;?
M[I/=?8\4 <;!8Z3K7C;PYJ43WLD5WHDMRCR74JNV&M]I(# 9P>0.">3FL[Q/
M>R2Z1K7B32[26$6<TBQZA<ZO+&PDC?81'" R[=RD;6V[L^]>CWFAZ5?BT%UI
M]M+]D.;?=&/W73[OH.!Q["JT_A+P_<W4]S-H]G)+<;O-+1@ARPP21TR02,]:
M ,$Z+8R?%@SL+CS/[,6X&+J4#>)B.@;&.GR]/:N<MEU?6=#O]8E@9-1$LX%\
MVLM"+)D=@%\O&U57 R#][DG.:],N]&TV_O+6[N[*":YM3N@E= 6C.0>#]0#^
M JM=>%=!O=0-_<Z3:2W)8,TC1@[R.A8=&([$]* -&S,[64#7.S[08U,NPY7=
MCG'MFO/[:\A@\.WMK)!<W$M_XCO+:&&WN# 7?SY&PT@(*KA&SZ],'->C5G7&
M@Z5=6,ME/I]O);2RF=XV08,A;<7_ -[/.>N: .%L;/4IKKQ9X=@<6$BZ?!-;
M16^HR7(MYV,N"'95*YV(2O3O_$:CA\53ZCJ-EXN6ZDAT6T^SV5W#N(C#3)F1
MF'JCO ,]L/7H&GZ)IFDLS6%C!;LRA&:-,%@"2,GJ>6)Y]32?V%I0TV?31I]M
M]BN&9IH/+&QRQRQ([Y/- '%16&JZKX:T>[:7[1+>W$VH3Z;->O;F>.3)1%9<
MD>6K)\O3CG%=/X1NK>XT0QV\=Y%]FGE@DAO)O-DB=6.4WY.X#H#D\8J_J&B:
M7JMM%;W]C!/%"<Q!U_U9QC*GJO''%3V-A::99QVEC;16]O'G;'$H51DY/YGF
M@# T,D>+?%Q(W3B>WVCUC^SIM_#=YGZUQ%@NN:GX3CUY(O+U>4>;_:,VLLB1
M2[O]6T6-JH#\A3^O->E_V/L\3?VS#.8S):_9KB';D2[6W1MG/!7<X[Y#>U1O
MX5T&34O[1?2;1KLOYID,8Y?^^1T+>_6@!GB74KFP\,:O<:?L?4K:RDFCB&&(
M;:2#M[C(/UQ7&^(].TS3/ J:OI^N7HNI?(*7OVZ1C=EG7((+8.1GH/E[8 KO
MY=/BCGNK^SM[9-3FA\OSW3[VW.T,1R5!-<1+X4N=3_T4^$](TB2:5&O+^"17
M)0.&81 *&RVW'.,9R<T >@B:(S-")$\U5#%-PR >AQZ<'\J6.1)8UDC=71AE
M64Y!'L:S[[1K>Z6^FMUCMM1NK4VWVU8P75<';Z9P3G&:M6%E#INGVUC;+M@M
MHEBC7T51@?H* +%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C>
M)M:DT32EEMH%GOKF>.UM(G.%:5SA=Q[*.2?8&MFL#Q=I5YJ>E02Z<$>_L+J*
M]MXW;:LK(>4)[;E+#/8D4 5FT#Q((//3Q=<'4!SL>TA^RD_W=@7>%]]^?>M+
M4O$NDZ-,MOJ%ZJ3^6)&1(V<JO3<0H.U<@\GC@^E9I\;VQ@V1Z1K3:D1@6!T^
M56W>A<CRP/\ :W8]ZS]5U'5#XANK>[FUBQM1#$;.+3+(3?:&(.\-*8W"D-Q@
ME1CG..@!J:KJ+MXB\*?8[HM:7DLQ;RGRDR?9W9>G!&<$5D>*?$?]F^%+P_VX
M'N)M0^RQS6\)1H4\]4=!C/S(I(W=R,]:KZ!INH06'P_2>RN(WLQ,+D-&?W/[
MAU&[CCG 'X43Z;?GP?JL LK@S/XC\](Q$VYH_MR-O QRNT%L],<T =(FMZ%H
M6FV43ZC*R3(7MQ*\MQ/(N<EL'<Y SU/3@5=77])?2/[674(#I^0IN WR@E@N
M#Z'<<8/0]:PIYCH'C?4-4O[2[EL[ZT@C@N;>V>?R3&7W1LJ LH.X,#C!.>X%
M8=_I5YJ7AKQ1<KIEPEOJVHVTL%D\)$C(K0J\C)U7=M9B",X&30!V(\6Z#]C2
M[.I1);R2M#'*X95=PN\A21\WRC((X/;-.BU_3]5TN_FT[441K9&$DCQD&W;;
MD,R-@X[X.,U3\26+W>N^%&6V>:&WU%Y9"$++&!;S;6/I\Q7!]2*H:I873>(O
M%$L5K,8[G08HT98R1+*#<?*#W8!EXZ\CUH VI/$&G:7IU@^H:BDDEQ$&C>.)
MBT^%!+K&H)QR#[9%:%A?VFIV4=Y8W"3V\@)21#D'!P?Q!!!';%<5/=:I8P:!
M9SRZGIVFC3$\V:QL3/*9P%'EM\CE!CG[O)XR,5J> ;:ZMM&OA=P7<3R:C<2J
M+M0LC(S9#'  R<YXXSF@".*YU7Q5JFH)9:G)I>DV-PUIYEO&C3W,J_?.75E5
M ?EX&20>16OIEMJ.DI=G5-:%]9H \4UQ$D<D:@'=O9<*1TP=H[YK"LKF7P9J
M6IVM_9W<FE7EW)>VUY;6[SA#(=SQR*@+*0V2#C!!Z@BC7;FZ\7^%]5M=,TN\
M\E1$T;749@^V;9 [QJKX8 JNW+  [O2@#;T_Q7H>J7:6MGJ$<DTBEHE*LGF@
M=2A8 ./=<TV]\7Z!I\T\-SJ4:20-MF4*S&+@'+X!VC##D\>]8>JWX\42Z-9Z
M9IVH1SV^H074LMS920+:I&V6&YP 6893"DYW'MS5_0-.>+4O%TL]HR?:]0RC
M/&1YT8MX@,9ZC.X?7- &KJ'B#2M+BMY+N\15N 3"(U,C2 #)*A020 1STY%2
MP:SIMT+(V][#*+U6>V*-D2A1EL?2N#M+;[!X6\)27@UW3=1M=+6$7=G9F;RL
MJFZ*6/8YY*J>5_AZ@U;^TZK''X4U[5["X_T=KF.[%O:L7C5P1'(8ERPR%4D#
M.TM[4 =C/K&GVPOC-=1H+",2W6?^62$%LGVP"?PK/_X33P[OD4ZK #&I;)!
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MOXA\4RI;3-'/H4,43B,D2.#<Y53W/S+P/4>M &O:>+=!OKZ*SMM2BDFFSY6
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MC;EP2JY[D#GVW#UH OT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 9VJZ3'JK6#22LGV.[2Z7:/O%0PP?;YJT:** "BBB@ HHHH **
M** "BBB@ J V5N;];XQ*;I8C").X0D$C\2!^0J>B@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *IZEJVG:-:?:M3OK>SM\A?,GD"+D]LGO5
MRO./BY\/M1\>:;IPTR[ABN+*1V\J=BJ2!@.<@'D;>..YH ]"MKF"\MH[FUFC
MG@D7<DL;!E8>H(X-2URWP\\+7'@[P99Z-=72W$\9=W9,[%+,3M7/.!G^==30
M 5RNNW.J3>+]+TBQU5M/AFLKBXD=(8Y"S(\2J/G!P/G-=57&^(?#]IKWCO24
MU+3$O;!--NPQEBWHCEX=O.,!L;L=^M %KPYK%X^IZWIFHW]O>QZ9Y3"^1!&"
M'5B4< [0R[<DC'##@5I:;XGT35[G[-8:E!/-M+JBG!=1U9<_>'N,BN*_L/4(
MO .N>#K6R9)[$K]FEBA"+>VY8,.<;3(55D;/?D\-5O3U36=<T@G4]>NGLI3.
M%FTQ+9+<[&4K(QC7J&*[5)S]!F@#JH?$^B7&J?V;%J=NUWO:,1AOO.OWE!Z%
MA@Y .1@U#<^,?#MG(\<^KVR/&S)(-V?+*DJ=V/N@$$9.!P:Y?3;B6PUJRL=&
M.I/;M>O]HTS4-/(%HK%RTB3;0 ,GC+-G=@>R^&=>T[2(]?BNK"\6236+U@\%
MG),+H^:PX**?F&-N#CH#TH [>\U;3]/L!?W=Y#%:MMVRLXVMGIM]2>V.M-T[
M6=.U:WDGL;R*:.-MLF#@QG&<,#RIQSS7G?\ 8>K:9HGA.YF^V6D-A)<M/':P
M+<26BRDF+Y"K9"*=AV@D;N.,U9FT>XUW2?$\^G7FJWEW=V*6JRWELMK'<;=Q
MVJ J$G#%2Q&/FX)P< '61>-/#<SNL>L6K;59@0W#A>I4]&Q_LYK/T[QC:>(O
M#D>H6&H6]A+YT2R^<OFA-TNT)_#R^, ]B:NZ5XBTV_EM+*VT^_AF5>8I;"2(
M6N%Z,S*%']T8)SVXYKD[9)Y?AS;:0+.\%_8ZE:">)K:1<8O58E21AAM!;*D@
M#DT =MJ'B?1-+GD@O=2ABFCP6BR2X!&<[1SC'?I5B;6=,M]*75)K^W2P95=;
M@R#8P/3![YSQCK61I-DT?CSQ)>O;,HEAM$CF9" P"OD ]\$C./:N9LM/O;'0
M/#-[)IUS-;:7J5W)/:)$3(J,\RQR+'U;;N!  S@Y'2@#MK#Q)HVJ3I;V>H0R
MSL&(ASA\+C.5/(^\.OK5/7O&.F>'M6TW3[R5%>\=@S%L>4H1V#$8Y!*;?QK&
M&I6VJ_$S0[BWL+F)187:_:;FV>!I/FB^4*X#$#/4C'S<=ZTO%K-:ZIX;U)H+
MB2UL[YVG:"%I616@E0$JH)QN8#@=Z *L7BNRT[Q3KT6IZFL=LHMFMHV).%,>
M6( YQR"3T&1727&LZ;:Z6NISWUNEBZJR3EQL<-]W:>^>V.M8VB6A'C;Q+?M;
M.BW"6BQRO&5WJ(SD D=B>17)II6HVWAKPM=;;ZV@TV[NC.MO;"66%6:18Y!$
MRG(4'' ) ;(H ]%TS6=.UF*233[N.<1MMD"\,AZX93R/Q%,U/7M*T=E34;^&
MW=T+HCGYF (!P.IY8=/6L'PM!'=:]?:LE]JMXS6\=N9[NS6WCD 9F&T!%9BN
M3R1CYL GG%J\LFF^).DW;6S/%!I=V!-L)5',D  ST!*[OPS0!I65Z)M1O\ZC
M;RP(D3I L>UH 5)R[$\[NHX&,55A\9^'+AML6L6K98*IWX#DL%&T]&^9@.,]
M17/:SHVHZG+XYMK2%Q)=VULL!;*+-A&W(&Z<_=/IFJ_BO7+/4_#EE;0Z+J$<
MD5_8DK<V+PK:$7$8^\P"D\[0$)Z^E &N?$]KI7C+7+?5-1$5ND%JUO$Q)P2)
M-Y51SV7)^E6]:\;Z/HT6ERO=0RQ:C*BQR))\OEL#^\! .0,#\Z32[)D^('B&
M]>V91):V<<<S(<,!YFX ]^<9Q[5S<5K<V'@W1))+*Z$=CK\L\L:0,SQP_:)@
M&" ;BN&4\#ISTH ["Z\6:!9-"MSJMO$98UE7<W 1ONLQ_A![$XK8W+MW9&W&
M<YXQ7GOB&\6VO[[4-)DU:WU"ZM8V6VDTMY[?4,*=BD;<JW.TC<A'<=ZZ3Q/8
MZAK'@;4;*V01W]S9LHB#X&XKRF[WY7/O0!-9>+-!U&]6TM-5MI9WR(U5N),=
M=AZ-CV)K!M-<M-8^)-[8'5Y@MA%$+:UAE9$DD_>&7>!][ 51@\"H-9U"#Q'H
M]CHVD:;?0WXN;9U26RDA%@(Y%9F9BH4852 %)SG R#6YIEO,GCOQ#.\,BPR6
MUF$D*D*Q'FY /?&1GZB@#2U37-,T81'4+R. RDB-#DL^.N%&2<9&<#BD_M[2
M?[+BU/\ M&V^PRL%2X\P;"2< 9^O'UK#\3ZC?6NNV5N;J[T_3'MW9KRSLOM$
MC2[AB/[CA!CGE><8SQ7-V^EW=SX2-O<65]*)/$\4S)=0 2/";A&+NJJ  1DG
M  '.>] '?Z9X@TG6998M/OHIY(@"Z*2& /0X/.#C@]*=J$[Q7VF1I?06XFG9
M&BDCW-<8C9MBG(P1C=GGA369=6TO_"Q],NDA?RO[*NHY)0IVY\V JI/3/WB!
M]:7Q%;S3>(/"LD4,CI#J,CR,JDA%^S3#)/89('/<B@"W>^*-#T^^-E=ZG;Q7
M"X+HS?ZO/3>>BY]\5F^&-=CB\"VFJ:S?JH)D#SSOC/[U@HSW/0 5GZ+?P^'$
MU73-5L+U[R:_N)PT5G),+U)'+(0R@KG:50@D8V\\<UA6^E:C!X/\(70@O;&'
M3KB9[B""W$LMN&\Q5<1LIW;<XX!.&R.E 'HEGX@TF_LKF[MK^&2"V!,YS@Q
M#/S \KQSR*BM/%.A7VH)8VNJ6\MR^=B*WW\<D*>C$=P.17)1VG]H6WB348+O
M5]0F?27M!)<62P)-PY"HH16=@2><8^; /7%^]TV2/PWX.@M[-P;2\LB42,YB
M4(0Q([#!(/UH NZ?XVTO6-2U73;6[BCGM&VQR,2P?]V'+XXX4D@C/\-8^O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQJ'9$;G:>C#U7W'%<,=%=O@Y+8-ITAFENB[P&$[F)O,Y(QG[O/TKJ-2M9/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMZ$*=Q&T_*<=N17+77@+5+C3[ZP^Q:(]Q/</-_;$S,]S(#)O52"GRD#"Y#D
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M?WDK KYKR)-OVCG'SR\ GH.M6-4\.WM]JVL7=O>+:B]T=;"*5"?,BD#2G?\
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MQDN;::X$F>%$;1J1CW\P?E6;?^+[>P@UN62VD;^R[B&V(# >8\JQE>3PHS*
M2>F": .CHK!/B*:QTF]O]:TR2R6V"E?*E6<3[N%$9&"6)(&"!R13+;Q%>)J5
MG::OH[Z>+YBEM(+A907"EMCX^ZVU6(QD?*>?4 Z'I4<,\5S D\$J2Q2*&22-
M@RL#T((ZBN;7Q5=WL5S=:=H<]WI<+O&;E9E5Y=A*LT<9^\ 01R03C@'C+O !
M(^''A\JNYAIT) SC)V"@#<&I6!U(Z<+VV-\$\PVPE7S O][;G..1S5JO._#6
MN/I5MXHU35=,,$::G(6>.199'D.Q%B '4_= [<BNAC\2WMO?6<&LZ*^GQ7L@
MA@F6X691(02$?&-I.#C&1GC/2@#HZ*YZP\27&J:Y>V%II,A@L;HVUS=R3*J@
M[0PVCJQ^89'&,CFJGB36];T[Q1H=EI]@)[:Z:42#SD3S2(V;;R,KC .>_2@#
MJ$GADEEB25&DB($B*P)0D9&1VXYJ2N#L]2U*V\:>+(M.T=[Z42VTDF9UB51]
MG3"ACG+'!XQCCDC(K8/C"WGTG2;K3K.>[N=57-K:Y"-P,N7)X4+T)YYP!G-
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MEDGO-&9-,CE$;7!ND\S:6"^8(QU7)SUW8[=J .A$\+7#6XE0S(H=HPPW!3D
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M=V>XD7S-ZJ04RIQA<AB !P.P],HH H:Y8W&IZ#J%C:736MQ<6[Q1SKG,;%2
MW'/'M7):9X/O(-<T2^&CZ%I46G/(9ELF+R3[HG3=O,:GJ0<'.<DDY'/>44 <
MQ#X<NX_"NOZ69(//U&:^>)@3M43,Y7=QGC<,X!_&HY-#U;3=0L=5TL6EQ<1Z
M>EA=6UQ*T:R*AW*R.%;!!+<%>0W;%=710!SF@Z5K$'B'5]6U=[/-]#;QQ0VS
M,PA$?F94L0-WWP<X'4\# JYJTGB""[BETJWL+NUV%9;>>5H9-V>&5PK CV('
MU[5KT4 <2?".I76@:V+B>TAU74[V.^"Q;F@A>,QE%S@%A^Z7<V!G)XJY#IGB
M"_\ %6EZQJ4>GVL%E!/%]G@G>5BTFWYMQ1?[O3''J<X'544 <>WA2^/P^N=
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MI[*\BMA<L6=7C92VT;6'7]#QTH WZ*K7]Q/:V4DUM9R7DRX"P1LJEB3CJQ
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MJ0K/\S.>GRG))X% ':45SMKXKC":NNKVK:;-I42SW*F02+Y3!BKJPZCY6&,
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M;*3S+:YC$D;8QD$=QV/M0!:HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=JMQ(41A&X8@L%8C./2MZB@#D;_2?$OB6W;3M7;3M.TN7BZ2RF>:6=.Z;F1
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M_"+7)6U&2ZS=72QQ2QHJJXO7!;*J#R>3V&>,5ZM:VT=G:0VT._RX4"+O<NV
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M#3]/U)M.L)=)COF9(4>4,SL !O! R,9R#TXZYJMX=\$Q3^#='M+Z]U5+1K*
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M4>=&"2 P96Z%FP1@C)YIEIX0TNQTRPTZ#SQ;V-X;V$&3)#EF;!)ZC+GWZ<T
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MI5Z@ HHHH **YFV\?^';I()5N;J.WG(6*XGL)XH6).!^\9 O)]ZZ:@ HHHH
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M!-EJ]_;K!<R%T?8"%?:Q&Y0>QQ^>:ZJF0PQ6\*0PQI'$@"HB* J@=  .@I]
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MHC571-S%F7)P2 O)]0#T>N+>'6_!4.H7-G!;ZIHOG37KP[S%<PAV+R;2<K(
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M-:>DZ7;:-ID.GV@?R8@<%VW,Q)+,Q/<DDD_6@"[1110 4444 %%%% !1110
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M+2](FUR*>TTG3%LTAFN;C3YO]$8-N"G& $?Y>1Z%>3Q7;JRNH92"I&00>"*
M%HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ JM=Z?97X07EG;W(C.Y!-$K[3ZC(XJS10!G:G:WQL"FC
MO:07'F;RL\):.0?Q*V"",^O/T-8^FZ!J,FM6FH:G'IMI%8K)]GM-/W%2[@!G
M9BJ_P@@ #N>374T4 5#I6G&YDN386OGRC;)+Y*[G'H3C)J<P0LTC&)"TBA')
M499>>#ZCD_F:DHH C,$3(B&)"L9!0%1A2.F/3%0MIMB]\MZUE;F[48$YB7S
M/][&:M44 0M:6S72W36\1N%7:LI0;P/0'KBBXM+:[14N;>*958,HD0, 1W&>
M]344 ,6*--^R-5WG<^!C<<8R?4X J.2RM9K3[)+;0O;;0ODM&"F!T&WIBIZ*
M (K>V@LX%@MH(X(5^['$@51] *?Y48E,NQ?,*A2^.2/3/IR:=10!$UK;O'+&
M\$3),<RJ4!#\8Y'?@#KZ5'#IUC;6OV6"SMXK?.?)2)53/T Q5FB@"-H(FF29
MHD,J A7*C<H/4 ]J2YM;>\@:"Z@BGA;[T<J!E/U!J6B@"&"TMK:V%M!;Q10
M8$4:!5 ^@XJ1$6-%1%"HHPJJ, #T%.HH JR:;8RWB7DEE;O=(,),T2EU^C8R
M*)]-L+JU2UN+*VFMTQMBDB5D7'3 (P*M44 1+;6Z1O&L$2HXPRA  PQCD=^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU*>SU&.* K:K<HR.64KTD&2!G:<<X'#"F2:3>V]_<W.EWT4 NF#S13P&5=X
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M+FTE+(R%6Y&#E7!7ID]C6E%X<>VTS2X;:]V7FFQ[(KAHMRN" &#+GH<#H<Y
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MZTFXM#LTS;HJ&TCFBM(8[F?SYU0"278$WMW.!T^E35B:!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4T(H<N% 8]3CDTZB@ HHHH **** "@@$8(R#11
M0 BJJ*%50JCH , 4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_?U?_P B4>=XH_OZO_Y$KUFBC^SW_.P]CYGDWG>*/[^K_P#D2CSO%']_5_\
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MK#VM/^9?>:U%9/\ PE/A_P#Z#>G?^!*?XT?\)3X?_P"@WIW_ ($I_C1[*?\
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MD_\ "4^'_P#H-Z=_X$I_C1_PE/A__H-Z=_X$I_C1[*?\K#VM/^9?>:U%9/\
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M36GXQD6Y\(M,ARDD0=3[$5QGP[D_X^8SV8&NBNDJBL9Q^%GJ*:WJO?4[T_\
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MA<>*K75;B'4;;Q-::="54S6T]DKRQL.NTE?F_P _2O-?[ UG_H$W_P#X#/\
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MZG9VO@KQ%933JES<^5Y,9!R^&YQ6/_8&L_\ 0)O_ /P&?_"C^P-9_P"@3?\
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M!QQCCKUJY?>)-)F\9^&KX:D)H+6WVW$[(5(;!Y(QP3GH/6N$_L#6?^@3?_\
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MW$D,MS(Z./X@6.#6UKVKVEQX-\.V=K=;KFV603HN04R1C-8?]@:S_P! F_\
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M4['!_A[5IQW$\<_F-I5U)L"",L@RH4DX'R8 .>PSQ3/M5[D$:9<<1SI]UO\
MEH2<].V:Q+,YAJZ2B-K90Y<(!]FCY8C('W?2FK_:\I&RW4YR?^/:/L<'^'UX
MK5BO+^!6QIEP3Y$:1G:WR.BE0XX]S2W%Y=7;S)+I-RMO+&$*1@@@[MY(..Y)
MXH RD&KLQ#0*BK)LD8VJ80\<'CW%+(U[;:@D,RPM$9S&&-M& X#8)'%7+R>_
MN@!_9MPH%R)@-C'@*% Z>W6FWC7FIZA:SR:=<1R))@L4.-F[('3J,]: .;N4
M"W$JKP Y 'XU%MJW=+FXE/4%SS^-0E?TH @8=*W(?#D#^%9=6DO/+G&2D1P
M1G'UR>U4HH(X(UN;E=P)S%$>/,]S_L_SZ#OBK/))<2M)*VYC[=/0 =A[4 4V
M'-,9>:L%>:8RT 5F'%0E:MLM0[0.* *Y%-V%B% Y-3LM6],LS=7'^K=HEYE*
M@\(.6/MP,?C0!9L?(TJS:ZG'SR+^Y7;\Q]SSP".F/8]\-F7>LWERQ)?:H^ZH
M X^GI^&!3]5G>YOY"QR%.T8'''H/3^F*HB&1@S+&Q"C<2!G Z9/M0 +J%VC
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /'?B1_R-IY'^H3^M<AQDGMFNL^)AQXN..OV=/ZUR 8E1QQZ?Y_"NJ'P
MHR>Y( ,\48H!XIXY%4(:4##!Z5AZQH4=U&65?FKH -RTNW*D8H \L'VS0[X2
M(64J?P(]Z[S1-<@U6$?,%G ^9.].U/1H;Z%LJ,_2N&N["\T6[$L19=IR&%3K
M$>YZHF#0[X%<SH/B>._00SD).!CV-=$06Z5:=Q'&>-K9KA83(/E (BDQT/\
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MFLZFQ4=R<O)_>;\Z-SYQO;\ZD:)HW*LI5AU!&*-O&<5@7<DF+^5!\S?</?\
MVC5<L^?OM^=6IE_=0?[A_P#0C4)2@+D)9S_&W/O32SXY=C^-3%::5XH"Y6VD
M]14EI$CWL:N@==W*GH:<5('2I]/3_B8VX]7 H SIY'GD,DC98_D/8>@IT6G7
MEP@DAM)Y$/&Y(R1^8I77%;FF:;%J=_:0S$E!:E]@;!;#$8!_7\*!F$VD:@.M
ME<#ZQD57N;&ZMX_,E@=$SC<1QFK>J6D-IJ$]O!+YL:-@,1@_0^XZ?A44"_Z'
M>X'2-3_X^H_K0!FL.#4+# /UJVPJ6PTNYU6Z^SV<?F28W8R!@>O- &85K:\/
M,JK=@]HG)_%& 'YD5HW7A&,V]U)IFHI?R0%1Y,*Y?G@D\_RS6%I5U]CU!6;
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M2L ^Y0%X3&,-DMG Q@UTM<OJ/GV7C_3]0-G=36DMA):&2"(R".0RQL-^/NC
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M?R ]!51A5AASTJ)A0!!BHR.:F(P*B/6@"-J8P_G4A'<TTT 1$9-(13L4AZT
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M'!"NAZ\\^E &X\B1[=[JNYMJ[CC)]![TZN:T]AXKFLM8=?*M+"\N#:IG<+C
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M)^;';Z_Y]:EI(+LE=3;Z$0YPTI''J<YS^6X?45DBK>HW@NY@L8(BCX7W]_\
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M_P#WQ0!F$5$PK5;1=3_Y\9_^^#4;:)J9Z6$__?% S*(J)A6J="U,?\N$Y_X
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M%%B:/[%>-:L2<[R%5L^WWOTK1H AM+?[+9PV^Y6,:!2RH$!('7:.!]!4U%%
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MA@C.YA%&,_*-SH%!/16_#J&GA6=(&E03.I9(RPW,!C) ZD#(S]14E !1110
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MOS%VL#)/\A&W[HQP/<\U6T\:KK'@S_A*CX@N[:^EMWNXXD*_9H ,D1LA'S
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MGY>W( _"N:NK2X3PC%% (X],LO$MR;A)+9IHX[=99=NZ-64LBN4.,X &>@H
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M9[4ZC+:6YF66!7RRDICS<+N)0-G&1QFC17M=3\66%Y;>(=*O7M+>4.FDZ:R
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M<'O6'=^)A'JD^G6&E7VISVH4W)MO+58=PR%)D=06(P<#)P1G&16%X7U^RLM
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M_P#3'_O\G^-5F/%1,U("U]@N"0!Y1)Z 3)_C5&3*LRL,$'!%20-_I,/^^O\
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MU."V,HM7@,H$L#AC$WS*<.!CU&1P16[:>*KB?0=3\52I&NB06TDUK;IS-(J
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MULP^)5"_,^/QK@)[\;L(-QJG)/-+]YB!Z"O/5'N=KQ-MCT23QE#:WQ=GWHR
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M*N?E7Z\_2J6K>)-0U<)'<2JEM'_JK:%0D4?T4<?B>:QVEIA8L-+56XNQ$O\
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MKE=)M=(U==:O_$-SC4[:^N(Y6DN6C:RC5R(MF"-@V;6W#KN)R:RK2!=6\'^
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M7<EEJ%N]C:W8^US.K[I Y\XKD!3(Y'//'R@9[U#;7-G<6LFEZ=+)YS1D1-<
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MSB_]FKS:.+)Z5LYRE%1>R(LKW*[)M(&.U&VIYQB8CTXJ+%38!F*3%28I,46
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M((]J //],MKJY\::->Q+KUQ:PP7"37.J1F/:[!< (57'W3DX Z8SV@DL[]O
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MHL,X2>>ZN+F4S7%S<%3)*^ ,G: !@*     * -.BBB@ HHHH **** "BBB@
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MX5C Y7RS)DY]_,'Y4 +K6KG2/[/Q#YOVN]BM/O8V[\_-TYQCI0^L%?%":-Y
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MX^^!S4TT$-P@2:))%#*X5U# ,#D'GN" 1]*DHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#YI
M^-\DB?$9MK#'V2+C'UKSC)SGN>M>[?$WX9^(?%?B\ZGIBVIMS;I'^]FVG(SG
MC'O7'_\ "C_&/]RP_P# C_ZU:IJQ+1YUFC->B_\ "C_&7]RP_P# C_ZU'_"C
M_&/]RP_\"/\ ZU/F0K'G)--->C_\*/\ &7]RP_\  C_ZU(?@=XR_N6'_ ($?
M_6HYD%CS1JC)YKTUO@9XS/\ !8?^!'_UJC/P)\:?W+#_ ,"?_K4KH=CS,FF&
MO3O^%$>-/[EA_P"!/_UJ;_PH?QI_<T__ ,"?_K4706/,C25Z;_PH;QK_ '-/
M_P# G_ZU'_"AO&O_ #ST_P#\"?\ ZU*X6/,34DIS''_NUZ2?@+XU_N:?_P"!
M/_UJ<WP'\:E%&S3\@?\ /S_]:BX6/+:*]._X4)XV_N:?_P"!/_UJ/^%">-O[
MFG_^!/\ ]:E<+'F8I0:]-_X4+XU_N:?_ .!/_P!:C_A0OC7^Y8?^!/\ ]:BX
M6/,Z;&^79?2O3O\ A0OC7^YI_P#X$_\ UJ;_ ,*#\;"7<$T_'?\ TG_ZU%PL
M>=JV*] TQ\Z;;L3G]VO\JLCX$>-?[EA_X$__ %JZNQ^$_B:WL8(G6TWH@!Q-
MW_*E)W&CELY/2D#8.379_P#"KO$G]VT_[_?_ %J0_"_Q+V2U/_;;_P"M4C.-
M#<"C-=D/A=XEQREK_P!_O_K4?\*N\29^[:_]_O\ ZU '&AB:,UV/_"KO$O\
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MX5)XHS]VS_[_ '_UJ .%I1QQ7<?\*D\4?W+/_O\ _P#UJ7_A4GBC^Y9_]_\
M_P"M0!PW>@UW/_"I?%']RS_[_P#_ -:C_A4OBC^Y:?\ ?_\ ^M0!PW3I1GM7
M<_\ "I?%']VS_P"__P#]:E_X5+XHS]VS_P"__P#]:@#A?PH).:[G_A4GB?\
MNV?_ '__ /K4I^$OB<_PV?\ W_\ _K4 <(<Y%!)KN_\ A4OBC^[9_P#?_P#^
MM1_PJ7Q/C[MG_P!__P#ZU #/A/\ \CS%_P!>\G\J]\KROP'X UOP]XGCU"^6
MW$ B=#Y<NXY/3C%>J4 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !103@9/2D5E=0R,&4]"#D&@!:*** "BBB@ HHHH ****
M "BBB@ HHHH ***.M !1110 4444 %%%% !11UHH ***.M !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !63XG74G\,ZBN
MD%Q?F!O)\L@/GOM)X#8SC/?%:U5M06]:PF&G/ EYM_=-<*6CW?[0!!Q]/UZ4
M <QX8'AEM19])N+R&_CA/GV5U/,LI!Q\TD4IR2#QNQW//-;$?B2SDT'2]7$<
MWV?43;B%2HW+YQ4+N&<<;AG!/XUGPZ;K6J>(=.U+5K2PLH].678MM<-.\S.N
MTY)1-J 9..23CIBLZ'PYXB72-%T1CIJ66DW%LWV@3.SW$4+K@;-@"-M4'[S<
MC'0Y !HW/C>VMVU)QI>HRVFERM'?72*@2': Q;E@S *0QV@D#\JN:?XD%YJ,
M%G/IE[8M<Q--:O<!,3*N,\*Q*G# X8 X^A J7/AN[F\.>*=.66 2ZN;DP,2=
MJ^9$$7=QZCG&:T;O2YKC7-(OE>,1V2S"0$G)WJ ,<>U &-%\0+66PM=1&CZJ
M-/NG$,-QY:?/*<A4"[]W+#:&QMSWQS5JX\1PSZ5KD5_9ZCITUC9&XGC#H)?*
M97P\;HQ&?D<#D$%?H:C@\-7<7A71-*,L'G6%Q;RR,"=K".0,<<9S@<<"I-:\
M.W6I3Z^\4L*C4=&&GQ;R?ED!FY;C[O[U>F3P>* &'Q#?Q>,+31XM)NY;*2S\
MWS]T7/S(-^3(#M 8@C&2>@-6/%%W= Z7I5E<-;3:I=_9VN$QNBC6-Y'*YXW$
M)M![;L]J6XTS48?$6FZC:1VTT<=HUI<++,T956=&WKA6W8VG@XZCFK6OZ.^K
MVD!M[@6U]:3K<VDY7<$D (^8<94JS*1D<,>] %2'P=IEK<07-G+?V]S$X<RK
M>R.TH!Y63>2'![Y&?0@\TDWBH+)=-::/J-[:6DC1SW5NL>T,O#A59PS[3D':
M#R"!DC%(DOB^YEAADM-)L8U=3-<I<O.64'D)&8UP3TR6XSWJ"'3O$6D175AI
M2:=+:S3RS07%Q,ZO;^:[.P:,(0^&9L?,N1@''4@%ZX\30>9:PZ;:W&J3W-N+
MI$M2@ A/W79G90 >W.3@\<'&%H_B&WAU'Q1J-Q;7<!%W;P_97C'G&4Q(H0 $
M@DDC!!P<YSCFKMMX=O\ P[+9RZ&+>[6+3H=/FANY3$76'=L<.JM@_.^1CG(Y
M&.:-QX/U35;75GU633VN;J\@O((E#/"OE*H\M\@%@<$%O?.!TH Z+3M>-WJ)
MT^[TZ[TZ\,1FCCN#&PE0$ E61F'!901G(R.QS3M4UM=/NX+*"SN+Z^G5I$M[
M?:"$7 +LS$*HR0.3DD\ \UF>'O#[6&IO>R:%HVFXB,:?8W:61LD$Y<HF%X'&
M#G@Y&,5;U/3M1CUN'6=*6VFF%N;:>VN9&C5TW;E97"M@@YXP00>V* ,#Q;X@
M_M#PM-;QZ3?-*+^UMKVT8Q*T8:>+*ME\,KJVT%20=W) SCH-6 M/ ^H&UMC8
M;-/E=(4"J83Y9./D. 0?0XST-9TOAK4KZUO;B[DM4U"]O;.=HXV8Q1102HX0
M,0"QPKG.!DL!@ 9K?UFSDU'0]0L8F59+FVDA0OT!92!GVYH \\TV\L(KOPV-
M(FUN"]N)8Q<-?M=)!+'L)=?W_P KL?X=F3GGIFN\.OVHTS5;_P N;RM-:99A
M@;F,8RVWG\LXK#.C>(]3T_3]+U&/2K2RMI;>226VN))I)/)97 4-&@7)09.3
M@9INHZ#X@-EK^E:=_9_V75FE=+J:9P\/F(%9?+"$-SG!W#KT..0#4?Q2IOWM
MK32K^\$*Q-<20"/$/F#*Y4L&;CD[0>/RJ"Y\1V&C-K%S*-0F\F_@M98Q^\Q)
M(D6T1+GA?WBY'J6XK.USPOJFHD)!9Z4LX@2*#5%FDAN;4@<GY5/F ') W*.Q
M'4F]=>&KN>?49%E@Q<ZQ9WZ9)X2$0!@>/O'RFQVY'([ %R#Q1 )+R/4[*YTM
M[6V^UN+HHP,/.6!C9AQCD=>1ZTEMXF\R\M8+W2=0T]+PD6TUR(]LC!2VTA6)
M1BH) 8#ICKQ4.N^&&UV]N_-F6.UN=+EL6(Y=6=@0P'0@8]:H:3X6FM]2M9IM
M \/6AMLL;FW+R.[[2 44JOE\G)^9N,CWH O6OC*"?3)=5ETR_M]+6S>]CO)%
M1DDB49SA6+*2.0& )'N"*TM*U6?46D6?2;VP*JKJ;CRV5U;/1D9AD8Y!Y&17
M-67AC5X=0:ZBLM&TUOL\R2K:R2/!>R,.#)#M4*,Y)Y9N<9ZDWO#.@7FEZI<7
M+V=EIEH\*QBQL;AY8BX))DP54)QQA1SW[4 +>1/XB\5W.DS7$\6F:?;Q22Q0
M2M&;B60O@,RD'8JIT!&2W.<5;BTO2O"B7>J1W-S;6*0%IH&G>2(8YWA6R0V.
M/EZYZ$XI-3TK48=:&MZ*UNUR\*V]S:W+%([A%)*'>H)1E+-@X((8@CH16NM-
M\0>(;.\M=4^PZ;:RP%(H[=VN'\W(*R,Q5!@$?= .<\F@"U;^)BUW:PWVCZAI
MR7;;+>:Y\LJ[X)"G8[%&(!P& ].O%5(_'%O+"UVNE:C_ &='<M:S7A6,)&XD
M,9.-^XJ&ZD @?@</DL-?UBXL(]6ATZUM;2X2YD:UG>5IW3E0 R+L7=@GECQC
MWIC>&KL^";O1!+!]HFFGD5\G8 \[2#/&>C#MUH NW7B,IJ%Q9V&DWVI/:X%R
MUL8U6)B P7+NNYMI!P,X!&<9%9'@K6[9["" )-NU'4=3EBW)MVA;J0D,#R#\
MPXQZUH?8-;TG4M1ETF&PN[:_F%P5N;AX6ADV*A^ZC;E.P'L0<]>V;9>&]<TR
MUTZZ62QO-2M;N]FE1G:&.9+B1GX.UBI&5.,$<$9[T ;=UXGL;0:B)$G9[*XC
MM3&B!FFED1&54&>2?,4<X[YX&:RM<\6:II^B7%S'X<U&&YB>( 2F!DVLX&<B
M3!],9R"1QCFHT\,:S,-1O;FXLDU&74HM1MECW-$A2)(_+8D D$*PW =\X'2K
MNHV.OZYH=_:7<&G6DCK&;9([AY075@QWN47 . .%)')YZ4 ;]K/)<6B32VLM
MM(PR892I=?8[25_(FLJV\1/)J%M:7FCW]@+LLMM+<>45D8*6VD([%3M5CR!T
M/?BM +>W6E.DPCL[R2-ES#(95B8Y ()5<XX/05Q^D^$+^VU71+N;3='M7T^1
MFN+J&5YKB[S"\>XNR CE@2"6SZ\<@&G8^.+>_MK&]72M1BTV\D2&.\E6,*)'
M;:H*[]V-Q"YQC)].:N7'B4B\N;>PTB_U%;1MEQ+;>6%1L E1O=2[ $9"@]<=
M>*IQ>&KM/!6E:*98/M%G-9R2."=A$4R2-CC/(0XXZ^E2)8:]H]U?II4.GW5K
M>7#7*&YG>)H'?&X$*C;USDCE3SCWH / 4R7/@ZUGCSLDFN'7<I!P9Y",@\BN
M2T.;P[=6<K:JVO2WQO;I7>+^T&3B>0* 8_DP% ''3%=UX7TN[T;P_;V-]/'/
M<H\KR2Q A6+2,^0#T^]TK(TBR\6:'8M8P6&BW$(N)Y4E?4)8V(DE>0940'!&
M['4]* +$&OZA)XQU#16TBZ%G!:PNDY:+"[FF!<_O-Q5O+4 8SD'(&167X*\2
MK#X1\+P3:9?16DUI;VL=ZX3RVD\L #&[> 2" Q7!..Q!.X-/U.+Q5+J4<5J]
MO>64-O/F=E:%HVE;*C80X/FXY*XQ5>'PW=Q^$/#VD&6#S]-:R,K G:WDE"VW
MC/.TXR!^% $D>OV5A;7<B"_NI7U*2UCMR0\DDW4I'DX"@ GD@  DXI9?%,EN
ML,4^A:C'?3S^1!:L8LRG8SDA]^S 56SDYXZ<BJK^&K^(&[M9K;[=!JLVH6ZR
M%O+=75D*.0,J2K'D X('7I4FHV6NZO8;+_1]!N$$P;[%-.[C: ?F$OE_*^>1
M\G3OSF@#?L+MKZR2X>UN+5VR&AN  Z$$@YP2#TX()!'-6:Q_#.F7>DZ,MK>2
MAI/-D=465I5A1F)6,.WS,%! R<?0#BMB@ K+N_$.EV-T]M<7#I*F-P$+MU&>
MH!%:E% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z
M+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\
M\31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4
MG_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 36U10
M!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\_4G_
M (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);
MHO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X#R__
M !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z
M+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\
M\31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4
MG_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 36U10
M!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\_4G_
M (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);
MHO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X#R__
M !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z
M+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\
M\31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4
MG_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 36U10
M!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X#R__ !-;5% &+_PENB_\_4G_
M (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z+_S]2?\ @/+_ /$T?\);
MHO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\ \31_PENB_P#/U)_X#R__
M !-;5% &+_PENB_\_4G_ (#R_P#Q-'_"6Z+_ ,_4G_@/+_\ $UM44 8O_"6Z
M+_S]2?\ @/+_ /$T?\);HO\ S]2?^ \O_P 36U10!B_\);HO_/U)_P" \O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
*HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>ethicsemployeepolicybook009.jpg
<TEXT>
begin 644 ethicsemployeepolicybook009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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MT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+E6BNQF\-^'/^$AET"+5=0BOEN#:I)-:H86D#;0"5?(!/?%<G<V\EI=36TH
MDB<QN >A!P:49J6PY0<=R*BBBJ("BK-Y#:0^1]DNFN-\*O+F(IY<AZIUYQZ]
MZK4)W&PHHHH$%%%% !16CHNCS:W?&".2.&*.-IIYY#\D,:]6/^>216FMMX/>
M86W]H:LA)VB\:!/+SZF,'=M_'/M4N:3L6H-JYS=%/F18IY(TE65%8A9%! <
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M@)9W37,6Q27:(QX8@%EP3V.1GO5:FG<'H%%%% @HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ KV[X6^ HK*SC\1:M$IN9%WVT<
M@XB7^^<_Q'MZ#]/-_ /A\>)/%UI9RC-M'^_G]T7M^)P/QKVCXIZR^B^")T@.
MV6\86JD?PJ02WZ C\:XL54;DJ,=V=N&II1=670\T^(OQ#N-?O)=,TR9H]*C;
M:60X-P1W/^SZ#\?IPLFG7L, GEL[A(CTD:)@OYXKM?A#8V%[XTS>A'>&!I;=
M'Z&0$<X[D D_AGM6[J7CWQUH&K3'6-*1[$.08VMR(RN?X9!_7/TJU+V;]E36
MWF0X^T7M*CW/)**ZW1/#3>,VU[4EGBLA:HUSY,<.5.=QVCD8'&*I^#?"S>+M
M:?3ENQ:E8&FWF/?G! QC(]:W=2*3OTW,53D[6Z['/45VWAWX=S>(M!O=2BU*
M&#[+<&$K*N%P-I+%L\  D].U:C_"4WFG)=Z%XAL=24.$E(^54]3N!/3KCCBI
M>(IIV;*5"HU=(\UHKT6Y^%T4FAW=_HWB*TU2:T4M-#"H[#) (8\X!QQS5'0_
MAT^M>%HM=_M:WM(3*4E\]=JQJ#@L6S^F.]'MZ=KW%["I>UCB**]*G^$CRVMO
M>Z3X@L;RP<GSKEOD6)0#EL@D$#%4]9^&J6OAN;6]'UVWU:WM_P#7"),;0.I!
M#'IZ<<4EB*;TN-T*BZ'!%6"ABI"GH<<&DKT2[TN\NOA_X52]U>VATRXNRB;K
M<*8,E\LSYY P?3K73?$?PSI=SI>GSOKEG:26=BWE1%0#=84$;>1UQ[]:GZQ%
M22?6_P"!7U=N+:Z6/%:***Z#G"BBB@ HHHH *WO!5U;V7C32+BZ95A6X7+-T
M7/ )^A(-8-%*2YDT5%\K3+>J65UIVJ75G>HRW,4C+(&ZDYZ_CUS6OX3T^.74
MIKB[M//6WL9KN""13MG9%.!C^(9!)'?:13(O%VH?9XH;N"QU 0J%B>]M5E=%
M'0;CR1['-5)O$6K3ZM%JC7CK=PX$+1@*(U'154# 7KP!CDU#4VK%)P3N;^A:
MK=>)KRXTO5Q#/:R6LT@D\A$-JR1LP=2H&T9 !'0@U"]Y+X>\*:-/IBQQW&H"
M:2XNC&K/\KE1&"0=H  )QUW5F77BG4+FTFMD2SM4N!B<VEJD32CKABHSCV'%
M1:=X@O=.M&LU6WN+1G\SR+J!94#]-P##@_3K4^S?;3L5SKO\SH]0?^W-#\'B
M\BCMA<WUQ'+)$@17!:%3)@< ^N.,@UIW&H:=9^();"YU73TTF&<P2:6-.DXC
M!P1G9G?C^+.<\YKA]4\0:CK$%M#>S*T5L7,*)&J"/=MR %  'RCBKH\9:OQ(
M3:F\"[!>FV0W &,?ZS&<XXW=?>I]E*WW_GZ%>U5_N_K<QGC@-^T44I^SF4JD
MC#'RYX)_"NMU_7+SP_XCN=(TZ"WAT^SD\E;9[='691_$^1EBW7/OQBN+ZUO0
M^+]4BCAW"TFG@4)#<SVL<DL8'3#D9X[9SCM6DXMM=3.,DD^AUJ32>']6\7Z?
MII2&VAL/M$<31J_E.S0DKD@DA=Q7!]/6N LI&EUFWD<@N]PK,0,<EAV%+%JU
M[$]\XG+/?1F*X=_F+@L&/)[Y4'-58I&AF25#AT8,I]Q1"GRW'.?-8[_4O$&G
M6/Q"U#'AZW-PNH2(+J*60S!MY&]58LF[/(^7&?2L^;2ETZW\;6;N+F2T:)5F
M898_OP"WL?6J,GCG6GG>Y3[##=.Q9KB*QA67)ZG?MR#[]:R].UJ^TN\EN8)%
M=YU9)UF02+*I.2&#9SSS41IR2^[KV*=2+?WFG'"B_#Q[EX0?^)NB;\8) B8E
M<_E6UJ]T=;L-2;1KVRFL$C\W^S9;012VD8(Y0XP=O0D-DC.17,WOB74KVS2S
M9XHK6.99HX8(EC6-P" 5 ''WC]:EN_%FIWEO<1.+2-[E=MQ/#:I'+,,Y(9@,
M\D#/KWIN$F[@IQ2L=-I]O:_\)EX762VC>%](1Y(RHP_[J0G/O[UFZ;JL^OZ;
MKEG?I;M!#8M<VZI B>0Z.N-F!P,$C'>L*/Q!J,=]:7BRJ)[2 6\+;!\J!2N,
M=^&/-5K/4+FP%R+=PHN8&@ERH.4)!(]N@H]D_P OS%[1'; V^B:%HZV>L6NG
M275J+F>1[-I7F8LPQN"D;5QC;ZYSUJM_:>@6OB>2ZADC43V 7[3%9YCM[HXS
M(L; <'!Z#C?QTKG['Q'?6-DMD4M;JU1B\<5W;K*(V/4KN'&>XZ&B/Q-JB:G/
M?O-'-+<)Y4R2Q*T;H,84H1MP,#  XQQ2]D];_P!?@/VBT_K]3H9KC['K>D:K
MK$UEJ5@Z2K%>6MN,LP! 9T8+N9&93AAT ZU1\2B\NM)M[YM1LM3LQ.8ENHH/
M*E5B,['!4'& 2.HZ\UGOXJU0WEM<1O! +9&2*&*!%B56^\-F,'=WSG-0:EKM
MWJ=M':NEM!;1N9!!;0+$A<C!8@#DXXYIQIR33$YIIHUO"R-=Z#XETZW&;V>T
MCDB0=76.0,ZCU..<=\5RP!)  R3VJ:UNI[*ZCN;69X9XFW)(AP5/L:W?^$TU
M(2>>MKIBWO7[8MC&)<_WLXQGWQFKM)-M=2;Q:2?0L6'F:%X0FU2"!5U-]0-F
MTDL09K=50-P&'RLQ)&>ORG%)?2G6O!;:M?1QB^MKY+=;A8PAG1D9BK8 !*[0
M<]<-618^(-1L);EUE6=;HYN([E!*DQSG+!LY.>_6FZGK=[JJ0Q3F*.W@SY5O
M!$L<:9ZD*HZGU/-3R/FO^(^=6L=U?ZN\?Q1_L6*VM$TJ6^2VFM1 FV0.0&).
M,YY)![<8Z5AVRKH/AS4M3LHXVO1J7V))I$#F",*6R 1@,Q&,^QQ6!+K=]-KP
MUIY5-\)EG#[!C>I!!QT["GV.OW^GSW,D3QNEU_Q\0S1+)'+SGE2,<'H>HJ52
M:5EY%.JF[^IOR:I<ZK\/=3DNX8S*M_; W*QA#+\LO#8 !(]>OS?2JGB6W4>)
MM/BAA4"2TLB%1?O$Q)^>35"^\3:E?Z>^GNT$=DSK(+>"%8T5ES@@ =?F.3U/
M&>@J2+Q9JD-I;P@VS26R>7!<O;HTT2]@KD9&.W<=L4U"2=TOZT$YQ:LSI+V&
M#3]8\:ZK!;0O<V-V([9'C#)"'D8%]IXXP ,\ M6?X<\4:I=^*]%6>2!W-Y'&
MTQMX]Y1G7*EL=...XK$C\1ZG%K-SJJ3K]INBQG!C4I*&.6#(1@@^F*6[\17U
MRUL8UMK1;:3SHDM(%B"R<?-P.3P.M)4G:S5_^&'[17NOZU$\0ZA<ZCK5R]RZ
MLT<CQKMC5, ,?[H&?K70Z=+=:)IFGK<ZO:6*W">?';1V GDE1F.#(<8(., $
MGCL*Y?5-5GU>[^TW,=NLI'S&"!8@QR220H&22>M7(/%.I06<%N!:R-;+LMYY
M;='EA7.<*Y&1@DD>G;%5*#<4K$QFE)NYU5S%:Z'=>-VM;.W)M9H1;+)&&$):
M0C(!] >!]/2L>^G;7/"%G?WYC-Y'J1M3<A%5C$4#8; &<'.,^M8USK^HW9U$
MS3!CJ#(UR=@^<J<CZ<^E5O[0N/[+_LW>/LOG>?MVC._;MSGKTI1IM:O?_@#E
M43T6W_!.I\1:W=Z)XBN]&L;:WBTZSE\A;5[=&651QN<D98MUSG//&*H>/O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMW^DK+9FYL(!/-B4[0I&< [>N"*]"@\.1#XV/J8V_83:_P!I*_\ #DC9G/\
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MM?$^AP:E:D#>,21YYC<=5/\ GI7E8ZDU+G74]3!5$X\CZ''?$+X9IK[2:KI
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **^N?[*T[_GPM?^_*_P"%']E:=_SX6O\ WY7_  KSO[07
M\IZ'U!_S'R-17US_ &5IW_/A:_\ ?E?\*/[*T[_GPM?^_*_X4?V@OY0^H/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!EZ]!>W%BR6DRQK@F0GJ1CH*\]@@EN)5BA
M1GD;HHZFO4;E2]K*JC+%" /PKD_#6DWUIJWFW%LT:"-AN..O% '-"*1;D1,"
MD@;;@\$'->E:9%>06:QWLJRRJ<!E[CW]ZY74]'U";7Y9X[5VB,JD,,8(XKMJ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ]HMKJEKN$-PFX*W53T(/T((_"HKJ=DY--=T70Y+M133[,T****Y3I"BBB@
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M_CW ^]C'7CZUZI14JLU*4N]_Q*=%-178RO$T4D_A75X88VDEDLIE1$&2Q*$
M =S7*?"#3[W3?"-S#?6D]K*;UV"3QE&(V(,X/;@_E7H%%2JC4'#N-T[S4^QY
M;\9M*U'4[?1Q86%S=F-Y=X@B9]N0F,X''2O4(QB) >N!3J*)5'*$8=@C32FY
M=SRO4M*U%_CG9:@EA=-9*%W7 A8QC]V1][&.M>J4445*CG;R5@A3Y+^;N>??
M$CP)<>(O(U;2&":K:C 7=M\U0<C![,#T^M8EM\3_ !1I4 L]8\*7$]V@V^:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3'X7/AQ87_LT@@IYAW<MO^]UZUMT4.I)N]QJ$4K6,'5O!^CZSI]C9W44@6Q
M%M)'*5>,  <,/8#\JL6OAO3K36$U6))/MB6JV@=I"?W8Q@$>O YK6HI<\K6N
M')&][&+9^%=*L-"NM&@A=;*ZW^:AD))WC#<]14-]X,T74=!M-'GMW^S6F/L[
M+(0\9'<-7044_:2O>X<D;6L<_I'@O1=$U)=0LH)1=B$PM*\K.7!.26SU/O5*
M\^&_AR\O)K@P7$(G;?-#!.R1RGW4'^6*ZVBG[6=[W%[*%K6,36/"6C:YIUM8
MW=IB*U %NT3%&AP /E(^@_(55TOP)H6D:E;ZC;03&]@W8GDF9V?<,$MGKQ^5
M=+1252:5KZ![.#=[:A1114%A1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%9.O>(]-\.68N+^;!;B.)!EY#[#^O2JC&4GRQ5V3*48+FD[(UJ*\
MBO?C!?-*?L.F6\<?;SV9R?RQ57_A;VN_\^6G?]\/_P#%UVK+,0UM^)PO-,,G
MO^![/17C'_"WM=_Y\M._[X?_ .+H_P"%O:[_ ,^6G?\ ?#__ !=/^S,1V7WB
M_M3#]W]Q[/17C'_"WM=_Y\M._P"^'_\ BZ/^%O:[_P ^6G?]\/\ _%T?V9B.
MR^\/[4P_=_<>ST5XQ_PM[7?^?+3O^^'_ /BZ/^%O:[_SY:=_WP__ ,71_9F(
M[+[P_M3#]W]Q[/17C'_"WM=_Y\M._P"^'_\ BZ/^%O:[_P ^6G?]\/\ _%T?
MV9B.R^\/[4P_=_<>ST5XQ_PM[7?^?+3O^^'_ /BZ/^%O:[_SY:=_WP__ ,71
M_9F([+[P_M3#]W]Q[/17C'_"WM=_Y\M._P"^'_\ BZ/^%O:[_P ^6G?]\/\
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M/^%O:[_SY:=_WP__ ,71_9F([+[P_M3#]W]Q[/17C'_"WM=_Y\M._P"^'_\
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MS[T9O,V;\8&>F1573--_M'7;;3?-\OSYQ#YFW.,G&<9KHOABZKXXM@Q +12
M>YVD_P!*H^&K:8>/["$Q-YL=\-ZXY7:V3GZ8-.=22G-7V5_S%"E%P@[;R:?X
M&7K6G?V1K5WI_F^;]GD,?F;=N['?&3BJ%>EQ:AI%OXL\3BXN+:VOY+C;:7=Q
M!YL<9!.X8[$^O^3-9:"]YXX+ZW;Z:ZQ:?]JA-JF(;C! #L!UZY/T':LUB^5>
M^NE_73H:/!\TO<?6WIKU/+J*](U.ZTK4/#VHQZEJFCW%RB;[)K.W,;(PR=F<
M#(/3FN.\+:=;ZMXGT^QNCB"67#C.,@ G'XXQ^-;0K\T'*2M8QGA^6<8Q=[_U
MYF172^%]"T_4+'4]4U:6=;'3T4LEOC>[,3@ GZ?K746>L+J/C63PS/HEC_99
MEDMQ"MN \84'#;ASGC.:DT;4GTGPIXHMH(;25-+F$<3/"#YH,C<O_>]JYZN(
MFX\J5GIUZ-V.BCAH*7,W=*_3JE<\SNC ;N8VHD6W+MY0DQN"YXSCOBNKMO!=
MK::7!J/B/5TTQ+@;H8%B,DK#U('3\CUYQ7*B99+WSI47:TF]U48&,Y( KMOB
MI'-)K]K?#+V4]JGD2#[O<D#\\_C6U64N>--.U[Z^AC2C'DG4:O:VGKU.?U_1
MM-TZ*WN-,UJ'4()\X4(4D3']Y>WXX^E8=='X,T2+5?$^GP7\3_8Y2[#((678
MI.T'OR!FNIT75E\2^)I_#U_HUDFGN)41(H CV^T'!##H>,?4_A2E7=*\?BLK
MMZ;%1H*K:7PW=DM=SS.BO0M*FMM$^'MW?K96EW=0:HT4,DT88#Y5&?<8S@>I
MS4JZDMA\/+;6TTRSEOYKZ0>=) &$6XL<X_# STS0\2[Z1ZVW!856UETOL><4
M5Z+>V-IXET7P[JUU;0V=U>7ZV<[0+L$J$GYL>O&,^_TJS-K*V_CA?#$>B6']
ME>>ML8#;@L5./GW=<\YSZ?G2^M-Z*.JO?7L'U1+5RT=K:=SS&BO3-+L-.T7_
M (34?8X+R*P:,P).NX#EB 3UZX!]<57TJ]U!].FUZZ;0]-ANY]JW$UJ7=MJA
M=J* ?E^7\\T?6M[+33\5</JFUWKK\K-HX;3--NM7U"*PLHQ)<2YV*6"YP"3R
M?8&J\T3P320R##QL589Z$'!KU^#[/I_Q$T8V5O:!-4LA),R0[1N"N=R \KGB
MLC1!;Z_XEUK4=0M[!6TR!Q"AAQ%D,WSNH^]CO4+&/65M+)^>]C1X):14O>NU
MY;)GFE%>A:]<:7?^%KO[;J>E76IQ.K6LEG 8VQGE#P,C&<5RGAG1FU[Q#::>
M =COF4CL@Y;]/U-;PKIP<Y*UCGG0<9J$7>YI77@BZM?!L7B S@LP5WMMG*1L
M2%;.>_';O[5RU>WQ6PNO%6H>?JFDR:3>VPLDM([K,@4#"X7&,Y+=_P"*N(\.
MI8>'M5UK3M3E@MM20B*TNKB#S8T()R<=LC&#_D\U'%R<9<VKW^3_ ,CJKX2*
ME'ET6WS77Y]#AZ*](9H-,\8P7/B2/3/*FLB;6ZM8-T+N?NRLHZGK^GUI]SH\
M^L:]X?749-,NM.N97"WEC&(S-M!.Q\=/NXX]^]:_6TMUI:__  QC]3;ND];V
M_P"'[;GFE7O[(O?[%_M?RA]B\[R-^X9WXSC'7I7ILT^CO?7NG:KJ&AKIH#Q)
M;0VQ22W(X!#;>H[UFPZ_/;_"N.=+:R<QWHM0&@!4J$^\1_>]ZCZU-VY8]5^)
M?U2$;\TNC_ \VHKU#1Y[;4-'L++P])I NEMMMSI]];?-/(!\S;^_<C_./,I4
M>.9TD7:ZL0R^A[BNBE6]HVFK6.>M1]FDT[W&4445L8!1110!Z!\+/$,MEK7]
MCRN3:W>3&">$D SQ]0,?7%>SU\Y^$$=_&.D"/.[[4A./0')_3-?1E?/9K",:
MR:ZH^DRFI*5%Q?1A1117F'J!1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 (RAU*L 5(P0>]?/?C'PQ/X:UF2/8QLI6+6\O8K_=)]1T_6
MOH6JU_I]IJ=H]K?6\<\#]4<9_'V/O77@\4\/.^Z>YQXS"+$PMLUL?,-%>RWO
MPCTB:4O:7MU;*?X#AP/IG!_,FJO_  IVT_Z#$_\ WY'^->TLRP[6_P"!X;RO
M$I[?B>;7.MWEWHEGI,IC^RVC,T6%PV6))R>_6DTS6KO28;V*U*;;R P2[ES\
MIZX]#7I7_"G;3_H,3_\ ?D?XT?\ "G;3_H,3_P#?D?XU/U["6Y;Z>C*^H8R_
M-;7U1YYHGB74-!$T=J8I+>;_ %MO.F^-_J*36_$FH:]Y*71BCMX!B*W@39&G
MT%>B?\*=M/\ H,3_ /?D?XT?\*=M/^@Q/_WY'^-+Z[@^;GZ^C']1QO+R=/5'
M!:CXNU34[>T2X\@3VK*T=TD>V;*YQEOQS]:MW'C_ %BXMY4:&P6>6,QR7:VR
MB9U(P03T_2NR_P"%.VG_ $&)_P#OR/\ &C_A3MI_T&)_^_(_QI?6L%IY>3*^
MJ8[5]_-'G^B^*M1T.VEM81!<6DIW/;7,?F1D^N*D3QAJD6O_ -LQ"VCN/+\H
MHD(6,I_=('4=/?@5WG_"G;3_ *#$_P#WY'^-'_"G;3_H,3_]^1_C3>,P;;;Z
M^3$L'C4DET\T>?R^*+Z2'4X4BM88=1V>='%%M4;>FT=JGTSQGJFF6"6/EVEW
M;1'=$EW")/*/^SZ5W/\ PIVT_P"@Q/\ ]^1_C1_PIVT_Z#$__?D?XTGB\$U9
M_DP6#QJ=U^://U\5ZL/$::Z\ZRWR A2ZY4 @C '88)J"QU^]TY]0: QYOXGB
MFW+GY6ZX]*]'_P"%.VG_ $&)_P#OR/\ &C_A3MI_T&)_^_(_QI_7<':WZ,7U
M'&WO^JZGD\,TEO/'-$Y22-@Z,.H(.0:ZH?$76DNENDAT]+G&))UM0'E&,?,>
M_P"&.@KKO^%.VG_08G_[\C_&C_A3MI_T&)_^_(_QHGC<'/XM?DPA@<;3^#3Y
MH\V77;Q=$N-)!C^RW$_GO\OS;N.A].!2SZ]?3Z;I]@758M/9F@9!AE).<Y^M
M>D?\*=M/^@Q/_P!^1_C1_P *=M/^@Q/_ -^1_C3^O83OY[,7U#&=O+='(GXB
MZX6CEVV0NDP&NA;CS7 [$^A]L5S5_>S:CJ%Q>W&WSIW,C[1@9)R:]3_X4[:?
M]!B?_OR/\:/^%.VG_08G_P"_(_QI0QF#@[QT^3*G@L;45IZ_-'FUYK=Y?Z38
MZ;,8_L]EN\K:N#SUR>])IVM7>EVE_;6Q3R[Z+RIMRY.WGIZ=:]*_X4[:?]!B
M?_OR/\:/^%.VG_08G_[\C_&G]>PEN6^GHR?J&,OS6U]5Z'GNB>)]0T*.:"W\
MF:UFYDMKB/?&Q]<>M377B2_UW5M/-X\:002H(H8D"1QC(S@5WG_"G;3_ *#$
M_P#WY'^-'_"G;3_H,3_]^1_C2>,P?-S=?1E+!8U1Y>G:Z,WQ;XWO],\6WL5F
MMC<)%L\B:2$.T644G:WU)]:XRQ\2ZKI^L2ZI#=%KJ;/G&0!A(#U##TKT7_A3
MMI_T&)_^_(_QH_X4[:?]!B?_ +\C_&HIXG!0AR^5MMRZN%QM2?-;K=:[' :Q
MXJOM9LTLW@LK6V5_,\JU@$89NF3WS536=:N]=NHKB\*>9'$L*[%P-HSC^=>E
M?\*=M/\ H,3_ /?D?XT?\*=M/^@Q/_WY'^-:1QN#C:SV\F9RP.,E?F6_FCRF
MUN9[*ZBN;:5HIHF#(ZGD$5U<GQ)UUXGV1V,5RZ[6NH[<"4CZYQ^E=7_PIVT_
MZ#$__?D?XT?\*=M/^@Q/_P!^1_C2GC,'4=Y:_)CA@L;35H:?-'GND>);S2$N
M(UAM+J&X8-+'=P"0,PZ$]^_K4D_B_69M<AU<7"Q7,*".(1( B)_="^G)KOO^
M%.VG_08G_P"_(_QH_P"%.VG_ $&)_P#OR/\ &AXS!MN3W?DP6"QJ2BMEYHX7
M5/&6H:I82V36]C;0S,&F^S6X0RD'(+'GO6##-);S)-"[)+&P9'4X*D="*]8_
MX4[:?]!B?_OR/\:/^%.VG_08G_[\C_&G#'82"M%_@R9X#&3=Y+7U1Q\GQ#UQ
MXGP+..Z=-CWD=N%F8?[W_P!:L6TUN\LM*O\ 3HBGD7VWSMRY8[3D8->E?\*=
MM/\ H,3_ /?D?XT?\*=M/^@Q/_WY'^-3'%X**LOR94L'CI.[_-'DE='I'C?5
M](L18C[/=V8^[!=Q^8J_3D'\*[C_ (4[:?\ 08G_ ._(_P :/^%.VG_08G_[
M\C_&JGCL)-6D[_)DPP&,IN\%;YHX35/&>M:I<6TKW"VZVK!X(K9=B1MZ@?XU
M9N?B!K5Q;S1JMG;S3KMFN8( DL@]V_PKLO\ A3MI_P!!B?\ [\C_ !H_X4[:
M?]!B?_OR/\:CZU@=%V\B_JF/U??S/-5UJ[70'T4%/LC3^>?E^;=@#KZ<5V%M
MKTNC?#/36M6MI':]=98)E#JZ?,<,I[9 K:_X4[:?]!B?_OR/\:/^%.VG_08G
M_P"_(_QHJ8O"3LK];[,=/"8R%VETMNM#SS6_$VI:]) UR\<<=N,0PP+L2/Z#
M\!6HOQ$UQ8@2+-KI4V"]:W!F _WO_K5U_P#PIVT_Z#$__?D?XT?\*=M/^@Q/
M_P!^1_C3>+P32B]EY"6$QR;DMWYH\WM=>OK2RU*U1U=-1 ^T-(-S-@DYSZ\F
MK>F>+=0TS3/[.$-G=6JN7CCNX!((V/=<UWO_  IVT_Z#$_\ WY'^-'_"G;3_
M *#$_P#WY'^-.6-P<M_R9,<%C8[?FC@;KQ?K%YJMCJ<DR"[LE"1.J 9'/4=#
MG)I[^,=4_MU=8@%M;7/E^6X@B"I(,DG<.^2>OTKN_P#A3MI_T&)_^_(_QH_X
M4[:?]!B?_OR/\:7UO!?IL/ZGCOUW1P6K^++[5['[$UO96MMO\QH[6 1AV]35
M31M>O=!>XDL?+66>(Q&1ERRJ?[OIV_*O2/\ A3MI_P!!B?\ [\C_ !H_X4[:
M?]!B?_OR/\::QN#4>3IZ,3P6-<N?KZH\GAED@FCFB8K)&P96'4$'(-=*?'>J
M27UQ<SVVG3_:559HY;8,C[?ND]\CZUV?_"G;3_H,3_\ ?D?XT?\ "G;3_H,3
M_P#?D?XTYXW"3^)W^3"&!QD/A5OFCASXWU=M5^WN+5L0_9Q T"F(1_W0O8?C
M4&I^*]3U)[,YAM([-M]O%:1^6D;9SD#UKO\ _A3MI_T&)_\ OR/\:/\ A3MI
M_P!!B?\ [\C_ !J5B\$G=?D4\'CFK/\ -'&W/C[5[JVFC:&P2:>,QRW26P$K
MJ1@@G_ZU4-*\47^DZ;<:=$EM-:3-O,=Q$'"MC&X>AX'Y5Z#_ ,*=M/\ H,3_
M /?D?XT?\*=M/^@Q/_WY'^-"Q>"2Y5MZ,'A,<WS/?U1QEMX\U:UMHDC@T_SX
M8_*BNC:KYJ+C& >G3VKF&9G8LQ)9CDD]S7K7_"G;3_H,3_\ ?D?XT?\ "G;3
M_H,3_P#?D?XU4,;A(7<7:_DR9X'&324E>WFCR2BO6_\ A3MI_P!!B?\ [\C_
M !H_X4[:?]!B?_OR/\:O^TL-_-^#,_[,Q/\ +^*/)**];_X4[:?]!B?_ +\C
M_&M?2/AAH.FS+-.);Z13D"<C8#_NCK^.:F69X=*Z=_D5'*\0W9JWS.=^%GA:
M87/]OW<92-5*VH8<L3P7^F,@>N37J](JA5"J  !@ =J6O"Q%>5>HYR/H,-AX
MT*:A$****P-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/08)SSV]: -*BL$W]R/'PT\S'[)_99G\O QO\W;NSUZ5L6EY;7]LMS9W$5Q
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M_ID5_I]U#/$X&[RI5?RV(!*L0>&&1D4 :%%%% !1110 4444 %%%% !1110
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MD87@L 1R.M7X=0M- \8ZW=Z\IMC>K ;.YD0LAB6,!H0P! (?>=O?<#S7<44
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M_"&BHZE66P@!4C!!\M:UJ* ,3Q=!9W/AF[BOVN4MB4+26T1D>,AU(;: <@$
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M:Z?EP$E^61W().0H?>,#D8YKM;>R1_BEJ-Z\&632+:..4KTS+,6 /X+74T4
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M#M/.5''%5[;^S7\*Z[I&I-=V\L.JW$\GD6S/)$INS)%)C:0R\JW0C&:](HH
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MH!L=M$V1RE>%?S6QSZ]#7,B]TL?#'_A&&L9O[<^Q_9SIWD-YQN]N/,SC^_\
M/YF<=\UZC10!Q^G:=(/B*;B]C$MS#H-O%]H*\;S++OP?4X%5+/3(VM?B!)):
M R75U*A+)S(@MH\#W&2WXDUW=% ' M8"#POX#$-L4DM[JT)VI\R;HF#D^F<G
M/UYK$\5ZG=:AH_BNQEN?LMU_I$<.E6VG[I9U5<)*S$'(8 -N7&T8YR*]9HH
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MSX_CCMV9YPJP@+]\FT0<>O/%:/AW7],_X1[1(TE;S)A'9JGE,&\X1;F4@CC
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MT*ZOJ[&6YEARZ(PP(P,XRJA$XXSSZTS2?#,RZI92W'A?1;(6S>9)<1SM*68
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MF(I6V#<P((*AL],#&<\5F66K7MKXU\41V>BW-[.?LLLB)(B",>2."S$ L><
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MEWJ"JD<<$C-\J]/,?')R6Z# SWZUT/B/2[C58M-6W* V^HV]R^\X^1&R<>]
M%1O$<JW;Z;I6A7%W/:1H;J..2.-+=F7<(]Q."^"#@<8(Y&139_&UA#H,&JK:
MWD@DNQ9-:J@\Z.<L5V,N<9##'7'(.<<TS[!K6AZWJEWI5G;:A::E*MPT4EQY
M+PRA%0\[6#*0BGU!SP:JQ^$]073+42RV[WTFMIJMYL)$:_."53(R<*% SC.,
M\9H NW'BNXM+O3K";0KO^TK^.:2*V26-MHC*@[GSM'#@YYZ8ZX!JCQU+);WL
MT/AW4)/[-++J"AXP8&49*KEOWAVX;Y>S#N<5KW6EW$WC'3-54I]GMK.Y@<$_
M-ND:(K@>F(V_2JUEHEW;V_B=',>=3NY)H,-_"T$:#=QP<H: +EUK$_V.SN-+
MTV;4END\Q&CD2-%0@$%BQ'7/  -9\WC6TM_#QU::RNU,=XME-:A0TL<ID$>.
M#AN2#P>0163=>%M1^S^'TGL+75K6QTY;6:PFN"D8F 0>;@J5?[I'(XSD46/@
M[4+;P\;#RK"!SKL.HB*VRL4<2S1R%5X'0*0.!G';- &]8>(WFU=M+U'3)]-N
M3;M=1>;(CK)&I 8Y4D J67(]QR:BT_Q3<:I]GN;30;Z32KAPL5YNC&Y2<"3R
MRV[8>N>N.<8J74M$EU#Q/97K;?L<>GW5K,-V&S*T1&/P1OTJEH<'B;2+*PT5
M[&PGM[0)!]O^TE=\*X /E[<A]HQC.,\Y[4 2S^+W'VRXLM%O;W3K)WCGNXF0
M E#A]BE@S[2"#CN"!FNAMKF&\M8;JWD$D$R+)&XZ,I&0?R->??\ "$3V#WMM
M!X?TG4HYYY9H+NYN&0QB1BQ61 I+;2QP0>1CIUKM+6&\LKJSLK>ULTTF&TV%
MD8JR.N JJF,;-N>_I0!B?$ITC\$7!D\SROM5H)!&&+%3<QA@ O)R,C Y-0^'
MX/"1UB)]*TJ_@O$#%))[&ZB4#!!^:10O0FM7QCI=YJ_AN2TT](GNA<6\R+*^
MQ6\N9)""V#C(4]C3K&^\22WL:7VA6-M;$G?+'J1E9>.R^4,\X[B@#('Q#B_L
MK^V6T74%T=93#)=_(2K;]G" [F7=@9 Z^O6M73_$<MQK*:7J&E7.G7$T#7%O
MYKHXE12 PRI.&&Y<CWX)K+'A?4!\.ET',/VP3!\[CLQ]I\SKC^[[=:V;[2[B
MX\6:1J:%/L]I;W,<F3\V9/+VX'_ #^E &9;>-9[^QDO[#PYJ5S9PR21RR*T:
ML2C%6V*6R_W>WT&3D4R2^MM3\;^%;^SE$MM<:9>RQ./XE)MR#67X2N?$\?A;
MRM/L+"Y22XNA;W$MR8_*_?R#YTVG=@\\'D<<=3KZ7X3ETF]\-K%*LMMI>GW%
MK*[<,[N8B"!Z$HW?CB@!3XU+V<NIVNB7USHT1;=>QLGS*I(9TC+;F08/.,D#
M(!K6LM?M+[5Y=/B#;EM8KN&7(V3Q/D!E/L1@_4>M<[::5XGTGPY_PC-E;6$L
M$<36UMJ,EP1LB.0I>+;DNH., X)'49JKXLT633-)\.6>C7'E7Z :-"[?>>"2
M/:YX[J$$G_ />@#;3QE!<V-C-96%S=7&H/*+.W4JK21QM@RDDX5,8.2<_,O&
M3BIHO%MK'9ZG+J=O/I\^FJKW,$F';:V=C(5)#!L$#'.01C-9WB#P='<2:-<6
M%A:72:7"]J+&Y<HCPL%^ZP!VLNQ<9&",CCK5<>"AJ/AW6+*72].TB2^$8B6W
M)E(\L[D\UN-WS?P@< GDYH V;;Q--]OL[74]&N]-%\Q2UDEDC<,X4ML;:QVL
M5!('3@C.:33/$\NK7*&WT:[.G2320)>AXR-R%@2R;MRKE2 <9Z9 S65H_AJ5
M-6LY[CPOH]@ML2[SQW#3,SX(!C&T;>3G+<XXQSD,C\.ZJ_B6VODTNPTR5+HR
MW5]973 7<?/RM%M&6;(R6)QC()H [FL74_$!M=432K#3Y]0U Q>>\<;JBQ1D
MD!G9B ,D$ #).#V%3Z%J4VK6,MW)"(HS<RI !G+QHY57/^]M)^A%9M]IVJZ?
MXFFUO2;>"\2[MH[>ZM99O*8&,L4=&P1_&P(..QSVH Q_%OB62^^'?B3[-I]U
M%>VT$MO=V[NBO;9C)WD[L,N"""I.<^QQ4O'F/BKPK9MX4>*V2*Y9;8R0% <(
MN[ ;'RJ3[X;CO6E=>%]5U#P_XJ:Y-LFJZY"8UACD)BA58]B*6(!)Y))QWX'%
M;=YI5Q/XGT344*>190W$<N3SEQ'MP._W30!1MO$&F:7I6H7<<5Z^-4EMA"7,
MLDUP9-NV,$\ GH,@ >@JVOB.6UM+RZUK2;G3(+6'SC(SI*K#^Z-A)W>V.XQF
MLE_"FHG3)_)EMUOX=;EU6TWDF-LNQ"O@9&59AD9P3GG%6M2T[6/%>AZCI6J6
M-KIL,\(6)EN#.WFA@P)&U1L! XSD^U %FV\33?;K.WU/1;O34OF*6TLSQL"^
MTL$<*QV,0#CJ.,9SQ4%MXTCN4U*Z72[M-.TU[F.ZNW* !H2P8*N=S9VYR!CG
M'7.*&D>&I4U6SEN/"^C60MFWR7$<[3,S@'!B&T;>><MT'&#G(U]&TB_TS0M2
MML6S74]Y>7$(DRT9$LKN@?'.,,,X]Z )]&UJ[U-Q]HT:ZLHI(A-%,\D<B.IQ
MP2C'#<@XZ>];-<)I>F77AZ\N]:?2[?1M-MK&4SV5I=-+'/("&#JFT*F K $#
M)W<CBNQTR:ZN-+M)KV%8;J2%'FB4Y".0"5&?0\4 9.L>([K2#=3OH5Y+I]HN
M^>Z22,?*!N9D0MN8 =>AX.,T:AXH6UUBVTJSTZXO[NYM3=1")E5-@(!+,Q&!
MR/S%<OK7@O4M2.O02Z5IE_/?M*;74KV8N;9&7"HL94[2O;:0#P3S73V>BW4/
MB6QU%_+\F'239N W/F;T;CCIA3S0 V/QC9?V#<ZE<VUS!):W'V.:S*AI?/R
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MX-LWN;XW$;AO+0Q*OEX=L\CKGWK7U34[FT\2:#8Q,H@O7G68$9)"QEA@]N:
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M&7RV=2-O!4A&!!&1P<UARZ]XG3PIJ?B47]OMT^[N4CLOLXVSQ13LF';J&P,
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MO6^IP6\=S'(]MI[6ZF/R^0HD?[VX@<D$ $]#CG:\$?\ (A>'?^P9;?\ HM:
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MR!6SDD<'MG@BJKW>L:!KNDP7VI+J5EJ<S6WS0+')#*(VD4KMX*$(P((R..:
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M?>DUJX!S@C#*P*L.>A!_.F:+HL6C0W 6XGN9[J8W%Q<3E=\KD!<D* !@*H
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M;3H[.XBDV Q3B6.48!WJ< @<XPP!X[]: .8L- NKKQ5XJNX-2U'3))+V)0\
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MBP$ ]L4YK.U:"6!K:$PS$F2,H-KD]<COGOFGP6\-K D%O#'#"@PD<:A54>@
MX% 'E]C:^';GX?W&LZU)"NOK'(UW>N^+NWNAGY$;[RE6P%4<8QP<\Z']D07_
M (M\&WFL:;;MJDVES2W9>(;O.1;?!/NI+8]*[>31M+EU!=0DTVS>]7&VX:!3
M(/HV,U::&)IDF:-#*@(1RHW*#C(![9P/RH PO&=]!9>']EQ:)=)=7$5L(I9C
M%'N=P 9''1,]>#GICFN6T&,:=XOUC38$TNWB.DB66VTL$0K(&(!(Z!\'G &1
MC/:O1;BW@NX'@N88YH7&'CD4,K#T(/!J"UTO3[",1V=C:VZ*I4+#"J *3DC
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M^LEB@5'?ZD#)JS#;PV_F>3#''YCF1]B@;F/5CCJ?>@#F_B#_ ,BJ/^PA8_\
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MQ!>,^AP2*M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5F:WH<&O6
MJVMW<7*6I)\Z&&38LZGJC\9*GT!%:=% " !5"J  !@ =J6BB@ HHHH ****
M"BBB@ HHHH **** "BBB@ J"]M([^PN+.;=Y5Q$T3[3@X8$''YU/10!#:6T=
ME906D6?+@C6--QR<*,#/Y5-110 52O-+M[Z_T^\E+^;82O+#M.!N:-HSGUX<
MU=HH **** "J5YI=O?7NGW<Q?S+"9IH=IP-S(R'/J,.:NT4 %%%% !5+3]+M
M],>]: N3>7+7,FXY^<@ X]OE%7:* "BBB@ HHHH **** ([B!+FVEMY,[)4*
M-CK@C!J+3[&+3--M;"#<8;6%(8]QR=J@ 9]\"K-% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"5IY(_*::XN))Y-G]T-(S$+[ XJ230-+ET.+17LU.GPHD<<.X_($QMPV<@C
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MNQ%);2 L7=HR1Y@(VX'S?=/RG-;/@_01X;\,6NGLL:S_ #2W'E#Y?-<[FQ[
MG ]@*DU/PKH^KW;75W;R^=(@CE:&XDA\U!G"N$8!QR>&S0!HV%Q%>:=:W,$Q
MGAFA22.5A@R*0"&(P.HYZ"O.Y]3OM,T/6?L E$UWXF:U,D)0.BNR@E2Y"AC]
MT$G +"O28HHX(4AB18XT4*B*,!0.  /2J3:%I;V5Y9O91O;7LC2W$;Y82.V,
MDY^@Z=,4 <OI0UO3];C,.GZRFG-;2FXCU._BN"9% *-&1([@DY!'3D=*SXXK
MJ]^&\GBI_$E_%J4VGM>&5+@B")BA;RQ%]T!3\N<;N,YS79:9X:TO2+EKJUAE
M:Y*>6)KBYDG=4SG:K2,Q5>!P..!7%:CH$VH6M[:)X(-MJ5V'4W O$:Q1VR/.
MV[P21G=_JPV?SH V8;FZO=<T"QDO+E8;O09Y)O+D*EG#6X#Y'\0W-@^YKG]*
MBET;X6R7UG?7HG>]"9>X9@H^W%3M!/&03G'7->AVNCVEL]E-Y>^YL[8VL4I)
MR(SMW#'3DHI_"JJ>%-%CBNXELR(;N432Q>=)L+A]^57=A?FY.T#)ZT 8OV*Y
MUOQMKUG<:KJ$%E:PVQBAM;AH<.ZOEMR\_P (XZ'/(/%8=K+JB>!=-\5S:U?R
MZG]H@$@,I$$D;3K$4,0^7E3G.,YYSVKT:&PM8+ZYO8H@MQ<A!,^3\P0$+[<9
M-5QH.F#1TTD6J_8$*LL.YL JX<<YS]X ]: .9UZ8ZGK=[:V0UR:6QC19FM+Y
M;6"W<KO!^\"[;2"<AE QTK&2*3Q*WP^U.]O;U+F]MV:4V]PT0W?9F8LH4X4D
M]<=N*[>]\+:/J&H27UQ;2&:5568)<2(DX'02(K!9 !Q\P/'%+/X7T>XTRRTY
M[0K;66/LPCF>-H< K\KJ0PX)'7I0!R4USJ>L^(=;A:TUZ6#3[A;:W33;Z*W"
M?NT;>VZ16=B6S\P*X ]ZZ_PS)JDOAVS;64VZAM(E^9"6PQ"L=A*Y*@$X.,FF
M:AX6TC4[K[5<02K.4$;R6]S+ TB#HKE&&\>S9K3M+2WL;2*UM(4AMX5"1QQK
MA54= !0!R.J:E>Q:EXSCCNI52UT:&: !O]4Y6XRR^A^5?R%5%BOM)MO"^J_V
MO?W%U>W,$%XLTY:*594.<1_=7!P05 /'.<FNQET>PGEOI9+<,]] MO<G<?WD
M8# +UX^^W3UITNE64T%I!) &CLW22!=Q^1D&%/7G'O0!PMA;'0]2\=ZK;3WU
MS/8/YD<,MR[K*PLXW 89^8YX'H,#M4=@?$1MM+U*TMM=ENY9(9)Y[K4+=K6>
M-B-^(Q*0@VDE=B@Y Z\UW*Z'IRZS)JZ0,M[*H61UE<+( , L@.UB!QDC.*IV
MW@W0;2[BN(;)AY+^9#"T\C0Q/_>2(ML4^X48H RM%AN]0\1>(KRYU&^DBT_4
MO*M;2.8I&/W$3'('W@2_0Y ].:YK3[SQ+JOAJ#7K2TUR35KA!<1R&_@6SR3G
MRO*,N G\.2N_OUKTZUL+6RDNI+>(1O=3>?,02=[[57//LJCCTK*;P9H+W;7!
MLF^:7SF@$\@@:3.=YAW>63GG.WKS0!@>)?[1L]5OM2OWUA=)BB1X;C2KH#[$
M%7+F2$D>9SDYP_'88I]GI<4OQ0U&YBOKX_\ $MM;A!]I?82TL_!7."G'"]!D
M^M;]_P"$=$U.\ENKJT=I)\"=4N)(TGP,#S$5@K\ #Y@>.*LW6@:9>:G#J,UL
M3=1)Y2NLC(&3.=K $!UR2<,".: .4\-O>Z;K&GVNNRZQ'J=RCH97NA/9WL@7
M<2@R?+X!8+M3@8YKH/&#WMOX7N[W3Y)$N;+;=A8S@R+&P=D/J&4,N/>GZ=X3
MT72KN.YM+619(5*PB2XDD2 '@B-&8JG''R@<<5LLJNI5@"K#!!Z$4 >=OXNE
MMO$$_B&2\9O#+"6QC0'Y-\<7F^:/<E98_P#@*TQ].U*ZO/ UOJ-_=1WDL-U+
M=R1N1)ED5V16ZJ 3MR.0!QBNN_X1+03X>BT Z;$=+B8,EL2< AMX.<Y^]SUK
M1FL+6>]MKR6(-<6P<0OD_)N #>W( H X2]U?4?#.F^,(+6ZN+H:<L$EH]U)Y
MKQ"5<'+,?F"G+#<?8G%3Z?!KMGK&F/;6>O+$\NR^;4]0@FCDC*G+*HE;:P(!
M 0 8R,5V/]EV/GWLQMD9[U%2YW?,)54$ $'C&"15#3_"6BZ9=Q75M:R>;""(
M/.N))5@!&"(U=B$XX^4#CB@#DA;ZA?:!XHU:37-2CN;&\OOL(BN"B0B)F*@J
M.'&1C#9&, 8KOM,N7O=*L[J0 /- DC = 2H/]:C31[".RN[-+<"WO'E>=-Q^
M<R9WGKQG)Z5:@ACMK>."%=L42!$7T & * //M*TB.UO/',JWE_(89F0++=.Z
MMFSB.6!/)YX)[ >E0Z?:7>B^%?".JQ:K?R7$SV,$\3SDPO%+M0J(_NC:&&"!
MGY>2>:[=_#VEOJ=QJ)MV%S<Q^7.5E=5D&W;\R [2=O&<9QWJ9M'T]["TL6MP
M;:S:)H(]Q^0QD%.<Y."!U]* .(ENM4UOQ!KB-::])%8W7V6W73;Z*W6,!%;>
MP,BL[$MGY@5QC ZUV'AN34Y?#MD^LH%U#R\38*G<02 WRDKDC!X..:9J/A;2
M-4O&N[FWE6X= DDEO<R0&51T5_+8;Q[-FM.UM8+*UBM;6%(8(E"1QQKA54=
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M:1L$2 QLOE,Q !)<H=O4;<\4 ;7A[Q=I'B9KI-/O+>26WFDC,:3J[%4;;Y@
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ME>^MEC64PL[2J )!U0G/WO;K7*S7B^'_ !M%=ZS*4AN-'BMQ=;"4::.1RRY
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M0:':PI<R)R3YLV[GU.%)H WCX@T9=5&EG5;(:@3C[,9U\S.,XVYSG'.*;?\
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MQC+I!.KD#IG /3WJGX2O[G4-+NY;N4RNFI7D*D@#").ZJ./0 #\*Y.PNVO\
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M,LL.Z2-F'!4M\I;/?IWQ0!TNA:.FB:8+43-<3/(\T\[@!I978LS$#IR>!V
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M>PSC.: -V>>&VA>:>5(HD&6>1@JJ/4D]*S=1TZ'71I-U#=KY5K=I>H\8#K*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MS%T@+XGDUKS^7LTM/*V]-KLV[.?]K&,=JTZ** "BBB@#&?0Y[GQ+#JEY?"6"
MT#&SM5AVB)V7:SLV3N.-P' P&/6MFBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "L7Q7I=SK/ANYLK,QBY+121B4D*6217 ) .,[<9QWK:HH
M Y^'3]1N?%&FZS=00VXBT^XMY84F\PJ[R1,N#M&1A#GI67J?@VXU2V\20R/
MIOM0@O;3?EES%'" )!Z%HR#CL:[2B@#CM#\.O#K-O>3>&=(TU;=6(EBG,TI<
MC;\GRJ%7!;)/)SC K4\4:9>ZA;V$^G")[O3[U+M(IG*++@,K+N ."5<X.#SB
MMVB@#DK73?$$_B6^UJZ@L;?S=-%K;VYE,H5P[,#(0!D$MSCMZU0TWPE=/?W
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M[+_8^EBZQM^V_;&,(_V_+V;_ /@.?;=WI)=.UK2=?N=6TZ"VU!;Z")+J%Y3
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!-9^'-/UEIHVBO6=5C .Y=I(Y_*LBE'!866JC^8Y8[%Q=G+\CTW_ (7'=?\
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M4U /#%*,[XLMD8/8C=^8J_%X<T72_%&JZE?6L+Z-L@-LC+E,S,!D#T&&_"N
MU_Q'J'B.Z2:]= D8VQ0QC:D8]A4^H^+=0U+PY9Z),L8@M2N'7.YPH(4'GL#6
M'U:K;1VNW?R3=]/ZZG1]:I7U5^5*WFTK:_UT-_4- M/#F@>(9KNVCDF>]%I8
MF1<E5^]N'_ 3U]16M?MHNC^)=%TM/#UA,M_# )Y)4R1O.WY1T![D]ZXKQ!XL
MO_$EM907BQJMJI *9RY( W-D]>/U-)J'BBZU'6]/U22"%9;%8E1%SM;8VX9Y
MIK#U9).;UUOKZ)?D)XBE%M06FEM/-M_G8ZO2_"FFQ>(?$LCQV\D.F,!;PW<N
MV(%\D;SZ#&/>JOB2RTR;PO)=R-H,&JP2KM32IEVRQD@<IGJ,YS[5B0>,]0@U
M^]U18;=A?#;<6SJ6BD7'0@FH-8\11ZG9QV=OI%A80(_F'R(_F9L8Y8\X]J(T
M:WM$Y/M^6H2K4?9N,5WZ>>C^1U7BYM!T?4[?2ET:VCBN8X9+FY"_/&FX9\L#
MH< Y/?-.\364,FBWL^D:5H5UID84QW-D2)X!ZR<Y)_R:Y'5O$MSJ^M6^J3V]
MN)($1!'M+(P4Y&03S5Z\\9O-IMW9V6DV&G_;0!<R6ZG+CT&3@#K^=*-"I%0M
MNM]1RQ%*3G?9[:'7:QJMA8R^%[>YT>TOGN+&!'>Y7=L0X&%'0'DG/TJC!X>T
MRW\8>*K'[+');VU@\T"N-WEL55AC/IFN0U+Q)<ZG<:9-+#$K:?#'%&%S\P0Y
M!/-7#XTO3K6J:G]FM_-U&W-O(N&VJNT#(YZ_+26&J1C:/;OUOI^%QO$TI2O+
MNNG2VOXV-BT_LO2?AU8ZO+HUK>7KW3Q*TZY7^+[V/O# X'^%5?$EI8:AX0T[
MQ):V$5A/+.UO-# ,1L0"0RCM]W]?:M*VU8Z3\+--=K.VNX9;UXY(;A-RL/F/
MX'('-<MK_B>YUV*VMOL\%I96P(AMK=<*N>I]S3I1G*IS+I)ZWZ=K"JSA&FHO
MK%:6Z][F'1117H'FA1110 4444 %%%2VUM->7,=M;Q-+-(P5$49+$T-V!*^B
M/7_A!O\ ^$=O<Y\O[6=OUV+G^E>AUB^%-#'A[P[;6!(,H!>9AW<\G\NGX5M5
M\EBJBJ5I2CM<^PPM-TZ,82W2"BBBL#H"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MJ&K:-8:Y9&TU"W6:+J,\%3Z@]0:OU5OM3L-,C634+ZVM$<X5KB58PQ] 213C
M)Q=UN*45)6:T/.KWX.PM*6L=7>.,]$FBW$?B"/Y54_X4Y<_]!F+_ +\'_&O1
MK?Q)H5W<);VVM:=-,YPD<=TC,Q]  <FKEC?6VI6<=W9RB6"3.UUZ'!(/Z@UV
M+,<2E;F_!'$\MPS=^7\6>6_\*<N?^@S%_P!^#_C1_P *<N?^@S%_WX/^->M4
M4_[2Q/\ -^"%_9F&_E_%GDO_  IRY_Z#,7_?@_XT?\*<N?\ H,Q?]^#_ (UZ
M=J.JZ=I%N)]2O[:SA)P'N)5C4GTR33K#4[#5;;[3IU[;WD&<>9;RK(N?3(-'
M]I8G^;\$']F8;^7\6>7_ /"G+G_H,Q?]^#_C1_PIRY_Z#,7_ 'X/^->M44?V
MEB?YOP0?V9AOY?Q9Y+_PIRY_Z#,7_?@_XT?\*<N?^@S%_P!^#_C7K5%']I8G
M^;\$']F8;^7\6>2_\*<N?^@S%_WX/^-'_"G+G_H,Q?\ ?@_XUZU11_:6)_F_
M!!_9F&_E_%GDO_"G+G_H,Q?]^#_C1_PIRY_Z#,7_ 'X/^->M44?VEB?YOP0?
MV9AOY?Q9Y+_PIRY_Z#,7_?@_XT?\*<N?^@S%_P!^#_C7K5%']I8G^;\$']F8
M;^7\6>2_\*<N?^@S%_WX/^-'_"G+G_H,Q?\ ?@_XUZU11_:6)_F_!!_9F&_E
M_%GDO_"G+G_H,Q?]^#_C2CX.W0.1K,0/_7 _XUZE>WEOIUC/>W<HBMK>-I99
M#T50,D_E4RL&4,#D$9%']I8G^;\$']F8;^7\6>3GX/73'+:U$2>Y@/\ \52?
M\*<N?^@S%_WX/^->M44?VCB?YOP0?V9AOY?Q9Y+_ ,*<N?\ H,Q?]^#_ (T?
M\*<N?^@S%_WX/^->E66MZ?J-[=6EG.9I;5BDQ6-MBL#@KOQM)!X(!)'>M"C^
MTL3_ #?@@_LS#?R_BSR9?@]=J<KK40/J(#_\52?\*<N?^@S%_P!^#_C7I4.N
M:;<16$L5VC)?N4M2 ?WK!68@<>BL>?2M"C^T<3_-^"#^S,-_+^+/)?\ A3ES
M_P!!F+_OP?\ &C_A3ES_ -!F+_OP?\:]:HH_M+$_S?@@_LS#?R_BSR7_ (4Y
M<_\ 09B_[\'_ !H_X4Y<_P#09B_[\'_&O6J*/[2Q/\WX(/[,PW\OXL\E_P"%
M.7/_ $&8O^_!_P :/^%.7/\ T&8O^_!_QKUJBC^TL3_-^"#^S,-_+^+/)?\
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M230 M%-CD26-9(W5T8 JRG((/<&H8+ZVN;FZMX90\UJZI.H_@8J& /X,#^-
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M$J6(4XZ$]*UM7TC5[M!#:7]@]HT AEM]0L1,I(S\XVLO)SRIXXXQ56/PE<V
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M;ETF0HJ-\H=2#\@(YK2\2Z)_PD&B/8"987\V*9&>/S$+1NK@.N1N4E<$9'%
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M'=5?6=+U'4=1LRNG+(D=M9VABC(=-I)R['/3'8#([YH =X#_ .1<F_["=_\
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M3[0S+YD<>4BPI.7/\(.,#W(JS7)W,4VBZ]X9L+>_O98;F[N//-Q<-(TF+=V
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M"2&!SCKTH ]$N;J"RM9;FZFCA@B4O))(P55 ZDD]!4<UYY-]:VOV>X?[1O\
MWJ1YCCVC/SGMGMZUY=J[7EYX"\;Z?>S7T:Z8284DO/,D56@5MCN#\ZY8G!)Z
MC/2NQG6;2?$WAO3H+V[DMYOM1E$\[2&3" C)/7!/% '4U'#!#;J5AB2-6)8A
M% !)ZGCO7FI34I?!.O\ B%M<U(7UA<:A)9A9R(XUAEDVHR#AP=N/F!XX&,5N
M/)/XB\72Z9<7UU9V=KI\%TD%K.T+3M(S@L74AMJ[ , ]6Y[4 =E17)^%)+F/
MQ!XDT^;5)K^&SF@2$S,&:(&($J2.IYZ]3WYS75D;E(R1D8XH CANH+DRB":.
M0PR&.0(P.QP 2I]#@CCWJ6O+[19?#.B>-=7LKN\EN;2^F2,7%PTD8^2+]XRD
M\D9R3Z"MC6+.X\+V-EJUGK6HW=S]KMX98[FY,J7@DD5& 0_*APQ8; ,8]* .
MXHHKF_%=W&'T_35&J2W5T[O';Z=,(6D5!\Q:0E=JC<O1@2<=>E '245YA)J^
ML6_@SQ;"MS<P7.FWD<5J\TXFEB#+"VUG!^;!=NI)P<$UO/:W&A>+=$@BU34+
MF'4A/%=)=7!D#,L>\.H/"'((PN!@].* .QHKSZ+5=2DLK;PJU[-_;*:G]DFN
M0V)#;)^]\W/JT6Q<_P!YZ]!H **YGQ3=(]W8:5&NJS7<XDF6VTZX$!9$VAF>
M0E2J@NO1@23T-<L=5UG_ (0W58$O;FVN[37K>QAEDE6:6-'DM\JS='QYK#G.
M1P<T >GU!?7/V*PN;K9O\F)I-N<9P"<9_"N7BAGT'QK864-_?75K?V5Q)+%=
MW#38DB:/#*6^[D.P(&!TX%9%I:7&N?#Z7Q)=Z[?0WUU9R7#%;@BW@&T_N_*^
MZ54?*21NX)R#0!W>E7W]IZ/9:AY?E_:K>.;9G.W<H;&>^,U;K(\*?\B?HG_7
MA!_Z+6G^([^#3- N[FXFN8DVB,-:@&7<[!%"9XW%F &>.: -2N9L_%PN[#P_
M=?8MO]KW;VVWS<^5M25MW3YO]5C''7VK)T*XU"P\;6VG21:E;VMW833M!J%\
M+IM\;Q ,#N8KP[ C.#QCI6=HW_(!^'__ &%IO_1-U0!Z;5:2\\O4(+/[/<-Y
MR._G+'F--N.&;L3G@=\&K-<_J%W<1^.]#M$F=;>:RO'DC!^5F5H-I(]MS?F:
M .@HKRU3J:?#JZ\4OK>HMJ5J\\T(\\B()',P$;1_=8$+@E@3SP1@5T.JZ]+X
M7U[5)+V62:RN;'[79QL<XFBPKQ+_ +VZ,@>I:@#L:*\YNY==@O-"\/71U2\=
MM/>[O6L;F.&6>7>H*B1W4A%+'A3GE>PI+ZZ\1:=X.\09-]9"&6#^SYKR>.6=
M S(&5F1VR >FXY(;!S0!Z/5&XU6WBTZZO;=9+U;<NKQ6@\QRZG#( #RP/&*Y
MN6RGT;Q5H]I%JNI3P:G'<0W*W%RSY94W"1,_<;@_=P.>G%<[;V\NB?#[QAJ-
MEJ%^+F&YU!8V>Y9@I65L, 3][CD]30!ZF#D X(SZTM<E=B?7/&UUH\]]=VEC
M964,ZQ6LS0O<-(S@L77#;5V 8!'+<]JQ-3U35=/\/>+M/M]3GEDTN6!;2]D.
M9%\P(VQF'WBN>IY(89H ](HKCVMKC0?%VAQ1:G?W,6HB>*Z2ZG,BLRQ[PZ@\
M(<J1A<#!Z51T9[[3-<L4U^;6$O+F>2-;E;H2V-V2&95"9/E?*,@;5^[C)[@'
M?4UT61&1U#(PPRL,@CT-.J&[F:WLYYDC,CQQLZH.K$#.* *VJ7D>B:!>WT<"
MM'96TDPA7Y 0BEMHXXZ>E%MJ?VB:TB^R7 ^T6WVCS0F8D^[\A;^]\W QR :X
M*[L)M1^%=WX@N/$%\;V[TI[F1_M!^SC?&28Q%]P+SMSC=WSFMZSN[H>)=%LH
MIV6%]!EE\LGY3('@"L1[!C^9H ZZBO/=$N;[1KNWBUDZU_:TEM*?WET)[2_D
M5=Q,?)\L\$A0J<>N*T?"^FS:KHNE:_<:[J4E[=1QW4GE7!$'S ,8A%R@49V]
M-W'7- '8T5P^CV=QXHLK[5;S6M1M+@7=Q#%%:W)B2T6.1D4%!\KMA0QW@]?2
MH-)\27PB\-Z]J=SML=2M'MKKM$DRY>.8#L'"N/Q2@#OZ*\UN-6UQM'T1B;\O
MX@OY9F2WD1)8H-C/'"C2,JH2JKGD'[^.35VV;7-/CUM?L^J6NFKIKRQ'4+R.
M>6*< _=99';:1S\QX*\=: .TO[S[!:^?]GN+CYT3R[>/>_S,%SCT&<GT -6:
M\^D6^TSX>VNK'5K^?4;QM.::62<E1OGB#!%Z*"'(.!DCKFEU"\U+5O&&L6)M
M-;FM-.$,<,>F7D=L,O&',CDR(S')P!RORGOF@#T"BN >'Q5=:'I?VR&^E$$T
MZW=O:WL<%U/&"1$V]&"Y QN4.,D_A73>%KR&\T&)X+B]G$;R1.;X 3HRN04?
M ZJ1C/.<9R>M &S117+:Y)<:CXOT[0?MMQ9V4EI-=RM;R&.2=D9%"!QRH&\L
M=I!Z=LT :R:ON\3S:+Y&/+LDN_-W==SNNW&/]C.<]ZTZ\\Q+X=\7>(9H+N?4
M'M= 2>&&X<R2+M>5@A;[S D<9R>>O2JVGMXB>RTS4[2VUZ:]F>&2:>YO[<VL
M\;D;P(Q*0HVD[=JYSCKS0!Z5)&DL;1R(KHPP589!_"FPP16\0B@B2*,=%10H
M'X"N%U#6M1TE=?T,7+R:G/<1_P!DR2')V7)*K]1&PD/LJBH[Z?4KOQ3=:-Y&
MN7=GIMI;A!87L<#R,X;,DCM(C-]W  XR&SF@#K]8U?\ LEM.'D>;]MO4M/O;
M=FX,=W3G[O2M.O/)6U8Z7X>36(Y5FC\0HD33/&\CQ 2;"YC)7<!P<'J,]ZOZ
M9:3^*;C6+N\U;4;9K>_FL[>"SN6A6!8S@,0OWV;[WS9&&'&* .THKS:#5]4U
MNR\()+J\EJUY=7=O<3V^$-TL0D4$=AOV!N.F>.U;4(GT'QE::5;W]Y=65_93
MS/#=3M,]NT90!P[$MM;>1@G&0,=Z .OHKRJT35_^$"\-:X/$.I?VG?O9PS2M
M-N39,RH?W9^7< V0V,[ADD]*Z. W/A_Q9<V%O=7M[:2:2]XL%U.TS"6-PORL
MV2 P;ITR.* .RHKRS3KGQ+?:#8:W9VNNS:I<+%<>:]_;BSD#$$IY7FX5,$@?
M+O''.:Z!;*YUSQIX@M+G5=0AL;5+;R8+6X:':[(26W+@]AQG')R#Q@ ZZ:Z@
MMFB6>:.,S2".,.P&]R"=H]3@'CVJ6O+9HI]>T'P;=7]_>FY_M4VKR13F/?L\
M]=^%P-YV#GW-:?B&'4--O[J\O)M;;2+>"/R;K3;L;K0*OSM+$2/,/\1)#\=J
M ._HIL3K+$DB-N1E#*WJ#WIU %:WO//N[NW^SW$?V=E7S)(\)+E0<H?X@,X/
MO5FO/?$&K:E!9>.VMKV6.2S:W%JP;_5;HHR<?4DD_6I[_2;NS\4:+IL6O:L;
M;48YS>[[EBTAC"L"A_Y99).=F!CIB@#NZ*\WU*_U'2?#?C*RAU6X']F7$(M+
MN>0O)$DB1.0S'E@"S<DYQWK2UJUN/#,-AJMIK&HW-P][;P30W-P9$NEED5&
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M["UNKNTNIH@\]HS/ ^3\A92I/OP2.:XK4--DDU"]D;P,\U]+(Q2:&\06D_\
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MJVFSV<-Y%J%K);3NL<4RS*4D8G 4'."2>,>M3"[MC>-9BXB-TL8E,.\;PA)
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MI8(+6-4T]P]JB#:L1",@P!Q]UF&.G-16?B+1=0OGLK/5K&XNDSNABG5G&.O
M/;O2G7]'&J_V6=5LAJ&<?9O/7S,XSC;G.<<XH T:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "N?\97]SI^@^=;PQ/NN(DEDE@,R6Z%QF4H.6V]?U[5T%
M% 'G>BF74/&6HR0ZA+J,4^C^4+LVPBC=Q(?E4@#=C=UYZD9ZUG_VQ!/X$\,:
M+%%<-J-K<Z9#=V_DMNMC%-$'+\<#*XSWSD<5ZI10!R=C<167Q'UF"X#1R7T%
MJUJ3&<2[%DW8;&.._P!17.6VEBW^".GQ1692X0V\^T1_.)//5BWKGWKT^B@#
MBC>VGA_QSK-[K>84O(H!97;QED\M5PT08 [3OW-MXSN'7'&%)IAN_#[C[!(F
ME7WB>WGMK62(KBW,D88E",JK,';! X;WKU*B@#C_ !8UG9:OI]\=5?2;V*"6
M**XDM#-;LC%"R/V!RJD893P>M9MG&^K7_@:ZO-*CMC&+N3R8X2D<9"X1PI^[
MG[P!Y&?45Z%10!YSX@M9!;_$E(8'VSZ:C*%0_O',#@D>IX4?@*L7E]INE_$R
M"[U*$J$T2,)=&,LL!,KYW$ [<]-QXXQGGGOJS%T@+XGDUKSN7LUM/*V],.S;
MLY_VL8QVH YO1M0M+;5/%/B5 ]OH#10OYIB91-)&K^;*JXR0047('S%>,UVR
M-O16 (!&<$8-5[^PMM3M&M;N/S(&969,D9VL&&<=L@<=^E3^;&93$'7S H8I
MGD ]#CTX/Y4 8WC"TO;_ ,':O::=N^V36KI$%;:6)'W0>Q(R,^]<?XFU?0-5
M\)VFGZ98R23P7%J8K5+5E>RVRIDN,?N\#(]\XYKTNB@#SK4WN=(\=ZM>WFJI
MIL-W#"+2XEL?.1D5<-&'S\I#Y;;WW \]HULK#3?#NCW+ZK>V+1WEQ<V=W)IY
M6.'S-V5>,@A$(8[<E3R,$=*])IKRQQE [JI=MJACC<<9P/4X!_*@#SV&XNM2
ML/#<\EI$NSQ"W[VVMVB2=!'-^^V'E0Q/<G)YR<BK&D7UEH3ZWI^N6=P;ZZOY
MY219O,+V)V)CVE5(;";4V]MOI7>5S]UHVO-<W!LO$S0VT[%O+FLTE>'/41OD
M8'IN#8H XO2+&*\\'>!839'R$UIW,+#=Y847) ;Z'%=!J=G"_B[7UN+>X-G=
M: B7'V9"7D^>8$+CJ^TX'?I74:3IEMHNE6VG6@;R+= BESECZDGN2<D^YJY0
M!P/AO65CU?RA?6^JZ=:Z<[MJ/V(PRVBJ5Q%(W0[ADX 4C9R*[BSNHKZR@NX-
MWE3QK*FY2IVL,C(/(X/2FWUE;ZE87%C=H7M[B-HI4#%=RD8(R.>E3JH50J@
M 8 ':@".Z&;28#KY;?RKS7P#!-H<>B2ZU;R3-?:=;0V-\4.+4")<VS+_ ,L\
MD$AOXNAY KT^FF6,2K$742,"P3/) QDX_$?G0!Y];:5&? ?C96L\R75WJ;L"
MG,AW/L/OT&*FCN8](\3V&KZX'6TDT:&&VNW0LD$P),JL<'87!3DXSL([5WM%
M 'G*Z4^OV7C"XTN%X;.\:*;3BT9C$EU$NXS*IP<%UC&>^TGWK,DO=1CLO^%A
MV^GW)O+N66W%KY9WBW9!'$I'_7:-&]A(U>LT4 <[I^@:AI>CZ5I]AJB6\5I
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MA['!Z9 KNM'TR/3+O5MMTLTEY>&\9, &+<B( >?^F9.>/TK5H XW4I[?1OB
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MO08'TK5U37VD\0SQ-?KIEFUI$UK*EAYTU\K DA2P(P.FS!.3GO7>TC,%4LQ
M4#))[4 <W\/DEB\!:/%.DD<B0;"D@PRX)&".V*Z*5F2%V1-[JI*IG&X^E*CK
M(BNC!D895E.01ZBG4 >2#4KG5H/#CO>EKI=3M9)],M=/\I+'+@,')!9<;BN<
MC=D\8S78:!IT+>*O&,\UJI-Q=PQEG3_61BVBXYZC):NKHH \NTM6L-$\!:CJ
MD$S:;8VDB3;HV?[/*5412,N"0  ZYQQN%;.F7>GZI\4#J&FV[M$VD.DEZ(BL
M<S"6/ !(&X@=_P ,\<=Q33+&LJQ%U$C E5)Y(&,D#VR/SH =7-W$;GXEZ?*$
M;RQI%RI;' )F@P,^O!KI** /,(-,$'P1ABBM"MP"D^T1_.)//#;O7/O72R6\
M[_$*_:$%&;1(TCE*\!_-EQS[9!KJJ* /+DO=+3X9'PQ+8S'7/L9MVT[R&,SW
M>,>9G'0O\_F9QWS70:=IT@^(:7%]&)KF#0+>(W!7(W^;)OP?4X%=>TL:R)&S
MJ'?.U2>6QUP.].H X"#3(VT/X@,]IF6ZN;D$LG,BB!=H'J,DX]R:FGL!;Z1X
M#\BV*/;W< RJ<HIMY V?0'O7<T4 >3^*M3NK_2O%=C-<_9;G]_%#I=MI^^6X
M4+A)68@Y#  [EQM ZY%=-/<QV/CK1KN\WI#<:5);I*8V8&8R1$*2!P2,GGT-
M=E39)8XEW2.J+D+EC@9)P!^).* /-)K2;^R99IK2:>QMO%,US>P+&6+P!WPV
MT<L Y1\ 'A:V#?6?B#QQHEYH>9ELTG^VW:1E4\IDPL18@;B7VMMYQM)XKM:*
M /,AI:I\&?$2K9D7,S:C,1L^=I!/+L;UR J8^@KTN,DQ(3UVC-.HH YWQW97
MNH>"M3M=/5WN'13L09,B!U+J!W)0,,=\XKGM->#6?$&BF+7#=26+M(L=OI1A
M\E?+*E)&)^0'(&T\Y XXKT.B@#S"YTL+\+/&@6S/VBXN]1EP$^9V$S[&'<]%
MQ72ZK8QVWBGPA]EMPD<#W$/[M<!(_(;"\=!E5_$"NJHH \V\,:WX>TO3-;M]
M0@,4L^JWQD5K9G^V#SY -N =_'R[>O'3GF;1=/O[)/ ,%Y#*DL)N=R-R84,3
M[$8^H4JOU%=AH>D#1;&:V$_G>9=W%SNV[<>;*TFWJ>F[&>^*TZ /.-*U#2=(
M\*WNAZ[:R/JCR3_:K0V[/)?.[L0R8'SA@1@]NAQBENEO_!_AWPYXCODDGO-/
ML5L=21/F:1'4;?J5E"#/HS&O1JQM6T.?6-0LS/?!=,MY$G:S6'F65"64L^?N
M@[3MQU4<]J .-U30[_1]'\,333%5MKJ2ZU.86WV@)<2JQ\TIW4.S#/\ #D'M
MPILKK6[/Q/>:/J[WU]<Z7]E66*S^SQ2/\Q7#Y^9QDC(Z;ASZ>E44 >96!M]5
MGT&QCUAR]G<12QV<.D&*2UV#E7.?W:D90YZYXS4C7D6FZXUKI=Q]L,^KB2;2
M+VP;S4=Y!OFCDP,*O+AF!&!@$<5Z310 4444 %%%% !1110 4444 %%%% !1
M110 4444 %4-9UBVT/3FO+D2.-ZQQQ1+N>61B%5%'<DD"K]8WB;1[C6--A%G
M+''>VES%=VQE!*%T;.UL<X(R,CIG/:@"*/Q%-;6]W<ZUI-QI=M;0&X:>26.1
M-HZC*$G=[8Y[$U77Q;-"UK+J>A7VGV-U(D45S,\;;&<X02*K$IDD#O@D XIM
M]8ZUXHT?4-*U2QMM,M[BV,:R17)G?S<@AL;5&T8SSR?:J]]8>)/$5I!I6IV5
MA9VHFBDN[F&Y,AE$;A]L:%05W%1RQX&>M %RX\53?VQJ.E:=HEY?W.G[#,4>
M.-,.@9<,Q&2<D8]CG'&7/XPLGT?2[ZSM[F[EU3BTM(U D<X)8-D@*% .XDX&
M._&;.EZ7<6?B+7;^4IY-])"T6T\X2(*<^G(K M/"VK:;I'A^>U^RR:GI#3AH
M))"L<T<I.Y0^"5;[I!P>1COF@#9D\3/9:;-<ZII-Y:2I*D,< *2FX=SA5C*M
M@DDXYQCOQS3[#Q!+-JB:9J6ESZ==31-+ ))$D655QN 92<,-PR#V/&><9FM:
M-JWBO16BU"QL;6:"YBN;2!YC,KE.JRD*,!@2/ESC.>>E+X?\/&VUA;Z3PWI>
MEK%$RHT4QFF+G .#@!5QGU)R.F.0"3PWK^GM;:+86T%Y'#?6LDUK)<RF0G8P
MW(S$DEL-GZ ^E69O%]I%%>.EM<S&&^_L^!(P"UU/@$JF2!@'<"20!L;L*RE\
M+:I;>!M(M+5K8:YI,BSV[,Q\LL"0RDXSM9&9>G>EU#P.9O"6D:=']GN;O39E
MNBMSD1W4I#"7>0,C<9'.<'!QP: -O3=?>ZU1M+O].FT^^\DSQI(ZR++&" 2K
M*3R"0"#@\CKFMJN-TG2TT2:\UJY\/Z;I45M:OCR)3-,0/F?YL !<*..2<=NE
M=-I-Q=7>CV=S?0+!=2PI)+"I)$;$9*\^G2@"GJ^O#3KRUT^VLIK_ %&Y5GCM
MX2JX1<;G=F("J"0/4DX -<_INK"3Q_K-U?VLNG&UT:W\]9R"% EG8L&4D,N#
MG(]P<$$5K:QIFI1>(;77M)B@N9H[9[2>UFD,?F1LP8%6P<,".A&"#U&*H+X>
MU;6=3UN?6UMK>UU+2UL$AMY2[Q#,F[+$#)P^<CCMVR0"U#XO<BTNKO1;VTTR
M\D2."[E9."Y 0N@;<@8D 9Z$C.*M?\)59)HVKZE-'+$NE2RQ7$3 ;]R<C'KN
M!4KZ[A7-Z9X/GADL;:Z\,Z&/L[H9K\2LPD"\[DCV@AB0#R<*?[U:6K>%;N]\
M6174,D*Z1=/#-J,+$[GD@R8\#&""=F[/:,>M %^X\23_ &T6%AH]S>WJ0I-<
MQ+(B+;AL[59F."QP>!GIDX&,Y.IZM!K4OA*[@22/&MM%)#* 'BD2"X5D8 D9
M!!Z$CN.*36O"3-XFN]8BT:QU>.]CC62&XF,3Q.@VAE.""I&,C@@C(SFK$/A>
MXBM?#ZQ6FGV;6>I->W,-J6$8!BE3Y21EF^=<DXS@G Z4 7)?%,\MU>1Z5HEY
MJ4-E(8IYHI(T'F#[R(&8%R.AZ#/&<TVX\:V*VVCS65K=WW]KEUMD@4!MRKDA
MMQ&W&"#GI@YJO:V/B'P]+J%MIEC97]I=74MU!)-=&%H6D8LRN-IW*&)((YP<
M8XS6-<:3J/AZZ\&V%C+!<WL<MY)*9LHDS.C/( 0"5!+'!P<<=: .KTWQ"UUJ
MK:5?Z=/IU_Y1GCCD=76:,$ E&4D'!(!!P1D=C6W7+0VNI7&OKXBUN""Q@TZT
MEC@MXIO-8[RI=W;  XC  &>YSVK:T.\NM0T.RO;RW%O<7$*RO"#GR]PR%/N
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MD)\@1$;-N#T!!R.M $@\9M';0:C>:'?6ND3LH6]D:/Y Q 5WC#;E4Y'/49Y
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M(X+F(J;&#28K"/<WSY1R>>.F,4 =#1110 4444 %%%% !1110 4444 %%%%
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M0&"S@-S[#&.G.:TX[/5[CXAZQ!::H+4+IEEYUPL"O([AI\8#?* ?F)X],8H
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ML ,&X<]<Y'TQ6?IT.NG_ (2ZZT[5(K-+?4YWBC-NLGFN(T)WD]%Z#"X/4YH
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M/3K2ZDLX[=829&9-N79]V.I;Y0O3'- &+XLTJVO='TKP9:1WCS!K=5G6-O\
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MUC^Z&(C7D#U]37>-!"YB+11MY1W1Y4'8<$9'IP2/QI5AB69YEC02N &<*-S
M9P">^,G\Z /*99[V3P3X6MI9(I=/>_FM;HWL[)&ZHTJPI*X!.TE5'/!(4'K6
MA:6#V!\21VYT:TMAI+F73M,G9U20AMLFW:H0D;@<=<"O0C9VIM6M3;0FW;(:
M$QC8<G)R.G)-1VFEZ?86K6MG8VMM;MG=%#"J(<]<@#% 'GZ:)8:3H/@[5K.
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M+! L-Y:S!2-JA(IDD(  ]%.!Z^E7[/2--T^:6:RT^TMI9?\ 6/#"J,_U('-
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M%=S:Z;86-H;2TLK:WMCG,,,2HASU^4#%)8Z5IVEJZZ?86MHKG+BWA6,,?4X
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M=%D1D=0RL,%2,@B@#@YM/T73/%N@VWAR"TA>[,JW]M9@".2U\IOGD5>,A_+
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M^-;O=<UA;5;V>)+:&*VD:1(85);&YE4DLS$G@=%':@#H**** "BBB@ HHHH
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M2=I9<G"X;<>1U-5AI%]H]_J\,MOXBN!=7LUU;/IMPHBD$AW;6R1L8$[23Q@
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M(2CZ7*,HZ+M*.N0<'@@CCDYQW .BN/%VB6VFV6H/>$VU](8K=DB=C(X#'9M
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MY^S2>3!('*%9'V[5^8=ST(/0@U:T[Q5IFIWZ64)N8YI8S+!]HMI(A.@QED+
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M7'EV:QK+E2@5@&&P# (+9ZXZT ==#XO27QK=: ;*\"Q0Q,LOV.7!=GD4Y.W
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MLL!RH,><@<J<XSQ75V7VO['']N,!NL?O/(SLS[9YH 8LMA#>W"J]NET8UEG
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M0K#;0+B*&-0$4>BJ/Z"N1NO&T\6D170AM+8RZK<:>;BZD*P0+&\BAW(_O>6
M!P,MUJU=ZK(VGZ'-J5CIMU+<:I'%&\,GFQKG=MF0D<-@?AD\T =717)'7O$-
M_J>MVFE:?8;=+G$0DN96'GDQ))M 4?*?FY)XY'!YQ7NO'\#6&A/:/8VL^KVO
MVQ7U&X$44$8"YR?XFRP 48S@G( H [6BN'C\?$Z-K4RI8WEYI;0AWLKCS+=T
ME.%DW $J%^8L,$@(>M6F\4W]MX7O]7==+U!(-GDS:?<,\3AB 2_!*A,Y.,\
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MGC)SD5DVWQ#8/87%W<Z"UM>31Q&UM+\27-OYA"J2.CX)&X#&.3SB@#OZ***
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MK2+BW\8:;H\>N:O]AO;2>XNE>[<N[1-&!M?[T8/FY(0@?*,8KIT\.Z3'H_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$(9=IV!R0I;MDCH* 'T5P.A>)=7T_P .ZSJFMQPSPVU_=0Q+!,SR/)]H,:1
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M-:V]P\3S012-$VZ-G0,4/J,]#0!R]IX2:[\"II>I2E-0N&%Y<7"J"5NBXE+
M'@@/@8]!BKFE:1JT.H1W&H3Z4(HD*B.RLO+,C'^)F9B5QSP/7DFMQ;B![B2W
M2:-IH@K21A@60-G!(ZC.#CZ&H]/O1J%C%=K!<0"0$^7<1F.1><<J>10!RMMX
M/U+38#ING7>F)IH<F*2:Q\RXA0G.P$G:V,X!(X&,@XKL@ H  P!P*6B@#+\1
M:0=>\/WFF"?R&G0!9=N[:P(()'&1D#BLZYT/6);JRUB&^LHM:@B>";]PQMYX
MF8-M*[MRD$ AL]<\8.*Z6B@##T;1+JVU.\U?5+J*YU&ZC2']S&4BAB0L0B@D
MD\LQ))YST&*W*S=1U==/U/2;,PESJ-P\ 8-C9MB>3.._W,?C6E0!RMYX9O8=
M9O=0TF73L7Y5YX;^U,@60*%WH58'E57*GKC.1S4MSX5?4K?3K'5+N.ZTZW4O
M<VX@$:W<O\)8#@(#D[>YQDG'/2T4 <E)X.N)-#M;!]262;3;KS]-N)H?,*(
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M8M?3-;?3RBVW'^SC'M5_4O#6F:I<17,L<T-S$GE+/:7$EO)L_N%HV!*^QXH
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MOQQ]5SCM7=6%F+"RCMEGN)PF?WEQ(9'.23RQZ]:JQ>'M*AL[.TCM%6"SG%Q
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M01R"" 01R* .8FAN="\3:3IT&J7]Q::LL\,L5S.9'B*1EQ*CGYATVD9Q\RX
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M&",!CC'.>6%>IUBQ>$M$BLKRR%FS6EXVZ6WDFD>,'<6RBEB(_F)/RXYP>PH
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M[[5[C6(-.%Q&;:\L)4:W@BPH*RQ'GEMV6*MP1R,5NZ->W$_BCQ-;33LT5M/
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MZBJ46OZ-/J3:;#JUC)?KD-;)<(91CK\N<US(UJRUKXB:--IDAN[>'3KS=<1
MF,LS0X4-T+?+R.V17+R:M+JMCHCM=VT=V-7M)9=)L[#:UCFX4/YC'+*1D@MP
M&)Z8- 'IU]K^C:82+_5K"U(8(1/<(F&(! Y/7!!^AJGK/B[1M"NM.M[V^MXV
MOI-B%IT4(NQV\QLG[GR8SZD5GZ+IT#^./%US-;(SRM;1;W3.Y/(7(&>V>O\
M]:N:MA%9>#O UW?1[+:RU K-)(A(BC\N=%W>BY*#TY% '>:[XBT_P_X?GUF[
MGC-O'$9$Q(H,QVE@J$G!) X'>IDUW2)-+.IC4[+["OWKG[0GEJ?0MG'ZUF>-
M(/[1^'NMQVL7GM+ITQA1%R6)C.W ]:Q-1U#3)]1\-:V2D_A^W$ZR2)&3'!<%
M4\N1QCC $B[B/E+=J .TL-3L-5MOM.G7MM>09QYEO*LBY],@UF:GXOT72-=M
M-)O;^VAGN$=R9)T41;0,;LG(W;N/7!K*T6>VU3Q]=ZKHV'TTV AN;F-<17$^
M_*;3T<JNX%AG[P&:=XGEM+#QAX<U"^5([0)=1/,Z94.RIL!..,[6Q]* );#Q
M5:6NJZ]!K6KV=LD.I"WM%N94B^7R(6VC.,_,Y/?K6[<7$ZZG8117%FL$HD,D
M<I/FR8 (\OG''?KQ7.Z#I=K-K?C26XM$=KF_6%RZ9WQBVB^7GJ,EJR?#JSM;
M_#AI5D+)I\H<L#D'R%'- ';PZWI-QJ4FG0:I92WT>=]LDZM(N.N5!R*K^(];
M.AZ:DL5N;F\N)DMK2WW;?-E<\ GL!@DGL :XO1;VUL=9TO3=,N;?5+;[9+_H
M=Q9%+S3]P<M(6XP 25^902&^\>_3>,K*\FM--U&QMVN9]*ODO/LZ?>E0*R.J
M_P"UM<D#N1B@!ILO&D4:W*ZQI4\^06LVLVCA([JL@8L#_M$'Z5LZCK6E:.L;
M:IJ5G9"0X0W,ZQ[C[;B,UBGX@^'&A_T>]:YNSPMA#$QN2W]WRB P/UP!W(K/
M6_T_0O&VMW?B!DMC=I#]AN;A?D,(C :)6Z A]Y*YR=P/- '9_:K?[)]J\^+[
M-LW^=O&S;C.<],>]<U=>*+6]UOP]%HNK6EU;7%[)#=?9I4E! MY7 )&<?,H/
M;I7+FRE/A=[@6,_]@'Q +P6?DMG[%QD^7C.SS,R;<?=[5I7VIZ)K7CGPE/I(
M2[EAN)EDN[="4C0VTN$9@,9)Q@=L'IGD ["ZU[1[&^CL;O5;&WNY,;();A%=
ML],*3DUH5Y("UC#KVFZSJ]G:W%W=W#2VT^E--+=H['RS&0X\P;"H  ^7&.U>
MA:5=0:?'I>@S74\]\+%7$DD+ R*@52S'H&)(X)SS0!LT444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 ,FC,T$D:R/$74J)$QN7(ZC.1
MD5S$OAG6=1ACL=8\01W>FJZM)''8B*6<*0P61]Y&,@9VJN?:NJHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** ,?4]/UF:]6ZTK6DM!Y>Q[>YM!/$>2=P 9&#<_WL<#BG:'HITA+J6>Z
M:\OKV;S[FX9 F]MH4!5'W5"J !D].I-:U% !1110 4444 %%%% !1110 444
M4 %%%% &9!I'D>)K[6//W?:K6"W\K9]WRVD.<YYSYG3'&/>M.BB@ HHHH Q6
MT2XN?$L.JWU['+!:!_L5JD&SRV<!6=V+'>V,@8"X#'K6U110 4444 %%%% !
M1110 4444 %1W"S-;2K;R)'.4(C=T+JK8X)4$9&>V1]14E% &3H.C-I$-T]Q
M=?:[Z\G-Q<W CV!VP% 5<G"A550,GIUK6HHH **** "BBB@ K,T/2/[&@NXO
M/\[[1>SW>=FW;YCE]O4YQG&>]:=% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\)@TTK;^;Z;@L9C6F[[6Z+KL==_PN2'_ * C_P#@2/\ XFC_ (7)#_T!'_\
M D?_ !->445K_9V&_E_%F7]I8G^;\%_D>K_\+DA_Z C_ /@2/_B:/^%R0_\
M0$?_ ,"1_P#$UY111_9V&_E_%A_:6)_F_!?Y'J__  N2'_H"/_X$C_XFC_A<
MD/\ T!'_ / D?_$UY111_9V&_E_%A_:6)_F_!?Y'J_\ PN2'_H"/_P"!(_\
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M>&>-XI4.UT=<%3Z$5'1_9V&_E_%A_:6*_F_!?Y'J_P#PN2'_ * C_P#@2/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M (FO9**/[3Q'?\ _LO#=OQ/&_P#A4&L?]!"P_-__ (FC_A4&L?\ 00L/S?\
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MO!SGTQ7H&DRWLFAV4NHH@OVMT:X6-@5\S:-V".,9S5._\):%J=Y)=7=@KRS
M";;(Z+-C@>8JD!^./F!XK81%C1410J* %51@ >@H XKPII[>(-!L/$-[J^IC
M4+DB=_)O'2*([N81%G9@8VG*DG!YS2Z79-XIN-9N]0U+489+;4)K2"&TO)(%
MMDC.%.U" S,,/EL\,.,5M2>#]!DOVO&TY?,:43.@D<1O)G.]HP=A;/.2,YIV
MH>$]$U2[DNKNQW32J%E:.5X_- Z!PI <8X^;- ',Z3KNHWT'@J>XNV;[1?75
MO-(AVK=*D<X1B!P=VQ7QTSTJ77-5NDU#QQ'!>RK]BT&*6)4D(\F4K<'</[K8
M"'/L*ZN^T/3-1TV/3[FSC-K$5,4:93RBOW2A7!4CL1BH+?PMHMK#>10V"!;V
M'R+DEF9ID^;AV)RQ^=N2<\]: ,"?1-37PO:M8ZA>W5[<O!+>"74'B:X4*2R1
M-G$1.<_+MX&,]ZR[S6KBS\./8Z;_ &Q#='5H;*YBO+A7GM5D"MM25F((88"L
M6."_L .[O]%T[5+&.SO+598(BK1#)4QD# *L""I [@YJ&#PWH]OI=QIJV$;6
MER2T\<I,AE)QRQ8DL>!R3G@>E &!H5MJ]CXE@1+34+;398)/M$6H:D+H[P5V
MNF79AU((Z<BKGB>:XGUS0=%6[FM+2_>9IY8',<C^6@*Q*XY7=DDD8.$."*T]
M,\.:3H]P]Q96I6=TV&:65Y7V]=H9R2%]AQ5G4M*L=8M/LNH6R3Q;@X#<%6'1
ME(Y4CU'- ',0VC67B]O#L5_?S:=>:<]RZ/>2-+;.LB*"LI;> X8\;NJ''>I/
MAE91VG@73G22X<S1[F$L[R <D?*&)VCV&*WM+T+3=%\XV%MY<DQ!EE=VDDDQ
MTW.Q+'';)XJS8V-MIME%9V<2PV\0PD:]%% ')V-HWBC6=>;4-1U"'[#>&TM[
M:TNY+<0J$5@Y"$;F8L3ELC& !UI8[:36_%=_I-]J5^+33+6W\F."Z:![@N&W
M3.T94MRN,#"Y!XK;U+PMHVK79NKNSS<,@C>2.5XC(HZ*^PC</8Y%+>^%]&OU
MMEFL50VT?E0- [0M&G]P,A!"\#C.* .,O]1U2'POXBL+;5;EGT[5[6TM=0W9
MDVO) 2K'^(KYC(<]1P<\UMI:OH/C;2K6UOK^:VU"UN?/BNKIYP7C\LJZ[R=I
M^9@0,#GIQ6\F@:5'I*:7'8Q)8HZR"%1@;E<.&]SN .>YZU9EL;::]M[R2)6N
M+=76*0]4#8W?G@?E0!P>FV;:YX'E\1WVM7\%_/!-,[K=NL-KC=^[\K.PJN,'
M<"3@\YJ?P_=SQ#X?6RSND$^B/OC#$*[+% 5R.Y +8_&NAG\'>'[F[EN9=.0M
M,_F2H'<1R/\ WFC!V%O<C-3W7AO2+W3K2PFLQ]GLPHM@CLC0[5VC:ZD,...#
MTH Y/5O$-]8CQQ/:79+63VL<18[TMM\:!V /'R[BQ'MS700>$[6$#;J^M/YD
M964MJ<I\WH=W7Y#Q_!MZXZ<5?L?#^DZ;#<Q6EA%''=#$ZXW"7C'S9SG()R3U
MSS4&G>%-$TF[2YL[+9+&I6(M*[B)3U"!B0@_W0* .'T")]*^&?A2>SN[Q7N[
MO3EEW74C#:TJAE4$D*I!((&!6W#ILNN^+_$T%YJFI):6TD"V\-M=R0B-FA4L
MP*$$\]CQG)QS6_;>%]%M(3#!8JD7GI<B,.VU9%;<I49PN#S@8%7X;&VM[JYN
MH852:Z96F<=7*J%&?H !0!P%AJFH:W8>#].OM1GACU"&X:ZN(',4EP\. J!U
MP5+99CMP3M..]:NG0MI?Q'&EP:M>3V9TEY_L=Q<M-Y3>:@#98ECD9QDG'..#
MBKFMZ/'#H]II]GX<M]3T^*0E[4S!)(^I#1EN-V2>K+UX-5/#/A][?Q#-J_\
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M!6VG<0OR;>HQTP:T]+T06?B3PC$T5S+%8Z+<K'+<QX>-BT 4-C@-M+#&>QH
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M]<=*FN?$^A6>HC3[C5K.*[W!3$TP!!/0'T)[ ]:PM1T[R-*\&1VUJ5^R7UL
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M<]A'!!=)9B=8V5W+HW!V;MR'/0XQV%;?@NT2WTN[GCFNY4O+R2X#7-L("2<
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M'5K.XN "?+BE#$@=2/7'?%<9J%G>>)#XNO- BFBM[W2X[6-V0Q?:YU\PEEW
M'&UE3=T/T%%CY6KWVB6HU749'L[A)EM5TD0&UV*<K(VT!!C*8!YSQD4 >D44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%9/B+78O#NEK?2V\UPK3Q0"
M.$ N3(X08!Z\D<4 :U%<]/XCO+9+.WET:0ZM>,_DV*3HV$3&YW?HJC*YZ\D
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MK*I (W$A2,$-G/0^O%0VNORWLU_I=]8&ROHK7SPHF65'C.5R&'<$8(('4=:
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ML<A' YXR"1VZ5E>++2[\5:RVC:?<O VDV_V[S4; ^UG/V=3[##,1[K6FOC&
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M)N0<A2Q !]QP,U>N?$5TVI7=EI&D2ZBUD0MS)YR1(KE0P12WWFVD$C@#(YH
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M+2:YD!*0QM(P7J0!GB@# \(Z)=Z,E^9XH;.WN)5>WT^"=I8[8!0#AF QN/.
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M?0/,M_M;3-)NW'9@W!EZXS]WVZUU-A>1ZCIUK?0AEBN8DF0.,$!@",^_-6*
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MEFAC"K,R&$*R\DJ/G;C/?VJW-X84PV<=GJ^J6'V6W6V!MIEPZ*.-RNK+G_:
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M?:>Z+=Q*OE%P"N2P'.>W-&G^%XK+48+Z?4]1U"6VC:.V%Y(C"$-C=C:JDD@
M98D^]0>/K22^\#ZI:Q0/.\B*OEHI8L-ZYX'M0!3U2;7?#<=IJESK/V^![J&"
MZM&MD1 )76/,14;@06!PQ;(![\U2\3:_>07&JR:7K%^\E@A/V:UTP2P(ZIN*
MS2%3DGN%92 1QZ[D7A&W%W;2W6IZG?06D@EMK6ZF5HXG'W6X4,Y'8NS8Z]:9
M=^"[.ZEU #4-1AL]18O=V4,JB*5BH5CG:7&0!D!@#W')H H3:GK.L>(=+L+"
M_&G6UWI)OIG2%))%;<@ 7<"/XNX(P.F3D0^'['4(?'?B62369YDB^SEXVAB
MES$=N2%R-OMC..:Z6UT&TL[^UO(VE,MM9?84W,,&/*G)XZ_*.::- @3Q!+K$
M-U=123HJ7$".OE3;054L""<@'L1T&<T <=8ZQXE3P7HOBN[U=96G-K]HL5MX
MUB>.61(R0<;@_P ^[.<9XQBK>I>(KVZ\3ZIIT-YJ=C;:<8X@UAI;732R,BN2
MS>6ZJH#*-HP3R<]*Z(>&+ >%[7P_NF^Q6PA$9W#?^Z967)QZH,\4E_X:BN]2
MDU"UU&_TVZF18YWLW0"8+]W<KJPR,D!@ <<9H YU]>\1W6F^&XU_XE]]?ZA+
M:7#S6I7=&D<I$BQORI(C5P#W.#D4[7+W6])O1#=:QJ%MIT5JK)J46G)<+)-N
M;?YX5#L4#9]T*.3\U=*OAZS"Z2#)<N=+E::%I)B[,Q1T)=FR3Q(WXX^E1:KX
M<&J7,DRZOJEFLT0BFBMIEV2+SV=6VGD\KM/O0!K6THFM(95ECF#HK"2/[KY'
M4<G@]>IKD[K6-=EB\5QZ<OG7%A>PPVRI&I98VBA>0@' 9@'<@$\G KJ[2UAL
M;."TMD$<$$:Q1H/X548 _(5FR^&[60:F4N;R"349TN))8)MC(Z*BJ5([8C7@
MY!YSQQ0!4\*:D;W[;$VL7%^\+)NBO++[-<09!X==J@@XX(4=#R:F\4:B+&TM
MHUU*:RGN)MD?V:T^T3RX!)6-,'GN6(( !SZU/I&@Q:5=75V]Y=WU[<JB2W-T
MREBB9VJ BJH W,>!W.:76-"AUA[2;[5<V=W:.7@N;9E#IN&UAAE92".H(- '
M(?\ "4:Q!X7\6MYT[7>DH'M9[RV6*0AHPPWH %R#GD  C'%:6KSZ_P"'+"/6
M[G6!>1I-$MW9&W18MKNJ'RB!O!&[(W,V<8[U#XD\+QV'@KQ2;-KV]O=1M293
M*?,>5PNT8 '7'& ,<# %:J>#[8RVWVG4M2N[.UD66"QN)E:)&7E2<*'?:<$;
MV;H/2@"G$^NZSXFU^SBUDV%C8311P^1!&TI+0HY!+JPVY;TR<]1BLZ?Q)KQT
M<6T4]LNJ6^NII,MSY.8Y%.#OV9X.UU) /4$9%6K3P]/=^,/%%XE[J>F/)<0*
MDUL5 F06\8Z.K*<'<,@9!R,UM1>%--AT^TLD\[9;7BWOF-)N>68-N+.Q^\23
MS_2@#-FEUDZY:>&H-9E606CWESJ+P1&9EW[51%V[!U.25/ '<YJK>:[J^C6G
MBG3[B\6ZN]-THZA9WAB56(*R8$B@;=P:,]  01Q71:MH%OJMQ;W8N;FROK8,
ML5W:N%D56QN4[@593@'# C(!K'UGPY'I_@KQ0+9KN^U&^T^<2SS'S)IV$3!%
MPH P,X"J .3QS0!6U.Z\1:#X='B.XUE;HP(DUU8"WC$+(2-RQL!O# '@EB"1
MTYXMPW&M:EXVU6Q34_LNG:?]F<)'"C/*74EE+,#A>.W//!&.5L_!EM)96,5U
MJ&IS6,(CD739I5,*LN"H/R[V (&%9B.!QQ6];:7;VNJ7VHQE_/O1&)03\HV
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MJL/VN[M'1Q(DUK+L=6'U!##D\,"/:LQ?!VG-87=O=SW=W-=S)/+>2R 3>8@
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MVLNE0B"TNX) )40*%(.058$*,@J1D XXK0TK2ETN*53>7EY+,_F2374NYF.
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M>9-D#1N&0#"AF QC#%N.GK5^[\+:?>6^LPRM/LU=UDN-K#(*HB#;QQP@]>]
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M--0:U<6S$G ^?&,$\!ONGUK(O[RVU+XHVNGWME?30VMGYD*F!_*68R#][Z$
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M,86EH\H5<D9) QG@\9S[5CZIJ<-_JW@R\L;@R6EU=RNK)D!U^RS$9'Y<'N*
M.HBM;>#9Y,$4>Q=B[$ VKZ#';VIRQ1IOVQH-YR^!]X^I]:X?P==VVL^*?$%_
M-9WOVV*[,4$US Z"*$11?NQGA3DL2O4YS7=T 5;73;&R61;2RMK=9#EQ%$J!
MOK@<T6VFV%D +6RMH &+ 11*N">">!UKCM<NX'\:2V/B#5[O2].-M$=/\JZ>
MUCGD);S-TJD9884!2>AS@YKHFO+7PSH4!OM0N;M0PCBED'FS3LQ.U0$&7;'
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MXIU^*;3YS;W]TMW#=J4,>T01(5/S;@VY#V[BNEHH YWQ[_R3WQ'_ -@VX_\
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MT49[6+1H[1;AB,LZR$D>O3!J?PQ87-A_;/VF(Q^?JD\\7(.Y&VX/'K@UO44
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MCI\D8V26PCF#GNCHQ&WM@\@^HKE1X1U6+POHS?9YUDT_49KL:=:W6R2*"3S
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MMA-Y]X6$;,<?NU((P>_)].#5T7;'7M.@FM;?SY;*65I5.XH0T8*JV!E3N_'
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4BHJ+M
M10H] ,4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X511
M17R)YH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS9P,GH.#S4=X=,DMU>S2YAFW8:*1@ZX]0P _+%7R/ENV.VERC1114""BBB@
MHHHH **GMEMF:3[3)(BB-BFQ<Y;L#[4?9)?L/VS \GS?*SGG=C/\J?*QV(**
MNS6D<.DVURS-Y\\C[5[!%P,_4G/Y52H<6MP:L%%%3VZVS)-Y\DB,$)B"+G<W
MH?04DKB(***5068*.I.* $HJ:[M9+*[EMI@!)$Q5L'(S4-#33LP"BBB@ HHH
MH **GDM)8K."Z8#RIF94YYRN,_S%)<+;*(?L\DCYC!DWKC:_<#U%/E:W'8AH
MHHI""BBB@ HHHH **** "BKHLH[S4EM=.=I X^4R@*<[<G^M2:5:PW*WYE3=
MY5H\B<D88%<']35J#;L.S,ZBBBH$%%7-)M$O]6M;25F5)9 K%>H'M55U"R,H
MZ D4^5VYAVTN-HK3O=*,>H6MI:[Y'N(8G 8C[S@''TYJ::'1=/D-O+]IO9E.
M)'BD$: ]PN02?KQ5^R>M]+#Y68U%:L=EI]UJ]C;VEQ,T%PZJX=0'CR<$9Z'Z
MU82RT6YO_L$3WT,S2>4DDA5TW9P,@ '&::I-]4'*S"HI\L30S/$_WD8J?J*9
M61(4444 %%%% !1110 45/:K;-(PNI)$38Q4HN26QP/I4%%M+@%%%3WEI+8W
M3VTP D3&<'(Y&?ZT6=K@04444 %%%% !16AJMK#;+8>4FWS;1)'Y)RQ)R?TK
M/IRBXNS&U8***T+2UAET;4KATS+#Y7EMD\98@T1BY.R!*YGT45/9VDM]<K;P
M@&1@2,G'0$G]!22;=D(@HHHH ***EME@:YC6Y=TA+?.R#) ]A0E<"*BE?:';
M825SP2,$BDH **UKB.VLM&L_]%22XNXVD:5V;* ,0 H!QV[YZUDU4H\N@VK!
M1114B"BBB@ HHJ]I%E'J%_Y$K,J^7(^5ZY521_*G&+DTD-*[L4:**U[O16'B
M.32K,EL, K2'H,9))]!S3C!R5T"39D45KO\ V#;N8=MY=8X:=)%C!]U4@\?4
MTMGIUA>:]#:0W$TEI(I;=MVNN%)V\Y&>.M5[)MI)JX^4QZ*VK:QTK4Y?LMD]
MY#=,I,?G%65B!G!P 1TZUBU,H.*N)JP4445(@HHK1M+6&71M2N'3,L)B\MLG
MC<Q!IQBY.R&E<SJ***0@HHHH **GMK26[,HB /E1-*V3CY1UJ"BSM< HHHH
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MW-?([.+4;6SU!4M]7L+?38VVM:I"<L.G)(SFJ%C)::=8ZWK20(\4LS06J,,
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MNB7<I3*I!!((((Z@UL>%N/$=J2,C$AQZ_(U-;7%G;S+O3+.XG[RL&4L?5@I
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M=6X8LL<P/R$]=I!!&:CVBVOK;?\ K47,6[XB^T.WU&5$6Z%P8'95"^:-H()
MXR.F:=JT:CQC+&J +]I4!0..H[5GWVHRWPC1DCBAB!$<,2X5<]?Q/J:MGQ!,
M9(YVM;5KQ  +DJ=YQP"1G&??&:3G![OM^&X73-6VNYK76]?AA94C5+F15V#@
M@\=OTZ5R\\\ES,TTK!G;J0 /T%6X]7GCU2>_V1,\Y?S8V4E&#=1C.<<^M5)Y
M1-.TBQ1Q ]$CSM'TR2:FI4YHV3ZL4I71'1116) 4444 %%%% !1110 4444
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M S^%:EI8VMAXGL4>262&1H9;=U !.X@KN'YYQ4<UA:WVLWK1RRQ6T&^2XDD
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M;S'S,T)[73[>$NFHK<R9&V..)@,=]Q;&/PS6X^JVC:O#??VO*+-'5DLT1U*
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M.U,!:>095$8,?QP>.G>N@9VA\5Z[)&=K+;SL".QV]:S_  X8VBU*'RFEGD@
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M<Y[;\8_+BL6\ 6]G & )& 'XU%2$4KQ[M$R2Z$-%%%9$A1110 4444 %%%%
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M*#3-.N$W;[A'9\GCAR!C\!5KF=W?8>K*GGS%V?S7WN"&;<<L/0TQ69&#*2K
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M1@D?J*J\GKV'J-EFDGD,DTCR.>K.Q)/XFF5?OK.*WL=.F3=NN(F=\GN'(X_
M50HDFGJ#+$E_>30B&6[GDB'1&D)4?A4*R.J,BNP5L;@#P<>M-HI-M[A<*<TC
MNJJSLP484$YP/:FU?UFSBL-5FMH=WEH%QN.3RH/]:$GRMA;2Y2>1Y""[LQ
M!8YX'04K2R/+YK2,TA.=Q.3GZTRBE<1//>W=TJK<74TP7H))"V/SI+>[N;1B
MUM<2PD\$QN5S^50U;:R$M[%:V,OVIY N,+M^8CE>?2J7,W=;CU('GEE!$DKN
M"Q;#,3R>I^M->1Y'WN[,W RQR>*EMX896E$]P(-L;,I*EMS#HO'3/K4%)WW
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MB2223R2:2BI$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,CO6HVJ667ECTB%;AP>2Y:,$]2$/]216545I*5K"DTPKJY[**]\77IG"-'!
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MMPYV;4FF6,MVTZZK;"R9MV6)\T+Z;,9S^E2_VK#=:CK5TQ\I;FV=(E;J?F7
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MV<<;EEW*KA"!N'< XS7/44*JT[V[?@',=4+Z2*UOX[[5X9C+;NL4,+97/'/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1Y$/_/*/_OD5)119 1^1#_SRC_[Y%'D0_P#/*/\ [Y%24460$?D0_P#/*/\
M[Y%'D0_\\H_^^14E%%D!'Y$/_/*/_OD4>1#_ ,\H_P#OD5)119 1^1#_ ,\H
M_P#OD4>1#_SRC_[Y%24460$?D0_\\H_^^11Y$/\ SRC_ .^14E%%D!'Y$/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX2W1?^?J3_P'E_\ B:VJ* ,7_A+=%_Y^I/\ P'E_^)H_X2W1?^?J3_P'E_\
MB:VJ* ,7_A+=%_Y^I/\ P'E_^)H_X2W1?^?J3_P'E_\ B:VJ* ,7_A+=%_Y^
MI/\ P'E_^)H_X2W1?^?J3_P'E_\ B:VJ* ,7_A+=%_Y^I/\ P'E_^)H_X2W1
M?^?J3_P'E_\ B:VJ* ,7_A+=%_Y^I/\ P'E_^)H_X2W1?^?J3_P'E_\ B:VJ
M* ,7_A+=%_Y^I/\ P'E_^)H_X2W1?^?J3_P'E_\ B:VJ* ,7_A+=%_Y^I/\
MP'E_^)H_X2W1?^?J3_P'E_\ B:VJ* ,7_A+=%_Y^I/\ P'E_^)H_X2W1?^?J
M3_P'E_\ B:VJ* ,7_A+=%_Y^I/\ P'E_^)H_X2W1?^?J3_P'E_\ B:VJ* ,7
M_A+=%_Y^I/\ P'E_^)H_X2W1?^?J3_P'E_\ B:VJ* ,7_A+=%_Y^I/\ P'E_
M^)H_X2W1?^?J3_P'E_\ B:VJ* ,7_A+=%_Y^I/\ P'E_^)H_X2W1?^?J3_P'
ME_\ B:VJ* ,7_A+=%_Y^I/\ P'E_^)H_X2W1?^?J3_P'E_\ B:VJ* ,7_A+=
M%_Y^I/\ P'E_^)H_X2W1?^?J3_P'E_\ B:VJ* ,7_A+=%_Y^I/\ P'E_^)H_
MX2W1?^?J3_P'E_\ B:VJ* ,7_A+=%_Y^I/\ P'E_^)H_X2W1?^?J3_P'E_\
MB:VJ* ,7_A+=%_Y^I/\ P'E_^)H_X2W1?^?J3_P'E_\ B:VJ* ,7_A+=%_Y^
MI/\ P'E_^)H_X2W1?^?J3_P'E_\ B:VJ* ,7_A+=%_Y^I/\ P'E_^)H_X2W1
M?^?J3_P'E_\ B:VJ* ,7_A+=%_Y^I/\ P'E_^)H_X2W1?^?J3_P'E_\ B:VJ
M* ,7_A+=%_Y^I/\ P'E_^)H_X2W1?^?J3_P'E_\ B:VJ* ,7_A+=%_Y^I/\
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M^@]I?_@9'_C1R2[!SQ[FM163_P )5X=_Z#VE_P#@9'_C1_PE7AW_ *#VE_\
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M^@]I?_@9'_C1R2[!SQ[FM163_P )5X=_Z#VE_P#@9'_C1_PE7AW_ *#VE_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
8 !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>ethicsemployeepolicybook010.jpg
<TEXT>
begin 644 ethicsemployeepolicybook010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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MT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+E6BNQF\-^'/^$AET"+5=0BOEN#:I)-:H86D#;0"5?(!/?%<G<V\EI=36TH
MDB<QN >A!P:49J6PY0<=R*BBBJ("BK-Y#:0^1]DNFN-\*O+F(IY<AZIUYQZ]
MZK4)W&PHHHH$%%%% !16CHNCS:W?&".2.&*.-IIYY#\D,:]6/^>216FMMX/>
M86W]H:LA)VB\:!/+SZF,'=M_'/M4N:3L6H-JYS=%/F18IY(TE65%8A9%! <
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M@)9W37,6Q27:(QX8@%EP3V.1GO5:FG<'H%%%% @HHHH **** "BBB@ HHHH
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M43T6W_!.I\1:W=Z)XBN]&L;:WBTZSE\A;5[=&651QN<D98MUSG//&*H>/O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMW^DK+9FYL(!/-B4[0I&< [>N"*]"@\.1#XV/J8V_83:_P!I*_\ #DC9G/\
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MM?$^AP:E:D#>,21YYC<=5/\ GI7E8ZDU+G74]3!5$X\CZ''?$+X9IK[2:KI
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **^N?[*T[_GPM?^_*_P"%']E:=_SX6O\ WY7_  KSO[07
M\IZ'U!_S'R-17US_ &5IW_/A:_\ ?E?\*/[*T[_GPM?^_*_X4?V@OY0^H/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!EZ]!>W%BR6DRQK@F0GJ1CH*\]@@EN)5BA
M1GD;HHZFO4;E2]K*JC+%" /PKD_#6DWUIJWFW%LT:"-AN..O% '-"*1;D1,"
MD@;;@\$'->E:9%>06:QWLJRRJ<!E[CW]ZY74]'U";7Y9X[5VB,JD,,8(XKMJ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ]HMKJEKN$-PFX*W53T(/T((_"HKJ=DY--=T70Y+M133[,T****Y3I"BBB@
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M_CW ^]C'7CZUZI14JLU*4N]_Q*=%-178RO$T4D_A75X88VDEDLIE1$&2Q*$
M =S7*?"#3[W3?"-S#?6D]K*;UV"3QE&(V(,X/;@_E7H%%2JC4'#N-T[S4^QY
M;\9M*U'4[?1Q86%S=F-Y=X@B9]N0F,X''2O4(QB) >N!3J*)5'*$8=@C32FY
M=SRO4M*U%_CG9:@EA=-9*%W7 A8QC]V1][&.M>J4445*CG;R5@A3Y+^;N>??
M$CP)<>(O(U;2&":K:C 7=M\U0<C![,#T^M8EM\3_ !1I4 L]8\*7$]V@V^:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3'X7/AQ87_LT@@IYAW<MO^]UZUMT4.I)N]QJ$4K6,'5O!^CZSI]C9W44@6Q
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M>96HSHRY)K4]6C7A6ASP>@4445D:A1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@)%V[?F4'!..,D9QWH Y.QN+O7;GPYI-WJ%W#;2:&E],T$[12W4GR*09%(8
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M63AS(2SYYSR23^- '.?8[C0/%/AY(M3O[D:B9H+Q;JY:59&6(R!U4G"'*=%
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M_8SWMIJ5K-;0 F:5)05BP,G=_=XYY[5P-U+)?^%_"-Y:R7"6VE/&M\/L32-
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MNJ6DMSIEOIWE1V7[T;@S%2PQDC.[YLDXQFM/Q!:W#Z9\1PD$K&;RO* 0G?\
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M!N(;M%SA6 'W\Y)"L#\W?MV6@33W'A[39KJR6QG>VC:2U48$+%1E .V.F.U
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MB3[-+]G168Q9&X[7*_3J*DU#Q#)#JYTG3=-EU&]2)9IPLBQI"C$A=S-W.TX
M!Z$\4 ;*31R221I(C/&0'4,"5)&0#Z<$&GUP>AZ]!:7WC35[^WN+1(;N#S(9
M%!D#"WB7: "0Q)P!@X.1ZUN6WB2Y&HV=IJNC7&G?;B5MI'E20,X4ML;:?E;:
M"1U'!YH Z"BN=TGQ//K%Q&]OHUP=-EEDB2\$L9P4+ EDSE5)4@=3TR!FM/79
M8(/#^I2W*2/;I:RM*L;E&90A) 8$$''>@"_2$A022 !R2:YF3Q,EC+I&EV.F
M75W/>V1GMT$@PJIL'SNQXX<<\Y]R:Q?%OB.?4OAOXC\G39XKNW66SO(&E0&
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M6.DS7L\MA9.4\Q8UC ,WWF)QGG@#/0^E '=45GZ'J\.NZ1#J$$<D2R%E:*4
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M)NS,8SIURUP%"YWYB>/'M_K,_A63:^,'FFTQ[G1KJUL-481VMU(Z$EF4LH=
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M%RT4]R8'AEV*C<[&#*0BGL0<]>U:#PE?16NF&2>"2\763JMZRY5,LK@J@QG
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MG!!+<$<@]L5T>LZZFD26ENEG<WUY>,RP6UML#-M&YB2[*H 'J>XK5'(Z8]J
M.*;PE<2>%KJSAT[2=.NKF\MY_*M,[ D<L;X9\#<V%;G:!R![UN7^E7%UXHT;
M4HVC$%E'<+("3N)D"!<#'^R<ULT4 <,_AG6G\+:UX?\ +LO+GN9I[6Y\]LN)
M)S+AEV?+C<1D$YQ70?V5<?\ ":'5]T?V;^SQ:XR=V_S-W3'3'O6S10!P$G@6
MY?PWH<,L%A>7NE2RN;>X)\B=)"V5W;25."I!P<$=,&M#2?#]S9PZE<6^@Z#I
MMS-!Y5O$@:3=U)$K@+E2<?* <8SDYP.OR,XSUJM;ZA:W5W=VL,H>:T94G7!&
MPLH8#WX(/% ',^&/#]YINMW%Y_9]IH]B]OY9L+.Y:6-Y=V?,V[55,#(&!SGG
MH*O>+]'O-9T^TCM5BG2&Z6:>SFE:-+J,*P,;, >Y#8(()4 UT-% '!V/@Z\A
M'B5H]/TK38]5TU+6"ULN%C=1,,N0@!SYBG('MSC)V;[0KJYTKP_;(T0?3[JV
MFFRQP5C7#;>.3Z=*Z.B@ KCM+\+7]G8^$897@+:1/+)<;6."&AE0;>.>9%ZX
M[UU&H:A::5837U].L%M"NYY&Z#M^))P !R2:S],\3V&J7OV*.*^M[@QF5([N
MSD@,B @$KO4 XR..HSTH H:IX5?5]4U\W$JI9ZII45B&0Y=&5IB6QT_Y:+CG
ML:H:OI_C'6O#S:/+;Z5 YV"6\6Y=A,%8$[4V#;G'.2<=L]1V]% &+#I$R^+]
M1U23RFM;FP@ME3.6W(\I;(QC&)!^M9GA+PM>:)>W$M_/%,EO$+'3=A),=J&+
M -D?>Y53[1K76U6O-0M=/$!NI1&)YE@CR"=SMPHX]: .2MO"NJZ?HN@R6KVK
MZII$DS>5(["*9)"P9-P&5."I!P>1TP:NVMAK][XOL=9U&&RM;2VM)X%MHIFE
M<,[1G<6V@'.P\=L#DYXZ=Y$C1W9@%098^@J*RO;?4;&"]M)/,MYT$D;@$;E(
MR#@\T <'=>&?$S>$+SPK;1Z<+8N_E7SW#;FC,A<*8]G#<[2<X[\]*T-:\-WE
MYXFGOI-)TS6;6:"..WCU"4A;-EW;B$*,"&R#D8/&.E=G10!QFD^$[_3]/\)6
M\DEL6T>YFDG*9 96BF0;!CUD7CMS70:'J,^JVUS<RPK%$+J6*WQG+QHQ0,<^
MI5B/8BM.JUUJ%K8R6L=S*(WNI?)A&"=[X)QQTX4]?2@#(UO2]0.MV&NZ2();
MJUBDMY+:X<HLT3E6.& .U@R*1P0>1QUK.F\/ZOJYUK4-06UMKR[TQ].M+:*4
MR+&K;B6=]HR2Q'08 '?-=C67K6N1Z/\ 9(Q:7%Y=W<ABM[:WV[W(4L3EV50
M 222* +6FV[VFEVEM(07AA2-MO3(4 XJAJNE7%[KV@WT31B*PGEDE#$Y(:%T
M&..>6%;"$LBL5*DC)4]1[<4M &#I>A26X\0Q7A1H=3O9)E$;'(C:*-,'C@_*
M?TK%.C>*3X7_ .$4,>G?9OLWV+^U//;=Y&W9N\G9_K-O;=C/.>U=Q10!@V&A
MR6/BF:_0I]C.F6]G$NXEP8WD)SQTPZ_K69)X6OW^'>J: '@^UW4EVT;;CL E
MG>1<G&>C#/'6NQHR!CGK0 5QT?@Z5O&.H7ER\,FBSI))';<[A/*B1RD\8QM0
MX]Y&KJ(-0M;B]NK.*4-<6NSSDP?DW#*\]#D>E6: .!L_!>K1^ ]?TN\NK>?5
MM2@:W6?<=NQ8A%%N.,]%W'CJS5TFL:3<7]WH$L+1A=/OOM$NXD97R94XXY.7
M'X9K:HH XV7PE?R:=?".>WCO1K1U6S9LLF000K\9P1N!QTSGFK5_;^(]>T#6
M-.N[#3[(7-A+;Q;;MI2TKJ5!)V+M3GT)]AWZBJUMJ%K>3W4-O*'DM9!%,N"-
MC;0V.>O# \>M &5J>C7-Y%X?6)H@=/O8IYMQ/*K&ZG;QR<L/2MB\BDGLIX89
MC#+)&RI*!DHQ& WX=:FHH \WL/!-_'-H;-HVC6D^G7,<UU?)*99[O:"&.XH&
M&<[OF)YX]ZZS2-'N;&3Q TK1D:A?-<0[23A3#&GS<<'*'U[5>L]5@OM1U&RB
M602V$B1RE@,$LBN-O//##TYJ]0!E>&--GT?PII&F7)0SV=G%!(8SE2RH%.">
MV169J'AV\NKOQ5+&\(75=-CM+?+'AU68'=QP/WB],]ZZBJ.CZK!K>D6VI6JR
M+!<)O02 !@,XYP30!EW^AW5UIWA^WC:(/I]U;S398X*HI!V\<GGVJM;Z?K^@
MWVHII=K8WME?73W<;3W+0O!(^"X8!&W+G)!&#SCWKJZ* .*LO"NK1:#I-I=3
MVTEW;:R^H7$B9575II'^48X.'''ZU/JOA2ZO?%L-Y#+"NDW#PSZC Q.Z26#)
MB(&,8)*;L]HUKKJK7&H6MK=VMK-*$GNV98$P3O*J6/TX!/- &!J/A5]5U'Q'
M]ID5+/5M,ALE*'+H5,VXXZ?\M%QSV-4-7T_QCK7AY]&EM]*@<A!+>+<NPF"L
M"=J;!MSCG)..V>M=O63K&NII5S9VD=E<WUY>%_)M[;8&*H 68EV50!D=^XQ0
M!0O=/UBR\5S:QI5M:7D=W9QVTT4]P83&T;.RL"%;(/F,".O ZUBGPCK0\,06
M<[6EY,FK3WUU:^:T4-W&[R-L)P2.75L$$97!]:[^B@#@['P=>PIXG,=AI6FI
MJVFI;6]K9\)$X$P^<A0#GS%.0/;G&3UL-K=6_A^.TB,'VN.U$:F0%H]X7 SC
M!*Y_2K]% '&^'?#M]8>(?MXTRQT:T%N\<UK8W+21W$A92'V;55=N&YQD[N>E
M;/BG2KC6O#\MC;-&LKRPN#(2!A)4<] >RFMFC(SC/)H YB;3M9TKQ'J&IZ3;
M6M[!J0C,\$]P86CD1=@96"L"I4*".",9&<XK+;P9J>IZ%KMMJTUD;R_U)+^'
M8K/$I18MJ," 2N8]I]1SP3@=E;:A:WEQ=002AY;2013+@C8Q4-CGKPP/'K5F
M@#CM"\-O;ZS!>2^&-"TP6ZMB2W<S2LY&,H=B[5P6ZY)SC I6\+7Y^&NH^'M\
M'VRY2[5&W'8#+*[+DXST89XKL** .>NM-U.+QA::O9Q6T]NUI]CN%EF,;1CS
M V]<*0W&>..W-9A\+ZI#X5M[2$VLE]:ZN^HHCR%4D4W3RA2VTD$JV,X.#^==
MI10!P/C6QN[ZXT)(6CM=2U/?IMW'&Y?_ $9UWS$-@9V;.#@?>[9KNXHDAB2*
M) D:*%55&  . !6/$FCKXTN%2R U@V:3/<E0?W18H%!SD<IR .PK;H Y=M/U
MK1M=U.]TFUM+ZUU)TFDAFN# \4JHJ$@[6#*51?0@@]<U1U;P]JNH:Q:W]_I>
ME:Q']C6%K.XG98;>8,2TBAD8,""!DC<-HQUKMJ* .(TWPAJ%EH.BV#M9A['6
M9+Z00@I'Y;/*P"+CCB1>.@QUK>_LJX_X33^U]T?V;^S_ ++C)W;_ #-W3'3'
MO6SD @9ZT4 8GBW2KS6O#-U8:?+'%=R-$T<DOW5*R*V3Z_=Z5G7FG^(=?EL;
M34[6PL[*VNHKF>6"Y:5IS&P=552@V@L 222<#'/6NLHH X"Z\%26NK:E-!X?
MT;5H[ZX:Y26\E,<D#MC<K?(VY<Y(Q@\XQWKL]*LETW2K6S6*WB\J,*4MH]D8
M/?:N3@9SQFKE% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9/
MB34%TW1VE.H"Q=Y$CCE%N9W+$_=2,<LQ&<#!]<'%:U9NM:+!K=K#%+-/;R03
M+<03P, \4BYPPR"#P2,$$$$T <OI6O:V]QKNG0FYOKJWT];NQ.H6HMI'D;S%
M", %!7<BX.!U(/3--T[Q1+8V.J75[JMU=S66GO=RZ=>Z?]EG0H,DH0 &3MP&
MP2/FK<MO"5M#<7UU-J&HW-W?6PMI[AY@C[06(*[ H0C<?NX'XY)=9^%H8;Q[
MN_U"]U68V[6JF]\LA(F(+* B*#G:N2<DXZT 1:/9^(9%LK^]UV.3S5$EQ9K:
M)Y(!&=L;#YP02/F).<=*Y*'QCK.HZ,VNV<VIF=PTMMI<>AS/!(@)VH91&268
M#[P8*">F!78:=X6&F2VRQ:UJSV-J?W%D\R^6@Q@*6"AV4#H&8BHQX.@C:2*U
MU;5;73I)#*UA!,JQ9)R0K;?,1223A6 Y[4 5/MFMZMXQN].MM0.GV%O96MR0
M+=6EWR-)E?F! &$YXSP,8YK/\+K=Z6?%E[>Z\!!;W\WF-/ @0,(HCYC;<'C^
MZ"!Q78PZ5;P:U=ZJC2?:+J&*&0$C:%C+E<#'7]XV?PK,G\'V-Q)JPDN;PVFJ
MAOM-F'7RBY55,B_+N#84?Q8]J ,32/$&H+XFTRS>^U"^M-024%[W3?LH5E3>
M#&=JD@@$8;)Y!S23>(];D\/03VL\"WDWB"33@\D0*B(7$D8R!C.%4>A..O-;
MMMX4CCU2RU*\U;4M0NK+>(&N7C 564J1M1%!R#G)YR!SVJ5?"U@EI#;!Y]D6
MHMJ2G<,^:9&D(/'W<L>/3O0!FPZGJ6A^(;K3]1OWU*U_LQ]021H421#&P5D^
M0 $'<".,C!Y-<_:^+-<FTVTUB.75+JXG\N5M,30IA!Y;$95)?+SN"G(<L5)'
M3!KOGTFVDUM-68N9UM7M=N1L*,RL<C'7*BLNU\'Q61AA@U?54TV!P\6GK,HB
M3!R%#!?,V@X^7?CMC'% %=+G5]?U[5K>SU0Z99Z9,EL/*@222:0QK(2Q<$!0
M'4   GGFD\!K=):ZXMZ\3W(UBX$C1 A6.%Y ).,^F3CI5^]\,I/JDNHV6IW^
MF7-PJK<FT:/$X48!971AN XW#!QWX%5!X6?2M*&G:)<W,:7.HI=74TDY,@7<
M&DPW4EMNWU^8\T =102 "2< =312.BR(R. 588(/<4 >=_\ "4WL=]IUW:ZM
M>:E9W=_%;-G2_*M2DC[ 8Y",G!((.Y@<>]:B2^(-9\2>(;*VU@:?:Z?-$EN8
M[9)'9FA1R&W _*"<\8)SU&*GA\"6D4-C;/JNJ366GS1365K)(FR QL"HR$#,
M!C;\Q;CWYK<L]*M['4-1O8FD,M_*DLH8@@%45!CCCA1^- '*6WB;5=;TWPO;
MVLD5E>ZO!)/<7 CWB)8@N_8IXR688SG SP:DLK74;3XFVT=]?B^C_L><Q3-&
MJ2?ZZ'(8+A3VP0!UZ<9.H?!VGKH^G:?!/=P/IIS:7<4@$T1.0><8(()!!!!]
M*?IWA:"PUO\ MJ;4+Z^U$V[6S37+K@H65L!5557!7L!U.<T ;U8GB?4KG3+2
MPDM6"M-J5K;OE0<H\JJP_(FMNJ.J:5;ZM#;Q7#2!8+F*Y780/GC<,N>.F1S0
M!SHEU[6/$^OV%OK T^TL&A$#16Z2.6>)6(;<"-H//J<]1BJUMXGU;6-*\,VU
MN\-IJ&K+*T]R(]ZQ"(?.44\$DXQG( )ZXKJ[32K>SU+4+^)I#+?NCRAB, H@
M08XXX%9I\'Z>-&L=.BFNH6L',EK=1R 31,<Y(.,'(8@@@@CJ* ,GQ1::A9^&
MUCOM3-^IU73S$[P+&ZC[5%D,5PIYZ84?C6WI>I7-UXGUZQE93!9FW\D!0"-\
M>YLGOS3#X7CGL7MK_5-1OF>XAN3+/(@(:)U=0JJH11E1G"@GUI;[PQ'=:M+J
M5MJ5_I\UQ&L5R+1T"SJN=N=RL01DC<N#COTH P+3Q+J^I:-X?MH+B*+4-6N+
MA&NVB#"*.(N257H6(50,\<DG.*>]OJ.G_$+1S?ZC]O@73KUHY'B5)0=T&X$(
M I'3& .^:UT\%Z7#H%EI$#W4*6$IEM+B.3$T#DL<JV,'AF&"""#@YI]EX4AM
MM;AUFYU+4+_4(H7@$MRZ ;&*DC8BJHQM[ =3G/& #CK?QCK=YHL6O6TFJ37$
MJB>/2HM#F:!HSR$$WEY+;?X]VW/;%:^O:UJECKES]IU*?1].18S:3_V?Y]M)
MD?-Y[X)3!XZIQSDYK5A\'06Q6&VU;58--63S%T^*95B4YW8#;?,"Y_A#@=L8
MXJ35O"J:M+="36-4AM+Q=EU9Q2J8I5QM(^92R C@["N?KS0!O@Y (((/<4DA
M<1.8U#.%.T$X!/:A$6-%1 %50  .PHD02QM&Q8!@5)5BIY]".1]: .'\-Z]?
MF[C36M5N([XVSRW&F76G^3AU )\AP '4<]WR,'(K)M_&&MW6C0:[!)JD]Q,J
MSKI46AS&!HVP=BR^7DMM/W]VTGMBNQL/"L=IJ%K>7.JZEJ!LU9;5+MT(AW#!
M.50,QQQEBQP344'@Z&U*06VKZK#IJ2"1-/CF58E(.=H8+Y@7/\(?';&.* *L
MD^N:KXPU;2[75?L%E9V]O(KQP(\A>3?Q\X(V_+SQGI@BJ(U_7KSPEI=XGG*Y
MNYK?4;FPM1-(BQ-)'O2(Y^\R+GAL GCTZZWTJWMM7O=31I#/>)$D@)&T"/=M
MP,?[1S6>/"T,.FPV=CJ>HV1AN)KA)H)5W;I'9V#*RE&&7. 5..._- &5'X@N
M!IFA26VK1Z@+G5A:33_9O*8IAR5=#]UQM&>!]!5+0X-3L=:\:73:O)-]GN 2
MC01@2-]DB*L<#C' P.N*Z*W\)6,%O;1M/=320W_]H-/(Z[YIL$9;  Q@XP !
MP*D/AJW_ +5U"^CO+R-=03%S;*R^5(VP1A^5+!MH X..!Q0!DZ7X@OQ<>')=
M0E0V>KZ6K;MH79=!!(>?1D+G';R_>LV;Q?JATC3)@\D3:Y>2M;2163W#V]HH
M+(1&@)9V4*>00-Y)X&*Z34?".G:GX6M_#\[W"VMND:12QR;95V *"&QU(R#Q
MT)JUJ>@6>IV5M;$RVQM&5[6:V;8\# ;05/(Z$C!!!!P10!C^&=6U&XUFYL)V
MU"\LA LT5[>::]HP?=AHSE%5N,$$ =\UUE9FE:.VFRS3S:G?ZA<3!5:2Z=<
M#. J(JHO4\A<GN36G0!B:WJ5S9:SX>MH& BO;UX9P5!RH@E<8]/F1:YT7WB7
M4+/Q'?0:Q':KIEW<1VL*VR.)1&-P$A(SCM\N#WR>W7WVE6]_>Z==3-()+"=I
MX@I !8QM&<\<C#G\<5%;Z%:6UGJ5JC2F/4)99IB6&0T@PVWC@>G6@#D;PWVL
M>*_!NHPZC):I=V<TRPK$C"/,<;,,D9.<X]L<5?TV;Q#XEL)]8L]82PC::9+.
MT^S)(A6-V0&4GYB25)(4K@''-;D/AZS@ET>1'FSI4#06^6'*E54[N.3A1TQ5
M&;P="TETMIJVJ6%I=NTEQ:6LB"-V;EB"4+)N.2=C+R2>M &-'XDUCQ#)X673
MKA-.35K&XGNF\L2M&8_*^YG@\L0,\8.<5;1_$&I>)M6TF'6S:6VGPVY69;:-
MY))'0YSD;=N5R0!GG@C%;T7A^P@O-,N+>-H1IMO);6T2'"+&^S(Q[>6N.?6I
MK;2K>UU6^U&-I#->B,2AB-HV @8X]Z .(M==\1MX4TSQ7<ZC%MFG@2?3HX%$
M1C>58B58_/N^;=G..V*U/$.K7(U>>TT_6KV.>WB4M;6.E_: C$$@RN5( (QA
M05..>]:P\+6"^&8- #S_ &.!HV5MPWY202#)QCJH[=*CNO"D-QJ=Y>0ZEJ%H
ME]M^V6]NZ!)RJA022I93M !*,O % '*33ZEXCO\ P)JT>I-8O?V[R^7'"CB)
MS;EF(W YSG'-:NH^*=0T\^)@@BFDL[NTM+)9%PH:9(@"Y') :3)]N*U'\'V8
MTK1[&VO+VU;2%"VES"Z>8HV%"#N4J<J>>*L3>&--N5U=+E))DU4HURCM@95%
M0%2,$'"@YSG/(H RKN?6_#=UI<]WJ_\ :=K>7<=G/%);I&4:0X5XR@' ;&0V
M[@GGBJ(O/$NHV_B.\@UA+1=,NYXK6);9'$@10V)"1G'./EP>^3VW+;PHB7UK
M=7^K:EJ?V-M]K'>/'LB;!&["(NY@"0"V2,^O-7;;0[6UM=2MXVE*:A-)--EA
MD,X .WC@<>] $VD7QU31+#4"FPW5O'/L!^[N4-C]:NUEVNA163:6(+R]6+3K
M;[,D E_=RKM4 R+CYF 7@\8R:U* ,GQ)HIU[1GLDN/L\PDCGAFV;PDD;AU)7
MN,J,CTJA8Z_JEMK5OH_B"QMXI[F-WMKJSD+Q3; "RE6 9&P<XY!YYK8U738]
M6T][22>Y@#%666VE,<B,#D$$>XZ'(/<5GZ=X96UU1-3OM4OM4O(HVB@DN_+
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M;JR^5*0I56(*D@@>A X&0:JWG@W3+WPC:^&Y'N5M+6.*.&5) LJB,  AL=2
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MDB!)'/WF&Y"R$]RA7/7KS5R'PYIUM-I+VT;0)I<3Q6T2'Y0K* <YY/"CO^=
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MWE[:G2 !:7,+KYJX0ISN4J<J2#E:Z!1M4#).!C)ZF@!LLB0Q/+(ZHB*69V.
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M4.B9BY(4\!CP,]>*Q;:5+CPSX.M]9G9M$>XG@NVF?Y'*;U@24GJI*]^"0H-
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MF]/0K.9;BR@G1'19(U<+)]X C.#[T 34FY2Q7(R.2,U0U[_D7M3_ .O27_T
MUQ,5II/A_P"&FGS_ -EVUQ-J4-G#<23OY8F=]H#328)V M[C'&,&@#T565QE
M6##U!S1N4L5##<.HSS7EU@+K3/$&OVFBKI4=U_8;S);:3&5B%PI(3(S@OR.P
M.",]JVO#-EX+6PT:^MFL3J$FW9=-(!<S3%?F#MG<S=<J?3IQ0!UUC-=36OF7
MULEK+O<>6LOF#:&(4YP.HP<=LXJKXBU*72_"NK:G:^6TUK937$6[E2R(6&<=
M1D5PMO=P+X+TVPN+&TN_M^M7L*"^D*6Z,+BX?,G!W<+@+CDXJI%M@T/XD6$#
M6 MX=,WB+3D*0([0RA]HR0#\HSCC(]<T >J6LC36D,K8W/&K''J14M5]/_Y!
MMK_UQ3^0I-0:Y73;IK-0UT(7,(/0O@[?UQ0!8W+NV[ANQG&>:&95&6( ]2:\
MHDM_#2_#5=5MWA_X2/[,&CNP1]N:_P ?=)^^6\S@ITQD8Q6_'H]KJ_Q'O'U>
MUBN'@TBR?R9!OC$ADG^;:>"1@X/;)]: .YHHKE?B'+=P^$96M7V1F>%;I]S+
MM@,BB0DKR%VYR1R!DT =2&5L[6!P<'!Z5SFK>)U3PH^L:45?%W';CS4./^/E
M87XX_P!K'X5SFDZ/:_\ "2V<,">&K>WFM95NK+37+"\@*X&]-H4@,5^8]B1W
M-8T>F:/%\+-0ALX+6VO'U/R;AK<*DRJ-1PH)'(P,8STXQ0!Z^&5B0&!P<'!Z
M4;E#!2PR>@SUKC6TC3]!\>Z$-)LX;);NVNH[A8$"B8*$92P'WB#GD\\GUKEO
M[#T]/A1JVN?9D;58'O+B"\89EA:.>39L;JH&T<#CD^IH ]3$MW_:;0FU068A
M#"X\WYC)D@ILQTQ@YSWQBK&Y2Q7<-PYQGFN,U.2\3QGJ[Z>-UZ/#@:W7&<R>
M9+MX^N*A\+V?@W^R]%OXVL6U*381=22 74MP1\P=L[F;.<J?ICB@#NJ**Y+Q
MRR;=%BOI#'HLU^$U%MVU2FQ]BN>R&38#GCH#P: .L5E<95@P]0<U!>3316<[
MVD*3W2QLT4+2;!(P' W8. 3QG%<?:V^EZ?\ $#3[;PTEM#%):S-J4%D (@@V
M^4[*ORA]V0#U(W=A6+IFCV%O\']8U1;9&U";3;Y7NF&9-N9,(&ZA1@<#CCUH
M ].1R(%>8+&Q4%ANR%/IGO3+V6XBL9Y;.!;BY2,M%"TFP.V. 6P<9]<5PMRN
MEW'BVRM_$WV=M/\ [*B;3XKS'D/-EO-.&^4N%\O&>0"<=ZR#_9::/\2UT60-
M8KIN(_+;,:GR),B,]-H/IP#D#I0!ZJKGRE:4*C;06&[(4]^:>"",@Y%<+<:5
M9:OX]TN'4($N;=-#9_(E&Z-V\Q "RGAL9.,]^>U6_"4MIHUKX@MWECMM.L=6
M>*!7;:D*,D3!1Z#=(<#WQ0!U]%%87C8X\!>(B/\ H&7/_HIJ -S<I8KN&X<X
MSS0S*@RS  \<FO+]5MO#5MX-M-1T!K8ZZ3%]AN8V!NYK@LHVN?O-GD,K=!G(
M&.-46VC:EXTU^+Q1':3RP^5]AAO@IC6V,:DO&K<9,GF!F'/ 'I0!T?B/5+C2
M;>PDMPA-QJ-M;/O&?DDD"MCWP:EN]6;3+;5;[4H%@T^Q3S4F23>TB!-S$J!\
MI!R,<YQ7!P2&3PS9B*1Y=-C\4P)ITCL6W6XG7;@GDJ&W!3_= IWB:QM[_3/B
M6MQ;1W!AC6:$.@;8XLUPRYZ$9/(H ]#EN+K[59K;VR2VTN[SYC+M,0VY7"X^
M;)XZC'6K190P4L QZ#/6N(\C2[;7O!T>C1VD=F9+EMMH%"$F DGY>,U0T.U\
M,WNFW][XG^PG68[R87LUXX66W(D;RPC$AD4)LV[2,@Y[T >C%E4@%@">@)ZU
MCW.JW$/C'3=)4)]GN;*YG<D?-NC>$+@^F)&_2N%\4R6&JR>)9VL-$A>P!MVN
M;\E[IG$893$HP4^\-I!R3SBMS3IY+KQ1X0N)G+RR^'[AW8]6)-J2: .WH)P,
MGI17'^,?L\NN>'K75F4:'-),+A93B*28*/)23L5/SG!X)"T =>K*RAE((/0@
MT;EW;=PW8SC/->?+%867B;5[3P\(8]._L>5[Z&UP(8I\CRR .%<KYF0,9 !/
M:L6*V\*)\*;?4;1[?^VDL$-O=JP-Y]K"#8@/W\[\#9TQQC% 'J8FN_[3:$VJ
M"S$(87'F_,9,D%=F.F,'.>^,58W+NV[ANQG&>:XQFG;QE>_:0!,?#D9D4= W
MF29_6N?M-$T_3?A]X1UJVMD35?-TQFO<?OG$KQJZE^I4JY7:> ,>@H ]+@EN
MWO;J.:U2.WC*^1*)=QER,ME<?+@\=3GK5@,K$@,"1U /2O.-=FO(&\>26;S(
MZM9;WASO2(HGFLN.<B/>1CTJ34+3PYIUSX>E\*+8Q:C-?0JGV$KNGMR?WQDV
M_?4)N;<V<$ YS0!Z&65<98#)P,GO0S*HRQ 'J37 Z;X:TG7-7\92:G9179_M
M'RH_.7=Y0^S0G*9^ZQ)ZC!X'I6='"NN>&_!MU>7>DW=[_96\V&L',=SN2/,F
M><.N,9VMP[4 >H45SOA35M.G\-Z5Y$:623[XK>V:;S,E"P(1C]]<*2#_ '<'
MBNBH *165L[6!P<'!KCOB.;0:7I'V^9X;/\ M:#SI$8KA/FSDCD#U/89JJ]M
MHNG>,O#Z>%X[.&>=I/ML5CM"/:B-COD"\</Y>UCSR1ZT =%X;U>;5K*ZENO+
M62/4+NV0(,96*9T7OUPHS6B9KL:F(1:I]C\DN;CS?F$F0 FS'3&3G/;&*\S7
MP]I<_@;Q?JLUHDFH1WFJ307+#,D#1RRE?+;JF"N>,<D^M=/9RO/X^T^21LL^
M@%V]R98Z -7PIJL^M>$M,U2[$:SW-NLLFP84$^F>U;"L& *D$'H17E.D"UGT
M+P%::R4_L.6QDWI*<0RW(">4DF>"-OF$ \$CU K36'3;;7?$%CHUY'I^B_V0
MQO9+4@0VEP20KJ!PK[-Q(&/NJ30!Z&&5L[2#@X.#TH#*6*AAN'49Y%>6V9;1
MH=1L='T[2/[8?1)IK2\T9SMFV;0OF1]G+,"I);/(SUIVHVWABU\'66H^'&M3
MKCM";&YB8&ZN)RRY5S]Y\\[PV>,YZ4 >H,RJ,LP '<FL?Q1JMQHVBB\M1&9/
MM5M#\XR-LDR(WXX8XKEEM?#M]\2/$,.MBUGE$5LT-O>X,6/+.YE5OE+=,GJ!
MCIDUDW<<=SX'UVSLYI#H@URUAT^1)#\L9F@WB-O[JR&0*1TQQT% 'JX96SM8
M'!P<'I5>PFNY[-9+ZV2UN"6W1)+Y@ #$ [L#J,'IQG%<J-)T_0?B!HJZ39PV
M27EE=)<) @19=AB*%@.K#+<GGDUSUNT3>%/#$.I2;-#FU2Z2_+-A&^>;RUD/
M]POM!SP3@'K0!ZFK*R[E8$>H--,@,;.C!L \@YKB=9?PMH>BZA%I=CILGVB6
MW@N+2&810*9'VHTH7A%ZY..0,'-4O#,:6'CV\L+<:3#&^E>9-;Z4A2(.) %+
M#.-^&/. <$9[4 =?X5U.?6O"6DZI=!!<7=I'-((QA=S*"<#TK7KF_A]_R3KP
MY_V#H/\ T 5TE "%E#!2PW'H,\T%@H)8@ =2:\MT^V\,W/@F\U'Q UL-=7S3
M>W,K 7<%P"<*A^\I!P$"XXQCKS=MM,.O>)?#<?B2V6><>'FENK>9<HTV^('>
MO0X)/!X!^E 'HU%(JJB!%4*JC  & !7-?$3/_"O->VL5/V1\$=10!TH922 0
M2.O/2H+NX\K3[BXB*L8XF=3U&0":X7QAI-MHFDZ5::?:V=OIMQJ"C4GF8HDP
MV-M,[@9(9P@)/4X!X)INDV/V/5M6%K)HEM!_9C>?8:4[%=Y/R2%<!5. X]3Q
MZ4 =3H>J:AJ6DZ#>/:1,E]8I/=3+)M\IRBL J8.023WXQWK:W+NV[ANQG&>:
M\^T0D2?#H+U_L67C_MC!638Q^%IO MS=ZV]L/$?ER?;9G8"]CNN<JO\ &.>%
M4<$8P,&@#T^6:[74+:**U1[5U<S3F7!C(QM 7'S9R>XQCWJQN7<%W#<><9YK
M@-)+?;/A_MY8Z'-U/4^7;UDV=OX:F^'L^IZN]N/$*Q.UW=.P%Y%>#/RJ?OJ0
MW"J.,8P,&@#U:C-</9WD]MXOT";6I$M[JYT!DD,A"AIP\3.H[9&2<>E9*/8Z
MWHOBG&J6MO;2^(5$<MSS!,52#$;<C<CE<<'D'O0!Z:K!E#*00>A%+7)>"9;5
M)]7T^#3+&QEMID,W]G2[[:0LN05&!M; Y7'H><YKK: ,6SU::;Q5K&FR^6MM
M9V]M+&V,',GF;LG/^P,?C6U7GTUKX?O/BAK$&MBVE<V-JT%O=X,38,N3M;Y2
MPX]P"<=363=S36_ACQ+%H4O_ !(8=2@CBD21@D<!\O[2$9<D1@ELE?N_/CI0
M!ZLK*V=K X.#@USV@ZUJ>JZ'8WOV2&9YKN:&<B3RQ%&DDBAP#G<?E48XZDUS
MVA:?':^+=,>P;PY8J8)#-;Z5(Q-U%MX)4* <,5(8\]0.M5M-)'ASP?@_\S%/
M_P"A75 'I995(!8 GH">M8'B'4=0BU/2-)TV>&VFOWE+7$L7F>6D:;CA<C))
M(')XYKAY+8:AJOB1]:@\/RW$-W(N_59V26WMQ_JC'\OR+MP0RD<Y/6KYT*SN
M=9\#OJL-EJ=X]K*)KMH0QGV1*48EAD^O/<T >CJP!"%@7 Y]?KBG5YC#'INE
M^(8;TII&KBYUAD2^AE*7T,DDA&QL9WJF=I&0 J_=.*].H *165L[6!P<'!KE
M_'LC1Z#;[Y9(M/>]@34)(V*E;8M\^2.0O0,?[I-9<EKHNF^+_#T?A:.S@N)W
M<7D-B%"/:B)COD"\</Y>UCSDD#O0!WFY=P7(R>@S2UQ7@#1K!;*YU5K:-[]]
M1OE%PXW.B"YD&Q2>57C.!QDD]Z[6@!&94&68*/4G%8WBG5;G2='22R\K[5<7
M4%I$TJED1I95CW$ C.-V<9&<5A^*I+34/$UOI,VG:/-)#9FZ\_5SNB56;:0D
M?1F^7).1@$>M<O%96.K?#[1VO+>TO5@\1);0.T>Y5@-\%V)NR0A0 8S]T 4
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M*%& #@#.,9VB@#T%65L[6!P<'!I:X+PDUAI>OS:>-/T>WF-@)S>:1+B&2-6
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M07A6WOTN;1%DDM)+203;6)"L$QEE)!Y&<8.>E %Y](MGU:SU#Y@UG#)#!$N
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M-K(+B>[G4O';6L+2R%1U;"CA>1R<"@#3DC2:-HY45XV&&5AD$>A%06FG6-A
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M2=9BU7XB7@@:X18M*B$EO/&T;1OYK]4;H<8Y[C'-=C0 4444 %%%% !1110
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MI;<2:E=M+(TI=#C:SML& ?3.#QTSVNH:A:Z78RWM[,L-M$,N[9XYP.!R220
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M.'-O*K[3[X/%7Z /.K#2[ZX\2>'+U+#70EK-(UY/JEX6P6@D4;8]Y7[QP2H
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MLMP\I0GY03A5V=\9)Z<9K2\&6$^E^"=$L;J'R;BWL88Y8SCY7"#<./?-;E%
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M6RHW?(5+$KE@2?[O!I^FZCJ&A6FLZA=1:L^C6\$;6L.I,K7+398,BG))4YC
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M!/;S)I"I..Q#*?H:S['2IKZYTVVO-)\1+)!/'--]JU$&VA:,[@RD,?,&X#
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MW!D>W=49_F)X880C.%P<<5TMSILVI>';G3-2N5:6ZMY()IK:,Q#Y@1E5+-C
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!'%!# I6&)(P3DA% R?PJ2BB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *CB@A@!$,21@G)"*!D_A4E% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!''!#$[O'%&C.<
ML54 M]:DHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*9Y4?F^;Y:^9C;OQSCTS3Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUH)"0GG2!2^.N!U/X5%=:DDUA97>G:G8+!/<1*LTAWI,C-@JA##YFZ#KSV-
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MG ;D9XX93]"/6@#5HJC?:SIFFV:7E[?VUO;28"2R2@*^>1M/?/M6+XEUZ-_
MU[JVB:A')M"^7<0.' .]01]>HH ZBB@].*QK36K6VT2SNM5UC36:9"WVF)Q'
M#+@$DIECQ@9ZGI0!LT5B3^*]&&@7FKV^J64EM;AE,OG#8LF.%8YX))''N*R_
M".MV"^#(-:O_ !$ET)HXWN[BXN$V13%06C&,!<$XV]: .OHJA8ZWI>IVDMU8
MZA;7$$6?,>.0$1X&3N]./6H8O$VA3F7RM7LG$)C$A6=2$+D! 3G&22 /K0!J
MT5BKXO\ #CVTUPNN:>T,+!7<7"D G.T=>^#CUP:N)K.F2:5_:J:A:G3]N[[5
MYJ^6!G&=V<=>* +U%9,'BC0;FQN+V'5[)[:VQY\HF7;%GINYXSVSUK-TSQ?9
M^(]"L=1TK4K"!I9H!/%.XD*;S_JN&&)#T'OV- '445F:EXCT71YDAU+5;.TE
M==P2:95.WUP>@]^E3W.JZ=9V\5Q<W]M#!-_JY))557^4MP2<'Y03] 30!<HJ
MCIFL:;K,+RZ;?6]VD;;',,@;:WH<=#3[[4[#3$5[^]M[56SM,T@0' R<9] ,
MT 6Z*Q'\8^&X[2.[?7=/6"1F57,ZX)7[PZ]LC/ID5J&^M ULIN8<W1Q;_./W
MOREOE]?E!/'89H GHJ WMJLTT+7,(E@C$LJ%P#&ASAF'8':W/L?2LEO&7ATZ
M;=WT.LV$L-JNZ0K<+@9^[W[G@'O0!NT5E>'O$&G^)=(@U#3[B*5716D2.0.8
MF*ABC8Z,,\BGZGX@T?1I(X]3U.TM'D&Y5FE"DCN<'M[]* -*BJ5SJ^FV5O%/
M=:A:PPR@M'))*JJX"[B02<'@$_2FV.MZ7J=G+=V6H6T]O$2)9(Y 5C(&3N].
M.>: +]%9=EXDT34H;B:RU:SGCMEWS-',I$:XSN// P#STXJZ][:QQP2/<Q*D
M[*D+%P!(S?="^I/:@">BLYM?TA=033SJ5K]L>0QK;B4%RP )&WKP"/SIG_"2
MZ'_:G]F?VM9?;M^SR/.7?N_NXS][VZT :E%07M[:Z=9R7=Y<16]O$,O+*X55
M[<D].:XR?QQ::QX8TG5M*OXHO-U"R6Z1958PI)(-R/Z<9S0!W5%9^F:[I.LF
M4:9J-K=F''F"&4,5ST)QV/8]ZBM?$VAWVH&PM-7LI[OD>3',K,2.H&#SCOCI
M0!JT5SVD>--$UK6[[2K2_M7N+:0(@6=6,PV!R5 .2!D@^ZFG>(/%^D>&[S3[
M74+NWBDO)MF))E3RTVL?,.?X<KMSZD4 ;]%<@GBNRLO%6KKJ.KV\.GK:V<EK
MYDBA27$I8KZY"J?H*Z235-/BTW^TI+ZV6QV"3[2TJB/:>AW9QB@"W15'3-9T
MW68GETV^M[M$.US#(&VGT/I^-%[/+%J&G11W=K"DTKJ\4PR\P",<1\CD8R>#
MP#0!>HK(N?%7A^TN!!<:U812ES'L>X4$,#M(//'/'/?BL'Q=X@M(?$.C:%)K
MZ::MRTCW1CG2.4*$^1<G[H9C]3C% ':T5DWOB70M*NEL[_6+*WN, ^7-.JL
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M#?L4/R./GQ45_I"'X/:+IJV1*$:8)8!&<\S0E\C_ +Z)_'->A44 <M=6"/\
M$[2[LVP(BTFY42[.%;S(@!GL<,^/8FL5I[[1M'\2/:VH56U_EY+9I5AB<1%Y
MA&.6 )9N.^3V->AT4 <#X<DENO'T]TE]=ZC;OI6S[9+:K#&S"4':I"KNQNZG
M/4C/!K/TUS/\/O"^GI#.+O3]0T^*ZB:%U:)EE7=G([8/(XKTZB@#A[#4;/PW
MKGB$:XDL4][>>?#<&!Y%N(-BA$5E!R5P1LZ]\<UEV>C3_P!G^$XKK3Y([?\
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M\:H]F?,N[R_9@T?,HP0OU&.E6(HKA]3\#2/'*2EI+YK%3\I,"_>]#GUKM**
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M.J\COF@ TCQ!=ZG$L\VBSVMK+;_:89_.CD5EX(5MI^5B#G'(Z\\4?\)3;_\
M"*:=K_V>7R;[[+LBR-R^>Z*N>W&\9^E9&A^&;ZVUX7ATRPT:U^SR17-OI]RS
MQW4C%<-LV*J[<-SC<=V*ICPYXG?PQI?AQH].2WTV>U_TL3L3<10RHP 39\C$
M*">3R,=\@ WYO$\YUB]L;#1KB]2PDCCNI(Y8U96=58;48@L K D\=\9Q4EYX
MAN!JMQIVE:5+J,]JJFY82I$D9895,MU8CG X (R1FL7Q/X;U76+Z<V^FZ6EP
MVT6FL1W#PW-L./O *2Y!R0-P!Z$#G*:KX.8>([_5(M#TK6$O]C.E[)Y3PR*@
M3(;8V5(5>."#GKG@ UG\8VCZ787-I:7-S=W\KP06("K+YB;A(KY.%V;6W'..
M.,Y&<N'4+J\^)FE17NFRV,\6E7A*LZR(X,EO@JXZ]#D'!'I@@F=O#%[9V>BW
M>F6^F0ZCIKRNUK"K16TJR@B1 <$J>A#8.2.1SQ/::?K]YXPL]:U**RM;2"RG
MMUMH9FE<,[Q'<6V@'.P\=L#DYX .IHJGIC:BU@AU6.VCO-S;UMF9DQN.W!8
M_=QGWS5R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *@2RMDOI;U85%
MS+&L3R=V52Q4?@6;\ZGHH @O+*VU"TDM+N%9H)!AXVZ'G-3T44 %%%% $!LK
M8WZWQA4W2Q&%9>X0D$K],@'\*GHHH **** "BBB@!DL23PO%(NZ-U*L/4'@U
M7T[3++2+,6FGVL=O "6V1C )/))]2?6K=% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445
MD^(]8?0])%ZD*RDW-O!M8XXDE2,G\-V?PH UJ*R?$NL/H/A^YU)(5F:$H C-
M@'<ZKU_X%6JSJ@RS!1ZDXH 6BBB@ HI&957<S *.Y/%+D4 %%%('5B0K D<$
M ]* %HI-RA@NX9/09ZTM !12,RH,LP4>I.*6@ HHI%=6SM8'!P<'I0 M%('4
ML5# D=0#TH9U7&Y@,G R>IH 6BJ=]J=MISVB7+E6NYQ;Q8&<N59@#Z<*:N4
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M; RR[_-3 .XC VG)(QST]Z +-%(KJ^=K X.#@]*"Z@@%@"> ">M "T44C.J
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MAMET^[TV==7MK3 A )01$A> YS(/4C/H*@T6:YUC4])\-WC,\OAV1I=08_\
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M6WDG$<?EJ^ 03CS" >"1Z@5UG@JT-IJ.LK!<:6+3=$/L6FNS16\N#O(R %W
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M: (?%>OVFH_#O5KZPN73R<)+N#120N'7<K@X*D ]^Q]#6M;^+],N+RWMRMY
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MNSR-IT!9F.23L')-9&C-JWAW1'\/_P!@7-Y/"TJV]PC)]GG5G9E9V+97[WS
M@G.<9S6[X.LKG3O!6B65Y$8;FWL88Y8R0=K! "./>@#;HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBL3Q5XBA\,Z.+R3R?,EF2WA$\HBCWL>"
M[G[J@9)/H* -NBN-T/QHM[XAAT>?4=$U![F%Y8IM*N-X0IC*.N21P<AL\X/
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MYU:X7=';SVIV[@NYC!&JC)X&20,GIUI=-\=!]:TZQNM3\/7PU"0Q*NEW?F/
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MV^U/P[=Z=J.K++/<S))YL=L$CB"LK!%3.<?+U+$Y)^E:%]I'VW7-*U+S]GV
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MPR)-)8J?.C5N5;8'"GT)!!^A%&CW_P#:NB6&H^7Y7VNVCG\O=G;N4-C/?&:
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MY6!W Y)Y![UDW>D3ZOXHTE9M+:#3-$9IHIYI$8SR;=J! &+!1DDEL'*KUZT
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MC<R+L>>>9YY2O]W?(6;'MG%06_@WP_:W<=S#IRJT3^9%&97,43_WDB)V*?<
M4 9 L)]<\;:_:W6J:E%96T-L88+6Z>':[JV6RA![#C..N0>*P[5M1C\":9XJ
MEUG4)M5^T6_F9N&$,D;3K$4,(.SE3UQG/.:](BL;:"]N+R.(+<7(03."<N%!
M"_EDU7&AZ:-(CTH6B?88RI6')P"K!QWSPP!H YI+1];\<Z_9W6KWZ6MK';&.
MSMKMX,%D.7RA#8XZ @9SG/&*L6L/::3K>F7=YJ5XMMJB:?9SVT@%S,76-Q'O
M.!N!9E+$@X'7/-:/_")P:AXLUN^U*T?RIEMQ:W$4[1/@(0X#(P8#.,CH>.M;
M)\-:,=%&C_V?$+ $,(ERN&SNW!@<[L\[LYSSF@#C]/NM1T[5M;TUA>VT0T<W
M<<-SJ!NY(WRZ[@Y)9<XZ9(RN138(;W3O#_A773J^HSW]W/91W7FW+M%*DVU6
M7RR=@QNR" #QR3S786?AC1[%IG@L_P!Y/$8999)7D>1#U#,Q);\35IM(L'L;
M6R:V4V]HT;01Y.$,9!0CZ8% '':EK&HZ.=?T-;F1]0NI4;2))&);%P=F ?2-
M]Y]EVUW-K!]FM(8/,DE\I%3S)&W,V!C)/<GUKFSIESK'CBUU2]TPVMKI$4T=
MJ\K(SSR2$ N-I.$"KQG!R_08KJ: .(LK%M>\6>*(+S6-1$%I=0I#:6UY)!Y0
M:WC;=E"&P23@9QD,<9-9XUG5&T>/2SJ4NT^(#I!U/CS3  6SNQC?D>5NQUYZ
MUKV_A"WO?$/B&]U.S=1<W<;6T\5PT3O&((E(W1L&V[E/RGTZ5T!T+2CHO]C_
M -GV_P#9VW;]FV#9C.>GKGG/7//6@#GVAD\.>+M$L[*_OI[;4O.CGMKNZ>XV
M[(RXE5G)9>0%(S@[QQFLC1KJXMO#7A-8)I(UGUZ>*4(V-Z;KD[3ZC(!Q["NR
MTSPWI6D7+W-G;,+ATV&::9YI-O7:&<DA?8'%2QZ'IL4%I EH@BM)S<0+D_)(
M=V6'/^VWYT <UIEG)XIN=:NK[5=2@DMK^:T@AM+MX%MUC.%8JI 9F^_\^X88
M#&*CU76M1TB]\836\LMRVGZ+;SV\<ARHDQ/EL#CG:I.,9Q6_J'A/1-4O)+NZ
MLB9I5"S-',\0F X D", XQQ\V>*OPZ78V]S+<0VT:231)"Y X*)NVKCI@;F_
M.@#A;&#78)])N[2#63))/%]JGO=4BEAN(F^^1&)"JG!++L4= .E3#[;I7B%;
MG6I-7V3ZD8[>^M;[?:E7?;%#) 3A.JH2$/(SN&:Z.S\(:#I]W%<VU@%>$EH5
M:5VCA)[QH253J?N@4L?A'0HM1%\E@%F$QG"^:_E"0\[Q'G8&R<YQG/- &T"#
MG!SCK7)_$%)9=)TJ.";R9FUBR"2[0VP^:,'!ZX]*Z*RTRRTZ2[>TMUB:[F-Q
M.03\\A !8_@!3[RPM;](ENH1*L,R3Q@D_*Z'*M^!H Y[4#K_ (?T#5]4FU8:
MF]M8RRPP?9%C^=5W Y4Y/3I[UD:M:S:#X3C\1V>NZC=:A&(92TMV[PWA=E!3
MRB=BAMV%V@$9'-=^0""",@]0:P[;P;H%G=Q7,&GA6A?S(8S*[11-_>2,G8I]
MP!0!EVMK/JGC[6UN=2OA:6!M7@M8;AXTWE,DMM(W#@?*>#DY!KK;@2&VE$,B
MQRE#L=AD*<<$U'#8VT%Y<W<406>YV^<X)R^T87\A4LL4<T3Q2HLD;J5=&&0P
M/!!'<4 </X9-SIFKVEEJYUF+4KBV<;YK[[5:WCJ 6=,DE".H 5!@]#BJXUF[
M7X.:3J#7\HO95LE:<R'>S--&K#/4DC<#^-=7IGA;1M(NEN;*T*2JACC+S/((
ME.,J@9B$' X7'2H#X)\.F5W.FJ0TGG",RN8T?=NW*F[:ASW4#OZT 9PAD\1>
M,-:LKR_OH+731 D%M:73V^[>F\RLR$,W.5 SCY#QFJFH:.UQX[T&P?4[XQ1Z
M3=>;,LQ2:91) ,&1,$<X.5P3CKR:Z;4_#>E:Q<)<WELQN$38)H9GADV]=I9"
M"5]B<5-:Z)IMC):R6MG'"UK UO#LXV1L5+*/J54_A0!D>$GGBN=>TN6ZGN8M
M/U 16\EQ(9)!&T,<FTL>6P7(!.3C%,\<3W$5II$=OJ4NGFXU6"!YXV .UMV1
MSQSP.<C.*Z&WL;:UGNIX(@DMU()9V!/SL%" G_@*J/PK%\7:/)K<&E6XM4N8
M(]1BEN(WQM\H!@V0>O7I0!0GMY/#?BC0H;&_OYX=2FD@N+6[NGN,A8F?S5+D
ME<%0#@X^;ITJD=7NH_A9XEOI+Z5;NW;4TCF,AWQE991& >H(PH'X5U&F^&M)
MTF[:[M+5OM)3R_.FF>9U3KM4N257IP,#BJ]WX,\/WUQ=37.G+(;HDSQF5Q'(
MQ&"QC!V[O]K&?>@#&GM[G6/&L%A-J=_#8C1HYWAMKEXC)(9& )92&''7!&>,
M\#%)I6GMK^M>)5O=:U(QVNH^5!;6U[)#Y \J,YRA!.23@'*\'C)-=='IUI%>
MB\2%1<" 6XDR<^6#D+^9KF+#P;:W6I:]<ZK9.KW.HM)#+%<-&TD)BB&"8V!*
M[E;Y6]^.: ,BVUC4[^STG2)=2F2*?5[JPDU*,A))XH0Y4!AP&;:%+#^ZV,$U
ML1QSZ#XRL])LK^[GM;^RGE>&[N'N#;O&4VR!G);:=Y!!.,@8QS6_-H&DSZ.F
MDR6$'V", 1P*NU4QR"N.A!Y!'-1Z=X<TG2S.UM:9>X79-)/(TSR+_=+.22O)
MXSCF@#E/#SWFD:E9V^L?VQ_:D]O(!(U]]IM+^15W,4!)\LX!( 5!CCG%8^GW
M'B34_#-MKUK;ZN^K7"+<).VIQK:$DY\LPF3:$_AY7=[YKO\ 3?"FBZ3=I<V5
MF4EC4I%NE=UB4]1&K$A!QT4"HSX.T!KTW1T]=QE\XQ^8_DF3.=YBSLW9YSMS
MGF@#G?$/VW3M7U#5=3DU<Z5$T;PW6F7VU;) J[Q)!D!_FW,3A^&' Q7?]:Q+
MSPCH5_?27EQ8!I965I0)75)B,8+H"%<\#[P/2MN@#SO2='@M=2\<RI<W[M#-
ML"RWDCJP-G$<L"V&//!/(  [57TZRN-%\(^$-6AU34'NI9-/@F1[ES"\4I1"
MGE9V# ;@@ _*,D\UW+^']+?4Y]1-J!=3Q^7,ZNP$BXV_,H."<<9(SBIFTBP:
MPM;$VRFVM&B:"/)PAC(*8^A4?E0!P\L^IZYXBUR.2TUJ:*QN1;6Z:?J*VJQ#
MRU;>P\Q2[,6)^8%<8 '6NO\ #,FI2>'+)M8V_;]F)65E;=@D!LK\N2,$XXR:
M;J7A?1]6NS=7=HQG*"-Y(IGB,BCHK[&&X=>#D5IVUM!9VT5M;0I#!$H2..-0
MJJHZ  =!0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9'B/6O
M["TDW,<!N;J65+>UMPVWS9G8*JY[#)R3V -:]<]XQTV\O])MY].C$U[I]Y%?
M0P%MOG%#RF3T)4L ?7% $!TOQ@(/M*^([1KS&[[*UB!;$_W<Y\P#MNS[X[5K
MZCKNF:-'$=5U"UM&E^Z)) -Q'7:#R<5D'Q_HI@^1;Y[[&!IXLY!<;O[NPC@Y
M[YV]\XYJD;V'0_&VHZGK4,T,-[:VZVERT1=8@H;?"67(4[CN]&SP3B@#J?[7
MTTZ?%?B_MC9RE1'<"5?+8L<* V<')./K5%?&'AQ[:6Y77+!H8G".XG4X8YP.
MO?!QZX-<3=::]_H&J2+I\R:7J/B*SFM[62$J3%YL D<H1E59E=L$#@Y/6NGF
ML$;XH65X;;(CT>9!+LX5O-CP,^N"WX$T ;::SIDFG1:@FH6K64S*L=P)5V.6
M.T -G&2>/K46G>(M%U>X>WT[5;.ZF0;FCAF5CM]<#J/?I7G^L6ZV_AC5XKBP
MDFMCXJB86P3_ %J-/$2%!Z[B6]B2:V]1U"T\1Z[X>CT6.:2XLKSSYI_L[QBV
MA",'1BP&"V0NSKWQQ0!T<OB;0X=3&FRZO9)>EPGD&9=VX]%(SP3Z=:DU#7](
MTEV34-2M;9PJL4EE"MAL@''7G:W_ 'R?2O-/$^I:AJ7A_P 06LMS=07PEF6/
M2+33@255SMD9V4ELJH?<I'7 YKM(K(-\4;J]: G9HT,<<Q7@$S2E@#Z\+^E
M&Y#JVG7"6CPWUM(MYDVQ24$38&3M_O8 )X]*F%U;M>-9B>,W*QB5H@PW!"2
MQ'7!((S[&N!CTFY;PKJTEI R7FFZW=7]@A7;DK*S;1[.I=?3YZW/!;?VG!?>
M)F1E.L2B2 .,%;9!MB&/<;G_ .VAH ZBL>+Q7X>GN$@BUO3WE>/S%5;A3E=N
M[/7^[S].>E;%>7VVB(?A!X8L6T\Y^U6#RPF(Y&Z=/,)'T+9]B: /0-,UW2=:
M\W^S-1MKORB/,$,@8KGIG'8]CWJ*U\3:'?:@;"UU>RFN\D>5',K,2.H'/)'?
M'2LR[BFB^(D-W!;,_P#Q))U) P'998RBD],\MCZFN/6_O-63PV\EY=2W::C;
M2W.GP:;Y,5CSA@Q*[AC)7[W.2<8S0!Z<NI6+V$E\MY UI&'+SB0;%"$ALGH,
M$'/I@U8C=)8UDC8,C ,K Y!![UYUJUE-'XCN/",<;'3]>N5ORP'RQQ+S=(?3
M<53\9S7>0ZC;3ZG<Z=$Q,]K'&\HV_*H?=M&?7Y2<?3UH MU3_M?3C:6]W]OM
MOLURZQP2^:-LK,<*%/0DGH!5RO+&\.7FJZAJ/A9H98;+2WN;RRN"I">9.-T!
M4]_++S?3:M 'H&KZE';65['!J-C:7L-OY^ZZ.4B4D@.ZY!VY!YR.AJA)XTT:
MW\4IX>GO[5+LQ!B3,H_>%@HCVYSN.<@>E<?*M]KGP[\7:]<V$\-[J=J88[9H
MSO5(H]NW'7_6&4C_ 'A73WUPFG_$>QN+E95@N=-:UBD6)F4R^:I"D@'!QSSC
MH?2@"'0O%VGQ"]M]8UFUCNO[4NH84GE56"+,RH,>G&!GKBNQKS^UTI?^$$\:
M1M9'S;NZU-RIC^:7YG"G'?@#%=II&\Z-8^;N\S[/'NW=<[1G- $UU=6]C:R7
M-W/%!;QC<\LKA54>I)X%5=,UW2M:$G]F:C;79CQO$4@8KGID=1FL;QI!(RZ+
M>/;2W5A9:@L]Y#$A=BFQPK[1RP5V1L 'IGM55+NW\0>.M)O]'21X;.WG6\O/
M*9$97 V19(&X[ANP,XV]LT =%9Z_I&HWAM++4K6YN!'YICAE#D)D#)QVY'YU
M?DD2&)Y9'5(T4LS,<  =2:YGX>60L/ ^GQ?9S [>8\BE=I+%V))]ZZ=E#*58
M @C!![T 5CJ=BJ6CF\MPMX0+8F08F)&X!/[V0">.U5=4U)([>XCM=2L;>Z@>
M$2&Y.Y8P[@ , 006&0O/4BO.8=#U.[MKS3Q;3*_A2)ETMW4@32B7S(BI[XBC
MC0_]=&%:$MO<ZAX#U'6&M)TNM7U6WNO)=#YB1+<1)&".HQ&@)],F@#J8/&FB
MW'BJY\/K?6PNX53'[]<O(S.#&!G.Y=G(_P!H5G^$_%VGSZ18V^IZS:G5)I)$
M\N250['S7"C'J0!@=ZF2X2P^)=]]I65%O]/M8[9Q$Q5V1Y]R[@, @.IY]:YY
M=+:+X)W\$=DZW+>?-L$9WF3SV96QUSP,?04 =[J>MZ7HJQMJ6H6UIYA(C$T@
M4OCK@=33UU73GT]-02^MFLI"H2X64&-BQ"C#9QR2!]:YF>Z@T'QYJ.I:PDBV
MUW:01V=YY3.D80OOB) .PDD-S][\*Q;BRNKGPSXGO[*PN$L;G4[>]M+7RBLC
MI&T+2R+&1D;RCL!C)ZXYH ]#NM0L[)@MU=0P%D>0"1PN5098\]@#DGM65X:\
M7:3XHCG-A=0/+#+*C1),KMM20H'P/X6QD>Q%8[:O;ZYX\\/S:<D\UK!;W?F7
M/DNL89@F%RP'/!SZ<5;\$7"10ZEI<JRQWD.I7DKQO$R_(]P[(P)&""K C!H
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MM706R88$,648SP-OMD]*BU>QNY]!^(L<5M,\DUSNB14),@%K!]T=^A''<8H
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M+:[\L@2"&0,4STR.HJ"/Q5X?ENH[:/6K!YI%WHBW"G(QN]?3GZ<UAQ7<&O\
MCS3-1T=)'M[2UG2\O/*9$</MV1 D#>006XSMQ[UA1:*A^#6D6+:>2S75H\L)
MB.[+72;R1U^Z6S[9H [_ $S7M)UHRC3-2M;LQ8\P0RABN>A..Q['O5?_ (2[
MPYY\, US3S)-M\M1<+\V[[O?OV]:IW-NR_$G3;A(F"'2;F.20+QQ+"5!/XM@
M?6N.\-ZQHD?PI@T>339VN;BS9/L*VKLUT[ X92!A@Q(.[/R]\8X /43=0"[6
MT,T8N6C,@BW#<4! +8],D#/O6-XA\7Z3X=TJZOKB[@<V\@A:(3*&,F =G/\
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MX/@EK5O':.EQ-:Z@S1B,[W=FEQQU)(QCVQ6MJFDP?VQX'CCL@8;2XD  CXB
MMGVY]/F"_B!0!T=CK.F:E8O>V5_;SVL9(>5) 50CDACVQ[U7LO$^@ZB)S9ZO
M93B",RR^7,IVH.K'_9]^E<Y>M?:9JGC>\L-/-S*UI;211-&669]CJW ^]P!D
M#DX JCIUQ)?^-_#]Q%JEWJD4<5PDLWV$00Q%D!"@[0<G;]TDXP,\XH VK3QM
MIVO:+J4VDZMIUO=6KRKON)!(B*DA02, P.QL9!SW%;NIZYI>BK&=3U"VM?,R
M$$L@4OCK@=37 7+,W@'Q=HXAG_M!+J]E\GR7R4>X9D(.,,"&!&*W);N#0/'>
MIZCK"2);WEK EG>>4SH@3=OB) .PEB&YQNS[4 =.-6TYM.34%OK8V4FT)<"5
M3&VXA1ALXY) ^IJ+3O$&CZO/+#IVIVEW+$,ND,H8@>O';WZ5P%]ITE_X2\1R
M1V$R:;J6L6LMM:O$59H_,@$C[",J&97;! XY[UU6IVS+X\\.3Q0D*MM=Q.Z+
MP%Q&0I/ID<#VH Z:HYYX;6WEN+B5(H8D+R2.<*B@9))[ "H--U*VU:S^U6C,
MT/F/&&*D;BC%21[94X/>J'B^-Y?!6O1QHSR/IUPJJHR6)C;  H </%?A]I;B
M,:U8;[=2\H^T+\B@X)//8D ^A-7--U;3M8MVN-.O8+J)6*,T3AMK#L?0^QKE
M=0TB'/@.%+(&*UNU^41\1 6LA&?3Y@GX@5!K&EZA>:EXYM]-1XY[W2;=87'R
MAY=LZG#=,X"C/;B@#J;+Q+H>HWS65EJUE<7(S^ZBF5F..N,'G'?'2E'B+16U
M4Z6-5LS?AMOV?SEW[L9VX]<<XZUP]CY.JW&AV2ZK>L]G<13)9II'DM:^6.5=
ML (N,H>>=W&<U)#=C3M<BLM)FGNDFU5GFTJ]T]M\&^0F29),#"C+."VX$' (
MXH [0>(M%.J_V6-5L_M^[;]G\Y=^[&=N/7'..M-G\3:';:D-.GU>RCO"P3R6
MF4,&/0$9X)[#O7&QW8T[74L])FGN5FU8O/I-[I[;H2\A,DT<F!A1DN"VX$<
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MIZ$C(QFJLOC.<OJOV'0;N[BTJ9XKJ02HF=JACL!/S'!SCCMSF@#K**YVZ\5
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MU5@IW/G ZCD9Z@4^7Q+=37]U::3HTVH-9$)=2"=(T20J&\M2WWF (ST R.:
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M^AR#Q6A)XDGMKI-+T_29M0N(+**YG5)DCPC;@H4,?F8[&]!TYYH Z>BL*_\
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MDCUK TCPA+#XD&HMHVDZ39/ITUG);6)R[%WC.YF"*#PK#V]3DX[B@$$9'(H
MY31+7Q/HUE8:+]FTZ>TM D"WYN&5F@7 &8MGW]HQ][&>?:F66G^(_#R76GZ7
M:Z?>64EQ+/;33W+1-!YCEV5U"'< S-@@C(P..M==10!RJ:?KNAZIJ<^E6ME?
MVNHS"Y:.:Y:!H9MBHW(1MR'8#V(.>M00>$KV&UTHR7$$MW'K+:I>L,JA+K("
ML8Y.!O4#/4#-=CD9QGD44 <[JNF:G!XCAU[2([>YE-K]DN+6XE,6] VY65PK
M88$MP1@@]1BLW^P/$=]-XENKFZM;&YU/3XK6T-K(S&V*>;U; )YD!W #J>.
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MEV1J5;&_<-RDDD@X/ JS=^);Z_UW5;>&^U.PM]/G^S1BRT=[OS7"*S,[>6P
MRV HP<#.>174/X<LGT33=)+3?9]/>W>$[AN)@963)QSRHS_2H;SPQ'/J,]]9
M:IJ&F370 N?L;IMFP, D.K -@ ;EP< <\"@#!;7?$6H0^%H(\:7=ZD9TO/-M
MCN3RU)W*C\C.W(#=-PSG&#VUM%)#:Q133O<2(@5IG4 N>Y(4 #/L,5070+19
M]*E#W!;3%=8"\I<MN3:=Y;)8X]ZU* .$DOO$=\_BFXM]72TATBY=+6-;9'\P
MK"DA$A(SMRV/EP>3STIUOJFO6\/AS6+K45FAU>:*.>Q$"*D(E0LOEL!NRI !
MW$YYX%=-%H5I#%JT:M+MU25I9\L."T:QG;QP,*/7FFOX?LWT_2K(M-Y6F212
M0'<,DQKM7=QSQUZ4 <E/XFU#4=5U5(+_ %.PBLKEK6!+31I+I9&0#<TCB-@0
M23\JE2 .O/$]YKNOSZ;HMW/%J&DVT]L[WTEI8>?+#,"H"F-E9E0_.<[2>!R*
MW+OPK'+?W-W9:KJ.F-=D-<I9N@65@ -V&5MK8 &Y<'@5+=^'?.2T%GJ^J6#6
MT7DJT$X?>G'WA*KACQ][&[WH Y_4-:U0VFD7$.JSMI4MJSS:II>GB<M*"-N8
MR'*)C<3@'D8RM6;_ %POINCI!XB=I[J$R;]+T_SY+D #+JI#B-03SN!Y(&15
M]?",5M:6D&FZMJFGBVC:/=!,K>8&;<Q99%92Q))W  \]<4T>#+.W2P.FWU]I
MTUE UND\#HS/&Q#,'\Q6!RPSG&<T 8=MXLU>;0(H%91J4VL'2H[FXM]FT8+^
M8\>?O; 1MX!;';BM&637M&\3:#9RZR+^QOYI8YO/@C24%87< % !MROID8ZG
M/"ZAX;TO2/#5U;&RU/4(9KP7<A@<O<1RDC,JD$-D$;N,GDX!'%96FV"ZIXPT
M:^M)-;O(M.\Z2:\U2)X0H:,H(T5D3));)(7^$9/04 0?\)7JVIQW]_:7FI6[
M13S16EI#HDL\,@C=D'F2",DEBISL8;<XY(-7=7U[61):W5Q+?Z'ITFGQ3B6+
M3_M(CG;)=)_E)15&WLN<M\PQ6U/X0A>>Z-IJNIV%M=R&2XM;655C=F^\02I9
M">^QEYYZ\U/J7AO[?,7BUG5;)7A$$L=O,I5U&>TBMM/)^9<$^M &M:2B>S@F
M$T<XDC5A+$/D?(SN7D\'J.37*:OX@U&T7QJ895']E:>D]KE =KF)V)/KRHZU
MU5E9P:?86]E:IY=O;Q+%$F<[548 _(5G7?AJQO1K0E>8?VQ;BWN=K#A0C)\O
M'!PQZYH Q?MFO:7>>'[J]U1;J+5+@6UQ:"!$2%FB=P8V W<%,?,3D'M76W,<
MDMM)'#,8)&4A954,4/K@\'\:J7>C6UZ-.$K2#^SYUN(=I RRHR#/'(PQK0H
M\CCMK^#X.W4AOS<EKL"&*6-55&%]URH!.3R?3M7913ZQI'BO3+"]U4ZC;:C#
M,2'@2,PR1A6RFT#Y2"1ALD8'-3IX-LDTV[TW[9?-87$XG6W9UVP,)?-(0[<X
M+>I/'3%:USI=O=:K8ZC(9!-9"01 'Y3O !S^5 'GD7C#6=1TB36[.?4_/;?)
M:Z9'HDLD$B G:C2B,DLP'W@P )Z$#GTR"0S6\<I1HRZABCC!7(Z'WKGSX-@1
MI8K;5=4M-/ED,KV%O,JQ$L<MM;;O0$DDA6 Y-=)0!R<-QK/B+5=7%GJQTRST
MZY^R1K% DCRR!%9F<N#\OS@ #!XSGFC[3K6K>(+G1X=4%BFFVT#7-Q;VZEYY
M9 3\H?<$0!?<\XSQS>O/"T<VHW%_9:IJ&F370'VG[&Z;9B!@,0Z, V !N7!P
M!Z47/A6&2XAN[/4=0L+V.!;=KF"57>:->@D\Q6#D$DY(SR>>: ,.X\2ZM9:/
MJ]O/-$^HZ7J5K:FY2,!9HY7B()7H&V2$''<9&*WM1U*YM_%NAZ?&ZBWNXKEI
M5*C)*!-O/;[QI%\(Z6- N](?SY8[QS+<3O*3-)(2#YA;^\"JXQP-HP,"F6?A
M2&WUBUU:ZU/4;^^MHWBBDN73 1L9&U%4=ASC)[DX% &)H]]XJU#PE=ZXEXES
M>&.X2TL%@14+*[*K,>I;Y>F0.<>]-A\5R:7HVMWTVJ7.H36-I]H^PWUA]EN$
M;GKA5!0G R <<_,:Z>W\/VMIX>;189KJ.W._$B2E)5+,6)#+C')__75>U\*6
MJ2W4VHWEWJTMS;&T=KTIQ">2@"*HP<\G&3ZT <]9Z[K4-_II^TZKJ)N)TBN[
M>70Y;>*)6X+QN8P5"G!.]FR,]Z[JYG6UM9KAP2L2,Y ZD 9K%L/"XL;FV=M:
MU>Y@M3F"VFG78G&!DJH9\ _QLU;Y (P1D4 <&M[XFD\'?\):-6B#FT^WC3?(
M3R/*V[_++XW[MO&[=C/;'% 2[U#XEZ3?PZG-%!/H\EPL)A0[8_,@S'G&><Y)
MZCM6F? ME]F.GC4M2&C$\Z6)5\G;G.S.WS-G^SNQCCIQ6V=)MCK<.JC>)X;9
M[5%!&S8S*QXQUR@_6@"Q=W$=K9SW$LR0QQ1L[RR?=0 9+'V'6N%TSQ%J">(-
M%A.H:AJ%GJ4CQ.]UIGV:,$1/(K1':IQ\F,-NR#G/%=Q?V-OJ>G7-A=IYEM<Q
M-#*F<;E88(S]#6);>$(8[[3KRZU;4[Z73G+6OVB1,("C(00J+NX;J<G@<]<@
M&']O\37NF>(M3AUA+8:7=W26L"VR,LJQ$D"0D9P?N_*0>,Y.:[;3KO[?I=I>
M;-GVB%)=N<XW*#C]:IPZ!9P:=J5BK2^5J$DTLQ+#(,N=V...O%7K.UCL;&WM
M(BQC@C6)"QR<*,#/Y4 <[?ZW?0:OXEMHY%$=CI$5U -@.V1O/R3Z_P"K7CVK
M.AU'Q#967AS5[S5$N%U*:WAN;(6Z+&@E7@HP&[()&<D@\\"NFGT"SN+S4KIV
ME\S4;1+.;## 1?,QMXX/[QO7M1-H%I/I^FV3M+Y6GRPRPD,,DQ?=SQSTYH Y
MZY\3:CI^G^(+.4I+K%K=+!8#: )1.1]G) ZX)*G_ *YL:K7OB'4)?$%[I(U'
M4K6/3$AC>:QTEKIKB5HPY9B(W55PP^4 '.>0,5TUYX:T^^\1V.N3"3[79J50
M!L(W! +#N5W/CTW&F:AX:CN]2?4;34;[3+N5!'-)9LF)E&=NY75ER,G#  ^]
M '/2:YXCN/#VFW#V]]:9N98KZXMM/+3"-=P21(7!(#X4GY6(SC'>J6L/=ZQ8
M>%KFV\2?: =76+SHK1$.X"7!96&0Z@;2.!G/ KKYO#BM8V=O;:MJEK):[BEQ
M'<;W?=][?Y@97S[@X[8JNW@ZQ.D1V*W5ZLJ7?VX7@D7SO/R27)*[<G)&-N,<
M8H HWWB2[T2\\1?:&-W!I.CP7BKM"M)(?.W$D#C/EK["JFM/XJT7PO)K/]OP
MSW(6-IK=K5!"H9@"(R!NXSQN+9]LY'1/HEM;OJ%\T<]_/<V,=K-%(4/GK&'P
M,8 W-YC YP.1TK@;W3+;5])BT334\3O(TD2QV>H12I!9*'!+,[* P50< N_.
M,>H .J\0ZI,-7-E9:S?0S1PJ[6VGZ:+EE))PTC%6 !QPORG@G/IS]S=:IXDA
M\!ZI_:+64US<L&2*!"JR"WGW.-P)YP1@Y SZ\UV%YX8CN=5GU"WU/4+&2Z14
MNDM70+.%R!G<I*G!QE2IQ41\'6"Z)INEVUQ>6JZ9+YMI/"Z^9&V&'5E((VNP
MP0>#0!FZEXHO]'?Q.6V7/]FPV@ME<!09)05RQ';=@GT&:DU";7O#,=EJ-WK/
M]I0274-O=6[VR1A?-<1AHBHW##,#ABV1GG-;#>&M/F;4S<K)<KJ<,<-RDI&&
M5%*CH!@G)Y]>F*JP>$8EN;62]U;4]1BLW$EM;W<B%(W'W6.U07([%RV.O7F@
M#/CE\0ZUX@\1VEMK(L+;3[B.*V,=LCLS-!&Y#[@<J"W;!Y// K;\+:K+KGA;
M3-4G14FNK=))%3[H8CG'MG-6;+2K>QOM1NXC(9-0F6:8,<@,L:QC'' P@_'-
M&CZ5;Z)H]KIEJ9#!;1B-#(06('J0!0!>HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "J>IZG;:18M>7;%80Z1DJN3EW"+Q]6%7*X[XF6%A=^$))K
MZUMYOL]Q;LKS1AO+4SQAR">@VYS[4 =@655+,0 .22:K037<E[=1RVR1VR;/
M(F67<9<CYLKCY<'CJ<UQESH6AZAXYT:Q2SM)-*BTFZ=+6-5,#$31#E1\I +$
MXZ9YZBJFM&ZMCXZ_L[S8W1+(?Z./G2+8!)LQT(3=C'IQ0!Z.'5B0K D'!P>E
M#.JXW,!DX&3U->7Z[!X*AA\/MH!T]+I]4LO+_L]EW2IYR9,FWEE[Y;^+'<UH
MB/0+KQ?X@7Q:+%[F.1/L2:CMV+:^6OS1!^/O^9N(YR!GM0!Z!2*ZN,JP89QD
M'->0K+L\ WW]F3,=+;Q"R3RW$C@?92XSN<?,$/R@GKM)SWK>T*PCM?%<1L7\
M/V:&RD-Q9Z2Y/G)E=CLH4*"IX#=2&(H ] W+NV[ANQG&><4*ZL2%8$@X.#TK
MRG3]+73/@E!J6DVX75)]/@,]XH/G&(LGF#>/FPL>[ '0 8Z5?TC3[>#Q'HDN
MF2>&K$G>632Y69[N#8<A@  P!*MN;H1UYY /1F=5.W<-Q&0,\FLGPIJEQK7A
M+2=4N@@N+NUCFD$8PNYADX'I7&Z-;^&KG0[^^\1FU_MQ+F<7L\S 7,#AVV",
M_>4!=NP+U&,=:Z7X>X_X5WX>QG'V"'&?]T4 6_#^KS:DNI&Z,2FWU&:UCV\9
M5#@9YY-;5>::%9>$;R]\3_VVMA-<QZI<%UORI\J//!3=]T=<L.X//'"6$EQ9
M>&-!\4RR3-'IUQ-$TLQ.^339)2JLQ/)VJ(I,GLI]: /3*K0RW;7]S'+;)':H
M$,,PEW&0D'=E<?+CCN<Y[5A^#8VN+&[UV8$3:Q.;I=W58,!81_W[53]6-8&O
M?>^)'_8'C_\ 1,U 'H892Q4,"PZC/(H+JI + %N@)ZUP%QHFGZ))X0OM/MHX
M;V2]C@GN5'[RX1X9"PD;J^2 ><\@4S3K;P[?7_B*;Q2MC)J4-]*K&^*[H+8'
M]R8]WW%*8;*X^;/.: .AT'6=3U30[.\%K#-)+>S0SXD\L1Q)+(@<#!W'"+QQ
MG)Z5T+.JD!F +' R>M>6Z(8SX-\&F!Y7B/B&78\N=[+YES@MGG/KFM"RM?#V
MH:IXD?Q6MC+?PWDBXORN8+7 \HQ[ONJ5YW+CYL\Y% 'H+.J8W,%R<#)QDU5N
M]3MK*\L;6=B);V5HH0!G+!&<Y]/E4UPNLR:3JVM7=L;+0&AL+*'-YJ[&4M&Z
ME@8U_NXZONR3QVK*AL]*U+1?AWJ&NVMG<&1C;SW%[&K%E%O,55V;MN .#W]Z
M /4H);M[ZZCFMDCMDV>1,)=QER/FRN/EP>.IS4X=6)"L"5Z@'I7G&L27-O\
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M/[-N2[!'VXW^/ND_?W^9P5Z8XQB@#UFDW+NV[ANQG&><5 AF;3E-P )S"/,
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M<P"RG@8&YG8R+O$A^\X*[M^[ISGI0!Z517G6N37.@ZEJ^A6;%'\1E9-.8?\
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MD":=*Q2V4SQ*T:,<$ -N(QP,X'2O2K#3;'2K46NGV<%I;@DB*",(N3U.!WH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCW+U%4?[;TK_ *"=E_X$+_C1_;>E?]!.R_\  A?\:.278.>/<O451_MO2O\
MH)V7_@0O^-']MZ5_T$[+_P "%_QHY)=@YX]R]15'^V]*_P"@G9?^!"_XT?VW
MI7_03LO_  (7_&CDEV#GCW+U%4?[;TK_ *"=E_X$+_C1_;>E?]!.R_\  A?\
M:.278.>/<O451_MO2O\ H)V7_@0O^-']MZ5_T$[+_P "%_QHY)=@YX]R]15'
M^V]*_P"@G9?^!"_XT?VWI7_03LO_  (7_&CDEV#GCW+U%4?[;TK_ *"=E_X$
M+_C1_;>E?]!.R_\  A?\:.278.>/<O451_MO2O\ H)V7_@0O^-']MZ5_T$[+
M_P "%_QHY)=@YX]R]15'^V]*_P"@G9?^!"_XT?VWI7_03LO_  (7_&CDEV#G
MCW+U%4?[;TK_ *"=E_X$+_C1_;>E?]!.R_\  A?\:.278.>/<O451_MO2O\
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MCW+U%4?[;TK_ *"=E_X$+_C1_;>E?]!.R_\  A?\:.278.>/<O451_MO2O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^9K6P4H?"[ZVVM]WD<;16YJ_AB?3+&'4(;NVO[&5_*$]LQ(5_P"Z01D&M ^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>S>Z+F,1K*#N<=5!Z%AZ#FN7NDF\3:_J-[H FAC_ +$GLC>O$T2RSN08@NX
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M(])D^Y> _P# &_PJ7^V=/_Y^!_WR?\*\LBE,; BMNUN!(HYIJ0K'<_VSI_\
MS\#_ +Y/^%']LZ?_ ,_ _P"^3_A7'T4[A8Z_^V=/_P"?@?\ ?+?X4?VSI_\
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MA_WR?\*/[1M/^>P_[Y-<\*<!1S,.5&__ &A:_P#/4?D:7^T+7_GJ/R-8 %.
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MT ;%%-D9UB=HTWN%)5<XW'TSVKAM*\8ZK#H'B#5=8TUO(TV>Z(*S(3B-R!&
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MI?TIA8FBFFF,2I(WVL*C-%)@: (=*A;@U$MRD,;/*X1%&69C@ 5@:IXNM85
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M<7T"V]R]VX;S4&[ *@!1PQ&  /;K3-.\*QZ9/;F+5]6DM;;_ %%G)< Q(,8
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M FTI[DLOE_-D #'3_/ ^@I]EX6E:?[K8'0-7KS>&+9)PRI]WI[U9CTB*,@[
M"/:LI.6QT1C#=G):%X3B1E:6)>/2NZMK""&((J 8]J6* 1\594XKG>^IT]-"
M.6PBEB9?+49'/%>>>)_!]KLDD1"KEB<J/TYKT]&RE8NM1&6%AL.?7%4M-40]
M=&>3VFD^1$$5_JQ&"*T!I+1$"8EDP2">/R_G6^EO&BG<,'.".G-4A'<ZK<M:
MZ;"NQNLLG"C/;%:*39FX*)1.DW36C-;V\DA^[M52<^W\Z[WX<.YT>YAGC>.Y
MCGQ(CKM8<<9'T%,\(VMUI]N?M\BM*7VJ(P=J_P"<=:Z:PMFBOYI'PS.O+]V
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MH6B+I&B_8)Y1=O(\DUS(R "621R[G;S@$L<#TQ5^WLK2T55MK6&%4!"B.,*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MER2I(D((''3BN6T^7Q%J?A>WU^VM]1.KSHLZW;ZLJVP8G_5F$OM"?P8*[O\
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M&.M%OX@T>ZTV;48=3M6LX<B6;S0%C(ZAB?NGV- $ZZ99)%>1+;H$O79[@?\
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M[M[&W:XNYDAA4@%Y&P 20!S[D@?C33?6JWZ6!N(A=O&95@+#>4! +8],D#-
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MTS@%?0]SV%>8XM.S/:4DUS(KW*O.6@4M&K?ZT!L\>@^M6;>,11?(H51P !T
MID$16,%OO'D_6KJQ8C'M0]K M[D-M'ON5)'05T)(6RV''-95E'B0O^%:$CH!
MR23THMH)LN+"1!%&3P>&R,YS4Z3!5VNP0KP"3_6L\2R2+M9MJ^E.2.(?P GU
M;G^=.]B7&YJQZE';,K+=I$W]X/C-=%IU]#>*%9E$IZ<\/[BN/"J8WVJ <<8%
M21G:[!0 S -D<<UM3KN#.:MA(U5YGH 0"I ,5S>B>(H[A1!/("R\;CU'L?\
M&NA+UZ5.I&:O$\:K1E2ERR),TTM49>F%ZT,A[/43-2,U1,](#:THYMG_ -_^
M@J]6=HQS:O\ [Y_D*T:M;$L****8@HHHH **** "BBB@ HHHH *YSQG#+/IN
MFK#$\A75[%V"*3A1<(23CL!R371T4 <QHECL\;^*KM[8J9C:HLK)]]1$. >X
M!)J3P%!+:^"M.@EB>)HQ(OENI4J!(V!@^V*Z.B@#RCQ5?:GJ>B^*+&:XU"&\
M_P!(BM]+L].!$T8!"2-(R-N#* Q*LN.@Y KH[BX31/&[ZOJD,[6=SIL,%O=+
M"T@@=6<R(VT$KNW(<G@[<=A7:44 </J-W =;T#Q&+&Z.CPK=(W^B.&AE<KMG
M,>-V"%<;L<;\]S1K]U!K5G8:G86-U<V-CJL<]X@M'5KA%0C>JD R!&*-P#]S
MC.!7<44 <8;N'Q%XUT6]TF*=H;!)S=W;P/$I1TPL0+ ;CNVM@=-G.,U1T_0[
MR7X/7NFV5NT-_<QW7[LCRV=FE<X)/3<.,^A%>@T4 ><^)M7TW6?#%KI^G:3>
MR7$5S:LML;&1#9[94R6RH"X&1QUSQQDU<UG5+W_A)-2LKB\OM/MUCC%HEEIZ
MS/>@KD_.Z.O#$KMP,=2<&NV>>&*2*.25$DE)6-68 N0,D =^ 3^%24 ><:%I
ML[6WPW%U9REK.TD\P21G]RX@"C=Z'/ S4VMZ1J%]/XZMK&!]]W:6OEC[@G(5
M@ZANF2H"_B*]!HH YBWUW3=7MTT[3(+J"\\AUB5[&2/[&=A W$J F.F >>V1
M7&:?:--X:T[PU>:CJ\-S'Y,4FGQ:6NZ*1&!WB39C:&&[S-W/7))Q7K548-9T
MNZG:"WU*SFF63R6CCG5F#X)VD ]< G'7@T -US2X];T&_P!,E.%NH'BW?W21
M@'Z@X/X5YQ"^L2:<OCRZTNZ_M6RFAA-H(SYCP*ACE 7J09))''J$6O5Z* .$
MM]%N=,B\"6[QN\T-Y+->.JD@2/;3L[$]@7<]?45 [/'I?CW26M[D7LYN[B%/
M(<B6-H$"E6QM.3Q@'.0>*]"HH XS4-.,.C^#8K:T9?LE];?*B']TOE,K9]!@
MX/UK8\67E]8>&[FXT^ 2SAHU/[DR[$+J'?8.7VJ2V!UQ6N\\,4D4<DJ(\I*Q
MJS %R 20!W. 3^%24 >?Z"\UU\0K>[2_U'4K7^RIXS=W%HL,>_S83L7;&I/&
M3SGO@\-4.A65U'I7P]5[:96@GE,P:,@Q@V\P^;TY('/K7HU% &#XOOK[3]#$
MUC'EC<1+++Y!G,$98;I!&.6*CGVZ]JY*U,UQKVM7:WFHW]J^A-&+RZM5A5V#
M,=J[43(&[J<]3@\&O2Z@O+87EC<6I8J)HVC+ =,C&?UH \U34M/OOA1;^';/
M2KK^T;C34A@LA:N,2L@VR;\;=H8A]^??KQ6E]OM=%^)5W-J<,LCKHMI&;U(6
MD$9\R;(.T$J&(SG&/EP3R,]II=BNF:19:>KF1;6!(0Y&"P50N?TJ"'2$A\1W
M>L"5B]S:PVQCQPHC:1@<^_F'\J .$U&UN-0\/^-M0LK*XCL]1,1M8FA9'F95
M4/*$(R-W Y&3MSWK:U?3[^]\3^(8[(/%+<>'4@MY\$*)2\^/F]1N4_B*[.B@
M#DO#VN:5]@TK1TTZ[M[N%$C^QM9./LS*N"2VW: .?FS@YXSFN2O;_5-7TFV%
MS<:C_:2ZE;R3:5;Z<$BM@MRI)9RA8X SN#_-UZ9KUJB@#ADO[31/B%X@O-0L
MKB..>&V2*_6V>1#A6RF5!QS@^A^H%9L]E=7'AW7;RWL;B&TO]<M+FTMVB*OL
M$L >0IC*AF5WP0..3UKTNB@#SN_%UH_C;6KRZU.\T^"^$+6T\-@+A&14"F/=
MM8J0P8[>,[\C/-=/X/L%T_PW!%&;O8\DLRK=Q")U#NS8V#[HYX'88&!TK=HH
M Y+PYITT<7BLQQFVNKO4YRDS*03\BA6SW [?C7(Z?:/-X9T_PU>:CJ\-U'Y,
M4FGQ:6NZ*16!WB39C:&&[S-W/7.3BO6ZJG4K :BNG&]MQ?,F\6QE7S"OKMSG
M'O0!RMI>+X;\3:^^J6=ZQU"Y2>VNX+22<21B)%$7R*Q4JRMP<9W9'4U@643M
MX*O;BTTR:*.T\3"[:SC3,B1QW*.X"KGD*"=H],"NWOM&U26_FN=/\17-FDP&
M^!X4F12!C*;AE3[9(SSBK.@Z?9:7I8M+&X-PJ2R&:9G#O),6)D+D?Q;B<CC'
M3 H YZWU)-9^(VFW5E!<O8Q:7=(;IX'2-G:2 [06 Y 7_.#C)LKO4M(\'^'(
M/WMA;O-.+N\^R&:2V^9RF%(.W=G&X@@?C7I5% 'EHLKZ_P##?Q!CA74;MKR#
M-M)=6XBDN3]G"Y"JBCDC XR<"NCFNDUCQ%X4O[*.X>V1KH.[P.FP^5CD, 1S
MQ77T4 >=:5?VFB^$+GP_JVFW<VJ9G2:V6T>3[<[LQWJP!5@^0<D\=\8JUIFC
M7EMKO@J/4HFGN-/T6XCEG(W!)L0+][U(WCWYKNZ* . N["$OXS2^@OTLI=1M
M9T>SA+.K"* ^:BX.[:Z@G /W3D&M3PAJ%[?7VIK-+]NM(Q%Y.HM9FW>8G=N1
M@0 VW"_, !\V,<&NKHH XS7]5O(/%#6DU[=:78BU1X)[2P\^2YD+-N0,4<#;
MA?EVY.[-8FEZ9<2^&/!4%U97!,&N2R2QS1#=&%^TE2P P.=O3CICM7IU% '%
M:QIM]=^)_$$=@KPRWGAY88IP"J^=OF"_-ZC</< UB>(-3T^]^&4NA6NBWK7T
M=JD8T_[%(#;NN.2=NW"D9!!^;MG->H44 5M02.33;I)HI)HFA</%']YP0<@>
MYZ5Q?A6]F76K+3K*YN=2TR*T=3)>Z>8)K';M"H7VJ&STVXS\N<UWM% 'FFFZ
MK>Z=\.],LK:&>"ZLYHK;4'EL9)#:+N;,@0CY\%1R,@9!Z4ZP6XNM9\27$=QJ
M5_!-HJ1QW5U:K%YK@R_*@5$R!N')!/)Y(KTFB@#@Y=-:'P-X-@@LW5[:ZTYB
MBQG,?*AR1VX+9/N<U-87]OX:U_Q NL07*S7UX+BWN4MI)1/%Y:*J HIY4AAM
M]\CK7903PW,*302I+$XRKQL&5A[$=:DH \RTZXO](\&;K/3Y=-AEUR?S=]H9
M7LX&E=@XC'H0HSR!NSR!2VD=S<WOC"9)M2OX;C18TAN;JU6(SL//R$"HF0-P
M'(S[D8KTRB@#AM3TJ5?AYH4%O8/+!9-937-E&F6DB0J74+_$1][;WVX[TS5=
M4L=?\2^%9-.LKJX-MJ#-)=FTD18%,$@VDLHZG''; SCC/>44 >=?:FTW7/LV
MCR7DQGU7?<:3>Z>Q5=\N9)HY<#:HR9 26'88)P.J\6WE]8>')Y]/A$LP>-6/
MDF;RT+J'DV#E]JDM@>E;=% ' : \UU\0HKM+[4=1MO[*FC-W<VBPQ[_-B.Q=
ML:YX)/.>IP>&JG;Z5)!\$],M([&1+E/LLOE"(AUD\]&+8Z@]37I=% '&"\A\
M/>-M;O-6BG6*_2 VEVD#RKL1-K194':0VYL'KOXSBI? : #Q%,FG36$-QK$D
MT44T1C+*8HOGVGIN.3[9(/(-=5)/#"T:RRHC2MLC#, 7;!.!ZG )Q[&I* "B
MBB@ HHHH Y>]YU"3_KH?YUTEOQ GTKFKTXU"4_\ 30_SKH;.020+CTI("Q11
M13 R[X_O#]*S4YD_&M"^/SFJ$/,GXTR2X!2XIP'%!Z9H AE'%55DC1_F8"DN
M[GJ >*Q;B;RI%/5<' ]Z\W$8]4W:*N=]#!N:U9OM>6R\&09JK)JD>_9"I8^I
MX%82L)+032DEMQ[UFBXE-T45CY1X/->?4S:II96N=M/+8==38U35Y"ODPM\Q
MX)%5M.5HO,9SES@'FL02/%-<ABQ".B*?J?\ "M73W_UY[&4D?2N%UYU*G--G
M;[&-.'+%&W&Q9"/:N8U,K8W\.I-PL;X<_P"R>/\ "NBMVSGTQ6-J\2RVLR2<
MHV5(QUK:=3EM-=#*$;MQ[CKV\64!HCNSW%<WJE_<12B,N=N.-W4FH/#UY);P
MSZ=<,2\#$(Y[KVJAJ,@>\W;C@<Y]37?4GS1NGN32I\KLT2,SL-TAR?2I=,A+
M7&\T0PF9-Q)V@5?L(]DB\>]8\FIOS:#KB5K?Q1HSQY+&&7('IE:]$C<.BMZC
M->>69%[XM615)ALX"F[U9CR/TKN(9 (HP>A&*F.(]C6=NQSUJ*JTTF: %/ J
MI%.5;:_/O5Q6##(.17L4<1"JO=W/(JT9TWJ9UYUJD_2KUY]ZJ$QPM:]3/H0Y
MK)\2V!U+P_>0(,RA/,B_WU.Y?U%:2MS4&HW\6G63W$O0#"K_ 'CZ54FDM28)
MN2Y=SYWEN+.XC?9NBFY/E,"03UX/]#1I6D&]/FRK\@[=./6M#^P6O/%LBB,I
M;9-R<<#;GH/Q.*[&*P=+%E4(96R3Q@'VKEG445:/4]6G2<I-R6PO@>XM+>TU
M/2[UU6)?WBJW=",'_/O7G6OFU34IK:P.Z!7.ULY+?4UH:V]S?W BAMBB)^[=
MEY4L#TS6AH/A+?B:Y'T%/F44I2W)]FY-QCL'A**YL(F8$[)>67M]:Z812WUW
M$K(1'&VX^Y'2KUOIT<*!$4 "M*. 1QA0.3UKCJ/F?,]ST*4>2*BMB%(:G*?+
MBI F*JW\OV>REDW;<*>?>LK:&U]1'OU1_L\)&X?>;TI\,Z^7Y[\9[GTKGM'S
M<C:,%G/4GMWJ>YN3J%\+.V.(8^":;1*>IT$%]#.<(^6JVLF#6/!!';@!!SZU
M?1N.M9R1HC3ADYI[G !'WEZ54B;I5EOG7CK4CL3HR,Q8\/WK<TG5&0K:W#94
M\1O_ $-<\@R<&G9^7'I6M.HZ<KHPK48U8\K.[+5&7K+TO43<PF.0_O4')_O#
MUJZ7KUH34XW1\]4IRIR<9$C/4+-32U,+51!T.A'-G)_UT/\ (5J5E: <V4G_
M %T/\A6K6D=B7N%%%%,04444 %%%% !1110 4444 %5=0N+BULWEM;)[R8$!
M84=4SDXR2Q  '4]\#@&K58'B[1KK6]+@@M1!+Y5TDTMK<.R172+G,;D X!R#
MT(RHR,4 ,LO%<9;4XM6MUT^;3;=;J?$PFC\D[OG# #IL8$$ \>]/TS7=4U"6
MVDD\.W%O8W(RDSW"&1%QD&2/^$'V+$$C(K$L_!$DT^N?;+/3--LM5TU;'[+I
MH_U6#)EB=BACA\YP.F.V3LZ9_P )2C6MIJ%OI1MXAMFNXYW+3 # *Q; $).,
MY8@<XS0!%8^*+W5 EYIV@SW&DR2[$NO/17D7=M\Q8SU3ODD$CD"M&RUR.]BU
M:1874:=<26[@G[Y5%;(_[ZK'T;3?$OA^QMM$M8M,N-/MF$<-Y+.ZR+ #PK1!
M,,P7C(< ]>.E,DT;Q!9W&N6VFBP>SU69IUN)YF62V9HU1OD"D./ER/F7K@T
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M0XV$$ X(QR*T-5T[Q!K_ (<O+:ZBTZTNC-!-:Q),\BYCD63#OM'4ICA>,]Z
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MS(XZC*D'(!![<BHH_&#C0O[8NM(N(+:?R18Q>8K3732'"J$Z*22.IZ')Q@U
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M )0D<$ @@X]QBO-O#UQJ6B^"K.>/4Y9OM&O"VVR11X1&OW23&%'+ D\].V*
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MA9RI<01(T;LK%7C,:KQE<$-G@YSQ4'@>RO+?6/%#SZK<72KJ;1LDD4:AF\F
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M1\RXARR(V0"3CKG&3Q5ZVUJ[T^U\2VFJZP,Z7(BQ:C);J6VR1JR[HT #,&;
M"@9XXS0!V585GXKLKV+1I(X;@#5I9(H-RCY2BNQW<],1GIGJ*Q=!UK41XL@T
MNXN=3NK6ZLI;A7U*S2W=7C:,?+L5<J1)R&&1@<\UDZ!_QX_#[_K^N_\ T3<4
M >FT45SOB'4+_P#MG2=#TZY%G)?B:62[V!VCCB"Y"!N-Q+KR00 #P: .BHKD
MM5N-:T'3[>T35?MMUJ-_':6UU<VZ!H P)9F";5<@*V.%Y(!S3C/JN@>(=(L[
MK5I=4L]4DD@_TB&-)(9%C:0,IC505(1@01D9'- &]>:1IVHW-K<7EG#<36C;
MX'D0,8VXY&>_ _*JNJZZ-/U&STZ"QN+V]NU>18H2B[(T*AG8LP  +J/4YZ5R
M#:GXED\)ZWXC&M>6VF3WK06JVT9CFB@ED&V0E=V2$*Y4KV/)S5VZMKNY^*&C
MW4>J7$44FESS"$1QD*@DM]R9*YPW4G.1V(H [FBN%L+GQ%K?AC_A)K?6_LKS
M1-<VUA]GC:!4&2J2$C>20!DAA@DX'%*FM:OXCU?18=/OVTRSO]&_M&4K$DDJ
M$LF I<$9^?J01@=,G( .YHKA_.\0ZEJOB:&#7&LX-+E1+81V\3%V-O&Y$FY3
ME<MGC!Y// J"TU?7UTGPWXBN-4\R/5I[99M/$""&-)\;=C8W[EW+R6(.#P*
M._I&95QN(&3@9/>EKCOB':W-Q8Z08-0FM0-6LU*QQHV29T ;YE/*]1V/?- '
M8T5R/FZOJ7B&YT.#69K2'3;:%Y[I(8C/<22;L<,I15 3G"\D]L5>\-:E?3W>
MKZ3J,J7%SIEPL?VE$"><CQJZDJ. P#8...,\9Q0!T%%%% !1110!S<G.KO\
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MVZ"VB@'YF.!3V>@VKQ29S6H7!G>ZNV/S.2 ?J:IRW!M+6&QC_P!:PW-]30C
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MX>"-YN;4JQ93$P 9<'D$DG@=JM:=H L;E[F?5-2OYFC,2M=S A$)R0%157/
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MD(#"-57EVP03R ,COQ5_2)M<:6X@UFTM%\L*8KFTD)27.<C8WS*1@=R#GK0
M@\-V(\/W^B9E^R7WVGS?F^;]^S,^#CCESBIQH]J-5M=1!D\^VM7M8_FXV,4)
MR/7,:_K5U)HY&94D1F0X8*P)'UH:6-"H:1%+':H)QD^@H YR7P18ND]M'?ZE
M!IL[LTNG0SA86W'+ ?+O522<JK <GBM9-&LXM6AU&-"DL-J;2-%P$6,LK8Q_
MP$5=$L;2-&LBEUY90>1]10\T4>-\B+D[1N8#)]* *5OH]K;7&IS(9-^I2"2?
M+<9$:Q\>GRH/QJ >&[$:+I>E9E^S:8UNT'S?-F'&S<<<_=&:UF944LS!5 R2
M3@"D61'C$B.K(1D,#D'\: '50UG2+?7-/-G<M+&!(DJ20MM>-T8,K*?4$"KB
MRQL[(KJ77[R@\CZT[<-N[(QZT 85SX6AN)H+J/4M1MM0BA$#7L$B"29 <X<%
M2C<DD?+QDXQFKVCZ-::):R0VWFNTLAFFFF<O)-(<99F[G  ]   , 5'INJ2W
M^H:M&8E2TLIE@CESS(VP,Y^@+ ?4&M*.1)4#QNKH>C*<@T .HHHH **** .8
MNA_Q,9O]\_SJ=6*H,&HKD?\ $PF_WS_.GMPE"$Q5<[\YK3BN-R 9YK)3DU;@
M^]3$-O>:6S%)>5)9CB@"+5&VVP'JU8,G6MG5CEE7TYK':O$QTKU&CU\&K01
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MQK159D;9J%O*\A&T]2ZIG&/EP@Z$#GU"JXL;,7AO!:P"Z(P9O+&_'INZU8H
M*\:U*]M+O38M<M;?0M/N9-4C:...,O?[Q< -N<$%3C=N!! 7(KV6JPTZR$\D
MXL[<32_ZR3REW/\ 4XYH Y*#0]-U;XB>(WU*RAO%CMK14CN$#HNX29.T\9.
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M#)_>*J!G]*PU_M71/$VNRPZ-<7T6IO%/;RPO&$5UB6,K)N8%1\@.0#P?48H
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M\YC>V[1 Q_WMQX^HSD=Q4.G^++'4[B!+>UU$07.?L]T]FZQ2\$Y#8X! )!(
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MQ["N?M-:U2S\0MI6M_8F62R>]AN+1'0*J,JNK*Q.2-ZD$'GG@5B:CJOB76/
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MT*W&/D,P)3/N 0:\\\):QJFF> _#MI'%:7%]J+>18I\R*BA6=WD/.<!2>.O
M]Z /2:*YRTU?5;+Q!;:/K:V<AO8I)+6ZLU9%+)@LC(Q8@X.0<\X/ IG@W6-:
M\0Z7;:O?PV5M:7$.8X(@S2;LXW%B< '!^7&>1SVH Z:BBLOQ!J,FEZ6;F.[T
MZT.\*9M0D*QH#],;CZ+D9]: -2BN&MO'%P^@^)[C=8WESHMJ;E)K8.L,X,;,
MHVDDJ<H0>3V.:NQZ[KMI?:,^J6]B++5I?(6.#?YMLYC:1=S$X<80@X"X/K0!
MUE%<C)XMNH?#VI2O:Q'6;2]-@ML"0LDS,!"?7:RNC?0GTKK5W;1N(+8YP.,T
M +117&Z9K/BS6],EU"SM=*A2.>>*."?S"UP(Y&0'<#B/.W'(;UX% '945S-A
MXL&J7/APVT&VWU>VGG82??B,83Y?3JQ!^E5]8\6W6F6_BJ6.VBD.C11/$"3^
M\W)N(- '745R6HZSXETNWTP26FG3WNHWXMD@C9U6%#$[_,YSN*E.2 ,C.!FK
M,&KZOI^OV6EZVME*FH+)]FN;-&CVNB[BCJQ;JN2&!_A/ H Z2BN-M]?\2:IH
MS>(--M=..G%6EM[.;?Y\\0SAMX.U&8#(&T]1DU%J/C:5I]--C<Z;86=]8I>0
M76JAA',7/$0(("L!@G)/WA@'F@#MZ*XW7/&3:=J5EI)O-'TZ\EM!=SSW\^84
M!.T*@RID)(;G*X"Y[XK1\)^)5\16]ZIDM)9K*?R))K.3?#+E0P=#Z$-@C)P0
M1D]: .AHHHH KVM_9WQG%I=0SF"4PS"*0-Y;CJK8Z$>AI\=U;RSS01SQO-!@
M2QJP+)D9&1VR.:\OTE9/#MQJWBNV5FM?[8O8=6A49W0B=MLP']Z/)SZJ3Z"M
MF+7+?1]7\;:P5-Q#$+-XUB(_>DP@* >G)(&?>@#O**Y.XUCQ#HBVE[K46FR6
M,\\4$RV@</:F1@BG<Q(D&YE!X7KG':NLH *SK#7+'4[RZM;-Y96MF*22>0XC
MW X*B0C:Q!X(!.*NW'GFVE^S&,3[3Y9D!*ANV0.<5P/A*]U/3/ -Q=7%WH\*
MK=W'ERW+-%&F;F0.7))SS]T#&>A/>@#OKB>.UMI;B9ML42%W;&<*!DFDMKF*
M\M(;JW??#,BR1M@C<I&0>?8UQ-MXHDUC3_$>FSW%C=O;:<9TNK%66-U=9!@J
MQ)!!3U(((J/_ (22ZTC1_#5E'<:=I\,^EQR?;M25C"7"H!$""H#'.<D_0&@#
MOZ*XW6O&3Z9+I>GR76CV-]=VQN9;B[N";>)1@?)]TR$D\#(X!/UO>$_$ZZ^V
MH6S3V5Q/8R*K7%A)OAF5ERK+R<'@@KDX(ZG- '2445AZ[K%W9WVG:5ID,,FH
M7YD*-.2(XHXP"[L!R?O* !C);J* -RBN7BU[5+'4;K2M7BM'NEL9+VUN+8,L
M<JH0&5D8DJ067N<ANV*L^%-1UC6=)MM5U*.S@AO+>.:&"$,73<,_,Q.#D$'
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MW8(XQG-5+_PGH6IWCW=YIT<DT@ E(9E$H'0.H(#^GS UKHBQHJ(H5%&%51@
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M!HVD *YZ;O[N>V<9K.TFR*?$#Q%>O;D%[:SCCF9/O "3< ?KC./:LK0]0M=
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M]6&!S@8+$#'/.*LZ;=-8:U96&CO>SVS7SF;3+_3R&LU8NS2)-M& "3C);(;
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MSPI(UN98H+F>1FV95#Y#;2?3G&/>LC6M(U"_OO'-O81.DM[I=JL+<HLKXF#
M-TR1M4GMD4 =/9^*M!U"^%E9ZO:37#9"(DH._'7:>C8]LUK,RHI9B%4#)).
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M-;216[RB1DWAD^0'YN5..^:P[#3[B[\*^$TN].F1E\0RSRP2QDF(>9<,"P]
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MV!SQQDU%++_PDGB^UO=$6>..UL+F&>^>!XE9I-OEQC< 6(8%N.!CU- '0?\
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MOJ*WN&<-ELGTK/ED?R"_WCU&3UK-OM76UC'EC$K= #FDM2G9&MJ5[]EM/)W
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MCWNY#;0001M!0GG^+%(FN:X?B)<:3_9X.GI9Q2#]\GR@R2*9>F3D*!MSV]Z
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M8P"23TX)JWHNM?VJ;NWFM7L[ZSD$=Q;NP;:2H965APRD'@\=P0"* -6BBB@
MHHHH YB\_P"/V?\ WS_.J]3WG_'[/_OG^=05F6(:0TM(:!C)#A#532Y MQ<$
M]%7-6I?]6:CCMQ;VRJ1\\QW-[#TKGQ$N6#-:,7*: DXRWWB<FHV;-*[?-49K
MQVSU$1O49<BI/6J[G!K.1I$;(Y(K*NX68<5J$9%0R# K&>J-(Z,YOR2MUEN
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M?SIY65[:3RUC;Y I$@P@(&Y><CWKI;BTM[OR?M$*2>3()8]PSM<=&'OR:FH
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M$A02<5Y_IFFKJ7C#2-0M5UN>+3Q,\MYJR21'YD*+'&CJI_B))"_PC)/%>A4
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M/6[98Q)M\M3DIN]U.,\<C(/2MGP[=Z@FN:SHU_>M?"R\B6&YDC1)"DBM\K!
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MGWMS:1BU@16,K\8..339(A:PB%5#.!\QZX/I5[1H$CMKS4KDA4MP AVG[W7
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M>_7:QY]:[.O,IO\ D7[[_L<(O_2R.O1X[NWENYK6.9&G@"F6,'E V=N?K@T
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MY&X98*G?;NP>OI5NUM/!?D1#05TK[;+:2K:_9&7S)%*<YQRWONSS[T =CN&
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M ?\ 4989[4M *<-NTA8 3%U^;&^K]M;%]-NH@7$DD#*&8\<^]%M;WD<Q98R
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M",;R/][K4SQ1R,C.BLR'*DC.T^H]*R%\3Z>ND7.I7:W-E#;/Y<R74#(ZL<8
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MJT#&)9C(O[WTP ,;NW-/-VEQ-X*DMK^ZO(9-2N 9KC >3$%QPP  X(P..PH
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MW?YO2FI?:< $%U(3CC  )YQZ'O0Y0'RR-U;CS[5W+F-B>&'MU%007A:Z"M?
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M'2)58>A %<,VAZO<:%K&C#3WCG357U*UFE=/(N1]J\]$X)89'RG*\>]>@T4
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M\B8RQ?W2<U*LHF4-@ ]\5>NK=&R"HK(NO-M(VD7YE'4'K6=S11+EL0;@JW(
MQ6I'&A/"@U@Z9*96W'J:ZFUA211F0 ^XHYA.+&B*)NJ"IH[:('I5R.PC/)?/
MTJREG&O;-2V!6CAB J98D[ _E5I(0.PJ98_I6;9)46$?W:=Y&?X:T%08J01C
MTJ>8:92@MAG.*FO+8NR^@6K:1A3D&IIL-MXQQ3C(<MC%@TDW,ZQXX)Y]A760
MVZP1*BC"J,"FZ?;B&(R-]YOT%6(I%D1^.5.*<I7-J4>57,'Q%.HL)(1U:N*G
ML-\F0>&'Z5UVM[3>H#[_ ,JRFMU5E93^%=.&J6BSFQ<;R1BWFGRO:7&P,3N4
M+MZ]<Y_2L"TTJXB:X9G'F;23E=Q.<_D:] ,*O;Q= 1(2V?;'^-4K6*$H\N"6
M<;<=ACG^E='M=3D]F<I! T"QJD0)"DDD8R,FKZ&9'.\#(7TK:N88XI-J1@;%
M*DX_"H)-H?YT!R,FME45C-PU*".PA.&X;G'\ZJM(6+Q,N?1OPZ5M1>2Z%3"N
M<#VXS2K' 06:+&3G/%'.'(<_+:>:21&I+'?DG/(R0/UIMOIKLJ;491&7&!CG
M(X/Y_P!*ZO[-9O&0%8 '@U%)8Q[E5'ZY]12YT]QJ+6QS8M>)%"J#L"@D9)QU
M(],XJ:6.W*H3&,DX((/MV_.M<Z;(SET*C!]1^.*C;3 TH!CY7. 6Z57NB]XP
MI8;>2$VIA^4MO R3V^M+%IEK"%'EQ@XV[SC(_P XK0NX0A1RD850>% ST&/Z
M525?MEW NXE=_0]>E TQ^E0>7$LJHAW6PY/!&"5XYY^[Z5O63L82" (^A]0:
MYJRVM-"2<;;=RN%'.'?&:Z&QD9D*GI@-_(U,=BI;EB:2-HHG=GSYB*<G^\=A
M_+=FIXUB$"1+.9E7"B0\$X !_E5"X8O92JN!M0/GN""#_2M.]0HC2*FW8Q7:
M !MY/./0^M2VE+4:5XZ%73;5XM6MB#\K2+^/->@UR&C(T^I1!@/W1W?ABNNK
MS<P=YI'HX!>XV-:DQ3\<TA6O-:/13.N\)_\ (,E_Z['^0K>K!\)_\@V;_KL?
M_016]7K8?^$CRJ_\1A1116QB%%%% !1110 4444 %%%% !7)_$&?5K;P_#+I
M=S% ?MMJLC-NW'=<1J "I'!R0P[@D5UE9?B'1_[=T:6P%P;=R\<L<P7=L>-U
M=3CN,J,CTH YB].N#X@Z7';_ &$W[Z/.)IG1_)C'G1G(3.YNPQN'4G/&*GE\
M;S:;X=U*YU.&U%_87XTX[9#'!)(VPH^YLE%VR*3G.,'K6W;:+.NN6NKWEZDU
MS%9/:.(X?+5]SJ^X#<<8V8QD]>M59_",%Q;:O$]W*KW]^E_'+&H#6TJ+&$*Y
MR#@Q \]<D4 9NB^-#<^(;329]3T74C>(YCDTMSF)T&XJZEFR",X;(Y&,<UI^
M*M*OKYM*OM/B@N9],N_M/V2=]B3C8R8W8.&&[*DC&1^-6=-T_6HKT3ZGK45U
M&B%%@MK,0*Q./F?+.2>.Q4<GBI]8LM1O(H6TS5#83PR;_FA$L<HP1M=<@D<]
MF!S0!A2:U::GINOP2Z9-INL16#&XAN$7S&CVOM8.I(=,[@"#P<\"H/"6H:N?
M#^APMX7<6YM;=3<_:HL!=B_/MSGISCK6C;>&+J274[S5M22ZU"^M/L8>&W\J
M*"+YN%0LQ/+$DECGCI46G:!XETVRM+*/Q+:-;VT:1*#I?)50 .?-ZX'6@"+P
M[#'J7B_Q'JEXHDO+.[%A;!QGR(1$C_+Z;RY)/?CTKIUL+1+^2_2VA6[D01O.
M$&]E!R 3UQ6/J'ARY.L/K&BZB-/OYD6.X62'SH;@+]TNF5.X= P8''!S5C2M
M-U6"[DO-6UC[9*R;$@@@\F",9SD*68EO<M] * *?B77)]*N8(HM4T6Q$B%A]
MOWO)(0>BQJRG'^UD_2L[_A,[^Z\.^'K_ $^QMWN=5O39LCR'8A"RY8'&2H:/
M/3)'O6I>^'[\^(IM8TO4X;66YMTMIUGM//\ E0L5*'>NT_.>N0>..*ALO!RV
M6G:)9_;Y)?[+OY+P2.@W2[_-^4\\'][U[XZ#/  R+Q+>Z5=ZQ:^(!;/_ &?8
MC41/9HRJ\/S@@HS$A@8SW.<CI6#XNN?%%S\/-1O;NVTT6UQ:[FM(M_FP(V#D
MR$[7([C:O?!/?K[KP[;WNLWM[<OYD-YIPT^6W*\%-SDG.>X<C\*Q+WP9K.H:
M!)H-QXFSIWEB-&6R G91]T2/OPPX&<*I/KUR =;>.([&X<HKA8V)5AD'CH:Y
M"#Q'J+:?X0MM*L+&)]8L/.(8%8K4+$C\*.JC<0%X[<CK797$7GVTL.=OF(5S
MZ9&*P['PNMC_ ,(YB[+_ -BV;6H_=X\[*(F[KQ]S..>M #_#^K7]W>ZIIFJ)
M;_;-/E13+;!ECE1T#*P5B2IZ@C)Z=>:CU#5]3G\0MH>BI:I-#;K<W-S=JSI&
MKLRHH12"S'8QZ@ #OFK]EI L];U34A,7-_Y68]N-FQ=O7/.<U4U+0;J765UC
M2=02ROC +>;SH/.BFC!++N4,IRI9L$,/O'.: .8\3>(-;D\'>)[0&WL]6TJ+
M,\L+/M>)D+*\1!!5C@C!S@J>O!JSK;:XGB3PFN+&747:[7>%=847RQ\Q&2QP
M.V>3CD=:U/\ A#DN-%UNTO[^2XO=90I=7:QA,?+M4(G("J.@)/?).:M1:%>2
MW^D7VHZC'<7.G^<"T5MY2R!U"]-QQC'J<^U &8WB^YT>P\0MKD5N]QHPC??:
MY1)UD7*8#$[#NRIR2!US5/3_ !TQU;3K6YU30+];^7R/*TR8F2W<@D$Y8[UR
M,$X7&0<5NW?A6UOY]<:ZF=X=6ABB=%&TQ>6" RMZY.1QP13K#2]>BNX'U#7X
M[FW@SB.&R$33'&!YC%FSC.?E"\_E0!6T'6-:UK4[YFBLK?3;*^GM#PS2S;"0
M&'("]LYSG!Z<5+KVL:K::YI.EZ5;6TLE^D[/+<,0L(C"?,0.2/FZ=SCD=:OZ
M-I T>.]03&7[3>379)7&WS&W;>O./6N?\46US=>-O#*V=ZUG<+#>,DFP.O B
MX93C<I],@^A!H MV^N:I9ZM<Z1J\=H]R+)[VVN+561)40A65D8DJP++W.0W;
M%#^)[A?!FB:WY$7G:@UB'CYVKY[QJV._&\X^E6-/\/3KJD^J:Q?I?WLEN;5/
M*@\F**(G+*J[F.6(&26/0=,5E)X(U Z9IVDS:_OTW3)[>6U1;3;(RPNK(DC[
MR& "XR O."<XP0"*V_MM_'GB:/2A91)_HI>XNU:09\KA512I/N21CC@YX@UO
M69]4\+W%O?01P:AI^MV-M<I$Q9"?M,#JRD\[65E.#R.1VK;F\.:G#X@U#6-*
MUI+>2^$:O!<6OG1 (NT' =3N]P1[@\88/!J'1IK.6_DEN[F_AU"ZNVC&99(Y
M(WP%!PJXC50.P]>X!'=^)+?2+[Q3<RV,6-.@MY"\*@2W!96VJQ[\X ],UHZ:
M?$YN87U-=)^SR*3)%;^8)(#C@!B2).>#PGK[4RY\*VM]/KINY6D@UB&.&2-1
MM,812,AO7G/L13M-TW7K:YA^W:_%=VL((V)9".27C ,C[B#CK\JKD^W% ":Y
MK%[;:EI^CZ5# ^H7JR2"2X)\N&*/;N<@<L<NH !&<]1BJM]K.MZ/80Q7<%A=
M:G>7BVED8&>.-RREBS@Y*!0KD@%L[?>KVMZ')J5U97]E>FRU*R+B&8Q^8A1P
M-Z.F1N4[5/!!!4<U5N?#E_J>G!-2UC??Q7*W5K<VUL(EMG48&U"6)!!8$,QR
M&(XH ;!J^L:=KUCIFMK93)J =;>YLT>/;(B[RC(S-U4,0P/\)&!6(WC'Q"OA
MR[\1_8=/-A9W,L36P+^;.B3&,LK9PIXZ$'..HS706F@7\FLVVJ:WJ<5[-9JX
MM8K>V\B.,L,,Y!=RS8XZX )XYJ)O"*-X.NO#WVQMMQ)-)Y_E\KYDS2XQGMNQ
MUH 2UU;6[/Q%8:;K,=@\>H0RO$]HKJ870*2C;B=P()PPV].G-8TGC#Q"F@:C
MX@^Q:?\ V?IUU/$]O\_FW$<4K(65LX0X'0@Y(/(S76WND"\UO2]2,Q4V EQ'
MMSO\Q0O7/&,5F2>$4?PAJ6@?;&"WLEQ(9O+Y3S96DQC/.-V.O.* &VVKZY9^
M(-.L-9BL&BU*.0Q&T#AH)$4,48L3O!&?F 7D=.:$\3W#>"]:UOR(O.T]KX)'
MSM;R'D5<]^=@S]:U;[2!>ZSI6HF8H=/:5@FW._>A7KGC&<US][X*OKBPU?2;
M?71;Z3J;S2/$+7=+&TN2X63?C86).-N<$C(Z@ L7>NZQ-K]AI&F06:M<Z>;Q
M[BX#,L6&4?=!!;.X<9'KGC!IW'B2XD\+:C)J6GV4UWI^IQ6,\94M#(QEBPZ@
M\CY9%8 YP1UK?@T,0Z[;:G]H),%@;+R]GWLLK;LY_P!GI[U1N?"*7%AJ]K]L
M91J.I17Y;R_]64,1V]><^3U_VO:@ GU?6-0U^^TO1%LH4T\1BYN;Q'DW2.NX
M(J*R]%*DL3_$.#4>LZYJ.F6]BMSJ&@Z;<RQDRBY=Y=SC'$: H2/4YX]#UJS=
MZ!?QZU<ZKHNIQ64UVB+=17%MY\<A085P Z%6 XZX( XXJN_AK5(]5BU6TUN+
M[>;-;2YENK(2"159F#*%9-ARQ]0>,@XS0!@:AXBUK6_#WA[4M-FM;4RZLMM.
M,R%7=96CX((S&2I.#S@BMZ76UTS7-1.HVUJ&L=%CO;BZ@CP[#=+N49YVC82
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44$X&
M3TI%974,C!E/0@Y!H 6BBB@ HHHH **** "BBB@ HHHH **** "BBCK0 444
M4 %%%% !1110 44=:* "BBCK0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO(+R")0SPKY2J/+?(!8'!!;WS@=* .BT[7C=ZB=/N].N].O#$9HX[@QL)4!
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M5H=.M;6TN$N9&M9WE:=TY4 ,B[%W8)Y8\8]Z8WAJ[/@F[T02P?:)IIY%?)V
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M'T XK8H *R[OQ#I=C=/;7%PZ2IC<!"[=1GJ 16I10!B_\);HO_/U)_X#R_\
MQ-'_  ENB_\ /U)_X#R__$UM44 8O_"6Z+_S]2?^ \O_ ,31_P );HO_ #]2
M?^ \O_Q-;5% &+_PENB_\_4G_@/+_P#$T?\ "6Z+_P _4G_@/+_\36U10!B_
M\);HO_/U)_X#R_\ Q-'_  ENB_\ /U)_X#R__$UM44 8O_"6Z+_S]2?^ \O_
M ,31_P );HO_ #]2?^ \O_Q-;5% &+_PENB_\_4G_@/+_P#$T?\ "6Z+_P _
M4G_@/+_\36U10!B_\);HO_/U)_X#R_\ Q-'_  ENB_\ /U)_X#R__$UM44 8
MO_"6Z+_S]2?^ \O_ ,31_P );HO_ #]2?^ \O_Q-;5% &+_PENB_\_4G_@/+
M_P#$T?\ "6Z+_P _4G_@/+_\36U10!B_\);HO_/U)_X#R_\ Q-'_  ENB_\
M/U)_X#R__$UM44 8O_"6Z+_S]2?^ \O_ ,31_P );HO_ #]2?^ \O_Q-;5%
M&+_PENB_\_4G_@/+_P#$T?\ "6Z+_P _4G_@/+_\36U10!B_\);HO_/U)_X#
MR_\ Q-'_  ENB_\ /U)_X#R__$UM44 8O_"6Z+_S]2?^ \O_ ,31_P );HO_
M #]2?^ \O_Q-;5% &+_PENB_\_4G_@/+_P#$T?\ "6Z+_P _4G_@/+_\36U1
M0!B_\);HO_/U)_X#R_\ Q-'_  ENB_\ /U)_X#R__$UM44 8O_"6Z+_S]2?^
M \O_ ,31_P );HO_ #]2?^ \O_Q-;5% &+_PENB_\_4G_@/+_P#$T?\ "6Z+
M_P _4G_@/+_\36U10!B_\);HO_/U)_X#R_\ Q-'_  ENB_\ /U)_X#R__$UM
M44 8O_"6Z+_S]2?^ \O_ ,31_P );HO_ #]2?^ \O_Q-;5% &+_PENB_\_4G
M_@/+_P#$T?\ "6Z+_P _4G_@/+_\36U10!B_\);HO_/U)_X#R_\ Q-'_  EN
MB_\ /U)_X#R__$UM44 8O_"6Z+_S]2?^ \O_ ,31_P );HO_ #]2?^ \O_Q-
M;5% &+_PENB_\_4G_@/+_P#$T?\ "6Z+_P _4G_@/+_\36U10!B_\);HO_/U
M)_X#R_\ Q-'_  ENB_\ /U)_X#R__$UM44 8O_"6Z+_S]2?^ \O_ ,31_P )
M;HO_ #]2?^ \O_Q-;5% &+_PENB_\_4G_@/+_P#$T?\ "6Z+_P _4G_@/+_\
M36U10!B_\);HO_/U)_X#R_\ Q-'_  ENB_\ /U)_X#R__$UM44 8O_"6Z+_S
M]2?^ \O_ ,31_P );HO_ #]2?^ \O_Q-;5% &+_PENB_\_4G_@/+_P#$T?\
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M^@]I?_@9'_C1R2[!SQ[FM163_P )5X=_Z#VE_P#@9'_C1_PE7AW_ *#VE_\
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M^@]I?_@9'_C1R2[!SQ[FM163_P )5X=_Z#VE_P#@9'_C1_PE7AW_ *#VE_\
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/ 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>ethicsemployeepolicybook011.jpg
<TEXT>
begin 644 ethicsemployeepolicybook011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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MT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+E6BNQF\-^'/^$AET"+5=0BOEN#:I)-:H86D#;0"5?(!/?%<G<V\EI=36TH
MDB<QN >A!P:49J6PY0<=R*BBBJ("BK-Y#:0^1]DNFN-\*O+F(IY<AZIUYQZ]
MZK4)W&PHHHH$%%%% !16CHNCS:W?&".2.&*.-IIYY#\D,:]6/^>216FMMX/>
M86W]H:LA)VB\:!/+SZF,'=M_'/M4N:3L6H-JYS=%/F18IY(TE65%8A9%! <
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M@)9W37,6Q27:(QX8@%EP3V.1GO5:FG<'H%%%% @HHHH **** "BBB@ HHHH
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M43T6W_!.I\1:W=Z)XBN]&L;:WBTZSE\A;5[=&651QN<D98MUSG//&*H>/O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMW^DK+9FYL(!/-B4[0I&< [>N"*]"@\.1#XV/J8V_83:_P!I*_\ #DC9G/\
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MM?$^AP:E:D#>,21YYC<=5/\ GI7E8ZDU+G74]3!5$X\CZ''?$+X9IK[2:KI
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **^N?[*T[_GPM?^_*_P"%']E:=_SX6O\ WY7_  KSO[07
M\IZ'U!_S'R-17US_ &5IW_/A:_\ ?E?\*/[*T[_GPM?^_*_X4?V@OY0^H/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!EZ]!>W%BR6DRQK@F0GJ1CH*\]@@EN)5BA
M1GD;HHZFO4;E2]K*JC+%" /PKD_#6DWUIJWFW%LT:"-AN..O% '-"*1;D1,"
MD@;;@\$'->E:9%>06:QWLJRRJ<!E[CW]ZY74]'U";7Y9X[5VB,JD,,8(XKMJ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<;%Q^'7]:<9>Y*LTK[?\$4H^_&DF[;E"Y^&GBO2X#=Z1XMN;B[0;O*8O'O\
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M4-M)P">OL,>IKSCPAX>N==\8KX<U2[,UAH;S.8<_*V) "![%L9]LU] @!0
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M;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45Y5X>T6W
M\>W>N:AKUW=FYM[U[>&".<I]E0=" ._4<_W35O5K,:Q\0;'PG?7ETFD6VG"9
M8O/8-=.#CYFZMQD_\!/K6[HI/EOMN8*LVKVWV/2J*\PT\/X?\8:YX;T^ZGFT
ML:6UR(I)"_V:3'0$\CKG\17.1Z('^$4?BEK^^.JVYW02?:&Q$!-LV@?F<]<F
MJ6'7?>WXB==]MK_@>OWNNV.GZQI^ESLXNK_?Y "Y!VC)R>U1IJ&JMXHDL&TH
MKIBP!UOO,'S/_=V_G^5>=>(=&M=6\:>$+BZ:??JT#/<E)67E8EQMQ]W\.M;V
MG!K;XPS6222&WAT551&<D<,@S]?>ATHJ-UO;]0563EKW_0[ZBO#M(T%-4^&>
MIZY=WMZ]Y9M,]J1.P6+9@\#/4G.3]/2M^ZU.ZNKKX:7,]P^^X#&9MV!(Q6/K
MZY/\Z'A[.R??\%<%B-+M=OSL>I45Y^][(GQCNUB=I!#HQ;R0W&\,"!CUY'YU
MQ.FV^I>)- N-9?2-1O=4E:1H]334EB6W8'@!-PVJ..#^&.*4</=7;[?B$J]G
M9+O^![M7+W_B"]MOB)I.A1B+['=6LDLF5^;<H;&#GV%<EJ3:GK>N>%/#?B&:
M:TBGLS+>)'(%,\J[AM++Q_"#Q_>^E+!HUIH/QDT:RLKF9X!9RNL$LID,&5?@
M$\@'&<>YJHT4KW>MF*55NUEI='JE%%%<ITA1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M103@9/2@ HK'N/%6@6LACFUBR5QU43 D?7%1?\)IX;_Z#-I_WW6BHU'M%_<9
MNM36\E]YNT5A?\)IX;_Z#-I_WW1_PFGAO_H,VG_?=/V-7^5_<+V]+^9?>;M%
M87_":>&_^@S:?]]T?\)IX;_Z#-I_WW1[&K_*_N#V]+^9?>;M%87_  FGAO\
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M_F7WF[161;>*= NY!'!K%DSGHOG $_3-:]1*$H_$K%QG&7PNX4445)04444
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M_JU6]K>>ZM]^QR=%=:/!]E;:?9S:IKT5C<7L/GP1M;LZ;2,C<XX!]JY,@!B
M00#U'>M(5(SORD3I2IVYA****LS"NS\%^.KO0;N*TO97FTQB%96.3#_M+[>U
M<916=6E"K'EFM#2E5G2DIP>I]3(ZR(KHP96&00<@BEKF?A]>/>^"-.>0DM&K
M19/HK$#] *Z:ODJD.2;@^A]C2G[2"FNJ"BBBH+"BBB@ HHHH **** "BBB@
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M^HVWC'[):LNX6G]GHTR-C[H)7GGOG\>]><?V!K/_ $"+_P#\!G_PH_L#6?\
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M:["%@#NR,CK@X'Z]*;<76@:7X$U31;/5OME[-+'(6$3*K89>%SZ =3UKEO[
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MCO-+6'$VFW-F6<-C[JGG@'WQ7F\S1O/(T2%(RQ*J3T&>!5[^P-9_Z!%__P"
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR\_-O4RL>/3#"LJ&#Q+KG@.UT)K"TCBO;"."741<940L@#,(\9W[2>.@/?%
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M-5LK73EMI;$W7E*LX"_O"#\KC (YZ=0.: 'Z]J\.M>']*NHHI8637K.&6&8
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M]81;_.LB@ER,#YUW#![\5RM_K^IVWB:XM[O4HM)MTN(X[1;FQ9H+J,A<DSY
M#EBRA<C&!P<U#=:U_P (]J7CG51%YS0"TV1\_,QC"J#CG&2,XH [VBN$T_Q)
MJ<>KZ="]Y-J<5W+Y5P@T>>V%OE20ZLPQM! !#$GG.>,&OKGB^[TZ6\O;/5A>
MQ6EQL>U@TJ5H0H8*R-<#(#@9YR #P10!W]Q!%=6TMO,F^*5"CJ>ZD8(K*AUO
M1]/M+^$RBUM=&9+:9I>$C_=HR@'N,.H^M49[[5M6\37VE:;>16%OIT<1GF:
M2R2R2 D*H)P%"@9/))/;%<[%J&J:)IOCN^G-L^H07\1W(A\M_P#1X &VDG&1
M@XR<$]30!Z317*WU[K=YXVGT2PO(+.TCTZ&Z:8P>9(':25< $XP0@Y.<8]\B
MC'XJU9M!MH +4ZQ/JTFD"<H?)#(SYEV9S]R,G;GJ<9Q0!U-MHNGVFJ7&I0V^
M+VX&V29G9CMSG R3M&><# J_7)/<^(=)\3:'876H6U]8W\LJ22&W$4J%8G<
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MD9R#R*UT141410JJ,!0, "N$TK49]$^&GAU[)8I=0U06ZH\N=GGW'SO(^.2
M69L=^G&:TFO=9T#6=*@U*_AU&SU*<VNX6XBDAEV,ZD8)!4A&&#R..30!U5%<
MKX9O=;UB]O[JZO(([&UU"ZM([>.#YI521E5F<G@CC@#MGO@6=:U+4'UZPT'2
MY8K>>X@ENIKJ6/S/+B0JN%7(!8LXZ\  \&@#H:*XNYU[5]&.N:=>SP75S:Z4
M^HV=TL6S< &!61,XR& Y& 0>@Q5:;4_%EO%H,S7UBSZU(L#1&V.VT+1M)N4[
MLOA488.,D@\#B@#N;BXBM+:6YN)%CAB0R2.QX50,DG\*+>>*ZMHKB"19(94#
MQNIX92,@C\*Y./6-6L'\2Z?>W,-W-IUBE[;W'DA"RNLGRNH.,AHCR,9!K-G_
M +8U#Q7X2NH]4CM_M.F3R[!;!@IVP%A][G)/'I0!Z%17)?$M+IO &K-:W0MR
MD#,_[O<77'W1R,=N?:GW=[K<>J:=X=M[^ WL\,MU<7[VV D2,JX6/=@L2X&2
M<  G!H ZJBN<TC4=2M_$ESH&J3Q7;K:K=V]U''Y99"Q5E=<D;@0.1P0>@Q5;
MQ7J^HZ=J-K&ER^GZ8T+O)?I8M<A9 1A& ^XN,G)'/3(H ZRBO/KX:M?^*O"E
MQ;Z[:$7%I<.LEO;;XB=D>YERW(;/'/'O3_$_BB\TZ759]/U@2MIZ%_L<&E2S
MH"J;BDTRY"D\\Y7:""0: .^HKA)UU2\^).E7%OJ:P03:3+,L1MPVU/,@W+G/
M)).<]JIR>,M1OVU"ZL[YK5;>>:&UM!I$]PLWEL5)DD4?Q,I^[]T8SDY% 'H]
M%5-*O6U'2+.^>WDMGN($E:&0$-&64$J0>XSBLWQ)JMY9RZ9IVF^4M]J=P8(Y
M9E+)"JHSNY4$;B%4@#(Y(H W:*YBWOM6TGQ-9:1J=Y%?P:A%*T$ZPB*2-X\$
MJP!P5(.01@@C!SFF>![W6]:T6TUG5;R I=096U@@VA3GABQ))) /' &<=LD
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MHHH **** "BBB@ HHHH *H:MI,.L6]O#.\B+!=0W2E",EHG#J#D="5&:OT4
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M<-(Y<@8'3)XJ#6-!CU6:UNX[J>RO[0MY%U;[=RAL;E(8%64X&01V!X(K6HH
MYZ+PE ;;5!>WUU>WFIVYM9[N78'6/# *@50J@;B>G).3FKL^A6\ZZ.K22C^R
MY5EAP1\Q$;1_-QTPY/&.<5J44 9%QX>MKF]U2Z>68/J5DEG* 1A47S,%>.O[
MUNN>@J"Y\+QRC2'MM0N[2XTN(PPS1!&+1E55E8,I!SL4YQU%;U% %+5]+M];
MT>[TR[WB"ZB:)RAPP!'4'UK,N/##W4-E))K%[_:ED7\G456(2;6QN5E";&4X
M'!7L#UYJSX7U6?6_#UOJ%PD:2RM("L8(7Y9&4=2>P%:] &1I&@)IMW<W\]Y<
M7^H7*JDES<;00BYVHJJ %4$DX Y)R2:75-(N[VZ2XL]:OM/=4\MEA".CC.<[
M74@-[C\<UK56LI[F>.5KJS-JRRNB+Y@?>@.%?CID<XZB@#$/@ZUBM-(AL+Z\
MLI-*5D@GCV.S*XPX8.I!SUZ=>E0W?@F.Z34[5=7OX--U)Y)+FSB\L LXP^'*
ME@#U(SZ]CBNJK'UK5I]-O]#@B2-EO[[[-*7!RJ^3(^1SUR@ZYXS0 RY\-I+?
M:9>V^H75K<6,)MP\00^;$2A96#*1R47D8(JO+X399[LZ?K>H:=:WDC2SV]OY
M9&]OO,C,I9"W4X/4Y&#S6U9SW,QN!<V9MA',R1'S _FH ,/QTSD\'GBK- &2
MEK?CQ'&_FNNF6]EY:(9,F65FY+=SM5!R?[YJ36M%M];MHHY99H)H)1/;W$#
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M*H+$<$GMP,9-5E\(&#S+>RUS4K/399&D:R@* *6.6"/MWHI))P#QDXQ7344
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MQGFMG3=.M=(TVWT^RB\NVMT"1KG/ ]2>I[D]ZI:'JL^IW6M13)&JV.H&UC*
MY91%&^3D]<N?TK7H YR7PFZ7%VVFZWJ&FV]Y(TL]O;B,KO;[S(64E">IP>O/
M!YJU!X9T^TFT=K57ACTF.2*WB4Y4AU .[/)/&<YZDYK9HH S[32(+._U.\C>
M0R:C(DDH8C"E8UC&WCT4=>]4K'PK9V$.@QQS3L-%B,4&XCYP4V?-QUQZ8K=K
M'T;5I]1U+7;:5(U33[T6\10'+*88I,MSURYZ8X H 72]"&DZA?7$%]<M;7<K
MSFT<(421R"S*=N[DCH21R:-2T(7VKV6J0WUS9W5JCQ;H0A$D3E2R,&4]T7D8
M(J]-/<QWMK%%9F6WDW^=/Y@7R<#*_*>6R>..E6: .:D\(LDETFG:WJ.G6=W(
MTLUK;^65#,<N49E+)N)).#U)(P:W;"QMM,T^WL;.(16UO&(XD'\*@8 K/T;5
MI]1U+7+:5(U33[T6\10'+*88Y,MSURYZ8XQ6Q0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7.>,[+^T-+M;47EI"SW:%8+R0I%=X!/DL1S@]>
M ?N]"*Z.J]Y8VFHVKVM]:P75N_WHIXPZGZ@\4 >7ZM::1=^$;RVET>*SDTS6
M;6*:);@S01%Y8"WEMP A1AD87!SP*W-9M=.N]9M_#]IHNG7*V=E]IS?7+)!'
M&SE?E0!M[90Y/&T8YYQ77PZ/IEOIK:;#IUI'8L"#;)"HC(/4%<8J&?PWH5S!
M;03Z+ITL-MQ!&]JC+%_N@CY?PH \TCMK+5_ _ARXU$0W2PZ\;5)6<NHA^U.@
M4,>2NT* 3S@"M74[.2]\:R:0=.TR[T^VT^%K"SOKQXHBI+!W51&X<C"C)^Z,
M8^]7?R:98364EE+8VSVLI+20-$I1R3DDKC!R>?K4-WH.CW]G#9WFE6-Q:P "
M*&6W1DC &!M4C X]* ,?P?(UAH++>ZC8O!]M>*U,-X9DC4MA8?,<*6(;*@8]
M!6IXDU&#2/#>HW]S'+)#!;NSI$Y1F&.@8$;?KGCK2W6AVER=,15$-OI\XGC@
MB4*A(1E48[ ;L@#N!6BZ))&T<BJZ,"&5AD$'L10!YMIENVC^.M!ABL]+T[[=
M#/YL%A<O*94";E,A*J&((X;&>O/6J9T6TE^'?B36Y!(^IVL^ISVER9#OMFBF
ME*",Y^497.!UR<UZ-8Z!H^F$&PTFQM"&+@P6Z)AB,9X'7!(^AJU]AM/LLMK]
MEA^SR[_,B\L;'W$ELCH<DG/KDT <9K.KGPIJRZ[-N>TU.PV/&.ANXU+Q@>A=
M=R_55KI/#.F3:1X>L[2ZD,MWM,ES(3G=,Y+.?IN)Q[8JGJVDWVLZQI\$L-K'
MHUE.EV6$A:2:1 =B[-N%4-ALY.=H&.M=%0!Y/<Z3;'P3XNUUC(VIV=[J,UG<
MESOMC'*Y41G^$9&2!UR<\5OOHUGX>\4^%I--1H9+R2:WNWWDM<CR'?,A/WFW
M(#D\]?6NQ-C9FVFMC:P&"8L98C&-LA;EMPZ'.3G/6I'MX9)(I'AC9X26B9E!
M*$@@E3VX)''8T >2:U<Q3Z7)XHL=/L+%CJ 6"\DO':]=A.%(QC"@X;]WN("]
MAT'36VC:3'\5M3F-I +G^S[:XB+'!,AEG#,/?[OZ5T__  CNB&\FO#H^G_:I
MO];-]F3>_P#O-C)_&K$^FV%U=P7=Q96TUS;_ .IFDB5GC_W6(R/PH \EL;2_
MU'PFVKSIHMMK)9O,U:YU65+BVN-V-I7ROE"M\OEYP1QSG-=;_9%MK'Q)U$:F
MGGQV^F6;K 6)B\PR3_/MZ$C;P3TS73OH.CR:F-3DTFQ:_4@BZ:W0R@CI\V,U
M<6"%;A[A8HQ,ZA'D"C<RC. 3U(&3CZF@#S]]0BMM'\11W-NUV+GQ ;2.)K@P
MJ6?RPH9QRJ9Z]<],'.*KZ;$VF>(=>TM(=/M(CHQFDM-/E9HDDRP!((&&(/.
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M=H&: .9^'FD6@T9-7D0S:A)-=)]HE8LRIY[@(N?NKA1P._-'C+4V\+:S9^(
M&>*:UFL7C[/+CS(!CU+*Z?\  Q78P00VT0BMXHXHP20D:A0"3D\#U))_&DN+
M6WNT5+F"*95<2*)$# ,#D$9[@]#0!YC96]Y875GX"N;J6>:2\@OGF9CE[<*9
M9>?0SQLOTD K4T_PSI>N>(/&,FI0?:,:@L<:NQQ$?LL)W)_=;D?,.>!7=&UM
MS=K=F"(W*H8Q-L&\*3DKGKC(!Q[4L=O#"\KQ0QHTS;Y"J@%VP!D^IP ,^@%
M' :'?75\GPZN+F=Y)I[&5I78\R-Y"\GU/>CPSI^AZGH0UK7I(VUA;A_MES-<
M&.6VF$A'EAL@Q@8 "C (QUS7=QV%G"+<16D""V4K %C \H$8(7^Z,<<56FT#
M1KC4EU&?2;&6^0@K<O;H9 1TPQ&: .1T_P ,Z7KGB#QC)J5O]HQJ"QQJ['$1
M^S0G<G]UN1\PYX%=#X(NY[_P-H=U=2M+/+8Q-)(QR6;:,D^YK:CMX8GE>.&-
M&F;?(54 NV ,GU. !] *(((;6!(+>)(H8U"I'&H55 Z  =!0!)1110 4444
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M3QVZ;Y;=\JV[9U(."#C)X7CT .A@\3Z1<:5>ZBMRRP6*LUV)(722#:NX[HR
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M#3>;\OE@\%@F-_*]P,D"@#2_X2G15T-]9>]$5C'((I9)8V0Q.7";74C<IW,
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M+5Y-0C%A*XC6;#$;R2-I&,@Y!!!Q@\&KVGW\6I6:W4"7"1L2 +B!X7X./NN
M1^5<,-"U*;3EN9=/>-KWQ+#J1M#AF@B#(,M@D9^3><$X+5Z'0 4444 %%%%
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M+/5UN_[/ M;A3>6OVD.(RT<8PIVL_0-\W [X- &3J'A62[\(:7HZ7,/G:?\
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M,\A5'XDFK%QX<ODET"YL+VW2YTNW>U83PLR2HZH&(PP(.8P1^-=*S!5+,0%
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M4#G.%]ZT=0\*Z5J5[)>2I<Q3RJ$F:UNY8/.4< .$8;N..>W% '*7FL>(IO\
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M;-IK9_+6;9)*@E ' )"9XX&3BM+3]+:R\=^)ITU'4':"PMG DGW!BPGX88Y
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MQYZ[70A@#W&<&@#F/$,NI:,=&T2TNM6O%O[B7S)HWB^TB-$W"-7<J.?[Q);
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MY)"@G.!6EIEA'I>E6FGPDF.VA2%2>I"@#)]^* +=%%% !1110 4444 %%%%
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M(2.ZGM]5M"AMH2/LJ>8,A^/D&.-IP<XXXX /0TGAEEECCE1Y(B%D56!*$@$
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M@@N VUB/135'P^T.J>+XM1@UZVU%[>S>*0V.GF*-E9EPKR;V!8$9"]1\W3-
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MWCV8,D7V2-2R\<C<K#CN*A.F0VG@+P6+>U$<D%WIK@JF&4LR"0GOR&;/U.:
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M\VXGDN)I)7GGGD #2RN<LV!P/0 =  *OS1F6"2-9'B+J5#IC<N1U&<C(I]%
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M!(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %074IB12 3SVJ>HY=
MNT;NF: *BWH[J1^%2K=1GO3ML9["CR(SVH&.$L9[BG94^E1?9H^PH^S =&/Y
MT")=BGL*0Q(>U1B)QT<T[;*.^: '>2O;BCRR.C&D!D[BG;V[K0 ;7'>C+CM2
M^9[4N]: $WGN*-_M3MP]:.*  ,#02,=:,"D* T <YKY1G381N&<URUP\RG@
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ME_UW3_T(4"/7:***"0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MJK?.\<:E%R=U6JAN75$!;IF@"@MW*.L9J07I[HU2"2(^E/!B/I0,C%XO<'\J
M>+N,T[9&?2E\J,]A0 "XC/<4\2(?XA3/(C]*/LZ>E B4,I[BE^4^E1?9U]_S
MH$&.C&@"7:OM1L7TJ/RF[.:-D@_BH ?Y:TGE^YI,2CN*,R^@I@."8[T%6[&D
M5G[B@N1_": ,/7(Y5C$A;*@]*YJ6:,9W&NFUJX<Q!"A"YZUS4T2.#D"M([&4
MKWT&P3QY^4@UIPW) 'RUEP0Q1MG%:T$D(%61J3K= D96K*RJW:H%>%B.14ZK
M'V-(:)ATI#3@!BD- QAJ)ZD-1O5$LK/41J9ZA-,EB&FFG4TTQ"5QOC$?Z'+]
M#795R/B\?Z%+]#51W(GL>1"D-+2&H+&FF&G&FF@8TTAZ4II#0,BD^[67(/\
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M4=%GC_\ 0A1N+9'M]%%%9EA1110 4444 %%%% !1110 4444 %%%% !1110
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M"BBBLR@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI63>?>%:[]*R;T<U+V&CO?"I_P!&7Z5T+KDUSGA(YMU^E=.R_-7)+<]2E\)
MT51M#5S;2$ =ZBQI<SS!3&A-7F*BHR118+LI>410(SZU;.VF@;F"J,DG 'K3
ML)LZOX?:-]JU-K^4'RK?A<]"U>D!_,N!CH#63I5JNC>'[>V&!*R[G^IZUJ6
MW?,:WBK(X9SYI&@U0OTJ9Z@8T$DD1R#5/4%/E%1WJY!U-,N$W$_2F!R<B?O!
MZ=A5B+";3WS2WL)$A XQWJJ\V#WXIB.BM)?D%7)5#QUCV<F8P0:UHG#)BD,\
M=^,0$2:5"O :61S^2BNFT*/RM!L .T*_RKE?C0W_ !,M)C]!(?\ T&NFTBZ
MLK6!^"(4_D*[:G\"!Q4_X\CI;:Y 5>>E=#%()HA(IX(KAW9XCE3Q6]X?O?-$
MD#'G[P%<;1V(W"/EK'UVT%U:$$<BMKMBJMPFZ-AZBIV*9Y/\3KN6XTK2,LP#
M%PZ#IO&!7!O8R3Z6Q7.Z,[P/7UKU/Q;I U+1YD5<S6[&:,>I'WA^(_E7GMM<
M!&!'(Z&NM)3I\IQMNG44C)M)OW0 /-74<GD]:JZC;?8[L31#_1Y3QC^$^E/B
M;(!KS)Q<79GLTYJ<;HMAL]33-V3Q3"V!Q72Z396MA8IJ%Y&LT\@W11/]U1ZG
MU/M3ITW4=D*M5C2CS2':)X5O=3Q+(I@M_P#GHXQN^@[UVL>BV.@:=+=;=S(A
M(>3[Q/M7$W/BS66<^3>.!V 48'Z5TG@G2KW6;LZUK-Q-/# <0)(WRE_7'3C_
M #TKN6'5)<S/,>+E6?*BSH7A^XGF_M6^7RVDY2,]57L*["&/ QZ4Z63<^*DB
M'(%92DY.[-(0459&;K!E546-R%QD@=ZY[47Q&D7<?,:ZK5=J.K./E"9KCKIS
M+*SGN:2*90D(CC9SV%<E=,US<GW-=#J\VR#8.K5DVUO_ !$<U1#"&WVJ !5O
M9M3FIH8<+N-5[F49('04QE:9L$\U0E=BU6&.YL5!,AR.*!''^,(RT:-_=C)_
M\> _K1X+BWG?Z'^E3^,E*6\7O&P_\>6G>!U'V25O1A_*M_\ EV9;2/0M,EQ*
M%[C^5=K8(&B)]J\]L)L7Z<]>*]"T\[;8Y]*YV;(T/)"VJH/[N:X&YLI=4UXV
MD8."_P Y]!7HNY22#VK*BMX;*\EN47+2=:E%,GNWBTRPCMH !M4* *S+:':&
MF?K2R.]W<%GYYX%/O'$,&T=:H1CW\GF2$9XKIO!MKY<;RD?><5S"Q&1\]J[S
M2(OLVGVPQ@NRG]:3!'1T445F4%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !5'4[-;R!$:38%;.<>U7JS-:F,-M&1W?'Z&F@*(T6 =;H_@O\ ]>GC
M2;5>MS(?I6<;UO4TGVMCWIV$:HT^Q7K+*?\ @0IPMK!?[Y^KFLC[0WK2>>Q[
MT6 VP+%>D?YL?\:/.M%Z0K^-8GFMZTN\GO18#5DOH%!VPIGZ5PVIZAJL/B5)
M[>Y/V,_+);L>"/5?0UT+$XK"U2'+;QU!XI@=,+:[90RS@@C(.*3[->_\]A^5
M2Z#NO=*C8-@I\A_I^E:?V&0_QFBXK&*;>]_YZK^5-,%]_P ]$_*MO[!)_?H.
MGR'^/]*+A8P3!=9Y<'Z5%+',HP370KIL@;)?]*;/I+2*!OP1[47"QR4@F&[O
M6?-<SI_RSS74WVD300LZMN Y(Q7,RW<2_>-6C.7J0174[-CRB*O0R7![$532
M]@W<'GZ5:2\'851'S+T?V@X^8U?A:0?>)K+COFR/EJY'>$\$4QW1KQGY>:4F
MJL<Y*BG[\TK!<>33&--+4TMQ3"XUN349%*QIFZF(#3:7-)3)$K%\0#-F_P!*
MVC6-KPS9M]*:W)EL>)W/%U+_ +QJ(U/=C%Y,/]HU :EE+88:;3S330,::0TX
MTV@9&XXK+O16LW2J5S%NJ7L-;G7^$/\ 4+]*ZN3K7'>&KF.W0*QKIVU& _Q"
MN22U/2I22B2,Y%0/(U--] ?XA3?MEN?XA4V9KS(:S/Z5&6>I&N[?^\*3[3 ?
MXA19AS(CWMZ5I>'(3>>([&$C(,H)^@YJ@9X3_$*W_ SQ-XLM@""=K8_*G%.Y
M%2246>@ZM*T=TO\ = QBM/2I0\8(K.UB,M.>*@TJZ-M<>6Q^5NE='0X3J6-0
M/P?K4FX,F13.'7%(9)#T-.^\#]*9"<!@>U/0C-(#'O(=Q(K"OD*\+UKJ;I/F
M)K$O(<[CCK5(3(M.N/W>TGBMBUGP.:YJV)279ZFMBWD^8CTIM"/,?C(=^MZ8
M?]A_YBN@U.!].;3[E!^[>! V/7%<]\6L-=:5,"#EY5Z^FW_&O26L8M7\,6J9
M!S A5A_NBNRKI1@<='6M,IVN+B!6Z@BK-HK6UTLB<$&J.AEHBUG/Q)'QS6W+
M#M&0*XGH=JU.@C<21JZ]",TUAD&J&F3[5\ICUZ5I8J2CE=3A:*=B#@-T/I7E
M7B#3?[.U -%'L@F&\+V5LX8?3(_45[3JUMYT9P.17G_B*S-S9E6'0Y4^C?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQKLL$>>]8=W<;F/-6;ZZR2 :QI9,FF(;(_S'FF 9H ))J1%-  BUK:1:F>Z
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M>4445F4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ7&HS#WJK5S51C4YOK5,U#W+CL---S3C3*"A:2BBD E)2TE  *7%*@YJ4 4
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M/A9U@7O4L)8<,>,TQ3BI5Y-<9V$=U&)T9,5PFOZ2E];O;2C!1PRG'O\ X5Z
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MBVF6U:RR<XN$_P#0A5"L>H4445D6%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7-^,SC3;?_ *[?T-=)7->-3C3+?_KM_P"RFFMP9Q>>:>&J$&E#
M<59).&J16XJL&IX:@"R&J16JLK4\-2&6E:I5:JJM4JM0!9!XJ.9=R&A6XI6/
M%(92TEU@U>-)"?+9MK<XZ_Y_2NZ_LJU_N9_&O/+T&.42#L:[+2;B[O=.CG\]
M2,8(QSD4"-/^S+0?\LA4PMH0N-@Q6):S7UY<S+Y^R-&P,+UK4^SS;,&=ORH
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M:4445 PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YCQN<:9;_\
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M%\YR@IDJ9%0>&R7\.63%@V8@<COQ5Z0?+4]2UL5FZ#':F,,H?K3_ %II&$H
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M['^CM]*FJ&ZYMV^E,1X]XF&-4K&-;GB@8U+\ZPZF6Y</A$-(:4TE24(:***
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MQKW^VN(-4L(KJ!@8Y5##O^%)@B_!J5NZ"2*0.OM45WJ\DGRQ_**PKO2VC<O
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MZ'Q:,7B_C7.U,MRX; :2C-%24%)2TE( HHHH&**D7K3!3UH L1(7D5%&2Q
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M=S*/8]=0<4N,52TS4(K^P@NHF!25 P_$5=,@I%%75+HV.D75PI_>;#'%[NW
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M]X4#-BBBBLR@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4V@W4A\LDR6;-_$O=?PKLS?);Q-<RJ6C3^%>KGL!7"ZG';ZE&D*"6=H_F6[
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M26YXJG<M*ENCP(Q/FCH.VT"A :CV(:,/;JJ>P4<UGR;6)AN(0#V..*V+8^5
MH;]>M)/'#,F3B@#+M=-0<^7&>?[HJ^((XU^5%4^PI%D6)-J'(I/-)[4Q#E;&
M1@U,KL.V*K&8#J0*3[1S@<T 7Q)G@BA!^^0C^\*H&1R.#3+>:0WD8))&\?SI
M#.EHHHJ!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5SWB[;]@@W
M?\]?Z&NAKE_'&BOK>EV\,=S);M'-OW)U/RD8_6FMP.<C:/U%6%>/U%<X_@S7
MH>;?6V/M)&#4+:+XPM_N75I,!ZH15".MW(?2ERIKC2_BVW_UFGPRX_N.?\*8
M=?UFW_U^AW7_  #!H [)E4FFF,5QO_":K'Q/87T1_P!J$U+'XZTLG#SLA_VU
MQ0!URQ@4\(*YR'Q9IDWW+V$_\#%7H];MI -D\;?1A0!L!12A16<-2C_O"KUH
M7NB"H(7UI/0:U)EC+G '-7X+0(-S]:?'$D"9/6L[4-62)2 U1*1K&%RU>7R6
MZ$*>:Y'4=4>5R >*KW^K&4D!JS/,+G)KEG.YW4:5M6=EX2G+[\^M=9<?,E<9
MX1/+_6NV<93\*UI?"<^(TJ'-ZC#N5JX'6;7:Y..]>E7R\&N%U]>N*4T.FSBV
M.QJ=YO%,FX<U&.E)&C)O.([TJW!SUJLU-S@TR;&@)\]Z7[U4E)JS&U A7CQ5
M"]N7MTRIQ6H1D5F:A937*[8D+$^E)EK1E6TUE\\M6G!K,B3*R&LVV\,:@5SY
M+?D:U;#PQJ+SJ&B(&>IJ;2Z&G-"VK-:;QI]D@"F%Y'] ,UFR>+M:NCBVLF4'
MN179Z?X0C6(-. 6K8A\/6D?\ KKC>VIYL[7T/-(SK]ZW[TE0>PK;T_3=2C((
M0$^I&:[^+3K>/H@%65BB7HHJKD6.9MX-6P!OP*T(K;4?XIJV@8QV%.\Q: *,
M4%X,9E-7$CG'60T[SAZT></6D!,@<=6J4$CJ:J^<*/.'K0,N!J=OJEYPI?.]
MZ +H<$U/&5/4"LY90:M12"@"X\<<L+1D<,,<5SSP&VN&AEQZJP[BMU9!BL_6
M8_.M/,0X=.X]*B2NC2G*SL4O)*-O0UB>*+EXM-D"':2*M:;K(:8VMP-KCH_9
MO\#6E<VUM>Q-'-&&4CD-66ZT.A/E=V>*.S9WG)8GDU<A4M'R*ZGQ)HMEIL+2
MQ1A<?P[N#7(1ZO:9V-'+']1D?I4V6QKS/<G@GO-+N//M'P#RR-RK?A_6MB\\
M=Z<-/)NX9H;A1R%3<#]#_C6(+E)<^6P8>HJ&6R2Z&V5%(/;VHM8=^8Y:_P#$
MNJ6/C**]NK>2VB50L<9_BA;G.1P<@Y_*NTM?"^B:HR^2[>9*-Z9;&\'G(/>L
M;6M(?5?#LEL5WWFCCS(/66V)Y'N5YIG@"YN+NW^R>3,TL#;K>78<;<\C/L>?
MQKH>D;Q.!6E-J9T,OPWASP)A]&JK)\-P 6$LJ@=2V.*[6\\96$-RUM;)+=W
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MG]2/Y4"]#4;7AWE"+[4^+7(G<*CY/N:;!X9T>!?WBRW+#^*60_R&*UK%;6W
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+C[,P_ TG[5ZR3*7L8Z1:.]ET,3R,_\ PDDN3SUQ5BST*XMI5D3Q L@!Y20
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MK':EI@ %+B@4X4 )MJ2U7_3(/^NB_P Z;BI;8?Z7#_OK_.D!U=%%%0,****
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MU\QSS@4Q&Q<ZGP?FK'N+]WS@XJA+>#G')JG),S=^* +$USR<L2:I3.913&D
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M*OKH^T<&I%TPCO7,SI15BCS5^*/ IR696IUBQ0,%%/H I<4 +1110 44F:*
M"BF23)$,NP K%O?$$<9\N!3(_H.: -J25(EW.P K$O/$4:,8K53+)[5G_9K[
M4VW7$A2,_P  K5L].@M5 11GUIV SDLK_4FWWDI2,_\ +-36M:Z?;VJ@1H![
MU9 P*6@04AHS24P%S2TRG"@0\=*<*8*>*!CJFMA_I</^^O\ .HA4UM_Q]1?[
MZ_SI =11114#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK0"*YIA%3%:;MI#1'BC%/Q1BD,;BE I<4[%(8@%/44@%/ I#'J*F2HE%3H*
M)5J5:C45*HH&2+4BBF+4JBD ]14RBF**E44P' 4\"D J0"@! *>!0!3P*!"
M4\"@"G 4 )BFD4_%(10 S%)BGTF*8#,4;:?BEQ2 :!3U%*!3@*  "G8H IU(
M8TBFFGFFF@"-A49%2FF$4 1XHQ3\4F* &XI,4_%)BF(3%&*=BB@!N*0T[%!%
M $>*,4[%&*8#<4 4M+0(**** "BBE% !3A24X4 .%/%-%.% QU3VG_'Y!_UT
M7^=0"IK3_C\@_P"NB_SI =A1114#"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K@/BS_ ,B_9?\ 7U_[(U=_7G_Q:_Y%^R_Z^O\ V1J:W \BIV:C
MI0:L1)G-+3 :6@"0&EI@-.!H D%+3 :<* 'BG9IHXHS0 [-"#>V*KR3!>]1I
M>!6ZTF[%1C<ZC3;>-<&NBBN(XDZBN$BU<1KP:237)&Z$UE>YLH'<RZK&/XA5
M";6D&?F%<4^I2/WJ!KJ1NYHN'*CKY-<'.#5676B>AKF/,8]33MQ-(=D:TNK.
MQZU3DOW;O5,YHVYH$[$CW#MWJ(LQ/6GB/VJ18O:F2R *QIXC-65B]JE$7M5"
M*JQ5,D6*G$52".F(9&F*MQ+3%2IXUID,LQ597I5>,<U:6K1#$(S4;+4YJ-A5
M$E=EJ,BK#"HF%(HCQ1BG8HQ2 3% %. I<4AB 5(JT@6I%% P45,HIJK4JB@!
MZBI5%-45*!2 <HJ5135%2** )%%2J*8HJ510 \"G@4@IX% "@4X"BG 4  %+
M110 4F*6B@!N*,4ZDI@&*,4M%(!12BD IU "BE[4@I<T (:0TM-- QIIAIQI
M#0 VC%+10(3%)BG4E "8HI:* &T444P$Q2&G4E #<44M% A*6DI: "EI*44
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MS,\C'PEU3_H(6?\ X]_A3A\)]3'_ "_V?_CW^%>M446#F9Y0/A3J0_Y?[/\
M\>_PIP^%FI#_ )?K3_Q[_"O5:*8KL\M'PNU$?\OUI_X]_A3Q\,=0'_+]:_DW
M^%>GT4!=GF(^&6H?\_UK^3?X4[_A6FH#_E]M?_'O\*],HH"YYJ/AMJ _Y?;7
M_P >_P *>OPZOQ_R^6W_ (]_A7H]%.XCSY?A_?#_ )>[;_Q[_"I!X$O1_P O
M5O\ ^/?X5WM%',Q6.#_X06]_Y^K?_P >_P *:? =\?\ E[M__'O\*[ZBGS,.
M5'GY\ 7Q_P"7NV_\>_PIA^'U_P#\_EM_X]_A7H=%',PLCSO_ (5[?_\ /Y;?
M^/?X4?\ "O+_ /Y_+;_Q[_"O1**.9A8\\'P]O_\ G\MO_'O\*7_A7U__ ,_=
MM_X]_A7H5%*["QY\/ %\/^7NV_\ 'O\ "G#P%?#_ )>[?_Q[_"N_HHNQG!CP
M)>C_ )>K?_Q[_"G#P/>C_EZM_P!?\*[JBB[ XD>"KP?\O,'Z_P"%.'@V['_+
MS!^O^%=I11<#CAX/NQ_R\0?K_A3QX2NA_P O$/Z_X5UU%%P.4'A6Y'_+>']?
M\*>/#%R/^6\7ZUU%%%P.9_X1JX_Y[Q?K3AX<N/\ GM%^M=)11<#G/^$=N/\
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M*Y__ (3GPS_T&+?]?\*/^$Y\,_\ 08M_U_PH]A5_E?W!]8I?S+[T=!17/_\
M"<^&?^@Q;_K_ (4?\)SX9_Z#%O\ K_A1["K_ "O[@^L4OYE]Z.@HKG_^$Y\,
M_P#08M_U_P */^$Y\,_]!BW_ %_PH]A5_E?W!]8I?S+[T=!17/\ _"<^&?\
MH,6_Z_X4?\)SX9_Z#%O^O^%'L*O\K^X/K%+^9?>CH**Y_P#X3GPS_P!!BW_7
M_"C_ (3GPS_T&+?]?\*/85?Y7]P?6*7\R^]'045S_P#PG/AG_H,6_P"O^%'_
M  G/AG_H,6_Z_P"%'L*O\K^X/K%+^9?>CH**Y_\ X3GPS_T&+?\ 7_"C_A.?
M#/\ T&+?]?\ "CV%7^5_<'UBE_,OO1T%%<__ ,)SX9_Z#%O^O^%'_"<^&?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA:Q74C-(8R[,26 55'4_X557$1@TEW2?S5R:6&E--OLVODTCSI5+,%4$L3@
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M<M+'*5N?KVN_EMN==; .-^3IWLM.^^QYQ174V?A2S72(M5UG6%T^TN'9;8"
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M6-T_WY[>.1OJ5!_K7@9IAXPDIQZGT.58B52+IRUL7****\H]<**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** ,+QCI3ZUX4O[.)=TQ3?&!W92&
M_'&/QKYU(()!&"*^IZ\Y\9?#7^T[F34M&:..Y<[I;=CA7/JI[$_E]*]7+L7&
ME>G/1,\G,\'*K:I3U:/'J*VKCPCXBMI#')HMZ2.\<)<?FN14/_"-:]_T!=1_
M\!7_ ,*]Q5:;VDOO/!=*HMXO[CL=9G\(^(H=,DN?$,EK+;6:0,BVDC<@<\XJ
MCX?O?#_ASQ-<O#JK7%E)8/&L[0.I\PD?+MQGMUKG/^$:U[_H"ZC_ . K_P"%
M'_"-:]_T!=1_\!7_ ,*Y52IJ+ASZ>J_R.IUJCFI^SU[V?^9IZ%JUC9^$?$-A
M<3;+F\6(0)L)W8)SR!@?C7;Z'X@T72[!//\ %;7NG"W"&QN;7+[L= >N.V.1
M[UYK_P (UKW_ $!=1_\  5_\*/\ A&M>_P"@+J/_ ("O_A15H4:E[RW=^G:W
MZ#HUZU*UH;*W7NW^ITEKJ.@ZQX1?1KR_.E-!>M<P$PM("AS\O'<;C^0JU>^(
M]#.O^%);6Z<V>G1+'*SQL&0# &1CD\=LUR/_  C6O?\ 0%U'_P !7_PH_P"$
M:U[_ * NH_\ @*_^%/V-*]^?OU77<7MJUK<G;H^FJ-BP\2VVE_$2YUI TUG)
M<S$E1@F-R>0#WY!Q6_JGB=([&\EM_&MQ=&1"+>V2Q56Y[.Q&,8X[>OM7$?\
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MW?6$OFV\@C"OM*YP@!X(!ZBJ7_"-:]_T!=1_\!7_ ,*/^$:U[_H"ZC_X"O\
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MUKW_ $!=1_\  5_\*/94=?>WNMUU=V'M:VGN[-/9]%9&W'K>GKX4\2V1N/\
M2+V[62W38WSJ'!)SC X]:NWMYX>\6V6FSZAJ[:7>VENMO,C6[2"15[KCIW_/
MVKE_^$:U[_H"ZC_X"O\ X4?\(UKW_0%U'_P%?_"CV=*]U.SO?==K?H)5:MK.
M%U:VS[W_ %.JT'5]'L-"N["SUG^S+T7187[VA=IH>P&,E?I_B:GU3Q1I-SK_
M (6N4U&6XCL?^/F>6)@V<CYB,<YP3QFN._X1K7O^@+J/_@*_^%'_  C6O?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0I(YR<#@^E<Q#;SZ?I>J:)JFH:M'//<7.^U@TM9A>+([$,C["&W*PZM\O0X
MH ]%U'Q#I&D2^5J&HV]O*5#"-W^8@D@8'4_=;IZ&HKSQ5H.GSO!=ZM:0RQOY
M;H\@RAP#\WH,,O)XY%9&FZ2;7Q[#(\4THMM!AMDN9ER21(VX%AQN. 3BH]/T
MTB;QW)):-ON[HJI:,_OD%K$ !_>&2P^N: -^#Q)HMSJG]F0ZG;27N6 B5P22
MOW@.Q([@<BFPZG';_P!IS7VJ6C6]O<B/Y5V?9\JF$<DG+98'/'WA7+C39(O!
M7@:&.SD66VN+!G01G=%\F')';J<Y]3FJNLZ;<7/A[QQ;M9S2"YU:(HGED^8F
MRV!(]1PW(]#Z4 =KIWB/1M6NI+73]2MKF>-=Y2-P25SC</49[CBF3^*-"M=1
M_L^?5;6.Z#!#&T@^5CT4GH">, \G-4-7M7_X3+PO-# WEQ?:D=T3A%,8P"1T
M!('Y5Q-O:3V>@7WA[5=0U=;F:2=);.WTM9?M7F.QWI)L(;<"#N+#:>N,4 >M
M.ZHC.Q 51DD]A7!:EX^L=5\(^*7T>^2.^T^WN3$8Y S$(O$H]LD5W%I";>S@
M@,CR&.-4+O\ >; QD^]>=:AYO_",>/\ 1_LMU]NF:\N(8Q;N1+&\:[2K8VMD
MG& <\'CB@#M=/\2:-J-Y]AM=3MIKL*28T<$G'#8]<'KCI1>^*-"TV]^QWFJV
ML%P,;D>0#9GIN_NY[9Q67K5AY5[X/%I;$):W^W]VG$4?V:9<''1?NC\JY:.*
MXTI=;TW4M1U2&6ZO+B7R(-+6X6\21B5VML.X[2%()^7&.!B@#U/K64_B71(]
M5&F/JEJMZ7$?DF09WGD+Z;CZ=:GT:S_L[0["RWS/]GMXXMT^/,.U0/FQQGCG
M%<1/<OINN2PZ,]])+/J:O/I%YIY:-BT@WS1RA1M7&7#%F&1C /% '77?BC0K
M&_-C=:K:Q7(*JR-(/D)Z!CT4G(QG&<U@>(==M)?'.D^'Y-:>SC,4LL\<$WEN
M\N8A$A(Y (=C@=<"L3Q/?:GJ-AXHT^>XU*"X(GAM=-LM.5A<Q[,([2-&V0PZ
MD%<=.HKIHX+AO&?AZ=HI2B:/<I)(5.%8M;D GL3@\>QH U;CQ1H5KJ/]GSZK
M:QW08(8VD'RL>BD] 3Q@'DYJE-XUT>W\6?\ "/RW4*3^4'W&3^,L%$>/4YS7
M#V]I/9Z!?^']5U#5UN)I)TEL[?2UE^U>8['>DFPAMP(.2PVGKC%=6V='\=:8
MUR+N2"72A9)<>2TFZ42+PY4$*2.<G Z^E '1_P!KZ=_92ZI]M@^P,H<7&\;"
M#P#GZD5=Z5YS%8S#Q6O@WRF_LR&\_MH-_#Y&=RQ?A<9./[JUW][)/#87$MK$
M)KA(F:*,G&]@#@?B>* ,^Q\4:%J5Z+.RU6UGN""51) =^.NT]&QWQFFWGBSP
M_I\SQ7>KVD,B.4=6D&4(QG=_='(Y/'-<+#=7VJW?A>5KW5+NXBOHY+JV&FBW
M@L_W;J1DQAP06VXWGC)-=)H>FA?^$R::T(:[U"49>/\ UJ>1&!CU&=P_.@#H
MM0U?3M)M%NK^]AMX&(5'D<#>3T"^I/H*P],UZ/5O&\T5C?I<Z>-,20+&V563
MS7!SZ-@ 8-8&FK-I,/@K5]4M;E[.VT7[-*1"SM:3LL6'90"PR%92<<9YQFM3
M19X=1^(U_J5II]Q%;2:9%']KEMVB%PPD;IN )P,#)Z_3!H Z^YN8+*VDN;J:
M."")2SRR,%51ZDGI6;:^*-#O;>YGM]4MGCMEWS'=@QK_ 'B#R![]*S/'UC>7
MNAVK6@F9;6^AN9T@C$CM&I.=J$$.0<-MQSMXYQ5+0ECU3Q7!J*ZKJE^]K:R1
M^;+8"WBPY7Y"VQ2S94' SC!SC/(!S2^,[8^$)-1/B=UU+4;Y(''G#%M$;D*?
M+3&%(B.<]>YKT'194^TFWM]7CO+1;2*6)')>8!R^)&<GYE;&!Q_":Y6&QNQ\
M-=)MS:S><FKP.T?EG<%%^&)(ZXQSGTYJ]K.F:A?ZWXNAL@\4UWH,$%O,054R
M9N> WJ-R_3(H Z"T\4Z#?7XL;75K2:Y)*JB2 [R.H4]&([@9Q1#XIT*XU(:?
M#JMJ]T7,8C60'<PZJ#T+#!X'/!K-T37]*FM]-TR#3;R"YB0(+1[&1?LI52/F
M8KM4=@0><\9S7'S7NJ:Q8:2US<:FVHKJEI+=:9#IHC@M,7"%LL8]Q YY#\]?
MNYH ]$U+Q+HNCW"P:AJ=M;S,N_8[\A?[Q'9?<\5<M=0L[YY4M+J*=HMOF"-P
MVW<H9>GJ""/4&N1L;^W\,Z[XA&L6]RLE]=_:(+F.UDF6>+RU54!13RI!&T^N
M1UJMXGFN]&N[75M&MI(I-;M5TL0E-IBG()MW9>VW,@/IQZ4 =S:7EM?VRW%I
M,DT+$@2(<@D$@\_4$51U+Q-HFD7 M]0U.VMYMN\H[\JO]YO[H]S@59TK38-'
MTBTTVU&(+6%8DSU(48R?<]:Y33=0M_#&J:_%K%O=+/>7SW,,\=K),+F(JH10
M44\J!MVGGC(X- $OCCQ+:6%AIENFL)9C4+N%6GBD ;[.3EF1N<< #/OQ75V*
M1I86ZPS/-$(UV2R.79QC@ECU)]:X&TTJ_M?#'AR&2SEBQKPN5MMN3;0-)(R*
MV.FU64'TZ5Z!<I)+:31PR>7*R,J/_=)'!H S#XKT!=1_L\ZO:"Z\SRMGF#[_
M /<STW?[.<UI?:[<WIL_.3[2(Q*8L_-L)QNQZ9!%><)=VR?#3_A$WTB\.L_8
M39FQ^RN=T^W'F>9C;M+?/YF??KQ6Q),_A[Q;97FJ^>\$NCI:-=1PO*#.C[B&
MV@D%@V1GK@T =/+K6F0023RW]O'%%-]GD=I %63IM)['D5)I^I6>K6BW=A<)
M<6[$@2)T..N*\Y%G<:GH%QY^F7*I<>+(IC!-"0QA,T9W,N.!MY.>G.>E>H4
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M;.&26-H?M4X\P[@& . K!-Q'.>.!0!H>)O&>F/H%VNCZU;M?*\03R9 2W[U
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MXY%#(X*LIZ$'J*\GMM%U>?3[GS+2?[1X4B$&EEU.;AHY?,ROJ&BCA3/^TPH
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M';VNG0G:6)"()' 4OAG)/RC S]:[(9P,]>^*H:)JT.NZ)9:K;)(D-W$LJ+(
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MGEN[;U 4AL^8>"5Z=:M>)M)GUK2%M+=XTD%W;3YD) VQS)(PX!YPIQ[UL44
M<MXL\+#6[[3M2CLM.OI[(21FTU%,Q2H^W/.UMK J"&P>X[UGOX6MH_"^L1W]
MKHGAY+@(PDT] !!Y9#(TDA"A\.,XP!VYSFNYILD:31-'*BO&X*LK#(8'J"*
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MLH&%*H7.>?13TH OUQ%GX6UE/"MCH4_V$+I][:RPSI,Y\Z**<2$LI0;6VK@
M%AGN*[9F5!EF"C.,DXI: ,6^T:6\\4V&I%H_LL%E<VTB$G<QE:(C'&,8C;//
M<5R5C\/FL+:#2QX<\+7,$)5!J5Q!NE:('^.+9\SXXSO )Y]J]'HH  ,# KD!
MX4OA\-E\-^=;_; @7?N;R\B3=UQGI[5U]% '$ZUX-\WQ)=:Q#HFBZP+R.-98
M=2&UHG0;0R/Y;\$8!7';(/:DO?"%T^BZ5;Q:?HKBUN6N+K3(T-O:7&X, .%;
M)7*G)4@D9P.W;T4 <$G@K4&TCQ9;B+2K)]:M!#;V]ID10,(V3#$*,]0=P'KQ
MP*V[S2M3C\4:=J]BMI,D=H]G<1SRM&55G1MZ$*VXC:?E.,Y'(KHJK65_;:@D
MS6SLXAF>!\HRX=3AAR!GGN.* ,2U\/74&@:_8-)"9=1N+N6(@G:HESMW<=1G
MG&?QK9TJU>QT>RLY2K206\<3%>A*J <>W%6Z* /-+SP%JESI]_8_8=$DN9[A
MYAK,[,]Q(IDWJI4IE2!A<AB !P.U=G;:3/#XNU+5F>,P75G;VZ*"=P:-I22>
M,8_>+CGL:V*S]6UBWTC31?2AY8C-%"/*P3F218P>O0%AGVS0!SO_  B6H1:;
M&UO<6RZE::Q<ZG:EMQC82/)\C\9&4E() .#SSCFPNF^(M2\3:1JFHIIUI:V/
MG9MH)WF9RZ;0V\HH_#'J<GH.JHH H:U!=W.ERPV45E-*V 8;U28I%S\RG&<9
M&><''H:XY/!>IMHNLVT$=EIB7DEN\.F6]Q(UNHC;,BEMJE1*/E8*N  .O->@
M44 <;H7A>ZLO%4.L'3-'TNV2QEM?LEAR=S/&P8ML0'[A&,<<=<G$,W@:6Y\&
MZ?I=Q]AGN["\>\C2=#);R$O(=C@C."LA&<<'GG%=Q618:[_:6KWMG;6,YMK-
MS#)>,R",R@*2BC.XXW=<8R#0!F^'/#QL-3DO9/#WA_20(O+1=/3?*23R3)L3
M"\?=P?7/:L]-#N--^&EYHNN26D-M86A$%[!*S'$>664J5&UE(4X!;D=:[FJ-
M]I>FZPL0OK2WNT@DWQB50X5QWP>XH R_!5G=6_AV.[U%0NIZBQO;L 8VN^,+
M_P !4*O_  &G:OI6HKKUMKNC_9I;F.W:UGMKES&DL98,"'"L58$>A!!/3K70
M44 <K!H&IW<NLZEJ;6L>H7]F+*&"!V>.",!R 7*@L2SDD[1V 'KN:-9R:=H>
MGV,K*TEM;1PN4/!*J <>W%6YI4@ADFE8+'&I9F/8 9)K.T'6'US3DO\ ^S[B
MT@F >#SV3=+&0"&PI.W(/0\T :E%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5S_ (RU#4--T!9M+FBBO'O+6!'E7<@\R=$.1Z88^_I705S/CS3V
MU3PVEFMO).LE_9^8D8).P7$98\<@!<DGL!F@"O>2ZQX;U#2II]9EU*UOKQ+.
M>&>&)"C.#M>,HH( (&0V[@GGBL;Q-XGO;&+5]4TO5=2NETYG)@BT]/L8,?WX
MWD9=S'@@E6X/;C%=3:^%;>'4;>]NM0U'4'M23;)>3!DA)&-P  RV"1N;)Y//
M-5+SP'IU[;W]G)>ZBNG7S222V,<X6+>Y)9A\NX?,2V-VW/:@!EW-K&H>.[C2
M;;57L=/@T^"Y;RH8VD+M)*N 74@ A!GC/ QC)K'T2#4=-D\;WHUJYG:VNI#L
MDAA =Q:Q,'.$!R.!@8''3K7;QZ7;Q:S-JJE_M,UO';/D_+L1G8<>N7:J+>&+
M0W^I7*W%VB:DA6YMUD'E.Q0)OQC(;: .#CCI0!C1ZKJVLW6B:3;WYLGGTI=0
MN[N.)&D;.U0J!@5&2Q))!QP .:MWUQJVB/H-K)JAO#=ZL())7@17:$PRMM;:
M,9W(/F 7Z=<W;KPM97%OIZQ375I<:?%Y-M=6\@65$P 5.00P.T9!!&0#3H_#
M5L([,3W=]=2VEY]M2:XFW,TFQDYXP%PQ^50!0!C:8NOZ]<ZRQ\026,-KJ$MO
M;);6\3'"X_UA=3D<]!@^YSQ$GB>>\\,6ANM0ELM2>]FLV_L^U\^2X:%W1C$I
M#  [=V2"%&1[TFB^%Y9[K7K@WNJZ8]QJDY;[/)L$R?+M;#*1Z_,N#[\"MJ;P
MAIIL-.M;-[BP.G$FUFM9!YB;@0V2P8-NR<[@<GGK0!S#>*-8M?"OBYC-<M=Z
M0@>VGO+=$E(:,,-ZJ-IP<\@#((XK7DDUO1]>T2*ZUE[R/5))+>:)H(U6%Q"\
M@:+"@X&PC#%NM71X+TS^S]7M));R8:L@6\EEFW.Y"[<YQP<>G P, "M6]TNW
MO[S3[J;?YEA,T\.TX&XQM&<^HPYH X;0;77;+3?%MQIVI3WUZE]<I#!-%"%>
M7"?/PJ_-[9"^U;OA74GN;R[M9M8O[F9(T<VFI6*V\\6206&U5#(>G ."/O&K
MA\*V8N-2DCN[^*/4"7FABN"BK(=N9%(^96^4=#CKQS4NE^'H=-OI;Z2]O;Z\
MDB$/GW;J66,'.T!54 9.2<9/<T 9&N>)+O0-8U..9A+ ^F?:=/CV@$S(VQH\
M]\F2'&?4U4TSQ!K,[:/HMQ<H=834)H=2E6-0&BA7<6 QQO#P=.GF5TNK^'=/
MURZTVXO4=I-/N!<0[6P-PYPWJ,A3CU440>'=/M_$MSK\:.+ZYA6"0EOEVC'(
M'8G:H)_V1Z4 <18Q:W!H?BK5++66M!9ZE?S06Z01LDNQV8B0L"W)!'RE<#UK
MJ+76[J[\4Z5;!@EI=Z/)>-%@'YP\0'/7@.PK0CT"RBTO4=/7S?(OY)Y)LMSF
M4DO@]NIQ3K?0[.VO[2]C\SS;2S-E'EN/+)0\^_R+S]: . TS7;O3O!GA+3;-
MKB%]068R7%M:FXDC2,DG8F"-Q) R00!DX-=/X7U'5)M4O+*Z_M&YLDB26"\O
M[+[/)N)(:,X55;&%(( ZD'I5P^$=-_L6QTR-KF(6#;[6XCEVS0MSR&QW#$$$
M$$'D&KFE:,NEM/*U]>WMQ/M\R:[EW' S@!0 JCD] .O- '.:U8WDOQ.T"2/5
MKF%&M+MA$L<1"A3!N4$J3AN^3D8XQ4D>O:@? 7B/5&G7[79/J0@?8N%$+R"/
MC&#@*O7KWKI)M+MY]7M-3??]HM8I8H\'Y=LA0MD?\ 7]:Q;WP-IUZ-0A>\U"
M.QU!GDN;**8+$[M]YNFX9/) .">H- %.YO-:U'Q)I>EVNJ-8V\^E-=W$L<*-
M)N#(!MW @$[NX(QVSR(O#NG7T7Q \1/)K5W,D?V8O&\4($H,;8!(0$;>V,>^
M:Z>+1;6'4[?4%\SSX+0V:9;CRRRMR/7*CFHQH-NGB%]9AN+J*:5%2>))!Y4V
MT$*64CJ-QZ$=J //_#LNMZ-\,] UM=79HHUM4;3_ "8_):%Y%CQNV[]^&SG=
MC/;%;.I^(+Z[\4:GIT-UJUE;:=Y<8;3M.^T-+(R!R69D<!0&4!0 >ISTKHE\
M,:>OA>W\/#SOL-NL2I\_SXC967)QZJ*34/#4%YJ+ZA;WU]IUW(@CFDLY%7SE
M&<!@RL"1DX.,C/6@#G#K?B6\M?#5KYC:=>7U[<6US)):[2T<:2,)%1_NE@@8
M ]"><CBM1]0U"QU^?2S?27$<&BFY$DJ)O:4.1N.U0.@Z  >U:D?AZRB.E$-<
M,=,=Y(&DF+LS,C(Q<MDMP[=^M33:-:SZG+J#^9Y\MH;-L-QY98MT]<GK0!QM
MIJ7B*W\.^&_$5WK)N&OY;-+FR\B-8=DY5,J0N\,-X.=V"0> .FM#-JWB+6]8
MCM]7ETRSTVX%HD=O#&SROY:.SN9%;Y?G  &.A.>:UF\.V+:)I^DGS?LU@UNT
M/S?-F%E9,G'/*#-<[K:6,'B*ZGDLO$EE/*B!KG2HY)([P <!A&&PPY7+!3CH
M<4 :W@^_U*_T^_&JW$4]S;:A/;;X4V*51L# [?B2?<UE:'87J?$CQ#*VL73Q
MHEJS0F*(+(&63"DA,@+VP03W)K2\#:3+I&@2)+;-:FYNYKE;=VW/$CN2JL<G
M+;<$\GDGDUH'0;<>(3K,5Q=0SR1K'-%'(/+F"[MNY2.HW'H10!Y_H,NMZ-\-
M-(UQ-78QP^2#IXAC\EX6E"$%MN_?@YSNQGMBMK5=?OKKQ3J.F0W6JV5MIZQ+
MNTW3_M#RR.@?+,R.%4 @  9)SS70CPQIX\+Q>'AYWV&-45?G^?"L&'./4"C4
M/#<%[J)U"WO;[3KQXQ%++9R*OFJ,X#!E93C)P<9&>M "^%K_ %#4-#275+>2
M&Z222(F2$Q&558A9-AY7<N#CL2:YS4_$6L0^'O$ES:W$8N[/6([2U+Q@JJ,T
M VD=Q^\;GKSUZ5V>GV,6FV,5I"TKI&#\TTC2.Q)R268Y)))-9TWA?3YK._M7
M\[R[Z\6]FP_/F*4(QQP,QKQ]: ,LMK&F>)K'3)]<GO(=3M;CYY((E:VE0*0R
M;5 (PQX;=T')YKGM(OM0\,> M4U1+^>]D_M.YMX8984*I(]ZT?F810S<MN*Y
M]ACBO0KC2[>ZU6RU&3?Y]FLBQ8/&' #9'?[HK.C\(Z:D&I6KO<S6.H.[R6<D
MF8T9VW,R<94EB3UX/3% &+I6J:Q%KVGP";6M1M+DLET;[2_LX@.TLKJRHHQD
M;=IR?F'/',6G:UK$7AO6/%&H:@\\-@U^(;&**-4=(9)%7>VW=N^3&00,8R"<
MFNCT[PXMC>QW4NJZI?-$I2%;JX!6,'@\*!N/NVX^]6K#1K/3],ETZ-#);2R3
M2.DOS;C*[.X/MESQZ4 <79ZUK\<NG7(GUF_EGFB6[M9-(,5NJ.0&:-M@9=N<
M_,S9 /K5I=6U2W\2M'J^J7NG*]^8K:%K%'LYX2V$42A<B1AC[SCYN-I[[5CX
M2M[&:VVZGJLMK:L&M[.2YS%'C@#@!F [!F842>$;6:\$LVH:E+:BY%T+*2XW
M0^8&W@\C=@, 0N[;D=* .<T*RUNTNO&L]EJDU[>17;B&">.)4FF^RPE&8JH(
MY('! P/J:U?"FIS7&H2VEWJ^H370@$CV6I6*P2H<X+HRJJLG..-V#CYO73?P
MO:-J&HW2W5]$NHKBY@BG*(S; F\8^96VJ!D$=*73/#<.GZC_ &A+?WU_=B$P
M1RWDBL8XR02JA5 Y*KDG).!S0!4U:\U&]\56^@6%ZVGQBS:\N+F.-7E8;]BH
MF\%1SDDD'MZYK&U*XU4V?B?P[=:K)(]KIPNX;U(HQ(\3B0&.0;=N<QGD 9![
M$9KJ=6T"VU:>WNO/N;2]MPRQ75JX615;&Y3D$,IP.&!' -16?ABQM++4(#)<
MW$NHJ5N[J>3=+*-I4<XP  3@  #TH 3PA!-;^$M+6>\ENF:UB8/(J*5!084;
M0!@>_/O6!I&K:HFOP0:WJ=[9W4UQ*@LI[%/LLR_-L$,RK][ !^9R3@_+Z=I9
MVL=C8V]I#GRH(UB3<<G"C S^58L'A&UBO;>>74-3N8;64SV]K<7&^.)\$ Y(
MW-C<<;F(% &;HSZ[XFLFUJ+77L(Y)Y%MK2.VC>-420H/,W#>S':2=K+C..U0
MZGXKU#3+/Q7.N)GLM0M[.S7RMP3S8X "0O+8:4G'4]*UG\'VHN)WM=1U.RM[
MB4RSVMK<;(W<G+$<;DR>3L9<DD]ZN/X;TV:+5HIXFFBU6027*.W!(14&W'(X
M13GKGF@#G=*U36(M>L(!-K6HVER62Z-]I?V<0':65U9448R-NTY/S#GCG/.I
M^)7\'ZOXE_MLH^G37C0VBV\?E2Q0RN-LA*[LD(1E2N..ISGKM.\.+8WL=U+J
MNJ7SQ*4B6ZN 5C!Z\*!N/NVX^]._X1JP_P"$=O=#_>_8[S[1YOS?-^^9F?!Q
MQRYQ0!FW5[J6L^*'T>QU"33+:VLHKJ::*-&FD:5G"JN]64*!&23@DY'2J.M:
MMJVF7VEZ VH7DDL\4UQ/?VFGB28QHRA55 &4-\XRVW''09&-_4?#=M?W5O>1
M75W8WT$7DK=6D@5S'UV,&!5AGGD'!Z8J*;PI:36EI&;W4!=VCN\-_P#:"9U+
M_>^8@@@_W2-O XX% %?PIJ.IW5QJ-K?+?2V\!C:VO+RT^SR2A@=RLNU02I7J
M !AAQ4/B+4I3JXL++5M4BGCA$CVVF6*3,N2<-([JRJ#CA>"<&MS2M)32HY0+
MN[NY9GWR374N]F.,=!A5&!T4 54OO#,%WJLFHPW]_8SSQK%<"TE"B=5SMW9!
M((W'E<'GK0!S2>(M<U/0O",EM<QVMWJ=X]M=.80?E6.8L0IS@YCR.V>#D<&U
M)KNH>&9O$D%]=R:K'INF)J<$DJ(DA!\T&-MBJI&8L@X'![XK;L_"NF6-KI-M
M )5BTJ=Y[92^<,RNI!]1B1OTJV^BV4NIW=_+&9)+JT2SF1^4:-2Y Q_VT;-
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ME%50\A1N5+L!P0"1&I/6NCL-/73_ +3MN+F;[1</.?M$I?86Q\JY^ZHQP.U
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MK*ZJ(I=X*!B%8G P2.2.U<==Z?H47Q6MI[VSTY)I].\R&2:) TDXF4 J2.7
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M..IKGH+=;KP]?MJMUX>MM7,THN;FY#_;H)]YVE2#NR/EV!>",8ZT >RR31Q
MF21$ QDLP'7I1YT7G>3YB>;C.S<,X]<5Q,&C6NH_$F\;58(;R6VT>R($B!D\
MPR3Y<*>,\'!ZC)]:R#_9>E^(?M:_V-K'VC6L!P=FH6TSR;=O<NJ9Z?+\@[@<
M@'IY('4@=N:,C.,C/7%8OB_39=5\+7]O;?\ 'VB">V/I-&0\?_CRBN /B+9)
M_P +,59382%K 1\_\>^SY3CU^T@CZ-0!W^J:M-:>(M#LHVC^SWC3B8D<C9'N
M&#VYK9CDCFC#Q.KH>C*<@UYRWAN&*;P)I.IQK.0;F6Z1N5EF:(N^X=QO).#2
M7]M/I7_"=V7A^)K;;:6T\4-HNW8SJXD:-1T8J@Z=P.] 'HJ3Q22/&DJ,Z?>4
M,"5^H[43S);P/-(<(BEF/L*\YU./PM#8:+)X2^P#5FN[<63617S9$+KYN\CY
MBOE[RV[\>:[S6+*WU#1[NUN;:*YB>,YBE0.K$<C@^X!H =IVIVNIZ5;:E;R?
MZ-<0I.C-P0K*&&?3@U5\0:F]AX3U75+)XWDMK*:>)OO*65"1]1D5P&G7.A6W
MPZ\+VEI8:+,;\6T5P]QM6".<0[BTVT<OE2 #R6(YJ.!DCTCXCVL$VGO;II8D
MVZ="8H [0S!BJ[F&?E )!ZKZ@T >I6DYFL[:20C?+&K$=,DC)Q4GG1>=Y/FI
MYN,[-PW8]<5P?A8F/694UH ^(FM\Z?(_^I>VP,"#T(XWC[V><E<8Y2QM1=>%
M(6N+WP]::VTBB6[F5S?Q7F[G/\6[=Q@<8X^[0![54?GP^8L?FIO<95=PR1["
MG\[>>N.:\?T"/P4?A/#+<FT_M!;/YI'(^UK/M^0(?O@YQL [8QP: /7I9HH$
MWS2)&N<;G8 ?K3MR@ Y&#TYZUYU?W37=SHVFZS::(FI1:2ES<76LH'0,V%D5
M$R 2"N6.1@$>M9-E!#JG@[PS9W#+-:?\)+-"JHK(C1*UQA I)(3;@;23\O%
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M-R,PE@ W*>#C.>>X![4 =/?7%RFG-/IT4%S-\OEK)-L1@2,_, >V3TJQ+-%
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M\LZ*!),CP2EA(W5\E0><\C-9EGI^A:?;^/H+>STZVOXWN!$D<2)*L)M8S\H
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M.:/*EF .#(IY.<>]:Z:!)J6J^)UU"U:.QU6UMX5W,I)PCAAP3@@L/QZ5U5%
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M"MC=[X[BXCXS+&V<'J2%"GI@D=K:ZMKNLZAJ,>B#3X+2PG-L9;Q'D:>4 %@
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MMHWMH@_FQ"8A4?>3@\LI*[> >IQ3-0\=YUG4;*TU;0=/2PE\DC4Y#OGD"@G
M#+L49QN.[)!XXYW'\+H_AC2=%^UL%TYK1A+LY?R&1AQGC=L_#/>F3>'M2MM1
MO;G1-8CLH[Y_-N(9[3SU$FT*73YUVD@#.=PR,XZT 9$&LQ^(=9\$ZK''Y8N$
MNV*;MVUA'A@#W&0>>]=U6.VA,]_HMW+?2S2:8DBEI%&Z<N@4EB, 'C/ K8H
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M)\^9MDF=UWYYW;6!/O0!TU<E:ZSXCUNVN-2T:'34L4EDCMX;H.9+H(Q4MO!
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M,Y5@0$(Y !#9QU&:ZCQ'KT^FW%O'!JNBV(EC+@7P>220^BQJRG'^UD_2G_\
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M@X_#-,L='6RU/5[T3%SJ4J2%-N/+VQ+'C/?[N?QIV@:4-"\/:?I*S&86=ND
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M>T6TC%O;S">*/'"2!BP8>^234%]X9T;4K_[=>6$<MQM",Q) D4= X!PX&>C
MUK44 9DWA[2)](BTJ6PA:QAP8HL<1D="IZ@CU'--M_#6CVFG7=A#81BWO%*W
M(8EFF!&#O8DLW'')K5HH KSV%K<FV,T"N;602PY_@<*5!'X,1^-9VH>$]"U2
M\>[O-.BDFD 65@642@= X! <?[V:V:* *+Z/ISB[#6D6+R$07 Q@21@$!3[
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M4:W,?EF)ERI7&-I!ZC'%2T4 9.E^&=&T:X-Q86*12[/+#[F8HF<[5W$[5X'
MP.!4">#/#L<QE72H<F02A2251PP?<JYPIW 'Y0*W:* ,K4_#>D:Q<)<7UDLD
MZ+L$JLT;[>NTLI!*^QXJQ;:1I]G+!):V<,+00?9HO+7:$BR#M ';('Y5=HH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH **** "BBFNZ1KN=E5?5CB@!U%1RSPP1B2:5(T+!0SL "2< 9/<D@#ZU)0
M4444 %%%% !14<,\-Q'YD,J2)DKN1@1D'!&1W!!'X5)0 4444 %%1M/$DR0M
M*BRR E$+ ,P&,D#OC(_.I* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "N7\=DC1]/P<?\3BP_P#2F.NHK&\2Z3/K
M-A:P6[QJT5_:W+&0D K%,KL!@'G"G'O0!4N?$]V==O\ 2-,T66]N;)(Y)7:=
M8H\."0-QS\W!XQVY(XKG_$VNRZUHWAB\L=+>>VNM3A9HY950B16;]TP.>0RG
MGIE:ZS3]*GM/$NM:E(\9AOA (U4G<-BD'/'O6/;>%+Z'0=%L6EMS+8ZJ;V0A
MC@IYDCX''7#C]: +LOB.[?4)M.TG1FO)[-$^UDW"Q1PNRAA&&(.YL$'@8 (Y
MYJ&?QQ;1:+;7\>GW<LLU\-/>S&T2Q3Y(V'G'4=<XP0<XIS:;K>CZUJ5YHT%E
M>6VI2+/)!<W#0-%,$5"P8(^Y2$7C ((/7-58?"-ZEG9&6Y@DO3K(U6]8 JF<
M$%4')P!M SUQDXH M7'BB_M[^PTMM"=M4O()9UA2Y4I&$91\SXX&&!R >3CF
MJ8\<WCV-_=Q>'+EH]+9TU$&= 8V3EA'_ ,],+ANV01WR!MRZ5/)XRM-8#Q_9
MX=/FM64D[BSR1,".,8Q&>_I5.#P_=1:5XEM6DAWZI<3RPD$X4/&JC=QP<CMF
M@"]?:M=K;6L^E:;]NCN$\SS&N%AC1< C).3DYXP#T.<5S>L>,M1D\/6-_I%@
MZROJ<5G<H\J9C87"QM'SD$-D@,.@(-.OO"E^\^C2O8Z;J\-GIZVKV=],R1)*
M,?O5^1@3QCE0<8QW%-@\':G;>$9=/C;3Q>KJJZE"D8:.#Y9UE$? RH^7;P#C
MCK0!K+J5I%XD\R_M'M+U-),\TC3EHXXA)RI .TD'G=C.*K'QG<1:='K-UH5S
M!H;A7^U-,ID2-NDCQ=0O()Y) Y(ZU-/X>NM6U6:[U)8(H;K1WT^>*&4N59VR
M=K%1D8/7 Y[50N-$\4:AX=_X1B\_LU;-XA;3ZC',YDDAQ@XB*85V7C[Y SGG
MI0!J7WB6YC\0S:'I^DR7MW%:QW1<S+'$$9G7ECG!RG P<Y]C6AH6L1Z[I27J
M0R0-O>*6&3&Z*1&*.IQP<,IY[U!::1-;^+;[5-T?V:>QM[:- 3N!C>4G/'3$
MBXY[&E\.:5/I%G>0W#QLTU_<W*E"2 LDK.H.0.<,,T :5W-);VDLT-O)<R(I
M*PQE0SGT!8@?F:QM,\13W&M_V1J.G"RNV@:XBV7"S*Z*RJP) !# NO&._!-3
M^*=+NM:\.75A93+%/)L(+LRJX5PS(Q7D*P!4D=F-8>A^%KJS\4VVK_V3HVDV
MT5E-;&UL#EBS-&P8L$4'[A&,<>IR< &;X.U_4K+P-9S0>'[FYL;9)/,E69%D
M<!VW&.,_> YZD9QQGC/2W'BJ.66QM]%M&U.YO;87D8601QI <8=V/0$G  !)
MYXX-9&E:5XQT?PW'HD0TB8A61+UIW4PAB3S'L^<C/'S+GOCJ;$7A>]\/3Z;=
M:!]GN?LNG1Z;-;W<AC\V-#E'#A6PP);(P0=W;% %E_&4=OH^M75YI\UO>Z/%
MYMS9EU8E2I961APRL <'CD$$#%:NI:PFG7>EV[0M(VH7!MT((&TB)Y,G\(R/
MQK ?PG?:M8^(Y-5F@@OM:M1:!+<EX[:-58(-Q +G<[$G ZX[4K:7XFU35M N
MM2CTRVBTRX:65()WE,Y,+Q[AE%VX+_=YZGGCD D\):YK6JZAK$.I6'E0V]Z\
M2/YR'R@$C(CPHR?O$[O>NHGF2WMY)I,[(U+M@9. ,UAZ+IFI:7K>K[TM9-.O
MKHW:3"5A*K%$4H4VXQ\I.[=Z<5NRB0PN(6192IV%QE0>V0",C\: ,'0O$5YK
M44%TVC/!87,'GP7*W*2#;P0' ^ZQ!Z#<.#S6;:>.;R[\/P^(4\-W8TEH1/)(
M9D\U4QEF6/\ B4<]P3C(!XRS2?#6HVVOQZG)IVEZ2B0R+=#39G*WKL!@LFQ0
MN""<G<><9]<SPO!XJOOAGI.FP+IHM[K38XUOWE</#&R ?ZK;AF . =X!P"<=
M* .KO?$A%Y;V.D69U*ZGMQ=<2B.-(2<*[.<_>.<  DX/3%0?\)E;1Z1<75Q9
MW$=[;W2V3V"[6D-PVW:BG."&#*0<@8.3C!K+U7P+"NH6-[9Z5IFJI;V,=@UK
MJ7'R1DE&1]C889((QSD=,5./"$Y\/I';VND:7J,-\E_!'90D0*Z<*KG +Y7*
MEL#KP..0"QJ>K77_  CFM/KN@306D-A+,_DWBL)4"DLFY<,K8]!CWK-OKB[?
MXD^'XH])$UK'IUP8F>X7A2UN&?!YRH./4Y-:>HV?B37_  _K.FWEKIED+JPE
MMX1'<O,3(ZD!F8HNU>>F"?Y&Z=&N#XGTK4]\7DVFGSVLBY.XL[0D$<=/W;?F
M* ,VP\1:?IWAJUEL+"Y=[N^GMK6R$N^2642R;OF8\+\CL23@#\!6YI=]J-TT
MT>HZ2UB\>TJPG66.0'/0C!R,<@@=1C-<[%X2U&UT73?LT]L-5TS4+F\AWEO*
MD65Y<HQQD927J <$=ZZ+2Y=:F>9]5M;*U3"B**WG:9L\Y+,54>F !^/H +KT
M%]=>'M2M],E\F_EM9$MY,XVR%2%.>W..:Y'PU#X1CU'3K?\ L5M&U^%24CN(
M6AFE.W#_ +T<3CJ3\S>N*[B]6Z>RG6RDBCNBA$+RH616QP2 02,^]<O-IOB+
M7K[2AJ]GIUE;:?=+=O);W+3/,Z@A0H*+L4D\Y)../>@#9L]=CO+?5IEA=1IU
MQ) X)'SE%#$CZYK,?QDSG0XK+2IKFYUFQ:\@3S%58P!&2'8]!B3KSTQCFJ\N
MB^(;277;/31I[V>JS/.ES-,RR6S.BJPV!2'Y7(^8=<'I5C2?#=Y8WGAJ:62
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MKS6U7'^'?#E[8>(6U%M.TW2+<V[12VNG3LZ7,A92)"I1%7 # 8!)WG)XKL*
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MMXN\'ZC:DFWNM.NYXRPP=K" C(^AJ]H7B>ZUTV]S#H\BZ9<[O*NQ<(Q7&?\
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M9!?@KDD@^M=%X9TR;1?"VDZ7<,C36=I% [1DE254 D9 XXH U:*** "BBB@
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M7+)M(SC,@]* .XJ.>:.W@DGE.V.-2['!. !D\"N0/B&XFTK5=2EU-K*TFO\
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MKGPU/K$LWFV/VRVO_)B$T6UPK*P"[&ZC!VCOZ9I?AG!-#\/-$,UY)<"2TB=
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MM[^&QU>*.V!O687,RJCJTC!N5SYA ! P%' &!7=44 8EWX:6X:%K;5M4L3%
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MNIM4U&_G,?EJUW*"$7(. J*JYX')!/'6M:B@"E=Z7;WNH:?>R[_-L)'DAVG
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M5;ZS9"TNM_EB:*;Y#@[HW5U_#*BKU% %*WTNWMM6O=2CW^?>)$DN3\N(]VW
M_P"!&L__ (16VCTZ&TM+_4+,PSRW$<UO, VZ1V=@00589<\,IQ6[10!SQ\'Z
M>VCFP-Q>;S="]-YYH\\S@@^9G&,\ 8QC'&*OV^B6T&H/?-)-/<26<=G(\K [
MT0L03@#YB7;)_2M*B@#FX_!=A'H":-]LOWMH7C>T9IAYEJ4QL\ML?PX[Y]#D
M59TWPQ;:=J[ZLUY>WFH20?9WGN9 2R;MP&% 48/H .3W.:VZ* .=@\&:;!HT
MFD&>\DLMZO;H\W-J5;<OE, &7!Z$DGCTJS8^'5M99I;G5-3OY98C!NN9P-B'
MJ%$84 ]/FQNXZULT4 8.G^%H++4+>]FU'4;^2U1H[87DJL(0V <84$G QEB3
M[U;UC0[;61;O+)/;W-LY>WNK=]DD1(P<'!!!'!!!!]*TZ* ,G2O#]OI=S<7;
M7%U>WUPJI)=73AG*#.%& %5023@ <G-6=(TRWT72+33+3?\ 9[6)8H]YRVT#
M R:NT4 4=.TJWTLWAM]_^EW+74FXY^=@ <>W JJWAG3);?5K>:)Y8=5F\^Y5
MF_BV(H*D8*X"*1W!&:V** ,73O#HL;U+J;5M4OGB0I$MU."J ]>%5=Q]VR?>
ML\> M/%M'9-?ZDVGP3+-;V9F7RX65PZXPNX@$<!B0.W:NJHH S&T&QDN-4FD
M5W_M.)8;E"WRE%4K@>G#&JUIX7MK:/3%DO+VZ.FS&:V:XD4D9C:+:<*,@*Q]
M\]ZW** ,V;1+::_O;WS)X[B\M%LW>.3:512Y!4]0V9&Y^E7+.V%G906HEEE$
M,:QB29][O@8RQ[D]S4U% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%!.!D]*165U#(P93T(.0: %
MHHHH **** "BBB@ HHHH **** "BBB@ HHHZT %%%% !1110 4444 %%'6B@
M HHHZT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MENB_\_4G_@/+_P#$T?\ "6Z+_P _4G_@/+_\36U10!B_\);HO_/U)_X#R_\
MQ-'_  ENB_\ /U)_X#R__$UM44 8O_"6Z+_S]2?^ \O_ ,31_P );HO_ #]2
M?^ \O_Q-;5% &+_PENB_\_4G_@/+_P#$T?\ "6Z+_P _4G_@/+_\36U10!B_
M\);HO_/U)_X#R_\ Q-'_  ENB_\ /U)_X#R__$UM44 8O_"6Z+_S]2?^ \O_
M ,31_P );HO_ #]2?^ \O_Q-;5% &+_PENB_\_4G_@/+_P#$T?\ "6Z+_P _
M4G_@/+_\36U10!B_\);HO_/U)_X#R_\ Q-'_  ENB_\ /U)_X#R__$UM44 8
MO_"6Z+_S]2?^ \O_ ,31_P );HO_ #]2?^ \O_Q-;5% &+_PENB_\_4G_@/+
M_P#$T?\ "6Z+_P _4G_@/+_\36U10!B_\);HO_/U)_X#R_\ Q-'_  ENB_\
M/U)_X#R__$UM44 8O_"6Z+_S]2?^ \O_ ,31_P );HO_ #]2?^ \O_Q-;5%
M&+_PENB_\_4G_@/+_P#$T?\ "6Z+_P _4G_@/+_\36U10!B_\);HO_/U)_X#
MR_\ Q-'_  ENB_\ /U)_X#R__$UM44 8O_"6Z+_S]2?^ \O_ ,31_P );HO_
M #]2?^ \O_Q-;5% &+_PENB_\_4G_@/+_P#$T?\ "6Z+_P _4G_@/+_\36U1
M0!B_\);HO_/U)_X#R_\ Q-'_  ENB_\ /U)_X#R__$UM44 8O_"6Z+_S]2?^
M \O_ ,31_P );HO_ #]2?^ \O_Q-;5% &+_PENB_\_4G_@/+_P#$T?\ "6Z+
M_P _4G_@/+_\36U10!B_\);HO_/U)_X#R_\ Q-'_  ENB_\ /U)_X#R__$UM
M44 8O_"6Z+_S]2?^ \O_ ,31_P );HO_ #]2?^ \O_Q-;5% &+_PENB_\_4G
M_@/+_P#$T?\ "6Z+_P _4G_@/+_\36U10!B_\);HO_/U)_X#R_\ Q-'_  EN
MB_\ /U)_X#R__$UM44 8O_"6Z+_S]2?^ \O_ ,31_P );HO_ #]2?^ \O_Q-
M;5% &+_PENB_\_4G_@/+_P#$T?\ "6Z+_P _4G_@/+_\36U10!B_\);HO_/U
M)_X#R_\ Q-7=/U6RU02&SE:01XW9C9,9Z?> ]*NT4 %%%% !6->1RIXCTV4W
M,I21I%$.<( (R>G<Y[FMFJT]F)[RTN"Y!MV9@,?>RI7^M &?KL<OF6,ZW,J(
MMW"OE(<*Q,@!+=SQQCI6S5:]LQ>QQ(7*^7-'+P,YVL&Q^E6: "BBB@ HHHH
M**R?^$J\._\ 0>TO_P #(_\ &C_A*O#O_0>TO_P,C_QJN278GGCW-:BLG_A*
MO#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>
MTO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\
M R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^
M$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP
M[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_
M ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\
M:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV
M#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*
MR?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*
MO#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>
MTO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\
M R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^
M$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP
M[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_
M ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\
M:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV
M#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*
MR?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*
MO#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>
MTO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\
M R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^
M$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP
M[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_
M ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\
M:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV
M#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*
MR?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*
MO#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>
MTO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\
M R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^
M$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP
M[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_
M ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\
M:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV
M#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*
MR?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*
MO#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>
MTO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\
M R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^
M$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP
M[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_
M ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\
M:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV
M#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*
MR?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*
MO#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>
MTO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\
M R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^
M$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP
M[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_
M ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\
M:.278.>/<UJ*R?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV
M#GCW-:BLG_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*
MR?\ A*O#O_0>TO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*
MO#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:.278.>/<UJ*R?\ A*O#O_0>
MTO\ \#(_\:/^$J\._P#0>TO_ ,#(_P#&CDEV#GCW-:BLG_A*O#O_ $'M+_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
0* "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>ethicsemployeepolicybook012.jpg
<TEXT>
begin 644 ethicsemployeepolicybook012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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MT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+E6BNQF\-^'/^$AET"+5=0BOEN#:I)-:H86D#;0"5?(!/?%<G<V\EI=36TH
MDB<QN >A!P:49J6PY0<=R*BBBJ("BK-Y#:0^1]DNFN-\*O+F(IY<AZIUYQZ]
MZK4)W&PHHHH$%%%% !16CHNCS:W?&".2.&*.-IIYY#\D,:]6/^>216FMMX/>
M86W]H:LA)VB\:!/+SZF,'=M_'/M4N:3L6H-JYS=%/F18IY(TE65%8A9%! <
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M@)9W37,6Q27:(QX8@%EP3V.1GO5:FG<'H%%%% @HHHH **** "BBB@ HHHH
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M43T6W_!.I\1:W=Z)XBN]&L;:WBTZSE\A;5[=&651QN<D98MUSG//&*H>/O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMW^DK+9FYL(!/-B4[0I&< [>N"*]"@\.1#XV/J8V_83:_P!I*_\ #DC9G/\
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MM?$^AP:E:D#>,21YYC<=5/\ GI7E8ZDU+G74]3!5$X\CZ''?$+X9IK[2:KI
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **^N?[*T[_GPM?^_*_P"%']E:=_SX6O\ WY7_  KSO[07
M\IZ'U!_S'R-17US_ &5IW_/A:_\ ?E?\*/[*T[_GPM?^_*_X4?V@OY0^H/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!EZ]!>W%BR6DRQK@F0GJ1CH*\]@@EN)5BA
M1GD;HHZFO4;E2]K*JC+%" /PKD_#6DWUIJWFW%LT:"-AN..O% '-"*1;D1,"
MD@;;@\$'->E:9%>06:QWLJRRJ<!E[CW]ZY74]'U";7Y9X[5VB,JD,,8(XKMJ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<;%Q^'7]:<9>Y*LTK[?\$4H^_&DF[;E"Y^&GBO2X#=Z1XMN;B[0;O*8O'O\
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M4-M)P">OL,>IKSCPAX>N==\8KX<U2[,UAH;S.8<_*V) "![%L9]LU] @!0
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M;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUYR_C+47\6+XB$<"78 !10=A&W;@C.>GO4=CXLO['6-0U14AEN+^-XY?,!P
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M,-U^5CT31_#^J6?P_A&FM%%J.H3I<2/+($*Q*<H!GW /XFJGC[P\;CQ%I5^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?_LZ/^%-C_H._P#DK_\ 9UZG11_:.)_F_!?Y!_9N%_E_%_YGEG_"FQ_T'?\
MR5_^SH_X4V/^@[_Y*_\ V=>IT4?VCB?YOP7^0?V;A?Y?Q?\ F>6?\*;'_0=_
M\E?_ +.C_A38_P"@[_Y*_P#V=>IT4?VCB?YOP7^0?V;A?Y?Q?^9Y9_PIL?\
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M>IK1HK&KBJU56G*YM2PM&B[PC8****P.@**** "BBB@ HHHH **** "BBB@
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MT=SH\:V]Q=6JQ-<-Y=P#L543/.!TR>.H(H [NT\2Z)?:C_9]KJEK-=X)$22
MEL=<>N.^.G>K(U;3VTM]3%[!]A16=KC>-BA20Q)]B#GZ5S.I:<8M-\&QVUJR
M_9+ZWX1#^Z3R74Y]!S@_6LN]L9E\42^#TB8Z;J5VNK,P'RI"#NFC_P"!3*GX
M3'TH ZRWU*>&XUF]U26.UTJW=%MGFP@V! 7D+'L68@?[OO5S3-9TW68Y)-.O
M8;D1MMD$;9*'K@CJ/QJGXL@M;GPY<1WJWI@WQN6LH]\L96165PN#G:P#'@\
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M&PU"SU2T2[L+F*YMWR%DB8,,C@CZ@]JJ:EXCT;1YT@U#4K:VF==XCD<!MO\
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M:1J6H7S2+?:2;,!%>.5+A)HY <\ C!R,<\8Y&":J^-[BZMO!.LR6D!ED^QS
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MZ3>&!V749H844$90R#()^E5+;Q/=7VJ7$-EH\D]E;79LYKA;A Z.#@MY9YV
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MWCF.WA7<[!"Q ^@!)H S/$.D7=]-IVH:;)"NH:=,TL2SY$<JLA1T8C)7(/!
M."!P:KV>F:MJ'B.VUG68[2U%E#)%:VMM,TWS2;=SNY5>R@  =R<UTE% ')>'
M_"=SI/B&YNIYX9-/@$B:5"N=T*ROYDH;(QU"JN,_**B_X1+4(])C$%Q;+J5I
MK%QJ=J6W&-A))*=C\9&4E() .#R,XY[*H[B>.UMI;B9BL42%W(!. !D\#DT
M<P-.\1ZGXET?4]0CTZSM+!I2UM!.\SN7C*AMQ11QGICH2<]JB'A2^_LU;;S;
M?>/$!U3.YL>5]H,N.GWMO&.F>]=7;7,5Y:0W4#%H9D61&((RI&0<'D<'O4M
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MN/-ZXS]WCIUKJYITA@FE)W")2S!>O S4.EZA%JVD66I0*ZPW<"3HK@!@KJ&
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M8G#.@/J8PPYZ\'(SGH;OPK!/?W%Y::CJ.FR76#<BRE55F(&-Q#*V&P -RX/
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M;C/.:[B^LK;4K&>RO(5FMIT,<L;=&4C!%<^_@>TN!:K>ZKJU[%:3QSVT=Q<
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M-P&C4$8P< %^/[Y;\ZJ+X%T\0+9&]U%M)1@5TQIP;< '(7IO* _PEMO;&.*
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M]RRLF3CGE!F@#8KR^'Q5KFIZ3+K5G/JPN&+O:Z=%I#/;.JDA4:386)8#E@P
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ML?M5[-;V%Q'/:K-*&\K8I54!QRH![Y/O0!D7/B74['3M=T]Y%DUN"\6VL"4
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MB)\]1\X"_P# _:I])T&'2KFYNVN[N]O+E426YNF4N43.U0%55 &YCP.YK/\
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M/AJ>.91)?7EM%.=H^=74E@/3IVJW8>%K*RNKZZDFNKRXOX%@NI+IPWFJN['
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M %26W;@<#(8'. >M&E>&+32=4N-36YO+F^N85BFFN9=Q<*20<  #[V,  >U
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MM$2(XY5 HSM_WB3[UF+X)TP:=K%F\MW*NKKB\EDEW.YV[<@XX./P'8 <5T=
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M:AM*+9^6O,8?C!?S-Q'<<]JQ_LZZAX2TNU=I7TJ3Q(L=B68Y>TWL% /7:1N
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MS3&&X+;\ACUQM[5C"6*#PW<7%L__ !3UGXEM9+.4G*);+)%O*G_GF)/,P>@
MXX H ]5R,XSSZ4SSHO,6/S$WL,A=PR1]*Y :G97_ ,5+"*TN8IS#H]R7:)@R
M@M+!@9'&<#./0CU%<K;:)IUK\(+;6(K6(:I$R7$=Z5!F1A.,8?J !\N.F.*
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MSZ,U=;X-M)8M#-_=(4O=4F:_G4]5+_=0_P"Z@1?^ T =#1110 4444 %%%%
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MIN1V(!QD9R,C(&16Y9ZK:VUGJMT+F_OE@OI(W3R3(Z/E1Y<:HN2H)&.O4Y-
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M=Z?&S&XM%C:4%> 'SMP>_P!TUS6MZM#J<7AN[LI'\E]<$)."N2@F1@1Z;E-
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M0K@9QT[<&NYHH X70-(NX_&#ZDFFZE;6#::\ ?4;UIY6D\Q3T:1]H(Z8/8Y
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MF>5G$A)SN=RHP>!GL>F:VO&5A<ZIX*UNPLXO-NKBREBBC! W,5( R>.M;E%
M'+:G:W^G>*+77K:PEU"'[";*X@@91+'\X=74,0&'4$9ST(SBL?5=%U?7=/\
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M6.HV-Q>68M8)]4OFGD< EL,NYMJ;CZY.6X'?K]5U[2=$$9U/4;:T\W/EB60
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M/]5@A6:6VU!'6-NC?Z- ,5UVA:-%H>G&V2:2>625YYYY,;I97.68XX'/8=
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MD^M:%WX?U"Y-A?#5HH]:LQ(@NEM/W4D;D$H\6_)'RH>&!RN<]J ,BT^(,?\
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ML42_8=&MI6>VSME17N&W*IY4]1@D\CK5VYU[Q)I&E)KNJVVG?V>-CW-I#O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3M9X;[RK.)'6:U\D'SB<;3NZKMP>!US0!<HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*$@PSR[HU?@' S\V.O:L[;-K7B:XL=0GN+>*UM(95MK>X:+S'<MN8LA!(!4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW&N7UC]D=;=;2WC=E9]NXLS$J2.20 ,] ?6M^BGSL7(@HHHJ2@HHHH ****
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M/_BJ/^%OZ-_SX7_Y)_\ %5XW16O]F8?M^)E_:F)[K[CV3_A;^C?\^%_^2?\
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M0EP#DXZ#\12EEV&CO^81S+%2V_(]2_X6_HW_ #X7_P"2?_%4?\+?T;_GPO\
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M)>:%<Q07JHLDL2S+M;=\ISC^1H>789-+KZB698IIM;+R/4_^%OZ-_P ^%_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9?B61XO
M"VK21YWK9RD$=OD/-?-E?4<\,=S;RP2KNCD0HP]01@U\W:]HUQH&L3Z?<*<Q
MM\CXX=.S#ZU[>43C:4.IX><0E>,^FQFT445[)X9Z!XGEDLOAOX;M;(E+6Y5G
MN"G&Y\ X/KR6_+VKA[1)[J>*QBD8"XE5=NX[2Q. 2/QKH-$\7)9:2VC:MIZ:
MEI9;<L;-M:(^JG\_S/-.U#Q'HJ:<UIH>@):.SK(;J:0R2*5.1M)Z?G^%<=)3
MIWARWU>NG7N=M5TZEI\UM$K:WT73H:UW8^$=(UZ/PY<:9=7,N4CFO_M!4J[
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MZ=>[<6[^]UT\C-5*%DI)6]WIKYZCM:NO"B)>6%AHUS'<0L4ANS=$[R#@EE/
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M?\*C\0?\_.G?]_7_ /B*]JHH_M3$>7W!_96'\_O/%?\ A4?B#_GYT[_OZ_\
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M>SRRQP1-+-(D<:]6=@ /Q-/H_M3$>7W!_96'\_O/%?\ A4?B#_GYT[_OZ_\
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M4T /HHHH **** "BBB@ HHJO]NMO[1_L_P T?:_*\_RL'.S.W/Y\4 6****
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M<&P1'RP@VKD\#:, G/J3UJ:[\/:I=FPU!]2LUUJS62/SELSY$L;D91HRY/\
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M>#G% ';45YD+74XO#GA345U_5/MVJ26T-Y(;@LK1RQDL%0_*K#C# 9[DFMF
M7.C^(=9TFWOKR>U.E+>0BYG>9XI-TBG:[$M@[5."3@CCK0!VE%<+/J]TOP^\
M)W8O9!<W<VEH\N_YI=[Q[P3WR-V?QJ6*PN-=\7^)+:ZU;4HK.U:W6WAM;IH=
MC-$"6RI!/;CIG.0: .LN;S[-<6L/V:XE^T2%-\2;EBPI.7/8<8SZD4MM-:3&
M<6KQ,8Y2DPC(^63 )#8[X(_.N(TS6-1O-,\#//=R&6ZNY8+IU.WS@D$_+ >I
M16^M4])T"Z6P\6OI&HZBNHP:E(+;S+QV5W1(G 8$X.XC:2><&@#TNBN2T?7&
M\4>(K2YL9I$TVUT]9IHPV \\WW48>J*I)'JXJSXOO+J(:/86UT]FNI7ZVLUU
M'@-&FQWPI/1F*!0>V[CG% '24R*&*",1PQI&@Z*B@ ?@*Y,1R^'?&&CV%I?W
MMQ::DDXFM[NX><QF-0PD5G)8#/RD9Q\PX%)\/[:YN=#MM9O]3OKN[G$B8EG;
MRU02$ !.F<*/F.3R><<4 =A17(>--0OXK_1-*LX[QHK^67SOL<J12L$3<$5W
M90N>I(.<*<5F/)KNF:-XH_=:E:6,>E23VIO;U)YX9@CYVNKLVTX4C<>"#B@#
MT*BN#:"\T=O#&HC5K^XN;ZZBM[U9YV:*421L21&?E0A@"-H'OG-176K:E9VV
MJ^&%O)3JTM^L%A.S9<07&7$F>O[M5F&?^F0H [B&\\Z^NK;[-<1_9]G[V1,1
MR[AGY#WQT/H:LUP&LZC?6EEX_6&]N%-AIR/:MYAS$WD,=P/8Y .?6I]1@O-,
MMM%L4U>^$NLWJ0WE]),69/W3N1&#\L98J%&T#&?7!H [BBN02.7P]XRTG3K6
M_O+FSU&*?S;>[N&G,1C 82*SDL!D[2,X^8=*YM?[2C^',_BE]:U)]3M7EFB_
MTEA%L29@(VCSM8%1@E@3SP1@8 /4Z*XV>TN-9\?ZG83:G?PZ?!IUK*+>VN&A
MS(SS#=N4@CA>@.#QG.*Y^,ZG'X ;Q/+K>HRZG:3L$)G(B:..<Q;6B'R-N5>2
M1G))!'% 'J5%<%K%WJ.I^-+[3/LNK36=C;0ND6G7J6I9I-V7=C(C$?+@ ''!
MSVJ"YF\1+X?TFUNKN[LKB37%M5F\V-YFMCNP'*$J6QQ]5!(H ]$J&UNK>]M8
MKJUFCF@E4-')&VY6![@CK7)V]B]KXNNM!74=2>PNM-%SB2\D>2*19=I*2$[@
M"",C....M.^&-DEIX!TB59[B0SVL;%9IF=5..B@G"CV% '2:KJ"Z5I-WJ#02
MSK;1-,T<(!=@HR0 2,G IRZC:MI8U(3+]C,/VCS>WE[=V[Z8YJRRAE*L 01@
M@]Z\NW.-*;X=;F\XZC]C'//]G$>=N^GEYB^M '>Z3KBZM'9R)I][ EU:+=J\
MT8"J&/"$@G#X.<>E:M<CJVJ7>F>)[T6VZ2*UT"2YCM03M:17..!WP,5D7T-U
MIG@(>*X=?OY]3CM4O"[W+-;W!(#>7Y/W K9VC: 1D<YH [*'5_-\3WFC>1C[
M/:0W/F[OO>8\B[<8XQY><Y[^U:=<9/?P:=XT\1:A=R/!!!H-K-*ZC+(H>Y)(
M'<BLNRFU"R\2Z#&(M9MK;4VEAF&HZB)FE A=PP0,WEL"H^[@<XQTH [J;4X$
ML;RZMP]Y]EWB2*U >0NHR4 S][VJW&_F1J^UEW ':PP1[&O,;.R;1_"/CO4+
M2_U 7-O)?K&SW;L%*H"'P3]_(^]UK>8SZ]XJ.D7-_=VUG:Z;!<B.VG:%[EY&
M<%BZD-M78!@$<MSVH [*BO-M3U/4].T#QCI]MJ5Q*VEF'[)>2/NEC\P*Q1F_
MB*^IYPPSFMA[6?0/%N@QPZGJ%RFHM-#=)=7#2*Y6(R!U4\(<KC"@#!Z4 =C1
M6!XSU*ZTKPS-<6<H@F>6&#[05!$ DE5#)@\?*&)YXXYK*U&TE\+7VBW%EJFH
MSF[OX[.XM[RZ><3JX.6 8G:RXW?+@8!XH V;36;N_P#$M]I]O9P_8=/=8KBX
MDF(<R-&) $0+@@!ER2PZGCBMNN*\'Z5'9^*O%<BW5[(8[Y(P)KEW!!MH6R03
MR>< ]0.*F\::A?QZCHFE6<=XT5_)*9_L4J12N(T!"*[LH7.220=V%.* .OHK
MSR237=,T+Q5^ZU*TLHM)DGM#>WJ3SPS!'SM=79MO"D;CP0<58>WO-&E\,:@-
M6O[BXOKJ.WO5GG9HI0\3L2(S\J$,H(V@>AS0!W=5H;SS;^YM?LUPGD!#YSIB
M.3=GA#W(QSZ9%</<ZMJ5I:ZIX76\F.KRWZV]C<,V9!;SY<29Z_NT689_Z9"E
MU_4K^SM_'BP7MPGV'28I+8^8<Q/Y4I+ ^I*@Y]J /0**XC4X+S2X=%T]-7OA
M)K-ZL5Y?23%F7$3N5C!^6,N5"C:!C/'.#5B..7P_XRTK3K6_O+FSU&&<RV]W
M<-.8C&%(D5G)8 YVD9QR,8H Z^BO++7^TH?AQ:>*9-:U*75(V20;KEO*9/."
M^6T?W6!7@DC=GG-=#-:7&L^/M5L9]3OX=/M["UD6"VN&A_>.TPW;E((X7H#@
M\9S@4 =E17ET3:G'X!'B>76]1EU2UG(4F<B)XXY_*VM$/D;<J\DC.22".*T]
M7N]1U/QI?Z9]DU>>SL;>%DBTZ]2U+-)N)=V,B,1\NT ''!S0!WU%>=W,WB(:
M!H]I=7=W97$NN"U$WFQM,]L=^ Y0E2^./JH/6M*VL7M?%MWH"ZCJ3V%SIRW0
M$EY(\D4@DVDI(3N ((R,]N.M '66MU;WUK%=6LT<UO*H>.2-MRL#T((ZBH]2
MN_[/TN[O=GF?9X7EV9QNVJ3C/;I7GGAO[/I7PLT%3<:Q)-J:0110VMS^\9]I
M;8A<XC7"MD@C '7-36MS?0CQ=I%PMW';Q:2MQ%!=WGVIXV=9E;YR2<'8IP2<
M<^M '>Z;>?VAI=I>[/+^T0I+LSG;N4'&>_6JVCZO_:SZDOD>5]BO7M/O;M^U
M5.[IQ][I[4>&_P#D5M(_Z\H?_0!7)6]]#8Z9XE$KWJO<:^UO$MB0)G=A$ JE
MN!GD$DC SR.M 'H%%>=Z<NJOK&L>'TEU&P%QI/GP"YU W,L$I9D#J^20.G&2
M,KQWJM%XMU'4;C2-9BN'BL-.BMTU6 ?=:6<F-PW_ %R(5OHQH ]*,,1F$QC0
MR@;0^T;@/3/I3Z\^3^W-:T&+4[::ZN+>\U*6X:U@N_L\KVF&2)8WR-OW4D(!
M7.3S72>$[N&YTB1(I=19K>X>&6/46#30N.=C,,[L C!RV01R: -VBBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ JO>6%M?K"MU$)!#,D\>21M=3E3QZ&K%
M17%S!:6\EQ<S1PP1C<\DC!54>I)X% $4FG6DM^M]) K7*PM;ASS^[8@LN.F"
M5'Y5E6O@O0+.6"2*R8FW</;B2XD=8"#D>6K,0@]EP*N67B+1=1MI[FSU:RGA
MMQF:2.=2(QURQSP/<T_3->TC6C(-,U*TO#%C>()5<KGH3CL?6@#.3P1H$=S)
M<1VL\<DLQG?9>3*&<G)8@/CDU)=>#M!O;FXGN+(O]I.Z>+SY!%*V,;FC#;"W
M Y(SQ4Z>*- DO(;--:T]KF?'E1+<*6?/3 SR36M0!4CTNRAO(KN. ">&W^S(
M^3D1Y!V_FH_*J>H^&-(U2]^V7-O(+DH(VE@N)(6D4=%<HPW#D\'-3FZD36I8
MGO+,6R6JRF#I,IW,"Y.<;,#'3J#S45OXET*ZOX[&WUBQENI%W)#'<*S,,9X
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MGCE\J0Q2;&#;7'53CH1Z5R_COQ%!HUG8VAUB'39KV\BB>5I461(2W[QUW<#
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MY;S694MYZ2 I@=3NZ<4 9/@[0WT/17%Q#%%>WMS+>W21'*K)(V=H/<*-J_\
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M>E7VH6D,MPCNS27"((@ "-P)XW9X^E &M-IEG<1VD<L 9;2198!D_(R@@'\
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MA$MKJ4DDMW&,XE:08<GGO[5J5F:CXCT32+A+?4=6LK29QD1S3JC8Z9P3T]Z
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MSBTCR7M=@Y5S_P LUQE#ZYXS7I=% ''>']/AC7QC+/:2?Z3J,PD*(?,EC$2
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M10 4444 %%%% !1110 4444 %%%% !574+J>SLVFM[*:]ER L,3*I.3C.6(
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MS7)A>"5E 8'Y&W*2N<CD9(P:@@\)7MO8Z,C3PRW4.L/J=ZXRJEG$I8(/0&0
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MZEC2)Y.[(I8J/P+-^=3T44 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!117'>(/'\&@:M)I[V$DS(%.\2  Y&?2DW8:3>QV-%>;/\7;=.FC3'_ML/\
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M*\LL?C3:WQP-$F3ZS@_^RUN0_$>"5=W]G2#_ +:C_"DZL%U!49O9';T5Q?\
MPL.#_H'R?]_1_A3?^%BP;@O]GR<_]-1_A1[6'<'0J+H=M16;::NMU")!"5R,
MXW5/]N'_ #S/YU=T9V+=%5/MP_YYG\Z<+P'^ _G1<19HK&U37TTN RM;M(/0
M-BLA/'T+_P#,/D'_ &T'^%2ZD5NS2-*<E=(["BN1_P"$[@[V+_\ ?P?X4?\
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M\8PG_ET;_OL?X4X>+XC_ ,NC?]]C_"G[:'<?U>KV.DHKGE\5QL?^/5O^^_\
MZU/_ .$FC_Y]6_[[_P#K4>UAW%]7J=C>HK#'B.,_\NS?]]?_ %J1_$J+_P N
MK'_@?_UJ/:P[A["IV-VBN=/BI1_RYO\ ]]__ %JMZ;KR:C=>0MNR':6R6STH
M56#=DQ.A42NT:]%%%:&04444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5XYX]M3-XSNCVV1_^@BO8Z\G\:''C"Y_W(__ $$5$]C2EN<T-,&T9%1MI*'L
M*U"_%1DGUJ36QGKI"'^$4RXTN-%Z"M,.5ICJ9CB@$D<O=6ACR0*R9"=Y7%=G
M?6H$1R.U<R8 9SFES6-%34BHENS'-6%C*&KH"(G:H1\\G%9S=SIHVAN2P!B:
MO@?)3;>$!<TZ0[1@5$6*M+F*DJY:J\B$9-70-QJ*X "FM&]#DC'4RV)W$#O4
MJV,CIDYI+4JUWANF:Z!C&D?!&,5SJ-SH<K:'%W^86*FLAI_WF,UK:[(&N3MZ
M5SRG,U;4J?,8UJO*7A(<5%)-M-*,57F^8BM?9(Q]LV;VFS%L5T*;BHXKG-(
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MG4[*$-V&))EL5(V3VJO"IW5?6/('%(-$1*IQTIW0U8" "J\@^:@$[DH.14+
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7DOC7/_"87/\ N1_^@BO6J\A\<2F/QC=#'&R/_P!!%1/8TI;F
M;CBD.:B^V?+TIANL]JFYL2D$U)"I!JK]I]JD2Y(ZT"':A_JS]*Y"ZF$4K&NB
MU"[8QD 5QUZLTDAPM+ENS6,U%"M?EFQFK-M,-V2:R!:W&[.VK4<=PN/EIN*(
M=5MG217*[,9I'E!K*A6;'(-61%,>U8^S*]H783EJAO2 #4]M;R#DBH;^WE9&
M 6FUH)2,6WR921US6F[2F'DU6LK*8'YE[UJ26TGDXVUEJC.I)\QQ>K\,2>M8
M2O\ O#74:MIEQ*QVJ:Q4T&\,G*UTT7;<BJN9$0;BH9FP*UTT.Y Y4U%-H-TW
M1:TNKF23)=(9V*@$UUT-O,\8.363H.C3QD;UKN;>U*Q %:SDSJIQT.>>UD4<
MDU"T;KW-=%/;-S@5GR6DK=%I*14HI&>B.<<U<2%MM/6TE'&VK*02@?=J)M]
M@D9URA51S70:(3M45EW-I,X "UMZ/:R1JNX41O;4':YU,8_=BD84Y!B,4C4
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MHHKM/,"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *\[\8PRR:V[1IG 49_"O1*P-4B1[]R5!.!_
M*IEL5%V9S=@7:V&]<'%-O%)4D+GBMP0H/X108$/\(J;E'G=H;L:I.3"1'U!I
MELMZM].?*^0\BO1/LL8.=@_*D-K'G[@_*CF8CSVS6^1)U:(XR=M,@34%T^1#
M$=QR!7HHM4_NC\J46R?W1^5',P//-FH'2?+:(^81^M7=-MKI=.VS)\Q'>NW^
MRI_='Y4];9 ,;1^5)W8'"V=G<PREBG!J3^R))[KSBF#]*[E;=/[H_*GB!!_"
M*7*5S')?V4SC#)FE_L5?^>8_*NO\E?2E\E?2CE%SG'_V*/\ GF/RH_L?_8KL
M/*7T%)Y*_P!VCD'SLY#^Q^?]7^E+_8__ $S%=>(E]*=Y2^E'('.SC_[)/]RD
M.D9_@'Y5V/E)Z4GE+GI1R!SG(?V/_L#\J/[%;^Y^E=BL*^E2B%?2CD0<[.'?
M1BHR4&*Y+Q#K.G:2_E-.@D';&:].U^206GV:U8++(<,_]Q>Y'OZ5QLO@[1Y4
MS/;B5MVXLYY/U/6FJ=P]K8\YF^(4L,+I;+$1_"=AS_.N0U/Q#>:G*6E8(#V4
M5[9<^%-!:$I_9]L%_P!E0"*\N\7>%(=,F\S3RQCZE&.2/I5J"1'M+G&F3)S^
MIJ1&!!-1%03@C!J55VC%-@F#=*C?H*D?I43=*0,16*NK#JIR*]1TJY2YL8Y%
M/!4&O+P,UU?AB^,2FW<\=5K&O&ZN=.'E:5CMFE:"%I$QQZU3M[TWKMB4/@X(
M!Z5/&XD3:>AK#O=),-ZM[:_+,,\9P&^M<D==#ON^AOQ3K:3[Y%)!&,CM5]+N
M&=P8SFJ$5G->6HFMF\]"0OEM]X'O44<$MO-A6\MP>4E%-P*4CT#1Y4$>"<9%
M4];G-KJ484_(RY-9U@EU,F\SX"]D:J&IW#R7**S%FSBI'UN=+:S!@&JIXH\1
M1:%HDURYR^-L:_WF/051AOA#%CG->5^,M=?6M:**Y-O;_(@SQGN?Z?A5TJ?/
M(QKU5".FYA/(\\KS2,6D=BS$]R:EB7# 4R,9J:,?/7HGE&C;)]VNN@LI6@5A
M]Q4.[\?_ -5<YIL0DD12<9[^]>JZ3:I_PCLUSM!#J1SZYX'\ZAE%;PNL\92'
M;@"0C!['C^A'Y5Z9)%,+)"B_,!7+>&XT7?(5!+L7^F?_ -5>@( %''%)"DSF
M6N=5"A5@)JM+;ZE>/^\CP,5V8"XZ"EVKZ"B<%-69*=CD!97<:;0O:I;6VN8-
MS%>M=25!["DV+Z5A]4CH^QI[5G)RVUT\Y<+4]E93K,7<=372;%]!1M7TK3V,
M;W#VKM8RVMW+ XJ=8FQTJ]@>E&!35-(3J,RY+=V/2LO4-*FN1@5U&!1@>E/D
M0O:,X;_A&Y_>JM]X0EO(#$Q.#7H>!Z4F!Z4^1#=23/%V^%)R2&-/7X5O_>->
MRX'I1@>E7<S/(;?X7F*99-Q)4YKJH/#4T<2H.PQ7:X'I2\>E2XI[E1FX[''#
MP_-Z4\:!,.U==Q1Q4^S17M9''R:!.RX%,BT>\@B=0,YZ5VG'I2''I34$A.HV
M<*EEJ:(%VTCZ3>R7EO(Z95#DBNZPOH*,+Z"FXW5B'JC/:23R0H7G&*JZ!:7$
M.JW$LR\..#6W@>@J2''F=.U3*FI--] 18HHHK4 HHHH **** "BBB@ HHHH
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M]J['0())(<#9@*"-QZ=J:5QRT/0]&BV91?NJ5"X'MC%=JA^7%<[X?M"]FK2
MEB0S''!.!TKHE&/K4VL0W<D!XIU-!I0:H0M(:6DH ****0!1110 E%+10 E)
M2T4 )12T4 )1110 4444 **2EI,4 %%%%, J6#_6?A452P?ZS\* +-%%%, H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K%U&6-;Q@S ' _E6U7*:Y
M 9-4D;S2O"\?A4R=D5%79-YT7]\4OGQ?WQ63]D./]<:1;1F/^N:L^8OE-<W$
M0_C%(+J$_P 8K,;3R1_KFI@TX@?ZYJ+ARFM]JB_OBG"YB_OBL<6!S_KFH^QL
M#_KFHN'*;7VB+^^*<)XO[XK)6Q)&?-:GBR8?\M6HY@Y33,\9_B%/66/'WA6:
MMF?^>K4?9F'_ "U/Y4<X<AJ":/\ O"CSHQ_$*R_L[8_UIJO<P2>2Y29@0*.<
M/9G0*P89!R*?BL_2RQM5WG)Q6@*M:F;%Q2T@I:8"$@=:4,OK56Y<AL+UJG+#
M=2@XN?)_W5W&H<K,I1N@\2W8ATEHT;YIF"?AWKAV)M[G;GY216GK#.EZ(&N)
M)MHS\^."?I5&]3Y<]^M;0V,I[B(=FM$XXDCS]>:OR'%9DCG[58R>S*?R_P#K
M5?<Y6MTM#%D,[?N&KGV?S-1V\']T:WYAF)L'M7-61\S69!UVQG^=%@//M<T2
M6.]DN+4$MGYE'?WK$,TZ$QO*8ST*L,&O3+^#,SD#C-<Y>V*.JMY:MG<<D5$H
MFL9'(,,N23O/K2&%_+\PC@G%=)!I2B,LRC+<].@JKJ5L(PB!<5E)-*YK%W=C
M!QEQ71:;"SA5123["G>&/#B:S>,]S-Y5K&>2#RQZX%=NEGI^F.VW9'$#\N3D
MG^M<U6?1'92I2W93LM%E<*9>!W%;L5E80<R+'D5C7>MO(/+M4V@\!CU-0P:;
M=7)WR2,@/4YR:YFNYU*R6ATAOM.@'6-:LVMW%/(I3@'H:H2:7:";<UO"3&2%
M(0#\?TJ:&54E&P<]L5+78J+ON=1>Z/8ZGIT27=M',T1W(67E3['M6'J>G^59
MN(N5V].XKJ;!Y);",RKR.,^HJGJ%NRJ2!D'K5)Z&;W/FC4X3#JEVAZB5OYU%
M&*ZKQ[IHL];$Z+B.=<\?WAU_I7+QBO0B[Q3/-G&TFB9%R<5HVZY*U3A3)'%:
ML( * ^E)C1K6L 6-2.I(KN_"MO'-.K^6OEQH2W'4\5P\)Q:($.6;DCTYKT;P
MA#C3P!SEL$^O/^&*TI+4SJOW3T?3B!"%X  '2KN16=;GRXD [G%3%CZU-1VD
M*"NBV&'K2[AZU2W-ZTH9O6HYBN4N[AZT;QZU3);UI,MZT<P^4N[AZTFX>M55
M+'O1\WK1S"Y2UN'K1N'K5;+>M)\WK1S!REK</6C</6JHW>M&6SUHY@Y2WN'K
M1N'K54$^M&X^M%PY2UN'K1N'K5;)QUI,L>]%PY2SN'K1N'K54EO6D8L.]','
M*7 0>E%5[8MDY.:LYIIW$U82BES24Q 6 I-P]:@N"=R@&F$D#K2N4D6MP]:D
MMV!E_"J&3ZU9L2?M'7L:$PL:-%%%62%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %<SK'_ "$9/H/Y5TU<UJ__ "$9?H/Y5%38TI[E)?NT1\&A>E-3
M_6&L34L$\4U<T[%(OWL4T)ACYJ:W#8J0]:C=26%,"5#Q3B:C7@4_J*3!#E:F
MEN:4"D8<TAANXJ.4_NG^AIV,57N9/+B8^U(9H:6?]'%: K/TKFU4^U: K:.Q
MSO<4"EHHJA$$H^<8%.(4(6;H!DTL@^851UN<V^CS,#@L H_&HMJ6GH<->SF>
M\>8_Q,34EV2T2GVJFYSGUJW&_G6/NG!KIBCGEW*,DFV2R/\ TT*_H:U6^Y6)
M*^)8AU D!%;2GY.:TB9R("?E?/I7-Z$#)JMZ_P#=7;^M="Q)W>E8?A=,OJ$A
M[SE?R'_UZ8A;^W 5CCG&:Q)K-C'&&! V#/.<'C\JZ;4>&(XZ8K/_ '<C321_
M,">F,'%-H:9S[1;#CJ,<FL;5U53YGHF<5U<MN2<[?E/Z5RNK(TDC+C[S ?A7
M/7=HG3AU>1EZ6DC32;6944C@'OCK6TB%>223ZFH=(@Q$Y[ER/\_K6FT/'2N"
M;U/1@M!^F1&:^3 R!UK;N-6%M)]EMH&EE ZXX%4=#79<R<9.*OHB+-<2/P$)
M+5#1LMB&.'4;R7S+NZ*)_P \HN_U-:]H8XITZ$@\ UF_:KFX7$$:PJ>C2\G\
MA4VG6K1W?F2SO,V>"0 !]*A^926IZ1:3EK95=-HQD$=#3YH@Z$=C1IS1262#
M'('-6&3 XJUL82>IYAX]\,2:AIKM;INEC.]!ZGN/RKQU(B.""#TQ7U-+ LJE
M6'%>>ZSX+LK34Y-3VA;?!DD_V3U/YUT4):\K.>O&ZYD>3Q0,CC<,'WK3:/!!
M';_"M6'3OM5Q+?W$+F $LP4=NPIDJK*62"%@A ))4UTRA8YHRN6M/51;1HJA
MI'9>#WKTWPG;E+,$C'S''\J\^T2VD)8K&[2L D1"D@$]37K.D6@MK6*+.XHO
M)]3WJZ:,ZKZ&TH_<I[-4U)C*H*6L*GQ&D/A$[T\"FCK4P'%04-VTC#BI,4C#
MBBP#$Z4$\TBY)Q2[>:=@'8HQ2K1C-%@&@4N*<%Q2@4 ,QQ2 <5(1\M-3H: $
MQQ2"I .*;B@!G>D89-./6C'-*P#X!AC4QJ.'[QJ1C5K8E[B T\<U%4BFF(@G
M'SK3&%2S?>6F-TJ>I2V(ZLV0_?\ X&JYZU:LQ^^_"FMP9?HHHJR HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+U%%%62%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-(30.PQS5G24S<N_]U:JOTK1T=/W4K^IQ3CN3+8T!U-)2T@K0S"F'O3Z;WH
M; /G-6*AA^^:FIH3W"DI:*8B.3K3!3WZBFCK4E(2IK;_ %OX5":DMC^^_"A
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MH<PQ*AQC(K,B\1(<"6 K_NMFM&TU*VNY-D3G?C.TC%("Y1110 4444 %%%%
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M_)&.>W?FH]M%NR*=*25V=91115F84444 %%%% !1110 4444 %%%% !1110
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M_P"%/ZE+N'UR/8\^557[K ?2EV@_QBO0/[.LO^?.W_[]+_A1_9]E_P ^=O\
M]^A_A1]2EW%];CV/.)K:.0?? -8U[I$4C!L[7'*NO!%>P?V?9?\ /G;_ /?I
M?\*/[.L3_P N=O\ ]^E_PJEA)+J'UN+Z'C2N#MBOEW%3\EPHP0?Z5UNG-/\
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M'%9PJ5*C<E91O;ST-*E.E32C*[E:_EJ4:*[NX\.^%-'U&'1-4O-1?47"B6>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1QQ^IJ34_%FEW$?AZ&TAO1'I=P9)#.59G7>#G.>2<>P&<5!_PK3Q5_T#T_\
M B/_ !H_X5IXJ_Z!Z?\ @1'_ (TG]5YN;G7W^5@2Q:CR\C^[SN)_PEL4/Q"?
MQ#;QR_99)?GC8#<8RH5AC.,]QSZ4S7O%B7?B'3[W2H6@M--6-;6&0 8VG)R
M3U/'7H!4G_"M/%7_ $#T_P# B/\ QH_X5IXJ_P"@>G_@1'_C5*6%33YEHK;]
M!..+:<>5ZN^W4U;OQ?H-Y-+J#S>(8[B123917>V$.1U#9R!GGI^':N?C\00#
MP1>Z-(L[W=Q>BY\PX*XPN<G.<\'M5O\ X5IXJ_Z!Z?\ @1'_ (T?\*T\5?\
M0/3_ ,"(_P#&E%X6*LIKIU[#DL7)W<'UZ=R3PSKF@:1%:W$DVM6]Y"^Z5+:1
M3%<<Y ()'';%<YK6H+JVM7E^L(A6XE:0(.V?ZUO_ /"M/%7_ $#T_P# B/\
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M>1:G'!#:K!#<PR*)]P).]NQ//K_]:K_PK3Q5_P! ]/\ P(C_ ,:/^%:>*O\
MH'I_X$1_XT-X9RYN=?>)+%*/+R/[AGBWQ)::S9Z;96ANYDLE8&ZO"#+(6QUQ
MV&*I>%O$LGAR]E9H%N;.Y3R[FW8\.O\ CR?S-:'_  K3Q5_T#T_\"(_\:/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(PN!TQ0!Z%?ZC8Z7:FZU"\@M;<$ RSR!%R>@R:+'4+/4[5;JPNX+JW;A98)
MZGUY%>9FQU?2+7P==:I=&TAL["2&6:6W^TBUF;9LWC/!V!DW]CD?Q5U'@V&.
M2]UC4X=1>]2[DC#2+9FWB=U4@NG/SY!4%A_<% &[J&O:/I,\4&HZI96DLO\
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MFN?$EYHUGI5U.]C-''=7&Y%CC#HKA@2<MPW0#/!]1D WZ*1F5%+,0J@9))X
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MK%,[Q,(@993Y@&[(W%5' S\HR!0!TVA:.NB:;]F\]KB:21Y[BX=0#+*[%F;
MZ<G '8 #M6B\D<>W>ZKN;:NXXR?0>]4]8N[BQTBZN;6V>YGCC++&C*"??+$#
MCK^%<%>Z_?7W@_PCJVHZ=<+.]_9R;4V,URS1$Y0*V!DG@'&.^* /2Z*P;'Q
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MR7#%@RDAEP<Y!_(@B@#N**YF#Q<Y:SFO-%OK+3[V1(H+J9D^\YPF] Q9-Q(
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MLQ&#E.G4Y'H<59_$&G:KHVF7TL-[$'U2.V\E9/+>*X64H5?:V"H8'(R01ZT
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M0W4A0G#8VLR!MR@\=1QD9 KI;[5]-TOQ!J,]P+H2VFDBZF8.3'Y(=^B9QO\
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MC)P/6@#D=<\.:M>P11/IECJ%Y'9I##JPNFMKB*4+AF)5<[=WS *?48[TV_\
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M[4_MHZ5+*T9\M]LS1E]N<C(4-C/MFNOBTJ"+7;G5U:3[1<6\5LRDC:%C9V!
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MVSL-)%_&\<0CD?#/D,!QGY,<8'MUIFKZ3I6A:?H5J1K,*Z?"8+;5+&/S7MU
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MOVL5#A'^8!@ P!Y&:K:_J6H#6=+T/3)8[:>^6::2ZDCW^5%%MSM7H6)=0,\
M9.#6Q86:Z?8Q6J33S",8\R>0R.QZDECU/^1536="@U@VTIN+BTO+1R]O=6S
M21DC!'S @@CJ""#^ H Q]2O-=T:"RT\:A!=WNI7PMK:YEMMODIY;.S.JD!R
MC8 VY)&>]217FK:+XETW3-0OUU&UU)95CE:%8Y(I$7?@[>"I4'L""!R<U8D\
M*QW>G/;:AJFH7DYG6XCNW=4D@D484QA5"KCGC'.3G.:DT_PV+;5$U.^U*\U.
M]CC:*&2Y\M1"K8W;5C55!.!DX)XQTH Y0:[XF'@RZ\5/J-N%LY)F^Q+;#;-%
M'*RG<W4,0IP1@#C(/-:7B;6M4T_69$DOY-)TU+='@N_L!N(9)"6W"9A_JU&%
M_N]2=U;!\*V+>$[GPX9;C['<+*KON'F#S'9FP<8ZL<<4:MX<DU.:9DUO4[.&
MXB\J>"%HV1UP1P'1BA(."5Q^?- %2Z\1RV.MWRR-'-8VNB#4#Y2_?8,^2#SP
M0HQ7.^)XO$MU\,M4U.YU2V<W&FO++8BW BC1DR0CYW;@#U.02.@SQVD'AS3[
M>^%S&C;18)IXA8@Q^2I) P1DGG'7I6-<_#^"[T>71)M<U<Z.T9C2S$D8$:]@
M'V;R%XP&8C@9R.* *VL^);G_ (2231K>[NK&&TMHI99[;3)+N21WW84;5954
M!<DD9.>,8-0R>)]??PY:O%&L5^^L1Z>)[FSDA2:-CQ+Y;X8<$9'JI -=)J/A
MU;O4$U&SU"[TV^$0@>:VV'S8P20KJZLIP22#C(R>>:#X;MWL+*UGO+V<VMVM
MX)II=SO(K%OF.,8R>@  [8H PM9UO4=)O].T%M3N&GFAEN;C4(M-:>0(& 55
MCC4@'+?>8$ +W)J%/%^J6FBZJSPRW4UO/;P6-U=64EHLYG8(N]6 ^XQ^8K@$
M8Z9KI]7T&+59[:[CNKFQO[7<(;JV*[E5L;E(8%64X'!!Z \&HAX9MYM'O-.U
M&\O-16\;=-+<2X;/&"@4!4Q@$;0.1GKS0!SGB*QURT?06O-7CU"!M7M?-5K9
M8BC;N"FWMVP<GG.>.>^KF&\&BYGL9=2UW5;_ .PW"7%LLS1*JLIXW!$7<>V3
MD^F,FM32K>_CO=4N+Z5BL]S_ *-%ORL<2HJC [$D,Q^OM0!D?$F.XD^'>NFW
MN?(V64S/\@;>H1LKSTSZUF:U:ZNFN>$+=-2CDO&FN<W4D &Q/).<(#@G' ]S
MDYZ5V6IZ=;ZOI5WIMVK-;W4+PRA3@[6!!P?7FJ%OX=6.;3)[K4;V]N-.:0Q2
MS^6"V]=I#;4 .!TZ'US0!@S>)]1\/6GB=-0D749-(ABGMY?+$;2B4,%5PO'#
M*>0.AZ9J*Q\0ZM%JFFHUU?:DEU,(KJ)M#GMD@# _.CL@PH. 0Q/!Z\5T\WAS
M3[FZU6:Y1IEU2".WN8G/R%$# 8QR/OGOZ8Q4%AX<FL[JWEFU_5KR&VSY,$\B
M!1P1\Q15:3 /\1/KR>: ,#^T?$U]9>(K^WU.WMDTN[N([:'[,'$PCYQ(2<@'
MI\N#WR>@['2[W^T=)L[[9L^TP)-MSG;N4''ZU5@T"UM['4[1))C'J,LTTI)&
M5,@^;;QT],YJ[86<>G:=;6419HK>)(4+GDA0 ,^_% &#XFU5K6\M;.#6)K2:
M1&D,%II[7<[@$ -@!@JCG)*\^HJQX/UBYUO0?M%X/](BN)K9V\HQ;_+D9 Q0
M\J2 "1V.:DU+P[]MU9-4M=3O-.O!!]GDDMQ&PDCW%@")%89!)((P>35C0]$M
MO#]@UG:R3R1M-).6G?>Q9V+-SWY)Z\T :5%%% !1110 4444 %%%% !1110
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M9HID*GRD:0X+#&U23]XCG.: /4P<CBC(SBN$@&G:!XW>'08D2Q73)KC4;2S
M\N-E9/*8*.%=AY@P,9 ]JY^V,,-]X4U:SLM'TYM1O8RHM9VEN98G5MPE? WC
MD9SG#8YSB@#UO-5--U&VU;3XKZS<O;RYV,5(S@D'@^X-<?X?\.Z5JVJ^);O4
MK..]D75I8H_M WB)?+3(4'A<[CDCK^%<Y::;IL7PDA6Q6.VN9[^UCN9+8[)
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M'@R*6729M8N PN-7G:]*MU2-L")?;$:IQZYH Z.BBB@ HHHH **** "BBB@
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M><8^;UX '/856.B:2;!; Z99&S5MXMS;IY8;UVXQFI=/O[75-/@OK*99K:=
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M-]XDK@C&5(((.1P1S2V'B?3=0U!;%?M5O=.A>*.[M9(#*HZE-ZC=CN!R.XH
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MK8@B$YG$2"4J$,FT;MH.0,^F2>*XK06TBXGL&C\=7-Y=L$?[*=2B?S&QDJ5
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M):=I-U#H?BJ![4K+>WEW)$IQ^]5U 4_CBJ5M9:CH=UH&KOIMQ=QQ:,FGW,,
M#2V[_(VX+GY@2"#CG@=:[JB@#AXH-2U/7/$E^VCSV<%UI$5O;>;M#S,IFSN
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MW 0?F!YSG /&?5** ."\164]I>S2:58:[!J(M4CMKRP='CN"H.U958[>">K
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M7%I<13P.,K)$X96^A'!J:@ HHJ"RO;;4;*&\LYEFMIT#QR+T93T(H GHHHH
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M1VQ#EC&Q,A\SE>&!!QCUZUTG]NZSJ=]J$>A6%D]M83&W>6\G9#-*H!94"J<
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MQ1&YN626X",59EPI"C(.,YSCMFI],T?68;^"6_NM*\F 'BSL?+>8XP"Q9CM
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MU;J&8I("NUD*R,W(+ CITQBG?#R&\NO#&G:SJ.J7E[>7=JI822?NU';"#C.
M,L>3D_2@#L*H:WJT6A:'>ZI.CR1VL32%$ZMCH!]3Q6%=FYUOQI=:/)?W5E96
M5E#<>7:R>4]P\C.,EQ\VU=F, CEN>U<QXF^U3^%?&&CW.I7=Q'I+1M#<>9AW
M5T#>7(0/FVY^I!7/- 'I&G2WTUFKZC:PVMR2<Q0SF50.WS%5Y_#\ZIZQX@M]
M,\/W.KP;+R*!MN(I!@MO"$;AGD'(/N"*N16 BTPV/VJZ<%&3SWES+SGG=ZC/
M!^E>7+IK6WPAUF6*]NI))+NX15GE+HI6]<!@/4XR?6@#URJUC>"^A>407$&V
M1X]L\91CM8C(!_A.,@]P17,F"[T'Q;HD*:K?7<.HB>*Y2ZEW@LL>]748PAX(
MPN!@].*H1S:]JGAAGM);JX:/6[M+E()UBGDMTFF4)&[8 (PG<<*1D4 =]6+J
MOB2#3K^/3;>TNM1U)T\P6EHJEE3.-SLQ"HN>!DC/;-1^$[N*YTVXCCN-1D>W
MN&BEBU$#SX&P&\MB/O## @Y.0W4U0\-,D/C3Q;;W! OI+F&=-W5[;R45"/4!
MA(/8Y]: -72==?4;N6SNM)U#3KJ)!(4N45D92<961"R'Z9S[5L5B>+-:?0_#
M.IWUMY;7EO:O-%&Y].-Q'4J"036#K%M>^&-)MM:M]=U"]N4G@2:.XE#Q78DD
M5"%3&$/S979CH.HH [FLW1]7&KK?$0F+[)>2VARV=VPXW>V?2L&WBN?$GB+7
M$N-3OK2#3;A+6"VM)O*/,2.97(Y;)? !XPO0\USMOJ.HZ-X6U"*TN9;JZN?$
MDEFUU L8DPS@%@&(0.<;><#<>G:@#U*LO7]8.B:<D\=N;FXFGCMH(=^P/)(P
M5<M@X'.2<'@=#6!H:ZW:^(H(ULM:32Y87^T?VK=0S%)!@HR%9&;GY@1TY'2E
M^(.GB\AT1C=W<.-6MH\02E!\T@Y^H['M0!UEJUP]K$UW%'%<%?WD<4A=5/H&
M(!(]\"IJXV""XUWQ)J^GSZK?V]II(@@ABMYS&\I:,.97<?,V<X SCY3P:R9]
M6UF316L(]5E6XMO$4>F"_55WR1$KDD8VE@'*GC!*]* /2**JZ?9+I]FELMQ<
MSA23YES*9'.3GEC7FUMJ'B+6])N=7M[;Q!_:#23?93!<6RVL6QV54,;2C</E
MPQ8;LYQCB@#U.BO/O%GB'5O#D]G=Q3JLNHVH2XLY<R+8L,9N?E!^1-V&'0_+
MCO4NMW6H6^IZ)X>MI-6O+=[*2XGGLYHDN+DH44?.[* /GW':<\J!@9H [RBO
M/)=5\1:+X=UEI(KRVB6>VBL+C4I(I981*ZQN6*,P8)NW MR<X.0*WY-%FT:P
MO;N#6M5G=;27*7,XD#/MR'Y'RD8Z+@<]* .DJ$74#R3Q1RI)+!CS8T8%DR,C
M('(R.GK7(W6KW:>#/"=VMXPGO+G3DDDW<RAV3>/?(SFH] TH0>//$TXO[]S$
MT!"/.2K;HC]X=\9X]* .PL;L7]A!=B"> 3('\JXC*2)GLRGH?:K%>?Z'K.H0
M:5X+U>^O9);34+)+6\,C<"9T#QRGW+*R'_?%5[K7=9DT*PO(7O6'B#52L(MR
M@DAM=C&-8_,(56=8P<D_QG'.* /2**Y#PX-:M_$#P/9ZO'I#VQ8G5+F&9XY@
MPQL99&8AE+9!X!48ZU/KT]U>^*=+T".]FL;6XMI[J:6!MLDOEF-1&K?P_?W$
MCG ZCF@#IG=8T9V.%49)]JY*+QC?3:!8ZH-'C!U6:*/3(3=\R"0%@TIV8C^4
M$X&_\ZK^5<PZSJOAEM4OI[-M.6]CE:;,]N=Y4IYG4JVW(SD\,,XZ<U:Z&&\&
M_#Q_[3U,>?-:<"Y.(]ULQ^7TQC ] 30!Z?87TMT\T$]I+;W%N$$I*DQ,S*&/
MEN0-X&<9P.1T%7:X+5-?U'2H?&4D%R6:RDM8K9IOF6'S(XP7([@%BY^E;+:7
M-X>LKG5(M5U6^DM[621X+B<2).P7(XQ\IR/X,#GI0!TE%>8Z?<>)9M-TW5K2
MVU^>_F,,TKS75M]DF1B"ZB,2_*NTG:0-W3.>:WM*AO=3\8^('N=4O!::??1)
M;6L<FQ!F")FW8Y8$M]T\<GUH ["BN"T"74-.UJQ@\07&L1:C<M)'O:5);*\?
M:S80#/EX"E@,(?EQS6SXKO+M+C1=+M;I[-=3O#!+=)C<B+&\A52> S;-H/;)
MQSB@#I**Y*(7.@>,=-TR+4+N\LM1@G9X;N4RO"T>TAU8_-M.[!!.,XQCFF^
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MJ%YQCEAFLG5M5U72=(\8:;;ZE-,^F0V\UI=RD&2/S<_NV8?>V[<Y/.'&<]:
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M*6#POHEOH]QI$6G1+I]PY>2#DJ6.#D<\<@$8Z$<5)%XDT*=[E(M9T]VM5+7
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M>:6VF"W#^9/ ES*D$S=R\2L$8GOD<]\UI6^L:9=Z<VHV^HVDMB@):YCF5HU
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M/.#4L&O:/=:B^G6^JV,M\F=]M'<(TBXZY4'/%7R0H))  Y)/:@#D->\)6?\
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M\/R*3CC/F1\5AP:-./@18VFF6I2XDL;:2:)(LO(NY&F&W@L2N\8SSG%>F44
M>>:7);ZQXDT:2WU^VNY+'>RI9:6T7EH4*F.1MQ"#D':0#E1QQ1X7U'0]+\/Q
M:)KB(NL>>WVNVFMS)+<3F0GS0N"9 3A@PR ,=,<>AT4 >?X9-3\=:79L+?6+
MS,FG@KM+9M(U#*>F ZD9[$50U&^T6_\  =MH&BP%-:18DM+%82L]I<*1\[#&
M4VD$ECP<'DYY]-5T<L$=6VG:V#G!]#3J .4TFQB;XC>([V2W!E%O:)'*R]!M
M<D*?J!GZ"N?T^]MM/UNRT_3+F#4H7U*1FTZZLBMW9,[.SRA^"%!)Y9>0>&KT
MNB@#E?'EFE_IVE6TL/G0OJ]H)$(R"OF#.?;UIHTZ#_A:IN_LR[ET95$FSC/F
MD?GCCZ&NLIN]/,$>Y=Y&[;GG'KB@#S1H&L_"D[K!(+73O%#7#(B$^7 MWN8J
MH_A )/';-:D>KV.M?$2WFL7>YLH]$NE:YA5BC,98"55A]Y@!V]?6NYHH \X\
M*WEO%JVD:/87-KK%A%;R1HSV7EW6GHJC D/3G 4@JI)YYYK9^'D]LOA\Z>N$
MOK2:9;F$H5:,F:0KGCN.1[5UU% '!O?Z3I'Q-UB]U5!!FQM4AO94/EIS+N3?
MT4GCZXK'O;*ZU#P[XEN='MY$T>YU.WN(H1;D^="OE_:&6+@LK%6.WC?@_P![
MGU2B@#@-&D@UCQ9IEU#K]O?264,N19::T2B-EQY<C[B%YVL%/.5K7\9ZG)IR
M:6 ;6W@ENL2ZA=0>:EIA&(;&1@D_*&) &:ZBB@#R2XD:7PY\2)1<O=PRV"R)
M<>0(5F/DN"R@#!'RXW=\=^*U-:O]%U/PW9:+H,.W5XYH#9VBPE9;-U=27<8^
M0* V2>#SUSSVOB'2?[=\.:EI/G>1]MMI(/-V[MFY2,XR,]>F:T47:BKUP,4
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M*YP-@8?+L/))''''>T4 <QX9MQ%XC\6-Y(3.HQ[3MQD?98>GMG-5]6EM=/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M199);"S6.:4!7E9F=V4=!N8DX]LXK4HH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHH)P,GI2*RNH9&#*>A!R#0 M%%% !1110 4444 %%%% !1110 4444 %%%'6
M@ HHHH **** "BBB@ HHZT4 %%%'6@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMHQB5HPT\65;+X975MH*D@[N2!G'0:L!:>!]0-K;&PV:?*Z0H%4PGRR<?(<
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M*^3L >=I!GC/1AVZT 7;KQ&4U"XL[#2;[4GM<"Y:V,:K$Q 8+EW7<VT@X&<
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M7_GZD_\  >7_ .)K:HH Q?\ A+=%_P"?J3_P'E_^)H_X2W1?^?J3_P !Y?\
MXFMJB@#%_P"$MT7_ )^I/_ >7_XFC_A+=%_Y^I/_  'E_P#B:VJ* ,7_ (2W
M1?\ GZD_\!Y?_B:/^$MT7_GZD_\  >7_ .)K:HH Q?\ A+=%_P"?J3_P'E_^
M)H_X2W1?^?J3_P !Y?\ XFMJB@#%_P"$MT7_ )^I/_ >7_XFC_A+=%_Y^I/_
M  'E_P#B:VJ* ,7_ (2W1?\ GZD_\!Y?_B:/^$MT7_GZD_\  >7_ .)K:HH
MQ?\ A+=%_P"?J3_P'E_^)H_X2W1?^?J3_P !Y?\ XFMJB@#%_P"$MT7_ )^I
M/_ >7_XFC_A+=%_Y^I/_  'E_P#B:VJ* ,7_ (2W1?\ GZD_\!Y?_B:/^$MT
M7_GZD_\  >7_ .)K:HH Q?\ A+=%_P"?J3_P'E_^)H_X2W1?^?J3_P !Y?\
MXFMJB@#%_P"$MT7_ )^I/_ >7_XFC_A+=%_Y^I/_  'E_P#B:VJ* ,7_ (2W
M1?\ GZD_\!Y?_B:/^$MT7_GZD_\  >7_ .)K:HH Q?\ A+=%_P"?J3_P'E_^
M)H_X2W1?^?J3_P !Y?\ XFMJB@#%_P"$MT7_ )^I/_ >7_XFC_A+=%_Y^I/_
M  'E_P#B:VJ* ,7_ (2W1?\ GZD_\!Y?_B:/^$MT7_GZD_\  >7_ .)K:HH
MQ?\ A+=%_P"?J3_P'E_^)H_X2W1?^?J3_P !Y?\ XFMJB@#%_P"$MT7_ )^I
M/_ >7_XFC_A+=%_Y^I/_  'E_P#B:VJ* ,7_ (2W1?\ GZD_\!Y?_B:/^$MT
M7_GZD_\  >7_ .)K:HH Q?\ A+=%_P"?J3_P'E_^)H_X2W1?^?J3_P !Y?\
MXFMJB@#%_P"$MT7_ )^I/_ >7_XFC_A+=%_Y^I/_  'E_P#B:VJ* ,7_ (2W
M1?\ GZD_\!Y?_B:/^$MT7_GZD_\  >7_ .)K:HH Q?\ A+=%_P"?J3_P'E_^
M)H_X2W1?^?J3_P !Y?\ XFMJB@#%_P"$MT7_ )^I/_ >7_XFC_A+=%_Y^I/_
M  'E_P#B:VJ* ,7_ (2W1?\ GZD_\!Y?_B:/^$MT7_GZD_\  >7_ .)K:HH
MQ?\ A+=%_P"?J3_P'E_^)H_X2W1?^?J3_P !Y?\ XFMJB@#%_P"$MT7_ )^I
M/_ >7_XFC_A+=%_Y^I/_  'E_P#B:VJ* ,7_ (2W1?\ GZD_\!Y?_B:/^$MT
M7_GZD_\  >7_ .)K:HH Q?\ A+=%_P"?J3_P'E_^)H_X2W1?^?J3_P !Y?\
MXFMJB@#%_P"$MT7_ )^I/_ >7_XFC_A+=%_Y^I/_  'E_P#B:VJ* ,7_ (2W
M1?\ GZD_\!Y?_B:/^$MT7_GZD_\  >7_ .)K:HH Q?\ A+=%_P"?J3_P'E_^
M)H_X2W1?^?J3_P !Y?\ XFMJB@#%_P"$MT7_ )^I/_ >7_XFC_A+=%_Y^I/_
M  'E_P#B:VJ* ,7_ (2W1?\ GZD_\!Y?_B:/^$MT7_GZD_\  >7_ .)K:HH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
9HH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>ethicsemployeepolicybook013.jpg
<TEXT>
begin 644 ethicsemployeepolicybook013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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MT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+E6BNQF\-^'/^$AET"+5=0BOEN#:I)-:H86D#;0"5?(!/?%<G<V\EI=36TH
MDB<QN >A!P:49J6PY0<=R*BBBJ("BK-Y#:0^1]DNFN-\*O+F(IY<AZIUYQZ]
MZK4)W&PHHHH$%%%% !16CHNCS:W?&".2.&*.-IIYY#\D,:]6/^>216FMMX/>
M86W]H:LA)VB\:!/+SZF,'=M_'/M4N:3L6H-JYS=%/F18IY(TE65%8A9%! <
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M@)9W37,6Q27:(QX8@%EP3V.1GO5:FG<'H%%%% @HHHH **** "BBB@ HHHH
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M43T6W_!.I\1:W=Z)XBN]&L;:WBTZSE\A;5[=&651QN<D98MUSG//&*H>/O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMW^DK+9FYL(!/-B4[0I&< [>N"*]"@\.1#XV/J8V_83:_P!I*_\ #DC9G/\
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MM?$^AP:E:D#>,21YYC<=5/\ GI7E8ZDU+G74]3!5$X\CZ''?$+X9IK[2:KI
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **^N?[*T[_GPM?^_*_P"%']E:=_SX6O\ WY7_  KSO[07
M\IZ'U!_S'R-17US_ &5IW_/A:_\ ?E?\*/[*T[_GPM?^_*_X4?V@OY0^H/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!EZ]!>W%BR6DRQK@F0GJ1CH*\]@@EN)5BA
M1GD;HHZFO4;E2]K*JC+%" /PKD_#6DWUIJWFW%LT:"-AN..O% '-"*1;D1,"
MD@;;@\$'->E:9%>06:QWLJRRJ<!E[CW]ZY74]'U";7Y9X[5VB,JD,,8(XKMJ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ]HMKJEKN$-PFX*W53T(/T((_"HKJ=DY--=T70Y+M133[,T****Y3I"BBB@
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M_CW ^]C'7CZUZI14JLU*4N]_Q*=%-178RO$T4D_A75X88VDEDLIE1$&2Q*$
M =S7*?"#3[W3?"-S#?6D]K*;UV"3QE&(V(,X/;@_E7H%%2JC4'#N-T[S4^QY
M;\9M*U'4[?1Q86%S=F-Y=X@B9]N0F,X''2O4(QB) >N!3J*)5'*$8=@C32FY
M=SRO4M*U%_CG9:@EA=-9*%W7 A8QC]V1][&.M>J4445*CG;R5@A3Y+^;N>??
M$CP)<>(O(U;2&":K:C 7=M\U0<C![,#T^M8EM\3_ !1I4 L]8\*7$]V@V^:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3'X7/AQ87_LT@@IYAW<MO^]UZUMT4.I)N]QJ$4K6,'5O!^CZSI]C9W44@6Q
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MU_Z \W_?\?X4?V?B?Y?R#^T<-_-^9Z;17F7_  N*U_Z \W_?\?X4?\+BM?\
MH#S?]_Q_A1_9^)_E_(/[1PW\WYGIM%>9?\+BM?\ H#S?]_Q_A1_PN*U_Z \W
M_?\ '^%']GXG^7\@_M'#?S?F>FT5YE_PN*U_Z \W_?\ '^%'_"XK7_H#S?\
M?\?X4?V?B?Y?R#^T<-_-^9Z;17F7_"XK7_H#S?\ ?\?X4?\ "XK7_H#S?]_Q
M_A1_9^)_E_(/[1PW\WYGIM%>9?\ "XK7_H#S?]_Q_A1_PN*U_P"@/-_W_'^%
M']GXG^7\@_M'#?S?F>FT5YE_PN*U_P"@/-_W_'^%'_"XK7_H#S?]_P ?X4?V
M?B?Y?R#^T<-_-^9Z;17F7_"XK7_H#S?]_P ?X4?\+BM?^@/-_P!_Q_A1_9^)
M_E_(/[1PW\WYGIM%>9?\+BM?^@/-_P!_Q_A1_P +BM?^@/-_W_'^%']GXG^7
M\@_M'#?S?F>FT5YE_P +BM?^@/-_W_'^% ^,5KGG1YO^_P /\*/[/Q/\OY!_
M:.&_F_,]-HKC]%^).@ZO,L#O)93L<*MP %8^S X_/%=A7/4I3INTU8Z:=6%5
M7@[A11169H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 C,$4LQ 4#))["OGOQCXGG\2ZS)+
MO8643%;>+L%_O8]3U_2O</$S.GA75FCSO%G*1CM\AKYMKV<II1?-4>Z/$SBK
M)<M-;/4****]L\(Z?3O NI:CI-OJ:76GPV]QN\OSY]A."0>WM69K?A[4?#UQ
M'%?Q!1*NZ*1&#(X]B*[RWT[2M4^'WABUU._DM/,GD2%D3<&8NPP3V^M1ZK80
M:KXDT;P1$EQ#:Z?NWSS$;Y!MW$K[$#CZ].*\^.*GSOFV5[Z=%UOU/2GA(>S7
M+N^6VN[=M+=#S.BO5'\)6%Z+VS?0H--B2-C:WBWZR.6'3>NX]?TK$MK/P_IG
M@/3=:O=*-Y>3321A/.9%?#-RV.P [=:UCC(26B=[VZ=?G8QE@IQ>K25K]>GR
MOU.&HKNK[PYINM6FA:GI$!L(]1N?LLT!<N(VR?F4GZ'].E63%X3'B?\ X1?^
MPY"GF_9OMWVAO-\SINQTQG\.^.U5]:C;1.^M_*POJDKZM6TMOK?Y'GE3+:7+
M6C7:V\IMD;8TP0[%;T)Z9KN-*\-Z/96_B@ZO;O=#2I4$;(Y0L,MQP<?-@ ^F
M:T[;5]#D^'FH72^&T2S6\17M!=OAVPN&W8R.W'M4SQ>ON1;U2Z=?F5#":>_)
M+1OKT^7D<#=Z%=V>AV6K2/";>[9EC"OEP1ZC\*S*["XT;3U\*^&;U;;$][=.
MD[;V^=0Y '7 X]*Z)M*\*+XXD\+#1&/FC_CY^T-F-O+W */3'J>I]*/K2BG=
M-[_<GZA]4<FK-+;ONU?L>6T5VNDZ+I>EZ)JVMZK;-?BTNS9P6^\HK,,99B/K
M^E.O;/0=0\!W>MV&EM9W:72Q,OG,ZITSMSV(/?IS5_68\UDG:]K^9G]5ERW;
M5[7MY'$45H:':B\UJU@:QFOE9_FMX6VLX^O;_/2NZU/PU97'AK5+A]&MM+O+
M%1)&+>]$Y(SRKC)P?>G5Q$:<E%]?3_AQ4L/*I%RCT]?\K'FM%=[/;^'-"\.:
M!J%UHIO;B]B8R*9V53@C+'WY&!P.M69/!6E_\)_<V9\Q=+@M/MS1!CNV\?(#
MUZGZX_.H^MPU;3MK^#LR_J<W9)IO3Y75T<CX<T!O$-[<6ZW @,-L]QN*;L[2
M..H]:QZ]1\':EH>H:CJ7V#1CIUPEC+M*3%U>/(SN!Z'IT]Z\VL$BDU&U2<@0
MM*@DS_=R,_I54JLI3DI*UK:"JT8QA!Q=[WU^[N;^F^!=4O\ 3TU">:ST^TD_
MU<E[+Y>_W P?UJCKWAF^\/- ;IH)89P3%-!)O1\=<=_TK>^*<MR?%OV>3*VT
M4"?9TZ*%(Y('UR/PK'\(:(OB/Q#;V%Q*ZVZJSOM/.T<X'IDG]:BG5FZ?MIO2
MU[6_4NI2@JCH0C[U[7OU]# HKO\ 2H/#/BV^GT:TT5M/E\MFM;I9V<DK_?!X
MY_SZU7L+'0[#P)#K>H:6;RZ%\T(7SF0/P>&QV&">!U JOK*6CB[Z::==NI"P
MK>JDK:ZZ]-^GF<117I.I6WA32;C2+K^PFF35XHY#"]PP6W4XSM]3\W?TXQFF
M67A/1XO'VMZ5=Q/)86UFT\8WG<F0AX(/. Q'-2L9&UVGM?[G9]2G@I7LI+>W
M7JKKH><UN2^&Y(_#VEZJMRC?VA,T*Q$;=A#%<EL^U=!I=MX=\66]_I]GHQTZ
M[M[=I[><3L^\+CA\\<Y%,OD63X;>%D<95KR4$>HWM1+$-R44K.^OW-A'#I1<
MF[JVEN]TOU.6UK1[G0=4DT^[:)IHP"3$VY>1FL^N\U#P_9V_Q&NM-L]$EOK6
M*-66UCG* $HIRSGHN3Z]_P *D\2>'K+_ (1*358]-M].O+>=8WCMKOST=3Z\
MG!R:(XJ/NI];=NOE>X2PDO?:^S?OT\[6//Z*]+O+'POH^KZ+82:&;A]1MX3(
MQN' CWG;N SR<YSSV&*I6OA+2[7Q!XBDO1+-INCKY@@5L-)N!*J3] 136,@U
M=I_YZV_,'@YIV37;TTO^1P-%=;;IH_BS6=-TZPTC^RY992)GCG+@Q@9X!'7
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>I:?IF@):17T>UW-RTC@^N2.G/3BM/\ X5#KO_/[IW_?;_\ Q%'_  J'7?\
MG]T[_OM__B*VG7PDY<SE^?0PA0QD(\L8Z?+KN<QJVOG5-'TC3S;",:=&Z!]^
M?,W8YQCCI6I-X\NF\5QZ[!:I$5@$#P,^Y9$[@G _R*T_^%0Z[_S^Z=_WV_\
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M/M+;7="BU.2S79!-Y[1-M'16P#N%:?\ PJ'7?^?W3O\ OM__ (BC_A4.N_\
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M>V\V'L,9K:._DOZ1Y_17H'_"H==_Y_=._P"^W_\ B*7_ (5#KG>]T[_OM_\
MXFM?KN'_ )T8_4<1_(SSZO3OA/X>E:ZEUV="L2*8K?(^\Q^\P]@./Q/I5_1?
MA):V\RS:O>?:=ISY$(*J?JW4CZ8KT>&&*WA2&&-8XD 5448"@=@*\_'9A"4'
M3I:WZGHX'+IQFJE72VR'T445XI[@4444 %%%% !1110 4444 %%%% !1110
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M ***RO$^JRZ'X6U758(TDEL[62=$?.UBJD@'';B@#5HI%.Y%/J,TM !1110
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M(^5L;CTKT!55$5$4*JC  & !60?"GAXZG_:1T6P^V[_,\[R%W;_[W3[WOUH
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M/<,S#<CH8@&W?,OEYX)XQ@5ZS67%X;T.#4SJ46D6*7Q8M]H6!0^X]3G'4^M
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M<-']DA7_ %90 C9E</NZG/7BI+:RL?$'B[6+35I&N8;*.W%A;/.VPPM&"9@
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M%1O,*@(,'[N[/?B*/3-2N= .GO?Z:535S]GL&U-Y$EB"9-JTNT-D-N8#!P%
M((%=UJ.BZ9J]ND&HZ?;7449RBS1!@A]1GI^%,DT'1YM+32Y-+LVL$QLMC OE
MK[A<8!H \ZU2TTN_\-)!)ITUI)IWB"TMIH'O&E2$O- 6"/G&PJR^F"3P#723
M>;IOB^6VTU&98- =K>W+E@7$OR]3R>U=%'H6DQ:4VE)IEHNGN"&M1"OEMDY.
M5Q@\\U-:Z9861C-K96\!BB\F,QQA=L><[1CH,\XH \YEL]-B^&0\40ZA.VM_
M8Q<)J'GL9)+K&1&1G!!?Y/+QCMBMB;3DUSX@O!J@E:W71()'LQ*PC,AEE&2
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MUE*R7%JIF"DN.3E1C=U/7KS6J87\.>)-9M-"B<(VB&\BM-S,AN%9U!4$G!/
M..N!7:-96KI C6T)2W8-"I08C(& 5]" 2./6G?9H/M7VKR8_M&SR_-VC=LSG
M;GKC/.* .1\,Z1H3Z1H^M_;))KV=8Y#?/>.'GE8<JWS8/.1LZ#&,<5REM!JF
MK>'[_5[BWL8M266</J4^M20O92*[ +L\HJBK@?+G##KG->E1>&M#@U,ZE%H]
MBE\6+?:%@4/N/4YQU/KUHN/#>AW>I#4;C2+&6]!!$[P*7R.ASCJ.Q[4 <T-+
M_MCX@2PZN[3)#HUI(]O'*PA:8R39? (SC!QGU]ABM::%:ZW)XOGU"2YE>'4)
M8[;]^ZBWQ#&V4P?E;)SGV%=Z+:!;I[H0QBX=!&TH4;F4$D*3UP"2<>YI([2V
MA$PCMXD\]R\NU /,8@ EO4X &3Z4 >>?9[WQ#I7AN_E^RZM(='CFN--GO&MW
M9G53YZ[003D$?, !V(YKM/#-[;:CX9TZZLQ<"WD@78+AR\@ X^9B3N/'7)S2
MWGAK0]0M[>WO-'L9X;90D"20*1$N,;5&.!@#@<5HQ11P0I##&L<2*%1$& H'
M0 #H* 'T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !574-1M=+LV
MN[R7RX5(&0I8DDX   )))[ 9JU7/^+[C5+?3;9M--RJ-=(MW+:0B6>.#!W-&
MA!R<[1T) )('% %NS\2:5?6MY<0W#JEFNZY2:%XI(AC.61U# 8!(XYQQ4%GX
MOT*_O8+6VOB[W&1 YAD6.8@9(20KL8@ \ D\'TKE+.PO9[SQ5/';ZO+!=:-'
M#;2Z@A$DSCS\@*0"OWAP0#SG&"*U;S2[D>&/"5M#:/OL[NQ:2-4YB50 Q([
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MC&UO+;7EM].# >)XAITY0X,3)R9?^_)E&?5$KO(((K:WBMX4"11($1!T50,
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MN+.^L((8Y+2V>;;)$\I*L%!*Y$@P3QP>: -N37]*BTVXU&2]C2TMY7ADE;(
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MY77/&-SH%U(]Y!I:V<<BJ8SJ(%TZ$@;UBV8/7.W=D@?A5JT_Y*=JO_8(M/\
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M8:7#IK_86"3R7U]]G#2%0VQ %8G 898X&3CGG !UE%9V@ZS!K^B6VIVZLB3
MY1B"4925921P<,",CTK%\2^*KWP_)<3-;Z5]DMX_,VW&I"*>< 9/EIL(SU R
M>2.W6@#JZ*BMITNK6*XB),<J!UR.Q&17-:=XJO+YM3NYM.@M-(TRXNH+BYDN
M"7;R68;D0)C&%&<D=P,XR0#JJ*XB'QW.([._O+2PBTVZDCC"QZ@'N81(P5&>
M/;CJ1D!B5SWP:OKXAUO4-6U:PTK1K9ETVX$+7%W=F-)"8T?"A48Y^?G/ X.3
MG  .C-K ;M;LQ(;A8S&LF/F"D@D ^A('Y"I:Y4>-!+I=L\&G2-JUQ>/8+I[R
M ;)TR7#/@C8%4MN .1CC)Q5JRUV_CUR'2-;L(+:XN8GEM9K6<RQ2[,;U.Y5*
ML P/0@C//&* .@HK@)O%7B/5O!.HZU8:3:6ENMI.8WEOF$H9-P+J!&1@;21D
MC.!T!S75>';C4;K0[6;5(8(KAXU(\F<RAE*@[B2BX)YXP?J: -6JEKJFGWTL
MD5I?6UQ)']](IE<K]0#Q5'Q9IMWK'A74M/L) ES/"40LQ4-ZJ2.0",C/O6/H
MMWH#:Q96D_AW^Q-9BC86T4ULJY4#YQ%(F5<8[ YQSB@#L:*Y*T\2:_JPOY-,
MT&U,-E>3VI-S>F,SF-RN4Q&>N/XL<\=LT3^.;=]+TF>Q@1KK5-XABNYA L7E
M\2>8V#C:?EP 221CUH ZVBN:TKQ1-?R:E8R6UHVIV4*SJEK=B2&=&W;2'*C;
MRI!!''!Y!J+1_%LEYX@31KU=,,\L#SQMI]]]H"["H97!52I^8$'H<'IB@#I+
M6[M[ZW6XM9DFA8D!T.02"0?R((_"I00<X(XZUP'@C76.D6&D:;:_;+A9YVO'
M\S9':QF>3&YL'+GL@Y/4X'-7I_$5KHEAXKU.WTA=]AJ"1SK&^&NF,<)W].#B
M0#'/W>O- '945SEMKVJ1:]9Z;J^F6]LM_'(UM);W1E*L@!*."BX.#G()'!'N
M8+?Q+K&I03:EI>BPW&E1NZQL]T4GN A*LT:;"N,@X#,,^V: .JHK-\/:L==\
M.:=JQA\@WEND_E;MVS< <9P,]?2L+4/&[6.AZE=C3&FO[/4&L5LDEYE8$,"#
MCC,1W]/;WH Z^@$$9!R#7-W?B.VNII;.&U6[M&TAM0ED+X4HW")C!SO ?GMM
M[YK"_MC6UU'PC#HNG6,.G76GM)':O>L@P(XR%.(C@)GC&<]\4 =W!=V]T\ZP
M3)(T$GE2A3G8^ =I]#A@?QJ:O/M+U'6K34O%YTO2K>ZC@U1I9&GNC%O/D0_(
MF$;+8'4X'(]\=MI6HPZOI%EJ5N&$-W D\8;J%90PS[\T 6Z*** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ K$\4:+<ZYIL%O9W@LYX;N&Y68IOV^6X
M;IWZ5MT4 <R-%UG5-5T^XUNXL1;:?*9XH+-'_>R[2H9BQX #$A1GG'/%9O\
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MT,EY"7DM=J[?W>."I^]M..2>N:;#X:U6P\,:5H]N^EWL-I;^1/!?P%DFQC#
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MP]-$ES:I;B&82#(E)'SL?J23^-,L?"6F65[!=[KRYEMLBV^UW<DX@R,'8')
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M\4DD9E,BG<T3$% 4#<G/7MBK^OV>J^'](MKZW\3WTTS7EK%.+GRRLP>9%;8
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MSUL?/2*9R_DO.[QQDDD[%8D("6)P,?I0!EZ_<WESXDTG0+:]DL8;J&>YGGA
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MT6 4<#<2R_*#@L.1TYKN: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKR[A:PL6,MK:QPD-YI3;O=BQ!P"^  /O>U;=%  0",$9% &!@=*** $  S@
M9Y-+110 4444 (0&&" 1[TM%% !28 ).!D]32T4 8FH67B'^T'N-+UBU2"10
M#;7EF95C(_B1D=#SW!S[8J?0=&&BV,D37#7-Q/,]Q<W#*%,DC').!P!T '8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWM6U:>'(M%U2[OK]?,L;7F $9\YC]T>Y_K7%UW<MZL&E^%IKIR85DW/D\<8
M)^E=N&E&4;2^SJOGI_P36#36O0R;OPQK=_-)=O;PQR2_.+<.JL!V 6L>TTF\
MO'N4BBP]LA>57.TJ!UZUU5QH>K2^,A?Q_-;M,LJW(<;1'U]?3C%3V%S;W_BO
M78[5T_TBW*1G/#L  <?CDU;PT7+5-:VUZ^93@KG&6VFW-W9W-W"H,-L 9"6
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M\UE"BG4E%]+Z>G02C[S1C7?AW4;*XMXI8EQ<.$BD5P48GW[?C73>(;34=/\
M#%E!;,D5K' !=*K#YF.,_7DGI5*Z@ETGP,]EJ.%N9[@/!"3ED QD^W0_G4'B
MO_D&:!_UY+_):Z.6-*$[)W:77:[V+LHIG/6EK+>W45M" 99&VJ"<<UKGPAK
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M?#E03G;>8'MQ_P#7J7Q/:3W.CZ1?0QE[:*S17D!&%/ Y_&I=*FH2:5]$_3\
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MM_PKJ?\ Z",?_?H_XT?\*ZG_ .@C'_WZ/^-'U'$?R_D'LI]CB:*[;_A74_\
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M'$T5VW_"NI_^@C'_ -^C_C1_PKJ?_H(Q_P#?H_XT?4<1_+^0>RGV.)HKMO\
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MI_\ H(Q_]^C_ (T?4<1_+^0>RGV.)HKMO^%=3_\ 01C_ ._1_P :/^%=3_\
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M8_\ OT?\:/\ A74__01C_P"_1_QH^HXC^7\@]E/L=_1117TAW!1110 4444
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M*RTUV"3Q&^B"WNO.2W%QYQC_ '14G& WK6I4--;EII[!1112&%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<]XR\-
MGQ/H?V6&<07D$JW%M*>BR+G&?;D_SKH:*J,G%W0I14E9G$)JWQ DCCL_^$;L
M8K@$![Z2\#0D=SL'S<_6F#3_ !'X:\1:O>Z7I4.K6VJ,LI'VE86AD P<[NJ\
M]J[JBK]KVBC/V7FSS;_A"-6@\,Z3:XBFO1K::E>!& 1!SN"YZXX_6NBBT:]7
MXF3ZT8A]A?2Q;+)N&?,\P-C'7H.M=/10ZTGO_5P5&*V/'M;T;4]%\$VUM/%'
M'=2^(UFA#,&7#9VDX[>U=1_9_B+Q'XJTB]U72H=+L]*9Y?EN5F:=R,?+CHO
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MP",E9'5> ?,V -U.XBL Z%I[_#3Q#K3P!]4MYM1GMKMN9;=HYY2GEMU0 KG
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M)BNF!MP&8'[P.=V".N*M6WAW2=5\=^((M0L8;JVM[:S2&VF0-%'E'&0AXS@
M ]0.G4T =W29&0,\FN;\ O(_@VS621Y/)EG@5G8L=D<SHH)/7"J!^%<UI=EX
M:U#0M3U'Q0;8ZO%<3B]N+AP)[0J[;!&WWHP%VE=N,\'G- 'I5&<C(KS2&SFU
MZ?P%%XBC>6673KE[J&7@3';#@2+W[$@]Q79Z]=6F@>$KZX^R%K2TM6 MX#Y?
MR!<!01]T8[CH/I0!K@@YP>E+D9QGFO,M*@CTKQWH,5M;Z)8F[@G\Z'2F)WH$
MW*9&P _(X8C/7WHT.&PTC7-*F,6EZF;Z[E2WU>RG(NG9@['SE_C4 $'YB 0#
MM&. #M?#6JSZQI]S/<+&KQ7UU;+L! VQS.B]3UPHS[UL5Y/HK ZJ(M?)70FU
M>]^Q[3^Z>Z^U2X$_Z;!]TG.>=M=[XOU"#3/"U[<W%M]IB(6)HO-,0;>X0;G'
MW5RW)[#- &T"#T.:6O./#T"Z5\1K>QMX='M%GTN:2>VTD$(2LD6QGZ MAGP<
M X)]JV/&AADU/P_::F^S1+BYD6[#MMCD<(3$DA_NEL\'@D** .O!!&0<BBN!
ML[70[#XIV%KHODP@:7=-/:VQ AC)D@P0H^56/.<=@*R+C5+6W^"DT$MTBW2L
M]L8B_P"\$HG(*XZY'7Z<]* /5"0!DG%*3@9-><:[#-J7Q N[._L](O+>.SB>
MRM]6F98R"6\QT7:RLV< GJ!M]:B331=^%M/M9M7T6>)=4E>TM9IFEM;A ''V
M<L<%@I+$<$#8O!Q0!Z#?ZE;:;' ]RY59YX[>,A2<NYVJ./<]:<)KK^TVA-HH
MLQ"'%SYHR9,D%-F/3!SGOBO+[^UT+4?#=EYVBV5JFG^((;69!)YT"!I4W^6Y
M  C.X#&  <C'%=!<![/Q1J*:''&&A\-K]BBB V;A)+L '3&<4 =QD9QGGTI2
M0!DG KRF[M?#D'P[AUG2Y(CX@:%&MKU6S>37AQ\C-]YB7X9#QC(Q@5O2:+8Z
MU\2=175;6*ZBCTBT/V:8;XBYDG^8J>"1C )Z9- '<5C:!JT^IMJHN!&OV349
M;6/8",JH7&<GKR:H^ \QZ!<6H9FBM-1N[:$,Q)6-)W5%R>P  'L!7.Z'IOA7
M4=3\4_VRMG<W,6IS%DO2"($PN&0-]W/.6'.1UX% 'I-%>9V$MQ;>&-'\3F6:
M6#3+R>,2RDEI=->4H&8GDX41R9/4)GO6IIUMI6J>&]5UOQ"\:6&L7*S[IY3$
MJVZLJVXW9&,A5;KU<T =Q1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%5-2U2QT>S-WJ-U%;6X8*9)#@9)P!^= %B*&*!-D,:1IDMM10!D
MG)/'J235631],EU!;^33K-[U?NW#0*9!]&QFJ>G>+- U:\6TT_5;:XN&!(CC
M;)('6MF@"M?:=8ZG"(;^SM[N('<$GB610?7!'6I(;:"V#""&.(,02$4+D@ #
MI[ #Z 5+10!4OM*T[5$1-0L+6[5#E1<0K(%/J,@XIMUI&F7T<,=YIUI<)!_J
MEF@5Q'_N@CC\*CO=<TW3[34+F>[CV:<F^[5#O:(;=WS*.1D<CUK1!R,B@"$6
M=L%"BWAVB3S0-@P'Z[OK[T_R8O/$WEIYH78'VC=MSG&?3(I]% $5S;6]Y;O;
MW4$4\+C#1RH&5OJ#P:CMM-L;*S-G:V5O!:G.88HE5#GK\H&*LT4 5+'2M.TM
M773["UM%<Y<6\*QACZG &:E^R6WV=[?[/%Y#[M\>P;6W$ELCH<Y.?7-344 5
M[BPL[MH6N;2"9H&WQ&2,,8V]5ST/TJ$Z+I37<MVVF61N91MDF,"[W'H6QDT^
M\U*VL);.*X<J]Y/]GA 4G<^UFQ[<(WY5+;WEM=M,MO<13&"0Q2B-PVQP 2K8
MZ'!''O0!'?:9I^J1K'J%C;7<:G*K<1+( ?4 @T3:;87-O';SV5M+!$08XWB5
ME0CI@$8&*M44 ,EBCGB>*:-)(W!5D=00P]"#UJ*"QL[41BWM8(1$ACC$<878
MI.2!CH,@'%6** (U@A0R%8D4RG=(0H&\X R?7@ ?A5>RTG3=,:1K#3[2T,AR
MY@A6/<?? YJT[K&C.[!4499F. !ZFL%/'/AB298UUFVPS;5E)(B8^@D(VG\#
M0!T%9MMX>T2SO3>VNCZ?!=GK/%;(KG_@0&:TJ* *=]I.FZF8SJ&GVEV8SE/M
M$*R;?ID'%6&MX76-7BC81D,@*@[2.A'H:DHH 8(8A,9A&GFE0A?:-Q4'(&?3
MD_G6-KFAMJ$.GQV:P1+;ZE%>2@C:&"L6;&!RQSWZ^M;E% %.RTG3M-:1K#3[
M6U,IS(8(53>?? YJ;[';;=OV>';YGFXV#&_.=WUSSGKFIJ* *<VD:;<7RWLV
MGVDEV@VK.\*F0#T#$9J=+:WC:-D@B5HD\N,A "B\?*/0<#CV%2T4 ,6&)'D=
M(D5I3F0A0"YQC)]> !^%5;+2-,TV222QTZTM9)?]8T$"H7^I YJ[10!2BTC3
M+>^>^ATZTCO),[[A(%$C9]6 R:NT44 9@\.Z&NH?V@-&T\7N=WV@6J>9GUW8
MSFM"2&*8*)8TD"L'4,H.&!R"/<&GT4 ,$,0F,PC3S64(7VC<5&2!GTY/YU$]
MA9R67V)[2!K3;M\AHP4QZ;>F*L44 5;73;&RM#:6EE;06QSF&*)50YZ_*!BD
ML=+T_2T=-/L+6T5SEEMX5C#'U. ,U;HH AN[.UO[=K>\MH;B!OO1S('4_4'B
MF6VG6-F@2ULK>!53RPL42J N<[>!TR3Q5FB@"%+2VC$(2WB7R%VQ80#RQC&%
M]!@8XJ.^TRPU2)8M0L;:[C4[E6XB60 ^H!!JU10!$;:W-K]F,$9M]NSRM@V;
M?3'3'M4%II.G:?;O;V6GVMM!)G?'#"J*V>N0!@U<HH JPZ?9VD4:VEE;1>2&
M\E4C"!,]<8'&>^*RM"TF^AU34-9U<6PU"\$<2QVSLZ0PH#M4,RJ22S.Q.!U
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M3=-GAFM85@16Q$X95D8??&!C@#U.2* */BW4'NO#OQ M&@A1;2U"JZ+AI-T
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MMI&6[8QB0 +Y@\H;64'EN2>PYFD\4:KJ4GA9-(BM81KEC)=O)<JTGV<!8F&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML3&,DD]30!O45YQX<\1ZMXET"VTO2[HM?C<-0U.0!A:@NV%4=&E*XP.@')[
M]?>:O8^'X;2SN)KJYN9%(BCCC>>>4+C<Q"@G'(R>!S]* -BBL>#Q1I%Q!:RI
M<L%N;G[&H>)U9)L$^6ZD91N/XL=O45=&I6IU9M+$A-XL N&0*?E0L5!)Z#)!
MP.O!]* +=%<AJ\=WJ7CVVTM=5O[*U&F27!6TD"%G$JJ"<@]F-*)]4\+Z[IMI
M>:E+J>DZE*;:.6Y51-;S;2R@LH =&"L.1D'')H ZZBL2#Q1IE_J4VFV<ES+<
M12/#,\5LY2!USD.^W:IXXR>>/6DT'6[&YM=,M$U.6^N+FQ%W%/+%L:XCX!?
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MX2*.."4(!YN_=N^4_,-HSQ77V^FW4?CM+Z5&DB71UMC<D#YI/-)(_'@UTE%
M'!ZEX=U*^M_%R0VX\RXU*UN[5)& 6X$4=N2N>P)C9>:VAK-SJ]M<VB:%J=L6
MMI-SW**BJ^,!!\QW$Y/*Y''6NBHH X'P9H^I^$TL(9;.2YMM0MH/M$IP9[.9
M8E78Y_BBX(&/NG(Z'(R[;0;W3=*N="NK3Q'=.SS(@M+A5MKB-V8Y+'[F0WS
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M FG^2IC$2A@58]=Q&>?I77Z9X&TO3-3M-26XO[F\M59(Y;JX,AVD;=O/8 G
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MH/-)'(Z\@<8KM+#P)I>F:A%<V=UJ4,,4IECLDNV%NK'N$_'IFK%MX/TNUO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!FJEG!I%O\+KF.RBLHKY-0C2[6%565<7X"AP.>!TS^% 'K$T\-N@>>6.)2<
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M\,T7FQ2H\?\ ?5@1^= N(6=T$T9=!EU##*CU/I7GNIV=MIEUX[LK&".WM9-
MCN##$H5/,*W"E@HX!(1<^N!4=]X9T>*V\$(EC$#<7:17+A?FN4-O)(RR'JX+
MHI(;.<4 >A2W)>PEGL3#.X1C%F3",P' +#.!GOSBJ?\ ;=O!>Z?I]ZR17]Y
M\NQ&W(I0)N&[CNXQQS7)3VEOIFI>.;*QACM[5M&AN/)B4*@D9;A68*. 2$7/
MTJI+8Z&NM^";O5+33@DVERJ\UU&F'<)!L!9AR0 V/QQ0!WMAK-EJ5W?6UO)N
MELIA!*#CEMBOQZC#C]:MK/"\S1)+&TJ?>0,"5^HKS:VL;+3[KQY#HMI86^OH
M[G3XXHD28 VD1&P8S@MNZ<9S5+2[6RFC\/MI]_X<MKD7,3126L;F[D(.9$?G
M<2R[@^[IG)Y% 'JTEQ#"Z))+&C.<(&8 L?;UJ2O*)HXIM<\2_P!N/X<$XN6
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MV[A" 3']Y3GE6'/!Y^4^E0IXOT9[#6;U;AC#H\DD5V=AR&09.T?Q=P,=2"*
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M_(J ,WU/4U-10!#-9VMR\;SVT,KQG*-(@8J?;/2IJ** "BBB@ HHHH ****
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MHWKZT!<=13=Z^M&]?6@5T.HIN]?6@R*.] 70ZBHFN8EZMC\#4#:I9I]Z7'_
M3_A18+HN45275K)C@3?^.G_"ITNX'^Z^?P- 7)J*:'4]#2Y% Q:*0L!WIC3Q
MKU;'X4 2456:_MEZR?\ CIH74+9NDG_CIH LT5&MQ&W1L_A3PP/2@!:*** "
MBBB@ HHHH **** "BBB@ HI"0*8T\:]6_2@"2BJS:A;)]Z3'_ 34)UFP7K,?
M^^&_PH OT5G?VYI__/<_]\-_A1_;FG_\]S_W[;_"@+FC16?_ &YI_P#SW/\
MW[;_  H_MS3_ /GN?^^&_P * N:%%9IU[31UN#_W[;_"FGQ#I8_Y>3_W[;_"
M@5T:E%9@\0Z8?^7@_P#?MO\ "E_M_3?^?@_]^V_PH"Z-*BL[^WM._P"?@_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJT9TG::/1IU(U%>+.9BOM0GF>.2S#2!%"*ULV)%+-G<Q VC !Y Y_*I[>^U
MC=+:'S7*I&XMVR!N&_=D# &3CMQWK?HK(T.>LY+N-8 \3J"H4R?9226PN5('
MW5SNYX''YWM)FD^R)');-&V3DK%Y:_D<'\Q_C6G10!Y?\.Q_H.M_]A>X_F*Z
MJ1<UQ_@"[@@MM<CDE"L=7N"%[]178>?%)T<?CQ0Y*^X<DM[%&:/K6;/%S6Y*
ME9]PE,S,G9AJO6PQBH&7#59@% &G#TJR*K1=*L"D,?VI12"EH 6B@44 %%%%
M "BBBB@ I#TIU-- $#U >M6'J ]:8"K71:;_ ,>,?X_SKGD%=#IW_'C'^/\
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M05XSXB^)6L7VLMIWAKY(P_EH\<8DDF/J 0<#TXS4&F?$CQ+H&KK:^(DDFB!
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M>"_$;0;#P[J6GV5A&5C^R[F9CEG;<W)/K7L'AC_D4]'_ .O*'_T 5YE\8O\
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MTFG3_NY DTS$#"_WE SN&#GM3Y'2KOV:OH+G52BO:.QS-O\ $W7=)$%M>:1
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M^%><^%O&%QX(NK^WC@@OHI2 2DF!N7.&5L<CGTKMO$&GWFD?!N&R0,KHD9N
M.H#-N8?F0#6)\+]0\.65O?#57M(KQG&Q[G&#'CH">.N<COQ6<+<DY6NF]C2=
M^>"O9VW,[PA;GQ;X_&IWES;P.L_VHP[L-(0<A4'<# S["M;XRV=P-4TZ^VDV
M[0&$'L'#$_J#^E<MJ$UM-\0O-\.C;$UXGV;RQ@;LC.!Z;L_A7T!?V%IJEF]I
M?6Z3P/\ >1QD?_6/O16J>SJ0GTMMV%2A[2G*'6^YPWAWXB^'++PE9Q7$[0W%
MK;K$UN(V)8J,<8&.<9Z]^:X/X?127_Q#M9X(]B(\DS!>B+@\?J!^-0^.K+0=
M,UDZ=HD4FZ(XG<R%P&_N+]._OQVKU#X=^%?^$=T;[1<IC4+L!I,]8U[)_4^_
MTIRY*5-RC]KN$>>I447]D[7-&:9FC->:>@2 TX&H@:<7"J68X &2:!F;XAD4
MV"P[L.[@@>PY_P *S$^2W+-UQ5F1OM5RUPW3HH]!5&_GV1$#@FN.<^9W/4H0
MY8J)ROAL_P#%\8?]K39/YU[37B/A5MWQOMC_ -0R3^=>W5O3^!''B/XK.-O_
M .TO^%C'^S/LGG?V4-WVG=MV^;VV\YSBN:T_R3'I*:T5&E&\NC-DD1&;/R[O
M;KC/O[UZIY4?G>=Y:^;MV[\<X],^E,-I;&!H3;Q&)CEDV#:?J*YIX5R=[_UI
M_D>5/!N4N;FZM^6Z?Z:G#:;8:1?^+=0MM/@@N-%^RJ\R(-T(N >"O;.W/3WK
M,TZVL+'P=X;U$QPPR/JD9GG/&55Y/O'T %>G06\%M%Y4$,<48_@C4*/R%,:R
MM6@6!K:$PJ<B,QC:#]/Q-+ZIUTOKT[M"^H]=+Z].[3_"WXGG_BB]M;_5;R>S
MN(YXCH<PWQL&&?,'<54M6N[#4_#>CW6Z2%9TN;28]XV0Y0^ZD_D?I7I2V%F@
M(6T@ *E2!&.AZCITJ1K>!C&6AC)B_P!62H^3Z>E#PDG+G;U%+!2E/G<M?^">
M:> A9A]/9CH@GW28R3]KSEL>W_UJ]/JM'IUE%()([.W1QR&6)01^.*LUMAZ+
MI0Y6=&%H.A3Y&>._#;2-/N8=7OI[9);A-5G56?G: <\#IGGK7HC5Y9\/+N2*
M76@DQ54U*8E>Q)8]J]*MKM+J,E<!EX8>E:QFN9Q.RI2FHJ;V'2=*H7'>K\G2
ML^X[UH8&<Y^:I8>HJ&3K4D- &E%TJRM5HCQ5A>E2,D%*#313A0 \"GBFBG"@
M!:*7%&* $HHHH *::=330!"]0GK4SU : 'K6_I__ !Y1_C_.L!*W]/\ ^/)/
MQ_G04BU1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTCPY(9[9'ENB,>?,06 ]!C %;XIPK65>I)<K>AG&C3B[I%'6-$T_7K+[+J$
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MD-3!J0%A33LU"&I^Z@ 8U"U2,:C)H 45L67_ !Z)^/\ .L<5L67_ !Z)^/\
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M9K1EDZU1E(-,5S"NK8'/%8US:#GBNFGQS63<XIB.<EML'I4'D#-:<Y&35)F
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\-;5%.X<J,3_ (132?\ GE)_W\-.'A?2UZ1/_P!_#6S11<.5&2/#FFCI&_\
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M4[DV10_LBS_N-_WT:7^R+/\ N-_WT:O447"R*/\ 9-I_<;_OHTO]E6G]QO\
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M8H91$[;QNW'';\14O+\*M_S*68XJ6WY'I_\ PN#2O^@;>?FO^-'_  N#2O\
MH&WGYK_C7CU%5_9F'[?B3_:F)[_@>P_\+@TK_H&WGYK_ (T?\+@TK_H&WGYK
M_C7CU%']F8?M^(?VIB>_X'L/_"X-*_Z!MY^:_P"-'_"X-*_Z!MY^:_XUX]11
M_9F'[?B']J8GO^![#_PN#2O^@;>?FO\ C1_PN#2O^@;>?FO^->/5I:#H\FO:
MU;Z9%*L3S[L.XR!A2W]*4LNPT4Y-:+S*CF6*DU%/5^1Z?_PN#2O^@;>?FO\
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MM[>VULTAP@FE5"Q]LGFK5>77C_8O%OB$ZQJF@V+SR*8#J]B9?-MO+4!8V,J
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M5^5"W# <Y4<Y/(Y%06S-IGAOPQ?W:R6VEVNNRRQM."IM[1UG2$OG[J@.@YZ
MC- 'H]WJ%I912R7%Q%&(D\QPS@$*3@'D]SP/>JNCZ_IVMZ+!JMI<)]GEA69M
MSKF(,H;#X)"D \\URUO>:?XA\=ZU]D,5[:_V-!$'4!XY&$LI^4]&P2.1WXZB
MN<1K6X^&GA8:?-8K;6DEL-9!M_.6(K"1^_C5E) DV%@2,8!/ - 'J]G?V>HP
MF:RNX+F('!>"0.,^F16%XL\1PZ=X;UN33M1M?[4L[2258A(KNC 9!*?XBN=T
M^&2^U+5[W1->TF\OO[*D@"Z39-%$TIYB9Y/-=2ZD' ZX8]JQM=O/!S?"6>P@
M2V_M&*Q(%HJC[7%.%^9G7[X(.=S'J,Y)!Y /7U.5!]JAO+R"PLY;JYE2.&)=
MS,S #\S4R?<7Z56U.V2[TRY@DA697C8;&4,"<<<'WH KZ1KNGZUHT.J6MPGV
M>2%9FW.N8@RAL/@D*0#SS5FSU"RU&-I+&\M[J-3@M!*K@'TR#7F-I+I4W@+P
MBRBWETJTDMQKD4*@[&6 @><H[++L+!O3)X%;UO<:5J/C_3+CPS);3)';3+J4
M]D5,1C('E(S+\I;=R!U W=C0!W-17%Q!:0//<S1PPH,M)(P55^I/2I:X7QZL
MR:WX?N9KFSM]+A,WFS7ULT]O'.0OE,ZAT X\P!B< GU(H [2WO+:[MA<VUQ#
M- 1D2QN&4_B.*CL]3L-1\S[%>VUSY9P_D2J^T^^#Q7GL%Q%8Z1XJUBUNM,UN
M"2*))K:SL6BM"_*LY.]P_P K#?M[(,\TNC7,4OQ!TEK35-)O@UA<I(^E6OE1
M+S&50L'8-T) SD=>] 'H+:GIZ7RV+WULMVW*VYE42'Z+G-8FD^(XS>ZU%JFH
M6T(@U1K6U$KK&2HBB;:,XW'+GWYKG?"UWX7M= MM/UW["->\\?;;>Z0-<R76
M_._:1N;+8*L,C&.PJYH^B:=>W/C>6[LH9WFU!X7,B!LH+>(@#/;+&@#NZ*PO
M!4LD_@3P]+,[/*^FV[.S')),:Y)K=H IKJVG/<QVR:A:M<2KOCB$REG7U SD
MBGWFHV.G(KWUY;VJN=JF>54#'T&37F%KI5E:_!6PNX;6-;M&M[E9P@\P2>>O
MS;NN<<?3CI5[6'>S\?:I/J>IZ+812V\*V,NKV9E1H@IWJC^:B@[\EEZD%3TZ
M 'HWGPEXT\U-\BED7<,L!C)'J.1^=)]I@V2OYT>V$D2-O&$(&3GTX]:\V:*/
MP[X0T?Q''=?;+72[^2;=%:O"%M)F9'1(V).Q=RLO/1!CC%9[Z??:>D&A3I)Y
MOC!(Y;K&2(YM^^Z'MF%]H_W* /758,H92"I&00>"*6D "J%4  #  [5S?C^&
M]N/!.H1V 8RGR_,5$+EHA(IE 4$%LINX!!/0=: -NTU.POWD2SOK:Y:(XD$,
MJN4/O@\4AU33Q<16YO[43RDB./SEW/@D' SDX((_"N#T86>H>)]&EL?$&@SR
M6JNWE:1IK(QA*%2DC"5@BY*D!@/F48YK.FTFR'PH\2W8MD%V]]?3><%_>*ZW
M3A2K=1C QB@#T^VU&QO)I8K6]MYY83B5(I58H?0@'C\:CDU?3(9(HY=1M$>4
ME8U:=07(." ,\G((^M<Y?:;9Z7XT\*_8+6*V&RYMSY*!<QB(,%..H!4&N=\-
M7W@NU\/ZI#K/V&.>6^O?/CNU'F7 ^T2 >6#RX[ +GG/?- ';:IJ5U;>*=!L8
MG M[O[1YR[0=VQ 5Y[<UHR:II\-ZEE+?6J7;_=@:90[?1<Y-<-HT-_#+\/X]
M2$HNEM[D.)N74>4-H;_:"X!]\U1T^Y\,6W@N\T[Q$+8ZZYE%];2J#=3SEFPR
M#[S9XV%<\8QTH ]/66-I7B61#(@!9 PRH/3([9P?RJ-[RUCAEF>YA6*$D2.S
M@*A'4$]OQK@;RXOO"6F:#XHU-));E-.2QU95^9G8INC)QU(E!3_MJ:J:OI%W
MHVE>%_MMQ:16Z7$USJD]Y;M/ MU(-P>10Z_*'9P&)P#M]J /2K6\M;Z 3V=S
M#<0G@20N'4_B.*CM]3L+NYEMK:^MIIXO]9%'*K,GU .17G/V6ZO-,\6W>@:S
M8WMU-8+%LTBR:&)I1N^97\QU:3:2ORD$?+GM2:8MA?ZAX?AL-?T 26LZR16^
MFZ4Z7"(JG?&_[YC&I&5.\=<=\4 >HT56M;^VO7N5MI1(;:4P2X!^5P 2/?@C
MI5F@"K>:G8:>T:WM];6QD.$$TJIN/MD\UB>,M=.D:;:1V]_!9W%[=PVZS.5)
MC1G =P&X.!GKP,C-8MM=Z#IOB+Q'_P )5)90WL]QNADO]H66TV*$6,MP0#N!
M4?Q9SUK,33T?PCH7VBS_ -&_X2!/L,=Q'\Z6C7!\M2&Y VXX/; H WK;5YKO
MQ@NC0>)%>&QLHIB082][*S2 JY"\ +&"0@!^;-=+:7K)HL%YJ<]E&WE*\TL,
MO[@$]U9L?+Z$USMEIUE#\2=9:*S@0II5HR%8@-I,EP"1QP2,5S>FFV@\/?#R
MZUD+_8<.G?O6F&88K@QQ^4TF> ,>8 3P"1[4 >FP7UI=6GVNWNH);;!/G1R!
MDP.O(XI+34;&_A::SO;>XB0X9X95=0?<@UP/BF32K_0TG\//I[:>FJQ/JLT5
ML9H'4(>7"%?,4-Y9;#< <]"*=I:6]YKEY?6FNZ1>M'IDL4Z:18M'&X."GF2>
M:Z[EP<#KAF[4 =[#?V=S,T,%W!+*JAV2.0,P4]"0#T/8U8KD/!J:5X=^&^CW
MTB16L9TZWEGE"?,S,BDDX&22Q_6NOH *JVFIZ??R21V=];7$D7$BPS*Y3Z@'
MBJWB*\;3_#6IWB67VUH;:1_LV,^;A3\IZ\'Z5P&F74$WC3PLUIJ>BW8(GC==
M(M/+CB4PLP1G#MW4$*<'Y<X&* /1GU;3HIXH)-0M4EE8K'&TRAG8'! &>2#Q
M4MW>VEA 9[VZAMH0<>9-($7/U-><1Z-82?#SQI<26<3W$EUJDAD9 6#)))L(
M/48(!&.AYJ_<7-E;^+=+O_$DD*V+Z0BV=Q=X$*7!8F7);A79?+P3C(# =Z .
MATK5Y;_Q5K-HLZ2V5O;VLEN4P1^\$FX[AUSM%;U<-X,DTJ;QGXIET5%6S=+1
M@T:XBD;$NYD[%2>XX)R>]=S0!7O+^STZ(2WMW!;1DX#SR! 3Z9)KGX=:O[B\
M\4);3V;"R,/V-KAML(#0JY+,HSC))S5"_GTRP^(5S=>)'MXK=[&)--GO"!"I
M#/YRAF^4.?D/J1CT-<U<'39/"_Q*?1XMEDZ!H]JE4;,"Y9!_=)R1C@]1P: /
M4KC4;.RC+7EY;6^U0S&64* #P#SVS1=:G86,D4=W?6UO)*<1K+*J%_H">:YB
M;3K2^^*:R75M'/Y.C*8Q(H8*3,PS@\9QD9]SZUSD[K9^(/$BZUJN@64L]P2B
MZOI[2M-;;5""-O.4,HY&U1PV<\F@#T^XN;>S@:>YGC@A7[TDKA5'U)XK*U'Q
M7HVFVUG<2WT$D-Y.D$3Q2H02QQNSG[H[D=*X\6]MI,GA!]?NOM6B6]E*J75W
M"T4:7!V>4TJN3L/E[U!8\'/<U-XD?PO<Z/;:EI\>G264&MVSW=U%$OE#YE#L
M7Q@C&T$@XXYZ4 =S<:KIUI:QW5S?VL-O)C9+),JHV>F"3@U-]I@\E)O.C\IR
MH1]XVMDX&#WSD8KA5O-!M/&=S>ZQ-8I83V, T>YG*BW\K#>8L;'Y0Q.TGN1M
M["L:ZM8+SPKJZ6L170+OQ!9?84 *J8S- )"@[(7WD8XZD<&@#U*VO+:]B,MI
M<0SQABI:)PP!'49'>IJBM[:"TA$-M!'#$O1(T"J/P%2'.#CKVS0!5?5-/COE
ML7OK5;MONP-,HD/T7.:Y[Q%K+CQ-I&A6VLQZ<;E)I9Y4,;2C9L"( X(&XR9Z
M9.WBN5LKGPU!\/[C3-:6W/B!HY%O+5U!O)KLY^91]]B6P58=L8.!6U'IS'Q5
MX,.JV\,NH_V3<?:I&0,6F46V23W(.<&@#O*RM8\1:;H4EE'?3JC7<ZP("ZC!
M()W')'R\=?<5JUQ_CZ*Q2/0[Z_BMQ;V^JPF>>91MCC*N/F)Z+DKUXZ4 6U\1
M1P^+-1M[O4+:+3(K"TGA>1U5=TCS G<>N0BXY[5T/GP_9_M'FQ^3MW^9N&W;
MUSGICWKCK"PTS4/B1?W8@M[B)-%LQ;-M#($9Y^5[<@#D=OK7-7-O/'X.MH8C
M#%I5EXCNEN5FMVFACMUFF";XU928U?9QG P">!B@#U*SO[/483-97<%S$#@O
M!('&?3(-6*X7PND%WXNGO[77=)O=MGY4Z:38M'$^6!0O)YKJ67# #KACVKNJ
M ,#7-;N[?4K31=(MXI]4ND:;=.2(K>)2 9'QR>2 %&,GN,4ME'XJM=1@6]NM
M+O[*3(E>*W>VDA."00"[AQGC'!Y[UFZW-_PC_C6V\0W2.=+GL38W,ZJ6%LP?
M>CMCD(<L">@.,UJ0>+]"O;^WL=.U&#4+B<G"V3B81K@G<Y7(5>,9/<B@#1?5
M-/BOELI+ZU2[;[L#3*)#]%SFGW-_9V2LUW=P0*J[F,L@4 9QDY/3/%>96-SX
M9@\!7.FZX+8^(&607EK(H-Y-=$GYD'WV);!5AVQ@\5K:=IDESXR\/C7(5N+^
MW\.YE\P!@)]\89O3/+<^YH [-M6TU'MT;4+17N0# IF4&4'IMY^;\*EN+VUM
M QN;F&$*I<F20+A00">>V2.?>O-X]#TT>!?'1%C#N6YO_+.P9CV E O]T*>0
M!T).*LZE=:2GC7PY=:_Y9C&C2.LUP,Q1R%XOF<G@=2 3QDCN10!Z!;7=M>6Z
MW%K<13P-TDB<,I_$<5'::G8:@TBV5];7+1G#B&57*GWP>*\_DU"S@N_%>KZ!
M90W^C#3D$\<2YM[FYRX8C (;$97>5SD8'45'I-S#+X\T!K75-(O0;>XCD.D6
MGEQQKL5@C.';/W<A3@\9P* /0FU;3EN(K=M0M1-,2(XS,NYR#@X&<GD$<>E6
M5EC>1XTD1GC(#J&!*DC(R.W%>6C2+$?"#Q+>?9(S=F34KCSBHWB1)Y=C ]1C
M:N,5L^)KZX\+:HFNVL+2G5;3["T:C[UV 3;D_P"\2Z$_[M '<QRQS*6BD210
M2I*L",@X(_ \4^LW0-)30M!LM,1]YMX@KR'K(YY9C[EB3^-:5 $7VJW^S_:/
M/B\CKYF\;?3KTJ*ZU*QLE=KN]MK=4QO,LJH%SG&<GC.#^5>67&MZ?;?"2;1)
M+E/[6A8P2V(.9D83\DIU"@<[NF,>M;MQ=>'[/XHZK/K;6\3#3[403W>!$F6F
MR-S?*&/;/) ..] '>Q3130K-%*DD3#<KJP*D>H-06>IV&H&065];7)C.'$,J
MOM/O@\5YI-"+C1-?FTN&1O#$NJVTACMT.V6W&S[48U'5"0<XX.'QUK6N;O0M
M2\2>'#X5DLIKR"X)GDL-I6*T\M@RR%> "=F%/<#'0T =G+JVG02QQ3:A:QR2
M.41'F4%F!P0 3R<]JN5YQ9Z+I]SX:\<33V4,LLU[?!GD0,V%!V@$],'D8[DF
MNV\/RR3>&]+EE8M(]I$SLW4DH"2: -&BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH ***S]8UBUT2R6YNO,;?(L4442;Y)9&^ZBKW)_H2>!0!H45A
M)XGAALKVZU33K_2H[2,22&[12&4YQM:-F5CD8V@YR1QR*9;>*XWO;6VOM)U+
M3!>-LMI;Q$"2M@D+\CL58@' 8*3CUXH Z"D550850H] ,5R]QXYLX9-1\O3=
M3N(=,E:.^GBB39!M )8Y8%A@YPH) ZCIF>S\86MW?64#6%_;V^H$BRO)D017
M!"EL##%ERH)&Y5R!0!T5! (((R#VKEI_'5E"VHF/3=3GM],F:*^N(HDV0;>2
MQRP+ #GY02!U XJ>S\7VMW?V5N^GW]M#J&?L5W.B"*XPI; PQ925!(W*N0*
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M:<W=FD<6^!2,J23)L;<.@5F)P>.*NR^*].72=/U"V$]X-2 ^QP6Z9EF)7=@
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M$@;<GG& ,T ;](0",$ CTK!MO%4<E]:VE]I6I:8UV2MM)>)'LE;!.W*.VUL
MG#8)Q56?QW91'4'33=3FMM-F>&^N8XD\NWV]2<L"P Y^4$@<D"@#J%4*H50
M!T %"JJ#"J%'H!BN?LO%]M=ZA96SZ??VL5^&-E=3H@CN,*6P,,64E06 <+D
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MFET?58-;TJ#4K59%MYP3&9!@LH) ;KT.,CV(H O4444 %%%% !1110 4444
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MEA$>UE/.25'(R.:KMX>U _#SP_HXB3[99'3?.3>,#R9(FDP>AP$;ZUV-% '
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M:CYD7E>2T21Q!3U.U>K'U)Z= .: .-M_'FH-9VFJM=V<RSM&SZ5#92^9'&Y
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M\L<7E*W)QA<G'&!U/2LU_#HFM-,AN=0NKB2QNQ=^?,5+RN-W!P  /G.  ,
M5MT 87B?57TVWMA'JEI8/-(5!FMVG=P!G$<:D%CT]<#M7/#QIJ2^#M;OXXX;
MB_TR]2U1GMY(%G#>403&_P R'$N/J,CBNEUG09-1U"QU*TOWLKZS62..01K(
MK))MW*5/^XIR"",507P7#_96JV4VHW4[:E=QW<TT@7=O41],   ^4.,<9Q0
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MN1+,0SS,4=#NX _Y:$\ 8P!TJS;Z3';:[?ZJLCF2\AAB9#C"B,O@CZ^8?RH
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MA'(1E 22>^,\$<8 ,[5?&;OK*:;:7D.FHMI%=2SW-H\[DR9VHJ*1C 4DDGN
M!U(VO">MSZYI<TMRB>=;W#V[2QQLB38P0ZJW(!##CG!R,G%.U'P_)/J@U33=
M2ET^^,(@E=8UD2:,$E0RMW!)P00>3UK0TRRDL+)8)KVXO9=Q9YYR-S$G/0
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M2DJ$<_, PX;G&>0>..* .>OVU6Z\>Z)]@N+*.XFT2<RW&TRQJOF0$E!D;LG
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MR:9<FY$LQ#/,Q1T.[@#'[PG@#& .E '.20>(T^(FEPOK=FX.F3NW^@, 5$L
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MEM@0E'(RN54 ]?;%;6E6":5H]EIT;M(EI;QP*[=6"J%!/Y4 6Z*** "BBB@
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M-NR2 2I)^4]>F,5TT,%KX8\;/#:>=%I\ND2W<\'F,XWQ2(-X!)PQ5R#CK@4
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MV;@&0$%5XY]1Q@YQ7+Z1]ITWQ#KVE>5;V<0TE;@VEK>R7"1R$N-V75=C$8R
M.< T >C45YC;:<NG>$/".NQ7%TVJ33Z<LUR\[L94F9$=&!."N'.!CC K8LK"
MT\1>)_$(UIY9);&Y2&VMO/=%A@,2,)%"D<LQ?YNORX&,4 =!H.K2ZO%?M+&B
M&VOY[5=N>51L GWK6KC_ (<^3_8NI?9[MKN'^UKH).[;C(-_4MW^O?K5NTN&
M7XD:M;R2L$.EVDD<;-QQ).&8#_OG)^E '2T5Y<+J35/"5LT&H7 CNO%4D:SP
MS$,86NG&%8=!MX&.G&*VX[7_ (1[QG/::.D@BGT>6Y^RM(SJTT<BA6 )."0Y
M!QUXH Z;7M0?2?#NIZE$BO):6DLZHW1BB%@#[<5:M)C<6<$[  R1JY [9&:\
MPO-,TBX^$5UK]QJ,YU"XTMY)K]KEMS3,AW1E<XQN)3R\8'3&:OZH;[4/$FDZ
M2;2*[L1I*W$=M-?-;)-+NPQ.U3OVKM^4\#?GZ 'HU%>8WT.IVW@O5+5KU($7
M6+.*V%I?-<26BM/ &C,A .02Q /0,!TK6UOPRD5QI]KID5O=6\2S2RZ5<7\D
M33EM@\T-\Q9EP1\W'S]0: .OGO[6UNK6UFE"37;,D"8/SE5+$>W )Y]*LUY@
M]EH^NW?@FY$%X(I)[FU9;BZ=I!Y<4P*E@W.&4X8'D <XK8L].L_$/B;7X=9:
M25K":.&UM#.Z+% 8D82  C)9B_S=?EQQB@#MZ*\P@U"YN]*TO3[C4;@Z--KD
M]B;_ ,XAY[= YB4R YPSJ$W Y;'7YJVEMHO#_CBPT_1"XBNK.>2[LO-9D39M
M\N0 D["6)7_:S[4 =7J=TUCI-Y>(H9X('E56Z$JI.#^5-TF\;4-'L;UU"O<6
M\<K*O0%E!P/SKSNWT_3-0^&,_B+4=0G75);*26YO3<.K138.Z/;G "M\FS&#
MC&.:[KPZBR>$=)1AE6L(0><<>6* (M7\0PVOAG6]4L&2XDTR*<LC @>;&I)4
M_CCI6O!(9;>.0C!=0Q ]Q7ER:/86/@7X@36\;+*AU&#)E=L)LR!@DC/3GK6S
M-I,/A^]\*7EE+<?:KF\6UNY'G=OM*-!(QW@G!.Y5(],8&!Q0!WE%>6QP7^N3
MZ_=7EE!-/;7L\*SR:Q);-91H3Y9550A/EP^[/S9R>.!Z%H37C>'].;4)H9[P
MVT9FF@;<DC[1EE/<'K^- &A1110 4444 %%%% !1110 4444 %%%% !1110
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M<&H:?;7,41S&LL8;8>GR^GX5CZ[J?FS^%9]/O-UM>:FH+P2?+-&8)F R.HR
M?P%:%KJ=O;P:M=7FKQ2V]K<N)'=!$MJ JGRR?XL9SG_:H M1:1IL%G!9Q6%M
M';6[K)#"L2A8V!R& Q@$'G-7:RM,\2:5J]RUM:7#F=4\SRIH7A=DSC<H=067
MIR,CD5F:SXQT:*QU*WBU$K/%')'YR1OY:2A2 OF@; V>,;LYXZT :EYX;T/4
M+];Z\TFRGNEQ^^DA5F..F21SCMGI4TNC:9/IG]FRZ?:O8_\ /NT2F/KG[N,=
M>:J:-J"P>"M/U&_G;8FG1SSS/EC@1AF8]SW-6Y-9TZ&ZL+:2[B6;4 QM$SS,
M%7<<?AS0 RTT'2+&PEL;73+2*TFSYL*PKMDSP=PQ\WXTRR\-Z)IUM<6UGI5G
M!#<KLG1(5 E7!&&]1@D8/K4.H:M;.?*M]62UD@OX;:<^3YFYV*GR>> 6#*,C
MIFJFF^,['4_$FHZ+&DJR6Q58W,4@$A*EFSE0%QCN>>U #_$>G75TEO!%H6DZ
MOIJKA[2[(1E8?=9"59< 9&,#Z]JA\.>'&M7U.YO[&QMEOXX[<:?; -## @8!
M3\H#$EW)X YQSUK/\$^,M-G\+Z!;WNI22W\]O%&TLJ2,KS%1\IE(VESZ;LYK
MJ]7F^SZ+?3_;!9>7;R/]J,>\0X4G?M[XZX[XH F>QM9(H(WMHF2W97A4H"(V
M7[I7T([51N/#.A75^]]<:192W4@P\KP*6;C'/')QQGTK+E\:6-EXDL=#F:25
MYK5I6N%@DQN!C"@ *1AA(3D' Q@]:T%\5:*VJ?V<+W_2/-, /E/Y9E'5/,QL
MW?[.<T 6[O1=+O\ [+]KTZUG^R,&M_,B5O*(Q]W/3H.GI4%[X9T/4KT7M]I%
ME<7(Q^]E@5F..F21SCMGI5?Q5XGM_"VFQW4\;RM)-'$J*K'AI%5CE5.,!LX/
M7&!4USXGTBTM+6XFN7"W6?(C6"1I9,=<1A2YQWXXH M:EH^FZQ L&I6-O=1(
MVY%FC#;3ZC/0_2BPTC3=*!&GV%M:AE5#Y,03*J20#CT+-^9]:K_\)+HW]C_V
ML=0B6P$@B:9LJ$<L$VL#RIW$ @XQWJ!O%^AI:0W4EZ8H9W:.$R0R(9& SA05
MRV>V!SVS0!I7^FV6JVC6NH6D%U;L03',@=<CH<'O[U!;:#I%IILNG6^F6D=E
M+GS8!"NR3/7<,<_C6<WCGPZL)D^W.2I821K;2F2+;C)= NY ,CE@!S5Z\\1:
M58VEK=378:*[&;?R$:9IAC=E%0$L,<Y H =IWA_1](BFCT_3+6V688E$40&\
M>A]15K[#:?V>-/\ LL)LQ%Y/V<H/+V8QMV],8XQ2:?J%IJEE'>64ZS6\F=KK
M['!&#R""""#R"*LT 4;/1M,T]+=;/3[:!;976 1Q!?+#D%@N.F2 3ZXIYTRP
M-LUN;.#R'F\]H_+&TR;]^\C^]N^;/KS5NB@#.U30-(UHQMJ>FVMVT8(1IH@Q
M4'J >N#Z5'=^&M#OX[>.[TBRF2V79"K0*1&O]T#' XZ=*U:* *,FBZ7+ITNG
MR:=:M92L6>W,2^6Q)W$E<8SGGZU);:;8V;(UM9P0LD*P*8XPI6-3D(,?PC)X
M]ZM44 9-OX8T&UU'^T+?1[&*\W%A,D"A@QZD''!/<UHI:P1W,MRD,:SS*JR2
M!0&<+G:">^,G'U-2T4 16UK;V<1BMH8X8RS/MC4*-S$LQP.Y))/N:YM?"-I?
M:_K=UK&G6EW;W4T+VWFJ'*A8E1OIR/QKJ:* *JZ98+:6]JME;K;V[*\,0C 6
M,J<J5'0$'IBDU'2[#5[;[-J-G!=P[@P29 P!'0C/0^]6Z* *FGZ98:3:_9=/
MLX+6#);RX4"@D]2<=3[U5LO#.A:=?&^LM(LK>Z.?WL4"JPSUQ@<9[XZUJT4
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MH44 9$OA;0)[][Z71K![IR2\K0*68D8R>.3CC/6M2**."%(8D6..-0J(HP%
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MQR#P>AH EU'6H;!]* 4S+J-TMM&Z,,#,;N&]QA/UK0FE6&&25@Q5%+$*I8D
M9X Y)]J\TGTZZC\*^!8(-5NC-/J%LRSS!&:%3:R9"#:!P,XR#SUSTK<AGO\
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M1EE6,.P]!N)]\4 ;M%<=?IJ'A>\TBX76KV_BN[V.SN(+S8V_S,@.FU1M*GG
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M0(N6Q$K?+N! .?R!/M0!Z!17"&37H8_$^E6.HSW5UIOD75C).%,CAAO,+$
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M(R0" 3C(X%/U+^V-"\*#Q-_PD%U=W<,:7$\#A/L\ZDC<B*%RO!PI!SG&<\T
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MS0-Y0Z(=O!4=@1QVQ5^75-/AO4LI;^UCNW^[ TRAV^BYR:DN+VTLU+7-U#
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MWCBT_4)[?4;:\M;F\:6/[):-;P(=JAO*#,V5+ MD'!);%=2RAE*L 0>H(HX
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MQP3M\L$CJ<=Q4$,>AZU9> H;06=S:K>?OTAVE1*MG(Q#@?Q A<@\^M>F@
M# '0"EH \^U6RNX=9\:6N@Q^1=7&AP2Q+"-N9R;A=PQ_$0JC/L*R],6QOI_#
M]K9:]H"36UQ')%;6&DR)=1A?OH_[YC&"NY6+KCGGFO5:0*H8L% )ZG'6@#C?
M#&D6%SJWBVXGM(I9I=4>%G=03L\F+Y0>P^9OSKD8(;^\L7&V5KCP3%Y<.<_O
MI4ESQZ[K>)!_VV->PT4 >92C[;X*FUT@[M8UVSND+#!\D74*1?\ D-%/_ C3
M=?NM-TK6]6FAN=*U">>[ADGT:_M\7,D@5%7R&)R1A01\K#.>1S7I](54L&(&
MX=#CI0!YC?R-8^--??5M4T&P\\Q_96UBQ,HDMQ&HVQN947 ??E ,Y.3G(KL?
M!EI]B\)6$ NS=1A6:*0V[0?NRQ*J$8E@%4A1D] *W656QN4'!R,CO2T <3HF
MC:=?:YXUEN[.&=I;]8&,J!LI]FA.!GW8_P"17,"2[;P]X OKR\LX=.CT_P#>
M7&HV[3P1W!2,1M( Z8.T2 ,3@$^I!KUV@@$$$9![4 >62V=U=>&O%USHFJV=
M^URD*LFE6+Q0DJ?WI3]XWF.T9VG8P^Z!UJQI/V+4=?T(V/B#P_)):,SI#I&E
MO'((MC!HY#YS"-3D<,!\P7O7I0 4    = *0[(PSG:HZLW3\30!YSHUUX:L]
M+U.Q\2_91K4EW.;R&X4&XN29&\LQK]YP4V!=O3  Y%9$2S)X.\!7+S6MOI4,
M+&>34+=IX8I"H\II%#KC'S@,3@$CVKUU?+D"R+M;C*L.>#Z&E.,8.,'CF@#R
M\VMS>:1XMN]#U>SOYI[-(V31[-H8F<;MQ1_,<-*4.T[3QA<\XI/$E_X+N_#N
MF0:-]BDN(KVS^SQ6BCS+<>?&#Y@'*#'!#8YQWKU%5"J H  Z 4!5!)"@$]2!
MUH KQW]M-J$]C'*&N;=$DE0 _*KYVY/3G:>/:N0\=MID>O>%9-7CWV*74S2;
MEW(N(CAG']T'!.>!U/ KK;73K>TO+VZB#>=>2+),S'.2J! !Z !>GJ3ZU;H
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M]5MO$.GQ1:)J[#2BRZCI4  8X<)$Z@L _<8;\!Q7I@ 4    = *10JY"@#U
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M3/#IM=/N=3TR_P!0A9Q&J;)5&X^4RNP.=RC*D8^4@^E:=I!K?ANZU2"TT?\
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M8XT\J-<9+8+AV '4JIZ'TJE=>*;V'QQ:Z/#I-W<64MF\WFQB/YCOC =27'R
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MP4!2 %"XR2<G/&,9K=\+:S-KNB+=7,(CG262&3:K*CE6(WH&YVL,$9Z9QVH
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M,P)W%V^7@X7''')Q76KJ.OZ9KNC0:I/93V^JN\)C@@9#;2+$T@PQ8[UPC Y
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M=$B4W!R3'L$:Q_[JHH4?_7KH** .=L/#5]9-:P'Q%?2Z?:L#%;E$#L%^ZCR
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M2Y5<D%T(P""6P1C&2.13/^$.MGT2]L);RXFGOKA+FZO)-OF2NK*1P    BJ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M32]:T_64E:QG,AA8+*CQM&\9(R-RL PR/4<U)J.IV6DV;7=_<)! "%W-W)X
M '))[ <FL+PC=ZG<S:BES+>7-A&T?V2[OK/[-/(2#O#+M7('RX;:,Y/7&:A\
M;Z?>SS:+J-J]Z(K"Z:2<6,:23*K1L@=4=6#%2>@!.&..: -JS\1Z3?VMU<07
M?R6B[KA9(VC>(8SED8!@, D<<XJFOC?PVS$?VK$%VEE=E8))CJ$8C#D>BDGV
MKGX+ W\.OZA#+X@O)WTI[2.34+5(!+D,0J((T<D'N1CYCBK=UI$IT7P-;K8N
M197EL\B"/_4A;>09([8; ^N* .@L_$FDW]I>7,%W^[LP3<B2-HWB &[+(P##
MCGIS5>'QEX?N+F&"+4D)F8)%)L<1.YZ*)"-A;MC.<\5B:_:3QZKXNN_(=;>7
MPZB"7:0KNIN,C/0D K^!%9UU>MK/PZA\-V6AW\6H7-E';QQM:.((#M&)/.QL
MVK]X8.>!QGB@#I[6[F_X6!J]O)</]EBTRTE6-F^1&,DX9L= 2%7)]A4UIXPT
M&^NXK:WU!6>9BL+&-UCF/HCD!7/^Z36#KNA:CJFI>*K:V5U:\T&WMH)V!5'D
M#7&5W?\  ESZ!J9K%Z_B30;;0[#1=1M;YIH,B>S>*.R\MU8MYA&P[0IQL)SQ
MVH [*#4[*YCNGAN$9;61HIST\ME&2#GV(/T-4KCQ3HUK:V=Q)>92]C\VV6.)
MY'E3 .X(H+8P1SCN*Y7Q79W4/B)],LE;R/%4:V]PR''E-'CS7_X% 67/JB^M
M2:UI]SI?C%]2%SJ]KIT]A%;1R:7:)<&$QLY*,ACD8*0P(*C&0<]J .M&O:2V
MC'5Q?P?V> 2;@MA1SC!]\\8ZYXZU'I_B/2=3\\6UV T">9*DT;0LB?WBK@';
MP><8XKBKOP_=R>&8KRQ_MLN-:&ISK/'"+J10I0LD>S:#]UPK+G(/&2*N6=G#
MJFHW%]*?$NJ+!I\T!%[:1VJRK)MW1*#'$S,=HY^Z/49H ZC2_$VCZS<&WL;S
MS)?+\U5:-T+ID#>NX#<O(Y&1R*UJX7PW>7=MJL=O!-JTVAPV;M,VKV1A>T92
MNU%D*J9 1NS][&T'=Z]?I>H1ZKI5IJ$,<L<5U$LR)*H#A6&1D G!P: *^J>(
M-+T>6**]N2LTH+1PQQM+(P'4A$!; ]<8K"\7^+;2W\ WNJ:7J )EC:.WGA4L
M5?H>@.UASUQ@BEFE?P_XUU+4[RRO)[._MH$AN;6V>X,)CW[HV5 6 .X,#C&2
M<UCWNF:A>>$_&-W%IUQ"-6N%EM;(QGS2%2-"Y0<AF*%L=<8SSF@!LVIZ1)XD
MT'08-4U;^SVAGF?,]T))9=T0C#2'YROSN<9V],]JZ^TU>UM-&N;^_P!9@GMX
M;B9'N3&(E3$A7R\=RI&S/4D>]07EK._Q!T>Z6&0V\>G7D;RA3M5F> J">Q(5
ML?0US2Z5J,.AV5T=/N)A8>([N^EM GSRQ&:<*ZJ?O$;U<#OCCG% '867B;1]
M0CN7AO0HMD\R<3HT+1IS\Q#@$+P>>G%)IOBC1]6NA;6=YNF9#(B/$\9D4=63
M<!O'(Y7(YK"\1SR^,/"VIV.DV6HI(HAD#W%J;?SML@<QJ)0,DA2.5V_,,]ZK
MZ;"-6U_2Y9+OQ3<M9.T^;ZQBMHX6V,F&;RD+9#$80D=SP,T =%!XMT*YEFCA
MU&-_(1WF<*VR((2&WOC:I&#P2#CGI4VE^(M*UF62&QNB\L:AS&\3QMM/1@'
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MHM$)=KQQA6D\M07<("S$':H+9)QP :YSQ+K_ (DM_ VJ7T-A9P7,*92X@O\
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M7;+04GT10TBN;O;<S1+G,B1;-N"!D N"1Z=* .I-U;B\6T,T8N6C,JQ;OF*
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M;'<D< Y&I^*]8O=-\-:AHUE$D=[?+#-'/=;&#CS T1PC#;E#\P]!QS0!UO\
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M'6NA\+M='PSIPN[:&W=;=%6.&4R+M"C!R57MVQQZF@#7HHHH **** "BBB@
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M**5(S;W]O=$MGE8Y%<CZD"EUO29-4GTB2.1$%C?K=.&S\RA'7 ]_G'Y5K44
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M#3%N%@:8BXG>X?S96?YF.3C)X'H!P*N4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !103@9/2D5E=0R,&4]"#D&@!:*** "BBB@ HHHH **** "
MBBB@ HHHH ***.M !1110 4444 %%%% !11UHH ***.M !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
? "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>ethicsemployeepolicybook014.jpg
<TEXT>
begin 644 ethicsemployeepolicybook014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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MP**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH&%%%% "&B@T4 %%%% !1110
M4444 %%%%  :2E-)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%( HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHI*!A24M)0 M%%% !1110 4444 %%%% !1110 HHH%% #J***9
M(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110,**** $-%+1B@!**7%&* $HH
MHH **** "BBB@ -)2T8H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !2444# TE+1B@!!2T44 %%%% !1110 4444 %%%
M% "BBDHS0 ^BBBF2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444#"BBB@ %+
M2"E- "4444 )10:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M***0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %!HI#0 4444#"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@!]%%%,D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH&%%%%  *4T
M@I30 E%%% "&B@T4 %%%% !1110 4444 %%%% !1110 4444 %%%% "4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *0TM(: "BBB@84444 %%%% !1110 4444 %%%% !1
M110 4444 /HHHIDA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% PHHHH !2F
MD%*: $HHHH 0T4&B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !2&EI#0 4444#"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@!]%%%,D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH&%%%%  *4
MT@I30 E%%% "&B@T4 %%%% !1110 4444 %%%% !1110 4444 %%%% "4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *0TM(: "BBB@84444 %%%% !1110 4444 %%%% !
M1110 4444 /HHHIDA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444#"BBB@ HHHH !2
MFD%*: $HHHH 0T4&B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !2&EI#0 4444#"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@!]%%%,D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@84444 %%%% !1
M10: $HHHH 0TM(:!0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% "4444 )2BDH%(!:*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HH%*: $HHHH 2BBB@ HHHH&%%%% !1110 4444 %%%% !111
M0 4444 %%%% #Z***9(4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% PHHHH ****
M"@T4&@!**** $- H- H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@!**** $H%% I +1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444  I32"E- "4444 )1110 4444#"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@!]%%%,D**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@84444 %%
M%% !0:*#0 E%%% "&@4&@4 +1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 E%%% "4"B@4@%HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ****  4II!2F@!**** $HHHH ****!A1110 4444 %%%% !11
M10 4444 %%%% !1110 ^BBBF2%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110,****
M "BBB@ H-%!H 2BBB@!#0*#0* %HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH 2BBB@!*!10*0"T444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%%  *4T@I30 E%%% "4444 %%%% PHHHH **** "BBB@
M HHHH **** "BBB@ HHHH ?1113)"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH&%
M%%% !1110 4&B@T )1110 AH%!H% "T444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 )1110 E HH%(!:*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ %*:04IH 2BBB@!**** "BBB@84444 %%%% !1
M110 4444 %%%% !1110 4444 /HHHIDA1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
MHH&)12FDH ***2@!:*2B@ HHHH 2E%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !24&B@ HHHH 2E%%%( HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BD-% !1110 4444 %%%% PHHHH **** "
MBBB@ HHHH **** "BBB@ HHHH ?1113)"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I1
M24HH&!I*4TE !24M)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 AHH-% !1110 4444@"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH 0T4&B@ HHHH **** "BBB@84444 %%%%
M!1110 4444 %%%% !1110 4444 /HHHIDA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
MHI*44# TE*:2@ I*6DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0T4&B@ HHHH ****0!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 (:*#10 4444 %%%% !1110,**** "BBB
M@ HHHH **** "BBB@ HHHH **** 'T444R0HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*44E**!@:2E-)0 4E+24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 (:*#10 4444 %%%%( H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** $-%!HH **** "BBB@ HHHH&%%%% !11
M10 4444 %%%% !1110 4444 %%%% #Z***9(4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %**2E% P-)2FDH *2EI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $-%!HH **** "BBBD
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% "&B@T4 %%%% !1110 4444#"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@!]%%%,D**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "E%)10,4TE!-&: "DI<TF: "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HI** %HI** "BBB@ HHHH ***
M*0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !12FDH **** $-%%% !1110 4444#"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ?1113)"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH&!I*4TE !24M)0 "EI!2T %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4AI:0T %%%% !1110 4444 %%%% !
M1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ I124HH #24II*!A2&EI#0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% #Z***9(4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% P-)2FDH *2EI*  4M(*6@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "D-+2&@ HHHH **** "BBB@
M HHHH ****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %**2E%  :2E-)0,*0TM(: "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ?1113)"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH&!I*4TE !24M)0 "EI!2T %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4AI:0T %%%% !111
M0 4444 %%%% !1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ I124HH #24II*!A2&EI#0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #Z***9(
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% P-)2FDH *2EI*  4M(*6@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D-+2&@ HH
MHH **** "BBB@ HHHH ****0!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %**2E%  :2E-)0,*0TM(:
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M?1113)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH&!I*** "DI:* $%+110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2&EI#
M0 4444 %%%% !1110 4444 %%%%( HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "E%)10 II**,T#"D-
M+FDH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@!]%%%,D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ %+0** $HHHH *2BB@84444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2&
MEI#0 4444 %%%% !1110 4444 %%%%( HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!,T444#"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* 'T444R0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** %%% HH 2BBB@!****!A1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(:6
MD- !1110 4444 %%%% !1110 4444@"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****!B4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M/HHHIDA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 ***!10 E%%% "4444#"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0TM(:
M "BBB@ HHHH **** "BBB@ HHHI %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444#$HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ?1
M113)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH 444"B@!**** $HHHH&%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4AI:0T %
M%%% !1110 4444 %%%% !1112 **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH&)1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 ^BBB
MF2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 HHI*6@!**** $HHHH&%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4AI:0T %%%
M% !1110 4444 %%%% !1112 **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH&)1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 \T4&BJ
M)"BBB@ HHHH ****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110,**** "BBB@!,T9HHH #10:* "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0TM(: "BB
MB@ HHHH **** "BBB@ HHHH ****0!1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4E%% PHHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH >:*#15
M$A1110 4444 %%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@84444 %%%% !1110 E%%% "4HI*44 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4AI:0T %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%( HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *#10: "BBB@!****!A1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 \T4&B
MJ)"BBB@ HHHH ****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% PHHHH **** "BBB@!**** $I124HH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TAH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!1110 444
M4 %%%% !1110 4444 %%%% !1110 4&B@T %%%% "4444#"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!YHH-
M%42%%%% !1110 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH ****!A1110 4444 %%%% "4444 )2BDI10 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2&EI#0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444@"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ H-%!H **** $HHHH&%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #S10
M:*HD**** "BBB@ HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444#"BBB@ HHHH **** $HHHH 2E%)2B@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BGQQ22G$<;.?]D9J?\ LV^_Y\KG_OTW^%%T.S*M
M%326=U$,R6TR#_:0BH:!!1110 4444 %%%% !1110 4AI:0T %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%%( HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *#10: "BBB@!****!A1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!)24M%42)12T4
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M:0T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%(
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *#110 4444 )12T4#$HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH DHHHJB0HHHH **** "BBBD 4444 (:*#10 4444 %%%% !1110 4444
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M "BBB@ HHHH ****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXA\+:OX8NA!J=J4#?ZN53NCD^A_IUK&KLC)25T<;3B[,****8@HHHH ****
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MHHJB HHHH **** "DI:2@ I#2TAH&**6D%+0 4444""DI:0T#"BBBD 4444
M%%%% !1110 4444 %)2TE PH-%!H !10** "BBB@ KZ1^&&A?V)X+MC(N+B\
M_P!)D]0&'RC_ +YQ^9KP+PWI+:[XCL-,&0+B95<CLO5C^0-?5R(L<:HBA54
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MB@ HHHH **** "BBB@ HHHH **** )****H@**** "BBB@ I*6DH *0TM(:
M%%+2"EH **** "D-+2&@84444@"BBB@ HHHH **** "BBB@ I*6DH&%!HH-
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MC6KYNKZ1^%'_ "3G3?\ >F_]&M7H8_\ A+U.# _Q'Z'9M]T_2OC^X_X^9?\
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MDG$#10:*ZCE"DI:2@ HHHH **** "BBB@84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 244451 4444 %%%%
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M>SFU#?N:5M>VD_B);W4[8R6DEP99X8V(RI.2 ?QKMW^*%CI9,7AOPMIUI$O
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M]2_^A&NM^$=Q#;>.4DGFCB3[-(-TC!1V[FN2UE@VN:@RD%3<R$$'@C<:N/\
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MHHK<P$-%!HH **** "BBB@84444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 244451 4444 %%%% !1110 4444
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MH **** "@T4&@8E%%% !1110 4444 %%%% !3HY'BE22-BKH0RL.H(Z&FT4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI
M%%%% !1110 AHH-% !1110 4444#"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@"2BBBJ("BBB@ HHHH&%%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M!2T@I: $HHHH 2BBB@!:*** "BBB@!#10:* "BBB@ HHHI#"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"2BB
MBJ("BBB@ HHHH&%%%%( HHHH **** "BBB@ HHHH&%%%)F@!:*3-+F@ -)11
M0 4444 %%%% !1110 4444 %)2TF* "BC%&* "BC%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 444F: %HI,T9H 6@TF:* "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH !2TE% !1110 E%+BB@ HHHH **** $-%+28H **,48H ***
M*0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH DHHHJB HHHH ****!A1112 **** "BBB@ HHHH ****!A24M
M)0 444E "T4@I: "BBB@ HHHH **** "BBB@ HHHH **** "D-+2&@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH #24II* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2
MEI#2&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% $E%%%40%%%% !1110,****0!1110 4444 %%%% !1110,*
M2EI* "DI:2@ %+2"EH **** "BBB@ HHHH **** "BBB@ HHHH *0TM(: "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ -)2FDH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ I#2TAI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@"2BBBJ("BBB@ HHHH&%%%%( HHHH **** "BBB@ HH
MHH&%)2TE !24M)0 "EI!2T %%%% !1110 4444 %%%% !1110 4444 %(:6D
M- !1110 4444 %%%% !1110 4444 %%%% !1110 &DI324 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4AI:0TAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!)1115$!1110 4444#"BBBD 4444 %%%% !111
M0 4444#"DI:2@ I*6DH !2T@I: "BBB@ HHHH **** "BBB@ HHHH **** "
MD-+2&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH #24II* "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *0TM(:0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH DHHHJB HHHH ****!A1112 **** "BBB@
M HHHH ****!A24M)0 4E+24  I:** "BBB@ HHHH **** "BBB@ HHHH ***
M* "D-+2&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH #24II* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *0TM(:0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH DHHHJB HHHH ****!A1112 **** "B
MBB@ HHHH **** $HHHIC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *0TM% "44M% "44M% "44M% "44M% "44M(: "BBBD 4444 %)2T4 )12
MT4 )12T4 )12T4 )12T4 )12T4 )12T4 )12TAH **** "BGQ0R3RK%#&\DC
MG"HBDECZ "KVH:#J^E0)-J&F7EK$YVJ\\+(">N,D=:5TG8=GN9U%%%,04444
M %%%% !1110 4444 %%%.:-T"ED90PRI(QD>U(!M%%%, HHH% !12TE !112
M4 +12"EH **** "BBB@ HHHH **** "BBB@ HHHH *0TM(:0PHHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH DH
MHHJB HHHH ****!A1112 **** "BBB@ HHHH **** $HHHI@%%%% !1110 4
M444 %%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#
M2TAH ****0!7IGPQ^'MOXA1]8U=6:QC?9% #CS6'4D_W1TXZGZ<^9U]'^ MS
M?"NR%C_KOLTH3'_/3<_]:Y<74E"G[O4ZL)",Y^]T*-_XZ\"^&[MM+CLT?RCL
MD%I:H40]P3QG\,UPGQ)U#P7?6UI+H$$?V^7]X\ELOEHJ>CKC[V?H?7M7G3!@
M[!P0P/.>N:T-!TT:QX@T_3F8JMS<)$S#J 3R?RHAAHTWSW>@2Q$JBY;+4CL-
M'U/5-W]GZ==W>W[WD0L^/K@5%>6-YI\WDWMK/;2]=DT91OR->]>-?%L?PZT[
M3M-T;3H-TBML1P0B(N.PP223Z^M.MY[/XH_#R>:[LTBNDWHI'/E3* 0RGK@Y
M&1[D5"Q4K*;C[K*>&C=P4O>1X);:=?7D9DM;*XG0'!:*)F /ID"IH-$U:ZLS
M=V^EWLML,YFCMV9!_P " Q7M/P1_Y%"^_P"O]O\ T6E6/!'Q!;Q#XEN]%73X
M;:S@B9K7R\Y"JP7!'3H>V,8ISQ,TY*,?A"&&@U%N6YXUX4T!O$7B"UL&6<6\
MD@6:6),^6"#@DXP.G>MWQ[X"_P"$6N[=-.%[=P/"9)96CR$P>Y48''/-=K;Z
MFWACXQWND6%M +;5Y(7ER#E#L).W!QR6)JU\5?&5[H*C1[>WMY(=0LY%D>0-
MN7=E3C!QT-0ZU1U8\JT:*5&FJ4N9ZIGB5CIE_J<ACL+*YNG'58(F<C\A2W^E
M:CI;JFH6%S:,WW1/$R9^F1S7K'@2_P#&Q\(PVFC:)8I"')COKGY%=3_LC!8Y
M_BKLM>TV]U?X<ZA!XAAM/M\=O)+FV)*!T!96&>0>.?QJIXIQG9I6OWU)CAE*
M%TW?T/FQ$>614C1G=CA549)-:-SX<UNSMOM-SH^H0P 9,DELZJ!]2*]<^$.B
M6-CX:N/$=Q&KW+LX60C)CC3KCW)!_2L2Y^-VI2K>1PZ7;1JZE;=BQ+1GL6SP
MW';BK=><IN-.-[$JC",%*<K7*W@7X96_B?19KW4IKVSD68HBJ@ 9=JD-\P]S
M7GMY8W5C)MN;::#).WS8RN['IFOHCX9^);OQ-X:>:[BAC:UE%LOE@C<%13DY
M/7FO%/&/C*]\7W-LU[;V\)M0ZIY(;G)'7)/I4T:E25649;?D56ITXTHN._YB
M?#ZW@N_'>E07,,<T+R,&CD4,K?(W4'K75?&?3;'3M1TE;&RM[8/%(6$$2IN.
M1UP.:YKX;?\ )0M'_P"NK?\ H#5V'QQ_Y"VB_P#7*3_T(43;^LQ7E_F*"7U:
M3\_\CS"32=2A*"73[M#(VQ T+#<WH..31?:1J6F!#?Z?=V@?[OGPLF[Z9'-?
M1_C[Q)_PBN@1ZFEI%<W(G$< EZ(Q5LMZ] 1QZU0EOHO&_P );F_O+9$>6TFD
MV#D))'NP1GW7/XXJ(XN32DXZ-V+EA(IN*EK:YRGP3T0I<:CJEU:.LBI&EL\D
M9 VMN+%2>N<+R/ZU@_$[Q3J^K7TVF7>GBVT^UO'%O(8V#2;<KG<3@Y'/ [UZ
M!\)_$]WK^BRV=Q##&FF1P01&,'++M(RV3U^4=*YJXU2;X@_$>W\/:G;6ZV.G
M7EP?W>X-(J9&&R>^T9QCJ:A2?MY2FMOP+:7L(QB]_P 3S&RT'6-2A,MCI5[=
M1#^.&W9U_,"J=Q;SVDS0W,,D,J_>212K#Z@U[KXZ^(\O@[5;?1]+TZV<1Q*[
M^8"%53T50N,<#K[]*7QC;V'C;X8+XB%L(;N*#[1&Q^\N#ATSW'!_0UM'$RT<
MHV3,I8>.JC*[1X<FG7TEK]J2RN&MP"?-$3%,#J<XQQBI'T?5(UMV?3;M1<Y\
M@F!AYN!D[>.?PKWSX?S6]M\(;6>[026T4%S)*A&=RB20D8[\"N0TGQW/XT^(
M_AU9+*.UBM99S&%<L2&C/4_\!H6(FW*T=(W$\/!*-Y:NQYFFBZK+=+:QZ;>-
M<,NX1+ Q<CUQC.*CETR_@O1936-S'=MT@>)@Y_X#C->]>/\ QX_@W6+&*VT^
M&>6XC#3R29!\L,<*".^2W7IZ5J^.]>B\+:*FN1V,%Q?!A;P/(OW=_)Y'.,+T
M%2L5-\ON[[:E/"P5_>VW/G*^TG4M+*#4-/NK0O\ =\^%H]WTR*AMK6XO9Q!:
MP2SRMTCB0LQ_ 5]!ZA=Q>-/A!<ZE=VR([V<LX4<A)(]W(_%?R.*X'X7WWB>V
MM-0AT+1+>[24C_2I\(L;^A;@L,?P@\=>_-QQ#<&VM5YD2PZ4TD]'Y'"7V@ZQ
MID0EO]*O;6,\;YK=D7\R*Z+X?^"D\7:C/%>-=6]JD!=)HTX9@P&,D8[G\J]R
MT6WUZ]TR[M/%D&FR"4;56U+$,A!R&!_I7%?"C6;B'5M0\)F*+[+8^=(DO.]B
M) O/.,<^E9/$RE"5MT:K#1C.-]F>:>*_#4GACQ)<VT<%S/8V\B!9IHR%DRH.
M"0,=2178?$?QA;:[X7L[.+0KZT=)5;S+F#8L6%(V(>^?PX'Y)\4_&=[<:K?>
M%VM[<6D,T3+* V\_*&YYQW]*ZGXV?\B3:?\ 7_'_ .BY*?.VZ;FM?^&%R)*H
MH/0\+L[&\U";R;*UGN9>NR&,NWY"I;_1]3TO;_:&G7=IN^[Y\+)GZ9%>\2S6
M?PO^',$]K9I+=.(U8GCS9F&26/7 P<#V IO@GQ?'\1+#4=,UG3H-T:@NJ E)
M$;(Z')!!'K5/%2LYJ/NHE8:-U!R]YG@5M9W5XY2UMIIV49(B0L0/PJU;:'J]
MY++';:7>SO%Q(L=N[%/J .*]4^%VFC1OB%XCTU6+);(T:L>I42#&?PQ6Y<_$
M%K#XE)X9@TZ 6LDZ1RS<AVD< [O3J0.?2G/$2YG&"OI<4,/'E4INVMCP*6*2
M&1HI4:.13AE88(/H13*]6^.&GP0:MI=]&@6:YBD24@?>V%<$^_S8_ 5Y3712
MJ>T@I=S"K3]G-Q"DI:2M#,!2T@I: "BBB@ HHHH **** "BBB@ HHHH ****
M "D-+2&D,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** )****H@**** "BBB@84444@"BBB@ HHHH **** "BB
MB@!****8!1110 4444 %%%% !1110,**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *0TM(: "BBBD 5Z-\-/B%%X9WZ7JF_^SI7WI*HR86/
M7CNI]NGXUYS145*<:D>61=.I*G+FB?0-]X;^'7B.Z;5&N[+?(=\AAO!&'/<L
MN>#Z]#7)>.=4\':7)I;^&EA;5-/E1HWM#F(*ISAV_C.?0D]<FO*Z*QAAN5J\
MFTC:>(YD[12;/?+N^\$_$S2;4W]^MG=0Y(1IEBEC)QN W###@<X/X54UOQ5X
M:\$>$)-"\.7,=S=.C(GE2"3:6ZN[#C/M]. *\.HJ5A$M+NW8;Q3>ME?N>S_"
M'Q!H^D^%[N#4-3M+65KUG5)IE0E=B#.#VX-<M\+M3L-,\<W-S?7D%M UO*HD
ME<*I)9<#)K@:*T>'7O:_$1[=^[I\)Z1XG\1Z?;_&"VUJ"XCNK*%H2TD#!QC:
M V,=2.:ZKXA0^$O%&CMK"Z_;_:K2UD-O'%<I^].,A2IYSGMP>:\-HJ7AU>+3
MLT/ZP[236Y[U%K'A_P 7^ +73%\11Z/+'%&LJF58V4H,%<$C<OT/I]*=8:KX
M3T;P'J.CV&OV\[+#.F^:4!II"IY [C)P,>G?K7@=%1]46U]+W+^M/>VMK'JO
MPL\=Z=I-C+H6LR+# [EX9G&4&[[RMZ#OGIR<UI:CX'^',-K>78UZ.(2H3#B\
M1UB/4%5'S-],GBO&**N6']]RC)JY$<1[JC**=CUWX0>*-)TJTO\ 2;^]AMV>
M?SHI96V)(,!2,GH?E'7UKC_'NAZ%HFI0)H>IB]CF5GDQ,DGEG/ RO]:Y*BJC
M1Y:CFGN3*MS4U!K8Z3P#=V]CXYTJYNYXX((Y&+R2,%51M;J374_&'6--U;4]
M)?3K^WNUCC<.89 X4[AUQ7F5(:;I)U%4["55JFZ?<]K^+GB'1M5\)6\&GZI9
MW4RWJ.4AF5R%V.,X!Z<BE\*>(=&M?@^^GSZI9Q7AM;I?(>90^6+X&,YYR/SK
MQ.BL_JL>10OL[FGUF7.YVW5CUCX-ZWI6D6VL#4M1M;0R/$4$\H3=@-G&?J*Y
M*'Q&-"^)=UKEJ5GA6_F;Y&XDC9F!P?<'(/TKE**T5&/-*3ZD.L^6,5T/?=5M
M/ /Q"^SZG/JZ03QH%;;<)#)MZ[75P>F3R/SK%\?>--#L/"@\*^')8YE9%B=X
M6W)'&.HW?Q$_CU/>O'**RCA4FKMM+9&DL4VG9)-[L]K\-^(=&M_@S)ITVJ6<
M=Z;*[3[.TRA]S-)M&,YR<C\Z\Z^'MY;6'CO2[J[GC@@C=R\DC!57Y&')/O7,
MT5I&@DI*_P 1G*LVXNWPGHWQ@U;3]6U_3Y=.O;>[C2VVLT,@< [CP<5TOQ8\
M0Z-JG@VWM[#5+.ZF%W&QCAF5F "."< ^XKQ2BDL.ERZ_"4\0WS:?$>UZ!XAT
M:#X,2Z=+JEFEZ;&Z06[3*'W,9,#;G.3D?G2?#OQ'HEQX"?P]<:JFEWH$J&5I
M!&QWDD.K'C(SCUXKQ6BI>%BTU?=W&L3)-.VRL>_>#9O"/A"2_MAXJM[NZE*-
M-/-,JJ0-V IR02.<\GJ*X?P1XET[1/B9JEU>7")9WC3Q+/G*C,@96)]#CK[U
MYS136&7O7=[@\0_=LK6/5/BCIGAN9Y/$.GZU#<:A<S1JUO%<QNNT+@L .?X1
MWK6^+GB'1M5\(VMOI^J6=U,MZCE(9E<A=CC. >G(_.O%:*%A[<MW\(GB+\UE
MN>XZ#XK\->-?"$>@^([F.VND14?S9!'O*_==&/&?;Z\$5;L[WP1\,]*NFL-0
M6\NIL$HLZRRR$9VK\HPHY/.!^->!T5+PB=U=V?0I8IK6ROW/4/AAXDM$\7ZU
MJFLWUO:M>1ERTT@12Q<' S6=J6IV$GQJ344O(&LA?0/]H#@IM 7)W=,<&N H
M%:>P7.Y=U8S]L^51[.YZG\9=9TS5Y-&.FW]M=B(3;_(D#[<[,9QTZ'\J\LI:
M2KI4U3@HHFK4=23DPI*6DK0S 4M(*6@ HHHH **** "BBB@ HHHH **** "B
MBB@ I#2TAI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@"2BBBJ("BBB@ HHHH&%%%%( HHHH **** "BBB@
MHHHH 2BBBF 4444 %%%% !1110 4444#"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "D-+2&@ HHHI %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4AI:0T %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 % HH% "TE+24 %)2TE  *6D%+0 4444 %%%% !1110 4444 %
M%%% !1110 4AI:0TAA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!)1115$!1110 4444#"BBBD 4444 %%%%
M!1110 4444 )1113 **** "BBB@ HHHH ****!A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !2&EI#0 4444@"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *0TM(: "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "@44"@!:2EI* "DI:2@ %+2"EH **** "BBB@ HHHH
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M%%% !1110 4AI:*0"4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=J\YM;BUN&#M#)C(PPZ@C^8_"AH[^&+>P:?5XK^\O#(52U@811A<#YB_)/T
M[5JVW_)'+W_L,I_Z*%7AL\,^!-'U32])M;NZOS(;B^N(!-Y)5L!%!X4_7K@T
M^9I<OG;^F+E5^;RN9>IZ/HNH^%YM?T%+FU^R3)%=VEPXDVAONLK8&1GC!_\
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M\3:%>W_@3POJ-G&TZ6]FR31QC<R L2'P.<=03VP*GF=HIOJU^97*KR:71/\
M(J6&C^&O%XEL]$BN],UA49X()YA+%<8&2H; (;'X4SX;JR:UJZL"&&DW((/8
MX%+\.-*NE\2PZU<(]OIFG!I[BYD!50 IX![DD]*G\"W*WGBKQ#=*NU9M.O)
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M%40%%%% !1110,****0!1110 4&B@T )1110 E HH% "T444P"BBB@ HHHH
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MS_S-77H;=+OSXM;CU66<L\TJQR(0V>^\#).365115I65B&[NX4444Q!1110
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MZ_\ #EZMO>K&RR()(9HFW1S(>C*W<52J1;LF0Z<DKLFUK0%TG1]%OA<&4ZE
MTI0ICR\'&,YYK$KM/&/_ "*7@W_KRD_]#%4-,\'S76E)JVI:A:Z3ITA*Q2W)
M):8CKL0#)'O4PJ>[>3[_ )E3A[UH^7Y'-45TNI>#IK;2GU;3-0M=6T^(@32V
MQ(:'/3>A&0/>J']@7#>%?[?26)[=;K[-)&,[T;;D$\8P:I5(M7N2X270R:*W
M](\(ZAK6@:GK%L8Q!IXRZMG=)@98+QV'/XU6T#0)_$%U<0PRQ0I;6[W,LLN=
MJHO7H/>CGCKKL')+33<R:*V-!\-WGB!YVA>&WM+9=]Q=W#[(HAVR?4]@*U'\
M%)=6T\FA:Y9:M-;H9)+:)7CEVCJ55A\V/:DZD4[-@J<FKI')T5L>'?#EWXEN
M[JULF3SH+5[D(V<R;<#:,=SGBI]:\.6^BV0+ZW8W-^) DMG;DN8^#G+=#C&#
MCN:?/&_+U#DE;FZ&+:P_:+N&#=M\R14SC.,G%:VM^'9-,\73>'[60W4JS)#&
MQ4(79@,<9XY..M9VF?\ (5L_^NZ?^A"NF\>0/<_%#4+>)PDDMS&BL>Q*J :E
MR:G;R?Z#44X7\T<WJNEW>BZG/IU_$([F @.H8-C(!'(]B*IUM:AH=Y#XO?1+
MFY26[:Y6!IRQ(+,0,DGGO6O/X#73+M[?7->T_37WLL2N'=I "1OP!\JG'!.*
M?M(I*[#V<FW9''45K>(?#UYX;U!;6Z:*59(Q+#/"VZ.5#T935_3O![SZ5%JN
MJZE:Z38S$B![C<SS8ZE449(]Z?M(VO<7)*]K'-45OZUX5FTO3X]3M;VVU+3)
M'\L75L3A'_NNIY4U'I_AJ;4?#>I:TEW:QQ6+*&A=\.^?0?C^/-'/&U[AR2O:
MQB4Y$>218XU9W8@*JC))] *;6KH&OW/AR^>]LX;=[@Q,D;S1[C$3_&OHW^-4
M[VT)5KZD^O>$M6\-VEC<:I$D/VP,8X]V77;C.X=C\PK#KO/&%S/>?#[P?<W,
MKRS2&\9Y'.2Q\P<DUP=12DY1O+?7\RZL5&5H^7Y!766W@*[:QM[K4M4TO2?M
M*[X(KZ?8[J>C8 .![FN5C8)(K,H8 @E3W]J]%\::!JOBS71K^A0/J.G7L<8B
M,)!,)"@%&'\)!!/IS4U)--*]EW'3BFF[7.+UW0-0\.W_ -CU"-59E#QNC;DD
M4]&4]Q6GI/@;4M7T>/5([O3K>VD=D0W5R(R2.O45H>.9$L]&\.^'YIDGU'38
M9!=,C;A&78$1Y]5 Q6BF@7NN_"[0HK,VZ[+NX=VGG6,#G ^\1G\*AU'R)WM=
M_P"9:IKG:M>R_P CFM7\'7>C:>]Y-J6DSHI V6UV)'.3C@"J_A[PQ?>)6NA9
MRVT2VJ!Y7N)=B@$XZXINN>%]8\.M'_:5F8HY?]7*K!T?Z,,C\*Z/P#8SZCX>
M\66ML$,TMK$B[W"#ESU)P!TJI3:I\R=_,F,$ZG*U8I2?#R_CC=SK&A$*"<"_
M4D_I7(5T>J>!M>TK3VU"6UCFLU^_-;3+*J?7:>/KTKG*NF[J][DU%9VM8*ZV
MV\ WALK>XU+5=+TDW*AX(KZ?9(ZGH< ' ^M<K"ZQS1NRAU5@2I[C/2O1/&GA
M[5O%>O\ ]OZ' ^I:=?)'Y+PD'RB% *,,_*00?SJ:DFFE>WF.G%--VN<7KF@W
M_AW4/L>H1!7*AT=&W)(IZ,I[BM32O NI:MH\.J)=Z=;VTSLB&ZN1&25.#U%7
M_'<J6FE>'= DG2?4-,MY%NF1MP0LP(CSW*@8K1'A^^UWX7^'H[,VZ[+BY9VG
MG6,#+8'WB,]#TJ'4?)%WM=_YEJFN=JU[+_(YK6/!UWHVGM>3:CI4Z*P79;78
MD?GV%5]!\,:AXA,[VQ@@M;< SW=S)Y<40/3+?T%,USPQK'AQXQJ=FT22\QRJ
MP='^C#(_"L^&>[:$V4,LQBF=28%8[7;M\O<UHKN.COYF;LI:HZ.^\"WD&ESZ
MEI^HZ=JUM;C,YL9M[1#U92 <5RM>B^$-+O\ P>]_K6OPM861LY(%AG^5[EV'
M"*G4^N:\ZHIR;;5[^8ZD4DG:P5UMOX O/L=O/J>JZ5I+7*AX(;Z?9(RGH2 #
M@?6N6MY%BN8I'0.J.&*G^( ]*]"\:>'-7\4^(6U[1('U+3K]4,,D)!\O"@%&
M&?E((/7_ !I5)--*]EW"G%--VN<7KFA7_A[439:A$$DVAT96W+(IZ,I[BKVA
M^$;W6;"747N;33].B;8UW>R;$+?W5X))K6\>2QVVG>'M!>=)[_2[9TNG1MP1
MF((CSWV@8I_Q 8V&F>&-#B.V"#34N64=#+(3N)_+]:E3E)175E.$8MOHC#U[
MPI?:#;V]VTUM>6%P2(KRTDWQL1_#GL?8^_I5?0?#VH>([Q[>Q1 (T,DTTK;(
MXE_O,W85TGA!CJ/@GQ9I$OS116POH@?X'0\D?4 "D\&$:GX6\0>'+65(M4OA
M%);JS!?/"'+1@GOCH.^30ZDE%I[K^K@H1<D^C_JQ1O? EW%IUQ?:=J>FZM%;
M#=<+8S[WB']XJ0./<5S^G:==ZM?PV-C T]S,VU(UZG_ >]=]X-T34O!]_=:]
MK]NUA806\D;),0#<LPP(U7OD\^G%4/AB2=3UF*V(74I=*G6R.<'S..%]_P#
MTO:M*3O>W4?LTW%6M<A_X5S<M,;--?T)]2Z?8EN_GW?W<XQN]LUR=[97.G7L
MUG>0O#<0MMDC<<J:2."Y:\6"..7[5YFU4 ._?GICKG-=E\5./%5LDA4WB:?
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M#%2_$[=_:.C>5G^SO[+A^R8^[MQSCWZ?I7-ZIKT^JZ;I=C+%&B:=$T4;+G+
MG.36AIGC&6UTI-)U/3K75M.C):**YR&A)Z[''('M4J$HV?:_XC<XRNN]OP-3
MX8;O[6U;S<_V=_9DWVS/W=F._P#GUJ+P,?[3TWQ!X;;DWMF9[=?6:+Y@!]>?
MRJCJ?C&6YTJ32=+TZUTG3Y2#-';9+S8Z;W/)'M61HFKW&@ZU:ZI:A3-;ON4-
MT;L0?8@D4.$I*3V;_0%.,7%=%^IW]GJB>$I?"&D2X$4BFZU%3T(N/D ;_=2J
MMUIC^"_"?B:-\BXO;X:= QZF)?G9OHP(%<;KVM7'B'6KC5+I466<CY$^ZH
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M HHHH *2EI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ****!A1110 4444 %%%% !1110 4444 %%%%( HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $-%!HH **** "
MBBB@ HHHH **** "BBB@!**** $H%% H 6BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ****  4II!2F@!**** $-%!HI %%
M%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH DHHHJB HHHH ****!A1
M110 4444 %)2TE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% PHHHH **** "BBB@ HHHH **** "BBBD 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "&B@T4 %%%
M% !1110 4444 %%%% !1110 E%%% "4"B@4 +1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%%  *4T@I30 E%%% "&B@T4
M@"BBB@84444 %%%% !1110 4444 %%%% !1110 4444 244451 4444 %%%%
M PHHHH **** "DI:2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@84444 %%%% !1110 4444 %%%% !1112 ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#10:*
M"BBB@ HHHH **** "BBB@ HHHH 2BBB@!*!10* %HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ %*:04IH 2BBB@!#1
M0:*0!1110,**** "BBB@ HHHH **** "BBB@ HHHH **** )****H@**** "
MBBB@8444F: %HS29HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ****!A1110 4444 %%%% !1110 4444 %%%%(
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MDQ2T4 )BC%+10 F**6D- !1110 4444 %)110 4444 )BEHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ -)2TAI %%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH DHHHJ
MB HHHH ****!A24M)0 4AI:0T  I:04M !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% PHHHH **** "BBB@ HHHH *
M*** "BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %(:6D- !1110 4444 )1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %(:6D-( HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% $E
M%%%40%%%% !1110,*2EI* "D-+2&@ %+2"EH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH&%%%% !1110 4444 %%%
M% !1110 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ I#2TAH **** "BBB@!**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHI )12T4#$HI:* $HI324 %%%% !1110 4444 %%%% !11
M10!)1115$!1110 4444#"DI:2@ I#2TAH !2T@I: "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****!A1110 4444 %%%%
M !1110 4444 %%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *0TM(: "BBB@ HHHH 2BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKEHXLL!Z OC&.Q/7BAU$G8%3;1QM%=@8K1O%^GV9M(98+2T!^SB3>CN(VF*
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MHH **** )****HD**** "BBB@ I*6DH *0TM% !1110 4444 %%%% !1110
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MHHIDA1110 4AI:0TQA1110(**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@84444@"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "@44"@!:2EI* "DI324 )1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0T4&B@"
M2BBBF(**** "D-+2&F,****!!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444#"BBBD 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% "444F: "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ****0!1110 4444 %%%% !1110 4444 %%%% !1110 AHH-% $E
M%%%,04444 %(:6D-,84444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH&%%%%( HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *2BB@ I*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH ****0!1110 4444 %%%% !1110 4444 %%%% !1110 AHH-% $E%%
M%,04444 %(:**8PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110,****0!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !2&BB@ HHHH 2BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
J*** "BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 (:*** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>exhibit107-formofindemni001.jpg
<TEXT>
begin 644 exhibit107-formofindemni001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1XM(ETBTDTZ)M\=LT8*(WJH[=3T]36M##%;01P01I'%&H5$0850.@ ["GT4
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M9(X5AC'[B,D D2QL?F8NW;(9?2N?\$V@&D^)OAY=-<?9(7G@L+IXB%DMY5/
M; !92QSC\.!0!N^$S?>+]$B\0ZM>74$=[F2ULK6=H4@BR0NYDPSL0,DDXYX
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M6@ZW<2ZI]IC%O),PV7*/(2BR C'W2 2 *E_X2Y?$OPUUC4[1Y]/U6PM9_M$
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBL?4?$^EZ7>R6ER]R9XX1/(L%G-,$C)8!F*(0/NMU/:@
M#8HKG;+QQH.H"T:UGNW2\S]FD.GW"I+A2V%8H 3A3QGG'%:&A:[8^(]*34M.
M>1[9W=%,D90DHQ4\'D<@]: -*BJ1U2$:VND^7<>>UN;@/Y3>7M#;<;^F[)Z=
M<5=H ***J1ZI92ZM-I:7"&]AA2>2'NJ,6 /YJ?T]10!;HHHH **** "BBB@
MHHHH ***0L 0"0">GO0 M%07ETEC8W%W*LC1P1M(RQH78A1D@ <D\=*6SNDO
M;*"[C618YXUD59$*L PR 0>0>>AH FHHHH **** "BFR.(XV=@Q"@DA5+'\
M.3^%9^A:Y8^(])CU/3G=[61W16="A)1BIX/(Y4]: -*BBB@ HHHH ***JZAJ
M%KI=HUU=R>7$&5!P269B%50!R220 /4T 6J*R](U^TUF:]@@2XAN;*017$%Q
M$49"1D>Q!'(()I-?\0Z?X:T>75-1>46L1"LT4328). #M'')QDX% &K1110
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MQ4\'D<@]:TJ "BD+ $ D DX'O2T %%%% !1110 4444 %%%% !1110 4444
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M '!'IRNF^*-5_P"$E\-Z?/J"7BZM;3_:S' !##-&@;]Q(  Z@EEY+=!S5]O
M][>:QJ&HZGKOFR7^E'3)DMK40J%);YE)9B/O>IY[XX$5GX#U&"Y\-W%QXC,K
MZ$CPQ!+)$5XF0)C&3AL <\CT H BL?$VK6L'BC3=4N5DUG3IE6S"1*@F24 6
MY [EG.T]0#7:1L]EI@>]G\UX8MTTH7;N(&20!T^E<99_V%XV\<:?XATF9KF+
M3+>2.:= RI(Y8>7&<@;BOSM[$J>XKO&570HP#*PP0>A% 'G,_BO7/^%>)XZM
MYHS&!]I;3&C78;??C;O^\) O.[.,_P .*=K N;_XI>%9[;49(HI]/NY81Y2G
MRP1%D<CG/OTJ_;> 'MO#\WA@:KN\.O(2MNT!\Y(BV\Q"7=C;G(SMS@D9Z$:=
M]X:N+KQ=IFNPW\4*:?!)!';?9BP99 -V6WC^Z,<?G0 >/_\ DG7B7_L&7'_H
MMJUM&_Y >G_]>T?_ *"*RO'P)^'?B0 9)TRXX'_7-J=HWB+1/[!L#_;&GX6!
M$)^TIPP49'7J,CB@#H**S/\ A(]#_P"@SIW_ (%)_C1_PD>A_P#09T[_ ,"D
M_P : -.BLS_A(]#_ .@SIW_@4G^-'_"1Z'_T&=._\"D_QH TZ*S/^$CT/_H,
MZ=_X%)_C1_PD>A_]!G3O_ I/\: -.BLS_A(]#_Z#.G?^!2?XT?\ "1Z'_P!!
MG3O_  *3_&@#3KC_ (6_\D[TW_KI<?\ H^2MQO$FA)&TC:UIRHO5C=( /QS6
M%\+"#\.M,(.07N"#ZCSY* -/Q*D%OX=O[2&U2:XU%7ABM\?Z^5U(Y]L<D]E4
M]A7'RZ8^B^-/AIX?:4RV]E9W6&/225( H;'L"2/3-;^H>%_$ESKT^IVGBY;0
M,OEPP_V8D@A3T!9NI."3QG [  6Y_"TUS9:2\^J/-K&F3&>+4)(A\S-D."@(
M&QE8C:",8&#Q0!B:<BR_&+Q-9L@>UET^SGE0]/-5CM/UP!^5:=WIR:W\1-+U
M&)0(]"BG628?QRRJ%$0/?:N6/H67WQ.GABZ@AUFYMM4$.MZJ5\V_%OD1A5VJ
MJ1EN !G&2>22<]*JZ+X6\0:9/:)<>+6N-/@;<UK'I\<)DZGEP2WWN3W/.>IH
M 3P%_K_%O_8P7'_H$5=A7!>#-7TVQU#Q7;7>HVEO.VNW$@BEF5&*;(_FP3G'
M!Y]JZK_A(]#_ .@SIW_@4G^- &%XI_Y'GP/_ -?EU_Z2R5V%<)KVJZ=?_$#P
M7#9W]K<2QW5RSI#,KL@-K)@D \ Y%;GAZ+6HM0UC^TM1:]LVN-UFSVPA,8).
M8QC[R@;0&/4[J .=\00W]Q\6]+BTV[BM+AM%N!Y\D7F[!YL?(7(!/U./KTJE
M_P )%XP;P[XFM4GMY->\.W W21P#9>0E X.W^%]I/ [@#O76ZKX<N+KQ-9:_
M87\=M>6UN]J4G@\V.2-R&/ 92#E1SG\*@\S1? =C<:AK.HJDFI7FZXNY$($D
MS+A5 &=JA5P!V Y)/) )++6FUO4]).E7I>P>Q^V7#%%)97P(ATX)(D)Q_<(J
MSXGO+VQL;9[.XMK9'NHTN9YB,QQ'.3&""&<G  P>O0U0\ ^'[?0M#F>WAEA2
M]N9;F.*7.Z*)F)C3!^Z I!V]BQJUXH\.3:__ &9-::B;&[TZ[%U#(T/FHQ"E
M2&3(SPQYR"* .1G\9:Y%X6\:307*&YT.7_1Y[JTVN\9C5P'3Y<-R><#M\M:L
M.LZ]8^,/#MI?WUO<V>M6T[&%+?9]G>-%<$-G+9!(.?J .E-N/AY=7%MXF@;Q
M [)KX7S=]HI\L[%5B,$9X7CIC/.X\UJ3^%;NXUOP[J3ZG"&T:.1 @M3B;S$"
M,2=_R\ 8Z\^M '%>*M5U#Q7\&];\0PWH@LYUE$%H(E*F!)"F6.-V\[2W! &0
M,'DGU>U_X](?^N:_RK@9/AI>)X>U7PU9>(!!H-ZSM%;O9AY+;<VXJK[P"F<\
M%<\]:[VTA>WLX89)C,\:!6D*A=Q'? Z4 >/Z+=>)]'^'%YKND7]FMMIUY>SR
M6,MMN^T(L[E\R9RIQG&!VZ\\=8_B;4M?O;VUT5;J 6MI!*'ACA<F29/,4.)&
M'R@;>@R23R,5-;>!)X-&O- ;5@^B74\DLD7V?$Y21R[Q^9NQ@DD9VYP2/>GZ
MIX*O#XB&M^'-=;1;F6!+>ZC^RK/%.B?<.TD88#@'T_'(!@W-SXEOO$_@)=5F
M?2KVX2\-S:1!)$25(B-XZ@Y#' R< ^N:T+C7M:M-3\6:5/J")=6EHE[I3F!<
M21L",$?Q$2#8<=<C')K6U#P?+<W6@WEMK$T-YI+S'SY(EE,WFKB0D< $]1C@
M>F.*MZIX6M-5\1Z1K4LCK+IP=2B])E.TJ&]E=58>XH R?#GB*[\0Z7X;FANR
MLTT3SZB#$O&SY'3&/E/F$ ?[*MWYK.MO$?BO6=)T[7]$L9YXKB<.UDX@6%K8
ML1PY?>' P<],Y&VNHT#PM:>'M0UF[MG9CJ=U]H*'I$",E1[;R[?\"]JQ-(\!
M7^B3R65EXEN$\.-*TBZ8;=2R!CDQK-G(0DGC&<'KGF@""\\0>)-7AUF?PY!,
M9M/O)+6VAV0F*9HR XD+L&&3D#;C QUIYU;Q/?\ C@Z&MU;:=')HT=\1]G$K
MP2-)M9<[L,1CKT]CUJPW@C4K/Q!?W^A>)IM,LM2E\^\L_LJ2YD(PSQLQ^1CC
MG@\_AC0A\+36WB_^W8+^,(-.73DMW@+;45BP8OOR3D^G3\Z $\!ZW>Z_X3@O
M-1,;7B336\KQKM5S'(R;@.V0H.*Z6L'PEX=D\,:.VG/>K=J9Y9PXA\L@R.7(
MQN.>2:WJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J:EJ=GI%A)>WTPB@3 +
M8+$DG   Y))(  Y)-6ZY[QGX?;Q+H'V"&_-C>K/'<6=P!G9-&=RG'?H>/Q[4
M 3VWBBPGU.WTV2.\MKVX#-%%<VSIO51DD$C;QZ9R,CCFMJO.-&\5ZK%XET[P
M]XXTA;752SG3]2M3NM[E@A!Q_=;:3P?R'%(?$NMCP7XXO?[0)N]%O[J*UE\J
M/.R.-&4,-N#R3DX!H ](HK@[C6=>G\5^'--@U&*"VU+2Y9Y2+96974)\P)[_
M #''8=P>E9 UKQ8_A7Q7<C7D6X\.75S&DHLX]UT(T60"08P.&Q\H![YH ]3H
MK@KK7M<N_$WA6UM+V&UM=8TZ:XE40!RC*B-D$GG[_';CG/2LM=7\62>'O%K?
MV^BW'AVXG$<XLXRURJ1B0"08V@8./E /?Z@'HEYJ26=]8VK6]U(UX[(LD4)9
M(\*6R[#[H.,#WJX&4N4##< "1GD ]/Y&N'N/$NJR:IX$DBFBBM-:5FNH!$"2
M?LYD&&/09QT].M,\&1WC>-_&+3ZI=3I!?1QB.0)@@PJ0.%!&,\8(]\G)H ZC
M4M?LM+O(+2=+N2>9&D1+:TDG.U2 2=BG RPZUEV?Q T&_ABGMFOWMY+@6PG_
M +/G$8D+;-I;9@?,0.:Z;RT\SS-HWXV[L<X]*X'X1QI+X%E21593J5UPPR/]
M:: .KT/Q#8^(/M_V(3C[#=M:3>=$8SYBA2< \X^8=<5JUY!%/K6GZ1\0]6TG
M4ULSI^L7-SL^SK)YQ6*,E6+=%(&.,'GK752^([_5M8ATNQ6[A/\ 9<5_+)9B
M R!I20H'G';@;3G@DY'3'(!VM%>:W6L^-[*S\+P:A):V5_>ZF;*Y_=)()$VN
MRR<,0#A1E1WSR!6C=2^(=-F@T^]\1B9A92NLMI:)]IGFWG!,6UE6-5V@MP,G
MDB@#MW19%*NH93U##(-*JJBA5 51T & *\QA\7>(]2T?P'=6UW:V\NMLT5UF
MWW#<(V.X<],KG Q]<42^,==\)7OB33-:NHM5>RLXKZQNC"L)99'\L*ZK@<.1
MR,< _@ >GT5Q]M_PEH\1V\1-X^D3P.MS-<BU62VE RK1B,G<#TPP..#FL"W\
M7:Y-\,/#FOM>@7UU?PP7!$*;9$>X,9&,<<>F* /3MR[]FX;L9QGG%4],U)-4
M@EECM[J 1S/"5N83&S%3C< >JGL>]<?I4=])\6_$JG5;DQPV=HR1,J% &\T[
M<;<X!YX()SR35/3_ !GJR^&-]U/%+J-SXA?1X)C$%2,>:4#;1UPJD@9Y.,F@
M#TFBN3OU\6Z1!K<]K<1ZK MGYEA'*BBX$XSE2$559>A'?/%,\&^(X/$-S=O:
MZU-=QQ1HLEG>0)%<VLN6W;U55X(QZC(/- &QK_B73/#-O%<:H\T<,LBQ(\<#
MR NW1?E!P36K&XDC5PK*&&<,,$?45P?Q;_Y%C3?^PQ9_^C*LZA?Z]/\ $K^P
M+358[6QET=KL%;96>-Q*J9!;.3@]^.3P>* .UHKS;2O&>JS:#I=G<W$;:I=Z
MS-I+7GEA1MC9\R;>FXJF .F3G&.*[#2+;7+74]134;Z*\TXE&L9&4+.O'SJ^
MU54C.,$#.#S0!LT45D>)[J]L_#UU<:?<VEK<+M_?W;;8XU+ ,Q]PN<#N<4 :
M]8^O^)M,\,PP3:H\\<<\JPQM';O+EVZ+\@/)Q6)X9UZ^NO&>LZ/-<W%S9P6T
M%S;R75N(I1O+!@0%7C*Y&5!ZU4^+/_( T;_L.6?_ *'0!T(\8:*M[;V=S//9
M3W+;8%O;66W$C?W59U )]@<UNUQ_Q2M;2Z^&>O"\"[8K5IHV/\,B\H1Z'=@?
MC61H?B+6M6M=+TH&^CNH]#M;RZFMA 96DE! SYQQ@;"3@$DL.1CD [+6?$-C
MH4NG17@GW:A=):0&.(L/,<X&X]!^)[5JUYAKDNNR^'O!O_"26\<.IKXEM$D\
MLJ0X#/M?"D@$C&1GKFKGC+Q!K6D1>(KFWU-8WL+=)[.UMH5E^4+EC<94[ 3D
M##+D#C)H ]#HKB[O6M3M?%WA[SKQH]'UFV>,1B-/W-UL#K\Q7."-V!ZCTXK*
M\/\ BG5-4TO5;!]3D;6(]32VM9?(C7=!)AXY0NW!!B#N<_W3TH ])HKS_P 7
M:WK.DQZ_+!JH1K"Q6XLX+:%97;:C,[7&4(121@8*Y ..:34-:\17WB/PY8:?
MJ4%C#J^F37#G[,)#$ZJA!&X\\OTX'KF@#T&BO/SJGB346U?3=/NKI[W25CMA
M<V\-LJSW'E*Y>19&R%)8#"XQ@\GC'9:++J,^BV<NK6R6VHM$OVF*-@RJ_?!!
M/&?>@"]17#:7J/B+Q3X>M_$.C:C! TUVWEV4Z+Y)MTE*$,P4OO*J3D$#/&*G
ML]4U/Q3?^(HM.U)M.32[HV4&V)'WRJ@9FDW*<KE@ %QP#SSP =E4<MO#-CS8
M8Y,=-R@XKS&W\;:_KMAX+NK.>"P;5KB:UO(S!O >-7#,I)Z93('TR:O+/XO7
MQG#X7?Q) V=&:[>]&GHK[Q,%W!<D9P0/3KQG% '>?8+/_GT@_P"_8H^P6?\
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M,?3TT[XP>$M!::XGL+#2IY[5KJ4R,\Q+!B2>I"_EVKTVYM8+R)8KB,.BR)(
M>S(P93^! /X4 -^P6?\ SZ0?]^Q1]@L_^?2#_OV*Y"TU;6/%%OXBNM*U$V+:
M;>S65I$(D=9'B R9-P)PS$C"E<#'>L>#QCKOB)_!$NFW<.GQ:]!<_:$-N)#&
M\<9R5)/(W9(''09SR* /1_L%G_SZ0?\ ?L4?8+/_ )](/^_8K@HYO&$OC"?P
MP?$L"F+28KEKU=/3>7+LI(0DC)V_3KQW%32?'6LW%E8:-?/$NMR:W-H\]W'&
M-I$*[VE53QN*X !XR<X[4 >D?8+/_GT@_P"_8H^P6?\ SZ0?]^Q7'2ZWK&F>
M+KWPY+>BY6?2VO[&[FA7?$RMM9'"!58="#@>AS5#1-2\77O@*+Q-)K^GB2XT
MT,L-S;K%##)N&96D'/W<_+C&<?B >@?8+/\ Y](/^_8JCJDVG:7I<M^VG-=1
MQ$ QVEL)9"2P7A1UP3SZ8-<OI^N:C=>*]6T)=2O'M3I*7MO=36R131L79"5&
MP KQD;E_2N?L-5UO1/@)9ZY9ZJ[7?E0OF>)'QOE"L <#D[B<MNH ]9CMH(6+
M101H2,$J@%2URLVL76J>.+OPY:7<EE%8V27$TT2(TCO(Q"J-ZL H R>,DD=,
M<\I>^-/$47A?4@MQ;QZII&M1Z=--Y *W$;2(%?'125?D<].,4 >GW5S%96<]
MU,6$4,;2.54L=H&3@#D\#H*YZ'X@>'9[?1ITNI?+UB5H;5C X_>*P4J_'RG<
M0.>YJIIVH:U:_$:X\/W^IB]MI]+^WQ,+=8S XE"%5QU7D'YLGCK70KHMFMM!
M;X=HH9OM&TMGS)=V_>WJ=_S>F?H* )[+4+>_20PL0\3F.6-AAXW'.UA]"#Z$
M$$9!!JU7$W-T^G?&6R@C.(=5TEQ,@Z%X7RK_ %VNP_+TKMJ &NB2*5=593U#
M#(-0_8+/_GT@_P"_8K@O&?B/6M&@\17=OJ:))I\<<MG:6T*RC9M!8W!*_)N.
MX !EX'&:N7NJZ]=>/K'1[34HK2RO-(>[.+97>-PZ#()ZGYCC/'/(- '<*JHH
M55  &  .E98\0V)\4_\ ".@3_;A:F[YB(3RPP7ACU.3VSWKB;+QKJT?AR*UN
M9XIM6E\0/H4=V8@H.'(\TH.,A >!QG%6K:UNK7XVQ+<7\MXK>'Y"C3(BLO[]
M,CY%4$=^G<T =?K6MVF@V4=U>"4I+/';HL2;F:1VVJ /<FK5M,M[:I*]O)%D
MY\N=,,I![C]:Y?XB_P#()T?_ +#MA_Z/6NPH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ K.UG6(M$LGO+BWN98(T:21H(]_EJHR2>?2M&L7QA
M_P B3KW_ &#KC_T6U &G97<5_8V]Y 28;B)98R1@E6&1Q]#4]9'A7_D4-$_Z
M\(/_ $6M:] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !67KFD2:Q:P117\UC+!<).DT*@L"N
M<#!R,'//'(R.]:E,EEC@A>:5UCC12SNQP% Y))["@# ;PW<W^LZ?J&M:A%=?
MV<[2VL,%MY*B0KMWOEV+$ G&,#GITK*O?A]+<Q^(K2#79K?3=<9YIK86ZL4E
M= K,'SDJ< [>.G7&<]=:WT-U:QW(#1Q2D>691M+@]" >>>P.#[51L/$5GJ/B
M#4]&ACN%N=.6)IC)'M4B3=MVG.3]T]J ,Z+PC-%KFBZE_:K2'2K1K15D@&95
M8+N)((P?E&,#\ZKIX(F72/$NGG55*:]-+-,_V;F(R($8+\W3:!C/?UKL** .
M5A\'SQ:KX>OVU-6.BVKVJ)]FP)5954D_-P<(O3OGZ5''X+G2P\2VIU12->>1
MYF^S?ZHN@0[?F_N@8SW_ "KH9-5M(GO \NU+)-]S(?NQ<;L$^NWG'8$>HSGZ
MSXKL-!AL9K^&[1+Z9+>#;"6)E?.U"!R"<=Z *!\&S;O##?VHN= 7$7^C?Z[]
MWY?S?-Q\OIWY]JNZ=X9;3/%&JZO#J,OD:BZ2RVAC7:)%0)G=UQ@#CU_*MU&+
M(K%2I(SM;J/8XIU #)1(8F$3*LF/E9EW 'W&1G\ZP/!WAA_"6DR:<+_[7$TS
MSAFAV,&<[F'!((S5NV\16=UXFN] 2.X6[M8%N'9X]J%6) VG.3R#VQ6O0!QH
M\#3?V-XETUM54IKT\LTS_9N8C(H1@OS=,*,9_6FW_@.YFGTK4=,U^;3-8L+4
M61NXK=72>$=%>-C@\\]>I/MCM** .4OO!L]X-&8ZQ(T^G7GVYIIH0[7$V"I+
M8( 7!(P , #'2I;[PG+<^*VUVUU>>T::S%G<PI$CB1 Q8%2V=ARQ[&NFJE/J
M/D:M:6'V.[D^TI(WVB.+,,6W'#M_"3GCUP: /,-5T4>$Y? &A)KBM):ZA(8I
MKA$&Q/*? *@C*Y..N3GJ.,=M/X+L]3CU@ZS)]LGU:!;:9T3RQ'$N=JQC)(P2
M6R2<D^@ '1AHY&< JS(=K ')4X!P?3@@_C3Z .7\.^%M3TB2'^T_$UWJ\-J"
MMI'+"D?E\;<LR\R-M)&2>YXSS6.OPSF708=#'B*X73K6\6ZLXUMDW18D\P*S
M?QX)X)P/4'C'H%<B_P 2- CT6XU5Q?+;VUW]DG!M'WQMC.YEQD)CG/\ 7B@"
MZGAB2#Q=/K]OJDR&YMHX+B Q*1*8]VUL]1]XY QGVK)_X5S;S>%[_1+O499!
M<7SZA%<Q1^7);SL^_<O)Z'I[$UUEMJ5O<WD]HI9+B$!FC<8)0YVN/53@\CT(
M.#Q5N@#E[;PQJHTZ=-0\37-YJ+QB.&\%ND0@ 8-E47@DE1DDG.!TJWI_ASR/
M$<VOWD\4VH26BVFZ"#REV!MV2"S$MG'.> , 5NT4 <[XO\+OXKL+:S^W_9(X
M+F.YRL.]F=#E1R0,9]J7_A'+D^,4\1MJ,?G+8&Q\D6YV%2X<M]_.=P'X?G6Q
MJ-]%IFG7%],DCQ01F1UB0LQ &3@5G6OB6"]TW1=0MK&_F@U;88S'#N\E60L&
MEP?E';//)% '/O\ #:*;P]+IDNJS+.-1;5+2\AB"26T[,6R!D@C)/'H?QK9M
M- U2'2[Q+KQ%<7.JW$)B2_\ LZ((.#@I&/EZG)SDGCG &.AHH YF[L-<35O#
M_P!FUFX>.W79?1M;KY=R-N#(S?PMD<*.[>@-7/%7AY?$^B'3_M<EI(LT<\4\
M:ABDB,&4E3P1D=*VJ:9$$BQEU#L"0N>2!C)Q^(_.@#F],\)W%CXKFU^?6I[F
M:XM4MYXC"B*Y0L01@<#YCQU]2:?XO\+R>*K.TM1J'V..VNH[L%8=[,Z'*CD@
M8_#\:Z.B@#F-2\(OXA$,/B#5)+RQC=9#90Q"&*9@<CS.2S 'G&0/4&H_$'@V
M74M<M=<T?69]&U6"'[,TL4*RI+#G.QD;@X.<'MGZ8ZNB@#E=2\'2:A8Z3 =6
MD,MA?QZ@]Q+$'>XF3)&[! "\] .  !C%4]1^'SWTGB)$UVX@L]=3-Q;K"C;9
M-@3<&/.W 'R^W45VU% '-:IX/@UGPK9Z)?WL\C6TD,BW2@))NC8'(VXVY&5]
M@>YJPOA2PC\7IXBC!2=+,6@B483 )VMC^\ 64>Q-;M<_=^+[.UNFC2SOKJ&*
M[6RGN;:(.D$K8X89W8&Y<D*0"<$YS0!F:CX">^OO$4D6MW-O::] ([JW6%&(
M81^6"K'D#&,C]14UKX,N+;5M!OVUEIGTBU>U4/; >:KA0V<$8^Z,8'&.<TM]
MX^L[2*.>'2=8O[65Y(H;BQMA,LLB$AE #;NJM@D '!P<5U2-O16P5W '##!'
MUH Y'4O!-V_B>?7="\0W.CSWB(E]&D"3)/M&%;#\*P'&>?IUSU-G:I96<5M&
MSLL:XW2-N9CW)/<D\D^IJ>B@#BM/\ 3:5>W4-CX@NX= N9VGDTH1(0"QRRK(
M?F5">H'OSS5\>%9['7M2U31M3%E_:84W<$EOYJF11@2)\PVMCKG(/I7344 <
MB_@2&%?#D6FWGV6#0I&EA1XO,,K,"&+G(Z[F/'<YK)OYGD^.-O'9ZC;6]PN@
M,I$J>8&)G!V%0RG..>#GCTKN-3U.UTBQ:[NW*QAE0 #)=V8*J@=R6( ^M5M)
MUJ/5;F]MSI][97-FZI(EU$!G<,AE9258$>AX[XH QKKP!8W>B26<EU,M\]__
M &G_ &@@ =;H'(<#I@ !0O\ =XZ\UH0>'[@ZJ-8OKZ&YU.*V:VMW6W*11*Q!
M8[-Y)8D#)W=  ,<YF\1>);'PSH5UK%VLTUM;<2"V3>P.<>N!R>Y%:X.0#ZT
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MC8RLGRE@1_".H/? '49>D>,]6OO#?A>SFN5&JZM?3V<EXL:C"0,^YPN-N\A
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M*.  K89>#CIUS6/?:KXNLOA?#XM'B3?//8V;BW-G%M5W= S!L9R0_/'7I@8
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG98QP78*"57_ &CQ69J_C;2M+O-$M_,,XU9\Q2Q*73R]A;?D @YP !WSGH*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M NT444 %%%&: "BBB@ HHHH **** "BLW6M>T[P]9I=:E,T4+R+$K+&S_,Q
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M+IS[PJJ%W#,N-V!Z$9[4D_A2\D\<Z?XABU&!(;*T:T6V:W9F9&.22^_KP.U
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MX0UC7-!^'_@B[CFLVTVZN8;"2U,),FV5V7?YF[J#CY=OXFNHU#Q+KFH'7/\
MA'XB9=,G:VAB-MYBW$J*K,';<-H);:,=,9).<".+X?7T/@[0/#ZZQ;_\2B\B
MNEG-HW[WRWWJI7S..3R<U8E\':W9>)+[4O#WB&.PMM3=9+VUFM!,HE  ,D?S
M#!( X.1]>E '6:?<7%UI5M<W-HUM<R0J\MNS F-R,E<]#@\9KC?"GBZY\2W$
M,0U*WAOD5QJ.ES0>7/:/CC:"<LH. 3SG(.1TKMH;<6]E';)([;(P@=VRQP,9
M)[FN7MO"%U+K.B:IJUW:W%[I,;HMU! 8Y;G<A3YR6.!@DXYR>>.A ,-O&VMC
MX6/XEW6GVZ&^-NZ^2?+=?M7D]-V0<'/7K3[N'5Y_BUK$6C7=K:3G1K8F>XA,
MH7]Y)P$!7KZD\>AI;GX<:K+X9U'PY%KT$6F37GVJV_T,F1,SB8JYWX8 @XP
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M<[0[@&8%'; 4$L<C''J:N?\ "N=6&C1Z6GB&#[/:ZH-2M6>R+.6\TR8E;?\
M/R3R-I]^U %K1)-7G^*'BR)]21H+>"S$<;P9"JRRL ,,.A))/4^U5K#QWJ+>
M$+.[NEM6U6_UIM)@VH5B5O-9 Q7.<!5)QGG&,\YK?M?#5[9>,+_6[?5(_*O[
M>&.X@DM\L7B5@K!@P !W<C'T(K'B^'+GPB=&N-54W,.HMJ5G>PV^PP3&0N#M
M+'< 6(ZC@_C0!>?7-5TKQI9^'KR>"XBU2UEEL;KR=K1RQ@%T=0<,N""",'M[
MUS5IXT\4MX+T?Q3<3:;Y$M^MM<VD=NV9$:X,6Y7+?*1Q@8/3))S@=E%H%Y<Z
MW;:UJES:R7UG;206B0PLL<;/C>YRQ))V@8R,#/7.:PD^'E^G@&T\+C6;?_1[
ML7/VG[&WS8F\X+M\SUXSGI0!VNI7$]II=Y<VMN;BXB@>2* =9&"DA?Q/%<?X
M=\53>(;2:XL-:M9S%9NUQ;R6WES6MP"ORLA.=GWQ^'WC787UO<76DW-M#<_9
M[F6!HTG1?]6Y4@,!GL><9K MO";R>)H]>U%[0WB63V;M:0F/SPQ7+/DGIMX'
M.,GD\8 ,6/QGK$G@[P9K7^BB;5[ZVMKN/RCMVRD@E/FX(QWS56VA\0S^/?':
M^'[RQM9EELV+74#2[S]G&%P"-H/=N?I5B#X=ZS'H6C:._B"V^S:-?17-HPLC
MN98R2!)\_)Y ^7;WZ]MQ/#>J6/B/6-5TW4K5!JPB\Y9[8L87C38&3# $8['O
MWH PH/'FJW_A[P?JT4-M;_VIJB:??0,A8HV9 Q1MW S&>H/!Z\5=U#Q)K=^^
MN+X?C)ETN8V\,9M?,6XE5%=E=MPV@E@HQTQG/.*S=2L-+@A\(>'=!NH[I]+U
M^(W"+('D3;'*\C2 =#DY/3EJUKCP?K5GXFOM4\.^($L+?4F5[RUGM!,HD "^
M9'\PPQ '7C/KTH FL]?U77=5?28$72KJUT^"ZO!(@E:.:7=MC'.,+M.3WR,8
MK$UBY\4R:IX$BU"YMK"\N+J874$">9$9%BDPV<@D8YVYX)ZG K6U'P7J,6OV
MVN>'=;%E>BU6SNA=P>>ES&IRK, RG>#GG//MWLZIX2O+P:%<6^KA=1TNZ>X-
MQ<0>8LQ=65P5#+C[W&#Q@"@#.N?%]ROBJ[T*34+?3M0CFB6SM[N#"7L)"%F1
MR<%B2X !X(&0>:ZS7=7@T#0;_5KD%H;.!YF5>K;1G ]STKGM=\'7GB&RNM,U
M*^MKBQFN%FBE>W/GVP!4D(V<9.#@X&-QX(XKH]8TJVUS1KW2KP,;>[A:&3:<
M$!AC(]QUH \^\3MK%RO@2^O[JW9;G6[622WCBP(F9'("MG) !(.>IP1CI6];
MZ_K,WB;Q=I9DL]NF6UO-9MY#8_>+(QWC?\WW0."*H?\ "#^(9]/T*PN_$5I+
M'HM[%<6\OV%O,D6-6"B3]Y@G! XQZ\UK1>%K^'Q%XAU9=2MC_:]O% (S;-^Z
M\M64'._YOO'(X[4 8&F^+O$B^$-/\3:C+I\D.HP00P6D,#!EN)9516+;N5P2
M2H / &>YOS^)]=T&YU.ZU.RENM#M]/>[%T8! Z2KUBQN.0PZ'''0YJQ'X"$O
MPWA\(7VH%S!&B0WEO$8V1D(9' +'D$#OS[5+9^%M7OM,NK'Q7KB:G#-;O;!+
M>V$ *L,%VY.7QTZ 9/!H FM9/%3W6E7!DL9K*[A9KQ0A7[*Q3*&/G+C/!SUZ
M\=*Y'0/$VI:'X&U35[V[2_N'U>:U@22/9NF:?RU+$'[HZX & ,"NH\,^&M?T
MA+6TU/Q$M_I]B MM&EKY<C@#"^:^X[MH[ #) ))JB/AR9O#VL:%>:IOL+R[D
MN[4Q0;);>1I/,!+;CN*MTP%XSGKP 6[W6]6T#Q3HVFWT\%W9ZQYD*3+!L:"=
M5W#@'YD;D8ZC'4UEZ+K_ (QU/3]2U13ILT>FW5];M9Q6[A[HQ!A&%.X[<L ,
M<]3ST%;\?AZ_O=2TN_UN\MKB;2U<VX@@**\K+M,C L>V<*.F2<GC$.A^%=1T
M;0=:T\:O&9]0GN;F&YBMRAMWER<X+G=M)R.10!%X.\3CQ)*);;5[>\@6 _:;
M<P^3/;3Y'RLI.0OW@,CMU-:GB*_O[%]/%O+;VUI+,5N[J4@M$NTE0B'[S,V!
MW^AJK8^%Y%\6)XCOGM/MR6;6C&TA,8GRRDL^2<XV\#G&3R>,/\1^';[5=8T7
M5=.U&*TN=,DE(2> S1R+(NTY4,IW =#GN?6@#D[CQWKJ> -8U>#[(;S3-6:P
M+2V[H)D\U$#;204;#C.<\CI6W'X@U?2O&\FEZS<V<UC+IDFH(T$#1F#RW 92
M2QWC#9SQR.@JA/\ #C49O#^NZ1_;\1CU34O[0\Q[/+(=Z.0<.,\H.F,#/X;E
MWX6N;_Q=;ZU<7ENT":?)8RVHMV_>+(06.[?QTZ8/% '&>+M1U77_ (86FNR3
MPQ6E[=VDPLQ%DI$9TV?/G)?[I)Z<D =Z].U748='T>]U.XSY%I \\@7J552Q
MQ^5<(WPZUO\ X1(^%4\16YTN&:.2TDDLBTZ(DH<(QW@,!C'09XZ=*[V[L8M0
MTN>PO@LL5Q"T,X VAPPPW&>,Y- '$W_BO6M'\+:3XMNFMI;"Y,#7EFD1!@BF
MP%*/G)92RYR,-SC;2/%J+?&\A;Z((-"WA3;YQ']HY7[W7C[WZ5<MO!%X?#]E
MX;U'4XKO1K*6-D_<%9IHXV#1QN=V, JH) Y Z"M'_A'+W_A/CXE%_!Y7V 6/
MV7[.<[?,W[M^_KGCI0!SWA6VU(_$#QM&;ZV94EM4=3:_*V;8;<#?P!GD=^>F
M:?HWCC4KWP?H-S<+;?VMK&HRV*,J$11[9)06VYR<)'P,\DCFMW1_#FH:7XCU
M[5GU"VF_M9XW\H6S+Y1CCV+SO.> ,\"L1/AM./!-GHAUD)?Z=>M?6-_#;[3%
M*79^4+'</G88STQ0!?U'6]>\,V6L76II;7=I&T":;,HVO(\K!"LBCLK,.1C(
M]Z=9:AXI_P"$B^QM;^=ILULS+>36OE?9YQT4J'RR$?B/6EN?"%[KWAR_T[Q+
MJXNI[N-462TA\E(-K!E9%R26W $DGG &!4^AZ+XFM%!UKQ%#J,D"%+?9:>4"
MV,;Y,-ECCL,#D]3@@ YK1_%/C&]\")XL=;&XB-I(QL;>U<R;Q+M#CYN0%#';
MUXZY/'3^$M>3Q +FZL]9M=3T[9'Y3QQ[)8W^;>LB]OX,<#O]:@T'PIJ>@>!8
M/#]MK$7VJV8&&\%L0,>;YF&3?R#RIY'!JUH_A@6'B74-?E^SI=WL$<,D=K&4
M1MI8[VR?F<[L9[  <]: .BHHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I"0H))  Y)-+7$_%.2
M]A\(*]G>O;9O;:.38H.]6E52"3T'/;KTZ9H [:BN3.K7UWXN/A>"^,3VM@+N
MZNUB7>[,Y5%4$%0, DG![ 8YJ3P=X@O-6;5].U-8_P"T-(O&M998EVI,N R.
M!SM)!Y&>M '445QVI:YJE]KVJZ1I/VB)M.AB)EABBD+2R*6 8.P^0 #IR<GD
M8YSM6\0^+=(\)Z3XCU&VCM! Z_VW8*JNRQ[MI>)@3[';D\'J"* /0J*X+7M?
MUW2_ACJ'B2"\M6NC']JMU:$.J0L1M7*D!FVD9;D9Z#%+<:UXET'QAHD6J75G
M=Z5K4C0>7# 8VM)0I90&R=X.""3CUP.E '>45YU!XE\5:QI-AKVAV$UQ%<3A
MC9,D*Q-;%B,ARX8.!SGIGC;2S:UXJN]4\9V=MJ=E;+HOEO XL]Q8-#YFT@M[
MX)Y]@* /1*I7^J6^G2V4<R3LUY.((_*B9P&()RQ ^4<=37$77CR6'1_#&IZE
M)+IFFZI8B:XOX(/,2&<JA5&R#M0[GY([#D<U<U+7]8L(O![1WUC<QZG?1VUU
M+#%N$JLCMNC;=@ [?0]>M '<45QL>OWNF^.M4TK6;Q!8&P^W6$@B"_(I(E#'
MNR_*1['FF2:[K$4^C:/+YS:C?6TMY</#%'OA12H"*&(7=EP"3G[IXY& #M:S
M%U^P?Q*WA\/+_:"VINRAB8+Y88+D,1@\MVST-4O"=UX@GM;R+Q#:>5+#<LEM
M/\@-Q#_"[*K$*W8BLF3/_"[HL$ _\(W)@D?]/*4 =1I^JV^II=-"LR"UN'MY
M#-$T?S)U(SU7T(X-+>ZI;V%U8V\RSL][*8HC'$S@':6^8@?*,#J:\Q\0:_KF
MH_"KQK--?I%<V&H7%D)+:+8&B1E7;@DD9#')R3[UU6LZKK&BZQX5LEO(9H-0
MO&M[DM;@.P\MG&"#@#@#IGWH [&BN"U/Q1JC2^,C;7,=DWAZ%9((I(PPG_=>
M9N?/.TXVC:1T)R>@L+K&N2:=X?FOKNWLDOK9IKEX(,3B0JK)%'$V\DC+;C@G
MY>U ':$A1DD >]4Y=4@AUBWTMDG,]Q$\J,L3% %(!RV, \]*\PO_ !#K.O\
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MB(L:*B*%51@ #@"@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M F8J5P '&T8)]3GOVKJJ* /(M0NK?4?%VM7/_"7Z-I<\-R+=;/6K"*21%C
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M1B<DX' Y/ ' &!VKG;WP?<ZJ]O'JFHP7-O:ZE]OMV^RE9X\2&18P^\C X7(
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M.GI0!RX\#7:Z5X6L5UB''A^5)$<V9_?;$* $>9QP3^-:-IX;O;/Q5K.N1ZE
M6U*&*(0M:G$7EA@ISYG/WCG@?A71JRN,JP(R1D'N.#2T >?1_#2>W\+Z)I]K
MKSV^J:)([V.HQVP& Y.Y7C+$,"#@\CH/?/6Z)IM]80.^J:F=1OI<;YA$(D '
M150$X')/)))/7H FH^(;'2]6TW3;GSOM&HR&.#;$2A(4L<MT' /&<^U:M '.
MWOAJ>;QG;>([34OLSI9FRFA, <21[]XP<C:<]>#QZ=:QY/A]=2^$M?T%]9AV
MZQ=RW3S"R(,?F,&90/,YY'!_G7=44 <=-X+OWUR[U"+71$M_8)9WD8M Q.P,
M T9+'9]XY!#=_P ((/ -W;:5X8@BUW%YH#'R;AK0%70QF,KLW<?+WR>?R'<5
ME:GXAL=)U+3;"Z\[S]1F\F#;$2I;!/+=!P#QG/M0!<O+-;[3;BQE=MD\+0NX
MQG##!/IGFN/'@/43X?\ #^E2:_$XT6[@N(I#8_?$(PBD!_3J<G/;%=S10!R=
MQX+%_K^LWU_>1S6FJV"V,UJL!4J@W8(?>>?F/;TI/#?A76M'-O;ZCXHEU+3[
M,8MH#:K&^ ,+YC@DO@=.G(!/2NMHH P/%?AR;Q%;:?\ 9=0^PW5A>QWL,C1>
M:A901ADR,C#'N*AT+PO=:1XDUC6)M7:Z_M3R6EB^SJ@5T0)D$'I@<#MW)ZUT
MM% &!X?\*6GA[4M9O+>1F_M&Y\\1GI"",LJ_5R[=OO =JYS_ (5M?KHZ:4GB
M0BUMM3&HVFZR#,K>:9")&W?/R3R-OOGI7H5% '.6_AJ[M_&5SX@.IQR&:Q2S
M\EK;D!26#%@_)RQSP/PK$7X=W<?ARWTV/756XM-5_M2WN!9_*)-[,5="_P R
MY8]QVKOJ* .*_P"$"FGN?$LE[K<DT>OVJ07");JA1EC,>Y3D\8/ _,FKMKX5
MNI!H\>L:A#>0Z0RR6T<-L8@\BJ51WR[9(!. ,#)SZ =110!RUGX4O+2^\2W8
MU2%FULJV/LA A(01C^/YAM'MS^547\!71\(:%H"ZQ$!I%Q!.LYLR?,\HY0%?
M,X]SG\J[>B@#FYO#\EMXPD\3IJ@@B:R2"[@, .]8V9@P8GY>I!&#QZ'FLC1X
MM%\5^.D\6:1,;BVMK,0M.F1'-,2P7@@99$9P3_TT [5W=-1$C0(BJJCH%& *
M &7-M#>6DUK<()()D:.1#T92,$?D:Y"U\"3IX?M_#5YJJW6A6\J,D36^)GC1
MPZ1.^[!4$ 9"@D#''6NTHH YV3PW=OX[C\2KJ,(5+(V7V4VQ.4+AR=^_KD#M
MCVJQXK\-V_BO0)M+N)I("S+)%/%]Z*13E6'T(K:HH X^+PGK4WB+1=:U/Q!!
M<7&F131;8;#RUE$@4$G+G!^7G''3 '>K)\/[N7PWXDT=M9AVZY>274DHLCF+
MS,;E \SG[HP?KUKNJ* .7\0>$9=?T73X#JC6FJZ=(L]KJ%O%C9(!C.PDY4@X
M*YYJO=^";G7/#=YIWB'6Y;V[N FRZ@A$ MRAW(40$X.[DDG)Z<#%=A10!S>E
M>'M62VE37]?;5)&@:W0QVRVZJK#!8@$Y<X'/0=@,G.5%\/9E\,:3IDFM%KW1
MI8Y=.O$M@OE;!@!DW'>".&Y&>.E=S10!S\/AZY.K3ZU=WD$NJ/:?8X72W*Q0
MQ[MQ^4N226QD[AT XYS6T;PI?:)X&M_#MMK*B>UVB"\%MC 5P^&3><]P>1D&
MNIHH Y_2O#0LO$E]K]Q) U]=P1V[BVA,2$*2=Q!9BS'.,YZ #WKH*** ..U'
MP3=W>M:[>6^MM;VNMVJV]U ;8.RE4* HY/RC#'(P>^",Y#;+P1>VMWX5G?6H
MYO[ MWMU4V>/.#(J'H_RX"C'7G/TKLZ* .%N?AR-0L?$-K?:IN&KW:WJ206Y
MC>VF4*%*DN<XVCT[U9B\):U/XAT36=4\00W$^EQS1[8;'RA,) H).7;!^7DC
MCI@#OV-% &)XI\-P>*-(%E+/);313)<VUS& 6@F0Y5P#U^GH34=OX?N9=:M=
M8U:\@N;VSMWAMA#;F*.,OC>Y!=B2=H'48&?7-;]% ',^'O#5_H":SC5+>=M2
MO9;X$V9412/C(QYG*C;TX/O66GP^N5^&3^"SK,9B:,Q"Z^QG<$+EC\OF8SSC
M.?PKNJ* ./U?P;J%WK%AKNE:X-.UFWMOLDTOV7S(KB+.=K1EN,'D'=2ZUX(F
MU73M/:+6[BWURPG-S!JGEJQ\QAA@4X!0CC;Z #GG/7T4 <9JO@O5-<\)WNDZ
MCXA$UY>F,2W?V,!45&#*J1A@!R.222<GVQNWMAJD\ME-;ZC;QO"CI<1O;%HK
M@-C^'>"N,<<GJ:UJ* ,7PQX=@\,Z7)90,I$MQ+<N$38BL[%BJ+D[5'0#)Z5M
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %<5\7/\ DEFN_P#7-/\
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M\-^,-436;>-]!U&X2)%LU(E2-$;8V2< @GD<Y/7M7:ZEX=EU#Q9I&N"^6/\
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M8^O^*]<TB?5_#EO.\J7DD=O:L+<6\T<<IC8.S-Y@8A6.1C' P>ITO#W@6[T
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M.N*J+X$U25=#2^\4RW"Z-<":W9;-%=P%*@.23DX/WL#Z9Y !W%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 8&<XYHHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "@@$8(R*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#JE@+BV@-W")KE2\"%AF11R2H[XJO:^(M&O;I;:VU*WEF=&=%5_]8J\,5_O
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M6ECU^+4H4N/N)LVV>%&8]R]?7GGFI8?$VB3M,(]4M6,,7GO^\ Q'_?\ =?\
M:'% &K16:GB#1Y-)_M5-3M6T[./M0E!CZX^]TZ\5HJP90RG((R#0 M%9MOX@
MT>[O4LX-2MI+B0,8T5Q^\V_>V_WL=\9Q7+ZEXD_M3QI<^&+/7!IIBL0ZSP[&
M<W+2%0F&!!V[>5XSNH [JBN=UKQ'%X.\+PWFMW23W2K'"61-@GF.!D#G:">3
MZ"LG4?$[6GCW2@=8B70;C3KBXD#;!&&1D ;?C/\ $>,T =Q15"TUO2[[2?[5
MM=0MI;#!/VE9!L '!R>V*73]9TW57G2QO(IY(&"S(K?-&3R-R]1GMGK0!>HK
MEO%/B6XT[5-'T#2EB;5]7D81O*"R01(-SR, 1G Z#(R>_%37]CXBLK1)M/UF
M2]E66,S175O%AH]PW[-BJ0VW.,[O3WH Z.BLZ_U[2M+<I?:A!;LJAV#OC8I.
M S?W1GN<"B]U_1].>%+W5+.W>="\2R3*I=0"Q8<]  3GI0!HT5@CQOX6-L;D
M>(--,(A\\M]H7A-P7<>>.2!]:T(-:TNYTD:K!J%M)IY7<+E91Y>,X^]TZ\4
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M,4BN$LHT;:<X8#!!]ZXT3Z?)I?Q9<RVS.SS#=N7)'V8 #_OK/XUZZJA5"J
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M6.9+2!!X>80*ZJH#>>?N]LXW?AGWKDS:S:1ISZI;1D>&4\8B\*QCY%M@ IE
M'_+,2#(QQP".*](F\.7=Q\0?[?E6SDL?[.^P&!R2Q_>>9O\ NX[8Q^.>U=/M
M7;MP-N,8QQB@#A)O*O/BS8:IIMQ$]K!I,JZC/&X*;2P,2LPXSG<P]A7,>';C
M1K3X 37\VFV^I+"ERLT*'#$-.PPS+\RC&TG'\*_2O7XX(88O*BBC2/\ NJH
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M6('W3&<;F3_9+!L8X[CK792P0SQ[)HDD3.=KJ"/UJ0  8' H **** "BBB@
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M(+B!MR^:9%*C<.,CDX[52\*7OA;6])\/Z/?+J#^(-*D@!TR2696MYXL*9,=
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MS &ZTQBCEB&'.Q<LIW=-P ZYKJ_B)J5OI?AN&XNK2&>(WUNIDG4M':G>")G
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3LP"J%W!2<9XSSQFFW'AC47\>Z=XABN+?[-96;V8@D+&1U8Y+%O7@<8/UYH
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M'/&@<Q^8&97QDJ1UR,]\5%I7BSQ%=0ZKJE\-)ATG1K^[@O=J2>;)%"OWH^<
MY'?KGMCE;'P3K\%SX5N)M4TT-H,<D CAM659(VC"9^]][ 'L/0]*TM%\(36V
MC^(M+U6:">VUFZN;AO(RI19OO+SUQV/Z4 <UXIN]9U30_!VJ7;6:6]YK5A-]
ME2-M\(9PR#?NPQ .#\HY/&,<]_XDFN[;PUJ=Q83I!=16TDD<CQ[PI52>F1GI
M_P#KZ5QI\#^)Y=!T?19]:TUX-(O;>>WN#;.9)$A.4#C<!D  <=?4=^\O[/\
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M"@#J**\KE\:>*XO!NI^)&DTO9I6HRP2VZV[YN$281G#;_DX.?XLGTKU&42/
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M0P$)5 @!.[YA@#TK2U[7]/\ #6EOJ6IR21VJ$*S)$SX).!G:#C)(&3@<UIT
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M\K/WOFXY[<TQO!FH&Q\)VPU*V'_"/O&V[[.W[_9&8Q_'\O!SWYKM** ./O\
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M29X!)."0<9]>:T[7PU?VGB?7M8COK8C5(88DA,#?NO+5@I)W?-G<<\"NGHH
MX*W^']_:>&O#6G0:M;B\T&Y$T4[VI*2KAE(9-X.<.>C=J[N-66-5=R[  %B,
M9/K3J* "BBJ6H:K:Z8(5G+M+.Q6&&)"[R$ L0H'H 3Z4 7:*YR/QQHEQIJ7M
MM)<W >.23R(K=S,JQMMD+)C(VMQSWZ9J[X?\2:;XGLI+S2I)9;='V>8\+QAO
ME#97<!D88<T :U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@;5HK?PT\?B&+[;H0:.)WL<Q21-&(\%-X.[ ^]NZD\8.*KW'PWO9M UW2/\
MA(08M5U'[>7DL@61MZ.1PPSDH/08SQZ %P:]J^C^.'TW5[NVN;&;2Y;]?)MS
M&8#&P!4?,=P(;J><CM4FE7_B;6--T'7K.6T:WOW26YLG7"Q6S@D%'ZF11MSG
M@\\"KESX7N+SQ=:ZY/?P-'#8R64EK]E.)%<@L=V_CE1V/'K6?X=\$ZKH BTT
M>)))_#]M)OM[-K8"55#;A&TN>5!]@3TZ<4 5+KQ)XEU6RU&^\.6SRR6EY);V
M]L8HS'<")]C[W+!@20V,8QQUI-7\975MKT^E75X-"NI((WTW[7$&@N79<LK2
M=,AOEP"/7YLXJW'X(U;3M<OY]$\326&EZC.US<V9M5D9)&^^T3D_)N]P<&K6
MM^$+G6['4]*FOK9])OE54AFMC)):X14)1B^,_+N!(X)SS0!UE8?B6^OK&*R-
MK/;VUO)<A+JYE(W1QX/^K4_><MM4#!Z]#4%M;ZS;>,!''J!FT-;((;5[<#R9
M%VA3YO5RPSQV YQQE?$WARZUJ]T>_L-26RN]+N&FC\V#SHW#(48,NY><$X.>
M.: .0N_'&NQ> O%6I6\L!O-%U!K:*6>U93+'\A!9,C:^)/3''2MX:UK6E^.[
M+3=4N[6>QU"RGN%6* H;9HBI(W9.X$-U('([=*I77PXO;G1O$FF'Q"/*URY%
MR[O9 F-ODW=&&?N#'3 )Z]:V[OPQ=WOBG2=:FU&W(L+>6W: 6AQ*) NXY\SC
M[HQP?QH X;QCJFI^)O@W>>(!=)#:7;QNEEY0($/GJ%RW7?P&)Z=L=Z];E$AB
M<0NJ2$':SKN /N,C/YBO.Y/AIJ0\)7GA.W\11IH<CAK99+/?- OF!]F_> R@
M@X^7//6O0E2<6H0RHT^W'F%/E+>NW/3VS^- 'EL/C'Q6?A]I?BU[JP;-V(9[
M,6Y F5K@Q??SE<<8P#TYSFNFLM6URS^(#:#J%U;7L%SIK7T)C@\DQ.L@0I]X
MY4[AR>>*IK\.[M?A_;^%!K<.V&Y$_P!I^Q')Q-YP&WS/[W&<]*U;WPI=7WBM
M-:DU-$4:;)I[0QVY#%7(+,'W\'(&.#CWZT 8=GXLUB+7?#5K=W4$[ZI+-!>P
MPQ9AMY%1G BE'#$%=K EOPJU9>)]1L+WQ3IVN7"/=Z<@N++R80GG6[CY"!SN
M??E#VSCUJ*R^'NJ6UOX;BD\1HPT&4_9S'8!=T10IALL?GP?O=/533I!H7C;Q
MOI5_IES]I.D>;]KEAR$.&79$_')\Q0X';9GN* .RTY+U-+MUU":.2^\L><Z)
MA2^.<#TS7FUQXJ\6CPOXGUE+[3E.A:E<0B,6AQ<)$5^4Y?Y<@GU.3U&*]4.<
M<=:X=O -X_AGQ)HS:S#C7+N:Y>461_=>;C<H'F<]!@Y_.@"[_;]SK'BIM"L)
M_L:P:?'>3S! [[I#A$4-Q@ $DX/4 8KC?$7B;6=3\%:K:S7*VNHZ7K,.GW3V
M\>%N4:5 K $DJ"K9(SVQG!Q78MX1N[?7++7;#488M2CLQ8W6^W)AN8P<J=H?
M*L#T.3Z5#?\ @&.]\,:EIHOS'?ZA>K?S7ODY'G*ZL,)G[H"*H&>G<GF@#K;=
M)8[=$GF\Z4#YI-NW=^':O']%O/%&D?#_ %+7-'N[ 6NG7]]/)930%FN$69R^
M9-PVG&<  ].O.!Z_:1SQ6L:7,XGG ^>14V!C[+DX'H,GZGK7(6_@:Z@T:_T
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M*8!+'-$QR4="1QGD<\?E@ SK+Q+XC T?1M6M([+6-0O)X5G*J5:")-_FA Q
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MW*@>;&,E"&# X[C(&1W%;%% ')6_A'4H_$\'B";Q"9KU+ V4B_8U6-QO#@@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQZ9H\F+8B>4FQ,%5VC"XZ8]*R8_%N@2_:?*U:UD-M,L$JH^YA(WW4 ')8X/
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MP#.(8QE]YPHY;U^OO4E%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT8A2H_X$!7;>!Q9MX*T.6T$)!T^!"\0'9!D$CT)/'KFN@5550JJ HZ #@4M
M' V]\NC?%O7#K,R6]OJ%C;'3IYF"H5CW>9&&/&[<V['7'-<9>6\.G^#X_M;Q
M1Z;=^,UN;&.4@+]D,PY /\!PS>F&SWKV]XTD&'16&<X89IV* (XEB5-T*H%<
M[\H!AB>_'7/K7EFCWMK;>#O&.@Z^Z)JGVF\,L$I^>Y$N3&Z+U;<" N.X KU>
MFF-&=7**67HQ'(H \JU0OH^@_#*PUBZC2_@U"U\]99!N7$+J<_0D#/K6SJ^H
MV2_&+PXK7< 8:;=#!D'5C&5_, X]<5WV*,#TH \BU'SM2U3XKV6D3+)?S6MJ
ML21."[X@(8#'4]5^IKH=%\1^&O%L>E/I,4<NL6MNZQ+Y1#Z<3'M;=Q\O("X[
M]N,FN\Q351$+%54%CDD#J: /'O"MWX:U;0-&T#5VU!O$.FS1*VEO+*'2YC./
M, '&WJQ;H 3FNC\'2:?=?$'QR%:VFE^V6SK@JQPL*C(^C9^AKOMB!RX5=Y&"
MV.<4[% '$?$PW,&E:-?HCR6-AK%M=7ZHI8B!2<L0.H4[6_#/:HIS!JOQ4T75
M=(N89K:UTVX74+B%PR%&*^4A8<9W;F ] 37>4U(TC7:B*J^BC H X7X97MK<
MCQ2L%S%(Q\07D@"."2I9<-]#ZTOC.[@T[X@>"+V\D$-JCWL;2M]T,T("K]21
M@#O7=XH(!ZB@#RRVO-.?Q!\49'N+8[H85+,Z\K]FVD?3=Q]>*R-/UBVTFS\!
MZKJMU<1:(VA?86NX';;;W'[LX<KTR$V_4>U>U8'I36174JRAE/4$9!H YWP9
M;:)%87MSH"S&SO+M[AIY'=A<2,!ND7=V)XR."0<>M<SO3P7\6M8U356\C2/$
M%O!Y=Z_$44T0V^6[=%R,D$\=J]*  & , 4C*KJ58 J>"".M &8FM6>H,;?2K
MJ&[E*MF2!Q(D/!P6(X'.,#J?3 )'EMO-!=_ V[\-70'_  D,(DM7L&/[\W7F
MEE(7J<DA]PXQDYX->R)&D2!(T5%'0*,"CRT\SS-B[\8W8YQ]: /.;'[*?C$M
MI?S6UQ=KX9B@DW%6+2"9MXP>Y'./0U!H]QH,.O\ Q%AU9[15DNE$J2[0SQ&!
M> #R><\#N?>O3\5S/A[P[=Z7K>N7]X]K*FI70N46,',)"!,9(YX7.>/I0!P/
MA>'4/"FH^!I/$1:&S.C2V:R3'"VUP[APKD\*2@51GN,5%XGB1-$^*&I0RQC2
M;];=+5@PV33K&!*R=CS@$CJ5/I7M#(KJ5=0RGJ",@T      #H* . \3:KI&
MF67A6<16,<%Q=((M3D ,-H5B8!\@@$D95<G SD],5QMW/'<>"OBC:0SS74YN
MS/EX\.R&.+YR H !P2.!D D5[B5!&" 1Z&C YX'/7WH \X\4ZUI=[JO@*ZM[
MZ"2%M3W)(' #+Y+C(/<9(&>F>*7P]J%GI>K>-M,\2S10S3ZA)=K]H8 7%HZ*
MJ;<_> "[2!G!XKT; QC XI&C1V5F125.5)'3Z4 >,Z/;/I/_  JBPUMT2[A-
MV[1W! :-6B<Q@@]",HOU&.M=%X=UO2],\4_$*]N+V%+2WN89Y&4[L*(%#-A<
MD\@@X'6O1L4A564@@$$8((ZT ,M[B*[MHKB!]\,J"1&'=2,@_E4E%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5GRZYI<&K0Z7-?017\^?*MW;:TF!D[0>O'I6A7#_$'PY'XHNM%T
M]KB2UG$DTMM<Q'#0RJF58?0@<4 =9J&JV.E1QR7URD"2.$5GZ%B< 9]22 !W
MHO=5L-.@CFO+J.!)2%CWG#.3R J]2?8#->?VGBFYU;1O[#UV-;?Q)IFIZ>EW
M$.!,OVN';,GJK<?0GW%3Z#.^K?&OQ2]Y\W]CVMO;V2-TC65=[L!ZD@<^F!0!
MV]AK.G:I)+%9W22318\R$@K(F>A9#AAGW%0VWB/1[RYNK:VOX9I[09N(D)+1
M?[PZCH>M<=\299-)\0^"]9L_EO&U>/3WV]98)<[T/J. 1Z'FGWI7PQ\8K6^8
MB.Q\1V9MYF/ %S -R,3[IE10!V.F:]I6M6TESIE]#>01DAY(#N4'TR._M4VG
MZG9:M;F>PN4N(0Q0O&<C<#@C/J#Q7EG@W79?#E]XILY;=42]3^WM*M^F])CM
M">QW>6,>K&O4-&TX:3HUI8A][0QA7D_OO_$Q]R<G\: *%UXS\-V,D\=UK5E"
MUN_ES!Y0/+;I@^AJ2+Q;H$PG\K5;9_L\?FS!6R8T_O$=A[URWQ@MX;;X3ZPD
M,816GAD('=FN49C^))-=;KUM"VD7]R8P9DL9HU?N%*Y(_-1^5 $EMKVEWFEM
MJ=M>QS6(&3<1Y9,=SD=1[U7'BS0&TDZJNJVQTX'!NPW[KKC[W3KQ]:Y#X?ZI
M>1?"S1XDT#49D%C@2QR6X5NO(W2@X^HKGK/_ )-6;_KPD_\ 1QH ]07Q9H+M
M$HU6VS,ZI'EL!F8X4 ^I)&*6Z\5Z#97[V%UJMM#=HNYH7;#A?[V/3WZ5E6&H
MWMQ::#83Z!.MI<!%EGEDC94"Q%U("N3G<BXXKGM;U4:)\:IM0:RNKN.#PJ7D
M2U56<*+@DG!(ST[<T >B6>IV.H6(OK&[ANK4@D2P.)%..N"N<UFQ>,?#LWF>
M5J]M)Y;E'V-G:PZ@^A'I7/?##39$M-7\0^9 MMK]V;ZWMH'W+"A'<]-Y_B Z
M$5E^ =2O[&V\8_8]%N;\KXBOG4Q2Q("V5^7YF!_3O0!W4_BC0[738-1GU2VC
MLK@XBN&?Y'.<8#=,TZW\3:+=7T-E#J5NUU/GRHMV&? ). >N ":XGXG8'PKA
ME6 (TEW:S-&@Q\[RJS8STRQ/YUTSZI>W%U<-=Z!+;+8VQN[9YW1R\N&4A=C'
M&%..>NZ@#3O-?TNPN6MI[M?M"J':*-3(Z*>A95!('N>*FBU6PGTT:C!=Q369
M&[SHFWKCOR*X[X.@W'P[M-5F?S;[4YIKF[G;[TDGF,O/T"@?A5;0Y9-/^,_B
M?2+?BPNK"/4'C'W4GR$8@=BP.3ZXH ZFV\:>&;OR?(UW3W$S;(CYZ@2-Z*3U
M/L*OZIK.FZ);BXU.\BM("<>;*=JY],]*\,TF\.K?!C0/!26+)=ZTTT=M>715
M;=2MPSDA@2=X'1< D_KW?Q9MFLO@Y=6S2M.\ M(S(W5R)HQD^YH ["/Q/HDM
MQ#;IJ4'FS.$C0M@NQ[#/4UK5@-J-[>:K8V5UH$\%K(QD:>>2-@KIAD ",3G(
MSD\<>];] !6?8:WINJ7E[:V-VD\UDZI<*@/[MB,@9Z'CTKE_%5UK"?$'PC96
M5_!#;7)NG,<EN7!=(3RV'7(PYP.,'GGC&,ESK5GXL^(EUHIL5DMVMIF-VC.&
MVVP.T!2,9Q][/'H>P!ZC17%Q>-I-1@T*.TC\BZU/31J,C?9I+D0I\@V[$P22
MS]20!M/J*U?">JZMJNG7!UG3VM+JWN7A#>4T:7"#[LJJWS*"#T/((- &IJ&I
MV.E0+-?W45NC,$4R-@NQZ*HZD^PYJ"V\0:5=W26L5[']JDSMMWRDI !.=C -
MC /.,5QFC3-K'QN\1F\^8:)9P062-T3S5WNX'J>F?3BNXO;"SGN[34+A0)K!
MGDCE[J&0JPSZ8.<>H'I0!=HKS^;QKJ__  A'_":VT%I)I@)F-B8V\XVP?;N$
MF[ ?'S8VX[9[U+=^)O$E]XLFT708])V/I4>HVT]V)",-(5PP4YY [=,]\8(!
MW=%>>+XD\:ZC+XBM]+M=%$^CW/E@2^:PG'EJ^T8(P3GJ>.G'<6M'\>/XG_L*
MVTJ.*WNM2L'OYFG4R+ B,$( !7<2Y(!R.%)]J .YHKSG4O'NKZ;HGBR-K:R;
M6?#I1G)#B&>*0;D<+G(.,Y7<<$=:UYM3\66D"W%U'HZ6T]Q'B<,P%G 4)=I=
MS*'.X!1M(^]G':@#KZI7NK6.G7-E;W<XBEO9?)MU*D[WP6QP.. >M>;:]XOU
MC4/AMXQF@N((+K2[A[7[3% RB:(JIRJLV48A^N3TR.HQU&JZWK&C:EX8LI/L
M-PFI79MYY5B="OR,PVKN..%QDD_2@#KJ*Y&/7]7UQM=;0/L2II5R]FB7,3.;
MB9%#.,AAL&6V@X/()]JRH?B!J.L'P=-H]I:+;Z^LZNMRS;H7CC8D9'4!E/;G
M';.0 >AT5S'A+7=2U*]US3-76U-YI5TL)EM49$E1D5U.UB2#@X/)J;7=4U.S
MU.&W@:SL[)[=W-[<KYF^;("Q+&'5B2,MD9Z8H Z&BO.8_'VLW?ACPAJUK8V(
MDUJ\6TGCD9P%8[\E3V'[L]<XST-6X_&U[HTWBN'Q&MK)_8<$5TDMDC()4D5B
M$VLS8;<N,YP<CI0!UE]K>FZ;>V5G>7:17-[)Y=O$029&]!CZ=35^O-/$K:U+
MK'@2XU)[+9-JJ.T4$3*T3F)R%W%CN&"1G Y&>^!U'CV[O[#P)K=YIMRMM=6]
MI)*LA3<1A23CD8/H><>AH T[S6]-T_4;+3[J[2.[O6*6\1!+2$ D].G /)K0
MKR_61J*?\*Z+26T]V;O]V0C1)@VS8W<L3CN>_H*TX?&]_I<'BF+6XK6>ZT22
M!4>T1HTG$R@QC:2Q!W-@\GZ4 =[5+5-7T_1;0W6IW<5I;@X,LIPH[<GH.M<_
MI^N:ZWBFWL+BS-UIMQ S&\CL)K;[/(O.UO,)W!AT(QS53XP_\DGU_P#ZY)_Z
M,2@#L[:YAO+=+BW</%(,HX'##U%2UQNJZ]K-AXD\.:+I\-BT6IV\Q\R??E&C
M13GCM\W3OC&1G(I6_CR^LM"UI]5@M9M4T[4QID0MPT<=Q(^SRS@EBOW^>3C!
MH Z^76]-AUJ#1Y+M!J%PC21P<EBJC)/H/QK0KSR_34X_BWX3&HSVDRFRO2C0
M0M'@[8]P(+-D=,?4TX^-M:O-.M=9T?3VO;2:XQ]B2PF\QH-Q7>LV=F[ W8QC
MMGC- 'H-%<*WB+Q1>:UXJTRQ7286T<0M#),DCAP\9?:P##GH,Y&,=#GBI!XW
MUZ32O"VO26^GIINL7-O:RVRAS*C2\;P^<8##[NT\=Z /1:I:AJUCI;V:WMP(
MFO+A;: %2=\C D+P..AZ\5R,OB/Q1=:[XITRP328O[(2&2&69)'WAXV?:0&'
M)P!G(QCH<\#^-M0ET+P7JL%K:K'KEW;V]PC[B8S(K,=G(Z;2,GUZ4 =W17 6
M&JZG;_$+QA)?:A"VFZ;:VTAB%N<K%LE?"G?P>N20<^U2VOBO7[B?0[N'3C=6
M.HN@N(8[&9'M$<95_-;Y7"Y . ,]10!W5%>?7'C;6;K3/[8T/3S?0"Z,:V*V
M,QDFB60HS+-G8&X+ 8(QQG-=EK6KV^A:%>ZM=[O(M(&F< <D 9P/<]* #4-;
MTW2[FSMKV[2&>]E$-O&<DR.>@&*OUYCXGFUFZD\"7FH-9"*XUJWD,$,;!H6,
M;D+O+$, "03@<C/M6\GB+6-:@UVZT$60CTNYDM(XKB-F-S)& 7^8,-@).T<'
MIGVH [#I5#2];TW6UNFTV[2Y6UG-O,R X60 $KD]>&'2H/#.O0>)_#5AK5LC
M1Q7<0?8QR4/0KGO@@C/M7G-GJFN:)IWC_5=)6P,=CK5S<2I=*[&4+'&65=I&
MTX'4Y^G>@#URBN1NO%DMSJ,6G:=^YE:PCOI)6LY;H*)"0B[8R/[K$DGL, YX
MR9/&?BA+#PX9M&MK2]U'4&L;B*Y#J 0&(D0=0I"YYR><>] 'HE9]]K>FZ=?6
M5E=W:17-Z_EV\1!+2-C/;Z'DUS?_  D.MP7D.A7CV:ZNMJ;JYGM+*>XB"F1E
MC"H"&&0I))/&,#.<CG=9U76]5@\%W-]I:V>K)KC1>5,&CC<B*3#C(+!2,''7
MJ* /5J*X.T\1>*QK.K^&KR'2FUJ"R%_I\\22"">,MMVLI;*G=QG/?...;.D^
M++[6_#7A^ZM#:C4=1F\NXC>%ML)0,9AMWY!7:1DGDD>M '9T5GZ[=7]EHEW<
MZ79K>7T:9A@>0(K-GN21@#K^%<[I/BZXF\5ZAH\\UK?P0:<M_%=6<3)N^9E9
M "S!N1P0?;J* .RHKSG_ (3C7)="\,ZS;1:<\6O7:6JV[(^8-^XJ2P;YL;2&
MX'X8J]'KWBO4/%VMZ+81:.D>F/:-YD_F'?'("S#@_>P.#T&.^<@ [BBO/[CQ
MKK5UIC:OH=@;V!+IHUL5L9C)/$LAC9EF!V!N"P&",<=:LZEXLU2X;65T&%7E
MTR3R5BDL)IOM,H17*;D("?>"\YYY/'4 [>BJFEW<U_I5I=W%I):330J\EO+]
MZ)B,E3]#Q7%R^,]8L=0T9+^.Q1[_ %/[#/IZ O+:JQ?RV:17*Y(4-@@9#<=#
M0!W]%<3%XPN;WQ/>:-!=6%M>VMZD7]GW43++-;Y7=*C%@#\I9A@'I@^M=C<K
M.UNXM9(XYB/D>6,NH^J@J3^8H S3XHT8:K!IIO0+F=WCAS&P21T^\BOC:6&#
MD Y&#6LS*BEF("@9)/0"O)O!NM7&C?"W0+FY^R7<][>BUT]&A*E)Y9I 6=RQ
MSP6/ !P".^:[ >(-1TOQK8>']6^S3Q:I!+)9W-O$T9$D8!=&4LW\)!!!]L=Z
M +__  F'A_\ L2XUG^TXO[.MY&BDGPV RG! XR?PK9CD2:))8SE'4,I]0:\@
M/_)&O'G_ %_ZE_Z--=LFNW#:QIGAK3C#'=-I@OIYID+K'&"J* H(R2Q/?@+W
MS0!U=%>=W?C;7HM#\3+#:V3:WX<E4W,9C<Q7$!7>'0;@5)3)P2>5QGG(T#XP
MN%\;Z)I:W%E)I>K61N(95A;S-^-RJ3OP RAB./X2/>@#M**X;4?&=UI6EV%_
MJ$UI;V-_?/$E]]F<QP08;RW<;^KX7!R -W-;$5UXAO/#\-Q83://>/<\39;R
M)+??]Y=I8[BF#U(S0!T-%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVAXV>:7)V['5Q@#KDKZUK:A;WM[H5Q:H+=+J>%HB2Y**6!&>F3USCCZUHT4
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MM+,V%S#(6\JYASG&X#*D,-P.#Z5U]% &%HOAU;&YU>_O3'->ZO*KW.T?(%5
MB1C/4!1U/4DG Z5S0^&*IX.BT9=2E%W;WR7%M>_QPHCX1%^D1*^F23WKT*B@
M#'U+3KPQV<.FI9M9Q*T4]G<@^7+&5 "@@'&,>AXR,<UD:1X6U+PYX>>QT.ZL
M[:674&NC&\;/##$S@M%&.#@#H>.<\#/'7T4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2%2I!VGL>>M &E;7]G>/(EK=P3M&<.(I Q7ZX/%"7]G)<M;)=P-<*<-$L@+
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MD\T 0:9H.D:*93I>EV=B9CF3[- L>\^^!S26GA_1K#49M0L]*LK>]FSYMQ%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM+&QMK:V.<PP1*B<]?E Q33I&FG3O[..G6AL<8^S>2OE=<_=QCK[4 >9Z_8
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MZQFN7T+PB\7B+7]0UK3=-G2_NUN+9CB5XP$5<'<@Q]W/!H X_P &3:E9ZMX
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MZN3:IITNL?"\I>VS[$<L1(#M!M2!GTR>/?%>DVNEZ?9%S:6%K;[U"OY4*IN
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M6OB_1KOQ->Z#%?0&\LTC+@R@99M^4 [E0F3CID5B_"1E/PXL%0@HD]RB@'@
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M46DGQIOMBQ,DWAV%W  P^9WY([\8_2N(M+>QA^!FC7D<4"3+K$3B90 P(O2
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MHXE56^H P:DMK2VLT*6MO% I.2(D"@G\*FHH @NK*TOHA'>6L-Q&K!@LT8<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M HHHH **** "BBB@ HHHH **** "BBB@ JO]AM#_ ,NL'_?L58HH K_8;/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7!_#R1
MCJ7C>:Y.)AK\P8GKY:H@3\-M=Y6+#H[:?XEN]3LU5H=15!>19P1(@PLB_P#
M<*P_V01T((!YG$;58_ ^K:6-MO<ZX5CO9W#7ETC^;O,C #"DC&TYXVYP1BNK
M\5,Z_%#P$T!^=S?(^.\?D@G/MD*?KBMI/ GA5(_+70;$()Q<!?*&!(,X(].I
MXZ<]*GAT=KCQ,=<O% >" VUG%G/EHQ!=S_M-A1QT"^YH VJ*** "BBB@ K@=
M<_Y+5X4_[!]Y_):[ZLRX\/:5=:M%JLUH'OX1MBN"[;XP>H4YX'L* .8\>V\=
MWXG\%03;C&^I2A@K%<CR'XR.:Y6^F;PM;?$JWT5#:6EI+92)% "%@65$\YE
MQCY=QXQT[5ZK?:)IVIW5M=7ELLL]JVZ!RQ!B;U7!X/O3(= TJWN[VZCLH_.O
MEVW3,2WGC& 'R?FP..>@XH YG2=!L(/$^F:[8ZM8HMQ;/$MOIUKY<=XF-P9L
M.V=O9O?'>H_B=96ET/"C7-M#*?\ A(+2/,D8;Y&+;EY[' R.^*Z+1/"/A_PW
M+/+HVDVUG)/Q(\2\D=<9[#V'%7=4TC3];LOL>IVD5U;[@^R09 8'((]"* .!
MEAMM=\<Z_P"'+I]-2&"SMTL;:YM?,'D%#O:(;U PV02!GY5]!6?/X?LF\1>
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M>NT#H3W/>@>&-&47P%DH&H?\??SM^_[?/SSQQSVXH XH37-TOPZN[PF^M)+
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MYK7==6B[+>9G8M&IZ@$G@'OZ]Z /,M$L8O%O@^WUB\UFTL=4M;QIKFZCM?\
M2X)UD.8RV_.#PH7&"I  Z5I6(M/$J>/VUF&*>]L[N>UC24 M!;I&/**9^[D[
MFR,9//85V7_"&>&_[?\ [=_L:S_M3=O^T>7\V[^]CIN]\9IU_P"$= U/4FU&
M\TJWENWC\MY2""Z^C8^][9SB@#.^'EQ!'\//"\3S1K)+I\0C1F +X09P.^*B
M^*<2R?#+7RV<I:LZD,1@CZ5:N/!&C/-HPM=.M+6/2I?-@:)=K1X(.U<<?,5&
M2<\ COD.\?Z=?:QX&U;3-.M6N+N[@,4:!U4 GN2Q Q0!R6HZ!:Z'XH\%:MHB
MO'J%[="WO2)&8W4)B+.SY/.W;G/;(]!5#2;*+Q=X1;5+W6+2PU2TO9);FZ2U
MS=VLR2GY-^_.,84+C!4@ 5Z-H>AV5C;VMP+!H+I(!$%ED\PPCC*)\S!5X'"\
M<#TIC>#/#;Z^-=;1K,ZF&W_:/+^;=_>QTW>^,T <2GA[2]4\8_$2"^M5N(4B
MM76.1BRJQ@8E@,XW9Y!ZC)QC-5-"U234/^%;Z7JTGFV-WIDDS"8Y6YG1%"*V
M?O8!+8/?!Z@5Z4/#FDK<WMRMH%GOE"W4@=@9@!@!CGG X'H.*@G\(>'[G2(-
M)FTN![&W</!"<XA8=T.<K^&* .$M=-LK:_\ BI9V\*16ZQ0N(X_E"DVI;C'3
MG)JNUE!=Z+\)?-#_ +R.&-MKLN5^R$D<&O0X/"'A^V%X(-)MHS>H([EE7#2J
M!C:QZD8'([\YSDT__A%M$\NQC^P($L/^/0!V_<?[G/R^G% '"6ED=,N_B;I6
MB3Q:5##!#+;8;RXK>1[<EG']WD DCIUJ?2_#IU76/"&H6^DM8V]C9,=0W@)Y
MC%%\M>#\Y#Y;=TZ\Y.*Z3Q!X85](UF31+.U_M748A',UPS;;A> 5<\_P;@"0
M<9':N=TCP/:'4+6YM_!B>'KBWF24W27X8@*P)550G<& *G=@8)X/2@#9^)^I
M76E^!KFXMGDB0S0QW$L9(:.%I%#D$=."1GMFL_6M/ATCQWX2DT*".V6^::VO
M(;90B30"/<&8#CY3C!Z\X[UWMQ;PW5O);W$22PRJ4DCD4,K*>""#U%4-/\/:
M5I1!L[01D1^4C%V8QI_<0DDJO X&!P* .(^&_AS2I1?:I+;;[VQUN_2UE:1L
MQ+O*X SC&/7_  K4\87\<7C/PEINH,HTF]DN?-63_5R3*B^4K]B,EB >I ]*
MZ?2]%T[14F33K5;=9I#+(J$X9SU8@GJ>Y[T:QHFF>(+!K'5K*&\MB0WERKD
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MTC3Q*<-*@.[9RP^]Z?6N \0V5K8^(?!-]X=AAB>XN_LSBV4!9K-HF9MV/O*
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M]*V=4LY;W5_'FFR6\>ISWL$4=HXEC'V=C%\L;;B"FUB),C/WL]>* /4:*Q=
MM;7P[HFDZ--<6J7?D*FU6"F>15'F,HZG)R3]:J^/KG3[7P-JKZH]TEFT8CD^
MRN$D.Y@H4,>!DD D\8)H Z"*>*<$PRI( <$HP.#^%<WXQ\1W>A1::U@;1VGU
M&WM;A)<EE21PN0 1@_6N/GN+O1?'NO26<=E#>+X5,\=K9CY/-21O+!Z;VZ '
M X(&*IWT&DW/PU\#ZI"L,MRVIZ?))='!D:9G'F[FZDEMV<]Q[4 >PO-%&&,D
MJ(% +;F P#T)H,L8=4,BAW&57/)^E>=:=H&D:G\3?&]O?:?;W$#6]BYBD0,A
M9DERVT\;O?J,GU-<I8V%JOPG\%ZX(5.JIJ%FJWC<RA?/V; QYV[>-O3VH ]E
M4ZC_ &ZX:2S_ +,-N"D8#>?YNXY)YQLQCWS5KSXMRKYJ;F)"C<,DCKCZ5P\%
MG;'XU:I&8(RD^@1-*I7AR9G!SZ\ "N$L=*L+?X.:!K$5M&NHP:M'Y5UC,B#[
M:R[5;J%P3P..2>M 'M.=1_MX@R6?]F&V^6/#>?YV[DYSC9MQ[YJTL\+.RK+&
M64X8!AD'WKAO)@@^-5[(N(?,\.!Y'0<Y\\C=]< ?D*RO#4<^DZ[H>B:[IEE>
MQSVTL6F:U9@8NH_+W,LR'G)4;B<D$_C0!Z%I6MV&LZ>U]97"26JR21^;D;3L
M<H2#Z94X/I5PSPJKLTJ!8SAR6&%/OZ5X9+I^G#]GK591:VRW(N)SO5%#_+>$
M#GKP#CZ&NXUO1O#VCZYH=G9Z>!?ZA?/<11>9MAFD2(AI)L@[B <C')8@^IH
MZ_5M;L-%T:?5KVX1;2)-V\$'=Z!?4D\#ZTMXVH&^T\V<MFMF9&%T)@Q=EVG:
M(\'&<]<]J\8OXX'^%7CN&0VLHM?$$GDB- $C'F09**2=H^9NA_B/K7;>)+*P
MMO'O@(V=O;Q!+NZC A0* /(<D8'OD_4T =\'0YPRG'7FD>:*.,R/(BQCJS,
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M&B;;($<$H?0XZ&DCN[:601QW$3N5+!5<$D X)QZ \?6@#,_X1/P\+">Q&BV
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M'V6^]-X!VL",$>AH ZMKRWMUC2YNX%D,9?YG"[@!EF )Z=_:F?VMIIM([O\
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MO"(HPQ55^51TX4?4Y/>K$VD:;<7OVR?3[26Z\LQ>>\*L^P]5W$9QR>/>KE%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBHY9X8 IFE2,,=JEV
M R?04 2457L[ZTU&W^T65U#<P[BOF0N'7(.",CC@\5*DT4CR(DB,\9PZALE3
MC.#Z<'- #Z*** "BBB@ HIKND4;22,J(H+,S'  '4DU2_MS2/^@K8_\ @0G^
M- %^BJ7]L:89+>,:C:%[EBL"B9<RD=0HSSC!Z>E7: "BBB@ HHHH **** "B
MBHQ<0E%<31E6;8K;A@MG&![YXH DHJM>:A9:=$);Z[M[6,G >>0("?J33[>[
MMKM%>VN(IE9=P:-PP(]>.W!H FHHHH **** "BBB@ HHHH ***J3ZKIUK=I:
M7%_:Q7,GW(9)E5V^BDY- %NBFHZ2(KQLK(PRK*<@CVIU !1110 445"UW;)=
MI:M<1+<R*72$N [*.I ZD4 345#;7=M>P^=:W$4\62N^)PRY'!&14U !15:'
M4+.XO)[2&[@DN8 #-"D@+Q@YQN Y&<'KZ59H **KWM_9Z;:O=7UU!:VZ?>EG
MD"*/J3Q22:A917D%G)=P)=7 )AA:0!Y  22J]3@ F@"S1110 4444 %%%% !
M115>]O[/3+5KJ_NX+6W3[TL\@11^)XH L44=1FB@ HHHH **** "BBB@ HHH
MH ***HV>LZ7J%S+;66HVES/" 9(X9E=D!Z$@'@4 7J*** "BBB@ HHHH ***
M* "BBB@ HHJM_:%G_:']G_:X/MOEF7[/Y@\S8"!NV]<<CGWH LT444 %%5[R
M^M-/@$][<PVT1=4#S.$7<QP!D]R3BK% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<?X9OCXA
M\4^);Z8!X-.NO[*MD;D)L4-*?JS, ?90*["N-\)6+:%XJ\4Z;*,+?7G]JVS'
M_EHLB@28_P!UUP?3<OJ* .0\,>)-7\+^!)]0MM 2[T>SO[MKJ1;D)*J>>^6C
M3:00HZY(Z'C'-=9XMU9-*E\.>);-LPW%Y#:7!' EMI@<$_[K;6'ISZFJ-GX4
MUV'PEJGA-XK58+V>X_XF"S9 AF=F;Y,9W@,0!TSSGM5SQCHZZA#X9\,V:G8E
M]#/(.OEVT R2?J=BCW:@#MZ*** "BBB@"O?6<&HV%Q97*[X+B-HI%_O*PP1^
M1KS_ %C3+"/XQ^%8([&V6$Z?=YC6)0IP%QQBO2*X[5=$U>Z^).BZ[!;P&PL+
M::"3=-B1C)CD+C&!@=30!D^+=-MM&\2^#CI=A'O;59W6&/:@W-"Y(SV!/)_'
M@]*U+;QT]O;>(O[<L8[6ZT.2-)4MY_-242J#'M9E7DE@.0,&K7B?1]2U+Q#X
M;O;*&%X--NWN)]\NUB#&R848.3\V><5B7_@G4]8N_&B3M%:0ZU]E>SF23<T4
MD"C:6&/[R@\$\4 :^G>,)[CQ3!HUQ:0/'<P-+%=64K2HC+UCDRHP<<@]_04S
MQ]J^KZ2F@KI8@"WFKVUM*9)&5B"V=HP#@';@GG@]#FK7AU_&%P\0\10:;:I
MN&:SE:0W38QG! V+WQR<XZ#J>-M$U#6;'2WTQ8'N=/U.WOA%-(4601DY7< <
M'GKB@"#4_&$MK=7=A;1V!O[*!)+A)[ED4NREA&A"DG@?>('5>#DXH?\ "P+^
MZD\.1V'A]FDUR"=XTN9S$T4D2Y97&W@9_B].W2BZTCQ;I'BRYUS1(=.O8M5A
MB6_L[B=HA%-&NT.C[3E<<'C)QT]+-[HFNW'BOPMJD@MIUTU;G[6XDV9,R@8C
M7!X7'<YQCO0 V#Q9XAFU]M!/A^TBU(::E\=]_F-2SE"I(0G@J>@.>.G6L_\
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M#O?[1MV!MZ_)R>>1VXZY."30M:\06N@6FNV]O -+NXKNXFBFWBXDB!V[!@$
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M<_MF^=I2BEB7+*G!)^^ ,X^[VS6UK>E:Y/XRTW4[6&SO-.BMFB:UNIB@@F+
MB8 *P8X&WU'.",F@#"U#QQJFJ^%?"FKZ3;P6ZZIJT-K/').<@B5@5#!?NDQD
M%L=#TYXW=3\82VMU=V%M%8M?64"27"3W+(ID9=PC0A23P/O$#JO!R<<[:^"O
M$=KX(T;32FGO>Z1K*W\:"=@DZ"5W.6V_(2'Z8/3KS@:=SI'BW1_%EUK>B0Z=
M>Q:K#$+ZSN)VB$4T:[0Z/M.5QP>,G'3T .I\/:POB#0++55MIK7[3'N,$ZX>
M,YP5/T(/UKS>36%\$:QK=AXTT<SZ)J]])/'K"Q>=&4?[L4PQD;1A1].!CFO4
MK".ZCLHEO94ENL$R,BX7<3G"CT&<#/. ,USRQ^(TL=0L;[2;+5(9Y[CR";K"
MF%W8HLH9>,*0/EW<#I0!C:M?WF@Z;X(TWPY-:7&FW%Q!:+,9B/.18R5 (!PI
M"#)Y],=:TO$/C#4="MM6NGTJ)+;2X8Y&DN)S&+MBNYDA.W!VCC/<\8%98\":
MGI/A/PCI^FR6]W=:%?+=2+-(T:2 B3<%;#$8,G&1T%-UKPKXHU*X\41-'IUR
MFJV7DVEU+.P:U'E;6B5-IP"V3D$=<G.,4 7KWQ#K$WCWP]9V,=M_9UY82W>R
M25D9R-G+84] W [GJ1Q5I/&=TVG>*ISID(FT"1U*?:3MG"Q"3.[9\IP<8P:J
M#P]X@CUCPKJB0V#2V%C+97<1G8*@8)AE.WYL;.1@?7O5:\\->(HKCQE:6-O9
M2V>O(TD5Q).5:)S#Y90IMYR0,'( SGGI0!JCQJ)IM#M8X[2WN]5T\7T:W<Y1
M"2%_=*P7YF^;TZ#.#5M="BUK4="\17]A%:ZG:0[V&-TB,R$&/?Q\H+MVY..G
M.<63PO>WGAW3-$UW0]/U.R@T^.!UCGP\4Z#;O1F52 1C)R",<9YKIO"VF7FC
M>%].TW4+LW=W;PA))BQ;<?J>3@<9/7% #?#GARR\-6MU!8PQ01W-R;@Q0KMC
M0E57"CZ*,^I)/&<#-D\6S3ZWJFF:=;VLUUILD:26LMP4FD5E5C(B[3E0&_$J
M>G&>KKS_ ,5^$+WQ+-<;]/MH;^*=&TO689MDML@VD[\ $X._ Y!R.G6@"M'+
MJ-G\4/%S:-IUO<W+6-DY$TWDIP).I"L23VX^I'?<L/&-QK&A:!J.G:6^-51G
MDDE8^39A5)8R,!ZC:.F?:DLM'U:T\<Z_K)MH7M;ZU@A@ G^?=&&Y88P =WJ>
ME<]IGA#Q/IF@^$K(P6%W'I+3+>6,ER5BF+?ZN0'8<["2<%>O3G!H C\6>(8_
M%?P9\373VT226DDEJXCD\U"\<BC>C8&01@@X[UL^(40?$OP$X5=Y%\"V.2/(
M%94_@OQ)+X)\6Z(T>GF?5M0FN;=UF8+B1PQ+97Y<8QCG.>U=#JFCZM?>+?"F
MJQVT @TQ9_M*M/\ -F2,( O'.,9YQ0!J^*]:F\.>&-0UB&T6[-G$TIB:7R\@
M#GG!_E6'+XRUBWUG1[.;083'K,3FS9+SYA(J!R) 5PJXSRI8\=">*V/&FF7F
MM^#M5TJP6-KF\MV@3S'VJNX8R3@UCW>A:S<:SX.O5M8 FCB3[4#/R2\7E_)Q
MSCKSB@!UKX[:"QU]M;L8[6[T6>.&6.WF\Q)3(%,>UF"]2P'(XI]KXTG;Q =+
MN+!)U>T>YAGTZ1IEW+R8FRHPQ'0]_:LJ^\$:KJ\OC-)GALUUB2VGLITDWM%)
M"J[2PQ_>0'C/%:MG'XYU+2[JWU3^S=+N5MI(XI[.5I3+,5(5\%1L4$YQR2<=
M,8( VR\9WC:]HNEZAIT-O/J]K)<)"LY,MLRJ'V2J5&"0>OJ",=ZS)OB+J\>@
MZOK(\/0?9='OY;6\!O?F*QL%8Q_)\QY)YV^V>T6G>%O$T.H>$;R2PTN Z0L\
M=TJ73.TS21A6F)V#+$C.#R<\MZ$O@_7Y? WBS1OL]J+K6-0N+F _:/D5)7#?
M,=N<C'8&@#T8NSVYD@"LQ3*!C@$XXR<''Y5X[J^J:KKWP-\17NL1VSMYTP1X
MW+$%;G;@*5^4   <DXKU^R$JV4"S($E" .H;< 0/7O7F\W@SQ(?ASK?A5(K!
MFN+B5K:?[0PWJ\QDRPV_+@'&!G)],<@'2VWB>_B\6VVAZGID-K%>6DES:3)<
M^8V(RNY9%V@*<,#P6'N:S6^(P:/3K^VLXKK3;VX6+;#*S7$:,<+*4"XV]"1G
M(!'TJ[?Z+JE_XVT+5FM85L[2TGM[A3/\^90OW1CD#;ZCK6?X7T?QIX?MHO#;
M'3I='MFV0:GYK>>(,Y">7C!?' .<#KSC! .K\1:U'X=\/WNK31F2.V3>5!QW
M Y.#@<\G!P,UA:KXDUB+PIKFIV4.G2K:Z?\ :[2\BN#)#-\KEOX>J[!QG!W#
MD5T6LI?2:3,NG16\MR2N(K@XCD7<-RL<' *[AT/6N*MO ,D4/BB+3;=-(LM8
MTYK9+ 2[XUN&5P9<#A!AE&!UP3@<"@#5TW6]:CT#P\KZ>DT][ IDNS,S0PHL
M0;S)6V@AF/&.F3UK!UKQWJ=[\.[W5=+AMH+FWU+^SIV$Y=?]<L9:)@O(.X$$
MXP#WQ5M]!\5/:>%?,M--FCTQ3%=Z<UVPCE(C58Y"VPY*D,V-IQD8R1FJ<G@C
MQ%-X/\2:4_\ 9_VB\U<ZE:LLK;7S,DNUOE^7[N._7\P#JAXCOHO%]EX?N]/M
MT>ZLI;H317+.%*,HVX*#KN'/Z5F+\05CT2_OKVTAM&M-9;22SW!,0(8+YC/M
M&U>?3TYYR'ZII7B%O%&B>([6RL9KB&VFM;JU:Z9%02%6#*^P[L;<'Y1GL*IZ
M1X=\0Z;IVL6]U8Z7?1W^M37DD#R';-;R?>4AE(!R 0,G/0XH Z_2+R\O([@W
MEO!&$E"PRP2F1)XRBL'!(&.6(QS]WJ:IW>O2MXB.@Z9##+>QVHNIWFD*I$A;
M:HX!)8D'CC &?0&CX*\,-X9_M5(D-KIUU<"6TT_S?,%L-H#<]!N;)P"0..:;
M>:%J5AX]_P"$FTN..ZBNK,6E[:M)L;Y6RDB$\'J00<<<T 8VO>+KK5_AGXHF
MM+5;34M/2XL[Z%YSF!E0Y:-@OS9!!!PN<]L5T_AO3T-AI^HW6GV<6H)9);QS
M0MO;R<*0NXJI'(SCI[U@7G@[46\(>*;:%+=]6\0RRR.IE(CA#*%5=V,G:H&3
MCDD]J['2([B'2+2&ZB6.>*%(W57W#( !P?2@#E]=\<7>A07E_<Z4L5C;7Z68
M6XF,<URI* RQ+C#*"_ SR%/(KL;AY8[>1X8Q+*JDJA;:&/IG!Q7F6M>#O%6H
MZ7XFL3%IL\M]?+<6U]-<-YAA61'2#;M^4*%QUQ[<DUZ9&9C:J;A468KEUC)*
M@]P"0,CWP/H* /.4^)^IKX8TWQ5<>&UCT"X95N9A>;I8 S[0X3;RH.!U!/H!
MR=K6?&YM)-5338;2YDTOB6*:X*/,^P.4C 4\[6')[G'O7)^#](U#Q3\%M&T"
M2VCALKE5\ZZ\W/[E9=Q"KC.\XV\\#.<GI71-H_BSP_XJU2[\/PZ=?:7JTBSR
M0W<[1-;3!0K,"%.Y2%!QUX[=P!TWCK4[C4]/L-)T 32:AIC7\'VFY\DJ1MRC
MC:=N-V._..@Y%F#QA>WE_>V%M96?]H:>T2W-B]T1-\R(S.@"_,J[R ?XMIZ<
M4'0]9'C[2=8D$$]M;:=):3S&38[N[*Q94P1@%>F>_MSG^*O"%]XEGG+Z?;0Z
MA%<(VF:S#-LEMT!4G?@ G'S8'(.1TZT ;K^(;V]U+5;'0[.WN7TO:DS3SF,/
M*R[O+7"GL1ECT)Q@\XQ_^%CFZT[PY?:;I+7$6L7)M"DDX1X)5#;E(Q@X*$9R
M/7FK5GHFK^'?%>MW^G00WUAJ[).8WF\MX)PNT]004;@Y'(QT-9:^!M2TVQ\+
M6UF(+AM-U)]1O9&D*;V</N"#![OQG' % '0^&_$=YJFKZSI&IV$-I?:6\6_R
M)S+&Z2J60@E5.>"",=J?KOB*XT37=#LVL8GL=3N#:M=M.5,,FTLHV[3G=C Y
M'-5]%T?4K/QWXCU:XAA6SU)+982LN7'E*RG<,<9W<<GI5OQGH4OB+PM=V-LX
MCO5VSV<IXV3H0R'/;D ?0F@#-L_&LLUUXIM;FRMHI]! )1+HOYP9-ZG[@QGI
MCDYXK'O)=23XLZ=-!IML=3E\/2[XC/B-&\Y/O2;<D#ID*3[=QH-X%F7Q+HNI
M1W2[8X6CU7C'VIA()D;';][N/T..E7KC1]3;XE6^O1P0M81:8]F?WN'+-(KY
M"XQCY<=>] %6R\?"?PY!>7%@(]3EU)M)6S6;*FY#E3\^/NX!8G'0'@GKH6OB
M6>/Q:/#FK6D4%S/;&YM)X9"\<RJ<.O(!5AP<<@CG/:N53P'K<FB2\VL&J6OB
M"36K']Z6C?<Y;RW.,C()!(![5T\.C7FJ>+['Q#J5LEI]@M9(+> 2B1B\A&]B
M0,8 7 '?))Q0 [QOK"Z)HL%S+I<&HPO>01,DS !"TBJK@%3D@D'MTZU%J7BR
M:+7=0T;3H+6;4+.U6X6VN+@QO=;@QQ&-ISC;U]3CCK3O'FC:CK^@16.FQPM,
M+N"=C-)L4+'(KGL>3C%9GB_PO=>*$O;>ZTBUE?8ITR^6?RYK.7:,DD#.T/SP
M3GTZ4 =O+,D%N\\S!(T4N['HH R37&7'CRXM/#=KXJETQ!H$SH6<3'SXH7;:
MLI7;@CD$J#D ]3TKJO[/\_0_[-O9FGWVWD32]#)E=K-[$\FN'A\(:Y-X"7P/
M?+;FT0K!_:*2_?ME<,,)C(DVC;CIWR>E &E=^+M;;Q/J6AZ5H$%W-9P0W"R/
M>[%D1V(_N\'C@<]^>Q[.N4T[1=2M/B'J>KM;P+IUS90VT967+J8RQR5QT.[U
M[5U= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 445SWC/7[OPQH1U:WM8KB"&5!<[W*
MF.-F"EQ@'.W.2/2@#H:*Y=?%,R_$$>&IX[58I+#[;!.LI+2 -M*[<8!'7.>1
M34\1:M+8Z9,MA;QQWQED:\=B8+:!1E'?H<N,8&1C)YXY .JHK@X/B-&WA6/5
M;F.VMB=4;3))S(6MXV#$>:6Z[#@8Z<D#/>NKT>[O+R"9[Q+?"RXAEMW+)-'M
M4AQZ9)(QSTZGK0!HT5'<7$5K;2W$[A(8D+NQZ*H&2?RKBKGQU>67ABS\67&G
MQ#0KAHVD57/GP0R, DIXPW525'3/4XH [FJNH:E8Z39O=ZC>06ELGWI9Y BC
M\37*W'BKQ#-XJU70]*T:QF>QB@G66:\95DCD+9_@X; X'(X//0&7XI 'X8>(
M<@'_ $1C^HH ZY65T#*0589!'<4M<?8^)-3MO$ND:+J.GVT5MJ5I)):213EY
M%,2J2L@V@#(;/!..F3UJO+XWOK.]T<7]A!;+J>H&R6R>3%U"I+A)6'0J=F<8
MX##DT =Q17(P>+I]0UR^T_3Q9--8WR6T]G+(5N/*)7=,!_= 8D#'('7M72ZC
M=26.F75W#:RW4L,+2);Q??E(!(4>YZ4 6:*Y#2_%MU+XMMM OXK/S[BQ:[/V
M:0EK=U*AHG![_,.>.G2LZ?XA7H\,P^)K33K>;3IK_P"QI!)*T<@'FF(2%@&Q
M\P^[M) /4]* /0*BEMX9GB>2-6>)MT;$<J>G![<<5QU[XJ\2?\)/=:!I^AV$
MEW#81WJM)>L$(9RI7.P'.5...>I(Z5%J?CVZBM;Z]TO3TO8[&Y:W>V42&6X*
M-MD,952HP=V <YV]J .[J-+>&.:298U$LF-[]R!T&?0<\>Y]:Y34/&,C75W:
M:5%$9[6WCF<722?,SKN6/"@E3C!)/3(X/.$L/&DVL_V-:6>G/:ZGJ%J]W-!>
MAE^R1HP1BPP"Q+D #C(R>.A .ELM4L-2:<6-[;W)MW\N7R9 ^Q\9VG'0\]*M
MUP7PZ-P=9\:?:XHHY_[8^=8F)7/E)R,^O7\:LZKJFM)\4-)TJV:V%A)83SF-
MF8%F#("6P.P/ ]SD^@!VE(S*BEF8*JC)). !7'2^+[^YT?5=;TBQM[G3]-EE
MC,;R%9+D1?ZQD(&%Y#  YW8[9KIM*U.VUK2+/4[-BUM=PK-&6&#M89&1ZT .
ML-2L=5MS<:?=P74 <IYD+AUW#J,CCBK5>0>']>U[P[X4UG4M/T:UO-,LM6OI
M;H-<E)F03,6,:A2/E'/)&<' [GL+CQJMW.;?1O(9Q9Q7?F7*N5(E!,:80$@D
M#))Z9'!R< '7T5QVE^-;C6X='M[?3)+/5=0MY;B6WO R_94C8(Q(P"V6("CC
M(.>,8I[>+;^QTN+^U-(^SZI<:G_9MK!YO[NX8GB4-@D1E06Y&>,<\4 ==17+
M1^);^V\4MX<O[2V-Y-:-=6,T<C+%.%.&1L@E&'!_B!!S[5@0?$769/"FC^)G
MT2U&G7EPD$T2W1,R[Y3&"@*[2 <=2,^U 'I%%<E:^*[ZV\4WFC:[9VELL>G'
M4HIK:9I (E;:RME1\PX.1Q5.'QU>RW.BS)IGGV&J2I&5@20RV@<91W.W:5Z;
ML8VYZMUH [FBBN=UW6]1T^^>"WMK>&VCM#<-?7CE86?=A81C'S'&<]AC@YH
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M/4;E09WC&!*ZC"[FQD@#CGM7DVIZGJVM? ?7[W5F@E=YI<-&3G*W>,8/0#
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MC,%G@EW%E(*L%8,5('(XY-0P:/K'@3PQJ\V@Q:>GFWHN+?3KF:1XH(RH#(A
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MH&&!![D8]^ARH? OB33=$\,3:9J&G)KNAP-;$2!S;W$+ ;D8@;A]T$$#KVH
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M]CO97D$IC699 KH%P" ,9!.< 8[CIWT/5V^(%OXA/V)H(M,:R9/-=6+,ZON
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M?*('\..C9SVQCO0 V[\8:GI.EZ/KNI6MK_96HR1)+'%N\VS$OW&9B<. 2 V
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MH5G39][( )!(Z=15U?#VJQ^.[#6C-;3VMOIK6,C22,)I"S*Q? 7;U7IGOVH
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M@@8Y]JIOX]U*7X=:9XB2PL_/GO$M;F)V8HA\_P HE!WY&1D\>] ';?VUIO\
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MTN?4M1F\FT@ ,DFTMMR0!P 3U(H Q9=#U.3Q[:>(?]$$$.GO9M#YK;B697+
M[<<%<>_7CI6"WP^U.?0]2MFU"WM=0?6GUJPN8<N(92<A6! R,9&>^>G'/HH(
M(!'0U3U75++1-,GU+4)O)M+==TLFTMM&<= "3UH YN71O%>J^&M5M-9O=+-Y
M=V<EG$EFLB0('7!D;=DLWH, #!'?-0S^%=7EM_"$8>QW:$Z/+F1_WVV(QX7Y
M>,@YY^GO7:JP=0RG((R*6@#BIO!]_>:IXPEGN+:.V\06:6J%"S/#LC= Q! #
M9WYQD8QCGK4MOX7U*]L]!L=9:S6UT:2*9?LKLQN9(EQ&3N4; #\Q W9('('7
ML** .$L?"OBG0M3OK71M7L$T&]N7N=MQ"S7%H7.7$6#M(R21NZ9Z'G.II^@:
MA9^.]1UMWMVL[NTBME3S&,B^66(8Y&#G<<C/XFNGHH P/#]UK4^J:S%J<EG-
M:13C['-:JPPI+9C;/5E 7)'&6([<9WB+PWK;^)[;Q)X9O[2"_6V^QW-O?(S0
MSQ;BRYV\A@2>1Z_GV%% '&ZMX:US4UT&26\M)KJPU)=0N&;<B,0K+Y<:X;:N
M&ZDD\9/4U:L]#U2T\;:QKO\ H;PWUM#!'%YK!E,>[!)V]]WX>]=110!Y%?Z#
MJ7ACP]X"T9Y;26[M=?79(I;9)E9FYXROWL=_7VKN(M O9-=O_$%T+8:A+9"Q
MMH8Y&,<488L<N5!)9CG[HP% YZUL7NCZ9J4L,M_I]K=20G=$T\*N4/JI(X/T
MJ[0!YY:_#_4;7POX9MX[RU36?#LN^VF&XQ3*<AT88!4,IQQG&,^U;L.FBSUZ
MZ\6Z[/9VLJ62VBA9OW4$(8NQ:1@N26([  **Z:HKFVM[VVDMKJ".>"52LD4J
MAE<>A!X(H XWPKH]C)XQU[7].NO/T^:0"!8V#1>>RKY[H1P<[8P3ZAQ3(/"_
MBC1-=U)M U;3DT?4[EKJ6*\@=Y;:5_OF+! ;)YPW /XY[6WMH+.WCM[:&.""
M,;4CC4*JCT ' J6@#A[SPMXBTWQ1-K7A?4[("^ABBOK?4T=U=HUVK*K*0=VW
M@CO_ "["P@FMK***XN&N9P,R2D8W,3DX'89/ [# JQ2,P12S$!0,DGL* .&L
M_!NJZ3H^L>'=/N;0Z/?O,8992PELUESO4*!A\$DJ2R]><U;'A*YM/$_AZ\T_
M[,FFZ/9/9+%([>8R,%&>%QD;!]?:M:/Q7HDNAWFM1WP?3K-G6>98V(0I][C&
M3CV%:T4J30I+&=R.H93CJ#TH J:U8RZGH=_8073VLUS;R0I.G6-F4@,/IG-<
M=8^#_$$&H^%;VXO-)C71();=XH(7VLCHJEER1\QV>@ SWKOZI7NK6.GW=C:W
M4_ESWTABMUV,=[!2Q&0,#@'KB@#RS3!J=]#<Z_I]UX1NK"XO9+U6O7EB8$,=
MA=%)0.JA1DKN&!GG-=)<Z)XCN=7L_%OAZ>SL;Z]L8HM0T_45=HFQ\RG*X8.N
MXC_"NH7PUH*ZC_:*Z+IPOMV[[2+5/,SZ[L9S[UJ4 <??^&M9N]4\-WSWEK/+
MIEQ)<7#/N3S6=&4JB@':H#<9)Z#/.28)O!FH7D_C7[1/;1Q>(H%BC,99F@*P
M^4"00,YZ]O3GK73ZSKFF^'[ WNJ72VUN&"[V!/). , $]2*O.ZQHSNP55!))
M["@#.\/VE_8Z':VNI2V\ES#&L9-NK!,*H Z\GIGMUK!LO#.KZ#?:XFC3V;6&
MK3O=@7+,'M9W&'( !#J2 =N5QTSWK77Q;H;^'9M?6_#:7"662X$;D JVT\8R
M>>.!6RK!E##D$9% '$7O@>X@T3PMI&C26ZVVAWD-T6N&8-*8PV1P#@L6)SV]
M*UTN]<_X35;9FLGTAK3<\<88RP2@CEFZ8.< <$X)[&M&]US3=/U*RT^ZNECN
M[YBEO%@DN0"3T'' /6KLTJ00R32-MCC4LQQG  R: .?\6>&I==&FW=C<);ZG
MI=T+JUDD4E&.,,CXYVL.,CD5 WAV^O-8NM=O%M%U!M/-A;01RLT<:LVYF+E0
M22<?PC 7OFM!O%NAIIVF7[7ZK;:H\<=FQ1@96<@* ,9&<CJ!CO5W^UK'^V_[
M&\__ $_[/]J\K:W^JW;=V<8Z\8SF@#/\':/=^'O">G:/>/#)+9Q"'S(2=K@=
M#@@8/M5?6="O]0\8^'M8@>V%OI7G[TD9@\GFH$XP,#&,^_M72T4 <(OA#5_[
M&\8V)DL=WB"6:2-A(^(?,C$>#\O. ,]L^U=9HMI/8:'8V5R8S-;P)"QC)*DJ
M ,C('7&:OT4 >9Q> ?$D>BZ;IQU33'.FZNNHQSO#(9+G#LQ,IS][YNW7 Y%=
M_J4-_-I4T=A<1Q7Q4>5+(IV!@0>0.WM5VB@#CK#PC-:>(-2UV&UL+*YO+'[,
M]M:R-Y4LF[/FN=@Y[<*3UYYK.A\#ZQ#X2\*Z,)[%I-$OH;IY"[@3",MA0-O!
M.[KSC'?/'H5% ',0:'J</CN^\0?Z(T%Q8QVBQ>:P8%&9@Q.W');'M[]*P%\!
MZROP^MO#?VBP,T-^+OS][[2!.9L8V]<G'Z^U>C44 <Q<:%J,_CVQ\0!K5;>"
MP>T>/S&+Y=E8L/EQP5QCO[5S4'@'Q+%HNC:>VJ:6YTG5EOTG:&0O<\N2TG/W
MOG/3KZUZ910!S.@:#J.F>*?$&J73VK0ZK)#(JQ,VZ,QQB/G(P<@9]O>I/&?A
MJ7Q/HT,-K>?8]0L[F.\L[C;N"3)G&1W!!(/UKHJ* ..O/#_BC7?"^IV6KZM9
MVU]=6QMX?[.1UBCSR6)8[F+8QVP,XZFHK#POKT?BO2=;N;G2HUMM/>QEMK:%
MPJJ65ALR?]GOC ['K7;4R6*.:)HI45XV&&5AD$>XH \I\$Z+J'B3X166BRM:
MQZ9=22B697;S?*%PY9 N,9."-V[@'IQ6_J?@W6;G5O$;VE_8K8ZS8+:#SXF:
M2V"QE-J8(&TDEO8GH:Z_3],L-)M_L^G65O9P9SY=O$L:Y]< 8J+4M<TW2)K.
M&_NEADO9UM[=2"3)(QP ,#]3Q0!QG_"%>([!]!U72M2TY=:T_3UTVX2:-_L]
MQ ,$#@[@01G/?/;I6EK_ (9UK6O#]I:27MI)?+?PWL\C!DC'EL&"1KR0O ')
M]3U-=C10!R\N@ZA%X\'B2&ZM([:33TM+J*16++L=GRAX'.XCGIU]JR[>PTKQ
M!\28M=TG4(KFVALU-Y]FD5X99@2("2,@LJF0^WR>U=V0&!! (/!![U7L=.L=
M+MA;:?9V]I "6$5O$(UR>IP!B@"S7(?\(':RZ[K]U<2^9I^K0[?LF.(Y'39+
M)]654P?][UKKZ* .9T;PY=Z/X%&C?:4NM0:W:.6XE) DD*[<DX)P!@#V45D?
M\(3JR>$O"VGPW5DM_H%S%,K.&,4P1&0YX!!(;/?I7>T4 <K9Z#JUKXUU#7G>
MRE2YL8K4('9#NC+'<?E. 2QXYQZFL?3M+\3>#?".AZ18W&F33P7A696#L;B)
MY"Q"# VD;N2<@ 9]J]"HH RO$VE3ZYX9U'2[:[:TGNH&B2=?X"1[=NU<W9>%
MO$,7B+1M8FN-(0V-A)9/;6\3JFTE2-ASWV^G [&NVEE2"%Y9#M1%+,<9P!R:
M@TW4;35]-M]1L9?-M;E!)%)M*[E/0X(!'XT <&? FLGX<2>%_M%AYSWGVG[1
MO?:!]H\_&-N<Y^7K[^U;*>'=4TSQ=?:_I1M'&JPQ+?6=Q*R@2QC:KHX4YXX(
M*C/7(KK:* .$NO -Q'X>L+:PO(/[2MM876999D(CFF+LS# Y4?-@=> /K6C!
MH.KQ>.I?$,CV4J/I:6/EJS(2RNS[^AP"6QC)P.YKJJ* /-H?A[K-OX7TVVMM
M2M;;6M)OIKRSN5#/&WF,Y:-U(!VD.0<>E:6M>&O$WB/P9J>F:G?:=]OOXUA
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MV8A:8&_(69BJL/)7(R 2..^#2ZQX&U#5[#Q!<?;;>WU;5FM^!N:%(H2"L3'
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M.'5-"3*W=M P5T:$2#"LYVM@XSDX]#6E#K>KZ3+X,L))+*>#5 892MNZ.@6
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M0R+YS*K[CN _B!&,^GN;O_"%ZI%8>+-.@U&T-GKDMQ-&'A;?$\R!6R<X(&.
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M*D?:6'0$>OK7::YJ^JVE_'# ]G:6;6C2+=3KYK2W&>(DC5@QXRQ(!]!BL0^
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M'84 =)12#.!GKWI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ JL^FV,E\E\]E;M>1KM2X:)3(H] V,@<U9HH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]>];3K0W;J4:<P+O93P06QDBH?\ A'-"%HUI_8NG?9F;>T/V5-A;U*XQGWH
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MU@641!)K<Q?.%,BGI(7R!Z^U5DT+1HO%_@"SAW7]H+"^C2:["L\\:"/RRV
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M-&TX>;*)Y/\ 14^>0<ASQRPR>>M6AIUD-0.H"SMQ>E/+-SY2^85_N[L9Q[4
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M/)!XP*\]TV\M9/BSIRS:AILZS>'G@$=LP,0_>QE8\DDN<$]>HYP*YO[%80_
MR[O8K>!+B+5R8YE4;DQ?@#![8!/YF@#VF[U;3;"01WFH6EM(PW!9IE0D>N":
M6^U33],56O[ZVM%?[IGE6,'Z9->>>+_M^FWWB36-,FL]3T]8476M'N_E<(L8
M.Z)QT)0]",9!QS4MIKVEI\0?$UKXDFBM([ZQM6LOMSB,/;&,^8@).!ARV1G^
M5 '?7&J:?:;/M%];0[T,B^9*J[E R6&3R .<U3BNS<Z]!);:U9R6,ED9%LT"
ML\AW#$P<'.S!QTQR.:X2[TG03XS^'UK:649T\VM\D,<XW>9&L:;,[LEACD9]
M:T8].T^R^,UK:6MI;00GPW(GDQQJJE1.@ P.V.* .Q.NZ0)8(CJMCYEPQ2%/
MM"9D8'!"C/)!XP*J-XKT<>*?^$>^VP?;Q#YKH9 -I+ *GNQR3CK@>XKR>VT3
M1;KX'ZS*;2W-]%=72P2(@\U)A.WE(IZ@DE0 /[WO776$PL_BW"FIS1)=R>&K
M="78#S)?/8''J<GM0!Z')(D4;22.J(H)9F. !ZDU7LM2L-21WL+VVNE0[7:"
M57"GT.#Q7)_$Z];3M%TJ[F#'3(M7MGU' R!;@G)8=U#;"161XUETR\\-^*M4
M\)2I=ZS/IR+<W%E-Y@\I6'!VD@-L+XQS@?2@#T&UU;3;ZXDM[34+2XFC&7CB
MF5V49QR <CF@ZMIHO?L1U"T%UG;Y'G+OSZ;<YKAO$?V74)/ %_X>,?G'4(O(
M,./^/,QL91Q_#M"@^AP.M4H9K[0]4L61[76_#5]K;+"<;;JPN9)7W<]'4,7S
MW )[4 =MI'BW1M;O=1M;*^MY&L9C$Y$J_-A59B/51NP3TR#6C9ZII^HLZV5_
M:W+( 6$,RN5!Z9P>*\VT_P#LR:T^(NF7^H+9?:-3F5W5AOCC:*,;\?W1W[5K
M:!J^HZ7XCO[+Q6M@UQ;::MR-9MCLCEME<C]XI^XP)8\<=<4 =]7$7_B>35?%
M-_X=TC6K2PN+6T22.8E)/-N&9@(RIZ@!>0/F^;MCGL+*]MM1LH;RRGCN+:90
M\<L;;E8'N#7$V6?^%K^*UMMAN1I5J8P<<-^\Q_,?G0!U=GJUL9(-.N]1L&U<
M1CSK>&89+@#=M0G=C/KVJ:?5M-M;R.SN-0M(;J4@1PR3*KOGIA2<FO*O#,GA
M[Q#X5\/0:AX@NQJVGW,;'3U:%+A;Q3AOEV;SEBQ))Y!))X)HM9M#UG3O$N@^
M*=?FL;L:G.US:,T*/(/,W1-'N0NWRA N"3P .U 'JMUJVFV,PAN]0M+>5AD)
M+,J$CUP35RO*_$9O]'?7M6T^6#5M,6.%=:TB^.V=-L*8>-Q_$4*G!XR#CFO1
M[^[AAT2YO)XY?)2V:5T48?:%)('OC]: "WU?3+N[:UMM1M)KE 2T,<RLXP<'
M(!SUXIDNNZ1#CS=5L8\S>0-UP@_><'9U^]R..O(KRG3]2TXZS\-9H;NP@LA'
M<"&UCEWFWC:W.%D<G+,3@'@<@C!QFHY-,TT_#[XGR?8[8O%JE\$;8,IM1" /
M3!YX[T >PWM_::?!YMY=V]JA.U7GD"+GTY(KG? FNWNO66L2WUQ!<&UU:XM8
M9($"HT:;=I')ZYSU/6L'3]62+XGZ>FK3JD4OA^,Z<\S85W+9EVD\;R N>^!5
MOX6RV36_B>&SD@,:>(+LJD3 @(2NT@#MZ4 =G?:II^EHKZA?6MHC'"M<3+&#
M],D42:KIT4\,$E_:I-, 8HVF4,X/3:,\Y]JX"^U*S@^)6N:?KVL'2XKJQ@%D
MTODK'-" PD7=(I&=Q.0",Y]JCU#P[I\W@C0M(\.7,\FI6LAGT2ZG<&1 CY,A
M8#F+! Z8(9!W% 'H8U33C#/,+^U,5N2)G$R[8R.H8YX_&D@U;3KF]DLK?4+6
M6ZC4,\$<RLZ@]RH.0.17F>IWVG:Q\"M<"6PCN[6"5+Z";#217:G]X6/]XMEM
MW?-6=4T73X]9^']YH5O!%?M<AGDMU ,EJ8B968C[P^[R>[>IH ]#DU?38K]+
M"34+1+Q_NV[3*)&[\+G)IMSK>E60F-UJ=E ("HE\V=5\LMG:&R>,X.,]<5Y/
MI$FAZ]X3GTGQ%X@NK;5;;4)&N;!&A2X^TB8LICRF]B>,$$]<5M6.EZ9/X[^(
M@FL[9PMM:<-&IQN@?<?;/<T >AW.HV-G D]U>6\$+_<DEE55;C/!)YXI'U.P
MCL1?/>VRVAZ3F51'UQ][..M>7:%!J5WX0\#W6AZM;0:Y;:7(8;:\4M#=1?NP
MZG'*D$)@CI42^)(?/\&ZA?"3P_I<HO8&*%&BM[L.%'S.I4*<2!3CHQYQF@#U
M5=5TY]/&H)?VK61Z7 F4QGG'WLXZ\5):7MI?Q&6SN8;B,':7AD#C/ID?6O-W
MT32C9./#?B5TN[G6A=6]W+Y<MM)>>6Y:,! JD%0<X_BQCD8KI/ VI7=]#J\.
MI:;!9:G:WQBO#:L6AFD\M#O0GD94KD'D'KR: .AO=3L-,17O[ZVM5;[K3RJ@
M/TR:Q_&/BJW\+^$KO6%D@DD6+-LCR "5C@+CGD<@G':L?2KDCXN>)K34\;I;
M&U.G"3HUN WFA<_]-#S^'I7&7T+VGP+\41N1_9R:G*-,+'@6WVE FW_9SNQ[
M8H ]1T0:D][<3OK5KJFDR(OD.B*'20$AQN3Y2OIW'2M"75]-@OH[&;4+2.[D
M("0/,HD;/HI.35M0H4;0 .V*\;TZ70]<\-:IHGB;7[FTU*'4IFNK)6A29I1,
M6C:+*;V)&P+@GT'&!0!ZQ_:^F>=-#_:-IYL +2IYZ[HP.I89XQ[T_P#M.P\N
M"3[=;>7/GR6\U<28&3M.>> >GI7G'CVSVZPVN:5!+-)I]L(]>CA<*;BT)!,1
M]9 H+<8(7O\ ,M3>+CHFKZM\/[N-;6>PN;TI&^T;7C,+;4^A.!M_#% 'H-CJ
M5CJD!GT^]M[N$,5,EO*LB@CJ,@GFF6NKZ9>W$MO::C:3S0C,D<4RLR#W .17
ME>O:7<:9K7CYO#$!BMVT6(SQ6HV@7.6R% Z-Y7/'/S ]ZW=)_P"$3\1ZOH&J
M6>O2ZA=0P2);VL9@&R)DPZRQH@(48 PW ./6@#K;OQ3H%E:O<7&LV"1I&\I/
MVA22JG#$ ')P1CCOQUHTWQ-I6HZ#:ZP+ZVBMIT1B9)E C9E#;&.<!AGI7G7A
M+2-,;X,ZC>QV-JUXD&IJDPC!=07E& >H& .!5VT1M4\)^"CX?UNSMM:M+)'M
MTF DAF80()(W .0V&!XY S0!Z5;75O>VZW%K/%/"V=LD3AE.#@X(XZBF7U]:
MZ98S7M]<1V]K"I>261L*HKE?"GBFQ70(3JL5KHMU)J,]F8#,/+DN?,;?Y9/4
M%B3]>*Z#Q$N_PSJJ@9)LYL#'^P: (-(\4:3K&C66IPWMND5V$V*\RY#N 0AY
M^]R..M6#K^C+9I=MJU@+9V*K,;E-C$=0&S@D8YKRJZ_LN_\ AO\ #A2;:<IJ
M&F0RD$$KE,,A/;W%=/J+Z'H_CRRT^R@L-*NQIT\YNI<)"L;R+O"Q@A6D8KDD
M] ._2@#LI=8TR!('EU&TC2<9A9YU D'JO//7M4YO+878M#<0_:2N\0[QO*^N
MWKBO(_#VF?V_\"[./394DU;2II;RSQ@M'-%/(R+CMD#&/1JZ,:A>>)/ VM>*
M-+BECNKS2VCT],$2*%C)..^XR%A[[4- '9P:MIMU>26=MJ-I+=1@EX8YE9TY
MQRH.1S6%X*UC4=7'B!=2FBE>QUB:SB,4>P>6BH1QD_WCU)KF_#\GA;Q#_P (
MKJ%KX@GN+ZR %I91- LD64Q(CHJ!@H .<\<=\C.O\.F!G\8X(./$EUT_W(Z
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M"1*HV9)V\#IDGCWH \586C_ WYO)*+KI5>F #?=!Z?+^E=N(K:V^-D,-NL4
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MMKAKB"RMXIV&&D2)58CT) S4.FZ1;Z;+=SQJ@FNY?,E*1A%Z8  'XGG)))-
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M?6HX=.L;>W>W@L[>*!SEHDB558^X P: /'08#\"?!\CF/*7MD%8XX/GC.#]
M?RKKO&K2>&O$VC^,+>WDF3!TR^BB&6DCD.8C^$F!_P #KL_[,L#&(S8VVP$L
M%\I< GOC'L*G,49C6,QH47!5=HP,'(P/8@?E0!YSXL:3PQ;^$[J_N98;"*_>
M34[J!0PCFE1\2$$$;?,<]1QD=\5C>,+;P[+X$\;ZII.HMJ4EW# US=>8CPF1
M2 H4H N\#&<<\C/6O7Y8HYXFBFC62-QAD<9!'H0:A&G6*VJ6JV5N+=#E(A$N
MQ3[#&!UH YCQ+X3M-4\)2+HMO;6^HQ>5>6,\,:C]_$ 8R2.N0-N3V-2>"M0?
MQ-$_BF:V>W^TQ);P0R#!C5.9/SD+CW"*:T=:M->\NT@\.3Z;9PAF6X-S SE4
M(X,84@9!R<'@UI:?90Z;IUO8VX/E01K&NXY) &,D]SZF@#F/&-I=76L:,VD:
MQ#I^NPI</:1W*;X;E/D$D;#KW0@CD8-<<_B5D'A#5M4C;1-.%S?V]U+;[7AA
MNBV%<%E8;&(EP<<;CSCFO6;JQL[Y EY:P7"CH)HPX'YTZ2TMI;4VLEO$]N5V
M^4R ICTQTQ0!Y'XPM/#R?#?Q7>Z3>M?17=W;S3W;2(T33>:@;RRH SC&2O\
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MD$>AW9Y'>O0Z@ALK2WD,D%K#$Y&"R1A21]14] !1110 4444 %%%% !1110
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M@]NDP@:5;A2HD/1"<_>]NM</X=U+PEXFF\/74&HW5SJE@-T5F7VO9G;MDWJ
M-J@#'/!X SD51N;NPT/QA'XNC,9\)ZC>>3,1*-B78!0787IM)W(3_P #]* /
M1K[Q/H.FO.E[K%C;O;H'F62=08P3@$C/&3T]:LQZOILNEIJ<=_;/8. RW"R
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MFT$<9&^ (,2A@.0%4,&!]AZ5L:==VS?&K6HA<1&3^R+9=H<9R)'R,>O(_,4
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M@D77=.=+B7R8C'<HP=^/E&#UY'TS4*^-_#+6UU<+K=F8K5PDQ#\JQ!(&.IR
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEV,S!LD8));IV]:Z:@#@-5G31?BOI&H7ACAT:YTR:U@G.%BCN6D#G)Z NJ@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
(% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>exhibit107-formofindemni002.jpg
<TEXT>
begin 644 exhibit107-formofindemni002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJUS+!9:K<VHEEW/LB1@%&U1^N,UU=CXNT74=872K:Z<W3Q&:(/ Z)*@QDHY
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M0*JACCY<L,<XY% 'HU%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%9>N^
M(=.\-V*WFJ2O% TBQAUB9QN8@#) XY/4X% &I17-#QUHG]H7&GDWJWD48E2!
MK*4/.A.-T2[<N,]Q]>G-30>,]$N-"36$N7%N]P+4(T3"7S]VSRMF-V_=QC'Z
M4 ;]%<U=^-M.MM'UN^2&ZDFT=2;JT\DB5#MWC(Z8(YW=,5F3_$ 6^F>&I6T^
M[:;5Y8HW(M9 J93>VT8RV>0,9]>U '<45BZEXHT[2XYI)ENI!;Q":X\FW=S
MA&<N .. 3CKCG%5+WQ[X?LI;>-KJ:9[FU-W;BWMI)/.B !RA"_-P>@R1WQ0!
MTM!S@XZU@?\ "8:4;8W,8NI($6-I9$MG(B\Q590XQD':RDC' (SBM^@# \->
M'9O#\VKO)?)<C4;Y[Y@(/+V.X4$#YCD845OT44 %%%% !1110 4444 %%%%
M!7)V'A36-*9[>R\4W"Z<TKRB*6TCDE0NQ9@)#UY8GYE-=910!!9VD-A9Q6L
M(CC&!DY)]23W)/)-3T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!S]YX=GNO&6G^(!?QHME!) MN
M8"=ROM+$MNZ_*,<?G70444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JTU_!#
M>PV>2]S*"RQH,D*.K'T R.3]!S5FN'\$WQU'7?&FJW+?-#JC6"Y_@B@08 ]L
ML[?4F@#H_$7B&Q\+Z--JNHB<VT6 WDQ%SR0!TZ<D<G JVFH6[:B]@6*7*IYB
MHXQO3@%E]0"<'TXSU&?*/%NHZCXG^"U_XC:_>&"[*R)8K&AC$/GA5!;&[?@
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M\*",#@ $#VIN@ZCK>BZ3\/'_ +1273]2A@LI++R% 0&WW*X?[VX;>><'/04
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M(T0L!M'&X9Z X[9KK=,?Q3%XI6.XCN9]#EMR7DO/LZRPS \;?*/*D>HR#WH
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M^MZ/%?7JZDDDMMJL4*VEM"LD"V[.B!97*Y64ALX#9&1QB@#TJBN&FO?$-_\
M$'5=!M]9CL[2/3XKF)TM5=XRSLO&[()^7J<CV'49=MXWU9O 'A_7;Y;@02S2
MQ:I>6%N)'B5"Z!]A! 4LH+'!P.E 'IM%<OILNH:[X8L[G2?$T$Q:Z,GVY;=)
M!- )#^[*\!6VX4G ((/ KJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV@I,UJMH;<P<"-6+#YMV=V2>>G/2J$?@-6T+Q)I-UJ+2PZ[<2W,C)#L:)Y
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MW$RM,F04 #;LY4KG&W(ZUT<5RDD$$C!HC. 5CE&U\D9VD>H .1[&@":BBB@
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M(QT]M/DMO) C>)F#-WSDD>O3CWJCX?\  CZ T5LNOZA<Z/;/YEKITH3;$<Y
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MT%JR?P$ DAB.[88KGT)'>D\.>&K7PMH1TO3&*IYDDBO(-Q!8D@'U"C:H]E%
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M0 -QD,C*2K*0>H/UK4KAKB_U74_$&KZ%97-Z/[+MX%$T,D22-)(I;>VX8(X
M   X;.>,9UW>>+X[SP3I]_JRV=]?M<P:@+5(W1BD3D.I*\-@ X^Z#V.,$ ]*
MHKS^*YUJXU:_\-+J-_<R:5:0[[N%H8I99)=Y#MD8P %  &.N<\55DO?&$.I>
M"=.U/54M;V^-U#?BVCC=',<;%7&5X;&#C[H/8@8(!Z517EY\5ZMX?TWQ7:SW
M[7LNG:E;VEI=72+N19Q'@OM !V[R>@SC%=->KJWAJ34-7?57O=)@TV25[6X
M,IG0%MRL , J""/7H* .JHK@M.D\67<GA_5K:=GMK@(^H)<2Q>2\3J#NB"C*
MD$C SR.I)YJOH_B6Y?Q5;:3KEY?:9K'VJ8FVGC'V:^AP^P0MC'&4/4'@@YH
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M;3(O4J 2H=P>><#K4VN:=<V7Q \!M-JES>%KBY$@F"X+_9V^9< ;>_ XZ?B
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M877VX6D<;JLL84!T)7J=V<'('I5U;[4_#'CC3['6=<GN]*OM/<12S1QH!<Q
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M/(#$J%7YER,ALDT >GT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5PGQ8*
MMX4MH/-:.1]2M2"GWP%E4LP'/0<YQ@5W=% &+::&C:HNLW-ZUY>"W,%O+M4)
M$C$$E0.[87)]AC K%'PYM%T&+3(]6U!6M]1_M*VN1Y?F13;F8G&W:1EFX([U
MM#Q'"?&)\-FTN%G^Q&]$[;?+9 X3 P<YR>X'2KNEWTVH6C33V%Q8N)7C\JXV
M[B%8@-P3P<9% './\/X'EUZ1M9U-FUNV6WNRQC.<(4W#Y.#M)&.@STZ8LOX,
MB=O#S'4[O.A?\>_RQ_/\FSY_EY^7CC%=/10!@:)IVHV>O:U<3ZC>W-C<R*UO
M%=$8A8%MXC Y"8V 9ZX)]R_5_#::MKND:LU]<02Z6[O#'&$VL77:V[*DGY>.
M"*W"0 23@"F12QSPI-$ZO'(H9&4Y# \@B@#F-<\$1ZIKT>N6&KW^D:D(O(EF
MLV7$T><A75@02.Q_^M4NI^#;?4;+2;4:A>0IIMVE[&RE6>6923N<LISDL2>F
M2:Z6B@#D]9\#IJ6N1:W9:SJ&E:F(1!//9E,7$8Z!U8$$CL<<?E5BY\'6\U]H
MEU'J%Y$VCL\D(RK^:[@AVD+ DD@G/3DDUTE% '+:[X)BU778M<L=6O\ 2-36
M+R))[,KB:/.0KJP(.#T/_P!:I9?!UN^H:)>)?WB/I#2O$"5;S7D!#M(2"23D
M],<FKVJ:XFGWEOI\%N]WJ-Q')+%;(RJ2B8W,2QP!EE'U/U(RAXV$]INM-#U.
M:^CM1=SV#(L<\*;F4 JQY8E&P!U ]QD 27P#IUVGB&*_N;FZ@UUE>YC?: C*
M %*$ $$;1USR*L:+X2_LZ%H]1UB_UH>2;>,7Q4A(SP1A0-Q(X+-D_3)SHZ%J
MTNM:>;N73+W3LR,J17B!9&4=&P"< YZ'FM.@#D- \ Q:!-'%%KFJW&EV[[[7
M3IY%,4)SD<XW,%/(!.!@'DC-6HO""'^S8[W4;B]M],N!<VJ2H@97 (7+  E5
M#' XZ#)-=+10!F>(=#MO$N@7NCWC2);W<>QFC.&7G((SW! K-N?!Z7$^EW_]
MJ7@UC3@RQWY"%I%;[R.H4*5/H ,8R#G.>EHH S-)T6#2I+RX$CSWE[*);FXD
MQND8*%48  "A0 !_,DDZ=%% &9J.ESW>H6E];:C-:2VR21[%17CD5]I(8$9X
MV#&"*P+SX;Z7<:/9V=O=7EG=V5S)=V]_;L%E261BSGIC:V>5QC  KLJQ?$_B
M.'POI(U&XM+BXB\V.(^3M^4NP4$Y(XR1TS0!FWW@6/4_#%SHU]K.HSO=NC7-
MZQ3S9-C!E ^7:J@@< >O<DGHYK..ZTZ2RO/](BEB,4N\ >8I&#D#CD&K-% &
M/I7AVWT;PK!H-E-*D,,'DK,<%SGJW(QDDD].]8Z?#^VCT/0=)35;X0:)<I<V
MS8CW,R9VAOEY W'IBNPHH X_6=#DTF3Q#XEM7U"^O;NQ\DV<&T$A =NP@;@P
MW$YR3[=*YC0A<1I:0>'?&6LWLL(C065UI:A-HP")&,:E !GDMGTR>#ZO10!E
M>)-!M?$_A^[T>\DECAN N7A;#H58,I!]BH-9MEX.%MXD@UZ?6M1NKU+/[)*9
M3&%F3=N&0JC&#_=QGOGG/3T4 8?A;PS%X4TL:;;7UW<VJ,?(2X*GR5+%MHV@
M9Y8\G)_*DNO#$5QXKB\0Q7]W;7*VHM)(XBNR6,.74-E21AB>A&>G2MVB@#C7
M^'=K)X4U+P\^JWQM-0N6N9GQ'Y@9GWL =N "P]*EU?P,NHZS!K5GK6H:7JBP
MBWGN+0H/M$8Y =64J2.QQQ^5=;10!6L+*+3K&*TA:1E0'YY&W.Y)R68]R222
M?4UE:)X7AT6;5G%Y/=)JEPUS/'.J;0[ *<84<8 &#FMZF231PA3)(J;V"+N.
M,L>@'O0!R.A_#Z'0;A([?6]4DTB&3S8-+ED4PQ-G<!G&XJ#R%SC/7-8/B[P;
M#H7A+Q5/8:O?Q6-[;SRC2PRF(SNI^[\N\ GG:#@GU'%>GT4 <=#X<CUNT\.:
MU9ZK<V-Y9V0A$UL$;?&RKN0AU(ZKZ<&F_P#"MM*?0]5TF>\OYH-0O6O][2#?
M;S$Y#1MC.1@<DG]36WJNOK87RZ=:VDM]J+6SW0MHF53Y:D G+$#DD #N?H35
MJRU2*[T6+5)8IK*)X?.=+M/+>(8R=X/0CO0!B6G@V6/39X+SQ#JM[=R*J1WL
MK()(%#!AL 7:#E022"3@9Z58/A*VN;J_N]1N'NKJ]L3I\D@18\0')( '<ELD
M^PP!4][XCALO%.EZ#):7!EU%)7BG&WR\1J"PZYSR.W?K6U0!E^'M&_L#1K?3
M1?7-XENBQQR7&W<$4!57Y0!@ #MD]S5!O":P:W?ZGI>I7.GOJ(7[9'$J,KL!
M@2*&!VOCC/0]Q71U0UC6K#0; WNH3>7%O6- %+-(['"HJCEF)Z 4 8^H>!["
M[T32=(MKFXL;/3)XIX%@VDEXSE2Q8'//)]372H&5%#-N8#EL8S6!=^*_[-LC
M>:AHFJ6MMD#S&6)\$D 9".Q7D]2,#N170T <7)\.+23PUJ/A_P#M?45TZ]F:
M7RP8_P!R&D\QE4[.A;NV3CICG.M-X86?Q)INN2ZC<FXL(7@1 J!'5\;MWRYR
M=HZ$5O44 <9I_P .[;2[^7['K.IQ:/+,9VT@2+Y&XG) XW!">2H.#WR.*[":
M&.X@DAFC62*12CHPR&4C!!'<4^B@#E]+\(3Z##]BTG7KZWTP$F.T=(Y?(!.=
ML;LI('H&W8JQJOA&QU2UL5$T]O=V$_VFUO(V!E23^(DL"&#9.0>#^5=!10!S
MS^%(IX]4DN;V:2^U*V%K-=A5#)$ 0$1<84?,QYSR?ICE_B!I<>B_!XZ''=S3
MB'[)!;E@/-*)-'T"@9(5<YQVKO+W4/L^F75Y:6\E\\"OB"W(+NR\%1DXSD8J
MU#(TL$<C1M&SJ&*/C*DCH<=Q0!C6NAQ3ZG;:Q>7S:C-! T5JQ50B*^-S +P6
M8  GICH!DYS;;P#9VVER:(E]<G07F\T:<P4JHW;S&'QN\O=SMZ]LXXKKJ* ,
M.'PTD/B^?Q&+ZX,TULMJT!">7Y:DL,?+G.2><]ZP[GX9VEQ8:EIXUK4XK&\O
M/MRVZ&/$,QD$A*DKDC<.C$CGIGFNXHH Y\>%(D\3IKL6I7J7'V5+6:,%"LZH
M2RELKG.2?ND9Z=,@TH_A_IK:%J^CW=S=75MJEV]Y(7*J\4K,&+(5 Q@@$=>E
M:>M>(X=$U+2+.:TN)#J=R+:.5-NQ'P3\V3GHIZ UKRN8X7=8VD*J2$7&6]AG
MO0!BVOAQEO[6_P!0U&>_N[.)XK625$7R]P 9\*!ER !GIC. ,G.4_P .[5_"
M-[X;;5;XVEY<-<228C\P,TGF$ [<8W>U=1IMW+?Z9;W<UG-9R2QAVMY\;XR>
MQQQFL_Q3XCA\*Z))JMQ:7%Q#&Z(P@VY7<P4$[B.,D=,_2@#8C5DC57<NP&"Q
M !/OQ3J*I:M?3:;ILEU!87%_(A4"WM\;VRP!(R0.,Y^@H QQX/23[%%>:C<7
M=K8W@O;>*5$W)("2HW 9VJ6X'7@ DCBH!X$@_LKQ!IQU2],6N32371VQ[E+J
M%;9\O P .<UUE% '*)X&BBU6UU&#6-0AFBL4T^<1F,"XB4DKN^7Y3R>5P?3%
M5H/AS:V_AW2-%35]0\C2KQ+RW<^66W(Q**?EQM!)[9/K7:44 8:^&T7Q@?$A
MOK@W!LQ9&'">7Y8;?Z9SN).<T_Q1X=B\5:'+I-Q=3VT$K(SM!MW':P8#Y@1U
M4=JV:* ,%O#(;Q7%XA.HW/VJ.S-D(]J>64+!B2-N<[@#UK*?X;:;-X?NM)GO
M[Z037[:C%<AE26WN"Q;>A51CDGJ#U-=G10!S<'A-QHU_97NM7]]<WL!MY+R;
M9O6,@C:BA=J]3V))ZYP,07'@>*71-#L(-4O+>XT1D-E>*L9D4*FS# KM8%>#
MQ75UBWWB.&Q\4:5H4EI<&74EE:*<;?+'EKN8'G.>1V[]: ,H?#S393KXOKV]
MO8M<2-;N.9EQE$"AP0H(;(SQP.,  "FP^ Y!=:-<7GB35+N31W9K4NL0."NS
M#$)\WR\$GGZ5V-,,T:SI 742NI=4SR0, G'MN'YB@#CXOAW;6NK7<]EK.IVN
MFWLQGNM+BD7R9';[V,C<H;N 1GZ5T^JZ;;ZQH]YI=T&^S7<#P2;#@[6!!P>Q
MYI+&^FN[B]CEL+BU6WF\I))=N)Q@'>N">.<<^E7: ./MO *P7FB7DNOZI/<:
M0CQ0.YC :-E5=A 0=E'/WCW/3#7^'EK+X6U7P^^JWQM=3N7N9WQ'O#.V]@IV
MX )]J[*B@#AO%)L?$JMX(FM[VZNR\$DL[6[)'&@8,9!( %!P"!CN<>N.W1$B
MC6.-0J* JJ!@ #M3J* .<U3PF-575;>?4[C[!JFW[3:E$(4!%0[&(RN0HSUY
MY&#S534_ 4%SKHUG2]7U'1KMX5@N#9,NV=%X7<K C(' /:NNHH YQ_"%O_;F
MD:I%?7<;:5%)%#%E65Q)C>7+ LQ. <YZ\U;\1>&[#Q/:6UMJ"L4M[J.Y3:<<
MJ>0?9@2I]B:V** ,7Q+X<B\2V=M;37EQ;)!<QW0, 7)=#N7.X'C(K.U3P.EY
MXA.NV&LZAI5_+$L-V]H4Q<HO3<K*1N'0'M6\+Z8ZVVG_ &"X$(MQ-]L^7RBV
M['E]<[L<],8J[0!RNM^!+/5!ILUI?7NF:AIH*VU[;29DVM]Y7W9W@]3GOGU.
M=O2-+72;+R/M-Q=S.V^:YN&!DE? &3@ #@      5?HH XW4/AY:7\FO+_:V
MHP6>MC==6L3)L\S:%W@E=PX XS@XYXXJ]_PBDRQO%'K=X8Y;);.99DCD#J-W
MSXVC#X<C^[@#CBM^ZG-M:RSB&28QJ6\N/&YL=AD@9^IJAX<UR#Q+X>LM9MHI
M(H;M/,1),;@,D<XX[4 6=.TVVTO2;73+5"MK;0K!&I.2$48&3]!7(0?#*V@T
MW3=/77M6^S:7>+=6*[H_W.-WR_<^;[QY;)';'.>ZHH 0#  YX]:6BB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?Y]D<*GRT.. 21R.0 <'G-=%:>#[>/2+ZPU#4=0U1KZW:VFN+R4&3RR"-JX
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M=_#N;9&A'RJVTKQPQ(Y)SBMC1/AY8:#=K]EU356TV.7SH=+DN,V\39R,#&<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M& =J;1QQN]JVO$<NH>"M)U[5K?6'FM6@B^RVMTS2-;2%U1I [$L5^=3@Y H
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MM&/3$G'2F"3Q'XOLM9N=(O%M+VUU*:UM9#?.B0>4^T!X0A5]P&3NR?FXQ@4
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M.8OJ$<TD=QN78/+ +#&<YY'8=:I:!IVO:=XAOOMEY$VD7$2O;VKWDES+%("
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM],N5N+.*2Y7$)4$!00H)4 ]R2,8! R#J0^%;>#5M7U**_O5N-51([CF,@!
M57:-G& 2._7G-:FIWAT[2[J]6![@P1-)Y2$ M@9P"2!5?P]JZZ_X=T[5UA,*
MWMNDXC+;BFX9QGO0!0MO!FDP^#CX5F$UWI7E^4$N&!8+G( *@=#R#U%1Z+X)
ML-'@EAFOM3U5'A:W4:G<^<(XCP448  ( !XS@#FNEHH Y;P_X$T[PY-&;:_U
M2XMX"3:VEU=&2&VSD?(N!V) R3C)Q3X_ >BK9:O8RBYN+'5)))9K668F-&=M
MS% ,8^8 YY((XQ734V21(HWDD8*B LS'H .IH Q;+PQ#:W%I<7&H7U_-91M'
M:O=LA,(88)&U1EL#&YLG&>>3E-(\,V^@V6I06MW?2K?32W,F]TW"23EF0A1@
MD\^@]JRQXQU:Z@L+S2_"UQJ%AJ$8DMYH[I%*J2.9 P&S*G<,%L].#78T 8GA
M32;G1- BL;J[NKED=RC7<OFRJA8E59QU('IP.@X%,F\*6QUNZU>RO;W3KJ\C
M6.[-JR;9]HPI8.K88#C<,&M'4+J\M7LQ::>UXLUPL<S+*J>1&0<R'/W@,#@<
M\U=H YS4/!>F7^B6&CQR7-G8V,D<L,=LRCYD.5)+*2<'GW/7-3:EX8AU35=+
MU*?4+Y;C3&9K<QF,#<R[6)&SG(X]*W:I1W5XVLSVCZ>R6:0J\=YYJD2.2<IM
MZC  .?>@"BGAFT3Q+<ZZUQ<R7%S;"UEB<H8C&"2%QMSU)[]ZS]"^'^E^'[E6
MM+W5'LXG,EOI\UT6MH&)SE$QVR<9)P>>O-=710!R"?#G2(=9N;^WN]3M[>[E
M,USIT-T5M9G/4LF,\]QG!Z$8XK6L?#=O8>(]1UN.[NWN=05%GC<IY9" A, *
M", GOWYS6S10!@>&M&N=(FU5I;R^G@NKHS0QWLXE://WL$?=4GHO. !W)%1>
M(O!>G^([^TU%[J_T_4;52D5YI\_E2[#U0G!!7V(_G7244 <Y<>"[">/2D^UW
MR?V9<?:HF$JLSS<Y=V926)W-^?TJ>#PQ#;:]J6L17]ZMUJ$:13<QE0$!";1L
MXQD^O7G-'B'Q'_8%QI$364DZZE?QV0D5PJQL^<$]SP#T'XBMR@#R[Q!X:BT*
M#P7HFFR:H]K9:KYWG)'YCVZ;'^8LJ8QN;^('KSQ7<0^'+>)K^=KJZEO;Z,12
MWDA3S @!VJH"A0!DG[O4DG)K9HH Y=? >E+X=T[1A->;-,D66QN0ZB:W9>A5
M@N#W&"#G/.:M26EOX;@U#79$U#5+TQ*)76-9)Y$3.U$10JX!8G  SDDUO44
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M(&2>OL,=%10!YGX'\.C5/#^KVFHRZG#:W&J7,DUC)'Y22QM(2/O)OVL,9"L
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MLZ0N\<9D=5)5 0-Q[#)Z53M-1<Z5:76IV_\ 9UQ/L5K9Y Y21C@)N'!.3VH
MK6/AV*UOX+ZZO;O4;NWB:&":[*$Q*V-V BJ,G:N203QUH\0^&[3Q);VB7,US
M;RVEPMS;W%K($DCD (R"01T)&"#45GXC^U>,+_P\UE)$]I;1W'GLX(D5V(&
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M#M+%"ARN3TQ]#0!D:5J6I1:1?:-J.O7C'3_$(L89P"US?18#B ,""'(/+Y&
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MNWA2Z X'F!>O''&*T%\,V<?B$:W%-<178M/L2JA41K"#N"A=N.#SGK^'% '
MZ1XDU7_A&?#^G2WDD\MWK-SISW4]P8W>.(R[5,@!(9MJKD#)YZ$Y&Y_8NK6E
MCXEAU+4-VFSVQFM+5;^:6:W(0[_WA"L4)P<$D#ITK1?X>:%+X<FT*<7,UG)<
M&Z4O+^\BF)+%T8 $'))_$]JMV/A&SL-)N[!;W4IVNT\N>[NKDRSLF" NYLX
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M2QEVD&P98AB%Y/&WW.8K^#4+6?X>6VJZA'J%]!J<D4UU&.)"L4HY]QC!]P:
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MY,>[=@C.#SCC&.,XSS5_6M"L=?M88+Y9/W$RW$$D4C1O%*N=KJ1W&3^=:5%
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MH!;S_P"E2A9T P!(H;#XR>6S0!Q22W>JW?PO>XU&_5M1L)3>>5<N@F(M0V2
M< Y)^88//!'&*6H&>P\'_$C3[:^ODATNXWV;"[DWQ!HD8J'W;BN2>"2.:] M
M? V@V;:2T%O<*VDAELS]KE/E[AM/\7.5XYSP .E$W@;0;B+58I8+EH]68->J
M;R7]\0,#/S<< #C'% '.BW?1_B#X1:VO+USJMI=+>B:Y>192D:,IVD[5()/W
M0.M9VD0:IXN\)VGB.'6(;"_2X:XENS)(3%L<[H63(79M&-O3&#U.3WC^%M*D
MU#3+YTN6N=,5DM'-U)^[###<;L-D  YSTJE'\/O#<6O2:Q%8NEQ++Y\D:SN(
M7ESG>8\[2V>>G7GK0!S^EZ,NK_$3Q;!=:AJA@L+JQFMHDO9 $8Q!SWY4G/R]
M.3Q7>ZCIECJ]FUGJ-G!=VSD%HIXPZD@Y'!JI8^'=.TW6+[5;9)EO+\J;EVN)
M'$FT87Y22!@<# K5H YWQ+H]@FCZQJ<-LEOJ/]G21B\M_P!W,%525 =<, "!
MQGM7#644NGV'PUUB*_OGO+][>VNFENG998WMV8J4)V\%00<9SR<GFO4[^Q@U
M*PGLKD.8)T,<@1RA*G@C(((_"L<^"]$:TTJU,-SY.E,KV2B[E_=%1A3][G X
MYSQ0!R^E;O%^D>*[N]NKB&^M=1NK6W>.9D-F(@ FT C!_B)[YYR.*Q[!W\2Z
M[\,]5U6.3[;>Z=>&=ED9-^U$VL,$8SDMQCK7H=QX1TBXOKR[\N>)[Y0MXD%P
M\:7  P-ZJ0"<<9ZD<'-2ZEX7TC59-.>YM2&TXG[*896B\L$!2OR$94@ %3P0
M* *'Q$UJ\\/> -7U33\BZAB C8#.S<P4MC_9#$_A6+X@A;P[J?A*_P!%N+AE
MO=1BL+J-IV<7,4B,3(V2<LNW=NZ]><5WES;07EK+:W,22P2H4DC<95E(P01Z
M5DZ=X6TK2FMGA2XD%DI6U6>=Y1;J1C"!B<<<9ZXX''% 'G=KH3ZUH'C6>;6M
M7CN--U:\%C(+^0>08T4J>OS#H/FS@=,9)J736O/$WB/PJNIWNH1)J/AQKB\@
MANGB61\Q\@*1LSG)VX/;UK6\)^&5NY/%*ZK:ZA##?ZO/.(7:2..X@;;M)'3G
M!R."1P>.*L:OI,EW\4=(N%MKZ.RM=.E@^TVZLBQR,RE5R."-H/J/6@#D_P"U
MM4\.6^J>'EU"[DTZ/Q)::?'>R2EI8+:8!W7S.ORCY<]1N^E=;=+-X>^)F@6F
MFO*-/U>VN5NK9G9D1HE5EE )^4DMM..N1GFNC?POHTNB7.CS62S65TS/.LC%
MFE<G)=F)W%LX.<Y&!C&!4EAH%EI]Q]I4SSW(B\E9[F=I76/.=H+'@9 SW.!G
M.!0!P7AW4;K3=<TO3?$-E=1:LRRM;:C;SF6UU;Y"23SP^/F (XQQ@$"F:';:
MGXG\+Z+XGAUJ"TO!(MS<70DD;=R?,A9-VW;_  [>V!BNYT_PII>F-9>2MPZ6
M"E;-)[AY1 "NT[=Q/;C)S@$@8!JG:_#[PW8ZX^K6UB\<SR^>8EG?R?-_O^5G
M;N[].#R.: .4$B^+/"WCJ_OY)C<6EQ>VD"+*R_9DB3"@ '@GEB>^<'(&*[3P
M3SX \.?]@NV_]%+4-YX$T&]U"^O6AN(I+^,I>);W4D4=QQC+HK!6.#U(^M;.
MEZ9::-IEOIUC&T=K;H(XD:1GVJ. ,L2: /)+>X?PKX+^(FL:4DBWEKK%S%"W
MF,P0-Y0W;22"1DMDC/%=)K\3>'+_ ,(ZCHEQ</\ ;-1AL+I&F:1;J*16)=LD
MY9=NX-UZ]JZB'PIHL%YJ5REGEM2W&ZC>1FBD+ !CY9.T$@ $@9-)IOA32M+:
MU,"3NMF"MHD]P\JVX(QA Q...,]0.!Q0!D?%>WCN/AAKWF@D1VQD4!B/F'3.
M.OT-9&O:;"/$GP]LXI)XHGENLLDS;\&V8D!B21GIP<C/&*[_ %'3K35M-N=/
MOH1-:W,9BEC)(W*1@C(Y'X5DKX,T5)=,E\NZ,NF;C:R->2ED)&TDDM\Q(XYS
MQQTH X&;5[KPMI?CBTM+N=;2QU*TCA>:9I#;1SB+S"&8E@!N8CG@G-==IF@W
MNF^*X-134X8K&XMS%)81O)(L[CYA("S'# =2.HZUJ1^$=%2357:U:7^U@!>K
M-,\BS8&!E6) XXXQ3/#O@S1/"[,VF03*Q7RU,UP\IC3.=B;B=J\#@=<#/04
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M<8Q0!W&J:[=)K@T+2H8)=2-D][_I#%8P@8(HX&<LQ/TP>O2KJ:L;3PX-5UN
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M;.[/11WP3R<FJUM877C:QU\G5H+*_L]3G@2X*.9[$1/A-I\P8!4 GC!R<YH
M]4HKS1$G\7>(_$.C75]:R/:6]LD'FQ/D*\(8SQ@.-I+L>>HP!FH9--F7Q;X'
MTZ\UJZU'?9WT-S.DSQK<>6J@$J&.#R02#D]S0!ZC17CT6B6TGA_X@6KS7AM]
M(N+AM/C^U2 6Q\A9 5Y[-R,YQVZG.G;:G=:YJWAG2+ZXMV2Z\/1WNR[0NES.
M=H;(##<P'(!S]XG'&0 >G4C,%4LQ 4#))[5Y-K&BW>BZ7X>TZ37[F[9/%$$(
M:&1X_)A<%A"<L=VWC!/(&.E6AIUO9>(_&^B1>:VFR:1%=&WEF>0"0B0,PW$G
MG:,^N* /2+"^M]2L(+ZTD$EO.@DB<=&4\@U8KE/AK:P6WPZT!HD"&:P@=SG[
MS%!S75T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVYQQC'M7GNF>#XY(%ANO!VM6FLMEI;JUU7R;7S222Z[)OE7)R $) [&O7:*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "N<\7:=HESIDMUXCNI8]-MXR
M2BW#Q*#_ 'OD(+-Z#G'8<UT=9.H:U+8:E%9_V-J-S%+'N^TV\:O&K9QL;YL@
M^^,<]: ,OX;R2R?#_27FU(:BQC8BX\S>2N]MJLW=E7"GW!KJJXW1=/NO!GA3
M4[BVTF6YGGOI;V/3+9EW1B1QB,'.WA>3CCJ!GC/8J25!(()'0]J %HHHH **
M** "O.[2-(_C;JJ!9&ACT:.X2 ,2HD,A!95S@,0.M>B5PEK;7T7Q>U+5WTZ[
M&G2:7':I<>7D-(KEB,=>AZX[4 21_$W3I-+@U7^R=5737NOLLUT\2!;=O,\L
M;AOR1NQRH.,\\\5NW^N0_P!H3Z1;65SJ%U' );B.W95\I&R%!9F7YFPV #GC
M/ YKSQ]$UEO@[>Z*-(O/[2DU$S);[1DH;L2YSG'W??KQ6_;)JOA_XAZUJ/\
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MC")&?4N"00/]G)]J );G7UAU"33+:SGU"_@@6>XBMR@$:MD+DNRC+;6P/;G
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MSG891;<Y?^[O)( /3"YQV .TC\50IK=OI%_87=A=W<3RVHFV,L^T995*,1O
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MX+*XBFE:/ C>39M![_PG..E %N#QY83MITHL[Q;#4KQK&UO&5=CRJ6&"N[<
M2C $CMSBL[0K:(_%+QI"0QCDM;$L"Y[K+G'/'X5S<MCXFU&S\/W>H^'=0FUF
MQUR.XOI3)'M,8+C$ +X"8*_W>G.3DUUFD6][;?$;Q/J,]A<I:75M:I#*$R)&
MB5]X&.?XACCGM0 SX29_X5EI.22=UQR3DG]_)7;5R/PRL;W2_ =CI^HVDMK=
MP/-OBE R-TKL,$9!X85UU !1110 4444 %%%% !1110 4444 %%%% !1110
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M0X9&8?PG(SQ7*>+M3.KW?@>]_LF>"&?7+=[>YD9<E"K'#*#E=W# <].<$8H
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MU.=;Z%=GF/.-H>0_/C!) X)Z9Q0!N?\ "$>'_P#GTF_\"YO_ (NC_A"/#_\
MSZ3?^!<W_P 73+3Q<DWB6#1;G2[VS:[@>>SFGV;9U3&X8#%E(# X8 X].E:N
MKZO;:-9K<7 =S)*D$,48!>61SA47.!DGU( Y)P!0!F_\(1X?_P"?2;_P+F_^
M+H_X0CP__P ^DW_@7-_\73!XQMK:75HM7M)]..EP+<S22#?&\1!P48=3D$8Z
MYZ9I?^$M2WU/3;/4].N; :F2MI+*RLK/C/EO@G8Y'0<@X(SF@!W_  A'A_\
MY])O_ N;_P"+H_X0CP__ ,^DW_@7-_\ %UDS_$B..QUB\C\/ZK)#H]R\%Z1Y
M0\L(JLS??PW#=%R<#)QD9T;[QI!:ZU8:7;Z9?7DU_:M=6SPA-LBC'&2PP?F'
M+8'O0!+_ ,(1X?\ ^?2;_P "YO\ XNC_ (0CP_\ \^DW_@7-_P#%U!8>.+&[
MT*?49K:XM9K>].GRVDA4R"X#!=@(.TYR#G.,<D@ TR'Q]IB7VJ66IJ;&?3K7
M[;)EUD1X,XWJRDYP>", Y(QF@"U_PA'A_P#Y])O_  +F_P#BZ1O!7AY5+-:R
MA1R2;R;C_P ?H3Q1+_:MOIT^B7T,UW;/<6I.TA]H!*.0<(_(ZG'O7+V_B]=7
M^$]]K?B70I[FQ?S_ #H870AXQ,ZA1\P.%"J">">HS0!U/_"$>'_^?2;_ ,"Y
MO_BZ/^$(\/\ _/I-_P"!<W_Q=33:[!;7-CI=E:M/>SVQGCMT8*(X5P-S,>@R
M0!U)/;@D9%W\1=/L_#6I:N]A>E]+G^S7MF GFP/D 9^;!4[@05SD'ZX -O3_
M  QI.EW:W5I;R),H(#-<2..?9F(K7KG;/Q8MQXH&A7.EWEE++;M<VLL^S;.B
MD!L!6)4\@X8 XZXZ5/XG\1Q>%]/BOKBSN)[=ITA=X2H$6]@JLVXCY<D#- &W
M2%E7&2!DX&3U-8D?B6-_&$OAM[*XCN4M?M:S,R>7)'NVY7G.<\'CBL?5O$&E
MWEMX=N=3T.ZDCN]6CCL79D(CFRP24X?." Q'!XQG&: .TI P894@CIQ7(V.O
MWVJ>/-=T"XTP_P!GVD%N 2Z$'?YA+L,YPP   STYQFN6^'_BI/#_ ,/O#\5Q
MI=ZUC+=R6KWR[/+B=[APN06W$9(R0,#/4G(H ]%U;15U:2V<ZA?VA@+<6LVQ
M9 PP0X((8>G<=B*N6=G;Z?9065I$L-M!&L44:]%4#  _"EO+J*QLI[N<D0P1
MM*Y4$G:HR< =>!7/6'C*.[U+3;*?3;JV?5+1KRR+,I\Q5"DJP!^5\,IQT]Z
M.GHKA7^)MLFD7&K'0M4&GVEVUK>3-Y8^SE7"$D;\MR?X<X'>MW_A)HQXR7PW
M)8W$<SVQNHKABGE2H" 0O.2P)&1CWZ4 ;M%9^E:H-4^ULEM+%';W#VX=RI$I
M0X8K@G@$$<XY!K@?%,.E+\7]$74S;Q6<VFSM,)I D;N&&TMR 3R>: /3J*\F
M\,^)Y_#FF>,-4=-0U'PO8W8.F/OWL4YW[&=@6C!V@')]L\UV2^,E4'[3H^H6
MSS7$=O8I($!O"ZE@4^;@  D[L8 YYXH Z>BN>M_%]F-1U'3M3B?3KRPMOMDJ
MS,&5H.<RHPZJ""#T(/:FV_BP2ZEI=M-I5[!#JJ.]I.RAA\J[L2 '*$KR,_0X
M/% '1T5Q]U\0]-M%L[N2"0Z7=7(MDO5D0@,20K%,[@A(^]^.,<U+K/CNRTB"
M^NA:RW-GI\OE7<L4B H1C=M4D%MN>?QQD@T =73=Z!=VY<9QG/?.,?G6%-XC
MM[VY;3],M&U.0VJW,P1U5%BDSL!+?Q, <#T'..,^?^&K_2K+X.Z>^K:1<7=C
M)JDB"$;1Y3F[;86RP/#8Z9H ]?HKF;[QA]E\33>'[?1;^[OTLQ=H(S&$D0MM
MX8L .0?O8Z<9R*9;^.]-N/"]EK0@N%-Y="RBM& $IN"Y3RSS@<@\YQ@9H ZF
MBN?T_P 4B]\37?A^33;J&]M$625]R-$$8$JP.X,0<$?=X(YJWJ^MII=SI]HE
MM+<7=_*T4$:<+E5+L68\*  ?4^@H T)[:&Y,?G1AQ&X=0W3<.AQT.#R/0\U+
M7+P>.;&;29+QK>:&>/43I;6\C*"+D,%V[L[=O.<^GOQ6SIFH37QNTGL9;26V
MF\HJ[!@_R*VY2.J_-CL<@\4 7Z*Y.X\2:BGQ+@\/QZ>[6?\ 9S7+2+(F6)D1
M=V">%7YN.ISTXIUWXXMK?3;K5XK"ZN-'M)FBGO(BIQM;:[JN<LBD$$CT. 1S
M0!U5%0I<)/9K<VQ$Z/'YD90C#@C(P>G-<B_Q&M$\*-XA?2KY;:.[-I<1,8Q)
M;N)/+)<;L ;CZ]P: .TI%8,H92"#T(KG?$5ZEU9ZGH\ME)(ITQ[B63*E$!#!
M0><Y)4XP/X37-^"O%BZ;X7\&:==:7>1VU]:PVL-\VSRS-Y>0NW=OP=IP<8./
M3F@#T8,I8J",CJ,]*CDMH99XII(PSQ$F,GG:2,9 Z9QD9ZX)]37,6&L:)%XI
M\52-826-W80V\FHWDQ&V6/8Y1AACP%4^AYZ<58A\4K<:AIME<Z1>PP:M&[6L
MS*&4@+NQ( 3L)4Y&?H<'B@#HPP;."#@X.*6O)?"/B>+PGX4O99-*O)--AUJZ
MCGNHM@2W5IRJG!8,P&1G:#C]*]7F=XX'>.(RNJDK&" 6/ID\4 .9@JEF( ')
M)[4M>.^(M;NO%GP&U35=2L?*D+,\3;E*C%R5 7!S\J@+D@9_&O0+/Q8L_B<:
M'<Z9>64LMNUS:RS[-LZ*0&X#$J1D'# ''7'2@#HJ*Y";XAZ;;G3[B2"3^S+^
MX6V@O%D0C<Q(1F3.X(V.&^F0*Z>_@BN;">&>-9(V0AE89!XH L45Y3X$\1V_
MA?X/:#JMU9W5TUW+Y4LL(#/N:9E4OD[CV'&3VKM-.\6QW6OWFCWNG76FW-O;
M"\7[2T962#<5WY5B!@CD'F@"QJ'AVVOO$.G:W->74=QIP=8$1D$8$@ 8$%23
MG [_ $Q6U7EOCG65US1?#M_#I<_V*;6;-K6\<J"5,HPQ7.0K#D'Z9 S76:SX
MSMM*747BM)+Q-,&;PQRHI3Y0Y"AB-S!2"1[@9SQ0!TU%<G_PGEI/JEE8:?IM
M]>O?:?\ VA:R1; DJ97C+,-I^;G=C&.YQ5)OB5$-!NM6'A_5#%I\SPZDO[L&
MT9&PW5OGQU^7/'7% '<TC,J*68@*.I)Z5S5_XRBM-?MM&@TN^O+BZM&N[=H=
M@2500, EAC[W5L#Z\5DZMXOT?5/AUJVI:IHEY/9VTKVNH:>2F^-T8!@3N (!
MP<J3UH [RBN0U'Q+?VGCC1=#M=-9[.XM99V970%MNT  $C 7=D]SVZ<KJ_C^
MPTBVN;YK:6?3K.?[/<W$<B91@VUB$)W,%;@X]#@'% '745S6J^,K6P%Z;6W:
M^%C$)KGRI47:"N\!=Q&YMN&QZ$<Y.*V-)U2TUO2+75+%S):W42RQ,1@D$=QV
M- %P,K9P0<'!P>AI:XK2_$NA6&G^)=3ATR:P%MJAAO5D*[IK@^6N[.XJ 2RC
M.0.YQ72:?J,]W=W-K<6$MK) J-N+ATD#;N5(]-ISD#^M &C12$D*2!D^GK7'
M2?$*VB\-ZOK3Z1?^7I-T]K=V^8_-0KC<V-V"OS ]>G- '945E-K:K?6EM]FE
M87%L]TTJ,K+$B[>N#DYW#& <\^E96G^-X+V\T6)]/NK>#6UD:QF<K\VQ=^'4
M'*DJ,CK[X- '545S]GXI74)(GM+"::RDO'L_M*.IV.A96++G(7*D#OR.!FN@
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *Y/XE:;?ZSX U/3=,LWNKRY5$CC1E7HZDDEB!C
M -=910!QMS::E-\3-)U==+N18Q:9-!+*6C^1W9& (W9_A.2 :Y67PMXCDT:^
MN+?3'2^M/%3ZY:VTTJ 746[A<AB%)!/7'2O7** /.YK+5O$'CF'4)-"OK'3Y
MM$GL)))WB#Q/(ZG)4.>, ].?:F^$(O$-C:6&@:CX3@BGL=D+:L'C:&2), .H
M^_O*C&,=>3CI7HC21HR*[JK.<*"<%CC.!Z\"G4 >;0Z/K0\._$"U;1[D3:M<
MW,EDI>+]XLD*QK_'QR.^.*FN=*U=T\ ;=(N2=*=6O1OC_=8@,9_CYY/;/%>A
MTUY$CQO=5W$*-QQDGH* /-UT?6O["^(5L='N1+J\UP]DN^+]Z'A6-?X^.1WQ
MQ5@Z5JYU/X>S?V3<;-*BD6].^/\ <EK?R@/O<_-Z9XKT*B@#CM+L]2A^)VN:
MC+ILZ6%U:6\,-P6C*LT9?=P&W ?,.W:J0\/SQ_$^X2VE3^Q[I(M4O+?TN4)1
M#[!B _N8:[N:)9X)(7+!9%*G:Q4X(QP1R*S- \.6'ANS:VL?/?>07EN)FED?
M' !9CG '0=!0!JD9!%>1Q:!XC7X1V'AMM!N/MUE=0 @318D5)_,9E._[NT#&
M<$D].]>NT4 <)JFB:AJWQ GN#8W$6FW7AZ736NBR?)(\@;[N[/ [XZU7\()X
MAMK:PT34O"4%O<6(2*350\;0R1I@!T ^8NP'3 P3D^E>AT4 9GB))Y?#FHPV
MUO)<3RVTD<<494%F92!RQ Z^]>?IH>NKX$\$::=%N?M>E:C:37<?F1?(D6=Q
M!WX/48 YKU.FI(DJ[HW5UR1E3D9!P?UH \ZUSPSJNO>)/%2+:2V]KJ>BI907
M;LFWS5+GD!BP'S#MZU5NT\3:MI'A*VF\+WD5WI.J6TMX?.A\MEC1U9HSOY!S
MGG'7'->HT4 >:V5EKOAS7]7LO^$436;+4+Z2]M+U9(E$1D.YDEW<@*<\@'CH
M#TK6M].U2#XG?VG)I\C62Z&ED;B/8$:992Y"KNW 8/'%=H2 ,G@4U'21%=&#
M(PRK*<@CU% 'D\_AW7Y?A'KNAKHMP-1N[Z:6&$R1?,KS^8#G?@?+[]:Z=+74
MF^*7]M'2KE=/.B"U\TM'Q+YN_;C=GIWZ9KLZ* /)9?#OB!_A7J&C#1+G^T)M
M5:X2'S8N8S="7.=^/NCIGK747=EJD7Q.L-;@TR6>RFTEK*1ED1?(<RJ^7!.<
M8!^[GFNRHH \Q\-Z?X@\/Q/X9F\+0W:Q3.+36"\?E&)F+!I ?FW+GH!SCMUJ
M<V6M^'/%VLF/PN-=TW5;@7<$\<D2O!(4561]Y'R_*"".GOV]'H) !). * *]
MDDL5A"DZQ"98QO6$80-CD+[>E>877A_7I_ 'CC3%T:X%YJFJ7$]I&9(OGCD9
M2&SOP/NG(/->JHZR(KHP9&&593D$>HIU '%ZA9:G=>//"FI1Z7<"TL[:YCN9
M&:/]TTBH%!&[)Y4YQFK'C_1]4U32+&YT5$EU'2[^*_AMW;:)]F04R>!D,>:Z
MRB@#A-<LM;\?^"M6TV;2Y-$^T6X6&.ZD5G>4,&!.PD*F5QZG<3@8&5OK+5/%
MX\-1WVE3Z?)IU_%?WKRLA4/$K81"K'=N8CGIM!SSQ7=44 >9C1=;/A?X@V9T
M>Y$^KW5S)9*9(OWBR1*BG._CE3UQQ5RTTW5E\6>$KQ])N4M['29+:Y<O'^[D
M81@# ?)^X>1GM7H%% 'D\OA;Q#<:+KCP:9Y=]'XE;6;*"Y>/9=1C:-A(8XR
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MBQ )PHP!SR<GCH3H>%M0\475G::7JWA]]/DMHQ%=WCSHT<NT8S$%))+<'D
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M!(X/7K7)7W@^XN_&]_N1&\.ZM;QRZA&3]^>+*JH'8,"C$_\ 3/WKN54*H50
M , #M2T <5X-T+7-%\,745[)')JL,;65D[]###N$!;ZY+'V(]*YRSTGQ'-J7
M@[5;KPY=G4+&:4:G<7%S$SR.\+(6!#']V&.<#&!P%->L44 >:Q^'+T>)[+6=
M)TV\T74GO\ZHJ2+]DNK?)W.5#$%F&",#<">1WKTJBB@ HHHH **** "BBB@
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M>WM=:>2.SE=OG!4%AYB8&W<%)&">V<54\6ZVNK>&/%%K9Z8+^TL8)H+F5G4
M2B/)"*1\Q3()Y'/ R17/6VA>*9F\+7UWX>+:II]\7U&YFO(F>?*.N]2"?W>6
M!V\$= M7(-'\1Z)9>+=!BT:2_M=4ENKJRO(IXU53,IRD@9@P(/< YSVH U=
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MC/&.IXK;ETW5;;XI?VQ#8>?I]SI<=H\PF5?)=968[@3D@AN, \]<=: )-/\
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M;&ZMTCE5TN4!P0C';\P/4''7.2*XUO!&OQZ J6<L\G]E:U%J.D6=_.&D\E%
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M\I=H;?C/S=?NKD]/7%.L_&[S7VA17>DO:0ZWY@M"\O[U"JEAYL94;<@=BW-
M'7T5PFA^,;_/BR^UR&"#3]*O9(MT4Q<HJ1H=H&T;B<DYR.3C%7++QW!-XGL=
M$N(;97U")WMI;6\6X *#+))@#8V.1U!P<&@#KR<#)Z4R.:*90T4J.I. 58$&
MN4^(]IJMWX80Z5:?;C!=Q3W-ANQ]K@4Y>+WSQQWQC!S@Y?A+4_"/B?7(=4T.
M)+#5K.*2*ZT]XO(E .!\R#@X( W#.,X]J /0J*X'0O&6K-I7B?5-4TTRQZ=?
MSP)#9.97)CV*(U7:,Y.3NSW/ K8@\47<FOWN@2Z;"FJ06*WL2I=;XI%+%<,V
MP%2&']T\'- '345YSH?CS4T\ :5XAU73XYEO;A(RT5Q@CS92H.TKP%R!C/05
MTTWBA+;Q7<Z)<6I40Z:=2%PC[@8P^TC;C(.<^M '045S^A>(Y]<%E<1V,7]G
MWMLUQ%<PW/FA<%<(XVC#88\ G[I%=!0 45QUEXAU:;XBZUI<]O;)IMA:P.&\
M\Y4-YA+D;>IV@8SP!U.:)_'JVVAVWB.736'AZ>15^UB7]Y&C-M65H]O"$XZ,
M2 0<=0 #L:CFGBMTWS2I&F0NYV &3P!S4=[--#83S6L233)&6C1WV*QQP"V#
M@?@:\DU;5+SQ!\*- UO5K2%KE]2LYHY(SO8[IQG P-O'&,GB@#V.BN8LO%Y.
MO:AI.KZ<VF26EF+]7:=9%>WR5+';]T@CD<_6J$/Q&M&U/1X)((/LVK.([>2&
M[662-R,J)8P/DSTX+8/!Q0!VU5XKZTGN);>&Z@DGB_UD:2 LGU Y%9OBZ\O=
M/\(ZM=V"*;B&TE=6,FS9A&.X<')&.GZUQND7=OHNB^"M6O="@-W<QVNEPW45
MP3(JS(IW,-HR"02022#TZF@#TRH/MMI]F^T_:H?L^<>;Y@VYSCKTZ\5D0ZW'
MJ/B?4_#5U8*1;VT<Y=F#I+'(6 !4C@_*<CFO+DMX7_9ST9WB1GANH3&Q4$H3
M> ''IP2* /;Z:Z[T90S*2,;EZCZ5SNL^+H=.U"?3[86<MY;P+/*EU>K;C#9V
MJI(.6.T\8 '&2,BJ>F_$"SUN#1CI<*&XU6WEGBBO)O)QY;!63(5LMN/0#H"<
M^H!N:#H%EX;L&LM/,PMS(TFV60OAF)9B">>22:U*X;5O%&NQZYX1M;;3(X5U
M-YFGAFN-KADB<^62%( !P<]R />NNU+4K;2-)N=2OG\NWMHFEE8<X &3CU-
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M6M71],U.U^(FOZG/9.MC?6]M%#.9$.3$'!)4'(!W<<=N<5UU% 'F\?A_7/\
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MU>[O;[PC\.M5U"UCFOGU33W5XI-\DH:(L22RKM+'J,D>]='X8\.:I:?#W4-
MOX8[>ZF^UA&$@=")F=@<CGC?@\=JSF\/^(YO"_@VPETV%9]%O;268)<JP:.%
M"A()Q\S9R!T]30!M6OC?R9_$$&NV"Z=)HL"74ABG\Y9(6#$$':IW?*1C'7')
MJ.#QWNU_3],EL[:0:A&Y@DLKT3F-U7=LE 4!"1T()&<CWJCJ?A"_US7_ !7]
MHB^SV.L:;%9PS[U+(Z;OF*@],L/R[5I>';CQLZ0VVO:=90+:K^]NK>Y$C7A
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MM-,%>!0ORE0,ALGW_P#K &G1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MEK)9ZA/9%$D,@)C.TG) ZG/:M^@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2^UR,'D\KC;G/:MN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "J&KZ-8:]ITFGZG!Y]I(07BWLH;!
MR,[2,C/.*OT4 91\.:8VJ0:FT,IO8(O)BF-Q(65.Z_>Y![YZU7'@[0/[-O\
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M+&=1*^Z4MPQ=\[F)'!)/(K2H!!&0<B@"IINF6FD6$5C8QM%;0J%CC,C.$4#
M W$X ]*JS>&])GUEM7>S']H-$(3.KLK%1G'0CD9.#U&>#6KG-% & /!7A\:/
M#I L6&GPR^=';BXEVJ^=V1\WKS]>:M?\(YI9U9]5-NYOG@^S-*T\A+1?W"-V
M,9Y^O/6K&H-J:O9_V<MHRFX477VAF!$.#N*8_CSC&>.M7<CUH R=/\-:5IDE
MO):V[@VR&.W\V>240J>"$#L0O  XQQQTJQJFCZ?K5O';ZC;)<11R"5%8D;7
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M?-Z<?3CI2W'A/0[NQL+*XL1)!I[!K4-(Y,6!C ;.<8XP3C'%;61ZT9&<9YH
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MMU]H5O.6/#B-8@/EPZJ,DXP#CK0!H>%],.G:.KRP)#>7CM=W*J -LDA+%?\
M@((4?[M<=;6EM:?$KQO?6VG6SWMO86L]O^Z7<92DO(.,Y8X!/4UZ76<^A:7)
MK:ZRUC"=16/RQ<;?FV\\?J>?>@#RR[6.7X)V'BO3VSXBB2&Y6_7_ %TEP955
MT9NK DLNT\=!C@5Z9XEO;W3_  ?JU]91YOH+&66)0,_O A(X[\_G1!X6T2VN
MS<0V"(QF^T>6&;RA+_ST$>=@;_: S6Q0!Y+J<$-M\.O#'B30P/[9\VR9+E/]
M;=-*RK(DC=7W;CD'N/:K^E>&]+U?XE^,4OX9)TM;BPG@1IG 23RMVX8/7/\
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MHMQ^YC<&2=5$90S$  N23TS@D\G-8>HI9:]\ ;GQ#=I%/J\KB:XNF'[Q9?M
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MPL&B6]NX]*9I+>\(^RP1,^/-VX),A(QQC@')&1GBK%3J7@GX82W4\\DLFH)
M[B9@Q3;+QD'_ &1SUXKU>_\ #6BZIJ<&I7VG03WD";(Y77)"YSM/J,\X.:JQ
M>"O#EO;VL$&E1116DIG@6-F7RY#_ !C!^][]<<4 <IHOA[39?%?CKPRMN(M)
MEALW%NG"QN\;[G0?PME0<CN,U#X3;^UX--\(ZA;1FZ\.7#"_'E_*PC&(&'_7
M3<'SWV-ZUV=]IBZ3_:.M:+I O-:F1=T9NC&;C!P 6;(& 3C(XZ#%/\/V%S$;
MS4]1MHK?4=1D62:*-]XB55"HF_ W8 ))]6..,4 2^)_^13UG_KQG_P#19KA_
M"?A&+Q+\/?"8U74+B;3[>""Y6R555'=1\H<XRRCTR/?->BWUC;ZE9R6EVADM
MY5*R)N*A@>"#@C(/I4>F:79:-8I9:?#Y%M'PD08E4'H 3P/84 <!8>&]+UGX
MG^,8=0ADGBA&G3QQF9P%DVR-NX/4$?J?4UFV,<'B#X4:]KFH@)K\#WLSW72:
MTFB9C&JMU4*H08'8GU->F6VA:;::M<ZI!;;+ZY $\V]B9 .@.3@@=O3M4$OA
M;1)KV>[>P3S;A@\ZAF"3,.C.@.UR..2#0!Q6A7Y\0^+8-,\50Q23-X?M;F&T
MG0%'D?/GOM/&X':/4 ''4TR=;73-6\*^%XM36?1VBNXXI=37[0D\Z.H5&Y4-
MM!<+VX'!(!'<:[X4T+Q+Y!UC3(+MH"3$SY#)GJ 00<>W2EU/POH>L:/%I-_I
M=M-818\J IA8\# VXQMXXXQ0!Y]JEL/!]I:Z8-9A?3+S7D6Z1H"+>S5XV80[
M=_$9<(2NX  \\-RGBJTF\$:%XEU'3-5CC>\BMS):6-N8H[56D6-ID&YMK%2W
M(QDC/:O0D\+:%'X?.@KI5M_9;##6I3*GG.3ZG/.>N:;I?A/0=%TJ?3-/TJVA
MLK@$31;=PE!&,-G);CCF@#D=5TC2=/\ B1X!FTRUMX5D^V+OA  D46Y()(^]
MU/)YYK(FMHU\,?%:(&3;#/.Z?O&R"+96'.<]:[RT\">&+&6UD@T> /:,6MRY
M9_*S_=W$X'H.@[58_P"$3T3R;^(V(,>H'=>*97Q.?5^>?3Z4 <-!IMKI7BCX
M=7EFC1W-]!+%=R[R6G3[+N 8D\@$ @=L<56U#1[_ %K2O%^GK;/=ZW+JS?8-
M0C^[$F4*CS?^6?EKD,O'? ))KT4^&=(:2P<VA+Z>,6A,KY@&,?+SQQQ]..E<
M G@HW5]<MK?@*"\U&>XDD?4K;4%BADW,2"0&#K@8'W2>,\DT >GV5JEE90VT
M8PD:A1R3_/FIZI:/8OIFC6EE),TSP1*AD9BQ.!ZGD_4\^M7: "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "J.L:M:Z'I-QJ-XS"&!<D*,LQ)PJJ.Y)( 'J:O5PGQ/9Q;>%UY^
MSOXCLA<>FS<3S[;@M '9VCW/V-9+X11RD;F1#E8_;)ZX]>,^@HNKZULK"6^N
M;B.*UA0R22LWRJH&2<UR'BJZ+?$+PEIEZH.E7/VERCC*2SJ@V!AT. 6(![\]
M0*YC7;!;2;XD:9;P(=&71A>"#:#'!=&-^4'120H8X[X- '9:OXINK:\\*M8Q
M0-9:S<K%(90?,56C9QC!P#QWS75*ZN,HP89QD'/->6:G86']E_#BUA@BCAEO
MH3*D V;B;9B2=N.2,9]:I:@S>&3\3H-"B^R06T-E,D-LNU8MZ$2NH&,':">,
M=,T >P+(CE@KJQ4X8 YP?>@2(6VAU)YX!].#7!Z=H.CW&O:1K-IJMB8Y[:2!
M;?3[81QWD17.) &.0N,@]CQWJK\(_#^ECP=H^M?9%;4E6YB6X+$L$,[_ "]>
MG'\_4T =U=ZO966I6&GS3 75\[K!'GD[4+L<>@ Z^I'K6/H7B&]OO$_B72[]
M+6.+2I8$A>/(+"2/?\Q)Z\@< 5C>,-/L+GXF>"3=VEM*)!?+(98U;<%AR <C
MD Y(]*R)M&TW6/$GQ,^WVD5TL<=NT8D&Y4;[(,,!T#>C=1VH ]4>1(D+2.J*
M.I8X%*64*&+#![YKR[1[BVU6T\"V\X-YJQT3SUCNG'V<(4C5I7!!+OV &.K9
M(ZUSUO##=?#'PTDCAS!XG2&-HV*[(S=N %(.0,#CGC ]* /<5=7)VL#M.#@]
M#2NZHI9V"J.I)P!7!:+I]GHOQ?U2RTVWCM+6?18+B2&%=JM)YTB[R!WQWK0\
M7/92Z_X:L98WN+Z6XFDM+9Y MNY2,[FER#G:&RH SNQ[D '6JP90RD$'D$=Z
MY+7O$FKZ=XTT;0;*"RD75(YG268N#'Y2@D''7.?:J7PN;9I_B&V$D3)!KUVD
M2PC:BKE3A%R<+DGC/>J_BV)YOBYX(CBN9+=S!?XDC"DC]VO9@1^E &WX9\6R
M:QK.LZ'J%DMGJNDN@F6.3S(Y$<95U8@'D=B.,UTRNC9VLIQUP>E>=^*_!^G:
M/X"\97IDGO=0O[22>XN[I@7=D0[  H  7L *SM8TW3] TCPO-;6JPV^L7UC#
MJ\^XGST"$J)"3]TL1D]^AX- 'JJ2)(NZ-U9?53D4"1#(8PZ[P,E<\@?2O.=7
MBNM!^(DA\.P+&+G0KF>YMHEPAEC($3[1QN).W/<#VIWA6T\-ZQX6\)ZX;G&H
M1-&QN(I )IKEEVRI(>K98DL/09Z"@#T0R()!&74.>0I/)_"AI$0J'=5+'"Y.
M,GVKR'3[2U\7>&-1FU/6+6QU.TU&9[J=;<?:[22.8E-KEL@;0J@8Z<"KOV>W
M\5:YXPT;6+VRBN8Y1&BW5N&EBMC"A1XR6&WYMS9 X8Y/:@#U"618HRS,J@=W
M.!GZUR.B:_K^O>'=;E@73(=4LM1GLX3*'\C$; 9;!W<C/3VK%T66"\\?VVBZ
ME<_VC;6FA0R:>UTH/VDLQ$DV#P6("C/IGU-<M?65I'\%O'4$42"&VUJZ$*KT
M3$R 8_#B@#W+<% #,H./6E5E=0RL&4\@@Y!KS[7=)L+_ .,&CQW5LDT<VD7/
MFQMRL@#QX##HPYZ'BN=B@EA^&OBRPL)DMX+/Q%-## 7V*T(F0F!3VW9*@=]V
M.] 'L22)(NZ-U<=,J<USGC/7K_P_9Z=<645NZW&HV]I+YP8D+(X4E<$<\]ZS
M-+\/BX^(LGB*+3EL]/33DA6-PJL]QN/SA5)QA/ER>N>,@9H^*4:R^'M,C8L%
M?6;)258J<&4=".1]10!VRNC;MKJ=IP<'H:7(QG(Q7FY\,Z;I/Q2L[/2+*..P
MU'2YSJMHHS$ZJRB-V7IN)9AGO@^]4-"LTMWG^&4]LKI:WPN5=DR)+ MYJL3W
M.X"(_6@#UBFB1&=D#J67JH/(K$\8W5[IO@C6;G2E(NX+*1H-@Y4A3R!ZCJ/I
M7#ZO:VL'A#P;K?A]$343=V:PS1??N%EP)$<]6# DMGN": /4S(@."Z@Y P35
M35SJ(TJX.DM:+?A<PF\W>4#GG=MYQC/2N!\/>&M'U'X@^,&N[))OL>HVD]N&
M)Q%)Y*MN&#US6G\7X8YOA9KAD0,8X5=">QW#F@#MMV  [*&(]?SI5974,K!E
M/((.0:\]US2K&_\ BWH4=U;I+'-I-SYJ-RL@#1X##HPYZ'BK?PRB2UL?$5C
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M%I4MND+QY!821[_F)/7D#@"L;QAI]A<_$OP2;NTMI1)]M63S8U;<%AR <CD
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M>6OEC,6QNJA5"D8]SW-=MX-GOK_P/HT^K;C>S64;3EN&8E1R?<CD_6@#<,B
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MXU8R8M48;B>N"2>?>@#UB;S?)D\G9YNT[-^=N['&<=JK::U[_9=L=4>U-Z4
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M0\17#9WQ_P"Z>WX5@>&=>UOQ'X#TK6%ETZVO9[C_ $CS$;RO+$S(54;LAB
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M[34;B)(!;PR^:(8U).-^!DEF8G'&-HYQFMI[F".=('GC69QE8RX#-]!WJ6@
MZUE6/AO1M-G6:STZ"%U9F0(/EC+?>*+T4G)S@#-2:?)>H+]M2NK)U2Y<PF %
M?+AP"HDR?OCDD\#D5=6>%Y6B26-I% +(&!(!Z$B@"G9Z)IFGWUS>VEG%#=7)
M!GE4?-*1TW'O^-2ZEI=CK%DUGJ-K'=6SD%HI1E6QTR.]9WB[Q$GA;P[-J;1H
M["2.)!(VU SN%!9NRC.2?05"EWXBM=6TR&Z.G7EC>.R2W%M$\30XC9Q\I=PP
M)7&[(^G.0 7_ /A'])^W07ILHS=6Z>7#,<[XT_N@YX'M4NG:-IVD&<Z?:1VY
MN)#+-Y8QYCGJQ]2?7K5E[F".9(9)XTED^XC. S?0=Z)KF"V"F>>.(,=JF1PN
M3Z#- %6[T32[_4+:_N["WFO+8$0SN@+QY]#V]:J_\(GH/V&YL?[*M_LES)YL
M\.WY)7_O,.A/N:GN]=T^SUFSTF6X07MVKO''N&0BCECZ#.![GZ&GVAU#^UM0
M%S<6CVG[LVL<2D2QC;\WF$G!RW3 '% %35/"/A_6[:VM]3TBUNXK;B$2IN,8
M] >N.G%:T$$5M!'!!$D4,:A$C10JJHX  '04B7,$LSPQSQO+']]%<%E^H[4D
MEU;P[O-GB3:0IW.!@GH/QH JV6A:9IMQ<W%G9QP371S.Z9!E/JQ[GWZU@^(?
M"JKX<GL?#^E:>R7%RDUY9S'8ET@;<ZYP0&; ^8C^A'75SQ\03ZCX@N=&T5(F
M-CM^W7DP+1PLPR(U4$%WQR>0%&,Y/% '/:#X)M(]5MK^'PG;>'G@8EWAN]TD
MH*D%,)\NTYR23VX'<=1_PB/A_P#LU]-_LFV^PN_F-;[?W;-G.2O3.>?K6OB7
MR<;D\W;][:=N['7&>GMG\:YKP5XDN-<T(7.J26L=XUY<6ZI%\@;RY&4;022>
M!ZT ;$FA:5+J-MJ$NGV\E[:IY<%PZ!G1?0,>:LWEG;:A:2VEY;Q7%M*NV2*5
M0RL/0@TZ>Y@M4#W$\<*DX!D<*"?3FN>\2:YJ&DZ_X;M;;[.;74KPV\^]"7 V
M,P*G.!]WN#0!KV&BZ=IBN+.U6(NH1GR2Q4=%W$YP,G S@9I--T/3-':9M.LH
MK8SN9)?+&-['JQ]2<=>M6Y;F"!T2:>.-I#A%=P"Q]!GK3FFB5PC2('/12PR:
M *FI:+IFL^1_:5A;W?V>3S(O.C#;&]1FH!X;T<2WLHT^(27PQ=,,YG'H_KQQ
MSVXK16X@8,5FC(7DD,.*RKO6O[.UBQ@NC&;+47\FVG7^";:2$;UW -@^HQW%
M !<^$O#][HT>CW.D6LNG1',5NZ96,_[/]W\*T-/TZRTFQBL=/M8K6UB&$BB4
M*J_@*I>*+^[TGPMJFI6/D_:+.UDN$$RED.Q2V" 0><>M.T'5!J6BZ=/-+%]L
MGLXKB6-" 064$G'4#)H EU71-,UN%(M3L8+I8VWQ^8N2C>JGJI]Q3M/TBPTL
M-]CMEC9\!GR6=@.@+')/YU96>%PQ26-@HR<,#BG(ZR*&1@RGN#D4 9B>&M%C
MOGO4TZ!9WE\]B%^4R?W]O3?_ +6,^]2KHFF1ZN^K)91C4'78UP!\[+_=)]/;
MI5O[3!Y@C\Z/S"Q4+N&20,D8]<<T)<V\D[P)/&TR#+1AP67ZCJ* .)\.>$RV
ML^);C6M'VQZA?FXB+RJRR1;54(ZJQSR"<,".:ZW4='T[5HX4OK2.80OOA)&&
MC;U5ARI^E6!=6YN3;"XB,X&3%O&['KCK0]U;QSB![B)96&1&S@,1]* *4WAW
M1[G2CI<VG026+-O:!ERKMG)+#^(YYR>_-)?>'-&U.RM[._TZWN;>V8-"DJ[O
M+(Z8STJ_-<P6[(LT\<9D.$#N!N/H,]:>TB(5#.JECA03C)]!0!EIX7T&.*^B
M31[)8[\!;I1"H$H P P],4?\(QH>+$#3+<"P_P"/4*N/)/<KCH3W/>M*&>*X
M3?#*DB9(W(P(R/I2RS16\32S2)'&O5W8 #\30!G7GAO1[^]>\NM/ADN'01R.
M1CS4'17Q]\>S9%2W.B:9>7UK?7%G%)=6H(MY2/FBSUV^F>^.M27NHVUCI<^H
M22*;>&)I2RD'<H&>/7I6!X;U/7]932]6:336TJ_LQ/+ JL)K9V4,BALD.,'!
MR%Z9'I0!MV.BZ;IMS<7-E:1P37+;IW3K*?5O4^YHO]%TS5+FUN;^PM[F:T8O
M;R2QAC&3U(STZ#\A4*:Y9W>KW^C6=S$=0M(HWD#?,J%]VT$ @D_(21QP1ZUF
M^!?$DWB+PCINHZD]M'?79F_=Q?*#LD=?E!)/110!I7/AK1KN^DO9].@>XE"B
M5BN/- Z;QT?';=G%:C':A(4L0.%'4^U1S7-O;E!//'$7.U-[A=Q]!GK4M '"
M>#?"(MH=4;6M($<UQJL]X@>17217?<A958@LON..QKJWT33)-735GLXCJ"+L
M6Y(^<+_=!]/;I6'X<\1:IJOBWQ%I-VMFL&D211J\4;!I?,3<"<L0,<>N?:NF
M6ZMV=$6>(O("44.,L!UQZT 4K[P[I&HWGVN[L(9+CR_*:3&"Z?W&Q]Y?8Y%.
MU70-(UO3ET_4].MKJT4@K%)&"JD<#;Z<<<4[5[TV.GS/'/;17.QC )S\K,!G
M&,@G\#6?X2UR36/!.EZWJ+0Q2W-LLTI7Y44GTR>!^- %P^'-&;03H9TRU_LL
MKM^R","/&<]/7/.>N>:A@\)>'[65)8-(M(Y4@^SK(L8#+'DDJ#U&2Q)]<\UJ
MBXA,(F$T9B;&'W#:<].:;]JMSYN)XOW/^M^<?)_O>GXT 5]/T;3=*T\V%C90
MV]F<_N$7"<]1MZ<U5T;PIH'AZ:>;1](M+*2?_6/#&%+#T]A[=*U!/"81,)8_
M*(!#[AM(/3FB.>*5Y$CE1VC.'56!*GT/I0!4U;1-+UV".#5+""\CC<2(LR!M
MK#N/0TEAH>E:7<W%Q8:=;6LUQM\UX8@I? P,X[ "J#ZVV@>'YK_Q%>V3,D[(
MK6H*JV7(1 "?O] ??-;,MU;PP>?+/%'%_P ]&<!?SH YB'3=5UGQ7I6L:IIZ
M:<-)6Z1$6X$PF,FU58$ 8&U23D Y(^M:=SX0\/7E]=7MQH]I)<W<?ESR-'S(
MN-O/X<9ZXXK7>:*.$S/(BQ ;BY8  >N:HZK=W*Z#=7>D263W"Q%X'N9"(,CN
MS+VH AO?"N@ZA9VMI=:3:/;VAS;((PHA_P!S&-OX5B^(/"$":#<VWA[1-*W7
M,\<EY;2H(Q=1*P+)N ."<  XP/;K6[I&IS3^'++4-62*RGEA5YE+X16/H6['
MMGGFM)'21 \;JRGH5.10!P&@^";2+5K:_A\)VWAYX&+.\-WNDE!4@IA/EVG/
M))[<#N.G_P"$2T#^S)--_LFV^PROYDEMM_=LV<Y*]"<\U2F\276H^*;KP]H2
M0>;81I)?WEPI>. ORD812"S$ G[P 'J>*MV]WKD'B""QOH;2>REMY)!>6ZM&
M1(I3"%"6QD%CG<<XZ#'(!:.@:4U_;7S64;7=JNR"9LEXU] >P_G5=/"/AZ+7
M3KB:-9+J9)8W(B&_<>K?7WZUJBY@:X:W6>,SJ,M&'&X#U(ZT/<P1,5DFC1AC
MAF ZG _,]* ,\>&M&4WI&GP@WPQ=XS^__P!_^]Z<]J;)X7T*:SL[272;22WL
MFW6T;QAEA/3Y0>@]NE:3W5O&P5YXE9GV %P"6]/K[4L]Q#;1&2>6.*,<%I&"
MC\S0 ES;0WEM);7$8DAD7:Z'HP[@UF?\(IH7V>TM_P"S+?R;-M]L@'$+>J#^
M$_2M5I8UB\UI$$>,[R>,?6F->6J1/*]S"L<;;7<N %/H3V- %:WT73;74Y]2
M@M(TO;@ 33C[T@'0,>^.WI1J&BZ;JLEO)?V<=P]L_F0LXR8V_O+Z'WZTS5]>
MT[1=*_M&\N46W+*D9##]XS'"JOJ235R6ZMX(?.EN(HXNF]W 7\Z *<WA_2+G
M4I-1FTVUDO9(3 \[1@N4((*Y^A(^AI;#0M,TR19+.S2)D3RHSDGRTX^5,GY5
MX' P.!Z5H A@"""#R"*Y2V\0:EKFO:U8:1-IUN-)E6!TNHGDDF<J&SA778G.
M <-D@\<4 ;^J:1I^M6AM-3M(KNV)!,4HRI(Z9'0U6NO#&AWTMI+=Z7;7$EGD
M0/,F\H#V!/;VJE#XH%EX>M+[Q D5E=3W?V3R$?</,,QC4*3C=TSGTR:W);RU
M@5&FN88UD.$+N &/MGK0!#IND:=HT#P:;906D4DAD=84"AF/4G'>IK2SMK"S
MCM+2!(;>)=J1H,*H] *J7^NZ?INI:=I]S<(ESJ$CI A89.U&=F/L N,^I'K5
MX7$)5F$L95?O'<,#ZT 9UCX;T;39UFL].@A=69D"#Y8RWWBB]%SDYP!FI;/1
M-,T^^N;VTLXH;JY.9Y5'S2GL6/?\:MRW5O!$)99XHXR0 [N #GIS4BNKJ&1@
MRGN#D4 +144ES!#+'%+/&DDAPBLX!;Z#O3I)HHL>9(B9SC<P&<#)_2@!]%-1
MUD171@R,,JRG((]13J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *XCXEWDEIIVAB3C3)M9MHM18_=
M\@D\/_L%@H/MQWKMZBNK6WO;:2VNH(Y[>5=LD4JAE8>A!X- '#WVG)!\6M-C
ML8(_LM_I<XU2 (/+=$*B-F7H3EBH)[9%5?A#H.E)X(T75ULH?[1$<\0N<9<(
M9F^7/IP./KZFNXM-$TNP@DAM;"WBCE4+(%0?.HZ ^H'85)IVEZ?I%M]FTVQM
M[.#.?*MXA&N?7 XH Y?7IK*;Q]IMF%1M2CTZ>8-=M_H\4)959MG\;Y&, CY=
MV3TJ+X13+)\-].C$J2&.2X4!3T43R!>.PP./I74W^AZ5JES;7&H:;:74UL=T
M$D\*NT9_V21QT'Y5+8:98:7%)%I]E;VL<DAE=8(P@9SU8XZD^M '!WEO)=?'
MKRX;V>T?_A&,^9 $+?\ 'ST^=6'Z=JI^/O"6D^'_ (7:E%;1/)+)?07,MU.V
M^9Y7N(PSENQ()'&*]"_L'2/[4_M/^R[/[?\ \_7DKYO_ 'UC-2ZCI6GZO;?9
MM2L;>\@SN\NXB$BY]<'B@#@]<T[3M!\;^$[&WL(+71]0O+B6Z55Q'+="("'?
MV)ZD>K#/45B^*FU'0M5\=_\ "/B2*T.D074RP<"*X9RK,N/NL8E9B1Z UZK=
MZ5I]]8?8+NRMY[08Q#)&&48Z8';';TIUIIUE80-!:6L4,3DLZHH&\G@D^I]S
M0!R/E>&YO[/UKPZ\)U%=.FCT^.T<8="FX!T'4 @#GHQ ZFN=\-VNB^(/#WA7
M53KZQWUI/"^(41;AK@_+)&Y^\VXD[L]1STYKT?2O#FBZ')-)I6DV=D\YS*UO
M"J%OK@=/:FVWAG0K/5Y-6MM(LH=1DSON4@42'/7G'?OZT >:VL.F>*=)\1V>
MNZW%8WT&ISFYW(BSP[)28F1F^8 (%"D>A K<\/36^J^/O%=CK2K/-;P6T5O%
M=J,_9FCRQ /]YB=V.^ >@KKKGPSH5YJ\6K7.D64VHQ8*7+P*9 1T.<9R.WI3
MM0\.Z+JUY!=ZAI5G=7,'$4LT*LRCTR1T]J /(+&"V?X->"I-D;/!KD C?@E,
MW; X/N*ZU=$TJ_\ C)K$5WI]M/$^CV\CQ21AD=S)(-S*>"< <FNN'A7P^+**
MR_L33_LL3^8D1MD*J_\ > Q][WZU.-"TD7LEZ-,M!=R)Y;SB%=[+_=+8R1[4
M >4:6T@^$WA"03HT5MK0#6LDH7[3&D\H$0+$ D !@"0/D]J[+POH,8\:>(?$
MGV6WBCO3"MNH*-(I5,2.2I(7<<<9YVY-+XD\)DV6GVNBZ#HUQID$[376E3((
M4G)4A2I"D @DGD<^O%.\,>$H--U8:I'H&GZ$PA:(P64N\R[B#E\*J\;>!SUZ
MCH0"E\0=/L[WQ/X*^TV\<F_4GB<L.60PN2A]5..1T-4&M]+TWX@R>&Y'L]-T
M\:6ATVWEA1HFW22&<*&XW$E<CJ0/:O0+[1M,U.>":^T^UNI8#NA>:)7,9]5)
M'!^E,U?P_H^OQ1Q:OIEI?)$=R"XB#[3[9Z4 >:^(M$TO3?A;I]E:W1U*VM=4
MMXH+FX"L0IN5W*IQ]T<K]!CM6KJ4MI%\3!HUY<6EC:-I2G3XYH$,3L9'\X*&
MX#$;,CK@5VUWH6D7]G#:7FEV=Q;08\J&6!62/'3:I&!BF:GX<T76;6*UU/2K
M.[@A.8TFA#!#[9Z4 >97OAS1[)/ ^GV]R=2M(]:D@2>7!S&4D+1 CK&&R,=.
M"*T=4\)^'X?B3X:TN+2;1+!].O0]NL8".-R'##N,L2 >AKO9_#^C7*VJSZ59
M2+: "V#P*1#CILX^7\*DFT;3+C48M1FT^UDOH1B.X>)3(GT;&10!YO%::7?>
M(?%7AC4;RUL(X8XK>UMYHD.+/R5"^67Z -O/'0FK&B2VZ_$+2=%N[N2]L;?0
M0^ERW>#]H?>5:0=B^P+@]=N3W-=UJGAK0];N(9]4TBRO9H/]6]Q KE>^,D=/
M:GZIH.D:VD*:IIMK>+"VZ(3Q!MA]L]* .4^%\5M;P>*K>T6-(8_$5VJ)'C:H
MPF !V%-GMK$?'!))X+<$Z!Y@9T7[XN  V3_%T&>M=CI^CZ9I/F_V=I]K:&9M
M\A@B5-Y]3@<TMSI.G7E];7US86TUW:Y\B>2)6>+/7:2,C\* /+].2VUOX4>*
M;G5U0:O#/>O=RMQ)!/&6:/!ZC:!'MQV%>C^&GOI_"FDOJ@/V][*(W(8<^84&
M[(]<YI\OA[1Y]0:_ETRT>Z8J7E:(98K]TMZD=B>E:1&1@T >)7ME:#X5_$J$
M6\0B@UN[:) @Q&1Y>-H[8]JZ>;3+'2?B9X-DT^VBMY+RRO5N7C&&G 2-AO/5
MCG)R<FNP_P"$7T#[-<6W]BZ?Y%R_F3Q?9DVRM_>88P3[FI?[ T?[3;7/]EV?
MGVHVV\OD+NB'HIQE?PH A\2MI)T9[;7(HY-/NY$MI%E^[EV"KD]OF(Y[=:X.
MWTK5?AMXIT.PTK5)[_PYJMT;7^S;H[Y+4[2VZ-NNP8.1V'J3D>F7EC::A;FW
MO;:&Y@)!,<R!U)'3(/%5++P_H^FW/VFSTVVAG"[!(D8RJ_W5/8>PXH \RMH=
M,\4Z9XELM>UJ*QO8-3G-SN1%GA"29B9&;D (%"D>AK5TZ?3-3\7>+-'\22(T
MGV:". 7A",;1H1N*YZ'>6+8[X]!7:W/AG0KS5HM6N=(LIM0BQLN7@4R#'3G&
M>.WI2ZIX;T36KB"?5-)LKR:#_5//"KE?8$CI[4 <)+8Z-#X\\%+$D<MBNE72
MQS7.&,B((]C%FZ\#(/I52\:ZTN^^+$NB1^5=I!:R1B%<%6-N2S #OR3]:]-O
M-(TW49;:6]L+6YDM7WV[31*YB;U7(X/ Z>@HMM'TVSO9[VVT^UANKC_731Q*
MKR?[Q R?QH \\UJWM%\.^!M4\.I&EW]NM([:2$8:2*1?WJ,1U!4$MG^Z35 Z
M!I%RGQ0\_3K:00.[0AHP1$WV4-N4=%;/.1S7IMEX?T?3;CS[+3+6WERQ#11!
M=N[[V/3/?'6D'AS1 +L#2+$"\_X^?]'7]]_O\?-^- $'@^62?P3H,TKEY)-.
MMV9F.2Q,:Y)KS/2="MI/ /C*XO)I[;6K34+ZXDN%G='AF7YT<8/&1L/N*]?M
M+.UT^UCM;.WBM[>,82*) JJ/0 <"J\^BZ7<WANY]/MI+@[<R-&"6VG*Y]<'I
MGIVH C\-S7UQX7TF?4U*W\EG$]R",$2% 6R.W.:\BB\/:->?"+7]3N+6/^TX
M+N^>UNQ_KHY5G<QJC=1EL<#J3ZFO<*S$\.Z+%?M?1Z59K=,_FM(L*@E_[_\
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MB6)$Q_"!CG^M8VGVFN:CK:WFO6UC;P6$DOV*.WE,AD+?*)&) VD(6&!_?/3
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MCY%\_F74?D+MG;KEQCYCGN:;?^&-"U2QM[&^T>QN+6WP((9(%*Q=OE&./PH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXHCT]]2\!7%JML675DC$D07@&%R1D>^#BI/#0MM5UCQY8:_'&\_VXI(DV/\
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M"_AO=V<EL535[#;)N&X$Y\S)ZYW?>SWZUZCJ\,%UHE[%/''+"\#[E<!E(P:
M&:7<21Z/9'4M0M+BYD54:>'"1RN?[@R>OI5NVO+6\5VM;F&=48HQB<,%8=0<
M=#7CD=G:77P[^%IGAC=FU*UB+$<E"DF5SUP<#(KKO#-K;:?\4_%EK9016\!M
M+&0Q1*%7=B0$X'&< 4 =O/<0VL+37$T<,2\L\C!5'U)IL5U;S6HN8KB*2W*[
MA*C@H1ZYZ8KB_%.JPZ;\1O"XU618M*DBN1%)*<1BZPNTL3P#MW 9_O&L7Q)_
M9&E6VGG2&#:'<>)HY=6D60O#N?DC.<!-^S(' /'J* /3;6^M+Z(RVEU!<1@X
M+PR!P#Z9%,74K!Y88DO;9I)@3$@E4EP.NT9YQ@]*XR^L%/Q<@%O#&UK=Z/)_
M:L14%'4.!$7'0MDL 3S@'L*XC2]/LH/A-X$U*.VA2]_M>S_TD*/,YG*D;NN,
M<8Z4 >USZC8VHE-Q>6\0B"F3S)579NZ9R>,X./I4DUU;V]L;B:>** #)E=PJ
M@>N3Q7G-CHFDWGQ&\?)<Z?:RH+:R;8\8*AFBEW-CID^O7D^M8&B:L+31/AJ=
M3U!K/39;*:,7+!2B7 "B/<7! ^7> ?<T >R175O/;"YAN(I+<C<)4<%2/7(X
MQ5*Z\0Z1::/<ZM)J-L;&V4F29)0RC';(/7VZUYGK,>D^&K2&>RU*:\T2X\1P
MS:LY*-!%N5B1\@"A=_EEAZX]2*VO%MMX>F\.>-;[2VBN+VZTEGNGAD\R,;8V
M$9(!P&QGWP/S .JDU*34].TN]TO4;.WBFGB:;SP'WQD9,2X(PYR,=?I6G=:A
M96.S[7=P6_F'">=($W'T&3S7FVOII\F@_#Z>W6V9TUG3T\R,+E28R2,CUX./
MI6IX?:+4/'/C>PUF*.2;="L<<P!#69CX"Y_AW;B<=SS0!W,D\,)022HAD;:F
MY@-Q]!ZFFVUY;7L;26MQ#.BL5+1.& (ZC([UXKI]A]I\._#U=2C$X_MJ6"WD
MF&7>UQ+L4GJ5*A>.A&*[7PE;6]C\2?&UI:0QP6X6PD$,2A5#-&^2 . 3@9H
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M>Z\8QBJ.K0Q0^$?BO;6\:)#'=[UC08"DQ1EB .G.:]>FTRPN+B.XFL;:2:/
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M&!T"G'&/:@#RBRET/6]$U[0_%&OSV5\FISM=6>Z%)7;S2T31;D+M\NP+@GH
M.,"K_B1[_19]?U>QDM]7TC="-8TJZ^6>%EBC :-QQNV[#@]\XYKTB32=-FU"
M/4)=/M'O8QA+EH5,BCV;&122:/IDMY]LDTZT>ZR&\]H%+Y'0[L9XP* (=?N[
M:U\+ZG=WD4SVL=G+)-''D.4"$D#T.,UYG87]B?%_P^*WFGK:MIUS%';0R!A#
M&8H]D;N3EV/3D#)'2O7B RE6 ((P0>]4HM%TJ!(DATRSC6%F:() H"%N&*X'
M!/?'6@#QJ[T[3U^$/CJX2UMQ+%J]V(I @W)MG&T*>P'8#U]Z[.SU2*/XOZC!
MJTT<>[2H#IAE("LF29MI/&2VW/?"CL*[ :%I A>$:58B)V#,GV=-K$="1CDT
MZXT72KR*"*YTRSGCMSF%)8%81G_9!''X4 <A\)I+0^&M1ALY(3'%JUV%2)@0
MJF4[>G;'2LKQ9J.G2:CXXM(9+>TNH])2.[DNGW-< Q2%$B0D  ;N6YR3C'>O
M3+>TMK-&2VMXH$9B[+$@4%B<DG'<^M1RZ;83W8NY;*VDN0AC\YXE+[#U7=C.
M.3Q0!Y;:)I^I:S\*Y&6WN2^FSK(W#;BMM&<-ZX/8]#4EKI>F-_PM!&L[8I'(
M^Q3&"$W6REL>F2,G'<>U>E#1=*5H&&F68: !82(%S&!T"\<?A0-$TI1,!IED
M!-Q+BW7Y^<_-QSSZT >;:!?2IKOPZ-^^;"?P\$MG<_+]K*)G)_O; 0/J<=ZS
M_$ME+'I?Q66T7.E,D$B(H^07&P-,5]_NEO>O6GT?3);$6,FG6CV8.1;M ICS
MZ[<8J>*SM8+3[)#;0QVP4KY*( F#U&T<8H \]U/5-,O/B5X'\J\M9D:SO5)6
M16!W1Q[1^/I7)W>G:>OP@\<W"6MN)8M7NQ%($&Z/;<#:%/8#L!Z^]>S6^BZ5
M:+$MMIEE"L(81".!5";L;MN!QG SCKBFC0M($+PC2K$1.P9D^SIM8CH2,<F@
M#D9;BV@^--K)<2Q1B;P\5C9R!O<W"X ]3[5EZ3-?:'J>@QLUKK?AR]U"3^SK
MI1MNK.619"0XZ. #(">HYSTQ7I/]G6.^W?[%;[[8$0-Y2YB!Z[>/E_"H[?1]
M,M+DW%MIUI#.<YEB@56.>O(&: .2^,,4+_##57F1#Y;0,K,.4/G(,@]N,U3U
M?1[#3OB1X2O-$M88)!#=->?94 WVPCX+XZ_.5P3U)KH/'^AZAXE\'WFCZ:+<
M3W)C^:XD**H617[*2?NXK9T_3K2Q0M;Z?:6<L@'FBW10"?J ,T >/0ZMI;V7
M@"[L[JSM-/75BT-J9M\L,;++N,LA.<D]1@ $XR<9K6O6N;+5_BL^B)LO5LK1
MXQ",,&,#DL /XNI^M>E)HNE1C":99J/.$^%@4?O!_'T^][]:DATVQM[I[F"R
MMXKB3[\J1*KM]2!DT >6ZOJ.@3Z!\-KBQN;,11ZI:B,AU!C7RV#@^GS;<^^,
MUZ1XCBAG\,:HDR))$;24D. 0?E)I\6@:-!(9(M(L(Y#()BR6R F09 ;./O<G
MGKR:NSP0W,+0W$22Q.,,DBAE8>X- 'D M+.Z\)?"CSX89"]Q;QMN4'<OD/E3
MZC.,CI74^%8H+7XG^-[>WCCBB\O3W\N,!0&,;Y.!W.!75G0](*1H=*L2D1S&
MOV=,)]..*EBTVQM[I[J&RMH[A_ORI$H=OJ0,F@#E_%EIJ<OB+3[OP]J5K%K5
MM:S;;&]4F*ZA9DWC(Y4@JG(]1GBN2@\26QOO!M_>M+X>TBXLKJ&'!C,=O="1
M1@LZE0"JL%; X/'!->J7FEZ?J+(U[86MR4^Z9X5?;],CBEN=-L;RR^Q75E;3
MV@ 'D2Q*R8'3Y2,<4 >5Z[8:)IGAB.;2=0DO+*3Q1:W,UQ(Z-$KM*IDV%0%"
M^N. <CL:WY+RP3XSV<[7%NL,WA]UB<L-LC?:4P%/<_2NV;3K%K 6#65N;,*%
M%N8E\O Z#;C&*5[&SDE@E>U@:2WXA<Q@F+C'RGM^% 'DU_-<Q>'?B;)9B1W3
M5T:58L%C"%A\W _W _ZUT6FP^%=>\0V&KVFO/JUT;*2$1(T)06Y&2)D1 0 <
M8#=&(XZUVMMIMA9R226ME;0/)]]HHE4M]2!S4=MHNE64<\=KIEE!'<<S+% J
MB3_> '/XT >,VUA8?\*-\+7/V>$3?VE;'S@H#Y^TE3\W7ID?2NJU&V-A\4+^
M'18(K>Y?PG*8HX5"[I%FPAP.XZ"NZ.A:08%@.E6)A5BRQ_9TV@^H&,9J5=+T
MY+I;I;"U6X48680J' QC .,]* /,?#3>&/$6B^$Y'U^YDU"PEB,5@C0K-'.!
MMD1E"!ROWBV3R 23WK-ETS33\//B;+]CMB\6J7PC;8,IM"%0/3!YXKU^'2=-
MM[Z6^AT^TCNYAB2=(5$C_5@,G\:8-#T@121#2K$1R'+J+=,,?4C'- '#M=6\
M/Q+\,7%W-&BRZ!*!)*P&]]\1X)ZFM[XB7FGV7@VY?5+<W%J\T,9C\TQ+N,B[
M2[C[J X)/IFM_P#LRP_T?_0;;_1CF#]TO[H_[/'R_A4MQ;P7=N]O<PQS0R##
MQR*&5AZ$'@T >1:A?W7_  E/C0:?J5M<:I/X>0PFSPNZ1?-X0;B2P'N3]*Z;
MP]?^#M>M?"MU926\U_:0%;."&7]Y;[H]L@= >  ,'<,9QCDC/9P:=8VTJ2P6
M5O%(D8A1XXE4J@.=H('"Y[=*;:Z5IUC<33V=A:V\TYS+)#"J-(?]H@9/XT >
M/2R02?!;QI:1M&UU'>7S/$""ZJ+C.2.H%=-J6KZ;<_$_P4\%];2C['>#<D@(
MRR1E1D=SV%=\EA9QFX*6D"FY.9RL8'FG&/FX^;\:BMM&TNR\G[+IMG!Y&[R?
M*@5?+W8W;<#C.!G'7% 'CK:OI<^C>"[NQN;6ST__ (2-9(K5Y=T\:L\N]Y78
MY&2>1C W 9-=QH#JWQ:\7;6!S96!X/M)_C74C1=*7?C3+,;Y1,^(%^:0='/'
M+>_6GC2M.6XEN!86HGE!$D@A7<X/7)QDYH \W\+Z!'XI^#4NFJZK<&ZNY+6;
M_GE,MS(R-^>/P)]:WO!6IS^+737[VU:WEM(/L(B=<%9\@W!'MN5%'^ZWK6QJ
M5AJ=A9PQ^$K31K:1I@;@7,3(FS!R0(\9;..OO6AI.G+I6F0V8D,K)EI)2,&2
M1B6=R/5F)/XT <[XVO[&UU'PU#<I']JEOR;2:>0I# ZQMEGP1NX) 7C)(Y%>
M;:G-9W'P\^)D375K=2+JC3H5VX.1#\ZC)P"2>?U->X7EA9ZA"(;VT@N8@P8)
M-&'4$=#@]ZBET?3)A*)=.M)!,P>7= IWL!@$\<D#CF@#BM2M+;3OBCX7_LZW
M@ADETV^4B-0OF8$;*#CKSD_G7&7>I6%[^SO>K>30G5DF)O4F($PNOM +%@>=
MV/T]J]H&D:8)HIAIUH)80!&X@7<@'3!QQ3)=!T>:YEN9=)L9)Y@!+*]NA9P"
M"-QQD\@=?2@"V#!>6V08YX)5]F5U/Z$5XSH^FV\7P!EU33;")M2CBN09XHP9
MA%]H82*K8R/W8(Q[5[0\4<D)A>-&B8;2C#((],>E16EA9V$;1V=I!;(QR5AC
M" GZ"@#S^&X\)ZA?V/B.U\07.IW%K83[8+5H0PM_+)82)&BL ,  '&&(K!T_
M4M/_ +9^&D\%W8V]D$N!#;1R[FMXVMSA9)"<EB0 >!R".<9KUJRTG3=-:5K'
M3[2U:8YE,$*H7/JV!S^--AT72K=8UATRSC$<AF0) HVN?XA@<-[]: /.[.:^
MT+5-+PUKK?AN^U=Q:2@;;JQN)&DW ]G4$N">H&<]*ATE[>_^&?C2UUS9_:$5
MS>F_$GW@_)B8?\!V;3_LC'2O2X-'TRVNC=0:=:17!R3+' JOSUY S2S:1IMQ
M?)>S:?:27:8VSO"ID7'3#$9% 'FFFZ>TWC7P0NN6T<NHMX?D-T)D!9I%\K&_
M/4CGKWJG;7>EZ;X4\107=LLEJ/&#P01>:8HHG\V-E+D?=C!Y(_"O69-,L)KM
M;N6QMGN5Z3-$I<?\"QFHAHFDK;S6XTNR$,_^MC%NFV3_ 'AC!_&@#R]KR)M;
M^)<;ZC:W,T^BQ$&#"J[+#,#M&3G P#R:6?1=/?PG\/+G1[:W363<63Q36Z@2
M,FP&<L1R5V[MV?ZUZK#I]E;R^;!9V\4GEB+>D2J=@Z+D#H/3I3+/2-,T^626
MRTZTMI)/OO# J%OJ0.: ./T*WM[[XB_$&TN$26&5;&.6-N0RF @@CZ5G>$XK
MO[;'X'O8W>+P[<^<9F7Y9K<<VHSZY.>.A@]Z[B^TUK>UO+K0[+38]7D0^7+/
M%M5F_P!LJ-Q%-T'3KVUCGN]5DMY-3NV5IS;@B- HPJ)NYVCD\]2S'C.* ->B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *RO$<S0:%<M'K-OHTF!LOIU5DB.1U#$
M Y&1^-:M</\ &!8C\+-;:4(=J1E2PZ'S$Z>] '57.L:98RM#>:E:02I$9F66
M94(08RQ!/"\CGIS3[?5-/N].&HV]];2V)4N+E)5:/ ZG<#C P:XO4H+*?XT:
M&9(H)&.D7#C< 22)$VG\LXKCS>+IOAN_N57=I-CXXD>^2(95+</G) _A#E#C
MVH ]=3Q#HLEM-<IJ]@8("%EE%PFV,GD!CGC\:G.J:>+BWMS?6HGN5WP1^<NZ
M5<9RHSEACGBN(\0R^'=9\/\ BZ_T%H+Z^N-%E2YNK23S$($;;$.#C=R>!S@<
M]JR9-;TJXU/X8&+4+618PPD99 0A-J5 8]B3Q@\T >BGQ'H8F6$ZSIXD:5H5
M3[2F3(H!*XSU ()'N*=;:_H][<1V]KJMC/-)&TJ1Q7"LS(I*E@ >0"",^HKB
M_ 6F:1<ZIXP>6RLY9(?$$I4O&K&/$:8(STY+?K7-:-81?\,^27VEV44FH)'<
M R0QJ93']H/F*#C/,:XQZ 4 >N66M:5J4\D%CJ5I<S1@,\<,RNR@]"0#T]ZY
M;QQXM_LNVLX](UBR2\.HP6\\&4DD*-(JL,$\$ \\9Y[5DBZT+7YH=:\/:]<:
MKKT&G7"V<<;1 Q!HS@2HB*0-VT -_$1CO7/W>LZ)<?!WPLBW=L+BUO;'SXY'
M DCF61?.9@>0<ER2?7/>@#U[7)KFWT&_GLY5BN(K=Y(W=-X!"D],C/2L7P?X
MJM-5T'1([[5K-];N["*XEM_-196+(&)V#GWX%;&MD2^&]1:,AP]G*5*\[LH<
M8KRD:9IU[\*_!(TJ&V.MF6R:UD@"^8LBE3*21S@*&+9].: /6[75]-O99XK3
M4;2XD@_UR13*YC_W@#Q^-2VEY:W]N+BSN8;B$D@20R!U)'7D<5P/B+[=X3\:
MG4=*MR\?B2(63!5RL=\H/DR-_LE2P/\ NYKN]-L(=+TRUL+?/E6\2QJ3U( Q
MD^YZF@"*ZUO2K&Y6VN]2LX)V( CEG56)/3@GOV]:6]UG2].D\N^U*TMGV&3;
M-,J'8.K8)Z#UKSK19[6;P9XYT[7S&MZEY>->I+PS*PS$X![%=H4_[(Q5;3]/
M)\2_#FVUZ&*6_.C7(N$G4%F8)'@.#U(&>O<&@#UB">&ZMX[BWE2:&50\<D;!
ME=2,@@CJ#51-;TJ2_P#L":E9M>9(\@3J7R.HVYSD=_2H]5MY[?PQ?6VC1I#<
M)9R)9I&H54<(0@ '  .*\QO'AU;X&:%#I9 UF![.*U0<2QWJ2*LG'4-_K"?;
M)- 'I]WXBT2Q^T?:]7L(/LQ43^;<(OE%L[0V3QG!QGK@U?BECGA2:&19(G4,
MCH<A@>001U%>>Z99Z?+\4/''G06SD65GNW*#@%)-WY\9K4^%,GF?"WP\V[=B
MUVYSGHQ&/TH @T;Q>+;6O$EMXCUFQ@AL]02WM&F*0+AHE?:,GD_-ZFNON]1L
MK&V%S=W<$$!X$DL@53WX)ZUYWI=MH,WB3XA_VW%9M&+B,R_: I80F!,GGD#/
MIW%8.B75WX77P2OB:_N=+M'TF:".Y<)B&8R*RHY=6"'R@HYQC!'K0!W7BWQ'
M<6UCX>O]#U&V>TO=7M;662,+*LL4DF&VMD@=QD?I726&L:9JOG_V?J-I=^0V
MR;[/,K^6WHV#P:\MUNQT&V\.::NE73WFGWGBVUFDFE=6BF=G'F&/ "[.O08R
M&K0U6>PTOQ]XM>6V\RT7PPDMQ;6YVM*%:0$<=#MP,]LB@#T"SUO2M1G:WL=3
ML[F94WE(9E=@N<;L ],\9KF?#GBFX73O%%WKU]"T>F:M/;1N56)?+14*K]22
M>I)R:Y?3M5L6\<>!)4U*Q,+:;<0QPVS@I "D6R+<22S=N>3C[HS6KX9FB&B?
M$1O,3:NKWQ8YZ?NDZT :GA#5-4\20:7KD6NVLUK<6^^^TY41O(=AE C+\RD=
M"')S[5U%_J^FZ6%.H7]K:!@2//E5,@=3R>@K$^'+*_PV\-E6!']G0C(/<( :
MRM&NO(^*GBRUU5E1[BVM9+'S>CVRHP<+GL'+9'O0!K>-/%EOX8\)SZK%/;/,
MR*+57D&)&9E4$<_,!N#''859T,7QN;JZ;7X=5TB55-LX2/?&PR'&^,!67CTR
M.>:\PNXGL/@-JZ2OML3JF=.#G'^C?;$*8SV(!(]B.U>V @@$'(/>@#AM3\=V
MNH^%/$]WX=U*V^V:3'.48[9"_EQABP7/W=QVYY''>MW0?$%CJ-K8VKZG:2ZL
MUG%/-;K*OFC* EB@Y Y].]>>PWMJG@7XH637$0NA>ZK(82PWA2@PV.N#D8-7
M3%:6NL_"Q[=(8B\<PR@ W!K7)^N3C\: /0IM;TJVOTL9]2LXKN1@J0/.H=F/
M( 4G.3Z5=D5GC94<HQ'#  X_.O&]-N="U?PYJ7AWQ1K=U;ZG%J$QN-.#1)-+
M+YQ>-HLIO8G*XP3Z=*]E7A!G/ [T <3X)\5W&H>&KW6/$6HV<$<%[-;;R!#&
MJHVT$DGJ?K756VL:9>:A/86VHVDUY;C,UO',K21_[R@Y'XUXJK6\_P"S]XL8
MM$X74+DJ<@X)G&,>_/ZUVVJ0VUG\4?"BV$<$3OIEZBA %# ",J#CJ,Y/YT 6
MOB-XM_L+PM?RZ5K%E!JUN4Q$Q1W.64$!2>NTYZ'@=*ZK4-7TW245]1U"UM%;
M)!GF5,XZ]3[UXK=:OIUQ^SW>VEY<PC6(I2+V"9@)A<_:0S$J><GDY]/I747.
MN:;!\0]:M]:UW^SK/4+*W:PG9H1!<0A6#J'=2/O,QQD9W4 >A2ZOIEN\*3:A
M:1M,ADB#S*"Z@%BPYY  )SZ"JI\5^'1IZZ@=>TP63R>4MP;M/++_ -T-G&?:
MO/UTO1;+Q+\-K*Q5Y;%!?BW:[PSN@CRIY'*]"OMBI+.TT]K_ .*(,%N0IYRH
M^4-; M],D<^XH ]'GU73K66**XO[6*292\:R3*I=0"Q(!/( !)/H*JR:Q8:E
MX?N[S3-<LDA\MT34$D26*%\8#'G:<$@X)KS:PCM+N7X0&X2&5GLI =X!W8M!
MC.>N"!^-3E+46/Q:@"Q"%-[[.-JL;09..QR/SH [*X\7Z5HAT&PU'5[:>ZU%
M !<;EC5U$98S'G"JQ7CGJPQTK7O=<TG3GC2^U.SMFDP4$TZH6R<#&3W/%>=3
M7=M:#X47ES/%#:I"0TTCA44FS(&2>!DU"-1T:;6/&.A>*M=?33=W)D$4QBC6
MYM7C54*,Z$D@ C .0>G.: /3K_5M.TJ(2ZC?VUHC9PT\JH#CKU/:K,4L<\*3
M0R))$ZAD=&!5@>A!'45Y7#J-CH/C,V&K:O=Z387&C6L>G37GE .B!@Z.TBD!
M\L"1QGOVKN/!EAIFF>%;2TT:2XDTU-_V=YVW%E+$Y!_NG)(]L4 36EZD>J:Q
M+/K]I/:Q&,_9AL7["-I#;V!R=Q!/S8QBK$'B#1KJ\AL[?5K&6ZFB$T4*7",[
MQD9#!0<D$<Y]*X!$M?[>^*L96'RQ;6[,N!@?Z*W)'UJA##9VWA;X3S0I#%*U
MW:@NH )W6[;^?<XS0!Z_5&SUK2]0N'M[+4K2YG1=S1PS*[!<XS@'IGC-8?Q)
M%\WPZUP:<LCW'V?.V/[S)D;P,>J;JSUU;PUXE2VU#PW+;76MQZ=,EEY$GS6J
MLG D4'"C<%7##J>.] '5KK>E-?BP74K,WA)40"==Y(ZC;G.1Z4R[\0Z+8&X%
MYJ]C;FW"F82W"+Y>[.W=D\9P<9ZXKRVX>'5/@'IUO8G&M0-;PP1@XFCOEE4-
MQU#YWD^Q)Z5T6EV=C+\7/% N(+:1QIMH6W(#R?,W'\1C- ';2:MIT4=M))?V
MJI=%1;L9E F+=-G/S9SVI-.U?3=725M-U"UO%B?9(;>99 C>AP3@UXW8):7/
MPO\ AH+@0R@ZY!%\^#E=TP*\]N@Q6QKL5PGB/XAVVBKLO)-"MV6.#AF8"0<
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MX_XD>+1HOA/49-*UF"VU6W9%50$<[BRY3!R VTDXZ]Z[EF5$+,P50,DDX %
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M_I&F3K#?:E:VTA*C$L@7&[A<^F3TSUJ*^\4:#IDLT5]K-C;R0('E22=044D
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M#G'3O0!-#IMA;W+7,%E;13L,&5(E5B/3(&:'TVQDFEFDLK9Y9E"2.T2EG4=
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MDY [G %=YK>AZY/KXU/3KK39X&MQ UEJ4#,B88DNC*>"<C((.=H]*T-#T/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:8]Q'%JMC<6D=U9R<3Q2)<)YC,O49Y.?]KU- 'MUW=0V-I+=7#[(8E+NV"<
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M-0N+.WB"ZI9)M6[4C=\RC@.H'..,$4 >G_\ "0:8+:"<W2E9@2@168D+C<<
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M._\ ^OTJQHWB71?$(G_LC4[:]\AMLHAD#%#VS['!P>AKB_'YTI='\(7.+3[
MVNV1>0!?+*!'')Z;0/PQ5+Q)IESJ_B_Q!>^&&5I3X:DM9I;<C;).S9C3(X+[
M0?< KZB@#T*W\1Z/=7L5I#J$+S3;O)&<"7;UV'H^.^TG%02>,?#<5W]E?6[$
M3^>MML$P)\UNB<=_Y5P>HW5IXE\"^$;/1I$_M6&\LS' A_>VK18$NY>JA5#
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MZV)98X(7FFD6.*-2SNYP% Y))["O%+2ZL(?A5\.<3VZ,FLV3/\R@J0[;R?3
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MM0#Q,"K$$0J%;Z!L\^N:P_"MYX9UC0=#T+56U!O$&F2Q*=+>617CN8N/,P.
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M.*\J,^F_\*P^&R22VNU=4L=ZLRX&-V_(_'GZ\UUEG?64?QGUG_2H%!T6#?\
MO .5D<G/N 1^% &UI.NZ58>'=.DO/$\&H+<RF*"^F9%-RY<@!0N <'Y>/3-:
M&F>(]&UF2Z33M3MKEK4CSQ'(#LST)]C@\].*\>M+JP;X+>$(I9[<J-<A#H[#
M  NF+9'IM.3[&NGU;4K&V^)>OR^7'>JOA;+VL3C,Y620E!CN5Q^!H [JR\1:
M1J5TEK:7\4LTD9EC49'FITWIGAUZ<C(K&\#ZCJ%]<>)H=0O7NOL6L26T#.JJ
M5C"1D+\H [FN)TS6;"Y\6_#RZAU&&6 VEU"L-M'^YMB8HPL*G!8L,8(8D\ X
M&:ZCX=75O/J?C-8IXY&.NRN K _+Y<8S],@C/M0!+XUU35M/\0^&+/3M3DM8
M=3O&MIPL4;X4)NRNY3@\>]0Z7XMO--\<ZQX;UV]MIK2SLEOX]1<+"40D*4EQ
M\N<G@C'':J7Q)N+(^+/!%O<72Q?\3)F?$QC95*$9R"".2!FNCO\ 1=&T+P[K
MMY;0QPO=6LC7%S+*7>7Y"!ND<DD<X )H NV?BWP]?O*EKK%G(T5NMU)B4?)$
M1D.?08(_,59L=<TS4KJ2UM;M'N(T$C0D%7V'HVTX)4^O2O+YHB_P+\.W>F0+
M.EHEE+?1VZAG>*-E:52!R<'DCV-;^L/%XA\=^%;_ ,/7D,[VT%T]Q<0.&587
MC 0.1ZOC /H3V- '6MXBT=+]+)M0A$\DIA0$\-(/X W3?_LYS[47WB/1],G\
MF]U"&!]RHQ<_*C-]T,W12>V2,UY]X)US0+OPKI'AK5K;S?$&FW"J^G2QDRK<
M(Y/F].G)8OTY-4X+[P_Y_B3PQXPN+V&[GU&>1;3?(!>PR/NC,87[QQA<#GY1
M0!ZAJ6NZ7HX)O[R.#";VSD[4_O-CHON>*?<:QI]K;07$EW'Y=QCR"AWF;(R-
M@7);CGC/'->:2:CI6@^,M9T[Q1<W>FVE_;6QL7>9_+DB6$(\189RP;=]=Q]>
M7VMQIWA+QSX?>X633_#;Z+):Z=)>,0L,IFWD,S_<+(%QNP>U &AH/B1M0T+Q
MA-?^*!!;6^I2VUKJ3B-?(3RT*X& I()/&,Y]ZZY_$6C:<MK;7NM6HGD@\U3+
M(JM(@7)<CL,<]A7E[:A82>"?BF(KB$K+>W,D?. X:% I'KD@X]:VKJ[T^;QG
M\-";BV<"SNB"74X)AC"_J#CW% '>V&OZ3J>ER:G9ZC;RV,9823AP%3;][<3T
MQ[U%%XGT.:\CLQJ=LEU*%,<$S^7)(&^Z55L%@>Q&0:\PNCI]]X9^*-NU\(HC
MJ!FWP#S",)$<[1U!9<$_6MW0=:T?Q+X[L-5_M[1VOH-/>UCL[.Y+M,S$,Q^9
M5.!MX&#U)[4 >D45EZ'XBTGQ+:S7.D7B74,,S02,JLNUUZC! /<5J4 %%%%
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M,YVJH).,'/'%/77M,?38]02Z#6TKF.,JC%G<$@JJXW%LJW &>#0!?5$50JJ
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M(D=VXW-(QD(V*%7YL'Y1@'I6OI^IVFJ1RO:2EQ%(8I R,C(X )4A@"#@C\Z
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MB\C\VW09_>+MW<'&,[3G;UQVK)T'5+L>.?&=K?ZB\EC8"T>'SMJK K1L[\@
M8]SV')H [' !)QR>M(L:(6*(JECEB!C)]ZRK/Q/I%_.8+>Z+3>1]I6-H75I(
MO[Z @;U]USU%0_\ "8^'_P"RH=4&HH;":7R8[@(Y1GSC:#CKGCZ@CM0!N$!@
M00"#U!HVK_='3'2J,^L6-O<BVEE=9C"9]@B<G8.">!ZD#\:X'1_%"ZMID'B>
M]\0W6F)!?2^?"8&:W:W$K1I&<C ) 7Y\YR3[  'IFU?0?E6!8Z-JQUR2_P!8
MU2&[@AED:PMXK?RQ"&XRQR=S!25!XX9NN>-)]6L5U9-):Y"7TD9ECB*D%E'5
M@2,'&17/^ ;^_OH?$*W][+=O:ZY<VT4DH4$1IM"C"@#\A0!UU-*(7#E5+@8#
M8Y%.HH 3 SG S1M'H*6B@!-J^@_*C:/04M% ";5]!^5&!G.!2T4 ($48PH&.
MF!TH  Z "EHH 0@'J!2X!&***   #H*:D:1@A$503D[1C)IU% #0B!RX5=Y&
M"V.2*#&C.KE%++T8CD4ZB@!K1H^-Z*VTY&1G!H=$D7:ZJR^C#-.HH 0*H! 4
M8)STHVCT%+10!C^)-'N=9T@VME?_ &&=98Y5D\H2*VQ@VUUR,J<<C(JG::'J
MMW<V\VO3:5(+>02QK8VC1DN.A+.[$#O@8^N,@])10!3L-.BL/M#H2\MQ+YLS
MD ;FP%' X  4#\.Y))N444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MF*19HDE0Y1U#*<8X->5Z%K_B'3?@W?\ B+[9:7=W"UU.OGV[<D3R;LD/SGL
M !TYKK'\175YXBL/#]D\4-U+IO\ :-S.\>\(FX(JJN1R6)Y/0+T.> #JJ*\S
MU7Q[K>G>'/%0\JR_MGP]-&DC&-O*GBDP4<+NRI*GD9(!'OQNP:WKEGX]L]&U
M-K&6TU&SEN(1;Q,K0-&5RI8L=X(;KA>>PH Z^HKBXAM+:6YN)%CAA0R2.W15
M R2?PJ6HYX(KFWD@F0/%*I1T/1E(P10!A?\ "=>&O-AB_M1/,F!:)?+?,@')
M*C'(^E2)XRT"62RCCU%'>]G:W@"HQW2#.5/'!&#UQ7/>)/\ DL?@C_KWO_\
MT6M'CZ PZSX1:RCB%Q+K@?YR0I?R'&3CV _*@#OJ*X"/QKJ6CKXNAUL6UW-H
M8@>*2VB:%9A,OR*5+-@AN,Y/%:-CJ_B(>*+2TFM&NM+N87,MR+)[?[+*HR/O
M,=RMR!W![T ==1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1139)$BC:21U1%!9F8X  ZDF@!U
M%82^,-#:W-R+J468&?MAMI1;X_O>:5V;??.*V+:XBO+6&Y@</#,BR1L!C<I&
M0?RH EHHHH **** "BBB@ HIDDJQ1O(Q.U 6; R<#GH*KZ9J-OJ^F6^H6OF>
M1<('3S(RC8/JIY% %NBBB@ HHJEJVJV>B:9<:C?R-':VZ%Y76-GVJ.IPH)H
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MP6\(!?RHVD;D@<*H)/)H \VOIM/LO$BZUX5\26NGM+;1VEU;75C++%(D?",
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MW-W%L$OV>1MI!!!QCD9%==::K:WNH7UC#YOGV+(LVZ)E7++N&UB,-QZ=*NT
M>97&J6EYXB\.ZQ=>(K)Y=*6<2HEC,HE,JA3MZ[0 !USGVK/GM=#O[/Q);7GB
M)$.K7BWT$UO:RA[65 NTC(^;&P>G>O7:* //?#_B;[.XE\1>*K:]>--D26MC
M)"IZ9=^N6X[8 R>#GAWBN_\ "WB:UM2-:>SU"QG%S97D=N[-#(/8K\RGH5[U
MZ!10!P5OXN%Q$(-2U[3TCZ2265K.KR#VW?<SZ_,?3!Y%)=2TK2_%6I:UHNMV
MRIJB)]KMKFVE*B1!M61"H]."O?U%=_?ZE:Z;%&]RY!E<11(JEGD<@D*JCDG
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MF\N,[]QPN>",<#U/3LDT&ZN->CUN^NK>2\MK9[>S2.$B.+>07<Y;+$[5'48
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M,EL&8*\3'[Y*A6)&1UX'!K;U;P[<ZCXMT/6X[Z*)-*$P\AH"QE\U0I^;<,8
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MQ3_Y)?XA_P"O0_S%4KW5]:LM1\$Z9IMS:Q6^IP.DOFP%R"D&X'.X9'MQTZT
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MMS(T+QH"2#N&X DX''09STKO;:WU!=%CM[N^5]0$(62[BB"@OCE@AR!ZXZ4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M()'8\'MZ&JT7A2[TS7-2U+1=42V74]K74-Q;>:/-48\U,,NTD=0<@GFNHHH
MSM"T6T\/:):Z59!O(MTV@N<LQ)R6/N223]:Q(?!]UIUYK!T?54M++5Y6GG@D
MMO,,4K##O$VX8+=<$,,\^U;^G:DFI"Z*6]U#]FN'MS]HA,>\K_$N?O*<\-WJ
MXS!$+'. ,G )/Y#K0!RG_"$K;:IX:N-.O([:TT&&2&"V: N9%=0K;FW#G"@Y
MQUSG-=967H.OV7B.QDO+ 3"*.>2W;SHRC;D.&X/(Y]:T]RAPA8;B"0,\D#K_
M #'YT <$OPXND\$CPLNOYM(YTDA=[,%D19?-"G#C)W8!/H.@ZUMR^&[U_&,7
MB-=2@66/3VL?)-J2I!8.6SYF?O <>GYUT=% '(:9X$AM_ $WA#4;S[;9R+(G
MFI%Y3@.Y?/WF&0QR#["G:/X4UBVMS;:WXIN-5@CB:* "W6!E!4KN=@278*2
M>.N2"<$7M1\7Z?IL\J-#=SQ6\Z6]S/;Q>8EO(X!4/@YZ,N< XW#.*WF95*AF
M +' R>IH X*S^'>H6UMX=A?Q*SC0I<VQ2Q1<Q["FT_,?FP?O=./N]ZTHO \8
MG\10W%^TVE:X[RS6?E %'= C'S,Y(PH(&!@^M:^G>(;'5-9U32K<3BYTPQBX
M\R(H/W@)7;GKPO7IR*U: .1\/>%-:T@0P7_BF;4K.T7%I#):JA7 POF,#F3
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M.&T^X^S3>;$8_GVAN ><8([5JT <*O@"^'AK1=&;7U=-)NX+B&1K(<B$Y12
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M?$TVO:'X@N=&NKN-([U$@29+@*,*VU^ P'&>?IURZ^\$$ZMIVL:3JLUAJ=G
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M>6NU=IW'MUS^E $/C_4]0T7P-JVIZ7.D%W:P&5'>,../8\?GGZ5F:KJNO?\
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M2S$!DWREMH_?'&T!.P))/48Y0^ Y6\/^(M(;5@8]<N9;F:06V#&9  P7YNG
MQGWZTNH^!;J>_P!/U73-?FTO6+6U%G+<Q6ZNEQ$#D!XV.,@\@Y[_ $P ;7A6
M779O#]N?$EM'!JBEEE$;*5< G:WRD@9&"1GKFN:TN[\4ZSXKUZR778+>VTK4
M( %%DK>;$T:NT9R<KU^]DGZ=#V6F6!TZQ2!KB6YER6EGFQOE<]6.  /H. ,
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M6*-<_=51CD_UKS?P99RZ]9>,K&WUF*.RNM<O$F2.,/*(V(!*/NPNX=RK>HH
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M*2-% =$"[L@>@X'&/?K6-J5]:>)?'/AG^R;E+G^RKV[^W!,Y@Q$R?,#R,LP
M]>V: &1Z_K!T[QYF_8RZ+))]CE\I,@+ ) &&W!Y..G2I=/\ $U_K-_X<T6.Z
M-O<W>BIJU[<HBEB#L4*@8%1EF)/!P!@=<BQ>^!9KB^\0/:ZW-:V>N1D7-LL"
ML1)Y?E[E<G(!&,CVX(IC^ 'A_L*ZT[6Y[;5-(MA9I=O KK/!@#8Z# (XR.<C
MWH YK3]4U+PQHWQ(U&#_ $^^M-2+*S1@;OW48W,JX'RJ<G&,X/2NB34M:'CK
M3M*L]86]TZYTXWDLDENCE"& 4Y3: KYXZ\@XK/US0I/"_ASQ'=2ZQJ$IUFX0
MS306Z_Z+NVHTA"@DJ%'/MQU.:C\,3W:ZE;KHGB_3=;MY) +BWM]+CC")@Y=G
MB("D=@>O2@"C/XE\6+X"USQ$-:B$^D:A<1B$6B;)TCEV[6SR!CIC!]SVZ0ZG
MK>F>/=$L;O4DN[+6+>X8P?9U06[Q*K HP^8@AL?,32-\/Y'\(:QX=?5\Q:I<
MR7$DPML,AD;>P W8Z]/3WK4NO#-S=^(=#UB744$FE1RHL:V^!+YBA6)^;CA1
MCT]Z .;MM?\ %NNZ-8:_H5M<2">??]CD^S+;O;[R"-Q;S X49STSGC%++J?B
MB]U?QK90:Y':II B>V:.S1C\T/F;3NSQG@]2>V.^AIOP_GTB[FM['Q'>1>'I
MIFE;2?*0A=QRR+(?F5">P]3SSFKT7A*XBU'Q)>+J:%]<5%=3;<0[4\L;?FY^
M7U[\^U '*7&HZCX@U+X:7YU&XM#J,4LTL4 38)/LK-N 93D_,1SD 'CGFO2K
M[SUTZ<V\JQSB,E)'3< <=2.,URR> WBTWPU;PZQ)%<Z 2MO<) IWQE/+(922
M,[>_Z5U=S#)+92012A'9"@D==V.,9(R,T >;)XK\1S^!_!&J17T"W6K7\%M=
M%[<$.'W9X&,#Y1P,'W%=!X<U+5H_&NNZ!J6H"_BMH+>ZMYC"L;*)-P9"%&"
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M'=W;@KFN^KF[;PM*VLZ7JFJ7Z7EUID,D4$J6_E.^\!29#N.[@=  ,DG'ITE
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M]>W]K9)<^982F"Y\V(H$D'\.3U/TS6E8/=2Z=;27L217;1*9HT;<J/@;@#W
M.:\ST2XNK.U^)]W8S^1=6^H3S1R; V&6$,.#QVH ]4JGJNI0Z1I5UJ-PDKPV
MT;2N(DW-M R<#Z5P-GK/B"UE\"W]UK+74.MHD5U:F"-4!: N'4@;@V1SS@YX
M Z4^]U*_\5>%O&5[#J,MI;V37=E;P1(A#")"&9]RDG<<\ C QWYH [S2]0AU
M?2++4K=76&[@2>,2 !@KJ&&<9YP:M@ =!7FVAZU>/IWA;P]9B[7/AV"]E>T\
MGS"-J(H!E. .I. 3]WISEE_JGC72M&T1;^[CM[R7Q!#8ES%&YN+9V^5G"\*V
M."%QTX/- 'IE%<!;MXA?QSJGAEO$MP;;[!%?1W/V:'SHBSLA1?DVXRN>5)[>
M]9">*_$=QX%\,7Z:E&E]<:Y'IMU(;=2LZ_:&CR1VR%&=N.IQB@#U;I5#3-53
M4M*BU![:ZL5D)'DWL?E2+\Q4;ESQGMZY%<SH]YK,'CG6?#MUJ\EY$+"*\MYI
M88U>%F9U90%4 CY01G/XUR5UJFK:]\+?">I7FJW"W=QK4"3O"J()/]**C(VX
M^7:,#IQR#0![%17$W6J:G>^(=1T"RN-2_P")=:PEKBV%MYCR2;B&;S,+@!1P
MHY).>U5;77O$S3:-H&K0O%J\EE-=7K:>T)9MDBHNTR':,AMQQDC&![ '7Z[K
M5MX>T>;4[R.XD@AV[EMXC(YR0.%'UJW:74-]907=L^^">-98WQC<K#(/Y&L#
MPY!KUSH][9>)2VX7#I!,KHLLMN<;2_E\*^,@[<>U4/%^N2^&+G33(E[:>'1"
MZ3W>GP+(;9QM$>\%6Q'C=R!UQVZ@':5DWOB*RM-3&F1)/>:CL$C6UJFYD0]&
M8DA4![;B,]LU)X?N#=Z!8W!U"/43)$&^UQ !9O\ : & ,^G:N+^%$C74_C&\
MN^=1?7YXYMWW@B!0B_09(% '8V'B"SO]3ETU4N(;Z&(32P3PE"JDX!ST;)!Y
M4D<5JUA>*]3@\.:!J/B,VZRW%C:/L[;LX(4^VX+].:Y[5]7UKPW:>'=8DU-[
M^"]NH+6^MWB0+B;@/%M4$;6QP2<CKSS0!WU%>?:3+XFUKQ/X@M!XD-O;Z5J4
M2HJV<;>9&8U8QG(X'/7K6 NM^-)/AM)XOC\0(T^GRSN]H;2,1W,<<S*0YQD'
M:.-N.GJ<T >P4  =!7%:=KMUXL\1ZOI]K>SZ;;Z=;6K9A5#(\DZ&3)+JPPHV
M@#')SFN=;QCXCNO#^ELEY%;ZC#XE71+UU@!2?#[2P!Z C&0,=\8[ 'J]->1(
MU#.ZJ"0N6..2< ?B2!7&7"ZWIE]8Z?>>)I;J.5)W_P!'MHQ>3-N78 H0J$4$
MY;CG;G@UR=QJVK>(O W@;4;O4KB&ZN->BMYS J*)-LTBAB-I&1Y8./NY['C
M![#17$W>JZI?^(-4T*QGU%3IMM!F>U%MYCRR*QW/YF!C '"@#.[V%=!X9?69
M/#MF?$,4,>K!2MP(6!0L"0",<<C!QV)H AF\56275W#!;7UXMFVRZEM8#(D+
M8!*G'+, 1D*&(SS5_3]5L]3TJVU*VE!M+E5>)W&W<&.%X/KD<>]>?WUAXJ\%
MZOJ6M>&$BUS1+VY>ZN]+9L312D_O&B;OR#\OX8/6J^M:I:^(- \"ZCH5[>65
MA=:U#$(4VC:?G)# @\JR<#E?8\4 >JTUI$1D5G4%SA03]XX)P/P!/X5P'BO5
M=8TU-?:#69-]AIJW%G#:1(\@949GDN=R;5!*C !&0&P,U5NYKW5?&_@.Z.I7
M5M]MTVXN'BAV;$?RXR2 RGKO(YSQTQS0!Z717GL>NZR=*\?$ZG(9='EE^QR^
M5'N0+ ) "-N",GN,XJ+4/%U_I^E^'-0U66_M](N],26ZU&RMUD\JX94(,@VM
MM3!;H,9- 'H]%9^AS-<Z!I\SWT5^[VT9:[BQLF;:,N,<8)R:XN#7=:U_P;J_
MB?3=3:UDMI;DVEKY2-$4A) 63*[B7VG)##&1CIR >B55U"]ATO3KB^E21HH(
MS(XB3<Q Y. .M>??\)!KOB/7/#L6FZJ=,M=9T62\91;I(T+@)@@L.>6[\8_"
MNTU.*:'PA>17-P;B=+!UDF*!?,81G+8' R><"@"UH^J0:WHMEJMJLBV]Y"D\
M8D #!6&1D GGGUJ[7CVGWGB+PS\/O"7B&#6!/IZPV4%QIAMD"&*3:@*O]_>"
M1WP?0#BNH37[W0/&.M6&NZE+-8M9?;]-8Q1KA$SYJ?*HW.IVX'.010!W-%9V
MA1:A%HEH-5N&GOVC#3L5488\E1M &!TZ=JXK2;_Q%>:CXBN;GQ RV>AZHX,*
M6D>9X5B5S&3CCKP1SUZ\8 /1J*\]T[4?%VJVGA_6[ 3O'=M%->P3FW%O]GD7
M)\LJ?,#+D8SUYSZ54UOQ)K>F,;M-5^T2)KD=L\-M$K6T=N\@01NY4'S,')VL
M2#Z"@#TVBO/->\4W6F^)[S3M3U"ZT6*5XQI5X8$:TF!52RNY4[6+;AR1@8(]
M].VU.^\2^)/$6G6NI3:=#I+16\;0)&S/(R;R[;U/ R  ,=#G.1@ ["BO*8_&
M7B+4M$\,3QW<5I>3ZV=)O@L =)"N_+#/(!V X!'4C-=-X7O]43QAXCT'4-2D
MU"&R2VGMYI8T1U$JMN4[% (!7CCO0!V%)@#H *YC6]:N/^$QT?PU:SM;?:X)
MKJ>=%4N$3 "KN!&23R<=!QUR,RSU35)=6\4^%[V_F=K&".YM;]$C$IBD4G:P
MV[<@J1G;R#V/- &W9>+[._O[&W@L[YK:_$AM;X1!H)=F<\@DKP"06 ![9KH*
MXSX5021?#?0W>[FF62T0K'($ BZ\+M4''U)J#Q;JNJV=QK9MM5:+[+IOVBSM
MK*-9)%<!RSS[U(5/E '(R V,F@#NJ*\ZEU[7K_5/ B6^I+:1:Y82S72+;JV&
M$"/E<^[G';@9!Z%MG>>*[_0/%FG66LR2:QI%\\5E=/!%NF7RU=4==NW)W$9
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MX!;6VH(J%FBP!L=<!67@<$?G5N]\%F^L-.@EU>Y>>TOX]1DN9$5GGF3[NX#
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M5?N$KD89>@(/3C!JI=^ [:72].L;:^F@%GJ U-I2BN\]P&+EG/3EF)( '8#
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M+V:RN;&[2\MYXE5BLB@@95N",,>*SH?!!@N]>N1K5Y))K4"13^8D9 8)LWC
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MX2!=C.87.Y0 -HZC XP1W&:Z&T\$PG2KNQUO5;_6Q=0&V9[QE!2,]0H4#!)
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M%@6VE:R9=LT2_=#*X() X!H QM3U_P 0:'9Z//XH2ZCL_LKKJ%YI"B00W 8
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M6ZYJFFZ=KNIV>J7%S<V.HQ+&UMQ;6T1>-3#(#P[G<V<;B"P^[0!ZE17!W?\
M:M_\4+W1!KM];:>VCQW02 1JR.964[6V\<*.3D^XK(T?Q;JMWX;\*:=/>O\
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MNEO%;29(W2^CN;OS3(V,H\0" *<YR 0N#P*[&@ HHHH **** "BBB@ HHHH
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M>H/Z"K-WX#M;_P .3:/>:MJD_P!HD22XNY)4::0HP91DJ0%! X '?U.>KHH
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M'/-7: ,S7]!L?$FD2Z;J".87(8-&VUXW4Y5U/9@>:@M/#JQ7\>H7=_=7U]#
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MA03P">G-)932W-C;SS6[VTLD:N\#D%HV(R5)'!(Z<4 3T444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5R7Q/_Y)CXB_Z\GKK:S/$&AP>(]%N-*NYYXK6X79
M+Y!4,R^F2#C\* .+U";45U#X>V=IJMU:6][$\4\<.W#!;8L#R.OUR.AQ6=<^
M)]3\*:5XWMUOY[LZ;>V\-E/>-YC1>>J?>)ZA2Q(S]*[9O!]J]QHD[ZA?F31@
M1:G='W78=WR<_+Q_]?FHY/ VDW!UT7CW-W%K>W[9%,R[25 "E=J@J0 ,<]@>
MM &!K&E#3OB;X%9;V\GW&]5Q<SM)EA ?F&?ND]P,#IP*K6\WB?Q;X?DUK1[Z
M"SOEO9?)>6_D6*-(YBOER0B,J057DDDY.<@<#HK;P#:0WFDW=QK&L7DNE%_L
MIN+E?E#+M(.U1GCC)Y]2:9_PKK2$UJZU"WN]3MH+R4S76GP712UG<]2R8[]P
M" >_% &;;0ZCK/CWQ1I,^O:C%9Q6MI)$MM*$,1<29V,!P,@>YP,DUSUKJVN/
M\.O#'BN77+Y[]KRW@EB# 0RQF;RF#(!\Q(YW'G/3%>CP>&H+;7]1UF&^O$N]
M0C2.7E"H"9V;05XQD^O7G-9R_#[34\+6?AU;W4!86DRSQ#>F\,K[UR=G(#<_
M_6H RA!J.K_$/Q+I$FO:G!916=M+$EO(J&-G\S[I X' ]S@9..#D1>(=9O/A
MQX'U5]3N$NKG5+6WNFCP//0RE#NXSR%YP1G)S7>0>&(;?7;[68]0O1>7L*0R
MDF/;M3.W V<$9/YUGI\/M-B\/Z9HB7VH+9Z;<K=6WSIN#JQ9<G9R 23B@#'M
MX$M_BYXCNS+=OY&E6\XC%P^"<R?+C.,<=.F?K4.D_P#"4:[HWA_Q)9:A;0O,
MT=S>&74)&AEA8?/'Y7E[4(S@$'((Y)ZUV#^&+-O$XU\3W:79@6WE1)=L<RJ2
M5WKCD@D]"!ZYK+TKX=:3HVH&>SO-32R\[STTLW1^R))G.0F.QY )QGMP* ,*
M.3Q-XOTK4;_1[V*SOH=0FAMG>_D1(1%*5V20B,JV5&3G)^;J!@#T5/,GLEW2
MA)'C&9(2" 2.JDCGVR*Y>;X=Z2^NW6IP7FJ6BWK^9>65K=&.WN6[EU SSWP1
MG\376,F8BB,8^,!E ROTR,4 >0QZSKDGPDT741K5XM\^KB"6?()E4W;)AN,X
MQV&/3I74Z4][IGQ1N]%;5+V]LI](6^VW;ARDHF*';@#:".PXJTOP]TU/#=MH
M*WVH"RM[H74?SIN#A_,'.SD;B3_]:M1/#<"^*1XA-W=M>?9/L94E-ABW;L8"
M]=W.<_IQ0!G^*-6F@\0>&]#2=[>+59YA-,C;6VQQE]BM_"6.!D<X!Q@\UC^(
MKK5/!VEW*1ZU)<)J&IVUO:&8;Y+".5MK$LQ)?HVTMT/K73^)?"^G^*K"*VOC
M/&\$HGM[FVD\N6"0=&1NQJN?!6ES>'[K2-0DN]1CN\>?<7DY>9R/NG=QMVGD
M8  //<Y ,C4)KWP]X\T#3[2]NY=/UI+B":*>8S-#)&F]94+Y([@C[OM7(G4-
M<B^&=QXF;Q#J3WVGZHZ1J9 (Y$%V(RLB@?-E3]!@8 [^FV?AR*WNX;RYO[V_
MN[>%H;>>Z*%H5;&XJ%4 L<#+$$\?6LQOA]IK>%KCPZU]J!L+B<W$@WIO+%_,
M/S;.F_G_ .M0!GW4>H:A\4K[1FUO48-/;1X[D10.J%7,K+\K 9'"CGK[XXK'
MT3Q1J]UX9\)V$MT9KK4;Z[M9KF68Q-(D!EP-ZJ2K-M49 R<'&"<CN8_#,,?B
M.371?WIOI+06;$F/;Y8)8<;.NXD_CZ<5F/\ #C19/#":#)-?/;Q7!NK>;S0L
MUO*6+%T=5&#EF/.>M &)JE[XD\&Z1K$MWJ$!M;BZMH]/+7+7,MDLCA)&=G4;
ME&25SGT.:W[W0;FUGOI$UR\_LZ?3WB-G).[2><,GS$D+;E^7(*KQWXJ>/P3I
M;:!>Z1J$U[JD=ZH2XGOYS)*X'W1NXQM/(P!@Y/4FGZ%X0M=$C96U#4]28Q&%
M'U"Y\TQQGJB\  ' R<9.!SQ0!Y_%)>:1\ M)U#3M2O;>X\NT)*RYR&E1"HSG
M:,,?NXKL/M\NN_$+5- EN+BWL].LH9 D$S1-+)(3ERRD-A0  ,XR3G/&'_\
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MXY.8=6\!:=K$.GM+?ZI#J%AGR-2@N=MS\WW@6Q@@^F,>F* .?6]\1:5-X?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDN+-I0T<A 48Y!8 [1D!AGOU-2W/A:SEUJ;5[6YN["]N(EBN7M74"=5^[N#
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M$T,,=W>-*MLC#!$:GA>.,]<<9J_9>&;6TN[*YENKN\EL8VBM#=.K&%6 #8(
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MO>_#[0;_ $;3=,ECN533,"QGCN&2:W  &%<<XP .?0>E;>DZ3:Z+8+:6@DV
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M3MXKF(RS?:'M$N7%LTN<[S%G:3GGTSVJ_<^%--O--U6PN?/F@U1]]T'E)+'
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MU6$=TB*YDBM6NG:WA<]62,G:#R>>W;% '4T444 %%%% !1110 4444 %%%%
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M#:&SD \=!0!Z&?$4R^/4\-M9*(GTY[Y;D2Y)VNJ;=N./O'G-;]><264&B_&
M36,3X_X1N>00[V92RS)T!/&>,XZ]>M5M#L]2\0>'O#OB>#6X+:YWQ7%U<B21
MO/!XD@9<[<;CM _A(&* /4**\D.G?;M-^(IGU#4V.GW4SVA%]*#"RVZNI!#9
M.#T!R!V'6K \^U;X>:XM]>O?ZI)#%>M)<NR3));LQ!3.T $ C 'KUYH ]3JE
M>3ZA%>V,=I91SVTDC"ZE:;885VD@A<?-DX&*\OFTXWMI\1VGU'4S_9TTDEGB
M^E'DL+=7!!#9.#T!R!V%:D][=W-_\,KV2[N/,O5S<JLK!)2;4MEDSM)SSG%
M'H,5[;SW=Q:Q2J\UOM\U1_!N&0#[XY_*K%>36Y&@77Q.U;3XW^UV+^;#F1F
M;[,K$D$X;DYYK:T_2+W[5H?B&RUB)+8Q?OU6627^T5=?E#;CC=GD'&?PH [^
MBO*M$M]4\4^%='\3PZS!9W@E%S<77F2,3ACYD+)G;M_AV]L#'-=]XHAO[GPS
M?0:7<QVU])'L@DD<H-Q( 7<.1G[N1R,\4 2>(M4ET3P[J&JPVRW+6=N\YB,G
ME[@JEB,X/8>E3:1?'4]%L-0:,1FZMXYB@.=NY0V,_C7FQU6&Y\.>-;*XTR]T
M;5X]%<SZ=-)YD04)+B6%LX(8M@D8Y44ZQMFTC4?AS=VUW>>9J$'V>Z5[AV21
M/LVY1LSM&T@8P!0!ZI7/1>(YW\<7?AQK%%$.GK>QS^=GS SE I&WY>5/<UP6
ML7DJ6D>L:;>75T1XCCC_ +2>8QY4SA&@1!G=&HRASM!(R >M=3%_R6ZZ_P"Q
M=B_]*'H U_"7B&3Q+I4]Y+9K:/#>36IB63S!F-BN<X'7'I6]7%?##_D :G_V
M&K[_ -'-7:T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDB?HP_IZY[5DW>LZUIOV5[W1[>2*>YAMV>TNR_D^8X7<P9%RHSU'MP!R.AH
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M;'(9 VP+\V2!UW'M704 <_:^#=)L([5;+[9;&U@^S1M'=R9\O^Z<D[NV,\C
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M[QVE_/=1B/4%\IX;EXA"WD)^\PI )''7/3W.?2[&QM=,L8;*R@2&VA7:D:]
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M/MH66.X8?,)>7(W =6QR#R>:WH]!TN/3;G3S9I);76XW"RDR&8L,$NS$ECC
MR3V'I5/P]X-T'PL9#H]CY#.NTL\KR%5SG:I<G:OL,"@#(^*'_(MV'_87LO\
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M^<L'VN; ?=NS]_/WN?KS1K/@7PYK]_!?:CI_FW<*>6LRS2([)_=8JP+#ZYH
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M?4UHQ>&=)@UI-8C@E6_2 6ZR_:)/]4#G9MW8QGGIUYH Y/P5I-C:?$'QH88
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M&W@<?_7K6CT]O'#^*K>ZU*TM;VSU&6!)7MV:XLHTQY3QMYB[ 0-V0,$[LYH
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MT&#P_P#$3PU/HS7,<FJ/<0ZC&;AW^T1B,MYC9)^96Q\WN* /2**\;T;3TL?
M>O>)K9+B;6=*N=3^Q2/.[>4-SK]W.&P.>0>GTK1U>WBT[PKX2\0Z"2-2DN;-
M3,AR]ZDN ZRG^/.<Y.2",C% 'J=%>80QQ+_PM"W8*((2'2,\+'_HH;(';YN>
M.]$;W4GA_P"&TDN^ZTYH(_MMJOSO,3;91BG5PIRQ'/8XXH [;Q9K%SH'A74M
M7M+>*XELX&F\N5R@(49/(!_+CZBM#3KEKS3+2Z=0K30I(0.@)4'^M>8WVA7&
MF^!?B#>RQ306ES'<FP@DD8>7!Y?:,G" MN(& 0/3I4\6G6^E>,? -Q:"1)=1
MM9XKQS(S&=1;AU#9/8CCT[<4 >BV6I6NH/=K:RB3[).;>4KT$@56(_#<,^^1
M5NO/_ACIMA:/XGDM[2"*1->O(%9$ (C!4A1[>U6/&EOJO]L6M_8Z;::[;6UL
MRW.D3,%DPS#$L>006^4CGGL.M &MJOB"[T_QIX?T5;6%K75!<;IBYWJ8H]V
MN,<Y'.3WXKHJ\H9M,UW5?AD+(W/]FR6UXB+*Q63:L 4JQ!SGY<'GGGUJ&W:Q
MTK1/&ND27-Y:Z;#K,4%M%:/\X\P1'RD+<!68D'D !CTH ]:F,JPN8$1Y0#L5
MV*J3[D X_(UP/_"?ZBWPQT_Q8FGVIEN9DCDA,K!8PT_E CCYCT[C^E'A=);'
MXG:]8BWM[*!].MI_LEJV8D<LZYZ ;B ,D =NO6N5B_Y-PTK_ *^8/_2T4 >U
MUSOC7Q!=^&=!&I6EK#<8N(8G$KE=H>14R !S][ID5LZA<26NFW5Q#'YDL4+N
MB?WB 2!^->.ZG;V.J_!;3/$,NRXU2>YM9Y[P_P"L:1KA ZD_W020%Z#:..!0
M![752?4K6WU"UL))0+JZ#F*/N0HRQ^@R/S%<#/;'Q=XN\5Z)>7%DKVHBCMHK
MFV:1XHFB!\V(AUVG>6^8#/"\\"JB:-9CQ[X,BO)X=7D72[M)+Z6( W'EF,*Q
MSG..<')ZD]Z /5**\GMM/;QMIFO2W.KV=CJ-GJ<Z-=&W)N; 1R'9M?S!M78H
M[ '+9R<FK*>'['7_ (EZO9:F]S=6S:3:3,OGR1AI-[_/@,"O3IT'I0!Z?17C
M_P#8=E?:7\2?M0FF^QW4TEMYD[MY3K;JP89/4'H?_KU8%JEJWPXUV-YCJFH2
MPQ7=R\K,TZ/;,S*V3R,@$#MVH ]+MGU(ZG?+=16RV"^7]D>-R9'^7Y]X(P,'
MIC/%7:\SA@4^(OB=!YD_EBVMF7]\^5)MW;@YR.><"LBQL(=/T+X8ZS;M*NH7
M,]K;33F5B7B>!BR')QMX'% 'L=%>50Z>WCB'Q,ESJEI9WUGJ<T0G>W8W%BD;
M?NV1_,78NT \  Y;.>:]-L2S:?;%I_/8Q*3-LV^8<#YL=L]<4 6**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW,SGS2!A<Y)' X'H*R]#AU35]5CUS7=&CTNXMH'M[:V^T+.XWL"[EE&,'8@
M_P![UK:TDZF=/4ZN+07F]]PM"QCV[CMQNYSMQGWS5P$$9!!'M0 M8L'A/1+:
MY:>&Q";I_M!B$K^3YN<[Q%G8&SSG&<\]:V"ZA2Q8;1U.>!60^J7&K^&VU#PT
M]G+-+_Q[/=EA"X#X))7G! )&/:@"6Y\/:9=ZQ#JT\#M?P*4BF$SJ44]0 &P
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MLTG>T<O ^YE:,D8."I!P>XZ&J3>!?#+6=[9_V1"MM>RB:YB1F19&'(R 1QD
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MWG2;%;.[CYO7G'KS3O!^MS>(O".EZO<QQQSWD E9(\[03Z9)-;9(! ) STH
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M=-T6X9C]EL[:W8DPKCRD53RH XP!QQVJ/4=!TO5FMFOK19C:N)(,L0(F'1E
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MC6(-TUV?L\?^D.NUIOE'SD=B>OXU<HHH **** "BBB@ HHHH **** "BBB@
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MQAJ$5OXV\)66I,BZ1=/<;Q+_ *M[A57R@^>.[8![X/4"@#MED1XQ(KJR$9#
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M3;5-.@6WO-)N&NH0OR7)61"#(.CG))RV:Y;4[.VC^%7C6T2)5M[#Q(\=I&O
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M%D1XQ(KJR$9# Y&/K7E&FZO9ZEJ_@6T6P>ST.X2\VV4X!5;J,E1&W8[</M_
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M[4 4W\-Z+(]F[Z9;,UD,6I*<P#_8_N_A4TVC:;-JD>IR64+W\2[8[AE^=1Z
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MT3!HR+2,;".A''!%7!H^F 7@&GVN+TYNOW*_O^,?/Q\W'K0!P/B^ST34=6\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
A10 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>exhibit107-formofindemni003.jpg
<TEXT>
begin 644 exhibit107-formofindemni003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0RR00M+M#PLJG"@G!) Z=Z .CT_Q)I>J:K>Z9:32M>V(4W,3VTD9C#?=R64
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M#C JEX>UK1K?PGI<VGWM]?VMU(\5F]P6DGN&W.2/FP> K'G& M %C_A%9?\
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M\?-@=!R.N.3CK5#_ (3WPY]ATZ]%\Y@U";[/ P@?_6<Y1N/E88/!P>* )/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"%,AWW$98?(.-X(.#D#VKU.B@#RC4-(U#7+GXG6-E#<13:A';BTDDA>-)]D
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MX8UCPG?OK>GLD1\V!VMB4.%G$A^3;CGUSP :]2U"9;?3KB5PY58SPB%R>.P
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M"WD@MGD#2K*Y*':/E.&!^; ]2*Y.*&\'P6L+%M,U%;N/5ED:#[)(6V_;#)N
M Y&TYR.*]IHH QE\2V;>)DT$P7BW$EO]HCG: B%Q_=#_ -['.*Q/']K?+<^'
M-9M;>:ZM]*U$374$*%W\ME*%PHY8KNS@<\FNL-G";X7C M,J%$+'A <9P/?
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MXH+J2U:"66W=$E"0A6VL0 <'B@#I-1UBVTZ>VMF62:[NBWD6T*@NX498\D
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M=US<6$UI:RJ8VN?LN&8E3@C)R!D9.WT(H [VV\5:=/JTVESB>RO(K;[88KI
MFZ#.#(#DC /4'!'<4V'Q=ILFJ6-A(EU;OJ"LUE)/$52X &2%/4''.& .*Q+J
M^N/'?AG5;.QT:_TZ6XTZ: S:C;F!ED9<"-<\D9ZD<#'<GBEX5N;75)--@N/
M]S9:O9;?/GNK()% RC#-'(?O$XXV^O/ H Z6\\9Z58M$\_VA;*2X^RB^\O,
MEW;=I;KC<,;L;<\9J+Q)K]HFGZQ91+?2RVML6N9++(-ME25)8$'..<+DXYQ@
MC/$>&[5++3_^$3UOP5<7NIV\K)'=/9B2TN%WDI*TAX  ()SSQP">*T-/EOO#
MNH>,M)U#3-1F.IW<U]8W-O:O+',LD841EE!"E=H'S8% $^@ZGIY\&^ 1J]UJ
M'VRX\@VSQ-)B6;8>)&'!&,G#'G%;UUX]T>UO-4M%BU&>YTP(;F*"SD9E# MD
M#'3 SGIR,$YKC(+:^7P=\-[=]*U)9K"^MWND^QR$Q(D3J68 ' RPZUN6"SP^
M-?'ES)8WP@N8+402?9)"LQ2)E8(=OS8) XH Z8^*-+-AIEW#,UPNJ;?L,<2_
M//E=W .,84$DG &.:-'\3Z=KEY=V=J+I;JS<QW,<MLZB)QCY2^-A/(/!.0<]
M*\VB2;2O!GP_GDT[58]4TUV3$=D\CQ#RF$@:'AF!&!D8QUSV/6>!KS2Y]1UA
MXC?KJM]*+NY2]L9+4E0 B[%;^$  =2<GGJ* .FU#6+;3[BWM662:\N=QAMH5
M!=POWCR0 !D<D@<@=2*RI_'FAVWA^^UF62X6"PD,-W%]G<RP2#^%E XZCD\<
MCFLW6X+S2?B9IGB,V]Q<:7)ITFG3F")I#;L9!(KE5!.#@*2!QCFN9\2Z'?76
MA_$/5+:QO'&N?9XK*V2W<R2>4@4N4 RH)SU X7/<4 >DZ1KUKK<EVMK%=H+9
ME4O/;M&L@89#(2/F7'<?U%9\>HZ1_P )Q?QK+J!U.#3U::';*8O*WG!1,89B
M<\J#TQ6[9RB:RAD59%#(#MD0HPX[J0"/QKD(Q-%\7[^^:SO?LG]BQP"X%K(8
MVD65V*A@N"<$=.M %BV^)&@7=OI]U%]M-I?3_9X[HVKB))"Q55=L84DC]1G%
M=:S*B,[L%51DDG  KQR&RU!/@QH^G-I6I"^AU..22W^Q2[U479D)(V]-O.:]
M,\46%QK7@_5M/LGV7%W92Q1%LK\S(0 <].N* .-\8>(H[^3PC/IYU**"YURU
M6*X4LD-S&6.00#R#@$;@,@9&177:MXKL-(2[DECNIH;$ WDMO%O6W!&[YN_W
M2"0,D @D8(KS^[U&\U/POX.LQH&L17VF:I9&]@-C(!$(@0S!L;67C(*D\=<5
M9VKHGBG7K+7/"=]JUKJET;JSNK:S^T*ZNBJT3]EP5[\8ST% &OXH\2>;X@\*
MZ=;)<SZ;J3RS2M;*<7$:P,R*I!Y&2"?8>E78-5TOP;I=W!YNK7MG9.9+F5\S
M_8E;#;"?O$*I!P-Q (SQBL[5K>6V\6> S%I,\5O8"X^T)9VKO#:AH-BKE5QC
M/''IVK,"+HGB?7[#7/"=]JUOJ=VUU9W5M9^>DBNJ@Q/V7!&/FXQZ"@#KY_'&
MC0ZFFG1F[N;J2S%[$EO;._G1$@ H0,-G/;@8.2,5-9^,-*O]%M-3M6FD2[G-
MM# 8]LK3#=F,J<88;6SD@8!.:YZSMIK/XGZ?+_9<UM9P^'3:DV]LY@BD\U&$
M:L%QPH./I^%8FG:7!=>$Y[#6=*UF))O$5S-'-!;31S6NXR/'.N%SCH,X.-_-
M 'H:>([(V<MQ*EQ"8K@6IADB/F-*<855&<YW#!'&.<XYHTGQ'9:M?WNGHLUO
M?V17[1:W";74,,JPP2"I]037G-Y8>*&\-PW-U!/KT>C:V)XED@\N>^M!$4)*
M$#+C>0"1\VW/IGL_"CZ=?W4VI:=X:FTM6C$;SW=IY$TISG: ?F*CU/&2,9P:
M -K4-8MM/N;>T*RSWEP&:&VA4%W5<;FY(  R.20,D#J16<?%MG<^'=1U/3TF
MFDLO,CFMS$1)%*HY5U/(QQ^'(S63K,-YI/Q/T_Q$UO<7&E3:8^G3-!$TIMW\
MSS%<JH)VMC;D#C SBJMKIEQ"_CS7?LUTL&KJJ6MN(',C^7!LW^6!N&YB>HS@
M ]Z )_ EF-7TO1/$DUQJD>H-9*;K?*1%=M(H)8J<@@$_+C&.G3BMG5/&>E:5
M+J"RBXE3351[^2&/<ML'&5+<Y/'/R@X'6F^ 5EA\!:';3V]Q;W%O910RQ3PM
M&RNJ $88#N*XSQ@=5U1/&FF2Z1JA<VN-.6SMV$5POE<N\BX#L#D;">@ "DT
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M.>+4_%AGM+N!;C6)+B%I[=XQ)&410RE@,\J: .THHHH **** "BBB@ HHHH
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MN@H+1$XWJ5)5ESP<'@]<553QKIC7.FJT5TEKJDOE6-XR#RIWP2 .=PR <$J
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M.>, \F@#MZ*YJQU#1Y?&^JQ1+>)JD-G$;DS%EB$>6V[03C.<Y(&/>E_X3;3
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MI[;4;6Y>*!=SE$E4MM'<X[5U/V2#[9]K*9GV; Y).U>"0!T&<#..N!GH*FH
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M+#/!;F2*6*0HR,".000:Z^N4^)-K=:A\/]7T^QM9KF[NH/+BBB0L2<C\!^-
M&78/X7O(-$M+?5G;5+DQM'Y%_([;T3S&W#?TPA!!XYQ6S>>-]/T_6[S2;NTO
M8;BVM&O%+J@6>,''[L[OF.>,<&J\>KS1:'81Q>']2FU"WCC6%)+<JJ2[-F68
MG  W')';.,UF^,](O_$<DEY9P2V]]X?(N--D>WS]IGX) _Z9G;MP.YST4$@&
M[JGC*ST=M*COK'48YM38K#$L =E8*6VMM)&XXZ DU%I7CS2=175A<17FF7&E
M*'N[:^B"2(A&0P"D[@>V"?U&>=\2ZO/=7_@'4+G3+NVN#J+F:T:/,D;>0^X
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MI=&\T^*.9U(3$BOG:4.[OM/7%9?_  L71_[%T751;Z@UOK$X@MML&6#DL &
M/4[3@#)JGY>I:/\ $O4KW^RKN\M]3L+>**>W4;%DC+[@Y)^0?,#G^9KF-,TK
M6+?P/X#LI]%OTN--U=+BY3R]Q2(&7+\$_P!\<?>Z\4 =@_Q$M(Y[6UET+78K
MVZBFEAM'M )&\HX( W<D\$8.,'.:OS>+H4LWGATK4IWAMDNKFW2-%DMU9=P5
MP[#Y\ _*,GCW&<[6(+J3XG^'+V.RN9+.WM+F*:=8B4C:39M!/_ 3].]9&I6E
MUH?CW5KV[\)RZ_IFKB&2*6V@CEDMY$0(48.1A2%!SG _D =7%XOTR\M],DTT
M2W\FI0F>VA@ #&,8W.VX@* 2 <GJ<=:P/AC*9I?%K>7<Q :[*HBN6+.F(X_E
M)R>AST)'I5::RU7P_P"-]+\0KH;R:=-I;:?<6FG(&-DQE,BD*/O#G!*]P3Z5
MI^ [?4(-0\427NF75G'>:J]U T^T;T*(O0,3GY3[>] &=JM__8_QB6X2UO[Q
MI/#[D6UL#(S-YZ= 2%7@=20/QK3/Q*T?_A&CKHM-1-O%=?9+J,Q*LEI+D#;*
MK,-O)'.2.12:E#=:?\3[77'L;J;3FTA[)I;:(RE)3,KC<JY;&!U Q1HOA,76
MG^)_[7MS'%X@NI)&MB1NCB*!%SC(#G&[CH2/2@#HYM62'5[/33;3M-=1/,&7
M;MC5-H.[YL]64< ]:75=7MM'AA:?>\EQ,L$$,8!>60]%7) Z G)(  ))KFOA
MU9ZF-*>\UJ5)[N/_ (E\,JG(>"!F0/\ 5VW,3W&VI/'&EZC->^'M;TZW>[;2
M+TS36L9&^2)U*.5!ZL <@=^: -"+Q?9-<ZC9W%K>6U_80BXDM)$5I'B/1TVD
MAAD8X/!ZXIGASQC;>)S"]EINIQVLUJ+F.[G@"PL,XV!LGYAZ>QYK'NM/GU/Q
M==>)H[2ZCM8-%>QB5X626>1WW'"$;L# '(&2WH,UJ_#RVN;+P#HUE>6TUM=6
MMLL,L4J[2K#^8]Q0!I7^N0V>HQ:;%!->7\D33BW@V[EC! +,68 #) '.2>G0
MXQ[GXA:/;>%[O7GBO##93FWNK=8AYT$H8*5<9P.2.<XY&#56_L[[1_B:GB(6
MMQ=Z7>:<+*8VZ&1[>17+JQ0?,5()' .#UKG-?\,ZG+X/\9W$%A</=Z]?12VU
MFB9<(A0!F'120K-S[#KQ0!W5CXMM;SQ&=#>RO[2Y: W,#W,01+B,$ E>21@D
M<, >>E8GQ3*Q:#I=R6E7R=7LS^[9N095R"H^]QVP?:IKZ*YN/B?H.HQ65V;*
M*PN(I9C P5'<H5!R,_PGZ=ZL?$+3KW4?#UM]@M9+J2VU&VNGBC(W,D<@9MH)
M&3@=.] $^E^-[#4-;N-'N+._TR]BA-PJ7\0C$L0."Z$$@@=\X(].#@/C6P6[
MTR&XM;VWMM6?R[*\D51',Q&5'#;E+#D;E&:R-7T.?QEX@COHXI[*TMM+NK5)
M;B(QO)+.H7[APP50"<D#)(QGFJ/A!;M(-.TG4/ BVNIV&Q)]1>WB-N0F/WB.
M#N9V X '!// H J>&O%%MX4L?%<US9ZE=6EOX@NO.FA7S!;Q_( 69F!('H-Q
M [5W&H^*K6QU!K""UNKZZ2S^W/';!/EAR0#EV4$D@X R>*X5],U.3P'X^L1I
M=[]JU+4KN6SB,#9E20*$8>G0]<8[UIW9UJYU:&RN-'U"?2GTE%MUAQ&OVCD.
M)R2#@#& <KUX)Q0 >+=1M=9L_ NLV$LI@NM;M&C.YEW(RN<,N<9R!U]*?K=[
M)JGQ,M_#][I%Q=Z6-+EE,!,6R1C*B>;@N.%&0/XADX'>L6UTW5U\"> K*71K
M^.XTS5+:6YC,>XI'&&#.<$\988'4^E=/+%<_\+=M]1%C=FQ&CM:&Y$+;!*TR
ML%]>@Z]/>@#<#:=X.\,()KB?[#91A \SF60\X5<]6))  ^@J.#Q1;MKD.CWE
MG=V%[<1--;)<!,3A?O!61F&X9&0<''/2J/Q#T34-<\*-%I85[ZVN(;N&%FVB
M5HW#;">V<?GBJEW:S>*O%/AG4H[&\M(-*::XG:ZA,3!V38(P#][DDDC*X7KS
M0!D:;$OC?Q%XEM=9TR^1;:\BCMIQ+&KV(6-6 5E<E6+$DE<@YP3V'1^*_$UY
MH6I:#9VNG37(U&\$+R(R# "LQ4!F'S';U.!C/.<54\&PW4'B3Q7+<65U!%>Z
M@L]L\L)42((U7/MRIX.#4GCFSOI+WPSJ%G8SWB6&J":>.W +A#&Z[@"1G!84
M 8UOJC:/\3?%$J6&I7KOI]G*+6#]XX/[PMC<VT?3/TS766OBS3K_ $?3-1L5
MFN1J:[K6!% D? RV<D ;<'))QVZD9Q=,2[A^(WB#4I]/O([6XL+:..3R2P9T
MWEU&.N-PYZ'M7'V&@ZUIOA'P9?R>'9-0DT;[3!?Z5)&#(4E;.] W#$84\=<X
M]< 'I^@^)+/Q!]MCACFM[JQG,%U;3@!XGQD9VD@@CD$$@URWC%#_ ,++\#PK
M+.D-W)=BXC29E64)$&7<H.#@UT?AC;+;SW<7A\:+#,5V0R0I',^,Y9PA('7
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M1\Y(QGIFMJXTM_%WA76+;3_"Q\/R7%DT"O=V\<,LDI((4;"3Y>1R3UR,#@T
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M>/-*\53V,DUO+IKZ?>P6H,K6N9/,1@HY<=%)4=LXH T+GX@Z1:>'=2UB6"]
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MPP%W<]SV'% '6T5Y5H/B"/PF?&UP-+O[RUMM:EEG:W"D0QB./+$NPSCGA<G
M["O48)X[FWBGA;=%*@=&]01D&@"2BBO//'$:Z)XS\+>)<L+-KO[#?)N.S]X,
M12$=,JW?Z4 >AT5YC8W-OI'QTNK)1(;34K3;%O)*172*'=$!.!F-E8X[FME%
MTZ'2/%'B"[LI;BRN3,K0P\EK>-=C[02 -Q5WR",@CVH [6C/.*X*;Q4^FP>"
M+/1-(F.G:I&FQ0Z;DB$!=8QN;[V N23C ZDFJ%EJ3:'\1?&\]OI5[?.;>QE:
M"WVEE&R0L268*.O0')[ \T >CW4 NK2:W,DD8EC9"\3;77(QE3V/H:S]!T"V
M\/V300W%W=2.09;F]F,LTA P-S'L!P ,#\S52+QAIUUINCW=FDUQ)K"[K.W4
M .P"[F)R<*%'4Y]ADD9K/XZLH;'6Y9[&\CNM%3S+VSPGF+'M+!U.[:RD D8/
M;&,T =316#)XLM([_0;4VMU_Q.T9K:0!-JD1F0A_FR#M'8$52\(>)K_Q!?Z]
M%=:;+;QV6HO:QL7C(0(D?RG#9+$LS< @9QGB@#J^E&><5PWCN)/^$D\$S8/F
M?VP$SD]/*D.,?4"K]KJ>E#QKKRP:5=C5[:TA:YEX_?QY;8$&['][J!0!U5%<
M1#\3;"72])U8Z1JB:7J,JPI=F-"(W9BJ@J&+')'501SC)-:VF^+$OM<O-'GT
MN_LKZ"W%VD4XC)GA)*[E*L1U&,'!Y% '0YSTHS7FC^++71_AL-4\+Z-/#;RZ
M@T'ERLH:)VN-CN06.26)P,XY&<"N@O\ 4M,;QEX<@O\ 1[M-5ECN6LI7*[8<
M)^\!VN021M['KUH ZNBN(F^)=I%I^IWZZ)J[VVEW;VMZXCC'D[,;FY?YA\W1
M<G R<<9W[KQ%;Q:K:Z7:Q/=WUS;M=)'&0H$2D#>Q)& 2P ]3[ F@#8HK$\,^
M)K;Q192W=K:7<$<4C0L+E54[U)#+PQY!&#_6LV3Q)?/\1SX;_LV8V:Z=]H:5
M7CRVZ0)O.6!"KAAQR<].E '6YHKR?PIXH@\)>'M8EGTV^FT^#7;M)[F(*4MT
M,VU2=S!F R/N@X'6N_U+Q"EE=36EK9S7]U!")Y8H61=BG.T9=@"QVM@#TYQD
M9 -FL33/#-KI>K76IF]U"[N+AW*?;+DR+;AR"R1 \*I('Y"K.@:[8^)=#M-8
MTV1GM+I-R%A@C!(((]000?I7#N$\5>/O$FCZYH\\^GV]I:QQB1XL6P;S&:0'
M?D%L+@KEAM&<8H ]*HKD$\:Z=I^C6-\UK>C079+>+4I"K+C.Q7?+;]C''S$=
MP3US3[_QU%::Y?:/!H>K7MY9QQRNEO$AW(Y(W+EN0,>Q]NN #K**Y75O'=AI
M-I<:A):W,NEVL_V>XO(BA6-@VQCM+;F"MP2!U!QG%6[OQ5;Q7U[9V=K/?S6-
MLMU<B K\B-DJ!N(RQ"D@>@ZC(R ;]%<U:>-]/O\ 2=-OK:VNV.J2>78VY51)
M/A=Q8?-@* "221C'K@%T/BFSO3J]A<6-U%?:?'NN;)@I=XV'#(0V&4C/.1@\
M'% '1@Y&117#:?XOT/1/"/AF6PTJ_CTS4GCMK**-0YBW9*AOF)S@'IFM;3/&
M-I>SZQ;WMG=:7/I*+-<QW>PXB92P<%&8$84]^,4 ='17)GQW;*VC;]*U#R]:
M7=8NHC._Y=WS#=\I*_,!Z>_%=90 9K*U[0X]=MH(9-1U&Q$4PEWV%R8&?@C:
MQ'53GI6=X@O=)A\3^&[;4-/GGNYKF3[#<+PD,@C;=GYA_#GL>M<_?/\ \)%\
M3+_0M5T::ZTV/2T58I#$50O*X:;[^1D*,$?,,=!0!Z!:VL%E:0VMM&(X(4$<
M:+T50, 5-6+>W]GX2T2QA*7,R>9#8VT8;?)([$(@+,?S)-4'\<6D%EK\UQI]
MZD^A ->6ZA&;:4\P,IW8(*\]0>#Q0!U-%<K9>.;>ZU72K*32]0MDU:%I+*XF
M5 DK*F]EP&W XZ$@ XXJQI?C"UU.WUJ4V5W:-H\KQ7,5SY:ME5W$C#D8(.02
M0#0!T5%5;"Z_M'38+I[:6W$\8?R9P-Z@CHP!(S[9KQ^W.B12_$'^T]3:SEM;
MUQ9,EXT<D/[L%1$ P/WCP .>E 'M5%>>Z!XTU#2O"?A6/Q+I^H3:OJBF,&.)
M<EAN*A@2,,RA>V,GG'-;]MXM^UFVMHM(OUU.6!KE["78DD$88H"Y+8&X@XP3
MGKTS@ Z.BN;MO&VE7>C?V@BW D%W]@-FR 3BYSCRB,XW=\YQCG..:6/QC9I+
MJT.H6MS82Z6B23"50P=''RE&4D,2>,=<\4 ='17-P^,K0:\NCZA:S:?<26S7
M4+3/&R2(OW_F5CAEZD'MW-1CQS9+?Z5#<6=U;VVK/Y=E=/LVNY&5#*&W*6'3
M(^N#Q0!U%&1ZUYI\2->AU7X=>(OL=A=7-G KP&\C90@D4X) W!F56X)QC(/4
M FMQKW24\6>&K2ZTZX?5&LI6L[H?ZM%"+Y@^]R3\O4?C0!U]%<1-\2[2+3]3
MOUT/5WMM+NWMKUQ'&/)V8W-R_P PYZ+DX&3CC.]=>(K:+5+72[6)[N^N;=KI
M(XR !"I WL21@$L /4GTR: -FBL3PUXFMO%%E+=6MI=VZ12-"PN553O4D,O#
M'D$8/Z9I]YKZ1:I)I=E9S7]]%")YHH611&A)"[F8@9;#8'L<X% &Q17(W'Q$
MTB'PW;ZXD%[+;2W0LY$2(>9;RE]A612<@@^F?;.16[H^J2ZK;32S:9>Z>T<S
M1>7=JH9P,8<;205.?7L: -&BN4NO'EC:_:)VLKMK"VU :=/=@+M24L%SM)W%
M0S $X^@(YJ2Z\9I#K]]HEMHNIWE_:0)/LB6,"16) (9F '0]<>V: .GHKD?^
M%A:<=%T/5XK&_EL]7G6WCD54'DR,Q4+)EQCY@1D9''TK>&JJVO-I*VT[.EN+
MAYAM\M S%5!YW9)5L<=C0!H4=!DUFZGK,.G7-I9B*2XO;PL(+>+&Y@HRS$D@
M!1D9)]0!DD"N#^(&LVWB+X5Z_*MK<VT]A=);RQ3C:R2+*@."#A@0W!!((- '
MIU&<5B:EXC2RU;^RK>QN+R]%HUXT<6U0L0;;]YB!DG@#VYQ6+JGB7P_JVB>&
M-3N=/NKNSU'4+8V3 ;?)G+81G^8=#GU'% ':T5S%QXR5-=U'1;71=2N[^RA2
M8I$L8$BMG!5F<#^$]<'T!JC'\2M/FTK3=7CTO4_[*O)4A>\:-%6"1FV!6!;<
M<-P2H('K0!VM&<=:*YGQK>Z39V&GC6=/GO()=0MTB\K@1S%QY;-\PX!^OTH
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MI165Q;F>.\GC41$AMNS(8G=WZ8X//%=-0 4444 %%%% !1110 4444 %%%%
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M='V1WEM&4$B?Z.8R1N8*0&]^E:&G6NHV_C;Q=J$^F7*V][:VJ6[J PD:-'#
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M^DB%][@,?F61AL=588QGAN<Y%>G5S=QX+LI-5N=1M;_5-/FNG#W*6=V4CF8
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MDUV?#PT2%PJI#*B+,Y&<E@A( Z #.>O3BLN^L-0TCXE#Q%%:37FFWNGBRN!
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJH/<Y.>@QS%K&@ZW>> ?#OV&Q4:QHLEM<_8;ETQ,8XRCQE@2O(9L'/I0!?\
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M^@-PMI/(L9B48W;V)P,%@.,Y)XX!(I6'Q!TS4-(%W%#/]K-^=-^PY4R&Y'5
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M->V,\3IM/FCF.3<P*[6[X((/KQ0!I7GCZTBN=&AL-.O-1&LV\D]E);[ L@1
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M7%M%K<<DEC([*20B[R'7JA*\CK^%;FL:O::%I4VHWK,(8L<(,L[$@*JCN22
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MUV%TY$=Q"Z.)%;/S*21D C![^U1V_CJ,^);/1[[1[_3UU!6-A=7 39<%1DC
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M$2R.<L\#J'B+'N0"5)[[<]374UYSI<FH6&J>._%>GZ8VHM=7D-O;6PF6+S1
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MJ,@4 =PTL:2)&TB*[YV*3@MCK@=Z?7*ZAJ^F/XR\,V\NE&>YO(KB2QOVVXA
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M[IDVFQ:2TEQ(DTL;L\K)L"KL9OE&223CH..3CL*:[I&NYV51D#+''). /SH
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M3M6L_B;<:Q!I_P!IT^[TV*W:59E4Q.CNQ!4G)R&XQQGKCK7+R>&/$+_"?4=
M&CRC49]0:=$,\.-AN1-G=OQ]T8^OYUZO10!P%S:^)M"\9ZAJ^F:$NKZ=K*0M
M- ;F.&6UF1 F<L<%2 ,X)Y'Y]M8"Z%C%]M$0N2-TBQ?=4DYV@\9 Z9P,XS@5
M+!<0W,0EMY8Y8R2 \;!@2#@\CT((J2@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "N.^*D$4WPQU_S8D?9:,R[E!VD="/0UV-<WX]TV^UG
MP3JFE:=;^?=7D!A0%U55)[DD]/IF@#,A\1#PY:>$M'M=%DG&IVP2,PNB*K)#
MOQ@^N.O YSGC%6+3QY"FFZ]<:S8OI\^B2B.Y@243;MR@Q[&P,EMP &!R:I3Z
M/K$VI>![@:8X32 _VP&:/(+0&+Y?FYY.?I[\5F:OX*UG7%\;1"(6;:I/;7-A
M-)(K#?"J !PI)&2GOP?PH GU=[V;XJ>!IK[2H+21A>;9(Y_-8CR#\C':,$>V
M1R>:O:K\3+'3K:74(XK>XTZ"Y-O*4O%^T\/L9UAQ\RAL_P 0) SC%12VOBG6
M?$_A35;K0(K(::UQ]K5[U&&9(MF5VYR,\COZ@=:9H5AXS\,O<^'[73K.[TIK
MB62SU-[H*;>.1RY#QX)<J6.,8!]1V -5O&%_/KVL:/IN@/<W.GQ0RJSW21I,
ML@8CG!Q]WCKG/.*H0_$AI]'T;7%T.9='U":*W>X>=0\+NVSA,?,H;@G(/< U
M=TW3=3LO'WB'5Y+"1[.\MK:*!EDCW.T0?.1N&,[N/UQ7-P^%-?B^%6B^'CIV
M=0L[V*64">/9M2?S"0<\Y''UH Z:?QAJ#>(M6T33_#TMS=:?#%,"]TD:2J^[
MO@[?N\=2<]!UJC>^,=-U3PQX8UB70S>6VIW]O'&LQ7_196?:&YSDJ<X(';MF
MK=AI^J6WC[7=9DTV3[)>6=O%#B6/<6CWY!&[C.[CZ5SEMX4U^#X>>%=&;3<W
MNF:G#<W $\>WRXY2YVG/)(( 'KG\0#HK;7]7E^)6IZ3)!;+IMG90R@^>00'9
MLN1MY/RXQG@#KS58_$NR632YQ%;R:=J5PL$<D5VKSQ[_ +CO#CY5/^\2,C(!
MXJQ)H>I_\+!O]0%I')IFIZ;%:RRF8*T)5GR-N#G(;C'&:I^$[;QKHUE:>&KO
M3K-K.RQ#'K"W(^>!?NCR<9W[0%Y.!UYQ@@$VL?$FSTRWN[R&&VNK.RN#;SJM
MXJW!*MM=HXL?, <CD@G!QQ@GKYKF0Z:UU90BY<Q^9%&7V>9QD#.#C/TKA])L
M?&/AB_U#2+'3+._TFYNY;FTOI+H1_91*Q9E=,$OAB2-O7U&>._166-59R[
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M#C^[TZXYLZ18:KX6U#Q%;VMHFH66IWDE_:RK<1IY4L@&]) Q!VY (*AN,\4
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M=1+*@<88 CH1ZCI5ZH+-;A+2(7<B27&W]XR#"[N^!Z>G?%3T %%%% !1110
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M@\6S:CI^A76F:8\B:K;-<F69RD5JH0,1(X4\DG '?!YXH ZBBO-M5\>:E?\
M@>RU;2+:""6;58["X#W!.TB<(=C!?F#8^]@8!S@FO0T:Y-H&DAA6YVY,:RDI
MN]-VT''OM_"@ NKNVL+9[F\N(K>!!EI9G"*OU)X%3 Y&17C6LZIJGB+X(^([
MW6;>T9EFF$;QR%RI6XV@!2HV@ 8!R2?:N\M/%%XGBNUT/4=)6TCO+5[BSG%R
M)&81[=RNNT!3A@>"P]Z .IIDSQ)"S3LBQ8PQ<@#!]<UP\GQ)@6.POH;:WN=,
MO+A808;K=<QJQPLK1!?N]R-V0"#UR!W$L:2Q/'(BNC AE89!% $=K+:/&([2
M2%HXP%"Q$$*.PP.E+/:07+1/+&&>%]\;="A]B.1QD'U!(->3>!/$!\)? S0M
M2BTW[6'G:*15D$9R]RR!NAR>1_C7;67BRX'BB[T36--CL#'8G4(IEN1*&A#;
M6W_*-K XX!(YZT ='<WEK91K)=7,,",P16E<*"QX &>Y]*FKRKQOJUSK_A/1
M-572H4TZXU2SDMIGFS,J&52KE=N &&. Q(R/?'3:UXX6PEU2.QBLKF33 //B
MGO!"\C[ Y2-=K;CM(ZX&3CUP =3%:PPS2S)&!+,09')R6QT&3V&3@=!DU-7&
M)XZN+S5M*L=.T5Y?[3TYKZ!YYQ%MQMRKC:2N-W)YZ< U1/Q#U8^'=4U1?#:%
MM&N)8-2C-\ %,>"WE'9\_P I!Y"_4T >@UBZ[H^C7CVVJ:O(8AIK>=%,UT\*
M0G&-QPP'0D9/K6;>^,;F/Q#IFDV&D&Z_M&R>[@F>X$8^7;PPP2!\PR>3Z UF
M7GC877P^UW4]0\/13OID\MI?:<\RO&S(1G#%?F7!!^[0!WRL&4,I!4C(([TM
M<3JFNZU#XX\-Z78V]H+&[M9IRC3LA8HJC!PAP!OX'.3Z8INK_$2*PM[V\L[:
MVO+:QN#!-$+L+<R%6VN8X]IW8.>I&=I]L@'<45R&I^.8H'O8]-2RGELH4ED2
MZO/L[.63>$0;6);:0><#+ >N-_0]6BUW0[/5((I8H[J(2".5=KIZJ1Z@Y% %
MJZNK>RMGN+NXBMX$&7EE<*JCW)X%(U[:K<PVS7,(GG4O%$9!ND48R5'4@9'3
MUKS3X@:Y+XB^%_B"\L=-@GTI!)%'<238=]C[&E1-I& P('S D GT!Z9]6A@\
M9>']+ETB&2:XLII(+]BI>(*J[U48R,Y7/(H Z>YN;>SMWN+J>*"!!EY)7"JH
M]R>!6)>^#M U746U5[>5+N95WW%I=RP&4 <;C&R[N/7/%<CX\UR7Q!\-?$ES
M8Z;!<:7$LL*SRS8=RA*M(B[2,*P('S G!/IGT+3BRZ+:%5W,+="%SC)VCB@"
M6SLK;3[5+:TA6*%<X5?4\DD]R3R2>34]>=GXE7Z^'9-??PZ$TZUO6M;QC>C>
M@$OE;D4+\^"<D$K[9ZUTT^OSS:[>:-I%I#<W5E DURT\YB1"^=B9"L2Q"D],
M 8ZYQ0!O4$9&#7F^K>/+^_\ #ND7NC6T<$TNN0Z;?0W$I5X)!* T>54C!Q@M
M_=/0D\>AQO+]F5YXU67;ETC8N >X!(!/Y"@#-T#POHWA>VDM]&L5M8Y&W/AF
M=F/;+,2<#)P.@R:UZXVT\;W#:IH-K?Z2+-=;\SR8WG/GP[5+#S(RHQD ]"<'
MCGK4MQXOO9+"YU32=$?4M/MKHVS>3*?/EVOL=HXPI#!6SU89VD\<9 .MJ&ZN
M[:QMS<7=Q%;PJ0#),X102<#D\<D@?C7)Z=K6MW7Q,UG2I(;7^S[2VMV0"=@R
MARYWXV8+' !&0  .35WQYJT.B^%Y;RZTB+5+830I)!,5"C=(JJQ!!SABIZ=J
M -O4-,L-6MQ;ZC8VUY &#B.YB610P[X8$9Y/YUF?\(5X4_Z%C1?_   B_P#B
M:IZAXJU"#QB?#=EHJW$[6!O8II+H1H<.$PWRDJ.3R,GIQU(N^$_$)\3:&+Y[
M0VDZ32V\\!??Y<D;%6 ; R..N* $_P"$*\*?]"QHO_@!%_\ $T?\(5X4_P"A
M8T7_ , (O_B:CNO$<[>(+S1-+LH[F[L[1;J;SIC$OSDA$!"G).TY/0<=>V;I
MGQ 35="T:^ATXI<ZS.8;&V><?,%!+LS ?*%"MG@G@>M &M_PA7A3_H6-%_\
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M;NVOK9+FTN(KBWD&4EA<.K=N".#6=#X7T6#Q'/X@2Q7^U9U"O<%F)X7;P"<
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MV0_'(_QI>%+#QMHEI:^&[J#3WTZSQ'%JRSG>T"GY5\K;]_;\N2<#KSCGO:*
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MHEP&*F4*%"Y W8V\].O&:[*B@#S63P7K5]I/B> >78WEYK"ZMITS.'"NGEE
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M2F<C@'@D?E7 6OCN2U^'^E:[9^'[>*.[O_LK6<,P41;IVCROR@,21G^'DUZ
M0\<&%S*ZKQN."QQW->:P^"_$,7PZTO0##9&\M-36[=OM)V%!.9L [,YYQTH
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M</&Y)/[U\@J1\H'  !/ JQ%HUYJGBW3_ !!J=O':?V=:RPV\"R^8Q>3;O8D
M# "X [Y).*9X T35?#?AF+1M26UVVC.L,L$C,95+LVX@J-O# 8YZ'F@"W/KU
MQ<^(+O1-(@@EN;*!)KF2XD*HA?.Q. 220I)/88ZYQ6!)\29#HEC?0:,SW$FK
MKH]Y:FX >WGW;2 <8?VY7J.G.-!]"U/2?'=[XATR**[MM3MXXKRV>7RW22/(
M1U)!!&TD$<>O/2N5\2Z#<>']!TMQY,NI:AXOM]0E4,1'YLDG"!L9V@!1G'8G
M':@#I+'QCJP\27?A_5]$@M=0%H;VR,-V9(KB,'!4L4!5@?;^F<E/B;JJ>'-*
M\477AV.+0+ID6XF6[W2P;VVA]FW!0' Z@GT%=#_8UU>^*F\17\*6XMK![2V@
M#AV)<[G=B.!]T  9[D^E<=X3T?4/%/P<T/09K>*&PG2,SW/FY)A67?A5QG>=
MH7G@9)R>E ';/XBOK^_U:TT*SM[EM+*QRM/,4$LI7=Y:X4XP",L>YQCJ:S8?
MB-87]AH%Q:F&V_MGS0C7S[%B>/ :,D?QEC@#C."?0&6QT/5_#GB?6[S38(+W
M3]7D6Y\MYO*:"<+M;/!RC8!R.1CH:J0>"Y-.\-Z;H$^G66LZ;MG?4(Y2$9IW
M<.'CR.Q,@Z@@$<Y% &K=>*IK&+3K:]MH+75+UIL123$Q1K&<%]VW+ Y3' SN
M'3FLZU^();3;DW6FE-1CU!-.MXD<^5=R.?D9'*CY2,D\<!3U[Y:>!_$>CZ5X
M?N]'O+>;5='>X5;:[E9HY+:5L^3YF,Y4! #CMZ5HZ]X=\2^(]#M+N:2QM-;L
M;Z*_L[9'9X%,>1L=\ G<&.2!@<#L20""U^V_\+OB^W6]M&__  C\FV2W8D./
M/3KD @@_7M]!I?$#5]6TFTT;^R_('VK5[6VE:1RIVM(/E& < XP3Z$\'/$5G
MI?B.Y^(%IXBOK&QM;==,>REA2[:1U+2*^0=@!^[TXZ]>U:'C?1+_ %O2[$::
M(&NK'4;>^2.=RBR>6^XKN .,^N#0 ]M?O;G6I]$L+:U>_M+:.>\:29O*B9\[
M$!"Y).TG.!@8ZYQ4WA7Q)'XFTR:X^SM:W5K<R6EW;,VXPS(<,N>XY!!]#62F
MAZSI?C2X\1VD-M<IJ=I'#?V@F*E)8_N.C$888)4@X/?VK3\*: ^A6E^\[(UY
MJ-]+?W'EDE%=R/E4D D!0HS@9P3@9H RK35M:N?BAJFDR):MIUO8PNJ>:P(5
MV?+$;<,QVXQP .YYKE?"?B34/"_@"VO5TN"72(]4FAN)#<;9%$ETR!D0*00"
MPZD'KQWKLSHNKVGQ#N];M8[2:QO+&*"3S)2LD;1LQX7:0V0V,Y&/?&#SA\%^
M(3\+YO#7DV7VU[XW ?[2?+V_:?.Z[,YQQTH Z+6?&+6E[J5EIT=I+<:=&K2I
M<3,GF.R[Q&N%/.W')_O#@\XV]"U5=>T&SU(6TUN+F(.8)UP\9Z%2#Z'-<M<Z
M1XKT?Q=?:SH$.GW=KJZ1&[M+R=HS!,B! ZL%.1M R,9XKLK&.YBLHDNYEFN<
M9D=5VJ6/)VCL!T'? '6@#RK0-=UKPYH/B2^T[0H;W3K/6[^6YS<^7)L$ASY:
M[2#M SR1[9KKY_&\%S)'#I+6K.]C%?;[N1HUV2@F-?E!.2%)/IQUS6?:>&M?
ML])\1:''':&'5KRZFCOO./[J.<G.8]N2R@G !P3CD4V?PMKWAG7+74?"*V=U
M:FPAT^ZL;V4QY6+(CD5P#R 2#Q_/@ L6GQ#2]M="WVJ:9=:JLV$U%S&L;Q%0
M8P<?,6+97ID GKQ46O:_XDAU+PE!':6MJU]>21W,+3MR41R%W!?N< YQD\<
M5?U71M2U6SM;36M,T_6+.6.0WL&[9Y<A*^7Y18=%&X9RIZ'VK(C\%Z[I^C>$
MTMIK>\N]%O9)FCN;A@#$X=0@DVDG8K*,D<[>W2@#T"5IEM6:.)'G"Y"%]JEO
M3=@\>^*X"S\=O;^!O#6L6/A^".#5+V.T^R0S!/(WRE1M&T!NA_N\FN_<S+;$
MA5DF"_=!VAF^O.!7FUKX+\06_@+PQHAALFN])U.&[F87!V,D<I?"G;G)SCD=
MJ -V#Q5K#:IK>CW6FV5OJ5G9K>VQ2Y:2*2-MP&X[ 005YP.?;K5#PYXPO(?
MF@7VK?9Y+[5=J0,9B [%6=F?Y?E "G@9[#O6D-!U.7Q]J.KR10)8W>E+8J1*
M3(K!F;<5QC'S8Z]JP8?!GBB+P5H-M#)IUOK?AZ57LR)&DBN%"LC!SM!4,K=
M#C'7G@ N77Q$O;/2O$4[Z1'--HR+,LD<S+!<QL,Y1RGWEZ%?UK0?Q?J-DL1U
M32[:T-]*D>G9N]V\&-G<R87Y-H4\#.20 >]5M:TOQ9XE\%:O8WT&GVUY>P?9
MX;:*X9HX\]7=]N23Q@ <8ZG/$_B/P]K6I:/HEYIDEM:Z]I$JSQ)*Q:&3Y"CQ
ME@,X8$\X_*@"J?B(;2SUJ34+%4.F20*+F-F-M,DK!0X<KD!2WS#!QCC-.\4^
M)-<L_ NNZE9)8;K>V$EM>PS%XY$8'+KQ]X=ADCH<]JT GBR]T>>6^L]+6ZD:
M-!IWFEXFBW#S=[E.2RY &W P.N36 /AW.-!\7:?IL<>F6FL0*MK8&4M'!* =
MS\9"AB1PN<!<^P -RX\4S:6=#T^^^PV]YJ4;E)9KAO*^0+\NXJ"7;<,#CH>O
M /1:9/=W.GQRWUJMK<DL'A5]X4AB.&P,@@9S@=:YJ^TG4]6TNPLM:T/3+^R,
M#I>6@GW%'&T1LC,HR>'S]W&X8)QSI^#=%NO#WA:TTN[N#/)"7VDN7V(7)5-Q
MY.U2%S[4 49/%-]>1:S<Z)I\%W!I,SP2"68H]Q(B@R*F%(&,X!/4@C@<US_B
MOQ#-KFC>#-2T=8GL-0U>T<"64HQ;YF", I& RC)R>5Z&M73-!UOPU>:_;Z;#
M;7=CJEU)>V[RS%#;RR#YU<8.4R 01SU&.]5;OP3?6/A[PCHNCK!/%HE]!=S2
M3RF,R;-V[: #R2Y/M0!V%O8BS@NKBUL;.'4+K][/L)"22[<99@N2. ,XS[5Y
M1J6JZGKOP(?5-6C@DFENXI$>-R6)^V@$8(&T#@#D\>E>S*244LNUB.1G.#7E
M_P#PA7B5?A>WA+RM.,L5RIAF^TL Z+<>=N;Y/E.,#'/KGM0!T]KXJO8O%D^B
MZSI]O9I]@;4()HK@R?NU8*RN-HPPR#QD>YK/C^(,DDNC7$=A'/I^J3)$!!(S
MSVX<9221=N-O3=@_+GJ:LW_A[4=2\=0ZI-!"NG-I,NGS 3_O 9&5B0-N,#&.
MM5O"NF>-='MK30+U]-?3++;''J22-YTD"_=3R\8#8 4G/ ]3S0!8^*?B"[\-
M?#S4]0L'*79"0Q2#_EF78+N^H!)'OBMS1_#VG:5X?ATB.VBDMQ&%F$BAO.8C
MYF?/WBQR23US1XG\/VGBKPW>Z+>EA!=1[=Z]48$%6'N" ?PK,T:3Q=8V,.GZ
MAI]C>30J(Q?QW91)0. S(4+*V.H&1GO0 1W$'A=](\)Z3$LMQ.LSP+*Y5(($
M.26(R3C<J@=_4<U0NO'US8Z?XE6?2X_[5T",336XN"(YHF4LLB/MSR >".",
M9JQK'AS53X@T3Q'8S175_8)+!=0R'REN(I.2%.#M*GD ]1P3WJCJW@_4M3LO
M%EX([=-3URT6RAA:4[((U0@%F Y)+$G ]!D]: %OO&^OZ986NH7?AN'[)>7-
MI#;^7? R,)N#E=N 1QQG'/6K-MXWN[+Q)<Z/XFTR'32MD]_;W$-P9HY(D^^"
M=JD,HYZ?TSF^.HKVV\$>&X9(81>PZKIZ;/,)0NK@#YL9P2.N/PK5U#PK+XGU
MN2^U>$6MLNFSV$,*2!W)FXD<D<#   '/4DXZ4 1W'CBZL-$TSQ%>Z;''HE\\
M09EF)FMDEQY<CC&".5R >,_Q4X^+-=N/%&KZ)IV@VTSZ:UL7D>]VAHY<DD?)
M]X =.G!YZ T5\)ZWJ'@JR\':LEK]DMVABEOHY2?.@B=64*F,AR$53DX')R>E
M:^C:-JEEX\\0ZO/#;BQU)+=(BLQ+KY2L/F7;CG=Z]J *=UXXO+"YTYKW2X[:
M"_U3^SXX)92MR%+E%FV$8*D@' [$')I=&UC7KOXA>*+"6.T>TL4MEB03,NT,
MDC@_=.2Q(W'C  QG%8+>#?%KZ5;6\T6ESWEIK4>HO>O<OOO564L WR?)A2!_
M%@# %=-I^BZSIOCK6M56.SFL=4AMRS>:RR(\2,NT+MP021SGCWH I:/XUMU\
M'6>HII,-I<7NI/86UC"X"M,9F7E@HP/E9F./7@FM-/$UY;^)_P#A'M0LH%O+
MBU:YL98ICY4^TX9#E<JPX/0@CGVKF;?P%K7_  A5E9,]I!K&EZLVJ6;"5GB=
MC([[&.T$ AR#Q[UT8T>_U+Q19>(;^TBMWTZTEBMK99MY:23&YF;&  %P.O4D
MXZ4 8EG\1M4N/#^B^()="@ATN^NUM9C]K+2QEY3&&5=N"H(&<D$\\8Y/HM>8
MQ>"_$,7PTTCPYY-D;VSOH[B1_M!\LJLYEX.S.2#CI77VFIZR_C&ZTVZL[0::
M+59H)HI"TJM\H*R#H,DMMQU"&@#?HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***S-<O
M[W3[2%K"Q-W--<1PG)PD*L?FE?\ V5&2<?IUH TZ*X/_ (3ZZ&D^+)XK:RO)
M_#X#F2&<K#<(8_,R#AL$#((YY'6K%IXNU;^W?#UMJ&FVL5GKD+M \4Y:2-UC
M\SYQC&",]"<>M '5W^HV6E6;W>H7<%K;)]Z6:0(H_$U/'(DT22QL&1U#*PZ$
M'H:\U\8Z]>^(?AKXGOM.@MCI<<<]NIE8[Y@A*O(I'"@,&P"#G;U&:[_1SC0[
M G_GVC_]!% %EIXEG6 R*)7!94S\Q ZG'I[^]25P_@;4+W6_"-YXG@2.6_U2
M>:6!)F(41H[)%'D=  OYL3W-6='\77>M>$]+U.WMK=+^^N?L[6KLV(F#,)%)
MZY54=NG.WWH ZN&>&X5FAD20*Q1MISAAU!]"/2I*XW5KYM$^)6@K'Q;ZY%/;
M7"]O,B4/&_UQN7/ICT%:/C/7KSPSX>DU>UM8KF.W=3<*[$%8RP!<8!SMSDCT
M!H Z&JM[J-EIJP->W45N)YE@B,C!=\C?=4>I/I6 /%,R?$&#PW*MH(+FP-[!
M.LA+28."FWH/[V<\@&J.I>*;V#2] O9]+LIX=2U>&VC8R']W&\F(Y0I7EBHW
M=1C(ZT =K)(D4;22.J(H+,S'  '<FJ^GZC9:K9K>:?=0W5LY95FA<,K%20<$
M<'D$5RMAJ>M7'Q2UC3I)+8Z?:V=NR1C=E5=GR?=C@9[8 ^IY3PGXCU/PS\/-
M/ODT^UDTE-3E@N&:8B7$EVZ;D4#& 6'4\\].I /7Z*BNGFCM97MXTDF5241W
M**Q]"0#C\C7!Z3X^U:Y\*Q>*=0TFU@T>2T,BB.X+3&8R!$3;MQAB<9S[\=*
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MM-UH?A:.TLH(;[6[?S88 <10(J!G/') RH &,DCIUH [*BN6_MWQ%%870GT
MM>Q7R6L3QO\ N98F(_?^JJH))'/3KZ9,WC;4+C2?&45DU@]]H5N)8[N)BT,J
MM$S@A<G##:1C)&: .UO=1LM-2%[VZBMUFE6",R,%WR-PJCW-6J\_/B#4=,\'
M>$KB]L;.^-]<V-NTCR,6C\P+B3!4Y?J>HP<=:W7UZ]U'6]5TO18[4R:6L?GR
M7);:TKKN$8V]/EP2W.,C@\T ='17GY^(]Q<:-H.H6.D(S:CJ0TRX@EN-KV\P
MW;E^[@CY#SD=1QVK:\/>(=1OO$.LZ'JUI;07>GK#*KVLK.DD<@;'W@#D%2#Q
MS0!TU4[;5=/O;VZL[6]@GN;7;]HBCD#-$6S@,!T/!X/I7,>,-3UFS\4>%++3
MI+=+>\NY%E$F[+E8G8 D=%[^Y ].<>"XU>U^(OC=](M+2:Y%K8.QN92B#$<G
M' ))/0=!ZGL0#TNBN1M/%UWJN@Z!J5E8I##J<+37%S<-F&R"KGYN1G+?*.1W
M/M7.ZQXWU74OAZVI:<+:VN$U5=.N&1RZL!.(R8SZ,".3T!/UH ]0JKJ.IV.D
M6;WFHWD%I;)]Z6>0(H]LGO4D1N?LH,HB^T;3D(3LS]>N*\COM2U?6/@YXQN=
M6DMY2);J,&/<,%)=H !Z* !CG- 'L*LKH&4Y5AD$=Q2UQ]CXDU2U\3Z3HNI6
M%M%:ZE:226DD4Q>13$%+"08 Y# \$X/'/6J,GQ!NGM+/5;#33>Z=/<",PPPR
MM.(BQ43 A=I]=OIWH [N::*WA::>5(HD&6=V"J![DU!9:E8:DC/87MM=(IPS
M02JX'UP:M5X]X-\07/A3X$V&JVEC%=>7=2(Z/(4P'NF0$<<G+#@D?6@#V&JF
MH:KI^DQ)+J%[!:I(X1#-(%W,>@&>I]A7/6WBC4+?Q?-HNM6=I;1-I[:A!-!.
MS[41PK*^5'/(.1Q7*^-=8U'7_A[9ZNEK;QZ9=WUH\2,3YRQF=-CD],MQ\O8-
MU.* /5J*Y+6/%L\.H:G8:7%#)<:=&K2"9)&$DC+O$8V X^7;\Q_O#@\U37QQ
MJES?^&K:WT(0MK5M/*$NYFC>!XE&Y679P,L.>21V% '<T5YZOC3Q+)I.OR)I
M&G?;-!ED6[W7+B.5502#R_ESDJ?XL ''7)Q>N?&E^^H^%[?3M+@EBU^TDN(G
MFN"IC*QJ^& 4X'S#D9/!XH ZZ[N[>PLYKN[F2&WA0R22N<*B@9))I\,T5S!'
M/!(LD4BAT=3D,I&00?3%<./&6H/X2\4W-[I-G)?:')-%<VXF/DS*L8?()4GE
M3T(_&HM2US6G\0^!8;#[)#;:E%+,\)W %EMRVTD?PC=P/4#TH ] HKB-6\<7
M<4>J3:19)=_V9,86MRDIDN67&\(54A2,D#.<D'@#!,USXSEN)I;;2X%CN(;2
M*YD6\BDR&D4LL15!E6P.2>F1P>< '8U4L-5T_55G;3[V"Z6"0Q2M!('". "5
M)'?!%5?#>L2:_P"'K/4YK"XL)9T)>UN%*O$P)!!R <9'!QR,&O.]/UG5O#]M
MX^U/3;"TN(++6I[FX\^8H658HRRH #\V 3DX'3KS@ ])U;0].UR.&/4;<SI#
M()8U\QE"N.C<$<CL>U7U4*H49P!CDY/YFN:O_$5]OMVLK>WM[*6Q^UF_OFQ$
M&) 2'@CYCG.<\#L:HZ?X\_M;1?#4UI:*FHZ^K&*"1\I$J F1R0,D#' XR2.G
M) !U-MJNGWM[=6=K>P3W-IM^T11R!FB+9P& Z$[3P?2K=<#X0^U_\+/\;B]2
M$3"+3QNASM<;)<-@\CCMSTZFN^H **** "BBB@ IJHJEBJ@%CEB!U/3)_*G4
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7->-=&U36M.L8]+>V+6][%<36UT[+%=1
MKG,;$ \9(/0CCD5TM% 'G-SX.\27!\:9?2@/$-K''&!)(/*80^40?E/ ]>_H
MO;1F\-:U+J'@VY"V 71%<7(^T/ERT/E?)^[Y]><>GO7:T4 >8_\ "%>)K#PI
MKWA*Q.FSZ5>"<V5S-.Z20B0DE&0(0V"3\V1USCM7H6E6\]MI%I;7?E&>*%8Y
M/*)*D@8XR <5<HH X[X<V+Z#H$WAJ;B;2KF5$S_'"[L\;CV(;'U5AVJ?1/"3
M:1XNUC4Q< V%T_GVUL/^64T@ F;_ ($44CZMZUTS01-.LQC4RH"JOCD ]1GT
MX'Y5)0!Q^KV#:U\2-!>,9M]$BGN;ANWF2J$C3ZXW-] /45U-]9P:C87%E<H'
MM[B)HI%/=6&"/R-/BAB@5A%&J!F+-M&,D]2?>JUSK&G6>HVFGW%[#'>W9(@@
M9_GDP"3@=<8!YH X3_A6U\WA;2+635,ZS97*,U\O!,&WR613V_<_FPSWK?\
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M,WV8/EP@P-Q'8<CK5V@#F[/0[JZ\7+XDU..&":&R-G;V\4IDVAFW.[,5')P
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M(;F&8O<.R@".17QPISG;B@"I+XCUJQO(-+U*"QCU&[>:6!K1)KE([9 GS,H
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M49P5Y4 G[O&[DFLB/P#KL?A!M,^W:<U[;:P-3LFVN(W(F,F).I&<XP <>IH
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MBQF]M-0$FU)$4*)(R@R>  0<9Q^6GXB\,S:]X,GTB2\W7Y020W;#;MN%.]7
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MZUH'AR[L6M3=ZF_[]&B;;$%4F7C=D%2-O)/)'K6MXJUI_#OAN[U5(3+Y&S<
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MJN>H/T.1^% &G1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*YN3<SC)DE(V[F)).!V&3@#)P,"O.O"UMJU_!XYL;%K2.&YUV\B,\C-OA)5
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M;P3G'MCOGCT2B@#B+CPSXETWQ3?:MX;U+3HK?5-CWMI?Q/(L<JJ%\R,J022
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MJ2L\=PB$E7)7!WC)^N?SOW6CZQ-!;0W+Z?JL#Q2K?V]VI2.5V*E2@P^U5PP
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MGD#*XZ9K3TW0[S08="TO29K9=&LH6BNDF0F:3"C85(X!W9)SZUT%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MV/A<HQ^?.'['M[UVL4J31+)&ZNI_B4Y!KS'Q3!>Z+\2%.GI((_%EE]@D>/\
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MP_X72+Q1]IU$7]CJ"1RWT*A##$VTJ"@0<2-@'CDG:>XH [H75NS*JSQ%F&X
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M)/ KE1Z D=/:K$>IV$UTUK%?6SW*DAH5E4N".H(SGL:&U*Q2^6R:]MENV&1
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MP_HRR74BZ38A[L8N&%NF9AZ.<?-^-2:MJMEHFEW&I:C<)!:VZ%W=SC\!ZD]
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M3M0A2&]L+6YBC^XDT*NJ_0$<4 64BC2/RT153^Z!@?E7CL;VB?#'XBPJT*W
MOM4^0$!PN_TZXY'YBO88HHX(EBBC6.-1A508 ^@JG)H>D3&Y,FEV3FZ8-/NM
MT/FD="W'S$>] '!-8V>G^-/AS)9V\,$D]M=+*\:@-*/LX;YCU;GGGO6/I_\
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M*> =YX/!.>N:2UN['3?&-GI=_K5S:V#Z%#'I=Q>B+]\H9A(&,B$;R/+)'!(
MS7H]]HFDZG/#/?Z797<T!S%)/ KM'_NDCC\*=J.D:9K$*0ZGIUI>Q(VY4N85
MD"GU 8'F@#+\$Z;IND>&8;'2+R>\T^*200S3,K9&XD[2H *@Y X^G&*Y_P 7
M0ZI;Z]J&JZ+)8Z@8]-2/4M&O>/-@S(0R/_"3EQ@\'%=_'&D4:QQHJ1H JJHP
M% Z "J=WHNE7]P+B\TRSN)@NSS)H%=MOIDC./:@"+1+B'4O#&GW-M'+!!<V<
M;QH_WXU9 0#[@&N+^#LBZ7X7D\*7A6'5](N9HYX&.&96<LL@'=2&X/M7HX
M  P!6?J&@Z/J\D<FI:58WDD?"/<6Z2%?H2.* .5^)VIR?\(+JOV O(EO)"MZ
M8N<0F0>:N1WV9W#L#4?B*"*7QMX*N]'$1>4S1RF'&V2R\O)W8X* [,=LL,=:
M[F&UM[>V6VA@BCMU7:(D0!0/3 XQ5:RT72M,#BPTRSM1(,/Y$"IN'H<#F@#S
M?PEX=T.Z\.>*9YM*LII;?5M22%GA5C$H+ *N?NC!Z#CFL;^PM/?X0^$=3TRV
MA77Q/9?9;F,#S7E+JK*6ZD!0V0> %]!7K-QHUK9Z3?PZ1IMG!-<1,NV)%B#L
M01EB![^]9G@CPM%H'AS3(+S3;&/5+2 0R7$**Q8@8+!\ \T 8WAHVVI:MX]L
M-?2-I_MS+*LV/^/(Q@1=?X<!C]23UKE-(L&O+/X5_P!NP+-<2/=(S3KEGA$4
MAB5L\D;=G!]:]?O-%TK4;A+B]TRSN9HQM22:!791UP"1D"G76DZ;>SQ3W>GV
MEQ-%_JY)85=D^A(R* /.]8&B6.K>(=*TV&RTYK71%BG,_$?E-YC+'#%D#DDD
MMZE1@YK-TZXLI(?A-<3S6[(EM)'-([ A2+/[K$]_8UZM-I6G7-]'>SZ?:RW<
M:E$GDA5I%4]0&(R!R>*8=$TDV<%F=+LC:V[!X8?LZ;(F'0JN, \GD4 ><?:-
M)U37?&FB>(]<&GM/* (Y3"JR69B4(4:13T.X\'@G/4FO1M!@BMO#^GP037$T
M,=NB1R7/^L=0H +<#DC':EO=$TG4KF&YO],LKJ>#F*6>!7:/_=)&1^%7Z /*
M-8\.Z;J.F7/C[P?J[:)JBQ//</$X\B9DR629.F<@@GUY(-376H_VCK_PTU?6
M((;66YM[J2X64!55C; X.>@SG -=X_AG09)EE?1-.:1,;7:U0D8Z<X[5=N]/
MLK\1"\M(+@1.)(_.C#[&'1AD<'WH \;\::C87/A/QN^GRP6RIJB+.)Y-\\]P
MC1#<@)&Q %XZYP3Q76>?8?\ "ZUF:6VV2^'U\MRRX=_M)'![GH*["70='GGN
M9IM)L9);I-EP[VZ%I5]')'S#@<'TJ9M,L'N+>=K&V::V7;!(8E+1#IA3C*CZ
M4 >,:C<VD/P;\:6DDT*3#6+M1"6 ;/V@$#;UZ<_2NG\5"_BO]6UG19;#5K/^
MSXX]5TFY."\"AV#1..F0S\'@X/>NXD\/:+-<7-Q+I%@\UT MQ(ULA:4 @@,<
M9;D#KZ"G3Z#H]S,)KC2K&655"!WMT8A1T&2.GM0!#I>O:9>QV%M%<QQ7=Q9I
M=1V<C@3"(@8)7KQT_"LCQW>6%M%H<=Y%YDLVJPBTWRF.))@&*M(>ZC!.WN<=
M.HV)M"M+CQ#;:S)#!]HMHRD<BP@2<@C!?J5 9L+TR2?3%R^T^RU.V-M?V=O=
MP$@F*XB6121T.",4 <-X!NHCXR\:P?;;:>1KV&3]QA58^2NYE7)[\'D\]:M_
M$%%TF;1?&")\VCW06Z8#)-K+\DGUQE6_ UUUOIUC:3R3VUG;PS2JJR21Q*K.
M%&%!(&2 .!Z5--#%<0O#/&DL3C:R.H*L/0@]: /*-.CO;/Q)J7AZ:U,5MXLQ
MJ42JF!"I.+A&]&\L)_P)JWKFVMHOC7IICAB1I-#G#[5 W 2Q@ ^N!Q7<F&)I
MTG:-#*BLJR%1N4'&0#V!VC/T%5WTO3Y+];]["U:\486X,*F0#V;&: /'I(]/
MD^$/CB!TMFN(K_4'"$*73$W!QU&,C\ZZ2>PLM.^('@%[*WA@>XM+U96C4 R@
M1(WS'JW///?FNYDT+2)?M'F:58O]I8//NMT/FL.A;CYC[FC^Q-)\V"7^R[+S
M+<8A?[.F8A_LG''X4 >4Z'_8OB/P=':ZYX@N+;5K2_:2XM(S"EREXLI(V93>
M2QQC!.<X[5IZO+?:%?WVJ1BUUOPW-J\4EW;M\MU97*R1H"AZ. RH0#@X(QQS
M7H9T323JO]J'3++^T<8^U^0OFXQC[^,]/>@:)I(O3>C3++[47WF?R%WEO7=C
M.?>@#SS6I;[0K[4M5B%KK?AR;58I+VV;Y;JRN%>-04/1P"J$*><8QQS7I.H0
MPW&G7,-Q&DD+QL'1U!4C'<&H?[$TG[:;W^R[+[46WF?R%WEO7=C.?>KDT,5Q
M"\,\:2Q.,,CJ&5AZ$'K0!XI;6EK<_"[X9&>&-R=7M(]Q'.TF3*YZX..179Z!
M:VVG_%KQ';64$5O"^FV<C11*%4MF09P.,XQ74_\ "/:(8(H/['T_R8FWQQ_9
MDVHWJ!C@U/%I6G07K7L5A:QW;##3I"H<CW;&: .9\57UE#XO\-6["--287,E
MK/<2%880$ <E<C>V#@#(ZDY'?SA_L5U\,=2B,MO.]OXI/ELF!L5KM>5P?E!&
M<8KVZ]TS3]2\K[?8VUUY+;X_/A5]C>HR.#[BH)- T:9)$ETBP=993-(&MD(>
M0]7/'+>_6@#D8-/L;'XS?9;6TMX()_#C&6&.,*KXN !E1P>"169HMI+8:G<?
M#=X&-C#="_@<K\IT\L9-F>Y$H\LYZACZ5Z!<Z1:Q^;>V.FZ>-42$K;S20@8(
M'R@L!N"].G:JGA^PU59)M3U\V?\ :D\:1&.SW&**-<D %N2268D_0=LD W:\
ME^&_ABR\3?#.VM]2N;J:P:\G9[))0L4A$S$!L#<1T.-V*]7FABN(FBFC22-A
MAD=001[@U7L=+T_3$9-/L+6T5CEEMX5C!^N * .#O="T>^^,XM;O3K26!_#A
M+0O$"K8G"@D=#@<#TIWA5+.]O/'>EZW%"'6^:-XY  %L?*40X]$"ACZ DFNY
M.DZ<VH#4#I]J;T<"X,*^9_WUC--O-%TK4+A+B]TRSN9XQM22:!791UP"1G%
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M]4D79+J<\%R21M(C,T2Q ]P1&$R/7->DM9VS1W$;6\12XSYZE!B7("G<._
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M&FR6H34M5AT^43PE]H?=EE(8<C'2N@GUC3+ 2+>ZG9PO @>;S9E38#P&8$\
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MX!YW=NM5O#<WA?Q#8>$YUU^XEU"P:/[/81M"LL,@7;(K*J!]@&=V3@@9R>*
M/49YX;6!Y[B5(HD&6DD8*JCW)Z5R7CGQ/+8> M4UCP[J5G)/9[<NNV8 EE!'
M!P#AL\Y^E7O&MHE]H<5O_:G]F7#7<+6MT5#*LZN&C#*>""P Q[BO/?$^I:A/
M\.O'5CK=A:V^JVC6XN;FT8^3=%MFUAGD-M"@@^U 'K5MJFGW=W-9V]];37<
M'G01RJSQ_P"\H.1^--CUC2YKXV,6HVCW8)!@6=3)QU^7.>.]<9?PV>F?%?PX
MUK!%"'TJ\5Q"@!=5,; <=>YKD(=7TN2Q\ W=G=V=GIZZN6BM/.WR0(RR[C+(
MQSDGJ. ,XYQF@#T'2-7U>]\7^+M*ENH/+T];4V9$'">8C,=PW9;H.XZ=JL_#
M_6;WQ!X%TK5=0=7N[F-FD9%"C.]AP![ 5E^'77_A9WCSYAPFGD\]/W+5)\)"
M&^%F@D$$>2_3_KHU #K'Q3):^,_$]EKFIV5OIU@MH;9Y-L*J95<D%F/)^4=^
MW05UDM]:06GVN:Z@CML!O.>0!,'H=QXYK@;*QTF\^*?C1=5M[.919V1 N55@
M$V/O/S=NF37*:3<2^'=,\%OJ5[<Z?H)N[]8+E@I$(9O]&+;U8 %-^"1P&["@
M#VFSOK34;9;FRNH;F!ONRPR!U/T(XJE+)-_PDEM&NK6R0_9W+Z>44RR-D8D!
MSD <CICFLKP?9:+;7&L7.BZE-J"7ER)KB?S$:$S$?-LV +G&-V/;OFLZ_B@7
MXU:00D8DET:Y#G R_P"\CQGUXS0!U,FOZ-$4$FK6"%Y3 NZY0;I!C*#GEN1Q
MUY%3WVH6>G0B2\O+>U5CM5YY JDX]R,UXW/I^G?\*R^),HM;??'JUZ$<(,IM
M92H![8/0"NILM6CA^*RIJ\Z1I+H<)TUYF 5LMF;:3QN)VY[X44 ;'@?Q#<ZO
MHVJWFJ7EO(MIJ=S;K.@$<?E1M@'J>,<Y)/7K6_!K6E7-I+=P:E9RVT)(EF2=
M61".H9@<#\:\9MM3M;#PO//;W(CTJU\9S->/:A7\FW+-L<K@C:&\L]#T&*W]
M>L_#EUH/C/5M/U=M7N;C19/M,JR1/"I5&\LG8H DZX[X'TH ]&CUO29;HVL>
MIV3W B\XQ+.I<1XSNQG.W'.>E+;ZSI=W8R7UMJ5G-:1DAYXYU:-2.N6!P*\X
MOM.T[[3\,?\ 1;;$K$-\@^<&V).?7)P3GK4&I06B3_%VW$4(A33XI1&%&U7-
MH_S =CD#GUH ]/@UG2[F\%G!J5I+=&,2B&.=6<H1D-M!S@Y'/O52UO1;WFKS
M7FN64UK%(FV(;4^QC: 5=L\DGGG'6N#%K9V=[\+)K:&&&20,&=% +AK4DY/?
M)Q^-;/@Q((?&WCR.)8TC6]MR54  ?N%S^N: ,^R\1:QXI\.Q:[I7BO3-*1S+
M]I@N8HY%M8]S"-NH(?"C.XX.3@#&*] NM1LM-M$GU"^MK>,@#S9I%C5CCL2?
MQKQ^-+>;]EQV=8WVVDA4D X83, 1[UT6K:O!IWQ'L5U75GTNQN=&5+*Y/EB(
MRB0F1"TBL 2OEGMG ]J /0&U"R6Q%\UW;BT*AA.9!Y>#T.[.,5S/AKQ'<ZQX
MV\2V'VZUN].LX[5[5K=1@;Q)N!8$[CE0/PZ"N//]D>'-5\%PV=Y++X5.HW;F
MYN'4P_:"G[H@@!=F\R;>,9R1T!K?\+W-@WQ;\9K;3VY::"Q;$;@[V59 QXZD
M<9H [>\U"RTZ(2WUW!;1L=H::0(">N,FE6_LWL1?+=P&S*[Q<"0>7M]=W3'O
M7)^)M3L+;QSH5O(UO;:A]EN9(;V[D(BBC^4. N0'<X'4C !//2N#T^YM?^%6
M6Q75+5#8>)/.\J:0(DN+IF6-ST0-][)X&* /9;;5-/O6*VM];3L"01%,K$$=
M1P:;::QIE_</;V>HVEQ.@W-'#.KL!G&2 <XSQ7!1'1[C6/%7B^26SN8#I81K
M6TN(Y9]D:-O<E"=I(.T8/0<D5DZ?J5B?%WP\DCOK!+?[!<Q16\$@80(8H]D;
M.3EV[<XR1TH ](L+T0#5;B^URRN;:*Y;:5VQBT3:O[MVSR1UR<'D5<@U?3;J
M]>RM]0M);M$$C01S*SJIZ,5!SCD<^]>37$%H/ ?Q4B$4(CCU*Y9$"C"-Y,>"
M!V.:VIK6SLO&?PW:UAAA:6WNU8QJ%+C[.&Y(Z\\_6@#OAK&F&]^QC4;0W62O
MD"==^0,D;<YX%4="\5Z1XCGOHM-O(9FM)VA.R0$OM"Y8#KMRVW/0D5Q&ES7V
MAZGH:"2UUSPW?:C(+"<#;=64T@D)#8X<#,@)ZCG/2M?X<W-N+OQ7:>;&+H>(
M+Q_)W#>$RG..N.1S0!V-[J5CIL:R7U[;VJ,<*T\JH">O&37.>-M>O=,\/66I
M:-=VY26]MHF?8)!)')(JG:<X'!ZX-5M?U/3[?X@Z=;-);V>H#39I!?7<A\M(
MBZAD1,@,Y*YR3P!WZ5PEG=6[? S2(DN(V:'68U<;AE/].8@$=N.<>E 'I$NL
M:E'\4+713-$=-FTN6Z$8BPP=9$7);//4],?C5KQKJM]H7@_4]6T]H1<6<#3*
MLT9=6QV(!!_6L>[91\:],7(S_85QQG_IM'_@:N?$Q@OPS\1%B /L,@Y^E #K
M6;Q+<Z)8Z@FI::9;B.*7R&LV4-N 8H&\W@XS@XK=.K::+J2U.H6GVB-2SQ><
MN]0!DDC.0 *X_3;+0;'PWH6M7.IW"?8;>*X'F:A+*A)B*[1&SD9.[@ 9S@"J
M/Q!LI;K4HM6T*&5M6TVV+:BD,@1I;)_O0$C/SG#%<=-I.02N0#OUU73FAAF6
M_M3%.VR%Q,NV1O13GD^PHL-4T_54=].O[6[2-MCM;S+(%;T."<&O.O&%QH&M
M:/X#OK1+5],GUFVCC.T!1$4D'EGT' !7VQ5+Q+I%Q8^+/%<GA:#R"WAAOM,=
MHNT?:"Y\O '_ "TV!L=^GK0!ZA;:QIEY=26MKJ-I/<1#,D44ZLZ#.,D Y'-1
M_P!OZ,9((_[6L=]PYCA7[0F9&!P57GD@\8%</HK^$_$M[X<U&TUV:]N[:-EM
MK*,P!HD9,.DJ(@(0 8.>,XQU&>3:SL(?@;JEY'!;K/'J[%)E4!DQ>@+@]L _
MK[T >TWFKZ;I\@CO=0M+9R-P6:94)'KR:+_5=.TM5;4+^UM%?[IN)EC!^F37
MGWB_[=I]]XCUC2[BSU&R2W1=:T:\^5C&L>0T3CH2C'@C!(..:CDUFQ;QYK=K
MK^K2:/#J%A;/9BX\E$E@,9WIND4@$.6R,CK[4 >C76IZ?911R7=];01R<HTL
MJJ&[\$GFK$,T5Q"DT,B212*&1T8%6!Z$$=17F4>D36,6C_\ "%:NKW5CITBP
MV>K?,E[:-)D$,,%>5&& Z%,\5V?@S4(=4\&:3>6]B;&%[90EL3GRP/E ![CC
M@]QB@#0.L:6M^+!M1M!>%MHMS.OF$XSC;G.<<TM[JVFZ:R+?ZA:VI?[@GF5-
MW;C)YKQS5M7TRYT"WN+*XMK*V7Q2DIM7DW7&\7/[R60L?D'4X X!'/.*Z&PU
MK0F\1^-=*\4W=K%]M9&C-U*(UGLFA 4(Q(R!\YX/5B>M '97?B[1K+Q);Z%/
M?6Z7DT+3%6E5=B@J #GNV[@=\&KW]LZ7]D>[_M*S^S(_EO-YZ[%;^Z6S@'VK
MAO-T[3OB7X9Q_HEG_8$L5NMPV&P'BVK\QR6P!P>:P+N^L[7P/\3[*>XACNGU
M.]98&8!V#1H5(7J0<$Y]CZ4 >M7>JZ=I\22WM_:VT<@RCS3*@;C/!)YXKG_&
M>NWVF:?HMYI-U!Y-UJ=K;R-L$GF12. =K9P..^#U[5AIK.E-XET:**XM+>[.
M@!SJ%Q+NC\@NH,<:9"LY9<DGH!T.<#E]-NH)/@SX+19T=HM;M$<!@2A%RQP?
M0X[>E 'HC:Y?P?$Y](GN8%TH:,U]M,84HXE5"68GIC/H.:Z"/5]-FLY+R+4;
M1[6/[\ZS*47ZMG KE'9?^%XQ+D9_X1M^/^WE:QK>RFTGQ#J/@&.W;^R]4F^W
MVSJOR1VK'-S$?0;AM _Z;"@#TZ.2.:))8G5XW 974Y# ]"#WJI;:QI=Y=-:V
MNHVD]PH):**=6< '!X!SUXI=5GAL]&OKB='>"&WD>1(OO%0I)"X[XZ5Y+I^I
M:<VO?#66*\L(K(0W"Q6L4N_[/&UO\J2.3EF) '('(QB@#U637]&AV^;JU@FZ
M;R!NN4&9./DZ_>Y''7D58OM0L].A$EY>6]JK':KSR!5)Q[D9KQR73M./PX^)
MLHM;;?'JM\J-L&4V["H'I@\C'>NDL-62'XI6R:O.D<<N@Q'39)F 1F+9EVD\
M;SA<]\ 4 ;O@/7+W7M/U6:^N8;DV^JW%K%+"@5&C0@*1@GKUZGKUKJZX'X63
M6367B.*SE@:--?O"J1," A8;2 .Q'2N^H **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *AN;.U
MO8Q'=6T,Z Y"RH&&?H:FJM>ZA9:=$LM]=P6R,P16FD"!F/0#/4^U $?]C:6#
M&1IMGF+_ %?[A?D[\<<5)#IUC;RR2P65O%)(,.Z1*I8>Y YJM'X@T:6TENX]
M5LGMXI3#)*LZE5D'5"<_>]NM/CUO2I=,_M*/4K1K'./M(F4QYSC&[.,YXQZT
M +;:+I5DR-:Z990,C%E,4"J5)ZD8'!.!FGOI>GR7Z7[V-LUZ@PMPT*F11Z!L
M9%-M]8TR[LYKNWU"UDMH21+*LJE8R.H8YX([YI;/5=/U RBSOK><PX\T1R!C
M'G.-P'3.#UH 4Z5IQFDF-A:F64$2/Y*Y?/7)QS3#HNE&$0G3+/R@VX)Y"[0?
M7&.M)9ZWI6H7#6]EJ5I<3*N\QQ3*S;?[V >GOTJO+XJ\/0A3+KFFH&F-N"UT
M@!D&"4Z]1D<>XH MC2--$CR#3K0.XVLWDKEAZ$XYIIT72C$L1TRR\M265/(7
M )ZD#'7BEO\ 6--TK;_:%_;6NY2P$TH7*CJ>>PR,GM7.>)/$%UI_B3PI]FU&
M!-)U":47!VJ5=%A9PV\]%X!X_.@#JC9VQN8[DVT)GC78DNP;E7T!Z@>U1)I>
MGQW[WZ6-LMXXPUPL*B1AZ%L9-9USKMKJ7AG4+_0-5M+@PPR%)X&695=5S@X.
M,U3\,>)[:?PGX>N-9U6TCU'4;.*7;+*D;3.RC.U>,\GL* -V72]/GOH[Z6QM
MI+N(8CG>%3(GT;&15ET22-DD571AAE89!'H:A%_9F_-B+J#[8$\PV_F#S O]
M[;UQ[U1U><QWVEQ)K<&GL]R-T$BHS7BX/[M=QR#G!R.>* +!T72C;&V.F69@
M+;_*,"[=W3.,8S5FWMH+2!8+:".&)?NQQH%4?0"L^Z\3Z#8B<W>M:? +=U2;
MS+E%\MFSA6R>"<'CVJY<:C96MHMU<7<$5N^-LKR *V>F#WSVH 1M,T][A[AK
M&V,S@AI#$NY@1@@G&3Q2)I>GQVLEJEC:K;R_ZR)85"/]1C!J%?$&C/!;SKJU
MB8;E_*@?[0F)7SC:ISR<\8'-3#5=.-U/:B_M3<0)YDT7G+OC7^\PSD#W- $E
MI8VFGP>196L%M"#GRX8PBY^@I;:UM[.+RK6WB@CR6V1(%&3U.!6:/%?AUL8U
MW3.8C-_Q])_JP=I;KTR",U/!X@T:Y^T^1JME)]E57GVSJ?*5AE2W/R@CUH G
MDTVPFN))Y;*V>:2,Q/(T2EF0_P ).,D>U3+&(+<1V\2*$7$<8^51@<#@<#\*
MKV&K:=JD<LEA?6]RL3;)##(&V-Z-CH?K7*:EXL,GCSPMIVDZQ:3V=[)<+=00
M['9@L+,IW<D#([>G7K0!/X*\)/HEE-_:UCIKWOVR:XBN(?WC!9'9P-S(",;L
M<5U$EA9S72W4MI ]PJE%E:,%PIZ@'&<>U<Y\1]5U+0_ NH:II5RMO=6^PAVB
M#\%U4\'COZ&MJWU_1KN[NK2VU6RFN+0$W$4=PK-$!U+ 'C'O0!(-&TL>5C3;
M/]R (OW"_(!T"\<?A4\MI!+/'<-!"]Q$"(I70%DSUP>H_"JT&NZ1=6$M_;ZI
M936<6?,N([A&C3'7+ X%7(9HKB%)H)$EBD4,CHP*L#T((ZB@#!T'3M<-T=2\
M2RZ>]^D1@ACT]7$4:%@6.7.2S;4SV&T>]7Y=%MIM>@U>2.(SP1E(V6(!^>#N
M?J0 3@< ;CUXP\:YI+7XL!J=H;LL4$'G+O+#J ,]1Z=:CO/$>AZ=)+'>ZQ86
M[PA3(LMPBE-QP,@GC)Z4 7YX(;J!X+B*.:%QAHY%#*P]P>M0'2M.,RS&PM?-
M0!5?R5W* ,  X]*M%@%+$@*!DG/&*HV>MZ5J,[P66I6EQ*B[V2*96(7^]@'I
M[]* )8=,L+>.6.&QMHXY1B14B4!Q[@#FG66GV6FP>18VD%K#G=Y<$81<^N ,
M50D\5>'HMGF:YIJ[YC F;I!ND&,H.>HR./<5JR!FC8(P5R#M8C.#ZX[T 5[K
M3;"]=7N[*VN'48#2Q*Y _$4T:3IHE,HT^T$C+M+^2N2,8QG'3'%<GX(\9P7F
M@6:Z_K5D-6N;FXBC21TB>4+,Z+M3CLH'^)KJ]1UG3-)56U'4+6T5@2#/*J9
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MG64ET+J2SMWN!TE:)2X_'&:KW?B#1M/DFCO-5LK=X(_,E66=5,:Y !8$\#)
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M*M;>&",G.R) HSZX% '!>(I;76]6\"7N@2Q23?;1*K0D<61C;S<XZ+]Q>>Y
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M4*  _OCK5B:RM;F6*6>VAEDB.8W>,,4/J">E3D @@C(/4&@#P_4#:GX0_$(
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MSO4J,-G@Y]:2:"&X39-$DBYSM=0PS^- 'GVK7UK9^/? MU<W$45NVGWBK*[
M*6*18 /<GL.]9?EV4\'Q8DD6!W'F*68 D#[*.,_4?F*]3^RV^V-?(BVQ'=&-
M@PA]1Z4S^SK'YO\ 0[?YOO?NEY^O% &#X5UJPB\,^%+*>]B%[?:;$;>,M\TN
MR)2^/I73U EG:HT3);0J8L^60@&S/7'IFIZ "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&
M8*I9B H&23T%+7GOC&[O-8\=:3X2MK<3V@M7U*^@:7RTG16V1H[8)V;^2 #G
M@8QF@#NK2^M-0B,MG<Q7$8.-\3AE_,<58KG_  MXFCU];^U>R>PO],G^S75J
MS!@AQE2K#&5(Y!P/I704 %%%% !1110 5E3>)M MKA[>?7--BG3[\;W<:LOU
M!.16K7F\=U+:?&_6FAT^YO"VCVX*VYC!'SGD[V6@#O;#4]/U2-Y-/OK:[1&V
M.UO,L@5NN"03@U;KF8+S4;G0M0U;2])2#57ED!M+L[3*8F9%#%20&(4<\CIV
MYJ'PCXJN_%<45Y%!%%9QPA;OS$97CNN=\0!/\/&2?48[X .LHKC[7Q-K>JZ9
M8ZYI&FP7>F75T(Q;[MLWD;BOG;B=O;=LQT/7-5M5\;:@(]5GT6Q^UC39V@-M
M]EF=[IDQO".@VH0<@9#9([4 =S17#2>+?$-[XE?1=*TBSCE;2XM0B>^F=-@=
MB-LBA<A@01M&?J.E8=_XWUK5_"^G36\4.FW\?B&#2M2A.7VR"5<A6!'RGC/L
M2/>@#TJ34[*+4X--DNHUO9XVEB@)^9U7&2![9%6ZY>77+V#QYI6B7-G9L+FQ
MFG^U(QWAD*@J 1\H)([G.*SI?&NHS^%+KQ;IMI;3Z1;/*P@8L)IH(W*O(K9P
MI^5B%(.0!R,\ '<T5Q3>+]3OO%-KI.CV=E);WND?VE;7,\S#@N@!90O PW09
MSQR.:JQ?$.2/PG!J>HPV]E/_ &H^EW4QW/;V[JS*9#T.P[0.2.6&3WH [^BL
MW1;N[O+666Z-K(OFX@GM6S'-'M!#CDXY)&,GIU/6N;&I:RWQ:N-.:YMAIT&E
M)<+&5885I2&).>6^3KT [=20#MJ:[K&C.[!449+,< "N&F\<:A_PB#>,K6SM
MYM&1F<VWS"=K<.5,H;.T' W;,=/XLUVUM<17=K%<PMOBF02(WJI&0?RH S$\
M6>&Y9!''X@TIW+;0JWD9.?3&>M7[_4+32[":^OKA+>UA7?)*YPJCUKQ6RU>S
MMO"/B[19]/DNI]6\0WUG:AD"PF9R FZ1L*N#SZ\<<UW5R^I>!/A"IGCM]4O-
M,L5$ZSN0C@#D="6 Z '&0.U ';HZ2QK(C!D8!E8'((/>JFJ:OIVB637FIWL%
MI;@X\R9PHSZ#U/M6/>>(YEUS1M$M8XDNM0MI+EII5+)&B!> H(+$EAW& ":X
MGQ9XBO\ Q%\*?%QOK&VMSI]U]A)AF9_,DCF0,V"HP.A')[YZ4 >MT5R4/B+6
M8O&4>A:A9V4:7ME)<V;Q2,Q1D*@K)D '[P.1].>M0_#;4=7U7P_/>:K<03,U
M[<J"BE2"LS+CDGY0  !Z4 =G02 ,DX KG[O7;B?Q0WA[3/(6ZBM!=W$\ZEUC
M5FVHH4$$DX)ZC '?-<MKGBF^UKX;>+D6**SU/2TN+2^CW%EX0_-&>#A@01GI
MS]: .WL?$.D:E?/96>H037*1B4Q*W)0\!Q_>7_:&13TUO29=0;3X]4LGO5ZV
MZW"&0?\  <YJEX:LS_8^FW5W!:->):)%'-%'AEB*J=N3SU&2.G KF[,,/CEK
M31HK2?V%#M#' )\P]3@X[=C0!Z!37=(XVDD95102S,<  =R:\VC^(6OGPG#X
MEETK3TL([XVUU&)W,A7S_)RG&...O7G@<9ZJ77+N^\2WNAZ1]F673X(Y;J>X
M5F56DR4C"@@Y(4DG/ QP<\ &MINJ6.L68O-.NXKJV+,HEB;<I*G!P>_(-6Z\
ML\#>(&T;P+IT#0K]OU#5;R&.-5:18R)97=L*-S!0IX Y..@R1H7WCO7--T/Q
M)<RZ*KRZ0J2PW,D4UO!=1L.JAU)W*>"N?QH ]#HKB;GQ1XAM/$FE:;)INGM'
MK$$K6A6=@T3QJ&/F'&",'^$=>.>M5)O'6L6?AGQ3=7&GV3ZGH$Q218Y76&5-
MBN&&03G#?=]NM 'H-5+/4[+4);J.TNHYGM)C!.J')CD !*GWY%<U;^*-8B\5
M:-INI6-G':ZQ;RR6S02LTD;1JK$/D8Y#=NA[GK3=*U_4=5L/%0CM+*SN].OI
M+92A9U?;&C;R< DX/IV% &K>^-/#6FS-%>ZU:6[C/^L? ;#;3M/1B"<'&<=Z
MW:\CTW4;K0_@KHVN3Z9IFHM:00&#SU.Z,2,$+9(.6^89P5XSS7>7.M7EUX@N
MM$T@6XN+.V2XN)KA2RJ7+!$"@@DG:Q)SP,<'/ !T%%<H/$&NMI^D276E1:3+
M<I(]]-=R"2*R*< '##=O)XY&!UKF=5\9ZOJW@+3]2L3;VDTFLQV%SMW,& N
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ML#Y-Y+;W=BVY;FV1"RASSSDJO\( #=3BL[PUKGB-K7QC>S0Q:G-9:G/#!:0
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M3_\ A(-5G2;%QO-O&%"HJ$@!CA ><#+'IBNJ7.T;L;L<XI:* "BBB@ HHHH
M*\N&K6MG\0]2\11:_P"%)(KBT2T$$FLB-UV-G<3L/J>/UKU&F>3%_P \D_[Y
M% '!R^,1-!?R#Q1X4@N) D=K&FK*R0KSO<L5^9^>!MP,#WSGZ;=:#X?\72W>
MC^)_#B:)>PJ+VUEU52[3#CSEZC<1@-D_,>3S7IGDQ?\ /)/^^11Y,7_/)/\
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M$4 <5HFCV5U\1=5UO3KQ9].\N)VCB8-%]L92K.I'\7E;0?\ KI5^WT+5]/\
M'.L:U:/9266IP0!XY6=9%>)64 8!&#NZ]1CH:Z&PT^RTJRCL]/M8;6VC&$BA
M0(J_0"K- 'FT/@778?AWH_ASS-.-S87L=RTOG.$=4F,N!\F<G./UKH(]$U5/
MB#<^(=MD;:33$LEB\]M^Y79\GY,8);'Z^U;J:K8OK$FDK<H;^.%9W@YR(R2
MWIU!JY0!YM'X%UV/X;6'AG?IQN;:]6X:;SGV,HG,V!\F<\X_7VJ/5+?5=>\:
M:K+HPT.Y-K;QV-S%<W4]O(A(+NA,0S(AW+]X8Z@?Q9])GGBMH'GGD2.)!N=W
M. H]2:P!HWA'QA%!K9TO3-364?N[J2V5BX!QU(R1D=Z +'A2\GNM&$=Q8VEF
M]K(;8)92;X"% P8S@?*.F,<%2.U9#^$+R;Q+XGDFEM7T;7[>.*=<L)DVQ&(@
M<;<$'.<]L8[UU\44<$210QK'&@"JB# 4#H !TI] '!1^#]9O/"=CX3U>6QDT
MZT>%7NXI&\RXAB8,BF,KA2=J@G<>AQUX[/4K3^T-+N[+?L^T0O%NQG;N4C/Z
MU:HH \\_X0_Q&_A;PMI4KZ49=$O+68LLL@5T@& ,[#\S?0 >]7;_ ,&7>K^(
MO$$]\ULFG:OIBV'[N5C+'MW?-@J!_%TSVKJM.U6QU:*>2PN4G2"=[>4KGY9$
M.&7GTJM9^)='O]2&GVU]&]TT7G)'@CS(\XWH2,.ONI(H QO#6G>-+46UGKU_
MI<MG: *L]H)//N@!A=^[ 7L3C.2,=,YL^-?#=UXCTJU_LZ[2TU.PNX[VSFD4
ME!(F1A@.=I!(-=+10!QFH>&-:\6^%M1TSQ/<V5O)=1".)-.WM'$RL&$A+X+'
M<J\8& ",\YJ5M!UG6YM"/B 6*C29Q=DVLK/]HG52JM@HNP?,6QEN<#W/06FL
MZ;?ZC>:?:7D4UW9;?M,:')BW9V@]L_*>/:KU 'GW_"&ZVWA?Q?I1;3Q+KMY<
M7$3B=]L2RJJX;Y.2-O;KGM5]_#6M)X@\/:O;R6"R65@]C=1R,Y&&V'<A &XY
M7H<=>M=E10!R.@>'=7TY?$Z3SVT)U:\ENH)K:1G:$NBH,@J.1M!S6)I_@OQ/
M;KX3,LVBH^ARR;_+,K>>'C*-*20,N<Y([G)W5Z310!RWA71[_P /2^()]3>R
M6"^U"74%>*9CY:LJ@AMR@<!,Y]ZSM*TBQOOB3J&N:;>K/8""*25(F#1->%60
M."/XA$<$?[8/T[>:&*Y@D@GC26&12CQN,JRD8((/4$5!I^FV.DV26>G6D%I;
M)]V*",(H]>!0!:HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KFO'NNWGAKP;?ZO96UM<26X4F.
MX)VD%@O0=>O3(KI:YWQSH-WXG\(7VBV<D,4MV%7S)B<( P;. #GICMUH J:M
MXAUN'QQ:>'["VL#'=6,ERD\[.2K*RCD#M\W0=?45:\&:_>:_I=XVH0P1WUC?
M3V,_D9\MVC;&Y<\@$$<&HIM#U2?QSIVOG[&L5M8R6KQ>:Q8EV5B0=O0;<>_M
M4GA#0K[05UA;U[=_MVI37Z&%F.T2$':<@=,=>_H* ,Q[S67^,/\ 9ZWMN+"/
M1Q<+"8&/#3!6YW<M\@PW0#MU)Y73-?UGPQX4\2ZS96]C)8V6OWCW$<Q;S)5,
M^&"8P%(!ZG.?0=^ZO/#^I?\ "?0>(K&YM1"=/^PW$4RMNP)/,!4CC)R1STZ\
M]*P9O FL3^!?$7A]I[%9M6O9KE9@[E8Q))O((V\D8Q[Y[8Y .@N]>NX/B#IF
MB?9[8VEW9S3B;),@*%>/0#YAZ]*H>'?&%QXAU%(K>XT\-%=2PWVG.C)=6J*'
M"L<M\V6"?PX^;VJW/H.J7/C71]=8V:PV5I+;R1"1BS&3:20=O;;WZY[51/@^
M^U#6-$U+4UT^._TR?S&U&U9O.N4"LHC8;1@'(SR>AP!G@ [?I7B^I>(;*S\6
MZ3X\CU>VD2>[;3[FV6X4E+%OEC?;G( =?,/?]YCM7J7B2SU'4="N;'3)((I[
MA?*:29F78AX;&T$YQD#TSGMBH/$&@+K7@Z]T1;:V0W%J8%0L=D9Q@$$#/RG!
M''8=* $\4>('T*/2XX(T:?4K^*QB>3.R,OD[F QGA3@9&3CD5C1^*==&L^)=
M,:UT^5M&MTG68,\8EWH64%?FQC:0>>>/7C*UZ#5+7PKX=\,ZGJ.D-JLEPBI+
M=!_)N5A7=ECPR-D)RI))]B<6]+CUY)=1T:XMO#[S7]K)(UQ8W$K,'P$!F+@L
M00>#DGY<=.0 %AXTU\>&]/U_4K/3EM-2@MDM8;<R-+]HE8+\PP?DP2V!EN,<
MFK#^--1TBYU5]7T^2;3+2P-['?PV,ULI93@PE9"?F/!!!QS3F\$7=U\-;#PU
M/>QVU_IZ0_9;VWRP26$@H^"!Z<CWJ=/#WB#7M$OM.\77U@T=Q:O;!-,1U!W?
M\M&+GEA@8   YZ\8 &P>(_$ U_3[1]-^U6=Y&_F2QV-Q +.0+E0[N"'4]-P
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M&QSL P "1DXXXZ@ F7Q)K^K:5-K'AZQM+NVCO&@BLY/EEN423RW<2%@J<AB
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MH&!93@$\KD9[9KB;OX=3R:/XIMK!+#3VUY8T^S1.Q@@*@[I!\HRS9Y 4#@4
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MKQ)XB\'W6G7]]I_]H7<L+-Y0=8(5CD5P%!RS$E>2<=?85H7.AZG<>.M-U_\
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MX]:Z&LS1;?5HK9Y=:NK>:]E(W):JRPQ =%4,23W))ZY[ "M.@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "J>I:I8Z/9M>:C<I;6R?>EDX5?J>WXU<KDOB?_R3
M'Q%_UY/0!TUG>6^H6D=U:R"6"0!DD .&!Z$9ZCWJ>N#FU[6-,?P3IFG163Q:
MI 8G:?=N0I!O!&#TX'UQCC.1&GCN^TG3?%']N16UQ>:)<QP1FT5HDN#*JF(8
M8L5.7 /)H ["YUO3;36+/29[I4O[T,;>#!)<*I9N@P, 'K6A7G6L1ZM'\3?
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M$!9  2O(YX8=.*T*\RT+7$\/:;XVOS'YC_\ "320Q1X/S22>2B] 3C+ G'.
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MQ\8ZUKBR6KQZA!##'"2P*>4& )..<[CGT]ZPX_ .JQ?#W2_"XO;,R6-U'/\
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MZ;?6]VD;;7\F0,4;T8=0?8TNG:M9ZK]K^R.[_9+A[6;=&R8D7&0,@9'(Y'%
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M=QV5O>):/;3&R##[46*G>^0,8V\#D\_>X%=710 4444 %%%% !1110 4444
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M+P3Z\T ,\/RZS<?$?QA#)J43Q6PM4C1[<X56B=E PPP 6)/7/M2:/XJUW5/
M-EK##3X[J6^>&[G<^7#;PK,Z-( S<D!1@9ZGOTK7M?#E]8>,M7UNVU"'[-J:
M0F6V> EA)&A1</N^[SDC&>.HK#A^'VIVOA?2],@UFW^U:9J9U&&5K4F*0EW8
MHZ;\X!<X(/84 4=1\5ZQ>>%/'<,-XL=QHR9@O%MFC=XVA\P95CPW)&[IT(%:
M=UK.LZ#HO@X)/9S)J%[:V4V;=E81NF?E^<C(VXR<]>U2?\('>SMXL6\UF.2/
MQ#;K&_EVNTQ.(O+W#YCE1V7KZD]3+>>$=7O])\/6MQJUH9M)O8;LNMJP63RE
M*A -^1D$DG)Y[ <4 6(M:U/7]6UVST:XMK5=)D6W5YH3)YT^P,<\C"#('').
M3FL"+Q_K&J:;X5O+"WLX'U2^>QNX)U9C%*@?=M8'IE.F,D=Q701^&;_2O$NI
MZMHMY;QQZJ$:ZMKF)F5)E&!(A!'4=5/7'453/@)K:V\-VVGWT:1Z-=M>.TT)
M9KB1@VXG!&W)=CW[>E %SPMK.JW/B'Q#H>KRVUQ-I;P-'<6\)B#I*A8 J6;!
M!!'7FJ'BV;51\0?!UK9Z@D%O/)=,8VAW@ND#?,WS GAB .,=>:U])\/76G>+
MM=UN2[ADBU00#R5B*F+RE*CYMQSG/H*/$7AR[U;6=#U6POXK6ZTN65AYT!E5
MUD38PP&7G'(YH Y%'UJ'QG\0Y]'N;.WE@%I*7N(6EW%;;(4 ,N,X^]DX]*U[
M;QM<:K:^'HK:(PW>J:9_:,S1P&;RE&P850>[/U/ "].15R#PIJ$&J>*+W^T+
M9CK<<:*I@/[G9'Y8).[YLCGMS68?A]J=KI7AUM+UN.UUK0[<VL=R;<M%<0D
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M<NJD 1HWNL81?^ U8\5^'KC7X=,:SO([6ZTZ_CO8GEB,B,5##:RAE."&/0T
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M0:W:Y+P_X8UGP[X<T+1K75[<QV$W^DO]E_X^(>3M +':<D<^WX5UM !1110
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M7:6<.DLL <Q"0S3E-QW9Z( 5&!@DYY% &[HNL67B#2+?5-.D,EI< M$[*5+
M$C.#R.E7Z\H\#:[<6/@+P9H]HC_:-0@N)#)&@=DCC8[MH8@9)=>N<#/!J[J_
MB7QGHOA'5[VZMH(I;.]ACM;B>)<W4$DBIDJKD(XW<G&#Z4 >E45PT^I>*+?Q
MU%H!U&P>*_L9+F*7[(0;5D=00!N^?(;N1SS['(NO&?B*T^'VNZ@)[-]2T;5F
MT]Y6MR%G42HH8*&^4XD'J..E 'J%4=/U>UU."XF@,JQV\\D$AFC:/#(<,1N
MR/?I7.6VK:[9_$!-#U"[M+BWO=/DNX?+MRGD.CJNW[QW+ANIP<CM62=8U?7?
MAIXNEN[J&.YLY=0MM\,.%9(E9< $DC..N30!UECXLTG4=4AT^"2837$!N;9G
M@94N(AC+(Q&".1^!!Z5MUYFVHZYX:^'7AO5XKZ*2PABM/MRFV&Z*V94!93GJ
MO4Y[?2NSM;ZYO?$UW'!.C:;:P1JX"@[IGRV WH$*'_@8H V:*** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *R_$.EW.LZ/+8VUW%:M(5S))"9< ,#T#+Z>M:E(S!5+,0% R23P*
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M &1F,9_>?+\I/KS^5;]KX@L+S7[W1(3-]LLXTEF#Q,JA6) P2/FZ'D<>]:E
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M[>&\%I<6MW#>03-%YBAXVW#<N1D?B*W:I1ZG%)K,VEB*X$T4*S&0PD1$,2
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M2,,2V[+$\9/!^48(YR <YXYBUBV\.^'(IM:D-R^L645S)#$BK*6D!Z8X4$9
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MU@G7P_M998_,#?Z03MP&4YZ'K0!EOXU\4Q>%K@2368U?3-=CTJYE\CY+A6=
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MU- &WX<NVOM"M[IM1@U$2%V2Z@QMD3>VP\< [< ^X-85GJNJ^*+CQ$-*U 6
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M>(9-$2Y2-%9PK$[]I(3=M! Z#..O0@'I5%<QH#>)H]?OH=2CGDT=HE>UGNC
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M\1-"T<WYFL+JRN))%>) [/'LPQ8 ?WN@ % '7T5YS'XCUO6? .H>,=-U#R#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!6-XI\/Q^)]!ETR2YDMBSQRI-& 2CHX=3@\'E1Q6S6;KNMVOAW2)]4O4F-I
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M5&  .@%.HH P&\.2_P#"9OXD2^ E-C]A$!ARH3?O!SNR3N_#''O6-_PKP_\
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MZQ8I,_*K<\%3C)P15X>%1%XJM-:M;I84M+ V$5J(<H(B0>N[.<J/P'XUT5%
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M]XBM/#PL#=PW#B]NX[.,PID*[M@;B2,"@#7HK(3Q%:/XL?PX(;@7B6?VS>R
M1F/>$X.<DY/IVK7H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7T:\TWSV@6ZA:%Y%4%@K @XSQG!K!N/!)N-&T'3&U:98]%GAGMY!$NYS$NU
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M+">V64Q&:,IO"Y*Y&,@&N73P$D>C^'M,759Q%H4Z3VS&)=SL@(4/ZC#$<8H
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M[U32=?U+2DOV#7UM;%"DS 8W L"48CJPYH JG6=;UK5M0TF,75I<V%G;F7[
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MWOTK=H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8K)&B"D(\C84MDCCZ9Z5LUYCXNL]7L_#^B6NHZI'>W*^)[007'E_,L9ES&'
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M,DE>BA!T Y;G- ';4=*\RN;OQC9'P?8ZGK"0WUU?26MVUND;K*@C=E<Y7A\
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MRRHF%>8C+''!; 'Z4 345YSX3\03:EJ]OI.JWVIZ=KR6S_;-/NU 6=^/WL#
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MB=/N.I4 !A]*=IWA>2RT^YAN-<U&^N[B/RC>7+(7C3T0;=H]S@DGKG QT-%
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M  ';W.2<UFMX0CAU74;[3=2N]/\ [3P;R*$(5=P,>8NY3L<CJ1P>N,\UTE%
M'-:CX*L;W3=&TZWN;BPM-(GBN+:.WV??C^[N+*<CGGUK?E@\ZS>WD=COC*,_
M )R,$U-10!S]IX52*^TR[O=0N;^72XWCM'G5 R[U"EF*@;CM&.PYZ$\UC/\
M#*T?2)=(_MO5%TPW0NH+9&C MV\SS"%.S+#=G&XD#/3/-=S10!R>H>!(KK7S
MK=CK6IZ9>S1)#>/:.@%TJC + J0& XR ,5;?PC;?V]I6JQ7EU$VF0/!!""K(
M5?&[<6!8D[1SFNAHH Q?#_AN+P_+J;Q7MS<?VA=O>2B8)A9& !V[5'& .#FM
MJBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y#XGWU_IGP]U2
M_P!-OIK.ZMU1EDBVY.74$<@XX)Z8/O77UD^)?#]MXHT*XT>\GN(;:XP)# 5#
M$ @XRP..0* .<UF34Y_B;I^DPZS>6UA=:7/+)%"$&UE=!E25R"<]3G'.,=1D
MZ?JWB,^#]22V:[U:;2]>FLY-L@6YGM8WY"MQE\'M@D XYKLG\,12>([377U&
M]-W:VS6R#]WL9&(+9&SJ2 >,=*J6O@BWL8IEMM6U..2746U(RAHMPF8$-CY,
M;2"<@@T <CJ7B=9O .H:MH6LZB)H-3MT$5SE9K0,\2/#(&Y/5CSG[W7BNFN+
MR]'Q5BTN.^GCL[C199VB!!"RB5%#J"#@X)]O:K5WX'TR_P!*U>RNY;F1]6D2
M6ZN0RK)O0*$*X  V[%QQVYSDTEMX*A@UR#6I-8U2XU&&U:U\Z61/G4G/*A O
M! X  XY!)- ')>&I-;O/ #>);OQ?<07$<5Y&'NE3[.N)759'&W)*XXQQT&.Q
MTM&U"_'Q 31TN=3CL+G0VN0;Q@SF5957S5#;BF0Q^5@/]T5LP> M+A\&77A6
M2YO9]-N-^?-==Z%F+DJ54?Q'/(/Y<4MOX(MX-9M=7;6-7GU"WM6M?.EG4^8A
M((W *!P0#P #WS0!P=GJNOI\-]$\4R^(+Z6\74EB>)M@BEC:[:)@X Y..^>,
M# %=='<7GBK6?%.GQ:E<6#:8R6MIY#E2DC1!_-<#[_S-@*>,+TYJ=?AYIZ^%
M(/#8U+4A8P7 N$.Z+?N$GF#G9TW\_P#UJDU'P'9WNOMK5OJFJZ=>S1K%=O8S
MB,72J,#>-IY XR,&@#.>_P!7OO$4?AI[I9Y;728KBXEM[@VIGE9V1G!4$@*4
MZ# RW.<8KH/"<.N6VA);>(;JWNM0A=D,T+;MR9RN[Y5^;!&>/?O5+6O 6FZM
M/I]U;W5_I5[I\7D076GS;)!%_<;((9?J*W=,TZ'2K%+6%Y9 N2TLSEY)&/)9
MF/4G_P#5@4 <3ID&L:QXZ\36<GB348K72[RTD@CB$8W!HP[(WR\J<D8&#ZDU
M3LKOQ5XH\.6OB+1[N&WNGN&E'G7K"#R5D(,3Q!"/NC&[[V><]J[33/#<&EZ[
MJFKQ7MW+/J;(T\<I39E%VKM 4$8''6LFV^'.F6>K7%U:ZAJD%E<S&>;2X[G%
MJ[DY)*XS@GJH.#TQCB@".RNM2G^(WB32VU2Y^S1V%O+;KA/W#.7SM&W!Z#[P
M-<?:ZIX@/PY\*^)O^$@O6OY[R"&5&"F&1))2C!EQR<'.<\8XQ7HZ>&(8O$6H
M:W'J%ZEU?0+!( 8]BJN=NT%.HR>I/7G-9R_#[3T\+Z?X>34=16RL)TGA(:/?
MN5MZ@G9R W/3ZT 4[&6_TSXCWVB2:K>7UE/HWV[%VRL8Y1*4.W & 1VZ5Q.F
M?VSH'P;T3Q7IVN78>QCB+:<0GV>6(R[2FW&=QSG=DGTQQCU7_A&8#XI_X2!K
MV[>Z^Q_8C&2GEF+=NQ@+G.[G.?TJCI_@6PL+"UTPWM[<:3:2B6"QG9#&I5MR
M@D*&8*W(#$\@9S@4 4M-O+V?QEXTTV2]N#:VL%K);IOYA+QN6VGKU KF[;6=
M>O\ PS\.[@:W=13:I<"&[950^8"CMNY7K\O';U!KM[SP=:W7B&XUB/4-0M9+
MN%8+N&WD58[A5SMW94L",D94BJ=M\/-/M=.T.QAU/4UBT67SK4EXR=V"/FRG
M(P2,# YH Q-=N]0\(S0PZM=ZY>:"MH5_M:W;=+;3EW)>94 W*%* $@CY3D'-
M7!JUYK6NQ:)9W?VBWATB"[\^&[-NUPTA8>8&522 %!QP,OSGBNEO_#_VV_N+
MI-4OK;[3;+;311>68V4%B#AD.&^=AD>W'%96H_#O2;O^RY+&ZO\ 2;K3+<6M
MO<Z?-LD\D?\ +-MP(8=^1UH Y^[E\7:;%X1LM3UT"]FU1K2Y>TVLLL>QV4ME
M!\X 'MW(-6=-L]4O/%?BCPX_B35196B6T\$H=//5I5;(W[?N@KG&/TSGH;CP
M797"Z2/MU^ATRX^U1.)%9I)2""\A926)W'T'/TJ>W\,16NO:IK,.H7JW6HQI
M'*/W950@(3:-G&-QZYZ\YH XO0_%NKZSH'@BUED#W>L6]Q)<2"7R6E\D ;0P
M!VD[MQP ?E.,4WQ$WB_P]X,UF6?6?+,5];M8-'*)I5ADE5"DK,@) R<$')[G
MBN@?X::.WAC3M#6[U%%TR0RV-Y'*J7%NQ)/RL% QR>H/Z"K-UX$L[[P]+I%W
MJFJ3B>5)9[J296FE*,&4$E2  0,  #KZG(!GP'4+'XEG19-9OKJSO](DN7$S
M+F*59%7='M VC#'@>U)\(;<Q_#ZSG:XN)6EEN<B60L 1<2\C/<]2>YKH#X:A
M;Q1;^('OKQKN"V-J$/E[&0D$Y 3.20#P:HVO@:UL/#][HUEJVKVUM<NS1M%<
M!7M=SER(B%X!)/7)P>M '4T4U%V(J[BV!C+')/UIU !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,KQV[ND;MC:K,H(!^9?ID9QFM:@ HHHH **** "BBB@ HHHH **** "BBB@
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MG9)$.,,"7&3_  X.<8KN/^$6D_Z&37?_  (3_P"(H_X1:3_H9-=_\"$_^(H
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MFN?$?P;J&GQ7LMLMO>K))]CE C++'@,2O'(P>P[UT_\ PBTG_0R:[_X$)_\
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MRO8R9M';RSMPY&Y1N(0*WX9Y-=K_ ,(M)_T,FN_^!"?_ !%'_"+2?]#)KO\
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MXX7TVV579"%9DW[E!Q@D;AD"N5@5H_@UX/M7@F%S!J-JTL/DMOC"3;G++C(
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MW0G,5N\>!YP8DQ@8!*XY.0!UKT'Q+*D7AC5"Y/S6LJJ "2Q*'  '))]*U:*
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MKG2[=KA+R",3&.XMWA+QDX#IN W+D8R*Y'QYXGAN=)TN72[K4(UDU:VACN8
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M^2QTZ[FEB\0PZE%;/$\7VN*/RB0A(&<[3C'I]*Z_PM<Z-K.JC4]-\/WMK-'
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M4'D]-P!Q6SJCOXSM/"<-I:75O>6FI6][=K+;O&;18E)=6) &2?E '7.>@)H
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M<:QQG&6).!V%5]2U=[KXH^#HXX]3M$GCNW>&<LD<RB'*MLR1D$G@@,,C(Z4
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MXMM6D$=K)! SAF(/RGT;@C;UR,8JNOQ%TLSP6K:;K4=]/!)/'9R6#K*P1]I
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MULEM/>^2^XJRCL!C;NY)!XZ9O/?76M_$/POJMOH>KQ6D-K=QSO<VIB\IG$>
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MY8.@  #% <=\@>IKI-/\9:;J.A_VFD5S$1=&R:TE0"87 ;;Y6 2-V??&.20
M: .AHKE9?'FG6IU>*]LK^VN]*M_M4]JT:L[0X)\Q"K%2O!SSQWI]EXXLKV#S
MQINJ0PND#6TDUN%6Z:7[JQ'/)]<X '.<<T =/17+2^+M-NDUO3KZROK>XL+;
MS;JS=09'A8'YT*,01C(X.0>N*K6GB[0]%T#PQ';6>H+9:G#''8HL1D9%V;E5
MCDDG [$F@#LJ*Q-!\36VO7.HVBVEW97FGR*EQ;7:*'7<NY6^5F!!'OVJ74]?
M@T[4[33%M[BZO[M))(H(-H.Q,;F)9E &6 ZYY^M &M4=Q!'=6TMO,"T4J%'
M)&01@\CD5Q6J_$#_ (IS1=6T:PN;B/4M2BLSOV(T),NQU(9OO':RC'&><XZ]
MK'*S6RRO#)$Q7<8FP67V^4D$_0F@#FM/\%?8+=+(>(M:FTR-1&ME+)'M" 8"
M[P@DVXX^]TKJ%544*H"J!@ #  KSBX\6V6A_#S5]:\-Z7=X2_EB=;AAF.=I
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M-O(LL$J"2.13D,I&01[$5S</CO39GL)%MKP6-_>M8VUZ53RWF!9<8W;P"48
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MH8#G -9<7@_4);/7-"T2YU&/P]>Z2Z0V^IAQ]ENB?E2,N-VS&<]1TY->K44
M<!X3EFO9K.&Z\!C2=0M<?:KR6WB6($#!,+*=S%C[8 )Y. #I_$?3[W4O!TD=
MA:R74\5U;S^3'C>ZI,C-C/4X!XKK** .'E6\N?B9H^K'3+V*T33)X9'>+/EN
M[HRJ<9YPO;('0US$GA[6I_#^J36^D/-<VOBF75XK&Z3:+R DC W<9*L3@\@C
MITKU^B@#SNY5M7\(:^VG^#9])>XTR:U1);1([B>5U("@(3A >[8SD>E+KFC:
MIJ'PUT 66G>?J&E-:W+Z?<KM\XQ+M>(YXY!..W%>AT4 >::AH\GC3PAK-GIW
MA4^'I;BS,2O=V\<,LD@96"#82?+^7!)QG(P.#5S4(+[QE;>&+>73+NQN+#48
M+Z^,\1183$K956Z/N8@ KD8R3CI7?YHH XS1(;J+XF^);R6RNH[2\@M([>=H
MB$=HP^_GM]X<G&>U7/&\VL06%@VEVMS<0F]C%\+0 SBWP=QCSWSM!(Y )QCJ
M.GHH \G&@ZM-;_$6SM]"N[=-5M5:R,KH1(?LX7:6W'+ELYZ\]37H7AJ:>;P[
M8_:+*XLY$A1#%< !QA0#D G'.:UL_I10!PECI][)XS\<2&SGCAU&VMHK69XR
MJ2,D3JW/;!8=>O;-95CI0OOAYX>T3Q!X;U-4M52&62,'SK:5$($R;"6QGC(Y
M.>F*]0HH YGP-;ZQ::+/;ZO=7%T([J1;*>Z7$[V_&PR=]WWNN#C&<5F:?!?>
M&/'7B*XN;.ZN=.UAHKFWN+:(RE)%38T;A<D= 0<8QWKN:* /-XO ]\OPLO--
M*^5J[W$NIVR*0?(G\PRQJ".,C 4XXY-1S^%M;GUK2M7\H)/K4+VNO1ALB.)L
M.JCW55,6?5@>]>F9STHH XW6+:Y?XG>';R.SN'L[6TNHIITB)1&DV;1_XZ>G
M3O2^!+6ZM+KQ0;JTN+<76LS74!EC*B2)E0!A^*G@\UV-% 'G.OV=UH_CZXUB
M;PQ)K^DZC:Q1-]GA2::UEC+8PK$?*P;DYZC\]*_TPZSH-OX:FT06%IJ.YKE8
M85V6L>=P7(ROFG Y' .3GA<]I1D&@#RC49M5M_@[XET76+29)=-LY;>"[,6Q
M+N%>$<>AQ@$'ZCVVKFSF\4R>#UAL[F"/3+B.^N9IXB@39&0(U)^^69ARN1A3
MSTSU7B#1(?$>AW6DW,\\-O=(8Y6@*ABIZC+ X_*KEE;?8K*&U\Z281($$DF-
MS >N !^E 'E_A_3;S1HY?#.H>!UO[J.>06NJFWB>WEC9RRO*Y.01GD8)..*W
M+&WN[?QGXVO)+"[%M>06RVT@A8B8QQ,K!?Q('/7MQ7=T4 >46/AZ.Z\$^%=*
MUS2=6MKBSM7 OK-'$]C.NT#&S)PP)Y (^49]FW.E^)[:T\,:[JVDGQ!+8K<V
MU[:F-#.\,C@QRA#P9 $7(Z\_4UZS10!Q9UP^'_#EQK<'@^YM;=I5S9P0QI<"
M, [I9 IP .>,D\<XSQV:L'4,,X(R,U%<6T%Y$(YT$D>X$J2<$CU'<>QXJ;(S
MCO0!YA<> K_4'\2Z#)^ZT5Y7O],<-C;<RKGC'18W#MC_ &QZ5OZ;;:I_PK^\
MN=5MG.M:A:M)<0QKDB0QA%0 >P4'MG)KL*,T >7?V7JMOX/^'SC2KR6;1[B#
M[9;(@\Q (60D D @$CH:V],2[@^).NZG<:?=QVL]A;1QR>26#.F\NHQG.-PY
MZ'MFNVHH Y'X8V5WIGP\TK3[^UEM;NW5TEBE7!4[V(]CP1TK+NM$O=4\7^,H
M?L]Q!;ZII$=E!=-&0A<+(&Y]MX^O:O0J* /.?"'VETT_3K[P&MAJ=EL6XOY+
M>+R/DX+QN#N9FQP ."<D\<X)V-;ZUI%QX>\1RZ'=ZK+<-'86L<\<@60$[9 ^
M=K,FXKMR,D U[)U%<K8>!;;3%%O9:UK<.GJ3ML5N_P!TH)^ZK;?, ^C4 8FJ
M76IZ[JUR$TN^O=$O=*1]--OB.-I&#%O/R0<C*X5N.O!-9T&GZK_PB?P\MI-'
MOHYM+O8'NT,>3&B1,C,<$]V''7':O4X88[>".&%%CBC4(B*,!0!@ 4^@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "J&K:M;:/:QS7 =FEE6"&*, O+(QPJKG
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M9CM[*.- YBW E5;YB<X!Z9K5TWQC:7DNLPWMI=:7/I"++=1W>P[8F4LK@HS
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M'(SE5##=NY(Z@$#/7.:7PY>WUV\<UQX)_L:6W0FXD9(B7;:1MAVG)R3G<<#
MQSGCF;?0M;B^$_AW1VT>Z_M"SU&&:> ;<JB3F0G.[!^4]C0!U^F^)K^]^(&L
MZ&^FRI:6,-N5D#QGE_,)=OFS@X4 #)XR<9KK*XW3[/4K+XFZS>G39GL=3M+7
MR[H,H2,QAPP<$[L_,,  _A794 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1169K6M0
M:+!;-*-TEU<I:P(6"AI&S@%CT& ?RX!.!0!I,RHI9F"J.I)Q2UYM\2;K^T/
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M3K,YB;<K!=MUL 7'.0!C) SSZUZ%:>*Q-XH&AW6EW=E)+;M<VLLQ3;.BD!N
M25(R#@X..N.E '145QLWQ%TV Z?</"QTR_N%MH;M94)#,2%9DSN"-C@^XR!7
M57]O#=6$\,\22Q,A#(XR#Q0!+-"EQ"T4HW(XPPR1D>G%*B)'&J(H5% "JHP
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M[)QM.< UB6?A[7HOAG<> Y].=K@*]G%?AD\AH6<D2GYMP(4_=QG(]#FO4**
M.)BT;4=)^(]M>VNGR7.F-HL6G^>)4'E-'*6RP)R<J>, \^G48+^$]?OO#/BJ
MVCLVL]0FUYM6TXSNA24*T;*#M8XSL/7&,BO5** .+E&O>-/#>I:9J&C/H27-
ME+;MY\R2,TK+@%=A/R#GDX)XXZU'X5G\1RK:6.J^%8=/GM0%N+_S8WCEVC&8
MPOS9;'?& 3SG KN** ,3QA;W5[X.UFRLK9[FZNK*:WBC1E&6="HR6( &3ZUR
MNHZ7K4^@^!H(]%N6FTJ]M9KQ/,B'EK'$R-@[\'EN,>AKT**6.>,212)(AZ,A
MR#^-/H XW6-+U*Q^(6G^*K*TDO;9K!M.O((V421J7\Q9%!(#?-P1G..F:P/$
M/A+5[_0/'%Y;:?(U_P"(6@C@L_,0,B1*JAG);:"<,< G QWS7J-% '&:I9ZG
M>>//"FIQ:5<?9+*&Z6YD+QCRS*B!1C?D\J<XS4G@ZPU&RUSQ3/>Z?-;0WVH?
M:+=W=#O3RU7^%B0<J>M=?TIL<B31K)&ZNC#(93D'\: .2UO3]43XAZ'K-GI[
MWEK'9W%I,4E1?*9V0JS;B/E^4YQD^QK#&BZV?#GQ!M#H]P)M8N+A[)3)%^\$
MD*QKD[^.1GGM7I=-,L8D6,NHD8$JI/) ZX'XT >:2Z7X@T;5-&UVV\/G5(FT
MB'3K_3S)&)H6C)*NI)VGEF! -=[HWVLZ>)+RSBLI9&+BVC(;RAV!8<%NYQQS
M@9QDWDECD+A'5BC;6"G.TXS@^AP1^=.H X.WTC5/!_C/5]3T_3Y=2T?6G6>>
M*W=1-;3@$%@K$!E;.3@Y![>N[?P7GB;1M0T^2UETZUN[26WW3[3*2ZE<@*Q
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M2,&&))$(#$L%W;4).">3CMFNE\3KK<^LZ(T&F7-[HI63[=:0S)&^\@>7OW,
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M2Y\N0L2QXR?H23^==,OCG3I](T:]MS&)-7A,UM'<S+"%4 %B['. "0. 3DC
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M.,$$'K0!T$-Q#<H7@FCE0,5+1L& (X(X[BI*XCX4QI%X-DCC4(B:E>*JJ,
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M(K&7(D&P8.!CY2PZ\\<USXZ<>&O$6KG2QNT.ZFMYX?M'^L\H LRMM_VN 0*
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M%W;6FI&XF5)EA5(Q"C-MX.6ZG&/QZ9]/L;R+4-/MKV#/DW$2RID8.U@"/T-
M%BBBB@ HHHH *RM=\.:;XDMH+?4XI9(H9A,@CF>/Y@".2I!(P3Q6K10 R&&*
MW@C@AC6.*-0B(@P%4#  '84^BB@ HHHH **** "BBB@ HHHH **** "BBB@
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M Y70M0\87:I_;FB6UA]G0^88+M93=OC "+P$7//S'/ 'J:Y:#PIX@B^%^AZ
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MS($X $6,[RH"Y) '7G&#WE% &1XJM+G4/"6KV-G"9KFZLY8(TW!1N="H))/
MYKEAH>LBZ\ R?V:VW18F6\_?1_*3!Y7R_-\W//T]^*[N:X@MP#--'$#TWL%S
M^=/CECF0/$ZNAZ,IR#0!RWAK2]1LO%WBF_N[-H;;49X9;=S(C9"1!#D D@Y&
M1[54\0Z7K]AXVM?%.@646I!K+[!>6+SB%B@<NKHS<9!)R#V_3MJA:\M4NX[1
M[F%;F12R0EP'8#J0O4@4 <9K6A^(+Z[\/>)%B@;5=*N99&L$E&TPRJ$>-7(
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MX?6.STW47L[VY>]4")%0,9 -OS=>1V&.3DXZC25GCTFTCN8?*FCB5'3<&P0
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M#(S.KYQG[H"X)S0!3E^(DO\ 8%AK]MI*S:7?WHM(3]IVRC+F-792N "PZ9R
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M*KZ# ZD58\3Z3J.H>)?#-[9VRR6^FW4D\Y,@4X:-D 4'J><]J (+7QV(K3Q
MVMV*V-UHDJ1SQPS^:DGF*IC*N0OWMP'(&#4NF^-#=>*8=$GM[1OM$#30W-A=
M_:(P5^\CG:NUL<CL:Q=0\%ZKK-SXV1PMFFL-:RV,_F!BDD"KC>!TRR \9XS7
M0>';CQ?=O&/$&GV%@D"X=K:X\TW3XQD#:-B]\9)SCH,Y ,GXSQH_PGUPNBL5
M6(J2,X/FIR*T=1\2W&C:YHN@66C"X-_;RM XG$:J8U4D$8.!\PY^N >E)\2-
M%U'Q)X'U#1=+A22YNPBAI) B)M=6))Z] >@J*]TO5KSQGX7U86 2WTZ"XCN0
MTR[@TJJHVCN!MYZ<'\* $M/'R?V!JE[J6GFVO=.OSISVD,PE\V<E0@1B%R&W
MKU QSGI69=&];XQ^&VOK"UMY&T^[(DMYC)O^YP254_+_ %JI>>!]<U'3?$2(
ML-I>3ZTFKZ<[R!DW($"K)CIG:>F>M:PL/$VJ>-?#^N7>D6EE#9VUQ#<(;W>P
M,FSE<+S]WC]<4 -N/B7;10VM_!!:W6FSW(@/DW@:Y5"Q42^2%^[D9QNS@@^U
M6)?&>K27_B*RL/#T<T^BF,MYMZ$656CW\$(<-C&!C'7)'>CX8TGQGX;MU\,I
M;V$VDP.RVNJFX(DC@+$A3%M.YP#@<@=,Y[W;/1M7MM>\97SV0,6K+%]E F7)
M*1>6=WID\]^/?B@!D/C^YE@\.ZBVB>7H^M30V\<[7(\V.20$KF,+@KD8SNSW
MQ3[CQKJQU+Q%86'AY)YM%$;N9;T1K(K(7X(4D-@# P1UR1QG+_X1;75\%>#M
M)%E&;K1KZUN+G]^NTI#G.T]R<\9Q6G:Z-J\/B#QE?-8@Q:O%"MJ!,N<I$8SN
M],DY[\?E0 M[XLL[RR\'Z@=%2Z@UBZA\AYF7-I(Z%@P&#\P 89&/K2:;XCU8
M^.O%5MJ"6D>E:7#;L6$[9B0I(Y?&SYF/&>1@*,;JS(_"^NQ^&/ ^G_8HS/H=
MW#-=8G7!6-&4[/4G=GG'2M-_#&I2>+?%#210-I.OV<4+SB7$D.R-XR F.2=V
M<Y 'Z4 )#\0DDU#1D-K;26>JR".-K:\$LUNS#*>;&%^4'H2&.#ZU%?\ Q+M[
M2U_M&W@M;O3EN?(=8KL&ZVA]AD6$*<C(SC.=O/'2I?"L'C>QM[/1-5MM/6TL
M0L?]J17!9KB).%41%>&( !)/K@9JIH&D^,_#0E\.VMO83Z/YTC6FIO<%9+>)
MV+;6BVG>PR<<@=,T =GK6J1:)H5]JLR/)%9V[SLB#YF"J3@?E6#=:G-K7A[4
MEGL[*;3YM-DFBNK:Y\^*0X/R\H.1P??\*Z'5A>'2;H:?'%)>&,^2DQPC-V#>
MQ[UP]CX-N-.U#6;S1],.EVE]IKP/I@G7RY+ECQ(H!*H ,C/!.?NC'(!7\(>*
M+W2/#'@>TNM)"Z;J$$%G'=_:09!*8MRYCV_=.TX.[/J!6SK7CFXT6"\OKC2/
M+T^UOTLBT\QCFFR5!DB0KAE!?CYN0IZ8K,_X1G7!X8\#Z<+)#/H=W;S77[]<
M,L<;(=A[D[LC..E4=<\)>*M3TSQ+9/:6-S<7=\L]I?2W)#&!94=(0NWY H7'
M7&>>2<T ;<T,2_&^U=8T#2>'YMY Y;$\8Y]:7X;1I"OBR.)%1%\1W8"J, <)
MVJU_9>KO\1[+79;.,6J:4]G*4F!(D:17X!P2HVXSP?:I/!6DZCI#Z_\ VA;K
M$+[5I[Z$K(&^1]N <=&&WGM[T 9'B$RVWQ<T*>QL4N+N32[L!2XC#$-'@NV"
M0!]"?05HZ?XUNK[P_/=KH<S:E;ZD=,FLX9#(J2API8N%_P!6 0Q;;P.U2ZCI
M6I3?$;2=9BM0]C:6<UO(WF*&+2%2"%]!MY^M<X?#'BF+1M7BMK>)7NO$3:FU
MN;D*+JU8C="S#[I.!GMCC)R: .@M?&%Y=OXCLX-+@N-2T38QBAN\I<!T+ *V
MS(;Y2,$=1UJSIWBM]5T#0=2L[.&1]6*XB^T'$0VEF^;9R5"D'@<\9JCX8T/6
M--\9:YJ-S8V-M8:C#:^6EO,6\HQ(R[ -HSUSG@>@-2^%/"<_A_6=6=Y5;3OM
M$CZ9"/\ E@DNUY1]-XX] #ZT 4]5^)$%C:W-_:V]K>6=K<FWEB2\ NGVOL=H
MXMIW '/!(R 3Z9ZZ^N9H](GNK)(I9A"9(EE8HK'&1D@$@?A7%Z1I?C+PS>7N
MCZ?;:?=Z/<74MQ:WLUP4>T$C%F5H\'S,$DC!&>Y';NIH3+9R0;R2\93<>O(Q
MF@#R/4]1U#6OA;X8UC5;>&6ZDU.QFC>)][ONF!/!4!/3 )'O7;VGC&6+7-5T
MS7-/CT]K*Q&HK+'<><KV^6!)^4;6!7D<_6N:3PKXF'P]T+0)+"U^TZ9>6SDI
M=95TADW%LD#!88P/KDBMC4O#%]K/C/4[JXM_*TR_T%M*:02*75BS,6VYZ8;'
M7J/2@!\'Q 635='@>UMGM=4;9&]K>":6W8C*B5 N%!Z9!(!XYZUL>,?$,GA3
MPO>:TEE]L%JH9HO-\O() SG!]?2L?PM'XWMH+31]8M=/2WL@J-J4-P7:Y1>%
M C*_*3@9)/K@9Z7_ (@:1?:_X(U+2--B22ZNT$:;W"JOS Y)_#M0!EZ]XEO;
M73//UKPE"]HVH6T-N);I),AV4+(5VG:RL>G/(X/>MNZ\13'Q)-H.FVD=Q>06
M8NY3-,8T 9BJ*"%8DD@\XP..O2J'C32M5U[PS96MG9K]I6[M[B1))E 01N&(
MSW)Q@?TK'UX:M=^.IKK0]+AO9;2P2VN?*U'[+-&9"7V.=K!AMVD=QN)SR* ,
MSQ!XA7Q5X3\)^(%TMH=WB*S\B,NKR'$I5@#Q@[E(_"NJA\6:I)?ZYI4^DVUM
MJ=A:+=P*;LR131MN )8("I!4@C!^O>L.;3M0U?P_H^F:?X=33'T/6;:6:T^U
MHZ*D6V3Y7'WBP<=<'.<^^T-#U*;Q]JFJ/;K'8WFE)8HYD4LKJSMDJ.WS?I0!
M;\ :GJ6L>"],U#5%B\ZX@67S$E+%]W))!4;?H"?K735S7@/3=5T;PC8:5JUO
M;Q2V42P*89C() O&[H,9XXKI: "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN1^(^K:IHWA
M<7&EF)9'NH()'=B&"O(JG;@=3G&>P]Z .NHKG9=?O'UQ-!MK:V.IK:?:[DM,
MQBA0MM4 [<L6(/88 )] 9/"_B4>(8+Z.6V-I?Z?<M:7=OOWA7'.5; W*000<
M"@#>HKEM8\6FUU.]TVP%HUU9PI+)]JF**S,"51<*3G R2>!D=<G&=#X_O;R7
MPPEKH+*==2?"7,YB>"2)"2K KTR/O=<9.WH* .ZHK@H_&GB&6WUZ&/0;+^T-
M$D/VD&^81.FP2+Y9V;BQ4]" !Z]JGG\>73R^%UT[1A<KX@MGGAWW.PQE8A)M
M;Y3QR,D9Z' / (!V-S=6]G;O<74\4$"#+R2N%51[D\"E@GBNK>.X@D66&5 \
M<B'*LI&00>X(KSZZ\3W&N>%_&VBZSID=CJNEV$OFQ)+YL<B/$Q1T8@<<'MQ_
M+0T37C9Z!X/T:TB2;4+[3(Y$$C[4CC2)-SM@$]2 !W)ZC&: .UIKHDL;1R*K
MHP*LK#((/4$5QK>--16'Q!:)H\<NN:(JRO:+<$)<1,I97C;:3D@'Y2.",9[U
MH6OB>34+#P]<V%O!.=7 <J)B!%'L+,V=O..%P0.6 XH @;PKX-\-QF_FMK6Q
MMHVW?O[AE@0]1A&;8#GI@5U"QQJ[NB*&?!9@.6XP,^O%<9\745_A9KVY0V(5
M(R.AWK5RV\3:E'XOMM#U'2X;>.]M9+BSECN2[?NRH99!M 4X8'@L/<T =%:W
M]I?>=]DNH9_(E:&7RG#>7(O56QT(R.*L5P=IXV@LO#FO:K-I5M8_8=8:QF6.
M3Y&??&AF=@HXR^2<9P*ZC1[^\OC.;B*V, "-;W-K+YD<ZD<D<<8/&,GUSS0!
MJ45A7VO2#Q&F@:=%%+??93=RO,Y5(H]VU>@))8YP.. 3GH#SM]\1YK/POJVH
M?V0IU#2+Q;.^M#<<*6955T;;\RG<",A>] '?U6M]1LKRXN+>VNX)IK<@3)'(
M&:,G. P'0\'K5;1[G5KD71U73H;(K-B 17'F[X\ @G@8.<@CVK@K>]U/2?&W
MQ"N-'TVVN7A-G,ZS3^2N%MLD#"L2Q[< >I]0#T^BN1'CFVN;+17M5BCN-5LO
MMJ+<R%5ACPN=Q ))RX  ZX)R,5ER?$>]CT-+TZ"3.NK)IDT?GD*Q9@%DB)4;
MU(/&=M 'H5%9^CW&JW%I(VKV,%G<+*RJD$_G*R#[K9P.OICM6!-XOO9],U;5
MM)TZ&[L-,FEB</.5DN/*_P!84^4@8P0,GYB.W!H Z^BN1B\:FYUK0(+:TB;3
M-<M7GM+QIB&WJ@;RV3;P<'U['TJ+3?&]SJ&E:[,=/M5O]+OC8"U6Z+"63<%7
MYMG 8L .#[]* .SHKCY/%.NR>*-0\/V6BV;W5M:17*RRWI6-MY8<X3(Y4X !
MSW(K6\)^(%\4>%['65MS;FY0[H2V[8RL589[C*GF@">Z\/Z;>ZQ:ZM/#(U]:
M!A!*)Y%\L-PP"AL<X&>.:TZYB\\2W\TNLIH6G17K:1\DJR2E#-+L#F*/ /.T
MKR>YQCJ:>/$UQ>ZI;Z3860CU![!;ZX2[<J+96.%1@H.7)R,<8VDYZ @'245P
M<WQ%DBT"YOCI:"\L-233K^T:X(\MV=5#(VWYE.X$9 XK;D\17*>-F\.+8Q-N
MTUKZ*8SD;B) FQAMXY.<@GZ4 =#17G5I\1M4G\.Z3XBET&"+2[N\%K/_ *86
MEC+3&(,J[,, 0,Y()YXQR=JX\6S/KNJZ3IT%I->:=LW6LTY2:=60.7C&#D -
MCW((XX) .KJM+J-E#?064MW EW/DQ0-( \F 2<+U. ":YG6?&;6ESJEMIL5K
M//IBCS8YYF0RN4#^6F%/.TKR>YQCKC(O=0BUGQM\.-52VDMS<I>N8YDVR)FW
MY5OH: /0IYXK6WDN+B5(H8E+R2.V%50,DDGH *+>XANK:*XMY4E@E0/'(C!E
M=2,@@CJ"*H>([UM-\-ZE>BSCO!;VTDKV\K[5D55)92<'J >U<VWC&ZM;;P?'
M9Z) \>N0+L1+CRQ ?)\P*!MQM' SV /!X% ';T5SGAGQ%=ZO?:SIFI64-KJ&
ME3I'*()C+&ZN@=&5BJGH>A%6;_6Y4UZ'0M/ACEOY+9KIVF<JD408*"< DDL<
M >Q.>.0#:HKDH_%]XMIID%YH[VFM:A=R6L5G++\A\L%FEW8R4VKD<9.0/>FM
MXQN[74-8TB\TZ+^U+"R_M"%4G(BNH.06#%<J00000>W/H =?17!V7CO4Y8_"
M][>:-!!INO&.%'6Z+2QRO&77*[<;3@C[V>Y Z47'C?7"WB9+/0;1VT)_WIEO
MB!(GE^9\N$)W$'H0 /6@#O**Y.3QM;S1:2MF(4GU*P%^OVJ0JL41"XS@$DDM
MC ]&.> #6TWQZ^H65I$=,:'5[J^EL4MG<B-FC4NTJN5R8]@R#CG('O0!VM5[
MB_M+2:WAN+J&&6Y<QP)(X4R-C.%!ZG [5PGC#Q/XET_P3XFF&FI97=AM2.[W
MDQS1N!^\BXSN&<8/ /<]*U]5UJXL=8\,6E_I%E+)?W3Q+.)BYMV",<KE <E1
MC/'4]: .LHKEG\3W]Z-9DT/3X+N+29FMY!+,4:>5%#.B84XQD#)ZG(X S5#_
M (6"][-X7.CZ8MW;:_',T3R7'EM&T:%BK#:>A&"03T. >,@'<45SOA;Q%=:U
M+JUGJ%G%:W^F77V>9893)&X*AU96(!Y#=".U&H>(KK3_ !EIFB264/V;4HI3
M!=F<@^9&NXQE=O<<@YZ ^E '157^WVG]H?V?]JA^V^5YWV?>/,\O.-VWKC/&
M?6N4TSQO<ZCI.N3?V?:K?Z9?FP%JMT6$LFX*OS;. Q88X/OTJU'K,I^(3Z-)
MI-HMT-(^U)>"7+,/,"^63LR%W9/?L<4 =#?7]GIEJ]U?W4%K;I]Z6>0(H_$\
M5."&4,IR",@BO'=3U35M=^#/BVZU=+9RLMRB-&[':4EV@!2.  .#G-=M9>)M
M1@\4:;HFHZ9#!!J%I)+9RQW&]\QA=RR+M !PP/!(]S0!UM%8OB?Q##X:TN*\
MG\M4EN([?S)6VQQESC<[8X4?X=.M9.L^+=2T/PU=ZQ<:;:SQV]U%"ABNCLGB
MD,:B13M/\4A&/]D\F@#L**YZX\2M:>-4T*>VC6W?3I+X77FG*A&52"NW_:SG
M/:JEKXHU6^M]'U.UT0SZ5J<JJICD)FAB<$I,ZXQMQ@D9R,CD]* .CM-1LM0,
MPL[N"X\A_+E\F0/L? .TXZ'!'%620 23@"O*-.UC4O#I\?:AIFE6US!9:K)<
MW EN/*^188RP0!6RV 3S@=.O;U"QNX[_ $^VO(@1'<1+*@/7# $?SH @76M*
M>01IJ=DSDX"B=22?IFKU>/V:Z4VO?$FWO])FU#S;E%6&"R>9G)AZ JI"DD]2
M1ZUH^']6\2^#O"O@[1-3TX7NHW[/;L9;K:T) =T5OE.0%"@G/&#P<4 >GT5R
MEGXDU:[OH]&.G6D&M1VOVJ\1K@O# "Y5 &"Y8M@GM@>O>O:>/XKG33NL3'JZ
MZG_9+6)EX%QU^_C[FT%MV.@Z9XH [.BN5G\57NCQ:Q)KFEF&"P6)H;J%\Q77
MF' 5=P&&#$*<\<@U6A\<M!KC66HVT/V0VDET+VS=Y(XM@RR/E1@X!(/?'04
M=G5>]OK33;5[J^NH;6W3[TLT@11]2>*Y"#QY-)J.C V$<MGJCB,&VD:26U+#
M*&0;<8/0D'Y3Z]:Q?'6NW/B+X7^(KZPLK:32566&.224B20(VQI5&, !@< G
M) SQTH ](;4;)+NWM6NX%N+E6>"(R -(JX)*CJ0,CI5FN1?6?LWBSPWI+Z7;
MR&[LII(;UGS)'L1=R@;> <KSGMTK)G^(.M)HNO:I'X?M3!H=[+;W0:^.72/;
MN,?R<GDGG:,8ZG. #T2BN=N/$QD\06.B:="C7-U8M?F2<D(D0*J.!R22W3C
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MJ6UI D,"?=1!@#N?Q]ZGKE-*\6S:U>2K806DL4%])9W4/GD7%N$9E\QDQT)
M(''!!R>16?J?Q$:VL[G4=/LHKVTMKEH'@25OM,H5]CNBA2.""0">0,Y% '=T
M5R4GC"6XUG4]-TN"UFNK 1L;6>8QS3JZ*^]%P> &Q[D$<<$];0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA'(CAUD9B!GYE7@#@9Y.>)+&R\5ZYIEQIWBF+3K2WDMI+>5K&5I&N"ZE2V&
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MF=[9EG=@US*BAG12/N8R%!.<G/  R=*VDU^\V)>6EGIZ @R-#=&=FQ_"N44
M'U/..V>1BZ=X?UOPWJFN_P!DK9W-AJMRU[&+B9HVMIW #Y 4[D) (P01T]Z
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MD#'M7.+\2M>7PA8^+YO#]JNAL^+L)=%IXU,A3>J[<%1QU.3SP!S73-HFJO\
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M"$ISC&<G&>G'6LNY\!ZMJ-MXHCFN;6TEU*_BU"PGAD:0PR1A-NX%1W0=,]:
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M^4 ELG&X<'FN.\!>(&TGX<^&K-(O]-U">[5 (GE$8661G8J@W,!P,#'4<@4
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M#%=(PR"JR#((Q@C)QQSS0!TE%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5SWC70
M+GQ)X9ET^RFBBNA-#/$TV=A:.17PV.<';CBNAJIJ.IV.DVC76HW<-K;K]Z69
M@JCZD\"@#G6T+6YO&VF:],=/*6UC+;2HDC@EG96RN5/ V@<GGKQTK%;P!J\V
MB:G#]NM;346UQ]:T^XB9I%CD)R%<%1D8R#CUZ<8/H%I>6U_:I<VDR302#*2(
M<JP]0>XJ>@#C9])\6ZQX8U:SUB?25O+NRDLXHK0R+"N]2#(S,"2?0 #'/)SP
MW5/".I:EX(TC3H[R"SUG2&@FM;B/+Q>;$NT$@@':P)!&.,]^_2W&M:;:ZM::
M5->1I?W@8P09RSA06)QV  /6K] '%WGAC7?%GAC4=+\5W=C$]U"(HTTQ7,<;
M!@PD)?ECN5>., 'DYXF.@:QK3Z$/$)L0NDW"W9:UD9S<S(I5&(*C8/F+8RW.
M!]>NHH Y?1M#U2P\:Z_K%P+,VNJ"W"+'*Q>/RD*\@H <Y]>/>M'7+2_O%MX[
M6"QNK4EEN[6])"31D< ?*W(.#R/4=\UKU3U'5K'28X'O[A8%N)TMHBP)W2.<
M*O'K0!PG_"O=0M- L].T][...'75U80/,_EP(K!A#&=I)''4@8)/%:.I>%=:
MO_$NLZE#=6UFE_H_]G121RL987!9A)]T=V['/&:[:B@#S_3_  CXBAU7PK>S
M2Z-"NC6\UM+#;K(0RNJ#<I.,D[>A QGJU36WA/68O#_C#3W:P\W7;BYFA83/
MB(3($PWR<XQGCK[=:[JHKBXAM+>2XN)4BAC7<[N<!1ZDT 4O#]E<:;X>TZPN
M_*\^UMHX&,3%E;:H7(R ><>E<[:^'-=TNX\10V,M@UOK-V]TES([K);,Z*A'
MEA2'QMR/F7-=5INI6>KZ=#J%A.L]I.NZ.500&&<9YJU0!P%SX&U30[O1[_P;
M=VD<]A8#3I;?4-QCN(0=P)*#(<-DY [_ ('L=)AOX;('5+B*:\D8O)Y*E8T/
M3:@/. !WZG)XSBKU-DD2&)I)'5$0%F9C@ #N: //=9\$^(-0_P"$MMHKW3FM
M];0>5/<!S-$ @ BP!@(",@@G&3\IS6F?#>N+XET/6DN=/,MM8/8W:%7QM9E;
M='ZD;<<D>OM72:5JUAK>G1ZAIMRES:2%E25,X8JQ4XS[@BKM &)XPT*3Q+X1
MU31HIEAENX#&DCC(5NHS[9%9%SH&OWNO^%]4N3IN[2O.,Z1R2 ,9(]F%RIZ=
M<G&>F!UKLJ* //KKP%J.IQ>*HKFZM[4ZM=17EI/;NSO;RQ!=A(*C/* \'N1[
MUO\ AZW\6%U?Q+=:8?*7:B:<KXE;^^Y;IQ_"!C)SV%=%10!ROC#PYJFJ76E:
MOH-Y!;:QI<CF$7*DPRI( '1\<@' Y'3'XB46?BJ?276ZNK!;ZYD1)1;.Z1P0
M@_-Y9(),A!/S'&,CCY>>EHH Y'0O#%[X;\47[Z9]DC\.7H60V?F-OAG PSH-
MN &P,KGJ,Y[5RO@W2-3\1?"HZ+_HL6GWES<QR7(D8RK$;A]X";<%CR =W&<X
MXP?1]:U;2]'T]I]7NHK>U8B,F0_>)X  ')_"I=-TG3]'MS;Z;906D!);RX$"
M+D]3@4 <E=>&/$6D>*;G5O"EUIHMK^**.[L]0#[5:-=BNA3G.T $'T_*W<>'
M-8E\5^'=5:XM9TTR&X2X>1V1Y6F"Y*J%( !7@9Z<9XS7744 <3IWAWQ#IAUR
M6$Z8SZCJGVT1O*Y0QE55HV^3N%ZX/)Z<<Y[_  S,FFZ[%:2PZ1)>W,%Y9PVA
M+Q6D\7(< A>6/4    5W5OJUC=ZG>Z;!<*]Y9!#<1 ',>\97/;D#M5R@#G_#
M\'BHOYOB6YTS=&FQ(M.#[7)QEW+]^.% P,GKQB#Q)X<N[_6]&U_2I84U+2VD
M41SDB.>*08="0"5/ (.#@]JZ>J]]?VNF64M[?7$=O;0J6DED. HH PK/0;R+
M5]6U^=;4ZI>P1VT4*RMY<4:9P"^W))9B2=OH.V2_P-HE]X;\(V&BW[6[R6<?
MEB2!V(<9)S@J,=?>MNTO;>^L(+ZVE#VT\2S1R= R,,@\^QJ#2]9T[6X9IM-N
MX[F*&9H)'CZ!UQD9[XR.E &+<Z!JB?$%/$-E-:&WDT];*>*;=O&V0N"N..<D
M<].O/2N?F\"ZY-\/M<\.F33EN-1O9+E)?.<JBO*)"#\F21C'O[5Z110!P]_X
M=\46?BF3Q!X=N=,62_@CBU"ROC(8RR9"NC*,Y .,$#_#K]/AN;>QBCO+@7%S
MRTL@7:"Q))VCG"C. ,G@#DU89@JEF("@9))X JEI6L:?K=O)<:;=)<PQRM"S
MQYP'7J/?% '/:?X?UBS\?ZSXA=;%K>_MHH4B$[[U,8."?DQSG\/>L;_A!==_
MX5J?#'F:=]H-[]H\[SGV8^T>?C&S.?X?U]J](HH XQ/#NO:3XRU#6](?3WMM
M72+[;;74C@Q2HNT/&RJ=PQU! SZCMBVGP]\06'A;1([34["+7=%NII[638Y@
MD65F+QOWP0V,@<8_&N_O]8T[2WB2]O(HI)<^7&3EY,==JCD_@*++6=-U*5HK
M.^@GE1=SQHX+(/\ :7JOXT <IKWASQ1XD\$ZEIM_=:8NH7PC0)"9!;P*K!L@
MD%F8]^ .GISH7VAZK>^--"UO;9)!I\$\4L?GL68RA<E?DQQM[XSGM74T4 >;
MW_@;7;WP]XNTP/IR/KM[]IC<S.1$"$!!^3D_)^OM6]>:'JUWXST+6]MDD.GV
MTT,L?GN68R!<E?DQQM[]<]JZJB@#S_\ X0;5+CPGXOT:YGLXY-;O)[N"2-V<
M1^9MPK94=-HY'KTJ;5/#7BB6[TC7]-O-,AUZSA:VG@D#FVGA8@E2WWL@KD'%
M=U10!Q.M>%O$.KZ98WO]J6D'B2QN_M=NZ(WV9?EV&+!^;85SD]22>@X&]H4.
MO>7)/X@GLC<L JP6(?RHP,\Y;EF.?8   =R=BJ<FJV,.KP:5)<*M]/$TT4.#
MED4@,?3C(H PO$6A:M<^)]%U[1WLVFL4F@EANV95>.0+R"H/(*],<Y[5SMUX
M"\07'A7Q1I!O-->76=2-XDGSH$!9"<C!_P">?3WZG%>ET4 <M=:)JUSXYTG7
MMMDL%I:2V\D?GL6)D*DD?)C V_CGM6*/ .IW/AO6]/N+RWM;RZUB35[*YMV9
M_(E+AU# J,X(QGOFO0Z* .4LK3QM-IURVJ7ND17ZP-':K9+)Y1D.,22%N>WW
M0.YZ\8HV_@Z^M=<U+7=/BT_2;^ZTYK?RK:1GAEG+;A*XV+TQC@$D,>:ZZXU*
MSM1<F:=5%K$9ISR?+0#.3CIP"<=3BJS^(M)2RTV\:]06^IR1Q6;X.)FD&4 X
MXR/7% &+HOA)[+QC-XA-K9:<\]GY$]O8R,R7$A8-YC950",$#@D[CDTGC'3W
MCUWPUXF0$II%S(MSC^&"9-C/]%.TGV!/:NIANH+B26.*0,\+;)$Z%#[CW'(]
M1S4U ',:OH>H:AXU\/:U;M:_9--6X$BO(P=_-4+E<*1QC/7G/:J[Z>VK_%"#
M4U&;31K%X _9KB4C*C_=11G_ 'Q[UUD44<$2Q1(L<:C"JHP /84111P1B.*-
M8T'15& * .?\9Z#>:_I=FFGRP1W=E?P7T0N,A',;;MI(!(!]<56BT+61X^7Q
M#*;!XAI7V%D61U8OYGF;@-IP,\8S[^U=910!YK'\/];C\-PPP7]G:ZS8:K+J
M5E.A9XR9&8M&X*@[2'(./_K5V.@PZ_L>X\0S6/VA@%2"P#^4@'4Y?EF/T  '
M'<G9HH X[Q%X=U[_ (2FV\2^&+NR2\%M]CNK:_#>3-$&+*<KR&!)_/\ -NK^
M'-?U1= EEN;&:ZL=274+DEGC0X5E\N,;6(&&ZD]1GOQV$LL<$3RRNJ1H"S,Q
MP /4U6TO5;'6].BU#3;A;BTEW>7*F<-ABIQGW!H PK/1-5M/'&LZ[MLG@O;:
M&&*/SV# Q[L%ODQSN[9QCO7%7NA:IX8\.^ ='E:SEO+77AL9)&\N3*S-R2N5
M^]CH?7GI7KU4;_1=,U26"6_L8+F2!M\+2H&,;>JYZ'W% &-%H-])X@O_ !#=
M+:B_DL186L"2L42,,7)9]H)+,1T7@*.M8-IX!U2T\+^%X8[FS36O#LI:WD#,
M89T((=&.T%=RG&0#C'>O1:H:KK6FZ)!'-J5Y';)+(L2%SRS$X  ')Y- &1!I
M9M_$=SXLUR6TM9$L5LT5)LQPQ!R[,SL%R2V.P "]\UG>%M%LSXSU[6["Z\[3
MI)?W"(08EN'53.Z$=<[8QGL=X]:[&[M+:_M);2\@CN+>52LD4JAE<>A!ZT6E
MI;6%K':V=O%;V\2[8XHD"JH] !P* .3MO#>L07_B^Y/V$C6]I@43/^[*Q"/Y
MOD]!GCZ>]4F\':U_PB_A#2E;3_-T*[MYY7,S[91$I7"_)P3G//3'>NXO+VVT
M^U>ZO)T@@C&7DD.%4>I/84S3]3L=6M%NM/NHKJW;[LL+!E;Z$<&@#CX?#?BS
M0]?U.3P_?Z6=)U2Y:[ECODD:2VE;&\IMP&!/."1_,F_#X?U2W\>?VZ'MIK5=
M)73P))F\UV5R^]ODQR3@_G[5U=4+_6M-TNXM+>]O(X9KR40V\;'YI'/0 "@#
MB$\":S_P@;:*9[!;Z+4_[0@<.[1L?/\ -VM\H(ZD9 -=]%%++8B*^$3R.A64
M1@A.>H&><=O\*L44 >?6O@C5[?P9/X*>YM'T=BT4=[O;SUMV;<4,>W:6 )4-
MNQT..,'6OO#VHOXTT/5;-+);#2[::W$3RL'82!1QA2!C8._/M75T4 8WBSP]
M'XJ\+WVBRS-!]I0;)5&3&ZL&5OP8 UEZ=I'B;4M/EL?%MUISVS6[V[+IX<&X
MW*5+.6QC@GY0,9.<\ 5T.JZK8Z)ILNHZE<+;VD./,E8$A<D =.>I%7* .!B\
M&:O<>#[7P?JD]E+I=N\2-=QNWFS01.&1#&5PK$*JD[CQGCTNS^'-;MO&&KZG
MIDUA]CU>VABG^T;_ #(7C#*"J@88$-W(P?7OV-% 'G.G^"->LM&\&V3S:=(^
M@S^=*PD=1(-K+M7Y3_>)R<=.E:<?A[Q!:^(O$VK6DNGH^J?9?LX>1SL\D8(<
M;.C GIT_6NSI'=8T9W8*JC)). !0!Y]+\-HK^37V>*VTF+5[)+=[>P<NGG*Q
M83G*J-P.T8 YP>>:V?#UIXSC,2^(;[2Y8[92$:R$@>Z;! ,A;A1SDA0><'@#
M!V]*UC3];LS=Z;=)<VXD:/S$SC<IP1[\U>H YKP3H5_X>TJZM+]K9FEO9KE6
M@=F&)'+8.5'3./>F7VAZK%XZ7Q)IPL[A7TX6$MO<2M$5Q(7#A@K9ZXQ@?6MF
M\UK3;#4+.PNKR..[O6*V\)/S2$ DX ]@>:+36M-OM3O-.M;R.:[L@IN8D.3'
MNSC)Z9^4\>U &)9:7I7AS1K^'7;^S#:Q<33WC3N(XY7D'S(H8_=" #UP,TWX
M=:(^C>$X!+/-/)/\ZR3C#B$#;"I';$83(]2:T=>D\./=:;::ZEC+/-< 645S
M$)&,O8J"#@^];= '-^,=!OM<MM*?3I;=+K3M2AOD6X+!)-@8%25!(X;KCM4%
MKH6L0^.[G7Y?L,D4NFQV>Q975BZ,S[L;3@$MC&3@>M=710!YI;?#_7K+PKHT
M-G?V5OKNBWD]S:S9=X95E=R\;C (!#XR,]/?CM="AUP123Z]/9FZDPHAL@WD
MQ@9Z%N2QSR>.@&.,G6HH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KDOBA_R3
M'Q%_UY/76U@^,M&N_$7A34-&LWABDO(C$99B<(#U. .?TH PI?$&K:4?!6EZ
M?;6<D6J6YC9IV8%2D&\8QVX'KGIQUID?CR\TO3?$YUVWMI;S1+B.%?L89$N#
M*JF( ,25)+@'DXZU<E\,ZM-?>$KDO9#^PPWF@._[[=%Y7'R_+QSW]/>J.H?#
MZZUD>+8KVZAACUR2":"2$LSV\D2J%)R!NY4$].X]Z (M875U^)O@7^TI;*52
M;TC[-$R;&\CD?,S;ATP>.G2I;KQQJ\^FOJVB:<U];QW31+8K83M)/&LAC9EF
M'R \%@,'@8)STL?\(YXJU#7?#>J:I?:2LFD--YGD1R-YV]-A/)&">>.WOT$>
MF^$O$^A7EWI^E:S9)X>N9WG59H6-S:AR69(B"%ZDX+9QGH>X!./$'B34/%6O
M:'I\.EPFQ@MYH)K@2/GS YPZ@CGY0.,8YZ]*RK?Q]KTWA;0?$[6>G1Z=>W$-
MM<V_SM+EY/++HV< !NBD'CO71V.@ZE8^,M;UM3:/%?P0Q1Q&1@R^4& +':>N
M[\/>L&/P'J\7P[TKPP+FQ,UC=1SFX+/M<)+Y@&W'!/3K[^U &A)X@\2W?B[7
M-!TZ'2HOL5O#/#/<>8^=^[A@",_=[$8]^E4_^$\U"Y\&^%==ALK4'5KZWM;E
M)"Q\O?)L8H/J#C)XXZULV>A:I:^,M8UT_8V2^M88$A\QLH8]V"3MY!W'MQCO
M6'!X#U>#P3X>T 7-BTNDZA%=M,6<+*(Y"X4#'!.<9YQCWX +5OJ&K#XJ:S#/
MJ%O_ &=9Z=#,(C;M\J,SDX._[WR\M@YP!@8J.#QIK5W%HVIV6F/=V&H2Q^;;
M)83K)!"XR)?./R-@8) '?@G&3JOX:OO^$WN=:CN+;[#?6,=K=P.C%_D+'Y2"
M!@AB#FL[PWX6\5:!'#HIUNRF\/6S?N'\EA>>4#D1%L[0.V[!..F., $=]XUU
M>:QO-0T*P-XEK=O EG]@G=[E8Y-CE9E^13D,0,-P.>3@=N[^;I[2;&3?$6VN
M,$9'0CUKB[/PIXHT/5;^#1-9L4T*_N7N2ES SSVK.<N(B"%()R1NX&>AYSVD
M\4@L'BM\-)Y>U/-<X)QCD\F@#RGP;K^M:#X#\$2^38OI-Y-#8.AWF<&1F D#
M9V@ _P .#QW[#H/%OC/5_#=MJ]\T-A%#8NAM[6;+RWL7R[W!5_D +$#*GE>>
MO$47@;5X?!?AK0A<61ET:^ANFE+/B41,6  V\$YQWQCOGB/5_ 6O:C9^*[!-
M3L!;:Y)YRRRQ.TT9PH$1.<;!MX/. 3QS0!IZWXPELO$LFAQ75A87+6:SV1U"
M-MEY(2P**P90N,*.Y.[IQSV$)=H8S*H60J"P'8XYKD-;\,ZKKVG7>FZG'I%_
M:W-NJ+YJNAMIL$&1!AL]00,@\=>>.HTRR_L[2;.Q,SSFV@2'S9/O/M4#<?<X
MS0!Y'X;UWQ)X:^&$&LV5GIUQI%E<7+W,+L_VB2/[3)N9"/E7&>ASG&?:NUO?
M%MS=7]Y9:+M$EK;Q2F26PGN0[R*65,1XVC;@DDG[W3BJ=GX(U2'PG/X1GNK0
MZ3++(7NX]PG:)Y#(R;"-H)W%=VX\=LU/J/A77K#Q3)KGA._L(!=P1P7EG?Q.
MT3>6,(ZE""& .,=* $MO&M_>Q:7:2:=+IFJW5F]U<Q3V<MP;<*^S'EIACN;)
M!) P/<51F\;^);;1]-FGT2&"[FUN/2Y!<+)$LR,V%EC##*AA_>S@]CBK^L>$
MM=-_I>N:+K$ URTB>"X:\B8P74;MO*D*<J W*X)P,#/%/U?PSKVKZ?I(N;ZS
MEO;;58=2G.'2+]V>(HUY('N2><G'.  6="U[5I?%VJ>']82R,EO;Q7<$UHK*
M#&Y92K!B>05ZCKZ"K^OZEJ%A+8K:K:Q6LKL+J^NF'EVRA<K\NY2Q9L*,'BJM
MIH5_%X^O/$$CVWV:YLH[01*S%UV,S;NF#G<1BD\2:#JFHZ[H>JZ9=VJG37E+
MV]VC-&^]0N\;3]Y><?[QY% '/_\ "P-3_P"$-GUA8+-I[/6/[-F'EN$E'G+'
MO4%LIPP.#FN@FUS4?^$^?PY']E6&327OHIFB8LCB14PPW ,/FSQ@U@-\/M6D
M\+Z_I4FJ69EO=3.I6LJP, K^:LF'&3QE<8'0=S6M9>'=>;QQ;>)-0O-/!73F
MLI;>")R!F0/\I)_V1R?ICO0!PEU>:IJ/[/MS?ZE=QW4D]RKC;$4;=]OYR=Q!
M&>@ &!QS7>6WB+5K7QNVB:RE@+:;3WOH)+;>#$$<*R.6/S<,#N 7ITK%/@#6
MQ\.Y_"0O[!HOM&ZWF*."$\_SLOURV?EP, =<FN@N?#U_>>.+/7)?L@MHM/DL
MI8-[%FWLK$@[0.-N,=_:@#(G\;:LO@I?&D%M:R:3GS6LBC"?[/OV[Q)NV[L?
M-MVX[9[U+>>)_$EYXLN-$T&#22ITR/4+:>[:3:0SE<-MYYP>@XSU[&.U\#:G
M;^$9_!AO+9]$=F2.Z);[0ENS;C&5QM+<E0^[ISMXK6MO#MY:^/GUQ#:K8G34
MT]8 S;U".7#=,?Q8Q^O:@"'3]?UF^\0>*])6UL1<:9%;FT*EB)'D1V&\G'&0
M!QCO4$/B/6Y/&O\ 8<,VG7EO9Q>=JEREJ\8M@1E$!\QLNW7'8<\]*GB\/ZY9
M^(/%&K6=Q8I+JT4*6V_<WD-$A4,PQ\V=V<>V.>M,\-^&M5T'28=-7["1)-YU
M_=F1WENG)S(QRH&6Z=>!Q0!0C\;ZS>6NE:MIVF/>6%[,@>T33YQ+' QXE$Q^
M1B!@E<8YP#QDNUK7-1\0>&/%LFEFSCL;!+FSQ/&S/<,D9\P@A@$&25'#9QGI
MQ3_#OA3Q3X?1-$BUNSD\.0N3 QA?[8D6<^4&SMQVW<G'3'&(QX+UW3E\1Z=I
M-]8'2-::><+=*_F6TLJD.%V\,I/KC'OW .B\$?\ (@^'/^P7;?\ HI:X'1]0
M\3:7IGC"_P!"M=-F@M->OIIHKIG\R8 @LJ;<!3@<$YR>P[^C>&M-N-&\,Z;I
M=U/%/+9VT=N9(D*JP10HX)/I_P#JKGK?PIK-E;^(--MKNS^Q:S=SW/VIMPFM
M_.X90F"K$#H=P]2#TH (?&=Y-K7AF39;1Z%K]MOAE9&\V.;8'$3'=MY&<''4
M$8[UT&BW]WJ,VHRR>3]CCNF@M2B$,X3Y7+$D@_.&7@#[N>_',>+K+11X3A\)
M65]##JELMN-+@653/'(K 1.%ZX&,DX^[N-=GIMA%I>F6UC!DQV\:QJ6ZM@=3
MZD]30!R3W>LO\8A8+?P"PCT?[0L)MR<!I@K#.\?,=@PV, <;>I/*Z;KNM>&O
M"OB?6;"&PDLK+7[Q[B.?>9)5,P#!"" I /4[L^@[]W>>']1/CV#Q%8W5LL1L
M/L-Q#,C%MHD\P%2#C)Y'/3KSTK"E\"ZO-X(\1: UQ9"75[V:Z68,^V(2.'((
MV\D8QVSGMCD V-3\3W+ZS>:3I15)[2WCEDEDL9KE2TFXJF(L;>%R23W& <&M
M3PQJE[K/AVSO]2TV73;V13YUK*""C D=^<'&1[$5S^H>&?$=OXC7Q!X=O]/@
MNKFVCM]0M+Q'>"79G:ZE<-N&2*ZW3K>XM;&.*[N?M-SRTLNW:&8G)VC)PHS@
M#)P .3UH X7X8S-K6I^+?$%Y\]ZVK2V*%N3%!$%V(/0?,2?4\UT^NRZ;X=AO
M_%EQ$1):V3+*4 S*@.Y5^N<@?[QK,C\+ZGH/B/4-5\.36C6VIN)KS3[PLB^=
MWDC=02I/<%3FM&_T&?Q#HU_8:W*BQWENT'DVI)6('^+<0-S9P02 !CIUR 95
M]XHUC0DT.^U6*RDT_4YXK:5;=&5[1Y1\AW%B)%S\I.%]?:HK#Q#XLU;Q!J]A
M9VNC)#I=_'#*TSR9>)D#':1_'SU(Q[5-%X6U:_T[1=+UVXLY;72IXIS- 6WW
M9B'[O<I&$YP3@MG&.,U>\.Z%?Z5K_B"_NGMFAU2X6=%B9BT95 F#D#.0,YH
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M:-*/D.XL1(H/!^5?4>E68_#VN:YHU[8>+KZRD2XMGMO+TZ-T4[AS(Q8G+<#
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MPP9V?H1QC=COTH Q[?4-5'Q3UJ&XU&W&FV>G03"(V[?(C,Y.#O\ O?+RV#D
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M0+^>$HT,C?:(XU0D??&PX).><YQ@8R0#T"YU:RM-4LM-GF*W=\)#;Q[&._8
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M=A:74%]9P7=M();>>-98I%Z,K#((^H-34 <O=>&;R3Q7H&K17<9@TJWE@*3
MM)-Y@4%BW3(V@].<GI6+?> M9FT_Q1I-KJMG'INMSRW0+P,9HY) -RYSC;D9
MZ9[<=1Z%10!Q4GA#6+/Q#9:]I6IV8OELEL;Z.>!A#<(IRK !B58?4Y]JH?\
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M"-L('E$A&W//(QG/>KNH^%M?B\3OXA\/:M9VES>01PZA;74#2PRE.%=<$$,
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M1U&QNO".A^,M6N]1@B75)#+'+'$6^S.ZK$N[/! .TDG&.:[]W6.-G;.U02<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1FP6W'."I&<<CTZ"L_C?5_"VK:YIWB<VMZ+/3#JMK<6D1A\U VPQLI9L'<0
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M058>X(!_"LK2O#>M/9O:>)];BU6W\AK=8XK;R?,5EVEI#N.YMI(XP.2>3@@
MR+_Q;K6E>#M,\97)MI+"X\B6[LDC(,,,Q 4H^<EEW+G(P><;:F;6?%%_XH\3
MZ/97FFVZ:;#;RV\SVK.?WBNVTC?R> -V>,?=YXEMO ]Y_P (Y:^&+_4XKK1+
M62,K^Y(FEBC<.D3G=C *J"0.0,8&<U?MO#5_:^)M?UA+^V(U6&*)8C;M^Z\M
M6523O^;.XYX% &3IGC>[UO3O"4$"0V^HZY;O<3.5++"D:_.57/)+$ 9/&23G
M&#BQ7NJZ'K7Q/U!;FWEO;&UM;B.1H?E<) [ ,H/7 P2#[\=*U;?X<WUAI'AL
M6.LPQZOH =+>Y:V/E31/PR2)NSR.X/%78?!%[-=^*9M3U6"5/$%HEM,D%J4\
MK;$8\J2Y_O'@YZ#F@!\WB74X]4\%1@V_D:VC?:4,9RI$!DRASQSQ@@\5';ZW
MXCU_19=;\/\ V-D6\>&WLIUP)HHY3&Y9\_*QVLPP,#@'-16_@K76N/#,][KM
MH[Z$S",16159$,?E_-E\[B#U! ]J?8>"-7T>_O;;2_$(@T"]N'N'M#;;IH2Y
MRZQ2;OE!/<@X[<\T -T>759OBSXDAEU%7M;>UM"D)A^ZC>:=H.[@YY).<^V!
M6UXFU^329M(L+41_;=5NQ;1-("5C 4L[D C. .!D<D4R'PW=6OC>[UZVU"-+
M:]MXHKBV:#+$Q;MI5]V /FY&T_AVD\5>&AXBM[)X;HVFH:?<K=V=QLWA'7LR
MY&Y2"01D4 9\&N:I:^-9?"U[-#*;FQ-Y87HAP1AMK)(H."02"",9'%4/A9%>
M-H=_)<W,4T9U2\.SR<'?Y[9;=N/Y8X]:W[70;DZ\^O:A/;R:BMI]D@6*,B.)
M"VYCR2220/3  'J2SP?X=N_#.G7%G<WT-V);J6Y#QP&,@R,6(P6;@$F@#'UV
M753\5?#UI!J*Q6KV=S*(6AW ,NP$GYADD,0/3TY-8$-WKFG'XBZEH]S9P?8=
M0DNF6> RF;9 C%.&7:"!UYZ]L<]MK7ANZU#Q/I&N66H):RV,<T,B20>8)(Y-
MN<?,-K#;P3D<]#TK.7P7J L?%EL=4MC_ ,) \C%OLK?N-\8C/\?S<#VYH 63
MQ9<ZA>:?86*20RW&EQZE*\<'G,@<X10,@=0V2?0#OD:_A.^UJ_T7?K]@+._C
ME>-@HPLJ@_+(!D[01V)X.:P+GP+JL1T34-'UR*SUG3;);"25K;?#=0C&%9-V
M1R,\'O76Z39W-E9!+V]-Y=NQ>:;9L#-T^51]U0  ![<DDDT <S+K.H^(AXFC
MTNX@MK;2G>S4R1;S-,L89]W(P@W!>.<Y.>U8GA#7Y[3P=X.T2S5Q<76EFX>5
M(?-9(TVKPN1R2XY/  /'2MP>#M3T_7-9NM%U:W@L-9)ENK:XMC(8Y2NTO&P8
M8W=P0>?RK/3X=:C::'X>33]?2WUK0XVA@NQ:YCEB8#=&Z%CD<#G/X4 5O$%]
MXEO?A;XJ758%LYK:.X1)C#@7=OL.&"[OD8YP>O3ISQIQZS?:=#X?T<2+->7E
MHTWGPVN3%"BQC 7=RQ+KR3C@\5?U'PQJNJ^#]1TF\UF.2_U&,QS71MB(XU(Q
MA(PW  ]2>22?2JVL>#-1O[31+FRUA++7-'4I!=I!NCD0J%='0MT.T=^* ,G4
MO%7C#2O#-S=7-E;17$&IQ6T4L\)474$DBJ'"ACL;GG.1Z"M:UUS7K/QK>Z'?
MM:WP;2CJ-L+>$Q%6#[#%RS9SD8;CZ4:MX0U?6_#HL;W7(7OI+F&XEG^RGRP(
MV#*B('&!D<DDDY/L!:N_#&H7/BY]>74H8BVE/IPC2!MREFW^8&W=0PZ8H R_
M#7C<:M ]])JEO(EI923:E8-!Y5Q:S+M.T*3G:/G'(/('-+9^(O$]V^@ZA;6#
M7-GJ#QF[M_L^P6T3C(D20M\VW(SQ\W4 5>'@UK_7+35=9DLYKFWM);622V@,
M1NA(H4F3D\  X7GDYSVJ#PYX/U[0A!ILOB;[3H-HP-O ;8+/L4Y6-I,\J,#H
M,D#' XH V/%WB'_A&M >^2-9;B26.WMT<X4R2,%7/L,Y/L*SKK7-4T#Q=HNF
M:C-#>66L>9$DR0^6\$Z+NQC)!1AD#N".IK5\4^'+;Q5X?N-)N97A$A5XYH_O
M12*0RL/H0*J0^'KZ]U72]1UR[MKB73%<P+;PE%:1EVF1LL?X<X4=,GD\8 ,+
MPA#J#?$'QH+B]AEC6XMEF7[/CS/]'&,?,=H&??/M6SXR\2GPTNFR3N]KIUQ,
MT=U?B$RBW&TE<@= S8&X@@?CD2:'X=OM*\2:YJL]];SIJLL<AB2 H8MB;  V
MXYX [5H:K9:C<W-M+97-NL2+(EQ;7$1=)U;&!P1@C'7!ZD8YH YJ\\2ZK96G
MA>X2]TZ]CU35A9R2P1Y22%C(4="&.#M1<]>2:2^\:W.BZOXO6_6*:RT:R@NX
M%C0J[&0/\A.2#RH&<#K37^';6_ARSLM,OH;:[L]6.K0$P$P)(68^6$#9"88C
M@Y[U-_P@=Q>ZEKUQK&IQW,&M64=I<0Q6WE[2H8!D.XXQN. =QXZT :EH?%$>
MK:<T[V5SIUQ"YO=B>6UO)@%/+Y.Y2<@YY[Y[5YYH6L:WX<^'(UJTFL_L%MJ\
MJ36KPLSS(]X4)#[@%(W<#!Z=><#N?#OAWQ%ID<%OJGB*._M[)-EJJVOEL^%V
MJ96W'=@=ACGDDFLMOA[?MX G\+'6+;]]=_:?M/V1N/WXFV[=_P#>&,YZ4 >@
M5XMH=KJ6L_#7Q/H6G:.]U+>ZK>0K-)+&D,>9/O-EMWR]>%/.*]E(F^SX#1^=
MMZ[3MW?3.<?C7.^"O#%WX5L+RTN+^&\6XNY;L,D!B*M(<D<LV10!@>?XGT75
MM"\&Z=?6!']BL?M5Q SL)(@B;C\WS D].,9R<XP=/3M8UO7KO5K"SO+2WGTC
MR[:2;R"ZSW)C#.<%LK&"0,=>O-:%YX=O+CQS8>(4O8$AM;62V-N8"6=7*DG=
MNX.5&.*@3PQ>Z9XFU/5]%O;>)-4"&ZMKF$NHE48$B$,.HZKW]10!DZ-X]N/$
M5MH%K;PQV>HZD;D7.X;U@\@[9-HR,DL5QGH"2<XP;EWKVOZ%8B'58K:6ZNM4
M%EI\T*D^9&P+!W0'[P56X!&2!TJO=_#GR=,T3^P]4:RU;1Y))8;R2(2"4R\R
MB1<C(8^G3M5O5?!E[KOA_P"SZCK;_P!L)<1W<%];P[%MY4^YLCR?E&6SDDG<
M>>@ !3E\5Z[H,.NW6K6$D^FVELL]G=/$(6D<D+Y3C)_B(^8 <9JPFN>(;#6X
M&O;9[C16MI9+RX-KY!M'1=P(^8[E;!&.2#CFIQX4U'6-"O\ 3_%>KI?F[MS;
MC[+!Y"1J>=P&3E\@')X&. .<IHOAG7HH!9^(O$*:K911M%'&EMY32@J5S*VX
M[OE)X&.>3DB@#D_%NH:MKOPVT[799X(K6]O;.868BR4B:="GSYR7^[GMR0 .
MM=C_ &UJA^)$_A_?:BS_ +(^VPMY1W*YEV?,=WS#@GC'6L%OAWKG_"*)X77Q
M#;'3+:>*2TDDLBTRHD@=48AP"!C' &>.E=$/#E^/'!\2&_MC_P 2W[!Y'V=A
M_'OW[M_KVQT[T <A#XT\5?\ "$6GBJ>73?)CU#[/<6J6[9F0W)AR&+?(1Q@8
M/3)/.!U%UKFH7?B_4M!LYHK+[%IZ722RQ[_.=RP'!/W%V\XY)/48YR_^%>W_
M /PK\^%O[8MO^/O[3]I^R-_SW\[&W?\ WN,YZ5E>(9AJ?C>^B/B#0;.>QMHK
M=K;6;-7#%@7=XMSJ=AW*"><E<=AD [+P+K6H>(_"%CK.I)!'->+YBQPQ,@1>
M@'S,V>A.>.".*JP:SJGB'4=>M]&N;>U72IOLL9FA\SSIP@9MW(P@W!>.>"<]
MJT/"5Y?WNCL;]K&4Q2F.&XL4989XPJX= 2<#)*\$@[<C@U3B\,7VE>(M4U/1
M+ZWBBU4K)<6]S"7"3 8\Q"&'4=5/4CJ* .=B\?:SK&G^$;O38K.V.L7,MI=1
M3QLYBD17W$$,,J"A.,9/'(KOM(CU*+2X$U>>WN+Y0?-EMXRB-R<84DXXQ^-<
ML? +6L/AF#3+^.&'1)VN#YT!=KAV#!R2& &=['IU-=M0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!6N=/LKQ
MU>ZL[>=E^Z98E8CZ9%60,# HHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO<6%G=LC7
M-I!,R?=,L88K],]*L44 '08%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
,0 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>exhibit107-formofindemni004.jpg
<TEXT>
begin 644 exhibit107-formofindemni004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7EWC:C,HP%)Z@X!%)>^--'LM5NM+8W<M_;1"9[>"SED<J3@%0%^8<'D<#UH
MZ&BJ6D:M9:[I-MJFG3":TN4WQO@C(Z'(/((((Q[52U7Q3INCBY:Y-P\=HH:Z
M>"!I%MU(SER!QQSCD@<XQ0!M45AW?BW2;5PB2R73FT^W%;6,R8M^TG'8]NYP
M< U.?$6F'3K&]BN#/%J !M%A0L\^5W#:O7IR<]!UQ0!JT5YQXY\36VH^![F_
MTG4;FVEL=2@MK@*[0O$WG(KHXXXPWT.:ZW3/%.F:MJ]QI=NUPEY!&)C'/;O%
MOC)P'3<!N7/&10!M454U'4[32K=9[N78KR+%&JJ6:1V. JJ.23Z"J=GXET^]
MGO;9//2\LE#SVCPL)0IZ$+CY@>Q7/IUH UZ*\Z\(S/XR']K3WNKVMY;:G.Z^
M69(X6A20H(2I&PC:!D8W9R<@UV$OB+3X?$*:$[3?VA) UPB>0^UD7J0V-IP2
M!C.>: -6BL&U\8:1>:/>ZK ]PUK9RM#.3;2!E=3AEVD;B0>.!7--KW]D_%#5
M1<3ZC/;-I$$\=G&DDS!S(X8I$,XX SQQWH ]#HKDM7\1>']2\-:7J+ZG>Q6%
M]=0FVGLQ(K.^\;48@?*">"&QW%:^I^(K#2I)HI?.FE@A^T31V\1D:*/GYFQT
M'!P.IP< X- &M17GFL^(;<>-_!NIVFI7$FEW]M=R&.%G9)L1J4Q&/O-ECQC.
M:Z_0O$%AXBLY;FP:7$,S6\T<T31R12+C*LK $'D?G0!J45G7^M6NGW"6K":>
MZ>,RK;V\9D?8."Q Z#)QSU/ R:HP^,]$N['3;NRN6NUU/?\ 8XX8R7EV E^#
MC&W!SG&.G6@#?HK$M_%>DW>E1:A;S221RSFU2,1,)#,"08]IY# J<YZ $].:
MEC\1:>UG/<N9HE@G%L\<L+!_-.W"A<98G<,8SG/% &M16##XPT>3^T5EFEMI
MM."M=03Q,LB!OND+CY@>@VYR>.M7K#5X+^[N+18KB&XMT1Y(YXBF%?=M(/0_
M<;H3TH T**YG7?%R:-XGT71OL=S*=0,K/)' S@*B$X7');.WIT&<]JYS3_$\
M/A_Q=XV74KK4;FVM9K9XXU22Y,,9@#N< '8@))SP* /2:*S)=>L$M;.>*1[G
M[;'YMLENA=I4P#N ';!')P.1W(IVBZY8>(+$W>G3&2-)&AD5D*/'(IPR,IY5
MAZ&@#1HKA?$FN^9XZTKP]*FH"QDMKB:X%M'*K2L-@3#)@E1N;.#C.,]*O0Z]
MI7A+25M+W4M0O+:RD\B?4;A&E$;,W"R2 8XW!<]N,G- '645CZIXET_2A.9?
MM$PMXA-<?9H6E\F,Y^9MHXX!..N!G&*&\3Z8R0/:O)>":W%VOV6,R'R3T? [
M'L.IP< X- &Q14%G=PW]C;WENQ:&XC66,D8)5AD<=N#6,?&FBBYCC\Z4Q27G
MV!+D1,8C<9QY>[UR,9Z9XS0 :IX=GU'Q7HVMK?QQ#2Q,$@,!;S/-4*V6W#'
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MS+,Q9K=,MGG)4<YH N45Y=X9\<:?X>M-<CUN^U"9(=<NH?/>.6X6",.%3S'
M(4=ADUWUYKUE:;%3SKJ22+SUCM(S*QC_ +W';T]>V: -.BJ6D:O8Z[I<&I:;
M<+<6DXS'(H(SS@@@\@@@@@],5=H **** "BBB@ HHHH **** "BBB@ HHHH
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MMFD "N8\;B.,$@=#[U[310!PGA*=KCXB^+[M;2]CMKM+)H)IK62-9-D1#8+
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M9QZUDJDQ\-?$V+[%>^9>W%TUJAM),SAH%12@V_-E@1Q7JU% 'EEC<7.@>*M
MUN]LKYM*N?#T6G&2.UD=K6=6#$.@&Y0>F<=1[5EO::I=:+XCN;/2+^5[?Q2-
M46U>!XFNH $!"9 R>"<=<CIFO9Z* /.%N-(U?1M9U/2O#U_#,=*FMFN;FTD6
M9BP^6% <LW.2<< XZYXHS+,/"?PSB^Q7IELKJS:Y06DA: ) R,7&WY<,0.:]
M5HH \UNS(OC#QS+]DO#%/I$,4+K:R%9759 54A<,<LO3UJD4G7PI\,X?L5[Y
MME=6AND%I)F ) R,7&WY0&('->KT4 >?6,,\WC7X@!;6Y"WEK;);R/ ZI*RP
MNK!6(P<$@=:YU!?1^!?!6H+HNIW,6A%8M1LO(>.;!A,;,BG!;83GC@YZ]<>Q
MT4 >6:S91:UX9OM6\,>';E9$N+2Y<3Q/#-?B&0,4 ;YB !P>YX'2M_PM=:-K
M6J+J6F^'[VUFC@,<MW?V[Q.F2#Y2[^6YR3C@8]Z[2B@#C?'&GV6HWNE)/<:C
MIUW&LTEIJUD&/V9QL!5\ C:X/1L [,5S<LVMW-GX(DUBTGDO+?67EGE@LW :
M("55F=0/DW94X./O=J]6HH \PNYK^U\0?$:[LM'EOI);.U^RPSVKF*Y*1LKJ
M,C#XSR!UZ4W2IF?XBZ%J:6VM3V\NDS0/<W-I)&!)OC.-I $8 !Z  ]MQKU&B
M@#R)(KEOA7XYM18WWVFYO[YH(3:2!Y1(Y*%5VY(/J*]/T9Q)HEBP5U_<("KH
M58$* 00>15ZB@#RZP\RT\/\ C71+C3KM]0OM1OFMK8VSXG2;A&#8V[3GDYP.
M^*JBQE\$:YIIUK3[[4=,DT6UL3=64<DI@GAW @JG.UMQ(/K^->MT4 9'AFVM
M;718Q9:5_9=L[M)';%=K $]67LQZXZC//.:UZ** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"AP(U&#T !QQN- &O:>,[/7O!6M:AJUKJ%C81M<0R-#&V](U8IP4R0P ))'
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M3FY>")I3&'A9%)506(R1R!Q3M'TIK_QMKGB"2V>.PNK.&RC2>,H;C;N+N48
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M=\&WFJO<W\]Q9W,5H)H;F.5RX#N>$()P=W J6>'_ (1SQGJHUCPM<ZGINJ)
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MPSL#@B,;?O8^F: /0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9M5L&F"N0DJNA=L(K'<I.,9&>.E=E9>--+NCJZSQW=@^DQB:Z2\AV,L14L)
M 3E2%/OQTH Z*BN?L?%]G>W\-C]CO8+BYLS>VJRHG[^(8R5(8X/(X;!YJ#P5
MXGN/%.FSWD^GS6H6YFC3?M(VI(5 R"?F&.>V>A- '3T5P/CXS1^*/!J0WE[
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M;?4A8RW/V5[EK4B.!]_EC>2>,MZ9QD9QF@#LJ*YJ2_TG_A8/V41WS:S%I;R
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M _>''0]*]'HH \NTN&^D\<^&=5&CZV8S83P7-Q>1X99&\L_,I.(U&&X  /\
M"#6[\.(+W3M)O=+O=/NK:6"_N7\R5,)('E9E*'/S @]17:44 <'X[ANKCQ-X
M0DM[&\N([+43/<O#;NZQIL*Y) ]3T'-.TU9X/B#XNOI;*]6UN;6U6"7[+)B4
MQJX8+QSC</KVKNJ* /&]%T[6M#TGP#J[Z1?S)I$-Q::A9I QGB\W $BIU8#
MSC/%7;O1]5\1WWQ!BMM-O;5=6L[064UU%Y2R-'&<J<\C)('3C)SBO5Z* ."\
M,WL.I7-K++X#ETF^M%9KFXN+!$6([2"(6'S.2?0=,Y[ \TVFZD?@A<:0-*U#
M^T6OF<6WV5]Y4WGFYZ=-G/Z=:]BHH XF_$TGQ2T;44L[UK*+3+B.286LFU6=
MD90>.N%-<F^FZDWP7O-*&E:A_:#ZD9%M_LK[BIO!+GITV<_IUKV*B@#BFCGD
M^+UKJ"V=W]B_L1[<W!MW""1IE<*21P=H/TZ=:Y=-#UR7P'J>DPZ/.=0L-9>_
MCBN%"PW:BY\T(I)^8,OX9X->NT4 >;26,?C'P]JMOIOA"30KJ?3Y;<W%]9I!
M)O8<1J1R5SG+=.G7/%CPK<+J4UC%<> GTS4[3'VFZN+*-(HV P3$XY<L>F.@
M))/'/H-% &=KX5O#VHJ]@VH(;=PUHHR9P0<H/<]*Y+P;I=]H_B.6UTZYU.7P
MP;/<D.IQ.KVLVX8CC9P&*[<\<@8'/-=]10!P_C2/5--\3^'_ !-8Z=<ZE:V*
MSV]Y;6J[Y@DH7#HO\6"@R*J^*8M8\0:/IFLV.D7,)TS5H+]+"90EQ<1H"'RN
M<!L-PIY^7U( ]"HH XPV<GB#X@Z-KL%O=06>F6<Z.]S;O"TKR[0$"N Q  8D
MXQDCWQQ%O::Q#\-=&\._\(]JK7VEZI"UQ_H^$*K<%]R,>'!'.1P.Y'&?:J*
M.'TP7$'Q(\37\UC>QVL]E:I%(;9R'9 ^\ @')&X=.O;-<UHV@QW'@#POI.MZ
M7K5I=6J3E;RSAE6>QF#?*1M!.&#'G!''Y>NT4 >275CXFAT[PYK>K:7)KW]F
M7%W#<6WV=?/GMI"!'-Y1_C 125Z\\X.<:'B*U.J?#;Q%_9'A6;3GOX5CAMQ9
MB.YG8'[SHF<#L-W/!]17I=% %>Q?S+"W?:ZYC7Y9$*L..X/(KS?2-+N[#Q!I
MM_X>AU73X;JY9M7TBZ@?[+&I5BTD988#;L8"'G<.  17J%% 'D4^GZC+\./'
M=BNEW_VJ_P!4NY;6$VKAI4D8%&''0@'Z=\5L:E-JMYK,ME-I&IR:=+I*"T-M
M$8Q)-AMRSL2"N.,*Q"G)X)Q7HM% 'DMO::E_PA?P[MI-'U&.;3=0MWND-LQ:
M-$C=6<@9P,L.#R>N,5T]C#<#XMZI>-:72VDNEP0)<- PC9U=V8;L8Z,*[.B@
M#B_'EMJEO?\ A[Q%IEC-J']D74C7%G ,R/%)&49D'\3#/ ]ZH^*8]8\7^$I;
MG3-(N;62UNK>[M[:\41371B?<P*Y^48P!G!)'I@UZ%10!PVH6DOB[Q3X:O[:
MVOK2#3!<33RW-N\#JTD>Q8U# $G)))&1A>O(K LM,U2/X3W?@2YTNZ.K)')9
M1.(&-O*K.2LPEQL"@')!.[@\9Q7K%% 'G$<D>A_%RUMI%N9TB\+QP^9# \K?
M+.1DJH)YQUQ61=^%]6M=.EU^#1S>,?$<NK-I+J-\ENZ&(_*>/,P=^.O..HQ7
MH8\-QCQB?$GVZY^T&T^Q^1A/+\O?O_NYSGOFMN@#S/6(TUCP+XBDTGP?<Z;)
M=V36\:26 BN;B0C@;%R0H]6[GVYU=>O-5A\/>'6LM/OGMVFB2_$%N3<PQA"#
MM4C(.[ ) R 3CUKMZ* /(7T359]%^(VGV^B:A$;\"6T\_!\W]R@P&+$LQ(/<
M^YS5_6A?+J'A[Q,WA>]U+3XK-[*[L&M@]Q$&*,)%B/4Y4@C@X^M>GT4 8GAE
M(3937-OH2Z-#/)O6!H%BE?@?/(J]"3G@\X SUP,>WBN!\8+R\-G="T?1XK9;
M@P-Y9D65V*[L8Z,.>E=G10!Y586TFB:KK&C:OX(FUC[5?S7-E?16D<L4J2N7
M"RNWW"I)!SV_#,GB.'6;QO%&CSZ+?/$=+$6EKI\>RWD8PD,78$9(<X",>@&
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M49DQM4 GG)&,?2M+1]&O_!7BRUFGAN;W3)M%MM/:XMH7F:&: 8&44%MK DY
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&1R"5)'Y&O*O GC>W\-_#G0!J&F:D-/):*74Q&#!$S2L!NRV[&2,L!C)QG-
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M+[@2X!&T=/O'/ X. #KLT5QVJZ_H&H1>$KVXL+F[BU&\ADTZ91A8960E2_S
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M-97<EAI]XEE=W2A<1R,5'"DAF4%UR0._&<5<U#Q1%9W.HP6]C<WTFFPK-=+
M4W*&!( #,"QP"?Y9/% &_16#J'BB*SN=0M[>QN;Z33H%GND@*;E5@2  S L<
M*3_B>*D3Q) _B>?0/LER+R*R%ZK'9LDC+%1@[LYR#U H VJ*X]OB+IJ^'[/6
M?L&H_9[J^^P!?+0M')YAC^8!CQD'IDU*OC?=K%UHY\/ZJNIQ0K<0VQ$69XB2
MN\-OVJ 1SN(/3OQ0!U=%<W8>--.U#P_;:K'#<(UQ<-:):.%$OGJ6#1]=N1M8
MYSC )S4^B^*+;6-5U'2FMYK74=/V&:"4JV4<95U9200?S!ZB@#=HS7*:UXFO
M[#QQHNAV^FRS07<4TSR(\>7V ?* S# !8$G@],9YKE](UQ/"VK>.[A-*O[V"
MWU$33?9MI\J,0H68EV&>YP,GVH ]3HK%F\2VNVS6RB>]GO+?[5#%&RI^ZX^9
MBQ  .X =SZ<'#_#?B.R\4:6;ZR66/RY7@FAE #Q2H<,C8)&1[$]: ->BBB@
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M5M+*B>R=U!PPRKJV<%2,G/!X(P#5+Q/I.HIXOT'Q-IUNUXMBLUM=VJ,H=HI
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M3I/%44=O8!K5X[Z]1Y$M)Y%C,:H0&+L3@8)4<9Y(QGDCD8?"[WGA#PYHVO\
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M]FDF2Z7S5^?87$74IN[YSCG&* .@USPSIVOR6TUU]HBNK4L;>YM9WAEBW8W
M,I'!P,@Y%3:7HEKI6YXY+JXG8;6GN[AYI"/0%B<#V&!5J^O;?3M/N+Z[E$5M
M;QM++(>BJHR3^0K$MO$UU)J6EV]QHEU#;:G&[P7"GS/*VKNQ, ,1DCIR>>*
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MY! Z'G/%;DEKXH\/>,-3O].T*/5]-UCRIGC%TD3VDRH$.2WWE(4=/3\_0**
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MA6P1CJ./PK:\46'BCQ3X!U.SETJ&UO;SRD@LEND?R@KAF9Y.!DXQ@9Q@>IP
M:$WC#4+;Q+'HDWAZ437=N\]BPND/F[" PDX_=X# ]6X]3Q5.?XC-:^#]8UN?
M1)1<Z1=M:7=HMPI"N"O(? RN'4],\]*N:AIVIW?Q T#6(]/D%G:6MQ%,S21[
ME:79CC=SC;S^F:YK4?"OB"[\*>-=-CTPBXUG4S=6NZ>/&P^7]X[N#^[/KU%
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M(SCD'\?0]$GUB[@>YUBSBL'? CLTF$QC ZEG  ).>@X  ]Z ..\;65I-\4?
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MO(/2M.;QA/9.(=3TI-.GN+@Q60NKV,),@3<9&89V =",$Y(QG-<O?Z=J.K^
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M$*.PAU"YLK:UO(=/G,$T7VP)<2%2 _EQ[3NVG(Y(R5/L2 =N2 "2< =35/\
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M$NM.\5:+XPO=;T*PM=0L]7CB^U6=S<^2\$J+M#!@&!&W&1STJS>:/K=QXO\
M"VJ3113IIT=T+N1'"C=,J@!%/)5<8YP<8ZFNRILDB0QM)*ZHBC+,QP /4F@#
MS>\\':UJ'A[QSIY@BAEUJZ-S:%Y01C:@"OCH?D]QSUKO]->\DL(GO[>.WN2/
MFACD\P)[;L#/Y?GUJ2SO+74+5+JSN(KBWDSLEB<,K8.#@C@\@U/0!Y_IOAO7
M-"T37/#=K;17-G>23O87;3!1"LV<K*IY^4DG*YW>U2WOA6^LI/!=KI=M]HL]
M!<&:1Y%1G7RC'\H/5N<\X'O7=T4 9^MP7]YX?O[?3)Q:ZA+;.EO*W_+.0J=I
M.,]#7#:=X<\10ZYX6U)M(L+9-/MYX;M$NR[NTBH#(3M^9B5/4YYY//'I-% '
ME\_A#7YOAKX@T 6<0OM0OY;B$F==@1YA)R>H( QTZX_#<\>V$VI:-IMS93"R
MUVUO86L6.&*R.=C*<=5*%B?9<]JZ^XN;>TB\VYGCACSC?(X4?F:Q;/2_"]SX
MEEUVS2QGUAXPCW$<H=PH&WID@<<9 SCB@#6T^QATS3K:QMP1#;Q+$F3DX QS
MZFN6N-'U5_BK:^($LU.G1::UBS>:N\LTF[<%_N\#OGVKLJ* .8^(6CW_ (@\
M$ZAI&FQ))=7015\QPBKAU8DGZ#L*@\3Z'J6IWOA_7].B1=2TB=Y/LLT@ ECD
M79(FX9 ;'0]*ZZB@#@]7\$S>++S6K_4%^P/>:2-+MHRP=HQO,A=]IQ][;P">
M%Z\X%W0$\7WEI%I_B.SL;:&"(Q3W-O<F1KSY2N57:-@[DDYXQCFNOHH X'PI
MI_C70[2V\-W,&GR:=9D1Q:LLYWM I^5?*V_?V_+G.!UYQRECIGC#PUK6J6FE
M6FGW^D:A>27D,]Q<&-K-Y#N<,H!WKNR0!CZCMVTNHV4%[!937<$=U<9\F!I
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M &9"O_+&%SYC*/3+L1]$6NNJM/J-E:W4%K/=P17%P2L,3R /(0,G:.IX!Z4
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M2H"C([9ST'?9\-OXW$=O9:[96$4=HN)+RWN/,:\VC "H5&S/!))^@&<CL**
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M^.+S39K22\TN.WMKG51IT<,TI2X92^P3A2,%2><>A!SVIDOAW6I+SP3,+>U
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MCNY(]/B ^6$OM>X"GN/, 'L5(H WO&*AO!&O*P!!TZXX/_7-J\K&G2:QX(\
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MT;5-/\6>)=1NX;=;75)HI8#',69=D83##:,9QG@FNJH **** "BBB@ HHHH
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M& 9 A'"X)V@G.2#T'- '6T5PW_"?7-]=^%UT;3H;BVU^WFEBDFN"C1M&F2K
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M3VS6-DEJB1KNRJLDC CL6)/)]AZ5RW@?Q'JGA_X>>$9#I]L^DW%PEE(YF/G
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M\)3>KAL<%AD 8/((K7L/$-SJD6AR6"6LRZA:-=R$LP")A<8.#R68#GT)[8H
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M2/!+8)P![$U<LO'DHT*_GU*SBCU&SU7^R3%!(S1RS$KM8'&0N'!/!. >#TH
M[>BN'_X3/58;K5[:32DN/LE@U];W:++#!*%^]$Q93M<=1UR/2M/PEK6N:]9V
MNHWVG6EKI]W8PW$+1SEY-[ $AEQ@#G(Y/&,\YP :>M:#I&OVT4&L6$%Y!#()
MD2=<A6 //Y$U-INI:=J4#MIEW;W,,+F%FMW#*K #*Y''&17+W.IZT?BW;:5%
M);?V>-(DN/+;<"<S1JS'U88P.W)]:Y?2]>U7PUHOC35;'3[6XM++Q#>37(FF
M*.R[DR$ !Y YR<?C0!Z7JFAZ=K1MSJ$!F^S2B:']XZ[)!T<8(^8=CU%: &
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M"YE:(I,.#)&X5NO=2.O>M2_TB[\1Z/?V&L>5;07=L]OY%M(9-NX??+%1DCC
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MRJ\C.*Z:BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+HNH6VDRW6G:E+&KP164_FVT3C*RF3&Q@!@L !C/!/6I5\.>(=2\6V.LZO\
MV5%#'I\UE<6]L\DFX.5)*DJO7;^'O3/#/AWQAH4-OH<VJZ=-H5HP6"X5'%X8
M@<K&1]P<?+NYX]^0 5Y?&7B66Q\4W%KIVEHV@W$BL)99&$J)&KD# 'S$$\G
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M;^?H2PR@V1;;.LJDHH#<ALC;^-1R>%O$4^G^$X9WTLRZ)<QS2;))%5U2,Q@
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M'9GBV1/'D@J <[\\'C'>KFDV'BC3=!T.P$NDF2U>*&[.)"#;HFT[#Q\Y(!Y
M SCMD@'44444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MLB(I.,LV!FG$@*6)  Y)- "T4Q)8Y(O-21&CZ[E8$?G1'+'*H:.174\Y4Y%
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MSC&"3TH Z>BFJZL@=6!4C(8'@BDCECF0/%(KH?XE.10 ^BBB@ HHHH ****
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MRA,9*\]#SS77>5XN\GRL:%LV[<?ONE8T?@V]AW^5HGA1/,8N^V&0;F/4GU-
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MVTU"XU"WLH8KRXQYTZKAY,=-Q[X[9HU+1M,UA85U*PMKL02>9$)XP^QO49H
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MMH\4X'F3&W#@?WFVY_G7C%]]@UC]GR;6;E89M5>99;FX<#S5N/M"A@3U& <
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D)
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MIR:E5@RAE(*D9!'>O++76;#4/%UA#=78L+"\T"WETM+R-&#!BWF+\_&_'EY
MZA:[/P5IECH_AJ+3],OYKZR@DD6*:4@\;CE5(&"H.0/I0!M2WMK!GSKF&/#!
M3OD P3T'/<T_SXO.$/FIYI&=FX9_*O+=)\+^'-6UKX@6^J6%J\$=X,;U&( T
M"DNO]PYR=PP>*I>&C=+=?"B?5,BZ>SO4,DO#,OECRP2>^W% 'KRW,#QO(L\;
M(GWF#@A?J:8;ZT"2N;J )$ 9&,@PF>1GTKR"]6PN_"GQ6"+;RQK=22IM 8!A
M F&'OG//K717GA:WAT+1;CP\UAI^M32P3HUQ&6COI$A<[)<<GY6=MW7(SUH
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M-<1+!C)D+@*/QZ5+'+'-&LD3J\;#*LIR"/8UP%U/;I\4/#FGND TEM/G:T1
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MGF2JNP'@$Y/ -/EO;6"U^U37,,=L0#YSR )@]#D\<T 2QQI%&L<:*B*,!5&
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MGEJPSDGG+>M5_"NN:QXHATO7+6_L/[/N [7=@RYDA4[O+VL.=W SNX/.,=*
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MI)+2-F8^Y(H R!:Z!9:#JN@WMP;RRB626[$[F5E69W8*6)+%NN/XNG<BN?\
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M-NVFW$<-O#)N,41BCV*[D_.3CT'(/!ZU=T]A_P (Q\4N1Q?WV?\ P&2N_M]
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M=:7I][<07%W8VT\]N=T,DL*NT1]5)&1^%0'P]HC1I&='T\HDAE53;)A7)R6
MQP3ZT >;:R)M%UWXA#P_"MO.-#MYDCME"X<"0%@!_$%_D*?K%SH4FC?#2ZL)
M;01+JELL3!ERJ&)]X]OF"Y]^O->F1:5IT%Z][%I]K'=N,-.D*AV'NV,FJT/A
MC0+>0R0Z'IL;F43%DM$!\P @/P/O<GGKR: *'Q!AAG^'?B(31I(JZ=.ZAU!
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M\L;/4;<P7UK!=0DY\N>,.N?7!XJ :)I(N(K@:79>="H6*3[.FY .@!QD#Z4
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M]FDV,\>M6B([8)4"=A@'Z#]* /4X_%FCR^*)O#Z7L!OH8E>1?, PS$@(/5L
MDCMQZU>&L:8VH_V>-1M#>\_Z,)E\SCK\N<UQ8N5MOBUX@C66*.[GT>V%LLC
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M@+C#9X&<< =NM<!]KMW^%?Q)A2\BG<:G>/E2!E6V88 = 3G'K78:ZZ?\)O\
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M+9.!@$\\U=) !). .]>3?:]'N]6\::#XJUYM->XNF)AF:%%FM6C41E&="3@
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M-/OYIX;.^MKB6W;;,D,JNT9]& /!^M>(L]A<_#/483-!</!XI^4_+E5:['(
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MZ9-:J'A6.,F*XX)VN@'RX)^5LD<<T ;<&E:=;7<EW!86L5S)G?-'"JNV>N6
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MT%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@D''/%>F"QM%O#>+:P"Z(P9A&-Y'INZTDFGV4MRMS)9V[W"'*RM$"P/L<9H
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M)YO%EG%YVBVTL5MX@2-_EG*GY7VC[QB)7=ZYV_PFO3H]/LHI!)':6Z..C+&
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MQ;0B;.?,"#=GZT >1VEYH5]9>(_#7BW69[2[.I3F:Q8HK7*M)NB:+Y"[Y&P
M*2>!VQ6UH.K6NF_$3Q19Z]<):S206ILS>R ;[98R" QX.'+;L=R:]!>RM9;I
M+J2VA>XC&$E:,%U'L>HI9K.UN9(I)[:&62([HV= Q0^H)Z4 <5\'IK>3X9:7
M'!)&WE-.C*I!V'SG(!';@BN[ID4,4$2Q0QI'&O"HB@ ?0"GT %%%% !1110
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M%#\+]>$LB(7MBJ[FQN)(X'O6)J5UIUQXG^&1:>VE39.PRRD?\>PP?^^L8]Z
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MKP:6!("-T^HGR'*[ <@(H)!V@GDG*XH ]&N_$&C6%PL%WJMG!,T9E"23J#L
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M@ HHHH **** "BBB@ I" P((!!X(-+5+4]8T[1H$FU*]@M8Y'$:&5P-[$X
M[GZ4 22V[Q:?-#IWDVTIC80DQY1'(X)48R,]JS?#^E:C9B6\UJ]AO-4G5$DD
M@B,<:HF=JJ"2>K,2>Y;L !35\9^&WDNXUUFT+VBAIEW\@$X!'][)XXSSQ5F'
MQ)HUQHJZQ#J-N^GN=JSAN"V=NWUW9XQUSQ0!J5&D$,<KRI%&LC_><* 6^I[U
M5L-9T_4TN&M+I'-LVR=6!1HFQG#*V"O'/(KD-8\5";QIX2M=*U9S;7MQ*L\"
MQ@)/&(F975BN6&0.5..E '=K%&K;E10?4"G5E7?B31[&[6VNK^**0R"++9VB
M0]$+8VACD8!.>16K0!'%;P01F.*&.-"<E44 '\*/(AQCRDQ_NBLZ#Q)H]S>Q
M6D-_$TTV[R>H6;;UV,>'QWVDU6N_&WAFR^T_:-;LU^S.$FQ)NV,><''Z^G>@
M#>    & .U1I!#'*\J11K(_WG"@%OJ>]<EXKU:\MM6\(R:=J++9W^HK#*D81
MDFC,;L#NQGL.AQ70V6N:9J-Y=VEG>1S7%H<7$:9+1'T;T/M0!<>"*1T>2)'>
M,Y1F4$J?;TI3%&6W&-2WJ1S4-CJ%KJ=J+FSF6: DJ'7."0<'\CQ50>)-':SO
M+L7\7D63E+I^?W# 9(?CY< Y.: - P0E"ABC*GJI48-.,49W913NQNXZ_6LF
MZ\6>'[+RQ<ZQ91&2#[0@:49,6 =^/3D8]<U+I_B+1M5TA]5L=3MIK!-V^X$@
M"ICKN)^[CWH T/)B( ,28'0;13@ H    Z 5G6GB#2KVXEMX;U//BC\UXY 8
MV$?]_# ';_M=*HCQQX78VX77+)OM$OE1%9,AFW;<9Z=00#T)Z4 ;GD0^?Y_E
M1^=C'F;1NQZ9I6BC9MS1H3ZD42RQP0O--(D<2#<SN<!1ZDGI6-9>,?#FI7$<
M%GK-G-+)"\ZA)!S&I(9L], @_P ^E &Y4?D1;0OE)@=!M'%4+'Q#I.HWS65K
M>H]TL8E\H@JS(>-Z@@;E_P!H9%)'XDT>74(K%+^(SS,RQ#D+*R_>5&^ZQ'<
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MI'2]O8XC&H>7@D1*>C.0,(#@\M@<5*^LZ='?6EDUY$+B\4M;)G_7 #<2IZ'
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M^E2>-9Y--\9>#]7NB5T:VFN([J4_<ADDCVQNWH,[AN/ W>]=U2$ @@C(/8T
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MN\9WB5R5^H!''O7>!%#%@H#'J0.M+0!Q7Q8R/AY>R8)6.XM9'(&=JK<1DGZ
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ME>R!5#%@H#'J<<FEH \PO;RP37?ABT=Q;JJK-@JZ@!3;%?P!;CZ\5CM<V#^
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M/]@1Q=?XQ.[%?K@@X]*/A-<1CP5%IS"1;NSN+A+B-HV7RV,\A )(QG!!Q[T
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M_P!@1*)=XVY$SL0#T^Z0?IS0!L:QKNC7OARSOH_$9L;2[FB-O=VS#=*=X^0
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MP<]0>G&:],H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]1@9'6MFTU?3;'0-*E-_/<Q7$,:VTLBM)/=?)D-M W,Q4;CQZDXH V:*Q/\
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M"TP<B24C[IDQMW^V<]*ZK5/%&D:-YWVVX=%@ ,[I!)(L(/0R,JD)Z\XXYZ4
M;%%-CD2:))8W5XW 964Y# ]"#3J "BBB@ HHHH **** "BBB@ HHHH ****
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MY-S,S#^\H4JN>G4#H:[>J6KVM[?:5<6VG:BVG7;@".Z6)93&<@YVMP>./QH
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MQU6QMA:W3G]U&\6X/$7/ )+%AG&?K7?44 >+7NGR:?X6:2>)TM[_ ,8+J%M
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M>!R!D?-A1DXS@=:ZS5R;WXI1K97"J\WARXMXKA3\JR/(I0;AQG W >E>B44
M>.LIU?X+0^#UMWB\11)#9&Q92)(Y4D7]Y_N8&_?TQWKIM'>-?B_K>Y]S-IEM
M$LA'#LK.7 /3(R"1_A7>44 ><:7JUGI7BCX@ZE<H\MNDMM,BQQES-LA5?D'\
M1W@#CH<=*3PI+%<7$VM:E=))XFUH>3'%%EA80X+)$#V QECW;\*](HH \?\
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M%R,#)/3(!NQ>+]%FOK*U6Y<&^++:2M"ZQ7!49(1R,'CD<\]LTM]XOT;39/\
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M*4GR_&.0 ,DCCGK70ZW:SZK\1M4ALC(AN_"LEG#<[&$8F:1BHW8QD @XZXH
MZM/&&BO-:)]I=8KR3R;:X>%UAF?G"K(1M).#CGYNV:GC\2:9-<ZI;1RRM/I8
M0W<?V>3<@8$J0-OS9 )^7->=W,<OB+X3Z9X4BM+BWUZ+[):O \3*ULT+INE)
MQ@+M0D-G!R ,DUJ_:CHWQ#\7+=6MXQU2TM6LO*MW<3;(W5AN V@@D9W$=<T
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M0QQ\N2".:YW11906%SX0\1Z!JEYJB7,HCB*S/;7JM(723<#L4<@DG&,9Z\4
M=[=^.] L[K4;5[BX>YTX*;F&&TED= P)!P%R5P,EAP,CGD5!JWCJQLI?#PM(
MY[N#69!Y4\,#NHCV%LC R6.!\O7J3TK*TV18/'WCJ:6.589;6S6*0Q-MD*1R
M!@IQ\V"0./6N<TU)[+PA\-;F>SO FG76R[5;:1GA)BD4;D +=2!T[B@#V)6#
MH& (!&>1@_D:6LZTUF"[U>ZTQ8+J.>VBCE=I(2J$/G #="1CD5HT <_XRO+^
MWT"2UT<@:O?YMK(DXVN5)+Y[;55F^H%)X*\1CQ+X.L-6D&V=H]ETF.4E3Y7&
M.W(/'H15%5/B/Q==2Q7M]9)I<?V> QQ!?,9\-(X\Q"".$4$=PW8UB>&-_A+X
MBZYH;&[GTO4=NH173P'9'<'B5&95"@M@-V'XT ;Y^(_A@0?:/MLQMQ<&VDF%
MK+LA?=M_>';A!N.,MC-:Z>(M-?Q&^@"67^TDA^T&(P2 >7G&X,1M(SQP>O%>
M5W4<TGP?\86B6MR;FXU6Y>&'[.^^0-.&4JN,D$<Y]JZ[QS'<6T.D>,-'A^T7
MNFR*C0@[3<V\I"-'SWR589Z$4 ==8ZG:ZD]TMLTC&VF,$NZ)D <=0"0,]>HR
M*N5GZ'I[:7H]O:RN))P"\\@_CE8EG;\6+'\:T* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHJCJNKV>BVL<][(5$LR01*JEFDD<X5% ZDF@"]16/9^)]+NXM2=IFM
MCIC;;U+E=A@^7=ENV-O.02*Y/5]=-W\1/!2VS:G;Q7+W+-%('CCN(Q Q4[>A
M(/8@,,CCI0!Z)16)IWBK3-5MM2GMC/MTV5H;H20LA1U&6&#C.!C\Z9-XNTV(
MQ(L=W+/):?;?L\<!\Q(,XWLIQCGMU/.!P: &Z7X<GT[Q7K&MM?)+_::PJ\ @
MV[/*4JN&W'L3GC\JZ"N=G\<:!;P:3.UW(T.K#-FZ02,LGREL9 X.!]WKGC%3
M:;XNTC4K;49UEEM1IK8O$O(F@>$;=P+!@" 5Y!H W**Q;3Q3IMWJ\>E'[1;W
MDT!N(([B%H_.C!P67/IW!P?:HCXQTA;NRA=YDBOY?)M+IX6$,\G95?IS@X)X
M;L30!OT5C+XFL'N(XT2Y>*2Y:T2X6(F(RJ2K+N[8*L,GC(QG-7=4U2ST73)]
M1U"<0VL"[I'()QS@<#DDD@ #J30!<HK$A\5:=)<7UM*MU;W5E"MQ-!) Q<1-
MG#J%SN'!Z9(QS5&S^(7A^^?2_)ENO)U-A';7#6KK"TASA-Y& QP>,_K0!U-%
M<WXCU^SBL-5LT:\>:VMB]P]DK$VV5)4EEY!XS@9..<8I/A[<377P\T"XN)9)
MII+*-GDD8LS$CDDGDF@#I:*P5\7Z2VGZM>[KCRM)D:.]'D-NB*J&;C'( (.1
MFF7/C;1+6XTZWDFN#+J-N;BU5+61C*@4-\N%Y."/E&3STH Z&BL*P\7Z-?Z)
M=ZLMP\%M9R/%="XB:-X77&592,[N1QWR*YN;6)+KXMZ#;QG4K>.2PN9);:XW
MI&^-FQ@N=N?O>X[XH ]!HK F\8Z1;W%JDKS)!=7'V:&[,+>0\N2 H?W((!Z'
ML:KS>/\ 0HM2N-/!OI;FWN([>9(K&5C&S_=)^7A>G/0Y&,T =/17':+\0+*_
MT;5-6U"&>PM+*ZDB+2PMP%<(!QG+EOX1SR!6B^NV>K1:MI:-=VE_;6WF21.#
M%(JL#M=6!Z9!Y!XQSB@#H**X?P/XA2+P-X6CO9+JZO[ZTW JK2NV/O,Q[#D?
M,>.>O-:5MJNCIXIUUDN]1>\M+>$WD#)*T<:_-M,:8Y)YR5!SQ0!TU%<K9_$/
MP_?-IA@ENC!J;B*VN&M9!"TASA"Y& QP>/Y5HZAXFT[3[B[@;SII+*$7%V((
MR_D1G.&;'J 3@9.!G% &S16'!XLTN\M;.>R:XN1>AFMD2W=6E50"6 <+\H##
MYNAR,9S6EIVH0:I8I>6WF")RR@2(48%6*D%3R#D'K0!:HKE](\7IJGBC6]*-
MG<01::T:>;)$0"2A<LQZ*,;<9Z]>]68_&.D236*L\\<&H/Y=G<R0LL5PQY 5
MCW(Z9QN[9H WZ*JZEJ-MI.G7%_>,ZVUNADD9(V<JHY)PH)_2L6P\=:'J,330
MR70A$$4ZR/:R*L@D.%5#CYVR0N!DYXZYH Z2BN=;QOHT/]I+=M<VLVFPB>Y@
MEMW\Q8C_ ,M %!W+P>1G'?%06?Q"\/7NJ6.GQSW"27Z!K266V=(ICC.U7(VE
MAZ ]>.O% '4T5STWC71H)V5Y)C EX+"2Z6(F)+@D#86^I SC /!-6[7Q'87G
MB"[T.+SQ?VB"25'A95"GHP8C!!]J -:BJ6F:I;ZM;R3VPE$<<SPDR1E<LC%6
MQGJ 01GIQ6#?_$3P_I\^H0.U[+/I[*+J*&RE=HP1NW$;?N@8.[IR.>: .KHK
M#B\7:-//H\4-RTHUA6:QD2-BDNU2Q&<<$ '@XJ.;QIHUM!K$TTEPBZ.0+T?9
MG)CRNX' !R,<Y'% '045S=KXXT>]++!]K9MT2Q VSKYYD4LHC) #<*Q)!P,$
MYQS4L_C#2[2U%S="Z@C^UK9-OMVRDS;< CT.X8/3WH WZ*R_^$@T]==FT:21
MX[R&U^V,'0A?)W;=P;IUJG8^,M(U"[L+>)KA?[1C>6QDDA94N5498H?IS@X)
M'(H Z"BN1E^)/AR*VNKDR7K06=RUM=2+92XMV& 3)\ORC)QSCH<=*GO/%ZVW
MCBR\/)9W,BS6CW+3I$64X9 H7'4?,23T''O@ Z>BL+QCXB_X17PI?ZP+:2X:
MWC)2-%S\W8MZ+GJ?ZU*?$5I';6;2QW N;O(AMO)(ED*C+$*>@ [G Y'/(H V
M*R->TF_U5+9+'7+K2A'(6E-O&C&5",;<L#CV(J71]=L-<CG:SD;S+:4PW$,B
M%)(7'\+*>1]>A[9K+U7Q:-.\8Z7H LKF3[5%+,\R0EAA0  N.O+ D]!^/ !T
M%G:0V%E!:6R;(((UCC7T4# %35YGHOBNV\.ZCXQ.J7.I7-O:ZIP0DMR;>+RD
M))(SL0$GK[XZ&NHU?4M'?6?#J3WMZD]S,9+$6Y<13GRSPY VD;><$^E '245
MC2^)K".Y:()<R(MTEF\\<1:-9F8*%)'NP!/0'C.>*L>()[^U\.:E<:7%YVH1
MVLCVT>,[I I*C'?G'% &C17FGAB^LO%6D6%SH7B34O[7MYH'U&VN+QR[ .OF
MJ\3'"@C=R@ [=.*[35/$ECI)N!*ES.;:,37 MH3)Y*<_,V/H3CK@9Q0!KT5D
M'Q-ICP6<EI*UZU["9[:.U7>TD8QE\=AR.3CD@=>*PM1^(NGI8Z'=Z7%<7D.J
M7RVH=(6_=$$[U8==_P K +^/3J =I17.0ZAI=QX[$"W.H+JHTSS#:N)$A$)D
M'S[2-I?<<9&3P1VI\WC/1H%2:265;%Y_LPOO*/V?S-VW&_TW<;ONYXS0!T%%
M<]>^--(LM7N=)87DVH6\(F:W@LY'=E)P"H"_-T/(X'<UIZ-K%EK^D6VJ:=-Y
MMI<+NC?:0>N""#R""""/:@"]17GNL>((++QQ?Z;XBNK^TM9;:-M(-M+)&LYP
M?,4;"-TNX@!3GC&!SSUOAHZJ?#.G'7,?VIY"_:<8^_CG..,^N.,YQ0!JT5C2
M>)K".Y:()<R(MTMFT\<1:-9F8*%)'NP!/0'C.>*X^P\30^'O&/CA=0GU*ZMK
M66U>.-%DN3"A@#N<#.U 23V% 'I-%8TWB?3$&G"&1[J348C/:16Z;FEC"ABX
MS@ 8(ZXZ@=:Y;QSKL.J_#9=;T6_N8T-W JO$[PM_Q\+&Z,.#_>!!H ]"HKB]
M0EGB^+NB0I=7 MY]-N6>#S6\LLK( VW.,\GFCXJS36G@&[O+>[N+66&: B2&
M9H^#,BL#@C(P3P: .THKGM,\::-JNN/HT,ES%?",RQQW-L\/GH.K1E@-P^G\
MJ=)XQTB*YM(Y'F2"\G^SVUVT+>1++SA0_O@X/0XX)H WZ*H:SJ]IH.E3ZG?&
M1;6W7?*\:%RJ]S@<XJ"7Q'IT.IZ;I\CRB?4HWDM?W3%9 J[VYQP0.<&@#6HK
MD9?B3X<BMKFY,EZT%I<M;74BV4N+=@0"9/E^09..<=#Z5LWWB"SL9Y(2L\\D
M4 N9EMXC(8XCD!B!USM; &2<'B@#5HK*N/$%G!'"8X[BYEE@^T+!;Q%Y/+_O
M$=OQZG.,XJ&W\6Z/>:78ZA9W)N8K\E;5(D)DE89W +U!&#G.,8YQ0!MT5S0\
M=Z%]A-VTTZQI>_V?,# VZ&XW!=CC'')'/3GK6@_B+3X]<FT=S.+V&U^V&,0.
MVZ+=MW+@'=SQ@<^U &K6!%X<GC\;S>)#?(1+9K9FV\C&$5BX.[=UR3VQCM57
M3?B%X>U9%EM9[C[,UO)<?:9+9TB"(V&RY& >^.O(J_:>*-/NM9&DL+BVOFA\
M^**YA:,RQ@X++GKCN.H[B@#:K.URPO=2TUK?3]5FTNX+JPN8HUD( .2,,,8-
M</XY\30W>GZ)-ID^H1Q2ZS:Q1W4.](;A?- 9<C[RD XR,''!->B75U!96DUW
M<RK%;P(TDDC'A5 R2?H!0!!I>G1Z5I\=I$\DFTLSRR$%Y'8EF=L<9))/''/%
M7*PK'Q;IE_>Q6BBYBFGM3>6ZRP,//A&,LGKU'R\-STK/7XD^''MH[I9KLVCW
M'V9[C['((X7W[ )&*_)EN.<'D4 =;165J.M6EM<G3]MS/=-"96AM4+.D?3<2
M.G.<<Y)!QG!K ^%5Y+J'@.WN9KJ>Y9[JYQ+<.S.RB=PN2W/3'6@#M**YQ-1T
MK_A.+R);K4#J4&GAI;;;(81%O.'5,89B<C*YZ8JM;_$?PY=06-Q#-=-:WL_V
M>.Y-I((EDW% KL1A22. >>1G&: .LHKF;;Q:+GQU>^'197*K:V\;F8PG#,Y;
MG/9<+U/4Y_&=O&.D)=644CS)#?3>1:W30L(9I.<*K^^#@]#C@F@#?HKF5\>Z
M')JCZ=$U[)<QW:6<JK92_NY&'&[Y?E7GJ>#VS@U/)XQTB&YM(Y7F2"\G^S6]
MVT+>1)+R H?WP<'H<<$T ;]84_AZYN_$7]H76LW,NGH4DBTSRT$2R)T8MC<>
M?FQGK@]A4A\36 N/+5+EX_M7V/STB)C$V[:5)[8/!/3/&<\52T#Q:-<\0ZUI
MHLKF%-/F6!7DA(W'8&))Z#.1@'G'/>@#IJ*** "BBB@ HHHH **** "BBB@
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M%Y6T(8TV+M.?0<YSSZ4 >?6.B7WA'1OA_<7UG<F+3KNZ>[2WA:9K<3K)M!5
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MZYYSGH*UZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?1!=K%L3]W+YVS(.W/0="37*MXG\1MX"L]0CU8B]_M_["TCP1GS(OM)C (
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS%(QP$(QD'.!CW'K2ZAXN\/Z7<R6U]JMO!<1P?:'B8_.J9 R5ZYRP '4YZ4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA/A_')9ZKXW
MMIU)N!KLMQM[F.2-&3]*[NL]]*1=9&J6[^5</&(;@8RLR DKG_:4DX/^T1SQ
M@ \>77+*\TSP==QEK1+?7T\W3+>V81V'^M^5OEW%R3W/.3A17;^*(GNOBAX%
M6 '= +ZXE(_AC\I5Y^K,HKNJS[;2TBU2XU.9O-O)D$0?&!'$"2$4=N3DGN?8
M   T**** "BBB@!KND2,\C*B*,LS'  ]Z\/M;NV?X/>/8A-&9)=2O6C3=\SA
MV&T@=2#V]:]RHH \YO[JR/CWX>F&>#8MK=KE&& &B0*..F2"![BM+XG17I\-
MV5W:PR3PV.IVUY=PQJ6:2"-]S  =<<-C_9KM** .!O);77OB-X8U?1KN&XMK
M"UNWOKF%PR")T41HS#C.[+ 'D;2:PM"@FU'X1>*;;1MKZB]S?E%CQO.YVQCO
MEDX![\5ZWC%% 'D&I>)]%U;2? /V&4&2UU>U6>W6,E[8K$ZE74#*D'MWQD9
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MV4MD^G6J=PUOJ'Q%EU_3[J%]-M]"D@N[N.0&)V9\HFX<$@9/MD>HKT.C&.E
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MY XSS,^KQ:;\3]*U/6$.G)?>'!"B."<3^<',(P.6 /3J:])HH \7TO6K;3_
ML,L]HI4>)Y0US<P,4L<S.PF(XY'0<X!89]"EQ>VPB^*L7VJ><W-C$T,L\14S
M9M=H(^4#EN!@#/&,U[310!Y?/=6:ZQ\+VCFA"QQR@E6&%!M2HSZ9; ^O%:OP
M_N8H=8\7:;)N6\_MRXN/+*'_ %;+'M;.,8/;UQ7=T4 <+XSN8M/\>>";^Y+)
M:Q2WD;RA"P#/#A5X'4G@#O5+P]J-IHNJ^,M,\2RI!+=:A)>1?:./M5M(BJH3
M/W\!=I49(X%>CT8H Y7X;:9?Z/\ #O1;'4PZW<4'S(_WD!8LJGW"D#'M7544
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5@^+O$\'A31A?2P33,\J0QK'$SC<S!06(' Y_'H.36]
M7&?%-)&\#RR)')((;RUF<(I8A%G0L<#G@ F@"IJ/B(V/Q(TQY=1NX]*N-*GE
M-K)&RC>KH!B/:'+<G@@GTK4U;Q+H&H^"+G5%\02V&FR QF_M\I+$P;! !4D-
MD8QC-9-Q?VMW\6M"NT?]S_9-PH=U*X+.A4'/0D D9ZBN4O9$D^%GQ!@3YI)M
M9NFAC ^:0/(I4J.I!P2"/0^E 'K-WK=AIS+%/-*TGE>:1'"\K!!QN8(IP/<X
MZ'TJ[;7,5Y:PW4#[X9D62-L8W*1D'\C7GGBGR)M9BU'2?$)T?6H=-1XII,-;
M7D19R(F4\$@@]/F&_H:[/P[=7%QX7TVZO[-;"X>UC>6V VB$[1E<'H!Z'I0!
MA_$77M6T;0L:#&)=2 :Z*GM!#AY3^/RI_P #KI=*U.VUG2+34[1MUO=0K-&?
M9AGGWKF-+C_X2C5M4UBWU>YMXP_V&*.%(CF),Y8B1&(W.7/& 5"UB_#R6+2O
M[?\  MQ-++!83R?89L?ZVWD&XJI P64DYQZ].* .ND\:^'H1 TNHJD5PS+!,
MT3B.4KU"/C:WX$YIESX[\,VE[-9S:M&+B&:.&1%1VVO)P@.!W]>@R,XR*\ST
M'7/#USH_A32=2UV.TAT>[2YA\ZVEBE<J&$2.64(F XW$,0<<8'-=IX9E@;XI
M^-""I,JV0C;'W]D;!@I[X. <=#0!T-SXJT6TNX[>>\,9DG^S+*8G\GS>FSS<
M; V>,9SGCK3M4\3Z1HQE^W731K#M\Z187=(=W3S&52$ZC[Q'!S7F6@2Z.^CG
MP?XFT[5+C7;>=U^Q,]SY5T?,+)*I!V!3D$L<8Y-6Q>Z5I?B#Q+H7BVWU3_B8
MWLD]IY/VAHKV&15 C"QG!88VD$>E '?77B_0;._:PEU%#=K;_:?)C1I&,>0
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MUW?Q)>0LABC93"SG.Y02H('(.#[UU?C*"6Z\#^(+>"-I)I=-N$C11DLQC8
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MD:*0%"C1R*<,C*P!5AZ$5RNJ7=['\7-'TU-0NDT^XL)KB:W63Y6=" #Z@<]
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MBPU%80);@$,6B)7B0IQR/[WKP/6Z* ,[0KV+4-$M+B%9EC,2@>;$T9. /X6
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MTS13>;>.K< +)\[!1WQCKCI6]J4\<WQ.\(SP[FA6RNT>14.U2XCV!CC )P<
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M(^5B2J[>_7H,U/X GBANO&#R!H@^MSW"LZ%0\11 '!(Y7(/(KNZ* /%(E<?
M?3+(V\XNTU",M;^2WF*!>;R2N,XV\_2NKU*Y*_%>&[MX&N5'AZ>-=JG9)(9$
M=8]V,98 \5Z!10!XS97QNKWP%J/V34%,%Q(ES;1:?)%!9,T+*(D0*!@'C//3
M)(%=#X?G_L^?QW974%S'+)J,]TA:!]C1/$@4AL8.2"  <^U>BT4 >/:7%>6&
M@?#766M[AK+24D@U&)8F+P&2+8'9,9PISGC@&M75;;[=XB\4>(K/<=-;PZ;
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MB$?/M*D@C/(![5[!10!Y)%'+<ZSX_AMK?5+@ZEHL0M9;BWD!G(BF!ZJ ,E@
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MP*C #'S@'.0/3'>O4Z* /+=(NDF^)>B:A%_:=U;SZ/+!]IELWC3S/,C.T+M
M10 >V/<FLVRM6OO@O)X.^R2G7)'E@^QR0LK1,UPS"1LCA0"&W=/3GBO9** /
M/Y(I!\6A$LD@_P"*;-J+DH=OF^<"!NZ;L?-C.:PO"<FF3Z1I?AG6=!U5]?TU
MHXS;3^>T :,X$X?/EA<?-G\ #QGUVB@#$\96TUYX'U^VMXFEGFTZXCCC09+,
M8V  'J37#?:9E;X?^(4M[MM*TZ%[6]!MW5H6DA5!(5(SM# J6Q@<UZI10!Q>
MB6;7OQ*UCQ#:9_LV33X+028(6XE#,Q9?[P52JYZ<D=C3/&;-:>-/!FIO!</:
M6UQ=),\,+2["\!5,A03R>*[>B@#S>RF1?%7Q%FD1UCG@MA$S1G$FV JP4X^;
M#''&>:YZRDET72? ^L7]GJ4NE6^DOI]Z+42K+:2'RR&94(;&4P?P]J]IHH Y
M[PE%IAL[J\TG3IK2VNYS+YDZNLERV!F0J_S#/3)Y.,],9Y[5IE'QJT.;#F&+
M39XI)0A*([,"%+8P"<=*]"HH \BSN\$?$V$12F6[U"\:W3RFW3!XD52@Q\P)
M!P1Z5<L]0;0O&VDZOJ,5P=)O=!ALHKE(6<03*VYD< $KGW'48[<>HT4 >+B+
M4+CPSXCN;'3M0E:V\6-J9MA#)"]Q KH2$) .[@G Y!7UKH$O/#^L:9J^KZ3I
MNH&8:5-;R7MXDX<;AE8%\SECG)PN0#CUKTBB@#R:9@/!?PRB,<GF6E]9-<)Y
M39A"0LKEQCY0&(!)J_=S*OC?QK(5?RY=&BBC<1MMD=1)E5./F8;AP.>:]*HH
M \CW;?!GPRB,<HEM+VT:X3RFW0A875RXQ\H!(!)]:VM/5IO'GCU8XW/VFSM4
M@8H0LK+$X8*>AP2 <=*]"HH \9AENHO '@G4$T[4YX-"=4U*VBBEBF4&%HV9
M1\K-L+<X]>O7&AK-M::UX9U'6/"FCWTT@GM+B667SHYKX0R!S&N_YSM X/KP
M,XKU:B@#B?"UYH&O:Q'JFE:9J)N8H#'+=WZS*T()!\H&0_,<\D+D#'7D9[:B
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *HZKJ]GHUJD][*4625((E52S22.<*B@<
MDDU>KE?'E]=6&F:=);V4D\1U"%;B:*U^T26D?.943!^8' !P<9S@T 6F\9Z-
M'I^J7D\L\*Z4VV]C>W<R0G;N&5 )((.<C(QWI+'QIHNH:K::=#)<":\B,MJ\
MELZ1S@ %@CD;6(!R<&O/IXIUA^)D,6FZPPU"RC-HTUM*[39MMG4@G)8_=ZCT
M&,#:N/-;6/AO*MI>%+5)/M#"UDQ#FV*#?\OR_-QS0!<^(?B6W3P7X@6QN+Y)
M[2)D-U9JX6&;'"EU[Y(!QP,\XKL-*=FT6R=V+,;>,L3R2=HKR19KS3?AEXH\
M(W^G:BVLI]L,9CM))%NUD9G6174%?XNYSQCKQ7J^AN7T"P9HY8R+= R2QE'4
MA0""I (- &-HNMZ'#8:S?VVH7T\":F\4_P!J$A:.<[%\J-6 8#+* H'4UM:?
MJT&HSW,"1W$4UMM$L<T10C<,C'8CCJ"17G6GVMM/X=\96VKZ9J3VEWXA>4+'
M;RI)Y;/$%FCPN2%(W9&?NUT'@9=8M[[5K*\U";5=,@$7V'4;B+9-("&+1LV!
MOV\?-ZL?<  UM8\8Z/H6HII][)<?:Y(7GCBBM9)"ZKUVX7YCST&3ZX%)<>,=
M*@L/MO\ I<L"VZ74QBMG8P1,-P9QC*\<XZXYQ61K6_\ X6QX;F%M<O#%9W4<
MDR6[M&C/LV@L!@9VGO6)>21:%XWU^'7]$U*]L-6DCGL[FT@DF5OW2QM$X3H?
MEXSU!H [6;Q9I*&W6WEDO)+BU^VQI:1F0F#C]YQVY&.Y[ U)'XGTNXL=/N[.
M5[M-10R6JPH2TB@9)P<8 [YQ@X'4XKD9)9+'Q%8:4VAW>G::=+_<#3K9F=Y"
MY_T=I4'[L*,' 91DD[L=<'0M-@N_ 'A.QU&/6M&U"SCG$.HPPR1M:R@C*M\N
M-C!OXN#MQF@#TT>)=-.G6][OE"W,S001&%A+)(I8%0A&[(VMG(X ).!4*>+]
M'-GJ5Q)--$=+&;V%X'\V 8R"4 )((Y!&01GGBN%0>)(Y/!_B/6+:2YCTR[O(
M+QK>V*N\4N4CN3$!D9QN( R V<=:MZM8RW^L^+/$-I!<&RE\/G3X@L+[KJ8[
MVRJXRV 57..I..AH ZBQ\<Z'J%]IUI!+<!M1C\RTE>V=8I?EW%5<C:6 Z@'C
M!'7BI)O&FBP3NCS2^2EX+&2Y6)C$DY(&PMZY(&>@)P3FN-D6;^ROADOV.]WV
M<D)N0+63, %N4._Y?E^8@<UE>(;B^U/0]6CFTG5(KVVUN.3[':V4BPK"LZ'S
M<J,3,P&2<L<\@ #- '13>(DT#XG:XMY<ZC/;?V;;RQ6D2R7!5B[[BD:YP, 9
M. *?XR\06^K^!]-UO0=3F\B74;55DMY&CW*TRJRL.#Z@@U,ES_9OQ/OM3O;:
M[AL[W2;=()?LSL"ZNY9#M!PV&'!Y/:N<U#1+[3_ $X-A="74/$@U*.TB@:1X
M(3<*X#*H.,(N2.V<4 >E1>(].F\22Z K3#48H?/:-H'"^7G&X,1M(SQP>M6=
M/U2VU,7!MO,(MYF@<O&RC>IPP&1S@\9'%<GX]@O+-])\6:+")M0L95@:%CM^
MTP3D(4/N'*,/<&NJT;3AI6D6UEO\QXUS))WDD)R[GW9B3^- &5>>.-%L]0O]
M/+7DM[8HKS006<KOM;." %Y&!]X<=.>:NQ>)=+N-)L=2MIVN(+\ VHB0L\V0
M3@+UX .<],'.*YS3G:#XH^*+J6WNEMY+&U1)C;/L=DW[@K8P2-PZ5Q6EVU_I
M7@_P/JESHVHW%II@NK?4;..&19XA(WRR!."0-HS[&@#U*U\7Z+=:?=7@N6C6
MTG^SW$4L3++'+D (4QDL21@ '.1C-.M?%>DW$^H6\DS6MQI\8FNHKI#&8XR,
MA^>"N >1T[UPNMVOVC1(/$/AGPY=*EIJMM?S1/"T=Q?)&&#$(WS' 8;<\G!X
MZ9TM?N)?''@[6?[ TJYCF>V7;-=VQMWG=7#B(;L$C 8$],L,$\X .GM_%>ES
M:J--D:>UNGA-Q$EU"T7FQCJREAV[CJ.XI]GXEL+Z>".,7""X@:YAEEA9$DB7
M;E@QX'WEX.#@YQ7)Z/J&CZZ\=[#X2U!+ZS@E,WV^WD0P90AHU9OO%C@87MDG
M' -+P_:W>CZI;VVC37^H>&Y;*9Y=.U&!A)IY"@K&KL-PW'Y=ASP">>M '=6/
MB2QU"YMH85N1]JA,]O(\#*DL8Q\P8\?Q+P<'G.*K6GC/1KVYL8H9I?+U!W2S
MN&B817#)G<%;\#C.,XXS7(>&+:^T;6["#0)[^\T":UE>33M1B82::P4%$5V
M(R?EV'L">>M8\-S=WJ>#+^72M72YM=3_ -,MH["2*&SRD@")& !C)'S<^[#.
M* ._/Q!T WTEG&][+/%="TD2.QF8I(1D!OEX![$]><9P:MV?B_1[[PW-X@MY
MIFTZ'?OD-NX;Y3AOD(W'!!'3M6+X(WKXE\8M);7,2W&I":%Y;=T61/*1<J2
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M_P (WUI;';>HHN+-QU6>,[T(_P"! #Z$UQ<VG>(KG5-'\2PV\T%WK\+6&H0
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M:@E]=F:!XS;(J-NC8L!\Q8JN!UP3T&: ._HHHH **** "BBB@ HHHH ****
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M19=XLXWIMR'&>, D@]10!M45S6A>.-(\1SVT>FQWTB7"2.D[6CK$-C;2I8C
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M;CXD^$[R*SO6MHK2Z26;[)(%C+A-H8E>,[3UZ=Z[FB@#C_B+IVHWFE:7>Z;
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR@;/W@/;!QP37,-:WI3XE@:=?YU%"+/_ $5_WY^S"/Y>/[W'Z]*?+;7AA^'
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MHT>H^%/"UIJ>FZ[I5_8::J0:E9PR>=;2JJJRD("=K8Z,.=IZ9&6W%KXBM/\
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M_B:PNEM+RV,2F2"1B -V&*[3N&""0:WM'U?^UX[E_P"SK^R\B8Q 7L/EF0
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M 1S'*SEUCS@$H'P.F<?A7I=% '#3V$VJ>,W\2I:W45I:Z1):1B2!DEGD=MQ
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MAG))/<(, 9YQ7*^(+#5KG58?&VF:=/\ VEILXMH;!H,/=6Q)#Y)'!.XLIS@
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MF.< ]"!G(JUXFBUOQ?X2FGLM%DMI;:XM[JUL=1"K)<F)]S*Z@D*I' !/4'.
M17?YHH XWPY=1W;O?1^"Y=$$,+"5I[6-)G?CY(PF2R]<DXSQ@=<<5]GO-%^&
MOP_M+ZQN8[RSUZV66W*?/G=(>.QX(Z&O9ZQ=?\-P>(FT\W%Y=P?8+M+R(6Y0
M9E3.TG<IR.3Q0!A2Z1<:YXVN==AMY8;:+1GT^)IXS$TTCON/RL P50!R0,EN
M.E7?AU'>VO@?2]/O].N;*XLK=+=UGV@LRC!(P3QZ'O74@8 !)/N>]+D9QWH
MXF%;O1/B-K^HW&G7LMGJ-K:K;2VT)E#/&'#*=O*GYA@M@>]5[+P,\GPWU#1M
M09;:[O9I[X%6R+29I#(F"/[AVY(]#VKO20#@D>M8VN^&K;Q!-:/<WNHPQ0;@
M]O:W+11W"L "LH'WAQ[=3ZT 4O JW]QX=BUC5E0:GJ:I<3A.BC:%0#T&T!L>
MK-57QE:7W_"1^$]5M=/N+V&PO)C.EN%+J'A9 <$CC)&3GBNP50JA5 "@8 ':
MEH X/3X+R'QCXUO9M/NT@O;:U6V<0L1*T<;JX&!V+ >_4<5S%KHFKZ5H'@S4
MY?#DNIC2[.6QU'3'B5I5#E2'C5N&(*#IU!^N/8\@=:* ,3PRJO9RW,>A+HT,
MS I;M$D<I 'WI A(!/89) '/7 YV]TK4?#/Q%NO%-C83:AINJVZ0W\-L 9H9
M$X215)&Y<<$#GOS7>T4 94&HRZJ0EM9W4%N01)-=0M"W3HJMALYQR1CZUY_8
MZ1J\'PLN_ =QIEPVIK')90SB,FWEC9B5F\S[H #9()W9' ->JT4 <+INF7.G
M_$V!Q:W3V$.@1Z>+LQ':TJ2%L$_[O.>G;-4M U+[%XM\>Q_8+NY9KV,QK#"7
M$C>0GR$CA>W+8'/7@UZ/6+H_AN#1M4U34(KV[GEU*42SK,4V[@H4%=J@C@ =
M: .$T3PGJO@F[\)WY@DO8+33I;#4([8&1H#(_F[U4<L WRG'. #@T[Q!X>U"
M^TWQ[JMO8W)EUR""VL[7RR)'$:;=[+_#DDXW8("\XSBO4Z,YH XSQ#<ZPFD^
M'VL+&^DLVF1=1CMEVW*1[",+D@CYL E><=#SFN4D\.ZQ/X;^(6F0:%=6[:A)
MY]FLC(1(/+0;00QRWRG/49[UZ]10!P&O?;]4F\&74>D7\:VNHK<7"/%EHHQ&
MRY8*3W8<<G':GZ'%?^$]=\36]UI]Y=VNHWSZC93VT1D#EU :)L?<(*@ MA<'
MK7>44 >5:7X6U'PZGP\L7M9I_P"S);F6]DA0ND)E1\#/<!GQQV&:Z3PO;74/
MC?QA=36EQ#;WL]N]M+)&5614A5&Q_P "'?K78TF1G&1GTH XO5[*_P!+^)5C
MXFCM9[O3I=.;3KE8$+O ?,\Q9-@Y8$\' )%46T2\6R\>ZN+.X$FO1^7:6@0F
M0A(/+5BO\)9B3SC QG'0>AT4 8G@])8?!VC6UQ!+!<6UE#!+'*A4JZHH(YZ\
MCJ.*Q;"&^TKXE>);N73;J2RU&WM'BN8E#(/*1PP/.=V2,  DY].:[6B@#R"V
MT?5HOA+X;TI]*O?[0M-2AEG@\DY1$N"Y.>A^4CH?ZUH26ESH7B_63>^#I=>T
M_5IUNK2Z@MXY'C8HJM')YA&U?E!!)QS]<>GT4 5=.A:#3;>)X(+=UC ,, Q'
M&?[J^PZ5:HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ K%\3>)(?"^G1WUU:7,]NTR0N\&S]T78*
MK-N887) S6U6=K^CP:_H%_I-S_JKN!HB<?=)'##W!P?PH JQ^)87\7OX;:RN
MH[I;7[6LK[/+>/=MRN&R3GC&.*S;GQ[;6B:6TFDZG_Q,[A[>VVK&V]EW8/#]
M&V\'T()P*YAO"OBFXTW0-==EC\41.MI=,&R$MG3RF/O@XFQ_>+5O>*=+N5U3
MP>FFZ;/-::9>B27R@,11")D'4C/4<#)P* 'IKNFZCXH\-F_T#4;35YX;IK-K
MD*ODA0!(" _4@+C@\$<U2L_'>JR:3XNU&30IF&CW,Z11^;$% BC0E6.[.<EF
M. 1@X!)K0UVROI_B1X5OH;&>2SLHKM;B=0-J&54"=\GE3G XK*M-%UA=.\?:
M,VF2J=4GNY[2Y+IY4@EA544<YSD'.0 /6@#=TKQ1(_AS19[VTG_M&_A0QPYC
M!F/EAV<8;:J\D\D'H,9(!IS_ !*TRUTC4;Z>QOEDTVZ2TO+951GB=B K9#8*
MG<,$$_2L"\TS7CHW@_5X_#;W,NBP&UN]*N&C,DL;1HK.G)7(9,@$Y(]*M>)K
M+4];\ WT5AX7>QENI[8PV2K&LQ6.579Y-IVC@' R3Q[X !U.G>*XKWQ++H4^
MFWUC="V^UP&Y5 L\08*6&UB002/E;!YZ5+XF\3VOA:TM;F[MKJ:*XN8[8&W0
M-L9R "1G./H":R)K6]E^*FG:HMA<_8$TJ6V><J %D>1& (SGHIYQ3_B'97U_
MI.FQ6%C-=R1:I;7+K%CA(Y S'D@=!0!<@\6><$A?1[^WOY'E$=G<>6CLD> 9
M,[MNS+*,YY)X!J*Q\=Z7?:6UTD5PMRMZ=.:Q*KYWVD=8Q@[3QSG.,<Y&#65X
MPL-2@\3:3XELM$_MJUCMI+2\L<+YJHS*RN@;@D$8(_\ UBIK6GZU+;Z)XBTW
MPZL$FFZ@;@Z2A197A:,QL3@[?,Y) STQSGB@#HX_&"G5[[2IM(O8;ZSL_MK1
MEHR)(R<#8P;!.0>N.E,'CFP;1_#^J+:7AM=;GBMX#A,QO)G;O&[@<'IFL"PG
MGU?XJ:DTMC/8-/X;C5(;DKYB@S2#+!20/ID_T&/;:=XB/@[P?I!\-7RW&B:I
M:O=%GB =8RV6C.[D8YR<=0.: .ZUCQE:Z3!J%PME<W=MIIQ>RP%/W6 &8 ,P
M+%5()Q^I!%.E\8VC^<=-M9]2$%G'?2?9R@/E2!BFT,P+$A2<?3OQ7+0V6J^'
MO$VLP3>$/[;L]2NVO+2[C\K,3.!NCEWGY0".O/![T_Q1X=EU&5Y4TV]L]=L[
M1%T[5-)^17?;DQ,,XV!O[X P>HYH VW\4WY^(MMH,>F3-9MIC7;2*\>6)D10
MV"PPJY8'N2>G&:Z#5]6M-$TV2^O&81(54*HRSLQ"JJCN22 /K7)K8Z[:?$#1
M]6N;![P2:']@NIK=D"1S^8CLQ!((7AN@)]JT/B#H=_KGAR-=+"O?V5W#?01.
MVU96C;.PGMD9_'% %R'Q1%_;T>BWUC<V-]/"T]JLI1EN%7[P5E8C<.,@]N>1
M7(:-;1>-=<\2Q:[I%R1;ZFL=O.9$5K,1QQLJJRON4Y)/RY!W')K:N+*Y\2^+
MO#FKFPNK*WTA9Y9/M*A7:21 @C !.<<DGIP,$YX7P5:WUIK'BA[S3[BVCO=3
M:YMWD P\>Q%SP3CE3P<4 3^*O$M_HNN>'K"TTZ2X34;IHY'1T!PJ,VQ0Q')P
M#DX&!ZFN>M-1?1?B1XSFMM*O;V1K6RE-O;E2P^60L268*/H#D]@>:W?&ECJ$
MNK^%]3L;":^33[]I)XH&4.%:)DR-Q X)&>:K:;;:A;^._%6I3Z9<K;7EI:I
MZ@,)'C5PP'.>K#!(&: -F#Q=I]YH^E:A9K+/_:J;K2 ;5=OEW-G) &T#DY]A
MDD9D\/\ B:U\0/?P1PRV]YI\WD75M-M+(V,@@J2"I'((->=6GAS7]-\(>#+T
M:";V[T-9H+W2I2FZ2.3 +(22I(VJ1ZUZ)X;:6>WFNFT(:-%+M$=NZH)3C.6?
M82!UX&21C/?  .9\:V\;?$GP,A4[+F>Z6=02!*%B#*&'1L'UK3N?'T4-UK5K
M;Z%JMS/H^TW*1I&/E*;]P)< C;CC[QSP.M5?%MEJ%SX]\(7UKIUS<6FFRW#W
M4L8&$#QA5QD@GGTJ&UL=1BU[Q[<OIET(=1CA%FVT?OBL'ED#GCYO7'K0!T/_
M  EEA+::1+9)+=2ZO'YMG @ 9DVABS9("@ C.>Y &2<5RGA#4[;3=>\?7]Y#
M-9007<#/%*=S*?)&<8)SENF.NX>M4-,TC7M!'@O6AI%U<_V?IATS4+*,KYT6
M0IWH,X897G!Z?H^Z\.:[KT?CR)=,FL6U.6UN+%[IH]KM$D9VL Q(R4QZ<GGB
M@#L$\90#75T:ZTZ[MKV:W:YMD+1OYZK]Y5*L0''H<?6LR+XFV$ND:9K/]D:J
MNE7TPA^UF-,1.SE%#*&W')'501SC.>*D\.7M[=NDUQX*.BR6Z$W#LD1+MC&R
M'8<D9YW' P,<YXY>'0M;C^#VB:(VCW7]I6U[%)+ -N55+CS"<[L'Y?>@#N;'
MQ<EWKEUH\VDZA:7L-M]KBBF$9-Q%NV[EVN0#GC#8/(K+M/B98W>G:7J:Z1JD
M>F:A<"V%W(B!8I&<HH8;MV"1U (&<9SD4^6"]'Q5BU@:==-IZZ(UL9@H_P!:
M90X7&<]!Z8S7+P:%K<?PCT71FT>[_M&VU&.:6 ;<JBW)D)SNP?E/KUH [-=0
MTS_A8-[;QZ5<G7(M+5S/D!98/,.U%RV,[L\D#ZU3\*^-Y=2\'IK6JV4L!FN7
MBA561O-8SNB1IALY&%!+!1U/3)J2&TO6^+4VJFPN%T]]%2T6X8 +YHE9R,9S
MT8<XQFN4M_#/B+_A7%MI2:/C4M$U,WD<-RZ>5>@32-L4@G@H_5L<_F #M8?'
M&G+?ZE8:E%+I]SI]J+R192KAX.F]2A.>>,=<^M20>+[<^(K/1+VQN;*YOHGE
MM#*R,LNP99?E8X8 YP>W>N>O-,OO&'A35K.W\-+X>DFM3&AN5C$DDVY6 ^3.
M(\K@D]<CCBKWABZU&]F@-UX)71[BW4FYG=8MKMM(VPE3DY/.3@ 9&3F@#MJQ
M;OQ$L>H7=A86%SJ-U9QK)<I 4'E[@2JY9AEB 2 .V,XR,KX9UR;7],>XN=,G
MTVYBF:&6VG8,RD 'J.#PP_4=JP;&SU'PUXZ\07CV-S>:;K/E3Q2VRAVBE1-C
M1L,YP< @].Q(H LS?$32$TK1M2MX+VZMM6N!;0M#&,I*<_(X)!#95A@ \BM_
M1]1DU734NYM.N]/D9F4V]VH$BX8C)P2,'&1ST-><_P#"*ZKI>C>&H5T^:>X3
MQ$=6O(X2I%NC&3*Y)&2H=1QG.#BO50<C- ')>%-4;Q%'J/B)T:6(74MO81+C
MY8HSL) /&YV#$GTVCM6&VK^$A\(TO1H5XWAV28J;,'YU;[01ECOR!YG/!/6M
M'X96[Z+X5O-%G5C/I5_<PNH&68%S(C ?[2NI'UKFSH.M_P#"C'T#^Q[K^U3<
M$BV^7./M?FYSNQC;[]>* .P\7:@?#-QIVNQDK ]Y%:7Z?PO%(=H<C^\K;>?3
M(],=+>2B&RFE:&2950DQQ@%F&.@R1_.N.^)=N^M>&M/T>%&$^IZC;1JI&&55
M;S'8C_95"3797;%+.9EC>0A#A$&2QQT% '%:9XOT'1/!GANXT[2K^+2M1F2U
MLXHU#M$78X#?,3V)XW5NZ)XHCUC5M0TJ73[S3[ZQ".\-SL):-\[74HS C@]^
M*X2TT/6H/A_X&TY](NOMFF:K;SW<0VYCCC9BS9S@_>'3)KJ=.L[U?BEJ^HO8
MSI8W&GP017# ;6=&<L.N1]X<XH F\6>);[1-6T"RL]/DN%U&\\J1T= <!&;:
MH8CDXZG  [YKGK:_?1_B;XLFMM*O;V9[&SE-M;E2PXD+9+,%'T!Y[ UN>-K'
M4)K_ ,,ZC8V$UZNGZEYL\4)4/L,;KD;B <%AWJ#3;?4+?X@^(]3GTRY2UNK*
MVCB< ,'>,/N4<Y_B&"0,T :UMXPT^^T?2M0LDEG.JIOM8/E5R ,MNR< +W.>
MN ,DC,WA[Q-:>(?MT444MO=V$YM[JVFV[HVQD'*D@@CD$&O-K#PYK^E^%/!M
M]_8!O;G15N+>^TN4IO>.4@[D))4D;5/OTKTCPVTLUM+=/HBZ/'*1Y=LRH)2!
MU9]A(&<\#)QCWP !=0\1):WMQ96EE<7]W;0"XGC@*CRT.=H)8CYFVM@#TYQQ
M56+QG97D.C&PM;JXFU>)YK>$H(RJ(!N+EB N"0.^2>..:Q;M=<\,?$'4]6M=
M%NM7TO688 XM&3S+>:(%0"'8#:0<YSQ_.QK+^(Y-6T3[3I=Q<Z7+%*;RVL)5
M!68D>6KEF7<@7(.#@GDC&!0!H6GC;3[[1["^@@G\R^NVLH;:3:KB9=^Y6.=H
MQY;<Y.<#&20*MGQ+#%8O/=6=S;S"Z^R);/L\R20XP%PVW!!SDD# ).*X32/#
MLX\&_P!A:_X4GEM#J\[N(74M"C-(Z2Q;6#8!*CC!PQP,47/AGQ.?"<6SS=6D
MTG61>:?;:DP\ZYM A7RY">-WSOC=S@#..@ .YT?Q3;:KK-_H[V\UIJ-DJ220
MRE6#1M]UU9201V]0:LZCK<-CJ%MIL4,EUJ%RCR1V\1 (1<;G8D@!02H]R> :
MS_#$TUZSW1\,_P!AP[-FR9(Q-(V>>$)PHQWY.>@QS0UK3M0T_P"(FG>*;6UE
MO+,V#Z=>10X,D2EQ(LBK_$-PP0.<=C0!8F\8I=>&]<NK"TN5U'2Q)'<6DFP2
M02!203EMI7&"""<CIZ50\ Z/9WFC:#XBFTZ:WU4:=&LETTB@W>]%9G?:QWY.
M2-_()Z5&-#O0OCC6OL4PFUR%8;:T&/,*QP&-6;G +,2<$\#&<'('0^"X;BT\
M%Z+97=M+;W-K90V\L<@&0Z(%/(R",CK0!3U?QQ::2=68V-Y<6^C^7]NFB"@1
M[P&^4$@MA2"<>O<\5FZXL3?%?P9<Q9/G6M]ELG# (FWC_@1_.L?Q=IOB/6X/
M%VG7&BW5Z9(L:3(LJ"W6/8/X2V?-W;N2">0 0*UIK75+GQAX+OVTFZC@LK2Y
M2Z)*'R6D1%4'#<_=.<9Q0!)X(B2#Q?XXBC!"#482 23U@4GK[DUTVI:W#I][
M:6"127-_=AVAMXB 2J@;F)) "C(&?4C&:PO"=G?6WBSQ;<W5C/!!?7<<MM(X
M&)%6)4/0\<COBF>(--U&S\>Z/XHL[:6\M8[66QO(8L&2-&(99%4_>^88('..
M@- $>L^/Q;^$_$%_8V$W]J:."EQ9SE5:!B,J[<D,A'(*YS^>,OQ#>.WBKP!J
M<]C=+<F6Y4PC:SO_ *.V,!6*\D]R,9YP*-7\*:EJ]CX\U&"U>.XUNTBM[.VD
M(5V$49&YN< L20 3P ,XS@6[V'5=0USP/??V)>PQ6#RM=!]A:(-"8QG#'^(]
M!GCKCI0!MZ?XUL;JPU6XN[:ZT^72IA#=6UP%+JQ *8V$AMVX8P>2:1?&ENFM
M/I%UIUY;WWV5KN"(F-_/13A@I5B-P[@D?4UR6I^&-:UA_'<=O9/!)?7-I=:>
M]P!Y<Y@6,[3SQEDQSCKFM[0[R]O8VFD\%-HSPPMYQ=(B\CD8V1;3DC/.XXZ8
MP<Y !?\ #/C.+Q2+::TTC4HK*XMC/'>3QJ(B0VW9D,3N_#'!YXHUJ]TF/QIX
M:L[W3YY=0F>X-A=+_JXB(B9,_-U*C'0]:C^&]C>Z7X TG3M0M);6[M8O*EBD
MQD$$]""01S4/B6SOI_'?A"]M[&>:UL9;E[F5 ,1B2$HO4Y/)[9H CN/B+;PQ
M:S)%H6K3C1I2E[L2,;%"AB_+@$8/09/M6U-XFM-^G0V4<E[<ZA ;F"*+ /D@
M F1BQ 5?F4>I)X'6N1CTS5!8?$.,Z7=!]5>4V0PO[X- (QWX^8=\<5!9:=KF
M@ZUX9U]=(N[N!="CTB^M8MIFMW4A@X4G##(P<'H,T 2>!=5MM+B\8WES!/;(
M->:-;=\-)YC)$JH.2"2Q '..>N*Z+_A.;2'4-0TZ[T^\@OK.S^W" &-S- #@
MLA#8)!&""0?K7&S>&_$6HZ9XG>'1W@NFUV/5K**[>/9<A!'^[;#'&=IZ\=.:
MZ&TFO-3T;49$\&OH[?8I(MCI%YLTK# 5-I^[ZEL9XXZT 3I\1K,P:+=R:1JD
M=AJX1;:Z,:E?,9=RQ[0Q?)P1G;@GH2.:N6GC2&>76+>XTG4+2\TN)9Y;601L
M\D3 D,A5RI^Z>,\5R[Z3JX\%^ ;$:3=&YTJ]LY;R,!?W2Q(58YS@\D8QG-:-
MS9:C_P )OXEOETRZ:UNM(CMH) HQ)(N_*@9R/O#DX% %VR^(=G>?V'*VE:E!
M8ZR5CMKR5$">:RE@A&[=D@'G&">A(YJQINH:9)XP\2I9Z3=+J]M#;_:W)4?:
M 0_EA,OCH#R=O7FN7&D:NO@OP!8_V3=&YTJ_M9;R,!?W21HRL<YP>6'3.:W]
M'M;VV^(WBC49K"Y2RN[>U6";:")#$KA@!G/\0QD<T <?9+IGB#P=JNO>*=!O
M;K[)>7D[W$4B"0QH[*8@5D#;0@VE3\I [UZ#;:[8VNG:+::?:322WEHLEI9H
M1N2%57EBQP NY1G/4C&:Y32M+U:+X4^(M(FTF[CU"Z^W>3 0I+^<SE.0<?Q#
M.3Q1+8Z]HEWX6\16>CW%Z+72AIFHV"%1,@^0[D!.&PR\\],?4 '21>.;&72H
M[O[%>I.^H?V8+1XP)/M&<;<YV[>"=V<8]^*@OO''E>'?$=[;:9.;_0PXN+65
MD&"$WAMP."NTYXY]J@U^\\47.D6%U;Z5=10R7Z&[LK>5!=+:;>FX-@,6P3M;
M(!P#U-8=MX=U=[;XA6,6AR6<>K6^;+=)'M9C;A IPQ^;=G)Z9SR>M &Q>:W9
M7&A^%)_$.CWDDMW?6HMWRF$N2 4D.U^!RQQSTY'2M^[\2+'?WME86%SJ-Q8H
MKW*6Y0>7N&57YF&7(&<#MC)&1GDM4M=8U#POX.C70[V.>PU*SFN(6*%DCB7#
ML<-CKT&<GTK0TVUU'PSXT\0W#V%U>:;K#QW4$MNH9HY0FUHW&01G (/3U(H
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MMO&JEHG:9D)8;B>6R<+N]*U+'QNUUKUSH=SH=]8ZF+<W5K#<M'BZC!Q\K*Q
M.>H)XH ZRDW+NV[ANQG&><5R_P /_$%]XG\)VNJW]KY+W!=U(92K R-@#'.%
M  YZUSUU=2:/\7]6FT_1[C4+F;18',%L40L?-?+,S$ < #KD]A0!Z517$_\
M"RK%_#UGK,>G7K6\MZ+"Y5]J-93%@N)03P,D<C/4>M=*VJ8U]-*6V=R;<W#S
M!AMC&[: 1UR3G'^Z?2@""/P[;Q^*9/$(N;HW<EN+5D)7R_+#%@N-N>"2<YS6
MON7=MW#=C.,\XKE?&7B+4=#O- MK&R\Y=0U!+>1]Z@@8+;0#W(4\G@#W/&!%
M=3:9\5O$$UCHT]W=3:5:R-;0,BDMNDR69B%]!UR>W>@#TJBN9M?'&FWV@:3J
MENKDZKD6T$C*C;E!W[B3@!=IR?IC)(%3^&_%5KXCEU&V2)H+W3IA#<PLZN!D
M95E93AE(Z'V/% &_17 :C>2>)?BG_P (M*[KI&G6 O+J%6*BYE9@$1\=4 .<
M=">N:Z";PEIJ7^GWFFP1Z?)9S^:4MAY<<RE64AU7 ;AL@D9!'N: -^BN5N_&
M\%OIMYJ\.GW%SI%E*\5Q=Q,N?D.UW5,Y9%.03QT. 13=1\=1VNKPZ98Z1?:E
M/<6#7ULUN8]DZ K]TEN/O9YQ[9) H ZRBN*;X@S/=:G9VGA;5[B^TZ.&2>W'
ME @2(7Z[\9 QP.2>@X-7K/QSIFJ:7HUWIJ2W,NL;Q:V_"ME ?,WDG"A<8)YY
MQC.10!T]%<N/&ULMOK@GT^Z2_P!%3S;NS4H7,>TL'0D@,I /<'C&,U6M_'QF
MTV+4'\/ZG';7,=L;20A")WF( 48.5P3R3CCGN,@'8TC.J %F"Y( R<<UR5WX
MUEAT_P 3"/2W_M/081++;M*-CJT9=6#]Q@'/ /'2LZ?7X+CPAX6N_$>BS737
MMU9+&X:,JL[[=DIPW R2< 'IR* ._HK$N?$)_M.\TW3;&2_NK*-)+E5D5 FX
M$JF3U<@$XZ8QDC(K*F^(NF+H>D:O;6E[<VVI7B62A$7?#*S%2KJ3G((/ !Z>
MXH ["BN?T7Q1_:NMZAH]SIESI]]9I'-Y<[(WF1/G:P*$CJI!&>*NZMK<.EW%
ME:"-Y[V^D:.VMT(!<JI9F)/ 50,D_3&20* -.F^9'YOE;U\S&=N><>N*P;#Q
M2M]=:GIWV":/5].VF6S9U^=6Y5T?."IYYX((P0*Y?X;V%OXA\.:-K^J::?[3
MA>6XCO\ S 'E9W<-G:<D8P,-QP,=* /2*0,K9VL#@X.#T-<E-XBU%OB6/#HT
MXM8C3?M+.)%R^Z54W$'H%PPQU.>G2N3\,>)H_!_A_7YSI%U-IEKK]XL\\.P)
M;QF;:, D%L<<*#@4 >M4$9!'K6#JOB:*QO9;&V@%W>0PB>2,SI$%5B0HRQY8
M[6P/;DC(S:\.>(+'Q1H%IK.G%S;7*DJ'&&4@D%2/4$$4 7[>WAM81#!&J1C)
MP/4G))]23DD]ZEKD6\=HNE^(+QM(O ^A2F.ZM]R>85"[RZ\X*[2".1D9K33Q
M#YPTHV]C+/\ VC;M<H(Y$^1 JG)R0#G<HX[L/K0!MTBLKH&1@RD9!!R#7&:9
MX[_M^P^TP>&=5DT]TN!)(WE84QL5*$%^2<=>G.,G!QF-XK_L[PCX.D\-:.8=
M/U2[@MXXC(H,2$EM@R>2P4C.<#/7- '??88!J'VY5*7!3RW93CS%&<!AWP2<
M=QD^IS9KC[;Q-JL_Q%FT-],:*TAT^.X)\U"<NY!9N>@VD8&>YIL_Q%TVW-A<
MO"QTR^N5MHKM94)#,2%9DSN"$C@_3(% '5?8H#?_ &UE+SA/+1F.?+4XR%';
M) )[G ]!BQ7%7/Q"\M=<-OX>U*<Z+)MNP&B7:H0.6!+X/'( R?4"NML;V'4=
M-MK^V):"YA6:,D8)5@"/T- %BBN0T_QX-1O;B&'0=16"TOI+.\N)#&$MRBAB
MS88Y'7IG'?J 1?B#8"^TF.:W>.TU>016EQYJ,=[#*!T!W)N'3K[X- '7T5RF
MI>.(K+2-0UBWTRXO-+L&=)KB)T!8H<.44D;@K @GCH<9J[#XHBF\20:)]CF6
M:XT\W\4FY=A0%5*GG(.6';% &]17,6GC>PN-&NM1E@F@^SW[Z=Y+E=SSJ^S"
MG.,$]R0,9)P*K#XB:;;W&K6NH0M;W&FV@O65)%E66$G&Y&!QG=P0<8)';F@#
ML**YK4/$M]9:7JMR-&9I;*R^UQXG4Q3 AC@/[;<GCN,9JUX0U*\U?PGI=_?P
MM'<3VL4C,2I\PLBDN,= 23Q0!MT5S]UXG(N=1ATW3I]1.FX%UY3JN&*[MB9/
MS/M(..!R!G/%<WXV\4_VC\/['4=#62>RU.XMXS*K!3L:90T9!.<GYE/ISF@#
MT*.2.5=T;JZYQE3GFE9@JEF(  R2>U8^CZ+8Z6]YJ-GI7V*ZO@K7$".,,R A
M< '8"0>HQGC->=ZYKE[XJ^$?BVXU33EB\B2X2([U94,;[0HQSD8ZXYR: /70
M<C(Z45RNF>*P=:T[0[K2[NT-W:M+9W$I3;.(PNX;02RG!!PP!QZ=*KWOQ&TR
MRCM[QXF;2IKD6WVM94)4EMH<QYW;,CKU[XQS0!V5%1S0Q7,+0SQI)$XPR.N0
M1[BO*/ 7B"W\)_!RUURXLKBZW7,B3/#M+\W#1H6).2!E1QD^U 'K=(S*BEF8
M*!U).*YZP\6+<^)I=#N],NK"?[*;R!YV0K-$&"D_*QVD$C@\X-<;\0M:37O!
M-M?VVF22:>^HVWV:]9ESQ.HW[>H1@" >IR. #F@#U2BN:UGQA;Z7)?QP6QNY
M-/C$ETJS)&5RN[:H8_,VW!QP.1SDU53X@65S>:1;Z?IU]>#5K1[NTDC"!7"@
M94Y;@C(!S@#U- '7T5P__"QB=&U&_7PYJ3-I4LD6I0AXA]GV %B&+8?Y3D!<
M\=<<9T+WQK!;:KI6GV^F7UX^J6SW-J\00+(JJ&QRPP?F'WL#GK0!T[,J*69@
MJ@9))P *7K7#WOB_3=4\":]>:GHEV\-@\MIJ.GDH74J 6YW $8(.0>_%.O\
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M#XQT6T^W"6U^Q:A8JZI(Z [EDC+$*6& ,$C(%=%::C?:A)'LTRYLH0<R/>;
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M\$T:;"C!F'!&"".!C!]:PY?"&KV'AW1H(;![F[/B1-8O(X9$"P(9"Y4%F&2
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MANH PYF7=R N001DX&,CBCQ'X:OM1UBXU32M,N],\1Q7*+;ZE;RJL-U""O\
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M. 3*-H>;Y1AGR1QGG'7M747GBAM.>SL;I+&+4[B)YO+EOMD*HI R9"F<DL,
M*>_8$T =+17%V'Q'T^^TF.X,26]X]])I_D37"B,2H"S'S<8,>T9W <Y  R<5
MH>&?%T7B&_U33V@CBN].=!(89Q-#(KC*LD@ ST((P"#0!TE5VU"R6":=KNW$
M,#%99#(-L9'4,<\'D=?6LV_UPIKB:'8VL=W?M;FYE667RXXHL[068*QRQR
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M[< %1MP!M!R21Z5Z#:^*ISXL&A:CI+V/G6KW=K,TZOYB(P#!@!\C#<#U(]Z
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MF7>@2:6\OF)N1W?<3M#= #C/K[<T>%!XVL[6RT/5=-LXX+$)$VJQW083Q)@
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M(T3"7?NP?O9!P,=^N!S7-S^%=?G^'?BS11II6]U74;BXMP9X]NR60.-QW<$
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M_CC6-,L8;Z[\+E+2YN;6"W=;U2SB8XR5Q\I!(X[YZU87Q;K1\277AYO#T(U
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M@Q!I&7<(U(5LG;C). ,@>N,+4M$\0ZAH'A2!].@2YTS4;6ZG1+D,!'$I! )
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M4&GOIUEB.+5EG.]H%/RKY.W[^W"YS@=><<QIX=UO^R_'5N;) ^N22M:?OEP
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M7W J01\K KTYZ]J\ZB1#^SKH;%02MU;[3CI_I@Z4 >U22)%&TDCJB*,LS'
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MY=I8_*06^3 '3!Z\T =79:A9ZE"TUC=07,2N4+PR!U##J,CN*L5Y#H'B._\
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M9&"R&,8(^4YQD\[3TX) .KDC66)HV+!6&"58J?P(Y'X51T;0]/\ #^GK8:7
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M/M0*<[MP)((/ &>*I:II6JVOP<MO"]PD']K7%M#I<,<#EU)PJELD#HH9SQP
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MNNT;0.AP6ZY[<]5X??Q5<N)?$,&GV8C3:(K.5I/-?CYR2!M QPO/7D\5T%%
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M4\5^$]1T1YC#]JC 60#.QU8,IQW&Y163+HFL^(F\/KKMO;6XTJZ2]F>&;?\
M:)D5@FP8&%RVXYYX P>M=C10!RFBZ/JMEXZ\1:M<P6XLM36V6(I,6=/*1E.X
M;0.=W8U+XVT2_P!;TS3_ .S! UU8:E;WRQSN463RVR5W '&?7!KIJ* .1BT?
M6A\0QX@FM[3[/_9 LF6.<[O,\SS,@%?N]L]>^!TKGH? WB.W\-6GV66RM]<T
MS5IM1M<R,\,JR,^Z-SM!&5<C(';WX]/HH QM!;7YT>YUZ*TM9" L=K:R&0+Z
MLSD#)/' & !U.>-FBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *X+XLZG=6?AS3].M)G@;6-3@TZ2:,X9(W)W8/8D#'T)KO:P?&'A>#Q=X?DT
MV69K>4.LUO<(,M#*IRK@=_3'H30!H?V+IO\ 8W]C_88/[.\KR?LVP;-F,8Q6
M+'J+V&IV?A#2?+>YM-.2:2>YR5CC!$:<#!9F(/<8 SZ"I[";Q=]G6WOK+21.
MHVM>17+E&_VA%L!S_L[L>]4KOPWJ5EXRMO$NE2174C6/V&]@N9#&95#;ED5@
MI 8'.1C!![4 9=]\1KNT\+ZM?#28CJ6D7R65[;&<[06=55XSM^92&! .WOZ<
MV=1\5^)](O\ 3K6\T'3W;4;YK:W\F^8X7RRZELH,<@@GMC@'BJFL^!-4OO#6
MNPV[67]JZU?Q7<YDE811+&R%4!"$M@)C.!RQ/M4WCQ[L:UX(:**$W7]JD^6T
MA"9\E\C=MSZ\X_"@ B^(5QI,VOV?BNPAM+K2;5;U6LY3)'<0L<#;N (.["\]
MS6C=^*-2T2]T7^VK.V6SU:=;57MW8M;3N,HC9^^#@C<,8/:J>J^!&\42Z]<Z
MPT=O+J-@FGP)"Q?R(U8R!B2!EBY!QTPH&>:F;P_K6MP:#:Z^MDB:5=1W<LMO
M,SFYDB4A,*5&T$G<>3TQWS0 W2O%/B/5]8U"V@T6Q6WTW4C:7+F[8L8]@;<G
MRC+<]#@<@<\D,M?&U^NM:!9:C96UO)K!D4V8D/VBS(0NOF#OD+Z+@^M6_#WA
M_6-.N?$[7#VL(U6[>YMY;>5G:(E%09!0#C:#UK L/!GBF&'PL)?[&271;EWF
M=997-SN1D:5B5!WG.2IZG^(4 7_#.M>(+J;Q?-=K97(LM0EABA\QD V11X4'
M!P,9)..I/%3Z5XR%QX=\*_9K&"&_UU2+>V4[8H55"[L<#HJCH.I(''42Z9X>
MUK2K[Q0(_L$MGJER]W S2NL@=XU4JPVD #;G(SGTK*M? NL6?A_PDT4MD-;\
M-DA!YC&&XC9=LBEMN5)7H<'!'>@#4D\8WUE?:YI-W8V[ZIIUC_:$&R5DBNH.
M02."4((((Y[<^E6R\;ZP_P#PBMW>Z7:1:=KPCC4QSLTL<KQ%P2,8VG!'4G&#
M[5:N_#&H:C?ZQK4T=K'J-WI1TNU@$S%(T)9BSOMSDLPX X"CKFJ3>$M=_L3P
M59!=/\S09H9)V-P^)!'$8_E_=]\YYQZ4 =9X@UN#P[H5SJEPC2)" %C3J[LP
M55'U8@?C6<=:UC3=1D&L6$ TM+)[N2^MF.V!DY:-@W+<<AAC..@JSXO\/+XJ
M\*WVC&<V[SJICF SY;JP93_WTHK-L=,\3ZQID^G^+'TZ.WDMGMY!I[NQN"RE
M2[%@-HP2=HSR0<C&" 5;KQM?:=X?TWQ/>V,"Z)>M$9%5SYUK'*0$D8]&^\N5
M&,9X+8ITOBGQ!<>(/$6CZ=I5@9=*CAE26>Z;;(KJS<@+G/R@8Z#GGH#5C\'Z
MU>>#;/P?JS63Z?;M#')>12-OF@B=61?+*_*Q"JI^8@<D9Z5HVF@ZQ:^+?$^K
M>78M!JD$$=NOVA@RF)67YODP,[NV<8[T 54^(4%QI7AFZ8V^G_VY"TBS7C$Q
M1.H7]WD8R22<9(Z'OQ4^M>(=0TZS\/27VD6<DE]JT5G(#*6$)9V"R)\OS<#(
M.1U%4=*\)ZM9>$-&\/:CI^D:G96UM)!>6\DK$.<J8W0F/J/GR#CJ"#4)\"ZO
M;>%_#FDVLUK*=+U9+]A/</A(ED9EA1MA+8#!03CIT[  U[CQ=/+XAU31M/\
ML7V[3S'BSN'*RW*LBN7C]@&(Q@Y*G.,BH+'5-<N/BAK6GL]JUC:V=N\<66&
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M0MLK>2BJS ?*%4]VSCCZU3'BW6-/\8Z?I&NZ5;6UGJHD^Q7$%P9"CHNXI*"
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M171DBPV&(= R@["%SD\CI@XK0_X276H;J/1KR*SBUA;=KF>2VMI[J%4,C+&
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MHH'>N4G\1^)+;Q?%H,ECIA-]:27%I(LKXB*,H82<?-PP(V@<\>XI/XVU/_A
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MD [NBF1%FB1G7:Y4%AZ&GT %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN$M8-P)WRMG:HQZX- '.:UX:UK4(-"NH[VTEU33K_P"V2><K)"X*LI50,E0
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M *PGA!@'KTSVQT- %"/QC?Z3JGB*S\0QVC)I=@NI1RV2LNZ([\H0Q/S IC/
M.>@IUOXE\0/K&EQ?V?\ :+*^5A,\>GW$?V%]N5+,_$BYX) 7U]J?>^#KC5?$
MNLWE\T']GZII8TUXXW;S$ +'<"5QGYSQVP*=X9T7Q=IZVUCK.M6-SIUD L4E
MO"Z7%P%&%$A)P .,XY..3UR <7<W>K:A\'/&=SJE[#<GSKN/Y8"ARDNWKN(V
MX P,<>IKL+/7]9L?%6BZ/J,-C]BU2TE>W\C?YD+1*I(=B<,"&[ 8/K5"7P)K
M/_")>(O#L=]8FWU*XGD@=D<-&)7WG?UR1R !USG/:MBY\/:G=>)O#6JLUFL>
MDPS12QAV)D\U54E3MXQMSSUSCCK0!D_\)SK%W866L:3IKWMC<7 4V::?/YOD
M%BOF";[A.,-MQCG&>,FU:^(/%6I>+-:TFSMM(CATJZMED>9I"7AD0.P7'\>#
MU( R.^<B+0?"7B?P\6T6TUJR/AH2LT)>%_M<,;$L8E8';W(#')&>!TQKZ'H6
MH:=XL\0ZM</;-!JSPNJ1LVZ+RXQ&,Y&#D#/;'O0!:\4>(%\.Z5'<"(2W-S<Q
M6EM&S8#2R,%7)[ <D^PK.E\0ZII/B[3]"U-;.X7589397,$;1 2QKN:-U+-P
M1R&!]L=ZO>+_  TOBG0C8K<FUN8IDN;6X"[O*F0Y5L=QV/L:KKH>HZCKFFZS
MK"V:W&EQ2BVAMI&9'ED4*SLS*"HP" N#C<3DT 4/!OB#Q/XEBM]0N;?2H=.$
MUS!<*AD,I9'95*=L<8.?K[5<\3^(-6TG7_#^GZ?;6<L>IS20LT[L"I6-G&,=
M!Q[^F.]3>"=!O?#>AOIU[);RG[3-.KPENDCER"".Q;'O2>(="OM4\0^']1MG
MMUBTN=YW65F#2;D*8& <8!SF@#$'CV\TBP\5'7H+:6ZT*6)%-F&1+CS54QC#
M%BIRP!Y/K6C?>(=6\/ZWHMMJXLIK/5IOLBRVT3H;>X(RH.6;>K8(S\I&*HWW
M@";69?%\6HSPI:Z_Y!C,))>W:)0%/( /*ANW3'O6B/#^JZO/HC^()+-AI,PN
M0;8L?M,P4JKD$#8!N)V@MSCG Y *GP_N]8O;KQ-)J5_!<+#K,]N EN4(*+&H
MVG>0%P/NX)SSN-;&NZIJ-C?VD-O]DM;*2-VFO[OYU1Q@)&$#J2S9)Z_PX[U!
MX:\/:AH.JZVSW5O+I]_?27T:K&1*KR!<ACG&!MXP.<]J9K&@:O<>,=.UW3KR
MT"6]K):O!=QLZIO8'S$ (^?C!Z9'&: +'@GQ!-XH\)V>K7$*0SRF1)$CSMW)
M(R$C/(!VYP>F:A&MZEJ^IZO::*]G#'I;B"26ZB:3S9B@<J K+M #*">>2>..
M7>!_#U]X7\/_ -EWMW!<B.>5XGBC*_*\C/\ -D]?F[=/>L]?#.NZ1XIU6_T;
M4+%=+U5A/=0743,\,H4*6CP0#D <-WH I:9X[U.^TOP9?O;VBIKUPT,\85LQ
MX#L"IW>B <BKLOC>33+[QB-4CA-IH$,$T;0J5>02(S;3DD9R  >.M<WX4T"^
MUGX6>";O2Y[>.^TR7[5&MR&\N09=64E>1PW7VK=7P)>W][XJ;6KZVEM=?MX8
MG2WB96C9$*@J2>Q/&<YP#QTH L7WB?6-!.A7FK1V4EAJEQ':RK;HRO:22#Y#
MN+$.N?E)POK[5#IWB#Q9K&O:M86D&C0PZ9J"02R3&1BT10,=N",N,]\#M[U/
M'X7U;4+#1=-UVXLY;;2IXI_.@+;[MHA^[W*1A.<$X+9QVS5WPYH6H:3KNOWM
MT]LT.J7*W"+$S%HR$";3D#/"@YH P/\ A.]5_P"%:1^)_(LOM*WOV>6'8VQE
M^T^1E?FR#CGG-:ESKWB";QS?>'+&+38UCT]+R*XG#OC<Y7YE!&?N] 1USGC!
MPY_A]X@;PE>>&(=2TY+#[;]IM96B<R%3<";:_...>G7CIS720:#JD7CNX\0O
M)9R1R::EEY89E.Y79]W0X!+8QSCU- ',_P#"?>(QX'B\4O9Z6EO;7'V>^MQY
MC/+B?RF:,Y 3GD [O\?3J\Z?P'J[_#>[\+?:;$37%TTXN,OM4&?SL;<=<\=?
M?VKHX[K7O^$T6W=[%]):TW211!C)!*".2_0@YP!@$X)[&@#/\?WSC^P=$0D)
MK&IQV]QCO N7D7_@04*?8FM/4-9G'B6V\.Z;Y"73VCWDLTR%TBB5@@ 4%226
M/J, 'Z52\=:5-=P:1JUM&TDVC:A'>-&@RSQ#*R!1W.TD@=]N.]1>(/#^HZEK
M>F>*O"^HV<5_# T!%RI>"ZMW(;!*\C!Y!% $US%J^L^!=5@URSCL]019A$]N
M^5)3)BF3DE>0K $Y!%7O!FM/XB\&:1J\H FNK9'EP.-^,-CVR#5?4FU'3?"%
M_P#:YUO=7ND=(HX4*HTSKM2.-220HXY)_O,<<U>\+:*/#GA73-'#!S:6Z1,P
MZ,P'S'\3DT 9>AZYJNL:CXFL&2RM9]-NTAAD6-I%(**^6&Y23@XXQ6;\)8)Y
M_ASHEQ>O;W $9DM_W!#QL6?<2Q8Y)SU 7OUS6IHNA:II.K>)+]FLY#JDZSPH
M'8>650( QV\\#.1]/>I_ ^@WGACPE8Z)>203-9H46:$G#@L3R"..OJ: ,HW>
MLO\ &%K 7\ L8]'6X6$VY. TVUAG>/F.P?-C '&WJ3RNEZ]K7AGPAXAUFRAL
M7L;+7KMKB.;>9)4,^"$(("D ]3NSZ#OW=WX?U'_A/HO$5E=6RPMIXL9X9D8M
M@2&0%2#C)R1STZ\]*P9O FKS^!->\/-<V*RZI>RW(F#.5C$DF\C&WG&,>^>V
M.0#8U3Q-=MK-]I6E;$GLH(Y)))+&:Y5GD#%4Q%C;PN22?XN!P:RI/&?B1X_"
MBC18+*ZUEY89[>]+AX)$1CG''R_+N]2#CWJWJ/AGQ);^)CXA\.W^GP7-W;QP
M:A:7J.\,A3.UU*X;< 2.U3ZCX:U>ZU+PW>?;+>>32IY+B=Y=RF9I%92% !VJ
M-QQR> ![D @'B77/M$NCRFRCU>SMDENY;>QN+J R2%]BJJX91A<DL>_ /-;_
M (7U2^UGP[:7VI:;+IM[(")K64$%&!(XSS@XR/8UB:UX:UZ+Q8?$7A?4+*&>
MX@6WO;6_C9HI0I)1P5.0PR173Z;;W-M8QQWEU]IN>6EE"[06)R=JY.%&< 9/
M ')ZT <9KOC35]#:6XN8;&*--2CMDL6R\\MNSJ@FW*^%R22 5[8ZFK&I>(/%
M#^-+WP[H]MI(:+3TO89KMI".9"F&V\_PGIT]>QS+WP!XAN-'U?3$U33VBNM3
M&HPS2PN97/FJX20YQ@!< C/  XKH;70-4B\>R>()YK1X9-.2Q9$W*V5<OO P
M1R6(VY_$T 9-_P"--8EL]0O-#L1=FRNGMQ9_89Y&NC&VV3;*OR)R&QD-]T9Z
MX'=6\IGMHIC&\9D0-L<89<C."/45Q-MX5\4:)K6HC0=8L(]&U&Y>ZDCNX&>:
MUD<Y<Q8(!R>0&X'H><]O%&(HDC#,P10NYSDG'<GN: 'T444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 445S'CO7=2\.>'TU#38[:23[5#"ZSAB"))%3C!X/S>_TH Z>BN+B\3ZII
M7BZ_TO77LI+2/2FU6.6UB9#$J/M=&W,=W&"&X[\"J=[XRUC3O!EAXSGCM'TN
M;RIKBS2-O,B@E("LK[L,R[E)&T \XQ0!Z!6;JVL:5IK6MKJ<Z(;^9;6&-T+"
M5VX"X /7WXJ35]5M]%T2]U6Y)^SVD#SOMZD*,X'N:\]\43ZS>VO@;4+Z2S$-
MUKEG*UM%$P:$L&*@.6^; )!X&3R,=* .RTFV\,V.N7MAI&G6-IJ,$:/<BWLQ
M$=KYVY8* <X/<UO5R$7B;51XF\5:<UK#<)I5E%<VD4"L))BZR':22>25 &!3
M?"GB>?Q,HGLM4TZ[A^S$S1K"T<MM<97"NA<G;][L/N]3F@#I-)U:RUO3TO\
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MBH88)&&X(Z5<R,9R,4 >=_\ "O=67X?OX3&K6;0)<*\$QMV!5%F\[YOFY8G
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M;2M/GO[R0QVT"%Y'",VU1U.%!-+I]];ZGIUK?VKE[>ZB6:)B",HP!!P>G!H
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M$ R>N0,]JK^*/"^H:CK&FZ]H6H166KV"O$//C,D4\3XRC@$'J,@C_P#5U=%
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M]/TO6](T][FVNYE9[(V^T"V8GYA*6^^!@],'D8[UUOB?6U\.>'+S56C\TP*
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M-="W:'<%/[O.>1DX; /;TY-6QX'U#^PO%6F-JML?[?N)IS(+5OW'F($(QO\
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MR+B.(*<??^3(SSSR>V.==?$.N6WBGPW'=R6<FGZ\DN+>.%@]LRQ>8OSEOGR
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MQC: !B@# A\6^(]4TW3M<T:P>ZMKF<%K+[/@&V+$;A*6^^!@],=L=SVVL_\
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MPR@@XP 3QSC@[\?AS44\;-XC?4+9R=-%@81;,O1R^_.\]ST].] '.P^/KY/
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M !_+QSWYI;;3CJOQ%DU_K9Z?8FQMV[22L^Z1A[* JY]=P[4 =91110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 @4#. !DY..]+110 4444 %%%% !1110!'-!#<Q&*>))8S
MU1U# _@:DZ444 %%%% !1110 4444 %%%% !1110 4444 %%%% $-S:6UY&(
M[JWBGC!SME0,,^N#3XH8K>)8H8TCC485$4 #Z 4^B@ HHHH **** "BBB@ H
MHHH **** (Y8(9]GG11R;&#IO4':PZ$9Z&I*** "H+FSM;U EU;0SJ#D"6,,
M ?QJ>B@",6\(M_LXAC\G;M\O:-N/3'3%,MK*ULE9;6VA@5CDB*,*#^53T4 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5XK"S@N'GAM((
MYG^](D8#-]2!DU8HHH **** "BBB@ I&4,I5@"",$'O2T4 06UC:6086MK!
M&.6$487/UQ4]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!6ETZRN+A9YK.WDF7&V1XE+#'H2,U9HHH **** "BBB@ HHHH *1
M5"J%4 *!@ =!2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
L !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>exhibit107-formofindemni005.jpg
<TEXT>
begin 644 exhibit107-formofindemni005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN #AE89S@C'KGB@#;HK!3Q?I1O;FRF-U;W4%O]J,$ULX=X<XWJN,L,]0.1W
MJK9_$'P]?2:8()[@Q:DP2VN&M9%B=R"0F\C:&.#QG- &U'ID4&JS:A;L8GN
M!<(!\LI PK>S 8&>XX.<#%ZN9TGQ<FJ>+]8T1;.YC73_ "D$CP, S,K,23T5
M<!<9QGGVKIJ *4>F1+JKZE*QEN2GE1L1@11YR54>Y )/? [  7:R+_Q'8:?/
M<0,+B>6VC$MPEM"TIA0YP6P.^"<=2!G%5KOQMH%G;:9</>EX-3(%I)#"\BRG
M!. 0",\'CKVQF@#?8$J0&*DC@CM6)X?T"YTDR3ZEK%QJ]^ZB/[3-&D>V,$D*
MJJ,#DDD]3QZ !D'B[3+VTM);<7;RWBR-#;"W=9MJ-M=BA *@'C)P,D>HKGOA
M_KL8T3Q!>WM]=2V\>NW$,#7)=Y0N45(PI^;/( 7&<]J /0**YT^-M%C34S<R
M7%O+ID8FNX9;9_,CC(R'V@'*\'D9 [XJQHGBG3/$,TD>GM<-LACFWR6[HC*X
MX*L1ANA!QW% &U12,RHC.[!549))P *R;'Q'8ZC<VT,*7(^U0FXMY'@94EC&
MWY@W3^)>#@\]* ->BL'_ (3'1Q>64#RS)'?2>5:7+0L(9W[*KXP2<''9NV:R
M+3XAPS6OB6[?3;_RM'GDC"+;-N=4C1CD]%.6/!Q@8)Q0!VM%>;>(->NM5\'>
M%=8AEO+*:XU/3Q,B%X5<2,I9<'&Y.?<&NRU3Q'8:29Q,+B4V\7G7 MX&E,*<
M_,V!QT/'7 /% &O17/2^-] CN+"!;N25]0@-Q:^3;R.)D !^4A?F/(^4<\]*
MIGXC^'AIL]\'OC':R-'=QK92F2U*_>,JA<H!UR??&<&@#K:*S;G7+*WCMRC2
M7+W,9E@BMD,C2( "6 '\/(Y/'('4BLL^/_#BZ?8WQO7$%[<?98F,#C;+D@H_
M'R,,'AL=* .FHKFXO&VE3VFKS0QWS3:4@>XM7M'CFVD$J0C '! .#[<XJUX3
MUT^)/#5AJC020R7$"2.C1LH!90?E)^\.>HH VJ*;)(D4;22.J(@+,S'  '4D
MUB6WB[2;G4K*Q$DT<E^C2632PLBW*J,L4)'/!!YQD<C(H W:*P+CQEHUJOG2
MS2K9B?[,U[Y3&!9-VW:7Q@#=\N[[N>,YHOO&6CV&KS:3(UW)J$4 N#;PVDCN
MZ$X!4!?FYSTR!@YQB@#?HKFV\=:"NBZ=J_VB9K'4)1!!(EN[?O"VT(P ^4[@
M1SCD5JSZO:V]^ME()S,T#3X2!W&Q2 >0#SDCCJ>U %^BN8\.ZSHEMX+M+^TU
M*[NM-=V2&XNR\DTS&5E"X(W,2V0!C.,47GCG3+73M;N%BNGNM'B\VZLC"5E4
M%=RG'3:0,[N@YH Z>BN+G\1:;J.@>'+O5;C4;"6\N[7RA;QRQ"2<@$(3CF,D
M]S@@>U;]_P"(;&PN9K8K<7$\$0FFCMH6E:)#G!;'3.#@=3@X!H U:*Y^Y\;^
M'[6STR\>_P!UKJ;A+2:.)V1V.>-P& >#P<'@\59T7Q+IVO3WMO9FX2XLG59X
M+FW>&1-PRI*N <$<@T :]%4=0U:TTPP).S--<.4@AC4L\K 9. /0#)/0=S6:
M?&FB)I.H:C)/+'%IS%+R-K=_-@(&?F0#(&.<]".<T ;LHD,3")E63'RLR[@#
M[C(S^=8OA#PZ_A7PY;Z,UX+M(&<I)Y7EDAG+G(W'NQJ71?$VG:_-<1V!N&\A
M8W9Y('165P2I5B &'!Y&:DC\06$NKWNE(TQOK.)9I8O);.QB0"IQALX/2@#4
MHKF3X^\.+I6G:FU[(MGJ,IAMI6MY &<$@@Y7Y>5;KCI4^B^,M%UV>^@MIY8;
MBQ :XANX'@>-#R'*N =N.] &_16%#XNTF:ZL83)-$NH<64TT+)'<'&<*Q&,D
M<@'&1TS5.Z^(6@6K:BIDO)'TUMMVD5E*S1#&XLP"\*!SN/'IF@#J:*BMKF&\
MM8;JWD62"9%DC=>C*1D$?4&L1_&FBI<+&9I3$;S[!]I$3&+[1G'E[O7/&>F>
M,YH Z"BJ]]>P:=8S7ERS+!"A>1E1G(4=3A02?P%<W:_$?PU=W>FV\=U.!J04
M6L[VTBPR.PR$$A&W?[9X/'7B@#K**XK1+F:/XG>+8)KR=[2&ULY4CFF+)%N$
MA;:"<*.*V(?%VDS:E9V)>>)[Y2UG)- R1W  R=C$8)QS@XR.1F@#=HKGX?&F
MBSW%HB32F&\N6M+:Y\IO)EF7(**WKE6 /0X.":W)YX;6WEN+B1(H8E+R2.<*
MJ@9))[#% $E%8EOXKTNXO[2S9IX)+U2]F;B!HUN !D[21UQS@X..<5RTVH?\
M)3XWUW0+B75[6WM;6W2V>T$L+12OYA:0D8_NK@MQP<=30!Z)16+JFO:=X5T^
MQ_M:\FVR/':K.\9;>YP 7*C:N>N3@=:-*\4Z7J]_>6,#7$5U:*LDD5U;O VQ
MLX<!P,J<'F@#:HK!C\8Z/)-9*994AOW\NSN9(66&=^P5R,<XXSC=VS65I,UP
MOQ8\06K7=Q);+I]M*D,DI9(V9GSM!X&<#I0!V=%8'_"9:,&MF::5;6ZF\B"\
M:%A!))D@*'QCD@@'H>Q-;KNL:,[L%102S,< #U- #J*PK?Q?I%SJ-C9"2:-]
M05GLGEA9$N0HR=A(YX.><9'(R*;<^,M&M%::::46:S_9WO1"Q@23=MVE\8'S
M?*6^Z#P3F@#?HK OO&.CV&L2Z3(UT^H1V_VC[/#:2.SIG V +\W.>F<8.<8K
M,U;XA6%OX<TO6--BGO(=1O(K6,K"WR%I C[AU!'S +U)% '945DW?B*SM$&8
MKN67R?/:"&W=I$CY^9EQD=#@'DX. <&J+>//#@72G6^:1-51GLWC@D82A020
M"%^]QC;][.!C- '245B:;XMT?4].O[Y+A[>+3W9+L7<30O 5&3N5@"."#7,:
MEKC7?Q-\'0VTFI6\-PMVTD$RO%',@A)1MIX)!SP>1D9 XH ]"HK!O/&.CV,J
M?:)9EMVN/LOVOR6,"RYV[2^,#YN,] >,YJO/X]T&WU2XTTR7;W=M-%#-&EG*
MQ1I/ND_+]WI\W3D<\T =-3)D:2&1$D,;LI"NH!*GU&>*Q+[QAH^G.#<RS+;?
M:/LS78A8P)+G;M9\8'S?*3T!X)!K<DD2&)Y975(T4LS,<!0.I)H QO#VA7&D
M))+J&K3ZKJ$JJCW<T:QG8N=JA5& !N8]R23D],;=84'B[29KJQ@+SQ"__P"/
M*6:!DCN.,X5B.I'(!QD=,U6_X3W03JCZ<DEV]S'=):2*MG*?+D?[N[Y?E4Y'
MS'CTH Z:BL#QI>Z98^%;R75[R]L[(A5>XLMXE3YAC#("5R<#/3G'>J]]XM2R
M\:V'AT6=T_GVSSO,L+,."H &.OWN3T''X '3T5CKXET^2YCB07#I+<-:I.L+
M&)I5)#+N[8*L,GC(QG-;% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF>W=8Y&19-P#$8.-P[UW%% '%?$I99-*T=(;>XG9=8M)F6"%I"J)("S':#@
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M7MC;2I<VW]H FREN(MB7'&< ]CCD!@">PKF;F\/B?QYK'A^]BU..RM[*%83
M6C,4CL^9<@\'Y5VDYZ'U.4U%;CQCI?A:TBT^]M+RTU&VN[P3VSQBV$0)<;F
M!)/RC:3G.>F:OZ0)E^*WB&X>SO4MI[.UBBG>UD$;LF_< Q&.-P[T 7_%DVEZ
M1X,,6MW>I&S011/<P%_.9@RA2SH!@E@,G@'/O1=>*W@\?6WAM;"Y='LGN7F5
M,@G>BKCGH-S9/T]ZJ?%.WN+SX?:A:6=I<W5S*\(2*WA:1CB5&/"@]@345_\
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M4U*T62RNGD@N&98W 5=C!0Q7/WL]&'<=*Z&[\9Z58O$\_P!H6REN/LHOO+S
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M6S7:"RES %@9&+?+QAB!5S0Q=^';;Q5HNIZ?>W$ES>W-W9R0VSRI=QS#(7<
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M=K:Y5=S1$X#J59E89XX/!ZTS7/%FGZ!J-A8W<=V]Q?EU@6"!G#%5+8STR<8
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M=[ @$=203SCH:WM6\56FDI>R&UO+N.P4/>O;(K"W&-WS98$G;\Q"Y(!!QR*
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M]O$ 7E?!) !(' !))(  Y-9?_":Z5':ZM+<I=V\VDKOO;5X=TL:XW!L+D,I
M)W D<=10!T=%<E:_$71;K4M-LS#J$":FH-G=3VQ2&9B,[%?NWZ'L34-U\3=%
MMH=0F6SU:>/3KAH+MH;)CY&T EVSC"\]^>#Q@4 =G16/)XET_9I_V0O?2ZC$
M9K2*VP6EC !+_,0 H!')(Y('4XJO!XRTF?3;F[S-'):W*VD]K(@69)V8*L9&
M<9)9<'.TYSG% '045CCQ':I#>R7EO=67V,H)%G0$L7^Z%V%MV20!CN<=:BM?
M%=C+K$^DW<-QIU]#;?:_+NP@#PYP75E9EP#UYR/2@#=HKS3Q=KRZE=>#+BT@
MU*&WN=;MO*N&)2&XB.X\J&SS\I&]0<#CO7<^(-6.A>'[_51:R77V2!YC%&0"
MP49/)( ''/\ 7I0!I45S.E^*UE\-:/>W]M.E[J"1K#;JJ[[B0QAR4 ; 7&XY
M8C '.*T-)\0V>K7M[8JDUM?V147%K<* Z!AE6X)#*1T()% &M117 MXGN?$-
MEXRL7L+VSCT\20QRK($*E8@V2R-D$DY&.V,]Q0!J6G@ZYTV62/3O$^K6UA)*
M\QM-L,FUG8LVUWC+ $DGJ>M=):6L-E:QVT"[8XQ@ DDGU))Y))Y)/)-<-X+\
M86</AWPEI=U%?"6]L88HKN2$^3)*(@2F\G);@]L'!YK=U;QEI^D0W-U-!=RV
M-G((KN\AC#1P-QG/.XXR,E0<=^AP =%156[6.\TN8+(QBEB)#Q2%201P0RD$
M?4&O-_ GCRPTSP3X:M]4340+B-83J,ENQM_-9CA6D/<^O(]3P: /4J*PM6\5
M6FDI>R&UO+J*P4->R6R*PMQMW?-E@20I#$*"0""1R*'\5V##-C%<:B!:)>L;
M0*=L+YV-AF!.=K8 R>.G3(!NT5R4WC&;_A--,T6WTRYDM[JP:\,PV<C* 8!;
MH-QS^&,UUM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<OXYN=5M=,L7TVTN+
MB,WT0O#:Q"2>.#G<T:_WLX&1R 21SR.HHH \BFT_4$A^(\$.A:JD>J6<8LC(
MAD,I^S[,9R26+'G.<=\5L7$%T^K_  [F6POC'8I)]J/V5_W.ZW,8W<<?-Q^O
M3FO1:* /'4@UC3/AQXE\&W.B:G/J %W]FN(+=I(KI)&9PP<<!OF.5//H">*]
M3T4R?V%8>=!)!(MN@:*0#<I"@8.":OT4 >1W.GZC+X"^(-DFEWYN=0U2XEM(
MOLK@S(^P*PXZ?*?IWKH=02XN/'/@F\BL;TV]K;W2W$GV9P(C)&@4-QQDJ?IW
MKNZ* .9\<W.JVNAP2:5:37!^V0BZ^SQ"2:.#=\[1J>KCC'!QG/:L;P?:W5IX
M^\2SG2=2M[*^AM'@GNLMNV(X;<S,3NR1P<D=\5W]% '&>*8;B3QWX-N8K2ZE
M@M)[E[B6*!G6(/"R+D@=V-4;&*YB\1?$"X>PO1#>K";9OLLG[[;;B-MO'/S<
M?KTKT&B@#RO2&UK3]%\%Z=<:1J@L([!H;W[+ RSI.H4*C'AD0\_," 2!DXS6
M9#INJP^!8]-;0M2BGA\2BYV>07S$+DR%AMSD!<<]#VS7L]% '#2B=?BM<:G]
MBO39?V +<3+:R%3*)F?8..NTC^76N9MM.U*'X6^#-/?2[_[98ZI:RW,(M7+1
MI'*69CQTQ^?:O7Z* /+A"^A^*=<MM5\&W.MV>J71N[.[M[-)N'50T4F[&P C
MC/'-:EK:7-K\3]+F.ER06D6@M9LUM;M]GBE,J,(U8#& %//3Z=*[VB@"AKEM
M+>>']2M8%W336LL:+G&6*$ ?F:\W>+4)_!/@*T.C:G'/IFH6)ND:U;*+"A61
M\#/R@].Y[ UZO10!YY=+JT/C7Q9J&G:9/+)+H\<=F9H&$4TR>8=F2 #]Y>_/
MK6=IT6HS^+O!VJG1M;;9:W,-[-=Q[2DKK'U4D!%!#= !Z9KU2B@#B_A]!>Z=
M%K.G7FGW5NZZI=3K+(F(Y$>0LA0Y^;(/;ICFCQ#!>V_Q&\.:K%I]U=6J6MU;
M2-;IN\MWV%=W/ .T\GBNTHH \P6TO3HOQ)B_LZ_\S49)S9J;63,P: 1KMX_O
M#^O2JLMK>:1?>'M;NO#-WJ^G-HD.G75M':>9/:RH<AO+;D@Y(./3/IGUFB@#
M(\.11QZ89(=&CTB*:0R):B)8W ./F=5X#'&?I@'G-<S/'<_\+KM]2%C>FQ71
M6LVN1;.8Q*9MVW./0=>GO7>T4 >3M8Z@_@/X@V8TR_\ M.H:C=R6D1M7!F21
M5",..AP?IWQ5^W.HZ#XWM-;FTO4+K3+_ $>&S9K>V>22UEC).'C W!3D\XZU
MZ310!XV=&UV;P_J=U%X?N9)K3Q7-JJV-TBK]K@)8%5!)!.&)';CC/%;UT8=7
M\(^(9],\&W.ERSZ7/:KYVGK%<SR.A"H%7+;0>I/&2,=#7HU% 'FUU;W;0?#O
M;I]\382(UV!:R?N0(#&=W''S''Z]*COK6];5OB2ZZ=?,FHZ=##9L+5R)W6"1
M"%X_O,!^O2O3:* /-);:\-O\. -/OB=/9#=C[*_[C%N8SNX_O''Z]*FM]/OK
MK5OB.BV-T@U*)%LWEA9%F(MO+."1C[W'Z]*]%HH \EFM=5'ACP5JG_"-7=XN
MAPBVOM,F@'FR*851G1#][:R\=S].:N:WID^L^&GU+0O"*V3V][;7@L;FV2":
M^$1.Y74=L-A0W.0>.1GTZB@#DO"LUIJ-ZU_:>$)=%VPF.2:\LDMYF)(.Q0.2
MHP22<#.W&><0^+(KA_&O@ZXBL[J:"TN9WN)(8&=8U>%D4D@>I'\Z[.B@#S?7
M(9]#^(%YJEYX8N-=TG4[:%%>UM5N)+66/<,%#R%8-G/K4]ZVH65SX>MX/#MS
M9:+*)VN(-*A DA8D&-&*'Y <DL5(&[C..OH-% 'DFDZ*K^$[C1]=\.:LENVO
M3R+)"C>;;AC(Z31E"6.#M&X9'S=^:6?1O%3:%:7#O>:JNB:]'>6@N(_+N;NT
M5<-N4X)<;FP3@G;[BO6J* .*>V;6?'NF^(HK:\AL=,L)D=YK62-Y7D*X0(P#
M' !/3&2 ,\XY*VTW4HOA#X:TQ]*U 7UKJ4$DUO\ 97+(J7!=B>.FWFO8J* /
M)_%T>MZU:>,=.FT;5)6>'_B6"VC*P21^6/F8Y&^3.1M;)&  .M:T7VNS\<:+
MKMSI>HI8MH363E+9I7BE,J, Z1[F&0IYQ]<5Z%10!Y/KWAW4G\"^-KB+3[DW
M>O78EMK*.,M($&Q06 ^Z2%+'/3(!YXKI/'EK+/X9M?$&G*5U/1I%O;42*49P
M.'B(/(WJ2N/7%=I6)>>&8K_Q!%JEQJ.HM%$J8T_S\6Q=6W*Y3'+ X/7' ]*
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M ",]ZV?B'H=[XC\":GIFG$"\D5'B5C@.R.K[2??;C\:Z&:TAN)89)4WM"VY
M2<!O7'0D=B>G:IJ .#U-+CQE>>%I(]/OK)M/OEO[PW-N\7D[$8>6"P&\EF ^
M7(P"?3-GP!#<6\WB<7-G=6_VC6[BZA,\#()(F"A6&1['CK79T4 <;\08+FX7
MPX+:TN;@P:Y;7,OD0L^R)"=S' [9'O6+K>AWVN^*O%MM!!<PQZCH<=I;W,D+
MK&TH+DKNQT^8?F:],HH \UN[:^\5>$O#^AR:9>V>H6UU:O>&:!D2W$)!=ED(
MVOG&%VDYW#I@XUO#\%[8?$3Q6)]/NA;W\MO/!=!/W158 I^;/7<,8Z]^G-=I
M10!QGC&QOXO%'A?Q':VTUW;:9+/'=P0*7D$<R!?,51RVTCD#)P>!6+XATV6]
MG\9^)UAF@LV\-R6,0FB:-IF"R.S[& 8 951D#//:O3:H:UI:ZWHMYI<D\L$5
MW"T,CQ;=VU@0<9!'0^E ' K:R>*O"W@>PMK.Z1K.:RO;B::W:-(DB3)PQ&&+
M'"C:3UST%-T"_$+?$"S%A>74LVKW C2&W9UE9H4&PL!M7MG<0,'ZUZ%I.G#2
M=(M=.2>29+:)84DD W%5&!G  S@>E4=!\-QZ!<ZG-%>W-P=1NFNY5F"860@
M[=JCC"CCF@#B=*\.:GX+UCPK?2PSWMI;Z,=*O?LL;2M Y82!PB@LREAMR!P
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M" PG+J\V]3GIC;ZGC\JZB]CN9_B5X?U)+&\-G#I]Q%+,8& C=RA4'C/\)^E
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MP>A.!@'FM>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.E^EO9SVK./(,;6Y883'!!4<]: /6:Q&\2(GC./PV;*<2O9/>+<%EV,JLJX
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M:2Y 3>X+<I\Q4$8(![UW- !1110 4444 %%%% !1110 4444 %%%% !1110
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MBFL)OM%M>)+F=)3G<^YL[BV3D,"#GI5B/PQIYCU$7HDOY-1C$-W+<[2TL8!
M3"A0%&3P .23UYK9JEJUU>66G//8:>VH7"LH6W658RP+ $[FXX!)_"@#+T_P
MA:6(T]);V^O8--.ZRANG1E@.TJ""%!8A20"Q;&?7FN8\,Z3)J6O^,Q)=:K90
M7E_D*L7EK/%Y:J65G0GKN&5(/Z&O0VN84NX[5I%$\B-(D?<JI4,?P++^=2T
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MF611+$R9"\[<$8)'(/6J.MQ6_BB\3PG)HNH/;V=S!-->W4)\DHF'^20GYV;
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M[=K>/F/:4;&[(V=3@?EQ7->(_#*:+X:OK>T36;Z#4]42[OFM6!G@)8.\L80
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MZG.>OO0!Q<8U[Q?9ZXVFWQM;VSU*:SMI_P"T)8_L_E, -T*H5?<!N.[.=W8
M8C\3:OJ.F7%Q<:V;\Z/<6D21:MH]PY2QEV?,SQJ02I8A@Q!XP*Z6\^'NBW>O
M3ZNLNH6LMUC[9#:7;Q176./WBKUXZ],]^IJ[>>%+2]>_#75Y';:@@CNK6.11
M%(H0)C!4E<J,$J0?TH YF>"ZUWXE:AI8U_4X=+DT>&Z1+2X\O!:1AE6 X& #
MQR?7&0<;1O$FN+:6'AZ\O&N91K]WI37LTYA>XBA0LH,B@D,QP,@9.TC.3FMM
M=+EE^+=S+;C4K&U31HK6*Y@MR(BRR.2F70H< K_0UOW_ (&T+4?#B:'/;/\
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M<Y[9QQ0!A1'Q!XQTW5;O3+Y;*_M]2F@MYO[0E1;?RI-H5X50HV5&3NSG=VX
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M[!K#0K<><=[)]L$>">N-IZ#%=_9>"[&SUF+6&O\ 4[G48K8VJSSW18E"<\@
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M=NR1MXP:ZP3_ /"1>.O$&AWES<0PZ?:6_P!GB@G:(L90Q>7*D$D':!V&/4T
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M:/88'M7'>-[VY33?%^H:=J5[<7-@4*31S-#%I[*JDQKAOWC'.YOEQAL$\8H
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M2<'J>H^F*-/\&Z5IJVL47VE[6SD\VTM9IB\4#<X*@\\9.,DX[8KH** .8OO
M&@W^NRZN\=U#/< "ZCM[IXHKH#IYJ*0&_'KWS5O4O">F:GK%MJLANH+N"$V^
M^VN'B\R+.?+?:1E<\XJ/Q#XBFT/4]#M5LEFBU.]6T,IEVF(E6;.W!SPI[BMV
M4NL3M&@>0*2JDX!/89[4 <S'\/M!BTF#3(DNH[2"[^VQHMR^%F#;@PYXP3G
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M#P.U=%:>#-$LBJ06\JVJ3_:4LS.Y@23.[<L><#YN0.@/( -6G\.:6_B'^W3
MXU#REB9UF<*ZJ25W(#M8C)P2#C\J .=^)1G6T\/FVO;JT>37+.!GMYBF49\$
M$=&[=0>E9:Z9+H'Q&DTBQO\ 47TO4](FN)H9;R61H948#S%<MN7.['!Z_AC6
M^)-A/JFGZ-;06EU<A-7MKB<6ZME(4;+MN7D$#T.?2M^#0+!#<3G[1)<740BD
MN)9G\WRQG"@YRHY)P,<G/6@#SK0=*,OP=?Q))JFK-JCZ%/F7[?* " S*P .
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *SM:T+3O$-D+/4X7FMPXDV+,\8W Y!.TC." :T:
MPO&&O3^&/#%[K4-I'=BT3S'B>8Q[AD#@[3SSZ4 2ZYX7T;Q)IL=AJ]F+J")@
MT9:1@Z,.C!P=P/OFJTG@?P[+HL.D-I_^B0SBXCQ-()%E'1_,#;]WOG-)'JOB
M*2QM;P:-8/%-Y3.L=\Y=48C) ,0!(!SC(SCK714 <Z/ OAM6O7730K7HC%PR
MS2 N4(*G(;(;*@[A@DCDFK\/A_3(A=AK<SF[C$-PUS(TS21C.$)<GY?F;CIR
M?6M.B@#'TWPOI.E/ UK#*3;(8[<37$DH@4\$('8[>...W'2H!X,T$6&HV/V2
M7[-J,K37<9NI2)G;[Q/S=^,^M;]% &!)X*\/S7MO=R6!>>WMQ;*S3R'=$#D(
MXW8D'LV:9'X&\.P:5::;!IYBM[.7SK8QSR+)$_3*R!MPXXZ]..E=%10!F1Z!
MIL5C=V:POY=YG[2YF<R2Y&/FDSN/''7IQTK*O([WP[8V.B>&O#[75J\;Q+))
M=#RK3  7<')8KR>!V&.]=110!1T?2[?1-&L]+M5Q!:PK$G&,@#&?J>OXU7U;
MPSI&N7=G=W]J9+BS+>1*DKQLH;[PRI&0<<@\5K44 9>C>'=)\/)<II5FEJMS
M*9I%0D@L3DX!/ Y/ P!GI4MKHFFV6E2:7;V<26,GF;X,95O,)+@CT)8_G4C:
ME:KJR:7YH-X\#7 C'41JRKD^G+#'K@^E6Z .9M?A_P"&+-K!H=-.[3V+6K//
M(YCR,;068_+C^$\>U7(O">C01ZG'';S!=3):\'VJ4^:2,$GYN#CCC''%;5<[
MXI\07>@W.A)!:PRPZCJ45C([N0T>\,<A0.>%/?\  T ++X(\/S6^F0-9/MTP
M%;,K<RJT*D %0P;=MP -I.,#I0G@;PU%87EBFE1+;7D_VB:-78?O,Y#*<Y3!
MY&W&.U):^(+N;Q]>^'I;6%((+".[CE5RS/N<K@C  ^Z>.?K714 9UCH=CI[R
MRPI,T\J"-YYIWEE*CHN]B6 Y)P#U.>M4X_!OA^/0KG1/[/#Z;<L7EMY97D4L
M3DD;F)!SSD8YYK=HH Q_#_A;1_#%O)#I-H81)C>SRO([ =!N<DX&3@9P,FI=
M6\/:7KDEI)J-KYTEHYD@8.R%"1@\J1D$<$'@]Q6G37+!&* %\?*&. 3[GM0!
MCW7A31[O4)[Y[>2.XN(Q%<-!<21"=1P X1@&P..>W'2M>&&*WACAAC6.*-0B
M(@P%4<  =A6#X,\07/B70WOKNWBMYDNY[<QQ,64>7(5ZG&>GH*Z&@#%;PEHC
M7FH7?V,K-J*[;IDFD4/QM)P&PI(&"1@D5&?!NA&RTVS^RS?9]-D62S074N(6
M7A2/F[ D#/3-;U% '-ZAX!\,:IK?]L7FEH]ZP D<2.JR@=-Z@A7_ .! UT;*
M&0H<@$8X.#^8Z4M% '/1>"- @L]1LX[286^I,SWD?VN8B9F^\6^?J>Y[U.WA
M31VDTR1K>8OI8Q9G[5+^ZXQQ\W/''.>..E;5% '-7?@#PU>W.H32V#C^T ?M
M<<=S+'',3_$R*P4M[XSGGK3M4\">&]9M+&VO=-#)8#;:NDKQO$/0.K!L>V:Z
M.N=\,>(+O6[[7K:[M88&TV^^RJ(G+AAL5LDD#GYO2@">7PEHDL6FQ&S*1Z:V
M^T6.:1!$W/S?*PR>3R<DY/K4L?AO2XM3OM1CBG2[OD"7$JW4H+@9"C&[ QDX
MQC&>*IZ[X@N])\1^'M.CM87MM4N'ADE9SO0K&S\+C';KG\*Z*@#GHO _AZ&S
MT^TBLY4@TZ7SK1!=S8A?GD?/[G\SZU9'A?21?:A>B"87.HH([J074H,B@8 ^
M]Q@$XQC&36Q5*T?4FO[Y;R*V2T5U^QM$Y+NNWYMX(P#NSC':@#.?P9H,FAVN
MBM9-]@M)5EMX_M$FZ%U^Z5?=N&,GH>]1:OX#\-:Y=6UU?:8K3VT8BCDBE>)@
M@Z(2A&5]C71T4 8.M>"_#WB"TL[;4=-1H[+ MC$S1-", 85D((& .,XX%:FG
M:=::3816-C L%M$,(B_7)))Y)))))Y)-6J* .=O? GAK4+K4+BZTT2/J*[;I
M?.D"2\8W% VT-C^(#/O5B#PGHMKJ%M?P6LD=S;0?9HG6YE^6/.2N-V#D\G/4
M\GFMJB@#G_\ A"?#QTF^TM]/\RROIC/<12S2/ND)R7!9B5;/.1@TZP\&Z'IN
MIPZE!;3/?0P^0EQ/=2RN$SG!+L<C/KTK>KG?"OB"[UV?7(KRUAMWTW47LU$3
MEPP"(V22!S\WH* -#6- TW7DMTU*%Y5MYEGB"S/'MD7[K?*1R.WI5?7_  GH
MGB>V@@U>R%P+=M\+^8R21GU#J0PZ#OSBJX\07?\ PL3_ (1Q[6%;4Z8U\DX<
MEV(D5,$8 '4^O:NBH P)_!7A^YTFTTQ]/ MK.7SK?RY71XY.?F#JP;<<G)SS
MWIB^!?#:?;#'IHC-X\;S&.:1"60J58$-E3E5.1@DC)S7154O]2M=,BBDNY1&
MLT\=O'GJTDC!5 _$_EF@"M'X=TM8;V*2U^T"^01W)N7:5I5 ("L6). "<#IR
M?4TS3O#6EZ7)%);13,\$9BA,]Q),84.,JF]CM' Z>@]*J1^(+MOB'+X<DM85
MMETP7R3*Y+L3)LP1@ =_7MS714 8'_"%Z#_9VH:?]DE-KJ,K37<9NIB)7;[Q
M/S9Y[^M$O@KP_->P7DM@7GAMQ;!FGD.^(=$<;L2#_>S6_7,>*O%%YX>U'1+:
M#3H+I-4O%LP[W)C,;$$Y("'(P#WH FC\#^'8-+L].@L##!92&6V:.>19(G(Q
ME9 VX<<=>G'2KR>']-CT^[LA _E7F?M+&9S)+D8.Z3.X\#'7IQTK27.T;@ V
M.<'C-+0!RU]'?>'[&RT+PWH#7-K)$\*RR70,5I@ +N#DLR\]!V&.];FD:9;Z
M+H]GIEHNV"UA6%..H48S]3UK*TCQ!=W_ (RU_1+BUABBTV.W>*2-RS2"4.<M
MD#'W1Q^IKHJ ,V^T#3=1U2RU.ZAD>\L=QMI%GD7R]PPV K <C@Y'(J"/PIHL
M1U,_8O,&J?\ 'ZLTKR+-QCD,2.G'%;-% &!H'@OP_P"&5E72K 1"5=C>9*\I
MV?W1O)POL.*;HO@;PYX=O6N]+TT02DL5_>NRQ[NNQ6)"9_V0*Z&J3OJ0UF)$
MBMCIA@8R2%SYHER-H QC;C/>@#(B\ ^&(-??6XM*1+YY/.8K(XC,G7?Y>=F[
M/.<9SSUJW_PBND&:20P2LLMQ]J>%KB0Q-+NW;C&6VYW 'IC(![5>L=2M=2%P
MUI*)5@F:!V7IO7[P_ \?4&K= &,?"ND--+(T$K++<?:I(6N)#$\NX-N,9;;U
M /3&0/2JMYX#\-:A<:A/=:8)&U$8NE\Z0)(<8W; VT-C^( 'WKHZIZJVH)IE
MPVE16\M^%_<I<L5C+?[1'- %&W\*:-:ZI;ZE!:R)=V\'V>*07$G$><E<;L$$
M\G(Y/)YK/DCU'Q#X@BM]0T+[)IVE7GVF*YFE23[2RJ1&44<KRVXDX^Z!SDXZ
ME-VQ=X ;'(!R,TM !65'X;TB'6;O5DLE%Y=J%G8LQ5\+MR4)VYV\9QG'%:M%
M &)I_A+1=+: VMJZI;,7MX7GD>.!CG)1&8JO4]!QDXQFM'4=.M=6L);&]C,E
MO+C>H<J3@@CD$$<@=#5JB@#,@\/Z;";DF!YWN81!,]S*\S/$,_)ER3M^8\>Y
MK,M?A_X:LS8F*P=C8OOMC+<RR&+C& 68_*!T7H,]*Z:B@#G)? GAJ;7WUM],
M3[<[!Y&$CA)&'1FC!VL1ZD5=7PWI::K=ZHD4RWMX@CGE6YE!=1T&-V!C)QC&
M,\5K44 4-&T6P\/Z9'IVF0F"TBSLB,C.%R<G!8D@9[5GWO@K0=0U6?4YK-UN
MKF/RKAH;B2)9UQ@"158!^/[P-;]% '.77@/PU>>'[;0I]+1M/M2&@3S'#1$=
M"KYW _C4Y\':"?#K:"=/4Z<[!VC,C[F8$$,7SN+9 YSGBMRJEWJ5K97-G;3R
MA9KR4Q0)W=@K.?R"F@#(U;P+X<UR*S2_T[>;,$02I,Z2(#U^=6#'/4Y)R>>M
M3R^$M$F&F@V;(-,.;,13R1B(^H"L,GDY)R3DU>C?4CK,Z216PTP0J8I%<^:9
M,G<",8QC&.:NT 9DOA_39M=36GAD_M".(PK,)Y!A"<E=H;;C//2J8\%Z"-,O
M].^R2FTU"5IKJ,W4Q$KM]XD[L\]_6M^B@#'/A?26OM.O6@F-QIR&.TD-U*3&
MI&"/O<Y  .<YQ4(\&Z$++4K,6LOV?4I&DO$-U+B9FX8GYNXX..M;U<[H/B"[
MU3Q)XBTJZM881I4T,:-$Y?>)(]^22!V(XQ^= #W\%>'Y;NTNGL2TUK +:-C/
M(=T0.0C_ #?.OLV:C3P)X;CT:VTE--V6=K.+B!5FD#1R#.&#AMPZD=>G%='7
M.^-?$%WX8T#^TK2UAN,7$,3B5RNT/(J9  Y^]TR* +T7AS2X-;&L16[)?" 6
MPD$SX$0.0FW.W&><8ZU7@\'Z';3,\-FR1M/]I-N)G\CS<YWB+=L!SSTZ\]:A
MN?$%W;^/K#P^;6'[+=6<MR)]Y+Y0J,;<8 ^;U/X4>-O$%WX8\-R:K:6L-P8Y
M8D=97*X#R*F0 .>6Z9% %U?#NF+K-QJZQ3+?W$0AEF6YD&Y!T&-V!C)Q@<55
MA\%>'[?3["PBL66UT^[%Y:QFXD(CE!)##+>K$XZ<]*WZ* "L^\T6QO\ 4;2_
MN$E:YLR3 RW$B!"003M5@#D$CD=.*I>,M;NO#GA+4=8L[:&XEM(C+Y<KE00.
MO0'/TX^M;%K*9[2&9@ 9(U8@=LC- %#7?#NE^)K%;+5[9KFV5P_E^:Z L.A.
MTC./>F+X9TI=6AU3RK@WT,'V>.9KN4D1]2O+<\\\]ZUZ* .8FL_^$/LR?#GA
M^XU!KR[,EQ$M[C#-DM*3*QZG&<>N:TO#NDC1M'2W9(EN)9'N+CRAA3+(Q=\>
MV20/8"M6B@ HHKG;+Q!=W'CO4M FM88X+6SBN8Y4<LS[V8<\ #[O3GZT =%1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5Q_Q4_Y)?XA_Z]#_ #%=A5'5M'L-=L'L=2@,
M]K)]^+S&57]C@C(]C0!S]AI=S;Z?HFIW'B&\:SLHA/-#.L*QE/(9>J1JW&X'
MD]O6N8\?6L>C>(?[:L?-%M<6IAUV.*/?Y-L[ >>!_"_WAT.0"<?*:[C_ (0_
M1#%%"]M/)#$5*127<SQC:05^4N1@8'&*N'0M.9=15H&(U'_CZ!E<^9QM]>..
M.,<<4 <5XNT^Q?5_ MM92R16,MV\2BVN&57B,+GC![_WNO/6N>U;[3X%U#QG
M:>'Y)XM,72H+T1AV<6DKR%&*9.02@9^O;VKIO$?A(+>^$[+2=(N)-*TZ\::4
M17&/)0QLHVEG##!((V],<5V5KHNGVD-S%';!ENC_ *09F,K3<8^=G)+#'&">
MG% '*6/AFV77M+UBTUBSAM;J!X&M]/MVB6_5D+*S-YARRX+;NO;/-<+86$4'
MPH\-:^CSG5(=5C6.Y:9BRJUVR,O7&""<COWKU31? _AOP[)/)I.EQVDDZE'>
M-WW!2<D*2<H,]EQT'I2CP7X?&CQ:2+ C3X9/-CMQ/)M5\[L@;O7GZ\T <9XN
M>?2-7U?5-3TV/5O#\CQ^9=VS#[5I15$! !ZIG#_*?XSG.:L/;CQGXF\6:/=W
M5FLEL8H[:.XMVDDAA:%2)8CO7:=Y8[@,Y R> *[&7PKH\]Q<32VKN;EE:X0W
M$FR8J  73=M;A5'(.<5#K?@GPWXCOH;W5M)AN;J%=JRDLK;?[IVD;A['(YH
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MB@C\V:9YI-@Y"AG)(7/.,XK/M? OABRUY];MM'MX]0=S(95SC>>K!<[0W)Y
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M9B)G5Y@!&,G: 3@<C@$\\FMS3[-(OB3K6FSV5A!;7.@1236-N T.[S'4;@0
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MN/+D\E6W#!ZY/^>:R_#FCVUKX(U_Q#:6S2:UI=QJIL)2[,8B"X  S@_0@\T
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M''?K79:9I=EI/Q<U#3=/MUMK*[T)+B>&+*J\GG,N\_[6.,]: .STIM3-@#K
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M<,1WH ]H!##(((]J 0>A'3->::MX9M-/M/$MW%J5N%O=$F<Z?8P>3"2BY6?
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MP_=WGAVXM7F!EBMY;C)A+HQ7)VG)7*GD=JTXY#':))<R1!@@,CJ<)G')&>U
M%"Y\-:->:;%IT^GQ-91/O2 9"ALYW8'4YYR><\U(NA::NK)JHMR;](O)6X:1
MB_E_W<D],\X]>>M7_,3R_,WKLQG=GC'KFD\Q7+QI(GF*.1G)7/3(H S?$&B1
MZ[IJP&3RKB"9+FUFQGRID.Y6QW&>".X)%$VCVFK/97FJ6*_;;4[HL2DB)^A9
M"".OK@''7'2DTG6/MMW?:=<JL>HV#*)D7[KHPRDB_P"RPSQV((YQDZDDB1(7
MD=40=68X H S[30=,L;V[O;6V\JYO/\ CXE61MTO8%CGDCL>W:G:7HFFZ+%+
M%IUJMO'*YDD122&8]6P3U/<]ZO>8GE^9O79C.[/&/K0LB.S*KJS*<, <D?6@
M#$TOP9X;T35)=2TS1K2UO)<[I8TP1GKCLN?;%36GAO2-,:.6TL<&WW-!&)&9
M8R0<E%8[5)R1D8ZGU-9WC7Q'=^'].MI[#[))(UY!!+'-DD))($R ".>>]=-)
M)'#$\LKJD:*69V. H'4D]A0!PG@KPC]GL]1&MZ2\,LVJ3W:I).'CE5I"Z%D1
MRI8<?>'&!CI72:[X4T'Q-Y/]LZ7;WC0',;2+\R^H!'./;I6-KOC*6'0-%UC1
M?L\UIJ%_;V[-,I)\N20+N4 CG'//Y5V"2(Y8(ZL5.&P<X/H: ,K4_"^A:SI4
M.F:AI5K/908\F$I@18&!MQC;QQQ3G\-:*^@_V&VF6W]EX ^R[,)P<YQZYYSU
MSS6DLT32-&LB&1?O*&&1]15'7M<LO#>AW>KZC(4M;5-[D#)/8*!ZDD >YH C
M_P"$;T@7EE=BQ19[)=ELZDCR5/4+@\ ]_7O5V6QM9[RWO)8$>XMPPAD(Y0-@
M-CZX%8UG<^*+RP2_:WTZV:1!(FGRARX!&0K2@X5O7"$ ^M:&CZC->Z#:WU_"
MMG.\0:>)FXB?HRY]CD4 0Z[X7T/Q-%%'K6F07@A.Z,R#E#WP1R*T;2TM["TB
MM+2"."WA4)'%&H55 [ "I/,0Q^9O79C.[/&/7-()8SG$BG! //0GH/U% &9>
M>&M'O[Z2]N+%&N)4$<SJS+YR#HL@! <>S9%2:CH&EZM]F%]:+,+5Q) I8@1,
M.C* >".QZBM!)$DSL=6VG:=IS@^E(LL;2-&LB&1?O*&&1]10 Y%"(J#.%&!D
MDG\SR:PCX+\-FSN+/^Q[86US+YTT2@A9'SD$@=<'D#H#S6VTL:MM:10<@8)[
MGI0)HC,81(AE R4W#('TH H?V#IO]J0ZF;<M?0Q^5'.TC%E3^[DGIZCO52U\
M&>&['77UJUT:TBU)R6,ZI@Y/4@= 3SD@9Y-7K36;&^U2^T^VF62>QV"<*00C
M,"0OUP,GZBC2#J/]EQG5Y+-[T%O,:S#"+[QQC=STQGWS0!:N;:"\MI;:ZACF
M@E4I)'(H974]00>HK$L_ _AFPFM9K?1K99+0DV[,"YBS_=W$XZ<>G;&:W8Y8
MYDWQ2*Z_WE.10)HBRJ)$+-G:-PR<=<4 8I\&>&SX@_MTZ-:?VINW_:-G.[^]
MCIN]\9JZ-#TM=:;6180#4G01M<[?G*@8'/T.,]<<4NN7=S8:%?WEHL37%O \
MJ"7.TE03@XY[56\+ZN^M>&-'U"Y,2W=Y917,D<? !903@$DXR: (=.\%^&](
MU2;4].T:TMKV4$--$F",]=O]W/MBK5EX=TK3K>Z@L[0017;%YU21AYC'JQYZ
MGN>IK1::))%C:1%=_NJ6 +?04/+'']^15XS\QQ[4 8Y\(Z"=-MM._LY/L5M)
MYL$&]MD;CD%1G@@\CTR?6K/]@:9_:C:G]G/VYH?(-QYK[_+_ +N<],\X]>>M
M7VFB218VD17?[JE@"?H*YNP\0WDGCK6M&O!:QV5E:P3PR+D,?,+ [B3C^'L*
M +?_  AWA\:8NFC38_L*R^<MON;8'SG=C.,YY^O-66\/:4^I?VC):"2\,/V<
MS2.S,8NZ')Y4]<'C/-:1=1C+ 9Z<T9&<9&?2@# MO _A>T^S>1H=FGV63S8#
MY>2C>H)_ET%6O^$8T3S[^==-@674 1=N@VF4'&02/7 SZ]\U8U(ZB/L9T^2S
M0?:4^T_:0W,/.X)C^/IC/%6WFBC#%Y$4*,MN8# ]Z ,Q_#.C2:/#I+Z?$UC
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M+NXLE-QY?DF2-FC+Q_W&VD;E_P!DY%:444<$*0PQK'$BA41!@*!T  Z"GT4
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M&CZ<GP5UW45M(Q>V6I7!M;C'SP;;KC8W5?PQFO7]+\)^']$N+BXTO1[.SFN
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M&]&?['NTVV/V(8M<I_J/]S^[^%-?PQH<DEX[Z7:L]Z MT3&,S@= _P#>'UH
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M5R,Y*\\ \5!X<\2VVD^"?"6GA[7[;/H\,JK=7(@C5%C0$LY!ZE@  "3SV!-
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MJA\H^/G)4Y P.G..,@'=45S$_C6P$&EFU:W\[4K07L*WEP+=%B(4Y9L'!.X
M  ]^P)K)C^)]O+H]G?1:3<RO+JPTF>..5"(IB<<-GYP1R"!@^U '>T5R,/C"
M^ENM<TZ711:ZGIUJMU%%+<ADFC;=@EE!VD%2",'V)JUX#U74=;\&Z9J.I1QB
M:X@27>DF[?N&<XP-OTY^M '24$X&36!/XBGFU34-.T>P2^N-.1#<^9<>4H9Q
MN6-3M;+8YYP!D<^G)^,O%;:Y\+5U31HS]GO)X8)Q*_ER19G1'C*X.<_,IYZ'
MOF@#T2UO;2^1GM+J&X16VLT4@< ^AQWJ;(]169IND6MM<W.I?V=;VFH7JJMU
MY+E@X3(7)P >#UP/3M7F_ANW\/6_C?QPFH:*MRJ7\9C$>E/<A!Y8)QL1MN3S
MCC- 'KE%<4=8M_"_@)==T30GDTZ1?MKV<3"-H$?#,0NWH,DD=N:U;'Q,=2M[
MV]LK(76G01AH;B"8'[2VT,0@8 8&<$D]1CJ"  =!17GL?Q0<:7I&M7/AV[@T
M+4&2-KXSH?)9S@$IUVYXW<>P/&='7/']MI7]IM;Q6UR-+.+E'O5BE8A0S")"
M#O(!'4KD\ DYH [&BN.'CLW>M6NFZ7HUQ=M>:6-2MI6E2-70LH .<E?O<D\\
M8P<T6OC^VN/#UGJ$MH+6YN-0;3#;W$X5(KA2P(:0 C'R'! YR!CF@#L:*YVZ
M\4_V98/-JMHEI.;P6<,;7 V2L5#!@Y  7&221D!3QGBLE/B581#6H[V&))M+
MCCE+6UR)H94<A5*R8&,,0&R!CKS0!W%%9FF:C>7ES/%<V4<*)'')%/!/YL<P
M?=]T[5Z;?3N*CU36+FSU.STZST]KF>YCDE\R1S'#&J8SN<*V"2PP,>M &O17
M'VGC^TO= TC44@6&74[M[*.*XF"(DJ;]P:0 \?NR!@')*\<\='IEW<WD$K7=
MD;2:.5HRGF;PP'1@<#(/4<4 7:*X^\\:7XU_5=%TSPU<WUYI\44N#<1QK(K[
MN=QSC[O ZG/08)JJOQ,MI]$T/4[72+R9=4O18&+<JM!/\V48$]?E/H/4B@#N
MJ*YBV\4WUQ<VVEOHOV?6Y89+B2SFNE*0PJ^P.TBAOO'& %/?.,53E\?;?#>L
M:G%I,LEYHLK1ZA8>: \>T9+*V,,N/F!XR,]QB@#LZCBGAGW^3+')Y;E'V,#M
M8=0<=#[5EKK;RR:0MM;QSC4(C.62;A(PH)8?+\P^91VY8>^,'2?%>D6>A^(=
M5_LDZ:EGJLMO<0QA3)<W'R#=\O!9F8#KZ<T =DT\22QQ/*BR29V(6 +8Y.!W
MJ2O.-0:[D^+_ (1EO=+@M)FM+W][%-YF\;$^5CM4Y7\1\W!ZU=NOB=IULEK>
MJEO-I<]R+?S8[M3.@+%1(8<?<R/[V<$'% '<LP52S$!0,DGM38I8YXDEAD62
M-P&5T.0P/0@CK7'>)-;.K:)XEL['2XM0M;"&2"Z>64*#((]S*B[2&*@@G)49
MX!ZXT?A]_P DZ\-_]@RW_P#18H Z.BBB@ HHHH **** "BBB@ HHHH ****
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M<+=)&8)9% 9) QSC(&"H/^'0MX2\$I=):MX>\/K<.I9(C90AV ZD#;DBIO\
MA!_"7_0K:)_X+XO_ (F@#C8= UV+PKX$L)-/0W&C7L,]T([F,@(B.IP21EOF
MS@<<=:OPP>*?#'B;5QI>EVNKZ3JMS]L1WO5@:UE90'#Y!+*=H/R@FNA?P5X/
MC1G?PQH:HHR6:PA  _[YJO\ \(SX#%M!<_V)X;\B=E6&7[)!MD+'"A3C!)/3
M'6@#%\5^'9=?5XKW2C=7L%JAL-7LIXX)89\'=R7#!=V"/O=3QQST^FR:Y;3:
M987=O'=P+8+]KU,3 $W"X! 3&2&Y.:C;P3X012S>&-#"@9)-A%@?^.UJ:6FG
M1Z;"FDK:I8@$1+:!1$!DYV[>.N>E %NN;\>Z=?:QX)U72].MC<75Y 84&]5
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M950,Y_"MVB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD\DXV@<<X)XK8\4:1KJ>)=*\4^'[>&ZN;:"2UNK">41>="Y#?*_(#!AGT_J
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M2ET\2K(I8$;\G;GIA^/I3?"D7C>RM[/1-5L[!+:Q"QG5(KC<;B-. !%MR&(
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M_P#8,N?_ $4U<[8Z3?\ B;PYX.MKFR^RVM@;6^FF:16$ICC^18P#GDD$E@N
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ML)_+\W/(MI%V2@>X7##W44>--"O-0T;2K'2+1&%I?VUQLWA%6.)@<#/? P*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHKA?BKJ]YI_AVPL;&=[>;6-2@TXSQG#1(Y.X@]C@8S[T =1<7VC:@
MT^CSWMG,\R-%+:^>N]E(P05!STS1H6BZ3H.E1V6BVL5O9_?58R2&R/O%B26X
MQR2> *;_ ,(YH_\ 8?\ 8O\ 9UO_ &=Y?E^1L&W'^/?/7/-9L6HOIE[8^$M+
M2.YO+73UEDEG<HJ1KB-2< DLQ!X] 3GH" =-17 WOQ(DM/"^IZE_9&;[2KU;
M*^LS<?<9G50R-M^=3N!' [U/?^,=?TF^L+6]\,Q!M0OFM;;RK\,2HC+J3\H
M/!!YXQW[@';T5PMO\0VL9=>M?$^FKIMWI%L+QA!-YR3PG@,A(7G=\N"!R1^%
M^Y\5WNDWVC)K6FQ6]KJTJVT4L,Y<P3L,HC@J.N",CN.G>@#JZ*XO3/%^N:KJ
M]_:6_AZ+R=.U'['=2_;>0FP-O0;?F//W>.W7)P6OC>[.K:!::AI:6AUKS!'
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M1@IW'&/FX'S#KSBS8^,SK(TN#3+!EO[VS-Y)#=L8Q;1AMAW\$D[N  .<$Y%
M'5T5P%S\0[ZS\->(=5FT: RZ)?"SFA6[.)/]7\RML_Z:=".@KH+KQ%):>-+'
M09+1/)N[26Y6Y$W*^65!!7;_ +77- &_17!M\1@8]-O[>SAN=-O;A8@()BUS
M&C'"RM&%QMZ$C.0"/I6E9^+9M3U*\M].M[6865_]CN83<$7$:APIEV;?N\Y'
M/(&<]J .JHKC?"^L:WJ/C'Q/:WJ6OV6QN(X4$<S9C4QAQ@%>2=W)R/QQ794
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MCNLHY5PN]'V_,IW*>@[T =_17GGB3Q'XMM)M(C_LNSL8KO6H+5";PL\L9!<
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M4MY)K.5+GS'!C"EED7: O#9X+4 =91110 4444 %%%% !1110 4444 %%%%
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MOZ<MRG,SR:'CC[)EQ,.>W[W@_P"R@KNKO6])L+I+6\U2RM[AP"L4UPB.V>F
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M-<H/+EQG8ZL&4GVW*,UNT4 <=-HVL>(YM .MVL%J-)NEO9C%-O\ /G1&5=G
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M,6EPY\U5 VC'.-O/(ZUU-5)M4L+?4+?3YKVWCO+G/DV[2 228!)(7J0 #^5
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M^9LYQT'K7>66J6&HO.EC>V]R;=_+F\F0/Y;8SM..A]J/[4L/[3_LS[;;F_\
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MRT"-/"I^:,."5R/< U;KCH_%5S%KGC&"72XC_8MI#<1_9V+27(9)' )P.?E
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MM!(XSD^V> #T^BN*_P"$E\2WGBS6M$TW2]-/]FFU?S9[EP'CEW$]%^]A>!C
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M99)%$B . !\AY^?/;ICGK7I54;'6=-U.ZO+:QO(KB:S8)<+&<^6Q&0">F>*
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M&[#6K562&[B$@1NJ'H5/T((_"L.Q\,ZOH%_K@T::S>QU:=KL+<LRO:SN,.P
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MU/S=R*SH?$WB*P\:6V@ZW9::%U."673IK61\!XQEHY"PYX.=P ^GHWXM;_\
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MV]M$L,2^BJ  /R%<#-X"UMO NM>%TO; PWEQ*]O*5<,JO+YA+]<D=,#ZY[4
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M>+#$CV[*!^Z4J 0YPHSR,$DY.1F@#L=*U6RUO3(-2TZ;S[2==T<FTKN&<="
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MF!B^2&'!^7:,=,GK0!Z!1UK@/^$MU^TLO&=O=+IT^H^'HEN(Y8XGCBF1HC(
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MP3P O/&1UH [FBO/X_&NKV6B>)VU"WM[B^T.[2%I+2%]CQN$/F>7N+?*KEB
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M%*[U&Q\#W$^G7:V[&>"*0F/<61Y40@'(Q][GKQD<9S0!T;ZYIL>N1:*UTO\
M:,L;2I  22@ZG.,#J.M:%>>:XNJ+\3O#*0RVCWYTV]!F:)EB'S1\[-Q)QZ;N
M?45-8^.KV/PY>RZE#;OJ=KK)T8&WC?RY9-ZA7"9+8PV2H))P0.M '>T5RVBZ
MSKD_B:XTZ]LVFTXVPFAU!;*2V ?=AHF5R<G'(([<=:ZF@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *YWQEX9?Q/I4$5M>FRU"RN4O+.Y"[A'*F<9'<$$@CWKHJI:KJ
M]CHEB]]J,_D6L?WY2C%4'J2 <#W- '.7?A34_$OAK4--\5:A;R27<0B4:?$T
M<<)!#!P&8EFW!3S@<8 '),R^'=4U.;16\07%I,-)E%PAMPV;F8*55V!^YC<3
MM&><<X&#T5E>P:C9QW=J[/!*H9'*%=P/0C(''O5B@#A4\&ZHOA[Q9IC7-GNU
MZYGG60;L0"5 A!&/FP!UXS[59G\+:G-<^$YO/M!_863(/F_?$QF/CCY>#GOS
MQ[GH+K7=.L]:L=(GG*WU]O-O'Y;'?L4LWS8P, =SZ5HT <1%X/U1-&\76+7-
MGNU^::57&[$'F1B,@\?-@#/;-23>%-4E3PD!<68.@LK/][]_B,Q\<?+P<]^:
M[.B@#A;/PCXDT75+Z#1==M8="OKA[EHI[<O/:LYRXB8$#DY(W @9Z'OI6?A_
M4++QEJFN)+;/%=VD5M'"S-N7R]V&+8.<[CG^9KJ*I:EJUGI$=N]X[HMQ<);1
M[8V?,CG"CY0<#W/% '"6_P .=5LO#7A^"RU6WAUO0)97M;KRV:*5)"=Z.O4
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M.6W'A75)F\)L)[,'0B&?[W[X^68^./EX.>_/'N>AN]=TZRUFPTFXG*7M_O\
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M'S<<]N>/<=I10!Q+^$-4:R\(6XN+//A]HV<_-^_VQF/CCY<@Y[\UT7B31_\
MA(/#.I:1YWD_;;9X1)C.PL, X[UJ44 <7+X6UNYG\+W%Q>6#RZ-(9'"1NBR9
MC,>T<G'!SDYR3T%0W?@*;5I_%JW]U$EOK_D,A@SOMWA4!&Y^]RH;MTQ7=44
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MBY0[B<,"<YX&/UJ3Q=H;VOA3QIKE]+')?WFE20 1@A(8D1MJ#/))9B2>,Y'
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MZ?Q%864=K=I:W5E?0WT+R1&1"\9R R@@D')Z$4 <S=Q:J_Q@:&RNK6*[/AI
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M>1C&#CMF@#T>LN_\0:=INHZ=87,KK<:C(8[8+$S*Y )^\!M' [FJ'CZ:\MO
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MSN!QR,#/M5RR\*:I%XNM?$5[KD<\Z6!LIXHK,1HZ[PX*_,2O(YSGOC';K:*
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M]E'D[HL[4\H-]SDG[V<G.>@'8UFZ]KMEX;T:XU743*+6 9<Q1-(1^ ''U/%
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M_A'RVS-ECS08S'CA^,*??GVXKNJ* .(O?AXNJGQ2FHZBLD&O&%RL,!1K=XE
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M5;<>?F)Z=<=*7PYX6U?2'@CU/Q1<:K:6@Q:PO;I&5XP#(P),A ) SCU()Q@
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MI<^'HIGN+&\DM;>()!Y$YB;:_F%W#C<0V-N,#'6N@A\,RP>-3XA2]C6,V*V
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MQ!'>1I';V362VOV?@HS!B=V[@Y48XZ5DZ/X!O=$G>RL_$MROAPRM(NEFW0E
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MLV"21\N,#!Y-3P:OJ.M>+=0T!;TV!TRS@DN)+5$9I)I03\OF*PV*%],DGVY
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M4UE-?NXYY+,6=WB*,^>H8L",CY#EB. >/?FNKJEJ.HG3OLG^A7=U]HN$M_\
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MD<C)M8KG///7FMBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KE_']SJ^G^%+C5-&NY89K
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MTB'[/;ZA&$+M'@#8Z[0K#@<8JS>^"A?6.G02ZO=O-9W\>HO<R*K//,GW2W
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M'+>SWMS(V^:ZN,;Y&P!T4 *     !QZY-17VEW<^I1WUIJ+6[+"87A>(21R
MG.2,@Y';![GK0 _P_<_:_#]C<?VA'J/F1 _;(P LW^U@  9],<5R/AY_$FMZ
M]KB2>))(K?2M8,21K:Q'S8O+4[&..!\W!'/7.>,==H&B6OAS1+;2;+=Y%N"%
M+8R26+$\<<DD\<53T+PV=#O=7NDOY)VU.X-S(KQJ DF ORX[8 X.>G6@#D(?
M%>OV_P -M?U4S&\O[+4Y[99C"O[N)9@A?:HP=JY;IVYK6L;_ %.7XBIIMGK,
ME[HHTU;N5ML;[9"^U5+A> RY8#KP<<51UW0AX7\$7]B+S4IK?4=1$L]U;PAI
M+422;Y'*J#E.,8P>N#P>#PS-J$FJ6XTKQ=-K-DS-]ICDTR...-=I^;S%5?FW
M;>.2<GCJ0 <U:7FL:'\.]5\0:?JKP"QUJX;[(L*&.93=;6#E@6Z,<;2N/>NM
M$%R_QNF7^T[Q8ET1)A$"A09G(*@%> =HSCYO?I5A_AY%)X0O_#;:M<FUO;EK
MF27RT\P,TGF$#C&-P]*U9?"_F^*K;Q"-2N8KJ.T%I.D:J$G0/O&<@E?F)Z'I
MQ0!C_%L3?\*^NY(;N>W*SVX;RB!O#3(I#9!XPW3\\CBK$FI7D_C>+PG'J-RB
M0::;Z>YVQ^=,6DV*OW=H Y)PN?N^^=KQ-H$'B?P_=:1<S2PQS[#YL6-R,K!U
M(SQU450N?"1EU+3]7AU2XCUFSB:!KMD5OM$;')21  "N>1C&* (/!NM:A>:A
MK^B:G+]HN='NUB6ZV!3-$ZAT+  #< <'  Z<4FI:EJ5O\3-%TR.](T^\LKF1
MX/+7&]-F#G&?XCQG%;6CZ+!HZW3H[S7-Y.;BYG< -(Y '0<    #L!W.2:M[
MX<^V>*]/U_[;)'+8PR0QPA 497QNSWS\HQ]* . N=:\4CP?XLUE?$4JS:'JE
MS' @MHMLJ1,H"R?+R,9^[M.222>W6)K5UKOC*70[>ZDLK>ST^*ZG:$+YDDDI
M.U06!PJ@9X&22.PY1O *-X>UW1FU6<P:S<RW-P_EKN5I""X7L!P,9!Q4USX*
M+:S9:S8ZO<6.IP6PM)IHXT9;F('(#HP(R#T(H X[PWJ]YH>@7%I'+)->7_BV
MZLC<*J!\[F9F ;"!CL(&> 6Z'&*V-3N?&&D:/XINFNI8K*WL&NM/GN1"\\<B
M*2R$*"I4X!!/(J[_ ,*TL)- O]+N-3OY?M.H-J4=QE$DMIRQ8.A51S]??&*M
MCP9/<:!J&G:EX@OM0N+ZW:U>[F1 T<3#!5%4!03W)R3@9Z# !A2ZAXCMM1\'
M.NOR.NN1F&XA>VC*1GR-X=, '=D'J2"3TQQ37UG7M/LO']A_;,MQ/H<"7-G>
M30Q>8 T!DVL H4@%?3H:Z2;P>9G\/.=3E#:'S!B)?WAV%/G_ . GMCGFHKCP
M0+FX\2RMJDR_\)!"L%R!$O[M50H-GH=I/7- &+::IKUGK'@F>YUF2[@UN(QW
M-JT,:HI$'F*R$#<#D<Y)!ST'2M3P]?:IJ6O^+],NM4FV65U#';21QQJT2M$K
MD#*D'D]P:M/X.WOX=8ZG+G0O]1B)?WGR>7\__ ?3'/-6--\,OIFJ:WJ$.HR-
M-JSK)(&B7$;*H4%?^ COF@#SK1;K5=#_ &>3J^G:O<17,5L\D0:.)ECQ*P(7
MY<\Y[D^V*[F35;K4_&2^'8KR2TCATQ;V:2$+YDC.Y0 %@0 -I)P,DD<\',,?
MP_B3X?/X-_M2X-BRF/SC&OFA"Q8C/3J>N.E3:QX).I7^GZM::S=Z;K-G#]G^
MVVZ(?-B)R5=&!4C/(]#0!6FD\0Z=8Z+::MKML9FN)4NI+2+_ $BZ4*QC6--I
M&[[I? & "00*Y#6]6U;5_A9KC7=_=QS:?KGV(,!&KR1BXC4+)M&"0&YVX!QS
MGG/=7G@A)Y]'N[?6+^WU#37E87?R2/-YH DWAE*Y.!C P,  8 %5#\.+1M"U
MO27U6_>'5+LWFYBFZ&7>KY'R\_,HZY]L<T /U6]U32_''A#34U2::SOC=+<I
M+''NE*1%E)*J,8)[8Z"J5KJ^L>)= U_6=/U22REL[JXALH%C1H\0\#S RDG>
M0<\C (QR,G<N?"KW6KZ'J<VK7$EQI/FE"T:?OFD7:Y; ';H!C%0CP6MM/JRZ
M=J<]G9:L[2W=LB*V)&&'>-C]PL.O7U&* .<MO$^M>(=5\&M::@VGVNMZ=///
M"L*.8W14Y4L#W8XSD=,@UO\ @34M1O(=<LM2O&O9-,U66SCN'15>2,*K+N"@
M#(W8R .E66\(6Z:WHFH6EPUM%H]N]M;6J("GEL%4@D\]%&.>W>L^Y\(W>GZ/
MKJ:?K6H1W6J7?VSS+:-!(LIVY53T"D*!STZYH [,@D$ X/8UY5>>)?$,/PX\
M8ZBFK-]OTO5;BW@G\B/_ %:.JA<;<="><9S7I]FERFGVZ74BR72Q*)9%& SX
MY('IG-<E+\/8IO#FMZ(^JW!@UB[>[GD$:;U9V#,%[ 9 Z@]Z &I>ZSI?Q$TC
M3[G5GO;35;.XD>!X4189(]A!CVC=@AB,,6^M7_'T^L6/A*ZU+1;N2&YL0+AT
M1$;S8E.9%^93@[=Q!'<5//X9>Y\1Z3K4NHR&;38I(4C$2A9 X 8MWS\HQCI6
M\Z+)&T;J&1@0RD9!![4 >?GQ<\'Q"L5;5I9/#M_IYDC+1QB..X"^:%+A=W,7
MS8SW'7.!3\1)J<L7@>2YO)#>7.M"56GB7,"M%*53:H4$JI YZD&M]?ASHJ^%
MK#P^1*]M97272.QR[%6S@GT*DI_N\=JT]>\.?V[>Z5<F]DMSIMR+J)40$.X!
M7YL]L,>!B@#C;CQ?JGA2'QTEY>2:J-$CMIK22X1%<F93A6V!00& [ X-:NM:
MCJ_A:\\-W;:G+J%KJ-]%I]Y#+&@&Z4';)'M4%<$=.00?7FM%_!-G<ZEX@N;Z
MX>YAUR&.&ZMF0!55%*KM(Y!P3SZ\\4^R\)&-=+BU'4Y]0@TIP]FDL:J=P4JK
M2$??903@\>I!.#0!RK:VWAS6?B?JZ1K(]JUHZ*W0M]F0#/MDC-=!9)XIB\2Z
M?('N9M(EC=;Y;UH 5?&4>+R^>3D$'C%6$\%6CWGB*6]N'NH->55NH'0*JA4V
M#:1R/E^O/-,\.>#I]">%;GQ#J6IVUH-MG!=; (1C&25 +D D#)P,]* )/%^N
MSZ7+HFGVDGDSZM?I:^?M!\I,%F(!XW8&!D$9.<'&*S7U/5M+\<GPX^H2W%K?
MZ=)=6MQ)&ADMI$(#+P &4@@C(R#QTKH/$?ARU\2V$5O<22P36\Z7-K<PD!X)
M4/RLN01ZC!Z@U%#X=<7\NIW5\;C4VMOLD<_E!5ACSD[4]2<$DD]!T'% &'\.
M)M>UG0-*\0ZKKKW"75F0]F+=%3?OX?<!G. 1CIS[5=\0ZGJ-EX[\)6=O>%+&
M_EN4N8-BD/LA9E.[&1SZ'M6IX6T!/"_AZUT:*ZDN8+52L3RJ VW.<''!ZU'J
M_AP:KK^CZL;V2%]*>1XHU0%7+J4;=GG[IXQB@#BY]0\37-MXY=/$<T!T29VM
M?+MHLG; ) K94Y7/H ??M7?Z%?2ZKX;TW4) JRW=I%,P4<!F0,<?B:QE\%[8
M?$<?]IS$:\6-P?*7]WE-AV?\!'?-;>CZ>-%T.STXW!ECLX%A65P%)51@$XXS
M@4 >;I>^,=2\.^)M2MO$QAGT74;N."/[)$5F2'D*_'0@8&,<DDD\8UF\0:EK
M%IIU[%J#VJ7FB)>165B@>X$[#)=MRE1$!@ D@$YSGBL_P9IK:Y9>+[)=6:.R
MO-;O!-%&BEVB9ARC=@PXS@^V#743>"+<:[_:-AJ-W81O9)8S6T 39)$F=@!8
M$J0"1D=O3K0!RZ>)?$.I:/X NH=3%K+K+>5>;8$8,?*9BPR.#E<XZ9[8XJ>W
MTW5+;XJZ19WOB._O)(]%GD:4QQ(&_?Q\;-I R, GJ<#D5JV?P\6RL?#]K'K5
MVRZ'*9;<O&AW':5VG 'R[21Z\YS6QJ/AE+[Q-8Z[%?W-K<VT+V[K$%(FB9@Q
M4Y!(Y4<C!H W:Y+6M3U&S^(OA>PAO"MA?QW?GV_EK@F.,%3NQGJWKV%7O#EA
MJ=E>:NUYJ-U>6LUR9+472@-&#G<J@=$' &?0GH13]2\.?VCXFTC6S>R12:8)
M1%"J J_F *V[//0#&,8]Z .$GU7Q/+X>\;:@OB.:*30KZX%L$MHOG6.)'"/E
M3E>3TP<DY)Z#TW3+IK[2K.[=0K3P)*0.@+*#_6N;'@91I/B+3CJDQBUV:2:Y
M;RERAD4*P3T& !SFNDTRS.G:7:V1F,WV>)8A(R@%@HP"0.^!0!:HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=,OQ'!/.%\PQM&KA6*@ X)/.*S?B 9E\9^ S;QI)*+^;:LCE%/[H]2 <?D:
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M6\IGMHIFB>(R(&,<@PR9&<''<5)7GE]J.M2Z[X&M;?69[>+5;28W06.-LLL
M8,"5^]ECUR,XXXJM%KWB+3?#/CB&VN)M4O\ 1;EDLI9D5I"A1'^8* &*[F/3
MG% 'IE%<!9:A>W?CC2K;1]>N+W1I; W5V5,<H#@C9EBI*[\GY01]W(Q@UT'C
M&ZU6RT'[1I-K/<R)-&9XK;'G-!N^?R\]6Q^/7'.* )O%'B.W\*Z'+JUU;7$\
M$3*K" *2-S!03DCC)%;->1>)M:M-<^$7B2XL=5GO(Q=P*L5TFV:T_>0@Q."
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M22/(%".)-VTK@DG[IZXK9KS=M,O-5^*7BBWM-7N=,_XE]D6EM40R$_O,<L"
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MV^NS),BW!:R<N&E\D]%DP "0<C/>N;T9VE^/7B7[7_K(=+MULPW:$X+X]M]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M33USPI:ZQJ-IJD=S<6&K6@*0WMJ5#[#U1@P*NI]"/IBMZB@#,L]*FCFCGO\
M49[^6//E[T1$0D8)"J!SCC)SCG&,FL:+P%9065YI4-]=QZ)>2M++IPV[!N.7
M16QN5&/50>YP1FNLHH PAX8A7Q>OB)+VY69;/[$+=0GE>5NW8QMSG/?-<IX>
MMI=0\<^-_LVJSVB7%Q %,2J=ZB%5+H6!Y!R,C(]NE>D44 <U<>"-,\G1O[/:
M73KC1@4LIX,$JA&&1@P(96'7/.><@TEYX*M+_2-7LI[RZ\[6,"]NU""1U"[0
MH^7:J@< 8]3U)-=-10!S>J>#XM3T_2(6U.]@NM*E66VO8MGF A2O(*E3D'!X
MJJ/A]IYA\00S:AJ,\6N)MN5DD7Y6V!2ZX7[W /.0.@ '%==10!R]SX,6\M]&
MCN-9U&1]*N%N8I6\K=(ZJ5&[Y,8P2, #UZ\U,_A-(=;OM4TS4;K3Y=051>)"
M$99&48#@,IVOCC(X/<&NBHH YF3P18!] ^R7%S9PZ&2UK#%M*DE2I+EE).03
MWZDFE3P@L5[X@O(=7U"*XUI%661"BF$JFQ6C(7(('KFNEHH AM(#:V<%NTTD
M[11JAEE.7<@8W,?4]34U%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5S'Q#OM1TOP'J^H:7>?9+JV@:59!&'/';GC]*Z>N1^)
M[#_A6VNQ9S)+:M'&@Y9V/0 =S0!TMJTDNFPMOQ*\*G>1GDCKBN;\ :EJ.I:;
MJQU.[:ZFMM7NK59"BK\D;;5&  .@KH-,N(9-&M9TE0Q>0IWAN!@<\^U<I\,Y
M8WLM?4,-S:Y>2J#P2C295A[$=#T- '<45GZ/K-GKMDUW9&4Q+*\)\R)HSN1B
MIX8 XR*T* "BBB@ KSV.76-0^)VMZ(GB&_MK.WL(;B%8DA.QW)!^]&<CCH:]
M"KS&WMM-U7XS:\EXB302:;!$A)(5V!.Y01P3@\B@#1\#>.9-1\*2WGB">+SX
M-2DTY)X8SB\92-K(BY))R>%]"?IT+^,= CTF\U.74%BM;.0PW)EC=&B<=59"
M-P/(XQ6)XPEL_#>GZ!;6VFV]O8+?H@N([4.NGC:V)%0# 8YV@D8&XDYZ5Q%[
M,@\._$ZU O6DN75X3<0.K3;H4 ZJ.2<X'7 Z8% '=:K\3-"LT5;*66]G^VV]
MHZPV\C!#*PP20N#\NXC&<D8%:9U+3;GQ;I\2ZQ=1WAM)'73<%$D0[?G=2N0P
M[9(//2N>\:O&W@GP[>P*7M+74K">5HD+!(T<;C@<X'Z5+?7D%Q\6?#<Z%A&=
M,N5RRE<%BA4'/0D X!YH Z-?%NB/=PVRWOS37#6L4GE/Y4DPSE%DQL+<$8SU
M!'45DZ1>7K?%#Q%837T\UI%96LL,+D;8BQ?.T #T'7GWK@+C5H[_ $C0+@VU
MS9R6GB6*2XTRWLG6*R42ODMA?F8Y!)SR6. .:[71IXW^+WB%@V!)I]HJ9&,L
MI<LH]QD9':@"7XJ:EJ6B^![G4]*OY;.[AEA57158$/(JG(8$=":V;KQ-HNBW
M<>EWVJ?Z;Y)E".I:1U&.?E')Y& .3V%<W\97#?#F[MUR\\LT'EQ(-S-ME1C@
M#DX )I^H7=K/\6_#MQ'-')$--N5\U3E0S,FT9Z D!L4 =/9^)]&O]#?6;>_C
M.GQEA),X*;"IP0P8 @YXP1FN9BU^2\^+EI8V]]>_8VTF6:2SGA:%5<.@5MK*
MI.03R<]ZXV<W/]@ZS=V<,MS!9>-?[1NH(E+-+:JRDLJ_Q+D Y''RGTKI&UBS
MUOXIZ5=Z5-)-#+HMQ"ES' Y579T(R<<8P>O3O0!V+^*M%COH+1[PJ]Q,8(9&
MB<122#/R+)C86R", YR".HJI<^/?#-JEXTFJ*192>7<>7#))Y9QDD[5/ !&6
MZ#/6N#\*7&B7>BZ9X7UO2]4D\0Z<\<;6$KW!C$D9PLP;/EA,?-GZX!XSH6<]
MN'^)I+H!,Y,9/_+0?9PGR_WOFR.._% ':1>,- GU2VTV+4HWN+H9@VHQCEXW
M863&PG'.,YJO=>/O#%G]L\W55/V-]EP(XGD,9QDD[5/ &,MT&>37$2SPIX/^
M%Z;E#V]Y9F9>\06!E<M_= 8@'/<U:@GM_M/Q08NF)P/+)_Y:#[,$^7^]\V1Q
MWXH ['5-2TN35- 1M<FMI;B7S+6"W?Y;P%#PW!RN.>HZ5@ZGKG]L>.[GPR;K
M4[.VBT\.LMK%-&XG:0J'+!?NJ%X)^0Y.<XXQ%N(AI?PK!<;H&B\X'K%BV*'=
M_=^8XY[UO6UU!_PNG4#YBA3HT,(8_=,@F<E >FX!@<=: -'PG>V%MHFHS/XH
MGU=+6Y=;N]NR%6)U1=RC@ *.N!G&3S6G;>)](NKN>T6[,5Q!!]IDBN8G@81?
M\],.!E>.HX%>8217EWX2\:G3(6NIHO$QOQ;(/FN(4>)CM'\0.PXQUQ75R^*=
M&\0:5J6K:-HC:K<0Z;,LIFLV1BN,_9R67+;CU5<C@^HR =%9>*M'U"YCMK>Y
MD,TL!N85>WD3SHACYDW*-XY'W<]1ZUBVGC73-?\ #>M74MQ>:5:P// ;HPO&
M\:K\N\,5P'SDXZCC(KE=+U&&Y\:>![Z.6ZN(FL;F%BEF\<,+E(\1(H7Y0,$<
MDXQR>*DTZX2#X<>.=+F2:.[2;4\QO$PSYA?8 2,$MD8 ZT >A0ZMI]CHVFR/
M?2W"7$2+;R,C/-<_)G=M4;F) W' XY/%1MXOT%-'N=5?442SM7,=PSJRM$XZ
MJR$;@WL1FN'MYY-,U7P'KER2=&32#8S38RMI,R(0S_W0=FTD]".<54\0VAFM
M/B1K-L2=/U&QAM[8H,BYF6,AF3^]U"Y'4@^E 'H=EXNT+4=673+6_62[>(RQ
MIY;J)%'4JQ&UL9Y )([UMUYO>7%NWB_X<O'(ACC@N0[+T3= %4'TRPP,]QBN
MXTK6;/61>&S,I^R7+VLOF1,G[Q,9QD<CGJ.* +Y&01DC/<5PGA'5=0E\1^,$
MU'4KNZM=+O%BMXO+#%4*;CPB[F//N>*[LD*"20 .237G?@2\MU\7>.9'F1$E
MU!98W<[0Z"/!92>H!!Y% #_"=]<^,DCU@:IJ=G<P:A,6A6)Q;R6ZR,@B(8;"
M< 9(^8'/T&_?^+[:Q\8V?AUH+II9[=YVE2VD95 *@ $ YY;D]!CG&:R?A3-&
MW@XQ;L2K>W3-&PPP#3.RG!YP00:37)A8?%C0;R>.;[/+IMS;HZ1,X,A>,A>
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M;0KNDD<X"BJ,'B?1YVO$^U-%)91K+<1W$+PNB'HVUP"0<'D50^(%Z;#P7?7
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M-Y>6=I/(+BT"M-'/ \+!6SA@' RIP>1Q3(/%FC3ZC:6*W$BRWBEK1I('2.X
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:5IL>E:>EJDDDI!9Y)I<;Y78EF9L8&223P !T&!0!SGQ3MI[KX<:K';023R
MPOY<2EF(69&; ')P 3^%4-1OX;_XE^$+V%)_LZVMX#)) Z!-X0)NR!MW;3C.
M,UW]% 'C,T%_-H_BBXL+2YN6MO%2ZE]FB#(]S;KY>3&1@GH2".Z\5V?A6ZT#
M6M8.KZ1IM^9EMC!+?7JS*R@L"(1YOWN<DXR!CKS79T4 <%XYTN^MO%'AOQA8
MVDUXNDO+%=VT"[I&@D7:71?XBN2<#DYKHK?Q3IVHHHTMWO)WX$2QNNW_ 'R1
M\@'?//H">*VZ* . T2Z/AKQEXJAUH21QZA<I>V=R8V99T\L*8P0#\R[0-O4Y
MX%<S8Z5<:#H_@"TOH)4>'5I;J2+RRWV6)Q*5#8^[C>H.>ASZ5[+10!P&J7UK
M8?&G3I;N18HSH4RB1A\JGSDZGHO0C)]0.]<S>Z'J45O?>(K&RG:Q_P"$JAU7
M[(D9WS6\8VO(J=22V7 QR%!]*]%E\.3R>.(?$@OXP(K-K+[-Y!.49PY.[=UR
M!VZ5T% '"3^3K?Q%T37=/DS8:;8W/VNZ"D(WF;0D>3U(PS$=L<XR*Q/#UQ<:
M?\!9A#H_VZ\@2??I]Q;EMVZ=CEHR,L-K;L=P*]6HH \RT6Y23XJV=]$=4N[>
MYT)H5N[BUD17D\Y6( V@( /8#ZD\X:&4?L\W^C-9WBZA;QR0/ ULX8R&=B%7
M(^8XYXS@5[310!Y]-</I7Q+L]=NMYT6^T<6<=T%)2"59-^'_ +H8'J>XQ7->
M(M,N%\(^.+Z.";R-8U2VDLK<1,6D"/%OD"XSABK'IR%ST(KV:B@#AKN:.3XO
MZ/<1[FA_LB>,RJI*!F=&52W0$@$@59^*6Y_AMK<$:/)-/;^7%'&I9G8D< #D
MUV%% 'GNK3R6GC'PKXC(DET5;2:SGD1"PM7<*0[#J 2H4GMWQ6/X@L)+BW^(
MNM6R2&SU+3XK6V"H<W4JQL"RC&2.0H(ZX/85ZU10!G:!(DGAW36CX7[-&,8P
M1A0"".Q'3%>?^+HI;?6]:U3P_?W%IK<8C2;39HC+;ZLOEKM 0CEL'9E3D8YQ
MG->HT4 >?Z9=3>'_ (B^(+C6T>"VU>&UFM+@@M&#''M>(L. P)R!WR<5S3:5
M<Z5X<T(3P31K/XO748[<QMNM[8R,067'R@#!.>F[GFO9:* .%M9XD^,.J7+9
M6 Z-#&)BI"%ED=F4-T) (.*XK3UN['P5X:U,V%_/:Z5JMX]_:VXD2=(I7E"R
M ##<!P>.Q],U[?10!RWA%M%O;F^U;1M/NHX[D1K)>W2RJ]RR@@#$OS$*,#/3
MG Z5FWDDNA?%=M5U .-)O]+6UBNMI*02I(6V,?X0P.03P3Q7=T4 >,:]ID\7
M@_Q==BWG\C5]<@N+2V$+%G198M\FS&<-M9NG0 ]Z]ECD26-9(V#(PRI'<4ZB
M@#Q;QA=SZEX?\8V3:=>V]W#J"F.RM+)U2:-9(_\ 2'=5_>,P!/)[#C(S7LD,
MRW-LDR*ZJZ[@)$*M@^H/(^AYJ6F3+(T+K"ZI(1A6==P!]QD9_.@#Q/2T@\0?
M &R\.6:>;JER1'%"$.Y&^T%O,/'"@9.[IVSGBNOT>X;PSXZ\3IK1D2#47ANK
M*[9"4E58PC1Y ^\I PO4YXKI/"'AY_"OAJUT4W@NTM@P27RO+)!8MR,GUK<H
M \:72;C1?"/@^VN[>9&'B9;[[/Y98VT!>1AN 'R@!E)ST)KK/%$C6GQ%\(ZB
MT%Q):K#>0M)!"T@#NL>P':#C.#C/'%=S10!Y7>Z?=ZQK/Q.L;#>EQ?V=M':N
M5*K*RPLK*K'@\G:?3-2ZA)_PEOA7POIME!-#JEO>VDL\+Q,CV7E?ZPMD?+C!
M _O9&*]/HH \Q@D477Q-8HX%P!Y),9_? 6P3Y./F^;CC/-==X%)'@'P_&P99
M(M.MXI$92&5UC4,"#R""#7044 >5Z0[Z7X-\3^&-7MYGU1IKSRH_*9C?+,69
M&C./FR6P?3'.*DO+.?1!\-=.O&>2?3I%%TZ*76,"W9,L1T&X@ FO4** *UZC
M3Z;<I&-S/"P4#N2#BO(5G,GPG\(V1M;Q;BSU"Q6XC>UD4KY<@,G!&2% Y/3G
MK7L]% 'F6NVT^K>/O$%M8%@]YX5-I!-@A#,7D(7=TSA@?I2>%;[1];&CVEQH
M6JC7=/*&6&]$^RS=1AG#.2F.#M Y.0, 9QZ=10!S'Q%;_BWNO0JK/+/92Q11
MHI9G=E(  ')-86D7?ABP\*Z-</IA;4K.UA=4@L&$_G", KG;U))!R<<\UZ)1
M0!YOX[L)?$DGFZ?%$FI:!']J9Y5;9.2/FML\;D8 ANV=H[G$/BKQ#:ZOIO@;
M5S!/!&==@:6":)A)"WER9#+C/'KCIS7IU<_XD\.SZ]=:1-'?);#3;Q;Q5: R
M>8ZA@ 3N&!AC0!Q?B70KKQ1KWB74="&Z.3PZ=/65>$N9S(7VJ>C84!2>GS8S
MP<7_  YJN@^(+W3KC^QM435K ,\W]H"<#3SMP_SR':<XP .2.2!@X]%[<T4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEZ8;C[))IELL=P(',;E6<L%;&#PPZ5R*6]V/@5::=_9U_P#;5U!6-M]CE\P
M7OF9V[<XV<YH ]0U3Q)8:3YXF%Q*;:,37 MX&E\E.?F; XZ$XZX!.*J3>.=
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MMEN!"\RQW4[[&&1@@+N. 5VC!QZ5V]]XRT>PU>;29&NY-0A@$YMX;261V0G
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M*3M/!P1WP:YK0HK:VL)_"/B#PMJ%[J<5Q((BT+O:W:F0NDA?[BCD9)Z8]>*
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MRZ9,\%X?L[[HG0 ME<9( (Y'%377BC3;:6&!3/<7$MJ;Q8;>(NXA&/G([#)
M]3V!KSB^:XLO#WQ'T-].U"2_O;JZNK98K5V22*2)=K!\;>Q&,YSP 3Q6O_:%
MR=:TNSN-,U*"TDT9 DUM92+---G!@>0#=$HQG!*C)R3CJ 6_%^L)?Z7X1U;1
M]1G%K=ZW9*'AD9%FB=^59>,C@<&K'VJ>V^+]U";F[DM/[ %S]F#LZA_/*DJG
MK@ <"N.L8[M?ACX%M'TS44N++6;5[B,V<FY%21B[$8SM (YZ5V*>8?C.]R+>
MY^S'0E@$_D/Y?F><6V[\8SM.>M &S:>+]'OO#4OB"WFF?38MVZ3[.X;Y3M;"
M$;C@@CIVK8:XC2U-S(WE1*GF,9/EVKC)SGIBO/X-%O;/X@7>B0HIT"^E36WY
M_P!5(IPT>/1I!&_I@.*[C69)X=#U"6UM%N[A+:1HK9AD3.%.$/U.!^- &=8^
M,-(U"[L[>)YT:^@:XLVD@95N8U )9"1SP0<'!P<XJA)\2?#4=M-<FXNC;P7)
MMKB46<NVW<$*?,.WY!DX^;%<?I]Q-<>(_ FJ&QUAQ%#<Q79:QDBCMY&A4"-8
M\ (H((R!C &6.#B*XM[J7X7^/+1=/OC<W>JW;V\/V23?*KN"C*-N2"!UH ]0
MU#6;2SN8[)O.FNYHVD6"V0N^P<%^.@R0,G&3P,FN;^%]]+J/AW4)Y+JYN5&K
M72127+,S^6'PH.[D8&.#TK-AO9M!^(TNJ7]I?2:7JNF6\-O<Q6LDGDR1DYC9
M54LN=Q/(ZUI?#,3+I>LK/:75LS:S=RJ+B!H]R/(2I&1S^% &CJGCO0M'U"YL
M+F2Z-W;1+-)%%9RNVPG 887D>XX'K5C4_%VDZ2D\MR\YM[9E6YGC@=X[<G!&
M\@<<$$^F1G%8UMO_ .%S7TYMKD0-HT4"SFW<1F1978KOQMS@@]:YV V^DZUK
M^B>(_#FIW_VZ_FN;.2W@>6&ZBE.X(<':"N<'=@8ZF@#N]0\7Z1ITERCR2S_9
M;=;JY-M$9!#"<X=B.Q )P,G SC%6)?$-@OV80M+=-<P?:8EMHRY,7'S\=OF'
MN<\ UP.MM=M<^(-$DT>\MD&CQQV,>FVSE;MO*8$/,HZ(3M"D@8SP<@5%'8PZ
MAH/AIC-K.@:Q9:1$EOJ26[A00H5XI4*X(RH(5L;NH]P#T$^)-.^QZ?<1O+*=
M1C$EI"D3&25=H;.WJ  1DG &1GK59O&FAIH=[J[W,JVUB[1W:_9W,D#CJKH!
MN'UQCOG%<=8R:[9>(/"OB;7K&1(I-*DL+Q8(6(M9"X=79 ,J&"J#Q\IX.*@U
MO2KJ?3?B/J]O:W30:Q;Q6]G"L#EYV2(J7"8S@DX!QSMST(- '<V/C+1]0U>#
M3(9+A9[F$S6[2V[I'.H +>6Y&&P",X)I%\::*]Q;QB:4PW%V;&&Y\IO)><$@
MH&]<@C/0D8!KF[PR2>+/A[.EK=F*WAN!.XMI,0[H JASM^7+#'-<U=W5]J.E
MZ/<7.D:K#>V7B.*:ZLK>QD6"UC$S'*A5Q*2"&+#<<D] <4 ;UGXKMO#?C+QH
MFIW6HW%M!-;-%&B2W)A0PAG. #L3)SG@5?\ %FK)>?\ "%:GI&I3&TO=9@CW
M02LL<T3)(V& Z\J.#TQ3-,NQHOCOQ?/J%G>)'?\ V66UVVKR>>%A"LJE006!
MXQG/X5A#0K[0/"/@+39[2X:>VUQ+RXC@B:46\;&9B"5! "^8HS0!Z-8>(].U
M+6=0TFW:;[;I^TW,;P.FS=G;@D '.#C&:M:9J=MJ]D+NT\PPEV0&2-D)*D@X
M! XR#S7'>-;+4]/\1Z7KV@A?MEZ#I%RI.,K("8Y<=_+8%CWP37:V-G#IVGV]
ME;KM@MXUBC'HJC _E0!@6NL:-#K_ (DG2^U!Y[.. WT$B2M' -K;3&FWN 22
MN<\&BR\?Z!?SZ9'!-<;-3P+6=K618G<C(3>1MW8!XSGC'7BL* R1>-/'T[VM
MV(9[*V6&3[-)ME*1.&"''S$%@./6L=8KE/ /PYMS8WWGV6I6;W,?V23="J*P
M<L-N0 2.3ZT =_JGB[2-(%T]S),8;,J+N:*%G2W+8QO('!P02!D@$$X!JQ#X
MCTVXU>;2HI)'O(K87901-AHB<!E;&&!((X-<1I&IR^&]7\1:%K&B:C>"_P!1
MFO+)X+0S174<N#L+?=4KC!W8 'M5VYGET;XJ0ZA>V-UY%WH4=I&UI;O,GGK,
MS&/*CCAA@G QZ4 ;3^/?#T>CV>JO=RK9WES]DBD-O(!YN\H0WR_+R#]['0U#
M_P +%\/![>-WOXYKAYHXHI-/F5W:,98 %>3TP!R21Q7 6T5VOP[T*VDTO45G
M@\3+<2Q?8Y&*Q"Z9R_"G*[2.1Q79>)RS_$3P5<);7,D$#7;32QV[LL0>':NX
M@87)XYH V?\ A,-+;3X[R%+R96MQ=-'%:N9(XCG#.N,KT.!U.#@'%3CQ1I,E
MEI]U;7!NDU$9LTMU+M, ,D@=@!U)P!WP:XO5Y5T#XA:I<ZSI&HWFEZK# ;:Y
MLHI)1$Z*5:-U3GGJ.._UQ&T3>%O%_A_61H=Q:: VG36/V>V@:0V+O*)%9T0$
MC<  <9P<B@#6^'NH2:AJOBW-S>30PZH(XENV?=$/+7*8;D -GBHM<UG^Q/BK
M9-<75\UI+H\S_9(O,E#R"1 -D2YRV,]!TR?6IO DDC^(_%\K6=Y!%<Z@LT+S
MVSQB1/*09!8#G(Z=?:G:TS:=\4=)U:YAG&G_ -ESVQN$A9T20R(P5BH.W(4\
MGB@"\/B'X;/A[^W1=S&P6;[/*PMI"T,F0-LB@90Y('([CUK;FU6VM[^SLI!,
M)[Q6:)1$QX4 MN(&%QD=?6N2T7PNFJ1^,)+^V>'3_$%R?+@=-K^6(PGF%3RK
M,P+#//0T_P"'L.K7-L]WKN&N[ -I,4@.1*L3D/*/=RJ@_P#7.@#K=1U*TTJU
M%Q>2[$+K&H"EF=V.%55'+$GH!5*T\3:==W-Y:9GBO+-!+-:RP,)0AZ,J@'>#
MTRN>>.M8GQ!M+\GP_JUG;S74.E:FES=6\*EG:+:REE4<L5W9P.>M1"(:I\2+
M?Q':K,-/L=*D@EG,+KYK.X(101EMH!)P."0.N: -;0_&^B>(KB"'3);B83PO
M-'*;:18RJMM(W$8STXZ\BNBKB_A3%+;?#C2K6XMKBVN(1(LD4\+1LI,C'HP'
M8@UVE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME EU!=V13SH+J!HG"L"58 ]C@_ES5O4=6MM-:WCEWR7%RQ2"WB&YY2!DX'3
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MVXM#']G61 \[;2HW+QY9+?Q'D#VH V_#'AU_#D6H1F]%T+V]EO6/E;"KR'+
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,D9RIQZ9],]3<>'+?Q%X$U+3H='CT1;W=+;PB)8GCD&"DCA. ^Y0?7& ><T
M=#<:U;6E_-:SK)&L%M]JFN&VB../GECG(^ZW;L?2L]?&%BNK6FG75K?6<M[$
M\MFT\0Q<!1E@H4DAL<[6 /M6&NB:UXC^&FJ+J48M=>UBRVO&QP(R$VJA] 2"
MQ'8NU1^&+N+4)K,W'@&32]1M!NNKF>P14B(7!\EQRY8\#:.A/L" 7$^)>G75
MA)=Z?I6L7B(EP2RVNU%:+.Y6=B I.,C/\^*P-<UZXU7PIX%UVY2[LY9M5L'F
M"N0DJNNYL(K'<N>F1GCI6GX.T^^/PYU?3);*YM[R22^V1W$31EA([LA&X#J&
M'T[UD-%J,W@;P%:'1=3CGTS4+ W*-:L2BPKMD? S\H/3N>P- '<Z;XOT[4+C
M5()([JPFTQ%EN4O8_+(C()$@Y/RX4_3'(%)'XML7U>RTRYMKVSDU%&>RDN$"
MK<!1DA2&)5L'.&"FN2UO1+_7?$_C"VM[>YB34=$CM+>XDA=8VE7>2NXC&/F'
M/N:N>%;B/49K%+CP"^EZG:<W-U<6,:1Q,!@F%QRY8]-O8DGIR /\"W\6F:3X
MJN+VYE-O:Z_=QAY7:5@H*JJ@G+,>@ Y))%;J^,M.CU&ZT_4(KG3;FWM&O2ET
MJX>!?O.I1F!QCD9S[5PPT+5]0\&>+;:VT^9;U_$$FI6L%W"T:W,8E211\PP0
MP0C!_'%;6GW%IJEA>7=O\/9;*6&RF$R7EBD4DQ*']Q'CE@W()X&/<\ '2Q>)
MK8EC=6EW9Q"T:]\Z=5V&)<9.58\C<#@\U+I^O1W]Y%;?8;RW,UN;F)YE3:Z
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M.^N(50I"S 'H6#-@,I.T'K]:S]7&SXO>&I$:0B73[PLOF$J=OEXP"<#J?SH
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MS;R+)#,@DC=>C*1D$?A4M !1110 4444 %%%% !1110 4444 %%%% !1110
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M2O&N[*]@@BDV[P,QRER-@!'7T-=[X?T2'P[H=KI-M//-;VJ".)IRI8*.@RH
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MZ=^*P_"^FWFCVB^%]1\#K=WMM(T<&K-;Q-;2Q[B5D=R=P(!Y4 DX[9X]7HH
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MX_.']Y%=@2/<@9[9H Z&BJ&BZM!KFEQZA;QS1QN\B!)DV."CLAR.QRIXJ_0
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MG&?09P!6A0 4444 %>=:SX;U_3]>OO$O@7487FN'_P!/TFZ_U-PZC!*G^!\
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M47#32Q1-GY'=E4M@@X)R>O/%49/AMHLGABPT+S[](].D,ME=1S!+BV;)/RN
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M>ZJ+RZEFNT2-XY"A153=M"X4$ ;F[]SG-4[[PG:WWBJT\1&]O8;ZTB,,8B9
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M' <_-DCFNA\$ZW;:EJFIVY35;'4(HH1<:5J4KR& @O\ O$9B=RMD#(_NCUH
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M;F\=E\UT ("C"[5&">% ZD]3FMJB@#"7PCI1\)CPS<1R76EK$(5CF;+*@QM
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M>GH8K:XM&"LD9&"A!!5EX'# U>TO2K728)8[8,6FE:::5SEY9#U9CZ\ >@
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M=@5=@  1@#:0 ,8]!WKHZ* .?\.^#['PV2T%WJ-VX3RHVOKIIO)CX^1 >%'
MZ#G ]*Z"BB@ HHHH **** "BBL'1/$;ZOKNNZ7)8FV;2I8HRQE#>9O3>#@#C
M@CN: -ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M89I/.^\JYVX'08R>GK5)/ 6BQZ)I^CI]K6QT^X%S;1BX;*2 [E.>IP23@^M
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M/.*O-*NW:S$8Z;5P!@# XJ>?PKIMUK/]JW)GFNC:-9-OD.UH6Y9"O3D\YZT
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MN*J!@#)YP* /,?&&H75OH_B35M-U*]NKBRU*(+=K,T,5IAXE-NJ D28R=V0
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M$[MPP.<]!CIQ4EEX0TFSTB\TUQ<WD5[&8KF2\N'FDE3!&TNQR  3@#&,GN:
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M.1WQ74^"-1L=3\,0SZ>]X81-,K1WN?.A?S&+1ODDY4G;U/ % '0.6$;%%#.
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M(XR$,2JZ_*F 3O!(ZY/44 >KT56T^V-GI\%NSN[(@#-)*TA)[_,Q)//J:LT
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M(&>!Z5FP>!O#UOHE[HPL6?3;UR\UO+,\BEB<DKN)VG//RXYYI==\0W.D>(-
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M+A/*E:YF>9F3! 3+DD+@G@<<UN44 <K;?#OP[:K8*L%V_P#9\GF6ADO9F,.
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M(U7:%*@X QQQ@XXS4-UX(T"[U&2^DLF626W%M,D4[QQRQJ,*KHI"M@<#(X_
M5T-% '.6W@70;0Z288+A6TD$69^URYCR-I_BY^7CG/ QTJMKJ7?B+4)/#<^@
MR_V7YD,LU_,R&*1%(<JJYW;B5"]..3Z9ZRB@ K*D\.:9+XA776@<:@(A$769
MU5U!)7<@.UL$D@D''X"M6B@# @\&:);,RPV\JVK3_:?L?G/]G$N=VX1YV_>Y
MQTSSC-;Y (P>1110!S&E?#[PWHFJ-?Z?9/"^\R)%Y[F&-SU9(R=JGGJ!QVQ4
MP\$Z&--U/3_(N#:ZG*TUXANY?WKM]XD[LC.!G&*Z&B@#GI/!&A2W\%Z]O/Y\
M-L+7(NI )8AR$D ;]X!Z-FF1>!/#]OI5EIUO;30Q6,AEM9$N9!)"Y&,J^[/3
MC&<8XQ7244 9<?A[3H[&]M1'*1?9^U2M,QEER,<OG=TX&#P.!BJ%WX$\/7WA
MVUT&XLG>QM"IM@9GWP%>A1\[ACZUT=% &=HVB6.@V/V2PC=4+;W>21I'D;IN
M9F)). !R>@ J*\\-Z7?:Y;ZS-#)]O@B\E98YG3*;MP5@I 8!N0"#@\UK44 <
MV? N@-HM[H[6]P;"^F,]Q$;N4^8Y.XG.[/)Y.#2ZUX'T+7WLY;Z"<W-FNR&Y
MBN)(YE7NI=2"1]3ZUT=% %>QL;;3;**SLXEBMXEVH@[#ZGDGN2>36;J?A72]
M4U*/4Y$FM]1C3RUN[2=H9"G]UBI&Y?8Y%;5% %&TTBTM(I4"O,9EVRO<2-*T
MB\\$L3QR>.G)XYJAI_A#1],^S+;Q3&"T<R6MO+.[Q0,<\HI) QDX],\8K=HH
M R;+0--T?4=0U6VCN!<WI#W3&:23S"HP#M)(R!P,#VKD/ GA5)/#MQ;ZS:7T
M1;4)[B2TG9UBD!E+H2N<$8VY'3CD5Z+10!DW_AS3M0U2'4W6:&_BC,*W-O,T
M3F,G)1B#\RYYP>AY&*@N_!^B7NFVFG2VTBVMI,+B%(IY$(E!W!R58%FW$G))
MY)/6MVB@#%U+PKI.K:C9ZA=13?:[1#''-%<21,4/5&*L-RG'0YJHO@'PY'HS
MZ3'9.EFUR+I52XD5HY VX%&#93!)("D#D^IKI:* ,<>&-+76+351%,+RTA,$
M+_:),*AZ@C=@YP"2<DFH#X,T3SKIA;RK!=R^?<VJS.()9.,LT><<X&1T/<&M
M^B@#*?P[ITGB#^W"DPU'[.;82K<. (LYV[<[<9YZ=:=HN@:?X?MYH-.CECBF
ME:9U>9Y,NQRQ^8G&3S6G10!E3>'-,N/$$6N/ _\ :$<0A\Q9G560'< R@[6P
M22,@X/T%58O!FB0O*([>5;:6?[2]F)G^SF7.=WEYV]0#CIGG&:WZ*  @$8/0
MU@6'@S1=-6"*WAF^RV\OG6]K)<.\,+YR"J$D#!.1V!Y&*WZ* ,JV\.Z=9Z[=
MZU"DPOKM52=S.Y5POW1M)V\9.,#O54^#=%,>KH8;@KJ^?MP^U2_OLC:?XN..
M.,<<5OT4 83>$-'8Z23'<'^R?^/+_2I/W7&W^]SQQSGBN$C\/"?4KY]3\,^)
M8-4N+N65I=*U I;2 L=K*1*H!V[<Y .<_2O6** *&BVMU8Z-:6UY</<7$<85
MY'?>Q^K8&X@<9P,XSWJ_110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7-^-K;4[K2+=-)^S2W*W2
M2&SN)-B7B*&+0Y]P,\\?+SQFNDJCJ>DV>KQP)>)(?(E$T31S/&R. 0"&4@]&
M(_&@#RO5-4M+KP/>S6=G>:3?VNN6JW%G,V&M'9XE948'_5LO(QP<].E=8W'Q
MH^SJ[K%-X>=Y$1RH+>>J[L _>QQGK6[/X5T:YTF]TRXL_.MKYM]SYDC,\K<8
M8N3NR-JX.>,#&,5%9^#="L-0BU""TD^VQPF!;A[B1Y"A.3EF8EC[G)X'H* /
M+K^!+KX*ZF;II+A[?7'6-YI&=AB\5.I.2=I(R?6O:8+6"VM5MH4"0J" H)XS
M6.G@S0$T*[T7["6TZ[<R30//(P9B=Q8$L2#GG((YYK7L[."PM([6V0I%&,*"
MQ8^Y)))))Y))R: /&X)_^$7^&_C+4M*3[/<1ZY<VHFCSF&(W"H2/3:I.#VXK
MK-=MAX=\4^$KG0MT:WUV;*[@1B5N(C&S>8P[LNW._KR<DUTT'A30[:74I(]/
MC_XF1=KM'9G20O\ ?^4DJ-V!G &<#-.TWPSI6E20/;0REK>,QP>?<23>2AQE
M4WL=HX X[ #I0!E?$/5IM(\.V\D=Q]FBGO[>WN+@Y BB>0!B2""!C@D$$9X(
M-8]_X:FTHZW=QZPD%M=:1*1IUDCPKYB#/GJ1(=IY ., Y&:[O4-.L]6T^>PO
M[>.XM9UV212#(85BZ9X%\.Z/IMU865B\<%U'Y4V;B5G9/[@<MN"\G@$"@#A+
M*U_L_3?AEK$%Q=&^O7MK>XD>X=A)$]LQ*E2<8R!CCWZ\UL6>G6D'Q9\27$=H
M))8--MKB-0QR9"TI_4BNI/@[0VM=,MC:S>3IC*]F@NYOW)48!'S=AP,]N*L0
M^'-,M]<GUJ*&5=0G4)++]ID.Y1T!4MMP.PQ0!YHTSWOP47QE%=.OB".,WGVY
M6._S1(=T9]4ZILZ8[5I2:/'XB^)=[8ZG)?);S:%;W$ELEY(@24RMG&&R,8'
MX[XKLH_!^APSR21V;*DL_P!I>W$\GD-+G._RMVS.0#TZ@'K5E/#^FIK[ZXL,
M@U%XO):;[1)@IG(7;NVXSSC'6@#B-)M;;QII/B)]0OYK74+35)X%NHY-LM@D
M3#9L)^Z-J@D_Q9;-/='\7^*?$NC37< ^R10):I/$Y=(WB#><F'7#;F/S 9&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG=6-P;:YMKD+OC< 'JI((((((-37^N16>I0Z9#!+=ZA+$TX@A*@K&I +L6(
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M&OVF+=MW(=Q ^; PVTC(S4?@+Q'>>*?"\&J7EE);M,\C*2R%2OF. %P<_*
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M=#_LFV:=2C2.7,A<KU"@[5Y&3\W&,9;<Z?JGBCPOH&AW>EW-E=VES;27TD@
MCC$)RQ1P<-NQ@8S][G&*]&HH \\@L-12^^(,C:;=!=2"_8SL'[[%N(^.>/F]
M<<<UTW@NWN+/P1HEG=P207-M8PP2QR#E75 I^O(ZUNT4 >;1:=J]G8>/].;2
M+ISJ4]S<6LR%"DHEA5%4<YW;@<Y  ]:'TW4S8_#J,:9=E]*:(WHV#]R%@,9S
MSS\Q[9XKTFB@#RW2=.U+0-0U'1;KP6FK"6\FGL=3"1&,I(Y?$S-\R[2QS@$G
ML.F?3XE*1(AVY50#M&!^ [4^B@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KAOC!#'+\+M99
MT#&-8V0G^$^8O(_,UW-<G\2M-O\ 6? &IZ;IEH]U>7*HD<:,J]'4DDL0,8!H
M OZGXC^Q:HVF6NGSWEW'9F]<*0BB,-M W'JQ(.![<D5@ZEX[GFC\)7.C6$LU
MIKDXRS,BN%V,VS!/WN.3G''!.:=K$6N7WBD)-HUQ>Z)-IX6"+SHUCBN"3N,Z
MEOF&-N,!@.P)K!T[0?$-GX2\"^9H<[7.B7G^DVJ31>84\MTWC+!<98<9SB@#
ML=6\9P:8E^T=E+=?V<@>\5)8U:/Y0Y50S#<P4@X''(YSQ5.?XAVANK*WT[2M
M0U%[_3S?VA@" 3(,<#+#!YYW8Z8&20*R?LFN^'O%FK2CPL-:T[5Y4NHWBEB#
MVTVQ4='WX^7Y0016B=.U9?B+HFH2:83:P:9+;7$T!011R.R, H)#%1M(SCTH
M ZS^T(HM(_M*\5K.)8//F6? ,(V[F#8SR.<_2L(^-((3I4U]I]U:6&JNL5K=
M2%2-[C*"10<IN'3KZ'!K2\3Z.?$'A;5-(67RFO+9X5D/121P3[9KD)]*UCQ+
MX5T/0-0TJ:RN+2XMFO9W9#&%A(),9!)8OM&..,\XQR %Z[Z]\4+W1-4T=KO3
M4TI%$,C1E5#RL&FQNXR% X^88Z"MGQ1J'_"'^#K:TTLE;B22#3+ R,7*NY"*
M23DG:,GGKBHK:SU%/BM?ZH^FSKI\NF16B7.Y-I=9&8\;MV,-UQVIGQ.LI9_#
MMCJ$2EAI&IVVHR*!DF.-OG/X*Q/X4 :]S?6_AQ=,TNVM9KFYO9&BA4'[S*A=
MGD<^P)).22>]06=_;>--$O5C2>RNK2YEM6+$>9;7$?&Y2"0<9!!Z$'!')%5_
M%IUF2^T-M/L[B_T<RR'4(+.9$D<%?W?+,N4W9+#(SQG(R*I^!;&\\.VWB0:G
MIJZ;:'4Y[V)A(AC\I@I&W;T "G.0.V,\X -CP3X@?Q/X2L=4F14N75H[A%Z+
M*C%'Q[94D>Q%'_"4K)=W,=I8374-K>I8SR1NN8Y&*@G:3G:N\9/7@X!'-9WP
MOTRXTWP'9_:HVBGNY);QHV&"@D<LH/OM(_&L;6O#E[>:Y)JVD:;>:5XB2]55
MO()%%O>6X<<S#=@C9G@C=D#&1B@#H;/4=.?QOKD%MH\ZZQ;VD)FF9E'VB,EM
M@7YL=CUQ[TS1?'=OKOV>.TTR\%T]S+;SVLA026OEXW-(-W R0.,D[AZU!:6N
MI6GQ'U_5FTJY>RFL((H)$:/]Z\9<D %LC.X8)P*S(M*U[1_$]EXHL]-FGFU<
M>7K=BC1J(5 _=LI+ %D^Z>3NY/% '>:G>/I^FW%Y':37;0H7\B'&]\=0N2!G
MVS6-;>+[>]\-:5K5K9SS)J;QI! K)ORY[\XXP2>> #Z5T8.0#C'L:X'PMX?G
MT_QEJ]LLJ/HFGW#7%C$/^6,UPH:1?;:"V!Z3&@#2UGQY9:1;WMY]EEN;*PE\
MJ[FBD3*$$!MJ$Y;:3SCT.,X-2:AXVM[4:C):6-Q>P:;9I>W4L951Y3J6&S<1
MO.U2<<#ISGBN=T^RU[PYK6K:;_PBL>KVE[?2WEE?B2-5C$K;BDN[Y@%)/(!R
M.@-'B'2_$>HW/B+3;G2'U&UFTT1:5(DL:6\3^40Y9"V0^\_*<-@8P5Y- '0Z
MCXXMK*[T:V@TR_O6UB%YK,P!,/M3?MY8$'!'7 YZ\&D7QHTD%TT6BWC7-E:I
M<WEFSHLT6X$A0N?F;"D]NW4\5@VVFZW_ &E\/KB31+E$TJUEBO/WD1,1:!8Q
MGYN>03QGCWXJ3QGX=FUC4+VZM=+O[76[:,#2M6L)50R':#Y<GS?=#YSN&,'C
MO0!Z$[K'&SMPJ@D\9XKE]/\ '%O>W>BQOI]U!!K2R-8S.5^;8N[#KG*Y4$CK
M[XK=*Z@NB%0\3ZD+; 8C"&;;U^F[]*\TL])\1SZAX/U2Z\.79U&QGD&IW%Q<
MQ,\CO$R;E(8XB#'.!C Z*: +3!O%'C;Q;I>KZ#+?6L%K:PQ0O+&/(#+(Q*G=
M\I8XY7D;1G&!6IX/\8O/X!M=8U2UDA5Y#% !(KF4F9D2-23DD85<MC/4GJ:L
MZ#9ZC;_$3Q1?W&FSQ65^EHMO.S(0WE(P;(#$CEAC(KE[3POXD_X5C9Z0FEK%
MJNB7PNH$N)4,5X5F=]HP3A2K?Q8Y_.@#J_\ A/[2&[U2RN;"X6]T^S^WF&&2
M.3SH!P61MP&0>"#@^F:O>&_$[^(TCF31[ZUM)K2*YAN9PNR0.,[1@YR/<#/7
MH03C>9J^L>'-6_XI)M*>2PE@2!GB,LTKK@;2IP$'/)(SD<#'.]X.M[JS\&:+
M97MM);75K90P2Q.5)#(@4\J2",B@#-OO$FHP_$>R\/Q:<\EG)827+R+(F7.]
M%S@G@+D^YSTXYY3P[XA3PC9>,KA-'O+FRM?$%S).]OL"P1[8^?F8;L<\+G '
M..,]1JMAJ</Q+TK6K;3I+NS_ +.FLI&CD1?)9I$8,VX@[<*>@)]JY\Z)K;>#
M?'UA_8]R+G5KZZFLT+Q_O$D154YWX'*G.: .TOO$L%O<):VD7VNZ>W%UY8E6
M,",G"DLQ'WB" /8]*E\->(K+Q5H<.JV'F+%(65HY1AXW4X96 SR"*XJYT_7-
M&UZPUV#PXVK6ESI<-E>66Z,36\D9)5EW':1\Q! /O7>Z,+G^SE>[LXK*60E_
MLT1!$0/121P6QU(XR>,XS0!S?BG7(M0T'Q)96FG2W\-E;R17<B,H59/+W%5R
M?F905)Z8S@9/%0^%-=^P^$/"&EV]G+=7MUI$<J*I"HJ)&F2S'IRP '/7M6;:
MZ?K^@+XOT;^Q;F_M]5N+F\LKRWDCV@S+RD@9@5*GN <TFG67B6TL_">GWNAW
M4^E6^EBWN[2*>(8N5"A6D^<!H\!N,GKR"0!0!>U7X@32^&M"U;1M/F9=2U.*
MSD$K(K1'SMCIC."QVLH.<=\UNW_BE;226VAL9)[V"W6XGM_.C0QALX7)."QV
MG ''')&1GA+3PUXAMOA_I=BVB.+K2M?6]-O'-'F:(7#N?+Y QM88W$9P>!QG
M6OK77='\9W6M1^&#K%AJ]O")8$DB\ZTFC!4#YC@J01G!QD?F =IH&NV7B70;
M36-.9FM;I-Z;AAA@D$$>H((/TKAYM>O?$OAGQY;ZAIABM[(W5O%ET8)L@4@'
M!R6R2V1P,XSQ7?:6EPFFP_:K>&WF.6:&'E8\DD+GN0" 3W.37"Q:3K=G9^/=
M.&CSRC4YKBXM)TECV2B2%450"V0P(YR ,=Z +'A/Q6MII7A#2+G2[R&*_L(H
MK:]?9Y<DBPABNW=N P#@D#....:TKKQU;6OF7#:?='3XM1&FR77RC$I8)N"D
MY*!B!GKZ CFL1](U@V'P]C&D7)?27C-Z-\?[H+ 8S_%SR>V>*RM<T?Q3J^EZ
MA'>Z!<7FIPZM'/!<&>+RS;+,K*L +?*=@YR%SR22>* .OM/$NI7/Q&U'0CIS
MK9VEK"XD$B9)=F^<\YQ\N !D]SUXD\=^(;[P[H]K/86AFDN+V"V9]RCRP\@!
MX/4G) [#.3TYJVEEJUK\3+S4VTN1K/4=.MXS,LJ;8'1G+*W.3PPQ@'/MR18^
M(6F7^J>&X5TZU:ZN+:^MKKR%959UCD5F +$#. >IH P[ZXDL_C!9WD6E7$MY
M/X?ES;1%-[-YR8RQ;:, =2?S.!706/CC3[WP]%JA@GADDNFLOL<FT2"X5BI3
M.=O&TG.<8&:H_9M5F^)MEK3Z1<QV2Z/);.Y>,[)&D5PI ;/1><9&>YZUS(\,
M>(_^$=FGM])_XF%EXDGU:"SN9$VW4+EQLR"0"5<]>A% '=Z'XLMM8UC4-'>!
M[;4;%4>2,NKJ\;='1E/(['H0:YWXIV\3OX1<H-\OB*TMY&'!>)M^Y#ZJ<#CI
M70^&[B]OB]U<>'AHD6S:L4I0RR-W)V<!1VR<G/08&<GXB:=J>J/X:73=-GNQ
M8ZU;W\[1LBA8TW;OO,,GD<4 7KGQ>+77[KP]9:%?W-[:VJ7"1Q>4B.A)488L
M !P>N#Z T^T\<:=?>'-+U>WAN';4Y/(M;3 $K2@L&4Y.!MV,2<X 4^U4[:TU
M%/B??ZPVF7(L)=)BMTERG,BNSD8W9Z,!TZUR6G>&O$FF>'?"FH1Z1*]_H-_=
MRSV!ECW30SN^2A#%2P5AP2.] &QHEW':_%3Q7=WMK_9ZPZ7;RW!=@RD R$N"
M.HQ]#P>*W$\=VBZKIEE<64\*ZH&^QRF2-MS ;@C@-E&(Z9^AP:P)]$U;Q%XC
M\3/+I5UI]EJ^B)913SO'F-_WGWE5B?XATS[XJ]X5F\0-':6&I^$8K"YM%5;B
M_P!\31RA1UB ^8LV.^ ,GGC! '2_$R"/1;O6!H.J&QL;I[:\D/E@P;&"L<;_
M )N?[N>.]:T/B]6\26VCW&E7MK]MADEL9Y=FVX" %@ &RIP00& XZXKC9- U
MV3X9>+=)&C7 OM1O[J6VB,D7S)+)N4YWX''7)K?U.SU.Y\:>#]1BTJY-K80W
M(NG+1_NC)&JJ,;LGD'.,T ,E^)MO'I5[JG]@ZI]AT^\>UO93Y8\@JP4MC?\
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M\EC/)&ZYCD8J"=I.=J[QD]>#@$<UKZC?0Z7IMU?W.[R+:%YI-B[CM4$G [G
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M\L.AW\B)%>%P60.<(\B?PHW&#DD9&0* .MHKD9_&UQ_PD.I:-9>'-0N[G3S
M92LD2@I)GYP2W0 =.IYX&#774 %%86J^(9K+4Y-/M--DNIX;,WLC,_EQA 2
MH;!RY(/''3DBN?U'QQ=W*^#[G1;(O9ZY,"QED".!Y;-Y>.0#QR<]L<YX .]I
MKR)& 7=5!( +'')X JIJ5W/9:/<WD-L)IXH3(L)DV@D#."W;ZUY=K&IW.N?#
M_P &ZWJEFOVMM7T^99$PS-N<$[0.1GICZ4 >O45S%CXQC?5-5L-5L)M*ETZV
M6]8S2(X:W.[Y\H2!C:<C^=5H/B#9-K.E6,\"QQZKE;65+E)&5\9"RJ/N$CI@
MD9XXH ["BL/Q9XEC\)Z#+JTUE/=0QNB.(2N5W,%!.3G&6'0$^U4W\8/;D0W^
ME2:?=37#Q6D5W<1J)D50QD+ D*HR >IR0,&@#J**X^P^(FF7EC?2/"Z7EG>)
M8O:1NLAEF<XC$; X8-V)QC!SC%6X?%%T?% \/7.DF&]>R>]C=;@/$R*RKMS@
M$-EN>,>YH Z6BN.3X@6\G@[3O$JZ=/\ 9;RY6V,9==\9,IB!]"-P]:MZUXRM
M]+N;VVMXH;F>QB$MQ&]TD)Y!(5=WWGP,XX'(YYH Z:BN5LO'%GK(TY=&B%S+
M?61ODCFE$1\L-M('!R^[(QT&#DCC-*_\6:N/$WA2RMM+*0:I;RW,B22A9,K&
M"8SQQM+@GU(_, [>BJ6K:K::)I-UJ=_)Y=K;1F21L9.!V [D] /4UD'Q6UGJ
MVF6.K:;)8C5"4M)?-#CS,9\N3'W7(Z8R#@C- '02W$-OM\Z:./>=J[V W'T&
M>]25YM:Q-XH\?^+-*UO2$N;%+>TM]DDH(@1E=B5QSEC@Y&",#T%;?C/6K_PU
M8Z'#I5JLBW.I6MDS/+@JA<#:,YR6 *Y/3.: .L\Q/,$>]?,(W!<\X]<4ZO-I
MYIK'XQ27-KI#37L_AQ6>WB=%R_GGEG.!P!C/L*WK/QYI]WX;L=6,3P2WEPUK
M':S.JE9E+!E9LX &QB3Z#@$D"@#JZ*YSPYXOM=?U+4]+\M8;_3F3SE242QNK
MC*LCCJ/P!!ZBL3Q/?3:Q\2-&\'>:\>GM:/J-\L;%3.H)5(R1SMW#)'<<4 =Z
M&5LX8'!QP:6N?O?!VDS"T>RLX+":VN89U>UC$6X(X8HP7&Y2!C!X!P>HJ*Z\
M6D1ZK/IVFRW]MI4C17;QR!6+J SK&I^^5!YR5YX&30!TM%<A=^/[9;C0XM-T
MV[U%=:@DFLY(615?8FXJ=QR#R,Y  YYXQ4*^/;V34'TJ+PGJ3:JEE'=FU:6%
M0 Q(QOW8&"".>2>U ':T5R6G?$#3M3T*ROX+>X%U=W9L4L' 65;@9W(W8!0"
MQ/I[\5.GB]8]0U+2[S3IHM4LK;[8+>*17%Q#TWQL=H.",$'&#0!TU%<39_$*
M2[T1=:_X1O4ETZ6UCFAF4HQED=P@C"@Y'+#YB , GIC-T^+9Q<:WI[:8!JFE
MVJ70B$X,<R,#C#X!&"ISE?IF@#IY)(XDWR.J+D#+' R3@?K3J\W/B=;OX7Z7
MJWB;0S?Q71MF=59"I=V7:Y!(( 8C@9-===Z\PUF72--M!>7T$"W$ZM*(TC5B
M0H+8/S-AL#';DCC(!M45Q<OQ'L$T&TU6+3KV42Z@NG3P@*'M9]X4JXSDD'^[
MG/'K6GI'BA]0\17NAWFESZ?>6\"74:RR(XEA9BH;*D@$$8(_G0!T-%%<EK/C
MA='AU:[;2YY+#298XKN8ML8E@I)C4CYP XSR.^,T =;17/WWB8PZG>:=868O
M;JSM%NY8O.$;LC;MHC!!W'Y3UP!D<\UNQ2>; DFTKN4-@]1D4 /HKDK7QRD\
M^BM-ID]O9ZS,\-I*[8D#*&(\R,@%0P4XP3VSBN@U?5;30])N=3OY#';6R%W(
M&3[ #N2< #U- %MI$1E5G4,YPH)Y8XSQ^%"R1NSJCJQ0[6 .=IQG!].HKSC6
M)KFX^*7@6:\T@6<K_;"LGF*[%?(/R.0.&'H,CDX)YK1M?%&FZ?:>+]4MO#]Q
M#)IMRS7R(8Q).RQAB_WL8VX[Y]LT =Q17(P^.?\ 0EO+W1[FRMK@0"QDGEC
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M][=_81:NNUH)AG<)#SM VDYY[<<U%<_$&&T\.Z[J<VEW#3:)<-;W=O%(C<@
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M(8W@7@$1_?W[1C!XSR:ZCQ;X=@\6>%M0T.X<QI=1[5D SL<$,K8[X8 UM44
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M&MU:FYC1HD5?G;.2&QC@ Y.175#D5'+!%.$$T:R!&#J&&<,.A^HJ2@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
=HHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>exhibit107-formofindemni006.jpg
<TEXT>
begin 644 exhibit107-formofindemni006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4[,7D>'AC9'0NXRP&].!R"0?>NTTGQ/I.M2WL5G/();$@7$=Q \+Q@C*L5<
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MT98@#L.,DX R.>169-XXT&#0;O69;F5;6RD,-T/L[F2"0=5= ,J>G7CD<\T
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MYSP,]">@J4?$+PTWAZ'71?/]@EF%OO\ (?*29 VN,?(<D?>Q0!U%%<=>>*-
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M.XM9,0[K?8-_R_+EN.:]$HH \>U\2#3_ (KRM;W$<5Q#&\,DD#HL@6!58J2
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M,TL%K;2M!.LT162*56VF,IUW9(&!UR*D@\5V$NO#0Y8;VWU,QB8026[-^[/
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M0^,=&'.<5VU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ=HFH11W<UIK,JPVLJ1C D8X"/DC:<@CGC@T =115$:I&=<;2A#,9E@%PT@
MV*I)49.<Y)4]NQJAK?BS3= U&PL;Q;II[XN(!#;LX8JI8C(')., #)R1Q0!N
MT5R5M\1=%GTK5[Z2'4+=](_X_;2:U(GB&"02HSP0"<YQQ4]MXYTRXMY;@VVH
M0PCR!!)-:E1=-+]Q8C_&<\<?7IS0!TU%8UCXDM+S5Y](FBGLM1AB$YM[D*"T
M1.-ZE6*L,\'!X/7%5%\;:8;C30T5TEIJ<WD65ZR#R9WP2 .=PS@X)4 ]CTH
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MUI]SO\BYB:&38Q4[6&#@CIP:RX/%NEW>CZ9J5H\EPNI\6<,:_O)3@DC!( P
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M-OXK"\:ULX+H7,GD-B(R1JJ@C&>H/3I0!))\3=*CTZYU'^S=6-E9W;6MW/\
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MU5MEC=RJHCF;&57ABREAR-RC/UJ[XE\1V?A719=5OX[A[:(J&\A-Q&XA1GD
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M!Z#) [8KHM8M;^W^)NCZM#IUQ=6AT^>S=X=N(G9T8%LD87 /-<]_9VI/X/\
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M4AMTQ<)$6D8;#D<$E<E3D#.".: .CUKQ\+7P?K^J6&G7+7NDNT$UM-L4Q2
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ML+^W1HDN;*;8VQB"5((*L,@'D=JW** ,[3-'BTW<YN;J\N7 5[BZDWN0.@X
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M%1!C+,<#G@4 /HJE/?30ZM:62V%Q+%.CL]TFWRX2N,!N<Y.>,#M5V@ HHHH
M**P;WQ5;V/BBR\/O8WKW=ZCR0.@C\ME498Y+@C'N*-3\56^E>(M-T.6QO9+K
M4O,^S-$(RC[%W/R7!& >X^F: -ZBBB@ HHHH **** "BL7Q#XCA\._V<9[2X
MF6^O8K)7BVXC>1@H+9(..O0'I6U0 445!=W#VMJ\R6TURRC/E0[=[?3<0/UH
M GHK%\,^*=,\6Z.-2TJ1VC#M&\<@VR1N.JL,\'_&K&E:PNJR7B+975O]EF,#
MF?9@L "<;6.1@CF@#2HHID<T<I<1R*YC;8^TYVMUP??D4 /HK!USQ5;Z%J>G
M:?-87L\^HNT=MY CP[ 9()9QCCUJQ:ZV\^II87&DW]G))$TJ//Y11@I4$91V
MP?F'!]_2@#6HHHH **Q=0\1PZ=XET?1)+2X:35/-\J<;?+7RT+L#SG. .V.>
MM;5 !115*\OIK:^L;>.PN+A+EV62:/;M@ 4D%\G.#C'% %VBBB@ HHHH **R
MM2ULV%]!9Q:9?WTTL;28M53"*"!\Q=E SG@=\'TK&TWX@6NJV<=[;:-JYLWN
M1:FX,<6U'WA#N D+ !CR<4 ==16+X>\1P^(3J8BM+BV;3[U[*19]N2ZJI)&T
MD8^;UK:H ***I17TTFL7%BUA<)#%$DBW;;?+D))RHYSD8YX[T 7:**ANYS:V
MDMP(9)O+0MY<>-S8[#) S]30!-167X=UN'Q)X>LM9MXI(H;N/S$23&X#/?'%
M:E !1110 445FVNK[]+NK^_M)].BMFEWBYQG8A/[S@GY2!F@#2HKE%\97,EY
M811>&-7EM[Y8Y8;J-4:-8V(!9SN^0@$''7'T-=70 444R6:.%5:614#,$!8X
MRQ. /J30 ^BJ7VZ;^V_[/^P7'D?9_.^V?+Y6[=CR^N=V.>F,5=H **** "BB
MB@ HHK%7Q'"WC%O#9M+A+@61O1.VWRV3>$P,$G.2>H'2@#:HHHH **Q;KQ'#
M:^*[#P^]I<>=>PRS1S_+Y>(P-PZYS\P[=ZVJ "BBB@ HHHH **** "BBB@ H
MHIDDT<.WS)%3>P1=QQECT ]Z 'T444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %<E\3_P#DF/B+_KR>NMK+\1:'#XDT.YTBYN+B"WN5V2FW*ABO<993
MC\J ,O7]=.A>%K)T6X$ESY<"S06SSF#*Y+E4!)P <<8)P#QDUR'@[7-&/Q2U
M"UTZ.]2&;3;:&'S;.9"64R,Q<LH(SG.YOO$GDFO4+.V^QV<-MYTDWE*%$DFW
M<P'KM 'Z53@T*UM_$=YKJ/*;J[@CMY%+#8%0L1@8SGYCWH TZ*S]'TMM(LFM
MFO[R^+2O)YMY)O<;F)VYP.!T K0H **** "O/[52_P <M8579"=!A 9<97]Z
M>1G(_.O0*\^6"2#Q==>(DTCQ8;R> 6K*%L_+\L'( &[/!YSF@#G%U;Q#%\-C
MXH?Q%>R7EEJ9C$95!',GVORB) %YRI[8 P, =3V=O?S^(_&WB#23>7%K:Z/'
M;QJMN^QGEE0N7)ZX P .G7(/&.?.A1MX2F\-G2/&/V&6X^T,W^A>9N\SS.N>
MF_GI^E6KJSED\0C7;/2/%UA?R0K!=/;BTQ=*O3>K.1N'8@ B@#(\'ZM>:?X"
M\*:5;R?OM3U.\@DFW",E4DG<@'!"EBH'3N<8."-#Q"?%N@>%/%ER^K&&WBA6
MXTUA,)KB+ Q(C,R<KGH>H]:A'ANR/A./P^_A[Q:T,-P;JVN/,MQ-;REBVY&$
MG!RS=<]:L2:6]UX=OM(OM,\9W9OD$=Q=S/:M,R#H@R^U5Y/09Y/- $]\=9L_
M&/AFUC\0WIBUN"X6Y5EC*QF.-7#1#;\IZC)W>^36;=ZOK>G^%?']K%K5XTVB
M39M+N38TH5HE?8Q*X(!)YQGWK6GBEN-5T749-&\6&?2%=8,+9X;>NUBXW<Y
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M^25CU9CW/Z   8  K/7PO#'XCOM<CU&^6ZO+=;=U'E[%1<E=H*9R"3U)Z\T
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MV-_',%N(2>H#!<8/<8JW=^!;2_T#^RKK5=4E+SI<3732HTTKH05R2A  *C
M _,Y ,B2+5H?B1_8(\1:BUE?:6]W(6\LO&Z2JO[L[<("&]#^?(P[K7M>A^&^
MK2QZU<_;-+UYM/2Y94+S1"X1!OXZ[6ZC!XKT%_#,3^*(/$!U"]^UPVIM%3]W
ML*$ACD;,Y) /7]*RI/AU82Z-?Z4^JZI]GOK_ /M"8[H=WFEPYP?+X&Y0<>U
M$-G+J6G?$YM&DUB\N[2\TA[LB?83%*LJIE,* !ANF#TK"%S?ZQ\'/%<FH:C<
MSSV[:E&)<JI=8]ZA2  ,8'0 5W#>&(G\3P^(#J-[]LBM#9A?W>PH2&.1LSG(
M!Z_IQ5*#P-9V_AC4M 34M1-KJ+RO,Y:+S!YN?, /EX .3VX[8H YZ_EU#1?!
MW@R2QU6\07&H:?#,K%6#QR;04R5R!QV(ZGK6JES>^*=;\4:=!J4]@=+,=M:^
M0VTK(T0?S7_O#)P%/&%/'-:%[X,MK[1])TR74]0$6ES0SP.IB#EHL;-W[O!
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MBDT802,GF$HQ9E _UC>8-NTYX &.3FK=-XDBC\!6][K>H6]YJ,A34$_=@[C
MS,.%'((P,Y ]\4 >GT5Y["NHRZ_=^%(]0N[N/3;&*033ZBUO<2M*TAWEXT);
M: J@<#U!R,16][XDAO-!\*ZO>6UU?O:W,US/;W;P?:/+90B[U3<&VON; !.W
MKC((!Z/17EFN#Q7H'A<I=:Z1*NM6ZVS03>;(+:250(Y69 S8YY[CKFM'[)J"
M?$N;0!X@U4V%WI/VV0-,"ZR+*$^1L?("#R%QTXQ0!Z%17E6G>)M6A\-66GO>
M///+XCFT<7<\NQVB1I",N%.&(0+G&>?7FK>MVWBC0M!\5W1U?R+,6#W-C&EX
MUQ/!(B_-AY$R4/'<D=B,T >E5''/%,\R1R*[0OLD /W6VAL'WPP/XUYY!-J>
MG>*/!3MK-]<IK-O*EW#,X,9*P"12JX^4@CKU/<FK'PSLE@F\4R">ZD*:]=0@
M2SLX(&S!()Y;WZT =_6)J/B--.\4:-H;V<S-JGG>7<!EV+Y:%R",YST[8YZU
MB^-=3U#2=1L[N2RU&[T%('%V-,E99H)"1MD95(9D #=#@<D@X%8=[)'JVN_#
M5K+6);F.:*\"Z@H'F2#[/@MR.&.#G(X.: /4:9,[1PNZ1/*R@D1H0"WL,D#\
MS7FEIJ5_::/XRTV3Q%- NG:BD-M?W0,TJ1NL;%!CEF^9E7J<L*U?#6H7J_$+
M5])<WT=@-/@NHK>]F\UXV+.I(8LQ .T<$_ETH F/Q#M_^$"M/%BZ7=-;7$HC
M\H.FZ/,OE L<^N.F>OXUV=>*)_R;;8_]?,7_ *7BO:9%+QLBNT98$!UQE?<9
M!'YT .HKQF'4-<C^&5GXH?Q!J,E];:GY81I!Y<B&\,15U ^;*G\,#&*[*TO)
M?$WC/Q-I4]W=VUMI*V\,*6L[0MND0N9"5()[  Y'!X.: .PFGBMT5YI%16=4
M!8XRS$*H^I) I+F9K>UEF6&29D4L(XR-S>PR0/S->.7-_?\ B#0?"YU6YG:\
ML_%:Z;+-#(8A.$9QYF%P-W Y[$'&,U[$8Q%9F,,S!(]H+L6)P.Y/4^] &?X9
MUV+Q-X<L=9AA>&*[3>L;D%E&2.<?2M:O#=-35M"^#.B^+-.UR^6>QCC;[ 2O
MV:6,R[2A3&23G.[).>F.,=A//K?BN]\36NG7/V6;3[C[):,M^\!A81*PD9%0
MAP68_>R,#  Y) /0JQ/%GB-/"GAZXUB6SFNHH2H9(F4$;F"@G)'&2.F3[5;T
MV6\AT&WDU22&:]C@!N7MN4=P/F*\#@D&O*/$4T_B7X&W/B:YOKG[5=E)C$DQ
M\E$^T!1%L^[@ #G&[(SGM0![/17"WMUJ7B#Q5K^BVLK1)IL,"Q^7?O;,KR(6
M\SY%.[L,'CY3P<U4M[[Q%-JFD^%]4N;:XODTR2YNY+6\>W%PZR^6,.J;A@#)
M  Y/H,$ ]%HKR[5/^$KT71M$M[[7B;AO$D%J'MI!(6MI&!5)6* E@.O0$8SG
M-7;>ROS\0]4\.-X@U8Z=)IL5]S./-20R.A"OC*J< X&.>F!D$ ]$HKRK1O%&
MKW'ACPO82W1FNM0U&ZLI;F68Q-(D)EVC>%)#-L49 SUQ@G(L:O?>)?!NEZM)
M/?P&WO+FVATT/<-<RV9D8)(S,Z@LHZKG//!H [*\\1I9>+-,T![.8OJ$<TD=
MQN78/+ +#&<YY'8=:VZ\\U'3%T[XL^#REU=S*]K? K<3M+A@B98%B2,Y&0..
M!@"M[QMK-SHVDV?V5ECEO;^"R\UFVB,2-@G.#@X! .#@D'% '2T5QUAH>O1Z
MW?17.HF'1KNTQ' NH2S7$,X89='=00N#R"2,XXP<5C>!-0U#4-:ET;5]5EDN
MM%$F'69Q_:2-(0LQ!X*KMVX&1N)[8R >E5B)XC1O&K>&C9S)*MB;X7#,NQEW
MA,  D]2>N.E<UIS:EXTT?5[ZUUJXTW4(-2FM[5HV)CMEBD "O'D*^X D[L_?
MXQ@5.0L_QH0%]ROX9/S1L1D&X'((/'X&@#N:*\C.MZM_PIA=7_M.[_M"'43$
MMQYIW%?MOEX;U&SCFM3QAK5WH^LWYU<ZI:Z--$B66JV$C&.RDQ\WG(I_O$')
M!&, 8H [MKRY76H[(:?*UJT#2M>AUV*X8 )C.<D'.>G%7:XN2]NG^+%K9+J$
M[Z;<Z)+.(%<! WFHH92N#G!ZY/7BLK3-0U"U;Q'X5N]0NY=6%XBV%Q),=Y@F
M&8W7_KF Y;'79SUH ])HK@[B;4=:\2ZUH%I-(D>EV]ND9&HR6\F^1"WFDJK%
M^PP3C@Y!S73>&H]6B\.V<6N75M=:G&I2XFMCE'8,1GH.< 9X'.: -:LW5]9A
MTD6D;*9+F]G%O;1 XWN06Y/8 *23[=S@5P]GJ&H>)O!6N>(H=3N[/4+>>Z-F
ML4I6. 0DA$:/[KYVY;<"?F.,8&*FJ3-XEF^&VKW#7-O+J$H>2.*9D5";=V)7
M!XY/7KB@#T/1-3N=4M9GN],N-.GAG:%HIL$-C'SHP^\ASP>.]:55;QOLNE3L
MMRL'E0,1<3G<L>%^\V>H'4UYYI6IZA!XJ\'P1WVH3VVIV=P+FXN7.R[9(U<2
MQQL28QDDCA>#TQ0!Z;17CUQ<:V_@_P ;:H?$FJ"XT;5+H6A615&(PA 8 ?,.
MVWIR>,UTNL:A>:3XB\-Z]->7 T>_"VEY!YI\J&:11Y4F/0GY3VY!ZT =Y16'
MX9:6[M[O57GF>&^N&DMD>0LJ0CY4*@] V"__  /'85DQ7TGB'Q[KVAS7-S;V
MFE6UOY:6\S1-(\H9BY92"< * ,XZY!XP ==//%;1^9-(L:;E3<QP,L0H'XD@
M?C60GB-&\:-X:-G,DJV)O1<,R['7>$P "3U)ZXZ5YEJ%]?ZUX;L;;5+NXDN=
M*\81:8;B.0Q_:$65<.P7 +8(Y[$9ZUTEYIK7/Q?BLDOKNW0>&R&EBD_>L/M
MXWG)!]^OO0!Z)17E6D^)]6/AK1-.DNVGN;K6KC37NYI?+=XXC*5!<*<,VQ5R
M!GD]#R)_$$'BG0/"_BRY;6#!:K:_:=/2.[:>>!E'SC?(@)0G!ZY'K0!Z=16'
MX;TRXLX'O+G5[Z^>\CB=DN&!2)@O/E@#Y0<]"3TKF)K75-9^(^N:/_PD>J6E
MG%96UQ&MLZ*8V+OP#MZ?+SQD^M ';6EY<W&H7UO-I\MO#;L@AN'=2MP"N25
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MY4$D'C! '&,UJ:#?7UC\0M8\-2W$UU8+9Q7]J\[EWA#,4:,N>6&1D9R1SR:
M.SHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+)@2-G ;<1@<'GFM]22H+#!(Y&<XH Q/&6X^"M<C2.2226PGCC2-"[,S1L
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M=W(DF,7/R E<*.3T //6KWA?Q$/$MC=W(LWM#;7LUFT;N&.Z-MI/''7ZUMT
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M8)0L$QE5A<+M!+ #E<$D8/I7-/XTU.YLK;4-$\,3ZM879D6WDAND1B5)&7#
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MW *N,YQR/>@#-D^'NDMKEWJ4-WJ=JEZ_F7EE;W12WN6[EU SSWP1GOU-:?\
MPC=M_P )6OB(7-T+L6OV,1@IY?E;MVW&W/WN<YS^%5[;Q4MQXRN?#0TZX6XM
MH%N7F+)Y9C8X!'.<Y[8[5T- '%S_  STB?3[S3FOM573[FY^TBU6X CA?S!(
M=GRY +#N3C)Q@\UJ7GA*WO1J$4FI:B+74$$=U;"1"D@"!#RRE@2HP2"#^E=!
M10!B#PO:+XEM]<CGN8Y[>U^QQPJ5\H19!VXVYZ@'.<\5/+X?T^;Q+;^('ASJ
M$%L]LCYXV,0?S'./9F]:U** .8UWP-I^MZS#K"7NI:;J4<?DM<Z=<>4TL><[
M'X((_7]*W[*R@T^RBM+=2(HA@;F+,?4DGDDG))/))S5BB@#FF\$Z>)=3%O=W
MUK9ZHYDO;*%U$4S,,.>5+*6'7:PS5C4_"MGJ5YI-Q]IN;;^RGWVD=N45$.W;
MT*G/R\8Z5NT4 5KZQ@U+3;G3[M3);W,+0RKG&Y6!!''L37-6OP]TZUFT><ZE
MJ\TND!EM7ENLD(RA=AP ,8 Z8)[DUU*W,+W4ELLBF>)%=T'55;(4GZ[6_*J^
ME75Y>Z>L]_I[:?<%G!MVE60@!B =R\<@ ^V: ,/_ (02P_L?6=+-_J!MM8GD
MN+O+1[B[XWX.S@' X]N,51\0Q1ZE9'P)_9FIW:3P1(]]+ ! D>X98R# WJ%R
M !UV^]=O10 R&*."&.&) D<:A451@* , "L>^\,6MUKJ:W;W5U8:B(?L[SVI
M3]['G(5U=64X/(.,CUK;J*>YAMO+\Z14\UQ&F?XF/0"@#"O/!>DW>@1Z/FXA
MCCN1>+/%)B;SP^_S-Q!RQ8DG([U)'X5MXO$*:VM_?_;$L_L0W.C#R]V[G*DD
M[N<Y_3BET_Q']O\ %FK:";*2%M/BAE\YW!$HDW8P!T'R]^?85NT <BWPYT67
MPY/HD\MY-;2737B2-(JRPS%BQ=&51@Y)/?KZ5+_P@EE)X?O=)N=3U:[%Z@BN
M+JYN!).\8SA-Q7 7D] .IKJ:YO5?%G]F>)[#01I5U<7-_')) \;QA"$&6SN8
M$$9H W+*U^Q6,%J)I)A"@0/+C<0.F< #]*SK?PW;VWBBZ\0+=W9NKF)89(V*
M>647)4 ;<\$GG.>:BT_Q5;7FORZ#<VEU8:HD/VA8+@*1+%G&]&5B",\8R#[5
MO4 <?JWAYM(T[Q1JFFI?:C?ZK#^]M?,4;R%V#9@*00O8')QZ\USNB6#[[--"
MUSQMY\#1@V^J6[);H@(#!_,B (VYX5B?2O4JYU?%8?QK)X7&FW/VI+479FWI
MY?E%MN>N<Y[8H C7P59K;Z[!]OORFMEC>9:/DLNP[?DX^7C_ .OS2R>"=/D7
M0\W=^LFC1M#;31S!':-E"E&( R"% R,'CK72T4 <\_A"TFW17%]?3V;7OV[[
M'*R&,2>9Y@P=N[:'YQNQ^&:V-1L+?5--NM/NE+6]U"\,J@XRK @C/T-6:* .
M8;P-IS:3IUDUWJ!FTV19+.^,P,\+ !1@D;<;0 5*X/<$\UJZ;HL&FW-U=^;-
M<WMUM$US/MWN%&%7Y0% &3P .I/4UI44 %%%% !1110 4444 %%%% !1110
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MY*ON)'*@XW$?F:UY/A]H\VFWMC)->E+N^_M%I!-M>.YR#YB, -IX''3VI_\
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MI&Q 0@ (/3)YZ\\YK.E^'&@S>&;/06^UBWL9/-LYEFVS6S9)RC@9ZD]<_H,
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MO1;O4_LT$EV[1NJ;PJNO\>,#&>F!6OI6G:M='P[X@MM6CB@94:[9[V69;U)
M."C *K;CQCH>!QQ0!Z#17EFE#6_%GA6S\1VFJ16-Z+AKB2Y>]E*(JN=T+PXV
M;0HQCVSUYJQ'82ZKXJ\>V%SJNJ_9K5;9K=([V1/*9H"V5*D$#<2=O3U!P* /
M2Z*\@M[G4!X3\!>)7U;49-2O+ZSMK@M<MY<D4F593'G8?7.,YYS6N5U3QE/X
MHMK:[^S75E?-:6TBWTL36NU%*/L08;));)//(Z"@#TBH;N[@L;=KBYE6*)2
M6;U)  _$D#\:\\CMKW4/B+8Z;?:U>2P3>&_.N!9W+Q132B5%+IM(*@]<J0??
M!.><O1+J'PUM8KZZNKEK#Q.MI%+)</O,:W6T;B#\Q"\ GD=J /;**C@@2V@2
M&,N508!DD9V_%F))_$U@>,IUBT^QC;4+BU,U_#&(K9<RW?.?(4[EV[L<MD8
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MK>+4O;FYC73I_L5M#!.\7E 1AC)\I&69B<$YX4#US>^%?_)+O#W_ %ZC^9H
MZ/6+]]*T:\U!+<W!MH6E\H,%+!1DC)Z=*SM.UR^U31_#^I6FE!X=2CCFN?\
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M820O']W^Z1GMZ8/!((!ZE17EVJW]SX?UF5=>&IG27O(?L6MVMT[I %V+Y4Z
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M'=)+B,A'1!G"AV<'C^[D<5WNE^%M'T;0Y=&LK39I\H=7A>1G!5\[E^8G Y/
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MBHZ>MTTC*TT2>:NXX(Y.T MU^7K732:-:ZG\6=3L;A[D6HT*V4I%</&6'FR
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MZE;"S2!9,-';*#A-P/#,69B0>,@9XR;_ (8T4>'O#UKI:N62#?M!=GV*7+!
MS<D*"%!/8=J .4T9?^$R_P"$N.H7%Q#=6FIS6-J8YFC-HD:KL=,$8))+$]^G
M08KGM/OM1\3K\-KC4KR^ADU**[2\6"X>(3!(FPV%( ) SD8/S<$<8]'N?">D
MW.HW5_LGAGO$$=W]GN'B%PH&!O"D9('&>N.,T^Y\+:1=7VF7;V\B2Z6"MD(9
MWC6$$;2 JD#IQR.E $@@'ASPO)'9B>Y%C:N8A-(9'DVJ2 6/)]*\WO;JZ7X.
MV7C6SOKAM=CCAO&G$K$3.S@/$RYP4Y*A<8&!BO7:P+;P9HEF=D%O*MJ)_M*V
M?G.8%ESNW"/.T?-SCH#R!F@#G-&T^W;XQ>()S'(LOV"TFQYK??)D!SS@] ,=
M!CBN/L[9K'X3V?B"WN[R._M-7/DE+AU15:^*,NP':00QSD$G/7  KUN?PSI=
MQKO]M/#*M^81 TD<[H&4$E=R@@$@DD$C(_ 51_X0+P__ &!_8?V>Y_LWSO/\
MG[9-]_=OSG=G[WS=>M &!<BZ\5^*?%.C-<1QM8"&*W5II$:%7B#"50A'.YCS
M_L@50N=,N[CQ7X2TC4-=O+L3Z=>17LMM<R1+<-'L4-@-\K<G)&":Z_6/ >@:
M[J,&H7MM,+V&,1?:(+F2)W3^Z[*P+#ZU;?PKI#ZII^HBWDCN-.C,5IY<[HD2
M$ %0@.W! '4=A0!QE[#!X-\6K:W-SJ$^D:KI300K)=R.XN81G:I)X9U(Z8)9
M:C\&375]8VGA34YISJND7TAU%_M#EGCCPT;;LY(?S(^O!"OQ7H=_I-CJDEG)
M>6ZS-9W N8"W\$@! ;\-QI;?2K*UU2\U*&!4N[Q8UGD'5P@(7/T!- '"6JZC
M+KWQ(T^RU.6"94MDLY;F=F6!W@SP225&YNW3M5&#Q--I=EXB+Z1=Z/XCL-'>
MX^Q22&:WE"9Q-$V2#\Q&[N>,YQ7<'P?HK3:M*T$[/JZA+TFZE_>@# _B^7 X
M!7&*LVOA^PMKB2Y99;F=X/LQDNI#*WE9SL^;L3U[GC.<"@#E=+T>\DO- U^T
MUJ&*V9!Y^)9)/[0611MW;FQN!Y!QD?2N^KFM#\!>'?#E\;K3+22-@6,4;W$C
MQPENNQ&)"DY/(&<''2IO"GAR+PU9WL$ >.&YNFN$A>9I?*R%!&YNY(+'L"V.
M>I .9U#1K?7/C!?6EW+=+;G0(2RV\[0E_P!_)C+(0V/;./7-8&FZUJMI;:?X
M<NK^ZELCXHFTK[:\A\V2WC7<L9<<Y+?*2.<*17IM]X:TZ_U9-5;[1!?K%Y!G
MMKAXF:/.=C;3@C))YZ=L4ESX7T:[T--&EL4^PQL'1%9E9'!R'# [@^<G=G.2
M>>: .2NX'T_Q[=Z# TSZ-J.BRW,MJ96*PR(P7<O.5# X('!-<S'9QQ?!'PFT
M32(\]]IY9]Y;!\X<@-D#\L5ZU8Z)96$TTZB6:YF01R3W$AD=D&<+D]!R>!QD
MD]362GP^\.1Z3#I:VMP+.&99XHQ>3?(RG*X.[("G)"] 23CF@#+T> Z/\6+_
M $JUN+IK*XT>.]>*>X>;]]YS(6!<DC(QG'I6GXMDB:_T.S>YN&DGN7*:?#@?
M;=L;$AVR-J+D,>N< 8)(%:<?AW3H_$']NJDYU'[.+8RM<2$&,'.W:3MZ\].M
M)K7AO3/$#V<E_%+YUE(9+>:"=X9(R1@X9"#@C@C- ' :0=>N_"OB&RL94>[L
M_$4D4%I-=MMDA39(UNLAP0""P'MQTKIO FJVFH#5HHK2^TZ]AN%^UZ=>,2;9
MB@ "')&P[<C&!R>.:MQ>!/#]NMR+>UF@^T7*W;F*YD4B48PRX;Y3P,XZX&<U
MK:?I-IILES+"KM/<L'GFE<L\A P,D]@!@ <?G0!QMYIMK-\<+.1UDWMH<DA(
ME<<K.@'0]/;I67933>)?AMK?B.:\N;?6H9+R6.5)F4VC0LVR,#. NU5R,<Y.
M<YKO[_PYI>I:O::K<P.;RT5DCD29TRA()5@I 9<@'#9%59/!NBR7-[+Y$J1W
MS^9=V\<[K#<-W+H#@D]_[W?- %KPYJ%QJ?A72M2O4$5Q<V44\RXP%9D!/TY-
M>;QW4T+^#]2L+NZN8KS63!)J<TI1[Z-Q*2#%R/+X&W."-HPHZUZYM79LVC;C
M&,<8KE(OAOX7BMK>W2RG\FVN!<VZ&\F(@?GA/F^5>3D# /?H* ,;3(/^$VLO
M$S76IW-GJ%KJLUK#-#*5:R2)ALVC( R!DG^+<>P&"RT^TF^,]U,&DD+:%;S^
M8)67>WFN-Q /3 ''3VK?O/ /AR]UQ]7ELG6YE"B=8IW2.?'3S$4A7_$<]\UH
M7/AO2[O7H-;E@?[?#%Y*R),ZAD#;@&4$!@&Y&0<'F@#S1]=O]$\%>+IHKVYW
M)XF>R%S+,TCV\+-$I(9B2,*2!Z$BNDUF"3P]XW\,+I4DZVVJ236E[;><[+(H
MC+B3D\.N#EAR0>370VWA#1+6QU.R6T:2UU.5YKR*>9Y5E=OO-\Q."<#ICH*D
MT_PUIVG212Q_:9I8(C# ]Q</*T*'&0I8G'0<]3@9- 'D]W%<1?#+Q+K8U/4S
MJ&E:M<_8Y6O9#Y82<  C=AN./FSQ7MY ="IR PQP<'\ZYP^!/#[:)>Z.UO<&
MPO9C/<1&\E/F.3N)SNSR>2 :Z".%8K=859RJKM!9RS8^IYS[T >-WL]XOP?\
M43+J-^+BUUJ>.*?[5)Y@47*I@MG+#:2,'-=9';'1?BS8VUM=WCPZAI<\ERD]
MP\BO(CIM?#$A3\Q'RX&.,5KMX"\/OHMWH[6UP;"\G-S/$;R;YY"VXMG=GE@#
MUQD5>;PWIKZW:ZPZW#7UK$88I3<R'"'&05W8.<#.1VH YKXL6D-SX9L6E5B4
MU6TVX<C&9E!Z'K@GGM5?4])M[GXL:7I[/<);#0IPRQSNK,OG1\%P=V/H>V.F
M17::UHMAX@TR33M2A,MLY5B%=D8,I#*0RD$$$ Y!JK'X4TF+5H-42.Y%[! ;
M>.4W<IQ&3D@@M@Y/))R2>2: /.K'6[W3O"\&F_;9!;GQ5-I(GN)F+) &<JAD
MSNY*JN<YP>M=KX?T.^T7Q'?O)J47V*\B5X]-0NPA=2 SJ6)P#D9 XS5C_A!O
M#QT>_P!)DL6FL;^9KBXBFGDDW2,<EP68E3GG(Q5K0/#&E^&H)(].CFS)@/+/
M,\KL!T&YB3@9. ..3ZT ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5B^*]=E\
M->&KW68[1;M;2,RO$9O+)4=<':>:VJY+XG_\DQ\1?]>3T =#I-Y-J&DVM[/
MD#W$2R^6DF\*& .,X&>OI5RO,M4MC/J_PWB^TW<4=Q')'*L-PZ!E%J3T!P#U
MY'//6LB_U6Y\(:/\0+;3)YH;:ROK5+<LY?[*LZ1^8RELD8W$CT- 'H>J^(;G
M3O%^@:,+2)[?53.#.93N0QQE\;<8YXYSZ\5T-><ZMH^GZ;\2_ DEA%Y8?[8K
M%7)$F+?AFY^9N3\QY.>2:S;&SN_&?AF\U7^VK;3M3MK^<O>>4YFLC%*<)]\
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M&ZC!8*H/3S%R,#JR^] 'HU%97AS3'TK0[>WFQ]I;,MQ@Y'F,=S ?[()P!V
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M:6D2LL=Q#=>89F#<,%Q\JE?4Y!%;]>?322Z9\5-1%H9I%B\,^?';M*S)O$S
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ME89/)Y.2<GUJ'Q5X@N] FT,06L,T6H:G#8R.[D-&'SR !SP#W_.BW\07<GQ
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MM,,H^V2PO<+&.NQ6523Z<N/U]*MT 9=OX>TNUU:]U2*W?[7?*JW+M,["4 8
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M<<D8)KNK31K"RCN4BMPWVHYN&E8RM+QCYF8DL,<8)Z56T[POH^DR0O9VA3R
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MK/\ A"_#XT>'2!8$:?!)YL5N)Y J-G((^;UY^O--UCP/X:\07L%YJFDQ7-S
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M,Q!Z$$8P.!QQ5C0[2U\5VGC :NN;RUU*>TA=V/F6<4:J(C&>J_WMPZDD\UW
MT'31KIUH0-_:)C\DS^:^?+SG;C.-N><8QGFH;OPMHU[?SWLUF1/<(([AHY7C
M$ZC@"15(#C''S \<=* /-M/FN_$<GPMFUHR-<75M>F8ABC2#R1@DCGYE )]<
MU<T^UCM/#?Q)TFW:6*RLIIVM8TE8>3FW5\*0<@;N<=*]"N?#^EW>H65_+;'[
M38@BU=9&7R01@A0" ,C@\<CBH5\*:,D>HHMJ^W4L_;!Y\G[[(P=WS>G'TXZ4
M <!):1ZBOPGMK@R&.6T</LD*%A]C&1D'//>G0Z4NBZAX\T+3Y+A=%CTM+J.(
M3/BVG9')5&SD9"AL9]*[V7PIHLVGV5B]G^YL2#:%975X,# V.#N7CC@].*G7
M0=-73;G3Q;G[/=9^T#S&WS$C!+OG<Q(XR3TXZ4 >9O86=[I7PF>[MHIV=8HV
M:1 Q9?LI.#GMD _A7I>N6MO<>&[^VEACDMS:N/+905("G Q4$WA+0KC2K/3)
MK!7L[)U>VC9V/E%1@;3G( !QC.,<5L"*,1>4$41A=NS'&.F,>E 'C7V&VC^$
M7@801K"UQJ.F-*\0VLS%P-V1W]ZT[S?X3\5^+X]"1HP/#@U!8=Q<&X5I0'P2
M>2 ,^N*[-/ WAN.PAL8],5+6"83QQI*ZA9 <AAANW;T[8J_'H&FQ:P^KK WV
M]XO(:9I78M'_ '2"<$9YQCKS0!Q>C:'!='PUXFLM;M(1A0SVULP>_#K@I*QD
M.]LY.2"003Q@T[XSP3/X)M[I$9[>QU*WNKI5&<PJ2&X] 2#^%=)I'@;PSH.I
MR:CI>CP6UT^?G3<0N>NU2<+G_9 K>DC26-HY$5T<%65AD$'J"* &PW$-S;1W
M$,J20R('213E64C((/IBN'N[V'6/BC8Z/=JD^D-HK7EM$ZYBGF,H4D@\-M09
M&?[Q-;MIX+T&QREK9R16Y))M5NI?L_\ WYW>7CVVXJ]J>A:;K#6SWMONEMF+
MP31R-')$2,':Z$,,CK@\T >1>)$N;7PA\0]*2:?^S=,O+<V#"5AY7F>6SQ Y
MY5=W"G(&ZM_QCX8T[2M0\-_87O(&U#7XA=.MY+F3,3Y/+8!.T<C!],5V]SX6
MT6\T=])N+(26,C^9+$9&_>MG)+G.6.><DGFL#QSH5UJ1\,VMGIUS=VUEJD=S
M<,LX!2-4=<[F<,6RP/!SQ0!R>L1W7@/7_%4/ACSDLV\/'4/(WM(L%QYA0.NX
MG&5#-COM]JU=:MH=+T?P?KGA_P"6]FO;2%Y4.6O8I1\XD/\ 'D?-DY((S7H%
MEH]C8BX,,!+W.//>9VE>3 P S,22 . ,X%5=/\*Z-I4D+V=GY8@+-!&TKO'
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M<^M5CX/T(V-C9?8V^S6$@EM(Q/)B%QT*_-P1V].U &Y11T%% !1110 4444
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MC2.[FO[6#S(>MU!*I+B0_P >0-V3G!!-=!\3XUD^&GB MNREF[J58C! XZ4
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M)#*^\EMQ)SD=1GBET2VTCQ;X7UFYUVX:#5+74YC=74;!;BS,<I,:HQ!*@(%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&9))&D?8.BAF)(49/ XINLZ'I?B"P:QU:QAO+8D-Y<JYP1T([@^XIS'41KJ
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M(S@=*T-,T!=9U[PEJ<>DQ65OIMBPNU<QG>Y5?+50I.=K!FW'IGU)%=#KOA.
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MU*SANX P;RYD#+D=#@T <CJ4$2?&C09E11))I=T'8#EL-'C/YFN0EELI=/\
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MJP(RS9[J33=0-QH>M27U_8VNL>'[G6ED2_A^6ZL)_-"!6!'S(' 3CG''H*]
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MVL[8_&?6(S!&4N-"A:52.')F<'/KP *[:RLK73;.*SLK>*WMHEVQQ1*%51[
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M9R6=_;17-M(,/%*@93^!H X"^TY+7XC:K8V<"+I=[H#SWULJXC\X.51\= Q
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M9?9A<_;+?R"VT2^:NW/IG.,UY:= TBVUWX<V,$S:E:(;^!;FYPS31")L*2
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M%GD\V40IMWO@#)]\ 5YO'H.D7?B#XF)<:=;2I&L3(KQ@JC-:Y+*.@8GG(YH
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M%?"_A]8H(ET/31';L7A46J8B;U48X/TJ]/?V=J7%Q=P0E$\QQ)(%VIG&XY/
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MACFAD4J\<BAE8>A!X(K-GT&TBLG72;6RL+U+9X+2X2U3_1]P.,  ?+GG;T-
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MV=IH&C:>+@66DV%L+G_7B&V1/-_WL#G\:L66G6.FQ&*PLK>UC)R4@B5 3ZX
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M[VW>WNX(IX'X:.5 RM]0>#2165K;V@M(;:&.V"E1"D8"8/4;1QB@#S6_U_\
MX3#X$W-^]]%9W7D+%=M*VU1,CJ'C;'0.1CZ.*T;#3[#Q+\0(/$#0Z=Y=OI9M
M?LYEAG=G+[MPV%@%49&>IW'C'78U[PJ'T22U\.V6DVDLDT;SPR6X2*ZC4Y,;
ME!D ^N#Z8YK/TKP=')J-M>W?A;P]H[VSE]VG8>27*E2I;RTPISR/FSTXH Y'
M1=(MXOA-KVIZ780G6+:745MIXXQYL0\QU(C/5?ES@#U]ZZ#2$\,ZUJ'AS6=-
M\027-Y;PNEG:PF%2$9/F2140$*N.AQ@X[D9[RQTRPTQ'2PL;:T5SEE@B6,,?
M4X'-16.B:3IEQ-<6&F65K//S+)! J-)_O$#)_&@#RKP[_8GB/P=I<6K>(;F'
M5K*\$DMHAA2Y6]5SG *;R68GOSGKQ6A::/I<^L_$Q);"U=$*;5:,$)NM06('
M8D\DBO15T325U4ZHNEV0U$C!NQ OFD=/OXS^M(-"T@&X(TJQ!N1B<_9T_>CK
M\W'S?C0!Y9%9VEOX+^&&H101)>R:C8*]P%'F.&B8,"W4@@ 8]AZ581]'UJ;Q
MGH?B?73I\S:A)YL,IA0M;X'DNC.A. H&,'@_7GTH^']%:&&%M'T\Q0G=$AMD
MVH?51CC\*==:'I-[>PWMWI=E/=P8\J>6W5GCQTVL1D?A0!P5CH^FR_%J&*:U
M%PO_  C$+G[7&"\C"8KOD&,%\=217.0+!'\,M #",06WBM8UW8VQQB[?CV&*
M]C;2-,>]:\?3K1KIEVM.8%+D=,%L9Q4:Z#HZV,MBNDV(M)3F2 6R>6Y]2N,&
M@"L'\.2>(;1EDT]M8^RM]FPR^;Y&>=HZ[<@]/?WKG?C##!)\-=0DF1"8IK9E
M=ARG[^,$@]N"1D>M=+/X?LI]=L-4:WMEEL4*P,D($@RK+C?UV .WRCC)S6;\
M0-$U#Q'X/NM(TV.!IYY(CF>38JA)4<YP#UVX_&@#!U/P]IUC\4/"KZ+96\'G
M6]VFH) @"RVX0;3(!U^<J,GJ3[5A^&](AA^$NK:II%A =;MSJ*VD\<8,L7[R
M080]1\O0#^M>IV.DZ?:0OY&F6EJ9D"RI%$H##T.!R.34MCIEAID;1V%C;6B.
M<LL$2Q@GU.!0!YMJZVUYX$\#7V@;!>)>68L6B^]R,2J<=MH?</\ 9.>E7-7:
M?PE\09IK"']WXHMQ#'A,A+Z/A6;T4HQ)_P!PFNYM=%TJRNGNK33+."X<DO+%
M JNQ/7) SS5J2"*5XGDB1VB;?&S*"4;!&1Z'!(^A- ' >*=+LM,UKX?P01(I
MM]1$".0-^P0OP3[D GWJEI=[:7B_$>VUIH?MZ7,Z-'.0#]D$0$.,_P /WC]6
M)[UZ+=Z7I]_+%+>6%K<21',;S0JY3Z$CBHKO0M(O[Q+R\TJQN+J-=J3S6Z.Z
MCT#$9% 'E&AZO!:0?#T7VJ?8=-DT5HHKD>642[Q'PQ<%5.S< 3@\D=S4VIQ:
M3X>CTF.RU*6[\/77B02ZC-(R&!9&7<$!0!1'YFTD= 1CU%>I3:'I-QIJZ;/I
M=E)8+C;:O;J8ACIA2,5(=+TYM-_LTV%J;#;L^RF%?*V^FS&,>V* .+LY+%?C
MG?>1) ))M!B+[&&7<3-U]3MV_ABI?B.(%N?"$LXC"#Q! &9\8 *2<$GM75V6
MAZ1IKH]AI=E:ND?E*T%NJ%4R3M&!TR2<>YJ>\L;/4;<V]]:P74)(;RYXPZY'
M0X/% '"P66G:I\8-1\Z"VNX!H=LT:NH=,&23D#IT/7T/O7.^%KZRA\&^ [68
M*UX]]=BQDGE*P0F-I1E_[V%.%7C)QR*]6_L72OM3W7]F6?VB12KR^0N]AC&"
M<9(Q41\.:&UFMFVC:<;57\P0FU38'_O;<8S[T >.7LUO+\,?B+%]IMKATUQY
M5,6 -I: EU&3A22>_P"->X6TEM+;@VK1/#D@&(@KUYZ<=:A&DZ:%NE&GVH6[
M_P"/D>2N)N,?/Q\W''-6+>WAM+>.WMH8X88QM2.-0JJ/0 < 4 >36C6D7@GX
MGP@PI<"]U3"# ?9Y2]NN.15E+&SL-6^%]Q:V\,,TR2+)(B@-(#:$G<>K<X/-
M>C2:)I4SW+RZ99.UUC[0S6ZDRXZ;N/FQ[TW^P='S;G^R;'-MQ!_HZ?NN_P O
M'R_A0!Y9I_\ 8OB'PUJVE^(_$$]EJ,.IS/=VRF%)Q*)BT;1ED+DD; N"?[HX
MXKV%,B-022<#[W7\:I2:)I,VJ)J<FF63Z@@PETT"F5?H^,C\ZOT %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %8?BWQ-!X3T"34IHFGD+K#;VZ'#32L<*
M@/;/KZ UN5P'Q;TZ[NO#>G:C:0/<'1]3@U"6&,99XTSNP.^ <_0&@#?6V\5"
MP-P=1T\WY3=]E^S'R V/N[MV[VW?CM[5<MM5CM]"L;S69X+&:6"-I1.XC"R%
M067D^N>/:GVNOZ3>:2FJ6^HV\EDZAEF608Y[?7VZYXKE!?./C';"_5XK>YT3
M&G"88_>>9F51Z/MVY'H!0!V+ZII\=BM\]];+:/@K.95$;9Z8;.#4::WI,C%4
MU2R9A*82%N%)$@&2G7[P')'6O'-?L4A\$^.2%3^R5UV%K$G[J,98O.\L]AN+
M#CN&]ZZCQMH>A6>O^#@NFV$$5QJY6;9"J"7,+ !L#G.%&#UX% 'H%AJ=AJL+
M3:=?6UY$K%2]O*LB@^F03S3+75],O;E[:TU&TGG09>**9691G&2 <CFO)O%.
ME7=AK'CMO"D/DQOH</VF.U7:/M!<YP!_'Y.3QS\P/>M[Q";74[;P!?>'C'YW
M]HP&V,.,BU\L^<O'\(4 'W % '='6M*%PMN=3L_.:7R%C\]=QDQG8!G.[!!Q
MUYI8-8TNYO&LX-2M);I<YACG5G&.#\H.>.]<#X2T[1EU3QO=SZ=;3&RUAY4V
MQ*SQ[84.4_NG.[!&#FL"RU73#<_#BYMKRRMK%)I?)M4EWM;1M"XQ)(3DL3P>
M ,Y'.,T >EZ9XNT?7)M4MM/U*V,EC(T)?S%()"*2X&>5!;!/3(-6]+NQ!X=M
MKG4-7M;S;$#+?IMCBD/]X8. /QKB_#,EBTWC^PN6@,KZK<2&"0@DIY,?S;3V
MXZ]*P='NWM/#WPIGN6 T8,RW+'[BS&(K 6_X$6QGH<4 >MV^J:?=VCW=O?6T
MULA(>:.561<=<D' Q3(=:TJYNHK6#4[.6XEB$T<*3JSNA&0P .2N.<]*\^UN
MR!\:^,)($1M-D\-[KY< H;H%]A/;<(Q^6/:L^&UL[3PY\*;F"&&*=[JV#2HH
M#-NMFW9/4Y.,T >NR2)#$\LKJD: LS,<!0.I)KG/$GB%8_!^MZAH.I64MU86
MDD^5(F"E5+ $ \9VG&?R-6/&5O;7GA2]MKN_:PBE\M!=* ?*8NH5CGC&[&<]
MLUPNH:AJRZ%XYTKQ#:V;:G#H1<ZC9Y$=S$5E";E/W7!W\=\\< 4 =]H.NVFH
M65C!)J%K)JCV<4\UNLB^8-R@EB@Y R?3O5PZQI8OQ8'4;07A;:+<SKYA.,XV
MYSG'->="VL[/6/A=+;0PPO)'*K.B@%PUKDY/?)P?K6%JFKZ9<Z#97%E<6UE:
MKXICE^RO)NN XN?WDLA8_(#DG ' (YYQ0!Z);ZOJC_$K4=$>XA-G'I<=U HA
MP5=I&7YCG+?=]J?X"UC4-<\/376IRQRW*7US!NCCV+M21E&!]!6=8S1R_&B_
M:.175M MV4J<Y'G.<_J/SIWPL96\*W94@C^U;WH?^FS4 =7<ZMIMD\B76H6D
M#11^;(LLRJ43(&XY/ R0,^]2)?V<EB+Y+N!K,IO%P) 8ROKNZ8]ZXB6QL9_C
MD1+;02-_PCPD(9 ?F^T$;L>N.,UQVGW)L?"?AQF(71+;Q5.EWC[D2>=)Y>[L
M$#E3Z9Q0!["FMZ5+8SWL>I6<EK;Y\Z9)E9(\<G<0<"H/#OB+3_$^E1ZAITZ2
M1/D[0X+*,D#</X20,X-<Q=6LA^+CSZ?_ *J30V&H!/NLV_\ <[O]K[V.^ :G
M^$UU;3_#71(H9HI)(K51*J,"4.3P?0\&@"2+Q/+9>/-<L-8U*SM]*M+2WFA:
M3;$$,C."&9CR?E'I]*ZIKZT2R%Z]U MJ5#^>9 $VGH=W3%<+'9:9>?&#7DU*
MWM9P-)MF1;A%88W2!B WMU/O7(:?*WAW2_#T]S=3V7A@:[?&VN%"L(86W"V8
M[U8!22Y!(Z,#Z4 >TV5_9ZE;BXL;N"Z@)(\R"0.N1U&17/:GK&I6GQ%T'24F
MB_LZ^MKF22/ROFW1A<?-GI\W8#IWIOA&ST2/5=;OM&U2746O9(I+J821O#Y@
M4CY?+4+NQ@M]5S5/7F4?%OP>NX9^R7_&?]F/_"@#HM.GD^UZJT^L6MW#',-D
M4:JIM%VC*.03DYR<G'6I(]5M-3MKE=(U.RFGC3[T;K,(R1P6"M_45YE+<:5I
MFE_$]KVS,^GK?(LEM _E[MT<:XROW1N/)],]:T-,U"!OB^IDU2PN'F\/>6/L
MI CW"8$(O)+$ D]<X.< 4 ;W@7Q;%K7A;19=5U*S&L7T!E,'F(CO\S#*IG..
M/TJ>VUC4F^)U[HDTT36":7'=Q(L6UE9I&0Y.3G[OMUZ5YG;:/IUY\ ]'>QMK
M?^WFDB%E+$H\_P"TB;'##G(4'/HH]J[.[:X_X6OK2V; WO\ PBZ>2!_ST\V3
M'ZD4 =JFL:9+J!T^/4;1[T9S;K,ID&.ORYSQ4UW?6EA#YUY=06T6<;YI BY]
M,FO*O#$OAKQ#H'A5;C7[IM3TZ:$QZ<K0I/'<K\K@J$#E?O%B3R,DFNK^*T;2
M?"[Q"JJ6(M2V .P8$G]* .I-_9B\6S-W +IEW"'S!O*^NWKBJS:_HRM$K:M8
M!II3#&#<IEY!U4<\MR..M<3J>K:7>_$[P68;VUFC:SO4)6164EDCVKGID^G^
M-<E=V-@GP;\:W,=O;B6/5[KRY0HW)MN!M /;';'K[T >TW^HV>G0[[N^MK3?
MD(]Q(%4G'N1FN=\#>(;G5O"]SJ6KWENQAO;F(SJ!''L20J#UP!@>OXUF6FJP
MV_Q@U>#5YXXM^F6_]EM,P56CRQFVD\9+;<]\*/2N*TW5+73O"6ESI=^3H]KX
MHN?MDEL%<0(6E$3$$,-H8J>1V!'.* /9XM;TJ>QDOHM3LY+2(D23K.IC0CJ"
MV<"I;74;&]EFBM+RWGD@($JQ2JQC)&0& /&1ZUY9XIL?#LWA/QMJFFZJVK3W
M5@K74P>)X5=01&1L4 28].<8SU&?1O#VF:=8Z9;S6-G;0M/;Q&22*,!I<+P6
M8<MU/)]: *X\5Z5<>([GP];W]N-1AA5F#."%=B0%QD;F&,D ],>M9?@?Q8-3
M\.6,FN:G9KJEU<7$4<998C+LF= $3.3PH]:K6-S;6WQEUR.>6..2?3+01*[
M&0[Y =H[_A7#K;6:? [[>L4(N5UG>L^!O!%_@$-U^Z3^!H ]@,DQ\3B,:M;>
M0+,DZ;L7S2V\?O=V<[<$+C&,GK4\.KZ9<79M(=0M)+D$@PI,I?(Z\ YXKD62
M"/XY!E5%=_#;ERH +?Z0O)]:R/"\U_HVI^&=.EDM=;T*[20:/J48V7%NHB+;
M9 .&&WC([@9YQ0!ZC7'6?C4W'Q(N?#DD&RS:W)L[@])IHS^^4'OC<![%&K=\
M0:L-%T6>[&PSG$5M&YP))G(6-?Q8C\,UY[XQ\/:SH'A33M9BOK*YN/#4HO5,
M=JT<DP)_?;F,C#YP68\<GTH ]1N+FWLX3-<SQPQ @%Y'"J">!R:KQZQIDT#S
MQ:C:/"@+/(LZE5 ."2<\8-<7XOUBPG7P9X@AU&V%I]N$\<4\RQI.K0MSN8[0
MR@DC<1SQG)%94^F:;/X:^(FN+-IEP=1MY94B@DCF,"K!@%F7(#,R[B <9QR:
M /28=9TNX\[R=2LY/(19)=DZGRT895FP> 1R">U/L=3L-3C>2PO;:[1&VLT$
MJN%/H<'@UYAJ\-CHGP]\*:O;VZ6UJ9;!M3N[:%2_DA"0SDJ=P$A5N0>:?K\.
MG2Z/XJUGPUK-SJ^J7.F*MR]M+$Z>6I'7RU \PIOQU. ?:@#TFUUG2[Z:6&TU
M*TN)81F1(IU=D'J0#Q48U_1FDMHQJU@7N6*P*+E,RD'!"C/S$$$<=Q7':2?"
MGB/7-$U6SUZ74[N*WD2&W0PC9"R?,LR(@(4<##=&(]:XQ;.P7]GV&Y6" 2KJ
M(*R@ ,I%\0,-U'RDCZ4 >U6NJZ=?7,]M:7]K<3VYQ-%%,K-&?1@#D?C35UC3
M&U'^SUU&T-[S_HPF7S..ORYS7$ZA;)8?%BRCTN&&WG?P]<JBQJ%!(D38"!Z&
ML+PQ+X<\0>&/#<%]K]W_ &MIUQ$PTX-"EPEVAPWR[ Y!.XDD\C))X)H ]/N-
M?T:T#FYU:QA$<@B<R7"+M<\A3D\'VJIJGBW1](UK3]*N[V".ZO=S*KR!=B*I
M.YL] 2 !ZD\=#7 1Z;ILD7Q4+6ELWEF0+E%^0?903CTY&?J/:I8;R"#4OA3=
MWEQ''$=)N-\TK  DVT74GOUH ]*U75;'1-,N-1U&X2WM8$+O(Y[>@]2>P[U7
MT[Q!INHZ%#JZW=NEK)&KN[3+MB) .UFS@$9 JIXX7?X \1 #).F7.!C_ *9M
M7$_VK"+KX9S&>*31EC,4\BL#&ET;91"&/0'E@/<T >FV=]::A!Y]E=07,.2O
MF0R!UR.HR*)[ZTM98HKBZ@ADESY:22!2^ 2< ]< $GV%<AH]M)%\7/$,MEQI
M\EA;F["_=^UY;'_ O+ S]1GM4/C*UM)_B)X%\^"%R]Q=J=Z@[@+=B ?49QQ0
M!U/_  DFA?8/M_\ ;6G?8]_E_:/M2>7O_N[LXS[5;NM1L;&!)[N\MX(7.%DE
ME55;C/!)YXKSFPTW37\3_$J-K2V9$6$A2@(7=:@O@=LD<^N*IZ!JUC%IGP]A
MFD@AU'^R)'@OKN4B*% B*X"Y =S@ 9(P 3[$ ZWQGXAN]/T+3=2T2]MFAN-0
MMH6D51*)(Y) IVMG ZGGG\*Z4:A9->M9+>6YNU&3 )1Y@'7.W.:\2BNHG^%B
M6]O>0M+#XH4#.#LS=DJ2H(P#R<<5U^BZG>2^'?$^E21^5XVMK>4W!!RURY0^
M5+&>Z'Y< ?=Z8'< [J'6-,N+Y[&'4;22\0$M DRF1<<'*@YJS//#;0//<2I%
M"@W/)(P55'J2>E>7^&YO"_B&Q\)W":_<3:A8-']GL(VA66&0+MD5D5 VP#.[
M)P0,Y/%=1\0K[3['P[ =1MQ-'+?VT<8>4QQI)Y@*O(PZ(I&3ZXQ0!T%OJ^FW
M=M+<V^H6DT$)(EDCF5E0_P"T0<#\:;#K6E7-W':0:G9RW,L0FCA2=6=XR,A@
M <E<<YZ5Y:+FTN->^)$5S?V5XTVDP.#&%".RPS9*KD_=P.<G'K4D-K9VFB_"
MBYMX88IWFMPTB* S;K5MV3U.3C- 'J%MJNG7@E-KJ%K.(?\ 6F*96V?[V#Q^
M-3VUU;WD"SVL\4\+?=DB<,I^A'%>=ZPM[X4\:W46EQ,(/%:!(F1<BWOE^4R'
MV,9+GU,9KT&SL;>PTZ"PMXPMM!$L*)V"@8 _*@"M+X@T:%D675[!&DE,*!KE
M 6D&,J.>6Y''7FI;[5=.TP*;^_M;0,"5\^94R!UQDUY)9:/X?NO 7Q"^UVEH
M7AU/4%5B@WQ$',87N/F(P!U)]ZOP7L<%S#I^HR0V>MQ>&($OKJ]<EI%(.8XT
M) +;L[FYYP,'L >F2ZMIL,T,,NH6L<LX#1(TRAI >A49Y_"G2ZGI\$LL4U];
M1R1)YDB/,H*)_>()X'O7EFG6;ZG\&?#>L:24GU?0(8[J *<DE!^\A/\ O)D8
M]<5K:F\&O?#7Q5XEE@^34M.E:U69!N2!(V\KKTRQ=Q_OT =Q'K>DS77V6/4[
M)[CRA-Y2SJ7\O&=V,YVXYSTJ6PU.PU2!I]/O;:[A5BADMY5D4,.HR#UKS*]T
M[3MWPP_T6W_>N WR#YPUL20?4$XSGK576A-:W7Q4BTJ,JZPV$AAMP =IC_>X
M'J4!H ]4M=9TN^EEBM-2L[B2$9E6*=7*#U(!XIB:]H\DUO"FJV+2W.?(1;A"
MTN"0=HS\V""./0UQVE?\(IXBU_1]6L]>DU2[2VDCC@0PX6!E^83(B A0< !N
MC$5QEC:6,/P2\-WL4,"7"ZO PG"@,"+PC.[K]WCZ4 >LV_BS1[GQ/=:!%>P-
M>VT:-(OF#[S%OD [L N2!TR*V)98X(GEFD6.- 69W. H]23TKA]+N;:V^,/B
M2*:6..6>QLO)1F :3'F9VCO^%/\ B7<R6=KX?N),_P!EQZS;MJ!_A6+)P7_V
M0^PGZ"@#K+;5M-O()I[74+2>&'/FR13*RQX&3N(/''/-<AI/B._\67MU+HNM
M6,/V+4W@-DP203VT9"L^1\X)))5@=O08/6GW%NQ^,>GW.GD;'TF0:D4^ZR;Q
MY.[WSNQWP#VH^&31O8^(BA4_\5#?<C_KI0!UU[J5AIL:O?WMO:HQ(5IY50''
M)QDT-J5BD5O*U[;".Y95@<RKB4MT"G/S$]L5R6O:GI]O\0[&U:2WL]0&F2R?
M;KN0^6L)D4%$3(#.2N<GH!WZ5P&F?8+OX:> 8G,$SQ>)(X7!P2JF>;Y3Z9&.
M/3% 'L@\1:(UK<70UC3S;VS;)Y1<IMB;T8YP#]:M?;K3["+[[5!]D*;Q/Y@\
MO;Z[NF/>N&LM-TX_&;5XOL=L5_L>W<IY:XW;Y%W8]=N!GT-<CHEVUGX1\!RS
M,!HD.N7*71S\D9\V40;O10Q!YX!"^U 'L46L:9/9R7D.HVDEK$<23).I1#Z%
MLX%._M33Q]FS?6O^E8\C]\O[W/3;S\WX5PNI6<K?$O6WT]<V\WAQEOE3E6FW
M$19_V]N[\*YM-7TUO GPOC%];%X=1LO-'F#,>(W4[O3GCF@#UFYU[1[,2FZU
M6Q@$+A)#+<(NQCT!R>"<'BJ>K>+=&T;5=-TZ\OH([B_9M@:4*%149MY)Z#Y0
M!ZDUP]OIVF3:[\3]]I:N$CC RBD*#:Y;'ID\GZ56LKN""/X1W=Y/''"MG*'F
ME<!0?L@ R3[T >H2ZQID%VMK-J-I'<.558GF4.2WW0 3GGMZU=KRS5I[W1+W
M4-7LI+76O#\VK1->V$HVW-K<!XU#1L/O?,$8*>V,>M=AX^_M'_A =<_LG?\
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MB!K>-8V?=AL@%B%4$@CD]ZVM$BU&TTUEU74XM082,T=TL:Q[HNJ[MORYQU(
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M5Y<5W)X2E$"QX7,@F^3\NU>B36T%R )X(Y0.@= V/SIJV-HDJRK:P+(O1Q&
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MAO-<9^NW ^E=P]E:2HB26L+K&,(K1@A1Z#TI/L%GO+_9(-Y!!;RQD@C![>E
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MCSP!W]*XOQ-(MS\(O$NMW2^5)J]L\Z)+@,L94+"GL=H4X_O,U)JDFF'QA\-
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M0UV6LW=J?C!X4Q/"6:PO ,.,G/E[?SP<?C0!U4_B#2+:]6SGU&VCN&D$01I
M/G(R$ST#'L.II]IK6EW]Y<V=IJ%M/<VIQ/%'(&:+_> Z?C7FOA36M!E\+R>%
MO$L:2Z[;W\OG:?*I\VXG,S2(ZCJP.0=W0#KQ6OXK%_X8\7V^O:1;&;^VHAIE
MQ&HX%P ?L\K>P.5)[#% '=65_::E;_:+*YBN(=Q7?$P89!P1D>AXJ<D*"20
M.23VK#74-%\)Q:+H5S?)#+<_Z/:+)G=.Z@9YZ9)(Z]2WO5/XD07]S\.];BTV
M-Y+EK?B-/O.H(+J,>J[A^- &Q9:]I.HW9M;/4+>:<)Y@C1P2R9QN']Y<]QQ2
M#Q!H[7R60U*V^T.YC1/,'S..J@]"P[@<URT.N^'?%\4-YX;:&YUN.PF6V>,8
M:R#)T?LOS!1@\^G )KE9I8-7^!5AH]F0NO0FWMHK;.)XKQ)5#';U!X9B?0D]
M* /3;SQ7X>T]KI;O6K&%K7:)U:=<QDYP&&>"<'CKQ576?&NC:/'I+R7<4BZI
M,D=NZ."A1N2^[IM Y]ZY_2Y;#_A;OB@SRVID33+169BN1]_?]/X<_A7(Z3>V
MT'PU^&UW-<Q);6VM*)IF<!(A^_ W'H!R.M 'JMUXP\-V1D%SKNGQ&/9O#7"_
M+N^[GGC/-6)/$6CQ7PLY-2MEN#*( I<?ZPC(3/3<1_#UKCM/?2]1^,>LJ_V6
M<R:/;!4< DC>Y(P?;:2/I7(^(-<TRZ\.ZD8)X-.%OXB1YM/7F4,+E=\TQ;)4
M$\C&U1D#)H ]BU'7-+TDXU"_@MSMWD2/C:O3<?1?<\5G:CXST?3=>TS2);J+
MSKY&E5]_R+&%R#GH<D@ >^:Y&V\1Z-IGC/Q98>)[B*"#55AFM)+D$1W5L80F
MQ3WP=WR]<L?>IM3GT_2/&O@&4QC3M/2RO(8$F^79E(MB8/.X@<+USQUH ])J
ME?ZM8:9Y8O;J.%I,E%8_,P')( Y('?TJ+3O$&E:O?ZA8V%['/<Z?((KJ-<@Q
M,<\'(]CT]#7,>(M8L++XA:;:3R0:==/ITK)J4QR64R*#!$#\I<D!N03@  '-
M '6?VOIQTQ-2%];FQD *7 D!1\G P>^3P,=359?%&@L9@=8L4> $S)).J-&!
MUW*2"O;K7D6EWUC#\)?"UT^HQ0R:7KN\K/E8R_GS?)*P'R?(2V<<?+QR*ZC3
MKK1;Z?QGKT.MZ3<27UFH:VM;I9/)2.)E#,>.6+8Z8& ,F@#M+3Q3H-]))':Z
MQ92M%;BYD"S+\D1&0YYX&"#GW'K5BPUO3-4EGBLKZ&:6#'FQJWS)GH2.H!['
MO7EVV.'X'>'=2T^ 2K:)92WIM%!E,*2*\HX[@_,0?0YJSJ@T7Q+I>N:IX3U"
MZU76GT66V\^.0D+&?F$9&!\Y.<#KUH ]#M_$>BW=T]M!J=J\RQF4H)!R@ZN/
M51ZCBH/^$R\-9M@-=T\_:I#' 1<*1(P.W .>>01]:Y'0-3\(>*-1T+4+34+J
M[U.R5VCMVD(:R!3$GF  87C;SP3C%<G/-I__  H'7RLEMEM2F/#+DG[7E?QV
M]/:@#V.R\0:/J.HW&G66IVMQ>6XS+!%*&9!G!R!Z'@^AH;Q!HZZBFGMJ5L+N
M1S&D9D&6<=5'8M[=:Y#5I[1/BQX7CM)K9&;3+R.,(RXQ^[*# [<' ]C7->&+
MOP[J_AK2] UR\OCKUA<*KZ49"LHND8X=0!G!.6+9P 22>M 'I5SXR\-6:2O<
M:]IT:Q2^3(3<+A7Z[3SU]?2HM6\9:1I&MZ7I5Q<QB:_WN&+85(U0MN)Z<G
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M3PI>2^$Y8[<(X!\SS?DQ^>1[5G>%K[PKX@TOPU9SWE[)K.F20[=,9RDEM-&
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M,QH4/52HP?PH,49))C0Y !XZ@=*?10!'Y$7'[I..GRBE,,1F$QB0RJ,!RHW
M>F:?10!')!%,R-)$CE#N0LH.T^H]*>Y8(Q0 MC@$X!/UI:* .7\&^&KCP_8W
M$-^MI+.]W-<QS19)42N6*\@$8SCW]JZ2:"&X0)-$DJ@YPZAAG\:DHH :T:.
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M&C.<N54 L??UJ2B@!JQ1H<JBJ?4#%*0""",@]0:6B@!D,,5O'Y<,21H.=J*
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M:O4 %%%% !1110 4444 %%%4;K6M-L]3L]-N+R*.]O"PMX"?GDP"3@>F >:
M+U%%% !15'4]9TS18%GU2_MK*)C@27$H12?3)JU#-%<0K-"ZR1N,JRG((H D
MHHJB^LZ:FLQZ0UY%_:,D9E6W!R^P=21V'/>@"]1110 4444 %%4[S5;'3[FS
MMKNY2*:]D,5NC9S(X!.!^ -7* "BBB@ HHHH **** "BBB@ HJG9:K8ZC<7D
M%I<I++92^3<*N?W;X!P?P(JY0 451TW6=-UC[3_9UY%="VF,$QB.0K@ E<]#
MP1TJ]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MQ_Q3ACE^&7B R1JY2T=E+#.#ZBNPK"\9:-=>(?">H:/9O#')>1&+S)F(" ]\
M '/TXH DOK.]U#P>]GIUTEI=SV@CCG=2PCRH!. 1SC./>N9\&W%WI'B.3PWK
M>BZ7::A]E,]K?:;#LBNH58*P(ZJP)7(_^MGI[F'78_#T46FMI\>IQJ@_TC>\
M+ $9&1AAD=\<>])8Z7=RZK'J^K&W^V10-!#%;9*1*Q4O\S8+$E%YP, 8QU)
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ME>9#>+M<9X/.,=>E41K6B_\ "RW\3-XG\.FT;31IWD_;AOV^9OW],9[;?UH
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M',4H0G8X*<AADCTJ36?#6L:DOAYC>6T\^FZ@M_<22ED$C ,"B* =J_.<9)P
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MS,6NI8U(1B"HV#)W$ MD@<@4 8T_C3Q0VD^*;^WLM)0:!=RHZR-(WG1QQJY
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M..]<A%XYU*7P?X3UT6]J&UB]M[6XAVMA!*Y7*'/;'?-=XZ"2-D;HP(->:P>
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ME'<:39R6=PKAG5U94&Y.G/R9P?7K0!H>/KV_TWP'K5[IEPEO=6]I)(LC)NP
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MOLE2.)7&X;\@G)&0?PJT_BVYN;BPT^VVPW<VF1W\\HLI;D)OX50B$'J&Y)[
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M(@4,O8$DY]!WR #I**\UN_B%K$7AB\N8[*R&JZ;JR:9>1-N\MRSJH>/G(!#
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M^*@3:GWOW'[KRN>/FXY[<\4/X1U1K?PA$+BSSH!0N?F_?[8C'QQ\O!SWYKM
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MIJ!N5=Y/+6-F55"$M@'A.O'?BF?#W0;72M/OKRT=VM;VZD>R#]([4.QC5?\
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M]!M]'T>YGMGD:WO+B1[02=8[7>QB0?[/S,P_WZ[&BB@ HHHH **** "BBB@
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M9 L>!\K;B<D'//>N-N/AUJ<WAW7='_MV IJFI_V@)'M#N0^8DA! < \H!QC
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M7?RQVC)SCT'>M27PS>VOBV7Q'I5U;QSWEND%];SHQCE*?<=2#D,.1W!'IUH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>[T^RO
MU5;RT@N ARHFC#X^F15BB@!$18T5$4*JC 4#  ]*6BB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ IDL4<T312HLD;##*XR"/<4^B@""
MULK2QC,=I:PVZ$Y*PQA 3]!4]%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?7]J=6O+&.Y> .JNV5!+!.N/PK8N=6TVSN8K:ZU"U@N)2!'%+,JL^>F 3DT
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M2>[5,DM K*7/'8#GZ"EGTJWT[XH>&[CP]'%!#=VMR=22VP(Y80H\N1@."=[
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M[X7T%>ESP0W4#P7$22Q.,-'(H96'H0>M166GV6FP>386=O:Q9SL@B5%S] *
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP#XGT:)TCQK=[]D=.D$BR[HV&.F#@\=B?6@#TM[^SCN8;9[N!9YP3#$T@#2
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M[5V&MJ6T#454$L;64 #O\IKRB2[T^^^%7P_@$]O.B:CID,Z!@P!_B5O?KD4
M>LZ?K&F:MYW]G:A:7GD-LE^SS+)L;T.#P:;;ZYI-W>/9V^IV<UTBEFACG5G
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M7KN8)3$BW%LR*(RC,A8G QA3D$<5L*D-M\3/"%M&9E6/0IT1;@_O<#RL;O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWAE$,DJW"E4D/ 4G/!/I2WOB70M.>9+W6+&W>&,2RK).H*(2 "1G@$D >N:
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MU"NM:6[WB+J-JSV6#=*)1F#.<;Q_#G!Z^E']LZ9_9D>I"_MC8R8V7 E!1\G
MP>AR>!CK0!+-IUC<6RVT]G;RVZD%8GB5E!]@1BI);:">$0RPQR1#&$= 1QTX
MKD?"OB&XU;QIXJM3J27>G60M3;;54"+>KEP2!DG(QSR,5O)XGT)Y4B&KV0>0
M QAIU7S 3@%<GYAGC(S0!>^Q6OVG[3]FA\_KYOEC=Z=>M-&GV0O3>BSMQ=D8
M,_E+YF/3=C-9L_C#PU:Q-+/KVG)&DWD,QN4P), E<YZ@$9],U9C\0:-+J_\
M9,>J6;ZCMW_9EF4R8QGIG/3GZ4 66T^R>5I6L[<R-G<YB7)SP<G%4M0\/:?J
M%JEHUM;I;^8)'58%RV/0_P .>A/7!(&.M2W>OZ187:VMWJ5K!.S*@224 [F^
MZ#Z$]@>M1WGB;0M/DN([S6+&"2V4/,LDZ@Q@G W#/&3T]: -6JITS3VC6,V-
ML44DJIB7 )ZX&.]8^L^-=%T>QTR\>]@EBU*XBAMG20%7#L 7W=-J@DD^V.]7
M[GQ%HUG&LESJ=K$C1B;>T@VA#T8GH >Q/6@"VEC:1S^?':P)+_ST6,!OSI(M
M/LH)9I8K.WCDG_UKI$H,G^\<<_C5FN=\<>)D\)^$[_5-T/VF.(_9XY6P)).@
M&._7) ["@#7_ +*TX(4^P6NPG)7R5P3Z]/<U9CC2*-8XT5$48"J, #Z5Q4$U
MR=>TZ9/'\$MA<NNRR>*!I+AP"&1&4 [>AX!((ZUO77BWP[8B<W6N:?$+=Q'-
MNN%&QSG"GG@\'CVH T&TZQ=65K.W96<R,#$I!8]6/'7WH73[))5E6SMQ(N-K
MB)<C' P<4VXU.QM+1+J>[A2"3'ER%QA\C(V^N1SQ44>NZ5-IJ:C%J-M)9R-M
M29) RLV<;1CJ<\8ZT 6$L+..\>\2T@6Z<8:81@.P]"W4U8JM9:A9ZE 9K*YB
MN(@Q0O$P8!AU'U'<5+-/%;0O-/*D42#+.[!54>I)Z4 5WTC39+T7KZ?:-=@Y
M$YA4N/\ @6,U/<6T%W T%S#'-"_#1R*&4_4&LN'Q;X=N+VVLH=<T^2YNEWP1
M+<*6D!Z%1GG/;UJQJ&O:3I+A-0U&VMF.#B60+@$X!/H">,F@"R+"S6T6U%I
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M&C:?</;WFJV<$T<1F>.69594&!N(SP,D<^] %@Z;8&[%V;*V^TCD3>4N\?\
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M$)#:L"K;QROE.,@^F2/TK/M#IS^+OB<SFV)%O;JQ)7A?LV&'TR.?>O2C;0$
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MM,;4ZE<)([BXBC<%HQG@D(#G'0'!ZT =->>*#<_$?PQ8:;JK/97<5T]Q;>6
M&"Q@QN"5W$$EN0<''M5[XD:CJ&D>#Y=0TV]>UGBN+=2553N5YD0@[@<<,>F#
M6!J/B30]8^)'@2\TW4;:YB,=ZOF1-G;NB3:K>A]CS6O\68_,^'.H#RRZK-;,
MX"Y^43QEB1Z  D^U &Y8^+/#^J7%W;V&KVES-:*6G2*0,44=3@=1[BI8/$>C
MW6CR:O!J,$NG1@E[I&S& .ISZ#OZ5RUY%9ZS\2O"^H:(\$ZV%O<F\N+9@R"%
MT"QH6'!RQR!Z FJ-OIMWIWB^]\'1V['1-1G&K1R ?+%%NS/#]#($&/[LC4 >
MD)*DD*RJP\MEW!CQQUS6=9^)-'U"Z2VM=0ADED0R1 $@2H.K(3PX'JN14VM3
MK;:#J,[VK721VTCM;IUE 4G8/<]/QKR?3=;TZX\1_#F[AU"%K<0W,0M[9/W-
MH3  L(."Q<< AB2< X&: /1Y?''A:&,R2:]8!!.;<L)@0)!C(R/3<N3T&:OM
MK>F+K"Z0;V(:BR>8MMGYRO\ >QZ>]>3FYTY_ 'Q2(FMB\FIWN"&7+YC39]?F
MSCWSBNC\1AK;PUX>\:Z=^_GT:)))O*.XSVC*%F7W('S#T*T =Y;ZA:7=S<VT
M$ZR36K!)T'6-B,@'\"#]"*K:CX@TK29&COKV.%UC\UUY)2/.-[8!VKG^(X%1
M>'+2:WTD3W:%+V]=KJY4]5=^0G_ 5VI]%%</XHU>R_X23Q1IA:/3KLZ0HWA-
MT^H@I(0J @C:N2#@$G)Y&* .ZN_$VAV#Q)=:O90M+$9HP\RC=&!N+CG[N.<]
M*AA\8^&Y]%?68];L3IR,4>X,P"JW]TY[^W6O-M.O]-DN/A'/<30F"/3YXS)+
M@*)%MXAC)XR&&/J,=:@\46,8TGXHZG8A?[+NH;94:/\ U<DZ#]ZR]C@D D=\
M]Q0!ZI9>*-"U+5IM*LM6M)[^$$R01R L,=>.^._IWKF] UFZET_QD-7UWR$L
MM3GM8;Z81I]G01IM/0+D%L\CDU4U6"PU?Q5X'ET)K>2:SD>622VQB*U\H@AL
M= 6*J >^?>LW3KZR;PS\4?\ 2H"#>WI_U@Y!@50?Q((^M 'H=KJ5G9Z#I\]Q
MJ8N4EAC$=TP^:Z)7(8*HY+#G %.3Q%H\NF_VBFHP-:^9Y/F!O^6F<;,==^>-
MN,Y[5YK;ZW!H1^'FMZA)_P 2,:,;1[D?-';3M''@MCIG:5SVY]ZTM<UGPY9Z
M=8:AI]C:1V-[KBRC5)D(@2<J<W/;=_=!) )R>@Y -?QIXCW?#W7-4\/ZKY5U
M8HV7C52T;KC*,K@[3@]P#TK8TGQ5HFIWG]EVVKVD^I11@RP)("X('/'?!ZXZ
M5Y9>3QW6C?%.TM[B:]GD6*9"8_GD3R4^?"J!@]B!R!D9ZUU&H1Z?KVL^!WT"
M2VGGL9Q/)-:E6$-J(B&5BO0,2H [\^AH V/!^JWL][XKCU/4&GBT_4VABDE"
M((XA&C8.T 8&3S6[8Z_I6I7DEG:7L4ES&@D:+E6V'HP!ZK[CBO++B66]T#XD
M)I1^U7"ZPLY@@?+R1*(2X&.N55Q^8KI_#E_X1\3>(;'5]'NKO4=1@@=3(\LA
M^S1L.5D!XR3@!3SU(X!- '8:AK6F:5)!'J&H6UL\[;8EED"ES[ ]:AT;Q)HO
MB%)WTC4[:]$#;9?)<'8>V?R//>N6^)[VL?\ PB,EZ8A;+XAM_,,N-H'ER]<\
M8K#\3:5=:MXI\47OA@AV?PVUK-);GB6Y+Y501P7\L$>HW+ZT >BVWB/1[R\C
MM(-0A>>4%H5S@3 =2A/#X[[<U6F\:>&8)_(DUVP$OGBWV^<#^\(SMX[_ ,LU
MQ.J7=GXG\*>#8-$EC.I17UI(D,9_>6HC&)=Z]5"@,#GV'<5I^#7T^Z\?>.-K
M6TLOVZW<8*L<+"HR/HV?H: -"V\:Z1XA\,ZI=P:NNE11M-"MW)A3%@E1)AQC
M.1D \UO+J=G8Z592W-^)5E1%CE(^>X.W.551R2 3@#UKR^PU"SC^#WC/3I)X
MUNX&U-986.&1F>38#Z$Y&!W[=*T8+];#Q1X)U6[F3^Q9=%:TBN"P\J*Y8(?F
M;HI8+M&>X(H [MO$^AII#ZL^K6B6$;%'G:4!58=5.>C?[/7VI;/Q+HNH:I)I
MEIJ=M->QIO:!'!8+G!/X'@^G>O+?$T2+I'Q0U."5!I-]' ENP8;)IUCQ(4['
MDJ"1U(/I707]WIZ_$'X?""XM@OV.\4>6ZXP8DVCCL2#CZ4 >CT444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %(RJP(8 @]B*6H+N\MK"UDNKN9(8(QEG<X [#]>* )E140
M(JA5 P !@"D1$C4*BJJCH%&!6?::_IE])<Q07!\^V4/-!)$\<J*>A*, V#V.
M.:X_1-5N_&=]J,MKK-W83V&K/%#''"3$]O&5!5U8 $MECDG<,C'3% 'H.U<
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MR#RPQP?2JOP]U"[U7P!HE_?3M/=3VRO+*_5F.>: .DVK@C P>V*1XTD #HK
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MMN-1N)8K97N-M_%(Y>,QJAP3R!CMCV./8:* //-*DL[7XN7X9HH1%H-O%AY
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MGRXV;RG%LRE&P.&![=>]=)H%[:Q_$/Q^[W$2IBS.XN "%@(8_@>#Z&O0,44
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MUXIWB!=*?0)/$'ABTO+K3_[7LKS5+C=+)]KBB8EMJN<L%^0D@8./]DX]@HH
M\W77M*UCXN:%>:;=I=P2:3<1B:%2R[BZ$*2!P>#D=N^*TOB@@.@:9-)&6MX-
M8LYKAMI94B60%F;T4#J:[; %% '#)%;ZU\4[#6M(>*>UM-,EAN[N!@T<A=E,
M<>X<,1AFQVXSU%9VAZ7>Z?XJN?!Q@;^P[2Y&L6\G\(B9B5@]MLP+#V2O0KV*
MXFL+B*SN!;7+QLL4Q0.(V(X;:>N#SCO6?H&D76FPRS:GJ']HZG<;?/N?*$0(
M48554=%&2?JQ/?% &Q1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MNK@_:)@3%;Q1M+*X'4A$!8@=SC H T:*S++Q!IE_?FP@N#]M6,RM;2Q/'(J
M@;BK $#)&"1SVZ&M.@ HHHH *** 00"#D&@ HHHH **** "BB@$$ @Y!H **
M** "BLK4/$6EZ9>BSNIY!<F+SO+BMY)2$R1N.Q3@9!Z^E4[/QQX=OUMGM;YY
M([IMD$@MI0DK<\*Q7!/![]J .AHK.T77+#Q!9O=Z;*TL"3/ S-&R'>APPPP!
MX/M4DFJVL6LP:4WF_:IX6F3$3%-JD Y;& >1QF@"[1110 455&HV9U0Z8+A/
MMJPBX,.?F\LL5W?3((JU0 4444 %%%% !1110 4444 %%&0,9/7I10 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MEPP:7JS6K9LW)EB$:G &_P"4C=GJ<Y[8YF\/>"]:T'RM-'B9Y_#UN^Z"U:V
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M4<$2QPQI'&O144 #\!3Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"0Y&.,9/0UW'B?3-NNZ;)X=U2TTC7%AN)88I8E-O>1L8_,5P,'.5C.X<\?D
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M EYX>EBDG&H),AA(REIY;><#CHN-JD>N!UH ZR;Q=X<MUWRZ]IJ+YQM]S72
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M&5AD,#D$4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHJO>WUKIUL;B\N(X(00N]VP"2<
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M3Z:FD"X-N8PIBF\T+SP&^[@X/KGO76WE_:Z?&CW4PC#ML08)9VP3A0.2< G
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M/G8.I; R< <GCGBLC5=:TV[TK3[FU\36]C#<W,7D7$;QO]HPPS$N>N>AQR*
M-Z&"&VB6*")(HU^ZB*% ^@%-AL[:V>1X+:&)I#EV1 I8^^.M9>H>+O#NE2SQ
M7VM6,$D 4RH\R@QY.!D=LU8?7]*2[6U:^B$K2"%1G@R'H@/3=[9S0!;%E: $
M"UAP>H\L<U*D:1($C144=%48 IU5;[4K/38U>\N%B#'"@\LQQG  Y/'/% $K
M6MNV_=!$=YW-E!\Q]3ZT@L[8%2+>'*_=.P<?2LV3Q7H$5A:WSZO9K:73;()C
M*-DC=-H/K[=:O0:E97-Y<6D-S&]Q;8\Z-3\T>1D;O3(YH D^RVYNA=?9XOM
M&WS=@WX],]<5-69:^(='OKX6-MJ,$ERR&1(PW+J.K+_>'N,T2>(=(AOTLI-1
MMUN'E\E5+<&3KLSTW?[.<^U %J73[*>X6XFL[>2=/NR/$I9?H2,U/)&DL;1R
M(KHPPRL,@CW%9Z^(-(:&]E74+<I8G%T=_P#J#C/S_P!WCGFLW4?'&BZ=J.BV
MANXY/[5#212J<H(A&SA\],$@ >N?:@#>CM+:*W%O';PI /\ EFJ +^72N?\
M&WARY\0^$+O1-,%K ]RR$O*2JKM=6SA0<D[<=JU+_P 0:3I;E+V_@@*J'?<W
M^K4]&;^Z#SR<#BDO?$6C:;)#'>ZK9V[SHTD2R3*"Z!2Q8<]  3GI0!;L[6*W
MC)6U@MY)/FE$(&"WUP,_4BG?8[;[5]J^SP_:,8\W8-^/3/6LP>+- -E'>KJM
MLUK)%YPE5LJ(\D;F(^ZN01DXY!]*V%970,IRK#(/J* (_LT'F^;Y,?F==^T9
M_.D:TMG:1FMXB90!(2@^?'3/K4U% ##%&TBR-&A=00K%1D ]<&DCMX8<^5#'
M'GKM4#-244 006=K;*ZV]M#$)#EQ'&%W'WQUH^Q6FTK]EAP3DCRQ4]% "*BH
MH5%"J.@ P!2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %<A\0M3M-*T[29;R"!E;5(%2Y
MN<^59OR1,^".!CN0,D9-=?2,JNI5U#*>H(R* /%;G4;+[/\ %>(ZB+EI[*-X
MI9 %\T&UP&&  1G !'7CDYR=F:YT^+6_A:8I[9%$<P&UE P;4C]6P/K7J&Q2
M2=HR>O'6C8G]U>/:@#Q,:U9P_";Q?H>KW$47B&-[TW-O,0)979F9753RPV[<
M$<87T%>NZ#/%<>'=.FAD5XVMHR&4Y!^45=:")W+M$C,5VEBH)QZ?2I* /&)9
M8KOX;_%".U=)6_M6\DVQD,=N(^>.W!Y]C70:Q<VVKW.BW_A[Q/;Z?J\=E(;6
M27#VUW%E/,C;/7!5>5Y&#Z<>C!%&<*!GVICP0R($>)&0=%9010!B>"M1FU7P
M?IU[/8I8RRHVZ"/[@PQ&5_V6QN'L17$+=7&D:VLVC:E;ZMHUYKK17.DW 'VB
MTN#,=[Q$<X# O@C[O/?->K4P0Q"7S1&GF8QOVC./K0!Y'=:I8Z=9_%+3+NYC
MBO[AIY8;9C^\D1K5<,J]2.#DC@8YQ3]/\16>A:]X3U75+A8]%N?#D=G!=MS%
M#< JSJQZ*2JJ.?[N.U>LM#$[%FC0L5VDE1DCT^E$D4<J;)$5T_NL,B@#R[6=
M0TK1+OPMKUC:&#PM%J-R]Q+'&=F^6/:D^.NW<7&<=\C@BI/%5[I=QX?N=>\.
MVSW%DFJ6EWJ5U9*?])2-OG*_WB@"'(XX]0<>GLBNA1E#*1@@C((H5%1 BJ%4
M#  & !0!YC-)X'UZWU?5X-1O+V.32VM;V_BE8B"$L"%.1C>"2V,$@*<]0##'
M=7'EZ[HGB;4;?5M+_L<R?VY9 +*L+,5V28RN[DL".H!/.:]2CACB39'&B+G.
MU5 &:(X8HE*QQH@)R0J@9/K0!Y+<R>)Y].\0^'X[ZUUR=M$>6QU>T 65D+8$
M4FTD;V&XJ1UP3]+>JW5GXE\,>"X]#EC.H17]I)'%&1YELL8Q+N Y4*N0<\9P
M.XKT^.*.$$11H@)R0J@9/K0L,:.SI&BN_P!Y@H!;ZT <!X..FW7CCQSC[--*
M+^!QC:S86%>1]&SSV-9GA.ZN-,U7P[8Z?J5OKOAR\60V1<#[7IP$9.&*\,H!
MV'.""0/0'U0*H.0H!]A34ABC=G2-%=OO,% )^M ')_$+4[32M,TJ:\MX&1M4
M@5+FYSY5F^21,^".%QW(&2,FN$N-2LO+^*\;:D+DSZ?&\4L@5?-'V4@,N  1
MG !'7CDYR?:6574JZAE/4$9%)L4DG:,GKQUH \NEN=/BU3X6&*>V0!)0-K*
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ML?%\TM_Y7S"*+S7*.P'\ 8JWY&O<MBYSM&?I1L3:5VK@\$8ZT >>6.KZ5?\
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MHHVD61HU+K]UB.1]#3Z /)?"M_X5\0:;X;L9Y[Z37-,DAQIC.ZR6LT8"LQ7
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M@"#$QS@<CGH>1D<&N.\7:K!H/Q#TN^UFZN+/1KC3Y+6.[C)"13^8&(<@<!E
M_P"^?;CN+;38K?4+J^SNN+@*K-@ !%)VJ,?[Q.3R<^@ %J2-)4*2(KH>JL,@
MT ><2V/A2?P7=Z1IZM+!KMX_V/SIB#<3L 3-&6Y"J1NR!CY3@'(S1L+Z[N?
MWBSPEYJMXMLH9TF9'R]Z63*RKW)9<#'\) ' Q7JVU>/E''3CI1M4'.T9]<4
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M*EE!P?456ETV*?5(+Z4[GMP?*7 PI((+9ZDX)'IR?6@"Y1110 4444 %%%%
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M1VVLVTKK;K<E58Y\MB%!_$E0!UY''(J_;ZYIUS'=.ER$%H,W'G*T1A&,_,'
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MC7$$MY)+,RQ1E2PB.\XW$Y..HP>G&<L1V&N_#GP'IVE/!)JD,UC*BPD;[?8
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M XR.G2D(!ZC.*6B@ I,#.<<^M+10 4444 %%%%   !G ZT444 %%%% "  =
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M0 44UW6-&=SA5!))["J6D:UI^O6/VW3+@7%MYC1[PI7YE.&'(!ZB@"_1110
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M$31R,BJ?FSC V@CCK^LVB>'O$J0+9>)-=MM0L88VB006YBDN 5*YE8L0>">
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MOIX<U/49=&.OW5K.-)E%PA@1@;B8*561L_=QN)VC/..<#! */AS6_%6NZGJ
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MB"-R, 0<'D<$59KS.VUO5/#OP_\  VHPRVZZ.;6R@U$O$6:)'C4"0-N  #$
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MDI" 0P95).6W!3DG'R@ #G,L7AK4+V71VU[4+>\&DR>=%Y,!0S3!2JR/ECC
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MV[D;?--LV*6P!A5YVJ   ,GU)))-7Z** "BBB@ HHHH **** "BBB@ HHHH
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M'*3E 23VX[<\T 1KJ7BO5/&NO:-9ZE8VD%@MI-&SV9=MLFXLA^?DD+][/88
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 445A:[!XCO9EM]$O[738E
MCWO=36_GL[$G"*NX  8R2<]1CO0!NT5YW;>/]2MO -]J.I6D#:U::@^DA(R1
M%/<"0(K#OMR<G_=-;2:S?:/XOTS0M3NENTU6WE>WG\L(RS1 %TP.-I4Y'<8.
M2<\ '54444 %%%% !117G[>+]4TKXI+H.HO%)HUX!%:S^6%>.X*APC$<$$9
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M:\G3[/?:9;MI4S-\DD:%O-"'H3N8-QU&#TJS\,[62UTO6MG&FR:S=/IP'W1
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M\LTN]TV[N/A&&GMY?+M)5.X@X=;51W[AACZC'44Z[^P7NF?%:U:^$$)G$C/
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MEMV3^V[4.KL","5]P(/L>?K7<:;<6W_"ZM9CBFBW/H]ME589+"1^WJ 1^&*
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M2!->TYI;PD6ZBX4^;ABOR\\_,"!ZD<5S=]96=Y\4_"UWHH@;[+9W)O7ML;1
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU VLYB,FZ--[1)T\PC!"KG^)AB@#5J-((HW=TB16D.7(4 M]?6N+\$>+[=_
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M>HPF=T:2,-E1*B]61CPX'<J357_A.?"_[G&NV1$TODQL),AGSMQGIC/&>F:
M-Y8XT(*HHVC:,#H/3Z4H4 D@#)ZGUKGY/%^G1^,T\-9;[3]F\]VV-@$NJJH.
M.<Y;)[8K:N[RWL+<SW4HCC!"Y/<DX  ')))  '))H F50JA5 "@8 ':FRQ1S
MQF.6-)$/574$'\*XGQ[XCD3P!JVI:#J<D%U8RQQN4C 96+H"C!UR#M<'L>17
M2V'B/1M3U*XTZRU&WGO+==TD*-DA<XS[C/&1WH TO+38$V+M'1<<"E "C
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M%Q\,R?#OQ)J.B,\L6HW-H9;N65V6ZD69,[-YYVJ.2./^^3CV(@$$$ @]J
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M#&9",'U*[C],UW^** /$DGL6^&VKS_;DA%GXH>XB8 O&#]I!3>%Y$9SDGTY
M/0];X4U;1->\=7VM6VN:;->S6,=JME:3ESL1BQ<EE4DY;' X ]^.E\2:-?:M
M!9MIVI"RN;2X%PGF0^;%*0"-KKD$CG(P1@@'J!4=AH^HR7MO?:W<6$T]L6:!
M;*U,05BI4L2S,3P2,<#GG/& #%^)GE)!X8N+D*+2WU^VEN)''R1H%D&YCT R
M1R>.:2SM+?5?BM<ZQIPBFT\:/]DNYX\-'-*T@*KD<,0@.>N 0*[H@$8/(JIJ
M,%W+I=Q!IMQ':7;1D03-%O6-NQ*\9H X'PKI]]::Z_@^XB<Z7H5P;VVG;D20
MODV\9]=K&3\8EKJ?'44D_@#Q###&\DKZ=.JHBY+$QG  '4U;T+2KC3;>62_O
M!>ZC<L'N;@1B-6(4* JY.U0!TSU)/>M6@#RZX2P\0:;X!M]$DM[B]L;NVN':
MW()MH$3][N(^Z#PN#U.!VJ'2+VVM/!OB_P /Z^Z+JOVF],D$O^LNA+DQO&O5
M]V0!CN,5ZL%5<[5 R<G ZT%5+!BH+#H<<B@#RJS$WAWQ%\/4UR4QS)HTUJ[M
MELS;8L1Y'5N,8ZG%5ENK!]"^*Y\^W+RRW 4[ERX^S@+CU^;('OFO7Z* ,;PE
M,D_@[19$D60&QA^93GG8,_K7G&F7,"?"3Q!X8U@J=?C-Y%+:O_K;B:1W>-T7
MJVXLN",]/:O8*3:I8-M&X< XYH \RU"7^R_$OPRM-4O(OMMM%,ERSR#A_LNW
M)/NW /<UWOB"-YO#>J1QJ7=[.5551DDE#@"M&B@#QF;5=,N_AQ\.8A=0N(=2
MTZ.96/"E$PX.?[IZ^G>KVO"74?%_CJQTF9&OKGP]%'$D;C<[CS,J/]K! ]LB
MO6,44 >:^&]4\(^*K[1)[7[=<:S8Y9;:26;=8$KMDW@G '&WGKQBM#XM&%?!
MD37 4PKJ5F9-PR-OG+G(^E=R%4$D  GJ0.M<]XR\/W?B328+&UN(8#'=0W+/
M*I;_ %;AP !ZD=: .:UE;6]^(=AK&D11WT=AI%W]O^RD,)4*CRH<C@DG<0/0
M9KG-.UO3KG5_AQ?17D8MT:>,VMM$?)LBULP6'."Q?. <DDXR  :]GC7;& 55
M6/+!>F>].P!V% ' _#A[&YO/%YC:WDF_X2"XE!4@MMVH%8>WWL'ZUQJW]H?V
M:[NP,RBZMHF@FB889)/M!.PY_BXSCKC!KW&C% 'F6N:WI^B_$"#4-:N[BWT7
M4-*CBM+^"5Q$LJ.[,C,G]X,#D^E0W&EZ'#9Z(GAW5I_#L^^ZN-+N;@EHY@2G
MF!ED.2KD@@<<#(KU)E5AAE!'H10RJZE64$'L10!SO@;4;S5/"T-S?VD%O<F:
M97^S9\J4B1@94SSM<Y8>N:Z.BB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
BHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>exhibit107-formofindemni007.jpg
<TEXT>
begin 644 exhibit107-formofindemni007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7E=(FDVJ.IPH)P._'%>;7A;Q3\/_  _H5K;S0:S!/9K+ \3*]FT)7S';(^4
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MX^7YN.<<U!9)<:=XALY_#=Y<26EYJ;+?Z#>1EOL^78O/$2,HH.6'\)W<=0*
M/3KN[M["TEN[N9(;>%2\DCG"JHZDFL^T\2:9>:DNG+)-%>/$9HX;BW>%I$'5
MEW@;L=P.1WQ6/\2].U'4_ ]U%I<33W$4L-Q]G7K,L<BN4'J2!T[XQ5#4GB\6
M^*?"-[I!D9;":6ZN9C&RF%#'M\MLCAF) V]< GM0!6@U%_&?B3Q#I@U#6=.-
MG+#'82VT4\/E'RP[-("H7))(Q)U &!SD]'XG\5Q>&IM(MY+>YFDU"[2W#QP.
MX4<EB=HY; .%'/?&!63X-F1O&WC-L.JW%Y"\+,A42JL*J2I/W@"".*D^(@>*
M3PM>^3-);VFMQ2SM#$TAC39(NXA03C) Z=Z *2^)%TGXD:T+V^OY+'^S+>>&
MU$4DC*S,^[;$J[AP!GC([ULZOK^@W^AZ1?'6[JVL[ZZ@-I/9EU,S%AMC;"G"
MD\$''?I69IMU'_PMC6;R19(H'TFW59)(RHW*SLRY(QN (R*Y"T62/X/>%K5X
M)Q<0ZS$\D)A;>BK=,Y)7&0 I!SZ$4 >JZAXETS3'N5N))C]E0/<-%;O((01D
M;BH...?8<G K6KR[Q;&\6L:QJWA[4;BSUJ..-9+"6(RV^KKY8*J$(Y;!*94Y
M&.<9S7I0N/*L!<W:B$K&'E7.[8<<CCK0!Q7Q#\4ZGH#6D^F)OM]/DCO=6QR?
MLS/Y84#U.7;V\NNU:\MDL3?-/&MJ(_.,Q8!0F,[L^F.<UQVE:1_PE&DZCJ-S
MJ=_;QZNSB>U$40VQ8V(C"2,L#L )&>K$CK7/^'+H7/PJU[PSK,=[(VE07-H'
MCB97N;= =CQ9&&XP!]!GK0!W*^,]#-W:6KW$T<UZ@DM5DMI%\Y3W7*].1GTR
M,]:BM_'GAR[U!;&"^>2X:[:SVBWDPLH&2K';A?J< X..AKC-!UW1=2UWPO)J
MNKE+[2X&MK:,Z?/ )99$5"6=U"C@8"]R>O05I>%()+VQ\>V<&^&YO-4NVMW=
M"FY7C55<$CE<@\B@#JD\7:,]_:6GVEU:])6UE>!UBG(YPDA&UCCD8//;-)>^
M+M%T^8+=7+I'YXMVN/(<PI*3C:T@&T'/')X/!P:X;PG=:3J=GHNCZAH&J_V_
MICPB2WNEG\JW>/ ,P<DH!@$KCDY '6J>CMI\-A=^#_$NB:K=ZHMU+Y<&)VM[
MY6E,B2 @[%'())Q@C/6@#T"Z\;Z#:7>H6CW,TESIX5KF&&UED= P)!PJDD8!
M)(X'&>M,C\>>&Y9-/6+4#)'J#(EO.L$AB9V^ZADV[5<_W20?:L?1IH[?XF>,
M)Y@T<+VMFJ2,AVN45]X4XP<9&<5R-LKQ?!7PK:-!.+J#4;9I(/);S$"W&YB5
MQD +SGWH ]3U7Q-I>C>>;N6;;;H)+AH;>240*?XG* [1CGGMSTJO<^-- M;V
M&S>_WW$]M]JA2&%Y#+'Q@IM!W9R, 9)]*XJ:\LM&\7>(;+Q)8ZI-9ZO,MS97
M%JL\D5PC1(AB*Q\9&W&".0?3%7K>&&Q^)'AQ([$V5K;Z)-#Y6"R6Y9T*QEN@
M; /&: -;5_B%IEGX./B#3Q->1-,+= L#@I*7"8D& 5P3T.">@ZBNKMKA+JW2
M>-9%1QD"6)HV_%6 (_$5XY=0SS_#KQDL-M<._P#PDK7:QK"VYH?M,;[U7&2N
MT,<CT->PVEU'>VD=S$L@CD&5\R,HQ'KM(!'XT 9\/B33;NY@MH99R;IWC@E%
MN_ER,H8MM<KM. K'KSCC-<9X5\:66CV&KIKVJ74IBURYMEGE2241() B;W4$
M1KV&<#K[U4\/K/I>MZ.WA^]GGT>[G=KO1KV/+Z9E&9I$8@%%!RN#P=W&<UF7
M2O+\*/'=LD$QN+G5KMX(O*;?*'E!1E7&2"!D$>GM0!ZEJ7B/3-*N6MKB65KA
M8#<O%!"\K)$#@N0H.!G\\'&<5SGB[5FFC\&ZCI.IS"TOM9MHR8'VI/"ZLV#W
M(.T<&J>K:IY_BE[-[2ZB@GTA?L]S9VC-+>L2V8C*%)15Z[<KRQ)(%<_:2,?A
M[\.(6MKI)+35K4SH]NZE%17#,01PH+ ;NE '9V5S=K\7=2LFO;B2T_LB&=('
M?Y$<RLI*CH.%'O3/B+?S:6OAN[CU":TA.MVT5QLDV(\1)+!_4?+]*9:.#\9[
M^0*_E-HL,*R;#L9Q*[%0W0D @XJ7XCQ2FRT"Z6"66&SURUN;@Q1LYCB4MN<@
M G R* -?1O&&AZ_<7=O87A^T68#3PSPO"Z*>C;7 .WWZ4ZW\6:/<ZE:V"W$B
M3WB,]J98'C2X &3Y;, &XYX/3D<5QOB#1KCQ;X@U74-$_P!5_P ([/IZW0&U
M9YI#E44GJ% .3T!8#KG#O"^H:-K\FDPR:%J@URP*F6.]6<)9.!AF#.=O., #
MDY' &< 'H5]?VNF64MY>S+#;Q#+NW;L![DG  '))KBK?6Y+SXP6]G#=:@EL=
M&EEDL[B-XD#>8@5PK 9XSSSW''(JQ\3(;XZ)I=]96TUU'INK6U[=6\*[GDA0
MDL O<@E3CVK'N=0B\0?$>UN=*%VT$^@7-LEU]DE5$D9U*Y)7CH>3QGCK0!V0
M\7:+]NM+4W+J;R0Q6TS0.(9G'\*2$;23@XYY[9I+_P 7:+ICL+NY>.))A!)<
M>0YACD) "M(!M4Y(')X)P<5P7A*XTN^TW1O#^J:!JAU_3&A1[:X$YAA>+"^>
M')\L+@$C'K@=:ATM["UBU+PEXFT75;N_-[.\$2K.\%^DDK2(P(.P<MR6P!C)
MYS0!W]UXUT*TOKVQ>YFDN[)%>>"&UED<!LX("J2PX.2,@=\5$GC_ ,-2C3VB
MU R0W[(D$ZP2&+>WW49]NU&/]UB#[5D:/)';?%+Q%+(IBA_LZTC60J=A*;]R
MAB,$C(KD(5=/@5I-F;><7<>HQLUOY+>8H%WO)*XR!MYSZ4 >K:IXBT[2#*+E
MYF,,?G3+!;O,8H^?F8(#@<'KUP<=#1)XCTM;:RGCN?M"WZ[K5;=#*TRXR2H4
M$X QD]!D9KA+^^M=#\>ZTVO6FIR:7K"02V5U9B=XVVQA&B98NY(R..](NSPE
MXWT74Y=*GL?#TND/8PHD;2"SE,WF#>!DKN7:/J,9XS0!L_#G4YM3D\4-)>W=
MU%#K,D4!NMP:-!''\FT@%<$GC [UU%_K-EI]Q';RM(]S(C2)!!$TLA48RVU0
M2!R!D\9('6N5^'LWF:IXN;[/=1)/K#SQ--;O&'0QQC(+ =P>.M)<R2Z%\5YM
M3U$.NE:CIB6\-UM)2&6-R3&Q_AW!B03P3Q0!N3>-?#T&B1:S)J*BPEE$*RB-
MSA\[=K#&5.>"& QWJ[H^NZ?KT-Q+I\KR);S&"0O$\>' !Z,!D8(.1QS7E6M:
M9/!X0\2W7V>?R=6\0Q7=K;"%B[1K+'NDV8R VUFY'3![U[+'(DL:R(P9&&5(
M[B@#+D\2Z9%<^09)F_TA;4R);NT8E) "%P-H.2!UP#QUXKCM.\5P:!XH\9IK
M.I7LUK:7,!B7RY)S#&80[':BG:@)Y. *I74=QI_B":_\,WEQYL^K!+_0+J,N
MDQ\T*T\61E.!YFX?+Q[8J>"11J7Q-=D<+<(GDDQG]]BV"'9Q\WS<<9YH [BX
M\1Z7;_8@)VG>]C,UM';QM*TJ  E@%!^7!'/N/6N6\;Z\M]X!MM;T'5)TA>]M
ME26!C'O4SJC*V0&'\0(X]ZQ])U)[2U\$V5S:7-M!_8HC>^@LVDG$P5 ;;(4F
M/."3QDX&".M8\8E3X,)IS6=ZEU#K(W0R0/OP+TR'''S87DD9'OF@#O+RYNXO
MBYI=JM[<?9)M*N)&MM_[O>KH VWUY/)KJKV^MM-LY+N\F6*"/&YF]S@ #J22
M0 !R2<5QU]*K_%_1)TW-"-*GC,JJ2@9G0J"W0$@$@58^)$.H'0;"_P!/M9;Q
MM,U.WOIK:(9>6*-B6"CN1D'\* -JS\3:3>W-Y:K<-#<648EN(KF-H6CC(R'(
M<#Y>.O0=Z9;>*M(NKZULUGECENT+VOG021+< #)V,P ;CG YQSTKD_$,\?C[
MP;KJ^&K";[3/8^5]KFM6@>0A@WD@N 6XW _P@D<\G":M.OC.U\(QZ;%-'>VN
MIV]Y<QM$R-9I&K>8KY'RG/R@=\\9 S0!O7'Q$\,6T=Y(]]*RV4QAN3':ROY)
M !);"\*,CYCQ[UKW6O6%J\:&229Y(?/"V\+S'R_[^$!X]/7MG%>=(P/A_P"*
M">7)ONI[DVZ^6V9@UNJ*4X^8%@1QFG7-M!<V6AW-IK%WH.N6NBPB&\*$PS#!
M#02HPP2&7.W[WS< XH ZJ\\=64&NZ%I\$%U-%JL#W*SI:R,/+" C "Y))9<\
M<#KC(IT6MZ3:ZIXFO(M0U*\FLHX6O+(([K;X5MHB3;U8 DX)'0G%<TUWJ*ZY
M\/=8U;2Y[9_L-U%<16UN["&5TCVIM4$KG:< ].G:K=BCS^-?B$D<<A-U:VR0
M$H0)66%U8*>AP2 <4 ;&C>.]-OM!T;4+[S[235&BBB5K68(99!E4#;<'_>S@
M^M:4_BC2X+G4;3?/)=Z? +B>!+:0OL.<%?EPV<'H37G!F=OA9X+F^R7H71;^
MP>^#6L@:-8^)#M(RP7N0"/UK9L[HZG\1]>GMK6\-O=Z'%'!,]LZ(Y#2=R..O
M&[&>W&* .B\/^,;/5_"UGK5PDML+A5Q&T$F2S?=5./WA_P!W/>M+2=?T[6I+
MN&SE?[19N([B"6)HY(B1D;E8 X(Y!Z'M7E=O+=P_#SP7?)INISQ:%*JZE:QQ
M212J#$\;,HX9BF[/'KUZX[WPF^BZA>7FK:-I]TBSHB2WUTLJO<%<X4"3YB%'
M?IS@9P< '54444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4451U75[/1K5)[V4HLDJ01*JEFDD<X
M5% Y))H O45FZ5KMEK$MY#;&1;BRE$5S!*A1XF(##(/4$$$$9!IMSXAT^TUZ
MTT69IEOKM'D@40L5<*,MAL;>/3/<4 :E%85KXOTB\T_5+Z%[CR-+=X[LM;NI
MC9!EA@C)('/&:;?>,-*T\W E-RS6MLMU=K';LQMHFR0SC&1PK''7 /% &_17
M-ZGJFC3:SX;$FH7B374C2V*VY<17.8R?G(&TC;R 3Z5>T[Q)IVJW^HV-J9S<
MZ<P6YC>!T*$C('(&<CD8H UJ*QT\2Z?+96ES"+B7[8ADMX4@;S)$&,L%(R%Y
M')P.1ZC-%O'_ (<33;74'O)%@N;K[$I-O)E)LX*.,?(1_M8Z4 =-16?H^LVN
MN6)N[1;A8UD:(K<0/$X93@_*P!JC?>+](T\7,DTDQMK27R;FZCA9XH'XX9@.
MV1DC('?% &]17%>-_$;6-UX?L(/M1AU&^19Y+:-SOAVNVU&7N2HX!SC/K6[H
MUA!H.F7+G4+V6T=VNE^WREC;(0"4!;Y@HP3AB2,F@#8HK!L?%^DZA=VEM$UP
MCWMNUS9F6!E%S&H!+)QSP0<'!P0<50?XD^&DMI+K[1=&VAN3;3S"SEV0.&"G
MS#M^09./FQ0!UM%9(\1Z<?$I\/;IAJ7D?:-A@<*8\XW!\;2,D#KUJU8ZI;:C
M+=QV_FDVDQ@E+QLHW@ D D?-U'(H N45EWVOV=C=/:[;BXN8XA-)#;0M(R(2
M0&('3.#@=3@X!P:Q=9\>V%EIFB7VG+)?V^K7L5O%-#&S*%9OFSCG=@, O7(Z
M<&@#KJ*\\EUX:7\4[LS3ZE+:2Z'%<QV2))*WF&9@=L0!(.%&>..]=7:^*-)O
M=#M-7MKAI;6\.VW"1L7D?GY0N,[AM;([;23P#0!L45S;^.M"ATW4KZ>:>%=,
M<)>Q/;/YL!(R-R@$X(Z-T/K5_1_$6GZ[+=1V)G/V;9N:2!XU8,,J4+ !@0.H
MR/S% &K17,ZAX^T'3KV_LI9+N2[L55IX(;.5W ;)! "\K@$EAP..>13I/'GA
MR/3M+U#[<SVNJ.([26.%V5VY^7('#<'@\\$8H T];L;[4=+>VT[5)-,N2RE;
MF.)9"N#DC:W!R.*DTK34TJP2U2629MS/)-+C?*[$EF;  R23P!@=!@"LZV\7
MZ7>6MM+;K=O+<^88K7[,ZS$1MM<E" 5 .!DX'('4U'-XWT&#P[-KKW,IL+>0
MQ7#+;N7@<'!5T W*0>N1W% '1450EUBUAEL8G$V^]SY(6%CT7<=V!\O'K6+H
MFMZ)#INK7UMJ%]/ NIO%+]J$A9+ABJ^5&K ,!N95"XZF@#J:*YS5-?TN;0=9
M^VR:A8PVL)6[=(9%EA5E)W*5!/ YW#('KP:LQ:SIUCI6E*DUQ/\ :X5%HA!D
MGG 0')[YQ@DGCGD\T ;5%<\_C;0HM%OM5DN)4M[!S'=H;=S) X[,@&1]>GO3
M['QCH^H:S#I<,DZW$\)FMVEMW2.=1C=Y;D8?&1T- &]7/IX=G3QS+XD-^A$E
MD++[-Y!X0.7!W;NN2>V,=JS/BM-<6GPZU.[M;NXM9X3$RR02F,\RJI!([8)K
M8T_Q7I6I:W)I$#SK=I#YZB:W>-9H\X+QE@ ZY(Y'K0!MT5@OXQT>.ZM(9)9D
MBO)OL]M=-"P@EEYP@?&,G!P>AQP35>/Q[H,^IG3X9+N2X6[%E(JV<N(Y",C>
M=ORCGJ< \XZ&@#IJ*P6\8:.EW9PO+,D=[-Y%K<M"PAFDYPJOC&3@X[''!-+?
M^+M)T[[6\SSO!9/LN[B*!GCMS@'#$#L""<9QGG% &[17$^-?$ILYO#UG:M<M
M!J5]&LLMK&[;X=KMA'3N2HZ'.,^M;FDV4/A_2KF4WFHW%H[M<JET7FD@0@'R
MU&"^!SP<D9Q0!M45RUI\0O#M\VF&">X,.I.(K:X-K((FD.<(7(VAC@\9S6CJ
M'B;3M.ENHW^T3-9H)+K[/ TOD*1D%L#TYP,G'.,4 ;%%<_>^-=!L5TUI+QG3
M4P6LWAA>19AM+<%003@<+U)( %:>DZI;:SI<&HVHE$$P)431-&PP2#E6 (Y!
MH NT5C6OB/3]2DMH(/M6R]5C;3^4RI*H&2ROVXY&<9ZC(YKB_!?C.RTKPZ4U
MF]OIF.JW%N;J2.298LSLJ"23!"]@,GN.U 'IM%8NI^*=-TJYN+>8SRS6UO\
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M]RAL;21N'0U6\.Z'?Z;XMU'1&@8:!;77]JVDG\.Z4']R!TPK^8_M\OK7H%%
M'E1>#1?$_B'3/$6@:G?P:G=M<V<]K!)-'.CHJF)@O (QCYN,=<#&=2R@-I\4
MM*"Z;+:VT7AXV@$4#M##)YJ,(@X&WA0>_:O0:* ,^UU:*[U?4--6VNTDLA&7
MEDA*Q2;QD;&_BQCGT-:%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5BZ
M]XITSPZ(Q>FYDED!98;6W>>3:.K%4!PHSU/%;55;N:TTZ*?49]J;4"NX&68
MG:HQR3EC@#J3[T 0:1KVF:[H\>K:;=I/8R*6$HR,8Z@@\@CN#2:+KVG>(+6:
MYTR<S0Q3O S%&7YU^\,$ \5F^"=#DT31K@SQB&XU"]GOY8!C$)E;(3CCY5V@
MXXSFL[X:_P#(/\0_]C!??^C* .UHHHH **** "L?3_%&DZEK=UHT,\B:E:H)
M);::%XGVGHPW ;A[C(Y%;%>:^)O"USK/BC4]6T686WB+2TMY+*8GY9!M?=$_
MJK#CV_.@#NIM9M(-9ATEUN/M<\;2Q@0.5*J5#'<!@8+KW[BM"N!\.>++;Q3X
M@TN[\MK:\MM/OH;ZSD^_;2K);;E(]/0]Q^-5#XGUR^^'$OCFQO0FP272:<T2
M&%H$<@HS8W[RJDY#8SVQ0!Z064.$+#<02!GD@=?YC\ZIV&I)J$M[&EO=0FTG
M,#&>$H)" #N0G[R\]:X>RN+G5?BS:7,6IWD=I-X>2]CMR(RJAYERF"O0[1D_
M>]\8ID?C35=/T/Q7=7LT-S<6.LC3[,F+8BA_*5=P') ,A)YR<=: /2**Y2_G
MUWPTVH:M<Z@FH:+:Z;)<21S(J3B= 6PFQ -A4'KD@U2L;SQ?-?:)>Q13W%A=
M '4(Y_LR1QJRY#PE&+\'LQ;(]Z .XHKS[P]XKN=2\10:9J&I36&L1SR_:M)N
MH$19(L/L,#;<L,[#G<<@&O0: "J6IZO8Z/%!+?W"PI/<1VT9;^*1SA15VO-?
M'MM:^+)=4TF47FVPM<6KP6DTJB];#AMR*0"BA!UZ2M0!Z+<W"6MM)/('*1J6
M(C0NV!Z <FN>/CK1U\-Z=KV+HV6H2)% 1 2<LVU=W91GU-)X+\1'Q1X&M-2E
M!6Z,1BND(P4F3Y7!';D9QZ$5Y_#_ ,D"\*_]?=E_Z4B@#V>BF3+(T+K$X20@
MA69=P!]<9&:\HL?%/BD^!_#_ (IN-6BD\Z_2WN+1;5 LL;W!C)+=0P&,8P..
M<]: /6J1F5!EF"@D#)..3P*Y&VU34/$NO>(;"QU%].BTETMHVCB1VDE*;F9]
MZGY1D  8/!YY&.0N/$&I^*-,\%7DMW-87+:X;*\BM@OEM)&)/G&Y3GE 0#D<
M]"0#0!ZC_:2?VV=+^SW7F?9_M'G^2?)QNV[=_3?WV^G-7:XU]=U&P^(ESIEU
M=B;3(-"-_L$*A]XDVDDCJ< ],#GI3='N?$NN:1H/B"SU&W"7KI/=V,J+Y26S
M@G:C!=_F*-O);!.>G H [2BO.Y-=\5:[I=YJ?AR*X,T-[)#;6["W^SRI%*48
M2%F\P%@K'(QC(&#U)K7BV[L?$5SINHW\V@M*L7]ES20HUK.Q0%E>0J<,'W+U
M P >>X!Z)117(^.M5UC2I/#XTJ[A@^W:M#92B2'?E7#'/7_9Z#GW% '745PO
M]H:[;ZTGAB74;J]NX[-KV:]M+>WBD97E98UVR'8  IR0"3QTYS'::]XFC.A:
M!K"1VFL:C<7"FZ4(Q^SPKN\P*"5#ME1CD#DXZ"@#OJ*X"/5M;@UOQAI;ZM),
MFFZ?#<VDS0Q"1699&.["A6Y4#H./?FF?\)-K'_"/> -2^UCS=8N+:&]3REVR
M"2)G8CC*G*]CWH ]"HKSZYUOQ-KEOK%QX=6X6>QOI;2VB"VY@E,3;6$I=M_)
M#?=VX&.O.8M?\77^G:J]EJMY-X>-Q:1'3[DPI):M<%3O260JV"&P.H&!G/-
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MOA5+<1"!<#* @G<,YP3S0!IT444 %%%% !1110 4444 %%%% !1110 4444
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MT<[GB23;PA)/520"<'O7JE% 'GD]QI[>++/7K-/$5H8;/[%);IH-P5DB#[P
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M#4HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "N=\9ZEJ6E:+%=Z?;74Z+<)]K%F@
M>9(.=S(IR">G;H3]:Z*L_5M.N+];5K6^>SFMIQ,KJ@</\K*58'JI#>QXX(H
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M!&'#'G'3/3CBG7W@IK_3+&UFUBYDGM[Z/4);J2-2\\R8VY PJKP!M ' 'OD
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M<<],8!&.>39?6M9U;6KO1XUN[2>RL;>6?[ T#%9I0Q/,O!5=O&!SSD]*L3^
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M+ ?=)'##Z'!_"L.XT6;Q9X#;PYJ<TEE<^4EO>E%#$E<?,A/!5BN0>>"1P0<
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M(H!*GU ((_.@"2BO&%USQ;#\+-.\>'Q#+//;[9+BQ:",13QF78P.!G=SU!
M& .]=G8ZC>>*M?\ $=G%J-SI\.ER1VT'D!0WF%-QD;<#GDX Z8!SG/ !VE,D
MECB4-(ZH"P4%CC))P!]23BO,+?QKK=UX2TC5KVSO)+:*XN+;6)-,0&0&,E5D
M5>NS();'3Z<%FM7/]KV'@:[L_$=S>P7&N;%N8MJ[U/FLI9=N-Z@*N", @\4
M>JT5YSXNU35=.A\226VL3O-IU@L]I%9HI,!5"S/<%EV_,1PN?NCA:NW?B&\D
MUCPO;W=P;'3=2L7FFN$(0//M4K%O/W>"S>IQ['(!W-%>7V'B;7K7PTUS=7TU
MT][K@TNPG>.)08?,*K,N% )90<%LC(!QC@]/H<'B2V\2W2WDCOHDMN&A6YE1
MYHI@<$ J.4(.>>A'I0!U-%<7XQO=8M_%'A:QTW5'LX=1GFAG40HX(6)F##(S
MD8XYQG&0>AYZYU?Q)H1\9Z++K<]T^GZ7_:FGW\D4?FJ-K91QMVGYEZXZ9_
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M.#G...@KUJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1+6S:2XG 6-/GE?"CZGL*FK%U'Q'#IOB/1]%DM+AI-4,HBG7;Y:F-"Y!YSG
M]._6@#B?AQX?&K_#+1K+4+Z:2RC;S)K%D53N64L$<XSMR VWJ?7'%=?+X56/
MQ#=ZUIFH3Z?<WL:QWBQHCI-M&%?# X<#C/3U!KH:* .?A\*QZ=#IL6D7L]DM
M@DB*N%D6;S"&8R C))9=V00<D_2J<W@&P?2+.R@O+JUFM-1.II=0[-_GL6+'
M:5*X.\C&,#BNLHH XZ[^'MK=7&M,-7U.*WUF 17ENCH0["/RP^XJ6!QC(!P3
MUR.*Y[Q#:Q:5JVD:;<ZWKNFP6&GF.'4T@$R3LS %& C95*A!V&=WMSZE10!P
M=EX?E\4Z#J.EZUJE]J>ER^4]I>36PM;A) 22RX4<#"$,5YRW45O>'_#DNC$R
MWFM7^K7.SRTFO&7]VG!( 4 <X&2<DX%;U% 'G_CTA_&/@M$NS;/'>32-*H!\
ML&)@"V> "?EYZYXK<N/!T%Y9:U'<WL[76L1>1=72JH81!2H1 00H 9O4Y).:
MZ2B@#F]1\%V.K>$;;P_>W-TZ6HC^SW:,$FB>/A'4@8##UQZUS_BK0GT;X;^(
MC>:Q>ZK?3V$D$<MV5W<@X1%4 9)Z]2<#)X&/1** .4T+0H[ZPT&_O-0DOX[&
M%7M495"K)LV[FP/F8 L!TQD\9YJC_P *RM1I@TU-<U1+.&^%]:1*8\6T@D\S
M@E,L-Q/WL]:[FB@#GT\)VX\276LRW=Q.US9+8RV\H4QM$"2!TSG+')SSFL0?
M#*)=&CT4>(=5&E6]PEQ:V_[HF#:^\*'*%B >F<X]Z[NB@#GK'3-2@\97E\=3
MOIM.EME0VUP5\M)1MP8P ,<!RQZ$L,=.)]?\-VVO-8W#336M]I\WG6EU#C?$
MV,$8((*L."#UK:HH YV;PE#<VNKBYO9WO-5M_LUQ=A5#+%@@(@QA1\S'N<DG
MGBH6\%1-#X>C_M.\ T(J;8[8\OA-@W_+S\IQQBNHHH H:UI-OKVB7NDW9<6]
MY"T,A0X8!AC(]ZQ3X+#SZ'/-K5_--H[,\+N(_P!X2FP[@$QC;Q@8]>3S74T4
M <K)X$TZZD\0_;KBXNX=>"?:H7VA5**%4H0 00 .I/(!J;P[X3DT-T:ZUW4]
M6\E=EL+UU(A7I_"!N;'&XY.,@8R<])10!C>)/#L/B.TM(I+JXM);.[CO+>>#
M;N21,X.&!!&">"*@@\++;^)I==74[MKF2S6R*R!"NQ22#]W.[))SGO7044 <
M8OPZM5\*0>'1JU_]DAN_M:R8C\S?YGF8)V8QN.>E:T?AI4\7GQ&=0N6N6LQ9
MM"53RS&&+?W<YW$G.:W:* .0F\ Q"^UB6PU>^L+76 S7MI$(VC>1EP77<I*D
M]\'GVK>T+2$T'0[+2HKB:XBM(5AC>;;NVJ, ': . /2M&B@#B9OAQ;F'6K*S
MUF_L]+U?S&N+&,1LBR.,,R%E)4'J0#C\.*M1^!(8-4M;^WUG4XI(K%=/FVM'
M_I$*DE0QV?*1D\K@_P ZZRB@#A1#IG@3PW:^%#'J>KBZBEAMH6@,@D&/]6S(
MH50=V,GW)-=)X8T.+PWX9T_1X2"+6$(S#^)^K-^+$G\:UJ* ,#6?"R:KKFGZ
MQ#J5Y87MDCQ![?8?,C?&Y2'5AV'-9@^'5FOAC5?#ZZKJ(LM2G>63+(S('8LR
MJ2O<GJ<GWKLJ* .=U+PFFIKH[OJEY#=Z5*9(+J(1[SE"C @J5Y4^E4;OP#$_
MB"?5],UO5-*DNPHO8K21=MQM& QW X;'&X<_CS7844 <_'X3MX/%%KKD%Y<1
MM;67V".V 4Q^3D-@Y&[.5'.>U;5Y:Q7UE<6DX)BGC:)P#@[6&#^AJ:B@#CE\
M 1#1M%TU];U&2/2+F*XMF819S$,1J?DQM _$]S5Y_!UG/K>JZE=W,UPNJ6@L
M[FV<*(S&,X P,@_,><]ZZ.B@#E/#O@@>'Y(5;7=4O[.UXL[6ZD4I!Q@<@ M@
M' R<#TZ5I>)_#5GXITI;*[DFA:*9+BWN(&VR02K]UU/J.?SK9HH Y.+P.'UK
M^UM1UN_O;EK!M/E#+$BR1,<D$*@QSCI@^_:JMK\.(;:+1(VU_5I1HLF;,L8Q
MLCVE/+X09^4XW'GT(KMJ* .83P/IXFUU9KBZFL=9=I+FQ<KY8=E"LP(&[)"C
MO@=>N,)X<\&G0)(O.U[5-3@M@5M(;QU*P#&.P!8X) )Z G KJ** ,CQ%X=M/
M$EC#;W+RPRV\Z7-M<PD"2"5?NLN01Z\$$$&H8O#8^UW%_<WTL^I36WV1;G8J
M^5'G)"*!@9/))SD@=@!6[10!QZ_#^V3P[HNB+JE\+?2+F.YMWQ'O+1G*!OEP
M0"?05UXR ,G)]:6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MNETZM>Y^RO) Z1W&!GY'8!6XY&#R.1D59UW6(= T.\U6XBFEBM8FE9(8R[$
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M!TNW@T.>P\Z^@U>Y$,4T$$CJH&2V<#.[Y2-O7/;@T ==143W"):FX*R; F_
MB8OC&?N@;L^V,UYWH.K#Q+!<Z[=ZQJ6F-I^I3R,<21VQM8W*^6X8>6<J,G^,
M'/3&* /2:*R+7Q-I5UJ L%FEBNFB,R17$$D+2(.K+O4;@.^.G>LW_A8OAEY/
M+AO9KB4O+&(X;65V+Q@EEP%ZX!Z]<''2@#J:*\OUSQA-K/@31=?LKF\TWS=2
MM?-4*T2F-Y0"I8@;AMZE3CK7<Z5XGTG6KZZL;*X=KJU"M+%)"\3;6Z,-X&Y3
M@\C(H UZ*XGQ_J4VD7OA:Z749K2V?5TAN55]J/&4=CN[G[HXS6WHWB_0M?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHKF-/U)O$7B;5[=9'73])=;7$;E?-N"NYR2.<*"H ]23V7
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ML D,1R< @G:#COBK<VO6,-]I=J#+*VIAS;20QEXR%7=DL. "#QGK0!IT444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %</X!MY-.UWQII\X(E.LM>KGO',BE3]/E8?@:[BJ<NFP
MOJ46H(6CND3RV=/^6D><[6'< \CN#G'4@@'F=C:W9^&VN>%'TR\.KW4]Y%%"
M]LX3][*Q23S,;-H#!LY[8Z\5K>.M+D/AOPKH$+F6X;5+.%6'7$0+._X*A->A
M53_LZ%M3&H2DR3HACAW=(E.-VT>IP,GKQCI0!<HHHH **** &NX1&<YPHR<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M36:PY^2:1(]TC$=P&VI@]"C>M=?!J.DCQ_J-O_9DT&J6^FI)+>, 1)!O.T*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZCDB@#M*CGGAMH6FGE2*).6>1@JCZDUSEKXP&J:;H-UI>G33MK,;21^82D<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ***R?$&NQ:#:6SF+SKB[N8[2UAW;?,E<X )YP
M  23@\ \'I0!K45S$?B>[@\3?\(]J%C"E[/:M<V,D4Q,5P%.&0DKE6'!Z'CG
MVJOX.\6:QXKM;+46T**TTNYBE)F-V&=75RH7;M&00#SZ@\=,@'7T5QOB76-;
ML_'7AC3+!+5K6\^TNZR3,AD:.+HQ"G"C=GOD@=,59D\47UX-8DT33H;R+29F
M@E\R<QM/*BAG1,*>F0,GJ<C@<T =316=H.M6GB/0K+6+$L;:[C$B;A@CU!]P
M00?I6-IOBV?6;R9=/MK6:*WOWL[F+[01/ %<KYC)MZ$C(&>A!SU  .JHKC!X
MWNO^$?\ %.HG2X?-T"XFB>+[2=LRQQJY(;9P2#TQ^-7T\3RWUU86&G6L37US
M8+J$@FE(2"-L!<D EB6R ,#A2?0$ W+F_L[.6"*YNX(9)W$<*22!3(WHH/4_
M2K%>8>*=2O-2L_!>HW>B2V6HKXACC:U=ANR%E'RL<94X!!XXKJ_#WB.\U+7-
M8T;4["&TO=-\ISY$YECDCE!*D$JIR-I!XH Z2BL75M>^Q:OI^CVD*3:C?"1T
M5WVI'&@&YV(!/4@  <D]N37-:QXXU&'0?%D$5I!:Z]H<'FNKR%XFC9"RRH=H
M)X!^4@8(P30!V\]_9VUS!;3W<$4]P=L,3R -(<9PH/)X':K%>7ZY-?-=?#R\
MN+2*6_-T0HCFW%P;9L9=E&.>3P?QK>MO'36]MXB_MRQCM+K0Y(UE2WG\U)1*
MH,>UF5>3D#D#F@#LJ*X^U\97<OB*/2&L+:=KFW>6WGL[EI(U=>3'(Q0;>.0W
M?TI?!OBO5_%=I8ZDVAQ6FEW4#OYWVL.ZR*^T+LVC((!Y]CQTR =?16)J^L7U
MGJ,-G:V*&-K>2>6^N7,=O$%( 4L ?F.>G' )YZ5D:?X^CU3PYH5];67^GZU,
M\%O:-+P&0MYC%P/N*$8Y R>..: .JCO[.:]ELXKN![J%0TL*R N@/0D=1GWH
MN;^SLY(([FZ@ADG<1PK)(%,C'LH/4^PKSS3M0_LCXD^+]1UB*"UCM=)MYI7@
M8LKH#(=W(!SVQZCO3/%5YJ.HW?@6]N]-M[>&XUJ"1")BTL64<A&^4#D')P<
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MY ?L\AEV;A\IW;6!P>.U6TUG6G^*EUI)2U_LZ#38YP/.92 \A!<_+@M\G3@
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MLRE /GP22.1GN1VTK+1]5M/'VJZTT$<EG<6,-M$?.'F,T98Y88P =WK76T4
M>8+X,\0+\*;;PQ]GM/M\5X)BWVC]WM%SYW7;G...E=%::5JT/Q U'7GM(OLE
MQI\5LBB<;]Z,S<C&,'=CKVKK:* /,(?!GB"+X<Z/H!M[0WEEJ274C?:/D*+.
M9>#MSG!QTKHI=#U0?$1M:BBMGT^[TQ+.X$DI5XBLC,<  ALAL=1S^O6T4 <!
MX7TCQIX?MH?#;?V=+I%LVR#4_-;SA!G(7RMN"^.,YP.O..5L='\8>&]9U.UT
MB/3;O1]0NY+R*:YF9'LWD.YP5 .]<Y( (^HKOJ* (A$PM1"TA=MFTNPY8XQD
MXKSVP\':S-X L_!.HP6\5K"4CN;R.?>)8EDWX1< AFP!SP,D\UZ/10!P_CK1
MDUG4-"^PWOV?4ENGM6:,Y8VTD9\]3Z?(,@GH=O<BNVCC2*-8XU"H@"JH&  .
M@K-LO#FCZ=J]YJUIIT$.H7AS/<*OSO\ CVZ#IUK4H XR#0M;L/$WBFZA@M)K
M+5Q')$QG*NKK"(]A7;CJ,YST[$],E/".O1^#/!VD_9[8W.BW]O<7!^T?*R19
MSM.WDG/<#I7I-% '!II'B[P]XEU270X-.OM*U:?[44NYVB>TF*@.>%.Y3@'
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M)&+R$;V)'& %P/7))Q7444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=H8!ERIP.]6].\.:XGC4:S<0:7:V4NDK8/;6TCL8"KLP"_*H8?-UPN.F#C)
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M>V)AN6>"Y0-M*EBH*L"0.GOCUT?&6AWNMVNE/IY@-QIVI0WZQSL464)NRFX
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6
M>-#TX:R=8%M_Q,#'Y1N-[;MF<[>OW<\XZ9K0HH **** "BBB@ HHHH ****
M"H+VRMM1LIK.\@2>VF0I)%(,JRGJ"*GHH K:?IUGI5C%9:?:Q6MK$,)%$H55
M_ 59HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D"JI)  +')('4T
MM% !1110 4444 %%%% !1110 4444 %%%% !1110 5GS:%I-QK,.L3:=;2:E
M GEQ7+1@NB\\ ]NI_,UH44 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX8\,3:K906\[Q21*RS,0 'D5,@#K][U%;MV\T=I,]NB/,J$HLC%5)]R ?Y4
M345A>#-=F\2^$-,UFYBCBFO(O,:./.U>2.,\UNT %%%% !10"#T-&1ZT %%1
MW#2I;N8%1I<'8)&*J3[D _RK$\$Z]/XG\'Z=K-S#'#-=(S-''G:N&(P,^PH
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M9?LLQ)VJV%)"L2,X')KDXO#>G7?PIU_6)'F74M-NKZ6RNO/?? T<K%0O/&2
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M9_R:M>U3Q596L5K:Z3X>AMXE"1QQWDJJJCH !#Q6/+X3U*?49M0D\/Z U[,
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MLNWTS^SU%C;R>;#;B1]D;9R"!GC!Y'H<^M-U?P5X;UZ]@O-5T>VN[F!0J2R
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MEZ#;O!I5C!:12.9'6)<;F/))K0H **** "BBB@ HHHH **** "BBB@ HHHH
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M9VG_  ]\5YI8V-O8^,_B+=:9IEJ;^SM[:2R"P+E)#;.?EXXW'KCK6;?Q0O\
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M&<YYZ5R7POMX+2T\3VUJBI!%XANT1%Z*!LP![4NI6\(^,^C2!!OETBZ#G^\
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MWTV2*:]TZ,&17/R*Y4L%..<X&3]147@_6Y?$'A+2=4NQ#'=7ELLSQQY !/7
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MN)V ><(QZ?W@ ,9'8 UOT <[K6I:_9-J%Q96EC]AL[;S=]P[AY6 +,  ,8
MY]2?2J'A[7_$NN:3HVK?8=-%IJ,>]PDDF^ %&*D\8(W  _6M[Q)_R*VK_P#7
ME-_Z :R/AG_R3/PY_P!>,?\ *@";P/XAN?$GA.SU._6WBNIY)T,<.0OR2N@Q
MDD]%%=$\B1XWNJ[C@;CC)]*\+MM,LHOA!I6N);H-3M]84PW1YDC'VXJ0I[*0
M3D#@Y)ZUU,\4'B7QCXMT/5;JQCD18D@BN[<.RVS1*=\1+#'SEB2!P<9Z"@#T
MVN4T#Q'J6J>,?$.B7,5JD6CM"IEC#;IO-0N."?EQ^-:WAN!+;PWI]O'?R:A'
M%"$2[E^],HX#>^1CGOU[UR'AJ&*Y^)7Q'@F0/$YL593T(\@T >A>8A8*'7+9
MP,]<=:@OYY+>RE>%H1/M/E"4X4MCIQS7BFE:996WPQ\!ZU% JZF-5M$%WUD"
M-.RLF[KM()^7I[5UVD_8_$/B'QS!K4,4]S:3"WBAF /E6OE@J5!Z!CN8D=\>
M@H ZCP=KD_B#P9IFM7JPQ374'FR"/(1>3TR3Q^-;@="F\.NS&=V>,5XOX>OQ
M'H/PXT^[N+:#3KJRGPUU%YD+W"[=@89 S@OC)ZGUQ5GQ=X>L='^'?B*"WOQ=
M*-2MKA8HTV1V;O/'N2, G;D'.W/&[WH ]?\ ,0E@'7*_>&>GUH$B&/S ZE,9
MW9XQ]:\XOO#FCQ?%K3K6.PA6WOM*N&NX@/EN2LB$&4?QGD\MG/>N6U*SMX_A
M5XUM(XPEO8>(WCM(UX$"^=#\J^@^9N/<T >X!U9F4,"R]0#R*Q9=8FT+1-1U
M/Q'<6216TLC(UMN'[K/[M3N/,AX&!P21BN:72K'2/C!81Z?;);I>Z/<&Z"?\
MMV61,,_]YN3\QYYZUQVH6=L/@UXU0P1E+?7;GR=R@^7BX51C/3C(^E 'N#2(
MB%W=54=6)P!2[EV[LC;C.<\8KSO5WM(?B'IF@EM.L]-?3I'M(9[96@>X\SYP
M%RHW[<'UPS>M9%S#;^&#X?T4:S%-HLNK7"2R7$.ZWAD,>Z.#&X H&+8!/# ?
MW> #UI'61 Z,&4]"#D&E+*IP6 XSR>U<MX3T.UT35=:6UU))Q<R1W$EI!$$A
MMF((.P G!;&2,^A[UCZII5A??&>SCNK6.:.;0IC+&XRLF)HP-R]&'L?0>E '
M?^;'M5O,7#\*<_>^E*\D<0!D=4!. 6..:\0ET+3/^%8^.)#:1E]*U.^33V.2
M;14<,HB_N8/IC/>NJU,V.K:[+"RI<W\6@*UR;X@V\$3DG<J8RTC$<G(& .>U
M 'HV0.XI<C.,\UX]%ISWOPD\*^*((5N]6T&&*Z&X!FEB7_61D_[F2/<#%=UX
M6:TUN[O/%<,2E;X+!:2E,,;>///K\SES[@+Z4 =*[K&A=V"J.I8X KG/&NOW
MWAW1;>_L([:7?=P0/YV2-LDBID8(YY]:Q_$UX'^(^DZ3?7%K#9SZ?*]L+R'S
M(I;C>H(P6 W!.GL3ZUA:_I%MH7P\GT^TU(WL":];,H"[4M]T\;&)!D_*N>!D
MXR1VH ]8>1(P#(ZJ"< L<<TKNJ*6=@JCJ2< 5YS>&'6_B)X@T/5)[%0MG!]C
MAO;?S-\+*?,:/+#!W9!(YX7TJGIAM+#Q7X9\.ZAJ1U/2ETN<6,]V!MN+A9@O
MT8K&,*?0Y'6@#T34M8L=)BMI+N95%S<16T(R,N\C!5 ]>N3[ FKQ( R2 !SF
MO*?$^@Z#8:7X?LK%5N;6/Q5;H1-B18M[[GB0XP$Y VCCC!Y%>H+;6KV0M5@A
M:TV>6(@@*;<8VXZ8QQB@"#2=6L];T];^PE$ML[R(D@Z-L=D)'J"5.#Z5<21)
M 2CJP!QE3GFO$-,EATKX/>')(8HH(+S6(X-5EC4*QM?M4@;>1SMX"\]F([UV
MMY9#2/BOX>_L>%+>&_L[I=1AA4*C)&%,;E1QD,P7/7!Q0!WE%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 57O;&UU*REL[ZWBN;:5=LD4JAE8>X-6*YGQUKFH>'=
M CU#3_LY;[5!#()D+96214.,$8/S=\T 6[3P?X=L-(FTJUT>TAL)SF:!$PLG
M^]_>_&ICX;T8O9.=/A+6(Q:$YS /]C^[Z<=N*T8YXI7D2.5':,X=58$J?0^E
M-CN[:6:2&.XB>6/[Z*X++]1VH J6N@Z79:C/J%M91Q7EQ@S3+D-+@8&X_P 6
M.V>E1V_AK1;2\-U;Z=!'+YAF&U?E$AZN%Z!CS\P&>:T5N(75F6:,A>6(8<4V
M6[MH8?.EN(HXCQO=P%_.@"K!HFF6VJ3:G#9Q)?3C$MP!\[CL">X';TJL_A+P
M])KPUQ]'LVU0'(NC$-^>Q^OOUK8!# $$$'D$5B3>(K>Y_MFUTNY@DOM-3Y]_
MS()-I;:0""< <^F: 'ZOX2\/Z_=0W6K:/9WD\/$<DT08@=<>X]CQ4VJ^'='U
ML6_]I:=;W)MCNA9UYC_W2.1]*I^#]=?7?"NCW][) M]>VJSO%&<=>N%)SBMJ
M2Y@ADCCEGC220X16< L?8=Z *FF:'I6B^=_9FG6UIY[F24PQA2['N<?Y%+-H
MFFW&J1ZG+9QM?1KL2X.=ZJ>H![#VJ_5>2X62-X[:X@^T%&,89LC(XR0#D@'@
MT 9W_")Z!]@N+'^RK?[)<R>;/!M^25_[S#H3[FM6&"*"W2"- L2+M5>H ]*J
MZ=+<)HUO+J=S:O<"(&>:#Y8BV.2N3P*KZ[J4UIX6U#5-,DMI);>UDGB9P7C;
M:I./E(ZXQUH KP^"/"\"(D6@:>BI,+A0(%PL@S@CZ9/'3FI;CPEX>N]<CUJX
MT>SEU*,@K<M$"^1T/N1V/44[PYJQU7P]I-U<20B]N["&YDC0XY9 20N<XR:E
MT[7=/U6]O[2SN$EDL9O(FVL" ^T,0/ID ^_% $.L>%= \03P3ZOI%I>RP?ZM
MYHPQ4=<>X]CQ5F_T73=4B@BO+.*5;=@\)Q@Q,.,H1RIQZ8INHZYI^E7NGV=U
M.B7%_*8H(R1EB%+$_0 =?<>M7);JWM]GG3Q1^8<)O<#<?09ZT 49_#NCW.E'
M2YM.MY+%FWM RY1VSDEA_$<\Y/?FGWNA:7J6E?V7?6,-Q8@ "&5=RC'3&>A'
M8UH50MC?_P!LWPN+BT:RV1FVBC4B5#@[BYS@@D<8'8T 5+?PAX=M6E:'1;(-
M+#Y$C&$,7CYRI)Z@Y.?7O3;;P=X;LS:M;:+91-:;O(9(@&CW  D'KG '/M6N
MMU;O(D:SQ,[KN10X)8>H]15'7M1;3=(NIH)[:.[6%W@6X.0[*,XP""?P- $'
M_"(^'_[-?3?[)MOL,C^8]MM_=LV<Y*],YY^M+JWA/0-=6V&JZ3:WGV;B$SIN
M*CTR><>U-\,ZR^I^#-)UG4'ABDNK.*>9@=J*S*"<9/ R?6M?SX3$LOFIY;8V
MON&#GI@^] %#5?#NC:YIR:?J>F6UU:1X\N*2,83 P-OIQQQ5JPT^STNQBLK"
MVBMK6$;8XHE"JH]@*?\ :[;;*WVB+;"<2'>,(??T_&G>?%Y2R^:GEMC:^X8.
M>F#[T -N+2WNFA:XA24P2"6+>,[' (##WP3^=$=I;Q7<UU'"BW$ZJLL@'+A<
M[03WQD_G3HYXIF=8I4=HVVN%8':?0^AK N]<NO#O@N^U?6I;2ZN;2.:0BTRB
M2;2VU!DD@X !]\T :=OH>F6M[=7L%E$ES=C%Q(!S,!P-WK@<<U33P=X<CM(+
M2/1K-+>";SXHUCPJ2?WP!_%Z'J*SH)O%TM_8SK?Z&VDS>4\Q,3K*I/WHT^8@
MYR,$G/'0UU$US!;LBS3QQF0[4#N!N/H,]: ,Z?PYI,LMY<_V;;R75U T$SR9
M_?(01L8\G;S[T_P_HL'A[1(-,M@HBB+L%1=JJ6<N0HYPH+$ 9.!BKT]U;VH4
MW$\4(8X4R.%R?09JEJ.NZ?I=[I]G=7")<7\IB@3<,MA2Q/T '7W'K0 DWAW1
MI]0N+^33;9KRXC\J:?8-[IC&">O3CZ<5$?"F@FSM;3^R[?[-:2"2WBQ\L+CH
MRC^$CU%68VO_ .W9@]Q:'3C;J8H54^<'R=S$YQMQC''6K0N8&N&MQ/&9U&3&
M'&X#UQUH RM1\(^'=6U.'4M0T:SN;R'&R:6(,W'3/KCWK990RE3T(P:CEN;>
M .99XHP@#,7<#:#P"?2I000"#D'H10!BGPCX>;3)]-.D6ILIY/-D@*95GSG=
MC^]GOUJ>Q\.Z-IMZ;RQTNTM[DQ"$RQ1!6V#HN1VJ]+<P0/&DL\<;R'"*[@%C
MZ#UISRQQ[?,D5-V<;CC.!D_H"?PH KMI=@\%[ UI$8KXL;I-O$Q90IW>N5 '
MX4E]I5AJ5JEK>6L<T$;*Z(PX5E^Z1Z$=B.E6HY$EC62-U=&&593D$>H-,6Y@
M=PB31LY!(4,"3@X/Y'B@"*RT^TTY)%M81'YC;Y&R69VP!EF/+'  R3T J+4=
M$TW598);VT26: DPR\J\>>NUA@C/?GFK45S;SO(D,\<C1G#JC@E3Z''2J>F2
MWL=E,^K75E)(DTF'MP514W?*&R3\P&,^] !<:#I5UI0TJ;3[=]/ Q]FV8C]>
M5Z'GGZU;M;6&RMDM[=!'"@PJ G"CT'M2BY@+2J)XRT0S(-XRGU]*YOQQXAO-
M#\)/K.D/:2E)85)D4NK*\BH=I!'/S9[]* -67PWHL][=WDFF6K7-Y&(KB;RP
M&E3&,,>XP /H*C/A;0S;VEN=,@\FR8/;1X.(6'0H/X2/:M-;F!VE59HV,1Q(
M X.SZ^E+Y\.U6\V/:W .X8- &3?>$?#VIZO%JU[HUE<7\6"D\D0+<=,^N.V>
ME;+*'4JPR",$5'+<P0Y\V:./ R=[ 8&<9_/BD-U;K/Y!N(A-@'RRXW8/3CK0
M!DIX.\.QA%CTBV2)&#+ JXBW#D'RQ\I.><XS5V^T73-3NK2ZOK"WN)[1B]O)
M+&&,9/4@GIT'Y"K4ES;PRQQ2SQI)(<(C. 6/L.]+)/#%GS)43"ESN8#"CJ?I
M0!C2^"_#,S7;2Z%8.;QQ)<$PC]XV0V3^(!/K5TZ%I)U2'4_[.M?MT$7DQ3^4
M-Z)_=![#D_F:M&ZMP(B;B+]]_JOG'S_[OK^%+/<P6J![B>.%2<!I'"@GTYH
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MA7;,3UW#OU/YU+IVBZ=I6396J1,5"%\EFVCHN3D[1V'05D^"-=OO$&C7-SJ
M@$\-_<6W[A2JD1N5!P23V]:Z">Y@ME5KB>.)6.T&1PH)].: ):*:\B1@%W50
M2%!)QDGH*;%/%.&,4J2!6*ML8'!'4'WH DHHHH **** "BBB@ HHHH ****
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M*Q*)&'H6QG%10>'M'MKYKV#3+2.Y9S(9%B .\\%O]X]SU- '#V>@:1J/Q/\
M&<-[IUM/$;2R<QR1@J799<MMZ;O?KR?4UM?"N5YOA?X?>1R["U"Y)SP&( _
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MGEM<F)?,*_W=V,X]J /%KC2=/B^">O7J6D7VK3]0G6SG(R]NJ77RB-CR@'/
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MC(_"KK*KJ58 J1@@C@B@#Q_37M;?Q!\-9[8VUK92P7/DIO#3&$VY8&9^ 22
M2,8#9Y-0&6TUOX,^,+S4TADUA9KLWGF@;XI5<^6O/(VJ$"BO3[?PEX<M%A%O
MH6FQ"&;SXMEL@V2?WAQP?>B[\)>';Z]FO;K1+":YG39+*]NI9QC')QSQQ]*
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M2UBC2(1*BB,#:% XQZ5D#PAX:6220:!I@>1MSL+1,L?4G')H Y[Q#HNCZKX
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M%L9(H NT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+I6\7JVCF,Q_> _B(]PN2*Y?7H[6;2? .H>'1&MQ]OM4M6AP";=D/FH<?P[
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MB+3O"^CRZEJ4Z1QK\J*6 ,CGHJ^Y_3KT%8E_XFG@\<Z':PZA9MHE[:74TCJ
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M)6O;81W! A<RKB3/3:<\_A4<>M:5+%%+'J=D\<JLT;+.I#A<[B#GD#!SZ8H
M6_T;2]4>-]0TZTNWBSY;3PJY7/7&1QFEN])TV_MDMKS3[2Y@CQLBFA5U7'3
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M&J^V"(K+X>A=A@?-F=^2/IC]*X=+>P7]GJWF$< 8:DI$@ SD7V,Y_P!W(^E
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MNB:C<ZA87%MK/A^XUM5N]/E&+FTNC,JYC8?>PX5MI[8QQS0!ZG1110 4444
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MI<XQCKCTXJ.PUC3M3DFCLKR&>2''FHC?,F>1D=1GMZUR7B[Q:+:]\/P:/K,
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M7L$[0$"54<$QY&1N'49'(SUJ.RU[2=1NVM+/4;:>X5/,,<<@+%.FX#NON.*
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M#"\+V%] 6A8L0=X*G(;@#H>/3F@"G\/XM.*ZW?66J:=?2:AJ#W<J6,XE2#<
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M86B@>8,Y4R;A]1D9^M<>MTW_  @^M7EB/M=O8^+WO;R" [R]LLX<\#J. ?3
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M;W"H)3$<JQ0]' ."5]QQ7/?%&&^E\"W+64,DXAGAFN(8QEI(4D5G4#OP,X]
M:I:K/:^(_&_@V_T*ZBN3;-/-<30.&"6[1XP^.FYMH /?/H: &1:[<^+M=US3
MM+U]],EL9HH[%HXED63Y [LZL/F!R5QD<#/6M#XCZOJFA:!:7NF7S6\S7T%N
M^(T8,KMM/# X/I53P/?6D_C/QND-S#(S:C&RA7!) A4$CUY!'X57^,UQ:Q^$
M+2&YFB7?J5L2CL!E0^6./0#.: .I^Q:E;:E9!?$$\X+,TMM<10CS(P,'!1%(
M(+(>OMWJ1?%6A/'>2+JEN4LF"W1W?ZDDX ?T.?6L2&Y\%Z?KEG=Z5<:>^I3
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M7598]&GTJ>=H)$"J'5T4$#:&).>AS[5TL'B?1;G1$UB'487L';8LHSR^[;L
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MYRVT(5."&S@@CT- &GM'H*  .@%9]CKNFZC>2V=O<'[5$@D>"6-HI AZ-M<
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M)E>*\NMDB1>?(J1M(8X\XWL%!VKP>3@<'TH TBBLI4J"#U!%*JJBA54*HX
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M^D26!?7-*2*-[.6V8/921KL>0DC"@ $@YYR!UKGI9[23X;_$L+)"TDVJWA0
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M>2PMJ?C#:5WR:Y+*AQ]^,H@##U7(;D<5'\9F#_#'4[9,O<3M"(HE&6?$R$X
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M_9R>9;7$:RQL01E2,C@\CZ4 87A[QG9:^^KE8Y[:'3[F2$R7$#QKM15W,S,
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MNIRRA]OU&><'B@#JM7^(.DV.B0:C9M+>+-?)8@1P2$QR%PK!QC*$9^Z0"3@
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M%Q:P?:9(;BVDC?RLXWJK*"PSQQG!X- ">,?#\OBKPO>Z)'>):"[4(\K0^9@
M@\#<O/'K6S LJ01K,Z/*%PS(I4$^P)./S-<W'\0O#$@L'&HLL%_Q;W#V\BPL
M2"0ID*[5; /RD@U;LO&&BW[W\<-Q,DE@@DN(YK:6)U0YPP5E!93@\@&@#=HK
MF;3Q_P"&[Z73DM[YW746"6TOV>01NYR0F\KM#'!^4D'VJ6VU'3&\6:NL6IWT
MUY;VL9N+'#M%"H+89$V\LW.=N2<"@#H:*\LMM5C\4:;K.I7VMZ[H_P!@U&X
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MBO4Y'U#P5>:9J4PL[[4XT80R8CGB:)W&<=1P* .WHHHH *K3V,5S=6\TI=A
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M6IWJO#82:+):K<LA,8E\Y6V%@, E03SBN6U'1M2M+"_\1VVG7DED_B1=3-C
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M"78=C.)78J#C!;!!QUKT&B@#QJW#1_"[P!;M#,)[75K-YXO*;?$$<ERPQD
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MAO(I<$1X0[<C[IW8'3)K0\7:(/$5A:Z3IMO#97^B6JW*/(&*1_)M^SAN-R,
M0_4 8R.>/2:* /,O$6MGQ'X#T+6(M/NX#;:K97%Y:F!_,MPD@W_+C) [$#D4
MS4M3@T;Q[>:CK-IJ_P#8^KVEO]ENK59QY3Q[@8Y$C^8$[MPR.Y]\>H44 >8R
MVMG8>(_ $=CI<FG6,$U[)Y!1OW"/&P0O_<+$YP>A..U4=0MY[ZR^*D%K!-))
M=!6MU6,_O@(%4E./FY!''>O7** ,SP]>Q:AH-E/"LRQ^2BCS8FC)PHSPP!Z^
MU<%HFHZ=;77Q"M+Q2[S:E*! (RS7 ,*#8HQ\Q]AZCUKU"N?\.^'9]"OM8N9+
M]+D:G=F[95@,?EL5"X!W'(PHH \YM+&Z\#2>&9O$%MJ$NFC15L;B6Q:4FTG#
ME_F$9R5(;;WY45HZW#IT6F^&9-+TJXM+23Q-#?%7BD,C)M8-.ZG+*"<?>[8)
MQFO5:* .'U]U/Q3\(2 ,T<5O>B20(2J%U0("W09P<9K$MW7^R?B<NR3-U-.T
M \MOWP-NJ IQ\V6!'&>:]3HH \L\SY/A=E)<VRC[1^[;]S_HQ3Y^/E^;CGO6
MEI0EA\8>.[%[6Y$U\T<MNWDML=/LX7(?&W[PQUSFO0:* /&8);J+X>^"K]--
MU.>'0I%34K:**6*908GC9E'RLVPMSCUZ]<6_$-K:ZYX3U35?"FD7LSF2UEN)
M9TE66^6*0,8U$GS,% Z]#T&:];HH \VN]=M-=^(?@K4-/AO9;9(KU99/L<H$
M9=(P V5XYX/IWK9^*-M<77P\U%;:"2>2.2WF,<2EF*I,CM@#KA5)_"NPHH \
MZCUBWU#XKZ;JEM#>-IYT6:,736LBIN,J-SE>!A3R<#WKF5##X&16?D3_ &L:
MIO\ (\EO, ^V^9G;C.-G.?2O:Z* /.].U3_A'_B1XC.JQW/V;6!;3Z==1P/*
MDJI'M,8*@X8'D#OG/?GDM)^UZ=X*\':K-INJ26.F75XE_!!'+'*B2N^V50,%
ME&1G&>&KW&B@#R/Q6NDW_P .?$EYH6EWG_$Q-LOG2Q3&:]9) 3A'^<A5[XYY
M["O6898YX4EB8-&PRI'I3Z* .#TRX&E_$WQ?]KAN(TO(K26"7R',;(D3!CN
MP,'CD]3Q7(V:O%\(?!5LT$RW-MJUJ\T/E-OC"3EF++C( !SGW]Z]JHH \H:Z
ML='\4>(M,\36&K36^JW)N;*:U6>2&ZC>-5,16,XW#;CD<CVQ7H^GV,,>@6UB
M+06D MEB^S*V?*7;C9GV'%:%% 'G'P_ED\#:5)X3\0!K9;*:0V5\ZD07,+,6
M!W]%8%CE20>F,UC#P_/K6I_$ZXTBRVQZE:00Z?<>5Y:3,(2) C$#(+<$CC)K
MV"B@#SGPWJFA>(+O39CHNJ)J]@"\POQ.%L#MPYWR';SC  Y/<  XYJ4.WP/U
M2T6"?[6^J,ZP>2WF,#>!P0N,XV<Y]*]KHH \PU2_M]"^(&HWFM6^IR:1JUM;
MFTO+'SV1612K1L(CG)SD<=S2S6UGI_BCX?QV>ER:?8V[WS^1Y;'[.LD9"%^N
MPL3T/0DCM7IU% 'G/B6^DE\4ZUIDME=0"32U%M+9VC-)?L0^4:55)54)'RY'
MWB2<<5C03%O"GPQ0P7*-:7=OYX>!U,86!D9B".%#$#)XKU^B@ HHHH ****
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MCA:??I9Q=J]NZF,XW8Y'/'/&>*TK.[COK*&[A#B*9 Z>8A1L'IE3R/QKSA]
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M&3V QCG.[10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 0W=K'>VSV\I?RG&'"MMW#N,CG!]JE551 B*%51@
M #  I:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MYK\7<%S);B_L_*0(J38&8B!N!4L,;BV14-@;""\\027L6M7EOKC9NK<^'[I
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M5"Y/S 8XX'XCB@#M]0DN(M-NI+3R?M*0NT7GMMCW@'&X]ESC/M7#Z-XDU/\
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M"%R=VSS?O;,_P\9'&>3G6T3PW)I.L:U?R7RW"ZK*LTD7D;0C!0@P=QXV@=:
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M<9/"]S7(V7B/Q1_P@.A^*I]<,DK:@L$]J+:-8YHVN6B.XXR&QC!4@# X)YH
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ML5 !'((.,]N: .PHKFM>UBXC\3:'X?MIS;-J(GEDG4 LJ1*#M7<",DL.2#@
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M==TC1DG*Q+M;=(> !@]Z -VBO+9_%&O1>&O'9BOIH[C17WVDUQ!'YH0Q!PK
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1V9XV>%/WI9-AW 8 &W@ 8]233)? 5G>MXC74;F2Y@U[8;B(($\MD4*A0]B
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MFNWAEE2%"[K$ 6V@9) )&:J>']=MO$FCP:K913I:7 W1-,H4NN<9P"2.G?%
M%+Q3X3A\2BQG2]N-/U+3Y3+9WMO@M$2,,"#PRD=0>N*KW?@F#5- DT_5-2O+
MR\>5+C^T3M26.5/N,@4;5"]@!CDYR2374UCZ[XBMM ETQ+FWN)/[0O([*-XE
M!5'<X&[)&!UZ9Z4 16_A^7^TX]5O[X7FHP6[6]M)Y 1(@Q!9@H/+-M7)ST&
M!SG&7X>(G@RV\,#5IOLMO<BY67RE\PD2^: >V-Q].E=M10!SX\,%/%C^((M2
MGBEFMD@N(%1?+EV$E3R-P^\> >:R9?AXDWA75= ?5IO(U*\:\EE$2[U9G$C!
M>V-P'4=,_AVU% &!-X;DN/%6GZ_)J!\ZSMWMQ$L0".KX+$\YSE1CTK"G^&:S
M:)>Z(-?OH]+GNOM4-ND<?[AC*)2-V,L,@XSP,]#@5U^K:@^EZ9+>)8W5\T>W
M%O:(&D?+ < D=,Y//0&K1EC658BZB1P652>2!C) ]LC\Z .3U/P-+<:^-<TK
MQ!?Z5J$L*P7DD*1N+I5Z%E9=H8#C(''I73V-G'8645K$SLL8^_(VYG)Y+,>Y
M)))/J:L44 <FG@*Q,.OV=S=W%QINLS23RV;!0L<DF-S*P&[.5!&3@59M/"L@
MDTLZIJ<FHII1W6@>((=^TJ'D(^^P4D C Y)QG!'1U2TW4'U 71>QNK3R+AX
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M>LFNHJW.](S@A A88 Y('T&>G3&A+X4>;5/#]^^I-YFBHZ1*(1B7>FQBW/\
M=';'/Y5TM% &5XB\/V7B?19M+OO,$4A#+)$VUXW4Y5U/8@BJ]KX>E.IV>I:I
M?F_O+*)XK9O)$:IOP&<@$Y<@ 9X&,X R:W:* .>T3PU-HEUJ]Q%J1E?4[EKJ
M020C$<A 7Y<'I@#@YZ=:H6W@-;;P'<^$AJLSV<ZR*9FB7S%61F9QZ=6...*[
M"J]Q=QV\<Y :62&/S&ABP7(.<<9[X./H: .9U7P,;^32;ZTUBYT_6--A^SQW
MT$:GS(NZNC95AQGZT_5O MMJ^AP64^I7PO[>X%W%J:L!.LXXW\ #&.-H &
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M]Y(I#?N4\Q?+;<JJNW:%SG(QSDY/I?TO08M.U2_U224SW]^(UGEV!!MC!"@
M?4\G)Y]   #F-<MIY?B_X?5=1NXD;3[IMD;+M7:T?0%3USR>O3D5SY74X;/X
MD:EIVL7%A)87\UU&L$:'S'2W1L/N!RO&,#'?D]O0M6\,PZIKNFZPM]=VEU8K
M)&# 5Q+&^-RMN4X^Z.1@CU]*"^!X18^(;0ZI>&/7F=KH[8\J738VSY>/E '.
M: *UQJE[J$F@L;]XHKW3C.UE8C_2992$(8$C"QKDY)(&2H).<5R$^I:GXA\"
M^!-0O=1N4NIM?BMYFBV)YFV610S#&-P\L'TSVZ5VZ^!HXM0TN^MM9U"WN;&Q
M&GL\?E_OX 00K J0#D=5P:KQ?#BR@\-VNBQ:KJ*I97POK2<LA>!P[. ,K@C+
M-]X$G/T% '6M;LUD;?[3,&,>SSQM\S.,;NF,]^F/:O%DCG/[.L5Q)>SSR3W,
M+8F(8*WVX9(P 3D\G)->VPQ^3!'&9'D** 7<Y9O<^]<9_P *WM!X4?PVNL:D
M-.,ZRQK^[)B"R>:%4[.F[G)R>V<4 0'5=3\/^/;JRN]3N-1L9-%EU(QRHBF.
M2.0 A-JC"D'H<GCJ:BTVY\6:I:>'=<LIV*71BFOXIY8_(>"1<L(P!N5ER-O.
M3CYLUTDGA>.;Q3#K\U].\T=FUD82B>6\;$,V1C.20.]9FA_#Z#0;A8[?6M4?
M2(I?-@TN213#$V=P&<;BH/(7.,]<T ='K7_(!U'_ *]9/_037EVF:AJFF_"7
MP')I=^UJ\][:6LH\M75TDD((.1G\B.]>JZE9G4-.N+,3O )HVC,D8!8 C!QD
M$9_"N83X>V\?AS2-#75K[[-I5S'<V[[8]Y:-MR!CMP0#[4 9<GB'4?"GB#Q/
M;WNHW&JVEGHZZK$+A45U?+J4!15&T[1VXJAXB@OI])\":I=ZI//-<ZU82SQ8
M41%GRPV #*A>@YY'7)YKL9O!]K=>(+W5;NZFN!>V/]GSVSJHB:')..!G.6/.
M>]9*?#=5T[3=.?Q'JSV6F7<=S91D1;HO+SL7=LRP&<#/;CZ %:?4?$7B5-?.
MASSV]S87LEG:;)(A$KQA<^8&!+;B3GT!&!G)+A=>(+[X@0Z-<:Q+9PS: MW-
M%:I&WE3>:JMY;,IX]VSQG&,\:%SX B;Q!<ZMIVN:KI9O2IOH+210EP0,;N5.
MUB.I7!^AK0C\*00>*(]=@O)XI(K :?';A4\M8@VX=LYR!SF@#S^;6O$T?PWU
M;7CXAN#>:'>3P1@0Q!;E8IMO[T;<DE>/E*_B>:Z:^N-8O/B:NBPZW<VFGSZ*
MUV4BCC+1N)E7*,5.#C^]NZG&,@BRWP]M7\*ZIX>?5;XVNI7#W$SXCW@NVY@I
MVX )]JT4\+;/$\6OG4[EKN.Q^P[2D>PQ[@Q)&W.[< >OX4 </<^)=?C^$6IZ
MBNK2C4M-U![/[4(TW3(MR(_F!7 .T]1CD5M7UM/+\;+$#4;N./\ L2641JR[
M1B:,$ %3P<#)Z\#GBK<GP[M9?"VH>'WU:^^RWUV;N5\1[PYD$A .W&-P!Z5J
MWGA>.\\0Z?K?]HW<%Y:P-;.8=@$\;$,5;*G'*@Y7!H Y.'4_%7B70!KF@RO'
M=&[<PQ2RQBV,22E#&XP6R54Y/7=TP.*M7&I:_P"))?$46CS7%M/IUR;2T,4D
M019%C5MT@8$L"S8]-HXYR:NP_#NVM-5NYK+6=3M=,O)C/<Z7'(OD2.WWL9&Y
M5;N 1GZ<5+?^ XI_$<^M:;K>IZ1->!5O8[-U"7&T8!(93M;'&X?SH Z+3&O9
M-(M6U$1)?&%?M A.4$F/FVGTSG%<'I^M>)9O"?B2:WDN-3OK'79;9 BHLIMD
MD0,$  7?LW8XZUZ';VT=I:16T"[(HD"(,YP ,#KUKF[/P4MA97UO;ZQ?H]WJ
M)U(S 1[DE+!B!\N-IQ@@@\9H 3P5KMGKL=_/9:I<W4:2*IM;R/9/9MCE'& >
MH)R<]QGBL_Q#-K5Q\0[#1++7)[&SO--N)6$<4;&-U9 &4E>OS=\]\8.".DTK
M08M-U+4-3>4S7^H>6+B78$!$8(0 #TR>N3SZ8 ANO#:77BVS\0F^N$FM('@2
M!0GELC$%LY&<D@=^U '-&\U[5[G6])L;V[^TZ0L5K'<1-%&7F,*OYLBL#D%F
MQM'& ?PCO6U)_&/PX.L"$:D!>BY\@Y3S!;X)'MFMG5? L=[XC?7=.UG4M(O+
MA%CNS9LNVX5>%+!E(W < ^E6KGPC;3:MH=_%>7,)T82"WC7:P?>NURY8%F)'
M?/7F@# AU[4- U[Q+I6L7]Q>.MNM[I)945I(V^3RUVJ 7$A"\YSN6K%[<ZWI
M'B;P/ITVL37"W9GCOPT<8$[I S;N%!'S=AQP*=G3/&WBS3;J*QNMN@SS,\]Q
M;O$/,X58UW ;AD;\CIL7UK<U;PW'JVNZ1JS7MQ#+I;N\,<87:Q=2K;L@G[IQ
MP10!Q$]YXBNH/';+XENX?[%E=[0QPP@_+ ) K93!7/8 $]R:U9O$M]<2^"_M
M4WV+3]7M#-=W*$(#-Y2LD6X_<!)8^IVX!ZYU5\%1)'XA3^U+LC72QN?EC^3*
M;#L^7CY>.<UR_B.SBT>\\/Z3/J^M:;9Z=8,D&IPVXE21CM01N C*&"IG) ^]
MQWH Z'P%=ZO?P:M/J.H37=M%J$UM8R/'&HE@0X60%5&[/(ST.W(IT^HW\?Q4
MMM*6\D_L^XTB6X: JN%D61%# XST)XSBG^#CJ9-T9]7N]5TXJAMKB[LQ;R;O
MFW  *NY<;<$CN<$]K6L^%QJFN6.LVVIW>G7UK&\!DMU1O,B<@E2'5AU4$'M0
M!PMUXD\0Q^"]3O(=8D%U:>)7T])'BC.Z'[0L85OE'8]1@^]:=YJNM^#?&MM!
M?ZM/J^EZE8W5QLEB17@D@3>VW:!\I!P <_6J'C3PS;>&_ ]Y9VVH7DIU#6HK
MS;(RLT9:=6<IQDX')+9Z9KN[;089M335[Z[.HSK;M! S(HC2-\%B ."6PN3Z
M 8P,Y .+OO$&MV?PRL_'<>HO)<[(KNXLBJ^0\3L 8@,94J&X;.<KSG-:"R:U
MK'CW7]'3Q!>6EC%96T\(ABB$D3/OR 2IXXYR">G([Z5IX"M+72UT7[?=2Z%'
M,)H["0*0 'WB,OC<8PW..O&"2.*OP^&1;^)M1UV+4;D7%] D#QE4*(J9V[?E
MSD;CU)H K_#[6+S7_ 6D:GJ#B2[FA/FN% W,K%<X' SC-8GARVG_ .%D>.&?
M4;N1(3:XC=E*D- 6Q]W( +' &/?-=3X7\/0^%?#]OHUM<SW%O;[A&\^W< 26
MP=H /)/:JP\*1Q>(]2UJVU*\MY-1C19X4V&,LB%%?E2<A3TSC/)!H \X\,W6
MK:+\/O >IVVK3"&>]M[*6R\M/):*61E)Z;MW?.['M7:0ZEK'_"PO$&F1W9GB
MATN*XM()55525F<8R "1E1U)IZ?#VUC\-:/H2:K?"VTJZCNK=\1[RR-N4,=N
M" 3Z5>D\(Q2Z[J>K/J%UYNH60LI(P$"J@S@K\N006)ZT 8?@SQ(VIZS'8WU]
MJ-KJ\-FWV[2M0C52TF4_>QD+@KPX^4XPPX%=_6#:^&0FK6.I7]_-?75A"\-M
M)(BJP#XW,Q4#<Q"@=AUXK>H **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<MM>6V8$J4+,#N!(R-V3UY]*=EJ&M6EI\/M7EUR[N6U<P6]W;R!?*97MR^X
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M#XECO] \4RV.H:O8ZC8Z8TK:;?DB>TE17;>"V=RL=O<C@=,T >G45Y]+K&I
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MX "\\Y')(!)X&&Z#X*30E &N:Q?>4ACM?MDZR"V!&/D&W!..,L#QQT)SU%%
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MC<Q[D]2:GHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(RCYCP6^7D G!XK3O]:M+"YCM7\V6[D1I$MX(S(Y08!; Z#) R>YQUH SO\
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MCP2"!@G% ':T5SVD>*K>]\-:9J=S'-%->1Q[81 X:21D#D1J1EAC)R., G.
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ML[_N,6Q3Y^/E^;CFO5** /)M5TW4-7O?B7;:=;S>?=K9O:%XV1;@QQ+N56(
M/*E>O>M#3Y]-\61;M-T#4K368K69/M&H12I]A=XRI"N_!)8@87MDG&*])HH
M\6GU&2;X5:1H+:3J<>K:9<V4-S:BQE8KY4J98$+A@0,C!.<UZ[J,RC1[F8A]
MI@8@;#NY'3;C.?;&:N44 >.PQSQ_#?X>V[6=V+BSU6S>XB^S2;X50MO9AC(
MR.3ZU=:6VT;Q1XATWQ'HNJ7EOJET;FSGM899H[A'15,3!. 1MQSVZ\8SZK10
M!YY9P"S^*.CJNG26MM#X?:U"QQ,T4$AD1A%O VY"@]^U9GF6VC>)O$6E>)-$
MU2\AU*[:YLYK6&6:*XC=%4Q$(< C&/FXQUXQGU:B@#SZ:#[)\0_""1Z?);6]
MKI=Q"Z11LT5N6$>V/>!C^$@?2N?FCFD^&WQ"MEL[LSW>JWCV\7V:3=,KE=C*
M,9(.#R/2O8:* *5A*7T6WEB1F;R%(1@5).WH<]/QKR..[N;VV\'7TNEZI'<V
MNK@W=G#I\D<%EE9!L1 H!&2/F^8\\D9Q7M-% 'E\)?R/B;FVNA]K+FW!MW_?
M VP3Y./F^88XS573)[G0-9\'ZW?6EXVE'PZFF2LEN[-:7 *,2Z ;@#M"YQU%
M>M44 <-X!D=];\7R-:W<,=QJGGPM/;/&'0Q(,@L!W!XZCTJKXTLTE\027NGZ
MCJ&C:[:V*F"[BB:2"[7<Y\EUP5<@C./O?." :]#HH \TDN[W3_%OA+6]:TZ>
MW$NC26LZVML\JPW#&-MFU 2.A ^E<WJ3RQ?#KQ6;FQO("WBK[0J2P,"Z-=1X
MVG&&Z$?*37M]87BSPZ_BC1O[-%Y]EC,T<K.(MY)1PZ@<C'*C- &!J=G_ ,)+
MX^T+4-,+K%IMI=_:+K8RC,J!$CR0,L#N8CMCG&17/^$C9/I6F^&-9\+ZB^NZ
M<T<12:*5K?,9PLXD)V!<<^N> #Q7K2!Q&HD96?'S%1@$^PR<?G3J .!\*Q2S
MZSXZB5)[=[N]W0320N@9?)5-RD@9 8'I5/P/K+)H.D^%M0\/WBZUIA2!TFM&
M\E-AP)Q*1MQMY&#DG@=<UZ510!Y+:-::9J>N^'_$GA_5+V2[U">XM&AADEAO
M(I7+A20=H(S@[L 8Y-:6E7$OA/XA:TNJ6-S'9ZI;VAL9;:WDGC4Q1[&A^520
M022,CG\:](HH \0TV&_L?!OAC4Y-'U*>WTK4KQKZTCAD2;RI7DVR(."P4,#Q
MZGWKIKBW\-ZOH5_=1Z%J<%C?36Z2WJ12QW3.K';* 07Q&=OS8]>PY])HH X[
MP*=8BGU:SU"^;5+&WDC%CJ<D6R2=2I+*Q'W]G W=\GT(%3Q!>SGQM+I\]C>Q
MVTFFCR+BRM69[N3<V8FF4915X.,KU))Q7>44 >-6?GCX=?#RW:POTFL]7M6N
M$:TD#1JF_<Q&,A1D<]*ZZW+'XSW<_DS^0VB10+,86$9D$SL5W8QG!!ZUV]%
M'#?%218?#^E2NK,J:U9,512Q($HX ')/M27$4>J?$BRU^U5_L6FZ9-'<7(C;
M$C.PVQCC+$88G&<9'<UN>*?#LGB2UL[=;T6JVUW%=@^3O+-&VY1]X<9Z_P!*
MW5W!1N(+8Y(& 3]* /-?"B2V_P !?L<MK<Q74>G7$+6[P.)-YWX&W&23D=N]
M5+.*]TT?#O7);:Y;3['3#8WR"%B]J[Q(-[)C.-R[2<<5ZM10!Y7KFGS7;^/M
M<M89S:7^CK8VZK"VZZF$;_,JXR0-RJ#CGGTKOO##!O"ND@(Z%;2)"CH492$
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MTV2"]AO6@:X@@E@*M<(.NSU(X^4X(SR*X76='U35]1^(UO8V=RLMY'8O9M-
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M6\-E(192 12 9^<D?*.P)QG![#-<EX1-O-8Z5H6I^"KM-;TUHDDEGM<VZ&/
M\]93\IX&1CG)P..:W_ *S1:AXL$UI=P?:-9EN(6GMWC$D91 &4L!GE30!U.I
M:I::3;I-=R%1)(L4:*I9I';A54#DD_XGH*H0>*]-EDOX)!<07=A&);BUDA8R
MJAZ.JKG>ONN:Q_'MG?\ VOPYK5G;S74.DZAYUU;PJ6<Q,I0NJCEBN<X'/)JI
M<VK:GXXN/$EM#<BQMM$>S+FW=6GD=]P54(W,% ].K =C@ TK;XC^';JR>^66
M[2R2T^UFZDM7$13<%P&Q@MD@;1SDXZ@UJ6>O66JZA=Z.R75K?10K+)!*#&_E
MOD!U93TR".#D$=JXO3I-6TSX%V<=IH\\NI6UM'%)9SVC%UPX#D1L/F*C+ ="
M1WJ31#)'\4)-12QUM[&XT1$%W=V\F6=969LAA\G&/EPOLN",@&M\++B>Y^'M
MA+<W$UQ,9KD-+,Y=VQ/(!DGD\"MV^U^UL[R2S2*YN[J*(32PVL>]HT.0"?K@
MX'4X. <5@_"R&XM? =I:W5K<VUQ'-<%XKB%HV :9V'# =00:KV9N?#?Q'\17
M.H6]T^GZQ';S6MS# \JJT:;&B;8"0>X['GO0!KW'COP];Z7IFI&\>2SU*98;
M:6*%V5G)(P2!\IX/!P>#Q6II&L0:UIWVVWANHDWNACN8&BD!4D'Y6P>U>7OH
M=_I>@:'OL+QFF\6C56MXK=Y#;6Y=R-P4';@%21ZD^E>O@Y (S@^HQ0!S+^/=
M%30K[67^UBRL+AK:Z8VS;HI%(# KUX)'..]:EQKEM;7%M!)%=>9<0/.HCA9R
M$3&[(7)R-RC'?(Q7'7_A>\N/&6KZ2(7_ .$>U^!+J\D4X\N1!L=![O\ NB?4
M!JO> [75K30WN/$$;B[LX_[.C(4L7BA9@)  ,DN>>.H530!(GC_P]K.E3/$V
MIFRELI9FNHK.8 1J=K891PPSGCD>U0R^+[;1M.\(6VG6U_>6NJB-(IY%+OY7
ME%AN).6<@#]2>V:'A&"YM?@@;&>QO8KR.RN(FMGM9!)N8O@!<9.<CIZU3:WO
M+;PS\-KIM-U!AIDD*7D26DC2PG[.R$E -V W&<4 =7IWBXW_ (UU/0A874<=
ME#"WFO$1EGWDD^BX4 $]3FK'_"9:2+NPB<W$<.H2>59W3Q$0SOC(56]\'&0
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MTNG,\,MK+"8Y(I0. X/1>0<^G3GBM4^*+6-;"%X+IKZ]1GBM%BQ(P0 LV"0
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M%:)YC>5V?TP>W.3@XS@U!;^+='O-)L-1L[@W46H$K:)$A,DK#.5"GD$8.<X
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MKD/#8_X32^U:XU&/4[>YLM:E%M<Q2>7Y*1%5$/!/!YW+C!R><T >DT5R^O\
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M-G:A;U..V1G@D'-+I_C![OQ=KVESV$]O::4D6Z=PN!N5W9VYX4@+CC/!SC-
M&EX>\/?V'%(T^I7FIWDH57N[Q@7*+G:HP  !N8_4FMJN=T[QEIVHWNFVRPW4
M(U2!KBPEF0!+E% 8E<$D?*0<, <&L^R\2^'M-M/$^K0_VEY5G>,;_P R.1BL
M@12=B'E5QCL!^% '945S=CXVTN^U>QTY8;V)[^%I;2::W*1S[5#,%;N0#GT/
M8FEU#QKI>F)]IN([D:<MQ]FDU!4!@CDW;<$YW8#?*6 *@\9H GO/#AOO$$>H
MW&JWS6D80C3=RB R(=RN1C)(.#C/4#Z5N5SVMZ[:B/4M/BAOKF2VM]]T;(X:
MW# D98,IW8&<+EL=N1FI\,II;CX:Z!--(\DKVH+.[$ECD\DGK0!UE%>9:9XC
MA\-^)/'+W2:G>P6UW$^V)7N##'Y"LS$L?E4$DXSZX'%=Q)X@L_)LWM%EOI+V
M'[1;PVX&Z2/ ._YB !\R\DCD@=: -6BN3;XB^'TTRUOV>Z$=Q>_V>4^SL6AG
MS@I(/X2/3OVS5VV\5VUW;Q-%I^I"ZF>18[*6#RIF$9 9L.0 O(^8D#D#J<4
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MOY('N1;6X4L(E(!8EB!C+ =<G/ JO%XPTB?0M.U>"5Y8-2D6*T14Q)+(Q(V
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M1U*(RV<TUN4BFPNXJK=R!SZ''!-:7B#7K+PUHMQJVH";[- ,OY,1=OR'3ZG
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MEQ#((S:+'&C;00QP6)8G@YS[# !Z51110 4444 %%%% !1110 4444 %%%%
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M-G/Z=:UK]6T;QUJUYJ7A2[UK2]96&6VGMK$3O ZQA&C=6Y4' /.!S]<>FT4
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MN)Y'4@*%3)"#U;J3[<@'0V?C:RO86E73]3BC80_9GFM]JW;2@E5B.<,>#GH
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MAMYI(F59/+B*O@D=CZ]>V: +WB&]TB'Q#X=MM1@NWNY;IOL3Q;A&DFQL[R"
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MDQOED;JS8 &> . !@"N(U7XG2'P9>:WI.@:FT8L/M4%U.B)""3MP3NR2I.<
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M@JI3?N&YP#\O;.3V% '845R<7CZPFGT<BPU!=/U=DCM+]XU6)I&4LJ$;MXR
M1G;C/?O6SXBU271/#NH:I#:-=/:6[S")6"[MH).23TX^OH#0!IT5Y7KVIS:A
MH_P^UJ^M;F.Y?5+4N!AC*&A9B55&(P3C .#QT%=;:^.+"2'76OK.]TZ71$$M
MW#<*I81LI9678S @A3T/44 =/17.V?BV.ZU4:8^FWL%Y)8_;X(Y#&?.CR 0"
M&(# D<$CKUJ'P'XDO/%'A\:C>6,ELSSS!260J565U"C!R2H4 D@9/2@#J**Y
M.Y\37R?$>#PXFF3/:-IKW+2H\>6/F1H&Y8$*N6SW)/ XS7*>&O$T'A+3O%<\
MNG:A<V5MXANO/F@4,MO'E "2S MCT7) '..* /5Z*R+W7H[>Y-I9VD^H70@%
MPT4#(-L9)"DEV ^8A@!WP:?X>U^Q\3Z);ZMIS.;><' D7:R,"0RL.Q!!% &I
M17G%VP\2_$?5="U?1I[G38M.B1(W:+;$7=]TP^?()"K@CYAMZ"M>+QEI>DZ!
M:WBV]^^@0LMJ-3=E=< ^6)&RV\KN&-^.>O0YH ["BN4U/QU;Z?K=SI$6CZK?
M7L%JMWY=I"K>9&6VY7+#/(/I[9J35?&]GI5G=W[65Y/I]E)Y5W<PA"(FR WR
ME@S;21NV@XYZX. #IZ*PI_%-K_:#V-A;SZC<QVBWCI;E<"-L[>6(!+8.![<X
MXJK8^.M+U'0[+5+:"[9+^8064+(HDN'P3\HW8P,-DDC&TT =/16#9^*+:[O]
M0TR6SNK?4K*(3/9N%+R1MT="&(8$\=>#P<5A:5XO\/:)X(\/W>FZ9?Q:3?W"
MVMK$J>8T9>0@;OF)ZY/&3VH [NBN>TOQ=;7^I:EI]U97>FW-A$MQ(EX$&Z%L
MXD!5F&/E.>XJFWC^R2#2;DZ;J+6NKMML941#YI(RH(W97<H)&>WH>* .MHJ"
M]O;?3K&>]NY5AMH(VDED;HJ@9)KSOQ)J3:CXN\"W!TR^M5EOV:.29EPR>4YP
M5#':W(.",_D0 #TNBN;O?&5K:P:C=PV-Y>66FR-'>7%N$*QE1E\ L&;;GYL#
MUQD@BKDOB.T868T]'U"6\@-S D#*-T7'SDL0 /F4#N<].#@ V**Y>P\=Z9J=
MG:R6D-PUU<W<ED+-]J2)-&"SJV6VC &>"<Y&,UMZ7J']IV9G-K/:LLKQ-%.%
MW HQ4_=)&#C((/((H IZ]X<A\0-:^?J&I6T4!;?#9W)B2X5@ 5DQRPX]NIK7
M1$BC6.-0J* JJHP !V%<O<^.(8M6U;2[;1=5O+S3$CDECAC0!U<,05+,!C"]
M\$YX!YJU#XQTV[TK2+ZS6:X;5QFSMT $C_*6;.2 -H!R2<?4D9 .@HKD[OQQ
M%%I6OR1:=<?VIHL)EGL)F16V[2RN&#$%" 3D$G@C&>*U?"^I76K>&=.OKRWD
MAGFMXW??L^<E 2PVDX!)/!P?84 :]%<KJ?CRPTQ=3G>SO);+2[A+>]N8PNV)
MVV]BP9@-ZY('?C-/U+QK;Z?K\VAQ:3J=YJ$=J+I8K>)2)$+;>"6 '(/)P..Y
M(! .GHKC5^)>BMX;M]<%O?F"6\%C+%Y(\RWF+!2LBYXP2.F:M:9XRL]7U^X\
M/7.G:CIM]Y!FCCO(PGGQ9P60JQ_+@C\#@ ZBBO+O"'B.W\)?#/\ M"ZM+RXM
M4U.ZB=X-K&(&X=0S;F'&2!GGWKT&;5EAU>RTW[+.\MU$\V]-FV-4V@EOFSU=
M1P#UH T**Y?QMXCO/#MKIC6=D]PUYJ-O:LRL@V!W&1AB,DC('89R2,<WIO$2
MK>C3[?3[JYU!;<7,UM&T8,*$D+N8MMR2"  3T/;F@#:HK,T'7K'Q'I8O[%GV
M;VBDCE7;)%(IPR..S U!=^(DBU"ZL+*QN=0NK2)9;B.W*#RPV2JY=@"Q ) '
M;KC(R ;5%<E-\0]'32M'U*"*\N;;5;@6L+0Q9*2G/R."00V588&>16]H^I/J
MVG+=R:?>6#EF4V]X@61<$C) )&#C(.>E %^BO-?#KV>GV?Q#:[MY[BQBU.;S
MHHR6=H_(3<!D@],]ZVK?Q;I&CZ/X6@M=.OQ::K;QK8QQH'\M?*W*C'=G.T8[
M_7O0!V%%<A'X]69M3MH_#VL-J6FL/M%D$BWJC+N5]V_801T ;)YP#46J^(_#
MVJ:3X7U&YLKJ[M=1U"V:Q=!M\J=C\A?YAT^;(Y''>@#M**Y2Q\3WUW\0=5T)
MM,F6TLK>!A*'C/+E_G/S9P=H  R>#D#-2>-_$=YX<TZPELK)[A[J_@M2P90$
M#R 'AB,DC(';)R2,4 =/17G%W>/9?&"&[33KV:XF\/.?LD95G+>>O&2VQ>!U
MW <=<XKI-/\ &>G:CH%OJL4-RK3W#6B6CJHF\]6(,>,XR-K'.<8!.: .CHK#
MT;Q/;:OJNH:2UO/::C8;#-;S;22CC*NI4D$'ZY'<5S7Q&C']O>#"K.GGZPD,
MVQROF1[2=K8/(R!P: /0:*Y6X\:PP:OJ6C6FBZI=WFG11R-%!&@#HV<%2S 8
M^7O@GL#5B#QGIEWHFDZE:+//_:Q L[9% ED;!+#!.!M 8DDX&.O3(!T5%>;>
M&]2@LO'_ (^O[Z&:PAM[>RDF6=MVW"2DD8)!!ZC'KTSQ72KXP@CURVTB\TZ]
MM+J\A>:S$GEL)]@RRC:QPP'.#CZT =)17$+\3M.;1+76_P"R=572IIS!)=-$
MFV!O,,8W#=N(W#^$'&?7BM6S\70W.ORZ--I>H6ET+8W<'GH@%Q$"%)7#$@Y(
M^5L'GI0!T5%<1#\3=.FTNUU4:3JJZ;-=?99+IXD"P/YAC&\;LD%NZ@@9YYXK
M0>_TK_A8K6PTVZ;6X]):1;C("/!Y@^1<MC)<]P.G6@#IZ*XOPQXVEU+PY<ZO
MJMC-:HMY+!& 4;>?.,:1KALELX'( )/7%:$7C2P35KW3-2AFTRYM;,WS"X*%
M7MP2"X9&8<$8(Z_6@#I**YR/QA;+KFGZ7>6%Y92:DCM923[-LI49*G:Q*M@Y
MPP'Y\5!9Z?;^#V\2:[<W-PEA,3=O%),TNPKN9W4'[N[( 4=E'K@ '545EV&L
M/>7QM9=.N;5O)$Z/(R,CJ3C *L>1W^HZU5U_Q7:^'KW3;2XL[V>34)3% ;>,
M,-X4G:<D<G'^.!0!O45QD6NZ7J7BGPXU]H>IVFKSP7+6ANE">2HP) P#8)("
MXX/!'2K.H^/-/T^QU/4/LEW<:?IEQ]FN[F$*0D@P&PI8$A2P!('YX- '545Y
MOJ5^(OBIH>HQ6%[)+<:/<D6J@&1B'CP,%MJ\=R0/>K>L_$-U\"7.N:7IMR+B
M*[^PS0S[%:UE\P1G<-Q!(+#&,@Y&<#- '>T5AR^(_+O5L4TR[DOQ;?:I+57B
MWI'N*C^/!)(. ">G..*T[.\6]TVWO8XI%6>%95C8 , PR >V>: +-%<G+X_T
MZ+PKJ/B!K&_^S:=<R6US$%C\Q61MK'&_!&?0U8OO&,%GXC_L&/2]1NK\V9O(
MUAC3;(H8+@,6 !R>K8''7D9 .DHKFK/QOIEWX;CUD17,?F7!LUM'0>>;C?L\
MK&<;LCUQCDD#-<_97?\ Q>J[EN;2>QV>'B\@GD4J1YX^<$,1C P>GW?QH ]%
MHKF#XWLH[S2X[BRO(+;56V65TX39*Q&54@,64L.F0/?!J/2O'4&LZBUI::-J
MS".]EL9YC"OEP2(,DN=W /3C/;.,C(!U=%%% $)M83=BZ*9F5"BL23M!ZX'0
M9XSCK@>E3444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %<I\1M-OM4\'RPZ?;/=7$=S;SB%
M" SJDJ,P&2!G -=710!Q$L>H7/Q*T?5VTJ[BM(],GAE=E4^6[NK*IP3SA><9
M Z9KF9/#>NSZ!JDL&D&2[MO%$NL065T%"WD!)&W)R 2K'KT(KUVB@#F/"TK7
MDCW:^%3H40CV$3Q1I-(V0> A.$&._4D<#'.3XON3:?$SP/-Y$LRA-0#+"NY@
M/+CYQU./0<UWC,%4LQ  &23VK'U#PW;ZCXATW6I+N[2XTX2"W2,IL D #Y!4
MDY '?CMB@#C=1TSQ%#)XK\2:-9S)=:E):10P#:L[01<2. W <AFV@\@ <9XI
M++3]0MO&&KW\/AV_AL;W1DB1Y'5Y#(I?[_SDESD=SQU([>F44 >:_P!@:M=_
M 1O#XL98]5331;_9I, EUQP#G!SCCFKNNIJ6JW/@Z[CT:]C6TU 7%PCA2T,?
MELF6P2,Y;H"3C\J[VB@#S&&PU#P_XFUJVN?!O]N6NHWKWEG>Q)$=ADQNCE+D
M;0#WYX/2I/%'AZ6^FDG@T^^L-?L[1$T[4M)!5)6VY\IAG&P/_? &#UZUZ510
M!GBUNKSP\+2_D47<UIY4[QC@.4PQ'MDG%<?X)N_$NG:3I_A>^\/3Q7&GA;=]
M0+H;5X4X#*<[BQ4 !<=>3BN_W#=MR,XSBEH \YT>PU;P[H_B/P]+I=S>&YN+
MF;3YX@#'.DV2%=L_(02<[L<=,TW3O#=]H7B+P3;+;SW%MI.F3VMS=(N4$CA,
M8[XRI[<<5Z110!YK:Z=J<?ACX@6S:7=B?5+N[DLDV#,JR1!%/7CD'KC%/UC3
M]3N?A_X5LH=+NWN[.YL'N(0@S&(=I<]<'&.QY[5Z/10!QL5M>'XMRZG]AN18
M/HR6HN"N%\T2L^/7H>N,51L[+4(M5\?3OIMT(]1V&S.S_78@$9QSQ\P[XXYK
MT"B@#RYM*U4>"O %C_95V;G2[ZSEO(P@S$D2,KGK@\D=,YKO?$EG-J7A;5[&
MV4-/<V4T,:DXRS(0![<FM,,"2 02#@^U+0!YC-::O=>'O <)T.^BETN^MGND
M8*2B1PLC-PQXW'@=2!G%3W]MXDM_$7C?4-%L)1<W=A;)I\LBC9))&'#8R>OS
M<9X)]J]'HH \UTFPU$?$#1]83P_J4-J^ERVT\]Y*C2B0NC;I#O)Q@$#] !6S
M\-[/4=)\-MI&HZ=-:R6MS<?O792DH>9W!3!)(PPY('XUV-% '&ZC::C:_%.P
MUB'3I[JRDTF2Q:2(KB)S,CY?)!VX!Z9/M7-R:/J\G@+QWIXTJ[%WJ>I74UG$
M5&94DV[3G.!T/7&*]6HH \QO[#4=*\3V^N/X7DUO3K[3H+:X@6.-I[66/=@A
M7(!4AB#@]L^F>]T2.2/2XS+I\.GLY+BUB"XB!/ .W@MCKCC.>O4Z-% '$V]C
M>2?$O7;F6RNHK"[TZ&UCNMOREU+[L<Y'WN"1CBL*UT76O^%6S^ [C3)O[05&
MLH[D*#;O$7XFWYX 4YV_>R.E>IT4 <1IVF7=E\3VN!9W)TY-$AL4NF4;6D21
MFP><]".<8K&L-/U'P_K>K:;=>"QK,5Y?2W=CJ"+$4"RL6*3,W*[23S@\=!Z^
MGE@&"DC)Z#/6EH \TUB6]TKQS+<Z?I.IS2#2XK:YFTB.*0%MS$ QNPV%0,KU
MX;G@#-9-,SIGA>^\-:3J$:^&+QXKC3+M0EP4DC^=N3AGPX<8.#N./2NQN_!M
MI/K%QJEKJ.J:=<W14W(L[G:DQ4!064@C. !D8Z5M6-A!IUOY, <@G<[R.7=V
M[LS'DGIU] .@H Y>WT^:\\>S^*S:W$-K!I/V&))(]LLS&3S&.SJ , #.,DGL
M,GE+/1-9@^&W@W3'TB[^VZ?JT$]U"%!,<:2LS-G.#P1T.?UKURB@#A9;68?$
M/6M3NK"7^RI=$2W,TN$C=E9V922>!M;J>.M<OH=U]BTOP^NN^'?$Z6>CXGA+
M6\3P6YVD!F96WLJ*QP<9QR037K.HZ?:ZMIMSI][$);6YC:*6,DC<I&",CD5B
MV/@^VL]B2ZKJ][;IC9;7=V7C&.@/ +#V8D4 .\=Z'<^)? ^K:19N$N;F#$18
MX!8$, 3V!QC\:Y:^N==UZ[\'W#>%]2@FT^^\R]5_+"I^Z925)?YER<Y]/?BO
M2J* /.='L-6\.Z7XC\/S:7<WGVFYN9]/GB :.99LD*[9^0@DYW8&.F:SI?"N
MH^$9O#EVFBCQ%9VFE#3;VWC56D1@V\2QJ_7DL,<<8KU9F"C+$ >I-!(4$D@
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M9A=.MLR^=:S_ ,1VL1N5NN0<CTH WDT*PT35VUJ"065E#92QS6ZL5A7YD;S
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)%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>exhibit107-formofindemni008.jpg
<TEXT>
begin 644 exhibit107-formofindemni008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]S!<V2&&=)X&CVOO;(&X#/X9ZB@#2_X2^ ^.G\-"UN@T=J)VE^S2%2S/M7!
MP%X;+'C/&>#5F?Q?HELV9KIU@\_[,;KR7\A9<[=IDQM'/&<XSQG/%8-P9+3X
MPRR/#<K'>Z)';P31P,Z>8)G)!8# P&!YQQ7,V4<Q^#E[X*O+27_A((HY;,6I
MC),KM(2DJG&"G(8OT&#F@#U]B0I(&3C@>M>5^'-8N/%_AZ^6#Q'>V/C.(2B:
MS9PH@D!.$$+#:4Z#=C/J<UZ7I]O)9:3:VTLGFRP0)&TA_C95 )_'%>6>*8=
M\7^%X]8>SNM/\8I;"2U$$$D5V+C;\J@8RZ[N,\@ YR* /2SKEA#K,&BRS.NH
MRPM,D1B?#JN-Q#8VG&1QG/-9&J^)= O_  IK%P^KW=G9VSO:75U;QR136\@
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M^G+/*EQ=1M);":"2-;A1R3&S !L#GCMSTK1OK^UTVT:YO)A%$I"Y())8G 4
M<DDD  <DFN"\,ZEHOB*[TL_V'JBZU9'=*M\LX6Q;;AB&<[>>@ Y.1D  XTOB
M.E_%IVCZK96DUY'I6J17ES;PKN=X@&5BH[D;@<>WM0!LP^+=%E74B]Y]G;3$
M$EXES&T30J1D,0P!P1T(J2Q\3:7J%\]C%++'=);BZ\JX@>(F$G <;@,C/'MW
MQ7,:OXAM=4\*:YK&A>'3J1^R!6-U8LGVHY^YL90TBH"Q/;L#UQCVEU$WQ#@U
M%8]4U"TN/#TT/G3VDD:ROYBL5 V@(-H] /J: /0;'Q'IVH74%O;M.6N(C/ S
MV\B)+&,996( (^9>_<'I4 \7:*;ZTM3<NIO',=M,\#K#,X_A20C:3P<<\]LU
MPNA6=_:7UOI.@:K/?Z%>6$ZK#>QGS](;9\B[\;@"2%"-R,<9P33?"5QI5_IV
MC:#J>@:H=?TMH5>VN5G,,+Q87SPY)C"@ D8]<#K0!ZE=W=O86DMW=S)#;PJ7
MDD<X55'4DUGVGB33+S4ETY9)HKQXC-'#<6[PM(@ZLN\#=CN!R.^*Q_B7IVHZ
MGX'NHM+B:>XBEAN/LZ]9ECD5R@]20.G?&*H:D\7BWQ3X1O=(,C+832W5S,8V
M4PH8]OEMD<,Q(&WK@$]J *T&HOXS\2>(=,&H:SIQLY88["6VBGA\H^6'9I 5
M"Y))&).H P.<GM]0U>RTDVL=W,QFN7,<$2(7DE8 L<*HSP 23T%<KX-F1O&W
MC-L.JW%Y"\+,A42JL*J2I/W@"".*L>--2>PUKPZKVLBVLLTPEU&&T,\MJ=F%
M5,*VTODKG!X!'?( -"7QOX?@T1M8EOBEFDYMI&:%PT<H;:49<94YXY ZU+9^
M+]%O]0NK"WN)FN;:'[0T9MI09(LXWQY7]XN>,KFO*KI9!\._&.GBRU 3R>(O
M.BCFMY"[H9XF!R1ECM4D]<8YZBNXN)DD^,6EW$>YH3HTT1E524W-(C*I;ID@
M$XH WK7Q=HE[X<D\06]U))I:;MTXMI<_*<'"[=QP>.!VK91Q)&L@R%8!AN4J
M<>X/(_&O.[71[VQ\=WGAV*+.@7DR:WG/$3!OGBQZ-*(WQTQN%=CXFL[O4/"N
MKV=@VV\N+.:* YQAV0A>>W)ZT <?XS\4Q3CPVVDZA?1K/K=K#YD,;I#<H9,.
MN_&&''8X(SC(S726NH:4WB[5535KMKNWM8S<VDC,(($!;#@$ 9/.2"> *\]N
MM;BO_!'@^PCL-0CO],U/3TO+3[%*6@\H@-T7IP2,=1^-;[2Q?\+'\432VLL]
ML^B1)L\M@)BOF%HP<?>P1QUYH ZN#Q1I<[A0]PFZW:Z1I+61 \2E064E<'[Z
M\#GD<5FP_$GPG<36,<>J9%\P2WE,$@C9CT4N5VJQ]"0>GJ*Y_P *Q7FEZ];:
M?I>J3:OX=DLI6"W<?[_3"-NV,O@'#=-C<C;[5SNF1P>(O@)I7ARQ7S-4N/*2
M*((0T1$^XRGT4*"=W0].IQ0!ZQ%XCTN:[U*UCFE:XTQ4:[B%O)N0,"5(&WYL
M@'[N:QM2^(&FV\6@3627%Y;ZS.$AGBMI&4)@DG 7);Y>%QGOC K)6[&B_$GQ
M0+N"Z)U.RM39&*W=Q,41U8 @8!!(SDC .>E<[IGG6W@3X;W4UE>K'I]^HNA]
MDD+1@QR*#MVY(R1R!CF@#TW4O%&EZ5'*]U)/MAC$TYBMI)/(0\[I-JG;P">>
M< GM6G#=07-G'=P2":WDC$B21_,'4C((QUR/2O,)KVTT;Q?K]MXDT_5VL]8D
M2YLYK=)W253$D;0LL?1AMQ@CH?I7HVBVT5GHMG;P67V&&.(!+7.?*7LI]Q0!
MGOXUT!- EUQKV0:=%*89)OLTOR.&VD,NW</FXR1BG7WC#1-.U672Y[F0W\<'
MGFWBMY)'9,X^4*IW'/89/!]#7EFI320_#'Q;X=^Q7SZHNIS2>0EJYRC7(96#
M8P001C!R?2NTCN8I/C&+S;*EN?#WE^;)$R /Y^[82P&&V\X/.* .DM_%.C77
MA^+7(;U6T^4A4DV-N9MVW8$QN+;N-N,YXQ7-Z3K,M[\7-0M$N[[[)'HZ2M:W
M*M&L<AE()"D#^';SS]>M<;:"]M/#6CZFMG=36FE^);BZO+=(6\P0N\FV4)C)
M #9X]?:MZXG_ .$A^(.JMI:W7EWOA<VT%V;:1(_,,CX^8J .O4^AH [1/%VB
MO?6EI]I=&O,_99'@=8IR!DA'(VMQR,'D=,U!:>._#M]J,=A;7KR7$ER]H%%O
M)@2J,E6.W"]^N,X..AKC_"EYI&J6NC:7?:#J@U[3&B\V"[6?RK5X\ S!V)0#
M )7')R!WK;^'#*'\4@HZ-+KUU.F^,KOC;;M<9'(.#R* .NU#4;32[87%Y+Y:
M%UC7"EF=F. JJ,EB3T &:HP>*-)G%\/M#QRV"A[F&6%TDC4C(;81D@]B 0:P
MO'\-Y#>>&M9AAEN+/3-1$MY%$A=EC9"GF;1R=N[/'.#5*ZC34O'ESXCLV)TV
MWT)[26X53MFD9]RHO][ !)QG!8#K0!TFB^,M"\0W26VEW;SN]M]J4^0ZJT>0
M,AB ,Y(XSD4FI7FFKXNT2TGU2\@OV$[6]G$6$5R-GS>9Q@[0,C)&"?>J/PQ'
ME_#?0X&C>.6&V6.6-T*LCCJ"#R#57Q.W_%S/!3[7*0F\\UPA*Q[X@J[B.!D\
M#/6@"]/\1/#%O%=R/?2LEG,8;DQVLK^2P )+X7Y5Y'S'CWKIXY$EC62-@R.
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M_O/YC>X*T 4QXPTSP_X*T>[T^ZU+6;:]O%MH+NX225VW3;69SM!X^8*,9.
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M 9%R=N#UW<9SD>J4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MKO4;B"UU0A3LEN3;Q>4ARV =B D]<=_0T >EUS[>%I68G_A)-=&3G N$P/\
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MX?-S90M/<QB]B\RVE>UD$<WR[MJ-C#-CL,G/'7B@";_A%9?^AEU[_P "$_\
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MVE26MQ=6"HR3/&D11U"G!W#=G'M7;Z;I,MI+]IOM0FU"\V&,32(B!%)!(55
M !(!.<DX'/ K4H \MU6RMO%7A;6;GPOH%S!>/;Q@3WD+PR3E)%D\E=_)&%()
MZ9( )YQJ^'=2T76+^VU&W\,ZC:WEG&YGFOK:16M<KAD0M]YB>,+VR3C@'O:*
M /&(+>[3X'Z'8-I]^+V*_A9[?[')YB!;K>25VY V\YKI-7MY]1^)L@MX[E([
MCPU-:)=>0XC65Y 5!;& <<UZ'10!Y7X2EL;NRTC1=2\):@NN::T2R?:8',$3
M1X'GK(?EZ E<<DG XYJ#RYV\#?$FW%C?>=>ZA>/;1FTDW3*\:*I4;>02#T]*
M];HH \XW36OC'P?J+6-\]L='EM2T=J[%)3Y9"N,?)]T\M@<=:Z_1_$=IK5_J
M=E#;WD$^GS>5*MS"8]XRP#IG[R$JV#[5L57M[.&WFGF0$RSMF21CDG'0>P'8
M#W[DT <AXC\ZT^)7AG439W<UJ+6[MV>W@:0+(WEE0VT?+G!Y.!QR:PE68Z+\
M3H_L5[OO9)S:J;23,X:W"#9\OS988XKU2B@#R-WDT6_\.:SJ6DZE=:1+H4-A
M-]GAD,EI.AW9=!AL')'3J*]!\+P6<.E/)8:2VF6T\S3)"Z;)'SC+NIY5B1G!
MYQC.#D#;HH \_G9Q\<K:[^S79M5T1K4W MI#&)3-NV[\8S@9ZUA/%</X ^(U
ML+&^\^\U*\>VC^R2;IE=5"%1MY!(/(KUVB@#S*VNY]!\=V>KWUG?/I6H:+#:
M1SQVLDAMY48DHZ %ESGTZUABUU23P_JE[;Z/J$WV+Q=-J;V;0/&]S;$E3Y>0
M-Q^8G [K7M-% 'FEW+I6K^%?$FH:-X>OXI9M(GM?M%Q:2+-,[(=L2J<LP!ZG
MH#C!/.&7?FFW^&V+2\)M)(VN,6LA,(%NR'?\OR_,0.:].HH \NOQ,=8^)Q%G
M>E;S388K8BUD(G=8)%(0[?F.Y@./6EE$OV7X9@6=YFS:,W(%K)F "W*'?\OR
M_,<<UZA10!YM;VUS=:S\2XXK2ZS?0QK:L\#HLQ%ML.TD 'YN.*S)VO!X,\#Z
MJFC:E=6^B(D.H60@>.;!@\MF5#AFV'TX//;)KURB@#RO6K*+6/#5YJ_ACP[<
MJ\=U:73K/$\,VH"%]Q3#?,0%Z$]3P.E=#X6N=&UG5!J>F^'[VUFC@,<MW?V[
MQ.F2#Y2[^6YR3C@8]Z[.B@#B?&XD/B/P>R6]Q*L&I&69HH'<1IY3KEBH( R1
MUJ'29#;_ !%\:W,MO=+;S6]F(I3;2;9"B.'"G;AB"1TKO** /'_#UU?:7X3\
M"V5SIE_! J3Q7ES'I[O<6S@?*@&TL@?."P'0<$=:U_!NB)JOAGQ9H&IV%];P
MW6J79_TJ-@2DARC!F^\1UR">1UKTFLK7=*N]6M88;/6;O2GCF$C2VRH6=0""
MIW C!S^@H Y[X?)JUW:/?Z\%-[:*=+C<-N$@A<J\H/J[#G_<%.\?6M\MSX<U
MFUMYKJWTK41-=00H7?RV4H7"CEBN[.!SR:ZRPLH--L(+.V4B&% B[CDGW)[D
M]2>YJQ0!P%S!_:?CJ;Q):I/]@M=$DM7E$+@SR.^X(HQEL $G ZD#KG'.PPW,
M?PV^'ULUA?"XL]5LWN(OLDF^%48[V8;<@#/6O8:* .)T??\ \+9\0S&WN5@F
ML;6..9H'$;LA<L Q&"1N'>J&AZ+>V'C6]\/!%/A^UG&LV^#]QI-P$..RB0/(
M/]T5WM];R7>GW%O#<R6LDL;(D\6-T9(P&&>,CK5+0=%.C6CK-?7&H7DQ#3W=
MQC?(0 !P    . /<\DDD 7Q);S7?A;5[:WC,DTUE-'&@ZLQ0@#\ZX(6K^(O!
M?@[0K:VN5O;&:RDNC-;O']D\A1O)+ 8;@J .N<],FO4:* .(\&ED\7^,WDM[
MF))[V.6*26W=%D01*I*D@ \@]*X^^@NYOA=X]M(]/OVN;O6+F2WA^R2;Y5>1
M2K*-N2" 3GVKV>B@#A=3D-Q\3_"MU#;W36Z6=VLDPMI-B%Q'M#'&%)VGK7&Q
M7>DII%YX=U%]5M=&75Y)_+.DS2,$2<OM$R94J77.0"0#CKS7M3J'1D)(##!(
M.#^=<KI?A#4=)MHM/@\5:@=+A79' T,/F*G9?-VYQVSU]Z .@FN8;C1Y+J%5
MNX)+<R(JG(E4KD ?4?SK@/"5I=Z3XBTVUT2[O[GP[/;R-+9:C"PDTL@#:JNP
M!&3\NP]@3SUKT>""*UMXK>!!'#$@1$7HJ@8 'X5)0!X@C74/PKL?#QTK5&U+
M3M5C-S$ME(0JB[+Y!QAP5((VY_*NXC9W^,QNA;70MFT%8!,UNX3S/.+[-Q&,
M[><5V]% '$?"_P ZT\+MI5U9W=O=6EW<B7SH&1?FG=EVL1AL@@Y7(JKXBN[J
M7Q;J&G3:??);R:8!:S6-LQ:\D.[*/,H^0*2,*64?,23SBO0:* /&X)CIWA#X
M>7TEEJ=O?:;NBS]@DDV#R2L@:(8<@] 1C&,\CK?AU2S7PSXNN]%AEU;7+MOM
M<]E=:=)$&!VH-L+C+JJC/4Y([9 KMM;\.3ZEJ=KJEAK%UIM];1/"KQJDD;QL
M5+!D<$=57D8/%7-,TJ2SD-Q>7\U_>%-GG2HJ!5SG:JJ  ">3U)P,G@8 .%T>
M8_\ "T;74T@UJ>SN-":'[9=VLB[I!,K'*D 1C Z84'L#D9PY(+IO@]?V0T_4
M/M3ZT95@^QR[RGVP2;MNW.-@SFO::* .!U&0M\5(+Q;*YGM1H$\)?[._EL[2
M(P0MMP"0#Q5'PE:7>D^(M,MM$NK^X\.SP2--8:C"V_2R%!55=@",D[=A[ GG
MK7IE% '$?"WSK3P@FE75G=V]U97%RLPG@9%RT\C#:2,-E6!RN1S1J)FL?B]8
MW\EG=R6L^C/:)+# TBB7SE;:Q PORY.3@5V]% 'CTT-S)\-_B#;+87QN+S5;
MR2VB^R2;IE<KL91MR0<'FKU]<?V+XO35=4TG4KS1]3TVWB2>U@E=K:6+?\CH
MOS '?GIU_&O4Z* ,CPU:VUIHD26>E_V7;,S/':E=K*"2<L.S'J1VSSS7'Z D
MO@#Q/X@M-0MKDZ/JMZVH6E]#"TJ([_?CDV@E""!@G@CO7H]% '+>(?M'BOPG
MK.G:2DJ"YL98HYY4:(/(PP%4, 2#SENG(QGG',WPF\6>#O#FCP65W;:I;W=H
MUS'+ Z?8_)(\QBQ&.@(7!^;(QWKT^B@#B/">\>/_ !I(]M<QQW-Q;/#+);NB
M2A855MK$ '# CBN3TF6/4?A/K^A06TUQJ%W=WT$$(A;YW>9MK9QC:I();.!M
M->PN&*,$(5\?*6&0#[CC-8GA7PZWAC2Y;#[9]J1[B2<,8MA!=BS#J<C)XH Y
M;1K:Y\'>.;TZFL\MAJ&FV<4%XD3.B20(4:-L [2V2PSP?K6%=Z/>:?X<25K*
M\(OO&"ZK';);.[PV_F@Y90"5^5=V#TW8ZU['10!Q7B349HO%^D0265XNFS6L
MI-[96C22F0E<0[E4M$I')(QD@<C!KB[*UOH/AOH\;Z5J2/I?B5+FYC:V=I!&
M+IV+ 8)?"D$E<]>IYKVFB@#A;N5[CXKZ#>):7BVXTNX1I&MG"HSLA56.,*2
M>#R.^*Y[3(+RS^%.J^";ZQNI-;C2YM8D\ABMT9&8I*KXV[<N"23Q@YQ7K=%
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M2XEC4.F<@2F-%&,[G. ,#N<#-:%MXLTR;4+VPN3+87=G;_:I8KM0A\G_ )Z
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M=O=VT:S&.ZMVB+Q$D!UW=5R,5#_PF>E+=V$4@N(X-1?R[*[>+$-P^,A5;KR
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MGMD#.$!QN.2 .>!SDX.,X-9?A0Z?=27>HZ?X>DTJ.<(K2W%KY$TY&>J]=H!
M!/J<<#)Y[Q*LFB_$%M7OM!N]7T>_L8[<O:6YG>VEC9R,H.=K!^H[T ;[>/\
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M2M1OM'U'3([1FM;9Y);:5'9ANCQN"D,>W6G^)_ML\?A355T:[C@MM8$\MM!
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MIRQ6EY)<ZBLCVML%0.Z)C<^2P4+R,9/.1BLS7?%'AS4_A[-JU\+]M)E<1RK
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M98W7AJSUVW@N9;6\>-(455\QB[!5XW>I'?COC!P ;U%07EY;Z?8S7MY,L%M
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MIEK)HU[JF@ZMX'EU=YKV:>RODM(Y89HY7+@2R-]P@L0<YX'&>,^K44 5)_\
M1M*<&/.R'&R",GMT51D_05Y9;Z=J,7PT\#6+Z7?_ &NPU6TENH1:N6B2.0L[
M'CH 1]>U>O44 >7O#)H7B[7(M4\'W.N6.JW N[2[MK-)RI9%5HI-V-@!7C)Q
MS6E#9W-M\2M$F_LJ2WM8=&DM7^S6[>1!(SHP0,!C "GGI]*[ZB@#R]H)-!\6
MZ[;ZKX.N=<L]4N?M5G=VUHD^-R*K12;L; "O!)QS6E]EN-%^(&FZI-I4L6G_
M -A&Q(T^V::."7S5?9MC!(4 <'&/I7?44 <1HOA(7VE>*4U6W:&#Q#=R2_9V
MQNCC*A%)'9SMW>V1W%/^'EOJLFF/?ZXZ27T8_LZ.1#D/% S)YGU=MS'U&VM_
M7=$.N6\$(U74M.\J42%["?RFD&"-K'!RIS^@J_:6D%C9PVEM&(X(4$<:#^%0
M, 4 9GBS0QXD\*ZCI.=LD\1\E_[DH^9&_!@I_"N#ET/Q1=MH/B<0O!KE\AL=
M2B!/^CVTB  ^Q1E$F/[SD5ZK10!Q?B!KZR\0:)8P:;?/H0MY(W;3D_>+(-H1
M&8$%(\#J",D#)P#7'/I>K#X+ZUHG]AZBE\;^3RH/)+&0&Y\S*XSD!>=W0]B:
M]EHH X[QSI][=Z=IFO:+;//JNDW*W-O"5*--&WRRQ'(R-RGT_A%4O%_A_48_
M"FD/96::I=:7?I?W5J0/]+R'\W /&29&8"N^HH \^ TW5]#U&Y7P%<6]I+"D
M%Q!/8K!=7"LZ[@JJ=V%&6R<9.,=,U:\$Z?J>E:OJ%G'>:C=^'5@C:T?4XF6:
M*0EMT8+@,R ;3DCC.!T-=O10!QWB.YU)/%^FV[:??SZ+):R;I-/3YS/N7".X
M(*)@9Z@$XR<"N+T_3M5M_ WAC3I=$U**>P\2+<3)]G+;8A<2.7&,\!67GOGC
M->RT4 <9817'_"V=4O3:72VDNEP0).T#A&=7=F&XC'1A5#PUH5WI_C/4-)^0
MZ#ITYU&R4'E))P1Y>.P3]ZP'^VI]*[C4K(ZCIMS9BZN+4S1E//MGV21Y[J>Q
MJ#1=&AT2Q-O'/<W,CMOFN;J3?+,^ -S-W. !] * ,WQ[HUYX@\#ZKIE@0+N:
M(&$$X#,K!@N??;C\:A\/^)K_ %PP^?X<U'37A0F[>]@V!6Q]V+G+Y/.0,8'J
M0*ZFB@#R?3SKVE>!I4M=)OQ*VOR2W*+:DSK:O,S&2)6'+8QC&2,YZBKFCVUW
M9^(O&LW]BZK%:7]G;M;23(TC2%8G4@G)8L2PXY(SSBO3** /)XK'4(_!GPZM
M6TR_\_3K^WDO(_LKDPJD;JQ/'JP^M='IRS0?%#Q#?RV=XMI+8VT<<WV:0J[1
MERP!QS]X?7MFNUHH X_X76MU8?#[3K*]M9[6Z@,HDBGC*,,RNPZ]>".E5]/2
M\TKXD>*;B?3;U[74(;22&YBB+QXCC96!(YW9(&T DYZ8KN** /'K;3=2B^$W
MA337TO4!>V>IV\L\'V5RT:).79CQTVG/O6BT+Z'XLUR'5/!UUK=CJMP+NSN[
M>S2<C<BJT4F[&P KQGCFO4** *NFP&VTRVA-M!:E(U!@@ $<?'W5QV'2K5%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY3 )O.26!!V\XQSVS7+>)4UO5K_Q)82Z/J%U93Z:%TGR<)$6:)MYER0=X<C
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M*\]NDDEO+;NW6*4J67Z[21^1-<X/'>FM);.+:\^Q7.H'38KW:OEF?<5QC=N
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MV2L_*;23SSQT'3/IMM&8;6&-EC5D15(B7:@P/X1V'I0!+1110 4444 %%%%
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MZS%$9BKXQN7(P3D?6@#LJ*YF\\9);^(;K0K?1]2N]0@MEN0D2QA9$9BH(9F
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M>,A J(<-ALEB6)X! SC/%;&IZW!IUY9V*Q27%]>;_(MXL D*,LQ)( 49'/N
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MC=N#?WOE(QU]N:@\<>(KWPYIEE-96;7#W-]!;%@RC8'D /#$9)&0.V3DD8Y
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M& 37K5% '":)9:II5]XRMYM*N&BO;V6\M[A&0I(KQ(H4#=G=E3U  ]:Q-/\
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MGO+:*UN+6;9*B&(N4*LVXCY?E.<9/L: .BUC5K30M)N-2OG*6\"[F*C)))P
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M9D(R Q'.WC!)]<59\"V&J:1X0N[2_P!+GAN1=7,J1&2-C(LDC.N"'(Z,.I%
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MB01LG/SX)RV<*3Q[\4 ;5UXIVR:FNG:;/J*Z6=MV875</M#%$!/SN%()' Y
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MJ30VS7:Z8,WFR9$9?E#E4#$;V"D'''4#.>*A_P"$^MKC4[*QT[2[Z^>^T_\
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M@"W17-67BN6774T>\TMX+N:P-_ L<P?<@8*4.0NUP2..GO6/!\3/.T.RUMM
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MIHGAE#2!7MR)/+<<=3G(R/K6W&=/TGQ!;BTT.&'Q#J-L4,,4VU!!$1\SD#
M+  A2>0.@. #JX((K:".""-8XHU"HBC 4#H!4E<9=?$.WL]#UV\FTRY^VZ&X
M2]LE=-R9&5<,2 48<@]?:K:^+YD3-WHEU:M<3Q0:<KR(3>,ZEL@ _(% ).[H
M!Z\4 =117,'Q@ME'K']L:=/8MIAB#.#OBN/,^YY4A"AB20I!Q@]?6H+3Q]8M
MKTND7XM[>1;1KU)X;I9XFC7[X+ #:P')&,8Z&@#K))8X@#(ZH&8*"QQDDX ^
MII68*I9B  ,DGM7EWC'4Y-:B\%:D=(\JUGUZRDM;EW!E5&;(W+CY0PYX)[9P
M:[+QS!#<> O$"31)(HTZX8!U! (C8@_4'F@#>1UD171@R, 593D$>HIU>=>'
M_&DFDZ5X4L=1T2\MM/OK:VM+;46="C3&,;0R [E#8X)_(5T6D^*_[1O==L[B
MR^Q3Z.P$RS3 A@5W*X('"$#K]>.* .CHJEI%]+J6D6M]-:M:O<1K+Y+MED!&
M0#[XZBN>N?'(M3'<2Z7,FG/J@TL3.^V3S"VS?Y9'*;N,YSWQ0!UU%<E<>,[K
M^W-8T>Q\/7=U=Z;%%*09HT617#$$$DX^[QW.>@P349\?P/I?AS5(-/E>PUN1
M(4F>0*+>1^BN/J",C/(]Q0!V-%9T6IO-X@N=,2VREO DKSA^ 7+ )C'7Y2?H
M1ZU'J.M"TU*UTNV@^TZC=(\J1%]BK&F SNV#@991P"23TZD &K67KGA[3_$-
MM##?I+N@D$L$T,K121/@C<KJ00<$UEQ>-(SIL4MQIEW;7\M^=.BLI1@R3 GE
M6. 8\ MO] >,\5+;^*7;6;W0[JP^SZM;VPNXHO.W1W$6<;D? /!X(*C!QVYH
M NZ7X?M-+D\X3WMW. 5$U[=/,R@]0NXX7/? &>]:U<A'X]@E\-^']<33Y?LV
ML74-JJF0;XFD?:I(Z$9ZX-$OC:[;Q!JFC6/AN^N[C3FM_-*S1*"DN?G!+8X
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MLWSD8_V<8_'/.!U] !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]J\[.[?C[O'U_.O5Z* .)\?:7=WBZ)J>E3BSUN"[6"!G&24F&V52!P<+\_\
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M[R*<2\85E4J5QQRWJ:P[GXB_9?#&H:RVC2O]@U)M.FBCF!&X2+'N!QD@EA@
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M<13+*#D?-@CU'I4LNB:WXAT30M'UC3Q:FPN8)KRY$R/',(>1Y8!W?,0/O!<
MGKQD EN/'U^O_"0BT\-33'0W_P!(WW:)N0)O)'!YP>!S[D<5UVF7\.JZ59ZC
M;[O)NX$GCW#!VLH89_ UQ<6AZRC>.R=.;_B<Y-G^^C^;]R(OF^;CD9^GOQ6M
MX?37-*T?POI3:4ABBLQ;ZA,UPH,#1Q@*5 SO#,#Z8[T =11110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%9-SX:TJ\U?^T[BW=[DJB-F=_+<(VY-T>=K8/()'!K6HH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
4H **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>exhibit107-formofindemni009.jpg
<TEXT>
begin 644 exhibit107-formofindemni009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*7"_*!NPP8^IXZUG^'[J'Q'I>G:GX:\4WMVZ3PM?PS3*Q==PWJZ$?NSC)^7
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MLO[*BA262U:2/S Y)4':1D T ;]ZLD'A/Q#>66N7=TD<$TEM,906AEC1@P#
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MMDMT+M*F =P [8(Y.!R.Y%.T77+#Q!8&\TZ8R1K(T4BLA1XY%.&1E/*L#V-
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M6[U34FU"Z1"D;"%8DC!QG"C)R<#DD].,9.=>B@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "J]]!-<V%Q!;W3VL\D;)'<(H8Q,1@, >#CKS5BB
M@#)T'1I-(MI/M>H3:C?SD-<7DR*C2$#  50 J@=AZD]2:UJ** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<_\ @%!_\370T4 <]_8FO?\ 0V7/_@%!_P#$T?V)KW_0V7/_ (!0?_$UT-%
M'/?V)KW_ $-ES_X!0?\ Q-']B:]_T-ES_P" 4'_Q-=#10!SW]B:]_P!#9<_^
M 4'_ ,31_8FO?]#9<_\ @%!_\370T4 <]_8FO?\ 0V7/_@%!_P#$T?V)KW_0
MV7/_ (!0?_$UT-% '/?V)KW_ $-ES_X!0?\ Q-']B:]_T-ES_P" 4'_Q-=#1
M0!SW]B:]_P!#9<_^ 4'_ ,31_8FO?]#9<_\ @%!_\370T4 <]_8FO?\ 0V7/
M_@%!_P#$T?V)KW_0V7/_ (!0?_$UT-% '/?V)KW_ $-ES_X!0?\ Q-']B:]_
MT-ES_P" 4'_Q-=#10!SW]B:]_P!#9<_^ 4'_ ,31_8FO?]#9<_\ @%!_\370
MT4 <]_8FO?\ 0V7/_@%!_P#$T?V)KW_0V7/_ (!0?_$UT-% '/?V)KW_ $-E
MS_X!0?\ Q-']B:]_T-ES_P" 4'_Q-=#10!SW]B:]_P!#9<_^ 4'_ ,31_8FO
M?]#9<_\ @%!_\370T4 <]_8FO?\ 0V7/_@%!_P#$T?V)KW_0V7/_ (!0?_$U
MT-% '/?V)KW_ $-ES_X!0?\ Q-']B:]_T-ES_P" 4'_Q-=#10!#:1306L<4]
MPUS*HPTS*%+GUP.!^%3444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#//?O6B !G  SUI0 .E !116+>:-J=S=R30>)]1M(V.5@B@MF5/8%HB?S)H
MVJ*Y[_A']8_Z'+5O_ >T_P#C-'_"/ZQ_T.6K?^ ]I_\ &: .AHKGO^$?UC_H
M<M6_\![3_P",T?\ "/ZQ_P!#EJW_ (#VG_QF@#H:*Y[_ (1_6/\ H<M6_P#
M>T_^,T?\(_K'_0Y:M_X#VG_QF@#H:*Y[_A']8_Z'+5O_  'M/_C-'_"/ZQ_T
M.6K?^ ]I_P#&: .AHKGO^$?UC_H<M6_\![3_ .,T?\(_K'_0Y:M_X#VG_P 9
MH Z&BN>_X1_6/^ARU;_P'M/_ (S1_P (_K'_ $.6K?\ @/:?_&: .AHKGO\
MA']8_P"ARU;_ ,![3_XS1_PC^L?]#EJW_@/:?_&: .AHKGO^$?UC_H<M6_\
M >T_^,T?\(_K'_0Y:M_X#VG_ ,9H Z&BN>_X1_6/^ARU;_P'M/\ XS1_PC^L
M?]#EJW_@/:?_ !F@#H:*Y[_A']8_Z'+5O_ >T_\ C-'_  C^L?\ 0Y:M_P"
M]I_\9H Z&BN>_P"$?UC_ *'+5O\ P'M/_C-'_"/ZQ_T.6K?^ ]I_\9H Z&BN
M>_X1_6/^ARU;_P ![3_XS1_PC^L?]#EJW_@/:?\ QF@#H:*Y[_A']8_Z'+5O
M_ >T_P#C-'_"/ZQ_T.6K?^ ]I_\ &: .AHKGO^$?UC_H<M6_\![3_P",T?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOUW_ +YM?_C%'_"-W_\ T-^N_P#?-K_\8KH:* .>_P"$;O\ _H;]=_[YM?\
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MKO\ WS:__&*Z&B@#GO\ A&[_ /Z&_7?^^;7_ .,4?\(W?_\ 0WZ[_P!\VO\
M\8KH:* .>_X1N_\ ^AOUW_OFU_\ C%:6F:=/IZR"?5K[4"Y!!NQ$"GT\M%_7
M-7Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1AE2 2"1U'45
MS_\ PC=__P!#?KO_ 'S:_P#QBNAHH Y[_A&[_P#Z&_7?^^;7_P",4?\ "-W_
M /T-^N_]\VO_ ,8KH:* .>_X1N__ .AOUW_OFU_^,4?\(W?_ /0WZ[_WS:__
M !BNAHH Y[_A&[__ *&_7?\ OFU_^,4?\(W?_P#0WZ[_ -\VO_QBNAHH Y[_
M (1N_P#^AOUW_OFU_P#C%'_"-W__ $-^N_\ ?-K_ /&*Z&B@#GO^$;O_ /H;
M]=_[YM?_ (Q1_P (W?\ _0WZ[_WS:_\ QBNAHH Y[_A&[_\ Z&_7?^^;7_XQ
M1_PC=_\ ]#?KO_?-K_\ &*Z&B@#GO^$;O_\ H;]=_P"^;7_XQ1_PC=__ -#?
MKO\ WS:__&*Z&B@#GO\ A&[_ /Z&_7?^^;7_ .,4?\(W?_\ 0WZ[_P!\VO\
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MAHH AM('MK6.&2YFN708,TVW>_N=H _("IJ** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **1AN4C)&1C(ZBN?_X1>?\ Z&?7?^_L7_QN@#H:*Y[_ (1>?_H9]=_[
M^Q?_ !NC_A%Y_P#H9]=_[^Q?_&Z .AHKGO\ A%Y_^AGUW_O[%_\ &Z/^$7G_
M .AGUW_O[%_\;H Z&BN>_P"$7G_Z&?7?^_L7_P ;H_X1>?\ Z&?7?^_L7_QN
M@#H:*Y[_ (1>?_H9]=_[^Q?_ !NC_A%Y_P#H9]=_[^Q?_&Z .AHKGO\ A%Y_
M^AGUW_O[%_\ &Z/^$7G_ .AGUW_O[%_\;H Z&BN>_P"$7G_Z&?7?^_L7_P ;
MH_X1>?\ Z&?7?^_L7_QN@#H:*Y[_ (1>?_H9]=_[^Q?_ !NC_A%Y_P#H9]=_
M[^Q?_&Z .AHKGO\ A%Y_^AGUW_O[%_\ &Z/^$7G_ .AGUW_O[%_\;H Z&BN>
M_P"$7G_Z&?7?^_L7_P ;H_X1>?\ Z&?7?^_L7_QN@#H:*Y[_ (1>?_H9]=_[
M^Q?_ !NC_A%Y_P#H9]=_[^Q?_&Z .AHKGO\ A%Y_^AGUW_O[%_\ &Z/^$7G_
M .AGUW_O[%_\;H Z&BN>_P"$7G_Z&?7?^_L7_P ;H_X1>?\ Z&?7?^_L7_QN
M@#H:*Y[_ (1>?_H9]=_[^Q?_ !NC_A%Y_P#H9]=_[^Q?_&Z .AHKGO\ A%Y_
M^AGUW_O[%_\ &Z/^$7G_ .AGUW_O[%_\;H Z&BH;2W-K:QP-/-<%!@RS$%V]
MS@ ?I4U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 (PW*1DC(QD=:Y_P#X1,?]!_7O_ X_X5T-
M% '/?\(F/^@_KW_@<?\ "C_A$Q_T']>_\#C_ (5T-% '/?\ ")C_ *#^O?\
M@<?\*/\ A$Q_T']>_P# X_X5T-% '/?\(F/^@_KW_@<?\*/^$3'_ $']>_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MYM2NW20KA&W3R[L'D#<B8[YQ4VG:[>BW2"'4YG&L^();2"YGD#M!!&IW;<\
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M7SRV3)"!GH.E$.H:E>K8W(U2[ABU3Q$?L*_:#C[+$26)R?NLL1 7I^\SSD8
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MHG/]X>U7]4UK4;OPYXBU5+FYBNTO9=.T>U@<J?-1O+4D#[[,X+$-D!1TQDD
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!A^'=!ETG16TZ_FM[W=+)*[B$KYC.Y=BP).?F8UH6NDZ;8
MRO+::?:V\CC:S10JA8>A('2KE% '-ZEX6@N7MHHK33I=+AA:/^R[B >1N)!#
M@ 8##D?=/4XQSFQH'AJUT2T>!4C9#<FYAB"DQVQ*A=L08DJ, GZLW0'%;E%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
D !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>smmt-20251231_g1.jpg
<TEXT>
begin 644 smmt-20251231_g1.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &3 ?L# 2(  A$! Q$!_\0
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M!NZ\Q*:ZFOC)+EDT>')6;04445)(4444 %%%% !1110 4444 %%%% !1110
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MF7J".?2OS4_:N_9!\1_LQ^(#=1>=K7@:ZDVV6M;.8F/2&<#[K^C=&^N17T.
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M0,?FC;T^GH:V:S)"BBB@ HHHH **** "BBB@ HHHH **** "D9@JDDX YH)
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MBBBO%.4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:0!1110 4444 %%%% !1110 445Y_P"+/&<FH7#:1HS[B?EGND_A]54^OJ:
M#Q7XJDUFX?1]*;,>=MQ<+T]U4_S-<UK&J6WA?3C;PD>9CYF'\JDOKRV\)Z:8
MT*^>1\S5X[XI\3-=2.S.<9XYI@0>)_$CW$CLS_AFH/A;\4H?AWXNEU"YLXY[
M6\1;>ZF6,&=(P25VMUP"2=O0Y]:XG5-2,S$YXK/TO2[_ ,3ZQ;Z7I=N]W?7+
M;(XD_F?0#N: /L[XE?#/P1^TQ\-VTK5XX]5T>[7S;:]MR!+;R=I(FQ\K#T_
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ML-H9,[/.<+NQUQ7SV88_V[]G2^'\SCK5N;W8[%^BL+_A.O#W_09LO^_RT?\
M"=>'O^@S9?\ ?Y:\0Y3=HK"_X3KP]_T&;+_O\M'_  G7A[_H,V7_ '^6@#=H
MK"_X3KP]_P!!FR_[_+1_PG7A[_H,V7_?Y: -VBL+_A.O#W_09LO^_P M-D\>
M>'HXV?\ M>T;:,[5E!)]@.YH WZ*Y[PAXTL_&4-P]K')"T#!624#.#T/%;[,
M%4LQ"J!DD]!0 ZBOR]T/_@H%\49OVG--UV]O+=/V?M6\87'A.T1K.$8**JK+
MYH7?U=),[B,;ACBOO;XN_M'?#WX$ZEX>LO'/B"+P^^NM,MG-<1MY/[I0SEW
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M ':D>Z@L_P#P&O?JRO$7A71?&%BEGKND6.M6:2+,MOJ%LD\:NOW6"N",CL:
M/R'\;?LU_M!Z;^PSI_AB[\%^#[;PEX>3_A*UU&UOI3K"MAI7<K]W?L<@@=E
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M[77[17P*_:(^![_$31_B#KVA?%6UTBWL;/PQ;W]Q:JDHFW2*\2KL<@/)\X8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#G_D4;/ZO_Z$:Z:I **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT?\ WTW^-'_""Z%_T#H_^^F_QK>HH P?^$%T+_H'1_\ ?3?XT?\ ""Z%_P!
MZ/\ [Z;_ !K>HH P?^$%T+_H'1_]]-_C1_P@NA?] Z/_ +Z;_&MZB@#!_P"$
M%T+_ *!T?_?3?XT?\(+H7_0.C_[Z;_&MZB@#!_X070O^@='_ -]-_C1_P@NA
M?] Z/_OIO\:WJ* ,'_A!="_Z!T?_ 'TW^-'_  @NA?\ 0.C_ .^F_P :WJ*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
?!1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>smmt-20251231_g2.jpg
<TEXT>
begin 644 smmt-20251231_g2.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #A! (# 2(  A$! Q$!_\0
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M,G_13/$?_@7_ /6H_P"&J_C)_P!%,\1_^!?_ -:O+**/JM#_ )]K[D'UJO\
MSO[V>I_\-5_&3_HIGB/_ ,"__K4?\-5_&3_HIGB/_P "_P#ZU>644?5:'_/M
M?<@^M5_YW][/4_\ AJOXR?\ 13/$?_@7_P#6H_X:K^,G_13/$?\ X%__ %J\
MLHH^JT/^?:^Y!]:K_P [^]GJ?_#5?QD_Z*9XC_\  O\ ^M1_PU7\9/\ HIGB
M/_P+_P#K5Y911]5H?\^U]R#ZU7_G?WL]3_X:K^,G_13/$?\ X%__ %J/^&J_
MC)_T4SQ'_P"!?_UJ\LHH^JT/^?:^Y!]:K_SO[V>I_P##5?QD_P"BF>(__ O_
M .M1_P -5_&3_HIGB/\ \"__ *U>644?5:'_ #[7W(/K5?\ G?WL]3_X:K^,
MG_13/$?_ (%__6H_X:K^,G_13/$?_@7_ /6KRRBCZK0_Y]K[D'UJO_._O9ZG
M_P -5_&3_HIGB/\ \"__ *U'_#5?QD_Z*9XC_P# O_ZU>644?5:'_/M?<@^M
M5_YW][/4_P#AJOXR?]%,\1_^!?\ ]:C_ (:K^,G_ $4SQ'_X%_\ UJ\LHH^J
MT/\ GVON0?6J_P#._O9ZG_PU7\9/^BF>(_\ P+_^M1_PU7\9/^BF>(__  +_
M /K5Y911]5H?\^U]R#ZU7_G?WL]3_P"&J_C)_P!%,\1_^!?_ -:C_AJOXR?]
M%,\1_P#@7_\ 6KRRBCZK0_Y]K[D'UJO_ #O[V>I_\-5_&3_HIGB/_P "_P#Z
MU'_#5?QD_P"BF>(__ O_ .M7EE%'U6A_S[7W(/K5?^=_>SU/_AJOXR?]%,\1
M_P#@7_\ 6H_X:K^,G_13/$?_ (%__6KRRBCZK0_Y]K[D'UJO_._O9ZG_ ,-5
M_&3_ **9XC_\"_\ ZU'_  U7\9/^BF>(_P#P+_\ K5Y911]5H?\ /M?<@^M5
M_P"=_>SU/_AJOXR?]%,\1_\ @7_]:C_AJOXR?]%,\1_^!?\ ]:O+**/JM#_G
MVON0?6J_\[^]GJ?_  U7\9/^BF>(_P#P+_\ K4?\-5_&3_HIGB/_ ,"__K5Y
M911]5H?\^U]R#ZU7_G?WL]3_ .&J_C)_T4SQ'_X%_P#UJ/\ AJOXR?\ 13/$
M?_@7_P#6KRRBCZK0_P"?:^Y!]:K_ ,[^]GJ?_#5?QD_Z*9XC_P# O_ZU'_#5
M?QD_Z*9XC_\  O\ ^M7EE%'U6A_S[7W(/K5?^=_>SU/_ (:K^,G_ $4SQ'_X
M%_\ UJ/^&J_C)_T4SQ'_ .!?_P!:O+**/JM#_GVON0?6J_\ ._O9ZG_PU7\9
M/^BF>(__  +_ /K4?\-5_&3_ **9XC_\"_\ ZU>644?5:'_/M?<@^M5_YW][
M/4_^&J_C)_T4SQ'_ .!?_P!:C_AJOXR?]%,\1_\ @7_]:O+**/JM#_GVON0?
M6J_\[^]GJ?\ PU7\9/\ HIGB/_P+_P#K4?\ #5?QD_Z*9XC_ / O_P"M7EE%
M'U6A_P ^U]R#ZU7_ )W][/4_^&J_C)_T4SQ'_P"!?_UJ/^&J_C)_T4SQ'_X%
M_P#UJ\LHH^JT/^?:^Y!]:K_SO[V>I_\ #5?QD_Z*9XC_ / O_P"M1_PU7\9/
M^BF>(_\ P+_^M7EE%'U6A_S[7W(/K5?^=_>SU/\ X:K^,G_13/$?_@7_ /6H
M_P"&J_C)_P!%,\1_^!?_ -:O+**/JM#_ )]K[D'UJO\ SO[V>I_\-5_&3_HI
MGB/_ ,"__K4?\-5_&3_HIGB/_P "_P#ZU>644?5:'_/M?<@^M5_YW][/4_\
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MX:K^,G_13/$?_@7_ /6KRRBCZK0_Y]K[D'UJO_._O9ZG_P -5_&3_HIGB/\
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MG_13/$?_ (%__6KRRBCZK0_Y]K[D'UJO_._O9ZG_ ,-5_&3_ **9XC_\"_\
MZU'_  U7\9/^BF>(_P#P+_\ K5Y911]5H?\ /M?<@^M5_P"=_>SU/_AJOXR?
M]%,\1_\ @7_]:C_AJOXR?]%,\1_^!?\ ]:O+**/JM#_GVON0?6J_\[^]GJ?_
M  U7\9/^BF>(_P#P+_\ K4?\-5_&3_HIGB/_ ,"__K5Y911]5H?\^U]R#ZU7
M_G?WL]3_ .&J_C)_T4SQ'_X%_P#UJ/\ AJOXR?\ 13/$?_@7_P#6KRRBCZK0
M_P"?:^Y!]:K_ ,[^]GJ?_#5?QD_Z*9XC_P# O_ZU'_#5?QD_Z*9XC_\  O\
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M <5TQK4YSY(N[M?Y,YY4:D(\\EI>WS1B4445L8A1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'NW[<__ "=;X[_ZZ6W_ *3QUX37NW[<_P#R=;X[_P"NEM_Z3QUX37%@
MO]UI?X5^2.S&_P"\U/\ $_S/;?V*D4_M.^"3M&?M!YQ[5K_\%"D4_M-^)SM&
M?LL'./\ 8->:_ [XE1_"#XJ:!XNFL7U*#39O,DM8G"/(O< G@'ZUH?M'?%NU
M^.OQ7U3Q?:Z9-I-M>11Q"TN) [KM&,DCCFL'1G]?5:WN\MK^=S>-:"P+I7][
MFO;RL?3G_!0H@?!?X%9.,V*X_P# 6*H/"'_*+/Q1QC.H3D>_^DI7&^&_VT?#
MNO\ PJTSP1\6OA[_ ,)W!I86.SO+><02*B@!<GJ"  ,J1D 9KGOCY^US%\3?
MAW8?#[P9X5C\$>"[<JTEH) \DQ7HI(XQGD]R0.:\JGAL1R4\,X6Y9\W-=6M=
MOUZ]CU)XFASSQ*G\4;6UO>R7H?87A+XE#X7_  <_9\U&9PMA>W"Z9=%VPBQS
M#;O/TK#T'X+VO[._QF^-7Q8O5CAT33]/:ZT<RH!$99U+X4_[+ )_P.ODGXI?
MM-V?Q"^ 7@KX>6^A7-C>^'W5Y-0DF5HY2O3:HY'XUUWQY_;GNOC/\"['P'%H
MMQI=\ZPIJE])*KQ7*HO(11R,L%//I7.LOQ*=HJRFVI?X>:Z?W71O]>P[7O.[
M@DX^O+9K[[,^D?CK=1>-/A;\ ;O6HU:+5M>LY[R-^5_>89A],FO$/^"HMS=O
M\6O#%I,6&GQ:83;1GA.6&X@=^@KS[XR_M86WQ/\ @MX*\$V.A7FD:AX=:)SJ
M+7"E79% !0#D'(SS79WG[;W@_P")G@[2M*^+WPN'C'4M. 6+4+*Y$!8#')/W
M@3CD X)[5IA\)B,-*G5Y+\KEII>S>C6MC.OBJ&)C.ESVYE'76VBU3.V^!USJ
M=_\ \$XOB2FM!I+"!;M=*,XR/*"H1L)]'+_C79ZY\._!WQ._8L^">B^,_&0\
M%V<C6?V:Z-OYOVB8QNHA_P!DD$_-VQ7S%^T!^U[+\5/ ]AX$\(>'D\#>"+4#
M=I\3@R3$=%8KQM!YQW/7-9_Q3_:7L?B)^SAX&^&-OH=W87GAR2%Y-2>=3'-L
M1U^51R,[\\^E5]2Q$Y*I;E<IN6EO=5K>@EC</!.%^91@EK?5WOZGM/\ P41U
M>3P5X5\ _"^PTRY&@:?;B>+6+E@XNBHP%4^HZGZU\+7:JUO)D X4]17T=\7?
MVJK'XR_ /PQX,UOP[<-XNT)HQ#KPG4PE%^5OD^]ED"CGN,U\Z2IYD3)G&X8S
M7L9;2G0H*G45FF[^>N_S/(Q]6%:O[2F[II?+3;Y'W1_P4.13\'_@8"H.+$=1
M_P!.T597_!.WX@1:W=^)/@[X@MO[0\-:]:R3Q1N<K$^,.H7H PYSZ@5Y9^TG
M^TW8?'CP5X T*ST&ZTB7PS;^3+/<3K(LY\I$RH X^YGGUKE/V:_C/;_ 3XJV
M7BVZTR;5[:&&2%[6"0(YW @$$\=:X(8.H\N=&4?>U:];MH[IXNFLP5:,O=T3
M]+),]5_;U^*">(OBOI/@+2PT'AWP6L%E#"1PTV%!8>H"[5_"OJ']J7PK\*]0
M\8?"?7_B/X^;PJ^C6OGVNFI;L[7P4QL2)%!*895^N:_.SXP_$&'XH?%C7O&%
MO92:?!J5VMRMI*X=XP,<$C@GBO0OVK?VD[']HZ]\(36.A76AKH5E):NMU,LA
ME+%>1MZ ;>_K4O 5']7A&\5%.[5KIM>?=E+'07UB<K2;:LG>S2?Z(^F/"_[0
M>E?M ?MW>$+KP^LG]@Z5IUQ;02S)M:=CDLX[[>0 #Z5PG[7=]^S^GQ/\;1:O
MH?BV7QZ=P^U6\RBS\_;\AP6^[G&>*^=?V=/BY;? SXLZ9XPN]-FU>"TCDC:U
MMY!&[;AC()XXKV?X@?M+_ ;XD:YJFNZQ\$]3NM=OP3)>-J^W+XP&PK8X^E1+
M!RP^)BZ49."BE[K2UO?6[1I'&1Q&'DJDHJ;DWJGVMIHSY-3(4;NN.<4M/G9'
MGE:)#'$SDHA.=JYX'X"F5].?,A74_"SXA7/PH^(F@^+K2))Y]*N1-Y4GW77H
MP_$$URU=7\*O&MK\.OB%HWB.]T>V\06=C(S2Z9=J&CG5E*D$'COD9[BLZJYJ
M<E:^CT[^1I3=IQ=[:[]C[HNO#'P/_;TU"XU70-4O?"?Q.EM3(\)8K(=HQN90
M<.!P,@YQVKYP_93\*W7@G]M/PSH&H>4^H:7J=S:3O%RI=(W!(/I7>Z#^V9\+
MOAOJ.K^(/A]\&3H/BZ^A:);^XO1)%'GKA>P]0N,XKPGX4?&B?P+\>-.^)6MV
MTNMW,5Y+>W4,+"-YGD5@<$\#[WZ5\_0P^(C2K4DFH.-HJ33=[;*W3U/?K5\.
MZM*HVG-2O)I.UK];]3IOVU$7_AK;QR=HS]NM><?],8J^@_\ @I-QX ^%9[>1
MC/\ VS6ODCX\_$N#XQ?%[Q'XSM+&;2X-5ECD2UF</)%MC5.2..JYXKW+0OVT
M_#?B3X5Z9X*^+7P];QS%I@1+:\M[H0R;5&%+$\[L<$@\UK.A6A'#5(QNX+5:
M7U27IH90KTIRQ%-RLIO1]-'<]'M6 _X)>.<@ EP"3U_>FLC]J-0W[ WP0R <
M2VG7_KWDKRC]H/\ :V3XK> =.\ >$O"T7@OP19E'^Q"0/*[KG:"1QM&<^I/6
MNRLOVPOAIK?P:\&^ ?'/POU'Q/;^'8H@DB:@L2-*BE=X P<8)X/K7)'#8BGR
MUG!M\[E96NDUZV.IXBA4YJ2FE[BC?6S:?I<[;]EBY;4OV%/BU!X@FGDT"'[2
ML+.22B^4I(0GMG'3O5__ ()_>,]-^,?P]U;X0>*[=[ZVT=XM7L9&.<1),K!<
M]MK[<#T)%>*?'+]L@?$+X>Q> /!7A2'P-X/^4S6T;AI9<'[I*X&T]^YKF/V3
M/VAK+]FSQWJ_B"^T2YUV&^TTV*P6LRQLA\Q7W$MQCY<?C55,%6JX>M-QM.4N
M:*OJK6Z[7)IXRE3KTH<UXQ7*WT=_T#]L/XRR?&?XW:O>1,PT;2F.FZ?$1C:D
M;$,V/4MN_#%>)5>UW45UC7=3U!8S$MY=RW(C8Y*AW+8)]LU1KZ*A2C1I1IQ5
MDD?/UJCK5)5).[;"BBBMC$**** "BBB@ HHHH **** "OL;_ ()=?\ER\0_]
M@,_^C5KXYKVS]D[]H6R_9N\?:EXBO]%N=<BN[ V8@M9EC9#O#;LMP1QBO/S"
MG.MA:E.FKMH[\!4A2Q,)S=DF>;>*/^2GZS_V'IO_ $I-?H/^U#_R=C^SQ_U[
MO_Z&E?+'Q&^,/P/\3Z1J<GA[X0:AH7B>ZG^TQ:K+JAD6.4R!V8IN(.>>,=ZW
MOBS^V1IOQ(^+_P -?&MOX8O;*#PE&8YK.:X1GN<L#\K 8'3O7G5J=;$3IR5-
MJRDM;=8Z;-GI4JE&A"I%U$[N+TOT>O0^F?B8;'XM>.OC'\#M5F,E[?6ZZ_H,
MMP2YBN5B 94'0!=JD#_::N#_ &@;*XTW]G+]F:TNX6M[JWU>QBEB<89&"8(-
M?-WQ)_:8N_%'[1T'Q7\/V$NCS6LT,D%G<2AF94&"KE>"&YXKO_VD/VUM+^.E
MKX+@L/"5WHJ:!JZ:K*)KA'\XKU1=HXSSR:XX8'$4Y44H^[N_)\MG]^AU3QM"
MI&K>6NR\US77W:GT'^W'>?!.U\3>%Q\4-(\3:CJ)L3]E?0Y0B*F>0V6'.:_-
M[7FTUM<U%M&CGAT<SN;..Y.95AS\@<_WL=:^P?B;^V9\&OC+>:?>>,O@WJNL
MW5E#Y,,C:J(]J]Q\I&:^3_'NJ:!K?B[4;WPOHLGA[09GS:Z9+-YK0+Z%^]=^
M54JE"FJ=2,DTNK5OEJ<&:5:=:?/3E%J_1._ST/O#]D*TT7X#?LXR^*OB7KT1
M\&>-KA(;?1Y8#)%'N+)O?OEMO(Q@ "NY^-7[/7BCXYZ_IGA6SU^Q\-?!"VL%
MN[";1($=1(H^Y("0"N,D'I^-?*GPO_;#T;2?@W'\,/B/X$3QMX8M5V6@@G$,
MJ+N+<D]P2<%<'FO0-(_X*.:5X*LM%\.>$OALNG^"+.-H+C3[R\,L[1D8VQMG
M _X%FO)K83&JO*M3C[UWKI:W1K^]TU1ZM+%8-T(TJDO=LM-;WZI^7S/BW6+*
M/3=9U&RBF^T16MS+ DP&/,5'*AOQ S^-?:-M_P HJKO_ +"+_P#I97R/\2=>
MT3Q3X]UO5_#>C-X>T.]G\ZUTMY-YMP0-PW=\MD_C7JD7[2EC'^R++\&O["NC
M?R7+3_VMYR^2 9_-QL^]G'%>_BZ52M"BXK52BWY+J>'A*E.C.KS/1QDEY]C[
M2\8?%R+X4+^SZFJ2X\,^(=.FTC5(W/[O8T401R.^TD_]]5RO@;X4R?!?X5?M
M.^%PA%C#/Y]B_)#6TEMNCY[D @'WKY4_:(_:1LOC?X&^'F@V>B76CS>%H'CD
MN)YE<3L4104 Y&"F>?6O39/^"@/]H?L^W7@/4O"]Q=^(KC31ILFM>>OERJ!M
M61U^\6V_K7A_4,1"E'DCJW[RTZ2NG]VA[/U[#RJ2YI:):/UC9K[[&[\2E#?\
M$N_ .0#_ *?:]?\ KK+6E^P1=2WW[.WQFM-7EED\-Q6TN Y)6/-LQ?9GIZ\=
M\5YYX,_:Y^'L'[/GASX6>-_AQJ/BFPTDJ[/%?K#')(KLRL,888W'C-4/BS^V
MA;>(?AC)\/OAUX-B\!>&KE=EUMD#SR+D' 9?7').2:V^K8B=.>&]FUS3;YM+
M)7OWO?Y&;Q-",XXCVE[0M;6[=K>AZ^JPO_P3.TA.MLUU$N6[QFXQS^%-_P""
ME#2:9\,_AAIFFL8O#6T"-(CB)F6(;!QU^7M7A%S^U-8R_LGV_P 'T\/W*WT;
M#=JAG7R2NXMPOWL\UTO@G]M/1KKX36G@#XJ^!!X]TNP58[.>*<12HBC"Y8\[
M@.,J0<=:(X3$4JJK\E[3D[::I]4*6*H5:;H\]N:$5?71KHSY[^&/@ZZ^)?Q"
M\.>$[20M+J-[' JLQ*("<L<=A@&OU2ET7QWX=_:C\'VN@>%[J+X9:5H7]CW%
MZ)8Q 05W(P3=NRK!5/%?'OAG]K_X9^"O'OAG6?#WPEDT;2] M;F.WMK>YC:>
M:6;:-\DC E@H4XYR-QKQ+Q+^T)XZUKQ_J/B>T\4:W9"XU%K^&Q_M"7R8AOW+
M'M#8VCIC&*WQ.'Q&/GK'EBHO?75^CWL88>OA\##27-)M;::+U6U_R-']KOX7
M?\*F^.OBK1E@$6GW$AO[$,<DPR9.?^^MP_"OHC]M!%/['GP$!4$"&VP,?].8
MKQ7]J[]H_1_VDI/#-]:^&KC1-:TZV:WOKR>5'^U @;0-HR &W'G^]4GQQ_:9
ML/BY\%?AYX%MM!NM-N?"R1)+>S3*\=QLA$?RJ.1G&>:V5+$5%AI5(ZQ;YONM
M?YF4JE"F\1&$M)+3[T[?(]C^ 0Q_P3D^,>.,/=_^@1UJ_M33WFB_L&_"6TT<
M-!I5XEF-1\D85@8"WS$>LF/J:\%^'7[2]AX&_9G\;?"R;0;J[O/$+S-'J4<R
MK%"'"CYE/)QM[>M=%\&?VSH?!_PNE^'/Q \(IXZ\)!"D$?FA)D!.=I+<8';&
M"/6N6>$KQJRK*%[3YK::JUKHZHXJA*E&BY6O"U]='>^IWW_!+B:]'C?QQ;IN
M.CMI\9NE/^K#9.W([<%JZC]G:_\ ^$?^#_[1NJ:.RPMI?B*2]LO).$!B4.@X
M_AX''I7EVI_MK^'O!WPWU'PK\'OAZ/ ,FH@I<:C<7 GF"G()4]2V#@;B0,FN
M"^#/[2-G\*_@K\0_ ]QHEUJ=YXI8M'?).JI!F/8=X/)]>*57"UZ\JE9PMS.&
MFE[)ZM] I8JC05.CSWY5+76UVM$NI]G?#S0K#X@_'GX9_''P_"!8>)M&FMM6
M"  0WBJH^;!^\W(^BBOSY^/W_)>/B+_V,%[_ .C6KUO]DS]LC_AG+0]3T+6-
M#N?$FC33K=VD-O,L;6T^,.V6'0C'Y5X1\0O%*^.?'_B3Q(ENUHFKZC/?+;LV
MXQB1RVTGOC-=>"PU:AB9\Z]U))/RO=?=>WR.3&8FE7P\>1^\VVUYV2?W[G/T
M445[QX84444 %%%% !1110 4444 %%%% 'Z"_P#!.RUL[WX%_$ZWU"\_L^QE
M9DGN]F[R4,;;FQWP.<5=U?PYX?\ V8?V*_$<_@&[NOB+IWBPF.XUI<)!"KKY
M?F% <H #C _BZXKYS_9X_:HL?@?\-/&?A:Z\/76K3Z\K"*Y@G5$A)0K\P/)Z
MYXIWP$_:JL?A?\(/%7PY\4:!>>)=!UA9!;K;3I&;7>I#8W#U^;ZU\I6P6(=>
MI42O'FB[:>\E_D?44<90C1ITV[2Y9*^NC?\ F?37@^3P3;?\$[?#Q^(%IJ=_
MX:55$T.D,%G+;VVD$D<5XM^S2OPKU7]L?P*/AYINKV.A):W+RQ:^ZO(URL;%
M"N">.GXU%X#_ &P_ 6E? /3/A=XO^'>I>)M+M,[S'?K$LF&)4\8((!]:\L\>
M?%KP/;>)O#>O?"7P7>?#W4M)F\^26:^-QYS Y4<DX'KZU='"UKUJ<HR7.Y6=
MURZ[.U[_ (!5Q5*U*I&47RJ-U9\VGG;]3U#XU^&- ^)_[7'Q!T[XG^/Y_!-K
M:SK%I4L]JUP)(\*$1%Z!>2<_6E^)/[,%O^SC\8/A#]D\57/B6VU;5[:13<0"
M(1@2KC: QX(^E7M>_;4^'?Q5L]+NOBA\'U\0>)++:?[1TV[%N&*G([AL9[$D
M5ROQW_;#M_C)\1/ 6NV_AB32=*\*W,5RMH\X>:;:X;:&' &!BKI0QMX4^5J*
MBTU[MM%96ZZLBI/!VG4YDY-IIZWWN[]-#Z>\>?\ *3'PG_V+T?\ Z%+4OQ$L
MG_:(^%GQG^'T:B;Q#X5U:2ZTY!AII1GS0%!Z _,E?-OB']L[2];_ &J-&^+:
M>%[Z*PL-.6P?3&N$,SD%SN#?=_BZ>U9_PV_;&3X>_M'>*OB0N@7-QI'B%72?
M2EG43*N=R?-]W(/6N/ZAB5&$XQ]Z$(VV^)/;[CI>-P[E.+E[LI2OZ-;_ 'GV
M?\++B'X0Z_\ "'X,6C1/=)I$VK:J5&V02@+M+#W+./\ @-<7^S1L_P"&U?CU
MY@)3[&NX#KCSN:^9])_;+\G]JF]^+FIZ'=7EB]LUE;:6DR++#!@;5+XP2#D_
MC5WX4_MFZ5\//CM\0OB!=^%;V_L_%,0BCL(;E%D@ ?=\S$8/''%1++\0H5/=
MNY15]OB<KLTAC\/S0]ZRC+3_  J-D<!\=KWX$W&AWZ?#O1?%-CXJ&H,9I]8E
M5K<Q[G\T !CR3C%?;VH?%F'X/_#_ /9UO-0*MX?UVTCT75HG *-"]NNUFSP
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8I^./_1/+[_P(@_^+K]GZ*/]8\3_ "1_'_,/]7\-_-+\/\C\8/\ ABGXX_\
M1/+[_P "(/\ XNC_ (8I^./_ $3R^_\  B#_ .+K]GZ*/]8\3_)'\?\ ,/\
M5_#?S2_#_(_&#_ABGXX_]$\OO_ B#_XNC_ABGXX_]$\OO_ B#_XNOV?HH_UC
MQ/\ )'\?\P_U?PW\TOP_R/Q@_P"&*?CC_P!$\OO_  (@_P#BZ/\ ABGXX_\
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M3R^_\"(/_BZ_9^BC_6/$_P D?Q_S#_5_#?S2_#_(_&#_ (8I^./_ $3R^_\
M B#_ .+H_P"&*?CC_P!$\OO_  (@_P#BZ_9^BC_6/$_R1_'_ ##_ %?PW\TO
MP_R/Q@_X8I^./_1/+[_P(@_^+H_X8I^./_1/+[_P(@_^+K]GZ*/]8\3_ "1_
M'_,/]7\-_-+\/\C\8/\ ABGXX_\ 1/+[_P "(/\ XNC_ (8I^./_ $3R^_\
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MS2_#_(_&#_ABGXX_]$\OO_ B#_XNC_ABGXX_]$\OO_ B#_XNOV?HH_UCQ/\
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M(@_^+H_X8I^./_1/+[_P(@_^+K]GZ*/]8\3_ "1_'_,/]7\-_-+\/\C\8/\
MABGXX_\ 1/+[_P "(/\ XNC_ (8I^./_ $3R^_\  B#_ .+K]GZ*/]8\3_)'
M\?\ ,/\ 5_#?S2_#_(_&#_ABGXX_]$\OO_ B#_XNC_ABGXX_]$\OO_ B#_XN
MOV?HH_UCQ/\ )'\?\P_U?PW\TOP_R/Q@_P"&*?CC_P!$\OO_  (@_P#BZ/\
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MJ*?*+FU/B?3K]O _[2?@[X4>+VGFL_#%EK<]E?7&9/M>BW"H(\D<EDQ(I Y
M5:TM-U"_\"Q6GPK^'_CFQ^(W@OQ'H&J0Z':0E'U#PYB!WA+S*23%TB4.$()
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M[R7$32Q"YFN=NXI(&=E+$ A6? ...:\1>![KPM\(/C+>Z(G@70?",W@]H9M
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MC_Q^2?A_*JU*.R'+=A12@$]!FDIB"BBB@ HHHH **** "BBB@ HHHH ****
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M\*>*=+\;^'+#7M%NA>Z5?1^9!. 1D D$$'D$$$$=B"*U:=D%V<C_ ,*MT/\
MOW__ (%&C_A5NA_W[_\ \"C7744<J%S,Y'_A5NA_W[__ ,"C1_PJW0_[]_\
M^!1KKJ*.5!S,Y'_A5NA_W[__ ,"C1_PJW0_[]_\ ^!1KKJ*.5!S,Y'_A5NA_
MW[__ ,"C1_PJW0_[]_\ ^!1KKJ*.5!S,Y'_A5NA_W[__ ,"C1_PJW0_[]_\
M^!1KKJ*.5!S,Y'_A5NA_W[__ ,"C1_PJW0_[]_\ ^!1KKJ*.5!S,Y'_A5NA_
MW[__ ,"C1_PJW0_[]_\ ^!1KKJ*.5!S,Y'_A5NA_W[__ ,"C1_PJW0_[]_\
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M .!1H_X5;H?]^_\ _ HUU^/<?3/-(2JC+.BCN6<#'YT[(5V<C_PJW0_[]_\
M^!1H_P"%6Z'_ '[_ /\  HUUWT((]0<B@E0,LZ(/]IP/YT6079R/_"K=#_OW
M_P#X%&C_ (5;H?\ ?O\ _P "C77-A!EG1!_>9P!^9I3@ DLBCU9@!2LAW9R'
M_"K=#_OW_P#X%&C_ (5;H?\ ?O\ _P "C781J'D1/,CRY&/G&3[@9Y_"N(^%
M_P 4K/XHV^O2VUC)IITG5)]+9+B96:9HV(+KCL<=*/="\B?_ (5;H?\ ?O\
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M97.<XYI6BAW9/_PJW0_[]_\ ^!1H_P"%6Z'_ '[_ /\  HUUQPHRSHJ_WF8
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M\3_#S0]1B3PYXFM;""SBN@T:F6)5@1(V"L6^8#DU].5I'8B6X44451(4444
M%%%% !1110 4444 %%%% !1110 5\X?M:-*OQ%_9Y,(#2#QDVU6.!_QZ2]Z^
MCZ\U^*WPED^)?BSP#JK7RV<7A+53JT<8QFXD,31[3GH,,343=D"=CG?VOI]4
M/[,?Q1$EK;HAT2XW%923C'IBM3]G/5(-#_97^'6HW3*EM:>&+:>0NV!M6+/7
M\*ZCXQ>!#\5?ACXD\(?:ELEURS>SDN003"&_B [XKE8_A;K>@_"3P5X#TB[L
M[FRT6.WM;Z:\/S74$.,!<=&8@9SQBIO[UBD]+&3^SG\9-6\;^*?&7A/Q/>6M
MQK>FS1ZC8/:@JLNFS#]T<'J00P/TK@]1^.OBQO%7Q9T:'7$MM0TCQ)I>E^'K
M?R WG+*-\T1R<$E0QR3QBO6/&/PHNKGXI^"?''A@6&DWVCB2VU&(@!;VTD W
M1<=U()4GC)-<A#^S(^LZS\6Y-<O(5MO&&H6VIZ9<VC[9]+N+="L<@.>3N(/'
M4 @]:K78:MN;_P"U%XY\:_#[P%INK^"DCFUJVO8Y[G3Y$W_:K=.9H5']XC.#
M[5C_ !G^/\MG\*?"/BGPA?+#I^N3V-Q-J#)N\JSEF2-L#LQ9MOMFNFM?!_CC
M5-%\(1>)KW3-3U;1KO?>W</R)?1 ;<[2>&9>O;.:\WUW]D"[C^$WC#P;H^OI
M+'K&NP:CIPO#F/3+2*Y2<6R#/3*8X[\T,%;J>FVOCN\\>_&7Q)X-TK4/LFB^
M&K.$ZA<0L1<R7,N2(P2/E 7:V1G.ZL70_'6N^"/C[#\,-?U-]9TOQ!IDNJ:%
MJ+?\?5L(F"2PRG^/DY#>U7=9^%^NZ!\3A\1O",]H=3OM+CTW6M$NFQ#>B/F*
M1&!^6123DGJ,"MZP\ W-YX[7Q]K"VDOB"VTLZ?IMFI'EV:N0THW=268#GTH#
M0\V^$GQE\6:=K&J^"?B5=VRZQ>FZNO"NN0KY<6IVR,P\HCIY\>.1W!&*]'AU
MS7K'X8^'=3%^ES?S+;_:YYX^9-[@-@=NM87BWX#P_%'X16?AKQ-+%8Z]83O>
MZ?JVFMA["YWLR21$G/?!!X-=-<^%-9A^&FA:#'<6MYJ=G';I<7$AVI(8R"6
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M%+M^/FE&,.>!R<]!6?X@^&O@[Q;?6][KOA'0M;O;=0D-SJ.G13R1*.@5F4D
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M2+D,UO-!'Y:. Q!(7 XR#SCGKWK3J.WMX;.WB@MXH[>")0D<42A410,  #@
M#M4E60%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %20?ZT
M?0_RJ.E!QTXH _/;X:>,V^"WPL^&?Q8FOISIMVFK>&M1DEG:17N)+B0V3'KC
M:RL,^C5VOA;X>^&4\:>#_!OQDDM3HI\+MX@MK'6;HP64NK7%P6NG+LRAI%W,
M I/"\XKZ[E\%^';C1H]'E\/Z5+H\<@F33GLXS;I(#N#B/&T-GG.,YYH\4^"_
M#OCJVAMO$WA_2_$=O"_F10ZM9QW*1OC&Y0X.#CC(K/E-.8^'O!?A>R^)OCSX
M'>'/$%UJ&K^$)!XDCL8;JX=?[1T]'@$2S#@O&"3@'LJ\UD:W'J,&A>&/!,4&
MGZI\/[?QMK%F^F^(]8DLM.*QJ[P6\]PJL51" 44]6 &:_0-="TM+BQN%TRS6
MXL(S#9RK H:U0XRD9QE%.!D#'053U'P5X<U?2;O2[_P]I5]I=W+Y]S8W-G')
M!/)G.]T(PS9YR1G-'*',?&TOPKU,?!7[-JVM> )] LO$DVIZ?X.E\3F32)+0
M1X^Q_:R P,9RP&#C=SP:LZ7=?#7XO^,?"=EX]L+?PW\/$\&&ZT+0M2O&M[!+
MH3[)I8Y"R[W"Y"$G)3!Q7U5)\&OA[-I$.E2> O#,FE0RM-%8MI,!@CD;&YU3
M;@,<#) R<"M#7/A[X3\4:98Z;K7A;1=7TZP 6SL[^PBFAM@!@"-&4A !QQVH
MY6',CX9^-=_ MI^T+!I6M7T^F1Z/X5BM+I[IQ*(FN'0,"<$$KQG R .M=W??
ML_>!C^TIXS\#-83OX37P2NNS:,UY)Y-Q?^=Y7VN0;LF3:.N0,\XKZUNO".@7
MPNA<Z%IMP+M(H[GS;1&\](_]4KY'S!/X0>G:K9TBP;49=1-A;'4)8?LTEX8E
M\YX<Y\LOC)3/.WI3Y0YC\]M1\=6'Q!^"O@:TUC1]%\1ZQ9^$)]2>\\7^()-/
MM;91)*D+6FU29[C]V,^FU?6M'P;#X0^)'Q-^!B?%;4(KRUO/A6LCIJ]R88+R
M9;@\SMD#(QN&XCYAW/%?;NH_##P7K%MI]OJ'@[0+ZWTX%;*&YTV&1+4$Y(B!
M7" GDXQ4NK?#KPEK]JMMJGA31-2MEA%NL-WI\4J+$&W",!E("AN0.F>:7*PY
MD>5?LJ:CJ$_P#D.C$:M:VM]=P>'FU*9T2>T5_P!UND(+!<[@&P> .M<C\!-?
M^*MW\??B]%JWAKPS!;-JVG_VP;?79IC9-]@CV"W4Q /E<,<[,$D8/6OIZSL[
M?3K2&TL[>*TM($$<5O @2.-1T55' 'L*9;Z=:6=S=W-O:007-XRO<S11A7G9
M5VJSD<L0N ">@XI\NQ/-N?.?QQT[PEXL_:$T/P_\3;N*/P6- N+O3[34+HV]
MG-=!EWR,V0/,0$;1G/)P*X:'X3> _B=\;_&VFWGVCQ'X;L/!%L=/6XNGP5!P
MDN1@E@ -K'TKZV\2^#O#_C2UBM?$6@Z9X@MHG\R.'5+1+A$;^\H<$ ^]6;;0
M=+LIFFMM,L[>9X5MFDB@56:%?NQD@<H.R]!1RW8U(_/<7NN?$J+X<VOB2S\.
M^*=$'@T2V8\:>()-,M6N/.=))4=4(DE55C')R!D^]>A:!\+/^$P^*7PE\'?$
M:_MO%-K%X4NWGL]/U%Y["\1)V^SJ[C!F$8"X;CD9KZSUCX<^$?$.DVFEZMX4
MT35-+LR3;6-YI\4L$&>NQ&4A<^U7M-\*Z'HQM#I^BZ?8&SB,%J;:U2,P1'JB
M8'RK[#BERL?,?!O@CPIIWAOX3?#KQ_:SWE[XQL_'"Z3::K>7KO*MDK2JED"3
MCR1G[I!/O6GJ%OX2U/X<:]XVO=2(^/47BF2VCG%TRZI'*EYY=O;+#G(A,85?
MNX*'.>]?;Z^%=#6RBLET73ELHIOM$=L+5/+27_GH%Q@-_M=:K/X"\+R>*/\
MA)7\,Z.WB3I_;)L8S>=,?ZW&[IQUZ4<H<QY-^T_//X-\,^#/BE*TD$O@G4(+
M[6/+<@/8R)LN8RHZ_.RG_@->'>(O!+>,?AS;?$?5+_PWJ:ZSK5[KLWA?Q5JY
ML;'5[/88K1ED^\&2((ZX7!/!]:^WM1TZSUFPN+'4+2#4+&X4I-:W48DBE4]5
M93P1[&L77/AKX/\ %%K8VNM>$M#UBUL$$=G!?Z=%,EL@& L:LI" #C IN(E*
MQRWP>^+'@WQ7H'A71]%VZ)J%YHJZG:^&YE99K>T#%<\_P[AQSD@@UXE\3='^
M'_B?]LS5=*^)=[;KX?'@F.>WLM2O&@LY9A<G+-R!N48(R1STS7U7#H>F6]]'
M?0Z;9Q7T<(MDNHX%6581TC# 9"=/EZ5YMJ?P$TWQ)\<M7\;^(;;2?$&B7WA^
M'1UT74;(3[)8YS+YIW@KC' XSFAIVL":O<^-K*76?&L'PYT77[#1O%/@U-#O
M)=+M_'&N3:7:7*+.%69I AWRJIPH.#M)(]:]$\._#.?Q'XS^!W@OXAZC9^([
M4Z?JS2VFCZF]Q83VR%S;0&08,JQ)M7)YRM?8.O\ @?PUXKTNWTS7/#FDZSIM
ML08++4+*.:&(@8&Q&!"X'I4FE^$- T-+%=-T+3=.6P1H[,6MHD?V96^\L>!\
M@/<#K2Y1\Q\(>&O!^C^%_A)IGC>W>ZG\1^&O'HTC1[^XO'=K&R64(MK'DX\L
M"1OE.?K5"[TCX>_\(K\9?$,U_$WQ3TCQ7<?\(ZLETRW-O<B;,$=M&"-RL_7
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M;_"C=X[_ .>.B_\ ?UO\*ZVBBWF%_(Y+=X[_ .>.B_\ ?UO\*-WCO_GCHO\
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M;F2W@E5WCDAB,>#)(,!E+ # Y-:V@?M0ZHOC>ZT'Q-X;TF#S=+NM4T^#P[K
MU&]S "S6]S$ !%*5'0%AGC-:^I? [Q.OQ5\2^(-&U_3--T#Q1H4&DZI;"&47
M=K)$'"R6C*=JK\^,-T XK@?A=^R5XP^'WC3PYXG%_P"!;._\.Z7-IUJ-'TJ:
M$ZB[H0MQ>R$[W?.,X/()[TM4/W69/Q4_: ^*/B+]EOQGXUT"P\+Z*(H8)+._
MT3Q&\]W:HTH#^8OE8CF4;04]2PSQ7J'BOXN?$;P9X&T.ZNO"OA2/7I[5[F[D
MU3Q(;730JCY8XIV3=).P^;;L  S\U<=_PR-KWB/1?B4GB#4_"^A7_B_28M-2
MR\'V,MMIL4J2F7[7)&YRTK,<$]P!5GQQ^S;X]^(%]H&L:WJ7@76=7M='ET6Z
ML=5TV>XTR%6<%;NUB8DK<!1C+Y'/I1J&AS]S\?/B-X^^,WP3OO ^G:;_ ,(M
MXFT>_NGTV^U5X4N7C9%E,@6-O]4<F,C[^3G%;^A_M!:CIT.LZ9H.D7WB3QAJ
MOC*^T/2--UK5BUOF'<\KF4)F"!45B% ;D 59\-_LQ^+/ 6D?!N7P[XBT.3Q!
MX!M[VQN)-2M9?LE[;W,@9]BH0R,H'';/M4C_ +,'B/1VEUOP]XFTRV\86?BR
M\\2Z5/>6\C68CN0R26]PJG<PV.W*XYP:-0T/7?#WB#Q+J'@#4[WQ)H4?AKQ%
M:V]R)+:UN/M$!9(V*R0R$ LAXP2 <@\5\G? ?Q[KT5M\"];L_BCK7CCQ%XPD
M,7B'PUJ6II?0QQ&-G:58E -ML('+?2OK?PSHWBAO!=[9^+=6L-0\07T4R22Z
M9"T=G;[T*JD2M\Y09S\Q)SFN7_9R^ FA? /P'X>TN/2M$D\26-DMI?:[IM@L
M$MZ0<DL^-Q!//)IM-LE-)'S[\--)\>^(?V>[WXJV'Q6\6R>+["\O[N.PU2^^
MT:3/'#<R+Y#VVT?*47 ^;@@5]%:)\7](\:_"NVU:UU>PL?$&I: =2CTM+R/[
M7"[0E^(\[N.O3M7DOA']FWXL:#\.)?AG-XU\+6G@>YN[A[J_TJSN%U=K>6=I
M6C1G)C#'=M)QTS7MDGP7\%6MK*^D^%-$T[65L'L+75UL4^U0H8S&/WN-_0X/
M/3-"3Z#=C$_9^U?7_&O[._A74)]9=_$=_92?\3:]C$Y$GFN [KP&P !CBN?_
M &6]5\17<GQ)T[Q'XDOO%%QI7B!K:*[O2/E7!)6-1]Q,]%YQZT?!_P"'OQE^
M%WA*R\+R:UX!O])TNUEBL)DL[Q9VD+ED,OS;=OS'.WGTIWP'^%?Q,^&_BKQ3
M>^*-:\(ZEI7B&];4KB+1K6YCGBF(P%0R,5V?7FA7T$^IP/B3Q=XS\+_M=_$J
M7P=X;@\47$7A'3+F:#4-0:UMH8DDG+X(5OWC#[HQ@X.2*T/^&I-/?Q+9>*#8
MZVNER_#]_$YT\7W[@,)@GDFWQCS,G'F;NG:O4;;X0WD'QF\<^-CJ=N;7Q'X>
MMM$BLQ&WF0/%YN9&/0J?,' YX->!_$/]G:]^%?PPN=:U+4H];L=)\!MX4NK2
MP@97E9YPYG);[L(&=_\ $!D@T.Z'HR#XR_';X@^*/A]\2O"GB+P7H_A^WC\'
M1^(%OM)UJ2XG:*651%&J&-</\I#<@ XP37K?P?\ C%XIN/$_AKP;XN\'P:!#
MJNA+J.C7MM?&XD=$P#'=(5 CEQ\Q"EAU&:^=_A!X=@\;:9XH^%?AK4/!^N_\
M)+X:43^+/#E[>ZC_ &5Y10Q073W$CL%;YMB(0 0W%?6R?"F[7XA>!O$?]HP&
M#P[I#Z9+;^6V^=F&-ZGH![&DKC=EH<QXE2;QO^U/I6B"\FMH?#'AV348TA8@
M&>Z;;'(Z_P 6SRC@'U-5O!OQE\1Z!\5['X=^(]2T/XA74V[=J_AR-H;B!ADL
M+FV4-%"J=,F7><9VT>+]/_L7]J&"5P(E\:^%I=*@N6+J@FMB6".Z89<^;Q@@
M\''2I?A=\-/BG\.HX-)M_P#A6>C^'G8?;FT2PO1?38&/-,DC'S)?]N3))ZT=
M1=#R+X-^*/$OP_\ $>F?\+=OOBMIOB.\N[Z.TDUK4(G\.WTP:1X+=$3)!:-1
MM#8Z'FGP^+/&ND?"CPO\>&\<ZW?WNH:Y;I<^&+BX"Z.UE=7(@6(08^5XU<$/
MGEAFO59?@S\1OB%KWAR+XG>)_#NJ>%M OVU*"WT&UGANKV<!EA-P7)4!4=LA
M ,DUB:7^S'XP73-&\"ZIXJT>Z^%&D:PNK06T-K(-5E6.7SK>VD<GRMB.%&0,
MD"E9CNCS'P'^T'K_ (-NM0O=4U_7=<\17=I/%J>A:\'2TTS4?.<6RP;E 6/R
M@&<H7'"Y(+"NO\4>*;/4?@'X,\=Z)XUF\<:WX7\1VLUQK$RR0;I)YA#=)Y3A
M2D8C=PBD< #&>M>G>/\ X"WOQ4@\=OXEUN&6\UBW.G:']GB(BTFT#(^,'DR.
MZ#>1P550*\P^)WP_\1:'X,ETKQ%J.E:IX\^)'BK30\6C021V0BM2AD\M7)88
M@C9CGO3U#0^M8'2XEB=!^ZD*LO\ NGD?H:^/_A)\9?&&B_'?Q=;>+-9NM3\$
M:]K-YHVDRW##9I-]#N,<*^B/&O'JY KZ_B1+1HT3F.':JX]%X'\J\(?]F,:C
M\/\ XB^&]3U:&2?Q)K$NM:;?6R,C:=<;M\#^I9'VDXZXQ5NY"MU/$[?XB^+[
M[X3?!S6_&7B[Q;I'@;4;74(]<\4^'';[;#?+<NML;ED5F\G:K#A2/E&<5ZG?
M^(-8^)OCKP9\--!\?7R>'V\,_P#"1:EXKT258;_48A*(HECEY\LDD,YQD\C
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M.T]I#+]EE"X9P'/8]*K4G0] ^"WCOQ!\1?"YUK7+'PY:0S%3:-X<U=M1C92
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M_P#C1]4J^7]?(/KM'S_KYGJF]?[Z_P#?0HWK_?7_ +Z%>5_\(9I__/6\_P#
MI_\ &C_A#-/_ .>MY_X%/_C1]4J^7]?(/KM'S_KYGJF]?[Z_]]"LK4K76)[I
MGL=:M;*V*@"&2T$I![G=N'6N _X0S3_^>MY_X%/_ (T?\(9I_P#SUO/_  *?
M_&LYX&I-6?X-K\A/&47W_KYG:C3O$8Z>);+_ ,%R_P#Q=']G>(\D_P#"2V7/
M_4.7_P"+KBO^$,T__GK>?^!3_P"-'_"&:?\ \];S_P "G_QK'^RY=W_X%(7U
MNCY_U\SM1IWB,?\ ,RV7_@N7_P"+H_L[Q'Q_Q4MEQ_U#E_\ BZXK_A#-/_YZ
MWG_@4_\ C1_PAFG_ //6\_\  I_\:/[+EW?_ (%(/K='S_KYG:_V=XCR3_PD
MMED]?^)<O_Q=']G^)/\ H9;/_P %R_\ Q=<5_P (9I__ #UO/_ I_P#&C_A#
M-/\ ^>MY_P"!3_XT?V7+N_\ P*0?6Z/G_7S.S?2_$,B%'\16+H>JMIJD'\-U
M*--\1* !XDL@!P -.7 _\?KB_P#A#-/_ .>MY_X%/_C1_P (9I__ #UO/_ I
M_P#&C^RY=W_X%(/K='S_ *^9VO\ 9WB/.?\ A);+_P %R_\ Q=(-,\097=XB
ML64'[O\ 9R__ !5<7_PAFG_\];S_ ,"G_P :/^$,T_\ YZWG_@4_^-']ER[O
M_P "D'UNCY_U\STF_LH[_3Y[5IEB::/RWFBP&YZD>E.TRQMM(TZVL;7:EO;Q
MB.-=PZ"O-/\ A#-/_P">MY_X%/\ XT?\(9I__/6\_P# I_\ &M_J$^;GLK[?
MUH/ZY1WU_KYGJF]?[Z_]]"C>O]]?^^A7E?\ PAFG_P#/6\_\"G_QH_X0S3_^
M>MY_X%/_ (U?U2KY?U\A_7:/G_7S/5-Z_P!]?^^A1O7^^O\ WT*\K_X0S3_^
M>MY_X%/_ (T?\(9I_P#SUO/_  *?_&CZI5\OZ^0?7:/G_7S/5-Z_WU_[Z%&]
M?[Z_]]"O*_\ A#-/_P">MY_X%/\ XT?\(9I__/6\_P# I_\ &CZI5\OZ^0?7
M:/G_ %\SU3>O]]?^^A1O7^^O_?0KRO\ X0S3_P#GK>?^!3_XT?\ "&:?_P ]
M;S_P*?\ QH^J5?+^OD'UVCY_U\SU3>O]]?\ OH4;U_OK_P!]"O*_^$,T_P#Y
MZWG_ (%/_C1_PAFG_P#/6\_\"G_QH^J5?+^OD'UVCY_U\SU3>O\ ?7_OH4;U
M_OK_ -]"O*_^$,T__GK>?^!3_P"-'_"&:?\ \];S_P "G_QH^J5?+^OD'UVC
MY_U\SU3>O]]?^^A1O7^^O_?0KRO_ (0S3_\ GK>?^!3_ .-'_"&:?_SUO/\
MP*?_ !H^J5?+^OD'UVCY_P!?,]4WK_?7_OH4;U_OK_WT*\K_ .$,T_\ YZWG
M_@4_^-'_  AFG_\ /6\_\"G_ ,:/JE7R_KY!]=H^?]?,]4WK_?7_ +Z%&]?[
MZ_\ ?0KRO_A#-/\ ^>MY_P"!3_XT?\(9I_\ SUO/_ I_\:/JE7R_KY!]=H^?
M]?,]4WK_ 'U_[Z%&]?[Z_P#?0KRO_A#-/_YZWG_@4_\ C1_PAFG_ //6\_\
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MX0S3_P#GK>?^!3_XT?5*OE_7R#Z[1\_Z^9ZIO7^^O_?0HWK_ 'U_[Z%>5_\
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M>MY_X%/_ (T?5*OE_7R#Z[1\_P"OF>J;U_OK_P!]"C>O]]?^^A7E?_"&:?\
M\];S_P "G_QH_P"$,T__ )ZWG_@4_P#C1]4J^7]?(/KM'S_KYGJF]?[Z_P#?
M0HWK_?7_ +Z%>5_\(9I__/6\_P# I_\ &C_A#-/_ .>MY_X%/_C1]4J^7]?(
M/KM'S_KYGJF]?[Z_]]"C>O\ ?7_OH5Y7_P (9I__ #UO/_ I_P#&C_A#-/\
M^>MY_P"!3_XT?5*OE_7R#Z[1\_Z^9ZIO7^^O_?0HWK_?7_OH5Y7_ ,(9I_\
MSUO/_ I_\:/^$,T__GK>?^!3_P"-'U2KY?U\@^NT?/\ KYGJF]?[Z_\ ?0IL
MBPS "18I0"& D"M@CH1GH?>O+?\ A#-/_P">MY_X%/\ XT?\(9I__/6\_P#
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M\:/JE7R_KY!]=H^?]?,]4WK_ 'U_[Z%&]?[Z_P#?0KRO_A#-/_YZWG_@4_\
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M5\OZ^0?7:/G_ %\SU3>O]]?^^A1O7^^O_?0KRO\ X0S3_P#GK>?^!3_XT?\
M"&:?_P ];S_P*?\ QH^J5?+^OD'UVCY_U\SU3>O]]?\ OH4;U_OK_P!]"O*_
M^$,T_P#YZWG_ (%/_C1_PAFG_P#/6\_\"G_QH^J5?+^OD'UVCY_U\SU3>O\
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M4$<CM6Q7A/["W_)I/PX_Z\Y?_1SU[M713DYP4GU,*D5";BNC"BBBM#,****
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M?PIN]0O]5\,Z]X=GU>P9YF%QI@1A&\*R@[B"6W*2<C%'MDTFEH%H[<JO\_\
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MP9XU\2:YK$M[K^C'7Q&-:T_1M0^SVFJ;.GVB/:=V>AY&0:]L_LB__P"?*?\
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MG_[X-']D7_\ SY3_ /?!K52IQ5DT9N%1N[3*E%6_[(O_ /GRG_[X-']D7_\
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M_=FB SL88]:W&L+2/P1I?A^#7(4:SBAB-TT62_EX(..V<5WO_",2_P#0(/\
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M@7B:;(WB?Q>FHV=D^F/JL>K;;N\LW?<;:>39\\>0,# X[U[/_9%__P ^4_\
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MLQ^$KJPT"#3+_7_"UUHUDVGPZGH&H?9KN>!CN=)GVG?N;+'@?,<U[+_9%_\
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MPOX2URQOX=0U[4;/399)],T34K_SM/TYW/6"+:-N,\9)Q7KW]D7_ /SY3_\
M?!H_LB__ .?*?_O@T6H[Z!^]\RKUI*M_V1?_ //E/_WP:/[(O_\ GRG_ .^#
M6O/#NC/V<^S*E%6_[(O_ /GRG_[X-']D7_\ SY3_ /?!H]I#N@]G/LRI15O^
MR+__ )\I_P#O@T4>TAW0>SGV9ZG1117QI]J%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
/!1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>smmt-20251231_g3.jpg
<TEXT>
begin 644 smmt-20251231_g3.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &H UX# 2(  A$! Q$!_\0
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M *AG_D2MJB@#%_XJ'_J&?^1*/^*A_P"H9_Y$K:HH Q?^*A_ZAG_D2C_BH?\
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M'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_ *BNI_\
M@1_]:@#:HK%_X1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ -JBL7_A&O\
MJ*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_
M *BNI_\ @1_]:@#:HK%_X1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ -JB
ML7_A&O\ J*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_ ($?
M_6H_X1K_ *BNI_\ @1_]:@#:HK%_X1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!
M'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:_P"H
MKJ?_ ($?_6H_X1K_ *BNI_\ @1_]:@#:HK%_X1K_ *BNI_\ @1_]:C_A&O\
MJ*ZG_P"!'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q
M?^$:_P"HKJ?_ ($?_6H_X1K_ *BNI_\ @1_]:@#:HK%_X1K_ *BNI_\ @1_]
M:C_A&O\ J*ZG_P"!'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?
M_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_ *BNI_\ @1_]:@#:HK%_X1K_ *BN
MI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ/^$:_P"H
MKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_ *BNI_\ @1_]:@#:HK%_
MX1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ
M/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_ *BNI_\ @1_]
M:@#:HK%_X1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ -JBL7_A&O\ J*ZG
M_P"!'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_ *BN
MI_\ @1_]:@#:HK%_X1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ -JBL7_A
M&O\ J*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_
MX1K_ *BNI_\ @1_]:@#:HK%_X1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ
M -JBL7_A&O\ J*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_
M ($?_6H_X1K_ *BNI_\ @1_]:@#:HK%_X1K_ *BNI_\ @1_]:C_A&O\ J*ZG
M_P"!'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:
M_P"HKJ?_ ($?_6H_X1K_ *BNI_\ @1_]:@#:HK%_X1K_ *BNI_\ @1_]:C_A
M&O\ J*ZG_P"!'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?_6H
MVJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_ *BNI_\ @1_]:@#:HK%_X1K_ *BNI_\
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MM_%J_N]=^)?@+P/!K&H:/8ZHE]?:A)I4[6UQ(D$:>7&)5^95+N2=I!(3'&:
M/7**^6I_'&O6]O+\.SXCU,3_ /"=Q^'UUCSB;[^SGA^TD>=C/F ?N]_7!![5
MZ3\+KN^\-_%/QIX&GU74=9TRSM;+4]/FU2Y:YGA64.DD;2O\S#=&&7).-QH
M]<HHHH **J/J]A$[(][;HZG!5I5!!]#S3?[:T[_G_M?^_P O^- %VBJ7]M:=
M_P _]K_W^7_&C^VM._Y_[7_O\O\ C0!=HJE_;6G?\_\ :_\ ?Y?\:/[:T[_G
M_M?^_P O^- %VBJ7]M:=_P _]K_W^7_&C^VM._Y_[7_O\O\ C0!=HJE_;6G?
M\_\ :_\ ?Y?\:/[:T[_G_M?^_P O^- %VBJ7]M:=_P _]K_W^7_&C^VM._Y_
M[7_O\O\ C0!=HJE_;6G?\_\ :_\ ?Y?\:/[:T[_G_M?^_P O^- %VBJ7]M:=
M_P _]K_W^7_&C^VM._Y_[7_O\O\ C0!=HJE_;6G?\_\ :_\ ?Y?\:/[:T[_G
M_M?^_P O^- %VBJ7]M:=_P _]K_W^7_&C^VM._Y_[7_O\O\ C0!=HJE_;6G?
M\_\ :_\ ?Y?\:/[:T[_G_M?^_P O^- %VBJ7]M:=_P _]K_W^7_&C^VM._Y_
M[7_O\O\ C0!=HJE_;6G?\_\ :_\ ?Y?\:/[:T[_G_M?^_P O^- %VBJ7]M:=
M_P _]K_W^7_&C^VM._Y_[7_O\O\ C0!=HJE_;6G?\_\ :_\ ?Y?\:/[:T[_G
M_M?^_P O^- %VBJ7]M:=_P _]K_W^7_&C^VM._Y_[7_O\O\ C0!=HJE_;6G?
M\_\ :_\ ?Y?\:/[:T[_G_M?^_P O^- %VBJ7]M:=_P _]K_W^7_&C^VM._Y_
M[7_O\O\ C0!=HJE_;6G?\_\ :_\ ?Y?\:/[:T[_G_M?^_P O^- %VBJ7]M:=
M_P _]K_W^7_&C^VM._Y_[7_O\O\ C0!=HJE_;6G?\_\ :_\ ?Y?\:/[:T[_G
M_M?^_P O^- %VBJ7]M:=_P _]K_W^7_&C^VM._Y_[7_O\O\ C0!=HJE_;6G?
M\_\ :_\ ?Y?\:/[:T[_G_M?^_P O^- %VBJ7]M:=_P _]K_W^7_&C^VM._Y_
M[7_O\O\ C0!=HJE_;6G?\_\ :_\ ?Y?\:/[:T[_G_M?^_P O^- %VBJ7]M:=
M_P _]K_W^7_&C^VM._Y_[7_O\O\ C0!=HJE_;6G?\_\ :_\ ?Y?\:/[:T[_G
M_M?^_P O^- %VBJ7]M:=_P _]K_W^7_&C^VM._Y_[7_O\O\ C0!=HJE_;6G?
M\_\ :_\ ?Y?\:/[:T[_G_M?^_P O^- %VBJ7]M:=_P _]K_W^7_&C^VM._Y_
M[7_O\O\ C0!=HJE_;6G?\_\ :_\ ?Y?\:/[:T[_G_M?^_P O^- %VBJ7]M:=
M_P _]K_W^7_&C^VM._Y_[7_O\O\ C0!=HJE_;6G?\_\ :_\ ?Y?\:/[:T[_G
M_M?^_P O^- %VBJ7]M:=_P _]K_W^7_&C^VM._Y_[7_O\O\ C0!=KC?B_P#$
MS3OA!\.]9\5:D0T=E%^Y@W8,\QXCC'N6(^@R>U=+_;6G?\_]K_W^7_&OSJ_;
M8^+EU\;/BQIGPY\+2"]TW3+I;<>4X*7-^_RLV>FV,$IGL?,/2N[!X?ZS547\
M*U?H>9F&+^IT')?$]%ZC/V.OACJ/[0/QLU3XC^*P;VPTV[-].\@RES?,=T<8
M!_A3[V.P5!T-?I+7G/P4\"^'_@Q\-M'\+6%_:.;6/?=7 E7-Q<-S))U[MT'9
M0H[5W/\ ;6G?\_\ :_\ ?Y?\:>-Q'UBK=?"M%Z"R["?5*"C+XGJ_4NT52_MK
M3O\ G_M?^_R_XT?VUIW_ #_VO_?Y?\:X#U"[15+^VM._Y_[7_O\ +_C1_;6G
M?\_]K_W^7_&@"[15+^VM._Y_[7_O\O\ C1_;6G?\_P#:_P#?Y?\ &@"[15+^
MVM._Y_[7_O\ +_C1_;6G?\_]K_W^7_&@"[15+^VM._Y_[7_O\O\ C1_;6G?\
M_P#:_P#?Y?\ &@"X1D8/(JE<Z%IMYG[1I]K/G_GI K?S%+_;6G?\_P#:_P#?
MY?\ &C^VM._Y_P"U_P"_R_XT[M":3W,FY^''A*\SY_A?19\_\]-/A;^:UEW/
MP.^'-YGS_ 'A>8GN^C6Y/_H%=5_;6G?\_P#:_P#?Y?\ &C^VM._Y_P"U_P"_
MR_XU:J36S9FZ5-[Q7W' W/[-/PINL[_A[X>7_KG81I_Z"!67<_LB_!ZZSO\
M >FKG_GFTB?^@L*]2_MK3O\ G_M?^_R_XT?VUIW_ #_VO_?Y?\:M5ZRVF_O9
MD\+0>]-?<C\R;C_@E_\ %R#Q%K^H:;XB\!V\&IW\MVD3&])BC+?NXA^[)VHF
MU1DD\<DDYKZV_8A^ 7CS]G#X>:SX2\8ZWHVL6#:D]]I,6C^<5LTE^::+]XJX
M4R9< 9P7?GI7T'#JEG<2".*[@ED;HB2*2?P!JU1.O4J14)NZ0Z>&HT9N=.-F
M]PHHHK Z0HHHH *Q?#7_ #%?^O\ E_I6U6+X:_YBO_7_ "_TH /!W_(N6G_
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M=HH I?V+IW_/A:_]^5_PH_L73O\ GPM?^_*_X5=HH I?V+IW_/A:_P#?E?\
M"C^Q=._Y\+7_ +\K_A5VB@"E_8NG?\^%K_WY7_"C^Q=._P"?"U_[\K_A5VB@
M"E_8NG?\^%K_ -^5_P */[%T[_GPM?\ ORO^%7:* *7]BZ=_SX6O_?E?\*/[
M%T[_ )\+7_ORO^%7:* *7]BZ=_SX6O\ WY7_  H_L73O^?"U_P"_*_X5=HH
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M=_SX6O\ WY7_  H_L73O^?"U_P"_*_X5=HH I?V+IW_/A:_]^5_PH_L73O\
MGPM?^_*_X5=HH I?V+IW_/A:_P#?E?\ "C^Q=._Y\+7_ +\K_A5VB@"E_8NG
M?\^%K_WY7_"C^Q=._P"?"U_[\K_A5VB@"K#I=G;R"2*T@BD7HZ1J"/Q JU11
M0 4444 %%%% !6+X:_YBO_7_ "_TK:K%\-?\Q7_K_E_I0 >#O^1<M/\ @?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %?)?_!0#X[?\(-X%C\#Z3<[-;\01G[68V^:"RSA
ML_\ 70@I] _M7TWXR\6Z;X#\*ZKXAUB?[/IFFV[7$[@9.U1T [L3@ =R0*_-
MOX,^%=3_ &R/VEM0\2>(HB^AV\PO]0B)W1I IQ!:#V;:%]PKGK7K8"C%R>(J
M_##7Y]#PLUQ$U&.%H_'4T]%U?]>9]-?L%_ D_#;X='Q7JMOL\0>(XUD574AK
M>SZQIST+_?/L4'5:^HZ:B+&BHBA448"J, #TIU<%>M*O4=26[/4PV'AA:4:,
M-D%%%%8'2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5B^&O^8K_P!?\O\ 2MJL7PU_S%?^O^7^E !X._Y%RT_X'_Z&U;58
MO@[_ )%RT_X'_P"AM6U0!\K_ !?\%S)\63KNEV6B>/K+6-76VO\ 0'F$=Y%/
M%H]VAMQ)\P53#ND"MM._9C ;<.\T&'PSXY\(Z1XC\!Z1HVJ^(8="M;2TT_Q#
M?2,;6Q);:DB_O"K$JXWE<N4P7('%WQ]^SW:^*O&=CKVEZSJ?A]Y[[[3JZ:?=
M^4)@+.>W62,%&"S?O$0L"N4+_P 6TUJW_P !=!\S2YM!U#5O!UUI]@NEI<:#
M<)&TMJIRD<@D1U?!)(8C=EB<T >+::EM/\*OA)X:>U9[6+QS_9^LV=S&J)'<
MQR7,KV_E@L#&)?NC)&U%!ZU5^-2?V#K?Q?T?2K98-(U"U\/R7T5OB-(VEN_)
MD.!P"\8"D=3U[5[Y+\#O#3> +7PE%]MMK6UNA?P:A#<$7J78D,GVGS2#F7<2
M<D$<XQCBF67P+\/1^'?$VE:G<:CXA?Q)M_M/4-4G#74X10L8W(JA0F,J%48/
M- './IMIX8_:>\/V^C6<%A!J'A>Z2\@M8A&A6*>+RF*J  07903V.*E^)MM'
MK'Q]^%.FW]I'=:8L&K7BQS@/&\Z11*I*'N@=B"?[_'2NA\.?!JQ\/W6J7\OB
M#7]9UF_L/[,&KZE>*UU;6_)VPLB*%.X[MV"2P!).*-4^#&FZIX=\-:<VM:Y!
MJ'AW_D'Z]%=K_:"938^Z1D*ON4X8%2#QQ0!X#=VZ+XGG\*I9QOX5/Q5MU-O@
M>0-UH9V@V="AE&[;T!'(YKUSP!;1:)^T5\1M,TZ&.VTV?3=,OIH(4"QI<'S4
M+ #@%D5<^NT&MW_A1'AT^"7\.&?4BS:A_;!UC[3_ *?]NW[Q=>9C'F @#[N,
M#&,5L^ _AO8> I-5N8K_ %#6=5U65);W5-5E62XGV+LC4E550JC( "@#)]:
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M7_A)?^H5J?\ X#__ %Z/^$E_ZA6I_P#@/_\ 7K:HH Q?^$E_ZA6I_P#@/_\
M7H_X27_J%:G_ . __P!>MJB@#%_X27_J%:G_ . __P!>C_A)?^H5J?\ X#__
M %ZVJ* ,7_A)?^H5J?\ X#__ %Z/^$E_ZA6I_P#@/_\ 7K:HH Q?^$E_ZA6I
M_P#@/_\ 7H_X27_J%:G_ . __P!>MJB@#%_X27_J%:G_ . __P!>C_A)?^H5
MJ?\ X#__ %ZVJ* ,7_A)?^H5J?\ X#__ %Z/^$E_ZA6I_P#@/_\ 7K:HH Q?
M^$E_ZA6I_P#@/_\ 7H_X27_J%:G_ . __P!>MJB@#%_X27_J%:G_ . __P!>
MC_A)?^H5J?\ X#__ %ZVJ* ,7_A)?^H5J?\ X#__ %Z/^$E_ZA6I_P#@/_\
M7K:HH Q?^$E_ZA6I_P#@/_\ 7H_X27_J%:G_ . __P!>MJB@#%_X27_J%:G_
M . __P!>C_A)?^H5J?\ X#__ %ZVJ* ,7_A)?^H5J?\ X#__ %Z/^$E_ZA6I
M_P#@/_\ 7K:HH Q?^$E_ZA6I_P#@/_\ 7H_X27_J%:G_ . __P!>MJB@#%_X
M27_J%:G_ . __P!>C_A)?^H5J?\ X#__ %ZVJ* ,7_A)?^H5J?\ X#__ %Z/
M^$E_ZA6I_P#@/_\ 7K:HH Q?^$E_ZA6I_P#@/_\ 7H_X27_J%:G_ . __P!>
MMJB@#%_X27_J%:G_ . __P!>C_A)?^H5J?\ X#__ %ZVJ* ,7_A)?^H5J?\
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MC_A)?^H5J?\ X#__ %ZVJ* ,7_A)?^H5J?\ X#__ %Z/^$E_ZA6I_P#@/_\
M7K:HH Q?^$E_ZA6I_P#@/_\ 7H_X27_J%:G_ . __P!>MJB@#%_X27_J%:G_
M . __P!>C_A)?^H5J?\ X#__ %ZVJ* ,7_A)?^H5J?\ X#__ %Z/^$E_ZA6I
M_P#@/_\ 7K:HH Q?^$E_ZA6I_P#@/_\ 7H_X27_J%:G_ . __P!>MJB@#%_X
M27_J%:G_ . __P!>C_A)?^H5J?\ X#__ %ZVJ* ,7_A)?^H5J?\ X#__ %Z/
M^$E_ZA6I_P#@/_\ 7K:HH S+/7/MERD/]GWT&[/[R:':@XSR<UIT44 %%%%
M!1110 5B^&O^8K_U_P O]*VJQ?#7_,5_Z_Y?Z4 '@[_D7+3_ ('_ .AM6U6+
MX._Y%RT_X'_Z&U;5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5^:/[5/Q#U+]IKX_:9X"\*/\
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M:/[+U?\ Z#G_ )*)_C0!M45B_P!EZO\ ]!S_ ,E$_P :/[+U?_H.?^2B?XT
M;5%8O]EZO_T'/_)1/\:/[+U?_H.?^2B?XT ;5%8O]EZO_P!!S_R43_&C^R]7
M_P"@Y_Y*)_C0!M45B_V7J_\ T'/_ "43_&C^R]7_ .@Y_P"2B?XT ;5%8O\
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M]7_Z#G_DHG^- &U16+_9>K_]!S_R43_&C^R]7_Z#G_DHG^- &U16+_9>K_\
M0<_\E$_QH_LO5_\ H.?^2B?XT ;5%8O]EZO_ -!S_P E$_QH_LO5_P#H.?\
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MY*)_C1_9>K_]!S_R43_&@#:HK,L[#4H+E'N-5^TQ#.Z+[.J;N/45IT %%%%
M!1110 5B^&O^8K_U_P O]*VJQ?#7_,5_Z_Y?Z4 '@[_D7+3_ ('_ .AM6U6+
MX._Y%RT_X'_Z&U;5 %'4-$LM5N],NKJ'S9]-N#=VC[V'ERF*2$M@'!_=S2+@
MY'S9Z@$7J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH YGXE?$#3/A;X&UCQ1J[[;+3H#*4SAI7Z)&O\ M,Q"
MCW-?GI^S#\/]2_:C_:"U/QUXJ0W.EV-R-2OMP/ERS9_<6X_V5VC(_N1X/WA7
M1?MY?&&\^)/Q#TWX6>&=]Y!I]RB7$5N<FZU!_E6+T.P-C_>=L_=%?8_[/OP?
ML_@A\+]*\-P!'O@OVC4;E!_K[E@-[?08"C_945[L?]APO/\ ;J;>2/F)_P#"
MEC>3_EW2W\Y?U^O<](HHHKPCZ<**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K%\-?\ ,5_Z_P"7^E;5
M8OAK_F*_]?\ +_2@ \'?\BY:?\#_ /0VK:K%\'?\BY:?\#_]#:MJ@ HKY7^,
M_CGQ$/CAIVBS^*H/!5O8ZA'+H4M]91_99R^F70>XDFD!!'G.+<H","3(!;!'
MJ^KV'Q)\1ZMI-K!KMMX4TJ'1H[B^U?2X(+L7&H,</%&)P2(E"[@Q0%@X&00<
M 'J-%?/=K\8O$^M_!WP+/!?6MIXE\3Z[_82:LMNK1^6LLRM=QQ$X.8X,@,,9
M<<8QF#Q%\7O%/PQL?B)H6H:M#X@UO28M/FT?4KNVCA:47D@A E2,*I,<F6X
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!6+X:_YBO_7_ "_TK:K%\-?\Q7_K_E_I0 >#O^1<M/\ @?\ Z&U;58O@[_D7
M+3_@?_H;5M4 ?.GQAA\;#QOI.FZAX<MO'/AR^UQY=(MWFMX% .DWB/:S*V"0
M"7E#G=PI'WMJU4U7P7\1=%\&^#OAZOA^_P#$/A6PTV)-:O=*U&U@FOW'_+HI
MFE1DA'1F RR@*-H)KZ6HH \9\8^&->\5>"O"=_I7@U="U;PMK5OJ%KX>N;JW
M!E@B5HVB22)FC3<DAVY. 4&:YKQ%\(?%/Q.L?B)KNH:3#X?UO5HM/AT?3;NY
MCF:(6<@F!E>,LH,DF5X)PO?FOHNB@#QO1]*\8>)?B2_CG5_"9T-M'T*:QT[2
M)M1AEEN[F1P[GS(RRHF(U0%N?F)(&*/%6C^,-0U3X=>/H?"L<WB#2(;J#5/#
MT5]")=EQ&H81S,1&Q1T!P2 0S8.:]DHH ^<Y?A#XLGTF7Q:VDV__  E[>,8_
M%"Z(UTF1;I'Y M?.^X',>6W9V[L9/%=Y\,O#6NW/C_Q;XW\1:2= N-4AM;"R
MTQ[F.>6*"$,6:1HR4R[R' !. H]:]0HH **** ,F?PII=Q-)+):[I)&+,?,<
M9).3WJ/_ (0[2/\ GT_\BO\ XUM44 8O_"':1_SZ?^17_P :/^$.TC_GT_\
M(K_XUM44 8O_  AVD?\ /I_Y%?\ QH_X0[2/^?3_ ,BO_C6U10!B_P#"':1_
MSZ?^17_QH_X0[2/^?3_R*_\ C6U10!B_\(=I'_/I_P"17_QH_P"$.TC_ )]/
M_(K_ .-;5% &+_PAVD?\^G_D5_\ &C_A#M(_Y]/_ "*_^-;5% &+_P (=I'_
M #Z?^17_ ,:/^$.TC_GT_P#(K_XUM44 8O\ PAVD?\^G_D5_\:/^$.TC_GT_
M\BO_ (UM44 8O_"':1_SZ?\ D5_\:/\ A#M(_P"?3_R*_P#C6U10!B_\(=I'
M_/I_Y%?_ !H_X0[2/^?3_P BO_C6U10!B_\ "':1_P ^G_D5_P#&C_A#M(_Y
M]/\ R*_^-;5% &+_ ,(=I'_/I_Y%?_&C_A#M(_Y]/_(K_P"-;5% &+_PAVD?
M\^G_ )%?_&C_ (0[2/\ GT_\BO\ XUM44 8O_"':1_SZ?^17_P :/^$.TC_G
MT_\ (K_XUM44 8O_  AVD?\ /I_Y%?\ QH_X0[2/^?3_ ,BO_C6U10!B_P#"
M':1_SZ?^17_QH_X0[2/^?3_R*_\ C6U10!B_\(=I'_/I_P"17_QH_P"$.TC_
M )]/_(K_ .-;5% &+_PAVD?\^G_D5_\ &C_A#M(_Y]/_ "*_^-;5% &+_P (
M=I'_ #Z?^17_ ,:/^$.TC_GT_P#(K_XUM44 8O\ PAVD?\^G_D5_\:/^$.TC
M_GT_\BO_ (UM44 8O_"':1_SZ?\ D5_\:/\ A#M(_P"?3_R*_P#C6U10!B_\
M(=I'_/I_Y%?_ !H_X0[2/^?3_P BO_C6U10!B_\ "':1_P ^G_D5_P#&C_A#
MM(_Y]/\ R*_^-;5% &+_ ,(=I'_/I_Y%?_&C_A#M(_Y]/_(K_P"-;5% &+_P
MAVD?\^G_ )%?_&C_ (0[2/\ GT_\BO\ XUM44 8O_"':1_SZ?^17_P :/^$.
MTC_GT_\ (K_XUM44 8O_  AVD?\ /I_Y%?\ QH_X0[2/^?3_ ,BO_C6U10!B
M_P#"':1_SZ?^17_QH_X0[2/^?3_R*_\ C6U10!B_\(=I'_/I_P"17_QH_P"$
M.TC_ )]/_(K_ .-;5% &+_PAVD?\^G_D5_\ &C_A#M(_Y]/_ "*_^-;59WB+
MQ!8>%-!U#6=4N%M-.L('N+B9SPB*,D_IT[TTFW9";25V?+G[=/Q+TKX5_#Q/
M#ND)Y7B7Q"K1JRR/NM[4<22=>"WW!]6(^[6?^P7^SO:Z!X$?QQK]GOU774'V
M%')4P6><AA@]9#AO]U4]37@/@C2-4_;:_:?N=4U2.6/P_'(+FZ3/%M81G$4
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MLU.#_M%SWKV^BBO,JU)59NI+=GM4:,*%.-*&R"BBBLC8**** "BBB@ HHHH
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M@^[7Q>\?C+PVKK'KTNGI(ER)(PDPEM]X&' 4\,""H.: /#[F5K=Y_AD&NO\
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MMJB@#%_X3'2/^?O_ ,A/_A1_PF.D?\_?_D)_\*VJ* ,7_A,=(_Y^_P#R$_\
MA1_PF.D?\_?_ )"?_"MJB@#%_P"$QTC_ )^__(3_ .%'_"8Z1_S]_P#D)_\
M"MJB@#%_X3'2/^?O_P A/_A1_P )CI'_ #]_^0G_ ,*VJ* ,7_A,=(_Y^_\
MR$_^%'_"8Z1_S]_^0G_PK:HH Q?^$QTC_G[_ /(3_P"%'_"8Z1_S]_\ D)_\
M*VJ* ,7_ (3'2/\ G[_\A/\ X4?\)CI'_/W_ .0G_P *VJ* ,7_A,=(_Y^__
M "$_^%'_  F.D?\ /W_Y"?\ PK:HH Q?^$QTC_G[_P#(3_X4?\)CI'_/W_Y"
M?_"MJB@#%_X3'2/^?O\ \A/_ (4?\)CI'_/W_P"0G_PK:HH Q?\ A,=(_P"?
MO_R$_P#A1_PF.D?\_?\ Y"?_  K:HH Q?^$QTC_G[_\ (3_X4?\ "8Z1_P _
M?_D)_P#"MJB@#%_X3'2/^?O_ ,A/_A1_PF.D?\_?_D)_\*VJ* ,7_A,=(_Y^
M_P#R$_\ A1_PF.D?\_?_ )"?_"MJB@#%_P"$QTC_ )^__(3_ .%'_"8Z1_S]
M_P#D)_\ "MJO$/VNOCD/@C\*;J>RF">(]6W66F*#\R,1\\W_ &S4Y_WB@[UK
M2IRJS5..[,:U:%"G*K/9'R+^V?\ %^Y^._Q9TOP!X6=KO2M,N1;1[,[;F]<[
M7?IG:@.S)Z8D/0U]M?!KP_X7^#GPYT?PKIUV'6TBS<7 B<&XG;F20_+W;./0
M #M7S/\ \$[O@:X%Y\4=:@9I9?,M='\X<D<B:X!]SF,'_KIZBON>O3Q]2,%'
M"T_ACOYL\7*Z,ZCECJWQ3V\H]/Z]#%_X3'2/^?O_ ,A/_A1_PF.D?\_?_D)_
M\*VJ*\<^@,7_ (3'2/\ G[_\A/\ X4?\)CI'_/W_ .0G_P *VNE9EYXETG3\
M_:-1MHB/X3*-WY=:I1<M(JY+DHZMD'_"8Z1_S]_^0G_PH_X3'2/^?O\ \A/_
M (5DW?Q5\/VQPD\US_UQB/\ [-BNGTZ_AU2Q@N[=M\,RAU)&#BKG2J4U><6B
M(583=HRN9W_"8Z1_S]_^0G_PH_X3'2/^?O\ \A/_ (5<UR2\BTB[?3T#WJQD
MQ*1G+5Y.=-\=ZX2)&O44]0\HA7\LC^5;4<.JJ<G-12[F5:NZ3246WY'I3^-M
M$B&7OE0?[2./Z54F^)7AR$$_VB'/HD3G^E</;?!_5[IM]Y>V\1;J<M(W\A_.
MMNS^#&GQ\W5_<3GTB58Q^N:Z?8X2'QU+^B.?VN*G\-.WJSYX^+/Q=\6?&;XP
MZMX"\'^*=2\">%/#-E:W.K:EI*QKJ6H7-SYACACD=6$,2I'N+ ;F+ 9 %6?@
MO\4/%WPI^-&D_#WQ;XMOO&WA;Q-87=WI&IZRJ-J-A<VPC,D$DD:+YT;I)N#,
MNY2I&2#76?%;]D[5+CQE%XX^%OB&S\-^*)+5+#4[/7()+K3]5@0LT7F!&5XY
M$+-AT/1B"#6A\#?V:]?\*_$"7XA_$;Q%8^(O%T=F^G:9::-:O;Z=I5O(RM-Y
M8=F>220HF9&(X4  5G.>&]BXP3YK_P!?@7".(]JI3?NV_K\3V:]\8:<UG.+:
M]5;DQL(B\3X#8XS\O3->12'7]6<K=ZA,%)Y\Z=BOY#/\J]]HK&AB)4+\J3OW
M-JU"-:W,W\CPJT\$V\F#=:W;PYZ^7!(Y_516U:>"O"L?-SK-S.?1(B@_]!->
MMT5K+'8B7VK&4<%0C]D\^M-%\#6F#L\YA_%,)6_3&/TKH;/Q)H&GP+!;2QV\
M*]$B@90/P"UT%%<DZLZGQR;.J-.$/A21B_\ "8Z1_P _?_D)_P#"C_A,=(_Y
M^_\ R$_^%;5%9FAB_P#"8Z1_S]_^0G_PH_X3'2/^?O\ \A/_ (5M44 8O_"8
MZ1_S]_\ D)_\*/\ A,=(_P"?O_R$_P#A6U10!B_\)CI'_/W_ .0G_P */^$Q
MTC_G[_\ (3_X5M44 8O_  F.D?\ /W_Y"?\ PH_X3'2/^?O_ ,A/_A6U10!F
M6?B73=0N4M[>Y\R5\[5V,,X&>X]JTZ** "BBB@ HHHH *Q?#7_,5_P"O^7^E
M;58OAK_F*_\ 7_+_ $H /!W_ "+EI_P/_P!#:MJL7P=_R+EI_P #_P#0VK:H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW'*DR!XW61#T93D&N.4)0^)6.J,XS^%W'T445!84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%'2@ HKP_]
MIGX\ZE\+=-\/:#X.MK'5/'GBJ];3]+COG)M;0)$TLUU.JG<R1HI^5<%F*C(K
MQJ#X\_%WX)ZOI&L^/O$6C^/O ]W?6]AJIL]&&FW>E&>58H[B(K(RR1*[J&5A
MNVG(/%;QH5)P<TM$8RK4XR4&]6?:M%87C+Q*?"FC_;%MS<LT@C"YP 2"<D^G
M'ZUYQ)\4_$6IN4LK:*,]A!"9&_7/\JUHX2K6CS1V,JN*IT7RRW/8+BXBM())
MYY$AAB4N\DC!510,DDGH .]?E_X\UO4OVT?VEX;.QG>V\,0R?9;>X?Y4M;&,
MYDG;/ 9^6&>I9%["OI/XM?&^S\&[M)\;ZY):/>6Y=M,EB9C+$V5^:)%^Z<$?
M,,'!]#7:^ OAI<>)_#&F:M:I'I&GWT*SPP30E)1&PRI* ?+D8."<X(SCI7M8
M:C' Q=6I)7>B?];G@8R;S&2H4UI%W:ZOU['INBZYX0\%:)IVB:=>6UMI]C E
MM;PP9=410 !E0?S_ !KK8Y%E171@R, 0P.01ZUYW9?!BRCP;O4)Y_41($'ZY
MKT*WMX[2WB@B79%$H1%] !@"O$KJBK>RDV^MSZ"@ZMK5(I+I8S/%>J7>C:%<
MW=E;_:;B,#:A!(&2 3@<G%>8?\)-XWUP_P"CQW*QG_GA;;5'_ L?UKV:BG1K
MQI1LX)ONQ5J$JKNIM+R/&?\ A ?%VM\WLS*IY_TNZW?H":T[+X*R'!N]35?5
M88L_J2/Y5ZG16SS"L](V7HC)8&BM97?JSB;+X1Z';$&;[1=GTDDP/_'0*[&U
MM8K*VC@@C$4,:A41>@%2T5QU*U2K\<KG7"E"G\"L%%%%8FH4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !129Q7.>)/B3X5\(3-#K/B#3M/N% 8V
M\UPHEP>AV9W8_"HG.%-<TW9>9,IQ@KR=D=)17C^K?M7_  YTPXBU6XU%O[MI
M:/\ S<*/UK7^-GQD7X.Z-I]__9#:N+V5H5"W'E*I"[AD[6Z\_E7&\?A5"515
M$U'>VMK^AS/%T%&4U--1WMK;[BY-\?OAA;3212_$?PC%+&Q5T?7;4,I'!!!D
MX-=!X5\>>&?'4-Q+X:\1:3XABMV"S/I5]%<K$3R QC8X)P>M?CG\'?"?A_7?
MAWIFH7F@:9<7-Q)<2/+-:1R.2;B3JQ7)]*^P/^";.F6>D>.?CC;6-I!96RSZ
M,5AMXQ&@S;S$X  %<.$S6&+Q4\,H6<;Z^CL<>&S&.(Q$J"C:U]?1V/NFBBBO
M=/7"BBB@ K%\-?\ ,5_Z_P"7^E;58OAK_F*_]?\ +_2@ \'?\BY:?\#_ /0V
MK:K%\'?\BY:?\#_]#:MJ@#S3Q_\ M ^$OAWXHTW0]1OE-U-/LOC&DKC3XC;S
M2K+(41AR8E&TD':Y?[J&NF\3?$GPQX.T2RU?5]9MK33[UXTM9LE_M!D(">6J
M@E\[@> <#DX S7@_Q)T4W7Q976/!&NV5YJTVO"TU?0-;M6-G]JCT6[VEGPK!
M6M@R<;ERX8_=*U+\2Y- \=?LQZ1XVM?#MII5Y);Z1!:HD*YLH?[0M@88B -J
M C P!D <=J /H#Q7XNTCP/HD^KZY?1Z?I\)56FD!;+,<*JJH+,Q) "@$GTK)
MT7XL>$_$'AW5-<M-9B73-++"^DNHY+9[4A0Q\R.55=>"",CGMFN0^/\ YG]I
M_"O=Y?V+_A,[/SMV<[O*F\OVQOQU_BVXKR+X]>=_PD_Q@^R[/[-^R>&_[4W?
M=S]L[^_EXSGC9G/:@#Z.\$?%7PO\19KJ'0=2-U<6R))+!/;36TH1\[7"2HK%
M3@X8 CWJWXT\?Z#\/K&WN]>O_L4=Q*(($2&2:6:0@G:D<:L[G )X!K@M8W?\
M-4^&_LO^L_X16\^V;?\ GE]IB\O=[;]V/Q]Z3QW(TW[0WPDD+1/8O9ZPT# Y
MS*88>0>GW-V,<XW]J .P_P"%N>$/^$);Q;_;D \/JYB-T4<,)-VSR_+V[]^[
MC9MW9[5>\&?$#0?B#9W-SH-_]K2VE\B>.2&2"6%\ [7CD574X((R!FOF:Z\[
M_A/Y_+V?V#_PMRWSG[OVC[%\V.W^MQG_ &MN.<UZYX,W?\-+?$C[-_QZ_P!D
MZ5]JV]/M&)MN?]KR\?ACVH ]>KF/%OQ0\&^ 9XH?$_BW0O#DTJ>;''JVI0VK
M.F<;@)&&1GC-=/7Y[_M:^ /#'Q-_;^\&:3XNMH+_ $^T\!F^M-/NAF*[N%OI
MEVL/XPJ%GVG@[<D$ UI3@ZDU!=3.I-4X.;Z'V;X?^/?PR\67UO9:'\1?">LW
MERXB@M]/URUGDE<]%54<EC["N[K\N?CAX%^''P8^*'PB\;:9I6C>%]5_X22*
MSD6UMD@CEA,3DS%%  >)Q$PD !&<$\BO:];_ &IO"EO \DWBV;4%!&4AD>0\
MG' [_A7H?4DI\DZB3O9=W<\FIFE*G%.2W\S[6FN8;<9EE2,>KL!6=/XMT6V_
MUFJV8/H)E)_(&OAZ?]IGP=/L:RO&OBX'+D0G/IAR&S^&/2MRV\:>+=9M%N=(
M^'^L7MJ_W+B*WFD1OQ6/'ZUPXBK@,')PKU7==H2_1,Y7G"D[0C?[W^1]K6MW
M#?6Z3V\J30N,K(AR#^-+<3I:V\LSYV1J7; R< 9->#_%S4OB%X&\)Z'9^!],
MU&.59W$[VELE^[*1GYE\MMHR>N!7DI^)7[0S @V7B @\$'PVG_QBO!Q>:T<)
M7=)TYRMU2_X)VULQC0E[.<)-^2NOS/HNY^-4*DBWTN1_0R3!?T -9D_QGU)_
M]386L?IO+-_(BN:T5/%J_ F34I?"K'QCY,S":2PB%P'$S!,6QC_N 8&WD<]\
MUY+!X]^/MK_J=+UN'_KGX8C7^5O7H5\\P.&4']6G+F2?I?H]=S@K8NM347-R
M]Y7TBOQU6I[Q_P + \7Z@?\ 1H6&>@@M-W\P:"WC_4O^?],^PA_PK,_9_P#&
M'Q/UG^WO^$RTO4)_+^S_ &3[?9I88SYF_;^[7?T3/7''K7ENL?$C]H"+5[Y+
M:RUX6RSN(@GAY' 3<<8;R.1C'/>B?$5"E1A7CAG:5].5-JW?7[A3JJ-*-6;F
MU*^B6NG?4^I? =CK5CI4B:W*TDYDW1B23S'5<=VR>_O72U\L?"7Q]\:]2^(.
ME6WB33]8ET5_-^T)=:.EI&<1.5S+Y*[?F"]QDX'>KGQH\=?&32_'$L'A;3M6
MATD01E5L]*2\CWD?-^\\IN?;/%<$\XIU*3Q;IR2O:UM=K[7V.^GCJ<,/[11E
M9.VVOY['K%Y\';:[U">X_M*5(Y7+^7Y8)&3G&[//Y58@^#NBQ\R3WDOL74#]
M%KYD_P"%E_M#_P#/GX@_\)M/_C%>U?'OQ9\2-'TC2G\':5?07+SL)S8VR7Y*
M;>,KL;:,]^*Z*?$,ZU&=1*:4+:62;OVUU.>G6PM2$ZJI2]VVZWOVU/0X/AGX
M<@ _T#S#ZR2N?ZXK2M_"6BVF/+TJT!'0M"K'\S7R!_PLO]H?_GS\0?\ A-I_
M\8KVK2_%GQ(D^ SZA<:5?'QAY$Q$K6R+<;Q,P3_1MG79CC;R.>]8T,\^MN2Y
M9KE3>J[=%KN:X?%X>JY*%)JROJET_4]H@MXK5-D,21)UVHH4?I7AGQJTK]G3
MXH:I'9?$R_\  NHZOI+-"HU35;>"\M"3\T>X2+(@SU7('M7D'_"R_P!H?_GS
M\0?^$VG_ ,8KX_\ #OA^'Q5XK^(VH^+=%M+SQ!+XKO\ [6^H6$8F#Y4D%2HV
M\D\8&/2O-J9_3C3=14I:6W5M_FS.6;TXP<E3EIW5O\S]2?A)'\(+701X2^&T
M_A";2K%3,=*\/W%M.L88\R,D9)R3C+-U/>NFO_AOX?OQS8B!O[T#%/TZ?I7Y
M<?!GQ%JOPB_:.OKGP-I-K;2W'A3;<16U@&0K]L4Y*J!_= S7V/\ "7]I'Q[X
MN^(&E^']2TK3WBNO-W@0/!+A(F;AB^!RO<'O77A\_IN5."YHN=K=M?,J.8X:
MNX1G#65NE]_,]>O_ (+6SY-GJ4L7^S.@?]1C^58DGPQ\2:1*9-/N$D(Y#6\Y
MC8_GC^=<K\6OVH=:^&OC:31%\/6<L<<,<C"6=B^6&>J\=/:N>M?VY)\A9O!B
M2L3@>5J)7]#$:]&7%%"A4E2JU-5H[Q;_ "1A5K9=";A)N+7:_P#P3W/X?GQ3
M'?S0ZRLQLECX:X(+!\C&#U/&:[RO+/BI\<)/A-8:?=:IX>EE6\E:)%BNTR"!
MDGI7!0_MN>''QYOA[4XS_LO&P_F*6+S7"1K.-62C+L>C]:P^%?L:E35=SV_6
M/'FC:%J)LKRX9)P 7VQLP3(R,X'I5RQ\4Z1J1 MM2MI&/1/, ;\CS7E&I>)-
M#\:^!V\?2Z/=VNEF)G>Y6X59"J.8R2F#GE<>I&*\L?XG^!YW/D:X\([)<6TI
M/_?03%>@L3EG)'VE;D;5]6K/S7D95<9*E*[<6GJM;:?,^O\ K17SAX'U:_\
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M_H!_^3:?X4 ;5%8O]J:O_P! /_R;3_"C^U-7_P"@'_Y-I_A0!M45B_VIJ_\
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M4GZ&T:<(OFC%)A1116IH%%%% !6+X:_YBO\ U_R_TK:K%\-?\Q7_ *_Y?Z4
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MH2ZG=V^EZPL-OY\ARY5/*.,GW-?45%1.$:BM-77F3*$9JTE<\*^!?['O@_X
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MQUKFI^*O$WA+Q3%IPU[1EM[A;G2UDC@NK>925=4=F92K(ZL-Q'2@#T2BBB@
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M7(&=IKURB@ HHHH R9_#WG322?VEJ,>]BVQ)\*N3T QTJ/\ X1K_ *BNI_\
M@1_]:MJB@#%_X1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!'_UJVJ* ,7_A&O\
MJ*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?_6K:HH Q?^$:_P"HKJ?_ ($?_6H_X1K_
M *BNI_\ @1_]:MJB@#%_X1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!'_UJVJ*
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MU;5%(9B_\(U_U%=3_P# C_ZU'_"-?]174_\ P(_^M6U10!B_\(U_U%=3_P#
MC_ZU'_"-?]174_\ P(_^M6U10!B_\(U_U%=3_P# C_ZU'_"-?]174_\ P(_^
MM6U10!B_\(U_U%=3_P# C_ZU'_"-?]174_\ P(_^M6U10!B_\(U_U%=3_P#
MC_ZU'_"-?]174_\ P(_^M6U10!B_\(U_U%=3_P# C_ZU'_"-?]174_\ P(_^
MM6U10!B_\(U_U%=3_P# C_ZU'_"-?]174_\ P(_^M6U10!B_\(U_U%=3_P#
MC_ZU'_"-?]174_\ P(_^M6U10!B_\(U_U%=3_P# C_ZU'_"-?]174_\ P(_^
MM6U10!B_\(U_U%=3_P# C_ZU'_"-?]174_\ P(_^M6U10!B_\(U_U%=3_P#
MC_ZU'_"-?]174_\ P(_^M6U10!B_\(U_U%=3_P# C_ZU'_"-?]174_\ P(_^
MM6U10!B_\(U_U%=3_P# C_ZU'_"-?]174_\ P(_^M6U10!B_\(U_U%=3_P#
MC_ZU'_"-?]174_\ P(_^M6U10!B_\(U_U%=3_P# C_ZU'_"-?]174_\ P(_^
MM6U10!\\_M3?LF7/[2OAK0M$7X@:GX:LM-OQJ,D;6RWJ7,BJ1%N5F3[A9B.H
MR0<<"O"=%_X)8ZEHOB;0M<A^->H)>Z-?PZC:R0^'XHG22-LC#";C(R#V()!!
MK[\HK6-6<8N$79,QE1ISFJDHIM;/L8O_  C7_45U/_P(_P#K4?\ "-?]174_
M_ C_ .M6U161L8O_  C7_45U/_P(_P#K4?\ "-?]174__ C_ .M6U10!B_\
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MU_U%=3_\"/\ ZU'_  C7_45U/_P(_P#K5M44 8O_  C7_45U/_P(_P#K4?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_&C^Q=._Y\+7_ORO^%']BZ=_SX6O_?E?\* #^VM._P"?^U_[_+_C1_;6G?\
M/_:_]_E_QH_L73O^?"U_[\K_ (4?V+IW_/A:_P#?E?\ "@ _MK3O^?\ M?\
MO\O^-']M:=_S_P!K_P!_E_QH_L73O^?"U_[\K_A1_8NG?\^%K_WY7_"@ _MK
M3O\ G_M?^_R_XT?VUIW_ #_VO_?Y?\:/[%T[_GPM?^_*_P"%']BZ=_SX6O\
MWY7_  H /[:T[_G_ +7_ +_+_C1_;6G?\_\ :_\ ?Y?\:/[%T[_GPM?^_*_X
M4?V+IW_/A:_]^5_PH /[:T[_ )_[7_O\O^-']M:=_P _]K_W^7_&C^Q=._Y\
M+7_ORO\ A1_8NG?\^%K_ -^5_P * #^VM._Y_P"U_P"_R_XT?VUIW_/_ &O_
M '^7_&C^Q=._Y\+7_ORO^%']BZ=_SX6O_?E?\* #^VM._P"?^U_[_+_C1_;6
MG?\ /_:_]_E_QH_L73O^?"U_[\K_ (4?V+IW_/A:_P#?E?\ "@ _MK3O^?\
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M^U_[_+_C1_;6G?\ /_:_]_E_QH_L73O^?"U_[\K_ (4?V+IW_/A:_P#?E?\
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M?^_*_P"%']BZ=_SX6O\ WY7_  H /[:T[_G_ +7_ +_+_C1_;6G?\_\ :_\
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M_GPM?^_*_P"%']BZ=_SX6O\ WY7_  H /[:T[_G_ +7_ +_+_C1_;6G?\_\
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M,,T.C/IZK</'#()(8)+D/\R*RIT0$A1R*]IHHH **** "BBB@ HHHH ****
M"O-?C+\+M=^*-I8V-AXHM="TZWN(;MX9M*-V\DT4HD1@_G)@94 K@Y]17I5%
M 'D7Q"^#WBSX@V_AN*[\;6*Q:8WGW=I+H1DM=0N V4D>(7"_*O&(RS+D9.>
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M^E !X._Y%RT_X'_Z&U;58O@[_D7+3_@?_H;5M4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !6+X:_YBO_7_ "_TK:K%\-?\Q7_K_E_I0 >#O^1<M/\
M@?\ Z&U;58O@[_D7+3_@?_H;5M4 %%%% !1110!XW\<OVJ_!?P U6PTSQ!%J
M=[J-Y!]I2VTN&.1DBW,H=M\B  E6 Y[&O,?^'E7PQ_Z 7BW_ , [7_Y(KW/X
MF_ ;P'\8Y[.;Q?X?CU>>T4I!-]HF@=%)SMW1.I(R<X/%</\ \,-_!'_H2O\
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M=1DA">4.,]#BK.D_ 32=&@\(6,%W))I.@Z3J&E/;3)N>[6[\KS'9P1M.8V)
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M%\*>+/#.HZ=JFGV6HIX[DU1OMVGWGA&(6XADNB9LZL80S+Y;,0XF8MP-HZ
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M_P!0S_R)110 ?\5#_P!0S_R)1_Q4/_4,_P#(E%% !_Q4/_4,_P#(E'_%0_\
M4,_\B444 '_%0_\ 4,_\B4?\5#_U#/\ R)110 ?\5#_U#/\ R)1_Q4/_ %#/
M_(E%% !_Q4/_ %#/_(E'_%0_]0S_ ,B444 '_%0_]0S_ ,B4?\5#_P!0S_R)
M110 ?\5#_P!0S_R)1_Q4/_4,_P#(E%% !_Q4/_4,_P#(E'_%0_\ 4,_\B444
M '_%0_\ 4,_\B4?\5#_U#/\ R)110 ?\5#_U#/\ R)1_Q4/_ %#/_(E%% !_
MQ4/_ %#/_(E'_%0_]0S_ ,B444 '_%0_]0S_ ,B4?\5#_P!0S_R)110 ?\5#
M_P!0S_R)1_Q4/_4,_P#(E%% !_Q4/_4,_P#(E'_%0_\ 4,_\B444 '_%0_\
M4,_\B4?\5#_U#/\ R)110 ?\5#_U#/\ R)1_Q4/_ %#/_(E%% !_Q4/_ %#/
M_(E'_%0_]0S_ ,B444 '_%0_]0S_ ,B5/H6GW&GP7/VEHVFGG:8^5G:,XX&?
&I110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Feb. 17, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Summit Therapeutics Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">37-1979717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">601 Brickell Key Drive, Suite 1000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Miami<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">203-2034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SMMT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,483.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">775,372,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">Portions of the registrant&#8217;s definitive proxy statement relating to the registrant&#8217;s 2026 annual meeting of stockholders to be filed hereafter are incorporated by reference into Part III of this Annual Report on Form 10-K. The registrant&#8217;s definitive proxy statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001599298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers LLP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Jose, California<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 225,266<span></span>
</td>
<td class="nump">$ 104,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">316<span></span>
</td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">488,182<span></span>
</td>
<td class="nump">307,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">6,537<span></span>
</td>
<td class="nump">11,076<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">720,301<span></span>
</td>
<td class="nump">423,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,059<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">20,616<span></span>
</td>
<td class="nump">7,144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,001<span></span>
</td>
<td class="nump">1,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">7,205<span></span>
</td>
<td class="nump">2,548<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">751,182<span></span>
</td>
<td class="nump">435,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">20,292<span></span>
</td>
<td class="nump">4,636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">32,100<span></span>
</td>
<td class="nump">19,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">14,925<span></span>
</td>
<td class="nump">11,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current portion</a></td>
<td class="nump">3,388<span></span>
</td>
<td class="nump">3,765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">2,283<span></span>
</td>
<td class="nump">1,797<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">72,988<span></span>
</td>
<td class="nump">41,729<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">17,502<span></span>
</td>
<td class="nump">3,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">1,832<span></span>
</td>
<td class="nump">1,630<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">92,322<span></span>
</td>
<td class="nump">46,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 16)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value, 20,000,000 shares authorized; none issued and outstanding at December 31, 2025 and 2024, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value: 1,000,000,000 shares authorized; 775,371,200 and 737,626,004 shares issued and outstanding at December 31, 2025 and 2024, respectively</a></td>
<td class="nump">7,754<span></span>
</td>
<td class="nump">7,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">2,947,805<span></span>
</td>
<td class="nump">1,598,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(2,540)<span></span>
</td>
<td class="num">(2,285)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(2,294,159)<span></span>
</td>
<td class="num">(1,214,573)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">658,860<span></span>
</td>
<td class="nump">388,748<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 751,182<span></span>
</td>
<td class="nump">$ 435,560<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478064/805-740-55-13<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-39<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>May 13, 2024</div></th>
<th class="th"><div>Apr. 27, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 19, 2023</div></th>
<th class="th"><div>Jan. 18, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">775,371,200<span></span>
</td>
<td class="nump">737,626,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">775,371,200<span></span>
</td>
<td class="nump">737,626,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 537,674<span></span>
</td>
<td class="nump">$ 150,777<span></span>
</td>
<td class="nump">$ 59,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_AcquiredInProcessResearchAndDevelopmentExpense', window );">Acquired in-process research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,007<span></span>
</td>
<td class="nump">520,915<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">556,750<span></span>
</td>
<td class="nump">60,214<span></span>
</td>
<td class="nump">29,264<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,094,424<span></span>
</td>
<td class="nump">225,998<span></span>
</td>
<td class="nump">609,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,838<span></span>
</td>
<td class="nump">13,369<span></span>
</td>
<td class="nump">11,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,686)<span></span>
</td>
<td class="num">(16,461)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1,079,586)<span></span>
</td>
<td class="num">$ (221,315)<span></span>
</td>
<td class="num">$ (614,928)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_EarningsPerShareBasicAndDilutedEPSAbstract', window );"><strong>Net loss per share:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1.44)<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">$ (0.99)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1.44)<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">$ (0.99)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">747,702,265<span></span>
</td>
<td class="nump">718,541,896<span></span>
</td>
<td class="nump">619,646,180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">747,702,265<span></span>
</td>
<td class="nump">718,541,896<span></span>
</td>
<td class="nump">619,646,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (327)<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="num">$ (172)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax', window );">Reclassification of unrealized loss on short-term investments to other income, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax', window );">Reclassification of cumulative currency translation gain to other income, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(419)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Unrealized gain on short-term investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">72<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1,079,841)<span></span>
</td>
<td class="num">$ (221,152)<span></span>
</td>
<td class="num">$ (615,483)<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.92pt">Refer to Note 15 &#8211; Related Party Transactions for expenses incurred.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_AcquiredInProcessResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired-In-Process Research And Development Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_AcquiredInProcessResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_EarningsPerShareBasicAndDilutedEPSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share, Basic and Diluted EPS</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_EarningsPerShareBasicAndDilutedEPSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481724/830-30-40-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-17A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized loss realized upon the write-down of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-17A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Rights Offering</div></th>
<th class="th"><sup>[1]</sup></th>
<th class="th" colspan="2"><div>Private Placement</div></th>
<th class="th"><div>At Market Offering</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Rights Offering</div>
</th>
<th class="th"><sup>[1]</sup></th>
<th class="th" colspan="2">
<div>Common Stock </div>
<div>Private Placement</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>At Market Offering</div>
</th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>Rights Offering</div>
</th>
<th class="th"><sup>[1]</sup></th>
<th class="th" colspan="2">
<div>Additional Paid-In Capital </div>
<div>Private Placement</div>
</th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>At Market Offering</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Total Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211,091,425<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 126,654<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,110<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 504,767<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,893)<span></span>
</td>
<td class="num">$ (378,330)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Rights Offering of common stock, net of offering costs / Private placement of common stock, net of offering costs / Proceeds from at-the-market offering, net of commissions and offering costs (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="nump">476,190,471<span></span>
</td>
<td class="nump">2,976,190<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Rights Offering of common stock, net of offering costs / Private placement of common stock, net of offering costs / Proceeds from at-the-market offering, net of commissions and offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="nump">$ 499,381<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="nump">$ 4,762<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="nump">$ 494,619<span></span>
</td>
<td class="nump">$ 4,970<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock purchase plans and exercise of stock options and warrants (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">596,472<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under stock purchase plans and exercise of stock options and warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">929<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">922<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest', window );">Issuance of common stock in lieu of cash for Akeso upfront payment (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest', window );">Issuance of common stock in lieu of cash for Akeso upfront payment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">45,900<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,800<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of warrants (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">805,495<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,203<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,195<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,108<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,108<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net other comprehensive (loss) gain</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(555)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(555)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(614,928)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(614,928)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">701,660,053<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">77,692<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,017<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,066,381<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,448)<span></span>
</td>
<td class="num">(993,258)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Rights Offering of common stock, net of offering costs / Private placement of common stock, net of offering costs / Proceeds from at-the-market offering, net of commissions and offering costs (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">32,574,640<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,807,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Rights Offering of common stock, net of offering costs / Private placement of common stock, net of offering costs / Proceeds from at-the-market offering, net of commissions and offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">434,860<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 43,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 326<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">434,534<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 43,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock purchase plans and exercise of stock options and warrants (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,584,218<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under stock purchase plans and exercise of stock options and warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,334<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,319<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">50,981<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,981<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net other comprehensive (loss) gain</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">163<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (221,315)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(221,315)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">737,626,004<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">737,626,004<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 388,748<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,376<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,598,230<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,285)<span></span>
</td>
<td class="num">(1,214,573)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Rights Offering of common stock, net of offering costs / Private placement of common stock, net of offering costs / Proceeds from at-the-market offering, net of commissions and offering costs (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">26,682,846<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">5,339,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Rights Offering of common stock, net of offering costs / Private placement of common stock, net of offering costs / Proceeds from at-the-market offering, net of commissions and offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,037<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 104,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 267<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 499,770<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 104,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock purchase plans and exercise of stock options and warrants (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,723,011<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under stock purchase plans and exercise of stock options and warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,968<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,910<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">732,420<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">732,420<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net other comprehensive (loss) gain</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(255)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(255)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1,079,586)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,079,586)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">775,371,200<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">775,371,200<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 658,860<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,754<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,947,805<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,540)<span></span>
</td>
<td class="num">$ (2,294,159)<span></span>
</td>
</tr>
<tr><td colspan="21"></td></tr>
<tr><td colspan="21"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.92pt">Refer to Note 13 &#8211; Stockholders&#8217; Equity for related party transactions.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Issued For Related Party Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Issued For Related Party Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_StockIssuedDuringPeriodValueWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_StockIssuedDuringPeriodValueWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_RightsOfferingMember', window );">Rights Offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Adjustments to additional paid in capital, stock issued, issuance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 619<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private placement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Adjustments to additional paid in capital, stock issued, issuance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_AtMarketOfferingMember', window );">At Market Offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Adjustments to additional paid in capital, stock issued, issuance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,969<span></span>
</td>
<td class="nump">$ 1,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.92pt">Refer to Note 13 &#8211; Stockholders&#8217; Equity for related party transactions.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_RightsOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=smmt_RightsOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_AtMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=smmt_AtMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows used in operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1,079,586)<span></span>
</td>
<td class="num">$ (221,315)<span></span>
</td>
<td class="num">$ (614,928)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_InterestExpenseIncomeNoncash', window );">Non-cash interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of discount on short-term investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7,006)<span></span>
</td>
<td class="num">(2,576)<span></span>
</td>
<td class="num">(1,924)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Unrealized foreign exchange loss (gain)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(320)<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="num">(812)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome', window );">Reclassification of currency translation gain</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(419)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Impairment of fixed assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">146<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">198<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">732,420<span></span>
</td>
<td class="nump">50,981<span></span>
</td>
<td class="nump">14,108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on disposal of assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(109)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_AcquiredInProcessResearchAndDevelopmentExpense', window );">Acquired in-process research and development expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,007<span></span>
</td>
<td class="nump">520,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,866<span></span>
</td>
<td class="num">(7,370)<span></span>
</td>
<td class="nump">3,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,875)<span></span>
</td>
<td class="nump">2,470<span></span>
</td>
<td class="num">(3,421)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,303<span></span>
</td>
<td class="nump">2,015<span></span>
</td>
<td class="nump">2,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities and other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,930<span></span>
</td>
<td class="nump">11,879<span></span>
</td>
<td class="num">(2,377)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,909<span></span>
</td>
<td class="nump">6,557<span></span>
</td>
<td class="num">(235)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">80<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet', window );">Operating lease right-of-use assets and lease liabilities, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">203<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="num">(359)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(322,930)<span></span>
</td>
<td class="num">(142,106)<span></span>
</td>
<td class="num">(76,760)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows used in investing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments', window );">Maturities and sales of short-term investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">311,340<span></span>
</td>
<td class="nump">489,837<span></span>
</td>
<td class="nump">208,165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(484,993)<span></span>
</td>
<td class="num">(680,032)<span></span>
</td>
<td class="num">(321,022)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(657)<span></span>
</td>
<td class="num">(139)<span></span>
</td>
<td class="num">(128)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_PaymentsForCollaborativeArrangement', window );">Payments to Akeso for upfront milestone payments and associated direct transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(15,007)<span></span>
</td>
<td class="num">(475,015)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(174,310)<span></span>
</td>
<td class="num">(205,341)<span></span>
</td>
<td class="num">(587,774)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows provided by financing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from the issuance of common stock via private placements, net of offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">500,037<span></span>
</td>
<td class="nump">434,860<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">7,315<span></span>
</td>
<td class="nump">598<span></span>
</td>
<td class="nump">1,203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds received related to employee stock purchase plan and exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,653<span></span>
</td>
<td class="nump">2,736<span></span>
</td>
<td class="nump">929<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Transaction costs from the issuance of common stock for rights offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(619)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Re-payment of related party promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
<td class="num">(24,686)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">617,533<span></span>
</td>
<td class="nump">381,227<span></span>
</td>
<td class="nump">86,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of exchange rates on cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">102<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="nump">839<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">120,395<span></span>
</td>
<td class="nump">33,762<span></span>
</td>
<td class="num">(577,182)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">105,187<span></span>
</td>
<td class="nump">71,425<span></span>
</td>
<td class="nump">648,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">225,582<span></span>
</td>
<td class="nump">105,187<span></span>
</td>
<td class="nump">71,425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure of Cash Flow Information:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest on related party promissory note</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,806<span></span>
</td>
<td class="nump">10,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental Disclosure of Non-Cash Investing and Financing Activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Leased assets obtained in exchange for operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,056<span></span>
</td>
<td class="nump">4,216<span></span>
</td>
<td class="nump">4,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Unpaid amounts related to purchase of property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">291<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_AtMarketOfferingMember', window );">At Market Offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows provided by financing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">104,528<span></span>
</td>
<td class="nump">43,033<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_RightsOfferingMember', window );">Rights Offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows provided by financing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">104,686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental Disclosure of Non-Cash Investing and Financing Activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">395,314<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_AkesoLicenseAgreementMember', window );">Akeso License Agreement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental Disclosure of Non-Cash Investing and Financing Activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 45,900<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:120%">Refer to Note 13 &#8211; Stockholders&#8217; Equity for related party transactions.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_AcquiredInProcessResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired-In-Process Research And Development Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_AcquiredInProcessResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative Currency Translation Gains (Losses), Realized upon Sale or Liquidation, Reclassified From Other Comprehensive Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease Right-Of-Use-Asset And Operating Lease Liability, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_InterestExpenseIncomeNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense (Income), Noncash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_InterestExpenseIncomeNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_PaymentsForCollaborativeArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Collaborative Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_PaymentsForCollaborativeArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481926/830-20-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales, maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_AtMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=smmt_AtMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_RightsOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=smmt_RightsOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_AkesoLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=smmt_AkesoLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization</a></td>
<td class="text">Organization<div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Summit Therapeutics Inc. (&#8220;we&#8221;, &#8220;Summit&#8221; or the &#8220;Company&#8221;) is a biopharmaceutical company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The Company&#8217;s pipeline of product candidates is designed with the goal to become the patient-friendly, new-era standard-of-care medicines, in the therapeutic area of oncology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s current lead development candidate is ivonescimab, a novel, potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. On December 5, 2022, the Company entered into the License Agreement with Akeso, Inc. and its affiliates (collectively, &#8220;Akeso&#8221;) pursuant to which the Company has in-licensed intellectual property rights related to ivonescimab (as amended, the &#8220;License Agreement&#8221;), as further described in Note 4. Through the License Agreement, the Company obtained the rights to develop and commercialize ivonescimab in the United States, Canada, Europe, and Japan. The License Agreement and transaction closed in January 2023 following customary waiting periods. On June 3, 2024, the Company entered into an amendment to the License Agreement (the  &#8220;Second Amendment&#8221;) with Akeso to expand its territories covered under the License Agreement to also include Latin America, including Mexico and all countries in Central America and South America, the Middle East and Africa (collectively, and as expanded, the &#8220;Licensed Territory&#8220;) . The Company&#8217;s operations are focused on the development of ivonescimab and other future activities, as the Company determines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Basis of Presentation </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Any reference in these notes to applicable guidance is meant to refer to authoritative U.S. GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and as amended by Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;). Certain reclassifications have been made to the prior years&#8217; financial statements to conform to current year presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of income and expenses during the reporting period. On an on-going basis, management evaluates its estimates and judgments, including those related to accrued research and development expenses, stock-based compensation, and income taxes. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2025, the Company incurred a net loss of $1,079,586 and cash used in operating activities was $322,930. As of December 31, 2025, the Company had an accumulated deficit of $2,294,159, and cash and cash equivalents of $225,266 and short-term investments of $488,182. The Company expects to continue to generate operating losses for the foreseeable future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December 31, 2025, the Company raised gross proceeds of $500,037 from a private placement and $106,498 from the Company&#8217;s at-the-market sales agreement, both described further in Note 13. With these recent financings, the Company has evaluated and concluded that its cash, cash equivalents and short-term investments provide sufficient cash to fund its operating cash needs for at least the next 12 months from the date of issuance of these consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Until the Company can generate substantial revenue and achieve profitability, the Company will need to raise additional capital to fund its ongoing operations and capital needs. The Company continues to evaluate options to further finance its operating </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">cash needs for its product candidates through a combination of some, or all, of the following: equity and debt offerings, collaborations, strategic alliances, grants and clinical trial support from government entities, philanthropic, non-government and not-for-profit organizations, and marketing, distribution or licensing arrangements. There is no assurance, however, that additional financing will be available when needed or that management of the Company will be able to obtain financing on terms acceptable to the Company. If the Company is unable to obtain funding when required in the future, the Company could be required to delay, reduce, or eliminate research and development programs, product portfolio expansion, or future commercialization efforts, which could adversely affect its business prospects.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480922/205-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481034/205-10-S45-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies and Recent Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies and Recent Accounting Pronouncements</a></td>
<td class="text">Summary of Significant Accounting Policies and Recent Accounting Pronouncements<div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The significant accounting policies adopted by the Company in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. GAAP and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. The consolidated financial statements reflect the accounts of Summit Therapeutics Inc. and its wholly owned subsidiaries. Intercompany balances and transactions are eliminated in consolidation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company&#8217;s subsidiaries with functional currencies other than the U.S. dollar are translated into U.S. dollars using period-end exchange rates for assets and liabilities, historical exchange rates for stockholders&#8217; equity and weighted average exchange rates for operating results. Translation gains and losses are included in accumulated other comprehensive (loss) income in stockholders&#8217; equity. Foreign currency transaction gains and losses are included in other income</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, net in the consolidated statements of operations and comprehensive loss. The Company recorded realized and unrealized foreign currency transaction (loss) gain of ($610), $(97) and $613 for the years ended December 31, 2025, 2024 and 2023, respectively, which is included in other income, net in the consolidated statements of operations and comprehensive loss.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the diluted net loss by the weighted-average number of common shares outstanding for the period, including potentially dilutive common shares. The dilutive effect of share options and warrants are determined under the treasury stock method using the average market price for the period.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the assumed proceeds under the treasury stock method include the average unrecognized compensation expense of stock options and warrants that are in-the-money.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the consideration transferred over the fair value of net assets acquired. Goodwill is assigned to reporting units at the time of acquisition or when there is a change in the reporting structure and bases that allocation on which reporting units will benefit from the acquired assets and liabilities. Reporting units are defined as operating segments or one level below an operating segment, referred to as a component. Typically acquisitions related to a single reporting unit do not require the allocation of goodwill to multiple reporting units. If the net assets obtained in an acquisition are assigned to multiple reporting units, the goodwill is distributed to the respective reporting units as part of the purchase price allocation process.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill for impairment on an annual basis as of December 31 or more frequently when events and circumstances occur indicating that the recorded goodwill may be impaired. The Company regularly monitors current business conditions and other factors including, but not limited to, adverse industry or economic trends and lower projections of </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">profitability that may impact future operating results. The process of evaluating the potential impairment of goodwill requires significant judgment. In performing the Company&#8217;s annual goodwill impairment test, the Company is permitted to first assess qualitative factors to determine whether it is more likely than not that the fair value of the Company&#8217;s reporting unit is less than its carrying amount, including goodwill. In performing the qualitative assessment, the Company considers certain events and circumstances specific to the reporting unit and to the entity as a whole, such as macroeconomic conditions, industry and market considerations, overall financial performance and cost factors when evaluating whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. The Company is also permitted to bypass the qualitative assessment and proceed directly to the quantitative test. If the Company chooses to undertake the qualitative assessment and concludes that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, the Company would then proceed to the quantitative impairment test. In the quantitative assessment, the Company compares the fair value of the reporting unit to its carrying amount, which includes goodwill. If the fair value exceeds the carrying value, no impairment loss exists. If the fair value is less than the carrying amount, a goodwill impairment loss is measured and recorded.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for real estate. The Company does not have any finance leases. A contract is or contains a lease when the lessee has the right to control the use of an identified asset. The Company determines if an arrangement is a lease at inception of the contract, which is the date on which the terms of the contract are agreed to and the agreement creates enforceable rights and obligations. The lease term used to calculate the lease liability include options to extend or terminate the lease when it is reasonably certain that the option will be exercised.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">At the lease commencement date, the Company measures and recognizes a lease liability and a right-of-use asset in the financial statements. Lease liabilities are recognized based on the present value of the future lease payments over the lease term at commencement date. The right-of use asset is measured by taking the present value of future lease payments, plus any incremental direct costs incurred, less any lease incentives received. As most of the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">s leases do not provide an implicit rate, the Company uses an estimated incremental borrowing rate based on the lease term and the economic environment of the lease at the lease commencement date, which is then utilized to determine the present value of future lease payments. Lease expense for minimum lease payments are recognized on a straight-line basis over the lease term, with variable lease payments recognized in the periods in which they are incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has existing lease agreements with lease and non-lease components, has elected to account for the lease and non-lease components as a single lease component, and has allocated all of the contract consideration to the lease component only. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Leases with an initial lease term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for its short-term leases on a straight-line basis over the lease term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Acquired In-Process Research and Development</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company may enter into agreements with collaboration partners for the development and commercialization of its products. These arrangements may include payments contingent on the occurrence of certain events such as development, regulatory or sales-based milestones. The Company considers the unique nature, terms and facts and circumstances of each transaction. The Company considers whether or not the assets acquired have an alternative future use. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The fair value associated with acquired in-process research and development which does not have an alternative future use is expensed and is recorded as research and development expense. Any development or commercial milestone payments are recognized when the achievement of the associated milestone becomes probable and will either be expensed or capitalized depending upon whether or not regulatory approval has been obtained. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred to discover, research and develop product candidates, including personnel expenses, stock-based compensation expense, allocated facility-related and depreciation expenses, third-party license fees and external costs of outside vendors engaged to conduct preclinical and clinical development activities and clinical trials as well as to manufacture clinical trial materials. Non-</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">refundable prepayments for goods or services that will be used or rendered for future research and development activities are recorded as prepaid expenses. Such amounts are recognized as an expense as the goods are delivered or the related services are performed, or until it is no longer expected that the goods will be delivered, or the services rendered. Milestone and other payments made to third-parties with respect to in-process research and development, in accordance with the Company&#8217;s license, acquisition and other similar agreements are expensed when determined to be probable and estimable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has entered into various research and development contracts with other companies. These agreements are generally cancellable, and related payments are recorded as research and development expenses as incurred. The Company records accruals for estimated ongoing research and development costs or prepaid expenses where the payments made exceed the estimated costs. These amounts are determined based on the estimated costs to complete each study or activity, the estimation of the current stage of completion and the invoices received, as well as predetermined milestones which are not reflective of the current stage of development for prepaid expenses. Actual results could differ from the Company&#8217;s estimates. In all cases, the full cost of each study or activity is expensed by the time the final report or where applicable, product, has been received. The Company&#8217;s historical estimates have not been materially different from the actual costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all stock option awards based on the estimated fair value of the award on the grant date. The Company uses the Black-Scholes option pricing model to estimate the fair value of stock option awards. Additionally, the Company uses a Monte Carlo simulation model to calculate the estimated fair value on the date of grant related to awards with market-based service conditions. The fair value is recognized as expense, over the requisite service period, which is generally the vesting period of the respective award, on a straight-line basis for each separately vesting portion of the award when the only condition to vesting is continued service. If vesting is subject to a market or performance condition, recognition is based on the derived service period of the award. Expense for awards with performance conditions is estimated and adjusted on a quarterly basis based upon the assessment of the probability that the performance condition will be met. Use of the Black-Scholes option-pricing model requires management to apply judgment under subjective assumptions. These assumptions include:</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected term&#8212;The expected term of stock options represents the weighted-average period the stock options are expected to be outstanding. The Company uses the simplified method for estimating the expected term as provided by the SEC. The simplified method calculates the expected term as the average of the time-to-vesting and the contractual life of the options.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected volatility&#8212;The expected volatility is calculated based on historical volatility of the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">s share price.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk-free interest rate&#8212;The risk-free rate assumption is based on the U.S. Treasury instruments, the terms of which were consistent with the expected term of the Company&#8217;s stock options.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected dividend&#8212;The expected dividend assumption is based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not intend to pay dividends. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company uses a Monte Carlo simulation model to estimate the fair value of Performance and Market-based Stock Options at the date of grant which utilizes multiple input variables to estimate the probability that the market condition will be achieved. Key assumptions used in the model include the risk-free interest rate, which reflects the US Treasury Constant Maturity Yield with a term commensurate with the contractual term of the award, and stock price volatility, which is derived based on the historical volatility of the Company&#8217;s stock. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates expected forfeitures at the time of grant instead of accounting for forfeitures as they occur. Stock option awards have been granted at fair value to non-employees in connection with research and consulting services provided to the Company. Equity awards generally vest over terms of 3 or 4 years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies stock-based compensation expense in the consolidated statements of operations and comprehensive loss in the same manner in which the award recipient&#8217;s payroll costs are classified.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is determined using the asset and liability approach. Tax laws may require items to be included in tax filings at different times than the items are reflected in the financial statements. A current asset or liability is recognized </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">for the estimated taxes receivable or payable for the current year. Deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. Deferred taxes are initially recognized at enacted tax rates in force at the time of initial recognition and are subsequently adjusted for any enacted changes in tax rates and tax laws. Subsequent changes to deferred taxes originally recognized in equity are recognized in income. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. The Company has recorded a full valuation allowance against the deferred tax assets in excess of its deferred tax liabilities, as the deferred tax liabilities represent future reversals of existing taxable temporary differences. The Company records interest and penalties related to income tax matters as part of income tax expense.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash and short-term investments. The Company&#8217;s cash is comprised of short-term cash deposits at a variety of financial institutions which the Company believes are of high credit ratings in amounts that may exceed federally insured limits. The Company has not experienced any losses on such accounts. Cash balances maintained during the year have been principally held with U.S.-based and U.K.-based banks. The Company does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies, and expects to continue to rely, on a number of vendors to conduct its clinical trials and preclinical studies, manufacture drug product and supply clinical trial and preclinical study materials for its development programs. These programs could be adversely affected by a significant interruption in these services or the availability of materials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the provisions of fair value accounting, a fair value measurement assumes that the transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability and defines fair value based on the exit price model.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The fair value measurement guidance establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance describes three levels of inputs that may be used to measure fair value:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level 1</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Quoted prices in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level 2</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 2 assets and liabilities include debt securities with quoted prices that are traded less frequently than exchange-traded instruments or securities or derivative contracts that are valued using a pricing model with inputs that are observable in the market or can be derived principally from or corroborated by observable market data.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level 3</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the Company categorizes such assets and liabilities based on the lowest level input that is significant to the fair value measurement in its entirety. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers only those investments that are highly liquid, readily convertible to cash and that mature within 90 days or less from date of purchase to be cash equivalents. As of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025, cash equivalents were comprised of money market funds and U.S. treasury securities. As of </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">December 31,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> cash equivalents were comprised of money market funds.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash represents amounts which are legally restricted to withdrawal or usage and is presented in the consolidated balance sheet as restricted cash. As of December 31, 2025 the Company has $316 of restricted cash associated with an irrevocable letter of credit required by the landlord to enter into the lease for Company&#8217;s corporate office.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s total cash, cash equivalents and restricted cash balances were as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.794%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">225,266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104,862&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">71,425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">225,582&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">105,187&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">71,425&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Short-term Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consist of marketable securities with original maturities greater than ninety days from the date of acquisition. The Company classifies marketable securities with original maturities of greater than 90 days and less than one year as short-term, based on the liquid nature of the marketable securities and because such marketable securities represent the investment of cash that is available for current operations. The Company considers its investment portfolio of marketable securities as available-for-sale. Accordingly, these investments are recorded at fair value, which is based on quoted market prices or other observable inputs. Unrealized gains and losses are recorded as a component of other comprehensive income (loss). Realized gains and losses are determined on a specific identification basis and are included in other income, net. Amortization and accretion of discounts and premiums are also recorded in other income, net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">When the fair value is below the amortized cost of the asset, an estimate of expected credit losses is made. This estimate is limited to the amount by which fair value is less than amortized cost. The credit-related impairment amount is recognized in the consolidated statements of operations and comprehensive loss and the remaining impairment amount and unrealized gains are reported as a component of accumulated other comprehensive income (loss) in stockholders&#8217; equity. Credit losses are recognized through the use of an allowance for credit losses account and subsequent improvements in expected credit losses are recognized as a reversal of the allowance account. If the Company has the intent to sell the security or it is more likely than not that the Company will be required to sell the security prior to recovery of its amortized cost basis the allowance for credit loss is written off and the excess of the amortized cost basis of the asset over its fair value is recorded in the consolidated statements of operations and comprehensive loss.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update &#8220;ASU&#8221; 2023-09, &#8220;Improvements to Income Tax Disclosures&#8221;, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024 and allows for adoption on a prospective basis, with a retrospective option. Early adoption is permitted. The Company adopted ASU 2023-09 for the year ended December 31, 2025 using a retrospective approach. The adoption of ASU-2023-09 did not have a material impact on the Company&#8217;s consolidated financial statements and related disclosures.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, &#8220;Disaggregation of Income Statement Expenses&#8221;, which requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures. The guidance is to be applied prospectively, with the option for retrospective application and is effective for public business entities for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this standard on the Company&#8217;s consolidated financial statements and related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2025, the FASB issued ASU 2025-11, &#8220;Narrow-Scope Improvements&#8221;, which is intended to improve the navigability of the guidance in ASC 270 and clarify when the guidance is applicable. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this standard on the Company&#8217;s consolidated financial statements and related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other recent authoritative guidance issued by the FASB (including technical corrections to the FASB ASC), the American Institute of Certified Public Accountants, and the SEC did not or are not expected to have a material impact on the Company&#8217;s consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting <div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s chief operating decision makers (the &#8220;CODM function</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">), which are the Company</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">s Co-Chief Executive Officers, Mr. Duggan and Dr. Zanganeh, and Chief Operating Officer and Chief Financial Officer, Mr. Soni, utilize consolidated net loss that is reported on the consolidated statement of operations and comprehensive loss to make decisions about allocating resources and assessing performance for the entire Company. The CODM function approves of key operating and strategic decisions, including key decisions in clinical development and clinical operating activities, entering into significant contracts, such as revenue contracts and collaboration agreements and approves the Company</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">s consolidated operating budget. The CODM function views the Company's operations and manages its business on a consolidated basis and as a single reportable operating segment. The CODM function is regularly provided with the following significant segment expenses: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Oncology clinical trial related costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">266,439&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100,937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">35,224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">520,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Compensation related costs, excluding stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">75,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">48,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">732,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">50,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total segment expenses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,094,424&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">225,998&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">609,650&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,686)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16,461)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,079,586)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(221,315)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(614,928)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">  Other expenses include general and administrative expenses excluding compensation and stock-based compensation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of December 31, 2025 and 2024, substantially all of our long-lived assets are located in the United States.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Akeso License and Collaboration Agreement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Akeso License and Collaboration Agreement</a></td>
<td class="text">Akeso License and Collaboration Agreement<div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On December 5, 2022, the Company entered into the License Agreement with Akeso pursuant to which the Company is in-licensing its breakthrough bispecific antibody, ivonescimab. The License Agreement and transaction closed in January 2023 following customary waiting periods.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Ivonescimab, known as AK112 in China and Australia, and also as SMT112 in the United States, Canada, Europe, and Japan, is a novel, potential first-in-class bispecific antibody intending to combine the effect of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF into a single molecule. Ivonescimab was engineered to bring two well established oncology targeted mechanisms together. Ivonescimab is currently in clinical development and, pursuant to the terms of the License Agreement, Summit will design and conduct the clinical trial activities to support regulatory filings in the Licensed Territory that Summit will submit. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the License Agreement, Summit will have final decision making authority with respect to clinical development strategy and execution in the Licensed Territory. For co-joined studies in which both Summit and Akeso participate, mutual agreement is required for material decisions; Summit retains the exclusive decision making with respect to participating in, and continuing its participation in, co-joined studies. Pursuant to the terms of the License Agreement, Summit will have final decision-making authority with respect to commercial strategy, pricing and reimbursement and other commercialization matters in the Licensed Territory. In connection with the License Agreement, the Company agreed to purchase a certain portion of drug substance and/or drug product for clinical and commercial supply and to enter into a supply agreement with Akeso. Summit is not assuming any liabilities (including contingent liabilities), acquiring any physical assets or trade names, or hiring or acquiring any employees from Akeso in connection with the License Agreement. Through the License Agreement, the Company obtained the rights to develop and commercialize ivonescimab in the United States, Canada, Europe, and Japan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In exchange for the rights obtained, the Company made an upfront payment of $500,000 to Akeso, of which $274,900 was paid in cash and, pursuant to the License Agreement and Issuance Agreement, Akeso elected to receive 10,000,000 shares of the Company&#8217;s common stock, par value $0.01 per share (&#8220;common stock&#8221;) in lieu of $25,100 in cash. The remaining $200,000 amount of the upfront payment was paid on March 6, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Effective June 3, 2024, the Company and Akeso entered into the Second Amendment to the License Agreement to expand the Company&#8217;s territories covered under the License Agreement to include the Latin America, Middle East and Africa regions. Pursuant to the Second Amendment, the Company paid an upfront payment to Akeso of $15,000 in the third quarter of 2024. Akeso will also be eligible to receive up to an additional $55,000 upon the achievement of certain commercial milestones. Except as specifically modified by the Second Amendment, the terms and conditions of the License Agreement remain in full force and effect.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has accounted for the License Agreement and Second Amendment to acquire the rights to develop and commercialize ivonescimab as the acquisition of an asset. All of the consideration relates to ivonescimab and technological feasibility of the asset has not yet been established since ivonescimab is in clinical development. As such, the Company has expensed the consideration as acquired in-process research and development upon closing of the transaction in the consolidated statement of operations and comprehensive loss. Acquired in-process research and development expense for the year ended December 31, 2025 was nil. Acquired in-process research and development expense for the year ended December 31, 2024,  was $15,007 which is comprised of the upfront payment and immaterial transaction costs. For the year ended December 31, 2023, acquired in-process research and development expense totaled $520,915 pursuant to the License Agreement, which was comprised of the $474,900 paid in cash, the fair value of the 10,000,000 shares of common stock on the date of closing the transaction of $45,900, and $115 of direct transactions costs incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the payments already made to Akeso, under the License Agreement and Second Amendment, there are additional potential milestone payments of up to $4,555,000, as Akeso will be eligible to receive regulatory milestones of up to $1,050,000 and commercial milestones of up to $3,505,000. In addition, Akeso will be eligible to receive low double-digit royalties on net sales.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock', window );">Other Income, Net</a></td>
<td class="text">Other Income, Net<div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of other income, net:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency (loss) gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(610)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investment income </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of cumulative currency translation gain </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,838&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,369&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,183&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"> Investment income relates to the Company&#8217;s money market funds and short-term investments in U.S. treasury securities. Refer to Note 9 for details. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"> The reclassification of cumulative currency translation gain related to the reclassification of cumulative foreign currency translation gains from accumulated other comprehensive loss due to the dissolution of certain dormant entities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the components of non-operating income or non-operating expense, including, but not limited to, amounts earned from dividends, interest on securities, gain (loss) on securities sold, equity earnings of unconsolidated affiliates, gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax</a></td>
<td class="text">Income Tax&#160;<div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is primarily subject to corporation taxes in the U.S. and the U.K. The calculation of the Company&#8217;s tax provision involves the application of both U.S. and U.K. tax law and requires judgment and estimates. The Company has also assessed the applicability of the OECD/G20 Inclusive Framework on Base Erosion and Profit Shifting (BEPS) Pillar 2 rules, which establish a global minimum tax rate. Based on the Company&#8217;s current financial position and revenue it does not meet the thresholds for Pillar 2 to apply. Therefore, the provisions and requirements under Pillar 2 do not impact our financial statements for the reporting period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is determined using the asset and liability approach. Tax laws may require items to be included in tax filings at different times than the items are reflected in the financial statements. A current asset or liability is recognized for the estimated taxes receivable or payable for the current year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. Deferred taxes are initially recognized at enacted tax rates in force at the time of initial recognition and are subsequently adjusted for any enacted changes in tax rates and tax laws. Subsequent changes to deferred taxes originally recognized in equity are recognized in income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. The Company has recorded a full valuation allowance against the deferred tax assets in excess of its deferred tax liabilities, as the deferred tax liabilities represent future reversals of existing taxable temporary differences. The Company records interest and penalties related to income tax matters as part of income tax expense.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Uncertain Tax Positions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for uncertain tax positions taken in its tax filings by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities having full knowledge of the facts and applicable tax rules. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed as the amount of benefit to recognize in the consolidated financial statements. The amount of benefits that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate, as well as the related net interest and penalties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Due to the Company&#8217;s full valuation allowance, the unrecognized tax benefits are not expected to materially impact the Company&#8217;s effective tax rate when recognized or significantly increase or decrease in the next 12 months. In addition, the </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Company&#8217;s policy is to recognize interest and penalties related to uncertain tax positions as part of its income tax provision. However, for the years ended December 31, 2025 and 2024, the Company had no interest or penalties related to unrecognized tax benefits because any potential disallowance would not result in current tax but only result in a reduction to the Company&#8217;s net operating loss carryforwards.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Loss Before Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company&#8217;s loss before income taxes are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.378%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(326,729)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(199,040)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(499,810)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(752,857)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(22,275)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(115,118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,079,586)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(221,315)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(614,928)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not recognized a current or deferred provision for federal, state or non-United States income taxes in either of the years ending December 31, 2025 or December 31, 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes are recognized for temporary differences between the basis of assets and liabilities for financial statement and income tax purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The major components of deferred tax assets and liabilities are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.469%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforward</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">73,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">59,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credit carryforward</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 Research and Development Capitalization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">133,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">95,925&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(337)  </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(417)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets before valuation allowance </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">133,161</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">95,588</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(133,161)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(95,588)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2025 and 2024, the Company recorded a deferred tax asset of $133,578 and $95,925, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated the positive and negative evidence bearing upon its ability to realize its deferred tax assets, which are comprised primarily of net operating loss carryforwards, research and development credits, stock-based compensation expense, and research and development costs capitalized for tax purposes. Management has considered the Company&#8217;s history of cumulative net losses in each taxing jurisdiction, estimated future taxable income, as well as prudent and feasible tax planning strategies, and has concluded that it is more likely than not that the Company will not realize the tax benefits in each </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">jurisdiction. Accordingly, a full valuation allowance has been established against these net deferred tax assets as of December 31, 2025 and 2024, respectively. The Company reevaluates the positive and negative evidence at each reporting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the valuation allowance during the years ended December 31, 2025, 2024 and 2023 primarily related to net operating loss carryforwards and capitalized research and development expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The change in the valuation allowance was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance as of beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(95,588)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(84,751)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(64,016)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increases recorded to income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(37,573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(10,837)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(20,735)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance as of end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(133,161)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(95,588)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(84,751)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Net Operating Loss and Tax Credit Carryforwards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024, the Company had U.S. Federal gross operating loss carryforwards of approximately $93,210 and $44,270, respectively, which may be available to offset future income tax liabilities. The 2017 Tax Cuts and Jobs Act (&#8220;TCJA&#8221;) will generally allow losses incurred after 2017 to be carried over indefinitely but generally limits the net operating loss deduction to the lesser of the net operating loss carryover or 80% of a corporation&#8217;s taxable income (subject to Section 382 of the Internal Revenue Code of 1986, as amended). In addition, the Company has approximately $21,335 in U.S. State gross loss carryforwards which expire through various dates through 2044.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, the Company had an estimated U.S. federal and state research and development tax credit carryforwards of $15,565 and $5,002, respectively, which may be available to offset future tax liabilities, and each begin to expire in 2041 and 2037, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024, the Company had U.K. gross operating loss carryforwards of approximately $211,096 and $198,653 respectively, which may be available to offset future income tax liabilities. To the extent that U.K. taxable profits exceed &#163;5,000 in each year, the loss available to utilize against profits in excess of &#163;5,000 will be restricted to 50%. The U.K. loss carryforwards do not lapse and therefore, the full amount will be relieved over time provided there are sufficient profits against which the losses can be utilized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Utilization of the U.S. net operating loss carryforwards and research and development tax credit carryforwards may be subject to a substantial annual limitation under Section 382 of the Internal Revenue Code of 1986 due to ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50% over a three-year period. The Company has not completed a study to assess whether a change of ownership has occurred, or whether there have been multiple ownership changes since its formation. Any limitation may result in the loss of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">U.K. tax losses are subject to additional restrictions where there is a change in ownership in the business and certain other conditions are met. An ownership change of a U.K. tax resident company would occur where (directly or indirectly) a single person acquires more than half of the ordinary share capital of a company, or two or more persons each acquire a holding of at least 5% of the ordinary share capital of a company and these holdings together amount to more than half the ordinary share capital of a company. Where a change in ownership has occurred, and within three years prior to that change in ownership and five years afterwards, there is a major change in the nature and conduct of trade of that company or the trade of that business becomes small or negligible, any losses carried forward will be extinguished from the point of the change in ownership. In addition, losses accrued subsequent to April 1, 2017 will be extinguished on a change of ownership when there is a major change in the nature or conduct of a company&#8217;s business, or where there is a major change in the scale of that business, or a company ceases to carry on a particular trade or business. The Company has not completed a study to assess whether a change of ownership has occurred since its formation, or whether there has been a major change in the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">s business that would </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">restrict the U.K. tax losses. Any limitation may result in the loss of a portion of the net operating loss carryforwards before utilization.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Deemed U.S. Income Inclusions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The  TCJA created a requirement that US corporations include in income earnings of certain controlled foreign corporations under the global intangible low taxed income (&#8220;GILTI&#8221;) regime. Pursuant to the FASB Staff Q&amp;A, Topic 740 No.5. Accounting for Global Intangible Low-taxed Income, the Company is allowed to make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or to provide for the tax expense related to GILTI in the year the tax is incurred as period expense only. The Company has elected to account for GILTI in the year the tax is incurred and include the current tax impact of GILTI in the effective tax rate. Given the Company&#8217;s loss position in the U.S. and the valuation allowance recorded against its U.S. net deferred tax assets, these provisions have not had a material impact on the Company&#8217;s consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Annual Effective Tax Rate Reconciliation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the Company&#8217;s effective tax rate to the U.S. federal statutory rate is as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Tax at federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(226,702)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(46,476)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(129,048)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">State income tax, net of federal tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(17)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(6,828)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(4,782)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(2,275)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Nontaxable or nondeductible Items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">134,033</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(130)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">2,978</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">299</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">77</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">521</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Foreign Tax Effects</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Cayman Islands Statutory income tax rate differential</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">67,969</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">41,570</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(18.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">104,282</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Other foreign jurisdictions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">644</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">229</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">678</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Changes in unrecognized tax benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">1,357</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">956</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">800</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">29,228</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">8,573</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">22,064</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Unrecognized Tax Benefit Reconciliation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company records unrecognized tax benefits in accordance with ASC 740-10, Income Taxes. ASC 740-10 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of uncertain tax positions taken or expected to be taken in the Company&#8217;s income tax return and also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. As of December 31, 2025, 2024, and 2023, the Company had total unrecognized tax benefits of $3,903, $2,122, and $1,064, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of unrecognized tax benefits from continuing operations is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits, beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits, end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,903&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,122&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Audit Examinations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">In the U.S., the Company files a Federal consolidated income tax return and income tax returns in various states. In the U.S., the filings for tax years from 2020 remain subject to examination by the U.S. Internal Revenue Service and state tax authorities. The Company is not currently under examination by the Internal Revenue Service or any other jurisdiction for years 2020 through present. To the extent the Company has tax attribute carryforwards, the tax years in which the attribute was generated may be adjusted upon examination by the Internal Revenue Service or state tax authorities to the extent utilized in a future period. In the U.K., tax returns for the year ended December 31, 2023 remains subject to examination by HMRC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Legislative Impacts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">On July 4, 2025, H.R. 1, a U.S. budget reconciliation bill, was signed into law. The Company has assessed the provisions of the new legislation and has integrated the resulting impacts into its effective income tax rate. Management has concluded that the bill does not have an impact on the Company's consolidated financial statements for the current period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss per Share</a></td>
<td class="text">Net Loss per Share <div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per share: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,079,586)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(221,315)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(614,928)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average number of shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">747,702,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">718,541,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">619,646,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic net loss per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1.44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net loss per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1.44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the diluted net loss by the weighted-average number of common shares outstanding for the period, including potentially dilutive common shares. Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods, as the inclusion of all potential common share equivalents outstanding would have been antidilutive.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Because the 2023 Rights Offering (see Note 13) exercise price of $1.05 per share was less than the closing price of $1.82 per share on March 1, 2023, the expiration, the Company has retroactively adjusted earnings per share and the weighted average number of shares outstanding for the bonus element for the year ended December 31, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities were excluded from the computation of the diluted net loss per share of common stock for the periods presented because their effect would have been anti-dilutive:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">115,614,728</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">68,920,334</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,209,289</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,629,988</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,015,642</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares expected to be purchased under employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">65,905</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">86,550</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">155,163</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">115,680,633</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">73,636,872</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">59,380,094</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Stock options that are outstanding and contain improbable vesting criteria are excluded from the presentation of common stock equivalents outstanding in the table above.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">Goodwill<div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the Company expanded its activities in the field of infectious diseases with the acquisition of Discuva Limited, a privately held United Kingdom-based company. Through this acquisition, the Company obtained a bacterial genetics platform and a suite of software-based technologies, which facilitates the discovery and development of new mechanism antibiotics. This resulted in the recognition of goodwill of &#163;1.5&#160;million, which is translated into U.S. dollars at each reporting period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024, goodwill was $2,001 and $1,864, respectively. Changes year over year are the result of changes in foreign currency. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill for impairment on an annual basis as of December 31 or more frequently when events and circumstances occur indicating that recorded goodwill may be impaired. As of December 31, 2025, the Company performed its annual impairment assessment of goodwill and determined that it is more likely than not that the fair value of the reporting unit exceeds its carrying amount. The Company has recorded no goodwill impairment charges to date.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements and Short-Term Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">Fair Value Measurements and Short-Term Investments</a></td>
<td class="text">Fair Value Measurements and Short-Term Investments<div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables sets forth the Company&#8217;s fair value hierarchy for its assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2025 and 2024:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.138%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hierarchy Level</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Credit (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets included within cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">163,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">163,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government treasury bills</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets included within short-term investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of deposit</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government treasury bills</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">463,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">463,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">696,910&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">697,082&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hierarchy Level</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Credit (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets included within cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">88,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">88,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets included within short-term investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government treasury bills</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">307,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">307,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">395,986&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">396,086&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The tables above do not include cash at December 31, 2025 and 2024 of $16,366 and $16,263, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that the carrying amounts of prepaid expenses, other current assets, accounts payable, and accrued expenses approximates their fair values due to the short-term nature of those instruments. </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Realized gain (loss) on short-term investments for the years ended December 31, 2025 and 2024 were immaterial, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/825/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development Prepaid Expenses and Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">Research and Development Prepaid Expenses and Accrued Liabilities</a></td>
<td class="text">Research and Development Prepaid Expenses and Accrued Liabilities<div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Included within prepaid expenses and other current assets at December 31, 2025 and 2024 is $3,996 and $8,338, respectively, of prepayments relating to research and development expenditures. Included within accrued liabilities at December 31, 2025 and 2024 is $31,498 and $17,441, respectively, relating to research and development expenditures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These amounts are determined based on the estimated costs to complete each study or activity related to the ongoing clinical trials for ivonescimab, the estimation of the current stage of completion and the invoices received, as well as predetermined milestones which are not reflective of the current stage of development for prepaid expenses. However, accrued liabilities increase as the activities progress. The key sensitivity is the estimated current stage of completion of each study or activity, which is based on information received from the supplier and the Company&#8217;s operational knowledge of the work completed under those contracts.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for real estate. The Company does not have any finance leases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company leases its offices and facilities in Miami, FL, Palo Alto, CA, Princeton, NJ, Oxford, U.K., and Menlo Park, CA under non-cancellable operating lease agreements. The lease agreements for the Company&#8217;s offices and facilities in Miami, FL, Palo Alto, CA, Princeton, NJ and Oxford, U.K., expire in April 2029, October 2033, August 2028, and February 2027, respectively. The remaining lease agreement for the Company&#8217;s office and facility in Menlo Park, CA expires in May 2026. Under the terms of the lease agreements, the Company is responsible for certain repair and maintenance, utilities, licensing and permit fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2025, the Company recorded $17,056 of operating right-of-use assets and operating lease liabilities related to new leases for office space for its Palo Alto, CA and Princeton, NJ locations. Total future lease payments as of December 31, 2025 are approximately $23,117 on an undiscounted basis. The Palo Alto lease commenced on December&#160;1, 2025 and has a term of approximately 8 years. The Princeton, NJ lease commenced on August&#160;18, 2025 and has a term of 3 years. The Company recorded $4,216 of right-of-use assets during the year ended December 31, 2024 related to its Miami, Florida headquarters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the right-of-use assets as of December 31, 2025 and 2024 is $20,616 and $7,144, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The elements of lease expense were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Fixed lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Variable lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,078&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,509&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,297&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average discount rate and the weighted average remaining lease term were 7.6% and 6.7 years, respectively, as of December 31, 2025. The weighted average discount rate and the weighted average remaining lease term were 6.9% and 2.8 years, respectively, as of December 31, 2024. The Company made cash payments related to lease liabilities of $3,741 and $2,568 for the years ended December 31, 2025 and 2024, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Future lease payments under non-cancelable leases as of December 31, 2025 are detailed as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27,328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,890&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Operating lease liabilities, current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,388&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,502&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Promissory Note Payable to Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Promissory Note Payable to Related Parties</a></td>
<td class="text">Promissory Note Payable to Related Parties<div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">December 2022 Promissory Notes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On December 6, 2022, the Company entered into a Note Purchase Agreement (the &#8220;Note Purchase Agreement&#8221;), with Mr. Duggan and Dr. Zanganeh, pursuant to which the Company agreed to sell to each of Mr. Duggan and Dr. Zanganeh unsecured promissory notes in the aggregate amount of $520,000. Pursuant to the Note Purchase Agreement, the Company issued to Mr. Duggan and Dr. Zanganeh unsecured promissory notes in the amount of $400,000 (the &#8220;Duggan February Note&#8221;) and $20,000 (the &#8220;Zanganeh Note&#8221;), respectively, which matured and became due on February 15, 2023 and an unsecured promissory note to Mr. Duggan in the amount of $100,000 (the &#8220;Duggan September Note&#8221; and together with the Duggan February Note and the Zanganeh Note, the &#8220;December 2022 Notes&#8221;), which was originally due on September 15, 2023. The maturity dates of the December 2022 Notes could have been extended one or more times at the Company&#8217;s election, but in no event to a date later than September 6, 2024. In addition, if the Company consummated a public offering, then upon the later to occur of (i) <span style="-sec-ix-hidden:f-775">five</span> business days after the Company receives the net cash proceeds therefrom or (ii) May 15, 2023, the Duggan February Note and the Zanganeh Note were to be prepaid by an amount equal to the lesser of (a) 100% of the amount of the net proceeds of such offering and (b) the outstanding principal amount on such Notes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On January 19, 2023, the Company provided notice to extend the term of the Duggan February Note and Duggan September Note to a maturity date of September 6, 2024. Furthermore, on January 19, 2023, the Company and Mr. Duggan rectified the Duggan February Note and Duggan September Note in order to correctly reflect the parties&#8217; intent that the Company may only prepay (i) the Duggan February Note following the completion of a public rights offering to be conducted by Summit in the approximate amount of $500,000, or a similar capital raise, in an amount equal to the lesser of (x) the net proceeds of the rights offering or such capital raise or (y) the full amount outstanding of the Duggan February Note, and (ii) Duggan September Note following the completion of a capital raising transaction subsequent to the rights offering in an amount equal to the lesser of (A) the net proceeds of such capital raise or (B) the full amount outstanding of the Duggan September Note. Following the issuance of the two new Promissory Notes (the &#8220;Revised Duggan February Note&#8221; and the &#8220;Revised Duggan September Note&#8221;, respectively), the Duggan February Note and Duggan September Note were marked as &#8220;cancelled&#8221; on their face and replaced in their entirety by the Revised Duggan February Note and the Revised Duggan September Note (together with the Zanganeh Note, the &#8220;Notes&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 15, 2023, the $20,000 Zanganeh Note matured and the Company repaid the outstanding principal balance. In connection with the closing of the rights offering in 2023 (the &#8220;2023 Rights Offering&#8221;), the $400,000 Revised Duggan February Note matured and became due, and the Company repaid all principal and accrued interest thereunder using a combination of a portion of the cash proceeds from the 2023 Rights Offering and the extinguishment of a portion of the amount due equal to the subscription price of shares subscribed by Mr. Duggan in the 2023 Rights Offering.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Notes accrued interest at an initial rate of 7.5%. All interest on the Notes was paid on the date of signing for the period through February 15, 2023. Such prepaid interest was paid in a number of shares of the Company&#8217;s common stock equal to the dollar amount of such prepaid interest, divided by $0.7913 (the consolidated closing bid price immediately preceding the time the Company entered into the Note Purchase Agreement, plus $0.01), which was 9,720,291 shares. For all applicable periods following February 15, 2023, interest accrued on the outstanding principal balance of the Notes at the U.S. prime interest rate, as reported in the </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> plus 50 basis points, as adjusted monthly, for three months immediately following February 15, 2023, and thereafter at the U.S. prime rate plus 300 basis points, as adjusted monthly. Accrued interest was paid in cash, quarterly in arrears, on each of March 31, June 30, September 30 and December 31. Debt issuance costs associated with the Notes were $44 and were capitalized as part of the carrying value of the promissory notes payable to related parties. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 17, 2024, the Revised Duggan February Note was amended to extend the maturity date from September 6, 2024 to April 1, 2025. For all applicable periods commencing February 17, 2024, interest accrued on the outstanding principal balance at the greater of 12% or the U.S. prime interest rate, as reported in the </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> plus 350 basis points, as adjusted monthly, and compounded quarterly. Interest was paid upon maturity of the loan. The debt discount was amortized to interest expense using an effective interest rate method. The effective interest rate of the Revised Duggan February Note and Zanganeh Note was 8.9% and the effective interest rate of the Revised Duggan September Note was 11.3%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September 16, 2024, the Company used some of the proceeds raised from the September 2024 Private Placement (see Note 13 for further details) to repay $75,500 in principal on the Revised Duggan September Note. On October 1, 2024, the Company repaid the remaining outstanding balance of the Revised Duggan September Note in full, resulting in principal payments of $24,500 and accrued cash interest of $7,305.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of December 31, 2025 and 2024, the Company had no debt. During the year ended December 31, 2025, the Company incurred no interest expense. During the year ended December 31, 2024, the Company incurred interest expense of $8,686 related to the Revised Duggan September Note.</span></div>Related Party Transactions<div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">July 25, 2022 First Amendment to Sublease Agreement with Maky Zanganeh and Associates, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On July 25, 2022 the Company entered into a first amendment, dated July 19, 2022, to its existing sublease agreement with Maky Zanganeh and Associates, Inc. (&#8220;MZA&#8221;), an entity owned by Maky Zanganeh, consisting of 4,500 square feet of office space at 2882 Sand Hill Road, Menlo Park, California. The existing sublease term, which was set to expire on September 30, 2022, was extended for a period of thirty-nine months from October 1, 2022 through December 31, 2025. The rent payable under the terms of the sublease is equivalent to the proportionate share of the net payable by MZA to the third-party landlord, based on the square footage of office space sublet by the Company, and no mark-up has been applied. The agreement was further amended to include additional space, as noted below under the August 2, 2024 Third Amendment to Sublease Agreement with Maky Zanganeh and Associates, Inc. During the years ended December 31, 2025, 2024 and 2023, payments of $834, $795, and $762, respectively, were made pursuant to the first and third amendments to the Sublease Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">July 29, 2022 Second Amendment to Sublease Agreement with Maky Zanganeh and Associates, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On July 29, 2022, the Company entered into a second amendment to its existing sublease agreement with MZA, described above. The second amendment was effective as of August 1, 2022 and expires on December 31, 2025. The second amendment includes an additional 1,277 square feet of office space at 2882 Sand Hill Road, Menlo Park, California. The rent payable under the terms of the sublease is equivalent to the proportionate share of the net payable by MZA to the third-party landlord, based on the square footage of office space sublet by the Company, and no mark-up has been applied. During the years ended December 31, 2025, 2024 and 2023, payments of $232, $224 and $218, respectively, were made pursuant to the second amendment to the Sublease Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">April 1, 2024 Miami Sublease Agreements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2024, the Company entered into two sublease agreements of its Miami headquarters location, one with Genius 24C Inc. (&#8220;Genius&#8221;), an affiliate of the Company&#8217;s Co-CEO, Robert W. Duggan (the &#8220;Genius Sublease Agreement&#8221;) and one with Duggan Investments Research LLC (&#8220;Investments Research&#8221;), also an affiliate of the Company's Co-CEO, Robert W. Duggan (the &#8220;Investments Research Sublease Agreement&#8221;). Pursuant to the Genius Sublease Agreement, Genius sublet from the Company 848 square feet of office space in the Miami HQ for a sixty-two month term for total rental payments of approximately $446. Pursuant to the Investments Research Sublease Agreement, Investments Research sublet from the Company 848 square feet of office space in the Miami HQ for a sixty-two month term for total rental payments of approximately $446. During the years ended December 31, 2025 and 2024, the Company recognized $186 and $156, respectively, of sublease income recorded net of operating lease expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">August 2, 2024 Third Amendment to Sublease Agreement with Maky Zanganeh and Associates, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2024, the Company entered into a third amendment to its existing sublease agreement with MZA. The third amendment was effective August 1, 2024 and included an additional space of 145 square feet of office space located at 2882 </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Sand Hill Road, Menlo Park, California. The Company continues to be obligated to pay its proportionate share of the net payable by MZA to the third-party landlord, which is revised to 93.6% as of the effective date, based on the square footage of office space sublet by the landlord.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Promissory Note Payable to Related Parties</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 12 for disclosure of the promissory note payable to related parties issued December 6, 2022 and fully repaid as of October 1, 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Akeso Agreements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the License Agreement, the Board appointed Dr. Yu (Michelle) Xia to serve as a member of the Board pursuant to the terms of the License Agreement. Dr. Xia is the founder of Akeso, and has been the chairwoman, president and CEO of Akeso since its inception in 2012. Furthermore, in connection with the License Agreement, the Company also entered into a Supply Agreement with Akeso, pursuant to which Summit agreed to purchase a certain portion of drug substance for clinical and commercial supply (the &#8220;Supply Agreement&#8221;). Refer to Note 4 for details on the License Agreement and Second Amendment. In addition to the License and Second Amendment and supply agreements, the Company also entered into various clinical services agreements with Akeso. During the years ended December 31, 2025, 2024 and 2023, the Company incurred research and development expenses of $46,133, $24,635 and $6,207, respectively, under these agreements with Akeso. As of December 31, 2025 and 2024 the Company included in accrued expenses, related to Akeso, $1,215 and $3,956, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">2023 Rights Offering</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Refer to Note 13 for a discussion on the 2023 Rights Offering.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Private Placements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">October 2023 PIPE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 13 for a discussion on the participation by related parties in October 2023 PIPE.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">September 2024 PIPE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 13 for a discussion on the participation by related parties in September 2024 PIPE.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">October 2025 PIPE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 13 for a discussion on the participation by related parties in October 2025 PIPE.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Warrants Exercise</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2025, Mr. Duggan, the Company&#8217;s Co-Chief Executive Officer, exercised 2,936,221 of the 3,985,055 warrants which he received in connection with a private placement completed by the Company with Mr. Duggan and other investors on December 24, 2019, resulting in the purchase of 2,936,221 shares of common stock at an exercise price of $1.58.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On April 8, 2025, Mr. Duggan completed the exercise of the remaining warrants received in the December 24, 2019 private placement, resulting in the purchase of 1,048,834 shares of common stock at an exercise price of $1.58.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In October 2024, the Shaun Zanganeh Irrevocable Trust exercised a warrant to purchase 315,681 shares of Common Stock.  Refer to Note 13 for the warrants exercise activity for the year ended December 31, 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Professional Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December 31, 2025, the Company engaged the law firm Wilson Sonsini Goodrich &amp; Rosati P.C. (&#8220;WSGR&#8221;), where Mr. Kenneth A. Clark, a member of the Board, is a partner. Payments to be made by the Company to WSGR </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">were approved by the Audit Committee in accordance with its Related Party Transaction Policy. For the year ended December 31, 2025, the Company incurred expenses for legal services rendered by WSGR totaling approximately $1.4 million included in general and administrative expenses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders' Equity <div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and December 31, 2024, the Company had 20,000,000 shares of preferred stock, par value $0.01 authorized and no shares issued and outstanding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and December 31, 2024, the Company had authorized 1,000,000,000 shares of common stock, par value $0.01 (the &#8220;Common Stock&#8221;). As of December 31, 2025 and December 31, 2024, the Company had 775,371,200 shares and 737,626,004 shares of Common Stock issued and outstanding, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On December 6, 2022, the Company announced the 2023 Rights Offering for its existing shareholders to participate in the purchase of additional shares of its Common Stock for $1.05 per share. The 2023 Rights Offering commenced on February 7, 2023 and the associated subscription rights expired on March 1, 2023. Aggregate gross proceeds from the 2023 Rights Offering were $500,000 from the sale of 476,190,471 shares of the Company&#8217;s Common Stock and issuance costs were $619. Mr. Duggan and Dr. Zanganeh fully subscribed to their respective basic subscription rights at a price of $1.05 per share. To satisfy the $395,314 subscription price for the shares subscribed by Mr. Duggan in the 2023 Rights Offering, Mr. Duggan agreed with the Company to extinguish a portion of the amount due and payable to him by the Company at the closing of the 2023 Rights Offering pursuant to the $400,000 Duggan Promissory Note in an amount equal to the subscription price (see also Note 12).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;19, 2023, the Company filed Amendment No. 2 to the Restated Certificate of Incorporation (the &#8220;Amendment No. 2&#8221;) with the Secretary of State of the State of Delaware to increase the number of authorized shares of its Common Stock by 650,000,000 (from 350,000,000 to 1,000,000,000), which became effective on such date. </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 17, 2023, the Company filed a registration statement on Form S-3 to register for resale the following shares of the Company&#8217;s Common Stock at $0.01 par value: (i) 10,000,000 shares of Common Stock issued on January 17, 2023 in connection with the License Agreement (as defined in Note 4) with Akeso pursuant to which the Company issued Akeso such shares; and (ii) the 9,346,434 and 373,857 shares of Common Stock issued in December 2022 to Mr. Duggan and Dr. Zanganeh, respectively, as payment of prepaid interest in connection with the Note Purchase Agreement dated December 6, 2022 between Mr. Duggan, Dr. Zanganeh and the Company. On April 27, 2023, the SEC issued the Company a Notice of Effectiveness for the registration statement on Form S-3.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Soni entered into a share purchase agreement with the Company to purchase $5,000 of its Common Stock via a private placement. The transaction was effective October 13, 2023 with a closing price of $1.68, resulting in the purchase of 2,976,190 shares of the Company&#8217;s Common Stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">June 2024 PIPE (Private Investment in Public Equity)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On June 3, 2024, the Company entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with 667, L.P. and Baker Brothers Life Sciences, L.P., affiliates of Baker Bros. Advisors, L.P., for the sale by the Company in a private placement (the &#8220;June 2024 Private Placement&#8221;) of 22,222,222 shares (the &#8220;Shares&#8221;) of Common Stock, at a purchase price of $9.00 per share, for an aggregate purchase price of approximately $200,000. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The closing of the June 2024 Private Placement was June&#160;6, 2024. The Purchase Agreement contained customary representations, warranties and covenants by the Company, customary indemnification obligations of the Company, including for liabilities under the Securities Act of 1933, other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Purchase Agreement were made only for purposes of the Purchase Agreement and as of specific dates, were solely for the benefit of the parties to such agreements and were subject to limitations agreed upon by the contracting parties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;3, 2024, in connection with the Purchase Agreement, the Company entered into a Registration Rights Agreement with certain investors (the &#8220;Registration Rights Agreement&#8221;). The Registration Rights Agreement provides, among other things, that the Company will as soon as reasonably practicable, file with the SEC a registration statement registering the resale of the shares. The Company agreed to use its reasonable best efforts to have such registration statement declared effective as soon as practicable after the filing thereof. The Company filed the registration statement on August 6, 2024, which was automatically effective upon filing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">September 2024 PIPE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;11, 2024, the Company entered into securities purchase agreements (the &#8220;September 2024 Purchase Agreements&#8221;) with multiple  biotech institutional investors and individual accredited investors, for the sale by the Company in a private placement (the &#8220;September 2024 Private Placement&#8221;) for an aggregate of 10,352,418 shares of the Company&#8217;s Common Stock, par value $0.01 per share of Common Stock, at purchase price of $22.70 per share, which was the closing price of the Common Stock on September&#160;11, 2024, for aggregate gross proceeds to the Company of approximately $235,000, with offering costs of $140.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company's Section 16 officers participated in the capital raise. A total of $79,000 was raised by the Company's Co-Chief Executive Officer (&#8220;CEO&#8221;), Executive Chairman and majority stockholder, its CEO and the President and member of the Company's Board of Directors (the &#8220;Board&#8221;), its Chief Operating Officer (&#8220;COO&#8221;), Chief Financial Officer (&#8220;CFO&#8221;), and member of the Board, its Chief Accounting Officer (&#8220;CAO&#8221;), and a member of the Board, who invested via a controlled entity. The remaining $156,000 was raised with multiple leading biotech institutional investors. Refer to Note 15 Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">for further details regarding related parties' participation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The closing of the September 2024 Private Placement was September 13, 2024. The September 2024 Purchase Agreements contain customary representations, warranties and covenants by the Company, customary indemnification obligations of the Company, including for liabilities under the Securities Act, as amended (the &#8220;Securities Act&#8221;), other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the September 2024 Purchase </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Agreements were made only for purposes of the September 2024 Purchase Agreements and as of specific dates, were solely for the benefit of the parties to such agreements and were subject to limitations agreed upon by the contracting parties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;11, 2024, in connection with the September 2024 Purchase Agreements, the Company entered into Registration Rights Agreements with certain investors (the &#8220;September 2024 Registration Rights Agreements&#8221;). The September 2024 Registration Rights Agreements provide, among other things, that the Company will as soon as reasonably practicable file with the SEC a registration statement registering the resale of the shares. The Company filed the registration statement on September 19, 2024, which was automatically effective upon filing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">October 2025 PIPE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On October&#160;21, 2025, the Company entered into securities purchase agreements (the &#8220;October 2025 Purchase Agreements&#8221;)  with multiple  biotech institutional investors and individual accredited investors, for the sale by the Company in a private placement for an aggregate of 26,682,846 shares of the Company&#8217;s Common Stock, par value $0.01 per share of Common Stock, at purchase price of $18.74 per Share, which was the closing price of the Common Stock on October&#160;21, 2025, for aggregate gross proceeds to the Company of approximately $500,037, with immaterial offering costs. The private placement transaction was completed in October 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company's Section 16 officers participated in the capital raise. The Company's Co-CEO, Executive Chairman and majority stockholder, its Co-CEO and the President and member of the Board, its COO, CFO, and member of the Board, its CAO, and certain non-executive employees and other related persons purchased an aggregate of 14,514,402 shares of Common Stock for gross proceeds of approximately $272,000. Additionally, Akeso purchased 533,617 shares of Common Stock for gross proceeds of approximately $10,000. The remaining $218,037 was raised with multiple leading biotech institutional investors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The October 2025 Purchase Agreements contain customary representations, warranties and covenants by the Company, customary indemnification obligations of the Company, including for liabilities under the Securities Act, as amended (the &#8220;Securities Act&#8221;), other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the October 2025 Purchase Agreements were made only for purposes of the October 2025 Purchase Agreements and as of specific dates, were solely for the benefit of the parties to such agreements and were subject to limitations agreed upon by the contracting parties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;21, 2025, in connection with the October 2025 Purchase Agreements, the Company entered into Registration Rights Agreements with the Investors (the &#8220;October 2025 Registration Rights Agreements&#8221;). The October 2025 Registration Rights Agreements provide, among other things, that the Company will as soon as reasonably practicable, and in any event by no later than December 19, 2025, file with the SEC a registration statement registering the resale of the shares. The Company filed the registration statement on October 29, 2025, which was automatically effective upon filing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-the-Market Offering (ATM Offering)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On May 13, 2024, the Company entered into an at-the-market  (&#8220;ATM&#8221;) sales agreement (the &#8220;Original Distribution Agreement&#8221;) pursuant to which the Company may, subject to the terms and conditions set forth in the agreement offer and sell, from time to time, through or to the agents, acting as agents or principal, shares of the Company's Common Stock, par value $0.01, having an aggregate offering price of up to $90,000. On August 11, 2025, the Company entered into an amendment to the Original Distribution Agreement (as amended, the &#8220;Distribution Agreement&#8221;), which among other things, increased the aggregate offering price of Common Stock that the Company may offer and sell from time to time through the sales agent under the Distribution Agreement by an additional $360,000.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From the date of the Original Distribution Agreement through December 31, 2025, the Company sold 7,146,432 shares of Common Stock under the ATM at a weighted-average price of $21.09 per share, for gross proceeds of $150,721, with commissions and fees of approximately $3,160. The remaining gross proceeds available under the Distribution Agreement as of December 31, 2025 was approximately $299,279. The Company plans to use the net proceeds from this offering for working capital and general corporate purposes.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, the Company had no outstanding warrants. As of December 31, 2024, the Company had outstanding and exercisable warrants of 4,629,988 with a weighted average exercise price of $1.58. During the year ended December 31, 2025, 4,629,988 warrants were exercised with a weighted average exercise price of $1.58.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">2016 Long Term Incentive Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Upon the effectiveness of the 2020 Stock Incentive Plan (the &#8220;2020 Plan&#8221;), no additional grants will be made under the 2016 Long Term Incentive Plan, (the &#8220;2016 Plan&#8221;) and any outstanding awards continue with their original terms. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">2020 Stock Award Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, the Company&#8217;s Board of Directors approved the 2020 Stock Incentive Plan, which became effective on September 21, 2020. The 2020 plan provides for the grant of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units and other stock-based awards. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A total of 8,000,000 shares of Common Stock were initially reserved for issuance under the 2020 Plan. Additionally, up to 5,000,000 shares of Common Stock, including RSUs can be added to the 2020 Plan for future issuance from options that expire, lapse or are terminated from the 2016 Plan or any other predecessor plans. The number of shares of Common Stock that may be issued under the 2020 Plan will automatically increase on each January 1, beginning in 2021 and continuing for each fiscal year until, and including, the fiscal year ending December 31, 2030, equal to the lesser of (i) 6,400,000 shares of Common Stock, (ii) 4% of the common shares outstanding on the final day of the immediately preceding calendar year and (iii) an amount as determined by the Company&#8217;s Board of Directors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, there are 2,643,200 shares available to be issued under the 2020 Plan. The Company currently grants stock options to employees and directors under the 2020 Stock Incentive Plan (the &#8220;2020 Plan&#8221;) and formerly, the Company granted stock options under the 2016 Long Term Incentive Plan (the &#8220;2016 Plan&#8221;). The 2020 Plan is administered by the Compensation Committee of the Company's Board of Directors. The 2020 Plan is intended to attract and retain employees and directors and provide an incentive for these individuals to assist the Company to achieve long-range performance goals and to enable these individuals to participate in the long-term growth of the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Based on the provisions of the 2020 Plan, the number of shares of common stock available for issuance under the 2020 Plan increased by 6,400,000 shares on January 1, 2025. On September 18, 2025, the Board approved an increase of 8,000,000 shares of common stock available for issuance under the 2020 Plan (the &#8220;Incremental Pool&#8221;), subject to the approval of the holders of a majority of the shares voting at the Company&#8217;s stockholder meeting. As of December 31, 2025, there are 3,082,075 shares available to be issued under the Incremental Pool. The Company&#8217;s consolidated financial statements have treated the grant date of such stock options as the date Board approval was obtained.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On May 3, 2024, the Board adopted the 2024 Inducement Pool (the &#8220;Inducement Pool&#8221;), which mirrors the terms of the 2020 Plan, with a total of 2,000,000 shares of Common Stock reserved for issuance under the Inducement Pool. Effective January 22, 2025, the number of shares of common stock available under the Inducement Pool increased by 2,000,000 shares. The Inducement Pool provides for the grant of non-qualified stock options and was approved by the Compensation Committee of the Board without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Inducement Pool is administered by the Compensation Committee of the Board. In accordance with Rule 5635(c)(4) of the Nasdaq Listing Rules, non-qualified stock options under the Inducement Pool may only be made to an employee who has not previously been an employee of the Company or member of the Board (or any parent or subsidiary of the Company), if he or she is granted such non-qualified stock options in connection with his or her commencement of employment with the Company or a subsidiary and such grant is an inducement material to his or her entering into employment with the Company or such subsidiary. As of December 31, 2025, there were 1,936,452 shares available for grant under the Inducement Pool.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">2020 Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Employee Stock Purchase Plan (the &#8220;2020 ESPP&#8221;) was adopted by the Board of Directors and approved by the Company&#8217;s shareholders on July 17, 2020 and approved by the predecessor company shareholders on August 19, 2020 and is qualified under Section 423 of the Internal Revenue Code. The 2020 ESPP initially authorized the issuance of up to 1,000,000 shares of Common Stock to participating employees. The number of common shares that may be issued under the 2020 ESPP automatically increases on each fiscal year commencing January 1, 2021 and continuing for each fiscal year until, and including the fiscal year commencing on, January 1, 2030 equal to the lesser of (i) 1,600,000 shares of Common Stock, (ii) 1% of the common shares outstanding on such date and (iii) an amount as determined by the Company&#8217;s Board of Directors. As of December 31, 2025, there were 1,743,682 shares available to be issued under the 2020 ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 ESPP is comprised of purchase periods of six months in duration and commence immediately preceding the end of the previous offering period, unless otherwise determined by the Board of Directors or Compensation Committee. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2020 ESPP, eligible employees can purchase shares of Common Stock through payroll deductions of up to 15% of their compensation received during the plan period or such shorter period during which deductions from payroll are made, up to a defined maximum amount. The option price is determined based on the lesser of the closing price of Common Stock on (i) the first business day of the plan period or (ii) the exercise date, or shall be based solely on the closing price of the Common Stock on the exercise date; provided that such option price shall be at least 85% of the applicable closing price. In the absence of a determination by the Board of Directors or the Compensation Committee, the option price is 85% of the lesser of the closing price of the Common Stock on (i) the first business day of the plan period or (ii) the exercise date. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The closing price is the (a) the closing price (for the primary trading session) on the Nasdaq Global Select Market or (b) the average of the closing bid and asked prices in the over-the-counter-market, whichever is applicable, as published in the </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> or another source selected by the Board or the Committee. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended December 31, 2025 and 2024, 139,459 and 353,578 shares, respectively, were issued under the 2020 ESPP Plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair value of stock options granted to employees and directors using the Black-Scholes valuation model. Stock options granted under the 2016 and 2020 Plans generally vest over <span style="-sec-ix-hidden:f-888">three</span> or four years and expire after ten years. This valuation methodology utilizes several key assumptions as highlighted below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used in the Company&#8217;s valuation are summarized as follows, presented on a weighted average basis:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.8% - 3.9%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.5 - 6.2</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">124.9% -142.5%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">98.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected annual dividends per share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%">The following table summarizes the Company&#8217;s stock option activity for the year ended December 31, 2025:&#160;&#160;&#160;&#160;&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of share options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate intrinsic value </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2024*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">108,136,310</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.34</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,677,748&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,297,732</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,015,750)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(953,564)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.99</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">119,464,728</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,618,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">110,536,687</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.86</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,527,454&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">64,834,314</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.32</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">983,902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">* The stock option activity in the table above includes performance-based options outstanding as of December 31, 2024 of 48,220,320 of which 39,013,976 options were unvested and converted to time-based vesting. During the three months ended March 31, 2025, the company granted 5,475,000 performance-based options which were modified to time-based vesting during the three months ended June 30, 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2025, the Compensation Committee of the Board of Directors approved a modification to the Company's outstanding unvested performance-based stock option awards for certain employees and executives that will require only the service-based vesting requirements to continue to be satisfied in order to become fully vested, subject to employee consent. The Company accounted for this change as a Type III modification (improbable-to-probable) in accordance with the requirements of Accounting Standards Codification Topic 718 (ASC 718). As a result, 44,488,976 options were valued on the modification date. The Company is recognizing the newly assessed measurement date fair value of the awards as compensation expense over the remaining vesting period. During the year ended December 31, 2025, the Company recognized expense of $650,959 associated with the modification. As of December 31, 2025, the unrecognized compensation cost associated with the modification was $214,295 and is expected to be expensed over a weighted-average recognition period of approximately 1.6 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of stock options granted during the years ended December 31, 2025, 2024 and 2023 was $17.10, $3.40 and $1.41, per share, respectively. The aggregate intrinsic value of stock options exercised during the years ended December 31, 2025, 2024 and 2023 was $15,212, $863, and $474, respectively. The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options and the fair value of the Company&#8217;s common stock for those stock options that had exercise prices lower than the fair value of the Company&#8217;s common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, there was $345,387 total unrecognized compensation cost related to unvested stock option grants. The unvested amount is expected to be recognized over a weighted average period of approximately 1.8 years. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Stock&#8209;based compensation expense related to stock options is recorded within the consolidated statements of operations and comprehensive loss as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:83%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">218,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">513,856&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">34,974&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%">Total stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">732,420</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">50,981</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,108</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock-based compensation expense associated with each of our stock-based compensation arrangements:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:83%">Time-based stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">731,358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">39,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Performance and market-based stock options </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,062</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">599</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">184</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%">Total stock-based compensation</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">732,420</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">50,981</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,108</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Promissory Note Payable to Related Parties<div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">December 2022 Promissory Notes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On December 6, 2022, the Company entered into a Note Purchase Agreement (the &#8220;Note Purchase Agreement&#8221;), with Mr. Duggan and Dr. Zanganeh, pursuant to which the Company agreed to sell to each of Mr. Duggan and Dr. Zanganeh unsecured promissory notes in the aggregate amount of $520,000. Pursuant to the Note Purchase Agreement, the Company issued to Mr. Duggan and Dr. Zanganeh unsecured promissory notes in the amount of $400,000 (the &#8220;Duggan February Note&#8221;) and $20,000 (the &#8220;Zanganeh Note&#8221;), respectively, which matured and became due on February 15, 2023 and an unsecured promissory note to Mr. Duggan in the amount of $100,000 (the &#8220;Duggan September Note&#8221; and together with the Duggan February Note and the Zanganeh Note, the &#8220;December 2022 Notes&#8221;), which was originally due on September 15, 2023. The maturity dates of the December 2022 Notes could have been extended one or more times at the Company&#8217;s election, but in no event to a date later than September 6, 2024. In addition, if the Company consummated a public offering, then upon the later to occur of (i) <span style="-sec-ix-hidden:f-775">five</span> business days after the Company receives the net cash proceeds therefrom or (ii) May 15, 2023, the Duggan February Note and the Zanganeh Note were to be prepaid by an amount equal to the lesser of (a) 100% of the amount of the net proceeds of such offering and (b) the outstanding principal amount on such Notes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On January 19, 2023, the Company provided notice to extend the term of the Duggan February Note and Duggan September Note to a maturity date of September 6, 2024. Furthermore, on January 19, 2023, the Company and Mr. Duggan rectified the Duggan February Note and Duggan September Note in order to correctly reflect the parties&#8217; intent that the Company may only prepay (i) the Duggan February Note following the completion of a public rights offering to be conducted by Summit in the approximate amount of $500,000, or a similar capital raise, in an amount equal to the lesser of (x) the net proceeds of the rights offering or such capital raise or (y) the full amount outstanding of the Duggan February Note, and (ii) Duggan September Note following the completion of a capital raising transaction subsequent to the rights offering in an amount equal to the lesser of (A) the net proceeds of such capital raise or (B) the full amount outstanding of the Duggan September Note. Following the issuance of the two new Promissory Notes (the &#8220;Revised Duggan February Note&#8221; and the &#8220;Revised Duggan September Note&#8221;, respectively), the Duggan February Note and Duggan September Note were marked as &#8220;cancelled&#8221; on their face and replaced in their entirety by the Revised Duggan February Note and the Revised Duggan September Note (together with the Zanganeh Note, the &#8220;Notes&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 15, 2023, the $20,000 Zanganeh Note matured and the Company repaid the outstanding principal balance. In connection with the closing of the rights offering in 2023 (the &#8220;2023 Rights Offering&#8221;), the $400,000 Revised Duggan February Note matured and became due, and the Company repaid all principal and accrued interest thereunder using a combination of a portion of the cash proceeds from the 2023 Rights Offering and the extinguishment of a portion of the amount due equal to the subscription price of shares subscribed by Mr. Duggan in the 2023 Rights Offering.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Notes accrued interest at an initial rate of 7.5%. All interest on the Notes was paid on the date of signing for the period through February 15, 2023. Such prepaid interest was paid in a number of shares of the Company&#8217;s common stock equal to the dollar amount of such prepaid interest, divided by $0.7913 (the consolidated closing bid price immediately preceding the time the Company entered into the Note Purchase Agreement, plus $0.01), which was 9,720,291 shares. For all applicable periods following February 15, 2023, interest accrued on the outstanding principal balance of the Notes at the U.S. prime interest rate, as reported in the </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> plus 50 basis points, as adjusted monthly, for three months immediately following February 15, 2023, and thereafter at the U.S. prime rate plus 300 basis points, as adjusted monthly. Accrued interest was paid in cash, quarterly in arrears, on each of March 31, June 30, September 30 and December 31. Debt issuance costs associated with the Notes were $44 and were capitalized as part of the carrying value of the promissory notes payable to related parties. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 17, 2024, the Revised Duggan February Note was amended to extend the maturity date from September 6, 2024 to April 1, 2025. For all applicable periods commencing February 17, 2024, interest accrued on the outstanding principal balance at the greater of 12% or the U.S. prime interest rate, as reported in the </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> plus 350 basis points, as adjusted monthly, and compounded quarterly. Interest was paid upon maturity of the loan. The debt discount was amortized to interest expense using an effective interest rate method. The effective interest rate of the Revised Duggan February Note and Zanganeh Note was 8.9% and the effective interest rate of the Revised Duggan September Note was 11.3%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September 16, 2024, the Company used some of the proceeds raised from the September 2024 Private Placement (see Note 13 for further details) to repay $75,500 in principal on the Revised Duggan September Note. On October 1, 2024, the Company repaid the remaining outstanding balance of the Revised Duggan September Note in full, resulting in principal payments of $24,500 and accrued cash interest of $7,305.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of December 31, 2025 and 2024, the Company had no debt. During the year ended December 31, 2025, the Company incurred no interest expense. During the year ended December 31, 2024, the Company incurred interest expense of $8,686 related to the Revised Duggan September Note.</span></div>Related Party Transactions<div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">July 25, 2022 First Amendment to Sublease Agreement with Maky Zanganeh and Associates, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On July 25, 2022 the Company entered into a first amendment, dated July 19, 2022, to its existing sublease agreement with Maky Zanganeh and Associates, Inc. (&#8220;MZA&#8221;), an entity owned by Maky Zanganeh, consisting of 4,500 square feet of office space at 2882 Sand Hill Road, Menlo Park, California. The existing sublease term, which was set to expire on September 30, 2022, was extended for a period of thirty-nine months from October 1, 2022 through December 31, 2025. The rent payable under the terms of the sublease is equivalent to the proportionate share of the net payable by MZA to the third-party landlord, based on the square footage of office space sublet by the Company, and no mark-up has been applied. The agreement was further amended to include additional space, as noted below under the August 2, 2024 Third Amendment to Sublease Agreement with Maky Zanganeh and Associates, Inc. During the years ended December 31, 2025, 2024 and 2023, payments of $834, $795, and $762, respectively, were made pursuant to the first and third amendments to the Sublease Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">July 29, 2022 Second Amendment to Sublease Agreement with Maky Zanganeh and Associates, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On July 29, 2022, the Company entered into a second amendment to its existing sublease agreement with MZA, described above. The second amendment was effective as of August 1, 2022 and expires on December 31, 2025. The second amendment includes an additional 1,277 square feet of office space at 2882 Sand Hill Road, Menlo Park, California. The rent payable under the terms of the sublease is equivalent to the proportionate share of the net payable by MZA to the third-party landlord, based on the square footage of office space sublet by the Company, and no mark-up has been applied. During the years ended December 31, 2025, 2024 and 2023, payments of $232, $224 and $218, respectively, were made pursuant to the second amendment to the Sublease Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">April 1, 2024 Miami Sublease Agreements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2024, the Company entered into two sublease agreements of its Miami headquarters location, one with Genius 24C Inc. (&#8220;Genius&#8221;), an affiliate of the Company&#8217;s Co-CEO, Robert W. Duggan (the &#8220;Genius Sublease Agreement&#8221;) and one with Duggan Investments Research LLC (&#8220;Investments Research&#8221;), also an affiliate of the Company's Co-CEO, Robert W. Duggan (the &#8220;Investments Research Sublease Agreement&#8221;). Pursuant to the Genius Sublease Agreement, Genius sublet from the Company 848 square feet of office space in the Miami HQ for a sixty-two month term for total rental payments of approximately $446. Pursuant to the Investments Research Sublease Agreement, Investments Research sublet from the Company 848 square feet of office space in the Miami HQ for a sixty-two month term for total rental payments of approximately $446. During the years ended December 31, 2025 and 2024, the Company recognized $186 and $156, respectively, of sublease income recorded net of operating lease expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">August 2, 2024 Third Amendment to Sublease Agreement with Maky Zanganeh and Associates, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2024, the Company entered into a third amendment to its existing sublease agreement with MZA. The third amendment was effective August 1, 2024 and included an additional space of 145 square feet of office space located at 2882 </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Sand Hill Road, Menlo Park, California. The Company continues to be obligated to pay its proportionate share of the net payable by MZA to the third-party landlord, which is revised to 93.6% as of the effective date, based on the square footage of office space sublet by the landlord.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Promissory Note Payable to Related Parties</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 12 for disclosure of the promissory note payable to related parties issued December 6, 2022 and fully repaid as of October 1, 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Akeso Agreements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the License Agreement, the Board appointed Dr. Yu (Michelle) Xia to serve as a member of the Board pursuant to the terms of the License Agreement. Dr. Xia is the founder of Akeso, and has been the chairwoman, president and CEO of Akeso since its inception in 2012. Furthermore, in connection with the License Agreement, the Company also entered into a Supply Agreement with Akeso, pursuant to which Summit agreed to purchase a certain portion of drug substance for clinical and commercial supply (the &#8220;Supply Agreement&#8221;). Refer to Note 4 for details on the License Agreement and Second Amendment. In addition to the License and Second Amendment and supply agreements, the Company also entered into various clinical services agreements with Akeso. During the years ended December 31, 2025, 2024 and 2023, the Company incurred research and development expenses of $46,133, $24,635 and $6,207, respectively, under these agreements with Akeso. As of December 31, 2025 and 2024 the Company included in accrued expenses, related to Akeso, $1,215 and $3,956, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">2023 Rights Offering</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Refer to Note 13 for a discussion on the 2023 Rights Offering.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Private Placements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">October 2023 PIPE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 13 for a discussion on the participation by related parties in October 2023 PIPE.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">September 2024 PIPE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 13 for a discussion on the participation by related parties in September 2024 PIPE.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">October 2025 PIPE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 13 for a discussion on the participation by related parties in October 2025 PIPE.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Warrants Exercise</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2025, Mr. Duggan, the Company&#8217;s Co-Chief Executive Officer, exercised 2,936,221 of the 3,985,055 warrants which he received in connection with a private placement completed by the Company with Mr. Duggan and other investors on December 24, 2019, resulting in the purchase of 2,936,221 shares of common stock at an exercise price of $1.58.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On April 8, 2025, Mr. Duggan completed the exercise of the remaining warrants received in the December 24, 2019 private placement, resulting in the purchase of 1,048,834 shares of common stock at an exercise price of $1.58.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In October 2024, the Shaun Zanganeh Irrevocable Trust exercised a warrant to purchase 315,681 shares of Common Stock.  Refer to Note 13 for the warrants exercise activity for the year ended December 31, 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Professional Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December 31, 2025, the Company engaged the law firm Wilson Sonsini Goodrich &amp; Rosati P.C. (&#8220;WSGR&#8221;), where Mr. Kenneth A. Clark, a member of the Board, is a partner. Payments to be made by the Company to WSGR </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">were approved by the Audit Committee in accordance with its Related Party Transaction Policy. For the year ended December 31, 2025, the Company incurred expenses for legal services rendered by WSGR totaling approximately $1.4 million included in general and administrative expenses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Fixed asset purchase commitments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2025 and 2024, the Company had no capital commitments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Lease commitments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">11 for a discussion of the Company&#8217;s lease commitments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Other commitments</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company enters into contracts in the normal course of business with various third parties for clinical trials, preclinical research studies and testing, manufacturing and other services and products for operating purposes. Most contracts provide for termination upon notice, and therefore are cancellable contracts. The majority of these commitments are due within one year. As of December 31, 2025, total unconditional purchase obligations, excluding leases commitments, are estimated to be approximately $17,976.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has certain commitments under its agreements with Akeso. The License Agreement also contains certain manufacturing and purchase commitments. As of December 31, 2025, the Company is unable to estimate the amount, timing or likelihood of achieving the milestones, making future product sales or assessing estimated forecasts for manufacturing and supplied materials which these contingent payment obligations relate to. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation Relating to the December 2022 Notes Entered into in Connection with the License Agreement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">On March 17, 2025, Rainaldi Revocable Trust, a purported stockholder of the Company, filed a derivative lawsuit in the Delaware Court of Chancery against certain of the Company&#8217;s current and former directors and the Company, solely as a nominal defendant, concerning the December 2022 Notes entered into by the Company, Mr. Duggan and Dr. Zanganeh in connection with the License Agreement. The suit asserts claims for breach of fiduciary duty and unjust enrichment and seeks, among other things, unspecified damages, rescission of the shares that Mr. Duggan and Dr. Zanganeh received as part of prepaid interest payments under the December 2022 Notes, as well as attorneys&#8217; fees and costs. Defendants&#8217; Motion to Dismiss the complaint was filed on May 16, 2025. Plaintiff filed the Motion to Certify certain constitutional questions to the Delaware Supreme Court on May 29, 2025. Defendants agreed to a stipulation staying briefing on the Motion to Certify and the Motion to Dismiss pending the Delaware Supreme Court&#8217;s decision in another case involving substantially the same constitutional questions. On June 18, 2025, the Court granted such stipulation. Defendants believe that Plaintiff's allegations are without merit and plan to vigorously defend against its claims</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented a risk-based approach to identify and assess the cybersecurity threats that could affect our business and information systems. We use recognized commercially reasonable measures, tools and methodologies designed to manage cybersecurity risk that are tested on a regular cadence. We also monitor and evaluate our cybersecurity posture on an ongoing basis through regular vulnerability scans, penetration tests and third-party reviews. We rely on third-party service providers to provide the systems required to effectively run our clinical trials and endeavor to require third-party service providers that have access to personal, confidential or proprietary information to implement and maintain cybersecurity practices. Specific controls that are used in appropriate portions of our environment include endpoint threat detection and response, identity and access management, privileged access management, logging and monitoring involving the use of security information and event management, multi-factor authentication, firewalls and intrusion detection and prevention, and vulnerability and patch management. Our cybersecurity risk management processes are integrated into our enterprise risk management program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To manage our material risks from cybersecurity threats and to protect against, detect, and prepare to respond to cybersecurity incidents, we endeavor to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Monitor emerging data protection laws and implement changes to our processes to comply;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conduct annual cybersecurity management and incident training for employees that process sensitive data;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conduct onboarding and cybersecurity training for all employees on an ongoing basis;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conduct regular phishing email simulations for all employees; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Carry cybersecurity risk insurance meant to provide protection against the potential losses arising from a cybersecurity incident.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we engage several third-party consultants in connection with our risk assessment and risk management, and we have established separate processes and procedures to oversee and identify cybersecurity risks associated with third parties. All third parties involved in our cybersecurity risk assessments and risk management are required to provide reports designed to allow us to monitor and assess such third parties&#8217; security controls.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our incident response plan coordinates the activities that we and our third-party cybersecurity provider take to respond and recover from cybersecurity incidents, which include processes to triage, assess severity, investigate, escalate, contain, and remediate an incident, as well as to comply with legal obligations and attempt to mitigate brand and reputational damage. We have business continuity plans that we periodically review and update in line with our evolving applications architecture.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented a risk-based approach to identify and assess the cybersecurity threats that could affect our business and information systems. We use recognized commercially reasonable measures, tools and methodologies designed to manage cybersecurity risk that are tested on a regular cadence. We also monitor and evaluate our cybersecurity posture on an ongoing basis through regular vulnerability scans, penetration tests and third-party reviews. We rely on third-party service providers to provide the systems required to effectively run our clinical trials and endeavor to require third-party service providers that have access to personal, confidential or proprietary information to implement and maintain cybersecurity practices. Specific controls that are used in appropriate portions of our environment include endpoint threat detection and response, identity and access management, privileged access management, logging and monitoring involving the use of security information and event management, multi-factor authentication, firewalls and intrusion detection and prevention, and vulnerability and patch management. Our cybersecurity risk management processes are integrated into our enterprise risk management program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To manage our material risks from cybersecurity threats and to protect against, detect, and prepare to respond to cybersecurity incidents, we endeavor to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Monitor emerging data protection laws and implement changes to our processes to comply;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conduct annual cybersecurity management and incident training for employees that process sensitive data;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conduct onboarding and cybersecurity training for all employees on an ongoing basis;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conduct regular phishing email simulations for all employees; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Carry cybersecurity risk insurance meant to provide protection against the potential losses arising from a cybersecurity incident.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we engage several third-party consultants in connection with our risk assessment and risk management, and we have established separate processes and procedures to oversee and identify cybersecurity risks associated with third parties. All third parties involved in our cybersecurity risk assessments and risk management are required to provide reports designed to allow us to monitor and assess such third parties&#8217; security controls.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our incident response plan coordinates the activities that we and our third-party cybersecurity provider take to respond and recover from cybersecurity incidents, which include processes to triage, assess severity, investigate, escalate, contain, and remediate an incident, as well as to comply with legal obligations and attempt to mitigate brand and reputational damage. We have business continuity plans that we periodically review and update in line with our evolving applications architecture.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text">Our Board of Directors provides oversight to our cybersecurity efforts to ensure effective governance in assessing and managing risks associated with cybersecurity threats.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our cybersecurity leadership team is responsible for assessing and managing cybersecurity risks and is made up of experienced professionals with an extensive background in information security, risk management, and incident response. This team is led by our Head of Information Technology. The Head of Information Technology is a senior technology strategist and thought leader with over two decades of experience in the bio pharma, life sciences, and high-tech sectors.</span></div>status updates on various projects intended to enhance the overall cybersecurity posture of the Company, and information about the prevention, detection, mitigation and remediation of any cybersecurity incidents, as appropriate.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">Our Head of Information Technology provides periodic updates to senior management and quarterly updates to the Board of Directors regarding our cybersecurity program, including information about cyber risk management governance, status updates on various projects intended to enhance the overall cybersecurity posture of the Company, and information about the prevention, detection, mitigation and remediation of any cybersecurity incidents, as appropriate.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our cybersecurity leadership team is responsible for assessing and managing cybersecurity risks and is made up of experienced professionals with an extensive background in information security, risk management, and incident response. This team is led by our Head of Information Technology. The Head of Information Technology is a senior technology strategist and thought leader with over two decades of experience in the bio pharma, life sciences, and high-tech sectors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors provides oversight to our cybersecurity efforts to ensure effective governance in assessing and managing risks associated with cybersecurity threats. Our Head of Information Technology provides periodic updates to senior management and quarterly updates to the Board of Directors regarding our cybersecurity program, including information about cyber risk management governance, status updates on various projects intended to enhance the overall cybersecurity posture of the Company, and information about the prevention, detection, mitigation and remediation of any cybersecurity incidents, as appropriate.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our cybersecurity leadership team is responsible for assessing and managing cybersecurity risks and is made up of experienced professionals with an extensive background in information security, risk management, and incident response. This team is led by our Head of Information Technology. The Head of Information Technology is a senior technology strategist and thought leader with over two decades of experience in the bio pharma, life sciences, and high-tech sectors.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our cybersecurity leadership team is responsible for assessing and managing cybersecurity risks and is made up of experienced professionals with an extensive background in information security, risk management, and incident response. This team is led by our Head of Information Technology. The Head of Information Technology is a senior technology strategist and thought leader with over two decades of experience in the bio pharma, life sciences, and high-tech sectors.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text">Our Head of Information Technology provides periodic updates to senior management and quarterly updates to the Board of Directors regarding our cybersecurity program, including information about cyber risk management governance, status updates on various projects intended to enhance the overall cybersecurity posture of the Company, and information about the prevention, detection, mitigation and remediation of any cybersecurity incidents, as appropriate.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Basis of Presentation </span></div>The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Any reference in these notes to applicable guidance is meant to refer to authoritative U.S. GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and as amended by Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text">Certain reclassifications have been made to the prior years&#8217; financial statements to conform to current year presentation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of income and expenses during the reporting period. On an on-going basis, management evaluates its estimates and judgments, including those related to accrued research and development expenses, stock-based compensation, and income taxes. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. GAAP and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. The consolidated financial statements reflect the accounts of Summit Therapeutics Inc. and its wholly owned subsidiaries. Intercompany balances and transactions are eliminated in consolidation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company&#8217;s subsidiaries with functional currencies other than the U.S. dollar are translated into U.S. dollars using period-end exchange rates for assets and liabilities, historical exchange rates for stockholders&#8217; equity and weighted average exchange rates for operating results. Translation gains and losses are included in accumulated other comprehensive (loss) income in stockholders&#8217; equity. Foreign currency transaction gains and losses are included in other income</span>, net in the consolidated statements of operations and comprehensive loss.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the diluted net loss by the weighted-average number of common shares outstanding for the period, including potentially dilutive common shares. The dilutive effect of share options and warrants are determined under the treasury stock method using the average market price for the period.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the assumed proceeds under the treasury stock method include the average unrecognized compensation expense of stock options and warrants that are in-the-money.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the consideration transferred over the fair value of net assets acquired. Goodwill is assigned to reporting units at the time of acquisition or when there is a change in the reporting structure and bases that allocation on which reporting units will benefit from the acquired assets and liabilities. Reporting units are defined as operating segments or one level below an operating segment, referred to as a component. Typically acquisitions related to a single reporting unit do not require the allocation of goodwill to multiple reporting units. If the net assets obtained in an acquisition are assigned to multiple reporting units, the goodwill is distributed to the respective reporting units as part of the purchase price allocation process.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill for impairment on an annual basis as of December 31 or more frequently when events and circumstances occur indicating that the recorded goodwill may be impaired. The Company regularly monitors current business conditions and other factors including, but not limited to, adverse industry or economic trends and lower projections of </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">profitability that may impact future operating results. The process of evaluating the potential impairment of goodwill requires significant judgment. In performing the Company&#8217;s annual goodwill impairment test, the Company is permitted to first assess qualitative factors to determine whether it is more likely than not that the fair value of the Company&#8217;s reporting unit is less than its carrying amount, including goodwill. In performing the qualitative assessment, the Company considers certain events and circumstances specific to the reporting unit and to the entity as a whole, such as macroeconomic conditions, industry and market considerations, overall financial performance and cost factors when evaluating whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. The Company is also permitted to bypass the qualitative assessment and proceed directly to the quantitative test. If the Company chooses to undertake the qualitative assessment and concludes that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, the Company would then proceed to the quantitative impairment test. In the quantitative assessment, the Company compares the fair value of the reporting unit to its carrying amount, which includes goodwill. If the fair value exceeds the carrying value, no impairment loss exists. If the fair value is less than the carrying amount, a goodwill impairment loss is measured and recorded.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for real estate. The Company does not have any finance leases. A contract is or contains a lease when the lessee has the right to control the use of an identified asset. The Company determines if an arrangement is a lease at inception of the contract, which is the date on which the terms of the contract are agreed to and the agreement creates enforceable rights and obligations. The lease term used to calculate the lease liability include options to extend or terminate the lease when it is reasonably certain that the option will be exercised.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">At the lease commencement date, the Company measures and recognizes a lease liability and a right-of-use asset in the financial statements. Lease liabilities are recognized based on the present value of the future lease payments over the lease term at commencement date. The right-of use asset is measured by taking the present value of future lease payments, plus any incremental direct costs incurred, less any lease incentives received. As most of the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">s leases do not provide an implicit rate, the Company uses an estimated incremental borrowing rate based on the lease term and the economic environment of the lease at the lease commencement date, which is then utilized to determine the present value of future lease payments. Lease expense for minimum lease payments are recognized on a straight-line basis over the lease term, with variable lease payments recognized in the periods in which they are incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has existing lease agreements with lease and non-lease components, has elected to account for the lease and non-lease components as a single lease component, and has allocated all of the contract consideration to the lease component only. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Leases with an initial lease term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for its short-term leases on a straight-line basis over the lease term.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock', window );">Acquired In-Process Research and Development</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Acquired In-Process Research and Development</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company may enter into agreements with collaboration partners for the development and commercialization of its products. These arrangements may include payments contingent on the occurrence of certain events such as development, regulatory or sales-based milestones. The Company considers the unique nature, terms and facts and circumstances of each transaction. The Company considers whether or not the assets acquired have an alternative future use. </span></div>The fair value associated with acquired in-process research and development which does not have an alternative future use is expensed and is recorded as research and development expense. Any development or commercial milestone payments are recognized when the achievement of the associated milestone becomes probable and will either be expensed or capitalized depending upon whether or not regulatory approval has been obtained.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred to discover, research and develop product candidates, including personnel expenses, stock-based compensation expense, allocated facility-related and depreciation expenses, third-party license fees and external costs of outside vendors engaged to conduct preclinical and clinical development activities and clinical trials as well as to manufacture clinical trial materials. Non-</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">refundable prepayments for goods or services that will be used or rendered for future research and development activities are recorded as prepaid expenses. Such amounts are recognized as an expense as the goods are delivered or the related services are performed, or until it is no longer expected that the goods will be delivered, or the services rendered. Milestone and other payments made to third-parties with respect to in-process research and development, in accordance with the Company&#8217;s license, acquisition and other similar agreements are expensed when determined to be probable and estimable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has entered into various research and development contracts with other companies. These agreements are generally cancellable, and related payments are recorded as research and development expenses as incurred. The Company records accruals for estimated ongoing research and development costs or prepaid expenses where the payments made exceed the estimated costs. These amounts are determined based on the estimated costs to complete each study or activity, the estimation of the current stage of completion and the invoices received, as well as predetermined milestones which are not reflective of the current stage of development for prepaid expenses. Actual results could differ from the Company&#8217;s estimates. In all cases, the full cost of each study or activity is expensed by the time the final report or where applicable, product, has been received. The Company&#8217;s historical estimates have not been materially different from the actual costs.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all stock option awards based on the estimated fair value of the award on the grant date. The Company uses the Black-Scholes option pricing model to estimate the fair value of stock option awards. Additionally, the Company uses a Monte Carlo simulation model to calculate the estimated fair value on the date of grant related to awards with market-based service conditions. The fair value is recognized as expense, over the requisite service period, which is generally the vesting period of the respective award, on a straight-line basis for each separately vesting portion of the award when the only condition to vesting is continued service. If vesting is subject to a market or performance condition, recognition is based on the derived service period of the award. Expense for awards with performance conditions is estimated and adjusted on a quarterly basis based upon the assessment of the probability that the performance condition will be met. Use of the Black-Scholes option-pricing model requires management to apply judgment under subjective assumptions. These assumptions include:</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected term&#8212;The expected term of stock options represents the weighted-average period the stock options are expected to be outstanding. The Company uses the simplified method for estimating the expected term as provided by the SEC. The simplified method calculates the expected term as the average of the time-to-vesting and the contractual life of the options.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected volatility&#8212;The expected volatility is calculated based on historical volatility of the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">s share price.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk-free interest rate&#8212;The risk-free rate assumption is based on the U.S. Treasury instruments, the terms of which were consistent with the expected term of the Company&#8217;s stock options.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected dividend&#8212;The expected dividend assumption is based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not intend to pay dividends. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company uses a Monte Carlo simulation model to estimate the fair value of Performance and Market-based Stock Options at the date of grant which utilizes multiple input variables to estimate the probability that the market condition will be achieved. Key assumptions used in the model include the risk-free interest rate, which reflects the US Treasury Constant Maturity Yield with a term commensurate with the contractual term of the award, and stock price volatility, which is derived based on the historical volatility of the Company&#8217;s stock. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates expected forfeitures at the time of grant instead of accounting for forfeitures as they occur. Stock option awards have been granted at fair value to non-employees in connection with research and consulting services provided to the Company. Equity awards generally vest over terms of 3 or 4 years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies stock-based compensation expense in the consolidated statements of operations and comprehensive loss in the same manner in which the award recipient&#8217;s payroll costs are classified.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is determined using the asset and liability approach. Tax laws may require items to be included in tax filings at different times than the items are reflected in the financial statements. A current asset or liability is recognized </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">for the estimated taxes receivable or payable for the current year. Deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. Deferred taxes are initially recognized at enacted tax rates in force at the time of initial recognition and are subsequently adjusted for any enacted changes in tax rates and tax laws. Subsequent changes to deferred taxes originally recognized in equity are recognized in income. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. The Company has recorded a full valuation allowance against the deferred tax assets in excess of its deferred tax liabilities, as the deferred tax liabilities represent future reversals of existing taxable temporary differences. The Company records interest and penalties related to income tax matters as part of income tax expense.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk and Other Risks and Uncertainties</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash and short-term investments. The Company&#8217;s cash is comprised of short-term cash deposits at a variety of financial institutions which the Company believes are of high credit ratings in amounts that may exceed federally insured limits. The Company has not experienced any losses on such accounts. Cash balances maintained during the year have been principally held with U.S.-based and U.K.-based banks. The Company does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies, and expects to continue to rely, on a number of vendors to conduct its clinical trials and preclinical studies, manufacture drug product and supply clinical trial and preclinical study materials for its development programs. These programs could be adversely affected by a significant interruption in these services or the availability of materials.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Measurements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the provisions of fair value accounting, a fair value measurement assumes that the transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability and defines fair value based on the exit price model.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The fair value measurement guidance establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance describes three levels of inputs that may be used to measure fair value:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level 1</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Quoted prices in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level 2</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 2 assets and liabilities include debt securities with quoted prices that are traded less frequently than exchange-traded instruments or securities or derivative contracts that are valued using a pricing model with inputs that are observable in the market or can be derived principally from or corroborated by observable market data.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level 3</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the Company categorizes such assets and liabilities based on the lowest level input that is significant to the fair value measurement in its entirety. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div>The Company considers only those investments that are highly liquid, readily convertible to cash and that mature within 90 days or less from date of purchase to be cash equivalents.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span></div>Restricted cash represents amounts which are legally restricted to withdrawal or usage and is presented in the consolidated balance sheet as restricted cash.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Short-term Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Short-term Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consist of marketable securities with original maturities greater than ninety days from the date of acquisition. The Company classifies marketable securities with original maturities of greater than 90 days and less than one year as short-term, based on the liquid nature of the marketable securities and because such marketable securities represent the investment of cash that is available for current operations. The Company considers its investment portfolio of marketable securities as available-for-sale. Accordingly, these investments are recorded at fair value, which is based on quoted market prices or other observable inputs. Unrealized gains and losses are recorded as a component of other comprehensive income (loss). Realized gains and losses are determined on a specific identification basis and are included in other income, net. Amortization and accretion of discounts and premiums are also recorded in other income, net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">When the fair value is below the amortized cost of the asset, an estimate of expected credit losses is made. This estimate is limited to the amount by which fair value is less than amortized cost. The credit-related impairment amount is recognized in the consolidated statements of operations and comprehensive loss and the remaining impairment amount and unrealized gains are reported as a component of accumulated other comprehensive income (loss) in stockholders&#8217; equity. Credit losses are recognized through the use of an allowance for credit losses account and subsequent improvements in expected credit losses are recognized as a reversal of the allowance account. If the Company has the intent to sell the security or it is more likely than not that the Company will be required to sell the security prior to recovery of its amortized cost basis the allowance for credit loss is written off and the excess of the amortized cost basis of the asset over its fair value is recorded in the consolidated statements of operations and comprehensive loss.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update &#8220;ASU&#8221; 2023-09, &#8220;Improvements to Income Tax Disclosures&#8221;, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024 and allows for adoption on a prospective basis, with a retrospective option. Early adoption is permitted. The Company adopted ASU 2023-09 for the year ended December 31, 2025 using a retrospective approach. The adoption of ASU-2023-09 did not have a material impact on the Company&#8217;s consolidated financial statements and related disclosures.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, &#8220;Disaggregation of Income Statement Expenses&#8221;, which requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures. The guidance is to be applied prospectively, with the option for retrospective application and is effective for public business entities for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this standard on the Company&#8217;s consolidated financial statements and related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2025, the FASB issued ASU 2025-11, &#8220;Narrow-Scope Improvements&#8221;, which is intended to improve the navigability of the guidance in ASC 270 and clarify when the guidance is applicable. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this standard on the Company&#8217;s consolidated financial statements and related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other recent authoritative guidance issued by the FASB (including technical corrections to the FASB ASC), the American Institute of Certified Public Accountants, and the SEC did not or are not expected to have a material impact on the Company&#8217;s consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In Process Research And Development, Through A Collaboration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-4<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of restricted cash balances</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s total cash, cash equivalents and restricted cash balances were as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.794%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">225,266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104,862&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">71,425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">225,582&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">105,187&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">71,425&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of cash and cash equivalents</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s total cash, cash equivalents and restricted cash balances were as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.794%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">225,266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104,862&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">71,425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">225,582&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">105,187&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">71,425&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of significant expenses of the CODM function</a></td>
<td class="text">The CODM function is regularly provided with the following significant segment expenses: <div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Oncology clinical trial related costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">266,439&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100,937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">35,224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">520,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Compensation related costs, excluding stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">75,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">48,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">732,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">50,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total segment expenses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,094,424&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">225,998&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">609,650&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,686)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16,461)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,079,586)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(221,315)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(614,928)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">  Other expenses include general and administrative expenses excluding compensation and stock-based compensation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of other income, net</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of other income, net:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency (loss) gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(610)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investment income </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of cumulative currency translation gain </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,838&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,369&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,183&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"> Investment income relates to the Company&#8217;s money market funds and short-term investments in U.S. treasury securities. Refer to Note 9 for details. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"> The reclassification of cumulative currency translation gain related to the reclassification of cumulative foreign currency translation gains from accumulated other comprehensive loss due to the dissolution of certain dormant entities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of components of loss before income taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company&#8217;s loss before income taxes are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.378%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(326,729)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(199,040)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(499,810)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(752,857)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(22,275)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(115,118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,079,586)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(221,315)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(614,928)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of major components of deferred tax assets and liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The major components of deferred tax assets and liabilities are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.469%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforward</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">73,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">59,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credit carryforward</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 Research and Development Capitalization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">133,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">95,925&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(337)  </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(417)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets before valuation allowance </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">133,161</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">95,588</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(133,161)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(95,588)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Schedule of change in valuation allowance</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The change in the valuation allowance was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance as of beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(95,588)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(84,751)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(64,016)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increases recorded to income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(37,573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(10,837)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(20,735)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance as of end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(133,161)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(95,588)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(84,751)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation of the effective income tax rate to the statutory rate</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the Company&#8217;s effective tax rate to the U.S. federal statutory rate is as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Tax at federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(226,702)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(46,476)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(129,048)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">State income tax, net of federal tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(17)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(6,828)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(4,782)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(2,275)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Nontaxable or nondeductible Items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">134,033</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(130)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">2,978</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">299</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">77</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">521</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Foreign Tax Effects</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Cayman Islands Statutory income tax rate differential</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">67,969</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">41,570</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(18.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">104,282</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Other foreign jurisdictions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">644</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">229</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">678</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Changes in unrecognized tax benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">1,357</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">956</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">800</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">29,228</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">8,573</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">22,064</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of reconciliation of unrecognized tax benefits</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of unrecognized tax benefits from continuing operations is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits, beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits, end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,903&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,122&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of net loss per share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per share: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,079,586)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(221,315)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(614,928)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average number of shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">747,702,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">718,541,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">619,646,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic net loss per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1.44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net loss per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1.44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of potentially dilutive securities excluded from the computation of loss per share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities were excluded from the computation of the diluted net loss per share of common stock for the periods presented because their effect would have been anti-dilutive:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">115,614,728</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">68,920,334</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,209,289</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,629,988</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,015,642</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares expected to be purchased under employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">65,905</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">86,550</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">155,163</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">115,680,633</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">73,636,872</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">59,380,094</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements and Short-Term Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of assets and liabilities measured at fair value on a recurring basis</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables sets forth the Company&#8217;s fair value hierarchy for its assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2025 and 2024:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.138%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hierarchy Level</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Credit (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets included within cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">163,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">163,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government treasury bills</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets included within short-term investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of deposit</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government treasury bills</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">463,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">463,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">696,910&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">697,082&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hierarchy Level</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Credit (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets included within cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">88,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">88,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets included within short-term investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government treasury bills</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">307,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">307,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">395,986&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">396,086&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of lease expense</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The elements of lease expense were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Fixed lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Variable lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,078&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,509&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,297&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of future lease payments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Future lease payments under non-cancelable leases as of December 31, 2025 are detailed as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27,328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,890&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Operating lease liabilities, current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,388&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,502&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of weighted-average assumptions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used in the Company&#8217;s valuation are summarized as follows, presented on a weighted average basis:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.8% - 3.9%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.5 - 6.2</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">124.9% -142.5%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">98.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected annual dividends per share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of stock option activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%">The following table summarizes the Company&#8217;s stock option activity for the year ended December 31, 2025:&#160;&#160;&#160;&#160;&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of share options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate intrinsic value </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2024*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">108,136,310</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.34</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,677,748&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,297,732</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,015,750)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(953,564)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.99</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">119,464,728</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,618,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">110,536,687</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.86</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,527,454&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">64,834,314</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.32</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">983,902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">* The stock option activity in the table above includes performance-based options outstanding as of December 31, 2024 of 48,220,320 of which 39,013,976 options were unvested and converted to time-based vesting. During the three months ended March 31, 2025, the company granted 5,475,000 performance-based options which were modified to time-based vesting during the three months ended June 30, 2025.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of stock-based compensation expense</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Stock&#8209;based compensation expense related to stock options is recorded within the consolidated statements of operations and comprehensive loss as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:83%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">218,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">513,856&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">34,974&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%">Total stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">732,420</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">50,981</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,108</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock-based compensation expense associated with each of our stock-based compensation arrangements:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:83%">Time-based stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">731,358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">39,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Performance and market-based stock options </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,062</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">599</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">184</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%">Total stock-based compensation</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">732,420</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">50,981</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,108</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">20 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 21, 2025</div></th>
<th class="th"><div>Sep. 11, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,079,586<span></span>
</td>
<td class="nump">$ 221,315<span></span>
</td>
<td class="nump">$ 614,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">322,930<span></span>
</td>
<td class="nump">142,106<span></span>
</td>
<td class="nump">76,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,294,159<span></span>
</td>
<td class="nump">1,214,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,294,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,266<span></span>
</td>
<td class="nump">104,862<span></span>
</td>
<td class="nump">$ 71,425<span></span>
</td>
<td class="nump">225,266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">488,182<span></span>
</td>
<td class="nump">$ 307,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">488,182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">$ 500,037<span></span>
</td>
<td class="nump">$ 235,000<span></span>
</td>
<td class="nump">500,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_DistributionAgreementMember', window );">Distribution Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,721<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_DistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=smmt_DistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies and Recent Accounting Pronouncements - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency (loss) gain</a></td>
<td class="num">$ (610)<span></span>
</td>
<td class="num">$ (97)<span></span>
</td>
<td class="nump">$ 613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">$ 316<span></span>
</td>
<td class="nump">$ 325<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Equity award, vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Equity award, vesting period (in years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_SignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Significant Accounting Policies</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_SignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies and Recent Accounting Pronouncements - Total Cash, Cash Equivalents and Restricted Cash Balances (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 225,266<span></span>
</td>
<td class="nump">$ 104,862<span></span>
</td>
<td class="nump">$ 71,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">316<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 225,582<span></span>
</td>
<td class="nump">$ 105,187<span></span>
</td>
<td class="nump">$ 71,425<span></span>
</td>
<td class="nump">$ 648,607<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Significant Expense of the CODM Function (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Oncology clinical trial related costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 537,674<span></span>
</td>
<td class="nump">$ 150,777<span></span>
</td>
<td class="nump">$ 59,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_AcquiredInProcessResearchAndDevelopmentExpense', window );">Acquired in-process research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,007<span></span>
</td>
<td class="nump">520,915<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">732,420<span></span>
</td>
<td class="nump">50,981<span></span>
</td>
<td class="nump">14,108<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,094,424<span></span>
</td>
<td class="nump">225,998<span></span>
</td>
<td class="nump">609,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,838<span></span>
</td>
<td class="nump">13,369<span></span>
</td>
<td class="nump">11,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,686)<span></span>
</td>
<td class="num">(16,461)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,079,586)<span></span>
</td>
<td class="num">(221,315)<span></span>
</td>
<td class="num">(614,928)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=smmt_ReportableSegmentMember', window );">Reportable Segment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Oncology clinical trial related costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">266,439<span></span>
</td>
<td class="nump">100,937<span></span>
</td>
<td class="nump">35,224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_AcquiredInProcessResearchAndDevelopmentExpense', window );">Acquired in-process research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,007<span></span>
</td>
<td class="nump">520,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation', window );">Compensation related costs, excluding stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75,575<span></span>
</td>
<td class="nump">48,295<span></span>
</td>
<td class="nump">31,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">732,420<span></span>
</td>
<td class="nump">50,981<span></span>
</td>
<td class="nump">14,108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,990<span></span>
</td>
<td class="nump">10,778<span></span>
</td>
<td class="nump">8,032<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,094,424<span></span>
</td>
<td class="nump">225,998<span></span>
</td>
<td class="nump">609,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,838<span></span>
</td>
<td class="nump">13,369<span></span>
</td>
<td class="nump">11,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,686)<span></span>
</td>
<td class="num">(16,461)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1,079,586)<span></span>
</td>
<td class="num">$ (221,315)<span></span>
</td>
<td class="num">$ (614,928)<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.92pt">Refer to Note 15 &#8211; Related Party Transactions for expenses incurred.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_AcquiredInProcessResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired-In-Process Research And Development Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_AcquiredInProcessResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Labor And Related Expenses, Excluding Stock-Based Compensation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=smmt_ReportableSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=smmt_ReportableSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2025 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Akeso License and Collaboration Agreement (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 06, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 03, 2024</div></th>
<th class="th"><div>May 13, 2024</div></th>
<th class="th"><div>Apr. 27, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_PaymentsForCollaborativeArrangement', window );">Payments to Akeso for upfront milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 15,007<span></span>
</td>
<td class="nump">$ 475,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_AcquiredInProcessResearchAndDevelopmentExpense', window );">Acquired in-process research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 15,007<span></span>
</td>
<td class="nump">520,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative arrangement, transaction with party to collaborative arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment', window );">Collaborative arrangement, upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_CashPaymentForCollaborativeArrangementUpfrontPayment', window );">Cash payment for collaborative arrangement, upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">474,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_PaymentsForCollaborativeArrangement', window );">Payments to Akeso for upfront milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments', window );">Additional potential commercial milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts', window );">Collaborative arrangement, direct transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments', window );">Collaborative arrangement, additional potential milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,555,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments', window );">Collaborative arrangement, potential regulatory milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments', window );">Collaborative arrangement, potential commercial milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,505,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember', window );">Collaborative arrangement, transaction with party to collaborative arrangement, upfront payment one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_CashPaymentForCollaborativeArrangementUpfrontPayment', window );">Cash payment for collaborative arrangement, upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 274,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash', window );">Collaborative arrangement, common stock issued in lieu of cash upfront payment (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares', window );">Collaborative arrangement, upfront payment, paid in shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement', window );">Issuance of common stock in lieu of cash for Akeso upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember', window );">Collaborative arrangement, transaction with party to collaborative arrangement, upfront payment two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_CashPaymentForCollaborativeArrangementUpfrontPayment', window );">Cash payment for collaborative arrangement, upfront payment</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_AcquiredInProcessResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired-In-Process Research And Development Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_AcquiredInProcessResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_CashPaymentForCollaborativeArrangementUpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payment For Collaborative Arrangement, Upfront Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_CashPaymentForCollaborativeArrangementUpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights And Obligations, Additional Potential Commercial Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights And Obligations, Direct Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights And Obligations, Maximum Aggregate Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights And Obligations, Potential Commercial Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights And Obligations, Potential Regulatory Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights And Obligations, Upfront Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights And Obligations, Upfront Payment, Paid In Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights And Obligations, Upfront Payment, Shares Of Common Stock Issued In Lieu Of Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_PaymentsForCollaborativeArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Collaborative Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_PaymentsForCollaborativeArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, In Lieu Of Cash For Collaborative Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency (loss) gain</a></td>
<td class="num">$ (610)<span></span>
</td>
<td class="num">$ (97)<span></span>
</td>
<td class="nump">$ 613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNonoperating', window );">Investment income</a></td>
<td class="nump">15,501<span></span>
</td>
<td class="nump">13,466<span></span>
</td>
<td class="nump">10,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome', window );">Reclassification of cumulative currency translation gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(53)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(252)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">$ 14,838<span></span>
</td>
<td class="nump">$ 13,369<span></span>
</td>
<td class="nump">$ 11,183<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative Currency Translation Gains (Losses), Realized upon Sale or Liquidation, Reclassified From Other Comprehensive Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Liability for interest and penalties</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Deferred provision for non-United States income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current provision for state income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred provision for state income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current provision for federal income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred provision for federal income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Current provision for non-United States income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax asset</a></td>
<td class="nump">133,578<span></span>
</td>
<td class="nump">95,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">3,903<span></span>
</td>
<td class="nump">2,122<span></span>
</td>
<td class="nump">$ 1,064<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">U.S. Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">93,210<span></span>
</td>
<td class="nump">44,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">15,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">U.S. State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">21,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">5,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">U.K.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 211,096<span></span>
</td>
<td class="nump">$ 198,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax - Components of Loss Before Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">$ (326,729)<span></span>
</td>
<td class="num">$ (199,040)<span></span>
</td>
<td class="num">$ (499,810)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="num">(752,857)<span></span>
</td>
<td class="num">(22,275)<span></span>
</td>
<td class="num">(115,118)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax</a></td>
<td class="num">$ (1,079,586)<span></span>
</td>
<td class="num">$ (221,315)<span></span>
</td>
<td class="num">$ (614,928)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Tax - Major Components of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">$ 73,583<span></span>
</td>
<td class="nump">$ 59,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development credit carryforward</a></td>
<td class="nump">16,092<span></span>
</td>
<td class="nump">7,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">32,158<span></span>
</td>
<td class="nump">14,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment', window );">Section 174 Research and Development Capitalization</a></td>
<td class="nump">11,034<span></span>
</td>
<td class="nump">14,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">711<span></span>
</td>
<td class="nump">475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">133,578<span></span>
</td>
<td class="nump">95,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(417)<span></span>
</td>
<td class="num">(337)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(417)<span></span>
</td>
<td class="num">(337)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_DeferredTaxAssetsLiabilities', window );">Net deferred tax assets before valuation allowance</a></td>
<td class="nump">133,161<span></span>
</td>
<td class="nump">95,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(133,161)<span></span>
</td>
<td class="num">(95,588)<span></span>
</td>
<td class="num">$ (84,751)<span></span>
</td>
<td class="num">$ (64,016)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred tax, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Capitalized Research And Development</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_DeferredTaxAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets (Liabilities)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_DeferredTaxAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax - Valuation Allowance (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_DeferredTaxAssetsValuationAllowanceRollForward', window );"><strong>Deferred Tax Assets, Valuation Allowance [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance as of beginning of year</a></td>
<td class="num">$ (95,588)<span></span>
</td>
<td class="num">$ (84,751)<span></span>
</td>
<td class="num">$ (64,016)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net increases recorded to income tax provision</a></td>
<td class="num">(37,573)<span></span>
</td>
<td class="num">(10,837)<span></span>
</td>
<td class="num">(20,735)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance as of end of year</a></td>
<td class="num">$ (133,161)<span></span>
</td>
<td class="num">$ (95,588)<span></span>
</td>
<td class="num">$ (84,751)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_DeferredTaxAssetsValuationAllowanceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Valuation Allowance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_DeferredTaxAssetsValuationAllowanceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax - Reconciliation of the Effective Income Tax Rate to Statutory Rate (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Amount</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Tax at federal statutory rate</a></td>
<td class="num">$ (226,702)<span></span>
</td>
<td class="num">$ (46,476)<span></span>
</td>
<td class="num">$ (129,048)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income tax, net of federal tax benefit</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development credits</a></td>
<td class="num">(6,828)<span></span>
</td>
<td class="num">(4,782)<span></span>
</td>
<td class="num">(2,275)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract', window );"><strong>Nontaxable or nondeductible Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">134,033<span></span>
</td>
<td class="num">(130)<span></span>
</td>
<td class="nump">2,978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">299<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract', window );"><strong>Foreign Tax Effects</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingencies', window );">Changes in unrecognized tax benefits</a></td>
<td class="nump">1,357<span></span>
</td>
<td class="nump">956<span></span>
</td>
<td class="nump">800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">29,228<span></span>
</td>
<td class="nump">8,573<span></span>
</td>
<td class="nump">22,064<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Percent</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax at federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income tax, net of federal tax benefit</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research and development credits</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract', window );"><strong>Nontaxable or nondeductible Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="num">(12.40%)<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract', window );"><strong>Foreign Tax Effects</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies', window );">Changes in unrecognized tax benefits</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(2.70%)<span></span>
</td>
<td class="num">(4.00%)<span></span>
</td>
<td class="num">(3.60%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=country_KY', window );">CAYMAN ISLANDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract', window );"><strong>Foreign Tax Effects</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign Tax Effects</a></td>
<td class="nump">$ 67,969<span></span>
</td>
<td class="nump">$ 41,570<span></span>
</td>
<td class="nump">$ 104,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract', window );"><strong>Foreign Tax Effects</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign Tax Effects</a></td>
<td class="num">(6.30%)<span></span>
</td>
<td class="num">(18.80%)<span></span>
</td>
<td class="num">(17.00%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignTaxJurisdictionOtherMember', window );">Other foreign jurisdictions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract', window );"><strong>Foreign Tax Effects</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign Tax Effects</a></td>
<td class="nump">$ 644<span></span>
</td>
<td class="nump">$ 229<span></span>
</td>
<td class="nump">$ 678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract', window );"><strong>Foreign Tax Effects</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign Tax Effects</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Foreign Tax Effects, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Foreign Tax Effects, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(8)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(8)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=country_KY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=country_KY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignTaxJurisdictionOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignTaxJurisdictionOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax - Reconciliation of Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Unrecognized Tax Benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits, beginning of year</a></td>
<td class="nump">$ 2,122<span></span>
</td>
<td class="nump">$ 1,064<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increases related to prior year tax positions</a></td>
<td class="nump">592<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="nump">610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases related to current year tax positions</a></td>
<td class="nump">1,189<span></span>
</td>
<td class="nump">936<span></span>
</td>
<td class="nump">454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits, end of year</a></td>
<td class="nump">$ 3,903<span></span>
</td>
<td class="nump">$ 2,122<span></span>
</td>
<td class="nump">$ 1,064<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share - Computation of Net Loss per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,079,586)<span></span>
</td>
<td class="num">$ (221,315)<span></span>
</td>
<td class="num">$ (614,928)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average number of shares of common stock outstanding (in shares)</a></td>
<td class="nump">747,702,265<span></span>
</td>
<td class="nump">718,541,896<span></span>
</td>
<td class="nump">619,646,180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average number of shares of common stock outstanding (in shares)</a></td>
<td class="nump">747,702,265<span></span>
</td>
<td class="nump">718,541,896<span></span>
</td>
<td class="nump">619,646,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per share (in dollars per share)</a></td>
<td class="num">$ (1.44)<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">$ (0.99)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per share (in dollars per share)</a></td>
<td class="num">$ (1.44)<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">$ (0.99)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Net Loss per Share - Narrative (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 03, 2024</div></th>
<th class="th"><div>Mar. 01, 2023</div></th>
<th class="th"><div>Dec. 06, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price (in dollars per share)</a></td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_RightsOfferingMember', window );">Rights Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.05<span></span>
</td>
<td class="nump">$ 1.05<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_RightsOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=smmt_RightsOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share - Securities Excluded from the Computation of Loss per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from the computation of diluted loss per share (in shares)</a></td>
<td class="nump">115,680,633<span></span>
</td>
<td class="nump">73,636,872<span></span>
</td>
<td class="nump">59,380,094<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from the computation of diluted loss per share (in shares)</a></td>
<td class="nump">115,614,728<span></span>
</td>
<td class="nump">68,920,334<span></span>
</td>
<td class="nump">54,209,289<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from the computation of diluted loss per share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,629,988<span></span>
</td>
<td class="nump">5,015,642<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember', window );">Shares expected to be purchased under employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from the computation of diluted loss per share (in shares)</a></td>
<td class="nump">65,905<span></span>
</td>
<td class="nump">86,550<span></span>
</td>
<td class="nump">155,163<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Details)<br> $ in Thousands, &#163; in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Recognition of goodwill | &#163;</a></td>
<td class="nump">&#163; 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,001<span></span>
</td>
<td class="nump">$ 1,864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Cumulative goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478064/805-740-55-13<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-39<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements and Short-Term Investments - Measured at Fair Value on a Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">$ 696,910<span></span>
</td>
<td class="nump">$ 395,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest', window );">Credit (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">697,082<span></span>
</td>
<td class="nump">396,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">163,588<span></span>
</td>
<td class="nump">88,599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest', window );">Credit (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">163,588<span></span>
</td>
<td class="nump">88,599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Certificate of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest', window );">Credit (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | U.S. Government treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">463,022<span></span>
</td>
<td class="nump">307,387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest', window );">Credit (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">463,182<span></span>
</td>
<td class="nump">$ 307,487<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | U.S. Government treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">45,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest', window );">Credit (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">$ 45,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, before allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements and Short-Term Investments - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 16,366<span></span>
</td>
<td class="nump">$ 16,263<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Research and Development Prepaid Expenses and Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ResearchAndDevelopmentPrepaidExpensesCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 3,996<span></span>
</td>
<td class="nump">$ 8,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_AccruedResearchAndDevelopmentCurrent', window );">Accrued research and development expenditure</a></td>
<td class="nump">$ 31,498<span></span>
</td>
<td class="nump">$ 17,441<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_AccruedResearchAndDevelopmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Research And Development, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_AccruedResearchAndDevelopmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_ResearchAndDevelopmentPrepaidExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Prepaid Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_ResearchAndDevelopmentPrepaidExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 01, 2025</div></th>
<th class="th"><div>Aug. 18, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Leased assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">$ 17,056<span></span>
</td>
<td class="nump">$ 4,216<span></span>
</td>
<td class="nump">$ 4,245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">27,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 20,616<span></span>
</td>
<td class="nump">$ 7,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">7.60%<span></span>
</td>
<td class="nump">6.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">6 years 8 months 12 days<span></span>
</td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash payments related to lease liabilities</a></td>
<td class="nump">$ 3,741<span></span>
</td>
<td class="nump">$ 2,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=smmt_NewJerseyAndCaliforniaMember', window );">New Jersey And California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Leased assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">17,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">$ 23,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CA', window );">CALIFORNIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NJ', window );">NEW JERSEY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_FL', window );">FLORIDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Leased assets obtained in exchange for operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=smmt_NewJerseyAndCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=smmt_NewJerseyAndCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NJ">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NJ</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Fixed lease costs</a></td>
<td class="nump">$ 3,853<span></span>
</td>
<td class="nump">$ 3,461<span></span>
</td>
<td class="nump">$ 2,214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 4,078<span></span>
</td>
<td class="nump">$ 3,509<span></span>
</td>
<td class="nump">$ 2,297<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Future Lease Payments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2026</a></td>
<td class="nump">$ 3,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2027</a></td>
<td class="nump">4,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2028</a></td>
<td class="nump">4,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2029</a></td>
<td class="nump">3,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2030</a></td>
<td class="nump">3,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">9,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">27,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="nump">6,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">20,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: Operating lease liabilities, current portion</a></td>
<td class="nump">3,388<span></span>
</td>
<td class="nump">$ 3,765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">$ 17,502<span></span>
</td>
<td class="nump">$ 3,453<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Promissory Note Payable to Related Parties (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 01, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 16, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Feb. 17, 2024</div></th>
<th class="th">
<div>Feb. 15, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 19, 2023 </div>
<div>USD ($) </div>
<div>promissory_note</div>
</th>
<th class="th">
<div>Dec. 06, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of related party notes payable</a></td>
<td class="nump">$ 24,500<span></span>
</td>
<td class="nump">$ 75,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 24,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest on related party promissory note</a></td>
<td class="nump">$ 7,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">8,806<span></span>
</td>
<td class="nump">$ 10,650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_NotePurchaseAgreementMember', window );">Note Purchase Agreement | Chief Executive Officer and Chief Executive Officer and President</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 520,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator', window );">Prepaid interest, conversion amount (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice', window );">Prepaid interest, conversion amount base (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest', window );">Common stock issued for prepaid interest (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,720,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_NotePurchaseAgreementMember', window );">Note Purchase Agreement | Chief Executive Officer and Chief Executive Officer and President | Variable rate, three months immediately following February 15, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_NotePurchaseAgreementMember', window );">Note Purchase Agreement | Chief Executive Officer and Chief Executive Officer and President | Variable rate, thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_DugganFebruaryNoteAndZanganehNoteMember', window );">Duggan February Note and Zanganeh Note | Chief Executive Officer and Chief Executive Officer and President</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering', window );">Period from public offering (in business days)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering', window );">Public offering proceeds threshold percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_DugganFebruaryNoteMember', window );">Duggan February Note | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_ZanganehNoteMember', window );">Zanganeh Note | Chief Executive Officer and President</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of related party notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_DugganSeptemberNoteMember', window );">Duggan September Note | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember', window );">Revised Duggan February Note And Revised Duggan September Note | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_NotesPayableRelatedPartiesNewIssuances', window );">New note issuances | promissory_note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_RevisedDugganFebruaryNoteMember', window );">Revised Duggan February Note | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold', window );">Notes payable, maturity triggering event, public offering proceeds threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of related party notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_RevisedDugganSeptemberNoteMember', window );">Revised Duggan September Note | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_RevisedDugganSeptemberNoteMember', window );">Revised Duggan September Note | Related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Incurred interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_PromissoryNotesMember', window );">Promissory Notes | Related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Incurred interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_NotesPayableRelatedPartiesNewIssuances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Payable, Related Parties, New Issuances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_NotesPayableRelatedPartiesNewIssuances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Payable, Related Parties, Potential Prepayment, Maximum Amount, Percentage Of Net Proceeds From Public Offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Payable, Related Parties, Potential Prepayment, Period Post Receipt Of Cash Proceeds From Public Offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Payable, Related Parties, Potential Prepayment, Triggering Event, Public Offering Net Proceeds Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Payable, Related Party, Prepaid Interest, Equity Interests Issuable Calculation, Denominator</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Payable, Related Party, Prepaid Interest, Equity Interests Issuable Calculation, Denominator, Base Amount Added To Closing Bid Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Related Party Prepaid Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_NotePurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_NotePurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_VariableRatePeriodAxis=smmt_VariableRatePeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_VariableRatePeriodAxis=smmt_VariableRatePeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_VariableRatePeriodAxis=smmt_VariableRatePeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_VariableRatePeriodAxis=smmt_VariableRatePeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_DugganFebruaryNoteAndZanganehNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_DugganFebruaryNoteAndZanganehNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_DugganFebruaryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_DugganFebruaryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_ZanganehNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_ZanganehNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=smmt_ChiefExecutiveOfficerAndPresidentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=smmt_ChiefExecutiveOfficerAndPresidentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_DugganSeptemberNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_DugganSeptemberNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_RevisedDugganFebruaryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_RevisedDugganFebruaryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_RevisedDugganSeptemberNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_RevisedDugganSeptemberNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_PromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_PromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Preferred Stock and Common Stock (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="6">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 21, 2025</div></th>
<th class="th"><div>Sep. 11, 2024</div></th>
<th class="th"><div>Jun. 03, 2024</div></th>
<th class="th"><div>Oct. 13, 2023</div></th>
<th class="th"><div>Jan. 19, 2023</div></th>
<th class="th"><div>Dec. 06, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2025</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th"><div>May 13, 2024</div></th>
<th class="th"><div>Apr. 27, 2023</div></th>
<th class="th"><div>Mar. 01, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 18, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">775,371,200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">737,626,004<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">775,371,200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">737,626,004<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,222,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 619<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_CommonStockSharesAuthorizedIncreaseDecrease', window );">Increase in common stock, shares authorized (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from the issuance of common stock via private placements, net of offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,037<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">434,860<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer | Duggan February Note</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Promissory note</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">533,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefOperatingOfficerMember', window );">Chief Operations Officer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from the issuance of common stock via private placements, net of offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_RightsOfferingMember', window );">Rights Offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">104,686<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">476,190,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 395,314<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_RightsOfferingMember', window );">Rights Offering | Chief Executive Officer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 395,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_S3RegistrationStatementMember', window );">S-3 Registration Statement | Chief Executive Officer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_SaleOfStockNumberOfSharesRegisteredForResale', window );">Number of shares registered for resale (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,346,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_S3RegistrationStatementMember', window );">S-3 Registration Statement | Related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_SaleOfStockNumberOfSharesRegisteredForResale', window );">Number of shares registered for resale (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_S3RegistrationStatementMember', window );">S-3 Registration Statement | Chief Executive Officer and President</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_SaleOfStockNumberOfSharesRegisteredForResale', window );">Number of shares registered for resale (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private placement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 18.74<span></span>
</td>
<td class="nump">$ 22.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 500,037<span></span>
</td>
<td class="nump">$ 235,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,037<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">26,682,846<span></span>
</td>
<td class="nump">10,352,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private placement | Chief Operations Officer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,976,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="18"></td></tr>
<tr><td colspan="18"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:120%">Refer to Note 13 &#8211; Stockholders&#8217; Equity for related party transactions.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_CommonStockSharesAuthorizedIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Shares Authorized, Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_CommonStockSharesAuthorizedIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_SaleOfStockNumberOfSharesRegisteredForResale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Number Of Shares Registered For Resale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_SaleOfStockNumberOfSharesRegisteredForResale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_DugganFebruaryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_DugganFebruaryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefOperatingOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefOperatingOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_RightsOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=smmt_RightsOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_S3RegistrationStatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=smmt_S3RegistrationStatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=smmt_ChiefExecutiveOfficerAndPresidentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=smmt_ChiefExecutiveOfficerAndPresidentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Private Investment in Public Equity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 21, 2025</div></th>
<th class="th"><div>Sep. 11, 2024</div></th>
<th class="th"><div>Jun. 03, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>May 13, 2024</div></th>
<th class="th"><div>Apr. 27, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,222,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock aggregate price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares)</a></td>
<td class="nump">14,514,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock aggregate price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">$ 272,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock aggregate price</a></td>
<td class="nump">$ 218,037<span></span>
</td>
<td class="nump">$ 156,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares)</a></td>
<td class="nump">533,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares)</a></td>
<td class="nump">26,682,846<span></span>
</td>
<td class="nump">10,352,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price (in dollars per share)</a></td>
<td class="nump">$ 18.74<span></span>
</td>
<td class="nump">$ 22.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">$ 500,037<span></span>
</td>
<td class="nump">$ 235,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - At-the-Market Offering and Warrants (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">20 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 11, 2025</div></th>
<th class="th"><div>Jun. 03, 2024</div></th>
<th class="th"><div>May 13, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Apr. 27, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,222,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,629,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice', window );">Warrant weighted average exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ClassOfWarrantOrRightExercisesInPeriod', window );">Exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,629,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod', window );">Exercised (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_OriginalDistributionAgreementMember', window );">Original Distribution Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_SaleOfStockAggregateOfferingPrice', window );">Sale of stock, aggregate offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_DistributionAgreementMember', window );">Distribution Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_SaleOfStockAggregateOfferingPrice', window );">Sale of stock, aggregate offering price</a></td>
<td class="nump">$ 360,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,146,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_SaleOfStockAmountRemainingUnderTheOffering', window );">Remaining availability under the offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 299,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 299,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_ClassOfWarrantOrRightExercisesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Exercises In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_ClassOfWarrantOrRightExercisesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_SaleOfStockAggregateOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Aggregate Offering Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_SaleOfStockAggregateOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_SaleOfStockAmountRemainingUnderTheOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Amount Remaining Under The Offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_SaleOfStockAmountRemainingUnderTheOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_OriginalDistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=smmt_OriginalDistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=smmt_DistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=smmt_DistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Based Compensation - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 21, 2020</div></th>
<th class="th"><div>Aug. 19, 2020</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 18, 2025</div></th>
<th class="th"><div>Jan. 22, 2025</div></th>
<th class="th"><div>Jan. 01, 2025</div></th>
<th class="th"><div>May 03, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value of stock options granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.10<span></span>
</td>
<td class="nump">$ 3.40<span></span>
</td>
<td class="nump">$ 1.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,212<span></span>
</td>
<td class="nump">$ 863<span></span>
</td>
<td class="nump">$ 474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Equity award, vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Equity award, vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares initially reserve for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan', window );">Potential number of additional shares that can be added to the plan for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Maximum percentage of outstanding shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,743,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod', window );">Consecutive offering period (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum common stock purchase allowable as a percentage of compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock as a percentage of closing price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139,459<span></span>
</td>
<td class="nump">353,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock as a percentage of closing price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionPerformanceBasedMember', window );">Employee Stock Option, Performance Based</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Accelerated vesting, number (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,488,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost', window );">Accelerated charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650,959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount', window );">Cost not yet recognized due to accelerated vesting, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 214,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod', window );">Weighted average recognition period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionTimeBasedMember', window );">Time-based stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense, period of recognition (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionTimeBasedMember', window );">Time-based stock options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Equity award, vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionTimeBasedMember', window );">Time-based stock options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Equity award, vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=smmt_A2020StockIncentivePlanMember', window );">2020 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares initially reserve for future issuance (in shares)</a></td>
<td class="nump">8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration', window );">Number of shares that can be added to the plan upon option expiration (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan', window );">Potential number of additional shares that can be added to the plan for future issuance (in shares)</a></td>
<td class="nump">6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Maximum percentage of outstanding shares</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,643,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan', window );">Number of additional shares allowable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=smmt_A2020IncrementalPoolMember', window );">2020 Incremental Pool</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,082,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan', window );">Number of additional shares allowable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=smmt_A2024InducementPoolMember', window );">2024 Inducement Pool</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares initially reserve for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,936,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan', window );">Number of additional shares allowable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Additional Capital Shares Allowable For Future Issuance Upon Option Expiration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Consecutive Offering Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Allowable Under The Plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Potential Number of Additional Shares Allowable Under The Plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Payment Arrangement, Cost Not Yet Recogned Due To Accelerated Vesting, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Payment Arrangement, Weighted Average Recognition Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionPerformanceBasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionPerformanceBasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionTimeBasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionTimeBasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=smmt_A2020StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=smmt_A2020StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=smmt_A2020IncrementalPoolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=smmt_A2020IncrementalPoolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=smmt_A2024InducementPoolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=smmt_A2024InducementPoolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Based Compensation - Weighted-Average Assumptions used for Stock Option Awards (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 2 months 12 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107.80%<span></span>
</td>
<td class="nump">98.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected annual dividends per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionTimeBasedMember', window );">Time-based stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk- free interest rate, minimum</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk- free interest rate, maximum</a></td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected annual dividends per share</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionTimeBasedMember', window );">Time-based stock options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">124.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionTimeBasedMember', window );">Time-based stock options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">142.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionTimeBasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionTimeBasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Based Compensation - Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionTimeBasedMember', window );">Time-based stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of share options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">108,136,310<span></span>
</td>
<td class="nump">108,136,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,297,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,015,750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(953,564)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,464,728<span></span>
</td>
<td class="nump">108,136,310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 2.34<span></span>
</td>
<td class="nump">$ 2.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.14<span></span>
</td>
<td class="nump">$ 2.34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Stock option activity, additional disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual term, options outstanding (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
<td class="text">8 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,618,734<span></span>
</td>
<td class="nump">$ 1,677,748<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of share options, vested and expected to vest (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,536,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, vested and expected to vest (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term, vested and expected to vest (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value, vested and expected to vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,527,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of share options, exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,834,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, exercisable (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term, exercisable (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 983,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionPerformanceBasedMember', window );">Employee Stock Option, Performance Based</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of share options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">48,220,320<span></span>
</td>
<td class="nump">48,220,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">5,475,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,220,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Stock option activity, additional disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber', window );">Number of shares unvested and converted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,013,976<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding And Converted, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionTimeBasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionTimeBasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionPerformanceBasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionPerformanceBasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="nump">$ 732,420<span></span>
</td>
<td class="nump">$ 50,981<span></span>
</td>
<td class="nump">$ 14,108<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionTimeBasedMember', window );">Time-based stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="nump">731,358<span></span>
</td>
<td class="nump">39,349<span></span>
</td>
<td class="nump">12,606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionPerformanceAndMarketBasedMember', window );">Performance and market-based stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,033<span></span>
</td>
<td class="nump">1,318<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="nump">1,062<span></span>
</td>
<td class="nump">599<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="nump">218,564<span></span>
</td>
<td class="nump">16,007<span></span>
</td>
<td class="nump">4,408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="nump">$ 513,856<span></span>
</td>
<td class="nump">$ 34,974<span></span>
</td>
<td class="nump">$ 9,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionTimeBasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionTimeBasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionPerformanceAndMarketBasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=smmt_EmployeeStockOptionPerformanceAndMarketBasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 21, 2025 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 08, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 11, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 01, 2024 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 03, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 01, 2024 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>contract</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 29, 2022 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jul. 25, 2022 </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 537,674<span></span>
</td>
<td class="nump">$ 150,777<span></span>
</td>
<td class="nump">$ 59,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,100<span></span>
</td>
<td class="nump">$ 19,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ClassOfWarrantOrRightExercisesInPeriod', window );">Exercised (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,629,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,222,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice', window );">Warrant weighted average exercise price (in dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private placement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">26,682,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,352,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">533,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated entity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_LessorOperatingLeaseNumberOfContracts', window );">Number of sublease contracts to other party | contract</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,514,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=smmt_CoChiefExecutiveOfficerMember', window );">Co-Chief Executive Officer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ClassOfWarrantOrRightExercisesInPeriod', window );">Exercised (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,048,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,936,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice', window );">Warrant weighted average exercise price (in dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=smmt_CoChiefExecutiveOfficerMember', window );">Co-Chief Executive Officer | Private placement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,985,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember', window );">Wilson Sonsini Goodrich &amp; Rosati P.C. (&#8220;WSGR&#8221;)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_SubleaseAgreementFirstAndThirdAmendmentMember', window );">Sublease Agreement, First and Third Amendment | Affiliated entity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_RelatedPartyTransactionPaymentsToRelatedParty', window );">Payments to related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">834<span></span>
</td>
<td class="nump">$ 795<span></span>
</td>
<td class="nump">762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_SubleaseAgreementFirstAmendmentMember', window );">First amendment to sublease | Affiliated entity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_AreaOfPremisesSubleased', window );">Area of premises subleased (in square feet) | ft&#178;</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_RelatedPartyTransactionSubleaseExtensionTerm', window );">Sublease extension term (in months)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">39 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_SubleaseAgreementThirdAmendmentMember', window );">Sublease Agreement, Third Amendment | Affiliated entity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_AreaOfPremisesSubleased', window );">Area of premises subleased (in square feet) | ft&#178;</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage', window );">Proportionate share of net payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_SubleaseAgreementSecondAmendmentMember', window );">Second amendment to sublease | Affiliated entity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_AreaOfPremisesSubleased', window );">Area of premises subleased (in square feet) | ft&#178;</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_RelatedPartyTransactionPaymentsToRelatedParty', window );">Payments to related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232<span></span>
</td>
<td class="nump">224<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_GeniusSubleaseAgreementMember', window );">Genius Sublease Agreement | Affiliated entity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_LessorOperatingLeaseNumberOfContracts', window );">Number of sublease contracts to other party | contract</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_LessorOperatingLeaseAreaOfPremisesLeased', window );">Area of premises subleased to other party (in square feet) | ft&#178;</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseTermOfContract', window );">Sublease term to other party (in months)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">62 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">Total sublease rental payments to be received</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_InvestmentsResearchSubleaseAgreementMember', window );">Investments Research Sublease Agreement | Affiliated entity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_LessorOperatingLeaseNumberOfContracts', window );">Number of sublease contracts to other party | contract</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_LessorOperatingLeaseAreaOfPremisesLeased', window );">Area of premises subleased to other party (in square feet) | ft&#178;</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseTermOfContract', window );">Sublease term to other party (in months)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">62 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">Total sublease rental payments to be received</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember', window );">Genius Sublease Agreement And Investments Research Sublease Agreement | Affiliated entity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_AkesoSupplyAgreementMember', window );">Akeso Supply Agreement | Related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,133<span></span>
</td>
<td class="nump">24,635<span></span>
</td>
<td class="nump">$ 6,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,215<span></span>
</td>
<td class="nump">$ 3,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=smmt_ConsultingAgreementMember', window );">Consulting Agreement | Affiliated entity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_ClassOfWarrantOrRightExercisesInPeriod', window );">Exercised (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="14"></td></tr>
<tr><td colspan="14"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.92pt">Refer to Note 15 &#8211; Related Party Transactions for expenses incurred.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_AreaOfPremisesSubleased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area Of Premises Subleased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_AreaOfPremisesSubleased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_ClassOfWarrantOrRightExercisesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Exercises In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_ClassOfWarrantOrRightExercisesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Proportion Of Amount Payable, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_LessorOperatingLeaseAreaOfPremisesLeased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessor, Operating Lease, Area Of Premises Leased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_LessorOperatingLeaseAreaOfPremisesLeased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_LessorOperatingLeaseNumberOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessor, Operating Lease, Number Of Contracts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_LessorOperatingLeaseNumberOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_RelatedPartyTransactionPaymentsToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Payments To Related Party</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_RelatedPartyTransactionPaymentsToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_RelatedPartyTransactionSubleaseExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Sublease Extension Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_RelatedPartyTransactionSubleaseExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payments to be received by lessor for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=smmt_CoChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=smmt_CoChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_SubleaseAgreementFirstAndThirdAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_SubleaseAgreementFirstAndThirdAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_SubleaseAgreementFirstAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_SubleaseAgreementFirstAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_SubleaseAgreementThirdAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_SubleaseAgreementThirdAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_SubleaseAgreementSecondAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_SubleaseAgreementSecondAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_GeniusSubleaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_GeniusSubleaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_InvestmentsResearchSubleaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_InvestmentsResearchSubleaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_AkesoSupplyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_AkesoSupplyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=smmt_ConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=smmt_ConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Capital commitments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid', window );">Period for which the majority of contractual commitments are to be paid (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Contractual commitments</a></td>
<td class="nump">$ 17,976,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Commitment, Period for Which the Majority of Commitments are To Be Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>smmt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>228</ContextCount>
  <ElementCount>380</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>74</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952151 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952152 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952153 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952154 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952155 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952156 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/Organization</Role>
      <ShortName>Organization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements</Role>
      <ShortName>Summary of Significant Accounting Policies and Recent Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Akeso License and Collaboration Agreement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreement</Role>
      <ShortName>Akeso License and Collaboration Agreement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Other Income, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/OtherIncomeNet</Role>
      <ShortName>Other Income, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/IncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Net Loss per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/NetLossperShare</Role>
      <ShortName>Net Loss per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Fair Value Measurements and Short-Term Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestments</Role>
      <ShortName>Fair Value Measurements and Short-Term Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Research and Development Prepaid Expenses and Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/ResearchandDevelopmentPrepaidExpensesandAccruedLiabilities</Role>
      <ShortName>Research and Development Prepaid Expenses and Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Promissory Note Payable to Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/PromissoryNotePayabletoRelatedParties</Role>
      <ShortName>Promissory Note Payable to Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9952172 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTables</Role>
      <ShortName>Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/SegmentReporting</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Other Income, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/OtherIncomeNetTables</Role>
      <ShortName>Other Income, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/OtherIncomeNet</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Income Tax (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/IncomeTaxTables</Role>
      <ShortName>Income Tax (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/IncomeTax</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Net Loss per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/NetLossperShareTables</Role>
      <ShortName>Net Loss per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/NetLossperShare</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Fair Value Measurements and Short-Term Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsTables</Role>
      <ShortName>Fair Value Measurements and Short-Term Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestments</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/Leases</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Stock Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Organization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/OrganizationDetails</Role>
      <ShortName>Organization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/Organization</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies and Recent Accounting Pronouncements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements - Total Cash, Cash Equivalents and Restricted Cash Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTotalCashCashEquivalentsandRestrictedCashBalancesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies and Recent Accounting Pronouncements - Total Cash, Cash Equivalents and Restricted Cash Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Segment Reporting - Significant Expense of the CODM Function (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails</Role>
      <ShortName>Segment Reporting - Significant Expense of the CODM Function (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Segment Reporting - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>Segment Reporting - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Akeso License and Collaboration Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails</Role>
      <ShortName>Akeso License and Collaboration Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreement</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Other Income, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/OtherIncomeNetDetails</Role>
      <ShortName>Other Income, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/OtherIncomeNetTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Income Tax - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/IncomeTaxNarrativeDetails</Role>
      <ShortName>Income Tax - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Income Tax - Components of Loss Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/IncomeTaxComponentsofLossBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Tax - Components of Loss Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Income Tax - Major Components of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Tax - Major Components of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Income Tax - Valuation Allowance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/IncomeTaxValuationAllowanceDetails</Role>
      <ShortName>Income Tax - Valuation Allowance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Income Tax - Reconciliation of the Effective Income Tax Rate to Statutory Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails</Role>
      <ShortName>Income Tax - Reconciliation of the Effective Income Tax Rate to Statutory Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Income Tax - Reconciliation of Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/IncomeTaxReconciliationofUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Tax - Reconciliation of Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Net Loss per Share - Computation of Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/NetLossperShareComputationofNetLossperShareDetails</Role>
      <ShortName>Net Loss per Share - Computation of Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Net Loss per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/NetLossperShareNarrativeDetails</Role>
      <ShortName>Net Loss per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Net Loss per Share - Securities Excluded from the Computation of Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails</Role>
      <ShortName>Net Loss per Share - Securities Excluded from the Computation of Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/GoodwillDetails</Role>
      <ShortName>Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/Goodwill</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Fair Value Measurements and Short-Term Investments - Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements and Short-Term Investments - Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Fair Value Measurements and Short-Term Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements and Short-Term Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Research and Development Prepaid Expenses and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/ResearchandDevelopmentPrepaidExpensesandAccruedLiabilitiesDetails</Role>
      <ShortName>Research and Development Prepaid Expenses and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/ResearchandDevelopmentPrepaidExpensesandAccruedLiabilities</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Leases - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/LeasesLeaseCostDetails</Role>
      <ShortName>Leases - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Leases - Future Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails</Role>
      <ShortName>Leases - Future Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Promissory Note Payable to Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails</Role>
      <ShortName>Promissory Note Payable to Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/PromissoryNotePayabletoRelatedParties</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Stockholders' Equity - Preferred Stock and Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails</Role>
      <ShortName>Stockholders' Equity - Preferred Stock and Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Stockholders' Equity - Private Investment in Public Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails</Role>
      <ShortName>Stockholders' Equity - Private Investment in Public Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Stockholders' Equity - At-the-Market Offering and Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails</Role>
      <ShortName>Stockholders' Equity - At-the-Market Offering and Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Stock Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - Stock Based Compensation - Weighted-Average Assumptions used for Stock Option Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails</Role>
      <ShortName>Stock Based Compensation - Weighted-Average Assumptions used for Stock Option Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - Stock Based Compensation - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails</Role>
      <ShortName>Stock Based Compensation - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/RelatedPartyTransactions</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="smmt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.summitplc.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.summitplc.com/role/CommitmentsandContingencies</ParentRole>
      <Position>69</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="smmt-20251231.htm">smmt-20251231.htm</File>
    <File>smmt-20251231.xsd</File>
    <File>smmt-20251231_cal.xml</File>
    <File>smmt-20251231_def.xml</File>
    <File>smmt-20251231_lab.xml</File>
    <File>smmt-20251231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>smmt-20251231_g1.jpg</File>
    <File>smmt-20251231_g2.jpg</File>
    <File>smmt-20251231_g3.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="837">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2025</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>117
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "smmt-20251231.htm": {
   "nsprefix": "smmt",
   "nsuri": "http://www.summitplc.com/20251231",
   "dts": {
    "inline": {
     "local": [
      "smmt-20251231.htm"
     ]
    },
    "schema": {
     "local": [
      "smmt-20251231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-af-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-af-sub-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "smmt-20251231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "smmt-20251231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "smmt-20251231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "smmt-20251231_pre.xml"
     ]
    }
   },
   "keyStandard": 327,
   "keyCustom": 53,
   "axisStandard": 16,
   "axisCustom": 1,
   "memberStandard": 31,
   "memberCustom": 40,
   "hidden": {
    "total": 8,
    "http://xbrl.sec.gov/dei/2025": 4,
    "http://fasb.org/us-gaap/2025": 3,
    "http://www.summitplc.com/20251231": 1
   },
   "contextCount": 228,
   "entityCount": 1,
   "segmentCount": 74,
   "elementCount": 672,
   "unitCount": 9,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 837,
    "http://xbrl.sec.gov/dei/2025": 38,
    "http://xbrl.sec.gov/cyd/2025": 15,
    "http://xbrl.sec.gov/ecd/2025": 5
   },
   "report": {
    "R1": {
     "role": "http://www.summitplc.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.summitplc.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.summitplc.com/role/ConsolidatedBalanceSheets",
     "longName": "9952151 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.summitplc.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R5": {
     "role": "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
     "longName": "9952153 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity",
     "longName": "9952154 - Statement - Consolidated Statements of Stockholders' Equity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical",
     "longName": "9952155 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "shortName": "Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
     "longName": "9952156 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "smmt:InterestExpenseIncomeNoncash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.summitplc.com/role/Organization",
     "longName": "9952157 - Disclosure - Organization",
     "shortName": "Organization",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements",
     "longName": "9952158 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements",
     "shortName": "Summary of Significant Accounting Policies and Recent Accounting Pronouncements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.summitplc.com/role/SegmentReporting",
     "longName": "9952159 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreement",
     "longName": "9952160 - Disclosure - Akeso License and Collaboration Agreement",
     "shortName": "Akeso License and Collaboration Agreement",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.summitplc.com/role/OtherIncomeNet",
     "longName": "9952161 - Disclosure - Other Income, Net",
     "shortName": "Other Income, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.summitplc.com/role/IncomeTax",
     "longName": "9952162 - Disclosure - Income Tax",
     "shortName": "Income Tax",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.summitplc.com/role/NetLossperShare",
     "longName": "9952163 - Disclosure - Net Loss per Share",
     "shortName": "Net Loss per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.summitplc.com/role/Goodwill",
     "longName": "9952164 - Disclosure - Goodwill",
     "shortName": "Goodwill",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestments",
     "longName": "9952165 - Disclosure - Fair Value Measurements and Short-Term Investments",
     "shortName": "Fair Value Measurements and Short-Term Investments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.summitplc.com/role/ResearchandDevelopmentPrepaidExpensesandAccruedLiabilities",
     "longName": "9952166 - Disclosure - Research and Development Prepaid Expenses and Accrued Liabilities",
     "shortName": "Research and Development Prepaid Expenses and Accrued Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.summitplc.com/role/Leases",
     "longName": "9952167 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedParties",
     "longName": "9952168 - Disclosure - Promissory Note Payable to Related Parties",
     "shortName": "Promissory Note Payable to Related Parties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R21": {
     "role": "http://www.summitplc.com/role/StockholdersEquity",
     "longName": "9952169 - Disclosure - Stockholders' Equity",
     "shortName": "Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.summitplc.com/role/StockBasedCompensation",
     "longName": "9952170 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.summitplc.com/role/RelatedPartyTransactions",
     "longName": "9952171 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R24": {
     "role": "http://www.summitplc.com/role/CommitmentsandContingencies",
     "longName": "9952172 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "ecd:NonRule10b51ArrTrmntdFlag",
       "ecd:Rule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "ecd:NonRule10b51ArrTrmntdFlag",
       "ecd:Rule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies",
     "longName": "9955511 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)",
     "shortName": "Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTables",
     "longName": "9955512 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)",
     "shortName": "Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.summitplc.com/role/SegmentReportingTables",
     "longName": "9955513 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.summitplc.com/role/OtherIncomeNetTables",
     "longName": "9955514 - Disclosure - Other Income, Net (Tables)",
     "shortName": "Other Income, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.summitplc.com/role/IncomeTaxTables",
     "longName": "9955515 - Disclosure - Income Tax (Tables)",
     "shortName": "Income Tax (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.summitplc.com/role/NetLossperShareTables",
     "longName": "9955516 - Disclosure - Net Loss per Share (Tables)",
     "shortName": "Net Loss per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsTables",
     "longName": "9955517 - Disclosure - Fair Value Measurements and Short-Term Investments (Tables)",
     "shortName": "Fair Value Measurements and Short-Term Investments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.summitplc.com/role/LeasesTables",
     "longName": "9955518 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.summitplc.com/role/StockBasedCompensationTables",
     "longName": "9955519 - Disclosure - Stock Based Compensation (Tables)",
     "shortName": "Stock Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.summitplc.com/role/OrganizationDetails",
     "longName": "9955520 - Disclosure - Organization (Details)",
     "shortName": "Organization (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R38": {
     "role": "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails",
     "longName": "9955521 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements - Narrative (Details)",
     "shortName": "Summary of Significant Accounting Policies and Recent Accounting Pronouncements - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R39": {
     "role": "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTotalCashCashEquivalentsandRestrictedCashBalancesDetails",
     "longName": "9955522 - Disclosure - Summary of Significant Accounting Policies and Recent Accounting Pronouncements - Total Cash, Cash Equivalents and Restricted Cash Balances (Details)",
     "shortName": "Summary of Significant Accounting Policies and Recent Accounting Pronouncements - Total Cash, Cash Equivalents and Restricted Cash Balances (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R40": {
     "role": "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails",
     "longName": "9955523 - Disclosure - Segment Reporting - Significant Expense of the CODM Function (Details)",
     "shortName": "Segment Reporting - Significant Expense of the CODM Function (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-66",
      "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.summitplc.com/role/SegmentReportingNarrativeDetails",
     "longName": "9955524 - Disclosure - Segment Reporting - Narrative (Details)",
     "shortName": "Segment Reporting - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R42": {
     "role": "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails",
     "longName": "9955525 - Disclosure - Akeso License and Collaboration Agreement (Details)",
     "shortName": "Akeso License and Collaboration Agreement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-71",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-69",
      "name": "smmt:CollaborativeArrangementRightsAndObligationsUpfrontPayment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.summitplc.com/role/OtherIncomeNetDetails",
     "longName": "9955526 - Disclosure - Other Income, Net (Details)",
     "shortName": "Other Income, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentIncomeNonoperating",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.summitplc.com/role/IncomeTaxNarrativeDetails",
     "longName": "9955527 - Disclosure - Income Tax - Narrative (Details)",
     "shortName": "Income Tax - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.summitplc.com/role/IncomeTaxComponentsofLossBeforeIncomeTaxesDetails",
     "longName": "9955528 - Disclosure - Income Tax - Components of Loss Before Income Taxes (Details)",
     "shortName": "Income Tax - Components of Loss Before Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails",
     "longName": "9955529 - Disclosure - Income Tax - Major Components of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Tax - Major Components of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.summitplc.com/role/IncomeTaxValuationAllowanceDetails",
     "longName": "9955530 - Disclosure - Income Tax - Valuation Allowance (Details)",
     "shortName": "Income Tax - Valuation Allowance (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails",
     "longName": "9955531 - Disclosure - Income Tax - Reconciliation of the Effective Income Tax Rate to Statutory Rate (Details)",
     "shortName": "Income Tax - Reconciliation of the Effective Income Tax Rate to Statutory Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.summitplc.com/role/IncomeTaxReconciliationofUnrecognizedTaxBenefitsDetails",
     "longName": "9955532 - Disclosure - Income Tax - Reconciliation of Unrecognized Tax Benefits (Details)",
     "shortName": "Income Tax - Reconciliation of Unrecognized Tax Benefits (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.summitplc.com/role/NetLossperShareComputationofNetLossperShareDetails",
     "longName": "9955533 - Disclosure - Net Loss per Share - Computation of Net Loss per Share (Details)",
     "shortName": "Net Loss per Share - Computation of Net Loss per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R51": {
     "role": "http://www.summitplc.com/role/NetLossperShareNarrativeDetails",
     "longName": "9955534 - Disclosure - Net Loss per Share - Narrative (Details)",
     "shortName": "Net Loss per Share - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-147",
      "name": "us-gaap:SaleOfStockPricePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-89",
      "name": "us-gaap:SharePrice",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.summitplc.com/role/NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails",
     "longName": "9955535 - Disclosure - Net Loss per Share - Securities Excluded from the Computation of Loss per Share (Details)",
     "shortName": "Net Loss per Share - Securities Excluded from the Computation of Loss per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.summitplc.com/role/GoodwillDetails",
     "longName": "9955536 - Disclosure - Goodwill (Details)",
     "shortName": "Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-99",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "unitRef": "gbp",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-99",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "unitRef": "gbp",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails",
     "longName": "9955537 - Disclosure - Fair Value Measurements and Short-Term Investments - Measured at Fair Value on a Recurring Basis (Details)",
     "shortName": "Fair Value Measurements and Short-Term Investments - Measured at Fair Value on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsNarrativeDetails",
     "longName": "9955538 - Disclosure - Fair Value Measurements and Short-Term Investments - Narrative (Details)",
     "shortName": "Fair Value Measurements and Short-Term Investments - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:Cash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:Cash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.summitplc.com/role/ResearchandDevelopmentPrepaidExpensesandAccruedLiabilitiesDetails",
     "longName": "9955539 - Disclosure - Research and Development Prepaid Expenses and Accrued Liabilities (Details)",
     "shortName": "Research and Development Prepaid Expenses and Accrued Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "smmt:ResearchAndDevelopmentPrepaidExpensesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "smmt:ResearchAndDevelopmentPrepaidExpensesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.summitplc.com/role/LeasesNarrativeDetails",
     "longName": "9955540 - Disclosure - Leases - Narrative (Details)",
     "shortName": "Leases - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.summitplc.com/role/LeasesLeaseCostDetails",
     "longName": "9955541 - Disclosure - Leases - Lease Cost (Details)",
     "shortName": "Leases - Lease Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails",
     "longName": "9955542 - Disclosure - Leases - Future Lease Payments (Details)",
     "shortName": "Leases - Future Lease Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails",
     "longName": "9955543 - Disclosure - Promissory Note Payable to Related Parties (Details)",
     "shortName": "Promissory Note Payable to Related Parties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-128",
      "name": "us-gaap:RepaymentsOfRelatedPartyDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-128",
      "name": "us-gaap:RepaymentsOfRelatedPartyDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails",
     "longName": "9955544 - Disclosure - Stockholders' Equity - Preferred Stock and Common Stock (Details)",
     "shortName": "Stockholders' Equity - Preferred Stock and Common Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-136",
      "name": "smmt:CommonStockSharesAuthorizedIncreaseDecrease",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails",
     "longName": "9955545 - Disclosure - Stockholders' Equity - Private Investment in Public Equity (Details)",
     "shortName": "Stockholders' Equity - Private Investment in Public Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-146",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-146",
      "name": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails",
     "longName": "9955546 - Disclosure - Stockholders' Equity - At-the-Market Offering and Warrants (Details)",
     "shortName": "Stockholders' Equity - At-the-Market Offering and Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-157",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails",
     "longName": "9955547 - Disclosure - Stock Based Compensation - Narrative (Details)",
     "shortName": "Stock Based Compensation - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails",
     "longName": "9955548 - Disclosure - Stock Based Compensation - Weighted-Average Assumptions used for Stock Option Awards (Details)",
     "shortName": "Stock Based Compensation - Weighted-Average Assumptions used for Stock Option Awards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-180",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-180",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails",
     "longName": "9955549 - Disclosure - Stock Based Compensation - Stock Option Activity (Details)",
     "shortName": "Stock Based Compensation - Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-182",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-179",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails",
     "longName": "9955550 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details)",
     "shortName": "Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-179",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.summitplc.com/role/RelatedPartyTransactionsDetails",
     "longName": "9955551 - Disclosure - Related Party Transactions (Details)",
     "shortName": "Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-209",
      "name": "smmt:LessorOperatingLeaseNumberOfContracts",
      "unitRef": "contract",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.summitplc.com/role/CommitmentsandContingenciesDetails",
     "longName": "9955552 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:PurchaseObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:PurchaseObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "smmt-20251231.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "smmt_A2020IncrementalPoolMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "A2020IncrementalPoolMember",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2020 Incremental Pool",
        "label": "2020 Incremental Pool [Member]",
        "documentation": "2020 Incremental Pool"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_A2020StockIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "A2020StockIncentivePlanMember",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2020 Plan",
        "label": "2020 Stock Incentive Plan [Member]",
        "documentation": "2020 Stock Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_A2024InducementPoolMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "A2024InducementPoolMember",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Inducement Pool",
        "label": "2024 Inducement Pool [Member]",
        "documentation": "2024 Inducement Pool"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r851"
     ]
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Amortization of discount on short-term investments",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets",
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued liabilities",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "smmt_AccruedResearchAndDevelopmentCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "AccruedResearchAndDevelopmentCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/ResearchandDevelopmentPrepaidExpensesandAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued research and development expenditure",
        "label": "Accrued Research And Development, Current",
        "documentation": "Accrued Research And Development, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r60",
      "r118",
      "r628",
      "r661",
      "r662",
      "r1096"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r11",
      "r19",
      "r463",
      "r466",
      "r536",
      "r657",
      "r658",
      "r1003",
      "r1004",
      "r1005",
      "r1021",
      "r1022",
      "r1023",
      "r1024"
     ]
    },
    "smmt_AcquiredInProcessResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "AcquiredInProcessResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails",
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquired in-process research and development",
        "verboseLabel": "Acquired in-process research and development expense",
        "label": "Acquired-In-Process Research And Development Expense",
        "documentation": "Acquired-In-Process Research And Development Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r851",
      "r1168"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r678",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1097",
      "r1174"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r348"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to additional paid in capital, stock issued, issuance costs",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r78"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_AffiliatedEntityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "AffiliatedEntityMember",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails",
      "http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Affiliated entity",
        "label": "Affiliated Entity [Member]"
       }
      }
     },
     "auth_ref": [
      "r770",
      "r869",
      "r1050",
      "r1120",
      "r1121",
      "r1123",
      "r1169"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r898",
      "r909",
      "r919",
      "r952"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r901",
      "r912",
      "r922",
      "r955"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r986"
     ]
    },
    "smmt_AkesoLicenseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "AkesoLicenseAgreementMember",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Akeso License Agreement",
        "label": "Akeso License Agreement [Member]",
        "documentation": "Akeso License Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_AkesoSupplyAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "AkesoSupplyAgreementMember",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Akeso Supply Agreement",
        "label": "Akeso Supply Agreement [Member]",
        "documentation": "Akeso Supply Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r902",
      "r913",
      "r923",
      "r947",
      "r956",
      "r960",
      "r968"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails",
      "http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r380",
      "r386",
      "r395"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.summitplc.com/role/NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potentially dilutive securities excluded from the computation of diluted loss per share (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.summitplc.com/role/NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.summitplc.com/role/NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.summitplc.com/role/NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "smmt_AreaOfPremisesSubleased": {
     "xbrltype": "areaItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "AreaOfPremisesSubleased",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Area of premises subleased (in square feet)",
        "label": "Area Of Premises Subleased",
        "documentation": "Area Of Premises Subleased"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r452"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r97",
      "r117",
      "r146",
      "r147",
      "r148",
      "r182",
      "r193",
      "r211",
      "r215",
      "r254",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r453",
      "r455",
      "r495",
      "r615",
      "r616",
      "r622",
      "r708",
      "r802",
      "r803",
      "r814",
      "r851",
      "r864",
      "r865",
      "r876",
      "r1046",
      "r1047",
      "r1124"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r119",
      "r146",
      "r147",
      "r148",
      "r254",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r453",
      "r455",
      "r495",
      "r851",
      "r1046",
      "r1047",
      "r1124"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current assets:",
        "label": "Assets, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_AtMarketOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "AtMarketOfferingMember",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At Market Offering",
        "label": "At Market Offering [Member]",
        "documentation": "At Market Offering"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.summitplc.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r881",
      "r882",
      "r905"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.summitplc.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r881",
      "r882",
      "r905"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://www.summitplc.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r881",
      "r882",
      "r905"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized Gain",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unrealized (Loss)",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails",
      "http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails",
      "http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r352",
      "r353",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r1011"
     ]
    },
    "stpr_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2025",
     "localname": "CA",
     "presentation": [
      "http://www.summitplc.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CALIFORNIA",
        "label": "CALIFORNIA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unpaid amounts related to purchase of property, plant and equipment",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27",
      "r28"
     ]
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r625",
      "r680",
      "r703",
      "r851",
      "r864",
      "r865",
      "r876",
      "r1000"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTotalCashCashEquivalentsandRestrictedCashBalancesDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets",
      "http://www.summitplc.com/role/OrganizationDetails",
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTotalCashCashEquivalentsandRestrictedCashBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r114",
      "r782"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Axis]",
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Cash",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r84"
     ]
    },
    "us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTotalCashCashEquivalentsandRestrictedCashBalancesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTotalCashCashEquivalentsandRestrictedCashBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "totalLabel": "Total cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r71",
      "r143"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (decrease) in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r71"
     ]
    },
    "smmt_CashPaymentForCollaborativeArrangementUpfrontPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "CashPaymentForCollaborativeArrangementUpfrontPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash payment for collaborative arrangement, upfront payment",
        "label": "Cash payment For Collaborative Arrangement, Upfront Payment",
        "documentation": "Cash payment For Collaborative Arrangement, Upfront Payment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CertificatesOfDepositMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CertificatesOfDepositMember",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Certificate of deposit",
        "label": "Certificates of Deposit [Member]",
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r870",
      "r871",
      "r872",
      "r873"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r938"
     ]
    },
    "smmt_ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chief Executive Officer and Chief Executive Officer and President",
        "label": "Chief Executive Officer And Chief Executive Officer And President [Member]",
        "documentation": "Chief Executive Officer And Chief Executive Officer And President"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_ChiefExecutiveOfficerAndPresidentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "ChiefExecutiveOfficerAndPresidentMember",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chief Executive Officer and President",
        "label": "Chief Executive Officer And President [Member]",
        "documentation": "Chief Executive Officer And President"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ChiefExecutiveOfficerMember",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chief Executive Officer",
        "label": "Chief Executive Officer [Member]"
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "srt_ChiefOperatingOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ChiefOperatingOfficerMember",
     "presentation": [
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chief Operations Officer",
        "label": "Chief Operating Officer [Member]"
       }
      }
     },
     "auth_ref": [
      "r1032",
      "r1122"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_ClassOfWarrantOrRightExercisesInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "ClassOfWarrantOrRightExercisesInPeriod",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails",
      "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in shares)",
        "label": "Class Of Warrant Or Right, Exercises In Period",
        "documentation": "Class Of Warrant Or Right, Exercises In Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants outstanding (in shares)",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "smmt_ClassOfWarrantOrRightWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePrice",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails",
      "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant weighted average exercise price (in dollars per share)",
        "label": "Class Of Warrant Or Right, Weighted Average Exercise Price",
        "documentation": "Class Of Warrant Or Right, Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails",
      "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period",
        "documentation": "Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_CoChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "CoChiefExecutiveOfficerMember",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Co-Chief Executive Officer",
        "label": "Co-Chief Executive Officer [Member]",
        "documentation": "Co-Chief Executive Officer"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Akeso License and Collaboration Agreement",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r450",
      "r451"
     ]
    },
    "smmt_CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional potential commercial milestone payments",
        "label": "Collaborative Arrangement, Rights And Obligations, Additional Potential Commercial Milestone Payments",
        "documentation": "Collaborative Arrangement, Rights And Obligations, Additional Potential Commercial Milestone Payments"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_CollaborativeArrangementRightsAndObligationsDirectTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "CollaborativeArrangementRightsAndObligationsDirectTransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative arrangement, direct transaction costs",
        "label": "Collaborative Arrangement, Rights And Obligations, Direct Transaction Costs",
        "documentation": "Collaborative Arrangement, Rights And Obligations, Direct Transaction Costs"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Collaborative arrangement, additional potential milestone payments",
        "label": "Collaborative Arrangement, Rights And Obligations, Maximum Aggregate Milestone Payments",
        "documentation": "Collaborative Arrangement, Rights And Obligations, Maximum Aggregate Milestone Payments"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails": {
       "parentTag": "smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative arrangement, potential commercial milestone payments",
        "label": "Collaborative Arrangement, Rights And Obligations, Potential Commercial Milestone Payments",
        "documentation": "Collaborative Arrangement, Rights And Obligations, Potential Commercial Milestone Payments"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails": {
       "parentTag": "smmt_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative arrangement, potential regulatory milestone payments",
        "label": "Collaborative Arrangement, Rights And Obligations, Potential Regulatory Milestone Payments",
        "documentation": "Collaborative Arrangement, Rights And Obligations, Potential Regulatory Milestone Payments"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_CollaborativeArrangementRightsAndObligationsUpfrontPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "CollaborativeArrangementRightsAndObligationsUpfrontPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative arrangement, upfront payment",
        "label": "Collaborative Arrangement, Rights And Obligations, Upfront Payment",
        "documentation": "Collaborative Arrangement, Rights And Obligations, Upfront Payment"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative arrangement, upfront payment, paid in shares",
        "label": "Collaborative Arrangement, Rights And Obligations, Upfront Payment, Paid In Shares",
        "documentation": "Collaborative Arrangement, Rights And Obligations, Upfront Payment, Paid In Shares"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash",
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative arrangement, common stock issued in lieu of cash upfront payment (in shares)",
        "label": "Collaborative Arrangement, Rights And Obligations, Upfront Payment, Shares Of Common Stock Issued In Lieu Of Cash",
        "documentation": "Collaborative Arrangement, Rights And Obligations, Upfront Payment, Shares Of Common Stock Issued In Lieu Of Cash"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember",
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative arrangement, transaction with party to collaborative arrangement",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]",
        "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement."
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember",
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative arrangement, transaction with party to collaborative arrangement, upfront payment one",
        "label": "Collaborative Arrangement, Transaction With Party To Collaborative Arrangement, Upfront Payment One [Member]",
        "documentation": "Collaborative Arrangement, Transaction With Party To Collaborative Arrangement, Upfront Payment One"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember",
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative arrangement, transaction with party to collaborative arrangement, upfront payment two",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement, Upfront Payment Two [Member]",
        "documentation": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement, Upfront Payment Two"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r452"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note 16)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r88",
      "r624",
      "r694"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r287",
      "r288",
      "r765",
      "r1043",
      "r1045"
     ]
    },
    "smmt_CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares that can be added to the plan upon option expiration (in shares)",
        "label": "Common Stock, Additional Capital Shares Allowable For Future Issuance Upon Option Expiration",
        "documentation": "Common Stock, Additional Capital Shares Allowable For Future Issuance Upon Option Expiration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares initially reserve for future issuance (in shares)",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r866",
      "r867",
      "r868",
      "r870",
      "r871",
      "r872",
      "r873",
      "r1021",
      "r1022",
      "r1024",
      "r1097",
      "r1167",
      "r1174"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails",
      "http://www.summitplc.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails",
      "http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r695"
     ]
    },
    "smmt_CommonStockSharesAuthorizedIncreaseDecrease": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "CommonStockSharesAuthorizedIncreaseDecrease",
     "presentation": [
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized, Increase (Decrease)",
        "documentation": "Common Stock, Shares Authorized, Increase (Decrease)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r52",
      "r695",
      "r714",
      "r1174",
      "r1175"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.01 par value: 1,000,000,000 shares authorized; 775,371,200 and 737,626,004 shares issued and outstanding at December 31, 2025 and 2024, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r310",
      "r316",
      "r627",
      "r851"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r943"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r945"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Components of Deferred Tax Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities:",
        "label": "Components of Deferred Tax Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r125",
      "r127",
      "r132",
      "r613",
      "r637",
      "r638"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Credit Risk and Other Risks and Uncertainties",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r492",
      "r493"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r790"
     ]
    },
    "smmt_ConsultingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "ConsultingAgreementMember",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consulting Agreement",
        "label": "Consulting Agreement [Member]",
        "documentation": "Consulting Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "smmt_CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/OtherIncomeNetDetails": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/OtherIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Reclassification of currency translation gain",
        "terseLabel": "Reclassification of cumulative currency translation gain",
        "label": "Cumulative Currency Translation Gains (Losses), Realized upon Sale or Liquidation, Reclassified From Other Comprehensive Income",
        "documentation": "Cumulative Currency Translation Gains (Losses), Realized upon Sale or Liquidation, Reclassified From Other Comprehensive Income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current provision for federal income taxes",
        "label": "Current Federal Tax Expense (Benefit)",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r990",
      "r1012",
      "r1016",
      "r1091"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current provision for non-United States income taxes",
        "label": "Current Foreign Tax Expense (Benefit)",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r990",
      "r1012",
      "r1016"
     ]
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current provision for state income taxes",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r990",
      "r1012",
      "r1016",
      "r1091"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r890",
      "r979"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r890",
      "r979"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r892",
      "r981"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r892",
      "r981"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r894",
      "r983"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r892",
      "r981"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r885",
      "r974"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r886",
      "r975"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r886",
      "r975"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r884",
      "r973"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r884",
      "r973"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r884",
      "r973"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r887",
      "r976"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r889",
      "r978"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r889",
      "r978"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r890",
      "r979"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r893",
      "r982"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r891",
      "r980"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r888",
      "r977"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate margin",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective interest rate",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r305",
      "r514",
      "r515",
      "r849"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Credit (Loss)",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss, Excluding Accrued Interest",
        "documentation": "Amount excluding accrued interest, of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r262"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized Cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss",
        "documentation": "Amortized cost excluding accrued interest, before allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r262"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest",
        "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred provision for federal income taxes",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1016",
      "r1090",
      "r1091"
     ]
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredFinanceCostsGross",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt issuance costs",
        "label": "Debt Issuance Costs, Gross",
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r1113",
      "r1114"
     ]
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred provision for non-United States income taxes",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1016",
      "r1090"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "smmt_DeferredTaxAssetsLiabilities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r49",
      "r86",
      "r423"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred provision for state income taxes",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1016",
      "r1090",
      "r1091"
     ]
    },
    "smmt_DeferredTaxAssetsCapitalizedResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "DeferredTaxAssetsCapitalizedResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Section 174 Research and Development Capitalization",
        "label": "Deferred Tax Assets, Capitalized Research And Development",
        "documentation": "Deferred Tax Assets, Capitalized Research And Development"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "smmt_DeferredTaxAssetsLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax asset",
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "smmt_DeferredTaxAssetsLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "DeferredTaxAssetsLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets before valuation allowance",
        "label": "Deferred Tax Assets (Liabilities)",
        "documentation": "Deferred Tax Assets (Liabilities)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred tax, net",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforward",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1089"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1089"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development credit carryforward",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1089"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1089"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.summitplc.com/role/IncomeTaxValuationAllowanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Valuation allowance",
        "negatedPeriodStartLabel": "Valuation allowance as of beginning of year",
        "negatedPeriodEndLabel": "Valuation allowance as of end of year",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "smmt_DeferredTaxAssetsValuationAllowanceRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "DeferredTaxAssetsValuationAllowanceRollForward",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxValuationAllowanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Tax Assets, Valuation Allowance [Roll Forward]",
        "label": "Deferred Tax Assets, Valuation Allowance [Roll Forward]",
        "documentation": "Deferred Tax Assets, Valuation Allowance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilitiesOther",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxMajorComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other",
        "label": "Deferred Tax Liabilities, Other",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other."
       }
      }
     },
     "auth_ref": [
      "r1089"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r34",
      "r137",
      "r783",
      "r784",
      "r786",
      "r788"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r346",
      "r350",
      "r381",
      "r382",
      "r384",
      "r824"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_DistributionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "DistributionAgreementMember",
     "presentation": [
      "http://www.summitplc.com/role/OrganizationDetails",
      "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distribution Agreement",
        "label": "Distribution Agreement [Member]",
        "documentation": "Distribution Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r881",
      "r882",
      "r905"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r881",
      "r882",
      "r905",
      "r948"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. Federal",
        "label": "Domestic Tax Jurisdiction [Member]",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r405"
     ]
    },
    "smmt_DugganFebruaryNoteAndZanganehNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "DugganFebruaryNoteAndZanganehNoteMember",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Duggan February Note and Zanganeh Note",
        "label": "Duggan February Note And Zanganeh Note [Member]",
        "documentation": "Duggan February Note And Zanganeh Note"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_DugganFebruaryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "DugganFebruaryNoteMember",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Duggan February Note",
        "label": "Duggan February Note [Member]",
        "documentation": "Duggan February Note"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_DugganSeptemberNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "DugganSeptemberNoteMember",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Duggan September Note",
        "label": "Duggan September Note [Member]",
        "documentation": "Duggan September Note"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r937"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.summitplc.com/role/NetLossperShareComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Basic net loss per share (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r133",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r170",
      "r172",
      "r174",
      "r175",
      "r176",
      "r181",
      "r308",
      "r385",
      "r443",
      "r449",
      "r475",
      "r476",
      "r614",
      "r639",
      "r793"
     ]
    },
    "smmt_EarningsPerShareBasicAndDilutedEPSAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "EarningsPerShareBasicAndDilutedEPSAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share:",
        "label": "Earnings Per Share, Basic and Diluted EPS [Abstract]",
        "documentation": "Earnings Per Share, Basic and Diluted EPS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.summitplc.com/role/NetLossperShareComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted net loss per share (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r133",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r172",
      "r174",
      "r175",
      "r176",
      "r181",
      "r308",
      "r385",
      "r443",
      "r449",
      "r475",
      "r476",
      "r614",
      "r639",
      "r793"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r30",
      "r178"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/NetLossperShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r177",
      "r179",
      "r180"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rates on cash and cash equivalents",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation",
        "documentation": "Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r1112"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r827"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percent",
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax at federal statutory rate",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r150",
      "r405",
      "r434",
      "r827"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r827",
      "r1012",
      "r1017",
      "r1082"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Tax Effects",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile."
       }
      }
     },
     "auth_ref": [
      "r406",
      "r409",
      "r827",
      "r1012",
      "r1017",
      "r1082"
     ]
    },
    "smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignTaxEffectsAmountAbstract",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Tax Effects",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Tax Effects, Amount [Abstract]",
        "documentation": "Effective Income Tax Rate Reconciliation, Foreign Tax Effects, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignTaxEffectsPercentAbstract",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Tax Effects",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Tax Effects, Percent [Abstract]",
        "documentation": "Effective Income Tax Rate Reconciliation, Foreign Tax Effects, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationLineItems",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective Income Tax Rate Reconciliation [Line Items]",
        "label": "Effective Income Tax Rate Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r406",
      "r827"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAbstract",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nontaxable or nondeductible Items",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent",
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r827",
      "r1012",
      "r1017",
      "r1082",
      "r1084"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r827",
      "r1012",
      "r1017",
      "r1082",
      "r1083"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State income tax, net of federal tax benefit",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r408",
      "r827",
      "r1012",
      "r1017",
      "r1082"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationTable",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective Income Tax Rate Reconciliation [Table]",
        "label": "Effective Income Tax Rate Reconciliation [Table]",
        "documentation": "Disclosure of information about income tax rate reconciliation between amount of reported income tax expense (benefit) attributable to continuing operation to amount of income tax expense(benefit) that would result from applying statutory federal (national) tax rate to pretax income (loss) from continuing operation."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r406",
      "r827"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in unrecognized tax benefits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r827",
      "r1012",
      "r1017",
      "r1082"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Research and development credits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r827",
      "r1012",
      "r1017",
      "r1082",
      "r1084"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1078"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation expense, period of recognition (in years)",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1079"
     ]
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://www.summitplc.com/role/NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails",
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Shares expected to be purchased under employee stock purchase plan",
        "terseLabel": "ESPP",
        "netLabel": "Employee stock purchase plan",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.summitplc.com/role/NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails",
      "http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Options to purchase common stock",
        "terseLabel": "Stock options",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077"
     ]
    },
    "smmt_EmployeeStockOptionPerformanceAndMarketBasedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "EmployeeStockOptionPerformanceAndMarketBasedMember",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance and market-based stock options",
        "label": "Employee Stock Option, Performance And Market-Based [Member]",
        "documentation": "Employee Stock Option, Performance And Market-Based"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_EmployeeStockOptionPerformanceBasedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "EmployeeStockOptionPerformanceBasedMember",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option, Performance Based",
        "label": "Employee Stock Option, Performance Based [Member]",
        "documentation": "Employee Stock Option, Performance Based"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_EmployeeStockOptionTimeBasedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "EmployeeStockOptionTimeBasedMember",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails",
      "http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails",
      "http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Time-based stock options",
        "label": "Employee Stock Option, Time-Based [Member]",
        "documentation": "Employee Stock Option, Time-Based"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r989"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r931"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r104",
      "r105",
      "r106",
      "r129",
      "r130",
      "r131",
      "r153",
      "r154",
      "r155",
      "r157",
      "r164",
      "r166",
      "r168",
      "r183",
      "r255",
      "r256",
      "r280",
      "r307",
      "r332",
      "r385",
      "r432",
      "r433",
      "r440",
      "r441",
      "r442",
      "r444",
      "r448",
      "r449",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r474",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r516",
      "r518",
      "r536",
      "r635",
      "r657",
      "r658",
      "r659",
      "r678",
      "r739"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r898",
      "r909",
      "r919",
      "r952"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r895",
      "r906",
      "r916",
      "r949"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "stpr_FL": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2025",
     "localname": "FL",
     "presentation": [
      "http://www.summitplc.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FLORIDA",
        "label": "FLORIDA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r479",
      "r486",
      "r837"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r479",
      "r486",
      "r837"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of assets and liabilities measured at fair value on a recurring basis",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1099",
      "r1100"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r341",
      "r342",
      "r477",
      "r479",
      "r480",
      "r481",
      "r482",
      "r485",
      "r486",
      "r488",
      "r491",
      "r548",
      "r549",
      "r550",
      "r780",
      "r810",
      "r811",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r837",
      "r841",
      "r848"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r334",
      "r339",
      "r341",
      "r479",
      "r486",
      "r491",
      "r548",
      "r780",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r837",
      "r848"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r334",
      "r339",
      "r341",
      "r343",
      "r479",
      "r480",
      "r486",
      "r491",
      "r549",
      "r780",
      "r810",
      "r811",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r837",
      "r848"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r341",
      "r342",
      "r477",
      "r479",
      "r480",
      "r481",
      "r482",
      "r485",
      "r486",
      "r488",
      "r491",
      "r548",
      "r549",
      "r550",
      "r780",
      "r810",
      "r811",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r837",
      "r841",
      "r848"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r1106"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r304",
      "r330",
      "r461",
      "r472",
      "r489",
      "r494",
      "r497",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r621",
      "r636",
      "r808",
      "r837",
      "r839",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r852",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1098",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1107",
      "r1108"
     ]
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements and Short-Term Investments",
        "label": "Financial Instruments Disclosure [Text Block]",
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.K.",
        "label": "Foreign Tax Jurisdiction [Member]",
        "documentation": "Designated foreign jurisdiction entitled to levy and collect income tax outside country of domicile."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r406"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/OtherIncomeNetDetails": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/OtherIncomeNetDetails",
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency (loss) gain",
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r500",
      "r502",
      "r504",
      "r505",
      "r736"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unrealized foreign exchange loss (gain)",
        "label": "Unrealized Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r715",
      "r874",
      "r1110",
      "r1111",
      "r1173"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Translation",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "us-gaap_ForeignTaxJurisdictionOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignTaxJurisdictionOtherMember",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other foreign jurisdictions",
        "label": "Foreign Tax Jurisdiction, Other [Member]",
        "documentation": "Designated foreign jurisdiction entitled to levy and collect income tax outside country of domicile, classified as other."
       }
      }
     },
     "auth_ref": [
      "r827",
      "r1009",
      "r1087"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r902",
      "r913",
      "r923",
      "r956"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r902",
      "r913",
      "r923",
      "r956"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r902",
      "r913",
      "r923",
      "r956"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r902",
      "r913",
      "r923",
      "r956"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r902",
      "r913",
      "r923",
      "r956"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GainLossOnDispositionOfAssets1",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss on disposal of assets",
        "label": "Gain (Loss) on Disposition of Assets",
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee."
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r718"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "smmt_GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Genius Sublease Agreement And Investments Research Sublease Agreement",
        "label": "Genius Sublease Agreement And Investments Research Sublease Agreement [Member]",
        "documentation": "Genius Sublease Agreement And"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_GeniusSubleaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "GeniusSubleaseAgreementMember",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Genius Sublease Agreement",
        "label": "Genius Sublease Agreement [Member]",
        "documentation": "Genius Sublease Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets",
      "http://www.summitplc.com/role/GoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r267",
      "r612",
      "r803",
      "r809",
      "r828",
      "r829",
      "r830",
      "r833",
      "r838",
      "r851",
      "r1040",
      "r1041",
      "r1094"
     ]
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAcquiredDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/GoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recognition of goodwill",
        "label": "Goodwill, Acquired During Period",
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r445",
      "r446",
      "r447",
      "r809"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/Goodwill"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1039",
      "r1042"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r277",
      "r809"
     ]
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/GoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative goodwill impairment charges",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "documentation": "Amount of accumulated impairment loss for asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r276",
      "r278",
      "r447",
      "r809"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r881",
      "r882",
      "r905"
     ]
    },
    "smmt_InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquired In-Process Research and Development",
        "label": "In Process Research And Development, Through A Collaboration [Policy Text Block]",
        "documentation": "In Process Research And Development, Through A Collaboration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxComponentsofLossBeforeIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxComponentsofLossBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r149",
      "r404"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxComponentsofLossBeforeIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxComponentsofLossBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before income tax",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r92",
      "r96",
      "r615",
      "r617",
      "r633",
      "r785",
      "r787",
      "r789",
      "r797",
      "r802",
      "r1026",
      "r1028",
      "r1029",
      "r1030",
      "r1031"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxComponentsofLossBeforeIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxComponentsofLossBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r149",
      "r404"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Income Location, Balance [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r283",
      "r284",
      "r457",
      "r458",
      "r459",
      "r460",
      "r483",
      "r484",
      "r487",
      "r496",
      "r497",
      "r498",
      "r654",
      "r656",
      "r723",
      "r779",
      "r780",
      "r828",
      "r830",
      "r835",
      "r836",
      "r840",
      "r848",
      "r1092",
      "r1093",
      "r1138"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Income Location, Balance [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r284",
      "r457",
      "r458",
      "r459",
      "r460",
      "r483",
      "r484",
      "r487",
      "r496",
      "r497",
      "r498",
      "r654",
      "r656",
      "r723",
      "r779",
      "r780",
      "r828",
      "r830",
      "r835",
      "r836",
      "r840",
      "r848",
      "r1092",
      "r1093",
      "r1138"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails",
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Axis]",
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r405",
      "r406",
      "r416",
      "r429",
      "r827",
      "r1088"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails",
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Domain]",
        "label": "Income Tax Jurisdiction [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r405",
      "r406",
      "r416",
      "r429",
      "r827",
      "r1088"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTax"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r150",
      "r399",
      "r405",
      "r412",
      "r413",
      "r414",
      "r420",
      "r427",
      "r435",
      "r437",
      "r438",
      "r439",
      "r620",
      "r664",
      "r674",
      "r827"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r102",
      "r146",
      "r167",
      "r168",
      "r182",
      "r201",
      "r215",
      "r403",
      "r405",
      "r436",
      "r641",
      "r785",
      "r787",
      "r789",
      "r827"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount",
        "label": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r401",
      "r402",
      "r420",
      "r421",
      "r426",
      "r431",
      "r671"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r827",
      "r1082"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Tax Effects",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r406",
      "r409",
      "r827",
      "r1082"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax at federal statutory rate",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r827"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseAbstract",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nontaxable or nondeductible Items",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r827",
      "r1082",
      "r1084"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r827",
      "r1082",
      "r1083"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State income tax, net of federal tax benefit",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r408",
      "r827",
      "r1082"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationTaxContingencies",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in unrecognized tax benefits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r827",
      "r1082"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Research and development credits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r827",
      "r1082",
      "r1084"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for income taxes",
        "label": "Income Taxes Paid, Net",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r142",
      "r428",
      "r429"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued liabilities and other current liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets and lease liabilities, net",
        "label": "Increase (Decrease) In Operating Lease Right-Of-Use-Asset And Operating Lease Liability, Net",
        "documentation": "Increase (Decrease) In Operating Lease Right-Of-Use-Asset And Operating Lease Liability, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term liabilities",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other assets",
        "label": "Increase (Decrease) in Other Operating Assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r902",
      "r913",
      "r923",
      "r947",
      "r956",
      "r960",
      "r968"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r883",
      "r972"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r883",
      "r972"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r883",
      "r972"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incurred interest expense",
        "label": "Interest Expense, Debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r303",
      "r306",
      "r812",
      "r813",
      "r1170"
     ]
    },
    "smmt_InterestExpenseIncomeNoncash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "InterestExpenseIncomeNoncash",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash interest expense",
        "label": "Interest Expense (Income), Noncash",
        "documentation": "Interest Expense (Income), Noncash"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense",
        "negatedNetLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r785",
      "r789",
      "r1006"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for interest on related party promissory note",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activity",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r140",
      "r141"
     ]
    },
    "us-gaap_InvestmentIncomeNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentIncomeNonoperating",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/OtherIncomeNetDetails": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/OtherIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment income",
        "label": "Investment Income, Nonoperating",
        "documentation": "The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term Investments",
        "label": "Investment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r640",
      "r667",
      "r668",
      "r669",
      "r670",
      "r749",
      "r750"
     ]
    },
    "smmt_InvestmentsResearchSubleaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "InvestmentsResearchSubleaseAgreementMember",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments Research Sublease Agreement",
        "label": "Investments Research Sublease Agreement [Member]",
        "documentation": "Investments Research Sublease Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "country_KY": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "KY",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRatetoStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CAYMAN ISLANDS",
        "label": "CAYMAN ISLANDS"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_LaborAndRelatedExpensesExcludingStockBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "LaborAndRelatedExpensesExcludingStockBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation related costs, excluding stock-based compensation",
        "label": "Labor And Related Expenses, Excluding Stock-Based Compensation",
        "documentation": "Labor And Related Expenses, Excluding Stock-Based Compensation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/LeasesLeaseCostDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease cost",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r524",
      "r850"
     ]
    },
    "us-gaap_LeaseCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCostAbstract",
     "presentation": [
      "http://www.summitplc.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease, Cost [Abstract]",
        "label": "Lease, Cost [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of lease expense",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1116"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LegalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LegalFees",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal fees",
        "label": "Legal Fees",
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings."
       }
      }
     },
     "auth_ref": [
      "r991",
      "r1171",
      "r1172"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.summitplc.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r534"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.summitplc.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r534"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of future lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1117"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails",
      "http://www.summitplc.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total lease payments",
        "totalLabel": "Total lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r1013",
      "r1020",
      "r1132"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r1013",
      "r1020",
      "r1132"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r1013",
      "r1020",
      "r1132"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2030",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r1013",
      "r1020",
      "r1132"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r1013",
      "r1020",
      "r1132"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r1013",
      "r1020",
      "r1132"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r1013",
      "r1020",
      "r1132"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "smmt_LesseeOperatingLeaseProportionOfAmountPayablePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "LesseeOperatingLeaseProportionOfAmountPayablePercentage",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proportionate share of net payable",
        "label": "Lessee, Operating Lease, Proportion Of Amount Payable, Percentage",
        "documentation": "Lessee, Operating Lease, Proportion Of Amount Payable, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://www.summitplc.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease term (in years)",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1115"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "smmt_LessorOperatingLeaseAreaOfPremisesLeased": {
     "xbrltype": "areaItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "LessorOperatingLeaseAreaOfPremisesLeased",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Area of premises subleased to other party (in square feet)",
        "label": "Lessor, Operating Lease, Area Of Premises Leased",
        "documentation": "Lessor, Operating Lease, Area Of Premises Leased"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_LessorOperatingLeaseNumberOfContracts": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "LessorOperatingLeaseNumberOfContracts",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of sublease contracts to other party",
        "label": "Lessor, Operating Lease, Number Of Contracts",
        "documentation": "Lessor, Operating Lease, Number Of Contracts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LessorOperatingLeasePaymentsToBeReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total sublease rental payments to be received",
        "label": "Lessor, Operating Lease, Payment to be Received",
        "documentation": "Amount of lease payments to be received by lessor for operating lease."
       }
      }
     },
     "auth_ref": [
      "r535"
     ]
    },
    "us-gaap_LessorOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LessorOperatingLeaseTermOfContract",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sublease term to other party (in months)",
        "label": "Lessor, Operating Lease, Term of Contract",
        "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1118"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r41",
      "r42",
      "r43",
      "r45",
      "r46",
      "r47",
      "r50",
      "r146",
      "r147",
      "r148",
      "r254",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r454",
      "r455",
      "r456",
      "r495",
      "r693",
      "r796",
      "r814",
      "r876",
      "r1046",
      "r1124",
      "r1125"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders' equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r89",
      "r630",
      "r851",
      "r864",
      "r865",
      "r1012",
      "r1015",
      "r1037",
      "r1109"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r113",
      "r146",
      "r147",
      "r148",
      "r254",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r454",
      "r455",
      "r456",
      "r495",
      "r851",
      "r1046",
      "r1124",
      "r1125"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current liabilities:",
        "label": "Liabilities, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails",
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r188",
      "r289",
      "r290",
      "r291",
      "r292",
      "r345",
      "r376",
      "r377",
      "r378",
      "r396",
      "r482",
      "r576",
      "r653",
      "r655",
      "r663",
      "r685",
      "r686",
      "r747",
      "r751",
      "r753",
      "r754",
      "r756",
      "r760",
      "r761",
      "r763",
      "r764",
      "r776",
      "r777",
      "r807",
      "r815",
      "r823",
      "r828",
      "r831",
      "r832",
      "r841",
      "r842",
      "r846",
      "r847",
      "r861",
      "r1048",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails",
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r188",
      "r289",
      "r290",
      "r291",
      "r292",
      "r345",
      "r376",
      "r377",
      "r378",
      "r396",
      "r482",
      "r576",
      "r653",
      "r655",
      "r663",
      "r685",
      "r686",
      "r747",
      "r751",
      "r753",
      "r754",
      "r756",
      "r760",
      "r761",
      "r763",
      "r764",
      "r776",
      "r777",
      "r807",
      "r815",
      "r823",
      "r828",
      "r831",
      "r832",
      "r841",
      "r842",
      "r846",
      "r861",
      "r1048",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r1049",
      "r1051"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "stpr_NJ": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2025",
     "localname": "NJ",
     "presentation": [
      "http://www.summitplc.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NEW JERSEY",
        "label": "NEW JERSEY"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows provided by financing activities:",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows used in investing activities:",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/OrganizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "negatedLabel": "Net cash used in operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r72",
      "r73"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows used in operating activities:",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.summitplc.com/role/NetLossperShareComputationofNetLossperShareDetails",
      "http://www.summitplc.com/role/OrganizationDetails",
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss",
        "negatedTerseLabel": "Net loss",
        "terseLabel": "Net loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r73",
      "r93",
      "r106",
      "r111",
      "r123",
      "r126",
      "r131",
      "r146",
      "r147",
      "r148",
      "r152",
      "r156",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r167",
      "r168",
      "r173",
      "r254",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r308",
      "r311",
      "r313",
      "r317",
      "r385",
      "r443",
      "r449",
      "r476",
      "r495",
      "r634",
      "r716",
      "r737",
      "r738",
      "r785",
      "r787",
      "r789",
      "r874",
      "r1046"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Issued Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "smmt_NewJerseyAndCaliforniaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "NewJerseyAndCaliforniaMember",
     "presentation": [
      "http://www.summitplc.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Jersey And California",
        "label": "New Jersey And California [Member]",
        "documentation": "New Jersey And California"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r902",
      "r913",
      "r923",
      "r947",
      "r956"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.summitplc.com/role/OtherIncomeNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.summitplc.com/role/OtherIncomeNetDetails",
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income, net",
        "totalLabel": "Other income, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_NonrelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonrelatedPartyMember",
     "presentation": [
      "http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonrelated Party",
        "label": "Nonrelated Party [Member]",
        "documentation": "Party not related to reporting entity."
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1018",
      "r1019"
     ]
    },
    "smmt_NotePurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "NotePurchaseAgreementMember",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Note Purchase Agreement",
        "label": "Note Purchase Agreement [Member]",
        "documentation": "Note Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Promissory note",
        "label": "Notes Payable",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r87",
      "r1134",
      "r1135"
     ]
    },
    "smmt_NotesPayableRelatedPartiesNewIssuances": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "NotesPayableRelatedPartiesNewIssuances",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New note issuances",
        "label": "Notes Payable, Related Parties, New Issuances",
        "documentation": "Notes Payable, Related Parties, New Issuances"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public offering proceeds threshold percentage",
        "label": "Notes Payable, Related Parties, Potential Prepayment, Maximum Amount, Percentage Of Net Proceeds From Public Offering",
        "documentation": "Notes Payable, Related Parties, Potential Prepayment, Maximum Amount, Percentage Of Net Proceeds From Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Period from public offering (in business days)",
        "label": "Notes Payable, Related Parties, Potential Prepayment, Period Post Receipt Of Cash Proceeds From Public Offering",
        "documentation": "Notes Payable, Related Parties, Potential Prepayment, Period Post Receipt Of Cash Proceeds From Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes payable, maturity triggering event, public offering proceeds threshold",
        "label": "Notes Payable, Related Parties, Potential Prepayment, Triggering Event, Public Offering Net Proceeds Threshold",
        "documentation": "Notes Payable, Related Parties, Potential Prepayment, Triggering Event, Public Offering Net Proceeds Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid interest, conversion amount (in dollars per share)",
        "label": "Notes Payable, Related Party, Prepaid Interest, Equity Interests Issuable Calculation, Denominator",
        "documentation": "Notes Payable, Related Party, Prepaid Interest, Equity Interests Issuable Calculation, Denominator"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid interest, conversion amount base (in dollars per share)",
        "label": "Notes Payable, Related Party, Prepaid Interest, Equity Interests Issuable Calculation, Denominator, Base Amount Added To Closing Bid Price",
        "documentation": "Notes Payable, Related Party, Prepaid Interest, Equity Interests Issuable Calculation, Denominator, Base Amount Added To Closing Bid Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.summitplc.com/role/SegmentReportingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r803",
      "r1027"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.summitplc.com/role/SegmentReportingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r798",
      "r806",
      "r1027"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r789"
     ]
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed lease costs",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r525",
      "r850"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets",
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities, current portion",
        "verboseLabel": "Less: Operating lease liabilities, current portion",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets",
      "http://www.summitplc.com/role/LeasesFutureLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities, net of current portion",
        "verboseLabel": "Operating lease liabilities, net of current portion",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash payments related to lease liabilities",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r528"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets",
      "http://www.summitplc.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.summitplc.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average discount rate",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r531",
      "r850"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.summitplc.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining lease term (in years)",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r530",
      "r850"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss carryforwards",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Line Items]",
        "label": "Operating Loss Carryforwards [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLossCarryforwardsTable",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Table]",
        "label": "Operating Loss Carryforwards [Table]",
        "documentation": "Disclosure of information about operating loss carryforward. Includes, but is not limited to, tax authority, amount and expiration date of operating loss carryforward, and likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/Organization"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r107",
      "r108",
      "r109",
      "r665",
      "r666"
     ]
    },
    "smmt_OriginalDistributionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "OriginalDistributionAgreementMember",
     "presentation": [
      "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Original Distribution Agreement",
        "label": "Original Distribution Agreement [Member]",
        "documentation": "Original Distribution Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "us-gaap_OtherCommitment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherCommitment",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual commitments",
        "label": "Other Commitment",
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions."
       }
      }
     },
     "auth_ref": [
      "r1013",
      "r1020",
      "r1132"
     ]
    },
    "smmt_OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid",
     "presentation": [
      "http://www.summitplc.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Period for which the majority of contractual commitments are to be paid (in years)",
        "label": "Other Commitment, Period for Which the Majority of Commitments are To Be Paid",
        "documentation": "Other Commitment, Period for Which the Majority of Commitments are To Be Paid"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustments",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r58",
      "r59",
      "r60",
      "r501",
      "r503",
      "r507"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain on short-term investments",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax",
        "documentation": "Amount, after tax and before adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r121"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Reclassification of cumulative currency translation gain to other income, net",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax",
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r60",
      "r122",
      "r506"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net other comprehensive (loss) gain",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r11",
      "r83",
      "r124",
      "r127",
      "r164"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss):",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Reclassification of unrealized loss on short-term investments to other income, net",
        "label": "Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI for Write-down of Securities, Net of Tax",
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized loss realized upon the write-down of available-for-sale securities."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r60",
      "r122"
     ]
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherIncomeAndExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current liabilities",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r851"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Disclosure of Non-Cash Investing and Financing Activities:",
        "label": "Other Noncash Investing and Financing Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeAndExpenseTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/OtherIncomeNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Income, Net",
        "label": "Other Nonoperating Income and Expense [Text Block]",
        "documentation": "The entire disclosure for the components of non-operating income or non-operating expense, including, but not limited to, amounts earned from dividends, interest on securities, gain (loss) on securities sold, equity earnings of unconsolidated affiliates, gain (loss) on sales of business, interest expense and other miscellaneous income or expense items."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r135"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/OtherIncomeNetDetails": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/OtherIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other expense, net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r834"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r900",
      "r911",
      "r921",
      "r954"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r903",
      "r914",
      "r924",
      "r957"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r903",
      "r914",
      "r924",
      "r957"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "smmt_PaymentsForCollaborativeArrangement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "PaymentsForCollaborativeArrangement",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails",
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments to Akeso for upfront milestone payments and associated direct transaction costs",
        "terseLabel": "Payments to Akeso for upfront milestone payments",
        "label": "Payments For Collaborative Arrangement",
        "documentation": "Payments For Collaborative Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails",
      "http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedNetLabel": "Transaction costs from the issuance of common stock for rights offering",
        "terseLabel": "Offering costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireShortTermInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of short-term investments",
        "label": "Payments to Acquire Short-Term Investments",
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r938"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r938"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r931"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r987"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r319"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r695"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r319"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r695",
      "r714",
      "r1174",
      "r1175"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, $0.01 par value, 20,000,000 shares authorized; none issued and outstanding at December 31, 2025 and 2024, respectively",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r310",
      "r315",
      "r626",
      "r851"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical",
      "http://www.summitplc.com/role/OrganizationDetails",
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails",
      "http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Private Placement",
        "terseLabel": "Private placement",
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/OrganizationDetails",
      "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails",
      "http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the issuance of common stock via private placements, net of offering costs",
        "label": "Proceeds from Issuance of Private Placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds received related to employee stock purchase plan and exercise of stock options",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r15"
     ]
    },
    "us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturities and sales of short-term investments",
        "label": "Proceeds from Sale, Maturity and Collection of Short-Term Investments",
        "documentation": "The cash inflow from sales, maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of property, plant and equipment",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromWarrantExercises",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of warrants",
        "label": "Proceeds from Warrant Exercises",
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants."
       }
      }
     },
     "auth_ref": [
      "r1007"
     ]
    },
    "us-gaap_ProductInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProductInformationLineItems",
     "presentation": [
      "http://www.summitplc.com/role/OrganizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product Information [Line Items]",
        "label": "Product Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "smmt_PromissoryNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "PromissoryNotesMember",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Promissory Notes",
        "label": "Promissory Notes [Member]",
        "documentation": "Promissory Notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r533",
      "r619",
      "r632",
      "r851"
     ]
    },
    "us-gaap_PurchaseObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PurchaseObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital commitments",
        "label": "Purchase Obligation",
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier."
       }
      }
     },
     "auth_ref": [
      "r1013",
      "r1020",
      "r1132"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails",
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r188",
      "r289",
      "r290",
      "r291",
      "r292",
      "r333",
      "r345",
      "r376",
      "r377",
      "r378",
      "r384",
      "r396",
      "r482",
      "r551",
      "r560",
      "r576",
      "r653",
      "r655",
      "r663",
      "r685",
      "r686",
      "r747",
      "r751",
      "r753",
      "r754",
      "r756",
      "r760",
      "r761",
      "r763",
      "r764",
      "r776",
      "r777",
      "r807",
      "r815",
      "r823",
      "r828",
      "r831",
      "r832",
      "r841",
      "r842",
      "r846",
      "r847",
      "r861",
      "r868",
      "r1044",
      "r1048",
      "r1102",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails",
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r188",
      "r289",
      "r290",
      "r291",
      "r292",
      "r333",
      "r345",
      "r376",
      "r377",
      "r378",
      "r384",
      "r396",
      "r482",
      "r551",
      "r560",
      "r576",
      "r653",
      "r655",
      "r663",
      "r685",
      "r686",
      "r747",
      "r751",
      "r753",
      "r754",
      "r756",
      "r760",
      "r761",
      "r763",
      "r764",
      "r776",
      "r777",
      "r807",
      "r815",
      "r823",
      "r828",
      "r831",
      "r832",
      "r841",
      "r842",
      "r846",
      "r847",
      "r861",
      "r868",
      "r1044",
      "r1048",
      "r1102",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131"
     ]
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationofUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized Tax Benefits [Roll Forward]",
        "label": "Unrecognized Tax Benefits [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r895",
      "r906",
      "r916",
      "r949"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails",
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails",
      "http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Domain]",
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r151",
      "r152",
      "r223",
      "r340",
      "r344",
      "r540",
      "r541",
      "r623",
      "r631",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r713",
      "r746",
      "r1169"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails",
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails",
      "http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related party",
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r151",
      "r152",
      "r540",
      "r541",
      "r542",
      "r543",
      "r623",
      "r631",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r713",
      "r746"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails",
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Axis]",
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r151",
      "r152",
      "r540",
      "r541",
      "r1123"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails",
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Domain]",
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r151",
      "r152",
      "r1123"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails",
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Line Items]",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r151",
      "r152",
      "r223",
      "r540",
      "r541",
      "r543",
      "r719",
      "r720",
      "r723"
     ]
    },
    "smmt_RelatedPartyTransactionPaymentsToRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "RelatedPartyTransactionPaymentsToRelatedParty",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to related party",
        "label": "Related Party Transaction, Payments To Related Party",
        "documentation": "Related Party Transaction, Payments To Related Party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionRate",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "label": "Related Party Transaction, Rate",
        "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties."
       }
      }
     },
     "auth_ref": [
      "r1119"
     ]
    },
    "smmt_RelatedPartyTransactionSubleaseExtensionTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "RelatedPartyTransactionSubleaseExtensionTerm",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sublease extension term (in months)",
        "label": "Related Party Transaction, Sublease Extension Term",
        "documentation": "Related Party Transaction, Sublease Extension Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails",
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails",
      "http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Axis]",
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r151",
      "r152",
      "r223",
      "r340",
      "r344",
      "r540",
      "r541",
      "r623",
      "r631",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r713",
      "r746",
      "r1123",
      "r1169"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedParties",
      "http://www.summitplc.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Promissory Note Payable to Related Parties",
        "terseLabel": "Related Party Transactions",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r537",
      "r538",
      "r539",
      "r541",
      "r544",
      "r675",
      "r676",
      "r677",
      "r721",
      "r722",
      "r723",
      "r743",
      "r745"
     ]
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfRelatedPartyDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Re-payment of related party promissory notes",
        "terseLabel": "Repayment of related party notes payable",
        "label": "Repayments of Related Party Debt",
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "smmt_ReportableSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "ReportableSegmentMember",
     "presentation": [
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable Segment",
        "label": "Reportable Segment [Member]",
        "documentation": "Reportable Segment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails",
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "verboseLabel": "Oncology clinical trial related costs",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "documentation": "Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r1081"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Costs",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r397"
     ]
    },
    "smmt_ResearchAndDevelopmentPrepaidExpensesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "ResearchAndDevelopmentPrepaidExpensesCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/ResearchandDevelopmentPrepaidExpensesandAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Research And Development Prepaid Expenses, Current",
        "documentation": "Research And Development Prepaid Expenses, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/ResearchandDevelopmentPrepaidExpensesandAccruedLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Prepaid Expenses and Accrued Liabilities",
        "label": "Research, Development, and Computer Software Disclosure [Text Block]",
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period."
       }
      }
     },
     "auth_ref": [
      "r398",
      "r778"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r896",
      "r907",
      "r917",
      "r950"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r897",
      "r908",
      "r918",
      "r951"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r904",
      "r915",
      "r925",
      "r958"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Domain]",
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTotalCashCashEquivalentsandRestrictedCashBalancesDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets",
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails",
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTotalCashCashEquivalentsandRestrictedCashBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash, Current",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r1000",
      "r1010"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets",
      "http://www.summitplc.com/role/OrganizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "negatedTerseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r78",
      "r629",
      "r660",
      "r662",
      "r673",
      "r696",
      "r851"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r106",
      "r153",
      "r154",
      "r155",
      "r157",
      "r164",
      "r166",
      "r168",
      "r255",
      "r256",
      "r280",
      "r307",
      "r385",
      "r432",
      "r433",
      "r440",
      "r441",
      "r442",
      "r444",
      "r448",
      "r449",
      "r462",
      "r464",
      "r465",
      "r467",
      "r474",
      "r516",
      "r518",
      "r657",
      "r659",
      "r678",
      "r1174"
     ]
    },
    "smmt_RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revised Duggan February Note And Revised Duggan September Note",
        "label": "Revised Duggan February Note And Revised Duggan September Note [Member]",
        "documentation": "Revised Duggan February Note And Revised Duggan September Note"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_RevisedDugganFebruaryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "RevisedDugganFebruaryNoteMember",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revised Duggan February Note",
        "label": "Revised Duggan February Note [Member]",
        "documentation": "Revised Duggan February Note"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_RevisedDugganSeptemberNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "RevisedDugganSeptemberNoteMember",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revised Duggan September Note",
        "label": "Revised Duggan September Note [Member]",
        "documentation": "Revised Duggan September Note"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Leased assets obtained in exchange for operating lease liabilities",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r529",
      "r850"
     ]
    },
    "smmt_RightsOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "RightsOfferingMember",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical",
      "http://www.summitplc.com/role/NetLossperShareNarrativeDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rights Offering",
        "label": "Rights Offering [Member]",
        "documentation": "Rights Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "smmt_S3RegistrationStatementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "S3RegistrationStatementMember",
     "presentation": [
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "S-3 Registration Statement",
        "label": "S-3 Registration Statement [Member]",
        "documentation": "S-3 Registration Statement"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_SaleOfStockAggregateOfferingPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "SaleOfStockAggregateOfferingPrice",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, aggregate offering price",
        "label": "Sale of Stock, Aggregate Offering Price",
        "documentation": "Sale of Stock, Aggregate Offering Price"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_SaleOfStockAmountRemainingUnderTheOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "SaleOfStockAmountRemainingUnderTheOffering",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining availability under the offering",
        "label": "Sale Of Stock, Amount Remaining Under The Offering",
        "documentation": "Sale Of Stock, Amount Remaining Under The Offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock aggregate price",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical",
      "http://www.summitplc.com/role/NetLossperShareNarrativeDetails",
      "http://www.summitplc.com/role/OrganizationDetails",
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails",
      "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails",
      "http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails",
      "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails",
      "http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "smmt_SaleOfStockNumberOfSharesRegisteredForResale": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "SaleOfStockNumberOfSharesRegisteredForResale",
     "presentation": [
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares registered for resale (in shares)",
        "label": "Sale Of Stock, Number Of Shares Registered For Resale",
        "documentation": "Sale Of Stock, Number Of Shares Registered For Resale"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.summitplc.com/role/NetLossperShareNarrativeDetails",
      "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails",
      "http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock price (in dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.summitplc.com/role/NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/NetLossperShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of potentially dilutive securities excluded from the computation of loss per share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of cash and cash equivalents",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of the components of cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r452"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of major components of deferred tax assets and liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/NetLossperShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of net loss per share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1025"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of reconciliation of the effective income tax rate to the statutory rate",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r827",
      "r1082"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of components of loss before income taxes",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1016"
     ]
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/OtherIncomeNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of other income, net",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfProductInformationTable",
     "presentation": [
      "http://www.summitplc.com/role/OrganizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Operation, Product Information, Concentration of Risk [Table]",
        "label": "Nature of Operation, Product Information, Concentration of Risk [Table]",
        "documentation": "Disclosure of information about concentration risk of product within nature of operation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails",
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Table]",
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r151",
      "r152",
      "r540",
      "r541",
      "r543",
      "r719",
      "r720",
      "r723"
     ]
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of restricted cash balances",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r84",
      "r1136"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r33"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/SegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of significant expenses of the CODM function",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r33"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails",
      "http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r349",
      "r351",
      "r352",
      "r353",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r384"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of stock option activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r14",
      "r79"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of weighted-average assumptions",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable",
     "presentation": [
      "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails",
      "http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock [Table]",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock [Table]",
        "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of reconciliation of unrecognized tax benefits",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r417",
      "r826"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r95",
      "r96",
      "r97",
      "r182",
      "r190",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r215",
      "r216",
      "r217",
      "r222",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r279",
      "r285",
      "r286",
      "r445",
      "r446",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r799",
      "r802",
      "r803",
      "r809",
      "r863",
      "r1137",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.summitplc.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r220",
      "r221",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r615",
      "r616",
      "r617",
      "r618",
      "r682",
      "r683",
      "r684",
      "r748",
      "r752",
      "r755",
      "r757",
      "r760",
      "r762",
      "r763",
      "r764",
      "r766",
      "r767",
      "r768",
      "r769",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r781",
      "r794",
      "r816",
      "r817",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r862",
      "r868",
      "r1137",
      "r1139",
      "r1140",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r182",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r205",
      "r207",
      "r208",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r222",
      "r798",
      "r800",
      "r801",
      "r802",
      "r804",
      "r805",
      "r806"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other expenses",
        "label": "Segment Reporting, Other Segment Item, Amount",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r207",
      "r208",
      "r215",
      "r802"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accelerated charges",
        "label": "Share-Based Payment Arrangement, Accelerated Cost",
        "documentation": "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost."
       }
      }
     },
     "auth_ref": [
      "r1078"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity award, vesting period (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consecutive offering period (in months)",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Consecutive Offering Period",
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Consecutive Offering Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected annual dividends per share",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk- free interest rate, maximum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk- free interest rate, minimum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails",
      "http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r349",
      "r351",
      "r352",
      "r353",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r384"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum common stock purchase allowable as a percentage of compensation",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate",
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of additional shares allowable (in shares)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Allowable Under The Plan",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Allowable Under The Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares available for grant (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock option activity, additional disclosures",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of share options, exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r357"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, exercisable (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r357"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value of stock options exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r361"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average grant date fair value of stock options granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares unvested and converted (in shares)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding And Converted, Number",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding And Converted, Number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value, options outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r356"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of share options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in dollars per share)",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r356"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value, vested and expected to vest",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of share options, vested and expected to vest (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, vested and expected to vest (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum percentage of outstanding shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum",
        "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock."
       }
      }
     },
     "auth_ref": [
      "r1080"
     ]
    },
    "smmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potential number of additional shares that can be added to the plan for future issuance (in shares)",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Potential Number of Additional Shares Allowable Under The Plan",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Potential Number of Additional Shares Allowable Under The Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issued (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails",
      "http://www.summitplc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails",
      "http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r352",
      "r353",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r361"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r346",
      "r354",
      "r373",
      "r374",
      "r375",
      "r376",
      "r379",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394"
     ]
    },
    "smmt_ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost not yet recognized due to accelerated vesting, amount",
        "label": "Share-Based Payment Arrangement, Cost Not Yet Recogned Due To Accelerated Vesting, Amount",
        "documentation": "Share-Based Payment Arrangement, Cost Not Yet Recogned Due To Accelerated Vesting, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average recognition period (in years)",
        "label": "Share-Based Payment Arrangement, Weighted Average Recognition Period",
        "documentation": "Share-Based Payment Arrangement, Weighted Average Recognition Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharePrice",
     "presentation": [
      "http://www.summitplc.com/role/NetLossperShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share price (in dollars per share)",
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accelerated vesting, number (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number",
        "documentation": "Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1080"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration period (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationWeightedAverageAssumptionsusedforStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value, exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual term, exercisable (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual term, options outstanding (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual term, vested and expected to vest (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase price of common stock as a percentage of closing price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value."
       }
      }
     },
     "auth_ref": [
      "r1080"
     ]
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets",
      "http://www.summitplc.com/role/OrganizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term investments",
        "label": "Short-Term Investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91",
      "r1001"
     ]
    },
    "smmt_SignificantAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "SignificantAccountingPoliciesLineItems",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Accounting Policies [Line Items]",
        "label": "Significant Accounting Policies [Line Items]",
        "documentation": "Significant Accounting Policies"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_SignificantAccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "SignificantAccountingPoliciesTable",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Accounting Policies [Table]",
        "label": "Significant Accounting Policies [Table]",
        "documentation": "Significant Accounting Policies"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies and Recent Accounting Pronouncements",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r145"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. State",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r405"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.summitplc.com/role/SegmentReportingSignificantExpenseoftheCODMFunctionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r95",
      "r96",
      "r97",
      "r110",
      "r182",
      "r190",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r215",
      "r216",
      "r217",
      "r222",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r279",
      "r282",
      "r285",
      "r286",
      "r445",
      "r446",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r799",
      "r802",
      "r803",
      "r809",
      "r863",
      "r1137",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r52",
      "r55",
      "r56",
      "r104",
      "r105",
      "r106",
      "r129",
      "r130",
      "r131",
      "r153",
      "r154",
      "r155",
      "r157",
      "r164",
      "r166",
      "r168",
      "r183",
      "r255",
      "r256",
      "r280",
      "r307",
      "r332",
      "r385",
      "r432",
      "r433",
      "r440",
      "r441",
      "r442",
      "r444",
      "r448",
      "r449",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r474",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r516",
      "r518",
      "r536",
      "r635",
      "r657",
      "r658",
      "r659",
      "r678",
      "r739"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.summitplc.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r220",
      "r221",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r615",
      "r616",
      "r617",
      "r618",
      "r682",
      "r683",
      "r684",
      "r748",
      "r752",
      "r755",
      "r757",
      "r760",
      "r762",
      "r763",
      "r764",
      "r766",
      "r767",
      "r768",
      "r769",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r781",
      "r794",
      "r816",
      "r817",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r862",
      "r868",
      "r1137",
      "r1139",
      "r1140",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r183",
      "r309",
      "r310",
      "r312",
      "r314",
      "r518",
      "r577",
      "r667",
      "r679",
      "r681",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r695",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r704",
      "r705",
      "r706",
      "r707",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r717",
      "r718",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r739",
      "r787",
      "r789",
      "r869",
      "r1169"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r183",
      "r223",
      "r309",
      "r310",
      "r312",
      "r314",
      "r518",
      "r577",
      "r667",
      "r679",
      "r681",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r695",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r704",
      "r705",
      "r706",
      "r707",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r717",
      "r718",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r739",
      "r787",
      "r789",
      "r869",
      "r1169"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r899",
      "r910",
      "r920",
      "r953"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077"
     ]
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock",
        "label": "Stock Issued",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27",
      "r28"
     ]
    },
    "smmt_StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock in lieu of cash for Akeso upfront payment (in shares)",
        "label": "Stock Issued During Period, Shares, Issued For Related Party Interest",
        "documentation": "Stock Issued During Period, Shares, Issued For Related Party Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rights Offering of common stock, net of offering costs / Private placement of common stock, net of offering costs / Proceeds from at-the-market offering, net of commissions and offering costs (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r51",
      "r52",
      "r78",
      "r672",
      "r739",
      "r758"
     ]
    },
    "smmt_StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued for prepaid interest (in shares)",
        "label": "Stock Issued During Period, Shares, Related Party Prepaid Interest",
        "documentation": "Stock Issued During Period, Shares, Related Party Prepaid Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock under employee stock purchase plans and exercise of stock options and warrants (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r51",
      "r52",
      "r78"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.summitplc.com/role/StockBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedNetLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r51",
      "r52",
      "r78",
      "r360"
     ]
    },
    "smmt_StockIssuedDuringPeriodSharesWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "StockIssuedDuringPeriodSharesWarrantsExercised",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of warrants (in shares)",
        "label": "Stock Issued During Period, Shares, Warrants Exercised",
        "documentation": "Stock Issued During Period, Shares, Warrants Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock in lieu of cash for Akeso upfront payment",
        "label": "Stock Issued During Period, Value, In Lieu Of Cash For Collaborative Arrangement",
        "documentation": "Stock Issued During Period, Value, In Lieu Of Cash For Collaborative Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock in lieu of cash for Akeso upfront payment",
        "label": "Stock Issued During Period, Value, Issued For Related Party Interest",
        "documentation": "Stock Issued During Period, Value, Issued For Related Party Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rights Offering of common stock, net of offering costs / Private placement of common stock, net of offering costs / Proceeds from at-the-market offering, net of commissions and offering costs",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r51",
      "r52",
      "r78",
      "r678",
      "r739",
      "r758",
      "r875"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock under stock purchase plans and exercise of stock options and warrants",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r51",
      "r52",
      "r78"
     ]
    },
    "smmt_StockIssuedDuringPeriodValueWarrantsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "StockIssuedDuringPeriodValueWarrantsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of warrants",
        "label": "Stock Issued During Period, Value, Warrants Exercised",
        "documentation": "Stock Issued During Period, Value, Warrants Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets",
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders' equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r55",
      "r56",
      "r74",
      "r697",
      "r714",
      "r740",
      "r741",
      "r851",
      "r876",
      "r1012",
      "r1014",
      "r1015",
      "r1037",
      "r1109",
      "r1174"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 equity:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' Equity",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r318",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r331",
      "r332",
      "r461",
      "r473",
      "r742",
      "r744",
      "r759"
     ]
    },
    "smmt_SubleaseAgreementFirstAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "SubleaseAgreementFirstAmendmentMember",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First amendment to sublease",
        "label": "Sublease Agreement, First Amendment [Member]",
        "documentation": "Sublease Agreement, First Amendment"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_SubleaseAgreementFirstAndThirdAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "SubleaseAgreementFirstAndThirdAmendmentMember",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sublease Agreement, First and Third Amendment",
        "label": "Sublease Agreement, First and Third Amendment [Member]",
        "documentation": "Sublease Agreement, First and Third Amendment"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_SubleaseAgreementSecondAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "SubleaseAgreementSecondAmendmentMember",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Second amendment to sublease",
        "label": "Sublease Agreement, Second Amendment [Member]",
        "documentation": "Sublease Agreement, Second Amendment"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_SubleaseAgreementThirdAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "SubleaseAgreementThirdAmendmentMember",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sublease Agreement, Third Amendment",
        "label": "Sublease Agreement, Third Amendment [Member]",
        "documentation": "Sublease Agreement, Third Amendment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubleaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubleaseIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sublease income",
        "label": "Sublease Income",
        "documentation": "Amount of sublease income excluding finance and operating lease expense."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r850"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiaryOrEquityMethodInvesteeLineItems",
     "presentation": [
      "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails",
      "http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary or Equity Method Investee [Line Items]",
        "label": "Subsidiary or Equity Method Investee [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://www.summitplc.com/role/NetLossperShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]",
        "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.summitplc.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical",
      "http://www.summitplc.com/role/NetLossperShareNarrativeDetails",
      "http://www.summitplc.com/role/OrganizationDetails",
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails",
      "http://www.summitplc.com/role/StockholdersEquityAttheMarketOfferingandWarrantsDetails",
      "http://www.summitplc.com/role/StockholdersEquityPreferredStockandCommonStockDetails",
      "http://www.summitplc.com/role/StockholdersEquityPrivateInvestmentinPublicEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://www.summitplc.com/role/NetLossperShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of change in valuation allowance",
        "label": "Summary of Valuation Allowance [Table Text Block]",
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance."
       }
      }
     },
     "auth_ref": [
      "r1086"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Disclosure of Cash Flow Information:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r946"
     ]
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TangibleAssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of fixed assets",
        "label": "Tangible Asset Impairment Charges",
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r75"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credit carryforward",
        "label": "Tax Credit Carryforward, Amount",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r938"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r945"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r968"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.summitplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r304",
      "r330",
      "r461",
      "r472",
      "r489",
      "r494",
      "r497",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r621",
      "r636",
      "r837",
      "r839",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r852",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1098",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1107",
      "r1108"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r968"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r968"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.summitplc.com/role/AkesoLicenseandCollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r452"
     ]
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://www.summitplc.com/role/FairValueMeasurementsandShortTermInvestmentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. Government treasury bills",
        "label": "US Treasury Securities [Member]",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r791",
      "r792",
      "r818",
      "r820",
      "r822",
      "r837",
      "r1133"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r965"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails",
      "http://www.summitplc.com/role/IncomeTaxReconciliationofUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits",
        "periodStartLabel": "Unrecognized tax benefits, beginning of year",
        "periodEndLabel": "Unrecognized tax benefits, end of year",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r417",
      "r826"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability for interest and penalties",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r826"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationofUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increases related to current year tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r826"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxReconciliationofUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increases related to prior year tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r826"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.summitplc.com/role/SummaryofSignificantAccountingPoliciesandRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r101",
      "r184",
      "r186",
      "r187",
      "r188",
      "r615",
      "r617",
      "r795"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.summitplc.com/role/IncomeTaxValuationAllowanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net increases recorded to income tax provision",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.summitplc.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.summitplc.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease costs",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r850"
     ]
    },
    "smmt_VariableRatePeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "VariableRatePeriodAxis",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate Period [Axis]",
        "label": "Variable Rate Period [Axis]",
        "documentation": "Variable Rate Period"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_VariableRatePeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "VariableRatePeriodDomain",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate Period [Domain]",
        "label": "Variable Rate Period [Domain]",
        "documentation": "Variable Rate Period [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_VariableRatePeriodOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "VariableRatePeriodOneMember",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable rate, three months immediately following February 15, 2023",
        "label": "Variable Rate, Period One [Member]",
        "documentation": "Variable Rate, Period One"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_VariableRatePeriodTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "VariableRatePeriodTwoMember",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable rate, thereafter",
        "label": "Variable Rate, Period Two [Member]",
        "documentation": "Variable Rate, Period Two"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.summitplc.com/role/NetLossperShareSecuritiesExcludedfromtheComputationofLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r866",
      "r867",
      "r870",
      "r871",
      "r872",
      "r873"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.summitplc.com/role/NetLossperShareComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "verboseLabel": "Diluted weighted average number of shares of common stock outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r176"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.summitplc.com/role/NetLossperShareComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic (in shares)",
        "terseLabel": "Basic weighted average number of shares of common stock outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r176"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "presentation": [
      "http://www.summitplc.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average common shares outstanding:",
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "smmt_WilsonSonsiniGoodrichRosatiP.C.WSGRMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "WilsonSonsiniGoodrichRosatiP.C.WSGRMember",
     "presentation": [
      "http://www.summitplc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Wilson Sonsini Goodrich &amp; Rosati P.C. (\u201cWSGR\u201d)",
        "label": "Wilson Sonsini Goodrich &amp; Rosati P.C. (\u201cWSGR\u201d) [Member]",
        "documentation": "Wilson Sonsini Goodrich &amp; Rosati P.C. (\u201cWSGR\u201d)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "smmt_ZanganehNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.summitplc.com/20251231",
     "localname": "ZanganehNoteMember",
     "presentation": [
      "http://www.summitplc.com/role/PromissoryNotePayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zanganeh Note",
        "label": "Zanganeh Note [Member]",
        "documentation": "Zanganeh Note"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-15"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-16"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478353/942-405-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/808/tableOfContent"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481034/205-10-S45-5"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-3"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-17A"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-5"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-3"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-4"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-5"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/825/tableOfContent"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-17"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-9"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-3"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481724/830-30-40-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-12"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-12"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-6"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-12"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-19"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "39",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-39"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478064/805-740-55-13"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-4"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-3"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>118
<FILENAME>0001599298-26-000015-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001599298-26-000015-xbrl.zip
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M >H(Z1(DB32W*ADA'5IM!M [^#-HO;!-2L 4G\%96ZM)J-[=S5X1SNR%2<@
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M1J:A?168,GLPF"2?,'H7XGT@5'DSN9,04ZMT1%,4A,PXQQY)#5QE;1>)^P6
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MD\A>+(5Q2<4E47J:B[*E\R8A!B?'5&TS@6;) #O)S,<HPXP$/I"?6O6Q!)0
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MWLTA<;O&D'$RP$C_X5U[CT:,7U@:&J2X-DWK#7-@1 8OP5NZ&EH[+V=C&'7
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M%; N/P @??<8RE,6%\-VT-MZC =LU!=NL39KQCQBZ'M;-'THG)8NT_Q]5=^
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M?,4'/^[853@AGXWQ2=P]Z@%;=) UGGILN&,)$OYQ!\C^:.#><Z<Z8!X>D@N
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M:8G0WD2'2DEP8SVVV9KP9!,].VL*5JX)0N5UL6Q9+0%HX]T;[XG?E=>E4:Y
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M%:<6XZ)F-*TC-1EW$//+!'0=MGRGQ>>^/OH\-7\Q:V!'+A^<W(.2A_[LB\'
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MY15W45U.A)\!7Y2NH-J:,H3>O;Q[&'%;.Y]4[M*34/=5FDZ]S &N%UI^\&A
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M4+Y%>-%^ "^NL6&X8_7P>'-H@:< 6KU"BUB6-U =$PH(G&NL/>FS>T+,]:)
MS36TOF+F KXH!/9K)D!]X_>N'8C21AJD8A18',.3,#@N;Z.+KH,$EZ@>A&__
MYCH.$,@)CE7!2WH#_*V8N1NS4Y#SYJ5?MBNC">O4KZ0G"@)AN*(-BARRH<Y9
MCT,O48SR05XM!!OMGXKRLWB.0=QH3!#"4A,OH1G6&%?7:LKY]?'78\T8!.7
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MN/]WZ_CL"#ZU&V3_-!H?X4.G\]&:_,.+/]9KB&8-83NR4!A1\O ?/*"/Y'\
MU(7M@$$169W: 7*[>*0:,B+_TI0GJD_S*N+$PRY YK&;2VG7VK-/3!]DWE?3
MR\!BI"@2H3R)4:C>R8ZXL65+ZR!D#DW/HU=2KA5/)^:='5_-I_5RT?/O!J8
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MK')GJ-=1^C1S6=*.P9H0VIR1,$9!:,&%1(%9%D34(D[X;M"&HQ X7"O"=CD
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M_7IW<K\C^AI4&\CR2\KU*"5&ME]RT<%*5!'G(I*13#-!!Z%!.)C[ NJU6>.
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MHSS%$TI;701AU8JT:BLQ4K9L5$F?$:>:$V1:G%HMXZG+,GG%P](NXBKAAIY
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M.BKB)WB ']S*4E2C6@^KJ2+2%D7^8TS=!^ST!(6CY#N?IE^"^!C *ZFAWV#
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M5V1X<"P>\(7C998J)1')FFSU4&PE9J(V%2,3PX.S&F-Q-!?<])97!%$/^)W
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ML*;..:]= RF6<V_7.56*;"?N:2=Z?9G^> HD00D)"6@ 4 K[U[][/>NRU]X
M*3M)=^@9U53U."()[.NZ/NM9B.["J[7*6SV=[##TLVWP">A8[6(I73K[87=3
M2>,1N%_]HN4_6!DX17\V-R4@) +1"1('G!&+=5EO"&.0E9 '&[0"KV<?'TT
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M[QP.&?E\)",&=VF>S:X5TQ\&-E"H@G(-P84$V=U0W?3Y%=MC]B=&=,$U2]T
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M(W$2K)@%)YPT1%]5@A*1)&$SDS+"-T3=^U*8KM3'H3_VLS>QH_1D!%.J#X]
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M(*4DB\7)$<YMU6"_0F"3G"TY8#)Z@>[ *5M6Q#BP!1NC\L>0R@C;R@7!&R[
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M=UL%J0H#T I!*/3-18;)S/B!45=*R6W!#7.Y^2]GBZW@*JE;=]UJZ)81%YX
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MKCXI979FW=EU,9;$1/^WM5K^%.VU91!A%=453J*4#B24_WRNK)F[IE"T]\I
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MDE6@D\$UGR /"]?2<3_E81X-SB@X/S>RDT")C#8[[X6="="TC&*4'#PT @W
M/"1&) <:5"WC)D/)_&>CPX$;?%>CAYVCGW[ G1#NY.L'W,GDPEC0.I<6>@&#
M5# *%MSP'K7?VI:*H>B"-2MF3=EU[5V2>^<(EK\&C/>\HD+]</6;MCEQ@KS
M'\)KB!9%ZF$<Y[+3)5HGG'+J,(FE._]I,&E"P&CV+H9'Z*U:XA"U4=84XV8[
M]_UI^1E*3_ASNT6#56H;N5A/F2:?0ACS["EC7TIK!HGV.NOJBH4\L':FKLH#
MTLHP,DSC[),0:4NZPD)\O+Z21M8>7;Z3L62M?]Z24$?-4GBO4.YXW4C_>/[3
M7PNU)W\BI+>E?E]QAB-\]CUK,OW@.<#:6HCX RM!>N$/U!9]]K;JB,NKA^Y%
M"0GQF7$VA#&=,$E3:K]2.<GT1LT[+B<'">1UN5[IV[F*1N=2'D7_>AR'_]K6
MLZ'<_!,'=/#U. Y(4BDX]*4TIWL9+))J=L%F')4M46"TB[49J0R*]2K[;%64
MW[LSK)W$8LD8"CA2--T*@Q!;$@5FY2YNHMO4S*C2=M244BNM:0=5PNE-B7<0
MA08=Y<K@ ZCWH_ Q^A$N9LK+Y?*&P<8IT[ Z.U7(8ZE7A>#3S%HY2_R".:L,
MZ:36D2;L&O"G"BHJCEA$1)_B5/K49<FGCSEP@#W:B*DO*&6VAP8?EZ>\"O*\
M'S3K'F'*5,"M 9KYKI!1:S93Q1WJB&^8KY%U55((&ML#ROC]<S 56#Z8B71;
MJM#0>-&AG:!HP;Y:2#K7%KV0KL<,VICX M=;=C<MJHJI(N>*>QS%;R@/.6V+
M*.LJ=9^T&HL*E)"'17)HL>VX?>=XU5P*J@V"VCJ*=K))['PFUN^GJ03'V ,X
M*QER(''%)<.)"C%&Y;!3GA8 TV/&'3U?6P2?9%ALW?GZ/.72(5%D">L4LI7J
M).@R>O);"D3N*,U>D_H*>TNGQ+_E^=N+M^XU?%X2;RJ%'#0@HED89B&/1@#*
M15=/.AUI&U3B 9 3193.U#EEN\FX<!QL.$]?46V2<A/#1V70)*U1<7!=-!\Z
M$#WO7>\ N[]A.W5VD<P8RR>GOT\3L;'SA] 4*?HS;,5X35MMDK:3\,N& LOX
M7=6M*B$$X8A-3?*I%EX..VE9=N8((F,?"=R,U^#%KT%+]13;X=7XK@X:(+R^
M[,88SN,2&G0HOY,2YY[Z#@19>1'$9C5$TJE73=/>9BU[GWP[6Z"T$S0AY7S>
M 4HR54]*-T6KJ+VDZ:\I:,)=!>>V8-*U(UC%)Y)06#+7/AAUQL\Y=8L-%BV5
M"$)^$1L6C7Y*+[X.:P$.8'LY7VI]H7ZU:0=RTJQ98! (,!16\L7>4_^"3@3!
MOBKV']/ "@\'@![BN)YNK.X?/*^&NTI(U"8FH3=[/&:TE>PV?>3A+ AVJX<4
MN7)"'@BSFNR'4 ZCGG;PK;2)_/G7X,8,N_@7;@><%:M;Z2W5<KF=52YXZS["
MM;D=*W-0K<(1YEZXA[;\E?\9"ZETP\O)[0[2:'S8IM?.[Y5G8.#.E=(4"C%$
M^DAZLQ)OFJV%0MM%O4UN#QF>5Q2I-?)5<.HFG9C5G81AMJ$JEYLU=\/MY:X0
MCO>V7FZY25@VYOW'0[=#:./8FNK##A"WO8!FB#+;.',<'"89%&T:1:2%XA8%
M0@[E@405_X,4Y$8[[5DUL\;S&,7%DC2!/A\Z#/9V#F\H!YZ0Y6(VVOL50.FH
M6HO1Z7.(1BR-TB<A4?$A@SD"'7:8U?/P4D;PU^SL*3J3\YZ!<M^I.-/<VI.9
M&X"SO)8:?W\&A4XE$B)-MTCT%U/'&<MB]X\[;=40G[N@EN>SR?Y0[DU*,S4^
M!WFIRH&5XYX*JW;;R;)%S!EW\=V[1J-[>:H->5^F/]"&O+%JG?1%+U7"-1R>
MI644$-1#%SD3!(-4A-Z!K$Y4:SV13CF=/=\S9DM?:"<Z/\%D:H]8,Q#B*U*'
M^3,D0+^DB?WC:;DM/&'Q^;5B;"-NP>SQB=^WG7U]SIBPM%F]VNF@O52BE"X-
M!\MN33S]$0J?:&C4?X2HZ"I"[.%8\<FJR*-W6#;&_G)WO\<R-#Y],^G[Q9K#
M*+)CH48Q"]J9E]N'&9G8FR6O=";!'RA\30%A\L_7-<?!=T%J^S\0!G@!;$%X
M%IC"BKAB3*>SL*8][,]TV\7@CO#$HF >+MFE$$2;J#' FTG2=FJ1'+</_K'5
M76"O"W:U=Q*.7$W$,6<W5AD!-91HE,4(#94#,YVI5^1_[-CTVZD#DZ8@IZ12
M4!\2S:<>2U:BZ[@VAI2% U;4Y$RT<8$AG6^4;T6E2#D,Y>+:&/X:7WV<=CR/
MTPT/&01>+S>%K&^%VMM2.;!NHE,I<T_%$2.:!UH0FU3L\4'22GR,35OC)J5,
M$FY/X(IW-]?8/WNGT+Z$^9Q@/LEXQ 12>Z#6HB/NMRQ2DJM$>K?,L!48J=QQ
M\#5\=2G,,W<=Y=ZY=" (Q6A':.]WV'#T"(Z6X&'+%C($_=R8G/\N,2[8@330
M@R$+;$BN32S[+<MGLR TKRFU+JHE<V"(AX;"DEQ$G,QDBJ=!IE.(=&0@]%W5
M&0$>H"0&F;_I0&=)<CD)^DBG938*\,2*RQG".I4;UY J>X46/*.9#-5+N+(6
MY7%B6RA%KH1Q--1B1:E#'I+PE(3_YB$)/[DPGK@R"KI42@1'"TSU32K:4MYZ
M5Z+E3GRDZ<.)1]03_5W"5;E%.Q_]O$W*L]BX['/KDIO))WXP<5(KF^W<4]/]
M]S(W6."_(\WS)HB0MHOU7R]4=1^Y^?'.J\[9^].WIS/18Y(^O 5,2:B$IPU^
M!3F(=1MQ9:[LG,  E7(>&!6^]C@@I1+N9"V^B0V!!A:-(%#\).5ZOH)*[ H)
M)8TI*1UP<5P7U<'284W(%+[F5T\.I1Y5C[M?T:7RH#_.MN5LQ\E84-U])]1L
M]E)TX)D!Q5!P R*^3\CZTEM&SGYL4+]"GH[#/)3G)5ZDE#21YOI#.2RN3_Y>
M_DH0!@HX,VB/^RQ/39PJK&Z@JDG_L__M6MI7O][4<@O@JE(^Q_A-\,#3F5R;
M^,P%U9?*'S2 IOT<X]F4\<C+RC"&@<$99U_(.,S$42_9Y)&A+*&@*="FQEKL
M!$DK52ZN)_9%G.K,2O/V.=L+>#A34$G&OQ/,DH0UDG)B:Y(I@I(:7G&4Y":2
MI]+!=/T\F]F++66=.;LM1YQ=78*:4N^UG\.1Z)>*4,3VV[*.%C.YXTTZOOQ&
M_8:;!'%R&<WB=UVYA!!0S(TF&M^_O7SWDR8:9=E[QW8@B.A1;(FP!-/'E.O8
M5"*C\V)#CK%KO2B:\0CBB!^I=WZ"=W&").[SK+WQI^/XOC?$#L^'D]+G%&),
MVP:),X4[,^IKC+^ZI)>+^$<F4NVBV='IG&X,?+[_0W915BB0)=AQ(Z$C;>\I
MW2E7U9UVR'GZY$D1ULTE"_:XV1+[47Q,$@6C5$#3QB8,F@O).A(MN .!JA>M
M"Y"^[HE5YN7(>"PJIB>7 ('>.7>COT4B L*V+]=5GT6@:2V3B2A'!GFA!*+:
MLYUPRF5)TVK@G&"%:14I6"=Y"\EAYM\[U9,U>A<*VN?>]Q.L?HK>2O@T]S_-
M8F]AO6XK5L^Q]U3-Y4.^T9UK*E!X8(/3.4D_!"E,IN\B7QB11&[795WSO$IB
M5ZG*"(<Y.*YPOQOR_H X5\SJ4/Y*^>9E+7$=COK4OLN$HV^\*RFTB4H<[;+J
MI71U_&4XKT:88;IZ^XYIC&LC4+&H:M5.',!/[%,#KNR5+?'ZU_Q>#LOXMO;^
M#@=1A%BVF'9^D.-@4\VM1&^KYH0,))<<F(X;)M:DRN D:Q0.MC3L=+T<F:X!
MEGT>+ N/HX,DE&5)!"UV\Z;O^ZA[&!+EDL))TC8_B[I;;#>$!UB@,2@MT>1G
MTH6=\R5)#B*'>U-H2W!*=JK[+5:((^2Y3\O=2J?7&SA& )SHDH=+?VJXCK:C
MBAFM+F%1B#.3,N +!&$8+UR?KUSM9'6V=DA\S/42ID<07QU\=[RKO=M2N@'%
MIQ_!/=YK*'T]>;-=>=M/VZ&O)8F6Z+T_?U+W 0V9$3=>,D'0LB:4:8D*SBJU
M(N(6"@^NMN>R:*A43SGD;\MNE\7,$\N>Z,0')E+<-D.GY$6IOQ'ATL+T4DPS
MKX?_L+X0TQ6'(W(L1X8B',DB+PRV6GA0,YLF4Z1.&<KX[]+6.)Q[;KHE5Z@?
MBW)'0<*F%R\NMRC1H+E<0&0%D)VDIMJN&=DN_K;39"P\-[?PKF) +9.:(3%,
MC;\8-Q-J,Q+(1&LH,W+<NO#U9.?88<LM#D_TBL9+$2%UZ!3 .P58!G1;LS2>
MR7K6\7VZC[-ZCL0!ES$B\.%9N'*)9R[QH2%NZ(Z)F&-;%@U(*G3D4CM>,L2C
M5_F#846TK=MFC*'1]=[EJQTM1DFR=]./*)N64R=SU* J(PU*T]?0=#*B[-Y^
MZ#"@WZLKK/5Z)W4 N4&J1T&7]1CLN=^N!VB7':3:2Q)UBSC$$H8<I&GXZZ-_
M>F7+]* E-/(G%/I,C^?%Z?O3/W,ISHYG*1[_=\IB7*@B>8=\K)+C'O44[TUI
MI)/J9X]>O'\\^['UA =??O[59T^?G'UA0<B+=V]BK<,%4?5S(."5KQYP#\ S
MPQ.^_NS++[_2$.^RX@*96=FA)"O2K=*GWU]<%C/_[.<5M5LAFVWRP6=??O4M
M1);_"<@62#OZ[WW]E$;P/?5(>9W0/%UJO;M.\_O7EQ9IS1[]_;8FJ%+C@@'_
MV:Z#D3@[>T(VA3R!%KC;DGD5>WM)*7U2W3(E3A59Q[]DSP0HJ0@'<7Y1;N3H
M(X,HFFG\D% 5@K-ZR*I35OW;AZSZ=%:]<>FQFW79-,+"I[5N8W"]-$QW!<E"
M%I(<=3N6[\G"LO/^(CRWW01/^YR(,!^]>&&E5.*.H?P*?D5BAF@3!AZ#U@C(
M"^A4=0!&43LH"@:1B4:M&?^"K^2"[Y4K4G_+%RW*NU=O=41F_LOR*-@(J<"D
MFT.0%%3F7Y<S^GTQD\IZ\3H>>5=..4S[Q^+R4$R%6<L*G4^6TME$8 \LSZ%=
M"$OH@-KL="=>VTY<RDX\Y_&-IG-=KM?&LXO>5S(1R=Y:MN!U!<)HB8D+N252
M8+P--&DN&\,C"6*$%@.-^>#[GB"U"6^,YM5_T3;ES6NW)YA%^$OPO=;2C3)/
M@W$NCO-E=^+)YM_1N7*S.8"DE'^&UH*7G%Z#*#^81[<WR ?&?F?,3CM[=%F&
M_WV5,P2JD_"8:;+Y2WN_55 1;= [NC+IBO'"\JL+U0IU\,_O4&+344Q-6D%.
M33*^D_?^=/:"LKK3;Y.7!3=+VQ?&,Y-=/&P\K8'TG6N3Y1Z#VF);RL*^60_I
M)[[ZTU-D(";,/TE% V '*RJ5. (G[+X>7G\-=@C%/CX_*] OE/<L6%E@ZMG8
M6L_7X3B^Y-P]W<RP+P6:S7=5Q8'K(/$:J?*6&'8_A",&WEPKI(2S'H1/.T&M
M+F7PT% Q^<LV#"'TRYH8E^_,!0R#E"%]?F;S"'/X,KR &G[*$=YGGKS_+ A[
M2S(=1 W:VQ"QURH#R>WEPCR:?D^?/#D+UNMG+RX$_=_L9HV*1=\=-2E]I6?:
M,QYS6<#=;+7ETGVA"), E0R*-XRV!;];[SQD@N:S7D>3++G(QWY"=6X]+1'E
MM[0<.&CK3>QW]J'FZ#O@B EH<%V2R1T&U5-#4!5(8ZJUOU"&PMZV3*39C;9K
MA:8M)]2]WJ97;Y_%SPEN0Q%.5;P"V+WIB+M$.-!9"RJ?V$B?./(271C?2N,F
M]I%=C?B'K57D,RE6I$+IMH&HBS.RUT;MPE3[,:,T?G2OQ:8XB@Q+D3985'^#
M:QP9Q,IYL#5.10]!YN)=\72'M]$BDM_%;7O0+F*D[KA WRU7VM Y(6 /BZ9A
M1TK]()GCPK@TQ?"5\3UQ!!D3U5.Y93BR4:UBT 9Z:OK73[RG(\"1W##Z:K].
M/ W_#QP>RZI<\CV(/?2LQ8$_/LD^9L/SV\J7I&O7KB!K75&>?!:4'=T5;9 7
M6PNZA\<3!#O%\]'/E2 G[G"4AL&<D=?MF["QO]$S:)<,VQ=D#2^! B 4"*)2
M,I/0\98?-]+U<.7B-%JEF,6"P:R5#/$+C]5NPI#%Q#9@N$OD)K@K1A'[XUZ]
MW\Q=D,2;CWJ*AU5G3+KL2\NE^3*!P&+#76J!XS9],4M<<]A-XJOM?[Z7E.H\
MO3Z/+K9 B93 7OSF3!4EI=5RI5\0:TC;>9?.*;W\%]/"WA_P5-@_HHK%B:$4
M46#%X5%.;SML4>"^:*^:.K4-'C/4:GI],K0J8U/;=*6]-/=#OD1C%,MW,?_D
MOA>Y'Q;QV:(TPC.653 !D-&K1GTJ2-8&F[?'TOK>A10^>>T079>EE1@E08#9
MY;J,^W_YZC)&<!%NP'#9]0^V482J310L$8/A6EL7AI=#L^KR/3I['$_SB?72
M9?!3,7OT]#$T<]!6!HCJ9H\^?XPFW\365&K/>-[5-E9T3LZ?/@BS40ZL$<26
M6F=L>RDJQM,X\!RV?-W>';?TO-<JG[ZKH[I!08>NHOF[[XCJS=;(G MYP]<*
M=A(B+,$[ZUH] 7O">/5I=5HX]17MY5>+8#50M>/?ZFIQ34CDH:HY0O-CV]V5
MNW!?+UU)1!+QOT!ZXNNGE)-X\H7@"R;70:(XVW5/(C1I[:RA=U^=N-("#9@Q
M0J'!HDOP>O.:2HRN&U_:H7U0+)BOB#3!P#(.:B+H+S3,KH"2D9H",A+&L(6A
MEIP="92NF9$R. '-)5-*JD['OZ3'=QR(RD<B<F)J0)J8N&=<$MF44:73-;Y1
M(;JIA<OGMLJ!OJ.=[7LI]M!@)*'74<+ 7"7]H1,AHKZ]807"9O;^KY::XF=(
M;AXPLXH<9>1(ZPP6-._3V=\)#:A]=AP:>?*M:CQOB-!KT&/K$2H+HOKA".==
MQ1+.D*V?L#2+&/<]2I^]$G%ZL"JCF#8?<R89?=_'2/'%#RZ1!UQC.+TO7L=2
M67.FI)ZV-QCP-1X6I8+^NK:V9NGWT46);CG:B*1F&+#F")_C6GM*=@,4CYQ$
M3W70<_,$J=Q0GATKX=XCTV/^;Z^<]'8)%&WY*WCER*E#E:^=PN"#KK?1Q6YF
MP9"DQ7AZ]F2V+'?*,)*!PU5G1$.T8% H4VBNV\4OX:BU-PA=5,V>IMH(]DJM
M-K@PB+GV5TI/6<A7@SA2C3//(]5H-X4=@\&%:\T+*VYO."FGLY_8MRVF8B\0
MT7H>PL7?@O,DF#,P-X)31L$<"L6B35QPVCNFU8CKQG@J9W"J@QS>30-D4"_/
M'B)$UF0JFR:U_C\K6TQ2OHZX#7T!@1B2D,P+?!T)>8E%*'*RV"_I!_9KCX2M
MC7/M=/8J+ID4<O?:@=T5GL>Z63"TZ3%1.?>0AP[#>?KD(0\]N3!:R!FNZMF7
M?'(8X6<'C["3U.F[,UY0Y<+T)T^EUQ[Q1^S$5@ZN7&V<@6I:A3EZD@2?"4>B
MPNYYE!;A_O,X*W33Y(P-YV2*.'XSU4O/@4#*' *OL>R68&[W.Y?]-1(WGARC
M,0IPK@ ;"9!@G'"M^]F78277%2T<W\\P8*#O;T3JK? S'9<)"II#L==C0'A"
M(NHH0 OG%KTTN9:50XQ"&)V'<_<J,V1_LD?A14/Y"X/6=92:[;'0J:L6#9."
M4T(A3] *"[GHZ>P[!A&775>C$0K*X7CZ]CY&.^1#]J=K(AH]6OU[%D[*,/&E
MMTKP&"V@\+7[#" V;R=^*XX14PVO1@TU1!E.Q&0 5[XN:PGIE&!SF=URXXVI
MF:2/Y@'9]R[+;EV77.9-QM1UR:S0'%$6XVW9M;B= I@_5>]CSY,B_0D%S^L^
M3WON6W*N(1R@?2N$%HA IKT3WA]T@!40C-9:2H(Y_FGOY?P4$GR3Y] J2X-X
M:D^(WRUNS#Y!Q''$Q(KQA4>Z?X("G)<]6S'2[V%V]L6C;Q[3'PXX_:<SKFP:
MI?P-G))P549_,K4&27GXF)N3^]M&*]U%0N/"=-4UV=ZWP@$D4TAJ-:2&@Q>A
M(=-U[0 +( 7H*P9KM$ TA*<5U LD"'Z\DJM8!<]!M.MP%GS'GEAGE$_-H:S4
MM$U6!6PCC; A4Z:K1;T=:O'E;B2KPRQI4E6[FR 9G5B9BO[6$ T#<\WQN#B;
MP2R7Q/L:=1TU*0JGZJHJL@=YRU_&XFQ[?OP@%26,'0B[V"%T&SLK&<-0I!6R
M=D;D/G R#?I\33V@V()-6CL!6419T&ZHMAWA74_B?QK@BEU^Z/0-1*;8N-)C
MEK[R<Y#JYLM]AA.4IDSWWAER#<E.5\FLR;?4-\%U"C-?U<-GQ&R:Q2MX-A?:
M@';@YM6_Z0[G(7,/SE$V$8VT.8I[34S[TD,:X"JL/6H,QUUO)WL ?O[5?>&+
MA]:!']4Z,+WX8GU('UN"=3*ENC0^H(8;N,/*]\4F9,D&MZ*.K%6"J^)*LS\[
M+>AF6LGP1#X==/4RU0 A=/"HAW&MZG7UT-OS#S@)DZA=TR=R]<%Q6DNK"I&F
M"?4_$[PU2[GM)A@XI#'/,HKX-DL=Z8NB#T6I,9OM!875*-:V8]+.Z[:_J8$R
M;"P5M"B%Z"!HMF7=I@T("J8$\KC"\/">>HB'1SR<G=]_=F[*Q2]$Y;"NRM5:
M.D>BJE9VTRMUR!E@:"%_!FDA&[-]>JHH4DJ?1!#RJE0" GZIAK!Z1]WA_,O[
M3S4\U'ZVJ^C/Y3)H2.X(D^LS(+S0]NH \.(CE=6?P+?]6_5^VH8E&&6<<4>
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M___9TV^_/?OVW^PI1Z"KE,[^+=<R?KIZZ1-K/? 'MQDXT&(@;2^ *,D?T%M
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M&A_M,ZM-[QS !Q7^1YXB3D64'9 )B=I)4"GZ]<OK74]RHIE=JA1YNVWZ:ZJ
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M BB%$R\"C+8]C%O.PD_+T8CU--@PL0BP2!W(ZS"[V1RL0.)?,J%790R*''*
MY Z+T' ?58GF7RK31U@T#S1T/"N.O9^OHK;0L5!H97*JJ:[:H?8%0E.?:"F0
M[#+T0"H^3/XK'1(=466HTD=N);=)C9 H"YM<-WE[26&K"H@-E#F V*'LYO4
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MOR ??=E4)Y2)FW86GIF U(?C*/Q<Q"1,;H;,C*.>+]-'[5\,_145/17T-7<
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MCH T7F>62S<O[U98??+I'Z&P^NB/"^>YOS,>][_/&!Y+_"6FDHMM#?L[N_S
MR=VH*O-=N:(-L7AVV19%I)=A7X;B-12#V(8Y3XPK0] ,*J('!#*8-=/6A\V3
M*:$Z!4F<;]FS3?"625N\1L?(M%$\==O_G'W@^V3@T-H$WC]F"\6XLJ4"1C=)
MFJ2,@"2MVTFNVWD1F194)G)/G"G7F51'0"NUXEJLW;1/'%UT<L7T0?3Y!R()
M=]#ERLRVZ@5]6*(4 #_T/F_K*%Q+!$*9DP<B6/.:3T<.0Z 2X5.USIB[BY*#
M&0%(..]<(<&)?9[Z HS5B^,9#LUV<6V24SK.Q# A^Q"4"^,BE06?E$YD\6;
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M0C$L+^SUF6P_T MJ_OQ<#*9B\.,_;C'XZ, DICRQ#=<Y5&A@@,S,8,'?TAS
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M1#G9HCMT(3Z30C'#KAF/OT*9FEWG.$X>G<K+GS/AN%$G[B5Z9^)<T7E+M%7
M@R7'K'830EHFO$;+P&IWAL&A$)RU'W@'[/:#,-Z< $+&7A(WGE,0V(E]>K*]
M.D<1WB_1#O)2(CG!)7TEW9C(LX6I>@WWXT=V/W[_%[H_B#TJ<_".DR04D:.1
M$Q6%+A%H%E><>?+$X--Z7I:Q)3<Z6SQ[$Q:>7$QTHV,@I1Q=BV=*[\> "-:P
M;N,,3-]J%4&8N76V:+^!K&U]P1-J.+CMD(@S0T/TIFYN'A &.;KF=QAX'G>'
M<IL8:\L=#8QLHNV23>/^Z&N3U6U7OC,:L_&=RRZJB*\SQHR+QCFZ+HL:I&64
MWG.J.ZF\5]7P4O1F4<"S;(EX<8@^MS->J8WR#WSB:^/U]%AN66E0D2Y-"%8N
M-058AV#(I_O\']&O2EFB\"NZD".QVA:Q 8*[+*["X%\UU3I<;=-S.T8J'[C+
M#UR4BW?(YI+[4]2@N"5./W\!9& H+5Z9M+S,<7@(2?F.AT228-HJ5Z2R]>O3
M3Z[\@(,SK,G(#.'1\$FC:-J%-[/3S22XJF9;$#OW$BG,J$9=MJM^VR'#EZP<
MV764>M@GT']AG-0N2UD&Z^"TH+OQ8O&S$T/V8/U"ZDM'YW+4':SKQ?N[ZH%\
M\'M9%FY<JBAOPI0GXP\:2#OQ*.P,4QH^^JK?$D$QG:'<GU%L<F<RA2M L[<N
M@V?7\@;BZ+1PURMI,,H]=$(XX?W7AXLU"'ZT2.]PWG1?>69Y"K(HW:ZG%YZT
M(W3%3^]^16W'=1:*K_&$KR& O)NVI(9Y6EDEDY>V1;,Y^3AR+/OKN!MD!2#F
MX0..@>Q5TH(S=RZK2CTJF\IWS:M0,MY"F2JL"Q-N".]P+^UV7VM[YIBY%\>,
MMC?D[#_=4&X!_=5\G+I\,A?NT 5?,'%>2<K"8'N>G\JH)C#@T]"*.1GFVTZ@
M,W/4>YKE= YH^&E/[RN.DY &KSMQT]L%V3]N$*;.N6(3Z0= ,?2+$#5GEE&V
M=O>I]7 3#_*RU;((^W3G^7T/7*78;YQ>64HTIQ"<VX(_[U?Y!<)'>%IR\7Z]
MC_O/M(?O8Q*'RNR#D&;DNCB2"42U&L4G=<!4PJAO[]:<-TZ]G6?X76?X1E5\
M*?.@Z8_)/7DFT'L/XXT\HZ2@+;C4! ]2X$,.O;%B^B;2$"RK9O5FWG>5?-CT
ME<.G2(F(STL($16UL:](PDJ[CJ8O?R2>^@#"58)B(#&;R9!2GWS9%9D24.5M
MV]RP_WGCT&U(Z8%8=!7&89#%$0,8S%M!4)TC\V+F,%,9H6+F7G3Y"#.QYO[I
MR-;NG*<I:+T%F_2.'W66^F:F//G^)OR/6'A_^O!<>+\?*=&2_7Q:SL'P<=Z(
M/'NJ(80(X5*8P8C#A=<, TNA$+]%OM\H+U*0=BIIQ65+S;]'OL*)^[3%.KF5
M[^YQ=0HP> +"R"A%B(GXVBFNIPC(CLE"8SD FB6N7WF(+R?>Z>NB/0S?X\2-
MKHH;8?^ANV0VP0MJH9SID$P(!B9-NEO:%;I'\IBH):TA]A/1:2CL''R>D:J/
MIW5(D4RIQ9-D6RP8)G6^EF?89*-BEHXK[D[8ZU>5\P:7'[]*^A[*)0HO_:#.
M^ CJ=S Z-5_DD([% H"3$MBQ16?$J9L!\82T_SAN$T913",G9)D2CCYU[[.(
MT)UV] EF0U7]ON6.\HV4]\,02Q&P,3Y\PCJH!7";M=&TX6U6@8<1#M2(Y^V_
M5QWV^Z']<VR.M'BH7 FRD[*^*EHETG,,AQXU2"PIJ55*XF[!.B=<),[#8#;:
M??ZF ,,ES3&;/BG+$-U*T3I(2$STT@*KL;+9=1NR)<9L(-V"[*\11,K*E87A
M.'BU ,.RG)FL:[I:S#T;),0IM<=[Q;6>#(KUA?XN.S4[OE73Z1N&WWP @?!-
M!@'UM>K 4Z1<8B+"33HQKB!'&RV>8!&13(7==L^TV/B7Y 9XLG@ CS*&33@U
MO_0=D9<=<6M.QJ&),(BDH7*2VWD&R3"=%N&:\EQSC* 66.0TN6_,=2OX:4A/
M;;7)A,K1<:@,2S".9OL4\5&S;@D8,"-->:K&FPS:O68F\3'3,E="]C1Y.VVU
MN=.=X+3NIZ583WW\?^A;91@7@JKQ($0V2F9.(TQZN93D1>)=)#1XVJR8MC /
MZ/"X+37"]+?E&L]_A!R+4/&"@:1$@=C47T.4=;'X"4$U$Z^R&SP]RUXREAUI
M=E$Y*#?)^+0!(6'?EQ:DP\#8).1@$9\@4\(WTL)IPOB.4NTV> Z\,*-^O6..
MI8P&YQS\E*Y9Q[O0?,F@"WYRB<^9MP'N5A@3BLCSC[-)O/.T.Z.J!K#!Y"G%
M"5\X:4S&V2JJ*$&-.NE+)QB:=\**S"^ZE<$>/,J'L$.5R&Y@#PFK%7G^1_L7
MG_'R ?SYN@_S2Z0U3%4.Y)8'YVAE#LM."@4TKHUHG)UU!G_+)'6Z5X?-;^"P
M;(N]J"JO"XZ/E0=8]T>"CF<[@!PK5D$.I]%@ZD/'1.F)F[W?5F6:\\P[:3\H
MUN<RT'N=<7;''Q3;<*#A(*1FK6:O'.!W<DB.2Y$4E!+'-3WR#3DP,'#>=AP8
MM['1/0\:V3B@##:%Y \OXR$W:>"YT3;$PMRVG;23IXS7N:@&$+U6%X5ZZ0_6
MF4"D#HN!W[8Q8 +Y,M=Y6<&U%N1IQC&1]&0H,,DA&URW)>\D;I!P71 8)K2D
M:N\@A\.E-'J>=\AOL$,H8!VU0U*"B1@TRMK%Z@HQ9FKHP5J5Q9R%-X1,^>#/
M])5EV$'D DZ!9]O@P>2R3YCUA+80-<C77E\]?4[>:Y(5P!=$M# NZ&E5[F$[
M\GEAO=>%Q:E')Y;F*?FC49F4'4JY4[2#>!VF>$67:9BS17XR+(>7*YLPV.5F
M;#=3IH^$UD$O9K0OB;365)L5@]F%,2*I.VIH,U"H8D*;L-:) I4Y2O?!@+.R
M,?K5B:7EBSQY9M$'C)WNE.1R0:2KWVZ5""-2Q,34':7"W+Y.)#)B7F3R#H-#
MT<L8)I'[V5:_?UL-[P75=S0&AF@8G26TGS8J>W(<,]I:1GDH8%'6P*"K/\S'
M]N(F!W<N:G_7(70FR31Q71=.Y>J7H@G[=RU.5OBH".<<>:)F_O:26K6R8TS/
MQ;N?5]=[7UV&/)[O(HS0XZ%6G"7IDYESJR6M@%2EY#K.\_B.\R@=&L(!0LB?
M< +M;XB+='CB80ZD$)*;K4^P<]/33I=%?87++.EUSYOQ/<#(.8T>_&=J^'L;
MPC;PR<73?)35,S9&V-]=RPU(O:0)W>Q(&DJ4.^9GZ@\%87KT84"8SKOHMS*%
MHBLI_GC:P2QXCW:J,WZ: N,.N?ZYP$39W>(CB.Z?.SK!/[DLE;XH29UX8@F3
MF4V2EF? \WOUEHS_(VT(U09]WS^?LH-1?D+(1[T6!]>DG3;AAA%#=UI@*%U%
M5<X/KVCZ/*UHQMJ@ACO*LG*7T9B*^^LH4E)8O+LE8FHPQE(P7E4 %PPB;=Z^
MG<EF+POIL50^:<N4.B;"3 P-9X+7(BW(^67)0QL/CC[M7;/$D6,2!HH6V+J$
M[,G5J)/^]Y_U^P-+T-DJ%3+KO$F"C)C/%HA.JHTZG:SWL8G!Q[GGO7MC_+S6
MRCZ$)T5EVN/E &_F$3N[+](BJQ-)\C".UBR1$O%B;C-SZ"B:WN[RLAVU%TTN
M%:E:G<#\W\JFPCP%HD?.U$I#C+#3Z%6\B@RS;/A(HY6090',=73&('PF$O",
M"#!^+-$"(IY+,)&B.$A8U3%^N<I7;]0K<!R9, %>D'VP3%U__]1:JGWN?/!B
MX5<LVA;%.^*V&2*OHO@UC@G.+ [ '>%5VF+-4A@?_>G9CR_^]'%V*UJWK(^B
M&*0.=0"=3 .*>(P.V$)& /:989"F:,D$#_HG/X#U+78$,^ A+[2X8@= G*($
M@=]PQV\YK =VGJ5R,['H#W%A#V\ZAV(=H;,RE;U63_)8ST%$G KY3W"<Z!PZ
MNC6/+'\\/Z7'E1J#T:G ![*NR*+?3;_;8N[=9AYL$BX_@KLM8@]'),4A.E<6
M 8@/,CD=MPQ]I@G9Y.K!-!+[>WIB4/& D;CS$ZD^4U*?6.4M=5A8?SB@3SDG
M>-;]7N22$EH/9(56;&*8DL2?4$XOM')':NS(@FDL07C2^R4^+9PJ;\44?ZJS
M/OV"5N@NVNN2K&TP,.@?(:BUHSY)1\7<)D>&(+A/@.[SE=+_JG>Q98;@+*4'
MCKW>\NTPDEUC.R6Y%MP*'@/IRH_(+JVLQB(35/KDE8 AXL[(I8VN)MT2OR$2
M< &#WH_.&;?#3IX\Y6NB3BXW(P$!T[1@0R05CS$[\9$MQJU7J\(.R>F/C9Q+
M(ODMR>3&8 TP+\^A<L9O_88Q=SIQ16+E6<?$V@Y<=S\M%.T]R+NN;^FWYP3U
M>VCXWC5=5]+&3)K%AGZQ];Z)>*6;M?,LO,]90 90^6G32:#H8R7'#1]9*T@;
MTG%XGI;?=EJV98?.P%UPV =YX*EB=\("2;Q0;;XFIB^"IK)KH$RCYSSN^YZJ
M04<L*<L"N!FIV(Y9,Z1UV"5CXO!.4_=,5!"%HCB>FPM:_\WLAMNI3D-!](VQ
M<BF+)0D11S>8%)_*RWJZ_:\MKLOBAL(Y=LPM%"A5>V/@?T$P!FRC+J$][,YT
MK836,W+94)VT 0Y?,D8)IYH/9PGMU^EUP)\W(R@"6 U06\U<JV/*LZHPU]6W
MW_]XL7A%(3$_\DA_AH4ZY-L=4W#TRV VU)9[*$R^5(K.V( Y-7][(7,N:S 8
M39X*+IVV%(;".T]H*1UX'.5Q!#F(LP:\L>:K>^>L(YW:+@ELFWL_2#:7,_(M
M?\*3?-M#KT@4=Q Q^QC*VJ95CX^FQBKRRC3D /^83M#;SJT5M2WTRIPS".:$
M<=2WO/9T5Z/+FY?M[1G4)$+<<--TK<_E=9]\A/Y]>#+JE<JH=?@*W-61:U:;
MJ<;.H*Y.:YZ:7CC4==,6"Y4;!JA2<*/R8EM-KR0<7MK+,[LI)9H,AIU8^BHA
MW _OR_:?KEG4G8):D*:?>G_&:\9GY@+0:A4L1'P89[6J_$8;1R8?#&);D376
M[FRDKTD&"T'HP S!V@P[JZ'XSFTF)?W&-9D,J,HD/LJLUTW(>&[ &\0TM6GN
MQB^3UM(@VI.^+$A-J[-D>B/:#&V_VTO)D[]"R0S5L)"\%PB:UE$M$"U^N:L%
MII)C[@#.(J7&Q+98(X7&-XPI-"91YZ+?B:=$7M\C5S'5[.R6"QU*F:Y&E;I4
M$;A9,R72KK10?ZHQKZ_V,<LO?!:9LG,Y?@OXL?=X^L'3NIWD'WE(-M_EVIW(
M&EM,N+X>DZMOJ$R;.5Y-ZJ<IK\LJ;)<ZV#/85N[TS\9YLC\D/NKQAX&/^K</
M3-=WT'KE@(%6Z[K-)5YP^H+: <U4[J)*4Y3_ZMM"6E8(\=_-8!9<-3E3T1FX
MDNQ7F*NQ:B&N6WD*O"[3DR1)V2>:?SAOF06&?F(>F#O43$_<7OXP7TB<E.3=
M1IX.)KKR6G5S) 1I71)1TTH<\%G7"P4.45;/[8R,JG_I><^MYE(/%Y[88+X3
M4\B.)LG3TONCXX3JS54QX?0?C3U/9>X2\=$T]N)>,)*<4=7#80O8O)ZN 3N$
M;PN%4;B30V^.:1,B9H//N/L<8J,R7A)3),B3F62=$D3,%\413HE85L/EM@>F
M%26HILS!FDY\UF-44=[?:4C#S62P 9.@.O%$O#,_LBGHQ[((LB8D8$[JY-([
MR,9XO"IG5'AEH0B(BWWE#17YH*HS"!LL:9!6EZL\N#)7][H)T#8@,2+DV/SI
M8-(\'PHEF*@9W8H5$[-?U)?Y93&LE7I"/5XBJ6)M-SG)W14&<,4[>R!^@BJ^
M[FF.0_QCB1@SXP7;$*-<EVV/PU]#G>" P[N"'5/R"=S0H9,B0Q54E5=2*N[&
M=C),>06%]I("ZW)CR[NB?[?%KLJ%*=?R=*9B.#)NHE<]\2T@F :]CIO\NFGU
MJWTW$)N.95\HUZ1W4(J\.S@H&HFD\*5N 07SP7S3(0 )*YP/QY2YU44X@E-2
MS\')]IU\P?V[XTKP<()4'-K@;=FB*"4*9P$S#Y#(IG$1:6Y!%M)@DDFV/BS.
M2\)1S[A3=DHRRD/S$I:?HR.^6,]EN3QBR9(1 Q5TVI-AY835&7.&43_;HQ)Z
M/L=+-S(.!Q5,QP;4@V!;M-?A/"^>V]XE@;A.88/*(Q\0]@FZM )_!Q"?SNLN
M8P_2'6-[T>!S/"KPA-HCI%$#V3;=IS-8-O5I.*_;)\9VD+I=*J=XH6&^,"DF
MK"UL[V@5) 2+=Z88\ST9%XKNFLJ=%-*^.D$Y( L]:>\(IH[]#B7]Z3C!33,G
M#7:WHM5NKAJY8#&]9&':(L_EI/3T*'G[ZJK<8"CGN2Z96-1EV*;H+@EFU"63
M87@D9R&BR-^("O%.DW("[L:[8-<3*9X8OTPM)([BFI%H^I SB'1C.J93*:M#
MDMG*PS9D6EB1!A1U-[.#LI*58I'2QH/'.('QOB-6/*63T)$=CNJQG3 W4ZY\
MIR4*;?1*M(4I<:BW"Y?,???5X'-;4,,1P#K$"/O>96WT LPR3"EZM'.Z['UX
MMLZX=BX6SXS)>W*I#*T_.[@.&]=+!\(!^U5E'C4F]EEW1POK(7;L*+D]/=>^
M HQY^2$@M']@<5V/+QL-;L(3,_V:X1IDK+M8WG*D@EWA/[D,1\*Z"?^@I=P*
M\TAO[JS5I2QI] UH$'+:OX@ VF+++O>Q I8"LZ;L#0 *V#33%2RR%TP[Z!>G
M<$)6>:VYKWVS:BIG8I+;^%JA5CFMUMV/"UG!1U_G+>F70IR[1D>#,-33DNP6
MWS[_,9/R'QX>3%,A/ O/KL%W"$.(-EU0LD*:E32(R!!@O7<< % 3)>WA> 'S
M.]C=6U%G! TS4HB$AX9RN.;>]J:;F:':==F*2V=7I7(Q!UNYZ@ ..9-HJ9'X
M>"WWI.$%%QRCHK_^GLOB/WX5_L$%#E>W\<6:&KW?OA')HB]!& #$,3$F@K3_
M^N*G"W^VH.QS\?<+/M'_%ES6^M0WM7"M4RB7#8]BB?[5_.LI<=O^1B<QX360
M.IR@!V>?J9"T868LQK'I;%D,@PE58!Y9'#GH[HG?S_CP5Q9!YP4X,JU)@S"V
M ;/%0!XNPF\4S@C,RL!R5.#[&S05Y;FT-63$/M;RR9$3G-,1X]O-W2=<)/*<
M9H-Q3;1ACO4S39UT''3@42RURWF,R=R,9@K1::%$XA/O?I:?N;TV^>1<FYQS
ME 59QB9N4ART(78^44<R6B]+F4F&;60<)5* )^K%BJWF+\U:>;M7Y\,N'NG@
M!DR#@V;6\6XXGNF[-;A7)CE<,O9PD#Z.B1T@\40]95R+-7JBR&X&\N43./CN
M&9.^F,RING8:QT"04!L8-(=K91(4W%'<D#5/?O_!NG.=V+^2D;$JC"\NA_M0
MP^),4$Y*URN7DCZ$*0AC2WR:.#!(/H(]_N,J"%DL7*^ S6G<]$7J"!;&2S-X
M1\C;9]4 ;AD!3EY\>$B!G\ERK5(V:*-_%/J[HGACM@A0_@%_S,7B9Y'^A5>9
M@RUO76R@*N+;;Y4L-2&Z<)SM&7'/DVN@YKJ^#-/<[X0E(B=KU:F X9#&Q@26
MT@YT^"![)-SWHORDE8IZ+>V,<C5Z/<"F!MH"N@?&?W9W+8*5[AW7:L0T"/LO
M13&T1I0,6$@8T#O+"X[F(*J&305M_ ZH?Y573;/V6)MY!'<VV,*2LM65KO'0
M!%W$/DI-2FVG*MX: \2LBAG].-WABM1.&"5.I:2/)=!*Y3G6DPO@T+?A"-4&
MW+X6@;"] =%-JA92MI[$S8LR2J$W["]<+Y'=S(E6NJJ*^E)KZ%?N0IK'#N,;
M G1C!@UO&C',]OTO!'V^[L.Q?Q!\OU:#=,E)<H&J8Z^'U'06:%'UJ(041"I2
M-%7LT_<TQ@,)C8D@5D'9C).1LI-15@\,IZQX5?,6\LMT2U@?,4J%0[)6]$S7
MA67<9H,8JSG@;2$-R+@N(XJ5*HG):+@><^)V@]\M8JF-_RL]HZC(\8[G8\#9
M\,1^/4\IC2("^ZW*8!0/:#+ZK:28Z^*RV9>: UDWJQ[Z1FDQEQ<7G(<E$6_E
MB96-!J(M5FBKF2#1Z<0B5L=+E)A8"<O)=B@O#Z?D/, J#L&D, NVN?"K:Z%.
MJ-2+N-+Q?,5:'N#P 9QQ$X6M.(4#0JO&(8N6Q%*431$0>&S1(KJ8 ^J"D0NY
MZFE55B,78YJ?.Y,99%Y;"AG(X$QX:HBF:WP.6U*\IF;$GJ6>7>:N=]2U:?41
M]EX?%]HT>55T@W#%LD5CB5KX=F%K /AI'4OHU[^5R\=EH:1_@LARQ%O4X;<:
M\/QMU<^\SPW%^0@WC%TG4B\P7,:0PLP3+>FR\_:V[Z:6U'A%21)L2,1$[S#;
M S/@3#L2-BZ5P73K>"!H9DQPY_1BOZ.1WG?A> YC_SI_FRU>FBO$6=OGL6'F
M)5$7_/ZO<L\P=H86(LW=3=J04@]]ZDSQ/8Q]'=%(P;%?N2X]93^)]>^V*+?+
MONU$S14GOLA47!74"K6BQVH+;KJ!H""Y!%T*L/O@('6OK]+6"QRUEU34J:>R
MEID.)!5QPH?R2T4%^-$CCPBJ*(Y*BIHS6_)HUX6J+ZY(B*L]\#3CG\%5D48O
M,,2(=Q1.YTXZFJ! EX 8^3A?"#TBAPI)/CM8,,H'+AR'N;#[I:D1"P.@@CPE
M!QESMXM7M-3XH;DV*,(4+I^% R67I<>G"@_(DM90 4X7UA#@<48'(V2?#_'*
M$D38XJ5.6\K+E0WYIY<E>5"4]'1SY<A'H[*</5B(!4 ]+'=##D*;$?D:F..B
M6[7ECC,]J5<6GX5JE$G/L& BZ:^\@F@",+9<+24K*X\KBIS3S_4L2MCP*0#H
MNYQ&$\G#M*,9GB%7VWK&?&%I92C+AM&L!P1!/#VC/1#+WS-@7#L^,FTS9VP.
M!4G[*Z[ RU0)5B:X9#EC!@7])#5,47T;6#X[I50-3I1\DGMS28\7-F^@9R+Z
MJ_,4!<DX)K\J3;W/0;NHR-KOA,/?))%I]3NO:RI)58C9GCN&YR;MU.WB0*,O
M/89F46_CA$!2B$(<Z$7\"!")3+HTB;[=%UY!/#&Q!H\=V]J]US'5?M0*];L]
M 3N=>F#BJF%EQ:TJ!UVX$[A&E80X2;50&IT>0CY:HL3>>LJL!!T3+*6+"7UJ
M SF*SI'3'SE/I)<\2MTG<#P: 6L/-;3R"%=_L?@VOJDG (B/[OV!77X 6$?A
M0L=>7'Z'1OBB9J!)BA&2)*ZXS87/6:C"7+BA8,B==O5@("IR>F-3<=*KZ1JV
M]5G'[Q,\\1J^/0L3+K['HV!OB\.3!8>;%,'@YW!5N4-VBK1SPX$B/<)'S_[T
MW->91J0_?B3IF=J@E'^O"]/Q23AN 'R]3X!UC:MS0H[^X>D4Z<^H;W.5#*F:
MY^$]PP8#XBQ+%Z0*!AI'+X"^1.\;SC*-IET"16G;JD,D;4!JBG@OP@;<2:=&
M3_B#-IP=?.C_TK=EM_9M?_QR]/*%$<PJ)B4I/HAXBM#-=0BC:#BRE -1UJE*
M$76H Y*N-8WMN>1,)>>GYY+SY,#L(U5S8GR9TX+S!4K2X-*YLH[1($-522J>
M\'[L"N+"( J(C+.7=1-)W-2GN?WXTT--^YTD.1TL;2Z@Y4V;;T\HM)_-X0D_
M"9S3=FH$IE_<G>:4DKK-,U%TU""N%DK[(_>#:ZKWDD(-G4:<X76?O%B\3+Z(
M0E!T=R/[I_$):("439-R3![P$Q[E,#L].OOR1-U-,7;*X.)"1J8<]"^!Z$VZ
M$/"XS).,1%;ZR9)AGW%::%8Z_W/-]]?N8#[3Y])=1X!,[S18)[X?N(U::CD3
M32%)7'Y[)J(Z&$T0=_YH\X)\46XD^G\\+U;KV?4MK13O:%KO&<VL7EAXP\:<
M%@E=ED?-%L'HEQ)D,.QU]D4,3UP"46M$,G@*M06[O.2^*(J!*X /"DN[+EIV
M"=6L*)*YV_L>2@Z3(<>@X]!DTUHHV;2$5.9;23(.6A,,$MCK#0GQ C6N[:2C
MFR22A-#%1C>+I36SFY9"1LAV+7%NS.VX#;8E\KWPP.%A)XQ6:ZU*R%HQ=E**
M8^XHM'6@171SMY3"&D<1+9D2IH$:%*TUSJ2 )]\]KX*#L3[0E3BOT-Q("Y1?
MPMI-58<'W*'"N>9J(;QNE)KS0[1JT@XG%,078:?NV9YUYE];AY96UY9H#EKS
M.B8I;4HU"+G%$N/D6=9&X:2$%X*X07:*HQ.URC6^Y\38R;=\:U@#4"Q)[W-8
MAL*$+V:;C'C+16I^=I=81',C[ B"+#4F3;6F_<##*>^.O5Y.!%47"^!"@^^?
ML#IO=R#_D_J(YRN^B\_"BPM/&KSD*S=D#ZCT(4[,8)BTO=C,S8CE0BLBFHFF
M!&?LFA0:$.E<M;*/YQQA_>EA9B@G<275KI'>RU%&),D]X,+7J/\3(P^U*G,6
MD,_F4S][;G$C,L,.K(D)*P3-M*@EAYJEF<^D^,9$!C)+;!N4\IN8#)K=%>W8
M%;;P-MRA63-&AK.GZ/YR.PI&#3X/UM!HY?(!)R !S? F(>94!3]6TBWK?JW'
M4:1@CA5T]T#=H=L7VS3/SF[?8$5U%(;/@=[*C:UPH#HW)65"#DJL8L^:"?<\
MM\K3^><[\I?A=#CR @QU0F,>.Z6;L*I;"9(Y,2!&F-6'"UB,9=N$#5UKQX1X
M=*7T>ZA'4:M7HB8[RBAV>WPNCAF#8^A$AV$PDX>/RJ78AP[+A"N\W(XR=FTM
MNE=S2YD \7FM,4UR$S$J&%6VV/@/-0:9=6N8F#8H/A\4F30W239[E+6^TXRK
M^3A.^6CK(HS@*^;'XX?WIJ^>,'F$SZ0>'.[_P9-*LFA\O\21IIO/IQ;M)!:&
MI5L,($]"W!!JN$\27GG/,F[,L1ZAE;,L9!J#<1PH]BY1FAUQ6/FEQDOH]'$Z
M6FYSQ;U8IJH.UIJU^+Z $=:TKJ\ @D9LMCC7#4A\IZIPFCSNT@>1ZRMJ""E(
M9H;PU_!I<\J^ MZB,#ZG=X4:'Q>W5D5X5(93'B_<3:++3&7=W8(& "F2Q-OT
M>?R.GNLJ.'J(<FKU\L91E<;>L1>.,OW2VS!KA2\6/S;4NKFB,UV3J<,SQ@5*
M;+L4N,+4IBO&GXQ'/5/G;SP?3%TFIQR/<?HZ5WG'![EFPRBL009Y%6\&CI0E
M IN2B)3'2XZ?("?S551)W)8Y@<K+*+D9SKD'DA51M@;]>6I!TZ3J: CZBF<H
MEJ3=THR<-!9FN&[[?-AG&8.<?9C1POP1I"GM((Y<6K5H#DV>.I%5W^&;PH_!
M&QXP1\OA@!-10H%!!JFU&8@9JQ_[926E((0P%EPAES ZY6GPW0ZD85'11!U/
MVQQQV8^26>+;T/8N52^5D1AD7MPCQ1UE\S&1\1JFA"G,K9/\EZ82"&W/$+N6
MRD$]Y1"8^D2'ANP7H;2H5NC($ ZV4SVV)N)TA^?#AZB+^(-_L]2.[T7#D,JE
M7;,JX;_ .J\;&K7XM7KQ/,QI?O*<1 [B$=OB8X^^$'E5S4H2&OQ:ZF):_X"$
MKS";$XZ6VM(& 'IVAMVPYH/,(N&K4:40DYZAXBEV'N$& ?!2RZZ/YHX0EP%)
M> (TAHX "^YNDVB*MF+^=@Q$R=LDIRBT6KAI[,[ $Q^D8.B<;WD5:6A [HB?
M'O!FS9*4 CN23H/D0!RV("#TP=ZE2[IW%5 59P:M-)#D"R_;YH:NIL!R&YZ-
M1:C%6QX/'O!P C71/%KG"Z$*T,<<N[RIZP'D?3.+YGWMK'>7A/I#E5,_^3#*
MJ6=IE7M)JVA@;>:102OJ"<<^H%&$@RY"Q>-7!P^)XY/;].\@CI,05WF!]W&J
M"[OSK&_TKJ(Y&':A)@'@5F*>"(3:A[AAL[$N! E8.!&O+8GT3P<^=:;>UUG/
ML_6.LS6UDQ K \BTTBS<P,.@@LIYZ-]QZ(T_%*"L@>] %HKL$259V&?DY+CW
MJW3_K%UY,N(CIZY:D"+-B@O>D1AFH/UQ-H/O8W:I$A.B[!5VEE8*S29"N&FB
M\BT<4>?1?V<U4(?%81> *^]IT /R+3"Q0H6LKRS%9Q'4>2I^TZD@_$2']ADO
M9.9V"HZ:>63I>1+N- EZ?M/B#C%V&&54C@AMP,+=!PN;&5MP7O;O..)];11K
MQ [N^@B=+S5#H'9>[^]KO8<Q_NGBU059$:&F '-W8O8EP7==XF\=11Q,(Z&6
M"1]7@W465GW?KB^G#O-+$: 144//G8@B@N5I'3/(B:>H?^9V/(IF155@;XJR
M"OJPBI$PHJ_+CH3PM'8R]/%+KP5(%487F%UQ.F7EB"BP^(/]T5#"%3M=:CJ8
M)X+#L:$2)O*)5(RK#=#8N*;:D5S<JNG;/5J6.JL[AOB^6!="JY!Q12<E07 8
MEP%U#NN]4-4,=>J4L9RR"AB0L>Q;0DR7JJ)$!GIIJ166%!,BC%6G>S=H3R02
M?^D[DM$XDDH\C1H2K9@'[)H-$F@#&(5#9JE2P17JEW&C I?Y 76Q8[=H)G"P
M782?)']31.*<?.6*+-I%SNDOV8<)1RZR7MI_14V5W(\8.\CU$URT89B*WLMJ
MH[P4IT1&>=8 ).H159I+1X9"R7X..S8/=*I=++YBM!MCG%/2L?V5%M&DK9C+
M:T!!N<]J@2=7LAOA:G9U,;<D;BTO_BYD\:2:;IC,G(%%:/_1=MJP.%ZW_78W
M;&P53E=& #+TV+!X*%&##Q%LZCRW&8.1FW9<I1.ZLZ$I;!>L]V0'!N=)-2O*
MJ=*4$,SIK_(9$B,K9/-D>S<S>7 "=B]HFX=9$I9D(1D3Y)2PVY#=)6B]+EOH
MVQE#$#>""\47F=[PKV8;=8)DM!-@M2NLUHA(BIT4 8 (H&FJK:V1M7> IJ86
MU#UW_8]V4Y:P/PP&/O<31H:>L02&?.?=[&BS>!\8,Y)]@X?4D".*(7 54@"=
MVH+L,'O\<FU%TK+<@ASG]P%@3W*D@EPS,^L[4]N>K(-CLHAS<E,U-R=OMQ/$
MEQHYM=]S%);39"]ZWD7ES"SJQF8F2CPC'\VD&>SI^14G/3TX6^)YDKH4UHQ
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MPMPT8G?JJ2N)+":.!MD\E-X1#>A; N7^CQPI4Z\9^:),)QPUJ0DRVE/.J6U
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MQB98.^]>,_1Q:_BS/K% A6,CLY_3H]<;%#$R'M(-0QLQV':@IO"*@Z*=UG+
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M:N[1XZY$/>A>TF%F:A><6\%7OP6WW6N9_B3UZY+<LI 2!7*R3RMY/%;[1I1
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M]L=_UR3G*;JLN1N<GT[./^,D0O-$<$\6.==;)J27]BM\/= F=Z_RME*6M?"
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M!MMW)"G5*A(/@!O+C(IWD83.D)V"V3=9YXO8]E@DJ(1PI56[KEL+K//HN1_
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M+.:$'T&BP1S4JA5)D:MN/HH1K7H"MWHI"=;I8ADBZ\R@BO<X@3AP/F1TS@2
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MD\YCR.OFFG&W"LQ%6-2_)"C'VJCXO -3JYO;$,/UR":Q]B-5K<,*773[[8[
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M>L+K>A%6:QCRIBYG+] $'E;E*[G*!:#^X>X;ZJ"2 G7R%?WD3TSQ%KXP>^2
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MRU[^J]FE!+R44(89?7L_08XV66V44R]#:/E$$9*Y)AX?')AVL3,V?2'. S/
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M D>@;J);6&G$+D8I/Y]E\J]:0H-3(DP[?T?)0):D#.L:).E5KWA1 /SIWN/
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MD;OLVIMTC=:$EB4@.]0*DVJ/MJN/)*))R(3T;0B1/R9[ /03+=?<X\[:GVP
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MLQ\0*!26[03X4A@*!:"EC5E3(WVX1#3J$AYMM#DMA68O&8Y-3M(M#K%JD)[
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MTO0QR'1Z%\JB,3$G_-6RNZS(]\@\$COZ'V;N/8'\P31@!33X=4 +IA@HKPU
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MR>0WI<SQ@<T^[:U.IG_/1V'!.XR9N.S!\/-Z#\_R7LZ*+][CL3#QC-%4W/F
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M^2V NI]^>*#NTW.=*A0-/K0?Q<#N#_\<;U*B=@!#+0[Q1Q!1D%:@")J]'BA
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MO_OE__\QJQQ6K))^.C]RY\/!=!S,%J/18.%YT_&POQAZ_J _"V",?[BC\7A
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M(?H6L'JZX_AQ#OO?G<'#9**LL;I_%G<I]0%F@9\9M2C-<C 1938]YT2W@3<
M15PHN:'D6.U=ZY05,J89ST17"F3CP[\C3L/VJ4Q=7U (/V%Y!,7)H;;J\Z]?
M>4]7'CR3Y6R-LF%W:9#Y."%>[27Y4CQ,M%KDRX[2-\Z]?V&&!BD;.$B_-QXX
M+X_'_^Z<OG\#?XU<KOMTW\(?D\E;9_T_EMG;?@^)QWU5\ ?*EEZ[[+?DQO!H
M&01&,.D="?Z+."%1*FE^8ABGLK)+"#"%S;2G,NJ-MD<T ]F_Z^EI8'%JFG)6
MP\_O3[\TW2JP,!B1%G 9A=/DS OT8<_@#8+9!WH"V&5I*%@M?P\P!R3""HSN
M.E9@ >DNTF&+39&_]BL7:)D!)Z(4,TRB^4:5"A3(5<V9LU6QD".[I,HC?? P
MP7@%&T(3WYZS9>P67/;EEU/F"'M8NBP0A+]?*K%[\DIY<6 A!<'!3S:=$M[C
M"A$T!)LR@4TK]ELW7Y.7"J4%"P?311JV2NVCWG"R[LGU1@&)*\5"".^F!R1P
M2,)>@2'43SO7\&9)T.G3R8H4RZ)-G:$B,?I(AR\4+?_G%^<O**VF;QU+6DTL
M:35U7_6<OROO7/7V&,%]';G:I'KIE>A]#]HMD*Y1%L[A5\!;:2[I5/9^2#AG
M]\S5W'!.4@;!\%[D'<;#DM6H[?QD=K/Q='W(98HU)T1=; &A5$P"<K'BDDUP
MJBBV<)PXSQQO?@Z2E-*%=]S#F@#J+L_IL7UY3@::'-U>'_YS_1>X.<?35W*R
M/$$=IEOD";FNTGQ-467D,M2*<H*+(4_ 2C1W6&/61:^ K!Z]X&F0D7>'4R](
MD^=0!H8P'&G7'J3L,@Q36<4R7)%?E H4D+'BM:2D5+A-+?_:Y;84[JG\/(:Q
M212 J_/K+R==/3Z*5E!D)%9*5L?>>M GPX,JM4182:V^Y_Q<O.%^IV0*\41:
MG%=Z9Q71\$UGA9(K*4A-I.+>8&>/)>WDEO$RC659N)8LJ6%T47U)\9A*E-]D
MS^K)=E1F$$M*J L4>-O33A+': N-ER)1$>*+86#0B!)H)<]WSN-Y8<E%::I"
MX\H\T0<!QRN@J]N2/4B4'U5&4%>TBI<C":!\?LG$6OPE1IEVRW$UUU>" H?A
M6S5]R7^2R[Y6,]B:]$O1S$O7?=6C\)D[[$U%1WC5*=/5-M5725];.V7JC)2Q
MXVM(W'670"M!7_L"\G-Z9-_XEHCM]X[A*_TC%+7#X0"VYR,O"LZ7#]+>*89J
M$Y65LAF4DNPE*TK?*FO050NQWP&/;&U6M0V#([O37E_I6;8%XX[,YU4FC#*V
M>$^.1J^T5<53J!%[Q9A A\!',2][$V1<]T^ OF:AA=@*D$_=%-6^R*SP43FM
MOB 1V<3!2]K:)1P$*XC+.3CZ <G#"\JKH[0J!?S#LC2E@ 7<JSDO5!.5'J-*
MTDG K: =[,\^/<K0$:*W=45-/MY<H#.#KH_H<P34-L-F!NO&*V-XB#Y'A'GC
MX)X4&%>N<%QB0(2PYY3'W5NNST'J8;A*T*]QQ_S"T3!U\).,CSC?S)?V0:%V
M*P=CGQ5E?Q+7YG.L)@;35+2X0$4&U:_53)N^Q3][5I2SI'=4N\;(&P8D!#H<
MZP$_?S@Q03S4)QWI9XWC4 H7YH4F%!*."8Q;-#_,FD!]<Z<=I^5G15A0_ )*
MCRI-OZ@=E3UM'E?;>90XJ=3@0@+L9\FO^2PY-RJEB<K*>Z#OV3$UGQ&N5"H"
MJ)^4H^SSO;BO@IGJ,O4-(P"P5KXBT!.R%'*0RHE*<5)ZH%9$3PC!&/-VD#3I
M/O0#DX#$%PXA<E$.(2*Y>6!\PM82OIF&5^"$F((.K73T0M2J- %5*E]]'N8$
M*O16._*OO[$,Y()T-NG"(B^_!V!!KX%*XXC2> (-?4]^/97\Q?7*I/][/H+6
M2C6238'H5;26YQGJ9[K12[6]GAJ<H&)SR5LKT55SRQ7T.ENSMM#O[&F)"8.]
MEFAQ5N81A7-9_C"F<?&(*)^3+7T=3(9GV:@K':!2UQ?>19Q0]$!(LXL9[9I.
MP')<(T(&.3D\K-%=[$GB/85_8MSIQ6R6B5D^\I WQV8=HLT*B I^AS(')0GQ
M1)TPN=9^OUZV&#[6Z!!T98NB+D F&%MP4!: .!9BUQ.GM@PD9&#.-I6K,/ J
M]+MT_W!A+DP,[WIL6\,M"N#3C@U7L_+^C+&2&LOM@3-"*7R?!:3K^4@4W,[
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M'OJ(2+I VL09T,^5A,%1#9705Q&G/U0&NMV!LX*3.D_-COA$:(M"'@2O&!9
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M-_[WGG.R7%I=.2*MY::<P(\WIWRJ;HH4#%0\+%W:2JE;&M]_2SOL.5]S:J#
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M6'F?DN%@F!-%!=QA(HFV5X;=BY=HGZB^B0I!,:/.L=SF\ RW3:,S6'4,#,0
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M'^.(&A$>4 KWOT"*V*>J3ID6IHZ$[#]V %$/A\2G9 @BY#^B$ <BMV_JG 5
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M!7R<F'N@R6YA%:[6G'YN%\_,U75O7Q?ZNC?"?(5Y(:EU]5ORT=X5DCYZ_T#
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ME%)H$)X0":NP1I-\@TJ7I "BZF5A6\_MQ:_UXBWXY31?8Q:_AB4G<]VTS+'
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MF01L'D2%U)S#N/]EC7\2B:)__-8=OUQH+V7ALVJ'U"L';B:E8@GVJD,=OA_
M/J=]:K)]SK%QJ<6]".PZ3.YS)LTC&'A 5-J-!A.(MW]PH/#_,;D1XZ,'#P<[
MQS^#140^\O?&)]L8\5738@>8#^3L;-QU06O@_/+/2^]N6OD-YOB_/V;B_S.\
M>A/%T>_Y"GX_Y];'5]F78 %O[XY^<B+0IO[R4S#WW^ 2<87N29)\2U91YO^Z
M],Y^<OB(@+BNLC>+\"KP88[+-/B)*&[1';N'O.3W.+KI>P:W>,^)'Z,!M]^+
MAC?=M8/>,M+) 85W_:_#__X!8F+B-D!,G!:"1%^TBT!5T/P&UUGJAW-5 @:B
M^K,8I>\C+M6'+QHN6'X'4]H@8+2I(M>GB@SO(E5D,FIDJLAU^WP-'=SK\52S
M[N>3+]^<]^_?W[E*N=?;M[E=GYJ7G,'!9?$:'E4HM0?L\)YD-?VI_MW";Y,?
MBXB[0Z*Z_9Z.DX#E6>$J)C>OQF_\*^JF5&_;#(]!90B?BMG(?Q_HI$]$FS,@
M1@%U,,K.E05&-E5("U\G\=7&^(DU.!P8(Q/8##*V5T&022B94!BQLD?M5<C(
M)+)AOH.&7TB82%3"&1P>]-F3T*;]!A,:YYZY;L\.(EJ@E2TUW2$UW?3*V)/.
MA@VF,\<=]%2+BHWSZ1*;29^':]S;4P$5^IFPE3@:1=\+EK/VW#+&+*?H?#4'
M@G#*B%O7DFK3!-^DT00Y[&G2^R(EUDB2:8'./E,CVF]6Y71+9DTCL^,&DYG<
MKZ.>%76W2B5^59V-ORH\[Y:\?L"%^ZR,[M'CZDU3QZBW$PI'@RJA\-AM]?^^
M\7:,']Q)*))PC);&7@'5>M1 RT' ],+839IM$Y :7<*^6J?!&_4/+#=8+[W-
MFS"B&=*/WA;)#XG\ @$$YMY23IP.G[\6^A\->L='*"G_9Y; __OJQ<(=/5CQ
MZ^W/!^/>=%K]5;_G5GY^#T.-QCTXEIU#O:95\DIA+_%,_O+3\"<C2:B'SIN^
MX\)9O+[NL<'Z"A^TG3K8?6=KU^/U3_=__8WA4%^ZKTH2*_,?T:*V&) 6557;
M7+%*.NK7Q!B-]<*?&+39:_(L.OM!00MZHD(@(9#IN91Z,+P*UA9K0+O2CQ'6
M#QLC7N-$72Q^Q&XPP?E8$42ZVAM*)\"G@,Z\)DS#.4\P$O=OX<B='WG'_=%@
M=.R.YK/@R.T?#XX6?3_H^].YY_^CW^UW7?C?X6 Z09#3X\'_?.W]KSOW3>]'
M9 >'BN_W!AJ/>Z/^\:$WD'O<FXY&=W)MW.%0XVEO@'9',V^@^[Y\!N;R>9K7
MCM'O]KY_"FJX="L<#GK]\76VPOW?3<MEU2WAI%JG-4W!8LI]]76",_434[#R
M)LS<H;^5#=Y1*$C5!CJV:HTOH[V[(*C1X!7<4B )L@K\I&=I1H_KS>@#["Z3
MP]4DVWLOJ[>;!O,N#(Z-!]]P@?&FM;6>K*UUWS?=\$G==,JG<:!1=8\SO/O,
MX<%>!\U^GX=U:X]5'8.<DB!0>7N;DK:-. N6\665@7"_DA%N@EZ?;X-#1.,1
M6 Z[M>W]/Q\>W8T)<'34.W)W#[6G8-Q33O!&WJ'0.[H6^7&WL2[B@WGE=TL%
MNUXTWOPN8-6J$7N#!0;I/ G7A9P3+3TSK3O);X;L]KV+C;GF,>%C2D9;@R:/
M^K2C-F)KC&O(5/%^%,.AU[[R9D_=+8?<MTY -##LN?="^#=3'7Z [PPNIOU<
M> 5=7&ZQMP\Y-_'KG6?9.GWS^O7EY64/IM@[BR]>GR3S<T1)>1WX9U[R&JQ/
M[[4[/CX>'!^]AJFZ[O'0'8RQ&=S1M#]X[4\GD\'4#ZZ&;N\\6V$K+BG1.S5(
MSGA%O]?A7ZK]+$2#[3 PNFI%GCI 476=WTZEJ6SIMC^"R_[EKZ >.""&'9AN
M=S@YFDQ>=41GT,7$7PV@-V-P2/F659\*__<5J]&I<,H]HL*I_L-X-4D%J@IL
M/ FQ,6C%QO,5&P,6&R<K+I!4G>A)+OR\H?;8^PJ+0=.$Q2M;6CPUKAVV7/OD
MN9;_.1C@O(\FK]&-&&;H:/;600Y'@BW2X*46"S/>>>SLIP8@<@2-2:!W:E!\
MJ$?5_B4^_"4 >8"V_%?L5D!XWCA"1F-CF=IRXPRFQ'N#&ZL8_W%?\H*G>\S3
M?<J28M1*BN<B*88X;W?P6E8S=DLBHRPID)$&=R0O.%#VFQ?E*!A<9JSAGG)@
M_(!R0&8\Z/.,GZXH&#TW#\$U?L,'%06[YW9K5=\][O?'T^'HM3\Y&H[Z$]#U
M!]I%@$@_PM)?<#:I<Z+Z$Y3YF-@8F7G&C56]51R=54J!]7+.YD,,.GCF_!W;
M0IV=>?LZ&P;USH82_T]^#/^[?5[J?5H-]QS*$2E0[D'0RH*G+0NVS?Z1F/W$
M3UA%&$?8)@S[R?R=&AUG>W+MZ'E;_0_#OV5@B)9_GQW_ND7^?4]-#^/D8.YM
MG(/_Z7-ON<*LY=[GQ;U'W]W!C-G7"MN3;6UXYHM!X_R#0 Z_,LJ3XPX4@FBA
M!\=N?F=PW\*[K(ZZ"/KE*?#%PV2!._BY%0>W$P?E3-E6'#Q1<= _'KA'QV-T
MY@^.W./7P97;'V8QBH/Q9-+O3__ANGV4%OT#S/3?XPMFF GSRQYV.GOK/L=+
M+W%.I>OVK]C]F2SXKO-S&&?!_#R"33[;T#<:A/ZC=_[=6SG_!UC7BX)S$ @7
M,>79.]^2/-U7ZW#[O6%)[7B8L#YQH$BY^Z] :WG@>AZX+SVTS$8WO'8>,$/M
ML27'/<1E"X+'_;?G>-T^YY 8$]08@^>PLM'P'^CC=0=#]VK07["4@6?&SCOJ
M;9Z$:6"C9KVG[N@(P8*5=RNL5/:>_7[MZUPHW_+:H"!$J) 5&RW7!_WNKY9,
M'PZ'6J9CDPY.4+JA?#^!@UTZP_[S,"I S@V>I9Q[CBJ5BO=-QD?3T;'[VG>/
MQH/C8W+R#Y1\<R?.![0'OF'_6"/3$-A]?T=_K:>_NO*GQ,^WUM$^>AO''5",
M;M+J9T^L> %MPC8WX;G(JJG;'V%"HS^<C,=CEE5CEE4? B\-E'?CUV"6<&R>
ML@KQ/PONC8_O/I\Z'\-E!N+ALY=\)T'C.A^PX1OJ"I7?#]3W#!U8D\FPMU0<
M/[14A"T7S<:=MG*Q?77[ZO;5[:O;5S^+5S\2W?:9I> _2]UV,C@:'/7=HWX?
M#.]C[3]ST8$&G]L.M(*2JYL##@8E)7<69)<(=O4Q2&"58;#$]/PH2P+G0^9+
M,_ATGE]X6J/=VS-7F_=S/UHK^^/<(2WXJ-5:GVBT9=QZ(9^Y]!M62#^5M/A[
M''5-WQS5KXE*D9)PKON4.']$(+->?OGZQRN3_["_I*L-0K22KN&2KGUU^^KV
MU>VKVU<_WE<_)FUU<M<9B)/>>!]];!L,&/'2NL->!9+A# Q'5B-OTFGA"2C7
MSS*5R3T>'O4I:](=#(>4->E:69/N/X".K*Q)2S/]G,/00#/;F<.?0-DFKT,I
M<5@Y'>I2AV]3XXL)>(W(_!5LU0?*_&UI^'H:/CCS]V;FF>*"<9OW^Z3O]NF_
M_3_/\;9\]*XHF8K;GW:Q94.\P X6JR@LE[_2AP1;@XQMW$1[W6:!-S_'81#;
MNJ97N.XF_O131X]:I^UCY)2[+"]W^SIS=- 7+^R-LD8Q$[FM,+]W%CYN6?BY
ML+!=M3$\?IVN5ED7J;P/'R,/_ULX7AQ/^[/9;+B8S4?'Q].CHZ#O#3UW/CCJ
M]X]F_C_@OZ?F+OW$)>(GEU[B.S1%YRZDP%&5W=>>R*X3T?9INU/7[-3]7R:"
M&_H<+A.WW]XF[6UR $>Z W.;5 ?SC7UV=Q?,<7O!''I([06S[TXU](*I;?9Y
M;[TFJ]H<;G=)>H &E)/2GEG_V:Q>DFW?L[;O6=OWK.U[]D2,A0<'6-&4V-H+
M#^E 'EH.Y'>K]3+>!(&H^#HGX3 -OS:1]SDXDA^ DQ^N+5C+PC^8A8UM9)M)
M;I]86G+W@84G_T R)^P?M_]=<HMRT#PK$XJX$GW "&KN=A&3]WUCD /_A[=:
MOW5.TC2>A_!K*QA;%:F%E_(#^PN+22/RC%J$P:;3\\Z^U7>/T^ R=SP'M_&P
M3:=]'+?>M,%28N?<[D1*D'=P,)#F>MTHSH*U**@>7W$L*'Z'+W:DTS)_<P\9
M+.1]3MFT<$H/><NU]+L/_5YO)_7N\J9S^:8;/'$CZ>& '=KKH@GLMDYB)/TX
MV2#CC8XFTRMFM\_Z"P=OCKIK0CHN1-Z*VBW>_"8HI]FU-T%+FC6DV=X$/^(F
M&+<WP5-EMQI><X>3UQ7J5I2MD_UL!HW\,RE9#=<U[RA?$QVN44AZ6QTZ;FQ)
MW+-WO;P5S\%!,L$]'HS>MGZ'YR,^AD=3=^@.T LYH?XG7;?_#VGF=XK)'C/5
M:QN9Y4,X#Z*=DF-<XV\X^1ZD<<>X&+"TR5L :[*W_>X<[;5R@Z3$U^ZP!.D_
MF!P=#P<WK-8T4&G/0Z>8MCK%<Q *HE,,*5XQ>*UK'EUJ>H%\[V:Q)P&+$_69
M@%T#^^TA.!S]LW*#;Y=OW.&>R@<]8DN7 R0%&+A:=V#^A\<MV6%WXQ[TU;0J
ME(RGS?5'+=<_0ZY/ M_#/'D/>:O+-OP<;C^E&ZQ6F(3".?)IFGO(8%MZ@6;J
MZ3TQ]:!EZOV8^KAEZF?(U/HJ'Q:]<94^XG2+BX\/Y^*;>Y"'CY*5'ZJ_UC,M
MBGON/#T<O99.=,!L29!FR%68591FEGHNO66^R/?U]6V:X_,EL!1?VH/]6794
M;C[S'_>;SB3RZ3GPN]L,9UW+]0_&]3X8X:EDOPK\4)BDEF6-O%B?'LLL7O;7
M[7&C%Q-G25/7:;.'JNNMP+@W@3%HAL!HM?\'E1F#LLP ;HF1A0\1&L>MT'@F
M0F/XT%9%*R[N7UR,<-Y'8UVGX%Z)B1%0W1S\6TR+AP=J:,A.B(WU3GV:U<,;
M2\7%\*"$[%(6Q2W"H2 J_ROWD@RV:%,A+?_KSALDTVI'ST%6CEI9^?QD):E6
M\)&1$*LTCD(M'S*/)<0^HH&;\ECNU3UE0[0*@LSY"J]]''+A]_B"LR:F]Z](
M/8!<:!,QG[- &%REYUYBYV3>H"="*QF>I&28M)+A&4D&,B:&KHG!CMUE[$4Z
M2WM'O*:F>.?78);8Z16C^RKS'%<(B?OQP.@E2[QW]*KWM&5$FW+Y[&2$Y7 8
MD!_VBK.O,N1BJV%S?;H5 P*-RM+@YR2<?P^62^=OP88Z-P=)Q_GPX;0N_9H<
MLW> K/\@'@?G:<N%-BGS^<F%8RFE]+)5UP\1R'B6XZN\,Y8*OUB?52%";)0A
M<:"B\%OO<\_Y&">H(UB,B))C3^'PT.5<]MI;!-N;(=A.2WO6(MBV"+9W=97<
M%2VW"+8M@NT30[ ='/^_;5SI^2A\@F [<L>#8?\8$6R/!M,)0=BZ!WB.?\NC
MP"DK>YRG8R?0XZ?X]_L(IH3M! GYA3Y+@O 6P%_WK-_9RWT&L>9AOY4)K4RP
M^B)^"<[0]N."VR\XG?3A9<(#=UI\;C*A(14!K61X&/>0ZTX5TA:5[%[I8OU!
M5E6I/[AYI7Z]'*G!\.A45_56 ('<'GW_WIS-)_E9GF8"$#2ZSS#40TF8MH3@
MV4L8#VF]VY]<#4:JCN#*S\_.BF#\!4DQN%%P6D+2K(2@]$DQ'!Y0 OX!CN=^
M;XQEQ T2%,]!%1FV@J(5%-N"XBR(PCL7%'^%0?/4&8Q.#RPCFAPB&%J9<%N9
M,&IEPK.7"2M_:.H/NXLX<?M7_[P4F?#M/$QJ"A&5F!"N&1P@)XK6QS7]?O:6
M'=-6=MRG[!BW[LYG)#64NQ,X:N(>O?:GQ\?]_N#@$(C5(,_=VUFA)<4=145J
MQ,0.#RB+A!_3*'#P?$3&I!49K<@X-$+2 )$Q:$7&0XF,:6NA/#O!(1;*&/\]
MF+Q>>\O86Y*-TBWAI, GNW!1T']!K#(^S'UQDL[!X E!D3GWDI5W(Q#CP[V;
M=RXQQ"81L3E^VH5[PS;Y_ED(!]$JQN[T"/L8^>-)?W",2L6@'% %IMR=?%_B
MCWO/OV^$6O& 0N*A=(HV>?,Y"HS!:#P][K_^O^R]:W?;RI$N_%>P.#EG[/>%
M: *\RQFN)<MV1AEO6\OR3B:?LD"@*2(& 6Y<)"N__E15-RXDP M$D 3)/G/B
M;9,$T.AZJKKN9>G]3E];\%P0<P$KKO5@E!(.)M#;L-V,Y;%]34X-9$+<XD#7
M+T8H=&3VIA0*6=]$+!36^B@.(1%JH25<G$3H-+7_3PJ$TQ0(+)P"[_%V7PR8
MP['-E['G_8RGI%@T1O=#%, U ?"1YUJ1R7GY$UU*RD Q-Q]Q9&[S/&WW/]N_
MKEW/_1K-X'H3WL+%57Y'0II76H-\MD!3T[J^<P,;2/W#M^Z1IB"R[GW/O+&\
M.4C0SX[QV% F( &-\+\:]J_P>F+_8M95Z$< #-OZK\;DJML%SAXVM3^_6WCF
M2'H.3HW%=W0KMCI),["A]D_TI6MZ6_ME(\"XE!!84W[X!A)4(<2]G*\'3=>R
M!]YE3"Q87W9\7"98NS;!!!S!ND8([A*"?P71.,'P%U!<Z2B#+;8GL-V@+#[0
M][;A@_0\8S2W)9I/%,WM+)JC -2!(-;;W #-'0#T/1S:[!GL)G_J10&[];PY
M\]'W>H]#KA4;;CW'CFWP:Y_,-["K+&4>C4&&*X9I>I$;HE"?V/[L?)F@+47Z
MB3)!.RO2+2JZ$#R >XR2G+P1P FW4YM-P&@'(Y[F17V;P+>@MLPC'\<_\H3-
MU,)/K/L;L'>^1PY\I+6-*ZWSQGA+]H_6M>)_!8K!->N%FV$7CO[[=BOQ2CP8
M_M@ .^KJVR^'O="-X1N]U=+/FK-TR5FGR5EZREG_CEOWK^ M[TJRUY'8JRW9
MZS39JYVRE];ZB6WWUYY<GVW7<$W;<"Z5M8[AW&[KH!@>V[LMV6P'-M.S1E*G
MU1FV>D5LEH6_-E!^;SXT;YN"$;1VMZ6NYQ6X:TUX92L_Z;[89=A'C_%EAH).
MG5\J:0T_[&N\B8?I&,]CP_S)0TIQ#FIQB^9F.L7W:FP$P& 8OV5NP%GS5MQ*
M.):WC 8C%.O3Y?U\-5!,#;K[^E #)32^/M\$57R"S1>[\_#P>W1'/5J5__WP
M_0M /0@-Q.I'SXPH,>**D&7'GUOQYY8'#W>]4#'F<V;X\ M1HA$RE!UH9'T$
MAN0#X\?,-** 43\:>DYH/ )&?:9@(81E"1 G]T@7%#_O?.'Y</O?$IY;PO.'
M\<MSO=D+B+80)# *M =SRF9&@M?SQ<GMS1>)D]?CY-9PS,CA9_87V_V)1_E&
MU,B&Y2L;E@^6]DPV+)<-RZLRCJK"LFQ8+AN6[ZMA^1$T@(^?/DL-X/4:P$<V
ML5V[G )P^J#Y<O-!@N;UH/EBC)ES27BY__[I>'B9V9;EL!.'S+W/,+^II*EQ
MZLCIU  U!W[I6P\6HMR#C;/"[?6&9[&C(]@(%MQ:5$D$#S#@$PM]9VG7 >UM
MK32MLLK45II9G:&\#8[+J9\G#?+/%&+ 1COHH6T68?/DX^A'CZ%GS[W#4SCR
M73N8%E+YK ZIY0Y$EW).W7L^ZB(!SP&P T7$=96I\82Q&>8J'D[ Y2>1Z<WF
MCDW!'@HL?F>/L=_TX>I_E+N0S91>2WLS?OM&:[U]8S^]3<([&+R)RVQ=O'V@
M6 P.QAF=<N'4"$4PB9^+>$N;!Y%FF ..V4,TM2"@GX4O<Y9>E+EOZ#,#!QL$
MRMRWG^!*Q?/Q-)W8F"D.=VDJ>Q=3!R;A_W]\$^[PZI6HM!:9*P*T/+0=F""O
M*'F,@NB;,(VE KZU&=/&VS?=MTW, 4@']F").#UFPN6D$D3SN4-5XX;CP ]@
MD^<ON$KX9_+0=:MERL.G6R6:(_SA%S[[(V)!F 'M64G=-TL*[<6<JXBBE/*(
M@P04.9 VE9L41H"Z&$;Q]2CA8H0_VX"S,8OQB))U"55GCJC_.#Z>#NYQL# 5
M$.X%=P%[DS(PT'Y$FY.??B(ER?-?E+D#BX,/#=_']!_\<8'>OC*VN2JZ6!1G
MP\NP)!M.WLF8#7N:V6H9G;'5,;0._$7OM\R^T65FYY]#K;$0EMO;#N8"&12O
M)!&O]9IQ<M4##Z7FWF;MJQX\ROK5<UDSO^.'#D+7(=X\/)5X<P6LTFF48,O#
M,)'6A<UYN/O+UYL?OW__]+ 2DV6%1_8RFRH]K]N]0SMUVV@D9;*F\3#%,]3V
M&1^.Q'N*D;ZHM5&T:MTWUMLDIWI%=0-\K0W;'9Z<C=T,F:46VD@1J)%D05E<
ME_6YC(*5P#$?P%["%T)9'+.IX4PPKQ1O1+%J\0-JAARY<!'=SXC"J>?#!EBK
M!<B*7=^&5AFV>%]PF\,F7?2ZS<ZP7S;G0ALT^[U>):D2[:;6*9>FL>I._4ZS
M/VR73[H8UE2#*TXK>/C]M]_N?B@__OO3]YO[3[__N+M]4.Z^WA9Z%Y=.N\%K
M/=^]5[NTU^PH9X Z*,4?7JY+J,7'RLC9VE.'&3?5O\]1*/,N> =W&,-*E+\W
MQ>B]BOQ3]8'?5SC@KNG<^&&'#KM$+%89^3IJG=1*L![##A*1UI45W+S0)?[T
M=FK8/CQ)>7/OVZYISPTG?\W;U6Z1J@Z;O8=93T(HE#N3]N&W/H*H_\V8_C1F
MR3 T*>FK3>H\!0'ZT6^NA$$-9:A**4L4/./3@<'N-4///_Z:I12O <,?7XH?
M WI<E+LSQD+EH:D\>*Y=:32E/O0]#8%^/"2L1<%1)#F)\6]SAA4K[F,JQE>U
M8LD*]:QFG/OE2IFZ,EB4R<7M']AM2W&!CT;(KI.2=FZKZ6VJ:^]5Y:3>RBMZ
M2<&88>N4@C$'W)A-08171 OL( Y98JB <@:$PW_,'.\YC@1,/ ?^A=( .VA2
MLI<;!PO$@S-1!U%H;QISPTS[17C\4XL"S;8(.6\*'[PRUK-TV6'C!<-N4^MW
MR\8+]':SK:]WS9?P_NN#2N(%W6ZS4_)6^U^4AO&85P0QZE0?N64D Y6G<RH+
MW3:W"37%"WQO5#?*>'16:L#KU-]ZO?+&\,5^3(23<OB\PC^]O]DC=+-K.X1]
M,;?)#E_M8CG"?!1<49$5<GB0%1KHQV+"M&?7LFUS&4)H?P+H0'T)5C8EJ(^O
MLBZ>SWHA;U-(YY#>T)J><36.'\A3]G"GK#Q+3T.BK8M.RN.TIC_;7QOF>OB5
M2\3<+N?$W27.<Y##M^0A6#;T)(^CO1Q')R01#B0-Y&DE3ZM7G58?ID;PT_"5
M&Y!FUB6?5?_-# L#C5RN,SJ*^#%UDX[I6S)X:GHTY1<LSR9Y-A7DQ1V"]^7)
M5)>3J5Y&?"8J][FI?/"\L 9NR4,[,I9-'2F7+\B%M7?T2]$K1>\JT7OCL""
M8]\WE%L&?_&D\)7"]X*$[P'P+\6O%+^KQ.__,-=EX12'[_D_I>B5HO="1.^>
M<2]%;EU$[@FYP5 >_Y5-)LI_1^-EW^YE^<"+0Z]2.DMO,6S._EE$2F\IO5^7
M<N,%H3$QX$ZN\3B]Z)0;*<*E"%^=C'(8/I%RO"YRO%[&'XKJ?T3*_]J&]'A(
M@7PA'@]T-N\+]%+0[D'0'G]D>AT:I&BK&Z24Z /?3_K UZFKRJ9]?DT7G=%I
MC&D?MIIZOYKIZOUF5U_??'R?P]4)@!W-'!C#5D?O#+6..68#K374!Y.6Q5I6
MWS2L?[:N6E<:_%];[_<ZO49"MKUQTP[=PNNJW&TW9QV'B&[1_%SK['Y6''-T
M^O[GYQ1O[]W7CY_^5_GQ3;G]]O7AVY>[CS<_/GU4/M]]O?EZ>W?S17GX 1_\
M]NGKCX?7:!G[H]4!?5(K:3*9[$.SXTNSF.GY-(?MFD99X*]@.48=EJ%,?3;Y
MK\9_;#ZGM5:[,1)-NKR)<@>WF#,:AR%Z;C&?6<I]-'9L,YM=_MGV9W]^9^Q?
MK!:KULJ;^]N;;Q^4NX_7RI_M7]>NYWZ-9G O4\'14K QWW$#S"NMH;C&#!9E
M,?OZ)K)LL,1P[7=6@PZ2R547#@>]/?CSNX7;O*+$N!H'45:5J0.43A/1PW86
MG'L;(2>%4$4D&V*/!I?.<^S;IWPP'"K%>9@R%@8K:"G9\51H.^Q*=CSV,DJ0
M3-.7V/$AA/\DG4!%53<VZJ12.6\V]]F4N0$V!OGB!9)?3YWXPY[DUV,OHPS)
MNFOY]2'TS)]3S\%Y>_^I?/HCLL,7R:(G3N]A7[+HL9=1AF2#M2QZ:P13Y;/C
M/<NS\]2I/!Q(QCSV,DJ03-=P5#5VC0\]A2AWBF^P(%K2_D2ID)%BY<0Q.ARN
M%RO+'OSNOCSX,DB.07*]BB YN2KW%"5_93Q[W9 <39^7'[-]A'GO1*%7QS3*
MA/YW2B<X#%PU'4<>T$B7-;&:R60OE*"'*X>/$=%S/WB&3WV=X@P\[J[*6L-D
M'4>SF1TJ/Z;,-^8L@H,M ,B8^=$Q!R<IW:RH#53Q/G^;VZXMIN?@+)PB-8!V
MX X1ZL+GH#6$ON<H'ASHF9]SU@&../X6K"7PWYDR-9Z88F!8#S@:7]H =I[!
M,EZ0H<VL5C06(86 0@KK*$^;9,-O@F@<V)9M^#AEZ W>OG'+[]YXBZ..$%O,
M9+,Q;%];HQS'+ET,?\%A2*XE)BDYM(*%Y00+]I^WZ%(U%URJCA<$*OXJR$#W
M__['0-?Z[Q5&[AP^ VFBF&A'3M".5":>KS##G,8CE$+0-YCRP@P_B&<HP4-M
MSU)H7E/^353XF>E$J (LO(9+VO(;S&L"MH(%.B_PW83Y*%5!B8:-H:U:>-U)
M@J[TQ1MOFPK0T' "+T](L='_B8L5<#6S<$UOZ,=P7442%6@?,)H19?KP -\V
M%!:@&F,#&"S<C1Q+7-%'CSY7J'UCQIX]_Z?R1F]I[;>*'0010NHE7BK@*(3=
M15#-\;5]7,XW_]%P[7\+N@HR_("#W8+SG%\5!/"=\N;VV\.WMS60.&O9[<Y5
MO,@'J)*84?D4KDTT7D3&&$BG +(#/(LGANT[+X@R@("CS RB#-(SF .P OZ$
M]*:Q@ACOI$!(*48,(H<S'++W$M/A1U7R#_X*]@?N,T,.?;;#*8DGH6W,>=,^
M!VCSR%Q8B0-\!-^S><@QB4_XW;439Q&M^X:R$PSL8@%<8Q>0)-Z6F0&, __#
M46RKMYA-)IR)3X#-@$EJP",E3^4/1F!S,,7G\_%?826;XURY'PO"%^X$Y@BR
M,E"#< -O8&.Z*[X2D"780@BH].,8D BA5\".LS'>"!G5" (6!+0NP9_)+5WX
M@EA\^SOS@XYC]+?DC<41FPPQ] H O$IU4HSY'$0%_HU,?N4.]D(9WC25;\"P
MR3[:#HH&FYQ/[!=*QB#FYD2/$\1(5K-9YF8&(K[F&$W8&&4+G<D!/ZA]^)\R
MYW931I)-P&Z"RQ/+BB0=/ER86+%$RC8GA6<'"#J%:^EO%@3=6Y'>]9;>!!\K
MAE'2*3)&T*0F'3U-"+1X=F7\1)1[\%#?(LTO6=?OS8>F,F$6"ETE2&=:.L9S
MD!P60$!8/&5V^Y$CQDS"6T;.XH&>F8G)YV6)N9B9\SV^);U4#4386O[_.S&T
M%9E(CQ0!J_828.=:0,)D/_A+@E;M!=EO!07A)P;0#,Y.T,9I8^ 0Q2.2[SE_
M%%#1&Z.H@*N,P'.)",#QD<_[\XZ]".XQ97")OZ4:@B":^%Q%2XY!I$_\$S6Y
MH14Q8D??!UD#_W_BP[*X](E_\II3\]D(,F?RRB.Y[O#XEB)"$'SSYB?B5=":
MJS^>R:S(YXYW+LZYDF8'/X.59-KZH5O1<\5Z$*)<1%M<HB"4:5U-,!I!)<S\
M.'DW]@MVVJ7C!%E> 3D6HBBU4<MZP@E#)LJQ1^"&V*(R9B@/N=RP[, $0T_<
M<[MWY(>)H(;!%<)X-4^&$_'1"[%9G-<[(Y3S^'"<RFM/0-K!!L.R[1FIFS/#
M8JA\I3H #?A]9H!;^._2(Q#XB&BAWAM95;W,FY0ZNM,7Y@*#3EZ7'[DD>_"#
M<KH AV)B] +5.2",%)#/S/A)6@;[!6=>( P,W#AZ?&[W+88;S(_E9"+&9GTE
M.8>)@K0L^#>N: WA,Y .$*H>\4 &L$1!H@A@$H]4%Q3Y(, ZS1AWMF]&,]P^
M^()._C%S;/8DA'?F3(#;(K)A;S*">IQHO!G;I YRK:3F_FDVG]*K &U^,\"^
M7]7\O0ZB&1=\$Y 4B0@F0$L,:RI:K!-M(3&SJA-.[ 9013Z'2$A>*%CFQ/=F
M.7<56LUP)@O#.?,+Y <$.>E'S2+=.F:55%@ T&*AB(J(G3YGEK\<U0@Z0<#&
MMA_A581-,B."\7.?& 1X$*S2<79G3@^2'QD0CCM!<#^^V/#6J39Z#GY=5#%N
M%'/)Y"EQ'@1HHJ"T Z'*Y2ZW&F)15:A1+A[+/D@[0YAFL*V%+A"AT<-A-S?\
M!+Z%V@\YDGZ)%YA'_MP+6*$Z7> &*CRWF\I..\1/BD"H-7.0"69LO"PK06_L
MMWB@D"HNQ BIL(P/RH W]C&T;?&?DY\IL[\6@PL=%5\B0@^/P]W4W.^'CD&'
M3#;TK0$9 A04,:=CK:QP]R5Z)IZ 6:V3-N ]K!$7N8ZZ]"J+CR"3$E>.>QQD
MCD!$"D.'W5:DW8&(L5>25$V3V7,A\E;&&"\JO-Y>'5ZO6Z#\X.*1_4+7AQT2
MFRYR P%[S!!II+Q[KE/H!#$B8'X_&YK(^/DX_\4ATV5VPV^!Y3;Q7"I1@8_P
M0"<V FL=-@'6!**!F3%K16Z\'F*6/R*;0U5% T7%JS+B8&E!B0 4TH$8"MC-
ML41(*=7:N<(=Z].%5DC-#\8/S#1@2^+XA>V":H\4<U(]0"UQ$LR,%PSFQ12B
MC2:Z+%C< 8\UJ$CO?S$S00S";5%Y6[1H0)).(@2I")-PJ1M$XW]E''6I>256
M&]"JQB";9^A< 1#_$:%6-TY?G?O7 A%>$?HAP80+>C*X'H6O!V$"I_F"RRHY
M\KP%PP@?C.\/B\73J@9@**D=WJ(;TL0I4&1'<YOE%,(-9KQP[@#@NCN2;A:Y
M\#E%[QG8%ER[$U\;@!WR/J.Y01(!;16 L8C*)<Z$[7Q4W"]I!(N/]?QEU_/"
MUP+%_%%F$@9.3G;4GWC8G'NYN"(0")&6^'NX?\%GJ:S:UF:+Q?%;X(8GSWD2
M+EOR)=JDA0"W. YS'\FW(;@/6)3XA9B#_5+^%5F/@M5_3+.O*!B[D#Z@7GNP
M=A0@AH,$P7,&9 +&MC.&?RQOMS$_C9_,177,4)ZGGL.$SY4''N Y*CJC,HL3
MZGHQ>@@PJCBD2&57 J[0L=S2"F^ _@LWZSS+D\V#==KF%(1Q3.4Z"XUB_OL4
M6R;?P6PV?'@;FL0*)X+CS4D?N/6"\!2DR'*<S,^^D)5Y(5*@@B2"23']E4%\
M% E_ZK;[S3Z<BHY#:@FP!"<\F)IXEGINELL36V_E DS<43A6@P*OA%["7[/^
M <0VXEW)RHG=.4UED=@%>\.CC'80\C,T"#/.(%@?<@&J%<5+0*;#^)%BH@,6
M7R!8S"6R?>L*6!',:\ H)P43%FBR>?RAF!H5A>BI5$"ML% A!5D&FBHM0\2I
M4($Q 1.<A]%M%/\C^V:I'VKQ-R$*W"#KV$9ODN%&$[@"U9?%7R8R>L&=1>XR
M,I:(E'"')SB?O&@-"DGA@4<$7#'A?EJNU9*O[ ?YL0Q49-(05FI=FJC3. ZJ
MW:H(3?+TK+GQDOX^:^1NXH=@ 2,GP/#S9.QE[,WF)U;L>B9E#LP__BD=LL4!
M'VY%(S2WYEZNBA2?'/35%!:;T4,-WGH$=61,)0!N7[.45+-8EFG;RI::4^_&
MLOQ,D"7>MUB%*=Z:I< *W_(DLL:M 5=8E<12\3U(&Q'1J;):2<R'11&_..)3
MF'V2V#-+%-T *^&Z+'CL0IA'Q=@AOAI*#52=Q%*V12]%* ,#U3\1KP'5"K75
MS ;GQ3XO7J'4VHQ<XN)K44JK1$P0[@'W;CTQ$7'-W"(15.2JF) ^NO#$E$8D
M*-^GRNY2?,UTP/JG^"5WC:^5NC5G#UUTRRW=U>@K?)#T-.HW1O=P&7O&PVH*
MYQ"[]3 D$RA?OMPOMSJJ^6Z4WHDO'@="LAN#QN@!EOQ7#]U)MZ 8 ]A<[,JZ
MU3X<\%7CCKG_]S^T7NM]KFUN/>D3I^'#Y4]<TR@ZN>(#$(0^2&MX+:V9]W7O
MTH3S,KZ\R&A IYIBNV'MB^U*UI'5J-QNZRJJ&JUY3<>QU6&X&JS[#>7IP*$.
MR@TFE_W".*,23"G7@6>UB7_!JQEO2[_**]!V$AV0>WJSU]%+=4!>_7E[4$TO
M9:W7['3:=5Q4OXH.S]6V:Z]1R__B9KTY_^%!IC[4>P\Z"WNP:>R#8?Y\]#TP
M$Z_$4DV3@7%==@Q/Z,T//_#AAF+06Y!\XUMNZH.]ZOH2 QWJN[+2$)G0_SL)
MB-R*("5/5[A^%5:67K<T1>IZ?46B0:'_MNL* ,R539)F,;;\9#B\0T^U8J/,
MKK64F@]1^M/R[I1ZN]I.2!*NK<\^3TQ4(M?FCJTHL!I+GJYN0[&8:<\,)_BO
MQE4[]GM%P=6C8<RO$5<WKH7_^92"ZB:\-7P?W:U_,YR(-<@G;H1@+_\*K]UH
M=F5YU)X(;PLP@QUA!#CA. .+6=>[JM[KQ;ZR>*DC[J+:A2PQJVY-GFH.+<D7
MY\47O</S1:_5&&FMCCKHZ37ABXI4IGH?G=]9$/HVU:7BX;DWW4DOMV^%0N)D
MV6G#,9/2 #E*:+,%'*(U1FUMYU-C#4KW<6I(<.PF:[<%AP[@0-=(+<!Q$5;'
MP]3SPRM,A\' /)!IM@^38RLFV5;-.EDFV2!!B10_@!)W*2'*ZA_MQJ@S&*C:
MH"[ZAP3/821L%>#I@/1M]=7.H%\3\&R0P''4"!;*5F/M^+^Z"!W\'JLB;2N3
M,XI-#7CNZH)K4VKG1SA;!'4^<>* V?L-*</#$HDZ5DY:=!NCGMIM[RPKI"I?
M+R1M.&CV@*1>8Z1I:JM?%ZOP4H^=$PJH_O!"S.[?_6 Y6!#SG$3$AL-F)V'0
M;XSZ>DMMM[2<-) $KLD9L!.!!V"BZFVUWVVM)_ KQE><3D3[V->?\]GPU7.O
MS JR*2J2'+6[_D+,4:QJ$?WO,9EBSML4NBR4!NA1#%!.CWO'<$.P&C[%)/G*
M2I\@0[ 7U%9W6!-S04+H4);G.@@MHZ3?:HST;J<F&+F(6-*WI+6CPPQJC O?
M77F3*^S/LV<;[:)C QMD;T*7+TB6[_B0;Y/? T9J?$GAV]> K5IJ;_<0O@PP
MU0M$&Z1OI2#2P<A7M<[.TEDF26V/A;]XGO5L.XY4?X\@@N/-+\LH;9"V:JO
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M; +:@V.@(>A[\#LU0^B)[0>HS%Z9CA$$ .I@#M;C!/<(?C#VK!>!(=06@1I
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MD&6;OH'08$%2_0C_A5.)T;G+/1AU=T^_2C[[AHT"[=%'P3SW/1/#!Z5)WME
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M  !GBQ!X0.Y/+XG9YA.CV 1(CCY8[F/D:S,LH$W T W(G<S(".,HP(@N<41
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M<V=>2+:#\2KR0XJ<Z!0$]V)E4N1SQM9IVO(D>W!EM(ZDP#$;AH_KU3 8AQ3
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M<FOXCH='N>B)DSYP,3&D^'7=3#;+1+QIMOR'[QL=>CR-4K@>A.Z3':*@+#E
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MGMA;%I:_5CB$UP%XD+N[+<$[$(1Y)^@R%0G_#4@301!^96!1@ZOPLR@L-4;
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M\7:CGA$NF 4><#MS4G2.?5H)>YZW#Q,M6U-4@3A4_,@BY'3:1\OL2"LSPJ=
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M$I_Q?4NP[WZYROQ**)EN\A-] BHE#,I_DL/5.JHA0+RH=$<K.Y/ZWUE\?[(
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M0Y&%#E$APDO^QN=PG\SA=_?EFL_A7N \I@/.:-'A)26/\,WU'R@!T#J-!EV
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MHR)=%9,GQ]VUV9-[6O"W<]CCH&I6Y6"$T)=]&6NIA@6U5"V!')- UA=GG(9
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M44R*9(+,=>\'1RT0;^>P!S8SH]EQ&\SRI"EVF,?A0%C8ND$!!/$52A&/@;8
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MQA&%7_SL RJ%;MJ930:J:4,--UF1KK>738Y[G=E8,5%QAYE/_5Y%0ZK];-2
MC2HB"_G93;J8S&P!7J_C((RME(:%T*/A2HBWB?@+Y1-EY&V!T-]) 1(R'&0
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M<9%SS[X@6 &<%PX+?TL2N+[ "WYU0??+7%R_E+")'^("#*YYC;PGB%EGEEF
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M9.U=;7/;-A+^WE_!TY?KS52Q+=MIG6ERH\AVQC=.[+&5YNZ^=" 2E'"A"!T
MVM;]^L,"I$2*+R H*69"=Z:M16)WL?LL@,7BA;___6D>. ^8<4+#M[VC5X<]
M!X<N]4@X?=O[/+[L_];[^[N??OK]+_W^/]_?73OGU(WF.!3.B&$DL.<\$C%S
MQ P[7RC[2AZ0<QL@X5,V[_??*;(172P9F<Z$,S@<O$Z*)6_9F],)^M4]=E'_
M;' RZ)\,!FX?G1[Z_9.)_]OQV03Y1\>O?YF^&;B_>I/7_J!_=G3XNG]R,G'[
MD\.SP[X_>'UVBHZQ))XHID_\#7=G>(X<J5K(WSSQM[V9$(LW!P>/CX^O'H]?
M438]&!P>'AW\\^/UO2K:B\L&)/R:*?TT84%2_O@ 7D\0QTEQ/I^+3'$>S>=$
M+ +WE4OGDF9P>C0X/DJ* S-2P9Z$7*#07;'W!.N+Y0+S8AKY^@!>@YR3_N%1
M/RO)6U<M+>;T0+_L.4@(1B:1P)<2K7/LHRB0)%'XWP@%Q"?8DZX08  [4R#U
M6B VQ>(3FF.^0"ZN8XIW/SD.0$3F"\J$$^9H?<0GJJZ<"476<S2<U]1%0GDI
ME.2)6KGR!S@0''[UX=>K)^[U#NI+C7A_BM#"2G*:1DN/G]C4H,H=BJI12 *_
M^@E='Q[UCP;2+QK78>WQ=G5(Z+:L0Z&+EX%BHE2_><UJ%#>9FD9("$#[NO@K
M>H[=5U/Z<.#2*!1L6<<+BTB2'S;^EV6V]/K([_-H8E6%I1>+7Y$WKH&'B8WH
MI#C\T5@F=CT;F4EQ^*.Q3"X6S$;HJKSZJT L"D,J% =X$C];+$CH4_U /H+6
M^29IHG?83T:-W/ 7#Y9'9V=G!^JM'& 4,6(NHP&N+GRP8'2!F2"8IX=.Q6#&
ML/^V!P-H/QD;_EPP_$K6)"F2$Y#M9^"UE("Y'*"4OM=KA1(6T.*E% E%@+6)
MVJR_AWU;_24)"<D/H7V )K;:2Q(<?/>*NRBP55R2N%'0Q.N!?"S?.\1[VQM1
M&?GW''CV^>ZJ(GQ30G7IA%W"<.V![P[5/T=.?SU+Z#N*ZO>#S;(;7"*.O9OP
MG?I[LTW'Q'&1"L(-J]2FRS:B0K+X86*]"IL.(X^(JQ!F0*HFM<V;(S1:>I"U
MM&+@I#ATR.HC&G(:$ ^FI.]1 .'O_0QCP2V\NXQ#!0YG9Z>#HU/P^'MI.;QR
M^34K)^;E:&8OD A^BYC4:H8%D?7<'I\L.R-8@_I@.3]G>/^MH^"MK,6I?R,'
M-E4UCD)O1.=2RQD..7G UY0W:VP6[(W@'E>!NQ;D4-]9BW*D+"<CS %I+VC[
M]X*Z7V<T\##C%_^-B%ANC7 !2R.J)_513;/_JZ,%O !98/7M.V$;_D:(3[>#
M^*6GSD$R0GQV&=#'[3OE-2<CC*_KPPA<'<6V0V#=L"D*R?_L)@89(B,$O\*D
M@' WH#QB6/Y(DW?(U/?2D(@M9=]$IB'Q9;<0BJ&K$J,DG-Y*KW3E!%T._7?8
MQ9E7C(;R3U>[:FV4=B7/"/!OFP#'DE7?N);MK"4XB705Z6CYF=>9&G3)1_ 4
M5+[#D*F5EJ@/]B:A$;6S'&J:A;/BT2&[#[]B3J^)]$..5: ?!&A"=3@^G#*L
M'+%^XJ06-Q-"KP\W$5)\G9AQ/$E(L796O#N$W(T,L=A5*&V//^'Z$&V0&;$X
MR@UBP,#1''YQ)(\.V5QK/49/M<V]IC!:>K!I:4WK2.(.F5@Z%$SY%YC=S^1$
MHK:A-^F,YC[>-+?DH+(-CN3A*"8=,OL'2KU'$M2??ZX(C(8^V31T0MHA\UXB
MPOY 080_8@164.&=',?N9S+B&&,VOPH?,!=V<:X54R-,IYLP 7M'\7?2 M3P
MJT3T08:3$M(A0.]DY1%S9](8Y_@!!W0!%KAE>(&(=_&T@$ %L)"Q/8NP=TW0
MA 0$%B)KP[N%""/8KS?!3H0I=%/BG%B>DPA4!6*13DIFA["_EJW! L>XN!&3
M7+I $W;(L'+V.R><4[;\1 6^14LT";"@=SB K-4M8E;MIQXW(RRY2?Z:KP.,
MG9BS(Z@3\W9BYAV";HOUB0;K$*_S<_ANKS8H]=_+[D(MU<F.VBZO64)N@N'7
MW$1=,>HK3DZ:58>@2/4ORS%#T@"N6MNT&/=+&!CAR,W5T_W1TDDSZQ @T@^E
MB9/@>$15IA6'KLU84L7#"$MN8I_B%B>S4OPZA,R.$O5)P6^]0+"26^T!IZ='
MN8:YXX4"Y^>D>)?66W<$XQBBMV_N/+%4H^OD.H^=NXZN2:<<9V/-R-8#BLF-
M4.8RCKF%IRZ"D5V0L(2BD-@(1"XCF5O3Z"(0JZ4*2PPVZ8SFSV4:UPL=7;3[
MQLJ%I?6+J8T8Y!* ^=6/+F)ADU*W!*H!:R.*N92A?<Z^BRCKQ*HE?ADB(S*Y
MK*$F[Z*UBY-+MC%7%1,C&L7I0B>?I^HB/NE=B>=8(!)8Q%\%M"8T!KFL89J+
M\W/,ITL0[&A.^0DQV!#U@&UAW)=\HROL/3$B YND4B^>M46V@@H4P#YQ^!=6
M5QY0$,<O=S*28,05LF>6[^)C6_R9/+!Q/8V>NO<\3-]1E5>[\7_1>_)3"L0\
M$A7T^T2);GKV1A8F!4*\5X'Z<EH_NCG_>"FMW&1TVT*$T9]J)(/Z&<>*)8*_
MP1U/(-1)I+XX@+17\]'/Q,@(9BZA5 1FMP>B6EO#;9&S8FI$,9>7JKWMO).(
M9G.OUC.'0FHC1KF\54'JMH-8K'*PC3O!<@Y&3')9J%0^M^O=WLJLD&6@H3[&
M"7G6]]BG#*]>VT?,]IR-0.:25AD@UW(@!E&Y8BTJ5:RCL>C*V!_1?RA+ W*.
M?<P8]N2[(>=8S412NV8;@]Y4D-$'<JFRC \HL1N>D$A61;1L-5:FI'?;*2 ?
MKT.2(*"/,&-K#'LY*Q.PQ[FL6P;8%6-GQ;G;H,GY.@U=Z;^J0FJ>=^'[V(61
M;%T("2PHG*:/!&5+^-D8VFT%&AT@EVO+.$!6?#++7-4@71BDPF[G537TDQ=W
M2:'W.63RB9R]_T]UR>]Q*,6*YOV])7^C,U0<-BQTAK0\52B1V$G8-Q;=83R,
M1(S,QCM;Q!NP-H)=XZAC'-_%H@#QH@T!+U WGE^9^!A!S.68"D'L]FQKP\CW
MV(V8"D OGMP@\K#G,SJ'C&VZ5>VPM387:(0_EYPJA']= 2>I@0-5T"GC; -_
M:=RK4\^VL&_2&='+I:T2#ITTN\U6J+B(A\2*BH;H#OR<D7#Z'G%B'57M2[[1
M#7:Q7ZN?E/0<)-(,9*M&SJIBCJK9BWL9X&T\GF\EQ.@HN4Q<(T?I=C#0_/R\
MK2]L+\GH$+FTW-8']COI$WH79N-&7T)N0N\DEWN+=X-VO8EJ,ZC_CBBW7D,L
M(3?"D<N$K>!0?SC K,-X7$9"FD7]?8N6:C!IADP%(R-&N035"B/--88JX?L"
M5X&5_SS:&6!_'KU M@O(:EU*8MO:K)@:8<QE"^M?>-))2 MNW&;QDJAZI>_/
MG]-0_;+>G-:(NQ'D_(ZUHKN\ ?MD=5<?F8@OZ)?RX@<OB&M,R(-L".OI%PEO
MHTE 7/UZ%Z#7$F#$/9=&+,5=R4M-*!T2.EKDZJ;W%^BE&89"S/!'Q+YB<>/+
MMD+"J6PD7R"N;Q X->5O!#Z7@2P!?BCZ4EY?"W02B:K=)S*["WSN %KS/<?U
MV!EAS6442T^V=7VN66SQ+QB^AXR]X0-F:(J'7&*U@!<<Y/B4*;(;]6CXB)C7
MK$7O4*[1)?*WTI>[1%*-?EP/)U41!VKBR*K$#'1E'%V;%Q=:F3&-%.R5:3K>
MVS V.D']$Z_]#7AC22\ KW%8G4TK?!TG6G>$N94LDQN<UKZ@;^- 6UFIY!!2
M%YVC[%X^^]6":CY&4"VN^>LD4!67]=EB58.5$2Z[Z_]^=,1^/\A^!5O_SGPI
M&[Z3C0-]L KPA&_T_KGY3=;AA LFO;SGH/BOMSW!(MQ3G_G.?_QU73XD<(8+
MONRKR\-'?<F;A9SG4 _J^;;G1?J 5\_AD20C(H)?'QB-%F][NC@1>-YSA"JN
MG\#1W'!Z)9\#D_57P/.:N'*NQ;!W%=XRZF+.DZ6\86;Y,.YJT_KY*.!K!2W9
MV*BMWTWT\6+Y D^(L#+&G(;2B]FRACDN$ NEX?AMO",*]BVXH ,)(MFI7=S>
MFZ"VX?#<X-]!O,V3:?5'/)_ 9Y^+]2HNNW,-/,'Z\!=_X]$Y(F$=%Q;9A$2U
M'F6EVZ")BG2NY*0'>^<15.Y6B5=^Q/7S2\K20_95*+!\)TH;YC8L]^6>6G9C
M<ZB-)SNU1AV.6_18KNP8]]=E52*<9,DNGC!SB1P0FSE* 9LV.\?66I=Q::T3
MI,^>KPZ"&SK"*I(V](9)VXN#AOAX-@U=Q&>E@%83M37L&$5S%?8^X%'$F(R]
M]5Q,1\(?I+DX[(_&,JI" 1QZ^;R0DW,4X!MV363@Y:ER=]@-$.?$)[(;8W2N
M#J./TM^OUM8HM=TWKD5K&Y.L((/- >=8__\JC#\*'D[5I@$5"MWXGSE6!TQE
M<)=]G^QK6ZI/X94ZZBZ%M-6QD^T5EW ^>'5;Q0,>0M<ZC;_G6&*A6K0M=J+*
MF=!X)B5-9\/,'1[JCJ;E&#^)]X$<ERI\9P>\]]C%BT1*#3N=$YBN3!3KFB-7
M)4D;1J[*:\/4G8YEJM6AW(&&GG@SDR69&TWP5?/Y8V5MKTFH>/-&NJ:HGWV6
MK*Y-@AK$%RD9)LIEQ=O@F=?0'PSA_CDUQTFV9>OC67"I6,FG>THZHJ;LVCI<
ME8TSJ2SV%R)F.EM.RTI_7OB,AB(>OVY"7.TP>Q;:!K?;AXKC1_KM[9H2VF:[
MZF0=Q(R3@$Q5)7A6D?))P!8L6QN,P065<2TKHLFZ%FK$K+VV:0RXS@W=^*DM
MGSJ5<A5>$QS)%U4S];W+?>X,57,%;Q&1NF@U]V"_+/L?PC&'GJ>6_U!P2P5L
M2$4!> <D[E#PD028"RDXF5'NQ*:V(LUV)B$7"/J*-N2/=4X\U:":3.%WPON'
M<-!SPK";#CW@6-=N'+&,]?<69!?I]A$]D7DT'T[E-%\^POMIRC6DM+7UVJBY
MZJ?N\!02O90M]V//>H)^*)/N>[3YOL>8W'V0([0@0J\B%.<P2XW6A%5SL^RU
M(\RIDCH07U__#-'WHFG^ZL@[V1AD& #[N4OSOI9<GCMQ6'QC8O8Z.UE93*:A
M?*=+\^$<,J'&74:[8/U=VD=&D.J;&_LP4([W<UNHN$/;N,M#+]:6]YAV3%K:
M@\1WAA3K8K) />*V#IZ?\.,_,.-X*>L]D@.=3UE(4'7NLYJF#:E+=3@\@GMJ
M:N]8J21I@T[GT72*PDL\81'2Q]^E^?^-X(PDGL%/P[IF7?)VZFJK7)NTJ0]2
MN_&XQPNA*E47D$*"-NASAQ]@SUUAF\B\LU!Y.YZMMDI#Q5NK6U-46XM<]EH4
M7JU22>$VZ#&:$>Q?/&$W@NCZQO>)BV$+0-ES&6=RXAG']JW9MMDV6]J@E;K^
M@1B!.L"T2F?UAT^D=*]/6>G=[&7RR!RVEM)PB[U,^1J>*U/4UR@IWTYTC-M0
M*DG:J9-Q"T@E21MT4MU[?(55]H:L5<)73=3UNJVJVBWE K[?219"+YZIO:#8
MX[#;6M^)DYQM*IT0[UOLGO(F"=&N#9NL_ZC\6)P$0E/9 W_"8M_6;2I[C]Z[
MT+78M97'C$RGJO87#^!6&852VHYG<KR#NX!V8^ &8MNZ<EJN]R?\",OLZ@.\
M#<R6)=]3ZR6AP!*(YGHNXYSEZHR/NB8J^:5.,P+%:'V(_!R',I .8072UBI;
M"MMO\U1[=Y[)D+"=-UY)\#SLC>DHH!PNGR<R4)41ZS<UM+DR[0"B\G1EA3&:
M'=>L9/C<V^+NC^_P%$YP*!GPV:X:J5\#41M"N=1N1(W",!(SRF!=>O.L5\6.
M  L>SPXD'/W35P-]B@ '^2-V/X!*NIL^3<U14*ZQ'1.+)9I]:'PC0PG9[P0-
MSBS5(FV#&Z< 6>V'2J*EZOZ]!F5; ZMTU=5H<H?!7++BGT,/L_$,&X-^&Q8M
M76,=P<'=&S\^]W[#U#ZDC;L!D\/PU:[0@-.NFW:C8;JPWDE%^56H!UD[M0O(
MG[OGMH9G2Q-8LFY'R#8<' X.=9@5PG28/.!;V0H-ERI4$[6A@U=55-$$/(?=
MZS2HH50)15LT.KD*O<A5+^HI5$+0!GTNYHN +C%.7;DIFX:Z/$PZE3I.6:V?
M!8.6ZCLF\X:*YBC;H&$JKE\?&XDWKL:!OMK!**LIHUW]@8HD(0.W;&C5+IX6
M)*FI>0*Q(T'/''(G=ZAE3Q"G-DN_7ZZ+Q!NAU:7 JTQ@,JU8VV/#$$E\!AUU
M>7CWK>OQO=K]F<W=$2N/:,C7Z\1XG0#:O44K1#W_,D^^RFN%X!C4)RK^A6'=
MBDY#R)3A,1VZKF3#($'V!^9PYX2>K]6PW YDM'3J5Z7C1O2N%25Q4%'/Y9HP
M;9-S6389/8KRFT@ E' 1QE#=URMUE2KK+FKW#;6>U&?N\:I#4UEA?3OGUD%N
M,:<VQ(+WD:Q >@?S)6$<[O<:SPCSAO*)5R,?;L>DQ7IOI>]WH>=6N'Y'>-[#
MX9K&BI90MT'3#S@D$<_5N%I! U$;]$I]GSDY&F.II V'-FA< HKL-[>WQ6YX
MM\%*ZF;8^VBQ")8V=\F64+1!(YC#1(&*P^LI5$'0#GT*]PJ;=*HD:H->7TC
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M'US[Y++BD?@_K:>$7N#RWZOU\/);^AS&G_ ]C?-E*9CF@V!CX9%[4+Q^2=$
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M6?VJ/WT@OIKPN?RE&A-F;]&+X<77X:"\8V??>^-S'S(-)B5B54"#B4M<C!)
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MRD:EG2C[,(;CX>/>(C_[U%IUPZ!T5)WA>#T<=7M-SJF((;,R';&T<I:EP#2
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M:NNA8B[GQE0_2VFJ,]]_/YS@[_1\O^S+,(KXM]][?1A/A@.X6G'IP&V,RIF
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M]?D<B\\_FDNBWZK4GVPMVMKO[R*0VU5A[_$G@TG/]]&K^SJKV9OQ\_UP//F
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MU^;*1SQN9>XNM0:))F=_^E'ZA+]\^RCQ-BD\2A1'8FE/1(Y6*6&<K3[-^!:
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MX/A X<:#L9Y$GLM33^&(%4P0X;60-+K,7.UW63T Y 72Y9[PL8/I&^#B"F:
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ME*'2@2)+Z?9DW[6WD,C(&19H1H,$D2\2XP)Z&^\R%B/CD7>C34/MCIW9\(4
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M">J18:KV#&9]O.C^:K-@^1?'?K$X)=^WH0+/XOE/_IZ\)O*9=-:R@@S"GZE
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M4)0\*N;64YZ82,9&!4^B!! X77IG@S+Q\.E]P9S6@@'%A<W=2 ;@FQV8+\T
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M<6) 6MK.W^BZLYA7=6JUM,%<XJI=/ [,GBH@D'*Q0:3"Y<-*7?^^/UA&TD3
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M4'"'; 0:?0#)Z!LDH!$:XN7Y%H]JU:KG,DI47$8^6>^+3YVG*C7M4. 2XI=
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MAI@A":RBK,31,&$UG;!^*F42X/%D)H$>G\;?SA"7215?4!'Z@$[14U;7XJ/
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MZ@7C;;<Z^KJ#>L3[0_B,=.]9L6>8E&LP[_A*_(Q"6DUZZO5^VBO<)BTW[ZD
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MNMN2(DRF.NKK*]N,;B5.[T9EM$IY));_TR/D([L<(UU\\@^C\V',^/814>"
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M,C84A??S'_;G5H _K1C\O]A[SZ"FVK5A-(H4Z4BOH0I(DRXU(@(""B)*%;"
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M18)LD+P262T6QZ6:[MUQ#@@TS3@'^)T#S@&7(]W''I6_K-?@N6CVJU7Q9^<
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M$SJX)7!6RU57CW5>P+IMII=::"\JL8L4>SA2?W/0![__0: V+V#\5+H$D6Z
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M6-$?A\[SH3:%17CJD"S3+](,R1[5%+T6P9WVD@29*WW2#>$@'3^E)3!:-H^
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M (A!C@E XO%#DOGM(V9A\#SLF,U@S!PKCU?IT<:"\,%C%;<N/C&:-NUS$#K
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M=8M%@=^I5AT7TVU!T+*-#7 35-..Q9Y_.&Z< (3X0I^.@!='3 :CY?R2'Z6
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MZ'K"A>.L[2< )&L%B*.583Y\8$O#OZW)(L/"RN23R;B60=\1B M8_ 5X/I$
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M H<YO#(,_3?@0,_!C2>FR3OT!. -"/U^#;1[2 #>(G""_XH<.G\AAR;<:P*
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M0U?'U>4P?B\<YVZ<BB$ U*3MQZ\(@.J;8)^SPM*P&[;"BZ>:>-B(4@L(73A
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MI9&-/UQY9T4YZO_,_)SO.*5?B=/!B)7"6J9T((4_BU?U-V!M6N[J[^HL9ES
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M2_$D:E08SLRY%^XFMR]?5Y +ZU!JY_)YM[+=SHV9CBNNM:<JO/]F#1_X.H^
M@X_]&)K&/\[#)2'[IP[+. PHK ?;ZE63]RT5'8\VQ4&1BB -"D3-(WK$AT_Q
M^WZ7  OW?7 H:+F0\W;[K^:3$/%HGA&#ZB296HL2^5=]HU?4S_YX%">'CHX$
M1MV9*'2M<G)3=6G8W&X!\9;@P><<4"#6X+@1HY\153&N\>AW[5Q D@3Y:9#
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MLQ>&G/<KS!%/3 YO?0I]YN\T/S)W^.>&4 5+PWV]1_E48,U;?5)PV>G"V*[
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M_.G)H:Z#R=K&HA\5/O>R96PK&[%&D<MT$MX8S+P5-/A%LJHEJ?J@9+TQF[K
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M?<W[5:3^=%U6\!+I%-_CS7>C?7#G<2Y:D^VJTLJ5T;"F.# BR8%XCA_^M5T
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MP/R_P:;G?YL-5!]DG\@<O ,&$#>A?-Q-X^3='/T;Z*CN(LS\VR;2@_\=\AZ
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MW13F@A/0:YDIFG1ME8%X4=28=K;;;@U_*AC0N699Z$9_U,<\@,([GC\Q\RG
M>]V AR]/7$4&QNJAMS;C!OZ-IDJ?&.Q%J1=MZ;?GXX:9;49)U-'P".G=#"RG
MQ4V<?Z?[ULQ 7D]96OB18FVX_FK\O>BO"VLGED%$P[M/>\$BON>ZCLZY/G8.
M0H*"=68VIBE"T&?ERD4FLVR^LB5)JK,F0H@0?1VC:VXW--!9I#X->A<YNT=
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M0;:;O^%-5I;4$NA+](IK<MN9YY-U9?:B\U-%N, E( ZW@0DSPL5A)5&[*>@
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M%?*9"$<V<I7'F>"LKO*X$0)X$8:=2_UR$"8Y\,3X#-*P<+]+=!4:']T,(;Q
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M37_.PT.]NOR;F&-?-H^/Z^?+NY(W[H+.I^$A%KI>[$ :Q+[0]0&&,2$1#)S
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MJ^<8'I5FU"=\_,[EW,&CG.]Y@L>OU'<\W6*R6>/R8U;5M_)T;!<#J.A\.CG
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MAEK(\!E)E.=5XXWZDT8IFSTII[<$Q@+JS:'3LEFKC7%2&K.2-7LC+5>JYI@
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MG:9<LM 4.=[;,L@BBN++HK^ ROAI\(OL*OXD8TL>UY@VVVF=6PO*.:N ?*<
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MB(-'2?VB_]P4CI89NTQN<\H*//*R#;);.'E7]7&K*<8?\"'JJ5:;\7<#82[
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MN0"/DI^F]AKO.=*;_CHPJ^F#F<#34Q#[N'WI<+O9XM:P<K%MP3,.G+;>,(#
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MK05/1;XM5KJB:9@RQW.AXQ(*D2/F/^$!AWX8^,CQ/2\F@<H*;Y^UV0V" :\
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M:3_SM>R:>H/+^OFVQ&(?2N7L[XLDO_M>R[2T(I<-5E?81:[G(Q\B%A.(DC"
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M!$S/&M%G8>[C*QD-DJZ+;Q78R!5/V S%UM6(M]S\2<^",$!:S8"8%S\]-=!
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ME#LR?,=741@X(0\Q# E)(1*K/,0D26'@IV)7[U"7$:V578OZS--ZYY7+.CZ
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MW=2%R!%_)=05MHJ#$$:Q0T,2Z_ANS-B8>5.P:U.EMX(:8JJF+>9'2D^'2'[
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MPYI!*99<2IQXE&.6R Q'E!$:A %G*3$NY.Z H8D7NW4-96> CZN"MX 1J#7
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M4D1!DD<T _4K M*?^C0^*%/?GKWYD!^T5*P 53@07T.-/!UJ0 4[ &Q[#SH
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MFJ28L%Q@YD<YCI,X\&,A6!88W3*8D9OZHD'1UR[UIF[<#:+; ^6J8P*]:"X
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M:&GKDE9_XP/']YY?>K8),=L()@09MA/TC*".$_1IBVK+!1JP<8,Z!MUM!99
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M573+VZP&U(M:CVVM'R)V9OE#N<*2!=5;H-Y43:WR[8^R7B0P92G*!> A9ZJ
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MZ.>E<[20CP:?=:&>%^QX(5YXRA:IZGY+Y%1]6*[Q9I&(&"=IE &(4@)@F,4
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MQNV%U0*VYX$'QC.>#\+P\LX!JYX\;A. <#;?$P!J"4>HVC=]W9\^-67;_51
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M0Z'>EM]HWZV"FQ3RTT1."5RIBRUF8H8Y#Y)QB@4\SZFYQ_,H03U8HL9@:J>
M#M#TM\4B_SZ=S29:E7J-7P/&8,A**P6!,20!N5+011Y%:^!<OKN'Z*HQ1HX2
M:P=PN.&Y7TMD$C!*%(F!$462AU:[F>1 ;GP44F?RT)1\[,#Z**-R'R$]!$ZM
MC<G) N\ -5OZ)]Y*:30S8$4=ZN&C@<A$O9.163:)9?OH6(3C'> >#$A#=_<@
M0780$;V9ACB=3==37)%OM:GZ^+R8D=!7U<]:?[L2#2(JR5.$*&.M0T8+CID
MR(UE6F=)P5]C@.Q+V[A^RN"'FX.HJ /+<X.OW01%4%E%YQP47@=/V;KS9IU
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MXH^6W]@G[(_N>=>A89&!N90E%*TY*%$21,X13#6'TG'%=#G=-7PS[D'IH$[
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MP%6QMK6!>9":OG+I1R'ACH5I(_H./)Y+3JX"@2M&>.$II!!!1A]!Q>0@,!7
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MXB>UKC@WI+8T)6YDBJ7XAN:HEG.B2B,KT%ZS'+17CM?>*;<2,O KACX0=;K
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MC]*J8B3%(M_YE\=W__W4-1R_=B]G8Y5$T?<AFI.<LD@DA.R*B\+=TQLO0,G
MDI<8F;F^+T"J':*%+RG>%I-],9ZC!=_<EJ/)IWI8%+@]*.%]WB1H&5RD1",1
M68%67&-P02A8SQAXDIUP.1$5:U^#U^6@T8.T0Q#WQ($.I^(&]N<3>?[EQ_8/
M+!-\[B4JQ8!25*(H& >O50:=8I).6\V<KXSV'MD9.-0<$*63-B'3K/64(XW5
M*0:ESEG%!#"#K BI)%@6+3ANK:2<25^]:NXYFH;%<3/@Z03J(S79 #)?8;0[
M^9'2(M-X_ZU(<W44ABD%S4:A;()&1DB48&+6H)P+(8KL#*U="K63F!:Q>*S.
M-\L-JBB@B7*5?Y0K^?%\17X6A5K)P*5 D'SDP464C)="(&,6)53;I3TB8-A,
MOE?,'"_HUCS.BH60""O31,$FCRSH9,!FGR @2U9[GJ2H?5"]A8QA2RO/YV6.
M$'H3_N7$F&#M'(WJ*,NQJ$]$E\)Y 3XS]*Q!6N&T5*;ZU*%:M ]\/OG39!?'
M@:$!]WDBW\M'=%=>VH@V+H'Y4B 9N"J3PP($H9+3D09'6%L6L"2\Q4"P;\S5
M!?X1 *B&^MHW +]-)O&/T<W-"0?YFY^H<QZ_E[!*Q^IW:[P8QS=(Y?BZ]']>
M-H7;UG[&*IJL8YCD*@]"R(#Z9K:<@1+J,:HPNO9TA8,(/-4MWB\6_O=VA/C\
M];94=2P?D5]I0Z,6*6'"7RI#>-3@%?40F8Q6))E,KKW?[Z-G6"?6'VXV/54U
MG32P[=[Q<A5L"I1; BI3 0(]-ECTVI!9C"IS=*FA=NG>W=K#QG[GQ\U!LFX(
M(V^^?G,%[R]"N/UZ>U-&["S_J+3(7[SA%0+S-90 R*A8Z744P93>_)DHYA-7
M*?':-QZ=B1LV"SX_RNIJJ]E8Z35R5)K%IM^3*S)<C&MPX_CIRV0Z_YRF7Y?E
M;8L_7OU(=//[_VHR=A]+L#E=O00^I9EE7Z34B=W.(JA*,>#]J@^V,;LWCI0L
M\2P;W%PEP1#?*? B10B<4IX5(;9Z;^A]])SJ7>^_O?0&9?C?R/G1S2+]N5/$
M^_&]\/$'WDU*%Y<U7:R.'8PR.6@!VGO,OHB0I>L] V4S%UQ$SGWMT\9JQ \;
M.U;#VZ8S'D:Y#<0,]XS_\N/^E_\U2E,DZLN/M^E[NEE<67J&A!L?P!/B0'A;
MQNH0 5$P$G240MO>;'DO98W@\;RPV07>>CIL"9GK^^!3_E:7$RD$@P+#)(Y)
M] #.2F0.A9CPPX1:(H(-?0&T"X&-X+0B0G:!L+JZ6L+BF_&WV_EL(3&ZNL;2
MPI:S! ]!<@4BE[ZQE%APRBL::(I$]>8:GY+3",[J@V 7W$[42*/@8BM6$K$D
M14W $A4P]6,HK,@8,.X#2SI;[7MS:T_)&?8 :%AP':.1!L#UTLV^8-11_E5>
MD7UW-T5JRS(T2Y,T693.E*6_K_9@8RGWT4E)@:;CN:R,K=W4- *M0>.X2KIJ
M '4?$^9DHS!/<3M/V_]T96&1"^.SE*"R*\^#'%J81HDJZQP).22::A].GD+O
ML#MN+<P\F?AP)@4V -;?)^/TXW<W_5>:O[X=QSLNK%16.QXA8^!;^BV1,D0V
M812AC<J,:,9JPW [)4//<C@7$B;5U=( N/[VZ?-TL7_\>*B56'%21ETEN;3*
M"!BT>O 69959I)1H97FH?26^FYJAARD,!+)*ZFD :*]'8S<.(W?S9HRRO"W!
M\6(72$1[ELI05YY(Z1J.<;!'7K@GGLC B:&UG_+M(&78B[TV0KP:6FH ;(LV
M*+AR$>.G-/T^"F6\7M["W>PS?G*V_:]6F9I)UDKK.:!1H4>7UH!5D8!Q-A(=
M4)[5IR;5I'_@$Y<:@)HTHMT&D/TR3>>C/,(?*WS]FKZ5Z1^/=P0+D<4$6C('
M1E/<;:R/G+#L9*A=QK6'G&%Q-QQ&-I/F2@IK 'M[@I&,=IL8MZ!"N> ,7( S
MHKRQX=E'(P-EU2?+-1HK-H.\2NIJ '@U8J.W]\7E*5,AF&0@2V@DB$S@$R]5
M<Y1SYWAVNK:;K,K L/W(&XE3!T-$ ^;P:_+SM2?;W]WHI@CT]61:NB*]^#K!
M'>?_,%6=S.8/PZ%"F-ZF4C.8$##S7U*>3-/]3'3\3U\B'Z-E/1\/UM!2Q4<<
MAF4BE#=T(3.@E@E;SC>BKOWXI6>6&KEU/#]8)^TBIP%#VA3 AG@>"EY_FR)W
M9>29NRGR^0VWYJ4</KL_KZQ#AZ4R1G$I!63:</">$N3<<$=1':SZ>-(JA%_^
ME58=HS@_"BX8^L7,'YAV+B)MW$$F'L6N,)7'C(: )E$:%3%P3:U _Q'AEW_4
M-RSTCT?!X="W2^B/TW4AY/,04=3VW6[7#GFE')-!2PW48.8FLO/@.360)*<V
MZ/)4HG;]=&_,7'ZR<?;(J4>T7(KU[&2V]!O/#-.]I$U&%3 %EI=C7^%B5LED
M9VMO&,=1.NS@IDO!?14]_Q1/PFK,B3IIO?,_[CK+A*F]+VHLRU'HE"%D7F8;
MY 0VL$7V*:2CY;UT[0;J?;[@*N4#5X)3[;D/H)+%/$+0C,:*+'*A&;%&"VUJ
M5]26=1LY(3E5R]M*%@\2:;/.Z"-^I]0/HS'^6NI])]^*$7Z8IF]N%%_]^2V-
M9ZE8ZLH3K^T7)WBDTQ>MXY8J,U_)-_VZPD<)^F8OW;?1?)D=K>C"3?G]_$N:
M[GR=+8T7UCH*F0:&N"P/6Q2F4;A'XB:9G0JF_CGK222?-IQGI<07^Y3X$B,8
M_-,K*C+E60>0/F( X94#XTLG+.$%\:GDE?HY]!Z\ZK!.\)QP>CSIIR_%##T.
M:N4.MO-WQU# 8#2%,B@YT])DS0EP6BO@G.A@<8.0B71"6I?5ACUS'0QAU171
M[#;]%N/F5"4;V/&E.AMJ%S(K[9++I=9>P><<2\V7"Y2"2$Z#M20"LYZF$!+U
MK'95\6,*3HW2WR8TC[3XYJ]I%J:C14_BU="KQ)6B48"A08!@F@-RI2&[,E*9
M!\*K3^S80\ZPV]D)>M^,XFN)?,C]:#J_^H3"7V34OZ7)]=1]^S(*;OFP>5D(
M9M#7&25 !R-*LV+<8W72R(%RT73"#:ZRAAG\W0->]A(P-%(JJ7=26]9# R9=
M;[*PJ@O;8,)2#M;%A$SDH)U@*HA.7O0YP.PB8!C 5%3LI+:4AXYUWZ4__KM\
MZ<?B'<K-*$^FXY%[5&AZST@L0;NV*)\@J*8V*R*[Q;C[5AD0$W4T..E#G$/B
M8OYM>O7RQ2:YRFIP0I2V&4(R&:B0<E_!XRR%_[B>?/_/\KFELRB_6G,4RV4&
M4G]=94V.E]S0BG[WWYOD8JH.QIF,OZ7XYRH2X_?UWNRDZ'?_/4P.VZ.B#Y3<
MT(I^_7:37*DE6!HY).-BSHI*I?==?'12].NW RFZOD,_0FH-E&AM#XO?WE_K
M;K"#D3(8)B4@S)F,P:884I<8\.1D\VT;PQ=JIQ%]Z*$!6"WFNK_/?YLMBPO>
M^SG:5;FZ?_5GN6"Y+G?[[[^E<C TOEYP?7>=\F.3548S8%1MRIT:,2KP@(94
M&7(GD-MB5GLD;#;;7YQ)ATV,M5D*<@<[']R/Y7NIV[3)F4/_[@S^5GGFJ E2
M1EV[(T97VEKTC'6@V(MV&G"3V_@J!3#O\\O)>'FDN7G@X'%[48%!8%Z&:#$"
MK5[]_#Q5PY8VGQMI)VBD 8P]YF7#J6\R0QP%IT( XPTC.C/*?.W+A+T$#5L*
MW">RZNFA.5#](Q5N4GR!.[*[7M17E?E&']T\?4C34.Y=[_F32DC0G$9PDI;[
M76ZT"]+P4+M<_5 :AZW&/1_T*FNK=31^3"6G7_?E=)._D GXG 2:'"7>>,EM
MJCU6]U :.Z%1_71H/%5;S:'Q+CK=Y"(+41XP&5#"\RA#TE+WB[D[2CHA2U\^
MLHZ2?.,U/XM_ELJJDVM^GGRI9LW/?C+[J?FA3$>>4P:52GE7D E<U 82D=*;
M+#3Q]1/SNC4_*Z'=LV2LSC2$!#'KTL$T$+"A-%21W*1(8A2Z?J7/!A%#GV\=
MK>.GF=TIXFUN7RF<E#I9SHUA0*DW(+2AI15"!*T)*ZVYG;.UB[N?4M$ 0HY7
MZ]X=Y& 9-X"2O[OIJ-Q&/# @.4U4.PZ>(=F",0V.2@\177"F2@3K:C>_?$+$
MT$>3-3%RFH0;@,@#X=%E3JFB8)7*B&UOP0EB@29NB,R>&E+['=AAD.CQ#+$F
M)(Z3Z/%0F,S=3>^QYNO;^>TT/0JE3XXZ]WRS9OS9E?1^(E$I(DDIRN(.+ BJ
M#%A)-01)><Q2&,WKWYG7KSY__KKE'<KO\Q_IYGOZ?3*>?YE=I:BM*)??3HF$
MZ$<9F(3QF4]:D"PLU[GV5G,LK0U$+<<AYMB[L9.4U<2NU8W/?R8W_?S'Y(K'
MR)+R#J0C'(3D'-##9S!,28*;<O2B]GG+@20V$!2=%X+'J.;2D(=02E><!RJ8
ML>7YF@?ARA6A+DU0C;4D&R:<K#U5Z& B&XB_!D#?P>JY,/R]GMQ.KX1TRKB,
MH:QPICQRY. P_ 2I54HL*!]M[<NV0VD<^IYW$/0=K)Q+ ]_H>[IBEAGME0>.
M>1.() )XB?\(%AT]4X2A>(<$'](X]$WO,. [5#D7!+X7&=>\9S+2&"PI R\=
MURA1X\$Q'B'IS"27/B1YCI*I9PD=^HKW[# \7DT7A,4K;:T-Q!&(7# 0V5+P
M(6@,<6WVE*(!ZJ'@-_35[]D1=Y RJIW']02ROXWCJE8GQ5=_!OS1%U_+[ZY<
MCH&:[-"A^R))C2&%#Q*$C4()&9GEM5N4'45H)_B92X=?%34UX/!VU?93R:..
M1(-, 6.(2!186KARUB3!7::JWY+1P]Y>V O 4PU1-^"]=K!QUWM':87Y=;D;
M(9RCA (#(VP&3J51B@0K3>W,8#]%W<Z R>4"Z!C)-_$<9P<_[R;CL&*)A60E
MXPFE)00:A(BXIR<!*059LFC#J[\2>Y:H;GBZA$N%NO*O"*G:5YT?4(JCV6PR
M1=[FY;*PW.S/)Q_3HB/]!S<]L;GE0=^O<P5Z/$N5KD/75OJQ&%2&:$0V'I#I
ME#6.A0@^,U^NV@T&Y09W.6T$"D[X2.H/-]]/TZD.ZU/XDN+M37J?=ZWTRX]'
M?[-X,<QUD$)H!5IG D)+-%;B2YV]2MEKK52J?5-\%*%#3]^NB*=-3]>_XAH(
MY7>PMNAHY(RQV7$!EI59XB9@E*!E )-%$%81;5+UY]:[R1D6:6< P^8CZTJ:
M:1=DJYX:FACKG,^07"[S 9@%KX4$FA+A.2;&6>WK^+T$->G2#E=[-S@=H8/!
M6XV5V.6VM..>I1?7T[1HQ[9JPB-#UH*74DLO4SDY+N=YF@*QR #*2OK\;&#V
MW")-XN,8/4YZ$.K0X/CU]OK:C5\G/[UURS#WQ3C^_VZ,?YB^E-^N=6LBN#H*
M*@;0"@5EI%7 I=&!,)%4D)V TG'!(=N3U5+MI&<YMX>=%1-::&:-C."X=B"L
ML."D(!!S] 1]+K+ECP3+X.CH19'[D7*$5(>&QA:!>*<(MTI")CF74B$'5JH(
M7%$C-)<B;XZIW0&*(YU%/RWN>H?#B9(<&@A+^7Q*W^8+VM?A[(6E&O$K>;FY
M23Z4MZ3H2IWC1CI;YEP=X"2V+#%L56A/@4<=@0X-BX_I^VB6XE;K>?1WVQ@M
MMI2]8N7MH@9-<?_UV@E,&J7EBL6@H^N$G%.H&+;HLR=PG4TMS>)OQ8MR9M$J
M!F3I."F"2^5,/@&:DF61!>20G@:QP0.9\^FZ$\*.$'Q3(-HE)6(I 6.U >V)
M!^^"!^*M9"XDC "Z)4U5G%$_ 5 #,#I5]$/CZ/$UTVS%0<R>>J.0 ^<T6@)'
MV?CH00IGG0PN$ZXZ@6?KYX>M&N]I^SI=D.T>_FZ<ER_.-ZU*SJ!0@ 4,^X1#
MM^F\QD0@9A%"2EJJVI=>W:D;-OINYO[A5+TUALB[OMX^*B&3A*@QIQ56&+0I
MHR%'W+%S,H$EVB/R&KYX.%G?>V!UA/"'WMM>?AFE_.K/%&[+X++W.8]"FI9Q
M #O^_ -J<10?#EPU$]*7\RZMI"]O?#*8C!89LO(H-F\S[19"G4A(.U@[!@23
M@30R\$"FK2S=':)9Z:1D&F1$?R](.43#S .<BB$;X8(-^Z:L=!W)M(>$ 7._
MLV)@4E\AK7JU33E%KT@LA[0FE>NB1#18ES48P@2UVI86)R=YKV.\5#]YX""0
MZDL7C05==R*2Y=6#L9"I"2!HF<Z84P!IO24^:&%HGT%7:X?J)VR$E80\M!NZ
MZY^U:C@\FL1%N!FHTC1I@OZ3ER9:VH!120#-Q&)B$U-(II/7V?[]84^^SY?8
MU1)Q>RA960Y5+ ?$->BH)0B%SM!';8&(K ,S))F.L?6N%0:,<&KH;3\.CA!B
M>TAX/[X_>"=4:A,PZ+*Q]._@"ARC$@(FKCQ3HC(-1X+A?I&F\'",_O8CXCAA
MM@>*SW],[F(F99T11$&DN*T*%@,XQQ)D::G _1 %U6T0Z9Y%!HQ9SP&*XX39
M6 "ZMKV^?=1?G# B0)&D02?<6(WG";@+(?# J19G.GU^>]!$N]YN-9HY<SY.
M1PU@;G%MLWIGM4F[*R53Z#HA)!T<AO7:;1:,G8RO]?7;.?$[7;.32F(>>J]:
M)_SQ*[P/^#?C^<C=8-K_;=FU8NE_/TQF\X\8UHV^S=_GEV[VY<-T$E**L]<H
M\P^W_F84WF?D9#2^WA2%TNBAN>*+9A="Q,R)[%X-WQ^=[:3@U9#9FG8O"NB_
MNS]'7V^_+GMCK 8/N6O<AMZE>7=YB.#!)=QX/'/**D8B_GU]M!]';)/5=N>&
M_!GT?%&X_SP=75\O>'SUO7B$1VROR:2TJIQ]F=S$!U$X1#"4:U=P.@5(.3//
M7519\/J0/YC.)HMSSHWV?K7;+M#?I3_>S&:W;AS2;),ED3+8$&+I]*MX4,1I
M=2I@U]<;MIWC$, [6MH-9$L?[TQE]CCC_#7Y^0,O/CL'FD4-3DD%7B;'$K6:
M)5LY>]I'S[ =&GO-IJJIH0E(;154.<ZZ8T4"]<B 9@%E%!BZ5TF"4]$EDL_4
M:Z20,VP#QIX!54<)C>YQ/Q9[_"B^&>,Z:39_];^WH_F/N]_-%NX8_XN7[B;<
MWBPT^FL:3[Z.QF6M30$D7HYF'0-"M0R4).I4MY**/J@;MBWCV??/\VGR9X3R
M+^5]^2*7>U'&6WV>O+R9S#"V_644/TQ'X8FM>V/!.X%;2:0HK!A]]-WN9X>@
M?MB.DI=E"E61,+2I?)I/PK\*O^5Y3LG5EB=UG[Z@XF9[)+;)I,-=S86H0!G"
MC: T4"HZP?U8"@9N8MD?9L^BD@:BUQ)QOQG/YM/;$HZC58UFGY 6%]^/UR]F
MZ9,HBE(PDGF0)":??!8AU0YEN](V<.?+7@/;7O33!.Z6R[Y&=SX.B_&%L]^F
MD]ELDQ$,SJ$T40?GC&!.<.-R[0[V.XGIAJS+NC>JJX$FH+1N(G>.N%C%JYQ3
M*"7.#R?_#\P)XB3H\G36,V6!1$X,3TE87[OCX$$$=H/<9=W;]*^I!F!XQ\X'
MC ;>I;5 0#D?02L3T8 RA\BS<\QD(5CM.5@;)'2#TF5=BM20=D-@>?7GMS2>
MI?5SSSL6G))@F; 0 TV!\TCR9K^X:H!9(Z,;:"[K0J.6U*L!IW8C\46V4B[T
M<)UE&OWACK[%7[EQ?#GY^G4R7OSNA([BQRU4I[5X!28K]1A?KG[? 9HK4H9A
M**!!EU[WW"$D56ESF(DEN$^EZH;[F()Z_<,_W?K9*([<],?[Z7*-W]/\RP33
MV^]H-RDMZR^)ESPJ-!>OH@!TK19MAI8YXP0E88V/OO80E@-)'+82\01\[.X0
M7E\U#>R##TQ]<@LFB^DNGIVH')C/R8,7@8.P4H(15)81-#%&O<A%:F-L%S&M
M] 7O 0*;<*NBCQ: ]4#^._<5?_FT9PY+E.$67ZK('7)$LBV#>#/B0GOF$HE$
M=GK.?@C"GJ5J8*C54?\FJ.KJ8NC3^H^CZR^E<&%95K5ZJ>("B9:CT=DLRX@L
M@Y(*WH/4'G\P:2MRM]:<V[X^,"@JJV]24Y9#@^$3_YBN1V6C+^+XA%I9[WVM
M;#):879BC2L/K3TF*Y(PH))RG@Q)RG=KX+MWF8';1O4(CWK2;6!+^C =?2]O
MW&Y<6.<BLF"H$!0T3;*,V>/@-7- 9-G'?4B<UZXZVT[)P(_4^X%11>$W *%#
M&FA98[PT"ASE 9VH+NXT48@R6,F=S:Q;LYZ?NM%=_P%U3QIK#(OW72BMT"0N
MBBP8B$0]."<I4&(XC8($3?L<L]-"!-V7OI]O<7>(\%MN,B:5"8X8T)*6ID9:
M@A/* O.:^FB"M*338=JE-1FKI=FNK<,.$'-CSN:. R37,(&6@QL_B, D^$P<
M^,05LY@K<!=Z=#8MA-Z5L%))R$.G8EV[FO&,Z4$H'9(=QI(B2U*:2C!(1@:A
M$I/(5*>DK&:'N;-<Z)_B3_J2< M;T?W X<<^DD96DDH%V29;9N$9* WUP3-O
M5"9"8RY1:RO:3D([KQIK;$45Q-S85O1D>F*9;+;HPQC*U&MG!!B9(VB>")<N
M61=:&V=ZAJYS@V59!^ND77BM[,]1YHC,LFS $84DT+-*XR )P@7CB=-S#:]N
M.-DZ7.T'#3(]1 =#QT2[A\9X1BEFF(#1' >A7 +G.>[8ELJ<G?+6=VMXV=:8
MGAXTV&G0X"'B;,#)/.>1W]Z76X7H2,K<0%YT?\P4#<J[DC%F955*EKCJEZ1=
MB6NE==DYK^5KZJL!(#ZNX%J^KGEQBZQ-1_^7(LHL9Z(BVI$TM(RU,>!(="@S
M1B77CCT9@%GA;F0?1:U<SU>%P9.KDFHZ:0YAN"&\GR[N$>/?W<UM*3=?,'B5
M6$A)>0)2"W3@VN"64/8%S8,/S%#A;&T_UXVR@:]*!D!<%1TUA[RE';V_G<_F
M;AQ+DRD;&>=.4T@\9! V6# .K2EXC":LUUE4[TW_#$D#)XR#>;=CM=(HR);/
M5J\RTX'QK"$&14!P2TK_,@9E=G)65!)OSK%Y+JD9.%8;#%I'Z*(!5*W5T3_9
M_[4,F#Q;!YC6("M):7"E44\4FCGG)<N,5(;5'G*&;;]U'ES5TD9;P-JYS1M!
MC,P$!619>?PG!)B8'%CD2V3!DXJUS[@ZD#5L-ZZS ZV*=MH"W".'3!FC"<-&
MT#&AW0C+,8NQY9Z*9\%DMMS5#KYVD#)L5ZZ!/-@16F@13.N!(W,B!147,:-:
M5E183AQH8R6+:#*A>M^"??0,VU=K(%@=JX\&L+56_[IH8'3O<(6CVL3,P5N%
M#E=XACM\#A HSRQ2]+JJQV<JCV@9MD'5>3!510\-X&F]N_5=N];W><UBKI2+
M+D2F05"/LN',@2$Q@*)<Y6@H89NSK"KDA\\0-7 _J7/EB355TP#6UFOW;\M]
M&/YF;9M_,UZ[@KLRG.J0N =O=+E\LP9,>1RK;;*11Z:4K;U/'D+?P,VDSN[D
MZBJL 3!^N.\L?-_#[;Z_T95U,5L5/+!LRCD,#6"T%%#NM!/QS$1=>P#3/GH&
M[B]U)G=72R$-@&NM+2"]HDB;%TF!%)BS"&\%6.8<I""(-%$24GT#75]_X$Y1
M9_)4QPJ\ ; \FAFEM1&9) :1<@$"<UNP4G)@*N#?&%MZ]%4&R^&CN2[\ /YH
M@0]=IK7GA/?-.$R3*\V*EO\NKUX974Q6#&4[IB&7FW@-FLK,A5-!F(X#TKLO
M.G!3J'[1TZL&AD;6SDAO^; ZE0:0D^G'-'/%9$(VDCL&6J*3%8P8<(I0H(%I
M(:0VIB.T#EFU&[8N]&2]7QTTL,=MSV4W7UM?>6NRIYH!<8J6:MP,UC /E@3E
MM'?HBZO'W9THZX:^"S]^[T%)%]4*;\'G4J2%T=%X.1EK^=>5N^%U6JN_AGB'
ML]I/3SQ/:.!))*#6)-PCM0!C+04N=*(2@8M0KFSPP_;$4YG+*".'K#1'O\W1
M> A#AIT7F,<&F3<G3_Q;]\0[!!^G]L0[1#4-;*F[FW!QIA7+,8+6)?\5D8)1
MV:"75EY)C$.-K8ZQGZ,GWD$0Z-P3[Q!]M "LYUOL*..XD4Z#B(F6(7ZX^XNH
M(#C*H[#,Y5"]Z^+%]L0[2/V']\0[1!<-H&M'AR6B3$S>65"A./H8# H)<V?*
M<X[*>^]X_<C_Z/960S;1.TC?W=I;'2+\!B!T0/,<XH-B43&@I$B,EG$G+ >(
MB4FKK(DN]-EJZ&=J;W7*WMB3QAK#XLI )2*"E5.9*+W _#ACS!HP(S>>.1Z=
MIKIZG^\+;F]UD+Z?;V]UB/ '[BGR(N?1S:@P\ HS\/M>.H%PRS(UH'A@:&<Z
M@M.B3+@EDH?@7 J=2DZ?:2>R??5V8'.,/B=5A=N =WDW&4^?=EOB"K=_1@)N
MUZ1TA+,:3'F*%*(RW&GEC*SM8+82TEQ7JV/ 4D_4#>!E2VNNQ> 2'CQXZ1'G
M0@NP'/VKE#(EC"2C=[''W:C1WE:G(.5$(3< D^[7"0A^Z:7-0&1I[.9)!!ND
MP=^28#(-+++^CI)J]'5HIF]1G:.EFOIJ 8B'%!CF0%PP090N8@Z$,1(<,Q2\
M93('SA(FKLU7A Y_0W@01$XI"#U$7VUA\7%%/W,FN(![13;9EV<BIK3BQ5W#
MBZ!E3([FVB59)[VL:* .M!+&CM=#6WAZB:GO**;E>(*/*:31]Q3?/S*6TF)*
M8O"!VX,HSY"< 4]<*A/)798TNY1K/S0\B,!+Z?E0"7F5-=8 '+L\VBU1+,FD
MC$JD%#UV\F!X"I""YTDI5T1;&82UGE0W4))Z"O1J:Z<!P#W_?(G+Q*E"#RX-
MBR"(18:(LQ"T830JJHFI'=#5>5G60 7K*6"KJYD6H+;OZ8@*/+&D/' M,6S0
MBH!UG@):$II,E,&PZH-S3GW+TT 9ZTD JZ6/"RH??#&??TF_N^F_TOQN3ID;
MQW^X*88,\UG5ZL%N2_55/'@$H_W4#AJF7$#\@*0& S#+#)@@$Q#/$DU19\IK
MYV7#U@YR3JCVR:#1E'[YG' PMMBE"409BF*P?\W3/0X?I]8.'J*:!C;,/0,\
M&3%9<@K$E0N/Q!D8C=M_C$QYQ37WN;]&OA==.W@0!+K/TSU 'RT JT/]DI-H
M>$Z"S"R7@3$1G"@O%!1SV3'K:?47CI=;.WB0^H^H'3Q %T,_47L_'5V/QN[F
MUS+H<^1O%\JYGJ;U0C8=)??!2U#$E>M:J< 394'RTH0@*8I__UR\U76Q]@L%
M#U'NI$=)#XV<?7R(1%A,C("4MC0+)@1<QB!!&Z=)F?Z@1>B$F%.1,N3@W:.1
M4DNR+>Q<G3/CJ%C.@6C,ATN'IXP)K/?, TL"T6\PC4VU#Q3JWHDW4U):)V2J
MJ:\&@-CE*-AF;1GS&G1TY5F4$V"$YT"5C)G))$3U:OE:!_4-W( ?!(@C#NH/
MT<[0>^-ZP'F-'OP:V;D[UEE<OUX))7*V) &3'#<'W/@QC58>LD^"9Z4(Z1A3
M/;O4I=QN'X.?'H3=@*\ZJ!XD<1?1+LIL+:,QRO"AM"Q OV]T%LSJH*I?]U2O
MWVG@AOL4[]6;OMK"XN.Z$1.-YK;,,'8< ]&8*7A30M)L7'(V$R%KOS$_J7ZG
M@:OL2A@[7@\-X.GY6U)#.(GHK\NS.8%FH33XQ8YOI(E.4>9\[=+JG^;^^A2$
MU=5,"U#;=U_JF<B1)0Z1E4ZOTE,P,B:@QFAI?(R^>OGASW!_?1+ :NFCI>C^
MZ^1V//^8RH$/AIM_&Z.B/G^Y#S^O*'IF668UL/(>2@2KP$:N@1N3HO,RV-SM
M(*S[FI<RTJ!*O%]1_ UXK)<W;H;FL;KU?S_].+K^,E]OJY^D29)KY(>7@T1-
M//A2NZN]E%0Q$<3FX-C33RB>H>E21AV<=#Q14R]#>Z^MS/PCE7^F^.)[FKKK
M].K/- VC65JES]HJ2K4!3UTNS3P).(I"#%*(9+D4)#Y;;W/<TI<R\^!H7]:O
M,IJ$VAT[LS=C3&)&D[A\YT<3!::*S= 0P):)T$$$EV,D.KE\/+Z>K'<Q8P[J
MHNHTN3<)I7V&LI-=!LQ%#9I)"<:KB#ARB5(CDO"D'S=V) 0O]%!_"'VU7=+Z
MBYNEB)GTMS2>+3[YKHAE/OJ>3JU@??[+%0M6#V2C4GWJKZ-9N)G,;J?+TXC[
MQ5</QA?IX^(HS!?R[I+,^WI%XJ)7Y0512IA3XNXI,#3C'FB@PG$>J7QH;UPI
M9#Z-XGKUKZ\01I,?*7U*T^]H88LEG^CPQ<WBD_BK]_EC"I/K<6F[O33!!:7+
M2^6E,48%D=,(6J) #>4)M"".FNAB4-7KR_I@9-C;U#-B>7?M[5"P:"#!_G#C
MQJ5<9]DC"6G'Q"V#%$R5R709=SF'VXVF45#/I:K>\&5]_5;J< >#P^;QX+&Z
M:0A7J\JO#>JECV"("4!(-EXX&02IO><\IF!8;!VOR1V0.$*L0^<K+U!#9'G.
M/0ZE%_CWTA]RO-;99HT3&CAX+AA$)J0GQ!IMNIVH[%VF#10<H[Q)+Y)L A.+
M@29E6W<W'R:3FTTVC"@M;3/Z3.N<!$<2ID":44QVN@-BZQK#U@%51</I,FP!
M"N+-.-XN.\;NYL(J"QY% D&4!HZ1XJ;:'0E;EQBV)*<F$$Z78 .QPXL_W#1^
MQA]^O%TZ$R5NEY(AB)4#GH.1DFMKHJ\<.CPBH)52YU:BTN.UTP"T=DBM',E=
M+ZQF]LN/AY]9I9L+CA_8'L==%KN4@<T>?'E!E90Q).1L,#FM?1+0 Q_#!D<G
MP&HSKQ]:QPW@_-Y9E"AQ<Q=8LJ!5PE\1W%UH(-039KVH74:VA8R!D_S!L3&I
MJZBAP[9']+__5J2)NTV>3+^62J:%%!]Q90E0ZS)H'R@8A_QY99SG(4C&3*<P
MKO.2 ^_<K4"M1STUB+[/HZ^;[ 0A%L,KD!-M:;$C1<%J)Y-53MK8[5G)\VL-
M7-G?.MY.T<S +?0_%AD^#DP2"P93ZH"&X8R '(W(SBI<F7391)_IFG^_8"O-
MAX?./H[70@O0V=S8EV334D5 HD/_FI1@A!,6.IV"=P'/D-'6"<K:5/<1DAM8
MX;^/QJ.OMU^W$TZ8 R<\00E$+C/Q0JA.?6Z>4?FC10=6^C$JF]20W]"*=W_N
M)EPQBWNH<Y"\)#F0R)7L-!'J.<6O+SI,P%M-\4?+KZ6$^Z3]\>U]F=G&*7"F
M$HSR'$RBGF$$;E7]IG-U61CX#6(SD4L+"&G 0-:>S;UTWT9S=W,W='Z& EF,
MG']].[^=IKM74)L,:IW!.HNY!S&6ZBQ"2K5-X& B!VY$."2D=C>LZ$&_0Q\T
MK''W(L91D::[><1G$?,?Q4D\8?1OWU#TBPSXU9_?1LM6[YO,LX!2#CZ@)Z&6
M9N<"E=TN-6M3-NRA60N('E[A0Z/]V:.D72=)'R;S4H_B;NZZ/CS(;D-H=P\3
MRWG3IFRXP6!1$ ]!$\T31OA*="O^.3/APQ[.-&,K+<.E@<CG>/&D:2GO<M<8
MQ:Z]K5Q>%2V3I4U9!(EI4C0,E!8I":H=WWS"T__=\PG\#)LTM&!1S:'FDBWH
M<?.A%]_=Z&:U8_]6'F$]D8.U8 VWD"3+Y?^EYJP5ZWF&EV$;LOP4EE,3+1<;
MPAVY%:\J"R.*1"<!) 5'N-2&F(Y-^\Y"[[!-95HPDE;!<;'V4B:XI7!;BO#O
M6RP^O-9=NSOWB8*S^%MK!5>9$!$BZ]<V=M(V;$><R[>#.DJ_Y,AJ%4G>J_+6
MS\)TM#CT^.CFZ>GU30;/M0%F&'&">9I%]6:(/?$R;#^?%HRE*;2T8C7^>3GX
M)[G9[31\<:O^#H]:":ZRMDU)^&P!N8]@I4S1\=)?HGKSVMZX&;9947.6,SQB
M6K&=8WS(XP;"F]OMDGF.BG$\*Q#$*>V4B$$W<_RUC8&!.R\U9R*# ..2K6+Q
MC[^GV?P^!*5/=E-5FKL'"50DP6,9Z11K/_2H2?_ K:!^"ILX%1:MF,0Q6^;#
MI>MV7U &25G"$NI"2VYR-#SUDHO4(+Z;,?S4]_'# N*2+>%%".DF31>38Y:^
M8'F M_G&1QJ!^1;-D&E .3"11>[EQ6I-)KI9QD]]^]X&0%JQD*/VR0<!K/^7
M13>;,@A>@-.R%!S09)A-D2;:3!BUFX]N=O+7G?HY8-+.+<<==P^\%V;>3>;_
M3/.E!E+\]39]GCQU$<L6\YM\<VZ0;Y6!>Y\4]89*T:UY;$6BNF']I[X%'U3/
M+>-[H]7N2O1/HL)[1@U&A5ZC-7NA++-:9K8Y2N (0#]'13<$_SM=4?>LR4N.
M7I9%QK-%=<I]E^@-Z2S^\E<TZ]=N-%W,C[Q[>*T@4H]*$:(\ITL*G%74,<ZD
MK3[IY\PL=K.BG_J"^Q+ ]1/8WI,F[9\G<W?S9CR?CL:S45B3"<D4\%\>M#8)
MK/4>+!4D1*%2H,W<4AS 5S<K^^MF? @8-6!:G?3S;K*<L+ \L9XMV-Y,L=:C
MU:*]M9XBL\V]/A,'SA@&4AK%E')"A=H]J\_"6#?C^K>X/&\/2#^S=2W5]WHR
M78NKZ9-3#L' ^Y@@:N%82#+(ZA?MY^6PV[O'?XN;^(:A=6%3;3;"Y1<S_"^7
M[N86?S)/IFL>:"G'ZN-OCB>ASSDYE033QD"=J"@K<PTAVR!!6!;!9V,!#4UF
MKQ*WOO9%02L#=9Z->W<VG5LVU B>6Z$Y 2%I!*%IP&Q1&\C*9&,<=996OV.I
M1?Q%#\XY!+.[!^><4_T-Q%R/>Q0SKY.-7H%45(-(P8-Q@D#6+K!L.1&T=JGN
MX8W)SS NYZP@V-N,_!"-- "GXP6WIV.G3"Y8[TORX@4(+@S8C'%@EB;&:)UV
M^>Q/6B^\&?E!L#I',_)#=-P SK?T@EUO 1NE!:%<:0&;$U@J&?Z6:4642)K7
MWOYW$O,3-B8_""?[&I,?K;2A+X2[MR&.D*0N\U:2!R<R U[D@\ERLO:L#:+[
M+VP^3:/'=7GN)-X66O7>M:P-3&4*B42+1*L,CA@//*3(:%"&I$ZA7=4NSV>8
M,3-$*'>\Y%N RQK*U\C.G((+-(.1&!Q$F:-B/V=GY^[*VMW9N;/DAF[PN]F9
M>)UPRM!IZAA 1L*#,08M@5=0>9N=G;NK;%]GY\[R&UKQFYV)UPF/WH)7B@+5
M3EN'&USJ5CQ_D9V=CU/\T?)K('LY^FK_X3(F*!L520*"]!SW1HEQ.((<LC!.
M!>D$BK*5^H^W!_5O/L/DB2&/E\ZL^TM&^WT%V-I=SL?1[%^OIRF]&2.!:38O
MO1Y6F\#2"V252L\Y6YH#H2^1UH,I(X:$$I9KUXI-',A;XR<)E3%;RV3Z!-"_
MA6$]]'8L<LFHMQ!++Q4)-L<$TF1AM>%"VG1QAG5 =]#A!KI=NF$= :!_!\.Z
MXD0RD<LC82[+^;\AX*,R$&P.EK*H<[XXBVI\5MV%F])!D&G%AHYY0+Q-(*_^
M_);"/,7/:?J57@GOA5%$0DP9]>28!F=+OV$NM+,BE*E ?1A/+]P,/-.F :L9
M'B2MF$LM_[%1"O?WR0U^[68T_[%P),H:$Z2EH%S&'9GZB(ZD]).4/F6A*!>L
MTQBQH?:>O=P-V[.Z!7-J#T0_FWG=.9I?1]]',8WC0B"1)4P:"8=@1 )A:'FD
MYA3(3+(WDG!BFSY\V,;4L+VM?R9C.ADR%U:EOEYK'>;(]/Q']3+T/6OT66?>
ME;4V"LF]\=P&)T Q9D!PR\$3Y<%$JGT4/%KV5R'Y]E-^+@CN8C8"IQX3+L,C
M6*KQ5U$H;PQW7E>_8OFKD/Q S/972'Z(^AN(<![7EQ(?G';1E?YS#DE.#KQ<
MOMK*S"0N3*K=K_.G+"0_" 1["\D/T4@#<.JE>%3%,D[->6!)$1#6$Y2FRI <
M*Z-N"4$A_U5(?E A^4&P.D<A^2$ZOIQ27I1J(JK4L5K\%4I:)D>MXS(^"0(N
MM)1W># <5P7<23,- NU#FN;)]&L9[KK.%:<RRZQQP]%<E6-+!=;@UJ,5]9;H
M$//FX5QWO&U?LO$;T*%A5T%/E["=/W^6HFP!66)@<T*AJH"AD)(9LL^2<F5H
MDLVT@'][4,79!53!GQ*'GEGWEXSV5>.6M1FG'R<W-Z\GT_*75](DZE2T0!.*
M0GA!P2:JP0AT!BXSZFDS-9=[.6D\TJB,Q\I]M2J X^<RD55_;]P"J0C>0M!&
MHHM"=7AF%$17BK(UC2'TT@"^)A,7:A@5D=F?L1P!DZ/MY-NB*]"GN9O.F["6
MQQTO?YM.9K,KD3ES21C0+ ; 1*9D,AD51(2C.3BI;3/C#'>ST7CV<'D6<RI4
M?H*]!=60TVA^.WWH77EEG2.41PZ28>PKB&3@E3%@O/,\92)CMZ=Q9[26+6Q<
M:(EDN]9R*E0.MQ:[M)9QNG;+6K-:1E..')83YWZ]?9C^N^!^MMY5\JZO*PK>
MA6A]2N@,;&$T*_#></#""1J"Y,%4[P%\,)476M_8(^3[5?2IB'Z7V@B9GD:.
MRDIO<IFZF+D 05$*QBF-Z1]7GM)@I*K=EG>8!*.]\L1V-X#38')B@O%J'%NS
ME8VJS3L?LICU6W26[W0FB0HD6$B\Z,QR"=Y@&D9,\"H%[H1OIESQ:"XO-#EI
M[IRK#U#]!'E*1PE=H7?D-N4,5 KT2 )E8XPUP)-QR3)&.&UM.$I'UGZ:\[)>
M$#Z,01X$M\LY8=MY0=9EJ,QC >4HK13&0G BE+M;"H8)"<I[8I)0))NSGU37
M8^]"-[U&;7(@V%W"[OB<:+:<S>R5C[$ZZ!@"$$T5B! P['&,@_8^>,<I9>KL
MPU$K\_C3G/]=A&WV"<"?P4"?3(C:*QU*#"4!<WL2(R^'4 %5Z3(F)-G08(GT
MLCGS/(C#G^:D\B*,LS_P78)I5@KUA<CHH8("K45$CV4$F.P<"*T,,>4=+FFF
MC4@/F>4E')0V88P#P.TG.5I]$>-BII2[>7C4]O!2C5$7-0\)LL$X0>@8P4F5
MP#)#9=(IT=!+)Y*^&+K0^+2- ]-Z4&EE!_//"\,?[%(^IE*CCW_^<C)>B.;6
MW926+>Q*4&JX+W7Z"CV+8&4LO*"L#$[DD:BLM:D]_68 -B_[S+0BR&OU CH3
MXEHQRCK[_,8<X*A$3HPED"+@?IY- B^2!U2H2X)R#+\;OEL_8H9TLP>@/1O8
MX.CY"<SH[\LAI>-XWW%L4O[H:2F"E998&E!1@NA%E R>^U">I6' G#DJ[.R#
MLRKQ=J&18O-&U@NV_BUL;F_F&F*4BH4 &#X$$%Y3<#J5?DN!:&>"YJZU1.TT
MCB_[,/.2[;,:#ENQVA-B\H.EM2M4IU<I$<)BH) S1Z67Y_Y.20Z>"1)8M,2(
M7B[MF^#^LD]#V\T9!\)G*Y;=JQ]\<7T]7924;R0+U-@84=? C).8<PL%)GD#
MR:C *.K;L-8J3X]F]D(;:/X$NW -]/T$9KJ*/DH/B57>X&.2/"L%^&^"N3HZ
M*Y\I@6B*,BDZKN:*49\PT<FL]%]F=5ZT_%SFLC^,+V["*PZ4E6LFYA7X%#+(
MI#@1DE+I6GN[W9&U3J9E_C*M%I#5BL&=$(#O%LON2%MY:;-*'BC* T6$<C)6
M4?!"ALP-CXK9QC+!(]CL9(CVW]00&T;<SV64CZ-G>F645(9;"JE,(A+1:S!.
M$R R.2MH)$KUTL&U%VZZW<23OVQL(  -W;6SXH4IIJKH5=#/E!?VJT9(*<14
MFE0Z2CP(E1EXXBE$+B6ADD0G-ZI==G3Z[)7,"[U'.*TBK#'M7]KL#_Q!-_TQ
MR=O_NAS9C&>I_CB0@Y;M=4+(\0)H8VB(((FIQ"5HJ1"<WI4!#-1!%M00RVFR
MK'99>2M#0^X[ *?I=\S'=CB!F\4G\5?O\\<4)M?CT?\A48O"Y06ERZ:M0GA*
M8@K A#0@A,/=UY@ .D@7#.6:VNKUC'TP<M'#1 [!\NYA(D/!HH%LXLT8W5WZ
MA I?['IO5RPNI@]HE7.*$=,A@O&E6/0D*C4ISN,6*X@RUM5.!_:0T\K0D<'
M,NE'<^V"<-7O73/MDC8. LOE936W8#CEP)WB@@2;J:W]-'$O0<,"L9K:N\'I
M"!TT *B/J!,DX N&YK^F[^EF\JWPM K-5CW^A<C!$&HP*/?(DDH9;.0,4F0\
M,R7P3VMWO.] 5I/@.@8$DWXUT@#(?DOC-'4WR-&+^'4T'I609#[ZGAXSY:CD
MV6'NIR(IU=,4K9/AKYB2RG+MN*O>"+@38</6T?<'M/I::0!J3Z9"H7]7BS;!
MZ.:IM. Y+S-&O9-"R4AE[><<AX]_.\/8C58BL>.UTP"TCG_JOV=$CPC)T&@$
M9)?0O#QW8#W38)TD0E.F/&^G!]/%C(+K#JMSC(([1,=#G_5W&#CFF(U)9 PY
M0@D^HE'@9=(0B4J)FFR<VW"J?XV".Q(,!XZ".T0S#0)M;<08RNUW-_U7FJ^S
MIX)+F6D),I57JDJC85N3P6AEF;9!.W$T\)Y9N_&WE$,#L:;F&MCI'W&X8H%%
M#*8U+[?')&.D30QX8U%F6A.=3* 8'U?>J+>0T?ASPW/AL):B3F@27Z?=9YW
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MCB0U==;NK^Y*&C7KTK2]54#9Y!2V;RN?]UI/[[N?H.[;G[[^"5!+ P04
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M+N6Z:(>IU#K\[)Y*8]FZ,N]H'5*V.8L=V^)G5TOJ8_<BZK%] ?:_4$L#!!0
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MC ,I5PFRN"D()ES'<%#E++ &&KTY3!,AW!QC6DC\Z?(V_' P;.X$#!F)>(9
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M;WEE97!O;&EC>6)O;VLN:'1M4$L! A0#%     @ .H%77$^7_(]H'@  W'$
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M,#(U,3(S,5]C86PN>&UL4$L! A0#%     @ .H%77!'GYP9-8@  \Z,$ !4
M             ( !?.<# '-M;70M,C R-3$R,S%?9&5F+GAM;%!+ 0(4 Q0
M   ( #J!5UP>N%12 D   "!*   4              "  ?Q)! !S;6UT+3(P
M,C4Q,C,Q7V<Q+FIP9U!+ 0(4 Q0    ( #J!5UQ\+,U!LJD  ,[E   4
M          "  3"*! !S;6UT+3(P,C4Q,C,Q7V<R+FIP9U!+ 0(4 Q0    (
M #J!5UPQ@LSM1Y$  .74   4              "  10T!0!S;6UT+3(P,C4Q
M,C,Q7V<S+FIP9U!+ 0(4 Q0    ( #J!5US5J\C[MB0! +2<"P 5
M      "  8W%!0!S;6UT+3(P,C4Q,C,Q7VQA8BYX;6Q02P$"% ,4    "  Z
M@5=<H,)&@@:H   O) @ %0              @ %VZ@8 <VUM="TR,#(U,3(S
M,5]P<F4N>&UL4$L! A0#%     @ .H%77./CCDQC P  [Q<  !X
M     ( !KY(' '-U;2UE>#(Q,5\R,#(U,3(S,7AX<W5B<VED+FAT;5!+ 0(4
M Q0    ( #J!5UPB!X4:V (  *P(   >              "  4Z6!P!S=6TM
M97@R,S%?,C R-3$R,S%X>'5S8V]N<RYH=&U02P$"% ,4    "  Z@5=<'TU;
M(5<(   !*P  '0              @ %BF0< <W5M+65X,S$Q7S(P,C4Q,C,Q
M>&1U9V=A;BYH=&U02P$"% ,4    "  Z@5=<,]BFR6((   '*P  'P
M        @ 'TH0< <W5M+65X,S$R7S(P,C4Q,C,Q>'IA;F=A;F5H+FAT;5!+
M 0(4 Q0    ( #J!5UQ!GR^+4 @  !,K   >              "  9.J!P!S
M=6TM97@S,3-?,C R-3$R,S%X,3!K<V]N:2YH=&U02P$"% ,4    "  Z@5=<
M@%'(!IT%   ^*   '@              @ $?LP< <W5M+65X,S(Q7S(P,C4Q
E,C,Q>'@T,#0Y,#8N:'1M4$L%!@     1 !$ K 0  /BX!P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>smmt-20251231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2025"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:smmt="http://www.summitplc.com/20251231"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="smmt-20251231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <instant>2026-02-17</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AtMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AtMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AtMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AtMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AtMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AtMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AtMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AkesoLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AkesoLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:AkesoLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:DistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">smmt:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">smmt:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">smmt:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">smmt:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">smmt:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-06</startDate>
            <endDate>2023-03-06</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-03</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">smmt:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementUpfrontPaymentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:KY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:KY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:KY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignTaxJurisdictionOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignTaxJurisdictionOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignTaxJurisdictionOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-01</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <instant>2023-03-01</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">smmt:NewJerseyAndCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">smmt:NewJerseyAndCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-01</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-18</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:NotePurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-06</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:DugganFebruaryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-06</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:ZanganehNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-06</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:DugganSeptemberNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-06</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:DugganFebruaryNoteAndZanganehNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-06</startDate>
            <endDate>2022-12-06</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:RevisedDugganFebruaryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-19</startDate>
            <endDate>2023-01-19</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:RevisedDugganFebruaryNoteAndRevisedDugganSeptemberNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-19</startDate>
            <endDate>2023-01-19</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:ZanganehNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-15</startDate>
            <endDate>2023-02-15</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:RevisedDugganFebruaryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-15</startDate>
            <endDate>2023-02-15</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:NotePurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-06</startDate>
            <endDate>2022-12-06</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:NotePurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="smmt:VariableRatePeriodAxis">smmt:VariableRatePeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-06</startDate>
            <endDate>2022-12-06</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:NotePurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="smmt:VariableRatePeriodAxis">smmt:VariableRatePeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-06</startDate>
            <endDate>2022-12-06</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:RevisedDugganFebruaryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-17</startDate>
            <endDate>2024-02-17</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:RevisedDugganFebruaryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:ZanganehNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:RevisedDugganSeptemberNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <startDate>2024-09-16</startDate>
            <endDate>2024-09-16</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-01</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:PromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:PromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:PromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:RevisedDugganSeptemberNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-06</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-06</startDate>
            <endDate>2022-12-06</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:RightsOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-06</startDate>
            <endDate>2022-12-06</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <startDate>2023-01-19</startDate>
            <endDate>2023-01-19</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <instant>2023-01-18</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <instant>2023-01-19</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <instant>2023-04-27</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:S3RegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-27</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:S3RegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-27</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:ChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:S3RegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-27</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefOperatingOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-13</startDate>
            <endDate>2023-10-13</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefOperatingOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-13</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefOperatingOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-13</startDate>
            <endDate>2023-10-13</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <startDate>2024-06-03</startDate>
            <endDate>2024-06-03</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <instant>2024-06-03</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-11</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-11</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-11</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-21</startDate>
            <endDate>2025-10-21</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-21</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-21</startDate>
            <endDate>2025-10-21</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-21</startDate>
            <endDate>2025-10-21</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-21</startDate>
            <endDate>2025-10-21</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
        </entity>
        <period>
            <instant>2024-05-13</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:OriginalDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-13</startDate>
            <endDate>2024-05-13</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:DistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-11</startDate>
            <endDate>2025-08-11</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:DistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-13</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">smmt:DistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2020StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-21</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2020StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-21</startDate>
            <endDate>2020-09-21</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2020StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2020StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-01</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2020IncrementalPoolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-18</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2020IncrementalPoolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2024InducementPoolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-03</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2024InducementPoolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-22</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">smmt:A2024InducementPoolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-19</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-19</startDate>
            <endDate>2020-08-19</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-19</startDate>
            <endDate>2020-08-19</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionTimeBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionTimeBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionTimeBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionTimeBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionTimeBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionTimeBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionPerformanceBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionPerformanceBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionPerformanceBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionPerformanceBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionPerformanceBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionTimeBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionPerformanceAndMarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionPerformanceAndMarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">smmt:EmployeeStockOptionPerformanceAndMarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementFirstAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementFirstAndThirdAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementFirstAndThirdAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementFirstAndThirdAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementSecondAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-29</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementSecondAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementSecondAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementSecondAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-01</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:GeniusSubleaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-01</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:InvestmentsResearchSubleaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-01</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:GeniusSubleaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-01</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:InvestmentsResearchSubleaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-01</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:GeniusSubleaseAgreementAndInvestmentsResearchSubleaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementThirdAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-01</instant>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:SubleaseAgreementThirdAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-08-01</endDate>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:AkesoSupplyAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:AkesoSupplyAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:AkesoSupplyAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:AkesoSupplyAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:AkesoSupplyAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:CoChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:CoChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:CoChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:CoChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-08</startDate>
            <endDate>2025-04-08</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">smmt:ConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001599298</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">smmt:WilsonSonsiniGoodrichRosatiP.C.WSGRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>smmt:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="promissory_note">
        <measure>smmt:promissory_note</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="contract">
        <measure>smmt:contract</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-32">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-33">0001599298</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-34">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-35">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-466"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-467"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <smmt:NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering contextRef="c-115" id="f-775">P5D</smmt:NotesPayableRelatedPartiesPotentialPrepaymentPeriodPostReceiptOfCashProceedsFromPublicOffering>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-177" id="f-888">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2025-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-4">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-36866</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">Summit Therapeutics Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">37-1979717</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">601 Brickell Key Drive, Suite 1000</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">Miami</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">33131</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">305</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">203-2034</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">SMMT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-19">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-20">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-21">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-22">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-23">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-24">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-25">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-26">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-27">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-28">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-2" decimals="-5" id="f-29" unitRef="usd">2483800000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-30" unitRef="shares">775372700</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-31">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Portions of the registrant&#x2019;s definitive proxy statement relating to the registrant&#x2019;s 2026 annual meeting of stockholders to be filed hereafter are incorporated by reference into Part III of this Annual Report on Form 10-K. The registrant&#x2019;s definitive proxy statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c-1" id="f-37">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have implemented a risk-based approach to identify and assess the cybersecurity threats that could affect our business and information systems. We use recognized commercially reasonable measures, tools and methodologies designed to manage cybersecurity risk that are tested on a regular cadence. We also monitor and evaluate our cybersecurity posture on an ongoing basis through regular vulnerability scans, penetration tests and third-party reviews. We rely on third-party service providers to provide the systems required to effectively run our clinical trials and endeavor to require third-party service providers that have access to personal, confidential or proprietary information to implement and maintain cybersecurity practices. Specific controls that are used in appropriate portions of our environment include endpoint threat detection and response, identity and access management, privileged access management, logging and monitoring involving the use of security information and event management, multi-factor authentication, firewalls and intrusion detection and prevention, and vulnerability and patch management. Our cybersecurity risk management processes are integrated into our enterprise risk management program. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To manage our material risks from cybersecurity threats and to protect against, detect, and prepare to respond to cybersecurity incidents, we endeavor to:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Monitor emerging data protection laws and implement changes to our processes to comply;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Conduct annual cybersecurity management and incident training for employees that process sensitive data;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Conduct onboarding and cybersecurity training for all employees on an ongoing basis;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Conduct regular phishing email simulations for all employees; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Carry cybersecurity risk insurance meant to provide protection against the potential losses arising from a cybersecurity incident.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we engage several third-party consultants in connection with our risk assessment and risk management, and we have established separate processes and procedures to oversee and identify cybersecurity risks associated with third parties. All third parties involved in our cybersecurity risk assessments and risk management are required to provide reports designed to allow us to monitor and assess such third parties&#x2019; security controls.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our incident response plan coordinates the activities that we and our third-party cybersecurity provider take to respond and recover from cybersecurity incidents, which include processes to triage, assess severity, investigate, escalate, contain, and remediate an incident, as well as to comply with legal obligations and attempt to mitigate brand and reputational damage. We have business continuity plans that we periodically review and update in line with our evolving applications architecture.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c-1" id="f-36">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have implemented a risk-based approach to identify and assess the cybersecurity threats that could affect our business and information systems. We use recognized commercially reasonable measures, tools and methodologies designed to manage cybersecurity risk that are tested on a regular cadence. We also monitor and evaluate our cybersecurity posture on an ongoing basis through regular vulnerability scans, penetration tests and third-party reviews. We rely on third-party service providers to provide the systems required to effectively run our clinical trials and endeavor to require third-party service providers that have access to personal, confidential or proprietary information to implement and maintain cybersecurity practices. Specific controls that are used in appropriate portions of our environment include endpoint threat detection and response, identity and access management, privileged access management, logging and monitoring involving the use of security information and event management, multi-factor authentication, firewalls and intrusion detection and prevention, and vulnerability and patch management. Our cybersecurity risk management processes are integrated into our enterprise risk management program. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To manage our material risks from cybersecurity threats and to protect against, detect, and prepare to respond to cybersecurity incidents, we endeavor to:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Monitor emerging data protection laws and implement changes to our processes to comply;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Conduct annual cybersecurity management and incident training for employees that process sensitive data;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Conduct onboarding and cybersecurity training for all employees on an ongoing basis;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Conduct regular phishing email simulations for all employees; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Carry cybersecurity risk insurance meant to provide protection against the potential losses arising from a cybersecurity incident.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we engage several third-party consultants in connection with our risk assessment and risk management, and we have established separate processes and procedures to oversee and identify cybersecurity risks associated with third parties. All third parties involved in our cybersecurity risk assessments and risk management are required to provide reports designed to allow us to monitor and assess such third parties&#x2019; security controls.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our incident response plan coordinates the activities that we and our third-party cybersecurity provider take to respond and recover from cybersecurity incidents, which include processes to triage, assess severity, investigate, escalate, contain, and remediate an incident, as well as to comply with legal obligations and attempt to mitigate brand and reputational damage. We have business continuity plans that we periodically review and update in line with our evolving applications architecture.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c-1" id="f-38">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c-1" id="f-39">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c-1" id="f-40">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="c-1" id="f-41">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cybersecurity leadership team is responsible for assessing and managing cybersecurity risks and is made up of experienced professionals with an extensive background in information security, risk management, and incident response. This team is led by our Head of Information Technology. The Head of Information Technology is a senior technology strategist and thought leader with over two decades of experience in the bio pharma, life sciences, and high-tech sectors.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Board of Directors provides oversight to our cybersecurity efforts to ensure effective governance in assessing and managing risks associated with cybersecurity threats. Our Head of Information Technology provides periodic updates to senior management and quarterly updates to the Board of Directors regarding our cybersecurity program, including information about cyber risk management governance, status updates on various projects intended to enhance the overall cybersecurity posture of the Company, and information about the prevention, detection, mitigation and remediation of any cybersecurity incidents, as appropriate.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock contextRef="c-1" id="f-44">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cybersecurity leadership team is responsible for assessing and managing cybersecurity risks and is made up of experienced professionals with an extensive background in information security, risk management, and incident response. This team is led by our Head of Information Technology. The Head of Information Technology is a senior technology strategist and thought leader with over two decades of experience in the bio pharma, life sciences, and high-tech sectors.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-43">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cybersecurity leadership team is responsible for assessing and managing cybersecurity risks and is made up of experienced professionals with an extensive background in information security, risk management, and incident response. This team is led by our Head of Information Technology. The Head of Information Technology is a senior technology strategist and thought leader with over two decades of experience in the bio pharma, life sciences, and high-tech sectors.&lt;/span&gt;&lt;/div&gt;status updates on various projects intended to enhance the overall cybersecurity posture of the Company, and information about the prevention, detection, mitigation and remediation of any cybersecurity incidents, as appropriate.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-42">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cybersecurity leadership team is responsible for assessing and managing cybersecurity risks and is made up of experienced professionals with an extensive background in information security, risk management, and incident response. This team is led by our Head of Information Technology. The Head of Information Technology is a senior technology strategist and thought leader with over two decades of experience in the bio pharma, life sciences, and high-tech sectors.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="c-1" id="f-45">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c-1" id="f-46">Our Board of Directors provides oversight to our cybersecurity efforts to ensure effective governance in assessing and managing risks associated with cybersecurity threats.</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-48">Our Head of Information Technology provides periodic updates to senior management and quarterly updates to the Board of Directors regarding our cybersecurity program, including information about cyber risk management governance, status updates on various projects intended to enhance the overall cybersecurity posture of the Company, and information about the prevention, detection, mitigation and remediation of any cybersecurity incidents, as appropriate.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-47">Our Head of Information Technology provides periodic updates to senior management and quarterly updates to the Board of Directors regarding our cybersecurity program, including information about cyber risk management governance, status updates on various projects intended to enhance the overall cybersecurity posture of the Company, and information about the prevention, detection, mitigation and remediation of any cybersecurity incidents, as appropriate.</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c-1" id="f-49">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c-1" id="f-50">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-4" id="f-51">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-4" id="f-52">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-4" id="f-53">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-4" id="f-54">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-55">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <dei:AuditorFirmId contextRef="c-1" id="f-56">238</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c-1" id="f-57">PricewaterhouseCoopers LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-58">San Jose, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-59" unitRef="usd">225266000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-6" decimals="-3" id="f-60" unitRef="usd">104862000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c-5" decimals="-3" id="f-61" unitRef="usd">316000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c-6" decimals="-3" id="f-62" unitRef="usd">325000</us-gaap:RestrictedCashCurrent>
    <us-gaap:ShortTermInvestments contextRef="c-5" decimals="-3" id="f-63" unitRef="usd">488182000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-6" decimals="-3" id="f-64" unitRef="usd">307487000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-65" unitRef="usd">6537000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-6" decimals="-3" id="f-66" unitRef="usd">11076000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-5" decimals="-3" id="f-67" unitRef="usd">720301000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-6" decimals="-3" id="f-68" unitRef="usd">423750000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-3" id="f-69" unitRef="usd">1059000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-6" decimals="-3" id="f-70" unitRef="usd">254000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-71" unitRef="usd">20616000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-6" decimals="-3" id="f-72" unitRef="usd">7144000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-73" unitRef="usd">2001000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-6" decimals="-3" id="f-74" unitRef="usd">1864000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-5" decimals="-3" id="f-75" unitRef="usd">7205000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-6" decimals="-3" id="f-76" unitRef="usd">2548000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-5" decimals="-3" id="f-77" unitRef="usd">751182000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-6" decimals="-3" id="f-78" unitRef="usd">435560000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-5" decimals="-3" id="f-79" unitRef="usd">20292000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-6" decimals="-3" id="f-80" unitRef="usd">4636000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-81" unitRef="usd">32100000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-6" decimals="-3" id="f-82" unitRef="usd">19554000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-83" unitRef="usd">14925000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-6" decimals="-3" id="f-84" unitRef="usd">11977000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-85" unitRef="usd">3388000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-6" decimals="-3" id="f-86" unitRef="usd">3765000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-87" unitRef="usd">2283000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-6" decimals="-3" id="f-88" unitRef="usd">1797000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-89" unitRef="usd">72988000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-6" decimals="-3" id="f-90" unitRef="usd">41729000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-91" unitRef="usd">17502000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-6" decimals="-3" id="f-92" unitRef="usd">3453000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-5" decimals="-3" id="f-93" unitRef="usd">1832000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-6" decimals="-3" id="f-94" unitRef="usd">1630000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-5" decimals="-3" id="f-95" unitRef="usd">92322000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-6" decimals="-3" id="f-96" unitRef="usd">46812000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-97" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-6" id="f-98" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-99"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-6"
      decimals="INF"
      id="f-100"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-101" unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-6" decimals="INF" id="f-102" unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-5" decimals="INF" id="f-103" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c-6" decimals="INF" id="f-104" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-105" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-6" decimals="INF" id="f-106" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-5" decimals="-3" id="f-107" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-6" decimals="-3" id="f-108" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-109"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-6"
      decimals="INF"
      id="f-110"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-111" unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-6" decimals="INF" id="f-112" unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-113" unitRef="shares">775371200</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-5" decimals="INF" id="f-114" unitRef="shares">775371200</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-6" decimals="INF" id="f-115" unitRef="shares">737626004</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-6" decimals="INF" id="f-116" unitRef="shares">737626004</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="-3" id="f-117" unitRef="usd">7754000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-6" decimals="-3" id="f-118" unitRef="usd">7376000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-5" decimals="-3" id="f-119" unitRef="usd">2947805000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-6" decimals="-3" id="f-120" unitRef="usd">1598230000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-3" id="f-121" unitRef="usd">-2540000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-6" decimals="-3" id="f-122" unitRef="usd">-2285000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-123" unitRef="usd">-2294159000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-6" decimals="-3" id="f-124" unitRef="usd">-1214573000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-125" unitRef="usd">658860000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-3" id="f-126" unitRef="usd">388748000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-3" id="f-127" unitRef="usd">751182000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-6" decimals="-3" id="f-128" unitRef="usd">435560000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-1" decimals="-3" id="f-129" unitRef="usd">537674000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-7" decimals="-3" id="f-130" unitRef="usd">150777000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-8" decimals="-3" id="f-131" unitRef="usd">59471000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <smmt:AcquiredInProcessResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-132" unitRef="usd">0</smmt:AcquiredInProcessResearchAndDevelopmentExpense>
    <smmt:AcquiredInProcessResearchAndDevelopmentExpense contextRef="c-7" decimals="-3" id="f-133" unitRef="usd">15007000</smmt:AcquiredInProcessResearchAndDevelopmentExpense>
    <smmt:AcquiredInProcessResearchAndDevelopmentExpense contextRef="c-8" decimals="-3" id="f-134" unitRef="usd">520915000</smmt:AcquiredInProcessResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-135" unitRef="usd">556750000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-7" decimals="-3" id="f-136" unitRef="usd">60214000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-8" decimals="-3" id="f-137" unitRef="usd">29264000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-138" unitRef="usd">1094424000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-7" decimals="-3" id="f-139" unitRef="usd">225998000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-8" decimals="-3" id="f-140" unitRef="usd">609650000</us-gaap:OperatingExpenses>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-141" unitRef="usd">14838000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-7" decimals="-3" id="f-142" unitRef="usd">13369000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-8" decimals="-3" id="f-143" unitRef="usd">11183000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="-3" id="f-144" unitRef="usd">0</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-7" decimals="-3" id="f-145" unitRef="usd">8686000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-8" decimals="-3" id="f-146" unitRef="usd">16461000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-147" unitRef="usd">-1079586000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-148" unitRef="usd">-221315000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-8" decimals="-3" id="f-149" unitRef="usd">-614928000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-150"
      unitRef="usdPerShare">-1.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-151"
      unitRef="usdPerShare">-1.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-152"
      unitRef="usdPerShare">-0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-153"
      unitRef="usdPerShare">-0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-8"
      decimals="2"
      id="f-154"
      unitRef="usdPerShare">-0.99</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-8"
      decimals="2"
      id="f-155"
      unitRef="usdPerShare">-0.99</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-156" unitRef="shares">747702265</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-157" unitRef="shares">747702265</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="0" id="f-158" unitRef="shares">718541896</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="0" id="f-159" unitRef="shares">718541896</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-8" decimals="0" id="f-160" unitRef="shares">619646180</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-8" decimals="0" id="f-161" unitRef="shares">619646180</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-3" id="f-162" unitRef="usd">-327000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c-7" decimals="-3" id="f-163" unitRef="usd">60000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c-8" decimals="-3" id="f-164" unitRef="usd">-172000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax contextRef="c-1" decimals="-3" id="f-165" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax contextRef="c-7" decimals="-3" id="f-166" unitRef="usd">3000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax contextRef="c-8" decimals="-3" id="f-167" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax contextRef="c-1" decimals="-3" id="f-168" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax contextRef="c-7" decimals="-3" id="f-169" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax contextRef="c-8" decimals="-3" id="f-170" unitRef="usd">419000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax contextRef="c-1" decimals="-3" id="f-171" unitRef="usd">72000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax contextRef="c-7" decimals="-3" id="f-172" unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax contextRef="c-8" decimals="-3" id="f-173" unitRef="usd">36000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-174" unitRef="usd">-1079841000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-3" id="f-175" unitRef="usd">-221152000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-8" decimals="-3" id="f-176" unitRef="usd">-615483000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-9" decimals="INF" id="f-177" unitRef="shares">211091425</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-3" id="f-178" unitRef="usd">2110000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-3" id="f-179" unitRef="usd">504767000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-3" id="f-180" unitRef="usd">-1893000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-3" id="f-181" unitRef="usd">-378330000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-13" decimals="-3" id="f-182" unitRef="usd">126654000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-14" decimals="-3" id="f-183" unitRef="usd">619000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-15"
      decimals="INF"
      id="f-184"
      unitRef="shares">476190471</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-15" decimals="-3" id="f-185" unitRef="usd">4762000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-16" decimals="-3" id="f-186" unitRef="usd">494619000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-14" decimals="-3" id="f-187" unitRef="usd">499381000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-17"
      decimals="INF"
      id="f-188"
      unitRef="shares">596472</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-17" decimals="-3" id="f-189" unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-18" decimals="-3" id="f-190" unitRef="usd">922000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-8" decimals="-3" id="f-191" unitRef="usd">929000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <smmt:StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest
      contextRef="c-17"
      decimals="INF"
      id="f-192"
      unitRef="shares">10000000</smmt:StockIssuedDuringPeriodSharesIssuedForRelatedPartyInterest>
    <smmt:StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest contextRef="c-17" decimals="-3" id="f-193" unitRef="usd">100000</smmt:StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest>
    <smmt:StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest contextRef="c-18" decimals="-3" id="f-194" unitRef="usd">45800000</smmt:StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest>
    <smmt:StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest contextRef="c-8" decimals="-3" id="f-195" unitRef="usd">45900000</smmt:StockIssuedDuringPeriodValueIssuedForRelatedPartyInterest>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-19"
      decimals="INF"
      id="f-196"
      unitRef="shares">2976190</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-19" decimals="-3" id="f-197" unitRef="usd">30000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-20" decimals="-3" id="f-198" unitRef="usd">4970000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-21" decimals="-3" id="f-199" unitRef="usd">5000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <smmt:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="c-17"
      decimals="INF"
      id="f-200"
      unitRef="shares">805495</smmt:StockIssuedDuringPeriodSharesWarrantsExercised>
    <smmt:StockIssuedDuringPeriodValueWarrantsExercised contextRef="c-17" decimals="-3" id="f-201" unitRef="usd">8000</smmt:StockIssuedDuringPeriodValueWarrantsExercised>
    <smmt:StockIssuedDuringPeriodValueWarrantsExercised contextRef="c-18" decimals="-3" id="f-202" unitRef="usd">1195000</smmt:StockIssuedDuringPeriodValueWarrantsExercised>
    <smmt:StockIssuedDuringPeriodValueWarrantsExercised contextRef="c-8" decimals="-3" id="f-203" unitRef="usd">1203000</smmt:StockIssuedDuringPeriodValueWarrantsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-18" decimals="-3" id="f-204" unitRef="usd">14108000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-8" decimals="-3" id="f-205" unitRef="usd">14108000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-22" decimals="-3" id="f-206" unitRef="usd">-555000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-8" decimals="-3" id="f-207" unitRef="usd">-555000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-23" decimals="-3" id="f-208" unitRef="usd">-614928000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-8" decimals="-3" id="f-209" unitRef="usd">-614928000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-24"
      decimals="INF"
      id="f-210"
      unitRef="shares">701660053</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-3" id="f-211" unitRef="usd">7017000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-3" id="f-212" unitRef="usd">1066381000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-3" id="f-213" unitRef="usd">-2448000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-3" id="f-214" unitRef="usd">-993258000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-215" unitRef="usd">77692000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-29" decimals="-3" id="f-216" unitRef="usd">140000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-30"
      decimals="INF"
      id="f-217"
      unitRef="shares">32574640</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-30" decimals="-3" id="f-218" unitRef="usd">326000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-31" decimals="-3" id="f-219" unitRef="usd">434534000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-29" decimals="-3" id="f-220" unitRef="usd">434860000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-32"
      decimals="INF"
      id="f-221"
      unitRef="shares">1584218</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-32" decimals="-3" id="f-222" unitRef="usd">15000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-33" decimals="-3" id="f-223" unitRef="usd">3319000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-7" decimals="-3" id="f-224" unitRef="usd">3334000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-34" decimals="-3" id="f-225" unitRef="usd">1190000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-35"
      decimals="INF"
      id="f-226"
      unitRef="shares">1807093</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-35" decimals="-3" id="f-227" unitRef="usd">18000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-36" decimals="-3" id="f-228" unitRef="usd">43015000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-34" decimals="-3" id="f-229" unitRef="usd">43033000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-33" decimals="-3" id="f-230" unitRef="usd">50981000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-7" decimals="-3" id="f-231" unitRef="usd">50981000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-37" decimals="-3" id="f-232" unitRef="usd">163000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-3" id="f-233" unitRef="usd">163000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-38" decimals="-3" id="f-234" unitRef="usd">-221315000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-235" unitRef="usd">-221315000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-39"
      decimals="INF"
      id="f-236"
      unitRef="shares">737626004</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-3" id="f-237" unitRef="usd">7376000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-40" decimals="-3" id="f-238" unitRef="usd">1598230000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-3" id="f-239" unitRef="usd">-2285000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-42" decimals="-3" id="f-240" unitRef="usd">-1214573000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-3" id="f-241" unitRef="usd">388748000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-43"
      decimals="INF"
      id="f-242"
      unitRef="shares">26682846</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-43" decimals="-3" id="f-243" unitRef="usd">267000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-44" decimals="-3" id="f-244" unitRef="usd">499770000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-45" decimals="-3" id="f-245" unitRef="usd">500037000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-46"
      decimals="INF"
      id="f-246"
      unitRef="shares">5723011</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-46" decimals="-3" id="f-247" unitRef="usd">58000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-47" decimals="-3" id="f-248" unitRef="usd">12910000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-1" decimals="-3" id="f-249" unitRef="usd">12968000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-48" decimals="-3" id="f-250" unitRef="usd">1969000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-49"
      decimals="INF"
      id="f-251"
      unitRef="shares">5339339</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-49" decimals="-3" id="f-252" unitRef="usd">53000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-50" decimals="-3" id="f-253" unitRef="usd">104475000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-48" decimals="-3" id="f-254" unitRef="usd">104528000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-47" decimals="-3" id="f-255" unitRef="usd">732420000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-256" unitRef="usd">732420000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-51" decimals="-3" id="f-257" unitRef="usd">-255000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-258" unitRef="usd">-255000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-52" decimals="-3" id="f-259" unitRef="usd">-1079586000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-260" unitRef="usd">-1079586000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-53"
      decimals="INF"
      id="f-261"
      unitRef="shares">775371200</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-53" decimals="-3" id="f-262" unitRef="usd">7754000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-54" decimals="-3" id="f-263" unitRef="usd">2947805000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-55" decimals="-3" id="f-264" unitRef="usd">-2540000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-56" decimals="-3" id="f-265" unitRef="usd">-2294159000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-266" unitRef="usd">658860000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-267" unitRef="usd">-1079586000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-268" unitRef="usd">-221315000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-8" decimals="-3" id="f-269" unitRef="usd">-614928000</us-gaap:NetIncomeLoss>
    <smmt:InterestExpenseIncomeNoncash contextRef="c-1" decimals="-3" id="f-270" unitRef="usd">0</smmt:InterestExpenseIncomeNoncash>
    <smmt:InterestExpenseIncomeNoncash contextRef="c-7" decimals="-3" id="f-271" unitRef="usd">0</smmt:InterestExpenseIncomeNoncash>
    <smmt:InterestExpenseIncomeNoncash contextRef="c-8" decimals="-3" id="f-272" unitRef="usd">6253000</smmt:InterestExpenseIncomeNoncash>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-1" decimals="-3" id="f-273" unitRef="usd">7006000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-7" decimals="-3" id="f-274" unitRef="usd">2576000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-8" decimals="-3" id="f-275" unitRef="usd">1924000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-1" decimals="-3" id="f-276" unitRef="usd">320000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-7" decimals="-3" id="f-277" unitRef="usd">-229000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-8" decimals="-3" id="f-278" unitRef="usd">812000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome contextRef="c-1" decimals="-3" id="f-279" unitRef="usd">0</smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome>
    <smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome contextRef="c-7" decimals="-3" id="f-280" unitRef="usd">0</smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome>
    <smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome contextRef="c-8" decimals="-3" id="f-281" unitRef="usd">419000</smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-1" decimals="-3" id="f-282" unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-7" decimals="-3" id="f-283" unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-8" decimals="-3" id="f-284" unitRef="usd">474000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:Depreciation contextRef="c-1" decimals="-3" id="f-285" unitRef="usd">146000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-7" decimals="-3" id="f-286" unitRef="usd">89000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-8" decimals="-3" id="f-287" unitRef="usd">198000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-288" unitRef="usd">732420000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-7" decimals="-3" id="f-289" unitRef="usd">50981000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-8" decimals="-3" id="f-290" unitRef="usd">14108000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnDispositionOfAssets1 contextRef="c-1" decimals="-3" id="f-291" unitRef="usd">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1 contextRef="c-7" decimals="-3" id="f-292" unitRef="usd">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1 contextRef="c-8" decimals="-3" id="f-293" unitRef="usd">109000</us-gaap:GainLossOnDispositionOfAssets1>
    <smmt:AcquiredInProcessResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-294" unitRef="usd">0</smmt:AcquiredInProcessResearchAndDevelopmentExpense>
    <smmt:AcquiredInProcessResearchAndDevelopmentExpense contextRef="c-7" decimals="-3" id="f-295" unitRef="usd">15007000</smmt:AcquiredInProcessResearchAndDevelopmentExpense>
    <smmt:AcquiredInProcessResearchAndDevelopmentExpense contextRef="c-8" decimals="-3" id="f-296" unitRef="usd">520915000</smmt:AcquiredInProcessResearchAndDevelopmentExpense>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-297" unitRef="usd">-4866000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-7" decimals="-3" id="f-298" unitRef="usd">7370000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-8" decimals="-3" id="f-299" unitRef="usd">-3613000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-1" decimals="-3" id="f-300" unitRef="usd">4875000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-7" decimals="-3" id="f-301" unitRef="usd">-2470000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-8" decimals="-3" id="f-302" unitRef="usd">3421000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-303" unitRef="usd">15303000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-7" decimals="-3" id="f-304" unitRef="usd">2015000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-8" decimals="-3" id="f-305" unitRef="usd">2263000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-1" decimals="-3" id="f-306" unitRef="usd">12930000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-7" decimals="-3" id="f-307" unitRef="usd">11879000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-8" decimals="-3" id="f-308" unitRef="usd">-2377000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-1" decimals="-3" id="f-309" unitRef="usd">2909000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-7" decimals="-3" id="f-310" unitRef="usd">6557000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-8" decimals="-3" id="f-311" unitRef="usd">-235000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-1" decimals="-3" id="f-312" unitRef="usd">80000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-7" decimals="-3" id="f-313" unitRef="usd">95000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-8" decimals="-3" id="f-314" unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <smmt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet contextRef="c-1" decimals="-3" id="f-315" unitRef="usd">203000</smmt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet>
    <smmt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet contextRef="c-7" decimals="-3" id="f-316" unitRef="usd">-167000</smmt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet>
    <smmt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet contextRef="c-8" decimals="-3" id="f-317" unitRef="usd">-359000</smmt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-318" unitRef="usd">-322930000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-7" decimals="-3" id="f-319" unitRef="usd">-142106000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-8" decimals="-3" id="f-320" unitRef="usd">-76760000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments contextRef="c-1" decimals="-3" id="f-321" unitRef="usd">311340000</us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments contextRef="c-7" decimals="-3" id="f-322" unitRef="usd">489837000</us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments contextRef="c-8" decimals="-3" id="f-323" unitRef="usd">208165000</us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c-1" decimals="-3" id="f-324" unitRef="usd">484993000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c-7" decimals="-3" id="f-325" unitRef="usd">680032000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c-8" decimals="-3" id="f-326" unitRef="usd">321022000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-327" unitRef="usd">657000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-7" decimals="-3" id="f-328" unitRef="usd">139000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-8" decimals="-3" id="f-329" unitRef="usd">128000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-330" unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-7" decimals="-3" id="f-331" unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-8" decimals="-3" id="f-332" unitRef="usd">226000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <smmt:PaymentsForCollaborativeArrangement contextRef="c-1" decimals="-3" id="f-333" unitRef="usd">0</smmt:PaymentsForCollaborativeArrangement>
    <smmt:PaymentsForCollaborativeArrangement contextRef="c-7" decimals="-3" id="f-334" unitRef="usd">15007000</smmt:PaymentsForCollaborativeArrangement>
    <smmt:PaymentsForCollaborativeArrangement contextRef="c-8" decimals="-3" id="f-335" unitRef="usd">475015000</smmt:PaymentsForCollaborativeArrangement>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-336" unitRef="usd">-174310000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-7" decimals="-3" id="f-337" unitRef="usd">-205341000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-8" decimals="-3" id="f-338" unitRef="usd">-587774000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c-1" decimals="-3" id="f-339" unitRef="usd">500037000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c-7" decimals="-3" id="f-340" unitRef="usd">434860000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c-8" decimals="-3" id="f-341" unitRef="usd">5000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-48" decimals="-3" id="f-342" unitRef="usd">104528000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-34" decimals="-3" id="f-343" unitRef="usd">43033000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-57" decimals="-3" id="f-344" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-1" decimals="-3" id="f-345" unitRef="usd">7315000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-7" decimals="-3" id="f-346" unitRef="usd">598000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-8" decimals="-3" id="f-347" unitRef="usd">1203000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-1" decimals="-3" id="f-348" unitRef="usd">5653000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-7" decimals="-3" id="f-349" unitRef="usd">2736000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-8" decimals="-3" id="f-350" unitRef="usd">929000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-58" decimals="-3" id="f-351" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-59" decimals="-3" id="f-352" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-14" decimals="-3" id="f-353" unitRef="usd">104686000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-1" decimals="-3" id="f-354" unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-7" decimals="-3" id="f-355" unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-8" decimals="-3" id="f-356" unitRef="usd">619000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c-1" decimals="-3" id="f-357" unitRef="usd">0</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c-7" decimals="-3" id="f-358" unitRef="usd">100000000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c-8" decimals="-3" id="f-359" unitRef="usd">24686000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-360" unitRef="usd">617533000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-7" decimals="-3" id="f-361" unitRef="usd">381227000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-8" decimals="-3" id="f-362" unitRef="usd">86513000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-1" decimals="-3" id="f-363" unitRef="usd">102000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-7" decimals="-3" id="f-364" unitRef="usd">-18000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-8" decimals="-3" id="f-365" unitRef="usd">839000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-366" unitRef="usd">120395000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-7" decimals="-3" id="f-367" unitRef="usd">33762000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-8" decimals="-3" id="f-368" unitRef="usd">-577182000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-3" id="f-369" unitRef="usd">105187000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-28" decimals="-3" id="f-370" unitRef="usd">71425000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-13" decimals="-3" id="f-371" unitRef="usd">648607000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-372" unitRef="usd">225582000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-3" id="f-373" unitRef="usd">105187000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-28" decimals="-3" id="f-374" unitRef="usd">71425000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-375" unitRef="usd">0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-7" decimals="-3" id="f-376" unitRef="usd">8806000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-8" decimals="-3" id="f-377" unitRef="usd">10650000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-1" decimals="-3" id="f-378" unitRef="usd">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-7" decimals="-3" id="f-379" unitRef="usd">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-8" decimals="-3" id="f-380" unitRef="usd">52000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-381" unitRef="usd">17056000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-7" decimals="-3" id="f-382" unitRef="usd">4216000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-8" decimals="-3" id="f-383" unitRef="usd">4245000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-3" id="f-384" unitRef="usd">291000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-7" decimals="-3" id="f-385" unitRef="usd">0</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-8" decimals="-3" id="f-386" unitRef="usd">0</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:StockIssued1 contextRef="c-58" decimals="-3" id="f-387" unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-59" decimals="-3" id="f-388" unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-14" decimals="-3" id="f-389" unitRef="usd">395314000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-60" decimals="-3" id="f-390" unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-61" decimals="-3" id="f-391" unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-62" decimals="-3" id="f-392" unitRef="usd">45900000</us-gaap:StockIssued1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-393">Organization&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Summit Therapeutics Inc. (&#x201c;we&#x201d;, &#x201c;Summit&#x201d; or the &#x201c;Company&#x201d;) is a biopharmaceutical company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The Company&#x2019;s pipeline of product candidates is designed with the goal to become the patient-friendly, new-era standard-of-care medicines, in the therapeutic area of oncology.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s current lead development candidate is ivonescimab, a novel, potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. On December 5, 2022, the Company entered into the License Agreement with Akeso, Inc. and its affiliates (collectively, &#x201c;Akeso&#x201d;) pursuant to which the Company has in-licensed intellectual property rights related to ivonescimab (as amended, the &#x201c;License Agreement&#x201d;), as further described in Note 4. Through the License Agreement, the Company obtained the rights to develop and commercialize ivonescimab in the United States, Canada, Europe, and Japan. The License Agreement and transaction closed in January 2023 following customary waiting periods. On June 3, 2024, the Company entered into an amendment to the License Agreement (the  &#x201c;Second Amendment&#x201d;) with Akeso to expand its territories covered under the License Agreement to also include Latin America, including Mexico and all countries in Central America and South America, the Middle East and Africa (collectively, and as expanded, the &#x201c;Licensed Territory&#x201c;) . The Company&#x2019;s operations are focused on the development of ivonescimab and other future activities, as the Company determines.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Basis of Presentation &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;U.S. GAAP&#x201d;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Any reference in these notes to applicable guidance is meant to refer to authoritative U.S. GAAP as found in the Accounting Standards Codification (&#x201c;ASC&#x201d;) and as amended by Accounting Standards Updates (&#x201c;ASU&#x201d;) of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;). Certain reclassifications have been made to the prior years&#x2019; financial statements to conform to current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of income and expenses during the reporting period. On an on-going basis, management evaluates its estimates and judgments, including those related to accrued research and development expenses, stock-based compensation, and income taxes. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liquidity and Capital Resources&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2025, the Company incurred a net loss of $1,079,586 and cash used in operating activities was $322,930. As of December 31, 2025, the Company had an accumulated deficit of $2,294,159, and cash and cash equivalents of $225,266 and short-term investments of $488,182. The Company expects to continue to generate operating losses for the foreseeable future.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the year ended December 31, 2025, the Company raised gross proceeds of $500,037 from a private placement and $106,498 from the Company&#x2019;s at-the-market sales agreement, both described further in Note 13. With these recent financings, the Company has evaluated and concluded that its cash, cash equivalents and short-term investments provide sufficient cash to fund its operating cash needs for at least the next 12 months from the date of issuance of these consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Until the Company can generate substantial revenue and achieve profitability, the Company will need to raise additional capital to fund its ongoing operations and capital needs. The Company continues to evaluate options to further finance its operating &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;cash needs for its product candidates through a combination of some, or all, of the following: equity and debt offerings, collaborations, strategic alliances, grants and clinical trial support from government entities, philanthropic, non-government and not-for-profit organizations, and marketing, distribution or licensing arrangements. There is no assurance, however, that additional financing will be available when needed or that management of the Company will be able to obtain financing on terms acceptable to the Company. If the Company is unable to obtain funding when required in the future, the Company could be required to delay, reduce, or eliminate research and development programs, product portfolio expansion, or future commercialization efforts, which could adversely affect its business prospects.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-394">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Basis of Presentation &lt;/span&gt;&lt;/div&gt;The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;U.S. GAAP&#x201d;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Any reference in these notes to applicable guidance is meant to refer to authoritative U.S. GAAP as found in the Accounting Standards Codification (&#x201c;ASC&#x201d;) and as amended by Accounting Standards Updates (&#x201c;ASU&#x201d;) of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="c-1" id="f-395">Certain reclassifications have been made to the prior years&#x2019; financial statements to conform to current year presentation.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-396">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of income and expenses during the reporting period. On an on-going basis, management evaluates its estimates and judgments, including those related to accrued research and development expenses, stock-based compensation, and income taxes. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-397" unitRef="usd">-1079586000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-398" unitRef="usd">-322930000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-399" unitRef="usd">-2294159000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-400" unitRef="usd">225266000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="c-5" decimals="-3" id="f-401" unitRef="usd">488182000</us-gaap:ShortTermInvestments>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-45" decimals="-3" id="f-402" unitRef="usd">500037000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-63" decimals="-3" id="f-403" unitRef="usd">106498000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-404">Summary of Significant Accounting Policies and Recent Accounting Pronouncements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant accounting policies adopted by the Company in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. GAAP and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. The consolidated financial statements reflect the accounts of Summit Therapeutics Inc. and its wholly owned subsidiaries. Intercompany balances and transactions are eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial statements of the Company&#x2019;s subsidiaries with functional currencies other than the U.S. dollar are translated into U.S. dollars using period-end exchange rates for assets and liabilities, historical exchange rates for stockholders&#x2019; equity and weighted average exchange rates for operating results. Translation gains and losses are included in accumulated other comprehensive (loss) income in stockholders&#x2019; equity. Foreign currency transaction gains and losses are included in other income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, net in the consolidated statements of operations and comprehensive loss. The Company recorded realized and unrealized foreign currency transaction (loss) gain of ($610), $(97) and $613 for the years ended December 31, 2025, 2024 and 2023, respectively, which is included in other income, net in the consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Loss Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share is computed by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the diluted net loss by the weighted-average number of common shares outstanding for the period, including potentially dilutive common shares. The dilutive effect of share options and warrants are determined under the treasury stock method using the average market price for the period.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the assumed proceeds under the treasury stock method include the average unrecognized compensation expense of stock options and warrants that are in-the-money.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the consideration transferred over the fair value of net assets acquired. Goodwill is assigned to reporting units at the time of acquisition or when there is a change in the reporting structure and bases that allocation on which reporting units will benefit from the acquired assets and liabilities. Reporting units are defined as operating segments or one level below an operating segment, referred to as a component. Typically acquisitions related to a single reporting unit do not require the allocation of goodwill to multiple reporting units. If the net assets obtained in an acquisition are assigned to multiple reporting units, the goodwill is distributed to the respective reporting units as part of the purchase price allocation process.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses goodwill for impairment on an annual basis as of December 31 or more frequently when events and circumstances occur indicating that the recorded goodwill may be impaired. The Company regularly monitors current business conditions and other factors including, but not limited to, adverse industry or economic trends and lower projections of &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;profitability that may impact future operating results. The process of evaluating the potential impairment of goodwill requires significant judgment. In performing the Company&#x2019;s annual goodwill impairment test, the Company is permitted to first assess qualitative factors to determine whether it is more likely than not that the fair value of the Company&#x2019;s reporting unit is less than its carrying amount, including goodwill. In performing the qualitative assessment, the Company considers certain events and circumstances specific to the reporting unit and to the entity as a whole, such as macroeconomic conditions, industry and market considerations, overall financial performance and cost factors when evaluating whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. The Company is also permitted to bypass the qualitative assessment and proceed directly to the quantitative test. If the Company chooses to undertake the qualitative assessment and concludes that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, the Company would then proceed to the quantitative impairment test. In the quantitative assessment, the Company compares the fair value of the reporting unit to its carrying amount, which includes goodwill. If the fair value exceeds the carrying value, no impairment loss exists. If the fair value is less than the carrying amount, a goodwill impairment loss is measured and recorded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating leases for real estate. The Company does not have any finance leases. A contract is or contains a lease when the lessee has the right to control the use of an identified asset. The Company determines if an arrangement is a lease at inception of the contract, which is the date on which the terms of the contract are agreed to and the agreement creates enforceable rights and obligations. The lease term used to calculate the lease liability include options to extend or terminate the lease when it is reasonably certain that the option will be exercised.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the lease commencement date, the Company measures and recognizes a lease liability and a right-of-use asset in the financial statements. Lease liabilities are recognized based on the present value of the future lease payments over the lease term at commencement date. The right-of use asset is measured by taking the present value of future lease payments, plus any incremental direct costs incurred, less any lease incentives received. As most of the Company&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s leases do not provide an implicit rate, the Company uses an estimated incremental borrowing rate based on the lease term and the economic environment of the lease at the lease commencement date, which is then utilized to determine the present value of future lease payments. Lease expense for minimum lease payments are recognized on a straight-line basis over the lease term, with variable lease payments recognized in the periods in which they are incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has existing lease agreements with lease and non-lease components, has elected to account for the lease and non-lease components as a single lease component, and has allocated all of the contract consideration to the lease component only. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leases with an initial lease term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for its short-term leases on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acquired In-Process Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may enter into agreements with collaboration partners for the development and commercialization of its products. These arrangements may include payments contingent on the occurrence of certain events such as development, regulatory or sales-based milestones. The Company considers the unique nature, terms and facts and circumstances of each transaction. The Company considers whether or not the assets acquired have an alternative future use. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value associated with acquired in-process research and development which does not have an alternative future use is expensed and is recorded as research and development expense. Any development or commercial milestone payments are recognized when the achievement of the associated milestone becomes probable and will either be expensed or capitalized depending upon whether or not regulatory approval has been obtained. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred to discover, research and develop product candidates, including personnel expenses, stock-based compensation expense, allocated facility-related and depreciation expenses, third-party license fees and external costs of outside vendors engaged to conduct preclinical and clinical development activities and clinical trials as well as to manufacture clinical trial materials. Non-&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;refundable prepayments for goods or services that will be used or rendered for future research and development activities are recorded as prepaid expenses. Such amounts are recognized as an expense as the goods are delivered or the related services are performed, or until it is no longer expected that the goods will be delivered, or the services rendered. Milestone and other payments made to third-parties with respect to in-process research and development, in accordance with the Company&#x2019;s license, acquisition and other similar agreements are expensed when determined to be probable and estimable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has entered into various research and development contracts with other companies. These agreements are generally cancellable, and related payments are recorded as research and development expenses as incurred. The Company records accruals for estimated ongoing research and development costs or prepaid expenses where the payments made exceed the estimated costs. These amounts are determined based on the estimated costs to complete each study or activity, the estimation of the current stage of completion and the invoices received, as well as predetermined milestones which are not reflective of the current stage of development for prepaid expenses. Actual results could differ from the Company&#x2019;s estimates. In all cases, the full cost of each study or activity is expensed by the time the final report or where applicable, product, has been received. The Company&#x2019;s historical estimates have not been materially different from the actual costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures and recognizes compensation expense for all stock option awards based on the estimated fair value of the award on the grant date. The Company uses the Black-Scholes option pricing model to estimate the fair value of stock option awards. Additionally, the Company uses a Monte Carlo simulation model to calculate the estimated fair value on the date of grant related to awards with market-based service conditions. The fair value is recognized as expense, over the requisite service period, which is generally the vesting period of the respective award, on a straight-line basis for each separately vesting portion of the award when the only condition to vesting is continued service. If vesting is subject to a market or performance condition, recognition is based on the derived service period of the award. Expense for awards with performance conditions is estimated and adjusted on a quarterly basis based upon the assessment of the probability that the performance condition will be met. Use of the Black-Scholes option-pricing model requires management to apply judgment under subjective assumptions. These assumptions include:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Expected term&#x2014;The expected term of stock options represents the weighted-average period the stock options are expected to be outstanding. The Company uses the simplified method for estimating the expected term as provided by the SEC. The simplified method calculates the expected term as the average of the time-to-vesting and the contractual life of the options.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Expected volatility&#x2014;The expected volatility is calculated based on historical volatility of the Company&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s share price.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Risk-free interest rate&#x2014;The risk-free rate assumption is based on the U.S. Treasury instruments, the terms of which were consistent with the expected term of the Company&#x2019;s stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Expected dividend&#x2014;The expected dividend assumption is based on the Company&#x2019;s history and expectation of dividend payouts. The Company has not paid and does not intend to pay dividends. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company uses a Monte Carlo simulation model to estimate the fair value of Performance and Market-based Stock Options at the date of grant which utilizes multiple input variables to estimate the probability that the market condition will be achieved. Key assumptions used in the model include the risk-free interest rate, which reflects the US Treasury Constant Maturity Yield with a term commensurate with the contractual term of the award, and stock price volatility, which is derived based on the historical volatility of the Company&#x2019;s stock. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates expected forfeitures at the time of grant instead of accounting for forfeitures as they occur. Stock option awards have been granted at fair value to non-employees in connection with research and consulting services provided to the Company. Equity awards generally vest over terms of 3 or 4 years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies stock-based compensation expense in the consolidated statements of operations and comprehensive loss in the same manner in which the award recipient&#x2019;s payroll costs are classified.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes is determined using the asset and liability approach. Tax laws may require items to be included in tax filings at different times than the items are reflected in the financial statements. A current asset or liability is recognized &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for the estimated taxes receivable or payable for the current year. Deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. Deferred taxes are initially recognized at enacted tax rates in force at the time of initial recognition and are subsequently adjusted for any enacted changes in tax rates and tax laws. Subsequent changes to deferred taxes originally recognized in equity are recognized in income. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. The Company has recorded a full valuation allowance against the deferred tax assets in excess of its deferred tax liabilities, as the deferred tax liabilities represent future reversals of existing taxable temporary differences. The Company records interest and penalties related to income tax matters as part of income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk and Other Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash and short-term investments. The Company&#x2019;s cash is comprised of short-term cash deposits at a variety of financial institutions which the Company believes are of high credit ratings in amounts that may exceed federally insured limits. The Company has not experienced any losses on such accounts. Cash balances maintained during the year have been principally held with U.S.-based and U.K.-based banks. The Company does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company relies, and expects to continue to rely, on a number of vendors to conduct its clinical trials and preclinical studies, manufacture drug product and supply clinical trial and preclinical study materials for its development programs. These programs could be adversely affected by a significant interruption in these services or the availability of materials.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with the provisions of fair value accounting, a fair value measurement assumes that the transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability and defines fair value based on the exit price model.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value measurement guidance establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance describes three levels of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Quoted prices in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 2 assets and liabilities include debt securities with quoted prices that are traded less frequently than exchange-traded instruments or securities or derivative contracts that are valued using a pricing model with inputs that are observable in the market or can be derived principally from or corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the Company categorizes such assets and liabilities based on the lowest level input that is significant to the fair value measurement in its entirety. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers only those investments that are highly liquid, readily convertible to cash and that mature within 90 days or less from date of purchase to be cash equivalents. As of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 31, 2025, cash equivalents were comprised of money market funds and U.S. treasury securities. As of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; cash equivalents were comprised of money market funds.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash represents amounts which are legally restricted to withdrawal or usage and is presented in the consolidated balance sheet as restricted cash. As of December 31, 2025 the Company has $316 of restricted cash associated with an irrevocable letter of credit required by the landlord to enter into the lease for Company&#x2019;s corporate office.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s total cash, cash equivalents and restricted cash balances were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.016%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.794%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Short-term Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments consist of marketable securities with original maturities greater than ninety days from the date of acquisition. The Company classifies marketable securities with original maturities of greater than 90 days and less than one year as short-term, based on the liquid nature of the marketable securities and because such marketable securities represent the investment of cash that is available for current operations. The Company considers its investment portfolio of marketable securities as available-for-sale. Accordingly, these investments are recorded at fair value, which is based on quoted market prices or other observable inputs. Unrealized gains and losses are recorded as a component of other comprehensive income (loss). Realized gains and losses are determined on a specific identification basis and are included in other income, net. Amortization and accretion of discounts and premiums are also recorded in other income, net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the fair value is below the amortized cost of the asset, an estimate of expected credit losses is made. This estimate is limited to the amount by which fair value is less than amortized cost. The credit-related impairment amount is recognized in the consolidated statements of operations and comprehensive loss and the remaining impairment amount and unrealized gains are reported as a component of accumulated other comprehensive income (loss) in stockholders&#x2019; equity. Credit losses are recognized through the use of an allowance for credit losses account and subsequent improvements in expected credit losses are recognized as a reversal of the allowance account. If the Company has the intent to sell the security or it is more likely than not that the Company will be required to sell the security prior to recovery of its amortized cost basis the allowance for credit loss is written off and the excess of the amortized cost basis of the asset over its fair value is recorded in the consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update &#x201c;ASU&#x201d; 2023-09, &#x201c;Improvements to Income Tax Disclosures&#x201d;, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024 and allows for adoption on a prospective basis, with a retrospective option. Early adoption is permitted. The Company adopted ASU 2023-09 for the year ended December 31, 2025 using a retrospective approach. The adoption of ASU-2023-09 did not have a material impact on the Company&#x2019;s consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, &#x201c;Disaggregation of Income Statement Expenses&#x201d;, which requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures. The guidance is to be applied prospectively, with the option for retrospective application and is effective for public business entities for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this standard on the Company&#x2019;s consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2025, the FASB issued ASU 2025-11, &#x201c;Narrow-Scope Improvements&#x201d;, which is intended to improve the navigability of the guidance in ASC 270 and clarify when the guidance is applicable. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this standard on the Company&#x2019;s consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other recent authoritative guidance issued by the FASB (including technical corrections to the FASB ASC), the American Institute of Certified Public Accountants, and the SEC did not or are not expected to have a material impact on the Company&#x2019;s consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-405">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. GAAP and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. The consolidated financial statements reflect the accounts of Summit Therapeutics Inc. and its wholly owned subsidiaries. Intercompany balances and transactions are eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-406">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial statements of the Company&#x2019;s subsidiaries with functional currencies other than the U.S. dollar are translated into U.S. dollars using period-end exchange rates for assets and liabilities, historical exchange rates for stockholders&#x2019; equity and weighted average exchange rates for operating results. Translation gains and losses are included in accumulated other comprehensive (loss) income in stockholders&#x2019; equity. Foreign currency transaction gains and losses are included in other income&lt;/span&gt;, net in the consolidated statements of operations and comprehensive loss.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-1" decimals="-3" id="f-407" unitRef="usd">-610000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-7" decimals="-3" id="f-408" unitRef="usd">-97000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-8" decimals="-3" id="f-409" unitRef="usd">613000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-410">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Loss Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share is computed by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the diluted net loss by the weighted-average number of common shares outstanding for the period, including potentially dilutive common shares. The dilutive effect of share options and warrants are determined under the treasury stock method using the average market price for the period.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the assumed proceeds under the treasury stock method include the average unrecognized compensation expense of stock options and warrants that are in-the-money.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="c-1" id="f-411">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the consideration transferred over the fair value of net assets acquired. Goodwill is assigned to reporting units at the time of acquisition or when there is a change in the reporting structure and bases that allocation on which reporting units will benefit from the acquired assets and liabilities. Reporting units are defined as operating segments or one level below an operating segment, referred to as a component. Typically acquisitions related to a single reporting unit do not require the allocation of goodwill to multiple reporting units. If the net assets obtained in an acquisition are assigned to multiple reporting units, the goodwill is distributed to the respective reporting units as part of the purchase price allocation process.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses goodwill for impairment on an annual basis as of December 31 or more frequently when events and circumstances occur indicating that the recorded goodwill may be impaired. The Company regularly monitors current business conditions and other factors including, but not limited to, adverse industry or economic trends and lower projections of &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;profitability that may impact future operating results. The process of evaluating the potential impairment of goodwill requires significant judgment. In performing the Company&#x2019;s annual goodwill impairment test, the Company is permitted to first assess qualitative factors to determine whether it is more likely than not that the fair value of the Company&#x2019;s reporting unit is less than its carrying amount, including goodwill. In performing the qualitative assessment, the Company considers certain events and circumstances specific to the reporting unit and to the entity as a whole, such as macroeconomic conditions, industry and market considerations, overall financial performance and cost factors when evaluating whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. The Company is also permitted to bypass the qualitative assessment and proceed directly to the quantitative test. If the Company chooses to undertake the qualitative assessment and concludes that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, the Company would then proceed to the quantitative impairment test. In the quantitative assessment, the Company compares the fair value of the reporting unit to its carrying amount, which includes goodwill. If the fair value exceeds the carrying value, no impairment loss exists. If the fair value is less than the carrying amount, a goodwill impairment loss is measured and recorded.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-412">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating leases for real estate. The Company does not have any finance leases. A contract is or contains a lease when the lessee has the right to control the use of an identified asset. The Company determines if an arrangement is a lease at inception of the contract, which is the date on which the terms of the contract are agreed to and the agreement creates enforceable rights and obligations. The lease term used to calculate the lease liability include options to extend or terminate the lease when it is reasonably certain that the option will be exercised.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the lease commencement date, the Company measures and recognizes a lease liability and a right-of-use asset in the financial statements. Lease liabilities are recognized based on the present value of the future lease payments over the lease term at commencement date. The right-of use asset is measured by taking the present value of future lease payments, plus any incremental direct costs incurred, less any lease incentives received. As most of the Company&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s leases do not provide an implicit rate, the Company uses an estimated incremental borrowing rate based on the lease term and the economic environment of the lease at the lease commencement date, which is then utilized to determine the present value of future lease payments. Lease expense for minimum lease payments are recognized on a straight-line basis over the lease term, with variable lease payments recognized in the periods in which they are incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has existing lease agreements with lease and non-lease components, has elected to account for the lease and non-lease components as a single lease component, and has allocated all of the contract consideration to the lease component only. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leases with an initial lease term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for its short-term leases on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <smmt:InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock contextRef="c-1" id="f-413">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acquired In-Process Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may enter into agreements with collaboration partners for the development and commercialization of its products. These arrangements may include payments contingent on the occurrence of certain events such as development, regulatory or sales-based milestones. The Company considers the unique nature, terms and facts and circumstances of each transaction. The Company considers whether or not the assets acquired have an alternative future use. &lt;/span&gt;&lt;/div&gt;The fair value associated with acquired in-process research and development which does not have an alternative future use is expensed and is recorded as research and development expense. Any development or commercial milestone payments are recognized when the achievement of the associated milestone becomes probable and will either be expensed or capitalized depending upon whether or not regulatory approval has been obtained.</smmt:InProcessResearchAndDevelopmentThroughACollaborationPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c-1" id="f-414">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred to discover, research and develop product candidates, including personnel expenses, stock-based compensation expense, allocated facility-related and depreciation expenses, third-party license fees and external costs of outside vendors engaged to conduct preclinical and clinical development activities and clinical trials as well as to manufacture clinical trial materials. Non-&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;refundable prepayments for goods or services that will be used or rendered for future research and development activities are recorded as prepaid expenses. Such amounts are recognized as an expense as the goods are delivered or the related services are performed, or until it is no longer expected that the goods will be delivered, or the services rendered. Milestone and other payments made to third-parties with respect to in-process research and development, in accordance with the Company&#x2019;s license, acquisition and other similar agreements are expensed when determined to be probable and estimable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has entered into various research and development contracts with other companies. These agreements are generally cancellable, and related payments are recorded as research and development expenses as incurred. The Company records accruals for estimated ongoing research and development costs or prepaid expenses where the payments made exceed the estimated costs. These amounts are determined based on the estimated costs to complete each study or activity, the estimation of the current stage of completion and the invoices received, as well as predetermined milestones which are not reflective of the current stage of development for prepaid expenses. Actual results could differ from the Company&#x2019;s estimates. In all cases, the full cost of each study or activity is expensed by the time the final report or where applicable, product, has been received. The Company&#x2019;s historical estimates have not been materially different from the actual costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-415">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures and recognizes compensation expense for all stock option awards based on the estimated fair value of the award on the grant date. The Company uses the Black-Scholes option pricing model to estimate the fair value of stock option awards. Additionally, the Company uses a Monte Carlo simulation model to calculate the estimated fair value on the date of grant related to awards with market-based service conditions. The fair value is recognized as expense, over the requisite service period, which is generally the vesting period of the respective award, on a straight-line basis for each separately vesting portion of the award when the only condition to vesting is continued service. If vesting is subject to a market or performance condition, recognition is based on the derived service period of the award. Expense for awards with performance conditions is estimated and adjusted on a quarterly basis based upon the assessment of the probability that the performance condition will be met. Use of the Black-Scholes option-pricing model requires management to apply judgment under subjective assumptions. These assumptions include:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Expected term&#x2014;The expected term of stock options represents the weighted-average period the stock options are expected to be outstanding. The Company uses the simplified method for estimating the expected term as provided by the SEC. The simplified method calculates the expected term as the average of the time-to-vesting and the contractual life of the options.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Expected volatility&#x2014;The expected volatility is calculated based on historical volatility of the Company&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s share price.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Risk-free interest rate&#x2014;The risk-free rate assumption is based on the U.S. Treasury instruments, the terms of which were consistent with the expected term of the Company&#x2019;s stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Expected dividend&#x2014;The expected dividend assumption is based on the Company&#x2019;s history and expectation of dividend payouts. The Company has not paid and does not intend to pay dividends. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company uses a Monte Carlo simulation model to estimate the fair value of Performance and Market-based Stock Options at the date of grant which utilizes multiple input variables to estimate the probability that the market condition will be achieved. Key assumptions used in the model include the risk-free interest rate, which reflects the US Treasury Constant Maturity Yield with a term commensurate with the contractual term of the award, and stock price volatility, which is derived based on the historical volatility of the Company&#x2019;s stock. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates expected forfeitures at the time of grant instead of accounting for forfeitures as they occur. Stock option awards have been granted at fair value to non-employees in connection with research and consulting services provided to the Company. Equity awards generally vest over terms of 3 or 4 years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies stock-based compensation expense in the consolidated statements of operations and comprehensive loss in the same manner in which the award recipient&#x2019;s payroll costs are classified.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-64" id="f-416">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-65" id="f-417">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-418">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes is determined using the asset and liability approach. Tax laws may require items to be included in tax filings at different times than the items are reflected in the financial statements. A current asset or liability is recognized &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for the estimated taxes receivable or payable for the current year. Deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. Deferred taxes are initially recognized at enacted tax rates in force at the time of initial recognition and are subsequently adjusted for any enacted changes in tax rates and tax laws. Subsequent changes to deferred taxes originally recognized in equity are recognized in income. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. The Company has recorded a full valuation allowance against the deferred tax assets in excess of its deferred tax liabilities, as the deferred tax liabilities represent future reversals of existing taxable temporary differences. The Company records interest and penalties related to income tax matters as part of income tax expense.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-419">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk and Other Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash and short-term investments. The Company&#x2019;s cash is comprised of short-term cash deposits at a variety of financial institutions which the Company believes are of high credit ratings in amounts that may exceed federally insured limits. The Company has not experienced any losses on such accounts. Cash balances maintained during the year have been principally held with U.S.-based and U.K.-based banks. The Company does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company relies, and expects to continue to rely, on a number of vendors to conduct its clinical trials and preclinical studies, manufacture drug product and supply clinical trial and preclinical study materials for its development programs. These programs could be adversely affected by a significant interruption in these services or the availability of materials.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c-1" id="f-420">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with the provisions of fair value accounting, a fair value measurement assumes that the transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability and defines fair value based on the exit price model.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value measurement guidance establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance describes three levels of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Quoted prices in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 2 assets and liabilities include debt securities with quoted prices that are traded less frequently than exchange-traded instruments or securities or derivative contracts that are valued using a pricing model with inputs that are observable in the market or can be derived principally from or corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the Company categorizes such assets and liabilities based on the lowest level input that is significant to the fair value measurement in its entirety. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy contextRef="c-1" id="f-421">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;The Company considers only those investments that are highly liquid, readily convertible to cash and that mature within 90 days or less from date of purchase to be cash equivalents.</us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="c-1" id="f-422">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;Restricted cash represents amounts which are legally restricted to withdrawal or usage and is presented in the consolidated balance sheet as restricted cash.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:RestrictedCashCurrent contextRef="c-5" decimals="-3" id="f-423" unitRef="usd">316000</us-gaap:RestrictedCashCurrent>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="c-1" id="f-425">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s total cash, cash equivalents and restricted cash balances were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.016%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.794%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock contextRef="c-1" id="f-424">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s total cash, cash equivalents and restricted cash balances were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.016%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.794%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-426" unitRef="usd">225266000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-6" decimals="-3" id="f-427" unitRef="usd">104862000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-28" decimals="-3" id="f-428" unitRef="usd">71425000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c-5" decimals="-3" id="f-429" unitRef="usd">316000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c-6" decimals="-3" id="f-430" unitRef="usd">325000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c-28" decimals="-3" id="f-431" unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-432" unitRef="usd">225582000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-3" id="f-433" unitRef="usd">105187000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-28" decimals="-3" id="f-434" unitRef="usd">71425000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InvestmentPolicyTextBlock contextRef="c-1" id="f-435">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Short-term Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments consist of marketable securities with original maturities greater than ninety days from the date of acquisition. The Company classifies marketable securities with original maturities of greater than 90 days and less than one year as short-term, based on the liquid nature of the marketable securities and because such marketable securities represent the investment of cash that is available for current operations. The Company considers its investment portfolio of marketable securities as available-for-sale. Accordingly, these investments are recorded at fair value, which is based on quoted market prices or other observable inputs. Unrealized gains and losses are recorded as a component of other comprehensive income (loss). Realized gains and losses are determined on a specific identification basis and are included in other income, net. Amortization and accretion of discounts and premiums are also recorded in other income, net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the fair value is below the amortized cost of the asset, an estimate of expected credit losses is made. This estimate is limited to the amount by which fair value is less than amortized cost. The credit-related impairment amount is recognized in the consolidated statements of operations and comprehensive loss and the remaining impairment amount and unrealized gains are reported as a component of accumulated other comprehensive income (loss) in stockholders&#x2019; equity. Credit losses are recognized through the use of an allowance for credit losses account and subsequent improvements in expected credit losses are recognized as a reversal of the allowance account. If the Company has the intent to sell the security or it is more likely than not that the Company will be required to sell the security prior to recovery of its amortized cost basis the allowance for credit loss is written off and the excess of the amortized cost basis of the asset over its fair value is recorded in the consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-436">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update &#x201c;ASU&#x201d; 2023-09, &#x201c;Improvements to Income Tax Disclosures&#x201d;, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024 and allows for adoption on a prospective basis, with a retrospective option. Early adoption is permitted. The Company adopted ASU 2023-09 for the year ended December 31, 2025 using a retrospective approach. The adoption of ASU-2023-09 did not have a material impact on the Company&#x2019;s consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, &#x201c;Disaggregation of Income Statement Expenses&#x201d;, which requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures. The guidance is to be applied prospectively, with the option for retrospective application and is effective for public business entities for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this standard on the Company&#x2019;s consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2025, the FASB issued ASU 2025-11, &#x201c;Narrow-Scope Improvements&#x201d;, which is intended to improve the navigability of the guidance in ASC 270 and clarify when the guidance is applicable. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this standard on the Company&#x2019;s consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other recent authoritative guidance issued by the FASB (including technical corrections to the FASB ASC), the American Institute of Certified Public Accountants, and the SEC did not or are not expected to have a material impact on the Company&#x2019;s consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-437">Segment Reporting &lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company&#x2019;s chief operating decision makers (the &#x201c;CODM function&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x201d;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;), which are the Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2019;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;s Co-Chief Executive Officers, Mr. Duggan and Dr. Zanganeh, and Chief Operating Officer and Chief Financial Officer, Mr. Soni, utilize consolidated net loss that is reported on the consolidated statement of operations and comprehensive loss to make decisions about allocating resources and assessing performance for the entire Company. The CODM function approves of key operating and strategic decisions, including key decisions in clinical development and clinical operating activities, entering into significant contracts, such as revenue contracts and collaboration agreements and approves the Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2019;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;s consolidated operating budget. The CODM function views the Company's operations and manages its business on a consolidated basis and as a single reportable operating segment. The CODM function is regularly provided with the following significant segment expenses: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oncology clinical trial related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired in-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation related costs, excluding stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expenses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,094,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,686)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,079,586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(614,928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt;  Other expenses include general and administrative expenses excluding compensation and stock-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of December 31, 2025 and 2024, substantially all of our long-lived assets are located in the United States.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-438">The CODM function is regularly provided with the following significant segment expenses: &lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oncology clinical trial related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired in-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation related costs, excluding stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expenses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,094,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,686)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,079,586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(614,928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt;  Other expenses include general and administrative expenses excluding compensation and stock-based compensation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-66" decimals="-3" id="f-439" unitRef="usd">266439000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-67" decimals="-3" id="f-440" unitRef="usd">100937000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-68" decimals="-3" id="f-441" unitRef="usd">35224000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <smmt:AcquiredInProcessResearchAndDevelopmentExpense contextRef="c-66" decimals="-3" id="f-442" unitRef="usd">0</smmt:AcquiredInProcessResearchAndDevelopmentExpense>
    <smmt:AcquiredInProcessResearchAndDevelopmentExpense contextRef="c-67" decimals="-3" id="f-443" unitRef="usd">15007000</smmt:AcquiredInProcessResearchAndDevelopmentExpense>
    <smmt:AcquiredInProcessResearchAndDevelopmentExpense contextRef="c-68" decimals="-3" id="f-444" unitRef="usd">520915000</smmt:AcquiredInProcessResearchAndDevelopmentExpense>
    <smmt:LaborAndRelatedExpensesExcludingStockBasedCompensation contextRef="c-66" decimals="-3" id="f-445" unitRef="usd">75575000</smmt:LaborAndRelatedExpensesExcludingStockBasedCompensation>
    <smmt:LaborAndRelatedExpensesExcludingStockBasedCompensation contextRef="c-67" decimals="-3" id="f-446" unitRef="usd">48295000</smmt:LaborAndRelatedExpensesExcludingStockBasedCompensation>
    <smmt:LaborAndRelatedExpensesExcludingStockBasedCompensation contextRef="c-68" decimals="-3" id="f-447" unitRef="usd">31371000</smmt:LaborAndRelatedExpensesExcludingStockBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-66" decimals="-3" id="f-448" unitRef="usd">732420000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-67" decimals="-3" id="f-449" unitRef="usd">50981000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-68" decimals="-3" id="f-450" unitRef="usd">14108000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-66" decimals="-3" id="f-451" unitRef="usd">19990000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-67" decimals="-3" id="f-452" unitRef="usd">10778000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-68" decimals="-3" id="f-453" unitRef="usd">8032000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:OperatingExpenses contextRef="c-66" decimals="-3" id="f-454" unitRef="usd">1094424000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-67" decimals="-3" id="f-455" unitRef="usd">225998000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-68" decimals="-3" id="f-456" unitRef="usd">609650000</us-gaap:OperatingExpenses>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-66" decimals="-3" id="f-457" unitRef="usd">14838000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-67" decimals="-3" id="f-458" unitRef="usd">13369000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-68" decimals="-3" id="f-459" unitRef="usd">11183000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:InterestExpenseNonoperating contextRef="c-66" decimals="-3" id="f-460" unitRef="usd">0</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-67" decimals="-3" id="f-461" unitRef="usd">8686000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-68" decimals="-3" id="f-462" unitRef="usd">16461000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:NetIncomeLoss contextRef="c-66" decimals="-3" id="f-463" unitRef="usd">-1079586000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-67" decimals="-3" id="f-464" unitRef="usd">-221315000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-68" decimals="-3" id="f-465" unitRef="usd">-614928000</us-gaap:NetIncomeLoss>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="c-1" id="f-468">Akeso License and Collaboration Agreement&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 5, 2022, the Company entered into the License Agreement with Akeso pursuant to which the Company is in-licensing its breakthrough bispecific antibody, ivonescimab. The License Agreement and transaction closed in January 2023 following customary waiting periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ivonescimab, known as AK112 in China and Australia, and also as SMT112 in the United States, Canada, Europe, and Japan, is a novel, potential first-in-class bispecific antibody intending to combine the effect of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF into a single molecule. Ivonescimab was engineered to bring two well established oncology targeted mechanisms together. Ivonescimab is currently in clinical development and, pursuant to the terms of the License Agreement, Summit will design and conduct the clinical trial activities to support regulatory filings in the Licensed Territory that Summit will submit. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the terms of the License Agreement, Summit will have final decision making authority with respect to clinical development strategy and execution in the Licensed Territory. For co-joined studies in which both Summit and Akeso participate, mutual agreement is required for material decisions; Summit retains the exclusive decision making with respect to participating in, and continuing its participation in, co-joined studies. Pursuant to the terms of the License Agreement, Summit will have final decision-making authority with respect to commercial strategy, pricing and reimbursement and other commercialization matters in the Licensed Territory. In connection with the License Agreement, the Company agreed to purchase a certain portion of drug substance and/or drug product for clinical and commercial supply and to enter into a supply agreement with Akeso. Summit is not assuming any liabilities (including contingent liabilities), acquiring any physical assets or trade names, or hiring or acquiring any employees from Akeso in connection with the License Agreement. Through the License Agreement, the Company obtained the rights to develop and commercialize ivonescimab in the United States, Canada, Europe, and Japan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In exchange for the rights obtained, the Company made an upfront payment of $500,000 to Akeso, of which $274,900 was paid in cash and, pursuant to the License Agreement and Issuance Agreement, Akeso elected to receive 10,000,000 shares of the Company&#x2019;s common stock, par value $0.01 per share (&#x201c;common stock&#x201d;) in lieu of $25,100 in cash. The remaining $200,000 amount of the upfront payment was paid on March 6, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Effective June 3, 2024, the Company and Akeso entered into the Second Amendment to the License Agreement to expand the Company&#x2019;s territories covered under the License Agreement to include the Latin America, Middle East and Africa regions. Pursuant to the Second Amendment, the Company paid an upfront payment to Akeso of $15,000 in the third quarter of 2024. Akeso will also be eligible to receive up to an additional $55,000 upon the achievement of certain commercial milestones. Except as specifically modified by the Second Amendment, the terms and conditions of the License Agreement remain in full force and effect.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has accounted for the License Agreement and Second Amendment to acquire the rights to develop and commercialize ivonescimab as the acquisition of an asset. All of the consideration relates to ivonescimab and technological feasibility of the asset has not yet been established since ivonescimab is in clinical development. As such, the Company has expensed the consideration as acquired in-process research and development upon closing of the transaction in the consolidated statement of operations and comprehensive loss. Acquired in-process research and development expense for the year ended December 31, 2025 was nil. Acquired in-process research and development expense for the year ended December 31, 2024,  was $15,007 which is comprised of the upfront payment and immaterial transaction costs. For the year ended December 31, 2023, acquired in-process research and development expense totaled $520,915 pursuant to the License Agreement, which was comprised of the $474,900 paid in cash, the fair value of the 10,000,000 shares of common stock on the date of closing the transaction of $45,900, and $115 of direct transactions costs incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the payments already made to Akeso, under the License Agreement and Second Amendment, there are additional potential milestone payments of up to $4,555,000, as Akeso will be eligible to receive regulatory milestones of up to $1,050,000 and commercial milestones of up to $3,505,000. In addition, Akeso will be eligible to receive low double-digit royalties on net sales.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <smmt:CollaborativeArrangementRightsAndObligationsUpfrontPayment contextRef="c-69" decimals="-3" id="f-469" unitRef="usd">500000000</smmt:CollaborativeArrangementRightsAndObligationsUpfrontPayment>
    <smmt:CashPaymentForCollaborativeArrangementUpfrontPayment contextRef="c-70" decimals="-3" id="f-470" unitRef="usd">274900000</smmt:CashPaymentForCollaborativeArrangementUpfrontPayment>
    <smmt:CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash
      contextRef="c-70"
      decimals="INF"
      id="f-471"
      unitRef="shares">10000000</smmt:CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-71"
      decimals="INF"
      id="f-472"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <smmt:CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares contextRef="c-70" decimals="-3" id="f-473" unitRef="usd">25100000</smmt:CollaborativeArrangementRightsAndObligationsUpfrontPaymentPaidInShares>
    <smmt:CashPaymentForCollaborativeArrangementUpfrontPayment contextRef="c-72" decimals="-3" id="f-474" unitRef="usd">200000000</smmt:CashPaymentForCollaborativeArrangementUpfrontPayment>
    <smmt:PaymentsForCollaborativeArrangement contextRef="c-73" decimals="-3" id="f-475" unitRef="usd">15000000</smmt:PaymentsForCollaborativeArrangement>
    <smmt:CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments contextRef="c-74" decimals="-3" id="f-476" unitRef="usd">55000000</smmt:CollaborativeArrangementRightsAndObligationsAdditionalPotentialCommercialMilestonePayments>
    <smmt:AcquiredInProcessResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-477" unitRef="usd">0</smmt:AcquiredInProcessResearchAndDevelopmentExpense>
    <smmt:AcquiredInProcessResearchAndDevelopmentExpense contextRef="c-7" decimals="-3" id="f-478" unitRef="usd">15007000</smmt:AcquiredInProcessResearchAndDevelopmentExpense>
    <smmt:AcquiredInProcessResearchAndDevelopmentExpense contextRef="c-8" decimals="-3" id="f-479" unitRef="usd">520915000</smmt:AcquiredInProcessResearchAndDevelopmentExpense>
    <smmt:CashPaymentForCollaborativeArrangementUpfrontPayment contextRef="c-75" decimals="-3" id="f-480" unitRef="usd">474900000</smmt:CashPaymentForCollaborativeArrangementUpfrontPayment>
    <smmt:CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash
      contextRef="c-76"
      decimals="INF"
      id="f-481"
      unitRef="shares">10000000</smmt:CollaborativeArrangementRightsAndObligationsUpfrontPaymentSharesOfCommonStockIssuedInLieuOfCash>
    <smmt:StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement contextRef="c-76" decimals="-3" id="f-482" unitRef="usd">45900000</smmt:StockIssuedDuringPeriodValueInLieuOfCashForCollaborativeArrangement>
    <smmt:CollaborativeArrangementRightsAndObligationsDirectTransactionCosts contextRef="c-75" decimals="-3" id="f-483" unitRef="usd">115000</smmt:CollaborativeArrangementRightsAndObligationsDirectTransactionCosts>
    <smmt:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments contextRef="c-74" decimals="-3" id="f-484" unitRef="usd">4555000000</smmt:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePayments>
    <smmt:CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments contextRef="c-74" decimals="-3" id="f-485" unitRef="usd">1050000000</smmt:CollaborativeArrangementRightsAndObligationsPotentialRegulatoryMilestonePayments>
    <smmt:CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments contextRef="c-74" decimals="-3" id="f-486" unitRef="usd">3505000000</smmt:CollaborativeArrangementRightsAndObligationsPotentialCommercialMilestonePayments>
    <us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock contextRef="c-1" id="f-487">Other Income, Net&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the components of other income, net:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of cumulative currency translation gain &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt; Investment income relates to the Company&#x2019;s money market funds and short-term investments in U.S. treasury securities. Refer to Note 9 for details. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt; The reclassification of cumulative currency translation gain related to the reclassification of cumulative foreign currency translation gains from accumulated other comprehensive loss due to the dissolution of certain dormant entities.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock contextRef="c-1" id="f-488">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the components of other income, net:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of cumulative currency translation gain &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt; Investment income relates to the Company&#x2019;s money market funds and short-term investments in U.S. treasury securities. Refer to Note 9 for details. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt; The reclassification of cumulative currency translation gain related to the reclassification of cumulative foreign currency translation gains from accumulated other comprehensive loss due to the dissolution of certain dormant entities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-1" decimals="-3" id="f-489" unitRef="usd">-610000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-7" decimals="-3" id="f-490" unitRef="usd">-97000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-8" decimals="-3" id="f-491" unitRef="usd">613000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:InvestmentIncomeNonoperating contextRef="c-1" decimals="-3" id="f-492" unitRef="usd">15501000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InvestmentIncomeNonoperating contextRef="c-7" decimals="-3" id="f-493" unitRef="usd">13466000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InvestmentIncomeNonoperating contextRef="c-8" decimals="-3" id="f-494" unitRef="usd">10403000</us-gaap:InvestmentIncomeNonoperating>
    <smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome contextRef="c-1" decimals="-3" id="f-495" unitRef="usd">0</smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome>
    <smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome contextRef="c-7" decimals="-3" id="f-496" unitRef="usd">0</smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome>
    <smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome contextRef="c-8" decimals="-3" id="f-497" unitRef="usd">419000</smmt:CumulativeCurrencyTranslationGainsLossesRealizedUponSaleOrLiquidationReclassifiedFromOtherComprehensiveIncome>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-498" unitRef="usd">-53000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-7" decimals="-3" id="f-499" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-8" decimals="-3" id="f-500" unitRef="usd">-252000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-501" unitRef="usd">14838000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-7" decimals="-3" id="f-502" unitRef="usd">13369000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-8" decimals="-3" id="f-503" unitRef="usd">11183000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-504">Income Tax&#160;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is primarily subject to corporation taxes in the U.S. and the U.K. The calculation of the Company&#x2019;s tax provision involves the application of both U.S. and U.K. tax law and requires judgment and estimates. The Company has also assessed the applicability of the OECD/G20 Inclusive Framework on Base Erosion and Profit Shifting (BEPS) Pillar 2 rules, which establish a global minimum tax rate. Based on the Company&#x2019;s current financial position and revenue it does not meet the thresholds for Pillar 2 to apply. Therefore, the provisions and requirements under Pillar 2 do not impact our financial statements for the reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes is determined using the asset and liability approach. Tax laws may require items to be included in tax filings at different times than the items are reflected in the financial statements. A current asset or liability is recognized for the estimated taxes receivable or payable for the current year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. Deferred taxes are initially recognized at enacted tax rates in force at the time of initial recognition and are subsequently adjusted for any enacted changes in tax rates and tax laws. Subsequent changes to deferred taxes originally recognized in equity are recognized in income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. The Company has recorded a full valuation allowance against the deferred tax assets in excess of its deferred tax liabilities, as the deferred tax liabilities represent future reversals of existing taxable temporary differences. The Company records interest and penalties related to income tax matters as part of income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Uncertain Tax Positions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for uncertain tax positions taken in its tax filings by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities having full knowledge of the facts and applicable tax rules. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed as the amount of benefit to recognize in the consolidated financial statements. The amount of benefits that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate, as well as the related net interest and penalties.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the Company&#x2019;s full valuation allowance, the unrecognized tax benefits are not expected to materially impact the Company&#x2019;s effective tax rate when recognized or significantly increase or decrease in the next 12 months. In addition, the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company&#x2019;s policy is to recognize interest and penalties related to uncertain tax positions as part of its income tax provision. However, for the years ended December 31, 2025 and 2024, the Company had no interest or penalties related to unrecognized tax benefits because any potential disallowance would not result in current tax but only result in a reduction to the Company&#x2019;s net operating loss carryforwards.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Loss Before Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company&#x2019;s loss before income taxes are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.432%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(326,729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(499,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(752,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,079,586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(614,928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deferred Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has not recognized a current or deferred provision for federal, state or non-United States income taxes in either of the years ending December 31, 2025 or December 31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred taxes are recognized for temporary differences between the basis of assets and liabilities for financial statement and income tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The major components of deferred tax assets and liabilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.467%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.469%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforward&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development credit carryforward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 174 Research and Development Capitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337)  &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets before valuation allowance &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,161&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,588&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133,161)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,588)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December 31, 2025 and 2024, the Company recorded a deferred tax asset of $133,578 and $95,925, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has evaluated the positive and negative evidence bearing upon its ability to realize its deferred tax assets, which are comprised primarily of net operating loss carryforwards, research and development credits, stock-based compensation expense, and research and development costs capitalized for tax purposes. Management has considered the Company&#x2019;s history of cumulative net losses in each taxing jurisdiction, estimated future taxable income, as well as prudent and feasible tax planning strategies, and has concluded that it is more likely than not that the Company will not realize the tax benefits in each &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;jurisdiction. Accordingly, a full valuation allowance has been established against these net deferred tax assets as of December 31, 2025 and 2024, respectively. The Company reevaluates the positive and negative evidence at each reporting period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the valuation allowance during the years ended December 31, 2025, 2024 and 2023 primarily related to net operating loss carryforwards and capitalized research and development expenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the valuation allowance was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.523%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance as of beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84,751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,016)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increases recorded to income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,837)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,735)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance as of end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84,751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Operating Loss and Tax Credit Carryforwards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025 and 2024, the Company had U.S. Federal gross operating loss carryforwards of approximately $93,210 and $44,270, respectively, which may be available to offset future income tax liabilities. The 2017 Tax Cuts and Jobs Act (&#x201c;TCJA&#x201d;) will generally allow losses incurred after 2017 to be carried over indefinitely but generally limits the net operating loss deduction to the lesser of the net operating loss carryover or 80% of a corporation&#x2019;s taxable income (subject to Section 382 of the Internal Revenue Code of 1986, as amended). In addition, the Company has approximately $21,335 in U.S. State gross loss carryforwards which expire through various dates through 2044.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025, the Company had an estimated U.S. federal and state research and development tax credit carryforwards of $15,565 and $5,002, respectively, which may be available to offset future tax liabilities, and each begin to expire in 2041 and 2037, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025 and 2024, the Company had U.K. gross operating loss carryforwards of approximately $211,096 and $198,653 respectively, which may be available to offset future income tax liabilities. To the extent that U.K. taxable profits exceed &#xa3;5,000 in each year, the loss available to utilize against profits in excess of &#xa3;5,000 will be restricted to 50%. The U.K. loss carryforwards do not lapse and therefore, the full amount will be relieved over time provided there are sufficient profits against which the losses can be utilized.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Utilization of the U.S. net operating loss carryforwards and research and development tax credit carryforwards may be subject to a substantial annual limitation under Section 382 of the Internal Revenue Code of 1986 due to ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50% over a three-year period. The Company has not completed a study to assess whether a change of ownership has occurred, or whether there have been multiple ownership changes since its formation. Any limitation may result in the loss of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.K. tax losses are subject to additional restrictions where there is a change in ownership in the business and certain other conditions are met. An ownership change of a U.K. tax resident company would occur where (directly or indirectly) a single person acquires more than half of the ordinary share capital of a company, or two or more persons each acquire a holding of at least 5% of the ordinary share capital of a company and these holdings together amount to more than half the ordinary share capital of a company. Where a change in ownership has occurred, and within three years prior to that change in ownership and five years afterwards, there is a major change in the nature and conduct of trade of that company or the trade of that business becomes small or negligible, any losses carried forward will be extinguished from the point of the change in ownership. In addition, losses accrued subsequent to April 1, 2017 will be extinguished on a change of ownership when there is a major change in the nature or conduct of a company&#x2019;s business, or where there is a major change in the scale of that business, or a company ceases to carry on a particular trade or business. The Company has not completed a study to assess whether a change of ownership has occurred since its formation, or whether there has been a major change in the Company&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s business that would &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;restrict the U.K. tax losses. Any limitation may result in the loss of a portion of the net operating loss carryforwards before utilization.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deemed U.S. Income Inclusions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The  TCJA created a requirement that US corporations include in income earnings of certain controlled foreign corporations under the global intangible low taxed income (&#x201c;GILTI&#x201d;) regime. Pursuant to the FASB Staff Q&amp;amp;A, Topic 740 No.5. Accounting for Global Intangible Low-taxed Income, the Company is allowed to make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or to provide for the tax expense related to GILTI in the year the tax is incurred as period expense only. The Company has elected to account for GILTI in the year the tax is incurred and include the current tax impact of GILTI in the effective tax rate. Given the Company&#x2019;s loss position in the U.S. and the valuation allowance recorded against its U.S. net deferred tax assets, these provisions have not had a material impact on the Company&#x2019;s consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Annual Effective Tax Rate Reconciliation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the Company&#x2019;s effective tax rate to the U.S. federal statutory rate is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.356%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.700%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="24" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Tax at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(226,702)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(46,476)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(129,048)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;State income tax, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(6,828)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(4,782)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(2,275)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Nontaxable or nondeductible Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;134,033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(12.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;2,978&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;299&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;77&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;521&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Foreign Tax Effects&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Cayman Islands Statutory income tax rate differential&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;67,969&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;41,570&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(18.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;104,282&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(17.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Other foreign jurisdictions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;644&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;229&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;678&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Changes in unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;1,357&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;956&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;29,228&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;8,573&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;22,064&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unrecognized Tax Benefit Reconciliation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records unrecognized tax benefits in accordance with ASC 740-10, Income Taxes. ASC 740-10 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of uncertain tax positions taken or expected to be taken in the Company&#x2019;s income tax return and also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. As of December 31, 2025, 2024, and 2023, the Company had total unrecognized tax benefits of $3,903, $2,122, and $1,064, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of unrecognized tax benefits from continuing operations is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Audit Examinations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In the U.S., the Company files a Federal consolidated income tax return and income tax returns in various states. In the U.S., the filings for tax years from 2020 remain subject to examination by the U.S. Internal Revenue Service and state tax authorities. The Company is not currently under examination by the Internal Revenue Service or any other jurisdiction for years 2020 through present. To the extent the Company has tax attribute carryforwards, the tax years in which the attribute was generated may be adjusted upon examination by the Internal Revenue Service or state tax authorities to the extent utilized in a future period. In the U.K., tax returns for the year ended December 31, 2023 remains subject to examination by HMRC.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Legislative Impacts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On July 4, 2025, H.R. 1, a U.S. budget reconciliation bill, was signed into law. The Company has assessed the provisions of the new legislation and has integrated the resulting impacts into its effective income tax rate. Management has concluded that the bill does not have an impact on the Company's consolidated financial statements for the current period.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-5" decimals="-3" id="f-505" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-6" decimals="-3" id="f-506" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c-1" id="f-507">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company&#x2019;s loss before income taxes are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.432%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(326,729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(499,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(752,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,079,586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(614,928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-1" decimals="-3" id="f-508" unitRef="usd">-326729000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-7" decimals="-3" id="f-509" unitRef="usd">-199040000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-8" decimals="-3" id="f-510" unitRef="usd">-499810000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-1" decimals="-3" id="f-511" unitRef="usd">-752857000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-7" decimals="-3" id="f-512" unitRef="usd">-22275000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-8" decimals="-3" id="f-513" unitRef="usd">-115118000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-514" unitRef="usd">-1079586000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-7" decimals="-3" id="f-515" unitRef="usd">-221315000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-8" decimals="-3" id="f-516" unitRef="usd">-614928000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-517" unitRef="usd">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-7" decimals="-3" id="f-518" unitRef="usd">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-7" decimals="-3" id="f-519" unitRef="usd">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-7" decimals="-3" id="f-520" unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-7" decimals="-3" id="f-521" unitRef="usd">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-522" unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-523" unitRef="usd">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-524" unitRef="usd">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-525" unitRef="usd">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-526" unitRef="usd">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-7" decimals="-3" id="f-527" unitRef="usd">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-7" decimals="-3" id="f-528" unitRef="usd">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-529">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The major components of deferred tax assets and liabilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.467%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.469%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforward&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development credit carryforward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 174 Research and Development Capitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337)  &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets before valuation allowance &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,161&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,588&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133,161)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,588)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-5" decimals="-3" id="f-530" unitRef="usd">73583000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-6" decimals="-3" id="f-531" unitRef="usd">59413000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c-5" decimals="-3" id="f-532" unitRef="usd">16092000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c-6" decimals="-3" id="f-533" unitRef="usd">7869000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-5" decimals="-3" id="f-534" unitRef="usd">32158000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-6" decimals="-3" id="f-535" unitRef="usd">14001000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <smmt:DeferredTaxAssetsCapitalizedResearchAndDevelopment contextRef="c-5" decimals="-3" id="f-536" unitRef="usd">11034000</smmt:DeferredTaxAssetsCapitalizedResearchAndDevelopment>
    <smmt:DeferredTaxAssetsCapitalizedResearchAndDevelopment contextRef="c-6" decimals="-3" id="f-537" unitRef="usd">14167000</smmt:DeferredTaxAssetsCapitalizedResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-5" decimals="-3" id="f-538" unitRef="usd">711000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-6" decimals="-3" id="f-539" unitRef="usd">475000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-5" decimals="-3" id="f-540" unitRef="usd">133578000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-6" decimals="-3" id="f-541" unitRef="usd">95925000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="c-5" decimals="-3" id="f-542" unitRef="usd">417000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="c-6" decimals="-3" id="f-543" unitRef="usd">337000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-5" decimals="-3" id="f-544" unitRef="usd">417000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-6" decimals="-3" id="f-545" unitRef="usd">337000</us-gaap:DeferredIncomeTaxLiabilities>
    <smmt:DeferredTaxAssetsLiabilities contextRef="c-5" decimals="-3" id="f-546" unitRef="usd">133161000</smmt:DeferredTaxAssetsLiabilities>
    <smmt:DeferredTaxAssetsLiabilities contextRef="c-6" decimals="-3" id="f-547" unitRef="usd">95588000</smmt:DeferredTaxAssetsLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-3" id="f-548" unitRef="usd">133161000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-6" decimals="-3" id="f-549" unitRef="usd">95588000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-5" decimals="-3" id="f-550" unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-6" decimals="-3" id="f-551" unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-5" decimals="-3" id="f-552" unitRef="usd">133578000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-6" decimals="-3" id="f-553" unitRef="usd">95925000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:SummaryOfValuationAllowanceTextBlock contextRef="c-1" id="f-554">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the valuation allowance was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.523%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance as of beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84,751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,016)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increases recorded to income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,837)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,735)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance as of end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84,751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-6" decimals="-3" id="f-555" unitRef="usd">95588000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-28" decimals="-3" id="f-556" unitRef="usd">84751000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-13" decimals="-3" id="f-557" unitRef="usd">64016000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-1" decimals="-3" id="f-558" unitRef="usd">37573000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-7" decimals="-3" id="f-559" unitRef="usd">10837000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-8" decimals="-3" id="f-560" unitRef="usd">20735000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-3" id="f-561" unitRef="usd">133161000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-6" decimals="-3" id="f-562" unitRef="usd">95588000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-28" decimals="-3" id="f-563" unitRef="usd">84751000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:OperatingLossCarryforwards contextRef="c-77" decimals="-3" id="f-564" unitRef="usd">93210000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-78" decimals="-3" id="f-565" unitRef="usd">44270000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-79" decimals="-3" id="f-566" unitRef="usd">21335000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-77" decimals="-3" id="f-567" unitRef="usd">15565000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-79" decimals="-3" id="f-568" unitRef="usd">5002000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:OperatingLossCarryforwards contextRef="c-80" decimals="-3" id="f-569" unitRef="usd">211096000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-81" decimals="-3" id="f-570" unitRef="usd">198653000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-571">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the Company&#x2019;s effective tax rate to the U.S. federal statutory rate is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.356%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.700%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="24" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Tax at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(226,702)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(46,476)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(129,048)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;State income tax, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(6,828)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(4,782)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(2,275)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Nontaxable or nondeductible Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;134,033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(12.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;2,978&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;299&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;77&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;521&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Foreign Tax Effects&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Cayman Islands Statutory income tax rate differential&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;67,969&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;41,570&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(18.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;104,282&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(17.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Other foreign jurisdictions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;644&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;229&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;678&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Changes in unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;1,357&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;956&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;29,228&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;8,573&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;22,064&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.75pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="-3" id="f-572" unitRef="usd">-226702000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="3" id="f-573" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-7" decimals="-3" id="f-574" unitRef="usd">-46476000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-7" decimals="3" id="f-575" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-8" decimals="-3" id="f-576" unitRef="usd">-129048000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-8" decimals="3" id="f-577" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="-3" id="f-578" unitRef="usd">0</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="3" id="f-579" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-7" decimals="-3" id="f-580" unitRef="usd">-17000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-7" decimals="3" id="f-581" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-8" decimals="-3" id="f-582" unitRef="usd">0</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-8" decimals="3" id="f-583" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-1" decimals="-3" id="f-584" unitRef="usd">6828000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-1" decimals="3" id="f-585" unitRef="number">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-7" decimals="-3" id="f-586" unitRef="usd">4782000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-7" decimals="3" id="f-587" unitRef="number">-0.022</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-8" decimals="-3" id="f-588" unitRef="usd">2275000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-8" decimals="3" id="f-589" unitRef="number">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="-3" id="f-590" unitRef="usd">134033000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="3" id="f-591" unitRef="number">-0.124</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-7" decimals="-3" id="f-592" unitRef="usd">-130000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-7" decimals="3" id="f-593" unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-8" decimals="-3" id="f-594" unitRef="usd">2978000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-8" decimals="3" id="f-595" unitRef="number">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-1" decimals="-3" id="f-596" unitRef="usd">299000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-1" decimals="3" id="f-597" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-7" decimals="-3" id="f-598" unitRef="usd">77000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-7" decimals="3" id="f-599" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-8" decimals="-3" id="f-600" unitRef="usd">521000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-8" decimals="3" id="f-601" unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-82" decimals="-3" id="f-602" unitRef="usd">67969000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-82" decimals="3" id="f-603" unitRef="number">-0.063</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-83" decimals="-3" id="f-604" unitRef="usd">41570000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-83" decimals="3" id="f-605" unitRef="number">-0.188</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-84" decimals="-3" id="f-606" unitRef="usd">104282000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-84" decimals="3" id="f-607" unitRef="number">-0.170</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-85" decimals="-3" id="f-608" unitRef="usd">644000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-85" decimals="3" id="f-609" unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-86" decimals="-3" id="f-610" unitRef="usd">229000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-86" decimals="3" id="f-611" unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-87" decimals="-3" id="f-612" unitRef="usd">678000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-87" decimals="3" id="f-613" unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationTaxContingencies contextRef="c-1" decimals="-3" id="f-614" unitRef="usd">1357000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies contextRef="c-1" decimals="3" id="f-615" unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies contextRef="c-7" decimals="-3" id="f-616" unitRef="usd">956000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies contextRef="c-7" decimals="3" id="f-617" unitRef="number">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies contextRef="c-8" decimals="-3" id="f-618" unitRef="usd">800000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies contextRef="c-8" decimals="3" id="f-619" unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="-3" id="f-620" unitRef="usd">29228000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="3" id="f-621" unitRef="number">-0.027</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-7" decimals="-3" id="f-622" unitRef="usd">8573000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-7" decimals="3" id="f-623" unitRef="number">-0.040</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-8" decimals="-3" id="f-624" unitRef="usd">22064000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-8" decimals="3" id="f-625" unitRef="number">-0.036</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-626" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-627" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-3" id="f-628" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-7" decimals="3" id="f-629" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-8" decimals="-3" id="f-630" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-8" decimals="3" id="f-631" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-5" decimals="-3" id="f-632" unitRef="usd">3903000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-6" decimals="-3" id="f-633" unitRef="usd">2122000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-28" decimals="-3" id="f-634" unitRef="usd">1064000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="c-1" id="f-635">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of unrecognized tax benefits from continuing operations is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-6" decimals="-3" id="f-636" unitRef="usd">2122000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-28" decimals="-3" id="f-637" unitRef="usd">1064000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-13" decimals="-3" id="f-638" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-639" unitRef="usd">592000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-7" decimals="-3" id="f-640" unitRef="usd">122000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-8" decimals="-3" id="f-641" unitRef="usd">610000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-642" unitRef="usd">1189000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-7" decimals="-3" id="f-643" unitRef="usd">936000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-8" decimals="-3" id="f-644" unitRef="usd">454000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-5" decimals="-3" id="f-645" unitRef="usd">3903000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-6" decimals="-3" id="f-646" unitRef="usd">2122000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-28" decimals="-3" id="f-647" unitRef="usd">1064000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-648">Net Loss per Share &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net loss per share: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.870%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,079,586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(614,928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted weighted average number of shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747,702,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718,541,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619,646,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share is computed by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the diluted net loss by the weighted-average number of common shares outstanding for the period, including potentially dilutive common shares. Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods, as the inclusion of all potential common share equivalents outstanding would have been antidilutive.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because the 2023 Rights Offering (see Note 13) exercise price of $1.05 per share was less than the closing price of $1.82 per share on March 1, 2023, the expiration, the Company has retroactively adjusted earnings per share and the weighted average number of shares outstanding for the bonus element for the year ended December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially dilutive securities were excluded from the computation of the diluted net loss per share of common stock for the periods presented because their effect would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,614,728&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,920,334&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,209,289&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,629,988&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,015,642&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares expected to be purchased under employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,905&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,550&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,163&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,680,633&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,636,872&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,380,094&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options that are outstanding and contain improbable vesting criteria are excluded from the presentation of common stock equivalents outstanding in the table above.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-649">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net loss per share: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.870%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,079,586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(614,928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted weighted average number of shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747,702,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718,541,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619,646,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-650" unitRef="usd">-1079586000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-651" unitRef="usd">-221315000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-8" decimals="-3" id="f-652" unitRef="usd">-614928000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-653" unitRef="shares">747702265</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-654" unitRef="shares">747702265</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="0" id="f-655" unitRef="shares">718541896</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="0" id="f-656" unitRef="shares">718541896</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-8" decimals="0" id="f-657" unitRef="shares">619646180</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-8" decimals="0" id="f-658" unitRef="shares">619646180</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-659"
      unitRef="usdPerShare">-1.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-660"
      unitRef="usdPerShare">-0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-8"
      decimals="2"
      id="f-661"
      unitRef="usdPerShare">-0.99</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-662"
      unitRef="usdPerShare">-1.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-663"
      unitRef="usdPerShare">-0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-8"
      decimals="2"
      id="f-664"
      unitRef="usdPerShare">-0.99</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-88"
      decimals="2"
      id="f-665"
      unitRef="usdPerShare">1.05</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SharePrice
      contextRef="c-89"
      decimals="2"
      id="f-666"
      unitRef="usdPerShare">1.82</us-gaap:SharePrice>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-667">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially dilutive securities were excluded from the computation of the diluted net loss per share of common stock for the periods presented because their effect would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,614,728&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,920,334&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,209,289&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,629,988&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,015,642&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares expected to be purchased under employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,905&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,550&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,163&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,680,633&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,636,872&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,380,094&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-90" decimals="0" id="f-668" unitRef="shares">115614728</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-91" decimals="0" id="f-669" unitRef="shares">68920334</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-92" decimals="0" id="f-670" unitRef="shares">54209289</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-93" decimals="0" id="f-671" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-94" decimals="0" id="f-672" unitRef="shares">4629988</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-95" decimals="0" id="f-673" unitRef="shares">5015642</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-96" decimals="0" id="f-674" unitRef="shares">65905</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-97" decimals="0" id="f-675" unitRef="shares">86550</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-98" decimals="0" id="f-676" unitRef="shares">155163</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="0" id="f-677" unitRef="shares">115680633</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-7" decimals="0" id="f-678" unitRef="shares">73636872</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-8" decimals="0" id="f-679" unitRef="shares">59380094</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-680">Goodwill&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2017, the Company expanded its activities in the field of infectious diseases with the acquisition of Discuva Limited, a privately held United Kingdom-based company. Through this acquisition, the Company obtained a bacterial genetics platform and a suite of software-based technologies, which facilitates the discovery and development of new mechanism antibiotics. This resulted in the recognition of goodwill of &#xa3;1.5&#160;million, which is translated into U.S. dollars at each reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025 and 2024, goodwill was $2,001 and $1,864, respectively. Changes year over year are the result of changes in foreign currency. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses goodwill for impairment on an annual basis as of December 31 or more frequently when events and circumstances occur indicating that recorded goodwill may be impaired. As of December 31, 2025, the Company performed its annual impairment assessment of goodwill and determined that it is more likely than not that the fair value of the reporting unit exceeds its carrying amount. The Company has recorded no goodwill impairment charges to date.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-99" decimals="-5" id="f-681" unitRef="gbp">1500000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-682" unitRef="usd">2001000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-6" decimals="-3" id="f-683" unitRef="usd">1864000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="c-5" decimals="-3" id="f-684" unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock contextRef="c-1" id="f-685">Fair Value Measurements and Short-Term Investments&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables sets forth the Company&#x2019;s fair value hierarchy for its assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.138%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hierarchy Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Credit (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets included within cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Government treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets included within short-term investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificate of deposit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Government treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.284%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hierarchy Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Credit (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets included within cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets included within short-term investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Government treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables above do not include cash at December 31, 2025 and 2024 of $16,366 and $16,263, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes that the carrying amounts of prepaid expenses, other current assets, accounts payable, and accrued expenses approximates their fair values due to the short-term nature of those instruments. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized gain (loss) on short-term investments for the years ended December 31, 2025 and 2024 were immaterial, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c-1" id="f-686">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables sets forth the Company&#x2019;s fair value hierarchy for its assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.138%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hierarchy Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Credit (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets included within cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Government treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets included within short-term investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificate of deposit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Government treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.284%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hierarchy Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Credit (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets included within cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets included within short-term investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Government treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-100" decimals="-3" id="f-687" unitRef="usd">163588000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-100" decimals="-3" id="f-688" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-100" decimals="-3" id="f-689" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest contextRef="c-100" decimals="-3" id="f-690" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-100" decimals="-3" id="f-691" unitRef="usd">163588000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-101" decimals="-3" id="f-692" unitRef="usd">45300000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-101" decimals="-3" id="f-693" unitRef="usd">12000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-101" decimals="-3" id="f-694" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest contextRef="c-101" decimals="-3" id="f-695" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-101" decimals="-3" id="f-696" unitRef="usd">45312000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-102" decimals="-3" id="f-697" unitRef="usd">25000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-102" decimals="-3" id="f-698" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-102" decimals="-3" id="f-699" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest contextRef="c-102" decimals="-3" id="f-700" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-102" decimals="-3" id="f-701" unitRef="usd">25000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-103" decimals="-3" id="f-702" unitRef="usd">463022000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-103" decimals="-3" id="f-703" unitRef="usd">160000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-103" decimals="-3" id="f-704" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest contextRef="c-103" decimals="-3" id="f-705" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-103" decimals="-3" id="f-706" unitRef="usd">463182000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-5" decimals="-3" id="f-707" unitRef="usd">696910000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-5" decimals="-3" id="f-708" unitRef="usd">172000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-5" decimals="-3" id="f-709" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest contextRef="c-5" decimals="-3" id="f-710" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-5" decimals="-3" id="f-711" unitRef="usd">697082000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-104" decimals="-3" id="f-712" unitRef="usd">88599000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-104" decimals="-3" id="f-713" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-104" decimals="-3" id="f-714" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest contextRef="c-104" decimals="-3" id="f-715" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-104" decimals="-3" id="f-716" unitRef="usd">88599000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-105" decimals="-3" id="f-717" unitRef="usd">307387000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-105" decimals="-3" id="f-718" unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-105" decimals="-3" id="f-719" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest contextRef="c-105" decimals="-3" id="f-720" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-105" decimals="-3" id="f-721" unitRef="usd">307487000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-6" decimals="-3" id="f-722" unitRef="usd">395986000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-6" decimals="-3" id="f-723" unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-6" decimals="-3" id="f-724" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest contextRef="c-6" decimals="-3" id="f-725" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-6" decimals="-3" id="f-726" unitRef="usd">396086000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:Cash contextRef="c-5" decimals="-3" id="f-727" unitRef="usd">16366000</us-gaap:Cash>
    <us-gaap:Cash contextRef="c-6" decimals="-3" id="f-728" unitRef="usd">16263000</us-gaap:Cash>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="c-1" id="f-729">Research and Development Prepaid Expenses and Accrued Liabilities&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included within prepaid expenses and other current assets at December 31, 2025 and 2024 is $3,996 and $8,338, respectively, of prepayments relating to research and development expenditures. Included within accrued liabilities at December 31, 2025 and 2024 is $31,498 and $17,441, respectively, relating to research and development expenditures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These amounts are determined based on the estimated costs to complete each study or activity related to the ongoing clinical trials for ivonescimab, the estimation of the current stage of completion and the invoices received, as well as predetermined milestones which are not reflective of the current stage of development for prepaid expenses. However, accrued liabilities increase as the activities progress. The key sensitivity is the estimated current stage of completion of each study or activity, which is based on information received from the supplier and the Company&#x2019;s operational knowledge of the work completed under those contracts.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <smmt:ResearchAndDevelopmentPrepaidExpensesCurrent contextRef="c-5" decimals="-3" id="f-730" unitRef="usd">3996000</smmt:ResearchAndDevelopmentPrepaidExpensesCurrent>
    <smmt:ResearchAndDevelopmentPrepaidExpensesCurrent contextRef="c-6" decimals="-3" id="f-731" unitRef="usd">8338000</smmt:ResearchAndDevelopmentPrepaidExpensesCurrent>
    <smmt:AccruedResearchAndDevelopmentCurrent contextRef="c-5" decimals="-3" id="f-732" unitRef="usd">31498000</smmt:AccruedResearchAndDevelopmentCurrent>
    <smmt:AccruedResearchAndDevelopmentCurrent contextRef="c-6" decimals="-3" id="f-733" unitRef="usd">17441000</smmt:AccruedResearchAndDevelopmentCurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-734">Leases&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating leases for real estate. The Company does not have any finance leases. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company leases its offices and facilities in Miami, FL, Palo Alto, CA, Princeton, NJ, Oxford, U.K., and Menlo Park, CA under non-cancellable operating lease agreements. The lease agreements for the Company&#x2019;s offices and facilities in Miami, FL, Palo Alto, CA, Princeton, NJ and Oxford, U.K., expire in April 2029, October 2033, August 2028, and February 2027, respectively. The remaining lease agreement for the Company&#x2019;s office and facility in Menlo Park, CA expires in May 2026. Under the terms of the lease agreements, the Company is responsible for certain repair and maintenance, utilities, licensing and permit fees.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2025, the Company recorded $17,056 of operating right-of-use assets and operating lease liabilities related to new leases for office space for its Palo Alto, CA and Princeton, NJ locations. Total future lease payments as of December 31, 2025 are approximately $23,117 on an undiscounted basis. The Palo Alto lease commenced on December&#160;1, 2025 and has a term of approximately 8 years. The Princeton, NJ lease commenced on August&#160;18, 2025 and has a term of 3 years. The Company recorded $4,216 of right-of-use assets during the year ended December 31, 2024 related to its Miami, Florida headquarters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of the right-of-use assets as of December 31, 2025 and 2024 is $20,616 and $7,144, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The elements of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Fixed lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average discount rate and the weighted average remaining lease term were 7.6% and 6.7 years, respectively, as of December 31, 2025. The weighted average discount rate and the weighted average remaining lease term were 6.9% and 2.8 years, respectively, as of December 31, 2024. The Company made cash payments related to lease liabilities of $3,741 and $2,568 for the years ended December 31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future lease payments under non-cancelable leases as of December 31, 2025 are detailed as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.133%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Operating lease liabilities, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-106" decimals="-3" id="f-735" unitRef="usd">17056000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-107" decimals="-3" id="f-736" unitRef="usd">23117000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-108" id="f-737">P8Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-109" id="f-738">P3Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-110" decimals="-3" id="f-739" unitRef="usd">4216000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-740" unitRef="usd">20616000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-6" decimals="-3" id="f-741" unitRef="usd">7144000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-742">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The elements of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Fixed lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-3" id="f-743" unitRef="usd">3853000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-7" decimals="-3" id="f-744" unitRef="usd">3461000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-8" decimals="-3" id="f-745" unitRef="usd">2214000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-1" decimals="-3" id="f-746" unitRef="usd">225000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-7" decimals="-3" id="f-747" unitRef="usd">48000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-8" decimals="-3" id="f-748" unitRef="usd">83000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-3" id="f-749" unitRef="usd">4078000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-7" decimals="-3" id="f-750" unitRef="usd">3509000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-8" decimals="-3" id="f-751" unitRef="usd">2297000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-5" decimals="3" id="f-752" unitRef="number">0.076</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-5" id="f-753">P6Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-6" decimals="3" id="f-754" unitRef="number">0.069</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-6" id="f-755">P2Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-756" unitRef="usd">3741000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-7" decimals="-3" id="f-757" unitRef="usd">2568000</us-gaap:OperatingLeasePayments>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-758">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future lease payments under non-cancelable leases as of December 31, 2025 are detailed as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.133%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Operating lease liabilities, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-5" decimals="-3" id="f-759" unitRef="usd">3492000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-5" decimals="-3" id="f-760" unitRef="usd">4052000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-5" decimals="-3" id="f-761" unitRef="usd">4158000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-5" decimals="-3" id="f-762" unitRef="usd">3349000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-5" decimals="-3" id="f-763" unitRef="usd">3073000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-5" decimals="-3" id="f-764" unitRef="usd">9205000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-5" decimals="-3" id="f-765" unitRef="usd">27328000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-5" decimals="-3" id="f-766" unitRef="usd">6438000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-5" decimals="-3" id="f-767" unitRef="usd">20890000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-768" unitRef="usd">3388000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-769" unitRef="usd">17502000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-770">Promissory Note Payable to Related Parties&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 2022 Promissory Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 6, 2022, the Company entered into a Note Purchase Agreement (the &#x201c;Note Purchase Agreement&#x201d;), with Mr. Duggan and Dr. Zanganeh, pursuant to which the Company agreed to sell to each of Mr. Duggan and Dr. Zanganeh unsecured promissory notes in the aggregate amount of $520,000. Pursuant to the Note Purchase Agreement, the Company issued to Mr. Duggan and Dr. Zanganeh unsecured promissory notes in the amount of $400,000 (the &#x201c;Duggan February Note&#x201d;) and $20,000 (the &#x201c;Zanganeh Note&#x201d;), respectively, which matured and became due on February 15, 2023 and an unsecured promissory note to Mr. Duggan in the amount of $100,000 (the &#x201c;Duggan September Note&#x201d; and together with the Duggan February Note and the Zanganeh Note, the &#x201c;December 2022 Notes&#x201d;), which was originally due on September 15, 2023. The maturity dates of the December 2022 Notes could have been extended one or more times at the Company&#x2019;s election, but in no event to a date later than September 6, 2024. In addition, if the Company consummated a public offering, then upon the later to occur of (i) &lt;span style="-sec-ix-hidden:f-775"&gt;five&lt;/span&gt; business days after the Company receives the net cash proceeds therefrom or (ii) May 15, 2023, the Duggan February Note and the Zanganeh Note were to be prepaid by an amount equal to the lesser of (a) 100% of the amount of the net proceeds of such offering and (b) the outstanding principal amount on such Notes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 19, 2023, the Company provided notice to extend the term of the Duggan February Note and Duggan September Note to a maturity date of September 6, 2024. Furthermore, on January 19, 2023, the Company and Mr. Duggan rectified the Duggan February Note and Duggan September Note in order to correctly reflect the parties&#x2019; intent that the Company may only prepay (i) the Duggan February Note following the completion of a public rights offering to be conducted by Summit in the approximate amount of $500,000, or a similar capital raise, in an amount equal to the lesser of (x) the net proceeds of the rights offering or such capital raise or (y) the full amount outstanding of the Duggan February Note, and (ii) Duggan September Note following the completion of a capital raising transaction subsequent to the rights offering in an amount equal to the lesser of (A) the net proceeds of such capital raise or (B) the full amount outstanding of the Duggan September Note. Following the issuance of the two new Promissory Notes (the &#x201c;Revised Duggan February Note&#x201d; and the &#x201c;Revised Duggan September Note&#x201d;, respectively), the Duggan February Note and Duggan September Note were marked as &#x201c;cancelled&#x201d; on their face and replaced in their entirety by the Revised Duggan February Note and the Revised Duggan September Note (together with the Zanganeh Note, the &#x201c;Notes&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 15, 2023, the $20,000 Zanganeh Note matured and the Company repaid the outstanding principal balance. In connection with the closing of the rights offering in 2023 (the &#x201c;2023 Rights Offering&#x201d;), the $400,000 Revised Duggan February Note matured and became due, and the Company repaid all principal and accrued interest thereunder using a combination of a portion of the cash proceeds from the 2023 Rights Offering and the extinguishment of a portion of the amount due equal to the subscription price of shares subscribed by Mr. Duggan in the 2023 Rights Offering.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Notes accrued interest at an initial rate of 7.5%. All interest on the Notes was paid on the date of signing for the period through February 15, 2023. Such prepaid interest was paid in a number of shares of the Company&#x2019;s common stock equal to the dollar amount of such prepaid interest, divided by $0.7913 (the consolidated closing bid price immediately preceding the time the Company entered into the Note Purchase Agreement, plus $0.01), which was 9,720,291 shares. For all applicable periods following February 15, 2023, interest accrued on the outstanding principal balance of the Notes at the U.S. prime interest rate, as reported in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Wall Street Journal,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; plus 50 basis points, as adjusted monthly, for three months immediately following February 15, 2023, and thereafter at the U.S. prime rate plus 300 basis points, as adjusted monthly. Accrued interest was paid in cash, quarterly in arrears, on each of March 31, June 30, September 30 and December 31. Debt issuance costs associated with the Notes were $44 and were capitalized as part of the carrying value of the promissory notes payable to related parties. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 17, 2024, the Revised Duggan February Note was amended to extend the maturity date from September 6, 2024 to April 1, 2025. For all applicable periods commencing February 17, 2024, interest accrued on the outstanding principal balance at the greater of 12% or the U.S. prime interest rate, as reported in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Wall Street Journal&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; plus 350 basis points, as adjusted monthly, and compounded quarterly. Interest was paid upon maturity of the loan. The debt discount was amortized to interest expense using an effective interest rate method. The effective interest rate of the Revised Duggan February Note and Zanganeh Note was 8.9% and the effective interest rate of the Revised Duggan September Note was 11.3%.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 16, 2024, the Company used some of the proceeds raised from the September 2024 Private Placement (see Note 13 for further details) to repay $75,500 in principal on the Revised Duggan September Note. On October 1, 2024, the Company repaid the remaining outstanding balance of the Revised Duggan September Note in full, resulting in principal payments of $24,500 and accrued cash interest of $7,305.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of December 31, 2025 and 2024, the Company had no debt. During the year ended December 31, 2025, the Company incurred no interest expense. During the year ended December 31, 2024, the Company incurred interest expense of $8,686 related to the Revised Duggan September Note.&lt;/span&gt;&lt;/div&gt;Related Party Transactions&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;July 25, 2022 First Amendment to Sublease Agreement with Maky Zanganeh and Associates, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On July 25, 2022 the Company entered into a first amendment, dated July 19, 2022, to its existing sublease agreement with Maky Zanganeh and Associates, Inc. (&#x201c;MZA&#x201d;), an entity owned by Maky Zanganeh, consisting of 4,500 square feet of office space at 2882 Sand Hill Road, Menlo Park, California. The existing sublease term, which was set to expire on September 30, 2022, was extended for a period of thirty-nine months from October 1, 2022 through December 31, 2025. The rent payable under the terms of the sublease is equivalent to the proportionate share of the net payable by MZA to the third-party landlord, based on the square footage of office space sublet by the Company, and no mark-up has been applied. The agreement was further amended to include additional space, as noted below under the August 2, 2024 Third Amendment to Sublease Agreement with Maky Zanganeh and Associates, Inc. During the years ended December 31, 2025, 2024 and 2023, payments of $834, $795, and $762, respectively, were made pursuant to the first and third amendments to the Sublease Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;July 29, 2022 Second Amendment to Sublease Agreement with Maky Zanganeh and Associates, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On July 29, 2022, the Company entered into a second amendment to its existing sublease agreement with MZA, described above. The second amendment was effective as of August 1, 2022 and expires on December 31, 2025. The second amendment includes an additional 1,277 square feet of office space at 2882 Sand Hill Road, Menlo Park, California. The rent payable under the terms of the sublease is equivalent to the proportionate share of the net payable by MZA to the third-party landlord, based on the square footage of office space sublet by the Company, and no mark-up has been applied. During the years ended December 31, 2025, 2024 and 2023, payments of $232, $224 and $218, respectively, were made pursuant to the second amendment to the Sublease Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;April 1, 2024 Miami Sublease Agreements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2024, the Company entered into two sublease agreements of its Miami headquarters location, one with Genius 24C Inc. (&#x201c;Genius&#x201d;), an affiliate of the Company&#x2019;s Co-CEO, Robert W. Duggan (the &#x201c;Genius Sublease Agreement&#x201d;) and one with Duggan Investments Research LLC (&#x201c;Investments Research&#x201d;), also an affiliate of the Company's Co-CEO, Robert W. Duggan (the &#x201c;Investments Research Sublease Agreement&#x201d;). Pursuant to the Genius Sublease Agreement, Genius sublet from the Company 848 square feet of office space in the Miami HQ for a sixty-two month term for total rental payments of approximately $446. Pursuant to the Investments Research Sublease Agreement, Investments Research sublet from the Company 848 square feet of office space in the Miami HQ for a sixty-two month term for total rental payments of approximately $446. During the years ended December 31, 2025 and 2024, the Company recognized $186 and $156, respectively, of sublease income recorded net of operating lease expenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;August 2, 2024 Third Amendment to Sublease Agreement with Maky Zanganeh and Associates, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 2, 2024, the Company entered into a third amendment to its existing sublease agreement with MZA. The third amendment was effective August 1, 2024 and included an additional space of 145 square feet of office space located at 2882 &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sand Hill Road, Menlo Park, California. The Company continues to be obligated to pay its proportionate share of the net payable by MZA to the third-party landlord, which is revised to 93.6% as of the effective date, based on the square footage of office space sublet by the landlord.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Promissory Note Payable to Related Parties&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 12 for disclosure of the promissory note payable to related parties issued December 6, 2022 and fully repaid as of October 1, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Akeso Agreements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the closing of the License Agreement, the Board appointed Dr. Yu (Michelle) Xia to serve as a member of the Board pursuant to the terms of the License Agreement. Dr. Xia is the founder of Akeso, and has been the chairwoman, president and CEO of Akeso since its inception in 2012. Furthermore, in connection with the License Agreement, the Company also entered into a Supply Agreement with Akeso, pursuant to which Summit agreed to purchase a certain portion of drug substance for clinical and commercial supply (the &#x201c;Supply Agreement&#x201d;). Refer to Note 4 for details on the License Agreement and Second Amendment. In addition to the License and Second Amendment and supply agreements, the Company also entered into various clinical services agreements with Akeso. During the years ended December 31, 2025, 2024 and 2023, the Company incurred research and development expenses of $46,133, $24,635 and $6,207, respectively, under these agreements with Akeso. As of December 31, 2025 and 2024 the Company included in accrued expenses, related to Akeso, $1,215 and $3,956, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023 Rights Offering&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Refer to Note 13 for a discussion on the 2023 Rights Offering.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Private Placements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;October 2023 PIPE&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 13 for a discussion on the participation by related parties in October 2023 PIPE.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;September 2024 PIPE&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 13 for a discussion on the participation by related parties in September 2024 PIPE.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;October 2025 PIPE&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 13 for a discussion on the participation by related parties in October 2025 PIPE.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Warrants Exercise&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2025, Mr. Duggan, the Company&#x2019;s Co-Chief Executive Officer, exercised 2,936,221 of the 3,985,055 warrants which he received in connection with a private placement completed by the Company with Mr. Duggan and other investors on December 24, 2019, resulting in the purchase of 2,936,221 shares of common stock at an exercise price of $1.58.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On April 8, 2025, Mr. Duggan completed the exercise of the remaining warrants received in the December 24, 2019 private placement, resulting in the purchase of 1,048,834 shares of common stock at an exercise price of $1.58.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In October 2024, the Shaun Zanganeh Irrevocable Trust exercised a warrant to purchase 315,681 shares of Common Stock.  Refer to Note 13 for the warrants exercise activity for the year ended December 31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Professional Services&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the year ended December 31, 2025, the Company engaged the law firm Wilson Sonsini Goodrich &amp;amp; Rosati P.C. (&#x201c;WSGR&#x201d;), where Mr. Kenneth A. Clark, a member of the Board, is a partner. Payments to be made by the Company to WSGR &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;were approved by the Audit Committee in accordance with its Related Party Transaction Policy. For the year ended December 31, 2025, the Company incurred expenses for legal services rendered by WSGR totaling approximately $1.4 million included in general and administrative expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:NotesPayable contextRef="c-111" decimals="-3" id="f-771" unitRef="usd">520000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="c-112" decimals="-3" id="f-772" unitRef="usd">400000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="c-113" decimals="-3" id="f-773" unitRef="usd">20000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="c-114" decimals="-3" id="f-774" unitRef="usd">100000000</us-gaap:NotesPayable>
    <smmt:NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering contextRef="c-115" decimals="2" id="f-776" unitRef="number">1</smmt:NotesPayableRelatedPartiesPotentialPrepaymentMaximumAmountPercentageOfNetProceedsFromPublicOffering>
    <smmt:NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold contextRef="c-116" decimals="-3" id="f-777" unitRef="usd">500000000</smmt:NotesPayableRelatedPartiesPotentialPrepaymentTriggeringEventPublicOfferingNetProceedsThreshold>
    <smmt:NotesPayableRelatedPartiesNewIssuances
      contextRef="c-117"
      decimals="INF"
      id="f-778"
      unitRef="promissory_note">2</smmt:NotesPayableRelatedPartiesNewIssuances>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c-118" decimals="-3" id="f-779" unitRef="usd">20000000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c-119" decimals="-3" id="f-780" unitRef="usd">400000000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RelatedPartyTransactionRate contextRef="c-120" decimals="3" id="f-781" unitRef="number">0.075</us-gaap:RelatedPartyTransactionRate>
    <smmt:NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator
      contextRef="c-120"
      decimals="4"
      id="f-782"
      unitRef="usdPerShare">0.7913</smmt:NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominator>
    <smmt:NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice
      contextRef="c-120"
      decimals="2"
      id="f-783"
      unitRef="usdPerShare">0.01</smmt:NotesPayableRelatedPartyPrepaidInterestEquityInterestsIssuableCalculationDenominatorBaseAmountAddedToClosingBidPrice>
    <smmt:StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest
      contextRef="c-120"
      decimals="INF"
      id="f-784"
      unitRef="shares">9720291</smmt:StockIssuedDuringPeriodSharesRelatedPartyPrepaidInterest>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-121" decimals="4" id="f-785" unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-122" decimals="4" id="f-786" unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DeferredFinanceCostsGross contextRef="c-111" decimals="-3" id="f-787" unitRef="usd">44000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:RelatedPartyTransactionRate contextRef="c-123" decimals="2" id="f-788" unitRef="number">0.12</us-gaap:RelatedPartyTransactionRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-123" decimals="4" id="f-789" unitRef="number">0.0350</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-124" decimals="3" id="f-790" unitRef="number">0.089</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-125" decimals="3" id="f-791" unitRef="number">0.089</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-126" decimals="3" id="f-792" unitRef="number">0.113</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c-127" decimals="-3" id="f-793" unitRef="usd">75500000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c-128" decimals="-3" id="f-794" unitRef="usd">24500000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:InterestPaidNet contextRef="c-128" decimals="-3" id="f-795" unitRef="usd">7305000</us-gaap:InterestPaidNet>
    <us-gaap:NotesPayable contextRef="c-129" decimals="-3" id="f-796" unitRef="usd">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="c-130" decimals="-3" id="f-797" unitRef="usd">0</us-gaap:NotesPayable>
    <us-gaap:InterestExpenseDebt contextRef="c-131" decimals="-3" id="f-798" unitRef="usd">0</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-132" decimals="-3" id="f-799" unitRef="usd">8686000</us-gaap:InterestExpenseDebt>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-800">Stockholders' Equity &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025 and December 31, 2024, the Company had 20,000,000 shares of preferred stock, par value $0.01 authorized and no shares issued and outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025 and December 31, 2024, the Company had authorized 1,000,000,000 shares of common stock, par value $0.01 (the &#x201c;Common Stock&#x201d;). As of December 31, 2025 and December 31, 2024, the Company had 775,371,200 shares and 737,626,004 shares of Common Stock issued and outstanding, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 6, 2022, the Company announced the 2023 Rights Offering for its existing shareholders to participate in the purchase of additional shares of its Common Stock for $1.05 per share. The 2023 Rights Offering commenced on February 7, 2023 and the associated subscription rights expired on March 1, 2023. Aggregate gross proceeds from the 2023 Rights Offering were $500,000 from the sale of 476,190,471 shares of the Company&#x2019;s Common Stock and issuance costs were $619. Mr. Duggan and Dr. Zanganeh fully subscribed to their respective basic subscription rights at a price of $1.05 per share. To satisfy the $395,314 subscription price for the shares subscribed by Mr. Duggan in the 2023 Rights Offering, Mr. Duggan agreed with the Company to extinguish a portion of the amount due and payable to him by the Company at the closing of the 2023 Rights Offering pursuant to the $400,000 Duggan Promissory Note in an amount equal to the subscription price (see also Note 12).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January&#160;19, 2023, the Company filed Amendment No. 2 to the Restated Certificate of Incorporation (the &#x201c;Amendment No. 2&#x201d;) with the Secretary of State of the State of Delaware to increase the number of authorized shares of its Common Stock by 650,000,000 (from 350,000,000 to 1,000,000,000), which became effective on such date. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 17, 2023, the Company filed a registration statement on Form S-3 to register for resale the following shares of the Company&#x2019;s Common Stock at $0.01 par value: (i) 10,000,000 shares of Common Stock issued on January 17, 2023 in connection with the License Agreement (as defined in Note 4) with Akeso pursuant to which the Company issued Akeso such shares; and (ii) the 9,346,434 and 373,857 shares of Common Stock issued in December 2022 to Mr. Duggan and Dr. Zanganeh, respectively, as payment of prepaid interest in connection with the Note Purchase Agreement dated December 6, 2022 between Mr. Duggan, Dr. Zanganeh and the Company. On April 27, 2023, the SEC issued the Company a Notice of Effectiveness for the registration statement on Form S-3.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mr. Soni entered into a share purchase agreement with the Company to purchase $5,000 of its Common Stock via a private placement. The transaction was effective October 13, 2023 with a closing price of $1.68, resulting in the purchase of 2,976,190 shares of the Company&#x2019;s Common Stock.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;June 2024 PIPE (Private Investment in Public Equity)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On June 3, 2024, the Company entered into a securities purchase agreement (the &#x201c;Purchase Agreement&#x201d;) with 667, L.P. and Baker Brothers Life Sciences, L.P., affiliates of Baker Bros. Advisors, L.P., for the sale by the Company in a private placement (the &#x201c;June 2024 Private Placement&#x201d;) of 22,222,222 shares (the &#x201c;Shares&#x201d;) of Common Stock, at a purchase price of $9.00 per share, for an aggregate purchase price of approximately $200,000. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The closing of the June 2024 Private Placement was June&#160;6, 2024. The Purchase Agreement contained customary representations, warranties and covenants by the Company, customary indemnification obligations of the Company, including for liabilities under the Securities Act of 1933, other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Purchase Agreement were made only for purposes of the Purchase Agreement and as of specific dates, were solely for the benefit of the parties to such agreements and were subject to limitations agreed upon by the contracting parties.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;3, 2024, in connection with the Purchase Agreement, the Company entered into a Registration Rights Agreement with certain investors (the &#x201c;Registration Rights Agreement&#x201d;). The Registration Rights Agreement provides, among other things, that the Company will as soon as reasonably practicable, file with the SEC a registration statement registering the resale of the shares. The Company agreed to use its reasonable best efforts to have such registration statement declared effective as soon as practicable after the filing thereof. The Company filed the registration statement on August 6, 2024, which was automatically effective upon filing.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;September 2024 PIPE&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September&#160;11, 2024, the Company entered into securities purchase agreements (the &#x201c;September 2024 Purchase Agreements&#x201d;) with multiple  biotech institutional investors and individual accredited investors, for the sale by the Company in a private placement (the &#x201c;September 2024 Private Placement&#x201d;) for an aggregate of 10,352,418 shares of the Company&#x2019;s Common Stock, par value $0.01 per share of Common Stock, at purchase price of $22.70 per share, which was the closing price of the Common Stock on September&#160;11, 2024, for aggregate gross proceeds to the Company of approximately $235,000, with offering costs of $140.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company's Section 16 officers participated in the capital raise. A total of $79,000 was raised by the Company's Co-Chief Executive Officer (&#x201c;CEO&#x201d;), Executive Chairman and majority stockholder, its CEO and the President and member of the Company's Board of Directors (the &#x201c;Board&#x201d;), its Chief Operating Officer (&#x201c;COO&#x201d;), Chief Financial Officer (&#x201c;CFO&#x201d;), and member of the Board, its Chief Accounting Officer (&#x201c;CAO&#x201d;), and a member of the Board, who invested via a controlled entity. The remaining $156,000 was raised with multiple leading biotech institutional investors. Refer to Note 15 Related Party Transactions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for further details regarding related parties' participation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The closing of the September 2024 Private Placement was September 13, 2024. The September 2024 Purchase Agreements contain customary representations, warranties and covenants by the Company, customary indemnification obligations of the Company, including for liabilities under the Securities Act, as amended (the &#x201c;Securities Act&#x201d;), other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the September 2024 Purchase &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Agreements were made only for purposes of the September 2024 Purchase Agreements and as of specific dates, were solely for the benefit of the parties to such agreements and were subject to limitations agreed upon by the contracting parties.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September&#160;11, 2024, in connection with the September 2024 Purchase Agreements, the Company entered into Registration Rights Agreements with certain investors (the &#x201c;September 2024 Registration Rights Agreements&#x201d;). The September 2024 Registration Rights Agreements provide, among other things, that the Company will as soon as reasonably practicable file with the SEC a registration statement registering the resale of the shares. The Company filed the registration statement on September 19, 2024, which was automatically effective upon filing.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;October 2025 PIPE&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On October&#160;21, 2025, the Company entered into securities purchase agreements (the &#x201c;October 2025 Purchase Agreements&#x201d;)  with multiple  biotech institutional investors and individual accredited investors, for the sale by the Company in a private placement for an aggregate of 26,682,846 shares of the Company&#x2019;s Common Stock, par value $0.01 per share of Common Stock, at purchase price of $18.74 per Share, which was the closing price of the Common Stock on October&#160;21, 2025, for aggregate gross proceeds to the Company of approximately $500,037, with immaterial offering costs. The private placement transaction was completed in October 2025.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company's Section 16 officers participated in the capital raise. The Company's Co-CEO, Executive Chairman and majority stockholder, its Co-CEO and the President and member of the Board, its COO, CFO, and member of the Board, its CAO, and certain non-executive employees and other related persons purchased an aggregate of 14,514,402 shares of Common Stock for gross proceeds of approximately $272,000. Additionally, Akeso purchased 533,617 shares of Common Stock for gross proceeds of approximately $10,000. The remaining $218,037 was raised with multiple leading biotech institutional investors. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The October 2025 Purchase Agreements contain customary representations, warranties and covenants by the Company, customary indemnification obligations of the Company, including for liabilities under the Securities Act, as amended (the &#x201c;Securities Act&#x201d;), other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the October 2025 Purchase Agreements were made only for purposes of the October 2025 Purchase Agreements and as of specific dates, were solely for the benefit of the parties to such agreements and were subject to limitations agreed upon by the contracting parties.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October&#160;21, 2025, in connection with the October 2025 Purchase Agreements, the Company entered into Registration Rights Agreements with the Investors (the &#x201c;October 2025 Registration Rights Agreements&#x201d;). The October 2025 Registration Rights Agreements provide, among other things, that the Company will as soon as reasonably practicable, and in any event by no later than December 19, 2025, file with the SEC a registration statement registering the resale of the shares. The Company filed the registration statement on October 29, 2025, which was automatically effective upon filing.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;At-the-Market Offering (ATM Offering)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 13, 2024, the Company entered into an at-the-market  (&#x201c;ATM&#x201d;) sales agreement (the &#x201c;Original Distribution Agreement&#x201d;) pursuant to which the Company may, subject to the terms and conditions set forth in the agreement offer and sell, from time to time, through or to the agents, acting as agents or principal, shares of the Company's Common Stock, par value $0.01, having an aggregate offering price of up to $90,000. On August 11, 2025, the Company entered into an amendment to the Original Distribution Agreement (as amended, the &#x201c;Distribution Agreement&#x201d;), which among other things, increased the aggregate offering price of Common Stock that the Company may offer and sell from time to time through the sales agent under the Distribution Agreement by an additional $360,000.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From the date of the Original Distribution Agreement through December 31, 2025, the Company sold 7,146,432 shares of Common Stock under the ATM at a weighted-average price of $21.09 per share, for gross proceeds of $150,721, with commissions and fees of approximately $3,160. The remaining gross proceeds available under the Distribution Agreement as of December 31, 2025 was approximately $299,279. The Company plans to use the net proceeds from this offering for working capital and general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025, the Company had no outstanding warrants. As of December 31, 2024, the Company had outstanding and exercisable warrants of 4,629,988 with a weighted average exercise price of $1.58. During the year ended December 31, 2025, 4,629,988 warrants were exercised with a weighted average exercise price of $1.58.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-6" decimals="INF" id="f-801" unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-802" unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-803"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-6"
      decimals="INF"
      id="f-804"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-805" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-6" decimals="INF" id="f-806" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-5" decimals="INF" id="f-807" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c-6" decimals="INF" id="f-808" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-809" unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-6" decimals="INF" id="f-810" unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-811"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-6"
      decimals="INF"
      id="f-812"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="c-5" decimals="INF" id="f-813" unitRef="shares">775371200</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-814" unitRef="shares">775371200</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-6" decimals="INF" id="f-815" unitRef="shares">737626004</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-6" decimals="INF" id="f-816" unitRef="shares">737626004</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-133"
      decimals="2"
      id="f-817"
      unitRef="usdPerShare">1.05</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-134" decimals="-3" id="f-818" unitRef="usd">500000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-134"
      decimals="INF"
      id="f-819"
      unitRef="shares">476190471</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-134" decimals="-3" id="f-820" unitRef="usd">619000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-133"
      decimals="2"
      id="f-821"
      unitRef="usdPerShare">1.05</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssued1 contextRef="c-135" decimals="-3" id="f-822" unitRef="usd">395314000</us-gaap:StockIssued1>
    <us-gaap:NotesPayable contextRef="c-112" decimals="-3" id="f-823" unitRef="usd">400000000</us-gaap:NotesPayable>
    <smmt:CommonStockSharesAuthorizedIncreaseDecrease
      contextRef="c-136"
      decimals="INF"
      id="f-824"
      unitRef="shares">650000000</smmt:CommonStockSharesAuthorizedIncreaseDecrease>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-137"
      decimals="INF"
      id="f-825"
      unitRef="shares">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-138"
      decimals="INF"
      id="f-826"
      unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-139"
      decimals="INF"
      id="f-827"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <smmt:SaleOfStockNumberOfSharesRegisteredForResale
      contextRef="c-140"
      decimals="INF"
      id="f-828"
      unitRef="shares">10000000</smmt:SaleOfStockNumberOfSharesRegisteredForResale>
    <smmt:SaleOfStockNumberOfSharesRegisteredForResale
      contextRef="c-141"
      decimals="INF"
      id="f-829"
      unitRef="shares">9346434</smmt:SaleOfStockNumberOfSharesRegisteredForResale>
    <smmt:SaleOfStockNumberOfSharesRegisteredForResale
      contextRef="c-142"
      decimals="INF"
      id="f-830"
      unitRef="shares">373857</smmt:SaleOfStockNumberOfSharesRegisteredForResale>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c-143" decimals="-3" id="f-831" unitRef="usd">5000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-144"
      decimals="2"
      id="f-832"
      unitRef="usdPerShare">1.68</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-145"
      decimals="INF"
      id="f-833"
      unitRef="shares">2976190</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-146"
      decimals="INF"
      id="f-834"
      unitRef="shares">22222222</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-147"
      decimals="2"
      id="f-835"
      unitRef="usdPerShare">9.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-146" decimals="-3" id="f-836" unitRef="usd">200000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-148"
      decimals="INF"
      id="f-837"
      unitRef="shares">10352418</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-149"
      decimals="2"
      id="f-838"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-149"
      decimals="2"
      id="f-839"
      unitRef="usdPerShare">22.70</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-148" decimals="-3" id="f-840" unitRef="usd">235000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-148" decimals="-3" id="f-841" unitRef="usd">140000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-150" decimals="-3" id="f-842" unitRef="usd">79000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-151" decimals="-3" id="f-843" unitRef="usd">156000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-152"
      decimals="INF"
      id="f-844"
      unitRef="shares">26682846</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-153"
      decimals="2"
      id="f-845"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-153"
      decimals="2"
      id="f-846"
      unitRef="usdPerShare">18.74</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-152" decimals="-3" id="f-847" unitRef="usd">500037000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-154"
      decimals="INF"
      id="f-848"
      unitRef="shares">14514402</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-154" decimals="-3" id="f-849" unitRef="usd">272000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-155"
      decimals="INF"
      id="f-850"
      unitRef="shares">533617</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-155" decimals="-3" id="f-851" unitRef="usd">10000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-156" decimals="-3" id="f-852" unitRef="usd">218037000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-157"
      decimals="2"
      id="f-853"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <smmt:SaleOfStockAggregateOfferingPrice contextRef="c-158" decimals="-3" id="f-854" unitRef="usd">90000000</smmt:SaleOfStockAggregateOfferingPrice>
    <smmt:SaleOfStockAggregateOfferingPrice contextRef="c-159" decimals="-3" id="f-855" unitRef="usd">360000000</smmt:SaleOfStockAggregateOfferingPrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-160"
      decimals="INF"
      id="f-856"
      unitRef="shares">7146432</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-161"
      decimals="2"
      id="f-857"
      unitRef="usdPerShare">21.09</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-160" decimals="-3" id="f-858" unitRef="usd">150721000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-160" decimals="-3" id="f-859" unitRef="usd">3160000</us-gaap:PaymentsOfStockIssuanceCosts>
    <smmt:SaleOfStockAmountRemainingUnderTheOffering contextRef="c-161" decimals="-3" id="f-860" unitRef="usd">299279000</smmt:SaleOfStockAmountRemainingUnderTheOffering>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-5" decimals="INF" id="f-861" unitRef="shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-6" decimals="INF" id="f-862" unitRef="shares">4629988</us-gaap:ClassOfWarrantOrRightOutstanding>
    <smmt:ClassOfWarrantOrRightWeightedAverageExercisePrice
      contextRef="c-6"
      decimals="2"
      id="f-863"
      unitRef="usdPerShare">1.58</smmt:ClassOfWarrantOrRightWeightedAverageExercisePrice>
    <smmt:ClassOfWarrantOrRightExercisesInPeriod contextRef="c-1" decimals="INF" id="f-864" unitRef="shares">4629988</smmt:ClassOfWarrantOrRightExercisesInPeriod>
    <smmt:ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod
      contextRef="c-1"
      decimals="2"
      id="f-865"
      unitRef="usdPerShare">1.58</smmt:ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-866">Stock-Based Compensation&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2016 Long Term Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the effectiveness of the 2020 Stock Incentive Plan (the &#x201c;2020 Plan&#x201d;), no additional grants will be made under the 2016 Long Term Incentive Plan, (the &#x201c;2016 Plan&#x201d;) and any outstanding awards continue with their original terms. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020 Stock Award Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, the Company&#x2019;s Board of Directors approved the 2020 Stock Incentive Plan, which became effective on September 21, 2020. The 2020 plan provides for the grant of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units and other stock-based awards. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A total of 8,000,000 shares of Common Stock were initially reserved for issuance under the 2020 Plan. Additionally, up to 5,000,000 shares of Common Stock, including RSUs can be added to the 2020 Plan for future issuance from options that expire, lapse or are terminated from the 2016 Plan or any other predecessor plans. The number of shares of Common Stock that may be issued under the 2020 Plan will automatically increase on each January 1, beginning in 2021 and continuing for each fiscal year until, and including, the fiscal year ending December 31, 2030, equal to the lesser of (i) 6,400,000 shares of Common Stock, (ii) 4% of the common shares outstanding on the final day of the immediately preceding calendar year and (iii) an amount as determined by the Company&#x2019;s Board of Directors.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025, there are 2,643,200 shares available to be issued under the 2020 Plan. The Company currently grants stock options to employees and directors under the 2020 Stock Incentive Plan (the &#x201c;2020 Plan&#x201d;) and formerly, the Company granted stock options under the 2016 Long Term Incentive Plan (the &#x201c;2016 Plan&#x201d;). The 2020 Plan is administered by the Compensation Committee of the Company's Board of Directors. The 2020 Plan is intended to attract and retain employees and directors and provide an incentive for these individuals to assist the Company to achieve long-range performance goals and to enable these individuals to participate in the long-term growth of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Based on the provisions of the 2020 Plan, the number of shares of common stock available for issuance under the 2020 Plan increased by 6,400,000 shares on January 1, 2025. On September 18, 2025, the Board approved an increase of 8,000,000 shares of common stock available for issuance under the 2020 Plan (the &#x201c;Incremental Pool&#x201d;), subject to the approval of the holders of a majority of the shares voting at the Company&#x2019;s stockholder meeting. As of December 31, 2025, there are 3,082,075 shares available to be issued under the Incremental Pool. The Company&#x2019;s consolidated financial statements have treated the grant date of such stock options as the date Board approval was obtained.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On May 3, 2024, the Board adopted the 2024 Inducement Pool (the &#x201c;Inducement Pool&#x201d;), which mirrors the terms of the 2020 Plan, with a total of 2,000,000 shares of Common Stock reserved for issuance under the Inducement Pool. Effective January 22, 2025, the number of shares of common stock available under the Inducement Pool increased by 2,000,000 shares. The Inducement Pool provides for the grant of non-qualified stock options and was approved by the Compensation Committee of the Board without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Inducement Pool is administered by the Compensation Committee of the Board. In accordance with Rule 5635(c)(4) of the Nasdaq Listing Rules, non-qualified stock options under the Inducement Pool may only be made to an employee who has not previously been an employee of the Company or member of the Board (or any parent or subsidiary of the Company), if he or she is granted such non-qualified stock options in connection with his or her commencement of employment with the Company or a subsidiary and such grant is an inducement material to his or her entering into employment with the Company or such subsidiary. As of December 31, 2025, there were 1,936,452 shares available for grant under the Inducement Pool.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2020 Employee Stock Purchase Plan (the &#x201c;2020 ESPP&#x201d;) was adopted by the Board of Directors and approved by the Company&#x2019;s shareholders on July 17, 2020 and approved by the predecessor company shareholders on August 19, 2020 and is qualified under Section 423 of the Internal Revenue Code. The 2020 ESPP initially authorized the issuance of up to 1,000,000 shares of Common Stock to participating employees. The number of common shares that may be issued under the 2020 ESPP automatically increases on each fiscal year commencing January 1, 2021 and continuing for each fiscal year until, and including the fiscal year commencing on, January 1, 2030 equal to the lesser of (i) 1,600,000 shares of Common Stock, (ii) 1% of the common shares outstanding on such date and (iii) an amount as determined by the Company&#x2019;s Board of Directors. As of December 31, 2025, there were 1,743,682 shares available to be issued under the 2020 ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2020 ESPP is comprised of purchase periods of six months in duration and commence immediately preceding the end of the previous offering period, unless otherwise determined by the Board of Directors or Compensation Committee. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 2020 ESPP, eligible employees can purchase shares of Common Stock through payroll deductions of up to 15% of their compensation received during the plan period or such shorter period during which deductions from payroll are made, up to a defined maximum amount. The option price is determined based on the lesser of the closing price of Common Stock on (i) the first business day of the plan period or (ii) the exercise date, or shall be based solely on the closing price of the Common Stock on the exercise date; provided that such option price shall be at least 85% of the applicable closing price. In the absence of a determination by the Board of Directors or the Compensation Committee, the option price is 85% of the lesser of the closing price of the Common Stock on (i) the first business day of the plan period or (ii) the exercise date. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The closing price is the (a) the closing price (for the primary trading session) on the Nasdaq Global Select Market or (b) the average of the closing bid and asked prices in the over-the-counter-market, whichever is applicable, as published in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Wall Street Journal&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; or another source selected by the Board or the Committee. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fiscal year ended December 31, 2025 and 2024, 139,459 and 353,578 shares, respectively, were issued under the 2020 ESPP Plan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the fair value of stock options granted to employees and directors using the Black-Scholes valuation model. Stock options granted under the 2016 and 2020 Plans generally vest over &lt;span style="-sec-ix-hidden:f-888"&gt;three&lt;/span&gt; or four years and expire after ten years. This valuation methodology utilizes several key assumptions as highlighted below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumptions used in the Company&#x2019;s valuation are summarized as follows, presented on a weighted average basis:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8% - 3.9%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5 - 6.2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.9% -142.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected annual dividends per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%"&gt;The following table summarizes the Company&#x2019;s stock option activity for the year ended December 31, 2025:&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of share options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate intrinsic value &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2024*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,136,310&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.34&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,297,732&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,015,750)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(953,564)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.99&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,464,728&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,618,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,536,687&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,527,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,834,314&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* The stock option activity in the table above includes performance-based options outstanding as of December 31, 2024 of 48,220,320 of which 39,013,976 options were unvested and converted to time-based vesting. During the three months ended March 31, 2025, the company granted 5,475,000 performance-based options which were modified to time-based vesting during the three months ended June 30, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2025, the Compensation Committee of the Board of Directors approved a modification to the Company's outstanding unvested performance-based stock option awards for certain employees and executives that will require only the service-based vesting requirements to continue to be satisfied in order to become fully vested, subject to employee consent. The Company accounted for this change as a Type III modification (improbable-to-probable) in accordance with the requirements of Accounting Standards Codification Topic 718 (ASC 718). As a result, 44,488,976 options were valued on the modification date. The Company is recognizing the newly assessed measurement date fair value of the awards as compensation expense over the remaining vesting period. During the year ended December 31, 2025, the Company recognized expense of $650,959 associated with the modification. As of December 31, 2025, the unrecognized compensation cost associated with the modification was $214,295 and is expected to be expensed over a weighted-average recognition period of approximately 1.6 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant-date fair value of stock options granted during the years ended December 31, 2025, 2024 and 2023 was $17.10, $3.40 and $1.41, per share, respectively. The aggregate intrinsic value of stock options exercised during the years ended December 31, 2025, 2024 and 2023 was $15,212, $863, and $474, respectively. The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options and the fair value of the Company&#x2019;s common stock for those stock options that had exercise prices lower than the fair value of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025, there was $345,387 total unrecognized compensation cost related to unvested stock option grants. The unvested amount is expected to be recognized over a weighted average period of approximately 1.8 years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock&#x2011;based compensation expense related to stock options is recorded within the consolidated statements of operations and comprehensive loss as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:83%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732,420&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,981&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,108&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock-based compensation expense associated with each of our stock-based compensation arrangements:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:83%"&gt;Time-based stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;731,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Performance and market-based stock options &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732,420&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,981&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,108&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-162"
      decimals="INF"
      id="f-867"
      unitRef="shares">8000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <smmt:CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration
      contextRef="c-162"
      decimals="INF"
      id="f-868"
      unitRef="shares">5000000</smmt:CommonStockAdditionalCapitalSharesAllowableForFutureIssuanceUponOptionExpiration>
    <smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan
      contextRef="c-162"
      decimals="INF"
      id="f-869"
      unitRef="shares">6400000</smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="c-163"
      decimals="INF"
      id="f-870"
      unitRef="number">0.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-164"
      decimals="INF"
      id="f-871"
      unitRef="shares">2643200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan
      contextRef="c-165"
      decimals="INF"
      id="f-872"
      unitRef="shares">6400000</smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan>
    <smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan
      contextRef="c-166"
      decimals="INF"
      id="f-873"
      unitRef="shares">8000000</smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-167"
      decimals="INF"
      id="f-874"
      unitRef="shares">3082075</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-168"
      decimals="INF"
      id="f-875"
      unitRef="shares">2000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan
      contextRef="c-169"
      decimals="INF"
      id="f-876"
      unitRef="shares">2000000</smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-170"
      decimals="INF"
      id="f-877"
      unitRef="shares">1936452</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-171"
      decimals="INF"
      id="f-878"
      unitRef="shares">1000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan
      contextRef="c-171"
      decimals="INF"
      id="f-879"
      unitRef="shares">1600000</smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialNumberOfAdditionalSharesAllowableUnderThePlan>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum contextRef="c-172" decimals="2" id="f-880" unitRef="number">0.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-173"
      decimals="INF"
      id="f-881"
      unitRef="shares">1743682</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod contextRef="c-172" id="f-882">P6M</smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate contextRef="c-171" decimals="2" id="f-883" unitRef="number">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent contextRef="c-174" decimals="2" id="f-884" unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent contextRef="c-172" decimals="2" id="f-885" unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c-175"
      decimals="INF"
      id="f-886"
      unitRef="shares">139459</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c-176"
      decimals="INF"
      id="f-887"
      unitRef="shares">353578</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-178" id="f-889">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-179" id="f-890">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-891">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumptions used in the Company&#x2019;s valuation are summarized as follows, presented on a weighted average basis:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8% - 3.9%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5 - 6.2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.9% -142.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected annual dividends per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c-179" decimals="3" id="f-892" unitRef="number">0.038</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="c-179" decimals="3" id="f-893" unitRef="number">0.039</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-180" decimals="3" id="f-894" unitRef="number">0.042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-181" decimals="3" id="f-895" unitRef="number">0.046</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-177" id="f-896">P2Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-178" id="f-897">P6Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-180" id="f-898">P6Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-181" id="f-899">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="c-177" decimals="3" id="f-900" unitRef="number">1.249</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="c-178" decimals="3" id="f-901" unitRef="number">1.425</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="c-180" decimals="3" id="f-902" unitRef="number">1.078</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="c-181" decimals="3" id="f-903" unitRef="number">0.981</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-179"
      decimals="INF"
      id="f-904"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-180"
      decimals="INF"
      id="f-905"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-181"
      decimals="INF"
      id="f-906"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-907">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%"&gt;The following table summarizes the Company&#x2019;s stock option activity for the year ended December 31, 2025:&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of share options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate intrinsic value &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2024*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,136,310&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.34&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,297,732&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,015,750)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(953,564)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.99&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,464,728&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,618,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,536,687&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,527,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,834,314&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* The stock option activity in the table above includes performance-based options outstanding as of December 31, 2024 of 48,220,320 of which 39,013,976 options were unvested and converted to time-based vesting. During the three months ended March 31, 2025, the company granted 5,475,000 performance-based options which were modified to time-based vesting during the three months ended June 30, 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-182"
      decimals="INF"
      id="f-908"
      unitRef="shares">108136310</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-182"
      decimals="2"
      id="f-909"
      unitRef="usdPerShare">2.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-183" id="f-910">P8Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-182" decimals="-3" id="f-911" unitRef="usd">1677748000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-179"
      decimals="INF"
      id="f-912"
      unitRef="shares">13297732</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-179"
      decimals="2"
      id="f-913"
      unitRef="usdPerShare">19.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-179"
      decimals="INF"
      id="f-914"
      unitRef="shares">1015750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-179"
      decimals="2"
      id="f-915"
      unitRef="usdPerShare">10.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-179"
      decimals="INF"
      id="f-916"
      unitRef="shares">953564</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-179"
      decimals="2"
      id="f-917"
      unitRef="usdPerShare">3.99</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-184"
      decimals="INF"
      id="f-918"
      unitRef="shares">119464728</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-184"
      decimals="2"
      id="f-919"
      unitRef="usdPerShare">4.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-179" id="f-920">P7Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-184" decimals="-3" id="f-921" unitRef="usd">1618734000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="c-184"
      decimals="INF"
      id="f-922"
      unitRef="shares">110536687</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c-184"
      decimals="2"
      id="f-923"
      unitRef="usdPerShare">3.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="c-179" id="f-924">P7Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="c-184" decimals="-3" id="f-925" unitRef="usd">1527454000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-184"
      decimals="INF"
      id="f-926"
      unitRef="shares">64834314</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-184"
      decimals="2"
      id="f-927"
      unitRef="usdPerShare">2.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-179" id="f-928">P7Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-184" decimals="-3" id="f-929" unitRef="usd">983902000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-185"
      decimals="INF"
      id="f-930"
      unitRef="shares">48220320</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber
      contextRef="c-185"
      decimals="INF"
      id="f-931"
      unitRef="shares">39013976</smmt:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndConvertedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-186"
      decimals="INF"
      id="f-932"
      unitRef="shares">5475000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="c-187"
      decimals="INF"
      id="f-933"
      unitRef="shares">44488976</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost contextRef="c-188" decimals="-3" id="f-934" unitRef="usd">650959000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost>
    <smmt:ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount contextRef="c-189" decimals="-3" id="f-935" unitRef="usd">214295000</smmt:ShareBasedPaymentArrangementCostNotYetRecognedDueToAcceleratedVestingAmount>
    <smmt:ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod contextRef="c-188" id="f-936">P1Y7M6D</smmt:ShareBasedPaymentArrangementWeightedAverageRecognitionPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-1"
      decimals="2"
      id="f-937"
      unitRef="usdPerShare">17.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-7"
      decimals="2"
      id="f-938"
      unitRef="usdPerShare">3.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-8"
      decimals="2"
      id="f-939"
      unitRef="usdPerShare">1.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-1" decimals="-3" id="f-940" unitRef="usd">15212000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-7" decimals="-3" id="f-941" unitRef="usd">863000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-8" decimals="-3" id="f-942" unitRef="usd">474000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-184" decimals="-3" id="f-943" unitRef="usd">345387000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-179" id="f-944">P1Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-945">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock&#x2011;based compensation expense related to stock options is recorded within the consolidated statements of operations and comprehensive loss as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:83%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732,420&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,981&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,108&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock-based compensation expense associated with each of our stock-based compensation arrangements:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:83%"&gt;Time-based stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;731,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Performance and market-based stock options &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:103%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732,420&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,981&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,108&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-190" decimals="-3" id="f-946" unitRef="usd">218564000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-191" decimals="-3" id="f-947" unitRef="usd">16007000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-192" decimals="-3" id="f-948" unitRef="usd">4408000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-193" decimals="-3" id="f-949" unitRef="usd">513856000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-194" decimals="-3" id="f-950" unitRef="usd">34974000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-195" decimals="-3" id="f-951" unitRef="usd">9700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-952" unitRef="usd">732420000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-7" decimals="-3" id="f-953" unitRef="usd">50981000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-8" decimals="-3" id="f-954" unitRef="usd">14108000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-179" decimals="-3" id="f-955" unitRef="usd">731358000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-183" decimals="-3" id="f-956" unitRef="usd">39349000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-196" decimals="-3" id="f-957" unitRef="usd">12606000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-197" decimals="-3" id="f-958" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-198" decimals="-3" id="f-959" unitRef="usd">11033000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-199" decimals="-3" id="f-960" unitRef="usd">1318000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-175" decimals="-3" id="f-961" unitRef="usd">1062000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-176" decimals="-3" id="f-962" unitRef="usd">599000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-200" decimals="-3" id="f-963" unitRef="usd">184000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-964" unitRef="usd">732420000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-7" decimals="-3" id="f-965" unitRef="usd">50981000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-8" decimals="-3" id="f-966" unitRef="usd">14108000</us-gaap:AllocatedShareBasedCompensationExpense>
    <smmt:AreaOfPremisesSubleased contextRef="c-201" decimals="0" id="f-967" unitRef="sqft">4500</smmt:AreaOfPremisesSubleased>
    <smmt:RelatedPartyTransactionSubleaseExtensionTerm contextRef="c-201" id="f-968">P39M</smmt:RelatedPartyTransactionSubleaseExtensionTerm>
    <smmt:RelatedPartyTransactionPaymentsToRelatedParty contextRef="c-202" decimals="-3" id="f-969" unitRef="usd">834000</smmt:RelatedPartyTransactionPaymentsToRelatedParty>
    <smmt:RelatedPartyTransactionPaymentsToRelatedParty contextRef="c-203" decimals="-3" id="f-970" unitRef="usd">795000</smmt:RelatedPartyTransactionPaymentsToRelatedParty>
    <smmt:RelatedPartyTransactionPaymentsToRelatedParty contextRef="c-204" decimals="-3" id="f-971" unitRef="usd">762000</smmt:RelatedPartyTransactionPaymentsToRelatedParty>
    <smmt:AreaOfPremisesSubleased contextRef="c-205" decimals="0" id="f-972" unitRef="sqft">1277</smmt:AreaOfPremisesSubleased>
    <smmt:RelatedPartyTransactionPaymentsToRelatedParty contextRef="c-206" decimals="-3" id="f-973" unitRef="usd">232000</smmt:RelatedPartyTransactionPaymentsToRelatedParty>
    <smmt:RelatedPartyTransactionPaymentsToRelatedParty contextRef="c-207" decimals="-3" id="f-974" unitRef="usd">224000</smmt:RelatedPartyTransactionPaymentsToRelatedParty>
    <smmt:RelatedPartyTransactionPaymentsToRelatedParty contextRef="c-208" decimals="-3" id="f-975" unitRef="usd">218000</smmt:RelatedPartyTransactionPaymentsToRelatedParty>
    <smmt:LessorOperatingLeaseNumberOfContracts
      contextRef="c-209"
      decimals="INF"
      id="f-976"
      unitRef="contract">2</smmt:LessorOperatingLeaseNumberOfContracts>
    <smmt:LessorOperatingLeaseNumberOfContracts
      contextRef="c-210"
      decimals="INF"
      id="f-977"
      unitRef="contract">1</smmt:LessorOperatingLeaseNumberOfContracts>
    <smmt:LessorOperatingLeaseNumberOfContracts
      contextRef="c-211"
      decimals="INF"
      id="f-978"
      unitRef="contract">1</smmt:LessorOperatingLeaseNumberOfContracts>
    <smmt:LessorOperatingLeaseAreaOfPremisesLeased contextRef="c-212" decimals="0" id="f-979" unitRef="sqft">848</smmt:LessorOperatingLeaseAreaOfPremisesLeased>
    <us-gaap:LessorOperatingLeaseTermOfContract contextRef="c-212" id="f-980">P62M</us-gaap:LessorOperatingLeaseTermOfContract>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived contextRef="c-212" decimals="-3" id="f-981" unitRef="usd">446000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <smmt:LessorOperatingLeaseAreaOfPremisesLeased contextRef="c-213" decimals="0" id="f-982" unitRef="sqft">848</smmt:LessorOperatingLeaseAreaOfPremisesLeased>
    <us-gaap:LessorOperatingLeaseTermOfContract contextRef="c-213" id="f-983">P62M</us-gaap:LessorOperatingLeaseTermOfContract>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived contextRef="c-213" decimals="-3" id="f-984" unitRef="usd">446000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <us-gaap:SubleaseIncome contextRef="c-214" decimals="-3" id="f-985" unitRef="usd">186000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome contextRef="c-215" decimals="-3" id="f-986" unitRef="usd">156000</us-gaap:SubleaseIncome>
    <smmt:AreaOfPremisesSubleased contextRef="c-216" decimals="0" id="f-987" unitRef="sqft">145</smmt:AreaOfPremisesSubleased>
    <smmt:LesseeOperatingLeaseProportionOfAmountPayablePercentage contextRef="c-217" decimals="3" id="f-988" unitRef="number">0.936</smmt:LesseeOperatingLeaseProportionOfAmountPayablePercentage>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-218" decimals="-3" id="f-989" unitRef="usd">46133000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-219" decimals="-3" id="f-990" unitRef="usd">24635000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-220" decimals="-3" id="f-991" unitRef="usd">6207000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-221" decimals="-3" id="f-992" unitRef="usd">1215000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-222" decimals="-3" id="f-993" unitRef="usd">3956000</us-gaap:AccruedLiabilitiesCurrent>
    <smmt:ClassOfWarrantOrRightExercisesInPeriod
      contextRef="c-223"
      decimals="INF"
      id="f-994"
      unitRef="shares">2936221</smmt:ClassOfWarrantOrRightExercisesInPeriod>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-224"
      decimals="INF"
      id="f-995"
      unitRef="shares">3985055</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <smmt:ClassOfWarrantOrRightExercisesInPeriod
      contextRef="c-223"
      decimals="INF"
      id="f-996"
      unitRef="shares">2936221</smmt:ClassOfWarrantOrRightExercisesInPeriod>
    <smmt:ClassOfWarrantOrRightWeightedAverageExercisePrice
      contextRef="c-225"
      decimals="2"
      id="f-997"
      unitRef="usdPerShare">1.58</smmt:ClassOfWarrantOrRightWeightedAverageExercisePrice>
    <smmt:ClassOfWarrantOrRightExercisesInPeriod
      contextRef="c-226"
      decimals="INF"
      id="f-998"
      unitRef="shares">1048834</smmt:ClassOfWarrantOrRightExercisesInPeriod>
    <smmt:ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod
      contextRef="c-226"
      decimals="2"
      id="f-999"
      unitRef="usdPerShare">1.58</smmt:ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod>
    <smmt:ClassOfWarrantOrRightExercisesInPeriod
      contextRef="c-227"
      decimals="INF"
      id="f-1000"
      unitRef="shares">315681</smmt:ClassOfWarrantOrRightExercisesInPeriod>
    <us-gaap:LegalFees contextRef="c-228" decimals="-5" id="f-1001" unitRef="usd">1400000</us-gaap:LegalFees>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-1002">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fixed asset purchase commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2025 and 2024, the Company had no capital commitments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11 for a discussion of the Company&#x2019;s lease commitments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other commitments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company enters into contracts in the normal course of business with various third parties for clinical trials, preclinical research studies and testing, manufacturing and other services and products for operating purposes. Most contracts provide for termination upon notice, and therefore are cancellable contracts. The majority of these commitments are due within one year. As of December 31, 2025, total unconditional purchase obligations, excluding leases commitments, are estimated to be approximately $17,976.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has certain commitments under its agreements with Akeso. The License Agreement also contains certain manufacturing and purchase commitments. As of December 31, 2025, the Company is unable to estimate the amount, timing or likelihood of achieving the milestones, making future product sales or assessing estimated forecasts for manufacturing and supplied materials which these contingent payment obligations relate to. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation Relating to the December 2022 Notes Entered into in Connection with the License Agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%"&gt;On March 17, 2025, Rainaldi Revocable Trust, a purported stockholder of the Company, filed a derivative lawsuit in the Delaware Court of Chancery against certain of the Company&#x2019;s current and former directors and the Company, solely as a nominal defendant, concerning the December 2022 Notes entered into by the Company, Mr. Duggan and Dr. Zanganeh in connection with the License Agreement. The suit asserts claims for breach of fiduciary duty and unjust enrichment and seeks, among other things, unspecified damages, rescission of the shares that Mr. Duggan and Dr. Zanganeh received as part of prepaid interest payments under the December 2022 Notes, as well as attorneys&#x2019; fees and costs. Defendants&#x2019; Motion to Dismiss the complaint was filed on May 16, 2025. Plaintiff filed the Motion to Certify certain constitutional questions to the Delaware Supreme Court on May 29, 2025. Defendants agreed to a stipulation staying briefing on the Motion to Certify and the Motion to Dismiss pending the Delaware Supreme Court&#x2019;s decision in another case involving substantially the same constitutional questions. On June 18, 2025, the Court granted such stipulation. Defendants believe that Plaintiff's allegations are without merit and plan to vigorously defend against its claims&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:PurchaseObligation contextRef="c-5" decimals="INF" id="f-1003" unitRef="usd">0</us-gaap:PurchaseObligation>
    <us-gaap:PurchaseObligation contextRef="c-6" decimals="INF" id="f-1004" unitRef="usd">0</us-gaap:PurchaseObligation>
    <smmt:OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid contextRef="c-5" id="f-1005">P1Y</smmt:OtherCommitmentPeriodForWhichTheMajorityOfCommitmentsAreToBePaid>
    <us-gaap:OtherCommitment contextRef="c-5" decimals="-3" id="f-1006" unitRef="usd">17976000</us-gaap:OtherCommitment>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#f-130"
          xlink:label="f-130"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-129"
          xlink:label="f-129"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-131"
          xlink:label="f-131"
          xlink:type="locator"/>
        <link:footnote id="fn-1" xlink:label="fn-1" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.92pt">Refer to Note 15 &#x2013; Related Party Transactions for expenses incurred.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-130"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-129"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-131"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-218"
          xlink:label="f-218"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-243"
          xlink:label="f-243"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-186"
          xlink:label="f-186"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-183"
          xlink:label="f-183"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-216"
          xlink:label="f-216"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-244"
          xlink:label="f-244"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-219"
          xlink:label="f-219"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-245"
          xlink:label="f-245"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-200"
          xlink:label="f-200"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-203"
          xlink:label="f-203"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-220"
          xlink:label="f-220"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-185"
          xlink:label="f-185"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-187"
          xlink:label="f-187"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-201"
          xlink:label="f-201"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-242"
          xlink:label="f-242"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-184"
          xlink:label="f-184"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-202"
          xlink:label="f-202"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-217"
          xlink:label="f-217"
          xlink:type="locator"/>
        <link:footnote id="fn-2" xlink:label="fn-2" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.92pt">Refer to Note 13 &#x2013; Stockholders&#x2019; Equity for related party transactions.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-218"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-243"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-186"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-183"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-216"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-244"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-219"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-245"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-200"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-203"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-220"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-185"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-187"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-201"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-242"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-184"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-202"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-217"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-353"
          xlink:label="f-353"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-352"
          xlink:label="f-352"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-340"
          xlink:label="f-340"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-347"
          xlink:label="f-347"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-346"
          xlink:label="f-346"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-345"
          xlink:label="f-345"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-351"
          xlink:label="f-351"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-339"
          xlink:label="f-339"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-341"
          xlink:label="f-341"
          xlink:type="locator"/>
        <link:footnote id="fn-3" xlink:label="fn-3" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',serif;font-size:8.5pt;font-weight:400;line-height:120%">Refer to Note 13 &#x2013; Stockholders&#x2019; Equity for related party transactions.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-353"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-352"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-340"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-347"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-346"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-345"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-351"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-339"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-341"
          xlink:to="fn-3"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
